id|nct_id|mesh_term|downcase_mesh_term|mesh_type
44682598|NCT05431582|Growth Substances|growth substances|mesh-ancestor
44891938|NCT04214808|Dutasteride|dutasteride|mesh-list
44892088|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44892089|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44892090|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
44892091|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892092|NCT04213833|Analgesics|analgesics|mesh-ancestor
44892093|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44892094|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892095|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892096|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892097|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892098|NCT04213781|Sufentanil|sufentanil|mesh-list
44892099|NCT04213781|Propofol|propofol|mesh-list
44892100|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44892101|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892102|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892103|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44892104|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
44892105|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
44892106|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44892107|NCT04213781|Narcotics|narcotics|mesh-ancestor
44892108|NCT04213781|Analgesics|analgesics|mesh-ancestor
44892109|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
44892110|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892111|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44892112|NCT04213885|Riboflavin|riboflavin|mesh-list
44892113|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
44892114|NCT04213885|Vitamins|vitamins|mesh-ancestor
44892115|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
44892116|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892117|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44892118|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44682775|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
44930306|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930307|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930308|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
44930309|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930310|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930311|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930312|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930313|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44930314|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930315|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
44930316|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930317|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930318|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44930319|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44892294|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
44892295|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892296|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892297|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892298|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
44892299|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44892300|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
44892461|NCT04209699|BMS-986165|bms-986165|mesh-list
44892536|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44892537|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892538|NCT04209192|Amikacin|amikacin|mesh-list
44892539|NCT04209192|Fosfomycin|fosfomycin|mesh-list
44892540|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892541|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683274|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
44930320|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930321|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930322|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
44930323|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930324|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
44930325|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44930326|NCT03757221|Daratumumab|daratumumab|mesh-list
44930327|NCT03757221|Ixazomib|ixazomib|mesh-list
44930328|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930329|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
44930330|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930331|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930332|NCT03757156|Aspirin|aspirin|mesh-list
44930333|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44930334|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44930335|NCT03757156|Analgesics|analgesics|mesh-ancestor
44930336|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
44930337|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930338|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930339|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930340|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930341|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44930342|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44930343|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930344|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44930345|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44930346|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930347|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
44930348|NCT03757143|Ethanol|ethanol|mesh-list
44930349|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
44930350|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
44930351|NCT03757143|Povidone|povidone|mesh-list
44930352|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44930353|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930354|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930355|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930356|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
44930357|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
44930358|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
44930359|NCT03757117|Hormones|hormones|mesh-list
44930360|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930361|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930362|NCT03757052|Amoxicillin|amoxicillin|mesh-list
44930363|NCT03757052|Penicillins|penicillins|mesh-list
44930364|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930365|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930366|NCT03756987|Ropivacaine|ropivacaine|mesh-list
44930367|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
44930368|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
44930369|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930370|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930371|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
44930372|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930373|NCT03756818|Paclitaxel|paclitaxel|mesh-list
44930374|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44930375|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44930376|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930377|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
44930378|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
44930379|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
44930380|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930381|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
44930382|NCT03756727|Vitamins|vitamins|mesh-ancestor
44683353|NCT04853147|Aprepitant|aprepitant|mesh-list
44683618|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44892809|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44892810|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892811|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44892812|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44892813|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892814|NCT04206618|Denosumab|denosumab|mesh-list
44892815|NCT04206618|Teriparatide|teriparatide|mesh-list
44892816|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44892817|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892818|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44892819|NCT04206631|Doxycycline|doxycycline|mesh-list
44892820|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892821|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892822|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
44892823|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44892824|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44683626|NCT04547985|Naltrexone|naltrexone|mesh-list
44930383|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
44930384|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930385|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
44930386|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930387|NCT03756727|Protective Agents|protective agents|mesh-ancestor
44930388|NCT03756623|Metformin|metformin|mesh-list
44930389|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44930390|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930391|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44930392|NCT03756324|Cefdinir|cefdinir|mesh-list
44930393|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44930394|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930395|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
44930396|NCT03756298|Capecitabine|capecitabine|mesh-list
44930397|NCT03756298|Atezolizumab|atezolizumab|mesh-list
44930398|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930399|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
44930400|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930401|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930402|NCT03756272|Bupivacaine|bupivacaine|mesh-list
44930403|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
44930404|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
44930405|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930406|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930407|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
44930408|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930409|NCT03756246|Vaccines|vaccines|mesh-list
44930410|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
44930411|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930412|NCT03756233|Remifentanil|remifentanil|mesh-list
44930413|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44930414|NCT03756233|Narcotics|narcotics|mesh-ancestor
44930415|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930416|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930417|NCT03756233|Analgesics|analgesics|mesh-ancestor
44930418|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
44930419|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930420|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
44930421|NCT03756220|Thiamine|thiamine|mesh-list
44930422|NCT03756220|Vitamins|vitamins|mesh-ancestor
44930423|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
44892975|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
44893039|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44893040|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
44893041|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44893042|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
44893043|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893044|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
44893045|NCT04204083|Protective Agents|protective agents|mesh-ancestor
44893046|NCT04204096|Vaccines|vaccines|mesh-list
44893047|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
44893048|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893049|NCT04204304|Isotretinoin|isotretinoin|mesh-list
44893050|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683917|NCT04164732|Valsartan|valsartan|mesh-list
44930424|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930425|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
44930426|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930427|NCT03756220|Protective Agents|protective agents|mesh-ancestor
44930428|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
44930429|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44706043|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706044|NCT01426334|Cyclosporine|cyclosporine|mesh-list
44706045|NCT01426334|Dasatinib|dasatinib|mesh-list
44706046|NCT01426334|Cyclosporins|cyclosporins|mesh-list
44706047|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706048|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706049|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706050|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
44706051|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726988|NCT01551147|Montelukast|montelukast|mesh-list
44930430|NCT03756116|Epinephrine|epinephrine|mesh-list
44930431|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44930432|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44930433|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44930434|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930435|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930436|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930437|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44930438|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44930439|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
44930440|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930441|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44930442|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44930443|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
44930444|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
44930445|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44930446|NCT03756090|Paclitaxel|paclitaxel|mesh-list
44930447|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
44930448|NCT03756090|Epirubicin|epirubicin|mesh-list
44930449|NCT03756090|Palbociclib|palbociclib|mesh-list
44930450|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44930451|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930452|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44930453|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
44930454|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
44930455|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930456|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930457|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
44930458|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930459|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930460|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44930461|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
44930462|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44930463|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44930464|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44893126|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
44893203|NCT04202887|Analgesics|analgesics|mesh-ancestor
44684220|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44684221|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684222|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
44684223|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684224|NCT03917381|Docetaxel|docetaxel|mesh-list
44684225|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
44684226|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684227|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684228|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893456|NCT04197752|Anesthetics|anesthetics|mesh-list
44893457|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893458|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893459|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
44893460|NCT04197219|Axitinib|axitinib|mesh-list
44893461|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44893462|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893463|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893464|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893465|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893466|NCT04197050|Valsartan|valsartan|mesh-list
44893467|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44893468|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44893469|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44893470|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44893471|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930465|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44930466|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930467|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930468|NCT03756064|Carboplatin|carboplatin|mesh-list
44930469|NCT03756064|Docetaxel|docetaxel|mesh-list
44930470|NCT03756064|Trastuzumab|trastuzumab|mesh-list
44930471|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930472|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
44930473|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
44930474|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
44930475|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930476|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930477|NCT03755947|Venetoclax|venetoclax|mesh-list
44930478|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
44930479|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930480|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930481|NCT03755778|Itraconazole|itraconazole|mesh-list
44930482|NCT03755778|Rifampin|rifampin|mesh-list
44930483|NCT03755778|Quinidine|quinidine|mesh-list
44930484|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
44930485|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930486|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44930487|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44930488|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930489|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930490|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44930491|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44930492|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930493|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930494|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44930495|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44930496|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
44930497|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930498|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
44930499|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930500|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44930501|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44930502|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44930503|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44893658|NCT04188184|Epinephrine|epinephrine|mesh-list
44893659|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
44893660|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44893661|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44893662|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893663|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
44893664|NCT04188184|Coagulants|coagulants|mesh-ancestor
44893665|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44893666|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44893667|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44893668|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893669|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893670|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44893671|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44893672|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
44893673|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893674|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44893675|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
44893676|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
44893677|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
44893678|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44893679|NCT04188171|Polidocanol|polidocanol|mesh-list
44893680|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44893681|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44893682|NCT04187755|Ceftazidime|ceftazidime|mesh-list
44893683|NCT04187755|Cefepime|cefepime|mesh-list
44893684|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893685|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893686|NCT04187807|Melatonin|melatonin|mesh-list
44893687|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
44893688|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893689|NCT04187807|Protective Agents|protective agents|mesh-ancestor
44893690|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893691|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930504|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44930505|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44930506|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44930507|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44930509|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930510|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44930511|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
44930512|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44930513|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44893772|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
44893844|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893845|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44893846|NCT04185350|Incretins|incretins|mesh-ancestor
44893847|NCT04185350|Hormones|hormones|mesh-ancestor
44893848|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893849|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
44893850|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44893851|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
44893852|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
44893853|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893854|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893855|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893856|NCT04185233|Analgesics|analgesics|mesh-ancestor
44893857|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
44893858|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930514|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44930515|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44930516|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
44930517|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44930518|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44930519|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930520|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44930521|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
44930522|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44930523|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44930524|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930525|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44930526|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
44930527|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930528|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930529|NCT03755700|Vitamin E|vitamin e|mesh-list
44930530|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
44930531|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44930532|NCT03755700|Vitamins|vitamins|mesh-ancestor
44930533|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
44930534|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930535|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
44930536|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930537|NCT03755700|Protective Agents|protective agents|mesh-ancestor
44930538|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
44930539|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930540|NCT03755700|Expectorants|expectorants|mesh-ancestor
44930541|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44930542|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44930543|NCT03755700|Antidotes|antidotes|mesh-ancestor
44930544|NCT03755609|Fentanyl|fentanyl|mesh-list
44930545|NCT03755609|Oxycodone|oxycodone|mesh-list
44930546|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44930547|NCT03755609|Narcotics|narcotics|mesh-ancestor
44930548|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930549|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930550|NCT03755609|Analgesics|analgesics|mesh-ancestor
44930551|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
44930552|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930553|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44930554|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44930555|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
44930556|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
44930557|NCT03755557|Budesonide|budesonide|mesh-list
44930558|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930559|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44930560|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
44685133|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
44894019|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894020|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
44894021|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894206|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894207|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894208|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894209|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
44894210|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44894211|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44894212|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
44894213|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894214|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
44894215|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
44894216|NCT04181489|Prednisolone|prednisolone|mesh-list
44894217|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
44894218|NCT04181489|Rituximab|rituximab|mesh-list
44894219|NCT04181489|Doxorubicin|doxorubicin|mesh-list
44894417|NCT04178291|Erythritol|erythritol|mesh-list
44894418|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44894419|NCT04178512|Dexamethasone|dexamethasone|mesh-list
44894420|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
44894421|NCT04178512|Fentanyl|fentanyl|mesh-list
44894422|NCT04178512|BB 1101|bb 1101|mesh-list
44894423|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894424|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
44894425|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
44894426|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894427|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894428|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44894429|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
44894430|NCT04178512|Hormones|hormones|mesh-ancestor
44894431|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894432|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44894433|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894434|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
44894435|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894437|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44894652|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44894653|NCT04175158|Growth Substances|growth substances|mesh-ancestor
44894654|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894655|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
44894656|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44894657|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685864|NCT00120952|Cobalt|cobalt|mesh-list
44930561|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930562|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930563|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44930564|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
44930565|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
44930566|NCT03755557|Hormones|hormones|mesh-ancestor
44930567|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930568|NCT03755531|Oxytocin|oxytocin|mesh-list
44930569|NCT03755531|Carbetocin|carbetocin|mesh-list
44930570|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
44930571|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44930572|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930573|NCT03755479|Insulin|insulin|mesh-list
44930574|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44930575|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930576|NCT03755466|Tofacitinib|tofacitinib|mesh-list
44930577|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930578|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930579|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930580|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44930581|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44930582|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
44727121|NCT01551719|Teicoplanin|teicoplanin|mesh-list
44930583|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930584|NCT03755427|Antacids|antacids|mesh-ancestor
44930595|NCT03755193|Diphosphonates|diphosphonates|mesh-list
44930596|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44930597|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930598|NCT03755115|Epirubicin|epirubicin|mesh-list
44930599|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44930600|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930601|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44930602|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44930603|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930604|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930605|NCT03755089|Lidocaine|lidocaine|mesh-list
44930606|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44930607|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
44930608|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930609|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930610|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
44930611|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930612|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44930613|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44930614|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44930615|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930616|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930617|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44930618|NCT03755037|Estradiol|estradiol|mesh-list
44930619|NCT03755037|Estrogens|estrogens|mesh-ancestor
44706053|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706054|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706055|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706056|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44706057|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706058|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44706059|NCT01426399|Metformin|metformin|mesh-list
44706060|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706061|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706062|NCT01426464|Latanoprost|latanoprost|mesh-list
44706063|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44706064|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44706065|NCT01426490|Vitamins|vitamins|mesh-list
44894658|NCT04175067|Antioxidants|antioxidants|mesh-list
44894762|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894763|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894764|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
44894765|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894766|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894767|NCT04173403|Ezetimibe|ezetimibe|mesh-list
44894768|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894769|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894770|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
44894771|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894773|NCT04173585|Bortezomib|bortezomib|mesh-list
44895085|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44895086|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44895087|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44895088|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895089|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895090|NCT04170179|Lenvatinib|lenvatinib|mesh-list
44895091|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895092|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895093|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895094|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895095|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
44895096|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44895097|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44895098|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895099|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
44895100|NCT04170088|Coagulants|coagulants|mesh-ancestor
44895101|NCT04169945|Erythritol|erythritol|mesh-list
44895102|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895103|NCT04169867|Nivolumab|nivolumab|mesh-list
44895104|NCT04169867|Ipilimumab|ipilimumab|mesh-list
44895105|NCT04169867|Atezolizumab|atezolizumab|mesh-list
44895106|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895107|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895108|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44895109|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895110|NCT04169854|Lidocaine|lidocaine|mesh-list
44895111|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895112|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
44895113|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895114|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895130|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
44895205|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
44895206|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44895207|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895278|NCT04167306|Bupropion|bupropion|mesh-list
44895459|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895460|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
44895461|NCT04165902|Protective Agents|protective agents|mesh-ancestor
44895462|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
44895463|NCT04165850|Celecoxib|celecoxib|mesh-list
44895662|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44895663|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44895664|NCT04163237|Sorafenib|sorafenib|mesh-list
44895665|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895666|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895667|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895668|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895669|NCT04162743|Trazodone|trazodone|mesh-list
44895670|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44895671|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44895672|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895673|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895877|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44895878|NCT04161027|Pregabalin|pregabalin|mesh-list
44895879|NCT04161027|Analgesics|analgesics|mesh-ancestor
44895952|NCT04160611|Midazolam|midazolam|mesh-list
44896101|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44896102|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44896103|NCT04158830|Analgesics|analgesics|mesh-ancestor
44701956|NCT01405326|Adalimumab|adalimumab|mesh-list
44896330|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
44896331|NCT04156152|Protective Agents|protective agents|mesh-ancestor
44896332|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896333|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44896334|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896335|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44896336|NCT04155814|Hematinics|hematinics|mesh-ancestor
44896337|NCT04155879|Colchicine|colchicine|mesh-list
44896338|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
44896339|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896340|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896341|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896342|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896343|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896344|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896345|NCT04155983|Ropivacaine|ropivacaine|mesh-list
44896346|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
44896347|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
44896348|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896349|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896350|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
44896351|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896352|NCT04155658|Fluorides|fluorides|mesh-list
44896353|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
44896354|NCT04155658|Protective Agents|protective agents|mesh-ancestor
44896355|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896356|NCT04155918|Allopurinol|allopurinol|mesh-list
44896357|NCT04155918|Febuxostat|febuxostat|mesh-list
44896358|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
44896359|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896360|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896361|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
44896362|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896363|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44896374|NCT04155554|Tenofovir|tenofovir|mesh-list
44687764|NCT01341743|Entecavir|entecavir|mesh-list
44896466|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
44896543|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896544|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896545|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44896546|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896547|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
44896548|NCT04153201|Antimalarials|antimalarials|mesh-list
44896549|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44896550|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44896551|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896552|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896553|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896554|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896555|NCT04153383|Milrinone|milrinone|mesh-list
44896556|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44896557|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44896558|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
44896559|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44896560|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44896561|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896562|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896563|NCT04153383|Protective Agents|protective agents|mesh-ancestor
44896564|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896565|NCT04153253|Aflibercept|aflibercept|mesh-list
44896566|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44896567|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44896568|NCT04153253|Growth Substances|growth substances|mesh-ancestor
44896569|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896570|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
44896572|NCT04153123|Epinephrine|epinephrine|mesh-list
44896588|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
44688001|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
44896855|NCT04150107|Insulin|insulin|mesh-list
44896930|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
44896931|NCT04141787|Daptomycin|daptomycin|mesh-list
44896932|NCT04141787|Cloxacillin|cloxacillin|mesh-list
44896933|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896934|NCT04141319|Ketorolac|ketorolac|mesh-list
44896935|NCT04141319|Epinephrine|epinephrine|mesh-list
44896936|NCT04141319|Ropivacaine|ropivacaine|mesh-list
44896937|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
44896938|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
44896939|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896940|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896941|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
44896942|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896943|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44896944|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44896945|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
44896946|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896947|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896948|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44896949|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44896950|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
44896951|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44896952|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896953|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
44896954|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
44896955|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44896956|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44896957|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44896958|NCT04141319|Analgesics|analgesics|mesh-ancestor
44896959|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896978|NCT04139824|Naproxen|naproxen|mesh-list
44688569|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897213|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44897214|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44897215|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688581|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
44706066|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
44706067|NCT01426490|Folic Acid|folic acid|mesh-list
44706068|NCT01426490|Pyridoxine|pyridoxine|mesh-list
44706069|NCT01426490|Pyridoxal|pyridoxal|mesh-list
44706070|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
44706071|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
44706072|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
44706073|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706074|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
44706075|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706076|NCT01426490|Protective Agents|protective agents|mesh-ancestor
44706077|NCT01426490|Hematinics|hematinics|mesh-ancestor
44706078|NCT01426542|Topiramate|topiramate|mesh-list
44706079|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
44706080|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706081|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706082|NCT01426633|Gemcitabine|gemcitabine|mesh-list
44706083|NCT01426633|Trabectedin|trabectedin|mesh-list
44706084|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44706085|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
44706086|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706087|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706088|NCT01426633|Antiviral Agents|antiviral agents|mesh-ancestor
44706089|NCT01426633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706090|NCT01426633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706091|NCT01426633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706092|NCT01426633|Immunologic Factors|immunologic factors|mesh-ancestor
44706093|NCT01426633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706094|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44706095|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
44706096|NCT01426646|Cisplatin|cisplatin|mesh-list
44706097|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706098|NCT01426737|Vildagliptin|vildagliptin|mesh-list
44706099|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706100|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706101|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44706102|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
44706103|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706104|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727275|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
44930620|NCT03755037|Hormones|hormones|mesh-ancestor
44930621|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930622|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930623|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44930624|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
44930625|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44930626|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44930627|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44930628|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44930629|NCT03754959|Midazolam|midazolam|mesh-list
44930630|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44930631|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44930632|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930633|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930634|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44930635|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44930636|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44930637|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44930638|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
44930639|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
44930640|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
44930641|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
44930642|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930643|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930644|NCT03754842|Niacinamide|niacinamide|mesh-list
44930645|NCT03754842|Niacin|niacin|mesh-list
44930646|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
44930647|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
44930648|NCT03754842|Vitamins|vitamins|mesh-ancestor
44930649|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
44897224|NCT04137653|Paclitaxel|paclitaxel|mesh-list
44897296|NCT04136886|Cisplatin|cisplatin|mesh-list
44897369|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
44897370|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897371|NCT04135833|Itraconazole|itraconazole|mesh-list
44897372|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44897373|NCT04135833|Rifampin|rifampin|mesh-list
44897374|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
44897375|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897376|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44897377|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44897378|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897379|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897380|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44688872|NCT01344720|Etoricoxib|etoricoxib|mesh-list
44689039|NCT01346254|Pioglitazone|pioglitazone|mesh-list
44897689|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897690|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897691|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897692|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897693|NCT04133259|Tenofovir|tenofovir|mesh-list
44897694|NCT04133259|Entecavir|entecavir|mesh-list
44897695|NCT04133259|Antibodies|antibodies|mesh-list
44897696|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44897697|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
44897698|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897699|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
44897700|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897701|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44897702|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44897703|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897704|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897705|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44897706|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44689129|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
44930650|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930651|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44930652|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
44930653|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930654|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44930655|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
44930656|NCT03754816|Anesthetics|anesthetics|mesh-list
44930657|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
44930658|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930659|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930660|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
44930661|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
44930662|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930663|NCT03754712|Vitamin D|vitamin d|mesh-list
44930664|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
44930665|NCT03754712|Vitamins|vitamins|mesh-ancestor
44930666|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
44930667|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930668|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44930669|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44930670|NCT03754686|Acetaminophen|acetaminophen|mesh-list
44930671|NCT03754686|Oseltamivir|oseltamivir|mesh-list
44930672|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44930673|NCT03754686|Analgesics|analgesics|mesh-ancestor
44930674|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
44930675|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930676|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930677|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
44930678|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
44930679|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930680|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930681|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930682|NCT03754647|Ascorbic Acid|ascorbic acid|mesh-list
44930683|NCT03754647|Vitamins|vitamins|mesh-ancestor
44930684|NCT03754647|Micronutrients|micronutrients|mesh-ancestor
44930685|NCT03754647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930686|NCT03754647|Antioxidants|antioxidants|mesh-ancestor
44930687|NCT03754647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930688|NCT03754647|Protective Agents|protective agents|mesh-ancestor
44897707|NCT04133051|Bupivacaine|bupivacaine|mesh-list
44897795|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
44897872|NCT04131582|Incretins|incretins|mesh-ancestor
44897946|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897947|NCT04130672|Hemostatics|hemostatics|mesh-list
44897948|NCT04130672|Coagulants|coagulants|mesh-ancestor
44930689|NCT03754634|Diacetylrhein|diacetylrhein|mesh-list
44930690|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930691|NCT03754543|Iron|iron|mesh-list
44930692|NCT03754543|Trace Elements|trace elements|mesh-ancestor
44930693|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
44930694|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930695|NCT03754387|Ceftazidime|ceftazidime|mesh-list
44930696|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930697|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930698|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
44930699|NCT03754179|Trametinib|trametinib|mesh-list
44930700|NCT03754179|Dabrafenib|dabrafenib|mesh-list
44930701|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
44930702|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44930703|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44930704|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930705|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930706|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930707|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930708|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930709|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930710|NCT03754062|Haloperidol|haloperidol|mesh-list
44930711|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
44930712|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
44930713|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
44930714|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930715|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930716|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930717|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44930718|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44930719|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930720|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44930721|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44930722|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
44930723|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930724|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930725|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44930726|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
44930727|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44930728|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
44930729|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930730|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
44930731|NCT03754010|Protective Agents|protective agents|mesh-ancestor
44930732|NCT03753867|Acitretin|acitretin|mesh-list
44930733|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
44930734|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930735|NCT03753685|Ensartinib|ensartinib|mesh-list
44930736|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930737|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930738|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930739|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930740|NCT03753581|Cytarabine|cytarabine|mesh-list
44930741|NCT03753581|Methotrexate|methotrexate|mesh-list
44930742|NCT03753581|Etoposide|etoposide|mesh-list
44930743|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930744|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
44930745|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930746|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930747|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
44930748|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930749|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930750|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
44930751|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930752|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44930753|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44930754|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44930755|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930756|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44930757|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
44930758|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44930759|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706106|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898099|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898100|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898101|NCT04119921|Ketorolac|ketorolac|mesh-list
44898102|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44898103|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
44898104|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44898105|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898106|NCT04119921|Analgesics|analgesics|mesh-ancestor
44898107|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
44898108|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898109|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898110|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898111|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898112|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44898113|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898114|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898115|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44898155|NCT04119336|Dexamethasone|dexamethasone|mesh-list
44898265|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898266|NCT04117750|Vitamins|vitamins|mesh-ancestor
44898267|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
44898268|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44898413|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898414|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
44898415|NCT05590234|Bupivacaine|bupivacaine|mesh-list
44898416|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898417|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
44898418|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898419|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898420|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
44898421|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898422|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898423|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898424|NCT05590234|Analgesics|analgesics|mesh-ancestor
44898425|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44898426|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44898427|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44898428|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44898429|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898430|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898431|NCT05556265|BMS-986165|bms-986165|mesh-list
44898432|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898433|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44898434|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898435|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898436|NCT05530356|Dextrans|dextrans|mesh-list
44898437|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
44898438|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
44898439|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
44898440|NCT05527483|Listerine|listerine|mesh-list
44898441|NCT05527483|Fluorides|fluorides|mesh-list
44898442|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
44898443|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
44898444|NCT05527483|Protective Agents|protective agents|mesh-ancestor
44898445|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898446|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44690152|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44898571|NCT05079789|Amiloride|amiloride|mesh-list
44898640|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898641|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
44898642|NCT04973605|Hormones|hormones|mesh-ancestor
44898643|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898644|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898645|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898646|NCT04969887|Nivolumab|nivolumab|mesh-list
44898647|NCT04969887|Ipilimumab|ipilimumab|mesh-list
44898648|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898649|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898650|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898651|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898652|NCT04961190|Paroxetine|paroxetine|mesh-list
44898653|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44898654|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44898655|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44898656|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898657|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898694|NCT04793711|Decanoic acid|decanoic acid|mesh-list
44898829|NCT04276857|Leucovorin|leucovorin|mesh-list
44898830|NCT04276857|Gemcitabine|gemcitabine|mesh-list
44898831|NCT04276857|Paclitaxel|paclitaxel|mesh-list
44898832|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
44898833|NCT04276857|Irinotecan|irinotecan|mesh-list
44898834|NCT04276857|Folfirinox|folfirinox|mesh-list
44898835|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44898836|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898837|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44898838|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
44898839|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44898840|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898841|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44898842|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
44898843|NCT04276857|Antiviral Agents|antiviral agents|mesh-ancestor
44898844|NCT04276857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898845|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898846|NCT04276857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898847|NCT04276857|Immunologic Factors|immunologic factors|mesh-ancestor
44898848|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898849|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44898850|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44898851|NCT04276857|Antidotes|antidotes|mesh-ancestor
44898852|NCT04276857|Protective Agents|protective agents|mesh-ancestor
44898853|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
44898854|NCT04276857|Vitamins|vitamins|mesh-ancestor
44898855|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
44706107|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706108|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44706109|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
44706110|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706111|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706112|NCT01426815|Golimumab|golimumab|mesh-list
44706113|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44706114|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706115|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706116|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
44706117|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706118|NCT01426880|Paclitaxel|paclitaxel|mesh-list
44706119|NCT01426880|Carboplatin|carboplatin|mesh-list
44930760|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44930792|NCT03752931|Celiprolol|celiprolol|mesh-list
44930793|NCT03752931|Diltiazem|diltiazem|mesh-list
44930794|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44930795|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44930796|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930797|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930798|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44930799|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930800|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44930801|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44930802|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
44702331|NCT01407887|Artesunate|artesunate|mesh-list
44899101|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
44899102|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899103|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899104|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44899332|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
44691101|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
44899428|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44899498|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899499|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44899500|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44899501|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
44899502|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44899503|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44899504|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
44899505|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
44899506|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
44899507|NCT02386826|Bevacizumab|bevacizumab|mesh-list
44899508|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899509|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899510|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44899511|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44899512|NCT02386826|Growth Substances|growth substances|mesh-ancestor
44899513|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899514|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44899515|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44899516|NCT02324608|Cetuximab|cetuximab|mesh-list
44899517|NCT02324608|Antibodies|antibodies|mesh-list
44899518|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
44899519|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44899520|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
44899521|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899522|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899523|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
44899524|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44899525|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
44899526|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
44899527|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
44899528|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899529|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899530|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44899531|NCT02281084|Azacitidine|azacitidine|mesh-list
44899626|NCT04115800|Sirolimus|sirolimus|mesh-list
44691421|NCT01360788|Albuterol|albuterol|mesh-list
44899809|NCT04113772|Nitisinone|nitisinone|mesh-list
44899884|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
44899885|NCT04114097|Hormones|hormones|mesh-ancestor
44899886|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899887|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44899888|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44899898|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
44900014|NCT04111328|Dsuvia|dsuvia|mesh-list
44900015|NCT04111328|Hydromorphone|hydromorphone|mesh-list
44900016|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44900017|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900018|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900279|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44900280|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
44900281|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44900282|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900283|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44900284|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
44900285|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900286|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900287|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
44900288|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900289|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44900290|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44900291|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
44900292|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900293|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44900294|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44900295|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900296|NCT04108637|Penicillins|penicillins|mesh-list
44900297|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900298|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692043|NCT01365000|Naloxegol|naloxegol|mesh-list
44930803|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
44930804|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930805|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44930806|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44930807|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44930808|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44930809|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930810|NCT03752749|Prednisolone|prednisolone|mesh-list
44930811|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930812|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
44930813|NCT03752749|Hormones|hormones|mesh-ancestor
44930814|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930815|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930816|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44930817|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930818|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
44930819|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44930820|NCT03752736|Protective Agents|protective agents|mesh-ancestor
44930821|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930822|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930823|NCT03752658|Tenofovir|tenofovir|mesh-list
44930824|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
44930825|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930826|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44930827|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930828|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930829|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930830|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44930831|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44930832|NCT03752476|Lactams|lactams|mesh-list
44930833|NCT03752476|beta-Lactams|beta-lactams|mesh-list
44930834|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900299|NCT04108013|Paclitaxel|paclitaxel|mesh-list
44900473|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
44900474|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
44900475|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
44900476|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44900477|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900478|NCT04106011|Gabapentin|gabapentin|mesh-list
44900479|NCT04106011|Analgesics|analgesics|mesh-ancestor
44900480|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
44900481|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900482|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900483|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
44900484|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44900485|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44900486|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900487|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44900488|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44900489|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44900490|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900491|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900492|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
44900493|NCT04106050|Lidocaine|lidocaine|mesh-list
44900494|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900495|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
44900496|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900497|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900498|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
44900499|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900500|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44900501|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44900502|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44900503|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44900504|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900505|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44930835|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930836|NCT03752437|Heparin|heparin|mesh-list
44930837|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
44930838|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44930839|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44930840|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930841|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
44930842|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44900659|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44692486|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44692487|NCT01368003|Dutasteride|dutasteride|mesh-list
44692488|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44692489|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44692490|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692491|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692492|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
44692493|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692494|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692495|NCT01368016|Nicotine|nicotine|mesh-list
44692496|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44930843|NCT03752398|Ipilimumab|ipilimumab|mesh-list
44930844|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930845|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930846|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44930847|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930848|NCT03752294|Dabigatran|dabigatran|mesh-list
44930849|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
44930850|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44930851|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44930852|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930853|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930854|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
44930855|NCT03752229|Diazepam|diazepam|mesh-list
44930856|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44930857|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
44930858|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
44930859|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
44930860|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930861|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930862|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930863|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44930864|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930865|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44930866|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44930867|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44930868|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44930869|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44930870|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44930871|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
44930872|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
44930873|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
44930874|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
44930875|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930876|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930877|NCT03752190|Cosyntropin|cosyntropin|mesh-list
44930878|NCT03752190|Hormones|hormones|mesh-ancestor
44930879|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930880|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930881|NCT03752138|Decitabine|decitabine|mesh-list
44930882|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930883|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
44930884|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930885|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930886|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930887|NCT03752125|Caffeine|caffeine|mesh-list
44930888|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44930889|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930890|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44930891|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900885|NCT04101760|Lenograstim|lenograstim|mesh-list
44900886|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44900887|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
44900888|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900889|NCT04101370|Bosentan|bosentan|mesh-list
44900890|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44900891|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44900892|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900893|NCT04101136|Atorvastatin|atorvastatin|mesh-list
44900894|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44900895|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44900896|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
44900897|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900898|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44900899|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44900900|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900901|NCT04101019|Lidocaine|lidocaine|mesh-list
44900902|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900903|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
44900904|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900905|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900906|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
44900907|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900908|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44900909|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44900910|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44900911|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44900912|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900913|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
44900914|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44900915|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44900916|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44900917|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900918|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900919|NCT04100759|Urological Agents|urological agents|mesh-ancestor
44930892|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900947|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
44901099|NCT04097847|Protective Agents|protective agents|mesh-ancestor
44901100|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901101|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
44901102|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44901103|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
44901104|NCT04097847|Vitamins|vitamins|mesh-ancestor
44901105|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
44901106|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44693018|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
44930893|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44930894|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44930895|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
44930896|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930897|NCT03752112|Penicillins|penicillins|mesh-list
44930898|NCT03752112|Cefixime|cefixime|mesh-list
44930899|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44930900|NCT03752112|Penicillin G|penicillin g|mesh-list
44930901|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
44930902|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930903|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930904|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
44930905|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930906|NCT03751514|Azithromycin|azithromycin|mesh-list
44930907|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930908|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930909|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44930910|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44930911|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44930912|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930913|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930914|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44930915|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44930916|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44930917|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
44930918|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930919|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930920|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44930921|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44930922|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
44930923|NCT03751358|Anesthetics|anesthetics|mesh-list
44930924|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
44930925|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930926|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930927|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
44930928|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930929|NCT03751332|Tacrolimus|tacrolimus|mesh-list
44930930|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930931|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
44930932|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930933|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44930934|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930935|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930936|NCT03751228|BMS-986165|bms-986165|mesh-list
44930937|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930938|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930939|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930940|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930941|NCT03751202|Fluticasone|fluticasone|mesh-list
44930942|NCT03751202|Xhance|xhance|mesh-list
44930953|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44930954|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44930955|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44930956|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44930957|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
44930958|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930959|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930960|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
44693092|NCT01372306|Galantamine|galantamine|mesh-list
44901126|NCT04097574|Menthol|menthol|mesh-list
44901197|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44901272|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901273|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901274|NCT04095455|Ketamine|ketamine|mesh-list
44901275|NCT04095455|Analgesics|analgesics|mesh-ancestor
44901276|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
44901277|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901278|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901279|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44901280|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44901281|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
44901282|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
44901283|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901284|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44901285|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44901286|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901287|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901288|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44901289|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
44901290|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44901291|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44901292|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901293|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901294|NCT04095299|Capecitabine|capecitabine|mesh-list
44901295|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901296|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
44901297|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901298|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930962|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930963|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
44930964|NCT03751176|Leucovorin|leucovorin|mesh-list
44930965|NCT03751176|Folic Acid|folic acid|mesh-list
44930966|NCT03751176|Fluorouracil|fluorouracil|mesh-list
44930967|NCT03751176|Irinotecan|irinotecan|mesh-list
44930968|NCT03751176|Panitumumab|panitumumab|mesh-list
44930969|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
44930970|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
44930971|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930972|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930973|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930974|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930975|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
44930976|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930977|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44930978|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44901399|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901400|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44901402|NCT04094142|Growth Substances|growth substances|mesh-ancestor
44901545|NCT04091815|Anesthetics|anesthetics|mesh-list
44901618|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44901619|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44901620|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901621|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930979|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930980|NCT03751176|Antidotes|antidotes|mesh-ancestor
44930981|NCT03751176|Protective Agents|protective agents|mesh-ancestor
44930982|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
44930983|NCT03751176|Vitamins|vitamins|mesh-ancestor
44930984|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
44930985|NCT03751176|Hematinics|hematinics|mesh-ancestor
44930986|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930987|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
44930988|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
44930989|NCT03751163|Hydroquinone|hydroquinone|mesh-list
44930990|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44930991|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44930992|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930993|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
44930994|NCT03751163|Coagulants|coagulants|mesh-ancestor
44930995|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44930996|NCT03751163|Protective Agents|protective agents|mesh-ancestor
44930997|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930998|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930999|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
44706120|NCT01426880|Lapatinib|lapatinib|mesh-list
44706121|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44706122|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706123|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
44706124|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
44706125|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
44706126|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706127|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44706128|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931000|NCT03751111|Naloxone|naloxone|mesh-list
44931001|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44931002|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931003|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
44931004|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931005|NCT03751059|Dexamethasone|dexamethasone|mesh-list
44931006|NCT03751059|Bromfenac|bromfenac|mesh-list
44931007|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931008|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
44931009|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
44931010|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931011|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931012|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931013|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
44931014|NCT03751059|Hormones|hormones|mesh-ancestor
44931015|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931016|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931017|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931018|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931019|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931020|NCT03751059|Analgesics|analgesics|mesh-ancestor
44931021|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
44931022|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931023|NCT03750916|Docetaxel|docetaxel|mesh-list
44931024|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931025|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
44931026|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931027|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
44931028|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931029|NCT03750773|Gabapentin|gabapentin|mesh-list
44931030|NCT03750773|Analgesics|analgesics|mesh-ancestor
44931031|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
44931032|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931033|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931034|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
44931035|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931036|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44901622|NCT04090047|Itraconazole|itraconazole|mesh-list
44901755|NCT04088461|Linagliptin|linagliptin|mesh-list
44901830|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901831|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901832|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44901833|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901834|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901835|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44901836|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44901837|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901838|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901839|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44901840|NCT04087746|Ranibizumab|ranibizumab|mesh-list
44901841|NCT04087746|Aflibercept|aflibercept|mesh-list
44901842|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44901843|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44901844|NCT04087746|Growth Substances|growth substances|mesh-ancestor
44901845|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901846|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
44901847|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901848|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
44901849|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44901850|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
44901851|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901852|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
44901853|NCT04088006|Protective Agents|protective agents|mesh-ancestor
44901854|NCT04087967|Cytarabine|cytarabine|mesh-list
44901855|NCT04087967|Decitabine|decitabine|mesh-list
44901856|NCT04087967|Idarubicin|idarubicin|mesh-list
44901857|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901858|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
44901859|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901860|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901861|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
44901862|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901863|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901864|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
44901870|NCT04087668|Anesthetics|anesthetics|mesh-list
44901951|NCT04085913|Lidocaine|lidocaine|mesh-list
44902063|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902064|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44902065|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44902066|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
44902067|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902068|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902069|NCT04085354|Vitamins|vitamins|mesh-list
44902070|NCT04085354|Folic Acid|folic acid|mesh-list
44902071|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
44902072|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
44902073|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
44902074|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902075|NCT04085354|Hematinics|hematinics|mesh-ancestor
44902076|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
44931037|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931038|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931039|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44931040|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44931041|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931042|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931043|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
44931044|NCT03750760|Atorvastatin|atorvastatin|mesh-list
44931045|NCT03750760|Ezetimibe|ezetimibe|mesh-list
44931046|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44931047|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44931048|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
44931049|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931050|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44931051|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44931052|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931053|NCT03750721|Rifampin|rifampin|mesh-list
44931054|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44931055|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
44931056|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44931057|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931058|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
44931059|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44931060|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931061|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931062|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44931063|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44931064|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44931065|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44931066|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44931067|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44931068|NCT03750669|Folic Acid|folic acid|mesh-list
44931069|NCT03750669|Gemcitabine|gemcitabine|mesh-list
44931070|NCT03750669|Paclitaxel|paclitaxel|mesh-list
44931071|NCT03750669|Fluorouracil|fluorouracil|mesh-list
44931072|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
44727728|NCT01556672|Adalimumab|adalimumab|mesh-list
44931073|NCT03750669|Irinotecan|irinotecan|mesh-list
44931074|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44931075|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931076|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44931077|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931078|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44931079|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931080|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44931082|NCT03750669|Antiviral Agents|antiviral agents|mesh-ancestor
44931083|NCT03750669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931084|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902077|NCT04085120|Dexamethasone|dexamethasone|mesh-list
44902259|NCT04082962|Hormones|hormones|mesh-ancestor
44902333|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902334|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44902335|NCT04082559|Metronidazole|metronidazole|mesh-list
44902336|NCT04082559|Doxycycline|doxycycline|mesh-list
44902337|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
44902338|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44902339|NCT04082559|Complement Factor H|complement factor h|mesh-list
44902340|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902341|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
44902342|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44902343|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44902344|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
44902345|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44902346|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44902347|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902348|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902349|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902350|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44902351|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44902352|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44902353|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902354|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
44902355|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902356|NCT04082286|Antibodies|antibodies|mesh-list
44902357|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44902358|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
44902359|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694531|NCT01380457|Dronabinol|dronabinol|mesh-list
44931085|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931086|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
44931087|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931088|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44931089|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44931090|NCT03750669|Hematinics|hematinics|mesh-ancestor
44931091|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
44931092|NCT03750669|Vitamins|vitamins|mesh-ancestor
44931093|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
44931094|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
44931095|NCT03750656|Tamsulosin|tamsulosin|mesh-list
44931096|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44931097|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44931098|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44931099|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
44931100|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931101|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931102|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931103|NCT03750656|Urological Agents|urological agents|mesh-ancestor
44931104|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902394|NCT04081376|Hydromorphone|hydromorphone|mesh-list
44902470|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902471|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
44902472|NCT04080323|Dinoprostone|dinoprostone|mesh-list
44902473|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
44902474|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902475|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902476|NCT04080336|Misoprostol|misoprostol|mesh-list
44902477|NCT04080336|Dinoprostone|dinoprostone|mesh-list
44902478|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44902479|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
44902480|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902481|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902482|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44902483|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902484|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
44902485|NCT04080310|Ezetimibe|ezetimibe|mesh-list
44902486|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44902487|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44902488|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44902489|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
44902490|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902491|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44902492|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902493|NCT04079933|Nicotine|nicotine|mesh-list
44902494|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44902495|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
44902496|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902497|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902498|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44902499|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44902500|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
44902501|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902502|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931105|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44931106|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44931107|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
44931108|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931109|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44931110|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
44931111|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
44931112|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
44931113|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44931114|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44902578|NCT04078659|Lidocaine|lidocaine|mesh-list
44902725|NCT04077983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902726|NCT04077983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902727|NCT04077983|Immunologic Factors|immunologic factors|mesh-ancestor
44902728|NCT04077983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902729|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
44902730|NCT04077905|Doxorubicin|doxorubicin|mesh-list
44902731|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44902732|NCT04077905|Etoposide|etoposide|mesh-list
44902733|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44902734|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902735|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44902736|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44902737|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902738|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902739|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44902740|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902741|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
44902742|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
44902743|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902744|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902745|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902746|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
44902747|NCT04077905|Hormones|hormones|mesh-ancestor
44902748|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902749|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44902750|NCT04077905|Protective Agents|protective agents|mesh-ancestor
44902751|NCT04077736|Aldesleukin|aldesleukin|mesh-list
44902752|NCT04077736|Interleukin-2|interleukin-2|mesh-list
44902753|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902849|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902924|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44902925|NCT04075721|Dexamethasone|dexamethasone|mesh-list
44902926|NCT04075721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902927|NCT04075721|Antiemetics|antiemetics|mesh-ancestor
44902928|NCT04075721|Autonomic Agents|autonomic agents|mesh-ancestor
44902929|NCT04075721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902930|NCT04075721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902931|NCT04075721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902932|NCT04075721|Glucocorticoids|glucocorticoids|mesh-ancestor
44902933|NCT04075721|Hormones|hormones|mesh-ancestor
44902934|NCT04075721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902935|NCT04075721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902936|NCT04075721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902937|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44902938|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44902939|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44902940|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902941|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902942|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902943|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44902944|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44902945|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44902946|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902947|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902948|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44902949|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902950|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902951|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
44902952|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903087|NCT04073719|Acetic Acid|acetic acid|mesh-list
44903161|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44903162|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
44903163|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903164|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903165|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44903166|NCT04072640|Amebicides|amebicides|mesh-ancestor
44903167|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44903168|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44903169|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903170|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44903171|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903172|NCT04072900|Imiquimod|imiquimod|mesh-list
44903173|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44903174|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
44903175|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903176|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903177|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
44903178|NCT04072497|Vaccines|vaccines|mesh-list
44903179|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
44903180|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903181|NCT04072263|Interferons|interferons|mesh-list
44903182|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
44903183|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
44903184|NCT04072263|Paclitaxel|paclitaxel|mesh-list
44903185|NCT04072263|Carboplatin|carboplatin|mesh-list
44903186|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903187|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903188|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903189|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903190|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903191|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903192|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
44903193|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903194|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
44903195|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903196|NCT04072471|Lesinurad|lesinurad|mesh-list
44903197|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
44903200|NCT04072471|Renal Agents|renal agents|mesh-ancestor
44695734|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44903369|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44903370|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44903371|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44903372|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44903373|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44903374|NCT04070469|Amoxicillin|amoxicillin|mesh-list
44903375|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903376|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903377|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
44903378|NCT04070391|Pyridoxal|pyridoxal|mesh-list
44903379|NCT04070391|Pyridoxine|pyridoxine|mesh-list
44903380|NCT04070391|Vitamins|vitamins|mesh-ancestor
44903381|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
44903382|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903383|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
44903384|NCT04070482|Tenofovir|tenofovir|mesh-list
44903385|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
44903386|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903387|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44903388|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44903389|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903390|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903391|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44903392|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44903393|NCT04070079|Tenofovir|tenofovir|mesh-list
44903419|NCT04069845|Doxorubicin|doxorubicin|mesh-list
44903569|NCT04067856|Dexamethasone|dexamethasone|mesh-list
44903570|NCT04067856|Bevacizumab|bevacizumab|mesh-list
44903571|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903572|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903573|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903574|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903575|NCT04067856|Growth Substances|growth substances|mesh-ancestor
44903576|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903577|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903578|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903579|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
44903580|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
44903581|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903582|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903583|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
44903584|NCT04067856|Hormones|hormones|mesh-ancestor
44903585|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903586|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903587|NCT04067531|Clindamycin|clindamycin|mesh-list
44903588|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
44903589|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
44903590|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903591|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903592|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44903593|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903594|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903595|NCT04067505|Nadroparin|nadroparin|mesh-list
44903596|NCT04067505|Warfarin|warfarin|mesh-list
44903597|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
44903598|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
44903599|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44903600|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
44903601|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44903602|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
44903603|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903604|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903605|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44903606|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44931115|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
44903662|NCT04066881|Vaccines|vaccines|mesh-list
44903810|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
44903811|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44903812|NCT04065035|Protective Agents|protective agents|mesh-ancestor
44903813|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903814|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44903815|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
44903816|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44903817|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44903818|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
44903819|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903820|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903821|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903822|NCT04064619|Urological Agents|urological agents|mesh-ancestor
44903823|NCT04064632|Darunavir|darunavir|mesh-list
44903824|NCT04064632|Cobicistat|cobicistat|mesh-list
44903825|NCT04064632|Rilpivirine|rilpivirine|mesh-list
44903826|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44903827|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44903828|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44903829|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
44903830|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903831|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903832|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44903833|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44903834|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
44903835|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903836|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44903837|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44903838|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44903839|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44696247|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931116|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
44931117|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44931118|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931119|NCT03750383|Cyclosporine|cyclosporine|mesh-list
44931120|NCT03750383|Prednisone|prednisone|mesh-list
44931121|NCT03750383|Cyclosporins|cyclosporins|mesh-list
44931122|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931123|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
44931124|NCT03750383|Hormones|hormones|mesh-ancestor
44931125|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931126|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931127|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903840|NCT04064190|Durvalumab|durvalumab|mesh-list
44903930|NCT04063189|Clarithromycin|clarithromycin|mesh-list
44904004|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904005|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904006|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904007|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904008|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904009|NCT04061824|Olmesartan|olmesartan|mesh-list
44904010|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
44904011|NCT04061824|Giapreza|giapreza|mesh-list
44904012|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44904013|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
44904014|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44904015|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44904016|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44904017|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
44904018|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904019|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44904020|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44904021|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904022|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44904023|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44904024|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44904025|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44904026|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904027|NCT04061772|Prednisone|prednisone|mesh-list
44904028|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
44904029|NCT04061772|Etoposide|etoposide|mesh-list
44904030|NCT04061772|Bortezomib|bortezomib|mesh-list
44904031|NCT04061772|Epirubicin|epirubicin|mesh-list
44904187|NCT04060914|Clopidogrel|clopidogrel|mesh-list
44904257|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904258|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904259|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44904260|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904261|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904262|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904268|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
44904615|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44904616|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904617|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904618|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904619|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
44904620|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
44931128|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931129|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931130|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931131|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931132|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
44931133|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
44931134|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931135|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
44931136|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931137|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44931138|NCT03749915|Tetracaine|tetracaine|mesh-list
44931139|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931140|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
44931141|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931142|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931143|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
44931144|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931145|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
44931146|NCT03749850|Doxorubicin|doxorubicin|mesh-list
44931147|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44931148|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931149|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
44931150|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931151|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931152|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44931153|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
44931154|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931155|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931156|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44931157|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44931158|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44931159|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44931160|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931161|NCT03749733|Megestrol|megestrol|mesh-list
44931162|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44931163|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44931164|NCT03749733|Estradiol|estradiol|mesh-list
44931165|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44931166|NCT03749733|Estrogens|estrogens|mesh-ancestor
44931167|NCT03749733|Hormones|hormones|mesh-ancestor
44931168|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931169|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931170|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44931171|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
44931172|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931173|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44931174|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44931175|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44931176|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44931177|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931178|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931179|NCT03749642|Gabapentin|gabapentin|mesh-list
44931180|NCT03749642|Trazodone|trazodone|mesh-list
44931181|NCT03749642|Analgesics|analgesics|mesh-ancestor
44931182|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
44931183|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931184|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931185|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
44931186|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931187|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44931188|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931189|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931190|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44904621|NCT04048577|Natalizumab|natalizumab|mesh-list
44904666|NCT04048226|Ketamine|ketamine|mesh-list
44904741|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
44904811|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44904886|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904887|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
44904888|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44904889|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904890|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904891|NCT04046016|Paclitaxel|paclitaxel|mesh-list
44904892|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904893|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904894|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904895|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904896|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904897|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904898|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
44904899|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
44904900|NCT04046289|Calcium|calcium|mesh-list
44904901|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44904902|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904903|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44904904|NCT04046289|Antacids|antacids|mesh-ancestor
44904905|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904906|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697472|NCT05268718|Voriconazole|voriconazole|mesh-list
44931191|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44931192|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931193|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931194|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
44931195|NCT03749642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44931196|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44931197|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931198|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
44931199|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44931200|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
44931201|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
44931202|NCT03749590|Analgesics|analgesics|mesh-ancestor
44931203|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
44931204|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931205|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931206|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
44931207|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931208|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44931209|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
44931210|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44931211|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931212|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931213|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931214|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
44931215|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931216|NCT03749408|Mannitol|mannitol|mesh-list
44931217|NCT03749408|Bupivacaine|bupivacaine|mesh-list
44931218|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931219|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
44904953|NCT04045730|Immunologic Factors|immunologic factors|mesh-ancestor
44905027|NCT04044430|Nivolumab|nivolumab|mesh-list
44905099|NCT04043702|Topiramate|topiramate|mesh-list
44905158|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
44905233|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905234|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905235|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
44905236|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
44905237|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905238|NCT04041167|Protective Agents|protective agents|mesh-ancestor
44905239|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905240|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
44905241|NCT04041167|Vitamins|vitamins|mesh-ancestor
44905242|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
44905243|NCT04041128|Olaparib|olaparib|mesh-list
44905244|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44905245|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905246|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905247|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931220|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931221|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931222|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
44931223|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931224|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44706133|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44706134|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706135|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
44706136|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44706137|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706138|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706139|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44706140|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44706141|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44931255|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
44931256|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931257|NCT03748446|Xenon|xenon|mesh-list
44931258|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44931259|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
44931260|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
44931261|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931262|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931263|NCT03748303|Pregnanolone|pregnanolone|mesh-list
44931264|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
44931265|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931266|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931267|NCT03748290|Pregabalin|pregabalin|mesh-list
44931268|NCT03748290|Analgesics|analgesics|mesh-ancestor
44931269|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
44931270|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931271|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931272|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
44931273|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44931274|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931275|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931276|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931277|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931278|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44931279|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931280|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931281|NCT03748173|Calfactant|calfactant|mesh-list
44931282|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44931283|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
44931284|NCT03748147|Misoprostol|misoprostol|mesh-list
44905412|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
44905413|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931285|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44931286|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
44931287|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931288|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931289|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44931290|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931291|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
44931292|NCT03748108|Lidocaine|lidocaine|mesh-list
44931293|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931294|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
44931295|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931296|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931297|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
44931298|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931299|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44931300|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44931301|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44931302|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931303|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931304|NCT03748043|Lactoferrin|lactoferrin|mesh-list
44931305|NCT03748043|Teferrol|teferrol|mesh-list
44931306|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931307|NCT03748043|Hematinics|hematinics|mesh-ancestor
44931308|NCT03747978|Amlodipine|amlodipine|mesh-list
44931309|NCT03747978|Perindopril|perindopril|mesh-list
44931310|NCT03747978|Indapamide|indapamide|mesh-list
44931311|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
44931312|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44931313|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44931314|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931315|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931316|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931317|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931318|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44931319|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44931320|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44931321|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931322|NCT03747978|Diuretics|diuretics|mesh-ancestor
44931323|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
44931324|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44931325|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
44931326|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44931327|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44931328|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44931329|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931330|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931331|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44931332|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931333|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931334|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44931335|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931336|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44931337|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44931338|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931339|NCT03747679|Mannitol|mannitol|mesh-list
44931340|NCT03747679|Sorbitol|sorbitol|mesh-list
44931341|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44931342|NCT03747679|Diuretics|diuretics|mesh-ancestor
44931343|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
44931344|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931345|NCT03747679|Cathartics|cathartics|mesh-ancestor
44931346|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931347|NCT03747614|Fluorometholone|fluorometholone|mesh-list
44931348|NCT03747614|Tacrolimus|tacrolimus|mesh-list
44931349|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931350|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
44931351|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931352|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44931353|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931354|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905527|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905528|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905529|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44905530|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905531|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905532|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
44905533|NCT04036721|Prednisone|prednisone|mesh-list
44905534|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905535|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
44905536|NCT04036721|Hormones|hormones|mesh-ancestor
44905537|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905538|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905539|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44905540|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905541|NCT04036890|Minocycline|minocycline|mesh-list
44905542|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905543|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905544|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
44905545|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44905546|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44905547|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44905548|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905549|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905550|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
44905616|NCT04035889|Melatonin|melatonin|mesh-list
44905691|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44905692|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905693|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905694|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
44905695|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44905696|NCT04034771|Propofol|propofol|mesh-list
44905697|NCT04034771|Melatonin|melatonin|mesh-list
44905698|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905699|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905700|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905701|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905702|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
44905703|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
44905704|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
44905705|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905706|NCT04034771|Protective Agents|protective agents|mesh-ancestor
44905707|NCT04034836|Parecoxib|parecoxib|mesh-list
44905708|NCT04034836|Ropivacaine|ropivacaine|mesh-list
44905709|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905710|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
44905711|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905712|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905713|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
44905714|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905729|NCT04034524|Insulin|insulin|mesh-list
44905900|NCT04032834|Hormones|hormones|mesh-ancestor
44905975|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905976|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
44905977|NCT04031872|Capecitabine|capecitabine|mesh-list
44905978|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44905979|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
44905980|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905981|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905982|NCT04031755|Minocycline|minocycline|mesh-list
44905983|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905984|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905985|NCT04031703|Paclitaxel|paclitaxel|mesh-list
44905986|NCT04031703|Docetaxel|docetaxel|mesh-list
44905987|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
44905988|NCT04031703|Carboplatin|carboplatin|mesh-list
44905989|NCT04031703|Fluorouracil|fluorouracil|mesh-list
44905990|NCT04031703|Epirubicin|epirubicin|mesh-list
44905991|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44905992|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905993|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44905994|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44905995|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44905997|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44906146|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
44906147|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906148|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906149|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906150|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906151|NCT04027829|Analgesics|analgesics|mesh-ancestor
44906152|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
44906153|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906154|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906155|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44906156|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906157|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906158|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906159|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906160|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
44906161|NCT04027517|Hematinics|hematinics|mesh-ancestor
44906162|NCT04025840|Dexamethasone|dexamethasone|mesh-list
44906163|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
44906164|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906165|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
44906166|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
44906167|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906168|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906169|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906307|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
44906372|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
44906373|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906374|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906375|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44906376|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906377|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906378|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906379|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906380|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44906381|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44906382|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44906383|NCT04018313|Omalizumab|omalizumab|mesh-list
44906384|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44906385|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44906386|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44906387|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
44906388|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
44906389|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906390|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
44906391|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44906392|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
44906393|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
44906394|NCT04018274|Estradiol|estradiol|mesh-list
44906395|NCT04018274|Estrogens|estrogens|mesh-ancestor
44906396|NCT04018274|Hormones|hormones|mesh-ancestor
44906397|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906398|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906399|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44906400|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44906401|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44906402|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44906403|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44931355|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931356|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
44931357|NCT03747614|Hormones|hormones|mesh-ancestor
44931358|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931359|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44931360|NCT03747536|Bromides|bromides|mesh-list
44931361|NCT03747536|Ipratropium|ipratropium|mesh-list
44931362|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
44931363|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44931364|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
44906503|NCT04017598|Iron|iron|mesh-list
44906560|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
44906605|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906606|NCT04015908|Acetaminophen|acetaminophen|mesh-list
44906607|NCT04015908|Celecoxib|celecoxib|mesh-list
44906608|NCT04015908|Pregabalin|pregabalin|mesh-list
44906609|NCT04015908|Oxycodone|oxycodone|mesh-list
44906610|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906611|NCT04015908|Analgesics|analgesics|mesh-ancestor
44906612|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
44906673|NCT04015492|Factor VIII|factor viii|mesh-list
44906753|NCT04014101|Apatinib|apatinib|mesh-list
44906821|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
44906822|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906823|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906824|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44906825|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906826|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
44906827|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
44906828|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906829|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44906830|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44906831|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906832|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906833|NCT04013880|Decitabine|decitabine|mesh-list
44906834|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44906835|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
44906836|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906837|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906838|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931365|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931366|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931367|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44931368|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
44931369|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44931370|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
44931371|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931372|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931373|NCT03747523|Vitamin D|vitamin d|mesh-list
44931374|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
44931375|NCT03747523|Vitamins|vitamins|mesh-ancestor
44931376|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
44931377|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931378|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44931379|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931380|NCT03747341|Fentanyl|fentanyl|mesh-list
44931381|NCT03747341|Oxycodone|oxycodone|mesh-list
44931382|NCT03747341|Buprenorphine|buprenorphine|mesh-list
44931383|NCT03747341|Ondansetron|ondansetron|mesh-list
44931384|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44931385|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44931386|NCT03747341|Narcotics|narcotics|mesh-ancestor
44931387|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931388|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931389|NCT03747341|Analgesics|analgesics|mesh-ancestor
44931390|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
44931391|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931392|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44931393|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44931394|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
44931395|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
44931396|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44931397|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
44931398|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
44931399|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931400|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
44931401|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
44931402|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44931403|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
44907057|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44907058|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44907059|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44907060|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907061|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907062|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700051|NCT02539225|Paclitaxel|paclitaxel|mesh-list
44931404|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931405|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931406|NCT03747341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44931407|NCT03747341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44931436|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
44931437|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931438|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931439|NCT03746821|Biotin|biotin|mesh-list
44931440|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
44931441|NCT03746821|Vitamins|vitamins|mesh-ancestor
44931442|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
44931443|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931444|NCT03746782|Thrombin|thrombin|mesh-list
44931445|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
44931446|NCT03746782|Coagulants|coagulants|mesh-ancestor
44931447|NCT03746691|Citalopram|citalopram|mesh-list
44931448|NCT03746691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44931449|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44931450|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931451|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931452|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931453|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
44931454|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931455|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44931456|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44931457|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931458|NCT03746652|Dexamethasone|dexamethasone|mesh-list
44931459|NCT03746652|Daratumumab|daratumumab|mesh-list
44931460|NCT03746652|Ixazomib|ixazomib|mesh-list
44931461|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931462|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
44931463|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
44931464|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931465|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931466|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931467|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
44931468|NCT03746652|Hormones|hormones|mesh-ancestor
44931469|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931470|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931471|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931472|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
44931473|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706142|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44706143|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44706144|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44706145|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
44706146|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44706147|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44706148|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44706149|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
44706150|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706151|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706152|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44706153|NCT01426971|Ibuprofen|ibuprofen|mesh-list
44706154|NCT01426971|Caffeine|caffeine|mesh-list
44706155|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706156|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706157|NCT01426971|Analgesics|analgesics|mesh-ancestor
44706158|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
44706159|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907138|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44907215|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44907216|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
44907217|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907218|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907219|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44907220|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44907221|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
44907222|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907223|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44907224|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
44907225|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
44907226|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907227|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44252054|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
44907503|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907504|NCT04006470|Fluorides|fluorides|mesh-list
44907505|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
44907506|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
44907507|NCT04006470|Protective Agents|protective agents|mesh-ancestor
44907508|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907509|NCT04006639|Analgesics|analgesics|mesh-list
44907510|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
44907511|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907512|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907513|NCT04006483|Fluorides|fluorides|mesh-list
44907514|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
44907515|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
44907516|NCT04006483|Protective Agents|protective agents|mesh-ancestor
44907517|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907518|NCT04006262|Nivolumab|nivolumab|mesh-list
44907519|NCT04006262|Ipilimumab|ipilimumab|mesh-list
44907520|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44907521|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907522|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44907523|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907524|NCT04006691|Mitomycins|mitomycins|mesh-list
44907525|NCT04006691|Mitomycin|mitomycin|mesh-list
44907526|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44907527|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907528|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
44907529|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907530|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907531|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907532|NCT04006080|Vedolizumab|vedolizumab|mesh-list
44907533|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907534|NCT04006093|Apixaban|apixaban|mesh-list
44907535|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44907536|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
44907537|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44907538|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44907539|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907540|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907542|NCT04006041|Paclitaxel|paclitaxel|mesh-list
44700813|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
44907730|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44907731|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907746|NCT04004117|Fentanyl|fentanyl|mesh-list
44907893|NCT04002635|Letrozole|letrozole|mesh-list
44908017|NCT04001725|Metformin|metformin|mesh-list
44908018|NCT04001725|Dexamethasone|dexamethasone|mesh-list
44908019|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908020|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
44908021|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
44908022|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908023|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908024|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908025|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
44908026|NCT04001725|Hormones|hormones|mesh-ancestor
44908027|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908028|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908301|NCT03998696|Cisplatin|cisplatin|mesh-list
44908302|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908303|NCT03998670|Methamphetamine|methamphetamine|mesh-list
44908304|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908305|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908306|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
44908307|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
44908308|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908309|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
44908310|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908311|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908312|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908313|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44908314|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44908315|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908316|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44908317|NCT03998761|Progesterone|progesterone|mesh-list
44908318|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
44908319|NCT03998761|Progestins|progestins|mesh-ancestor
44908320|NCT03998761|Hormones|hormones|mesh-ancestor
44908321|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908322|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706160|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706161|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706162|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706163|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44706164|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706165|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706166|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44706167|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44706168|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44706169|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44706170|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
44706171|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706172|NCT01426984|Methylphenidate|methylphenidate|mesh-list
44706173|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44706174|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706175|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44706176|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44706177|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706178|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706179|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
44706180|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706181|NCT01427114|Prednisolone|prednisolone|mesh-list
44706182|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
44706184|NCT01427114|Vincristine|vincristine|mesh-list
44706185|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706186|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
44706187|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706188|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706189|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44908323|NCT03998826|Piroxicam|piroxicam|mesh-list
44908507|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908508|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
44908509|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44908510|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908511|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908512|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44908513|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908514|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908515|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44908516|NCT03996564|Narcotics|narcotics|mesh-ancestor
44908517|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908518|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
44908519|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
44908520|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44908521|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
44908522|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
44908523|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
44908524|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908525|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44908526|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44908527|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44908528|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44908529|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44908530|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44908531|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44908532|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
44908533|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
44908534|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
44908535|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
44908537|NCT03996434|Cetrorelix|cetrorelix|mesh-list
44908556|NCT03996252|Calcitriol|calcitriol|mesh-list
44908629|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
44908705|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908706|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908707|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44908708|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44908709|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
44908710|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44908711|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
44908712|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44908713|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44908714|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44908715|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44908716|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44908717|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44908718|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44908719|NCT03994107|Paclitaxel|paclitaxel|mesh-list
44908720|NCT03994107|Doxorubicin|doxorubicin|mesh-list
44908721|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44908722|NCT03994107|Trastuzumab|trastuzumab|mesh-list
44908723|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44908724|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908725|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908726|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44908727|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44908728|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44908729|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908730|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44908731|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44908732|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44908733|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908734|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908735|NCT03994055|Antioxidants|antioxidants|mesh-list
44908736|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908737|NCT03994055|Protective Agents|protective agents|mesh-ancestor
44908743|NCT03993431|Methamphetamine|methamphetamine|mesh-list
44908817|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
44908878|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44908879|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908880|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908881|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44908882|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908883|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
44908884|NCT03991364|Methamphetamine|methamphetamine|mesh-list
44908885|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908886|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908887|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
44908888|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
44908889|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908890|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
44908891|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908898|NCT03991559|Manganese|manganese|mesh-list
44909064|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909065|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
44909066|NCT03989310|Antiviral Agents|antiviral agents|mesh-ancestor
44909067|NCT03989310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909068|NCT03989310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909069|NCT03989310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909070|NCT03989310|Trace Elements|trace elements|mesh-ancestor
44909071|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
44909072|NCT03989700|Thiamine|thiamine|mesh-list
44909073|NCT03989700|Vitamins|vitamins|mesh-ancestor
44909074|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
44909077|NCT03989557|Aspirin|aspirin|mesh-list
44909280|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909281|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
44909282|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
44909283|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909284|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909285|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909286|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909287|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44909288|NCT03986905|Scopolamine|scopolamine|mesh-list
44909289|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44909290|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44909291|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
44909292|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
44909293|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909294|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909295|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909296|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
44909297|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44909298|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44909299|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909300|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909301|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44909302|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
44909303|NCT03986515|Apatinib|apatinib|mesh-list
44909304|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909305|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44909306|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909307|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909308|NCT03986268|Vitamin D|vitamin d|mesh-list
44909309|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
44909310|NCT03986268|Vitamins|vitamins|mesh-ancestor
44909366|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
44909516|NCT03983889|Fentanyl|fentanyl|mesh-list
44909517|NCT03983889|Midazolam|midazolam|mesh-list
44909518|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
44909519|NCT03983889|Remifentanil|remifentanil|mesh-list
44909520|NCT03983889|Propofol|propofol|mesh-list
44909521|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44909522|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909523|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909524|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44909525|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
44909526|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
44909527|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909528|NCT03983889|Analgesics|analgesics|mesh-ancestor
44909529|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
44909530|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909531|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44909532|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44909533|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44909534|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909535|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909536|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909537|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909538|NCT03983889|Narcotics|narcotics|mesh-ancestor
44909539|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44909540|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44909541|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44909542|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44909543|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
44909544|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
44909545|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
44909546|NCT03983915|Remifentanil|remifentanil|mesh-list
44909547|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44909551|NCT03983915|Analgesics|analgesics|mesh-ancestor
44909727|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44909728|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44909729|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
44909730|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909731|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44909732|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44909733|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909734|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
44909735|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909736|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909737|NCT03981770|Anesthetics|anesthetics|mesh-list
44909738|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909739|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909740|NCT03981484|Thrombin|thrombin|mesh-list
44909741|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
44909742|NCT03981484|Coagulants|coagulants|mesh-ancestor
44909743|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
44909744|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44909745|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
44909746|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909747|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
44909748|NCT03981458|Protective Agents|protective agents|mesh-ancestor
44703049|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
44706190|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
44706191|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706192|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706193|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44706194|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706195|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44706196|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
44706197|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931474|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931475|NCT03746444|Anesthetics|anesthetics|mesh-list
44931476|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931477|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931478|NCT03746366|Corticosterone|corticosterone|mesh-list
44931479|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931481|NCT03746340|Sevoflurane|sevoflurane|mesh-list
44931482|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44931483|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931484|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931485|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44931486|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
44931487|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
44931488|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44931489|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44931490|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
44931491|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44931492|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931493|NCT03746249|Lenvatinib|lenvatinib|mesh-list
44931494|NCT03746249|Antibodies|antibodies|mesh-list
44931495|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
44931496|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
44909749|NCT03981068|Nimorazole|nimorazole|mesh-list
44910157|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910158|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44910159|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44910160|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44910161|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910269|NCT03975166|Xhance|xhance|mesh-list
44910363|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
44910364|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910365|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44910366|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
44910367|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910368|NCT03974867|Prednisone|prednisone|mesh-list
44910369|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
44910370|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44910371|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44910372|NCT03974867|Prednisolone|prednisolone|mesh-list
44910373|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
44910374|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44910375|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
44910376|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910377|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
44910378|NCT03974867|Hormones|hormones|mesh-ancestor
44910379|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910380|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910381|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910382|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910383|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
44910384|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
44910385|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910386|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910387|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44910388|NCT03974867|Protective Agents|protective agents|mesh-ancestor
44910389|NCT03974360|Erenumab|erenumab|mesh-list
44910390|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44910391|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910392|NCT03974360|Analgesics|analgesics|mesh-ancestor
44910393|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
44910394|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910395|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910396|NCT03974425|Aflibercept|aflibercept|mesh-list
44910397|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44910403|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
44910582|NCT03972358|Mifepristone|mifepristone|mesh-list
44910583|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44910584|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
44910585|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44910586|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910587|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44910588|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910589|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
44910590|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44910591|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44910592|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44910593|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44910594|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
44910595|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44910596|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44910597|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
44910598|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910599|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
44910600|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44910601|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44910602|NCT03972462|Sirolimus|sirolimus|mesh-list
44910603|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910604|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910605|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44910606|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910607|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
44910608|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44910611|NCT03972046|Trametinib|trametinib|mesh-list
44910628|NCT03971370|Vaccines|vaccines|mesh-list
44703240|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910782|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910783|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910784|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44910785|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44910786|NCT03969017|Interferons|interferons|mesh-list
44910787|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910788|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
44910789|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931497|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931498|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931499|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44931500|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931501|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931502|NCT03746223|Rituximab|rituximab|mesh-list
44931503|NCT03746223|Methotrexate|methotrexate|mesh-list
44931504|NCT03746223|Lenalidomide|lenalidomide|mesh-list
44931505|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44931506|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931507|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
44931508|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931509|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931510|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44931511|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
44931512|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931513|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44931514|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
44931515|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931516|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44931517|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931518|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44931519|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931520|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44931521|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44931522|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44931523|NCT03746223|Growth Substances|growth substances|mesh-ancestor
44931524|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
44931525|NCT03746158|Curcumin|curcumin|mesh-list
44931526|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931527|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931528|NCT03746158|Analgesics|analgesics|mesh-ancestor
44931529|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
44931530|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931531|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931532|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931533|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931534|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931535|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931536|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931537|NCT03746119|Nicotine|nicotine|mesh-list
44931538|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44931539|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
44931540|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931541|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931542|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44931543|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44931544|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
44931545|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931546|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931547|NCT03745911|Paclitaxel|paclitaxel|mesh-list
44931548|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44931549|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931550|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44931551|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931552|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44931553|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910992|NCT03966560|Latanoprost|latanoprost|mesh-list
44910993|NCT03966560|Brinzolamide|brinzolamide|mesh-list
44910994|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44910995|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44910996|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44910997|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
44910998|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910999|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911000|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911001|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44911002|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44911003|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911006|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911053|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
44911202|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44911203|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911204|NCT03964779|Antibodies|antibodies|mesh-list
44911205|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
44911206|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
44911207|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911208|NCT03964493|Vancomycin|vancomycin|mesh-list
44911209|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911210|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911211|NCT03964350|Ethanol|ethanol|mesh-list
44911212|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44911213|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911214|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911215|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911216|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
44911217|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44911218|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
44911219|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911220|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911221|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44911222|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44911223|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44911224|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
44911225|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911226|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911227|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44911228|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
44911229|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
44911230|NCT03964324|Protective Agents|protective agents|mesh-ancestor
44931554|NCT03745807|Nivolumab|nivolumab|mesh-list
44931555|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44931556|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931557|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44931558|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931559|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
44931560|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44931561|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44931562|NCT03745664|Prednisolone|prednisolone|mesh-list
44931563|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
44931564|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44931565|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
44931566|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931567|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
44931568|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
44931569|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931570|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911261|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
44911416|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44911417|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911418|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44911419|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911420|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44911421|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911422|NCT03961464|Cycloserine|cycloserine|mesh-list
44911423|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44911424|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911425|NCT03961464|Renal Agents|renal agents|mesh-ancestor
44911426|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44911427|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
44911428|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911429|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
44911430|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911431|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44911432|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44911433|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
44911434|NCT03961503|Vancomycin|vancomycin|mesh-list
44911435|NCT03961503|Daptomycin|daptomycin|mesh-list
44911436|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911437|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911438|NCT03961698|Paclitaxel|paclitaxel|mesh-list
44911439|NCT03961698|Bevacizumab|bevacizumab|mesh-list
44911440|NCT03961698|Atezolizumab|atezolizumab|mesh-list
44911441|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44911442|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911443|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44911444|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44911445|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44911446|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911447|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44911448|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44911449|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44911450|NCT03961698|Growth Substances|growth substances|mesh-ancestor
44911451|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911452|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
44911453|NCT03961360|Aspirin|aspirin|mesh-list
44911677|NCT03957291|Povidone|povidone|mesh-list
44911678|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44911679|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911680|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
44911681|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
44911682|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
44911683|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
44911684|NCT03957174|Rivastigmine|rivastigmine|mesh-list
44911685|NCT03957174|Reboxetine|reboxetine|mesh-list
44911686|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44911687|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911688|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911689|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44911690|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911691|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911692|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44911693|NCT03957174|Protective Agents|protective agents|mesh-ancestor
44911694|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
44911695|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911696|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44911697|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44911698|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44911699|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911700|NCT03956966|Dexamethasone|dexamethasone|mesh-list
44911701|NCT03956966|Bupivacaine|bupivacaine|mesh-list
44911702|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911703|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
44911704|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
44911705|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911706|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911707|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911708|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
44911709|NCT03956966|Hormones|hormones|mesh-ancestor
44911720|NCT03956953|BMS-986165|bms-986165|mesh-list
44911745|NCT03957083|Oxytocin|oxytocin|mesh-list
44911895|NCT03954873|Glucagon|glucagon|mesh-list
44911905|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911906|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911907|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
44911908|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931571|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931572|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
44931573|NCT03745664|Hormones|hormones|mesh-ancestor
44931574|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931575|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44931576|NCT03745664|Protective Agents|protective agents|mesh-ancestor
44931577|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931578|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931579|NCT03745625|Propofol|propofol|mesh-list
44931580|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44931581|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931582|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931583|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44931584|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
44931585|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
44931586|NCT03745599|Diclofenac|diclofenac|mesh-list
44931587|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
44931588|NCT03745599|Benzydamine|benzydamine|mesh-list
44931589|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931590|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931591|NCT03745599|Analgesics|analgesics|mesh-ancestor
44931592|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
44931593|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931594|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931595|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706198|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
44706199|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706200|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
44706201|NCT01427114|Hormones|hormones|mesh-ancestor
44706202|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706203|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44706204|NCT01427127|Ramosetron|ramosetron|mesh-list
44706205|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
44706206|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
44706207|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706208|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706209|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706210|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44706211|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
44706212|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706213|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706214|NCT01427192|Acetazolamide|acetazolamide|mesh-list
44706215|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
44706216|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44706217|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706218|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706219|NCT01427192|Diuretics|diuretics|mesh-ancestor
44706220|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
44706221|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706222|NCT01427205|Cetuximab|cetuximab|mesh-list
44706223|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706224|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706225|NCT01427244|Trastuzumab|trastuzumab|mesh-list
44728332|NCT05569577|Progestins|progestins|mesh-ancestor
44931596|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931597|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44931598|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931599|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931600|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
44931601|NCT03745586|Hormones|hormones|mesh-ancestor
44931602|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931603|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931604|NCT03745404|Lidocaine|lidocaine|mesh-list
44931605|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931606|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
44931607|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911909|NCT03954756|Apatinib|apatinib|mesh-list
44912005|NCT03953001|Lidocaine|lidocaine|mesh-list
44912074|NCT03952572|Doxorubicin|doxorubicin|mesh-list
44912075|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44912076|NCT03952572|Vincristine|vincristine|mesh-list
44912077|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912078|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
44912079|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912080|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912081|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44912082|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
44912083|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912084|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912085|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44912086|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44912087|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44912088|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44912089|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912090|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912091|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
44912092|NCT03952572|Hormones|hormones|mesh-ancestor
44912093|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912094|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44912095|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912096|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912097|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912098|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912099|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44912100|NCT03952481|Lifitegrast|lifitegrast|mesh-list
44912101|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44912102|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
44912103|NCT03952325|Nivolumab|nivolumab|mesh-list
44912121|NCT03951987|Charcoal|charcoal|mesh-list
44912270|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
44912271|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912272|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912273|NCT03950518|Levamisole|levamisole|mesh-list
44912274|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44912275|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
44912276|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912277|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
44912278|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
44912279|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44912280|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912281|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912282|NCT03950544|Meropenem|meropenem|mesh-list
44912283|NCT03950544|Fosfomycin|fosfomycin|mesh-list
44912284|NCT03950544|Tigecycline|tigecycline|mesh-list
44912285|NCT03950544|Polymyxins|polymyxins|mesh-list
44912286|NCT03950544|Polymyxin B|polymyxin b|mesh-list
44912287|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912288|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912371|NCT03949634|Paclitaxel|paclitaxel|mesh-list
44912518|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
44912519|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44912520|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44912521|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912522|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44912523|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44912524|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
44912525|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912526|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912527|NCT03947242|Trastuzumab|trastuzumab|mesh-list
44912528|NCT03947242|Vinorelbine|vinorelbine|mesh-list
44912529|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912530|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912531|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912532|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912533|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912534|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912535|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912536|NCT03947229|Clopidogrel|clopidogrel|mesh-list
44912537|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44912538|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44912539|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44912540|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44912541|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
44912542|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912543|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912544|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912545|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
44912546|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44912547|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44912551|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
44912633|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912634|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
44912635|NCT03945396|Antacids|antacids|mesh-ancestor
44912636|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912637|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912638|NCT03944980|Docetaxel|docetaxel|mesh-list
44912639|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912640|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912641|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912642|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912643|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912644|NCT03944889|Capsaicin|capsaicin|mesh-list
44912645|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
44912646|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
44912647|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
44912648|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912649|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703677|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703678|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703679|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44703680|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703681|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
44703682|NCT01417390|Gemcitabine|gemcitabine|mesh-list
44703683|NCT01417390|Cisplatin|cisplatin|mesh-list
44703684|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703685|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703686|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
44703687|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703688|NCT01417390|Antiviral Agents|antiviral agents|mesh-ancestor
44703689|NCT01417390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931608|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931609|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
44931610|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931611|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44931612|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44931613|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44931614|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931615|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931616|NCT03745300|Atorvastatin|atorvastatin|mesh-list
44931617|NCT03745300|Simvastatin|simvastatin|mesh-list
44931618|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44931619|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44931620|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
44912732|NCT03943823|Estrogens|estrogens|mesh-list
44913020|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913021|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913022|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913023|NCT03940235|Androgens|androgens|mesh-list
44913024|NCT03940235|Hormones|hormones|mesh-ancestor
44913025|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913026|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913027|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
44913028|NCT03940391|Midazolam|midazolam|mesh-list
44913029|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44913030|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913031|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913032|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913033|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44913034|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44913035|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44913036|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44913037|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
44913038|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
44913039|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
44913040|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
44913041|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913042|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913043|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
44913044|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
44913045|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44913046|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
44913047|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
44913048|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44913049|NCT03940430|Lactoferrin|lactoferrin|mesh-list
44913050|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706840|NCT01431092|Melatonin|melatonin|mesh-list
44931621|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931622|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44931623|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44931624|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931625|NCT03745261|Fluticasone|fluticasone|mesh-list
44931627|NCT03745261|Bromides|bromides|mesh-list
44931628|NCT03745261|Albuterol|albuterol|mesh-list
44931629|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
44931630|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44931631|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44931632|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931633|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44931634|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
44931635|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913051|NCT03940469|Dexamethasone|dexamethasone|mesh-list
44913200|NCT03938259|Narcotics|narcotics|mesh-ancestor
44913201|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913202|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913203|NCT03938259|Analgesics|analgesics|mesh-ancestor
44913204|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
44913205|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913206|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44913207|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44913208|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
44913209|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
44913210|NCT03937869|Secnidazole|secnidazole|mesh-list
44913211|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913212|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913213|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913214|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
44913215|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913216|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913217|NCT03937687|Caffeine|caffeine|mesh-list
44913218|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44913219|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913220|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44913221|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913222|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913223|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44913224|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44913225|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
44913226|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931636|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931637|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44931638|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
44931639|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
44931640|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44931641|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
44931642|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44931643|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
44931644|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931645|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931646|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44931647|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44931648|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44931649|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44931650|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
44931651|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
44931652|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931653|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
44931654|NCT03745261|Hormones|hormones|mesh-ancestor
44931655|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913345|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913346|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913347|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913348|NCT03935815|Ropivacaine|ropivacaine|mesh-list
44913349|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
44913350|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
44913351|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913352|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913353|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
44913354|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913355|NCT03935984|Calcitonin|calcitonin|mesh-list
44913356|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
44913357|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44913358|NCT03935984|Katacalcin|katacalcin|mesh-list
44913359|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913360|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913361|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913362|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
44913363|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
44913364|NCT03935152|Progestins|progestins|mesh-ancestor
44913365|NCT03935152|Hormones|hormones|mesh-ancestor
44913366|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913367|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913368|NCT03935139|Glycerol|glycerol|mesh-list
44913369|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44913370|NCT03935139|Protective Agents|protective agents|mesh-ancestor
44913371|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913372|NCT03935217|Secnidazole|secnidazole|mesh-list
44913373|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913374|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913375|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913376|NCT03935074|Melphalan|melphalan|mesh-list
44913377|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44913378|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
44913379|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913380|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913385|NCT03935347|Vidarabine|vidarabine|mesh-list
44913491|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44913565|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913566|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913567|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44913568|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44913569|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
44913570|NCT03933293|Ezetimibe|ezetimibe|mesh-list
44913571|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44913572|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44913573|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
44913574|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913575|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44913576|NCT03933345|Naloxone|naloxone|mesh-list
44913577|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44913578|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913579|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
44913580|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913581|NCT03933358|Hormones|hormones|mesh-list
44913582|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913583|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913592|NCT03932916|Donepezil|donepezil|mesh-list
44913780|NCT03931135|Dexamethasone|dexamethasone|mesh-list
44913824|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44913825|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44913826|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913827|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
44931656|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
44931657|NCT03745157|Insulin|insulin|mesh-list
44931658|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
44931659|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44931660|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931661|NCT03745105|Dexamethasone|dexamethasone|mesh-list
44931662|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
44931663|NCT03745105|Piroxicam|piroxicam|mesh-list
44931664|NCT03745105|Mepivacaine|mepivacaine|mesh-list
44931665|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44931666|NCT03745105|BB 1101|bb 1101|mesh-list
44931667|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931668|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
44931669|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
44931670|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931671|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728376|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
44931672|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931673|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
44931675|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931676|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931677|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931678|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931679|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
44931680|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931681|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
44931682|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
44931683|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931684|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931685|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931686|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931687|NCT03745105|Analgesics|analgesics|mesh-ancestor
44931688|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931689|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44931690|NCT03745040|Bupivacaine|bupivacaine|mesh-list
44931691|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931692|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
44931693|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931694|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931695|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
44931696|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931697|NCT03744988|Androgens|androgens|mesh-list
44931698|NCT03744988|Hormones|hormones|mesh-ancestor
44931699|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931700|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931701|NCT03744949|Remifentanil|remifentanil|mesh-list
44931702|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44931703|NCT03744949|Narcotics|narcotics|mesh-ancestor
44931704|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931705|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931706|NCT03744949|Analgesics|analgesics|mesh-ancestor
44931707|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
44931708|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931709|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44931710|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931711|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931712|NCT03744806|Bevacizumab|bevacizumab|mesh-list
44931713|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44931714|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931715|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44931716|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44931717|NCT03744806|Growth Substances|growth substances|mesh-ancestor
44931718|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931719|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44931720|NCT03744767|Spironolactone|spironolactone|mesh-list
44931721|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44931722|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
44913977|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44913978|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
44913979|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913980|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913981|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913982|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44913983|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
44913984|NCT03928145|Amiloride|amiloride|mesh-list
44913985|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44913986|NCT03928145|Diuretics|diuretics|mesh-ancestor
44913987|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
44913988|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913989|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44913990|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913991|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913999|NCT03928210|Digoxin|digoxin|mesh-list
44914148|NCT03926806|Vitamins|vitamins|mesh-list
44914206|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
44914207|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44914208|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
44914209|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44914210|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914211|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914212|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914213|NCT03926000|Pregabalin|pregabalin|mesh-list
44914214|NCT03926000|Analgesics|analgesics|mesh-ancestor
44914215|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
44914216|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914217|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914218|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
44914219|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44914220|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914221|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914222|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914223|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44914224|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44914225|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914226|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44914227|NCT03925818|Metronidazole|metronidazole|mesh-list
44914228|NCT03925818|Tetracycline|tetracycline|mesh-list
44914229|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44914230|NCT03925818|Pantoprazole|pantoprazole|mesh-list
44914231|NCT03925818|Bismuth|bismuth|mesh-list
44914232|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914233|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44914234|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44914235|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44914236|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44914237|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914238|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44914239|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914240|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914241|NCT03925818|Antacids|antacids|mesh-ancestor
44914242|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44931723|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914243|NCT03925714|Metformin|metformin|mesh-list
44914427|NCT03924492|Brexanolone|brexanolone|mesh-list
44914428|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
44914429|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914430|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914431|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914432|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
44914433|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
44914434|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
44914435|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914436|NCT03923881|Cetuximab|cetuximab|mesh-list
44914437|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914438|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914439|NCT03923842|Denosumab|denosumab|mesh-list
44914440|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914441|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914442|NCT03923803|Calcitonin|calcitonin|mesh-list
44914443|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
44914444|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44914445|NCT03923803|Katacalcin|katacalcin|mesh-list
44914560|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
44914637|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44914638|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914639|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914640|NCT03921567|Analgesics|analgesics|mesh-ancestor
44914641|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44914642|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914643|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
44914644|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44914645|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44914646|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914647|NCT03921775|Propofol|propofol|mesh-list
44914648|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914649|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914650|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914651|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914652|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
44914653|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
44914654|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
44914655|NCT03921177|Micronutrients|micronutrients|mesh-list
44914656|NCT03921177|Trace Elements|trace elements|mesh-list
44914657|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914658|NCT03921034|Ropivacaine|ropivacaine|mesh-list
44914659|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
44914660|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
44914661|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914662|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914663|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
44914664|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914665|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
44914666|NCT03921099|Vitamins|vitamins|mesh-ancestor
44914667|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
44914668|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914669|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
44914670|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914671|NCT03921099|Protective Agents|protective agents|mesh-ancestor
44914826|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914899|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44914977|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914978|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914979|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914980|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44914981|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44914982|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44914983|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44914984|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914985|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
44914986|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
44914987|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
44914988|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
44914989|NCT03918551|Febuxostat|febuxostat|mesh-list
44914990|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
44914991|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914992|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
44914993|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
44914994|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44914995|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
44914996|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914997|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914998|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44914999|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
44915000|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915001|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915002|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44915003|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915004|NCT03918265|Tacrolimus|tacrolimus|mesh-list
44915005|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915006|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
44915007|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915008|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44915009|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915010|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931724|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931725|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44931726|NCT03744767|Diuretics|diuretics|mesh-ancestor
44931727|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
44931728|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
44931729|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
44931730|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931731|NCT03744702|Protective Agents|protective agents|mesh-ancestor
44915011|NCT03918187|Midazolam|midazolam|mesh-list
44915146|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44915147|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
44915148|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
44915149|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915150|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915151|NCT05402865|Denosumab|denosumab|mesh-list
44915152|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44915153|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915154|NCT05402735|Uric Acid|uric acid|mesh-list
44915155|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
44915156|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915157|NCT05402735|Protective Agents|protective agents|mesh-ancestor
44915158|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915159|NCT05402722|Antibodies|antibodies|mesh-list
44915160|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
44915161|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915162|NCT05402553|Ondansetron|ondansetron|mesh-list
44915163|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
44915164|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
44915165|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915166|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915167|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915168|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
44915169|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915170|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44915171|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
44915172|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915173|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915174|NCT05402553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44915175|NCT05402553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44915176|NCT05402553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915177|NCT05402553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915178|NCT05402553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931732|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931733|NCT03744702|Vitamins|vitamins|mesh-ancestor
44931734|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
44931735|NCT03744689|Bupivacaine|bupivacaine|mesh-list
44931736|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931737|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
44931738|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931739|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931740|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
44931741|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931742|NCT03744364|Misoprostol|misoprostol|mesh-list
44915253|NCT05401032|Urological Agents|urological agents|mesh-ancestor
44915254|NCT05401019|Pramipexole|pramipexole|mesh-list
44915255|NCT05401019|Risperidone|risperidone|mesh-list
44915256|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44915257|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
44915258|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915259|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915427|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44915499|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44915500|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915501|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915502|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
44915503|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915504|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915505|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44915506|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
44915507|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915508|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44915509|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44915510|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44915511|NCT05252585|Everolimus|everolimus|mesh-list
44915512|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915513|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915514|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
44915515|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915516|NCT05221645|Rituximab|rituximab|mesh-list
44915517|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
44915518|NCT05221645|Carboplatin|carboplatin|mesh-list
44915519|NCT05221645|Etoposide|etoposide|mesh-list
44915520|NCT05221645|Ifosfamide|ifosfamide|mesh-list
44915521|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915522|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915523|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
44915524|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915525|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915526|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44915527|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44915528|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44915529|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915530|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915531|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44915532|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
44915533|NCT05219929|Tetracycline|tetracycline|mesh-list
44931743|NCT03744364|Dinoprostone|dinoprostone|mesh-list
44915684|NCT05032508|Lidocaine|lidocaine|mesh-list
44915757|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915758|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915759|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44915760|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915761|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44915762|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
44915763|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915764|NCT04910022|Lomustine|lomustine|mesh-list
44915765|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44915766|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
44915767|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915768|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915769|NCT04906720|Colchicine|colchicine|mesh-list
44915770|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
44915771|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915772|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
44915773|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
44915774|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
44915775|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915776|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915777|NCT04880499|Folic Acid|folic acid|mesh-list
44915778|NCT04880499|Riboflavin|riboflavin|mesh-list
44915779|NCT04880499|Vitamins|vitamins|mesh-ancestor
44915780|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
44915781|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915782|NCT04880499|Hematinics|hematinics|mesh-ancestor
44915783|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
44915784|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44915785|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915786|NCT04867785|Dulaglutide|dulaglutide|mesh-list
44915787|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44915788|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915789|NCT04861064|Sirolimus|sirolimus|mesh-list
44915790|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915791|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915792|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44915875|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
44915950|NCT04625283|Ketamine|ketamine|mesh-list
44916165|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916166|NCT04246996|Gentamicins|gentamicins|mesh-list
44916167|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916168|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916169|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44916170|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916171|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931744|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44931745|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
44931764|NCT03744104|Vaccines|vaccines|mesh-list
44931765|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
44931766|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931767|NCT03744091|Dronabinol|dronabinol|mesh-list
44931768|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
44931769|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931770|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931771|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931772|NCT03744091|Analgesics|analgesics|mesh-ancestor
44931773|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
44931774|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931775|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44931776|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44706226|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706227|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706228|NCT01427270|Oxycodone|oxycodone|mesh-list
44706229|NCT01427270|Naloxone|naloxone|mesh-list
44706230|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44706231|NCT01427270|Narcotics|narcotics|mesh-ancestor
44706232|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706233|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706234|NCT01427270|Analgesics|analgesics|mesh-ancestor
44706235|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
44706236|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706237|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44706238|NCT01427283|Oxycodone|oxycodone|mesh-list
44706239|NCT01427283|Naloxone|naloxone|mesh-list
44706240|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44706241|NCT01427283|Narcotics|narcotics|mesh-ancestor
44706242|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706243|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706244|NCT01427283|Analgesics|analgesics|mesh-ancestor
44706245|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
44706246|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706247|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44706248|NCT01427322|Lapatinib|lapatinib|mesh-list
44706249|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706250|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44257776|NCT00626600|Oxycodone|oxycodone|mesh-list
44706251|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706252|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706253|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
44706255|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706256|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706257|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44706258|NCT01427387|Linaclotide|linaclotide|mesh-list
44706259|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44706260|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
44706261|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706262|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706263|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
44706264|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44706265|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44706266|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44706267|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706268|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706269|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706270|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706271|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916172|NCT03991013|Dolutegravir|dolutegravir|mesh-list
44916234|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916308|NCT03513328|Thiotepa|thiotepa|mesh-list
44916382|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916383|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916384|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
44916385|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916870|NCT00396279|Vitamins|vitamins|mesh-ancestor
44916871|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
44916872|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916873|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44916874|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44916875|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
44916876|NCT00358215|Hematinics|hematinics|mesh-ancestor
44916877|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
44916878|NCT00321464|Denosumab|denosumab|mesh-list
44916879|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44916880|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916881|NCT00246324|Interferons|interferons|mesh-list
44916882|NCT00246324|Interferon-beta|interferon-beta|mesh-list
44916883|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
44916884|NCT00246324|Doxycycline|doxycycline|mesh-list
44916885|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916886|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
44916887|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916888|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916889|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
44916890|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44916891|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44916892|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
44916893|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916894|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44917055|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917056|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917057|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917058|NCT04958746|Propofol|propofol|mesh-list
44917059|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44917060|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917061|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917062|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44917063|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
44917064|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
44917065|NCT04916392|Bupivacaine|bupivacaine|mesh-list
44917066|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44917067|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
44917068|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917069|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917070|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
44917071|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917072|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
44917073|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917074|NCT04880655|Bacitracin|bacitracin|mesh-list
44917075|NCT04880655|Petrolatum|petrolatum|mesh-list
44917076|NCT04880655|Emollients|emollients|mesh-ancestor
44917077|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44917078|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44917079|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917080|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44917081|NCT04865835|Metformin|metformin|mesh-list
44917082|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44917083|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917084|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
44917085|NCT04813016|Tramadol|tramadol|mesh-list
44917086|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44917101|NCT04778982|Fulvestrant|fulvestrant|mesh-list
44917269|NCT03530800|Analgesics|analgesics|mesh-ancestor
44917416|NCT02671890|Disulfiram|disulfiram|mesh-list
44917417|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917418|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
44917419|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917420|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917421|NCT02671890|Antiviral Agents|antiviral agents|mesh-ancestor
44917422|NCT02671890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917423|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917424|NCT02671890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917425|NCT02671890|Immunologic Factors|immunologic factors|mesh-ancestor
44917426|NCT02671890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917427|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44917428|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44917429|NCT02655692|Ketamine|ketamine|mesh-list
44917430|NCT02655692|Analgesics|analgesics|mesh-ancestor
44917431|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
44917432|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917433|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917434|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44917435|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44917436|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
44917437|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
44917438|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917439|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44917440|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44917441|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917442|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706272|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44706273|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706274|NCT01427478|Afatinib|afatinib|mesh-list
44706275|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706276|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44706277|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706278|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706279|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44706280|NCT01427491|Laxatives|laxatives|mesh-ancestor
44706281|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706282|NCT01427582|Trabectedin|trabectedin|mesh-list
44706283|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44706284|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
44706285|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706286|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706287|NCT01427686|Dobutamine|dobutamine|mesh-list
44706288|NCT01427686|Dopamine|dopamine|mesh-list
44931778|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931779|NCT03744091|Hormones|hormones|mesh-ancestor
44917678|NCT03915444|Cisplatin|cisplatin|mesh-list
44917679|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917680|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917681|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917682|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917683|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917684|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917685|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917686|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
44917687|NCT03915444|Antiviral Agents|antiviral agents|mesh-ancestor
44917688|NCT03915444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917689|NCT03915444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917690|NCT03915444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917691|NCT03915444|Immunologic Factors|immunologic factors|mesh-ancestor
44917692|NCT03915444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917693|NCT03915561|Parecoxib|parecoxib|mesh-list
44917694|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44917695|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44917696|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917697|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917698|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44917699|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917700|NCT03915561|Analgesics|analgesics|mesh-ancestor
44917701|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
44917702|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917703|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917704|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917705|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917706|NCT03915340|Propafenone|propafenone|mesh-list
44917707|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44917708|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44917709|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44917718|NCT03914755|Tucatinib|tucatinib|mesh-list
44917943|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917944|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44917945|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44917946|NCT03912415|Paclitaxel|paclitaxel|mesh-list
44917947|NCT03912415|Bevacizumab|bevacizumab|mesh-list
44917948|NCT03912415|Cisplatin|cisplatin|mesh-list
44917949|NCT03912415|Carboplatin|carboplatin|mesh-list
44917950|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917951|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917952|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917953|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917954|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917955|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917956|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917957|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44917958|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44917959|NCT03912415|Growth Substances|growth substances|mesh-ancestor
44917960|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917961|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44917962|NCT03912285|Losartan|losartan|mesh-list
44917963|NCT03912285|Amlodipine|amlodipine|mesh-list
44917964|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44917965|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44917966|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917967|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917968|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44917969|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917970|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44917971|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44917972|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44917973|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44931780|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931781|NCT03743987|Pemetrexed|pemetrexed|mesh-list
44931782|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931783|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931784|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931785|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44931786|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44931787|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
44931788|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
44931789|NCT03743922|Vitamin D|vitamin d|mesh-list
44917974|NCT03911817|Midodrine|midodrine|mesh-list
44918070|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
44918071|NCT03910543|Tofacitinib|tofacitinib|mesh-list
44918072|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44918073|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918074|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918075|NCT03910361|Pioglitazone|pioglitazone|mesh-list
44918076|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44918077|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918078|NCT03910504|Rocuronium|rocuronium|mesh-list
44918079|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44918080|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44918081|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44918082|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918083|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918084|NCT03910231|Tolvaptan|tolvaptan|mesh-list
44918085|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44918086|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918087|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
44918088|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918089|NCT03910088|Acetaminophen|acetaminophen|mesh-list
44918090|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
44918091|NCT03910088|Diclofenac|diclofenac|mesh-list
44918092|NCT03910088|Pregabalin|pregabalin|mesh-list
44918093|NCT03910088|Caffeine|caffeine|mesh-list
44918095|NCT03910088|Analgesics|analgesics|mesh-ancestor
44918196|NCT03908619|Esomeprazole|esomeprazole|mesh-list
44918247|NCT03908489|Protective Agents|protective agents|mesh-ancestor
44918321|NCT03907371|Donepezil|donepezil|mesh-list
44918466|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918467|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918468|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44918469|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44918470|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44918471|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918472|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918473|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
44918474|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44918475|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918476|NCT03905564|Pyridoxine|pyridoxine|mesh-list
44918477|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
44918478|NCT03905564|Doxylamine|doxylamine|mesh-list
44918479|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
44918480|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
44918481|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
44918482|NCT03905564|Vitamins|vitamins|mesh-ancestor
44918483|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
44918484|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918485|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
44918486|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
44918487|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918488|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918489|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44918490|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
44918491|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
44918492|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918493|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918494|NCT03904849|Cannabidiol|cannabidiol|mesh-list
44918495|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
44918496|NCT03905018|Tadalafil|tadalafil|mesh-list
44918497|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
44918498|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44918499|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44918500|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918501|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918502|NCT03905018|Urological Agents|urological agents|mesh-ancestor
44713071|NCT01474967|Metformin|metformin|mesh-list
44918670|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918671|NCT03903133|Protective Agents|protective agents|mesh-ancestor
44918672|NCT03902925|Lidocaine|lidocaine|mesh-list
44918673|NCT03902925|Ropivacaine|ropivacaine|mesh-list
44918674|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918675|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
44918676|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918677|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918678|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
44918679|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918680|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918681|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44918682|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44918683|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918684|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931790|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931791|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931792|NCT03743922|Vitamins|vitamins|mesh-ancestor
44931793|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
44931794|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44931795|NCT03743896|Capsaicin|capsaicin|mesh-list
44931796|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
44931797|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
44931798|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
44931799|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931800|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931801|NCT03743883|Aspirin|aspirin|mesh-list
44931802|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931803|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931804|NCT03743883|Analgesics|analgesics|mesh-ancestor
44931805|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
44931806|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931807|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931808|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931809|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931810|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44931811|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44931812|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931813|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44931814|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44931815|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931816|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
44931817|NCT03743870|Bupivacaine|bupivacaine|mesh-list
44931818|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
44931819|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
44931820|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
44931821|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931822|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931823|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
44931824|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931825|NCT03743805|Naloxone|naloxone|mesh-list
44931826|NCT03743805|Flumazenil|flumazenil|mesh-list
44931827|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44931828|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931829|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
44931830|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931831|NCT03743805|Antidotes|antidotes|mesh-ancestor
44931832|NCT03743805|Protective Agents|protective agents|mesh-ancestor
44931833|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
44918685|NCT03902782|Dexamethasone|dexamethasone|mesh-list
44918763|NCT03901716|Analgesics|analgesics|mesh-ancestor
44918836|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918837|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44918838|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44918839|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918840|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918841|NCT03900871|Aspirin|aspirin|mesh-list
44918842|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44918843|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918844|NCT03900871|Analgesics|analgesics|mesh-ancestor
44918845|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
44918846|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918847|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918848|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918849|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918850|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44918851|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44918852|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918853|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44918854|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44918855|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918856|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
44918857|NCT03900858|Isoniazid|isoniazid|mesh-list
44918858|NCT03900858|Rifapentine|rifapentine|mesh-list
44918859|NCT03900858|Rifampin|rifampin|mesh-list
44918860|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
44918884|NCT03900026|Evolocumab|evolocumab|mesh-list
44919019|NCT03898752|Vitamins|vitamins|mesh-ancestor
44919088|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
44919089|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44919090|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919091|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919092|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44919093|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919094|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44919095|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44919096|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919097|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44919098|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44919099|NCT03898128|Immunotoxins|immunotoxins|mesh-list
44919100|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
44919101|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931834|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
44931835|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931836|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931837|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
44931838|NCT03743727|Ledipasvir|ledipasvir|mesh-list
44931839|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44931840|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
44931841|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931842|NCT03743649|Lorazepam|lorazepam|mesh-list
44931843|NCT03743649|Haloperidol|haloperidol|mesh-list
44931844|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
44931845|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
44931846|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
44931847|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931848|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931849|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931850|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44706289|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44931851|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44931852|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931853|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931854|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44931855|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
44931856|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931857|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931858|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44931859|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
44931860|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44931861|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931862|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
44931863|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
44931864|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
44931865|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44931866|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931867|NCT03743259|Charcoal|charcoal|mesh-list
44931868|NCT03743259|Antidotes|antidotes|mesh-ancestor
44931869|NCT03743259|Protective Agents|protective agents|mesh-ancestor
44931870|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931871|NCT03743103|Nitroprusside|nitroprusside|mesh-list
44931872|NCT03743103|Esmolol|esmolol|mesh-list
44931873|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44931874|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
44931875|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44931876|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931877|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44931878|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44931879|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44931880|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919183|NCT03896113|Celecoxib|celecoxib|mesh-list
44919187|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
44919188|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919189|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919190|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919191|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919192|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44919193|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44919194|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919334|NCT03894085|Paroxetine|paroxetine|mesh-list
44919444|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44919448|NCT03893526|Hormones|hormones|mesh-ancestor
44919516|NCT03892525|Atezolizumab|atezolizumab|mesh-list
44919756|NCT03891472|Irinotecan|irinotecan|mesh-list
44919825|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919826|NCT03890341|Drospirenone|drospirenone|mesh-list
44919827|NCT03890341|Midazolam|midazolam|mesh-list
44919828|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44919829|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44919830|NCT03890341|Betadex|betadex|mesh-list
44919831|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44919832|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919833|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919834|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919835|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44919836|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44919837|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44919838|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919839|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
44919840|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
44919841|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
44919842|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
44919843|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919844|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919845|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44919846|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44919847|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44919848|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
44919849|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919850|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44919851|NCT03890341|Estrogens|estrogens|mesh-ancestor
44919852|NCT03890341|Hormones|hormones|mesh-ancestor
44919853|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919854|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44919855|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
44919856|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44919857|NCT03890341|Diuretics|diuretics|mesh-ancestor
44919858|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
44919859|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
44714624|NCT01485081|Paclitaxel|paclitaxel|mesh-list
44931881|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931882|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931883|NCT03742947|Hemostatics|hemostatics|mesh-list
44931884|NCT03742947|Coagulants|coagulants|mesh-ancestor
44920018|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
44920019|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44920020|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44920021|NCT03888157|Liraglutide|liraglutide|mesh-list
44920022|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44920023|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920024|NCT03888157|Incretins|incretins|mesh-ancestor
44920025|NCT03888157|Hormones|hormones|mesh-ancestor
44920026|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931885|NCT03742908|Clindamycin|clindamycin|mesh-list
44931886|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
44931887|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
44931888|NCT03742908|Cefazolin|cefazolin|mesh-list
44931889|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44931890|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931891|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44931892|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931893|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931894|NCT03742713|Docetaxel|docetaxel|mesh-list
44931895|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931896|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
44931897|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931898|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
44931899|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931900|NCT03742557|Ketamine|ketamine|mesh-list
44931901|NCT03742557|Analgesics|analgesics|mesh-ancestor
44931902|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
44931903|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931904|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931905|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44931906|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44931907|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
44931908|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
44931909|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931910|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44931911|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44931912|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931913|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931914|NCT03742531|Oxytocin|oxytocin|mesh-list
44931915|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
44931916|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931917|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931918|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
44931919|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44931920|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44931921|NCT03742466|Prednisolone|prednisolone|mesh-list
44931922|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
44931923|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44931924|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
44931925|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931926|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
44931927|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
44931928|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931929|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931930|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931932|NCT03742466|Hormones|hormones|mesh-ancestor
44931933|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931934|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44931935|NCT03742466|Protective Agents|protective agents|mesh-ancestor
44931936|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931937|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931938|NCT03742336|Dabigatran|dabigatran|mesh-list
44931939|NCT03742336|Abrocitinib|abrocitinib|mesh-list
44931940|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
44931941|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44931942|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44931943|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920169|NCT03886779|Nepafenac|nepafenac|mesh-list
44920235|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920236|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44920237|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
44920238|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44920239|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
44920240|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920241|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
44920242|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920243|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
44920244|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920245|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920246|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920247|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
44920248|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44920249|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44920250|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920251|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
44920252|NCT03885895|Coagulants|coagulants|mesh-ancestor
44715140|NCT01487629|Ranibizumab|ranibizumab|mesh-list
44931944|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931945|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
44931946|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44931947|NCT03742323|Idelalisib|idelalisib|mesh-list
44931948|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931949|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931950|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931951|NCT03742310|Vitamin D|vitamin d|mesh-list
44931952|NCT03742310|Calcitriol|calcitriol|mesh-list
44931953|NCT03742310|Vitamins|vitamins|mesh-ancestor
44931954|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
44931955|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931956|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44931957|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44931958|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44706290|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
44706291|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
44706292|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706293|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706294|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44706295|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44706296|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44706297|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
44706298|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706299|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706300|NCT01427686|Protective Agents|protective agents|mesh-ancestor
44706301|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
44706302|NCT01427699|Antibodies|antibodies|mesh-list
44706303|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
44706304|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706305|NCT01427842|Vancomycin|vancomycin|mesh-list
44706306|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44706307|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706308|NCT01427868|Maleic acid|maleic acid|mesh-list
44706309|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706310|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706311|NCT01427946|Everolimus|everolimus|mesh-list
44706312|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706313|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920377|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44920378|NCT03884530|Aspirin|aspirin|mesh-list
44920379|NCT03884530|Ticagrelor|ticagrelor|mesh-list
44920380|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920381|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920382|NCT03884530|Analgesics|analgesics|mesh-ancestor
44920394|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
44920599|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920672|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44920673|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920674|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
44920675|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920676|NCT03881423|Bromides|bromides|mesh-list
44920677|NCT03881423|Rocuronium|rocuronium|mesh-list
44920678|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44920679|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
44920680|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44920681|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44920682|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920683|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715681|NCT01490229|Ezetimibe|ezetimibe|mesh-list
44706314|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
44706315|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706316|NCT01427985|Atropine|atropine|mesh-list
44706317|NCT01427985|Fentanyl|fentanyl|mesh-list
44706318|NCT01427985|Mivacurium|mivacurium|mesh-list
44706319|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44706320|NCT01427985|Narcotics|narcotics|mesh-ancestor
44706321|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706322|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706323|NCT01427985|Analgesics|analgesics|mesh-ancestor
44706324|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
44706325|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706326|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44706327|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44706328|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
44706329|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
44706330|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44706331|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44706332|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
44706333|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44706334|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706335|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
44706336|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
44931996|NCT03742232|Laxatives|laxatives|mesh-ancestor
44931997|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931999|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
44932000|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44932001|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932002|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932003|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932004|NCT03742180|Analgesics|analgesics|mesh-ancestor
44932005|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
44932006|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932007|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44932008|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44932009|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44932010|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
44932011|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932012|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932013|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44932014|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932015|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932016|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44932017|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932018|NCT03742115|Dexamethasone|dexamethasone|mesh-list
44932019|NCT03742115|Etoposide|etoposide|mesh-list
44932020|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
44932021|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932022|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
44932023|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
44932024|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932025|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920771|NCT03880916|Analgesics|analgesics|mesh-ancestor
44920854|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
44920966|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
44920967|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44920968|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
44920969|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920970|NCT03879356|Expectorants|expectorants|mesh-ancestor
44920971|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920972|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44920973|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
44920974|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920975|NCT03879356|Protective Agents|protective agents|mesh-ancestor
44920976|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920977|NCT03879356|Antidotes|antidotes|mesh-ancestor
44920978|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
44920979|NCT03879382|Fludarabine|fludarabine|mesh-list
44920980|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920981|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
44920982|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920983|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920984|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44920985|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
44920986|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920987|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920988|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44920989|NCT03879174|Tamoxifen|tamoxifen|mesh-list
44920990|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
44920991|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921017|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44921206|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
44921275|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44921276|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44921277|NCT03876444|Prednisolone|prednisolone|mesh-list
44921278|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
44921279|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44921280|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
44921281|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921282|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
44921283|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
44921284|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921285|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921286|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921287|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
44921288|NCT03876444|Hormones|hormones|mesh-ancestor
44921289|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921290|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44921291|NCT03876444|Protective Agents|protective agents|mesh-ancestor
44921292|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44921293|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921294|NCT03876548|Iodine|iodine|mesh-list
44921295|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
44921296|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44921297|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921298|NCT03876548|Trace Elements|trace elements|mesh-ancestor
44921299|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
44921300|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921301|NCT03876587|Docetaxel|docetaxel|mesh-list
44921302|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921303|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44921304|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44921305|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44921306|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932026|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932027|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
44932028|NCT03742115|Hormones|hormones|mesh-ancestor
44932029|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932030|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932031|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932032|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932033|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44932034|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44932035|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932036|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932037|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
44921458|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921459|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
44921460|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
44921461|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
44921462|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704938|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704939|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704940|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704941|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
44704942|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704943|NCT01424709|Gemcitabine|gemcitabine|mesh-list
44704944|NCT01424709|Cisplatin|cisplatin|mesh-list
44704945|NCT01424709|Docetaxel|docetaxel|mesh-list
44704946|NCT01424709|Irinotecan|irinotecan|mesh-list
44704947|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704948|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44704949|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
44704950|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704951|NCT01424709|Antiviral Agents|antiviral agents|mesh-ancestor
44704952|NCT01424709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704953|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704954|NCT01424709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704955|NCT01424709|Immunologic Factors|immunologic factors|mesh-ancestor
44704956|NCT01424709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704957|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44704958|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44704959|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704960|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44704961|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44704962|NCT01424761|Ubiquinone|ubiquinone|mesh-list
44704963|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
44921614|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921615|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921616|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921617|NCT03871517|Aspirin|aspirin|mesh-list
44921618|NCT03871517|Indobufen|indobufen|mesh-list
44921619|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921620|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921621|NCT03871517|Analgesics|analgesics|mesh-ancestor
44921622|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
44921623|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921624|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921625|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921626|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921627|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44921628|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44921629|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921630|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44921631|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44921632|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921633|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
44921634|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
44921635|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44921636|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
44921637|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921638|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
44921639|NCT03871218|Protective Agents|protective agents|mesh-ancestor
44921640|NCT03871322|Vitamin D|vitamin d|mesh-list
44921736|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921737|NCT03869762|Denosumab|denosumab|mesh-list
44921738|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921739|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921740|NCT03869528|Lidocaine|lidocaine|mesh-list
44921741|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921742|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
44921743|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921744|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921745|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
44921746|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921747|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44921748|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44921749|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44921795|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
44921946|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921947|NCT03866681|Sirolimus|sirolimus|mesh-list
44921948|NCT03866681|Warfarin|warfarin|mesh-list
44921949|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921950|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921951|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44921952|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921953|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
44921954|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921955|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
44921956|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921957|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
44921958|NCT03866629|Lifitegrast|lifitegrast|mesh-list
44921959|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44921960|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44921961|NCT03866733|Narcotics|narcotics|mesh-list
44921962|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921963|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921964|NCT03866733|Analgesics|analgesics|mesh-ancestor
44921965|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
44921966|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922244|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
44922245|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922246|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922247|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922248|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
44922249|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922250|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
44922251|NCT03864016|Sufentanil|sufentanil|mesh-list
44922252|NCT03864016|Dsuvia|dsuvia|mesh-list
44922253|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
44922254|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922255|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922256|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44922257|NCT03864016|Narcotics|narcotics|mesh-ancestor
44922258|NCT03864016|Analgesics|analgesics|mesh-ancestor
44922259|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
44922260|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922261|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44922262|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922263|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
44717448|NCT01500850|Insulin|insulin|mesh-list
44932038|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44932039|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932040|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
44932041|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44932042|NCT03741686|Cathartics|cathartics|mesh-ancestor
44932043|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932044|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44932045|NCT03741660|Cathartics|cathartics|mesh-ancestor
44932046|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932047|NCT03741621|Psyllium|psyllium|mesh-list
44932048|NCT03741621|Cathartics|cathartics|mesh-ancestor
44932049|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932050|NCT03741478|Insulin|insulin|mesh-list
44932051|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44932052|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
44932053|NCT03741478|Olanzapine|olanzapine|mesh-list
44932054|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44932055|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932056|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
44932057|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
44932058|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932059|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932060|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44932061|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44932062|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932063|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44932064|NCT03741478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44932065|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44932066|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44932067|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932068|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932069|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
44932070|NCT03741426|Durvalumab|durvalumab|mesh-list
44932071|NCT03741426|Olaparib|olaparib|mesh-list
44932072|NCT03741426|Cediranib|cediranib|mesh-list
44932073|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932074|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922264|NCT03863691|Amisulpride|amisulpride|mesh-list
44922432|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44922433|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922434|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44922435|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44717689|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
44932075|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44932076|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932077|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932078|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932079|NCT03741309|Calcium|calcium|mesh-list
44932080|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44932081|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932082|NCT03741244|Temozolomide|temozolomide|mesh-list
44932083|NCT03741244|Apatinib|apatinib|mesh-list
44932084|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932085|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
44932086|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932087|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932088|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932089|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932090|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
44932091|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44932092|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44932093|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932094|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
44932095|NCT03741075|Coagulants|coagulants|mesh-ancestor
44932096|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44932097|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44932098|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
44932099|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932100|NCT03740893|Durvalumab|durvalumab|mesh-list
44932101|NCT03740893|Olaparib|olaparib|mesh-list
44932102|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932103|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932104|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44932105|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932106|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932107|NCT03740581|Insulin|insulin|mesh-list
44932108|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44932109|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932110|NCT03740568|Progesterone|progesterone|mesh-list
44932111|NCT03740568|Progestins|progestins|mesh-ancestor
44932112|NCT03740568|Hormones|hormones|mesh-ancestor
44932113|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932114|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932115|NCT03740516|Apremilast|apremilast|mesh-list
44932116|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44932117|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932118|NCT03740516|Analgesics|analgesics|mesh-ancestor
44932119|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
44932120|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932121|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932122|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932123|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932124|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44932125|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44932126|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932127|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932128|NCT03740464|Lenograstim|lenograstim|mesh-list
44932129|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44932130|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
44932131|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932132|NCT03740438|Chrysarobin|chrysarobin|mesh-list
44932133|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44932134|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932135|NCT03740438|Analgesics|analgesics|mesh-ancestor
44932136|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
44932137|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922522|NCT03860012|Folic Acid|folic acid|mesh-list
44922588|NCT03859375|Disinfectants|disinfectants|mesh-list
44922632|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44922633|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922634|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
44922635|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44922636|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
44922637|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922638|NCT03858972|Capecitabine|capecitabine|mesh-list
44922639|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44922640|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
44922641|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922642|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717956|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
44932138|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932139|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932140|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932141|NCT03740399|Anesthetics|anesthetics|mesh-list
44932142|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932143|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932144|NCT03740386|Phentolamine|phentolamine|mesh-list
44932145|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44932146|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44932147|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44932148|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932149|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932150|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932151|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44932152|NCT03740373|Budesonide|budesonide|mesh-list
44932153|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
44932154|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
44932155|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932156|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44932157|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
44932158|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932159|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932160|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44932161|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
44932162|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
44932163|NCT03740373|Hormones|hormones|mesh-ancestor
44932164|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932165|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44932166|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44932167|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44932168|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
44932169|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932170|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932171|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44932172|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44932173|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44932174|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44932175|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44932176|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
44932177|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932178|NCT03740295|Protective Agents|protective agents|mesh-ancestor
44932179|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932180|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44932181|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44932182|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932183|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44932184|NCT03740243|Buprenorphine|buprenorphine|mesh-list
44706337|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44706338|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44706339|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706340|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922648|NCT03858465|Ephedrine|ephedrine|mesh-list
44922793|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44922794|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922795|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44922796|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922797|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922798|NCT03856970|Protective Agents|protective agents|mesh-ancestor
44922799|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922800|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44718179|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
44706341|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706342|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44706343|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44706344|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44706345|NCT01428037|Misoprostol|misoprostol|mesh-list
44706346|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44706347|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
44706348|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706349|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706350|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44706351|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706352|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
44706353|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44706354|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
44706355|NCT01428154|Hematinics|hematinics|mesh-ancestor
44706356|NCT01428180|Ibuprofen|ibuprofen|mesh-list
44706357|NCT01428180|Indomethacin|indomethacin|mesh-list
44706358|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706359|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706360|NCT01428180|Analgesics|analgesics|mesh-ancestor
44706361|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
44706362|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706363|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706364|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706365|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706366|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44706367|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706368|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706369|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
44706370|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
44706371|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706372|NCT01428284|Canagliflozin|canagliflozin|mesh-list
44706373|NCT01428284|Probenecid|probenecid|mesh-list
44729016|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
44932215|NCT03739671|Vitamin D|vitamin d|mesh-list
44932216|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
44932217|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
44932218|NCT03739671|Vitamins|vitamins|mesh-list
44932219|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
44932220|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932221|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44932222|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44932223|NCT03739606|Antibodies|antibodies|mesh-list
44932224|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
44932225|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44932226|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44932227|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
44932228|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932229|NCT03739541|Benzonidazole|benzonidazole|mesh-list
44932230|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932231|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
44932232|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932233|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44932234|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44932235|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44932236|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932237|NCT05632445|Apixaban|apixaban|mesh-list
44932238|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44932239|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
44922879|NCT03855865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44922991|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922992|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
44922993|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44922994|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922995|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922996|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44922997|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
44922998|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44922999|NCT03854942|Naltrexone|naltrexone|mesh-list
44923000|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44923001|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44923002|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923003|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
44923131|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44923132|NCT03853200|Acetic Acid|acetic acid|mesh-list
44923133|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
44923134|NCT03853200|Edetic Acid|edetic acid|mesh-list
44923135|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
44923136|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44923137|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923138|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
44923139|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923140|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
44923141|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44923142|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
44923143|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
44923144|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923145|NCT03853200|Antidotes|antidotes|mesh-ancestor
44923146|NCT03853200|Protective Agents|protective agents|mesh-ancestor
44923194|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44923250|NCT03851432|Metformin|metformin|mesh-list
44923405|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44923406|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923407|NCT03849729|Phentermine|phentermine|mesh-list
44923408|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44923409|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923410|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
44923411|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44923412|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
44923413|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
44923414|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923415|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44923416|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923417|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932240|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44932241|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
44932242|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932243|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932244|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
44932245|NCT05632133|Lacosamide|lacosamide|mesh-list
44932246|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
44932247|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44932248|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44932249|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44932250|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932251|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44932252|NCT05631717|Aldesleukin|aldesleukin|mesh-list
44932253|NCT05631717|Interleukin-2|interleukin-2|mesh-list
44932254|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932255|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932256|NCT05631717|Analgesics|analgesics|mesh-ancestor
44932257|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
44932258|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932259|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932260|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44932261|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44932262|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
44932263|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932264|NCT05627544|Anesthetics|anesthetics|mesh-list
44932265|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932266|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932267|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
44932268|NCT05626387|Prednisolone|prednisolone|mesh-list
44932269|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44932270|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
44932271|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44932272|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
44932273|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44932274|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
44932275|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44932276|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932277|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44932278|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
44932279|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44932280|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932281|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932282|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932283|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932284|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
44932285|NCT05626387|Hormones|hormones|mesh-ancestor
44932286|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932287|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923573|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44923574|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923575|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923576|NCT03847558|Androgens|androgens|mesh-ancestor
44923577|NCT03847363|Anesthetics|anesthetics|mesh-list
44923578|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923579|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923580|NCT03847207|Pasireotide|pasireotide|mesh-list
44923581|NCT03847207|Hormones|hormones|mesh-ancestor
44923582|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923583|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923584|NCT03847246|Entecavir|entecavir|mesh-list
44923585|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
44923587|NCT03847155|Nicotine|nicotine|mesh-list
44923837|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923838|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
44923839|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
44923840|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44932288|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932289|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
44932290|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
44729128|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
44932291|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932292|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932293|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44932294|NCT05626387|Protective Agents|protective agents|mesh-ancestor
44932295|NCT05625555|Midazolam|midazolam|mesh-list
44932296|NCT05625555|Ketamine|ketamine|mesh-list
44932297|NCT05625555|Analgesics|analgesics|mesh-ancestor
44932298|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
44932299|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932300|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932301|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44932302|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44932303|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
44932304|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
44932305|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932306|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44932307|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44932308|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932309|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932310|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44932311|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44932312|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44932313|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44932314|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44932315|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
44932316|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
44932317|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44932318|NCT05617664|Mirabegron|mirabegron|mesh-list
44932319|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44932320|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44932321|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44932322|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44932323|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932324|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932325|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932326|NCT05617664|Urological Agents|urological agents|mesh-ancestor
44932327|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
44932328|NCT05617664|Coagulants|coagulants|mesh-ancestor
44932329|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44932330|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
44932331|NCT05616000|Folic Acid|folic acid|mesh-list
44932332|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
44932333|NCT05616000|Hematinics|hematinics|mesh-ancestor
44932334|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
44932335|NCT05616000|Vitamins|vitamins|mesh-ancestor
44932336|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
44932337|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932338|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
44932339|NCT05593601|Neomycin|neomycin|mesh-list
44932340|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44932341|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932342|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44932343|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932344|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932345|NCT05570786|Gestrinone|gestrinone|mesh-list
44932346|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44932347|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44932348|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44932349|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
44932350|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44932351|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932352|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44932353|NCT05570786|Progestins|progestins|mesh-ancestor
44932354|NCT05570786|Hormones|hormones|mesh-ancestor
44932355|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932356|NCT05570708|Psilocybin|psilocybin|mesh-list
44705247|NCT05386121|Fentanyl|fentanyl|mesh-list
44924035|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44924036|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924037|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
44924038|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
44924039|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924040|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44924041|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44924042|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924043|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924044|NCT03842631|Timolol|timolol|mesh-list
44924045|NCT03842631|Maleic acid|maleic acid|mesh-list
44924046|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44924047|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44924048|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924049|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924050|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924051|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924052|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44924053|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44924054|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924055|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
44924056|NCT03842488|Darunavir|darunavir|mesh-list
44924057|NCT03842488|Cobicistat|cobicistat|mesh-list
44924058|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44924059|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44924060|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
44924061|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924062|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44924063|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44924064|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924065|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924066|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44924067|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44924068|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44924071|NCT03842423|Anesthetics|anesthetics|mesh-list
44924170|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924171|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
44924172|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924173|NCT03841474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44924174|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
44924175|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924176|NCT03841136|Etoposide|etoposide|mesh-list
44924177|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44924178|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924179|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44924180|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44924181|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924182|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924183|NCT03840122|Anesthetics|anesthetics|mesh-list
44924184|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
44924185|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924186|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924187|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
44924188|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924189|NCT03840057|Azithromycin|azithromycin|mesh-list
44924190|NCT03840057|Metoclopramide|metoclopramide|mesh-list
44924191|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44924192|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924193|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
44924194|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
44924195|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924196|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924197|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924198|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44924199|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44924200|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
44924201|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924202|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932357|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
44932358|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932359|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44932360|NCT05569811|Letrozole|letrozole|mesh-list
44932361|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44932362|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932363|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44932364|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924353|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924354|NCT03827408|Analgesics|analgesics|mesh-ancestor
44924355|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
44924356|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924357|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44924358|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44924359|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44924360|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924361|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924362|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924363|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44924364|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44924365|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924366|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924367|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924368|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
44924369|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
44924370|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
44924371|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
44924372|NCT03827044|Avelumab|avelumab|mesh-list
44924373|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924374|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932365|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932366|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932367|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44932373|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
44932374|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932375|NCT05546567|Niacinamide|niacinamide|mesh-list
44932376|NCT05546567|Niacin|niacin|mesh-list
44932377|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
44932378|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
44932379|NCT05546567|Vitamins|vitamins|mesh-ancestor
44932380|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
44932381|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932382|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44932383|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
44932384|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932385|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44932386|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
44932387|NCT05505409|Pirfenidone|pirfenidone|mesh-list
44932388|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
44932389|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44932390|NCT05505409|Hormones|hormones|mesh-ancestor
44932391|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932392|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932393|NCT05505409|Analgesics|analgesics|mesh-ancestor
44932394|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
44932395|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932396|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44932397|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932398|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932399|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932400|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932401|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
44932402|NCT05499832|Tenecteplase|tenecteplase|mesh-list
44924452|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44924626|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44924627|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924628|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924629|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44924630|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44924631|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924632|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924633|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
44924634|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44924635|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924636|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924637|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924638|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44924639|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44924640|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924641|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
44924642|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44924643|NCT03818919|Narcotics|narcotics|mesh-ancestor
44924644|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
44924645|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
44924646|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44924647|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
44924648|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
44924649|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924650|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924651|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44924652|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44924653|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924654|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
44924655|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
44924656|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
44924657|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
44932403|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44932404|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44932405|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706374|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44706375|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706376|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706377|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706378|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
44706379|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
44706380|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706381|NCT01428284|Renal Agents|renal agents|mesh-ancestor
44706382|NCT01428375|Acetaminophen|acetaminophen|mesh-list
44924658|NCT03818581|Suvorexant|suvorexant|mesh-list
44924732|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924757|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924758|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924759|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
44924760|NCT03817112|Propofol|propofol|mesh-list
44924761|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924762|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924763|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924764|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924765|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
44924766|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
44924767|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924768|NCT03817112|Analgesics|analgesics|mesh-ancestor
44924769|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
44924770|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924771|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44924772|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44925042|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925043|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925044|NCT03813979|Dolutegravir|dolutegravir|mesh-list
44925045|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44925046|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44925047|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925048|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925049|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44925050|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44925051|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
44925052|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925053|NCT03814148|Indapamide|indapamide|mesh-list
44925054|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44925055|NCT03814148|Diuretics|diuretics|mesh-ancestor
44925056|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
44925057|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925058|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44925059|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925060|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705431|NCT04765371|BB 1101|bb 1101|mesh-list
44706383|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706384|NCT01428375|Analgesics|analgesics|mesh-ancestor
44706385|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
44706386|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706387|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706388|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
44706389|NCT01428388|Bevacizumab|bevacizumab|mesh-list
44706390|NCT01428388|Ranibizumab|ranibizumab|mesh-list
44706391|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706392|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706393|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44706394|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44706395|NCT01428388|Growth Substances|growth substances|mesh-ancestor
44706396|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706397|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
44706398|NCT01428414|Paclitaxel|paclitaxel|mesh-list
44706399|NCT01428414|Carboplatin|carboplatin|mesh-list
44706400|NCT01428414|Trastuzumab|trastuzumab|mesh-list
44706401|NCT01428414|Epirubicin|epirubicin|mesh-list
44706402|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44706403|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706404|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
44706405|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
44706406|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932406|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44932407|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44932408|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44932409|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44932410|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932411|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932412|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932414|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
44932415|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932416|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
44932417|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925061|NCT03813927|Vitamin D|vitamin d|mesh-list
44925144|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
44925285|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925286|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925287|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925288|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925289|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
44925290|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925291|NCT03812770|Antidotes|antidotes|mesh-ancestor
44925292|NCT03812770|Protective Agents|protective agents|mesh-ancestor
44925293|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
44925294|NCT03812770|Vitamins|vitamins|mesh-ancestor
44925295|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
44925296|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925297|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925298|NCT03812354|Nicotine|nicotine|mesh-list
44925299|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44925300|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
44925301|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925302|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925303|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44925304|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44925305|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
44925306|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925307|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925308|NCT03812315|Propolis|propolis|mesh-list
44925309|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925310|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44925311|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
44925312|NCT03812120|Coagulants|coagulants|mesh-ancestor
44925313|NCT03812003|Remifentanil|remifentanil|mesh-list
44925314|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925315|NCT03812003|Narcotics|narcotics|mesh-ancestor
44925316|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925436|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925437|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
44925438|NCT03810261|Vitamin D|vitamin d|mesh-list
44925439|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
44925440|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
44925441|NCT03810261|Vitamins|vitamins|mesh-list
44925442|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
44925443|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925444|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44925445|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44925446|NCT03809897|Nicotine|nicotine|mesh-list
44925447|NCT03809897|Varenicline|varenicline|mesh-list
44925686|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925687|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925688|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44925689|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44721599|NCT01520818|Insulin|insulin|mesh-list
44932418|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
44932419|NCT05387642|Pramoxine|pramoxine|mesh-list
44932420|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
44932421|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
44932422|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932423|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932424|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
44932425|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932426|NCT05331911|Propofol|propofol|mesh-list
44932427|NCT05331911|Sevoflurane|sevoflurane|mesh-list
44932428|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44932429|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932430|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932431|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44932432|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
44932433|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
44932434|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44932435|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44932436|NCT05269706|Cannabidiol|cannabidiol|mesh-list
44932437|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
44932438|NCT05259696|Pembrolizumab|pembrolizumab|mesh-list
44932439|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932440|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932441|NCT05234684|Prednisone|prednisone|mesh-list
44932442|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
44932443|NCT05234684|Vincristine|vincristine|mesh-list
44932444|NCT05234684|Rituximab|rituximab|mesh-list
44932445|NCT05234684|Doxorubicin|doxorubicin|mesh-list
44932446|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932447|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
44932448|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932449|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932450|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932451|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
44932452|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932453|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932454|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44932455|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932456|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
44932457|NCT05234684|Hormones|hormones|mesh-ancestor
44932458|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932459|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932460|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932461|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932462|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932463|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932464|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932465|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44932466|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44932467|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44932468|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932469|NCT05077488|Lidocaine|lidocaine|mesh-list
44932470|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
44932471|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
44932472|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932473|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932474|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
44932475|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932476|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44932477|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44932478|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44932479|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44932489|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932490|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932491|NCT04833946|Andrographolide|andrographolide|mesh-list
44932492|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925861|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44925862|NCT03796364|Growth Substances|growth substances|mesh-ancestor
44925863|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925864|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
44925865|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925866|NCT03795909|Dexamethasone|dexamethasone|mesh-list
44925867|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925868|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
44925869|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
44925870|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925871|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925872|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925873|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
44925874|NCT03795909|Hormones|hormones|mesh-ancestor
44925875|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925876|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44925877|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925878|NCT03795844|Liver Extracts|liver extracts|mesh-list
44925879|NCT03795844|Hematinics|hematinics|mesh-ancestor
44925880|NCT03795792|Curcumin|curcumin|mesh-list
44925881|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44925882|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44925883|NCT03795792|Analgesics|analgesics|mesh-ancestor
44925884|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
44925885|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925886|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925887|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925888|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44925889|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925890|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925891|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925892|NCT03795584|Hemostatics|hemostatics|mesh-list
44925893|NCT03795584|Coagulants|coagulants|mesh-ancestor
44705576|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932493|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44932494|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932495|NCT04833946|Analgesics|analgesics|mesh-ancestor
44932496|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
44932497|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932498|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932499|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932500|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925974|NCT03795207|Durvalumab|durvalumab|mesh-list
44926117|NCT03794167|Melphalan|melphalan|mesh-list
44926118|NCT03794167|Busulfan|busulfan|mesh-list
44926119|NCT03794167|Etoposide|etoposide|mesh-list
44926120|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926121|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
44926122|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926123|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926124|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44926125|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
44926126|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926127|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926128|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44926129|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44926130|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44926131|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44926132|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926133|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
44926134|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926135|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
44926136|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926137|NCT03794297|Trametinib|trametinib|mesh-list
44926138|NCT03794297|Dabrafenib|dabrafenib|mesh-list
44926139|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44926140|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926141|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926142|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926143|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926144|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44926145|NCT03794297|Protective Agents|protective agents|mesh-ancestor
44926146|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926147|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44926148|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
44926149|NCT03793725|Apatinib|apatinib|mesh-list
44926154|NCT03793517|Decitabine|decitabine|mesh-list
44926160|NCT03793309|Vitamin D|vitamin d|mesh-list
44926188|NCT03793205|Lenograstim|lenograstim|mesh-list
44926490|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
44926491|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44926492|NCT03791762|Protective Agents|protective agents|mesh-ancestor
44926493|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705624|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44705625|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705626|NCT03945084|Niraparib|niraparib|mesh-list
44705627|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44705628|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705629|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705630|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705631|NCT03882463|Insulin|insulin|mesh-list
44705632|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705633|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705634|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
44705635|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705636|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
44722546|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44932501|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44932502|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932503|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
44932504|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44932505|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
44932506|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932507|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932508|NCT04753515|Midazolam|midazolam|mesh-list
44932509|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
44932510|NCT04753515|Remifentanil|remifentanil|mesh-list
44932511|NCT04753515|Propofol|propofol|mesh-list
44932512|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44932513|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932514|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932515|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44932516|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
44932517|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
44932518|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932519|NCT04753515|Analgesics|analgesics|mesh-ancestor
44932520|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
44932521|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932522|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44932523|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44932524|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44932525|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44932526|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932527|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932528|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44932529|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44932530|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44932531|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44932532|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
44932533|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
44932534|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44932535|NCT04753515|Narcotics|narcotics|mesh-ancestor
44932536|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44932537|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
44932538|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
44932539|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932540|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932541|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44926643|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
44926715|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926716|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926717|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44926718|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
44926719|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
44926720|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
44926721|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926722|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926723|NCT03790085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44926724|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44926725|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926726|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44926727|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
44926728|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44926729|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44926730|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44926731|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44926732|NCT03790007|Bupivacaine|bupivacaine|mesh-list
44926733|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926734|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
44926735|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926736|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926737|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
44926738|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926739|NCT03789695|Dabigatran|dabigatran|mesh-list
44926740|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
44926741|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44926742|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
44926743|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926744|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926745|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
44926746|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
44926747|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
44926748|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44926749|NCT03789799|Protective Agents|protective agents|mesh-ancestor
44926750|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927017|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927018|NCT03787641|Coagulants|coagulants|mesh-ancestor
44932542|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44932543|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
44932544|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932545|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932546|NCT04749108|Folfirinox|folfirinox|mesh-list
44932547|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932548|NCT04730219|Paclitaxel|paclitaxel|mesh-list
44932549|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932550|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932551|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932552|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932553|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932554|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932555|NCT04681417|Carboplatin|carboplatin|mesh-list
44932556|NCT04681417|Etoposide|etoposide|mesh-list
44932557|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
44932558|NCT04681417|Vincristine|vincristine|mesh-list
44932559|NCT04681417|Melphalan|melphalan|mesh-list
44932560|NCT04681417|Topotecan|topotecan|mesh-list
44932561|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932562|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932563|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44932564|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44932565|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932566|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932567|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932568|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932569|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932570|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932571|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
44932572|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44932573|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932574|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
44932575|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932576|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44932577|NCT04674683|Nivolumab|nivolumab|mesh-list
44932578|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932579|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932580|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44932581|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932582|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
44932583|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44932584|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
44932585|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44932586|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932587|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44932588|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44932589|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44932590|NCT04662567|Acetaminophen|acetaminophen|mesh-list
44932591|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44932592|NCT04662567|Analgesics|analgesics|mesh-ancestor
44932593|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
44932594|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932595|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932596|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
44932597|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
44932598|NCT04393350|Lenvatinib|lenvatinib|mesh-list
44932599|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932600|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932601|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932602|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932603|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932604|NCT04389177|Paclitaxel|paclitaxel|mesh-list
44932605|NCT04389177|Cisplatin|cisplatin|mesh-list
44932606|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
44932607|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932608|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932609|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932610|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932611|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932612|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927188|NCT03785184|Dexamethasone|dexamethasone|mesh-list
44927189|NCT03785184|Lenalidomide|lenalidomide|mesh-list
44927190|NCT03785184|Venetoclax|venetoclax|mesh-list
44927191|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927192|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
44927193|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
44927194|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927195|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927196|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927197|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
44927198|NCT03785184|Hormones|hormones|mesh-ancestor
44927199|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927200|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44927201|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927202|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
44927203|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44927204|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44927205|NCT03785184|Growth Substances|growth substances|mesh-ancestor
44927206|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
44927207|NCT03785041|Tramadol|tramadol|mesh-list
44927208|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
44927209|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927210|NCT03785041|Narcotics|narcotics|mesh-ancestor
44927211|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927212|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927213|NCT03785041|Analgesics|analgesics|mesh-ancestor
44927214|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
44927215|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927216|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927217|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
44932613|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932614|NCT04351256|Durvalumab|durvalumab|mesh-list
44932615|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932616|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932617|NCT04336098|Gemcitabine|gemcitabine|mesh-list
44932618|NCT04336098|Paclitaxel|paclitaxel|mesh-list
44932619|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
44932620|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44932621|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932622|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932623|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932624|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932625|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932626|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932627|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44932628|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
44932629|NCT04336098|Antiviral Agents|antiviral agents|mesh-ancestor
44932630|NCT04336098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927293|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44927426|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927427|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927428|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44927429|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44927430|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927431|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927432|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
44927433|NCT03783429|Digoxin|digoxin|mesh-list
44927434|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927435|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44927436|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927740|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44927741|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44927742|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927743|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
44927744|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44927745|NCT03780634|Sorafenib|sorafenib|mesh-list
44927746|NCT03780634|Antibodies|antibodies|mesh-list
44927747|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
44927748|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
44927749|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927750|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927751|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44927752|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927753|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927754|NCT03780192|Sirolimus|sirolimus|mesh-list
44927755|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927756|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927757|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44927758|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927759|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
44927760|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927761|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
44927762|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927763|NCT03780569|Temozolomide|temozolomide|mesh-list
44927764|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44927765|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
44927782|NCT03780361|Aflibercept|aflibercept|mesh-list
44928063|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
44928139|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928140|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
44928141|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
44928142|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928143|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
44928144|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44928145|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44928146|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44928147|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44928148|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928149|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44928150|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
44928151|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928152|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928153|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44928154|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928155|NCT03778008|Hematinics|hematinics|mesh-ancestor
44724443|NCT01535989|Sirolimus|sirolimus|mesh-list
44932631|NCT04336098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932632|NCT04336098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932633|NCT04336098|Immunologic Factors|immunologic factors|mesh-ancestor
44932634|NCT04336098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932635|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932636|NCT04236258|Enalapril|enalapril|mesh-list
44932637|NCT04236258|Nifedipine|nifedipine|mesh-list
44932638|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44932639|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44932640|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932641|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44932642|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932643|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
44932644|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
44932645|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44932646|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44932647|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
44932648|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932649|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44932650|NCT04233879|Tenofovir|tenofovir|mesh-list
44932651|NCT04233879|Emtricitabine|emtricitabine|mesh-list
44932652|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44932653|NCT04233879|Islatravir|islatravir|mesh-list
44932654|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
44932655|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932656|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44932657|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44932658|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932659|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932660|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44932661|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44706407|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706408|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706409|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44706410|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44706411|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44706412|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706413|NCT01428427|Gemcitabine|gemcitabine|mesh-list
44928156|NCT03778242|Oxytocin|oxytocin|mesh-list
44928233|NCT03777644|Morphine|morphine|mesh-list
44928315|NCT03776838|Fentanyl|fentanyl|mesh-list
44928370|NCT03776279|Analgesics|analgesics|mesh-ancestor
44928371|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
44928372|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928373|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928374|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928375|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44928376|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44928377|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928378|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928379|NCT03776305|Imipenem|imipenem|mesh-list
44928380|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928381|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928382|NCT03776240|Trastuzumab|trastuzumab|mesh-list
44928383|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928384|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928385|NCT03776058|Cinacalcet|cinacalcet|mesh-list
44928386|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928387|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928388|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44928389|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
44928390|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928391|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
44928392|NCT03776032|Hematinics|hematinics|mesh-ancestor
44928393|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
44928394|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928395|NCT03775993|Hormones|hormones|mesh-list
44928396|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928397|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706414|NCT01428427|Trametinib|trametinib|mesh-list
44706415|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44706416|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
44706417|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706418|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706419|NCT01428427|Antiviral Agents|antiviral agents|mesh-ancestor
44706420|NCT01428427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706421|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706422|NCT01428427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706423|NCT01428427|Immunologic Factors|immunologic factors|mesh-ancestor
44706424|NCT01428427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706425|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44706426|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44706427|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706428|NCT01428492|Dexamethasone|dexamethasone|mesh-list
44706429|NCT01428492|Bortezomib|bortezomib|mesh-list
44706430|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706431|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
44706432|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
44928398|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
44928625|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44928626|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705853|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705854|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44705855|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44705856|NCT02197221|Bortezomib|bortezomib|mesh-list
44705857|NCT02197221|Melphalan|melphalan|mesh-list
44705858|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705859|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44705860|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
44705861|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705862|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44705863|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705864|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
44705865|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705866|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
44705867|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44705868|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
44705869|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705870|NCT02124941|Expectorants|expectorants|mesh-ancestor
44705871|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
44705872|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44705873|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
44705874|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705875|NCT02124941|Protective Agents|protective agents|mesh-ancestor
44705876|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705877|NCT02124941|Antidotes|antidotes|mesh-ancestor
44705878|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
44705879|NCT02094794|Etoposide|etoposide|mesh-list
44705880|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
44705881|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705894|NCT02010385|Octreotide|octreotide|mesh-list
44928793|NCT03771846|Antidotes|antidotes|mesh-ancestor
44928856|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44928857|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44928858|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928859|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928860|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44928861|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44705895|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705896|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705897|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705898|NCT01949714|Epinephrine|epinephrine|mesh-list
44705899|NCT01949714|Racepinephrine|racepinephrine|mesh-list
44705900|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
44706433|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706434|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706435|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706436|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
44706437|NCT01428492|Hormones|hormones|mesh-ancestor
44706438|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706439|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44706440|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706441|NCT01428518|Lamotrigine|lamotrigine|mesh-list
44706442|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
44706443|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44706444|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706445|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706446|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706447|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706448|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44706449|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44706450|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706451|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44706452|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44706453|NCT01428531|PENTA|penta|mesh-list
44706454|NCT01428531|Fondaparinux|fondaparinux|mesh-list
44706455|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44706456|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
44706457|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44706458|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
44729621|NCT01571908|Rocuronium|rocuronium|mesh-list
44932662|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
44932663|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44932664|NCT04223765|Fludarabine|fludarabine|mesh-list
44932665|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932666|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
44932667|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932668|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932669|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932670|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
44932671|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932672|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932673|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44932674|NCT04218851|Posaconazole|posaconazole|mesh-list
44932675|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
44932676|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932677|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44932678|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44932679|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44932680|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44932681|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44932682|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932683|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932684|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44928943|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
44929008|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929009|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
44929010|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929012|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44929282|NCT03767218|Hormones|hormones|mesh-ancestor
44929347|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929348|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929349|NCT03766867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44929350|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44929351|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44929352|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929353|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929354|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
44929355|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44929356|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44929357|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44929358|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44932685|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
44932686|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932687|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932689|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932690|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932691|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
44932692|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932693|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932694|NCT03991988|Montelukast|montelukast|mesh-list
44932695|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44932696|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
44932697|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44932698|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
44932699|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932700|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932701|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44932702|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44932703|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932704|NCT03936933|Goserelin|goserelin|mesh-list
44932705|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932706|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932707|NCT03936218|Goserelin|goserelin|mesh-list
44932708|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932709|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932710|NCT03933202|Cladribine|cladribine|mesh-list
44932711|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932712|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932713|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
44932714|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932715|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44932716|NCT03848403|Ixekizumab|ixekizumab|mesh-list
44932717|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44932718|NCT03842228|Durvalumab|durvalumab|mesh-list
44932719|NCT03842228|Olaparib|olaparib|mesh-list
44932720|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44932721|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
44932722|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44932723|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
44932724|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932725|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932726|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
44932727|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932728|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932729|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932730|NCT03840902|Paclitaxel|paclitaxel|mesh-list
44932731|NCT03840902|Etoposide|etoposide|mesh-list
44932732|NCT03840902|Cisplatin|cisplatin|mesh-list
44932733|NCT03840902|Carboplatin|carboplatin|mesh-list
44929359|NCT03766854|Insulin|insulin|mesh-list
44929482|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929483|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929484|NCT03765450|Infliximab|infliximab|mesh-list
44929485|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
44929486|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44929487|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929488|NCT03765346|Oxycodone|oxycodone|mesh-list
44929489|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929490|NCT03765346|Narcotics|narcotics|mesh-ancestor
44929759|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
44929760|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
44929761|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929762|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929763|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44929764|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44929765|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929766|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
44929767|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929768|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44929769|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44929770|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44929771|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44929772|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44929773|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44929774|NCT03762889|Anesthetics|anesthetics|mesh-list
44929775|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929776|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929777|NCT03762824|Vaccines|vaccines|mesh-list
44929778|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44929779|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
44929780|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929781|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
44929782|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929783|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929784|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929785|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929786|NCT03762785|Analgesics|analgesics|mesh-ancestor
44929787|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
44930018|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930019|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930020|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930021|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
44930022|NCT03760354|Hormones|hormones|mesh-ancestor
44930023|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930024|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44930025|NCT03760354|Protective Agents|protective agents|mesh-ancestor
44930026|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44930027|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930028|NCT03760302|Analgesics|analgesics|mesh-list
44930029|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44930030|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
44930218|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930219|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930508|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44930585|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930586|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930587|NCT03755310|Suvorexant|suvorexant|mesh-list
44930588|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44930589|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44930590|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930591|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930592|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44930593|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930594|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706052|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
44932734|NCT03840902|Pemetrexed|pemetrexed|mesh-list
44932735|NCT03840902|Durvalumab|durvalumab|mesh-list
44932736|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932752|NCT03724890|Peposertib|peposertib|mesh-list
44932753|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932754|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932755|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932756|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932757|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932758|NCT03684564|Warfarin|warfarin|mesh-list
44932759|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
44932760|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
44932761|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44932762|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
44932763|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44932764|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
44932765|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932766|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932767|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
44932768|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44932769|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44932770|NCT03661567|Prednisolone|prednisolone|mesh-list
44932771|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
44932772|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44932773|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
44932774|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932775|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
44932776|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
44932777|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932778|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932779|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932780|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
44932781|NCT03661567|Hormones|hormones|mesh-ancestor
44932782|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932783|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44932784|NCT03661567|Protective Agents|protective agents|mesh-ancestor
44932785|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932786|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932787|NCT03644186|Paclitaxel|paclitaxel|mesh-list
44932788|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44932789|NCT03644186|Trastuzumab|trastuzumab|mesh-list
44932790|NCT03644186|Letrozole|letrozole|mesh-list
44932791|NCT03644186|Palbociclib|palbociclib|mesh-list
44932792|NCT03644186|Pertuzumab|pertuzumab|mesh-list
44932793|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932794|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932795|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932796|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932797|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932798|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932799|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932800|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44930761|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930762|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930763|NCT03753477|Amlodipine|amlodipine|mesh-list
44930764|NCT03753477|Olmesartan|olmesartan|mesh-list
44930765|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44930766|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
44930767|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44930768|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44930769|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44930770|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930771|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930772|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44930773|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930774|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
44930775|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44930776|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44930777|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
44930778|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44930779|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44930780|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930781|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44930782|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44930783|NCT03753269|Fasudil|fasudil|mesh-list
44930784|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44930785|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930786|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930787|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44930788|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930789|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
44930790|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930791|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932801|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44932802|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932803|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44932804|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
44932805|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932806|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932807|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932808|NCT03636542|Bupivacaine|bupivacaine|mesh-list
44930943|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44930944|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44930945|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930946|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44930947|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
44930948|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930949|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930950|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44930951|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
44930952|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44930961|NCT03751202|Hormones|hormones|mesh-ancestor
44931081|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
44931225|NCT03749408|Diuretics|diuretics|mesh-ancestor
44931226|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
44931227|NCT03749356|Tacrolimus|tacrolimus|mesh-list
44931228|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931229|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
44931230|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931231|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44931232|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931233|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931234|NCT03749226|Aztreonam|aztreonam|mesh-list
44931235|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44931236|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44931237|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
44931238|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44931239|NCT03749096|Antibodies|antibodies|mesh-list
44931240|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
44931241|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44931242|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
44931243|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931244|NCT03748940|Mirikizumab|mirikizumab|mesh-list
44931245|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44931246|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44931247|NCT03748940|Analgesics|analgesics|mesh-ancestor
44931248|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
44931249|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931250|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931251|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931252|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931253|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44931254|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706129|NCT01426906|Rifampin|rifampin|mesh-list
44706130|NCT01426906|Ketoconazole|ketoconazole|mesh-list
44706131|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44706132|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
44931408|NCT03747341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44931409|NCT03747341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44931410|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
44931411|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931412|NCT03747094|Fentanyl|fentanyl|mesh-list
44931413|NCT03747094|Ketamine|ketamine|mesh-list
44931414|NCT03747094|Analgesics|analgesics|mesh-ancestor
44931415|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
44931416|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44931417|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931418|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44931419|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44931420|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
44931421|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
44931422|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44931423|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44931424|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44931425|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931426|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931427|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44931428|NCT03747094|Narcotics|narcotics|mesh-ancestor
44931429|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44931430|NCT03747081|Warfarin|warfarin|mesh-list
44931431|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
44931432|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
44931433|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44931434|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
44931435|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44931480|NCT03746340|Propofol|propofol|mesh-list
44931626|NCT03745261|Xhance|xhance|mesh-list
44931674|NCT03745105|Hormones|hormones|mesh-ancestor
44931746|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44931747|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931748|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44931749|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44931750|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
44931751|NCT03744247|Lenvatinib|lenvatinib|mesh-list
44931752|NCT03744247|Antibodies|antibodies|mesh-list
44931753|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
44931754|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
44931755|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931756|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931757|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44931758|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931759|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931760|NCT03744208|Antibodies|antibodies|mesh-list
44931761|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44931762|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
44931763|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728533|NCT05219604|Promethazine|promethazine|mesh-list
44932809|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44932810|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
44932811|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932812|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932813|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
44932814|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932815|NCT03629340|Metformin|metformin|mesh-list
44932816|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44932817|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932818|NCT03617172|Misoprostol|misoprostol|mesh-list
44932819|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44932820|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
44932821|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44932822|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932823|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44932824|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932825|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
44932826|NCT03512223|Dexamethasone|dexamethasone|mesh-list
44932827|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44932829|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
44932830|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932831|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932832|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932833|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
44932834|NCT03512223|Hormones|hormones|mesh-ancestor
44932835|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932836|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44932837|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932838|NCT03464734|Paclitaxel|paclitaxel|mesh-list
44932839|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
44932840|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44932841|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932842|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932843|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932844|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932845|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932846|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932847|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932848|NCT03345784|Cisplatin|cisplatin|mesh-list
44931777|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44931931|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
44931959|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44931960|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931961|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44931962|NCT03742258|Prednisone|prednisone|mesh-list
44931963|NCT03742258|Cortisone|cortisone|mesh-list
44931964|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
44931965|NCT03742258|Rituximab|rituximab|mesh-list
44931966|NCT03742258|Doxorubicin|doxorubicin|mesh-list
44931967|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44931968|NCT03742258|Vincristine|vincristine|mesh-list
44931969|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44931970|NCT03742258|Antibodies|antibodies|mesh-list
44931971|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
44931972|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44931973|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44931974|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
44931975|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44931976|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44931977|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44931978|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
44931979|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44931980|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44931981|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44931982|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44931983|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44931984|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44931985|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44931986|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44931987|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
44931988|NCT03742258|Hormones|hormones|mesh-ancestor
44931989|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44931990|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44931991|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44931992|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44931993|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44931994|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44931995|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44931998|NCT03742180|Ketorolac|ketorolac|mesh-list
44932185|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44932186|NCT03740243|Naloxone|naloxone|mesh-list
44932187|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44932188|NCT03740243|Narcotics|narcotics|mesh-ancestor
44932189|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44932190|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932191|NCT03740243|Analgesics|analgesics|mesh-ancestor
44932192|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
44932193|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44932194|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44932195|NCT03740178|Donepezil|donepezil|mesh-list
44932196|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44932197|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932198|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932199|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
44932200|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44932201|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932202|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
44932203|NCT03739801|Irinotecan|irinotecan|mesh-list
44932204|NCT03739801|Ramucirumab|ramucirumab|mesh-list
44932205|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44932206|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44932207|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932208|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932209|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932210|NCT03739788|BMS-986165|bms-986165|mesh-list
44932211|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44932212|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932213|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932214|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729055|NCT02553941|Azacitidine|azacitidine|mesh-list
44932849|NCT03345784|Adavosertib|adavosertib|mesh-list
44932850|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932851|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932852|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932853|NCT03255252|Cisplatin|cisplatin|mesh-list
44932854|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932855|NCT03249142|Durvalumab|durvalumab|mesh-list
44932856|NCT03249142|Tremelimumab|tremelimumab|mesh-list
44932857|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44932858|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932859|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932860|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
44932861|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932862|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
44932368|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
44932369|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44932370|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932371|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932372|NCT05553301|Vaccines|vaccines|mesh-list
44932413|NCT05396014|Analgesics|analgesics|mesh-ancestor
44932480|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932481|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44932482|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44932483|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932484|NCT04904692|Dimercaprol|dimercaprol|mesh-list
44932485|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
44932486|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
44932487|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932863|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44932864|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932865|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932866|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
44932867|NCT03190265|Nivolumab|nivolumab|mesh-list
44932868|NCT03190265|Ipilimumab|ipilimumab|mesh-list
44932869|NCT03190265|Pancrelipase|pancrelipase|mesh-list
44932870|NCT03190265|Vaccines|vaccines|mesh-list
44932871|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
44932872|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932873|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932874|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932875|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932876|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
44932877|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932878|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932879|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44932880|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932881|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44932882|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932883|NCT03172754|Nivolumab|nivolumab|mesh-list
44932884|NCT03172754|Axitinib|axitinib|mesh-list
44932885|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932886|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932887|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44932888|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932889|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44932890|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932891|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
44932892|NCT03012386|Citric Acid|citric acid|mesh-list
44932893|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
44932894|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
44932895|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44932896|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
44932897|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
44932898|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932899|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
44932900|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44932901|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44729870|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
44932902|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932903|NCT03012386|Urological Agents|urological agents|mesh-ancestor
44932904|NCT03001817|Fenofibrate|fenofibrate|mesh-list
44932905|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44932906|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
44932907|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932908|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44932909|NCT02965898|Vitamin D|vitamin d|mesh-list
44932910|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
44932911|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
44932912|NCT02965898|Vitamins|vitamins|mesh-list
44932913|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
44932914|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932915|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44932916|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44932917|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
44932918|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
44932919|NCT02918292|Fludarabine|fludarabine|mesh-list
44932920|NCT02918292|Tacrolimus|tacrolimus|mesh-list
44932921|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
44932488|NCT04893252|Durvalumab|durvalumab|mesh-list
44932688|NCT04212013|Rituximab|rituximab|mesh-list
44932737|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932738|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932739|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932740|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932741|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932742|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44932743|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44932744|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932745|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44932746|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44932747|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44932748|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44932749|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
44932750|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932922|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44932923|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932924|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
44932925|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932926|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44932927|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44932928|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
44932929|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932930|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932931|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44932932|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44932933|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932934|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44932935|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44932936|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
44932937|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44932938|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932939|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
44932940|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44932941|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
44932942|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44932943|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
44932944|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932945|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
44932946|NCT02861183|Protective Agents|protective agents|mesh-ancestor
44932947|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
44932948|NCT02616302|Lansoprazole|lansoprazole|mesh-list
44932949|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44932950|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932951|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44932952|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932953|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932954|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
44932955|NCT02615184|Lansoprazole|lansoprazole|mesh-list
44932956|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44932957|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44932958|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44932959|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706459|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706460|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706461|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
44706462|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44706463|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44257997|NCT00627692|Prucalopride|prucalopride|mesh-list
44706465|NCT01428544|Fondaparinux|fondaparinux|mesh-list
44706466|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44706467|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
44932751|NCT03724890|Avelumab|avelumab|mesh-list
44932828|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
44706468|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44706469|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44706470|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706471|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706472|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
44706473|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44932960|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932961|NCT02585895|Evolocumab|evolocumab|mesh-list
44932962|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44932963|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44932964|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
44932965|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932966|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44932967|NCT02584647|Sirolimus|sirolimus|mesh-list
44932968|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44932969|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44932970|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44932971|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932972|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
44932973|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44932974|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
44932975|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44932976|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44932977|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44932978|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44932979|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
44932980|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932981|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44932982|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44932983|NCT02542293|Gemcitabine|gemcitabine|mesh-list
44932984|NCT02542293|Paclitaxel|paclitaxel|mesh-list
44932985|NCT02542293|Cisplatin|cisplatin|mesh-list
44932986|NCT02542293|Carboplatin|carboplatin|mesh-list
44932987|NCT02542293|Pemetrexed|pemetrexed|mesh-list
44932988|NCT02542293|Durvalumab|durvalumab|mesh-list
44932989|NCT02542293|Tremelimumab|tremelimumab|mesh-list
44932990|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44932991|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44932992|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44932993|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44932994|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44932995|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44932996|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44932997|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
44932998|NCT02542293|Antiviral Agents|antiviral agents|mesh-ancestor
44932999|NCT02542293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933000|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933001|NCT02542293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933002|NCT02542293|Immunologic Factors|immunologic factors|mesh-ancestor
44933003|NCT02542293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933004|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44933005|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44933006|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933007|NCT02414750|Vemurafenib|vemurafenib|mesh-list
44933008|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933009|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44933010|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933011|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933012|NCT02359513|Fluoxetine|fluoxetine|mesh-list
44933013|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
44933014|NCT02359513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44933015|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44933016|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933017|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933018|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933019|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
44933020|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933021|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44933022|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44933023|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44933024|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44933025|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933026|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44933027|NCT02296125|Gefitinib|gefitinib|mesh-list
44933028|NCT02296125|Osimertinib|osimertinib|mesh-list
44933029|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933030|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44933031|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933032|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933033|NCT02217267|Lidocaine|lidocaine|mesh-list
44933034|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933035|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
44933036|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933037|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933038|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
44730006|NCT01573806|Exenatide|exenatide|mesh-list
44933039|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933040|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933041|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933042|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933043|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933044|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933045|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
44933046|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933047|NCT01879319|Evolocumab|evolocumab|mesh-list
44933048|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44933049|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44933050|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44933051|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
44933052|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933053|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44933054|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
44933055|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933056|NCT01811368|Cyclosporine|cyclosporine|mesh-list
44933057|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
44933058|NCT01811368|Rituximab|rituximab|mesh-list
44933059|NCT01811368|Cyclosporins|cyclosporins|mesh-list
44933060|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
44933061|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44933062|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
44933063|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933064|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933065|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
44933066|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933067|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933068|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933069|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933070|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933071|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
44933072|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933073|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933074|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44933075|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44933076|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44933077|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
44933078|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933079|NCT01765400|Clopidogrel|clopidogrel|mesh-list
44933080|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44933081|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44933082|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44933083|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44933084|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44933085|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
44933086|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933087|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933088|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933089|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44933090|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
44933091|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933092|NCT01613118|Irbesartan|irbesartan|mesh-list
44933093|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44933094|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44933095|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44933096|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933097|NCT01495676|Gemcitabine|gemcitabine|mesh-list
44933098|NCT01495676|Cisplatin|cisplatin|mesh-list
44706474|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44706475|NCT01428622|Olodaterol|olodaterol|mesh-list
44706476|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44706477|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
44706478|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706479|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706480|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44706481|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706482|NCT01428817|Carbetocin|carbetocin|mesh-list
44706483|NCT01428817|Oxytocin|oxytocin|mesh-list
44706484|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
44706485|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706486|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706487|NCT01428908|Vaccines|vaccines|mesh-list
44706488|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
44933099|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933100|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44933101|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
44933102|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933103|NCT01495676|Antiviral Agents|antiviral agents|mesh-ancestor
44933104|NCT01495676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933105|NCT01495676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933106|NCT01495676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933107|NCT01495676|Immunologic Factors|immunologic factors|mesh-ancestor
44933108|NCT01495676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933109|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
44933110|NCT00858364|Hematinics|hematinics|mesh-ancestor
44933111|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
44933112|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44933113|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933114|NCT03739294|Fluticasone|fluticasone|mesh-list
44933115|NCT03739294|Xhance|xhance|mesh-list
44933116|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933117|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44933118|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
44933119|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933120|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933121|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44933122|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44933123|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933124|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44933125|NCT03739112|Vaccines|vaccines|mesh-list
44933126|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
44933127|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933128|NCT03739021|Ropivacaine|ropivacaine|mesh-list
44933129|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933130|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
44933131|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933132|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933133|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
44933134|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933135|NCT03738956|Tofacitinib|tofacitinib|mesh-list
44933136|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44933137|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933138|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933139|NCT03738943|Pyridoxine|pyridoxine|mesh-list
44933140|NCT03738943|Pyridoxal|pyridoxal|mesh-list
44933141|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
44933142|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44933143|NCT03738943|Adenosine|adenosine|mesh-list
44933144|NCT03738943|Nitroprusside|nitroprusside|mesh-list
44933145|NCT03738943|Acetylcholine|acetylcholine|mesh-list
44933146|NCT03738943|Vitamins|vitamins|mesh-ancestor
44933147|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
44933148|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933149|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
44933150|NCT03738943|Analgesics|analgesics|mesh-ancestor
44933151|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
44933152|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933153|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933154|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
44933155|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44933156|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
44933157|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
44933158|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933159|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933160|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44933161|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44933162|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44933163|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44933164|NCT03738800|Trifarotene|trifarotene|mesh-list
44933165|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933166|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44933167|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933168|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
44933169|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44933170|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44933171|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933172|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
44933173|NCT03738527|Coagulants|coagulants|mesh-ancestor
44933174|NCT03738176|Triamcinolone|triamcinolone|mesh-list
44933175|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933176|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
44933177|NCT03738176|Hormones|hormones|mesh-ancestor
44933178|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933179|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933180|NCT03738137|Lidocaine|lidocaine|mesh-list
44933181|NCT03738137|Midazolam|midazolam|mesh-list
44933182|NCT03738137|Sufentanil|sufentanil|mesh-list
44933183|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933184|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
44933185|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933186|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933187|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
44933188|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933189|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934606|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
44934622|NCT03725020|Fluorides|fluorides|mesh-list
44934776|NCT03723135|Cc-486|cc-486|mesh-list
44933190|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933191|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933192|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933193|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933194|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44933195|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44933196|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44933197|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44933198|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44933199|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44933200|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
44933201|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
44933202|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
44933203|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933204|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44933205|NCT03738137|Narcotics|narcotics|mesh-ancestor
44933206|NCT03738137|Analgesics|analgesics|mesh-ancestor
44933207|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
44933208|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44933209|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933210|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933211|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933212|NCT03738059|Analgesics|analgesics|mesh-ancestor
44933213|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
44933214|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933215|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44933216|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44933217|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44933218|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933219|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933220|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933221|NCT03737968|Durvalumab|durvalumab|mesh-list
44933222|NCT03737968|Tremelimumab|tremelimumab|mesh-list
44933223|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44933224|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933225|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933226|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
44933227|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933228|NCT03737773|Methamphetamine|methamphetamine|mesh-list
44933229|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44933230|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933231|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
44933232|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
44933233|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933234|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
44933235|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933236|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730218|NCT01576094|Simendan|simendan|mesh-list
44933237|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933238|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44933239|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44933240|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933241|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44933242|NCT03737721|Avelumab|avelumab|mesh-list
44933243|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933244|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933245|NCT03737708|Adalimumab|adalimumab|mesh-list
44933246|NCT03737708|Methotrexate|methotrexate|mesh-list
44933247|NCT03737708|Abatacept|abatacept|mesh-list
44933248|NCT03737708|Tacrolimus|tacrolimus|mesh-list
44933249|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44933250|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
44933251|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44933252|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933253|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44933254|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
44933255|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933256|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933257|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933258|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933259|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44933260|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933261|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
44933262|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933263|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44933264|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44933265|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933266|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44933267|NCT03737656|Progesterone|progesterone|mesh-list
44933268|NCT03737656|Progestins|progestins|mesh-ancestor
44933269|NCT03737656|Hormones|hormones|mesh-ancestor
44933270|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933271|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933272|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
44933273|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
44933274|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933275|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933276|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933277|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
44933278|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
44933279|NCT03737448|Trimetazidine|trimetazidine|mesh-list
44933280|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
44933281|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44933282|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933283|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
44933284|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44933285|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44933286|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933287|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
44933288|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933289|NCT03736980|Psilocybin|psilocybin|mesh-list
44933290|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
44933291|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933292|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44933293|NCT03736369|Esomeprazole|esomeprazole|mesh-list
44933294|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44933295|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933296|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44933297|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933298|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933299|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
44933300|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933301|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933302|NCT03736187|Metronidazole|metronidazole|mesh-list
44933303|NCT03736187|Cephalexin|cephalexin|mesh-list
44933304|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933305|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933306|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44933307|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44933308|NCT03736161|Methotrexate|methotrexate|mesh-list
44933309|NCT03736161|Tofacitinib|tofacitinib|mesh-list
44933310|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44933311|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
44935549|NCT03716115|Budesonide|budesonide|mesh-list
44935624|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
44935648|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44933312|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730301|NCT01576692|Aldesleukin|aldesleukin|mesh-list
44933313|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933314|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44933315|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
44933316|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933317|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933318|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933319|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933320|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44933321|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933322|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
44933323|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933324|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44933325|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44935784|NCT03714165|Defensins|defensins|mesh-list
44935875|NCT03712735|Narcotics|narcotics|mesh-ancestor
44706489|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706490|NCT01428986|Maraviroc|maraviroc|mesh-list
44706491|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44706492|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44706493|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706494|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44706495|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44706496|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
44706497|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706498|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44706499|NCT01429025|Rituximab|rituximab|mesh-list
44706500|NCT01429025|Lenalidomide|lenalidomide|mesh-list
44706501|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44706502|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44935985|NCT03711708|Sertraline|sertraline|mesh-list
44706503|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706504|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
44706505|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706506|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706507|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44706508|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44706509|NCT01429025|Growth Substances|growth substances|mesh-ancestor
44707061|NCT01431690|Warfarin|warfarin|mesh-list
44936280|NCT03708848|Clarithromycin|clarithromycin|mesh-list
44936360|NCT03708458|Expectorants|expectorants|mesh-ancestor
44706510|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
44706511|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44706512|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
44933326|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44933327|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933328|NCT03735771|Bupivacaine|bupivacaine|mesh-list
44933329|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933330|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
44933331|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933332|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933333|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
44933334|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933335|NCT03735563|Fentanyl|fentanyl|mesh-list
44933336|NCT03735563|Ketamine|ketamine|mesh-list
44933337|NCT03735563|Analgesics|analgesics|mesh-ancestor
44933338|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
44933339|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933340|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933341|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44933342|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44933343|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
44933344|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
44933345|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933346|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44936441|NCT03707795|Hormones|hormones|mesh-ancestor
44936481|NCT03707535|Infliximab|infliximab|mesh-list
44933347|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44933348|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933349|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933350|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44933351|NCT03735563|Narcotics|narcotics|mesh-ancestor
44933352|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44933353|NCT03735446|Cytarabine|cytarabine|mesh-list
44933354|NCT03735446|Etoposide|etoposide|mesh-list
44933355|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
44933356|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44933357|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933358|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44933359|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44933360|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933361|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933362|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44933363|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
44933364|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
44933365|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933366|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933367|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
44933368|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933369|NCT03735446|Analgesics|analgesics|mesh-ancestor
44933370|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
44933371|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933372|NCT03735433|Aspirin|aspirin|mesh-list
44933373|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44933374|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933375|NCT03735433|Analgesics|analgesics|mesh-ancestor
44933376|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
44933377|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933378|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933379|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933380|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933381|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44933382|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44933383|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933384|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44933385|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44933386|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933387|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
44933388|NCT03735368|Pregabalin|pregabalin|mesh-list
44933389|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
44933390|NCT03735368|Benoxinate|benoxinate|mesh-list
44933391|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
44933392|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933393|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933394|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44933395|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933396|NCT03735368|Analgesics|analgesics|mesh-ancestor
44933397|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
44933398|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933399|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44933400|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44933401|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44933402|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933403|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933404|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933405|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
44933406|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44933407|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933408|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44933409|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44933410|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44933411|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44933412|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933413|NCT03735264|Docetaxel|docetaxel|mesh-list
44933414|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933415|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
44933416|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
44933417|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
44933418|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933419|NCT03735251|Metoprolol|metoprolol|mesh-list
44933420|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44933421|NCT03735251|Diuretics|diuretics|mesh-list
44933422|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
44933423|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933424|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933425|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44933426|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
44933427|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
44933428|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933429|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44933430|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44933431|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44933432|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933433|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933434|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933435|NCT03735134|Colchicine|colchicine|mesh-list
44933436|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
44933437|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933438|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
44933439|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
44933440|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
44933441|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933442|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933443|NCT03735082|Paclitaxel|paclitaxel|mesh-list
44933444|NCT03735082|Carboplatin|carboplatin|mesh-list
44933445|NCT03735082|Apatinib|apatinib|mesh-list
44937025|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44933446|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44933447|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933448|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44933449|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44933450|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44933451|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933452|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44933453|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933454|NCT03734627|Acetaminophen|acetaminophen|mesh-list
44933455|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
44933456|NCT03734627|Octreotide|octreotide|mesh-list
44933457|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933458|NCT03734627|Analgesics|analgesics|mesh-ancestor
44933459|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
44933460|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933461|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933462|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
44933463|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933464|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44933465|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933466|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933467|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44933468|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933469|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933470|NCT03734614|Aspirin|aspirin|mesh-list
44933471|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44933472|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933473|NCT03734614|Analgesics|analgesics|mesh-ancestor
44933474|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
44730486|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
44933475|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933476|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933477|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933478|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933479|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44933480|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44933481|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933482|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44933483|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44933484|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933485|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
44933486|NCT03734562|Amiodarone|amiodarone|mesh-list
44933487|NCT03734562|Sotalol|sotalol|mesh-list
44933488|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44933489|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44933490|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44933491|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933492|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933493|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933494|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44933495|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44937118|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
44933496|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933497|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44933498|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44933499|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44933500|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44933501|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44933502|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933503|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933504|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933505|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
44933506|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
44933507|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933508|NCT03734445|Vitamins|vitamins|mesh-list
44933509|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
44933510|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933511|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
44933512|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
44933513|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933514|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933515|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933516|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
44933517|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
44933518|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
44933519|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
44933520|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933521|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937267|NCT04698031|Aspirin|aspirin|mesh-list
44937470|NCT03476577|Ibuprofen|ibuprofen|mesh-list
44937544|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
44933522|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933523|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
44933524|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
44933525|NCT03734159|Ropivacaine|ropivacaine|mesh-list
44933526|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933527|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
44933528|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933529|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933530|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
44933531|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933532|NCT03734068|Doxorubicin|doxorubicin|mesh-list
44933533|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44933534|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933535|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44933536|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44933537|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933538|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937904|NCT00673010|Trace Elements|trace elements|mesh-ancestor
44933539|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44933540|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
44933541|NCT03733873|Coagulants|coagulants|mesh-ancestor
44933542|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44933543|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
44933544|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933545|NCT03733860|Alprostadil|alprostadil|mesh-list
44933546|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44933547|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
44933548|NCT03733860|Urological Agents|urological agents|mesh-ancestor
44933549|NCT03733691|Lenalidomide|lenalidomide|mesh-list
44933550|NCT03733691|Ixazomib|ixazomib|mesh-list
44933551|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
44933552|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933553|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44933554|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44933555|NCT03733691|Growth Substances|growth substances|mesh-ancestor
44933556|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
44933557|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933558|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
44933559|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933560|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933561|NCT03733652|Interferons|interferons|mesh-list
44933562|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
44933563|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
44933564|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933565|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
44933566|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933567|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
44933568|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933569|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44933570|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
44933571|NCT03733639|Coagulants|coagulants|mesh-ancestor
44933572|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
44933573|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933574|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
44938417|NCT04782830|Midodrine|midodrine|mesh-list
44933575|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933576|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933577|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44933578|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
44933579|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933580|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933581|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44933582|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44933583|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44933584|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44933585|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933586|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933587|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933588|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933589|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
44933590|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44933591|NCT03733561|Rotigotine|rotigotine|mesh-list
44933592|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
44933593|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
44933594|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933595|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933596|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933597|NCT03733379|Amoxicillin|amoxicillin|mesh-list
44933598|NCT03733379|Metronidazole|metronidazole|mesh-list
44933599|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933600|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933601|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44933602|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44933603|NCT03733340|Imipenem|imipenem|mesh-list
44933604|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933605|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933606|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
44933607|NCT03733327|Busulfan|busulfan|mesh-list
44933608|NCT03733327|Etoposide|etoposide|mesh-list
44933609|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933610|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
44933611|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933612|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44933613|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44933614|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
44933615|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933616|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933617|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44933618|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44933619|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44933620|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44933621|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730635|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44933622|NCT03733275|Lidocaine|lidocaine|mesh-list
44933623|NCT03733275|Bupivacaine|bupivacaine|mesh-list
44933624|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933625|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
44938471|NCT04691856|Analgesics|analgesics|mesh-ancestor
44933626|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933627|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933628|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
44933629|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933630|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933631|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933632|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933633|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933634|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933635|NCT03733171|Epinephrine|epinephrine|mesh-list
44933636|NCT03733171|Hemostatics|hemostatics|mesh-list
44933637|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44933638|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44933639|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933640|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933641|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933642|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933643|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44933644|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44933645|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
44933646|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933647|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44933648|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44933649|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
44933650|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
44933651|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44933652|NCT03733171|Coagulants|coagulants|mesh-ancestor
44933653|NCT03732963|Melatonin|melatonin|mesh-list
44933654|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
44938647|NCT02714322|Adalimumab|adalimumab|mesh-list
44938690|NCT01673867|Docetaxel|docetaxel|mesh-list
44938840|NCT02785224|Coagulants|coagulants|mesh-ancestor
44933655|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933656|NCT03732963|Protective Agents|protective agents|mesh-ancestor
44933657|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933658|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933659|NCT03732703|Thalidomide|thalidomide|mesh-list
44933660|NCT03732703|Dexamethasone|dexamethasone|mesh-list
44933661|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
44933662|NCT03732703|Venetoclax|venetoclax|mesh-list
44933663|NCT03732703|Daratumumab|daratumumab|mesh-list
44933664|NCT03732703|Pomalidomide|pomalidomide|mesh-list
44933665|NCT03732703|Ixazomib|ixazomib|mesh-list
44933666|NCT03732703|BB 1101|bb 1101|mesh-list
44933667|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44933668|NCT03732703|Glycine|glycine|mesh-list
44933669|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933670|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
44933671|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
44933672|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933673|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933674|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933675|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
44933676|NCT03732703|Hormones|hormones|mesh-ancestor
44933677|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933678|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44933679|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933680|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
44933681|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933682|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939342|NCT03948035|Elotuzumab|elotuzumab|mesh-list
44933683|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
44933684|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44933685|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44933686|NCT03732703|Growth Substances|growth substances|mesh-ancestor
44933687|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44933688|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933689|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
44933690|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933691|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933692|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
44933693|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933694|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
44933695|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44933696|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44933697|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
44933698|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933699|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44933700|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44933701|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933702|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933703|NCT03732547|Poly I-C|poly i-c|mesh-list
44933704|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
44933705|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933706|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
44933707|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
44933708|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933709|NCT03732508|Fluorouracil|fluorouracil|mesh-list
44933710|NCT03732508|Irinotecan|irinotecan|mesh-list
44706513|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706514|NCT01429090|Methantheline|methantheline|mesh-list
44706515|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44706516|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44706517|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706518|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706519|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706520|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706521|NCT01429129|Nicotine|nicotine|mesh-list
44706522|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44706523|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
44706524|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706525|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706526|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44706527|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44706528|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706529|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706530|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706531|NCT01429181|Methadone|methadone|mesh-list
44706532|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44706533|NCT01429181|Narcotics|narcotics|mesh-ancestor
44706534|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706535|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706536|NCT01429181|Analgesics|analgesics|mesh-ancestor
44706537|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
44939665|NCT05570812|Neurosteroids|neurosteroids|mesh-list
44706538|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706539|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
44706540|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706541|NCT01429337|Midostaurin|midostaurin|mesh-list
44706542|NCT01429337|Staurosporine|staurosporine|mesh-list
44706543|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706544|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44706545|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706546|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706547|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
44706548|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44706549|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44706550|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44706551|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706552|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706553|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706554|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706555|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706556|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44706557|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706558|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
44706559|NCT01429415|Analgesics|analgesics|mesh-ancestor
44706560|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
44706561|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706562|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706563|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
44706564|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706565|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44706566|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
44706567|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44706568|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706569|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706570|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706571|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
44706572|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706573|NCT01429545|Nifedipine|nifedipine|mesh-list
44706574|NCT01429545|Vasotocin|vasotocin|mesh-list
44706575|NCT01429545|Atosiban|atosiban|mesh-list
44706576|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44730786|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
44933711|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
44933712|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933713|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44933714|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933715|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44933716|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
44933717|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933718|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44933719|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44933720|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933721|NCT03732482|Temozolomide|temozolomide|mesh-list
44933722|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44933723|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
44933724|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933725|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933726|NCT03732469|Acetaminophen|acetaminophen|mesh-list
44933727|NCT03732469|Fentanyl|fentanyl|mesh-list
44933728|NCT03732469|Propofol|propofol|mesh-list
44933729|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44933730|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933731|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933732|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44933733|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
44933734|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
44933735|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44933736|NCT03732469|Narcotics|narcotics|mesh-ancestor
44933737|NCT03732469|Analgesics|analgesics|mesh-ancestor
44933738|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
44933739|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933740|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44933741|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44933742|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
44933743|NCT03732391|Carboplatin|carboplatin|mesh-list
44933744|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
44933745|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933746|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933747|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44933748|NCT03732365|Cefazolin|cefazolin|mesh-list
44933749|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933750|NCT03732287|Anesthetics|anesthetics|mesh-list
44933751|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933752|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933753|NCT03732235|Bevacizumab|bevacizumab|mesh-list
44933754|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
44933755|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44933756|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933757|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44933758|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44933759|NCT03732235|Growth Substances|growth substances|mesh-ancestor
44933760|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933761|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44933762|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44933763|NCT03732235|Estrogens|estrogens|mesh-ancestor
44933764|NCT03732235|Hormones|hormones|mesh-ancestor
44933765|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933766|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44933767|NCT03732105|Apatinib|apatinib|mesh-list
44933768|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44933769|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933770|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44933771|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933772|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933773|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44933774|NCT03732105|Growth Substances|growth substances|mesh-ancestor
44933775|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933776|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
44933777|NCT03732040|Fluorides|fluorides|mesh-list
44933778|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
44933779|NCT03732040|Protective Agents|protective agents|mesh-ancestor
44933780|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933781|NCT03732001|Docetaxel|docetaxel|mesh-list
44933782|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933783|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
44933784|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44933785|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
44933786|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933787|NCT03731988|Lidocaine|lidocaine|mesh-list
44933788|NCT03731988|Prilocaine|prilocaine|mesh-list
44933789|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44933790|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933791|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
44933792|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933793|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933794|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
44933795|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933796|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933797|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933798|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933799|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933800|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933801|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44933802|NCT03731897|Lidocaine|lidocaine|mesh-list
44933803|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933804|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
44940133|NCT03671759|Caffeine|caffeine|mesh-list
44933805|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933806|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933807|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
44933808|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933809|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933810|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933811|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933812|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933813|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933814|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
44933815|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44933816|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933817|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
44933818|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
44933819|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44933820|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933821|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933822|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44933823|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44933824|NCT03731741|Protective Agents|protective agents|mesh-ancestor
44933825|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933826|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
44933827|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44933828|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
44933829|NCT03731494|Nickel|nickel|mesh-list
44933830|NCT03731494|Trace Elements|trace elements|mesh-ancestor
44933831|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
44933832|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933833|NCT03731468|Dexamethasone|dexamethasone|mesh-list
44933834|NCT03731468|Anesthetics|anesthetics|mesh-list
44933835|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
44933836|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933837|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
44933838|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
44933839|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933840|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933841|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933842|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
44933843|NCT03731468|Hormones|hormones|mesh-ancestor
44933844|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933845|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44933846|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933847|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933848|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
44933849|NCT03731442|Paclitaxel|paclitaxel|mesh-list
44933850|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44933851|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933852|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44933853|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44933854|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44933855|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933856|NCT03731429|Lidocaine|lidocaine|mesh-list
44933857|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
44933858|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
44933859|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933860|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933861|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
44940282|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44940301|NCT03221309|Narcotics|narcotics|mesh-ancestor
44933862|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933863|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44933864|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44933865|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44933866|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933867|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933868|NCT03731403|Fluorides|fluorides|mesh-list
44933869|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
44933870|NCT03731403|Protective Agents|protective agents|mesh-ancestor
44933871|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933872|NCT03731286|Caffeine|caffeine|mesh-list
44933873|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44933874|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933875|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44933876|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933877|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933878|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44933879|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44933880|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
44933881|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933882|NCT03731169|Voriconazole|voriconazole|mesh-list
44933883|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
44933884|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933885|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44933886|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44933887|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933888|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933889|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44933890|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
44933891|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933892|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933893|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44933894|NCT03731117|Furosemide|furosemide|mesh-list
44933895|NCT03731117|Diuretics|diuretics|mesh-ancestor
44933896|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
44933897|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933898|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44933899|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933900|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940557|NCT05181033|Letrozole|letrozole|mesh-list
44933901|NCT03731091|Calcitriol|calcitriol|mesh-list
44933902|NCT03731091|Betamethasone|betamethasone|mesh-list
44933903|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
44933904|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44933905|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
44933906|NCT03731091|Calcipotriene|calcipotriene|mesh-list
44933907|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44933908|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44933909|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
44933910|NCT03731091|Hormones|hormones|mesh-ancestor
44933911|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44933912|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933913|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44933914|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
44933915|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
44933916|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44933917|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44933918|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933919|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933920|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44933921|NCT03731091|Vitamins|vitamins|mesh-ancestor
44933922|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
44933923|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44933924|NCT03730857|Olanzapine|olanzapine|mesh-list
44933925|NCT03730857|Risperidone|risperidone|mesh-list
44933926|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44933927|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
44933928|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44933929|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
44933930|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933931|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933932|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933933|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44933934|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933935|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44706577|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706578|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706579|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706580|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706581|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
44706582|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
44706583|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706584|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
44706585|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706586|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
44706587|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44706588|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44706589|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706590|NCT01429610|Cytarabine|cytarabine|mesh-list
44706591|NCT01429610|Rituximab|rituximab|mesh-list
44706592|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706593|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706594|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
44706595|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706596|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706597|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44706598|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
44706599|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706600|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
44706601|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706602|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706603|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
44706604|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44706605|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706606|NCT01429701|Gentamicins|gentamicins|mesh-list
44706607|NCT01429701|Polymyxins|polymyxins|mesh-list
44706608|NCT01429701|Polymyxin B|polymyxin b|mesh-list
44706609|NCT01429701|Prednisolone|prednisolone|mesh-list
44706610|NCT01429701|Betamethasone|betamethasone|mesh-list
44706611|NCT01429701|Benzocaine|benzocaine|mesh-list
44706612|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706613|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
44706614|NCT01429701|Hormones|hormones|mesh-ancestor
44706615|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706616|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706617|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44933936|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44933937|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
44933938|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
44933939|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
44933940|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933941|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933942|NCT03730857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44933943|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44933944|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44933945|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44933946|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44933947|NCT03730766|Amoxicillin|amoxicillin|mesh-list
44933948|NCT03730766|Metronidazole|metronidazole|mesh-list
44933949|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
44933950|NCT03730766|Esomeprazole|esomeprazole|mesh-list
44933951|NCT03730766|Bismuth|bismuth|mesh-list
44933952|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933953|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44933954|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44933955|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44933956|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44933957|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44933958|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44933959|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44933960|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44933961|NCT03730766|Antacids|antacids|mesh-ancestor
44933962|NCT03730766|Diuretics|diuretics|mesh-ancestor
44933963|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
44933964|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933965|NCT03730766|Expectorants|expectorants|mesh-ancestor
44933966|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
44933967|NCT03730740|Lenalidomide|lenalidomide|mesh-list
44933968|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
44933969|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933970|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44933971|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44933972|NCT03730740|Growth Substances|growth substances|mesh-ancestor
44933973|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
44933974|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44933975|NCT03730714|Epinephrine|epinephrine|mesh-list
44933976|NCT03730714|Racepinephrine|racepinephrine|mesh-list
44933977|NCT03730714|Morphine|morphine|mesh-list
44933978|NCT03730714|Anesthetics|anesthetics|mesh-list
44933979|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
44933980|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
44933981|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44933982|NCT03730714|Narcotics|narcotics|mesh-ancestor
44933983|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44933984|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44933985|NCT03730714|Analgesics|analgesics|mesh-ancestor
44933986|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
44933987|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44933988|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44933989|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44933990|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44933991|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44933992|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44933993|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44933994|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44933995|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
44933996|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44933997|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
44933998|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
44933999|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
44934000|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44934001|NCT03730675|Sorafenib|sorafenib|mesh-list
44934002|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934003|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934004|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934005|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934006|NCT03730584|Ropivacaine|ropivacaine|mesh-list
44934007|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934008|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
44934009|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934010|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934011|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
44934012|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934013|NCT03730558|Aflibercept|aflibercept|mesh-list
44934014|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44934015|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44934016|NCT03730558|Growth Substances|growth substances|mesh-ancestor
44934017|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934018|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44941383|NCT04606914|Maytansine|maytansine|mesh-list
44934019|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934020|NCT03730402|Bupivacaine|bupivacaine|mesh-list
44934021|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
44941757|NCT04266665|Analgesics|analgesics|mesh-ancestor
44934022|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
44934023|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934024|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934025|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
44934026|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934027|NCT03730363|Pentamidine|pentamidine|mesh-list
44934028|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
44941985|NCT02535091|Cenobamate|cenobamate|mesh-list
44942050|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934029|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934030|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44934031|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44934032|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44934033|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
44934034|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44934035|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44934036|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
44934037|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934038|NCT03730272|Analgesics|analgesics|mesh-list
44934039|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
44934040|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934041|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934042|NCT03730181|Isoniazid|isoniazid|mesh-list
44934043|NCT03730181|Rifapentine|rifapentine|mesh-list
44934044|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
44934045|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934046|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934047|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44934048|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934049|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
44934050|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934051|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934052|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44934053|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
44934054|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
44934055|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44934056|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
44934057|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934058|NCT03730064|Expectorants|expectorants|mesh-ancestor
44934059|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
44934060|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44934061|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
44934062|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934063|NCT03730064|Protective Agents|protective agents|mesh-ancestor
44934064|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934065|NCT03730064|Antidotes|antidotes|mesh-ancestor
44934066|NCT03730038|Pitavastatin|pitavastatin|mesh-list
44934067|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44934068|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44934069|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934070|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
44934071|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934072|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934073|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934074|NCT03729973|Lidocaine|lidocaine|mesh-list
44934075|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
44934076|NCT03729973|Ketamine|ketamine|mesh-list
44934077|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44934078|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934079|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
44934080|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934081|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934082|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
44934083|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934084|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934085|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44934086|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44934087|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934088|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934089|NCT03729973|Analgesics|analgesics|mesh-ancestor
44934090|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44934091|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934092|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
44934093|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44934094|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44934095|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934096|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
44934097|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934098|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934099|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
44934100|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44934101|NCT03729804|Dexamethasone|dexamethasone|mesh-list
44934102|NCT03729804|Lenalidomide|lenalidomide|mesh-list
44934103|NCT03729804|Bortezomib|bortezomib|mesh-list
44934104|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934105|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
44934106|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
44934107|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934108|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934109|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44934110|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
44934111|NCT03729804|Hormones|hormones|mesh-ancestor
44942689|NCT05184049|Epalrestat|epalrestat|mesh-list
44942787|NCT05170139|Caffeine|caffeine|mesh-list
44934112|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934113|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44934114|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934115|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
44934116|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44934117|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44934118|NCT03729804|Growth Substances|growth substances|mesh-ancestor
44934119|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
44934120|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44934121|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
44934122|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934123|NCT03729687|Capecitabine|capecitabine|mesh-list
44934124|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
44934125|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44934126|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
44934127|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934128|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934129|NCT03729674|Infliximab|infliximab|mesh-list
44934130|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
44934131|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44934132|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44934133|NCT03729505|Lidocaine|lidocaine|mesh-list
44934134|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
44934135|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934136|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
44934137|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934138|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934139|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
44934140|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934141|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934142|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44934143|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44934144|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934145|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934146|NCT03729505|Analgesics|analgesics|mesh-ancestor
44934147|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
44934148|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934149|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934150|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
44934151|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44934152|NCT03729375|Bupivacaine|bupivacaine|mesh-list
44934153|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934154|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
44934155|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934156|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934157|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
44934158|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934159|NCT03729310|Triamcinolone|triamcinolone|mesh-list
44934160|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934161|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
44934162|NCT03729310|Hormones|hormones|mesh-ancestor
44934163|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934164|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934165|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44934166|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44934167|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44934168|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934169|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934170|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934171|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934172|NCT03729284|Analgesics|analgesics|mesh-ancestor
44934173|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
44934174|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934175|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
44934176|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44942941|NCT04791176|Lenvatinib|lenvatinib|mesh-list
44934177|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
44934178|NCT03729128|Memantine|memantine|mesh-list
44934179|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
44934180|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44934181|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44934182|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
44934183|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934184|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934185|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943156|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934186|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44934187|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44934188|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
44934189|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
44934190|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
44934191|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
44934192|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934193|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
44934194|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934195|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934196|NCT03728946|Bupivacaine|bupivacaine|mesh-list
44934197|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934198|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
44934199|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934200|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934201|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
44934202|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934203|NCT03728894|Midazolam|midazolam|mesh-list
44934204|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
44934205|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44934206|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44934207|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706618|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706619|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706620|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44706621|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706622|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44706623|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706624|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44706625|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706626|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706627|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
44706628|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
44706629|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706630|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
44706631|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
44706632|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44706633|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44706634|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44706635|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706636|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706637|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706638|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
44706639|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
44706640|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706641|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
44706642|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44706643|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706644|NCT01429818|Metformin|metformin|mesh-list
44706645|NCT01429818|Glimepiride|glimepiride|mesh-list
44706646|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706647|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706648|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44706649|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943299|NCT04291599|Hydromorphone|hydromorphone|mesh-list
44706650|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
44706651|NCT01429831|Aripiprazole|aripiprazole|mesh-list
44706652|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
44706653|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44706654|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44706655|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44706656|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706657|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706658|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
44706659|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
44706660|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706661|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706662|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44706663|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44706664|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
44706665|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44706666|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44706667|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44706668|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44706669|NCT01429844|Cyclosporine|cyclosporine|mesh-list
44706670|NCT01429844|Tacrolimus|tacrolimus|mesh-list
44706671|NCT01429844|Cyclosporins|cyclosporins|mesh-list
44943614|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
44943750|NCT03269409|Coal Tar|coal tar|mesh-list
44706672|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706673|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
44706674|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706675|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44706676|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706677|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706678|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
44706679|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706680|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706681|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706682|NCT01429870|Triamcinolone|triamcinolone|mesh-list
44706683|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706684|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
44706685|NCT01429870|Hormones|hormones|mesh-ancestor
44706686|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706687|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706688|NCT01429935|Ibuprofen|ibuprofen|mesh-list
44706689|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706690|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44934208|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934209|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44934210|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44934211|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934212|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934213|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
44934214|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
44934215|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
44934216|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
44934217|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934218|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934219|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
44934220|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44934221|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44934222|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
44934223|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
44934224|NCT03728829|Carboplatin|carboplatin|mesh-list
44934225|NCT03728829|Docetaxel|docetaxel|mesh-list
44934226|NCT03728829|Trastuzumab|trastuzumab|mesh-list
44934227|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934228|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44934229|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44934230|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44934231|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934232|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934233|NCT03728777|Resveratrol|resveratrol|mesh-list
44934234|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
44934235|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934236|NCT03728777|Protective Agents|protective agents|mesh-ancestor
44934237|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934238|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934239|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934240|NCT03728465|Nivolumab|nivolumab|mesh-list
44934241|NCT03728465|Ipilimumab|ipilimumab|mesh-list
44934242|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934243|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934244|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44934245|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934246|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
44934247|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44934248|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
44934249|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934250|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
44934251|NCT03728244|Protective Agents|protective agents|mesh-ancestor
44934252|NCT03728192|Camptothecin|camptothecin|mesh-list
44934253|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44934254|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934255|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44934256|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44934257|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934258|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934259|NCT03728153|Fluoxetine|fluoxetine|mesh-list
44934260|NCT03728153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44934261|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44934262|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943904|NCT02818868|Apixaban|apixaban|mesh-list
44943976|NCT02556606|Midazolam|midazolam|mesh-list
44944049|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
44934263|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934264|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934265|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
44934266|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934267|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44934268|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
44934269|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934270|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44934271|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44934272|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934273|NCT03728101|Dabigatran|dabigatran|mesh-list
44934274|NCT03728101|Simvastatin|simvastatin|mesh-list
44944199|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934275|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44934276|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934277|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
44934278|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934279|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934280|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44934281|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731357|NCT01591226|Mannitol|mannitol|mesh-list
44934282|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
44934283|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44934284|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44934285|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
44934286|NCT03727867|Mitogens|mitogens|mesh-list
44934287|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44934288|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934289|NCT03727763|Cetuximab|cetuximab|mesh-list
44934290|NCT03727763|Vemurafenib|vemurafenib|mesh-list
44934291|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934292|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934293|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934294|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934295|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934296|NCT03727646|Niacinamide|niacinamide|mesh-list
44934297|NCT03727646|Niacin|niacin|mesh-list
44934298|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
44934299|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
44934300|NCT03727646|Vitamins|vitamins|mesh-ancestor
44934301|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
44934302|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934303|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934304|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
44934305|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934306|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934307|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
44934308|NCT03727620|Amoxicillin|amoxicillin|mesh-list
44934309|NCT03727620|Metronidazole|metronidazole|mesh-list
44934310|NCT03727620|Doxycycline|doxycycline|mesh-list
44934311|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934312|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934313|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44934314|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44934315|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
44934316|NCT03727607|Propofol|propofol|mesh-list
44934317|NCT03727607|Desflurane|desflurane|mesh-list
44934318|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44934319|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934320|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934321|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934322|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
44934323|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
44934324|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44934325|NCT03727464|Propofol|propofol|mesh-list
44934326|NCT03727464|Sevoflurane|sevoflurane|mesh-list
44934327|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44944821|NCT01509339|Vancomycin|vancomycin|mesh-list
44934328|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934329|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934330|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934331|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
44934332|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
44934333|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934334|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44934335|NCT03727412|Naproxen|naproxen|mesh-list
44934336|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44934337|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44934338|NCT03727412|Analgesics|analgesics|mesh-ancestor
44934339|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
44934340|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934341|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934342|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934343|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44934344|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
44934345|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44934346|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934347|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934348|NCT03727295|Idebenone|idebenone|mesh-list
44934349|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
44934350|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934351|NCT03727295|Protective Agents|protective agents|mesh-ancestor
44934352|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934353|NCT03727282|Dobutamine|dobutamine|mesh-list
44934354|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44934355|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
44934356|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
44934357|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934358|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934359|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44934360|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44934361|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44934362|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
44934363|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934364|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934365|NCT03727282|Protective Agents|protective agents|mesh-ancestor
44934366|NCT03727100|Clonidine|clonidine|mesh-list
44934367|NCT03727100|Analgesics|analgesics|mesh-ancestor
44934368|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
44934369|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934370|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934371|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44934372|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
44934373|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
44934374|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44934375|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44934376|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44934377|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
44934378|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934379|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934380|NCT03727048|Ketorolac|ketorolac|mesh-list
44934381|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44934382|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44945137|NCT04297592|Doxycycline|doxycycline|mesh-list
44934383|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44934384|NCT03727048|Analgesics|analgesics|mesh-ancestor
44934385|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
44934386|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934387|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934388|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934389|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44934390|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44934391|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934392|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934393|NCT03726788|Triamcinolone|triamcinolone|mesh-list
44934394|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44934395|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44934396|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
44934397|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44934398|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44934399|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44934400|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44934401|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934402|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934403|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
44934404|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934405|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934406|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44934407|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934408|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934409|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
44934410|NCT03726788|Hormones|hormones|mesh-ancestor
44934411|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934412|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934413|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
44934414|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934415|NCT03726736|Docetaxel|docetaxel|mesh-list
44934416|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934417|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
44934418|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44934419|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
44934420|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934421|NCT03726593|Artesunate|artesunate|mesh-list
44934422|NCT03726593|Mefloquine|mefloquine|mesh-list
44934423|NCT03726593|Atovaquone|atovaquone|mesh-list
44934424|NCT03726593|Pyronaridine|pyronaridine|mesh-list
44934425|NCT03726593|Proguanil|proguanil|mesh-list
44934426|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44934427|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
44934428|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44934429|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44934430|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934431|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934432|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
44934433|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
44934434|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44934435|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
44934436|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934437|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934438|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
44934439|NCT03726580|Propofol|propofol|mesh-list
44934440|NCT03726580|Sevoflurane|sevoflurane|mesh-list
44934441|NCT03726580|Isoflurane|isoflurane|mesh-list
44934442|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44934443|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934444|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934445|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934446|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
44934447|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
44934448|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934449|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44934450|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
44934451|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934452|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934453|NCT03726398|Macitentan|macitentan|mesh-list
44945216|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945218|NCT03615664|Gemcitabine|gemcitabine|mesh-list
44945295|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
44945596|NCT00867178|Cisplatin|cisplatin|mesh-list
44934454|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44706691|NCT01429935|Analgesics|analgesics|mesh-ancestor
44706692|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
44706693|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706694|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706695|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706696|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706697|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44706698|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706699|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706700|NCT01430013|Endostar protein|endostar protein|mesh-list
44706701|NCT01430013|Endostatins|endostatins|mesh-list
44706702|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44706703|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44706704|NCT01430013|Growth Substances|growth substances|mesh-ancestor
44706705|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706706|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
44706707|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706708|NCT01430052|Gemcitabine|gemcitabine|mesh-list
44706709|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44706710|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
44706711|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706712|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706713|NCT01430052|Antiviral Agents|antiviral agents|mesh-ancestor
44706714|NCT01430052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706715|NCT01430052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706716|NCT01430052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706717|NCT01430052|Immunologic Factors|immunologic factors|mesh-ancestor
44706718|NCT01430052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706719|NCT01430065|Tacrolimus|tacrolimus|mesh-list
44706720|NCT01430065|Peficitinib|peficitinib|mesh-list
44706721|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706722|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
44706723|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706724|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44706725|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706726|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706727|NCT01430078|Niacinamide|niacinamide|mesh-list
44706728|NCT01430078|Peficitinib|peficitinib|mesh-list
44706729|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706730|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706731|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706732|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
44706733|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945937|NCT05154994|Durvalumab|durvalumab|mesh-list
44706734|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
44706735|NCT01430078|Vitamins|vitamins|mesh-ancestor
44706736|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
44706737|NCT01430195|Afamelanotide|afamelanotide|mesh-list
44706738|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706739|NCT01430234|Pancreatin|pancreatin|mesh-list
44706740|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706741|NCT01430260|Ciclesonide|ciclesonide|mesh-list
44706742|NCT01430260|Cetirizine|cetirizine|mesh-list
44706743|NCT01430260|Levocetirizine|levocetirizine|mesh-list
44706744|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
44706745|NCT01430260|Hormones|hormones|mesh-ancestor
44706746|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706747|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706748|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44706749|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44706750|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44706751|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
44706752|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
44706753|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731662|NCT01593137|Incretins|incretins|mesh-ancestor
44934455|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44934456|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934457|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44934458|NCT03726372|Bromides|bromides|mesh-list
44934459|NCT03726372|Rocuronium|rocuronium|mesh-list
44934460|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
44934461|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44934462|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44934463|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44934464|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934465|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934466|NCT03726281|Nivolumab|nivolumab|mesh-list
44934467|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934468|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934469|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44934470|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934471|NCT03726242|Cromakalim|cromakalim|mesh-list
44934472|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44934473|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44934474|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
44934475|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946095|NCT04820205|Ketamine|ketamine|mesh-list
44946194|NCT04620252|Calcium|calcium|mesh-list
44946268|NCT04442022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934476|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934477|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44934478|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
44934479|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
44934480|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
44934481|NCT03726216|Dalbavancin|dalbavancin|mesh-list
44934482|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44946568|NCT02821026|Analgesics|analgesics|mesh-ancestor
44934483|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934484|NCT03726177|Aspirin|aspirin|mesh-list
44934485|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44934486|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44934487|NCT03726177|Analgesics|analgesics|mesh-ancestor
44934488|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
44934489|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934490|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934491|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934492|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44934493|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44934494|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44934495|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934496|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934497|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44934498|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934499|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
44934500|NCT03726125|Insulin|insulin|mesh-list
44934501|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44934502|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
44934503|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44934504|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934505|NCT03726099|Amoxicillin|amoxicillin|mesh-list
44934506|NCT03726099|Tetracycline|tetracycline|mesh-list
44934507|NCT03726099|Furazolidone|furazolidone|mesh-list
44934508|NCT03726099|Esomeprazole|esomeprazole|mesh-list
44934509|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934510|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934511|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44934512|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44934513|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44934514|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934515|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934516|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44934517|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44934518|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44934519|NCT03726099|Renal Agents|renal agents|mesh-ancestor
44934520|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44934521|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44934522|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44934523|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44934524|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
44934525|NCT03726021|Irinotecan|irinotecan|mesh-list
44934526|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934527|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44934528|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44934529|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731675|NCT01593163|Ibuprofen|ibuprofen|mesh-list
44934530|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934531|NCT03725995|Lidocaine|lidocaine|mesh-list
44934532|NCT03725995|Midazolam|midazolam|mesh-list
44934533|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934534|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
44934535|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934536|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934537|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
44934538|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934539|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934540|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44934541|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44934542|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934543|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934544|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44934545|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44934546|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44934547|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44934548|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934549|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934550|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
44934551|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
44934552|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
44934553|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934554|NCT03725904|Progesterone|progesterone|mesh-list
44934555|NCT03725904|Progestins|progestins|mesh-ancestor
44934556|NCT03725904|Hormones|hormones|mesh-ancestor
44946786|NCT03728179|Aspirin|aspirin|mesh-list
44947015|NCT00796068|Cyclosporine|cyclosporine|mesh-list
44934557|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934558|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934559|NCT03725891|Aspirin|aspirin|mesh-list
44934560|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44934561|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44934562|NCT03725891|Analgesics|analgesics|mesh-ancestor
44934563|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
44934564|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934565|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934566|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934567|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44934568|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44934569|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44934570|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934571|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934572|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44934573|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934574|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
44934575|NCT03725878|Folic Acid|folic acid|mesh-list
44934576|NCT03725878|Hematinics|hematinics|mesh-ancestor
44934577|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
44934578|NCT03725878|Vitamins|vitamins|mesh-ancestor
44934579|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
44934580|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934581|NCT03725709|Anesthetics|anesthetics|mesh-list
44934582|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934583|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934584|NCT03725553|Vasopressins|vasopressins|mesh-list
44934585|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
44934586|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
44934587|NCT03725553|Coagulants|coagulants|mesh-ancestor
44934588|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44934589|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44934590|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
44934591|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934592|NCT03725423|Apatinib|apatinib|mesh-list
44934593|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934594|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934595|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934596|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934597|NCT03725267|Melatonin|melatonin|mesh-list
44934598|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
44934599|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934600|NCT03725267|Protective Agents|protective agents|mesh-ancestor
44934601|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934602|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934603|NCT03725228|Lidocaine|lidocaine|mesh-list
44934604|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
44934605|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934607|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934608|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934609|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
44934610|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934611|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934612|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44934613|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44934614|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934615|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934616|NCT03725228|Analgesics|analgesics|mesh-ancestor
44934617|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
44934618|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934619|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934620|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
44934621|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44934623|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
44934624|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
44934625|NCT03725020|Protective Agents|protective agents|mesh-ancestor
44934626|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934627|NCT03724955|Estradiol|estradiol|mesh-list
44934628|NCT03724955|Estrogens|estrogens|mesh-ancestor
44934629|NCT03724955|Hormones|hormones|mesh-ancestor
44934630|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934631|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934632|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
44934633|NCT03724838|Esomeprazole|esomeprazole|mesh-list
44934634|NCT03724838|Citric Acid|citric acid|mesh-list
44934635|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
44934636|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
44934637|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44934638|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
44934639|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
44934640|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934641|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
44947298|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
44947377|NCT05032950|Ritonavir|ritonavir|mesh-list
44934642|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44934643|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44934644|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934645|NCT03724838|Urological Agents|urological agents|mesh-ancestor
44934646|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44934647|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44934648|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44934649|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
44934650|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44934651|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
44934652|NCT03724578|Fluorides|fluorides|mesh-list
44934653|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
44934654|NCT03724578|Protective Agents|protective agents|mesh-ancestor
44934655|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934656|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44947584|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
44934657|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934658|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
44934659|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934660|NCT03724266|Chitosan|chitosan|mesh-list
44934661|NCT03724266|Calcium|calcium|mesh-list
44934662|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934663|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934664|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44934665|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934666|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
44934667|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934668|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934669|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
44934670|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
44934671|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
44934672|NCT03724266|Coagulants|coagulants|mesh-ancestor
44934673|NCT03724071|Flucytosine|flucytosine|mesh-list
44934674|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
44934675|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934676|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
44934677|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934678|NCT03723941|Cisplatin|cisplatin|mesh-list
44934679|NCT03723941|Etoposide|etoposide|mesh-list
44934680|NCT03723941|Mitotane|mitotane|mesh-list
44934681|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934682|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44934683|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44934684|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44934685|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934686|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934687|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44934688|NCT03723824|Grazoprevir|grazoprevir|mesh-list
44934689|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44934690|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
44934691|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934692|NCT03723785|Insulin|insulin|mesh-list
44934693|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44934694|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731903|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44934695|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934696|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
44947682|NCT04214860|Venetoclax|venetoclax|mesh-list
44934697|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
44934698|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44934699|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44934700|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934701|NCT03723395|Repaglinide|repaglinide|mesh-list
44934702|NCT03723395|Tolbutamide|tolbutamide|mesh-list
44934703|NCT03723395|Itraconazole|itraconazole|mesh-list
44934704|NCT03723395|Rifampin|rifampin|mesh-list
44948217|NCT01881048|Celecoxib|celecoxib|mesh-list
44934705|NCT03723395|Tucatinib|tucatinib|mesh-list
44934706|NCT03723395|Digoxin|digoxin|mesh-list
44934707|NCT03723395|Midazolam|midazolam|mesh-list
44934708|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
44934709|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44934710|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44934711|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934712|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934713|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44934714|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44934715|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934716|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934717|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
44934718|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
44934719|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
44934720|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
44934721|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934722|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934723|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
44934724|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934725|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44934726|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44934727|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934728|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44934729|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
44934730|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934731|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44934732|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44934733|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
44934734|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934735|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
44934736|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44934737|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44934738|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44934739|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44934740|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44934741|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44934742|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44934743|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934744|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44934745|NCT03723395|Protective Agents|protective agents|mesh-ancestor
44706754|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706755|NCT01430312|Azelaic acid|azelaic acid|mesh-list
44706756|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706757|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44258256|NCT00628706|Hormones|hormones|mesh-ancestor
44706758|NCT01430351|Metformin|metformin|mesh-list
44706759|NCT01430351|Mefloquine|mefloquine|mesh-list
44706760|NCT01430351|Temozolomide|temozolomide|mesh-list
44706761|NCT01430351|Memantine|memantine|mesh-list
44706762|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44706763|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706764|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44706765|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
44706766|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706767|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706768|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44706769|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44706770|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
44706771|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706772|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44706773|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44706774|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
44706775|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44706776|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44706777|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706778|NCT01430520|Citalopram|citalopram|mesh-list
44706779|NCT01430520|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44731980|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44934746|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44934747|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934748|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934749|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934750|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
44934751|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44934752|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44934753|NCT03723291|Tocopherols|tocopherols|mesh-list
44934754|NCT03723291|Vitamin E|vitamin e|mesh-list
44934755|NCT03723291|Tocotrienols|tocotrienols|mesh-list
44934756|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
44934757|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
44934758|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44934759|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934760|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934761|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44934762|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44934763|NCT03723291|Protective Agents|protective agents|mesh-ancestor
44948497|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
44934764|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934765|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44934766|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44934767|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
44934768|NCT03723291|Vitamins|vitamins|mesh-ancestor
44934769|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
44934770|NCT03723187|Heparin|heparin|mesh-list
44934771|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
44934772|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44934773|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44934774|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934775|NCT03723135|Azacitidine|azacitidine|mesh-list
44934777|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44934778|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
44934779|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934780|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934781|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934782|NCT03723109|Anesthetics|anesthetics|mesh-list
44934783|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934784|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934785|NCT03723096|Pomalidomide|pomalidomide|mesh-list
44934786|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
44934787|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934788|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44934789|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44934790|NCT03723096|Growth Substances|growth substances|mesh-ancestor
44934791|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
44934792|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934793|NCT03723083|Thalidomide|thalidomide|mesh-list
44934794|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934795|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
44934796|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934797|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
44934798|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934799|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934800|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44934801|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44934802|NCT03723083|Growth Substances|growth substances|mesh-ancestor
44934803|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
44934804|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934805|NCT03723031|Misoprostol|misoprostol|mesh-list
44934806|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44934807|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
44934808|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44934809|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934810|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44934811|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44934812|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
44934813|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
44934814|NCT03722940|Analgesics|analgesics|mesh-ancestor
44934815|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
44934816|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934817|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934818|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
44934819|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934820|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934821|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
44934822|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934823|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934824|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934825|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934826|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
44948649|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
44948668|NCT05392361|Gabapentin|gabapentin|mesh-list
44948748|NCT05125276|Aspirin|aspirin|mesh-list
44948817|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44934827|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44934828|NCT03722914|Benzonatate|benzonatate|mesh-list
44934829|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
44934830|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
44934831|NCT03722875|Apatinib|apatinib|mesh-list
44934832|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934833|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934834|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934835|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934836|NCT03722823|Tucatinib|tucatinib|mesh-list
44948893|NCT04721873|Topiramate|topiramate|mesh-list
44948949|NCT04450212|Vitamin K|vitamin k|mesh-list
44949031|NCT03668041|Gabapentin|gabapentin|mesh-list
44934837|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934838|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934839|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934840|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934841|NCT03722498|Leucovorin|leucovorin|mesh-list
44934842|NCT03722498|Fluorouracil|fluorouracil|mesh-list
44949259|NCT00446225|Cisplatin|cisplatin|mesh-list
44934843|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
44934844|NCT03722498|Sorafenib|sorafenib|mesh-list
44934845|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
44934846|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934847|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44934848|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934849|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934850|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
44949393|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44934851|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934852|NCT03722498|Antidotes|antidotes|mesh-ancestor
44934853|NCT03722498|Protective Agents|protective agents|mesh-ancestor
44934854|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
44934855|NCT03722498|Vitamins|vitamins|mesh-ancestor
44934856|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
44934857|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934858|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934859|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
44934860|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934861|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44934862|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934863|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934864|NCT03722381|Amlodipine|amlodipine|mesh-list
44934865|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44934866|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934867|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934868|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934869|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934870|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934871|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
44934872|NCT03722355|Carmustine|carmustine|mesh-list
44934873|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44934874|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
44934875|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934876|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934877|NCT03722329|Eculizumab|eculizumab|mesh-list
44934878|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44934879|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934880|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
44934881|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934882|NCT03722303|Cortisone|cortisone|mesh-list
44934883|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44934884|NCT03722290|Metformin|metformin|mesh-list
44934885|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44934886|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934887|NCT03722173|Itraconazole|itraconazole|mesh-list
44934888|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
44934889|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934890|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44934891|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44934892|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934893|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934894|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44934895|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
44934896|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44934897|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934898|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44934899|NCT03721991|Butyric Acid|butyric acid|mesh-list
44934900|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934901|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934902|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934903|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
44934904|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
44934905|NCT03721900|Ketamine|ketamine|mesh-list
44934906|NCT03721900|Analgesics|analgesics|mesh-ancestor
44934907|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
44934908|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934909|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934910|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44934911|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44934912|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
44934913|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
44934914|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732174|NCT01595867|Naltrexone|naltrexone|mesh-list
44934915|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44934916|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44934917|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44934918|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934919|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
44934920|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44934921|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934922|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44934923|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934924|NCT03721757|Nivolumab|nivolumab|mesh-list
44934925|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934926|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934927|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44934928|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934929|NCT03721744|Gemcitabine|gemcitabine|mesh-list
44934930|NCT03721744|Paclitaxel|paclitaxel|mesh-list
44934931|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44934932|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934933|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44934934|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44934935|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44934936|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934937|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44934938|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
44934939|NCT03721744|Antiviral Agents|antiviral agents|mesh-ancestor
44934940|NCT03721744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934941|NCT03721744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44934942|NCT03721744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934943|NCT03721744|Immunologic Factors|immunologic factors|mesh-ancestor
44934944|NCT03721744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934945|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
44934946|NCT03721679|Nivolumab|nivolumab|mesh-list
44934947|NCT03721679|Durvalumab|durvalumab|mesh-list
44934948|NCT03721679|Atezolizumab|atezolizumab|mesh-list
44934949|NCT03721679|Poly ICLC|poly iclc|mesh-list
44934950|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44934951|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934952|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44934953|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934954|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
44934955|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
44934956|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934957|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
44934958|NCT03721627|Ledipasvir|ledipasvir|mesh-list
44934959|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44934960|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
44934961|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934962|NCT03721614|Sirolimus|sirolimus|mesh-list
44934963|NCT03721614|Everolimus|everolimus|mesh-list
44934964|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44934965|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44934966|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
44934967|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934968|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44934969|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44934970|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44934971|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
44934972|NCT03721432|Pregabalin|pregabalin|mesh-list
44934973|NCT03721432|Analgesics|analgesics|mesh-ancestor
44934974|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
44934975|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950432|NCT05548426|Penicillins|penicillins|mesh-list
44934976|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934977|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
44934978|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44934979|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44934980|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44934981|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44934982|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44934983|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44934984|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934985|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44934986|NCT03721380|Methadone|methadone|mesh-list
44934987|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44934988|NCT03721380|Narcotics|narcotics|mesh-ancestor
44934989|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44934990|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44934991|NCT03721380|Analgesics|analgesics|mesh-ancestor
44934992|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
44934993|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44934994|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
44934995|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
44706780|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44706781|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706782|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706783|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706784|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
44706785|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706786|NCT01430520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44706787|NCT01430520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44706788|NCT01430520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44706789|NCT01430533|Azelaic acid|azelaic acid|mesh-list
44706790|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706791|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706792|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
44706793|NCT01430650|Urological Agents|urological agents|mesh-ancestor
44706794|NCT01430689|Vaccines|vaccines|mesh-list
44706795|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
44706796|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706797|NCT01430793|Vitamin D|vitamin d|mesh-list
44706798|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
44706799|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
44706800|NCT01430793|Vitamins|vitamins|mesh-list
44706801|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
44706802|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706803|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44706804|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706805|NCT01430806|Dronedarone|dronedarone|mesh-list
44706806|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44706807|NCT01430910|Ceftazidime|ceftazidime|mesh-list
44706808|NCT01430910|Avibactam|avibactam|mesh-list
44706809|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44706810|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706811|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44706812|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706813|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706814|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44706815|NCT01430923|Latanoprost|latanoprost|mesh-list
44706816|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44706817|NCT01431053|Aspirin|aspirin|mesh-list
44706818|NCT01431053|Exemestane|exemestane|mesh-list
44706819|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706820|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706821|NCT01431053|Analgesics|analgesics|mesh-ancestor
44706822|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
44706823|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706824|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706825|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706826|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706827|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44706828|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44950690|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44950928|NCT03502031|Diuretics|diuretics|mesh-ancestor
44706829|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706830|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44706831|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44706832|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706833|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
44706834|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706835|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44706836|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44706837|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44706838|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
44706839|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706841|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
44706842|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706843|NCT01431092|Protective Agents|protective agents|mesh-ancestor
44706844|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706845|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706846|NCT01431118|Camphor|camphor|mesh-list
44706847|NCT01431118|Salicylates|salicylates|mesh-list
44706848|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
44706849|NCT01431118|Menthol|menthol|mesh-list
44706850|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44934996|NCT03721081|Lidocaine|lidocaine|mesh-list
44934997|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
44934998|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
44934999|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935000|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935001|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
44935002|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935003|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935004|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44935005|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44935006|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935007|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935008|NCT03720899|Nicotine|nicotine|mesh-list
44935009|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44935010|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
44935011|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935012|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935013|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44935014|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44935015|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
44951007|NCT02923739|Paclitaxel|paclitaxel|mesh-list
44935016|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935017|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935018|NCT03720886|Teriparatide|teriparatide|mesh-list
44935019|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935020|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935021|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44935022|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44935023|NCT03720873|Gefitinib|gefitinib|mesh-list
44935024|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935025|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44935026|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935027|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935028|NCT03720756|Nickel|nickel|mesh-list
44935029|NCT03720756|Trace Elements|trace elements|mesh-ancestor
44935030|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
44935031|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935032|NCT03720665|Caffeine|caffeine|mesh-list
44935033|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44935034|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935035|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44935036|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935037|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935038|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44935039|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44935040|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
44935041|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935042|NCT03720522|Adenosine|adenosine|mesh-list
44935043|NCT03720522|Analgesics|analgesics|mesh-ancestor
44935044|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
44935045|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935046|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935047|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935048|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
44935049|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44935050|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
44935051|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
44935052|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935053|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935054|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
44935055|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44935056|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
44935057|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935058|NCT03720483|Expectorants|expectorants|mesh-ancestor
44935059|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
44935060|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44935061|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
44935062|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935063|NCT03720483|Protective Agents|protective agents|mesh-ancestor
44935064|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935065|NCT03720483|Antidotes|antidotes|mesh-ancestor
44935066|NCT03720340|Oprelvekin|oprelvekin|mesh-list
44935067|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935068|NCT03720288|Acetazolamide|acetazolamide|mesh-list
44935069|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
44935070|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44935071|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935072|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935073|NCT03720288|Diuretics|diuretics|mesh-ancestor
44935074|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
44935075|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935076|NCT03720249|Vitamins|vitamins|mesh-list
44935077|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
44935078|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
44935079|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
44935080|NCT03720249|Betaine|betaine|mesh-list
44935081|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
44935082|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935083|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935084|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
44935085|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935086|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
44935087|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935088|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935089|NCT03720223|Bupivacaine|bupivacaine|mesh-list
44935090|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
44935091|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
44935092|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935093|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935094|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
44935095|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935096|NCT03720067|Propranolol|propranolol|mesh-list
44935097|NCT03720067|Carvedilol|carvedilol|mesh-list
44935098|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44935099|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44935100|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935101|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
44935102|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935103|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935104|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44935105|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935106|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44935107|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44935108|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
44935109|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935110|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935111|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935112|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44935113|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44935114|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
44935115|NCT03720067|Protective Agents|protective agents|mesh-ancestor
44935116|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44935117|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935118|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935119|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44935120|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44935121|NCT03720041|Dexamethasone|dexamethasone|mesh-list
44935122|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
44935123|NCT03720041|Lenalidomide|lenalidomide|mesh-list
44935124|NCT03720041|Ixazomib|ixazomib|mesh-list
44935125|NCT03720041|BB 1101|bb 1101|mesh-list
44935126|NCT03720041|Glycine|glycine|mesh-list
44935127|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935128|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
44935129|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
44935130|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935131|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935132|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935133|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
44935134|NCT03720041|Hormones|hormones|mesh-ancestor
44935135|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935136|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44935137|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935138|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
44935139|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935140|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935141|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
44935142|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44935143|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44935144|NCT03720041|Growth Substances|growth substances|mesh-ancestor
44935145|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
44935146|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
44935147|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935148|NCT03719989|Azacitidine|azacitidine|mesh-list
44935149|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44935150|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
44935151|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935152|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935153|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935154|NCT03719820|Clopidogrel|clopidogrel|mesh-list
44935155|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44935156|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935157|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935158|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44935159|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951413|NCT04326439|Cytarabine|cytarabine|mesh-list
44951491|NCT03902509|Pirfenidone|pirfenidone|mesh-list
44951564|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951715|NCT02688881|Sirolimus|sirolimus|mesh-list
44935160|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44935161|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44935162|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44935163|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
44935164|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935165|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44935166|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935167|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
44935168|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935169|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44935170|NCT03719729|Rifaximin|rifaximin|mesh-list
44935171|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935172|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935173|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935174|NCT03719625|Norepinephrine|norepinephrine|mesh-list
44935175|NCT03719625|Ephedrine|ephedrine|mesh-list
44935176|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44935177|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44935178|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
44935179|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935180|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935181|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732490|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
44935182|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
44935183|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
44935184|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935185|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44935186|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44935187|NCT03719560|Cytarabine|cytarabine|mesh-list
44935188|NCT03719560|Methotrexate|methotrexate|mesh-list
44935189|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44935190|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
44935191|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44935192|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935193|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44935194|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
44935195|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935196|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935197|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
44935198|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935199|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44935200|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44935201|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
44935202|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44935203|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44935204|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
44935205|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935206|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
44935207|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44935208|NCT03719404|Eusol|eusol|mesh-list
44935209|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44935210|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935211|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
44935212|NCT03719391|Nicotine|nicotine|mesh-list
44935213|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44935214|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
44935215|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935216|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935217|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44935218|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44935219|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
44935220|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951880|NCT00979212|Paclitaxel|paclitaxel|mesh-list
44951951|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
44935221|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935222|NCT03719313|Interferons|interferons|mesh-list
44935223|NCT03719313|Ritonavir|ritonavir|mesh-list
44935224|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
44935225|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44935226|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
44935227|NCT03719313|Lonafarnib|lonafarnib|mesh-list
44935228|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935229|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
44935230|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935231|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44935232|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44935233|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
44935234|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935235|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935236|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44935237|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44935238|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44935239|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44935240|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
44935241|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935242|NCT03719274|Ascorbic Acid|ascorbic acid|mesh-list
44935243|NCT03719274|Vitamins|vitamins|mesh-ancestor
44935244|NCT03719274|Micronutrients|micronutrients|mesh-ancestor
44935245|NCT03719274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935246|NCT03719274|Antioxidants|antioxidants|mesh-ancestor
44935247|NCT03719274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935248|NCT03719274|Protective Agents|protective agents|mesh-ancestor
44935249|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44935250|NCT03719261|Eusol|eusol|mesh-list
44935251|NCT03719261|Chitosan|chitosan|mesh-list
44935252|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44935253|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935254|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
44935255|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935256|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935257|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
44935258|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
44935259|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
44935260|NCT03719261|Coagulants|coagulants|mesh-ancestor
44935261|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
44935262|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935263|NCT03719157|Anesthetics|anesthetics|mesh-list
44935264|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
44935265|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935266|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935267|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
44935268|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935269|NCT03719053|Tenofovir|tenofovir|mesh-list
44935270|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
44935271|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935272|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44935273|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44935274|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952176|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952262|NCT03354728|Vaccines|vaccines|mesh-list
44952336|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
44935275|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935276|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44935277|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44935278|NCT03718884|Mirikizumab|mirikizumab|mesh-list
44935279|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44935280|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44935281|NCT03718884|Analgesics|analgesics|mesh-ancestor
44935282|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
44935283|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935284|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935285|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935286|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44935287|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44935288|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935289|NCT03718715|Metformin|metformin|mesh-list
44935290|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44935291|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935292|NCT03718676|Pemetrexed|pemetrexed|mesh-list
44935293|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935294|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935295|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935296|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44935297|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44935298|NCT03718624|Paclitaxel|paclitaxel|mesh-list
44935299|NCT03718624|Apatinib|apatinib|mesh-list
44935300|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44935301|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935302|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44935303|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44935304|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44935305|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935306|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44935307|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935308|NCT03718507|Atropine|atropine|mesh-list
44935309|NCT03718507|Fentanyl|fentanyl|mesh-list
44935310|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935311|NCT03718507|Narcotics|narcotics|mesh-ancestor
44935312|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935313|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935314|NCT03718507|Analgesics|analgesics|mesh-ancestor
44935315|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
44935316|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935317|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44935318|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44935319|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
44935320|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
44935321|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935322|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44935323|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
44935324|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44935325|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44935326|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
44935327|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
44935328|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44935329|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44935330|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44935331|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935332|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732641|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935333|NCT03718377|Anesthetics|anesthetics|mesh-list
44935334|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935335|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935336|NCT03718273|Digoxin|digoxin|mesh-list
44935337|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935338|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44935339|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935340|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935341|NCT03718273|Protective Agents|protective agents|mesh-ancestor
44935342|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935343|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
44935344|NCT03718182|Vitamin D|vitamin d|mesh-list
44935345|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935346|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935347|NCT03718182|Vitamins|vitamins|mesh-ancestor
44935348|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
44935349|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44935350|NCT03718039|Aprepitant|aprepitant|mesh-list
44935351|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
44935352|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
44935353|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935354|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935355|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935356|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44935357|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935358|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935359|NCT03717909|Valproic Acid|valproic acid|mesh-list
44935360|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
44935361|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952802|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44935362|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935363|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
44935364|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935365|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935366|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
44935367|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935368|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935369|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935370|NCT03717740|Esomeprazole|esomeprazole|mesh-list
44935371|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44935372|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935373|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44935374|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935375|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935376|NCT03717701|Metformin|metformin|mesh-list
44935377|NCT03717701|Esomeprazole|esomeprazole|mesh-list
44935378|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44935379|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935380|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44935381|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935382|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44935383|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935384|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935385|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44935386|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44953336|NCT03120624|Iodine|iodine|mesh-list
44935387|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44935388|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44935389|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935390|NCT03717688|Incretins|incretins|mesh-ancestor
44935391|NCT03717688|Hormones|hormones|mesh-ancestor
44935392|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935393|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44935394|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935395|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935396|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44935397|NCT03717662|Nicotine|nicotine|mesh-list
44935398|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44935399|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
44935400|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935401|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935402|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44935403|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44935404|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
44935405|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935406|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935407|NCT03717558|Ivermectin|ivermectin|mesh-list
44935408|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44935409|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935410|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
44935411|NCT03717467|Analgesics|analgesics|mesh-ancestor
44935412|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
44935413|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935414|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935415|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
44935416|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935417|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935418|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
44935419|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44935420|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706851|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706852|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
44706853|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44706854|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706855|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706856|NCT01431118|Analgesics|analgesics|mesh-ancestor
44953999|NCT04178993|Analgesics|analgesics|mesh-ancestor
44706857|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
44706858|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706859|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706860|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706861|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706862|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44706863|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706864|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706865|NCT01431326|Vancomycin|vancomycin|mesh-list
44706866|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
44706867|NCT01431326|Tazobactam|tazobactam|mesh-list
44706868|NCT01431326|Piperacillin|piperacillin|mesh-list
44706869|NCT01431326|Tobramycin|tobramycin|mesh-list
44706870|NCT01431326|Amikacin|amikacin|mesh-list
44706871|NCT01431326|Fosfomycin|fosfomycin|mesh-list
44706872|NCT01431326|Cefepime|cefepime|mesh-list
44954057|NCT03951961|Midostaurin|midostaurin|mesh-list
44954181|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
44954247|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
44706873|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44706874|NCT01431326|Nafcillin|nafcillin|mesh-list
44706875|NCT01431326|Cidofovir|cidofovir|mesh-list
44706876|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
44706877|NCT01431326|Bosentan|bosentan|mesh-list
44706878|NCT01431326|Labetalol|labetalol|mesh-list
44706879|NCT01431326|Nifedipine|nifedipine|mesh-list
44706880|NCT01431326|Spironolactone|spironolactone|mesh-list
44706881|NCT01431326|Pentobarbital|pentobarbital|mesh-list
44706882|NCT01431326|Oxycodone|oxycodone|mesh-list
44706883|NCT01431326|Alfentanil|alfentanil|mesh-list
44706884|NCT01431326|Haloperidol|haloperidol|mesh-list
44706885|NCT01431326|Zolpidem|zolpidem|mesh-list
44706886|NCT01431326|Ziprasidone|ziprasidone|mesh-list
44706887|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44706888|NCT01431326|Clozapine|clozapine|mesh-list
44706889|NCT01431326|Molindone|molindone|mesh-list
44706890|NCT01431326|Warfarin|warfarin|mesh-list
44706891|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
44706892|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
44706893|NCT01431326|Rocuronium|rocuronium|mesh-list
44706894|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
44706895|NCT01431326|Sevelamer|sevelamer|mesh-list
44706896|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706897|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
44706898|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
44706899|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706900|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706901|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706902|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
44706903|NCT01431326|Hormones|hormones|mesh-ancestor
44706904|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706905|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44706906|NCT01431326|Protective Agents|protective agents|mesh-ancestor
44706907|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706908|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44706909|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44706910|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706911|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
44706912|NCT01431326|Coagulants|coagulants|mesh-ancestor
44706913|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44706914|NCT01431326|Narcotics|narcotics|mesh-ancestor
44706915|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706916|NCT01431326|Analgesics|analgesics|mesh-ancestor
44706917|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
44706918|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
44935421|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935422|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935423|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
44935424|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44935425|NCT03717415|Carboplatin|carboplatin|mesh-list
44935426|NCT03717415|Rebastinib|rebastinib|mesh-list
44935427|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935428|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44935429|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935430|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935431|NCT03717350|Meropenem|meropenem|mesh-list
44935432|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935433|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935434|NCT03717168|Hormones|hormones|mesh-list
44935435|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935436|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935437|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
44935438|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935439|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935440|NCT03717038|Trifluridine|trifluridine|mesh-list
44935441|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
44935442|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935443|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
44935444|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935445|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
44935446|NCT03716856|Fludarabine|fludarabine|mesh-list
44935447|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44935448|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
44935449|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935450|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44935451|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44935452|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
44935453|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935454|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935455|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44935456|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
44935457|NCT03716804|Cefuroxime|cefuroxime|mesh-list
44935458|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
44935459|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
44935460|NCT03716804|Cefixime|cefixime|mesh-list
44935461|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935462|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935463|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44935464|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44935465|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935466|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935467|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935468|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44935469|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44935470|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44935471|NCT03716804|Renal Agents|renal agents|mesh-ancestor
44935472|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
44935473|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935474|NCT03716765|Vitamin D|vitamin d|mesh-list
44935475|NCT03716765|Vitamins|vitamins|mesh-ancestor
44935476|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
44935477|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935478|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44935479|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
44935480|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
44935481|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44935482|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44954809|NCT04668365|Prednisone|prednisone|mesh-list
44935483|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
44935484|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935485|NCT03716622|Clarithromycin|clarithromycin|mesh-list
44935486|NCT03716622|Furazolidone|furazolidone|mesh-list
44935487|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935488|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935489|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44935490|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935491|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935492|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44935493|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44935494|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44935495|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44935496|NCT03716622|Renal Agents|renal agents|mesh-ancestor
44935497|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44935498|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44935499|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44935500|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44935501|NCT03716596|Antibodies|antibodies|mesh-list
44935502|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
44935503|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935504|NCT03716583|Melatonin|melatonin|mesh-list
44935505|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44935506|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
44935507|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935508|NCT03716583|Protective Agents|protective agents|mesh-ancestor
44935509|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935510|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935511|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44935512|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44935513|NCT03716427|Tolbutamide|tolbutamide|mesh-list
44935514|NCT03716427|Midazolam|midazolam|mesh-list
44935515|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
44935516|NCT03716427|Omeprazole|omeprazole|mesh-list
44935517|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44935518|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44935519|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935520|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935521|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44935522|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935523|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935524|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44935525|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
44935526|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
44935527|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
44935528|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
44935529|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935530|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935531|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44935532|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935533|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44935534|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935535|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
44935536|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
44935537|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44935538|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44935539|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44935540|NCT03716388|Mesalamine|mesalamine|mesh-list
44935541|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44935542|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44935543|NCT03716388|Analgesics|analgesics|mesh-ancestor
44935544|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
44935545|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935546|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935547|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935548|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44935550|NCT03716115|Teduglutide|teduglutide|mesh-list
44935551|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935552|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44935553|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
44955322|NCT02740127|Clonidine|clonidine|mesh-list
44935554|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935555|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935556|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44935557|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
44935558|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
44935559|NCT03716115|Hormones|hormones|mesh-ancestor
44935560|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935561|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935562|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44935563|NCT03716115|Protective Agents|protective agents|mesh-ancestor
44935564|NCT03715998|Ramipril|ramipril|mesh-list
44935565|NCT03715998|Firibastat|firibastat|mesh-list
44935566|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44935567|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44935568|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935569|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935570|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44935571|NCT03715881|Prednisolone|prednisolone|mesh-list
44935572|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
44935573|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935574|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
44935575|NCT03715881|Hormones|hormones|mesh-ancestor
44935576|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935577|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935578|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44935579|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935580|NCT03715881|Hematinics|hematinics|mesh-ancestor
44935581|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44935582|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44935583|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935584|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935585|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44935586|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935587|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935588|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
44935589|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935590|NCT03715725|Warfarin|warfarin|mesh-list
44935591|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
44935592|NCT03715725|Dabigatran|dabigatran|mesh-list
44935593|NCT03715725|Apixaban|apixaban|mesh-list
44935594|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
44935595|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44935596|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
44935597|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44935598|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
44935599|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935600|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935601|NCT03715699|Prednisone|prednisone|mesh-list
44935602|NCT03715699|Leflunomide|leflunomide|mesh-list
44935603|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935604|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
44935605|NCT03715699|Hormones|hormones|mesh-ancestor
44935606|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935607|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935608|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44935609|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935610|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935611|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935612|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44935613|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
44935614|NCT03715634|Buprenorphine|buprenorphine|mesh-list
44935615|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935616|NCT03715634|Narcotics|narcotics|mesh-ancestor
44935617|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935618|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935619|NCT03715634|Analgesics|analgesics|mesh-ancestor
44935620|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
44935621|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935622|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44935623|NCT03715582|Trimetazidine|trimetazidine|mesh-list
44732979|NCT05691010|Paclitaxel|paclitaxel|mesh-list
44935625|NCT03715556|Amiodarone|amiodarone|mesh-list
44935626|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935627|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
44935628|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44935629|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935630|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935631|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44935632|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44935633|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44935634|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935635|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44935636|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44935637|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44935638|NCT03715517|Morphine|morphine|mesh-list
44935639|NCT03715517|Hydromorphone|hydromorphone|mesh-list
44935640|NCT03715517|Bupivacaine|bupivacaine|mesh-list
44935641|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44935642|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
44935643|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
44935644|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935645|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935646|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
44706919|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44706920|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706921|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44706922|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44706923|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44706924|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44706925|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44706926|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706927|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44706928|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44706929|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44706930|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
44706931|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44706932|NCT01431326|Diuretics|diuretics|mesh-ancestor
44706933|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
44706934|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44706935|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706936|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706937|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
44706938|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
44706939|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706940|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44706941|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44706942|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44706943|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44706944|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44706945|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
44706946|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44706947|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44706948|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44706949|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44706950|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44706951|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
44706952|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
44706953|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44706954|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
44706955|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44706956|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44706957|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
44706958|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
44706959|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44706960|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44706961|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44706962|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44706963|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44706964|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44706965|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
44706966|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44706967|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
44706968|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44935647|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935649|NCT03715517|Narcotics|narcotics|mesh-ancestor
44935650|NCT03715517|Analgesics|analgesics|mesh-ancestor
44935651|NCT03715478|Dexamethasone|dexamethasone|mesh-list
44935652|NCT03715478|Pomalidomide|pomalidomide|mesh-list
44935653|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935654|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
44935655|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
44935656|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956522|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44956569|NCT04968366|Temozolomide|temozolomide|mesh-list
44935657|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935658|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44935659|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
44935660|NCT03715478|Hormones|hormones|mesh-ancestor
44935661|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935662|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44935663|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935664|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
44935665|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44956711|NCT04530305|Upadacitinib|upadacitinib|mesh-list
44935666|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44935667|NCT03715478|Growth Substances|growth substances|mesh-ancestor
44935668|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
44935669|NCT03715413|Tamoxifen|tamoxifen|mesh-list
44935670|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44935671|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
44935672|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44935673|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956799|NCT04065789|Hormones|hormones|mesh-ancestor
44935674|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44935675|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935676|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44935677|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44935678|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44935679|NCT03715387|Bacitracin|bacitracin|mesh-list
44935680|NCT03715387|Polymyxin B|polymyxin b|mesh-list
44935681|NCT03715387|Tacrolimus|tacrolimus|mesh-list
44935682|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44935683|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
44935684|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935685|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44935686|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935687|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935688|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44957008|NCT02767531|Orlistat|orlistat|mesh-list
44957212|NCT00921856|Acetylcholine|acetylcholine|mesh-list
44935689|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935690|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935691|NCT03715348|Thrombin|thrombin|mesh-list
44935692|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
44935693|NCT03715348|Coagulants|coagulants|mesh-ancestor
44935694|NCT03715322|Tobramycin|tobramycin|mesh-list
44935695|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935696|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935697|NCT03715309|Lenalidomide|lenalidomide|mesh-list
44935698|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
44935699|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935700|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44935701|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44935702|NCT03715309|Growth Substances|growth substances|mesh-ancestor
44935703|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
44935704|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935705|NCT03715296|Lenalidomide|lenalidomide|mesh-list
44935706|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
44935707|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935708|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44935709|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44935710|NCT03715296|Growth Substances|growth substances|mesh-ancestor
44935711|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957292|NCT05215743|Siderophores|siderophores|mesh-ancestor
44957422|NCT04620798|Antibodies|antibodies|mesh-list
44935712|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935713|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44935714|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44935715|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935716|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
44935717|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935718|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44935719|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44935720|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935721|NCT03715023|PC-786|pc-786|mesh-list
44935722|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
44935723|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935724|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935725|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935726|NCT03714867|Pregabalin|pregabalin|mesh-list
44935727|NCT03714867|Analgesics|analgesics|mesh-ancestor
44935728|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
44935729|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935730|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935731|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
44935732|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44935733|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935734|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935735|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935736|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44935737|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935738|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935739|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935740|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
44935741|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44935742|NCT03714737|Vaccines|vaccines|mesh-list
44935743|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
44935744|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935745|NCT03714685|Firibastat|firibastat|mesh-list
44935746|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44935747|NCT03714555|Copper|copper|mesh-list
44935748|NCT03714555|Gemcitabine|gemcitabine|mesh-list
44935749|NCT03714555|Paclitaxel|paclitaxel|mesh-list
44935750|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44935751|NCT03714555|Folfirinox|folfirinox|mesh-list
44935752|NCT03714555|Disulfiram|disulfiram|mesh-list
44935753|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44935754|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935755|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44935756|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44935757|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44935758|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935759|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44935760|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
44935761|NCT03714555|Antiviral Agents|antiviral agents|mesh-ancestor
44935762|NCT03714555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935763|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935764|NCT03714555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44935765|NCT03714555|Immunologic Factors|immunologic factors|mesh-ancestor
44935766|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935767|NCT03714555|Trace Elements|trace elements|mesh-ancestor
44935768|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
44935769|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44935770|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44935771|NCT03714490|Capecitabine|capecitabine|mesh-list
44935772|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
44935773|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44935774|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
44935775|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935776|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935777|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
44935778|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44935779|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44935780|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935781|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
44935782|NCT03714360|Coagulants|coagulants|mesh-ancestor
44733136|NCT05689957|Rocuronium|rocuronium|mesh-list
44935783|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44935785|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
44935786|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935787|NCT03714113|Antibodies|antibodies|mesh-list
44935788|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
44935789|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935790|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
44935791|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
44935792|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935793|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706969|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44706970|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
44706971|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
44706972|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
44706973|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44706974|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44706975|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
44706976|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44706977|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
44706978|NCT01431352|Letrozole|letrozole|mesh-list
44706979|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706980|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44706981|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44706982|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44706983|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706984|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44706985|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
44706986|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706987|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706988|NCT01431404|Etanercept|etanercept|mesh-list
44706989|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44706990|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44706991|NCT01431404|Analgesics|analgesics|mesh-ancestor
44706992|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
44706993|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706994|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706995|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44706996|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44706997|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44706998|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44706999|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
44707000|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
44707001|NCT01431430|Vitamin D|vitamin d|mesh-list
44707002|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44707003|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707004|NCT01431430|Vitamins|vitamins|mesh-ancestor
44707005|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
44707006|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44707007|NCT01431443|Theobromine|theobromine|mesh-list
44707008|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44707009|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
44958027|NCT04903210|Niacinamide|niacinamide|mesh-list
44707010|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707011|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707012|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44707013|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44707014|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
44707015|NCT01431456|Nadroparin|nadroparin|mesh-list
44707016|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
44707017|NCT01431456|Dabigatran|dabigatran|mesh-list
44707018|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44707019|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
44707020|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44707021|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
44707022|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707023|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707024|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
44707025|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44707026|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44707027|NCT01431495|Clopidogrel|clopidogrel|mesh-list
44707028|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44707029|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44935794|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733210|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733211|NCT05689151|Abrocitinib|abrocitinib|mesh-list
44935795|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
44935796|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935797|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935798|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935799|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44935800|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935801|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935802|NCT03713762|Lidocaine|lidocaine|mesh-list
44935803|NCT03713762|Fentanyl|fentanyl|mesh-list
44935804|NCT03713762|Bupivacaine|bupivacaine|mesh-list
44935805|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
44935806|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
44935807|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935808|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935809|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
44935810|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935811|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935812|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44935813|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44935814|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44935815|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935816|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935817|NCT03713762|Narcotics|narcotics|mesh-ancestor
44935818|NCT03713762|Analgesics|analgesics|mesh-ancestor
44935819|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44935820|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44935821|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
44935822|NCT03713658|Risperidone|risperidone|mesh-list
44935823|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44935824|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44935825|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
44935826|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935827|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935828|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935829|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44935830|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935831|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935832|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935833|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44935834|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
44935835|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44935836|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44935837|NCT03713372|Antibodies|antibodies|mesh-list
44935838|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44935839|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
44935840|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935841|NCT03713346|Caseins|caseins|mesh-list
44935842|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
44935843|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
44935844|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935845|NCT03713216|Morphine|morphine|mesh-list
44935846|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935847|NCT03713216|Narcotics|narcotics|mesh-ancestor
44935848|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935849|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935850|NCT03713216|Analgesics|analgesics|mesh-ancestor
44935851|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
44935852|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935853|NCT03713190|Empagliflozin|empagliflozin|mesh-list
44935854|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44935855|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935856|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44935857|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935858|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44935859|NCT03712956|Doxorubicin|doxorubicin|mesh-list
44935860|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44935861|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935862|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44935863|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44935864|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935865|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935866|NCT03712735|Fentanyl|fentanyl|mesh-list
44935867|NCT03712735|Bupivacaine|bupivacaine|mesh-list
44935868|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
44935869|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
44935870|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935871|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935872|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
44935873|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935874|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935876|NCT03712735|Analgesics|analgesics|mesh-ancestor
44935877|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44935878|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44935879|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
44935880|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
44935881|NCT03712670|Aflibercept|aflibercept|mesh-list
44935882|NCT03712670|Carotenoids|carotenoids|mesh-list
44935883|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44935884|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490382|NCT05249309|Ketamine|ketamine|mesh-list
44935885|NCT03712670|Growth Substances|growth substances|mesh-ancestor
44935886|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935887|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
44935888|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935889|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
44935890|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935891|NCT03712670|Protective Agents|protective agents|mesh-ancestor
44958880|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958947|NCT05197374|Estradiol|estradiol|mesh-list
44935892|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44935893|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44935894|NCT03712670|Analgesics|analgesics|mesh-ancestor
44935895|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
44935896|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935897|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935898|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44935899|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
44935900|NCT03712540|Rifampin|rifampin|mesh-list
44935901|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44935902|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
44935903|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44935904|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935905|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
44935906|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44935907|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959103|NCT04891250|Ivermectin|ivermectin|mesh-list
44959311|NCT05706701|Nicotine|nicotine|mesh-list
44959614|NCT05646862|Fulvestrant|fulvestrant|mesh-list
44960029|NCT05382338|Mesna|mesna|mesh-list
44960131|NCT05330429|Growth Substances|growth substances|mesh-ancestor
44960132|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960133|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
44960134|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
44960136|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44960422|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960423|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960424|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44960484|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
44960558|NCT04994132|Dactinomycin|dactinomycin|mesh-list
44960738|NCT04858334|Olaparib|olaparib|mesh-list
44960784|NCT04781192|Durvalumab|durvalumab|mesh-list
44960930|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
44961169|NCT04310007|Antibodies|antibodies|mesh-list
44961789|NCT03444298|Vitamin E|vitamin e|mesh-list
44961863|NCT03271372|Avelumab|avelumab|mesh-list
44962091|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
44962172|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44962173|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962434|NCT02521493|Etoposide|etoposide|mesh-list
44962533|NCT02404155|Clozapine|clozapine|mesh-list
44962808|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962809|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962810|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
44962811|NCT02048813|Rituximab|rituximab|mesh-list
44962812|NCT02048813|Fludarabine|fludarabine|mesh-list
44962813|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
44962815|NCT02048813|Antibodies|antibodies|mesh-list
44963071|NCT01358877|Epirubicin|epirubicin|mesh-list
44963233|NCT00972478|Hormones|hormones|mesh-ancestor
44682599|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682600|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682601|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44682602|NCT05421741|Vancomycin|vancomycin|mesh-list
44682603|NCT05421741|Gentamicins|gentamicins|mesh-list
44682604|NCT05421741|Tobramycin|tobramycin|mesh-list
44682605|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682606|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44682607|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682608|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682609|NCT05418049|Memantine|memantine|mesh-list
44682610|NCT05418049|Baclofen|baclofen|mesh-list
44682611|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44682612|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44682613|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
44682614|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682615|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682616|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682617|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44682618|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44682619|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44682620|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44682621|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682622|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44682623|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
44682624|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
44701600|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44701601|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701602|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701603|NCT01404130|Isotretinoin|isotretinoin|mesh-list
44701604|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44701605|NCT01404156|Leucovorin|leucovorin|mesh-list
44701606|NCT01404156|Paclitaxel|paclitaxel|mesh-list
44701607|NCT01404156|Docetaxel|docetaxel|mesh-list
44701608|NCT01404156|Cisplatin|cisplatin|mesh-list
44701609|NCT01404156|Carboplatin|carboplatin|mesh-list
44683011|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683012|NCT05199311|Dexamethasone|dexamethasone|mesh-list
44683013|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683014|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
44683015|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
44683016|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683017|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683018|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683019|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
44683020|NCT05199311|Hormones|hormones|mesh-ancestor
44683021|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234264|NCT00548379|Vitamin D|vitamin d|mesh-list
44683022|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683023|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683024|NCT05194124|alpha-MSH|alpha-msh|mesh-list
44683025|NCT05194124|Hormones|hormones|mesh-ancestor
44683026|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683027|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701610|NCT01404156|Fluorouracil|fluorouracil|mesh-list
44701611|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
44701612|NCT01404156|Epirubicin|epirubicin|mesh-list
44701613|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44701614|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701615|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
44701616|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701617|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
44701618|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701619|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
44701620|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701621|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701622|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
44701623|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701624|NCT01404156|Antidotes|antidotes|mesh-ancestor
44891913|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44891914|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891915|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44891916|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44891917|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891918|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
44891919|NCT04214977|Anesthetics|anesthetics|mesh-list
44891920|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891921|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891922|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
44891923|NCT04214821|Levofloxacin|levofloxacin|mesh-list
44891924|NCT04214821|Ofloxacin|ofloxacin|mesh-list
44891925|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44891926|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44891927|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891928|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891929|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44891930|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891931|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891932|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891933|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891934|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44891935|NCT04214821|Renal Agents|renal agents|mesh-ancestor
44891936|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44891937|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891939|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44891940|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44891941|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891942|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891943|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
44891944|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891945|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891946|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
44891947|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
44891948|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891949|NCT04214665|Protective Agents|protective agents|mesh-ancestor
44891950|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891951|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
44891952|NCT04214665|Vitamins|vitamins|mesh-ancestor
44891953|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
44891954|NCT04214626|Prednisone|prednisone|mesh-list
44891955|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
44891956|NCT04214626|Rituximab|rituximab|mesh-list
44891957|NCT04214626|Methotrexate|methotrexate|mesh-list
44891958|NCT04214626|Vincristine|vincristine|mesh-list
44891959|NCT04214626|Lenalidomide|lenalidomide|mesh-list
44891960|NCT04214626|Epirubicin|epirubicin|mesh-list
44891961|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891962|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
44891963|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891964|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891965|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44891966|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
44891967|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891968|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891969|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44891970|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891971|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891972|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
44891973|NCT04214626|Hormones|hormones|mesh-ancestor
44891974|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891975|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44891976|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44891977|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
44891978|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891979|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891980|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
44891981|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891982|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891983|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44891984|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891985|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44891986|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44891987|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44891988|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44891989|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891990|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891991|NCT04214626|Growth Substances|growth substances|mesh-ancestor
44891992|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891993|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44891994|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44891995|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891996|NCT04214145|Phenylephrine|phenylephrine|mesh-list
44891997|NCT04214145|Vasopressins|vasopressins|mesh-list
44891998|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
44891999|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
44892000|NCT04214145|Norepinephrine|norepinephrine|mesh-list
44892001|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44892002|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
44892003|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
44892004|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892005|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892006|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
44892007|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44892008|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
44892009|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44892010|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44892011|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892012|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892013|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892014|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892015|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892016|NCT04214145|Protective Agents|protective agents|mesh-ancestor
44892017|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
44892018|NCT04214145|Coagulants|coagulants|mesh-ancestor
44892019|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44892020|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
44892021|NCT04214106|Thiamine|thiamine|mesh-list
44892022|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
44892023|NCT04214106|Vitamins|vitamins|mesh-ancestor
44892024|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
44892025|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892026|NCT04213924|Ibuprofen|ibuprofen|mesh-list
44892027|NCT04213924|Lidocaine|lidocaine|mesh-list
44892028|NCT04213924|Bupivacaine|bupivacaine|mesh-list
44892029|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892030|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
44892031|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892032|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892033|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
44892034|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892035|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892036|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44892037|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44892038|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892039|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892040|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892041|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892042|NCT04213924|Analgesics|analgesics|mesh-ancestor
44892043|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892044|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892045|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44892046|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892047|NCT04213937|Paclitaxel|paclitaxel|mesh-list
44892048|NCT04213937|Topotecan|topotecan|mesh-list
44892049|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892050|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892051|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892052|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892053|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892054|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892055|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44892056|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892057|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892058|NCT04214054|Calcium|calcium|mesh-list
44892059|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44892060|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892061|NCT04213898|Paclitaxel|paclitaxel|mesh-list
44892062|NCT04213898|Epirubicin|epirubicin|mesh-list
44892063|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44892064|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892065|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892066|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892067|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892068|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892069|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892070|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44892071|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892072|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892073|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892074|NCT04213833|Lidocaine|lidocaine|mesh-list
44892075|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
44892076|NCT04213833|Propofol|propofol|mesh-list
44892077|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892078|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
44892079|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892080|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892081|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
44892082|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892083|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892084|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44892085|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44892086|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892087|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892119|NCT04213378|Paclitaxel|paclitaxel|mesh-list
44892120|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44892121|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892122|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892123|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892124|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892125|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892126|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892127|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
44892128|NCT04213716|Calcium|calcium|mesh-list
44892129|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44892130|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892131|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44892132|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
44892133|NCT04213612|Doxorubicin|doxorubicin|mesh-list
44892134|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44892135|NCT04213612|Vincristine|vincristine|mesh-list
44892136|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44892137|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
44892138|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892139|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892140|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44892141|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
44892142|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892143|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892144|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44892145|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44892146|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892147|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892148|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892149|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892150|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892151|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892152|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892153|NCT04213495|Anesthetics|anesthetics|mesh-list
44892154|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892155|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892156|NCT04213170|Bevacizumab|bevacizumab|mesh-list
44892157|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892158|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892159|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44892160|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44892161|NCT04213170|Growth Substances|growth substances|mesh-ancestor
44892162|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892163|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44892164|NCT04213573|Fluorides|fluorides|mesh-list
44892165|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
44892166|NCT04213573|Protective Agents|protective agents|mesh-ancestor
44892167|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892168|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44892169|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892170|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892171|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892172|NCT04213287|Analgesics|analgesics|mesh-ancestor
44892173|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
44892174|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892175|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892176|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892177|NCT04213391|Sulforaphane|sulforaphane|mesh-list
44892178|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44892179|NCT04213391|Protective Agents|protective agents|mesh-ancestor
44892180|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892181|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892182|NCT04213222|Bevacizumab|bevacizumab|mesh-list
44892183|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892184|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892185|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44892186|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44892187|NCT04213222|Growth Substances|growth substances|mesh-ancestor
44892188|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892189|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44892190|NCT04213105|Denosumab|denosumab|mesh-list
44892191|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44892192|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892193|NCT04212793|Bevacizumab|bevacizumab|mesh-list
44682923|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
44682924|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682925|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44682926|NCT05250973|Dexamethasone|dexamethasone|mesh-list
44682927|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
44682928|NCT05250973|Bortezomib|bortezomib|mesh-list
44682929|NCT05250973|Daratumumab|daratumumab|mesh-list
44682930|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682931|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
44682932|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682933|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682934|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44682935|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
44682936|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682937|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682938|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44682939|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682940|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
44682941|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
44682942|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682943|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682944|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
44682945|NCT05250973|Hormones|hormones|mesh-ancestor
44682946|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682947|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44234237|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701625|NCT01404156|Protective Agents|protective agents|mesh-ancestor
44701626|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
44701627|NCT01404156|Vitamins|vitamins|mesh-ancestor
44701628|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
44701629|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44701665|NCT01404364|Triamcinolone|triamcinolone|mesh-list
44701666|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
44701667|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701668|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
44701669|NCT01404364|Hormones|hormones|mesh-ancestor
44701670|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701671|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701672|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701673|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
44701674|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
44701675|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701676|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701677|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44701678|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701679|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701680|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701681|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44892194|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701682|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
44701683|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892195|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892196|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44892197|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44892198|NCT04212793|Growth Substances|growth substances|mesh-ancestor
44892199|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892200|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
44892201|NCT04212832|Bupivacaine|bupivacaine|mesh-list
44892202|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892203|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
44892204|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892205|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892206|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
44892207|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892208|NCT04212845|Dexamethasone|dexamethasone|mesh-list
44892209|NCT04212845|Bupivacaine|bupivacaine|mesh-list
44892210|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892211|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
44892212|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
44892213|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892214|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892215|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892216|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
44892217|NCT04212845|Hormones|hormones|mesh-ancestor
44892218|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892219|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44892220|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892221|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892222|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
44892223|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892224|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
44892225|NCT04212702|Everolimus|everolimus|mesh-list
44892226|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892227|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44892228|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
44892229|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892230|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
44892231|NCT04212429|Levofloxacin|levofloxacin|mesh-list
44892232|NCT04212429|Ofloxacin|ofloxacin|mesh-list
44892233|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44892234|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44892235|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892236|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892237|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892238|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892239|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892240|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892241|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892242|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44892243|NCT04212429|Renal Agents|renal agents|mesh-ancestor
44892244|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44892245|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892246|NCT04212650|Losartan|losartan|mesh-list
44892247|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892248|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892249|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44892250|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44892251|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892252|NCT04212403|Levofloxacin|levofloxacin|mesh-list
44892253|NCT04212403|Ofloxacin|ofloxacin|mesh-list
44892254|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44892255|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892256|NCT04212403|Renal Agents|renal agents|mesh-ancestor
44892257|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892258|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892259|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892260|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892261|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892262|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892263|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44892264|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892265|NCT04212533|Vitamin D|vitamin d|mesh-list
44892266|NCT04212533|Vitamins|vitamins|mesh-ancestor
44892267|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
44892268|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892269|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44892270|NCT04211896|Nivolumab|nivolumab|mesh-list
44892271|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892272|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892273|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44892274|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892275|NCT04212078|Levofloxacin|levofloxacin|mesh-list
44892276|NCT04212078|Ofloxacin|ofloxacin|mesh-list
44892277|NCT04212078|Cefuroxime|cefuroxime|mesh-list
44892278|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
44892279|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44892280|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892281|NCT04212078|Renal Agents|renal agents|mesh-ancestor
44892282|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892283|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892284|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892285|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892286|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892287|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892288|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44892289|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892290|NCT04211961|Scopolamine|scopolamine|mesh-list
44892291|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44892292|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44892293|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
44892301|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892302|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892303|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44892304|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
44892305|NCT04211987|Cytarabine|cytarabine|mesh-list
44892306|NCT04211987|Methotrexate|methotrexate|mesh-list
44892307|NCT04211987|Etoposide|etoposide|mesh-list
44892308|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44892309|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
44892310|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892311|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892312|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
44892313|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892314|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44892315|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
44892316|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892317|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892318|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892319|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892320|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892321|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44892322|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
44892323|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44892324|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44892325|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44892326|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892327|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44892328|NCT04212065|Buprenorphine|buprenorphine|mesh-list
44892329|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44892330|NCT04212065|Narcotics|narcotics|mesh-ancestor
44892331|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892332|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892333|NCT04212065|Analgesics|analgesics|mesh-ancestor
44892334|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
44892335|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892336|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44892337|NCT04212000|Ketoconazole|ketoconazole|mesh-list
44892338|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
44892339|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892340|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44892341|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892342|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892343|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892344|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44892345|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44892346|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892347|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892348|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44892349|NCT04211805|Tenofovir|tenofovir|mesh-list
44892350|NCT04211805|Vaccines|vaccines|mesh-list
44892351|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
44892352|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892353|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
44892354|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892355|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44892356|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44892357|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892358|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892359|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44892360|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44683101|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683102|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683103|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44683104|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683105|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683106|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683107|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683108|NCT05073744|Morphine|morphine|mesh-list
44683109|NCT05073744|Nalbuphine|nalbuphine|mesh-list
44683110|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44683111|NCT05073744|Narcotics|narcotics|mesh-ancestor
44683112|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683113|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683114|NCT05073744|Analgesics|analgesics|mesh-ancestor
44683115|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
44683116|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683117|NCT05069597|Pancrelipase|pancrelipase|mesh-list
44683118|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683119|NCT05065957|Capecitabine|capecitabine|mesh-list
44683120|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683121|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
44683122|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683123|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701684|NCT01404377|Ropivacaine|ropivacaine|mesh-list
44701685|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
44701686|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
44701687|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701688|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701689|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
44701690|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701691|NCT01404442|Midazolam|midazolam|mesh-list
44701692|NCT01404442|Ketamine|ketamine|mesh-list
44701693|NCT01404442|Analgesics|analgesics|mesh-ancestor
44701694|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
44701695|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701696|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701697|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44701698|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701699|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
44701700|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
44701701|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701702|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44701703|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44701704|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701705|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701706|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44701707|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701708|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44701709|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701710|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701711|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
44701712|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
44701713|NCT01404468|Lidocaine|lidocaine|mesh-list
44892361|NCT04211558|Ozanimod|ozanimod|mesh-list
44892362|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44892363|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892364|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44892365|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
44892366|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892367|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
44892368|NCT04211844|Ledipasvir|ledipasvir|mesh-list
44892369|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
44892370|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892371|NCT04211545|Rabeprazole|rabeprazole|mesh-list
44892372|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44892373|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892374|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44892375|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892376|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892377|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
44892378|NCT04211298|Propofol|propofol|mesh-list
44892379|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44892380|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892381|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892382|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44892383|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
44892384|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
44892385|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892386|NCT04211298|Analgesics|analgesics|mesh-ancestor
44892387|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
44892388|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892389|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44892390|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892391|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892392|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892393|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892394|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892395|NCT04211012|Paclitaxel|paclitaxel|mesh-list
44892396|NCT04211012|Cisplatin|cisplatin|mesh-list
44892397|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892398|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892399|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892400|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892401|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892402|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892403|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
44892404|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892405|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892406|NCT04211168|Lenvatinib|lenvatinib|mesh-list
44892407|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892408|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44892409|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892410|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892411|NCT04210739|Betamethasone|betamethasone|mesh-list
44892412|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
44892413|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44892414|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
44892415|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44892416|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
44892417|NCT04210739|Hormones|hormones|mesh-ancestor
44892418|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892419|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892420|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892421|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44892422|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
44892423|NCT04210453|Ascorbic Acid|ascorbic acid|mesh-list
44892424|NCT04210453|Vitamins|vitamins|mesh-ancestor
44892425|NCT04210453|Micronutrients|micronutrients|mesh-ancestor
44892426|NCT04210453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683190|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
44892427|NCT04210453|Antioxidants|antioxidants|mesh-ancestor
44892428|NCT04210453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892429|NCT04210453|Protective Agents|protective agents|mesh-ancestor
44892430|NCT04210765|Clomiphene|clomiphene|mesh-list
44892431|NCT04210765|Enclomiphene|enclomiphene|mesh-list
44892432|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
44892433|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44892434|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
44892435|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892436|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892437|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44892438|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
44892439|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44892440|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44892441|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44892442|NCT04210544|Caseins|caseins|mesh-list
44892443|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
44892444|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
44892445|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892446|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
44892447|NCT04209933|Bismuth|bismuth|mesh-list
44892448|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892449|NCT04209933|Antacids|antacids|mesh-ancestor
44892450|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892451|NCT04209933|Diuretics|diuretics|mesh-ancestor
44892452|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
44892453|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892454|NCT04209933|Expectorants|expectorants|mesh-ancestor
44892455|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
44892456|NCT04209920|Chromium|chromium|mesh-list
44892457|NCT04209920|Nickel|nickel|mesh-list
44892458|NCT04209920|Trace Elements|trace elements|mesh-ancestor
44892459|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
44892460|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892462|NCT04209699|Famotidine|famotidine|mesh-list
44892463|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44892464|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892465|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44892466|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
44892467|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
44892468|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892469|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892470|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892471|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44892472|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44892473|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892474|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44892475|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892476|NCT04209959|Nifekalant|nifekalant|mesh-list
44892477|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892478|NCT04209803|Minoxidil|minoxidil|mesh-list
44892479|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892480|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
44892481|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44892482|NCT04209439|Bupivacaine|bupivacaine|mesh-list
44892483|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892484|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
44892485|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892486|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892487|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
44892488|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892489|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892490|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892491|NCT04209439|Analgesics|analgesics|mesh-ancestor
44892492|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892493|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892494|NCT04209478|Morphine|morphine|mesh-list
44892495|NCT04209478|Tramadol|tramadol|mesh-list
44892496|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44892497|NCT04209478|Narcotics|narcotics|mesh-ancestor
44892498|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892499|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892500|NCT04209478|Analgesics|analgesics|mesh-ancestor
44892501|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
44892502|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892503|NCT04209426|Tacrine|tacrine|mesh-list
44892504|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44892505|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892506|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892507|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
44892508|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892509|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892510|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44892511|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
44892512|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892513|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
44892514|NCT04209166|Norepinephrine|norepinephrine|mesh-list
44892515|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44892516|NCT04209166|Serotonin|serotonin|mesh-list
44892517|NCT04209166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44892518|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
44892519|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
44892520|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44892521|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44892522|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44892523|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892524|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892525|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892526|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892527|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892528|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892529|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892530|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
44892531|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
44892532|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892533|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44892534|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44892535|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
44892542|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
44892543|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892544|NCT04208854|Vinorelbine|vinorelbine|mesh-list
44892545|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892546|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892547|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892548|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683348|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683349|NCT04853147|Dexamethasone|dexamethasone|mesh-list
44683350|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
44683351|NCT04853147|Palonosetron|palonosetron|mesh-list
44683352|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
44683354|NCT04853147|BB 1101|bb 1101|mesh-list
44683355|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683356|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
44683357|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
44683358|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683359|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683360|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683361|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
44683362|NCT04853147|Hormones|hormones|mesh-ancestor
44683363|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683364|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683365|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683366|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44683367|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683368|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683369|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44683370|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44683371|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
44683372|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683373|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44683374|NCT04848480|Insulin|insulin|mesh-list
44683375|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44683376|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
44683377|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44683378|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683379|NCT04844606|Mirikizumab|mirikizumab|mesh-list
44683380|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44683381|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683382|NCT04844606|Analgesics|analgesics|mesh-ancestor
44892549|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892550|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892551|NCT04208776|Propranolol|propranolol|mesh-list
44892552|NCT04208776|Midodrine|midodrine|mesh-list
44892553|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44892554|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44892555|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892556|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892557|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892558|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892559|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892560|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892561|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44892562|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
44892563|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
44892564|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892565|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44892566|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44892567|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892568|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892569|NCT04208945|Colistin|colistin|mesh-list
44892570|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892571|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892572|NCT04208958|Vancomycin|vancomycin|mesh-list
44892573|NCT04208958|Nivolumab|nivolumab|mesh-list
44892574|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892575|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892576|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44892577|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892578|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892579|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892580|NCT04208594|Propranolol|propranolol|mesh-list
44892581|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44892582|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44892583|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892584|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892585|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892586|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892587|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892588|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892589|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44892590|NCT04208555|Terconazole|terconazole|mesh-list
44892591|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
44892592|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892593|NCT04208763|Imipenem|imipenem|mesh-list
44892594|NCT04208763|Colistin|colistin|mesh-list
44892595|NCT04208763|Tigecycline|tigecycline|mesh-list
44892596|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892597|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892598|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44892599|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892600|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892601|NCT04208373|Itraconazole|itraconazole|mesh-list
44892602|NCT04208373|Etravirine|etravirine|mesh-list
44892603|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
44892604|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892605|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44892606|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892607|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892608|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892609|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44892610|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
44892611|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892612|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892613|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44892614|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44892615|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44892616|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
44892617|NCT04208581|Fluticasone|fluticasone|mesh-list
44892618|NCT04208581|Xhance|xhance|mesh-list
44892619|NCT04208581|Budesonide|budesonide|mesh-list
44892620|NCT04208581|Bromides|bromides|mesh-list
44892621|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
44892622|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
44892623|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44892624|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44892625|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892626|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44892627|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
44892628|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892629|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892630|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44892631|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
44892632|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44892633|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44892634|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
44892635|NCT04208581|Hormones|hormones|mesh-ancestor
44892636|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892637|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44892638|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44892639|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892640|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892641|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892642|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892643|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
44892644|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44892645|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
44892646|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
44892647|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
44892648|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
44892649|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892650|NCT04208334|Curcumin|curcumin|mesh-list
44892651|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892652|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892653|NCT04208334|Analgesics|analgesics|mesh-ancestor
44892654|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
44892655|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892656|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892657|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892658|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892659|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892660|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892661|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892662|NCT04208516|Dexamethasone|dexamethasone|mesh-list
44892663|NCT04208516|Lidocaine|lidocaine|mesh-list
44892664|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
44892665|NCT04208516|Ropivacaine|ropivacaine|mesh-list
44892666|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892667|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
44892668|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
44892669|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892670|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892671|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892672|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
44892673|NCT04208516|Hormones|hormones|mesh-ancestor
44892674|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892675|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44892676|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892677|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892678|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
44892679|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892680|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
44892681|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892682|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44892683|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44892684|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892685|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892686|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44683258|NCT04923893|Dexamethasone|dexamethasone|mesh-list
44683259|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
44683260|NCT04923893|Fludarabine|fludarabine|mesh-list
44683261|NCT04923893|Lenalidomide|lenalidomide|mesh-list
44683262|NCT04923893|Bortezomib|bortezomib|mesh-list
44683263|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683264|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
44683265|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683266|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892687|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892688|NCT04208516|Analgesics|analgesics|mesh-ancestor
44892689|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44892690|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892691|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892692|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892693|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892694|NCT04208061|Ritonavir|ritonavir|mesh-list
44892695|NCT04208061|Darunavir|darunavir|mesh-list
44892696|NCT04208061|Dabigatran|dabigatran|mesh-list
44892697|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44892698|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44892699|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
44892700|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892701|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892702|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44892703|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44892704|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
44892705|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892706|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44892707|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892708|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
44892709|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44892710|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
44892711|NCT04207957|Olorofim|olorofim|mesh-list
44892712|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
44892713|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892714|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
44892715|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44892716|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44892717|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44892718|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892719|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892720|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
44892721|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892722|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892723|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44892724|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892725|NCT04207684|Testosterone|testosterone|mesh-list
44892726|NCT04207684|Androgens|androgens|mesh-ancestor
44892727|NCT04207684|Hormones|hormones|mesh-ancestor
44892728|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892729|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892730|NCT04207411|Lidocaine|lidocaine|mesh-list
44892731|NCT04207411|Bupivacaine|bupivacaine|mesh-list
44892732|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892733|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
44892734|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892735|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892736|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
44892737|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892738|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44892739|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44892740|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44892741|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892742|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892743|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44892744|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44892745|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44892746|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892747|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892748|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892749|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892750|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44892751|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
44892752|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44892753|NCT04207515|Anesthetics|anesthetics|mesh-list
44892754|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892755|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892756|NCT04207450|Glutaral|glutaral|mesh-list
44892757|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
44892758|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892759|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44892760|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44892761|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892762|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892763|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892764|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892765|NCT04207723|Paroxetine|paroxetine|mesh-list
44892766|NCT04207723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44892767|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44892768|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44892769|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892770|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892771|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
44892772|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892773|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44892774|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
44892775|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44892776|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44892777|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892778|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892779|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
44892780|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
44892781|NCT04207112|Linezolid|linezolid|mesh-list
44892782|NCT04207112|Bedaquiline|bedaquiline|mesh-list
44892783|NCT04207112|Clofazimine|clofazimine|mesh-list
44892784|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892785|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892786|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892787|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892788|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892789|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892790|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892791|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44892792|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
44892793|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892794|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
44892795|NCT04207021|Curcumin|curcumin|mesh-list
44892796|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892797|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892798|NCT04207021|Analgesics|analgesics|mesh-ancestor
44892799|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
44892800|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892801|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892802|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892803|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892804|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683619|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683620|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
44683621|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458706|NCT01591785|Petrolatum|petrolatum|mesh-list
44701714|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
44701715|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
44701716|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701717|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701718|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
44701719|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701720|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44701721|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44701722|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44701723|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44701724|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701725|NCT01404507|Abciximab|abciximab|mesh-list
44701726|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
44701727|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44701728|NCT01404598|Naproxen|naproxen|mesh-list
44701729|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44701730|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44701731|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701732|NCT01404598|Analgesics|analgesics|mesh-ancestor
44701733|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
44701734|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701735|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701736|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701737|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701738|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
44701739|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44701740|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701741|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701742|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44701744|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44701745|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44701746|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44701747|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44701748|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701749|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701750|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701751|NCT01404637|Urological Agents|urological agents|mesh-ancestor
44701752|NCT01404676|Glimepiride|glimepiride|mesh-list
44701753|NCT01404676|Vildagliptin|vildagliptin|mesh-list
44701754|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44701755|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701756|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701757|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701758|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
44701759|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44701760|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
44701761|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701762|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701763|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
44701764|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701765|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701766|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701767|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701768|NCT01404689|Analgesics|analgesics|mesh-ancestor
44701769|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
44701770|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701771|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44701772|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44701773|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44701774|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44701775|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701776|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701777|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
44892805|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892806|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892807|NCT04206865|Valsartan|valsartan|mesh-list
44892808|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
44892825|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44892826|NCT04206228|Hematinics|hematinics|mesh-ancestor
44892827|NCT04206358|Molgramostim|molgramostim|mesh-list
44892828|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892829|NCT04206176|Ticagrelor|ticagrelor|mesh-list
44892830|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44892831|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44892832|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44892833|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44892834|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
44892835|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892836|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892837|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892838|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
44892839|NCT04205916|Dexamethasone|dexamethasone|mesh-list
44892840|NCT04205916|Ketorolac|ketorolac|mesh-list
44892841|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892842|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
44892843|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
44892844|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892845|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892846|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892847|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
44892848|NCT04205916|Hormones|hormones|mesh-ancestor
44892849|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44892850|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44892851|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892852|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892853|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892854|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892855|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892856|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892857|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892858|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892859|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892860|NCT04205916|Analgesics|analgesics|mesh-ancestor
44892861|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
44892862|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892863|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44892864|NCT04205903|Paclitaxel|paclitaxel|mesh-list
44892865|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44892866|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44892867|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892868|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
44892869|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
44892870|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
44892871|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892872|NCT04205890|Ketamine|ketamine|mesh-list
44892873|NCT04205890|Analgesics|analgesics|mesh-ancestor
44892874|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
44892875|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892876|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892877|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44892878|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44892879|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
44892880|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
44892881|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892882|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44892883|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44892884|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892885|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892886|NCT04205851|Gimsilumab|gimsilumab|mesh-list
44892887|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892888|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
44892889|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892890|NCT04205682|Cannabidiol|cannabidiol|mesh-list
44892891|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
44892892|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44892893|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44892894|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44892895|NCT04205578|Protective Agents|protective agents|mesh-ancestor
44892896|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892897|NCT04205565|Oxiracetam|oxiracetam|mesh-list
44892898|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44892899|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
44683700|NCT04427072|Docetaxel|docetaxel|mesh-list
44892900|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
44892901|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
44892902|NCT04205240|Melphalan|melphalan|mesh-list
44892903|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
44892904|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44892905|NCT04205240|Fludarabine|fludarabine|mesh-list
44892906|NCT04205240|Daratumumab|daratumumab|mesh-list
44892907|NCT04205240|Tacrolimus|tacrolimus|mesh-list
44892908|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44892909|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
44892910|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892911|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892912|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44892913|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
44892914|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892915|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892916|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44892917|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44892918|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892919|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44892920|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44892921|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
44892922|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892923|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892924|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44892925|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44892926|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44892927|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44892928|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44892929|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44892930|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892931|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892932|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892933|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
44892934|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892935|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892936|NCT04205344|Bupivacaine|bupivacaine|mesh-list
44892937|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
44892938|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
44892939|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892940|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892941|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
44892942|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892943|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
44892944|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892945|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44892946|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44892947|NCT04205357|Analgesics|analgesics|mesh-ancestor
44892948|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
44892949|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892950|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892951|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44892952|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44892953|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44892954|NCT04205097|Neostigmine|neostigmine|mesh-list
44892955|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44892956|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892957|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892958|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
44892959|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892960|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892961|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44892962|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
44892963|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44892964|NCT04204837|Nivolumab|nivolumab|mesh-list
44892965|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44892966|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892967|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44892968|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892969|NCT04204980|Daratumumab|daratumumab|mesh-list
44892970|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44892971|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892972|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
44892973|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892974|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
44892976|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44892977|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44892978|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44892979|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44892980|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892981|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892982|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44892983|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44892984|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44892985|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44892986|NCT04205058|Caffeine|caffeine|mesh-list
44892987|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44892988|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44892989|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44892990|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44892991|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44892992|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44892993|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44892994|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
44892995|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44892996|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
44892997|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44892998|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44892999|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893000|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893001|NCT04204798|Analgesics|analgesics|mesh-ancestor
44893002|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
44893003|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893004|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44893005|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44893006|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44893007|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
44893008|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893009|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893010|NCT04204772|Charcoal|charcoal|mesh-list
44893011|NCT04204772|Antidotes|antidotes|mesh-ancestor
44893012|NCT04204772|Protective Agents|protective agents|mesh-ancestor
44893013|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893014|NCT04204577|Apatinib|apatinib|mesh-list
44893015|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893016|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893017|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893018|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893019|NCT04204902|Tepotinib|tepotinib|mesh-list
44893020|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893021|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
44893022|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44893023|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
44893024|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893025|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
44893026|NCT04204278|Protective Agents|protective agents|mesh-ancestor
44893027|NCT04204382|Levofloxacin|levofloxacin|mesh-list
44893028|NCT04204382|Ofloxacin|ofloxacin|mesh-list
44893029|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44893030|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893031|NCT04204382|Renal Agents|renal agents|mesh-ancestor
44683850|NCT04185883|Everolimus|everolimus|mesh-list
44683851|NCT04185883|Atezolizumab|atezolizumab|mesh-list
44683852|NCT04185883|Palbociclib|palbociclib|mesh-list
44683853|NCT04185883|Trametinib|trametinib|mesh-list
44683854|NCT04185883|Afatinib|afatinib|mesh-list
44683855|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683856|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893032|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44683857|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44683858|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683859|NCT04185883|Growth Substances|growth substances|mesh-ancestor
44893033|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44893034|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44893035|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893036|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893037|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893038|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44893051|NCT04204044|Folic Acid|folic acid|mesh-list
44893052|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
44893053|NCT04204044|Inositol|inositol|mesh-list
44893054|NCT04204044|Metformin|metformin|mesh-list
44893055|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893056|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893057|NCT04204044|Hematinics|hematinics|mesh-ancestor
44893058|NCT04204044|Vitamins|vitamins|mesh-ancestor
44893059|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
44893060|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
44893061|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44893062|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
44893063|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893064|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
44893065|NCT04204265|Protective Agents|protective agents|mesh-ancestor
44893066|NCT04203732|Anesthetics|anesthetics|mesh-list
44893067|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893068|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893069|NCT04203771|Ibuprofen|ibuprofen|mesh-list
44893070|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44893071|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893072|NCT04203771|Analgesics|analgesics|mesh-ancestor
44893073|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
44893074|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893075|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893076|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893077|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893078|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44893079|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893080|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893081|NCT04203914|Empagliflozin|empagliflozin|mesh-list
44893082|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44893083|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893084|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893085|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893086|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
44893087|NCT04203680|Tryptophan|tryptophan|mesh-list
44893088|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44893089|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44893090|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
44893091|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44893092|NCT04203186|Lumefantrine|lumefantrine|mesh-list
44893093|NCT04203186|Artemether|artemether|mesh-list
44893094|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44893095|NCT04203186|Atovaquone|atovaquone|mesh-list
44893096|NCT04203186|Proguanil|proguanil|mesh-list
44893097|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44893098|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
44893099|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44893100|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44893101|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893102|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893103|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893104|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
44893105|NCT04203342|Ketoconazole|ketoconazole|mesh-list
44893106|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
44893107|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893108|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44893109|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44893110|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893111|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893112|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44893113|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
44893114|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893115|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893116|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44893117|NCT04203368|Adenosine|adenosine|mesh-list
44893118|NCT04203368|Verapamil|verapamil|mesh-list
44893119|NCT04203368|Analgesics|analgesics|mesh-ancestor
44893120|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
44893121|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893122|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893123|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44893124|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
44893125|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44683994|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893127|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
44893128|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893129|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893130|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44893131|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44893132|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44893133|NCT04203212|Goserelin|goserelin|mesh-list
44893134|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44893135|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893136|NCT04203043|Pycnogenols|pycnogenols|mesh-list
44893137|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44893138|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
44893139|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893140|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
44893141|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893142|NCT04203043|Protective Agents|protective agents|mesh-ancestor
44893143|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44893144|NCT04202978|Capecitabine|capecitabine|mesh-list
44893145|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
44893146|NCT04202978|Apatinib|apatinib|mesh-list
44893147|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44893148|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
44893149|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893150|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893151|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893152|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893153|NCT04203511|Paclitaxel|paclitaxel|mesh-list
44893154|NCT04203511|Etoposide|etoposide|mesh-list
44893155|NCT04203511|Cisplatin|cisplatin|mesh-list
44893156|NCT04203511|Carboplatin|carboplatin|mesh-list
44893157|NCT04203511|Pemetrexed|pemetrexed|mesh-list
44893158|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44893159|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893160|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
44893161|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893162|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
44893163|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893164|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44893165|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44893166|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893167|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44893168|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44893169|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
44893170|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
44893171|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893172|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
44893173|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
44893174|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44893175|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44893176|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
44893177|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893178|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893179|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44893180|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
44893181|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893182|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893183|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44893184|NCT04203485|Paclitaxel|paclitaxel|mesh-list
44893185|NCT04203485|Carboplatin|carboplatin|mesh-list
44893186|NCT04203485|Pemetrexed|pemetrexed|mesh-list
44893187|NCT04203485|Apatinib|apatinib|mesh-list
44893188|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44893189|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893190|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
44893191|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893192|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
44893193|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893194|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893195|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44893196|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44893197|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684070|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893198|NCT04202887|Fentanyl|fentanyl|mesh-list
44893199|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44893200|NCT04202887|Narcotics|narcotics|mesh-ancestor
44893201|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893202|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893204|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
44893205|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893206|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44893207|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44893208|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
44893209|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
44893210|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44893211|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893212|NCT04202536|Tenofovir|tenofovir|mesh-list
44893213|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
44893214|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893215|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44893216|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44893217|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893218|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893219|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44893220|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44893221|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
44893222|NCT04202484|Tegafur|tegafur|mesh-list
44893223|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893224|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44893225|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
44893226|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893227|NCT04202380|Azithromycin|azithromycin|mesh-list
44893228|NCT04202380|Ampicillin|ampicillin|mesh-list
44893229|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893230|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893231|NCT04202367|Bupivacaine|bupivacaine|mesh-list
44893232|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893233|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
44893234|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893235|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893236|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
44893237|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893238|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
44893239|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44893240|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893241|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
44893242|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
44893243|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44893244|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893245|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893246|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44893247|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44893248|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
44893249|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44893250|NCT04202406|Acetaminophen|acetaminophen|mesh-list
44893251|NCT04202406|Codeine|codeine|mesh-list
44893252|NCT04202406|Caffeine|caffeine|mesh-list
44893253|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893254|NCT04202406|Analgesics|analgesics|mesh-ancestor
44893255|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
44893256|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893257|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893258|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
44893259|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44893260|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44893261|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893262|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893263|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44893264|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44893265|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
44893266|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893267|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44893268|NCT04202406|Narcotics|narcotics|mesh-ancestor
44893269|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893270|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
44893271|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
44893272|NCT04202224|Acetaminophen|acetaminophen|mesh-list
44893273|NCT04202224|Ibuprofen|ibuprofen|mesh-list
44893274|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893275|NCT04202224|Analgesics|analgesics|mesh-ancestor
44893276|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
44893277|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684229|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684230|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684231|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684232|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
44684233|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684234|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684235|NCT03850418|Azacitidine|azacitidine|mesh-list
44684236|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684237|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
44684238|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684239|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684240|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684241|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
44684242|NCT03850366|Bortezomib|bortezomib|mesh-list
44684243|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684244|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
44684245|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684246|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684247|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684248|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
44684249|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684250|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684251|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44235594|NCT00555256|Sirolimus|sirolimus|mesh-list
44701778|NCT01404702|Aldesleukin|aldesleukin|mesh-list
44701779|NCT01404702|Interleukin-2|interleukin-2|mesh-list
44893278|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893279|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
44893280|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44893281|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893282|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893283|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44893284|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893285|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893286|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
44893287|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44893288|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44893289|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893290|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
44893291|NCT04201951|Coagulants|coagulants|mesh-ancestor
44893292|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
44893293|NCT04202068|Sulbactam|sulbactam|mesh-list
44893294|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893295|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893296|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44893297|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893298|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893299|NCT04201808|Tenofovir|tenofovir|mesh-list
44893300|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
44893301|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893302|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44893303|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44893304|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893305|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893306|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44893307|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44893308|NCT04201860|Hemostatics|hemostatics|mesh-list
44893309|NCT04201860|Coagulants|coagulants|mesh-ancestor
44893310|NCT04201990|Apatinib|apatinib|mesh-list
44893311|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893312|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893313|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893314|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893315|NCT04201678|Anesthetics|anesthetics|mesh-list
44893316|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893317|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893318|NCT04201769|Dexamethasone|dexamethasone|mesh-list
44893319|NCT04201769|Palonosetron|palonosetron|mesh-list
44893320|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893321|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
44893322|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
44893323|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893324|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893325|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893326|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
44893327|NCT04201769|Hormones|hormones|mesh-ancestor
44893328|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893329|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44893330|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893331|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44893332|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44893333|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
44893334|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893335|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893336|NCT04201561|Selenious Acid|selenious acid|mesh-list
44893337|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
44893338|NCT04201561|Paclitaxel|paclitaxel|mesh-list
44893339|NCT04201561|Carboplatin|carboplatin|mesh-list
44893340|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44893341|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893342|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
44893343|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893344|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44893345|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893346|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893347|NCT04201561|Trace Elements|trace elements|mesh-ancestor
44893348|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
44893349|NCT04201652|Anesthetics|anesthetics|mesh-list
44893350|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
44893351|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893352|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893353|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
44893354|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893355|NCT04201054|Fluconazole|fluconazole|mesh-list
44893356|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
44893357|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893358|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44893359|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44893360|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893361|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893362|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44893363|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
44893364|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893365|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893366|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44893367|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44893368|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
44893369|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44893370|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893371|NCT04201249|Piroxicam|piroxicam|mesh-list
44893372|NCT04201249|Lidocaine|lidocaine|mesh-list
44893373|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893374|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
44893375|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893376|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893377|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
44893378|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893379|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44893380|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44893381|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44893382|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44893383|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893384|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44893385|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893386|NCT04201249|Analgesics|analgesics|mesh-ancestor
44893387|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893388|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893389|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44893390|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893391|NCT04200885|Dexamethasone|dexamethasone|mesh-list
44893392|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44893393|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44893394|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893395|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
44893396|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
44893397|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893398|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893399|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893400|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
44893401|NCT04200885|Hormones|hormones|mesh-ancestor
44893402|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893403|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44893404|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893405|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44893406|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893407|NCT04200885|Analgesics|analgesics|mesh-ancestor
44893408|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
44893409|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893410|NCT04200599|Oxytocin|oxytocin|mesh-list
44893411|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
44893412|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44893413|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893414|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
44893415|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44893416|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893417|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893418|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893419|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
44893420|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44893421|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893422|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893423|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893424|NCT04200235|Analgesics|analgesics|mesh-ancestor
44893425|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
44893426|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893427|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44893428|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44893429|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44893430|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
44893431|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893432|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893433|NCT04200092|Granisetron|granisetron|mesh-list
44893434|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
44893435|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
44893436|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893437|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893438|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893439|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44893440|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
44893441|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893442|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893443|NCT04200222|Vanadium|vanadium|mesh-list
44893444|NCT04200222|Trace Elements|trace elements|mesh-ancestor
44893445|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
44893446|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893447|NCT04200040|Dacarbazine|dacarbazine|mesh-list
44893448|NCT04200040|Molgramostim|molgramostim|mesh-list
44893449|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44893450|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
44893451|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893452|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893453|NCT04199364|Poractant alfa|poractant alfa|mesh-list
44893454|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44893455|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
44893472|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
44893473|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44893474|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893475|NCT04193631|Cannabidiol|cannabidiol|mesh-list
44893476|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
44893477|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
44893478|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44893479|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893480|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893481|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893482|NCT04191681|Valsartan|valsartan|mesh-list
44893483|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44893484|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44893485|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44893486|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44893487|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893488|NCT04191863|Valproic Acid|valproic acid|mesh-list
44893489|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
44893490|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893491|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893492|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
44893493|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893494|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893495|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
44893496|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44893497|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893498|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44893499|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44893500|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
44893501|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44893502|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
44893503|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44893504|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893505|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44893506|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44893507|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893508|NCT04189744|Metronidazole|metronidazole|mesh-list
44893509|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
44893510|NCT04189744|Piperaquine|piperaquine|mesh-list
44893511|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
44893512|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44893513|NCT04189744|Artenimol|artenimol|mesh-list
44893514|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893515|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893516|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44893517|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44893518|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
44893519|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44893520|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893521|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893522|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44893523|NCT04189744|Renal Agents|renal agents|mesh-ancestor
44893524|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
44893525|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
44893526|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893527|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
44893528|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
44893529|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893530|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
44893531|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893532|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893533|NCT04189484|Evolocumab|evolocumab|mesh-list
44893534|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44893535|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44893536|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44893537|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
44893538|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893539|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44893540|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
44893541|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893542|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
44893543|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
44893544|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893545|NCT04189211|Trastuzumab|trastuzumab|mesh-list
44893546|NCT04189211|Maytansine|maytansine|mesh-list
44684563|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684564|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684565|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
44684566|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44684567|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
44684568|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44684569|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
44684570|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684571|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684572|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
44684573|NCT03390504|Docetaxel|docetaxel|mesh-list
44684574|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
44684575|NCT03390504|Mitogens|mitogens|mesh-list
44684576|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684577|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684578|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684579|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684580|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684581|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684582|NCT03365362|Varenicline|varenicline|mesh-list
44684583|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44684584|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44684585|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
44684586|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684587|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684588|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684589|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
44684590|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
44684591|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684592|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684593|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44684594|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684595|NCT03331562|Vitamins|vitamins|mesh-ancestor
44684596|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
44684597|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44701780|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701781|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701782|NCT01404702|Analgesics|analgesics|mesh-ancestor
44701783|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
44701784|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893547|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44893548|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893549|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44893550|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44893551|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44893552|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44893553|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893554|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44893555|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
44893556|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893557|NCT04189094|Cisplatin|cisplatin|mesh-list
44893558|NCT04189094|Etoposide|etoposide|mesh-list
44893559|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893560|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44893561|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44893562|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44893563|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893564|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893565|NCT04189055|Irinotecan|irinotecan|mesh-list
44893566|NCT04189055|Cetuximab|cetuximab|mesh-list
44893567|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44893568|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44893569|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893570|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893571|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893572|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44893573|NCT04188782|Sevoflurane|sevoflurane|mesh-list
44893574|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44893575|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44893576|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
44893577|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
44893578|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893579|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893580|NCT04189666|Melatonin|melatonin|mesh-list
44893581|NCT04189666|Rivastigmine|rivastigmine|mesh-list
44893582|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
44893583|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893584|NCT04189666|Protective Agents|protective agents|mesh-ancestor
44893585|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893586|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893587|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44893588|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893589|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44893590|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893591|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44893592|NCT04189198|Bupivacaine|bupivacaine|mesh-list
44893593|NCT04189198|Carticaine|carticaine|mesh-list
44893594|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893595|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
44893596|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893597|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893598|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
44893599|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893600|NCT04188691|Vaccines|vaccines|mesh-list
44893601|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
44893602|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893603|NCT04188483|Selenium|selenium|mesh-list
44893604|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
44893605|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893606|NCT04188483|Protective Agents|protective agents|mesh-ancestor
44893607|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893608|NCT04188483|Trace Elements|trace elements|mesh-ancestor
44893609|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
44893610|NCT04188431|Dexamethasone|dexamethasone|mesh-list
44893611|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893612|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
44893613|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
44893614|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893615|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893616|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893617|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
44893618|NCT04188431|Hormones|hormones|mesh-ancestor
44893619|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893620|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44893621|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893622|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
44893623|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44893624|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
44893625|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893626|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
44893627|NCT04188561|Protective Agents|protective agents|mesh-ancestor
44893628|NCT04188353|Mannitol|mannitol|mesh-list
44893629|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44893630|NCT04188353|Diuretics|diuretics|mesh-ancestor
44893631|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
44893632|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893633|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
44893634|NCT04188106|Varenicline|varenicline|mesh-list
44893635|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44893636|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44893637|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
44893638|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893639|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893640|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893641|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
44893642|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893643|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44893644|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
44893645|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
44893646|NCT04188249|Golimumab|golimumab|mesh-list
44893647|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44893648|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893649|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44893650|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
44893651|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893652|NCT04188158|Capecitabine|capecitabine|mesh-list
44893653|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
44893654|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44893655|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
44893656|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893657|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893692|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
44893693|NCT04187469|Rifampin|rifampin|mesh-list
44893694|NCT04187469|Isoniazid|isoniazid|mesh-list
44893695|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
44893696|NCT04187469|Ethambutol|ethambutol|mesh-list
44893697|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44893698|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893699|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44893700|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44893701|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893702|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496951|NCT03820180|Hormones|hormones|mesh-ancestor
44893703|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893704|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44893705|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
44893706|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
44893707|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44893708|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44893709|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44893710|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44683416|NCT04749628|Cannabidiol|cannabidiol|mesh-list
44893711|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44893712|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44893713|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44893714|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44893715|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44893716|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
44893717|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44893718|NCT04187417|Tetracaine|tetracaine|mesh-list
44893719|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893720|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
44893721|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893722|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893723|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
44893724|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893725|NCT04187456|Midazolam|midazolam|mesh-list
44893726|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44893727|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44893728|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893729|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893730|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44893731|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44893732|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44893733|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44893734|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
44893735|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
44893736|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
44893737|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
44893738|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893739|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893740|NCT04186702|Ranibizumab|ranibizumab|mesh-list
44893741|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44893742|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44893743|NCT04186702|Growth Substances|growth substances|mesh-ancestor
44893744|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893745|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
44893746|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893747|NCT04186936|Simethicone|simethicone|mesh-list
44893748|NCT04186936|Loperamide|loperamide|mesh-list
44893749|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
44893750|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893751|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
44893752|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893753|NCT04186936|Emollients|emollients|mesh-ancestor
44893754|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893755|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
44893756|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
44893757|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44893758|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44893759|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893760|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
44893761|NCT04187014|Coagulants|coagulants|mesh-ancestor
44893762|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
44893763|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44893764|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893765|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893766|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44893767|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44893768|NCT04186559|Protective Agents|protective agents|mesh-ancestor
44893769|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893770|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
44893771|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44893773|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
44893774|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893775|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
44893776|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
44893777|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893778|NCT04186299|Clonidine|clonidine|mesh-list
44893779|NCT04186299|Epinephrine|epinephrine|mesh-list
44893780|NCT04186299|Carticaine|carticaine|mesh-list
44893781|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44893782|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44893783|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
44893784|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893785|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893786|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893787|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44893788|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44893789|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
44893790|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893791|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44893792|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
44893793|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
44893794|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
44893795|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44893796|NCT04186299|Analgesics|analgesics|mesh-ancestor
44893797|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
44893798|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44893799|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
44893800|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44893801|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893802|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
44893803|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893804|NCT04186026|Glucagon|glucagon|mesh-list
44893805|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44893806|NCT04186026|Incretins|incretins|mesh-ancestor
44893807|NCT04186026|Hormones|hormones|mesh-ancestor
44893808|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893809|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893810|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893811|NCT04185857|Olmesartan|olmesartan|mesh-list
44893812|NCT04185857|Canrenone|canrenone|mesh-list
44893813|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44893814|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44893815|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44893816|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893817|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44893818|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44893819|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44893820|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893821|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44893822|NCT04185857|Diuretics|diuretics|mesh-ancestor
44893823|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
44893824|NCT04185675|Anesthetics|anesthetics|mesh-list
44893825|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893826|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893827|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44893828|NCT04185831|Everolimus|everolimus|mesh-list
44893829|NCT04185831|Atezolizumab|atezolizumab|mesh-list
44893830|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893831|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44893832|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
44893833|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893834|NCT04185649|Capecitabine|capecitabine|mesh-list
44893835|NCT04185649|Lapatinib|lapatinib|mesh-list
44893836|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44893837|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
44893838|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893839|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893840|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893841|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893842|NCT04185350|Exenatide|exenatide|mesh-list
44893843|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893859|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44893860|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893861|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893862|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893863|NCT04185077|Heparin|heparin|mesh-list
44893864|NCT04185077|Calcium heparin|calcium heparin|mesh-list
44893865|NCT04185077|Bivalirudin|bivalirudin|mesh-list
44893866|NCT04185077|Antithrombins|antithrombins|mesh-list
44893867|NCT04185077|Thrombin|thrombin|mesh-list
44893868|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
44893869|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44893870|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44893871|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893872|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
44893873|NCT04185077|Coagulants|coagulants|mesh-ancestor
44893874|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44893875|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
44893876|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893877|NCT04185194|Lidocaine|lidocaine|mesh-list
44893878|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
44893879|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
44893880|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893881|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893882|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
44893883|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893884|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44893885|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44893886|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44893887|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44893888|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893889|NCT04185103|Valsartan|valsartan|mesh-list
44893890|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44893891|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44893892|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44893893|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44893894|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893895|NCT04184921|Aspirin|aspirin|mesh-list
44893896|NCT04184921|Osimertinib|osimertinib|mesh-list
44893897|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44893898|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893899|NCT04184921|Analgesics|analgesics|mesh-ancestor
44893900|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
44893901|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893902|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893903|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893904|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893905|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44893906|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44893907|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893908|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44893909|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44893910|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893911|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
44893912|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893913|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893914|NCT04184518|Durvalumab|durvalumab|mesh-list
44893915|NCT04184518|Cediranib|cediranib|mesh-list
44893916|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44893917|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44893918|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893919|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893920|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44893921|NCT04184466|Insulin|insulin|mesh-list
44893922|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44893923|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
44893924|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
44893925|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44893926|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893927|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893928|NCT04184492|Insulin|insulin|mesh-list
44893929|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44893930|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
44893931|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
44893932|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44893933|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
44893934|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44893935|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
44893936|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44893937|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893938|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44893939|NCT04183881|Brodalumab|brodalumab|mesh-list
44893940|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893941|NCT04184141|Alprazolam|alprazolam|mesh-list
44893942|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
44893943|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44893944|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44893945|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893946|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44893947|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44893948|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44893949|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
44893950|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
44893951|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683480|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
44893952|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893953|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
44893954|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
44893955|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44893956|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
44893957|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
44893958|NCT04184115|Scopolamine|scopolamine|mesh-list
44893959|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44893960|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
44893961|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
44893962|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893963|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893964|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44893965|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
44893966|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44893967|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
44893968|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893969|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893970|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44893971|NCT04183634|Rotigotine|rotigotine|mesh-list
44893972|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
44893973|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
44893974|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44893975|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893976|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893977|NCT04183556|Naproxen|naproxen|mesh-list
44893978|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44893979|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44893980|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44893981|NCT04183556|Analgesics|analgesics|mesh-ancestor
44893982|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
44893983|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44893984|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44893985|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893986|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
44893987|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44893988|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893989|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893990|NCT04183725|Oseltamivir|oseltamivir|mesh-list
44893991|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
44893992|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44893993|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44893994|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44893995|NCT04183608|Adalimumab|adalimumab|mesh-list
44893996|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44893997|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44893998|NCT04183738|Ritonavir|ritonavir|mesh-list
44893999|NCT04183738|Darunavir|darunavir|mesh-list
44894000|NCT04183738|Dolutegravir|dolutegravir|mesh-list
44894001|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44894002|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44894003|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
44894004|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894005|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894006|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44894007|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44894008|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
44685050|NCT02843451|Silymarin|silymarin|mesh-list
44685124|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685125|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685126|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685127|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44685128|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44685129|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685130|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44685131|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44685132|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701785|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701786|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44701787|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44701788|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
44701789|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701790|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44701791|NCT01404715|Metformin|metformin|mesh-list
44701792|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
44701793|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701794|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701795|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701796|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44701797|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701798|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701799|NCT01404741|Azacitidine|azacitidine|mesh-list
44701800|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701801|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
44701802|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701803|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701804|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701805|NCT01404767|Metoprolol|metoprolol|mesh-list
44701806|NCT01404767|Esmolol|esmolol|mesh-list
44701807|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44701808|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44701809|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
44701810|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
44701811|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701812|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701813|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44701814|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44701815|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44701816|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
44701817|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701818|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701819|NCT01404793|Rocuronium|rocuronium|mesh-list
44701820|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44701821|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44701822|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44701823|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701824|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701825|NCT01404806|Dolutegravir|dolutegravir|mesh-list
44701826|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44701827|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44701828|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701829|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701830|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44701831|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44701832|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
44701833|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701834|NCT01404819|Anesthetics|anesthetics|mesh-list
44701835|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701836|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701837|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44701838|NCT01404871|Citalopram|citalopram|mesh-list
44894009|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894010|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44894011|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44894012|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44894013|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44894014|NCT04183491|Interferons|interferons|mesh-list
44894015|NCT04183491|Interferon-beta|interferon-beta|mesh-list
44894016|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
44894017|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894018|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
44894022|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44894023|NCT04183361|Cortisone|cortisone|mesh-list
44894024|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894025|NCT04183192|Reslizumab|reslizumab|mesh-list
44894026|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44894027|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
44894028|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44894029|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
44894030|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894031|NCT04183387|Simvastatin|simvastatin|mesh-list
44894032|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894033|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894034|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
44894035|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894036|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894037|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44894038|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894039|NCT04183114|Vaccines|vaccines|mesh-list
44894040|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
44894041|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894042|NCT04183075|Vitamins|vitamins|mesh-list
44894043|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
44894044|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
44894045|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894046|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
44894047|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894048|NCT04183075|Protective Agents|protective agents|mesh-ancestor
44894049|NCT04183257|Vitamin D|vitamin d|mesh-list
44894050|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
44894051|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
44894052|NCT04183257|Vitamins|vitamins|mesh-list
44894053|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
44894054|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894055|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44894056|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894057|NCT04183296|Propofol|propofol|mesh-list
44894058|NCT04183296|Sevoflurane|sevoflurane|mesh-list
44894059|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44894060|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894061|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894062|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44894063|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
44894064|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
44894065|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44894066|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44894067|NCT04182932|Vaccines|vaccines|mesh-list
44894068|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
44894069|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894070|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
44894071|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44894072|NCT04182737|Antibodies|antibodies|mesh-list
44894073|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
44894074|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
44894075|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
44894076|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894077|NCT04182568|Paclitaxel|paclitaxel|mesh-list
44894078|NCT04182568|Docetaxel|docetaxel|mesh-list
44894079|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
44894080|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894081|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894082|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894083|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894084|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894085|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894086|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894087|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
44894088|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894089|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894090|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44894091|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
44894092|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44894093|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44894094|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44894095|NCT04182854|Diuretics|diuretics|mesh-ancestor
44894096|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
44894097|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894098|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44894099|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894100|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894101|NCT04182724|Paclitaxel|paclitaxel|mesh-list
44894102|NCT04182724|Apatinib|apatinib|mesh-list
44894103|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894104|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894105|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894106|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894107|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894108|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894109|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44894110|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894111|NCT04182828|Lidocaine|lidocaine|mesh-list
44894112|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894113|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
44894114|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894115|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894116|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
44894117|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894118|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44894119|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44894120|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44894121|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894122|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894123|NCT04182191|Tenoxicam|tenoxicam|mesh-list
44894124|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44894125|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894126|NCT04182191|Analgesics|analgesics|mesh-ancestor
44894127|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
44894128|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894129|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894130|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894131|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894132|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44685209|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685210|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44685211|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44685212|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44685213|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44685214|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44685215|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
44685216|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
44685217|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44685218|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44685219|NCT02440230|Anastrozole|anastrozole|mesh-list
44685220|NCT02440230|Exemestane|exemestane|mesh-list
44685221|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685222|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685223|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44685224|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44685225|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685226|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685227|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44685228|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685229|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685230|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685231|NCT02422641|Methotrexate|methotrexate|mesh-list
44685232|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44685233|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
44685234|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44685235|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685236|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44685237|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
44685238|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685239|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685240|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
44894133|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894134|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894135|NCT04182399|Zonisamide|zonisamide|mesh-list
44894136|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
44894137|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44894138|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894139|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894140|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894141|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894142|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44894143|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44894144|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894145|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44894146|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44894147|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894148|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894149|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
44894150|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894151|NCT04181645|Gemcitabine|gemcitabine|mesh-list
44894152|NCT04181645|Paclitaxel|paclitaxel|mesh-list
44894153|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894154|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894155|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894156|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894157|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894158|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894159|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44894160|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
44894161|NCT04181645|Antiviral Agents|antiviral agents|mesh-ancestor
44894162|NCT04181645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894163|NCT04181645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894164|NCT04181645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894165|NCT04181645|Immunologic Factors|immunologic factors|mesh-ancestor
44894166|NCT04181645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683495|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44683496|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44683497|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44683498|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44683499|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44683500|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683501|NCT04700176|Dexamethasone|dexamethasone|mesh-list
44683502|NCT04700176|Daratumumab|daratumumab|mesh-list
44683503|NCT04700176|Pomalidomide|pomalidomide|mesh-list
44683504|NCT04700176|Tretinoin|tretinoin|mesh-list
44683505|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683506|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
44683507|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
44683508|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683509|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683510|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683511|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
44683512|NCT04700176|Hormones|hormones|mesh-ancestor
44683513|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683514|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683515|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683516|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
44683517|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44894167|NCT04181567|S 20098|s 20098|mesh-list
44894168|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44894169|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894170|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894171|NCT04181749|Aspirin|aspirin|mesh-list
44894172|NCT04181749|Atorvastatin|atorvastatin|mesh-list
44894173|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44894174|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894175|NCT04181749|Analgesics|analgesics|mesh-ancestor
44894176|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
44894177|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894178|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894179|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894180|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894181|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44894182|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44894183|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894184|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44894185|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44894186|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894187|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
44894188|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894189|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894190|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
44894191|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894192|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44894193|NCT04181385|Bromocriptine|bromocriptine|mesh-list
44894194|NCT04181385|Olanzapine|olanzapine|mesh-list
44894195|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
44894196|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
44894197|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894198|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894199|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44894200|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44894201|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894202|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894203|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894204|NCT04181385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44894205|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44894220|NCT04181489|Vincristine|vincristine|mesh-list
44894221|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894222|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
44894223|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894224|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894225|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44894226|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
44894227|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894228|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894229|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44894230|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894231|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44894232|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44894233|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44894234|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894235|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894236|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894237|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894238|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894239|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894240|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
44894241|NCT04181489|Hormones|hormones|mesh-ancestor
44894242|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894243|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44894244|NCT04181346|Pregabalin|pregabalin|mesh-list
44894245|NCT04181346|Analgesics|analgesics|mesh-ancestor
44894246|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
44894247|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894248|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894249|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
44894250|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44894251|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894252|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894253|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894254|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44894255|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894256|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894257|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894258|NCT04180982|Febuxostat|febuxostat|mesh-list
44894259|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
44894260|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894261|NCT04180657|Protein C|protein c|mesh-list
44894262|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
44894263|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44894264|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44894265|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894266|NCT04180384|Paclitaxel|paclitaxel|mesh-list
44894267|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44894268|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894269|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894270|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894271|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894272|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894273|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894274|NCT04180072|Bevacizumab|bevacizumab|mesh-list
44894275|NCT04180072|Atezolizumab|atezolizumab|mesh-list
44894276|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894277|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894278|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44894279|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44894280|NCT04180072|Growth Substances|growth substances|mesh-ancestor
44894281|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894282|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
44894283|NCT04180150|Entecavir|entecavir|mesh-list
44894284|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
44894285|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894286|NCT04180007|Apatinib|apatinib|mesh-list
44894287|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894288|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44894289|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894290|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894291|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
44894292|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894293|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
44894294|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44894295|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44894296|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894297|NCT04179747|Urological Agents|urological agents|mesh-ancestor
44894298|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
44894299|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44894300|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
44894301|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894302|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894303|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44894304|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44894305|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44894306|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
44894307|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894308|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894309|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44894310|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
44894311|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
44894312|NCT04179942|Protective Agents|protective agents|mesh-ancestor
44894313|NCT04179604|Simendan|simendan|mesh-list
44894314|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44894315|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
44894316|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44894317|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44894318|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894319|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894320|NCT04179604|Protective Agents|protective agents|mesh-ancestor
44894321|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894322|NCT04179513|Methotrexate|methotrexate|mesh-list
44894323|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44894324|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
44894325|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44894326|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894327|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44894328|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
44894329|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894330|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894331|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
44894332|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894333|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44894334|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894335|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
44894336|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894337|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44894338|NCT04179617|Nicotine|nicotine|mesh-list
44894339|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44894340|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
44894341|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894342|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894343|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44894344|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44894345|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44894346|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894347|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894348|NCT04179071|Famotidine|famotidine|mesh-list
44894349|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44894350|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44894351|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44894352|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
44894353|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
44894354|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894355|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894356|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894357|NCT04178863|Timolol|timolol|mesh-list
44894358|NCT04178863|Latanoprost|latanoprost|mesh-list
44894359|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44894360|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44894361|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894362|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894363|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894364|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894365|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44894366|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44894367|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44894368|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44894369|NCT04179045|Sirolimus|sirolimus|mesh-list
44894370|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894371|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894372|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44894373|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894374|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
44894375|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894376|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
44894377|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894378|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
44894379|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894380|NCT04178980|Simvastatin|simvastatin|mesh-list
44894381|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894382|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894383|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
44894384|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894385|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894386|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44894387|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894388|NCT04178850|Folic Acid|folic acid|mesh-list
44894389|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
44894390|NCT04178850|Infliximab|infliximab|mesh-list
44894391|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44894392|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44894393|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894394|NCT04178850|Hematinics|hematinics|mesh-ancestor
44894395|NCT04178850|Vitamins|vitamins|mesh-ancestor
44894396|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
44894397|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894398|NCT04178876|Ethanol|ethanol|mesh-list
44894399|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44894400|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894401|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894402|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894403|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
44894404|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44894405|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44894406|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894407|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
44894408|NCT04178655|Coagulants|coagulants|mesh-ancestor
44894409|NCT04178785|Remifentanil|remifentanil|mesh-list
44894410|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44894411|NCT04178785|Narcotics|narcotics|mesh-ancestor
44894412|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894413|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894414|NCT04178785|Analgesics|analgesics|mesh-ancestor
44894415|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
44894416|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894436|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894438|NCT04178512|Narcotics|narcotics|mesh-ancestor
44894439|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894440|NCT04178512|Analgesics|analgesics|mesh-ancestor
44894441|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
44894442|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44894443|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44894444|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
44894445|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
44894446|NCT04178148|Amikacin|amikacin|mesh-list
44894447|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894448|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894449|NCT04178200|Lidocaine|lidocaine|mesh-list
44894450|NCT04178200|Bupivacaine|bupivacaine|mesh-list
44894451|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44894452|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894453|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
44894454|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894455|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894456|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
44894457|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894458|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44894459|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44894460|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44894461|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894462|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894463|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44894464|NCT04178057|Antibodies|antibodies|mesh-list
44894465|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
44894466|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44894467|NCT04178057|Mitogens|mitogens|mesh-list
44894468|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
44894469|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
44894470|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894471|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894472|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894473|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894474|NCT04178057|Growth Substances|growth substances|mesh-ancestor
44685624|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685625|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44685626|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685627|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685628|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44685629|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
44685630|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44685631|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685632|NCT01642004|Docetaxel|docetaxel|mesh-list
44683551|NCT04661137|Dexamethasone|dexamethasone|mesh-list
44683552|NCT04661137|Daratumumab|daratumumab|mesh-list
44683553|NCT04661137|Pomalidomide|pomalidomide|mesh-list
44685633|NCT01642004|Nivolumab|nivolumab|mesh-list
44685634|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685635|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685636|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685637|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685638|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685639|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685640|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44685641|NCT01489176|Regadenoson|regadenoson|mesh-list
44685642|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44685643|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44685644|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
44685645|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
44685646|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685647|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685648|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701839|NCT01404871|Clomipramine|clomipramine|mesh-list
44701840|NCT01404871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44701841|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44701842|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44701843|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701844|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701845|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
44701846|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701847|NCT01404871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44701848|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
44701849|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701850|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701851|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44701852|NCT01404871|Analgesics|analgesics|mesh-ancestor
44701853|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
44701854|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
44701855|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44701856|NCT01405079|Cisplatin|cisplatin|mesh-list
44701857|NCT01405079|Vinorelbine|vinorelbine|mesh-list
44701858|NCT01405079|Gefitinib|gefitinib|mesh-list
44701859|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701860|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894475|NCT04177875|Paclitaxel|paclitaxel|mesh-list
44894476|NCT04177875|Docetaxel|docetaxel|mesh-list
44894477|NCT04177875|Cisplatin|cisplatin|mesh-list
44894478|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44894479|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44894480|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894481|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894482|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894483|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894484|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894485|NCT04177641|Antioxidants|antioxidants|mesh-list
44894486|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894487|NCT04177641|Protective Agents|protective agents|mesh-ancestor
44894488|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894489|NCT04178109|Acetaminophen|acetaminophen|mesh-list
44894490|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44894491|NCT04178109|Tramadol|tramadol|mesh-list
44894492|NCT04178109|Ropivacaine|ropivacaine|mesh-list
44894493|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
44894494|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894495|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
44894496|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894497|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894498|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
44894499|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894500|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894501|NCT04178109|Analgesics|analgesics|mesh-ancestor
44894502|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
44894503|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44894504|NCT04178109|Narcotics|narcotics|mesh-ancestor
44894505|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44894506|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894507|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894508|NCT04177719|Oxytocin|oxytocin|mesh-list
44894509|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
44894510|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44894511|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894512|NCT04177602|Trifluridine|trifluridine|mesh-list
44894513|NCT04177602|Capecitabine|capecitabine|mesh-list
44894514|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44894515|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
44894516|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894517|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894518|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
44894519|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894520|NCT04177342|Fentanyl|fentanyl|mesh-list
44894521|NCT04177342|Oxycodone|oxycodone|mesh-list
44894522|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44894523|NCT04177342|Narcotics|narcotics|mesh-ancestor
44894524|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894525|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894526|NCT04177342|Analgesics|analgesics|mesh-ancestor
44894527|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
44894528|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894529|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44894530|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44894531|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
44894532|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
44894533|NCT04177173|Methotrexate|methotrexate|mesh-list
44894534|NCT04177173|Simvastatin|simvastatin|mesh-list
44894535|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44894536|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
44894537|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44894538|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894539|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44894540|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
44894541|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894542|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894543|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
44894544|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894545|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44894546|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894547|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
44894548|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894549|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44894550|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894551|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894552|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894553|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44894554|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
44894555|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44894556|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894557|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894558|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
44894559|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894560|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894561|NCT04177303|Metformin|metformin|mesh-list
44894562|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44894563|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894564|NCT04177043|Antibodies|antibodies|mesh-list
44894565|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44894566|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
44894567|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894568|NCT04177095|Sirolimus|sirolimus|mesh-list
44894569|NCT04177095|Prednisone|prednisone|mesh-list
44894570|NCT04177095|Everolimus|everolimus|mesh-list
44894571|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894572|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
44894573|NCT04177095|Hormones|hormones|mesh-ancestor
44894574|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894575|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894576|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685649|NCT01439802|Copper|copper|mesh-list
44894577|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497935|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
44894578|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894579|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
44894580|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44894581|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894582|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894583|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
44894584|NCT04176887|Phenytoin|phenytoin|mesh-list
44894585|NCT04176887|Levetiracetam|levetiracetam|mesh-list
44894586|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
44894587|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
44894588|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44894589|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44894590|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894591|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894592|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44894593|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44894594|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44894595|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44894596|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44894597|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
44894598|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894599|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894600|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44894601|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894602|NCT04176224|Edaravone|edaravone|mesh-list
44894603|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44894604|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
44894605|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894606|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44894607|NCT04176224|Protective Agents|protective agents|mesh-ancestor
44894608|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894609|NCT04176367|Nicergoline|nicergoline|mesh-list
44894610|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44894611|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44894612|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894613|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894614|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894615|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894616|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
44894617|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
44894618|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
44894619|NCT04175990|Progestins|progestins|mesh-ancestor
44894620|NCT04175990|Hormones|hormones|mesh-ancestor
44894621|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894622|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894623|NCT04176328|Teicoplanin|teicoplanin|mesh-list
44894624|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894625|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894626|NCT04176068|Calcium|calcium|mesh-list
44894627|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894628|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894629|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44894630|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
44894631|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44894632|NCT04175522|Antibodies|antibodies|mesh-list
44894633|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
44894634|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
44894635|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894636|NCT04175587|Tretinoin|tretinoin|mesh-list
44894637|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
44894638|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894639|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
44894640|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44894641|NCT04175171|Trastuzumab|trastuzumab|mesh-list
44894642|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894643|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894644|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
44894645|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894646|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894647|NCT04175158|Bevacizumab|bevacizumab|mesh-list
44894648|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
44894649|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894650|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894651|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44497961|NCT01457716|Hormones|hormones|mesh-ancestor
44894659|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894660|NCT04175067|Protective Agents|protective agents|mesh-ancestor
44894661|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894662|NCT04175002|Progesterone|progesterone|mesh-list
44894663|NCT04175002|Progestins|progestins|mesh-ancestor
44894664|NCT04175002|Hormones|hormones|mesh-ancestor
44894665|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894666|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894667|NCT04174872|Midazolam|midazolam|mesh-list
44894668|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
44894669|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44894670|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894671|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894672|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894673|NCT04174872|Analgesics|analgesics|mesh-ancestor
44894674|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
44894675|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894676|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44894677|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44894678|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44894679|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894680|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894681|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894682|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44894683|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44894684|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894685|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894686|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44894687|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
44894688|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
44894689|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
44894690|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
44894691|NCT04174339|Apatinib|apatinib|mesh-list
44894692|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894693|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44894694|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894695|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894696|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44894697|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
44894698|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44894699|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
44894700|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44894701|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894702|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44894703|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44894704|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894705|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
44894706|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
44894707|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894708|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894709|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894710|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
44894711|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
44894712|NCT04174261|Clopidogrel|clopidogrel|mesh-list
44894713|NCT04174261|Ticagrelor|ticagrelor|mesh-list
44894714|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44894715|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44894716|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44894717|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44894718|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
44894719|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894720|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894721|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894722|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
44894723|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44894724|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44894725|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894726|NCT04173832|Amantadine|amantadine|mesh-list
44894727|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44894728|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44894729|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
44894730|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894731|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
44685952|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44685953|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44685954|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44685955|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44685956|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685957|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44685958|NCT01330654|Metoprolol|metoprolol|mesh-list
44685959|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44685960|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44685961|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
44685962|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
44685963|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685964|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685965|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44685966|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44685967|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44685968|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44685969|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685970|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685971|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44685972|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44685973|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44685974|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44685975|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685976|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44685977|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685978|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685979|NCT01330706|Polihexanide|polihexanide|mesh-list
44685980|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
44685981|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701861|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
44701862|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701863|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
44701864|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701865|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44701866|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701867|NCT01405118|Metformin|metformin|mesh-list
44701868|NCT01405118|Tofacitinib|tofacitinib|mesh-list
44701869|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701870|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701871|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44701872|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894732|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894733|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894734|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894735|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894736|NCT04173832|Analgesics|analgesics|mesh-ancestor
44894737|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
44894738|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894739|NCT04174131|Lidocaine|lidocaine|mesh-list
44894740|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
44894741|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894742|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
44894743|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894744|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894745|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
44894746|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894747|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44894748|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44894749|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44894750|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894751|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894752|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44894753|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
44894754|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
44894755|NCT04174131|Protective Agents|protective agents|mesh-ancestor
44894756|NCT04173858|Naloxegol|naloxegol|mesh-list
44894757|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44894758|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894759|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
44894760|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894761|NCT04173793|Ezetimibe|ezetimibe|mesh-list
44894772|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44894774|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
44894775|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894776|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894777|NCT04173390|Pregabalin|pregabalin|mesh-list
44894778|NCT04173390|Analgesics|analgesics|mesh-ancestor
44894779|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
44894780|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894781|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894782|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
44894783|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44894784|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894785|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894786|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894787|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44894788|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894789|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894790|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894791|NCT04173611|Bupivacaine|bupivacaine|mesh-list
44894792|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894793|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
44894794|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894795|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894796|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
44894797|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894798|NCT04173039|Antibodies|antibodies|mesh-list
44894799|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
44894800|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894801|NCT04172987|Tirzepatide|tirzepatide|mesh-list
44894802|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44894803|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894804|NCT04172987|Incretins|incretins|mesh-ancestor
44894805|NCT04172987|Hormones|hormones|mesh-ancestor
44894806|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894807|NCT04172922|Sirolimus|sirolimus|mesh-list
44894808|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894809|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894810|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44894811|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894812|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
44894813|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894814|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
44894815|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894816|NCT04172727|Bupivacaine|bupivacaine|mesh-list
44894817|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894818|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
44894819|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894820|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894821|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
44894822|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894823|NCT04172740|Calcium|calcium|mesh-list
44894824|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44894825|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685982|NCT01330810|Curcumin|curcumin|mesh-list
44894826|NCT04172311|Levetiracetam|levetiracetam|mesh-list
44894827|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
44894828|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
44894829|NCT04172220|Midazolam|midazolam|mesh-list
44894830|NCT04172220|Anesthetics|anesthetics|mesh-list
44894831|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894832|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894833|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44894834|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44894835|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44894836|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894837|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894838|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44894839|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
44894840|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
44894841|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
44894842|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894843|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894844|NCT04172064|Dobutamine|dobutamine|mesh-list
44894845|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44894846|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
44894847|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
44894848|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894849|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894850|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44894851|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44894852|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44894853|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894854|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894855|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894856|NCT04172064|Protective Agents|protective agents|mesh-ancestor
44894857|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
44894858|NCT04172259|Docetaxel|docetaxel|mesh-list
44894859|NCT04172259|Doxorubicin|doxorubicin|mesh-list
44894860|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44894861|NCT04172259|Trastuzumab|trastuzumab|mesh-list
44894862|NCT04172259|Epirubicin|epirubicin|mesh-list
44894863|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44894864|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
44894865|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894866|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44894867|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44894868|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
44894869|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894870|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894871|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44894872|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894873|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894874|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894875|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44894876|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44894877|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44894878|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894879|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44894880|NCT04171791|Venetoclax|venetoclax|mesh-list
44894881|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894882|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
44894883|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44894884|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894885|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
44894886|NCT04171687|Clopidogrel|clopidogrel|mesh-list
44894887|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44894888|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44894889|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44894890|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44894891|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
44894892|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894893|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894894|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894895|NCT04171388|Micronutrients|micronutrients|mesh-list
44894896|NCT04171388|Trace Elements|trace elements|mesh-list
44894897|NCT04171388|Azithromycin|azithromycin|mesh-list
44894898|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894899|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894900|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894901|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
44894902|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
44894903|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894904|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894905|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894906|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
44894907|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44894908|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894909|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894910|NCT04171739|Itraconazole|itraconazole|mesh-list
44894911|NCT04171739|Olorofim|olorofim|mesh-list
44894912|NCT04171739|Rifampin|rifampin|mesh-list
44894913|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
44894914|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894915|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44894916|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44894917|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44894918|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894919|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44894920|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44894921|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894922|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894923|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44894924|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44894925|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
44894926|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894927|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
44894928|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44894929|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44894930|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44894931|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44894932|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44894933|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44894934|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44894935|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
44894936|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44894937|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44894938|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44894939|NCT04171180|Budesonide|budesonide|mesh-list
44894940|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
44894941|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44894942|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44894943|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
44894944|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894945|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894946|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44894947|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44894948|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
44894949|NCT04171180|Hormones|hormones|mesh-ancestor
44894950|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44894951|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44894952|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44894953|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44894954|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894955|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894956|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894957|NCT04171193|Isoflurane|isoflurane|mesh-list
44894958|NCT04171193|Sertraline|sertraline|mesh-list
44894959|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
44894960|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44894961|NCT04171193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44894962|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44894963|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44894964|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894965|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894966|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
44894967|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894968|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44894969|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
44894970|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
44894971|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894972|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
44894973|NCT04171349|Carticaine|carticaine|mesh-list
44894974|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44894975|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44894976|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44894977|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44894978|NCT04171349|Analgesics|analgesics|mesh-ancestor
44894979|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
44894980|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44894981|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44894982|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44894983|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44894984|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
44894985|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44894986|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894987|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
44894988|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
44894989|NCT04171284|Docetaxel|docetaxel|mesh-list
44894990|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44894991|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44894992|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44894993|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44894994|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44894995|NCT04170751|Vasopressins|vasopressins|mesh-list
44894996|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
44894997|NCT04170751|Norepinephrine|norepinephrine|mesh-list
44894998|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44894999|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44895000|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44895001|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895002|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895003|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895004|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
44895005|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
44895006|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895007|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44895008|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
44895009|NCT04170751|Coagulants|coagulants|mesh-ancestor
44895010|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44895011|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
44895012|NCT04170959|Metformin|metformin|mesh-list
44895013|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44895014|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895015|NCT04170595|Trastuzumab|trastuzumab|mesh-list
44895016|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895017|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895018|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
44895019|NCT04170530|Irinotecan|irinotecan|mesh-list
44895020|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895021|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44895022|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895023|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895024|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895025|NCT04170790|Saxagliptin|saxagliptin|mesh-list
44895026|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
44895027|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895028|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44895029|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44895030|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895031|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895032|NCT04170790|Urological Agents|urological agents|mesh-ancestor
44895033|NCT04170790|Incretins|incretins|mesh-ancestor
44895034|NCT04170790|Hormones|hormones|mesh-ancestor
44895035|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895036|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895037|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44895038|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44895039|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44895040|NCT04170647|Plasminogen|plasminogen|mesh-list
44895041|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44895042|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44895043|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895044|NCT04170439|Chromium|chromium|mesh-list
44895045|NCT04170439|Metformin|metformin|mesh-list
44895046|NCT04170439|Citric Acid|citric acid|mesh-list
44895047|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
44895048|NCT04170439|Clomiphene|clomiphene|mesh-list
44895049|NCT04170439|Enclomiphene|enclomiphene|mesh-list
44895050|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
44895051|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44895052|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686279|NCT01332552|Ritonavir|ritonavir|mesh-list
44686280|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44686281|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44686282|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44686283|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686284|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686285|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44686286|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44686287|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
44686288|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686289|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44686290|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44686291|NCT01332565|Dolutegravir|dolutegravir|mesh-list
44686292|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44686293|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44686294|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686295|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686296|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44686297|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44686298|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
44686299|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686300|NCT01332604|Bevacizumab|bevacizumab|mesh-list
44686301|NCT01332604|Capecitabine|capecitabine|mesh-list
44686302|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44686303|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686304|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44686305|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44686306|NCT01332604|Growth Substances|growth substances|mesh-ancestor
44686307|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686308|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44686309|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686310|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
44686311|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701873|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701874|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
44701875|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44701876|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44701877|NCT01405131|Prednisolone|prednisolone|mesh-list
44701878|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
44701879|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44701880|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
44895053|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
44895054|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44895055|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
44895056|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
44895057|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895058|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44895059|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
44895060|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895061|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44895062|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
44895063|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44895064|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44895065|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44895066|NCT04170439|Trace Elements|trace elements|mesh-ancestor
44895067|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
44895068|NCT04170504|Methotrexate|methotrexate|mesh-list
44895069|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44895070|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
44895071|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44895072|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895073|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895074|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
44895075|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895076|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895077|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44895078|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895079|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44895080|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895081|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
44895082|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895083|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44895084|NCT04170270|Omeprazole|omeprazole|mesh-list
44895115|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
44895116|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895117|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44895118|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44895119|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44895120|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895121|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895122|NCT04169841|Durvalumab|durvalumab|mesh-list
44895123|NCT04169841|Olaparib|olaparib|mesh-list
44895124|NCT04169841|Tremelimumab|tremelimumab|mesh-list
44895125|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895126|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895127|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44895128|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895129|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895131|NCT04169919|Povidone|povidone|mesh-list
44895132|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
44895133|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
44895134|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44895135|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895136|NCT04169763|Nelfinavir|nelfinavir|mesh-list
44895137|NCT04169763|Cisplatin|cisplatin|mesh-list
44895138|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895139|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44895140|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44895141|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
44895142|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895143|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895144|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44895145|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44895146|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
44895147|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895148|NCT04169256|Bupivacaine|bupivacaine|mesh-list
44895149|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895150|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
44895151|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895152|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895153|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
44895154|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895155|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
44895156|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
44895157|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895158|NCT04169230|Citalopram|citalopram|mesh-list
44895159|NCT04169230|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44895160|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44895161|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895162|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895163|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895164|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
44895165|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895166|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44895167|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895168|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895169|NCT04169269|Enoxaparin|enoxaparin|mesh-list
44895170|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
44895171|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44895172|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
44895173|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44895174|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44895175|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895176|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895177|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
44895178|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44895179|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44895180|NCT04168879|Bupivacaine|bupivacaine|mesh-list
44895181|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895182|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
44895183|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895184|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895185|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
44895186|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895187|NCT04168944|Lenvatinib|lenvatinib|mesh-list
44895188|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44895189|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895190|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895191|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895192|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895193|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
44895194|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895195|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
44895196|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44895197|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895198|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895199|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895200|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895201|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895202|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895203|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895204|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44895208|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44895209|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44895210|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44895211|NCT04168619|Methotrexate|methotrexate|mesh-list
44895212|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44895213|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
44895214|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44895215|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895216|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895217|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
44895218|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895219|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895220|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
44895221|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895222|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44895223|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895224|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
44895225|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895226|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44895227|NCT04168294|Propofol|propofol|mesh-list
44895228|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44895229|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895230|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895231|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44895232|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
44895233|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
44895234|NCT04168138|Cytarabine|cytarabine|mesh-list
44895235|NCT04168138|Decitabine|decitabine|mesh-list
44895236|NCT04168138|Aclarubicin|aclarubicin|mesh-list
44895237|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895238|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
44895239|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895240|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895241|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
44895242|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895243|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895244|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
44895245|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895246|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895247|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44895248|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895249|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895250|NCT04168099|Cefotaxime|cefotaxime|mesh-list
44895251|NCT04168099|Cefoxitin|cefoxitin|mesh-list
44895252|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
44895253|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895254|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895255|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895256|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895257|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895258|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895259|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895260|NCT04167774|Paclitaxel|paclitaxel|mesh-list
44895261|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44895262|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44895263|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895264|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
44895265|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
44895266|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
44895267|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895268|NCT04167982|Isotretinoin|isotretinoin|mesh-list
44895269|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44895270|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44895271|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44895272|NCT04167566|Artemisinins|artemisinins|mesh-list
44895273|NCT04167566|Artemisinin|artemisinin|mesh-list
44895274|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
44895275|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44895276|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44895277|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895279|NCT04167306|Varenicline|varenicline|mesh-list
44895280|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44895281|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895282|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895283|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44895284|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44895285|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895286|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895287|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
44895288|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895289|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895290|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44895291|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44895292|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895293|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44895294|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44895295|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
44895296|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
44895297|NCT04167696|Fludarabine|fludarabine|mesh-list
44895298|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
44895299|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895300|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
44895301|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895302|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895303|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44895304|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
44895305|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895306|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895307|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44895308|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895309|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
44895310|NCT04167592|Benzydamine|benzydamine|mesh-list
44895311|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895312|NCT04167137|Atezolizumab|atezolizumab|mesh-list
44895313|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895314|NCT04167228|Ceftazidime|ceftazidime|mesh-list
44895315|NCT04167228|Avibactam|avibactam|mesh-list
44895316|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44895317|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895318|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895319|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44895320|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895321|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895322|NCT04167280|Ipratropium|ipratropium|mesh-list
44895323|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44895324|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
44895325|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895326|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895327|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44895328|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
44895329|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44895330|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44895331|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895332|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895333|NCT04166721|Atezolizumab|atezolizumab|mesh-list
44895334|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895335|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
44895336|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895337|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895338|NCT04166890|Epinephrine|epinephrine|mesh-list
44895339|NCT04166890|Carticaine|carticaine|mesh-list
44895340|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44895341|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44895342|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44895343|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895344|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895345|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895346|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44895347|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44895348|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
44895349|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895350|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44686535|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686610|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686611|NCT01334151|Insulin|insulin|mesh-list
44686612|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44686613|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
44686614|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686615|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686616|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44686617|NCT01334177|Cetuximab|cetuximab|mesh-list
44686618|NCT01334177|Antibodies|antibodies|mesh-list
44686619|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
44686620|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44686621|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
44686622|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686623|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686624|NCT01334203|Ranolazine|ranolazine|mesh-list
44686625|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44686626|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44686627|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686628|NCT01334268|Paclitaxel|paclitaxel|mesh-list
44686629|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686630|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686631|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686632|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686633|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686634|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686635|NCT01334333|Tacrolimus|tacrolimus|mesh-list
44683609|NCT04633226|Vaccines|vaccines|mesh-list
44686636|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686637|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
44686638|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686639|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44686640|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686641|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238101|NCT00566332|Chlorambucil|chlorambucil|mesh-list
44701881|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701882|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
44701883|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
44701884|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701885|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701886|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701887|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
44253328|NCT05293041|Coagulants|coagulants|mesh-ancestor
44701888|NCT01405131|Hormones|hormones|mesh-ancestor
44895351|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
44701889|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895352|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
44895353|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
44895354|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44895355|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895356|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
44895357|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895358|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
44895359|NCT04166604|Trifluridine|trifluridine|mesh-list
44895360|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
44895361|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895362|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
44895363|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895364|NCT04167007|Gemcitabine|gemcitabine|mesh-list
44895365|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895366|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
44895367|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895368|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895369|NCT04167007|Antiviral Agents|antiviral agents|mesh-ancestor
44895370|NCT04167007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895371|NCT04167007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895372|NCT04167007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895373|NCT04167007|Immunologic Factors|immunologic factors|mesh-ancestor
44895374|NCT04167007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895375|NCT04166786|Ethanol|ethanol|mesh-list
44895376|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
44895377|NCT04166786|Petrolatum|petrolatum|mesh-list
44895378|NCT04166786|Testosterone|testosterone|mesh-list
44895379|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
44895380|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
44895381|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44895382|NCT04166786|Androgens|androgens|mesh-ancestor
44895383|NCT04166786|Hormones|hormones|mesh-ancestor
44895384|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895385|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895386|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44895387|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895388|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
44895389|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44895390|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895391|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895392|NCT04166786|Emollients|emollients|mesh-ancestor
44895393|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
44895394|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
44895395|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44895396|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
44895397|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895398|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895399|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44895400|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44895401|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44895402|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
44895403|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895404|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895405|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44895406|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895407|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
44895408|NCT04166812|Protective Agents|protective agents|mesh-ancestor
44895409|NCT04166578|Lidocaine|lidocaine|mesh-list
44895410|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895411|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
44895412|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895413|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895414|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
44895415|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895416|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44895417|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44895418|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44895419|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895420|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895421|NCT04166565|Dexamethasone|dexamethasone|mesh-list
44895422|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
44895423|NCT04166565|Bortezomib|bortezomib|mesh-list
44895424|NCT04166565|Daratumumab|daratumumab|mesh-list
44895425|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895426|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
44895427|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895428|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895429|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44895430|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
44895431|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895432|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895433|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44895434|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895435|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
44895436|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
44895437|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895438|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44895439|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
44895440|NCT04166565|Hormones|hormones|mesh-ancestor
44895441|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895442|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44895443|NCT04166006|Interleukin-2|interleukin-2|mesh-list
44895444|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895445|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44895446|NCT04166006|Analgesics|analgesics|mesh-ancestor
44895447|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
44895448|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895449|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895450|NCT04166253|Vitamin D|vitamin d|mesh-list
44895451|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
44895452|NCT04166253|Vitamins|vitamins|mesh-ancestor
44895453|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
44895454|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895455|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44895456|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
44895457|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44895458|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
44895464|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44895465|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44895466|NCT04165850|Analgesics|analgesics|mesh-ancestor
44895467|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
44895468|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895469|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895470|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895471|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895472|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44895473|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44895474|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895475|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895476|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895477|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895478|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895479|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895480|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895481|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44895482|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44895483|NCT04165512|Triamcinolone|triamcinolone|mesh-list
44895484|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44895485|NCT04165512|Bupivacaine|bupivacaine|mesh-list
44895486|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895487|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
44895488|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895489|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895490|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
44895491|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895492|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895493|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
44895494|NCT04165512|Hormones|hormones|mesh-ancestor
44895495|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895496|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895497|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
44895498|NCT04165629|Aspirin|aspirin|mesh-list
44895499|NCT04165629|Clopidogrel|clopidogrel|mesh-list
44895500|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44895501|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44895502|NCT04165629|Analgesics|analgesics|mesh-ancestor
44895503|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
44895504|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895505|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895506|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895507|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895508|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44895509|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44895510|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895511|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44895512|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44895513|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895514|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
44895515|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44895516|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44895517|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44895518|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
44895519|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895520|NCT04165174|Apatinib|apatinib|mesh-list
44895521|NCT04165174|Antibodies|antibodies|mesh-list
44895522|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44895523|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
44895524|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895525|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895526|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895527|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895528|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895529|NCT04164823|Analgesics|analgesics|mesh-list
44895530|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
44895531|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895532|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895533|NCT04164615|Capecitabine|capecitabine|mesh-list
44895534|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895535|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
44895536|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895537|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895538|NCT04164524|Gentamicins|gentamicins|mesh-list
44895539|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895540|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895541|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44895542|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895543|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895544|NCT04164797|Endostar protein|endostar protein|mesh-list
44895545|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44895546|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44895547|NCT04164797|Growth Substances|growth substances|mesh-ancestor
44895548|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895549|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44895550|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895551|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
44895552|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895553|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895554|NCT04164459|Latanoprost|latanoprost|mesh-list
44895555|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44895556|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44895557|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
44895558|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44895559|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895560|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895561|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44498951|NCT05029856|Vaccines|vaccines|mesh-list
44895562|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895563|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44895564|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895565|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44895566|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895567|NCT04164693|Heparin|heparin|mesh-list
44895568|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44895569|NCT04164693|Tinzaparin|tinzaparin|mesh-list
44895570|NCT04164693|Dalteparin|dalteparin|mesh-list
44895571|NCT04164693|Warfarin|warfarin|mesh-list
44895572|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
44895573|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44895574|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44895575|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895576|NCT04164238|Paclitaxel|paclitaxel|mesh-list
44895577|NCT04164238|Cisplatin|cisplatin|mesh-list
44895578|NCT04164238|Carboplatin|carboplatin|mesh-list
44895579|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44895580|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895581|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
44895582|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
44895583|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
44895584|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895585|NCT04164355|Tadalafil|tadalafil|mesh-list
44895586|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895587|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44895588|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44895589|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895590|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895591|NCT04164355|Urological Agents|urological agents|mesh-ancestor
44895592|NCT04164368|Lenalidomide|lenalidomide|mesh-list
44895593|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
44895594|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895595|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44895596|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44895597|NCT04164368|Growth Substances|growth substances|mesh-ancestor
44895598|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
44895599|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895600|NCT04164329|Anesthetics|anesthetics|mesh-list
44895601|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
44895602|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895603|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686794|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895604|NCT04164264|Propofol|propofol|mesh-list
44895605|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44895606|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895607|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895608|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44895609|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
44895610|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
44895611|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
44895612|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895613|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895614|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895615|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895616|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
44895617|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44895618|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44895619|NCT04163536|Prednisolone|prednisolone|mesh-list
44895620|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
44895621|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44895622|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
44895623|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895624|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
44895625|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
44895626|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895627|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895628|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44895629|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
44895630|NCT04163536|Hormones|hormones|mesh-ancestor
44895631|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44895632|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44895633|NCT04163536|Protective Agents|protective agents|mesh-ancestor
44895634|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44895635|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895636|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
44895637|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895638|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895639|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895640|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895641|NCT04163471|Hemostatics|hemostatics|mesh-list
44895642|NCT04163471|Coagulants|coagulants|mesh-ancestor
44895643|NCT04163354|Listerine|listerine|mesh-list
44895644|NCT04163354|Fluorides|fluorides|mesh-list
44686867|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686868|NCT01335516|Terlipressin|terlipressin|mesh-list
44686869|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44686870|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44686871|NCT01335529|Interferons|interferons|mesh-list
44686872|NCT01335529|Ribavirin|ribavirin|mesh-list
44686873|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
44686874|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
44686875|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44686876|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686877|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
44686878|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686879|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
44686880|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686881|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
44686882|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686883|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44686884|NCT01335646|Analgesics|analgesics|mesh-list
44895645|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
44895646|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
44895647|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
44895648|NCT04163354|Protective Agents|protective agents|mesh-ancestor
44895649|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895650|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44895651|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895652|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44895653|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44895654|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895655|NCT04163588|Metolazone|metolazone|mesh-list
44895656|NCT04163588|Diuretics|diuretics|mesh-list
44895657|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44895658|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
44895659|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895660|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895661|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895674|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895675|NCT04162743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44895676|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44895677|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895678|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895679|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895680|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
44895681|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44895682|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895683|NCT04162834|Papaverine|papaverine|mesh-list
44895684|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44895685|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895686|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895687|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895688|NCT04162834|Urological Agents|urological agents|mesh-ancestor
44895689|NCT04162535|Lidocaine|lidocaine|mesh-list
44895690|NCT04162535|Propofol|propofol|mesh-list
44895691|NCT04162535|Anesthetics|anesthetics|mesh-list
44895692|NCT04162535|Sevoflurane|sevoflurane|mesh-list
44895693|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44895694|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895695|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895696|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895697|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
44895698|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895699|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44895700|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44895701|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44895702|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895703|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895704|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44895705|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
44895706|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44895707|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44895708|NCT04162522|Citalopram|citalopram|mesh-list
44895709|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
44895710|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44895711|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44895712|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895713|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895714|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895715|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
44895716|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895717|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44895718|NCT04162522|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895719|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895720|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
44895721|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
44686926|NCT01336166|Vaccines|vaccines|mesh-list
44895722|NCT04162028|Ketamine|ketamine|mesh-list
44895723|NCT04162028|Analgesics|analgesics|mesh-ancestor
44895724|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
44895725|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895726|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895727|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44895728|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44895729|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
44895730|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
44895731|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895732|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44895733|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44895734|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895735|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895736|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
44895737|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44895738|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895739|NCT04161768|Norfloxacin|norfloxacin|mesh-list
44895740|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895741|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895742|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895743|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895744|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895745|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895746|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895747|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44895748|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44895749|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44895750|NCT04161690|Ropivacaine|ropivacaine|mesh-list
44895751|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895752|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
44895753|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895754|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895755|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
44895756|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895757|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44895758|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44895759|NCT04161690|Analgesics|analgesics|mesh-ancestor
44895760|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895761|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895762|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
44895763|NCT04161729|Analgesics|analgesics|mesh-ancestor
44895764|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
44683679|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683680|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
44683681|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683682|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683683|NCT04480372|Antiviral Agents|antiviral agents|mesh-ancestor
44683684|NCT04480372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895765|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895766|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895767|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
44895768|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895769|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44895770|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
44895771|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44895772|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895773|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895774|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44895775|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
44895776|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44895777|NCT04161586|Prilocaine|prilocaine|mesh-list
44895778|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44895779|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
44895780|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895781|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895782|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
44895783|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895784|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
44895785|NCT04161508|Neostigmine|neostigmine|mesh-list
44895786|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44895787|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895788|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895789|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
44895790|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895791|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895792|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44895793|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
44895794|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895795|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44895796|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44895797|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44895798|NCT04161560|Cetuximab|cetuximab|mesh-list
44895799|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44895800|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895801|NCT04161482|Furosemide|furosemide|mesh-list
44895802|NCT04161482|Diuretics|diuretics|mesh-ancestor
44895803|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
44895804|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895805|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44895806|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895807|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895808|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
44895809|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
44895810|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44895811|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44895812|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895813|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895814|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895815|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895816|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
44895817|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44895818|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895819|NCT04161404|Metformin|metformin|mesh-list
44895820|NCT04161404|Andrographolide|andrographolide|mesh-list
44895821|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44895822|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895823|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895824|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44895825|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44895826|NCT04161404|Analgesics|analgesics|mesh-ancestor
44895827|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
44895828|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895829|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895830|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44895831|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44895832|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895833|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
44895834|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44895835|NCT04161209|Citalopram|citalopram|mesh-list
44895836|NCT04161209|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44895837|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44499240|NCT01890863|Fluticasone|fluticasone|mesh-list
44895838|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895839|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895840|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895841|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
44895842|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895843|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44895844|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
44895845|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895846|NCT04161014|Nintedanib|nintedanib|mesh-list
44895847|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895848|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44895849|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895850|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895851|NCT04161053|Rifaximin|rifaximin|mesh-list
44895852|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
44895853|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895854|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895855|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44895856|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44895857|NCT04161001|Amlodipine|amlodipine|mesh-list
44895858|NCT04161001|Olmesartan|olmesartan|mesh-list
44895859|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44895860|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
44895861|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44895862|NCT04161001|Ezetimibe|ezetimibe|mesh-list
44895863|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44895864|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44895865|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895866|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895867|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44895868|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687075|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687151|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687152|NCT01337804|Omeprazole|omeprazole|mesh-list
44687153|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44687154|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44687155|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687156|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44687157|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687158|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701890|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44701891|NCT01405131|Protective Agents|protective agents|mesh-ancestor
44701892|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701893|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701894|NCT01405144|Fluorouracil|fluorouracil|mesh-list
44701895|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
44701896|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701897|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701898|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701899|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701900|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
44701901|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701902|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
44701903|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44701904|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44701905|NCT01405157|Prednisolone|prednisolone|mesh-list
44701906|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
44701907|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44701908|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
44701909|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701910|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
44701911|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
44701912|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701913|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701914|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701915|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
44701916|NCT01405157|Hormones|hormones|mesh-ancestor
44701917|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701918|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44701919|NCT01405157|Protective Agents|protective agents|mesh-ancestor
44701920|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701921|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701922|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
44701923|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44701924|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44701925|NCT01405170|Prednisolone|prednisolone|mesh-list
44701926|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
44701927|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44701928|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
44701929|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701930|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
44701931|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
44701932|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701933|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701934|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701935|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
44701936|NCT01405170|Hormones|hormones|mesh-ancestor
44701937|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701938|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44701939|NCT01405170|Protective Agents|protective agents|mesh-ancestor
44701940|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701941|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701942|NCT01405235|Paclitaxel|paclitaxel|mesh-list
44701943|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44701944|NCT01405235|Cisplatin|cisplatin|mesh-list
44701945|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44701946|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701947|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44895869|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
44895870|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44895871|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44895872|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
44895873|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44895874|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44895875|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895876|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44895880|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
44895881|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895882|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895883|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
44895884|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44895885|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44895886|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895887|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44895888|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44895889|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44895890|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895891|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895892|NCT04160897|Tenofovir|tenofovir|mesh-list
44895893|NCT04160897|Entecavir|entecavir|mesh-list
44895894|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
44895895|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895896|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44895897|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44895898|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895899|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895900|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44895901|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44895902|NCT04160598|Fentanyl|fentanyl|mesh-list
44895903|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44895904|NCT04160598|Narcotics|narcotics|mesh-ancestor
44895905|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895906|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895907|NCT04160598|Analgesics|analgesics|mesh-ancestor
44895908|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
44895909|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895910|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44895911|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44895912|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
44895913|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
44895914|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
44895915|NCT04160676|Thiamine|thiamine|mesh-list
44895916|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
44895917|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44895918|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
44895919|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895920|NCT04160676|Protective Agents|protective agents|mesh-ancestor
44895921|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895922|NCT04160676|Vitamins|vitamins|mesh-ancestor
44895923|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
44895924|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
44895925|NCT04160416|Capecitabine|capecitabine|mesh-list
44895926|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
44895927|NCT04160416|Irinotecan|irinotecan|mesh-list
44895928|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44895929|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
44895930|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895931|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895932|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44895933|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895934|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895935|NCT04160520|Morphine|morphine|mesh-list
44895936|NCT04160520|Pramipexole|pramipexole|mesh-list
44895937|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44895938|NCT04160520|Narcotics|narcotics|mesh-ancestor
44895939|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895940|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895941|NCT04160520|Analgesics|analgesics|mesh-ancestor
44895942|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
44895943|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44895944|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
44895945|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895946|NCT04160520|Protective Agents|protective agents|mesh-ancestor
44895947|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44895948|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44895949|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
44895950|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
44895951|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895953|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44895954|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44895955|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44895956|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895957|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44895958|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44895959|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44895960|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44895961|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
44895962|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
44895963|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
44895964|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
44895965|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44895966|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895967|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
44895968|NCT04160195|Fludarabine|fludarabine|mesh-list
44895969|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44895970|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
44895971|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44895972|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44895973|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44895974|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
44895975|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895976|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44895977|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44895978|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
44895979|NCT04160026|Piperaquine|piperaquine|mesh-list
44895980|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
44895981|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44895982|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
44895983|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44895984|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44895985|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895986|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44683719|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44683720|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
44683721|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683722|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683731|NCT04345718|Buprenorphine|buprenorphine|mesh-list
44683732|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
44895987|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895988|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44895989|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44895990|NCT04160026|Renal Agents|renal agents|mesh-ancestor
44895991|NCT04159870|Rifaximin|rifaximin|mesh-list
44895992|NCT04159870|Norfloxacin|norfloxacin|mesh-list
44895993|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44895994|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44895995|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44895996|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44895997|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44895998|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44895999|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896000|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896001|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44896002|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44896003|NCT04159896|Nivolumab|nivolumab|mesh-list
44896004|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896005|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896006|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44896007|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896008|NCT04159649|Letrozole|letrozole|mesh-list
44896009|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896010|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44896011|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44896012|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896013|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896014|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44896015|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
44896016|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44896017|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896018|NCT04159597|Upadacitinib|upadacitinib|mesh-list
44896019|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44896020|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44896021|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896022|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896023|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896024|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
44687239|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
44896025|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44896026|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44896027|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44896028|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
44896029|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896030|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896031|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896032|NCT04159181|Lactulose|lactulose|mesh-list
44896033|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
44896034|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896035|NCT04159181|Cathartics|cathartics|mesh-ancestor
44896036|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
44896037|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
44896038|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896039|NCT04159142|Paclitaxel|paclitaxel|mesh-list
44896040|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44896041|NCT04159142|Carboplatin|carboplatin|mesh-list
44896042|NCT04159142|Capecitabine|capecitabine|mesh-list
44896043|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44896044|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896045|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896046|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896047|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896048|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896049|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44896050|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
44896051|NCT04159077|Tamsulosin|tamsulosin|mesh-list
44896052|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44896053|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44896054|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44896055|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
44896056|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896057|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896058|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896059|NCT04159077|Urological Agents|urological agents|mesh-ancestor
44896060|NCT04158947|Trastuzumab|trastuzumab|mesh-list
44896061|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44896062|NCT04158947|Afatinib|afatinib|mesh-list
44896063|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896064|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896065|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44896066|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896067|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896068|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896069|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896070|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896071|NCT04158674|Simendan|simendan|mesh-list
44896072|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44896073|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
44896074|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44896075|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44896076|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896077|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896078|NCT04158674|Protective Agents|protective agents|mesh-ancestor
44896079|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896080|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44896081|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
44896082|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896083|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896084|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
44896085|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896086|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896087|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44896088|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44896089|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896090|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44896091|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
44896092|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896093|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896094|NCT04158713|Piperaquine|piperaquine|mesh-list
44896095|NCT04158713|Artenimol|artenimol|mesh-list
44896096|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
44896097|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44896098|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44896099|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896100|NCT04158830|Aspirin|aspirin|mesh-list
44896104|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
44896105|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896106|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896107|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896108|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896109|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44896110|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44896111|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896112|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44896113|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44896114|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896115|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
44896116|NCT04158856|Trastuzumab|trastuzumab|mesh-list
44896117|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896118|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896119|NCT04158076|Amlodipine|amlodipine|mesh-list
44896120|NCT04158076|Telmisartan|telmisartan|mesh-list
44896121|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44896122|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44896123|NCT04158076|Ezetimibe|ezetimibe|mesh-list
44896124|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44896125|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44896126|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896127|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896128|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44896129|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896130|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
44896131|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44896132|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44896133|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
44896134|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44896135|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44896136|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896137|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44896138|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44896139|NCT04158102|Bupivacaine|bupivacaine|mesh-list
44896140|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
44896141|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
44896142|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896143|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896144|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
44896145|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896146|NCT04158167|Oxytocin|oxytocin|mesh-list
44896147|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
44896148|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896149|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896150|NCT04158050|Omalizumab|omalizumab|mesh-list
44896151|NCT04158050|Antibodies|antibodies|mesh-list
44896152|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
44896153|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896154|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44896155|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44896156|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896157|NCT04158388|Tryptophan|tryptophan|mesh-list
44896158|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44896159|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
44896160|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896161|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
44896162|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896163|NCT04157803|Acetic Acid|acetic acid|mesh-list
44896164|NCT04157803|Retinol acetate|retinol acetate|mesh-list
44896165|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896166|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896167|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44896168|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
44896169|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896170|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44896171|NCT04157803|Protective Agents|protective agents|mesh-ancestor
44896172|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687459|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687460|NCT01339884|Resveratrol|resveratrol|mesh-list
44687461|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
44687462|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687463|NCT01339884|Protective Agents|protective agents|mesh-ancestor
44687464|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687465|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687466|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44701948|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701949|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44701950|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701951|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44701952|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44701953|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44701954|NCT01405248|Protective Agents|protective agents|mesh-ancestor
44701955|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701957|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701958|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701959|NCT01405339|Budesonide|budesonide|mesh-list
44701960|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701961|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44701962|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
44701963|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701964|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701965|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44701966|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
44701967|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
44701968|NCT01405339|Hormones|hormones|mesh-ancestor
44701969|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701970|NCT01405352|Vitamin A|vitamin a|mesh-list
44701971|NCT01405352|Vitamins|vitamins|mesh-ancestor
44701972|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
44701973|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701974|NCT01405365|Metronidazole|metronidazole|mesh-list
44701975|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701976|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701977|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44701978|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44701979|NCT01405430|Bevacizumab|bevacizumab|mesh-list
44701980|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701981|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701982|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44701983|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44701984|NCT01405430|Growth Substances|growth substances|mesh-ancestor
44701985|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701986|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
44701987|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
44701988|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44701989|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44701990|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44701991|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44701992|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701993|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44701994|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701995|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701996|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44701997|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701998|NCT01405521|Vaccines|vaccines|mesh-list
44701999|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
44702000|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702001|NCT01405573|Sorafenib|sorafenib|mesh-list
44702002|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702003|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702004|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702005|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896173|NCT04157959|Febuxostat|febuxostat|mesh-list
44896174|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
44896175|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896176|NCT04157998|Metoclopramide|metoclopramide|mesh-list
44896177|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
44896178|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
44896179|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896180|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896181|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896182|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44896183|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44896184|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
44896185|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896186|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896187|NCT04157491|Antibodies|antibodies|mesh-list
44896188|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
44896189|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896190|NCT04157478|Temozolomide|temozolomide|mesh-list
44683736|NCT04345718|Analgesics|analgesics|mesh-ancestor
44896191|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44896192|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
44896193|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896194|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896195|NCT04157699|Tenofovir|tenofovir|mesh-list
44896196|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
44896197|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896198|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44896199|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896200|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896201|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896202|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44896203|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44896204|NCT04157257|Tenofovir|tenofovir|mesh-list
44896205|NCT04157257|Entecavir|entecavir|mesh-list
44896206|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
44896207|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896208|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44896209|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896210|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896211|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896212|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44896213|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44896214|NCT04156984|Golimumab|golimumab|mesh-list
44896215|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44896216|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896217|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896218|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
44896219|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896220|NCT04157010|Methotrexate|methotrexate|mesh-list
44896221|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44896222|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
44896223|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896224|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896225|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44896226|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
44896227|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896228|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896229|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
44896230|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896231|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44896232|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896233|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
44896234|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896235|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896236|NCT04156750|Metformin|metformin|mesh-list
44896237|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896238|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896239|NCT04156815|Isotretinoin|isotretinoin|mesh-list
44896240|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44896241|NCT04156425|Golimumab|golimumab|mesh-list
44896242|NCT04156425|Dexetimide|dexetimide|mesh-list
44896243|NCT04156425|Citalopram|citalopram|mesh-list
44896244|NCT04156425|Calcium|calcium|mesh-list
44896245|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44896246|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896247|NCT04156425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44896248|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44896249|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896250|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896251|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896252|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
44687467|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
44896253|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44896254|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
44896255|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896256|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44896257|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44896258|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
44896259|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
44896260|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896261|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44896262|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44896263|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
44896264|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44896265|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896266|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896267|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
44896268|NCT04156451|Furosemide|furosemide|mesh-list
44896269|NCT04156451|Diuretics|diuretics|mesh-ancestor
44896270|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
44896271|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896272|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44896273|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896274|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896275|NCT04156464|Lorazepam|lorazepam|mesh-list
44896276|NCT04156464|Phenobarbital|phenobarbital|mesh-list
44896277|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
44896278|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
44896279|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
44896280|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896281|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896282|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896283|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44896284|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896285|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44896286|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44896287|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896288|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
44896289|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
44896290|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896291|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896292|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44896293|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44896294|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44896295|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44896296|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44896297|NCT04156204|Tacrolimus|tacrolimus|mesh-list
44896298|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896299|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
44896300|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896301|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44896302|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896303|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896304|NCT04156035|Lamotrigine|lamotrigine|mesh-list
44896305|NCT04156035|Ketamine|ketamine|mesh-list
44896306|NCT04156035|Analgesics|analgesics|mesh-ancestor
44896307|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
44896308|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896309|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896310|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44896311|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44896312|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
44896313|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
44896314|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896315|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44896316|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44896317|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896318|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896319|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
44896320|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44896321|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896322|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44896323|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44896324|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44896325|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896326|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44896327|NCT04156152|Listerine|listerine|mesh-list
44896328|NCT04156152|Fluorides|fluorides|mesh-list
44896329|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
44687541|NCT01340521|Clomiphene|clomiphene|mesh-list
44896364|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
44896365|NCT04155918|Protective Agents|protective agents|mesh-ancestor
44896366|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896367|NCT04155697|Ethanol|ethanol|mesh-list
44896368|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
44896369|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44896370|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896371|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499879|NCT01895621|Protective Agents|protective agents|mesh-ancestor
44896372|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896373|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
44896375|NCT04155554|Lamivudine|lamivudine|mesh-list
44896376|NCT04155554|Emtricitabine|emtricitabine|mesh-list
44896377|NCT04155554|Dolutegravir|dolutegravir|mesh-list
44896378|NCT04155554|Abacavir|abacavir|mesh-list
44896379|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44896380|NCT04155554|Triumeq|triumeq|mesh-list
44896381|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
44896382|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896383|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44896384|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896385|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896386|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896387|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44896388|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44896389|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44896390|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44896391|NCT04155515|Ribavirin|ribavirin|mesh-list
44896392|NCT04155515|Yimitasvir|yimitasvir|mesh-list
44896393|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
44896394|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896395|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
44896396|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896397|NCT04155229|Acetaminophen|acetaminophen|mesh-list
44896398|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44896399|NCT04155229|Oxycodone|oxycodone|mesh-list
44896400|NCT04155229|Hydrocodone|hydrocodone|mesh-list
44896401|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44896402|NCT04155229|Analgesics|analgesics|mesh-ancestor
44896403|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
44896404|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896405|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896406|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
44896407|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44896408|NCT04155229|Narcotics|narcotics|mesh-ancestor
44896409|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896410|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
44896411|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896412|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44896413|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896414|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896415|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
44896416|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44896417|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
44896418|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
44896419|NCT04154852|Folic Acid|folic acid|mesh-list
44896420|NCT04154852|Adalimumab|adalimumab|mesh-list
44896421|NCT04154852|Methotrexate|methotrexate|mesh-list
44896422|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44896423|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
44896424|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896425|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896426|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44896427|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
44896428|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896429|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896430|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44896431|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896432|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44896433|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896434|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
44896435|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896436|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896437|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896438|NCT04154852|Hematinics|hematinics|mesh-ancestor
44896439|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
44896440|NCT04154852|Vitamins|vitamins|mesh-ancestor
44896441|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
44896442|NCT04154813|Topiramate|topiramate|mesh-list
44896443|NCT04154813|Fluoxetine|fluoxetine|mesh-list
44896444|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
44896445|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687691|NCT01341353|Amiodarone|amiodarone|mesh-list
44896446|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896447|NCT04154813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44896448|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44896449|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896450|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687759|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687760|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687761|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44687762|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687763|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
44687765|NCT01341743|Adefovir|adefovir|mesh-list
44687766|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44687767|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
44687768|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687769|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44687770|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687771|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687772|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239339|NCT00573001|Nevirapine|nevirapine|mesh-list
44702006|NCT01405586|Gemcitabine|gemcitabine|mesh-list
44702007|NCT01405586|Cisplatin|cisplatin|mesh-list
44702008|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702009|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44702010|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
44702011|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702012|NCT01405586|Antiviral Agents|antiviral agents|mesh-ancestor
44702013|NCT01405586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702014|NCT01405586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702015|NCT01405586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702016|NCT01405586|Immunologic Factors|immunologic factors|mesh-ancestor
44702017|NCT01405586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702018|NCT01405612|Midazolam|midazolam|mesh-list
44702019|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44702020|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44702021|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702022|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702023|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44702024|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44702025|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702026|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44702027|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
44702028|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
44702029|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
44702030|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
44702031|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702032|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702033|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
44702034|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702035|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702036|NCT01405846|Gefitinib|gefitinib|mesh-list
44702037|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702038|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702039|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702053|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44702055|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702056|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44702057|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
44702058|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702059|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702060|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44702061|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44702062|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
44702063|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702064|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
44896451|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896452|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
44896453|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44896454|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44896455|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44896456|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44896457|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44896458|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896459|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
44896460|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44896461|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
44896462|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896463|NCT04154982|Expectorants|expectorants|mesh-ancestor
44896464|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896465|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44896467|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896468|NCT04154982|Protective Agents|protective agents|mesh-ancestor
44896469|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896470|NCT04154982|Antidotes|antidotes|mesh-ancestor
44896471|NCT04154748|Omeprazole|omeprazole|mesh-list
44896472|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44896473|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896474|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44896475|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896476|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896477|NCT04154735|Rifaximin|rifaximin|mesh-list
44896478|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
44896479|NCT04154735|Fludarabine|fludarabine|mesh-list
44896480|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
44896481|NCT04154735|Tacrolimus|tacrolimus|mesh-list
44896482|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896483|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
44896484|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896485|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896486|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44896487|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
44896488|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896489|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896490|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44896491|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44896492|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896493|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896494|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896495|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896496|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896497|NCT04154722|Azithromycin|azithromycin|mesh-list
44896498|NCT04154722|Meropenem|meropenem|mesh-list
44896499|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896500|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896501|NCT04154449|Insulin|insulin|mesh-list
44235119|NCT00553124|Vitamin E|vitamin e|mesh-list
44896502|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896503|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896504|NCT04153968|Retinol acetate|retinol acetate|mesh-list
44896505|NCT04153968|Protective Agents|protective agents|mesh-ancestor
44896506|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896507|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44896508|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
44896509|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44896510|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896511|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
44896512|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896513|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896514|NCT04154033|Naltrexone|naltrexone|mesh-list
44896515|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44896516|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44896517|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896518|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
44896519|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896520|NCT04153708|Antibodies|antibodies|mesh-list
44896521|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
44896522|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44896523|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
44896524|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896525|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
44896526|NCT04153487|Vitamins|vitamins|mesh-ancestor
44896527|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
44896528|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896529|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
44896530|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896531|NCT04153487|Protective Agents|protective agents|mesh-ancestor
44896532|NCT04153734|Paclitaxel|paclitaxel|mesh-list
44896533|NCT04153734|Carboplatin|carboplatin|mesh-list
44896534|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
44896535|NCT04153734|Pemetrexed|pemetrexed|mesh-list
44896536|NCT04153734|Cisplatin|cisplatin|mesh-list
44896537|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44896538|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896539|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896540|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896541|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896542|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896571|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896573|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44896574|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44896575|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
44896576|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896577|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896578|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896579|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44896580|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44896581|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
44896582|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896583|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44896584|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896585|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
44896586|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
44896587|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44687864|NCT01342224|Gemcitabine|gemcitabine|mesh-list
44896589|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44896590|NCT04153084|Cathartics|cathartics|mesh-ancestor
44896591|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896592|NCT04153084|Laxatives|laxatives|mesh-ancestor
44896593|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
44896594|NCT04152655|Idebenone|idebenone|mesh-list
44896595|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
44896596|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896597|NCT04152655|Vitamins|vitamins|mesh-ancestor
44896598|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
44896599|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896600|NCT04152655|Protective Agents|protective agents|mesh-ancestor
44896601|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44896602|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896603|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896604|NCT04152681|Apatinib|apatinib|mesh-list
44896605|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896606|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44896607|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896608|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896609|NCT04152759|Golimumab|golimumab|mesh-list
44896610|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44896611|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896612|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896613|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
44896614|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896615|NCT04152889|Docetaxel|docetaxel|mesh-list
44896616|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896617|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896618|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896619|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896620|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896621|NCT04152434|Erenumab|erenumab|mesh-list
44896622|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44896623|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896624|NCT04152434|Analgesics|analgesics|mesh-ancestor
44896625|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
44896626|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896627|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896628|NCT04152629|Methylphenidate|methylphenidate|mesh-list
44896629|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44896630|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44896631|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896632|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44896633|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44896634|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896635|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896636|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
44896637|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896638|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44896639|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44896640|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44896641|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
44896642|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44896643|NCT04152317|Misoprostol|misoprostol|mesh-list
44896644|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44896645|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
44896646|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896647|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896648|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44896649|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896650|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
44896651|NCT04152356|Sorafenib|sorafenib|mesh-list
44896652|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896653|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44896654|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896655|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896656|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
44896657|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44896658|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
44896659|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896660|NCT04152057|Paclitaxel|paclitaxel|mesh-list
44896661|NCT04152057|Trastuzumab|trastuzumab|mesh-list
44687942|NCT01342614|Metformin|metformin|mesh-list
44896662|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44687998|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687999|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44688000|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
44688002|NCT01342874|Inositol|inositol|mesh-list
44688003|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
44688004|NCT01342874|Vitamins|vitamins|mesh-ancestor
44688005|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
44688006|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688007|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44688008|NCT01342939|Incretins|incretins|mesh-list
44688009|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44688010|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688011|NCT01342939|Hormones|hormones|mesh-ancestor
44688012|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688013|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44688014|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688015|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688016|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688017|NCT05251584|Gentamicins|gentamicins|mesh-list
44688018|NCT05251584|Mupirocin|mupirocin|mesh-list
44688019|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44688020|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688021|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44688022|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688023|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688024|NCT05250843|Lenvatinib|lenvatinib|mesh-list
44688025|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688026|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688027|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688028|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688029|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
44688030|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44688031|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688032|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44688033|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688034|NCT05250661|Propolis|propolis|mesh-list
44896663|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896664|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896665|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896666|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896667|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896668|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896669|NCT04151823|Vitamin D|vitamin d|mesh-list
44896670|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
44896671|NCT04151823|Vitamins|vitamins|mesh-ancestor
44896672|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
44896673|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896674|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44896675|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44896676|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44896677|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896678|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896679|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896680|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
44896681|NCT04151706|Busulfan|busulfan|mesh-list
44896682|NCT04151706|Thiotepa|thiotepa|mesh-list
44896683|NCT04151706|Fludarabine|fludarabine|mesh-list
44896684|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896685|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
44896686|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896687|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896688|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44896689|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
44896690|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896691|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896692|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44896693|NCT04151472|Ubiquinone|ubiquinone|mesh-list
44896694|NCT04151472|Idebenone|idebenone|mesh-list
44896695|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
44896696|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896697|NCT04151472|Protective Agents|protective agents|mesh-ancestor
44896698|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896699|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
44896700|NCT04151719|Bromides|bromides|mesh-list
44896701|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
44896702|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
44896703|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44896704|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896705|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
44896706|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896707|NCT04151459|Metformin|metformin|mesh-list
44896708|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896709|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896710|NCT04151355|Atorvastatin|atorvastatin|mesh-list
44896711|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44896712|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44896713|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
44896714|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896715|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44896716|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44896717|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896718|NCT04151381|Aminophylline|aminophylline|mesh-list
44896719|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44896720|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
44896721|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896722|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896723|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44896724|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
44896725|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44896726|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44896727|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896728|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896729|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44896730|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44896731|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
44896732|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896733|NCT04151381|Protective Agents|protective agents|mesh-ancestor
44896734|NCT04151147|Mitogens|mitogens|mesh-list
44896735|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896736|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896737|NCT04150965|Thalidomide|thalidomide|mesh-list
44896738|NCT04150965|Dexamethasone|dexamethasone|mesh-list
44896739|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
44896740|NCT04150965|Pomalidomide|pomalidomide|mesh-list
44896741|NCT04150965|Elotuzumab|elotuzumab|mesh-list
44896742|NCT04150965|BB 1101|bb 1101|mesh-list
44896743|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896744|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
44896745|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
44896746|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896747|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896748|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896749|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
44896750|NCT04150965|Hormones|hormones|mesh-ancestor
44896751|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44896752|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44896753|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896754|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
44896755|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896756|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896757|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
44896758|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44896759|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44896760|NCT04150965|Growth Substances|growth substances|mesh-ancestor
44896761|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44896762|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44896763|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
44896764|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896765|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896766|NCT04150575|Paclitaxel|paclitaxel|mesh-list
44896767|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44896768|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44896769|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896770|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896771|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896772|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
44896773|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896774|NCT04150536|Lidocaine|lidocaine|mesh-list
44896775|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
44896776|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
44896777|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896778|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896779|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
44896780|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896781|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44896782|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44896783|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44896784|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44896785|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896786|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44896787|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44896788|NCT04150731|Estradiol|estradiol|mesh-list
44896789|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44896790|NCT04150731|Estrogens|estrogens|mesh-ancestor
44896791|NCT04150731|Hormones|hormones|mesh-ancestor
44896792|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44896793|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896794|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44896795|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
44896796|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896797|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44896798|NCT04150757|Ketamine|ketamine|mesh-list
44896799|NCT04150757|Analgesics|analgesics|mesh-ancestor
44896800|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
44896801|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896802|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896803|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44896804|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44896805|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
44896806|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
44896807|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44896808|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44896809|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44896810|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44896811|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896812|NCT04150289|Panobinostat|panobinostat|mesh-list
44896813|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896814|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44896815|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896816|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896817|NCT04150367|Rifampin|rifampin|mesh-list
44896818|NCT04150367|Isoniazid|isoniazid|mesh-list
44896819|NCT04150367|Ethambutol|ethambutol|mesh-list
44896820|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44896821|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44896822|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
44896823|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44896824|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896825|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
44896826|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44896827|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896828|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896829|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44896830|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44896831|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44896832|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44896833|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44896834|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44896835|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44896836|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44896837|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
44896838|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44896839|NCT04150172|Rebamipide|rebamipide|mesh-list
44896840|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44896841|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896842|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
44896843|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896844|NCT04150172|Protective Agents|protective agents|mesh-ancestor
44896845|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896846|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688186|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44688187|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688188|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44688189|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44688190|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688191|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702065|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
44702066|NCT01406002|Rifampin|rifampin|mesh-list
44702067|NCT01406002|Darexaban|darexaban|mesh-list
44702068|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44702069|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
44702070|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702071|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702072|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
44702073|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44702074|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702075|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702076|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44702077|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44702078|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44702079|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44702080|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44702081|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44702082|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44702083|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
44702084|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702085|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702086|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
44702087|NCT01406080|Adapalene|adapalene|mesh-list
44702088|NCT01406080|Tretinoin|tretinoin|mesh-list
44702089|NCT01406080|Emollients|emollients|mesh-list
44702090|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44702091|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702092|NCT01406080|Analgesics|analgesics|mesh-ancestor
44702093|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
44702094|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702095|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702096|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702097|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702098|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702099|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702100|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
44702101|NCT01406132|Peficitinib|peficitinib|mesh-list
44702102|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702103|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702104|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702105|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
44702106|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702107|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
44702108|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44702109|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44702110|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44702111|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702112|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702113|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702114|NCT01406158|Urological Agents|urological agents|mesh-ancestor
44702115|NCT01406171|Isavuconazole|isavuconazole|mesh-list
44702116|NCT01406171|Midazolam|midazolam|mesh-list
44702117|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44702118|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44702119|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702120|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702121|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44702122|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44702123|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702124|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44702125|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
44702126|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
44702127|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
44896847|NCT04150146|Rebamipide|rebamipide|mesh-list
44896848|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44896849|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896850|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
44896851|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896852|NCT04150146|Protective Agents|protective agents|mesh-ancestor
44896853|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896854|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896856|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44896857|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896858|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896859|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
44896860|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
44896861|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44896862|NCT04149106|Amodiaquine|amodiaquine|mesh-list
44896863|NCT04149106|Artenimol|artenimol|mesh-list
44896864|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
44896865|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44896866|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44896867|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896868|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44896869|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896870|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896871|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44896872|NCT04149106|Renal Agents|renal agents|mesh-ancestor
44896873|NCT04148833|Paclitaxel|paclitaxel|mesh-list
44896874|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44896875|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896876|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
44896877|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
44896878|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683817|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44896879|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896880|NCT04148183|Metformin|metformin|mesh-list
44896881|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
44896882|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896883|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896884|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44896885|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44896886|NCT04147728|Growth Substances|growth substances|mesh-ancestor
44896887|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896888|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
44896889|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896890|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44896891|NCT04146883|Cephalexin|cephalexin|mesh-list
44896892|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896893|NCT04146220|Prednisolone|prednisolone|mesh-list
44896894|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896895|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
44896896|NCT04146220|Hormones|hormones|mesh-ancestor
44896897|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44896898|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896899|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44896900|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896901|NCT04145336|Indomethacin|indomethacin|mesh-list
44896902|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44896903|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44896904|NCT04145336|Analgesics|analgesics|mesh-ancestor
44896905|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
44896906|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896907|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896908|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44896909|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896910|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
44896911|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
44896912|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44896913|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44896914|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896915|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896916|NCT04143802|Dulaglutide|dulaglutide|mesh-list
44896917|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896918|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896919|NCT04142411|Insulin|insulin|mesh-list
44896920|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44896921|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
44896922|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44896923|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896924|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44896925|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
44896926|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
44896927|NCT04142411|Protective Agents|protective agents|mesh-ancestor
44896928|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44896929|NCT04141787|Cefazolin|cefazolin|mesh-list
44896960|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896961|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44896962|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896963|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
44896964|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
44896965|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896966|NCT04139928|Cathartics|cathartics|mesh-ancestor
44896967|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44896968|NCT04139928|Antacids|antacids|mesh-ancestor
44896969|NCT04139915|Dactolisib|dactolisib|mesh-list
44896970|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44896971|NCT04139941|Antibodies|antibodies|mesh-list
44896972|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44896973|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
44896974|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896975|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
44896976|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44896977|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688276|NCT03363035|Enoxaparin|enoxaparin|mesh-list
44896979|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44896980|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44896981|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44896982|NCT04139824|Analgesics|analgesics|mesh-ancestor
44896983|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
44896984|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896985|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896986|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44896987|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
44896988|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44896989|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44896990|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44896991|NCT04139668|Naltrexone|naltrexone|mesh-list
44896992|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44896993|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44896994|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44896995|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
44896996|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44896997|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
44896998|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44896999|NCT04139772|Docetaxel|docetaxel|mesh-list
44897000|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
44897001|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897002|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897003|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897004|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897005|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897006|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44897007|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897008|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
44897009|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897010|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897011|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44897012|NCT04139629|Antibodies|antibodies|mesh-list
44897013|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
44897014|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897015|NCT04139681|Menthol|menthol|mesh-list
44897016|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
44897017|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
44897018|NCT04139226|CC-11050|cc-11050|mesh-list
44897019|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44897020|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44897021|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897022|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897023|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
44897024|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897025|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
44897026|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897027|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897028|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44897029|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
44897030|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897031|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897032|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44897033|NCT04138992|Bevacizumab|bevacizumab|mesh-list
44897034|NCT04138992|Cisplatin|cisplatin|mesh-list
44897035|NCT04138992|Docetaxel|docetaxel|mesh-list
44897036|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897037|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897038|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44897039|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44897040|NCT04138992|Growth Substances|growth substances|mesh-ancestor
44897041|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897042|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
44897043|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897044|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897045|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897046|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897047|NCT04139070|Bleomycin|bleomycin|mesh-list
44897048|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44897049|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897050|NCT04138901|Ropivacaine|ropivacaine|mesh-list
44897051|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
44897052|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
44897053|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897054|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897055|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
44897056|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897057|NCT04138420|Bevacizumab|bevacizumab|mesh-list
44897058|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897059|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897060|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44897061|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44897062|NCT04138420|Growth Substances|growth substances|mesh-ancestor
44897063|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897064|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
44897065|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
44897066|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897067|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44897068|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897069|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897070|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44897071|NCT04138888|Olmesartan|olmesartan|mesh-list
44897072|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44897073|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44897074|NCT04138888|Diuretics|diuretics|mesh-ancestor
44897075|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
44897076|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897077|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44897078|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897079|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897080|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44897081|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44897082|NCT04138836|Itraconazole|itraconazole|mesh-list
44897083|NCT04138836|Midazolam|midazolam|mesh-list
44897084|NCT04138836|Esomeprazole|esomeprazole|mesh-list
44897085|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44897086|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44897087|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897088|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897089|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44897090|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44897091|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44897092|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44897093|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
44897094|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
44897095|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
44897096|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
44897097|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897098|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897099|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44897100|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44897101|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44897102|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897103|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
44897104|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897105|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44897106|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44897107|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44897108|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
44897109|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897110|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44897111|NCT04138719|Paclitaxel|paclitaxel|mesh-list
44897112|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44897113|NCT04138719|Carboplatin|carboplatin|mesh-list
44897114|NCT04138719|Epirubicin|epirubicin|mesh-list
44897115|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897116|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897117|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897118|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897119|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897120|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897121|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44897122|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44897123|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44897124|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897125|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
44897126|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
44897127|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44897128|NCT04138472|Lidocaine|lidocaine|mesh-list
44897129|NCT04138472|Fentanyl|fentanyl|mesh-list
44897130|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
44897131|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
44897132|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
44897133|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897134|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897135|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
44897136|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897137|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44897138|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44897139|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44897140|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897141|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897142|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44897143|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897144|NCT04138472|Analgesics|analgesics|mesh-ancestor
44897145|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44897146|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44897147|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44897148|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897149|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897150|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44897151|NCT04138472|Narcotics|narcotics|mesh-ancestor
44897152|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44897153|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44897154|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
44897155|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
44897156|NCT04138264|Narcotics|narcotics|mesh-ancestor
44897157|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897158|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897159|NCT04138264|Analgesics|analgesics|mesh-ancestor
44897160|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
44897161|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897162|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
44897163|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
44897164|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897165|NCT04138251|Empagliflozin|empagliflozin|mesh-list
44897166|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44897167|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897168|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44897169|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897170|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
44897171|NCT04137978|Diuretics|diuretics|mesh-ancestor
44897172|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
44897173|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897174|NCT04137978|Expectorants|expectorants|mesh-ancestor
44897175|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897176|NCT04138004|Lubiprostone|lubiprostone|mesh-list
44897177|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44897178|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897179|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897180|NCT04138238|Sirolimus|sirolimus|mesh-list
44897181|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44897182|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897183|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44897184|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897185|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
44897186|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897187|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
44897188|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897189|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
44897190|NCT04137640|Docetaxel|docetaxel|mesh-list
44897191|NCT04137640|Letrozole|letrozole|mesh-list
44897192|NCT04137640|Epirubicin|epirubicin|mesh-list
44897193|NCT04137640|Palbociclib|palbociclib|mesh-list
44897194|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897195|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
44897196|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897197|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897198|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44897199|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
44897200|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688496|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44897201|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688570|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
44688571|NCT00166504|Atorvastatin|atorvastatin|mesh-list
44688572|NCT00166504|Simvastatin|simvastatin|mesh-list
44688573|NCT00166504|Ezetimibe|ezetimibe|mesh-list
44688574|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688575|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688576|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
44688577|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688578|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688579|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688580|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702128|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
44702129|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702130|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702131|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
44702132|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702133|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
44702134|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
44702135|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702136|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702137|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44702138|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44702139|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702140|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702141|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702142|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702143|NCT01406262|Incretins|incretins|mesh-ancestor
44702144|NCT01406262|Hormones|hormones|mesh-ancestor
44702145|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702146|NCT01406275|Amoxicillin|amoxicillin|mesh-list
44702147|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
44702148|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
44702149|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702150|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702151|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44702152|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702153|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702154|NCT01406301|PENTA|penta|mesh-list
44702155|NCT01406301|Fondaparinux|fondaparinux|mesh-list
44702156|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44702157|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
44702158|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702159|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702160|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702161|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702162|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
44702163|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44702164|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44702165|NCT01406327|Ambrisentan|ambrisentan|mesh-list
44702166|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702167|NCT01406392|Misoprostol|misoprostol|mesh-list
44702168|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44702169|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
44702170|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44702171|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702172|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44702173|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702174|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
44702175|NCT01406431|Valsartan|valsartan|mesh-list
44702176|NCT01406431|Pitavastatin|pitavastatin|mesh-list
44702177|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702178|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44702179|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44897202|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44897203|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897204|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897205|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897206|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44897207|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44897208|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897209|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44897210|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
44897211|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897212|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44897216|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44897217|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44897218|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897219|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897220|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44897221|NCT04137588|Growth Substances|growth substances|mesh-ancestor
44897222|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897223|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
44897225|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44897226|NCT04137653|Carboplatin|carboplatin|mesh-list
44897227|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897228|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897229|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897230|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897231|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897232|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897233|NCT04137432|Oxytocin|oxytocin|mesh-list
44897234|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
44897235|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44897236|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897237|NCT04137198|Sufentanil|sufentanil|mesh-list
44897238|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44897239|NCT04137198|Narcotics|narcotics|mesh-ancestor
44897240|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897241|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897242|NCT04137198|Analgesics|analgesics|mesh-ancestor
44897243|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
44897244|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897245|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44897246|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44897247|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
44897248|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
44897249|NCT04137328|Liraglutide|liraglutide|mesh-list
44897250|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44897251|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897252|NCT04137328|Incretins|incretins|mesh-ancestor
44897253|NCT04137328|Hormones|hormones|mesh-ancestor
44897254|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897255|NCT04137276|Vitamins|vitamins|mesh-list
44897256|NCT04137276|Ascorbic Acid|ascorbic acid|mesh-list
44897257|NCT04137276|Thiamine|thiamine|mesh-list
44897258|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
44897259|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
44897260|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897261|NCT04137276|Antioxidants|antioxidants|mesh-ancestor
44897262|NCT04137276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897263|NCT04137276|Protective Agents|protective agents|mesh-ancestor
44897264|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
44897265|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897266|NCT04137380|Mirikizumab|mirikizumab|mesh-list
44897267|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44897268|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897269|NCT04137380|Analgesics|analgesics|mesh-ancestor
44897270|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
44897271|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897272|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897273|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897274|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897275|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44897276|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44897277|NCT04137029|Bromides|bromides|mesh-list
44897278|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
44897279|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
44897280|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44897281|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
44897282|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897283|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897284|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44897285|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897286|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44897287|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44897288|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44897289|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897290|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897291|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897292|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
44897293|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44897294|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
44897295|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
44897297|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897298|NCT04136613|Copper|copper|mesh-list
44897299|NCT04136613|Trace Elements|trace elements|mesh-ancestor
44897300|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
44897301|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897302|NCT04136782|Paclitaxel|paclitaxel|mesh-list
44897303|NCT04136782|Docetaxel|docetaxel|mesh-list
44897304|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44897305|NCT04136782|Carboplatin|carboplatin|mesh-list
44897306|NCT04136782|Epirubicin|epirubicin|mesh-list
44897307|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897308|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897309|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897310|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897311|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897312|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897313|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44897314|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44897315|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44897316|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897317|NCT04136535|Carboplatin|carboplatin|mesh-list
44897318|NCT04136535|Pemetrexed|pemetrexed|mesh-list
44897319|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897320|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897321|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897322|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44897323|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44897324|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
44897325|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
44897326|NCT04136639|Fluorides|fluorides|mesh-list
44897327|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
44897328|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
44897329|NCT04136639|Protective Agents|protective agents|mesh-ancestor
44897330|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897331|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897332|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897333|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897334|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
44897335|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897336|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44897337|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44897338|NCT04136470|Nivolumab|nivolumab|mesh-list
44897339|NCT04136470|Ipilimumab|ipilimumab|mesh-list
44897340|NCT04136470|Atezolizumab|atezolizumab|mesh-list
44897341|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897342|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897343|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44897344|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897345|NCT04136600|Antibodies|antibodies|mesh-list
44897346|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
44897347|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897348|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44897349|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44897350|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897351|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44897352|NCT04136015|Dasatinib|dasatinib|mesh-list
44897353|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897354|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44897355|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897356|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897357|NCT04135898|Bevacizumab|bevacizumab|mesh-list
44897358|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897359|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897360|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44897361|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44897362|NCT04135898|Growth Substances|growth substances|mesh-ancestor
44897363|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688726|NCT01344174|Hormones|hormones|mesh-ancestor
44897364|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44897365|NCT04135885|Folic Acid|folic acid|mesh-list
44897366|NCT04135885|Hematinics|hematinics|mesh-ancestor
44897367|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
44897368|NCT04135885|Vitamins|vitamins|mesh-ancestor
44897381|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
44683928|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44897382|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897383|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897384|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44897385|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44897386|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
44897387|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44897388|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
44897389|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44897390|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44897391|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44897392|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44897393|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44897394|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44897395|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44897396|NCT04135781|Paclitaxel|paclitaxel|mesh-list
44897397|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44897398|NCT04135781|Capecitabine|capecitabine|mesh-list
44897399|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
44897400|NCT04135781|Tegafur|tegafur|mesh-list
44897401|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897402|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897403|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897404|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897405|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897406|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897407|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897408|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
44897409|NCT04135508|Adalimumab|adalimumab|mesh-list
44897410|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897411|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897412|NCT04135313|Capecitabine|capecitabine|mesh-list
44897413|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
44897414|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897415|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
44897416|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897417|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897418|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
44897419|NCT04135378|Vitamins|vitamins|mesh-ancestor
44897420|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
44897421|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897422|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
44897423|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897424|NCT04135378|Protective Agents|protective agents|mesh-ancestor
44897425|NCT04135690|Sorafenib|sorafenib|mesh-list
44897426|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897427|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44897428|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897429|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688801|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
44688870|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688871|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44688873|NCT01344720|Oxycodone|oxycodone|mesh-list
44688874|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44688875|NCT01344720|Narcotics|narcotics|mesh-ancestor
44688876|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688877|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688878|NCT01344720|Analgesics|analgesics|mesh-ancestor
44688879|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
44688880|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688881|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688882|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688883|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688884|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688885|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44688886|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44688887|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688888|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702180|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702181|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44702182|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44702183|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44702184|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
44702185|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702186|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44702187|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
44702188|NCT01406470|Antibodies|antibodies|mesh-list
44702189|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
44702190|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44702191|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44702192|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
44702193|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
44702194|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702195|NCT01406496|Insulin|insulin|mesh-list
44702196|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44702197|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702198|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702199|NCT01406522|Tacrine|tacrine|mesh-list
44702200|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44702201|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702202|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702203|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
44702204|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702205|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702206|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44702207|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
44702208|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702209|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
44702210|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44702211|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
44702212|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44702213|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44702214|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702215|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897430|NCT04135456|Mannitol|mannitol|mesh-list
44897431|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44897432|NCT04135456|Diuretics|diuretics|mesh-ancestor
44897433|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
44897434|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897435|NCT04134897|Capecitabine|capecitabine|mesh-list
44897436|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
44897437|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897438|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
44897439|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897440|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897441|NCT04135014|Midazolam|midazolam|mesh-list
44897442|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
44897443|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44897444|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897445|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897446|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897447|NCT04135014|Analgesics|analgesics|mesh-ancestor
44897448|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
44897449|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897450|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44897451|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44897452|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44897453|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897454|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897455|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897456|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44897457|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44897458|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44897459|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44897460|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44897461|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
44897462|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
44897463|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
44897464|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
44897465|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
44897466|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44897467|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
44897468|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897469|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
44897470|NCT04134611|Protective Agents|protective agents|mesh-ancestor
44897471|NCT04134650|Metformin|metformin|mesh-list
44897472|NCT04134650|Linagliptin|linagliptin|mesh-list
44897473|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44897474|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897475|NCT04134650|Incretins|incretins|mesh-ancestor
44897476|NCT04134650|Hormones|hormones|mesh-ancestor
44897477|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897478|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44897479|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
44897480|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897481|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897482|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
44897483|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
44897484|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44897485|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897486|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44897487|NCT04134468|Gemcitabine|gemcitabine|mesh-list
44897488|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44897489|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897490|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
44897491|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897492|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897493|NCT04134468|Antiviral Agents|antiviral agents|mesh-ancestor
44897494|NCT04134468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897495|NCT04134468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897496|NCT04134468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897497|NCT04134468|Immunologic Factors|immunologic factors|mesh-ancestor
44897498|NCT04134468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897499|NCT04134416|Donepezil|donepezil|mesh-list
44897500|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44897501|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897502|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897503|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
44897504|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897505|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897506|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
44897507|NCT04134182|Nivolumab|nivolumab|mesh-list
44897508|NCT04134182|Ipilimumab|ipilimumab|mesh-list
44897509|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897510|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897511|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44897512|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897513|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
44897514|NCT04134130|Testosterone|testosterone|mesh-list
44897515|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
44897516|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
44897517|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44897518|NCT04134130|Androgens|androgens|mesh-ancestor
44897519|NCT04134130|Hormones|hormones|mesh-ancestor
44897520|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897521|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897522|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44897523|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897524|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
44897525|NCT04134273|Clindamycin|clindamycin|mesh-list
44897526|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
44897527|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
44897528|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44897529|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897530|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44897531|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897532|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897533|NCT04134598|Tamoxifen|tamoxifen|mesh-list
44897534|NCT04134598|Letrozole|letrozole|mesh-list
44897535|NCT04134598|Anastrozole|anastrozole|mesh-list
44897536|NCT04134598|Exemestane|exemestane|mesh-list
44897537|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897538|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44897539|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44897540|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897541|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897542|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44897543|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
44897544|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897545|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897546|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44897547|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44897548|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44897549|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44897550|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
44897551|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44897552|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
44897553|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897554|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897555|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44897556|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897557|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44897558|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
44897559|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897560|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897561|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44897562|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44897563|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
44897564|NCT04134078|Protective Agents|protective agents|mesh-ancestor
44897565|NCT04134065|Vitamin D|vitamin d|mesh-list
44897566|NCT04134065|Vitamins|vitamins|mesh-ancestor
44897567|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
44897568|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897569|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44897570|NCT04134052|Midazolam|midazolam|mesh-list
44897571|NCT04134052|Ketamine|ketamine|mesh-list
44897572|NCT04134052|Analgesics|analgesics|mesh-ancestor
44897573|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
44897574|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897575|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897576|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44897577|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44897578|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
44897579|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
44897580|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897581|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44897582|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44897583|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897584|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897585|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44897586|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44897587|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44897588|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44897589|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44897590|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
44897591|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
44897592|NCT04133961|Phenylephrine|phenylephrine|mesh-list
44897593|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
44897594|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44897595|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
44897596|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
44897597|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897598|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897599|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
44689040|NCT01346254|Vildagliptin|vildagliptin|mesh-list
44689041|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44689042|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689043|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44689044|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
44689045|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689046|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689047|NCT01346670|Lovastatin|lovastatin|mesh-list
44689048|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44689049|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44689050|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
44689051|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689052|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44689053|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44689054|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240663|NCT00582582|Vitamin D|vitamin d|mesh-list
44702216|NCT01406535|Urological Agents|urological agents|mesh-ancestor
44702217|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44702218|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44702219|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702220|NCT01406639|Ranibizumab|ranibizumab|mesh-list
44702221|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44702222|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44702223|NCT01406639|Growth Substances|growth substances|mesh-ancestor
44702224|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702225|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
44702226|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702227|NCT01406678|Sufentanil|sufentanil|mesh-list
44702228|NCT01406678|Dsuvia|dsuvia|mesh-list
44702229|NCT01406678|Isoflurane|isoflurane|mesh-list
44702230|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
44702231|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702232|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702233|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44702234|NCT01406678|Narcotics|narcotics|mesh-ancestor
44702235|NCT01406678|Analgesics|analgesics|mesh-ancestor
44702236|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
44702237|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702238|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44702239|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44702240|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
44702241|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44702242|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
44702243|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
44702244|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702245|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702246|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
44702247|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702248|NCT01406704|Protective Agents|protective agents|mesh-ancestor
44702249|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
44702250|NCT01406704|Vitamins|vitamins|mesh-ancestor
44253582|NCT04688658|Nivolumab|nivolumab|mesh-list
44702251|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
44702252|NCT01406782|Rituximab|rituximab|mesh-list
44702253|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702278|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702279|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897600|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44702280|NCT01407432|Folic Acid|folic acid|mesh-list
44702281|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
44702282|NCT01407432|Hematinics|hematinics|mesh-ancestor
44897601|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
44897602|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897603|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44897604|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44897605|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44897606|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897607|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897608|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897609|NCT04133961|Protective Agents|protective agents|mesh-ancestor
44897610|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
44897611|NCT04134026|Hematinics|hematinics|mesh-ancestor
44897612|NCT04133974|Methadone|methadone|mesh-list
44897613|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44897614|NCT04133974|Narcotics|narcotics|mesh-ancestor
44897615|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897616|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897617|NCT04133974|Analgesics|analgesics|mesh-ancestor
44897618|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
44897619|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897620|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
44897621|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897622|NCT04134637|Bupivacaine|bupivacaine|mesh-list
44897623|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
44897624|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
44897625|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897626|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897627|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
44897628|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897629|NCT04133571|Lidocaine|lidocaine|mesh-list
44897630|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
44897631|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
44897632|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897633|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897634|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
44897635|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897636|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44897637|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44897638|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44897639|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897640|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897641|NCT04133428|Valsartan|valsartan|mesh-list
44897642|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44897643|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44897644|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44897645|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44897646|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897647|NCT04133155|Gemcitabine|gemcitabine|mesh-list
44897648|NCT04133155|Paclitaxel|paclitaxel|mesh-list
44897649|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44897650|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897651|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
44897652|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
44897653|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897654|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897655|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897656|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
44897657|NCT04133155|Antiviral Agents|antiviral agents|mesh-ancestor
44897658|NCT04133155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897659|NCT04133155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897660|NCT04133155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897661|NCT04133155|Immunologic Factors|immunologic factors|mesh-ancestor
44897662|NCT04133155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897663|NCT04133337|Apatinib|apatinib|mesh-list
44897664|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897665|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44897666|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897667|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897668|NCT04133506|Aspirin|aspirin|mesh-list
44897669|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44897670|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897671|NCT04133506|Analgesics|analgesics|mesh-ancestor
44897672|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
44897673|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897674|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897675|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897676|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897677|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44897678|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44897679|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897680|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44897681|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44897682|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897683|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
44897684|NCT04133194|Mesalamine|mesalamine|mesh-list
44897685|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44897686|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897687|NCT04133194|Analgesics|analgesics|mesh-ancestor
44897688|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
44897708|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
44897709|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
44897710|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897711|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897712|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
44897713|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897714|NCT04132583|Diclofenac|diclofenac|mesh-list
44897715|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44897716|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897717|NCT04132583|Analgesics|analgesics|mesh-ancestor
44897718|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
44897719|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897720|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897721|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897722|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897723|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44897724|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897725|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897726|NCT04132479|Amoxicillin|amoxicillin|mesh-list
44897727|NCT04132479|Clarithromycin|clarithromycin|mesh-list
44897728|NCT04132479|Tinidazole|tinidazole|mesh-list
44897729|NCT04132479|Rabeprazole|rabeprazole|mesh-list
44897730|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44897731|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897732|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44897733|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897734|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897735|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44897736|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44897737|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44897738|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44897739|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44897740|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
44897741|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44897742|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44897743|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44897744|NCT04132674|Tenofovir|tenofovir|mesh-list
44897745|NCT04132674|Emtricitabine|emtricitabine|mesh-list
44897746|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44897747|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
44897748|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897749|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44897750|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44897751|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897752|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897753|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44897754|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44897755|NCT04132713|Capecitabine|capecitabine|mesh-list
44897756|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897757|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
44897758|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897759|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897760|NCT04132635|Mitogens|mitogens|mesh-list
44897761|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44897762|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897763|NCT04132648|Curcumin|curcumin|mesh-list
44897764|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44897765|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897766|NCT04132648|Analgesics|analgesics|mesh-ancestor
44897767|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
44897768|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897769|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897770|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897771|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897772|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897773|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897774|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897775|NCT04132570|Budesonide|budesonide|mesh-list
44897776|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897777|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44897778|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
44897779|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897780|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689277|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44689278|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689279|NCT01348503|Lenalidomide|lenalidomide|mesh-list
44689280|NCT01348503|Sorafenib|sorafenib|mesh-list
44689281|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
44689282|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689283|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44689284|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44689285|NCT01348503|Growth Substances|growth substances|mesh-ancestor
44689286|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44689287|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689288|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44689289|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689290|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702283|NCT01407432|Vitamins|vitamins|mesh-ancestor
44702284|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
44702285|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702286|NCT01407471|Clobetasol|clobetasol|mesh-list
44702287|NCT01407471|Spironolactone|spironolactone|mesh-list
44702288|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44702289|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
44702290|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702291|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702292|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44702293|NCT01407471|Diuretics|diuretics|mesh-ancestor
44702294|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
44702295|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702296|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
44702297|NCT01407471|Hormones|hormones|mesh-ancestor
44702298|NCT01407484|Prednisone|prednisone|mesh-list
44702299|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702300|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
44702301|NCT01407484|Hormones|hormones|mesh-ancestor
44702302|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702303|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702304|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44702305|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702306|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44702307|NCT01407679|Alitretinoin|alitretinoin|mesh-list
44702308|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702309|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
44253674|NCT04480918|Ketamine|ketamine|mesh-list
44702311|NCT01407822|Cisplatin|cisplatin|mesh-list
44702312|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44702313|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702314|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44702315|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
44702316|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702317|NCT01407822|Antiviral Agents|antiviral agents|mesh-ancestor
44702318|NCT01407822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702319|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702320|NCT01407822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702321|NCT01407822|Immunologic Factors|immunologic factors|mesh-ancestor
44702322|NCT01407822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702323|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702324|NCT01407848|Furosemide|furosemide|mesh-list
44702325|NCT01407848|Diuretics|diuretics|mesh-ancestor
44702326|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
44702327|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702328|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44702329|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702330|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897781|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44897782|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897783|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
44897784|NCT04132570|Hormones|hormones|mesh-ancestor
44897785|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897786|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
44897787|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44897788|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
44897789|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44897790|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897791|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44897792|NCT04132557|Methylphenidate|methylphenidate|mesh-list
44897793|NCT04132557|Amphetamine|amphetamine|mesh-list
44897794|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44897796|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44897797|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44897798|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897799|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44897800|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44897801|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897802|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897803|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
44897804|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897805|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44897806|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897807|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
44897808|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
44897809|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897810|NCT04132063|Levetiracetam|levetiracetam|mesh-list
44897811|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
44897812|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
44897813|NCT04132115|Vancomycin|vancomycin|mesh-list
44897814|NCT04132115|Gentamicins|gentamicins|mesh-list
44897815|NCT04132115|Meropenem|meropenem|mesh-list
44897816|NCT04132115|Tazobactam|tazobactam|mesh-list
44897817|NCT04132115|Linezolid|linezolid|mesh-list
44897818|NCT04132115|Piperacillin|piperacillin|mesh-list
44897819|NCT04132115|Daptomycin|daptomycin|mesh-list
44897820|NCT04132115|Amikacin|amikacin|mesh-list
44897821|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44897822|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
44897823|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44897824|NCT04132115|Acyclovir|acyclovir|mesh-list
44897825|NCT04132115|Ganciclovir|ganciclovir|mesh-list
44897826|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44897827|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897828|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44897829|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897830|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897831|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44897832|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
44897833|NCT04132011|Morphine|morphine|mesh-list
44897834|NCT04132011|Oxycodone|oxycodone|mesh-list
44897835|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
44897836|NCT04132011|Hydromorphone|hydromorphone|mesh-list
44897837|NCT04132011|Narcotics|narcotics|mesh-ancestor
44897838|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44897839|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897840|NCT04132011|Analgesics|analgesics|mesh-ancestor
44897841|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
44897842|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897843|NCT04132102|Afatinib|afatinib|mesh-list
44897844|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897845|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44897846|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897847|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897848|NCT04131621|Nivolumab|nivolumab|mesh-list
44897849|NCT04131621|Ipilimumab|ipilimumab|mesh-list
44897850|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897851|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897852|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44897853|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897854|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
44897855|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44897856|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44897857|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44897858|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897859|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897860|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
44897861|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897862|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897863|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44897864|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897865|NCT04131582|Metformin|metformin|mesh-list
44897866|NCT04131582|Empagliflozin|empagliflozin|mesh-list
44897867|NCT04131582|Linagliptin|linagliptin|mesh-list
44897868|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44897869|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897870|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44897871|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897873|NCT04131582|Hormones|hormones|mesh-ancestor
44897874|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897875|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44897876|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
44897877|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897878|NCT04131283|Epinephrine|epinephrine|mesh-list
44897879|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44897880|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44897881|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
44897882|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897883|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897884|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897885|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44897886|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44897887|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
44897888|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897889|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44897890|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44897891|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
44897892|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
44897893|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44897894|NCT04131309|Dexamethasone|dexamethasone|mesh-list
44897895|NCT04131309|Bortezomib|bortezomib|mesh-list
44897896|NCT04131309|Daratumumab|daratumumab|mesh-list
44897897|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897898|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
44897899|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
44897900|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897901|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897902|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44897903|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
44897904|NCT04131309|Hormones|hormones|mesh-ancestor
44897905|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44897906|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44897907|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897908|NCT04131231|Aldesleukin|aldesleukin|mesh-list
44897909|NCT04131231|Methotrexate|methotrexate|mesh-list
44897910|NCT04131231|Interleukin-2|interleukin-2|mesh-list
44897911|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44897912|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
44897913|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44897914|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897915|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44897916|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
44897917|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897918|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897919|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44897920|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897921|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44897922|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44897923|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
44897924|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897925|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44897926|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44897927|NCT04131231|Analgesics|analgesics|mesh-ancestor
44897928|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
44897929|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897930|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44897931|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44897932|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
44897933|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44897934|NCT04131322|Adalimumab|adalimumab|mesh-list
44897935|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44897936|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44897937|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44897938|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44897939|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44897940|NCT04130815|Furosemide|furosemide|mesh-list
44897941|NCT04130815|Diuretics|diuretics|mesh-ancestor
44897942|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
44897943|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897944|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44897945|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44897949|NCT04130399|Folfirinox|folfirinox|mesh-list
44897950|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897951|NCT04130477|Nickel|nickel|mesh-list
44897952|NCT04130477|Trace Elements|trace elements|mesh-ancestor
44897953|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
44897954|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897955|NCT04130230|Choline|choline|mesh-list
44897956|NCT04130230|Neostigmine|neostigmine|mesh-list
44897957|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
44897958|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44897959|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
44897960|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897961|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44897962|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44897963|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
44897964|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44897965|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897966|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44897967|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44897968|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897969|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44897970|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
44897971|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44897972|NCT04130087|Selegiline|selegiline|mesh-list
44897973|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
44897974|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44897975|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44897976|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44897977|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44897978|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44897979|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897980|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44897981|NCT04130087|Protective Agents|protective agents|mesh-ancestor
44897982|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897983|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
44897984|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44897985|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
44897986|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44897987|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
44897988|NCT04130100|Protective Agents|protective agents|mesh-ancestor
44897989|NCT04128891|Valsartan|valsartan|mesh-list
44897990|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44897991|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44897992|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44897993|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44897994|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44897995|NCT04127747|Rituximab|rituximab|mesh-list
44897996|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44897997|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44897998|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
44897999|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898000|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898001|NCT04127084|Empagliflozin|empagliflozin|mesh-list
44898002|NCT04127084|Canagliflozin|canagliflozin|mesh-list
44898003|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44898004|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898005|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898006|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898007|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44898008|NCT04126304|Azithromycin|azithromycin|mesh-list
44898009|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898010|NCT04125121|Propofol|propofol|mesh-list
44898011|NCT04125121|Sevoflurane|sevoflurane|mesh-list
44898012|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898013|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898014|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898015|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44898016|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
44898017|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
44898018|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44898019|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44898020|NCT04124757|Rocuronium|rocuronium|mesh-list
44898021|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44898022|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44689519|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898023|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44898024|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898025|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898026|NCT04123652|Lidocaine|lidocaine|mesh-list
44898027|NCT04123652|Ketamine|ketamine|mesh-list
44898028|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898029|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
44898030|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898031|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898032|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
44898033|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898034|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44898035|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44898036|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44898037|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898038|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898039|NCT04123652|Analgesics|analgesics|mesh-ancestor
44898040|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44898041|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44898042|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
44898043|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44898044|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44898045|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898046|NCT04123041|Nicotine|nicotine|mesh-list
44898047|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44898048|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
44898049|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898050|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898051|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44898052|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44898053|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
44898054|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898055|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898056|NCT04122716|Liraglutide|liraglutide|mesh-list
44898057|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898058|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898059|NCT04122716|Incretins|incretins|mesh-ancestor
44898060|NCT04122716|Hormones|hormones|mesh-ancestor
44898061|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898062|NCT04122222|Vaccines|vaccines|mesh-list
44898063|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
44898064|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898065|NCT04122040|Roxithromycin|roxithromycin|mesh-list
44898066|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898067|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898068|NCT04121611|Aspirin|aspirin|mesh-list
44898069|NCT04121611|Heparin|heparin|mesh-list
44898070|NCT04121611|Calcium heparin|calcium heparin|mesh-list
44898071|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
44898072|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44898073|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44898074|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898075|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44898076|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898077|NCT04121611|Analgesics|analgesics|mesh-ancestor
44898078|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
44898079|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898080|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898081|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898082|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898083|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44898084|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44898085|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898086|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
44898087|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
44898088|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898089|NCT04120337|Lidocaine|lidocaine|mesh-list
44898090|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898091|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
44898092|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898093|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898094|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
44898095|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898096|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44898097|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44898098|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44898116|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44898117|NCT04119752|Curcumin|curcumin|mesh-list
44898118|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44898119|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898120|NCT04119752|Analgesics|analgesics|mesh-ancestor
44898121|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
44898122|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898123|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898124|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898125|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898126|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898127|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898128|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898129|NCT04119622|Capecitabine|capecitabine|mesh-list
44898130|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
44898131|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44898132|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
44898133|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898134|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898135|NCT04119674|Temozolomide|temozolomide|mesh-list
44898136|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44898137|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
44898138|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898139|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898140|NCT04119297|Heparinoids|heparinoids|mesh-list
44898141|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898142|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
44898143|NCT04119739|Ibuprofen|ibuprofen|mesh-list
44898144|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44898145|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898146|NCT04119739|Analgesics|analgesics|mesh-ancestor
44898147|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
44898148|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898149|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898150|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898151|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898152|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44898153|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898154|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898156|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
44898157|NCT04119336|Nivolumab|nivolumab|mesh-list
44898158|NCT04119336|Ixazomib|ixazomib|mesh-list
44898159|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898160|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
44898161|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898162|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898163|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44898164|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
44898165|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898166|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898167|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44898168|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898169|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
44898170|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
44898171|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898172|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898173|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
44898174|NCT04119336|Hormones|hormones|mesh-ancestor
44898175|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898176|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898177|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898178|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898179|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44898180|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898181|NCT04118855|Axitinib|axitinib|mesh-list
44898182|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898183|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44898184|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898185|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898186|NCT04118842|Rifampin|rifampin|mesh-list
44898187|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44898188|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
44898189|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898190|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898191|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
44898192|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44898193|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898194|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898195|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44898196|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44898197|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44898198|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44898199|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44898200|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44898201|NCT04118699|Rifaximin|rifaximin|mesh-list
44898202|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898203|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898204|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898205|NCT04118777|Ropivacaine|ropivacaine|mesh-list
44898206|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898207|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
44898208|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898209|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898210|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
44898211|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898212|NCT04118153|Abatacept|abatacept|mesh-list
44898213|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898214|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898215|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898216|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898217|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
44898218|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898219|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898220|NCT04117919|Triamcinolone|triamcinolone|mesh-list
44898221|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44898222|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44898223|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
44898224|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44898225|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44898226|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44898227|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44689768|NCT01351597|Docetaxel|docetaxel|mesh-list
44898228|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898229|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
44689815|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
44689816|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
44689817|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
44689818|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689819|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689820|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689821|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
44689822|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44689823|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44689824|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
44689825|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689826|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689827|NCT01352130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44689828|NCT01352130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44689829|NCT01352130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689830|NCT01352130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44689831|NCT01352130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44689832|NCT01352143|Thrombin|thrombin|mesh-list
44689833|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
44689834|NCT01352143|Coagulants|coagulants|mesh-ancestor
44689835|NCT01352234|Aspirin|aspirin|mesh-list
44689836|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44689837|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689838|NCT01352234|Analgesics|analgesics|mesh-ancestor
44689839|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
44689840|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689841|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689842|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689843|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689844|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44689845|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44689846|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689847|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44689848|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44689849|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689850|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
44689851|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
44898230|NCT04117919|Hormones|hormones|mesh-ancestor
44898231|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898232|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898233|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898234|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
44898235|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898236|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898237|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44898238|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
44898239|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44898240|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
44898241|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898242|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
44898243|NCT04117893|Protective Agents|protective agents|mesh-ancestor
44898244|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44898245|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44898246|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898247|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898248|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898249|NCT04117893|Analgesics|analgesics|mesh-ancestor
44898250|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
44898251|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898252|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
44898253|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898254|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
44898255|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
44898256|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44898257|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44898258|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898259|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
44898260|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898261|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
44898262|NCT04117750|Vitamin D|vitamin d|mesh-list
44898263|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
44898264|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44898269|NCT04117750|Antacids|antacids|mesh-ancestor
44898270|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898271|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898272|NCT04117698|Ethambutol|ethambutol|mesh-list
44898273|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
44898274|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898275|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898276|NCT04118322|Peppermint oil|peppermint oil|mesh-list
44898277|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
44898278|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
44898279|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898280|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898281|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898282|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
44898283|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44898284|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44898285|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898286|NCT04117178|Memantine|memantine|mesh-list
44898287|NCT04117178|Donepezil|donepezil|mesh-list
44898288|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44898289|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898290|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898291|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
44898292|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898293|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898294|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
44898295|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44898296|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44898297|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
44898298|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44898299|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44898300|NCT04117009|Remifentanil|remifentanil|mesh-list
44898301|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44898302|NCT04117009|Narcotics|narcotics|mesh-ancestor
44898303|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898304|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898305|NCT04117009|Analgesics|analgesics|mesh-ancestor
44898306|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
44898307|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898308|NCT04117243|Misoprostol|misoprostol|mesh-list
44898309|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
44898310|NCT04117243|Oxytocin|oxytocin|mesh-list
44898311|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
44898312|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44898313|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898314|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44898315|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44898316|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898317|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
44898318|NCT04117243|Coagulants|coagulants|mesh-ancestor
44898319|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44898320|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
44898321|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44898322|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898323|NCT04117191|Tryptophan|tryptophan|mesh-list
44898324|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44898325|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
44898326|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898327|NCT04116931|Clopidogrel|clopidogrel|mesh-list
44898328|NCT04116931|Ticagrelor|ticagrelor|mesh-list
44898329|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44898330|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44898331|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44898332|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44898333|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
44898334|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898335|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898336|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898337|NCT04116554|Bupivacaine|bupivacaine|mesh-list
44898338|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898339|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
44898340|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898341|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898342|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
44898343|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898344|NCT04116827|Tamoxifen|tamoxifen|mesh-list
44898345|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44898346|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
44898347|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898348|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898349|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898350|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898351|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44898352|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44898353|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44898354|NCT04116411|Valganciclovir|valganciclovir|mesh-list
44898355|NCT04116411|Temozolomide|temozolomide|mesh-list
44898356|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44898357|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
44898358|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898359|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898360|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
44898361|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898362|NCT04116359|Cisplatin|cisplatin|mesh-list
44898363|NCT04116359|Etoposide|etoposide|mesh-list
44898364|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
44898365|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
44898366|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898367|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44898368|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44898369|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44898370|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898371|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898372|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
44898373|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898374|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44898375|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44898376|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44898377|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
44898378|NCT04115982|Vitamin D|vitamin d|mesh-list
44898379|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44898380|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898381|NCT04115982|Vitamins|vitamins|mesh-ancestor
44898382|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
44898383|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44898384|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
44898385|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898386|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
44898387|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
44898388|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898389|NCT04115904|Ibuprofen|ibuprofen|mesh-list
44898390|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44898391|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898392|NCT04115904|Analgesics|analgesics|mesh-ancestor
44898393|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
44898394|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898395|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898396|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898397|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898398|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44898399|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898400|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898401|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
44898402|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
44898403|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898404|NCT05603429|Antioxidants|antioxidants|mesh-list
44898405|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898406|NCT05603429|Protective Agents|protective agents|mesh-ancestor
44898407|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898408|NCT05599880|Bortezomib|bortezomib|mesh-list
44898409|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898410|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
44898411|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44898412|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
44898447|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898448|NCT05525611|Cabergoline|cabergoline|mesh-list
44898449|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44898450|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44898451|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
44898452|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
44898453|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898454|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898455|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898456|NCT05500586|Glucagon|glucagon|mesh-list
44898457|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898458|NCT05500586|Hormones|hormones|mesh-ancestor
44898459|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898460|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898461|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
44898462|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898463|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898464|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898465|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898466|NCT05500261|Analgesics|analgesics|mesh-ancestor
44898467|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
44898468|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898469|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44898470|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44898471|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44898472|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44898473|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898474|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898475|NCT05487859|Acarbose|acarbose|mesh-list
44898476|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44898477|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898478|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898479|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898480|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898481|NCT05483400|Atezolizumab|atezolizumab|mesh-list
44898482|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898483|NCT05461456|Fexofenadine|fexofenadine|mesh-list
44898484|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44898485|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44898486|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44898487|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
44898488|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
44898489|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898490|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898491|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898492|NCT05425355|Acetaminophen|acetaminophen|mesh-list
44898493|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898494|NCT05425355|Analgesics|analgesics|mesh-ancestor
44898495|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
44898496|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898497|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898498|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
44898499|NCT05423392|Lidocaine|lidocaine|mesh-list
44898500|NCT05423392|Carticaine|carticaine|mesh-list
44898501|NCT05423392|Anesthetics|anesthetics|mesh-list
44898502|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898503|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898504|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898505|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
44898506|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898507|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44898508|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44898509|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44898510|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898511|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898512|NCT05385406|Acetic Acid|acetic acid|mesh-list
44898513|NCT05385406|Retinol acetate|retinol acetate|mesh-list
44898514|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898515|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898516|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44898517|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
44898518|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898519|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44898520|NCT05385406|Protective Agents|protective agents|mesh-ancestor
44898521|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898522|NCT05382208|Doxycycline|doxycycline|mesh-list
44898523|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898524|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898525|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
44898526|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44898527|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44898528|NCT05312385|Propofol|propofol|mesh-list
44898529|NCT05312385|Isoflurane|isoflurane|mesh-list
44898530|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898531|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690153|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44690154|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
44690155|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690156|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44690157|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44690158|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44690159|NCT01353846|Estradiol|estradiol|mesh-list
44690160|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44690161|NCT01353846|Progesterone|progesterone|mesh-list
44690162|NCT01353846|Estrogens|estrogens|mesh-ancestor
44690163|NCT01353846|Hormones|hormones|mesh-ancestor
44690164|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690165|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690166|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44690167|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
44690168|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44690169|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44690170|NCT01353846|Progestins|progestins|mesh-ancestor
44690171|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
44690172|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690173|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690174|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
44690175|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44690176|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
44690177|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690178|NCT01353937|Plerixafor|plerixafor|mesh-list
44690179|NCT01353937|Becaplermin|becaplermin|mesh-list
44690180|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44690181|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44690182|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
44690183|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690184|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
44690185|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44690186|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44690187|NCT01353937|Growth Substances|growth substances|mesh-ancestor
44690188|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690189|NCT01354158|Droxidopa|droxidopa|mesh-list
44690190|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44898532|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898533|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44898534|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
44898535|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
44898536|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44898537|NCT05269615|Valsartan|valsartan|mesh-list
44898538|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44898539|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44898540|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44898541|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898542|NCT05227742|Psilocybin|psilocybin|mesh-list
44898543|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
44898544|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898545|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898546|NCT05221229|Liraglutide|liraglutide|mesh-list
44898547|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898548|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898549|NCT05221229|Incretins|incretins|mesh-ancestor
44898550|NCT05221229|Hormones|hormones|mesh-ancestor
44898551|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898552|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
44898553|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898554|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898555|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898556|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898557|NCT05208892|Analgesics|analgesics|mesh-ancestor
44898558|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
44898559|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898560|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44898561|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44898562|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44898563|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44898564|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898565|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898566|NCT05187039|Anesthetics|anesthetics|mesh-list
44898567|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898568|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898569|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44898570|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44898572|NCT05079789|Furosemide|furosemide|mesh-list
44898573|NCT05079789|Diuretics|diuretics|mesh-ancestor
44898574|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
44898575|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898576|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44898577|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898578|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898579|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44898580|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44898581|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44898582|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44898583|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
44898584|NCT05073822|Tacrolimus|tacrolimus|mesh-list
44898585|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898586|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
44898587|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898588|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44898589|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898590|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898591|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44898592|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898593|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44898594|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
44898595|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898596|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898597|NCT05024344|Dexamethasone|dexamethasone|mesh-list
44898598|NCT05024344|Ropivacaine|ropivacaine|mesh-list
44898599|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898600|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
44898601|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
44898602|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898603|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898604|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898605|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
44898606|NCT05024344|Hormones|hormones|mesh-ancestor
44898607|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898608|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898609|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898610|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
44898611|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
44898612|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898613|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
44898614|NCT05017155|Mexiletine|mexiletine|mesh-list
44898615|NCT05017155|Lamotrigine|lamotrigine|mesh-list
44898616|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
44898617|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44898618|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898619|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684277|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44898620|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44898621|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898622|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44898623|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44898624|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898625|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898626|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44898627|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44898628|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44898629|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
44898630|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898631|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
44898632|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
44898633|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898634|NCT04973605|Dexamethasone|dexamethasone|mesh-list
44898635|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898636|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
44898637|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
44898638|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898639|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898658|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898659|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
44898660|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898661|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44898662|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
44898663|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898664|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44898665|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44898666|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898667|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44898668|NCT04935229|Nivolumab|nivolumab|mesh-list
44898669|NCT04935229|Ipilimumab|ipilimumab|mesh-list
44898670|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898671|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898672|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898673|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898674|NCT04932135|Hormones|hormones|mesh-list
44898675|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898676|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898677|NCT04915365|Acetazolamide|acetazolamide|mesh-list
44898678|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
44898679|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44898680|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898681|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898682|NCT04915365|Diuretics|diuretics|mesh-ancestor
44898683|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
44898684|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898685|NCT04868773|Trifluridine|trifluridine|mesh-list
44898686|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
44898687|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898688|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
44898689|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898690|NCT04868461|Caseins|caseins|mesh-list
44898691|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
44898692|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
44898693|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898695|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
44898696|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898697|NCT04776525|Doxorubicin|doxorubicin|mesh-list
44898698|NCT04776525|Ifosfamide|ifosfamide|mesh-list
44898699|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44898700|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898701|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44898702|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44898703|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898704|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898705|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44898706|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
44898707|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
44898708|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
44898709|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44898710|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502513|NCT02992912|Atezolizumab|atezolizumab|mesh-list
44898711|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898712|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
44898713|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44898714|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898715|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898716|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44898717|NCT04773353|Hormones|hormones|mesh-ancestor
44898718|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898719|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898720|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44898721|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44898722|NCT04704063|Vitamin E|vitamin e|mesh-list
44898723|NCT04704063|Tocopherols|tocopherols|mesh-list
44898724|NCT04704063|Tocotrienols|tocotrienols|mesh-list
44898725|NCT04704063|Tocovid|tocovid|mesh-list
44898726|NCT04704063|Vitamins|vitamins|mesh-ancestor
44898727|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
44898728|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898729|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
44898730|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898731|NCT04704063|Protective Agents|protective agents|mesh-ancestor
44898732|NCT04676958|Vitamin K|vitamin k|mesh-list
44898733|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
44898734|NCT04676958|Vitamins|vitamins|mesh-ancestor
44898735|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
44898736|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898737|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44898738|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44898739|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898740|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
44898741|NCT04676958|Coagulants|coagulants|mesh-ancestor
44898742|NCT04669717|Amoxicillin|amoxicillin|mesh-list
44898743|NCT04669717|Azithromycin|azithromycin|mesh-list
44898744|NCT04669717|Metronidazole|metronidazole|mesh-list
44898745|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898746|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898747|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44898748|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44898749|NCT04669002|Olaparib|olaparib|mesh-list
44898750|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44898751|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898752|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898753|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898754|NCT04668300|Durvalumab|durvalumab|mesh-list
44898755|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
44898756|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44898757|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
44898758|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898759|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898760|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
44898761|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898762|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
44898763|NCT04665453|Melatonin|melatonin|mesh-list
44898764|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44898765|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898766|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898767|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44898768|NCT04665453|Analgesics|analgesics|mesh-ancestor
44898769|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
44898770|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898771|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44898772|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44898773|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44898774|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
44898775|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898776|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898777|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
44898778|NCT04665453|Protective Agents|protective agents|mesh-ancestor
44898779|NCT04618289|Vitamin D|vitamin d|mesh-list
44898780|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
44898781|NCT04618289|Vitamins|vitamins|mesh-ancestor
44898782|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
44898783|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898784|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44898785|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44898786|NCT04607954|Durvalumab|durvalumab|mesh-list
44898787|NCT04607954|Topotecan|topotecan|mesh-list
44898788|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
44898789|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44898790|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
44898791|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898792|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898793|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
44898794|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898795|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44898796|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44898797|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898798|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898799|NCT04570475|Vitamin D|vitamin d|mesh-list
44898800|NCT04570475|Vitamins|vitamins|mesh-ancestor
44898801|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
44898802|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898803|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44898804|NCT04517396|Fenofibrate|fenofibrate|mesh-list
44898805|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
44898806|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44898807|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
44898808|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898809|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44898810|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44898811|NCT04450394|Insulin|insulin|mesh-list
44690419|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690420|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690421|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690422|NCT01355718|Repaglinide|repaglinide|mesh-list
44690423|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690424|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690425|NCT01355757|Anesthetics|anesthetics|mesh-list
44690426|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
44690427|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690428|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690429|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
44690430|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690431|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
44690432|NCT01354301|Everolimus|everolimus|mesh-list
44690433|NCT01354301|Tacrolimus|tacrolimus|mesh-list
44690434|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
44690435|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690436|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
44690447|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
44898812|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44898813|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898814|NCT04444869|Cisplatin|cisplatin|mesh-list
44898815|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898816|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
44898817|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
44898818|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44898819|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44898820|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898821|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898822|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898823|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898824|NCT04309409|Nivolumab|nivolumab|mesh-list
44898825|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898826|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898827|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898828|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898856|NCT04248829|Gefitinib|gefitinib|mesh-list
44898857|NCT04248829|Lazertinib|lazertinib|mesh-list
44898858|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898859|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44898860|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898861|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898862|NCT04167462|BMS-986165|bms-986165|mesh-list
44898863|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
44898864|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44898865|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898866|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898867|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
44898868|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898869|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898870|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
44898871|NCT04066114|Prednisone|prednisone|mesh-list
44898872|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
44898873|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44898874|NCT04066114|Everolimus|everolimus|mesh-list
44898875|NCT04066114|Abatacept|abatacept|mesh-list
44898876|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
44898877|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44898878|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898879|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
44898880|NCT04066114|Hormones|hormones|mesh-ancestor
44898881|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898882|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898883|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898884|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898885|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44898886|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
44898887|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44898888|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44898889|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
44898890|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898891|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898892|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898893|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898894|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
44898895|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
44898896|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898897|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44898898|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44898899|NCT04066114|Protective Agents|protective agents|mesh-ancestor
44898900|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898901|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44898902|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44898903|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
44898904|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44898905|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
44898906|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44898907|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898908|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44898909|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898910|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898911|NCT04054635|Fluorides|fluorides|mesh-list
44898912|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
44898913|NCT04054635|Protective Agents|protective agents|mesh-ancestor
44898914|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898915|NCT04041791|Amoxicillin|amoxicillin|mesh-list
44898916|NCT04041791|Gentamicins|gentamicins|mesh-list
44898917|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
44898918|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
44898919|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
44898920|NCT04041791|Penicillins|penicillins|mesh-list
44898921|NCT04041791|Ampicillin|ampicillin|mesh-list
44898922|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44898923|NCT04041791|Penicillin G|penicillin g|mesh-list
44898924|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44898925|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
44898926|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44898927|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44898928|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44898929|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898930|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898931|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44898932|NCT03993535|Serotonin|serotonin|mesh-list
44898933|NCT03993535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44898934|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44898935|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
44898936|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898937|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898938|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898939|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44898940|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44898941|NCT03990896|Talazoparib|talazoparib|mesh-list
44898942|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44898943|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898944|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898945|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898946|NCT03958201|Rocuronium|rocuronium|mesh-list
44898947|NCT03958201|Neostigmine|neostigmine|mesh-list
44898948|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44898949|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44898950|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44898951|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898952|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898953|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44898954|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898955|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898956|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
44898957|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44898958|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44898959|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
44898960|NCT03927105|Nivolumab|nivolumab|mesh-list
44898961|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44898962|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898963|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44898964|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898965|NCT03908060|Morphine|morphine|mesh-list
44898966|NCT03908060|Methadone|methadone|mesh-list
44898967|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44898968|NCT03908060|Narcotics|narcotics|mesh-ancestor
44898969|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44898970|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898971|NCT03908060|Analgesics|analgesics|mesh-ancestor
44898972|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
44898973|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44898974|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
44898975|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
44898976|NCT03903835|Prednisone|prednisone|mesh-list
44898977|NCT03903835|Carboplatin|carboplatin|mesh-list
44898978|NCT03903835|Docetaxel|docetaxel|mesh-list
44898979|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
44898980|NCT03903835|Niraparib|niraparib|mesh-list
44898981|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44898982|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44898983|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44898984|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44898985|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44898986|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44898987|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44898988|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44898989|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
44898990|NCT03903835|Hormones|hormones|mesh-ancestor
44898991|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44898992|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44898993|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44898994|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44898995|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44898996|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
44898997|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44898998|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44898999|NCT03899597|Oxytocin|oxytocin|mesh-list
44899000|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
44899001|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899002|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899003|NCT03894345|Prazosin|prazosin|mesh-list
44899004|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44899005|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44899006|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44899007|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44899008|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899009|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899010|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899011|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899012|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
44899013|NCT03859921|Progestins|progestins|mesh-ancestor
44899014|NCT03859921|Hormones|hormones|mesh-ancestor
44899015|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899016|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899017|NCT03851835|Ondansetron|ondansetron|mesh-list
44899018|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
44899019|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
44899020|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899021|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899022|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899023|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
44899024|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899025|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44899026|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
44899027|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899028|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899029|NCT03851835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44899030|NCT03851835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44899031|NCT03851835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899032|NCT03851835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44899033|NCT03851835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44899034|NCT03819231|Oxytocin|oxytocin|mesh-list
44899035|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
44899036|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899037|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899038|NCT03684980|Leucovorin|leucovorin|mesh-list
44899039|NCT03684980|Rituximab|rituximab|mesh-list
44899040|NCT03684980|Methotrexate|methotrexate|mesh-list
44899041|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899042|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899043|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
44899044|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899045|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899046|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44899047|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
44899048|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899049|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899050|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
44899051|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899052|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899053|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899054|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44899055|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899056|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899057|NCT03684980|Antidotes|antidotes|mesh-ancestor
44899058|NCT03684980|Protective Agents|protective agents|mesh-ancestor
44899059|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
44899060|NCT03684980|Vitamins|vitamins|mesh-ancestor
44899061|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
44899062|NCT03648437|Acetaminophen|acetaminophen|mesh-list
44899063|NCT03648437|Ibuprofen|ibuprofen|mesh-list
44899064|NCT03648437|Indomethacin|indomethacin|mesh-list
44899065|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44899066|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44899067|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899068|NCT03648437|Analgesics|analgesics|mesh-ancestor
44899069|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
44899070|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899071|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899072|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899073|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899074|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44899075|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899076|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899077|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
44899078|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
44899079|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
44899080|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899081|NCT03643276|Cytarabine|cytarabine|mesh-list
44899082|NCT03643276|Dexamethasone|dexamethasone|mesh-list
44899083|NCT03643276|Prednisone|prednisone|mesh-list
44690783|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44690784|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
44690785|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690786|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690787|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44690788|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
44690789|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690790|NCT01357681|Protective Agents|protective agents|mesh-ancestor
44690791|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690792|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44690793|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44690794|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690795|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44690796|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
44702332|NCT01407887|Amodiaquine|amodiaquine|mesh-list
44702333|NCT01407887|Methylene Blue|methylene blue|mesh-list
44702334|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
44702335|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44702336|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44702337|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702338|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702339|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
44702340|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
44702341|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44702342|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
44702343|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702344|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702345|NCT01408004|Everolimus|everolimus|mesh-list
44702346|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702347|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702348|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
44702349|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702350|NCT01408056|Mupirocin|mupirocin|mesh-list
44702351|NCT01408056|Timolol|timolol|mesh-list
44702352|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44702353|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44702354|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44702355|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702356|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702357|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702358|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44702359|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702360|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702361|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702362|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44702363|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702364|NCT01408095|Glimepiride|glimepiride|mesh-list
44702365|NCT01408095|Globalagliatin|globalagliatin|mesh-list
44702366|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44702367|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702368|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702369|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702370|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
44702371|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
44702372|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702373|NCT01408160|Cytarabine|cytarabine|mesh-list
44702374|NCT01408160|Immunotoxins|immunotoxins|mesh-list
44702375|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44702376|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
44702377|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702378|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899084|NCT03643276|Prednisolone|prednisolone|mesh-list
44899085|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
44899086|NCT03643276|Ifosfamide|ifosfamide|mesh-list
44899087|NCT03643276|Doxorubicin|doxorubicin|mesh-list
44899088|NCT03643276|Methotrexate|methotrexate|mesh-list
44899089|NCT03643276|Fludarabine|fludarabine|mesh-list
44899090|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
44899091|NCT03643276|Etoposide|etoposide|mesh-list
44899092|NCT03643276|Vincristine|vincristine|mesh-list
44899093|NCT03643276|Bortezomib|bortezomib|mesh-list
44899094|NCT03643276|Daunorubicin|daunorubicin|mesh-list
44899095|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
44899096|NCT03643276|Pegaspargase|pegaspargase|mesh-list
44899097|NCT03643276|Blinatumomab|blinatumomab|mesh-list
44899098|NCT03643276|Vindesine|vindesine|mesh-list
44899099|NCT03643276|Asparaginase|asparaginase|mesh-list
44899100|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899105|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
44899106|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899107|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899108|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44899109|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899110|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
44899111|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
44899112|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899113|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899114|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
44899115|NCT03643276|Hormones|hormones|mesh-ancestor
44899116|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899117|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899118|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44899119|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44899120|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44899121|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899122|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44899123|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
44899124|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899125|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899126|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
44899127|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899128|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44899129|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899130|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899131|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
44899132|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899133|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899134|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899135|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899136|NCT03641209|Acetaminophen|acetaminophen|mesh-list
44899137|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44899138|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899139|NCT03641209|Analgesics|analgesics|mesh-ancestor
44899140|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
44899141|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899142|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899143|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
44899144|NCT03635437|Alprazolam|alprazolam|mesh-list
44899145|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44899146|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44899147|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899148|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899149|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44899150|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44899151|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44899152|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
44899153|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
44899154|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899155|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899156|NCT03631784|Paclitaxel|paclitaxel|mesh-list
44899157|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44899158|NCT03631784|Cisplatin|cisplatin|mesh-list
44899159|NCT03631784|Carboplatin|carboplatin|mesh-list
44899160|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
44899161|NCT03631784|Pemetrexed|pemetrexed|mesh-list
44899162|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899163|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899164|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899165|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899166|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899167|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899168|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899169|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899170|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44899171|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899172|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
44899173|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899174|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899175|NCT03540914|Acetazolamide|acetazolamide|mesh-list
44899176|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
44899177|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44899178|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899179|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899180|NCT03540914|Diuretics|diuretics|mesh-ancestor
44899181|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
44899182|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899183|NCT03540017|Cisplatin|cisplatin|mesh-list
44899184|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899185|NCT03539367|Acetazolamide|acetazolamide|mesh-list
44899186|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
44899187|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44899188|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899189|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899190|NCT03539367|Diuretics|diuretics|mesh-ancestor
44899191|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
44899192|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899193|NCT03537924|Acetazolamide|acetazolamide|mesh-list
44899194|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
44899195|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44899196|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899197|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899198|NCT03537924|Diuretics|diuretics|mesh-ancestor
44899199|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
44899200|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899201|NCT03511846|Capsaicin|capsaicin|mesh-list
44899202|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
44899203|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899204|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
44899205|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899206|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899207|NCT03466346|Fluoxetine|fluoxetine|mesh-list
44899208|NCT03466346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44899209|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44899210|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44899211|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899212|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899213|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
44899214|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899215|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44899216|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
44899217|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44899218|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44899219|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44899220|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899221|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44899222|NCT03462329|Doxycycline|doxycycline|mesh-list
44899223|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899224|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
44899225|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44899226|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44899227|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44899228|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899229|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899230|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44899231|NCT03422705|Lisinopril|lisinopril|mesh-list
44899232|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44899233|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
44899234|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899235|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899236|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44899237|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44899238|NCT03422705|Protective Agents|protective agents|mesh-ancestor
44684384|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44684385|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44684386|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684387|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
44684388|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44684389|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44684390|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44684391|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
44684392|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684393|NCT03636295|Warfarin|warfarin|mesh-list
44684394|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
44684395|NCT03621761|Modafinil|modafinil|mesh-list
44684396|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44684397|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684398|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44684399|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44684400|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44899239|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899240|NCT03416361|Vitamin D|vitamin d|mesh-list
44899241|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
44899242|NCT03416361|Vitamins|vitamins|mesh-ancestor
44899243|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
44899244|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899245|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44899246|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44899247|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44899248|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44899249|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899250|NCT03336216|Leucovorin|leucovorin|mesh-list
44899251|NCT03336216|Gemcitabine|gemcitabine|mesh-list
44899252|NCT03336216|Paclitaxel|paclitaxel|mesh-list
44899253|NCT03336216|Fluorouracil|fluorouracil|mesh-list
44899254|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
44899255|NCT03336216|Nivolumab|nivolumab|mesh-list
44899256|NCT03336216|Irinotecan|irinotecan|mesh-list
44899257|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899258|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899259|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899260|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899261|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899262|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899263|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899264|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
44899265|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
44899266|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899267|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899268|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899269|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
44899270|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899271|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899272|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44899273|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44899274|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44899275|NCT03336216|Antidotes|antidotes|mesh-ancestor
44899276|NCT03336216|Protective Agents|protective agents|mesh-ancestor
44899277|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44899278|NCT03336216|Vitamins|vitamins|mesh-ancestor
44899279|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
44899280|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44899281|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
44899282|NCT03321201|Coagulants|coagulants|mesh-ancestor
44899283|NCT03307785|Paclitaxel|paclitaxel|mesh-list
44899284|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44899285|NCT03307785|Bevacizumab|bevacizumab|mesh-list
44899286|NCT03307785|Carboplatin|carboplatin|mesh-list
44899287|NCT03307785|Pemetrexed|pemetrexed|mesh-list
44899288|NCT03307785|Niraparib|niraparib|mesh-list
44899289|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899290|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899291|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899292|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899293|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899294|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899295|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899296|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44899297|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44899298|NCT03307785|Growth Substances|growth substances|mesh-ancestor
44899299|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899300|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
44899301|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899302|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44899303|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899304|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44899305|NCT03292666|Warfarin|warfarin|mesh-list
44899306|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
44899307|NCT03292666|Dabigatran|dabigatran|mesh-list
44899308|NCT03292666|Apixaban|apixaban|mesh-list
44899309|NCT03292666|Anticoagulants|anticoagulants|mesh-list
44899310|NCT03292666|Edoxaban|edoxaban|mesh-list
44899311|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44899312|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
44899313|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44899314|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
44899315|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899316|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899317|NCT03236324|Epinephrine|epinephrine|mesh-list
44899318|NCT03236324|Bupivacaine|bupivacaine|mesh-list
44899319|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
44899320|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
44899321|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899322|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899323|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
44899324|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899325|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44899326|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44899327|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899328|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899329|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899330|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44899331|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44899333|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44899334|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44899335|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
44899336|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
44899337|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44899338|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
44899339|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44899340|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899341|NCT03215927|Abatacept|abatacept|mesh-list
44899342|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44899343|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899344|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899345|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899346|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
44899347|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899348|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899349|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
44899350|NCT03200847|Tretinoin|tretinoin|mesh-list
44899351|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899352|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899353|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
44899354|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899355|NCT03193190|Leucovorin|leucovorin|mesh-list
44899356|NCT03193190|Gemcitabine|gemcitabine|mesh-list
44899357|NCT03193190|Paclitaxel|paclitaxel|mesh-list
44899358|NCT03193190|Bevacizumab|bevacizumab|mesh-list
44899359|NCT03193190|Fluorouracil|fluorouracil|mesh-list
44899360|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
44899361|NCT03193190|Atezolizumab|atezolizumab|mesh-list
44899362|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899363|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899364|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899365|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899366|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899367|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899368|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899369|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44899370|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44899371|NCT03193190|Growth Substances|growth substances|mesh-ancestor
44899372|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899373|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
44899374|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899375|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
44899376|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
44899377|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899378|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899379|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899380|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
44899381|NCT03193190|Antidotes|antidotes|mesh-ancestor
44899382|NCT03193190|Protective Agents|protective agents|mesh-ancestor
44899383|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
44899384|NCT03193190|Vitamins|vitamins|mesh-ancestor
44899385|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
44899386|NCT03161652|Ranibizumab|ranibizumab|mesh-list
44899387|NCT03161652|Dopamine|dopamine|mesh-list
44899388|NCT03161652|Sulpiride|sulpiride|mesh-list
44899389|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44899390|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44899391|NCT03161652|Growth Substances|growth substances|mesh-ancestor
44899392|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899393|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
44899394|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899395|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44899396|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
44899397|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
44899398|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899399|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
44899400|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899401|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899402|NCT03161652|Protective Agents|protective agents|mesh-ancestor
44899403|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44691097|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
44691098|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
44691099|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691100|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44691102|NCT01359423|Cilostazol|cilostazol|mesh-list
44691103|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44691104|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
44691105|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691106|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691107|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44691108|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691109|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44691110|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44691111|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691112|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44691113|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691114|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44691115|NCT01359423|Protective Agents|protective agents|mesh-ancestor
44691116|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44691117|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44691118|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691119|NCT01359436|Antibodies|antibodies|mesh-list
44691120|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
44691121|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242785|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
44702379|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
44702380|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702381|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702382|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
44702383|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702384|NCT01408173|Caffeine|caffeine|mesh-list
44702385|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
44702386|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702387|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44702388|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702390|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702391|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44702392|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44702393|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
44702394|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702395|NCT01408186|Rabeprazole|rabeprazole|mesh-list
44702396|NCT01408186|Famotidine|famotidine|mesh-list
44702397|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44702398|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702399|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44702400|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702401|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899404|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44899405|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899406|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44899407|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44899408|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44899409|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
44899410|NCT03122262|Tenofovir|tenofovir|mesh-list
44899411|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44899412|NCT03122262|Dolutegravir|dolutegravir|mesh-list
44899413|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44899414|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
44899415|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899416|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44899417|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899418|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899419|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899420|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44899421|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44899422|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44899423|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44899424|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
44899425|NCT03076021|Isotretinoin|isotretinoin|mesh-list
44899426|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
44899427|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
44899429|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44899430|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899431|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899432|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899433|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899434|NCT02926898|Fenfluramine|fenfluramine|mesh-list
44899435|NCT02926898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44899436|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44899437|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44899438|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899439|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899440|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
44899441|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899442|NCT02864394|Docetaxel|docetaxel|mesh-list
44899443|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
44899444|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899445|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899446|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899447|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899448|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899449|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899450|NCT02852486|Pioglitazone|pioglitazone|mesh-list
44899451|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
44899452|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44899453|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899454|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899455|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44899456|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899457|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899458|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44899459|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44899460|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44899461|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899462|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899463|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899464|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
44899465|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899466|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44899467|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44899468|NCT02823665|Atropine|atropine|mesh-list
44899469|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44899470|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44899471|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44899472|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
44899473|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899474|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899475|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44899476|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
44899477|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
44899478|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
44899479|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44899480|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44899481|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
44899482|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899483|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899484|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
44899485|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44899486|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899487|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44899488|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44899489|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44899490|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899491|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899492|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44899493|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44899494|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44899495|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44899496|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899497|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691122|NCT01359462|Tolvaptan|tolvaptan|mesh-list
44899532|NCT02281084|Durvalumab|durvalumab|mesh-list
44899533|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899534|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
44899535|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899536|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899537|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899538|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691194|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899539|NCT01731444|Phenylephrine|phenylephrine|mesh-list
44899540|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
44899541|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44899542|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
44899543|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
44899544|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899545|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899546|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
44899547|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44899548|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
44899549|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
44684465|NCT03526679|Lenvatinib|lenvatinib|mesh-list
44684466|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684467|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684468|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684469|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684470|NCT03510468|Pyridoxine|pyridoxine|mesh-list
44684471|NCT03510468|Isoniazid|isoniazid|mesh-list
44684472|NCT03510468|Rifapentine|rifapentine|mesh-list
44684473|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
44684474|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44684475|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684476|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44684477|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44684478|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
44684482|NCT03510468|Vitamins|vitamins|mesh-ancestor
44899550|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44899551|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44899552|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44899553|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899554|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899555|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899556|NCT01731444|Protective Agents|protective agents|mesh-ancestor
44899557|NCT01602380|Fulvestrant|fulvestrant|mesh-list
44899558|NCT01602380|Anastrozole|anastrozole|mesh-list
44899559|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899560|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899561|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44899562|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44899563|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
44899564|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899565|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899566|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44899567|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44899568|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899569|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899570|NCT01558115|Denosumab|denosumab|mesh-list
44899571|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44899572|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899573|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44899574|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
44899575|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44899576|NCT01227876|Prednisolone|prednisolone|mesh-list
44899577|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
44899578|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44899579|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
44899580|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899581|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
44899582|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
44899583|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899584|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899585|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899586|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
44899587|NCT01227876|Hormones|hormones|mesh-ancestor
44899588|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899589|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44899590|NCT01227876|Protective Agents|protective agents|mesh-ancestor
44899591|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899592|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899593|NCT00415233|Hormones|hormones|mesh-list
44899594|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899595|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899596|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
44899597|NCT00077285|Ifosfamide|ifosfamide|mesh-list
44899598|NCT00077285|Carboplatin|carboplatin|mesh-list
44899599|NCT00077285|Doxorubicin|doxorubicin|mesh-list
44899600|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44899601|NCT00077285|Irinotecan|irinotecan|mesh-list
44899602|NCT00077285|Etoposide|etoposide|mesh-list
44899603|NCT00077285|Vincristine|vincristine|mesh-list
44899604|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
44899605|NCT00077285|Razoxane|razoxane|mesh-list
44899606|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899607|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
44899608|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899609|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899610|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44899611|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
44899612|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899613|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899614|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44899615|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44899616|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44899617|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44899618|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899619|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44899620|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899621|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899622|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899623|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899624|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44899625|NCT00077285|Protective Agents|protective agents|mesh-ancestor
44899627|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44899628|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899629|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44899630|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899631|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
44899632|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899633|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
44899634|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899635|NCT04115423|Adalimumab|adalimumab|mesh-list
44899636|NCT04115423|Etanercept|etanercept|mesh-list
44899637|NCT04115423|Golimumab|golimumab|mesh-list
44899638|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44899639|NCT04115423|Infliximab|infliximab|mesh-list
44899640|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899641|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899642|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899643|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899644|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44899645|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899646|NCT04115423|Analgesics|analgesics|mesh-ancestor
44899647|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
44899648|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899649|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899650|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899651|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
44899652|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
44899653|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44899654|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899655|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899656|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899657|NCT04115449|Analgesics|analgesics|mesh-ancestor
44899658|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
44899659|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899660|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44899661|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44899662|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44899663|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899664|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899665|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899666|NCT04115410|Gemcitabine|gemcitabine|mesh-list
44899667|NCT04115410|Cisplatin|cisplatin|mesh-list
44899668|NCT04115410|Carboplatin|carboplatin|mesh-list
44899669|NCT04115410|Docetaxel|docetaxel|mesh-list
44899670|NCT04115410|Pemetrexed|pemetrexed|mesh-list
44899671|NCT04115410|Vinorelbine|vinorelbine|mesh-list
44899672|NCT04115410|Gefitinib|gefitinib|mesh-list
44899673|NCT04115410|Mitomycins|mitomycins|mesh-list
44899674|NCT04115410|Mitomycin|mitomycin|mesh-list
44899675|NCT04115410|Osimertinib|osimertinib|mesh-list
44899676|NCT04115410|Vinblastine|vinblastine|mesh-list
44899677|NCT04115410|Afatinib|afatinib|mesh-list
44899678|NCT04115410|Crizotinib|crizotinib|mesh-list
44899679|NCT04115410|Ceritinib|ceritinib|mesh-list
44899680|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
44899681|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44899682|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899683|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
44899684|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899685|NCT04115410|Antiviral Agents|antiviral agents|mesh-ancestor
44899686|NCT04115410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899687|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899688|NCT04115410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899689|NCT04115410|Immunologic Factors|immunologic factors|mesh-ancestor
44899690|NCT04115410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899691|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899692|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899693|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899694|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44899695|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44899696|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44899697|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899698|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44691415|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691416|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44691417|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44691418|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44691419|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691420|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691422|NCT01360788|Ipratropium|ipratropium|mesh-list
44691423|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44691424|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
44691425|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691426|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691427|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44691428|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691429|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
44691430|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691431|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44691432|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44691433|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44691434|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
44691435|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691436|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691437|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44691438|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
44691439|NCT01360827|Cisplatin|cisplatin|mesh-list
44691440|NCT01360827|Fluorouracil|fluorouracil|mesh-list
44691441|NCT01360827|Cetuximab|cetuximab|mesh-list
44691442|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691443|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
44691444|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691445|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44691446|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691447|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
44691448|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691450|NCT01361022|Brotizolam|brotizolam|mesh-list
44899699|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
44899700|NCT04115462|Morphine|morphine|mesh-list
44899701|NCT04115462|Histamine|histamine|mesh-list
44899702|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
44899703|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44899704|NCT04115462|Narcotics|narcotics|mesh-ancestor
44899705|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899706|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899707|NCT04115462|Analgesics|analgesics|mesh-ancestor
44899708|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
44899709|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899710|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
44899711|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
44899712|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899713|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899714|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
44899715|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44899716|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899717|NCT04115111|Durvalumab|durvalumab|mesh-list
44899718|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899719|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899720|NCT04115163|Gemcitabine|gemcitabine|mesh-list
44899721|NCT04115163|Paclitaxel|paclitaxel|mesh-list
44899722|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44899723|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44899724|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899725|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44899726|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44899727|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44899728|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899729|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44899730|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
44899731|NCT04115163|Antiviral Agents|antiviral agents|mesh-ancestor
44899732|NCT04115163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899733|NCT04115163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899734|NCT04115163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899735|NCT04115163|Immunologic Factors|immunologic factors|mesh-ancestor
44899736|NCT04115163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899737|NCT04115020|Naltrexone|naltrexone|mesh-list
44899738|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44899739|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44899740|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899741|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
44899742|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899743|NCT04115072|Praziquantel|praziquantel|mesh-list
44899744|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
44899745|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44899746|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899747|NCT04114643|Thrombin|thrombin|mesh-list
44899748|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
44899749|NCT04114643|Coagulants|coagulants|mesh-ancestor
44899750|NCT04114630|Erenumab|erenumab|mesh-list
44899751|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44899752|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899753|NCT04114630|Analgesics|analgesics|mesh-ancestor
44899754|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
44899755|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899756|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899757|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
44899758|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899759|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44899760|NCT04114383|Protective Agents|protective agents|mesh-ancestor
44899761|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899762|NCT04114526|Nicotine|nicotine|mesh-list
44899763|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44899764|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
44899765|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899766|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899767|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44899768|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44899769|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
44899770|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899771|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899772|NCT04114461|Tofacitinib|tofacitinib|mesh-list
44899773|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899774|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44899775|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899776|NCT04114396|Antibodies|antibodies|mesh-list
44899777|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
44899778|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899779|NCT04114188|Prednisolone|prednisolone|mesh-list
44899780|NCT04114188|Infliximab|infliximab|mesh-list
44899781|NCT04114188|Tacrolimus|tacrolimus|mesh-list
44899782|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
44899783|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44899784|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
44899785|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44899786|NCT04114188|Antibodies|antibodies|mesh-list
44899787|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899788|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
44899789|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899790|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44899791|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899792|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899793|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899794|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
44899795|NCT04114188|Hormones|hormones|mesh-ancestor
44899796|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899797|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899798|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899799|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899800|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899801|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899802|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
44899803|NCT04114149|Narcotics|narcotics|mesh-ancestor
44899804|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899805|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899806|NCT04114149|Analgesics|analgesics|mesh-ancestor
44899807|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
44899808|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899810|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899811|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899812|NCT04113863|Anastrozole|anastrozole|mesh-list
44899813|NCT04113863|Tretinoin|tretinoin|mesh-list
44899814|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899815|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899816|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44899817|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44899818|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899819|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899820|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44899821|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
44899822|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899823|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899824|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
44899825|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899826|NCT04113954|Prilocaine|prilocaine|mesh-list
44899827|NCT04113954|Mepivacaine|mepivacaine|mesh-list
44899828|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
44899829|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
44899830|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899831|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899832|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
44899833|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899834|NCT04113915|Cyclosporine|cyclosporine|mesh-list
44899835|NCT04113915|Dexamethasone|dexamethasone|mesh-list
44899836|NCT04113915|Cyclosporins|cyclosporins|mesh-list
44899837|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899838|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
44899839|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899840|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899841|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899842|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
44899843|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
44899844|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899845|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899846|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
44899847|NCT04113915|Hormones|hormones|mesh-ancestor
44899848|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899849|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44899850|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899851|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684514|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
44684515|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44684516|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684517|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684518|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44684519|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684520|NCT03457142|Dexamethasone|dexamethasone|mesh-list
44684522|NCT03457142|Abatacept|abatacept|mesh-list
44899852|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899853|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
44899854|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44899855|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899856|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44899857|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
44899858|NCT04113889|Metformin|metformin|mesh-list
44899859|NCT04113889|Pioglitazone|pioglitazone|mesh-list
44899860|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44899861|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899862|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
44899863|NCT04113889|Vitamins|vitamins|mesh-ancestor
44899864|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
44899865|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
44899866|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
44899867|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
44899868|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899869|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44899870|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899871|NCT04114097|Betamethasone|betamethasone|mesh-list
44899872|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
44899873|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44899874|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
44899875|NCT04114097|Tacrolimus|tacrolimus|mesh-list
44899876|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44899877|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44899878|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
44899879|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899880|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44899881|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899882|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899883|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691530|NCT01361789|Dexamethasone|dexamethasone|mesh-list
44899889|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44899890|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44899891|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899892|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899893|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44899894|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44899895|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899896|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
44899897|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899899|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44899900|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44899901|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
44899902|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44899903|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899904|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44899905|NCT04113668|Diflunisal|diflunisal|mesh-list
44899906|NCT04113668|BMS-986165|bms-986165|mesh-list
44899907|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44899908|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44899909|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899910|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899911|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44899912|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899913|NCT04113668|Analgesics|analgesics|mesh-ancestor
44899914|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
44899915|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899916|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899917|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899918|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899919|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44899920|NCT04113551|Guanfacine|guanfacine|mesh-list
44899921|NCT04113551|Methylphenidate|methylphenidate|mesh-list
44899922|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44899923|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44899924|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44899925|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44899926|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899927|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44899928|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44899929|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899930|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44899931|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44691606|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691607|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691608|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691609|NCT01362218|Analgesics|analgesics|mesh-ancestor
44691610|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
44691611|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691612|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691613|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691614|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691615|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44691616|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44691617|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44691619|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
44899932|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
44899933|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44899934|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44899935|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44899936|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44899937|NCT04113226|Rituximab|rituximab|mesh-list
44899938|NCT04113226|Lenalidomide|lenalidomide|mesh-list
44899939|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899940|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899941|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
44899942|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899943|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899944|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44899945|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44899946|NCT04113226|Growth Substances|growth substances|mesh-ancestor
44899947|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
44899948|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44899949|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
44899950|NCT04113005|Coagulants|coagulants|mesh-ancestor
44899951|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44899952|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
44899953|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899954|NCT04112550|Acetaminophen|acetaminophen|mesh-list
44899955|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44899956|NCT04112550|Oxycodone|oxycodone|mesh-list
44899957|NCT04112550|Methadone|methadone|mesh-list
44899958|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44899959|NCT04112550|Analgesics|analgesics|mesh-ancestor
44899960|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
44899961|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899962|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899963|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
44899964|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44899965|NCT04112550|Narcotics|narcotics|mesh-ancestor
44899966|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899967|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
44899968|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44899969|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44899970|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44899971|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44899972|NCT04112212|Vedolizumab|vedolizumab|mesh-list
44899973|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44899974|NCT04112147|Ubiquinone|ubiquinone|mesh-list
44899975|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
44899976|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899977|NCT04112498|Nivolumab|nivolumab|mesh-list
44899978|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44899979|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44899980|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44899981|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899982|NCT04112394|Anesthetics|anesthetics|mesh-list
44899983|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
44899984|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44899985|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44899986|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
44899987|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44899988|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
44899989|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44899990|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44899991|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899992|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
44899993|NCT04111822|Coagulants|coagulants|mesh-ancestor
44899994|NCT04111614|Tofacitinib|tofacitinib|mesh-list
44899995|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44899996|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44899997|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44899998|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
44899999|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44900000|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44900001|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
44900002|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900003|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900004|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44900005|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900006|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44900007|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
44900008|NCT04111484|Protective Agents|protective agents|mesh-ancestor
44900009|NCT04111432|Vaccines|vaccines|mesh-list
44900010|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
44900011|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900012|NCT04111328|Sufentanil|sufentanil|mesh-list
44900013|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
44900019|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900020|NCT04111328|Analgesics|analgesics|mesh-ancestor
44900021|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
44900022|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900023|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44900024|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44900025|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44900026|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900027|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900028|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900029|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900030|NCT04111328|Narcotics|narcotics|mesh-ancestor
44900031|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44900032|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900033|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
44900034|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
44900035|NCT04111159|Propofol|propofol|mesh-list
44900036|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44900037|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900038|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900039|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900040|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
44900041|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
44900042|NCT04111302|Dezocine|dezocine|mesh-list
44900043|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900044|NCT04111302|Narcotics|narcotics|mesh-ancestor
44900045|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900046|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900047|NCT04111302|Analgesics|analgesics|mesh-ancestor
44900048|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
44900049|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900050|NCT04111848|Ketamine|ketamine|mesh-list
44900051|NCT04111848|Analgesics|analgesics|mesh-ancestor
44900052|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
44900053|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900054|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900055|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44900056|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900057|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
44900058|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
44900059|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900060|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44900061|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44900062|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900063|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900064|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
44900065|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
44900066|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900067|NCT04111003|Anesthetics|anesthetics|mesh-list
44900068|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900069|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900070|NCT04110665|Acetaminophen|acetaminophen|mesh-list
44900071|NCT04110665|Morphine|morphine|mesh-list
44900072|NCT04110665|Oxycodone|oxycodone|mesh-list
44900073|NCT04110665|Tramadol|tramadol|mesh-list
44900074|NCT04110665|Nefopam|nefopam|mesh-list
44900075|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900076|NCT04110665|Narcotics|narcotics|mesh-ancestor
44900077|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900078|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900079|NCT04110665|Analgesics|analgesics|mesh-ancestor
44900080|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
44900081|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900082|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900083|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
44900084|NCT04110873|Ubiquinone|ubiquinone|mesh-list
44900085|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
44900086|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900087|NCT04110834|Itraconazole|itraconazole|mesh-list
44900088|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44900089|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
44900090|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900091|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44900092|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44900093|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900094|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900095|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44900096|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
44900097|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900098|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900099|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44900100|NCT04110860|Voriconazole|voriconazole|mesh-list
44900101|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
44900102|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900103|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44900104|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44900105|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900106|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900107|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44900108|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
44900109|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900110|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900111|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44900112|NCT04110808|Phentolamine|phentolamine|mesh-list
44900113|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
44900114|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
44900115|NCT04110808|Anesthetics|anesthetics|mesh-list
44900116|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900117|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900118|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44900119|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44900120|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44900121|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900122|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900123|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900124|NCT04111380|Paclitaxel|paclitaxel|mesh-list
44900125|NCT04111380|Cisplatin|cisplatin|mesh-list
44900126|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44900127|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900128|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
44900129|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
44900130|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
44900131|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900132|NCT04111289|Tirofiban|tirofiban|mesh-list
44900133|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44900134|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44900135|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900136|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44900137|NCT04110535|Midazolam|midazolam|mesh-list
44900138|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44900139|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44900140|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900141|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900142|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44900143|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44900144|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44900145|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900146|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
44900147|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
44900148|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
44900149|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
44900150|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900151|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900152|NCT04110418|Terlipressin|terlipressin|mesh-list
44900153|NCT04110418|Methylene Blue|methylene blue|mesh-list
44900154|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900155|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900156|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44900157|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44900158|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44691816|NCT01363544|Methylphenidate|methylphenidate|mesh-list
44900159|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44900160|NCT04110587|Analgesics|analgesics|mesh-list
44900161|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
44900162|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900163|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44900164|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
44900165|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900166|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
44900167|NCT04110587|Protective Agents|protective agents|mesh-ancestor
44900168|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
44900169|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900170|NCT04110132|Bupivacaine|bupivacaine|mesh-list
44900171|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900172|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
44900173|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900174|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900175|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
44900176|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900177|NCT04110028|Niacinamide|niacinamide|mesh-list
44900178|NCT04110028|Niacin|niacin|mesh-list
44900179|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
44900180|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
44900181|NCT04110028|Vitamins|vitamins|mesh-ancestor
44900182|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
44900183|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900184|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44900185|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
44900186|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900187|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44900188|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
44900189|NCT04110210|Morphine|morphine|mesh-list
44900190|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900191|NCT04110210|Narcotics|narcotics|mesh-ancestor
44900192|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900193|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900194|NCT04110210|Analgesics|analgesics|mesh-ancestor
44900195|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
44900196|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900197|NCT04110288|Paclitaxel|paclitaxel|mesh-list
44900198|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44900199|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900200|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
44900201|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
44900202|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
44900203|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900204|NCT04110275|Plasminogen|plasminogen|mesh-list
44900205|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44900206|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44900207|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44900208|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900209|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44900210|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900211|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900212|NCT04110119|Diclofenac|diclofenac|mesh-list
44900213|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44900214|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900215|NCT04110119|Analgesics|analgesics|mesh-ancestor
44900216|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
44900217|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900218|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900219|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900220|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900221|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44900222|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900223|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900224|NCT04109872|Lenalidomide|lenalidomide|mesh-list
44900225|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
44900226|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900227|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44900228|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44900229|NCT04109872|Growth Substances|growth substances|mesh-ancestor
44900230|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44900231|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900232|NCT04109742|Curcumin|curcumin|mesh-list
44900233|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44900234|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900235|NCT04109742|Analgesics|analgesics|mesh-ancestor
44900236|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
44900237|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900238|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900239|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900240|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900241|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900242|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900243|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900244|NCT04109859|Methylene Blue|methylene blue|mesh-list
44900245|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900246|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900247|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44900248|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900249|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
44900250|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691967|NCT01364675|Simvastatin|simvastatin|mesh-list
44691968|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44691969|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691970|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44691971|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44691972|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
44691973|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691974|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44691975|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44691976|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691977|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44691978|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
44691979|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691980|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
44691981|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44691982|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44691983|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691984|NCT01364688|Vitamins|vitamins|mesh-ancestor
44691985|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
44691986|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
44691987|NCT01364701|Tadalafil|tadalafil|mesh-list
44691988|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691989|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44691990|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44691991|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691992|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691993|NCT01364701|Urological Agents|urological agents|mesh-ancestor
44691994|NCT01364792|Valacyclovir|valacyclovir|mesh-list
44691995|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
44691996|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900251|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900252|NCT04109261|Palbociclib|palbociclib|mesh-list
44900253|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900254|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44900255|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900256|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900257|NCT04109339|Oxytocin|oxytocin|mesh-list
44900258|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
44900259|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44900260|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900261|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
44900262|NCT04109534|Miotics|miotics|mesh-ancestor
44900263|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
44900264|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900265|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900266|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44900267|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44900268|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900269|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44900270|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44900271|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
44900272|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900273|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900274|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44900275|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
44900276|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900277|NCT04108468|Golimumab|golimumab|mesh-list
44900278|NCT04108468|Methotrexate|methotrexate|mesh-list
44900300|NCT04108013|Carboplatin|carboplatin|mesh-list
44900301|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44900302|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900303|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44900304|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44900305|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44900306|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900307|NCT04107896|Tamsulosin|tamsulosin|mesh-list
44900308|NCT04107896|Silodosin|silodosin|mesh-list
44900309|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44900310|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44900311|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44900312|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900313|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900314|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900315|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900316|NCT04107896|Urological Agents|urological agents|mesh-ancestor
44900317|NCT04107805|Midazolam|midazolam|mesh-list
44900318|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44900319|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44900320|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900321|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900322|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44900323|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44900324|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44900325|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900326|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
44900327|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
44900328|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
44900329|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
44900330|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900331|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900332|NCT04107740|TA 0910|ta 0910|mesh-list
44900333|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
44900334|NCT04107428|Somatostatin|somatostatin|mesh-list
44900335|NCT04107428|Hormones|hormones|mesh-ancestor
44900336|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900337|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900338|NCT04107779|Menthol|menthol|mesh-list
44900339|NCT04107779|Nicotine|nicotine|mesh-list
44900340|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44900341|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
44900342|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900343|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900344|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44900345|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44900346|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
44900347|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900348|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900349|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
44900350|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
44900351|NCT04107480|Dopamine|dopamine|mesh-list
44900352|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
44900353|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44900354|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
44900355|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
44900356|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900357|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900358|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
44900359|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900360|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900361|NCT04107480|Protective Agents|protective agents|mesh-ancestor
44900362|NCT04107194|Amoxicillin|amoxicillin|mesh-list
44900363|NCT04107194|Metronidazole|metronidazole|mesh-list
44900364|NCT04107194|Clarithromycin|clarithromycin|mesh-list
44900365|NCT04107194|Levofloxacin|levofloxacin|mesh-list
44900366|NCT04107194|Tetracycline|tetracycline|mesh-list
44900367|NCT04107194|Rifabutin|rifabutin|mesh-list
44900368|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44900369|NCT04107194|Pantoprazole|pantoprazole|mesh-list
44900370|NCT04107194|Bismuth|bismuth|mesh-list
44900371|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900372|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900373|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44900374|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44900375|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44900376|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900377|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900378|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44900379|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44900380|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44900381|NCT04107194|Renal Agents|renal agents|mesh-ancestor
44900382|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44900383|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44900384|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900385|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44900386|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44900387|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900388|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44900389|NCT04107194|Antacids|antacids|mesh-ancestor
44900390|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44900391|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
44900392|NCT04107220|Valsartan|valsartan|mesh-list
44900393|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44900394|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44900395|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44900396|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44900397|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900398|NCT04107103|Nivolumab|nivolumab|mesh-list
44900399|NCT04107103|Pemetrexed|pemetrexed|mesh-list
44900400|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44900401|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900402|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44900403|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900404|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900405|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44900406|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44900407|NCT04106752|Caffeine|caffeine|mesh-list
44900408|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44900409|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900410|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44900411|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900412|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900413|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44900414|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44900415|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
44900416|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900417|NCT04106700|Apixaban|apixaban|mesh-list
44900418|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44900419|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
44900420|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44900421|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
44900422|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900423|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900424|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
44900425|NCT04106804|Abatacept|abatacept|mesh-list
44900426|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44900427|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900428|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900429|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44900430|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
44900431|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900432|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900433|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44900434|NCT04106557|Gaboxadol|gaboxadol|mesh-list
44900435|NCT04106557|Analgesics|analgesics|mesh-ancestor
44900436|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
44900437|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900438|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900439|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
44900440|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
44900441|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
44900442|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900443|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900444|NCT04106726|Ivermectin|ivermectin|mesh-list
44900445|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44900446|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900447|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44900448|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692170|NCT01366235|Chloroquine|chloroquine|mesh-list
44692238|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692239|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692240|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
44692241|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692242|NCT01366391|Metformin|metformin|mesh-list
44692243|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44692244|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692245|NCT01366547|Lamivudine|lamivudine|mesh-list
44692246|NCT01366547|Abacavir|abacavir|mesh-list
44692247|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
44692248|NCT01366547|Dolutegravir|dolutegravir|mesh-list
44692249|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44692250|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44692251|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692252|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692253|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
44692254|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692255|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44692256|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44692257|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44692258|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44692259|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
44684654|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684655|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44684656|NCT03229538|Protective Agents|protective agents|mesh-ancestor
44684657|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684659|NCT03213652|Ensartinib|ensartinib|mesh-list
44692260|NCT01366651|Doripenem|doripenem|mesh-list
44692261|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44692262|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702402|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44702403|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
44702404|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
44702405|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702406|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702407|NCT01408199|Lenalidomide|lenalidomide|mesh-list
44702408|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
44702409|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702410|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44702411|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44702412|NCT01408199|Growth Substances|growth substances|mesh-ancestor
44702413|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44702414|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702415|NCT01408342|Rituximab|rituximab|mesh-list
44702416|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
44702417|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702418|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702419|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
44702420|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702421|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702422|NCT01408394|Ecopipam|ecopipam|mesh-list
44702423|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44702424|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44702425|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702426|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702427|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702428|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44702429|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
44900449|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44900450|NCT04106362|Cisplatin|cisplatin|mesh-list
44900451|NCT04106362|Cetuximab|cetuximab|mesh-list
44900452|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44900453|NCT04106362|Antibodies|antibodies|mesh-list
44900454|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
44900455|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44900456|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
44900457|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900458|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900459|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
44900460|NCT04105985|Tetracaine|tetracaine|mesh-list
44900461|NCT04105985|Carticaine|carticaine|mesh-list
44900462|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900463|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
44900464|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900465|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900466|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
44900467|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900468|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44900469|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44900470|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900471|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900472|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900506|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
44900507|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44900508|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
44900509|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900510|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
44900511|NCT04105920|Protective Agents|protective agents|mesh-ancestor
44900512|NCT04105764|Bromides|bromides|mesh-list
44900513|NCT04105764|Rocuronium|rocuronium|mesh-list
44900514|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44900515|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
44900516|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44900517|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44900518|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900519|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900520|NCT04105374|Flucytosine|flucytosine|mesh-list
44900521|NCT04105374|Temozolomide|temozolomide|mesh-list
44900522|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44900523|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
44900524|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900525|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900526|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
44900527|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900528|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
44900529|NCT04105426|Antioxidants|antioxidants|mesh-list
44900530|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900531|NCT04105426|Protective Agents|protective agents|mesh-ancestor
44900532|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900533|NCT04105140|Oxytocin|oxytocin|mesh-list
44900534|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
44900535|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44900536|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900537|NCT04105205|Apramycin|apramycin|mesh-list
44900538|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900539|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900540|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
44900541|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44900542|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900543|NCT04105023|Genistein|genistein|mesh-list
44900544|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44900545|NCT04105023|Protective Agents|protective agents|mesh-ancestor
44900546|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900547|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900548|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44900549|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900550|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900551|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
44900552|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44900553|NCT04105023|Estrogens|estrogens|mesh-ancestor
44900554|NCT04105023|Hormones|hormones|mesh-ancestor
44900555|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900556|NCT04104867|Domperidone|domperidone|mesh-list
44900557|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
44900558|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
44900559|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900560|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900561|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900562|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44900563|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
44900564|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900565|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900566|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
44900567|NCT04104984|Progesterone|progesterone|mesh-list
44900568|NCT04104984|Progestins|progestins|mesh-ancestor
44900569|NCT04104984|Hormones|hormones|mesh-ancestor
44900570|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900571|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900572|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44900573|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
44900574|NCT04104789|Tetracaine|tetracaine|mesh-list
44900575|NCT04104789|Carticaine|carticaine|mesh-list
44900576|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900577|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
44900578|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900579|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900580|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
44900581|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900582|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44900583|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44900584|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900585|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900586|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900587|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
44900588|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
44900589|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
44900590|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44900591|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900592|NCT04104204|Morphine|morphine|mesh-list
44900593|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900594|NCT04104204|Narcotics|narcotics|mesh-ancestor
44900595|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900596|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900597|NCT04104204|Analgesics|analgesics|mesh-ancestor
44900598|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
44900599|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900600|NCT04104334|Remifentanil|remifentanil|mesh-list
44900601|NCT04104334|Desflurane|desflurane|mesh-list
44900602|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
44900603|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900604|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900605|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44900606|NCT04104334|Narcotics|narcotics|mesh-ancestor
44900607|NCT04104334|Analgesics|analgesics|mesh-ancestor
44900608|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
44900609|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900610|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44900611|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
44900612|NCT04103684|Dexamethasone|dexamethasone|mesh-list
44900613|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
44900614|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44900615|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44900616|NCT04103684|Prednisolone|prednisolone|mesh-list
44900617|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
44900618|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44900619|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
44900620|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900621|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
44900622|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
44900623|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900624|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900625|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900626|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
44900627|NCT04103684|Hormones|hormones|mesh-ancestor
44900628|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900629|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44900630|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900631|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44900632|NCT04103684|Protective Agents|protective agents|mesh-ancestor
44900633|NCT04103905|Antibodies|antibodies|mesh-list
44900634|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44900635|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
44900636|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900637|NCT04103697|Capecitabine|capecitabine|mesh-list
44900638|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
44900639|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44900640|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
44900641|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900642|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900643|NCT04103489|Eculizumab|eculizumab|mesh-list
44900644|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44900645|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44900646|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
44900647|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900648|NCT04103398|Sorafenib|sorafenib|mesh-list
44900649|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
44900650|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900651|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44900652|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900653|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900654|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44900655|NCT04103398|Estrogens|estrogens|mesh-ancestor
44900656|NCT04103398|Hormones|hormones|mesh-ancestor
44900657|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900658|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900660|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
44900661|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44900662|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
44900663|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900664|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
44900665|NCT04103125|Protective Agents|protective agents|mesh-ancestor
44900666|NCT04102995|Pregnanolone|pregnanolone|mesh-list
44900667|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
44900668|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900669|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900670|NCT04102878|Anesthetics|anesthetics|mesh-list
44900671|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
44900672|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900673|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900674|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
44900675|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900676|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
44900677|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900678|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44900679|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
44900680|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
44900681|NCT04102670|Protective Agents|protective agents|mesh-ancestor
44900682|NCT04102943|Tacrolimus|tacrolimus|mesh-list
44900683|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44900684|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
44900685|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900686|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44900687|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900688|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900689|NCT04102592|Permethrin|permethrin|mesh-list
44900690|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900691|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900692|NCT04102267|Epinephrine|epinephrine|mesh-list
44900693|NCT04102267|Bupivacaine|bupivacaine|mesh-list
44900694|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
44900695|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
44900696|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900697|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900698|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
44900699|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900700|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44900701|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44900702|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900703|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900704|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900705|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44900706|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44900707|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
44900708|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44900709|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900710|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
44900711|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
44900712|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44900713|NCT04102449|Apremilast|apremilast|mesh-list
44900714|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44900715|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900716|NCT04102449|Analgesics|analgesics|mesh-ancestor
44900717|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
44900718|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900719|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900720|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900721|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900722|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44900723|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44900724|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900725|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900726|NCT04102566|Ibuprofen|ibuprofen|mesh-list
44900727|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44900728|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44900729|NCT04102566|Analgesics|analgesics|mesh-ancestor
44900730|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
44900731|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900732|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900733|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44692549|NCT01368419|Endostar protein|endostar protein|mesh-list
44900734|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900735|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44900736|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900737|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900738|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
44900739|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
44900740|NCT04102176|Protective Agents|protective agents|mesh-ancestor
44900741|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900742|NCT04101929|Irinotecan|irinotecan|mesh-list
44900743|NCT04101929|Apatinib|apatinib|mesh-list
44900744|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44900745|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44900746|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900747|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900748|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900749|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44900750|NCT04102072|Dobutamine|dobutamine|mesh-list
44900751|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44900752|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
44900753|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
44900754|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900755|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900756|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44900757|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44900758|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44900759|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44900760|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900761|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900762|NCT04102072|Protective Agents|protective agents|mesh-ancestor
44900763|NCT04101812|Doxorubicin|doxorubicin|mesh-list
44900764|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44900765|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44900766|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900767|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44900768|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44900769|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900770|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900771|NCT04101500|Aminophylline|aminophylline|mesh-list
44900772|NCT04101500|Bromides|bromides|mesh-list
44900773|NCT04101500|Ipratropium|ipratropium|mesh-list
44900774|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
44900775|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44900776|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
44900777|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900778|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900779|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44900780|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44900781|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44900782|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
44900783|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900784|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900785|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44900786|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44900787|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900788|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44900789|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44900790|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
44900791|NCT04101500|Protective Agents|protective agents|mesh-ancestor
44900792|NCT04101474|Ketamine|ketamine|mesh-list
44900793|NCT04101474|Analgesics|analgesics|mesh-ancestor
44900794|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
44900795|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900796|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900797|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44900798|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900799|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
44900800|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
44900801|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900802|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44900803|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44900804|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900805|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900806|NCT04101682|Bupivacaine|bupivacaine|mesh-list
44900807|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
44692625|NCT01368887|Niacin|niacin|mesh-list
44900808|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
44900809|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900810|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900811|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
44900812|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900813|NCT04101578|Cyclosporine|cyclosporine|mesh-list
44900814|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
44900815|NCT04101578|Prednisone|prednisone|mesh-list
44900816|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
44900817|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
44900818|NCT04101578|Methotrexate|methotrexate|mesh-list
44900819|NCT04101578|Azathioprine|azathioprine|mesh-list
44900820|NCT04101578|Bromides|bromides|mesh-list
44900821|NCT04101578|Tacrolimus|tacrolimus|mesh-list
44900822|NCT04101578|Cyclosporins|cyclosporins|mesh-list
44900823|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44900824|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
44900825|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44900826|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
44900827|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44900828|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44900829|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
44900830|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900831|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44900832|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44900833|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
44900834|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900835|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900836|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44900837|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44900838|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
44900839|NCT04101578|Hormones|hormones|mesh-ancestor
44900840|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900841|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44900842|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44900843|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
44900844|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44900845|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44900846|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
44900847|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44900848|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900849|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44900850|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44900851|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44900852|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
44900853|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900854|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44900855|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44900856|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
44900857|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900858|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
44900859|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
44900860|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900861|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900862|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44900863|NCT04101578|Protective Agents|protective agents|mesh-ancestor
44900864|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
44900865|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44900866|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
44900867|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44900868|NCT04101708|Amoxicillin|amoxicillin|mesh-list
44900869|NCT04101708|Clarithromycin|clarithromycin|mesh-list
44900870|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44900871|NCT04101708|Lansoprazole|lansoprazole|mesh-list
44900872|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
44900873|NCT04101708|Bismuth|bismuth|mesh-list
44900874|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44900875|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900876|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44900877|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44900878|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900879|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44900880|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44900881|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44900882|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900883|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44900884|NCT04101708|Antacids|antacids|mesh-ancestor
44692846|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44692847|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44692848|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692849|NCT01370291|Risperidone|risperidone|mesh-list
44692850|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44692851|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
44692852|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692853|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692854|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692855|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44692856|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44692857|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692858|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692859|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44692860|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
44692861|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44692862|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44692863|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692864|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692865|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692866|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692867|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692868|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692869|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692870|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702430|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702431|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702432|NCT01408446|Menthol|menthol|mesh-list
44702433|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
44702434|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702435|NCT01408498|Testosterone|testosterone|mesh-list
44702436|NCT01408498|Androgens|androgens|mesh-ancestor
44702437|NCT01408498|Hormones|hormones|mesh-ancestor
44702438|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702439|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702440|NCT01408524|Diltiazem|diltiazem|mesh-list
44702441|NCT01408524|Labetalol|labetalol|mesh-list
44702442|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702443|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44702444|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702445|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702446|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44702447|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702448|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44702449|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44900920|NCT04100655|Molgramostim|molgramostim|mesh-list
44900921|NCT04100655|Estradiol|estradiol|mesh-list
44900922|NCT04100655|Sargramostim|sargramostim|mesh-list
44900923|NCT04100655|Estrogens|estrogens|mesh-ancestor
44900924|NCT04100655|Hormones|hormones|mesh-ancestor
44900925|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900926|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900927|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
44900928|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900929|NCT04101383|Insulin|insulin|mesh-list
44900930|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44900931|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
44900932|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44900933|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900934|NCT04100824|Nimodipine|nimodipine|mesh-list
44900935|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44900936|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44900937|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44900938|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900939|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44900940|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900941|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
44900942|NCT04100330|Cytarabine|cytarabine|mesh-list
44900943|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44900944|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
44900945|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900946|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44900948|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44900949|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44900950|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
44900951|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900952|NCT04100473|Insulin|insulin|mesh-list
44900953|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44900954|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
44900955|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44900956|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900957|NCT04100226|Vitamin D|vitamin d|mesh-list
44900958|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
44900959|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
44900960|NCT04100226|Vitamins|vitamins|mesh-ancestor
44900961|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
44900962|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900963|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44900964|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44900965|NCT04100226|Antacids|antacids|mesh-ancestor
44900966|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900967|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44900968|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
44900969|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44900970|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44900971|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900972|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
44900973|NCT04100447|Coagulants|coagulants|mesh-ancestor
44900974|NCT04100434|Evolocumab|evolocumab|mesh-list
44900975|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44900976|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44900977|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
44900978|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44900979|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44900980|NCT04100083|Spironolactone|spironolactone|mesh-list
44900981|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44900982|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
44900983|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44900984|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900985|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44900986|NCT04100083|Diuretics|diuretics|mesh-ancestor
44900987|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
44900988|NCT04099771|Ketamine|ketamine|mesh-list
44900989|NCT04099771|Analgesics|analgesics|mesh-ancestor
44900990|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
44900991|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44900992|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44900993|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44900994|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44900995|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
44900996|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
44900997|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44900998|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44900999|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44901000|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901001|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901002|NCT04099563|Abrocitinib|abrocitinib|mesh-list
44901003|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44901004|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901005|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901006|NCT04099732|Dabigatran|dabigatran|mesh-list
44901007|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44901008|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44901009|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44901010|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
44901011|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901012|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44901013|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44901014|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901015|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
44901016|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44684725|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
44901017|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901018|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
44901019|NCT04099407|Pirfenidone|pirfenidone|mesh-list
44901020|NCT04099407|Analgesics|analgesics|mesh-ancestor
44901021|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
44901022|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901023|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901024|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44901025|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901026|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901027|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44901028|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901029|NCT04099238|Warfarin|warfarin|mesh-list
44901030|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
44901031|NCT04099238|Dabigatran|dabigatran|mesh-list
44901032|NCT04099238|Apixaban|apixaban|mesh-list
44901033|NCT04099238|Anticoagulants|anticoagulants|mesh-list
44901034|NCT04099238|Edoxaban|edoxaban|mesh-list
44901035|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
44901036|NCT04099238|Phenindione|phenindione|mesh-list
44901037|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44901038|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
44901039|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44901040|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901041|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901042|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901043|NCT04099069|Anesthetics|anesthetics|mesh-list
44901044|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901045|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901046|NCT04098861|Timolol|timolol|mesh-list
44901047|NCT04098861|Latanoprost|latanoprost|mesh-list
44901048|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44901049|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44901050|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901051|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901052|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901053|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901054|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44901055|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44901056|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44901057|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44901058|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
44901059|NCT04098653|Busulfan|busulfan|mesh-list
44901060|NCT04098653|Decitabine|decitabine|mesh-list
44901061|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901062|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
44901063|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901064|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44901065|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44901066|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
44901067|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901068|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901069|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44901070|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901071|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
44901072|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901073|NCT04098796|Antibodies|antibodies|mesh-list
44901074|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
44901075|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901076|NCT04098081|Gemcitabine|gemcitabine|mesh-list
44901077|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
44901078|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901079|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
44901080|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901081|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901082|NCT04098081|Antiviral Agents|antiviral agents|mesh-ancestor
44901083|NCT04098081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901084|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901085|NCT04098081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901086|NCT04098081|Immunologic Factors|immunologic factors|mesh-ancestor
44901087|NCT04098081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901088|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
44901089|NCT04097847|Tocopherols|tocopherols|mesh-list
44901090|NCT04097847|Vitamin E|vitamin e|mesh-list
44901091|NCT04097847|Tocotrienols|tocotrienols|mesh-list
44901092|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
44901093|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
44901094|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44901095|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901096|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901097|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44901098|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44693090|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693091|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44693093|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44693094|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693095|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693096|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
44693097|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693098|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693099|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44693100|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
44693101|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693102|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
44702450|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44702451|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
44702452|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702453|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
44702454|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
44702455|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702456|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44702457|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44702458|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44702459|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44702460|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44702461|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702462|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702463|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
44702464|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702465|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702466|NCT01408680|Ubiquinone|ubiquinone|mesh-list
44702467|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
44702468|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
44702469|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702470|NCT01408680|Vitamins|vitamins|mesh-ancestor
44702471|NCT01408797|Bortezomib|bortezomib|mesh-list
44702472|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702473|NCT01408810|Infliximab|infliximab|mesh-list
44702474|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702475|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702476|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702477|NCT01408836|Prednisolone|prednisolone|mesh-list
44702478|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44702479|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
44702480|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44702481|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
44702482|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44702483|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
44702484|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702485|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
44702486|NCT01408836|Hormones|hormones|mesh-ancestor
44702487|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702488|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702489|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44702490|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702491|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
44702492|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
44702493|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702494|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702495|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44702496|NCT01408836|Protective Agents|protective agents|mesh-ancestor
44702497|NCT01408849|Omeprazole|omeprazole|mesh-list
44901107|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
44702498|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44901108|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44901109|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
44901110|NCT04097613|Budesonide|budesonide|mesh-list
44901111|NCT04097613|Povidone|povidone|mesh-list
44901112|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901113|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44901114|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
44901115|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901116|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901117|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44901118|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
44901119|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
44901120|NCT04097613|Hormones|hormones|mesh-ancestor
44901121|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901122|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
44901123|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
44901124|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44901125|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901127|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
44901128|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901129|NCT04097444|Leucovorin|leucovorin|mesh-list
44901130|NCT04097444|Bevacizumab|bevacizumab|mesh-list
44901131|NCT04097444|Fluorouracil|fluorouracil|mesh-list
44901132|NCT04097444|Capecitabine|capecitabine|mesh-list
44901133|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
44901134|NCT04097444|Irinotecan|irinotecan|mesh-list
44901135|NCT04097444|Calcium|calcium|mesh-list
44901136|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
44901137|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901138|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901139|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44901140|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44901141|NCT04097444|Growth Substances|growth substances|mesh-ancestor
44901142|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901143|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
44901144|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44901145|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
44901146|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901147|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901148|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901149|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
44901150|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44901151|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44901152|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901153|NCT04097444|Antidotes|antidotes|mesh-ancestor
44901154|NCT04097444|Protective Agents|protective agents|mesh-ancestor
44901155|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
44901156|NCT04097444|Vitamins|vitamins|mesh-ancestor
44901157|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
44901158|NCT04097288|Dexetimide|dexetimide|mesh-list
44901159|NCT04097288|Citalopram|citalopram|mesh-list
44901160|NCT04097288|Reboxetine|reboxetine|mesh-list
44901161|NCT04097288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44901162|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44901163|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901164|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901165|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901166|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
44901167|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901168|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44901169|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
44901170|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44901171|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44901172|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44901173|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
44901174|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
44901175|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901176|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44901177|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44901178|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
44901179|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44901180|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901181|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
44901182|NCT04096768|Ketamine|ketamine|mesh-list
44901183|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44901184|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901185|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901186|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901187|NCT04096768|Analgesics|analgesics|mesh-ancestor
44901188|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
44901189|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901190|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44901191|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44901192|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44901193|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901194|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901195|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901196|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44901198|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
44901199|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
44901200|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44901201|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44901202|NCT04096599|Fluorides|fluorides|mesh-list
44901203|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
44901204|NCT04096599|Protective Agents|protective agents|mesh-ancestor
44901205|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901206|NCT04096742|Tretinoin|tretinoin|mesh-list
44901207|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901208|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
44901209|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901210|NCT04096638|Atezolizumab|atezolizumab|mesh-list
44901211|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901212|NCT04096690|Pegaspargase|pegaspargase|mesh-list
44901213|NCT04096690|Antibodies|antibodies|mesh-list
44901214|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44901215|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
44901216|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901217|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901218|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
44901219|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44901220|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
44901221|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44901222|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901223|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901224|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901225|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
44901226|NCT04096157|Isavuconazole|isavuconazole|mesh-list
44901227|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
44901228|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901229|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44901230|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44901231|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901232|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901233|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
44901234|NCT04095754|Anesthetics|anesthetics|mesh-list
44901235|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901236|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901237|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44901238|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901239|NCT04095754|Analgesics|analgesics|mesh-ancestor
44901240|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
44901241|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901242|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44901243|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44901244|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44901245|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901246|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901247|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901248|NCT04096027|Cabergoline|cabergoline|mesh-list
44901249|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44901250|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44901251|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
44901252|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
44901253|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901254|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901255|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901256|NCT04095832|Anesthetics|anesthetics|mesh-list
44901257|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901258|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901259|NCT04095312|Pancrelipase|pancrelipase|mesh-list
44901260|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901261|NCT04095390|Capecitabine|capecitabine|mesh-list
44901262|NCT04095390|Letrozole|letrozole|mesh-list
44901263|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901264|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
44901265|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901266|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901267|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44901268|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44693178|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901269|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901270|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44901271|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44901299|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
44901300|NCT04095169|Complement C3|complement c3|mesh-list
44901301|NCT04095169|Complement C3d|complement c3d|mesh-list
44901302|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
44901303|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901304|NCT04095013|Fentanyl|fentanyl|mesh-list
44901305|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
44901306|NCT04095013|Bupivacaine|bupivacaine|mesh-list
44901307|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901308|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
44901309|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901310|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901311|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
44901312|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901313|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44901314|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901315|NCT04095013|Analgesics|analgesics|mesh-ancestor
44901316|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44901317|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44901318|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44901319|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901320|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901321|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901322|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44901323|NCT04095013|Narcotics|narcotics|mesh-ancestor
44901324|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44901325|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44901326|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
44901327|NCT04094805|Calcitriol|calcitriol|mesh-list
44901328|NCT04094805|Dexamethasone|dexamethasone|mesh-list
44901329|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901330|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
44901331|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
44901332|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901333|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901334|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901335|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
44901336|NCT04094805|Hormones|hormones|mesh-ancestor
44901337|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901338|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44901339|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901340|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44901341|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44901342|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901343|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901344|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44901345|NCT04094805|Vitamins|vitamins|mesh-ancestor
44901346|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
44901347|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44901348|NCT04094909|Paclitaxel|paclitaxel|mesh-list
44901349|NCT04094909|Cisplatin|cisplatin|mesh-list
44901350|NCT04094909|Carboplatin|carboplatin|mesh-list
44901351|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
44901352|NCT04094909|Pemetrexed|pemetrexed|mesh-list
44901353|NCT04094909|Endostatins|endostatins|mesh-list
44901354|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44901355|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901356|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
44901357|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
44901358|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
44901359|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901360|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901361|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901362|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44901363|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44901364|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44901365|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44901366|NCT04094909|Growth Substances|growth substances|mesh-ancestor
44901367|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901368|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
44901369|NCT04094727|Lumefantrine|lumefantrine|mesh-list
44901370|NCT04094727|Artemether|artemether|mesh-list
44901371|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44693325|NCT01373554|Oltipraz|oltipraz|mesh-list
44901372|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
44505314|NCT00249288|Folic Acid|folic acid|mesh-list
44901373|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44901374|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44693399|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44693400|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44693401|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693402|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693403|NCT01373749|Urological Agents|urological agents|mesh-ancestor
44693404|NCT01373970|Pantoprazole|pantoprazole|mesh-list
44693405|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44693406|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44693407|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44693408|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693409|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693410|NCT01373983|Ziconotide|ziconotide|mesh-list
44693411|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44693412|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693413|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693414|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44693415|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693416|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44693417|NCT01373983|Protective Agents|protective agents|mesh-ancestor
44693418|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693419|NCT01373983|Analgesics|analgesics|mesh-ancestor
44693420|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
44693421|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702499|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702500|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44702501|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702502|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702503|NCT01408927|Aspirin|aspirin|mesh-list
44702504|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44702505|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702506|NCT01408927|Analgesics|analgesics|mesh-ancestor
44702507|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
44702508|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702509|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702510|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702511|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702512|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44702513|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44702514|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702515|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44702516|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44702517|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702518|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
44702519|NCT01408953|Bevacizumab|bevacizumab|mesh-list
44702520|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702521|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702522|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44702523|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44702524|NCT01408953|Growth Substances|growth substances|mesh-ancestor
44901375|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901376|NCT04094597|Lactoferrin|lactoferrin|mesh-list
44901377|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901378|NCT04094532|Bupivacaine|bupivacaine|mesh-list
44901379|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901380|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
44901381|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901382|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901383|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
44901384|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901385|NCT04094467|Leuprolide|leuprolide|mesh-list
44901386|NCT04094467|Cetrorelix|cetrorelix|mesh-list
44901387|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44901388|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
44901389|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44901390|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901391|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44901392|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901393|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
44901394|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901395|NCT04094142|Lenalidomide|lenalidomide|mesh-list
44901396|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
44901397|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901398|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
44901401|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44901403|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
44901404|NCT04093895|Taurolidine|taurolidine|mesh-list
44901405|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901406|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44901407|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901408|NCT04093518|Estradiol|estradiol|mesh-list
44901409|NCT04093518|Estrogens|estrogens|mesh-ancestor
44901410|NCT04093518|Hormones|hormones|mesh-ancestor
44901411|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901412|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901413|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
44901414|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901415|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901416|NCT04093713|Nordefrin|nordefrin|mesh-list
44901417|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44901418|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
44901419|NCT04093648|Fludarabine|fludarabine|mesh-list
44901420|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901421|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
44901422|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901423|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44901424|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44901425|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
44901426|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901427|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901428|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44901429|NCT04093206|Vitamins|vitamins|mesh-list
44901430|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
44901431|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
44901432|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901433|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
44901434|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901435|NCT04093206|Protective Agents|protective agents|mesh-ancestor
44901436|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
44901437|NCT04093271|Promethazine|promethazine|mesh-list
44901438|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44901439|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44901440|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901441|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901442|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901443|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
44901444|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
44901445|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901446|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
44901447|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
44901448|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901449|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44901450|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
44901451|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
44901452|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901453|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901454|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44901455|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
44901456|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901457|NCT04093050|Vasopressins|vasopressins|mesh-list
44901458|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
44901459|NCT04093050|Coagulants|coagulants|mesh-ancestor
44901460|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44901461|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44901462|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
44901463|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901464|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
44901465|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
44901466|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901467|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
44901468|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
44901469|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901470|NCT04092868|Protamines|protamines|mesh-list
44901471|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
44901472|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901473|NCT04092868|Coagulants|coagulants|mesh-ancestor
44901474|NCT04092621|Amiodarone|amiodarone|mesh-list
44901475|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44901476|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
44901477|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44901478|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901479|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901480|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44901481|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44901482|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44901483|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901484|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44901485|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44901486|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44901487|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44901488|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44901489|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44901490|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
44901491|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901492|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44901493|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44901494|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901495|NCT04092387|Nicotine|nicotine|mesh-list
44901496|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44901497|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
44901498|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901499|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901500|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44901501|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44901502|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
44901503|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901504|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901505|NCT04092478|Anesthetics|anesthetics|mesh-list
44901506|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901507|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901508|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
44901509|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
44901510|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
44901511|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901512|NCT04092309|Valsartan|valsartan|mesh-list
44901513|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44901514|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44901515|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44901516|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44901517|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44901518|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901519|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901520|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901521|NCT04091971|Ketamine|ketamine|mesh-list
44901522|NCT04091971|Analgesics|analgesics|mesh-ancestor
44901523|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
44901524|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901525|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901526|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44901527|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44901528|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
44901529|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
44901530|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901531|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44901532|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44901533|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901534|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901535|NCT04092101|Nicotine|nicotine|mesh-list
44901536|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44901537|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
44901538|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901539|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901540|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44901541|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44901542|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44901543|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693516|NCT01374633|Sevoflurane|sevoflurane|mesh-list
44901544|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901546|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901547|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901548|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
44901549|NCT04091698|Ubiquinone|ubiquinone|mesh-list
44901550|NCT04091698|Vitamins|vitamins|mesh-ancestor
44901551|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
44901552|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901553|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
44901554|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44901555|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901556|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901557|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901558|NCT04091763|Polidocanol|polidocanol|mesh-list
44901559|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44901560|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44901561|NCT04091503|Temozolomide|temozolomide|mesh-list
44901562|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44901563|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
44901564|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901565|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901566|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44901567|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44901568|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44901569|NCT04091412|Protective Agents|protective agents|mesh-ancestor
44901570|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901571|NCT04091204|Olaparib|olaparib|mesh-list
44901572|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44901573|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901574|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901575|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901576|NCT04091074|Clopidogrel|clopidogrel|mesh-list
44901577|NCT04091074|Ticagrelor|ticagrelor|mesh-list
44901578|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44901579|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44901580|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44901581|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44901582|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
44901583|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901584|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901585|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901586|NCT04091178|Vitamin D|vitamin d|mesh-list
44901587|NCT04091178|Vitamins|vitamins|mesh-ancestor
44901588|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
44901589|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901590|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44901591|NCT04091009|Buprenorphine|buprenorphine|mesh-list
44901592|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44901593|NCT04091009|Naloxone|naloxone|mesh-list
44901594|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44901595|NCT04091009|Narcotics|narcotics|mesh-ancestor
44901596|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901597|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901598|NCT04091009|Analgesics|analgesics|mesh-ancestor
44901599|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
44901600|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901601|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44901602|NCT04090801|Ethanol|ethanol|mesh-list
44901603|NCT04090801|Minoxidil|minoxidil|mesh-list
44901604|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44901605|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901606|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901607|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901608|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44901609|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
44901610|NCT04090112|Lidocaine|lidocaine|mesh-list
44901611|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901612|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
44901613|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901614|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901615|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
44901616|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901617|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44901623|NCT04090047|PF-06700841|pf-06700841|mesh-list
44901624|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
44901625|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901626|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44901627|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44901628|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901629|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901630|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44901631|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
44901632|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901633|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901634|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44901635|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44901636|NCT04090021|Amoxicillin|amoxicillin|mesh-list
44901637|NCT04090021|Metronidazole|metronidazole|mesh-list
44901638|NCT04090021|Clarithromycin|clarithromycin|mesh-list
44901639|NCT04090021|Levofloxacin|levofloxacin|mesh-list
44901640|NCT04090021|Ofloxacin|ofloxacin|mesh-list
44901641|NCT04090021|Rifabutin|rifabutin|mesh-list
44901642|NCT04090021|Esomeprazole|esomeprazole|mesh-list
44901643|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44901644|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901645|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44901646|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44901647|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44684751|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684752|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684753|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684754|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684755|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684756|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684757|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684758|NCT03126110|Nivolumab|nivolumab|mesh-list
44684759|NCT03126110|Ipilimumab|ipilimumab|mesh-list
44684760|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684761|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684762|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44684763|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684764|NCT03093922|Gemcitabine|gemcitabine|mesh-list
44684765|NCT03093922|Cisplatin|cisplatin|mesh-list
44684766|NCT03093922|Atezolizumab|atezolizumab|mesh-list
44684767|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901648|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901649|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44901650|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901651|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901652|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44901653|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44901654|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44901655|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44901656|NCT04090021|Renal Agents|renal agents|mesh-ancestor
44901657|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44901658|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44901659|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901660|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44901661|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44901662|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
44693723|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693724|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693725|NCT01375634|Midazolam|midazolam|mesh-list
44693726|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44693727|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44693728|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693729|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693730|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44693731|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44693732|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693733|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44693734|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
44693735|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
44693736|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
44693737|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
44693738|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693739|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693740|NCT01375699|Doxorubicin|doxorubicin|mesh-list
44901663|NCT04089657|Apatinib|apatinib|mesh-list
44901664|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901665|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44901666|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901667|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901668|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
44901669|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44901670|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901671|NCT04089813|Metformin|metformin|mesh-list
44901672|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44901673|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901674|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
44901675|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901676|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901677|NCT04089631|Capecitabine|capecitabine|mesh-list
44901678|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901679|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
44901680|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901681|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901682|NCT04089605|Dexamethasone|dexamethasone|mesh-list
44901683|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
44901684|NCT04089605|Ranibizumab|ranibizumab|mesh-list
44901685|NCT04089605|BB 1101|bb 1101|mesh-list
44901686|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901687|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
44901688|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
44901689|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901690|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901691|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44901692|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
44901693|NCT04089605|Hormones|hormones|mesh-ancestor
44901694|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901695|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44901696|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901697|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901698|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901699|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901700|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44901701|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44901702|NCT04089605|Growth Substances|growth substances|mesh-ancestor
44901703|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
44901704|NCT04089592|Fentanyl|fentanyl|mesh-list
44901705|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
44901706|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44901707|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901708|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901709|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901710|NCT04089592|Analgesics|analgesics|mesh-ancestor
44901711|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
44901712|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901713|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44901714|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44901715|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44901716|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901717|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901718|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901719|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44901720|NCT04089592|Narcotics|narcotics|mesh-ancestor
44901721|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44901722|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44901723|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
44901724|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
44901725|NCT04089345|Ustekinumab|ustekinumab|mesh-list
44901726|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901727|NCT04089163|Flucytosine|flucytosine|mesh-list
44901728|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
44901729|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901730|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
44901731|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901732|NCT04089176|Oxytocin|oxytocin|mesh-list
44901733|NCT04089176|Carbetocin|carbetocin|mesh-list
44901734|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
44901735|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44901736|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901737|NCT04088851|Metformin|metformin|mesh-list
44901738|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44901739|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901740|NCT04088903|Daratumumab|daratumumab|mesh-list
44901741|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901742|NCT04088604|Fluorouracil|fluorouracil|mesh-list
44901743|NCT04088604|Irinotecan|irinotecan|mesh-list
44901744|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
44901745|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901746|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901747|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901748|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44901749|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
44901750|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901751|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44901752|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44901753|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901754|NCT04088461|Metformin|metformin|mesh-list
44901756|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44901757|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901758|NCT04088461|Incretins|incretins|mesh-ancestor
44901759|NCT04088461|Hormones|hormones|mesh-ancestor
44901760|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901761|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44901762|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
44901763|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901764|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901765|NCT04088448|Metformin|metformin|mesh-list
44901766|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44901767|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901768|NCT04088266|Buprenorphine|buprenorphine|mesh-list
44901769|NCT04088266|Naloxone|naloxone|mesh-list
44901770|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44901771|NCT04088266|Narcotics|narcotics|mesh-ancestor
44901772|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901773|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901774|NCT04088266|Analgesics|analgesics|mesh-ancestor
44901775|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
44901776|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901777|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44901778|NCT04088032|Durvalumab|durvalumab|mesh-list
44901779|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44901780|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44901781|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901782|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44901783|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901784|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901785|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44901786|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44901787|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901788|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901789|NCT04088175|Menthol|menthol|mesh-list
44901790|NCT04088175|Nicotine|nicotine|mesh-list
44901791|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44901792|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
44901793|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901794|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901795|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44901796|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44901797|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
44901798|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901799|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901800|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
44901801|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901802|NCT04087915|Evolocumab|evolocumab|mesh-list
44901803|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44901804|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44901805|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
44901806|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901807|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44901808|NCT04088084|Palmidrol|palmidrol|mesh-list
44901809|NCT04088084|Analgesics|analgesics|mesh-ancestor
44901810|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
44901811|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901812|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901813|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44901814|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901815|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901816|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44901817|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
44901818|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901819|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44901820|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44901821|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901822|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901823|NCT04088084|Hormones|hormones|mesh-ancestor
44901824|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901825|NCT04088110|Trastuzumab|trastuzumab|mesh-list
44901826|NCT04088110|Letrozole|letrozole|mesh-list
44901827|NCT04088110|Anastrozole|anastrozole|mesh-list
44901828|NCT04088110|Exemestane|exemestane|mesh-list
44901829|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44901865|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901866|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901867|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44901868|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44901869|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44901871|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901872|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901873|NCT04087759|Bedaquiline|bedaquiline|mesh-list
44901874|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
44901875|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
44901876|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44901877|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901878|NCT04087421|Glycerol|glycerol|mesh-list
44901879|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44901880|NCT04087421|Protective Agents|protective agents|mesh-ancestor
44901881|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901882|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44901883|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
44901884|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901885|NCT04086940|Esmolol|esmolol|mesh-list
44901886|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44901887|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44901888|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44901889|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901890|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901891|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901892|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901893|NCT04087317|Acetaminophen|acetaminophen|mesh-list
44901894|NCT04087317|Ibuprofen|ibuprofen|mesh-list
44901895|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44901896|NCT04087317|Analgesics|analgesics|mesh-ancestor
44901897|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
44901898|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901899|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901900|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
44901901|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44901902|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44901903|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44901904|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44901905|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901906|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901907|NCT04086537|Hepcidins|hepcidins|mesh-list
44901908|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901909|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
44901910|NCT04086719|BMS-986165|bms-986165|mesh-list
44901911|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
44901912|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44901913|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44901914|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44901915|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44901916|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901917|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901918|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44901919|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44901920|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44901921|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
44901922|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901923|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901924|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901925|NCT04086290|Androgens|androgens|mesh-list
44901926|NCT04086290|Hormones|hormones|mesh-ancestor
44901927|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44901928|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901929|NCT04086264|Azacitidine|azacitidine|mesh-list
44901930|NCT04086264|Decitabine|decitabine|mesh-list
44901931|NCT04086264|Venetoclax|venetoclax|mesh-list
44901932|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901933|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
44901934|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901935|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901936|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901937|NCT04086186|Bupivacaine|bupivacaine|mesh-list
44901938|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901939|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
44901940|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901941|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694001|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44901942|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
44901943|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901944|NCT04086238|Decitabine|decitabine|mesh-list
44901945|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
44901946|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44901947|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
44901948|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901949|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44901950|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44901952|NCT04085913|Epinephrine|epinephrine|mesh-list
44901953|NCT04085913|Racepinephrine|racepinephrine|mesh-list
44901954|NCT04085913|Bupivacaine|bupivacaine|mesh-list
44901955|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
44901956|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
44694074|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44694075|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44694076|NCT01377324|Estradiol|estradiol|mesh-list
44694077|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44694078|NCT01377324|Estrogens|estrogens|mesh-ancestor
44694079|NCT01377324|Hormones|hormones|mesh-ancestor
44694080|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694081|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694082|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44694083|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
44694084|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44694085|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44694086|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44694087|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694088|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44694089|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694090|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694091|NCT01377415|Bupivacaine|bupivacaine|mesh-list
44694092|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
44694093|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
44694094|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694095|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694096|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
44694097|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694098|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
44694099|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44694100|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
44694101|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694102|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694103|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44901957|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
44901958|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44901959|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901960|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
44901961|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901962|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44901963|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44901964|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44901965|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901966|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901967|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44901968|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44901969|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901970|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901971|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44901972|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44901973|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
44901974|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44901975|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
44901976|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
44901977|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
44901978|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44901979|NCT04085562|Amlodipine|amlodipine|mesh-list
44901980|NCT04085562|Bisoprolol|bisoprolol|mesh-list
44901981|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44901982|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44901983|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44901984|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44901985|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44901986|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44901987|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44901988|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
44901989|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
44901990|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44901991|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44901992|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44901993|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44901994|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
44901995|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44901996|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
44901997|NCT04085744|Lidocaine|lidocaine|mesh-list
44901998|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
44901999|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
44902000|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902001|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902002|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
44902003|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902004|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44902005|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44902006|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44902007|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902008|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902009|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902010|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44902011|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44902012|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
44902013|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44902014|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
44902015|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44902016|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44902017|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902018|NCT04085770|Vitamins|vitamins|mesh-ancestor
44902019|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
44902020|NCT04085757|Dinoprostone|dinoprostone|mesh-list
44902021|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
44902022|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902023|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902024|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
44902025|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44902026|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44902027|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902028|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
44902029|NCT04085575|Coagulants|coagulants|mesh-ancestor
44902030|NCT04085627|Amlodipine|amlodipine|mesh-list
44902031|NCT04085627|Valsartan|valsartan|mesh-list
44902032|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44902033|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44902034|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44902035|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902036|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902037|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44902038|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902039|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
44902040|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44902041|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44902042|NCT04085393|Granisetron|granisetron|mesh-list
44902043|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
44902044|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
44902045|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902046|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902047|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902048|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44902049|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
44902050|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902051|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902052|NCT04085640|Ropivacaine|ropivacaine|mesh-list
44902053|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902054|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
44902055|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902056|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902057|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
44902058|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902059|NCT04085094|Pilocarpine|pilocarpine|mesh-list
44902060|NCT04085094|Miotics|miotics|mesh-ancestor
44902061|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
44902062|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902078|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
44902079|NCT04085120|Lidocaine|lidocaine|mesh-list
44902080|NCT04085120|Ropivacaine|ropivacaine|mesh-list
44902081|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902082|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
44902083|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
44902084|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902085|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902086|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902087|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
44902088|NCT04085120|Hormones|hormones|mesh-ancestor
44902089|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902090|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902091|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902092|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902093|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
44902094|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902095|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
44902096|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44902097|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44902098|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44902099|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902100|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902101|NCT04084977|Antibodies|antibodies|mesh-list
44902102|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
44902103|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902104|NCT04084912|Dexamethasone|dexamethasone|mesh-list
44902105|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
44902106|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44902107|NCT04084912|BB 1101|bb 1101|mesh-list
44902108|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902109|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
44902110|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
44902111|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902112|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902113|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902114|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
44902115|NCT04084912|Hormones|hormones|mesh-ancestor
44902116|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902117|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902118|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902119|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
44902120|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902121|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902122|NCT04084496|Folfirinox|folfirinox|mesh-list
44902123|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902124|NCT04084158|Paclitaxel|paclitaxel|mesh-list
44902125|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44902126|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44902127|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902128|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44902129|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44902130|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44902131|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902132|NCT04084171|Insulin|insulin|mesh-list
44902133|NCT04084171|Pancrelipase|pancrelipase|mesh-list
44902134|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44902135|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902136|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902137|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44902138|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44902139|NCT04083911|Cytarabine|cytarabine|mesh-list
44902140|NCT04083911|Decitabine|decitabine|mesh-list
44902141|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
44902142|NCT04083911|Aclarubicin|aclarubicin|mesh-list
44902143|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44902144|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
44902145|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902146|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902147|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
44902148|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902149|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902150|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
44902151|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902152|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694345|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44694346|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
44694347|NCT01379079|Calcium|calcium|mesh-list
44694348|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44694349|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694350|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44694351|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694352|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694353|NCT01379079|Analgesics|analgesics|mesh-ancestor
44694354|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
44694355|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694356|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694357|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694358|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44694359|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44694360|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694361|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694362|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694363|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694364|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
44694365|NCT01379144|Latanoprost|latanoprost|mesh-list
44694366|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44694367|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44694368|NCT01379157|Imipenem|imipenem|mesh-list
44694369|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694370|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694371|NCT01379196|Azithromycin|azithromycin|mesh-list
44694372|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694373|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702525|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702526|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
44702527|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
44702528|NCT01408979|Analgesics|analgesics|mesh-ancestor
44702529|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
44702530|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702531|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702532|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
44702533|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702534|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44702535|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
44702537|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702538|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702539|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44702540|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
44702541|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44702542|NCT01409005|Gemcitabine|gemcitabine|mesh-list
44902153|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44902154|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44902155|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44902156|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44902157|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44902158|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44902159|NCT04083807|Thrombin|thrombin|mesh-list
44902160|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
44902161|NCT04083807|Coagulants|coagulants|mesh-ancestor
44902162|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
44902163|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902164|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
44902165|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902166|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902167|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
44902168|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902169|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44902170|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902171|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902172|NCT04083651|Bromides|bromides|mesh-list
44902173|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
44902174|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
44902175|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44902176|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902177|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
44902178|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902179|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44902180|NCT04083417|Penicillins|penicillins|mesh-list
44902181|NCT04083417|Penicillin V|penicillin v|mesh-list
44902182|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902183|NCT04083664|Hepcidins|hepcidins|mesh-list
44902184|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902185|NCT04083625|Carbetocin|carbetocin|mesh-list
44902186|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
44902187|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902188|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902189|NCT04083105|Midazolam|midazolam|mesh-list
44902190|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
44902191|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902192|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902193|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902194|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902195|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44902196|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44902197|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902198|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902199|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
44902200|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
44902201|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
44902202|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
44902203|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902204|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902205|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44902206|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902207|NCT04083105|Analgesics|analgesics|mesh-ancestor
44902208|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
44902209|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902210|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
44902211|NCT04083209|Narcotics|narcotics|mesh-ancestor
44902212|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902213|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902214|NCT04083209|Analgesics|analgesics|mesh-ancestor
44902215|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
44902216|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902217|NCT04083066|Cytarabine|cytarabine|mesh-list
44902218|NCT04083066|Dexamethasone|dexamethasone|mesh-list
44902219|NCT04083066|Rituximab|rituximab|mesh-list
44902220|NCT04083066|Methotrexate|methotrexate|mesh-list
44902221|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44902222|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902223|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
44902224|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902225|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902226|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902227|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
44902228|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
44902229|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902230|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902231|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
44902232|NCT04083066|Hormones|hormones|mesh-ancestor
44902233|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902234|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902235|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44902236|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
44902237|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902238|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44902239|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
44902240|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902241|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
44902242|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902243|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44902244|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902245|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44902246|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
44902247|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902248|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44902249|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
44902250|NCT04082949|Coagulants|coagulants|mesh-ancestor
44902251|NCT04082962|Dexamethasone|dexamethasone|mesh-list
44902252|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902253|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
44902254|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
44902255|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902256|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902257|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902258|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
44902260|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902261|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902262|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902263|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44902264|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44902265|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902266|NCT04082715|Celecoxib|celecoxib|mesh-list
44902267|NCT04082715|Levodopa|levodopa|mesh-list
44902268|NCT04082715|Carbidopa|carbidopa|mesh-list
44902269|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44902270|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44902271|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902272|NCT04082715|Analgesics|analgesics|mesh-ancestor
44902273|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
44902274|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902275|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902276|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902277|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902278|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44902279|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44902280|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902281|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902282|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44902283|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44902284|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
44902285|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902286|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44902287|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44902288|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
44902289|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
44902290|NCT04082858|Midazolam|midazolam|mesh-list
44902291|NCT04082858|Ketamine|ketamine|mesh-list
44902292|NCT04082858|Analgesics|analgesics|mesh-ancestor
44902293|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
44902294|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902295|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902296|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44902297|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902298|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
44902299|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
44902300|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902301|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44902302|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44902303|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902304|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902305|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902306|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902307|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44902308|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44902309|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902310|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
44902311|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
44902312|NCT04082793|Diclofenac|diclofenac|mesh-list
44902313|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44902314|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902315|NCT04082793|Analgesics|analgesics|mesh-ancestor
44902316|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
44902317|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902318|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902319|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902320|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902321|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44902322|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902323|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902324|NCT04082598|Amoxicillin|amoxicillin|mesh-list
44902325|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
44902326|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
44902327|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44902328|NCT04082598|Lactoferrin|lactoferrin|mesh-list
44902329|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902330|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902331|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44902332|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694604|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694605|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44694606|NCT01380808|Capecitabine|capecitabine|mesh-list
44694607|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44694608|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
44694609|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694610|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694611|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44694612|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
44694613|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44694614|NCT01380912|Prednisolone|prednisolone|mesh-list
44694615|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
44694616|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44694617|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
44694618|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694619|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
44694620|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
44694621|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694622|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694623|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44694624|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
44694625|NCT01380912|Hormones|hormones|mesh-ancestor
44694626|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694627|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44694628|NCT01380912|Protective Agents|protective agents|mesh-ancestor
44694629|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44694630|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694631|NCT01380951|Telbivudine|telbivudine|mesh-list
44694632|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
44694633|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694634|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44694635|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694636|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702543|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44702544|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
44702545|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702546|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702547|NCT01409005|Antiviral Agents|antiviral agents|mesh-ancestor
44702548|NCT01409005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702549|NCT01409005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702550|NCT01409005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902360|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
44902361|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44902362|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902363|NCT04081909|Fentanyl|fentanyl|mesh-list
44902364|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
44902365|NCT04081909|Ketamine|ketamine|mesh-list
44902366|NCT04081909|Remifentanil|remifentanil|mesh-list
44902367|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902368|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902369|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902370|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902371|NCT04081909|Analgesics|analgesics|mesh-ancestor
44902372|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
44902373|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902374|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44902375|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44902376|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44902377|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
44902378|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902379|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902380|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44902381|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902382|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
44902383|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
44902384|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44902385|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44902386|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44902387|NCT04081909|Narcotics|narcotics|mesh-ancestor
44902388|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902389|NCT04081805|Estradiol|estradiol|mesh-list
44902390|NCT04081805|Estrogens|estrogens|mesh-ancestor
44902391|NCT04081805|Hormones|hormones|mesh-ancestor
44902392|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902393|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902395|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44902396|NCT04081376|Narcotics|narcotics|mesh-ancestor
44902397|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902398|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902399|NCT04081376|Analgesics|analgesics|mesh-ancestor
44902400|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
44902401|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902402|NCT04081480|Valacyclovir|valacyclovir|mesh-list
44902403|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
44902404|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902405|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
44902406|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44902407|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
44902408|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902409|NCT04081012|Expectorants|expectorants|mesh-ancestor
44902410|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
44902411|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44902412|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
44902413|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902414|NCT04081012|Protective Agents|protective agents|mesh-ancestor
44902415|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902416|NCT04081012|Antidotes|antidotes|mesh-ancestor
44902417|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
44902418|NCT04081077|Linezolid|linezolid|mesh-list
44902419|NCT04081077|Bedaquiline|bedaquiline|mesh-list
44902420|NCT04081077|Clofazimine|clofazimine|mesh-list
44902421|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902422|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902423|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44902424|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44902425|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902426|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902427|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902428|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44902429|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
44902430|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902431|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
44902432|NCT04080726|Esomeprazole|esomeprazole|mesh-list
44902433|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44902434|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902435|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44902436|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902437|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902438|NCT04080375|Dinoprostone|dinoprostone|mesh-list
44902439|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
44902440|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902441|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902442|NCT04080388|Diuretics|diuretics|mesh-list
44902443|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
44902444|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902445|NCT04080713|Budesonide|budesonide|mesh-list
44902446|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902447|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44902448|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
44902449|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902450|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902451|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44902452|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44902453|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
44902454|NCT04080713|Hormones|hormones|mesh-ancestor
44902455|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902456|NCT04080622|Selenium|selenium|mesh-list
44902457|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
44902458|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902459|NCT04080622|Protective Agents|protective agents|mesh-ancestor
44902460|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902461|NCT04080622|Trace Elements|trace elements|mesh-ancestor
44902462|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
44902463|NCT04080349|Misoprostol|misoprostol|mesh-list
44902464|NCT04080349|Dinoprostone|dinoprostone|mesh-list
44902465|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44902466|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
44902467|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902468|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902469|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44902503|NCT04079517|Tamoxifen|tamoxifen|mesh-list
44902504|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44902505|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
44902506|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902507|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902508|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902509|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902510|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44902511|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44902512|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44902513|NCT04079725|Mitomycins|mitomycins|mesh-list
44902514|NCT04079725|Mitomycin|mitomycin|mesh-list
44902515|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44902516|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902517|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
44902518|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902519|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44902520|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902521|NCT04079413|Insulin|insulin|mesh-list
44902522|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44902523|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
44902524|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
44902525|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44902526|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44902527|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902528|NCT04079426|Dimercaprol|dimercaprol|mesh-list
44902529|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
44902530|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
44902531|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902532|NCT04079231|Aflibercept|aflibercept|mesh-list
44902533|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44902534|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44902535|NCT04079231|Growth Substances|growth substances|mesh-ancestor
44902536|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902537|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
44902538|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902539|NCT04079374|Etanercept|etanercept|mesh-list
44902540|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44902541|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902542|NCT04079374|Analgesics|analgesics|mesh-ancestor
44902543|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
44902544|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902545|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902546|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902547|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902548|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902549|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902550|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
44902551|NCT04079088|Interferons|interferons|mesh-list
44902552|NCT04079088|Interferon-beta|interferon-beta|mesh-list
44902553|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
44902554|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
44902555|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
44902556|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902557|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
44902558|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902559|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
44902560|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902561|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44902562|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902563|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902564|NCT04079140|Dinoprostone|dinoprostone|mesh-list
44902565|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
44902566|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902567|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902568|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44902569|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44902570|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
44902571|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902572|NCT04078711|Losartan|losartan|mesh-list
44902573|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44902574|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44902575|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44902576|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44902577|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902579|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
44902580|NCT04078659|Fentanyl|fentanyl|mesh-list
44902581|NCT04078659|Propofol|propofol|mesh-list
44902582|NCT04078659|Atracurium|atracurium|mesh-list
44902583|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902584|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
44902585|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902586|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902587|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
44902588|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902589|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44902590|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44902591|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44902592|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902593|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902594|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902595|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902596|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
44902597|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44902598|NCT04078659|Narcotics|narcotics|mesh-ancestor
44902599|NCT04078659|Analgesics|analgesics|mesh-ancestor
44902600|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902601|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
44902602|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44902603|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44902604|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
44902605|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902606|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44902607|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44902608|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44902609|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44902610|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44902611|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44902612|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902613|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
44902614|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
44902615|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902616|NCT04078880|Protective Agents|protective agents|mesh-ancestor
44902617|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902618|NCT04078880|Vitamins|vitamins|mesh-ancestor
44902619|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
44902620|NCT04078399|Interferons|interferons|mesh-list
44902621|NCT04078399|Azacitidine|azacitidine|mesh-list
44902622|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902623|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
44902624|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902625|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44902626|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
44902627|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902628|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902629|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44902630|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
44902631|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902632|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902633|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44902634|NCT04078425|Diuretics|diuretics|mesh-ancestor
44902635|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
44902636|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44902637|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44902638|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44902639|NCT04078204|Protective Agents|protective agents|mesh-ancestor
44902640|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902641|NCT04078048|Vitamins|vitamins|mesh-list
44902642|NCT04078048|Ascorbic Acid|ascorbic acid|mesh-list
44902643|NCT04078048|Vitamin E|vitamin e|mesh-list
44902644|NCT04078048|Antioxidants|antioxidants|mesh-list
44902645|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
44902646|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902647|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902648|NCT04078048|Protective Agents|protective agents|mesh-ancestor
44902649|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44902650|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44902651|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44902652|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
44694864|NCT01381848|Doripenem|doripenem|mesh-list
44902653|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902654|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902655|NCT04077853|Progestins|progestins|mesh-ancestor
44902656|NCT04077853|Hormones|hormones|mesh-ancestor
44902657|NCT04077827|Propofol|propofol|mesh-list
44902658|NCT04077827|Desflurane|desflurane|mesh-list
44902659|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902660|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902661|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902662|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902663|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
44902664|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
44902665|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44902666|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
44902667|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
44902668|NCT04077957|Etanercept|etanercept|mesh-list
44902669|NCT04077957|Methotrexate|methotrexate|mesh-list
44902670|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44902671|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
44902672|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44902673|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902674|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44902675|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
44902676|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902677|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902678|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
44902679|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902680|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44902681|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44902682|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
44902683|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44902684|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44902685|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
44902686|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44902687|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44902688|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902689|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44902690|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902691|NCT04077957|Analgesics|analgesics|mesh-ancestor
44902692|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
44902693|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902694|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902695|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902696|NCT04077892|Budesonide|budesonide|mesh-list
44902697|NCT04077892|Montelukast|montelukast|mesh-list
44902698|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902699|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44902700|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
44902701|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902702|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902703|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44902704|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
44902705|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
44902706|NCT04077892|Hormones|hormones|mesh-ancestor
44902707|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902708|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44902709|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
44902710|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44902711|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44902712|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902713|NCT04077983|Gemcitabine|gemcitabine|mesh-list
44902714|NCT04077983|Paclitaxel|paclitaxel|mesh-list
44902715|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44902716|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902717|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44902718|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44902719|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44902720|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902721|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44694939|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694940|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44694941|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44902722|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
44902723|NCT04077983|Antiviral Agents|antiviral agents|mesh-ancestor
44902724|NCT04077983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902754|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902755|NCT04077736|Analgesics|analgesics|mesh-ancestor
44902756|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
44902757|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902758|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902759|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44902760|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44902761|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
44902762|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902763|NCT04077944|Trace Elements|trace elements|mesh-list
44902764|NCT04077944|Micronutrients|micronutrients|mesh-list
44902765|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902766|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44902767|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44902768|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
44902769|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44902770|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
44902771|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902772|NCT04077580|Methenamine|methenamine|mesh-list
44902773|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
44902774|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
44902775|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44902776|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902777|NCT04077580|Renal Agents|renal agents|mesh-ancestor
44902778|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902779|NCT04077684|Interleukin-2|interleukin-2|mesh-list
44902780|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902781|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902782|NCT04077684|Analgesics|analgesics|mesh-ancestor
44902783|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
44902784|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902785|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902786|NCT04077398|Ropivacaine|ropivacaine|mesh-list
44902787|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902788|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
44902789|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902790|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902791|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
44902792|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902793|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44902794|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44902795|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44902796|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902797|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44902798|NCT04076865|Lidocaine|lidocaine|mesh-list
44902799|NCT04076865|Histamine|histamine|mesh-list
44902800|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
44902801|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
44902802|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902803|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902804|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
44902805|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902806|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44902807|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44902808|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44902809|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902810|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902811|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
44902812|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
44902813|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902814|NCT04077255|Paclitaxel|paclitaxel|mesh-list
44902815|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44902816|NCT04077255|Antibodies|antibodies|mesh-list
44902817|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44902818|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902819|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
44902820|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
44902821|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
44902822|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902823|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
44902824|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902825|NCT04077125|Rifaximin|rifaximin|mesh-list
44902826|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902827|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902828|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902829|NCT04076436|Fosfomycin|fosfomycin|mesh-list
44902830|NCT04076436|Lactams|lactams|mesh-list
44902831|NCT04076436|beta-Lactams|beta-lactams|mesh-list
44902832|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902833|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902834|NCT04076709|Anesthetics|anesthetics|mesh-list
44902835|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902836|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902837|NCT04076826|Midazolam|midazolam|mesh-list
44902838|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
44902839|NCT04076826|Propofol|propofol|mesh-list
44902840|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44902841|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902842|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902843|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44902844|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
44902845|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
44902846|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44902847|NCT04076826|Analgesics|analgesics|mesh-ancestor
44902848|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
44902850|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44902851|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44902852|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44902853|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44902854|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902855|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902856|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44902857|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44902858|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44902859|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902860|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
44902861|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
44902862|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44902863|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44902864|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902865|NCT04076371|Olanzapine|olanzapine|mesh-list
44902866|NCT04076371|Risperidone|risperidone|mesh-list
44902867|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44902868|NCT04076371|Ziprasidone|ziprasidone|mesh-list
44902869|NCT04076371|Sertraline|sertraline|mesh-list
44902870|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44902871|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
44902872|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902873|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902874|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902875|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44902876|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44902877|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902878|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902879|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44902880|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
44902881|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
44902882|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
44902883|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902884|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902885|NCT04076371|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44902886|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44902887|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902888|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
44902889|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44902890|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44902891|NCT04076098|Minocycline|minocycline|mesh-list
44902892|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44902893|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902894|NCT04076137|Decitabine|decitabine|mesh-list
44902895|NCT04076137|Antibodies|antibodies|mesh-list
44902896|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44902897|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
44902898|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902899|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44902900|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
44902901|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902902|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902903|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44902904|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
44902905|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44902906|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902907|NCT04075955|Olanzapine|olanzapine|mesh-list
44902908|NCT04075955|Aprepitant|aprepitant|mesh-list
44902909|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
44902910|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
44902911|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902912|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902913|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902914|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44902915|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44902916|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902917|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44902918|NCT04075955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44902919|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44902920|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44902921|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902922|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902923|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
44902953|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44902954|NCT04075227|Dexamethasone|dexamethasone|mesh-list
44902955|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44902956|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
44902957|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
44902958|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902959|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902960|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44902961|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
44902962|NCT04075227|Hormones|hormones|mesh-ancestor
44902963|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44902964|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44902965|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902966|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44902967|NCT04075006|Ketamine|ketamine|mesh-list
44902968|NCT04075006|Analgesics|analgesics|mesh-ancestor
44902969|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
44902970|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44902971|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902972|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44902973|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44685042|NCT02849171|Choline|choline|mesh-list
44902974|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
44902975|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
44902976|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44902977|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44902978|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44902979|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44902980|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44902981|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
44902982|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44902983|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44902984|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
44902985|NCT04075188|Aflibercept|aflibercept|mesh-list
44902986|NCT04075188|Verteporfin|verteporfin|mesh-list
44902987|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44902988|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44902989|NCT04075188|Growth Substances|growth substances|mesh-ancestor
44902990|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902991|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44902992|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44902993|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44902994|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44902995|NCT04075201|Vaccines|vaccines|mesh-list
44902996|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
44902997|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44902998|NCT04074473|Propranolol|propranolol|mesh-list
44902999|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44903000|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44903001|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903002|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903003|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903004|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903005|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44903006|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44903007|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
44903008|NCT04074551|Losartan|losartan|mesh-list
44903009|NCT04074551|Amlodipine|amlodipine|mesh-list
44903010|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44903011|NCT04074551|Ezetimibe|ezetimibe|mesh-list
44903012|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44903013|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44903014|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44903015|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903016|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44903017|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903018|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44903019|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44903020|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44903021|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
44903022|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44903023|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44903024|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903025|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44903026|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44903027|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44903028|NCT04074421|Rifaximin|rifaximin|mesh-list
44903029|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903030|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903031|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903032|NCT04074213|Clozapine|clozapine|mesh-list
44903033|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44903034|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
44903035|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903036|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903037|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903038|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44903039|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44903040|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903041|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44903042|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
44903043|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
44903044|NCT04073953|Primaquine|primaquine|mesh-list
44903045|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
44903046|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44903047|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44903048|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903049|NCT04074317|Insulin|insulin|mesh-list
44903050|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44903051|NCT04074317|Pramlintide|pramlintide|mesh-list
44695395|NCT01385891|Etoposide|etoposide|mesh-list
44695396|NCT01385891|Clofarabine|clofarabine|mesh-list
44695397|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44695398|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695399|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44695400|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695401|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695402|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695403|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695404|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
44695405|NCT01385956|Gemcitabine|gemcitabine|mesh-list
44695406|NCT01385956|Pasireotide|pasireotide|mesh-list
44695407|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695408|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
44695409|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695410|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695411|NCT01385956|Antiviral Agents|antiviral agents|mesh-ancestor
44695412|NCT01385956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695413|NCT01385956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695414|NCT01385956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695415|NCT01385956|Immunologic Factors|immunologic factors|mesh-ancestor
44695416|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695417|NCT01385956|Hormones|hormones|mesh-ancestor
44695418|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695419|NCT01386086|Aripiprazole|aripiprazole|mesh-list
44695420|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
44695421|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44695422|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44695423|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44695424|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44695425|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695426|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
44903052|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44903053|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903054|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
44903055|NCT04073849|Hematinics|hematinics|mesh-ancestor
44903056|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
44903057|NCT04073758|Remifentanil|remifentanil|mesh-list
44903058|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44903059|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903060|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903061|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44903062|NCT04073758|Analgesics|analgesics|mesh-ancestor
44903063|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
44903064|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903065|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44903066|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44903067|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44903068|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903069|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903070|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903071|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44903072|NCT04073758|Narcotics|narcotics|mesh-ancestor
44903073|NCT04073550|Topotecan|topotecan|mesh-list
44903074|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44903075|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903076|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903077|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903078|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903079|NCT04073537|Paclitaxel|paclitaxel|mesh-list
44903080|NCT04073537|Carboplatin|carboplatin|mesh-list
44903081|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903082|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903083|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903084|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903085|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903086|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903088|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903089|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903090|NCT04073602|Trastuzumab|trastuzumab|mesh-list
44903091|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903092|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903093|NCT04073680|Canagliflozin|canagliflozin|mesh-list
44903094|NCT04073680|Serabelisib|serabelisib|mesh-list
44903095|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44903096|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903097|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44903098|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903099|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903100|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
44903101|NCT04073173|Analgesics|analgesics|mesh-list
44903102|NCT04073173|Narcotics|narcotics|mesh-ancestor
44903103|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903104|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903105|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
44903106|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903107|NCT04073160|Durvalumab|durvalumab|mesh-list
44903108|NCT04073160|Tremelimumab|tremelimumab|mesh-list
44903109|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903110|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903111|NCT04073134|Evolocumab|evolocumab|mesh-list
44903112|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44903113|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44903114|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
44903115|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903116|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44903117|NCT04074122|Adenosine|adenosine|mesh-list
44903118|NCT04074122|Isoproterenol|isoproterenol|mesh-list
44903119|NCT04074122|Epinephrine|epinephrine|mesh-list
44903120|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44903121|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44903122|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903123|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903124|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903125|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903126|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44903127|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44903128|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
44903129|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903130|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44903131|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
44903132|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
44903133|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
44903134|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44903135|NCT04074122|Analgesics|analgesics|mesh-ancestor
44903136|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
44903137|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44903138|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
44903139|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44903140|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
44903141|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
44903142|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44903143|NCT04074122|Protective Agents|protective agents|mesh-ancestor
44903144|NCT04073927|Butyric Acid|butyric acid|mesh-list
44903145|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
44903146|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
44903147|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903148|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903149|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903150|NCT04072640|Voriconazole|voriconazole|mesh-list
44903151|NCT04072640|Amphotericin B|amphotericin b|mesh-list
44903152|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44903153|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44903154|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
44903155|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
44903156|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903157|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44903158|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44903159|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903160|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903198|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44903199|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
44903201|NCT04072068|Edoxaban|edoxaban|mesh-list
44903202|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44903203|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
44903204|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44903205|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
44903206|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903207|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903208|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
44903209|NCT04072198|Leucovorin|leucovorin|mesh-list
44903210|NCT04072198|Bevacizumab|bevacizumab|mesh-list
44903211|NCT04072198|Nivolumab|nivolumab|mesh-list
44903212|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
44903213|NCT04072198|Irinotecan|irinotecan|mesh-list
44903214|NCT04072198|Fluorouracil|fluorouracil|mesh-list
44903215|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903216|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903217|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903218|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903219|NCT04072198|Growth Substances|growth substances|mesh-ancestor
44903220|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903221|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903222|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44903223|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903224|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44903225|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903226|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903227|NCT04072198|Antidotes|antidotes|mesh-ancestor
44903228|NCT04072198|Protective Agents|protective agents|mesh-ancestor
44903229|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
44903230|NCT04072198|Vitamins|vitamins|mesh-ancestor
44903231|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
44903232|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
44903233|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44903234|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44903235|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
44903236|NCT04072328|Midazolam|midazolam|mesh-list
44903237|NCT04072328|Propofol|propofol|mesh-list
44903238|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44903239|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903240|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903241|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44903242|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
44903243|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
44903244|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44903245|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44903246|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44903247|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44903248|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
44903249|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
44903250|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903251|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903252|NCT04071639|Ubiquinone|ubiquinone|mesh-list
44903253|NCT04071639|Haloperidol|haloperidol|mesh-list
44903254|NCT04071639|Risperidone|risperidone|mesh-list
44903255|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
44903256|NCT04071639|Sertraline|sertraline|mesh-list
44903257|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
44903258|NCT04071639|Idebenone|idebenone|mesh-list
44903259|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44903260|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
44903261|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903262|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903263|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903264|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44903265|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44903266|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903267|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44903268|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44903269|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
44695588|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44903270|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
44903271|NCT04071639|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44903272|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44903273|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44903274|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
44903275|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
44903276|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903277|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903278|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44903279|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
44903280|NCT04071639|Protective Agents|protective agents|mesh-ancestor
44903281|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
44903282|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44903283|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903284|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44903285|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44903286|NCT04071574|Cetrorelix|cetrorelix|mesh-list
44903287|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44903288|NCT04071574|Hormones|hormones|mesh-ancestor
44903289|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903290|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903291|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
44903292|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44903293|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
44903294|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44903295|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44903296|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903297|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903298|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44903299|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
44903300|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
44903301|NCT04071262|Prednisolone|prednisolone|mesh-list
44903302|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
44903303|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903304|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
44903305|NCT04071262|Hormones|hormones|mesh-ancestor
44903306|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903307|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903308|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903309|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903310|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44903311|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903312|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903313|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
44903314|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44903315|NCT04071353|Interferons|interferons|mesh-list
44903316|NCT04071353|Ribavirin|ribavirin|mesh-list
44903317|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903318|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
44903319|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903320|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
44903321|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903322|NCT04071106|Betamethasone|betamethasone|mesh-list
44903323|NCT04071106|Calcipotriene|calcipotriene|mesh-list
44903324|NCT04071106|Petrolatum|petrolatum|mesh-list
44903325|NCT04071106|Turmeric extract|turmeric extract|mesh-list
44903326|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903327|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
44903328|NCT04071106|Hormones|hormones|mesh-ancestor
44903329|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903330|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903331|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44903332|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44903333|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44903334|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
44903335|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903336|NCT04071106|Protective Agents|protective agents|mesh-ancestor
44903337|NCT04071106|Emollients|emollients|mesh-ancestor
44903338|NCT04070742|Minocycline|minocycline|mesh-list
44903339|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903340|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903341|NCT04070755|Minocycline|minocycline|mesh-list
44903342|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903343|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903344|NCT04070794|Metformin|metformin|mesh-list
44903345|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44903346|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903347|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
44903348|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44903349|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
44903350|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44903351|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
44903352|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903353|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
44903354|NCT04070729|Protective Agents|protective agents|mesh-ancestor
44903355|NCT04070495|Clarithromycin|clarithromycin|mesh-list
44695733|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44695735|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695736|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695737|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
44695738|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44695739|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
44695740|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695741|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
44695742|NCT01387620|Protective Agents|protective agents|mesh-ancestor
44695743|NCT01387880|Everolimus|everolimus|mesh-list
44695744|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695745|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695746|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
44695747|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702551|NCT01409005|Immunologic Factors|immunologic factors|mesh-ancestor
44702552|NCT01409005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702553|NCT01409018|Itraconazole|itraconazole|mesh-list
44702554|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44702555|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
44702556|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702557|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44702558|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44702559|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702560|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702561|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44702562|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
44702563|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702564|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702565|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44685184|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702566|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44702567|NCT01409148|Antibodies|antibodies|mesh-list
44702568|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44702569|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
44702570|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702571|NCT01409174|Interferons|interferons|mesh-list
44702572|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
44702573|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
44702574|NCT01409174|Aldesleukin|aldesleukin|mesh-list
44702575|NCT01409174|Cisplatin|cisplatin|mesh-list
44702576|NCT01409174|Temozolomide|temozolomide|mesh-list
44702577|NCT01409174|Ipilimumab|ipilimumab|mesh-list
44702578|NCT01409174|Interleukin-2|interleukin-2|mesh-list
44702579|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702580|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
44702581|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702582|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44702583|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
44702584|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702585|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702586|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44702587|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
44702588|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702589|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702590|NCT01409174|Analgesics|analgesics|mesh-ancestor
44702591|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
44702592|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702593|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44702594|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44702595|NCT01409187|Interferons|interferons|mesh-list
44903356|NCT04070495|Rifampin|rifampin|mesh-list
44903357|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903358|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903359|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44903360|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903361|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903362|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44903363|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44903364|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44903365|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
44903366|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
44903367|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44903368|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44903394|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
44903395|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903396|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44903397|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44903398|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903399|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903400|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44903401|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44903402|NCT04070001|Ibuprofen|ibuprofen|mesh-list
44903403|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44903404|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44903405|NCT04070001|Analgesics|analgesics|mesh-ancestor
44903406|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
44903407|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903408|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903409|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903410|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44903411|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44903412|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903413|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903414|NCT04069949|Sorafenib|sorafenib|mesh-list
44903415|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903416|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44903417|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903418|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695748|NCT01387906|Bimatoprost|bimatoprost|mesh-list
44903420|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44903421|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44903422|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903423|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44903424|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903425|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903426|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903427|NCT04069858|Entecavir|entecavir|mesh-list
44903428|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
44903429|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903430|NCT04069234|Clopidogrel|clopidogrel|mesh-list
44903431|NCT04069234|Ticagrelor|ticagrelor|mesh-list
44903432|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44903433|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44903434|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44903435|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44903436|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
44903437|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903438|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903439|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903440|NCT04069169|Lidocaine|lidocaine|mesh-list
44903441|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
44903442|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
44903443|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903444|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903445|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
44903446|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903447|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44903448|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44903449|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44903450|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44903451|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903452|NCT04069208|Cytarabine|cytarabine|mesh-list
44903453|NCT04069208|Idarubicin|idarubicin|mesh-list
44903454|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44903455|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
44903456|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903457|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903458|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
44903459|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903460|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44903461|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
44903462|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903463|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44903464|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44903465|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903466|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903467|NCT04069325|Febuxostat|febuxostat|mesh-list
44903468|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
44903469|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44903470|NCT04069429|Heparin|heparin|mesh-list
44903471|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
44903472|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44903473|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44903474|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903475|NCT04069286|Amoxicillin|amoxicillin|mesh-list
44903476|NCT04069286|Omeprazole|omeprazole|mesh-list
44903477|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903478|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903479|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44903480|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903481|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44903482|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903483|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903484|NCT04069078|Scopolamine|scopolamine|mesh-list
44903485|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44903486|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44903487|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
44903488|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
44903489|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903490|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903491|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903492|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
44903493|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44903494|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
44903495|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903496|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903497|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44903498|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
44903499|NCT04069065|Tacrolimus|tacrolimus|mesh-list
44903500|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44903501|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
44903502|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903503|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44903504|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903505|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903506|NCT04068766|Bupivacaine|bupivacaine|mesh-list
44903507|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
44903508|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
44903509|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903510|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903511|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
44903512|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903513|NCT04068974|Apatinib|apatinib|mesh-list
44903514|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903515|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44903516|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903517|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903518|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
44903519|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44903520|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903521|NCT04068506|Gabapentin|gabapentin|mesh-list
44903522|NCT04068506|Analgesics|analgesics|mesh-ancestor
44903523|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
44903524|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903525|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903526|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
44903527|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44903528|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44903529|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903530|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44903531|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44903532|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44903533|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903534|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903535|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
44903536|NCT04068207|Minocycline|minocycline|mesh-list
44903537|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903538|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903539|NCT04067986|Apatinib|apatinib|mesh-list
44903540|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903541|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44903542|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903543|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903544|NCT04067791|Melatonin|melatonin|mesh-list
44903545|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
44903546|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903547|NCT04067791|Protective Agents|protective agents|mesh-ancestor
44903548|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903549|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903550|NCT04067817|Phenylephrine|phenylephrine|mesh-list
44903551|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
44903552|NCT04067817|Norepinephrine|norepinephrine|mesh-list
44903553|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44903554|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44903555|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
44903556|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
44903557|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903558|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903559|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
44903560|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
44903561|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
44903562|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44903563|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44903564|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44903565|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903566|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903567|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903568|NCT04067817|Protective Agents|protective agents|mesh-ancestor
44903607|NCT04067024|Anesthetics|anesthetics|mesh-list
44903608|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903609|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903610|NCT04067102|Paclitaxel|paclitaxel|mesh-list
44903611|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44903612|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
44903613|NCT04067102|Carboplatin|carboplatin|mesh-list
44903614|NCT04067102|Epirubicin|epirubicin|mesh-list
44903615|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903616|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903617|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903618|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903619|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903620|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903621|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44903622|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
44903623|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903624|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44903625|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44903626|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
44903627|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44903628|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44903629|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44903630|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903631|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903632|NCT04067037|Vincristine|vincristine|mesh-list
44696047|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44696048|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
44696049|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
44696050|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696051|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44696052|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44696053|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696054|NCT01389440|Gemcitabine|gemcitabine|mesh-list
44696055|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44696056|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696057|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
44696058|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696059|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696060|NCT01389440|Antiviral Agents|antiviral agents|mesh-ancestor
44696061|NCT01389440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696062|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685280|NCT02352753|Denosumab|denosumab|mesh-list
44685281|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44685282|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685283|NCT02339090|Hormones|hormones|mesh-list
44685284|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685285|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685286|NCT02332850|Dexamethasone|dexamethasone|mesh-list
44685287|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685288|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
44685289|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
44685290|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685291|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685292|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44685293|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
44696063|NCT01389440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696064|NCT01389440|Immunologic Factors|immunologic factors|mesh-ancestor
44696065|NCT01389440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696066|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44696067|NCT01389505|Bevacizumab|bevacizumab|mesh-list
44696068|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696069|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696070|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903633|NCT04067037|Epirubicin|epirubicin|mesh-list
44903634|NCT04067037|Dacarbazine|dacarbazine|mesh-list
44903635|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903636|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903637|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903638|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903639|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903640|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903641|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44903642|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44903643|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44903644|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903645|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44903646|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
44903647|NCT04066803|Folic Acid|folic acid|mesh-list
44903648|NCT04066803|Hematinics|hematinics|mesh-ancestor
44903649|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
44903650|NCT04066803|Vitamins|vitamins|mesh-ancestor
44903651|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
44903652|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903653|NCT04066790|Paclitaxel|paclitaxel|mesh-list
44903654|NCT04066790|Trastuzumab|trastuzumab|mesh-list
44903655|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903656|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903657|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903658|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903659|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903660|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903661|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903663|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
44903664|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903665|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
44903666|NCT04066621|Sulbactam|sulbactam|mesh-list
44903667|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903668|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903669|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44903670|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903671|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903672|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
44903673|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44903674|NCT04066452|Antibodies|antibodies|mesh-list
44903675|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
44903676|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903677|NCT04066179|Prednisolone|prednisolone|mesh-list
44903678|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903679|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
44903680|NCT04066179|Hormones|hormones|mesh-ancestor
44903681|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903682|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903683|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903684|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903685|NCT04066296|Bupivacaine|bupivacaine|mesh-list
44903686|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
44903687|NCT04066296|Anesthetics|anesthetics|mesh-list
44903688|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903689|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903690|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
44903691|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903692|NCT04066257|Metronidazole|metronidazole|mesh-list
44903693|NCT04066257|Tetracycline|tetracycline|mesh-list
44903694|NCT04066257|Bismuth|bismuth|mesh-list
44903695|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903696|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903697|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44903698|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44903699|NCT04066257|Antacids|antacids|mesh-ancestor
44903700|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903701|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903702|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44903703|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903704|NCT04066231|Erythromycin|erythromycin|mesh-list
44903705|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
44903706|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44903707|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
44903708|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
44903709|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903710|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903711|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903712|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44903713|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903714|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903715|NCT04066660|Fucoidan|fucoidan|mesh-list
44903716|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44903717|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903718|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
44903719|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903720|NCT04066088|Guanfacine|guanfacine|mesh-list
44903721|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44903722|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44903723|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44903724|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44903725|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903726|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903727|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903728|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903729|NCT04065906|Methylphenidate|methylphenidate|mesh-list
44903730|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44903731|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44903732|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903733|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44903734|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44903735|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44903736|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903737|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
44903738|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903739|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44903740|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903741|NCT04065919|Epinephrine|epinephrine|mesh-list
44903742|NCT04065919|Bupivacaine|bupivacaine|mesh-list
44903743|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
44903744|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
44903745|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903746|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903747|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
44903748|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903749|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44903750|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44903751|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44903752|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903753|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903754|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44903755|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44903756|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
44903757|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44903758|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
44903759|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
44903760|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
44903761|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44903762|NCT04065932|BMS-986165|bms-986165|mesh-list
44903763|NCT04065932|Famotidine|famotidine|mesh-list
44903764|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44903765|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903766|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44903767|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
44903768|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
44903769|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903770|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903771|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903772|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
44903773|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44903774|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903775|NCT04065529|Zinc|zinc|mesh-list
44903776|NCT04065529|Trace Elements|trace elements|mesh-ancestor
44903777|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
44903778|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903779|NCT04065581|Metformin|metformin|mesh-list
44903780|NCT04065581|Acarbose|acarbose|mesh-list
44903781|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44903782|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903783|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44903784|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903785|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903786|NCT04065230|Tenofovir|tenofovir|mesh-list
44903787|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
44903788|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903789|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44903790|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44903791|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903792|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903793|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44903794|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44903795|NCT04065165|Lanreotide|lanreotide|mesh-list
44903796|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903797|NCT04065308|Daratumumab|daratumumab|mesh-list
44903798|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903799|NCT04065282|Capecitabine|capecitabine|mesh-list
44903800|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
44903801|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44903802|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
44903803|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903804|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903805|NCT04065269|Olaparib|olaparib|mesh-list
44903806|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44903807|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903808|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903809|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903841|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44903842|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903843|NCT04064125|Minocycline|minocycline|mesh-list
44903844|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903845|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903846|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
44903847|NCT04063839|Grazoprevir|grazoprevir|mesh-list
44903848|NCT04063839|Ledipasvir|ledipasvir|mesh-list
44903849|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44903850|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
44903851|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903852|NCT04064138|Anesthetics|anesthetics|mesh-list
44903853|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903854|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903855|NCT04064073|Metformin|metformin|mesh-list
44903856|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44903857|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903858|NCT04063904|Misoprostol|misoprostol|mesh-list
44685304|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685305|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685306|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
44685307|NCT02288247|Hormones|hormones|mesh-ancestor
44685308|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685309|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685310|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685311|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
44685312|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44685313|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
44685314|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903859|NCT04063904|Mifepristone|mifepristone|mesh-list
44903860|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44903861|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
44903862|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44903863|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903864|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44903865|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903866|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
44903867|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44903868|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44903869|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44903870|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44903871|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
44903872|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44903873|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44903874|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44903875|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903876|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
44903877|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44903878|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44903879|NCT04063865|Everolimus|everolimus|mesh-list
44903880|NCT04063865|Tacrolimus|tacrolimus|mesh-list
44903881|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44903882|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
44903883|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903884|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44903885|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903886|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903887|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903888|NCT04063683|Paclitaxel|paclitaxel|mesh-list
44903889|NCT04063683|Cisplatin|cisplatin|mesh-list
44903890|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903891|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903892|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903893|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903894|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903895|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903896|NCT04063527|Paclitaxel|paclitaxel|mesh-list
44903897|NCT04063527|Carboplatin|carboplatin|mesh-list
44903898|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44903899|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903900|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44903901|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44903902|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44903903|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903904|NCT04063540|Amiloride|amiloride|mesh-list
44903905|NCT04063540|Diuretics|diuretics|mesh-ancestor
44903906|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
44903907|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903908|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44903909|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44903910|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44903911|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903912|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44696324|NCT01390935|Diuretics|diuretics|mesh-ancestor
44903913|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44696395|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696396|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
44696397|NCT01391377|Vitamins|vitamins|mesh-ancestor
44696398|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
44696399|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696400|NCT01391390|Melatonin|melatonin|mesh-list
44696401|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
44696402|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696403|NCT01391390|Protective Agents|protective agents|mesh-ancestor
44696404|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696405|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696406|NCT01391403|Artemisinins|artemisinins|mesh-list
44696407|NCT01391403|Artemisinin|artemisinin|mesh-list
44696408|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
44696409|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44696410|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44696411|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702596|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
44702597|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
44702598|NCT01409187|Aldesleukin|aldesleukin|mesh-list
44702599|NCT01409187|Ipilimumab|ipilimumab|mesh-list
44702600|NCT01409187|Interleukin-2|interleukin-2|mesh-list
44702601|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702602|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
44702603|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702604|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44702605|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44702606|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702607|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
44702608|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702609|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702643|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702644|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
44702645|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44702646|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44702647|NCT01409499|Sorafenib|sorafenib|mesh-list
44702648|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702649|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702650|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702651|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253962|NCT03823768|Tacrolimus|tacrolimus|mesh-list
44702652|NCT01409603|Naproxen|naproxen|mesh-list
44702653|NCT01409603|Darexaban|darexaban|mesh-list
44702654|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44702655|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702656|NCT01409603|Analgesics|analgesics|mesh-ancestor
44702657|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
44702658|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702659|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702660|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702661|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702662|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
44702663|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44702664|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702665|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702666|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44702667|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
44702668|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702669|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702670|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
44702671|NCT01409616|Aspirin|aspirin|mesh-list
44903914|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44903915|NCT04063449|Endostar protein|endostar protein|mesh-list
44903916|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903917|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903918|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903919|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903920|NCT04063449|Growth Substances|growth substances|mesh-ancestor
44903921|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903922|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903923|NCT04063358|Ranibizumab|ranibizumab|mesh-list
44903924|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903925|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903926|NCT04063358|Growth Substances|growth substances|mesh-ancestor
44903927|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903928|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903929|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903931|NCT04063189|Dexamethasone|dexamethasone|mesh-list
44903932|NCT04063189|Lenalidomide|lenalidomide|mesh-list
44903933|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903934|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
44903935|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
44903936|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903937|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903938|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44903939|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
44903940|NCT04063189|Hormones|hormones|mesh-ancestor
44903941|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44903942|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44903943|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903944|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
44903945|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903946|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903947|NCT04063189|Growth Substances|growth substances|mesh-ancestor
44903948|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903949|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903950|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903951|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44903952|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903953|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903954|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44903955|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44903956|NCT04063046|Anesthetics|anesthetics|mesh-list
44903957|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44903958|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903959|NCT04062760|Diuretics|diuretics|mesh-list
44903960|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
44903961|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903962|NCT04062890|Vigabatrin|vigabatrin|mesh-list
44903963|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
44903964|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903965|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903966|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
44903967|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44903968|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903969|NCT04062175|Azithromycin|azithromycin|mesh-list
44903970|NCT04062175|Cephalosporins|cephalosporins|mesh-list
44903971|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44903972|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44903973|NCT04062591|Piroxicam|piroxicam|mesh-list
44903974|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44903975|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44903976|NCT04062591|Analgesics|analgesics|mesh-ancestor
44903977|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
44903978|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44903979|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903980|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44903981|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44903982|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44903983|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44903984|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903985|NCT04062565|Treprostinil|treprostinil|mesh-list
44903986|NCT04062565|Riociguat|riociguat|mesh-list
44903987|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44903988|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
44903989|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44903990|NCT04062370|Ranibizumab|ranibizumab|mesh-list
44903991|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44903992|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44903993|NCT04062370|Growth Substances|growth substances|mesh-ancestor
44903994|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44903995|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44903996|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44903997|NCT04062357|Lidocaine|lidocaine|mesh-list
44903998|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
44903999|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
44904000|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904001|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904002|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
44904003|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904032|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904033|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
44904034|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904035|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904036|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44904037|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
44904038|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904039|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904040|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44904041|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904042|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
44904043|NCT04061772|Hormones|hormones|mesh-ancestor
44904044|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904045|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904046|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904047|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44904048|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44904049|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904050|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44904051|NCT04062019|Aldesleukin|aldesleukin|mesh-list
44904052|NCT04062019|Interleukin-2|interleukin-2|mesh-list
44904053|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904054|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904055|NCT04062019|Analgesics|analgesics|mesh-ancestor
44904056|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
44904057|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904058|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904059|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44904060|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44904061|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
44904062|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904063|NCT04062045|Ropivacaine|ropivacaine|mesh-list
44904064|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904065|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
44904066|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904067|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904068|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
44904069|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904070|NCT04061863|Nivolumab|nivolumab|mesh-list
44904071|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904072|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904073|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44904074|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904075|NCT04062006|Aldesleukin|aldesleukin|mesh-list
44904076|NCT04062006|Interleukin-2|interleukin-2|mesh-list
44904077|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904078|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904079|NCT04062006|Analgesics|analgesics|mesh-ancestor
44904080|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
44904081|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904082|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904083|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44685332|NCT02177695|Gemcitabine|gemcitabine|mesh-list
44685333|NCT02177695|Cisplatin|cisplatin|mesh-list
44685334|NCT02177695|Doxorubicin|doxorubicin|mesh-list
44685335|NCT02177695|Methotrexate|methotrexate|mesh-list
44685336|NCT02177695|Vinblastine|vinblastine|mesh-list
44685337|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904084|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44904085|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
44904086|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904087|NCT04061512|Dexamethasone|dexamethasone|mesh-list
44904088|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
44904089|NCT04061512|Rituximab|rituximab|mesh-list
44904090|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904091|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
44904092|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904093|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904094|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44904095|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
44904096|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904097|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904098|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44904099|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904100|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904101|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
44904102|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
44904103|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904104|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44904105|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
44904106|NCT04061512|Hormones|hormones|mesh-ancestor
44904107|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904108|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904109|NCT04061655|Iron|iron|mesh-list
44904110|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44904111|NCT04061655|Trace Elements|trace elements|mesh-ancestor
44904112|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
44904113|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904114|NCT04061655|Hematinics|hematinics|mesh-ancestor
44904115|NCT04061447|Clarithromycin|clarithromycin|mesh-list
44904116|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44904117|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904118|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44904119|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904120|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904121|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44904122|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44904123|NCT04061265|Lidocaine|lidocaine|mesh-list
44904124|NCT04061265|Epinephrine|epinephrine|mesh-list
44904125|NCT04061265|Carticaine|carticaine|mesh-list
44904126|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
44696559|NCT01392716|Rituximab|rituximab|mesh-list
44904127|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
44904128|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904129|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904130|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
44904131|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904132|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904133|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904134|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904135|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904136|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904137|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904138|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904139|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904140|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904141|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44904142|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44904143|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
44904144|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44904145|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
44904146|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
44904147|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
44904148|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44904149|NCT04061538|Zinc|zinc|mesh-list
44904150|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
44904151|NCT04061538|Trace Elements|trace elements|mesh-ancestor
44904152|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
44904153|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904154|NCT04061538|Astringents|astringents|mesh-ancestor
44904155|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44904156|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44904157|NCT04061473|Empagliflozin|empagliflozin|mesh-list
44904158|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904159|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904160|NCT04061473|Incretins|incretins|mesh-ancestor
44904161|NCT04061473|Hormones|hormones|mesh-ancestor
44904162|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904163|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44904164|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904165|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904166|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904167|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44696635|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44696636|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696637|NCT01392898|Incretins|incretins|mesh-ancestor
44696638|NCT01392898|Hormones|hormones|mesh-ancestor
44696639|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696640|NCT01392911|Rifampin|rifampin|mesh-list
44696641|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44696642|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
44696643|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44696644|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696645|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
44696646|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44696647|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696648|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696649|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44696650|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44904168|NCT04061200|Empagliflozin|empagliflozin|mesh-list
44904169|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44904170|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904171|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904172|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904173|NCT04060888|Ustekinumab|ustekinumab|mesh-list
44904174|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44904175|NCT04061057|Lidocaine|lidocaine|mesh-list
44904176|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904177|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
44904178|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904179|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904180|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
44904181|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904182|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904183|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904184|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904185|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904186|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904188|NCT04060914|Ticagrelor|ticagrelor|mesh-list
44904189|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44904190|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44904191|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44904192|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44904193|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
44904194|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904195|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904196|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904197|NCT04060771|Dexamethasone|dexamethasone|mesh-list
44904198|NCT04060771|Palonosetron|palonosetron|mesh-list
44904199|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904200|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
44904201|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
44904202|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904203|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904204|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44904205|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
44904206|NCT04060771|Hormones|hormones|mesh-ancestor
44904207|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904208|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904209|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904210|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44904211|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44904212|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
44904213|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904214|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904215|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
44904216|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44904217|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
44904218|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904219|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904220|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44904221|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44904222|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44904223|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
44904224|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904225|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904226|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44904227|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
44904228|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
44904229|NCT04060979|Protective Agents|protective agents|mesh-ancestor
44904230|NCT04060836|Factor VIII|factor viii|mesh-list
44904231|NCT04060836|Coagulants|coagulants|mesh-ancestor
44904232|NCT04060719|Rifampin|rifampin|mesh-list
44904233|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44904234|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
44904235|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44904236|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904237|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
44904238|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44904239|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904240|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904241|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44685374|NCT02152995|Iodine|iodine|mesh-list
44904242|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44904243|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44904244|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44904245|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44904246|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44904247|NCT04060381|Ibuprofen|ibuprofen|mesh-list
44904248|NCT04060381|Dopamine|dopamine|mesh-list
44904249|NCT04060381|Epinephrine|epinephrine|mesh-list
44904250|NCT04060381|Norepinephrine|norepinephrine|mesh-list
44904251|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44904252|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904253|NCT04060381|Analgesics|analgesics|mesh-ancestor
44904254|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
44904255|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904256|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904263|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904264|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904265|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904266|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44904267|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44904269|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44904270|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
44904271|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
44904272|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
44904273|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44904274|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44904275|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
44904276|NCT04060381|Protective Agents|protective agents|mesh-ancestor
44904277|NCT04060472|Paclitaxel|paclitaxel|mesh-list
44904278|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
44904279|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44904280|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904281|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904282|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904283|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904284|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904285|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904286|NCT04060459|Paclitaxel|paclitaxel|mesh-list
44904287|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904288|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904289|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904290|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904291|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904292|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904293|NCT04060407|Nivolumab|nivolumab|mesh-list
44904294|NCT04060407|Ipilimumab|ipilimumab|mesh-list
44904295|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904296|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904297|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44904298|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904299|NCT04060264|Eculizumab|eculizumab|mesh-list
44904300|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44904301|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904302|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
44904303|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904304|NCT04060550|Omalizumab|omalizumab|mesh-list
44904305|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44904306|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44904307|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44904308|NCT04060043|Goserelin|goserelin|mesh-list
44904309|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904310|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904311|NCT04060095|Anesthetics|anesthetics|mesh-list
44904312|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904313|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904314|NCT04059224|Trametinib|trametinib|mesh-list
44904315|NCT04059224|Dabrafenib|dabrafenib|mesh-list
44904316|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904317|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44904318|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904319|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904320|NCT04058522|Triamcinolone|triamcinolone|mesh-list
44904321|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904322|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
44904323|NCT04058522|Hormones|hormones|mesh-ancestor
44904324|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904325|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904326|NCT04058236|Polygeline|polygeline|mesh-list
44904327|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
44904328|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
44904329|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
44904330|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904331|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44904332|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44904333|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44904334|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904335|NCT04058132|Urological Agents|urological agents|mesh-ancestor
44904336|NCT04057300|Aspirin|aspirin|mesh-list
44904337|NCT04057300|Clopidogrel|clopidogrel|mesh-list
44904338|NCT04057300|Ticagrelor|ticagrelor|mesh-list
44904339|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44904340|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904341|NCT04057300|Analgesics|analgesics|mesh-ancestor
44904342|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
44904343|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904344|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904345|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904346|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904347|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44904348|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44904349|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904350|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44904351|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44904352|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904353|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
44904354|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44904355|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44904356|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44904357|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
44904358|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904359|NCT04057014|Amoxicillin|amoxicillin|mesh-list
44904360|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44904361|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904362|NCT04056039|Colchicine|colchicine|mesh-list
44904363|NCT04056039|Atorvastatin|atorvastatin|mesh-list
44904364|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44904365|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44904366|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
44904367|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904368|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44904369|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44904370|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904371|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
44904372|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904373|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904374|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904375|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904376|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904377|NCT04055623|Aldesleukin|aldesleukin|mesh-list
44904378|NCT04055623|Interleukin-2|interleukin-2|mesh-list
44904379|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904380|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904381|NCT04055623|Analgesics|analgesics|mesh-ancestor
44904382|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
44904383|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904384|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904385|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44904386|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44904387|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
44904388|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904389|NCT04055233|Biguanides|biguanides|mesh-list
44904390|NCT04055233|Polihexanide|polihexanide|mesh-list
44904391|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904392|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
44904393|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904394|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904395|NCT04054128|Heparin|heparin|mesh-list
44904396|NCT04054128|Calcium heparin|calcium heparin|mesh-list
44904397|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
44904398|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44904399|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44904400|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904401|NCT04053621|Thiamine|thiamine|mesh-list
44696846|NCT01394341|Liraglutide|liraglutide|mesh-list
44904402|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
44904403|NCT04053621|Metformin|metformin|mesh-list
44904404|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904405|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904406|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
44904407|NCT04053621|Vitamins|vitamins|mesh-ancestor
44904408|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
44904409|NCT04052867|Lidocaine|lidocaine|mesh-list
44904410|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904411|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
44904412|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904413|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904414|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
44904415|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904416|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904417|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904418|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904419|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904420|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904421|NCT04053205|Paclitaxel|paclitaxel|mesh-list
44904422|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904423|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904424|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904425|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904426|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904427|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904428|NCT04051723|Dexamethasone|dexamethasone|mesh-list
44904429|NCT04051723|Ropivacaine|ropivacaine|mesh-list
44904430|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904431|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
44904432|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
44904433|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904434|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904435|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44904436|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
44904437|NCT04051723|Hormones|hormones|mesh-ancestor
44904438|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904439|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904440|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904441|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904442|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
44904443|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904444|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
44904445|NCT04051567|Aspirin|aspirin|mesh-list
44904446|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44904447|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904448|NCT04051567|Analgesics|analgesics|mesh-ancestor
44904449|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
44904450|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904451|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904452|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904453|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904454|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44904455|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44904456|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904457|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44904458|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44904459|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904460|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
44904461|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
44904462|NCT04051099|Bupivacaine|bupivacaine|mesh-list
44904463|NCT04051099|Propofol|propofol|mesh-list
44904464|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904465|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
44904466|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904467|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904468|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
44904469|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904470|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44904471|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904472|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
44904473|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904474|NCT04051099|Analgesics|analgesics|mesh-ancestor
44904475|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44904476|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904477|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904478|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904479|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904480|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904481|NCT04050826|Lidocaine|lidocaine|mesh-list
44904482|NCT04050826|Prilocaine|prilocaine|mesh-list
44904483|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904484|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
44904485|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904486|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904487|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
44904488|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904489|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904490|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904491|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904492|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904493|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904494|NCT04050059|Lidocaine|lidocaine|mesh-list
44904495|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44904496|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904497|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
44904498|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904499|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904500|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
44904501|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904502|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904503|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44904504|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44904505|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44904506|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904507|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44904508|NCT04049916|Artesunate|artesunate|mesh-list
44904509|NCT04049916|Piperaquine|piperaquine|mesh-list
44904510|NCT04049916|Primaquine|primaquine|mesh-list
44904511|NCT04049916|Artenimol|artenimol|mesh-list
44904512|NCT04049916|Pyronaridine|pyronaridine|mesh-list
44904513|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
44904514|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44904515|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44904516|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904517|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904518|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
44904519|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
44904520|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44904521|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
44904522|NCT04049747|Bicalutamide|bicalutamide|mesh-list
44904523|NCT04049747|Finasteride|finasteride|mesh-list
44904524|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
44904525|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
44904526|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904527|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904528|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904529|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44904530|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44696996|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696997|NCT01394796|Protective Agents|protective agents|mesh-ancestor
44696998|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696999|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44697000|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44697001|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697002|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44697003|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44697004|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
44697005|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44697006|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44904531|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904532|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904533|NCT04049747|Urological Agents|urological agents|mesh-ancestor
44904534|NCT04049409|Trastuzumab|trastuzumab|mesh-list
44904535|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904536|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904537|NCT04049539|Cytarabine|cytarabine|mesh-list
44904538|NCT04049539|Daunorubicin|daunorubicin|mesh-list
44904539|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44904540|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
44904541|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904542|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904543|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
44904544|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904545|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904546|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
44904547|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904548|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44904549|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44904550|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44904551|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904552|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
44904553|NCT04049513|Fludarabine|fludarabine|mesh-list
44904554|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904555|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
44904556|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904557|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904558|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44904559|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
44904560|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904561|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904562|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44904563|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
44904564|NCT04049344|Decitabine|decitabine|mesh-list
44904565|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904566|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44904567|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
44904568|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904569|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904570|NCT04049201|Midazolam|midazolam|mesh-list
44904571|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44904572|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44904573|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904574|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904575|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44904576|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44904577|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44904578|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904579|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
44904580|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
44904581|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
44904582|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
44904583|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904584|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904585|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44904586|NCT04048889|Ropivacaine|ropivacaine|mesh-list
44904587|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44904588|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904589|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
44904590|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904591|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904592|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
44904593|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904594|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
44904595|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44904596|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904597|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904598|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904599|NCT04049227|Letrozole|letrozole|mesh-list
44904600|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904601|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44904602|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44904603|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904604|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904605|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44904606|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
44904607|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904608|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904609|NCT04049045|Empagliflozin|empagliflozin|mesh-list
44904610|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44904611|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904612|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904613|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685423|NCT02038634|Hormones|hormones|mesh-ancestor
44697058|NCT01395147|Vortioxetine|vortioxetine|mesh-list
44904614|NCT04048811|Propofol|propofol|mesh-list
44904622|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
44904623|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904624|NCT04048655|Neostigmine|neostigmine|mesh-list
44904625|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44904626|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904627|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904628|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
44904629|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904630|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904631|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44904632|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
44904633|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904634|NCT04048707|Octreotide|octreotide|mesh-list
44904635|NCT04048707|Midodrine|midodrine|mesh-list
44904636|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
44904637|NCT04048707|Giapreza|giapreza|mesh-list
44904638|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
44904639|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44904640|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904641|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904642|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
44904643|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
44904644|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904645|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904646|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44904647|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44904648|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904649|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904650|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904651|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904652|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904653|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44904654|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904655|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904656|NCT04048317|Doxorubicin|doxorubicin|mesh-list
44904657|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44904658|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
44904659|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44904660|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904661|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44904662|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44904663|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697207|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
44697208|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697209|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697210|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
44697211|NCT01395849|Hormones|hormones|mesh-ancestor
44697212|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697213|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
44697214|NCT01395862|Fluticasone|fluticasone|mesh-list
44697215|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44697216|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44697217|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697218|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44697219|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
44697220|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697221|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697222|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44697223|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44697224|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697225|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44697226|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44697227|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44697228|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44697229|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
44697230|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697231|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697232|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
44697233|NCT01395862|Hormones|hormones|mesh-ancestor
44697234|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697235|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
44697236|NCT01395875|Fluticasone|fluticasone|mesh-list
44697237|NCT01395875|Xhance|xhance|mesh-list
44904664|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904665|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
44904667|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44904668|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904669|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904670|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904671|NCT04048226|Analgesics|analgesics|mesh-ancestor
44904672|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
44904673|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904674|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44904675|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904676|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904677|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904678|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904679|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904680|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44904681|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904682|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
44904683|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
44904684|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44904685|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44904686|NCT04048200|Fentanyl|fentanyl|mesh-list
44904687|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
44904688|NCT04048200|Ketamine|ketamine|mesh-list
44904689|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
44904690|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44904691|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904692|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904693|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904694|NCT04048200|Analgesics|analgesics|mesh-ancestor
44904695|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
44904696|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904697|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44904698|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44904699|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44904700|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904701|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904702|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904703|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44904704|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904705|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
44904706|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
44904707|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44904708|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44904709|NCT04048200|Narcotics|narcotics|mesh-ancestor
44904710|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44904711|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
44904712|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44904713|NCT04048070|Sufentanil|sufentanil|mesh-list
44904714|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44904715|NCT04048070|Narcotics|narcotics|mesh-ancestor
44904716|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904717|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904718|NCT04048070|Analgesics|analgesics|mesh-ancestor
44904719|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
44904720|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904721|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44904722|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44904723|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
44904724|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
44904725|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44904726|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44904727|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44904728|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904729|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44904730|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904731|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904732|NCT04047654|Anticoagulants|anticoagulants|mesh-list
44904733|NCT04047706|Nivolumab|nivolumab|mesh-list
44904734|NCT04047706|Temozolomide|temozolomide|mesh-list
44904735|NCT04047706|Linrodostat|linrodostat|mesh-list
44904736|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904737|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904738|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44904739|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904740|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44904742|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904743|NCT04047940|Metformin|metformin|mesh-list
44904744|NCT04047940|Valsartan|valsartan|mesh-list
44904745|NCT04047940|Atorvastatin|atorvastatin|mesh-list
44904746|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904747|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904748|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44904749|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44904750|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
44904751|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904752|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44904753|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44904754|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904755|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44904756|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44904757|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44904758|NCT04047758|Letrozole|letrozole|mesh-list
44904759|NCT04047758|Palbociclib|palbociclib|mesh-list
44904760|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904761|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44904762|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44904763|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904764|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904765|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44904766|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
44904767|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904768|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904769|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44904770|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44904771|NCT04047849|Amoxicillin|amoxicillin|mesh-list
44904772|NCT04047849|Azithromycin|azithromycin|mesh-list
44904773|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904774|NCT04047914|Mupirocin|mupirocin|mesh-list
44904775|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44904776|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904777|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44904778|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904779|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904780|NCT04047875|Norethindrone|norethindrone|mesh-list
44904781|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
44904782|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44904783|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44904784|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44904785|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
44904786|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44904787|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904788|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44904789|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44904790|NCT04047745|Bupivacaine|bupivacaine|mesh-list
44904791|NCT04047745|Ropivacaine|ropivacaine|mesh-list
44904792|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
44904793|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
44904794|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904795|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904796|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
44904797|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904798|NCT04047680|Ritonavir|ritonavir|mesh-list
44904799|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
44904800|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44904801|NCT04047680|Grazoprevir|grazoprevir|mesh-list
44904802|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44904803|NCT04047680|Ledipasvir|ledipasvir|mesh-list
44904804|NCT04047680|Velpatasvir|velpatasvir|mesh-list
44904805|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44904806|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44697323|NCT01396642|Emollients|emollients|mesh-list
44697324|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697325|NCT01396655|Docetaxel|docetaxel|mesh-list
44697326|NCT01396655|Doxorubicin|doxorubicin|mesh-list
44904807|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44904808|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904809|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904810|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904812|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44904813|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
44904814|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904815|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44904816|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44904817|NCT04047797|Rituximab|rituximab|mesh-list
44904818|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44904819|NCT04047797|Ixazomib|ixazomib|mesh-list
44904820|NCT04047797|Antibodies|antibodies|mesh-list
44904821|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
44904822|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44904823|NCT04047797|Glycine|glycine|mesh-list
44904824|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
44904825|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904826|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904827|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904828|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904829|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904830|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904831|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
44904832|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904833|NCT04047329|Anesthetics|anesthetics|mesh-list
44904834|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44904835|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904836|NCT04047394|Rasburicase|rasburicase|mesh-list
44904837|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
44904838|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44904839|NCT04047355|Propranolol|propranolol|mesh-list
44904840|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44904841|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44904842|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44904843|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904844|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904845|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904846|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44904847|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44904848|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
44904849|NCT04047017|Apatinib|apatinib|mesh-list
44904850|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904851|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44904852|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904853|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904854|NCT04046874|Analgesics|analgesics|mesh-list
44904855|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
44904856|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44904857|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904858|NCT04047186|Nivolumab|nivolumab|mesh-list
44904859|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904860|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904861|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44904862|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904863|NCT04046822|Liraglutide|liraglutide|mesh-list
44904864|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44904865|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904866|NCT04046822|Incretins|incretins|mesh-ancestor
44904867|NCT04046822|Hormones|hormones|mesh-ancestor
44904868|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904869|NCT04046510|Oxytocin|oxytocin|mesh-list
44904870|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
44904871|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44904872|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904873|NCT04046653|Sulforaphane|sulforaphane|mesh-list
44904874|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44904875|NCT04046653|Protective Agents|protective agents|mesh-ancestor
44904876|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904877|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904878|NCT04046679|Bleomycin|bleomycin|mesh-list
44904879|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44904880|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904881|NCT04046029|Heparin|heparin|mesh-list
44904882|NCT04046029|Bivalirudin|bivalirudin|mesh-list
44904883|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
44904884|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44904885|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44904907|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
44904908|NCT04046133|Capecitabine|capecitabine|mesh-list
44904909|NCT04046133|Mitomycins|mitomycins|mesh-list
44904910|NCT04046133|Mitomycin|mitomycin|mesh-list
44904911|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904912|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904913|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44904914|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
44904915|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904916|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44904917|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
44904918|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44904919|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904920|NCT04046302|Dinoprostone|dinoprostone|mesh-list
44904921|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
44904922|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697545|NCT05009355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697546|NCT05009355|Protective Agents|protective agents|mesh-ancestor
44697547|NCT04975269|Acetazolamide|acetazolamide|mesh-list
44697548|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
44697549|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44697550|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697551|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697552|NCT04975269|Diuretics|diuretics|mesh-ancestor
44697553|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
44697554|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697555|NCT04965870|Trifluridine|trifluridine|mesh-list
44697556|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
44697557|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697558|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
44697559|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697560|NCT04941937|Thalidomide|thalidomide|mesh-list
44697561|NCT04941937|Dexamethasone|dexamethasone|mesh-list
44697562|NCT04941937|Lenalidomide|lenalidomide|mesh-list
44697563|NCT04941937|Pomalidomide|pomalidomide|mesh-list
44697564|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697565|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
44697566|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
44697567|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697568|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697569|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697570|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
44697571|NCT04941937|Hormones|hormones|mesh-ancestor
44697572|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697573|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697574|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904923|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904924|NCT04045678|Rotigotine|rotigotine|mesh-list
44904925|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
44904926|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
44904927|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44904928|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904929|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904930|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
44904931|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44904932|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904933|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44904934|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44904935|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904936|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904937|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904938|NCT04045730|Gemcitabine|gemcitabine|mesh-list
44904939|NCT04045730|Paclitaxel|paclitaxel|mesh-list
44904940|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
44904941|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44904942|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904943|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
44904944|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
44904945|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
44904946|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904947|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44904948|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
44904949|NCT04045730|Antiviral Agents|antiviral agents|mesh-ancestor
44904950|NCT04045730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904951|NCT04045730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904952|NCT04045730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44904954|NCT04045730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904955|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44904956|NCT04045821|Plerixafor|plerixafor|mesh-list
44904957|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44904958|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44904959|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
44904960|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44904961|NCT04045548|Dinoprostone|dinoprostone|mesh-list
44904962|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
44904963|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44904964|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904965|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
44904966|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44904967|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904968|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44904969|NCT04046185|Progesterone|progesterone|mesh-list
44904970|NCT04046185|Progestins|progestins|mesh-ancestor
44904971|NCT04046185|Hormones|hormones|mesh-ancestor
44904972|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904973|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904974|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904975|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904976|NCT04046159|Tamoxifen|tamoxifen|mesh-list
44904977|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44904978|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
44904979|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44904980|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904981|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44904982|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44904983|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44904984|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44904985|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44904986|NCT04045431|Hylan|hylan|mesh-list
44904987|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
44904988|NCT04045431|Protective Agents|protective agents|mesh-ancestor
44904989|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44904990|NCT04045093|Warfarin|warfarin|mesh-list
44904991|NCT04045093|Dabigatran|dabigatran|mesh-list
44904992|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
44904993|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
44904994|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44904995|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44904996|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44904997|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44904998|NCT04044976|Caffeine|caffeine|mesh-list
44904999|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
44905000|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905001|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44905002|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905003|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44905004|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905005|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44905006|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44905007|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
44905008|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905009|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44905010|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905011|NCT04044651|Nivolumab|nivolumab|mesh-list
44905012|NCT04044651|Lenvatinib|lenvatinib|mesh-list
44905013|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905014|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905015|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44905016|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905017|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44905018|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905019|NCT04044703|Vancomycin|vancomycin|mesh-list
44905020|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905021|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905022|NCT04044378|Ifosfamide|ifosfamide|mesh-list
44905023|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44905024|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
44905025|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905026|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905028|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905029|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905030|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44905031|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905032|NCT04044417|Curcumin|curcumin|mesh-list
44905033|NCT04044417|Simvastatin|simvastatin|mesh-list
44905034|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44905035|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44905036|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
44905037|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905038|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44905039|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44905040|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905041|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905042|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905043|NCT04044417|Analgesics|analgesics|mesh-ancestor
44905044|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
44905045|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905046|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905047|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905048|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905049|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905050|NCT04044547|Rotigotine|rotigotine|mesh-list
44905051|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
44905052|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
44905053|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905054|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905055|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905056|NCT04044313|Lenvatinib|lenvatinib|mesh-list
44905057|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905058|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44905059|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905060|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905061|NCT04044287|Misoprostol|misoprostol|mesh-list
44905062|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44905063|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
44905064|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44905065|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905066|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44905067|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44905068|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
44905069|NCT04043897|Rifaximin|rifaximin|mesh-list
44905070|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905071|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905072|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44905073|NCT04043858|Midodrine|midodrine|mesh-list
44905074|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
44905075|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
44905076|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905077|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905078|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44905079|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44905080|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44905081|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44905082|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
44905083|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905084|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905085|NCT04044079|Misoprostol|misoprostol|mesh-list
44905086|NCT04044079|Dinoprostone|dinoprostone|mesh-list
44905087|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44905088|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
44905089|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44905090|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905091|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44905092|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44905093|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
44905094|NCT04043676|Ponatinib|ponatinib|mesh-list
44905095|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905096|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44905097|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697666|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905098|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905100|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
44905101|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44905102|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905103|NCT04043624|Lidocaine|lidocaine|mesh-list
44905104|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905105|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
44509108|NCT01834235|Gemcitabine|gemcitabine|mesh-list
44905106|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905107|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905108|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
44905109|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905110|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44905111|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44905112|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44905113|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905114|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905115|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
44905116|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905117|NCT04043325|Antibodies|antibodies|mesh-list
44905118|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
44905119|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905120|NCT04042948|Acetaminophen|acetaminophen|mesh-list
44905121|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905122|NCT04042948|Analgesics|analgesics|mesh-ancestor
44905123|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
44905124|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905125|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905126|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
44905127|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
44905128|NCT04043195|Nivolumab|nivolumab|mesh-list
44905129|NCT04043195|Ipilimumab|ipilimumab|mesh-list
44905130|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905131|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905132|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44905133|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905134|NCT04042974|Dinoprostone|dinoprostone|mesh-list
44905135|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
44905136|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44905137|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905138|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
44697739|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697740|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697741|NCT03121534|Dexamethasone|dexamethasone|mesh-list
44697742|NCT03121534|Blinatumomab|blinatumomab|mesh-list
44697743|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697744|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
44697745|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
44697746|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697747|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697748|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697749|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
44697750|NCT03121534|Hormones|hormones|mesh-ancestor
44697751|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697752|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697753|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697754|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
44697755|NCT03116997|Neostigmine|neostigmine|mesh-list
44697763|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
44905139|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44905140|NCT04042805|Lenvatinib|lenvatinib|mesh-list
44905141|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905142|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44905143|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905144|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905145|NCT04042506|Nivolumab|nivolumab|mesh-list
44905146|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905147|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905148|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44905149|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905150|NCT04042441|Insulin|insulin|mesh-list
44905151|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
44905152|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44905153|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905154|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
44905155|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44905156|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44905157|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905159|NCT04042688|Coagulants|coagulants|mesh-ancestor
44905160|NCT04042558|Bevacizumab|bevacizumab|mesh-list
44905161|NCT04042558|Carboplatin|carboplatin|mesh-list
44905162|NCT04042558|Pemetrexed|pemetrexed|mesh-list
44905163|NCT04042558|Atezolizumab|atezolizumab|mesh-list
44905164|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44905165|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905166|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905167|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44905168|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44905169|NCT04042558|Growth Substances|growth substances|mesh-ancestor
44905170|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905171|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44905172|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905173|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905174|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44905175|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44905176|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
44905177|NCT04042714|Trifluridine|trifluridine|mesh-list
44905178|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
44905179|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905180|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
44905181|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905182|NCT04042233|Vancomycin|vancomycin|mesh-list
44905183|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905184|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905185|NCT04041934|Tryptophan|tryptophan|mesh-list
44905186|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44905187|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
44905188|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44905189|NCT04042051|Trastuzumab|trastuzumab|mesh-list
44905190|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44905191|NCT04042051|Maytansine|maytansine|mesh-list
44905192|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905193|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905194|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44905195|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
44905196|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
44905197|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44905198|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905199|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
44905200|NCT04042220|Hormones|hormones|mesh-ancestor
44905201|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905202|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905203|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
44905204|NCT04041856|Povidone|povidone|mesh-list
44905205|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
44905206|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
44905207|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44905208|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905209|NCT04041492|Vitamin D|vitamin d|mesh-list
44905210|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
44905211|NCT04041492|Vitamins|vitamins|mesh-ancestor
44905212|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
44905213|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905214|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44905215|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44905216|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44905217|NCT04041362|UB-421|ub-421|mesh-list
44905218|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
44905219|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905220|NCT04041349|Mitogens|mitogens|mesh-list
44905221|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44905222|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905223|NCT04041427|Albendazole|albendazole|mesh-list
44905224|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
44905225|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44905226|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905227|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
44905228|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44905229|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44905230|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44905231|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
44905232|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
44905248|NCT04041648|Treprostinil|treprostinil|mesh-list
44905249|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44905250|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44905251|NCT04040491|Gemcitabine|gemcitabine|mesh-list
44905252|NCT04040491|Lenalidomide|lenalidomide|mesh-list
44905253|NCT04040491|Antibodies|antibodies|mesh-list
44905254|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
44905255|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
44905256|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905257|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44905258|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
44905259|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905260|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905261|NCT04040491|Antiviral Agents|antiviral agents|mesh-ancestor
44905262|NCT04040491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905263|NCT04040491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905264|NCT04040491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44905265|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44905266|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44905267|NCT04040491|Growth Substances|growth substances|mesh-ancestor
44905268|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44905269|NCT04040322|Iloprost|iloprost|mesh-list
44905270|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44905271|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
44905272|NCT04040465|Aspirin|aspirin|mesh-list
44905273|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905274|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905275|NCT04040465|Analgesics|analgesics|mesh-ancestor
44905276|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
44905277|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905278|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905279|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905280|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905281|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44905282|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44905283|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905284|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44905285|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44905286|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905287|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
44905288|NCT04040309|Lidocaine|lidocaine|mesh-list
44905289|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905290|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
44905291|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905292|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905293|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
44905294|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905295|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44905296|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44905297|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44905298|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905299|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905300|NCT04039854|Propofol|propofol|mesh-list
44905301|NCT04039854|Sevoflurane|sevoflurane|mesh-list
44905302|NCT04039854|Desflurane|desflurane|mesh-list
44905303|NCT04039854|Isoflurane|isoflurane|mesh-list
44905304|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905305|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905306|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905307|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905308|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
44905309|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
44905310|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44905311|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44905312|NCT04039828|Zinc|zinc|mesh-list
44905313|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
44905314|NCT04039828|Trace Elements|trace elements|mesh-ancestor
44905315|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
44905316|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905317|NCT04039828|Astringents|astringents|mesh-ancestor
44905318|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
44905319|NCT04039880|Olorofim|olorofim|mesh-list
44905320|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
44905321|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905322|NCT04040023|Vitamins|vitamins|mesh-list
44697946|NCT05273398|Diazepam|diazepam|mesh-list
44905323|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
44905324|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698021|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698022|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698023|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698024|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
44698025|NCT05271539|Hormones|hormones|mesh-ancestor
44698026|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698027|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44698028|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698029|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44698030|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44698031|NCT05271539|Growth Substances|growth substances|mesh-ancestor
44698032|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
44702672|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
44702673|NCT01409616|Salicylates|salicylates|mesh-list
44702674|NCT01409616|Darexaban|darexaban|mesh-list
44702675|NCT01409616|Clopidogrel|clopidogrel|mesh-list
44702676|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44702677|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44702678|NCT01409616|Analgesics|analgesics|mesh-ancestor
44702679|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
44702680|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702681|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702682|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702683|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702684|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44702685|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44702686|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702687|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44702688|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44702689|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702690|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
44702691|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44702692|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44702693|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44702694|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
44702695|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702696|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702697|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
44702698|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
44702699|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702700|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44702701|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
44702702|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702703|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702704|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
44702705|NCT01409694|Vitamin D|vitamin d|mesh-list
44702706|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
44702707|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
44702708|NCT01409694|Vitamins|vitamins|mesh-list
44702709|NCT01409694|Memantine|memantine|mesh-list
44702710|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
44702711|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702712|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44702713|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44702714|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44702715|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44702716|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
44702717|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702718|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702719|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44702720|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44702721|NCT01409733|Doxorubicin|doxorubicin|mesh-list
44702722|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44905325|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
44905326|NCT04039815|Thiamine|thiamine|mesh-list
44905327|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
44905328|NCT04039815|Vitamins|vitamins|mesh-ancestor
44905329|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
44905330|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905331|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905332|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
44905333|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
44905334|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905335|NCT04039815|Protective Agents|protective agents|mesh-ancestor
44905336|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
44905337|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44905338|NCT04039698|Velpatasvir|velpatasvir|mesh-list
44905339|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
44905340|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905341|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44905342|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
44905343|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905344|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
44905345|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44905346|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905347|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44905348|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
44905349|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905350|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905351|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685565|NCT01845441|Narcotics|narcotics|mesh-ancestor
44905352|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905353|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44905354|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44905355|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905356|NCT04039126|Iodine|iodine|mesh-list
44905357|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
44905358|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
44905359|NCT04039126|Tetracycline|tetracycline|mesh-list
44905360|NCT04039126|Povidone|povidone|mesh-list
44905361|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44905362|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905363|NCT04039126|Trace Elements|trace elements|mesh-ancestor
44905364|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
44905365|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905366|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
44905367|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
44905368|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905369|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44905370|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905371|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905372|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44905373|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905374|NCT04038970|Methotrexate|methotrexate|mesh-list
44905375|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44905376|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
44905377|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44905378|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905379|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44905380|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
44905381|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905382|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905383|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44905384|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905385|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44905386|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44905387|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
44905388|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905389|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44905390|NCT04038853|Vitamin D|vitamin d|mesh-list
44905391|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
44905392|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44905393|NCT04038853|Calcitriol|calcitriol|mesh-list
44905394|NCT04038853|Vitamins|vitamins|mesh-ancestor
44905395|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
44905396|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905397|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44905398|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44905399|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44905400|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905401|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905402|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44905403|NCT04038749|Cabergoline|cabergoline|mesh-list
44905404|NCT04038749|Bromocriptine|bromocriptine|mesh-list
44905405|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44905406|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44905407|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
44905408|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
44905409|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698033|NCT05271448|Losartan|losartan|mesh-list
44905410|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698034|NCT05271448|Valsartan|valsartan|mesh-list
44905411|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905414|NCT04038411|Etoposide|etoposide|mesh-list
44905415|NCT04038411|Lenalidomide|lenalidomide|mesh-list
44905416|NCT04038411|Antibodies|antibodies|mesh-list
44905417|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
44905418|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698185|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
44698186|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698187|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698188|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698189|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44698190|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698191|NCT05248724|Ketorolac|ketorolac|mesh-list
44698192|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44698193|NCT05248724|Epinephrine|epinephrine|mesh-list
44698194|NCT05248724|Racepinephrine|racepinephrine|mesh-list
44698195|NCT05248724|Morphine|morphine|mesh-list
44698196|NCT05248724|Ropivacaine|ropivacaine|mesh-list
44698197|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
44698198|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44698199|NCT05248724|Narcotics|narcotics|mesh-ancestor
44698200|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698201|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698202|NCT05248724|Analgesics|analgesics|mesh-ancestor
44698203|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
44698204|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698205|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
44698206|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
44698207|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44698208|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698209|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698210|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698211|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44698212|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698213|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698214|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44698215|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698216|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698217|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698218|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44698219|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44698220|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
44905419|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44905420|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905421|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44905422|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44905423|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905424|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905425|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44905426|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44905427|NCT04038411|Growth Substances|growth substances|mesh-ancestor
44905428|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
44905429|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
44905430|NCT04038320|Ledipasvir|ledipasvir|mesh-list
44905431|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
44905432|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905433|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
44905434|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44905435|NCT04038671|Charcoal|charcoal|mesh-list
44905436|NCT04038671|Antidotes|antidotes|mesh-ancestor
44905437|NCT04038671|Protective Agents|protective agents|mesh-ancestor
44905438|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905439|NCT04038307|Acetaminophen|acetaminophen|mesh-list
44905440|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905441|NCT04038307|Analgesics|analgesics|mesh-ancestor
44905442|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
44905443|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905444|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905445|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
44905446|NCT04038008|Fluconazole|fluconazole|mesh-list
44905447|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
44905448|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905449|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44905450|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44905451|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905452|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905453|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44905454|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
44905455|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905456|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905457|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44905458|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44905459|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
44905460|NCT04038034|Vitamins|vitamins|mesh-ancestor
44905461|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
44905462|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905463|NCT04037878|Tramadol|tramadol|mesh-list
44905464|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44905465|NCT04037878|Narcotics|narcotics|mesh-ancestor
44905466|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905467|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905468|NCT04037878|Analgesics|analgesics|mesh-ancestor
44905469|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
44905470|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905471|NCT04038125|Dexamethasone|dexamethasone|mesh-list
44905472|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905473|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
44905474|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
44905475|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905476|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905477|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44905478|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
44905479|NCT04038125|Hormones|hormones|mesh-ancestor
44905480|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905481|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44905482|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905483|NCT04038073|Antibodies|antibodies|mesh-list
44905484|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
44905485|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
44905486|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905487|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
44905488|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905489|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905490|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905491|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905492|NCT04037774|Analgesics|analgesics|mesh-ancestor
44905493|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
44905494|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905495|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44905496|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44905497|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44905498|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
44905499|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905500|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905501|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
44905502|NCT04037566|Fludarabine|fludarabine|mesh-list
44905503|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44905504|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
44905505|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905506|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905507|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44905508|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
44905509|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905510|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905511|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44905512|NCT04037657|Propofol|propofol|mesh-list
44905513|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905514|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905515|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905516|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905517|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
44905518|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
44905519|NCT04037514|Acetaminophen|acetaminophen|mesh-list
44905520|NCT04037514|Ibuprofen|ibuprofen|mesh-list
44905521|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905522|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905523|NCT04037514|Analgesics|analgesics|mesh-ancestor
44905524|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
44905525|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905526|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698226|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
44698229|NCT05233982|Olaparib|olaparib|mesh-list
44905551|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905552|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905553|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44905554|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905555|NCT04036487|Propofol|propofol|mesh-list
44905556|NCT04036487|Desflurane|desflurane|mesh-list
44905557|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905558|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905559|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905560|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905561|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
44905562|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
44905563|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44905564|NCT04036500|Estradiol|estradiol|mesh-list
44905565|NCT04036500|Estrogens|estrogens|mesh-ancestor
44905566|NCT04036500|Hormones|hormones|mesh-ancestor
44905567|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905568|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905569|NCT04036448|Lenalidomide|lenalidomide|mesh-list
44905570|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
44905571|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905572|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44905573|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44905574|NCT04036448|Growth Substances|growth substances|mesh-ancestor
44905575|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44905576|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698309|NCT05162118|Nivolumab|nivolumab|mesh-list
44905577|NCT04036526|Vaccines|vaccines|mesh-list
44905578|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
44698375|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
44698376|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44698377|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698378|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698379|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698380|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
44698381|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
44698382|NCT05088928|Apixaban|apixaban|mesh-list
44698383|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44698384|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
44698385|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44698386|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698387|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698388|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698389|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
44698390|NCT05087771|Naltrexone|naltrexone|mesh-list
44698391|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44698392|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44698393|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698394|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
44698395|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698396|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
44698397|NCT05075122|Sargramostim|sargramostim|mesh-list
44698398|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698399|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698400|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
44698401|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698402|NCT05074056|Ketorolac|ketorolac|mesh-list
44698403|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44698404|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698405|NCT05074056|Analgesics|analgesics|mesh-ancestor
44698406|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
44698407|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698408|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698409|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698410|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698411|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44905579|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905580|NCT04036201|Bupivacaine|bupivacaine|mesh-list
44905581|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
44905582|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905583|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
44905584|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905585|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905586|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
44905587|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905588|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44905589|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
44905590|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
44905591|NCT04036201|Protective Agents|protective agents|mesh-ancestor
44905592|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
44905593|NCT04036253|Hematinics|hematinics|mesh-ancestor
44905594|NCT04035850|Vortioxetine|vortioxetine|mesh-list
44905595|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
44905596|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44905597|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44905598|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44905599|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905600|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905601|NCT04035850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44905602|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44905603|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905604|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905605|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905606|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
44905607|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44905608|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44905609|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44905610|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44905611|NCT04035876|Apatinib|apatinib|mesh-list
44905612|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905613|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44905614|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905615|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905617|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
44905618|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905619|NCT04035889|Protective Agents|protective agents|mesh-ancestor
44905620|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905621|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905622|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44905623|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905624|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44905625|NCT04035798|Memantine|memantine|mesh-list
44905626|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44905627|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44905628|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
44905629|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905630|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905631|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905632|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44905633|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44905634|NCT04035707|Rocuronium|rocuronium|mesh-list
44905635|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905636|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44905637|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44905638|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44905639|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905640|NCT04035603|Cycloserine|cycloserine|mesh-list
44905641|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44905642|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905643|NCT04035603|Renal Agents|renal agents|mesh-ancestor
44905644|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44905645|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
44905646|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905647|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
44905648|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905649|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
44905650|NCT04035525|Ubiquinone|ubiquinone|mesh-list
44905651|NCT04035525|Vitamins|vitamins|mesh-ancestor
44905652|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
44905653|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905654|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
44905655|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44905656|NCT04035135|Antibodies|antibodies|mesh-list
44905657|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
44905658|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44905659|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
44905660|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905661|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
44905662|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44905663|NCT04035330|Eusol|eusol|mesh-list
44905664|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
44905665|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905666|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44905667|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905668|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
44905669|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
44905670|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905671|NCT04035096|Protective Agents|protective agents|mesh-ancestor
44905672|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905673|NCT04035096|Vitamins|vitamins|mesh-ancestor
44905674|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
44905675|NCT04034823|Docetaxel|docetaxel|mesh-list
44905676|NCT04034823|Trastuzumab|trastuzumab|mesh-list
44905677|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905678|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
44905679|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
44905680|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
44905681|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905682|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905683|NCT04035070|Clindamycin|clindamycin|mesh-list
44905684|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
44905685|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
44905686|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44905687|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44905688|NCT04035070|Eusol|eusol|mesh-list
44905689|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44905690|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905715|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44905716|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44905717|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905718|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905719|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905720|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905721|NCT04034836|Analgesics|analgesics|mesh-ancestor
44905722|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905723|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905724|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
44905725|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44905726|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905727|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44905728|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905730|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44905731|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44905732|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905733|NCT04034589|Fulvestrant|fulvestrant|mesh-list
44905734|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44905735|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905736|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44905737|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44905738|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
44905739|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905740|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905741|NCT04034368|Tenofovir|tenofovir|mesh-list
44905742|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
44905743|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905744|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44905745|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44905746|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905747|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905748|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44905749|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44905750|NCT04034173|Leucovorin|leucovorin|mesh-list
44905751|NCT04034173|Folic Acid|folic acid|mesh-list
44905752|NCT04034173|Irinotecan|irinotecan|mesh-list
44905753|NCT04034173|Panitumumab|panitumumab|mesh-list
44905754|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
44905755|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44905756|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44905757|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905758|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905759|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905760|NCT04034173|Antidotes|antidotes|mesh-ancestor
44905761|NCT04034173|Protective Agents|protective agents|mesh-ancestor
44905762|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905763|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
44905764|NCT04034173|Vitamins|vitamins|mesh-ancestor
44905765|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
44905766|NCT04034173|Hematinics|hematinics|mesh-ancestor
44905767|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905768|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
44905769|NCT04034199|Denosumab|denosumab|mesh-list
44905770|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44905771|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905772|NCT04033939|Propofol|propofol|mesh-list
44905773|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905774|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905775|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905776|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905777|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
44905778|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
44905779|NCT04033562|Lidocaine|lidocaine|mesh-list
44905780|NCT04033562|Bupivacaine|bupivacaine|mesh-list
44905781|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905782|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
44905783|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905784|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905785|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
44905786|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905787|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44905788|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44905789|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44905790|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44905791|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905792|NCT04033471|Midazolam|midazolam|mesh-list
44905793|NCT04033471|Morphine|morphine|mesh-list
44905794|NCT04033471|Bupivacaine|bupivacaine|mesh-list
44905795|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905796|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
44905797|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905798|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905799|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
44905800|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905801|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44905802|NCT04033471|Narcotics|narcotics|mesh-ancestor
44905803|NCT04033471|Analgesics|analgesics|mesh-ancestor
44905804|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44905805|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44905806|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44905807|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44905808|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44905809|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44905810|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
44905811|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
44905812|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
44905813|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905814|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905815|NCT04033250|Bisacodyl|bisacodyl|mesh-list
44905816|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
44905817|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
44905818|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
44905819|NCT04033250|Citric Acid|citric acid|mesh-list
44698642|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
44698643|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44698644|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
44698645|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250313|NCT03245892|Paclitaxel|paclitaxel|mesh-list
44702723|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702724|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44702725|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44702726|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702727|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702728|NCT01409772|Ethanol|ethanol|mesh-list
44702729|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44702730|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702731|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702732|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702733|NCT01410162|Tacrolimus|tacrolimus|mesh-list
44702734|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702735|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
44702736|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702737|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44702738|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702739|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702740|NCT01410201|Dexamethasone|dexamethasone|mesh-list
44702741|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
44702742|NCT01410201|BB 1101|bb 1101|mesh-list
44702743|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702744|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
44702745|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
44702746|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702747|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702748|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702749|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
44702750|NCT01410201|Hormones|hormones|mesh-ancestor
44702751|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702752|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44702753|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702754|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702755|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702756|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702757|NCT01410214|Cisplatin|cisplatin|mesh-list
44702758|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44702759|NCT01410214|Vinorelbine|vinorelbine|mesh-list
44702760|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702761|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702762|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702763|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702764|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44702765|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44702766|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44702767|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44702768|NCT01410370|Endostar protein|endostar protein|mesh-list
44702769|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44702770|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44702771|NCT01410370|Growth Substances|growth substances|mesh-ancestor
44702772|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702773|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44702774|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702775|NCT01410630|Telbivudine|telbivudine|mesh-list
44702776|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
44702777|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702778|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44702779|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702780|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702781|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
44702782|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44702783|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702784|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
44702785|NCT01410708|Dasatinib|dasatinib|mesh-list
44702786|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702787|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702788|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905820|NCT04033250|Cathartics|cathartics|mesh-ancestor
44905821|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44905822|NCT04033250|Laxatives|laxatives|mesh-ancestor
44905823|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
44905824|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44905825|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
44905826|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
44905827|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905828|NCT04033250|Antacids|antacids|mesh-ancestor
44905829|NCT04033172|Fulvestrant|fulvestrant|mesh-list
44905830|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44905831|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905832|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44905833|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44905834|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44905835|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905836|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905837|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44905838|NCT04033029|Tazobactam|tazobactam|mesh-list
44905839|NCT04033029|Piperacillin|piperacillin|mesh-list
44905840|NCT04033029|Daptomycin|daptomycin|mesh-list
44905841|NCT04033029|Ceftazidime|ceftazidime|mesh-list
44905842|NCT04033029|Cefepime|cefepime|mesh-list
44905843|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44905844|NCT04033029|Ceftolozane|ceftolozane|mesh-list
44905845|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905846|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44905847|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905848|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905849|NCT04033055|Ropivacaine|ropivacaine|mesh-list
44905850|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
44905851|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
44905852|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905853|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905854|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
44905855|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905856|NCT04033094|Morphine|morphine|mesh-list
44905857|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44905858|NCT04033094|Narcotics|narcotics|mesh-ancestor
44905859|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44905860|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905861|NCT04033094|Analgesics|analgesics|mesh-ancestor
44905862|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
44905863|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905864|NCT04032691|Clonidine|clonidine|mesh-list
44905865|NCT04032691|Analgesics|analgesics|mesh-ancestor
44905866|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
44905867|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905868|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905869|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44905870|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
44905871|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
44905872|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44905873|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44905874|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44905875|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44905876|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905877|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905878|NCT04032860|Tenofovir|tenofovir|mesh-list
44905879|NCT04032860|Entecavir|entecavir|mesh-list
44905880|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
44905881|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905882|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44905883|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44905884|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905885|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905886|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44905887|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44905888|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
44905889|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44905890|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905891|NCT04032834|Budesonide|budesonide|mesh-list
44905892|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905893|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44905894|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
44905895|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905896|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905897|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44905898|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
44905899|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
44698646|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
44905901|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44905902|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
44905903|NCT04032548|Propolis|propolis|mesh-list
44905904|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44905905|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905906|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
44905907|NCT04032236|Caffeine|caffeine|mesh-list
44905908|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44905909|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905910|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44905911|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905912|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905913|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44905914|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44905915|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
44905916|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905917|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
44905918|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44905919|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
44905920|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905921|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905922|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44905923|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
44905924|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44905925|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
44905926|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905927|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44905928|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44905929|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
44905930|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
44905931|NCT04032366|Protective Agents|protective agents|mesh-ancestor
44905932|NCT04032132|Curcumin|curcumin|mesh-list
44905933|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905934|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905935|NCT04032132|Analgesics|analgesics|mesh-ancestor
44905936|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
44905937|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905938|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905939|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905940|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905941|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44905942|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44905943|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905944|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
44905945|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44905946|NCT04032184|Fluorides|fluorides|mesh-list
44905947|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
44905948|NCT04032184|Protective Agents|protective agents|mesh-ancestor
44905949|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905950|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44905951|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44905952|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
44905953|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
44905954|NCT04032210|Zinc|zinc|mesh-list
44905955|NCT04032210|Fluorides|fluorides|mesh-list
44905956|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
44905957|NCT04032210|Protective Agents|protective agents|mesh-ancestor
44905958|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905959|NCT04032210|Trace Elements|trace elements|mesh-ancestor
44905960|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
44905961|NCT04031859|Aspirin|aspirin|mesh-list
44905962|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44905963|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44905964|NCT04031859|Analgesics|analgesics|mesh-ancestor
44905965|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
44905966|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44905967|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44905968|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44905969|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44905970|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44905971|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44905972|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905973|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44905974|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44905996|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44905998|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
44905999|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906000|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906001|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44906002|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
44906003|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44906004|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
44906005|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44906006|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44906007|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44906008|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44698798|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698799|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
44698800|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
44510125|NCT01720940|Vancomycin|vancomycin|mesh-list
44698801|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698802|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698803|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698804|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
44698805|NCT04674514|Hormones|hormones|mesh-ancestor
44698806|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698807|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44698808|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698809|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
44698810|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44698811|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44698812|NCT04674514|Growth Substances|growth substances|mesh-ancestor
44698813|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
44698814|NCT04641702|Atropine|atropine|mesh-list
44698815|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44698816|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44906009|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698817|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44698818|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
44906010|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
44906011|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906012|NCT04031027|Apremilast|apremilast|mesh-list
44906013|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906014|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906015|NCT04031027|Analgesics|analgesics|mesh-ancestor
44906016|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
44906017|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906018|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906019|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906020|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906021|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44906022|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44906023|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906024|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906025|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
44906026|NCT04030663|Papaverine|papaverine|mesh-list
44906027|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
44906028|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44906029|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906030|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906031|NCT04030663|Urological Agents|urological agents|mesh-ancestor
44906032|NCT04030988|Dexamethasone|dexamethasone|mesh-list
44906033|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906034|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
44906035|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
44906036|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906037|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906038|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906039|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
44906040|NCT04030988|Hormones|hormones|mesh-ancestor
44906041|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906042|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906043|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906044|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44906045|NCT04030715|Bismuth|bismuth|mesh-list
44906046|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906047|NCT04030715|Antacids|antacids|mesh-ancestor
44906048|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906049|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906050|NCT04030741|Metronidazole|metronidazole|mesh-list
44906051|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906052|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906053|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44906054|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44906055|NCT04030442|Morphine|morphine|mesh-list
44906056|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44906057|NCT04030442|Narcotics|narcotics|mesh-ancestor
44906058|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906059|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906060|NCT04030442|Analgesics|analgesics|mesh-ancestor
44906061|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
44906062|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906063|NCT04030533|Ustekinumab|ustekinumab|mesh-list
44906064|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44906065|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
44906066|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
44906067|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906068|NCT04030572|Clonidine|clonidine|mesh-list
44906069|NCT04030572|Analgesics|analgesics|mesh-ancestor
44906070|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
44906071|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906072|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906073|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906074|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
44906075|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
44906076|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906077|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44906078|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906079|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906080|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906081|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906082|NCT04030481|Anesthetics|anesthetics|mesh-list
44906083|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906084|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906085|NCT04030260|Nivolumab|nivolumab|mesh-list
44906086|NCT04030260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44906087|NCT04030260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906088|NCT04030260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44906089|NCT04030260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906090|NCT04030039|Interferons|interferons|mesh-list
44906091|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906092|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
44906093|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906094|NCT04030091|Insulin|insulin|mesh-list
44906095|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44906096|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
44906097|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906098|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906099|NCT04029831|Ketamine|ketamine|mesh-list
44906100|NCT04029831|Propofol|propofol|mesh-list
44906101|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906102|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906103|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906104|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906105|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
44906106|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
44906107|NCT04029831|Analgesics|analgesics|mesh-ancestor
44906108|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
44906109|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906110|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44906111|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44906112|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44906113|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906114|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906115|NCT04029675|Ascorbic Acid|ascorbic acid|mesh-list
44906116|NCT04029675|Vitamins|vitamins|mesh-ancestor
44906117|NCT04029675|Micronutrients|micronutrients|mesh-ancestor
44906118|NCT04029675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906119|NCT04029675|Antioxidants|antioxidants|mesh-ancestor
44906120|NCT04029675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906121|NCT04029675|Protective Agents|protective agents|mesh-ancestor
44906122|NCT04029428|Octreotide|octreotide|mesh-list
44906123|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44906124|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44906125|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906126|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906127|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906128|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906129|NCT04028622|Anesthetics|anesthetics|mesh-list
44698929|NCT04454203|Anesthetics|anesthetics|mesh-list
44698930|NCT04454203|Mepivacaine|mepivacaine|mesh-list
44698931|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
44698932|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698933|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698934|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
44698935|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698936|NCT04433390|Naloxegol|naloxegol|mesh-list
44698937|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44698938|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698939|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
44698940|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698941|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
44698942|NCT04399746|Vitamin D|vitamin d|mesh-list
44698943|NCT04399746|Azithromycin|azithromycin|mesh-list
44698944|NCT04399746|Ivermectin|ivermectin|mesh-list
44698947|NCT04399746|Vitamins|vitamins|mesh-ancestor
44906130|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906131|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906132|NCT04028596|Acetaminophen|acetaminophen|mesh-list
44906133|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906134|NCT04028596|Analgesics|analgesics|mesh-ancestor
44906135|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
44906136|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906137|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906138|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
44906139|NCT04028323|Octreotide|octreotide|mesh-list
44906140|NCT04028323|Terlipressin|terlipressin|mesh-list
44906141|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906142|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906143|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906144|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906145|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44906170|NCT04025840|Hormones|hormones|mesh-ancestor
44906171|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906172|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906173|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906174|NCT04025203|Ibuprofen|ibuprofen|mesh-list
44906175|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
44906176|NCT04025203|Gabapentin|gabapentin|mesh-list
44906177|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906178|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906179|NCT04025203|Analgesics|analgesics|mesh-ancestor
44906180|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
44906181|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906182|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906183|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906184|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906185|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44906186|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906187|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906188|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
44906189|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44906190|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44906191|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906192|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906193|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44906194|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44906195|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906196|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
44699067|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
44699068|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
44699069|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699070|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699071|NCT04011150|Fentanyl|fentanyl|mesh-list
44699072|NCT04011150|Ropivacaine|ropivacaine|mesh-list
44699073|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
44699074|NCT04011150|Anesthetics|anesthetics|mesh-list
44699075|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699076|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699077|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
44699078|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699079|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44699080|NCT04011150|Narcotics|narcotics|mesh-ancestor
44699081|NCT04011150|Analgesics|analgesics|mesh-ancestor
44699082|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44699083|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44699084|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
44699085|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
44699086|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699087|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699088|NCT04008082|Lenvatinib|lenvatinib|mesh-list
44699089|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699090|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44699091|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699092|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699093|NCT04002180|Vedolizumab|vedolizumab|mesh-list
44699094|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702789|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702790|NCT01410747|Tacrolimus|tacrolimus|mesh-list
44702791|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702792|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
44702793|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702794|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44702795|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702796|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702797|NCT01410916|Eculizumab|eculizumab|mesh-list
44702798|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44702799|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702800|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
44702801|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702802|NCT01410968|Poly ICLC|poly iclc|mesh-list
44702803|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
44702804|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
44702805|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702806|NCT01411072|Gemcitabine|gemcitabine|mesh-list
44702807|NCT01411072|Fluorouracil|fluorouracil|mesh-list
44702808|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44702809|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
43830478|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906197|NCT04021498|Simvastatin|simvastatin|mesh-list
44906198|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44906199|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44906200|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
44906201|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906202|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44906203|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44906204|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906205|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44906206|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906207|NCT04020003|Simendan|simendan|mesh-list
44906208|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44906209|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
44906210|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44906211|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44906212|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906213|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906214|NCT04020003|Protective Agents|protective agents|mesh-ancestor
44906215|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906216|NCT04019782|Hylan|hylan|mesh-list
44906217|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
44906218|NCT04019782|Protective Agents|protective agents|mesh-ancestor
44906219|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906220|NCT04019496|Calcitonin|calcitonin|mesh-list
44906221|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
44906222|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44906223|NCT04019496|Antibodies|antibodies|mesh-list
44906224|NCT04019496|Katacalcin|katacalcin|mesh-list
44906225|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
44906226|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906227|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44906228|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44906229|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44906230|NCT04019548|Cisplatin|cisplatin|mesh-list
44906231|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906232|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44906233|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
44906234|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906235|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
44906236|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906237|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906238|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44906239|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44906240|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906241|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906242|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906243|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
44906244|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44906245|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906246|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906247|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44906248|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44906249|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906250|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906251|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906252|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44906253|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
44906254|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44906255|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906256|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44906257|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44906258|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44906259|NCT04019106|Budesonide|budesonide|mesh-list
44906260|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44906261|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906262|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44906263|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
44906264|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906265|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906266|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44906267|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44906268|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
44906269|NCT04019106|Hormones|hormones|mesh-ancestor
44906270|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906271|NCT04018833|Ranibizumab|ranibizumab|mesh-list
44906272|NCT04018833|Aflibercept|aflibercept|mesh-list
44906273|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44906274|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44906275|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44906276|NCT04018833|Growth Substances|growth substances|mesh-ancestor
44906277|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906278|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
44906279|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906280|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
44906281|NCT04018482|Povidone|povidone|mesh-list
44906282|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
44906283|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
44906284|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44906285|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906286|NCT04018703|Midazolam|midazolam|mesh-list
44906287|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
44906288|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906289|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906290|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906291|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906292|NCT04018703|Analgesics|analgesics|mesh-ancestor
44906293|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
44906294|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906295|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906296|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699095|NCT03974243|Chiauranib|chiauranib|mesh-list
44906297|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906298|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906299|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906300|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906301|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44906302|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44906303|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44906304|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906305|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906306|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
44906308|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
44906309|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
44906310|NCT04018690|Triamcinolone|triamcinolone|mesh-list
44906311|NCT04018690|Ropivacaine|ropivacaine|mesh-list
44906312|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44906313|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
44906314|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906315|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906316|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
44906317|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906318|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906319|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
44906320|NCT04018690|Hormones|hormones|mesh-ancestor
44906321|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906322|NCT04018417|Amphotericin B|amphotericin b|mesh-list
44906323|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44906324|NCT04018417|Amebicides|amebicides|mesh-ancestor
44906325|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44906326|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44906327|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906328|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906329|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
44906330|NCT04018365|Empagliflozin|empagliflozin|mesh-list
44906331|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44906332|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906333|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906334|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906335|NCT04018768|Acetaminophen|acetaminophen|mesh-list
44906336|NCT04018768|Ibuprofen|ibuprofen|mesh-list
44906337|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44906338|NCT04018768|Oxycodone|oxycodone|mesh-list
44906339|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906340|NCT04018768|Analgesics|analgesics|mesh-ancestor
44906341|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
44906342|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906343|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906344|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
44906345|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906346|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906347|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906348|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44906349|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906350|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906351|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44906352|NCT04018768|Narcotics|narcotics|mesh-ancestor
44906353|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906354|NCT04018378|Varenicline|varenicline|mesh-list
44906355|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44906356|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44906357|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
44906358|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906359|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906360|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906361|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
44906362|NCT04018157|Ketamine|ketamine|mesh-list
44906363|NCT04018157|Propofol|propofol|mesh-list
44906364|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906365|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906366|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906367|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906368|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
44906369|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
44906370|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906371|NCT04018157|Analgesics|analgesics|mesh-ancestor
44699171|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44699322|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
44699323|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699324|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702810|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702811|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702812|NCT01411072|Antiviral Agents|antiviral agents|mesh-ancestor
44702813|NCT01411072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702814|NCT01411072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702815|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44702816|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
44702817|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702818|NCT01411098|Cisplatin|cisplatin|mesh-list
44702819|NCT01411098|Etoposide|etoposide|mesh-list
44702820|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
44702821|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702822|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44702823|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44702824|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44702825|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702826|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702827|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44702828|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44702829|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44702830|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
44702831|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702832|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44702833|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44702834|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702835|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
44702836|NCT01411124|Promethazine|promethazine|mesh-list
44702837|NCT01411124|Gabapentin|gabapentin|mesh-list
44702838|NCT01411124|Analgesics|analgesics|mesh-ancestor
44702839|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
44702840|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702841|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702842|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
44702843|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44702844|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44702845|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702846|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702847|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44702848|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44702849|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702850|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702851|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
44702852|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44702853|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44702854|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
44702855|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
44702856|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
44702857|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
44702858|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702859|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44702860|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
44702861|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
44702862|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44702863|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
44702864|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702865|NCT01411176|Menthol|menthol|mesh-list
44702866|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
44702867|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702868|NCT01411189|Menthol|menthol|mesh-list
44702869|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
44702870|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44702871|NCT01411202|Doxycycline|doxycycline|mesh-list
44702872|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702873|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702874|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
44702875|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44702876|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44702877|NCT01411254|Betamethasone|betamethasone|mesh-list
44702878|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
44702879|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44702880|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
44702881|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44906404|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
44906405|NCT04017897|Nivolumab|nivolumab|mesh-list
44906406|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44906407|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906408|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44906409|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906410|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
44906411|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44906412|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44906413|NCT04017741|Prednisolone|prednisolone|mesh-list
44906414|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
44906415|NCT04017741|Lidocaine|lidocaine|mesh-list
44906416|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44906417|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
44906418|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
44906419|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
44906420|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906421|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906422|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
44906423|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906424|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44906425|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44906426|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44906427|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906428|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906429|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906430|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
44906431|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
44906432|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906433|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
44906434|NCT04017741|Hormones|hormones|mesh-ancestor
44935908|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906435|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906436|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44906437|NCT04017741|Protective Agents|protective agents|mesh-ancestor
44906438|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906439|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906440|NCT04018131|Cimetidine|cimetidine|mesh-list
44906441|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44906442|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906443|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44906444|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
44906445|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
44906446|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906447|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906448|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906449|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44906450|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44906451|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906452|NCT04017845|Tribenoside|tribenoside|mesh-list
44906453|NCT04017845|Lidocaine|lidocaine|mesh-list
44906454|NCT04017845|Diltiazem|diltiazem|mesh-list
44906455|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
44906456|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
44906457|NCT04017845|Bisacodyl|bisacodyl|mesh-list
44906458|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
44906459|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
44906460|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906461|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906462|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
44906463|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906464|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44906465|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44906466|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44906467|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906468|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906469|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44906470|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44906471|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906472|NCT04017845|Cathartics|cathartics|mesh-ancestor
44906473|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906474|NCT04017845|Laxatives|laxatives|mesh-ancestor
44906475|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906476|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906477|NCT04017845|Analgesics|analgesics|mesh-ancestor
44906478|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906479|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906480|NCT04017988|Ethanol|ethanol|mesh-list
44699325|NCT03620903|Rituximab|rituximab|mesh-list
44906481|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44906482|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906483|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906484|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906485|NCT04017624|Nicotine|nicotine|mesh-list
44906486|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44906487|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
44906488|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906489|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906490|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44906491|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44906492|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44906493|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906494|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906495|NCT04017377|Paclitaxel|paclitaxel|mesh-list
44906496|NCT04017377|Cisplatin|cisplatin|mesh-list
44906497|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44906498|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906499|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44906500|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44906501|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44906502|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906504|NCT04017598|Trace Elements|trace elements|mesh-ancestor
44906505|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
44906506|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906507|NCT04017455|Bevacizumab|bevacizumab|mesh-list
44906508|NCT04017455|Atezolizumab|atezolizumab|mesh-list
44906509|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44906510|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906511|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44906512|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44906513|NCT04017455|Growth Substances|growth substances|mesh-ancestor
44906514|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906515|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
44906516|NCT04017338|Ezetimibe|ezetimibe|mesh-list
44906517|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44906518|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44906519|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
44906520|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906521|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44906522|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44906523|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
44906524|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906525|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906526|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906527|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906528|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44906529|NCT04016922|Hematinics|hematinics|mesh-ancestor
44906530|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44906531|NCT04017104|Edotreotide|edotreotide|mesh-list
44906532|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44906533|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906534|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
44906535|NCT04016740|Ketamine|ketamine|mesh-list
44906536|NCT04016740|Remifentanil|remifentanil|mesh-list
44906537|NCT04016740|Propofol|propofol|mesh-list
44906538|NCT04016740|Ropivacaine|ropivacaine|mesh-list
44906539|NCT04016740|Sevoflurane|sevoflurane|mesh-list
44906540|NCT04016740|Rocuronium|rocuronium|mesh-list
44906541|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906542|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906543|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906544|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906545|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
44906546|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
44906547|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906548|NCT04016740|Analgesics|analgesics|mesh-ancestor
44906549|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
44906550|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906551|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906552|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44906553|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906554|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906555|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906556|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906557|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44906558|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44906559|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44906561|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44906562|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44906563|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44906564|NCT04016740|Narcotics|narcotics|mesh-ancestor
44906565|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44906566|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44906567|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44906568|NCT04016246|Propofol|propofol|mesh-list
44906569|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44906570|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906571|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906572|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44906573|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
44906574|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
44906575|NCT04016233|Tenofovir|tenofovir|mesh-list
44906576|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
44906577|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906578|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44906579|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44699473|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44699474|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699475|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699476|NCT03254394|Lidocaine|lidocaine|mesh-list
44699477|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699478|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
44699479|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699480|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699481|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
44699482|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699483|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44699484|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44699485|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44699486|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699487|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699488|NCT03209687|Menotropins|menotropins|mesh-list
44699489|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44699490|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
44699491|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44699492|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699493|NCT03203876|Nivolumab|nivolumab|mesh-list
44699494|NCT03203876|Ipilimumab|ipilimumab|mesh-list
44699495|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699496|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699497|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44906580|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906581|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906582|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44906583|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44906584|NCT04016051|Clarithromycin|clarithromycin|mesh-list
44906585|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906586|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906587|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44906588|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906589|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906590|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44906591|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44906592|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
44510790|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906593|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44906594|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906595|NCT04016220|Budesonide|budesonide|mesh-list
44906596|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906597|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44906598|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
44906599|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906600|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906601|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44906602|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
44906603|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
44906604|NCT04016220|Hormones|hormones|mesh-ancestor
44906613|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906614|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906615|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
44906616|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
44906617|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44906618|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906619|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906620|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44906621|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44906622|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44906623|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906624|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906625|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44906626|NCT04015908|Narcotics|narcotics|mesh-ancestor
44906627|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906628|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906629|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906630|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44906631|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44906632|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906633|NCT04016207|Guanfacine|guanfacine|mesh-list
44906634|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906635|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44906636|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44906637|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44906638|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906639|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906640|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906641|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906642|NCT04015596|Naproxen|naproxen|mesh-list
44906643|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906644|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906645|NCT04015596|Analgesics|analgesics|mesh-ancestor
44906646|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
44906647|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906648|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906649|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906650|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906651|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
44906652|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44906653|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906654|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906655|NCT04015557|Acetaminophen|acetaminophen|mesh-list
44906656|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
44906657|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44906658|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906659|NCT04015557|Analgesics|analgesics|mesh-ancestor
44906660|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
44906661|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906662|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906663|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
44906664|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
44906665|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906666|NCT04015557|Expectorants|expectorants|mesh-ancestor
44906667|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
44906668|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44906669|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
44906670|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906671|NCT04015557|Protective Agents|protective agents|mesh-ancestor
44906672|NCT04015557|Antidotes|antidotes|mesh-ancestor
44906674|NCT04015492|BAX 855|bax 855|mesh-list
44906675|NCT04015492|Coagulants|coagulants|mesh-ancestor
44906676|NCT04015687|Lamotrigine|lamotrigine|mesh-list
44906677|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
44906678|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44906679|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906680|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906681|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44906682|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906683|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44906684|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44906685|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906686|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906687|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44906688|NCT04015778|Paclitaxel|paclitaxel|mesh-list
44906689|NCT04015778|Carboplatin|carboplatin|mesh-list
44906690|NCT04015778|Nivolumab|nivolumab|mesh-list
44906691|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44906692|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906693|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44906694|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44906695|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44906696|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906697|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44906698|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44906699|NCT04015661|Paclitaxel|paclitaxel|mesh-list
44906700|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44906701|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44906702|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906703|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
44906704|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
44906705|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
44906706|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906707|NCT04015375|Dapsone|dapsone|mesh-list
44906708|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906709|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
44906710|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44906711|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44906712|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44906713|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906714|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906715|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
44906716|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44906717|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
44906718|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44906719|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44906720|NCT04014634|Prednisolone|prednisolone|mesh-list
44906721|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
44906722|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44906723|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
44906724|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906725|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
44906726|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
44906727|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906728|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906729|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906730|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
44906731|NCT04014634|Hormones|hormones|mesh-ancestor
44906732|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906733|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44906734|NCT04014634|Protective Agents|protective agents|mesh-ancestor
44906735|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906736|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906737|NCT04014855|Lactoferrin|lactoferrin|mesh-list
44906738|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906739|NCT04014556|Aflibercept|aflibercept|mesh-list
44906740|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44906741|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44906742|NCT04014556|Growth Substances|growth substances|mesh-ancestor
44906743|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906744|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
44906745|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906746|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
44906747|NCT04014192|Empagliflozin|empagliflozin|mesh-list
44906748|NCT04014192|Canagliflozin|canagliflozin|mesh-list
44906749|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44906750|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906751|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906752|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906754|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906755|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44906756|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906757|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906758|NCT04014244|Triamcinolone|triamcinolone|mesh-list
44906759|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44906760|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44906761|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44906762|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906763|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
44906764|NCT04014244|Hormones|hormones|mesh-ancestor
44906765|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906766|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906767|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44906768|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
44906769|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906770|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906771|NCT04014361|Itraconazole|itraconazole|mesh-list
44906772|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
44906773|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906774|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44906775|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44906776|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906777|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906778|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44906779|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
44906780|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906781|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906782|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44906783|NCT04014283|Selenium|selenium|mesh-list
44906784|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
44906785|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906786|NCT04014283|Protective Agents|protective agents|mesh-ancestor
44906787|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906788|NCT04014283|Trace Elements|trace elements|mesh-ancestor
44906789|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
44906790|NCT04013815|Ropivacaine|ropivacaine|mesh-list
44906791|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
44906792|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
44906793|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906794|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906795|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
44906796|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906797|NCT04013581|Empagliflozin|empagliflozin|mesh-list
44906798|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44906799|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906800|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906801|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906802|NCT04013919|Insulin|insulin|mesh-list
44906803|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44906804|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906805|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906806|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
44906807|NCT04013646|Hematinics|hematinics|mesh-ancestor
44906808|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44906809|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44906810|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44906811|NCT04013620|Abatacept|abatacept|mesh-list
44906812|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44906813|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906814|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906815|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44906816|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
44906817|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906818|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906819|NCT04013958|Ketamine|ketamine|mesh-list
44906820|NCT04013958|Analgesics|analgesics|mesh-ancestor
44699676|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
44906839|NCT04013386|Dexamethasone|dexamethasone|mesh-list
44906840|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
44906841|NCT04013386|Aprepitant|aprepitant|mesh-list
44906842|NCT04013386|Mirtazapine|mirtazapine|mesh-list
44906843|NCT04013386|BB 1101|bb 1101|mesh-list
44906844|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906845|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
44906846|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
44906847|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906848|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906849|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44906850|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
44906851|NCT04013386|Hormones|hormones|mesh-ancestor
44906852|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906853|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44906854|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906855|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
44906856|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906857|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906858|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44906859|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906860|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
44906861|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906862|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44906863|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
44906864|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
44906865|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44906866|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44906867|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906868|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44906869|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44906870|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44906871|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44906872|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44906873|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44906874|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
44906875|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44906876|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44906877|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44906878|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
44906879|NCT04013438|Estradiol|estradiol|mesh-list
44906880|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44906881|NCT04013438|Estrogens|estrogens|mesh-ancestor
44906882|NCT04013438|Hormones|hormones|mesh-ancestor
44906883|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906884|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906885|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44906886|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
44906887|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44906888|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44906889|NCT04013438|Urological Agents|urological agents|mesh-ancestor
44906890|NCT04013477|Donepezil|donepezil|mesh-list
44906891|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44906892|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906893|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906894|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
44906895|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906896|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906897|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
44906898|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
44906899|NCT04013243|Analgesics|analgesics|mesh-ancestor
44906900|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
44906901|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906902|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906903|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
44906904|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906905|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44906906|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
44906907|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44906908|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906909|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906910|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44906911|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
44906912|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44906913|NCT04013464|Citalopram|citalopram|mesh-list
44906914|NCT04013464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44906915|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44906916|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44906917|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906918|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44906919|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
44906920|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906921|NCT04013464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44906922|NCT04013464|Antidepressive Agents|antidepressive agents|mesh-ancestor
44906923|NCT04013464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44906924|NCT04012918|Capecitabine|capecitabine|mesh-list
44906925|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44906926|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44906927|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
44906928|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906929|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906930|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44906931|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906932|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44906933|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
44906934|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44906935|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906936|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44906937|NCT04012619|Cisplatin|cisplatin|mesh-list
44906938|NCT04012619|Carboplatin|carboplatin|mesh-list
44906939|NCT04012619|Pemetrexed|pemetrexed|mesh-list
44906940|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906941|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906942|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906943|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44906944|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44906945|NCT04012775|Insulin|insulin|mesh-list
44906946|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44906947|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44906948|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906949|NCT04012606|Cisplatin|cisplatin|mesh-list
44906950|NCT04012606|Carboplatin|carboplatin|mesh-list
44906951|NCT04012606|Etoposide|etoposide|mesh-list
44906952|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906953|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44906954|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44906955|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44906956|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906957|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906958|NCT04012450|Anesthetics|anesthetics|mesh-list
44906959|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44906960|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906961|NCT04012424|Curcumin|curcumin|mesh-list
44906962|NCT04012424|Analgesics|analgesics|mesh-list
44906963|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906964|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906965|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
44906966|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906967|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44906968|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906969|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906970|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44906971|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906972|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906973|NCT04012307|Candesartan|candesartan|mesh-list
44906974|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
44906975|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906976|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44906977|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44906978|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906979|NCT04012268|Aspirin|aspirin|mesh-list
44906980|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44906981|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44906982|NCT04012268|Analgesics|analgesics|mesh-ancestor
44906983|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
44906984|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44906985|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699901|NCT02666794|Sufentanil|sufentanil|mesh-list
44906986|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44906987|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44906988|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44906989|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44906990|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44906991|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44906992|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44906993|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44906994|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
44906995|NCT04012047|Cromakalim|cromakalim|mesh-list
44906996|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44906997|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44906998|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
44906999|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907000|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907001|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44907002|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44907003|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
44907004|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
44907005|NCT04012294|Allopurinol|allopurinol|mesh-list
44907006|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
44907007|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907008|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907009|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
44907010|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907011|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44907012|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
44907013|NCT04012294|Protective Agents|protective agents|mesh-ancestor
44907014|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907015|NCT04011930|Vitamin D|vitamin d|mesh-list
44907016|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
44907017|NCT04011930|Calcitriol|calcitriol|mesh-list
44907018|NCT04011930|Vitamins|vitamins|mesh-ancestor
44907019|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
44907020|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907021|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44907022|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907023|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44907024|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907025|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907026|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44907027|NCT04011813|Antioxidants|antioxidants|mesh-list
44907028|NCT04011813|Hypotaurine|hypotaurine|mesh-list
44907029|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907030|NCT04011813|Protective Agents|protective agents|mesh-ancestor
44907031|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907032|NCT04011670|Caffeine|caffeine|mesh-list
44907033|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44907034|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907035|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44907036|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907037|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907038|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44907039|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44907040|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
44907041|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907042|NCT04011878|Mitomycins|mitomycins|mesh-list
44907043|NCT04011878|Mitomycin|mitomycin|mesh-list
44907044|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44907045|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907046|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
44907047|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907048|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907049|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907050|NCT04011345|Folic Acid|folic acid|mesh-list
44907051|NCT04011345|Hematinics|hematinics|mesh-ancestor
44907052|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
44907053|NCT04011345|Vitamins|vitamins|mesh-ancestor
44699978|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699979|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44699980|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44699981|NCT02636322|Growth Substances|growth substances|mesh-ancestor
44699982|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44907054|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
44907055|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907056|NCT04011280|Varenicline|varenicline|mesh-list
44907063|NCT04011124|Rifampin|rifampin|mesh-list
44907064|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44907065|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
44907066|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44907067|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907068|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
44907069|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907070|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907071|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907072|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44907073|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44907074|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44907075|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44907076|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44907077|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44907078|NCT04010955|Edoxaban|edoxaban|mesh-list
44907079|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44907080|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
44907081|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44907082|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
44907083|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907084|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907085|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
44907086|NCT04011241|Itraconazole|itraconazole|mesh-list
44907087|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
44907088|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907089|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44907090|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44907091|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907092|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907093|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44907094|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
44907095|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907096|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907097|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44907098|NCT04011098|Fentanyl|fentanyl|mesh-list
44907099|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44907100|NCT04011098|Narcotics|narcotics|mesh-ancestor
44907101|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907102|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907103|NCT04011098|Analgesics|analgesics|mesh-ancestor
44907104|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
44907105|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511262|NCT01720836|Poly ICLC|poly iclc|mesh-list
44907106|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44907107|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44907108|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
44907109|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
44907110|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
44907111|NCT04011033|Interleukin-2|interleukin-2|mesh-list
44907112|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907113|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
44907114|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907115|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907116|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44907117|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
44907118|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907119|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907120|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44907121|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907122|NCT04011033|Analgesics|analgesics|mesh-ancestor
44907123|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
44907124|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907125|NCT04010929|Pemetrexed|pemetrexed|mesh-list
44907126|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907127|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907128|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907129|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44907130|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907131|NCT04010942|Metformin|metformin|mesh-list
44907132|NCT04010942|Clomiphene|clomiphene|mesh-list
44907133|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907134|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907135|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44907136|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44907137|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907139|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
44907140|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907141|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44907142|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44907143|NCT04010903|Insulin|insulin|mesh-list
44907144|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907145|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907146|NCT04010669|Somatostatin|somatostatin|mesh-list
44907147|NCT04010669|Hormones|hormones|mesh-ancestor
44907148|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907149|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907150|NCT04010578|Vitamin D|vitamin d|mesh-list
44907151|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
44907152|NCT04010578|Vitamins|vitamins|mesh-ancestor
44907153|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
44907154|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907155|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44907156|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907157|NCT04010318|Anesthetics|anesthetics|mesh-list
44907158|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907159|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907160|NCT04010071|Axitinib|axitinib|mesh-list
44907161|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907162|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44907163|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907164|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907165|NCT04009759|Ketamine|ketamine|mesh-list
44907166|NCT04009759|Morphine|morphine|mesh-list
44907167|NCT04009759|Analgesics|analgesics|mesh-ancestor
44907168|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
44907169|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907170|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907171|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44907172|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44907173|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
44907174|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
44907175|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907176|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44907177|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44907178|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907179|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907180|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44907181|NCT04009759|Narcotics|narcotics|mesh-ancestor
44907182|NCT04009772|Metronidazole|metronidazole|mesh-list
44907183|NCT04009772|Cefuroxime|cefuroxime|mesh-list
44907184|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
44907185|NCT04009772|Cefepime|cefepime|mesh-list
44907186|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907187|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44907188|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44907189|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44907190|NCT04009889|Silicon|silicon|mesh-list
44907191|NCT04009889|Trace Elements|trace elements|mesh-ancestor
44907192|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
44907193|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907194|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
44907195|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44907196|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907197|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
44907198|NCT04009603|Metformin|metformin|mesh-list
44907199|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907200|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907201|NCT04009525|Cyclosporine|cyclosporine|mesh-list
44907202|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
44907203|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
44907204|NCT04009525|Busulfan|busulfan|mesh-list
44907205|NCT04009525|Methotrexate|methotrexate|mesh-list
44907206|NCT04009525|Fludarabine|fludarabine|mesh-list
44907207|NCT04009525|Tacrolimus|tacrolimus|mesh-list
44907208|NCT04009525|Cyclosporins|cyclosporins|mesh-list
44907209|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
44907210|NCT04009525|Basiliximab|basiliximab|mesh-list
44907211|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907212|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
44907213|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907214|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907228|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907229|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44907230|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
44907231|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907232|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44907233|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44907234|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
44907235|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44907236|NCT04009317|Crizotinib|crizotinib|mesh-list
44907237|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907238|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44907239|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907240|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907241|NCT04008979|Aspirin|aspirin|mesh-list
44907242|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44907243|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907244|NCT04008979|Analgesics|analgesics|mesh-ancestor
44907245|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
44907246|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907247|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907248|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907249|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907250|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44907251|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44907252|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907253|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44907254|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44907255|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907256|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
44907257|NCT04009018|Anesthetics|anesthetics|mesh-list
44907258|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907259|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907260|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
44907261|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
44907262|NCT04008784|Triamcinolone|triamcinolone|mesh-list
44907263|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44907264|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44907265|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44907266|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907267|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
44907268|NCT04008784|Hormones|hormones|mesh-ancestor
44907269|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907270|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907271|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907272|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
44907273|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907274|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907275|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44907276|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44907277|NCT04008966|Cetrorelix|cetrorelix|mesh-list
44907278|NCT04008966|Progesterone|progesterone|mesh-list
44907279|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44907280|NCT04008966|Progestins|progestins|mesh-ancestor
44907281|NCT04008966|Hormones|hormones|mesh-ancestor
44907282|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907283|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907284|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
44907285|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44907286|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
44907287|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907288|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44907289|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44907290|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907291|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44907292|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
44907293|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
44907294|NCT04008888|Dexamethasone|dexamethasone|mesh-list
44907295|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
44907296|NCT04008888|Fludarabine|fludarabine|mesh-list
44907297|NCT04008888|Melphalan|melphalan|mesh-list
44907298|NCT04008888|BB 1101|bb 1101|mesh-list
44907299|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907300|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
44907301|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
44907302|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907303|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907304|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907305|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
44907306|NCT04008888|Hormones|hormones|mesh-ancestor
44907307|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907308|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44907309|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907310|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44907311|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907312|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907313|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907314|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
44907315|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44907316|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
44907317|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44907318|NCT04008511|Capecitabine|capecitabine|mesh-list
44907319|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
44907320|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44907321|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
44907322|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907323|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907324|NCT04008290|Liraglutide|liraglutide|mesh-list
44907325|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907326|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907327|NCT04008290|Incretins|incretins|mesh-ancestor
44907328|NCT04008290|Hormones|hormones|mesh-ancestor
44907329|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907330|NCT04008225|Dimercaprol|dimercaprol|mesh-list
44907331|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
44907332|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
44907333|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907334|NCT04008186|Metformin|metformin|mesh-list
44907335|NCT04008186|Repaglinide|repaglinide|mesh-list
44907336|NCT04008186|Itraconazole|itraconazole|mesh-list
44907337|NCT04008186|Digoxin|digoxin|mesh-list
44907338|NCT04008186|Verapamil|verapamil|mesh-list
44907339|NCT04008186|Midazolam|midazolam|mesh-list
44907340|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44907341|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
44907342|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907343|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907344|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44907345|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44907346|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907347|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44907348|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44907349|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44907350|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44907351|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
44907352|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
44907353|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
44907354|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
44907355|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907356|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907357|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44907358|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44907359|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
44907360|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44907361|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44907362|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907363|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
44907364|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907365|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44907366|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44907367|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44907368|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
44907369|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907370|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44907371|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44907372|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44907373|NCT04008186|Protective Agents|protective agents|mesh-ancestor
44907374|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44907375|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907376|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907377|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
44907378|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44907379|NCT04008433|Lidocaine|lidocaine|mesh-list
44907380|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
44907381|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
44907382|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907383|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907384|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
44907385|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907386|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44907387|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44907388|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44907389|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907390|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907391|NCT04008316|Colchicine|colchicine|mesh-list
44907392|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
44907393|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907394|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
44907395|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
44907396|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
44907397|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907398|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907399|NCT04008043|Acetaminophen|acetaminophen|mesh-list
44907400|NCT04008043|Dexamethasone|dexamethasone|mesh-list
44907401|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44907402|NCT04008043|Hydrocodone|hydrocodone|mesh-list
44907403|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907404|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
44907405|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
44907406|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907407|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907408|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907409|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
44907410|NCT04008043|Hormones|hormones|mesh-ancestor
44907411|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907412|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44907413|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907414|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907415|NCT04008043|Analgesics|analgesics|mesh-ancestor
44907416|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
44907417|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
44907418|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44907419|NCT04008043|Narcotics|narcotics|mesh-ancestor
44907420|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907421|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
44907422|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
44907423|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44907424|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700437|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44700514|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44700515|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702898|NCT01411410|Paclitaxel|paclitaxel|mesh-list
44702899|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44702900|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702901|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
44702902|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
44702903|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
44702904|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702905|NCT01411423|Sorafenib|sorafenib|mesh-list
44702906|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702907|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702908|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702909|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702910|NCT01411436|Sorafenib|sorafenib|mesh-list
44702911|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702912|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44702913|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702914|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702915|NCT01411514|Prednisone|prednisone|mesh-list
44702916|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702917|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
44702918|NCT01411514|Hormones|hormones|mesh-ancestor
44702919|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702920|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702921|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44702922|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702923|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44702924|NCT01411670|Protein C|protein c|mesh-list
44702925|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
44702926|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44702927|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44702928|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702929|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702930|NCT01411735|Enalapril|enalapril|mesh-list
44702931|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44702932|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
44702933|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702934|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702935|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702936|NCT01411930|Olanzapine|olanzapine|mesh-list
44702937|NCT01411930|Aripiprazole|aripiprazole|mesh-list
44702938|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
44702939|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
44702940|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702941|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702942|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702943|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44702944|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44702945|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702946|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44702947|NCT01411930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44702948|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44702949|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702950|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702951|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702952|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
44702953|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
44702954|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
44702955|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
44702956|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44702957|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44702958|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44702959|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44702960|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44702961|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44702962|NCT01411969|Phenylephrine|phenylephrine|mesh-list
44702963|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
44702964|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44702965|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44907425|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44907426|NCT04007835|Gefitinib|gefitinib|mesh-list
44907427|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907428|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44907429|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907430|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907431|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
44907432|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
44907433|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907434|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
44907435|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
44907436|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44907437|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44907438|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907439|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907440|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907441|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907442|NCT04007588|Nivolumab|nivolumab|mesh-list
44907443|NCT04007588|Ipilimumab|ipilimumab|mesh-list
44907444|NCT04007588|Linrodostat|linrodostat|mesh-list
44907445|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44907446|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907447|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44907448|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907449|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907450|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
44907451|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44907452|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44907453|NCT04007328|Prednisolone|prednisolone|mesh-list
44907454|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
44907455|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44907456|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
44907457|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907458|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
44907459|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
44907460|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907461|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907462|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907463|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
44907464|NCT04007328|Hormones|hormones|mesh-ancestor
44907465|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907466|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44907467|NCT04007328|Protective Agents|protective agents|mesh-ancestor
44907468|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44907469|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907470|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
44907471|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44907472|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907473|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907474|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907475|NCT04007341|Analgesics|analgesics|mesh-ancestor
44907476|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
44907477|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907478|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44907479|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44907480|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44907481|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
44907482|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907483|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907484|NCT04007003|Insulin|insulin|mesh-list
44907485|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907486|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907487|NCT04006873|Ivacaftor|ivacaftor|mesh-list
44907488|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44907489|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907490|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907491|NCT04006847|Dasatinib|dasatinib|mesh-list
44907492|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907493|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44907494|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907495|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907496|NCT04006821|Apatinib|apatinib|mesh-list
44907497|NCT04006821|Antibodies|antibodies|mesh-list
44907498|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
44907499|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907500|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907501|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44907502|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907541|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
44907543|NCT04006041|Cisplatin|cisplatin|mesh-list
44907544|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44907545|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907546|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44907547|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44907548|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44907549|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907550|NCT04006353|Rifampin|rifampin|mesh-list
44907551|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44907552|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
44907553|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44907554|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907555|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
44907556|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907557|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907558|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907559|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44907560|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44907561|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44907562|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44907563|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44907564|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44907565|NCT04006054|Midazolam|midazolam|mesh-list
44907566|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
44907567|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44907568|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907569|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907570|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907571|NCT04006054|Analgesics|analgesics|mesh-ancestor
44907572|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
44907573|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907574|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44907575|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44907576|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44907577|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
44907578|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907579|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907580|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44907581|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44907582|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44907583|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44907584|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44907585|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
44907586|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
44907587|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
44907588|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
44907589|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
44907590|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
44907591|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44907592|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44907593|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907594|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907595|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907596|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907597|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
44907598|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
44907599|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44907600|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44907601|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907602|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907603|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907604|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907605|NCT04005612|Vitamin D|vitamin d|mesh-list
44907606|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
44907607|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
44907608|NCT04005612|Vitamins|vitamins|mesh-list
44907609|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
44907610|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907611|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44907612|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907613|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44907614|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907615|NCT04005664|Phenylephrine|phenylephrine|mesh-list
44907616|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
44907617|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44907618|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
44907619|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
44907620|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907621|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907622|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
44907623|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44907624|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
44907625|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
44907626|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44907627|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44907628|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44907629|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44907630|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907631|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907632|NCT04005664|Protective Agents|protective agents|mesh-ancestor
44907633|NCT04005469|Treprostinil|treprostinil|mesh-list
44907634|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44907635|NCT04005430|Dexamethasone|dexamethasone|mesh-list
44907636|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
44907637|NCT04005430|BB 1101|bb 1101|mesh-list
44907638|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907639|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
44907640|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
44907641|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907642|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907643|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907644|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
44907645|NCT04005430|Hormones|hormones|mesh-ancestor
44907646|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907647|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44907648|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907649|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
44907650|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907651|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907652|NCT04005365|Propranolol|propranolol|mesh-list
44907653|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44907654|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44907655|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
44907656|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907657|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907658|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907659|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44907660|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44907661|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
44907662|NCT04005222|Selenium|selenium|mesh-list
44907663|NCT04005222|Melatonin|melatonin|mesh-list
44907664|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
44907665|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907666|NCT04005222|Protective Agents|protective agents|mesh-ancestor
44907667|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907668|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907669|NCT04005222|Trace Elements|trace elements|mesh-ancestor
44907670|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
44907671|NCT04005417|Fluorides|fluorides|mesh-list
44907672|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
44907673|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
44907674|NCT04005417|Protective Agents|protective agents|mesh-ancestor
44907675|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907676|NCT04004754|Miltefosine|miltefosine|mesh-list
44907677|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
44907678|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907679|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907680|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44907681|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44907682|NCT04004871|Paclitaxel|paclitaxel|mesh-list
44907683|NCT04004871|Cisplatin|cisplatin|mesh-list
44907684|NCT04004871|Fluorouracil|fluorouracil|mesh-list
44907685|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44907686|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907687|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
44907688|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700743|NCT01398267|Lisinopril|lisinopril|mesh-list
44907689|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
44907690|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907691|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
44907692|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700812|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44700814|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700815|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700816|NCT01398618|Rifampin|rifampin|mesh-list
44700817|NCT01398618|Isoniazid|isoniazid|mesh-list
44700818|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44700819|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
44700820|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700821|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700822|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
44700823|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44700824|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700825|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700826|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44700827|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44700828|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44700829|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44700830|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44700831|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44700832|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44700833|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44700834|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
44700835|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44700836|NCT01398657|Androgens|androgens|mesh-list
44700837|NCT01398657|Hormones|hormones|mesh-ancestor
44700838|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700839|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700840|NCT01398670|Insulin|insulin|mesh-list
44700841|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44700842|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
44700843|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700844|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700845|NCT01398722|Insulin|insulin|mesh-list
44700846|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44700847|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700848|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907693|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907694|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
44907695|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907696|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
44907697|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44907698|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
44907699|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907700|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907701|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44907702|NCT04004988|Tirzepatide|tirzepatide|mesh-list
44907703|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44907704|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907705|NCT04004988|Incretins|incretins|mesh-ancestor
44907706|NCT04004988|Hormones|hormones|mesh-ancestor
44907707|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907708|NCT04004702|Levetiracetam|levetiracetam|mesh-list
44907709|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
44907710|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
44907711|NCT04004507|Phentolamine|phentolamine|mesh-list
44907712|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44907713|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44907714|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44907715|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44907716|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
44907717|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907718|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907719|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907720|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44907721|NCT04004572|Pegaspargase|pegaspargase|mesh-list
44907722|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907723|NCT04004234|Manganese|manganese|mesh-list
44907724|NCT04004234|Gemcitabine|gemcitabine|mesh-list
44907725|NCT04004234|Paclitaxel|paclitaxel|mesh-list
44907726|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44907727|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44907728|NCT04004234|Antibodies|antibodies|mesh-list
44907729|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
44907732|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
44907733|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
44907734|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
44907735|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907736|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
44907737|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907738|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44907739|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
44907740|NCT04004234|Antiviral Agents|antiviral agents|mesh-ancestor
44907741|NCT04004234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907742|NCT04004234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907743|NCT04004234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907744|NCT04004234|Trace Elements|trace elements|mesh-ancestor
44907745|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
44907747|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44907748|NCT04004117|Narcotics|narcotics|mesh-ancestor
44907749|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907750|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907751|NCT04004117|Analgesics|analgesics|mesh-ancestor
44907752|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
44907753|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907754|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44907755|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44907756|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
44907757|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
44907758|NCT04003844|Aspirin|aspirin|mesh-list
44907759|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
44907760|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44907761|NCT04003844|Antibodies|antibodies|mesh-list
44907762|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
44907763|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
44907764|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907765|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44907766|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907767|NCT04003844|Analgesics|analgesics|mesh-ancestor
44907768|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
44907769|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907770|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907771|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907772|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44907773|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44907774|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907775|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44907776|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44907777|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907778|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
44907779|NCT04003792|Bevacizumab|bevacizumab|mesh-list
44907780|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
44907781|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44907782|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907783|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44907784|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44907785|NCT04003792|Growth Substances|growth substances|mesh-ancestor
44907786|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907787|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
44907788|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
44907789|NCT04003688|Analgesics|analgesics|mesh-ancestor
44907790|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
44907791|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907792|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907793|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
44907794|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907795|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44907796|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
44907797|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44907798|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907799|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907800|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907801|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
44907802|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907803|NCT04003376|Vitamin D|vitamin d|mesh-list
44907804|NCT04003376|Triamcinolone|triamcinolone|mesh-list
44907805|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44907806|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44907807|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44907808|NCT04003376|Vitamins|vitamins|mesh-ancestor
44907809|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
44907810|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907811|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44907812|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907813|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
44907814|NCT04003376|Hormones|hormones|mesh-ancestor
44907815|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907816|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44907817|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
44907818|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907819|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907820|NCT04003467|Teriparatide|teriparatide|mesh-list
44907821|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44907822|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907823|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44907824|NCT04003402|Ethanol|ethanol|mesh-list
44907825|NCT04003402|ASP8062|asp8062|mesh-list
44907826|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44907827|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907828|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907829|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907830|NCT04003402|Analgesics|analgesics|mesh-ancestor
44907831|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
44907832|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907833|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
44907834|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
44907835|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907836|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907837|NCT04003350|Acetaminophen|acetaminophen|mesh-list
44907838|NCT04003350|Meloxicam|meloxicam|mesh-list
44907839|NCT04003350|Oxycodone|oxycodone|mesh-list
44907840|NCT04003350|Tramadol|tramadol|mesh-list
44907841|NCT04003350|Gabapentin|gabapentin|mesh-list
44907842|NCT04003350|Esomeprazole|esomeprazole|mesh-list
44907843|NCT04003350|Metaxalone|metaxalone|mesh-list
44907844|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44907845|NCT04003350|Narcotics|narcotics|mesh-ancestor
44907846|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907847|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907848|NCT04003350|Analgesics|analgesics|mesh-ancestor
44907849|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
44907850|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907851|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
44907852|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44907853|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44907854|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44907855|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44907856|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44907857|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907858|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907859|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
44907860|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44907861|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907862|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44907863|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907864|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907865|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
44907866|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44907867|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907868|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907869|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44907870|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44907871|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44907872|NCT04003207|Hormones|hormones|mesh-list
44907873|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907874|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907875|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44907876|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
44907877|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907878|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907879|NCT04003012|Lidocaine|lidocaine|mesh-list
44907880|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44907881|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
44907882|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907883|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907884|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
44907885|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907886|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44907887|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44907888|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44907889|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44907890|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907891|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44907892|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
44907894|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44907895|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44907896|NCT04002635|Estradiol|estradiol|mesh-list
44907897|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44907898|NCT04002635|Progesterone|progesterone|mesh-list
44907899|NCT04002635|Estrogens|estrogens|mesh-ancestor
44907900|NCT04002635|Hormones|hormones|mesh-ancestor
44907901|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907902|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907903|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44907904|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
44907905|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44907906|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44907907|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44907908|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44907909|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44907910|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907911|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907912|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44907913|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
44907914|NCT04002635|Progestins|progestins|mesh-ancestor
44907915|NCT04002323|Lamivudine|lamivudine|mesh-list
44907916|NCT04002323|Dolutegravir|dolutegravir|mesh-list
44907917|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44907918|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44907919|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44907920|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907921|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
44907922|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907923|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44907924|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44907925|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44907926|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44907927|NCT04002700|Haloperidol|haloperidol|mesh-list
44907928|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
44907929|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
44907930|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
44907931|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
44907932|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907933|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907934|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44907935|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701000|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701001|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701002|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
44701003|NCT01400464|Prednisone|prednisone|mesh-list
44701004|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701005|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
44701006|NCT01400464|Hormones|hormones|mesh-ancestor
44701007|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701008|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701009|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701011|NCT01400568|Fluticasone|fluticasone|mesh-list
44907936|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907937|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44907938|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44907939|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
44907940|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907941|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907942|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44907943|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
44907944|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44907945|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44907946|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44907947|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907948|NCT04002349|Budesonide|budesonide|mesh-list
44907949|NCT04002349|Levocabastine|levocabastine|mesh-list
44907950|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907951|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44907952|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
44907953|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907954|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907955|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44907956|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
44907957|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
44907958|NCT04002349|Hormones|hormones|mesh-ancestor
44907959|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44907960|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44907961|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44907962|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
44907963|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
44907964|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44907965|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907966|NCT04001959|Fluorides|fluorides|mesh-list
44907967|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
44907968|NCT04001959|Protective Agents|protective agents|mesh-ancestor
44907969|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907970|NCT04002089|Bupivacaine|bupivacaine|mesh-list
44907971|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44907972|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
44907973|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44907974|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907975|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
44907976|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907977|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44907978|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907979|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
44907980|NCT04002024|Salicylates|salicylates|mesh-list
44907981|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44907982|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
44907983|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
44907984|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
44907985|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44907986|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44907987|NCT04002024|Analgesics|analgesics|mesh-ancestor
44907988|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
44907989|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44907990|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44907991|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44907992|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44907993|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44907994|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935909|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44907995|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907996|NCT04001712|Caffeine|caffeine|mesh-list
44907997|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
44907998|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44907999|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908000|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908001|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44908002|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908003|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44908004|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44908005|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
44908006|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908007|NCT04001855|Acetic Acid|acetic acid|mesh-list
44908008|NCT04001855|Retinol acetate|retinol acetate|mesh-list
44908009|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44908010|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908011|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44908012|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
44908013|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908014|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44908015|NCT04001855|Protective Agents|protective agents|mesh-ancestor
44908016|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908029|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908030|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44908031|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
44908032|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
44908033|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908034|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
44908035|NCT04001465|Miotics|miotics|mesh-ancestor
44908036|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
44908037|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908038|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908039|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44908040|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44908041|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44908042|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44908043|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44908044|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
44908045|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908046|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908047|NCT04001231|Exenatide|exenatide|mesh-list
44908048|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44908049|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908050|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44908051|NCT04001231|Incretins|incretins|mesh-ancestor
44908052|NCT04001231|Hormones|hormones|mesh-ancestor
44908053|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908054|NCT04001400|Rabeprazole|rabeprazole|mesh-list
44908055|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44908056|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908057|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44908058|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908059|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908060|NCT04001387|Anesthetics|anesthetics|mesh-list
44908061|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908062|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908063|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44908064|NCT04001374|Ticagrelor|ticagrelor|mesh-list
44908065|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44908066|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44908067|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44908068|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44908069|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
44908070|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908071|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908072|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908073|NCT04001569|Paclitaxel|paclitaxel|mesh-list
44908074|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908075|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908076|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44908077|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44908078|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44908079|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701148|NCT01401179|Cefazolin|cefazolin|mesh-list
44908080|NCT04001348|Diazepam|diazepam|mesh-list
44908081|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44908082|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
44908083|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
44908084|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
44908085|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908086|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908087|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908088|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44908089|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908090|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44908091|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44908092|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44908093|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44908094|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44908095|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44908096|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
44908097|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
44908098|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
44908099|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
44908100|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908101|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908102|NCT04000919|Carbidopa|carbidopa|mesh-list
44908103|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44908104|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44908105|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
44908106|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908107|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908108|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908109|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44908110|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908111|NCT04000789|Vitamins|vitamins|mesh-list
44908112|NCT04000789|Vitamin E|vitamin e|mesh-list
44908113|NCT04000789|Vitamin A|vitamin a|mesh-list
44908114|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
44908115|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
44908116|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908117|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
44908118|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908119|NCT04000789|Protective Agents|protective agents|mesh-ancestor
44908120|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44908121|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
44908122|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
44908123|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
44908124|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908125|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
44908126|NCT04000932|Hormones|hormones|mesh-ancestor
44908127|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908128|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908129|NCT04000633|Lidocaine|lidocaine|mesh-list
44908130|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908131|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
44908132|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908133|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908134|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
44908135|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908136|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44908137|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44908138|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44908139|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908140|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908141|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
44908142|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
44908143|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
44908144|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44908145|NCT04000386|Protective Agents|protective agents|mesh-ancestor
44908146|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908147|NCT04000295|Paclitaxel|paclitaxel|mesh-list
44908148|NCT04000295|Etoposide|etoposide|mesh-list
44908149|NCT04000295|Apatinib|apatinib|mesh-list
44908150|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908151|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908152|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
44908153|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701224|NCT01402024|Aprepitant|aprepitant|mesh-list
44908154|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
44908155|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908156|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44908157|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44908158|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908159|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44908160|NCT04000126|Lidocaine|lidocaine|mesh-list
44908161|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908162|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
44908163|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908164|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908165|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
44908166|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908167|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44908168|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44908169|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44908170|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908171|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908172|NCT03999580|Vitamin D|vitamin d|mesh-list
44908173|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
44908174|NCT03999580|Vitamins|vitamins|mesh-ancestor
44908175|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
44908176|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908177|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44908178|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44908179|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
44908180|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
44908181|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44908182|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
44908183|NCT03999775|Vitamin D|vitamin d|mesh-list
44908184|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
44908185|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
44908186|NCT03999775|Vitamins|vitamins|mesh-list
44908187|NCT03999775|Calcium|calcium|mesh-list
44908188|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
44908189|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908190|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44908191|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44908192|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
44908193|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44908194|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
44908195|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908196|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
44908197|NCT03999372|Protective Agents|protective agents|mesh-ancestor
44908198|NCT03999437|Terbinafine|terbinafine|mesh-list
44908199|NCT03999437|Butenafine|butenafine|mesh-list
44908200|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
44908201|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908202|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908203|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908204|NCT03999099|Suvorexant|suvorexant|mesh-list
44908205|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44908206|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44908207|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908208|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908209|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44908210|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908211|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908212|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
44908213|NCT03999203|Citric Acid|citric acid|mesh-list
44908214|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
44908215|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44908216|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
44908217|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908218|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908219|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44908220|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
44908221|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44908222|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
44908223|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908224|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908225|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44908226|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44908227|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
44908228|NCT03999203|Protective Agents|protective agents|mesh-ancestor
44908229|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
44908230|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44701365|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701366|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701367|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701368|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
44701369|NCT01402674|Phentermine|phentermine|mesh-list
44701370|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44701371|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701372|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
44701373|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44701374|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
44701375|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
44701376|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701377|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
44701378|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701379|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702966|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
44702967|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702968|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702969|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702970|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
44254266|NCT03013504|Docetaxel|docetaxel|mesh-list
44702971|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
44702972|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702973|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
44702974|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44702975|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
44702976|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44702977|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
44702978|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44702979|NCT01411969|Protective Agents|protective agents|mesh-ancestor
44702980|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
44702981|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44702982|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702983|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702984|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
44702985|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702986|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702987|NCT01412073|Misoprostol|misoprostol|mesh-list
44702988|NCT01412073|Oxytocin|oxytocin|mesh-list
44702989|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
44702990|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44702991|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702992|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44702993|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
44702994|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44702995|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702996|NCT01412294|Cisplatin|cisplatin|mesh-list
44702997|NCT01412294|Capecitabine|capecitabine|mesh-list
44702998|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702999|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703000|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
44703001|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703002|NCT01412307|Lenalidomide|lenalidomide|mesh-list
44703003|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44703004|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
44703005|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703006|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44703007|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44703008|NCT01412307|Growth Substances|growth substances|mesh-ancestor
44703009|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
44908231|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
44908232|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
44908233|NCT03999190|Raclopride|raclopride|mesh-list
44908234|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
44908235|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908236|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908237|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44908238|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44908239|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908240|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908241|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
44908242|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908243|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44908244|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44908245|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908246|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44908247|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44908248|NCT03999008|Budesonide|budesonide|mesh-list
44908249|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908250|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44908251|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
44908252|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908253|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908254|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44908255|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44908256|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
44908257|NCT03999008|Hormones|hormones|mesh-ancestor
44908258|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908259|NCT03999125|Dexamethasone|dexamethasone|mesh-list
44908260|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
44908261|NCT03999125|Ranibizumab|ranibizumab|mesh-list
44908262|NCT03999125|Aflibercept|aflibercept|mesh-list
44908263|NCT03999125|BB 1101|bb 1101|mesh-list
44908264|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908265|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
44908266|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
44908267|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908268|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908269|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908270|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
44908271|NCT03999125|Hormones|hormones|mesh-ancestor
44908272|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908273|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908274|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908275|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
44908276|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908277|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908278|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44908279|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44908280|NCT03999125|Growth Substances|growth substances|mesh-ancestor
44908281|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44908282|NCT03998982|Dexamethasone|dexamethasone|mesh-list
44908283|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
44908284|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908285|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
44908286|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
44908287|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908288|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908289|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908290|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
44908291|NCT03998982|Hormones|hormones|mesh-ancestor
44908292|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908293|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908294|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908295|NCT03998969|Pantoprazole|pantoprazole|mesh-list
44908296|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44908297|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908298|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44908299|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908300|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701380|NCT01402843|Valsartan|valsartan|mesh-list
44701381|NCT01402843|Pitavastatin|pitavastatin|mesh-list
44701382|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44701383|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44701384|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44701385|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701386|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44701387|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44701388|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44701389|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
44701390|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701391|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44701392|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
44701393|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44701394|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44701395|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701396|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
44701397|NCT01402882|Coagulants|coagulants|mesh-ancestor
44252930|NCT00867321|Bevacizumab|bevacizumab|mesh-list
44908324|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44908325|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44908326|NCT03998826|Analgesics|analgesics|mesh-ancestor
44908327|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
44908328|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908329|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908330|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908331|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908332|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44908333|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908334|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908335|NCT03998592|Vaccines|vaccines|mesh-list
44908336|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
44908337|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908338|NCT03998436|Esmolol|esmolol|mesh-list
44908339|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44908340|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44908341|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44908342|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908343|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908344|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908345|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908346|NCT03997864|Prazosin|prazosin|mesh-list
44908347|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44908348|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44908349|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44908350|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44908351|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908352|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908353|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908354|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908355|NCT03997539|Vinorelbine|vinorelbine|mesh-list
44908356|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908357|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908358|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
44908359|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
44908360|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44908361|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908362|NCT03997500|Norepinephrine|norepinephrine|mesh-list
44908363|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44908364|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44908365|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908366|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908367|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908368|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908369|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
44908370|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
44908371|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908372|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44908373|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44908374|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44908375|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44908376|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908377|NCT03997279|Amoxicillin|amoxicillin|mesh-list
44908378|NCT03997279|Metronidazole|metronidazole|mesh-list
44908379|NCT03997279|Clarithromycin|clarithromycin|mesh-list
44908380|NCT03997279|Rabeprazole|rabeprazole|mesh-list
44908381|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44908382|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908383|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44908384|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44908385|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44908386|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908387|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908388|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44908389|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44908390|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44908391|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908392|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44908393|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
44908394|NCT03997019|Narcotics|narcotics|mesh-ancestor
44908395|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908396|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908397|NCT03997019|Analgesics|analgesics|mesh-ancestor
44908398|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
44908399|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908400|NCT03997006|Atropine|atropine|mesh-list
44908401|NCT03997006|Aminophylline|aminophylline|mesh-list
44908402|NCT03997006|Neostigmine|neostigmine|mesh-list
44908403|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44908404|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44908405|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44908406|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
44908407|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908408|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908409|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44908410|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
44908411|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
44908412|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
44908413|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44908414|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44908415|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
44908416|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908417|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908418|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44908419|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908420|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44908421|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44908422|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44908423|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44908424|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44908425|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
44908426|NCT03997006|Protective Agents|protective agents|mesh-ancestor
44908427|NCT03997058|Estazolam|estazolam|mesh-list
44908428|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
44908429|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44908430|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44908431|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908432|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908433|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44908434|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
44908435|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
44908436|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908437|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908438|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
44908439|NCT03996772|Apixaban|apixaban|mesh-list
44908440|NCT03996772|Edoxaban|edoxaban|mesh-list
44908441|NCT03996772|Dabigatran|dabigatran|mesh-list
44908442|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44908443|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
44908444|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44908445|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44908446|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908447|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908448|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
44908449|NCT03996993|Bicalutamide|bicalutamide|mesh-list
44908450|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
44908451|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
44908452|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908453|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908454|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908455|NCT03996538|Metformin|metformin|mesh-list
44908456|NCT03996538|Vaccines|vaccines|mesh-list
44908457|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
44908458|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908459|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44908460|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
44908461|NCT03996421|Trace Elements|trace elements|mesh-ancestor
44908462|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
44908463|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908464|NCT03996577|Lidocaine|lidocaine|mesh-list
44908465|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908466|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
44908467|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908468|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908469|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
44908470|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908471|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44908472|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44701630|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44701631|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44701632|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701633|NCT01404169|Donepezil|donepezil|mesh-list
44701634|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44512713|NCT03402698|Vitamin D|vitamin d|mesh-list
44701635|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701636|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701637|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44701638|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701639|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701640|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
44701641|NCT01404182|Vaccines|vaccines|mesh-list
44701642|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
44701643|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701644|NCT01404312|Pyridoxine|pyridoxine|mesh-list
44701645|NCT01404312|Pyridoxal|pyridoxal|mesh-list
44701646|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
44701647|NCT01404312|Isoniazid|isoniazid|mesh-list
44701648|NCT01404312|Rifapentine|rifapentine|mesh-list
44701649|NCT01404312|Vitamins|vitamins|mesh-ancestor
44701650|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
44701651|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701652|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
44701653|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
44701654|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701655|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701656|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44701657|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44701658|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
44701659|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701660|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44701661|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44701662|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
44701663|NCT01404338|Halobetasol|halobetasol|mesh-list
44701664|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44253168|NCT05340153|Artenimol|artenimol|mesh-list
44703010|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703011|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44703012|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
44703013|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703014|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
44703015|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44703016|NCT01412385|Antibodies|antibodies|mesh-list
44908473|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44908474|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908475|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908476|NCT03996603|Estrogens|estrogens|mesh-list
44908477|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44908478|NCT03996603|Hormones|hormones|mesh-ancestor
44908479|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908480|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908481|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
44908482|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
44908483|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
44908484|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44908485|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
44908486|NCT03996486|Paraproteins|paraproteins|mesh-list
44908487|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
44908488|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908489|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
44908490|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44908491|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44908492|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908493|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44908494|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
44908495|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908496|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44908497|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
44908498|NCT03996564|Acetaminophen|acetaminophen|mesh-list
44908499|NCT03996564|Diclofenac|diclofenac|mesh-list
44908500|NCT03996564|Ketorolac|ketorolac|mesh-list
44908501|NCT03996564|Diazepam|diazepam|mesh-list
44908502|NCT03996564|Hydrocodone|hydrocodone|mesh-list
44908503|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44908504|NCT03996564|Analgesics|analgesics|mesh-ancestor
44908505|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
44908506|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908536|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908538|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44908539|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
44908540|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44908541|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908542|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
44908543|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908544|NCT03996655|Neostigmine|neostigmine|mesh-list
44908545|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44908546|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908547|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908548|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
44908549|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908550|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908551|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44908552|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
44908553|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908554|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
44908555|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44908557|NCT03996252|Fluorouracil|fluorouracil|mesh-list
44908558|NCT03996252|Calcipotriene|calcipotriene|mesh-list
44908559|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
44908560|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908561|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44908562|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908563|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44908564|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
44908565|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908566|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
44908567|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44908568|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44908569|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908570|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44908571|NCT03996252|Vitamins|vitamins|mesh-ancestor
44908572|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
44908573|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44908574|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
44908575|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
44908576|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908577|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44908578|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
44908579|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
44908580|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908581|NCT03995563|Dexamethasone|dexamethasone|mesh-list
44908582|NCT03995563|Ropivacaine|ropivacaine|mesh-list
44908583|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908584|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
44908585|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
44908586|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908587|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908588|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908589|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
44908590|NCT03995563|Hormones|hormones|mesh-ancestor
44908591|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908592|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908593|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908594|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908595|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
44908596|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908597|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
44908598|NCT03995251|Testosterone|testosterone|mesh-list
44908599|NCT03995251|Androgens|androgens|mesh-ancestor
44908600|NCT03995251|Hormones|hormones|mesh-ancestor
44908601|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908602|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908603|NCT03995147|Prednisone|prednisone|mesh-list
44908604|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
44908605|NCT03995147|Doxorubicin|doxorubicin|mesh-list
44908606|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
44908607|NCT03995147|Vincristine|vincristine|mesh-list
44908608|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44908609|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
44908610|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908611|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908612|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44908613|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
44908614|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908615|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908616|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44908617|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908618|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44908619|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44908620|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44908621|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908622|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908623|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
44908624|NCT03995147|Hormones|hormones|mesh-ancestor
44908625|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908626|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908627|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44701743|NCT01404637|Tamsulosin|tamsulosin|mesh-list
44908628|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
44908630|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
44908631|NCT03995277|Biotin|biotin|mesh-list
44908632|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
44908633|NCT03995277|Vitamins|vitamins|mesh-ancestor
44908634|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
44908635|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908636|NCT03995134|Remifentanil|remifentanil|mesh-list
44908637|NCT03995134|Propofol|propofol|mesh-list
44908638|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44908639|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908640|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908641|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44908642|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
44908643|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
44908644|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44908645|NCT03995134|Narcotics|narcotics|mesh-ancestor
44908646|NCT03995134|Analgesics|analgesics|mesh-ancestor
44908647|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
44908648|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908649|NCT03994965|Pimavanserin|pimavanserin|mesh-list
44908650|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44908651|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44908652|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44908653|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44908654|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908655|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908656|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44908657|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44908658|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44908659|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
44908660|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908661|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908662|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
44908663|NCT03994783|Rituximab|rituximab|mesh-list
44908664|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
44908665|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44908666|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
44908667|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44908668|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908669|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908670|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
44908671|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908672|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908673|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908674|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
44908675|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
44908676|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908677|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908678|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
44908679|NCT03994783|Hormones|hormones|mesh-ancestor
44908680|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908681|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44908682|NCT03994783|Protective Agents|protective agents|mesh-ancestor
44908683|NCT03994692|Ether|ether|mesh-list
44908684|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44908685|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
44908686|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
44908687|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908688|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908689|NCT03994744|Metformin|metformin|mesh-list
44908690|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44908691|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44908692|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908693|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908694|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908695|NCT03994211|Itraconazole|itraconazole|mesh-list
44908696|NCT03994211|Rifampin|rifampin|mesh-list
44908697|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
44908698|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908699|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44908700|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44908701|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908702|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908703|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44908704|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44908738|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908739|NCT03994393|Durvalumab|durvalumab|mesh-list
44908740|NCT03994393|Tremelimumab|tremelimumab|mesh-list
44908741|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908742|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908744|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908745|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908746|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
44908747|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
44908748|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908749|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
44908750|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908751|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908752|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908753|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44908754|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44908755|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908756|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44908757|NCT03993626|Nivolumab|nivolumab|mesh-list
44908758|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908759|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908760|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44908761|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908762|NCT03993366|Pramlintide|pramlintide|mesh-list
44908763|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
44908764|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44908765|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908766|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44908767|NCT03993236|Ezetimibe|ezetimibe|mesh-list
44908768|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44908769|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44908770|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
44908771|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908772|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44908773|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44908774|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908775|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
44908776|NCT03992937|Progesterone|progesterone|mesh-list
44908777|NCT03992937|Progestins|progestins|mesh-ancestor
44908778|NCT03992937|Hormones|hormones|mesh-ancestor
44908779|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908780|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908781|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44908782|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
44908783|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44908784|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44908785|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44908786|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44908787|NCT03992885|Pemetrexed|pemetrexed|mesh-list
44908788|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908789|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686103|NCT01331902|Nicorandil|nicorandil|mesh-list
44908790|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908791|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44908792|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44908793|NCT03992911|Cisplatin|cisplatin|mesh-list
44908794|NCT03992911|Carboplatin|carboplatin|mesh-list
44908795|NCT03992911|Etoposide|etoposide|mesh-list
44908796|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
44908797|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908798|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908799|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44908800|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44908801|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908802|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908803|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44908804|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908805|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
44908806|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908807|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908808|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
44908809|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908810|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44908811|NCT03992586|Methamphetamine|methamphetamine|mesh-list
44908812|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44908813|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908814|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
44908815|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
44908816|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908818|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908819|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908820|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908821|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44908822|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44908823|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908824|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44908825|NCT03992755|Treprostinil|treprostinil|mesh-list
44908826|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44908827|NCT03992170|Daratumumab|daratumumab|mesh-list
44908828|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908829|NCT03992144|Amoxicillin|amoxicillin|mesh-list
44908830|NCT03992144|Metronidazole|metronidazole|mesh-list
44908831|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44908832|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908833|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44908834|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44908835|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
44908836|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
44908837|NCT03992066|Hematinics|hematinics|mesh-ancestor
44908838|NCT03992261|Halobetasol|halobetasol|mesh-list
44908839|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44908840|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
44908841|NCT03992326|Fludarabine|fludarabine|mesh-list
44908842|NCT03992326|Interleukin-2|interleukin-2|mesh-list
44908843|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44908844|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
44908845|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908846|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908847|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44908848|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
44908849|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908850|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908851|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44908852|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44908853|NCT03992326|Analgesics|analgesics|mesh-ancestor
44908854|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
44908855|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908856|NCT03992365|Bisacodyl|bisacodyl|mesh-list
44908857|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
44908858|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44908859|NCT03992365|Cathartics|cathartics|mesh-ancestor
44908860|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44908861|NCT03992365|Laxatives|laxatives|mesh-ancestor
44908862|NCT03991845|Levocetirizine|levocetirizine|mesh-list
44908863|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44702040|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702041|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
44702042|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44702043|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
44702044|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702045|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702046|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
44702047|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702048|NCT01405989|Ketoconazole|ketoconazole|mesh-list
44702049|NCT01405989|Darexaban|darexaban|mesh-list
44702050|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
44702051|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702052|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44702054|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908864|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44908865|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
44908866|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
44908867|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44908868|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908869|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908870|NCT03991910|Ramipril|ramipril|mesh-list
44908871|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44908872|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44908873|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908874|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908875|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44908876|NCT03991442|Amlodipine|amlodipine|mesh-list
44908877|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44908892|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908893|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44908894|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44908895|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44908896|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908897|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44908899|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44908900|NCT03991559|Antibodies|antibodies|mesh-list
44908901|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
44908902|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
44908903|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908904|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908905|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908906|NCT03991559|Trace Elements|trace elements|mesh-ancestor
44908907|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
44908908|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44908909|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908910|NCT03991312|Itraconazole|itraconazole|mesh-list
44908911|NCT03991312|Rifampin|rifampin|mesh-list
44908912|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
44908913|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908914|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44908915|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44908916|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44908917|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908918|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44908919|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
44908920|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44908921|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908922|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44908923|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44908924|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
44908925|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44908926|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
44908927|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44908928|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44908929|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44908930|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44908931|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44908932|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44908933|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44908934|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
44908935|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44908936|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44908937|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
44908938|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44908939|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44908940|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44908941|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
44908942|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908943|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
44908944|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44908945|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908946|NCT03990701|Metomidate|metomidate|mesh-list
44908947|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44908948|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908949|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908950|NCT03990922|Morphine|morphine|mesh-list
44908951|NCT03990922|Ropivacaine|ropivacaine|mesh-list
44908952|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44908953|NCT03990922|Narcotics|narcotics|mesh-ancestor
44908954|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44908955|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908956|NCT03990922|Analgesics|analgesics|mesh-ancestor
44908957|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
44908958|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908959|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
44908960|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
44908961|NCT03990480|Amlodipine|amlodipine|mesh-list
44908962|NCT03990480|Valsartan|valsartan|mesh-list
44908963|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44908964|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44908965|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44908966|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44908967|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44908968|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908969|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
44908970|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44908971|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44908972|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44908973|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44908974|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44908975|NCT03990129|Dipyrone|dipyrone|mesh-list
44908976|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44908977|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44908978|NCT03990129|Analgesics|analgesics|mesh-ancestor
44908979|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
44908980|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44908981|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908982|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44908983|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44908984|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
44908985|NCT03990194|Leuprolide|leuprolide|mesh-list
44908986|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44908987|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
44908988|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44908989|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44908990|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44908991|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908992|NCT03990103|Paclitaxel|paclitaxel|mesh-list
44908993|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44908994|NCT03990103|Bevacizumab|bevacizumab|mesh-list
44908995|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
44908996|NCT03990103|Tegafur|tegafur|mesh-list
44908997|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44908998|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44908999|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44909000|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44909001|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44909002|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909003|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909004|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44909005|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44909006|NCT03990103|Growth Substances|growth substances|mesh-ancestor
44909007|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909008|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
44909009|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909010|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
44909011|NCT03990038|Ropivacaine|ropivacaine|mesh-list
44909012|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44909013|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
44909014|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909015|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909016|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
44909017|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909018|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44909019|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909020|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44909021|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44909022|NCT03989817|Protective Agents|protective agents|mesh-ancestor
44909023|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909024|NCT03989778|Vitamin D|vitamin d|mesh-list
44909025|NCT03989778|Vitamins|vitamins|mesh-ancestor
44909026|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
44909027|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909028|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44909029|NCT03989830|Endostatins|endostatins|mesh-list
44909030|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44909031|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44909032|NCT03989830|Growth Substances|growth substances|mesh-ancestor
44909033|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909034|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44909035|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909036|NCT03989336|Manganese|manganese|mesh-list
44909037|NCT03989336|Paclitaxel|paclitaxel|mesh-list
44909038|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44909039|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44909040|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44909041|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702254|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44702255|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
44702256|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702257|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44702258|NCT01407016|Metronidazole|metronidazole|mesh-list
44702259|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44702260|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44702261|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44702262|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44702263|NCT01407211|Vitamin A|vitamin a|mesh-list
44702264|NCT01407211|Vitamins|vitamins|mesh-ancestor
44702265|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
44702266|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702267|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
44702268|NCT01407237|Giapreza|giapreza|mesh-list
44702269|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
44702270|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44702271|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44702272|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
44909042|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44702273|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702274|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702275|NCT01407289|Insulin|insulin|mesh-list
44702276|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
44702277|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
44909043|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44909044|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44909045|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909046|NCT03989336|Trace Elements|trace elements|mesh-ancestor
44909047|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
44909048|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909049|NCT03989310|Manganese|manganese|mesh-list
44909050|NCT03989310|Gemcitabine|gemcitabine|mesh-list
44909051|NCT03989310|Paclitaxel|paclitaxel|mesh-list
44909052|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44909053|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44909054|NCT03989310|Antibodies|antibodies|mesh-list
44909055|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
44909056|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44909057|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909058|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44909059|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44909060|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44909061|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909062|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
44909063|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909075|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909076|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
44909078|NCT03989557|Clopidogrel|clopidogrel|mesh-list
44909079|NCT03989557|Ticagrelor|ticagrelor|mesh-list
44909080|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44909081|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909082|NCT03989557|Analgesics|analgesics|mesh-ancestor
44909083|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
44909084|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909085|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909086|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909087|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909088|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44909089|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44909090|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909091|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44909092|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44909093|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909094|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
44909095|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44909096|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44909097|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44909098|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
44909099|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909100|NCT03989271|Quercetin|quercetin|mesh-list
44909101|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
44909102|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909103|NCT03989271|Protective Agents|protective agents|mesh-ancestor
44909104|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909105|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
44909106|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909107|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909108|NCT03989037|Carboplatin|carboplatin|mesh-list
44909109|NCT03989037|Docetaxel|docetaxel|mesh-list
44909110|NCT03989037|Trastuzumab|trastuzumab|mesh-list
44909111|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909112|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44909113|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44909114|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44909115|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909116|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909117|NCT03989024|Clomiphene|clomiphene|mesh-list
44909118|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44909119|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44909120|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
44909121|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909122|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909123|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44909124|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
44909125|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44909126|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44909127|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44909128|NCT03989024|Hormones|hormones|mesh-ancestor
44702310|NCT01407822|Gemcitabine|gemcitabine|mesh-list
44909129|NCT03988725|Vitamin E|vitamin e|mesh-list
44909130|NCT03988725|Vitamins|vitamins|mesh-ancestor
44909131|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
44909132|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909133|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
44909134|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909135|NCT03988725|Protective Agents|protective agents|mesh-ancestor
44909136|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
44909137|NCT03988530|Scopolamine|scopolamine|mesh-list
44909138|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44909139|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44909140|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
44909141|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
44909142|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909143|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909144|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909145|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
44909146|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44909147|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
44909148|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909149|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909150|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44909151|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
44909152|NCT03988231|Enoxaparin|enoxaparin|mesh-list
44909153|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
44909154|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44909155|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44909156|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909157|NCT03988452|Ritonavir|ritonavir|mesh-list
44909158|NCT03988452|Darunavir|darunavir|mesh-list
44909159|NCT03988452|Tenofovir|tenofovir|mesh-list
44909160|NCT03988452|Lamivudine|lamivudine|mesh-list
44909161|NCT03988452|Zidovudine|zidovudine|mesh-list
44909162|NCT03988452|Dolutegravir|dolutegravir|mesh-list
44909163|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44909164|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44909165|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
44909166|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909167|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909168|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44909169|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44909170|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
44909171|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909172|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44909173|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44909174|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44909175|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44909176|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
44909177|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44909178|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44909179|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44909180|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44909181|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44909182|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
44909183|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909184|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44909185|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44909186|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909187|NCT03988010|Amantadine|amantadine|mesh-list
44909188|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44909189|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44909190|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
44909191|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909192|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
44909193|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909194|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909195|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909196|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909197|NCT03988010|Analgesics|analgesics|mesh-ancestor
44909198|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
44909199|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909200|NCT03987867|Paclitaxel|paclitaxel|mesh-list
44909201|NCT03987867|Carboplatin|carboplatin|mesh-list
44909202|NCT03987867|Pemetrexed|pemetrexed|mesh-list
44702389|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44909203|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44909204|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44909205|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909206|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44909207|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44909208|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44909209|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909210|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909211|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44909212|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44909213|NCT03988075|Acetaminophen|acetaminophen|mesh-list
44909214|NCT03988075|Ibuprofen|ibuprofen|mesh-list
44909215|NCT03988075|Hydrocodone|hydrocodone|mesh-list
44909216|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909217|NCT03988075|Analgesics|analgesics|mesh-ancestor
44909218|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
44909219|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909220|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909221|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
44909222|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44909223|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909224|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909225|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44909226|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909227|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909228|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909229|NCT03988075|Narcotics|narcotics|mesh-ancestor
44909230|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909231|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
44909232|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
44909233|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44909234|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
44909235|NCT03988036|Trastuzumab|trastuzumab|mesh-list
44909236|NCT03988036|Pertuzumab|pertuzumab|mesh-list
44909237|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909238|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909239|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44909240|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44909241|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909242|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909243|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44909244|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
44909245|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909246|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909247|NCT03987893|Lactulose|lactulose|mesh-list
44909248|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44909249|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909250|NCT03987893|Laxatives|laxatives|mesh-ancestor
44909251|NCT03987815|Nivolumab|nivolumab|mesh-list
44909252|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909253|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909254|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44909255|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909256|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44909257|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909258|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909259|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
44909260|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909261|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909262|NCT03987529|Propofol|propofol|mesh-list
44909263|NCT03987529|Sevoflurane|sevoflurane|mesh-list
44909264|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44909265|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909266|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909267|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44909268|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
44909269|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
44909270|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44909271|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44909272|NCT03987152|Sirolimus|sirolimus|mesh-list
44909273|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909274|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909275|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44909276|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909277|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
44909278|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909279|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
44909311|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
44909312|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909313|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44909314|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44909315|NCT03986385|Capecitabine|capecitabine|mesh-list
44909316|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
44909317|NCT03986385|Apatinib|apatinib|mesh-list
44909318|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909319|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
44909320|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909321|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909322|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44909323|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44702536|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44909324|NCT03986294|Leucovorin|leucovorin|mesh-list
44909325|NCT03986294|Antidotes|antidotes|mesh-ancestor
44909326|NCT03986294|Protective Agents|protective agents|mesh-ancestor
44909327|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909328|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
44909329|NCT03986294|Vitamins|vitamins|mesh-ancestor
44909330|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
44909331|NCT03986073|Linagliptin|linagliptin|mesh-list
44909332|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702610|NCT01409187|Analgesics|analgesics|mesh-ancestor
44702611|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
44702612|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702613|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44702614|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44702615|NCT01409278|Ropivacaine|ropivacaine|mesh-list
44702616|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
44702617|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
44702618|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44702619|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702620|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
44702621|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44702622|NCT01409369|Charcoal|charcoal|mesh-list
44702623|NCT01409369|Antidotes|antidotes|mesh-ancestor
44702624|NCT01409369|Protective Agents|protective agents|mesh-ancestor
44702625|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702626|NCT01409395|Metformin|metformin|mesh-list
44702627|NCT01409395|Nizatidine|nizatidine|mesh-list
44702628|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44702629|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702630|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44702631|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44702632|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44702633|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
44702634|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
44702635|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44702636|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702637|NCT01409408|Amlodipine|amlodipine|mesh-list
44702638|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44702639|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44702640|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702641|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909333|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702642|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44909334|NCT03986073|Incretins|incretins|mesh-ancestor
44909335|NCT03986073|Hormones|hormones|mesh-ancestor
44909336|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909337|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44909338|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
44909339|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909340|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909341|NCT03985891|Antibodies|antibodies|mesh-list
44909342|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44909343|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
44909344|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909345|NCT03986008|Liraglutide|liraglutide|mesh-list
44909346|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909347|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909348|NCT03986008|Incretins|incretins|mesh-ancestor
44909349|NCT03986008|Hormones|hormones|mesh-ancestor
44909350|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909351|NCT03985969|Indomethacin|indomethacin|mesh-list
44909352|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44909353|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909354|NCT03985969|Analgesics|analgesics|mesh-ancestor
44909355|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
44909356|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909357|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909358|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909359|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909360|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
44909361|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
44909362|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44909363|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44909364|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909365|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909367|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44909368|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44909369|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44909370|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909371|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909372|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
44909373|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909374|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909375|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44909376|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909377|NCT03985865|Quinine|quinine|mesh-list
44909378|NCT03985865|Denatonium|denatonium|mesh-list
44909379|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
44909380|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44909381|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44909382|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909383|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44909384|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909385|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44909386|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909387|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909388|NCT03985865|Analgesics|analgesics|mesh-ancestor
44909389|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
44909390|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
44909391|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909392|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
44909393|NCT03985735|Anesthetics|anesthetics|mesh-list
44909394|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909395|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909396|NCT03985722|Trabectedin|trabectedin|mesh-list
44909397|NCT03985722|Olaratumab|olaratumab|mesh-list
44909398|NCT03985722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44909399|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44909400|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
44909401|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909402|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909403|NCT03985722|Immunologic Factors|immunologic factors|mesh-ancestor
44909404|NCT03985722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909405|NCT03985319|Esomeprazole|esomeprazole|mesh-list
44909406|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44909407|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909408|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44909409|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909410|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909411|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
44909412|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909413|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909414|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44909415|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44909416|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909417|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909418|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909419|NCT03985280|Anesthetics|anesthetics|mesh-list
44909420|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
44909421|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909422|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909423|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
44909424|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909425|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
44909426|NCT03985358|Narcotics|narcotics|mesh-ancestor
44909427|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909428|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909429|NCT03985358|Analgesics|analgesics|mesh-ancestor
44909430|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
44909431|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909432|NCT03984656|Lidocaine|lidocaine|mesh-list
44909433|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
44909434|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
44909435|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909436|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909437|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
44909438|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909439|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44909440|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44909441|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44909442|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909443|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909444|NCT03984760|Sevelamer|sevelamer|mesh-list
44909445|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
44909446|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
44909447|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909448|NCT03984591|Eplerenone|eplerenone|mesh-list
44909449|NCT03984591|Spironolactone|spironolactone|mesh-list
44909450|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44909451|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
44909452|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909453|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909454|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44909455|NCT03984591|Diuretics|diuretics|mesh-ancestor
44909456|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
44909457|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44909458|NCT03984526|Atropine|atropine|mesh-list
44909459|NCT03984526|Ephedrine|ephedrine|mesh-list
44909460|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44909461|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44909462|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44909463|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
44909464|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909465|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909466|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44909467|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
44909468|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
44909469|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
44909470|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44909471|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44909472|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
44909473|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909474|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909475|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44909476|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
44909477|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44909478|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909479|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
44909480|NCT03984409|Diuretics|diuretics|mesh-ancestor
44909481|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
44909482|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909483|NCT03984409|Expectorants|expectorants|mesh-ancestor
44909484|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44909485|NCT03984110|Dexamethasone|dexamethasone|mesh-list
44909486|NCT03984110|Aflibercept|aflibercept|mesh-list
44909487|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909488|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
44909489|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
44909490|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909491|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909492|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909493|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
44909494|NCT03984110|Hormones|hormones|mesh-ancestor
44909495|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909496|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44909497|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909498|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44909499|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44909500|NCT03984110|Growth Substances|growth substances|mesh-ancestor
44909501|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
44909502|NCT03984357|Gemcitabine|gemcitabine|mesh-list
44909503|NCT03984357|Cisplatin|cisplatin|mesh-list
44909504|NCT03984357|Antibodies|antibodies|mesh-list
44909505|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
44909506|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
44909507|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909508|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909509|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909510|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
44909511|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909512|NCT03984357|Antiviral Agents|antiviral agents|mesh-ancestor
44909513|NCT03984357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909514|NCT03984357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909515|NCT03984357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909548|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909549|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909550|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909552|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
44909553|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909554|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44909555|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44909556|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44909557|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909558|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909559|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909560|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909561|NCT03983915|Narcotics|narcotics|mesh-ancestor
44702882|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44702883|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
44702884|NCT01411254|Hormones|hormones|mesh-ancestor
44702885|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44702886|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702887|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44702888|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
44702889|NCT01411280|Methylphenidate|methylphenidate|mesh-list
44702890|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44702891|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44702892|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44702893|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44702894|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44702895|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44702896|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
44702897|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703017|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
44703018|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44703019|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
44703020|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
44703021|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703022|NCT01412411|Micronutrients|micronutrients|mesh-list
44703023|NCT01412411|Trace Elements|trace elements|mesh-list
44703024|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703025|NCT01412437|Verapamil|verapamil|mesh-list
44703026|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44703027|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44703028|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703029|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703030|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703031|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703032|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703033|NCT01412515|Everolimus|everolimus|mesh-list
44703034|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703035|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703036|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
44703037|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703038|NCT01412567|Vaccines|vaccines|mesh-list
44703039|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
44703040|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703041|NCT01412632|Remifentanil|remifentanil|mesh-list
44703042|NCT01412632|Propofol|propofol|mesh-list
44703043|NCT01412632|Prilocaine|prilocaine|mesh-list
44703044|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44703045|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703046|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703047|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44703048|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
44703050|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44703051|NCT01412632|Narcotics|narcotics|mesh-ancestor
44703052|NCT01412632|Analgesics|analgesics|mesh-ancestor
44703053|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
44703054|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703055|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
44703056|NCT01412645|Resveratrol|resveratrol|mesh-list
44703057|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
44703058|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703059|NCT01412645|Protective Agents|protective agents|mesh-ancestor
44909562|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44909563|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
44909564|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909565|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909566|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909567|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909568|NCT03983460|Betamethasone|betamethasone|mesh-list
44909569|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
44909570|NCT03983460|Clobetasol|clobetasol|mesh-list
44909571|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909572|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
44909573|NCT03983460|Hormones|hormones|mesh-ancestor
44909574|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909575|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909576|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44909577|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44909578|NCT03983239|Efavirenz|efavirenz|mesh-list
44909579|NCT03983239|Rifampin|rifampin|mesh-list
44909580|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44909581|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44909582|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909583|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909584|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
44909585|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909586|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44909587|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44909588|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44909589|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44909590|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44909591|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44909592|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44909593|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
44909594|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909595|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
44909596|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44909597|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44909598|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44909599|NCT03982992|Blinatumomab|blinatumomab|mesh-list
44909600|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909601|NCT03983057|Antibodies|antibodies|mesh-list
44909602|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44909603|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
44909604|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909605|NCT03982862|Triamcinolone|triamcinolone|mesh-list
44909606|NCT03982862|Lidocaine|lidocaine|mesh-list
44909607|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
44909608|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44909609|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44909610|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
44909611|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
44909612|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909613|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909614|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
44909615|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909616|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44909617|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44909618|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44909619|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909620|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909621|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44909622|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
44909623|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909624|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909625|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
44909626|NCT03982862|Hormones|hormones|mesh-ancestor
44909627|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909628|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44909629|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
44909630|NCT03982771|Bortezomib|bortezomib|mesh-list
44909631|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909632|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
44909633|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909634|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909635|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44909636|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
44909637|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909638|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909639|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44909640|NCT03982849|Silymarin|silymarin|mesh-list
44909641|NCT03982849|Hydroquinone|hydroquinone|mesh-list
44909642|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
44909643|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909644|NCT03982849|Protective Agents|protective agents|mesh-ancestor
44909645|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909646|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44909647|NCT03982784|Morphine|morphine|mesh-list
44909648|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909649|NCT03982784|Narcotics|narcotics|mesh-ancestor
44909650|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909651|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909652|NCT03982784|Analgesics|analgesics|mesh-ancestor
44909653|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
44909654|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909655|NCT03982381|Metformin|metformin|mesh-list
44909656|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
44909657|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909658|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909659|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44909660|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909661|NCT03982680|Gemcitabine|gemcitabine|mesh-list
44909662|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909663|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
44909664|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909665|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909666|NCT03982680|Antiviral Agents|antiviral agents|mesh-ancestor
44909667|NCT03982680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909668|NCT03982680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909669|NCT03982680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909670|NCT03982680|Immunologic Factors|immunologic factors|mesh-ancestor
44909671|NCT03982680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909672|NCT03982134|Panobinostat|panobinostat|mesh-list
44909673|NCT03982134|Spartalizumab|spartalizumab|mesh-list
44909674|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909675|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44909676|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909677|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909678|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44909679|NCT03982277|Rifampin|rifampin|mesh-list
44909680|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44909681|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
44909682|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909683|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909684|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
44909685|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44909686|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909687|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909688|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44909689|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44909690|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44909691|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44909692|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44909693|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44909694|NCT03982173|Durvalumab|durvalumab|mesh-list
44909695|NCT03982173|Tremelimumab|tremelimumab|mesh-list
44909696|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909697|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909698|NCT03982238|Metformin|metformin|mesh-list
44909699|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
44909700|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909701|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909702|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44909703|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909704|NCT03982121|Nivolumab|nivolumab|mesh-list
44909705|NCT03982121|Ipilimumab|ipilimumab|mesh-list
44909706|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909707|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909708|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44909709|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909710|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
44909711|NCT03982004|Imiquimod|imiquimod|mesh-list
44909712|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909713|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909714|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44909715|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
44909716|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909717|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
44909718|NCT03981887|Nafithromycin|nafithromycin|mesh-list
44909719|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909720|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909721|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44909722|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909723|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909724|NCT03981601|Lovastatin|lovastatin|mesh-list
44909725|NCT03981601|L 647318|l 647318|mesh-list
44909726|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
44909750|NCT03981068|Cisplatin|cisplatin|mesh-list
44909751|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909752|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44909753|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44909754|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44909755|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909756|NCT03981081|Prednisone|prednisone|mesh-list
44909757|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909758|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
44909759|NCT03981081|Hormones|hormones|mesh-ancestor
44909760|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909761|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703060|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703061|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703062|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44703063|NCT01412658|Caseins|caseins|mesh-list
44703064|NCT01412658|Glycerol|glycerol|mesh-list
44703065|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
44703066|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
44703067|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703068|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44703069|NCT01412658|Protective Agents|protective agents|mesh-ancestor
44703070|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703071|NCT01412671|Sorafenib|sorafenib|mesh-list
44703072|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703073|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44703074|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703075|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703076|NCT01412840|Diclofenac|diclofenac|mesh-list
44703077|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44703078|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44703079|NCT01412840|Analgesics|analgesics|mesh-ancestor
44703080|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
44703081|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703082|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703083|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44703084|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703085|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44703086|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703087|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703088|NCT01412892|Everolimus|everolimus|mesh-list
44703089|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703090|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703091|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
44703092|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703093|NCT01413022|Leucovorin|leucovorin|mesh-list
44703094|NCT01413022|Fluorouracil|fluorouracil|mesh-list
44703095|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
44703096|NCT01413022|Irinotecan|irinotecan|mesh-list
44703097|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
44703098|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703099|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703100|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703101|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703102|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
44703103|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703104|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44703105|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44703106|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703107|NCT01413022|Antidotes|antidotes|mesh-ancestor
44703108|NCT01413022|Protective Agents|protective agents|mesh-ancestor
44703109|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
44703110|NCT01413022|Vitamins|vitamins|mesh-ancestor
44703111|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
44703112|NCT01413048|Carvedilol|carvedilol|mesh-list
44703113|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44703114|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44703115|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703116|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703117|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703118|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703119|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44703120|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
44254405|NCT02697448|Propofol|propofol|mesh-list
44703121|NCT01413048|Protective Agents|protective agents|mesh-ancestor
44703129|NCT01413230|Vitamin D|vitamin d|mesh-list
44909762|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44909763|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909764|NCT03981094|Pirfenidone|pirfenidone|mesh-list
44909765|NCT03981094|Analgesics|analgesics|mesh-ancestor
44909766|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
44909767|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909768|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909769|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44909770|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909771|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909772|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909773|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909774|NCT03981029|Folic Acid|folic acid|mesh-list
44909775|NCT03981029|Hematinics|hematinics|mesh-ancestor
44909776|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
44909777|NCT03981029|Vitamins|vitamins|mesh-ancestor
44909778|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
44909779|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909780|NCT03980847|Alendronate|alendronate|mesh-list
44909781|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44909782|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909783|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
44909784|NCT03980951|Narcotics|narcotics|mesh-ancestor
44909785|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909786|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909787|NCT03980951|Analgesics|analgesics|mesh-ancestor
44909788|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
44909789|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909790|NCT03980990|Metformin|metformin|mesh-list
44909791|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44909792|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909793|NCT03980756|Esomeprazole|esomeprazole|mesh-list
44909794|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44909795|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909796|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44909797|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909798|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909799|NCT03980379|Rituximab|rituximab|mesh-list
44909800|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909801|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909802|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
44909803|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909804|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909805|NCT03980496|Omeprazole|omeprazole|mesh-list
44909806|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44909807|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909808|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44513963|NCT02243553|Vitamins|vitamins|mesh-ancestor
44909809|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909810|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909811|NCT03980223|Doxycycline|doxycycline|mesh-list
44909812|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909813|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909814|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
44909815|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44909816|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44909817|NCT03980249|Carvedilol|carvedilol|mesh-list
44909818|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44909819|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44909820|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909821|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909822|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909823|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909824|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44909825|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
44909826|NCT03980249|Protective Agents|protective agents|mesh-ancestor
44909827|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44909828|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909829|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44909830|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
44909831|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44909832|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44909833|NCT03979976|Ramipril|ramipril|mesh-list
44909834|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44909835|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44909836|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
44909837|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909838|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44909839|NCT03980002|Thalidomide|thalidomide|mesh-list
44909840|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44909841|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
44909842|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909843|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
44909844|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909845|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909846|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44909847|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44909848|NCT03980002|Growth Substances|growth substances|mesh-ancestor
44909849|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
44909850|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909851|NCT03979859|Nafithromycin|nafithromycin|mesh-list
44909852|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44909853|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909854|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44909855|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909856|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909857|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44909858|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909859|NCT03979989|Tapentadol|tapentadol|mesh-list
44909860|NCT03979989|Omeprazole|omeprazole|mesh-list
44909861|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44909862|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909863|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44909864|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909865|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909866|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909867|NCT03979989|Narcotics|narcotics|mesh-ancestor
44909868|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909869|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909870|NCT03979989|Analgesics|analgesics|mesh-ancestor
44909871|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
44909872|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909873|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44909874|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44909875|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909876|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909877|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909878|NCT03979664|Dexamethasone|dexamethasone|mesh-list
44909879|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909880|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
44909881|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
44909882|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909883|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909884|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44909885|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
44909886|NCT03979664|Hormones|hormones|mesh-ancestor
44909887|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44909888|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44909889|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909890|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
44909891|NCT03979651|Trametinib|trametinib|mesh-list
44909892|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
44909893|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44909894|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44909895|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44909896|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909897|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909898|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909899|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909900|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44909901|NCT03979456|Rituximab|rituximab|mesh-list
44909902|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44909903|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44909904|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
44909905|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909906|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909907|NCT03979469|Fentanyl|fentanyl|mesh-list
44909908|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
44909909|NCT03979469|Ketamine|ketamine|mesh-list
44703210|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44909910|NCT03979469|Remifentanil|remifentanil|mesh-list
44909911|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44909912|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909913|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909914|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909915|NCT03979469|Analgesics|analgesics|mesh-ancestor
44909916|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
44909917|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909918|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44909919|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44909920|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44909921|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
44909922|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909923|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909924|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44909925|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44909926|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
44909927|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
44909928|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44909929|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44909930|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44909931|NCT03979469|Narcotics|narcotics|mesh-ancestor
44909932|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44909933|NCT03979248|BMS-986165|bms-986165|mesh-list
44909934|NCT03979248|Rabeprazole|rabeprazole|mesh-list
44909935|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44909936|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703122|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44703123|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703124|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703125|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703126|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44703127|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44703128|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
44703130|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703131|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703132|NCT01413230|Vitamins|vitamins|mesh-ancestor
44703133|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
44703134|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44254470|NCT02265367|Analgesics|analgesics|mesh-ancestor
44703135|NCT01413477|Calcitriol|calcitriol|mesh-list
44703136|NCT01413477|Betamethasone|betamethasone|mesh-list
44703137|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
44703138|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44703139|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
44703140|NCT01413477|Calcipotriene|calcipotriene|mesh-list
44703141|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44703142|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44703143|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
44703144|NCT01413477|Hormones|hormones|mesh-ancestor
44703145|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703146|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703147|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44703148|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703149|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
44703150|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703151|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44703152|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703153|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703154|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44703155|NCT01413477|Vitamins|vitamins|mesh-ancestor
44703156|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
44703157|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44703158|NCT01413490|Rimantadine|rimantadine|mesh-list
44703159|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
44703160|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703161|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44703162|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703163|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703164|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
44703165|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703166|NCT01413620|Vitamins|vitamins|mesh-list
44703167|NCT01413620|Vitamin E|vitamin e|mesh-list
44703168|NCT01413620|Tocopherols|tocopherols|mesh-list
44703169|NCT01413620|Tocotrienols|tocotrienols|mesh-list
44703170|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
44703171|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
44703172|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703173|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
44909937|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44909938|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909939|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909940|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44909941|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44909942|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
44909943|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44909944|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
44909945|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909946|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
44909947|NCT03979586|Protective Agents|protective agents|mesh-ancestor
44909948|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
44909949|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909950|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
44909951|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44909952|NCT03978988|Aspirin|aspirin|mesh-list
44909953|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44909954|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44909955|NCT03978988|Analgesics|analgesics|mesh-ancestor
44909956|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
44909957|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44909958|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909959|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44909960|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44909961|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44909962|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44909963|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909964|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44909965|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44909966|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44909967|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
44909968|NCT03979105|Ketamine|ketamine|mesh-list
44909969|NCT03979105|Analgesics|analgesics|mesh-ancestor
44909970|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
44909971|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686312|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
44909972|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909973|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44909974|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44909975|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
44909976|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
44909977|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44909978|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44909979|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44909980|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44909981|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909982|NCT03978884|Losartan|losartan|mesh-list
44909983|NCT03978884|Amlodipine|amlodipine|mesh-list
44909984|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44909985|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44909986|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44909987|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44909988|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44909989|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44909990|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44909991|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
44909992|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44909993|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44909994|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44909995|NCT03978884|Diuretics|diuretics|mesh-ancestor
44909996|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
44909997|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44909998|NCT03978845|Lidocaine|lidocaine|mesh-list
44909999|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
44910000|NCT03978845|Anesthetics|anesthetics|mesh-list
44910001|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910002|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910003|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
44910004|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910005|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44910006|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44910007|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44910008|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910009|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910010|NCT03978494|Tacrolimus|tacrolimus|mesh-list
44910011|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44910012|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
44910013|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910014|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44910015|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910016|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910017|NCT03978559|Trimethoprim|trimethoprim|mesh-list
44910018|NCT03978559|Caspofungin|caspofungin|mesh-list
44910019|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
44910020|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
44910021|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910022|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
44910023|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
44910024|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910025|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910026|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910027|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
44910028|NCT03978559|Hormones|hormones|mesh-ancestor
44910029|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910030|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44910031|NCT03978559|Protective Agents|protective agents|mesh-ancestor
44910032|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44910033|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910034|NCT03978559|Renal Agents|renal agents|mesh-ancestor
44910035|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
44910036|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44910037|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44910038|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44910039|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910040|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910041|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44910042|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44910043|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44910044|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
44910045|NCT03978364|Azacitidine|azacitidine|mesh-list
44910046|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44910047|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
44910048|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910049|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910050|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910051|NCT03978286|Vortioxetine|vortioxetine|mesh-list
44910052|NCT03978286|Sertraline|sertraline|mesh-list
44910053|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
44910054|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910055|NCT03978286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44910056|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44910057|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910058|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910059|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910060|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
44910061|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910062|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44910063|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44910064|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910065|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44910066|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44910067|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44910068|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44910069|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44910070|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
44910071|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910072|NCT03978052|Protective Agents|protective agents|mesh-ancestor
44910073|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910074|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44910075|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44910076|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910077|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44910078|NCT03978156|Dronabinol|dronabinol|mesh-list
44910079|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
44910080|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910081|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910082|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44910083|NCT03978156|Analgesics|analgesics|mesh-ancestor
44910084|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
44910085|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910086|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44910087|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44910088|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910089|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910090|NCT03978156|Hormones|hormones|mesh-ancestor
44910091|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910092|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44910093|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44910094|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44910095|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910096|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910097|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
44910098|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910099|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910100|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44910101|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910102|NCT03977675|Ketamine|ketamine|mesh-list
44910103|NCT03977675|Analgesics|analgesics|mesh-ancestor
44910104|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
44910105|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910106|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910107|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44910108|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44910109|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
44910110|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
44910111|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910112|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44910113|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44910114|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514329|NCT02245191|Phenylephrine|phenylephrine|mesh-list
44910115|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910116|NCT03977792|Docosanol|docosanol|mesh-list
44910117|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
44910118|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910119|NCT03977649|Erenumab|erenumab|mesh-list
44910120|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44910121|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910122|NCT03977649|Analgesics|analgesics|mesh-ancestor
44910123|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
44910124|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910125|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910126|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44910127|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44910128|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910129|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44910130|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44910131|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910132|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910133|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44910134|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910135|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910136|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
44910137|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910138|NCT03977441|Pramipexole|pramipexole|mesh-list
44910139|NCT03977441|S 20098|s 20098|mesh-list
44910140|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
44910141|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910142|NCT03977441|Protective Agents|protective agents|mesh-ancestor
44910143|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910144|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44910145|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44910146|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
44910147|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
44910148|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910149|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44910150|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910151|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
44910152|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44910153|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910154|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
44910155|NCT03977220|Paclitaxel|paclitaxel|mesh-list
44910156|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44910162|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
44910163|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44910164|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910165|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
44910166|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
44910167|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44910168|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910169|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
44910170|NCT03977012|Buprenorphine|buprenorphine|mesh-list
44910171|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910172|NCT03977012|Narcotics|narcotics|mesh-ancestor
44910173|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910174|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910175|NCT03977012|Analgesics|analgesics|mesh-ancestor
44910176|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
44910177|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910178|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44910179|NCT03976713|Bromides|bromides|mesh-list
44910180|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
44910181|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44910182|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
44910183|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910184|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910185|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44910186|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44910187|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
44910188|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44910189|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
44910190|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910191|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910192|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
44910193|NCT03976518|Atezolizumab|atezolizumab|mesh-list
44910194|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910195|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44910196|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44910197|NCT03976544|Estradiol|estradiol|mesh-list
44910198|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44910199|NCT03976544|Progesterone|progesterone|mesh-list
44910200|NCT03976544|Estrogens|estrogens|mesh-ancestor
44910201|NCT03976544|Hormones|hormones|mesh-ancestor
44910202|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910203|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910204|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44910205|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
44910206|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44910207|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44910208|NCT03976544|Progestins|progestins|mesh-ancestor
44910209|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44910210|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703174|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703175|NCT01413620|Protective Agents|protective agents|mesh-ancestor
44703176|NCT01413711|Vigabatrin|vigabatrin|mesh-list
44703177|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
44703178|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703179|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703180|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
44703181|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703182|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703183|NCT01413763|Imiquimod|imiquimod|mesh-list
44703184|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44703185|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
44703186|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703187|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703188|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
44703189|NCT01413854|Diclofenac|diclofenac|mesh-list
44703190|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44910211|NCT03976102|Rituximab|rituximab|mesh-list
44910212|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44910213|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910214|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
44910215|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910216|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44910217|NCT03976037|Misoprostol|misoprostol|mesh-list
44910218|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44910219|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
44910220|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44910221|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910222|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44910223|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910224|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
44910225|NCT03975374|Tobramycin|tobramycin|mesh-list
44910226|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44910227|NCT03975374|Dexamethasone|dexamethasone|mesh-list
44910228|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44910229|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910230|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
44910231|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
44910232|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910233|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910234|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910235|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
44910236|NCT03975374|Hormones|hormones|mesh-ancestor
44910237|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910238|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910239|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910240|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910241|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910242|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44910243|NCT03975283|Bupivacaine|bupivacaine|mesh-list
44910244|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
44910245|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
44910246|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910247|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910248|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
44910249|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910250|NCT03975270|Paclitaxel|paclitaxel|mesh-list
44910251|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44910252|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910253|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44910254|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44910255|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44910256|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910257|NCT03975114|Durvalumab|durvalumab|mesh-list
44910258|NCT03975114|Tremelimumab|tremelimumab|mesh-list
44910259|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44910260|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910261|NCT03975088|Ranibizumab|ranibizumab|mesh-list
44910262|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44910263|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44910264|NCT03975088|Growth Substances|growth substances|mesh-ancestor
44910265|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910266|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44910267|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910268|NCT03975166|Fluticasone|fluticasone|mesh-list
44910270|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44910271|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44910272|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910273|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44910274|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
44910275|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910276|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910277|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44910278|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
44910279|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
44910280|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44910281|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44910282|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44910283|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44910284|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
44910285|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703605|NCT01416909|Laxatives|laxatives|mesh-list
44910286|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910287|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
44910288|NCT03975166|Hormones|hormones|mesh-ancestor
44910289|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910290|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
44910291|NCT03975205|Doxorubicin|doxorubicin|mesh-list
44910292|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44910293|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910294|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44910295|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44910296|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910297|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910298|NCT03975036|Antibodies|antibodies|mesh-list
44910299|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
44910300|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910301|NCT03975010|Naltrexone|naltrexone|mesh-list
44910302|NCT03975010|Buprenorphine|buprenorphine|mesh-list
44910303|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910304|NCT03975010|Narcotics|narcotics|mesh-ancestor
44910305|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910306|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910307|NCT03975010|Analgesics|analgesics|mesh-ancestor
44910308|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
44910309|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910310|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44910311|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44910312|NCT03975062|Dabigatran|dabigatran|mesh-list
44910313|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
44910314|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44910315|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
44910316|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910317|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910318|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
44910319|NCT03974984|Anesthetics|anesthetics|mesh-list
44910320|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910321|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910322|NCT03974789|Dexamethasone|dexamethasone|mesh-list
44910323|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910324|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
44910325|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
44910326|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910327|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910328|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910329|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
44910330|NCT03974789|Hormones|hormones|mesh-ancestor
44910331|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910332|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910333|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910334|NCT03974932|Acetaminophen|acetaminophen|mesh-list
44910335|NCT03974932|Ibuprofen|ibuprofen|mesh-list
44910336|NCT03974932|Celecoxib|celecoxib|mesh-list
44910337|NCT03974932|Bupivacaine|bupivacaine|mesh-list
44910338|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
44910339|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
44910340|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910341|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910342|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
44910343|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910344|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44910345|NCT03974932|Analgesics|analgesics|mesh-ancestor
44910346|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
44910347|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44910348|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910349|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44910350|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44910351|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910352|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910353|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44910354|NCT03974685|Niacinamide|niacinamide|mesh-list
44910355|NCT03974685|Niacin|niacin|mesh-list
44910356|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
44910357|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
44910358|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
44910359|NCT03974685|Vitamins|vitamins|mesh-ancestor
44910360|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
44910361|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910362|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44910398|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44910399|NCT03974425|Growth Substances|growth substances|mesh-ancestor
44910400|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910401|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
44910402|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910404|NCT03973840|Testosterone|testosterone|mesh-list
44910405|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
44910406|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
44910407|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44910408|NCT03973840|Androgens|androgens|mesh-ancestor
44910409|NCT03973840|Hormones|hormones|mesh-ancestor
44910410|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910411|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910412|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910413|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910414|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
44910415|NCT03973775|Permethrin|permethrin|mesh-list
44910416|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910417|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910418|NCT03973879|Atezolizumab|atezolizumab|mesh-list
44910419|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910420|NCT03973957|Fentanyl|fentanyl|mesh-list
44910421|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910422|NCT03973957|Narcotics|narcotics|mesh-ancestor
44910423|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910424|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910425|NCT03973957|Analgesics|analgesics|mesh-ancestor
44910426|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
44910427|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910428|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44910429|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44910430|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
44910431|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
44910432|NCT03974035|Ropivacaine|ropivacaine|mesh-list
44910433|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
44910434|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
44910435|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910436|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910437|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
44910438|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910439|NCT03973567|Norepinephrine|norepinephrine|mesh-list
44910440|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
44910441|NCT03973567|Serotonin|serotonin|mesh-list
44910442|NCT03973567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44910443|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910444|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44910445|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
44910446|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910447|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910448|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910449|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44910450|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44910451|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44910452|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
44910453|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
44910454|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910455|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44910456|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44910457|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910458|NCT03973138|Ranibizumab|ranibizumab|mesh-list
44910459|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44910460|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44910461|NCT03973138|Growth Substances|growth substances|mesh-ancestor
44910462|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910463|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
44910464|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910465|NCT03973411|Ondansetron|ondansetron|mesh-list
44910466|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
44910467|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
44910468|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910469|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910470|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910471|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
44910472|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
44910473|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44910474|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
44910475|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910476|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910477|NCT03973411|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44910478|NCT03973411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44910479|NCT03973411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910480|NCT03973411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910481|NCT03973411|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44910482|NCT03973203|Niacin|niacin|mesh-list
44910483|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
44910484|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44910485|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
44910486|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910487|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44910488|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44910489|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
44910490|NCT03973203|Vitamins|vitamins|mesh-ancestor
44910491|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
44910492|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910493|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
44910494|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44910495|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44910496|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910497|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910498|NCT03973086|Protective Agents|protective agents|mesh-ancestor
44910499|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910500|NCT03972748|Itraconazole|itraconazole|mesh-list
44910501|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
44910502|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910503|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44910504|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44703191|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44703192|NCT01413854|Analgesics|analgesics|mesh-ancestor
44703193|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
44703194|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703195|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703196|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44703197|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703198|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44703199|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703200|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703201|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
44703202|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44703203|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
44703204|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44703205|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703206|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44703207|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44703208|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44703209|NCT01414231|Cytarabine|cytarabine|mesh-list
44254547|NCT00765310|Vitamins|vitamins|mesh-ancestor
44703211|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
44935910|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44703212|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703213|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703214|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
44703215|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703216|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703217|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
44703218|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703219|NCT01414465|Orlistat|orlistat|mesh-list
44703220|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703221|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703222|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44703223|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44703224|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44703225|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
44703226|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703227|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
44703228|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
44703229|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44703230|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703231|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44703232|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44703233|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703234|NCT01414556|Incretins|incretins|mesh-ancestor
44703235|NCT01414556|Hormones|hormones|mesh-ancestor
44703236|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703237|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703238|NCT01414569|Dexamethasone|dexamethasone|mesh-list
44703239|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
44910505|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910506|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910507|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44910508|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
44910509|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910510|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910511|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44910512|NCT03972982|Insulin|insulin|mesh-list
44910513|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44910514|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44910515|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910516|NCT03973047|Ondansetron|ondansetron|mesh-list
44910517|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
44910518|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
44910519|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910520|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910521|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910522|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
44910523|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
44910524|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44910525|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
44910526|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910527|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910528|NCT03973047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44910529|NCT03973047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44910530|NCT03973047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910531|NCT03973047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910532|NCT03973047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44910533|NCT03972592|Sirolimus|sirolimus|mesh-list
44910534|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910535|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910536|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44910537|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910538|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
44910539|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44910540|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
44910541|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910542|NCT03972683|Atropine|atropine|mesh-list
44910543|NCT03972683|Adenosine|adenosine|mesh-list
44910544|NCT03972683|Nitroprusside|nitroprusside|mesh-list
44910545|NCT03972683|Phenylephrine|phenylephrine|mesh-list
44910546|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
44910547|NCT03972683|Acetylcholine|acetylcholine|mesh-list
44910548|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44910549|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
44910550|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
44910551|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910552|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910553|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
44910554|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44910555|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
44910556|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44910557|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44910558|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44910559|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44910560|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
44910561|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910562|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910563|NCT03972683|Protective Agents|protective agents|mesh-ancestor
44910564|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44910565|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44910566|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44910567|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44910568|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
44910569|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44910570|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44910571|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
44910572|NCT03972683|Analgesics|analgesics|mesh-ancestor
44910573|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
44910574|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44910575|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44910576|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
44910577|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
44910578|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44910579|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44910580|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44910581|NCT03972358|Misoprostol|misoprostol|mesh-list
44910609|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
44910610|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910612|NCT03972046|Dabrafenib|dabrafenib|mesh-list
44910613|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44910614|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910615|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44910616|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910617|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910618|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44910619|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
44910620|NCT03971604|Vitamins|vitamins|mesh-list
44910621|NCT03971604|Vitamin E|vitamin e|mesh-list
44910622|NCT03971604|Vitamin A|vitamin a|mesh-list
44910623|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
44910624|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910625|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
44910626|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910627|NCT03971604|Protective Agents|protective agents|mesh-ancestor
44703994|NCT01419041|Crizotinib|crizotinib|mesh-list
44910629|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
44910630|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910631|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
44910632|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
44910633|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910634|NCT03971201|Sorafenib|sorafenib|mesh-list
44910635|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910636|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44910637|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910638|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910639|NCT03971279|Dexamethasone|dexamethasone|mesh-list
44910640|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910641|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
44910642|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
44910643|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910644|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910645|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910646|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
44910647|NCT03971279|Hormones|hormones|mesh-ancestor
44910648|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910649|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910650|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910651|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44910652|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910653|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910654|NCT03970798|Midazolam|midazolam|mesh-list
44910655|NCT03970798|Caffeine|caffeine|mesh-list
44910656|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44910657|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44910658|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44910659|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910660|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910661|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44910662|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44910663|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44910664|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44910665|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
44910666|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
44910667|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
44910668|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
44910669|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910670|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910671|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44910672|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44910673|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
44910674|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44910675|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44910676|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910677|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44910678|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44910679|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44910680|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44910681|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
44910682|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
44910683|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
44910684|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44910685|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
44910686|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910687|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44910688|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44910689|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
44910690|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910691|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910692|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44910693|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44910694|NCT03970772|Glucagon|glucagon|mesh-list
44910695|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910696|NCT03970772|Hormones|hormones|mesh-ancestor
44910697|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910698|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910699|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
44910700|NCT03971019|Atorvastatin|atorvastatin|mesh-list
44910701|NCT03971019|Simvastatin|simvastatin|mesh-list
44910702|NCT03971019|Calcium|calcium|mesh-list
44910703|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44910704|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703241|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
44703242|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
44703243|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703244|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703245|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703246|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
44703247|NCT01414569|Hormones|hormones|mesh-ancestor
44703248|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703249|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44703250|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703251|NCT01414608|Paclitaxel|paclitaxel|mesh-list
44703252|NCT01414608|Cisplatin|cisplatin|mesh-list
44703253|NCT01414608|Carboplatin|carboplatin|mesh-list
44703254|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44703255|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44703256|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703257|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
44703258|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
44703259|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
44703260|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703261|NCT01414816|Interferons|interferons|mesh-list
44703262|NCT01414816|Interferon-beta|interferon-beta|mesh-list
44703263|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
44703264|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703265|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
44703266|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703267|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
44703268|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703269|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44703270|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
44703271|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44703272|NCT01414868|Montelukast|montelukast|mesh-list
44703273|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44703274|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44703275|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703276|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703277|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703278|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703279|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44703280|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44703281|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703282|NCT01414881|Mipomersen|mipomersen|mesh-list
44703283|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44703284|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44703285|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
44703286|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703287|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44703288|NCT01414972|Vitamin A|vitamin a|mesh-list
44703289|NCT01414972|Vitamins|vitamins|mesh-ancestor
44703290|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
44737963|NCT02702492|Niacin|niacin|mesh-list
44703291|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703292|NCT01414998|Nicotine|nicotine|mesh-list
44703293|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44703294|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
44703295|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703296|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703297|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44703298|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44703299|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
44703300|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703301|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703302|NCT01415011|Afatinib|afatinib|mesh-list
44703303|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703304|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44703305|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703306|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703307|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
44703308|NCT01415128|Desipramine|desipramine|mesh-list
44703309|NCT01415128|Omeprazole|omeprazole|mesh-list
44703310|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44703311|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703312|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44910705|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44910706|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44910707|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44910708|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
44910709|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910710|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44910711|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44910712|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910713|NCT03970759|Fluorides|fluorides|mesh-list
44910714|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
44910715|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
44910716|NCT03970759|Protective Agents|protective agents|mesh-ancestor
44910717|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910718|NCT03970577|Prednisone|prednisone|mesh-list
44910719|NCT03970577|Rituximab|rituximab|mesh-list
44910720|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44910721|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910722|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
44910723|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910724|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44910725|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910726|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
44910727|NCT03970577|Hormones|hormones|mesh-ancestor
44910728|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910729|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910730|NCT03970668|Insulin|insulin|mesh-list
44910731|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44910732|NCT03970668|Linagliptin|linagliptin|mesh-list
44910733|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44910734|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910735|NCT03970668|Incretins|incretins|mesh-ancestor
44910736|NCT03970668|Hormones|hormones|mesh-ancestor
44910737|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910738|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44910739|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
44910740|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910741|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910742|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
44910743|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44910744|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44910745|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910746|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
44910747|NCT03970213|Coagulants|coagulants|mesh-ancestor
44910748|NCT03970239|Ketanserin|ketanserin|mesh-list
44910749|NCT03970239|Fluorides|fluorides|mesh-list
44910750|NCT03970239|Altanserin|altanserin|mesh-list
44910751|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
44910752|NCT03970239|Protective Agents|protective agents|mesh-ancestor
44910753|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910754|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44910755|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
44910756|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910757|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910758|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44910759|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44910760|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
44910761|NCT03970044|Exenatide|exenatide|mesh-list
44910762|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44910763|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910764|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44910765|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910766|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44910767|NCT03970044|Incretins|incretins|mesh-ancestor
44910768|NCT03970044|Hormones|hormones|mesh-ancestor
44910769|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910770|NCT03969758|Metronidazole|metronidazole|mesh-list
44910771|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
44910772|NCT03969758|Cefixime|cefixime|mesh-list
44910773|NCT03969758|Liver Extracts|liver extracts|mesh-list
44910774|NCT03969758|Hematinics|hematinics|mesh-ancestor
44738371|NCT01604135|Riboflavin|riboflavin|mesh-list
44910775|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910776|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910777|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44910778|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44910779|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44910780|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44910781|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910790|NCT03968835|Bacitracin|bacitracin|mesh-list
44910791|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44910792|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910793|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910794|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
44910795|NCT03968640|Vitamins|vitamins|mesh-ancestor
44910796|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
44910797|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910798|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
44910799|NCT03968588|Tacrolimus|tacrolimus|mesh-list
44910800|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44910801|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
44910802|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910803|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44910804|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910805|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910806|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44910807|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910808|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44910809|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
44910810|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44910811|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910812|NCT03968861|Xenon|xenon|mesh-list
44910813|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44910814|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
44910815|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
44910816|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910817|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910818|NCT03968263|Hydrocodone|hydrocodone|mesh-list
44910819|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910820|NCT03968263|Narcotics|narcotics|mesh-ancestor
44910821|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910822|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910823|NCT03968263|Analgesics|analgesics|mesh-ancestor
44910824|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
44910825|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910826|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
44910827|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
44910828|NCT03968185|Analgesics|analgesics|mesh-list
44910829|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
44910830|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910831|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910832|NCT03968146|Acetaminophen|acetaminophen|mesh-list
44910833|NCT03968146|Ketorolac|ketorolac|mesh-list
44910834|NCT03968146|Fentanyl|fentanyl|mesh-list
44910835|NCT03968146|Meperidine|meperidine|mesh-list
44910836|NCT03968146|Morphine|morphine|mesh-list
44910837|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910838|NCT03968146|Narcotics|narcotics|mesh-ancestor
44738760|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738817|NCT01612832|Pregabalin|pregabalin|mesh-list
44910839|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739082|NCT01613963|Analgesics|analgesics|mesh-ancestor
44910840|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910841|NCT03968146|Analgesics|analgesics|mesh-ancestor
44910842|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
44910843|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910844|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44910845|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44910846|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
44910847|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
44910848|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44910849|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
44910850|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44910851|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44910852|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44910853|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44910854|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910855|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910856|NCT03968224|Metformin|metformin|mesh-list
44910857|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
44910858|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44910859|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910860|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44910861|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910862|NCT03968237|Buprenorphine|buprenorphine|mesh-list
44910863|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44910864|NCT03968237|Naloxone|naloxone|mesh-list
44910865|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44910866|NCT03968237|Narcotics|narcotics|mesh-ancestor
44910867|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910868|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910869|NCT03968237|Analgesics|analgesics|mesh-ancestor
44910870|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
44910871|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910872|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44910873|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
44910874|NCT03967964|Testosterone|testosterone|mesh-list
44910875|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
44910876|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
44910877|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44910878|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44910879|NCT03967964|Androgens|androgens|mesh-ancestor
44910880|NCT03967964|Hormones|hormones|mesh-ancestor
44910881|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44910882|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910883|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44910884|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910885|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
44910886|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44910887|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
44910888|NCT03967886|Esomeprazole|esomeprazole|mesh-list
44910889|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44910890|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44910891|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44910892|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910893|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910894|NCT03968042|Thiamine|thiamine|mesh-list
44910895|NCT03968042|Edaravone|edaravone|mesh-list
44910896|NCT03968042|Mitogens|mitogens|mesh-list
44910897|NCT03968042|Vitamins|vitamins|mesh-ancestor
44910898|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
44910899|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910900|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44910901|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910902|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
44910903|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44910904|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
44910905|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44910906|NCT03968042|Protective Agents|protective agents|mesh-ancestor
44910907|NCT03967938|Olaparib|olaparib|mesh-list
44910908|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44910909|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910910|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910911|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44910912|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
44910913|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44910914|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
44910915|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44910916|NCT03967665|Expectorants|expectorants|mesh-ancestor
44910917|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
44910918|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44910919|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
44910920|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910921|NCT03967665|Protective Agents|protective agents|mesh-ancestor
44910922|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910923|NCT03967665|Antidotes|antidotes|mesh-ancestor
44910924|NCT03967392|Lidocaine|lidocaine|mesh-list
44910925|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44910926|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
44910927|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910928|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739863|NCT01618643|Acetic Acid|acetic acid|mesh-list
44910929|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
44910930|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910931|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44740085|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
44740281|NCT01621022|Bupropion|bupropion|mesh-list
44740350|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44910932|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44910933|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44910934|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910935|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910936|NCT03967171|Oxytocin|oxytocin|mesh-list
44910937|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
44910938|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44910939|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910940|NCT03967496|Metformin|metformin|mesh-list
44910941|NCT03967496|Amlodipine|amlodipine|mesh-list
44910942|NCT03967496|Lisinopril|lisinopril|mesh-list
44910943|NCT03967496|Bisoprolol|bisoprolol|mesh-list
44910944|NCT03967496|Hydralazine|hydralazine|mesh-list
44910945|NCT03967496|Anesthetics|anesthetics|mesh-list
44910946|NCT03967496|Atorvastatin|atorvastatin|mesh-list
44910947|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44910948|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910949|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910950|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44910951|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44910952|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
44910953|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44910954|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44910955|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44910956|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44910957|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740611|NCT01622790|Lamivudine|lamivudine|mesh-list
44910958|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44910959|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44910960|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44910961|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44910962|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44910963|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
44910964|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44910965|NCT03967496|Protective Agents|protective agents|mesh-ancestor
44910966|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
44910967|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
44910968|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910969|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44910970|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44910971|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44910972|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
44910973|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44910974|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44910975|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44910976|NCT03967327|Morphine|morphine|mesh-list
44910977|NCT03967327|Buprenorphine|buprenorphine|mesh-list
44910978|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44740851|NCT01624207|Atorvastatin|atorvastatin|mesh-list
44740878|NCT01624441|Epirubicin|epirubicin|mesh-list
44910979|NCT03967327|Narcotics|narcotics|mesh-ancestor
44910980|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44910981|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44910982|NCT03967327|Analgesics|analgesics|mesh-ancestor
44910983|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
44910984|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44910985|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44910986|NCT03966560|Timolol|timolol|mesh-list
44910987|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44910988|NCT03966560|Bimatoprost|bimatoprost|mesh-list
44910989|NCT03966560|Travoprost|travoprost|mesh-list
44910990|NCT03966560|Dorzolamide|dorzolamide|mesh-list
44703313|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703314|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703315|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44703316|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703317|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44703318|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44703319|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44703320|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44703321|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703322|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703323|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703324|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703325|NCT01415141|Ribavirin|ribavirin|mesh-list
44703326|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44703327|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
44703328|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703329|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
44741087|NCT01625871|Lumefantrine|lumefantrine|mesh-list
44703330|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703331|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44703332|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
44703333|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
44703334|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
44703335|NCT01415336|Doxorubicin|doxorubicin|mesh-list
44703336|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44703337|NCT01415336|Capecitabine|capecitabine|mesh-list
44703338|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703339|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
44703340|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703341|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703342|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44910991|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44911004|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44911005|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44911007|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44911008|NCT03966859|Atorvastatin|atorvastatin|mesh-list
44911009|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44911010|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44911011|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
44911012|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911013|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44911014|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44911015|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911016|NCT03966950|Melatonin|melatonin|mesh-list
44911017|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
44911018|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911019|NCT03966950|Protective Agents|protective agents|mesh-ancestor
44911020|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911021|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911022|NCT03966547|Anesthetics|anesthetics|mesh-list
44911023|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
44911024|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911025|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911026|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
44911027|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911028|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
44911029|NCT03966378|Calcium|calcium|mesh-list
44911030|NCT03966378|Caseins|caseins|mesh-list
44911031|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911032|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911033|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
44911034|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
44911035|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911036|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44911037|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911038|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
44911039|NCT03966378|Protective Agents|protective agents|mesh-ancestor
44911040|NCT03966898|Letrozole|letrozole|mesh-list
44911041|NCT03966898|Anastrozole|anastrozole|mesh-list
44911042|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911043|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44741352|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44911044|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44911045|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911046|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911047|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44911048|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44911049|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911050|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911051|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704490|NCT01422291|Morphine|morphine|mesh-list
44911052|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44911054|NCT03966326|Fentanyl|fentanyl|mesh-list
44911055|NCT03966326|Anesthetics|anesthetics|mesh-list
44911056|NCT03966326|Sevoflurane|sevoflurane|mesh-list
44911057|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911058|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911059|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44911060|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44911061|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
44911062|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44911063|NCT03966326|Narcotics|narcotics|mesh-ancestor
44911064|NCT03966326|Analgesics|analgesics|mesh-ancestor
44911065|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
44911066|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911067|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44911068|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911069|NCT03966235|Melatonin|melatonin|mesh-list
44911070|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
44911071|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911072|NCT03966235|Protective Agents|protective agents|mesh-ancestor
44911073|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911074|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911075|NCT03966079|Plasminogen|plasminogen|mesh-list
44911076|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44911077|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44911078|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911079|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911080|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44911081|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911082|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911083|NCT03966040|Vaccines|vaccines|mesh-list
44911084|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
44741474|NCT01628471|Decitabine|decitabine|mesh-list
44741598|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911085|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911086|NCT03965871|Esketamine|esketamine|mesh-list
44911087|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
44911088|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911089|NCT03966118|Paclitaxel|paclitaxel|mesh-list
44911090|NCT03966118|Avelumab|avelumab|mesh-list
44911091|NCT03966118|Ramucirumab|ramucirumab|mesh-list
44911092|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44911093|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911094|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44911095|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44911096|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44911097|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911098|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44911099|NCT03965949|Hormones|hormones|mesh-list
44911100|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911101|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911102|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
44911103|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44911104|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911105|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911106|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
44911107|NCT03965767|Coagulants|coagulants|mesh-ancestor
44911108|NCT03965858|Esketamine|esketamine|mesh-list
44911109|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
44911110|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911111|NCT03965819|Acetaminophen|acetaminophen|mesh-list
44911112|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911113|NCT03965819|Analgesics|analgesics|mesh-ancestor
44911114|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
44911115|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911116|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911117|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
44911118|NCT03966066|Erythromycin|erythromycin|mesh-list
44911119|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
44911120|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44911121|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
44911122|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911123|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911124|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911125|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44911126|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704569|NCT01422616|Analgesics|analgesics|mesh-ancestor
44911127|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911128|NCT03965546|Sorafenib|sorafenib|mesh-list
44911129|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911130|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44911131|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911132|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911133|NCT03965624|Ixazomib|ixazomib|mesh-list
44741832|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
44741930|NCT01631409|Aspirin|aspirin|mesh-list
44911134|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911135|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44911136|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741995|NCT01631539|Irinotecan|irinotecan|mesh-list
44742153|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
44911137|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911138|NCT03965442|Esmolol|esmolol|mesh-list
44911139|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44911140|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44911141|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44911142|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911143|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911144|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911145|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911146|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
44911147|NCT03965637|Vitamins|vitamins|mesh-ancestor
44911148|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
44911149|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911150|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
44911151|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911152|NCT03965637|Protective Agents|protective agents|mesh-ancestor
44911153|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
44911154|NCT03965286|Ledipasvir|ledipasvir|mesh-list
44911155|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44911156|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
44911157|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911158|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
44911159|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
44911160|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911161|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911162|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911163|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
44911164|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44911165|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911166|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911167|NCT03965208|Heparin|heparin|mesh-list
44911168|NCT03965208|Calcium heparin|calcium heparin|mesh-list
44911169|NCT03965208|Bivalirudin|bivalirudin|mesh-list
44911170|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
44911171|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44911172|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911173|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911174|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
44911175|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44911176|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
44911177|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911178|NCT03964935|Minocycline|minocycline|mesh-list
44911179|NCT03964935|Lycopene|lycopene|mesh-list
44911180|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911181|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911182|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911183|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
44911184|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911185|NCT03964935|Protective Agents|protective agents|mesh-ancestor
44911186|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911187|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44911188|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44911189|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911190|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
44911191|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44911192|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911193|NCT03965195|Vaccines|vaccines|mesh-list
44911194|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
44911195|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911196|NCT03964753|Paclitaxel|paclitaxel|mesh-list
44911197|NCT03964753|Cisplatin|cisplatin|mesh-list
44911198|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44703343|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
44911199|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911200|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44911201|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44911231|NCT03963752|Megestrol|megestrol|mesh-list
44911232|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
44911233|NCT03963752|Leuprolide|leuprolide|mesh-list
44911234|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44911235|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44742486|NCT01635296|Cytarabine|cytarabine|mesh-list
44742767|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742846|NCT01636895|Renal Agents|renal agents|mesh-ancestor
44911236|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44911237|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
44911238|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911239|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911240|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44911241|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44911242|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44911243|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911244|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
44911245|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44911246|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44911247|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
44911248|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
44911249|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44911250|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
44911251|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911252|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911253|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44742985|NCT01637545|Ramosetron|ramosetron|mesh-list
44743044|NCT01637675|Tanshinone|tanshinone|mesh-list
44743182|NCT01638299|Insulin|insulin|mesh-list
44743275|NCT01638767|NuvaRing|nuvaring|mesh-list
44911254|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
44911255|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44911256|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
44911257|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911258|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911259|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44911260|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703344|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703345|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703346|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44703347|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44703348|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44703349|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44703350|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703351|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703352|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
44703353|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44703354|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44703355|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44703356|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44703357|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703358|NCT01415505|Valsartan|valsartan|mesh-list
44703359|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44703360|NCT01415505|Nebivolol|nebivolol|mesh-list
44703361|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44703362|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44703363|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44703364|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703365|NCT01415505|Diuretics|diuretics|mesh-ancestor
44703366|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
44703367|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703368|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44703369|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703370|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703371|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44703372|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44703373|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44703374|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703375|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703376|NCT01415557|Micronutrients|micronutrients|mesh-list
44703377|NCT01415557|Trace Elements|trace elements|mesh-list
44703378|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703379|NCT01415596|Albuterol|albuterol|mesh-list
44703380|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44703381|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
44703382|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703383|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703384|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44703385|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703386|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
44704806|NCT01423864|Hormones|hormones|mesh-ancestor
44911262|NCT03963648|Protective Agents|protective agents|mesh-ancestor
44911263|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
44911264|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44911265|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911266|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911267|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
44911268|NCT03963466|Coagulants|coagulants|mesh-ancestor
44911269|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
44911270|NCT03963479|Pyridoxal|pyridoxal|mesh-list
44911271|NCT03963479|Pyridoxine|pyridoxine|mesh-list
44911272|NCT03963479|Vitamins|vitamins|mesh-ancestor
44743350|NCT01639027|Drotaverin|drotaverin|mesh-list
44743529|NCT01642771|Docetaxel|docetaxel|mesh-list
44911273|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
44911274|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911275|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
44911276|NCT03963336|Acetazolamide|acetazolamide|mesh-list
44911277|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
44911278|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44911279|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911280|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743690|NCT01649960|Sirolimus|sirolimus|mesh-list
44743951|NCT01651390|Sirolimus|sirolimus|mesh-list
44911281|NCT03963336|Diuretics|diuretics|mesh-ancestor
44911282|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
44911283|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911284|NCT03963193|Cisplatin|cisplatin|mesh-list
44911285|NCT03963193|Irinotecan|irinotecan|mesh-list
44911286|NCT03963193|Etoposide|etoposide|mesh-list
44911287|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911288|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44911289|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44911290|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911291|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911292|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44911293|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44911294|NCT03963115|Epinephrine|epinephrine|mesh-list
44911295|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44911296|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911297|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911298|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911299|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911300|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911301|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44911302|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44911303|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
44911304|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911305|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44911306|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
44911307|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
44911308|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
44911309|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44911310|NCT03963024|Treosulfan|treosulfan|mesh-list
44911311|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44911312|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
44911313|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911314|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911315|NCT03963128|Vitamin D|vitamin d|mesh-list
44911316|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
44911317|NCT03963128|Vitamins|vitamins|mesh-ancestor
44911318|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
44911319|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911320|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44911321|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911322|NCT03962881|Vaccines|vaccines|mesh-list
44911323|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
44911324|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911325|NCT03962920|Tigecycline|tigecycline|mesh-list
44911326|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911327|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911328|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44744175|NCT01652378|Lidocaine|lidocaine|mesh-list
44911329|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911330|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911331|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
44911332|NCT03962907|Mupirocin|mupirocin|mesh-list
44911333|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44911334|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911335|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
44744494|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44911336|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911337|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44911338|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911339|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911340|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
44911341|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44911342|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
44911343|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911344|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744706|NCT01655199|Albuterol|albuterol|mesh-list
44744728|NCT01655303|Metoprolol|metoprolol|mesh-list
44744861|NCT01655888|Tremelimumab|tremelimumab|mesh-list
44744941|NCT01656057|Acetaminophen|acetaminophen|mesh-list
44911345|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911346|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
44911347|NCT03962725|Ketamine|ketamine|mesh-list
44911348|NCT03962725|Propofol|propofol|mesh-list
44911349|NCT03962725|Anesthetics|anesthetics|mesh-list
44911350|NCT03962725|Rocuronium|rocuronium|mesh-list
44911351|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44911352|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911353|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911354|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911355|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911356|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
44911357|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911358|NCT03962725|Analgesics|analgesics|mesh-ancestor
44911359|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
44911360|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911361|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44911362|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44911363|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911364|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911365|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911366|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911367|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44911368|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44911369|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44911370|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44911371|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44911372|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
44911373|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44911374|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911375|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
44911376|NCT03962803|Vaccines|vaccines|mesh-list
44911377|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
44911378|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911379|NCT03962816|Vaccines|vaccines|mesh-list
44911380|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
44911381|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911382|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
44911383|NCT03962296|Calcium|calcium|mesh-list
44911384|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911385|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911386|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
44911387|NCT03962296|Coagulants|coagulants|mesh-ancestor
44911388|NCT03962283|Rifaximin|rifaximin|mesh-list
44911389|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911390|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911391|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911392|NCT03961867|Docetaxel|docetaxel|mesh-list
44911393|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
44911394|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911395|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44911396|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44911397|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745178|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
44745245|NCT01657682|Crenolanib|crenolanib|mesh-list
44745316|NCT01657890|Isavuconazole|isavuconazole|mesh-list
44745395|NCT01658202|Nicotine|nicotine|mesh-list
44911398|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911399|NCT03961958|Propofol|propofol|mesh-list
44911400|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911401|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911402|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911403|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911404|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
44911405|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
44911406|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
44911407|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911408|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
44911409|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44911410|NCT03961828|Ledipasvir|ledipasvir|mesh-list
44911411|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
44911412|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911413|NCT03961659|Metformin|metformin|mesh-list
44911414|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
44911415|NCT03961659|Acarbose|acarbose|mesh-list
44704968|NCT01424826|Rifampin|rifampin|mesh-list
44911454|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44911455|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911456|NCT03961360|Analgesics|analgesics|mesh-ancestor
44911457|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
44911458|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911459|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911460|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911461|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911462|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44911463|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911464|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911465|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44911466|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44911467|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911468|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
44911469|NCT03960970|Azithromycin|azithromycin|mesh-list
44911470|NCT03960970|Cefoxitin|cefoxitin|mesh-list
44911471|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911472|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911473|NCT03961334|Aspirin|aspirin|mesh-list
44911474|NCT03961334|Dabigatran|dabigatran|mesh-list
44911475|NCT03961334|Apixaban|apixaban|mesh-list
44911476|NCT03961334|Edoxaban|edoxaban|mesh-list
44911477|NCT03961334|Clopidogrel|clopidogrel|mesh-list
44911478|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44911479|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911480|NCT03961334|Analgesics|analgesics|mesh-ancestor
44911481|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
44911482|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911483|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911484|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911485|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911486|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44911487|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745487|NCT01658878|Nivolumab|nivolumab|mesh-list
44745560|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
44745748|NCT01659944|Metoprolol|metoprolol|mesh-list
44911488|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911489|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44911490|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44911491|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911492|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
44911493|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44911494|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44911495|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44911496|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
44911497|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911498|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
44911499|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44911500|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44911501|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
44911502|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44911503|NCT03961126|Clobetasol|clobetasol|mesh-list
44911504|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911505|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
44911506|NCT03961126|Hormones|hormones|mesh-ancestor
44911507|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911508|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911509|NCT03961048|Ropivacaine|ropivacaine|mesh-list
44911510|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44911511|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911512|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
44911513|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911514|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911515|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
44911516|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911517|NCT03960905|Meropenem|meropenem|mesh-list
44911518|NCT03960905|Ceftazidime|ceftazidime|mesh-list
44911519|NCT03960905|Cefepime|cefepime|mesh-list
44911520|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
44911521|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911522|NCT03961087|Ubiquinone|ubiquinone|mesh-list
44911523|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
44911524|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
44911525|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
44911526|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911527|NCT03961087|Vitamins|vitamins|mesh-ancestor
44911528|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44911529|NCT03961087|Protective Agents|protective agents|mesh-ancestor
44911530|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
44911531|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
44911532|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911533|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44745986|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
44911534|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911535|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911536|NCT03960775|Analgesics|analgesics|mesh-ancestor
44911537|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
44911538|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911539|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44911540|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44911541|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911542|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911543|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911544|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911545|NCT03960866|Phentolamine|phentolamine|mesh-list
44911546|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44911547|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44911548|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44911549|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44911550|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911551|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911552|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911553|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911554|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44911555|NCT03960801|Remifentanil|remifentanil|mesh-list
44911556|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44911557|NCT03960801|Narcotics|narcotics|mesh-ancestor
44911558|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911559|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911560|NCT03960801|Analgesics|analgesics|mesh-ancestor
44911561|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
44911562|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911563|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
44911564|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44911565|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911566|NCT03960671|Midazolam|midazolam|mesh-list
44911567|NCT03960671|Diazepam|diazepam|mesh-list
44911568|NCT03960671|Propofol|propofol|mesh-list
44911569|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911570|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911571|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746137|NCT01662622|Sevoflurane|sevoflurane|mesh-list
44911572|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911573|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
44911574|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
44746328|NCT01664650|Genistein|genistein|mesh-list
44911575|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44746601|NCT01666171|Metformin|metformin|mesh-list
44911576|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44911577|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44911578|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911579|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
44911580|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
44911581|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911582|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911583|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
44911584|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
44911585|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
44911586|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911587|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911588|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44911589|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44911590|NCT03960268|Brodalumab|brodalumab|mesh-list
44911591|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44911592|NCT03960411|Doxycycline|doxycycline|mesh-list
44911593|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911594|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911595|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
44911596|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44911597|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44911598|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44703387|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44703388|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44703389|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44703390|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44703391|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703392|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703393|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911599|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44911600|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911601|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
44911602|NCT03957902|Aspirin|aspirin|mesh-list
44911603|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44911604|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911605|NCT03957902|Analgesics|analgesics|mesh-ancestor
44911606|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
44911607|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911608|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746903|NCT01668121|Budesonide|budesonide|mesh-list
44747096|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911609|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911610|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911611|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44911612|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911613|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911614|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44911615|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44911616|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911617|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
44911618|NCT03957720|Penicillamine|penicillamine|mesh-list
44911619|NCT03957720|Succimer|succimer|mesh-list
44911620|NCT03957720|Antidotes|antidotes|mesh-ancestor
44911621|NCT03957720|Protective Agents|protective agents|mesh-ancestor
44911622|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911623|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
44911624|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
44911625|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911626|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911627|NCT03957668|Lactulose|lactulose|mesh-list
44911628|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44911629|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911630|NCT03957668|Laxatives|laxatives|mesh-ancestor
44911631|NCT03957499|Dexamethasone|dexamethasone|mesh-list
44911632|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
44911633|NCT03957499|Bupivacaine|bupivacaine|mesh-list
44911634|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911635|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
44911636|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
44911637|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911638|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911639|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911640|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
44911641|NCT03957499|Hormones|hormones|mesh-ancestor
44911642|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911643|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44911644|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911645|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911646|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
44911647|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911648|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
44911649|NCT03957499|Analgesics|analgesics|mesh-ancestor
44911650|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44911651|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
44911652|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44911653|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44911654|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911655|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911656|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
44911657|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911658|NCT03957629|Interferons|interferons|mesh-list
44911659|NCT03957629|Tenofovir|tenofovir|mesh-list
44911660|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
44911661|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
44911662|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44911663|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911664|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
44911665|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911666|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44911667|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44911668|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911669|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911670|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44911671|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44911672|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
44911673|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911674|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
44911675|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44911676|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
44911710|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911711|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44911712|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911713|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911714|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
44911715|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911716|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
44911717|NCT03957109|Anesthetics|anesthetics|mesh-list
44911718|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911719|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705260|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
44911721|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
44911722|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44911723|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911724|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911725|NCT03956732|Vitamin D|vitamin d|mesh-list
44911726|NCT03956732|Caseins|caseins|mesh-list
44911727|NCT03956732|Vitamins|vitamins|mesh-ancestor
44911728|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
44747609|NCT05596071|Dsuvia|dsuvia|mesh-list
44747647|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44747648|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44747649|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747650|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
44747651|NCT05595447|Nivolumab|nivolumab|mesh-list
44747652|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44747653|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747654|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747655|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44747656|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747657|NCT05567822|Esmolol|esmolol|mesh-list
44747715|NCT05488847|Oxycodone|oxycodone|mesh-list
44747791|NCT05423951|Sufentanil|sufentanil|mesh-list
44748014|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
44911729|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911730|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44911731|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
44911732|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
44911733|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911734|NCT03956823|Amlodipine|amlodipine|mesh-list
44911735|NCT03956823|Telmisartan|telmisartan|mesh-list
44911736|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44911737|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44911738|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44911739|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911740|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911741|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911742|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
44911743|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44703394|NCT01415687|Bisacodyl|bisacodyl|mesh-list
44703395|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
44703396|NCT01415687|Citric Acid|citric acid|mesh-list
44703397|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
44703398|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
44703399|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44703400|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
44703401|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
44703402|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703403|NCT01415687|Cathartics|cathartics|mesh-ancestor
44703404|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703405|NCT01415687|Laxatives|laxatives|mesh-ancestor
44703406|NCT01415713|Leucovorin|leucovorin|mesh-list
44703407|NCT01415713|Gemcitabine|gemcitabine|mesh-list
44703408|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
44703409|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703410|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
44703411|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703412|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703413|NCT01415713|Antiviral Agents|antiviral agents|mesh-ancestor
44703414|NCT01415713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703415|NCT01415713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703416|NCT01415713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703417|NCT01415713|Immunologic Factors|immunologic factors|mesh-ancestor
44703418|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703419|NCT01415713|Antidotes|antidotes|mesh-ancestor
44703420|NCT01415713|Protective Agents|protective agents|mesh-ancestor
44703421|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
44703422|NCT01415713|Vitamins|vitamins|mesh-ancestor
44703423|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
44703424|NCT01415765|Prednisone|prednisone|mesh-list
44703425|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
44703426|NCT01415765|Rituximab|rituximab|mesh-list
44703427|NCT01415765|Doxorubicin|doxorubicin|mesh-list
44703428|NCT01415765|Etoposide|etoposide|mesh-list
44703429|NCT01415765|Vincristine|vincristine|mesh-list
44703430|NCT01415765|Pevonedistat|pevonedistat|mesh-list
44525376|NCT03451110|Lemborexant|lemborexant|mesh-list
44703431|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703432|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
44703433|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748437|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
44703434|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703435|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44703436|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
44703437|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703438|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703439|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44703440|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44703441|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44703442|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44703443|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44703444|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748580|NCT03518086|Mirikizumab|mirikizumab|mesh-list
44748713|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
44748966|NCT02066636|Nivolumab|nivolumab|mesh-list
44703445|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44703446|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
44703447|NCT01415765|Hormones|hormones|mesh-ancestor
44911744|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44911746|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
44911747|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911748|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911749|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
44911750|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44911751|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
44911752|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911753|NCT03956888|Expectorants|expectorants|mesh-ancestor
44911754|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
44911755|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44911756|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
44911757|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911758|NCT03956888|Protective Agents|protective agents|mesh-ancestor
44911759|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911760|NCT03956888|Antidotes|antidotes|mesh-ancestor
44911761|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
44911762|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911763|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
44911764|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911765|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911766|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
44911767|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911768|NCT03956212|Doxycycline|doxycycline|mesh-list
44911769|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44911770|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911771|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
44911772|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44911773|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44911774|NCT03956017|Ubiquinone|ubiquinone|mesh-list
44911775|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
44911776|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
44911777|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911778|NCT03956017|Vitamins|vitamins|mesh-ancestor
44911779|NCT03955939|Midazolam|midazolam|mesh-list
44911780|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44911781|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911782|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911783|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911784|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44911785|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44911786|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44911787|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911788|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
44911789|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
44911790|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
44911791|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
44911792|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911793|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911794|NCT03955809|Ketamine|ketamine|mesh-list
44911795|NCT03955809|Analgesics|analgesics|mesh-ancestor
44911796|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
44911797|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911798|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911799|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44911800|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911801|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
44911802|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
44911803|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911804|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44911805|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44911806|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911807|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911808|NCT03956134|Tapentadol|tapentadol|mesh-list
44911809|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44911810|NCT03956134|Narcotics|narcotics|mesh-ancestor
44749037|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44749117|NCT01686386|Hormones|hormones|mesh-ancestor
44749179|NCT01689753|Citric Acid|citric acid|mesh-list
44911811|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911812|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911813|NCT03956134|Analgesics|analgesics|mesh-ancestor
44911814|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
44911815|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911816|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44911817|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44911818|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749536|NCT01691742|Laxatives|laxatives|mesh-list
44911819|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911820|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911821|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911822|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
44911823|NCT03956121|Analgesics|analgesics|mesh-ancestor
44911824|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
44911825|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911826|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911827|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
44911828|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911829|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44911830|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
44911831|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44911832|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44911833|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911834|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44911835|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
44911836|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911837|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
44911838|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44911839|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
44911840|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911841|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911842|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44911843|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
44911844|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911845|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911846|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44911847|NCT03955705|Nefopam|nefopam|mesh-list
44911848|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911849|NCT03955705|Analgesics|analgesics|mesh-ancestor
44911850|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
44911851|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911852|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911853|NCT03955406|Anesthetics|anesthetics|mesh-list
44911854|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911855|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911856|NCT03955354|Apatinib|apatinib|mesh-list
44911857|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911858|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44911859|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911860|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911861|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
44911862|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44911863|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44911864|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
44911865|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44911866|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44911867|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911868|NCT03955458|Bupivacaine|bupivacaine|mesh-list
44911869|NCT03955458|Ropivacaine|ropivacaine|mesh-list
44911870|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911871|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
44911872|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911873|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911874|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
44911875|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911876|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
44911877|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44911878|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
44911879|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749618|NCT01692704|Cisplatin|cisplatin|mesh-list
44749767|NCT01693601|Panobinostat|panobinostat|mesh-list
44911880|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
44911881|NCT03955497|Protective Agents|protective agents|mesh-ancestor
44911882|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
44911883|NCT03954964|Narcotics|narcotics|mesh-ancestor
44911884|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911885|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911886|NCT03954964|Analgesics|analgesics|mesh-ancestor
44911887|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
44911888|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911889|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
44911890|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44911891|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44911892|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911893|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
44911894|NCT03954860|Coagulants|coagulants|mesh-ancestor
44749903|NCT05288179|Pirfenidone|pirfenidone|mesh-list
44749904|NCT05288179|Analgesics|analgesics|mesh-ancestor
44749905|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
44749911|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911896|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44911897|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911898|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44911899|NCT03954873|Hormones|hormones|mesh-ancestor
44911900|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911901|NCT03954873|Incretins|incretins|mesh-ancestor
44911902|NCT03954639|Bupivacaine|bupivacaine|mesh-list
44911903|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
44911904|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
44703448|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703449|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44703450|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44703451|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
44703452|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
44703453|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
44703454|NCT01415778|Bicalutamide|bicalutamide|mesh-list
44703455|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
44703456|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703457|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703458|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703459|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703460|NCT01415791|Bicalutamide|bicalutamide|mesh-list
44703461|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
44703462|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703463|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703464|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703465|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703466|NCT01415895|Clonidine|clonidine|mesh-list
44703467|NCT01415895|Naltrexone|naltrexone|mesh-list
44703468|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44703469|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44703470|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703471|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
44703472|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703473|NCT01415895|Analgesics|analgesics|mesh-ancestor
44703474|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44703475|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
44703476|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
44703477|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44703478|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44703479|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44703480|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703481|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703482|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703483|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
44703484|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703485|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
44703486|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703487|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703488|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44703489|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
44703490|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703491|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703492|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44703493|NCT01416116|Lidocaine|lidocaine|mesh-list
44703494|NCT01416116|Tramadol|tramadol|mesh-list
44703495|NCT01416116|Capsaicin|capsaicin|mesh-list
44703496|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
44703497|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
44703498|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703499|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703500|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
44703501|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703502|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44703503|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44703504|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44703505|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703506|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703507|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44703508|NCT01416116|Narcotics|narcotics|mesh-ancestor
44703509|NCT01416116|Analgesics|analgesics|mesh-ancestor
44750212|NCT05294536|Liraglutide|liraglutide|mesh-list
44703510|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
44703511|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44911910|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911911|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44911912|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911913|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911914|NCT03954197|Hormones|hormones|mesh-list
44911915|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911916|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911917|NCT03953989|Ranolazine|ranolazine|mesh-list
44911918|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44911919|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44911920|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911921|NCT03953950|Losartan|losartan|mesh-list
44911922|NCT03953950|Spironolactone|spironolactone|mesh-list
44911923|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44911924|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44911925|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44911926|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44911927|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911928|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44911929|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
44911930|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911931|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911932|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44911933|NCT03953950|Diuretics|diuretics|mesh-ancestor
44911934|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
44911935|NCT03954262|Propofol|propofol|mesh-list
44911936|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911937|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44911938|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911939|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44911940|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
44911941|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
44911942|NCT03953781|Levetiracetam|levetiracetam|mesh-list
44911943|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
44911944|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
44911945|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
44750400|NCT05280405|Infliximab|infliximab|mesh-list
44750472|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911946|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44911947|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44911948|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750708|NCT05159427|Rifaximin|rifaximin|mesh-list
44911949|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911950|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911951|NCT03953677|Analgesics|analgesics|mesh-ancestor
44911952|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
44911953|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911954|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44911955|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44911956|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44911957|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
44911958|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911959|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911960|NCT03953729|Ibuprofen|ibuprofen|mesh-list
44911961|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44911962|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44911963|NCT03953729|Analgesics|analgesics|mesh-ancestor
44911964|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
44911965|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44911966|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911967|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44911968|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44911969|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44911970|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44911971|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911972|NCT03953716|Desogestrel|desogestrel|mesh-list
44911973|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44911974|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44911975|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44911976|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
44911977|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44911978|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911979|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44703512|NCT01416207|Interferons|interferons|mesh-list
44911980|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44911981|NCT03953716|Progestins|progestins|mesh-ancestor
44911982|NCT03953716|Hormones|hormones|mesh-ancestor
44911983|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44911984|NCT03953326|Nitroprusside|nitroprusside|mesh-list
44911985|NCT03953326|Acetylcholine|acetylcholine|mesh-list
44911986|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44911987|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
44911988|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44911989|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44911990|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44911991|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
44911992|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44911993|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44911994|NCT03953235|Nivolumab|nivolumab|mesh-list
44911995|NCT03953235|Ipilimumab|ipilimumab|mesh-list
44911996|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44911997|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44911998|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44703513|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
44703514|NCT01416207|Interferon-beta|interferon-beta|mesh-list
44703515|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703516|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
44703517|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703518|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44703519|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
44703520|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703521|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
44703522|NCT01416220|Paroxetine|paroxetine|mesh-list
44703523|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
44703524|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44703525|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703526|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703527|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
44703528|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750872|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44703529|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703530|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703531|NCT01416220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44703532|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703533|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254849|NCT00612274|Sirolimus|sirolimus|mesh-list
44703534|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703535|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
44703536|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44703537|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44703538|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44703539|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
44703540|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44703541|NCT01416337|Trametinib|trametinib|mesh-list
44703542|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703543|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44703544|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703545|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703546|NCT01416350|Azithromycin|azithromycin|mesh-list
44703547|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44703548|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703549|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44703550|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44703551|NCT01416480|Theobromine|theobromine|mesh-list
44703552|NCT01416480|Dipropizine|dipropizine|mesh-list
44703553|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44751022|NCT04835584|Dasatinib|dasatinib|mesh-list
44703554|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
44703555|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703556|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703557|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44703558|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703559|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703560|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
44703561|NCT01416558|Paclitaxel|paclitaxel|mesh-list
44703562|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44703563|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703564|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44703565|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44703566|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44911999|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912000|NCT03953170|Teduglutide|teduglutide|mesh-list
44912001|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912002|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44912003|NCT03953170|Protective Agents|protective agents|mesh-ancestor
44912004|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912006|NCT03953001|Epinephrine|epinephrine|mesh-list
44912007|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
44912008|NCT03953001|Anesthetics|anesthetics|mesh-list
44912009|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912010|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912011|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
44912012|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912013|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44912014|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44912015|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44912016|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912017|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912018|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44912019|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44912020|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
44912021|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912022|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44912023|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44912024|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
44912025|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44912026|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912027|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
44912028|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
44912029|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44912030|NCT03953287|Acetaminophen|acetaminophen|mesh-list
44912031|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44912032|NCT03953287|Analgesics|analgesics|mesh-ancestor
44912033|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
44912034|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912035|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912036|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
44912037|NCT03953209|Spironolactone|spironolactone|mesh-list
44912038|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44912039|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44912040|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912041|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912042|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44912043|NCT03953209|Diuretics|diuretics|mesh-ancestor
44912044|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
44912045|NCT03953066|Melatonin|melatonin|mesh-list
44912046|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
44912047|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912048|NCT03953066|Protective Agents|protective agents|mesh-ancestor
44912049|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912050|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912051|NCT03952715|Ibuprofen|ibuprofen|mesh-list
44912052|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44912053|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44912054|NCT03952715|Analgesics|analgesics|mesh-ancestor
44912055|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
44912056|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912057|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912058|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912059|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912060|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44912061|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912062|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912063|NCT03953118|Azithromycin|azithromycin|mesh-list
44912064|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912065|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912066|NCT03952832|Leflunomide|leflunomide|mesh-list
44912067|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912068|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912069|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912070|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
44912071|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912072|NCT03952572|Prednisone|prednisone|mesh-list
44912073|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
44703567|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703568|NCT01416649|Exenatide|exenatide|mesh-list
44703569|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44703570|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703571|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44703572|NCT01416649|Incretins|incretins|mesh-ancestor
44703573|NCT01416649|Hormones|hormones|mesh-ancestor
44703574|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703575|NCT01416662|Gemcitabine|gemcitabine|mesh-list
44703576|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703577|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
44703578|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703579|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703580|NCT01416662|Antiviral Agents|antiviral agents|mesh-ancestor
44703581|NCT01416662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703582|NCT01416662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703583|NCT01416662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703584|NCT01416662|Immunologic Factors|immunologic factors|mesh-ancestor
44703585|NCT01416662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703586|NCT01416701|Vitamin D|vitamin d|mesh-list
44703587|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
44703588|NCT01416701|Vitamins|vitamins|mesh-list
44703589|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
44703590|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703591|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44703592|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703593|NCT01416870|Bicalutamide|bicalutamide|mesh-list
44703594|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
44703595|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703596|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703597|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703598|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703599|NCT01416883|Bicalutamide|bicalutamide|mesh-list
44703600|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
44703601|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703602|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703603|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703604|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703606|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703607|NCT01416948|Methylphenidate|methylphenidate|mesh-list
44703608|NCT01416948|Galantamine|galantamine|mesh-list
44703609|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44703610|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703611|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44703612|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703613|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703614|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703615|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
44703616|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703617|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44703618|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703619|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
44703620|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44703621|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
44703622|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703623|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
44703624|NCT01416961|Etoposide|etoposide|mesh-list
44703625|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
44703626|NCT01416961|Cisplatin|cisplatin|mesh-list
44703627|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44703628|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703629|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44703630|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44703631|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703632|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703633|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
44703634|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703635|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
44703636|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703637|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703638|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44703639|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
44912104|NCT03952325|Atezolizumab|atezolizumab|mesh-list
44912105|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912106|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912107|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44912108|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912109|NCT03952273|Sirolimus|sirolimus|mesh-list
44912110|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912111|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912112|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44912113|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912114|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
44912115|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912116|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
44912117|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912118|NCT03952260|Anesthetics|anesthetics|mesh-list
44912119|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912120|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912122|NCT03951987|Antidotes|antidotes|mesh-ancestor
44912123|NCT03951987|Protective Agents|protective agents|mesh-ancestor
44912124|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912125|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44912126|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912127|NCT03951558|Diuretics|diuretics|mesh-ancestor
44912128|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
44912129|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912130|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44912131|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912132|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912133|NCT03951831|Docetaxel|docetaxel|mesh-list
44912134|NCT03951831|Leuprolide|leuprolide|mesh-list
44912135|NCT03951831|Cemiplimab|cemiplimab|mesh-list
44912136|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912137|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912138|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912139|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912140|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912141|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44912142|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
44912143|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44912144|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912145|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44912146|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912147|NCT03951636|Chlorhexidine|chlorhexidine|mesh-list
44912148|NCT03951636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44912149|NCT03951636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912150|NCT03951636|Disinfectants|disinfectants|mesh-ancestor
44912151|NCT03951753|Tirzepatide|tirzepatide|mesh-list
44912152|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44912153|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912154|NCT03951753|Incretins|incretins|mesh-ancestor
44912155|NCT03951753|Hormones|hormones|mesh-ancestor
44912156|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912157|NCT03951597|Gemcitabine|gemcitabine|mesh-list
44912158|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
44912159|NCT03951597|Lenvatinib|lenvatinib|mesh-list
44912160|NCT03951597|Antibodies|antibodies|mesh-list
44912161|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
44912162|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912163|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44912164|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
44752028|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912165|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912166|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912167|NCT03951597|Antiviral Agents|antiviral agents|mesh-ancestor
44912168|NCT03951597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912169|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912170|NCT03951597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912171|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912172|NCT03951415|Durvalumab|durvalumab|mesh-list
44912173|NCT03951415|Olaparib|olaparib|mesh-list
44912174|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44912175|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912176|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912177|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912178|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912179|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
44912180|NCT03951402|Tapentadol|tapentadol|mesh-list
44912181|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44912182|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912183|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912184|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44912185|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44912186|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912187|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912188|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912189|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44912190|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
44912191|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44912192|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912193|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44912194|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44912195|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44912196|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44752345|NCT03576417|Nivolumab|nivolumab|mesh-list
44912197|NCT03951402|Narcotics|narcotics|mesh-ancestor
44912198|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912199|NCT03951402|Analgesics|analgesics|mesh-ancestor
44912200|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
44912201|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912202|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44912203|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44912204|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912205|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752591|NCT03223974|Paclitaxel|paclitaxel|mesh-list
44752672|NCT05437224|Ambrisentan|ambrisentan|mesh-list
44912206|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912207|NCT03951285|Niacinamide|niacinamide|mesh-list
44912208|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
44912209|NCT03951285|Vitamins|vitamins|mesh-ancestor
44912210|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
44912211|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912212|NCT03950830|Disulfiram|disulfiram|mesh-list
44912213|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44912214|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44912215|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912216|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912217|NCT03950960|Itraconazole|itraconazole|mesh-list
44912218|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
44912219|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912220|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44912221|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44912222|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912223|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912224|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44912225|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
44912226|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912227|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912228|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44912229|NCT03951051|Olmesartan|olmesartan|mesh-list
44912230|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44912231|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912232|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44912233|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44912234|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912235|NCT03950700|Epinephrine|epinephrine|mesh-list
44912236|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44912237|NCT03950700|Bupivacaine|bupivacaine|mesh-list
44912238|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44912239|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
44912240|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
44912241|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912242|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912243|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
44912244|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912245|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44912246|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44912247|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44912248|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912249|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912250|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44912251|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44912252|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
44912253|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44912254|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912255|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
44912256|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
44912257|NCT03950804|Eculizumab|eculizumab|mesh-list
44912258|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44912259|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912260|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
44912261|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912262|NCT03950505|Pioglitazone|pioglitazone|mesh-list
44912263|NCT03950505|Alogliptin|alogliptin|mesh-list
44912264|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44912265|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912266|NCT03950505|Incretins|incretins|mesh-ancestor
44912267|NCT03950505|Hormones|hormones|mesh-ancestor
44912268|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912269|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44912289|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44912290|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912291|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912292|NCT03950141|Apatinib|apatinib|mesh-list
44912293|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912294|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912295|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752673|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912296|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912297|NCT03950362|Avelumab|avelumab|mesh-list
44912298|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912299|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912300|NCT03950154|Bevacizumab|bevacizumab|mesh-list
44912301|NCT03950154|Capecitabine|capecitabine|mesh-list
44912302|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
44912303|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912304|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912305|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44912306|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44912307|NCT03950154|Growth Substances|growth substances|mesh-ancestor
44912308|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752804|NCT04485949|Temozolomide|temozolomide|mesh-list
44912309|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44912310|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44912311|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
44912312|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912313|NCT03950271|Capecitabine|capecitabine|mesh-list
44912314|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
44912315|NCT03950271|Trastuzumab|trastuzumab|mesh-list
44912316|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44912317|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
44912318|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912319|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912320|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912321|NCT03950050|Ambroxol|ambroxol|mesh-list
44912322|NCT03950050|Expectorants|expectorants|mesh-ancestor
44912323|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912324|NCT03949985|Hemostatics|hemostatics|mesh-list
44912325|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
44912326|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44912327|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912328|NCT03949985|Coagulants|coagulants|mesh-ancestor
44705991|NCT01425996|Camptothecin|camptothecin|mesh-list
44912329|NCT03949686|Bupivacaine|bupivacaine|mesh-list
44753110|NCT03070392|Ipilimumab|ipilimumab|mesh-list
44753148|NCT03026972|Vaccines|vaccines|mesh-list
44753228|NCT03001011|Sevelamer|sevelamer|mesh-list
44912330|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
44912331|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
44912332|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912333|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912334|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
44912335|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912336|NCT03949842|Fluticasone|fluticasone|mesh-list
44912337|NCT03949842|Xhance|xhance|mesh-list
44912338|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
44912339|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
44912340|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44912341|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912342|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44912343|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
44912344|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912345|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912346|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44912347|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912348|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44912349|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44912350|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912351|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912352|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44912353|NCT03949517|Piperidine|piperidine|mesh-list
44912354|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44912355|NCT03949517|Bombesin|bombesin|mesh-list
44912356|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912357|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44912358|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912359|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912360|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44912361|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912362|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44912363|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44912364|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44912365|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44912366|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
44912367|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912368|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44703640|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703641|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703642|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44703643|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44703644|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
44703645|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44703646|NCT01417065|Sirolimus|sirolimus|mesh-list
44753587|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
44753655|NCT02204241|Hormones|hormones|mesh-ancestor
44753868|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703647|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44703648|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703649|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44703650|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703651|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
44703652|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703653|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
44703654|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703655|NCT01417169|Micafungin|micafungin|mesh-list
44703656|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
44703657|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703658|NCT01417273|Vitamin A|vitamin a|mesh-list
44703659|NCT01417273|Vitamins|vitamins|mesh-ancestor
44703660|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
44703661|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703662|NCT01417351|Vitamin D|vitamin d|mesh-list
44703663|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
44703664|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
44703665|NCT01417351|Vitamins|vitamins|mesh-list
44255001|NCT00612950|Incretins|incretins|mesh-ancestor
44703666|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
44703667|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703668|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44703669|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44703670|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
44703671|NCT01417364|Testosterone|testosterone|mesh-list
44703672|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
44703673|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
44703674|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44703675|NCT01417364|Androgens|androgens|mesh-ancestor
44703676|NCT01417364|Hormones|hormones|mesh-ancestor
44912369|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44912370|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912372|NCT03949634|Docetaxel|docetaxel|mesh-list
44912373|NCT03949634|Doxorubicin|doxorubicin|mesh-list
44912374|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912375|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912376|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912377|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912378|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912379|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912380|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44912381|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44912382|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44912383|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912384|NCT03949101|Atropine|atropine|mesh-list
44912385|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44912386|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44912387|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44912388|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44912389|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44912390|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
44912391|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912392|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912393|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44912394|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912395|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
44912396|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
44912397|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44912398|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44912399|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44912400|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912401|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912402|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44912403|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
44912404|NCT03949062|Rituximab|rituximab|mesh-list
44912405|NCT03949062|Lenalidomide|lenalidomide|mesh-list
44753945|NCT01630590|Androgens|androgens|mesh-list
44754031|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
44912406|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912407|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912408|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
44912409|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912410|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912411|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44912412|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44912413|NCT03949062|Growth Substances|growth substances|mesh-ancestor
44912414|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
44912415|NCT03949075|Enalapril|enalapril|mesh-list
44912416|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44912417|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
44912418|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912419|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912420|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912421|NCT03948685|Carvedilol|carvedilol|mesh-list
44912422|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44912423|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44912424|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44912425|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912426|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912427|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912428|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912429|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
44912430|NCT03948685|Protective Agents|protective agents|mesh-ancestor
44912431|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44912432|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912433|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44912434|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
44912435|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44912436|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44912437|NCT03948737|Tocopherols|tocopherols|mesh-list
44912438|NCT03948737|Vitamin E|vitamin e|mesh-list
44706105|NCT01426802|Vildagliptin|vildagliptin|mesh-list
44912439|NCT03948737|Tocotrienols|tocotrienols|mesh-list
44912440|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
44912441|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
44912442|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912443|NCT03948737|Protective Agents|protective agents|mesh-ancestor
44912444|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912445|NCT03948737|Vitamins|vitamins|mesh-ancestor
44912446|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
44912447|NCT03948620|Penicillins|penicillins|mesh-list
44912448|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912449|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912450|NCT03948477|Pantoprazole|pantoprazole|mesh-list
44912451|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44912452|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912453|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44912454|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912455|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912456|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44912457|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44912458|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
44912459|NCT03948243|Tolbutamide|tolbutamide|mesh-list
44912460|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
44912461|NCT03948243|Alprazolam|alprazolam|mesh-list
44912462|NCT03948243|Caffeine|caffeine|mesh-list
44912463|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44912464|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912465|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44912466|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912467|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912468|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44912469|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44912470|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
44912471|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912472|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
44912473|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912474|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44912475|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44912476|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44912477|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912478|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44912479|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44912480|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44912481|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
44912482|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
44912483|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44912484|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
44912485|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
44912486|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44912487|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44912488|NCT03948191|Prednisolone|prednisolone|mesh-list
44912489|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
44912490|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44912491|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
44912492|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44912493|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912494|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
44912495|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
44912496|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912497|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912498|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912499|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
44912500|NCT03948191|Hormones|hormones|mesh-ancestor
44912501|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912502|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44912503|NCT03948191|Protective Agents|protective agents|mesh-ancestor
44912504|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44912505|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912506|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44912507|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44912508|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912509|NCT03948178|Simendan|simendan|mesh-list
44912510|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44912511|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44912512|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44912513|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44912514|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912515|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912516|NCT03948178|Protective Agents|protective agents|mesh-ancestor
44912517|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706183|NCT01427114|Rituximab|rituximab|mesh-list
44912548|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912549|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44912550|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44912552|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754903|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44912553|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912554|NCT03947411|Oseltamivir|oseltamivir|mesh-list
44912555|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
44912556|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912557|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912558|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706254|NCT01427335|Calcium|calcium|mesh-list
44912559|NCT03947125|Buprenorphine|buprenorphine|mesh-list
44912560|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44912561|NCT03947125|Narcotics|narcotics|mesh-ancestor
44912562|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755216|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
44755232|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755308|NCT01700569|Leucovorin|leucovorin|mesh-list
44755452|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44912563|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912564|NCT03947125|Analgesics|analgesics|mesh-ancestor
44912565|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
44912566|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912567|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44912568|NCT03946657|Anesthetics|anesthetics|mesh-list
44912569|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44912570|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912571|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912572|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
44912573|NCT03946826|Halometasone|halometasone|mesh-list
44912574|NCT03946826|Petrolatum|petrolatum|mesh-list
44912575|NCT03946826|Emollients|emollients|mesh-ancestor
44912576|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44912577|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912578|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
44912579|NCT03946826|Hormones|hormones|mesh-ancestor
44912580|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912581|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912582|NCT03946514|Losartan|losartan|mesh-list
44912583|NCT03946514|Amlodipine|amlodipine|mesh-list
44912584|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44912585|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912586|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44912587|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912588|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912589|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44912590|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912591|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
44912592|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44912593|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44912594|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44912595|NCT03946514|Diuretics|diuretics|mesh-ancestor
44912596|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
44912597|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44912598|NCT03945955|Melatonin|melatonin|mesh-list
44912599|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
44912600|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912601|NCT03945955|Protective Agents|protective agents|mesh-ancestor
44912602|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912603|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912604|NCT03945539|Itraconazole|itraconazole|mesh-list
44912605|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
44912606|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
44912607|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912608|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44755625|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
44912609|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44912610|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912611|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912612|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44912613|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
44912614|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912615|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912616|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44689198|NCT01347996|Histamine|histamine|mesh-list
44912617|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
44912618|NCT03945227|Spartalizumab|spartalizumab|mesh-list
44912619|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44912620|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912621|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912622|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
44912623|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44912624|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
44912625|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912626|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912627|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44912628|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44912629|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
44912630|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44912631|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
44912632|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912650|NCT03944733|Iron|iron|mesh-list
44912651|NCT03944733|Trace Elements|trace elements|mesh-ancestor
44912652|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
44912653|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912654|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44912655|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912656|NCT03944655|Anesthetics|anesthetics|mesh-list
44912657|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912658|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912659|NCT03944473|Neostigmine|neostigmine|mesh-list
44912660|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44912661|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912662|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912663|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44912664|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912665|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912666|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44912667|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
44912668|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912669|NCT03944317|Azithromycin|azithromycin|mesh-list
44912670|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
44912671|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
44912672|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44912673|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912674|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912675|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
44912676|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44912677|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44912678|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44912679|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912680|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912681|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44912682|NCT03944317|Renal Agents|renal agents|mesh-ancestor
44912683|NCT03944291|Bupivacaine|bupivacaine|mesh-list
44912684|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
44912685|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
44912686|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912687|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912688|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
44912689|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912690|NCT03944252|Cetuximab|cetuximab|mesh-list
44912691|NCT03944252|Avelumab|avelumab|mesh-list
44756312|NCT01706887|Amiloride|amiloride|mesh-list
44756502|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
44756575|NCT01708616|Risperidone|risperidone|mesh-list
44912692|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44912693|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912694|NCT03944070|Ranibizumab|ranibizumab|mesh-list
44912695|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44912696|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44912697|NCT03944070|Growth Substances|growth substances|mesh-ancestor
44912698|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912699|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
44912700|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912701|NCT03944005|Anesthetics|anesthetics|mesh-list
44912702|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912703|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912704|NCT03943992|Esomeprazole|esomeprazole|mesh-list
44912705|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44912706|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912707|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44912708|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912709|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912710|NCT03943459|Atorvastatin|atorvastatin|mesh-list
44912711|NCT03943459|Quercetin|quercetin|mesh-list
44912712|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44912713|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44912714|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
44912715|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912716|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44912717|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44912718|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912719|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
44912720|NCT03943459|Protective Agents|protective agents|mesh-ancestor
44912721|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912722|NCT03943784|Propranolol|propranolol|mesh-list
44912723|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44912724|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44706464|NCT01428544|PENTA|penta|mesh-list
44912725|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756713|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
44756782|NCT01709942|Cetrorelix|cetrorelix|mesh-list
44757003|NCT01710904|Oxycodone|oxycodone|mesh-list
44912726|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912727|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912728|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912729|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44912730|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44912731|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
44912733|NCT03943823|Hormones|hormones|mesh-ancestor
44912734|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912735|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912736|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
44912737|NCT03943472|Fludarabine|fludarabine|mesh-list
44912738|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912739|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
44912740|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912741|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912742|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44912743|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
44912744|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912745|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912746|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44912747|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
44912748|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44912749|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
44912750|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912751|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
44912752|NCT03943186|Protective Agents|protective agents|mesh-ancestor
44912753|NCT03943407|Imiquimod|imiquimod|mesh-list
44912754|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
44912755|NCT03943407|Doxepin|doxepin|mesh-list
44912756|NCT03943407|Menthol|menthol|mesh-list
44912757|NCT03943407|Histamine|histamine|mesh-list
44912758|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
44912759|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44912760|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
44912761|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
44912762|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912763|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912764|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912765|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44912766|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
44912767|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912768|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
44912769|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912770|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44912771|NCT03943407|Protective Agents|protective agents|mesh-ancestor
44912772|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44757055|NCT01711229|Acetaminophen|acetaminophen|mesh-list
44757207|NCT01711827|Isavuconazole|isavuconazole|mesh-list
44757271|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
44912773|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44912774|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912775|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44912776|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
44912777|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44912778|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
44912779|NCT03943043|Gemcitabine|gemcitabine|mesh-list
44912780|NCT03943043|Paclitaxel|paclitaxel|mesh-list
44912781|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
44912782|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912783|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912784|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912785|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912786|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912787|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912788|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44912789|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
44912790|NCT03943043|Antiviral Agents|antiviral agents|mesh-ancestor
44912791|NCT03943043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912792|NCT03943043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912793|NCT03943043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912794|NCT03943043|Immunologic Factors|immunologic factors|mesh-ancestor
44912795|NCT03943043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912796|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
44912797|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44912798|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44912799|NCT03942861|Prednisolone|prednisolone|mesh-list
44912800|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
44703690|NCT01417390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912801|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44912802|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
44912803|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912804|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
44912805|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
44912806|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912807|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912808|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912809|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
44912810|NCT03942861|Hormones|hormones|mesh-ancestor
44912811|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912812|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44912813|NCT03942861|Protective Agents|protective agents|mesh-ancestor
44912814|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44912815|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912816|NCT03942991|Mepivacaine|mepivacaine|mesh-list
44912817|NCT03942991|Carticaine|carticaine|mesh-list
44757994|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
44912818|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
44912819|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
44912820|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912821|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912822|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
44912823|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912824|NCT03942757|Bilirubin|bilirubin|mesh-list
44912825|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
44912826|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912827|NCT03942757|Protective Agents|protective agents|mesh-ancestor
44912828|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912829|NCT03942926|Sirolimus|sirolimus|mesh-list
44912830|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912831|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912832|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44912833|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912834|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
44912835|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912836|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
44912837|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912838|NCT03942796|Pregabalin|pregabalin|mesh-list
44912839|NCT03942796|Analgesics|analgesics|mesh-ancestor
44912840|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
44912841|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912842|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912843|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
44912844|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44912845|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44912846|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912847|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44912848|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44912849|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44912850|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912851|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44758106|NCT01716767|Analgesics|analgesics|mesh-list
44912852|NCT03942601|Sirolimus|sirolimus|mesh-list
44912853|NCT03942601|Dexamethasone|dexamethasone|mesh-list
44912854|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
44912855|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44912856|NCT03942601|BB 1101|bb 1101|mesh-list
44912857|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912858|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
44912859|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
44912860|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912861|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912862|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44912863|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
44912864|NCT03942601|Hormones|hormones|mesh-ancestor
44912865|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912866|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44912867|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912868|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912869|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912870|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44912871|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
44912872|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44912873|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
44912874|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
44912875|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912876|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912877|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
44912878|NCT03942354|Linezolid|linezolid|mesh-list
44912879|NCT03942354|Bedaquiline|bedaquiline|mesh-list
44912880|NCT03942354|Clofazimine|clofazimine|mesh-list
44912881|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44912882|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912883|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44912884|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44912885|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912886|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912887|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912888|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44912889|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
44758390|NCT01718496|Morphine|morphine|mesh-list
44758466|NCT01718834|Vaccines|vaccines|mesh-list
44758700|NCT01719835|Hormones|hormones|mesh-ancestor
44912890|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44912891|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
44912892|NCT03942289|Norepinephrine|norepinephrine|mesh-list
44912893|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44912894|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44912895|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
44912896|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912897|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912898|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912899|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
44912900|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
44912901|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912902|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44912903|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
44912904|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44912905|NCT03941925|Levan|levan|mesh-list
44912906|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912907|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
44912908|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44912909|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
44912910|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
44912911|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912912|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912913|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44912914|NCT03941990|Analgesics|analgesics|mesh-ancestor
44912915|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
44912916|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912917|NCT03942029|Fluconazole|fluconazole|mesh-list
44912918|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
44912919|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44912920|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44912921|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44912922|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912923|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912924|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44912925|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
44912926|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44912927|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912928|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44912929|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44912930|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
44912931|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
44912932|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
44912933|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44912934|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912935|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
44912936|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912937|NCT03941886|Aspirin|aspirin|mesh-list
44912938|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44912939|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44912940|NCT03941886|Analgesics|analgesics|mesh-ancestor
44912941|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
44912942|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44912943|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758764|NCT01720719|Vitamin E|vitamin e|mesh-list
44758778|NCT01722214|Adalimumab|adalimumab|mesh-list
44758983|NCT01730222|Paclitaxel|paclitaxel|mesh-list
44912944|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44703691|NCT01417390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703692|NCT01417390|Immunologic Factors|immunologic factors|mesh-ancestor
44703693|NCT01417390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703694|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
44703695|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
44703696|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44703697|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44912945|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44912946|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44912947|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44912948|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912949|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44912950|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44912951|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912952|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
44912953|NCT03942068|Paclitaxel|paclitaxel|mesh-list
44912954|NCT03942068|Apatinib|apatinib|mesh-list
44912955|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44912956|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44912957|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912958|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
44912959|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
44912960|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44912961|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912962|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912963|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912964|NCT03942458|Clopidogrel|clopidogrel|mesh-list
44912965|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44912966|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44912967|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44912968|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44912969|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
44912970|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44912971|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912972|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912973|NCT03941561|Tegafur|tegafur|mesh-list
44912974|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44912975|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
44912976|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912977|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912978|NCT03941795|Axitinib|axitinib|mesh-list
44912979|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912980|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912981|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912982|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912983|NCT03941535|Vitamin K|vitamin k|mesh-list
44912984|NCT03941535|Vitamins|vitamins|mesh-ancestor
44912985|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
44912986|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44912987|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44912988|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44912989|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912990|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
44912991|NCT03941535|Coagulants|coagulants|mesh-ancestor
44912992|NCT03941340|Aflutinib|aflutinib|mesh-list
44912993|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912994|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44912995|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44912996|NCT03940976|Afatinib|afatinib|mesh-list
44912997|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44912998|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44912999|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913000|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913001|NCT03940742|Tirzepatide|tirzepatide|mesh-list
44913002|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913003|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913004|NCT03940742|Incretins|incretins|mesh-ancestor
44913005|NCT03940742|Hormones|hormones|mesh-ancestor
44913006|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913007|NCT03940664|Formaldehyde|formaldehyde|mesh-list
44913008|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
44759061|NCT01730976|Vitamin D|vitamin d|mesh-list
44759151|NCT01731184|Midazolam|midazolam|mesh-list
44759200|NCT01731561|Rituximab|rituximab|mesh-list
44913009|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913010|NCT03940651|Anesthetics|anesthetics|mesh-list
44913011|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
44913012|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913013|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913014|NCT03940378|Levamisole|levamisole|mesh-list
44913015|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44913016|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
44913017|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913018|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
44913019|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
44913052|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
44913053|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
44913054|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913055|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
44913056|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
44913057|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913058|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913059|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913060|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
44913061|NCT03940469|Hormones|hormones|mesh-ancestor
44913062|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913063|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44913064|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913065|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913066|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913067|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913068|NCT03940469|Analgesics|analgesics|mesh-ancestor
44913069|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
44913070|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44913071|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44913072|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44913073|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913074|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913075|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913076|NCT03939663|Misoprostol|misoprostol|mesh-list
44913077|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44913078|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
44913079|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913080|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913081|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44913082|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913083|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
44913084|NCT03939884|Diclofenac|diclofenac|mesh-list
44913085|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44913086|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913087|NCT03939884|Analgesics|analgesics|mesh-ancestor
44913088|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
44913089|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913090|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913091|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913092|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913093|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44913094|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913095|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913096|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
44913097|NCT03939923|Rocuronium|rocuronium|mesh-list
44913098|NCT03939923|Neostigmine|neostigmine|mesh-list
44913099|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44759426|NCT01733108|Glyburide|glyburide|mesh-list
44913100|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44913101|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44913102|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913103|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913104|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44913105|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913106|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913107|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
44913108|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913109|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44913110|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
44913111|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44759704|NCT01735097|Vitamin E|vitamin e|mesh-list
44913112|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44913113|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44913114|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
44913115|NCT03939975|Nivolumab|nivolumab|mesh-list
44913116|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44913117|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913118|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44913119|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913120|NCT03939871|Vinorelbine|vinorelbine|mesh-list
44913121|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44913122|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913123|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913124|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913125|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
44759897|NCT01736449|Bevacizumab|bevacizumab|mesh-list
44760081|NCT01737671|Leucovorin|leucovorin|mesh-list
44913126|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913127|NCT03940001|Paclitaxel|paclitaxel|mesh-list
44913128|NCT03940001|Carboplatin|carboplatin|mesh-list
44913129|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44913130|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913131|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913132|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913133|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913134|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913135|NCT03939806|Oxytocin|oxytocin|mesh-list
44913136|NCT03939806|Carbetocin|carbetocin|mesh-list
44913137|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
44913138|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913139|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913140|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44913141|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913142|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913143|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913144|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913145|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913146|NCT03939273|Metronidazole|metronidazole|mesh-list
44913147|NCT03939273|Vancomycin|vancomycin|mesh-list
44913148|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
44913149|NCT03939273|Fluconazole|fluconazole|mesh-list
44913150|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913151|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44913152|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913153|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913154|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44913155|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44913156|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913157|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913158|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913159|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44913160|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44913161|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
44760157|NCT01738178|Caffeine|caffeine|mesh-list
44760263|NCT01738893|Gabapentin|gabapentin|mesh-list
44760277|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
44913162|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44913163|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44913164|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44913165|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913166|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913167|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44913168|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44913169|NCT03938740|Insulin|insulin|mesh-list
44913170|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44913171|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
44913172|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
44913173|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913174|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913175|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
44913176|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44913177|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
44913178|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913179|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
44913180|NCT03938883|Protective Agents|protective agents|mesh-ancestor
44913181|NCT03938662|Choline|choline|mesh-list
44760464|NCT01740245|Biguanides|biguanides|mesh-list
44913182|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
44913183|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44913184|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
44913185|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913186|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913187|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44913188|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
44913189|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44913190|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913191|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
44913192|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44913193|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913194|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913195|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
44913196|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913197|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913198|NCT03938259|Fentanyl|fentanyl|mesh-list
44913199|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44913227|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
44913228|NCT03937544|Fludarabine|fludarabine|mesh-list
44913229|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44913230|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
44913231|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913232|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913233|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44913234|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
44913235|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913236|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913237|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44913238|NCT03937648|Lasmiditan|lasmiditan|mesh-list
44913239|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44913240|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
44913241|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913242|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913243|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913244|NCT03937401|Oxytocin|oxytocin|mesh-list
44913245|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
44913246|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913247|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913248|NCT03937258|Probenecid|probenecid|mesh-list
44913249|NCT03937258|Abrocitinib|abrocitinib|mesh-list
44913250|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
44913251|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
44913252|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913253|NCT03937258|Renal Agents|renal agents|mesh-ancestor
44913254|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44913255|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913256|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913257|NCT03936907|Nabiximols|nabiximols|mesh-list
44913258|NCT03936907|Analgesics|analgesics|mesh-ancestor
44913259|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
44913260|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913261|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913262|NCT03936517|Prednisolone|prednisolone|mesh-list
44913263|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
44913264|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913265|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
44913266|NCT03936517|Hormones|hormones|mesh-ancestor
44913267|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913268|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913269|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44703698|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703699|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703700|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703701|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44703702|NCT01417429|Galantamine|galantamine|mesh-list
44703703|NCT01417429|Nicotine|nicotine|mesh-list
44703704|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44703705|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
44703706|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703707|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703708|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44703709|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44703710|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
44703711|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703712|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703713|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44703714|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703715|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44703716|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
44703717|NCT01417494|Leucovorin|leucovorin|mesh-list
44703718|NCT01417494|Bevacizumab|bevacizumab|mesh-list
44703719|NCT01417494|Fluorouracil|fluorouracil|mesh-list
44703720|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
44703721|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761292|NCT01745263|Vitamin D|vitamin d|mesh-list
44761506|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
44703722|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703723|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44703724|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44703725|NCT01417494|Growth Substances|growth substances|mesh-ancestor
44703726|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703727|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
44703728|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
44913270|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913271|NCT03936426|Copper|copper|mesh-list
44913272|NCT03936426|Trace Elements|trace elements|mesh-ancestor
44913273|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
44913274|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913275|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44913276|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913277|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913278|NCT03936062|Incretins|incretins|mesh-ancestor
44913279|NCT03936062|Hormones|hormones|mesh-ancestor
44913280|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913281|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44913282|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913283|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913284|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913285|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44913286|NCT03936374|Omeprazole|omeprazole|mesh-list
44913287|NCT03936374|Linrodostat|linrodostat|mesh-list
44913288|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44913289|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913290|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44913291|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913292|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913293|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
44913294|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913295|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913296|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913297|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913298|NCT03936205|Analgesics|analgesics|mesh-ancestor
44913299|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
44913300|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913301|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44913302|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44913303|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44913304|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913305|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913306|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913307|NCT03936049|Liraglutide|liraglutide|mesh-list
44913308|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44913309|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913310|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913311|NCT03936049|Incretins|incretins|mesh-ancestor
44913312|NCT03936049|Hormones|hormones|mesh-ancestor
44913313|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913314|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913315|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913316|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913317|NCT03936140|Iloprost|iloprost|mesh-list
44913318|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44913319|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
44913320|NCT03936036|Linagliptin|linagliptin|mesh-list
44913321|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913322|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913323|NCT03936036|Incretins|incretins|mesh-ancestor
44913324|NCT03936036|Hormones|hormones|mesh-ancestor
44913325|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913326|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44913327|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913328|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913329|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761833|NCT01748344|Cetirizine|cetirizine|mesh-list
44913330|NCT03936023|Saxagliptin|saxagliptin|mesh-list
44913331|NCT03936023|Incretins|incretins|mesh-ancestor
44913332|NCT03936023|Hormones|hormones|mesh-ancestor
44913333|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913334|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913335|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44913336|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913337|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913338|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913339|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913340|NCT03936010|Canagliflozin|canagliflozin|mesh-list
44913341|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44913342|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44913343|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913344|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44707188|NCT01432470|Oxytocin|oxytocin|mesh-list
44913381|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44913382|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44913383|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
44913384|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913386|NCT03935347|Aldesleukin|aldesleukin|mesh-list
44913387|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
44913388|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
44913389|NCT03935347|Fludarabine|fludarabine|mesh-list
44913390|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
44913391|NCT03935347|Interleukin-2|interleukin-2|mesh-list
44690047|NCT01353339|Ofloxacin|ofloxacin|mesh-list
44913392|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
44913393|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
44913394|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44913395|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
44913396|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913397|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913398|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44913399|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
44913400|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913401|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913402|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44913403|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44913404|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44913405|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
44913406|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
44913407|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913408|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913409|NCT03935347|Analgesics|analgesics|mesh-ancestor
44913410|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
44913411|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913412|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44913413|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44913414|NCT03935256|Paclitaxel|paclitaxel|mesh-list
44913415|NCT03935256|Carboplatin|carboplatin|mesh-list
44913416|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44913417|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913418|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913419|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913420|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913421|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913422|NCT03934710|Serotonin|serotonin|mesh-list
44913423|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
44913424|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
44913425|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762885|NCT01755494|Metformin|metformin|mesh-list
44913426|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913427|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913428|NCT03934450|Primaquine|primaquine|mesh-list
44913429|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
44913430|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913431|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913432|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913433|NCT03936491|Methylphenidate|methylphenidate|mesh-list
44913434|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44913435|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44913436|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913437|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44913438|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44913439|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913440|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913441|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
44913442|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913443|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44913444|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913445|NCT03934411|Tramadol|tramadol|mesh-list
44913446|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44913447|NCT03934411|Narcotics|narcotics|mesh-ancestor
44913448|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913449|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913450|NCT03934411|Analgesics|analgesics|mesh-ancestor
44913451|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
44913452|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913453|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
44913454|NCT03934203|BI 409306|bi 409306|mesh-list
44763293|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
44913455|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44913456|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913457|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44913458|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44913459|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913460|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913461|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913462|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44913463|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
44913464|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44913465|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44913466|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913467|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
44913468|NCT03934047|Coagulants|coagulants|mesh-ancestor
44913469|NCT03934294|Metoclopramide|metoclopramide|mesh-list
44913470|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
44913471|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
44913472|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913473|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913474|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913475|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44913476|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44913477|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
44913478|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913479|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913480|NCT03933956|Empagliflozin|empagliflozin|mesh-list
44913481|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44913482|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913483|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913484|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913485|NCT03934333|Budesonide|budesonide|mesh-list
44913486|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913487|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44913488|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
44703729|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703730|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703731|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703732|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
44703733|NCT01417494|Antidotes|antidotes|mesh-ancestor
44703734|NCT01417494|Protective Agents|protective agents|mesh-ancestor
44703735|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
44703736|NCT01417494|Vitamins|vitamins|mesh-ancestor
44703737|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
44703738|NCT01417572|Lidocaine|lidocaine|mesh-list
44703739|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
44703740|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
44703741|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703742|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763379|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
44703743|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
44255070|NCT00613288|Hormones|hormones|mesh-ancestor
44703744|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703745|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44703746|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44703747|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44703748|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703749|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703750|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44703751|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44703752|NCT01417754|Toremifene|toremifene|mesh-list
44703753|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44703754|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703755|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44703756|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44703757|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44703758|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703759|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703760|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44703761|NCT01417767|Decitabine|decitabine|mesh-list
44703762|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44703763|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
44703764|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703765|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703766|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703767|NCT01417806|Topotecan|topotecan|mesh-list
44703768|NCT01417806|Pasireotide|pasireotide|mesh-list
44703769|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44703770|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44703771|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703772|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707421|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
44913489|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913490|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913492|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44913493|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
44913494|NCT03934333|Hormones|hormones|mesh-ancestor
44913495|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913496|NCT03933982|Vinorelbine|vinorelbine|mesh-list
44913497|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44913498|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913499|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913500|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913501|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913502|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913503|NCT03933787|Saxagliptin|saxagliptin|mesh-list
44913504|NCT03933787|Incretins|incretins|mesh-ancestor
44913505|NCT03933787|Hormones|hormones|mesh-ancestor
44913506|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913507|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913508|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44913509|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
44913510|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913511|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913512|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913513|NCT03933748|Teicoplanin|teicoplanin|mesh-list
44913514|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44913515|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913516|NCT03933501|Amoxicillin|amoxicillin|mesh-list
44913517|NCT03933501|Metronidazole|metronidazole|mesh-list
44913518|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44913519|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913520|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913521|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913522|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
44913523|NCT03933280|Nalbuphine|nalbuphine|mesh-list
44913524|NCT03933280|Propofol|propofol|mesh-list
44913525|NCT03933280|Benoxinate|benoxinate|mesh-list
44913526|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44913527|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913528|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764060|NCT01761201|Ofloxacin|ofloxacin|mesh-list
44764097|NCT01761318|Hormones|hormones|mesh-ancestor
44913529|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913530|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44913531|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
44913532|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
44913533|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913534|NCT03933280|Analgesics|analgesics|mesh-ancestor
44913535|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
44913536|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913537|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44913538|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44913539|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44913540|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913541|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913542|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764372|NCT01762787|Aspirin|aspirin|mesh-list
44764465|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764539|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
44913543|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44913544|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44764790|NCT01765010|Vitamin D|vitamin d|mesh-list
44764954|NCT01765842|Rituximab|rituximab|mesh-list
44913545|NCT03933280|Narcotics|narcotics|mesh-ancestor
44913546|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44913547|NCT03933605|Midazolam|midazolam|mesh-list
44913548|NCT03933605|Palonosetron|palonosetron|mesh-list
44913549|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44913550|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913551|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913552|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913553|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44913554|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44913555|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44913556|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44913557|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
44913558|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
44913559|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
44913560|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
44913561|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913562|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913563|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
44913564|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
44913584|NCT03933319|Doxorubicin|doxorubicin|mesh-list
44913585|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44913586|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44913587|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913588|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44913589|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44913590|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913591|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913593|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44913594|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913595|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913596|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
44913597|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913598|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913599|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
44913600|NCT03932864|Plerixafor|plerixafor|mesh-list
44913601|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44913602|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44913603|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
44913604|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913605|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
44913606|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44913607|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
44913608|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
44913609|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913610|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913611|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913612|NCT03932825|Analgesics|analgesics|mesh-ancestor
44913613|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
44913614|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913615|NCT03932981|Temozolomide|temozolomide|mesh-list
44913616|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44913617|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
44913618|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913619|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913620|NCT03933098|Vaccines|vaccines|mesh-list
44913621|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
44913622|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913623|NCT03932578|Atropine|atropine|mesh-list
44913624|NCT03932578|Metoclopramide|metoclopramide|mesh-list
44913625|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44765026|NCT01766258|Carbidopa|carbidopa|mesh-list
44913626|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44913627|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44913628|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
44913629|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913630|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913631|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44913632|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
44913633|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
44913634|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
44913635|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44913636|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44913637|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
44913638|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913639|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913640|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
44913641|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913642|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44913643|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44913644|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
44913645|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
44913646|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44913647|NCT03932721|Evolocumab|evolocumab|mesh-list
44913648|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44913649|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44913650|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
44913651|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913652|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44913653|NCT03932292|Calcium|calcium|mesh-list
44913654|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913655|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913656|NCT03932526|Apatinib|apatinib|mesh-list
44913657|NCT03932526|Vinorelbine|vinorelbine|mesh-list
44913658|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913659|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44913660|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913661|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913662|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44765249|NCT01767623|Vemurafenib|vemurafenib|mesh-list
44913663|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913664|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913665|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913666|NCT03932123|Vancomycin|vancomycin|mesh-list
44913667|NCT03932123|Meropenem|meropenem|mesh-list
44913668|NCT03932123|Tazobactam|tazobactam|mesh-list
44913669|NCT03932123|Piperacillin|piperacillin|mesh-list
44913670|NCT03932123|Cefotaxime|cefotaxime|mesh-list
44913671|NCT03932123|Cefoxitin|cefoxitin|mesh-list
44913672|NCT03932123|Azlocillin|azlocillin|mesh-list
44913673|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44913674|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913675|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44913676|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913677|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913678|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44913679|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913680|NCT03932266|Cisplatin|cisplatin|mesh-list
44913681|NCT03932266|Docetaxel|docetaxel|mesh-list
44913682|NCT03932266|Endostar protein|endostar protein|mesh-list
44913683|NCT03932266|Endostatins|endostatins|mesh-list
44913684|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913685|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913686|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913687|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913688|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913689|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44913690|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44913691|NCT03932266|Growth Substances|growth substances|mesh-ancestor
44913692|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913693|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
44707610|NCT01434914|Octenidine|octenidine|mesh-list
44913694|NCT03931915|Leuprolide|leuprolide|mesh-list
44913695|NCT03931915|Relugolix|relugolix|mesh-list
44913696|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44913697|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
44913698|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913699|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913700|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44913701|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913702|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
44913703|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
44913704|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913705|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
44913706|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913707|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913708|NCT03931668|Maleic acid|maleic acid|mesh-list
44913709|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913710|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913711|NCT03931863|Ondansetron|ondansetron|mesh-list
44913712|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
44913713|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
44913714|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913715|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913716|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913717|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
44913718|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44913719|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44913720|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
44913721|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913722|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913723|NCT03931863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44913724|NCT03931863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44913725|NCT03931863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913726|NCT03931863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44913727|NCT03931863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44913728|NCT03931928|Tamoxifen|tamoxifen|mesh-list
44913729|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44913730|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
44913731|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913732|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913733|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44913734|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913735|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44913736|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44913737|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913738|NCT03931889|Vitamin D|vitamin d|mesh-list
44913739|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
44913740|NCT03931889|Vitamins|vitamins|mesh-ancestor
44913741|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
44913742|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913743|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913744|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913745|NCT03931343|Epinephrine|epinephrine|mesh-list
44913746|NCT03931343|Racepinephrine|racepinephrine|mesh-list
44913747|NCT03931343|Bupivacaine|bupivacaine|mesh-list
44913748|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
44913749|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
44913750|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
44913751|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913752|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913753|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
44913754|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913755|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44913756|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44913757|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913758|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913759|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913760|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44913761|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44913762|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
44913763|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44913764|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
44913765|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
44913766|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
44913767|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44913768|NCT03931239|Vaccines|vaccines|mesh-list
44913769|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
44913770|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913771|NCT03931317|Timolol|timolol|mesh-list
44913772|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44913773|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44913774|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913775|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913776|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913777|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913778|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44913779|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44913781|NCT03931135|Morphine|morphine|mesh-list
44913782|NCT03931135|Cyclizine|cyclizine|mesh-list
44913783|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913784|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
44913785|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
44913786|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913787|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913788|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913789|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
44913790|NCT03931135|Hormones|hormones|mesh-ancestor
44913791|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913792|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44913793|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913794|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44913795|NCT03931135|Narcotics|narcotics|mesh-ancestor
44913796|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913797|NCT03931135|Analgesics|analgesics|mesh-ancestor
44913798|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
44913799|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44913800|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
44913801|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
44913802|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913803|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913804|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
44913805|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44913806|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913807|NCT03931369|Tolvaptan|tolvaptan|mesh-list
44913808|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44913809|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913810|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
44913811|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913812|NCT03930875|Aspirin|aspirin|mesh-list
44913813|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44913814|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44913815|NCT03930875|Analgesics|analgesics|mesh-ancestor
44913816|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
44913817|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913818|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766274|NCT01773408|Cytarabine|cytarabine|mesh-list
44766350|NCT01773798|Insulin|insulin|mesh-list
44913819|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44913820|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913821|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44913822|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44913823|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703773|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703774|NCT01417806|Hormones|hormones|mesh-ancestor
44703775|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44703776|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703777|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44703778|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44703779|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44703780|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44703781|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44766559|NCT01775891|Propafenone|propafenone|mesh-list
44703782|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703783|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703784|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703785|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703786|NCT01417897|Insulin|insulin|mesh-list
44703787|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44703788|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
44703789|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
44703790|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44703791|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703792|NCT01417923|Vitamin D|vitamin d|mesh-list
44703793|NCT01417923|Vitamins|vitamins|mesh-ancestor
44703794|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
44707743|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44913828|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44913829|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44913830|NCT03930706|Estradiol|estradiol|mesh-list
44913831|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44913832|NCT03930706|Estrogens|estrogens|mesh-ancestor
44913833|NCT03930706|Hormones|hormones|mesh-ancestor
44913834|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913835|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913836|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44913837|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
44913838|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913839|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44913840|NCT03930433|Nebivolol|nebivolol|mesh-list
44913841|NCT03930433|Diltiazem|diltiazem|mesh-list
44913842|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44913843|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44913844|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44913845|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44913846|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44913847|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
44913848|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913849|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913850|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913851|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44913852|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913853|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913854|NCT03930069|Vasopressins|vasopressins|mesh-list
44913855|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
44913856|NCT03930069|Misoprostol|misoprostol|mesh-list
44913857|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44913858|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
44913859|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913860|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913861|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44913862|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44913863|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
44913864|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
44913865|NCT03930069|Coagulants|coagulants|mesh-ancestor
44913866|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44913867|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44913868|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
44913869|NCT03930212|Progesterone|progesterone|mesh-list
44913870|NCT03930212|Progestins|progestins|mesh-ancestor
44913871|NCT03930212|Hormones|hormones|mesh-ancestor
44913872|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913873|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913874|NCT03929861|Fluconazole|fluconazole|mesh-list
44913875|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
44913876|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913877|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44913878|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44913879|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913880|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913881|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44913882|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44913883|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44913884|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913885|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44913886|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44913887|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
44913888|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44913889|NCT03929835|Protective Agents|protective agents|mesh-ancestor
44913890|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913891|NCT03929419|Insulin|insulin|mesh-list
44913892|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913893|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913894|NCT03929744|Midazolam|midazolam|mesh-list
44913895|NCT03929744|Atorvastatin|atorvastatin|mesh-list
44913896|NCT03929744|Simvastatin|simvastatin|mesh-list
44913897|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44913898|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44913899|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913900|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913901|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44913902|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44913903|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44913904|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44913905|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
44913906|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
44913907|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
44913908|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
44913909|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913910|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913911|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44913912|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44913913|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
44913914|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44913915|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44913916|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913917|NCT03929575|Calcium|calcium|mesh-list
44913918|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913919|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913920|NCT03929094|Gemcitabine|gemcitabine|mesh-list
44913921|NCT03929094|Paclitaxel|paclitaxel|mesh-list
44913922|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44767183|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44767200|NCT01780740|Atorvastatin|atorvastatin|mesh-list
44913923|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44913924|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44913925|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
44913926|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
44913927|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
44913928|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913929|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44913930|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
44913931|NCT03929094|Antiviral Agents|antiviral agents|mesh-ancestor
44913932|NCT03929094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913933|NCT03929094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913934|NCT03929094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44913935|NCT03929094|Immunologic Factors|immunologic factors|mesh-ancestor
44913936|NCT03929094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913937|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
44913938|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
44913939|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44913940|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44913941|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44913942|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44913943|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913944|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44913945|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44913946|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44913947|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44913948|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913949|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913950|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
44913951|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44913952|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913953|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44913954|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913955|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
44913956|NCT03928691|Analgesics|analgesics|mesh-ancestor
44913957|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
44913958|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44913959|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913960|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
44913961|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44913962|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44913963|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
44913964|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44767677|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
44767869|NCT01785693|Analgesics|analgesics|mesh-ancestor
44767945|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
44913965|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44913966|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44913967|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44913968|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
44913969|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44913970|NCT03928340|Metformin|metformin|mesh-list
44913971|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44913972|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44913973|NCT03928353|Ticagrelor|ticagrelor|mesh-list
44913974|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44913975|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44913976|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44913992|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44913993|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44913994|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44913995|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44913996|NCT03928262|Benralizumab|benralizumab|mesh-list
44913997|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44913998|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703795|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703796|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44703797|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44703798|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
44703799|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703800|NCT01418118|Dobutamine|dobutamine|mesh-list
44703801|NCT01418118|Epinephrine|epinephrine|mesh-list
44703802|NCT01418118|Norepinephrine|norepinephrine|mesh-list
44703803|NCT01418118|Dopexamine|dopexamine|mesh-list
44703804|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44703805|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44703806|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703807|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703808|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703809|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703810|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44703811|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44703812|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
44703813|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703814|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44703815|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44703816|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
44703817|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
44703818|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44703819|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44703820|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44703821|NCT01418118|Protective Agents|protective agents|mesh-ancestor
44703822|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703823|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
44703824|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
44703825|NCT01418131|Tacrolimus|tacrolimus|mesh-list
44703826|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44703827|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703828|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
44703829|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703830|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768007|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44703831|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703832|NCT01418144|Ropivacaine|ropivacaine|mesh-list
44914000|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44914001|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44914002|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914003|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914004|NCT03928210|Protective Agents|protective agents|mesh-ancestor
44914005|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914006|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
44914007|NCT03927963|Propofol|propofol|mesh-list
44914008|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914009|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914010|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914011|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914012|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
44914013|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
44914014|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914015|NCT03927963|Analgesics|analgesics|mesh-ancestor
44914016|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
44914017|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914018|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44914019|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44914020|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44914021|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914022|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914023|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914024|NCT03927807|Misoprostol|misoprostol|mesh-list
44914025|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44914026|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
44914027|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44914028|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914029|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44914030|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914031|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
44914032|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
44914033|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44914034|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
44914035|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
44914036|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914037|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914038|NCT03927352|Adalimumab|adalimumab|mesh-list
44914039|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914040|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914041|NCT03927456|Fulvestrant|fulvestrant|mesh-list
44914042|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44914043|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914044|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44914045|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44914046|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
44914047|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914048|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914049|NCT03927495|Paclitaxel|paclitaxel|mesh-list
44914050|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44914051|NCT03927495|Cisplatin|cisplatin|mesh-list
44914052|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914053|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914054|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914055|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914056|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914057|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914058|NCT03927118|Dexamethasone|dexamethasone|mesh-list
44914059|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
44914060|NCT03927118|BB 1101|bb 1101|mesh-list
44914061|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914062|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
44914063|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
44914064|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914065|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914066|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768601|NCT01794208|Hormones|hormones|mesh-ancestor
44914067|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
44914068|NCT03927118|Hormones|hormones|mesh-ancestor
44914069|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914070|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44914071|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914072|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914073|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914074|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914075|NCT03927170|Metformin|metformin|mesh-list
44914076|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44914077|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44914078|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914079|NCT03927170|Incretins|incretins|mesh-ancestor
44914080|NCT03927170|Hormones|hormones|mesh-ancestor
44914081|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914082|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44914083|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914084|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914085|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914086|NCT03927313|Aspirin|aspirin|mesh-list
44914087|NCT03927313|Rifampin|rifampin|mesh-list
44914088|NCT03927313|Linezolid|linezolid|mesh-list
44914089|NCT03927313|Dexamethasone|dexamethasone|mesh-list
44914090|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914091|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
44914092|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
44914093|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914094|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914095|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914096|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
44914097|NCT03927313|Hormones|hormones|mesh-ancestor
44914098|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914099|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44914100|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914101|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44914102|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914103|NCT03927313|Analgesics|analgesics|mesh-ancestor
44914104|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
44914105|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914106|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44914107|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44914108|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914109|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44914110|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44914111|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914112|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
44914113|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44914114|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
44914115|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44914116|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914117|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
44914118|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914119|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44914120|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44914121|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44914122|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44914123|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44914124|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44914125|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44914126|NCT03927248|Nivolumab|nivolumab|mesh-list
44914127|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914128|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914129|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44914130|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914131|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44914132|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44914133|NCT03927079|Dimercaprol|dimercaprol|mesh-list
44914134|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914135|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
44914136|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
44914137|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
44914138|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914139|NCT03926780|Warfarin|warfarin|mesh-list
44914140|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
44914141|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
44914142|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44914143|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
44914144|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44914145|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914146|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914147|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769011|NCT01801644|Cisplatin|cisplatin|mesh-list
44914149|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
44914150|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
44914151|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914152|NCT03926962|Nafithromycin|nafithromycin|mesh-list
44914153|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769327|NCT01804127|Rituximab|rituximab|mesh-list
44769460|NCT01805232|Artesunate|artesunate|mesh-list
44914154|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914155|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44914156|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914157|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914158|NCT03926936|Fulvestrant|fulvestrant|mesh-list
44914159|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44914160|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914161|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44914162|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44914163|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
44914164|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914165|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914166|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
44914167|NCT03926663|Bupivacaine|bupivacaine|mesh-list
44914168|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
44914169|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
44914170|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914171|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914172|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
44914173|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914174|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914175|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914176|NCT03926663|Analgesics|analgesics|mesh-ancestor
44914177|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44914178|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44914179|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44914180|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914181|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914182|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914183|NCT03926559|Morphine|morphine|mesh-list
44914184|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44914185|NCT03926559|Narcotics|narcotics|mesh-ancestor
44914186|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914187|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914188|NCT03926559|Analgesics|analgesics|mesh-ancestor
44914189|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
44914190|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914191|NCT03926377|Clobetasol|clobetasol|mesh-list
44914192|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914193|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
44914194|NCT03926377|Hormones|hormones|mesh-ancestor
44914195|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914196|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914197|NCT03926403|Anesthetics|anesthetics|mesh-list
44914198|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914199|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914200|NCT03926182|Aflutinib|aflutinib|mesh-list
44914201|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44914202|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914203|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914204|NCT03926156|Warfarin|warfarin|mesh-list
44703833|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
44703834|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
44703835|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703836|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703837|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
44703838|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703839|NCT01418157|Acetazolamide|acetazolamide|mesh-list
44703840|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
44703841|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44703842|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703843|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703844|NCT01418157|Diuretics|diuretics|mesh-ancestor
44703845|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
44769546|NCT01808014|Nefopam|nefopam|mesh-list
44703846|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703847|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
44703848|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
44703849|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
44914205|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
44914244|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44914245|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914246|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
44914247|NCT03925779|Remifentanil|remifentanil|mesh-list
44914248|NCT03925779|Propofol|propofol|mesh-list
44914249|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914250|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914251|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914252|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914253|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
44914254|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
44914255|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914256|NCT03925779|Analgesics|analgesics|mesh-ancestor
44914257|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
44914258|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914259|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44914260|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44914261|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44914262|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914263|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914264|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914265|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44914266|NCT03925779|Narcotics|narcotics|mesh-ancestor
44914267|NCT03925740|Listerine|listerine|mesh-list
44914268|NCT03925740|Fluorides|fluorides|mesh-list
44914269|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
44914270|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
44914271|NCT03925740|Protective Agents|protective agents|mesh-ancestor
44914272|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914273|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44914274|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914275|NCT03925701|Metformin|metformin|mesh-list
44914276|NCT03925701|Vildagliptin|vildagliptin|mesh-list
44914277|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44914278|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914279|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44914280|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914281|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914282|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914283|NCT03925662|Mebendazole|mebendazole|mesh-list
44914284|NCT03925662|Piperazine|piperazine|mesh-list
44914285|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
44914286|NCT03925662|Bevacizumab|bevacizumab|mesh-list
44914287|NCT03925662|DMP 777|dmp 777|mesh-list
44914288|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914289|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914290|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914291|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547756|NCT01364727|Amrubicin|amrubicin|mesh-list
44914292|NCT03925662|Growth Substances|growth substances|mesh-ancestor
44914293|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914294|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914295|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
44914296|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
44914297|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44914298|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914299|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914300|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914301|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914302|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914303|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770049|NCT01811836|Zinc|zinc|mesh-list
44914304|NCT03925233|Tamoxifen|tamoxifen|mesh-list
44914305|NCT03925233|Toremifene|toremifene|mesh-list
44914306|NCT03925233|Gemcitabine|gemcitabine|mesh-list
44914307|NCT03925233|Vinorelbine|vinorelbine|mesh-list
44914308|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
44914309|NCT03925233|Bevacizumab|bevacizumab|mesh-list
44914310|NCT03925233|Carboplatin|carboplatin|mesh-list
44914311|NCT03925233|Doxorubicin|doxorubicin|mesh-list
44914312|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44914313|NCT03925233|Fluorouracil|fluorouracil|mesh-list
44914314|NCT03925233|Capecitabine|capecitabine|mesh-list
44914315|NCT03925233|Methotrexate|methotrexate|mesh-list
44914316|NCT03925233|Trastuzumab|trastuzumab|mesh-list
44914317|NCT03925233|Letrozole|letrozole|mesh-list
44914318|NCT03925233|Apatinib|apatinib|mesh-list
44914319|NCT03925233|Epirubicin|epirubicin|mesh-list
44914320|NCT03925233|Olaparib|olaparib|mesh-list
44914321|NCT03925233|Fulvestrant|fulvestrant|mesh-list
44914322|NCT03925233|Anastrozole|anastrozole|mesh-list
44914323|NCT03925233|Exemestane|exemestane|mesh-list
44914324|NCT03925233|Endostatins|endostatins|mesh-list
44914325|NCT03925233|Pirarubicin|pirarubicin|mesh-list
44914326|NCT03925233|Citric Acid|citric acid|mesh-list
44914327|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
44914328|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914329|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914330|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914331|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914332|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914333|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914334|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44914335|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
44914336|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914337|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914338|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44914339|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
44914340|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44914341|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914342|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914343|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44914344|NCT03925233|Growth Substances|growth substances|mesh-ancestor
44914345|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914346|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914347|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
44914348|NCT03925233|Antiviral Agents|antiviral agents|mesh-ancestor
44914349|NCT03925233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914350|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914351|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44914352|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44770743|NCT01815255|Tenofovir|tenofovir|mesh-list
44914353|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44914354|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44914355|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
44914356|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44914357|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
44914358|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44914359|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914360|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
44914361|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44914362|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
44914363|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
44914364|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44914365|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44914366|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44914367|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
44914368|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914369|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44914370|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44914371|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44914372|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44914373|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914374|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44770966|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
44771108|NCT01817829|Acetaminophen|acetaminophen|mesh-list
44914375|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44914376|NCT03925285|Bevacizumab|bevacizumab|mesh-list
44914377|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914378|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914379|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914380|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44914381|NCT03925285|Growth Substances|growth substances|mesh-ancestor
44914382|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914383|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914384|NCT03925428|Entinostat|entinostat|mesh-list
44914385|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44914386|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914387|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914388|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914389|NCT03925090|Cisplatin|cisplatin|mesh-list
44914390|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914391|NCT03925155|Iodine|iodine|mesh-list
44914392|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
44914393|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44914394|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914395|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
44914396|NCT03925155|Trace Elements|trace elements|mesh-ancestor
44914397|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
44914398|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914399|NCT03925051|Denosumab|denosumab|mesh-list
44914400|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914401|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914402|NCT03924544|Mitomycins|mitomycins|mesh-list
44914403|NCT03924544|Mitomycin|mitomycin|mesh-list
44914404|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44914405|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914406|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
44914407|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914408|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914409|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914410|NCT03924596|Boswellic acid|boswellic acid|mesh-list
44914411|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44914412|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914413|NCT03924596|Analgesics|analgesics|mesh-ancestor
44914414|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
44914415|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914416|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914417|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914418|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914419|NCT03924245|Olaparib|olaparib|mesh-list
44914420|NCT03924245|Entinostat|entinostat|mesh-list
44914421|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44914422|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914423|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914424|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914425|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44914426|NCT03924492|Pregnanolone|pregnanolone|mesh-list
44703850|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44703851|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703852|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
44703853|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703854|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44703855|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44703856|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
44703857|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703858|NCT01418274|Ritonavir|ritonavir|mesh-list
44703859|NCT01418274|Citalopram|citalopram|mesh-list
44703860|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44703861|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44703862|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
44703863|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771220|NCT01818973|Bevacizumab|bevacizumab|mesh-list
44771289|NCT01819285|Hormones|hormones|mesh-ancestor
44703864|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703865|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44703866|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44703867|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
44703868|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703869|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44703870|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44703871|NCT01418274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44703872|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44771471|NCT01820624|Tretinoin|tretinoin|mesh-list
44771548|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
44771595|NCT01821235|Gabapentin|gabapentin|mesh-list
44703873|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703874|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703875|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
44703876|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703877|NCT01418274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44703878|NCT01418274|Antidepressive Agents|antidepressive agents|mesh-ancestor
44703879|NCT01418274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44703880|NCT01418417|Pantoprazole|pantoprazole|mesh-list
44703881|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44703882|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703883|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44703884|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703885|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703886|NCT01418430|Daclizumab|daclizumab|mesh-list
44703887|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703888|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
44703889|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703890|NCT01418443|Pantoprazole|pantoprazole|mesh-list
44703891|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44703892|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44703893|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44703894|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703895|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708492|NCT04801966|Olaparib|olaparib|mesh-list
44914446|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914447|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914448|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914449|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
44914450|NCT03923829|Zinc|zinc|mesh-list
44914451|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
44914452|NCT03923829|Trace Elements|trace elements|mesh-ancestor
44771860|NCT01822808|Hydralazine|hydralazine|mesh-list
44771928|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
44914453|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
44914454|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914455|NCT03923829|Astringents|astringents|mesh-ancestor
44914456|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
44914457|NCT03923751|Anesthetics|anesthetics|mesh-list
44914458|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914459|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914460|NCT03923114|Exenatide|exenatide|mesh-list
44914461|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44914462|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914463|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44914464|NCT03923114|Incretins|incretins|mesh-ancestor
44914465|NCT03923114|Hormones|hormones|mesh-ancestor
44914466|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914467|NCT03923166|Capecitabine|capecitabine|mesh-list
44914468|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914469|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
44914470|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914471|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914472|NCT03923361|Propofol|propofol|mesh-list
44914473|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914474|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914475|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914476|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914477|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
44914478|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
44914479|NCT03923218|Vitamin D|vitamin d|mesh-list
44914480|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
44914481|NCT03923218|Vitamins|vitamins|mesh-ancestor
44914482|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
44914483|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914484|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914485|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914486|NCT03923140|Tranilast|tranilast|mesh-list
44914487|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44914488|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914489|NCT03923140|Analgesics|analgesics|mesh-ancestor
44914490|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
44914491|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914492|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914493|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914494|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914495|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44914496|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914497|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914498|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772014|NCT01824225|Aflibercept|aflibercept|mesh-list
44772089|NCT01824524|Analgesics|analgesics|mesh-ancestor
44914499|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44914500|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
44914501|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
44914502|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914503|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44914504|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44914505|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
44914506|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914507|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914508|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914509|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914510|NCT03923075|Analgesics|analgesics|mesh-ancestor
44914511|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
44914512|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914513|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44914514|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44914515|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44914516|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914517|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914518|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914519|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44914520|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44914521|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914522|NCT03923231|Ritonavir|ritonavir|mesh-list
44914523|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44914524|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44914525|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44914526|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914527|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914528|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914529|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44914530|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44914531|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
44914532|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914533|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44914534|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44914535|NCT03923179|Etoposide|etoposide|mesh-list
44914536|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914537|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914538|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44914539|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44914540|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914541|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914542|NCT03923010|Itraconazole|itraconazole|mesh-list
44914543|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
44914544|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914545|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44914546|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44914547|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914548|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914549|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44914550|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44914551|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44914552|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914553|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44914554|NCT03922815|Fentanyl|fentanyl|mesh-list
44914555|NCT03922815|Propofol|propofol|mesh-list
44914556|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914557|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914558|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914559|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44914561|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
44914562|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44914563|NCT03922815|Narcotics|narcotics|mesh-ancestor
44914564|NCT03922815|Analgesics|analgesics|mesh-ancestor
44914565|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
44914566|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914567|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44914568|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
44914569|NCT03922919|Cefotaxime|cefotaxime|mesh-list
44914570|NCT03922919|Cefoxitin|cefoxitin|mesh-list
44914571|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772539|NCT01827865|Etodolac|etodolac|mesh-list
44772607|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
44914572|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914573|NCT03923036|Cetuximab|cetuximab|mesh-list
44914574|NCT03923036|Panitumumab|panitumumab|mesh-list
44914575|NCT03923036|Aflibercept|aflibercept|mesh-list
44914576|NCT03923036|Capecitabine|capecitabine|mesh-list
44772840|NCT01830907|Vitamins|vitamins|mesh-list
44772991|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
44914577|NCT03923036|Irinotecan|irinotecan|mesh-list
44914578|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
44914579|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914580|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914581|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44914582|NCT03923036|Growth Substances|growth substances|mesh-ancestor
44914583|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914584|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914585|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914586|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
44914587|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914588|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44914589|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44914590|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914591|NCT03922373|Benzonatate|benzonatate|mesh-list
44914592|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
44914593|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
44914594|NCT03921684|Capecitabine|capecitabine|mesh-list
44914595|NCT03921684|Nivolumab|nivolumab|mesh-list
44914596|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914597|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
44914598|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914599|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914600|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914601|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44914602|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44914603|NCT03921736|Perindopril|perindopril|mesh-list
44914604|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44914605|NCT03921736|Diuretics|diuretics|mesh-ancestor
44914606|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
44914607|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914608|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44914609|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914610|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914611|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44914612|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
44914613|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914614|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44914615|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914616|NCT03921671|Paclitaxel|paclitaxel|mesh-list
44914617|NCT03921671|Carboplatin|carboplatin|mesh-list
44914618|NCT03921671|Ramucirumab|ramucirumab|mesh-list
44914619|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914620|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914621|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914622|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914623|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914624|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914625|NCT03921593|Pancrelipase|pancrelipase|mesh-list
44914626|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914627|NCT03921567|Lidocaine|lidocaine|mesh-list
44914628|NCT03921567|Ketamine|ketamine|mesh-list
44914629|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
44914630|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
44914631|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914632|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914633|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
44914634|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914635|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44914636|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44703896|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44703897|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703898|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44703899|NCT01418534|Isosorbide|isosorbide|mesh-list
44703900|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44703901|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44703902|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44703903|NCT01418534|Diuretics|diuretics|mesh-ancestor
44703904|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
44773278|NCT01841775|Interferons|interferons|mesh-list
44703905|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703906|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703907|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44703908|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703909|NCT01418547|Isosorbide|isosorbide|mesh-list
44703910|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44703911|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44703912|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44703913|NCT01418547|Diuretics|diuretics|mesh-ancestor
44703914|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
44703915|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703916|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
44703917|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44703918|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703919|NCT01418586|Alfuzosin|alfuzosin|mesh-list
44703920|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44703921|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44703922|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44703923|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703924|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703925|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703926|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703927|NCT01418586|Urological Agents|urological agents|mesh-ancestor
44703928|NCT01418599|Alfuzosin|alfuzosin|mesh-list
44703929|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44703930|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44703931|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44703932|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44703933|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703934|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703935|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703936|NCT01418599|Urological Agents|urological agents|mesh-ancestor
44703937|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44703938|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44703939|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703940|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703941|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703942|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703943|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703944|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44703945|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
44703946|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44703947|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44703948|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44703949|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703950|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703951|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703952|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703953|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703954|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44703955|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
44703956|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44703957|NCT01418651|Milnacipran|milnacipran|mesh-list
44703958|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44703959|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44703960|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44703961|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703962|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703963|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914672|NCT03920631|Nivolumab|nivolumab|mesh-list
44914673|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914674|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914675|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44914676|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914677|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
44914678|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
44914679|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773666|NCT01843998|Sirolimus|sirolimus|mesh-list
44773785|NCT01844804|Infliximab|infliximab|mesh-list
44914680|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914681|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914682|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44914683|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
44914684|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914685|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914686|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914687|NCT03920878|Aflibercept|aflibercept|mesh-list
44914688|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914689|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44914690|NCT03920878|Growth Substances|growth substances|mesh-ancestor
44914691|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914692|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914693|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914694|NCT03920618|Tenofovir|tenofovir|mesh-list
44914695|NCT03920618|Entecavir|entecavir|mesh-list
44914696|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
44914697|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914698|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44914699|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914700|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914701|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914702|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44914703|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44914704|NCT03920839|Gemcitabine|gemcitabine|mesh-list
44914705|NCT03920839|Paclitaxel|paclitaxel|mesh-list
44914706|NCT03920839|Cisplatin|cisplatin|mesh-list
44914707|NCT03920839|Carboplatin|carboplatin|mesh-list
44914708|NCT03920839|Pemetrexed|pemetrexed|mesh-list
44914709|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914710|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914711|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914712|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914713|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914714|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914715|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44914716|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
44914717|NCT03920839|Antiviral Agents|antiviral agents|mesh-ancestor
44914718|NCT03920839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914719|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914720|NCT03920839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44914721|NCT03920839|Immunologic Factors|immunologic factors|mesh-ancestor
44914722|NCT03920839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914723|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44914724|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914725|NCT03920644|Scopolamine|scopolamine|mesh-list
44914726|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44914727|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44914728|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
44914729|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
44914730|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914731|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914732|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914733|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
44914734|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44914735|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
44914736|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914737|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773925|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
44914738|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44914739|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
44914740|NCT03920605|Tenofovir|tenofovir|mesh-list
44914741|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44914742|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44914743|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
44914744|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914745|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44914746|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914747|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914748|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914749|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44914750|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44914751|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
44708828|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
44914752|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44914753|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
44914754|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914755|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
44914756|NCT03920553|Protective Agents|protective agents|mesh-ancestor
44914757|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44914758|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44914759|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914760|NCT03920150|Vitamin D|vitamin d|mesh-list
44914761|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
44914762|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
44914763|NCT03920150|Vitamins|vitamins|mesh-list
44914764|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
44914765|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914766|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914767|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914768|NCT03920137|Nicotine|nicotine|mesh-list
44914769|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44914770|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
44914771|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914772|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914773|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44914774|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44914775|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44914776|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914777|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914778|NCT03920475|Sertraline|sertraline|mesh-list
44914779|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44914780|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
44914781|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44914782|NCT03920475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44914783|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44914784|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914785|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914786|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774200|NCT01847456|Insulin|insulin|mesh-list
44774334|NCT01848236|Vitamin D|vitamin d|mesh-list
44914787|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
44914788|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774473|NCT01849211|Rocuronium|rocuronium|mesh-list
44774548|NCT01850095|Azelaic acid|azelaic acid|mesh-list
44914789|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44914790|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44914791|NCT03920319|Bupropion|bupropion|mesh-list
44914792|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44914793|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
44914794|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44914795|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44914796|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44914797|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914798|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914799|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
44914800|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914801|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914802|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44914803|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44914804|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914805|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
44914806|NCT03920397|Vitamin D|vitamin d|mesh-list
44914807|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914808|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914809|NCT03920397|Vitamins|vitamins|mesh-ancestor
44914810|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
44914811|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914812|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
44914813|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44774630|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
44914814|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44914815|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914816|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
44914817|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914818|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914819|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
44914820|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44914821|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914822|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44914823|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
44914824|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44914825|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914827|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914828|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44914829|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914830|NCT03919786|Anesthetics|anesthetics|mesh-list
44914831|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914832|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914833|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
44914834|NCT03919812|Vitamin D|vitamin d|mesh-list
44914835|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44914836|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914837|NCT03919812|Vitamins|vitamins|mesh-ancestor
44914838|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
44914839|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44914840|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
44914841|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44914842|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914843|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44914844|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914845|NCT03919552|Cisplatin|cisplatin|mesh-list
44914846|NCT03919552|Carboplatin|carboplatin|mesh-list
44914847|NCT03919552|Docetaxel|docetaxel|mesh-list
44914848|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914849|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914850|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914851|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914852|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914853|NCT03919565|Tenofovir|tenofovir|mesh-list
44914854|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44914855|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44914856|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
44914857|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44914858|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44914859|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44914860|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914861|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914862|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44914863|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44914864|NCT03919253|Paclitaxel|paclitaxel|mesh-list
44914865|NCT03919253|Maleic acid|maleic acid|mesh-list
44914866|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44914867|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914868|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44914869|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44914870|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44914871|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914872|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914873|NCT03919383|Lenvatinib|lenvatinib|mesh-list
44914874|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914875|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44914876|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914877|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914878|NCT03919448|Bevacizumab|bevacizumab|mesh-list
44914879|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914880|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914881|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44914882|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44914883|NCT03919448|Growth Substances|growth substances|mesh-ancestor
44914884|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914885|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44914886|NCT03919084|Nicotine|nicotine|mesh-list
44914887|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44914888|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
44914889|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914890|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914891|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44914892|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44914893|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
44775400|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775468|NCT01856101|Dactolisib|dactolisib|mesh-list
44914894|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914895|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914896|NCT03919461|Etodolac|etodolac|mesh-list
44914897|NCT03919461|Propranolol|propranolol|mesh-list
44914898|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44708975|NCT02635061|Nivolumab|nivolumab|mesh-list
44914900|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
44914901|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44703964|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44703965|NCT01418651|Analgesics|analgesics|mesh-ancestor
44703966|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
44703967|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44703968|NCT01418729|Pravastatin|pravastatin|mesh-list
44703969|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44703970|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44703971|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
44775573|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
44935911|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44775863|NCT01858025|Mitomycins|mitomycins|mesh-list
44703972|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703973|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44703974|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44703975|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703976|NCT01418742|Doxycycline|doxycycline|mesh-list
44703977|NCT01418742|Panitumumab|panitumumab|mesh-list
44703978|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44703979|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703980|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
44703981|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44703982|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44703983|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44703984|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703985|NCT01418794|Sirolimus|sirolimus|mesh-list
44703986|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44703987|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44703988|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44703989|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703990|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
44703991|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44703992|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
44703993|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44703995|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44703996|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44703997|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44703998|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44703999|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
44704000|NCT01419119|Vitamin D|vitamin d|mesh-list
44704001|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44704002|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704003|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704004|NCT01419119|Vitamins|vitamins|mesh-ancestor
44704005|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
44704006|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44704007|NCT01419132|Furosemide|furosemide|mesh-list
44704008|NCT01419132|Diuretics|diuretics|mesh-list
44704009|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
44704010|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704011|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44704012|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704013|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704014|NCT01419262|Vitamin D|vitamin d|mesh-list
44704015|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
44704016|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
44704017|NCT01419262|Vitamins|vitamins|mesh-list
44704018|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
44704019|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704020|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44704021|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704022|NCT01419340|Donepezil|donepezil|mesh-list
44704023|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44704024|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704025|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704026|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
44704027|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704028|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704029|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
44704030|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44704031|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44704032|NCT01419353|Estradiol|estradiol|mesh-list
44704033|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44704034|NCT01419353|Estrogens|estrogens|mesh-ancestor
44704035|NCT01419353|Hormones|hormones|mesh-ancestor
44709051|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44553913|NCT01263015|Dolutegravir|dolutegravir|mesh-list
44775999|NCT01858571|Thalidomide|thalidomide|mesh-list
44914902|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914903|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914904|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44914905|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44914906|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
44776263|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776369|NCT01860716|Melatonin|melatonin|mesh-list
44914907|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44914908|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914909|NCT03919461|Analgesics|analgesics|mesh-ancestor
44914910|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
44914911|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914912|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914913|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914914|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44914915|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44914916|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914917|NCT03919175|Rituximab|rituximab|mesh-list
44914918|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44914919|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44914920|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
44914921|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914922|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914923|NCT03918993|Tadalafil|tadalafil|mesh-list
44914924|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44914925|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44914926|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44914927|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44914928|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914929|NCT03918993|Urological Agents|urological agents|mesh-ancestor
44914930|NCT03918616|Dopamine|dopamine|mesh-list
44914931|NCT03918616|Memantine|memantine|mesh-list
44914932|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
44914933|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44914934|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44914935|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
44914936|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44914937|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914938|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914939|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44914940|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44914941|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44914942|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
44914943|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
44914944|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914945|NCT03918616|Protective Agents|protective agents|mesh-ancestor
44914946|NCT03918590|Nepafenac|nepafenac|mesh-list
44914947|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44914948|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44914949|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914950|NCT03918590|Analgesics|analgesics|mesh-ancestor
44914951|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
44914952|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914953|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914954|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44914955|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44914956|NCT03918590|Laxatives|laxatives|mesh-ancestor
44914957|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44914958|NCT03918694|Ascorbic Acid|ascorbic acid|mesh-list
44914959|NCT03918694|Vitamins|vitamins|mesh-ancestor
44914960|NCT03918694|Micronutrients|micronutrients|mesh-ancestor
44914961|NCT03918694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914962|NCT03918694|Antioxidants|antioxidants|mesh-ancestor
44914963|NCT03918694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44914964|NCT03918694|Protective Agents|protective agents|mesh-ancestor
44914965|NCT03918889|Midazolam|midazolam|mesh-list
44914966|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
44914967|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44914968|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44914969|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44914970|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44914971|NCT03918889|Analgesics|analgesics|mesh-ancestor
44914972|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
44554581|NCT04673578|Celecoxib|celecoxib|mesh-list
44776583|NCT01862497|Carvedilol|carvedilol|mesh-list
44776819|NCT01863719|Colistin|colistin|mesh-list
44914973|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44914974|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44914975|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44914976|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44915012|NCT03918187|Nalbuphine|nalbuphine|mesh-list
44915013|NCT03918187|Bupivacaine|bupivacaine|mesh-list
44915014|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915015|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
44915016|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915017|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915018|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
44915019|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915020|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44915021|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44915022|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44915023|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44915024|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915025|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915026|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
44915027|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
44915028|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
44915029|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915030|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915031|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44915032|NCT03918187|Narcotics|narcotics|mesh-ancestor
44915033|NCT03918187|Analgesics|analgesics|mesh-ancestor
44915034|NCT03918135|Acetaminophen|acetaminophen|mesh-list
44915035|NCT03918135|Ibuprofen|ibuprofen|mesh-list
44915036|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44915037|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915038|NCT03918135|Analgesics|analgesics|mesh-ancestor
44915039|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
44915040|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915041|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915042|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915043|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915044|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44915045|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915046|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915047|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
44915048|NCT03917940|Glimepiride|glimepiride|mesh-list
44915049|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44915050|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44915051|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915052|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915053|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
44915054|NCT03917784|Curcumin|curcumin|mesh-list
44915055|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44915056|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915057|NCT03917784|Analgesics|analgesics|mesh-ancestor
44915058|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
44915059|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915060|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915061|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915062|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915063|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915064|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915065|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915066|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
44915067|NCT03917758|Empagliflozin|empagliflozin|mesh-list
44776888|NCT01864161|Iron|iron|mesh-list
44915068|NCT03917758|Canagliflozin|canagliflozin|mesh-list
44915069|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44915070|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915071|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44915072|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915073|NCT03917459|Enalapril|enalapril|mesh-list
44915074|NCT03917459|Enalaprilat|enalaprilat|mesh-list
44915075|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44915076|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44915077|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
44915078|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915079|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915080|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44915081|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44915082|NCT03917537|Nivolumab|nivolumab|mesh-list
44915083|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915084|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915085|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44915086|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915087|NCT03917628|Adalimumab|adalimumab|mesh-list
44915088|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915089|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915090|NCT03917420|Tenofovir|tenofovir|mesh-list
44915091|NCT03917420|Emtricitabine|emtricitabine|mesh-list
44915092|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44915093|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
44915094|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915095|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44915096|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44915097|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915098|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915099|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44915100|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44915101|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
44915102|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
44915103|NCT03917095|Mesalamine|mesalamine|mesh-list
44915104|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44915105|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915106|NCT03917095|Analgesics|analgesics|mesh-ancestor
44915107|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
44915108|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915109|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915110|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915111|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915112|NCT03916926|Fluorides|fluorides|mesh-list
44915113|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
44915114|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
44915115|NCT03916926|Protective Agents|protective agents|mesh-ancestor
44915116|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915117|NCT03917134|Metronidazole|metronidazole|mesh-list
44915118|NCT03917134|Cephalosporins|cephalosporins|mesh-list
44915119|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915120|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915121|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44915122|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44915123|NCT03917082|Tamoxifen|tamoxifen|mesh-list
44915124|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44915125|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915126|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44915127|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
44915128|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915129|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915130|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44915131|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915132|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44915133|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44915134|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44915135|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44915136|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915137|NCT03917394|Iron|iron|mesh-list
44915138|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44915139|NCT03917394|Trace Elements|trace elements|mesh-ancestor
44915140|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
44915141|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915142|NCT03917394|Hematinics|hematinics|mesh-ancestor
44915143|NCT03917186|Sevoflurane|sevoflurane|mesh-list
44915144|NCT03917186|Desflurane|desflurane|mesh-list
44704036|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704037|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704038|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44704039|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
44704040|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44704041|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44704042|NCT01419366|Donepezil|donepezil|mesh-list
44704043|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44704044|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704045|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704046|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
44704047|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704048|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704049|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
44709289|NCT01439230|Donepezil|donepezil|mesh-list
44915145|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44915179|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44915180|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44915181|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915182|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
44777411|NCT01868581|Insulin|insulin|mesh-list
44915183|NCT05402189|Fentanyl|fentanyl|mesh-list
44915184|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44915185|NCT05402189|Narcotics|narcotics|mesh-ancestor
44915186|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915187|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915188|NCT05402189|Analgesics|analgesics|mesh-ancestor
44915189|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
44915190|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915191|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44915192|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915193|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
44915194|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
44915195|NCT05402124|Aspirin|aspirin|mesh-list
44915196|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44915197|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915198|NCT05402124|Analgesics|analgesics|mesh-ancestor
44915199|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
44915200|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915201|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915202|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915203|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915204|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44915205|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44915206|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915207|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44915208|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44915209|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915210|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
44915211|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
44915212|NCT05401812|Hormones|hormones|mesh-ancestor
44915213|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915214|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915215|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
44915216|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
44915217|NCT05401721|Coagulants|coagulants|mesh-ancestor
44915218|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44915219|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44915220|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
44915221|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915222|NCT05401370|Methylene Blue|methylene blue|mesh-list
44915223|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915224|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915225|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44915226|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44915227|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915228|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915229|NCT05401071|Rifapentine|rifapentine|mesh-list
44915230|NCT05401071|Rifampin|rifampin|mesh-list
44915231|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44915232|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
44915233|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915234|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915235|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
44915236|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44915237|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915238|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915239|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44915240|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44915241|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44915242|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44915243|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44915244|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44915245|NCT05401032|Tamsulosin|tamsulosin|mesh-list
44915246|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44915247|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44915248|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44915249|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
44915250|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915251|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915252|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915260|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915261|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44915262|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44915263|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915264|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915265|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44915266|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
44915267|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
44915268|NCT05401019|Protective Agents|protective agents|mesh-ancestor
44915269|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44915270|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44915271|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
44915272|NCT05401006|Acitretin|acitretin|mesh-list
44915273|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
44915274|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915275|NCT05400915|Paclitaxel|paclitaxel|mesh-list
44556345|NCT01239992|Niacin|niacin|mesh-list
44915276|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44915277|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915278|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44915279|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44915280|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44915281|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915282|NCT05400902|Apatinib|apatinib|mesh-list
44915283|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915284|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44915285|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915286|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915287|NCT05610007|Prilocaine|prilocaine|mesh-list
44915288|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915289|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
44915290|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915291|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915292|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
44915293|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915294|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
44915295|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44915296|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915297|NCT05607147|Antibodies|antibodies|mesh-list
44915298|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
44915299|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915300|NCT05597462|Minocycline|minocycline|mesh-list
44915301|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915302|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915303|NCT05594472|Gentamicins|gentamicins|mesh-list
44915304|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915305|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915306|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44915307|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778185|NCT01872546|Adalimumab|adalimumab|mesh-list
44778198|NCT01872754|Remifentanil|remifentanil|mesh-list
44935912|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44915308|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915309|NCT05555862|Artesunate|artesunate|mesh-list
44915310|NCT05555862|Artenimol|artenimol|mesh-list
44915311|NCT05555862|Artemisinins|artemisinins|mesh-list
44915312|NCT05555862|Artemisinin|artemisinin|mesh-list
44915313|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
44915314|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44915315|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44915316|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915317|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915318|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
44915319|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
44915320|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44915321|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
44704050|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
44709494|NCT01440790|Protective Agents|protective agents|mesh-ancestor
44915322|NCT05553145|Antibodies|antibodies|mesh-list
44915323|NCT05553145|Autoantibodies|autoantibodies|mesh-list
44915324|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
44915325|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915326|NCT05550337|Trifarotene|trifarotene|mesh-list
44915327|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915328|NCT05549531|Itraconazole|itraconazole|mesh-list
44915329|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
44778486|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44915330|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915331|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44915332|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44915333|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915334|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915335|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44915336|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44915337|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915338|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915339|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44915340|NCT05533372|Methotrexate|methotrexate|mesh-list
44915341|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44915342|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
44915343|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44915344|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915345|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44915346|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
44915347|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915348|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915349|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915350|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915351|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44915352|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915353|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
44915354|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778775|NCT01876290|Hormones|hormones|mesh-ancestor
44915355|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44915356|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44915357|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44915358|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915359|NCT05490134|Naloxone|naloxone|mesh-list
44915360|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44915361|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915362|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
44915363|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915364|NCT05488613|Midostaurin|midostaurin|mesh-list
44915365|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915366|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44915367|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915368|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915369|NCT05487196|Clonidine|clonidine|mesh-list
44915370|NCT05487196|Fentanyl|fentanyl|mesh-list
44915371|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
44915372|NCT05487196|Ropivacaine|ropivacaine|mesh-list
44915373|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44915374|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915375|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915376|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915377|NCT05487196|Analgesics|analgesics|mesh-ancestor
44915378|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
44915379|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915380|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44915381|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44915382|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44915383|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
44915384|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915385|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915386|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915387|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
44915388|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44915389|NCT05487196|Narcotics|narcotics|mesh-ancestor
44915390|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44915391|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915392|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
44915393|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44915394|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
44915395|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
44709569|NCT01441232|Incretins|incretins|mesh-ancestor
44915396|NCT05485662|Listerine|listerine|mesh-list
44915397|NCT05485662|Fluorides|fluorides|mesh-list
44915398|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
44915399|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
44915400|NCT05485662|Protective Agents|protective agents|mesh-ancestor
44915401|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915402|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44915403|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915404|NCT05480488|Midazolam|midazolam|mesh-list
44915405|NCT05480488|Warfarin|warfarin|mesh-list
44915406|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44915407|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44915408|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915409|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915410|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44915411|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44915412|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915413|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915414|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
44915415|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
44915416|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
44915417|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
44915418|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915419|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915420|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
44915421|NCT05480475|Dabigatran|dabigatran|mesh-list
44915422|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44704051|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704052|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44704053|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44704054|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44704055|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704056|NCT01419392|Urological Agents|urological agents|mesh-ancestor
44704057|NCT01419405|Pregabalin|pregabalin|mesh-list
44704058|NCT01419405|Remifentanil|remifentanil|mesh-list
44704059|NCT01419405|Analgesics|analgesics|mesh-ancestor
44704060|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
44704061|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704062|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704063|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
44704064|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44704065|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704066|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704067|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704068|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44704069|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704070|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704071|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704072|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44704073|NCT01419405|Narcotics|narcotics|mesh-ancestor
44704074|NCT01419457|Favipiravir|favipiravir|mesh-list
44704075|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
44704076|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704077|NCT01419548|Paclitaxel|paclitaxel|mesh-list
44704078|NCT01419548|Carboplatin|carboplatin|mesh-list
44704079|NCT01419548|Veliparib|veliparib|mesh-list
44704080|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704081|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704082|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
44704083|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
44704084|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704085|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704086|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44704087|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704088|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44704089|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704090|NCT01419691|Auranofin|auranofin|mesh-list
44704091|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704092|NCT01419730|Vitamin D|vitamin d|mesh-list
44704093|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
44704094|NCT01419730|Vitamins|vitamins|mesh-ancestor
44704095|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
44704096|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704097|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44704098|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44915423|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44915424|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44915425|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
44915426|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915428|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44915429|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915430|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
44915431|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44915432|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
44915433|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
44915434|NCT05461573|Drospirenone|drospirenone|mesh-list
44915435|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44915436|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
44915437|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779420|NCT01881763|Ketamine|ketamine|mesh-list
44915438|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915439|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44915440|NCT05461573|Diuretics|diuretics|mesh-ancestor
44915441|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
44915442|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
44915443|NCT05410821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44915444|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44915445|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
44915446|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
44915447|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915448|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
44915449|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44915450|NCT05327361|Protective Agents|protective agents|mesh-ancestor
44915451|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915452|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915453|NCT05320094|Sorbitol|sorbitol|mesh-list
44915454|NCT05320094|Charcoal|charcoal|mesh-list
44915455|NCT05320094|Antidotes|antidotes|mesh-ancestor
44915456|NCT05320094|Protective Agents|protective agents|mesh-ancestor
44915457|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779571|NCT01883232|Lidocaine|lidocaine|mesh-list
44779701|NCT01884298|Lidocaine|lidocaine|mesh-list
44779844|NCT01884896|Metoprolol|metoprolol|mesh-list
44915458|NCT05320094|Cathartics|cathartics|mesh-ancestor
44915459|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915460|NCT05308212|Vaccines|vaccines|mesh-list
44915461|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
44915462|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915463|NCT05291598|Ketorolac|ketorolac|mesh-list
44915464|NCT05291598|Meloxicam|meloxicam|mesh-list
44915465|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44915466|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915467|NCT05291598|Analgesics|analgesics|mesh-ancestor
44915468|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
44915469|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915470|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915471|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915472|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915473|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44915474|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915475|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915476|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44915477|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44915478|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915479|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915480|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
44915481|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915482|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915483|NCT05275179|Posaconazole|posaconazole|mesh-list
44915484|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
44915485|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915486|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44915487|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44915488|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44915489|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44915490|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44915491|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915492|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915493|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44915494|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
44915495|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915496|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915497|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
44915498|NCT05256901|Neostigmine|neostigmine|mesh-list
44915534|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44915535|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915536|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44915537|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915538|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915539|NCT05210153|Sertraline|sertraline|mesh-list
44915540|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
44915541|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915542|NCT05210153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44915543|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44915544|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915545|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915546|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915547|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
44915548|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915549|NCT05210140|Citalopram|citalopram|mesh-list
44915550|NCT05210140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44915551|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44915552|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915553|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915554|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915555|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
44915556|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915557|NCT05210140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44915558|NCT05210140|Antidepressive Agents|antidepressive agents|mesh-ancestor
44915559|NCT05210140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915560|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44915561|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44915562|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915563|NCT05195944|Incretins|incretins|mesh-ancestor
44915564|NCT05195944|Hormones|hormones|mesh-ancestor
44915565|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915566|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44915567|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44915568|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915569|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915570|NCT05191394|Antibodies|antibodies|mesh-list
44915571|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
44915572|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915573|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
44915574|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44915575|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915576|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44915577|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915578|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44915579|NCT05120934|Amitriptyline|amitriptyline|mesh-list
44915580|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44915581|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44915582|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915583|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915584|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915585|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915586|NCT05120934|Analgesics|analgesics|mesh-ancestor
44915587|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
44915588|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915589|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
44915590|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915591|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
44915592|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44915593|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915594|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44915595|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44915596|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44915597|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
44915598|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44915599|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
44780640|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44780713|NCT01889680|Leucovorin|leucovorin|mesh-list
44915600|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44915601|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915602|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44915603|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44915604|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915605|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44915606|NCT05110144|Amitriptyline|amitriptyline|mesh-list
44915607|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44915608|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44915609|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915610|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915611|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915612|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915613|NCT05110144|Analgesics|analgesics|mesh-ancestor
44915614|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
44915615|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915616|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
44915617|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915618|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
44915619|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44915620|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44915621|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44915622|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
44915623|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
44915624|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44915625|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
44915626|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915627|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915628|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44915629|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
44915630|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44915631|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
44915632|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915633|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915634|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44915635|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
44915636|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
44915637|NCT05109611|Protective Agents|protective agents|mesh-ancestor
44915638|NCT05109052|Bevacizumab|bevacizumab|mesh-list
44780820|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
44781121|NCT01900509|Hormones|hormones|mesh-ancestor
44915639|NCT05109052|Atezolizumab|atezolizumab|mesh-list
44915640|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915641|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915642|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44915643|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44915644|NCT05109052|Growth Substances|growth substances|mesh-ancestor
44915645|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915646|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
44915647|NCT05107193|Afatinib|afatinib|mesh-list
44915648|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915649|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44915650|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915651|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915652|NCT05088889|Nivolumab|nivolumab|mesh-list
44915653|NCT05088889|Ipilimumab|ipilimumab|mesh-list
44915654|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915655|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915656|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44915657|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915658|NCT05088252|Propofol|propofol|mesh-list
44915659|NCT05088252|Desflurane|desflurane|mesh-list
44915660|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44915661|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915662|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915663|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915664|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
44915665|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
44915666|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44915667|NCT05068037|Antiemetics|antiemetics|mesh-list
44915668|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
44915669|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915670|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915671|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915672|NCT05044429|Lidocaine|lidocaine|mesh-list
44781197|NCT01900847|Ketamine|ketamine|mesh-list
44781438|NCT01902225|Doxorubicin|doxorubicin|mesh-list
44915673|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915674|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
44915675|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915676|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915677|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
44915678|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915679|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44915680|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44915681|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44915682|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915683|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915685|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915686|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
44915687|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915688|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915689|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
44915690|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915691|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44915692|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44915693|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44915694|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915695|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915696|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
44915697|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44915698|NCT04983940|Testosterone|testosterone|mesh-list
44915699|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
44915700|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
44915701|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44915702|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915703|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
44915704|NCT04983940|Hormones|hormones|mesh-ancestor
44915705|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915706|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915707|NCT04983940|Androgens|androgens|mesh-ancestor
44915708|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
44915709|NCT04976634|Lenvatinib|lenvatinib|mesh-list
44915710|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915711|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915712|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44915713|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915714|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915715|NCT04966299|Erythritol|erythritol|mesh-list
44915716|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
44915717|NCT04956692|Paclitaxel|paclitaxel|mesh-list
44915718|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44915719|NCT04956692|Cisplatin|cisplatin|mesh-list
44915720|NCT04956692|Carboplatin|carboplatin|mesh-list
44915721|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
44781561|NCT01902875|Paclitaxel|paclitaxel|mesh-list
44915722|NCT04956692|Pemetrexed|pemetrexed|mesh-list
44915723|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44915724|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915725|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
44915726|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
44915727|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
44915728|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915729|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915730|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915731|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44915732|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44915733|NCT04917406|Dexamethasone|dexamethasone|mesh-list
44915734|NCT04917406|Lidocaine|lidocaine|mesh-list
44915735|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915736|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
44915737|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
44915738|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915739|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915740|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915741|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
44915742|NCT04917406|Hormones|hormones|mesh-ancestor
44915743|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915744|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44915745|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915746|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
44915747|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
44915748|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915749|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
44915750|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44915751|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44915752|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44915753|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915754|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915755|NCT04913922|Nivolumab|nivolumab|mesh-list
44704099|NCT01419821|Vitamin D|vitamin d|mesh-list
44704100|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
44915756|NCT04913922|Azacitidine|azacitidine|mesh-list
44915793|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915794|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
44915795|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915796|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
44915797|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915798|NCT04828538|Vitamin D|vitamin d|mesh-list
44915799|NCT04828538|Vitamins|vitamins|mesh-list
44915800|NCT04828538|Ascorbic Acid|ascorbic acid|mesh-list
44915801|NCT04828538|Folic Acid|folic acid|mesh-list
44915802|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
44915803|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
44915804|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915805|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44915806|NCT04828538|Antioxidants|antioxidants|mesh-ancestor
44915807|NCT04828538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915808|NCT04828538|Protective Agents|protective agents|mesh-ancestor
44915809|NCT04828538|Hematinics|hematinics|mesh-ancestor
44915810|NCT04818489|Colchicine|colchicine|mesh-list
44915811|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
44915812|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44915813|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44915814|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44915815|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44915816|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915817|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915818|NCT04781959|Lenograstim|lenograstim|mesh-list
44915819|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44915820|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
44915821|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915822|NCT04767243|Methamphetamine|methamphetamine|mesh-list
44915823|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44915824|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915825|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
44915826|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
44915827|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915828|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
44915829|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915830|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915831|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44915832|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44915833|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44915834|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44915835|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44915836|NCT04751604|Niacinamide|niacinamide|mesh-list
44915837|NCT04751604|Niacin|niacin|mesh-list
44915838|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
44915839|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
44915840|NCT04751604|Vitamins|vitamins|mesh-ancestor
44915841|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
44915842|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915843|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44915844|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
44915845|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915846|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44915847|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
44915848|NCT04748419|Durvalumab|durvalumab|mesh-list
44915849|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44915850|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915851|NCT04745273|Ondansetron|ondansetron|mesh-list
44915852|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
44915853|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
44915854|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915855|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915856|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915857|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
44915858|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915859|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44915860|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
44915861|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781972|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
44915862|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915863|NCT04745273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44915864|NCT04745273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44915865|NCT04745273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915866|NCT04745273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915867|NCT04745273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44915868|NCT04722978|Gemcitabine|gemcitabine|mesh-list
44915869|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
44915870|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44915871|NCT04722978|Carboplatin|carboplatin|mesh-list
44915872|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44915873|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710127|NCT01444339|Vaccines|vaccines|mesh-list
44915874|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44915876|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915877|NCT04722978|Antiviral Agents|antiviral agents|mesh-ancestor
44915878|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915879|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915880|NCT04722978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915881|NCT04722978|Immunologic Factors|immunologic factors|mesh-ancestor
44915882|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915883|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44915884|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44915885|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44915886|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
44915887|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44915888|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44915889|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44915890|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44915891|NCT04721613|Melatonin|melatonin|mesh-list
44915892|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
44915893|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915894|NCT04721613|Protective Agents|protective agents|mesh-ancestor
44915895|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915896|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915897|NCT04713098|Coal Tar|coal tar|mesh-list
44915898|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
44915899|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
44915900|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44915901|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44915902|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915903|NCT04671043|Caffeine|caffeine|mesh-list
44915904|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44915905|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915906|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44915907|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915908|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915909|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44915910|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44915911|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
44915912|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915913|NCT04659161|Xanomeline|xanomeline|mesh-list
44915914|NCT04659161|Trospium chloride|trospium chloride|mesh-list
44915915|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
44915916|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
44915917|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915918|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915919|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44915920|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44915921|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
44915922|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915923|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915924|NCT04659161|Urological Agents|urological agents|mesh-ancestor
44915925|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44915926|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44915927|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44915928|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44915929|NCT04630730|Gemcitabine|gemcitabine|mesh-list
44915930|NCT04630730|Cisplatin|cisplatin|mesh-list
44915931|NCT04630730|Atezolizumab|atezolizumab|mesh-list
44915932|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
44915933|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915934|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44915935|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
44915936|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915937|NCT04630730|Antiviral Agents|antiviral agents|mesh-ancestor
44915938|NCT04630730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44915939|NCT04630730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915940|NCT04630730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44915941|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
44915942|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915943|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44915944|NCT04629781|Docetaxel|docetaxel|mesh-list
44915945|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915946|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44915947|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44915948|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704101|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
44915949|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915951|NCT04625283|Analgesics|analgesics|mesh-ancestor
44915952|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
44915953|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915954|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915955|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44915956|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44915957|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
44915958|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
44915959|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915960|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44915961|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44915962|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44915963|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44915964|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
44915965|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44915966|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44915967|NCT04624776|Prednisolone|prednisolone|mesh-list
44915968|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
44915969|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44915970|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
44915971|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44915972|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
44915973|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
44915974|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915975|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915976|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915977|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
44915978|NCT04624776|Hormones|hormones|mesh-ancestor
44782494|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
44782726|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44915979|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44915980|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44915981|NCT04624776|Protective Agents|protective agents|mesh-ancestor
44915982|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44915983|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44915984|NCT04595591|Remifentanil|remifentanil|mesh-list
44915985|NCT04595591|Rocuronium|rocuronium|mesh-list
44915986|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44915987|NCT04595591|Narcotics|narcotics|mesh-ancestor
44915988|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44915989|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44915990|NCT04595591|Analgesics|analgesics|mesh-ancestor
44915991|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
44915992|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44915993|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44915994|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44915995|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44915996|NCT04585295|Betaine|betaine|mesh-list
44915997|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44915998|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
44915999|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44916000|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
44916001|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916002|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916003|NCT04582448|Insulin|insulin|mesh-list
44916004|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44916005|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916006|NCT04576455|Fulvestrant|fulvestrant|mesh-list
44916007|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44916008|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44916009|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916010|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44916011|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44710274|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44710275|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44710276|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44710277|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44710278|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44710279|NCT01445236|Cyclosporine|cyclosporine|mesh-list
44710280|NCT01445236|Tacrolimus|tacrolimus|mesh-list
44710281|NCT01445236|Cyclosporins|cyclosporins|mesh-list
44710282|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710283|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
44710284|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916012|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
44916013|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916014|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704102|NCT01419821|Vitamins|vitamins|mesh-list
44704103|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
44704104|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783117|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
44704105|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44704106|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704107|NCT01419847|Ciclopirox|ciclopirox|mesh-list
44704108|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
44704109|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704110|NCT01419873|Insulin|insulin|mesh-list
44704111|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44704112|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704113|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704114|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44704115|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44704116|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704117|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704118|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
44704119|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704120|NCT01420094|Aspirin|aspirin|mesh-list
44704121|NCT01420094|Acetaminophen|acetaminophen|mesh-list
44704122|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704123|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704124|NCT01420094|Analgesics|analgesics|mesh-ancestor
44704125|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
44704126|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704127|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704128|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704129|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704130|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44704131|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44704132|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704133|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44704134|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44704135|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704136|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
44704137|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
44704138|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44704139|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
44704140|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
44704141|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704142|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704143|NCT01420302|Insulin|insulin|mesh-list
44704144|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44704145|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704146|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704147|NCT01420328|Simvastatin|simvastatin|mesh-list
44704148|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44704149|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44704150|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44704151|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
44704152|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704153|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44704154|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44704155|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704156|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44704157|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44704158|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704159|NCT01420341|Renal Agents|renal agents|mesh-ancestor
44704160|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44704161|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
44704162|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44704163|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44704164|NCT01420367|Metronidazole|metronidazole|mesh-list
44704165|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704166|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44704167|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44704168|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44704169|NCT01420406|Vitamin A|vitamin a|mesh-list
44704170|NCT01420406|Vitamins|vitamins|mesh-ancestor
44704171|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
44704172|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704173|NCT01420471|Triamcinolone|triamcinolone|mesh-list
44916015|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44916016|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916017|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916018|NCT04528082|Apremilast|apremilast|mesh-list
44916019|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916020|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916021|NCT04528082|Analgesics|analgesics|mesh-ancestor
44916022|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
44916023|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916024|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916025|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916026|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916027|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44916028|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44916029|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783360|NCT01914692|Hormones|hormones|mesh-ancestor
44783405|NCT01914939|Oxytocin|oxytocin|mesh-list
44916030|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916031|NCT04504825|Dexamethasone|dexamethasone|mesh-list
44916032|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
44916033|NCT04504825|Bortezomib|bortezomib|mesh-list
44916034|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916035|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
44916036|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916037|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916038|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916039|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
44916040|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916041|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916042|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44916043|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916044|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
44916045|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
44916046|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916047|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916048|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
44916049|NCT04504825|Hormones|hormones|mesh-ancestor
44916050|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916051|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44916052|NCT04484025|Ebselen|ebselen|mesh-list
44916053|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916054|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916055|NCT04484025|Analgesics|analgesics|mesh-ancestor
44916056|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
44783629|NCT01916265|Hormones|hormones|mesh-ancestor
44783667|NCT01916642|Lidocaine|lidocaine|mesh-list
44783968|NCT01918098|Analgesics|analgesics|mesh-ancestor
44916057|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916058|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916059|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916060|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916061|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44916062|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916063|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
44916064|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916065|NCT04484025|Protective Agents|protective agents|mesh-ancestor
44916066|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44916067|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916068|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44916069|NCT04483973|Ebselen|ebselen|mesh-list
44916070|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916071|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916072|NCT04483973|Analgesics|analgesics|mesh-ancestor
44916073|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
44916074|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916075|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916076|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916077|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916078|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44916079|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916080|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
44916081|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916082|NCT04483973|Protective Agents|protective agents|mesh-ancestor
44916083|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44916084|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916085|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44916086|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
44916087|NCT04478292|Cisplatin|cisplatin|mesh-list
44710341|NCT01445561|Interleukin-2|interleukin-2|mesh-list
44916088|NCT04478292|Carboplatin|carboplatin|mesh-list
44916089|NCT04478292|Doxorubicin|doxorubicin|mesh-list
44916090|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44916091|NCT04478292|Fluorouracil|fluorouracil|mesh-list
44916092|NCT04478292|Irinotecan|irinotecan|mesh-list
44916093|NCT04478292|Vincristine|vincristine|mesh-list
44916094|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916095|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44916096|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44916097|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44916098|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916099|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916100|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
44916101|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916102|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916103|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
44916104|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916105|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44916106|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44916107|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916108|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916109|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916110|NCT04478292|Antidotes|antidotes|mesh-ancestor
44916111|NCT04478292|Protective Agents|protective agents|mesh-ancestor
44916112|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
44916113|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
44916114|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916115|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916116|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
44916117|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
44916118|NCT04469075|Clindamycin|clindamycin|mesh-list
44916119|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
44916120|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
44916121|NCT04469075|Triamcinolone|triamcinolone|mesh-list
44916122|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44916123|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44916124|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44916125|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916126|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
44916127|NCT04469075|Hormones|hormones|mesh-ancestor
44916128|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916129|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916130|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916131|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
44916132|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916133|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916134|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916135|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916136|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44916137|NCT04338061|Teriflunomide|teriflunomide|mesh-list
44916138|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916139|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916140|NCT04338061|Analgesics|analgesics|mesh-ancestor
44916141|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
44916142|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916143|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916144|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916145|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916146|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916147|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
44916148|NCT04338022|Teriflunomide|teriflunomide|mesh-list
44916149|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916150|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916151|NCT04338022|Analgesics|analgesics|mesh-ancestor
44916152|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
44916153|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916154|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916155|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916156|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916157|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916158|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
44916159|NCT04330625|Volagidemab|volagidemab|mesh-list
44916160|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44916161|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916162|NCT04316806|Rifaximin|rifaximin|mesh-list
44916163|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710419|NCT01446107|Fluorides|fluorides|mesh-list
44916164|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916173|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44916174|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44916175|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916176|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916177|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44916178|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44916179|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
44916180|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916181|NCT03959527|Azithromycin|azithromycin|mesh-list
44916182|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
44916183|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916184|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916185|NCT03913442|Colchicine|colchicine|mesh-list
44916186|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
44916187|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916188|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916189|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916190|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916191|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916192|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916193|NCT03859973|BI 425809|bi 425809|mesh-list
44784620|NCT01930812|Listerine|listerine|mesh-list
44916194|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
44916195|NCT03812224|Erenumab|erenumab|mesh-list
44916196|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44916197|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916198|NCT03812224|Analgesics|analgesics|mesh-ancestor
44916199|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
44916200|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916201|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916202|NCT03790800|Urapidil|urapidil|mesh-list
44916203|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44916204|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
44916205|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44916206|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
44916207|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916208|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916209|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916210|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44916211|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44916212|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44916213|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44916214|NCT03784781|Dimercaprol|dimercaprol|mesh-list
44916215|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
44916216|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
44916217|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916218|NCT03760263|Tacrolimus|tacrolimus|mesh-list
44916219|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916220|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
44916221|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916222|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44916223|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916224|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916225|NCT03747497|Linezolid|linezolid|mesh-list
44916226|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916227|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916228|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44916229|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916230|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784914|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
44916231|NCT03739710|Docetaxel|docetaxel|mesh-list
44916232|NCT03739710|Ipilimumab|ipilimumab|mesh-list
44704174|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44704175|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44704176|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44704177|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704178|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
44704179|NCT01420471|Hormones|hormones|mesh-ancestor
44704180|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704181|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704182|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704183|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
44704184|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704185|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704186|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
44710622|NCT01447212|Heroin|heroin|mesh-list
44916233|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916235|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916236|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916237|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916238|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916239|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916240|NCT03727724|Cetuximab|cetuximab|mesh-list
44916241|NCT03727724|Afatinib|afatinib|mesh-list
44916242|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916243|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916244|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44916245|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916246|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916247|NCT03720990|Cholic Acids|cholic acids|mesh-list
44916248|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916249|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
44916250|NCT03714594|Saxagliptin|saxagliptin|mesh-list
44916251|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44916252|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916253|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44916254|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916255|NCT03714594|Incretins|incretins|mesh-ancestor
44916256|NCT03714594|Hormones|hormones|mesh-ancestor
44916257|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916258|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44916259|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
44916260|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916261|NCT03679013|Acetaminophen|acetaminophen|mesh-list
44916262|NCT03679013|Gabapentin|gabapentin|mesh-list
44916263|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916264|NCT03679013|Analgesics|analgesics|mesh-ancestor
44916265|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
44785286|NCT01935141|Growth Substances|growth substances|mesh-ancestor
44916266|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916267|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916268|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
44916269|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
44916270|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44916271|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44916272|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916273|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44916274|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44916275|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44916276|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916277|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916278|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
44916279|NCT03674541|Bromides|bromides|mesh-list
44916280|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44916281|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
44916282|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44916283|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916284|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916285|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
44916286|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916287|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916288|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
44916289|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44916290|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
44916291|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44916292|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916293|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44785367|NCT01935531|Diclofenac|diclofenac|mesh-list
44916294|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44916295|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44916296|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
44916297|NCT03633630|Antacids|antacids|mesh-ancestor
44916298|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916299|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916300|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44916301|NCT03559647|Atezolizumab|atezolizumab|mesh-list
44916302|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916303|NCT03532451|Nivolumab|nivolumab|mesh-list
44916304|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916305|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916306|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916307|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916309|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916310|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
44916311|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916312|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916313|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44916314|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916315|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
44916316|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916317|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
44916318|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916319|NCT03467932|Insulin|insulin|mesh-list
44916320|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44916321|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44916322|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916323|NCT03445533|Ipilimumab|ipilimumab|mesh-list
44916324|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916325|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916326|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916327|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916328|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
44916329|NCT03431831|Naltrexone|naltrexone|mesh-list
44916330|NCT03431831|Bupropion|bupropion|mesh-list
44916331|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44916332|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44916333|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44916334|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916335|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
44916336|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916337|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44916338|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
44916339|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44916340|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44916341|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44916342|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44916343|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916344|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
44916345|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786005|NCT01939093|Thiamine|thiamine|mesh-list
44786053|NCT01939379|Acetaminophen|acetaminophen|mesh-list
44786199|NCT01939743|Analgesics|analgesics|mesh-ancestor
44916346|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44916347|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44916348|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916349|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44916350|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44916351|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916352|NCT03425201|Niraparib|niraparib|mesh-list
44916353|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44916354|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916355|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916356|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916357|NCT03417284|Melphalan|melphalan|mesh-list
44916358|NCT03417284|Lenograstim|lenograstim|mesh-list
44916359|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44916360|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
44916361|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916362|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916363|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
44916364|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916365|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916366|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44916367|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916368|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
44916369|NCT03414502|Minocycline|minocycline|mesh-list
44916370|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
44916371|NCT03414502|Adalimumab|adalimumab|mesh-list
44916372|NCT03414502|Etanercept|etanercept|mesh-list
44916373|NCT03414502|Golimumab|golimumab|mesh-list
44916374|NCT03414502|Rituximab|rituximab|mesh-list
44916375|NCT03414502|Methotrexate|methotrexate|mesh-list
44916376|NCT03414502|Abatacept|abatacept|mesh-list
44916377|NCT03414502|Azathioprine|azathioprine|mesh-list
44916378|NCT03414502|Infliximab|infliximab|mesh-list
44916379|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
44916380|NCT03414502|Leflunomide|leflunomide|mesh-list
44916381|NCT03414502|Tofacitinib|tofacitinib|mesh-list
44916386|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916387|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44916388|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
44916389|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44916390|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916391|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
44916392|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916393|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
44916394|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916395|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44916396|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916397|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44916398|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916399|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
44916400|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44916401|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44916402|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916403|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916404|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44916405|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916406|NCT03414502|Analgesics|analgesics|mesh-ancestor
44786680|NCT01942551|Tadalafil|tadalafil|mesh-list
44786777|NCT01943487|Verapamil|verapamil|mesh-list
44916407|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
44916408|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916409|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916410|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916411|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44916412|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44916413|NCT03396445|Paclitaxel|paclitaxel|mesh-list
44916414|NCT03396445|Carboplatin|carboplatin|mesh-list
44916415|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
44916416|NCT03396445|Pemetrexed|pemetrexed|mesh-list
44916417|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44916418|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916419|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916420|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916421|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916422|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916423|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916424|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916425|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44916426|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44916427|NCT03389724|Captopril|captopril|mesh-list
44916428|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44916429|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
44916430|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916431|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916432|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44916433|NCT03319667|Dexamethasone|dexamethasone|mesh-list
44916434|NCT03319667|Lenalidomide|lenalidomide|mesh-list
44916435|NCT03319667|Bortezomib|bortezomib|mesh-list
44916436|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916437|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
44916438|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
44916439|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916440|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916441|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916442|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
44916443|NCT03319667|Hormones|hormones|mesh-ancestor
44916444|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916445|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44916446|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916447|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
44916448|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786916|NCT01944384|Diuretics|diuretics|mesh-ancestor
44916449|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916450|NCT03319667|Growth Substances|growth substances|mesh-ancestor
44916451|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916452|NCT03310125|Colchicine|colchicine|mesh-list
44916453|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
44916454|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916455|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916456|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916457|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916458|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916459|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916460|NCT03301415|Valganciclovir|valganciclovir|mesh-list
44916461|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
44916462|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916463|NCT03236857|Venetoclax|venetoclax|mesh-list
44916464|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916465|NCT03226418|Cytarabine|cytarabine|mesh-list
44916466|NCT03226418|Azacitidine|azacitidine|mesh-list
44916467|NCT03226418|Decitabine|decitabine|mesh-list
44916468|NCT03226418|Daunorubicin|daunorubicin|mesh-list
44916469|NCT03226418|Venetoclax|venetoclax|mesh-list
44916470|NCT03226418|Idarubicin|idarubicin|mesh-list
44916471|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916472|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
44916473|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916474|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916475|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
44916476|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916477|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916478|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
44916479|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916480|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916481|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44916482|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44916483|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44916484|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
44916485|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
44916486|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44916487|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44916488|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916489|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916490|NCT03199612|Urological Agents|urological agents|mesh-ancestor
44916491|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
44916492|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916493|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916494|NCT03070184|Metoprolol|metoprolol|mesh-list
44704187|NCT01420523|Maraviroc|maraviroc|mesh-list
44704188|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44704189|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44704190|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
44704191|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704192|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44704193|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44704194|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704195|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704196|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44704197|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44704198|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44704199|NCT01420575|Olanzapine|olanzapine|mesh-list
44704200|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
44704201|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
44704202|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704203|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704204|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44704205|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44704206|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704207|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704208|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704209|NCT01420575|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44704210|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44704211|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704212|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704213|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704214|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
44704215|NCT01420666|Acetaminophen|acetaminophen|mesh-list
44704216|NCT01420666|Ibuprofen|ibuprofen|mesh-list
44704217|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704218|NCT01420666|Analgesics|analgesics|mesh-ancestor
44710855|NCT01448746|Dalteparin|dalteparin|mesh-list
44916495|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44916496|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44916497|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
44916498|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
44916499|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787203|NCT05165082|Timolol|timolol|mesh-list
44916500|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916501|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44916502|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44916503|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44916504|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44916505|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916506|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916507|NCT02939209|Hydromorphone|hydromorphone|mesh-list
44916508|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44916509|NCT02939209|Narcotics|narcotics|mesh-ancestor
44916510|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916511|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916512|NCT02939209|Analgesics|analgesics|mesh-ancestor
44916513|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
44916514|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916515|NCT02924324|Propofol|propofol|mesh-list
44916516|NCT02924324|Ropivacaine|ropivacaine|mesh-list
44916517|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44916518|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916519|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916520|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44916521|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
44787577|NCT03148366|Ofloxacin|ofloxacin|mesh-list
44916522|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
44916523|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
44916524|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
44916525|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916526|NCT02902198|Quinine|quinine|mesh-list
44916527|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
44916528|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44916529|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44916530|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916531|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44916532|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916533|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44916534|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916535|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44916536|NCT02902198|Analgesics|analgesics|mesh-ancestor
44916537|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
44916538|NCT02842424|Ramipril|ramipril|mesh-list
44916539|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44916540|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44916541|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916542|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916543|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44916544|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
44916545|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916546|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916547|NCT02685826|Dexamethasone|dexamethasone|mesh-list
44916548|NCT02685826|Lenalidomide|lenalidomide|mesh-list
44916549|NCT02685826|Durvalumab|durvalumab|mesh-list
44916550|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916551|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
44916552|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
44916553|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916554|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916555|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916556|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
44916557|NCT02685826|Hormones|hormones|mesh-ancestor
44916558|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916559|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44916560|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916561|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
44916562|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44916563|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916564|NCT02685826|Growth Substances|growth substances|mesh-ancestor
44916565|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916566|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916567|NCT02664935|Docetaxel|docetaxel|mesh-list
44916568|NCT02664935|Durvalumab|durvalumab|mesh-list
44916569|NCT02664935|Palbociclib|palbociclib|mesh-list
44916570|NCT02664935|Osimertinib|osimertinib|mesh-list
44916571|NCT02664935|Crizotinib|crizotinib|mesh-list
44916572|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787970|NCT05167760|Apraclonidine|apraclonidine|mesh-list
44704219|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
44916573|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916574|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916575|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916576|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916577|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916578|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44916579|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916580|NCT02572167|Nivolumab|nivolumab|mesh-list
44916581|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44916582|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916583|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916584|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916585|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916586|NCT02561273|Prednisone|prednisone|mesh-list
44916587|NCT02561273|Cortisone|cortisone|mesh-list
44916588|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
44916589|NCT02561273|Doxorubicin|doxorubicin|mesh-list
44916590|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44916591|NCT02561273|Etoposide|etoposide|mesh-list
44916592|NCT02561273|Vincristine|vincristine|mesh-list
44916593|NCT02561273|Lenalidomide|lenalidomide|mesh-list
44916594|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
44916595|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
44916596|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916597|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
44916598|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916599|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916600|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916601|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
44916602|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916603|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916604|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44916605|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44916606|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44916607|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44916608|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916609|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44916610|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
44916611|NCT02561273|Hormones|hormones|mesh-ancestor
44916612|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788370|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
44916613|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44916614|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44916615|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916616|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916617|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916618|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44916619|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916620|NCT02561273|Growth Substances|growth substances|mesh-ancestor
44916621|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916622|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
44916623|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44916624|NCT02430233|Progesterone|progesterone|mesh-list
44916625|NCT02430233|Progestins|progestins|mesh-ancestor
44916626|NCT02430233|Hormones|hormones|mesh-ancestor
44916627|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916628|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916629|NCT02410317|Morphine|morphine|mesh-list
44916630|NCT02410317|Ropivacaine|ropivacaine|mesh-list
44916631|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44916632|NCT02410317|Narcotics|narcotics|mesh-ancestor
44916633|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916634|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916635|NCT02410317|Analgesics|analgesics|mesh-ancestor
44916636|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
44916637|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916638|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
44916639|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
44916640|NCT02392559|Evolocumab|evolocumab|mesh-list
44916641|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44916642|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44916643|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
44916644|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916645|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916646|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
44916647|NCT02334124|Floxacillin|floxacillin|mesh-list
44916648|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916649|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916650|NCT02282358|Mocetinostat|mocetinostat|mesh-list
44916651|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44916652|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916653|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916654|NCT02258451|Everolimus|everolimus|mesh-list
44916655|NCT02258451|Exemestane|exemestane|mesh-list
44916656|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44916657|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916658|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916659|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
44916660|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916661|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44916662|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44916663|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916664|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916665|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44916666|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
44916667|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916668|NCT02115139|Ipilimumab|ipilimumab|mesh-list
44916669|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916670|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916671|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916672|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916673|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
44788535|NCT01442246|Leuprolide|leuprolide|mesh-list
44916674|NCT02061293|Promethazine|promethazine|mesh-list
44916675|NCT02061293|Psilocybin|psilocybin|mesh-list
44916676|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44916677|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44916678|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916679|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916680|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
44916681|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
44916682|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
44916683|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916684|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
44916685|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
44916686|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916687|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44916688|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
44916689|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
44916690|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916691|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916692|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44916693|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
44916694|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44916695|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
44916696|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44916697|NCT02047981|Azithromycin|azithromycin|mesh-list
44916698|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44916699|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916700|NCT01982955|Cisplatin|cisplatin|mesh-list
44916701|NCT01982955|Carboplatin|carboplatin|mesh-list
44916702|NCT01982955|Pemetrexed|pemetrexed|mesh-list
44916703|NCT01982955|Gefitinib|gefitinib|mesh-list
44916704|NCT01982955|Tepotinib|tepotinib|mesh-list
44916705|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916706|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916707|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916708|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44916709|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44916710|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44916711|NCT01763866|Atorvastatin|atorvastatin|mesh-list
44916712|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44916713|NCT01763866|Simvastatin|simvastatin|mesh-list
44916714|NCT01763866|Ezetimibe|ezetimibe|mesh-list
44916715|NCT01763866|Evolocumab|evolocumab|mesh-list
44916716|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44916717|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44916718|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44916719|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
44916720|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916721|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916722|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44916723|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916724|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
44916725|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916726|NCT01763827|Ezetimibe|ezetimibe|mesh-list
44916727|NCT01763827|Evolocumab|evolocumab|mesh-list
44916728|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44916729|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44916730|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44916731|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
44916732|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916733|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916734|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
44916735|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916736|NCT01732783|Panitumumab|panitumumab|mesh-list
44916737|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916738|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916739|NCT01693783|Ipilimumab|ipilimumab|mesh-list
44916740|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916741|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916742|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44916743|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916744|NCT01631214|Alendronate|alendronate|mesh-list
44916745|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44916746|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44916747|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916748|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
44916749|NCT01375777|Ezetimibe|ezetimibe|mesh-list
44916750|NCT01375777|Evolocumab|evolocumab|mesh-list
44788802|NCT05251493|Iron|iron|mesh-list
44788817|NCT05216952|Misoprostol|misoprostol|mesh-list
44916751|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44916752|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44916753|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44916754|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
44916755|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916756|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44916757|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
44788889|NCT04875715|Hydroquinone|hydroquinone|mesh-list
44789106|NCT03712228|Antibodies|antibodies|mesh-list
44916758|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916759|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
44916760|NCT01345019|Denosumab|denosumab|mesh-list
44916761|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44916762|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916763|NCT01265537|Tacrolimus|tacrolimus|mesh-list
44916764|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916765|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
44916766|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916767|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44916768|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916769|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916770|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
44916771|NCT01145209|Fludarabine|fludarabine|mesh-list
44916772|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
44916773|NCT01145209|Ofatumumab|ofatumumab|mesh-list
44916774|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916775|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
44916776|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916777|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916778|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916779|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
44916780|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916781|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916782|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44916783|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916784|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
44916785|NCT00911820|Bevacizumab|bevacizumab|mesh-list
44916786|NCT00911820|Cisplatin|cisplatin|mesh-list
44916787|NCT00911820|Docetaxel|docetaxel|mesh-list
44916788|NCT00911820|Irinotecan|irinotecan|mesh-list
44916789|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916790|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916791|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44916792|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916793|NCT00911820|Growth Substances|growth substances|mesh-ancestor
44916794|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916795|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916796|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916797|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916798|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916799|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916800|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44916801|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44916802|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916803|NCT00876031|Etoposide|etoposide|mesh-list
44916804|NCT00876031|Idarubicin|idarubicin|mesh-list
44916805|NCT00876031|Trofosfamide|trofosfamide|mesh-list
44916806|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44916807|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916808|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44916809|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44916810|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916811|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916812|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44916813|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916814|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
44916815|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916816|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44916817|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
44916818|NCT00845026|Olanzapine|olanzapine|mesh-list
44916819|NCT00845026|Risperidone|risperidone|mesh-list
44916820|NCT00845026|Aripiprazole|aripiprazole|mesh-list
44916821|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44916822|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
44916823|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916824|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916825|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916826|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44916827|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44916828|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916829|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44916830|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44916831|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
44916832|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
44916833|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
44916834|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916835|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44916836|NCT00845026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44916837|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44916838|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44916839|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
44916840|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
44916841|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44916842|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44916843|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44916844|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44916845|NCT00807859|Paclitaxel|paclitaxel|mesh-list
44789588|NCT01946906|Rifaximin|rifaximin|mesh-list
44916846|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44916847|NCT00807859|Capecitabine|capecitabine|mesh-list
44916848|NCT00807859|Trastuzumab|trastuzumab|mesh-list
44916849|NCT00807859|Lapatinib|lapatinib|mesh-list
44916850|NCT00807859|Trebananib|trebananib|mesh-list
44916851|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44916852|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916853|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44916854|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44916855|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44916856|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916857|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916858|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
44916859|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44916860|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44916861|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916862|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44916863|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916864|NCT00807859|Growth Substances|growth substances|mesh-ancestor
44916865|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916866|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916867|NCT00396279|Vitamin D|vitamin d|mesh-list
44916868|NCT00396279|Denosumab|denosumab|mesh-list
44704220|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704221|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704222|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
44704223|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704224|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704225|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704226|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44704227|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711202|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916869|NCT00396279|Calcium|calcium|mesh-list
44916895|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
44916896|NCT00093015|Hematinics|hematinics|mesh-ancestor
44916897|NCT00089791|Denosumab|denosumab|mesh-list
44916898|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44916899|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916900|NCT00003838|Cyclosporine|cyclosporine|mesh-list
44916901|NCT00003838|Methotrexate|methotrexate|mesh-list
44916902|NCT00003838|Cyclosporins|cyclosporins|mesh-list
44916903|NCT00003838|Lenograstim|lenograstim|mesh-list
44916904|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44916905|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
44916906|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44916907|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916908|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44916909|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
44916910|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916911|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916912|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44916913|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44916914|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44789857|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
44789944|NCT01949129|Busulfan|busulfan|mesh-list
44790008|NCT01949571|Mirtazapine|mirtazapine|mesh-list
44916915|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44916916|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
44916917|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44916918|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44916919|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
44916920|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916921|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44916922|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44711267|NCT01457508|Edetic Acid|edetic acid|mesh-list
44916923|NCT05382871|Vaccines|vaccines|mesh-list
44916924|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
44916925|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916926|NCT05335018|Lenalidomide|lenalidomide|mesh-list
44916927|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
44916928|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916929|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44916930|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44916931|NCT05335018|Growth Substances|growth substances|mesh-ancestor
44916932|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44916933|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44916934|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
44916935|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44916936|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44916937|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44916938|NCT05282940|Estradiol|estradiol|mesh-list
44916939|NCT05282940|Estrogens|estrogens|mesh-ancestor
44916940|NCT05282940|Hormones|hormones|mesh-ancestor
44916941|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44916942|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916943|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44916944|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
44916945|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44916946|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44916947|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44916948|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44916949|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44916950|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44916951|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44916952|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44916953|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44916954|NCT05255484|Antibodies|antibodies|mesh-list
44916955|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
44916956|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916957|NCT05173688|Propofol|propofol|mesh-list
44916958|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44916959|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916960|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916961|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44916962|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
44916963|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
44916964|NCT05161156|Bromides|bromides|mesh-list
44916965|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
44916966|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44916967|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
44916968|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44916969|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916970|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44916971|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
44916972|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
44916973|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44916974|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
44916975|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44916976|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916977|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
44916978|NCT05160363|Piperaquine|piperaquine|mesh-list
44916979|NCT05160363|Pyronaridine|pyronaridine|mesh-list
44916980|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
44916981|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44916982|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44916983|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44916984|NCT05158998|Propofol|propofol|mesh-list
44916985|NCT05158998|Sevoflurane|sevoflurane|mesh-list
44916986|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44916987|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44916988|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916989|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44916990|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
44916991|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
44790381|NCT01951846|Nintedanib|nintedanib|mesh-list
44916992|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44916993|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44916994|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
44916995|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44916996|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44916997|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44916998|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44916999|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
44917000|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44917001|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
44917002|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917003|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
44917004|NCT05086939|Protective Agents|protective agents|mesh-ancestor
44917005|NCT05055024|Mazindol|mazindol|mesh-list
44917006|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44917007|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917008|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44917009|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44917010|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917011|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917012|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917013|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917014|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44917015|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
44917016|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44917017|NCT05039073|Nivolumab|nivolumab|mesh-list
44917018|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44917019|NCT05039073|Antibodies|antibodies|mesh-list
44917020|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
44917021|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44917022|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
44917023|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
44917024|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917025|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917026|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44917027|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917028|NCT05000047|Silicon|silicon|mesh-list
44917029|NCT05000047|Trace Elements|trace elements|mesh-ancestor
44917030|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
44917031|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917032|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
44917033|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44917034|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
44917035|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917036|NCT04982146|Expectorants|expectorants|mesh-ancestor
44917037|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
44917038|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44917039|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
44917040|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917041|NCT04982146|Protective Agents|protective agents|mesh-ancestor
44917042|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917043|NCT04982146|Antidotes|antidotes|mesh-ancestor
44917044|NCT04971746|Pirfenidone|pirfenidone|mesh-list
44917045|NCT04971746|Nintedanib|nintedanib|mesh-list
44917046|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917047|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917048|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917049|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917050|NCT04971746|Analgesics|analgesics|mesh-ancestor
44917051|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
44917052|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917053|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917054|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704228|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704229|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
44704230|NCT01420692|Gliclazide|gliclazide|mesh-list
44704231|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704232|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704233|NCT01420822|Fluticasone|fluticasone|mesh-list
44704234|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704235|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44704236|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
44790774|NCT01954043|Rifampin|rifampin|mesh-list
44790851|NCT01954784|Fludarabine|fludarabine|mesh-list
44704237|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704238|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704239|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44704240|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
44704241|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
44704242|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44704243|NCT01420900|Tacrine|tacrine|mesh-list
44704244|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44704245|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711423|NCT01460797|Metformin|metformin|mesh-list
44917087|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917088|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917089|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917090|NCT04813016|Analgesics|analgesics|mesh-ancestor
44917091|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
44917092|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917093|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44917094|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917095|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917096|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917097|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917098|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917099|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44917100|NCT04813016|Narcotics|narcotics|mesh-ancestor
44711476|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
44917102|NCT04778982|Palbociclib|palbociclib|mesh-list
44917103|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44917104|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917105|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44917106|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44917107|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570151|NCT01028391|Incretins|incretins|mesh-ancestor
44791102|NCT01955967|Lidocaine|lidocaine|mesh-list
44917108|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917109|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917110|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917111|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917112|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917113|NCT04776447|Carboplatin|carboplatin|mesh-list
44791412|NCT01958684|Copper|copper|mesh-list
44917114|NCT04776447|Atezolizumab|atezolizumab|mesh-list
44917115|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917116|NCT04744480|Anesthetics|anesthetics|mesh-list
44917117|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917118|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917119|NCT04729543|Azacitidine|azacitidine|mesh-list
44917120|NCT04729543|Interleukin-2|interleukin-2|mesh-list
44917121|NCT04729543|Valproic Acid|valproic acid|mesh-list
44917122|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917123|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
44917124|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917125|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917126|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791676|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44917127|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917128|NCT04729543|Analgesics|analgesics|mesh-ancestor
44917129|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
44917130|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917131|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917132|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
44917133|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
44917134|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917135|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
44917136|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44917137|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917138|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917139|NCT04718792|Psilocybin|psilocybin|mesh-list
44917140|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
44917141|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917142|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917143|NCT04707391|Vaccines|vaccines|mesh-list
44917144|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
44917145|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917146|NCT04669457|Midazolam|midazolam|mesh-list
44917147|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
44917148|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44917149|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917150|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917151|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917152|NCT04669457|Analgesics|analgesics|mesh-ancestor
44917153|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
44917154|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917155|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44917156|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917157|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917158|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917159|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917160|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917161|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44917162|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44917163|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44917164|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917165|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44917166|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
44917167|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
44917168|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
44917169|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
44917170|NCT04620382|Midodrine|midodrine|mesh-list
44917171|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
44917172|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
44917173|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917174|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917175|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44917176|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44917177|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917178|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917179|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917180|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917181|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917182|NCT04564157|Paclitaxel|paclitaxel|mesh-list
44917183|NCT04564157|Carboplatin|carboplatin|mesh-list
44917184|NCT04564157|Nivolumab|nivolumab|mesh-list
44917185|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917186|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917187|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917188|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917189|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917190|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917191|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917192|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44704246|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704247|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44704248|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704249|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704250|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44704251|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
44704252|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704253|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
44704254|NCT01420913|Pregabalin|pregabalin|mesh-list
44704255|NCT01420913|Analgesics|analgesics|mesh-ancestor
44704256|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
44704257|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704258|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704259|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
44704260|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44704261|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704262|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704263|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704264|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44704265|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704266|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704267|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704268|NCT01421043|Triazolam|triazolam|mesh-list
44704269|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44704270|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44704271|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704272|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704273|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704274|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704275|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
44704276|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
44704277|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704278|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704279|NCT01421121|Vaccines|vaccines|mesh-list
44704280|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
44704281|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704282|NCT01421160|Citric Acid|citric acid|mesh-list
44704283|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
44704284|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
44704285|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44704286|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
44704287|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
44704288|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704289|NCT01421173|Gemcitabine|gemcitabine|mesh-list
44704290|NCT01421173|Dexamethasone|dexamethasone|mesh-list
44791972|NCT01963546|Analgesics|analgesics|mesh-ancestor
44792121|NCT01964170|Goserelin|goserelin|mesh-list
44792261|NCT01964586|Analgesics|analgesics|mesh-ancestor
44704291|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
44704292|NCT01421173|Rituximab|rituximab|mesh-list
44704293|NCT01421173|Melphalan|melphalan|mesh-list
44704294|NCT01421173|Busulfan|busulfan|mesh-list
44704295|NCT01421173|Vorinostat|vorinostat|mesh-list
44704296|NCT01421173|BB 1101|bb 1101|mesh-list
44704297|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44704298|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704299|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
44704300|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704301|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704302|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704303|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
44704304|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
44704305|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711632|NCT01463332|Analgesics|analgesics|mesh-ancestor
44917193|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
44917194|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44917195|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
44917196|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917197|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917198|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44917199|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
44917200|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44917201|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
44917202|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917203|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917204|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44917205|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44917206|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
44917207|NCT04460183|Protective Agents|protective agents|mesh-ancestor
44917208|NCT04006288|Aspirin|aspirin|mesh-list
44917209|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
44917210|NCT04006288|Clopidogrel|clopidogrel|mesh-list
44917211|NCT04006288|Ticagrelor|ticagrelor|mesh-list
44917212|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44917213|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44917214|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917215|NCT04006288|Analgesics|analgesics|mesh-ancestor
44917216|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
44917217|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917218|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917219|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917220|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917221|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44917222|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44792396|NCT01965405|Bupropion|bupropion|mesh-list
44917223|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917224|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44917225|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44917226|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917227|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
44917228|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44917229|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44917230|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44917231|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
44917232|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917233|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44917234|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
44917235|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44917236|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
44917237|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
44917238|NCT03942328|Vaccines|vaccines|mesh-list
44917239|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
44917240|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917241|NCT03898895|Antibodies|antibodies|mesh-list
44917242|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
44917243|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917244|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
44917245|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917246|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917247|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
44917248|NCT03733145|Giapreza|giapreza|mesh-list
44917249|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
44917250|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44917251|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44917252|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
44917253|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917254|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917255|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44917256|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917257|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44917258|NCT03625141|Atezolizumab|atezolizumab|mesh-list
44917259|NCT03625141|Vemurafenib|vemurafenib|mesh-list
44917260|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917261|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917262|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917263|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917264|NCT03530800|Dronabinol|dronabinol|mesh-list
44917265|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
44917266|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917267|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917268|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711644|NCT01463592|Iodine|iodine|mesh-list
44917270|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
44917271|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917272|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44917273|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44917274|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917275|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917276|NCT03530800|Hormones|hormones|mesh-ancestor
44917277|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917278|NCT03518606|Durvalumab|durvalumab|mesh-list
44917279|NCT03518606|Vinorelbine|vinorelbine|mesh-list
44917280|NCT03518606|Tremelimumab|tremelimumab|mesh-list
44917281|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917282|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917283|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917284|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917285|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917286|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917287|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917288|NCT03477175|Sorafenib|sorafenib|mesh-list
44917289|NCT03477175|Lenvatinib|lenvatinib|mesh-list
44917290|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917291|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917292|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917293|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917294|NCT03439891|Nivolumab|nivolumab|mesh-list
44917295|NCT03439891|Sorafenib|sorafenib|mesh-list
44917296|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917297|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917298|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44917299|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917300|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917301|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917302|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
44917303|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44917304|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
44917305|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917306|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
44917307|NCT03431584|Protective Agents|protective agents|mesh-ancestor
44917308|NCT03412643|Paclitaxel|paclitaxel|mesh-list
44917309|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
44917310|NCT03412643|Doxorubicin|doxorubicin|mesh-list
44917311|NCT03412643|Trastuzumab|trastuzumab|mesh-list
44917312|NCT03412643|Pertuzumab|pertuzumab|mesh-list
44917313|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917314|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917315|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917316|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917317|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917318|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793017|NCT01969149|Insulin|insulin|mesh-list
44793034|NCT01969357|Hormones|hormones|mesh-ancestor
44793177|NCT01970202|Enoxaparin|enoxaparin|mesh-list
44917319|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917320|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
44917321|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917322|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917323|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917324|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
44917325|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44917326|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44917327|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44917328|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44917329|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917330|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917331|NCT03380455|Cimetidine|cimetidine|mesh-list
44917332|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44917333|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44917334|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44917335|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
44917336|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
44917337|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917338|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917339|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917340|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44917341|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44711722|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44917342|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917343|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
44917344|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917345|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
44917346|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917347|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917348|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917349|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
44917350|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917351|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917352|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44917353|NCT03172624|Nivolumab|nivolumab|mesh-list
44917354|NCT03172624|Ipilimumab|ipilimumab|mesh-list
44917355|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917356|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917357|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44917358|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917359|NCT03113123|Tenofovir|tenofovir|mesh-list
44917360|NCT03113123|Emtricitabine|emtricitabine|mesh-list
44917361|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44917362|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
44917363|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917364|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44917365|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44917366|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917367|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917368|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44917369|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44917370|NCT03106324|Lenalidomide|lenalidomide|mesh-list
44917371|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
44917372|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917373|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44917374|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44793253|NCT01971047|Insulin|insulin|mesh-list
44917375|NCT03106324|Growth Substances|growth substances|mesh-ancestor
44917376|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44917377|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917378|NCT03063203|Decitabine|decitabine|mesh-list
44917379|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917380|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
44917381|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917382|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917383|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917384|NCT03015896|Nivolumab|nivolumab|mesh-list
44917385|NCT03015896|Lenalidomide|lenalidomide|mesh-list
44917386|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917387|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917388|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44917389|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917390|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
44917391|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917392|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44917393|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44917394|NCT03015896|Growth Substances|growth substances|mesh-ancestor
44917395|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44917396|NCT02938923|Testosterone|testosterone|mesh-list
44917397|NCT02938923|Androgens|androgens|mesh-ancestor
44917398|NCT02938923|Hormones|hormones|mesh-ancestor
44917399|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917400|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917401|NCT02780310|Lenvatinib|lenvatinib|mesh-list
44917402|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917403|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917404|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917405|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917406|NCT02713386|Paclitaxel|paclitaxel|mesh-list
44917407|NCT02713386|Carboplatin|carboplatin|mesh-list
44917408|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44917409|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917410|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917411|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917412|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917413|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917414|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917415|NCT02671890|Gemcitabine|gemcitabine|mesh-list
44917443|NCT02526004|Tobramycin|tobramycin|mesh-list
44917444|NCT02526004|Ceftazidime|ceftazidime|mesh-list
44917445|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44917446|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917447|NCT02452983|Sertraline|sertraline|mesh-list
44917448|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
44917449|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917450|NCT02452983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44917451|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44704306|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44704307|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
44704308|NCT01421173|Hormones|hormones|mesh-ancestor
44704309|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704310|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704311|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44704312|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
44704313|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704314|NCT01421173|Antiviral Agents|antiviral agents|mesh-ancestor
44704315|NCT01421173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704316|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704317|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704318|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44704319|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
44704320|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44704321|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44704322|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
44704323|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
44704324|NCT01421212|Antibodies|antibodies|mesh-list
44704325|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
44704326|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44704327|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44704328|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
44704329|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
44704330|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704331|NCT01421264|Gabapentin|gabapentin|mesh-list
44704332|NCT01421264|Analgesics|analgesics|mesh-ancestor
44704333|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
44704334|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704335|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704336|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
44704337|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44704338|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704339|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704340|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704341|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44704342|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44704343|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704344|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704345|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
44704346|NCT01421368|Tenofovir|tenofovir|mesh-list
44704347|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44704348|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
44704349|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
44704350|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
44704351|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
44704352|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704353|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44704354|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44704355|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704356|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704357|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44704358|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44704359|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44704360|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704361|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44704362|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44704363|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44704364|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44704365|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44704366|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44255762|NCT00616876|Lactulose|lactulose|mesh-list
44704367|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704368|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
44704369|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
44704370|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44917452|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917453|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917454|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917455|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
44917456|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917457|NCT02348203|Aspirin|aspirin|mesh-list
44917458|NCT02348203|Zileuton|zileuton|mesh-list
44917459|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44917460|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917461|NCT02348203|Analgesics|analgesics|mesh-ancestor
44917462|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
44917463|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917464|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917465|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917466|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917467|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44917468|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44917469|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917470|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44917471|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44917472|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917473|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
44917474|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44917475|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44917476|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
44917477|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917478|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
44917479|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44917480|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
44917481|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917482|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
44917483|NCT02287428|Temozolomide|temozolomide|mesh-list
44917484|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917485|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917486|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917487|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
44917488|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917489|NCT01967238|Vaccines|vaccines|mesh-list
44917490|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
44917491|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917492|NCT01883297|Aldesleukin|aldesleukin|mesh-list
44917493|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
44917494|NCT01883297|Interleukin-2|interleukin-2|mesh-list
44917495|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917496|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
44917497|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917498|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794290|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
44917499|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917500|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
44917501|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917502|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917503|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44917504|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917505|NCT01883297|Analgesics|analgesics|mesh-ancestor
44917506|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
44917507|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917508|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44917509|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44917510|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
44917511|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917512|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
44917513|NCT01864109|Temozolomide|temozolomide|mesh-list
44917514|NCT01864109|Ifosfamide|ifosfamide|mesh-list
44917515|NCT01864109|Doxorubicin|doxorubicin|mesh-list
44917516|NCT01864109|Irinotecan|irinotecan|mesh-list
44917517|NCT01864109|Etoposide|etoposide|mesh-list
44917518|NCT01864109|Vincristine|vincristine|mesh-list
44917519|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
44917520|NCT01864109|Razoxane|razoxane|mesh-list
44917521|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917522|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
44917523|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917524|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917525|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917526|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
44917527|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917528|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917529|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44794463|NCT01980329|Maraviroc|maraviroc|mesh-list
44794635|NCT01981525|Metformin|metformin|mesh-list
44917530|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44917531|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44917532|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44917533|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917534|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44917535|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917536|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917537|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917538|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917539|NCT01864109|Protective Agents|protective agents|mesh-ancestor
44917540|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44917541|NCT01862315|Gemcitabine|gemcitabine|mesh-list
44917542|NCT01862315|Dexamethasone|dexamethasone|mesh-list
44917543|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
44917544|NCT01862315|Floxuridine|floxuridine|mesh-list
44917545|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917546|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
44917547|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
44917548|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917549|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917550|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44917551|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
44917552|NCT01862315|Hormones|hormones|mesh-ancestor
44917553|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917554|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44917555|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917556|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917557|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
44917558|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917559|NCT01862315|Antiviral Agents|antiviral agents|mesh-ancestor
44917560|NCT01862315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917561|NCT01862315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917562|NCT01862315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917563|NCT01862315|Immunologic Factors|immunologic factors|mesh-ancestor
44917564|NCT00999804|Trastuzumab|trastuzumab|mesh-list
44917565|NCT00999804|Letrozole|letrozole|mesh-list
44917566|NCT00999804|Lapatinib|lapatinib|mesh-list
44917567|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917568|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917569|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44917570|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44917571|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917572|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917573|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44917574|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
44917575|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917576|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917577|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917578|NCT00458003|Phenylephrine|phenylephrine|mesh-list
44917579|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
44917580|NCT00458003|Ephedrine|ephedrine|mesh-list
44917581|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44917582|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
44917583|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
44917584|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917585|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917586|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
44917587|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44917588|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
44917589|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
44917590|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44917591|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917592|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917593|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917594|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917595|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917596|NCT00458003|Protective Agents|protective agents|mesh-ancestor
44917597|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44917598|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
44917599|NCT03916679|Fludarabine|fludarabine|mesh-list
44917600|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917601|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
44794709|NCT01982201|Renal Agents|renal agents|mesh-ancestor
44917602|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712035|NCT01467986|Sirolimus|sirolimus|mesh-list
44917603|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917604|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44917605|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
44917606|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917607|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917608|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44917609|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
44917610|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44917611|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917612|NCT03916250|Petrolatum|petrolatum|mesh-list
44917613|NCT03916250|PF-06700841|pf-06700841|mesh-list
44917614|NCT03916250|Emollients|emollients|mesh-ancestor
44917615|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44917616|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917617|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917618|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917619|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44917620|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44917621|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
44917622|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44917623|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795099|NCT01984931|Medazepam|medazepam|mesh-list
44917624|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44917625|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44917626|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44917627|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917628|NCT03916510|Capecitabine|capecitabine|mesh-list
44917629|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44917630|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
44917631|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917632|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917633|NCT03916432|Sirolimus|sirolimus|mesh-list
44917634|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44917635|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917636|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44795371|NCT01986322|Vaccines|vaccines|mesh-list
44917637|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917638|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
44917639|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44917640|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
44917641|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917642|NCT03916406|Midazolam|midazolam|mesh-list
44917643|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44795576|NCT01987739|Zolpidem|zolpidem|mesh-list
44917644|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44917645|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917646|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917647|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44917648|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44917649|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917650|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44917651|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
44917652|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
44917653|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
44917654|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
44917655|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917656|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917657|NCT03915938|Ketamine|ketamine|mesh-list
44917658|NCT03915938|Analgesics|analgesics|mesh-ancestor
44917659|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
44795808|NCT01989897|Phenol|phenol|mesh-list
44795909|NCT01990755|Olanzapine|olanzapine|mesh-list
44917660|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917661|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917662|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44917663|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44917664|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
44917665|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
44917666|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917667|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44917668|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44917669|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917670|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917671|NCT03915366|Valganciclovir|valganciclovir|mesh-list
44917672|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
44917673|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
44917674|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44917675|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712129|NCT01468415|Phenol|phenol|mesh-list
44917676|NCT03915444|Gemcitabine|gemcitabine|mesh-list
44917677|NCT03915444|Paclitaxel|paclitaxel|mesh-list
44917710|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917711|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917712|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44917713|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
44917714|NCT03914963|Coagulants|coagulants|mesh-ancestor
44917715|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
44917716|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917717|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704371|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704372|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44917719|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917720|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917721|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917722|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917723|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
44917724|NCT03914690|Hematinics|hematinics|mesh-ancestor
44917725|NCT03914638|Albuterol|albuterol|mesh-list
44917726|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44917727|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
44917728|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917729|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917730|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44917731|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
44917732|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
44917733|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44917734|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44917735|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44917736|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917737|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917738|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917739|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917740|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
44917741|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
44917742|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917743|NCT03914404|Protective Agents|protective agents|mesh-ancestor
44917744|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917745|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
44917746|NCT03914404|Vitamins|vitamins|mesh-ancestor
44917747|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
44917748|NCT03914677|Mecamylamine|mecamylamine|mesh-list
44917749|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44917750|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44796090|NCT01991626|Iron|iron|mesh-list
44796128|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
44917751|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
44917752|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917753|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917754|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44917755|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44917756|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
44917757|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917758|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917759|NCT03914534|Valproic Acid|valproic acid|mesh-list
44917760|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
44917761|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917762|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917763|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
44917764|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917765|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917766|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
44917767|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44917768|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917769|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917770|NCT03914352|Antibodies|antibodies|mesh-list
44917771|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
44917772|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917773|NCT03914118|Modafinil|modafinil|mesh-list
44917774|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44917775|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917776|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44917777|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44917778|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44917779|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917780|NCT03914092|Triamcinolone|triamcinolone|mesh-list
44917781|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44917782|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44917783|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44917784|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917785|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
44917786|NCT03914092|Hormones|hormones|mesh-ancestor
44917787|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917788|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917789|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796439|NCT01994460|Linezolid|linezolid|mesh-list
44917790|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
44917791|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917792|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917793|NCT03913884|Mitogens|mitogens|mesh-list
44917794|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44796629|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
44796727|NCT01996150|Eusol|eusol|mesh-list
44917795|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917796|NCT03914235|Lidocaine|lidocaine|mesh-list
44917797|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
44917798|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
44917799|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917800|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917801|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
44917802|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917803|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44917804|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44917805|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44917806|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917807|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917808|NCT03913858|Anesthetics|anesthetics|mesh-list
44917809|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917810|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917811|NCT03913650|Bupivacaine|bupivacaine|mesh-list
44917812|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
44917813|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
44917814|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917815|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917816|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
44917817|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917818|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
44917819|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44917820|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44917821|NCT03913702|Prednisolone|prednisolone|mesh-list
44917822|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
44917823|NCT03913702|Ketorolac|ketorolac|mesh-list
44917824|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44917825|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44917826|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
44917827|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44917828|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
44917829|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
44917830|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917831|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917832|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44917833|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
44917834|NCT03913702|Hormones|hormones|mesh-ancestor
44917835|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44917836|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44917837|NCT03913702|Protective Agents|protective agents|mesh-ancestor
44917838|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44917839|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917840|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44917841|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917842|NCT03913702|Analgesics|analgesics|mesh-ancestor
44917843|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
44917844|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44917845|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44917846|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935913|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44797146|NCT01998685|Fentanyl|fentanyl|mesh-list
44797224|NCT01999270|Bevacizumab|bevacizumab|mesh-list
44917847|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917848|NCT03913806|Bevacizumab|bevacizumab|mesh-list
44917849|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917850|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917851|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44917852|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44917853|NCT03913806|Growth Substances|growth substances|mesh-ancestor
44917854|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917855|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44917856|NCT03913455|Carboplatin|carboplatin|mesh-list
44917857|NCT03913455|Guadecitabine|guadecitabine|mesh-list
44917858|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917859|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
44917860|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
44917861|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917862|NCT03913468|Protective Agents|protective agents|mesh-ancestor
44917863|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917864|NCT03913468|Vitamins|vitamins|mesh-ancestor
44917865|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
44917866|NCT03912974|Citalopram|citalopram|mesh-list
44917867|NCT03912974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44917868|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44917869|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917870|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917871|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917872|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
44917873|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917874|NCT03912974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44917875|NCT03912974|Antidepressive Agents|antidepressive agents|mesh-ancestor
44917876|NCT03912974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44917877|NCT03912857|Apatinib|apatinib|mesh-list
44917878|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917879|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44917880|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917881|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917882|NCT03913182|Apatinib|apatinib|mesh-list
44917883|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917884|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44797529|NCT02001363|Hormones|hormones|mesh-ancestor
44797666|NCT02002000|Vitamin D|vitamin d|mesh-list
44917885|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917886|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917887|NCT03913052|Viscosupplements|viscosupplements|mesh-list
44917888|NCT03913052|Protective Agents|protective agents|mesh-ancestor
44917889|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917890|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
44917891|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
44917892|NCT03912766|Coagulants|coagulants|mesh-ancestor
44917893|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44917894|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44917895|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
44917896|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917897|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
44917898|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
44917899|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917900|NCT03912727|Protective Agents|protective agents|mesh-ancestor
44917901|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917902|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
44917903|NCT03912727|Vitamins|vitamins|mesh-ancestor
44917904|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
44917905|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
44917906|NCT03912740|Remifentanil|remifentanil|mesh-list
44917907|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44917908|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917909|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917910|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44917911|NCT03912740|Analgesics|analgesics|mesh-ancestor
44917912|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
44917913|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917914|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44917915|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917916|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917917|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917918|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917919|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917920|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44917921|NCT03912740|Narcotics|narcotics|mesh-ancestor
44917922|NCT03912402|Paclitaxel|paclitaxel|mesh-list
44917923|NCT03912402|Bevacizumab|bevacizumab|mesh-list
44917924|NCT03912402|Cisplatin|cisplatin|mesh-list
44917925|NCT03912402|Carboplatin|carboplatin|mesh-list
44917926|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44917927|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917928|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
44917929|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
44917930|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
44917931|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917932|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44917933|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44917934|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44797744|NCT02002286|Triptolide|triptolide|mesh-list
44917935|NCT03912402|Growth Substances|growth substances|mesh-ancestor
44917936|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917937|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
44798081|NCT02004782|Hormones|hormones|mesh-ancestor
44798203|NCT02005588|Iron|iron|mesh-list
44917938|NCT03912389|Cisplatin|cisplatin|mesh-list
44917939|NCT03912389|Carboplatin|carboplatin|mesh-list
44917940|NCT03912389|Pemetrexed|pemetrexed|mesh-list
44917941|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44917942|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44917975|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
44917976|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
44917977|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917978|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917979|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44917980|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44917981|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44917982|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44917983|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
44917984|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44917985|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917986|NCT03911648|Lidocaine|lidocaine|mesh-list
44917987|NCT03911648|Bupivacaine|bupivacaine|mesh-list
44917988|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
44917989|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
44917990|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44917991|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44917992|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
44917993|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44917994|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44704373|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44704374|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44704375|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44704376|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704377|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704378|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704379|NCT01421706|Clarithromycin|clarithromycin|mesh-list
44704380|NCT01421706|Sibutramine|sibutramine|mesh-list
44704381|NCT01421706|Clopidogrel|clopidogrel|mesh-list
44704382|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44704383|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44704384|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44704385|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44704386|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
44704387|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704388|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704389|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704390|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798266|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
44704391|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704392|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44704393|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704394|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44704395|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44704396|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
44704397|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704398|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
44704399|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44704400|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
44704401|NCT01421901|Ertapenem|ertapenem|mesh-list
44704402|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44704403|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704404|NCT01421914|Bupivacaine|bupivacaine|mesh-list
44704405|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
44704406|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
44704407|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704408|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704409|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
44704410|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704411|NCT01421927|Lenalidomide|lenalidomide|mesh-list
44704412|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
44704413|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704414|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44798481|NCT02007837|Aspirin|aspirin|mesh-list
44798630|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
44704415|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44704416|NCT01421927|Growth Substances|growth substances|mesh-ancestor
44704417|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
44704418|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704419|NCT01421940|Udenafil|udenafil|mesh-list
44704420|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44704421|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44704422|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704423|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704424|NCT01421979|Caffeine|caffeine|mesh-list
44704425|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44917995|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44917996|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44917997|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44917998|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44917999|NCT03911440|Azithromycin|azithromycin|mesh-list
44918000|NCT03911440|Doxycycline|doxycycline|mesh-list
44918001|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44918002|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918003|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
44918004|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44918005|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44918006|NCT03911570|Acetaminophen|acetaminophen|mesh-list
44918007|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44918008|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44918009|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918010|NCT03911570|Analgesics|analgesics|mesh-ancestor
44918011|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
44918012|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918013|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918014|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
44918015|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918016|NCT03911271|Atropine|atropine|mesh-list
44918017|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44918018|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918019|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44918020|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
44918021|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918022|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918023|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44918024|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
44918025|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
44918026|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
44918027|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44918028|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44918029|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918030|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918031|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918032|NCT03910803|Brodalumab|brodalumab|mesh-list
44918033|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
44918034|NCT03910647|Pantoprazole|pantoprazole|mesh-list
44918035|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44918036|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918037|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44918038|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918039|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918040|NCT03910634|Carboplatin|carboplatin|mesh-list
44918041|NCT03910634|Fluorouracil|fluorouracil|mesh-list
44918042|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798884|NCT02010944|Mirabegron|mirabegron|mesh-list
44918043|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
44918044|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918045|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44918046|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918047|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
44918048|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918049|NCT03910712|Trastuzumab|trastuzumab|mesh-list
44918050|NCT03910712|Letrozole|letrozole|mesh-list
44918051|NCT03910712|Anastrozole|anastrozole|mesh-list
44918052|NCT03910712|Exemestane|exemestane|mesh-list
44918053|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44918054|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918055|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918056|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44918057|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918058|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918059|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44918060|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
44918061|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918062|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918063|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918064|NCT03910556|Propofol|propofol|mesh-list
44918065|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44918066|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918067|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918068|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44918069|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
44918094|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918096|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
44918097|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918098|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918099|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
44918100|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
44918101|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44918102|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918103|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918104|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44918105|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44918106|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44918107|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918108|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918109|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918110|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44918111|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44918112|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918113|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44918114|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44918115|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
44918116|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918117|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44918118|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918119|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44712653|NCT01471730|Thrombin|thrombin|mesh-list
44918120|NCT03909776|Cisplatin|cisplatin|mesh-list
44918121|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918122|NCT03909594|Ketamine|ketamine|mesh-list
44918123|NCT03909594|Bupivacaine|bupivacaine|mesh-list
44798944|NCT02011321|Clevidipine|clevidipine|mesh-list
44918124|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918125|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
44918126|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918127|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918128|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
44918129|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918130|NCT03909594|Analgesics|analgesics|mesh-ancestor
44918131|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44918132|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44918133|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
44918134|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44918135|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44918136|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918137|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918138|NCT03909477|Xenon|xenon|mesh-list
44918139|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44918140|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
44918141|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
44918142|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918143|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918144|NCT03909724|Sunitinib|sunitinib|mesh-list
44918145|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918146|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44918147|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918148|NCT03909724|Growth Substances|growth substances|mesh-ancestor
44918149|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918150|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
44918151|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44918152|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918153|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918154|NCT03909529|Digoxin|digoxin|mesh-list
44918155|NCT03909529|Spironolactone|spironolactone|mesh-list
44918156|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44918157|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
44918158|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918159|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918160|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44918161|NCT03909529|Diuretics|diuretics|mesh-ancestor
44918162|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
44918163|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918164|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44918165|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918166|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918167|NCT03909529|Protective Agents|protective agents|mesh-ancestor
44918168|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
44918169|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
44918170|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918171|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
44918172|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918173|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918174|NCT03909646|Fluorouracil|fluorouracil|mesh-list
44918175|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44918176|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44918177|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
44918178|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918179|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44918180|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918181|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918182|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
44918183|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918184|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44918185|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
44918186|NCT03908944|Methadone|methadone|mesh-list
44918187|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44918188|NCT03908944|Narcotics|narcotics|mesh-ancestor
44918189|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799241|NCT02012933|Amifampridine|amifampridine|mesh-list
44799399|NCT02013570|Analgesics|analgesics|mesh-ancestor
44799482|NCT02014454|Propranolol|propranolol|mesh-list
44918190|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918191|NCT03908944|Analgesics|analgesics|mesh-ancestor
44918192|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
44918193|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918194|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
44918195|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
44918197|NCT03908619|Omeprazole|omeprazole|mesh-list
44918198|NCT03908619|Rabeprazole|rabeprazole|mesh-list
44918199|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44918200|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918201|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44918202|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918203|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918204|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44918205|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44918206|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918207|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918208|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44918209|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918210|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918211|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918212|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918213|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
44918214|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
44918215|NCT03908528|Doxorubicin|doxorubicin|mesh-list
44918216|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44918217|NCT03908528|Paclitaxel|paclitaxel|mesh-list
44918218|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44918219|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918220|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
44918221|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918222|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918223|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44918224|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
44918225|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918226|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918227|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44918228|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44918229|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44918230|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44918231|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918232|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44918233|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918234|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
44918235|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918236|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
44918237|NCT03908528|Protective Agents|protective agents|mesh-ancestor
44918238|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
44918239|NCT03908528|Vitamins|vitamins|mesh-ancestor
44799886|NCT02016703|Erythritol|erythritol|mesh-list
44800034|NCT02018094|Iodine|iodine|mesh-list
44800057|NCT02018133|Vitamin D|vitamin d|mesh-list
44918240|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
44918241|NCT03908814|Antibodies|antibodies|mesh-list
44918242|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
44918243|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918244|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
44704426|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704427|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44704428|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704429|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704430|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44704431|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44704432|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
44704433|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704434|NCT01421992|Methylphenidate|methylphenidate|mesh-list
44704435|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44704436|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704437|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44704438|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44704439|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704440|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704441|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
44704442|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704443|NCT01422018|Bevacizumab|bevacizumab|mesh-list
44704444|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44704445|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704446|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44704447|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918245|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
44712797|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918246|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918248|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918249|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44918250|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918251|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44918252|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918253|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
44918254|NCT03908333|Gemcitabine|gemcitabine|mesh-list
44918255|NCT03908333|Paclitaxel|paclitaxel|mesh-list
44918256|NCT03908333|Cisplatin|cisplatin|mesh-list
44918257|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44918258|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44918259|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918260|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918261|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44918262|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918263|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918264|NCT03908333|Vitamins|vitamins|mesh-ancestor
44918265|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
44918266|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918267|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44918268|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
44918269|NCT03908333|Antiviral Agents|antiviral agents|mesh-ancestor
44918270|NCT03908333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918271|NCT03908333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918272|NCT03908333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918273|NCT03908333|Immunologic Factors|immunologic factors|mesh-ancestor
44918274|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
44918275|NCT03908333|Protective Agents|protective agents|mesh-ancestor
44918276|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
44918277|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918278|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918279|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918280|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44918281|NCT03908372|Cisplatin|cisplatin|mesh-list
44918282|NCT03908372|Docetaxel|docetaxel|mesh-list
44918283|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918284|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918285|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44800128|NCT02018367|Proflavine|proflavine|mesh-list
44800142|NCT02018536|Simeprevir|simeprevir|mesh-list
44918286|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918287|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918288|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
44918289|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44918290|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44918291|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44918292|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918293|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918294|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918295|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918296|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918297|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44918298|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918299|NCT03907813|Bupivacaine|bupivacaine|mesh-list
44918300|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918301|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
44918302|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918303|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918304|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
44918305|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918306|NCT03907423|Metformin|metformin|mesh-list
44918307|NCT03907423|Glimepiride|glimepiride|mesh-list
44918308|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44918309|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44918310|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918311|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44918312|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44918313|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
44918314|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918315|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44918316|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44918317|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918318|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918319|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918320|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
44918322|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44918323|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918324|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918325|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918326|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918327|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918328|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
44918329|NCT03907098|Endostar protein|endostar protein|mesh-list
44918330|NCT03907098|Endostatins|endostatins|mesh-list
44918331|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44918332|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918333|NCT03907098|Growth Substances|growth substances|mesh-ancestor
44918334|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918335|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
44918336|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918337|NCT03906916|Micafungin|micafungin|mesh-list
44918338|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
44918339|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918340|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
44918341|NCT03907215|Citalopram|citalopram|mesh-list
44918342|NCT03907215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44800567|NCT02021123|Anidulafungin|anidulafungin|mesh-list
44918343|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44918344|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918345|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918346|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918347|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
44918348|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918349|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44918350|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
44918351|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918352|NCT03907163|Dronabinol|dronabinol|mesh-list
44918353|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
44918354|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918355|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918356|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918357|NCT03907163|Analgesics|analgesics|mesh-ancestor
44918358|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
44918359|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918360|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44918361|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44918362|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918363|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918364|NCT03907163|Hormones|hormones|mesh-ancestor
44918365|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918366|NCT03907111|Chitosan|chitosan|mesh-list
44918367|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44918368|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44918369|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
44918370|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918371|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44918372|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
44918373|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
44918374|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
44918375|NCT03907111|Coagulants|coagulants|mesh-ancestor
44918376|NCT03906838|Ropivacaine|ropivacaine|mesh-list
44918377|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918378|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
44918379|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918380|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918381|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
44918382|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918383|NCT03906669|Tamoxifen|tamoxifen|mesh-list
44918384|NCT03906669|Letrozole|letrozole|mesh-list
44918385|NCT03906669|Progesterone|progesterone|mesh-list
44918386|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918387|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44918388|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44918389|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918390|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918391|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44918392|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
44918393|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918394|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712986|NCT01473914|Zinc|zinc|mesh-list
44918395|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918396|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44918397|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44918398|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44918399|NCT03906669|Progestins|progestins|mesh-ancestor
44918400|NCT03906669|Hormones|hormones|mesh-ancestor
44918401|NCT03905837|Lidocaine|lidocaine|mesh-list
44918402|NCT03905837|Piperidine|piperidine|mesh-list
44800712|NCT02022254|Metformin|metformin|mesh-list
44918403|NCT03905837|Remifentanil|remifentanil|mesh-list
44918404|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918405|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
44918406|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918407|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918408|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
44918409|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918410|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918411|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44918412|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44918413|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918414|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918415|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44918416|NCT03905837|Narcotics|narcotics|mesh-ancestor
44918417|NCT03905837|Analgesics|analgesics|mesh-ancestor
44918418|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44918419|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44918420|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44918421|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44918422|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44918423|NCT03906123|Protective Agents|protective agents|mesh-ancestor
44918424|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801149|NCT02024555|Ofloxacin|ofloxacin|mesh-list
44918425|NCT03905967|Lenvatinib|lenvatinib|mesh-list
44918426|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918427|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44918428|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918429|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918430|NCT03905759|Colchicine|colchicine|mesh-list
44918431|NCT03905759|Amiodarone|amiodarone|mesh-list
44918432|NCT03905759|Dronedarone|dronedarone|mesh-list
44918433|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
44918434|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918435|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918436|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
44918437|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918438|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918439|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918440|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44918441|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44918442|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44918443|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918444|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44918445|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44918446|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44918447|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918448|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44918449|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44918450|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44918451|NCT03905317|Bevacizumab|bevacizumab|mesh-list
44918452|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918453|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918454|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44918455|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918456|NCT03905317|Growth Substances|growth substances|mesh-ancestor
44918457|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918458|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
44918459|NCT03905486|Pregabalin|pregabalin|mesh-list
44918460|NCT03905486|Analgesics|analgesics|mesh-ancestor
44918461|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
44918462|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918463|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918464|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
44918465|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44704448|NCT01422018|Growth Substances|growth substances|mesh-ancestor
44704449|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704450|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44704451|NCT01422096|Leuprolide|leuprolide|mesh-list
44918503|NCT03904836|Tobramycin|tobramycin|mesh-list
44918504|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44918505|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918506|NCT03904888|Anesthetics|anesthetics|mesh-list
44918507|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
44918508|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918509|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918510|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
44918511|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918512|NCT03904680|Vitamin D|vitamin d|mesh-list
44918513|NCT03904680|Methotrexate|methotrexate|mesh-list
44918514|NCT03904680|Vitamins|vitamins|mesh-ancestor
44918515|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
44918516|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918517|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44918518|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44918519|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44918520|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44918521|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44918522|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
44918523|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918524|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918525|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44918526|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918527|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44918528|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918529|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
44918530|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918531|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44918532|NCT03904719|Vorolanib|vorolanib|mesh-list
44918533|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44918534|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918535|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918536|NCT03904745|Atosiban|atosiban|mesh-list
44918537|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
44918538|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918539|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918540|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
44918541|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44918542|NCT03904563|Bevacizumab|bevacizumab|mesh-list
44918543|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918544|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918545|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44918546|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918547|NCT03904563|Growth Substances|growth substances|mesh-ancestor
44918548|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918549|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44918550|NCT03904732|Aspirin|aspirin|mesh-list
44918551|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44918552|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918553|NCT03904732|Analgesics|analgesics|mesh-ancestor
44918554|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
44918555|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918556|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918557|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918558|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918559|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44918560|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44918561|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918562|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44918563|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44918564|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918565|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
44801730|NCT02027792|Diclofenac|diclofenac|mesh-list
44918566|NCT03904537|Antibodies|antibodies|mesh-list
44801940|NCT02028923|Morphine|morphine|mesh-list
44918567|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
44918568|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918569|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44918570|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44918571|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918572|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44918573|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44918574|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918575|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
44918576|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
44918577|NCT03903952|Vitamins|vitamins|mesh-ancestor
44918578|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
44918579|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918580|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
44918581|NCT03903952|Hematinics|hematinics|mesh-ancestor
44918582|NCT03904225|Tegafur|tegafur|mesh-list
44918583|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44918584|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
44918585|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918586|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918587|NCT03904056|Ranibizumab|ranibizumab|mesh-list
44918588|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44918589|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44918590|NCT03904056|Growth Substances|growth substances|mesh-ancestor
44801995|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44802146|NCT02031367|Triamcinolone|triamcinolone|mesh-list
44918591|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918592|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
44918593|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918594|NCT03903887|Antibodies|antibodies|mesh-list
44918595|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
44918596|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918597|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
44918598|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44918599|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918600|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918601|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918602|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918603|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918604|NCT03903718|Oseltamivir|oseltamivir|mesh-list
44918605|NCT03903718|MEDI8852|medi8852|mesh-list
44918606|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
44918607|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918608|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918609|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918610|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
44918611|NCT03903783|Cefotaxime|cefotaxime|mesh-list
44918612|NCT03903783|Cefoxitin|cefoxitin|mesh-list
44918613|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44918614|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918615|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44918616|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44918617|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918618|NCT03903367|Fentanyl|fentanyl|mesh-list
44918619|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44918620|NCT03903367|Narcotics|narcotics|mesh-ancestor
44918621|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918622|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918623|NCT03903367|Analgesics|analgesics|mesh-ancestor
44802346|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918624|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
44918625|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918626|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44918627|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44918628|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
44918629|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
44918630|NCT03903458|Nivolumab|nivolumab|mesh-list
44918631|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918632|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918633|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44918634|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918635|NCT03903302|Valproic Acid|valproic acid|mesh-list
44918636|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
44918637|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918638|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918639|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
44918640|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918641|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918642|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
44918643|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44918644|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918645|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802671|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
44918646|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
44918647|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44918648|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44918649|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44918650|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918651|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918652|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
44918653|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802968|NCT02044965|Trimethoprim|trimethoprim|mesh-list
44918654|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918655|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44918656|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918657|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44918658|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44918659|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44918660|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
44918661|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918662|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44918663|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44918664|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918665|NCT03903133|Vitamin E|vitamin e|mesh-list
44918666|NCT03903133|Antioxidants|antioxidants|mesh-list
44918667|NCT03903133|Vitamins|vitamins|mesh-ancestor
44918668|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
44704452|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44704453|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
44704454|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44704455|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704456|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704457|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704458|NCT01422109|Aspirin|aspirin|mesh-list
44704459|NCT01422109|Clopidogrel|clopidogrel|mesh-list
44704460|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704461|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704462|NCT01422109|Analgesics|analgesics|mesh-ancestor
44704463|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
44704464|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704465|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704466|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704467|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704468|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44704469|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44704470|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704471|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44704472|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44704473|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704474|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
44704475|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44704476|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44704477|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44704478|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
44704479|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704480|NCT01422122|Vitamin D|vitamin d|mesh-list
44803018|NCT02045069|Ivermectin|ivermectin|mesh-list
44704481|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
44803261|NCT02046538|Vitamins|vitamins|mesh-ancestor
44704482|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
44704483|NCT01422122|Vitamins|vitamins|mesh-list
44704484|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
44704485|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704486|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44704487|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704488|NCT01422291|Acetaminophen|acetaminophen|mesh-list
44704489|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44704491|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44704492|NCT01422291|Narcotics|narcotics|mesh-ancestor
44704493|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704494|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704495|NCT01422291|Analgesics|analgesics|mesh-ancestor
44704496|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
44704497|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704498|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704499|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
44704500|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704501|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704502|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704503|NCT01422317|Tocopherols|tocopherols|mesh-list
44704504|NCT01422317|Vitamin E|vitamin e|mesh-list
44704505|NCT01422317|Tocotrienols|tocotrienols|mesh-list
44704506|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
44704507|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
44704508|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704509|NCT01422317|Protective Agents|protective agents|mesh-ancestor
44704510|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704511|NCT01422317|Vitamins|vitamins|mesh-ancestor
44803439|NCT02047175|Vitamins|vitamins|mesh-ancestor
44803593|NCT02048228|Ticagrelor|ticagrelor|mesh-list
44704512|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
44704513|NCT01422330|Etravirine|etravirine|mesh-list
44918669|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918686|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
44918687|NCT03902782|Epinephrine|epinephrine|mesh-list
44918688|NCT03902782|Bupivacaine|bupivacaine|mesh-list
44918689|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918690|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
44918691|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
44918692|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918693|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918694|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918695|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
44918696|NCT03902782|Hormones|hormones|mesh-ancestor
44918697|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918698|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918699|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918700|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918701|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
44918702|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918703|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
44918704|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44918705|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44918706|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
44918707|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918708|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918709|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44918710|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44918711|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44918712|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
44918713|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
44918714|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
44918715|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44918716|NCT03902522|Leronlimab|leronlimab|mesh-list
44918717|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44918718|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44918719|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918720|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44918721|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44918722|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
44918723|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918724|NCT03902106|Albuterol|albuterol|mesh-list
44918725|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44918726|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
44918727|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918728|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918729|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44918730|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44918731|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
44918732|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44918733|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44918734|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44918735|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44918736|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44918737|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918738|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918739|NCT03902340|Analgesics|analgesics|mesh-list
44918740|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
44918741|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918742|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918743|NCT03902249|Dexamethasone|dexamethasone|mesh-list
44918744|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918745|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
44918746|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
44918747|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918748|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918749|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918750|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
44918751|NCT03902249|Hormones|hormones|mesh-ancestor
44918752|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918753|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918754|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918755|NCT03901716|Fentanyl|fentanyl|mesh-list
44918756|NCT03901716|Midazolam|midazolam|mesh-list
44918757|NCT03901716|Sufentanil|sufentanil|mesh-list
44918758|NCT03901716|Remifentanil|remifentanil|mesh-list
44918759|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44918760|NCT03901716|Narcotics|narcotics|mesh-ancestor
44918761|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918762|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918764|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
44918765|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918766|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44918767|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44918768|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
44918769|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
44918770|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44918771|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44918772|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44918773|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918774|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
44918775|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
44918776|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918777|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918778|NCT03901612|Ropivacaine|ropivacaine|mesh-list
44918779|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
44918780|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
44918781|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918782|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918783|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
44918784|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918785|NCT03901768|Dexamethasone|dexamethasone|mesh-list
44918786|NCT03901768|Triamcinolone|triamcinolone|mesh-list
44918787|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918788|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
44918789|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
44918790|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918791|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918792|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918793|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
44918794|NCT03901768|Hormones|hormones|mesh-ancestor
44918795|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918796|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918797|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918798|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
44918799|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44918800|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
44918801|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
44918802|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918803|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918804|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918805|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44918806|NCT03901482|Analgesics|analgesics|mesh-ancestor
44918807|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
44918808|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918809|NCT03901690|Imiquimod|imiquimod|mesh-list
44918810|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44918811|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
44918812|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918813|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918814|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
44918815|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
44918816|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918817|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918818|NCT03901118|Paclitaxel|paclitaxel|mesh-list
44918819|NCT03901118|Etoposide|etoposide|mesh-list
44918820|NCT03901118|Chiauranib|chiauranib|mesh-list
44918821|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44918822|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918823|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918824|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44918825|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918826|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918827|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44918828|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44918829|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918830|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44804215|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44804239|NCT02052128|Onapristone|onapristone|mesh-list
44804327|NCT02052726|Vaccines|vaccines|mesh-list
44918831|NCT03901170|Letrozole|letrozole|mesh-list
44918832|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918833|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44918834|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44918835|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713466|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44918861|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44918862|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918863|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44918864|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44804559|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
44918865|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
44918866|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918867|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44918868|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44918869|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
44918870|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44918871|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918872|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44918873|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44918874|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44918875|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44918876|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44918877|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44918878|NCT03900377|Rituximab|rituximab|mesh-list
44918879|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918880|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918881|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
44918882|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918883|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918885|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44918886|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44918887|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
44918888|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918889|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44918890|NCT03899675|Caffeine|caffeine|mesh-list
44918891|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44918892|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918893|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44918894|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918895|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918896|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44918897|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44918898|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
44918899|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918900|NCT03899610|Durvalumab|durvalumab|mesh-list
44918901|NCT03899610|Tremelimumab|tremelimumab|mesh-list
44918902|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918903|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918904|NCT03899506|Midazolam|midazolam|mesh-list
44918905|NCT03899506|Olanzapine|olanzapine|mesh-list
44918906|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44918907|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44918908|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44918909|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918910|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44918911|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44918912|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918913|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44918914|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
44918915|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
44918916|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
44918917|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
44918918|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918919|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918920|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
44918921|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
44918922|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918923|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44918924|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44918925|NCT03899506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44918926|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44918927|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918928|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
44918929|NCT03899337|Prednisolone|prednisolone|mesh-list
44918930|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
44918931|NCT03899337|Rituximab|rituximab|mesh-list
44918932|NCT03899337|Doxorubicin|doxorubicin|mesh-list
44918933|NCT03899337|Vincristine|vincristine|mesh-list
44918934|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
44918935|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44918936|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
44918937|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918938|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44918939|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44704514|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44704515|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44704516|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704517|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704518|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
44704519|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704520|NCT01422460|Mitogens|mitogens|mesh-list
44704521|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704522|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704523|NCT01422499|Vorinostat|vorinostat|mesh-list
44704524|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704525|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44704526|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704527|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704528|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44704529|NCT01422590|Mitiglinide|mitiglinide|mesh-list
44704530|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704531|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704532|NCT01422590|Incretins|incretins|mesh-ancestor
44918940|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
44918941|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918942|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44918943|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44918944|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44918945|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44918946|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44918947|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44918948|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918949|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44918950|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
44918951|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
44918952|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
44918953|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44918954|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
44918955|NCT03899337|Hormones|hormones|mesh-ancestor
44918956|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44918957|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44918958|NCT03899246|Capsaicin|capsaicin|mesh-list
44918959|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
44918960|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44918961|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
44918962|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44918963|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918964|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
44918965|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44918966|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918967|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918968|NCT03899571|Oseltamivir|oseltamivir|mesh-list
44918969|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
44918970|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44918971|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44918972|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918973|NCT03899324|Bumetanide|bumetanide|mesh-list
44918974|NCT03899324|Diuretics|diuretics|mesh-ancestor
44918975|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
44918976|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44918977|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44918978|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918979|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918980|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
44918981|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44918982|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44918983|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918984|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
44918985|NCT03899233|Coagulants|coagulants|mesh-ancestor
44918986|NCT03899194|Citalopram|citalopram|mesh-list
44918987|NCT03899194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44918988|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44918989|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44918990|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44918991|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44918992|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
44918993|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805819|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
43611293|NCT03172988|BB 1101|bb 1101|mesh-list
44918994|NCT03899194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44918995|NCT03899194|Antidepressive Agents|antidepressive agents|mesh-ancestor
44918996|NCT03899194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44918997|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
44918998|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44918999|NCT03899142|Antibodies|antibodies|mesh-list
44919000|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
44919001|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919002|NCT03899077|Goserelin|goserelin|mesh-list
44919003|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44919004|NCT03899077|Leuprolide|leuprolide|mesh-list
44919005|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44919006|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919007|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
44919008|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44919009|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
44919010|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919011|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919012|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44919013|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44919014|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
44919015|NCT03899038|Anesthetics|anesthetics|mesh-list
44919016|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919017|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919018|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
44919020|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
44919021|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919022|NCT03899285|Citalopram|citalopram|mesh-list
44919023|NCT03899285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44919024|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44919025|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919026|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919027|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919028|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
44919029|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919030|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44919031|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
44919032|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44919033|NCT03898882|Oxytocin|oxytocin|mesh-list
44919034|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
44919035|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919036|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919037|NCT03898635|Linezolid|linezolid|mesh-list
44919038|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919039|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919040|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44919041|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919042|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919043|NCT03898583|Calcitriol|calcitriol|mesh-list
44919044|NCT03898583|Betamethasone|betamethasone|mesh-list
44919045|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
44919046|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44919047|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
44919048|NCT03898583|Calcipotriene|calcipotriene|mesh-list
44919049|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44919050|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919051|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
44919052|NCT03898583|Hormones|hormones|mesh-ancestor
44919053|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919054|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919055|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919056|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919057|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919058|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44919059|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44919060|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919061|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919062|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44919063|NCT03898583|Vitamins|vitamins|mesh-ancestor
44919064|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
44919065|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44919066|NCT03898193|Montelukast|montelukast|mesh-list
44919067|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919068|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919069|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44919070|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44919071|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919072|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919073|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44919074|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44919075|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919076|NCT03898466|Fluticasone|fluticasone|mesh-list
44919077|NCT03898466|Xhance|xhance|mesh-list
44919078|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919079|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44919080|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
44919081|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919082|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919083|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919084|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919085|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919086|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44919087|NCT03898011|Lamotrigine|lamotrigine|mesh-list
44919102|NCT03898336|Micronutrients|micronutrients|mesh-list
44919103|NCT03898336|Trace Elements|trace elements|mesh-list
44919104|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919105|NCT03897660|Vitamins|vitamins|mesh-list
44919106|NCT03897660|Vitamin K|vitamin k|mesh-list
44919107|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
44919108|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
44919109|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919110|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44919111|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44919112|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919113|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
44919114|NCT03897660|Coagulants|coagulants|mesh-ancestor
44919115|NCT03897413|Antacids|antacids|mesh-list
44919116|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
44919117|NCT03897413|Calcium|calcium|mesh-list
44919118|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44919119|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919120|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919121|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806485|NCT02066350|Pancrelipase|pancrelipase|mesh-list
44919122|NCT03897452|Fentanyl|fentanyl|mesh-list
44919123|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44919124|NCT03897452|Narcotics|narcotics|mesh-ancestor
44919125|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919126|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919127|NCT03897452|Analgesics|analgesics|mesh-ancestor
44919128|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
44919129|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919130|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44919131|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919132|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
44919133|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
44919134|NCT03896971|Cyclosporine|cyclosporine|mesh-list
44919135|NCT03896971|Cyclosporins|cyclosporins|mesh-list
44919136|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919137|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919138|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919139|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
44919140|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919141|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
44919142|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919143|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919144|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919145|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44919146|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
44919147|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44919148|NCT03896932|Antibodies|antibodies|mesh-list
44919149|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
44919150|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44919151|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
44919152|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919153|NCT03897062|Suvorexant|suvorexant|mesh-list
44919154|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44919155|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919156|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919157|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919158|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44919159|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919160|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919161|NCT03896893|Emollients|emollients|mesh-list
44919162|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919163|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
44919164|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
44919165|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
44919166|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919167|NCT03896321|Anticoagulants|anticoagulants|mesh-list
44919168|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44919169|NCT03896256|Ketamine|ketamine|mesh-list
44919170|NCT03896256|Analgesics|analgesics|mesh-ancestor
44919171|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
44919172|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919173|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713893|NCT01479751|Analgesics|analgesics|mesh-ancestor
44919174|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44919175|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919176|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
44919177|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
44919178|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919179|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44919180|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44919181|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919182|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919184|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44919185|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44919186|NCT03896113|Analgesics|analgesics|mesh-ancestor
44704533|NCT01422590|Hormones|hormones|mesh-ancestor
44704534|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704535|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44704536|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44704537|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704538|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704539|NCT01422603|Clofarabine|clofarabine|mesh-list
44704540|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44704541|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
44704542|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704543|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704544|NCT01422616|Metoprolol|metoprolol|mesh-list
44704545|NCT01422616|Clonidine|clonidine|mesh-list
44704546|NCT01422616|Labetalol|labetalol|mesh-list
44704547|NCT01422616|Hydralazine|hydralazine|mesh-list
44704548|NCT01422616|Nicardipine|nicardipine|mesh-list
44704549|NCT01422616|Phentolamine|phentolamine|mesh-list
44704550|NCT01422616|Urapidil|urapidil|mesh-list
44704551|NCT01422616|Enalaprilat|enalaprilat|mesh-list
44704552|NCT01422616|Enalapril|enalapril|mesh-list
44704553|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44704554|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
44807314|NCT02071342|Everolimus|everolimus|mesh-list
44807383|NCT02071589|Nifedipine|nifedipine|mesh-list
44704555|NCT01422616|Esmolol|esmolol|mesh-list
44704556|NCT01422616|Glycerol|glycerol|mesh-list
44704557|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44704558|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44704559|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
44704560|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
44704561|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704562|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704563|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44704564|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44704565|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44704566|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44704567|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704568|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704570|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
44704571|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44704572|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44704573|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44704574|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44704575|NCT01422616|Protective Agents|protective agents|mesh-ancestor
44704576|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
44704577|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44704578|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44704579|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
44704580|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44704581|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44704582|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44704583|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704584|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44704585|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44704586|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
44704587|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44704588|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
44704589|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704590|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
44704591|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704592|NCT01422733|Dexamethasone|dexamethasone|mesh-list
44704593|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
44704594|NCT01422733|Cosyntropin|cosyntropin|mesh-list
44704595|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704596|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
44704597|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
44704598|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704599|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704600|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44704601|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
44919195|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919196|NCT03896074|Bevacizumab|bevacizumab|mesh-list
44919197|NCT03896074|Atezolizumab|atezolizumab|mesh-list
44807475|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
44919198|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919199|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919200|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44919201|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44919202|NCT03896074|Growth Substances|growth substances|mesh-ancestor
44919203|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919204|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
44919205|NCT03895892|Caffeine|caffeine|mesh-list
44919206|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44919207|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919208|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44919209|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919210|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919211|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44919212|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44919213|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
44807664|NCT02073227|Metformin|metformin|mesh-list
44807717|NCT02073916|Paclitaxel|paclitaxel|mesh-list
44807798|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
44919214|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919215|NCT03896217|Simvastatin|simvastatin|mesh-list
44919216|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44919217|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44919218|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
44919219|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919220|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44919221|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44919222|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919223|NCT03895788|Niraparib|niraparib|mesh-list
44919224|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44919225|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919226|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919227|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919228|NCT03895671|Azacitidine|azacitidine|mesh-list
44919229|NCT03895671|Ponatinib|ponatinib|mesh-list
44919230|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44919231|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
44919232|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919233|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919234|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919235|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919236|NCT03895528|Lonafarnib|lonafarnib|mesh-list
44919237|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919238|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919239|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
44919240|NCT03895970|Lenvatinib|lenvatinib|mesh-list
44919241|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919242|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919243|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919244|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919245|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919246|NCT03895229|Empagliflozin|empagliflozin|mesh-list
44919247|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44919248|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919249|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44919250|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919251|NCT03895411|Sotalol|sotalol|mesh-list
44919252|NCT03895411|Propafenone|propafenone|mesh-list
44919253|NCT03895411|Metoprolol|metoprolol|mesh-list
44919254|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44919255|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44919256|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919257|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919258|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919259|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919260|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44919261|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
44919262|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
44919263|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919264|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44919265|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44919266|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919267|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44919268|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44919269|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
44919270|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44919271|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44919272|NCT03894839|Glutaral|glutaral|mesh-list
44919273|NCT03894839|Eusol|eusol|mesh-list
44919274|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44919275|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919276|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
44919277|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919278|NCT03894826|Vorinostat|vorinostat|mesh-list
44919279|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919280|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44919281|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807938|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44935914|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44919282|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919283|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
44919284|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44919285|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919286|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
44919287|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44919288|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44919289|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44919290|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919291|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919292|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
44919293|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919294|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919295|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44919296|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919297|NCT03894800|Fentanyl|fentanyl|mesh-list
44919298|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
44919299|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44919300|NCT03894800|Narcotics|narcotics|mesh-ancestor
44919301|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919302|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919303|NCT03894800|Analgesics|analgesics|mesh-ancestor
44919304|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
44919305|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919306|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44919307|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919308|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
44919309|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
44919310|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44919311|NCT03894683|Melatonin|melatonin|mesh-list
44919312|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
44919313|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919314|NCT03894683|Protective Agents|protective agents|mesh-ancestor
44919315|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919316|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919317|NCT03894189|Theophylline|theophylline|mesh-list
44919318|NCT03894189|Doxapram|doxapram|mesh-list
44919319|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44919320|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
44919321|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919322|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919323|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919324|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919325|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44919326|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919327|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808369|NCT02078440|Bromocriptine|bromocriptine|mesh-list
44919328|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
44919329|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44919330|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44919331|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
44919332|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919333|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44919335|NCT03894085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44919336|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44919337|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919338|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919339|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919340|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
44919341|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919342|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44919343|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44919344|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44919345|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44919346|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44919347|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919348|NCT03894280|Fluticasone|fluticasone|mesh-list
44919349|NCT03894280|Xhance|xhance|mesh-list
44919350|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44919351|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44919352|NCT03894280|Charcoal|charcoal|mesh-list
44919353|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919354|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44919355|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
44919356|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919357|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919358|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919359|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919360|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919361|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44919362|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44919363|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44919364|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44919365|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919366|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919367|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919368|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
44919369|NCT03894280|Hormones|hormones|mesh-ancestor
44919370|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919371|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
44919372|NCT03894280|Antidotes|antidotes|mesh-ancestor
44919373|NCT03894280|Protective Agents|protective agents|mesh-ancestor
44919374|NCT03894046|Imipenem|imipenem|mesh-list
44919375|NCT03894046|Colistin|colistin|mesh-list
44919376|NCT03894046|Sulbactam|sulbactam|mesh-list
44808617|NCT02080104|Oxytocin|oxytocin|mesh-list
44919377|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919378|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919379|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44919380|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919381|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919382|NCT03894007|Maytansine|maytansine|mesh-list
44919383|NCT03894007|Docetaxel|docetaxel|mesh-list
44919384|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44919385|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
44919386|NCT03894007|Carboplatin|carboplatin|mesh-list
44919387|NCT03894007|Trastuzumab|trastuzumab|mesh-list
44919388|NCT03894007|Atezolizumab|atezolizumab|mesh-list
44919389|NCT03894007|Epirubicin|epirubicin|mesh-list
44919390|NCT03894007|Pertuzumab|pertuzumab|mesh-list
44808732|NCT02080858|Apixaban|apixaban|mesh-list
44919391|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44919392|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919393|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44919394|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44919395|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44919396|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919397|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919398|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
44808809|NCT02081404|Esomeprazole|esomeprazole|mesh-list
44919399|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919400|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919401|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44919402|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
44919403|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44919404|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919405|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44919406|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44919407|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44919408|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919409|NCT03893695|Nivolumab|nivolumab|mesh-list
44935915|NCT03712475|Pregabalin|pregabalin|mesh-list
44919410|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919411|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919412|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44919413|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919414|NCT03893734|Methadone|methadone|mesh-list
44919415|NCT03893734|Hydromorphone|hydromorphone|mesh-list
44919416|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44919417|NCT03893734|Narcotics|narcotics|mesh-ancestor
44919418|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919419|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919420|NCT03893734|Analgesics|analgesics|mesh-ancestor
44919421|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
44919422|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919423|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
44919424|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919425|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44919426|NCT03893591|Dalteparin|dalteparin|mesh-list
44919427|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
44919428|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44919429|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44919430|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919431|NCT03893864|Ubiquinone|ubiquinone|mesh-list
44919432|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
44919433|NCT03893864|Antioxidants|antioxidants|mesh-list
44919434|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919435|NCT03893864|Protective Agents|protective agents|mesh-ancestor
44919436|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919437|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
44919438|NCT03893864|Vitamins|vitamins|mesh-ancestor
44919439|NCT03893747|Vaccines|vaccines|mesh-list
44919440|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
44919441|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919442|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44919443|NCT03893526|Valsartan|valsartan|mesh-list
44704602|NCT01422733|Hormones|hormones|mesh-ancestor
44704603|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704604|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704605|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704606|NCT01422785|Clindamycin|clindamycin|mesh-list
44704607|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
44704608|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
44809222|NCT02084589|Narcotics|narcotics|mesh-ancestor
44704609|NCT01422785|Tretinoin|tretinoin|mesh-list
44809369|NCT02085538|Palbociclib|palbociclib|mesh-list
44704610|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44704611|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44704612|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704613|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44704614|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704615|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704616|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44704617|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704618|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
44704619|NCT01422954|Chloroquine|chloroquine|mesh-list
44704620|NCT01422954|Mefloquine|mefloquine|mesh-list
44704621|NCT01422954|Proguanil|proguanil|mesh-list
44704622|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44704623|NCT01422954|Amebicides|amebicides|mesh-ancestor
44704624|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44704625|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44704626|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704627|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
44704628|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704629|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
44704630|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704631|NCT01423019|Synephrine|synephrine|mesh-list
44704632|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44704633|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44704634|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44704635|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704636|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919445|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44919446|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919447|NCT03893526|Incretins|incretins|mesh-ancestor
44919449|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919450|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44919451|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
44919452|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919453|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919454|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44935916|NCT03712475|Analgesics|analgesics|mesh-ancestor
44809790|NCT02087384|Vaccines|vaccines|mesh-list
44809871|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
44919455|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44919456|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44919457|NCT03893097|Artesunate|artesunate|mesh-list
44919458|NCT03893097|Mefloquine|mefloquine|mesh-list
44919459|NCT03893097|Praziquantel|praziquantel|mesh-list
44919460|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
44919461|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44919462|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44919463|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919464|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919465|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
44919466|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
44919467|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44919468|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
44919469|NCT03893032|Modafinil|modafinil|mesh-list
44919470|NCT03893032|Amphetamine|amphetamine|mesh-list
44919471|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44919472|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919473|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44919474|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44919475|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44919476|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919477|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
44919478|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
44919479|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919480|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
44919481|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919482|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919483|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44919484|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44919485|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919486|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44919487|NCT03893136|Leflunomide|leflunomide|mesh-list
44919488|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919489|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919490|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919491|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
44919492|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919493|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44919494|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44919495|NCT03893045|Hematinics|hematinics|mesh-ancestor
44919496|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44919497|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44919498|NCT03893240|Antibodies|antibodies|mesh-list
44919499|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
44919500|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
44919501|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919502|NCT03892902|Zopiclone|zopiclone|mesh-list
44919503|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919504|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919505|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919506|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
44919507|NCT03892668|Oxytocin|oxytocin|mesh-list
44919508|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
44919509|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919510|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919511|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44919512|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44919513|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919514|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
44919515|NCT03892668|Coagulants|coagulants|mesh-ancestor
44714238|NCT01481831|Palonosetron|palonosetron|mesh-list
44919517|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919518|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
44919519|NCT03892928|Propofol|propofol|mesh-list
44919520|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919521|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919522|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919523|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919524|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
44919525|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
44919526|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44919527|NCT03892928|Analgesics|analgesics|mesh-ancestor
44919528|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
44919529|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809924|NCT02088008|Valsartan|valsartan|mesh-list
44809952|NCT02088411|Diclofenac|diclofenac|mesh-list
44810041|NCT02088866|Lidocaine|lidocaine|mesh-list
44919530|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44919531|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44919532|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44919533|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919534|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919535|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919536|NCT03892499|Itraconazole|itraconazole|mesh-list
44919537|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
44919538|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919539|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44919540|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44919541|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919542|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919543|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44919544|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
44919545|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919546|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919547|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44919548|NCT03892447|Ferulic acid|ferulic acid|mesh-list
44919549|NCT03892447|Dopamine|dopamine|mesh-list
44919550|NCT03892447|Alprostadil|alprostadil|mesh-list
44919551|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44919552|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
44919553|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
44919554|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919555|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919556|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
44919557|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919558|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919559|NCT03892447|Protective Agents|protective agents|mesh-ancestor
44919560|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44919561|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
44919562|NCT03892447|Urological Agents|urological agents|mesh-ancestor
44919563|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44919564|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44919565|NCT03892447|Analgesics|analgesics|mesh-ancestor
44919566|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
44919567|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919568|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919569|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
44919570|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44919571|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44919572|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44919573|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44919574|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
44919575|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
44919576|NCT03892512|Esmolol|esmolol|mesh-list
44919577|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919578|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919579|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919580|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44919581|NCT03892512|Analgesics|analgesics|mesh-ancestor
44919582|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
44919583|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919584|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44919585|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44919586|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44919587|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919588|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714323|NCT01482156|Everolimus|everolimus|mesh-list
44919589|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919590|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44919591|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44919592|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44919593|NCT03892434|Dexamethasone|dexamethasone|mesh-list
44919594|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
44919595|NCT03892434|Bevacizumab|bevacizumab|mesh-list
44919596|NCT03892434|BB 1101|bb 1101|mesh-list
44919597|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919598|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919599|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44919600|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44919601|NCT03892434|Growth Substances|growth substances|mesh-ancestor
44919602|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919603|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
44919604|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919605|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
44919606|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
44919607|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919608|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44919609|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
44919610|NCT03892434|Hormones|hormones|mesh-ancestor
44919611|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919612|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44919613|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
44919614|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919615|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919616|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
44919617|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
44919618|NCT03892330|Doxorubicin|doxorubicin|mesh-list
44919619|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44919620|NCT03892330|Vincristine|vincristine|mesh-list
44919621|NCT03892330|Pirarubicin|pirarubicin|mesh-list
44919622|NCT03892330|Epirubicin|epirubicin|mesh-list
44919623|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919624|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
44919625|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919626|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919627|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44919628|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
44919629|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919630|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919631|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44919632|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44919633|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44919634|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44919635|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919636|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44919637|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
44919638|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
44919639|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
44919640|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919641|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919642|NCT03892421|Cytarabine|cytarabine|mesh-list
44919643|NCT03892421|Dexamethasone|dexamethasone|mesh-list
44919644|NCT03892421|Rituximab|rituximab|mesh-list
44919645|NCT03892421|Carboplatin|carboplatin|mesh-list
44919646|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919647|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919648|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
44919649|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919650|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919651|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44919652|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
44919653|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
44919654|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919655|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44919656|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
44919657|NCT03892421|Hormones|hormones|mesh-ancestor
44919658|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919659|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44919660|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44919661|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
44919662|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919663|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
44919664|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919665|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919666|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
44919667|NCT03892122|Propofol|propofol|mesh-list
44919668|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44919669|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919670|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919671|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919672|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
44919673|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
44919674|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704637|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704638|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
44704639|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
44255982|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704640|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704641|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44704642|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
44704643|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44704644|NCT01423032|Fludarabine|fludarabine|mesh-list
44704645|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44704646|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704647|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704648|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44810892|NCT02094599|Dronabinol|dronabinol|mesh-list
44704649|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
44704650|NCT01423123|Paclitaxel|paclitaxel|mesh-list
44704651|NCT01423123|Trastuzumab|trastuzumab|mesh-list
44704652|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704653|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704654|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44704655|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44704656|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704657|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704658|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44704659|NCT01423175|Clofarabine|clofarabine|mesh-list
44704660|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44704661|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
44704662|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704663|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704664|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44704665|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44704666|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704667|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704668|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704669|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704670|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44704671|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44704672|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44704673|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44704674|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704675|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704676|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44704677|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44704678|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
44704679|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44704680|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44704681|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
44704682|NCT01423292|Bupivacaine|bupivacaine|mesh-list
44704683|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
44704684|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
44704685|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704686|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704687|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
44704688|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704689|NCT01423305|Budesonide|budesonide|mesh-list
44704690|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
44704691|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44704692|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704693|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44704694|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
44704695|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704696|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704697|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44704698|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
44704699|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
44919675|NCT03892122|Analgesics|analgesics|mesh-ancestor
44919676|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
44919677|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919678|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44919679|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44919680|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44919681|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919682|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919683|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919684|NCT03892213|Benzonidazole|benzonidazole|mesh-list
44919685|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919686|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
44919687|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919688|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44919689|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44919690|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44919691|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919692|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44919693|NCT03892148|Furosemide|furosemide|mesh-list
44919694|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44919695|NCT03892148|Diuretics|diuretics|mesh-ancestor
44919696|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
44919697|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919698|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44919699|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919700|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919701|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44919702|NCT03891979|Metronidazole|metronidazole|mesh-list
44919703|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
44919704|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
44919705|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919706|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919707|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919708|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919709|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44919710|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44919711|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44919712|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44811661|NCT02098629|Esmolol|esmolol|mesh-list
44812010|NCT02099604|Vitamin D|vitamin d|mesh-list
44919713|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919714|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919715|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44919716|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44919717|NCT03892070|Mannitol|mannitol|mesh-list
44919718|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44919719|NCT03892070|Diuretics|diuretics|mesh-ancestor
44919720|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
44919721|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812304|NCT02101164|Denosumab|denosumab|mesh-list
44919722|NCT03892161|Ritonavir|ritonavir|mesh-list
44919723|NCT03892161|Darunavir|darunavir|mesh-list
44919724|NCT03892161|Rifampin|rifampin|mesh-list
44919725|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44919726|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44919727|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
44919728|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919729|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919730|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44919731|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44919732|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
44919733|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919734|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44919735|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44919736|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44919737|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
44919738|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919739|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
44919740|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44919741|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44919742|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44919743|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44812455|NCT02102516|Ketorolac|ketorolac|mesh-list
44812583|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
44919744|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44919745|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44919746|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44919747|NCT03891615|Niraparib|niraparib|mesh-list
44919748|NCT03891615|Osimertinib|osimertinib|mesh-list
44919749|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44919750|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919751|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919752|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919753|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919754|NCT03891472|Fluorouracil|fluorouracil|mesh-list
44919755|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
44919757|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
44919758|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919759|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44919760|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919761|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919762|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
44919763|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919764|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44919765|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44919766|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919767|NCT03891420|Galidesivir|galidesivir|mesh-list
44919768|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
44919769|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919770|NCT03891433|Meropenem|meropenem|mesh-list
44919771|NCT03891433|Tazobactam|tazobactam|mesh-list
44919772|NCT03891433|Piperacillin|piperacillin|mesh-list
44919773|NCT03891433|Ertapenem|ertapenem|mesh-list
44919774|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44919775|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919776|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44919777|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919778|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919779|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44919780|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
44919781|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44919782|NCT03891316|Sevoflurane|sevoflurane|mesh-list
44919783|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44919784|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44919785|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
44919786|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
44813036|NCT02105675|Docetaxel|docetaxel|mesh-list
44813243|NCT02107235|Cisplatin|cisplatin|mesh-list
44919787|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919788|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919789|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
44919790|NCT03891277|Hematinics|hematinics|mesh-ancestor
44919791|NCT03891095|Oxytocin|oxytocin|mesh-list
44919792|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
44919793|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919794|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919795|NCT03891238|Avelumab|avelumab|mesh-list
44919796|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44919797|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919798|NCT03890809|BMS-986165|bms-986165|mesh-list
44919799|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919800|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919801|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919802|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919803|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
44919804|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44919805|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44919806|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44919807|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919808|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919809|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
44919810|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919811|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919812|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44919813|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919814|NCT03891043|Selenium|selenium|mesh-list
44919815|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
44919816|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919817|NCT03891043|Protective Agents|protective agents|mesh-ancestor
44919818|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919819|NCT03891043|Trace Elements|trace elements|mesh-ancestor
44919820|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
44919821|NCT03890770|BMS-986165|bms-986165|mesh-list
44919822|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44919823|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919824|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919860|NCT03890406|Rocuronium|rocuronium|mesh-list
44919861|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44919862|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44919863|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44919864|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704700|NCT01423305|Hormones|hormones|mesh-ancestor
44704701|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704702|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44704703|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44704704|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44704705|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813455|NCT02108743|Albuterol|albuterol|mesh-list
44813524|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813579|NCT02109510|Analgesics|analgesics|mesh-ancestor
44704706|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704707|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704708|NCT01423370|Tadalafil|tadalafil|mesh-list
44704709|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
44704710|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44704711|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44704712|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704713|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704714|NCT01423370|Urological Agents|urological agents|mesh-ancestor
44704715|NCT01423435|Beraprost|beraprost|mesh-list
44813784|NCT02110719|Acetaminophen|acetaminophen|mesh-list
44813858|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813944|NCT02111434|Hormones|hormones|mesh-ancestor
44704716|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44704717|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44704718|NCT01423487|Metformin|metformin|mesh-list
44704719|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704720|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704721|NCT01423500|Fludarabine|fludarabine|mesh-list
44704722|NCT01423500|Etoposide|etoposide|mesh-list
44704723|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
44704724|NCT01423500|Thiotepa|thiotepa|mesh-list
44814229|NCT02112916|Hormones|hormones|mesh-ancestor
44704725|NCT01423500|Treosulfan|treosulfan|mesh-list
44704726|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704727|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704728|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704729|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
44704730|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704731|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704732|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44704733|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44704734|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704735|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44704736|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
44704737|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44704738|NCT01423539|Rituximab|rituximab|mesh-list
44704739|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44704740|NCT01423539|Navitoclax|navitoclax|mesh-list
44704741|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44704742|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704743|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
44704744|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704745|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704746|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44704747|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
44814480|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814627|NCT02115035|Vemurafenib|vemurafenib|mesh-list
44704748|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704749|NCT01423591|Infliximab|infliximab|mesh-list
44704750|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
44704751|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44704752|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704753|NCT01423695|Paclitaxel|paclitaxel|mesh-list
44704754|NCT01423695|Trastuzumab|trastuzumab|mesh-list
44704755|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704756|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704757|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44704758|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44704759|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44704760|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704761|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44704762|NCT01423708|Everolimus|everolimus|mesh-list
44704763|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704764|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704765|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
44704766|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704767|NCT01423747|Fludarabine|fludarabine|mesh-list
44704768|NCT01423747|Etoposide|etoposide|mesh-list
44595847|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595848|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595849|NCT00815295|Cetuximab|cetuximab|mesh-list
44704769|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
44704770|NCT01423747|Thiotepa|thiotepa|mesh-list
44919865|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919866|NCT03890510|Anesthetics|anesthetics|mesh-list
44919867|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919868|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919869|NCT03890094|Sufentanil|sufentanil|mesh-list
44919870|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815163|NCT02118532|Paclitaxel|paclitaxel|mesh-list
44919871|NCT03890094|Narcotics|narcotics|mesh-ancestor
44919872|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44919873|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919874|NCT03890094|Analgesics|analgesics|mesh-ancestor
44919875|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
44919876|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919877|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44919878|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44919879|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
44919880|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
44919881|NCT03889717|Vitamin D|vitamin d|mesh-list
44919882|NCT03889717|Vitamins|vitamins|mesh-ancestor
44919883|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
44919884|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919885|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44919886|NCT03889808|Antitoxins|antitoxins|mesh-list
44919887|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
44919888|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919889|NCT03890042|Dienogest|dienogest|mesh-list
44919890|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44919891|NCT03890042|Gestodene|gestodene|mesh-list
44919892|NCT03890042|Femovan|femovan|mesh-list
44919893|NCT03890042|Estradiol|estradiol|mesh-list
44919894|NCT03890042|Estrogens|estrogens|mesh-ancestor
44919895|NCT03890042|Hormones|hormones|mesh-ancestor
44919896|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44919897|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919898|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44919899|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
44919900|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44919901|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44919902|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44919903|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44919904|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44919905|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
44919906|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44919907|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919908|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44919909|NCT03890042|Progestins|progestins|mesh-ancestor
44919910|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44919911|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
44919912|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44919913|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919914|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
44919915|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44919916|NCT03889288|Analgesics|analgesics|mesh-list
44919917|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
44919918|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919919|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919920|NCT03889379|Albuterol|albuterol|mesh-list
44919921|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44919922|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
44919923|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919924|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919925|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44919926|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
44919927|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
44919928|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44815251|NCT02118987|Omalizumab|omalizumab|mesh-list
44815354|NCT02120092|Ticagrelor|ticagrelor|mesh-list
44919929|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44919930|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44919931|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44919932|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
44919933|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919934|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919935|NCT03889626|Capecitabine|capecitabine|mesh-list
44919936|NCT03889626|Apatinib|apatinib|mesh-list
44919937|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44919938|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
44919939|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919940|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919941|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44919942|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919943|NCT03889366|Aprepitant|aprepitant|mesh-list
44919944|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
44919945|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
44919946|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44919947|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919948|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44919949|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44919950|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44919951|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919952|NCT03888924|Vaccines|vaccines|mesh-list
44919953|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
44919954|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
44919955|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919956|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44919957|NCT03888846|Colchicine|colchicine|mesh-list
44919958|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
44919959|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
44815430|NCT02120612|Naloxone|naloxone|mesh-list
44815472|NCT02120859|Paclitaxel|paclitaxel|mesh-list
44815547|NCT02121457|Selenium|selenium|mesh-list
44919960|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919961|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44919962|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44919963|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44919964|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919965|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44919966|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44919967|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44919968|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44919969|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44919970|NCT03888846|Protective Agents|protective agents|mesh-ancestor
44919971|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919972|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
44919973|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44919974|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
44919975|NCT03889145|Amlodipine|amlodipine|mesh-list
44919976|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44919977|NCT03889145|Telmisartan|telmisartan|mesh-list
44919978|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44919979|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44919980|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44919981|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919982|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44919983|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919984|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
44919985|NCT03889145|Diuretics|diuretics|mesh-ancestor
44919986|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
44919987|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44919988|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44919989|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44919990|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
44919991|NCT03888677|Epirubicin|epirubicin|mesh-list
44919992|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44919993|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
44919994|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44919995|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44919996|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44919997|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
44919998|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44919999|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920000|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44920001|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44920002|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44920003|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44920004|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920005|NCT03888664|Interferons|interferons|mesh-list
44920006|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
44920007|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920008|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
44920009|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920010|NCT03888729|Velpatasvir|velpatasvir|mesh-list
44920011|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
44920012|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920013|NCT03888534|Ixazomib|ixazomib|mesh-list
44920014|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920015|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
44815701|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
44920016|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815979|NCT02124070|Hormones|hormones|mesh-list
44920017|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920027|NCT03888144|Ketorolac|ketorolac|mesh-list
44920028|NCT03888144|Oxycodone|oxycodone|mesh-list
44920029|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920030|NCT03888144|Narcotics|narcotics|mesh-ancestor
44920031|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920032|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920033|NCT03888144|Analgesics|analgesics|mesh-ancestor
44920034|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
44920035|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920036|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920037|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920038|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920039|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920040|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44920041|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920042|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920043|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44920044|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44920045|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
44920046|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920047|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44920048|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44920049|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
44920050|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
44920051|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920052|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920053|NCT03887650|Dexamethasone|dexamethasone|mesh-list
44920054|NCT03887650|Epinephrine|epinephrine|mesh-list
44920055|NCT03887650|Bupivacaine|bupivacaine|mesh-list
44920056|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920057|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
44920058|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
44920059|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920060|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920061|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44920062|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
44920063|NCT03887650|Hormones|hormones|mesh-ancestor
44920064|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920065|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44920066|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920067|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920068|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920069|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
44920070|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920071|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
44920072|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44920073|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44920074|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920075|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920076|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44920077|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44920078|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920079|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920080|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
44920081|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
44920082|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44920083|NCT03887754|Risperidone|risperidone|mesh-list
44920084|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44920085|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
44920086|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920087|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920088|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920089|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44920090|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920091|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920092|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920093|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44920094|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
44920095|NCT03887871|Tamsulosin|tamsulosin|mesh-list
44920096|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44920097|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44920098|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44920099|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920100|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920101|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920102|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920103|NCT03887871|Urological Agents|urological agents|mesh-ancestor
44920104|NCT03887858|Tamsulosin|tamsulosin|mesh-list
44920105|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44920106|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44920107|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44920108|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920109|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920110|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920111|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816326|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
44920112|NCT03887858|Urological Agents|urological agents|mesh-ancestor
44816484|NCT02127437|Lanreotide|lanreotide|mesh-list
44920113|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
44920114|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44920115|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920116|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44920117|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920118|NCT03887260|Fentanyl|fentanyl|mesh-list
44920119|NCT03887260|Morphine|morphine|mesh-list
44920120|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920121|NCT03887260|Narcotics|narcotics|mesh-ancestor
44920122|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920123|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920124|NCT03887260|Analgesics|analgesics|mesh-ancestor
44920125|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
44920126|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920127|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44920128|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44920129|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
44920130|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
44920131|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
44920132|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
44920133|NCT03887169|Vitamins|vitamins|mesh-ancestor
44920134|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
44920135|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920136|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
44920137|NCT03887169|Hematinics|hematinics|mesh-ancestor
44920138|NCT03887130|Gemcitabine|gemcitabine|mesh-list
44920139|NCT03887130|Paclitaxel|paclitaxel|mesh-list
44920140|NCT03887130|Vinorelbine|vinorelbine|mesh-list
44920141|NCT03887130|Docetaxel|docetaxel|mesh-list
44920142|NCT03887130|Capecitabine|capecitabine|mesh-list
44920143|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44920144|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920145|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
44920146|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
44920147|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
44920148|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920149|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44920150|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
44920151|NCT03887130|Antiviral Agents|antiviral agents|mesh-ancestor
44920152|NCT03887130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920153|NCT03887130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920154|NCT03887130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920155|NCT03887130|Immunologic Factors|immunologic factors|mesh-ancestor
44920156|NCT03887130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920157|NCT03886896|Lidocaine|lidocaine|mesh-list
44920158|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920159|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
44920160|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920161|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920162|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
44704771|NCT01423747|Treosulfan|treosulfan|mesh-list
44704772|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704773|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704774|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44704775|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
44704776|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704777|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704778|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816775|NCT02128308|Ofloxacin|ofloxacin|mesh-list
44704779|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44704780|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704781|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44704782|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
44704783|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44704784|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
44704785|NCT01423838|Oxybutynin|oxybutynin|mesh-list
44715007|NCT01486888|Insulin|insulin|mesh-list
44920163|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920164|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44920165|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44920166|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44920167|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920168|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920170|NCT03886779|Bromfenac|bromfenac|mesh-list
44920171|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920172|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920173|NCT03886779|Analgesics|analgesics|mesh-ancestor
44920174|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
44920175|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920176|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920177|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920178|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920179|NCT03886948|Mirikizumab|mirikizumab|mesh-list
44935917|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
44817413|NCT02131948|Insulin|insulin|mesh-list
44817491|NCT02132416|Acetaminophen|acetaminophen|mesh-list
44920180|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920181|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920182|NCT03886948|Analgesics|analgesics|mesh-ancestor
44920183|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
44920184|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920185|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920186|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920187|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920188|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44920189|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44920190|NCT03887013|Trimetazidine|trimetazidine|mesh-list
44920191|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
44920192|NCT03886766|Efavirenz|efavirenz|mesh-list
44920193|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44920194|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44920195|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920196|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920197|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
44920198|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920199|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44920200|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44920201|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44920202|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44920203|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44920204|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44920205|NCT03886441|Beclomethasone|beclomethasone|mesh-list
44920206|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920207|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
44920208|NCT03886441|Hormones|hormones|mesh-ancestor
44920209|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920210|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920211|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920212|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920213|NCT03886662|LB100|lb100|mesh-list
44920214|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920215|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920216|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920217|NCT03886311|Nivolumab|nivolumab|mesh-list
44920218|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44920219|NCT03886311|Trabectedin|trabectedin|mesh-list
44920220|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44920221|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920222|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44920223|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920224|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44920225|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
44920226|NCT03885947|Fludarabine|fludarabine|mesh-list
44920227|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
44920228|NCT03885947|Thiotepa|thiotepa|mesh-list
44920229|NCT03885947|Valproic Acid|valproic acid|mesh-list
44920230|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920231|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920232|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920233|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
44920234|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715072|NCT01487226|Paclitaxel|paclitaxel|mesh-list
44920253|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44920254|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
44920255|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920256|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
44920257|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44920258|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920259|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817557|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
44817647|NCT02133755|Bromocriptine|bromocriptine|mesh-list
44817790|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
44920260|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920261|NCT03885804|Analgesics|analgesics|mesh-ancestor
44920262|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
44920263|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920264|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44920265|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44920266|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44920267|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920268|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920269|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920270|NCT03885258|Melatonin|melatonin|mesh-list
44920271|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
44920272|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920273|NCT03885258|Protective Agents|protective agents|mesh-ancestor
44920274|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920275|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920276|NCT03885427|Ketamine|ketamine|mesh-list
44920277|NCT03885427|Analgesics|analgesics|mesh-ancestor
44920278|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
44920279|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920280|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920281|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44920282|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44920283|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
44920284|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
44920285|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920286|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44920287|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44920288|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920289|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920290|NCT03885219|Paclitaxel|paclitaxel|mesh-list
44920291|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44920292|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920293|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
44920294|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
44920295|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
44920296|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920297|NCT03885180|Warfarin|warfarin|mesh-list
44920298|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
44920299|NCT03885388|Dactinomycin|dactinomycin|mesh-list
44920300|NCT03885388|Methotrexate|methotrexate|mesh-list
44920301|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44920302|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
44920303|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44920304|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920305|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44920306|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
44920307|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920308|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920309|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
44920310|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920311|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44920312|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920313|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
44920314|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920315|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44920316|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920317|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920318|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44920319|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44920320|NCT03885297|Liraglutide|liraglutide|mesh-list
44920321|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44920322|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920323|NCT03885297|Incretins|incretins|mesh-ancestor
44920324|NCT03885297|Hormones|hormones|mesh-ancestor
44920325|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715223|NCT01488266|Milnacipran|milnacipran|mesh-list
44920326|NCT03884881|Meropenem|meropenem|mesh-list
44920327|NCT03884881|Imipenem|imipenem|mesh-list
44920328|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920329|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920330|NCT03885141|Zolpidem|zolpidem|mesh-list
44920331|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44920332|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44920333|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920334|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920335|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44920336|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
44920337|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
44920338|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920339|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920340|NCT03884972|Venetoclax|venetoclax|mesh-list
44920341|NCT03884972|Trabectedin|trabectedin|mesh-list
44920342|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920343|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44920344|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
44920345|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920346|NCT03884491|Vortioxetine|vortioxetine|mesh-list
44920347|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
44920348|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920349|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44920350|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920351|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920352|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920353|NCT03884491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44920354|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44920355|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920356|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920357|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920358|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
44920359|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44920360|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44818223|NCT02136875|Xhance|xhance|mesh-list
44920361|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44920362|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44920363|NCT03884348|Amoxicillin|amoxicillin|mesh-list
44920364|NCT03884348|Metronidazole|metronidazole|mesh-list
44920365|NCT03884348|Clarithromycin|clarithromycin|mesh-list
44920366|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44920367|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920368|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920369|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44920370|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44920371|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44920372|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920373|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920374|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44920375|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44920376|NCT03884465|Treprostinil|treprostinil|mesh-list
44704786|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44704787|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44704788|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44256136|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
44704789|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704790|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704791|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704792|NCT01423838|Urological Agents|urological agents|mesh-ancestor
44704793|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
44704794|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
44704795|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704796|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44704797|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44704798|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
44704799|NCT01423864|Prednisolone|prednisolone|mesh-list
44704800|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
44704801|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44704802|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44704803|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
44704804|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704805|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
44704807|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704808|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920383|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
44920384|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920385|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920386|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920387|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920388|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44920389|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44920390|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920391|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44920392|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44920393|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920395|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44920396|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44920397|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44920398|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
44920399|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920400|NCT03884127|Orlistat|orlistat|mesh-list
44920401|NCT03884127|Ezetimibe|ezetimibe|mesh-list
44920402|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44920403|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44920404|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
44920405|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920406|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44920407|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920408|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44920409|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44920410|NCT03883841|Hematinics|hematinics|mesh-ancestor
44920411|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44920412|NCT03883880|Capsaicin|capsaicin|mesh-list
44920413|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
44920414|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
44920415|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
44920416|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920417|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920418|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
44920419|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920420|NCT03883880|Protective Agents|protective agents|mesh-ancestor
44920421|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44920422|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44920423|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920424|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44920425|NCT03884036|Vitamin D|vitamin d|mesh-list
44920426|NCT03884036|Vitamins|vitamins|mesh-ancestor
44920427|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
44920428|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920429|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44920430|NCT03883984|Cysteamine|cysteamine|mesh-list
44920431|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44920432|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920433|NCT03883776|Octreotide|octreotide|mesh-list
44920434|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
44920435|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818793|NCT02139761|Analgesics|analgesics|mesh-ancestor
44920436|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44920437|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920438|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44920439|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920440|NCT03883763|Bupivacaine|bupivacaine|mesh-list
44920441|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920442|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
44920443|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920444|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920445|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
44920446|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920447|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
44920448|NCT03883347|Remifentanil|remifentanil|mesh-list
44920449|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44920450|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920451|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920452|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920453|NCT03883347|Analgesics|analgesics|mesh-ancestor
44920454|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
44920455|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920456|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44920457|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44920458|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44920459|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920460|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920461|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920462|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920463|NCT03883347|Narcotics|narcotics|mesh-ancestor
44920464|NCT03883360|Cannabidiol|cannabidiol|mesh-list
44920465|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
44920466|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
44920467|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
44920468|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920469|NCT03883269|Ethanol|ethanol|mesh-list
44920470|NCT03883269|Clindamycin|clindamycin|mesh-list
44920471|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
44920472|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
44920473|NCT03883269|Erythromycin|erythromycin|mesh-list
44920474|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
44920475|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44920476|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
44920477|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44920478|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920479|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920480|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920481|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920482|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44920483|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920484|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920485|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44920486|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
44920487|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44920488|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
44920489|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920490|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
44920491|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920492|NCT03883022|Vancomycin|vancomycin|mesh-list
44920493|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920494|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920495|NCT03883204|Risperidone|risperidone|mesh-list
44920496|NCT03883204|Aripiprazole|aripiprazole|mesh-list
44920497|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44920498|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
44920499|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920500|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920501|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920502|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44920503|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920504|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920505|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920506|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44920507|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
44920508|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44920509|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
44920510|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44920511|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44920512|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44920513|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44920514|NCT03882710|Metoprolol|metoprolol|mesh-list
44920515|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44920516|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44920517|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
44920518|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
44920519|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920520|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920521|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44715422|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
44920522|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44920523|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44920524|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920525|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819277|NCT05574998|Paclitaxel|paclitaxel|mesh-list
44920526|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920527|NCT03882814|Meperidine|meperidine|mesh-list
44920528|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920529|NCT03882814|Narcotics|narcotics|mesh-ancestor
44920530|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920531|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920532|NCT03882814|Analgesics|analgesics|mesh-ancestor
44920533|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
44920534|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920535|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44920536|NCT03882775|Heparin|heparin|mesh-list
44920537|NCT03882775|Bivalirudin|bivalirudin|mesh-list
44920538|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
44920539|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44920540|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44920541|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920542|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
44920543|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44920544|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44920545|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920546|NCT03882788|Fentanyl|fentanyl|mesh-list
44920547|NCT03882788|Isoflurane|isoflurane|mesh-list
44920548|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920549|NCT03882788|Narcotics|narcotics|mesh-ancestor
44920550|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920551|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920552|NCT03882788|Analgesics|analgesics|mesh-ancestor
44920553|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
44920554|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920555|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44920556|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44920557|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
44920558|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
44920559|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44920560|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
44920561|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920562|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
44920563|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920564|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920565|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
44819588|NCT05422534|Ubiquinone|ubiquinone|mesh-list
44920566|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920567|NCT03882541|Midazolam|midazolam|mesh-list
44920568|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44920569|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44920570|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920571|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920572|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44920573|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920574|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920575|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44920576|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
44920577|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
44920578|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
44920579|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
44920580|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920581|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920582|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
44920583|NCT03882099|Vitamin D|vitamin d|mesh-list
44920584|NCT03882099|Vitamins|vitamins|mesh-ancestor
44920585|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
44920586|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920587|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44920588|NCT03882164|Tacrolimus|tacrolimus|mesh-list
44920589|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920590|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
44920591|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920592|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44920593|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920594|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920595|NCT03882255|Propranolol|propranolol|mesh-list
44715496|NCT01489631|Analgesics|analgesics|mesh-ancestor
44920596|NCT03882255|Ponesimod|ponesimod|mesh-list
44920597|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44920598|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44920600|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920601|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920602|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920603|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44920604|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44920605|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
44920606|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44920607|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920608|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
44920609|NCT03882008|Abatacept|abatacept|mesh-list
44920610|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44920611|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920612|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920613|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920614|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
44920615|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920616|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920617|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
44920618|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44920619|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920620|NCT03881943|Aspirin|aspirin|mesh-list
44920621|NCT03881943|Ticagrelor|ticagrelor|mesh-list
44920622|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920623|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920624|NCT03881943|Analgesics|analgesics|mesh-ancestor
44920625|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
44920626|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920627|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819739|NCT05206955|Tadalafil|tadalafil|mesh-list
44819819|NCT05085873|Midazolam|midazolam|mesh-list
44920628|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920629|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920630|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44920631|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44920632|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920633|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44920634|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44920635|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920636|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
44920637|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44920638|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44920639|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44920640|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
44920641|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920642|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44920643|NCT03881904|Gestodene|gestodene|mesh-list
44819888|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819947|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
44820095|NCT04723134|Calcium|calcium|mesh-list
44920644|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44920645|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44920646|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44920647|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
44920648|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44920649|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920650|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44920651|NCT03881904|Estrogens|estrogens|mesh-ancestor
44920652|NCT03881904|Hormones|hormones|mesh-ancestor
44920653|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920654|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44920655|NCT03881904|Progestins|progestins|mesh-ancestor
44920656|NCT03881644|Sumatriptan|sumatriptan|mesh-list
44920657|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44920658|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44920659|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44920660|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44920661|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
44920662|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920663|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920664|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920665|NCT03881644|Growth Substances|growth substances|mesh-ancestor
44920666|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44920667|NCT03881787|Cetuximab|cetuximab|mesh-list
44920668|NCT03881787|Antibodies|antibodies|mesh-list
44920669|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44920670|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
44920671|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920684|NCT03881293|Lidocaine|lidocaine|mesh-list
44920685|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920686|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
44920687|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920688|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920689|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
44920690|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920691|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44920692|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44920693|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44920694|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920695|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920696|NCT03881111|Cisplatin|cisplatin|mesh-list
44704809|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44704810|NCT01423864|Protective Agents|protective agents|mesh-ancestor
44704811|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704812|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704813|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
44704814|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
44704815|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704816|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820369|NCT04404387|Vitamins|vitamins|mesh-ancestor
44704817|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
44704818|NCT01423955|Hematinics|hematinics|mesh-ancestor
44256216|NCT00618696|Antibodies|antibodies|mesh-list
44704819|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
44704820|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44704821|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704822|NCT01424111|Citalopram|citalopram|mesh-list
44704823|NCT01424111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44704824|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44704825|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704826|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704827|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704828|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
44704829|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704830|NCT01424111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44704831|NCT01424111|Antidepressive Agents|antidepressive agents|mesh-ancestor
44704832|NCT01424111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704833|NCT01424124|Montelukast|montelukast|mesh-list
44704834|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44704835|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
44704836|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44704837|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44704838|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704839|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704840|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44704841|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44704842|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704843|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44704844|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44704845|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
44704846|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704847|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704848|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44704849|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
44704850|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
44704851|NCT01424137|Hormones|hormones|mesh-ancestor
44704852|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44704853|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
44704854|NCT01424176|Pramipexole|pramipexole|mesh-list
44704855|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
44704856|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704857|NCT01424176|Protective Agents|protective agents|mesh-ancestor
44704858|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704859|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44704860|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44704861|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
44704862|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
44704863|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704864|NCT01424241|Octreotide|octreotide|mesh-list
44704865|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44704866|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44704867|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704868|NCT01424319|Atrasentan|atrasentan|mesh-list
44920697|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
44920698|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920699|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44920700|NCT03881449|Aripiprazole|aripiprazole|mesh-list
44920701|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
44920702|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920703|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44920704|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44920705|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920706|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920707|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
44920708|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
44920709|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935918|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820446|NCT04299438|Propranolol|propranolol|mesh-list
44820644|NCT04099355|Hormones|hormones|mesh-ancestor
44920710|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820824|NCT03871491|Azithromycin|azithromycin|mesh-list
44820911|NCT03704584|Lidocaine|lidocaine|mesh-list
44920711|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44920712|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44920713|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
44920714|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44920715|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44920716|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44920717|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44920718|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
44920719|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
44920720|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44920721|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920722|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44920723|NCT03880981|Acetaminophen|acetaminophen|mesh-list
44920724|NCT03880981|Ibuprofen|ibuprofen|mesh-list
44920725|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920726|NCT03880981|Analgesics|analgesics|mesh-ancestor
44920727|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
44920728|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920729|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920730|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
44920731|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920732|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920733|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920734|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44920735|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920736|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920737|NCT03880903|Albuterol|albuterol|mesh-list
44920738|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44920739|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
44920740|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920741|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920742|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920743|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920744|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
44920745|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44920746|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44920747|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44920748|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44920749|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920750|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920751|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920752|NCT03880968|Etanercept|etanercept|mesh-list
44920753|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44920754|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44920755|NCT03880968|Analgesics|analgesics|mesh-ancestor
44920756|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
44920757|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920758|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920759|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920760|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44920761|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44920762|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44920763|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
44920764|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44920765|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44920766|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44920767|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920768|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715732|NCT01490437|Cisplatin|cisplatin|mesh-list
44920769|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920770|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920772|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
44920773|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821101|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
44821194|NCT02911792|Metformin|metformin|mesh-list
44920774|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
44920775|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920776|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
44920777|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
44920778|NCT03880734|Vitamin D|vitamin d|mesh-list
44920779|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44920780|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920781|NCT03880734|Vitamins|vitamins|mesh-ancestor
44920782|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
44920783|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44920784|NCT03880877|Leucovorin|leucovorin|mesh-list
44920785|NCT03880877|Antidotes|antidotes|mesh-ancestor
44920786|NCT03880877|Protective Agents|protective agents|mesh-ancestor
44920787|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920788|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
44920789|NCT03880877|Vitamins|vitamins|mesh-ancestor
44920790|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
44920791|NCT03880695|Doxorubicin|doxorubicin|mesh-list
44920792|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44920793|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44920794|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920795|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44920796|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44920797|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920798|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920799|NCT03880448|Metronidazole|metronidazole|mesh-list
44920800|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920801|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44920802|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44920803|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44920804|NCT03880487|Oxycodone|oxycodone|mesh-list
44920805|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44920806|NCT03880487|Narcotics|narcotics|mesh-ancestor
44920807|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920808|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920809|NCT03880487|Analgesics|analgesics|mesh-ancestor
44920810|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
44920811|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920812|NCT03880825|Metformin|metformin|mesh-list
44920813|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44920814|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920815|NCT03880357|Betamethasone|betamethasone|mesh-list
44920816|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
44920817|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44920818|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
44920819|NCT03880357|Calcipotriene|calcipotriene|mesh-list
44920820|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44920821|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920822|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
44920823|NCT03880357|Hormones|hormones|mesh-ancestor
44920824|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920825|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920826|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920827|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44821414|NCT02066415|Erenumab|erenumab|mesh-list
44821727|NCT00140855|Antibodies|antibodies|mesh-list
44920828|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
44920829|NCT03880409|Lidocaine|lidocaine|mesh-list
44920830|NCT03880409|Epinephrine|epinephrine|mesh-list
44920831|NCT03880409|Racepinephrine|racepinephrine|mesh-list
44920832|NCT03880409|Carticaine|carticaine|mesh-list
44920833|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
44920834|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
44920835|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
44920836|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920837|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920838|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
44920839|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920840|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44920841|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44920842|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44920843|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920844|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920845|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44920846|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44920847|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920848|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920849|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44920850|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44920851|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
44920852|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920853|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920855|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
44821803|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
44920856|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44920857|NCT03880045|Vasopressins|vasopressins|mesh-list
44920858|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
44920859|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
44920860|NCT03880045|Coagulants|coagulants|mesh-ancestor
44920861|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44920862|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44920863|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
44920864|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920865|NCT03879889|Nicotine|nicotine|mesh-list
44920866|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44920867|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
44920868|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920869|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920870|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44920871|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44920872|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
44920873|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920874|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920875|NCT03880123|Ixazomib|ixazomib|mesh-list
44920876|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920877|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
44920878|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920879|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920880|NCT03879837|Fluticasone|fluticasone|mesh-list
44920881|NCT03879837|Xhance|xhance|mesh-list
44920882|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920883|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44920884|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
44920885|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920886|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920887|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920888|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920889|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44920890|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44920891|NCT03879811|Nivolumab|nivolumab|mesh-list
44920892|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44920893|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920894|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44920895|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920896|NCT03879707|Melatonin|melatonin|mesh-list
44920897|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
44920898|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920899|NCT03879707|Protective Agents|protective agents|mesh-ancestor
44920900|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920901|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920902|NCT03879746|Paroxetine|paroxetine|mesh-list
44920903|NCT03879746|Tamsulosin|tamsulosin|mesh-list
44920904|NCT03879746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44920905|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44920906|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44920907|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920908|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920909|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
44920910|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920911|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44920912|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
44822122|NCT02142920|Gedatolisib|gedatolisib|mesh-list
44920913|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44920914|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44920915|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44920916|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920917|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44920918|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44715893|NCT01491191|Hormones|hormones|mesh-ancestor
44920919|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44920920|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
44920921|NCT03879746|Urological Agents|urological agents|mesh-ancestor
44920922|NCT03879590|Budesonide|budesonide|mesh-list
44920923|NCT03879590|Doxofylline|doxofylline|mesh-list
44920924|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44920925|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44920926|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
44920927|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920928|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920929|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44920930|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
44920931|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
44920932|NCT03879590|Hormones|hormones|mesh-ancestor
44920933|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920934|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
44920935|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44920936|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44920937|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920938|NCT03879460|Naltrexone|naltrexone|mesh-list
44920939|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44920940|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44920941|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920942|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
44920943|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920944|NCT03879564|Ketamine|ketamine|mesh-list
44920945|NCT03879564|Analgesics|analgesics|mesh-ancestor
44822454|NCT02145546|Amiodarone|amiodarone|mesh-list
44822529|NCT02145715|Bortezomib|bortezomib|mesh-list
44822601|NCT02145975|Analgesics|analgesics|mesh-ancestor
44920946|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
44920947|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44920948|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920949|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44920950|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44920951|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
44920952|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
44920953|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44920954|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44920955|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44920956|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44920957|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44920958|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
44920959|NCT03879486|Formaldehyde|formaldehyde|mesh-list
44920960|NCT03879486|Povidone|povidone|mesh-list
44920961|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
44920962|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
44920963|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44920964|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44920965|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
44704869|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704870|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44704871|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44704872|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704873|NCT01424332|Aspirin|aspirin|mesh-list
44704874|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
44704875|NCT01424332|Salicylates|salicylates|mesh-list
44822904|NCT02147964|Acyline|acyline|mesh-list
44704876|NCT01424332|Darexaban|darexaban|mesh-list
44704877|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44704878|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44704879|NCT01424332|Analgesics|analgesics|mesh-ancestor
44704880|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
44704881|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44704882|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704883|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44704884|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44704885|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44704886|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44704887|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704888|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44704889|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44704890|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704891|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
44704892|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704893|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
44704894|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
44704895|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
44704896|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44704897|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
44715963|NCT01491867|Travoprost|travoprost|mesh-list
44920992|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44920993|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44920994|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44920995|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44920996|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44920997|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44920998|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44920999|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44921000|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921001|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
44921002|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
44921003|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
44921004|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921005|NCT03879057|Antibodies|antibodies|mesh-list
44921006|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44921007|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
44921008|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921009|NCT03878888|Bupivacaine|bupivacaine|mesh-list
44921010|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921011|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
44921012|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921013|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921014|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
44921015|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921016|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
44921018|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921019|NCT03878771|Clobetasol|clobetasol|mesh-list
44921020|NCT03878771|Benzocaine|benzocaine|mesh-list
44921021|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823371|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
44921022|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
44921023|NCT03878771|Hormones|hormones|mesh-ancestor
44921024|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921025|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921026|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921027|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
44921028|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921029|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
44921030|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921031|NCT03878784|Sumatriptan|sumatriptan|mesh-list
44921032|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44921033|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44921034|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44921035|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
44921036|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921037|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921038|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921039|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44921040|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
44921041|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921042|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44921043|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921044|NCT03878693|Fomepizole|fomepizole|mesh-list
44921045|NCT03878693|Antidotes|antidotes|mesh-ancestor
44921046|NCT03878693|Protective Agents|protective agents|mesh-ancestor
44921047|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921048|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921049|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921050|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
44921051|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
44921052|NCT03878667|Calcium|calcium|mesh-list
44921053|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44921054|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921055|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921056|NCT03878667|Antacids|antacids|mesh-ancestor
44921057|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921058|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921059|NCT03878264|Cortisone|cortisone|mesh-list
44921060|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921061|NCT03878082|Acetaminophen|acetaminophen|mesh-list
44921062|NCT03878082|Propacetamol|propacetamol|mesh-list
44921063|NCT03878082|Analgesics|analgesics|mesh-ancestor
44921064|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
44921065|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921066|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921067|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921068|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921069|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921070|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921071|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
44921072|NCT03877705|Listerine|listerine|mesh-list
44921073|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
44921074|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44921075|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921076|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
44921077|NCT03877705|Protective Agents|protective agents|mesh-ancestor
44921078|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921079|NCT03877718|Promethazine|promethazine|mesh-list
44921080|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
44921081|NCT03877718|Sumatriptan|sumatriptan|mesh-list
44921082|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44823503|NCT02152423|Enoxaparin|enoxaparin|mesh-list
44921083|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44921084|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44921085|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
44921086|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921087|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921088|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921089|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
44921090|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44921091|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44921092|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
44921093|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
44921094|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44921095|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44921096|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44921097|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921098|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921099|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
44921100|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
44921101|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921102|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
44921103|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
44921104|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921105|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44921106|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44921107|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44921108|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
44921109|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921110|NCT03877874|Terbutaline|terbutaline|mesh-list
44921111|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44921112|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
44921113|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921114|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921115|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44921116|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
44921117|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
44921118|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
44921119|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44921120|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44921121|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44921122|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44921123|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921124|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921125|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921126|NCT03877692|Labetalol|labetalol|mesh-list
44921127|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44824230|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824231|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
44824232|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44824233|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
44824234|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
44824235|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
44824236|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44824237|NCT02157792|Gemcitabine|gemcitabine|mesh-list
44824238|NCT02157792|Cisplatin|cisplatin|mesh-list
44824347|NCT02158689|Letrozole|letrozole|mesh-list
44824422|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44921128|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44921129|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921130|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921131|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921132|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921133|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44921134|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
44921135|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
44921136|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921137|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44921138|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44921139|NCT03877679|Triamcinolone|triamcinolone|mesh-list
44921140|NCT03877679|Curcumin|curcumin|mesh-list
44921141|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921142|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
44921143|NCT03877679|Hormones|hormones|mesh-ancestor
44921144|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921145|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921146|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921147|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921148|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921149|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921150|NCT03877679|Analgesics|analgesics|mesh-ancestor
44921151|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
44921152|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921153|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824516|NCT02159573|Natalizumab|natalizumab|mesh-list
44824668|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
44824724|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
44921154|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921155|NCT03877562|Olanzapine|olanzapine|mesh-list
44921156|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
44921157|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
44921158|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921159|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921160|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921161|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44921162|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44921163|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921164|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44921165|NCT03877562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44921166|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44921167|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921168|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921169|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921170|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
44921171|NCT03877601|Bevacizumab|bevacizumab|mesh-list
44921172|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921173|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921174|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44921175|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44921176|NCT03877601|Growth Substances|growth substances|mesh-ancestor
44921177|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921178|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
44921179|NCT03877120|Diazepam|diazepam|mesh-list
44921180|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
44921181|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44921182|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921183|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921184|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921185|NCT03877120|Analgesics|analgesics|mesh-ancestor
44921186|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
44921187|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921188|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44921189|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44921190|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44921191|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921192|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921193|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921194|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44921195|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
44921196|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
44921197|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
44921198|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824775|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824801|NCT02161354|Buprenorphine|buprenorphine|mesh-list
44825029|NCT02162485|Xhance|xhance|mesh-list
44825048|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
44704898|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44704899|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
44704900|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
44704901|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44704902|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
44704903|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704904|NCT01424384|Citalopram|citalopram|mesh-list
44704905|NCT01424384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44704906|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44704907|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44704908|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704909|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704910|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
44704911|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704912|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44704913|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
44704914|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704915|NCT01424449|Aripiprazole|aripiprazole|mesh-list
44704916|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
44704917|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44704918|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44704919|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44704920|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44704921|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704922|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
44704923|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
44704924|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44704925|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704926|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44704927|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44704928|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
44704929|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44704930|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44704931|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44704932|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44704933|NCT01424618|Leuprolide|leuprolide|mesh-list
44704934|NCT01424618|Ganirelix|ganirelix|mesh-list
44704935|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44704936|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
44704937|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44921199|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44921200|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44921201|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44921202|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44921203|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44921204|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44921205|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
44921207|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
44921208|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
44921209|NCT03877003|Choline|choline|mesh-list
44921210|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
44921211|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921212|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
44921213|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921214|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921215|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921216|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
44921217|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
44921218|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921219|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921220|NCT03876899|Analgesics|analgesics|mesh-ancestor
44825265|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
44921221|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
44921222|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921223|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921224|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921225|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921226|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921227|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
44921228|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921229|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921230|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
44921231|NCT03876704|Vitamins|vitamins|mesh-list
44921232|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
44921233|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921234|NCT03876938|Olanzapine|olanzapine|mesh-list
44921235|NCT03876938|Aprepitant|aprepitant|mesh-list
44921236|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
44921237|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
44921238|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921239|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921240|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921241|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44921242|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44921243|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921244|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44921245|NCT03876938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44921246|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44921247|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921248|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921249|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921250|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
44921251|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44921252|NCT03876886|Paclitaxel|paclitaxel|mesh-list
44921253|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44921254|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
44921255|NCT03876886|Carboplatin|carboplatin|mesh-list
44921256|NCT03876886|Epirubicin|epirubicin|mesh-list
44921257|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44921258|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921259|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44921260|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44921261|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44921262|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921263|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921264|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
44921265|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921266|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921267|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44921268|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
44921269|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44921270|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44921271|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44921272|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44921273|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921274|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
44921307|NCT03876574|Gemcitabine|gemcitabine|mesh-list
44921308|NCT03876574|Dexamethasone|dexamethasone|mesh-list
44921309|NCT03876574|Floxuridine|floxuridine|mesh-list
44921310|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921311|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
44921312|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
44921313|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921314|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921315|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921316|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
44921317|NCT03876574|Hormones|hormones|mesh-ancestor
44921318|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921319|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44921320|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921321|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44921322|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
44921323|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921324|NCT03876574|Antiviral Agents|antiviral agents|mesh-ancestor
44921325|NCT03876574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921326|NCT03876574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921327|NCT03876574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921328|NCT03876574|Immunologic Factors|immunologic factors|mesh-ancestor
44921329|NCT03876041|Dexamethasone|dexamethasone|mesh-list
44921330|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
44921331|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
44921332|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44921333|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44921334|NCT03876041|BB 1101|bb 1101|mesh-list
44921335|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921336|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
44921337|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
44921338|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921339|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921340|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921341|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
44921342|NCT03876041|Hormones|hormones|mesh-ancestor
44921343|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921344|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44921345|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921346|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
44921347|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921348|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921349|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44921350|NCT03876041|Protective Agents|protective agents|mesh-ancestor
44921351|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44921352|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921353|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
44921354|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44921355|NCT03875911|Mitomycins|mitomycins|mesh-list
44921356|NCT03875911|Mitomycin|mitomycin|mesh-list
44921357|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44921358|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921359|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
44921360|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921361|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44825699|NCT02167958|Tacrolimus|tacrolimus|mesh-list
44825750|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
44825912|NCT02169752|Ambrisentan|ambrisentan|mesh-list
44921362|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921363|NCT03875274|Morphine|morphine|mesh-list
44921364|NCT03875274|Ropivacaine|ropivacaine|mesh-list
44921365|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44921366|NCT03875274|Narcotics|narcotics|mesh-ancestor
44921367|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921368|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921369|NCT03875274|Analgesics|analgesics|mesh-ancestor
44921370|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
44921371|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921372|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921373|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
44921374|NCT03874975|Vitamin D|vitamin d|mesh-list
44921375|NCT03874975|Vitamins|vitamins|mesh-ancestor
44921376|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
44921377|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826153|NCT02170766|Pantoprazole|pantoprazole|mesh-list
44921378|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921379|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
44921380|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44716487|NCT01495117|Iodine|iodine|mesh-list
44921381|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
44921382|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
44921383|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921384|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921385|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921386|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921387|NCT03874832|Analgesics|analgesics|mesh-ancestor
44921388|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
44921389|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921390|NCT03874806|Ropivacaine|ropivacaine|mesh-list
44921391|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44921392|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921393|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
44921394|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921395|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921396|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
44921397|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921398|NCT03874585|Nicotine|nicotine|mesh-list
44921399|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44921400|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
44921401|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921402|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921403|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44921404|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44921405|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
44921406|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921407|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921408|NCT03874364|Lidocaine|lidocaine|mesh-list
44921409|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921410|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
44921411|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921412|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921413|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
44921414|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921415|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44921416|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44921417|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44921418|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921419|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921420|NCT03874273|Crizotinib|crizotinib|mesh-list
44921421|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921422|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44921423|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921424|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921425|NCT03874130|Scopolamine|scopolamine|mesh-list
44921426|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44921427|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44921428|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
44921429|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
44921430|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921431|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921432|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921433|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
44921434|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44921435|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
44921436|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921437|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921438|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44921439|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
44921440|NCT03874260|Fenofibrate|fenofibrate|mesh-list
44921441|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921442|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
44826653|NCT02171793|Olodaterol|olodaterol|mesh-list
44826783|NCT02172209|Empagliflozin|empagliflozin|mesh-list
44921443|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921444|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921445|NCT03874000|Metformin|metformin|mesh-list
44921446|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44921447|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921448|NCT03874026|Cetuximab|cetuximab|mesh-list
44921449|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921450|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921451|NCT03874156|Atorvastatin|atorvastatin|mesh-list
44921452|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44921453|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921454|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
44921455|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921456|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921457|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44704964|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
44704965|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44704966|NCT01424761|Vitamins|vitamins|mesh-ancestor
44256342|NCT00619541|Sorafenib|sorafenib|mesh-list
44704967|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
44704969|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44704970|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44704971|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
44704972|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44704973|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44704974|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44704975|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704976|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704977|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44704978|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
44704979|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921463|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
44921464|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44921465|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
44921466|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921467|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921468|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44921469|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44921470|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44921471|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
44921472|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921473|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921474|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44921475|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44921476|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
44921477|NCT03873298|Protective Agents|protective agents|mesh-ancestor
44921478|NCT03873740|Vaccines|vaccines|mesh-list
44921479|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
44921480|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921481|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
44921482|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921483|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921484|NCT03872661|Bevacizumab|bevacizumab|mesh-list
44921485|NCT03872661|Carboplatin|carboplatin|mesh-list
44921486|NCT03872661|Pemetrexed|pemetrexed|mesh-list
44921487|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921488|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921489|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44921490|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44921491|NCT03872661|Growth Substances|growth substances|mesh-ancestor
44921492|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921493|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
44921494|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921495|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921496|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44921497|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44921498|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
44921499|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921500|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921501|NCT03872830|Analgesics|analgesics|mesh-ancestor
44921502|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
44921503|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921504|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921505|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921506|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827537|NCT02174211|Aflibercept|aflibercept|mesh-list
44921507|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44921508|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
44921509|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44921510|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44921511|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44921512|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921513|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921514|NCT03872570|Phenylephrine|phenylephrine|mesh-list
44921515|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
44921516|NCT03872570|Norepinephrine|norepinephrine|mesh-list
44921517|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44921518|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
44921519|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
44921520|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921521|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921522|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
44921523|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44921524|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
44921525|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
44921526|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44921527|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44921528|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44921529|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921530|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921531|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921532|NCT03872570|Protective Agents|protective agents|mesh-ancestor
44921533|NCT03872505|Paclitaxel|paclitaxel|mesh-list
44921534|NCT03872505|Carboplatin|carboplatin|mesh-list
44921535|NCT03872505|Durvalumab|durvalumab|mesh-list
44921536|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44921537|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921538|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
44921539|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
44921540|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
44921541|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921542|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44921543|NCT03872336|Labetalol|labetalol|mesh-list
44921544|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44921545|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44921546|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921547|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921548|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921549|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921550|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44921551|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
44921552|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
44921553|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921554|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44921555|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44921556|NCT03873415|BMS-986165|bms-986165|mesh-list
44921557|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44921558|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44921559|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921560|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921561|NCT03873532|Capecitabine|capecitabine|mesh-list
44921562|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44921563|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
44921564|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921565|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921566|NCT03872232|Telmisartan|telmisartan|mesh-list
44921567|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44921568|NCT03872232|Ezetimibe|ezetimibe|mesh-list
44921569|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44921570|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921571|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
44921572|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921573|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921574|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44921575|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921576|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44921577|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44827692|NCT02175017|Nivolumab|nivolumab|mesh-list
44827836|NCT02175901|Metronidazole|metronidazole|mesh-list
44921578|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44921579|NCT03871972|Sirolimus|sirolimus|mesh-list
44921580|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921581|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921582|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44921583|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921584|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
44921585|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921586|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
44921587|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921588|NCT03872011|Vitamins|vitamins|mesh-list
44921589|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
44921590|NCT03872011|Thiamine|thiamine|mesh-list
44921591|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
44921592|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
44921593|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921594|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921595|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
44921596|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921597|NCT03872011|Protective Agents|protective agents|mesh-ancestor
44921598|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
44921599|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
44921600|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44921601|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921602|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
44921603|NCT03871621|Metformin|metformin|mesh-list
44921604|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
44921605|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44921606|NCT03871621|Meglitinide|meglitinide|mesh-list
44828230|NCT02177461|Telmisartan|telmisartan|mesh-list
44921607|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44921608|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921609|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44921610|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921611|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44921612|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44921613|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921641|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
44921642|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
44921643|NCT03871322|Vitamins|vitamins|mesh-list
44921644|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
44921645|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828376|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828514|NCT02179294|Meperidine|meperidine|mesh-list
44921646|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921647|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44921648|NCT03871478|Lidocaine|lidocaine|mesh-list
44921649|NCT03871478|Bupivacaine|bupivacaine|mesh-list
44921650|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921651|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
44921652|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921653|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921654|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
44921655|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921656|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44921657|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44921658|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44921659|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921660|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704980|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
44921661|NCT03871062|Anesthetics|anesthetics|mesh-list
44921662|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921663|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921664|NCT03871114|Triamcinolone|triamcinolone|mesh-list
44921665|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44921666|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44921667|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44921668|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829303|NCT02182622|Hormones|hormones|mesh-ancestor
44829690|NCT02183272|Ketamine|ketamine|mesh-list
44829747|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829748|NCT02183350|Incretins|incretins|mesh-ancestor
44829749|NCT02183350|Hormones|hormones|mesh-ancestor
44829750|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829751|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829805|NCT02183415|Hormones|hormones|mesh-ancestor
44921669|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
44921670|NCT03871114|Hormones|hormones|mesh-ancestor
44921671|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921672|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921673|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921674|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
44921675|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921676|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921677|NCT03870828|Dimercaprol|dimercaprol|mesh-list
44921678|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
44921679|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
44921680|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921681|NCT03870594|Chrysarobin|chrysarobin|mesh-list
44921682|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921683|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921684|NCT03870594|Analgesics|analgesics|mesh-ancestor
44921685|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
44921686|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921687|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921688|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921689|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921690|NCT03870581|Warfarin|warfarin|mesh-list
44921691|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
44921692|NCT03870711|Lidocaine|lidocaine|mesh-list
44921693|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921694|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
44921695|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921696|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921697|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
44921698|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921699|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44921700|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44921701|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44921702|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921703|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921704|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
44830360|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44830511|NCT02186145|Metronidazole|metronidazole|mesh-list
44921705|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44921706|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
44921707|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921708|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
44921709|NCT03870646|Protective Agents|protective agents|mesh-ancestor
44921710|NCT03870503|Misoprostol|misoprostol|mesh-list
44921711|NCT03870503|Oxytocin|oxytocin|mesh-list
44921712|NCT03870503|Carbetocin|carbetocin|mesh-list
44921713|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
44921714|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44921715|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921716|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44921717|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
44921718|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44921719|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921720|NCT03870490|Cefepime|cefepime|mesh-list
44921721|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921722|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921723|NCT03870256|Misoprostol|misoprostol|mesh-list
44921724|NCT03870256|Carbetocin|carbetocin|mesh-list
44921725|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44921726|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
44921727|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44921728|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921729|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44921730|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921731|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
44921732|NCT03869931|Fenofibrate|fenofibrate|mesh-list
44921733|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921734|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
44921735|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44704981|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44921750|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921751|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921752|NCT03869281|Pancrelipase|pancrelipase|mesh-list
44921753|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44921754|NCT03869398|Calcitriol|calcitriol|mesh-list
44921755|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44921756|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921757|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44921758|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921759|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921760|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44921761|NCT03869398|Vitamins|vitamins|mesh-ancestor
44921762|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
44921763|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921764|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
44921765|NCT03869047|Bupivacaine|bupivacaine|mesh-list
44921766|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921767|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
44921768|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921769|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921770|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
44921771|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921772|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44830670|NCT02186951|Amoxicillin|amoxicillin|mesh-list
44830815|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921773|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921774|NCT03869047|Analgesics|analgesics|mesh-ancestor
44921775|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44921776|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44921777|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44921778|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921779|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921780|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921781|NCT03868852|Apatinib|apatinib|mesh-list
44921782|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921783|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44921784|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921785|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921786|NCT03869073|Evolocumab|evolocumab|mesh-list
44921787|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44921788|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921789|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
44921790|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921791|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921792|NCT03868969|Fosfomycin|fosfomycin|mesh-list
44921793|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921794|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716898|NCT01497470|Paclitaxel|paclitaxel|mesh-list
44921796|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44921797|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
44921798|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
44921799|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921800|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921801|NCT03868306|Chrysarobin|chrysarobin|mesh-list
44921802|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921803|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921804|NCT03868306|Analgesics|analgesics|mesh-ancestor
44921805|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
44921806|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921807|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921808|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921809|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921810|NCT03868072|Tofacitinib|tofacitinib|mesh-list
44921811|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44921812|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921813|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921814|NCT03868124|Travoprost|travoprost|mesh-list
44921815|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44921816|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44921817|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44921818|NCT03868137|Ibuprofen|ibuprofen|mesh-list
44921819|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921820|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921821|NCT03868137|Analgesics|analgesics|mesh-ancestor
44921822|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
44921823|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921824|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921825|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921826|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921827|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44831048|NCT02188615|Cisplatin|cisplatin|mesh-list
44831056|NCT02188654|Metformin|metformin|mesh-list
44921828|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921829|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921830|NCT03868111|Sufentanil|sufentanil|mesh-list
44921831|NCT03868111|Remifentanil|remifentanil|mesh-list
44921832|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44921833|NCT03868111|Narcotics|narcotics|mesh-ancestor
44921834|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831415|NCT02191319|Nevirapine|nevirapine|mesh-list
44921835|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921836|NCT03868111|Analgesics|analgesics|mesh-ancestor
44921837|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
44921838|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921839|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44921840|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44921841|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
44921842|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
44921843|NCT03868202|Estradiol|estradiol|mesh-list
44921844|NCT03868202|Progesterone|progesterone|mesh-list
44921845|NCT03868202|Estrogens|estrogens|mesh-ancestor
44921846|NCT03868202|Hormones|hormones|mesh-ancestor
44921847|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44921848|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921849|NCT03868202|Progestins|progestins|mesh-ancestor
44921850|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
44921851|NCT03868033|Denosumab|denosumab|mesh-list
44921852|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921853|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921854|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44921855|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921856|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921857|NCT03867929|Vitamin D|vitamin d|mesh-list
44921858|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44921859|NCT03867929|Calcifediol|calcifediol|mesh-list
44921860|NCT03867929|Vitamins|vitamins|mesh-ancestor
44921861|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
44921862|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921863|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921864|NCT03867994|Carvedilol|carvedilol|mesh-list
44921865|NCT03867994|Atorvastatin|atorvastatin|mesh-list
44921866|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44921867|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44921868|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
44921869|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921870|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44921871|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44921872|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921873|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44921874|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44921875|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
44921876|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921877|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921878|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44921879|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
44921880|NCT03867994|Protective Agents|protective agents|mesh-ancestor
44921881|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44921882|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44921883|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44921884|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
44831488|NCT02191826|Tolcapone|tolcapone|mesh-list
44921885|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44921886|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44921887|NCT03867695|Ropivacaine|ropivacaine|mesh-list
44921888|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
44921889|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
44921890|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921891|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921892|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
44921893|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921894|NCT03867097|Iloprost|iloprost|mesh-list
44921895|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44832022|NCT02195180|Leucovorin|leucovorin|mesh-list
44921896|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
44921897|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
44921898|NCT03867071|Hematinics|hematinics|mesh-ancestor
44921899|NCT03867370|Lenvatinib|lenvatinib|mesh-list
44921900|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921901|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44921902|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921903|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921904|NCT03867214|Tranexamic Acid|tranexamic acid|mesh-list
44921905|NCT03867214|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44921906|NCT03867214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44832096|NCT02195492|Hylan|hylan|mesh-list
44921907|NCT03867214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921908|NCT03867214|Hemostatics|hemostatics|mesh-ancestor
44921909|NCT03867214|Coagulants|coagulants|mesh-ancestor
44921910|NCT03867123|Temozolomide|temozolomide|mesh-list
44921911|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44921912|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
44921913|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921914|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921915|NCT03867240|Gabapentin|gabapentin|mesh-list
44921916|NCT03867240|Analgesics|analgesics|mesh-ancestor
44921917|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
44921918|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921919|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921920|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
44921921|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44921922|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44921923|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44921924|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44921925|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44921926|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44921927|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44921928|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921929|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
44921930|NCT03866993|Paclitaxel|paclitaxel|mesh-list
44921931|NCT03866993|Carboplatin|carboplatin|mesh-list
44921932|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44921933|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921934|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44921935|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44921936|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44921937|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921938|NCT03866928|Stiripentol|stiripentol|mesh-list
44921939|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
44921940|NCT03866746|Aflibercept|aflibercept|mesh-list
44921941|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44921942|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44921943|NCT03866746|Growth Substances|growth substances|mesh-ancestor
44921944|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921945|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
44921967|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
44921968|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44921969|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44921970|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44832572|NCT02199171|Carboplatin|carboplatin|mesh-list
44921971|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44921972|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921973|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921974|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44921975|NCT03866447|Vitamin D|vitamin d|mesh-list
44921976|NCT03866447|Adapalene|adapalene|mesh-list
44921977|NCT03866447|Vitamins|vitamins|mesh-ancestor
44921978|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
44921979|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921980|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44921981|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44921982|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44921983|NCT03866447|Analgesics|analgesics|mesh-ancestor
44921984|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
44921985|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44921986|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44921987|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44921988|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
44921989|NCT03865888|Cyclosporine|cyclosporine|mesh-list
44921990|NCT03865888|Tacrolimus|tacrolimus|mesh-list
44921991|NCT03865888|Cyclosporins|cyclosporins|mesh-list
44921992|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44921993|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
44921994|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44921995|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44832991|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
44921996|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44921997|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44921998|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
44921999|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922000|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922001|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717128|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
44922002|NCT03865550|Ketamine|ketamine|mesh-list
44922003|NCT03865550|Analgesics|analgesics|mesh-ancestor
44922004|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
44922005|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922006|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922007|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44922008|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922009|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
44922010|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
44922011|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922012|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44922013|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44922014|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922015|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922016|NCT03865563|Gemcitabine|gemcitabine|mesh-list
44922017|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
44704982|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44704983|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44704984|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44704985|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44704986|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44704987|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44704988|NCT01424839|Cisplatin|cisplatin|mesh-list
44704989|NCT01424839|Carboplatin|carboplatin|mesh-list
44704990|NCT01424839|Etoposide|etoposide|mesh-list
44704991|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
44704992|NCT01424839|Ifosfamide|ifosfamide|mesh-list
44704993|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
44704994|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44704995|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44704996|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44704997|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44704998|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44704999|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705000|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44705001|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
44705002|NCT01424891|Simvastatin|simvastatin|mesh-list
44705003|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44705004|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44705005|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
44705006|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705007|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44705008|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44705009|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705010|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
44705011|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44705012|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705013|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44705014|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44705015|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705016|NCT01425073|Renal Agents|renal agents|mesh-ancestor
44705017|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44705018|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
44705019|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44705020|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44705021|NCT01425099|Dolutegravir|dolutegravir|mesh-list
44705022|NCT01425099|Prednisone|prednisone|mesh-list
44705023|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705024|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
44705025|NCT01425099|Hormones|hormones|mesh-ancestor
44705026|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705027|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705028|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705029|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705030|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44705031|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44705032|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833494|NCT02205502|Lidocaine|lidocaine|mesh-list
44696246|NCT01390519|Everolimus|everolimus|mesh-list
44705033|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705034|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44705035|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44705036|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
44705037|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705038|NCT01425125|Tolvaptan|tolvaptan|mesh-list
44717198|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922018|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44922019|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
44922020|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922021|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922022|NCT03865563|Antiviral Agents|antiviral agents|mesh-ancestor
44922023|NCT03865563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922024|NCT03865563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922025|NCT03865563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44922026|NCT03865563|Immunologic Factors|immunologic factors|mesh-ancestor
44922027|NCT03865563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922028|NCT03865680|Fluorides|fluorides|mesh-list
44922029|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
44922030|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
44922031|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44922032|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922033|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
44922034|NCT03865680|Protective Agents|protective agents|mesh-ancestor
44922035|NCT03865511|Osimertinib|osimertinib|mesh-list
44922036|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922037|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44922038|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922039|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922040|NCT03865160|Atropine|atropine|mesh-list
44922041|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44922042|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44922043|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44922044|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922045|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922046|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
44922047|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922048|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922049|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922050|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922051|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
44922052|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
44922053|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44922054|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44922055|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
44922056|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922057|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922058|NCT03865004|Acetaminophen|acetaminophen|mesh-list
44833748|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
44922059|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44922060|NCT03865004|Morphine|morphine|mesh-list
44922061|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44922062|NCT03865004|Narcotics|narcotics|mesh-ancestor
44922063|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922064|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922065|NCT03865004|Analgesics|analgesics|mesh-ancestor
44922066|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
44922067|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922068|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922069|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
44922070|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922071|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922072|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922073|NCT03864913|Testosterone|testosterone|mesh-list
44922074|NCT03864913|Androgens|androgens|mesh-ancestor
44922075|NCT03864913|Hormones|hormones|mesh-ancestor
44834091|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44922076|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922077|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922078|NCT03865147|Acetaminophen|acetaminophen|mesh-list
44922079|NCT03865147|Cetrimonium|cetrimonium|mesh-list
44922080|NCT03865147|Ibuprofen|ibuprofen|mesh-list
44922081|NCT03865147|Lidocaine|lidocaine|mesh-list
44922082|NCT03865147|Epinephrine|epinephrine|mesh-list
44922083|NCT03865147|Racepinephrine|racepinephrine|mesh-list
44922084|NCT03865147|Bupivacaine|bupivacaine|mesh-list
44922085|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44922086|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
44922087|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922088|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
44922089|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922090|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922091|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
44717215|NCT01499485|Acetazolamide|acetazolamide|mesh-list
44834220|NCT02209909|Aspirin|aspirin|mesh-list
44922092|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922093|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922094|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44922095|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44922096|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922097|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922098|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922099|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922100|NCT03865147|Analgesics|analgesics|mesh-ancestor
44922101|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922102|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922103|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44922104|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922105|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
44922106|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44922107|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44922108|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922109|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922110|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44922111|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922112|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
44922113|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922114|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922115|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
44922116|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
44922117|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44922118|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44922119|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44922120|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922121|NCT03865121|Nicotine|nicotine|mesh-list
44922122|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44922123|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
44834447|NCT02220296|Insulin|insulin|mesh-list
44834672|NCT02221414|Metformin|metformin|mesh-list
44922124|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922125|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922126|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44922127|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44922128|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
44922129|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922130|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922131|NCT03864978|Rifaximin|rifaximin|mesh-list
44922132|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922133|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922134|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922135|NCT03864783|Curcumin|curcumin|mesh-list
44922136|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922137|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922138|NCT03864783|Analgesics|analgesics|mesh-ancestor
44922139|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
44922140|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922141|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922142|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922143|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922144|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922145|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922146|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922147|NCT03864666|Cilostazol|cilostazol|mesh-list
44922148|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922149|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
44922150|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922151|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922152|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922153|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922154|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44922155|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44922156|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922157|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922158|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922159|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44922160|NCT03864666|Protective Agents|protective agents|mesh-ancestor
44922161|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44922162|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44922163|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922164|NCT03864705|Metformin|metformin|mesh-list
44922165|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922166|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922167|NCT03864250|Prednisone|prednisone|mesh-list
44922168|NCT03864250|Tacrolimus|tacrolimus|mesh-list
44922169|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922170|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
44922171|NCT03864250|Hormones|hormones|mesh-ancestor
44922172|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922173|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922174|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44922175|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922176|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44922177|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
44922178|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44922179|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922180|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922181|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
44922182|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
44922183|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922184|NCT03864523|Pioglitazone|pioglitazone|mesh-list
44922185|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922186|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922187|NCT03864588|Ropivacaine|ropivacaine|mesh-list
44922188|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922189|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
44922190|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922191|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922192|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
44922193|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922194|NCT03864575|Celecoxib|celecoxib|mesh-list
44922195|NCT03864575|Nivolumab|nivolumab|mesh-list
44922196|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44922197|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922198|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44922199|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922200|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922201|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922202|NCT03864575|Analgesics|analgesics|mesh-ancestor
44922203|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
44922204|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922205|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922206|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922207|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922208|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44922209|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44922210|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922211|NCT03864185|Rituximab|rituximab|mesh-list
44922212|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44922213|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922214|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
44922215|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922216|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922217|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
44922218|NCT03864172|Calcium|calcium|mesh-list
44922219|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44922220|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922221|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44922222|NCT03863925|Propofol|propofol|mesh-list
44922223|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44922224|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922225|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922226|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922227|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
44922228|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
44922229|NCT03863977|Dexamethasone|dexamethasone|mesh-list
44922230|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
44922231|NCT03863977|Bupivacaine|bupivacaine|mesh-list
44922232|NCT03863977|BB 1101|bb 1101|mesh-list
44922233|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922234|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
44922235|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
44922236|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922237|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922238|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922239|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
44922240|NCT03863977|Hormones|hormones|mesh-ancestor
44922241|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922242|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44922243|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922265|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44922266|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44922267|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922268|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922269|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44922270|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44922271|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
44922272|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922273|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922274|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44922275|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44922276|NCT03863405|Metformin|metformin|mesh-list
44922277|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922278|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922279|NCT03863392|Misoprostol|misoprostol|mesh-list
44922280|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44922281|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
44922282|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44922283|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922284|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44922285|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922286|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
44922287|NCT03863626|Furosemide|furosemide|mesh-list
44922288|NCT03863626|Diuretics|diuretics|mesh-ancestor
44922289|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
44835353|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835418|NCT02226510|Metformin|metformin|mesh-list
44922290|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922291|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44922292|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922293|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922294|NCT03863613|Progesterone|progesterone|mesh-list
44922295|NCT03863613|Progestins|progestins|mesh-ancestor
44922296|NCT03863613|Hormones|hormones|mesh-ancestor
44922297|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922298|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922299|NCT03863366|Prucalopride|prucalopride|mesh-list
44922300|NCT03863366|Laxatives|laxatives|mesh-ancestor
44922301|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922302|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44922303|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44922304|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
44922305|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922306|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922307|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922308|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44922309|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922310|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44922311|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922312|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922313|NCT03862768|Sunitinib|sunitinib|mesh-list
44922314|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
44922315|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922316|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44922317|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44922318|NCT03862768|Growth Substances|growth substances|mesh-ancestor
44922319|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922320|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
44922321|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44922322|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922323|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922324|NCT03862456|Azithromycin|azithromycin|mesh-list
44922325|NCT03862456|Metronidazole|metronidazole|mesh-list
44922326|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922327|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922328|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44922329|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44922330|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
44922331|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44922332|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
44922333|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922334|NCT03862586|Expectorants|expectorants|mesh-ancestor
44922335|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922336|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44922337|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
44922338|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922339|NCT03862586|Protective Agents|protective agents|mesh-ancestor
44922340|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922341|NCT03862586|Antidotes|antidotes|mesh-ancestor
44922342|NCT03862651|Cangrelor|cangrelor|mesh-list
44922343|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922344|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44922345|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44922346|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44922347|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
44922348|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922349|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922350|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922351|NCT03862612|Anesthetics|anesthetics|mesh-list
44922352|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922353|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922354|NCT03862404|Epinephrine|epinephrine|mesh-list
44922355|NCT03862404|Bupivacaine|bupivacaine|mesh-list
44835571|NCT02227212|Insulin|insulin|mesh-list
44835649|NCT02227914|Sorafenib|sorafenib|mesh-list
44705039|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44256419|NCT00620100|Docetaxel|docetaxel|mesh-list
44705040|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705041|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
44705042|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705043|NCT01425164|Carvedilol|carvedilol|mesh-list
44705044|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44705045|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44705046|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
44705047|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705048|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705049|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705050|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705051|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
44705052|NCT01425164|Protective Agents|protective agents|mesh-ancestor
44705053|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44705054|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705055|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44705056|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
44705057|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44705058|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44705059|NCT01425216|Sorafenib|sorafenib|mesh-list
44705060|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705061|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44705062|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705063|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705064|NCT01425242|Amlodipine|amlodipine|mesh-list
44705065|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705066|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44705067|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705068|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705069|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44705070|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705071|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
44705072|NCT01425320|Dapsone|dapsone|mesh-list
44705073|NCT01425320|Adapalene|adapalene|mesh-list
44705074|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44705075|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44705076|NCT01425320|Analgesics|analgesics|mesh-ancestor
44705077|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
44705078|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705079|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705080|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705081|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705082|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705083|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705084|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
44705085|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44705086|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44705087|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44705088|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705089|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705090|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
44705091|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922356|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922357|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
44922358|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922359|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922360|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
44836248|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
44836318|NCT02231632|Vaccines|vaccines|mesh-list
44922361|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922362|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44922363|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44922364|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922365|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922366|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922367|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44922368|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922369|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
44922370|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922371|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922372|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
44922373|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
44922374|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44922375|NCT03862391|Analgesics|analgesics|mesh-list
44922376|NCT03862391|Antiemetics|antiemetics|mesh-list
44922377|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
44922378|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922379|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922380|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
44922381|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922382|NCT03862287|Lidocaine|lidocaine|mesh-list
44922383|NCT03862287|Bupivacaine|bupivacaine|mesh-list
44922384|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922385|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
44922386|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922387|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922388|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
44922389|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922390|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922391|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44922392|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44922393|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922394|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922395|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44922396|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44922397|NCT03862079|Tazobactam|tazobactam|mesh-list
44922398|NCT03862079|Piperacillin|piperacillin|mesh-list
44922399|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44922400|NCT03862079|Nystatin|nystatin|mesh-list
44922401|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922402|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922403|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44922404|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922405|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922406|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
44836614|NCT02233023|Bromocriptine|bromocriptine|mesh-list
44836691|NCT02233244|Midazolam|midazolam|mesh-list
44922407|NCT03862079|Ionophores|ionophores|mesh-ancestor
44922408|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922409|NCT03862144|Palonosetron|palonosetron|mesh-list
44922410|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
44922411|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
44922412|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922413|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922414|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922415|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44922416|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44922417|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
44922418|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922419|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922420|NCT03861598|Carvedilol|carvedilol|mesh-list
44922421|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44922422|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44922423|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922424|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922425|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922426|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837022|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
44922427|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44922428|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
44922429|NCT03861598|Protective Agents|protective agents|mesh-ancestor
44922430|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44922431|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922436|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
44922437|NCT03861403|Avelumab|avelumab|mesh-list
44922438|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44837697|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
44837772|NCT02238418|Vitamin D|vitamin d|mesh-list
44922439|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
44922440|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922441|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922442|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44922443|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
44922444|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922445|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922446|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44922447|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44922448|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44922449|NCT03861364|Propofol|propofol|mesh-list
44922450|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44922451|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922452|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922453|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922454|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
44922455|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
44922456|NCT03860870|Clenbuterol|clenbuterol|mesh-list
44922457|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44922458|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44922459|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922460|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922461|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922462|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922463|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922464|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
44922465|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922466|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922467|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922468|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
44922469|NCT03860831|Midazolam|midazolam|mesh-list
44922470|NCT03860831|Ketamine|ketamine|mesh-list
44922471|NCT03860831|Analgesics|analgesics|mesh-ancestor
44922472|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
44922473|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922474|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922475|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44922476|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922477|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
44922478|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
44922479|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922480|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44922481|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44922482|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922483|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837956|NCT02239835|Ritonavir|ritonavir|mesh-list
44922484|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44922485|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44922486|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44922487|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44922488|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44922489|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
44922490|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
44922491|NCT03860662|Baclofen|baclofen|mesh-list
44922492|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44922493|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922494|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44922495|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922496|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44922497|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
44922498|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
44922499|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922500|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922501|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44922502|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44922503|NCT03860636|Estradiol|estradiol|mesh-list
44922504|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44922505|NCT03860636|Progesterone|progesterone|mesh-list
44922506|NCT03860636|Estrogens|estrogens|mesh-ancestor
44922507|NCT03860636|Hormones|hormones|mesh-ancestor
44922508|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922509|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717768|NCT01501708|Amebicides|amebicides|mesh-ancestor
44922510|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44922511|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
44922512|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44922513|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44922514|NCT03860636|Progestins|progestins|mesh-ancestor
44922515|NCT03860480|Bupivacaine|bupivacaine|mesh-list
44922516|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922517|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
44922518|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922519|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922520|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
44922521|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922523|NCT03860012|Hematinics|hematinics|mesh-ancestor
44922524|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
44922525|NCT03860012|Vitamins|vitamins|mesh-ancestor
44922526|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
44922527|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922528|NCT03860129|Sevoflurane|sevoflurane|mesh-list
44922529|NCT03860129|Desflurane|desflurane|mesh-list
44922530|NCT03860129|Isoflurane|isoflurane|mesh-list
44922531|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922532|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44922533|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
44922534|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
44838182|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922535|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838358|NCT05000736|Fulvestrant|fulvestrant|mesh-list
44838434|NCT04509336|Orphenadrine|orphenadrine|mesh-list
44922536|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922537|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44922538|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44922539|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44922540|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
44922541|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922542|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44922543|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44922544|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44922545|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922546|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44922547|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922548|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44922549|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922550|NCT03859934|Melatonin|melatonin|mesh-list
44922551|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
44922552|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922553|NCT03859934|Protective Agents|protective agents|mesh-ancestor
44922554|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922555|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922556|NCT03859908|Ethanol|ethanol|mesh-list
44922557|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
44922558|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44922559|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44922560|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922561|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922562|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922563|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
44922564|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922565|NCT03859856|Hormones|hormones|mesh-list
44922566|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922567|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922568|NCT03859583|Capsaicin|capsaicin|mesh-list
44922569|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
44922570|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922571|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
44922572|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922573|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922574|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
44922575|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44922576|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922577|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922578|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922579|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44922580|NCT03859570|Protective Agents|protective agents|mesh-ancestor
44922581|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922582|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922583|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44922584|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
44922585|NCT03859362|Ertapenem|ertapenem|mesh-list
44838503|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44838655|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44838759|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
44922586|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922587|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922589|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922590|NCT03859141|Vaccines|vaccines|mesh-list
44922591|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
44922592|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922593|NCT03859102|Acetaminophen|acetaminophen|mesh-list
44922594|NCT03859102|Dexamethasone|dexamethasone|mesh-list
44922595|NCT03859102|Gabapentin|gabapentin|mesh-list
44922596|NCT03859102|Ondansetron|ondansetron|mesh-list
44922597|NCT03859102|Anesthetics|anesthetics|mesh-list
44922598|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
44922599|NCT03859102|Lansoprazole|lansoprazole|mesh-list
44922600|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
44922601|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922602|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
44922603|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
44922604|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922605|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922606|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922607|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
44922608|NCT03859102|Hormones|hormones|mesh-ancestor
44922609|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922610|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44922611|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922612|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922613|NCT03859102|Analgesics|analgesics|mesh-ancestor
44922614|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
44922615|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
44922616|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838877|NCT02684162|Guadecitabine|guadecitabine|mesh-list
44922617|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
44922618|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44922619|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44922620|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44922621|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44922622|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44922623|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922624|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839231|NCT02251184|Aspirin|aspirin|mesh-list
44839458|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
44922625|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
44922626|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
44922627|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922628|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44922629|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
44705092|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44705093|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44705094|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44705095|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
44705096|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705097|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44705098|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44705099|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705100|NCT01425411|Valsartan|valsartan|mesh-list
44705101|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705102|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44705103|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44705104|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705105|NCT01425424|Vitamin D|vitamin d|mesh-list
44705106|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
44705107|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
44705108|NCT01425424|Vitamins|vitamins|mesh-list
44705109|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
44705110|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705111|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44705112|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44705113|NCT01425476|Vitamin D|vitamin d|mesh-list
44705114|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
44705115|NCT01425476|Celecoxib|celecoxib|mesh-list
44705116|NCT01425476|Vitamins|vitamins|mesh-ancestor
44705117|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
44705118|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705119|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44705120|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44705121|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44717911|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
44922630|NCT03859102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44922631|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44922643|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
44922644|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44922645|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922646|NCT03858465|Phenylephrine|phenylephrine|mesh-list
44922647|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
44922649|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44922650|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
44839728|NCT02253420|Itraconazole|itraconazole|mesh-list
44922651|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
44922652|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922653|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922654|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
44922655|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44922656|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
44922657|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922658|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44922659|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44922660|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44922661|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922662|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922663|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922664|NCT03858465|Protective Agents|protective agents|mesh-ancestor
44922665|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44922666|NCT03858387|Meropenem|meropenem|mesh-list
44922667|NCT03858387|Imipenem|imipenem|mesh-list
44922668|NCT03858387|Cilastatin|cilastatin|mesh-list
44922669|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922670|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922671|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
44922672|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922673|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922674|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44922675|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922676|NCT03858270|Memantine|memantine|mesh-list
44922677|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44922678|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44922679|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
44922680|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922681|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922682|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922683|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44922684|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44922685|NCT03858062|Insulin|insulin|mesh-list
44922686|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44922687|NCT03858062|Pancrelipase|pancrelipase|mesh-list
44922688|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922689|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922690|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922691|NCT03857854|Pirfenidone|pirfenidone|mesh-list
44922692|NCT03857854|Analgesics|analgesics|mesh-ancestor
44922693|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
44922694|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922695|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922696|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922697|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922698|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922699|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922700|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922701|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44922702|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922703|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922704|NCT03857399|Caspofungin|caspofungin|mesh-list
44922705|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
44922706|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922707|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922708|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922709|NCT03857711|Amiodarone|amiodarone|mesh-list
44922710|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922711|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922712|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44922713|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922714|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922715|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44922716|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44718032|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922717|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44922718|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922719|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44922720|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44840176|NCT02254629|Laxatives|laxatives|mesh-list
44840234|NCT02254967|Vancomycin|vancomycin|mesh-list
44840385|NCT02255812|Quinine|quinine|mesh-list
44922721|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44922722|NCT03857763|Paclitaxel|paclitaxel|mesh-list
44922723|NCT03857763|Cisplatin|cisplatin|mesh-list
44922724|NCT03857763|Apatinib|apatinib|mesh-list
44922725|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44922726|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922727|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44922728|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44922729|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44922730|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922731|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44922732|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922733|NCT03857386|Anesthetics|anesthetics|mesh-list
44922734|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922735|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922736|NCT03857815|Antibodies|antibodies|mesh-list
44922737|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
44922738|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922739|NCT03857581|Olanzapine|olanzapine|mesh-list
44922740|NCT03857581|Clozapine|clozapine|mesh-list
44922741|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
44922742|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
44922743|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922744|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922745|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922746|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44922747|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44922748|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922749|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44922750|NCT03857581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44922751|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44922752|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922753|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922754|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922755|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
44922756|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44922757|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
44922758|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
44922759|NCT03857334|Cortivazol|cortivazol|mesh-list
44922760|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922761|NCT03856853|Pirfenidone|pirfenidone|mesh-list
44922762|NCT03856853|Analgesics|analgesics|mesh-ancestor
44922763|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
44922764|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922765|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922766|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44922767|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44922768|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922769|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922770|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922771|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
44922772|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
44922773|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44922774|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44922775|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922776|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840704|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922777|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922778|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44922779|NCT03856970|Glyburide|glyburide|mesh-list
44922780|NCT03856970|Digoxin|digoxin|mesh-list
44922781|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44922782|NCT03856970|Norethindrone|norethindrone|mesh-list
44922783|NCT03856970|Estradiol|estradiol|mesh-list
44922784|NCT03856970|Estrogens|estrogens|mesh-ancestor
44922785|NCT03856970|Hormones|hormones|mesh-ancestor
44922786|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922787|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922788|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44922789|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
44922790|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44922791|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44922792|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44922801|NCT03856671|Metronidazole|metronidazole|mesh-list
44922802|NCT03856671|Neomycin|neomycin|mesh-list
44922803|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922804|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44922805|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44922806|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44922807|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44922808|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922809|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922810|NCT03856697|Gefitinib|gefitinib|mesh-list
44922811|NCT03856697|Maleic acid|maleic acid|mesh-list
44922812|NCT03856697|Abivertinib|abivertinib|mesh-list
44922813|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922814|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922815|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922816|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44922817|NCT03856502|Dexamethasone|dexamethasone|mesh-list
44922818|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
44922819|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
44922820|NCT03856502|BB 1101|bb 1101|mesh-list
44922821|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922822|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
44922823|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
44922824|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922825|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922826|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922827|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
44922828|NCT03856502|Hormones|hormones|mesh-ancestor
44922829|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922830|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44922831|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922832|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44922833|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922834|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922835|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
44922836|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
44922837|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922838|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
44922839|NCT03856242|Tamsulosin|tamsulosin|mesh-list
44922840|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44922841|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44922842|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44922843|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
44922844|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922845|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922846|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840912|NCT02258282|Etanercept|etanercept|mesh-list
44922847|NCT03856242|Urological Agents|urological agents|mesh-ancestor
44841076|NCT02259777|Amlodipine|amlodipine|mesh-list
44922848|NCT03856112|Dexamethasone|dexamethasone|mesh-list
44922849|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
44922850|NCT03856112|Venetoclax|venetoclax|mesh-list
44922851|NCT03856112|Ixazomib|ixazomib|mesh-list
44922852|NCT03856112|Ichthammol|ichthammol|mesh-list
44922853|NCT03856112|BB 1101|bb 1101|mesh-list
44922854|NCT03856112|Glycine|glycine|mesh-list
44922855|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44922856|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
44922857|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
44922858|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922859|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922860|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44922861|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
44922862|NCT03856112|Hormones|hormones|mesh-ancestor
44922863|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44922864|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44922865|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922866|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922867|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44922868|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922869|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
44922870|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922871|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
44922872|NCT03855865|Vortioxetine|vortioxetine|mesh-list
44922873|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
44922874|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44922875|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44922876|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44922877|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922878|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922880|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44922881|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922882|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922883|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44922884|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
44922885|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44922886|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44922887|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44922888|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44922889|NCT03855826|Amiodarone|amiodarone|mesh-list
44922890|NCT03855826|Nifekalant|nifekalant|mesh-list
44922891|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44922892|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922893|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44922894|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44922895|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922896|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44922897|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44922898|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44922899|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841220|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44841242|NCT02260037|Epinastine|epinastine|mesh-list
44922900|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44922901|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44922902|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44922903|NCT03855501|Calcium|calcium|mesh-list
44922904|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44922905|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922906|NCT03855579|Simendan|simendan|mesh-list
44922907|NCT03855579|Milrinone|milrinone|mesh-list
44922908|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44922909|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922910|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44922911|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44922912|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705122|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44705123|NCT01425476|Analgesics|analgesics|mesh-ancestor
44705124|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
44705125|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705126|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705127|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705128|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44705129|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44705130|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705131|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705132|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44705133|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44705134|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44705135|NCT01425580|Metformin|metformin|mesh-list
44705136|NCT01425580|Liraglutide|liraglutide|mesh-list
44705137|NCT01425580|Glimepiride|glimepiride|mesh-list
44705138|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705139|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705140|NCT01425580|Incretins|incretins|mesh-ancestor
44705141|NCT01425580|Hormones|hormones|mesh-ancestor
44705142|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705143|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44705144|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705145|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
44705146|NCT01425619|Lidocaine|lidocaine|mesh-list
44705147|NCT01425619|Prilocaine|prilocaine|mesh-list
44705148|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705149|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
44705150|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705151|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705152|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
44705153|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705154|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44705155|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44705156|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44705157|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705158|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922913|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922914|NCT03855579|Protective Agents|protective agents|mesh-ancestor
44922915|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922916|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922917|NCT03855423|Tocotrienols|tocotrienols|mesh-list
44922918|NCT03855423|Vitamin E|vitamin e|mesh-list
44922919|NCT03855423|Tocopherols|tocopherols|mesh-list
44922920|NCT03855423|Tocovid|tocovid|mesh-list
44922921|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
44922922|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922923|NCT03855423|Protective Agents|protective agents|mesh-ancestor
44922924|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922925|NCT03855423|Vitamins|vitamins|mesh-ancestor
44922926|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
44922927|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
44922928|NCT03855527|Fluorides|fluorides|mesh-list
44922929|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
44922930|NCT03855527|Protective Agents|protective agents|mesh-ancestor
44922931|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922932|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44922933|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44922934|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
44922935|NCT03855306|Glyburide|glyburide|mesh-list
44922936|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44922937|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922938|NCT03855384|Cisplatin|cisplatin|mesh-list
44922939|NCT03855384|Carboplatin|carboplatin|mesh-list
44922940|NCT03855384|Fluorouracil|fluorouracil|mesh-list
44922941|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44922942|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
44922943|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922944|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44922945|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44922946|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
44922947|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922948|NCT03855332|Cilostazol|cilostazol|mesh-list
44922949|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
44922950|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
44922951|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44922952|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44922953|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44922954|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44922955|NCT03855332|Urological Agents|urological agents|mesh-ancestor
44922956|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44922957|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
44922958|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922959|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922960|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44922961|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
44922962|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44922963|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44922964|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44922965|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44922966|NCT03855332|Protective Agents|protective agents|mesh-ancestor
44922967|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44922968|NCT03855267|Propofol|propofol|mesh-list
44922969|NCT03855267|Etomidate|etomidate|mesh-list
44922970|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44841876|NCT02263677|Incretins|incretins|mesh-ancestor
44842018|NCT02264171|Ketoconazole|ketoconazole|mesh-list
44922971|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922972|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922973|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922974|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
44922975|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
44922976|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
44922977|NCT03854812|Fentanyl|fentanyl|mesh-list
44922978|NCT03854812|Propofol|propofol|mesh-list
44922979|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44922980|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44922981|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44922982|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44922983|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
44922984|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
44922985|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44922986|NCT03854812|Narcotics|narcotics|mesh-ancestor
44922987|NCT03854812|Analgesics|analgesics|mesh-ancestor
44922988|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
44922989|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44922990|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44923004|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923005|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
44923006|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923007|NCT03854708|Hormones|hormones|mesh-ancestor
44923008|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923009|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923010|NCT03854383|Isosorbide|isosorbide|mesh-list
44923011|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44923012|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44923013|NCT03854383|Misoprostol|misoprostol|mesh-list
44923014|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44923015|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
44923016|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923017|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923018|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44923019|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923020|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
44923021|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44923022|NCT03854383|Diuretics|diuretics|mesh-ancestor
44923023|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
44923024|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923025|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44923026|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923027|NCT03854617|Vinorelbine|vinorelbine|mesh-list
44923028|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44923029|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842171|NCT02264912|Ticagrelor|ticagrelor|mesh-list
44923030|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
44923031|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
44923032|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
44923033|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923034|NCT03854409|Aripiprazole|aripiprazole|mesh-list
44923035|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
44923036|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44923037|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44923038|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44923039|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923040|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923041|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
44923042|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
44923043|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923044|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923045|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44923046|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44923047|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
44923048|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44923049|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44923050|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44923051|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44923052|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44923053|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44923054|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
44923055|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923056|NCT03854266|Heparin|heparin|mesh-list
44923057|NCT03854266|Calcium heparin|calcium heparin|mesh-list
44923058|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44923059|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
44923060|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44923061|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44923062|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923063|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
44923064|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44923065|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44923066|NCT03854175|Estradiol|estradiol|mesh-list
44842612|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
44923067|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44923068|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923069|NCT03854175|Estrogens|estrogens|mesh-ancestor
44923070|NCT03854175|Hormones|hormones|mesh-ancestor
44923071|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923072|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923073|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44923074|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
44923075|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923076|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44923077|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923078|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44923079|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44923080|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923081|NCT03854175|Urological Agents|urological agents|mesh-ancestor
44923082|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
44923083|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44923084|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
44923085|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
44923086|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923087|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923088|NCT03853993|Vaccines|vaccines|mesh-list
44923089|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
44923090|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923091|NCT03853785|Podophyllin|podophyllin|mesh-list
44923092|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44923093|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923094|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
44923095|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923096|NCT03853525|Petrolatum|petrolatum|mesh-list
44923097|NCT03853525|Emollients|emollients|mesh-ancestor
44923098|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923099|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
44923100|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44923101|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
44923102|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923103|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923104|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44923105|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44923106|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44923107|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
44923108|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923109|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923110|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44923111|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923112|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
44923113|NCT03853642|Protective Agents|protective agents|mesh-ancestor
44923114|NCT03853538|Petrolatum|petrolatum|mesh-list
44923115|NCT03853538|Emollients|emollients|mesh-ancestor
44923116|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923117|NCT03853304|Folic Acid|folic acid|mesh-list
44923118|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
44923119|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
44923120|NCT03853304|Vitamins|vitamins|mesh-ancestor
44923121|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
44923122|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923123|NCT03853304|Hematinics|hematinics|mesh-ancestor
44923124|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
44923125|NCT03853512|Petrolatum|petrolatum|mesh-list
44923126|NCT03853512|Emollients|emollients|mesh-ancestor
44923127|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923128|NCT03853369|Nifekalant|nifekalant|mesh-list
44923129|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923130|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
44923147|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842699|NCT02268773|Aspirin|aspirin|mesh-list
44842778|NCT02269202|Midazolam|midazolam|mesh-list
44923148|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44923149|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44923150|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
44923151|NCT03853096|Cefazolin|cefazolin|mesh-list
44923152|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44923153|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923154|NCT03852979|Paclitaxel|paclitaxel|mesh-list
44923155|NCT03852979|Carboplatin|carboplatin|mesh-list
44923156|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44923157|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923158|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44923159|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44923160|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44923161|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923162|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
44923163|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44923164|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
44923165|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923166|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
44923167|NCT03852914|Protective Agents|protective agents|mesh-ancestor
44923168|NCT03852628|Naltrexone|naltrexone|mesh-list
44923169|NCT03852628|Buprenorphine|buprenorphine|mesh-list
44923170|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44923171|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44923172|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923173|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
44923174|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923175|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923176|NCT03852628|Narcotics|narcotics|mesh-ancestor
44923177|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923178|NCT03852628|Analgesics|analgesics|mesh-ancestor
44923179|NCT03852303|Ivermectin|ivermectin|mesh-list
44923180|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
44923181|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44923182|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923183|NCT03852602|Analgesics|analgesics|mesh-list
44923184|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
44923185|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923186|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923187|NCT03852446|Tryptophan|tryptophan|mesh-list
44923188|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44923189|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
44923190|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44923191|NCT03852563|Petrolatum|petrolatum|mesh-list
44923192|NCT03852563|Emollients|emollients|mesh-ancestor
44923193|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705159|NCT01425658|Clonidine|clonidine|mesh-list
44843378|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
44923195|NCT03852160|Mirtazapine|mirtazapine|mesh-list
44923196|NCT03852160|Trazodone|trazodone|mesh-list
44923197|NCT03852160|S 20098|s 20098|mesh-list
44923198|NCT03852160|Citalopram|citalopram|mesh-list
44923199|NCT03852160|Bupropion|bupropion|mesh-list
44843749|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
44923200|NCT03852160|Sertraline|sertraline|mesh-list
44923201|NCT03852160|Esketamine|esketamine|mesh-list
44923202|NCT03852160|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44923203|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44923204|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923205|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923206|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923207|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
44923208|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923209|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44923210|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
44923211|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44923212|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923213|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44923214|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
44923215|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44923216|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44923217|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923218|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44923219|NCT03852160|Analgesics|analgesics|mesh-ancestor
44923220|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
44923221|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44923222|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
44923223|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
44923224|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44923225|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44923226|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923227|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44923228|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44923229|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44923230|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
44923231|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44923232|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44923233|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44923234|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44923235|NCT03852056|Fluorides|fluorides|mesh-list
44923236|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
44923237|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
44923238|NCT03852056|Protective Agents|protective agents|mesh-ancestor
44923239|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923240|NCT03851731|Naltrexone|naltrexone|mesh-list
44923241|NCT03851731|Naloxone|naloxone|mesh-list
44923242|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44923243|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44923244|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923245|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
44844099|NCT04397484|Lidocaine|lidocaine|mesh-list
44923246|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705160|NCT01425658|Fentanyl|fentanyl|mesh-list
44705161|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44705162|NCT01425658|Narcotics|narcotics|mesh-ancestor
44705163|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705164|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705165|NCT01425658|Analgesics|analgesics|mesh-ancestor
44705166|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
44705167|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705168|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44705169|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44705170|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
44705171|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
44705172|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705173|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
44705174|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
44705175|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44705176|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44705177|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44705178|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
44705179|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718670|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923247|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44923248|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
44923249|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923251|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923252|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923253|NCT03851562|Alprostadil|alprostadil|mesh-list
44923254|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44923255|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923256|NCT03851562|Urological Agents|urological agents|mesh-ancestor
44923257|NCT03851289|Calcium|calcium|mesh-list
44923258|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44923259|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923260|NCT03851341|Metformin|metformin|mesh-list
44923261|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44923262|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923263|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923264|NCT03851341|Incretins|incretins|mesh-ancestor
44923265|NCT03851341|Hormones|hormones|mesh-ancestor
44923266|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923267|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44923268|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
44923269|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923270|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923271|NCT03851172|Ketorolac|ketorolac|mesh-list
44923272|NCT03851172|Nepafenac|nepafenac|mesh-list
44923273|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
44923274|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44923275|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923276|NCT03851172|Analgesics|analgesics|mesh-ancestor
44923277|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
44923278|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923279|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923280|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923281|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923282|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44923283|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844638|NCT03201458|Atezolizumab|atezolizumab|mesh-list
44844849|NCT01750281|Docetaxel|docetaxel|mesh-list
44844918|NCT00873275|Antidotes|antidotes|mesh-ancestor
44923284|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923285|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
44923286|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
44923287|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
44923288|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44923289|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44923290|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
44923291|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923292|NCT03851393|Citric Acid|citric acid|mesh-list
44923293|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
44923294|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
44923295|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44923296|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
44923297|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
44923298|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923299|NCT03851263|Evolocumab|evolocumab|mesh-list
44923300|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44923301|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44923302|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
44923303|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923304|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44923305|NCT03850886|Niacinamide|niacinamide|mesh-list
44923306|NCT03850886|Niacin|niacin|mesh-list
44923307|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
44923308|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44923309|NCT03850886|Vitamins|vitamins|mesh-ancestor
44923310|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
44923311|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923312|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
44923313|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44845271|NCT02280616|Budesonide|budesonide|mesh-list
44923314|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
44923315|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923316|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44923317|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923318|NCT03850769|Paclitaxel|paclitaxel|mesh-list
44923319|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44923320|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923321|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44923322|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44923323|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44923324|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923325|NCT03850561|Ubiquinone|ubiquinone|mesh-list
44923326|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
44923327|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
44923328|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923329|NCT03850561|Vitamins|vitamins|mesh-ancestor
44923330|NCT03850652|Iron|iron|mesh-list
44923331|NCT03850652|Trace Elements|trace elements|mesh-ancestor
44923332|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
44923333|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923334|NCT03850587|Celecoxib|celecoxib|mesh-list
44923335|NCT03850587|Tramadol|tramadol|mesh-list
44923336|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44923337|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923338|NCT03850587|Analgesics|analgesics|mesh-ancestor
44923339|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
44923340|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923341|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923342|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923343|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923344|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44923345|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44923346|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845388|NCT02281201|Thrombin|thrombin|mesh-list
44845453|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
44923347|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923348|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923349|NCT03850587|Narcotics|narcotics|mesh-ancestor
44923350|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923351|NCT03850314|Glycine|glycine|mesh-list
44923352|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
44923353|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923354|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923355|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923356|NCT03850028|Atezolizumab|atezolizumab|mesh-list
44923357|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923358|NCT03849833|Vitamin D|vitamin d|mesh-list
44923359|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
44923360|NCT03849833|Vitamins|vitamins|mesh-ancestor
44923361|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
44923362|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923363|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44923364|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44923365|NCT03849508|Phenylephrine|phenylephrine|mesh-list
44923366|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
44923367|NCT03849508|Norepinephrine|norepinephrine|mesh-list
44923368|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44923369|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
44923370|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
44923371|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923372|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923373|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
44923374|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44923375|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
44923376|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44923377|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44923378|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44923379|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44923380|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
44923381|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923382|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923383|NCT03849508|Protective Agents|protective agents|mesh-ancestor
44923384|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
44923385|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923386|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923387|NCT03849664|Riboflavin|riboflavin|mesh-list
44923388|NCT03849664|Niacinamide|niacinamide|mesh-list
44923389|NCT03849664|Niacin|niacin|mesh-list
44923390|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
44923391|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
44923392|NCT03849664|Povidone|povidone|mesh-list
44923393|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44845681|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845855|NCT02283710|Protective Agents|protective agents|mesh-ancestor
44845928|NCT02284048|Ticagrelor|ticagrelor|mesh-list
44923394|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923395|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
44923396|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
44923397|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
44923398|NCT03849664|Vitamins|vitamins|mesh-ancestor
44923399|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
44923400|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44923401|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923402|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44923403|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
44923404|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923418|NCT03849404|Adalimumab|adalimumab|mesh-list
44923419|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923420|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923421|NCT03849209|Pancrelipase|pancrelipase|mesh-list
44923422|NCT03849209|Pancreatin|pancreatin|mesh-list
44923423|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923424|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
44923425|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44923426|NCT03849235|Glucagon|glucagon|mesh-list
44923427|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923428|NCT03849235|Hormones|hormones|mesh-ancestor
44923429|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923430|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923431|NCT03849196|Bisacodyl|bisacodyl|mesh-list
44923432|NCT03849196|Cathartics|cathartics|mesh-ancestor
44923433|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923434|NCT03849196|Laxatives|laxatives|mesh-ancestor
44923435|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
44923436|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44923437|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
44923438|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
44923439|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923440|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923441|NCT03848611|Vorolanib|vorolanib|mesh-list
44923442|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44923443|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923444|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923445|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
44923446|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923447|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923448|NCT03848806|Calcitriol|calcitriol|mesh-list
44923449|NCT03848806|Calcipotriene|calcipotriene|mesh-list
44923450|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923451|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44923452|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923453|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44923454|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923455|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923456|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44923457|NCT03848806|Vitamins|vitamins|mesh-ancestor
44923458|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
44923459|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44923460|NCT03848533|Metformin|metformin|mesh-list
44923461|NCT03848533|Melatonin|melatonin|mesh-list
44923462|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923463|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923464|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
44923465|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923466|NCT03848533|Protective Agents|protective agents|mesh-ancestor
44923467|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923468|NCT03848182|Gemcitabine|gemcitabine|mesh-list
44923469|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44923470|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
44923471|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923472|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923473|NCT03848182|Antiviral Agents|antiviral agents|mesh-ancestor
44923474|NCT03848182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923475|NCT03848182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923476|NCT03848182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44923477|NCT03848182|Immunologic Factors|immunologic factors|mesh-ancestor
44923478|NCT03848182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923479|NCT03848780|Desflurane|desflurane|mesh-list
44923480|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44923481|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
44923482|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
44923483|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923484|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923485|NCT03848234|Estradiol|estradiol|mesh-list
44846277|NCT02286635|Rifampin|rifampin|mesh-list
44846349|NCT02286986|Cannabidiol|cannabidiol|mesh-list
44923486|NCT03848234|Estrogens|estrogens|mesh-ancestor
44923487|NCT03848234|Hormones|hormones|mesh-ancestor
44923488|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923489|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923490|NCT03848104|Cefoxitin|cefoxitin|mesh-list
44923491|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44923492|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923493|NCT03848065|Vaccines|vaccines|mesh-list
44923494|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
44923495|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923496|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44923497|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923498|NCT03848039|Vaccines|vaccines|mesh-list
44923499|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
44923500|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923501|NCT03847818|Carboplatin|carboplatin|mesh-list
44923502|NCT03847818|Docetaxel|docetaxel|mesh-list
44923503|NCT03847818|Trastuzumab|trastuzumab|mesh-list
44923504|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923505|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
44923506|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
44923507|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
44923508|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923509|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44923510|NCT03847792|Dexamethasone|dexamethasone|mesh-list
44923511|NCT03847792|Fentanyl|fentanyl|mesh-list
44923512|NCT03847792|Bupivacaine|bupivacaine|mesh-list
44923513|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923514|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
44923515|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
44923516|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923517|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923518|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923519|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
44923520|NCT03847792|Hormones|hormones|mesh-ancestor
44923521|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923522|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44923523|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923524|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923525|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
44923526|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923527|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
44923528|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923529|NCT03847792|Narcotics|narcotics|mesh-ancestor
44923530|NCT03847792|Analgesics|analgesics|mesh-ancestor
44923531|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44923532|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846605|NCT02289261|Morphine|morphine|mesh-list
44846686|NCT02289547|Capecitabine|capecitabine|mesh-list
44923533|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
44923534|NCT03847571|Acetazolamide|acetazolamide|mesh-list
44923535|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
44923536|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44923537|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923538|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923539|NCT03847571|Diuretics|diuretics|mesh-ancestor
44923540|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
44923541|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923542|NCT03847922|Lidocaine|lidocaine|mesh-list
44923543|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
44923544|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923545|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
44923546|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923547|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923548|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
44923549|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923550|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923551|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44923552|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44923553|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923554|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923555|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44923556|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
44923557|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923558|NCT03847922|Analgesics|analgesics|mesh-ancestor
44923559|NCT03847623|Curcumin|curcumin|mesh-list
44923560|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44923561|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923562|NCT03847623|Analgesics|analgesics|mesh-ancestor
44923563|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
44923564|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923565|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923566|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923567|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923568|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923569|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923570|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923571|NCT03847558|Hormones|hormones|mesh-list
44923572|NCT03847558|Testosterone|testosterone|mesh-list
44923586|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923588|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44923589|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
44923590|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923591|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923592|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44923593|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44923594|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44923595|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923596|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719103|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
44719104|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719105|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719106|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44719107|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
44719108|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
44719109|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44719110|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44719111|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44719112|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719113|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719114|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719115|NCT01507727|Tolvaptan|tolvaptan|mesh-list
44719116|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44719117|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719118|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
44719119|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719120|NCT01507740|Bevacizumab|bevacizumab|mesh-list
44719121|NCT01507740|Sorafenib|sorafenib|mesh-list
44719122|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719123|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719124|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44719125|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44719126|NCT01507740|Growth Substances|growth substances|mesh-ancestor
44719127|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719128|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
44719129|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44719130|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719131|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719132|NCT01507792|Loratadine|loratadine|mesh-list
44719133|NCT01507792|Omeprazole|omeprazole|mesh-list
44719134|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44719135|NCT01507792|Histamine|histamine|mesh-list
44719136|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719137|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923597|NCT03847272|Prednisone|prednisone|mesh-list
44923598|NCT03847272|Ustekinumab|ustekinumab|mesh-list
44923599|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923600|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
44923601|NCT03847272|Hormones|hormones|mesh-ancestor
44923602|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923603|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847006|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
44923604|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44923605|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923606|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923607|NCT03847441|Vitamin D|vitamin d|mesh-list
44923608|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
44705180|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705181|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
44705182|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44705183|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44705184|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705185|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
44705186|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705187|NCT01425736|Cisplatin|cisplatin|mesh-list
44705188|NCT01425736|Docetaxel|docetaxel|mesh-list
44705189|NCT01425736|Fluorouracil|fluorouracil|mesh-list
44705190|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
44705191|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705192|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
44705193|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44705194|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
44705195|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847184|NCT02293525|Oxycodone|oxycodone|mesh-list
44705196|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
44705197|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44705198|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705199|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
44705200|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705201|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705202|NCT01425775|Vitamin D|vitamin d|mesh-list
44705203|NCT01425775|Vitamins|vitamins|mesh-ancestor
44705204|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
44705205|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705206|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44705207|NCT05386446|Interferons|interferons|mesh-list
44705208|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
44705209|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705210|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
44705211|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705212|NCT05386290|Mesalamine|mesalamine|mesh-list
44705213|NCT05386290|Infliximab|infliximab|mesh-list
44705214|NCT05386290|Ustekinumab|ustekinumab|mesh-list
44705215|NCT05386290|Vedolizumab|vedolizumab|mesh-list
44705216|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705217|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705218|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705219|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44705220|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847726|NCT02295930|Bevacizumab|bevacizumab|mesh-list
44705221|NCT05386290|Analgesics|analgesics|mesh-ancestor
44705222|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
44705223|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705224|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705225|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705226|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44705227|NCT05386186|Glimepiride|glimepiride|mesh-list
44705228|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44705229|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705230|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705231|NCT05386186|Incretins|incretins|mesh-ancestor
44705232|NCT05386186|Hormones|hormones|mesh-ancestor
44705233|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705234|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705235|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705236|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705237|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44705238|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705239|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
44923609|NCT03847441|Calcipotriene|calcipotriene|mesh-list
44705240|NCT05386160|Ranibizumab|ranibizumab|mesh-list
44705241|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44705242|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44705243|NCT05386160|Growth Substances|growth substances|mesh-ancestor
44705244|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923610|NCT03847441|Vitamins|vitamins|mesh-ancestor
44923611|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
44923612|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923613|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44923614|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44923615|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923616|NCT03847376|Rilpivirine|rilpivirine|mesh-list
44923617|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44923618|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44923619|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923620|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923621|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
44923622|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923623|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44923624|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44923625|NCT03846739|Oxytocin|oxytocin|mesh-list
44923626|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
44923627|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923628|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923629|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
44923630|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44923631|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44923632|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923633|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
44923634|NCT03846973|Coagulants|coagulants|mesh-ancestor
44923635|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
44923636|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44923637|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44923638|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
44923639|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923640|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923641|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44923642|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
44923643|NCT03846271|Oxytocin|oxytocin|mesh-list
44923644|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
44923645|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923646|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923647|NCT03846388|Hormones|hormones|mesh-list
44923648|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44923649|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923650|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923651|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44923652|NCT03846583|Trastuzumab|trastuzumab|mesh-list
44923653|NCT03846583|Tucatinib|tucatinib|mesh-list
44923654|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44923655|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44923656|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923657|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44923658|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923659|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923660|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44923661|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
44923662|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923663|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923664|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44923665|NCT03846180|Octreotide|octreotide|mesh-list
44923666|NCT03846180|Terlipressin|terlipressin|mesh-list
44923667|NCT03846180|Somatostatin|somatostatin|mesh-list
44923668|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923669|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44923670|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923671|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44923672|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44923673|NCT03846180|Hormones|hormones|mesh-ancestor
44923674|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923675|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923676|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
44923677|NCT03846284|Bupivacaine|bupivacaine|mesh-list
44923678|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
44923679|NCT03846284|Anesthetics|anesthetics|mesh-list
44923680|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
44923681|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923682|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923683|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
44705245|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
44848149|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848308|NCT02299726|Spironolactone|spironolactone|mesh-list
44923684|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923685|NCT03846284|Analgesics|analgesics|mesh-ancestor
44923686|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923687|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
44923688|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44923689|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923690|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923691|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44923692|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
44923693|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923694|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44923695|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44923696|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923697|NCT03846102|Acetaminophen|acetaminophen|mesh-list
44923698|NCT03846102|Morphine|morphine|mesh-list
44923699|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
44923700|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923701|NCT03846102|Narcotics|narcotics|mesh-ancestor
44923702|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923703|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923704|NCT03846102|Analgesics|analgesics|mesh-ancestor
44923705|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
44923706|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923707|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923708|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
44923709|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923710|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
44923711|NCT03845699|Fentanyl|fentanyl|mesh-list
44923712|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923713|NCT03845699|Narcotics|narcotics|mesh-ancestor
44923714|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923715|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923716|NCT03845699|Analgesics|analgesics|mesh-ancestor
44923717|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
44848554|NCT02301676|Propofol|propofol|mesh-list
44923718|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923719|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44923720|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44923721|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
44923722|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
44923723|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44923724|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923725|NCT03845881|Oxycodone|oxycodone|mesh-list
44923726|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923727|NCT03845881|Narcotics|narcotics|mesh-ancestor
44923728|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923729|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923730|NCT03845881|Analgesics|analgesics|mesh-ancestor
44923731|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
44923732|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923733|NCT03845673|Psyllium|psyllium|mesh-list
44923734|NCT03845673|Cathartics|cathartics|mesh-ancestor
44923735|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44923736|NCT03845387|Pramipexole|pramipexole|mesh-list
44923737|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
44923738|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923739|NCT03845387|Protective Agents|protective agents|mesh-ancestor
44848830|NCT02303223|Propofol|propofol|mesh-list
44923740|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923741|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44923742|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44923743|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
44923744|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
44923745|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923746|NCT03845322|Curcumin|curcumin|mesh-list
44923747|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44923748|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923749|NCT03845322|Analgesics|analgesics|mesh-ancestor
44923750|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
44923751|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923752|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923753|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44923754|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923755|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923756|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923757|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923758|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44923759|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44923760|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923761|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923762|NCT03845179|Incretins|incretins|mesh-ancestor
44923763|NCT03845179|Hormones|hormones|mesh-ancestor
44923764|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923765|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
44923766|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923767|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923768|NCT03845153|Metformin|metformin|mesh-list
44923769|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44923770|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923771|NCT03845049|Aflibercept|aflibercept|mesh-list
44923772|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44923773|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44923774|NCT03845049|Growth Substances|growth substances|mesh-ancestor
44923775|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923776|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44923777|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923778|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
44923779|NCT03844841|Propofol|propofol|mesh-list
44923780|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44923781|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923782|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923783|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44923784|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
44923785|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
44923786|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923787|NCT03844841|Analgesics|analgesics|mesh-ancestor
44923788|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
44923789|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923790|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44923791|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44923792|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44923793|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44923794|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849073|NCT02304354|Rituximab|rituximab|mesh-list
44849153|NCT02305394|Ketamine|ketamine|mesh-list
44923795|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923796|NCT03844984|Lidocaine|lidocaine|mesh-list
44923797|NCT03844984|Midazolam|midazolam|mesh-list
44923798|NCT03844984|Ketamine|ketamine|mesh-list
44923799|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923800|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
44923801|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923802|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923803|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
44923804|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923805|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923806|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44923807|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44923808|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923809|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923810|NCT03844984|Analgesics|analgesics|mesh-ancestor
44923811|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44923812|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44923813|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
44923814|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44923815|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44923816|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923817|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44923818|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44923819|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44923820|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44923821|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44923822|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
44923823|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
44923824|NCT03844932|Cyclosporine|cyclosporine|mesh-list
44923825|NCT03844932|Cyclosporins|cyclosporins|mesh-list
44923826|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923827|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923828|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44923829|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
44923830|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923831|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
44923832|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923833|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
44923834|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923835|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44923836|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
44923841|NCT03844581|Propiverine|propiverine|mesh-list
44923842|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
44923843|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
44923844|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923845|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923846|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44923847|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44923848|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
44923849|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923850|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923851|NCT03844581|Urological Agents|urological agents|mesh-ancestor
44923852|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44923853|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
44923854|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44923855|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
44923856|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923857|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923858|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44923859|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44923860|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44923861|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923862|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44923863|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44923864|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44923865|NCT03844451|Epinephrine|epinephrine|mesh-list
44923866|NCT03844451|Bupivacaine|bupivacaine|mesh-list
44923867|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923868|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
44923869|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923870|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923871|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
44923872|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923873|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44923874|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44923875|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
44923876|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44923877|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923878|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44923879|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44923880|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
44923881|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44923882|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
44923883|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
44923884|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
44923885|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44705246|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705248|NCT05386121|Meperidine|meperidine|mesh-list
44705249|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44705250|NCT05386121|Narcotics|narcotics|mesh-ancestor
44705251|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849791|NCT02309385|BB 1101|bb 1101|mesh-list
44849845|NCT02309801|Daidzin|daidzin|mesh-list
44705252|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705253|NCT05386121|Analgesics|analgesics|mesh-ancestor
44705254|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
44705255|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705256|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44705257|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44705258|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
44705259|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
44705261|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705262|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705263|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
44705264|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705265|NCT05385887|Metronidazole|metronidazole|mesh-list
44705266|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
44705267|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705268|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44705269|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44705270|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44705271|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44705272|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705273|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705274|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705275|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705276|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44923886|NCT03844776|Acetaminophen|acetaminophen|mesh-list
44923887|NCT03844776|Amoxicillin|amoxicillin|mesh-list
44923888|NCT03844776|Metronidazole|metronidazole|mesh-list
44923889|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44923890|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
44923891|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44923892|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44923893|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44923894|NCT03844776|Analgesics|analgesics|mesh-ancestor
44923895|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
44923896|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850044|NCT02311530|Felodipine|felodipine|mesh-list
44923897|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923898|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
44923899|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44923900|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
44923901|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44923902|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44923903|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44923904|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923905|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923906|NCT03844529|Lidocaine|lidocaine|mesh-list
44923907|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923908|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
44923909|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923910|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923911|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
44923912|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923913|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923914|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44923915|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44923916|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923917|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923918|NCT03844594|Eptifibatide|eptifibatide|mesh-list
44923919|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44923920|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
44923921|NCT03844763|Avelumab|avelumab|mesh-list
44923922|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44923923|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
44923924|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923925|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44923926|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44923927|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
44923928|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923929|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923930|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44923931|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44923932|NCT03844139|Glycerol|glycerol|mesh-list
44923933|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44850263|NCT02313064|CXA-10|cxa-10|mesh-list
44923934|NCT03844139|Protective Agents|protective agents|mesh-ancestor
44923935|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923936|NCT03844217|Tryptophan|tryptophan|mesh-list
44923937|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44923938|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
44923939|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44923940|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
44923941|NCT03844360|Bortezomib|bortezomib|mesh-list
44923942|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
44923943|NCT03844360|Dasatinib|dasatinib|mesh-list
44923944|NCT03844360|Pegaspargase|pegaspargase|mesh-list
44923945|NCT03844360|Lenograstim|lenograstim|mesh-list
44923946|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923947|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44923948|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44923949|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923950|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44923951|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
44923952|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923953|NCT03844243|Mitogens|mitogens|mesh-list
44923954|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44923955|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923956|NCT03843749|Trastuzumab|trastuzumab|mesh-list
44923957|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44923958|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44923959|NCT03844178|Tetracaine|tetracaine|mesh-list
44923960|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923961|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
44923962|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923963|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923964|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
44923965|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923966|NCT03843879|Lidocaine|lidocaine|mesh-list
44923967|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
44923968|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
44923969|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44923970|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923971|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
44923972|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44923973|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44923974|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44923975|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44923976|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44923977|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44923978|NCT03843736|Drospirenone|drospirenone|mesh-list
44923979|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
44923980|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44923981|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
44923982|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44923983|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44923984|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44923985|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44923986|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44923987|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44923988|NCT03843736|Estrogens|estrogens|mesh-ancestor
44923989|NCT03843736|Hormones|hormones|mesh-ancestor
44923990|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44923991|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44923992|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
44923993|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44923994|NCT03843736|Diuretics|diuretics|mesh-ancestor
44923995|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
44923996|NCT03843281|Acetaminophen|acetaminophen|mesh-list
44923997|NCT03843281|Morphine|morphine|mesh-list
44923998|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44923999|NCT03843281|Narcotics|narcotics|mesh-ancestor
44924000|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924001|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924002|NCT03843281|Analgesics|analgesics|mesh-ancestor
44850977|NCT02318537|Cannabidiol|cannabidiol|mesh-list
44851015|NCT02319018|Leucovorin|leucovorin|mesh-list
44851167|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44924003|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
44924004|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924005|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924006|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
44924007|NCT03843229|Bufanolides|bufanolides|mesh-list
44924008|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44924009|NCT03843229|Protective Agents|protective agents|mesh-ancestor
44924010|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924011|NCT03843515|Nivolumab|nivolumab|mesh-list
44924012|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924013|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924014|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44924015|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924016|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
44924017|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924018|NCT03843060|Itraconazole|itraconazole|mesh-list
44924019|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
44924020|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924021|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44924022|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924023|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924024|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924025|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924026|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
44924027|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924028|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924029|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924030|NCT03842800|Ketamine|ketamine|mesh-list
44924031|NCT03842800|Analgesics|analgesics|mesh-ancestor
44924032|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
44924033|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924034|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924069|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924070|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924072|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924073|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719652|NCT01510847|Hormones|hormones|mesh-ancestor
44924074|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
44924075|NCT03842254|Hematinics|hematinics|mesh-ancestor
44851257|NCT02320448|Cisplatin|cisplatin|mesh-list
44924076|NCT03842046|Phenylephrine|phenylephrine|mesh-list
44924077|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
44924078|NCT03842046|Norepinephrine|norepinephrine|mesh-list
44924079|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44924080|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
44924081|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
44924082|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924083|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924084|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
44924085|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44924086|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
44924087|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
44924088|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44924089|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44924090|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44924091|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924092|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924093|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924094|NCT03842046|Protective Agents|protective agents|mesh-ancestor
44924095|NCT03842020|Amiodarone|amiodarone|mesh-list
44924096|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44924097|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
44924098|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44924099|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924100|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924101|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44924102|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44924103|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924104|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924105|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44924106|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44924107|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924108|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
44924109|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44924110|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
44924111|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924112|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44924113|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924114|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44924115|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924116|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924117|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924118|NCT03841890|Tolnaftate|tolnaftate|mesh-list
44924119|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
44924120|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924121|NCT03841721|Linezolid|linezolid|mesh-list
44924122|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44924123|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924124|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44924125|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924126|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924127|NCT03841747|Paclitaxel|paclitaxel|mesh-list
44924128|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
44924129|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44924130|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924131|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
44924132|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
44924133|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
44924134|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924135|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924136|NCT03841526|Glucagon|glucagon|mesh-list
44924137|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44924138|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924139|NCT03841526|Hormones|hormones|mesh-ancestor
44924140|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924141|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924142|NCT03841526|Incretins|incretins|mesh-ancestor
44924143|NCT03841812|Propofol|propofol|mesh-list
44924144|NCT03841812|Sevoflurane|sevoflurane|mesh-list
44924145|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924146|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924147|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924148|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924149|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
44924150|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
44924151|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44924152|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44924153|NCT03841591|Metformin|metformin|mesh-list
44924154|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44924155|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924156|NCT03841383|Dipyridamole|dipyridamole|mesh-list
44924157|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44924158|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924159|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924160|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44924161|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
44924162|NCT03841305|Liver Extracts|liver extracts|mesh-list
44924163|NCT03841305|Hematinics|hematinics|mesh-ancestor
44924164|NCT03841474|Citalopram|citalopram|mesh-list
44924165|NCT03841474|Sertraline|sertraline|mesh-list
44924166|NCT03841474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44924167|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44851677|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851790|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
44924168|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924169|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705277|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44705278|NCT05385861|Carboplatin|carboplatin|mesh-list
44705279|NCT05385861|Irinotecan|irinotecan|mesh-list
44705280|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705281|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44705282|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705283|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705284|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705285|NCT05385744|Teriflunomide|teriflunomide|mesh-list
44705286|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44705287|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44705288|NCT05385744|Analgesics|analgesics|mesh-ancestor
44705289|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
44705290|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705291|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705292|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705293|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705294|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705295|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
44705296|NCT05385185|Endostatins|endostatins|mesh-list
44705297|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705298|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44705299|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44705300|NCT05385185|Growth Substances|growth substances|mesh-ancestor
44705301|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705302|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
44705303|NCT05385094|Cystatins|cystatins|mesh-list
44705304|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44705305|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705306|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705307|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705308|NCT05385068|Niraparib|niraparib|mesh-list
44705309|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44705310|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705311|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705312|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705313|NCT05385029|Carbimazole|carbimazole|mesh-list
44705314|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
44705315|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705316|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705317|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705318|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
44851946|NCT04715191|Fludarabine|fludarabine|mesh-list
44705319|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44705320|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44705321|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44705322|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705323|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705324|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
44705325|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705326|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705327|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44705328|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705329|NCT05379374|Morphine|morphine|mesh-list
44924203|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
44924204|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44924205|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
44924206|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924207|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
44924208|NCT03840070|Protective Agents|protective agents|mesh-ancestor
44924209|NCT03838783|Insulin|insulin|mesh-list
44924210|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44924211|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924212|NCT03838029|Etodolac|etodolac|mesh-list
44924213|NCT03838029|Propranolol|propranolol|mesh-list
44924214|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44924215|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44852226|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
44852301|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
44924216|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924217|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924218|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924219|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924220|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44924221|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44924222|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
44924223|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44924224|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924225|NCT03838029|Analgesics|analgesics|mesh-ancestor
44924226|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
44924227|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924228|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924229|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924230|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44924231|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44924232|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924233|NCT03837470|Furosemide|furosemide|mesh-list
44924234|NCT03837470|Diuretics|diuretics|mesh-ancestor
44924235|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
44924236|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924237|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44924238|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924239|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924240|NCT03835715|Vortioxetine|vortioxetine|mesh-list
44924241|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
44924242|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924243|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44924244|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924245|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924246|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924247|NCT03835715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44924248|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44924249|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924250|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924251|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924252|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
44924253|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44924254|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44924255|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44924256|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44924257|NCT03834831|Selenium|selenium|mesh-list
44924258|NCT03834831|Ubiquinone|ubiquinone|mesh-list
44924259|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
44924260|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
44924261|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924262|NCT03834831|Protective Agents|protective agents|mesh-ancestor
44924263|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924264|NCT03834831|Trace Elements|trace elements|mesh-ancestor
44924265|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
44924266|NCT03834831|Vitamins|vitamins|mesh-ancestor
44924267|NCT03834454|Bupivacaine|bupivacaine|mesh-list
44924268|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
44924269|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
44924270|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924271|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924272|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
44924273|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924274|NCT03833570|Melatonin|melatonin|mesh-list
44924275|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
44924276|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924277|NCT03833570|Protective Agents|protective agents|mesh-ancestor
44924278|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924279|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924280|NCT03832621|Nivolumab|nivolumab|mesh-list
44852611|NCT01802086|Lidocaine|lidocaine|mesh-list
44924281|NCT03832621|Ipilimumab|ipilimumab|mesh-list
44924282|NCT03832621|Temozolomide|temozolomide|mesh-list
44924283|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924284|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924285|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44924286|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924287|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44924288|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
44924289|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
44924290|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924291|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924292|NCT03832426|Ritonavir|ritonavir|mesh-list
44924293|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44924294|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44924295|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
44924296|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924297|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924298|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44924299|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44924300|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
44924301|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924302|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924303|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924304|NCT03831269|Azithromycin|azithromycin|mesh-list
44924305|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44924306|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924307|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
44924308|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
44924309|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924310|NCT03830489|Protective Agents|protective agents|mesh-ancestor
44924311|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924312|NCT03830489|Vitamins|vitamins|mesh-ancestor
44924313|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
44924314|NCT03829943|Vitamin D|vitamin d|mesh-list
44924315|NCT03829943|Vitamins|vitamins|mesh-ancestor
44924316|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
44924317|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924318|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44924319|NCT03829930|Entinostat|entinostat|mesh-list
44924320|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924321|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44924322|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924323|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924324|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
44924325|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
44924326|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924327|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924328|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924329|NCT03829150|Amoxicillin|amoxicillin|mesh-list
44924330|NCT03829150|Metronidazole|metronidazole|mesh-list
44924331|NCT03829150|Clarithromycin|clarithromycin|mesh-list
44924332|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
44924333|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44924334|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924335|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44924336|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44924337|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44924338|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924339|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924340|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924341|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924342|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44924343|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924344|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44924345|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
44924346|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44924347|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924348|NCT03827408|Midazolam|midazolam|mesh-list
44924349|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
44924350|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924351|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924352|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924375|NCT03826940|Lovastatin|lovastatin|mesh-list
44924376|NCT03826940|L 647318|l 647318|mesh-list
44924377|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
44924378|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44924379|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44924380|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
44924381|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924382|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44924383|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44924384|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924385|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
44924386|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44924387|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
44924388|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924389|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
44924390|NCT03825133|Protective Agents|protective agents|mesh-ancestor
44924391|NCT03824691|Durvalumab|durvalumab|mesh-list
44924392|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853075|NCT05078931|Lenvatinib|lenvatinib|mesh-list
44924393|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924394|NCT03824119|Ibuprofen|ibuprofen|mesh-list
44924395|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44924396|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924397|NCT03824119|Analgesics|analgesics|mesh-ancestor
44924398|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
44924399|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924400|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924401|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924402|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924403|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44924404|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924405|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924406|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
44924407|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44924408|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44924409|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924410|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
44924411|NCT03823417|Coagulants|coagulants|mesh-ancestor
44924412|NCT03823482|Lidocaine|lidocaine|mesh-list
44924413|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
44924414|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
44924415|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924416|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924417|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
44924418|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924419|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44924420|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44924421|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44924422|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924423|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924424|NCT03822663|Caffeine|caffeine|mesh-list
44924425|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44924426|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924427|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44924428|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924429|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924430|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44924431|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44924432|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
44924433|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924434|NCT03822845|Edetic Acid|edetic acid|mesh-list
44924435|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44924436|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
44924437|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
44924438|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924439|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
44924440|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44924441|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44924442|NCT03821623|Niacinamide|niacinamide|mesh-list
44924443|NCT03821623|Niacin|niacin|mesh-list
44924444|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
44924445|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
44924446|NCT03821623|Vitamins|vitamins|mesh-ancestor
44924447|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
44924448|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924449|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44924450|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
44924451|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924453|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
44924454|NCT03821480|Fluconazole|fluconazole|mesh-list
44924455|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
44924456|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924457|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44924458|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924459|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924460|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924461|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924462|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44924463|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924464|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924465|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44924466|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44924467|NCT03821493|Itraconazole|itraconazole|mesh-list
44924468|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44924469|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
44924470|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924471|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44924472|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924473|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705330|NCT05379374|Bupivacaine|bupivacaine|mesh-list
44705331|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705332|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
44705333|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705334|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705335|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
44705336|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705337|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44705338|NCT05379374|Narcotics|narcotics|mesh-ancestor
44705339|NCT05379374|Analgesics|analgesics|mesh-ancestor
44705340|NCT05375708|Bevacizumab|bevacizumab|mesh-list
44705341|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705342|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705343|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44705344|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44705345|NCT05375708|Growth Substances|growth substances|mesh-ancestor
44705346|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705347|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
44705348|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44705349|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44705350|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44705351|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853558|NCT05150899|Tamsulosin|tamsulosin|mesh-list
44853572|NCT05108740|Everolimus|everolimus|mesh-list
44705352|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705353|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44705354|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705355|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705356|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
44705357|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705358|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44705359|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44705360|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705361|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
44705362|NCT05176379|Fluconazole|fluconazole|mesh-list
44705363|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
44705364|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705365|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44705366|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44705367|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705368|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705369|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44705370|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705371|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705372|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705373|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44705374|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44705375|NCT05113615|Bromides|bromides|mesh-list
44705376|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
44720200|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924474|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924475|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924476|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
44924477|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924478|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924479|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924480|NCT03819790|Insulin|insulin|mesh-list
44924481|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44924482|NCT03819790|Metformin|metformin|mesh-list
44924483|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
44924484|NCT03819790|Lixisenatide|lixisenatide|mesh-list
44924485|NCT03819790|Gliclazide|gliclazide|mesh-list
44924486|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44924487|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924488|NCT03819647|Stiripentol|stiripentol|mesh-list
44924489|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
44924490|NCT03819556|Caseins|caseins|mesh-list
44924491|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
44924492|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
44924493|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924494|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
44924495|NCT03819348|Clotrimazole|clotrimazole|mesh-list
44924496|NCT03819348|Miconazole|miconazole|mesh-list
44924497|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924498|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44924499|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44924500|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44924501|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924502|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924503|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924504|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
44924505|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924506|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924507|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44853787|NCT03356483|Niacin|niacin|mesh-list
44638603|NCT00384293|Niacin|niacin|mesh-list
44924508|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44924509|NCT03819101|Aspirin|aspirin|mesh-list
44924510|NCT03819101|Atorvastatin|atorvastatin|mesh-list
44924511|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44924512|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44924513|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
44924514|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924515|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44924516|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44924517|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924518|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44924519|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924520|NCT03819101|Analgesics|analgesics|mesh-ancestor
44924521|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
44924522|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924523|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924524|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924525|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924526|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44924527|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44924528|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44924529|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44924530|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
44924531|NCT03819127|Metformin|metformin|mesh-list
44924532|NCT03819127|Vildagliptin|vildagliptin|mesh-list
44924533|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44924534|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924535|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44924536|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
44924537|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924538|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924539|NCT03819010|Letrozole|letrozole|mesh-list
44924540|NCT03819010|Palbociclib|palbociclib|mesh-list
44924541|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854131|NCT05258474|Niacin|niacin|mesh-list
44924542|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44924543|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44924544|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924545|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924546|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44924547|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44924548|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924549|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924550|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44924551|NCT03818997|Paclitaxel|paclitaxel|mesh-list
44924552|NCT03818997|Atezolizumab|atezolizumab|mesh-list
44854203|NCT05008003|Vitamin D|vitamin d|mesh-list
44854278|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
44924553|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44924554|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924555|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44924556|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44924557|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
44924558|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924559|NCT03818945|Listerine|listerine|mesh-list
44924560|NCT03818945|Fluorides|fluorides|mesh-list
44924561|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
44924562|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
44924563|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
44924564|NCT03818945|Protective Agents|protective agents|mesh-ancestor
44924565|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924566|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44924567|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924568|NCT03818932|Acetaminophen|acetaminophen|mesh-list
44924569|NCT03818932|Celecoxib|celecoxib|mesh-list
44924570|NCT03818932|Ketorolac|ketorolac|mesh-list
44924571|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44924572|NCT03818932|Diazepam|diazepam|mesh-list
44924573|NCT03818932|Gabapentin|gabapentin|mesh-list
44924574|NCT03818932|Hydrocodone|hydrocodone|mesh-list
44924575|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924576|NCT03818932|Analgesics|analgesics|mesh-ancestor
44924577|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
44924578|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924579|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924580|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
44924581|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44924582|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924583|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924584|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44924585|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44924586|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924587|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924588|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
44924589|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44924590|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924591|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924592|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924593|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44924594|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44924595|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924596|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
44924597|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44924598|NCT03818932|Narcotics|narcotics|mesh-ancestor
44924599|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
44924600|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
44924601|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44924602|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
44924603|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
44924604|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924605|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924606|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44924607|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44924608|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924609|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
44924610|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
44924611|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
44924612|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
44924613|NCT03818919|Acetaminophen|acetaminophen|mesh-list
44924614|NCT03818919|Celecoxib|celecoxib|mesh-list
44924615|NCT03818919|Ketorolac|ketorolac|mesh-list
44924616|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44924617|NCT03818919|Diazepam|diazepam|mesh-list
44924618|NCT03818919|Gabapentin|gabapentin|mesh-list
44924619|NCT03818919|Hydrocodone|hydrocodone|mesh-list
44924620|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44924621|NCT03818919|Analgesics|analgesics|mesh-ancestor
44924622|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
44720333|NCT01513941|Ribavirin|ribavirin|mesh-list
44924623|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924624|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924625|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
44924659|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44924660|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924661|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924662|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924663|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44924664|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924665|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924666|NCT03818282|Paclitaxel|paclitaxel|mesh-list
44924667|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44924668|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924669|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
44924670|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
44924671|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
44924672|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924673|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
44854638|NCT03380507|Thiamine|thiamine|mesh-list
44924674|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44924675|NCT03818308|Velpatasvir|velpatasvir|mesh-list
44924676|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
44924677|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924678|NCT03818295|Praliciguat|praliciguat|mesh-list
44924679|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44924680|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
44924681|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924682|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924683|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
44924684|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44924685|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
44924686|NCT03817931|Mirabegron|mirabegron|mesh-list
44924687|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44924688|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
44924689|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
44924690|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
44924691|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44924692|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
44924693|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924694|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924695|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924696|NCT03817931|Urological Agents|urological agents|mesh-ancestor
44924697|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44924698|NCT03818048|Propofol|propofol|mesh-list
44924699|NCT03818048|Sevoflurane|sevoflurane|mesh-list
44924700|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44854792|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854830|NCT04454905|Apatinib|apatinib|mesh-list
44854906|NCT02536183|Doxorubicin|doxorubicin|mesh-list
44924701|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924702|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924703|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924704|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
44924705|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
44924706|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44924707|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44924708|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
44924709|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
44924710|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44924711|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
44924712|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924713|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924714|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44924715|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
44924716|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924717|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924718|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44924719|NCT03817541|Propofol|propofol|mesh-list
44924720|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924721|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924722|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924723|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924724|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
44924725|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
44924726|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44924727|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
44924728|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924729|NCT03817567|Antibodies|antibodies|mesh-list
44924730|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44924731|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
44720456|NCT01514721|Timolol|timolol|mesh-list
44924733|NCT03817411|Capecitabine|capecitabine|mesh-list
44924734|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
44924735|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44924736|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
44924737|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924738|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924739|NCT03817476|BI 425809|bi 425809|mesh-list
44924740|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
44924741|NCT03817359|Remifentanil|remifentanil|mesh-list
44924742|NCT03817359|Propofol|propofol|mesh-list
44924743|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924744|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924745|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924746|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924747|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
44924748|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
44924749|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44924750|NCT03817359|Narcotics|narcotics|mesh-ancestor
44924751|NCT03817359|Analgesics|analgesics|mesh-ancestor
44924752|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
44924753|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924754|NCT03817268|Capecitabine|capecitabine|mesh-list
44924755|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44924756|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
44705377|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44705378|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
44705379|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705380|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705381|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44705382|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
44705383|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
44705384|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44705385|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
44705386|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705387|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705388|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
44705389|NCT05007652|Plerixafor|plerixafor|mesh-list
44705390|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44705391|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44705392|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
44705393|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705394|NCT04930042|Ustekinumab|ustekinumab|mesh-list
44705395|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705396|NCT04850378|Dalteparin|dalteparin|mesh-list
44705397|NCT04850378|Tinzaparin|tinzaparin|mesh-list
44705398|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44705399|NCT04850378|Apixaban|apixaban|mesh-list
44705400|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44705401|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
44705402|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44705403|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705404|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705405|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705406|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
44705407|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44705408|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44705409|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
44705410|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44705411|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
44705412|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44705413|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705414|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705415|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705416|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
44705417|NCT04809103|Cisplatin|cisplatin|mesh-list
44705418|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705419|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44705420|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44705421|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705422|NCT04765371|Dexamethasone|dexamethasone|mesh-list
44705423|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
44705424|NCT04765371|Prednisolone|prednisolone|mesh-list
44705425|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44705426|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
44705427|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44705428|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
44705429|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44924773|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44924774|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924775|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924776|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924777|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
44924778|NCT03816592|Anesthetics|anesthetics|mesh-list
44855561|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
44924779|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924780|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924781|NCT03816592|Narcotics|narcotics|mesh-ancestor
44924782|NCT03816592|Analgesics|analgesics|mesh-ancestor
44924783|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
44924784|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924785|NCT03816553|Apatinib|apatinib|mesh-list
44924786|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924787|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44924788|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924789|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924790|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
44924791|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44924792|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924793|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44924794|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924795|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924796|NCT03816267|Albuterol|albuterol|mesh-list
44924797|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44924798|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
44924799|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924800|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924801|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44924802|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
44924803|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
44924804|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44924805|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44924806|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44924807|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44924808|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924809|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924810|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924811|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44924812|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44924813|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924814|NCT03816020|Niacinamide|niacinamide|mesh-list
44924815|NCT03816020|Niacin|niacin|mesh-list
44924816|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
44924817|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
44924818|NCT03816020|Vitamins|vitamins|mesh-ancestor
44924819|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
44924820|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924821|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44924822|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
44924823|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924824|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44924825|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
44924826|NCT03816072|Phenylephrine|phenylephrine|mesh-list
44924827|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
44924828|NCT03816072|Propofol|propofol|mesh-list
44924829|NCT03816072|Sevoflurane|sevoflurane|mesh-list
44924830|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924831|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924832|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924833|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924834|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
44924835|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
44924836|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44924837|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44856060|NCT03122431|Thalidomide|thalidomide|mesh-list
44856099|NCT02421341|Fentanyl|fentanyl|mesh-list
44924838|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44924839|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
44924840|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
44924841|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924842|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
44924843|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44924844|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
44924845|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44924846|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44924847|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44924848|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44924849|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44924850|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924851|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924852|NCT03816072|Protective Agents|protective agents|mesh-ancestor
44924853|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
44924854|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44924855|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44924856|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44924857|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44924858|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924859|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
44924860|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924861|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924862|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44924863|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924864|NCT03815864|Antibodies|antibodies|mesh-list
44924865|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
44924866|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
44924867|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924868|NCT03815942|Nivolumab|nivolumab|mesh-list
44924869|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44924870|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924871|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44856255|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856295|NCT04606394|Albuterol|albuterol|mesh-list
44856333|NCT04496596|Suramin|suramin|mesh-list
44924872|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924873|NCT03815838|Fallypride|fallypride|mesh-list
44924874|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44924875|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44924876|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
44924877|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924878|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924879|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924880|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
44924881|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44924882|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
44924883|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924884|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
44924885|NCT03815539|Protective Agents|protective agents|mesh-ancestor
44924886|NCT03815487|Insulin|insulin|mesh-list
44924887|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44924888|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44924889|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856445|NCT00893789|Modafinil|modafinil|mesh-list
44856514|NCT05162937|Antibodies|antibodies|mesh-list
44924890|NCT03815474|Epirubicin|epirubicin|mesh-list
44924891|NCT03815474|Ifosfamide|ifosfamide|mesh-list
44924892|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44924893|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924894|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44924895|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44924896|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44924897|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924898|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44924899|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
44924900|NCT03815461|Paclitaxel|paclitaxel|mesh-list
44924901|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44924902|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924903|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
44924904|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
44924905|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
44924906|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924907|NCT03815344|Misoprostol|misoprostol|mesh-list
44924908|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44924909|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
44924910|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44924911|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924912|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44924913|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924914|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
44924915|NCT03815305|Petrolatum|petrolatum|mesh-list
44924916|NCT03815305|Emollients|emollients|mesh-ancestor
44924917|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
44924918|NCT03815435|Anesthetics|anesthetics|mesh-list
44924919|NCT03815435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924920|NCT03815435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924921|NCT03815279|Dexamethasone|dexamethasone|mesh-list
44924922|NCT03815279|Lenalidomide|lenalidomide|mesh-list
44924923|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44924924|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
44924925|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
44924926|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924927|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924928|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44924929|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
44924930|NCT03815279|Hormones|hormones|mesh-ancestor
44924931|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44924932|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44924933|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924934|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
44924935|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44924936|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856627|NCT03901144|Glycerol|glycerol|mesh-list
44856698|NCT03050814|Leucovorin|leucovorin|mesh-list
44924937|NCT03815279|Growth Substances|growth substances|mesh-ancestor
44924938|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
44924939|NCT03814733|Ketamine|ketamine|mesh-list
44924940|NCT03814733|Alprazolam|alprazolam|mesh-list
44924941|NCT03814733|Analgesics|analgesics|mesh-ancestor
44924942|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
44924943|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44924944|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924945|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44924946|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44924947|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
44924948|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
44924949|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44924950|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44924951|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44924952|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44924953|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924954|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44924955|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44924956|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44924957|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44924958|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
44924959|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
44924960|NCT03814759|Cisplatin|cisplatin|mesh-list
44924961|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924962|NCT03814577|Antioxidants|antioxidants|mesh-list
44924963|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705430|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
44924964|NCT03814577|Protective Agents|protective agents|mesh-ancestor
44924965|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924966|NCT03814629|Vitamins|vitamins|mesh-list
44924967|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
44924968|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924969|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
44924970|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44924971|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
44924972|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924973|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
44924974|NCT03814707|Protective Agents|protective agents|mesh-ancestor
44924975|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
44924976|NCT03814447|Fludarabine|fludarabine|mesh-list
44924977|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856878|NCT05164848|Afatinib|afatinib|mesh-list
44924978|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
44924979|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44924980|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44924981|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44924982|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
44924983|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44924984|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924985|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44924986|NCT03814616|Artesunate|artesunate|mesh-list
44924987|NCT03814616|Pyronaridine|pyronaridine|mesh-list
44924988|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
44924989|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44924990|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44924991|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44924992|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44924993|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
44924994|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
44924995|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44924996|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
44924997|NCT03814642|Esomeprazole|esomeprazole|mesh-list
44924998|NCT03814642|Clopidogrel|clopidogrel|mesh-list
44924999|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44925000|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44925001|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44925002|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44925003|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
44925004|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925005|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925006|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925007|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44925008|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925009|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44925010|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925011|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44925012|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
44925013|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925014|NCT03814343|Amphotericin B|amphotericin b|mesh-list
44925015|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44925016|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44925017|NCT03814343|Amebicides|amebicides|mesh-ancestor
44925018|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925019|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44925020|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925021|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44925022|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
44925023|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44925024|NCT03814343|Protective Agents|protective agents|mesh-ancestor
44925025|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925026|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44925027|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
44925028|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925029|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44925030|NCT03814226|Growth Substances|growth substances|mesh-ancestor
44925031|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857148|NCT05261139|Ritonavir|ritonavir|mesh-list
44857304|NCT04854434|Trifluridine|trifluridine|mesh-list
44857390|NCT04799275|Hormones|hormones|mesh-ancestor
44857456|NCT04534218|Aspirin|aspirin|mesh-list
44925032|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
44925033|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925034|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925035|NCT03813784|Capecitabine|capecitabine|mesh-list
44925036|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
44925037|NCT03813784|Apatinib|apatinib|mesh-list
44925038|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925039|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
44925040|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925041|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925062|NCT03813927|Vitamins|vitamins|mesh-ancestor
44925063|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
44925064|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925065|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44925066|NCT03813940|Vaccines|vaccines|mesh-list
44925067|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
44925068|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925069|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
44925070|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
44925071|NCT03813771|Etanercept|etanercept|mesh-list
44925072|NCT03813771|Methotrexate|methotrexate|mesh-list
44925073|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44925074|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
44925075|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44925076|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925077|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925078|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
44925079|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925080|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925081|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
44925082|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925083|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44925084|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925085|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
44925086|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44925087|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44925088|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
44925089|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925090|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44925091|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925092|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44925093|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44925094|NCT03813771|Analgesics|analgesics|mesh-ancestor
44925095|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
44925096|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925097|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925098|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925099|NCT03813641|Capecitabine|capecitabine|mesh-list
44925100|NCT03813641|Raltitrexed|raltitrexed|mesh-list
44925101|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925102|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
44925103|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925104|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925105|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44925106|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925107|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
44925108|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44925109|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44925110|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925111|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
44925112|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44925113|NCT03813394|Bevacizumab|bevacizumab|mesh-list
44925114|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
44925115|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925116|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925117|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44925118|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44925119|NCT03813394|Growth Substances|growth substances|mesh-ancestor
44925120|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925121|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
44925122|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
44925123|NCT03813329|Calcium|calcium|mesh-list
44925124|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44925125|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925126|NCT03813329|Antacids|antacids|mesh-ancestor
44925127|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925128|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925129|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
44925130|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44925131|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925132|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925133|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44925134|NCT03813277|Analgesics|analgesics|mesh-ancestor
44925135|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
44720929|NCT01517022|Nicotine|nicotine|mesh-list
44925136|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925137|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44925138|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44925139|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44858399|NCT05439798|BB 1101|bb 1101|mesh-list
44858542|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
44925140|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
44925141|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925142|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925143|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44925145|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44925146|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44925147|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44925148|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925149|NCT03813316|Incretins|incretins|mesh-ancestor
44925150|NCT03813316|Hormones|hormones|mesh-ancestor
44925151|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925152|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
44925153|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925154|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925155|NCT03813303|Fentanyl|fentanyl|mesh-list
44925156|NCT03813303|Midazolam|midazolam|mesh-list
44925157|NCT03813303|Propofol|propofol|mesh-list
44925158|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44925159|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925160|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925161|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925162|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
44925163|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
44925164|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925165|NCT03813303|Narcotics|narcotics|mesh-ancestor
44925166|NCT03813303|Analgesics|analgesics|mesh-ancestor
44925167|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
44925168|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925169|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44925170|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44925171|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44925172|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925173|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
44925174|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
44925175|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925176|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925177|NCT03813043|Midazolam|midazolam|mesh-list
44925178|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44925179|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44925180|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925181|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925182|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44925183|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44925184|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925185|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925186|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
44925187|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
44925188|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
44925189|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
44925190|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925191|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925192|NCT03813069|Permethrin|permethrin|mesh-list
44925193|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925194|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925195|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44925196|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
44925197|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44925198|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
44925199|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44925200|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44925201|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44925202|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925203|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925204|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
44925205|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925206|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925207|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44925208|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925209|NCT03813186|Decitabine|decitabine|mesh-list
44721015|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
44925210|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925211|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
44925212|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925213|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858815|NCT04750616|Niacin|niacin|mesh-list
44925214|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925215|NCT03812939|Octreotide|octreotide|mesh-list
44925216|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925217|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44925218|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925219|NCT03813030|Lidocaine|lidocaine|mesh-list
44925220|NCT03813030|Prilocaine|prilocaine|mesh-list
44925221|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925222|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
44925223|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925224|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925225|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
44925226|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925227|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44925228|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44925229|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44925230|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925231|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925232|NCT03812783|Sorafenib|sorafenib|mesh-list
44925233|NCT03812783|Folfirinox|folfirinox|mesh-list
44925234|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925235|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925236|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925237|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925238|NCT03812796|Avelumab|avelumab|mesh-list
44925239|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925240|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925241|NCT03812731|Fentanyl|fentanyl|mesh-list
44925242|NCT03812731|Ropivacaine|ropivacaine|mesh-list
44925243|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925244|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
44925245|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925246|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925247|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
44925248|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925249|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925250|NCT03812731|Narcotics|narcotics|mesh-ancestor
44925251|NCT03812731|Analgesics|analgesics|mesh-ancestor
44925252|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44925253|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925254|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
44925255|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44925256|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44925257|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44925258|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858989|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
44925259|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925260|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925261|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925262|NCT03812523|Analgesics|analgesics|mesh-ancestor
44925263|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
44925264|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925265|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
44925266|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925267|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
44925268|NCT03812562|Nivolumab|nivolumab|mesh-list
44925269|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925270|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925271|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44925272|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925273|NCT03812419|Esomeprazole|esomeprazole|mesh-list
44925274|NCT03812419|Pantoprazole|pantoprazole|mesh-list
44925275|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44925276|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925277|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44925278|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925279|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925280|NCT03812770|Leucovorin|leucovorin|mesh-list
44925281|NCT03812770|Fluorouracil|fluorouracil|mesh-list
44925282|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
44925283|NCT03812770|Sorafenib|sorafenib|mesh-list
44925284|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
44721102|NCT01517997|Paclitaxel|paclitaxel|mesh-list
44925317|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925318|NCT03812003|Analgesics|analgesics|mesh-ancestor
44925319|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
44925320|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925321|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
44925322|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
44925323|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925324|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925325|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925326|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
44925327|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44925328|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925329|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925330|NCT03811418|Docetaxel|docetaxel|mesh-list
44925331|NCT03811418|Trastuzumab|trastuzumab|mesh-list
44925332|NCT03811418|Vinorelbine|vinorelbine|mesh-list
44925333|NCT03811418|Pertuzumab|pertuzumab|mesh-list
44925334|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925335|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44925336|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44925337|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44925338|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925339|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925340|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44925341|NCT03811509|Denosumab|denosumab|mesh-list
44925342|NCT03811509|Diphosphonates|diphosphonates|mesh-list
44925343|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44925344|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925345|NCT03810872|Paclitaxel|paclitaxel|mesh-list
44925346|NCT03810872|Afatinib|afatinib|mesh-list
44925347|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44925348|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925349|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44925350|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44925351|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44935919|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935920|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
44859394|NCT02974621|Olaparib|olaparib|mesh-list
44925352|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925353|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925354|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925355|NCT03811223|Evolocumab|evolocumab|mesh-list
44925356|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44925357|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44925358|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
44925359|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705432|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705433|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
44705434|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
44705435|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705436|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705437|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705438|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
44705439|NCT04765371|Hormones|hormones|mesh-ancestor
44705440|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705441|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705442|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705443|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705444|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859546|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
44859675|NCT01425541|Progesterone|progesterone|mesh-list
44705445|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705446|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44705447|NCT04765371|Protective Agents|protective agents|mesh-ancestor
44705448|NCT04744363|Ustekinumab|ustekinumab|mesh-list
44705449|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705450|NCT04729517|Azelastine|azelastine|mesh-list
44705451|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44705452|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
44705453|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705454|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705455|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44705456|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
44705457|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44705458|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705459|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705460|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44705461|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44705462|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44705463|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
44705464|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
44705465|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705466|NCT04698525|Valproic Acid|valproic acid|mesh-list
44705467|NCT04698525|Memantine|memantine|mesh-list
44705468|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44705469|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44705470|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
44705471|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705472|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705473|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705474|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44705475|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44925360|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44925361|NCT03811054|Apatinib|apatinib|mesh-list
44925362|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925363|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925364|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925365|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925366|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44925367|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925368|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925369|NCT03810703|Amphetamine|amphetamine|mesh-list
44925370|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
44925371|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44925372|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925373|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
44925374|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
44925375|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925376|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
44925377|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925378|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925379|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
44925380|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44925381|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44925382|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925383|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44925384|NCT03810547|Ketamine|ketamine|mesh-list
44925385|NCT03810547|Propofol|propofol|mesh-list
44925386|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44925387|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925388|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925389|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925390|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
44925391|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
44925392|NCT03810547|Analgesics|analgesics|mesh-ancestor
44925393|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
44925394|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925395|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44925396|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44925397|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44925398|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925399|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925400|NCT03810391|Butorphanol|butorphanol|mesh-list
44925401|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925402|NCT03810391|Narcotics|narcotics|mesh-ancestor
44925403|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925404|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925405|NCT03810391|Analgesics|analgesics|mesh-ancestor
44925406|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
44925407|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925408|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
44925409|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
44925410|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44925411|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
44925412|NCT03810209|Analgesics|analgesics|mesh-ancestor
44925413|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
44859971|NCT04765709|Durvalumab|durvalumab|mesh-list
44925414|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925415|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925416|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
44925417|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925418|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44925419|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
44925420|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44925421|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925422|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925423|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44925424|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
44925425|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44925426|NCT03809949|Fentanyl|fentanyl|mesh-list
44925427|NCT03809949|Anesthetics|anesthetics|mesh-list
44925428|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925429|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925430|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925431|NCT03809949|Narcotics|narcotics|mesh-ancestor
44925432|NCT03809949|Analgesics|analgesics|mesh-ancestor
44925433|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
44925434|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925435|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44925448|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44925449|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
44925450|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925451|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925452|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44925453|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44925454|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
44925455|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925456|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925457|NCT03807882|Clozapine|clozapine|mesh-list
44925458|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44925459|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
44925460|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925461|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925462|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925463|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44925464|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44925465|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925466|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44925467|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
44925468|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
44925469|NCT03807271|Anesthetics|anesthetics|mesh-list
44925470|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925471|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925472|NCT03806816|Melatonin|melatonin|mesh-list
44925473|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
44925474|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925475|NCT03806816|Protective Agents|protective agents|mesh-ancestor
44925476|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925477|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925478|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44925479|NCT03806101|Abrocitinib|abrocitinib|mesh-list
44925480|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44925481|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44925482|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
44925483|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925484|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44925485|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44925486|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925487|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925488|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
44925489|NCT03805035|Maleic acid|maleic acid|mesh-list
44925490|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
44925491|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44925492|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44860184|NCT04255381|Pancrelipase|pancrelipase|mesh-list
44860186|NCT04219735|Minocycline|minocycline|mesh-list
44925493|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925494|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925495|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
44925496|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925497|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925498|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
44925499|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44925500|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44925501|NCT03804541|Ensartinib|ensartinib|mesh-list
44925502|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925503|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44925504|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925505|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925506|NCT03804034|Molybdenum|molybdenum|mesh-list
44925507|NCT03804034|Trace Elements|trace elements|mesh-ancestor
44925508|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
44925509|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925510|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
44925511|NCT03804177|Melatonin|melatonin|mesh-list
44860267|NCT03861611|Ibuprofen|ibuprofen|mesh-list
44925512|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
44860540|NCT03224104|Temozolomide|temozolomide|mesh-list
44925513|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
44925514|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925515|NCT03804177|Protective Agents|protective agents|mesh-ancestor
44925516|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925517|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925518|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44925519|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
44925520|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
44925521|NCT03804177|Vitamins|vitamins|mesh-ancestor
44925522|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
44925523|NCT03803371|Acetaminophen|acetaminophen|mesh-list
44925524|NCT03803371|Tramadol|tramadol|mesh-list
44925525|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44925526|NCT03803371|Analgesics|analgesics|mesh-ancestor
44925527|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
44925528|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925529|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925530|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
44925531|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925532|NCT03803371|Narcotics|narcotics|mesh-ancestor
44925533|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925534|NCT03803007|Glenzocimab|glenzocimab|mesh-list
44925535|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
44925536|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
44925537|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
44925538|NCT03802422|Vitamins|vitamins|mesh-ancestor
44925539|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
44925540|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925541|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
44925542|NCT03802422|Hematinics|hematinics|mesh-ancestor
44925543|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
44925544|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44925545|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
44925546|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44925547|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860723|NCT02977494|Hormones|hormones|mesh-ancestor
44860836|NCT02451423|Atezolizumab|atezolizumab|mesh-list
44925548|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44925549|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
44925550|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44925551|NCT03801707|Velpatasvir|velpatasvir|mesh-list
44925552|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
44925553|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925554|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
44925555|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44925556|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
44925557|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925558|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
44925559|NCT03801564|Protective Agents|protective agents|mesh-ancestor
44925560|NCT03801317|Micronutrients|micronutrients|mesh-list
44925561|NCT03801317|Trace Elements|trace elements|mesh-list
44925562|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925563|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
44925564|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44861126|NCT00006455|Vitamins|vitamins|mesh-ancestor
44925565|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
44861351|NCT01111565|Aripiprazole|aripiprazole|mesh-list
44861423|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925566|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925567|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
44925568|NCT03800810|Protective Agents|protective agents|mesh-ancestor
44925569|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
44925570|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
44925571|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925572|NCT03800667|Protective Agents|protective agents|mesh-ancestor
44925573|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925574|NCT03800667|Vitamins|vitamins|mesh-ancestor
44925575|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
44925576|NCT03799809|Voriconazole|voriconazole|mesh-list
44721414|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
44925577|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
44925578|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925579|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44925580|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44925581|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925582|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925583|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44925584|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44925585|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925586|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925587|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44925588|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
44925589|NCT03799536|Sotalol|sotalol|mesh-list
44925590|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44925591|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44925592|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44925593|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925594|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925595|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925596|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44925597|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
44925598|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
44925599|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925600|NCT03799406|Vitamin D|vitamin d|mesh-list
44925601|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
44925602|NCT03799406|Vitamins|vitamins|mesh-ancestor
44925603|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
44925604|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925605|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44925606|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44925607|NCT03799224|Decitabine|decitabine|mesh-list
44925608|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925609|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
44925610|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925611|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925612|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925613|NCT03799315|Nicotine|nicotine|mesh-list
44925614|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44925615|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
44925616|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925617|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925618|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44925619|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44925620|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44925621|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925622|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925623|NCT03799172|Echinocandins|echinocandins|mesh-list
44925624|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
44861489|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
44925625|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925626|NCT03799120|Tamsulosin|tamsulosin|mesh-list
44925627|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44925628|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44925629|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44925630|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44925631|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925632|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925633|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925634|NCT03799120|Urological Agents|urological agents|mesh-ancestor
44925635|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
44925636|NCT03799094|Vitamins|vitamins|mesh-ancestor
44925637|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
44925638|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925639|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
44925640|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925641|NCT03799094|Protective Agents|protective agents|mesh-ancestor
44925642|NCT03798912|Octreotide|octreotide|mesh-list
44925643|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925644|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44925645|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925646|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
44925647|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44925648|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
44925649|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
44925650|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925651|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925652|NCT03798834|Anesthetics|anesthetics|mesh-list
44925653|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925654|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925655|NCT03798821|Sulfalene|sulfalene|mesh-list
44925656|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925657|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44925658|NCT03798821|Renal Agents|renal agents|mesh-ancestor
44925659|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
44925660|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925661|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44925662|NCT03798600|Caspofungin|caspofungin|mesh-list
44925663|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
44925664|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925665|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925666|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925667|NCT03798522|Nalbuphine|nalbuphine|mesh-list
44925668|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44925669|NCT03798522|Narcotics|narcotics|mesh-ancestor
44925670|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925671|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925672|NCT03798522|Analgesics|analgesics|mesh-ancestor
44925673|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
44925674|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925675|NCT03798392|Anesthetics|anesthetics|mesh-list
44925676|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925677|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925678|NCT03798106|Durvalumab|durvalumab|mesh-list
44925679|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925680|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925681|NCT03798119|Tenofovir|tenofovir|mesh-list
44925682|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
44925683|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705476|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
44705477|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705478|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
44705479|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
44705480|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44705481|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705482|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44705483|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
44705484|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44705485|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44705486|NCT04673162|Prednisolone|prednisolone|mesh-list
44705487|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
44705488|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44705489|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
44705490|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705491|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
44705492|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
44705493|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705494|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705495|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705496|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
44705497|NCT04673162|Hormones|hormones|mesh-ancestor
44705498|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705499|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44705500|NCT04673162|Protective Agents|protective agents|mesh-ancestor
44705501|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705502|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705503|NCT04638660|Phentolamine|phentolamine|mesh-list
44705504|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44705505|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44705506|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44705507|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44705508|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
44705509|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705510|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705511|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705512|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705513|NCT04622020|Anesthetics|anesthetics|mesh-list
44705514|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705515|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705516|NCT04560556|Antibodies|antibodies|mesh-list
44705517|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
44705518|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256970|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
44705519|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
44925684|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44925685|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44925690|NCT03799822|Vitamin K|vitamin k|mesh-list
44925691|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
44925692|NCT03799822|Vitamins|vitamins|mesh-ancestor
44925693|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
44925694|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925695|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44925696|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
44925697|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44925698|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44925699|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861958|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862133|NCT04755972|Antidotes|antidotes|mesh-ancestor
44925700|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925701|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
44925702|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44925703|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44925704|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
44925705|NCT03799822|Coagulants|coagulants|mesh-ancestor
44925706|NCT03799900|Ketamine|ketamine|mesh-list
44925707|NCT03799900|Analgesics|analgesics|mesh-ancestor
44925708|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
44925709|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925710|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925711|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44925712|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44925713|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
44925714|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
44925715|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925716|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44925717|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44925718|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44925719|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925720|NCT03799757|Bupivacaine|bupivacaine|mesh-list
44925721|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925722|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
44925723|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925724|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925725|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
44925726|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925727|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
44925728|NCT03799913|Fludarabine|fludarabine|mesh-list
44925729|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925730|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
44925731|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925732|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44925733|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44925734|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
44925735|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925736|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925737|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44925738|NCT03799601|Carboplatin|carboplatin|mesh-list
44925739|NCT03799601|Docetaxel|docetaxel|mesh-list
44925740|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925741|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44925742|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44925743|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44925744|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925745|NCT03797703|Lidocaine|lidocaine|mesh-list
44925746|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925747|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
44925748|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925749|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925750|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
44925751|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925752|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44925753|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44925754|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44925755|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925756|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925757|NCT03797729|Tirofiban|tirofiban|mesh-list
44925758|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44925759|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44925760|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925761|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44925762|NCT03797625|Cisplatin|cisplatin|mesh-list
44925763|NCT03797625|Irinotecan|irinotecan|mesh-list
44925764|NCT03797625|Endostar protein|endostar protein|mesh-list
44925765|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925766|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44862258|NCT03987919|Hormones|hormones|mesh-ancestor
44862321|NCT03252925|Expectorants|expectorants|mesh-ancestor
44925767|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44925768|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925769|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925770|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44925771|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44925772|NCT03797625|Growth Substances|growth substances|mesh-ancestor
44925773|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925774|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
44925775|NCT03797508|Progesterone|progesterone|mesh-list
44925776|NCT03797508|Progestins|progestins|mesh-ancestor
44925777|NCT03797508|Hormones|hormones|mesh-ancestor
44925778|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925779|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925780|NCT03797079|Bupivacaine|bupivacaine|mesh-list
44925781|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925782|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
44925783|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925784|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925785|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
44925786|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925787|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
44925788|NCT03797443|Gemcitabine|gemcitabine|mesh-list
44925789|NCT03797443|Paclitaxel|paclitaxel|mesh-list
44925790|NCT03797443|Cisplatin|cisplatin|mesh-list
44925791|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44925792|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925793|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44925794|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44925795|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44925796|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925797|NCT03797443|Vitamins|vitamins|mesh-ancestor
44925798|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
44925799|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925800|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925801|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
44925802|NCT03797443|Antiviral Agents|antiviral agents|mesh-ancestor
44925803|NCT03797443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925804|NCT03797443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925805|NCT03797443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925806|NCT03797443|Immunologic Factors|immunologic factors|mesh-ancestor
44925807|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
44925808|NCT03797443|Protective Agents|protective agents|mesh-ancestor
44925809|NCT03796975|Metformin|metformin|mesh-list
44925810|NCT03796975|Pioglitazone|pioglitazone|mesh-list
44925811|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44925812|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925813|NCT03796572|Ropivacaine|ropivacaine|mesh-list
44925814|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925815|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
44925816|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925817|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925818|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
44925819|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925820|NCT03796533|Posaconazole|posaconazole|mesh-list
44925821|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
44925822|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925823|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44925824|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925825|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44925826|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44925827|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44925828|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925829|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925830|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44925831|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
44925832|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925833|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925834|NCT03796403|Diclofenac|diclofenac|mesh-list
44925835|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44648618|NCT00267046|Cisplatin|cisplatin|mesh-list
44862693|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44925836|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44925837|NCT03796403|Analgesics|analgesics|mesh-ancestor
44925838|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
44705520|NCT04425902|Metoprolol|metoprolol|mesh-list
44925839|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925840|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925841|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925842|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44925843|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44925844|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925845|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925846|NCT03796507|Temozolomide|temozolomide|mesh-list
44925847|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44925848|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
44925849|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925850|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925851|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
44925852|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44925853|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
44925854|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44925855|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
44925856|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925857|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925858|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
44925859|NCT03796364|Endostar protein|endostar protein|mesh-list
44925860|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44705521|NCT04425902|Digoxin|digoxin|mesh-list
44705522|NCT04425902|Midazolam|midazolam|mesh-list
44705523|NCT04425902|Caffeine|caffeine|mesh-list
44705524|NCT04425902|Omeprazole|omeprazole|mesh-list
44705525|NCT04425902|Pravastatin|pravastatin|mesh-list
44705526|NCT04425902|Montelukast|montelukast|mesh-list
44705527|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44705528|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44705529|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705530|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705531|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44705532|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44705533|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44705534|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44705535|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
44705536|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
44705537|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
44705538|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
44705539|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705540|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705541|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44705542|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705543|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44705544|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705545|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44705546|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44705547|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44705548|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44705549|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
44705550|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44705551|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
44705552|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44705553|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705554|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705555|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44705556|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44705557|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44705558|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44705559|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
44705560|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
44705561|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705562|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44705563|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44705564|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44705565|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44705566|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44705567|NCT04425902|Protective Agents|protective agents|mesh-ancestor
44705568|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44705569|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44705570|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
44705571|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44705572|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44863218|NCT05172518|Taxane|taxane|mesh-list
44705573|NCT04425902|Analgesics|analgesics|mesh-ancestor
44705574|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
44705575|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44925894|NCT03795571|Gemcitabine|gemcitabine|mesh-list
44925895|NCT03795571|Dexamethasone|dexamethasone|mesh-list
44925896|NCT03795571|Rituximab|rituximab|mesh-list
44925897|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
44925898|NCT03795571|Lenalidomide|lenalidomide|mesh-list
44925899|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925900|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925901|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
44925902|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925903|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44925904|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44925905|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
44925906|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
44925907|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925908|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44925909|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
44925910|NCT03795571|Hormones|hormones|mesh-ancestor
44925911|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44925912|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44925913|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44925914|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
44925915|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925916|NCT03795571|Antiviral Agents|antiviral agents|mesh-ancestor
44925917|NCT03795571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925918|NCT03795571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925919|NCT03795571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925920|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44925921|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44925922|NCT03795571|Growth Substances|growth substances|mesh-ancestor
44925923|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44925924|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
44925925|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44925926|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44925927|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925928|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
44925929|NCT03795649|Coagulants|coagulants|mesh-ancestor
44925930|NCT03795597|Melphalan|melphalan|mesh-list
44925931|NCT03795597|Busulfan|busulfan|mesh-list
44925932|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44925933|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
44925934|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925935|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925936|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44925937|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44925938|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
44925939|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925940|NCT03795805|Lidocaine|lidocaine|mesh-list
44925941|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
44925942|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
44925943|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44925944|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925945|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
44925946|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925947|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44935921|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44925948|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44925949|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44925950|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44925951|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925952|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
44925953|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44925954|NCT03795259|Rocuronium|rocuronium|mesh-list
44863714|NCT04526470|Paclitaxel|paclitaxel|mesh-list
44925955|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44925956|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44925957|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44925958|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44925959|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925960|NCT03795272|Rucaparib|rucaparib|mesh-list
44925961|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44925962|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44925963|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925964|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925965|NCT03795311|Bevacizumab|bevacizumab|mesh-list
44925966|NCT03795311|Folfirinox|folfirinox|mesh-list
44925967|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44721914|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925968|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925969|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44925970|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44925971|NCT03795311|Growth Substances|growth substances|mesh-ancestor
44925972|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925973|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
44925975|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44925976|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44925977|NCT03794765|Metronidazole|metronidazole|mesh-list
44925978|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
44925979|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44925980|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44925981|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44925982|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44925983|NCT03794843|Nimodipine|nimodipine|mesh-list
44925984|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44925985|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44925986|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863831|NCT04525235|Tolbutamide|tolbutamide|mesh-list
44863982|NCT04523818|Fluorouracil|fluorouracil|mesh-list
44925987|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44925988|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44925989|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44925990|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
44925991|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
44925992|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44925993|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44925994|NCT03794505|Prednisolone|prednisolone|mesh-list
44925995|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
44925996|NCT03794505|Lidocaine|lidocaine|mesh-list
44925997|NCT03794505|Ropivacaine|ropivacaine|mesh-list
44925998|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44925999|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
44926000|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926001|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
44926002|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926003|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926004|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
44926005|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926006|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44926007|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44926008|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44926009|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926010|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926011|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926012|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
44926013|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
44926014|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926015|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
44926016|NCT03794505|Hormones|hormones|mesh-ancestor
44926017|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926018|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44926019|NCT03794505|Protective Agents|protective agents|mesh-ancestor
44926020|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926021|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926022|NCT03794544|Durvalumab|durvalumab|mesh-list
44926023|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926024|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926025|NCT03794518|Pioglitazone|pioglitazone|mesh-list
44864060|NCT04523233|Vitamins|vitamins|mesh-list
44864246|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
44926026|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44926027|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926028|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
44926029|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
44926030|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
44926031|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
44926032|NCT03794492|Prednisolone|prednisolone|mesh-list
44926033|NCT03794492|Tacrolimus|tacrolimus|mesh-list
44926034|NCT03794492|Basiliximab|basiliximab|mesh-list
44926035|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926036|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
44926037|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926038|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44926039|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926040|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926041|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44926042|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926043|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44926044|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
44926045|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44864541|NCT04508894|Ketamine|ketamine|mesh-list
44864705|NCT04506242|Apatinib|apatinib|mesh-list
44926046|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926047|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926048|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
44926049|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
44926050|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926051|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926052|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
44926053|NCT03794492|Hormones|hormones|mesh-ancestor
44926054|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926055|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44926056|NCT03794492|Protective Agents|protective agents|mesh-ancestor
44926057|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926058|NCT03794596|Aspirin|aspirin|mesh-list
44926059|NCT03794596|Avelumab|avelumab|mesh-list
44926060|NCT03794596|Lansoprazole|lansoprazole|mesh-list
44926061|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
44926062|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44926063|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926064|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926065|NCT03794596|Analgesics|analgesics|mesh-ancestor
44926066|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
44926067|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926068|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926069|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926070|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926071|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44926072|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44926073|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926074|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44926075|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44926076|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926077|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
44926078|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926079|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926080|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44926081|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926082|NCT03794219|Naproxen|naproxen|mesh-list
44926083|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926084|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926085|NCT03794219|Analgesics|analgesics|mesh-ancestor
44926086|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
44926087|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926088|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926089|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926090|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926091|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
44926092|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44926093|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926094|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926095|NCT03794440|Sorafenib|sorafenib|mesh-list
44926096|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926097|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926098|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926099|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926100|NCT03794271|Anesthetics|anesthetics|mesh-list
44926101|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926102|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926103|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44926104|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44926105|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44926106|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926107|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926108|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926109|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926110|NCT03794154|Analgesics|analgesics|mesh-ancestor
44926111|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
44926112|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926113|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
44926114|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926115|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
44926116|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
44926150|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926151|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926152|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926153|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926155|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44926156|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
44926157|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926158|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926159|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722140|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
44926161|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
44926162|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
44926163|NCT03793309|Vitamins|vitamins|mesh-list
44926164|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
44926165|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926166|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44926167|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44926168|NCT03793283|Insulin|insulin|mesh-list
44926169|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44926170|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44926171|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926172|NCT03793075|Ketamine|ketamine|mesh-list
44926173|NCT03793075|Propofol|propofol|mesh-list
44926174|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926175|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926176|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926177|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44926178|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
44926179|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
44926180|NCT03793075|Analgesics|analgesics|mesh-ancestor
44926181|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
44926182|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926183|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44926184|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44926185|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44926186|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705577|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705578|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705579|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44705580|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44705581|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705582|NCT04370093|Pioglitazone|pioglitazone|mesh-list
44705583|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705584|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705585|NCT04311762|Cisplatin|cisplatin|mesh-list
44705586|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705587|NCT04203472|Budesonide|budesonide|mesh-list
44705588|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864916|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
44864941|NCT04502277|Fluconazole|fluconazole|mesh-list
44705589|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44705590|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
44705591|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705592|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705593|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44705594|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257054|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
44705595|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
44705596|NCT04203472|Hormones|hormones|mesh-ancestor
44705597|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705598|NCT04166071|Naltrexone|naltrexone|mesh-list
44705599|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44705600|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44705601|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705602|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
44705603|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705604|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44705605|NCT04072146|Varenicline|varenicline|mesh-list
44705606|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44705607|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44705608|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
44705609|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705610|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705611|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705612|NCT03996265|Bupropion|bupropion|mesh-list
44705613|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44705614|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
44705615|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44705616|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44705617|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44705618|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705619|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705620|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
44705621|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705622|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705623|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44865375|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
44926187|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926189|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44926190|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
44926191|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926192|NCT03792776|Lidocaine|lidocaine|mesh-list
44926193|NCT03792776|Anesthetics|anesthetics|mesh-list
44926194|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926195|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926196|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926197|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
44926198|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926199|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44926200|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44926201|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44926202|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926203|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865709|NCT04493099|Decitabine|decitabine|mesh-list
44926204|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44926205|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44926206|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44926207|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926208|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926209|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926210|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926211|NCT03792828|Analgesics|analgesics|mesh-ancestor
44926212|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
44926213|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926214|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
44926215|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926216|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
44926217|NCT03792724|Nivolumab|nivolumab|mesh-list
44926218|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926219|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926220|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44926221|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926222|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
44926223|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
44926224|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
44926225|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
44926226|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44926227|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44926228|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926229|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926230|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926231|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
44926232|NCT03792971|Protective Agents|protective agents|mesh-ancestor
44926233|NCT03792984|Vitamin D|vitamin d|mesh-list
44926234|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
44926235|NCT03792984|Metformin|metformin|mesh-list
44926236|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
44926237|NCT03792984|Calcium|calcium|mesh-list
44926238|NCT03792984|Vitamins|vitamins|mesh-ancestor
44926239|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
44926240|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926241|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44926242|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44926243|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44926244|NCT03792984|Antacids|antacids|mesh-ancestor
44926245|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926246|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926247|NCT03792815|Etoposide|etoposide|mesh-list
44926248|NCT03792815|Melphalan|melphalan|mesh-list
44926249|NCT03792815|Busulfan|busulfan|mesh-list
44926250|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44926251|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926252|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44926253|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44926254|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926255|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926256|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44926257|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
44926258|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44722260|NCT01524432|Miconazole|miconazole|mesh-list
44926259|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926260|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
44926261|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926262|NCT03792906|Norepinephrine|norepinephrine|mesh-list
44926263|NCT03792906|Bupivacaine|bupivacaine|mesh-list
44926264|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926265|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
44926266|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926267|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926268|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
44926269|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926270|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44926271|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44926272|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44926273|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926274|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926275|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
44926276|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
44926277|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44926278|NCT03792620|Daratumumab|daratumumab|mesh-list
44926279|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926280|NCT03792503|Pemetrexed|pemetrexed|mesh-list
44926281|NCT03792503|Apatinib|apatinib|mesh-list
44926282|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926283|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926284|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926285|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44926286|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44926287|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926288|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44926289|NCT03792217|Eusol|eusol|mesh-list
44926290|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
44926291|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926292|NCT03792139|Itraconazole|itraconazole|mesh-list
44926293|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
44926294|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926295|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44926296|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44926297|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926298|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926299|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44926300|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
44866073|NCT04487834|Emollients|emollients|mesh-ancestor
44926301|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926302|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926303|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44926304|NCT03792269|Capecitabine|capecitabine|mesh-list
44926305|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
44926306|NCT03792269|Irinotecan|irinotecan|mesh-list
44926307|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44926308|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
44926309|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926310|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926311|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44926312|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44926313|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926314|NCT03792295|Acetaminophen|acetaminophen|mesh-list
44926315|NCT03792295|Ibuprofen|ibuprofen|mesh-list
44926316|NCT03792295|Oxycodone|oxycodone|mesh-list
44926317|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926318|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926319|NCT03792295|Analgesics|analgesics|mesh-ancestor
44926320|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
44926321|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926322|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926323|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926324|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926325|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44926326|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926327|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926328|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44926329|NCT03792295|Narcotics|narcotics|mesh-ancestor
44926330|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926331|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
44926332|NCT03792152|Warfarin|warfarin|mesh-list
44926333|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
44926334|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
44926335|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44926336|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
44926337|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44926338|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44926339|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926340|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926341|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
44926342|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926343|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926344|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
44926345|NCT03792321|Testosterone|testosterone|mesh-list
44926346|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
44926347|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
44926348|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44926349|NCT03792321|Androgens|androgens|mesh-ancestor
44926350|NCT03792321|Hormones|hormones|mesh-ancestor
44926351|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926352|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926353|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926354|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926355|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
44926356|NCT03792009|Bupivacaine|bupivacaine|mesh-list
44926357|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926358|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
44926359|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926360|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926361|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
44926362|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926363|NCT03791957|Chrysarobin|chrysarobin|mesh-list
44926364|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926365|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926366|NCT03791957|Analgesics|analgesics|mesh-ancestor
44926367|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
44926368|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926369|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926370|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926371|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926372|NCT03792074|Paclitaxel|paclitaxel|mesh-list
44926373|NCT03792074|Bevacizumab|bevacizumab|mesh-list
44926374|NCT03792074|Carboplatin|carboplatin|mesh-list
44926375|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44926376|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926377|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
44926378|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
44926379|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
44866504|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
44926380|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926381|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926382|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44926383|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44926384|NCT03792074|Growth Substances|growth substances|mesh-ancestor
44926385|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926386|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
44926387|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44926388|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
44926389|NCT03792113|Coagulants|coagulants|mesh-ancestor
44926390|NCT03791905|Leucovorin|leucovorin|mesh-list
44926391|NCT03791905|Paclitaxel|paclitaxel|mesh-list
44926392|NCT03791905|Cisplatin|cisplatin|mesh-list
44926393|NCT03791905|Fluorouracil|fluorouracil|mesh-list
44926394|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
44926395|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44926396|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926397|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44926398|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44926399|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44926400|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926401|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
44866658|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866707|NCT04480827|Cholic Acids|cholic acids|mesh-list
44926402|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44926403|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926404|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
44926405|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926406|NCT03791905|Antidotes|antidotes|mesh-ancestor
44926407|NCT03791905|Protective Agents|protective agents|mesh-ancestor
44926408|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
44926409|NCT03791905|Vitamins|vitamins|mesh-ancestor
44926410|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
44926411|NCT03791918|Lenvatinib|lenvatinib|mesh-list
44926412|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
44926413|NCT03791918|Antibodies|antibodies|mesh-list
44926414|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
44926415|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
44926416|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926417|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926418|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926419|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926420|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926421|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44926422|NCT03791918|Estrogens|estrogens|mesh-ancestor
44926423|NCT03791918|Hormones|hormones|mesh-ancestor
44866909|NCT04477642|Abatacept|abatacept|mesh-list
44926424|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926425|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926426|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44926427|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
44926428|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926429|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
44926430|NCT03791801|Rocuronium|rocuronium|mesh-list
44926431|NCT03791801|Neostigmine|neostigmine|mesh-list
44926432|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44926433|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44926434|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44926435|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926436|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926437|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44926438|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926439|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926440|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
44926441|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926442|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44926443|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
44926444|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44926445|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44926446|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44926447|NCT03791775|Polidocanol|polidocanol|mesh-list
44926448|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44926449|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44926450|NCT03791827|Cyclosporine|cyclosporine|mesh-list
44926451|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
44926452|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
44926453|NCT03791827|Prednisone|prednisone|mesh-list
44926454|NCT03791827|Prednisolone|prednisolone|mesh-list
44926455|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
44926456|NCT03791827|Rituximab|rituximab|mesh-list
44926457|NCT03791827|Azathioprine|azathioprine|mesh-list
44926458|NCT03791827|Tacrolimus|tacrolimus|mesh-list
44926459|NCT03791827|Cyclosporins|cyclosporins|mesh-list
44926460|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926461|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
44926462|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926463|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926464|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44926465|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
44926466|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926467|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926468|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44926469|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926470|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926471|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
44926472|NCT03791827|Hormones|hormones|mesh-ancestor
44926473|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926474|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926475|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44926476|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926477|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
44926478|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926479|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44926480|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44926481|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44926482|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
44926483|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44926484|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
44926485|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44926486|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44926487|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
44926488|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44926489|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44926494|NCT03791723|Valsartan|valsartan|mesh-list
44926495|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44926496|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44926497|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44867211|NCT04473053|Analgesics|analgesics|mesh-ancestor
44654138|NCT00129259|Iron|iron|mesh-list
44926498|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44926499|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926500|NCT03791515|Calcitonin|calcitonin|mesh-list
44926501|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
44926502|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44926503|NCT03791515|Katacalcin|katacalcin|mesh-list
44926504|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44926505|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926506|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44926507|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
44926508|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
44926509|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926510|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926511|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926512|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44926513|NCT03791424|Midazolam|midazolam|mesh-list
44926514|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44926515|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926516|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926517|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926518|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44926519|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44926520|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926521|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44926522|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
44926523|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
44926524|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
44926525|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
44926526|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926527|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926528|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
44926529|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
44926530|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44926531|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
44926532|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926533|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
44926534|NCT03791294|Protective Agents|protective agents|mesh-ancestor
44926535|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
44926536|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44926537|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44926538|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44926539|NCT03791099|Metronidazole|metronidazole|mesh-list
44926540|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926541|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44926542|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44926543|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44926544|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
44926545|NCT03791255|Calcium|calcium|mesh-list
44926546|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44926547|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926548|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44926549|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44926550|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44926551|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926552|NCT03790839|Incretins|incretins|mesh-ancestor
44926553|NCT03790839|Hormones|hormones|mesh-ancestor
44926554|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926555|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44926556|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
44926557|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926558|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926559|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
44926560|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926561|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926562|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926563|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44926564|NCT03790787|Empagliflozin|empagliflozin|mesh-list
44926565|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44926566|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722602|NCT01526278|Alendronate|alendronate|mesh-list
44926567|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44926568|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926569|NCT03790540|Benzocaine|benzocaine|mesh-list
44926570|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926571|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
44926572|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926573|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926574|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
44926575|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926576|NCT03790605|Curcumin|curcumin|mesh-list
44926577|NCT03790605|Iproplatin|iproplatin|mesh-list
44926578|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926579|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926580|NCT03790605|Analgesics|analgesics|mesh-ancestor
44926581|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
44926582|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926583|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926584|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926585|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926586|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926587|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926588|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926589|NCT03790345|Vitamins|vitamins|mesh-list
44926590|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
44926591|NCT03790345|Pyridoxine|pyridoxine|mesh-list
44926592|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
44926593|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
44926594|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
44926595|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926596|NCT03790618|Methamphetamine|methamphetamine|mesh-list
44926597|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44926598|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
44926599|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926600|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926601|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
44926602|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926603|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926604|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44926605|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44926606|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926607|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867925|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
44926608|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44926609|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
44926610|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
44926611|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926612|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
44926613|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44926614|NCT03790566|Bupivacaine|bupivacaine|mesh-list
44926615|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926616|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
44926617|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926618|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926619|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
44926620|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926621|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
44926622|NCT03790215|Progestins|progestins|mesh-ancestor
44926623|NCT03790215|Hormones|hormones|mesh-ancestor
44926624|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926625|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926626|NCT03790228|Carboplatin|carboplatin|mesh-list
44926627|NCT03790228|Pemetrexed|pemetrexed|mesh-list
44926628|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926629|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926630|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926631|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44926632|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44926633|NCT03790371|Misoprostol|misoprostol|mesh-list
44926634|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44926635|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
44926636|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44926637|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926638|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44926639|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926640|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
44926641|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
44926642|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926644|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926645|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926646|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
44926647|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926648|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44926649|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
44926650|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926651|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926652|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44926653|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
44926654|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926655|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926656|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44926657|NCT03790384|Mitomycins|mitomycins|mesh-list
44926658|NCT03790384|Mitomycin|mitomycin|mesh-list
44926659|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
44926660|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44926661|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926662|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
44926663|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926664|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44926665|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926666|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44926667|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
44926668|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926669|NCT03790293|Rituximab|rituximab|mesh-list
44926670|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44926671|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926672|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
44926673|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926674|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926675|NCT03790020|Bupivacaine|bupivacaine|mesh-list
44926676|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926677|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
44926678|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926679|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926680|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
44926681|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926682|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
44926683|NCT03790072|Fludarabine|fludarabine|mesh-list
44926684|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926685|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
44926686|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926687|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926688|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44926689|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
44926690|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926691|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926692|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44926693|NCT03789890|Itraconazole|itraconazole|mesh-list
44926694|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
44926695|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926696|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44926697|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44926698|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926699|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926700|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44926701|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
44926702|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926703|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926704|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44868378|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
44926705|NCT03790085|Olanzapine|olanzapine|mesh-list
44926706|NCT03790085|Risperidone|risperidone|mesh-list
44926707|NCT03790085|Aripiprazole|aripiprazole|mesh-list
44926708|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44926709|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
44926710|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926711|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926712|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926713|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44926714|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722753|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
44926751|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44926752|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44722830|NCT01527279|Antazoline|antazoline|mesh-list
44926753|NCT03789370|Propofol|propofol|mesh-list
44926754|NCT03789370|Sevoflurane|sevoflurane|mesh-list
44926755|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926756|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926757|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926758|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44926759|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
44926760|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
44926761|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44926762|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44926763|NCT03789539|Vaccines|vaccines|mesh-list
44926764|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
44926765|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926766|NCT03789422|Cetirizine|cetirizine|mesh-list
44926767|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
44926768|NCT03789422|Levocetirizine|levocetirizine|mesh-list
44926769|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44926770|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44926771|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926772|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
44926773|NCT03789422|Coagulants|coagulants|mesh-ancestor
44926774|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44926775|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44926776|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
44926777|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
44926778|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926779|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926780|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44926781|NCT03789123|Dienogest|dienogest|mesh-list
44926782|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44926783|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44926784|NCT03789123|Estradiol|estradiol|mesh-list
44926785|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44926786|NCT03789123|Nandrolone|nandrolone|mesh-list
44926787|NCT03789123|Estrogens|estrogens|mesh-ancestor
44926788|NCT03789123|Hormones|hormones|mesh-ancestor
44926789|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926790|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926791|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44926792|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
44926793|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44926794|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44926795|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44926796|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44926797|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44926798|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
44926799|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44926800|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926801|NCT03789123|Androgens|androgens|mesh-ancestor
44926802|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
44926803|NCT03789058|Ibuprofen|ibuprofen|mesh-list
44926804|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926805|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926806|NCT03789058|Analgesics|analgesics|mesh-ancestor
44926807|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
44926808|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926809|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926810|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926811|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926812|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44926813|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926814|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926815|NCT03788889|Ketamine|ketamine|mesh-list
44926816|NCT03788889|Lorazepam|lorazepam|mesh-list
44926817|NCT03788889|Phenobarbital|phenobarbital|mesh-list
44926818|NCT03788889|Analgesics|analgesics|mesh-ancestor
44926819|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
44926820|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926821|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926822|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44926823|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44926824|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
44926825|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
44926826|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926827|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44926828|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44926829|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926830|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926831|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
44926832|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
44926833|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
44926834|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926835|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926836|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44926837|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44926838|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44926839|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
44926840|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
44926841|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44926842|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44926843|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44926844|NCT03788902|Methylphenidate|methylphenidate|mesh-list
44926845|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44926846|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926847|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44926848|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44926849|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926850|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926851|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
44926852|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926853|NCT03788863|Diflucortolone|diflucortolone|mesh-list
44926854|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
44926855|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926856|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
44926857|NCT03788863|Hormones|hormones|mesh-ancestor
44926858|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926859|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926860|NCT03789032|Rabeprazole|rabeprazole|mesh-list
44926861|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44926862|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44926863|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44926864|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926865|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926866|NCT03788733|Melatonin|melatonin|mesh-list
44926867|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
44926868|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705637|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705638|NCT03821649|Naloxone|naloxone|mesh-list
44705639|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44705640|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705641|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
44705642|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705643|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
44705644|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705645|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
44705646|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705647|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705648|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
44705649|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705650|NCT03771612|Naproxen|naproxen|mesh-list
44705651|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44705652|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44705653|NCT03771612|Analgesics|analgesics|mesh-ancestor
44705654|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
44705655|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705656|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705657|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705658|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705659|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
44705660|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44705661|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705662|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705663|NCT03759028|Acetaminophen|acetaminophen|mesh-list
44705664|NCT03759028|Ibuprofen|ibuprofen|mesh-list
44705665|NCT03759028|Oxycodone|oxycodone|mesh-list
44705666|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44705667|NCT03759028|Analgesics|analgesics|mesh-ancestor
44257123|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
44705668|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
44705669|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705670|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705671|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
44926869|NCT03788733|Protective Agents|protective agents|mesh-ancestor
44926870|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926871|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926872|NCT03788694|Ketamine|ketamine|mesh-list
44926873|NCT03788694|Analgesics|analgesics|mesh-ancestor
44926874|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
44868772|NCT04453436|Tenofovir|tenofovir|mesh-list
44926875|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926876|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926877|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44926878|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44926879|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
44926880|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
44926881|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926882|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44926883|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44926884|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926885|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926886|NCT03789006|Interleukin-2|interleukin-2|mesh-list
44926887|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
44926888|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44926889|NCT03789006|Antibodies|antibodies|mesh-list
44926890|NCT03789006|Basiliximab|basiliximab|mesh-list
44926891|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
44926892|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44926893|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
44926894|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926895|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926896|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926897|NCT03789006|Analgesics|analgesics|mesh-ancestor
44926898|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
44926899|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926900|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44926901|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44926902|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44926903|NCT03788681|Estradiol|estradiol|mesh-list
44926904|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44926905|NCT03788681|Estrogens|estrogens|mesh-ancestor
44926906|NCT03788681|Hormones|hormones|mesh-ancestor
44926907|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44926908|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926909|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44926910|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
44926911|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44926912|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44926913|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
44926914|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926915|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926916|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926917|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926918|NCT03788538|Analgesics|analgesics|mesh-ancestor
44926919|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
44926920|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926921|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44926922|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44926923|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44926924|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
44926925|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926926|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926927|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44926928|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44926929|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
44926930|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
44926931|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44926932|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44926933|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44926934|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926935|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926936|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
44926937|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926938|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926939|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44926940|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926941|NCT03787992|Gefitinib|gefitinib|mesh-list
44926942|NCT03787992|Aflutinib|aflutinib|mesh-list
44926943|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926944|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869030|NCT04449185|Amoxicillin|amoxicillin|mesh-list
44926945|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926946|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926947|NCT03787940|Isoniazid|isoniazid|mesh-list
44926948|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
44926949|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44926950|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44926951|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44926952|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44926953|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
44926954|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926955|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44926956|NCT03787953|Antibodies|antibodies|mesh-list
44926957|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
44926958|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926959|NCT03788018|Lidocaine|lidocaine|mesh-list
44926960|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
44926961|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
44926962|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
44926963|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44926964|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926965|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
44926966|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926967|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44926968|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44926969|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44926970|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44926971|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926972|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44926973|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926974|NCT03788018|Analgesics|analgesics|mesh-ancestor
44926975|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44926976|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44926977|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44926978|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
44926979|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44926980|NCT03788174|Apatinib|apatinib|mesh-list
44926981|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44926982|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44926983|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44926984|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44926985|NCT03787927|Aspirin|aspirin|mesh-list
44926986|NCT03787927|Clopidogrel|clopidogrel|mesh-list
44926987|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44926988|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44926989|NCT03787927|Analgesics|analgesics|mesh-ancestor
44926990|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
44926991|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44926992|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44926993|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44926994|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44926995|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44926996|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44926997|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869123|NCT04447326|Endostar protein|endostar protein|mesh-list
44926998|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44926999|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44927000|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927001|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
44927002|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44927003|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44927004|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44927005|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
44927006|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927007|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44927008|NCT03787550|Analgesics|analgesics|mesh-list
44927009|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44927010|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927011|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
44927012|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927013|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927014|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927015|NCT03787641|Protamines|protamines|mesh-list
44927016|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
44927019|NCT03787147|Lidocaine|lidocaine|mesh-list
44927020|NCT03787147|Bupivacaine|bupivacaine|mesh-list
44927021|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927022|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
44927023|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927024|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927025|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
44927026|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927027|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927028|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44927029|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44927030|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927031|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927032|NCT03786887|Nalbuphine|nalbuphine|mesh-list
44927033|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927034|NCT03786887|Narcotics|narcotics|mesh-ancestor
44869537|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
44869616|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927035|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927036|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927037|NCT03786887|Analgesics|analgesics|mesh-ancestor
44927038|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
44927039|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927040|NCT03787043|Metformin|metformin|mesh-list
44927041|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44927042|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927043|NCT03787017|Metformin|metformin|mesh-list
44927044|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44927045|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927046|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
44927047|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44927048|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
44927049|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44927050|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
44927051|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935922|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927052|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927053|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
44927054|NCT03787030|Vitamin E|vitamin e|mesh-list
44927055|NCT03787030|Tocopherols|tocopherols|mesh-list
44927056|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
44927057|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
44927058|NCT03787030|Vitamins|vitamins|mesh-ancestor
44927059|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
44927060|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927061|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
44927062|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927063|NCT03787030|Protective Agents|protective agents|mesh-ancestor
44927064|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44927065|NCT03787069|Lidocaine|lidocaine|mesh-list
44927066|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927067|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
44927068|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927069|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927070|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
44927071|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927072|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927073|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44927074|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44927075|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927076|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927077|NCT03786562|Morphine|morphine|mesh-list
44927078|NCT03786562|Nalbuphine|nalbuphine|mesh-list
44927079|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927080|NCT03786562|Narcotics|narcotics|mesh-ancestor
44927081|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927082|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927083|NCT03786562|Analgesics|analgesics|mesh-ancestor
44927084|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
44927085|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927086|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
44927087|NCT03786289|Hematinics|hematinics|mesh-ancestor
44927088|NCT03786419|Atezolizumab|atezolizumab|mesh-list
44927089|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927090|NCT03786120|Zolpidem|zolpidem|mesh-list
44723246|NCT01529190|Pregabalin|pregabalin|mesh-list
44927091|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44927092|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44927093|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927094|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927095|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44927096|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
44927097|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
44927098|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927099|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927100|NCT03785873|Leucovorin|leucovorin|mesh-list
44927101|NCT03785873|Fluorouracil|fluorouracil|mesh-list
44927102|NCT03785873|Nivolumab|nivolumab|mesh-list
44927103|NCT03785873|Irinotecan|irinotecan|mesh-list
44927104|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
44927105|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927106|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927107|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927108|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927109|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
44927110|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927111|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44927112|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44927113|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44927114|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44927115|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927116|NCT03785873|Antidotes|antidotes|mesh-ancestor
44927117|NCT03785873|Protective Agents|protective agents|mesh-ancestor
44927118|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
44927119|NCT03785873|Vitamins|vitamins|mesh-ancestor
44927120|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
44927121|NCT03786029|Acetaminophen|acetaminophen|mesh-list
44927122|NCT03786029|Ibuprofen|ibuprofen|mesh-list
44927123|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927124|NCT03786029|Analgesics|analgesics|mesh-ancestor
44927125|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
44927126|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927127|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927128|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
44927129|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927130|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927131|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44927132|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44927133|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927134|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927135|NCT03785756|Ibuprofen|ibuprofen|mesh-list
44927136|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927137|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927138|NCT03785756|Analgesics|analgesics|mesh-ancestor
44927139|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
44927140|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927141|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927142|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927143|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44927144|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44927145|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927146|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927147|NCT03785496|Spartalizumab|spartalizumab|mesh-list
44927148|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44927149|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927150|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927151|NCT03785613|Buprenorphine|buprenorphine|mesh-list
44927152|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927153|NCT03785613|Narcotics|narcotics|mesh-ancestor
44927154|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927155|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927156|NCT03785613|Analgesics|analgesics|mesh-ancestor
44927157|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
44927158|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927159|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44927160|NCT03785522|Insulin|insulin|mesh-list
44927161|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44927162|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927163|NCT03785223|Methylphenidate|methylphenidate|mesh-list
44927164|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44927165|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927166|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44927167|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44927168|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927169|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927170|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
44927171|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927172|NCT03785015|Aspirin|aspirin|mesh-list
44927173|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927174|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927175|NCT03785015|Analgesics|analgesics|mesh-ancestor
44927176|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
44927177|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927178|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927179|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927180|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44927181|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44927182|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44870318|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
44870326|NCT04892940|Analgesics|analgesics|mesh-list
44927183|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927184|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44927185|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44927186|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705672|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44705673|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705674|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705675|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44705676|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705677|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705678|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44705679|NCT03759028|Narcotics|narcotics|mesh-ancestor
44705680|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705681|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
44705682|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705683|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705684|NCT03737292|Bupivacaine|bupivacaine|mesh-list
44705685|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705686|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
44705687|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705688|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870532|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705689|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
44705690|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705691|NCT03734211|Evolocumab|evolocumab|mesh-list
44705692|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44705693|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44705694|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
44705695|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705696|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44705697|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
44705698|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44705699|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44705700|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705701|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
44705702|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
44705703|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44705704|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705705|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705706|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705707|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44705708|NCT03708198|Bupivacaine|bupivacaine|mesh-list
44705709|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705710|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
44871026|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
44705711|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705712|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705713|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
44705714|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705715|NCT03666065|Insulin|insulin|mesh-list
44705716|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44705717|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
44705718|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705719|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705720|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
44705721|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44705722|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705723|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705724|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44705725|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44705726|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
44705727|NCT03512405|Blinatumomab|blinatumomab|mesh-list
44705728|NCT03512405|Antibodies|antibodies|mesh-list
44927187|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
44927218|NCT03784794|Thrombin|thrombin|mesh-list
44927219|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
44927220|NCT03784794|Coagulants|coagulants|mesh-ancestor
44927221|NCT03785067|Amlodipine|amlodipine|mesh-list
44927222|NCT03785067|Telmisartan|telmisartan|mesh-list
44927223|NCT03785067|Indapamide|indapamide|mesh-list
44927224|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44927225|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44927226|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927227|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927228|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44927229|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927230|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44927231|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44927232|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44927233|NCT03785067|Diuretics|diuretics|mesh-ancestor
44927234|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
44927235|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44927236|NCT03784495|Melatonin|melatonin|mesh-list
44927237|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
44927238|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927239|NCT03784495|Protective Agents|protective agents|mesh-ancestor
44927240|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927241|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927242|NCT03784703|Atorvastatin|atorvastatin|mesh-list
44927243|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44927244|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44927245|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44927246|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
44927247|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927248|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44927249|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44927250|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927251|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44927252|NCT03784443|Ranibizumab|ranibizumab|mesh-list
44927253|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44927254|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44927255|NCT03784443|Growth Substances|growth substances|mesh-ancestor
44927256|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927257|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44927258|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927259|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927260|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
44927261|NCT03784443|Hormones|hormones|mesh-ancestor
44927262|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927263|NCT03784378|Agerafenib|agerafenib|mesh-list
44927264|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44927265|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927266|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927267|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
44927268|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
44927269|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927270|NCT03784391|Nifurtimox|nifurtimox|mesh-list
44871483|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
44927271|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44927272|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44927273|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44927274|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927275|NCT03784105|Codeine|codeine|mesh-list
44927276|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927277|NCT03784105|Narcotics|narcotics|mesh-ancestor
44927278|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927279|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927280|NCT03784105|Analgesics|analgesics|mesh-ancestor
44927281|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
44927282|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927283|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
44927284|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44927285|NCT03784261|Abatacept|abatacept|mesh-list
44927286|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44927287|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927288|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927289|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927290|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
44927291|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927292|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705729|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
44927294|NCT03783897|Norgestimate|norgestimate|mesh-list
44927295|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
44927296|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
44927297|NCT03783897|Estradiol|estradiol|mesh-list
44927298|NCT03783897|Estrogens|estrogens|mesh-ancestor
44927299|NCT03783897|Hormones|hormones|mesh-ancestor
44927300|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927301|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927302|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44927303|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44927304|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44927305|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44927306|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44927307|NCT03783949|Gemcitabine|gemcitabine|mesh-list
44927308|NCT03783949|Paclitaxel|paclitaxel|mesh-list
44927309|NCT03783949|Carboplatin|carboplatin|mesh-list
44927310|NCT03783949|Niraparib|niraparib|mesh-list
44927311|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44927312|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927313|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44927314|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44927315|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44927316|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927317|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927318|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
44927319|NCT03783949|Antiviral Agents|antiviral agents|mesh-ancestor
44927320|NCT03783949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927321|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927322|NCT03783949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927323|NCT03783949|Immunologic Factors|immunologic factors|mesh-ancestor
44927324|NCT03783949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927325|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44927326|NCT03783936|Leucovorin|leucovorin|mesh-list
44927327|NCT03783936|Fluorouracil|fluorouracil|mesh-list
44927328|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
44927329|NCT03783936|Trastuzumab|trastuzumab|mesh-list
44927330|NCT03783936|Avelumab|avelumab|mesh-list
44927331|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
44927332|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927333|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927334|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927335|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927336|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
44927337|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871665|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
44927338|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44927339|NCT03783936|Antidotes|antidotes|mesh-ancestor
44927340|NCT03783936|Protective Agents|protective agents|mesh-ancestor
44927341|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
44927342|NCT03783936|Vitamins|vitamins|mesh-ancestor
44927343|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
44927344|NCT03784040|Nivolumab|nivolumab|mesh-list
44927345|NCT03784040|Ipilimumab|ipilimumab|mesh-list
44927346|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44927347|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927348|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44927349|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927350|NCT03783845|Amoxicillin|amoxicillin|mesh-list
44927351|NCT03783845|Metronidazole|metronidazole|mesh-list
44927352|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927353|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927354|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44927355|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44927356|NCT03783728|Pyridoxine|pyridoxine|mesh-list
44927357|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
44927358|NCT03783728|Isoniazid|isoniazid|mesh-list
44927359|NCT03783728|Rifapentine|rifapentine|mesh-list
44927360|NCT03783728|Vitamins|vitamins|mesh-ancestor
44927361|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
44927362|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927363|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
44927364|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
44927365|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927366|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927367|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44927368|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44927369|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
44927370|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927371|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44927372|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44927373|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
44927374|NCT03783754|Amlodipine|amlodipine|mesh-list
44927375|NCT03783754|Telmisartan|telmisartan|mesh-list
44927376|NCT03783754|Indapamide|indapamide|mesh-list
44927377|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44872054|NCT04423926|Prednisolone|prednisolone|mesh-list
44872177|NCT04422275|Hormones|hormones|mesh-ancestor
44927378|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44927379|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927380|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927381|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44927382|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927383|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
44927384|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44927385|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44927386|NCT03783754|Diuretics|diuretics|mesh-ancestor
44927387|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
44927388|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44927389|NCT03783494|Propofol|propofol|mesh-list
44927390|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44927391|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927392|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927393|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44927394|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
44927395|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
44927396|NCT03783676|Remifentanil|remifentanil|mesh-list
44927397|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927398|NCT03783676|Narcotics|narcotics|mesh-ancestor
44927399|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927400|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927401|NCT03783676|Analgesics|analgesics|mesh-ancestor
44927402|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
44927403|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927404|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
44927405|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44927406|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
44927407|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927408|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
44927409|NCT03783455|Protective Agents|protective agents|mesh-ancestor
44927410|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44927411|NCT03783520|Eusol|eusol|mesh-list
44927412|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
44927413|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927414|NCT03783338|Vitamin D|vitamin d|mesh-list
44927415|NCT03783338|Vitamins|vitamins|mesh-ancestor
44927416|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
44927417|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927418|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44927419|NCT03783312|Acetaminophen|acetaminophen|mesh-list
44927420|NCT03783312|Ibuprofen|ibuprofen|mesh-list
44927421|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927422|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927423|NCT03783312|Analgesics|analgesics|mesh-ancestor
44927424|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
44927425|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705730|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44705731|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
44705732|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44705733|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
44705734|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705735|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705736|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705737|NCT03507699|Nivolumab|nivolumab|mesh-list
44705738|NCT03507699|Ipilimumab|ipilimumab|mesh-list
44705739|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705740|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705741|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44705742|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705743|NCT03495713|Nivolumab|nivolumab|mesh-list
44705744|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705745|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705746|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44705747|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705748|NCT03444753|Nivolumab|nivolumab|mesh-list
44705749|NCT03444753|Ipilimumab|ipilimumab|mesh-list
44705750|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705751|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927437|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927438|NCT03783429|Protective Agents|protective agents|mesh-ancestor
44927439|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927440|NCT03783299|Lumefantrine|lumefantrine|mesh-list
44927441|NCT03783299|Artemether|artemether|mesh-list
44927442|NCT03783299|Primaquine|primaquine|mesh-list
44927443|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44927444|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
44927445|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44927446|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44927447|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927448|NCT03783273|Vitamin D|vitamin d|mesh-list
44927449|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
44927450|NCT03783273|Vitamins|vitamins|mesh-ancestor
44927451|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
44927452|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927453|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44927454|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44927455|NCT03782987|Itraconazole|itraconazole|mesh-list
44927456|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
44927457|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927458|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44927459|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44927460|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927461|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660134|NCT00041132|Leucovorin|leucovorin|mesh-list
44927462|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44927463|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
44927464|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927465|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927466|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44927467|NCT03783065|Propranolol|propranolol|mesh-list
44927468|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44927469|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44927470|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44927471|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927472|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927473|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927474|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927475|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44927476|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44927477|NCT03782935|Choline|choline|mesh-list
44927478|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
44927479|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44927480|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
44927481|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927482|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927483|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44927484|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
44927485|NCT03782831|Antibodies|antibodies|mesh-list
44927486|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
44927487|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927488|NCT03783000|BI 425809|bi 425809|mesh-list
44927489|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
44723692|NCT01531517|Propolis|propolis|mesh-list
44927490|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
44927491|NCT03782805|Vitamin D|vitamin d|mesh-list
44927492|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872642|NCT04415567|Lenvatinib|lenvatinib|mesh-list
44927493|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927494|NCT03782805|Vitamins|vitamins|mesh-ancestor
44927495|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
44927496|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44927497|NCT03782662|Itraconazole|itraconazole|mesh-list
44927498|NCT03782662|Rifampin|rifampin|mesh-list
44927499|NCT03782662|Verapamil|verapamil|mesh-list
44927500|NCT03782662|Midazolam|midazolam|mesh-list
44927501|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44927502|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44927503|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927504|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927505|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44927506|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44927507|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44927508|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44927509|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
44927510|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
44927511|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
44927512|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
44872933|NCT04411706|Apatinib|apatinib|mesh-list
44927513|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927514|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927515|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
44927516|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927517|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44873006|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927518|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44927519|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927520|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44927521|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
44927522|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927523|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44927524|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44927525|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
44927526|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927527|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
44927528|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44927529|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44927530|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44927531|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44927532|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44873311|NCT04407715|Anesthetics|anesthetics|mesh-list
44927533|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44927534|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44927535|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927536|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44927537|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927538|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44927539|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
44927540|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44927541|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44927542|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
44927543|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927544|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
44927545|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44927546|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44927547|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927548|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
44927549|NCT03782025|Coagulants|coagulants|mesh-ancestor
44927550|NCT03782025|Vitamins|vitamins|mesh-ancestor
44927551|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
44927552|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927553|NCT03781947|Antarelix|antarelix|mesh-list
44927554|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
44927555|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927556|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927557|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
44927558|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44927559|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927560|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
44927561|NCT03781895|Vitamin D|vitamin d|mesh-list
44927562|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44927563|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927564|NCT03781895|Vitamins|vitamins|mesh-ancestor
44927565|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
44927566|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44927567|NCT03781843|Lidocaine|lidocaine|mesh-list
44927568|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927569|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
44927570|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927571|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927572|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
44927573|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927574|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927575|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44927576|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44927577|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927578|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927579|NCT03781869|Cisplatin|cisplatin|mesh-list
44927580|NCT03781869|Etoposide|etoposide|mesh-list
44927581|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
44927582|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927583|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44927584|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44927585|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44927586|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927587|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927588|NCT03781687|Morphine|morphine|mesh-list
44927589|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927590|NCT03781687|Narcotics|narcotics|mesh-ancestor
44927591|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927592|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927593|NCT03781687|Analgesics|analgesics|mesh-ancestor
44927594|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
44927595|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927596|NCT03781596|Fluticasone|fluticasone|mesh-list
44927597|NCT03781596|Omeprazole|omeprazole|mesh-list
44927598|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927599|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44927600|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
44927601|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927602|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873591|NCT04404751|Iron|iron|mesh-list
44927603|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44927604|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44927605|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
44927606|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44927607|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44927608|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927609|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44927610|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927611|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927612|NCT03781674|Progesterone|progesterone|mesh-list
44927613|NCT03781674|Progestins|progestins|mesh-ancestor
44927614|NCT03781674|Hormones|hormones|mesh-ancestor
44927615|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927616|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927617|NCT03781635|Ketamine|ketamine|mesh-list
44927618|NCT03781635|Analgesics|analgesics|mesh-ancestor
44927619|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
44927620|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927621|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927622|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44927623|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44927624|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
44927625|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
44927626|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927627|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44927628|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44927629|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927630|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927631|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
44927632|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44927633|NCT03781505|Acetaminophen|acetaminophen|mesh-list
44927634|NCT03781505|Ropivacaine|ropivacaine|mesh-list
44873738|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
44927635|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927636|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
44927637|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927638|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927639|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
44927640|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927641|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927642|NCT03781505|Analgesics|analgesics|mesh-ancestor
44927643|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
44927644|NCT03781466|Progesterone|progesterone|mesh-list
44927645|NCT03781466|Progestins|progestins|mesh-ancestor
44927646|NCT03781466|Hormones|hormones|mesh-ancestor
44927647|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873888|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
44874025|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
44874169|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
44927648|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927649|NCT03781258|Warfarin|warfarin|mesh-list
44927650|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
44927651|NCT03781115|Olanzapine|olanzapine|mesh-list
44927652|NCT03781115|Ziprasidone|ziprasidone|mesh-list
44927653|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
44927654|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
44927655|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927656|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927657|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927658|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44927659|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44927660|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927661|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44927662|NCT03781115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44927663|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44927664|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927665|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927666|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927667|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
44927668|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44927669|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44927670|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
44927671|NCT03781050|Sirolimus|sirolimus|mesh-list
44927672|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927673|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927674|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44927675|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927676|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
44927677|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927678|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
44927679|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927680|NCT03781011|Choline|choline|mesh-list
44927681|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
44927682|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44927683|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
44927684|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927685|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927686|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44927687|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
44927688|NCT03780933|Ascorbic Acid|ascorbic acid|mesh-list
44927689|NCT03780933|Vitamins|vitamins|mesh-ancestor
44927690|NCT03780933|Micronutrients|micronutrients|mesh-ancestor
44927691|NCT03780933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927692|NCT03780933|Antioxidants|antioxidants|mesh-ancestor
44927693|NCT03780933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927694|NCT03780933|Protective Agents|protective agents|mesh-ancestor
44927695|NCT03780673|Rifaximin|rifaximin|mesh-list
44927696|NCT03780673|Simvastatin|simvastatin|mesh-list
44927697|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44927698|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44927699|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
44927700|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927701|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44927702|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44927703|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927704|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927705|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927706|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927707|NCT03780686|Dopamine|dopamine|mesh-list
44927708|NCT03780686|Norepinephrine|norepinephrine|mesh-list
44927709|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44927710|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44927711|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
44927712|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927713|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927714|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927715|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
44927716|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
44927717|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927718|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44927719|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44927720|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
44927721|NCT03780686|Protective Agents|protective agents|mesh-ancestor
44927722|NCT03780556|Lornoxicam|lornoxicam|mesh-list
44927723|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927724|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927725|NCT03780556|Analgesics|analgesics|mesh-ancestor
44927726|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
44927727|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927728|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927729|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927730|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44927731|NCT03780621|Andrographolide|andrographolide|mesh-list
44927732|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927733|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44927734|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927735|NCT03780621|Analgesics|analgesics|mesh-ancestor
44927736|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
44927737|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927738|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927739|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705752|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44705753|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705754|NCT03375203|Zolpidem|zolpidem|mesh-list
44705755|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44705756|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44705757|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705758|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705759|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44705760|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
44705761|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
44705762|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705763|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705764|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
44705765|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705766|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705767|NCT03142035|Dienogest|dienogest|mesh-list
44705768|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44705769|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
44705770|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44705771|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705772|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44705773|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44705774|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44705775|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44705776|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705777|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705778|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705779|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874505|NCT04394234|Warfarin|warfarin|mesh-list
44705780|NCT02860000|Fulvestrant|fulvestrant|mesh-list
44705781|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705782|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705783|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44705784|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44705785|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705786|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705787|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705788|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
44705789|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44705790|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705791|NCT02786875|Vitamin D|vitamin d|mesh-list
44705792|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
44705793|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
44705794|NCT02786875|Vitamins|vitamins|mesh-list
44705795|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
44705796|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705797|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44705798|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44705799|NCT02767882|Dexamethasone|dexamethasone|mesh-list
44705800|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705801|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
44705802|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
44927766|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927767|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927768|NCT03780205|Methamphetamine|methamphetamine|mesh-list
44927769|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44927770|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927771|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
44927772|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
44927773|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927774|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
44927775|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927776|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927777|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
44927778|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44927779|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44927780|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927781|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44927783|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44927784|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44927785|NCT03780361|Growth Substances|growth substances|mesh-ancestor
44927786|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874701|NCT04392557|Hormones|hormones|mesh-ancestor
44927787|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
44927788|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927789|NCT03780270|Fluorides|fluorides|mesh-list
44927790|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
44927791|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
44927792|NCT03780270|Protective Agents|protective agents|mesh-ancestor
44927793|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927794|NCT03779776|Vitamins|vitamins|mesh-list
44927795|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
44927796|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927797|NCT03780049|Leucovorin|leucovorin|mesh-list
44927798|NCT03780049|Fluorouracil|fluorouracil|mesh-list
44927799|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
44927800|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
44927801|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927802|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927803|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927804|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927805|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
44875252|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
44927806|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927807|NCT03780049|Antidotes|antidotes|mesh-ancestor
44927808|NCT03780049|Protective Agents|protective agents|mesh-ancestor
44927809|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44927810|NCT03780049|Vitamins|vitamins|mesh-ancestor
44927811|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
44927812|NCT03779685|Anesthetics|anesthetics|mesh-list
44927813|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927814|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875411|NCT04384653|Furosemide|furosemide|mesh-list
44927815|NCT03779633|Estradiol|estradiol|mesh-list
44927816|NCT03779633|Estrogens|estrogens|mesh-ancestor
44927817|NCT03779633|Hormones|hormones|mesh-ancestor
44927818|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927819|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927820|NCT03779516|Lidocaine|lidocaine|mesh-list
44927821|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927822|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
44927823|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927824|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927825|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
44927826|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927827|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927828|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44927829|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44927830|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44927831|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927832|NCT03779451|Progesterone|progesterone|mesh-list
44927833|NCT03779451|Progestins|progestins|mesh-ancestor
44927834|NCT03779451|Hormones|hormones|mesh-ancestor
44927835|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927836|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927837|NCT03779594|Acetazolamide|acetazolamide|mesh-list
44927838|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
44927839|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44927840|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927841|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927842|NCT03779594|Diuretics|diuretics|mesh-ancestor
44927843|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
44927844|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927845|NCT03779464|Gemcitabine|gemcitabine|mesh-list
44927846|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927847|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
44927848|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927849|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927850|NCT03779464|Antiviral Agents|antiviral agents|mesh-ancestor
44927851|NCT03779464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927852|NCT03779464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927853|NCT03779464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927854|NCT03779464|Immunologic Factors|immunologic factors|mesh-ancestor
44927855|NCT03779464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927856|NCT03779568|Bupivacaine|bupivacaine|mesh-list
44875604|NCT04382027|Vitamins|vitamins|mesh-list
44927857|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
44927858|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
44927859|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927860|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927861|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
44927862|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927863|NCT03779659|Anesthetics|anesthetics|mesh-list
44927864|NCT03779659|Benzocaine|benzocaine|mesh-list
44927865|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
44927866|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927867|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927868|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
44927869|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927870|NCT03779672|Memantine|memantine|mesh-list
44927871|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44927872|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44927873|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
44927874|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927875|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927876|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875956|NCT04378283|Lidocaine|lidocaine|mesh-list
44927877|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44927878|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44927879|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
44927880|NCT03779282|Ketamine|ketamine|mesh-list
44927881|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44927882|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927883|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927884|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44927885|NCT03779282|Analgesics|analgesics|mesh-ancestor
44927886|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
44927887|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927888|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44927889|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44927890|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44927891|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
44927892|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927893|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876166|NCT04374981|Celecoxib|celecoxib|mesh-list
44927894|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44927895|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44927896|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
44927897|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
44927898|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44927899|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44927900|NCT03779360|Clindamycin|clindamycin|mesh-list
44927901|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
44927902|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
44927903|NCT03779360|Erythromycin|erythromycin|mesh-list
44927904|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
44927905|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44927906|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
44927907|NCT03779360|Prednisolone|prednisolone|mesh-list
44927908|NCT03779360|Clobetasol|clobetasol|mesh-list
44927909|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44927910|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
44927911|NCT03779360|Hormones|hormones|mesh-ancestor
44927912|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44927913|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927914|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44927915|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927916|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927917|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927918|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927919|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44927920|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927921|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927922|NCT03779347|Praziquantel|praziquantel|mesh-list
44927923|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
44927924|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44927925|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927926|NCT03779178|Landiolol|landiolol|mesh-list
44927927|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44876389|NCT04372407|Itraconazole|itraconazole|mesh-list
44876564|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
44927928|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44927929|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
44927930|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44927931|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927932|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927933|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44927934|NCT03779035|Gemcitabine|gemcitabine|mesh-list
44927935|NCT03779035|Capecitabine|capecitabine|mesh-list
44927936|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44927937|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
44927938|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927939|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927940|NCT03779035|Antiviral Agents|antiviral agents|mesh-ancestor
44927941|NCT03779035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927942|NCT03779035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927943|NCT03779035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44927944|NCT03779035|Immunologic Factors|immunologic factors|mesh-ancestor
44927945|NCT03779035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927946|NCT03779191|Bevacizumab|bevacizumab|mesh-list
44927947|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44927948|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927949|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44927950|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44927951|NCT03779191|Growth Substances|growth substances|mesh-ancestor
44927952|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927953|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
44927954|NCT03779087|Amoxicillin|amoxicillin|mesh-list
44927955|NCT03779087|Levofloxacin|levofloxacin|mesh-list
44927956|NCT03779087|Ofloxacin|ofloxacin|mesh-list
44927957|NCT03779087|Tetracycline|tetracycline|mesh-list
44927958|NCT03779087|Esomeprazole|esomeprazole|mesh-list
44927959|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44927960|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44927961|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44927962|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44927963|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44927964|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927965|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927966|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44927967|NCT03779087|Renal Agents|renal agents|mesh-ancestor
44927968|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44927969|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44927970|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927971|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44927972|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44927973|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44927974|NCT03779100|Lenvatinib|lenvatinib|mesh-list
44927975|NCT03779100|Antibodies|antibodies|mesh-list
44927976|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
44927977|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
44927978|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927979|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44927980|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44927981|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44927982|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44927983|NCT03778723|Fentanyl|fentanyl|mesh-list
44927984|NCT03778723|Anesthetics|anesthetics|mesh-list
44927985|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927986|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927987|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44927988|NCT03778723|Narcotics|narcotics|mesh-ancestor
44927989|NCT03778723|Analgesics|analgesics|mesh-ancestor
44927990|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
44927991|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44927992|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44927993|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44927994|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
44927995|NCT03779061|Propofol|propofol|mesh-list
44927996|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44927997|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44927998|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44927999|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928000|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
44928001|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
44928002|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
44928003|NCT03778619|Rituximab|rituximab|mesh-list
44928004|NCT03778619|Fludarabine|fludarabine|mesh-list
44928005|NCT03778619|Interleukin-2|interleukin-2|mesh-list
44928006|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928007|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
44928008|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928009|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928010|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44928011|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
44928012|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928013|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928014|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44928015|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928016|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44928017|NCT03778619|Analgesics|analgesics|mesh-ancestor
44928018|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
44928019|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928020|NCT03778645|Epinephrine|epinephrine|mesh-list
44928021|NCT03778645|Racepinephrine|racepinephrine|mesh-list
44928022|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
44928023|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44928024|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44928025|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44928026|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928027|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928028|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928029|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44928030|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44928031|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
44928032|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928033|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44928034|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
44928035|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
44928036|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
44877187|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928037|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44928038|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
44928039|NCT03778450|Analgesics|analgesics|mesh-list
44928040|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
44928041|NCT03778450|Narcotics|narcotics|mesh-ancestor
44928042|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928043|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928044|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
44928045|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928046|NCT03778359|Leuprolide|leuprolide|mesh-list
44928047|NCT03778359|Dienogest|dienogest|mesh-list
44928048|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
44928049|NCT03778359|Progestins|progestins|mesh-list
44928050|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44928051|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
44928052|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928053|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928054|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44928055|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44928056|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44928057|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44705803|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705804|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705805|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705806|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
44705807|NCT02767882|Hormones|hormones|mesh-ancestor
44705808|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705809|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705810|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705811|NCT02547662|Dexamethasone|dexamethasone|mesh-list
44705812|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
44705813|NCT02547662|Pomalidomide|pomalidomide|mesh-list
44705814|NCT02547662|Ixazomib|ixazomib|mesh-list
44705815|NCT02547662|Ichthammol|ichthammol|mesh-list
44705816|NCT02547662|BB 1101|bb 1101|mesh-list
44705817|NCT02547662|Glycine|glycine|mesh-list
44705818|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44705819|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
44705820|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
44705821|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705822|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705823|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44705824|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
44705825|NCT02547662|Hormones|hormones|mesh-ancestor
44705826|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705827|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705828|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705829|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705830|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
44705831|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877638|NCT04360031|Tacrolimus|tacrolimus|mesh-list
44877702|NCT04359576|Hemostatics|hemostatics|mesh-list
44705832|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
44705833|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44705834|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44705835|NCT02547662|Growth Substances|growth substances|mesh-ancestor
44928058|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
44928059|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44928060|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928061|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44928062|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44928064|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928065|NCT03778359|Hormones|hormones|mesh-ancestor
44928066|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
44928067|NCT03778502|Apixaban|apixaban|mesh-list
44928068|NCT03778502|Edoxaban|edoxaban|mesh-list
44928069|NCT03778502|Dabigatran|dabigatran|mesh-list
44928070|NCT03778502|Anticoagulants|anticoagulants|mesh-list
44928071|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44928072|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
44928073|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44877903|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
44928074|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44928075|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928076|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928077|NCT03778281|Baclofen|baclofen|mesh-list
44928078|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44928079|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928080|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44928081|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928082|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44928083|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
44928084|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
44928085|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928086|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928087|NCT03778567|Lamivudine|lamivudine|mesh-list
44928088|NCT03778567|Telbivudine|telbivudine|mesh-list
44928089|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44928090|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44928091|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928092|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928093|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
44928094|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928095|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44928096|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44928097|NCT03778541|Temozolomide|temozolomide|mesh-list
44928098|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44928099|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
44928100|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928101|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928102|NCT03778593|Leucovorin|leucovorin|mesh-list
44928103|NCT03778593|Fluorouracil|fluorouracil|mesh-list
44928104|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
44928105|NCT03778593|Irinotecan|irinotecan|mesh-list
44928106|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
44928107|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928108|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928109|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928110|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928111|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
44928112|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928113|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44928114|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44928115|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928116|NCT03778593|Antidotes|antidotes|mesh-ancestor
44928117|NCT03778593|Protective Agents|protective agents|mesh-ancestor
44928118|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
44928119|NCT03778593|Vitamins|vitamins|mesh-ancestor
44928120|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
44928121|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
44928122|NCT03778008|Hydroxocobalamin|hydroxocobalamin|mesh-list
44928123|NCT03778008|Gentamicins|gentamicins|mesh-list
44928124|NCT03778008|Dexamethasone|dexamethasone|mesh-list
44928125|NCT03778008|Lidocaine|lidocaine|mesh-list
44928126|NCT03778008|Mitogens|mitogens|mesh-list
44928127|NCT03778008|Vitamins|vitamins|mesh-ancestor
44928128|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
44878432|NCT04352959|Betadex|betadex|mesh-list
44928129|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928130|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44928131|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
44928132|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
44928133|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928134|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928135|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
44928136|NCT03778008|Hormones|hormones|mesh-ancestor
44928137|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928138|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44928157|NCT03778242|Oxytocics|oxytocics|mesh-ancestor
44928158|NCT03778242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928159|NCT03778242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928160|NCT03778138|Pemetrexed|pemetrexed|mesh-list
44928161|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928162|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928163|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928164|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44928165|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44928166|NCT03777956|Lacosamide|lacosamide|mesh-list
44928167|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
44928168|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44928169|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44928170|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44928171|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928172|NCT03777878|Oxytocin|oxytocin|mesh-list
44928173|NCT03777878|Carbetocin|carbetocin|mesh-list
44928174|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
44928175|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928176|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928177|NCT03777930|Thalidomide|thalidomide|mesh-list
44928178|NCT03777930|Megestrol|megestrol|mesh-list
44928179|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
44928180|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928181|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
44928182|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928183|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
44928184|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928185|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928186|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44928187|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44928188|NCT03777930|Growth Substances|growth substances|mesh-ancestor
44928189|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44928190|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928191|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44928192|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44928193|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44928194|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
44928195|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928196|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44928197|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44928198|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44928199|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
44928200|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44928201|NCT03777579|Paclitaxel|paclitaxel|mesh-list
44928202|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44928203|NCT03777579|Antibodies|antibodies|mesh-list
44928204|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
44928205|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44928206|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928207|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44928208|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44928209|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44928210|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928211|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
44928212|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928213|NCT03777696|Misoprostol|misoprostol|mesh-list
44928214|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44928215|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
44928216|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928217|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928218|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44928219|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928220|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
44928221|NCT03777423|Cobalt|cobalt|mesh-list
44928222|NCT03777423|Chromium|chromium|mesh-list
44928223|NCT03777423|Trace Elements|trace elements|mesh-ancestor
44928224|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
44928225|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928226|NCT03777787|Denatonium|denatonium|mesh-list
44928227|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
44928228|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928229|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
44724517|NCT01536249|Cimetidine|cimetidine|mesh-list
44928230|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928231|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
44928232|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928234|NCT03777644|Ropivacaine|ropivacaine|mesh-list
44928235|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44928236|NCT03777644|Narcotics|narcotics|mesh-ancestor
44928237|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928238|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928239|NCT03777644|Analgesics|analgesics|mesh-ancestor
44928240|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
44928241|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928242|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
44928243|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
44928244|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
44928245|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
44928246|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
44928247|NCT03777761|Tucatinib|tucatinib|mesh-list
44928248|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928249|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928250|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44928251|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44928252|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928253|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928254|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928255|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928256|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
44928257|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44928258|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44928259|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928260|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
44928261|NCT03777488|Coagulants|coagulants|mesh-ancestor
44928262|NCT03777514|Ascorbic Acid|ascorbic acid|mesh-list
44928263|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44879059|NCT04347252|Glucagon|glucagon|mesh-list
44928264|NCT03777514|Vitamins|vitamins|mesh-ancestor
44928265|NCT03777514|Micronutrients|micronutrients|mesh-ancestor
44928266|NCT03777514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928267|NCT03777514|Antioxidants|antioxidants|mesh-ancestor
44928268|NCT03777514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928269|NCT03777514|Protective Agents|protective agents|mesh-ancestor
44928270|NCT03777514|Hematinics|hematinics|mesh-ancestor
44928271|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44928272|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44928273|NCT03777085|Rituximab|rituximab|mesh-list
44928274|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928275|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928276|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
44928277|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928278|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928279|NCT03777124|Carboplatin|carboplatin|mesh-list
44928280|NCT03777124|Pemetrexed|pemetrexed|mesh-list
44928281|NCT03777124|Apatinib|apatinib|mesh-list
44928282|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928283|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928284|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928285|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44928286|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44928287|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928288|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
44928289|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44928290|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44928291|NCT03777254|Growth Substances|growth substances|mesh-ancestor
44928292|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928293|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
44928294|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928295|NCT03777280|Cobalt|cobalt|mesh-list
44928296|NCT03777280|Chromium|chromium|mesh-list
44928297|NCT03777280|Trace Elements|trace elements|mesh-ancestor
44928298|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
44928299|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928300|NCT03777163|Vaccines|vaccines|mesh-list
44928301|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
44928302|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928303|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
44928304|NCT03777033|Calcium|calcium|mesh-list
44928305|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928306|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928307|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44928308|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
44928309|NCT03776851|Hematinics|hematinics|mesh-ancestor
44928310|NCT03776916|Simethicone|simethicone|mesh-list
44928311|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
44928312|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928313|NCT03776916|Emollients|emollients|mesh-ancestor
44928314|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
44928316|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44928317|NCT03776838|Narcotics|narcotics|mesh-ancestor
44928318|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928319|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928320|NCT03776838|Analgesics|analgesics|mesh-ancestor
44928321|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
44928322|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928323|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44928324|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928325|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
44928326|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
44928327|NCT03777345|Cobalt|cobalt|mesh-list
44928328|NCT03777345|Chromium|chromium|mesh-list
44928329|NCT03777345|Trace Elements|trace elements|mesh-ancestor
44928330|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
44928331|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928332|NCT03776955|Carvedilol|carvedilol|mesh-list
44928333|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44928334|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44879518|NCT04343729|Hormones|hormones|mesh-ancestor
44928335|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
44928336|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928337|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928338|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928339|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44928340|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
44928341|NCT03776955|Protective Agents|protective agents|mesh-ancestor
44928342|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44879819|NCT04341545|Letrozole|letrozole|mesh-list
44928343|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44928344|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928345|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
44928346|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44928347|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44928348|NCT03776409|Vancomycin|vancomycin|mesh-list
44928349|NCT03776409|Tazobactam|tazobactam|mesh-list
44928350|NCT03776409|Piperacillin|piperacillin|mesh-list
44879925|NCT04340388|Tenofovir|tenofovir|mesh-list
44928351|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44928352|NCT03776409|Lactams|lactams|mesh-list
44928353|NCT03776409|beta-Lactams|beta-lactams|mesh-list
44928354|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928355|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928356|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44928357|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928358|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928359|NCT03776448|Charcoal|charcoal|mesh-list
44928360|NCT03776448|Antidotes|antidotes|mesh-ancestor
44928361|NCT03776448|Protective Agents|protective agents|mesh-ancestor
44928362|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928363|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44928364|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928365|NCT03776500|Macozinone|macozinone|mesh-list
44928366|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
44928367|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928368|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44705836|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44705837|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705838|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
44705839|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705840|NCT02246257|Metformin|metformin|mesh-list
44705841|NCT02246257|Losartan|losartan|mesh-list
44705842|NCT02246257|Simvastatin|simvastatin|mesh-list
44705843|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44705844|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705845|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44880194|NCT04337450|Lamivudine|lamivudine|mesh-list
44705846|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44705847|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
44705848|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705849|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44705850|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44705851|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880402|NCT04334512|Vitamin D|vitamin d|mesh-list
44705852|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44928369|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
44928399|NCT03775876|Propofol|propofol|mesh-list
44928400|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44928401|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928402|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928403|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928404|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
44928405|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
44928406|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44928407|NCT03775876|Analgesics|analgesics|mesh-ancestor
44928408|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
44928409|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928410|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44928411|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44928412|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44928413|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
44928414|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928415|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928416|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
44928417|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44928418|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928419|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928420|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928421|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928422|NCT03775863|Liver Extracts|liver extracts|mesh-list
44928423|NCT03775863|Hematinics|hematinics|mesh-ancestor
44928424|NCT03775707|Lenvatinib|lenvatinib|mesh-list
44928425|NCT03775707|Antibodies|antibodies|mesh-list
44928426|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
44928427|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928428|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928429|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928430|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928431|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928432|NCT03775902|Nicorandil|nicorandil|mesh-list
44928433|NCT03775902|Glimepiride|glimepiride|mesh-list
44928434|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44928435|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44928436|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928437|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928438|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
44928439|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44928440|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
44928441|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
44928442|NCT03775902|Vitamins|vitamins|mesh-ancestor
44928443|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
44928444|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
44928445|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44928446|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928447|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928448|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44928449|NCT03775655|Analgesics|analgesics|mesh-ancestor
44928450|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
44928451|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928452|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44928453|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44928454|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44928455|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44928456|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928457|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699507|NCT03180294|Bupropion|bupropion|mesh-list
44928458|NCT03775590|Acetic Acid|acetic acid|mesh-list
44928459|NCT03775590|Retinol acetate|retinol acetate|mesh-list
44928460|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44928461|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928462|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44928463|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
44928464|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928465|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44928466|NCT03775590|Protective Agents|protective agents|mesh-ancestor
44928467|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928468|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
44928469|NCT03775746|Clopidogrel|clopidogrel|mesh-list
44928470|NCT03775746|Ticagrelor|ticagrelor|mesh-list
44928471|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44928472|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44724799|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
44928473|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44928474|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44928475|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
44928476|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928477|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928478|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928479|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44928480|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
44928481|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44928482|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
44928483|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928484|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
44928485|NCT03775928|Capecitabine|capecitabine|mesh-list
44928486|NCT03775928|Apatinib|apatinib|mesh-list
44928487|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928488|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
44928489|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928490|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928491|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928492|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928493|NCT03775538|Dopamine|dopamine|mesh-list
44928494|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44928495|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
44928496|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
44928497|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928498|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928499|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
44928500|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928501|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928502|NCT03775538|Protective Agents|protective agents|mesh-ancestor
44928503|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44928504|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
44880883|NCT04329403|Adapalene|adapalene|mesh-list
44928505|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928506|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
44928507|NCT03775382|Vitamins|vitamins|mesh-ancestor
44928508|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
44928509|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928510|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
44928511|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928512|NCT03775382|Protective Agents|protective agents|mesh-ancestor
44928513|NCT03775395|Sorafenib|sorafenib|mesh-list
44928514|NCT03775395|Lenvatinib|lenvatinib|mesh-list
44928515|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928516|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928517|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928518|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928519|NCT03775356|Anesthetics|anesthetics|mesh-list
44928520|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928521|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928522|NCT03774901|Avelumab|avelumab|mesh-list
44928523|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928524|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928525|NCT03774953|Vitamins|vitamins|mesh-list
44928526|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
44928527|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928528|NCT03774706|Misoprostol|misoprostol|mesh-list
44928529|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
44928530|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44928531|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44928532|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928533|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
44928534|NCT03774706|Coagulants|coagulants|mesh-ancestor
44928535|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44928536|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
44928537|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928538|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928539|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44928540|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928541|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
44928542|NCT03774771|Cinacalcet|cinacalcet|mesh-list
44928543|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928544|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928545|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44928546|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44724874|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928547|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928548|NCT03774693|Fentanyl|fentanyl|mesh-list
44928549|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
44881109|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928550|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928551|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928552|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44928553|NCT03774693|Narcotics|narcotics|mesh-ancestor
44928554|NCT03774693|Analgesics|analgesics|mesh-ancestor
44928555|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
44928556|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928557|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44928558|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928559|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
44928560|NCT03774836|Morphine|morphine|mesh-list
44928561|NCT03774836|Tramadol|tramadol|mesh-list
44928562|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44928563|NCT03774836|Narcotics|narcotics|mesh-ancestor
44928564|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928565|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928566|NCT03774836|Analgesics|analgesics|mesh-ancestor
44928567|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
44928568|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928569|NCT03774680|Cetuximab|cetuximab|mesh-list
44928570|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928571|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928572|NCT03774615|Ferric maltol|ferric maltol|mesh-list
44928573|NCT03774615|Hematinics|hematinics|mesh-ancestor
44928574|NCT03774524|Misoprostol|misoprostol|mesh-list
44928575|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44928576|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
44928577|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928578|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928579|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44928580|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928581|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
44928582|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
44928583|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44928584|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
44928585|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928586|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928587|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44928588|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
44928589|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44928590|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
44928591|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928592|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928593|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44928594|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
44928595|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
44928596|NCT03773991|Protective Agents|protective agents|mesh-ancestor
44928597|NCT03774108|Metformin|metformin|mesh-list
44928598|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44928599|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928600|NCT03774446|Roscovitine|roscovitine|mesh-list
44928601|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928602|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
44928603|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928604|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928605|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928606|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928607|NCT03774095|Pycnogenols|pycnogenols|mesh-list
44928608|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44928609|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
44928610|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928611|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
44928612|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928613|NCT03774095|Protective Agents|protective agents|mesh-ancestor
44928614|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44928615|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
44928616|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
44928617|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928618|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
44928619|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928620|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928621|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44928622|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
44928623|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928624|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705882|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
44705883|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705884|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705885|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44705886|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
44705887|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705888|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705889|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44705890|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44705891|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44705892|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705893|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928627|NCT03773536|Artesunate|artesunate|mesh-list
44928628|NCT03773536|Primaquine|primaquine|mesh-list
44928629|NCT03773536|Amodiaquine|amodiaquine|mesh-list
44928630|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
44928631|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44928632|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44928633|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928634|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928635|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
44928636|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
44928637|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44928638|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
44928639|NCT03773809|Vitamin D|vitamin d|mesh-list
44928640|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
44928641|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
44928642|NCT03773809|Vitamins|vitamins|mesh-list
44928643|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
44928644|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928645|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44928646|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928647|NCT03773588|Propofol|propofol|mesh-list
44928648|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881510|NCT04322240|Vitamins|vitamins|mesh-ancestor
44881550|NCT04321850|Zinc|zinc|mesh-list
44881591|NCT04321070|Clindamycin|clindamycin|mesh-list
44928649|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881669|NCT04319978|Hormones|hormones|mesh-ancestor
44881760|NCT04319289|Vitamins|vitamins|mesh-list
44928650|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928651|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928652|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
44928653|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
44928654|NCT03773510|Trabectedin|trabectedin|mesh-list
44928655|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44928656|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
44928657|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928658|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928659|NCT03773367|Fluorouracil|fluorouracil|mesh-list
44928660|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
44928661|NCT03773367|Irinotecan|irinotecan|mesh-list
44928662|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
44928663|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928664|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928665|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928666|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928667|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
44928668|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928669|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44928670|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44928671|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928672|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
44928673|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44928674|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44928675|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928676|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
44928677|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
44928678|NCT03773042|Propofol|propofol|mesh-list
44928679|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44882031|NCT04315688|Insulin|insulin|mesh-list
44928680|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928681|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928682|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928683|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
44928684|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
44928685|NCT03772613|Heparin|heparin|mesh-list
44928686|NCT03772613|Calcium heparin|calcium heparin|mesh-list
44928687|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
44928688|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44928689|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44928690|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928691|NCT03772990|Calcium|calcium|mesh-list
44928692|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44928693|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928694|NCT03772483|Anesthetics|anesthetics|mesh-list
44928695|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928696|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928697|NCT03772561|Durvalumab|durvalumab|mesh-list
44928698|NCT03772561|Olaparib|olaparib|mesh-list
44928699|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928700|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928701|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44928702|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928703|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928704|NCT03772262|Metformin|metformin|mesh-list
44928705|NCT03772262|Furosemide|furosemide|mesh-list
44928706|NCT03772262|Midazolam|midazolam|mesh-list
44928707|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44928708|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44928709|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928710|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44928711|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44928712|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928713|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44928714|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44928715|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44928716|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928717|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
44928718|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
44928719|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
44928720|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
44928721|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928722|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928723|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44928724|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44928725|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
44928726|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44928727|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44928728|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928729|NCT03772262|Diuretics|diuretics|mesh-ancestor
44928730|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
44928731|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44928732|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44928733|NCT03772223|Budesonide|budesonide|mesh-list
44928734|NCT03772223|Albuterol|albuterol|mesh-list
44928735|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44928736|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44928737|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
44928738|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928739|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928740|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44928741|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
44928742|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
44928743|NCT03772223|Hormones|hormones|mesh-ancestor
44928744|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928745|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
44928746|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928747|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44928748|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44928749|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44928750|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
44928751|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44928752|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928753|NCT03772106|Propofol|propofol|mesh-list
44928754|NCT03772106|Sevoflurane|sevoflurane|mesh-list
44928755|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44928756|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928757|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928758|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928759|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
44928760|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
44928761|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44928762|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44928763|NCT03772054|Propofol|propofol|mesh-list
44928764|NCT03772054|Sevoflurane|sevoflurane|mesh-list
44928765|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44928766|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928767|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928768|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44928769|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
44928770|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
44928771|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44928772|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44928773|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
44928774|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44928775|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928776|NCT03771846|Leucovorin|leucovorin|mesh-list
44928777|NCT03771846|Gemcitabine|gemcitabine|mesh-list
44928778|NCT03771846|Fluorouracil|fluorouracil|mesh-list
44928779|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
44928780|NCT03771846|Irinotecan|irinotecan|mesh-list
44928781|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928782|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
44928783|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928784|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882303|NCT04312061|Tramadol|tramadol|mesh-list
44928785|NCT03771846|Antiviral Agents|antiviral agents|mesh-ancestor
44928786|NCT03771846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928787|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928788|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928789|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
44928790|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928791|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44928792|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44928794|NCT03771846|Protective Agents|protective agents|mesh-ancestor
44928795|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
44928796|NCT03771846|Vitamins|vitamins|mesh-ancestor
44928797|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
44928798|NCT03771755|Acetaminophen|acetaminophen|mesh-list
44928799|NCT03771755|Ibuprofen|ibuprofen|mesh-list
44928800|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44928801|NCT03771755|Analgesics|analgesics|mesh-ancestor
44928802|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
44928803|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928804|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928805|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
44928806|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44928807|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44928808|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928809|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44928810|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928811|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928812|NCT03771729|Valsartan|valsartan|mesh-list
44928813|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44928814|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44928815|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44928816|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44928817|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928818|NCT03772067|Insulin|insulin|mesh-list
44928819|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44928820|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44928821|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44928822|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928823|NCT03772067|Incretins|incretins|mesh-ancestor
44928824|NCT03772067|Hormones|hormones|mesh-ancestor
44928825|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928826|NCT03771677|Interferons|interferons|mesh-list
44928827|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
44928828|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
44928829|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928830|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
44928831|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44928832|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
44928833|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928834|NCT03771781|Empagliflozin|empagliflozin|mesh-list
44928835|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44928836|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928837|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44928838|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928839|NCT03771768|Triamcinolone|triamcinolone|mesh-list
44928840|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44928841|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44928842|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44928843|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44928844|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
44928845|NCT03771768|Hormones|hormones|mesh-ancestor
44928846|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928847|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928848|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44928849|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
44928850|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928851|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928852|NCT03771638|Tenofovir|tenofovir|mesh-list
44928853|NCT03771638|Emtricitabine|emtricitabine|mesh-list
44928854|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
44928855|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725229|NCT01540032|Salicylates|salicylates|mesh-list
44928862|NCT03771222|Decitabine|decitabine|mesh-list
44928863|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928864|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
44928865|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928866|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928867|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928868|NCT03771066|Bisphenol A|bisphenol a|mesh-list
44928869|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44928870|NCT03771066|Estrogens|estrogens|mesh-ancestor
44928871|NCT03771066|Hormones|hormones|mesh-ancestor
44928872|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928873|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928874|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44928875|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
44928876|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928877|NCT03771066|Protective Agents|protective agents|mesh-ancestor
44928878|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
44928879|NCT03771092|Hematinics|hematinics|mesh-ancestor
44928880|NCT03770923|Montelukast|montelukast|mesh-list
44928881|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44928882|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
44928883|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44928884|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44928885|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928886|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928887|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44928888|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44928889|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928890|NCT03770936|Candesartan|candesartan|mesh-list
44928891|NCT03770936|Ramipril|ramipril|mesh-list
44928892|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44928893|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44928894|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44928895|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928896|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44928897|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
44928898|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928899|NCT03770806|Acetaminophen|acetaminophen|mesh-list
44928900|NCT03770806|Celecoxib|celecoxib|mesh-list
44928901|NCT03770806|Oxycodone|oxycodone|mesh-list
44928902|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44928903|NCT03770806|Analgesics|analgesics|mesh-ancestor
44928904|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
44928905|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928906|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928907|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
44928908|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44928909|NCT03770806|Narcotics|narcotics|mesh-ancestor
44928910|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44928911|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44928912|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44928913|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928914|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44928915|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44928916|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928917|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928918|NCT03771053|Simvastatin|simvastatin|mesh-list
44928919|NCT03771053|Ezetimibe|ezetimibe|mesh-list
44928920|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44928921|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44928922|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
44928923|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928924|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44928925|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44928926|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928927|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44928928|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928929|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
44928930|NCT03770663|Azathioprine|azathioprine|mesh-list
44928931|NCT03770663|Tacrolimus|tacrolimus|mesh-list
44928932|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882972|NCT04303598|Tenofovir|tenofovir|mesh-list
44928933|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
44928934|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725350|NCT01540812|Cytarabine|cytarabine|mesh-list
44928935|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44928936|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44928937|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
44928938|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928939|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928940|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44928941|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44928942|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883164|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
44928944|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44928945|NCT03770637|Glucagon|glucagon|mesh-list
44928946|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44928947|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44928948|NCT03770637|Hormones|hormones|mesh-ancestor
44928949|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928950|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928951|NCT03770637|Incretins|incretins|mesh-ancestor
44928952|NCT03770208|Lidocaine|lidocaine|mesh-list
44928953|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
44928954|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
44928955|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883241|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
44883386|NCT04297033|Lovastatin|lovastatin|mesh-list
44883397|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
44928956|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928957|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
44928958|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44928959|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44928960|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44928961|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44928962|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44928963|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928964|NCT03770000|Romidepsin|romidepsin|mesh-list
44928965|NCT03770000|Tenalisib|tenalisib|mesh-list
44928966|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44928967|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44928968|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
44928969|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928970|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928971|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44928972|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44928973|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44928974|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
44928975|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928976|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928977|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44928978|NCT03770039|PF-06700841|pf-06700841|mesh-list
44928979|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44928980|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44928981|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44928982|NCT03770026|Clomiphene|clomiphene|mesh-list
44928983|NCT03770026|Enclomiphene|enclomiphene|mesh-list
44928984|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
44928985|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44928986|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44928987|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44928988|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44928989|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44928990|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
44928991|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44928992|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44928993|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44928994|NCT03770013|Clonidine|clonidine|mesh-list
44928995|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
44928996|NCT03770013|Bupivacaine|bupivacaine|mesh-list
44928997|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
44928998|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
44928999|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929000|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929001|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
44929002|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929003|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929004|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929005|NCT03770013|Analgesics|analgesics|mesh-ancestor
44929006|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44929007|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929011|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929013|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
44929014|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
44929015|NCT03769935|Etoposide|etoposide|mesh-list
44929016|NCT03769935|Cisplatin|cisplatin|mesh-list
44929017|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44929018|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929019|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44929020|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44929021|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929022|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929023|NCT03769870|Atorvastatin|atorvastatin|mesh-list
44929024|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44929025|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44929026|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
44929027|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929028|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44929029|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44929030|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929031|NCT03769818|Dexamethasone|dexamethasone|mesh-list
44929032|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
44929033|NCT03769818|Bupivacaine|bupivacaine|mesh-list
44929034|NCT03769818|BB 1101|bb 1101|mesh-list
44929035|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929036|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
44929037|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
44929038|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929039|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929040|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44929041|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
44929042|NCT03769818|Hormones|hormones|mesh-ancestor
44929043|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929044|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929045|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929046|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44929047|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883698|NCT04292990|Fentanyl|fentanyl|mesh-list
44929048|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929049|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929050|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
44929051|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929052|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
44929053|NCT03769714|Bupivacaine|bupivacaine|mesh-list
44929054|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929055|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
44929056|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929057|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929058|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
44929059|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929060|NCT03769402|Citric Acid|citric acid|mesh-list
44929061|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
44929062|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
44929063|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44929064|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
44929065|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
44929066|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929067|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
44929068|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929069|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929070|NCT03769064|Methylphenidate|methylphenidate|mesh-list
44929071|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44929072|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929073|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44929074|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44929075|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44929076|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929077|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
44929078|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929079|NCT03768908|Artesunate|artesunate|mesh-list
44929080|NCT03768908|Lumefantrine|lumefantrine|mesh-list
44929081|NCT03768908|Artemether|artemether|mesh-list
44929082|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44929083|NCT03768908|Amodiaquine|amodiaquine|mesh-list
44929084|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
44929085|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44929086|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44929087|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929088|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929089|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
44929090|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
44929091|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44929092|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
44929093|NCT03768882|Acetaminophen|acetaminophen|mesh-list
44929094|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44929095|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929096|NCT03768882|Analgesics|analgesics|mesh-ancestor
44929097|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
44929098|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929099|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929100|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
44929101|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44929102|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929103|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929104|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44929105|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44929106|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929107|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
44929108|NCT03768713|Suvorexant|suvorexant|mesh-list
44929109|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44929110|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929111|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929112|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929113|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44929114|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929115|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929116|NCT03768609|Cyclosporine|cyclosporine|mesh-list
44929117|NCT03768609|Cyclosporins|cyclosporins|mesh-list
44929118|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929119|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929120|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44929121|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
44929122|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929123|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
44929124|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929125|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44929126|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929127|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44929128|NCT03768557|Minocycline|minocycline|mesh-list
44929129|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929130|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929131|NCT03768531|Nivolumab|nivolumab|mesh-list
44929132|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929133|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929134|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44929135|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929136|NCT03768518|Exenatide|exenatide|mesh-list
44929137|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44929138|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929139|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44929140|NCT03768518|Incretins|incretins|mesh-ancestor
44929141|NCT03768518|Hormones|hormones|mesh-ancestor
44929142|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929143|NCT03768427|Atorvastatin|atorvastatin|mesh-list
44929144|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44929145|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44929146|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
44929147|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929148|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44929149|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44929150|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725575|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44929151|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
44725576|NCT01541943|Losartan|losartan|mesh-list
44929152|NCT03768258|Anastrozole|anastrozole|mesh-list
44929153|NCT03768258|Testosterone|testosterone|mesh-list
44929154|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
44929155|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
44929156|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44929157|NCT03768258|Androgens|androgens|mesh-ancestor
44929158|NCT03768258|Hormones|hormones|mesh-ancestor
44884117|NCT04289103|Inolimomab|inolimomab|mesh-list
44884142|NCT04289207|Danazol|danazol|mesh-list
44929159|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929160|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929161|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929162|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929163|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
44929164|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44929165|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44929166|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929167|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929168|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44929169|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
44929170|NCT03769103|Osimertinib|osimertinib|mesh-list
44929171|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929172|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44929173|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929174|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929175|NCT03768037|Pemetrexed|pemetrexed|mesh-list
44929176|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929177|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929178|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929179|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44929180|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44929181|NCT03768024|Hydromorphone|hydromorphone|mesh-list
44929182|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929183|NCT03768024|Narcotics|narcotics|mesh-ancestor
44929184|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929185|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929186|NCT03768024|Analgesics|analgesics|mesh-ancestor
44929187|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
44929188|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884431|NCT04285073|Paclitaxel|paclitaxel|mesh-list
44929189|NCT03767920|Dexamethasone|dexamethasone|mesh-list
44929190|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
44929191|NCT03767920|Bupivacaine|bupivacaine|mesh-list
44929192|NCT03767920|BB 1101|bb 1101|mesh-list
44929193|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929194|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
44929195|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
44705901|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44705902|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44705903|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44705904|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705905|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705906|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705907|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44705908|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44705909|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
44705910|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705911|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44705912|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
44705913|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
44705914|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
44705915|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44705916|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44705917|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44705918|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
44705919|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705920|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705921|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
44705922|NCT01231906|Ifosfamide|ifosfamide|mesh-list
44705923|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
44705924|NCT01231906|Doxorubicin|doxorubicin|mesh-list
44705925|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44705926|NCT01231906|Etoposide|etoposide|mesh-list
44705927|NCT01231906|Vincristine|vincristine|mesh-list
44705928|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
44705929|NCT01231906|Topotecan|topotecan|mesh-list
44705930|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
44705931|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
44705932|NCT01231906|Razoxane|razoxane|mesh-list
44705933|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
44705934|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44705935|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
44929196|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929197|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929198|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44929199|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
44929200|NCT03767920|Hormones|hormones|mesh-ancestor
44929201|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929202|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929203|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929204|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
44929205|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929206|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929207|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929208|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
44929209|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929210|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
44929211|NCT03767660|Sirolimus|sirolimus|mesh-list
44929212|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929213|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929214|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44929215|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929216|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
44929217|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44929218|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
44929219|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929220|NCT03767569|Folic Acid|folic acid|mesh-list
44929221|NCT03767569|Inositol|inositol|mesh-list
44929222|NCT03767569|Hematinics|hematinics|mesh-ancestor
44929223|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
44929224|NCT03767569|Vitamins|vitamins|mesh-ancestor
44929225|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
44929226|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929227|NCT03767504|Thymol|thymol|mesh-list
44929228|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929229|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44929230|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
44929231|NCT03767439|Nivolumab|nivolumab|mesh-list
44929232|NCT03767439|Ipilimumab|ipilimumab|mesh-list
44929233|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929234|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929235|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44929236|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929237|NCT03767335|Trastuzumab|trastuzumab|mesh-list
44929238|NCT03767335|Fulvestrant|fulvestrant|mesh-list
44929239|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929240|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929241|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929242|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44929243|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44929244|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44929245|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929246|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929247|NCT03767322|Allopurinol|allopurinol|mesh-list
44929248|NCT03767322|Febuxostat|febuxostat|mesh-list
44929249|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
44929250|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929251|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929252|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
44929253|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929254|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44929255|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
44929256|NCT03767322|Protective Agents|protective agents|mesh-ancestor
44929257|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929258|NCT03767296|Phenylephrine|phenylephrine|mesh-list
44929259|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
44929260|NCT03767296|Ephedrine|ephedrine|mesh-list
44929261|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
44929262|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44929263|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
44929264|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
44929265|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929266|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929267|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
44929268|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44929269|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
44929270|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44725692|NCT01542697|Analgesics|analgesics|mesh-ancestor
44929271|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44929272|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929273|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929274|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44929275|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929276|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929277|NCT03767296|Protective Agents|protective agents|mesh-ancestor
44885294|NCT04267237|Atezolizumab|atezolizumab|mesh-list
44885334|NCT04267146|Nivolumab|nivolumab|mesh-list
44885413|NCT04265274|Copper|copper|mesh-list
44929278|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44929279|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44929280|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44929281|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44929283|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929284|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929285|NCT03767036|Ketorolac|ketorolac|mesh-list
44929286|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44929287|NCT03767036|Tramadol|tramadol|mesh-list
44929288|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44929289|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929290|NCT03767036|Analgesics|analgesics|mesh-ancestor
44929291|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
44929292|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929293|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929294|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929295|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929296|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44929297|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929298|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929299|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929300|NCT03767036|Narcotics|narcotics|mesh-ancestor
44929301|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929302|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
44929303|NCT03766997|Betamethasone|betamethasone|mesh-list
44929304|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44929305|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929306|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
44929307|NCT03766997|Hormones|hormones|mesh-ancestor
44929308|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929309|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929310|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44929311|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
44929312|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
44929313|NCT03766984|Diclofenac|diclofenac|mesh-list
44929314|NCT03766984|Tramadol|tramadol|mesh-list
44929315|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44929316|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929317|NCT03766984|Analgesics|analgesics|mesh-ancestor
44929318|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
44929319|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929320|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929321|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929322|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44929323|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44929324|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929325|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929326|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929327|NCT03766984|Narcotics|narcotics|mesh-ancestor
44929328|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929329|NCT03766893|Naltrexone|naltrexone|mesh-list
44929330|NCT03766893|Buprenorphine|buprenorphine|mesh-list
44929331|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44929332|NCT03766893|Naloxone|naloxone|mesh-list
44929333|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929334|NCT03766893|Narcotics|narcotics|mesh-ancestor
44929335|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929336|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929337|NCT03766893|Analgesics|analgesics|mesh-ancestor
44929338|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
44929339|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929340|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44929341|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44929342|NCT03766867|Vortioxetine|vortioxetine|mesh-list
44929343|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
44929344|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44929345|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44885544|NCT04263844|Analgesics|analgesics|mesh-ancestor
44929346|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44929360|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44929361|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
44929362|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44929363|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929364|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
44929365|NCT03766724|Empagliflozin|empagliflozin|mesh-list
44929366|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44929367|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929368|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44929369|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929370|NCT03766607|Paclitaxel|paclitaxel|mesh-list
44929371|NCT03766607|Trastuzumab|trastuzumab|mesh-list
44929372|NCT03766607|Ramucirumab|ramucirumab|mesh-list
44929373|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44929374|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929375|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
44929376|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
44929377|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
44929378|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929379|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929380|NCT03766594|Folic Acid|folic acid|mesh-list
44929381|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
44929382|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929383|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44929384|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44929385|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44929386|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929387|NCT03766594|Urological Agents|urological agents|mesh-ancestor
44929388|NCT03766594|Hematinics|hematinics|mesh-ancestor
44929389|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
44929390|NCT03766594|Vitamins|vitamins|mesh-ancestor
44929391|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
44885665|NCT04261907|Ritonavir|ritonavir|mesh-list
44885750|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
44885816|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
44885817|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885818|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44885819|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44929392|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929393|NCT03766490|Gefitinib|gefitinib|mesh-list
44929394|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929395|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44929396|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885828|NCT04260360|Docetaxel|docetaxel|mesh-list
44885947|NCT04258657|Paclitaxel|paclitaxel|mesh-list
44929397|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929398|NCT03766425|Aflibercept|aflibercept|mesh-list
44929399|NCT03766425|Mitomycins|mitomycins|mesh-list
44929400|NCT03766425|Mitomycin|mitomycin|mesh-list
44929401|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44929402|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44929403|NCT03766425|Growth Substances|growth substances|mesh-ancestor
44929404|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929405|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
44705936|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705937|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44705938|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44705939|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
44705940|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886146|NCT04256473|Saruplase|saruplase|mesh-list
44886336|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44705941|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705942|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44705943|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44705944|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44705945|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705946|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705947|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44705948|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44705949|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44705950|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44705951|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44705952|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
44705953|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44705954|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44705955|NCT01231906|Protective Agents|protective agents|mesh-ancestor
44705956|NCT00223145|Goserelin|goserelin|mesh-list
44705957|NCT00223145|Bicalutamide|bicalutamide|mesh-list
44705958|NCT00223145|Androgens|androgens|mesh-list
44705959|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44705960|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705961|NCT00223145|Hormones|hormones|mesh-ancestor
44886402|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
44886458|NCT04254042|Perindopril|perindopril|mesh-list
44705962|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705963|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725920|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
44929406|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929407|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44929408|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
44929409|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929410|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44929411|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929412|NCT03766269|Dronabinol|dronabinol|mesh-list
44929413|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
44929414|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929415|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44929416|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929417|NCT03766269|Analgesics|analgesics|mesh-ancestor
44929418|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
44929419|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886640|NCT04252521|Ketoprofen|ketoprofen|mesh-list
44929420|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44929421|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44929422|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929423|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929424|NCT03766269|Hormones|hormones|mesh-ancestor
44929425|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929426|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
44929427|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44929428|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929429|NCT03766074|Vitamin D|vitamin d|mesh-list
44929430|NCT03766074|Vitamins|vitamins|mesh-ancestor
44929431|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
44929432|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929433|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44929434|NCT03765944|Sirolimus|sirolimus|mesh-list
44929435|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929436|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929437|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44929438|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929439|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
44929440|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44929441|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
44929442|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929443|NCT03765931|Amoxicillin|amoxicillin|mesh-list
44929444|NCT03765931|Doxycycline|doxycycline|mesh-list
44929445|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929446|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929447|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
44929448|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44929449|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44929450|NCT03765827|Vitamins|vitamins|mesh-list
44929451|NCT03765827|Vitamin E|vitamin e|mesh-list
44929452|NCT03765827|Tocopherols|tocopherols|mesh-list
44929453|NCT03765827|Tocotrienols|tocotrienols|mesh-list
44929454|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
44929455|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
44929456|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929457|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
44929458|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929459|NCT03765827|Protective Agents|protective agents|mesh-ancestor
44929460|NCT03765697|Lidocaine|lidocaine|mesh-list
44929461|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929462|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
44929463|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929464|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929465|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
44929466|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929467|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44929468|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44929469|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44929470|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44929471|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929472|NCT03765645|Tazobactam|tazobactam|mesh-list
44929473|NCT03765645|Piperacillin|piperacillin|mesh-list
44929474|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44929475|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929476|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929477|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44929478|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929479|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929480|NCT03765554|PF-06700841|pf-06700841|mesh-list
44929481|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44929491|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929492|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929493|NCT03765346|Analgesics|analgesics|mesh-ancestor
44929494|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
44929495|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929496|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
44887065|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44887151|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929497|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44726040|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726041|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44929498|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44929499|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929500|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
44929501|NCT03765021|Coagulants|coagulants|mesh-ancestor
44929502|NCT03764722|Simendan|simendan|mesh-list
44929503|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44929504|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
44929505|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44929506|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44929507|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929508|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929509|NCT03764722|Protective Agents|protective agents|mesh-ancestor
44929510|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929511|NCT03764683|Suvorexant|suvorexant|mesh-list
44929512|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44929513|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929514|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929515|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929516|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44929517|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929518|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726042|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726043|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
44726044|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726045|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726046|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726047|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726048|NCT01544829|Theobromine|theobromine|mesh-list
44726049|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44726050|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
44726051|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726052|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726053|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44726054|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44726055|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726056|NCT01544842|Triamcinolone|triamcinolone|mesh-list
44726057|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44726058|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44726059|NCT01544842|Tacrolimus|tacrolimus|mesh-list
44726060|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44726061|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726062|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
44726063|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726064|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44726065|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726066|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726067|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929519|NCT03764605|Metformin|metformin|mesh-list
44929520|NCT03764605|Tolvaptan|tolvaptan|mesh-list
44929521|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44929522|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929523|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44929524|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929525|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
44929526|NCT03764527|Artesunate|artesunate|mesh-list
44929527|NCT03764527|Lumefantrine|lumefantrine|mesh-list
44929528|NCT03764527|Artemether|artemether|mesh-list
44929529|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44929530|NCT03764527|Amodiaquine|amodiaquine|mesh-list
44929531|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
44929532|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44929533|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44929534|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929535|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929536|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
44929537|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
44929538|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44929539|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
44929540|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
44929541|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44929542|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929543|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44929544|NCT03764462|AD 101|ad 101|mesh-list
44929545|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44929546|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
44929547|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929548|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929549|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44929550|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44929551|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44929552|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44929553|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929554|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44929555|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44929556|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
44929557|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929558|NCT03764293|Sorafenib|sorafenib|mesh-list
44929559|NCT03764293|Apatinib|apatinib|mesh-list
44929560|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929561|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44929562|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929563|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929564|NCT03764280|Insulin|insulin|mesh-list
44929565|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
44929566|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44929567|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929568|NCT03764267|Lidocaine|lidocaine|mesh-list
44929569|NCT03764267|Remifentanil|remifentanil|mesh-list
44929570|NCT03764267|Anesthetics|anesthetics|mesh-list
44929571|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
44929572|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929573|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929574|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929575|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
44929576|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929577|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44929578|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44929579|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44929580|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44929581|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929582|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929583|NCT03764267|Narcotics|narcotics|mesh-ancestor
44929584|NCT03764267|Analgesics|analgesics|mesh-ancestor
44929585|NCT03764241|Vitamin K|vitamin k|mesh-list
44929586|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
44929587|NCT03764241|Vitamins|vitamins|mesh-ancestor
44929588|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
44929589|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929590|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44929591|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
44929592|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44929593|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
44726090|NCT01544959|Fentanyl|fentanyl|mesh-list
44929594|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929595|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929596|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
44929597|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44929598|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44929599|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
44929600|NCT03764241|Coagulants|coagulants|mesh-ancestor
44929601|NCT03764202|Sufentanil|sufentanil|mesh-list
44929602|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929603|NCT03764202|Narcotics|narcotics|mesh-ancestor
44929604|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929605|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929606|NCT03764202|Analgesics|analgesics|mesh-ancestor
44929607|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
44929608|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929609|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44929610|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44887786|NCT03205956|Levodopa|levodopa|mesh-list
44929611|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
44929612|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
44929613|NCT03764163|Xenon|xenon|mesh-list
44929614|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44929615|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
44929616|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
44929617|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929618|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929619|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
44929620|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44929621|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929622|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
44929623|NCT03764020|Melatonin|melatonin|mesh-list
44929624|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
44929625|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929626|NCT03764020|Protective Agents|protective agents|mesh-ancestor
44929627|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929628|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929629|NCT03763786|Cetrorelix|cetrorelix|mesh-list
44929630|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44929631|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
44929632|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44929633|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929634|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
44929635|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929636|NCT03763760|Dexamethasone|dexamethasone|mesh-list
44929637|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929638|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
44929639|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
44929640|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929641|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929642|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44929643|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
44929644|NCT03763760|Hormones|hormones|mesh-ancestor
44929645|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929646|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929647|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929648|NCT03763734|Dexamethasone|dexamethasone|mesh-list
44929649|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44929650|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
44929651|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
44929652|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929653|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929654|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44929655|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
44929656|NCT03763734|Hormones|hormones|mesh-ancestor
44929657|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929658|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44929659|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929660|NCT03763669|Folic Acid|folic acid|mesh-list
44929661|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
44929662|NCT03763669|Inositol|inositol|mesh-list
44929663|NCT03763669|Hematinics|hematinics|mesh-ancestor
44929664|NCT03763669|Vitamins|vitamins|mesh-ancestor
44929665|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
44929666|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929667|NCT03763409|Losartan|losartan|mesh-list
44929668|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44929669|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44929670|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44929671|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44929672|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929673|NCT03763396|Ketoconazole|ketoconazole|mesh-list
44929674|NCT03763396|Posaconazole|posaconazole|mesh-list
44929675|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
44929676|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929677|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44929678|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44929679|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929680|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929681|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44929682|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
44929683|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44705964|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
44705965|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
44705966|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44705967|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44705968|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44705969|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44705970|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705971|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44705972|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705973|NCT01425827|Analgesics|analgesics|mesh-ancestor
44705974|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
44705975|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705976|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
44705977|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44705978|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
44705979|NCT01425840|Lidocaine|lidocaine|mesh-list
44705980|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
44705981|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
44888451|NCT04243954|Morphine|morphine|mesh-list
44705982|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44705983|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44705984|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
44705985|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44705986|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44705987|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44705988|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44705989|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257515|NCT00625196|Fluticasone|fluticasone|mesh-list
44705990|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705992|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44705993|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44705994|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44705995|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44705996|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44705997|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44705998|NCT01426022|Ethanol|ethanol|mesh-list
44705999|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44706000|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706001|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706002|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706003|NCT01426074|Bevacizumab|bevacizumab|mesh-list
44706004|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44706005|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44706006|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44706007|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44706008|NCT01426074|Growth Substances|growth substances|mesh-ancestor
44706009|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706010|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
44706011|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44706012|NCT01426087|Somatostatin|somatostatin|mesh-list
44706013|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44706014|NCT01426087|Hormones|hormones|mesh-ancestor
44706015|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44706016|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706017|NCT01426100|Telmisartan|telmisartan|mesh-list
44706018|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44706019|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44706020|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44706021|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706022|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
44929684|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929685|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44929686|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44929687|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44929688|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44929689|NCT03763279|Triclosan|triclosan|mesh-list
44888717|NCT04240834|Aspirin|aspirin|mesh-list
44929690|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44929691|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929692|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44929693|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44929694|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
44929695|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929696|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44929697|NCT03763227|Ranibizumab|ranibizumab|mesh-list
44929698|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
44929699|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44929700|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44929701|NCT03763227|Growth Substances|growth substances|mesh-ancestor
44929702|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929703|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
44929704|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929705|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929706|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929707|NCT03763123|Paclitaxel|paclitaxel|mesh-list
44929708|NCT03763123|Topotecan|topotecan|mesh-list
44929709|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44929710|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929711|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44929712|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44929713|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44929714|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929715|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44929716|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44929717|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929718|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44929719|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44929720|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929721|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
44929722|NCT03763084|Acetaminophen|acetaminophen|mesh-list
44929723|NCT03763084|Sufentanil|sufentanil|mesh-list
44929724|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929725|NCT03763084|Analgesics|analgesics|mesh-ancestor
44929726|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
44929727|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929728|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929729|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
44929730|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44929731|NCT03763084|Narcotics|narcotics|mesh-ancestor
44929732|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929733|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44929734|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44929735|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
44929736|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
44929737|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
44929738|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
44929739|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44929740|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44929741|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929742|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929743|NCT03763045|Urological Agents|urological agents|mesh-ancestor
44929744|NCT03762967|Hormones|hormones|mesh-list
44929745|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44929746|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929747|NCT03762928|Efavirenz|efavirenz|mesh-list
44929748|NCT03762928|Midazolam|midazolam|mesh-list
44929749|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44929750|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929751|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888794|NCT04239755|Doxycycline|doxycycline|mesh-list
44888919|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
44929752|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888994|NCT04237246|Tacrolimus|tacrolimus|mesh-list
44929753|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44929754|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44929755|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44929756|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44929757|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
44929758|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
44726245|NCT01546090|Alprazolam|alprazolam|mesh-list
44929788|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929789|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44929790|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929791|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929792|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44929793|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929794|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929795|NCT03762538|Propofol|propofol|mesh-list
44929796|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929797|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929798|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929799|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44929800|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
44929801|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
44929802|NCT03762382|Tenofovir|tenofovir|mesh-list
44929803|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
44929804|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
44929805|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929806|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44929807|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44929808|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929809|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929810|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44929811|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44929812|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44929813|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
44929814|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44929815|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929816|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44929817|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44929818|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44929819|NCT03762369|Latanoprost|latanoprost|mesh-list
44929820|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44929821|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44929822|NCT03762317|Clonidine|clonidine|mesh-list
44929823|NCT03762317|Analgesics|analgesics|mesh-ancestor
44929824|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
44929825|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929826|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929827|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44929828|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
44929829|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
44929830|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44929831|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929832|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929833|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
44929834|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929835|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929836|NCT03762148|Vitamins|vitamins|mesh-list
44929837|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
44929838|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
44929839|NCT03762148|Iron|iron|mesh-list
44929840|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
44929841|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929842|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
44929843|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929844|NCT03762148|Protective Agents|protective agents|mesh-ancestor
44929845|NCT03762148|Trace Elements|trace elements|mesh-ancestor
44929846|NCT03761485|Fluorides|fluorides|mesh-list
44929847|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
44929848|NCT03761485|Protective Agents|protective agents|mesh-ancestor
44929849|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929850|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
44929851|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44929852|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
44929853|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929854|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
44929855|NCT03761472|Protective Agents|protective agents|mesh-ancestor
44929856|NCT03761329|Lidocaine|lidocaine|mesh-list
44929857|NCT03761329|Anesthetics|anesthetics|mesh-list
44929858|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44929859|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929860|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929861|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
44929862|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929863|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44929864|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44929865|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44929866|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44929867|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929868|NCT03761264|Amoxicillin|amoxicillin|mesh-list
44706023|NCT01426165|Analgesics|analgesics|mesh-ancestor
44706024|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
44706025|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44706026|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706027|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
44706028|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44706029|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44706030|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
44706031|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44929869|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
44929870|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929871|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44929872|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44929873|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44929874|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
44929875|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44929876|NCT03761264|Protective Agents|protective agents|mesh-ancestor
44929877|NCT03761004|Levodopa|levodopa|mesh-list
44929878|NCT03761004|Carbidopa|carbidopa|mesh-list
44929879|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44929880|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44929881|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44929882|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
44929883|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929884|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929885|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929886|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44929887|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929888|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44929889|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
44929890|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
44929891|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
44929892|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929893|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929894|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929895|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929896|NCT03760978|Analgesics|analgesics|mesh-ancestor
44929897|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
44929898|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929899|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44929900|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929901|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929902|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
44889622|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44889706|NCT04227808|Lenvatinib|lenvatinib|mesh-list
44929903|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929904|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929905|NCT03760848|Midazolam|midazolam|mesh-list
44929906|NCT03760848|Atorvastatin|atorvastatin|mesh-list
44929907|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44929908|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929909|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929910|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929911|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44929912|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44929913|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44929914|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44929915|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
44929916|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
44929917|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
44929918|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
44929919|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929920|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929921|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44929922|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44929923|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
44929924|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44929925|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44929926|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929927|NCT03760822|Paclitaxel|paclitaxel|mesh-list
44929928|NCT03760822|Ramucirumab|ramucirumab|mesh-list
44929929|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44929930|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929931|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
44929932|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
44929933|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
44929934|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929935|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
44929936|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929937|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929938|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929939|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44929940|NCT03760809|Analgesics|analgesics|mesh-ancestor
44726467|NCT01548001|Methotrexate|methotrexate|mesh-list
44929941|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
44929942|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44929943|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44929944|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44929945|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44929946|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
44929947|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929948|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929949|NCT03760770|Riboflavin|riboflavin|mesh-list
44929950|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
44929951|NCT03760770|Vitamins|vitamins|mesh-ancestor
44929952|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
44929953|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929954|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44929955|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44929956|NCT03760614|Entinostat|entinostat|mesh-list
44929957|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929958|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44929959|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929960|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929961|NCT03760588|Valsartan|valsartan|mesh-list
44929962|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44929963|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44929964|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44929965|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44889833|NCT04226105|Insulin|insulin|mesh-list
44929966|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929967|NCT03760445|Cytarabine|cytarabine|mesh-list
44929968|NCT03760445|Posaconazole|posaconazole|mesh-list
44929969|NCT03760445|Daunorubicin|daunorubicin|mesh-list
44929970|NCT03760445|Idarubicin|idarubicin|mesh-list
44929971|NCT03760445|Midostaurin|midostaurin|mesh-list
44929972|NCT03760445|Midazolam|midazolam|mesh-list
44929973|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44929974|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
44929975|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44929976|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44929977|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
44929978|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890151|NCT04222517|Hemostatics|hemostatics|mesh-list
44929979|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44929980|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
44929981|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44929982|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44929983|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44929984|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44929985|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44929986|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44929987|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44929988|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44929989|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
44929990|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
44929991|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
44929992|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
44929993|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44929994|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44929995|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44929996|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44929997|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44929998|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
44929999|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44930000|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44930001|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44930002|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44930003|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44930004|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44930005|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
44930006|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930007|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930008|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
44930009|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44930010|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44930011|NCT03760354|Prednisolone|prednisolone|mesh-list
44930012|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
44930013|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44930014|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
44890262|NCT04220996|Vortioxetine|vortioxetine|mesh-list
44930015|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930016|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
44930017|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
44726541|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
44930031|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930032|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930033|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930034|NCT03760276|Voriconazole|voriconazole|mesh-list
44930035|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
44930036|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930037|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44930038|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44930039|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930040|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930041|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44930042|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44930043|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930044|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930045|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44930046|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44930047|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44930048|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930049|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930050|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44930051|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930052|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930053|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
44930054|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930055|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
44930056|NCT03759938|Apixaban|apixaban|mesh-list
44930057|NCT03759938|Edoxaban|edoxaban|mesh-list
44930058|NCT03759938|Dabigatran|dabigatran|mesh-list
44930059|NCT03759938|Anticoagulants|anticoagulants|mesh-list
44930060|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44890441|NCT04218500|Niacinamide|niacinamide|mesh-list
44930061|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
44930062|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44930063|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
44930064|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930065|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930066|NCT03759886|Metronidazole|metronidazole|mesh-list
44930067|NCT03759886|Paromomycin|paromomycin|mesh-list
44930068|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930069|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930070|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44930071|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44930072|NCT03759860|Ranibizumab|ranibizumab|mesh-list
44930073|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44930074|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44930075|NCT03759860|Growth Substances|growth substances|mesh-ancestor
44930076|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930077|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
44930078|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930079|NCT03759782|Tenofovir|tenofovir|mesh-list
44930080|NCT03759782|Ribavirin|ribavirin|mesh-list
44930081|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
44930082|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930083|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44930084|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930085|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930086|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930087|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44930088|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44930089|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
44930090|NCT03759353|Lactoferrin|lactoferrin|mesh-list
44930091|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930092|NCT03759301|Cetrorelix|cetrorelix|mesh-list
44930093|NCT03759301|Hormones|hormones|mesh-list
44930094|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930095|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930096|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44930097|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
44930098|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44930099|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
44930100|NCT03759262|Vitamin D|vitamin d|mesh-list
44930101|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
44930102|NCT03759262|Vitamins|vitamins|mesh-ancestor
44930103|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
44930104|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930105|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44930106|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44930107|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
44930108|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44930109|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
44930110|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930111|NCT03759158|Expectorants|expectorants|mesh-ancestor
44930112|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
44930113|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44930114|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
44930115|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930116|NCT03759158|Protective Agents|protective agents|mesh-ancestor
44930117|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930118|NCT03759158|Antidotes|antidotes|mesh-ancestor
44930119|NCT03759093|Thalidomide|thalidomide|mesh-list
44890977|NCT05450718|Naloxone|naloxone|mesh-list
44930120|NCT03759093|Dexamethasone|dexamethasone|mesh-list
44930121|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
44930122|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
44930123|NCT03759093|Bortezomib|bortezomib|mesh-list
44930124|NCT03759093|BB 1101|bb 1101|mesh-list
44930125|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930126|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
44930127|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930128|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44930129|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44930130|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
44930131|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930132|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930133|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44930134|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930135|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
44930136|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
44930137|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930138|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930139|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
44930140|NCT03759093|Hormones|hormones|mesh-ancestor
44706032|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44706033|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44706034|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44706035|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
44706036|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44706037|NCT01426256|Vitamin D|vitamin d|mesh-list
44706038|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
44706039|NCT01426256|Vitamins|vitamins|mesh-ancestor
44706040|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
44706041|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44706042|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44726690|NCT01549093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930141|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44930142|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44930143|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44930144|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930145|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
44930146|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930147|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930148|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44930149|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44930150|NCT03759093|Growth Substances|growth substances|mesh-ancestor
44930151|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44930152|NCT03759067|Clopidogrel|clopidogrel|mesh-list
44930153|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44930154|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44930155|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44930156|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44930157|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
44930158|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930159|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930160|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930161|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44930162|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
44930163|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44930164|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
44930165|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930166|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
44930167|NCT03758859|Protective Agents|protective agents|mesh-ancestor
44930168|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44930169|NCT03758729|Nivolumab|nivolumab|mesh-list
44930170|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44930171|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930172|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44930173|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930174|NCT03758677|Gemcitabine|gemcitabine|mesh-list
44930175|NCT03758677|Docetaxel|docetaxel|mesh-list
44930176|NCT03758677|Pemetrexed|pemetrexed|mesh-list
44930177|NCT03758677|Apatinib|apatinib|mesh-list
44891182|NCT04641975|Mirabegron|mirabegron|mesh-list
44891216|NCT04602026|Coal Tar|coal tar|mesh-list
44891401|NCT04008030|Antidotes|antidotes|mesh-ancestor
44930178|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44930179|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
44930180|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930181|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930182|NCT03758677|Antiviral Agents|antiviral agents|mesh-ancestor
44930183|NCT03758677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930184|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930185|NCT03758677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44930186|NCT03758677|Immunologic Factors|immunologic factors|mesh-ancestor
44930187|NCT03758677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930188|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44930189|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44930190|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44930191|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44930192|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930193|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930194|NCT03758469|Rifampin|rifampin|mesh-list
44930195|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44930196|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
44930197|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930198|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930199|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
44930200|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44930201|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930202|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930203|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44930204|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44930205|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44930206|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44930207|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44930208|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44930209|NCT03758339|Tucatinib|tucatinib|mesh-list
44930210|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930211|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44930212|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930213|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930214|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44930215|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44930216|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44930217|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44930220|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44930221|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44930222|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930223|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
44930224|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930225|NCT03758144|Rifaximin|rifaximin|mesh-list
44930226|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930227|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930228|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930229|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44930230|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
44930231|NCT03758079|Gabapentin|gabapentin|mesh-list
44930232|NCT03758079|Doxepin|doxepin|mesh-list
44930233|NCT03758079|Analgesics|analgesics|mesh-ancestor
44930234|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
44930235|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930236|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930237|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
44930238|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44930239|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44930240|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930241|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44930242|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44930243|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44930244|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44930245|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930246|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
44930247|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44930248|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44930249|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44930250|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
44930251|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
44930252|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
44930253|NCT03758014|Lomustine|lomustine|mesh-list
44930254|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44930255|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
44930256|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930257|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44930258|NCT03757923|Metformin|metformin|mesh-list
44930259|NCT03757923|Pioglitazone|pioglitazone|mesh-list
44930260|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44930261|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930262|NCT03757910|Corticosterone|corticosterone|mesh-list
44930263|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44930264|NCT03757858|Antibodies|antibodies|mesh-list
44930265|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
44930266|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930267|NCT03757650|Amoxicillin|amoxicillin|mesh-list
44930268|NCT03757650|Clarithromycin|clarithromycin|mesh-list
44930269|NCT03757650|Omeprazole|omeprazole|mesh-list
44930270|NCT03757650|Bismuth|bismuth|mesh-list
44930271|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44930272|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44930273|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44930274|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44930275|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44930276|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44930277|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930278|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930279|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44930280|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44930281|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44930282|NCT03757650|Antacids|antacids|mesh-ancestor
44930283|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
44930284|NCT03757559|Hydromorphone|hydromorphone|mesh-list
44930285|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44930286|NCT03757559|Narcotics|narcotics|mesh-ancestor
44930287|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44930288|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44930289|NCT03757559|Analgesics|analgesics|mesh-ancestor
44930290|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
44930291|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44930292|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44930293|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44930294|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44930295|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44930296|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
44930297|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44930298|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44930299|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44930300|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44930301|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44930302|NCT03757364|Methotrexate|methotrexate|mesh-list
44930303|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44930304|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
44930305|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891766|NCT04215653|Rabeprazole|rabeprazole|mesh-list
44707161|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707162|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707163|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44707164|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707165|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707166|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44707167|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
44707168|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707169|NCT01432223|Paclitaxel|paclitaxel|mesh-list
44707170|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44707171|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707172|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44707173|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44707174|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44707175|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707176|NCT01432249|Etanercept|etanercept|mesh-list
44707177|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44707178|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44707179|NCT01432249|Analgesics|analgesics|mesh-ancestor
44707180|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
44707181|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707182|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707183|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707184|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707185|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44707186|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707187|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
44936492|NCT03707509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936493|NCT03707509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936494|NCT03707509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44936495|NCT03707509|Immunologic Factors|immunologic factors|mesh-ancestor
44936496|NCT03707509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936497|NCT03707483|Ascorbic Acid|ascorbic acid|mesh-list
44936498|NCT03707483|Vitamins|vitamins|mesh-ancestor
44936499|NCT03707483|Micronutrients|micronutrients|mesh-ancestor
44936500|NCT03707483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936501|NCT03707483|Antioxidants|antioxidants|mesh-ancestor
44936502|NCT03707483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936503|NCT03707483|Protective Agents|protective agents|mesh-ancestor
44936504|NCT03707457|Nivolumab|nivolumab|mesh-list
44936505|NCT03707457|Ipilimumab|ipilimumab|mesh-list
44936506|NCT03707457|Antibodies|antibodies|mesh-list
44936507|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44936508|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
44936509|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936510|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936511|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936512|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44936513|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936514|NCT03707418|Heparin|heparin|mesh-list
44936515|NCT03707418|Calcium heparin|calcium heparin|mesh-list
44936516|NCT03707418|Bivalirudin|bivalirudin|mesh-list
44936517|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
44936518|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44936519|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936520|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936521|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
44936522|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44936523|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
44936524|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936525|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
44936526|NCT03707249|Hematinics|hematinics|mesh-ancestor
44936527|NCT03707171|Liraglutide|liraglutide|mesh-list
44936528|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44936529|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936530|NCT03707171|Incretins|incretins|mesh-ancestor
44936531|NCT03707171|Hormones|hormones|mesh-ancestor
44936532|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936533|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
44936534|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44936535|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44936536|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
44936537|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936538|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44936539|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
44936540|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44936541|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44936542|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936543|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936544|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
44936545|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936546|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44936547|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44936548|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
44936549|NCT03706781|Benzydamine|benzydamine|mesh-list
44936550|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44936551|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936552|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936553|NCT03706755|Norepinephrine|norepinephrine|mesh-list
44936554|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44936555|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44936556|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
44936557|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936558|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936559|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936560|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
44936561|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
44936562|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936563|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44936564|NCT03706703|Carboplatin|carboplatin|mesh-list
44936565|NCT03706703|Docetaxel|docetaxel|mesh-list
44936566|NCT03706703|Pemetrexed|pemetrexed|mesh-list
44936567|NCT03706703|Endostar protein|endostar protein|mesh-list
44936568|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936569|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44936570|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44936571|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44936572|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936573|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936574|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44936575|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44936576|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44936577|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44936578|NCT03706703|Growth Substances|growth substances|mesh-ancestor
44936579|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936580|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44936581|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
44936582|NCT03706547|Fludarabine|fludarabine|mesh-list
44936583|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44936584|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
44936585|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936586|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936587|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44936588|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
44936589|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936590|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936591|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44936592|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
44936593|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44936594|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936595|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936596|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
44936597|NCT03706339|Coagulants|coagulants|mesh-ancestor
44936598|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
44936599|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
44936600|NCT03706300|Ephedrine|ephedrine|mesh-list
44936601|NCT03706300|Guaifenesin|guaifenesin|mesh-list
44936602|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44936603|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44936604|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
44936605|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936606|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936607|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44936608|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
44936609|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
44936610|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44936611|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44936612|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
44936613|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
44936614|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936615|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936616|NCT03706300|Expectorants|expectorants|mesh-ancestor
44936617|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44936618|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44936619|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
44936620|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44936621|NCT03706287|Cisplatin|cisplatin|mesh-list
44936622|NCT03706287|Carboplatin|carboplatin|mesh-list
44936623|NCT03706287|Pemetrexed|pemetrexed|mesh-list
44936624|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936625|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936626|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936627|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44936628|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44936629|NCT03706222|Grazoprevir|grazoprevir|mesh-list
44936630|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44936631|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
44936632|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936633|NCT03706157|Doxorubicin|doxorubicin|mesh-list
44936634|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44936635|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44936636|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936637|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44936638|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44936639|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936640|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936641|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
44936642|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
44936643|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44936644|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
44936645|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936646|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
44936647|NCT03705949|Protective Agents|protective agents|mesh-ancestor
44936648|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44936649|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44936650|NCT03705884|Prednisolone|prednisolone|mesh-list
44936651|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936652|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
44936653|NCT03705884|Hormones|hormones|mesh-ancestor
44936654|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936655|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936656|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44936657|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936658|NCT03705858|Lintuzumab|lintuzumab|mesh-list
44936659|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936660|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936661|NCT03705780|Fentanyl|fentanyl|mesh-list
44936662|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44936663|NCT03705780|Narcotics|narcotics|mesh-ancestor
44936664|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936665|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936666|NCT03705780|Analgesics|analgesics|mesh-ancestor
44936667|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
44936668|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936669|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44936670|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44936671|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
44936672|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
44936673|NCT03705728|Remifentanil|remifentanil|mesh-list
44936674|NCT03705728|Propofol|propofol|mesh-list
44936675|NCT03705728|Sevoflurane|sevoflurane|mesh-list
44936676|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44936677|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936678|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936679|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44936680|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
44936681|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
44936682|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44936683|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44936684|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44936685|NCT03705728|Narcotics|narcotics|mesh-ancestor
44936686|NCT03705728|Analgesics|analgesics|mesh-ancestor
44936687|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
44936688|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936689|NCT03705533|Telmisartan|telmisartan|mesh-list
44936690|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44936691|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44936692|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44936693|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936694|NCT05177666|Trastuzumab|trastuzumab|mesh-list
44936695|NCT05177666|Pertuzumab|pertuzumab|mesh-list
44936696|NCT05177666|Vemurafenib|vemurafenib|mesh-list
44936697|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936698|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936699|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936700|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936701|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936702|NCT05177601|Cycloserine|cycloserine|mesh-list
44936703|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44936704|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936705|NCT05177601|Renal Agents|renal agents|mesh-ancestor
44936706|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44936707|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
44936708|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44936709|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
44936710|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936711|NCT05177588|Metformin|metformin|mesh-list
44936712|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44936713|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936714|NCT05177406|Erenumab|erenumab|mesh-list
44936715|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44936716|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936717|NCT05177406|Analgesics|analgesics|mesh-ancestor
44936718|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
44936719|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936720|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936721|NCT05177276|Irinotecan|irinotecan|mesh-list
44936722|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44936723|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44936724|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936725|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936726|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936727|NCT05177237|Endostar protein|endostar protein|mesh-list
44936728|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44936729|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44936730|NCT05177237|Growth Substances|growth substances|mesh-ancestor
44936731|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936732|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
44936733|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936734|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44936735|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
44936736|NCT05176548|Paraproteins|paraproteins|mesh-list
44936737|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
44936738|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936739|NCT05176119|Ketamine|ketamine|mesh-list
44936740|NCT05176119|Nalbuphine|nalbuphine|mesh-list
44936741|NCT05176119|Analgesics|analgesics|mesh-ancestor
44936742|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
44936743|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936744|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936745|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44936746|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44936747|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
44936748|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
44936749|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936750|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44936751|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44936752|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936753|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936754|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44936755|NCT05176119|Narcotics|narcotics|mesh-ancestor
44936756|NCT05175703|Paclitaxel|paclitaxel|mesh-list
44936757|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44936758|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936759|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44936760|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44936761|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44936762|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936763|NCT05175547|Clevidipine|clevidipine|mesh-list
44936764|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44936765|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44936766|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936767|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44936768|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936769|NCT05175508|Azacitidine|azacitidine|mesh-list
44936770|NCT05175508|Tretinoin|tretinoin|mesh-list
44936771|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44936772|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
44936773|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936774|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936775|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936776|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
44936777|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44936778|NCT05175131|Mebeverine|mebeverine|mesh-list
44936779|NCT05175131|Simethicone|simethicone|mesh-list
44936780|NCT05175131|Alverine|alverine|mesh-list
44936781|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
44936782|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936783|NCT05175131|Emollients|emollients|mesh-ancestor
44936784|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
44936785|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
44936786|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
44936787|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
44936788|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936789|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936790|NCT05175066|Bisoprolol|bisoprolol|mesh-list
44936791|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44936792|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
44936793|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
44936794|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936795|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936796|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44936797|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44936798|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44936799|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
44936800|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936801|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936802|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
44936803|NCT05175027|Povidone|povidone|mesh-list
44936804|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
44936805|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
44936806|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44936807|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936808|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
44936809|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
44474964|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474965|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
44474966|NCT04192916|Apixaban|apixaban|mesh-list
44474967|NCT04192916|Edoxaban|edoxaban|mesh-list
44474968|NCT04192916|Dabigatran|dabigatran|mesh-list
44936810|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936811|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
44936812|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44936813|NCT05173441|Antibodies|antibodies|mesh-list
44936814|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
44936815|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936816|NCT05156684|Zinc|zinc|mesh-list
44936817|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
44936818|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
44936819|NCT05156684|Trace Elements|trace elements|mesh-ancestor
44936820|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
44936821|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936822|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44936823|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936824|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936825|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44936826|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44936827|NCT05156684|Protective Agents|protective agents|mesh-ancestor
44936828|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
44936829|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44936830|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
44936831|NCT05156684|Astringents|astringents|mesh-ancestor
44936832|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
44936833|NCT05155540|Plasminogen|plasminogen|mesh-list
44936834|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44936835|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44734347|NCT04182334|TEMPO|tempo|mesh-list
44936836|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936837|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936838|NCT05133310|Simvastatin|simvastatin|mesh-list
44936839|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44936840|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44936841|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
44936842|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936843|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44936844|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44936845|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936846|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
44936847|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44936848|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
44936849|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936850|NCT05122559|Expectorants|expectorants|mesh-ancestor
44936851|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
44936852|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44936853|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
44936854|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936855|NCT05122559|Protective Agents|protective agents|mesh-ancestor
44936856|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936857|NCT05122559|Antidotes|antidotes|mesh-ancestor
44936858|NCT05095831|Pancrelipase|pancrelipase|mesh-list
44936859|NCT05095831|Pancreatin|pancreatin|mesh-list
44936860|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936861|NCT05065801|Folfirinox|folfirinox|mesh-list
44936862|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707189|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
44707190|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44707191|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707192|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
44707193|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707194|NCT01432496|Ropivacaine|ropivacaine|mesh-list
44707195|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
44707196|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
44707197|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707198|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707199|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
44707200|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707201|NCT01432522|Epinephrine|epinephrine|mesh-list
44707202|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44707203|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44707204|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707205|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707206|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707207|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707208|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44707209|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44707210|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
44707211|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707212|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44707213|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
44707214|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
44707215|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
44707216|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44707217|NCT01432587|Diflunisal|diflunisal|mesh-list
44707218|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44707219|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44707220|NCT01432587|Analgesics|analgesics|mesh-ancestor
44707221|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
44707222|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707223|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707224|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707225|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707226|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44707227|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707228|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707229|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
44707230|NCT01432665|Testosterone|testosterone|mesh-list
44707231|NCT01432665|Androgens|androgens|mesh-ancestor
44707232|NCT01432665|Hormones|hormones|mesh-ancestor
44707233|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707234|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707235|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
44707236|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44707237|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44936863|NCT05052307|Vaccines|vaccines|mesh-list
44936864|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
44936865|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936866|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
44936867|NCT04976790|Analgesics|analgesics|mesh-ancestor
44936868|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
44936869|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936870|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936871|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44936872|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44936873|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936874|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936875|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44936876|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936877|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936878|NCT04973670|Sivelestat|sivelestat|mesh-list
44936879|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44936880|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
44936881|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936882|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936883|NCT04911361|Dexamethasone|dexamethasone|mesh-list
44936884|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936885|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
44936886|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
44936887|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936888|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936889|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936890|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
44936891|NCT04911361|Hormones|hormones|mesh-ancestor
44936892|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936893|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44936894|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936895|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44936896|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44936897|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936898|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
44936899|NCT04763928|Decitabine|decitabine|mesh-list
44936900|NCT04763928|Venetoclax|venetoclax|mesh-list
44936901|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44936902|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
44936903|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936904|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936905|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936906|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
44936907|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936908|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44936909|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936910|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936911|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
44936912|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936913|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936914|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44936915|NCT04724668|Melatonin|melatonin|mesh-list
44936916|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
44936917|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936918|NCT04724668|Protective Agents|protective agents|mesh-ancestor
44936919|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936920|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936921|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
44936922|NCT04722848|Blinatumomab|blinatumomab|mesh-list
44936923|NCT04722848|Ponatinib|ponatinib|mesh-list
44936924|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936925|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936926|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936927|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936928|NCT04682860|Scopolamine|scopolamine|mesh-list
44936929|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44936930|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44936931|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
44936932|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
44936933|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936934|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936935|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936936|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
44734373|NCT04123444|Iloprost|iloprost|mesh-list
44936937|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44936938|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
44936939|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936940|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936941|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44936942|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
44936943|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44936944|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936945|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936946|NCT04602507|Ivermectin|ivermectin|mesh-list
44936947|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44936948|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936949|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44936950|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936951|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936952|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936953|NCT04533568|Ibuprofen|ibuprofen|mesh-list
44936954|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44936955|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44936956|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44936957|NCT04533568|Analgesics|analgesics|mesh-ancestor
44936958|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
44936959|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936960|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936961|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936962|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936963|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44936964|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936965|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936966|NCT04507373|Simvastatin|simvastatin|mesh-list
44936967|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44936968|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44936969|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
44936970|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936971|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44936972|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44936973|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936974|NCT04475731|Ponatinib|ponatinib|mesh-list
44936975|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936976|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936977|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936978|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936979|NCT04469491|Interferons|interferons|mesh-list
44936980|NCT04469491|Interferon Type I|interferon type i|mesh-list
44936981|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936982|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
44936983|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936984|NCT04394481|Dexamethasone|dexamethasone|mesh-list
44936985|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
44936986|NCT04394481|Ropivacaine|ropivacaine|mesh-list
44936987|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936988|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
44936989|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
44936990|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936991|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936992|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936993|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
44936994|NCT04394481|Hormones|hormones|mesh-ancestor
44936995|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936996|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44936997|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936998|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44936999|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937000|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44937001|NCT04394481|Analgesics|analgesics|mesh-ancestor
44937002|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
44937003|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44937004|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44937005|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44937006|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44937007|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937008|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937009|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44937010|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
44937011|NCT04370847|Ephedrine|ephedrine|mesh-list
44937012|NCT04370847|Fentanyl|fentanyl|mesh-list
44937013|NCT04370847|Bupivacaine|bupivacaine|mesh-list
44937014|NCT04370847|Oxytocin|oxytocin|mesh-list
44937015|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44937016|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
44937017|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937018|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937019|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
44937020|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937021|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44937022|NCT04370847|Narcotics|narcotics|mesh-ancestor
44937023|NCT04370847|Analgesics|analgesics|mesh-ancestor
44937024|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44937026|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
44937027|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
44937028|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44937029|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44937030|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
44937031|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
44937032|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44937033|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44937034|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937035|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937036|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
44937037|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
44937038|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44937039|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44937040|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937041|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937042|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937043|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937044|NCT05309538|Betahistine|betahistine|mesh-list
44937045|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
44937046|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
44937047|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
44937048|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937049|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937050|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937051|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
44937052|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44937053|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
44937054|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937055|NCT05309070|Expectorants|expectorants|mesh-ancestor
44937056|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
44937057|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44937058|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
44474976|NCT04192812|Leuprolide|leuprolide|mesh-list
44937059|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937060|NCT05309070|Protective Agents|protective agents|mesh-ancestor
44937061|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937062|NCT05309070|Antidotes|antidotes|mesh-ancestor
44937063|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44937064|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44937065|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937066|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44937067|NCT05308849|beta-Lactams|beta-lactams|mesh-list
44937068|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937069|NCT05308628|Complement C3|complement c3|mesh-list
44937070|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
44937071|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937072|NCT05308602|Vaccines|vaccines|mesh-list
44937073|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
44937074|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937075|NCT05308342|Hormones|hormones|mesh-list
44937076|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937077|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937078|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44937079|NCT05303324|Choline|choline|mesh-list
44937080|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
44937081|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44937082|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
44937083|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937084|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937085|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44937086|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
44937087|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
44937088|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
44937089|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937090|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937091|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937092|NCT05303324|Growth Substances|growth substances|mesh-ancestor
44937093|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937094|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937095|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937096|NCT05294172|Gemcitabine|gemcitabine|mesh-list
44937097|NCT05294172|Cisplatin|cisplatin|mesh-list
44937098|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937099|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937100|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
44937101|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937102|NCT05294172|Antiviral Agents|antiviral agents|mesh-ancestor
44937103|NCT05294172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937104|NCT05294172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937105|NCT05294172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937106|NCT05294172|Immunologic Factors|immunologic factors|mesh-ancestor
44937107|NCT05294172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937108|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
44937109|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
44937110|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
44937111|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44937112|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
44937113|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937114|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
44937115|NCT05291650|Protective Agents|protective agents|mesh-ancestor
44937116|NCT05291650|Hormones|hormones|mesh-ancestor
44937117|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707238|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707239|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707240|NCT01432665|Urological Agents|urological agents|mesh-ancestor
44707241|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
44707242|NCT01432704|Vitamin D|vitamin d|mesh-list
44707243|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44734687|NCT03328884|Irinotecan|irinotecan|mesh-list
44937119|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937120|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937121|NCT05275569|Antiemetics|antiemetics|mesh-list
44937122|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
44937123|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937124|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937125|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937126|NCT05254847|Capecitabine|capecitabine|mesh-list
44937127|NCT05254847|Lenvatinib|lenvatinib|mesh-list
44937128|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937129|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
44937130|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937131|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937132|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937133|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937134|NCT05249699|Isoniazid|isoniazid|mesh-list
44937135|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
44937136|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44937137|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937138|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44937139|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44937140|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
44937141|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937142|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44937143|NCT05207709|Paclitaxel|paclitaxel|mesh-list
44937144|NCT05207709|Letrozole|letrozole|mesh-list
44937145|NCT05207709|Fulvestrant|fulvestrant|mesh-list
44937146|NCT05207709|Palbociclib|palbociclib|mesh-list
44937147|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937148|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937149|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44937150|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44937151|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44937152|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937153|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44937154|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44937155|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937156|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44937157|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44937158|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937159|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937160|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937161|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44937162|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937163|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
44937164|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
44937165|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44937166|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44937167|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937168|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937169|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937170|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937171|NCT04952610|Etripamil|etripamil|mesh-list
44937172|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44937173|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937174|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937175|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44937176|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937177|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
44937178|NCT04862585|Promethazine|promethazine|mesh-list
44937179|NCT04862585|Dexamethasone|dexamethasone|mesh-list
44937180|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
44937181|NCT04862585|Paclitaxel|paclitaxel|mesh-list
44937182|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44937183|NCT04862585|Famotidine|famotidine|mesh-list
44937184|NCT04862585|Ranitidine|ranitidine|mesh-list
44937185|NCT04862585|Cimetidine|cimetidine|mesh-list
44937186|NCT04862585|BB 1101|bb 1101|mesh-list
44937187|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937188|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937189|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44937190|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44937191|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734744|NCT05705505|Letrozole|letrozole|mesh-list
44937192|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937193|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937194|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
44937195|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
44937196|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937197|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937198|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937199|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
44937200|NCT04862585|Hormones|hormones|mesh-ancestor
44937201|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937202|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937203|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44937204|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937205|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44937206|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44937207|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937208|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
44937209|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
44937210|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
44937211|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44937212|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
44937213|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
44937214|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937215|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44937216|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
44937217|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44937218|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44937219|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44937220|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44937221|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44937222|NCT04788667|Erenumab|erenumab|mesh-list
44937223|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
44937224|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44937225|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937226|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937227|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
44937228|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937229|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937230|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44937231|NCT04788667|Analgesics|analgesics|mesh-ancestor
44937232|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
44937233|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937234|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44937235|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44937236|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937237|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
44937238|NCT04776499|Perphenazine|perphenazine|mesh-list
44937239|NCT04776499|Riociguat|riociguat|mesh-list
44937240|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
44937241|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
44937242|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937243|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44937244|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44937245|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937246|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937247|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44937248|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44937249|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
44937250|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937251|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
44937252|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
44937253|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
44937254|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937255|NCT04732910|Ivacaftor|ivacaftor|mesh-list
44937256|NCT04732910|Elexacaftor|elexacaftor|mesh-list
44937257|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44937258|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937259|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937260|NCT04703920|Talazoparib|talazoparib|mesh-list
44937261|NCT04703920|Belinostat|belinostat|mesh-list
44937262|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44937263|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937264|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937265|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937266|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44937268|NCT04698031|Clopidogrel|clopidogrel|mesh-list
44937269|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44937270|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44937271|NCT04698031|Analgesics|analgesics|mesh-ancestor
44937272|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
44937273|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937274|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937275|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937276|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937277|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44937278|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44937279|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937280|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44937281|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44937282|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937283|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
44937284|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44937285|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44937286|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44937287|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
44937288|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937289|NCT04689347|Leucovorin|leucovorin|mesh-list
44937290|NCT04689347|Bevacizumab|bevacizumab|mesh-list
44937291|NCT04689347|Fluorouracil|fluorouracil|mesh-list
44937292|NCT04689347|Irinotecan|irinotecan|mesh-list
44937293|NCT04689347|Temozolomide|temozolomide|mesh-list
44937294|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937295|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937296|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937297|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937298|NCT04689347|Growth Substances|growth substances|mesh-ancestor
44937299|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937300|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937301|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
44937302|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937303|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937304|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937305|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
44937306|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44937307|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937308|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937309|NCT04689347|Antidotes|antidotes|mesh-ancestor
44937310|NCT04689347|Protective Agents|protective agents|mesh-ancestor
44937311|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
44937312|NCT04689347|Vitamins|vitamins|mesh-ancestor
44937313|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
44937314|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44937315|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
44937316|NCT04678479|Ganaxolone|ganaxolone|mesh-list
44937317|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
44937318|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937319|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937320|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937321|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
44937322|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
44937323|NCT04672291|Poly I-C|poly i-c|mesh-list
44937324|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44937325|NCT04672291|Poly ICLC|poly iclc|mesh-list
44937326|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
44937327|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
44937328|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937329|NCT04672291|Laxatives|laxatives|mesh-ancestor
44937330|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937331|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
44937332|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937333|NCT04623684|Phenylephrine|phenylephrine|mesh-list
44937334|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
44937335|NCT04623684|Tropicamide|tropicamide|mesh-list
44937336|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44937337|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
44937338|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
44937339|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937340|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937341|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
44937342|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44937343|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
44937344|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44937345|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44937346|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44937347|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44937348|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
44937349|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937350|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937351|NCT04623684|Protective Agents|protective agents|mesh-ancestor
44937352|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44937353|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44937354|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
44937355|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44937356|NCT04616196|Cetuximab|cetuximab|mesh-list
44937357|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937358|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937359|NCT04578652|Metformin|metformin|mesh-list
44937360|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44937361|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937362|NCT04546581|Remdesivir|remdesivir|mesh-list
44937363|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
44937364|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44937365|NCT04546581|Antibodies|antibodies|mesh-list
44937366|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
44937367|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937368|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
44937369|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937370|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
44937371|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937372|NCT04401384|Pyridoxine|pyridoxine|mesh-list
44937373|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
44937374|NCT04401384|Doxylamine|doxylamine|mesh-list
44937375|NCT04401384|Dicyclomine|dicyclomine|mesh-list
44937376|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
44937377|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
44937378|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937379|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937380|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937381|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44937382|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
44937383|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
44937384|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937385|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937386|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
44937387|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44937388|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44937389|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
44937390|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
44937391|NCT04401384|Vitamins|vitamins|mesh-ancestor
44734974|NCT05704049|BB 1101|bb 1101|mesh-list
44937392|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
44937393|NCT04239222|Ibuprofen|ibuprofen|mesh-list
44937394|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44937395|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44937396|NCT04239222|Analgesics|analgesics|mesh-ancestor
44937397|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
44937398|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937399|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937400|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937401|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937402|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44937403|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937404|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937405|NCT04080804|Nivolumab|nivolumab|mesh-list
44937406|NCT04080804|Ipilimumab|ipilimumab|mesh-list
44937407|NCT04080804|Antibodies|antibodies|mesh-list
44937408|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
44937409|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
44937410|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937411|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937412|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937413|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44937414|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937415|NCT03915626|Rivastigmine|rivastigmine|mesh-list
44937416|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44937417|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937418|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937419|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44937420|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937421|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937422|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44937423|NCT03915626|Protective Agents|protective agents|mesh-ancestor
44937424|NCT03698279|Vaccines|vaccines|mesh-list
44937425|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
44937426|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937427|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
44937428|NCT03680274|Vitamins|vitamins|mesh-ancestor
44937429|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
44937430|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937431|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
44937432|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937433|NCT03680274|Protective Agents|protective agents|mesh-ancestor
44937434|NCT03572764|Cytarabine|cytarabine|mesh-list
44937435|NCT03572764|Daunorubicin|daunorubicin|mesh-list
44937436|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937437|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
44937438|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937439|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937440|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
44937441|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937442|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937443|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
44937444|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937445|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44937446|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937447|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937448|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937449|NCT03559010|Norgestrel|norgestrel|mesh-list
44937450|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44937451|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44937452|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44937453|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
44937454|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44937455|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937456|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44937457|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44937458|NCT03478930|Omalizumab|omalizumab|mesh-list
44937459|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44937460|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44937461|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44937462|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
44474980|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474983|NCT04192617|Methotrexate|methotrexate|mesh-list
44937463|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937464|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937465|NCT03476603|Irbesartan|irbesartan|mesh-list
44937466|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44937467|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44937468|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44937469|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937471|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44937472|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44937473|NCT03476577|Analgesics|analgesics|mesh-ancestor
44937474|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
44937475|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937476|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937477|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937478|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937479|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44937480|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937481|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937482|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44937483|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44937484|NCT03476551|Diuretics|diuretics|mesh-ancestor
44937485|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
44937486|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937487|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44937488|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937489|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937490|NCT03476538|Gabapentin|gabapentin|mesh-list
44937491|NCT03476538|Analgesics|analgesics|mesh-ancestor
44937492|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
44937493|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937494|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937495|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
44937496|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44937497|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44937498|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937499|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44937500|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44937501|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44937502|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937503|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937504|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
44937505|NCT03476525|Fluoxetine|fluoxetine|mesh-list
44937506|NCT03476525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44937507|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44937508|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937509|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937510|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937511|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
44937512|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937513|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44937514|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
44937515|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44937516|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44937517|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44937518|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937519|NCT03425838|Letrozole|letrozole|mesh-list
44937520|NCT03425838|Fulvestrant|fulvestrant|mesh-list
44937521|NCT03425838|Palbociclib|palbociclib|mesh-list
44937522|NCT03425838|Anastrozole|anastrozole|mesh-list
44937523|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44937524|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937525|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44937526|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937527|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937528|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44937529|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
44937530|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937531|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937532|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937533|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44937534|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937535|NCT03404960|Nivolumab|nivolumab|mesh-list
44937536|NCT03404960|Ipilimumab|ipilimumab|mesh-list
44937537|NCT03404960|Niraparib|niraparib|mesh-list
44937538|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937539|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937540|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44937541|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937542|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44937543|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937545|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44937546|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
44937547|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
44937548|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937549|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937550|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44937551|NCT03283670|Analgesics|analgesics|mesh-ancestor
44937552|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
44937553|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937554|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
44937555|NCT03239145|Trebananib|trebananib|mesh-list
44937556|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937557|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937558|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937559|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937560|NCT03239145|Growth Substances|growth substances|mesh-ancestor
44937561|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937562|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937563|NCT03233217|Vaccines|vaccines|mesh-list
44937564|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
44937565|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937566|NCT03205358|Vaccines|vaccines|mesh-list
44937567|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
44937568|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937569|NCT03011671|Temozolomide|temozolomide|mesh-list
44937570|NCT03011671|Acetazolamide|acetazolamide|mesh-list
44937571|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44937572|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
44937573|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937574|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937575|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
44937576|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44937577|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937578|NCT03011671|Diuretics|diuretics|mesh-ancestor
44937579|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
44937580|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937581|NCT03008616|Digoxin|digoxin|mesh-list
44937582|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44937583|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44937584|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937585|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937586|NCT03008616|Protective Agents|protective agents|mesh-ancestor
44937587|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937588|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44937589|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44937590|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44937591|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
44937592|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937593|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937594|NCT02931695|Hormones|hormones|mesh-list
44937595|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937596|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937597|NCT02921035|Interferons|interferons|mesh-list
44937598|NCT02921035|Interferon-beta|interferon-beta|mesh-list
44937599|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
44937600|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937601|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
44937602|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937603|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
44937604|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937605|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44937606|NCT02885753|Leucovorin|leucovorin|mesh-list
44937607|NCT02885753|Folic Acid|folic acid|mesh-list
44937608|NCT02885753|Bevacizumab|bevacizumab|mesh-list
44937609|NCT02885753|Panitumumab|panitumumab|mesh-list
44937610|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
44937611|NCT02885753|Irinotecan|irinotecan|mesh-list
44937612|NCT02885753|Fluorouracil|fluorouracil|mesh-list
44937613|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
44468559|NCT01435577|Tapentadol|tapentadol|mesh-list
44937614|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937615|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937616|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937617|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937618|NCT02885753|Growth Substances|growth substances|mesh-ancestor
44937619|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937620|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937621|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44937622|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937623|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937624|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937625|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
44937626|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937627|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937628|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
44937629|NCT02885753|Antidotes|antidotes|mesh-ancestor
44937630|NCT02885753|Protective Agents|protective agents|mesh-ancestor
44937631|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
44937632|NCT02885753|Vitamins|vitamins|mesh-ancestor
44937633|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
44937634|NCT02885753|Hematinics|hematinics|mesh-ancestor
44937635|NCT02824575|Paclitaxel|paclitaxel|mesh-list
44937636|NCT02824575|Rebastinib|rebastinib|mesh-list
44937637|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937638|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937639|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
44937640|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
44937641|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
44937642|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937643|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937644|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937645|NCT02807181|Gemcitabine|gemcitabine|mesh-list
44937646|NCT02807181|Cisplatin|cisplatin|mesh-list
44937647|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937648|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937649|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
44937650|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937651|NCT02807181|Antiviral Agents|antiviral agents|mesh-ancestor
44937652|NCT02807181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937653|NCT02807181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937654|NCT02807181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937655|NCT02807181|Immunologic Factors|immunologic factors|mesh-ancestor
44937656|NCT02807181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937657|NCT02749968|Bupivacaine|bupivacaine|mesh-list
44937658|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
44937659|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
44937660|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44937661|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937662|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
44937663|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937664|NCT02713776|Pasireotide|pasireotide|mesh-list
44937665|NCT02713776|Somatostatin|somatostatin|mesh-list
44937666|NCT02713776|Hormones|hormones|mesh-ancestor
44937667|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937668|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937669|NCT02637531|Nivolumab|nivolumab|mesh-list
44937670|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937671|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937672|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44937673|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937674|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
44937675|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44937676|NCT02573233|Fluticasone|fluticasone|mesh-list
44937677|NCT02573233|Xhance|xhance|mesh-list
44937678|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
44937679|NCT02573233|Budesonide|budesonide|mesh-list
44937680|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
44937681|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44937682|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937683|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44937684|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
44937685|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937686|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937687|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44937688|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
44937689|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
44937690|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44937691|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
44937692|NCT02573233|Hormones|hormones|mesh-ancestor
44937693|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937694|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44937695|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44937696|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44937697|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
44937698|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937699|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937700|NCT02439658|Sotalol|sotalol|mesh-list
44937701|NCT02439658|Dofetilide|dofetilide|mesh-list
44937702|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44937703|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44937704|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
44937705|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937706|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937707|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937708|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44937709|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
44937710|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
44937711|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937712|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44937713|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937714|NCT02420795|TIC10 compound|tic10 compound|mesh-list
44937715|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937716|NCT02384759|Aflibercept|aflibercept|mesh-list
44937717|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937718|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937719|NCT02384759|Growth Substances|growth substances|mesh-ancestor
44937720|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937721|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937722|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937723|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
44937724|NCT02367846|NuvaRing|nuvaring|mesh-list
44937725|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
44937726|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44937727|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44937728|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937729|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44937730|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44937731|NCT02274662|Cyclosporine|cyclosporine|mesh-list
44937732|NCT02274662|Tacrolimus|tacrolimus|mesh-list
44937733|NCT02274662|Cyclosporins|cyclosporins|mesh-list
44937734|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44937735|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
44937736|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937737|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
44937738|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937739|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44937740|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937741|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937742|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
44937743|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937744|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44937745|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937746|NCT02243878|Ranibizumab|ranibizumab|mesh-list
44937747|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44937748|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44937749|NCT02243878|Growth Substances|growth substances|mesh-ancestor
44937750|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937751|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44937752|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937753|NCT02199691|Vaccines|vaccines|mesh-list
44937754|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
44937755|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937756|NCT02199665|Dexamethasone|dexamethasone|mesh-list
44937757|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937758|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
44937759|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
44937760|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937761|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937762|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937763|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
44937764|NCT02199665|Hormones|hormones|mesh-ancestor
44937765|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937766|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937767|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937768|NCT02143726|Everolimus|everolimus|mesh-list
44937769|NCT02143726|Sorafenib|sorafenib|mesh-list
44937770|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937771|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937772|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
44937773|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937774|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937775|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937776|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937777|NCT02088112|Durvalumab|durvalumab|mesh-list
44937778|NCT02088112|Gefitinib|gefitinib|mesh-list
44937779|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937780|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937781|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937782|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937783|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937784|NCT02076620|Doxorubicin|doxorubicin|mesh-list
44937785|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44937786|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937787|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937788|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937789|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937790|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937791|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44937792|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44937793|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
44937794|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937795|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44937796|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937797|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44937798|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937799|NCT01732627|Vaccines|vaccines|mesh-list
44937800|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
44937801|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937802|NCT01702571|Trastuzumab|trastuzumab|mesh-list
44937803|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44937804|NCT01702571|Maytansine|maytansine|mesh-list
44937805|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44937806|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937807|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937808|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44937809|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44937810|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44937811|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937812|NCT01578239|Octreotide|octreotide|mesh-list
44937813|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44937814|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937815|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937816|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937817|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44937818|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937819|NCT01411267|Cytarabine|cytarabine|mesh-list
44937820|NCT01411267|Methotrexate|methotrexate|mesh-list
44937821|NCT01411267|Etoposide|etoposide|mesh-list
44937822|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
44937823|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44937824|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
44937825|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44468775|NCT01431287|Olodaterol|olodaterol|mesh-list
44937826|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937827|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937828|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
44937829|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937830|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937831|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44937832|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937833|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44937834|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937835|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
44937836|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937837|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44937838|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937839|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937840|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937841|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
44937842|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937843|NCT01336634|Trametinib|trametinib|mesh-list
44937844|NCT01336634|Dabrafenib|dabrafenib|mesh-list
44937845|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937846|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44937847|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937848|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937849|NCT01220531|Cyclosporine|cyclosporine|mesh-list
44937850|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
44937851|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
44937852|NCT01220531|Prednisolone|prednisolone|mesh-list
44937853|NCT01220531|Tacrolimus|tacrolimus|mesh-list
44937854|NCT01220531|Cyclosporins|cyclosporins|mesh-list
44937855|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44937856|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
44937857|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937858|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
44937859|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937860|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44937861|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937862|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937863|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
44937864|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937865|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44937866|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937867|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44937868|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937869|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44937870|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
44937871|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44937872|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44937873|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
44937874|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
44937875|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44937876|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44937877|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
44937878|NCT01220531|Hormones|hormones|mesh-ancestor
44937879|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937880|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44937881|NCT01220531|Protective Agents|protective agents|mesh-ancestor
44937882|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44937883|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
44937884|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44937885|NCT01155375|Hematinics|hematinics|mesh-ancestor
44937886|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44937887|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44937888|NCT01155375|Trace Elements|trace elements|mesh-ancestor
44937889|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
44937890|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937891|NCT00785798|Doxorubicin|doxorubicin|mesh-list
44937892|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44937893|NCT00785798|Vorinostat|vorinostat|mesh-list
44937894|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44937895|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937896|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937897|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937898|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937899|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937900|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44937901|NCT00673010|Iodine|iodine|mesh-list
44937902|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44937903|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937905|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
44937906|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937907|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
44937908|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44937909|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937910|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
44937911|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44937912|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44937913|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937914|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937915|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937916|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937917|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937918|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937919|NCT00360425|Hematinics|hematinics|mesh-ancestor
44937920|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44937921|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44937922|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44937923|NCT00233597|Hematinics|hematinics|mesh-ancestor
44937924|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44937925|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44937926|NCT04335669|Paclitaxel|paclitaxel|mesh-list
44937927|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44937928|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
44937929|NCT04335669|Carboplatin|carboplatin|mesh-list
44937930|NCT04335669|Capecitabine|capecitabine|mesh-list
44937931|NCT04335669|Epirubicin|epirubicin|mesh-list
44937932|NCT04335669|Taxane|taxane|mesh-list
44937933|NCT04335669|Antimetabolites|antimetabolites|mesh-list
44937934|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44937935|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937936|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44937937|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44937938|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44937939|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937940|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44937941|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
44937942|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937943|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44937944|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44937945|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
44937946|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44937947|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44937948|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44937949|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44937950|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44937951|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937952|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
44937953|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44937954|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44937955|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44937956|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44937957|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937958|NCT04323189|Incretins|incretins|mesh-ancestor
44937959|NCT04323189|Hormones|hormones|mesh-ancestor
44937960|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44937961|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44937962|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
44937963|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937964|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937965|NCT04282811|Venetoclax|venetoclax|mesh-list
44937966|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44937967|NCT04235855|Liver Extracts|liver extracts|mesh-list
44937968|NCT04235855|Hematinics|hematinics|mesh-ancestor
44937969|NCT04234945|Doxycycline|doxycycline|mesh-list
44937970|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44937971|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937972|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
44937973|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44937974|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44937975|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
44937976|NCT04188028|Paroxetine|paroxetine|mesh-list
44937977|NCT04188028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44937978|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44937979|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44937980|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44937981|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44937982|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
44937983|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44937984|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44937985|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
44937986|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44937987|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44937988|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44937989|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44937990|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
44937991|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
44937992|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44937993|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44937994|NCT04154800|Itraconazole|itraconazole|mesh-list
44937995|NCT04154800|Diltiazem|diltiazem|mesh-list
44937996|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
44937997|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44937998|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44937999|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938000|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938001|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938002|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44938003|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
44938004|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938005|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938006|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44938007|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44938008|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44938009|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938010|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44938011|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
44938012|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
44938013|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44938014|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938015|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938016|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938017|NCT04031508|SMOFlipid|smoflipid|mesh-list
44938018|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44938019|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44938020|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44938021|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44938022|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938023|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938024|NCT04017832|Incretins|incretins|mesh-ancestor
44938025|NCT04017832|Hormones|hormones|mesh-ancestor
44938026|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938027|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44938028|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44938029|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938030|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938031|NCT03945825|Vaccines|vaccines|mesh-list
44938032|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
44938033|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938034|NCT03942419|Atropine|atropine|mesh-list
44938035|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44938036|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44938037|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44938038|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44938039|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44938040|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
44938041|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938042|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938043|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44938044|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
44938045|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
44938046|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
44938047|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44938048|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44938049|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
44938050|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938051|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938052|NCT03877354|Anesthetics|anesthetics|mesh-list
44938053|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938054|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938055|NCT03733925|Golimumab|golimumab|mesh-list
44938056|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44938057|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938058|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938059|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
44938060|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938061|NCT03659578|Thymalfasin|thymalfasin|mesh-list
44938062|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44938063|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
44938064|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938065|NCT03629873|Cytarabine|cytarabine|mesh-list
44938066|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
44938067|NCT03629873|Carmustine|carmustine|mesh-list
44938068|NCT03629873|Etoposide|etoposide|mesh-list
44938069|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938070|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
44938071|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938072|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938073|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44938074|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
44938075|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938076|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938077|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44938078|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44938079|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44938080|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44938081|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938082|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44938083|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
44938084|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
44938085|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938086|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44938087|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938088|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938089|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44938090|NCT03608865|Durvalumab|durvalumab|mesh-list
44938091|NCT03608865|Tremelimumab|tremelimumab|mesh-list
44938092|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938093|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938094|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
44938095|NCT03560193|Ethanol|ethanol|mesh-list
44938096|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
44938097|NCT03560193|Povidone|povidone|mesh-list
44938098|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44938099|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938100|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
44938101|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938102|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938103|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
44938104|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
44938105|NCT03557281|GSK656|gsk656|mesh-list
44938106|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44938107|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938108|NCT03557242|Aspirin|aspirin|mesh-list
44938109|NCT03557242|Warfarin|warfarin|mesh-list
44938110|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938111|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938112|NCT03557242|Analgesics|analgesics|mesh-ancestor
44938113|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
44938114|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938115|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938116|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938117|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938118|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44938119|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44938120|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938121|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44938122|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44938123|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938124|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
44938125|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
44938126|NCT03508739|Valsartan|valsartan|mesh-list
44938127|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44938128|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44938129|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44938130|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44938131|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938132|NCT03473561|Racecadotril|racecadotril|mesh-list
44938133|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
44938134|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938135|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
44938136|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938137|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938138|NCT03367299|Blinatumomab|blinatumomab|mesh-list
44938139|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938140|NCT03341806|Avelumab|avelumab|mesh-list
44938141|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938142|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938143|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
44938144|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938145|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938146|NCT03171480|Isosorbide|isosorbide|mesh-list
44938147|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44938148|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44938149|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44938150|NCT03171480|Diuretics|diuretics|mesh-ancestor
44938151|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
44938152|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938153|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
44938154|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44938155|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938156|NCT03164655|Leucovorin|leucovorin|mesh-list
44938157|NCT03164655|Bevacizumab|bevacizumab|mesh-list
44938158|NCT03164655|Cetuximab|cetuximab|mesh-list
44938159|NCT03164655|Panitumumab|panitumumab|mesh-list
44938160|NCT03164655|Fluorouracil|fluorouracil|mesh-list
44938161|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
44938162|NCT03164655|Irinotecan|irinotecan|mesh-list
44938163|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938164|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938165|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44938166|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44938167|NCT03164655|Growth Substances|growth substances|mesh-ancestor
44938168|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938169|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
44938170|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
44938171|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938172|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44938173|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938174|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
44938175|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44938176|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44938177|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938178|NCT03164655|Antidotes|antidotes|mesh-ancestor
44938179|NCT03164655|Protective Agents|protective agents|mesh-ancestor
44938180|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
44938181|NCT03164655|Vitamins|vitamins|mesh-ancestor
44938182|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
44938183|NCT03074240|Anesthetics|anesthetics|mesh-list
44938184|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
44938185|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938186|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938187|NCT05276687|Vancomycin|vancomycin|mesh-list
44938188|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
44938189|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44938190|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938191|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44938192|NCT05276596|Norepinephrine|norepinephrine|mesh-list
44938193|NCT05276596|Ephedrine|ephedrine|mesh-list
44938194|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44938195|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44938196|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938197|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938198|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938199|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938200|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
44938201|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
44938202|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469134|NCT01426113|Timolol|timolol|mesh-list
44938203|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44938204|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44938205|NCT05276492|Prednisone|prednisone|mesh-list
44938206|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938207|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
44938208|NCT05276492|Hormones|hormones|mesh-ancestor
44938209|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938210|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938211|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44938212|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938213|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
44938214|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938215|NCT05276258|Bupivacaine|bupivacaine|mesh-list
44938216|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
44938217|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
44938218|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938219|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938220|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
44938221|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938222|NCT05275777|Paclitaxel|paclitaxel|mesh-list
44938223|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
44938224|NCT05275777|Doxorubicin|doxorubicin|mesh-list
44938225|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44938226|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938227|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938228|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
44938229|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938230|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938231|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938232|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
44938233|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938234|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938235|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44938236|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
44938237|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44938238|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44938239|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44938240|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44938241|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938242|NCT05275699|Glycine|glycine|mesh-list
44938243|NCT05275699|Glycine Agents|glycine agents|mesh-ancestor
44938244|NCT05275699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938245|NCT05275699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938246|NCT05275699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938247|NCT05275270|Oxytocin|oxytocin|mesh-list
44938248|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
44938249|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44938250|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938251|NCT05274984|Lidocaine|lidocaine|mesh-list
44938252|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
44938253|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
44938254|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938255|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938256|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
44938257|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938258|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44938259|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44938260|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44938261|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938262|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938263|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44938264|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938265|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
44938266|NCT05274672|Cephalexin|cephalexin|mesh-list
44938267|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44938268|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
44938269|NCT05274672|Trimethoprim|trimethoprim|mesh-list
44938270|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
44938271|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44938272|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938273|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44938274|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44938275|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938276|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938277|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938278|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44938279|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938280|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44938281|NCT05274672|Renal Agents|renal agents|mesh-ancestor
44938282|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
44938283|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44938284|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44938285|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44938286|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44938287|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44938288|NCT05255471|Olaparib|olaparib|mesh-list
44938289|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44938290|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938291|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938292|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938293|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44938294|NCT05232396|Antibodies|antibodies|mesh-list
44938295|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
44938296|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44938297|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
44938298|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938299|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938300|NCT05222724|Ibuprofen|ibuprofen|mesh-list
44938301|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938302|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938303|NCT05222724|Analgesics|analgesics|mesh-ancestor
44938304|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
44938305|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938306|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938307|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938308|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938309|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44938310|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938311|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938312|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44938313|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938314|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938315|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
44938316|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44938317|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44938318|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938319|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938320|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44938321|NCT05216614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44938322|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44938323|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938324|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938325|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938326|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
44938327|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44938328|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
44938329|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44938330|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938331|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938332|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44938333|NCT05200312|Prednisone|prednisone|mesh-list
44938334|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
44938335|NCT05200312|Rituximab|rituximab|mesh-list
44938336|NCT05200312|Doxorubicin|doxorubicin|mesh-list
44938337|NCT05200312|Vincristine|vincristine|mesh-list
44938338|NCT05200312|Lenalidomide|lenalidomide|mesh-list
44938339|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
44938340|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938341|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
44938342|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938343|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938344|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44938345|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
44938346|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938347|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938348|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44938349|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938350|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44938351|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44938352|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44938353|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938354|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938355|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
44938356|NCT05200312|Hormones|hormones|mesh-ancestor
44938357|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938358|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44938359|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44938360|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938361|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44426698|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44426699|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426700|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426701|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44938362|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938363|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44938364|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44938365|NCT05200312|Growth Substances|growth substances|mesh-ancestor
44938366|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
44938367|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44938368|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
44938369|NCT05040984|Mirabegron|mirabegron|mesh-list
44938370|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44938371|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44938372|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44938373|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938374|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938375|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938376|NCT05040984|Urological Agents|urological agents|mesh-ancestor
44938377|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44938378|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44938379|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44938380|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938381|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
44938382|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44938383|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938384|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938385|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44938386|NCT04949269|BMS-986165|bms-986165|mesh-list
44938387|NCT04949269|Famotidine|famotidine|mesh-list
44938388|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44938389|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938390|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44938391|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
44938392|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
44938393|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938394|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938395|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938396|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
44938397|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44938398|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938399|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
44938400|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44938401|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
44938402|NCT04893915|Fludarabine|fludarabine|mesh-list
44938403|NCT04893915|Interleukin-2|interleukin-2|mesh-list
44938404|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938405|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
44938406|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938407|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938408|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44938409|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
44938410|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938411|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938412|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44938413|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938414|NCT04893915|Analgesics|analgesics|mesh-ancestor
44938415|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
44938416|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938418|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44938419|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44938420|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44938421|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938422|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938423|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938424|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938425|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938426|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
44938427|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
44938428|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938429|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44938430|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44938431|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44938432|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44938433|NCT04781426|Tenofovir|tenofovir|mesh-list
44938434|NCT04781426|Lamivudine|lamivudine|mesh-list
44938435|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
44938436|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938437|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44938438|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44938439|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938440|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938441|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44938442|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44938443|NCT04774666|Antibodies|antibodies|mesh-list
44938444|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
44938445|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938446|NCT04707534|Dexamethasone|dexamethasone|mesh-list
44938447|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938448|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
44938449|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
44938450|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938451|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938452|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938453|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
44938454|NCT04707534|Hormones|hormones|mesh-ancestor
44938455|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938456|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44938457|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938458|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
44938459|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44938460|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
44938461|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938462|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
44938463|NCT04697823|Protective Agents|protective agents|mesh-ancestor
44938464|NCT04691856|Acetaminophen|acetaminophen|mesh-list
44938465|NCT04691856|Ibuprofen|ibuprofen|mesh-list
44938466|NCT04691856|Morphine|morphine|mesh-list
44938467|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44469429|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
44938468|NCT04691856|Narcotics|narcotics|mesh-ancestor
44938469|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938470|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938472|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
44938473|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938474|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938475|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938476|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938477|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938478|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44938479|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938480|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938481|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
44938482|NCT04671966|Cetrorelix|cetrorelix|mesh-list
44938483|NCT04671966|Estradiol|estradiol|mesh-list
44938484|NCT04671966|Estrogens|estrogens|mesh-ancestor
44938485|NCT04671966|Hormones|hormones|mesh-ancestor
44938486|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938487|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938488|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44938489|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44938490|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
44938491|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
44938492|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
44938493|NCT04632459|Ramucirumab|ramucirumab|mesh-list
44938494|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938495|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938496|NCT04301765|Testosterone|testosterone|mesh-list
44938497|NCT04301765|Androgens|androgens|mesh-ancestor
44938498|NCT04301765|Hormones|hormones|mesh-ancestor
44938499|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938500|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938501|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44938502|NCT04280328|Daratumumab|daratumumab|mesh-list
44938503|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938504|NCT04251884|Ropivacaine|ropivacaine|mesh-list
44938505|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
44938506|NCT04251884|Anesthetics|anesthetics|mesh-list
44938507|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938508|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938509|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
44938510|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938511|NCT03783286|Ivacaftor|ivacaftor|mesh-list
44938512|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44938513|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938514|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938515|NCT03708003|Venetoclax|venetoclax|mesh-list
44938516|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938517|NCT03648489|Paclitaxel|paclitaxel|mesh-list
44938518|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44938519|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938520|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938521|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44938522|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938523|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938524|NCT03622073|Misoprostol|misoprostol|mesh-list
44938525|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44938526|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
44938527|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44938528|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938529|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44938530|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938531|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
44938532|NCT03469492|Insulin|insulin|mesh-list
44938533|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938534|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938535|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
44938536|NCT03448978|Fludarabine|fludarabine|mesh-list
44938537|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938538|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
44938539|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938540|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938541|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44938542|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
44938543|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938544|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938545|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44938546|NCT03439033|Edetic Acid|edetic acid|mesh-list
44938547|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
44938548|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
44938549|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
44938550|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938551|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
44938552|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44938553|NCT03340896|Cisplatin|cisplatin|mesh-list
44938554|NCT03340896|Docetaxel|docetaxel|mesh-list
44938555|NCT03340896|Fluorouracil|fluorouracil|mesh-list
44938556|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938557|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938558|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
44938559|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938560|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938561|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
44938562|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44938563|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475043|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44475045|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
44938564|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
44469577|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938565|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938566|NCT03330249|Cisplatin|cisplatin|mesh-list
44938567|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938568|NCT03316807|Vaccines|vaccines|mesh-list
44938569|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
44938570|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938571|NCT03304379|Celecoxib|celecoxib|mesh-list
44938572|NCT03304379|Diclofenac|diclofenac|mesh-list
44938573|NCT03304379|Fasinumab|fasinumab|mesh-list
44938574|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938575|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938576|NCT03304379|Analgesics|analgesics|mesh-ancestor
44938577|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
44938578|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938579|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938580|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938581|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938582|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44938583|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44938584|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938585|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938586|NCT03268499|Cisplatin|cisplatin|mesh-list
44938587|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938588|NCT03122522|Nivolumab|nivolumab|mesh-list
44938589|NCT03122522|Ipilimumab|ipilimumab|mesh-list
44938590|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938591|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938592|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44938593|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938594|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
44938595|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44938596|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
44938597|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44938598|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
44938599|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938600|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938601|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
44938602|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
44938603|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44938604|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938605|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938606|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938607|NCT02958150|Analgesics|analgesics|mesh-ancestor
44938608|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
44938609|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938610|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44938611|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44938612|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44938613|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938614|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938615|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938616|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
44938617|NCT02955134|Antacids|antacids|mesh-ancestor
44938618|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938619|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938620|NCT02807805|Niclosamide|niclosamide|mesh-list
44938621|NCT02807805|Prednisone|prednisone|mesh-list
44938622|NCT02807805|Cortisone|cortisone|mesh-list
44938623|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
44938624|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938625|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
44938626|NCT02807805|Hormones|hormones|mesh-ancestor
44938627|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938628|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938629|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44938630|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938631|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44938632|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475054|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44938633|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938634|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
44938635|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938636|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
44938637|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44938638|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
44938639|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44938640|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938641|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
44938642|NCT02764268|Apatinib|apatinib|mesh-list
44938643|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938644|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44938645|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938646|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938648|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938649|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938650|NCT02553473|Doxycycline|doxycycline|mesh-list
44938651|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44938652|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938653|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
44938654|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44938655|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44938656|NCT02472912|Adalimumab|adalimumab|mesh-list
44938657|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938658|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938659|NCT02356458|Bortezomib|bortezomib|mesh-list
44938660|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938661|NCT01974609|Acetaminophen|acetaminophen|mesh-list
44938662|NCT01974609|Ibuprofen|ibuprofen|mesh-list
44938663|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44938664|NCT01974609|Hydrocodone|hydrocodone|mesh-list
44938665|NCT01974609|Narcotics|narcotics|mesh-list
44938666|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938667|NCT01974609|Analgesics|analgesics|mesh-ancestor
44938668|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
44938669|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938670|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938671|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
44938672|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938673|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938674|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938675|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44938676|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938677|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938678|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44938679|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938680|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
44938681|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
44938682|NCT01758081|Vitamin D|vitamin d|mesh-list
44938683|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
44938684|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
44938685|NCT01758081|Vitamins|vitamins|mesh-list
44938686|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
44938687|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938688|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44938689|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44938691|NCT01673867|Nivolumab|nivolumab|mesh-list
44938692|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938693|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44938694|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44938695|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938696|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938697|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938698|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44938699|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44938700|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44938701|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938702|NCT01182727|Analgesics|analgesics|mesh-ancestor
44938703|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
44938704|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938705|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938706|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938707|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938708|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
44938709|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44938710|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
44938711|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
44938712|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938713|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938714|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938715|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938716|NCT00335777|Analgesics|analgesics|mesh-ancestor
44938717|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
44938718|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938719|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
44938720|NCT00159588|Gabapentin|gabapentin|mesh-list
44938721|NCT00159588|Valproic Acid|valproic acid|mesh-list
44938722|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
44938723|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
44938724|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44938725|NCT00159588|Analgesics|analgesics|mesh-ancestor
44938726|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
44938727|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938728|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938729|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
44938730|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44938731|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44938732|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938733|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44938734|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44938735|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44938736|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938737|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938738|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
44938739|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938740|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
44938741|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44938742|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44938743|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938744|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
44938745|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938746|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
44938747|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938748|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938749|NCT02988401|Insulin|insulin|mesh-list
44938750|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938751|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938752|NCT02987530|Tenofovir|tenofovir|mesh-list
44938753|NCT02987530|Emtricitabine|emtricitabine|mesh-list
44938754|NCT02987530|Dolutegravir|dolutegravir|mesh-list
44938755|NCT02987530|Darunavir|darunavir|mesh-list
44938756|NCT02987530|Cobicistat|cobicistat|mesh-list
44938757|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44938758|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
44938759|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938760|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44938761|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44938762|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938763|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938764|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44938765|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44938766|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44938767|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44938768|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44938769|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44938770|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
44938771|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44938772|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938773|NCT02965690|Cimetidine|cimetidine|mesh-list
44938774|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44938775|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938776|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44938777|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
44938778|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
44938779|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938780|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938781|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938782|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44938783|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44938784|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938785|NCT02889809|Fluticasone|fluticasone|mesh-list
44938786|NCT02889809|Xhance|xhance|mesh-list
44938787|NCT02889809|Montelukast|montelukast|mesh-list
44938788|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938789|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44938790|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
44938791|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938792|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938793|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44938794|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
44938795|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
44938796|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44938797|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44938798|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44938799|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938800|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44938801|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44938802|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938803|NCT02884648|Bevacizumab|bevacizumab|mesh-list
44938804|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938805|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938806|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44938807|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44938808|NCT02884648|Growth Substances|growth substances|mesh-ancestor
44938809|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938810|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44938811|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
44938812|NCT02818023|Vemurafenib|vemurafenib|mesh-list
44938813|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938814|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938815|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44938816|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938817|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938818|NCT02808572|Mitogens|mitogens|mesh-list
44938819|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44938820|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938821|NCT02785224|Vasopressins|vasopressins|mesh-list
44938822|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
44938823|NCT02785224|Epinephrine|epinephrine|mesh-list
44938824|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44938825|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44938826|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
44938827|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938828|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938829|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938830|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44938831|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44938832|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
44938833|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938834|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44938835|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
44938836|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
44938837|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
44938838|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44938839|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
44938841|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44938842|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
44938843|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44938844|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938845|NCT02778204|Maraviroc|maraviroc|mesh-list
44938846|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44938847|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44938848|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938849|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44938850|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44938851|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
44938852|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938853|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44938854|NCT02670044|Venetoclax|venetoclax|mesh-list
44938855|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938856|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
44938857|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938858|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938859|NCT02547493|Abatacept|abatacept|mesh-list
44938860|NCT02547493|Vaccines|vaccines|mesh-list
44938861|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44938862|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
44938863|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938864|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44938865|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938866|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938867|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938868|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44938869|NCT02496611|Exenatide|exenatide|mesh-list
44938870|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938871|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938872|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44938873|NCT02496611|Incretins|incretins|mesh-ancestor
44938874|NCT02496611|Hormones|hormones|mesh-ancestor
44938875|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938876|NCT02476097|Esomeprazole|esomeprazole|mesh-list
44938877|NCT02476097|Omeprazole|omeprazole|mesh-list
44938878|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44938879|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938880|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44938881|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938882|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938883|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44938884|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
44938885|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44938886|NCT02459392|Prednisolone|prednisolone|mesh-list
44938887|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
44938888|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
44938889|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44938890|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
44938891|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44938892|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
44938893|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938894|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
44938895|NCT02459392|Protective Agents|protective agents|mesh-ancestor
44938896|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44938897|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
44938898|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
44938899|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938900|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44938901|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
44938902|NCT02459392|Hormones|hormones|mesh-ancestor
44938903|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938904|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44938905|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44938906|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938907|NCT02361125|Methylphenidate|methylphenidate|mesh-list
44938908|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44938909|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938910|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44938911|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44938912|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938913|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938914|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
44938915|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44938916|NCT02338921|Metformin|metformin|mesh-list
44938917|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44938918|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
44938919|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938920|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938921|NCT02338921|Incretins|incretins|mesh-ancestor
44938922|NCT02338921|Hormones|hormones|mesh-ancestor
44938923|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44938924|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44938925|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
44938926|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938927|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938928|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44938929|NCT02145403|Tacrolimus|tacrolimus|mesh-list
44938930|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938931|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
44938932|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938933|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44938934|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938935|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938936|NCT01988571|Atorvastatin|atorvastatin|mesh-list
44938937|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44938938|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44938939|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
44938940|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938941|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44938942|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44938943|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938944|NCT01526135|Gemcitabine|gemcitabine|mesh-list
44938945|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44938946|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
44938947|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938948|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938949|NCT01526135|Antiviral Agents|antiviral agents|mesh-ancestor
44938950|NCT01526135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938951|NCT01526135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938952|NCT01526135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44938953|NCT01526135|Immunologic Factors|immunologic factors|mesh-ancestor
44938954|NCT01526135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938955|NCT01332266|Cetuximab|cetuximab|mesh-list
44938956|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44938957|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938958|NCT01222754|Lenalidomide|lenalidomide|mesh-list
44938959|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
44938960|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938961|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44938962|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44938963|NCT01222754|Growth Substances|growth substances|mesh-ancestor
44938964|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
44938965|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44938966|NCT01150890|Brodalumab|brodalumab|mesh-list
44938967|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
44938968|NCT01143779|Telbivudine|telbivudine|mesh-list
44938969|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
44938970|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44938971|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44938972|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44938973|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938974|NCT01140867|Zonisamide|zonisamide|mesh-list
44938975|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
44938976|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44938977|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938978|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44938979|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44938980|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938981|NCT01137773|Insulin|insulin|mesh-list
44938982|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44938983|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44938984|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938985|NCT01127256|Carbamazepine|carbamazepine|mesh-list
44938986|NCT01127256|Zonisamide|zonisamide|mesh-list
44938987|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
44938988|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
44938989|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44475114|NCT04190004|Vasopressins|vasopressins|mesh-list
44938990|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44938991|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44938992|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44938993|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44938994|NCT01127256|Analgesics|analgesics|mesh-ancestor
44938995|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
44938996|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44938997|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44938998|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44938999|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939000|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44939001|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44939002|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44939003|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44939004|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
44939005|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939006|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44939007|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939008|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939009|NCT00381381|Donepezil|donepezil|mesh-list
44939010|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44939011|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939012|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939013|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44939014|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939015|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939016|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
44939017|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
44939018|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939019|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44939020|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939021|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939022|NCT05179525|Risperidone|risperidone|mesh-list
44939023|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44939024|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
44939025|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939026|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939027|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939028|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44939029|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44939030|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939031|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44939032|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44939033|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
44939034|NCT05179512|Fluticasone|fluticasone|mesh-list
44939035|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
44939036|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44939037|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44939038|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939039|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44939040|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
44939041|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939042|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939043|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44939044|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
44939045|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
44939046|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44939047|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
44939048|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44939049|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
44939050|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939051|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939052|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44939053|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44939054|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939055|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939056|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
44939057|NCT05179512|Hormones|hormones|mesh-ancestor
44939058|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939059|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
44939060|NCT05179213|Azacitidine|azacitidine|mesh-list
44939061|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939062|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
44939063|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939064|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939065|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939066|NCT05179070|Carvedilol|carvedilol|mesh-list
44939067|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44939068|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44939069|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939070|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939071|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939072|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939073|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44939074|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
44939075|NCT05179070|Protective Agents|protective agents|mesh-ancestor
44939076|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44939077|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939078|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44939079|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
44939080|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44939081|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44939082|NCT05179018|Autoantibodies|autoantibodies|mesh-list
44939083|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
44939084|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939085|NCT05178953|Zinc|zinc|mesh-list
44939086|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
44939087|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
44939088|NCT05178953|Trace Elements|trace elements|mesh-ancestor
44939089|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
44939090|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939091|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44939092|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939093|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939094|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44939095|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44939096|NCT05178953|Protective Agents|protective agents|mesh-ancestor
44939097|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
44939098|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44939099|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
44939100|NCT05178953|Astringents|astringents|mesh-ancestor
44939101|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
44939102|NCT05178745|Fluorouracil|fluorouracil|mesh-list
44939103|NCT05178745|Irinotecan|irinotecan|mesh-list
44939104|NCT05178745|Aflibercept|aflibercept|mesh-list
44939105|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
44939106|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939107|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939108|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939109|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939110|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
44939111|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939112|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44939113|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939114|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939115|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939116|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939117|NCT05178745|Growth Substances|growth substances|mesh-ancestor
44939118|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939119|NCT05178511|Ensartinib|ensartinib|mesh-list
44939120|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939121|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44939122|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939123|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939124|NCT05177926|Tenofovir|tenofovir|mesh-list
44939125|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
44939126|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939127|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44939128|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44939129|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939130|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939131|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44939132|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44939133|NCT05158491|Irinotecan|irinotecan|mesh-list
44939134|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44939135|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939136|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939137|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939138|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939139|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
44939140|NCT05121714|Caffeine|caffeine|mesh-list
44939141|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44939142|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939143|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44939144|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939145|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939146|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44939147|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44939148|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
44939149|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939150|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44939151|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44939152|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939153|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44939154|NCT05121714|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44939155|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44939156|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939157|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
44939158|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44939159|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
44939160|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44939161|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44939162|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44939163|NCT05117710|Ebselen|ebselen|mesh-list
44939164|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44939165|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44939166|NCT05117710|Analgesics|analgesics|mesh-ancestor
44939167|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
44939168|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939169|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939170|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939171|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939172|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44939173|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939174|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
44939175|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939176|NCT05117710|Protective Agents|protective agents|mesh-ancestor
44939177|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44939178|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939179|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44939180|NCT05035303|Epinephrine|epinephrine|mesh-list
44939181|NCT05035303|Norepinephrine|norepinephrine|mesh-list
44939182|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44939183|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939184|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939185|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939186|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939187|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939188|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44939189|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44939190|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
44939191|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939192|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44939193|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
44939194|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
44939195|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
44939196|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44470197|NCT01408641|Topiramate|topiramate|mesh-list
44939197|NCT05011149|Ibuprofen|ibuprofen|mesh-list
44939198|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161354|NCT00244972|Sorafenib|sorafenib|mesh-list
44939199|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44939200|NCT05011149|Analgesics|analgesics|mesh-ancestor
44939201|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
44939202|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939203|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939204|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939205|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939206|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44939207|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939208|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939209|NCT04929548|Maleic acid|maleic acid|mesh-list
44939210|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939211|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939212|NCT04745845|Norepinephrine|norepinephrine|mesh-list
44939213|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44939214|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939215|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939216|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939217|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939218|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939219|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
44939220|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
44939221|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939222|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44939223|NCT04728646|Dexamethasone|dexamethasone|mesh-list
44939224|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939225|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
44939226|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
44939227|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939228|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939229|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939230|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
44939231|NCT04728646|Hormones|hormones|mesh-ancestor
44939232|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939233|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44939234|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939235|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44939236|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
44939237|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939238|NCT04594408|Epinephrine|epinephrine|mesh-list
44939239|NCT04594408|Racepinephrine|racepinephrine|mesh-list
44939240|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
44939241|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
44939242|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44939243|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44939244|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939245|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
44939246|NCT04594408|Coagulants|coagulants|mesh-ancestor
44939247|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44939248|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939249|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939250|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939251|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939252|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44939253|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44939254|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
44939255|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939256|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44939257|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44939258|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
44939259|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
44939260|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44939261|NCT04580134|Risperidone|risperidone|mesh-list
44939262|NCT04580134|Clozapine|clozapine|mesh-list
44939263|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44939264|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
44939265|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939266|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939267|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939268|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44939269|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44939270|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939271|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44939272|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44939273|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
44939274|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
44939275|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
44939276|NCT04529720|Vaccines|vaccines|mesh-list
44939277|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
44939278|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939279|NCT04522284|Capecitabine|capecitabine|mesh-list
44939280|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939281|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
44939282|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939283|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939284|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
44939285|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44939286|NCT04423237|Deferasirox|deferasirox|mesh-list
44939287|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44939288|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
44939289|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
44939290|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939291|NCT04409795|Metformin|metformin|mesh-list
44939292|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44939293|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44939294|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939295|NCT04409795|Incretins|incretins|mesh-ancestor
44939296|NCT04409795|Hormones|hormones|mesh-ancestor
44939297|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939298|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44939299|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
44939300|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939301|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939302|NCT04367740|Antibodies|antibodies|mesh-list
44939303|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
44939304|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
44939305|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939306|NCT04297605|Paclitaxel|paclitaxel|mesh-list
44939307|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
44939308|NCT04297605|Pemetrexed|pemetrexed|mesh-list
44939309|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44939310|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939311|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
44939312|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
44939313|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
44939314|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939315|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939316|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939317|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44939318|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44939319|NCT04222426|Atezolizumab|atezolizumab|mesh-list
44939320|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939321|NCT04183101|Enalapril|enalapril|mesh-list
44939322|NCT04183101|Enalaprilat|enalaprilat|mesh-list
44939323|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44939324|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44939325|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939326|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939327|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44939328|NCT04084626|Lenalidomide|lenalidomide|mesh-list
44939329|NCT04084626|Antibodies|antibodies|mesh-list
44939330|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
44939331|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939332|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939333|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939334|NCT04084626|Growth Substances|growth substances|mesh-ancestor
44939335|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939336|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939337|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44939338|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44939339|NCT03948035|Dexamethasone|dexamethasone|mesh-list
44939340|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
44939341|NCT03948035|Lenalidomide|lenalidomide|mesh-list
44939343|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939344|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
44939345|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
44939346|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939347|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939348|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939349|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
44939350|NCT03948035|Hormones|hormones|mesh-ancestor
44939351|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939352|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44939353|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939354|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
44939355|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939356|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939357|NCT03948035|Growth Substances|growth substances|mesh-ancestor
44939358|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939359|NCT03810417|Digoxin|digoxin|mesh-list
44939360|NCT03810417|Antibodies|antibodies|mesh-list
44939361|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
44939362|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
44939363|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939364|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44939365|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44939366|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939367|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939368|NCT03810417|Protective Agents|protective agents|mesh-ancestor
44939369|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44939370|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44939371|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939372|NCT03557749|Dimercaprol|dimercaprol|mesh-list
44939373|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
44939374|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
44939375|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939376|NCT03532555|Zinc|zinc|mesh-list
44939377|NCT03532555|Trace Elements|trace elements|mesh-ancestor
44939378|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
44939379|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939380|NCT03511599|Cycloserine|cycloserine|mesh-list
44939381|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44939382|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939383|NCT03511599|Renal Agents|renal agents|mesh-ancestor
44939384|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44939385|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
44939386|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939387|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
44939388|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939389|NCT03441282|Fentanyl|fentanyl|mesh-list
44939390|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44939391|NCT03441282|Narcotics|narcotics|mesh-ancestor
44939392|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939393|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939394|NCT03441282|Analgesics|analgesics|mesh-ancestor
44939395|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
44939396|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939397|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44939398|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44939399|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
44939400|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
44939401|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44939402|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
44939403|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939404|NCT03125642|Cytarabine|cytarabine|mesh-list
44939405|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
44939406|NCT03125642|Melphalan|melphalan|mesh-list
44939407|NCT03125642|Carmustine|carmustine|mesh-list
44939408|NCT03125642|Etoposide|etoposide|mesh-list
44939409|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939410|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
44470415|NCT01403051|Vitamin D|vitamin d|mesh-list
44939411|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939412|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939413|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44939414|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
44939415|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939416|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939417|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44939418|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44939419|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44939420|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939421|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939422|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939423|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
44939424|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
44939425|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939426|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44939427|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44939428|NCT03007030|Antibodies|antibodies|mesh-list
44939429|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
44939430|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44939431|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
44939432|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
44939433|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939434|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939435|NCT02918500|Nicotine|nicotine|mesh-list
44939436|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44939437|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
44939438|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939439|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939440|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44939441|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44939442|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
44939443|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939444|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939445|NCT02903381|Dexamethasone|dexamethasone|mesh-list
44939446|NCT02903381|Nivolumab|nivolumab|mesh-list
44939447|NCT02903381|Lenalidomide|lenalidomide|mesh-list
44939448|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939449|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
44939450|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
44939451|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939452|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939453|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939454|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
44939455|NCT02903381|Hormones|hormones|mesh-ancestor
44939456|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939457|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44939458|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939459|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939460|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44939461|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939462|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
44939463|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939464|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939465|NCT02903381|Growth Substances|growth substances|mesh-ancestor
44939466|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939467|NCT02774265|Aspirin|aspirin|mesh-list
44939468|NCT02774265|Heparin|heparin|mesh-list
44939469|NCT02774265|Enoxaparin|enoxaparin|mesh-list
44939470|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44939471|NCT02774265|Tinzaparin|tinzaparin|mesh-list
44939472|NCT02774265|Dalteparin|dalteparin|mesh-list
44939473|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44939474|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44939475|NCT02774265|Analgesics|analgesics|mesh-ancestor
44939476|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
44939477|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939478|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939479|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939480|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939481|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44939482|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44939483|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939484|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44939485|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44939486|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939487|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
44939488|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
44939489|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
44939490|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939491|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939492|NCT02695992|Metoprolol|metoprolol|mesh-list
44939493|NCT02695992|Diltiazem|diltiazem|mesh-list
44939494|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44939495|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44939496|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
44939497|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
44939498|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939499|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939500|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44939501|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44939502|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44939503|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939504|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939505|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939506|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44939507|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939508|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44939509|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44939510|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
44939511|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
44939512|NCT02652468|Rituximab|rituximab|mesh-list
44939513|NCT02652468|Fludarabine|fludarabine|mesh-list
44939514|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
44939515|NCT02652468|Tacrolimus|tacrolimus|mesh-list
44939516|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939517|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
44939518|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939519|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939520|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44939521|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
44939522|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939523|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939524|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44939525|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939526|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939527|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
44939528|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44939529|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939530|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44939531|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44939532|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
44939533|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939534|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939535|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44939536|NCT02579265|SMOFlipid|smoflipid|mesh-list
44939537|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44939538|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44939539|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44939540|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44939541|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44939542|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939543|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44939544|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
44939545|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
44939546|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939547|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939548|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
44939549|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939550|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44939551|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44939552|NCT02307656|Cobicistat|cobicistat|mesh-list
44939553|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44939554|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44939555|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
44939556|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939557|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939558|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44939559|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44939560|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
44939561|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939562|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44470574|NCT01401465|Hormones|hormones|mesh-ancestor
44939563|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44939564|NCT05572476|Carboplatin|carboplatin|mesh-list
44939565|NCT05572476|Etoposide|etoposide|mesh-list
44939566|NCT05572476|Durvalumab|durvalumab|mesh-list
44939567|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939568|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44939569|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44939570|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939571|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939572|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939573|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939574|NCT05572255|Cenobamate|cenobamate|mesh-list
44939575|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
44939576|NCT05572229|Lenalidomide|lenalidomide|mesh-list
44939577|NCT05572229|Daratumumab|daratumumab|mesh-list
44939578|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
44939579|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939580|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939581|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939582|NCT05572229|Growth Substances|growth substances|mesh-ancestor
44939583|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939584|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939585|NCT05572060|Metformin|metformin|mesh-list
44939586|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44939587|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939588|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
44939589|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44939590|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939591|NCT05571787|Rabeprazole|rabeprazole|mesh-list
44939592|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44939593|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939594|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44939595|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939596|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939597|NCT05571722|Vancomycin|vancomycin|mesh-list
44939598|NCT05571722|Linezolid|linezolid|mesh-list
44939599|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939600|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939601|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44939602|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939603|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939604|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
44939605|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44939606|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
44939607|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939608|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
44939609|NCT05571527|Protective Agents|protective agents|mesh-ancestor
44939610|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
44939611|NCT05571514|Calcium|calcium|mesh-list
44939612|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44939613|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475147|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
44939614|NCT05571514|Antacids|antacids|mesh-ancestor
44939615|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939616|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939617|NCT05571332|Cyclosporine|cyclosporine|mesh-list
44939618|NCT05571332|Cyclosporins|cyclosporins|mesh-list
44939619|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939620|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939621|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939622|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
44939623|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939624|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
44939625|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939626|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
44939627|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939628|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44939629|NCT05571267|Bevacizumab|bevacizumab|mesh-list
44939630|NCT05571267|Ranibizumab|ranibizumab|mesh-list
44939631|NCT05571267|Aflibercept|aflibercept|mesh-list
44939632|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939633|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939634|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44939635|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44939636|NCT05571267|Growth Substances|growth substances|mesh-ancestor
44939637|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939638|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
44939639|NCT05571202|Anesthetics|anesthetics|mesh-list
44939640|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939641|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939642|NCT05571176|Ketamine|ketamine|mesh-list
44939643|NCT05571176|Esketamine|esketamine|mesh-list
44939644|NCT05571176|Analgesics|analgesics|mesh-ancestor
44939645|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
44939646|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939647|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939648|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44939649|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44939650|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
44939651|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
44939652|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939653|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44939654|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44939655|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939656|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939657|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
44939658|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44939659|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
44939660|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
44939661|NCT05571046|Hormones|hormones|mesh-ancestor
44939662|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939663|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939664|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939666|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939667|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939668|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939669|NCT05568836|Vitamin D|vitamin d|mesh-list
44939670|NCT05568836|Vitamins|vitamins|mesh-ancestor
44939671|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
44939672|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939673|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44939674|NCT05566548|Bilirubin|bilirubin|mesh-list
44939675|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
44939676|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939677|NCT05566548|Protective Agents|protective agents|mesh-ancestor
44939678|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939679|NCT05559814|Peppermint oil|peppermint oil|mesh-list
44939680|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
44939681|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
44939682|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939683|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939684|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939685|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
44939686|NCT05559164|Atorvastatin|atorvastatin|mesh-list
44939687|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44939688|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44939689|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
44939690|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939691|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44939692|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44939693|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939694|NCT05540223|Sirolimus|sirolimus|mesh-list
44939695|NCT05540223|Everolimus|everolimus|mesh-list
44939696|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939697|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939698|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
44939699|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939700|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939701|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939702|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44939703|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
44939704|NCT05487586|Ceftazidime|ceftazidime|mesh-list
44939705|NCT05487586|Avibactam|avibactam|mesh-list
44939706|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44939707|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939708|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939709|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44939710|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939711|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939712|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
44939713|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44939714|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939715|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939716|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44939717|NCT05431322|Analgesics|analgesics|mesh-ancestor
44939718|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
44939719|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939720|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44939721|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44939722|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939723|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939724|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939725|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939726|NCT05427669|Leucovorin|leucovorin|mesh-list
44939727|NCT05427669|Fluorouracil|fluorouracil|mesh-list
44939728|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
44939729|NCT05427669|Irinotecan|irinotecan|mesh-list
44939730|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
44939731|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
44939732|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939733|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939734|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939735|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939736|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
44939737|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939738|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44939739|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939740|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939741|NCT05427669|Antidotes|antidotes|mesh-ancestor
44939742|NCT05427669|Protective Agents|protective agents|mesh-ancestor
44939743|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
44939744|NCT05427669|Vitamins|vitamins|mesh-ancestor
44939745|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
44470862|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470863|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470864|NCT01397201|Fluticasone|fluticasone|mesh-list
44470865|NCT01397201|Xhance|xhance|mesh-list
44470868|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
44939746|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
44939747|NCT05355051|Azacitidine|azacitidine|mesh-list
44939748|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939749|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939750|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939751|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
44939752|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939753|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939754|NCT05325632|Paclitaxel|paclitaxel|mesh-list
44939755|NCT05325632|Trastuzumab|trastuzumab|mesh-list
44939756|NCT05325632|Pertuzumab|pertuzumab|mesh-list
44939757|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44939758|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939759|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
44939760|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
44939761|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
44939762|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939763|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939764|NCT05307874|Aldesleukin|aldesleukin|mesh-list
44939765|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939766|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44939767|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44939768|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
44939769|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939770|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
44939771|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44939772|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939773|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939774|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44939775|NCT05305248|Analgesics|analgesics|mesh-ancestor
44939776|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
44939777|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939778|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44939779|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44939780|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44939781|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939782|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939783|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939784|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
44939785|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44939786|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939787|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
43622484|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
43622486|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
43622487|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
43622501|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
44939788|NCT05169944|Magrolimab|magrolimab|mesh-list
44939789|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939790|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939791|NCT05153668|Everolimus|everolimus|mesh-list
44939792|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939793|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939794|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
44939795|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939796|NCT05040217|Mitogens|mitogens|mesh-list
44939797|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44939798|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939799|NCT05013216|Poly ICLC|poly iclc|mesh-list
44939800|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
44939801|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
44939802|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939803|NCT04914234|Metoprolol|metoprolol|mesh-list
44939804|NCT04914234|Atenolol|atenolol|mesh-list
44939805|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44939806|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44939807|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
44939808|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
44939809|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939810|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939811|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44939812|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44939813|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44939814|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44939815|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939816|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939817|NCT04901494|Serotonin|serotonin|mesh-list
44939818|NCT04901494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44939819|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44939820|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
44939821|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939822|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939823|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939824|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44939825|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939826|NCT04895748|Everolimus|everolimus|mesh-list
44939827|NCT04895748|Spartalizumab|spartalizumab|mesh-list
44939828|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939829|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939830|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
44939831|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939832|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44939833|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939834|NCT04862780|Osimertinib|osimertinib|mesh-list
44939835|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939836|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44939837|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939838|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939839|NCT04801849|Vitamin E|vitamin e|mesh-list
44939840|NCT04801849|Tocopherols|tocopherols|mesh-list
44939841|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
44939842|NCT04801849|Vitamins|vitamins|mesh-ancestor
44939843|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
44939844|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939845|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
44939846|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939847|NCT04801849|Protective Agents|protective agents|mesh-ancestor
44939848|NCT04800367|Denosumab|denosumab|mesh-list
44939849|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44939850|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939851|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
44939852|NCT04789096|Trastuzumab|trastuzumab|mesh-list
44939853|NCT04789096|Capecitabine|capecitabine|mesh-list
44939854|NCT04789096|Tucatinib|tucatinib|mesh-list
44939855|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939856|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939857|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939858|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
44939859|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939860|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44939861|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939862|NCT04781972|Methylphenidate|methylphenidate|mesh-list
44939863|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44939864|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939865|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44939866|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44939867|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939868|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939869|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
44939870|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939871|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
44939872|NCT04757337|Doxorubicin|doxorubicin|mesh-list
44939873|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939874|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
44939875|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939876|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939877|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44939878|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
44939879|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939880|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939881|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44939882|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44939883|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44939884|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44939885|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939886|NCT04752163|Leucovorin|leucovorin|mesh-list
44939887|NCT04752163|Cytarabine|cytarabine|mesh-list
44939888|NCT04752163|Voriconazole|voriconazole|mesh-list
44939889|NCT04752163|Posaconazole|posaconazole|mesh-list
44939890|NCT04752163|Dexamethasone|dexamethasone|mesh-list
44939891|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
44939892|NCT04752163|Prednisone|prednisone|mesh-list
44939893|NCT04752163|Cortisone|cortisone|mesh-list
44939894|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
44939895|NCT04752163|Rituximab|rituximab|mesh-list
44939896|NCT04752163|Methotrexate|methotrexate|mesh-list
44470948|NCT01396148|Sunitinib|sunitinib|mesh-list
44939897|NCT04752163|Vincristine|vincristine|mesh-list
44939898|NCT04752163|Azacitidine|azacitidine|mesh-list
44939899|NCT04752163|Venetoclax|venetoclax|mesh-list
44939900|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44939901|NCT04752163|Antibodies|antibodies|mesh-list
44939902|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
44939903|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44939904|NCT04752163|Lenograstim|lenograstim|mesh-list
44939905|NCT04752163|BB 1101|bb 1101|mesh-list
44939906|NCT04752163|Mesna|mesna|mesh-list
44939907|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44939908|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
44939909|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939910|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44939911|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44939912|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
44939913|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939914|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939915|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44939916|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44939917|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
44939918|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
44939919|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44939920|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44939921|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
44939922|NCT04752163|Hormones|hormones|mesh-ancestor
44939923|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44939924|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44939925|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
44939926|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939927|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44939928|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
44939929|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44939930|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44939931|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
44939932|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
44939933|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44939934|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44939935|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
44939936|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939937|NCT04752163|Antidotes|antidotes|mesh-ancestor
44939938|NCT04752163|Protective Agents|protective agents|mesh-ancestor
44939939|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
44939940|NCT04752163|Vitamins|vitamins|mesh-ancestor
44939941|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
44939942|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44939943|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44939944|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44939945|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44939946|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44939947|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
44939948|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44939949|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44939950|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44939951|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
44939952|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44939953|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44939954|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44939955|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44939956|NCT04673877|Vancomycin|vancomycin|mesh-list
44939957|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44939958|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939959|NCT04647500|Methylphenidate|methylphenidate|mesh-list
44939960|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44939961|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939962|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44939963|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44939964|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44939965|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939966|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
44939967|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44939968|NCT04635423|Vaccines|vaccines|mesh-list
44939969|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
44939970|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939971|NCT04584684|Ethanol|ethanol|mesh-list
44939972|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44939973|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
44939974|NCT04584684|Povidone|povidone|mesh-list
44939975|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44939976|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44939977|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44939978|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44939979|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
44939980|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
44939981|NCT04543409|Benralizumab|benralizumab|mesh-list
44939982|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44939983|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44939984|NCT04526691|Cisplatin|cisplatin|mesh-list
44939985|NCT04526691|Carboplatin|carboplatin|mesh-list
44939986|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
44939987|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44939988|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44939989|NCT04502589|Disulfiram|disulfiram|mesh-list
44939990|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44939991|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44939992|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44939993|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939994|NCT04485039|Sevelamer|sevelamer|mesh-list
44939995|NCT04485039|Calcium acetate|calcium acetate|mesh-list
44939996|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
44939997|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
44939998|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44939999|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44940000|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
44940001|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940002|NCT04473716|Paclitaxel|paclitaxel|mesh-list
44940003|NCT04473716|Cisplatin|cisplatin|mesh-list
44940004|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44940005|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940006|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44940007|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44940008|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44940009|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940010|NCT04472494|Abatacept|abatacept|mesh-list
44940011|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44940012|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940013|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940014|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940015|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
44940016|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940017|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940018|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
44940019|NCT04428333|Fluorouracil|fluorouracil|mesh-list
44940020|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940021|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940022|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
44940023|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940024|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940025|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940026|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
44940027|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940028|NCT04343872|Metformin|metformin|mesh-list
44940029|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44940030|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940031|NCT04303390|Cefazolin|cefazolin|mesh-list
44940032|NCT04303390|Cefuroxime|cefuroxime|mesh-list
44940033|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
44940034|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940035|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940036|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44940037|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940038|NCT04229095|Suvorexant|suvorexant|mesh-list
44940039|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44940040|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44940041|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940042|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940043|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44940044|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940045|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940046|NCT04218708|Nicotine|nicotine|mesh-list
44940047|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44940048|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
44940049|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940050|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940051|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44940052|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44940053|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
44940054|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940055|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940056|NCT04170946|Talazoparib|talazoparib|mesh-list
44940057|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44940058|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940059|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940060|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940061|NCT04079881|Insulin|insulin|mesh-list
44940062|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44940063|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44940064|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940065|NCT03999710|Durvalumab|durvalumab|mesh-list
44940066|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940067|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940068|NCT03953807|Dexamethasone|dexamethasone|mesh-list
44940069|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940070|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
44940071|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
44940072|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940073|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940074|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940075|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
44940076|NCT03953807|Hormones|hormones|mesh-ancestor
44940077|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940078|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940079|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940080|NCT03946527|Lanreotide|lanreotide|mesh-list
44940081|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940082|NCT03897673|Iron|iron|mesh-list
44940083|NCT03897673|Trace Elements|trace elements|mesh-ancestor
44940084|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
44940085|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940086|NCT03847896|Budesonide|budesonide|mesh-list
44940087|NCT03847896|Albuterol|albuterol|mesh-list
44940088|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940089|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44940090|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
44940091|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940092|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940093|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44940094|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
44940095|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
44940096|NCT03847896|Hormones|hormones|mesh-ancestor
44940097|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940098|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
44940099|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44940100|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44236602|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940101|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44940102|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44940103|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
44940104|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940105|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940106|NCT03784326|Fluorouracil|fluorouracil|mesh-list
44940107|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
44940108|NCT03784326|Atezolizumab|atezolizumab|mesh-list
44940109|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44940110|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
44940111|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940112|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940113|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940114|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940115|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
44940116|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940117|NCT03764137|Panitumumab|panitumumab|mesh-list
44940118|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940119|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940120|NCT03697720|Naproxen|naproxen|mesh-list
44940121|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44940122|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44940123|NCT03697720|Analgesics|analgesics|mesh-ancestor
44940124|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
44940125|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940126|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940127|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940128|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940129|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
44940130|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44940131|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940132|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940134|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44940135|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940136|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44940137|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940138|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940139|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44940140|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44940141|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
44940142|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940143|NCT03649659|Fluorides|fluorides|mesh-list
44940144|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
44940145|NCT03649659|Protective Agents|protective agents|mesh-ancestor
44940146|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940147|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
44940148|NCT03579771|Gemcitabine|gemcitabine|mesh-list
44940149|NCT03579771|Paclitaxel|paclitaxel|mesh-list
44940150|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44940151|NCT03579771|Cisplatin|cisplatin|mesh-list
44940152|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44940153|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940154|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44940155|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44940156|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44940157|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940158|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940159|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
44940160|NCT03579771|Antiviral Agents|antiviral agents|mesh-ancestor
44940161|NCT03579771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940162|NCT03579771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940163|NCT03579771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940164|NCT03579771|Immunologic Factors|immunologic factors|mesh-ancestor
44940165|NCT03579771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940166|NCT03559049|Carboplatin|carboplatin|mesh-list
44940167|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
44940168|NCT03559049|Pemetrexed|pemetrexed|mesh-list
44940169|NCT03559049|Rucaparib|rucaparib|mesh-list
44940170|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940171|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940172|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940173|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940174|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44940175|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44940176|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44940177|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
44940178|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
44940179|NCT03477500|Cladribine|cladribine|mesh-list
44940180|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
44940181|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940182|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
44940183|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940184|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940185|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44940186|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
44940187|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940188|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940189|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44940190|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940191|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44940192|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44940193|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940194|NCT03411031|Thalidomide|thalidomide|mesh-list
44940195|NCT03411031|Dexamethasone|dexamethasone|mesh-list
44940196|NCT03411031|Lenalidomide|lenalidomide|mesh-list
44940197|NCT03411031|Elotuzumab|elotuzumab|mesh-list
44940198|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940199|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
44940200|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
44940201|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940202|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940203|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940204|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
44940205|NCT03411031|Hormones|hormones|mesh-ancestor
44940206|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940207|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940208|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940209|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
44940210|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44940211|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44940212|NCT03411031|Growth Substances|growth substances|mesh-ancestor
44940213|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44940214|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940215|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
44940216|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940217|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940218|NCT03382301|Cyclosporine|cyclosporine|mesh-list
44940219|NCT03382301|Cyclosporins|cyclosporins|mesh-list
44940220|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940221|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940222|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940223|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
44475188|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44475189|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44475190|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44475191|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
44475192|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44475193|NCT04198662|Epinephrine|epinephrine|mesh-list
44475194|NCT04198662|Ropivacaine|ropivacaine|mesh-list
44475195|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475196|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
44475197|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940224|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940225|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
44940226|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940227|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940228|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940229|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44940230|NCT03338790|Prednisone|prednisone|mesh-list
44940231|NCT03338790|Docetaxel|docetaxel|mesh-list
44940232|NCT03338790|Nivolumab|nivolumab|mesh-list
44940233|NCT03338790|Rucaparib|rucaparib|mesh-list
44940234|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940235|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44940236|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44940237|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44940238|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940239|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940240|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
44940241|NCT03338790|Hormones|hormones|mesh-ancestor
44940242|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940243|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940244|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940245|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940246|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44940247|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44940248|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940249|NCT03304080|Trastuzumab|trastuzumab|mesh-list
44940250|NCT03304080|Pertuzumab|pertuzumab|mesh-list
44940251|NCT03304080|Palbociclib|palbociclib|mesh-list
44940252|NCT03304080|Anastrozole|anastrozole|mesh-list
44940253|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940254|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940255|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940256|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940257|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940258|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940259|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44940260|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44940261|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44940262|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44940263|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940264|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940265|NCT03287375|Cisplatin|cisplatin|mesh-list
44940266|NCT03287375|Doxorubicin|doxorubicin|mesh-list
44940267|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
44475198|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475199|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
44475200|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475201|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44475202|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44475203|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
44475204|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475205|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475206|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44475207|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44475208|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
44475209|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44940268|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940269|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44940270|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44940271|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940272|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940273|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940274|NCT03282981|Timolol|timolol|mesh-list
44940275|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44940276|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44940277|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
44940278|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940279|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940280|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940281|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44940283|NCT03260504|Aldesleukin|aldesleukin|mesh-list
44940284|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
44940285|NCT03260504|Interleukin-2|interleukin-2|mesh-list
44940286|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
44940287|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
44940288|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940289|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940290|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
44940291|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940292|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44940293|NCT03260504|Analgesics|analgesics|mesh-ancestor
44940294|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
44940295|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940296|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44940297|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44940298|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
44940299|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940300|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
44940302|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940303|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940304|NCT03221309|Analgesics|analgesics|mesh-ancestor
44940305|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
44940306|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940307|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
44940308|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
44940309|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44940310|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44940311|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940312|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940313|NCT03142568|Urological Agents|urological agents|mesh-ancestor
44940314|NCT03113968|Ketamine|ketamine|mesh-list
44940315|NCT03113968|Analgesics|analgesics|mesh-ancestor
44940316|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
44940317|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940318|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940319|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44940320|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44940321|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
44940322|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
44940323|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940324|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44940325|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44940326|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940327|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940328|NCT03106987|Olaparib|olaparib|mesh-list
44940329|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44940330|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940331|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940332|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940333|NCT03034356|Levetiracetam|levetiracetam|mesh-list
44940334|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
44940335|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
44940336|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
44940337|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940338|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940339|NCT02960230|Nivolumab|nivolumab|mesh-list
44940340|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940341|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940342|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44940343|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940344|NCT02864992|Tepotinib|tepotinib|mesh-list
44940345|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940346|NCT02861417|Vidarabine|vidarabine|mesh-list
44940347|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
44940348|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
44940349|NCT02861417|Busulfan|busulfan|mesh-list
44940350|NCT02861417|Thiotepa|thiotepa|mesh-list
44940351|NCT02861417|Fludarabine|fludarabine|mesh-list
44940352|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
44940353|NCT02861417|Tacrolimus|tacrolimus|mesh-list
44940354|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940355|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
44940356|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940357|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940358|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44940359|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
44940360|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940361|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940362|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44940363|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940364|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
44940365|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
44940366|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940367|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44940368|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940369|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44940370|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44940371|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
44940372|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940373|NCT02736227|Everolimus|everolimus|mesh-list
44940374|NCT02736227|Tacrolimus|tacrolimus|mesh-list
44471548|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44940375|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940376|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
44940377|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940378|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44940379|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940380|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940381|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940382|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44940383|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44940384|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940385|NCT02499328|Durvalumab|durvalumab|mesh-list
44940386|NCT02499328|Tremelimumab|tremelimumab|mesh-list
44940387|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940388|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940389|NCT00688870|Vaccines|vaccines|mesh-list
44940390|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44940391|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
44940392|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940393|NCT00574496|Gemcitabine|gemcitabine|mesh-list
44940394|NCT00574496|Cyclosporine|cyclosporine|mesh-list
44940395|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
44940396|NCT00574496|Prednisone|prednisone|mesh-list
44940397|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
44940398|NCT00574496|Melphalan|melphalan|mesh-list
44940399|NCT00574496|Ifosfamide|ifosfamide|mesh-list
44940400|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
44940401|NCT00574496|Methotrexate|methotrexate|mesh-list
44940402|NCT00574496|Fludarabine|fludarabine|mesh-list
44940403|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
44940404|NCT00574496|Vincristine|vincristine|mesh-list
44940405|NCT00574496|Vinorelbine|vinorelbine|mesh-list
44940406|NCT00574496|Procarbazine|procarbazine|mesh-list
44940407|NCT00574496|Cyclosporins|cyclosporins|mesh-list
44940408|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940409|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
44940410|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940411|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940412|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44940413|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
44940414|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940415|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940416|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44940417|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940418|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
44940419|NCT00574496|Antiviral Agents|antiviral agents|mesh-ancestor
44940420|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940421|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940422|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940423|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
44940424|NCT00574496|Hormones|hormones|mesh-ancestor
44940425|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940426|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940427|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44940428|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
44940429|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44940430|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940431|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44940432|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44940433|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44940434|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44940435|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44940436|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44940437|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
44940438|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44940439|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44940440|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44940441|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
44940442|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940443|NCT02015351|Bevacizumab|bevacizumab|mesh-list
44940444|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940445|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940446|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44940447|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44940448|NCT02015351|Growth Substances|growth substances|mesh-ancestor
44940449|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940450|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44940451|NCT02013167|Blinatumomab|blinatumomab|mesh-list
44940452|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940453|NCT01996436|Verapamil|verapamil|mesh-list
44940454|NCT01996436|Nicardipine|nicardipine|mesh-list
44940455|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
44940456|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
44940457|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44940458|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44940459|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44940460|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940461|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44940462|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940463|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44940464|NCT01957332|Trastuzumab|trastuzumab|mesh-list
44940465|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940466|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940467|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
44940468|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940469|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940470|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940471|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940472|NCT01765140|Amifampridine|amifampridine|mesh-list
44940473|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44940474|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940475|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940476|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44940477|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44940478|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940479|NCT01761890|Dasatinib|dasatinib|mesh-list
44940480|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940481|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940482|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940483|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940484|NCT01556776|Lenalidomide|lenalidomide|mesh-list
44940485|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
44940486|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940487|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44940488|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44940489|NCT01556776|Growth Substances|growth substances|mesh-ancestor
44940490|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
44940491|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940492|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
44940493|NCT01186640|Fludarabine|fludarabine|mesh-list
44940494|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
44940495|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
44940496|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
44940497|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940498|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
44940499|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940500|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940501|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44940502|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
44940503|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940504|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940505|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44940506|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44940507|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
44940508|NCT01186640|Analgesics|analgesics|mesh-ancestor
44940509|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
44940510|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940511|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44940512|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940513|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940514|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940515|NCT00688376|Donepezil|donepezil|mesh-list
44940516|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44940517|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940518|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940519|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
44940520|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940521|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940522|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
44940523|NCT00492349|Varenicline|varenicline|mesh-list
44940524|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44471670|NCT01387607|Pregabalin|pregabalin|mesh-list
44940525|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44940526|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
44940527|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940528|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940529|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940530|NCT05181852|Pregabalin|pregabalin|mesh-list
44940531|NCT05181852|Analgesics|analgesics|mesh-ancestor
44940532|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
44940533|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940534|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940535|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
44940536|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44940537|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44940538|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940539|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44940540|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44940541|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44940542|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940543|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44940544|NCT05181592|Luspatercept|luspatercept|mesh-list
44940545|NCT05181592|Hematinics|hematinics|mesh-ancestor
44940546|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44940547|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44940548|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44940549|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44940550|NCT05181150|Glucagon|glucagon|mesh-list
44940551|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44940552|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940553|NCT05181150|Hormones|hormones|mesh-ancestor
44940554|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940555|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940556|NCT05181150|Incretins|incretins|mesh-ancestor
44471738|NCT01386970|Lamivudine|lamivudine|mesh-list
44940558|NCT05181033|Fulvestrant|fulvestrant|mesh-list
44940559|NCT05181033|Lenvatinib|lenvatinib|mesh-list
44940560|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940561|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44940562|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44940563|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940564|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940565|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44940566|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
44940567|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940568|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940569|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940570|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44940571|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940572|NCT05180461|Ivermectin|ivermectin|mesh-list
44940573|NCT05180461|Emodepside|emodepside|mesh-list
44940574|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44940575|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940576|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
44940577|NCT05156814|Progestins|progestins|mesh-ancestor
44940578|NCT05156814|Hormones|hormones|mesh-ancestor
44940579|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940580|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940581|NCT05152017|Vaccines|vaccines|mesh-list
44940582|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
44940583|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940584|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
44940585|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44940586|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
44940587|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940588|NCT05142735|Expectorants|expectorants|mesh-ancestor
44940589|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
44940590|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44940591|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
44940592|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940593|NCT05142735|Protective Agents|protective agents|mesh-ancestor
44940594|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940595|NCT05142735|Antidotes|antidotes|mesh-ancestor
44940596|NCT05135312|Etanercept|etanercept|mesh-list
44940597|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44940598|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44940599|NCT05135312|Analgesics|analgesics|mesh-ancestor
44940600|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
44940601|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940602|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940603|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940604|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940605|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940606|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940607|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
44940608|NCT05089123|Vaccines|vaccines|mesh-list
44940609|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
44940610|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940611|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44940612|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
44940613|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
44940614|NCT05064332|Estradiol|estradiol|mesh-list
44940615|NCT05064332|Estrogens|estrogens|mesh-ancestor
44940616|NCT05064332|Hormones|hormones|mesh-ancestor
44940617|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940618|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940619|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44940620|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44940621|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44940622|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44940623|NCT05034029|Metformin|metformin|mesh-list
44940624|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44940625|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940626|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
44940627|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940628|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940629|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44940630|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940631|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940632|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940633|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940634|NCT04936984|Abaloparatide|abaloparatide|mesh-list
44940635|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44940636|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44940637|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940638|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44940639|NCT04855526|Dronabinol|dronabinol|mesh-list
44940640|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
44940641|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940642|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44940643|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44940644|NCT04855526|Analgesics|analgesics|mesh-ancestor
44940645|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
44940646|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940647|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44940648|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44940649|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940650|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940651|NCT04855526|Hormones|hormones|mesh-ancestor
44940652|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940653|NCT04812951|Cyclosporine|cyclosporine|mesh-list
44940654|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44940655|NCT04812951|Cyclosporins|cyclosporins|mesh-list
44940656|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940657|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940658|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940659|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
44940660|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940661|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
44940662|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940663|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940664|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940665|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44940666|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44940667|NCT04696146|Complement C1s|complement c1s|mesh-list
44940668|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44940669|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44940670|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
44940671|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940672|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44940673|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940674|NCT04663464|Abaloparatide|abaloparatide|mesh-list
44940675|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44940676|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44940677|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940678|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44940679|NCT04639466|Vaccines|vaccines|mesh-list
44940680|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
44940681|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940682|NCT04624945|Thromboplastin|thromboplastin|mesh-list
44940683|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
44940684|NCT04624945|Coagulants|coagulants|mesh-ancestor
44940685|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
44940686|NCT04540380|Rituximab|rituximab|mesh-list
44940687|NCT04540380|Fludarabine|fludarabine|mesh-list
44940688|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940689|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
44940690|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940691|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940692|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44940693|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
44940694|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940695|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940696|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44940697|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44940698|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44940699|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44940700|NCT04499131|Progesterone|progesterone|mesh-list
44940701|NCT04499131|Progestins|progestins|mesh-ancestor
44940702|NCT04499131|Hormones|hormones|mesh-ancestor
44940703|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940704|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940705|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44940706|NCT04469595|Aflibercept|aflibercept|mesh-list
44471885|NCT01383954|Analgesics|analgesics|mesh-ancestor
44940707|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44940708|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44940709|NCT04469595|Growth Substances|growth substances|mesh-ancestor
44940710|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940711|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44940712|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940713|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940714|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
44940715|NCT04469595|Hormones|hormones|mesh-ancestor
44940716|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940717|NCT04454424|Midazolam|midazolam|mesh-list
44940718|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44940719|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44940720|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940721|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940722|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44940723|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44940724|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44940725|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44940726|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
44940727|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
44940728|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
44940729|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
44940730|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940731|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940732|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
44940733|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44940734|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
44940735|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940736|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940737|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44940738|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
44940739|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44940740|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
44940741|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940742|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940743|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44940744|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
44940745|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
44940746|NCT04338828|Protective Agents|protective agents|mesh-ancestor
44940747|NCT04217135|Hydralazine|hydralazine|mesh-list
44940748|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44940749|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
44940750|NCT04178603|Insulin|insulin|mesh-list
44940751|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44940752|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940753|NCT04170972|Insulin|insulin|mesh-list
44940754|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44940755|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940756|NCT04133623|Ibuprofen|ibuprofen|mesh-list
44940757|NCT04133623|Ketorolac|ketorolac|mesh-list
44940758|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44940759|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44940760|NCT04133623|Analgesics|analgesics|mesh-ancestor
44940761|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
44940762|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475222|NCT04194775|Lenvatinib|lenvatinib|mesh-list
44940763|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940764|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940765|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44940766|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44940767|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940768|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940769|NCT04064411|Abaloparatide|abaloparatide|mesh-list
44940770|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44940771|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44940772|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940773|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44940774|NCT03907826|Antibodies|antibodies|mesh-list
44940775|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
44940776|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
44940777|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940778|NCT03727971|Omalizumab|omalizumab|mesh-list
44940779|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44940780|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44940781|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
44940782|NCT03386214|Pevonedistat|pevonedistat|mesh-list
44940783|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940784|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940785|NCT03369665|Cladribine|cladribine|mesh-list
44940786|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940787|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44940788|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
44940789|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940790|NCT03220178|Letrozole|letrozole|mesh-list
44940791|NCT03220178|Fulvestrant|fulvestrant|mesh-list
44940792|NCT03220178|Palbociclib|palbociclib|mesh-list
44940793|NCT03220178|Anastrozole|anastrozole|mesh-list
44940794|NCT03220178|Exemestane|exemestane|mesh-list
44940795|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940796|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44940797|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44940798|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940799|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940800|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44940801|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
44940802|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940803|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940804|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940805|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44940806|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940807|NCT03032510|Levofloxacin|levofloxacin|mesh-list
44940808|NCT03032510|Ofloxacin|ofloxacin|mesh-list
44940809|NCT03032510|Ertapenem|ertapenem|mesh-list
44940810|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44940811|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940812|NCT03032510|Renal Agents|renal agents|mesh-ancestor
44940813|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940814|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44940815|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940816|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940817|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940818|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940819|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44940820|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44940821|NCT03022292|Aflibercept|aflibercept|mesh-list
44940822|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44940823|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44940824|NCT03022292|Growth Substances|growth substances|mesh-ancestor
44940825|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940826|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
44940827|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940828|NCT02968602|Minocycline|minocycline|mesh-list
44940829|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940830|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940831|NCT02946047|Ixazomib|ixazomib|mesh-list
44940832|NCT02946047|Glycine|glycine|mesh-list
44940833|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940834|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44940835|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940836|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940837|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
44940838|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940839|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940840|NCT02832648|Selenium|selenium|mesh-list
44940841|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
44940842|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940843|NCT02832648|Protective Agents|protective agents|mesh-ancestor
44940844|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940845|NCT02832648|Trace Elements|trace elements|mesh-ancestor
44940846|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
44940847|NCT02784704|Meropenem|meropenem|mesh-list
44940848|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940849|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940850|NCT05224895|Anesthetics|anesthetics|mesh-list
44940851|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940852|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940853|NCT05186623|Ustekinumab|ustekinumab|mesh-list
44940854|NCT05186623|Vedolizumab|vedolizumab|mesh-list
44940855|NCT05186623|Tofacitinib|tofacitinib|mesh-list
44940856|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940857|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44940858|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940859|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940860|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940861|NCT05118724|Atezolizumab|atezolizumab|mesh-list
44940862|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940863|NCT05099666|Doxorubicin|doxorubicin|mesh-list
44940864|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44940865|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940866|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44940867|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940868|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940869|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940870|NCT05095064|Irinotecan|irinotecan|mesh-list
44940871|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44940872|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44940873|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940874|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940875|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940876|NCT04984083|Vitamin K|vitamin k|mesh-list
44940877|NCT04984083|Vitamins|vitamins|mesh-ancestor
44940878|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
44940879|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940880|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44940881|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44940882|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940883|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
44940884|NCT04984083|Coagulants|coagulants|mesh-ancestor
44940885|NCT04976777|Dexamethasone|dexamethasone|mesh-list
44940886|NCT04976777|Dexamethasone acetate|dexamethasone acetate|mesh-list
44940887|NCT04976777|BB 1101|bb 1101|mesh-list
44940888|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44940889|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
44940890|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
44940891|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940892|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940893|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940894|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
44940895|NCT04976777|Hormones|hormones|mesh-ancestor
44940896|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44940897|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44940898|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940899|NCT04976777|Protease Inhibitors|protease inhibitors|mesh-ancestor
44940900|NCT04976777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940901|NCT04976777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940902|NCT04971954|Nicotine|nicotine|mesh-list
44940903|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44940904|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
44940905|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940906|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940907|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44940908|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44940909|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
44940910|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44940911|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940912|NCT04959006|Antioxidants|antioxidants|mesh-list
44940913|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940914|NCT04959006|Protective Agents|protective agents|mesh-ancestor
44940915|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940916|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44940917|NCT04851522|Eusol|eusol|mesh-list
44940918|NCT04851522|Petrolatum|petrolatum|mesh-list
44940919|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
44940920|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940921|NCT04851522|Emollients|emollients|mesh-ancestor
44940922|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940923|NCT04788017|Ziresovir|ziresovir|mesh-list
44940924|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
44940925|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940926|NCT04724447|Valganciclovir|valganciclovir|mesh-list
44940927|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
44940928|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940929|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
44940930|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44940931|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44940932|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940933|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
44940934|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
44940935|NCT04710732|Enoxaparin|enoxaparin|mesh-list
44940936|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
44940937|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
44940938|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44940939|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44940940|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940941|NCT04671875|Antibodies|antibodies|mesh-list
44940942|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44940943|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
44940944|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940945|NCT05442008|Erenumab|erenumab|mesh-list
44940946|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44940947|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940948|NCT05442008|Analgesics|analgesics|mesh-ancestor
44940949|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
44940950|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44940951|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940952|NCT05441410|Artesunate|artesunate|mesh-list
44940953|NCT05441410|Pyronaridine|pyronaridine|mesh-list
44940954|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
44940955|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44940956|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44940957|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940958|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940959|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
44940960|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
44940961|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44940962|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
44940963|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44940964|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44940965|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940966|NCT05431075|Amoxicillin|amoxicillin|mesh-list
44940967|NCT05431075|Tetracycline|tetracycline|mesh-list
44940968|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
44940969|NCT05431075|Esomeprazole|esomeprazole|mesh-list
44940970|NCT05431075|Bismuth|bismuth|mesh-list
44940971|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940972|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44940973|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44940974|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44940975|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44940976|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44940977|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44940978|NCT05431075|Antacids|antacids|mesh-ancestor
44940979|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44940980|NCT05431075|Diuretics|diuretics|mesh-ancestor
44940981|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
44940982|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44940983|NCT05431075|Expectorants|expectorants|mesh-ancestor
44940984|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
44940985|NCT05420467|Paclitaxel|paclitaxel|mesh-list
44940986|NCT05420467|Docetaxel|docetaxel|mesh-list
44940987|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44940988|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
44940989|NCT05420467|Carboplatin|carboplatin|mesh-list
44940990|NCT05420467|Trastuzumab|trastuzumab|mesh-list
44940991|NCT05420467|Epirubicin|epirubicin|mesh-list
44940992|NCT05420467|Pertuzumab|pertuzumab|mesh-list
44940993|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44940994|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44940995|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
44940996|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
44940997|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
44940998|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44940999|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941000|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
44941001|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941002|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941003|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941004|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
44941005|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44941006|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941007|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44941008|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44941009|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44941010|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941011|NCT05420454|Paclitaxel|paclitaxel|mesh-list
44941012|NCT05420454|Docetaxel|docetaxel|mesh-list
44941013|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44941014|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
44941015|NCT05420454|Carboplatin|carboplatin|mesh-list
44941016|NCT05420454|Trastuzumab|trastuzumab|mesh-list
44941017|NCT05420454|Epirubicin|epirubicin|mesh-list
44941018|NCT05420454|Pertuzumab|pertuzumab|mesh-list
44941019|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44941020|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941021|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
44941022|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
44941023|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
44941024|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941025|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941026|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
44941027|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941028|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941029|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941030|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
44941031|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44941032|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941033|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44941034|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44941035|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44941036|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941037|NCT05406102|Propofol|propofol|mesh-list
44941038|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44941039|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941040|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472325|NCT05366192|Ritonavir|ritonavir|mesh-list
44941041|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44941042|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
44941043|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
44941044|NCT05375097|Erenumab|erenumab|mesh-list
44941045|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44475256|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
44475257|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44475258|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475259|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
44475260|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
44475261|NCT04198428|Narcotics|narcotics|mesh-ancestor
44475262|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475263|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475264|NCT04198428|Analgesics|analgesics|mesh-ancestor
44475265|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
44475266|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475267|NCT04191382|Letrozole|letrozole|mesh-list
44163560|NCT00253305|Naftifine|naftifine|mesh-list
43622897|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
43622898|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622899|NCT03105180|Cathartics|cathartics|mesh-ancestor
43622900|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622901|NCT03105115|Fentanyl|fentanyl|mesh-list
43622902|NCT03105115|Bupivacaine|bupivacaine|mesh-list
43622903|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
44941046|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941047|NCT05375097|Analgesics|analgesics|mesh-ancestor
44941048|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
44941049|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941050|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941051|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44941052|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44941053|NCT05353829|Methotrexate|methotrexate|mesh-list
44941054|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44941055|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
44941056|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44941057|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941058|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941059|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
44941060|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941061|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941062|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941063|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941064|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44941065|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941066|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
44941067|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941068|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44941069|NCT05352321|Gemcitabine|gemcitabine|mesh-list
44941070|NCT05352321|Cisplatin|cisplatin|mesh-list
44941071|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941072|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941073|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
44941074|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941075|NCT05352321|Antiviral Agents|antiviral agents|mesh-ancestor
44941076|NCT05352321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941077|NCT05352321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941078|NCT05352321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941079|NCT05352321|Immunologic Factors|immunologic factors|mesh-ancestor
44941080|NCT05352321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941081|NCT05303727|Cyclosporine|cyclosporine|mesh-list
44941082|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
44941083|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
44941084|NCT05303727|Melphalan|melphalan|mesh-list
44941085|NCT05303727|Busulfan|busulfan|mesh-list
44941086|NCT05303727|Thiotepa|thiotepa|mesh-list
44941087|NCT05303727|Methotrexate|methotrexate|mesh-list
44941088|NCT05303727|Fludarabine|fludarabine|mesh-list
44941089|NCT05303727|Topotecan|topotecan|mesh-list
44941090|NCT05303727|Tacrolimus|tacrolimus|mesh-list
44941091|NCT05303727|Cyclosporins|cyclosporins|mesh-list
44941092|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44941093|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941094|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
44941095|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941096|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941097|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941098|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
44941099|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941100|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941101|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44941102|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44941103|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
44941104|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44941105|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941106|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
44941107|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941108|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941109|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44941110|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44941111|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44941112|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
44941113|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941114|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44941115|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44475268|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475269|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44475277|NCT04194528|Acetaminophen|acetaminophen|mesh-list
44941116|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
44472385|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44941117|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44941118|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44941119|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44941120|NCT05263921|Ritonavir|ritonavir|mesh-list
44941121|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44941122|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44941123|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
44941124|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941125|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941126|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44941127|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44941128|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
44941129|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941130|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44941131|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44941132|NCT05224089|Dexamethasone|dexamethasone|mesh-list
44941133|NCT05224089|Epinephrine|epinephrine|mesh-list
44941134|NCT05224089|Bupivacaine|bupivacaine|mesh-list
44941135|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941136|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
44941137|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
44941138|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941139|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941140|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941141|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
44941142|NCT05224089|Hormones|hormones|mesh-ancestor
44941143|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941144|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941145|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941146|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941147|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44941148|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
44941149|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941150|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
44941151|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44941152|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44941153|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
44941154|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941155|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44941156|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44941157|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44941158|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44941159|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
44941160|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
44941161|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44941162|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44941163|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
44941164|NCT05199324|Cefazolin|cefazolin|mesh-list
44941165|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
44941166|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44941167|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
44941168|NCT05199324|Trimethoprim|trimethoprim|mesh-list
44941169|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
44941170|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941171|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44941172|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44941173|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941174|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941175|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941176|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44941177|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44941178|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44941179|NCT05199324|Renal Agents|renal agents|mesh-ancestor
44941180|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
44941181|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44941182|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44941183|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44941184|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44941185|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44941186|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44941187|NCT05132101|Palbociclib|palbociclib|mesh-list
44941188|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941189|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941190|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941191|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941192|NCT05097326|Misoprostol|misoprostol|mesh-list
44941193|NCT05097326|Mifepristone|mifepristone|mesh-list
44941194|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44941195|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
44941196|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44941197|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941198|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44941199|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941200|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
44941201|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44941202|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44941203|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44941204|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44941205|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
44941206|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44941207|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44941208|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
44941209|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941210|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
44941211|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44475278|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44475279|NCT04194528|Oxycodone|oxycodone|mesh-list
44475280|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475281|NCT04194528|Analgesics|analgesics|mesh-ancestor
44475282|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
44475283|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475284|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475285|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
44475286|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44475287|NCT04194528|Narcotics|narcotics|mesh-ancestor
44475288|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475289|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44475290|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475291|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475292|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44475293|NCT04195100|Pilocarpine|pilocarpine|mesh-list
44941212|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44941213|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
44941214|NCT05030129|Pyridoxal|pyridoxal|mesh-list
44941215|NCT05030129|Pyridoxine|pyridoxine|mesh-list
44941216|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
44941217|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44941218|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
44941219|NCT05030129|Vitamins|vitamins|mesh-ancestor
44941220|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
44941221|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941222|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
44941223|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44941224|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
44941225|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941226|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44941227|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44941228|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
44941229|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941230|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941231|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
44941232|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
44941233|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
44941234|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
44941235|NCT05017025|Osimertinib|osimertinib|mesh-list
44941236|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941237|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941238|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941239|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941240|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
44941241|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44941242|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941243|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941244|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941245|NCT04969705|Analgesics|analgesics|mesh-ancestor
44941246|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
44941247|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941248|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44941249|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44941250|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44941251|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44941252|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941253|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941254|NCT04958486|Trastuzumab|trastuzumab|mesh-list
44941255|NCT04958486|Azacitidine|azacitidine|mesh-list
44941256|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941257|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941258|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941259|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
44941260|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941261|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941262|NCT04945616|Aspirin|aspirin|mesh-list
44941263|NCT04945616|Clopidogrel|clopidogrel|mesh-list
44941264|NCT04945616|Ticagrelor|ticagrelor|mesh-list
44941265|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44941266|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941267|NCT04945616|Analgesics|analgesics|mesh-ancestor
44472509|NCT05632328|Gemcitabine|gemcitabine|mesh-list
44941268|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
44941269|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941270|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941271|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941272|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941273|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44941274|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44941275|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941276|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44941277|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44941278|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941279|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
44941280|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44941281|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44941282|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44941283|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
44941284|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941285|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
44941286|NCT04902040|Nivolumab|nivolumab|mesh-list
44941287|NCT04902040|Durvalumab|durvalumab|mesh-list
44941288|NCT04902040|Avelumab|avelumab|mesh-list
44941289|NCT04902040|Atezolizumab|atezolizumab|mesh-list
44941290|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
44941291|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44941292|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
44941293|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941294|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941295|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44941296|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941297|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
44941298|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941299|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
44941300|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941301|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941302|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
44941303|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44941304|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44941305|NCT04874610|Prednisolone|prednisolone|mesh-list
44941306|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
44941307|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44941308|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
44941309|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941310|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
44941311|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
44941312|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941313|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941314|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941315|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
44941316|NCT04874610|Hormones|hormones|mesh-ancestor
44941317|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941318|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44941319|NCT04874610|Protective Agents|protective agents|mesh-ancestor
44941320|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941321|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941322|NCT04783857|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44941323|NCT04783857|Medroxyprogesterone|medroxyprogesterone|mesh-list
44941324|NCT04783857|Progesterone|progesterone|mesh-list
44941325|NCT04783857|Progestins|progestins|mesh-ancestor
44941326|NCT04783857|Hormones|hormones|mesh-ancestor
44941327|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941328|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941329|NCT04783857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44941330|NCT04783857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44941331|NCT04783857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44941332|NCT04783857|Contraceptive Agents|contraceptive agents|mesh-ancestor
44941333|NCT04783857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44941334|NCT04783857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44941335|NCT04783857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44941336|NCT04783857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44941337|NCT04783857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941338|NCT04783857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941339|NCT04718155|Atorvastatin|atorvastatin|mesh-list
44941340|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44941341|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44941342|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
44941343|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941344|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44941345|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44941346|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941347|NCT04715763|Telmisartan|telmisartan|mesh-list
44941348|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44941349|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44941350|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44941351|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941352|NCT04668859|Midodrine|midodrine|mesh-list
44941353|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
44941354|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
44941355|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941356|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941357|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44941358|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44941359|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44941360|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44941361|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
44941362|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941363|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941364|NCT04648969|Hormones|hormones|mesh-list
44941365|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941366|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941367|NCT04641351|Triamcinolone|triamcinolone|mesh-list
44941368|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44941369|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44941370|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44941371|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941372|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
44941373|NCT04641351|Hormones|hormones|mesh-ancestor
44941374|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941375|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941376|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941377|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
44941378|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941379|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941380|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
44941381|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
44941382|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941384|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44941385|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941386|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44941387|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44941388|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44941389|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941390|NCT04521114|Leronlimab|leronlimab|mesh-list
44941391|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44941392|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44941393|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941394|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44941395|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44941396|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
44941397|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941398|NCT04504942|Leronlimab|leronlimab|mesh-list
44941399|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44941400|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44941401|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941402|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44941403|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44941404|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
44941405|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941406|NCT04483115|Tadalafil|tadalafil|mesh-list
44941407|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44941408|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44941409|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44941410|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941411|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941412|NCT04483115|Urological Agents|urological agents|mesh-ancestor
44941413|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
44941414|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44941415|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
44941416|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941417|NCT04467281|Daratumumab|daratumumab|mesh-list
44941418|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941419|NCT04428671|Cemiplimab|cemiplimab|mesh-list
44941420|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941421|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941422|NCT04414722|Amoxicillin|amoxicillin|mesh-list
44941423|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
44941424|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
44941425|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44941426|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44941427|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941428|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44941429|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941430|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941431|NCT04377451|Metformin|metformin|mesh-list
44941432|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44941433|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941434|NCT04360551|Telmisartan|telmisartan|mesh-list
44941435|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44941436|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44941437|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44941438|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941439|NCT04354025|Cytarabine|cytarabine|mesh-list
44941440|NCT04354025|Fludarabine|fludarabine|mesh-list
44941441|NCT04354025|Interleukin-2|interleukin-2|mesh-list
44941442|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941443|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941444|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
44941445|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941446|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941447|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
44941448|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941449|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
44941450|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941451|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941452|NCT04354025|Analgesics|analgesics|mesh-ancestor
44941453|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
44941454|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941455|NCT04348383|Defibrotide|defibrotide|mesh-list
44941456|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44472751|NCT05633914|Paclitaxel|paclitaxel|mesh-list
44941457|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44941458|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941459|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44941460|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44941461|NCT04216017|Lidocaine|lidocaine|mesh-list
44941462|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
44941463|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
44941464|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941465|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941466|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
44941467|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941468|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44941469|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44941470|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44941471|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941472|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941473|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941474|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
44941475|NCT04216017|Hormones|hormones|mesh-ancestor
44941476|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941477|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941478|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
44941479|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44941480|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44941481|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941482|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941483|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44941484|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
44941485|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941486|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941487|NCT03648892|Raclopride|raclopride|mesh-list
44941488|NCT03648892|Fallypride|fallypride|mesh-list
44941489|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44941490|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44941491|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941492|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941493|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941494|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44941495|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
44941496|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941497|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941498|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44941499|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
44941500|NCT03638947|Povidone|povidone|mesh-list
44941501|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
44941502|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
44941503|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44941504|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941505|NCT03564470|Dasatinib|dasatinib|mesh-list
44941506|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941507|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941508|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941509|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941510|NCT03502681|Avelumab|avelumab|mesh-list
44941511|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941512|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941513|NCT03382977|Carmustine|carmustine|mesh-list
44941514|NCT03382977|Lomustine|lomustine|mesh-list
44941515|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941516|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
44941517|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941518|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941519|NCT03367715|Nivolumab|nivolumab|mesh-list
44941520|NCT03367715|Ipilimumab|ipilimumab|mesh-list
44941521|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941522|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941523|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44941524|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941525|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
44941526|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941527|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941528|NCT03132454|Dexamethasone|dexamethasone|mesh-list
44941529|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
44941530|NCT03132454|Sorafenib|sorafenib|mesh-list
44941531|NCT03132454|Decitabine|decitabine|mesh-list
44941532|NCT03132454|Palbociclib|palbociclib|mesh-list
44941533|NCT03132454|Ichthammol|ichthammol|mesh-list
44941534|NCT03132454|BB 1101|bb 1101|mesh-list
44941535|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941536|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
44941537|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
44941538|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941539|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941540|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941541|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
44941542|NCT03132454|Hormones|hormones|mesh-ancestor
44941543|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941544|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941545|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941546|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
44941547|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941548|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941549|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941550|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941551|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
44941552|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941553|NCT03092817|Dexamethasone|dexamethasone|mesh-list
44941554|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941555|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
44941556|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
44941557|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941558|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941559|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941560|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
44941561|NCT03092817|Hormones|hormones|mesh-ancestor
44941562|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941563|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941564|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941565|NCT03075462|Apatinib|apatinib|mesh-list
44941566|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941567|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941568|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941569|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941570|NCT02963766|Dulaglutide|dulaglutide|mesh-list
44941571|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44941572|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941573|NCT02956447|Hormones|hormones|mesh-list
44941574|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941575|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941576|NCT02820519|Loxapine|loxapine|mesh-list
44941577|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44941578|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44941579|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941580|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941581|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941582|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44941583|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
44941584|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941585|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941586|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
44941587|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941588|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941589|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941590|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941591|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44941592|NCT02725177|Hormones|hormones|mesh-ancestor
44941593|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941594|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941595|NCT02694588|Infliximab|infliximab|mesh-list
44941596|NCT02694588|Vedolizumab|vedolizumab|mesh-list
44941597|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941598|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941599|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941600|NCT02682511|Ifetroban|ifetroban|mesh-list
44941601|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44941602|NCT02343042|Clarithromycin|clarithromycin|mesh-list
44941603|NCT02343042|Dexamethasone|dexamethasone|mesh-list
44941604|NCT02343042|Lenalidomide|lenalidomide|mesh-list
44941605|NCT02343042|Bortezomib|bortezomib|mesh-list
44941606|NCT02343042|Daratumumab|daratumumab|mesh-list
44941607|NCT02343042|Pomalidomide|pomalidomide|mesh-list
44941608|NCT02343042|Ixazomib|ixazomib|mesh-list
44941609|NCT02343042|Elotuzumab|elotuzumab|mesh-list
44941610|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44941611|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
44941612|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
44941613|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941614|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941615|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44941616|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
44941617|NCT02343042|Hormones|hormones|mesh-ancestor
44941618|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941619|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44941620|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941621|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
44941622|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44941623|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44941624|NCT02343042|Growth Substances|growth substances|mesh-ancestor
44941625|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
44941626|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44941627|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941628|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44941629|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941630|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941631|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44941632|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44941633|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
44941634|NCT02317991|Paclitaxel|paclitaxel|mesh-list
44941635|NCT02317991|Ramucirumab|ramucirumab|mesh-list
44941636|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44941637|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941638|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44941639|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44941640|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44941641|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941642|NCT02260193|Glycine|glycine|mesh-list
44941643|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
44941644|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941645|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941646|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941647|NCT01952782|Naloxone|naloxone|mesh-list
44941648|NCT01952782|Hormones|hormones|mesh-list
44941649|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941650|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941651|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44941652|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
44941653|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941654|NCT01759238|Bevacizumab|bevacizumab|mesh-list
44941655|NCT01759238|Capecitabine|capecitabine|mesh-list
44941656|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941657|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941658|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44941659|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44941660|NCT01759238|Growth Substances|growth substances|mesh-ancestor
44941661|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941662|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
44941663|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941664|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
44941665|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941666|NCT01320280|Afatinib|afatinib|mesh-list
44941667|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941668|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941669|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941670|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941671|NCT01156220|Furosemide|furosemide|mesh-list
44941672|NCT01156220|Diuretics|diuretics|mesh-ancestor
44941673|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
44941674|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941675|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44941676|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941677|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472946|NCT00216736|Hormones|hormones|mesh-ancestor
44941678|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
44941679|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44941680|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44941681|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44941682|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44941683|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941684|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941685|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941686|NCT00852696|Urological Agents|urological agents|mesh-ancestor
44941687|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
44941688|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44941689|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
44941690|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44941691|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941692|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44941693|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44941694|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44941695|NCT00493961|Hormones|hormones|mesh-list
44941696|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44941697|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941698|NCT04623099|Citalopram|citalopram|mesh-list
44941699|NCT04623099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44941700|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44941701|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941702|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941703|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941704|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
44941705|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941706|NCT04623099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44941707|NCT04623099|Antidepressive Agents|antidepressive agents|mesh-ancestor
44941708|NCT04623099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941709|NCT04563247|Antibodies|antibodies|mesh-list
44941710|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
44941711|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941712|NCT04508855|Heparin|heparin|mesh-list
44941713|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44941714|NCT04508855|Tinzaparin|tinzaparin|mesh-list
44941715|NCT04508855|Dalteparin|dalteparin|mesh-list
44941716|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
44941717|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44941718|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44941719|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941720|NCT04495621|Cetuximab|cetuximab|mesh-list
44941721|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941722|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941723|NCT04463394|Vasopressins|vasopressins|mesh-list
44941724|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
44941725|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
44941726|NCT04463394|Coagulants|coagulants|mesh-ancestor
44941727|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44941728|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44941729|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
44941730|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941731|NCT04447846|Cannabidiol|cannabidiol|mesh-list
44941732|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
44941733|NCT04398329|Bupivacaine|bupivacaine|mesh-list
44941734|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44941735|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
44941736|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941737|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941738|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
44941739|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941740|NCT04371380|Rilpivirine|rilpivirine|mesh-list
44941741|NCT04371380|Cabotegravir|cabotegravir|mesh-list
44941742|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44941743|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44941744|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941745|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941746|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
44941747|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941748|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44941749|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44941750|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44941751|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44941752|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
44941753|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44941754|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941755|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941756|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941758|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
44941759|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941760|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44941761|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44941762|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44941763|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
44941764|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941765|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941766|NCT04259749|Menthol|menthol|mesh-list
44941767|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
44941768|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941769|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44941770|NCT04250636|Antibodies|antibodies|mesh-list
44941771|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
44941772|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44941773|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
44941774|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941775|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941776|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44941777|NCT04245748|Citalopram|citalopram|mesh-list
44941778|NCT04245748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44941779|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44941780|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941781|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941782|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941783|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
44941784|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941785|NCT04245748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44941786|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
44941787|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941788|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941789|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44941790|NCT04245748|Analgesics|analgesics|mesh-ancestor
44941791|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
44941792|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
44941793|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44941794|NCT04245436|Citalopram|citalopram|mesh-list
44941795|NCT04245436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44941796|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44941797|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941798|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941799|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941800|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
44941801|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941802|NCT04245436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44941803|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
44941804|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941805|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941806|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44941807|NCT04245436|Analgesics|analgesics|mesh-ancestor
44941808|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
44941809|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
44941810|NCT04221997|Sertraline|sertraline|mesh-list
44941811|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
44941812|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44941813|NCT04221997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44941814|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44941815|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941816|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475338|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475339|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
44475340|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475341|NCT04196400|Betamethasone|betamethasone|mesh-list
44475342|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475343|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
44475344|NCT04196400|Hormones|hormones|mesh-ancestor
44475345|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475346|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475347|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44475348|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
44941817|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941818|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
44941819|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941820|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
44941821|NCT04130828|Trace Elements|trace elements|mesh-ancestor
44941822|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
44941823|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941824|NCT03881059|Ustekinumab|ustekinumab|mesh-list
44941825|NCT03881059|BMS-986165|bms-986165|mesh-list
44941826|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941827|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941828|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941829|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941830|NCT03697629|Daratumumab|daratumumab|mesh-list
44941831|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941832|NCT03677830|Acetaminophen|acetaminophen|mesh-list
44941833|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941834|NCT03677830|Analgesics|analgesics|mesh-ancestor
44941835|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
44941836|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941837|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941838|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
44941839|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44941840|NCT03526848|Antibodies|antibodies|mesh-list
44941841|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
44941842|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44941843|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
44941844|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941845|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941846|NCT03501381|Aldesleukin|aldesleukin|mesh-list
44941847|NCT03501381|Interleukin-2|interleukin-2|mesh-list
44941848|NCT03501381|Entinostat|entinostat|mesh-list
44941849|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941850|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44941851|NCT03501381|Analgesics|analgesics|mesh-ancestor
44941852|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
44941853|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941854|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941855|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44941856|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44941857|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
44941858|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941859|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44941860|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941861|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941862|NCT03495973|Ustekinumab|ustekinumab|mesh-list
44941863|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
44941864|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
44941865|NCT03445858|Decitabine|decitabine|mesh-list
44941866|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941867|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941868|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44941869|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
44941870|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941871|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941872|NCT03442413|Nicotine|nicotine|mesh-list
44941873|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44941874|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
44941875|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941876|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941877|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44941878|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44941879|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
44941880|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941881|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941882|NCT03379727|Midostaurin|midostaurin|mesh-list
44941883|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941884|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941885|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941886|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941887|NCT03326492|Antivenins|antivenins|mesh-list
44941888|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
44941889|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941890|NCT03260023|Avelumab|avelumab|mesh-list
44941891|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941892|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941893|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44941894|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44941895|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
44941896|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941897|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
44941898|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941899|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941900|NCT03035630|Sunitinib|sunitinib|mesh-list
44941901|NCT03035630|Avelumab|avelumab|mesh-list
44941902|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941903|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44941904|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44941905|NCT03035630|Growth Substances|growth substances|mesh-ancestor
44941906|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941907|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44941908|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44941909|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941910|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941911|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941912|NCT02962297|Vitamin E|vitamin e|mesh-list
44941913|NCT02962297|Vitamins|vitamins|mesh-ancestor
44941914|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
44941915|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941916|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
44941917|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941918|NCT02962297|Protective Agents|protective agents|mesh-ancestor
44941919|NCT02913664|Losartan|losartan|mesh-list
44941920|NCT02913664|Amlodipine|amlodipine|mesh-list
44941921|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
44941922|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
44941923|NCT02913664|Giapreza|giapreza|mesh-list
44941924|NCT02913664|Calcium|calcium|mesh-list
44941925|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44941926|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
44941927|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44941928|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941929|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44941930|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44941931|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941932|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
44941933|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44941934|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44941935|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44941936|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44941937|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
44941938|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44941939|NCT02889133|Iron|iron|mesh-list
44941940|NCT02889133|Dextrans|dextrans|mesh-list
44941941|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
44941942|NCT02889133|Trace Elements|trace elements|mesh-ancestor
44941943|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
44941944|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941945|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
44941946|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
44941947|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
44941948|NCT02889133|Hematinics|hematinics|mesh-ancestor
44941949|NCT02818582|Remdesivir|remdesivir|mesh-list
44941950|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
44941951|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941952|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
44941953|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44941954|NCT02668770|Ipilimumab|ipilimumab|mesh-list
44941955|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44941956|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941957|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44941958|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941959|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
44941960|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941961|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
44941962|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941963|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941964|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941965|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
44941966|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941967|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44941968|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44941969|NCT02554253|Ketamine|ketamine|mesh-list
44941970|NCT02554253|Propofol|propofol|mesh-list
44941971|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44941972|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44941973|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941974|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44941975|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
44941976|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
44941977|NCT02554253|Analgesics|analgesics|mesh-ancestor
44941978|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
44941979|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44941980|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44941981|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44941982|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44941983|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44941984|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44941986|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
44941987|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
44941988|NCT02308527|Temozolomide|temozolomide|mesh-list
44941989|NCT02308527|Bevacizumab|bevacizumab|mesh-list
44941990|NCT02308527|Irinotecan|irinotecan|mesh-list
44941991|NCT02308527|Topotecan|topotecan|mesh-list
44941992|NCT02308527|Dinutuximab|dinutuximab|mesh-list
44941993|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44941994|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
44941995|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44941996|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44941997|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44941998|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
44941999|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942000|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942001|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44942002|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942003|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44942004|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44942005|NCT02308527|Growth Substances|growth substances|mesh-ancestor
44942006|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
44942007|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44942008|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44942009|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942010|NCT02121184|Oxytocin|oxytocin|mesh-list
44942011|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
44942012|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44942013|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942014|NCT01524536|Prednisone|prednisone|mesh-list
44942015|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942016|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
44942017|NCT01524536|Hormones|hormones|mesh-ancestor
44942018|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942019|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942020|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44942021|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942022|NCT01485874|Doxorubicin|doxorubicin|mesh-list
44942023|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44942024|NCT01485874|Nintedanib|nintedanib|mesh-list
44942025|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44942026|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942027|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44942028|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44942029|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942030|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942031|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44942032|NCT01307046|Losartan|losartan|mesh-list
44942033|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942034|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942035|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942036|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942037|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942038|NCT01307033|Losartan|losartan|mesh-list
44942039|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942040|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942041|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942042|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942043|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942044|NCT00739674|Losartan|losartan|mesh-list
44942045|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942046|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
44942047|NCT00739674|Calcium|calcium|mesh-list
44942048|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44942049|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942051|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942052|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942053|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942054|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942055|NCT00739674|Diuretics|diuretics|mesh-ancestor
44942056|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942057|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942058|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942059|NCT00731757|Adalimumab|adalimumab|mesh-list
44942060|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942061|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942062|NCT00730717|Adalimumab|adalimumab|mesh-list
44942063|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942064|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942065|NCT00546754|Losartan|losartan|mesh-list
44942066|NCT00546754|Valsartan|valsartan|mesh-list
44942067|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942068|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942069|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942070|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942071|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942072|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942073|NCT00546754|Diuretics|diuretics|mesh-ancestor
44475416|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
44475417|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475418|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475419|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
44475420|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475421|NCT04020601|Ropivacaine|ropivacaine|mesh-list
44475422|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475423|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
44475424|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475425|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475426|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
44475427|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475428|NCT04029636|Xenon|xenon|mesh-list
44475429|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44475430|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
44942074|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942075|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942076|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942077|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942078|NCT00480805|Losartan|losartan|mesh-list
44942079|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942080|NCT00480805|Ramipril|ramipril|mesh-list
44942081|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942082|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942083|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942084|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942085|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942086|NCT00480805|Diuretics|diuretics|mesh-ancestor
44942087|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942088|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942089|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942090|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942091|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44942092|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44942093|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942094|NCT00457275|Ezetimibe|ezetimibe|mesh-list
44942095|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942096|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942097|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
44942098|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942099|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942100|NCT00449111|Losartan|losartan|mesh-list
44942101|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942102|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942103|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942104|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942105|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942106|NCT00406783|Desloratadine|desloratadine|mesh-list
44942107|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44942108|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
44942109|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942110|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942111|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942112|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44942113|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44942114|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
44942115|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
44942116|NCT00405964|Desloratadine|desloratadine|mesh-list
44942117|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44942118|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
44942119|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942120|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942121|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942122|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44942123|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44942124|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
44942125|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
44942126|NCT00400218|Losartan|losartan|mesh-list
44942127|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942128|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942129|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942130|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942131|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942132|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942133|NCT00400218|Diuretics|diuretics|mesh-ancestor
44942134|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942135|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942136|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942137|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942138|NCT00398541|Losartan|losartan|mesh-list
44942139|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942140|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942141|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942142|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942143|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942144|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942145|NCT00398541|Diuretics|diuretics|mesh-ancestor
44942146|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942147|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942148|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942149|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942150|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
44942151|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
44942152|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942153|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
44942154|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942155|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942156|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942157|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942158|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942159|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942160|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942161|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942162|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942163|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942164|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942165|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942166|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942167|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
44942168|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
44942169|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942170|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
44942171|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942172|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942173|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942174|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942175|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942176|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942177|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942178|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942179|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942180|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942181|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942182|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942183|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942184|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
44473403|NCT03599635|Bupivacaine|bupivacaine|mesh-list
44473404|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473405|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
44473406|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473407|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473408|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
44473409|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475431|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
44475432|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475433|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475434|NCT04029350|Osimertinib|osimertinib|mesh-list
44475435|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475436|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44475437|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475438|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475439|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
44475440|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44475444|NCT04029467|Analgesics|analgesics|mesh-ancestor
44942185|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
44942186|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942187|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
44942188|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942189|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942190|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942191|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942192|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942193|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942194|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942195|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942196|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942197|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942198|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942199|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942200|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942201|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
44942202|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
44942203|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942204|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
44942205|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942206|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942207|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942208|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942209|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942210|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942211|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942212|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942213|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942214|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942215|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942216|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942217|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942218|NCT00379288|Fluticasone|fluticasone|mesh-list
44942219|NCT00379288|Xhance|xhance|mesh-list
44942220|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
44942221|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44942222|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44942223|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942224|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942225|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
44942226|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942227|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942228|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942229|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942230|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942231|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942232|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942233|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942234|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942235|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942236|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942237|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942238|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
44942239|NCT00379288|Hormones|hormones|mesh-ancestor
44942240|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942241|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
44942242|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
44942243|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942244|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942245|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44942246|NCT00338260|Atenolol|atenolol|mesh-list
44942247|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942248|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942249|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942250|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942251|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
44942252|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942253|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942254|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942255|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
44942256|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44942257|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44942258|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44942259|NCT00308347|Losartan|losartan|mesh-list
44942260|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942261|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942262|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942263|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942264|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942265|NCT00307060|Losartan|losartan|mesh-list
44942266|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942267|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942268|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942269|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942270|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942271|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942272|NCT00307060|Diuretics|diuretics|mesh-ancestor
44942273|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942274|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942275|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942276|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942277|NCT00092690|Atorvastatin|atorvastatin|mesh-list
44942278|NCT00092690|Simvastatin|simvastatin|mesh-list
44942279|NCT00092690|Ezetimibe|ezetimibe|mesh-list
44942280|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942281|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942282|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
44942283|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942284|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942285|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942286|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942287|NCT00092664|Simvastatin|simvastatin|mesh-list
44942288|NCT00092664|Ezetimibe|ezetimibe|mesh-list
44942289|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942290|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942291|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
44942292|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942293|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942294|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942295|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942296|NCT00092651|Simvastatin|simvastatin|mesh-list
44942297|NCT00092651|Ezetimibe|ezetimibe|mesh-list
44942298|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44942299|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942300|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942301|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
44942302|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942303|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942304|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942305|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942306|NCT00092638|Ezetimibe|ezetimibe|mesh-list
44942307|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942308|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942309|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
44942310|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942311|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942312|NCT00092625|Ezetimibe|ezetimibe|mesh-list
44942313|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942314|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942315|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
44942316|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942317|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942318|NCT00092612|Ezetimibe|ezetimibe|mesh-list
44942319|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942320|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942321|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
44942322|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942323|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942324|NCT00092599|Ezetimibe|ezetimibe|mesh-list
44942325|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942326|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942327|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
44942328|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942329|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942330|NCT00092586|Ezetimibe|ezetimibe|mesh-list
44942331|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942332|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942333|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
44942334|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942335|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942336|NCT00092573|Ezetimibe|ezetimibe|mesh-list
44942337|NCT00092573|Fenofibrate|fenofibrate|mesh-list
44942338|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942339|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942340|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
44942341|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942342|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942343|NCT00092560|Ezetimibe|ezetimibe|mesh-list
44942344|NCT00092560|Fenofibrate|fenofibrate|mesh-list
44475447|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44475448|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44475449|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44475450|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44475451|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475452|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475453|NCT04029090|Edaravone|edaravone|mesh-list
44475454|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44475455|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
44475456|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475457|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44942345|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942346|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942347|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
44942348|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942349|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942350|NCT00092209|Losartan|losartan|mesh-list
44942351|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44942352|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942353|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942354|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942355|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942356|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942357|NCT00092209|Diuretics|diuretics|mesh-ancestor
44942358|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
44942359|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942360|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44942361|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942362|NCT00092157|Simvastatin|simvastatin|mesh-list
44942363|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942364|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942365|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
44942366|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942367|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942368|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942369|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942370|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44942371|NCT00090298|Simvastatin|simvastatin|mesh-list
44942372|NCT00090298|Ezetimibe|ezetimibe|mesh-list
44942373|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942374|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942375|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
44942376|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942377|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942378|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942379|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942380|NCT00090181|Diclofenac|diclofenac|mesh-list
44942381|NCT00090181|Etoricoxib|etoricoxib|mesh-list
44942382|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44942383|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44942384|NCT00090181|Analgesics|analgesics|mesh-ancestor
44942385|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
44942386|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942387|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942388|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942389|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942390|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44942391|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942392|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942393|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44942394|NCT00090168|Atorvastatin|atorvastatin|mesh-list
44942395|NCT00090168|Simvastatin|simvastatin|mesh-list
44942396|NCT00090168|Ezetimibe|ezetimibe|mesh-list
44942397|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942398|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942399|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
44942400|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942401|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942402|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942403|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942404|NCT00089895|Eptifibatide|eptifibatide|mesh-list
44942405|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44942406|NCT02765854|Dexamethasone|dexamethasone|mesh-list
44473628|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
44942407|NCT02765854|Lenalidomide|lenalidomide|mesh-list
44942408|NCT02765854|Ixazomib|ixazomib|mesh-list
44942409|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942410|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
44942411|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
44942412|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942413|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942414|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44942415|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
44942416|NCT02765854|Hormones|hormones|mesh-ancestor
44942417|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942418|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44942419|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942420|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
44942421|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44942422|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44942423|NCT02765854|Growth Substances|growth substances|mesh-ancestor
44942424|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
44942425|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942426|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
44942427|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942428|NCT02207504|Crizotinib|crizotinib|mesh-list
44942429|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942430|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44942431|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942432|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942433|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
44942434|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942435|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942436|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44942437|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942438|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942439|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44942440|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942441|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44942442|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44942443|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942444|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44942445|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44942446|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
44942447|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942448|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942449|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44942450|NCT02118610|Analgesics|analgesics|mesh-ancestor
44942451|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
44942452|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942453|NCT02083250|Fludarabine|fludarabine|mesh-list
44942454|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
44942455|NCT02083250|Busulfan|busulfan|mesh-list
44942456|NCT02083250|Vorinostat|vorinostat|mesh-list
44942457|NCT02083250|Clofarabine|clofarabine|mesh-list
44942458|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
44942459|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44942460|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942461|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44942462|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
44942463|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942464|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942465|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
44942466|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942467|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
44942468|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44942469|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44942470|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44942471|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942472|NCT01857934|Aldesleukin|aldesleukin|mesh-list
44942473|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
44942474|NCT01857934|Melphalan|melphalan|mesh-list
44942475|NCT01857934|Busulfan|busulfan|mesh-list
44942476|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
44942477|NCT01857934|Doxorubicin|doxorubicin|mesh-list
44942478|NCT01857934|Etoposide|etoposide|mesh-list
44942479|NCT01857934|Vincristine|vincristine|mesh-list
44942480|NCT01857934|Topotecan|topotecan|mesh-list
44942481|NCT01857934|Interleukin-2|interleukin-2|mesh-list
44473667|NCT03598075|Pramlintide|pramlintide|mesh-list
44942482|NCT01857934|Molgramostim|molgramostim|mesh-list
44942483|NCT01857934|Dinutuximab|dinutuximab|mesh-list
44942484|NCT01857934|Levetiracetam|levetiracetam|mesh-list
44942485|NCT01857934|Isotretinoin|isotretinoin|mesh-list
44942486|NCT01857934|Antibodies|antibodies|mesh-list
44942487|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
44942488|NCT01857934|Sargramostim|sargramostim|mesh-list
44942489|NCT01857934|Lenograstim|lenograstim|mesh-list
44942490|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942491|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
44942492|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942493|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942494|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44942495|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
44942496|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942497|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942498|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44942499|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44942500|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44942501|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44942502|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942503|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44942504|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44942505|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44942506|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
44942507|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44942508|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44942509|NCT01857934|Analgesics|analgesics|mesh-ancestor
44942510|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
44942511|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942512|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44942513|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44942514|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
44942515|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942516|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44942517|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
44942518|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
44942519|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942520|NCT01841177|Milrinone|milrinone|mesh-list
44942521|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44942522|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44942523|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942524|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44942525|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44942526|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942527|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942528|NCT01841177|Protective Agents|protective agents|mesh-ancestor
44942529|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942530|NCT01444092|Budesonide|budesonide|mesh-list
44942531|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942532|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942533|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
44942534|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942535|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942536|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942537|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942538|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
44942539|NCT01444092|Hormones|hormones|mesh-ancestor
44942540|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942541|NCT01265784|Ertapenem|ertapenem|mesh-list
44942542|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44942543|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942544|NCT00392327|Vitamin A|vitamin a|mesh-list
44942545|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
44942546|NCT00392327|Cisplatin|cisplatin|mesh-list
44942547|NCT00392327|Carboplatin|carboplatin|mesh-list
44942548|NCT00392327|Vincristine|vincristine|mesh-list
44942549|NCT00392327|Tretinoin|tretinoin|mesh-list
44942550|NCT00392327|Isotretinoin|isotretinoin|mesh-list
44942551|NCT00392327|Lenograstim|lenograstim|mesh-list
44942552|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942553|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
44942554|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942555|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942556|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44942557|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
44942558|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942559|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942560|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44942561|NCT00392327|Vitamins|vitamins|mesh-ancestor
44942562|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
44942563|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44942564|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44942565|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
44942566|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
44942567|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
44942568|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
44942569|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942570|NCT00116220|Goserelin|goserelin|mesh-list
44942571|NCT00116220|Flutamide|flutamide|mesh-list
44942572|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942573|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44942574|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942575|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
44942576|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
44942577|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942578|NCT05187507|Theobromine|theobromine|mesh-list
44942579|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942580|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
44942581|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942582|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942583|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942584|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942585|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942586|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44942587|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
44942588|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
44942589|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942590|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942591|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
44942592|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942593|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44942594|NCT05186649|Warfarin|warfarin|mesh-list
44942595|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
44942596|NCT05186194|Vitamin D|vitamin d|mesh-list
44942597|NCT05186194|Calcium|calcium|mesh-list
44942598|NCT05186194|Vitamins|vitamins|mesh-ancestor
44942599|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
44942600|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942601|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44942602|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44942603|NCT05185869|Gemcitabine|gemcitabine|mesh-list
44942604|NCT05185869|Paclitaxel|paclitaxel|mesh-list
44942605|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44942606|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942607|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
44942608|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
44942609|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
44942610|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942611|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44942612|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
44942613|NCT05185869|Antiviral Agents|antiviral agents|mesh-ancestor
44942614|NCT05185869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942615|NCT05185869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942616|NCT05185869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942617|NCT05185869|Immunologic Factors|immunologic factors|mesh-ancestor
44942618|NCT05185869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942619|NCT05185804|Enoxaparin|enoxaparin|mesh-list
44942620|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
44942621|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
44942622|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44942623|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44942624|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942625|NCT05185544|Cisplatin|cisplatin|mesh-list
44942626|NCT05185544|Pemetrexed|pemetrexed|mesh-list
44942627|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942628|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942629|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942630|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44942631|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44942632|NCT05185518|Insulin|insulin|mesh-list
44942633|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475508|NCT04028518|Plasminogen|plasminogen|mesh-list
44942634|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942635|NCT05185505|Bevacizumab|bevacizumab|mesh-list
44942636|NCT05185505|Atezolizumab|atezolizumab|mesh-list
44942637|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942638|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942639|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44942640|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44942641|NCT05185505|Growth Substances|growth substances|mesh-ancestor
44942642|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942643|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44942644|NCT05185284|Favipiravir|favipiravir|mesh-list
44942645|NCT05185284|Remdesivir|remdesivir|mesh-list
44942646|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
44942647|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942648|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
44942649|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942650|NCT05184530|Evolocumab|evolocumab|mesh-list
44942651|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942652|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942653|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
44942654|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942655|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942656|NCT05184517|Cyclosporine|cyclosporine|mesh-list
44942657|NCT05184517|Cyclosporins|cyclosporins|mesh-list
44942658|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942659|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942660|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942661|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
44942662|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942663|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
44942664|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942665|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
44942666|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942667|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44942668|NCT05184465|Anesthetics|anesthetics|mesh-list
44942669|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942670|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942671|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44942672|NCT05184374|Hormones|hormones|mesh-ancestor
44942673|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44942674|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942675|NCT05184179|Olmesartan|olmesartan|mesh-list
44942676|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44942677|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44942678|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942679|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942680|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
44942681|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942682|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44473851|NCT03595514|Lidocaine|lidocaine|mesh-list
44942683|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942684|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942685|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942686|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44942687|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44942688|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
44942690|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44942691|NCT05184049|Vitamins|vitamins|mesh-ancestor
44942692|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
44942693|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942694|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942695|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942696|NCT05183997|Verapamil|verapamil|mesh-list
44942697|NCT05183997|Thrombin|thrombin|mesh-list
44942698|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942699|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44942700|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942701|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942702|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44942703|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942704|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942705|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
44942706|NCT05183997|Coagulants|coagulants|mesh-ancestor
44942707|NCT05183841|Fenoterol|fenoterol|mesh-list
44942708|NCT05183841|Ipratropium|ipratropium|mesh-list
44942709|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
44942710|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
44942711|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942712|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942713|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942714|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942715|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44942716|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
44942717|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942718|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942719|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
44942720|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
44942721|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44942722|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942723|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942724|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942725|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942726|NCT05183555|Edotreotide|edotreotide|mesh-list
44942727|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44942728|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942729|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
44942730|NCT05183334|Tramadol|tramadol|mesh-list
44942731|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942732|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44942733|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44942734|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942735|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942736|NCT05183334|Urological Agents|urological agents|mesh-ancestor
44942737|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44942738|NCT05183334|Narcotics|narcotics|mesh-ancestor
44942739|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942740|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942741|NCT05183334|Analgesics|analgesics|mesh-ancestor
44942742|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
44942743|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942744|NCT05182970|Metformin|metformin|mesh-list
44942745|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44942746|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942747|NCT05182957|Lenalidomide|lenalidomide|mesh-list
44942748|NCT05182957|Azacitidine|azacitidine|mesh-list
44942749|NCT05182957|Antibodies|antibodies|mesh-list
44942750|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
44942751|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44942752|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
44942753|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942754|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44942755|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44942756|NCT05182957|Growth Substances|growth substances|mesh-ancestor
44942757|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44942758|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942759|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44942760|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
44942761|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942762|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942763|NCT05182138|Zinc|zinc|mesh-list
44942764|NCT05182138|Trace Elements|trace elements|mesh-ancestor
44942765|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
44942766|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942767|NCT05181969|Dextrans|dextrans|mesh-list
44942768|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
44942769|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
44942770|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
44942771|NCT05180292|Carvedilol|carvedilol|mesh-list
44942772|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44942773|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44942774|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942775|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942776|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942777|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942778|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44942779|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
44942780|NCT05180292|Protective Agents|protective agents|mesh-ancestor
44942781|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44942782|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942783|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44942784|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942785|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44942786|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44942788|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44942789|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942790|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44942791|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942792|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942793|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44942794|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44942795|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
44942796|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942797|NCT05166291|Anesthetics|anesthetics|mesh-list
44942798|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942799|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942800|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
44942801|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44942802|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44942803|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
44942804|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942805|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
44942806|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44942807|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942808|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
44942809|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44942810|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
44942811|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942812|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942813|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44942814|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
44942815|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942816|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942817|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44942818|NCT05153772|Octreotide|octreotide|mesh-list
44942819|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44942820|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44942821|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942822|NCT05151159|Antibodies|antibodies|mesh-list
44942823|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
44942824|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942825|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
44942826|NCT05150782|Curcumin|curcumin|mesh-list
44942827|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
44942828|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942829|NCT05150782|Protective Agents|protective agents|mesh-ancestor
44942830|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942831|NCT05150782|Vitamins|vitamins|mesh-ancestor
44942832|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
44942833|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44942834|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44942835|NCT05150782|Analgesics|analgesics|mesh-ancestor
44942836|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
44942837|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942838|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942839|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44942840|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942841|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942842|NCT05130060|Trifluridine|trifluridine|mesh-list
44942843|NCT05130060|Vaccines|vaccines|mesh-list
44942844|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
44942845|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942846|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
44942847|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942848|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
44942849|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942850|NCT05099107|Albuterol|albuterol|mesh-list
44942851|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44942852|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
44942853|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942854|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942855|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44942856|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
44942857|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
44942858|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44942859|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44942860|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44942861|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44942862|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
44942863|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942864|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474139|NCT03591991|Empagliflozin|empagliflozin|mesh-list
44942865|NCT05089643|Capecitabine|capecitabine|mesh-list
44942866|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44942867|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
44942868|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942869|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942870|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
44942871|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44942872|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942873|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942874|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942875|NCT05064488|Metformin|metformin|mesh-list
44942876|NCT05064488|Digoxin|digoxin|mesh-list
44942877|NCT05064488|Sumatriptan|sumatriptan|mesh-list
44942878|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44942879|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44942880|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942881|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44942882|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44942883|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
44942884|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942885|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44942886|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44942887|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942888|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44942889|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44942890|NCT05064488|Protective Agents|protective agents|mesh-ancestor
44942891|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44942892|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44942893|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44942894|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
44942895|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44942896|NCT05000710|Durvalumab|durvalumab|mesh-list
44942897|NCT05000710|Tremelimumab|tremelimumab|mesh-list
44942898|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942899|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942900|NCT04965519|Trastuzumab|trastuzumab|mesh-list
44942901|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942902|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942903|NCT04943549|Bupivacaine|bupivacaine|mesh-list
44942904|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
44942905|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
44942906|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942907|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942908|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
44942909|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942910|NCT04931667|Lorecivivint|lorecivivint|mesh-list
44942911|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44942912|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
44942913|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
44942914|NCT04889599|Docetaxel|docetaxel|mesh-list
44942915|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942916|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44942917|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44942918|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44942919|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942920|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
44942921|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
44942922|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
44942923|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942924|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942925|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
44942926|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942927|NCT04802863|Imipenem|imipenem|mesh-list
44942928|NCT04802863|Cilastatin|cilastatin|mesh-list
44942929|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44942930|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942931|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
44942932|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942933|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942934|NCT04801043|Imipenem|imipenem|mesh-list
44942935|NCT04801043|Cilastatin|cilastatin|mesh-list
44942936|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44942937|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942938|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
44942939|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942940|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942942|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942943|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44942944|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942945|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942946|NCT04787562|Imipenem|imipenem|mesh-list
44942947|NCT04787562|Cilastatin|cilastatin|mesh-list
44942948|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44942949|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942950|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44942951|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44942952|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942953|NCT04786756|Bupivacaine|bupivacaine|mesh-list
44942954|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
44942955|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
44942956|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942957|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942958|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
44942959|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942960|NCT04782791|Nivolumab|nivolumab|mesh-list
44942961|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942962|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942963|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44735813|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735814|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
44735815|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
44735816|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735817|NCT04935359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735818|NCT04935359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735819|NCT04935359|Immunologic Factors|immunologic factors|mesh-ancestor
44735820|NCT04935359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942964|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942965|NCT04768426|Capecitabine|capecitabine|mesh-list
44942966|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44942967|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
44942968|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942969|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942970|NCT04762836|Cycloserine|cycloserine|mesh-list
44942971|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44942972|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44942973|NCT04762836|Renal Agents|renal agents|mesh-ancestor
44942974|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44942975|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
44942976|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44942977|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
44942978|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942979|NCT04758949|Nivolumab|nivolumab|mesh-list
44942980|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44942981|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44942982|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44942983|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44942984|NCT04750395|Haloperidol|haloperidol|mesh-list
44942985|NCT04750395|Olanzapine|olanzapine|mesh-list
44942986|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
44942987|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
44942988|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
44942989|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44942990|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44942991|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44942992|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44942993|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44942994|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44942995|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44942996|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44942997|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44942998|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44942999|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943000|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943001|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
44943002|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44943003|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
44943004|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44943005|NCT04739735|Anesthetics|anesthetics|mesh-list
44943006|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943007|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943008|NCT04735965|Meperidine|meperidine|mesh-list
44943009|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
44943010|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44943011|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943012|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943013|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943014|NCT04735965|Analgesics|analgesics|mesh-ancestor
44735821|NCT04929028|Fluorouracil|fluorouracil|mesh-list
44735822|NCT04929028|Capecitabine|capecitabine|mesh-list
44735823|NCT04929028|Nivolumab|nivolumab|mesh-list
44735824|NCT04929028|Mitomycins|mitomycins|mesh-list
44735825|NCT04929028|Mitomycin|mitomycin|mesh-list
44735826|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
44735827|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735828|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735829|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735830|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943015|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
44943016|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943017|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44943018|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44943019|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44943020|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
44943021|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943022|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943023|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44943024|NCT04735965|Narcotics|narcotics|mesh-ancestor
44943025|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44943026|NCT04734535|Thrombin|thrombin|mesh-list
44943027|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44943028|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
44943029|NCT04734535|Coagulants|coagulants|mesh-ancestor
44943030|NCT04734379|Fasudil|fasudil|mesh-list
44943031|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44943032|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943033|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943034|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44943035|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943036|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
44943037|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943038|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943039|NCT04714190|Paclitaxel|paclitaxel|mesh-list
44943040|NCT04714190|Irinotecan|irinotecan|mesh-list
44943041|NCT04714190|Apatinib|apatinib|mesh-list
44943042|NCT04714190|Trastuzumab|trastuzumab|mesh-list
44943043|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735831|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
44943044|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735832|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735833|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735834|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44735835|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44735836|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
44735837|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44735838|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735839|NCT04928846|Docetaxel|docetaxel|mesh-list
44735840|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735841|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735842|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735843|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943045|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943046|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943047|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943048|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943049|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44943050|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44943051|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943052|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943053|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943054|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
44943055|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44943056|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
44943057|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943058|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
44943059|NCT04702802|Protective Agents|protective agents|mesh-ancestor
44943060|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
44943061|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44943062|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
44943063|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943064|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
44943065|NCT04702776|Protective Agents|protective agents|mesh-ancestor
44943066|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
44943067|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44943068|NCT04686773|Vaccines|vaccines|mesh-list
44943069|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
44943070|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943071|NCT04684953|Hormones|hormones|mesh-list
44943072|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943073|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943074|NCT04674020|Erenumab|erenumab|mesh-list
44943075|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44943076|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943077|NCT04674020|Analgesics|analgesics|mesh-ancestor
44943078|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
44943079|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943080|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943081|NCT04641312|Dulaglutide|dulaglutide|mesh-list
44943082|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943083|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943084|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
44943085|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44943086|NCT04611763|Analgesics|analgesics|mesh-ancestor
44943087|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
44943088|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943089|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943090|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943091|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943092|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943093|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943094|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44943095|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943096|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943097|NCT04608786|Capecitabine|capecitabine|mesh-list
44943098|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44943099|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
44943100|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943101|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943102|NCT04595266|Leucovorin|leucovorin|mesh-list
44943103|NCT04595266|Bevacizumab|bevacizumab|mesh-list
44943104|NCT04595266|Fluorouracil|fluorouracil|mesh-list
44943105|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
44943106|NCT04595266|Irinotecan|irinotecan|mesh-list
44943107|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943108|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943109|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44943110|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44943111|NCT04595266|Growth Substances|growth substances|mesh-ancestor
44943112|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943113|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
44943114|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
44943115|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943116|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44943117|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943118|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
44943119|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44943120|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44943121|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943122|NCT04595266|Antidotes|antidotes|mesh-ancestor
44943123|NCT04595266|Protective Agents|protective agents|mesh-ancestor
44943124|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
44943125|NCT04595266|Vitamins|vitamins|mesh-ancestor
44943126|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
44943127|NCT04594798|Prednisone|prednisone|mesh-list
44943128|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
44943129|NCT04594798|Rituximab|rituximab|mesh-list
44943130|NCT04594798|Doxorubicin|doxorubicin|mesh-list
44943131|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943132|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
44943133|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943134|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943135|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44943136|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
44943137|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943138|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943139|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44943140|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943141|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44943142|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44943143|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44943144|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943145|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943146|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
44943147|NCT04594798|Hormones|hormones|mesh-ancestor
44943148|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943149|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44943150|NCT04592536|Alprazolam|alprazolam|mesh-list
44943151|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44943152|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943153|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943154|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44943155|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44474372|NCT03594058|Solabegron|solabegron|mesh-list
44943157|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
44943158|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
44943159|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943160|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943161|NCT04541797|Empagliflozin|empagliflozin|mesh-list
44943162|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44943163|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943164|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943165|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943166|NCT04520685|Cannabidiol|cannabidiol|mesh-list
44943167|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
44943168|NCT04508790|Dexamethasone|dexamethasone|mesh-list
44943169|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
44943170|NCT04508790|Pomalidomide|pomalidomide|mesh-list
44943171|NCT04508790|Ichthammol|ichthammol|mesh-list
44943172|NCT04508790|BB 1101|bb 1101|mesh-list
44943173|NCT04508790|Leflunomide|leflunomide|mesh-list
44943174|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943175|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
44943176|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
44943177|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943178|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943179|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943180|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
44943181|NCT04508790|Hormones|hormones|mesh-ancestor
44943182|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943183|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44943184|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943185|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44943186|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943187|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943188|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
44943189|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44943190|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44943191|NCT04508790|Growth Substances|growth substances|mesh-ancestor
44943192|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44943193|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943194|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943195|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44943196|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44943197|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943198|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
44943199|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44943200|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44943201|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44943202|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
44943203|NCT04481672|Analgesics|analgesics|mesh-ancestor
44943204|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
44943205|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943206|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943207|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
44943208|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943209|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44943210|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
44943211|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44943212|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943213|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943214|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44943215|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
44943216|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44943217|NCT04470778|Famotidine|famotidine|mesh-list
44943218|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44943219|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943220|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44943221|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
44943222|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
44943223|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474447|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474448|NCT04191135|Antiviral Agents|antiviral agents|mesh-ancestor
44474449|NCT04191135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474450|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474451|NCT04191135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44474452|NCT04191135|Immunologic Factors|immunologic factors|mesh-ancestor
44943224|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943225|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943226|NCT04418427|Aflibercept|aflibercept|mesh-list
44943227|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44943228|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44943229|NCT04418427|Growth Substances|growth substances|mesh-ancestor
44943230|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943231|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
44943232|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943233|NCT04412863|Interferons|interferons|mesh-list
44943234|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
44943235|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
44943236|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44943237|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943238|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
44943239|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943240|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
44943241|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943242|NCT04412785|Cyclosporine|cyclosporine|mesh-list
44943243|NCT04412785|Cyclosporins|cyclosporins|mesh-list
44943244|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943245|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943246|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943247|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
44943248|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943249|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
44943250|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943251|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943252|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943253|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44943254|NCT04386616|Astegolimab|astegolimab|mesh-list
44943255|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44943256|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943257|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
44943258|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943259|NCT04385433|Pravastatin|pravastatin|mesh-list
44943260|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44943261|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44943262|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
44943263|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943264|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44943265|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44943266|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943267|NCT04377711|Ciclesonide|ciclesonide|mesh-list
44943268|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
44943269|NCT04377711|Hormones|hormones|mesh-ancestor
44943270|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943271|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943272|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44943273|NCT04356209|Pravastatin|pravastatin|mesh-list
44943274|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44943275|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44943276|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
44943277|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943278|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44943279|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44943280|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943281|NCT04347408|Antibodies|antibodies|mesh-list
44943282|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
44943283|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943284|NCT04296942|Trastuzumab|trastuzumab|mesh-list
44943285|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44943286|NCT04296942|Maytansine|maytansine|mesh-list
44943287|NCT04296942|Entinostat|entinostat|mesh-list
44943288|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943289|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943290|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44943291|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943292|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943293|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943294|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943295|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44943296|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943297|NCT04291599|Ketorolac|ketorolac|mesh-list
44943298|NCT04291599|Morphine|morphine|mesh-list
44474466|NCT04192110|Diuretics|diuretics|mesh-list
44943300|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44943301|NCT04291599|Narcotics|narcotics|mesh-ancestor
44943302|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943303|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943304|NCT04291599|Analgesics|analgesics|mesh-ancestor
44943305|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
44943306|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943307|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943308|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943309|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943310|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943311|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44943312|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943313|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943314|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
44943315|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44943316|NCT04269356|Antacids|antacids|mesh-ancestor
44943317|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943318|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943319|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44943320|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
44943321|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44943322|NCT04074967|Nivolumab|nivolumab|mesh-list
44943323|NCT04074967|Ipilimumab|ipilimumab|mesh-list
44943324|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943325|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943326|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44943327|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943328|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
44943329|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943330|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943331|NCT04074174|Acetaminophen|acetaminophen|mesh-list
44943332|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
44943333|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
44943334|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943335|NCT04074174|Analgesics|analgesics|mesh-ancestor
44943336|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
44943337|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943338|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943339|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
44943340|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44943341|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44943342|NCT04040959|Niacinamide|niacinamide|mesh-list
44943343|NCT04040959|Niacin|niacin|mesh-list
44943344|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
44943345|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
44943346|NCT04040959|Vitamins|vitamins|mesh-ancestor
44943347|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
44943348|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943349|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44943350|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
44943351|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943352|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44943353|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
44943354|NCT04019262|Temozolomide|temozolomide|mesh-list
44943355|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44943356|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
44943357|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943358|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943359|NCT04001894|Clopidogrel|clopidogrel|mesh-list
44943360|NCT04001894|Ticagrelor|ticagrelor|mesh-list
44943361|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44943362|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44943363|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44943364|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44943365|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
44943366|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943367|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943368|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943369|NCT03988920|Sevelamer|sevelamer|mesh-list
44943370|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
44943371|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
44943372|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943373|NCT03982485|Paclitaxel|paclitaxel|mesh-list
44943374|NCT03982485|Cisplatin|cisplatin|mesh-list
44943375|NCT03982485|Apatinib|apatinib|mesh-list
44943376|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44943377|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943378|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943379|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943380|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943381|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943382|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943383|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943384|NCT03969121|Palbociclib|palbociclib|mesh-list
44943385|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943386|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943387|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943388|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943389|NCT03966339|Hormones|hormones|mesh-list
44943390|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943391|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943392|NCT03948022|Progesterone|progesterone|mesh-list
44943393|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
44943394|NCT03948022|Progestins|progestins|mesh-ancestor
44943395|NCT03948022|Hormones|hormones|mesh-ancestor
44943396|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943397|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943398|NCT03937596|Cycloserine|cycloserine|mesh-list
44943399|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44943400|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943401|NCT03937596|Renal Agents|renal agents|mesh-ancestor
44943402|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44943403|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
44943404|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44943405|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
44943406|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943407|NCT03928158|Valsartan|valsartan|mesh-list
44943408|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44943409|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44735844|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735845|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
44735846|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44735847|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44735848|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475563|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
44475564|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44475565|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475566|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475567|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475568|NCT04027192|Midazolam|midazolam|mesh-list
44475569|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44475570|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44475572|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943410|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44943411|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44943412|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943413|NCT03902314|Lidocaine|lidocaine|mesh-list
44943414|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44943415|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
44943416|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943417|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943418|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
44943419|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943420|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44943421|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44943422|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44943423|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943424|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943425|NCT03894501|Methadone|methadone|mesh-list
44943426|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44943427|NCT03894501|Narcotics|narcotics|mesh-ancestor
44943428|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943429|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943430|NCT03894501|Analgesics|analgesics|mesh-ancestor
44943431|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
44943432|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943433|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
44943434|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
44943435|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
44943436|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44943437|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
44943438|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
44943439|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943440|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943441|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943442|NCT03879538|Analgesics|analgesics|mesh-ancestor
44943443|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
44943444|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943445|NCT03853317|Avelumab|avelumab|mesh-list
44943446|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943447|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943448|NCT03772951|Clozapine|clozapine|mesh-list
44943449|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44943450|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
44943451|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943452|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943453|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943454|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44943455|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44943456|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943457|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44943458|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
44943459|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
44943460|NCT03753087|Empagliflozin|empagliflozin|mesh-list
44943461|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44943462|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943463|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943464|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943465|NCT03735420|Xanthohumol|xanthohumol|mesh-list
44943466|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943467|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44943468|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44943469|NCT03735420|Growth Substances|growth substances|mesh-ancestor
44943470|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943471|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
44943472|NCT03730337|Nivolumab|nivolumab|mesh-list
44943473|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943474|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943475|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44943476|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943477|NCT03721328|Vancomycin|vancomycin|mesh-list
44943478|NCT03721328|Tobramycin|tobramycin|mesh-list
44943479|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44943480|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943481|NCT03715153|Bumetanide|bumetanide|mesh-list
44943482|NCT03715153|Diuretics|diuretics|mesh-ancestor
44943483|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
44943484|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943485|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44943486|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943487|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943488|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
44943489|NCT03706898|Dolutegravir|dolutegravir|mesh-list
44943490|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
44943491|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
44943492|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943493|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44943494|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44943495|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943496|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943497|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44943498|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44943499|NCT03694002|Paclitaxel|paclitaxel|mesh-list
44943500|NCT03694002|Carboplatin|carboplatin|mesh-list
44943501|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44943502|NCT03694002|Ramucirumab|ramucirumab|mesh-list
44943503|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44943504|NCT03694002|Antibodies|antibodies|mesh-list
44943505|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
44943506|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44943507|NCT03694002|Lexatumumab|lexatumumab|mesh-list
44943508|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44943509|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943510|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943511|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943512|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943513|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943514|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
44943515|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943516|NCT03691727|Tirofiban|tirofiban|mesh-list
44943517|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44943518|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44943519|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943520|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44474760|NCT04194957|Capecitabine|capecitabine|mesh-list
44943521|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
44475602|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
44475603|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475604|NCT04026685|Phenylephrine|phenylephrine|mesh-list
44475605|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
44475606|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44475607|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
44475608|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
44475609|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475610|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475611|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
44475612|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44943522|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44943523|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44943524|NCT03647852|Prednisolone|prednisolone|mesh-list
44943525|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
44943526|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44943527|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
44943528|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943529|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
44943530|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
44943531|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943532|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943533|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943534|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
44943535|NCT03647852|Hormones|hormones|mesh-ancestor
44943536|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943537|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44943538|NCT03647852|Protective Agents|protective agents|mesh-ancestor
44943539|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44943540|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943541|NCT03629327|Aspirin|aspirin|mesh-list
44943542|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943543|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943544|NCT03629327|Analgesics|analgesics|mesh-ancestor
44943545|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
44943546|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943547|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943548|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943549|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943550|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44943551|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44943552|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943553|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44943554|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44943555|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943556|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
44943557|NCT03604159|Buprenorphine|buprenorphine|mesh-list
44943558|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44943559|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44943560|NCT03604159|Narcotics|narcotics|mesh-ancestor
44943561|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943562|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943563|NCT03604159|Analgesics|analgesics|mesh-ancestor
44943564|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
44943565|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943566|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44943567|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
44943568|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
44943569|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943570|NCT03578172|Menotropins|menotropins|mesh-list
44943571|NCT03578172|Hormones|hormones|mesh-list
44943572|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943573|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943574|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44943575|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
44943576|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44943577|NCT03578081|Dexamethasone|dexamethasone|mesh-list
44943578|NCT03578081|Ondansetron|ondansetron|mesh-list
44943579|NCT03578081|Olanzapine|olanzapine|mesh-list
44943580|NCT03578081|Palonosetron|palonosetron|mesh-list
44943581|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
44943582|NCT03578081|Aprepitant|aprepitant|mesh-list
44943583|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943584|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
44943585|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
44943586|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943587|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943588|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943589|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
44943590|NCT03578081|Hormones|hormones|mesh-ancestor
44943591|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943592|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44943593|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943594|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
44943595|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943596|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44943597|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
44943598|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943599|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943600|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44943601|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44943602|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943603|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44943604|NCT03578081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44943605|NCT03578081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44943606|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44943607|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943608|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44943609|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44943610|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44943611|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943612|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943613|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943615|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
44943616|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44943617|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943618|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943619|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943620|NCT03539601|Analgesics|analgesics|mesh-ancestor
44943621|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
44943622|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943623|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943624|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943625|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943626|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943627|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
44943628|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44943629|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943630|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943631|NCT03522844|Citalopram|citalopram|mesh-list
44943632|NCT03522844|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44943633|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44943634|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943635|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943636|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943637|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
44943638|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943639|NCT03522844|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44943640|NCT03522844|Antidepressive Agents|antidepressive agents|mesh-ancestor
44943641|NCT03522844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44943642|NCT03514719|Avelumab|avelumab|mesh-list
44943643|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44943644|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943645|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943646|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
44943647|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943648|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
44943649|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943650|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943651|NCT03465280|Interferons|interferons|mesh-list
44943652|NCT03465280|Acyclovir|acyclovir|mesh-list
44943653|NCT03465280|Cidofovir|cidofovir|mesh-list
44943654|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
44943655|NCT03465280|Artemisinins|artemisinins|mesh-list
44943656|NCT03465280|Artemisinin|artemisinin|mesh-list
44943657|NCT03465280|Celecoxib|celecoxib|mesh-list
44943658|NCT03465280|Methotrexate|methotrexate|mesh-list
44943659|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
44943660|NCT03465280|Isotretinoin|isotretinoin|mesh-list
44943661|NCT03465280|Cimetidine|cimetidine|mesh-list
44943662|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943663|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943664|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44943665|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
44943666|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44943667|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44943668|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
44943669|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943670|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943671|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943672|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44943673|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943674|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
44943675|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943676|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44943677|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
44943678|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943679|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943680|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943681|NCT03465280|Analgesics|analgesics|mesh-ancestor
44943682|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
44943683|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943684|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943685|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44943686|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44943687|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44943688|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943689|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44943690|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
44943691|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
44943692|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943693|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44943694|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44943695|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
44943696|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44943697|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44943698|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44943699|NCT03465280|Protective Agents|protective agents|mesh-ancestor
44943700|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44943701|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
44943702|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943703|NCT03421041|Dexamethasone|dexamethasone|mesh-list
44943704|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943705|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
44943706|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
44943707|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943708|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943709|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943710|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
44943711|NCT03421041|Hormones|hormones|mesh-ancestor
44943712|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943713|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44943714|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943715|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44943716|NCT03377790|Cantharidin|cantharidin|mesh-list
44943717|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943718|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943719|NCT03353675|Nivolumab|nivolumab|mesh-list
44943720|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943721|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943722|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44943723|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943724|NCT03319316|Durvalumab|durvalumab|mesh-list
44943725|NCT03319316|Tremelimumab|tremelimumab|mesh-list
44943726|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943727|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943728|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44943729|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44943730|NCT03300518|Estradiol|estradiol|mesh-list
44943731|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44943732|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44943733|NCT03300518|Ganirelix|ganirelix|mesh-list
44943734|NCT03300518|Estrogens|estrogens|mesh-ancestor
44943735|NCT03300518|Hormones|hormones|mesh-ancestor
44943736|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943737|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943738|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44943739|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
44943740|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44943741|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44943742|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
44943743|NCT03294109|Bupivacaine|bupivacaine|mesh-list
44943744|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
44943745|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
44943746|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943747|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943748|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
44943749|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943751|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
44943752|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44943753|NCT03268005|Insulin|insulin|mesh-list
44943754|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44943755|NCT03268005|Metformin|metformin|mesh-list
44943756|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
44943757|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
44943758|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44943759|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943760|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943761|NCT03257618|Temozolomide|temozolomide|mesh-list
44943762|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44943763|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
44943764|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943765|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943766|NCT03228186|Docetaxel|docetaxel|mesh-list
44943767|NCT03228186|Pevonedistat|pevonedistat|mesh-list
44943768|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943769|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943770|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943771|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943772|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943773|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943774|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44943775|NCT03220854|Antibodies|antibodies|mesh-list
44943776|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
44943777|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44943778|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
44943779|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943780|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943781|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
44943782|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
44943783|NCT03168438|Fludarabine|fludarabine|mesh-list
44943784|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943785|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
44943786|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943787|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943788|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44943789|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
44943790|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943791|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943792|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44943793|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943794|NCT03132038|Nivolumab|nivolumab|mesh-list
44943795|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943796|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943797|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44943798|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943799|NCT03110380|Dolutegravir|dolutegravir|mesh-list
44943800|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44943801|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44943802|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44943803|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943804|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943805|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44943806|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44943807|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
44943808|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943809|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44943810|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44943811|NCT03078478|Insulin|insulin|mesh-list
44943812|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44943813|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
44943814|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943815|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943816|NCT03046927|Vitamin D|vitamin d|mesh-list
44943817|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
44943818|NCT03046927|Vitamins|vitamins|mesh-ancestor
44943819|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
44943820|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943821|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44475036|NCT04191954|Fasudil|fasudil|mesh-list
44943822|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44943823|NCT03009487|Amlodipine|amlodipine|mesh-list
44943824|NCT03009487|Olmesartan|olmesartan|mesh-list
44943825|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44943826|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
44943827|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44943828|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44943829|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44943830|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44943831|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943832|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44943833|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943834|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44943835|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44943836|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44943837|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
44943838|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44943839|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44943840|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943841|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44475613|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
44475614|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475616|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44943842|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44943843|NCT02961881|Blinatumomab|blinatumomab|mesh-list
44943844|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943845|NCT02954523|Dasatinib|dasatinib|mesh-list
44943846|NCT02954523|Osimertinib|osimertinib|mesh-list
44943847|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943848|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943849|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943850|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943851|NCT02927249|Aspirin|aspirin|mesh-list
44943852|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44943853|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44943854|NCT02927249|Analgesics|analgesics|mesh-ancestor
44943855|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
44943856|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943857|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943858|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44943859|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44943860|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44943861|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44943862|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943863|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44943864|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44943865|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943866|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
44943867|NCT02924272|Ixazomib|ixazomib|mesh-list
44943868|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943869|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
44943870|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943871|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943872|NCT02908087|Liraglutide|liraglutide|mesh-list
44943873|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44943874|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943875|NCT02908087|Incretins|incretins|mesh-ancestor
44943876|NCT02908087|Hormones|hormones|mesh-ancestor
44943877|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943878|NCT02901483|Cisplatin|cisplatin|mesh-list
44943879|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943880|NCT02874651|Apatinib|apatinib|mesh-list
44943881|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943882|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943883|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943884|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943885|NCT02873195|Bevacizumab|bevacizumab|mesh-list
44943886|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44943887|NCT02873195|Capecitabine|capecitabine|mesh-list
44943888|NCT02873195|Atezolizumab|atezolizumab|mesh-list
44943889|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
44943890|NCT02873195|Antibodies|antibodies|mesh-list
44943891|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
44943892|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44943893|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
44943894|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943895|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44943896|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44475166|NCT04195633|Cyclosporine|cyclosporine|mesh-list
44943897|NCT02873195|Growth Substances|growth substances|mesh-ancestor
44943898|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943899|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44943900|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
44943901|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44943902|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
44943903|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943905|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44943906|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
44943907|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44943908|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
44943909|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943910|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943911|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
44943912|NCT02809131|Levofloxacin|levofloxacin|mesh-list
44943913|NCT02809131|Ofloxacin|ofloxacin|mesh-list
44943914|NCT02809131|Clindamycin|clindamycin|mesh-list
44943915|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
44943916|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
44943917|NCT02809131|Cephalexin|cephalexin|mesh-list
44943918|NCT02809131|Polymyxins|polymyxins|mesh-list
44943919|NCT02809131|Bacitracin|bacitracin|mesh-list
44943920|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44943921|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44943922|NCT02809131|Renal Agents|renal agents|mesh-ancestor
44943923|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44943924|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44943925|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44943926|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943927|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943928|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943929|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44943930|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44943931|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44943932|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44943933|NCT02785952|Nivolumab|nivolumab|mesh-list
44943934|NCT02785952|Ipilimumab|ipilimumab|mesh-list
44943935|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44943936|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943937|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44943938|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943939|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44943940|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44943941|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44943942|NCT02730429|Letrozole|letrozole|mesh-list
44943943|NCT02730429|Palbociclib|palbociclib|mesh-list
44943944|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943945|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44943946|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44943947|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943948|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943949|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44943950|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
44943951|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44943952|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943953|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943954|NCT02730416|Paclitaxel|paclitaxel|mesh-list
44943955|NCT02730416|Carboplatin|carboplatin|mesh-list
44943956|NCT02730416|Nintedanib|nintedanib|mesh-list
44943957|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44943958|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943959|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
44943960|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
44943961|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
44943962|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943963|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44943964|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44943965|NCT02589860|Melphalan|melphalan|mesh-list
44943966|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44943967|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
44943968|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943969|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44943970|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44943971|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44943972|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
44943973|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943974|NCT02583789|Treprostinil|treprostinil|mesh-list
44943975|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44943977|NCT02556606|Ketamine|ketamine|mesh-list
44943978|NCT02556606|Analgesics|analgesics|mesh-ancestor
44943979|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
44943980|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44943981|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44943982|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44943983|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44943984|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
44943985|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
44943986|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44943987|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44943988|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44943989|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44943990|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44943991|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44943992|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44943993|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44943994|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44943995|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44943996|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
44943997|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
44943998|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
44943999|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44944000|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44944001|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44944002|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944003|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
44944004|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944005|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944006|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44944007|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944008|NCT02545283|Cytarabine|cytarabine|mesh-list
44944009|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944010|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
44944011|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944012|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944013|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
44944014|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944015|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944016|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
44944017|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944018|NCT02532231|Nivolumab|nivolumab|mesh-list
44944019|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944020|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944021|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44944022|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944023|NCT02507505|Anesthetics|anesthetics|mesh-list
44944024|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944025|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944026|NCT02465593|Fluorouracil|fluorouracil|mesh-list
44944027|NCT02465593|Capecitabine|capecitabine|mesh-list
44944028|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
44944029|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944030|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944031|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944032|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944033|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
44944034|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944035|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44944036|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944037|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
44944038|NCT02424019|Hormones|hormones|mesh-ancestor
44944039|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944040|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944041|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
44944042|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44944043|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44944044|NCT02422368|Prednisolone|prednisolone|mesh-list
44944045|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
44944046|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44944047|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
44944048|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944050|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
44944051|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944052|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944053|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944054|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
44944055|NCT02422368|Hormones|hormones|mesh-ancestor
44944056|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944057|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44944058|NCT02422368|Protective Agents|protective agents|mesh-ancestor
44944059|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944060|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944061|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
44944062|NCT02333162|Fludarabine|fludarabine|mesh-list
44944063|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
44944064|NCT02333162|Melphalan|melphalan|mesh-list
44944065|NCT02333162|Tacrolimus|tacrolimus|mesh-list
44944066|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944067|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944068|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
44944069|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944070|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944071|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
44944072|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944073|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44944074|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944075|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44944076|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44944077|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
44944078|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944079|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944080|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44944081|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
44944082|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44944083|NCT02318342|Warfarin|warfarin|mesh-list
44944084|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
44944085|NCT02304991|Glycerol|glycerol|mesh-list
44944086|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44944087|NCT02304991|Protective Agents|protective agents|mesh-ancestor
44944088|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944089|NCT02225600|Oxytocin|oxytocin|mesh-list
44944090|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
44944091|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944092|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944093|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
44944094|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44944095|NCT02223520|Mupirocin|mupirocin|mesh-list
44944096|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44944097|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944098|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
44944099|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
44944100|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944101|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44944102|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944103|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944104|NCT02220309|Pramipexole|pramipexole|mesh-list
44944105|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
44944106|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944107|NCT02220309|Protective Agents|protective agents|mesh-ancestor
44944108|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944109|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44944110|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44944111|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
44944112|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
44944113|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944114|NCT02122198|Leuprolide|leuprolide|mesh-list
44944115|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44944116|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
44944117|NCT02122198|Estradiol|estradiol|mesh-list
44475386|NCT04026009|Vaccines|vaccines|mesh-list
44944118|NCT02122198|Estrogens|estrogens|mesh-ancestor
44944119|NCT02122198|Hormones|hormones|mesh-ancestor
44944120|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944121|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944122|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44944123|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
44944124|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944125|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44944126|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44944127|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
44944128|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944129|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944130|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44944131|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44944132|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44944133|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44944134|NCT02079948|Folic Acid|folic acid|mesh-list
44944135|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
44944136|NCT02079948|Methotrexate|methotrexate|mesh-list
44944137|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44944138|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
44944139|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944140|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944141|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944142|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
44944143|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944144|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475650|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
44475651|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44475652|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
44475653|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
44475654|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44475662|NCT04026022|Fentanyl|fentanyl|mesh-list
44944145|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
44944146|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944147|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44944148|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944149|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
44944150|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944151|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44944152|NCT02079948|Hematinics|hematinics|mesh-ancestor
44944153|NCT02079948|Vitamins|vitamins|mesh-ancestor
44944154|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
44944155|NCT02060188|Nivolumab|nivolumab|mesh-list
44944156|NCT02060188|Ipilimumab|ipilimumab|mesh-list
44944157|NCT02060188|Daratumumab|daratumumab|mesh-list
44944158|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944159|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944160|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44944161|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944162|NCT02055053|Bupivacaine|bupivacaine|mesh-list
44944163|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
44944164|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
44944165|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944166|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944167|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
44944168|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944169|NCT02004275|Dexamethasone|dexamethasone|mesh-list
44944170|NCT02004275|Pomalidomide|pomalidomide|mesh-list
44944171|NCT02004275|Ixazomib|ixazomib|mesh-list
44944172|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944173|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
44944174|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
44944175|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944176|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944177|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944178|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
44944179|NCT02004275|Hormones|hormones|mesh-ancestor
44944180|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944181|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944182|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944183|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
44944184|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944185|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944186|NCT02004275|Growth Substances|growth substances|mesh-ancestor
44944187|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944188|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
44944189|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944190|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944191|NCT01978938|Levofloxacin|levofloxacin|mesh-list
44944192|NCT01978938|Ofloxacin|ofloxacin|mesh-list
44944193|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44944194|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944195|NCT01978938|Renal Agents|renal agents|mesh-ancestor
44944196|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944197|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44944198|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944200|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944201|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944202|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44944203|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44944204|NCT01854385|Sumatriptan|sumatriptan|mesh-list
44944205|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44944206|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44944207|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44944208|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
44944209|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944210|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944211|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944212|NCT01844856|Ertapenem|ertapenem|mesh-list
44944213|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944214|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944215|NCT01817166|Vitamin D|vitamin d|mesh-list
44944216|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
44944217|NCT01817166|Vitamins|vitamins|mesh-ancestor
44944218|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
44944219|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944220|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44944221|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44944222|NCT01712789|Dexamethasone|dexamethasone|mesh-list
44944223|NCT01712789|Pomalidomide|pomalidomide|mesh-list
44944224|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944225|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
44944226|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
44944227|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944228|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944229|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944230|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
44944231|NCT01712789|Hormones|hormones|mesh-ancestor
44944232|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944233|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944234|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944235|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
44944236|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944237|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944238|NCT01712789|Growth Substances|growth substances|mesh-ancestor
44944239|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944240|NCT01665794|Dexamethasone|dexamethasone|mesh-list
44944241|NCT01665794|Daratumumab|daratumumab|mesh-list
44944242|NCT01665794|Pomalidomide|pomalidomide|mesh-list
44944243|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944244|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
44944245|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
44944246|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944247|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944248|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944249|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
44944250|NCT01665794|Hormones|hormones|mesh-ancestor
44944251|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944252|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944253|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944254|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
44944255|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944256|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944257|NCT01665794|Growth Substances|growth substances|mesh-ancestor
44944258|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44707244|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944259|NCT01543633|Propofol|propofol|mesh-list
44944260|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44944261|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944262|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944263|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44944264|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
44944265|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
44944266|NCT01542736|Carboplatin|carboplatin|mesh-list
44944267|NCT01542736|Vincristine|vincristine|mesh-list
44944268|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944269|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944270|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944271|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944272|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944273|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944274|NCT01481974|Treprostinil|treprostinil|mesh-list
44944275|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44944276|NCT01442649|Leucovorin|leucovorin|mesh-list
44944277|NCT01442649|Folic Acid|folic acid|mesh-list
44944278|NCT01442649|Bevacizumab|bevacizumab|mesh-list
44944279|NCT01442649|Cetuximab|cetuximab|mesh-list
44944280|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
44944281|NCT01442649|Irinotecan|irinotecan|mesh-list
44944282|NCT01442649|Fluorouracil|fluorouracil|mesh-list
44944283|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
44944284|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944285|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944286|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944287|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944288|NCT01442649|Growth Substances|growth substances|mesh-ancestor
44944289|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944290|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944291|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44944292|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944293|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944294|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944295|NCT01442649|Antidotes|antidotes|mesh-ancestor
44944296|NCT01442649|Protective Agents|protective agents|mesh-ancestor
44944297|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
44944298|NCT01442649|Vitamins|vitamins|mesh-ancestor
44944299|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
44944300|NCT01442649|Hematinics|hematinics|mesh-ancestor
44944301|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
44944302|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944303|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944304|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
44944305|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
44944306|NCT01147666|Hematinics|hematinics|mesh-ancestor
44944307|NCT00982111|Cisplatin|cisplatin|mesh-list
44944308|NCT00982111|Pemetrexed|pemetrexed|mesh-list
44944309|NCT00982111|Necitumumab|necitumumab|mesh-list
44944310|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944311|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944312|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944313|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44944314|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44944315|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944316|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
44944317|NCT00116142|Docetaxel|docetaxel|mesh-list
44944318|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
44944319|NCT00116142|Androgens|androgens|mesh-list
44944320|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44944321|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944322|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944323|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944324|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944325|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944326|NCT00116142|Hormones|hormones|mesh-ancestor
44944327|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944328|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944329|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
44944330|NCT00116142|Protective Agents|protective agents|mesh-ancestor
44944331|NCT00116142|Vitamins|vitamins|mesh-ancestor
44944332|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
44944333|NCT00116142|Estrogens|estrogens|mesh-ancestor
44944334|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944335|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
44944336|NCT00070018|Prednisone|prednisone|mesh-list
44944337|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
44944338|NCT00070018|Rituximab|rituximab|mesh-list
44944339|NCT00070018|Doxorubicin|doxorubicin|mesh-list
44944340|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44944341|NCT00070018|Vincristine|vincristine|mesh-list
44944342|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44944343|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944344|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
44944345|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944346|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944347|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44944348|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
44944349|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944350|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944351|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44944352|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944353|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44944354|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44944355|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944356|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944357|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944358|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
44944359|NCT00070018|Hormones|hormones|mesh-ancestor
44944360|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944361|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944362|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944363|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944364|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944365|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944366|NCT05189184|Paclitaxel|paclitaxel|mesh-list
44944367|NCT05189184|Cisplatin|cisplatin|mesh-list
44944368|NCT05189184|Apatinib|apatinib|mesh-list
44944369|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44944370|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944371|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944372|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944373|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944374|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944375|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944376|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44944377|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944378|NCT05189093|Antibodies|antibodies|mesh-list
44944379|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44944380|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
44944381|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944382|NCT05189067|Paclitaxel|paclitaxel|mesh-list
44944383|NCT05189067|Docetaxel|docetaxel|mesh-list
44944384|NCT05189067|Trastuzumab|trastuzumab|mesh-list
44944385|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944386|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944387|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944388|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944389|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944390|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944391|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944392|NCT05188911|Prednisone|prednisone|mesh-list
44944393|NCT05188911|Androgens|androgens|mesh-list
44944394|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944395|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
44944396|NCT05188911|Hormones|hormones|mesh-ancestor
44944397|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944398|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944399|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944400|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944401|NCT05188859|Cisplatin|cisplatin|mesh-list
44944402|NCT05188859|Pemetrexed|pemetrexed|mesh-list
44944403|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944404|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944405|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944406|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44944407|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44944408|NCT05188833|Paroxetine|paroxetine|mesh-list
44944409|NCT05188833|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44944410|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44944411|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44944412|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944413|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944414|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
44944415|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944416|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44944417|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
44944418|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44944419|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44944420|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44944421|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944422|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
44944423|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944424|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944425|NCT05188768|Mitogens|mitogens|mesh-list
44944426|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944427|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944428|NCT05188742|Mirabegron|mirabegron|mesh-list
44944429|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44944430|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44944431|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44944432|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
44944433|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944434|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944435|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944436|NCT05188742|Urological Agents|urological agents|mesh-ancestor
44944437|NCT05188495|Trastuzumab|trastuzumab|mesh-list
44944438|NCT05188495|Pertuzumab|pertuzumab|mesh-list
44944439|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944440|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944441|NCT05188131|Diclofenac|diclofenac|mesh-list
44944442|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44944443|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944444|NCT05188131|Analgesics|analgesics|mesh-ancestor
44944445|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
44944446|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944447|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944448|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944449|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944450|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44944451|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944452|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944453|NCT05188118|Nivolumab|nivolumab|mesh-list
44944454|NCT05188118|Ipilimumab|ipilimumab|mesh-list
44944455|NCT05188118|Everolimus|everolimus|mesh-list
44944456|NCT05188118|Lenvatinib|lenvatinib|mesh-list
44944457|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944458|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944459|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44944460|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944461|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944462|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
44944463|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944464|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44944465|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944466|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
44944467|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44944468|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944469|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
44944470|NCT05169424|Fluticasone|fluticasone|mesh-list
44944471|NCT05169424|Xhance|xhance|mesh-list
44944472|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
44944473|NCT05169424|Olodaterol|olodaterol|mesh-list
44944474|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944475|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44944476|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
44944477|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944478|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944479|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44944480|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44944481|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44944482|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44944483|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
44944484|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44944485|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
44944486|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944487|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944488|NCT05160896|Bevacizumab|bevacizumab|mesh-list
44707245|NCT01432704|Vitamins|vitamins|mesh-ancestor
44944489|NCT05160896|Cetuximab|cetuximab|mesh-list
44944490|NCT05160896|Irinotecan|irinotecan|mesh-list
44944491|NCT05160896|Raltitrexed|raltitrexed|mesh-list
44944492|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944493|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944494|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944495|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944496|NCT05160896|Growth Substances|growth substances|mesh-ancestor
44944497|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944498|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944499|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44944500|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944501|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944502|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944503|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944504|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
44944505|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44944506|NCT05124509|Vaccines|vaccines|mesh-list
44944507|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
44944508|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944509|NCT05076409|Fluconazole|fluconazole|mesh-list
44944510|NCT05076409|BI 425809|bi 425809|mesh-list
44944511|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
44944512|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944513|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44944514|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44944515|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944516|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944517|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44944518|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
44944519|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944520|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944521|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44944522|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44944523|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
44944524|NCT05008575|Fludarabine|fludarabine|mesh-list
44944525|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
44944526|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944527|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944528|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944529|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
44944530|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944531|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944532|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44944533|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
44944534|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44944535|NCT04984369|Cetuximab|cetuximab|mesh-list
44944536|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944537|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944538|NCT04971473|Hormones|hormones|mesh-list
44944539|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944540|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944541|NCT04925193|Dexamethasone|dexamethasone|mesh-list
44944542|NCT04925193|Daratumumab|daratumumab|mesh-list
44944543|NCT04925193|Pomalidomide|pomalidomide|mesh-list
44944544|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944545|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
44944546|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
44944547|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944548|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944549|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944550|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
44944551|NCT04925193|Hormones|hormones|mesh-ancestor
44944552|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944553|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944554|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944555|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
44944556|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944557|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944558|NCT04925193|Growth Substances|growth substances|mesh-ancestor
44944559|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944560|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
44944561|NCT04925180|Cyproterone|cyproterone|mesh-list
44944562|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
44944563|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
44944564|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944565|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944566|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944567|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44944568|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
44944569|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944570|NCT04775680|Antibodies|antibodies|mesh-list
44944571|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
44944572|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944573|NCT04595513|Sirolimus|sirolimus|mesh-list
44944574|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944575|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944576|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44944577|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944578|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
44944579|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944580|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
44944581|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944582|NCT04560881|Vaccines|vaccines|mesh-list
44944583|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
44944584|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944585|NCT04501120|Azacitidine|azacitidine|mesh-list
44944586|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944587|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
44944588|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944589|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944590|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944591|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
44944592|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44944593|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944594|NCT04447287|Buprenorphine|buprenorphine|mesh-list
44944595|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44944596|NCT04447287|ASP8062|asp8062|mesh-list
44944597|NCT04447287|Naloxone|naloxone|mesh-list
44944598|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44475867|NCT04023149|Analgesics|analgesics|mesh-ancestor
44944599|NCT04447287|Narcotics|narcotics|mesh-ancestor
44944600|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944601|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944602|NCT04447287|Analgesics|analgesics|mesh-ancestor
44944603|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
44944604|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944605|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44944606|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
44944607|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
44944608|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944609|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944610|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
44944611|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44944612|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
44944613|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44944614|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44944615|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944616|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944617|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
44944618|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
44944619|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
44944620|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44944621|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44944622|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944623|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944624|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944625|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944626|NCT04175834|Cetirizine|cetirizine|mesh-list
44944627|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
44944628|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44944629|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44944630|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44944631|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
44944632|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944633|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944634|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944635|NCT04039503|Tirzepatide|tirzepatide|mesh-list
44944636|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44944637|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944638|NCT04039503|Incretins|incretins|mesh-ancestor
44944639|NCT04039503|Hormones|hormones|mesh-ancestor
44944640|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944641|NCT03913195|Ibalizumab|ibalizumab|mesh-list
44944642|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44944643|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44944644|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
44944645|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944646|NCT03695172|Ropivacaine|ropivacaine|mesh-list
44944647|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
44944648|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
44944649|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944650|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944651|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
44944652|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944653|NCT03552380|Nivolumab|nivolumab|mesh-list
44944654|NCT03552380|Ipilimumab|ipilimumab|mesh-list
44944655|NCT03552380|Entinostat|entinostat|mesh-list
44944656|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944657|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944658|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44475702|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475703|NCT04025593|Prednisone|prednisone|mesh-list
44475704|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
44475705|NCT04025593|Rituximab|rituximab|mesh-list
44475706|NCT04025593|Doxorubicin|doxorubicin|mesh-list
44475707|NCT04025593|Vincristine|vincristine|mesh-list
44475708|NCT04025593|Lenalidomide|lenalidomide|mesh-list
44475709|NCT04025593|Decitabine|decitabine|mesh-list
44475710|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475711|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
44475712|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944659|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944660|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44944661|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944662|NCT03467360|Etoposide|etoposide|mesh-list
44944663|NCT03467360|Acetazolamide|acetazolamide|mesh-list
44944664|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944665|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944666|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44944667|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944668|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944669|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944670|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
44944671|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44944672|NCT03467360|Diuretics|diuretics|mesh-ancestor
44944673|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
44944674|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944675|NCT03452072|Timolol|timolol|mesh-list
44944676|NCT03452072|Petrolatum|petrolatum|mesh-list
44944677|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44944678|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44944679|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44944680|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944681|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944682|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944683|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44944684|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44944685|NCT03452072|Emollients|emollients|mesh-ancestor
44944686|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
44944687|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44944688|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44944689|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44944690|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
44944691|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944692|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944693|NCT03433040|Progestins|progestins|mesh-ancestor
44944694|NCT03433040|Hormones|hormones|mesh-ancestor
44944695|NCT03432065|Buspirone|buspirone|mesh-list
44944696|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44944697|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44944698|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944699|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944700|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44944701|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44944702|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
44944703|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944704|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944705|NCT03412799|Gemcitabine|gemcitabine|mesh-list
44944706|NCT03412799|Paclitaxel|paclitaxel|mesh-list
44944707|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44944708|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944709|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944710|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944711|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944712|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944713|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944714|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944715|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
44944716|NCT03412799|Antiviral Agents|antiviral agents|mesh-ancestor
44944717|NCT03412799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944718|NCT03412799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944719|NCT03412799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944720|NCT03412799|Immunologic Factors|immunologic factors|mesh-ancestor
44944721|NCT03412799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944722|NCT03066622|Olanzapine|olanzapine|mesh-list
44944723|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
44944724|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
44944725|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944726|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944727|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944728|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44944729|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44944730|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944731|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44944732|NCT03066622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44944733|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44944734|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44944735|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944736|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944737|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
44707246|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
44944738|NCT02799212|Somatostatin|somatostatin|mesh-list
44944739|NCT02799212|Hormones|hormones|mesh-ancestor
44944740|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944741|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944742|NCT02358681|Ketorolac|ketorolac|mesh-list
44944743|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44944744|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44944745|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944746|NCT02358681|Analgesics|analgesics|mesh-ancestor
44944747|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
44944748|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944749|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944750|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944751|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944752|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44944753|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944754|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944755|NCT02101788|Tamoxifen|tamoxifen|mesh-list
44944756|NCT02101788|Paclitaxel|paclitaxel|mesh-list
44944757|NCT02101788|Doxorubicin|doxorubicin|mesh-list
44944758|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44944759|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44944760|NCT02101788|Letrozole|letrozole|mesh-list
44944761|NCT02101788|Topotecan|topotecan|mesh-list
44944762|NCT02101788|Trametinib|trametinib|mesh-list
44944763|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44944764|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944765|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944766|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944767|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944768|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944769|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944770|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44944771|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44944772|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944773|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944774|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44944775|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44944776|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44944777|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
44944778|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944779|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944780|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44944781|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944782|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44944783|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44944784|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44944785|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44944786|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44475713|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475714|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44475726|NCT04025593|Hormones|hormones|mesh-ancestor
44944787|NCT02101788|Protective Agents|protective agents|mesh-ancestor
44944788|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44944789|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
44944790|NCT02081378|Niacinamide|niacinamide|mesh-list
44944791|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
44944792|NCT02081378|Dasatinib|dasatinib|mesh-list
44944793|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944794|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44944795|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944796|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944797|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
44944798|NCT02081378|Vitamins|vitamins|mesh-ancestor
44944799|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
44944800|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944801|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
44944802|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944803|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944804|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44944805|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44944806|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944807|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944808|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944809|NCT01842282|Amlexanox|amlexanox|mesh-list
44944810|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44944811|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
44944812|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
44944813|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944814|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944815|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44944816|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
44944817|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944818|NCT01622335|Analgesics|analgesics|mesh-ancestor
44944819|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
44944820|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475728|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44475729|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475730|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475731|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475732|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475733|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44475734|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44475735|NCT04025593|Growth Substances|growth substances|mesh-ancestor
44475736|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
44475737|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44475738|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
44475739|NCT04025177|Indomethacin|indomethacin|mesh-list
44944822|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44944823|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944824|NCT01362374|Leucovorin|leucovorin|mesh-list
44944825|NCT01362374|Paclitaxel|paclitaxel|mesh-list
44944826|NCT01362374|Docetaxel|docetaxel|mesh-list
44944827|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
44944828|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44944829|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944830|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44944831|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44944832|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44944833|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944834|NCT01362374|Antidotes|antidotes|mesh-ancestor
44944835|NCT01362374|Protective Agents|protective agents|mesh-ancestor
44944836|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944837|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
44944838|NCT01362374|Vitamins|vitamins|mesh-ancestor
44944839|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
44944840|NCT01164228|Gemcitabine|gemcitabine|mesh-list
44944841|NCT01164228|Sunitinib|sunitinib|mesh-list
44944842|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944843|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
44944844|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944845|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944846|NCT01164228|Antiviral Agents|antiviral agents|mesh-ancestor
44944847|NCT01164228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944848|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944849|NCT01164228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944850|NCT01164228|Immunologic Factors|immunologic factors|mesh-ancestor
44944851|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944852|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944853|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944854|NCT01164228|Growth Substances|growth substances|mesh-ancestor
44944855|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944856|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44944857|NCT01012167|Galantamine|galantamine|mesh-list
44944858|NCT01012167|Oxytocin|oxytocin|mesh-list
44944859|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
44944860|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944861|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944862|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44944863|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944864|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944865|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44944866|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944867|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44944868|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
44944869|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944870|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
44944871|NCT00924326|Vidarabine|vidarabine|mesh-list
44944872|NCT00924326|Aldesleukin|aldesleukin|mesh-list
44944873|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
44944874|NCT00924326|Fludarabine|fludarabine|mesh-list
44944875|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
44944876|NCT00924326|Interleukin-2|interleukin-2|mesh-list
44944877|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44944878|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
44944879|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944880|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944881|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44944882|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
44944883|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944884|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944885|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44944886|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944887|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
44944888|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
44944889|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44944890|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944891|NCT00924326|Analgesics|analgesics|mesh-ancestor
44944892|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
44944893|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944894|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44944895|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44944896|NCT00321100|Bevacizumab|bevacizumab|mesh-list
44944897|NCT00321100|Cetuximab|cetuximab|mesh-list
44944898|NCT00321100|Capecitabine|capecitabine|mesh-list
44944899|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
44944900|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44944901|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944902|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44944903|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44944904|NCT00321100|Growth Substances|growth substances|mesh-ancestor
44944905|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944906|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
44944907|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44944908|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
44944909|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944910|NCT05190952|Dexamethasone|dexamethasone|mesh-list
44944911|NCT05190952|Ketamine|ketamine|mesh-list
44944912|NCT05190952|Bupivacaine|bupivacaine|mesh-list
44944913|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944914|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
44944915|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
44944916|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944917|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944918|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44944919|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
44944920|NCT05190952|Hormones|hormones|mesh-ancestor
44944921|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44944922|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44944923|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944924|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
44944925|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
44944926|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944927|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
44944928|NCT05190952|Analgesics|analgesics|mesh-ancestor
44944929|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44944930|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44944931|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
44944932|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44944933|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44944934|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44944935|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944936|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
44944937|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944938|NCT05190562|Astringents|astringents|mesh-ancestor
44944939|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
44944940|NCT05190341|Ibuprofen|ibuprofen|mesh-list
44944941|NCT05190341|Ketorolac|ketorolac|mesh-list
44944942|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44944943|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944944|NCT05190341|Analgesics|analgesics|mesh-ancestor
44944945|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
44944946|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944947|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944948|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944949|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944950|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44944951|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944952|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944953|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
44944954|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44944955|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
44944956|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44944957|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944958|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44944959|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44944960|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44944961|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
44944962|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44944963|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944964|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
44944965|NCT05167084|Metyrapone|metyrapone|mesh-list
44944966|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944967|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
44944968|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44944969|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44944970|NCT05165992|Fentanyl|fentanyl|mesh-list
44944971|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44944972|NCT05165992|Narcotics|narcotics|mesh-ancestor
44944973|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44944974|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944975|NCT05165992|Analgesics|analgesics|mesh-ancestor
44944976|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
44944977|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944978|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44944979|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44944980|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
44944981|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
44944982|NCT05154968|Mannitol|mannitol|mesh-list
44944983|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44944984|NCT05154968|Diuretics|diuretics|mesh-ancestor
44944985|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
44944986|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476251|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
44944987|NCT05118256|Pirfenidone|pirfenidone|mesh-list
44944988|NCT05118256|Analgesics|analgesics|mesh-ancestor
44944989|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
44944990|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44944991|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44944992|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44944993|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44944994|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44944995|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44944996|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944997|NCT05106335|Docetaxel|docetaxel|mesh-list
44944998|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44944999|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945000|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945001|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945002|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945003|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44945004|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44945005|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
44945006|NCT05042947|Hormones|hormones|mesh-ancestor
44945007|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945008|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945009|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945010|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945011|NCT05033847|Vaccines|vaccines|mesh-list
44945012|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
44945013|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945014|NCT05019560|Sevoflurane|sevoflurane|mesh-list
44945015|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44945016|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44945017|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
44945018|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
44945019|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945020|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945021|NCT04989829|Omeprazole|omeprazole|mesh-list
44945022|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44945023|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945024|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44945025|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945026|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945027|NCT04939090|Megestrol|megestrol|mesh-list
44945028|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
44945029|NCT04939090|Olanzapine|olanzapine|mesh-list
44945030|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
44945031|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
44945032|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945033|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945034|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945035|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44945036|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44945037|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945038|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44945039|NCT04939090|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44945040|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44945041|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44945042|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945043|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945044|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
44945045|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44945046|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44945047|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44945048|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
44945049|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945050|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44945051|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44945052|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945053|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945054|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
44945055|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44945056|NCT04865497|Vaccines|vaccines|mesh-list
44945057|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
44945058|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945059|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
44945060|NCT04816162|Ketamine|ketamine|mesh-list
44476283|NCT04021862|Antibodies|antibodies|mesh-list
44945061|NCT04816162|Propofol|propofol|mesh-list
44945062|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44945063|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945064|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945065|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44945066|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
44945067|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
44945068|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44945069|NCT04816162|Analgesics|analgesics|mesh-ancestor
44945070|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
44945071|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945072|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44945073|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44945074|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44945075|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
44945076|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945077|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945078|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44945079|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44945080|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44945081|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
44945082|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44945083|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945084|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
44945085|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
44945086|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945087|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
44945088|NCT04676802|Narcotics|narcotics|mesh-ancestor
44945089|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945090|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945091|NCT04676802|Analgesics|analgesics|mesh-ancestor
44945092|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
44945093|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945094|NCT04631471|Ibudilast|ibudilast|mesh-list
44945095|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44945096|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
44945097|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945098|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945099|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44945100|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
44945101|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44945102|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945103|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945104|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44945105|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
44945106|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
44945107|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44945108|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945109|NCT04550455|Cladribine|cladribine|mesh-list
44945110|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945111|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945112|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
44945113|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945114|NCT04505735|Corticosterone|corticosterone|mesh-list
44945115|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945116|NCT04420455|Enoximone|enoximone|mesh-list
44945117|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44945118|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
44945119|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44945120|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44945121|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945122|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945123|NCT04420455|Protective Agents|protective agents|mesh-ancestor
44945124|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945125|NCT04419337|Metformin|metformin|mesh-list
44945126|NCT04419337|Pioglitazone|pioglitazone|mesh-list
44945127|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44945128|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44945129|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945130|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945131|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
44945132|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945133|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945134|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
44945135|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44945136|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945138|NCT04297592|Cephalexin|cephalexin|mesh-list
44945139|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44945140|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945141|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
44945142|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44945143|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44945144|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
44945145|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945146|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945147|NCT04234464|Budesonide|budesonide|mesh-list
44945148|NCT04234464|Albuterol|albuterol|mesh-list
44945149|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945150|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44945151|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
44945152|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945153|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945154|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44945155|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44945156|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
44945157|NCT04234464|Hormones|hormones|mesh-ancestor
44945158|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945159|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
44945160|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945161|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44945162|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44945163|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44945164|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
44945165|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945166|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945167|NCT04089514|Adalimumab|adalimumab|mesh-list
44945168|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945169|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945170|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
44945171|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44945172|NCT03845114|Insulin|insulin|mesh-list
44945173|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44945174|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44945175|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945176|NCT03789318|Acetaminophen|acetaminophen|mesh-list
44945177|NCT03789318|Fentanyl|fentanyl|mesh-list
44945178|NCT03789318|Oxycodone|oxycodone|mesh-list
44945179|NCT03789318|Hydromorphone|hydromorphone|mesh-list
44945180|NCT03789318|Bupivacaine|bupivacaine|mesh-list
44945181|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
44945182|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
44945183|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945184|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945185|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
44945186|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945187|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44945188|NCT03789318|Narcotics|narcotics|mesh-ancestor
44945189|NCT03789318|Analgesics|analgesics|mesh-ancestor
44945190|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44945191|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44945192|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
44945193|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44945194|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
44945195|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
44945196|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
44945197|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945198|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945199|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945200|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
44945201|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
44945202|NCT03631004|Olanzapine|olanzapine|mesh-list
44945203|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
44945204|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
44945205|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945206|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945207|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945208|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44945209|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44945210|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945211|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44945212|NCT03631004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44945213|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44945214|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44945215|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945217|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
44476501|NCT04149964|Analgesics|analgesics|mesh-ancestor
44945219|NCT03615664|Dexamethasone|dexamethasone|mesh-list
44945220|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44945221|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945222|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
44945223|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
44945224|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945225|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945226|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945227|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
44945228|NCT03615664|Hormones|hormones|mesh-ancestor
44945229|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945230|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945231|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945232|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945233|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
44945234|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945235|NCT03615664|Antiviral Agents|antiviral agents|mesh-ancestor
44945236|NCT03615664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945237|NCT03615664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945238|NCT03615664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945239|NCT03615664|Immunologic Factors|immunologic factors|mesh-ancestor
44945240|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945241|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
44945242|NCT03556345|Trastuzumab|trastuzumab|mesh-list
44945243|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945244|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945245|NCT03513250|Scopolamine|scopolamine|mesh-list
44945246|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44945247|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44945248|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
44945249|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
44945250|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945251|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945252|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945253|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
44945254|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44945255|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
44945256|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945257|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945258|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44945259|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
44945260|NCT03368963|Trifluridine|trifluridine|mesh-list
44945261|NCT03368963|Irinotecan|irinotecan|mesh-list
44945262|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44945263|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44945264|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945265|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945266|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945267|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
44945268|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
44945269|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945270|NCT03345823|Upadacitinib|upadacitinib|mesh-list
44945271|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44945272|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44945273|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945274|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945275|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945276|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
44945277|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945278|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945279|NCT03127215|Olaparib|olaparib|mesh-list
44945280|NCT03127215|Trabectedin|trabectedin|mesh-list
44945281|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44945282|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945283|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945284|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945285|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945286|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
44945287|NCT02935595|Ketamine|ketamine|mesh-list
44945288|NCT02935595|Analgesics|analgesics|mesh-ancestor
44945289|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
44945290|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945291|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945292|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44945293|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44945294|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
44945296|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945297|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44945298|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44945299|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945300|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945301|NCT02887248|Gemcitabine|gemcitabine|mesh-list
44945302|NCT02887248|Paclitaxel|paclitaxel|mesh-list
44945303|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945304|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945305|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945306|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945307|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945308|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945309|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945310|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
44945311|NCT02887248|Antiviral Agents|antiviral agents|mesh-ancestor
44945312|NCT02887248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945313|NCT02887248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945314|NCT02887248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945315|NCT02887248|Immunologic Factors|immunologic factors|mesh-ancestor
44945316|NCT02887248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945317|NCT02849990|Prednisone|prednisone|mesh-list
44945318|NCT02849990|Cortisone|cortisone|mesh-list
44945319|NCT02849990|Indomethacin|indomethacin|mesh-list
44945320|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
44945321|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945322|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
44945323|NCT02849990|Hormones|hormones|mesh-ancestor
44945324|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945325|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945326|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945327|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945328|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44945329|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945330|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945331|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
44945332|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44945333|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44945334|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44945335|NCT02849990|Analgesics|analgesics|mesh-ancestor
44945336|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
44945337|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945338|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945339|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
44945340|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
44945341|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945342|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44945343|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
44945344|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945345|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945346|NCT02817347|Tazobactam|tazobactam|mesh-list
44945347|NCT02817347|Piperacillin|piperacillin|mesh-list
44945348|NCT02817347|Dexamethasone|dexamethasone|mesh-list
44945349|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
44945350|NCT02817347|BB 1101|bb 1101|mesh-list
44945351|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945352|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
44945353|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
44945354|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945355|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945356|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945357|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
44945358|NCT02817347|Hormones|hormones|mesh-ancestor
44945359|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945360|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945361|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945362|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
44945363|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475805|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
44475806|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945364|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475809|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945365|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44945366|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476632|NCT04149275|Nivolumab|nivolumab|mesh-list
44945367|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44945368|NCT02800824|Budesonide|budesonide|mesh-list
44945369|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945370|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44945371|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
44945372|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945373|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945374|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44945375|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44945376|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
44945377|NCT02800824|Hormones|hormones|mesh-ancestor
44945378|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945379|NCT02780401|Vaccines|vaccines|mesh-list
44945380|NCT02780401|Sargramostim|sargramostim|mesh-list
44945381|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
44945382|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945383|NCT02673151|Edetic Acid|edetic acid|mesh-list
44945384|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44945385|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
44945386|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
44945387|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945388|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
44945389|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44945390|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44945391|NCT02653092|Heparin|heparin|mesh-list
44945392|NCT02653092|Anticoagulants|anticoagulants|mesh-list
44945393|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44945394|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44945395|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44945396|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945397|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44945398|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44945399|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44945400|NCT02567578|YH12852|yh12852|mesh-list
44945401|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44945402|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44945403|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
44475817|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475818|NCT04024072|Brinzolamide|brinzolamide|mesh-list
44475819|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44475820|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475821|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475822|NCT04023760|Apixaban|apixaban|mesh-list
44475823|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44475824|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
44475825|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44945404|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945405|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945406|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945407|NCT02523274|Resveratrol|resveratrol|mesh-list
44945408|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
44945409|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945410|NCT02523274|Protective Agents|protective agents|mesh-ancestor
44945411|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945412|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945413|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44945414|NCT02452554|Maytansine|maytansine|mesh-list
44945415|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44945416|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44945417|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945418|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945419|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945420|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945421|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945422|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945423|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945424|NCT02432560|Sirolimus|sirolimus|mesh-list
44945425|NCT02432560|Everolimus|everolimus|mesh-list
44945426|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945427|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945428|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
44945429|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945430|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44945431|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945432|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44945433|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
44945434|NCT02359175|Acetaminophen|acetaminophen|mesh-list
44945435|NCT02359175|Fentanyl|fentanyl|mesh-list
44945436|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
44945437|NCT02359175|Bupivacaine|bupivacaine|mesh-list
44945438|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
44945439|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
44945440|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945441|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945442|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
44945443|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945444|NCT02359175|Narcotics|narcotics|mesh-ancestor
44945445|NCT02359175|Analgesics|analgesics|mesh-ancestor
44945446|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44945447|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44945448|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
44945449|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44945450|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
44945451|NCT02323659|Interferons|interferons|mesh-list
44945452|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
44945453|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
44945454|NCT02323659|Methotrexate|methotrexate|mesh-list
44945455|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44945456|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
44945457|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945458|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945459|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945460|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
44945461|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945462|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945463|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945464|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945465|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44945466|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945467|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
44945468|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945469|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44945470|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
44945471|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945472|NCT02318277|Durvalumab|durvalumab|mesh-list
44945473|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945474|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945475|NCT02296801|Letrozole|letrozole|mesh-list
44945476|NCT02296801|Palbociclib|palbociclib|mesh-list
44945477|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945478|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44945479|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44945480|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945481|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945482|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44945483|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
44945484|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945485|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945486|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44945487|NCT02283853|Interferons|interferons|mesh-list
44945488|NCT02283853|Interferon-beta|interferon-beta|mesh-list
44945489|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
44945490|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44945491|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945492|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
44945493|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945494|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945495|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945496|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
44945497|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945498|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44945499|NCT02176668|Esomeprazole|esomeprazole|mesh-list
44945500|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44945501|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945502|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44945503|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945504|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945505|NCT02143063|Cocaine|cocaine|mesh-list
44945506|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
44945507|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
44945508|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945509|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945510|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
44945511|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945512|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44945513|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44945514|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44945515|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44945516|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945517|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
44945518|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945519|NCT02073097|Acyclovir|acyclovir|mesh-list
44945520|NCT02073097|Prednisone|prednisone|mesh-list
44945521|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
44945522|NCT02073097|Rituximab|rituximab|mesh-list
44945523|NCT02073097|Doxorubicin|doxorubicin|mesh-list
44945524|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44945525|NCT02073097|Vincristine|vincristine|mesh-list
44945526|NCT02073097|Lenograstim|lenograstim|mesh-list
44945527|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945528|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
44945529|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945530|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945531|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945532|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
44945533|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945534|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945535|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44945536|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945537|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44945538|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44945539|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44945540|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945541|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945542|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
44945543|NCT02073097|Hormones|hormones|mesh-ancestor
44945544|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945545|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945546|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945547|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945548|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945549|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945550|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44945551|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
44945552|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945553|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
44945554|NCT02017964|Carboplatin|carboplatin|mesh-list
44945555|NCT02017964|Methotrexate|methotrexate|mesh-list
44945556|NCT02017964|Etoposide|etoposide|mesh-list
44945557|NCT02017964|Vincristine|vincristine|mesh-list
44945558|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
44945559|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
44945560|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945561|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
44945562|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945563|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945564|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945565|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
44945566|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945567|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945568|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44945569|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44945570|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
44945571|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945572|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945573|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
44945574|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945575|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945576|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44945577|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44945578|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945579|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44945580|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44945581|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945582|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945583|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945584|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
44945585|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44945586|NCT01956110|Hormones|hormones|mesh-ancestor
44945587|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945588|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945589|NCT01335581|Tretinoin|tretinoin|mesh-list
44945590|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945591|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
44945592|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945593|NCT00867178|Vitamin A|vitamin a|mesh-list
44945594|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
44945595|NCT00867178|Thiotepa|thiotepa|mesh-list
44945597|NCT00867178|Carboplatin|carboplatin|mesh-list
44945598|NCT00867178|Etoposide|etoposide|mesh-list
44945599|NCT00867178|Vincristine|vincristine|mesh-list
44945600|NCT00867178|Vorinostat|vorinostat|mesh-list
44945601|NCT00867178|Tretinoin|tretinoin|mesh-list
44945602|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
44945603|NCT00867178|Isotretinoin|isotretinoin|mesh-list
44945604|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945605|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
44945606|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945607|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945608|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945609|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
44945610|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945611|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945612|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44945613|NCT00867178|Vitamins|vitamins|mesh-ancestor
44945614|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
44945615|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945616|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44945617|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44945618|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945619|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945620|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945621|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945622|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44945623|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
44945624|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945625|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44945626|NCT00787176|Oxytocin|oxytocin|mesh-list
44945627|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
44945628|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945629|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945630|NCT00352534|Dactinomycin|dactinomycin|mesh-list
44945631|NCT00352534|Cactinomycin|cactinomycin|mesh-list
44945632|NCT00352534|Doxorubicin|doxorubicin|mesh-list
44945633|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44945634|NCT00352534|Vincristine|vincristine|mesh-list
44945635|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44945636|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945637|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44945638|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44945639|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945640|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945641|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945642|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945643|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945644|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945645|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44945646|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945647|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44945648|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44945649|NCT00033293|Prednisone|prednisone|mesh-list
44945650|NCT00033293|Cortisone|cortisone|mesh-list
44945651|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
44945652|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
44945653|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44945654|NCT00033293|Antibodies|antibodies|mesh-list
44945655|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
44945656|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44945657|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
44945658|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945659|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
44945660|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945661|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945662|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945663|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
44945664|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945665|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945666|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44945667|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945668|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
44945669|NCT00033293|Hormones|hormones|mesh-ancestor
44945670|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945671|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945672|NCT05193370|Vasopressins|vasopressins|mesh-list
44945673|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
44945674|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
44945675|NCT05193370|Giapreza|giapreza|mesh-list
44945676|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
44945677|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
44945678|NCT05193370|Coagulants|coagulants|mesh-ancestor
44945679|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44945680|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44945681|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
44945682|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945683|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44945684|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44945685|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945686|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945687|NCT05193292|Trastuzumab|trastuzumab|mesh-list
44945688|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945689|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945690|NCT05193227|Lidocaine|lidocaine|mesh-list
44945691|NCT05193227|Bupivacaine|bupivacaine|mesh-list
44945692|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
44945693|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
44945694|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945695|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945696|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
44945697|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945698|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44945699|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44945700|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44945701|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44945702|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945703|NCT05193214|Antibodies|antibodies|mesh-list
44945704|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44945705|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
44945706|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945707|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44945708|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945709|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945710|NCT05192902|Anesthetics|anesthetics|mesh-list
44945711|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945712|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945713|NCT05192681|Docetaxel|docetaxel|mesh-list
44945714|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945715|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945716|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945717|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945718|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945719|NCT05192304|Maleic acid|maleic acid|mesh-list
44945720|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945721|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945722|NCT05192213|Ascorbic Acid|ascorbic acid|mesh-list
44945723|NCT05192213|Thiamine|thiamine|mesh-list
44945724|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
44945725|NCT05192213|Vitamins|vitamins|mesh-ancestor
44945726|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
44945727|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945728|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945729|NCT05192213|Antioxidants|antioxidants|mesh-ancestor
44945730|NCT05192213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945731|NCT05192213|Protective Agents|protective agents|mesh-ancestor
44945732|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
44945733|NCT05191914|Fulvestrant|fulvestrant|mesh-list
44945734|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44945735|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945736|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44945737|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44945738|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
44945739|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945740|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945741|NCT05191888|Amoxicillin|amoxicillin|mesh-list
44945742|NCT05191888|Metronidazole|metronidazole|mesh-list
44945743|NCT05191888|Clarithromycin|clarithromycin|mesh-list
44945744|NCT05191888|Rabeprazole|rabeprazole|mesh-list
44945745|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44945746|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945747|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44945748|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44945749|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44945750|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945751|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945752|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44945753|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44945754|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44945755|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945756|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44945757|NCT05173857|Paclitaxel|paclitaxel|mesh-list
44945758|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945759|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945760|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945761|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945762|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945763|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945764|NCT05168527|Gemcitabine|gemcitabine|mesh-list
44945765|NCT05168527|Paclitaxel|paclitaxel|mesh-list
44945766|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44945767|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945768|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945769|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945770|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945771|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945772|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945773|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
44945774|NCT05168527|Antiviral Agents|antiviral agents|mesh-ancestor
44945775|NCT05168527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945776|NCT05168527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945777|NCT05168527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945778|NCT05168527|Immunologic Factors|immunologic factors|mesh-ancestor
44945779|NCT05168527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945780|NCT05133297|Tofacitinib|tofacitinib|mesh-list
44945781|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44945782|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945783|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945784|NCT05123820|Midazolam|midazolam|mesh-list
44945785|NCT05123820|Omeprazole|omeprazole|mesh-list
44945786|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44945787|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44945788|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44945789|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945790|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44945791|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44945792|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44945793|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44945794|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
44945795|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
44945796|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
44945797|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
44945798|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945799|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945800|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44945801|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44945802|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44945803|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945804|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
44945805|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44945806|NCT04871165|Antibodies|antibodies|mesh-list
44945807|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
44945808|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945809|NCT04666389|Atorvastatin|atorvastatin|mesh-list
44945810|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44945811|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44945812|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
44945813|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945814|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44945815|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44945816|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945817|NCT04635631|Talazoparib|talazoparib|mesh-list
44945818|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44945819|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945820|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945821|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945822|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44945823|NCT04614168|Glycerol|glycerol|mesh-list
44945824|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945825|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44945826|NCT04614168|Protective Agents|protective agents|mesh-ancestor
44945827|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
44945828|NCT04477837|Apixaban|apixaban|mesh-list
44945829|NCT04477837|Edoxaban|edoxaban|mesh-list
44945830|NCT04477837|Dabigatran|dabigatran|mesh-list
44945831|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44945832|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
44945833|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44945834|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
44945835|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945836|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945837|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
44945838|NCT04473807|Sotalol|sotalol|mesh-list
44945839|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44945840|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44945841|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
44945842|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945843|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945844|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945845|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44945846|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
44945847|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
44945848|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945849|NCT04347239|Leronlimab|leronlimab|mesh-list
44945850|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44945851|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44945852|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945853|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44945854|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44945855|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
44945856|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945857|NCT04285086|Anagrelide|anagrelide|mesh-list
44945858|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44945859|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44945860|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945861|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44945862|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
44945863|NCT04230265|Fludarabine|fludarabine|mesh-list
44945864|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945865|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
44945866|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945867|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945868|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44945869|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
44945870|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945871|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945872|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44945873|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
44945874|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44945875|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
44945876|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44945877|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
44945878|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945879|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945880|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
44945881|NCT05347316|Colchicine|colchicine|mesh-list
44945882|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
44945883|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945884|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945885|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945886|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945887|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945888|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945889|NCT05324423|Colchicine|colchicine|mesh-list
44945890|NCT05324423|Febuxostat|febuxostat|mesh-list
44945891|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
44945892|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945893|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44945894|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44945895|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44945896|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945897|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945898|NCT05322707|Budesonide|budesonide|mesh-list
44945899|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
44945900|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44945901|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44945902|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44945903|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
44945904|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945905|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945906|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44945907|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
44945908|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
44945909|NCT05322707|Hormones|hormones|mesh-ancestor
44945910|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945911|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44945912|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44945913|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44945914|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44945915|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945916|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945917|NCT05200143|Nivolumab|nivolumab|mesh-list
44945918|NCT05200143|Ipilimumab|ipilimumab|mesh-list
44945919|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945920|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945921|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44945922|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945923|NCT05160090|Bupropion|bupropion|mesh-list
44945924|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44945925|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
44945926|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44945927|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44945928|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44945929|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44945930|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945931|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
44945932|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945933|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945934|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44945935|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44945936|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945938|NCT05154994|Ipilimumab|ipilimumab|mesh-list
44945939|NCT05154994|Tremelimumab|tremelimumab|mesh-list
44945940|NCT05154994|Belinostat|belinostat|mesh-list
44945941|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
44945942|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44945943|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
44945944|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44945945|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945946|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
44945947|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945948|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44945949|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945950|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44945951|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945952|NCT05132699|Cannabidiol|cannabidiol|mesh-list
44945953|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44945954|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
44945955|NCT05114486|Pilocarpine|pilocarpine|mesh-list
44945956|NCT05114486|Miotics|miotics|mesh-ancestor
44945957|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
44945958|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44945959|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945960|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44945961|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44945962|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
44945963|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44945964|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945965|NCT05103228|Menotropins|menotropins|mesh-list
44945966|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44945967|NCT05103228|Hormones|hormones|mesh-ancestor
44945968|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44945969|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945970|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44945971|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
44945972|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945973|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
44945974|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44945975|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
44945976|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945977|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
44945978|NCT05082480|Protective Agents|protective agents|mesh-ancestor
44945979|NCT05067166|Ansuvimab|ansuvimab|mesh-list
44945980|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
44945981|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44945982|NCT05008887|Fluorouracil|fluorouracil|mesh-list
44945983|NCT05008887|Methotrexate|methotrexate|mesh-list
44945984|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
44945985|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44945986|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44945987|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44945988|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44945989|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
44945990|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44945991|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44945992|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
44945993|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44945994|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
44945995|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44945996|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44945997|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44945998|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44945999|NCT05007522|Ketotifen|ketotifen|mesh-list
44946000|NCT05007522|Indomethacin|indomethacin|mesh-list
44946001|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946002|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946003|NCT05007522|Analgesics|analgesics|mesh-ancestor
44946004|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
44946005|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946006|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946007|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946008|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946009|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
44946010|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
44946011|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946012|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44946013|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946014|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946015|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
44946016|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946017|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44946018|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
44946019|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
44946020|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946021|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44946022|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
44946023|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44946024|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44946025|NCT04988425|Prednisolone|prednisolone|mesh-list
44946026|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
44946027|NCT04988425|Antibodies|antibodies|mesh-list
44946028|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44946029|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44946030|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
44946031|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
44946032|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946033|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946034|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
44946035|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
44946036|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946037|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946038|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
44946039|NCT04988425|Hormones|hormones|mesh-ancestor
44946040|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946041|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44946042|NCT04988425|Protective Agents|protective agents|mesh-ancestor
44946043|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946044|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946045|NCT04959760|Antibodies|antibodies|mesh-list
44946046|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
44946047|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
44946048|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
44946049|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946050|NCT04944771|Rabeprazole|rabeprazole|mesh-list
44946051|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44946052|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946053|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44946054|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946055|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946056|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
44946057|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946058|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946059|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946060|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946061|NCT04878510|Analgesics|analgesics|mesh-ancestor
44946062|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
44946063|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946064|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44946065|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44946066|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946067|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946068|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946069|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946070|NCT04865289|Paclitaxel|paclitaxel|mesh-list
44946071|NCT04865289|Carboplatin|carboplatin|mesh-list
44946072|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
44946073|NCT04865289|Lenvatinib|lenvatinib|mesh-list
44946074|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44946075|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946076|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
44946077|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
44946078|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
44946079|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946080|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946081|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44946082|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946083|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44946084|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
44946085|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
44946086|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946087|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946088|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44946089|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44946090|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44946091|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
44946092|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946093|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44946094|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
44946096|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
44946097|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946098|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946099|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946100|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946101|NCT04820205|Analgesics|analgesics|mesh-ancestor
44946102|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
44946103|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946104|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44946105|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44946106|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946107|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946108|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946109|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946110|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44946111|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44946112|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
44946113|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
44946114|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44946115|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44946116|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
44946117|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44946118|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
44946119|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946120|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946121|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44946122|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44946123|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44946124|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
44946125|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946126|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946127|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44946128|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
44946129|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
44946130|NCT04776408|Protective Agents|protective agents|mesh-ancestor
44946131|NCT04739995|Naltrexone|naltrexone|mesh-list
44946132|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44946133|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44946134|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946135|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
44946136|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946137|NCT04677959|Fluticasone|fluticasone|mesh-list
44946138|NCT04677959|Xhance|xhance|mesh-list
44946139|NCT04677959|Albuterol|albuterol|mesh-list
44946140|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44946141|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946142|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44946143|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
44946144|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946145|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946146|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44946147|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44946148|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946149|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44946150|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44946151|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44946152|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946153|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946154|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946155|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946156|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
44946157|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946158|NCT04624984|Gemcitabine|gemcitabine|mesh-list
44946159|NCT04624984|Doxorubicin|doxorubicin|mesh-list
44946160|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44946161|NCT04624984|Vinorelbine|vinorelbine|mesh-list
44946162|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44946163|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946164|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
44946165|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946166|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946167|NCT04624984|Antiviral Agents|antiviral agents|mesh-ancestor
44946168|NCT04624984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946169|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946170|NCT04624984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946171|NCT04624984|Immunologic Factors|immunologic factors|mesh-ancestor
44946172|NCT04624984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946173|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44946174|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946175|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946176|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44946177|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
44946178|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
44946179|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
44946180|NCT04624958|Rituximab|rituximab|mesh-list
44946181|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
44946182|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946183|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946184|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
44946185|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946186|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946187|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44946188|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946189|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946190|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
44946191|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
44946192|NCT04620252|Citric Acid|citric acid|mesh-list
44946193|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
44946195|NCT04620252|Fluorides|fluorides|mesh-list
44946196|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44946197|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946198|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44946199|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
44946200|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44946201|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
44946202|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
44946203|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946204|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
44946205|NCT04620252|Protective Agents|protective agents|mesh-ancestor
44946206|NCT04620252|Antacids|antacids|mesh-ancestor
44946207|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946208|NCT04594759|Isotretinoin|isotretinoin|mesh-list
44946209|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946210|NCT04585893|Rituximab|rituximab|mesh-list
44946211|NCT04585893|Etoposide|etoposide|mesh-list
44946212|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946213|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946214|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
44946215|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946216|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946217|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44946218|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946219|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946220|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946221|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946222|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44946223|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44946224|NCT04544267|Vaccines|vaccines|mesh-list
44946225|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
44946226|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946227|NCT04490018|Vaccines|vaccines|mesh-list
44946228|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
44946229|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946230|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
44946231|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946232|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946233|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946234|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946235|NCT04454515|Analgesics|analgesics|mesh-ancestor
44946236|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
44946237|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946238|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44946239|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44946240|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946241|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946242|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946243|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946244|NCT04442022|Gemcitabine|gemcitabine|mesh-list
44946245|NCT04442022|Dexamethasone|dexamethasone|mesh-list
44946246|NCT04442022|Rituximab|rituximab|mesh-list
44946247|NCT04442022|Cisplatin|cisplatin|mesh-list
44946248|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946249|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946250|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
44946251|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946252|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946253|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946254|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
44946255|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
44946256|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946257|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946258|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
44946259|NCT04442022|Hormones|hormones|mesh-ancestor
44946260|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946261|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946262|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946263|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
44946264|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946265|NCT04442022|Antiviral Agents|antiviral agents|mesh-ancestor
44946266|NCT04442022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946267|NCT04442022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946269|NCT04342715|Paromomycin|paromomycin|mesh-list
44946270|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44946271|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44946272|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946273|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44946274|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44946275|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
44946276|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44946277|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
44946278|NCT04269213|Cytarabine|cytarabine|mesh-list
44946279|NCT04269213|Daunorubicin|daunorubicin|mesh-list
44946280|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946281|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
44946282|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946283|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946284|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
44946285|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946286|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946287|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
44946288|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946289|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44946290|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946291|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946292|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946293|NCT04055116|Lidocaine|lidocaine|mesh-list
44946294|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
44946295|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
44946296|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946297|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946298|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
44946299|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946300|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44946301|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44946302|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44946303|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44946304|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946305|NCT04045795|Dexamethasone|dexamethasone|mesh-list
44946306|NCT04045795|Pomalidomide|pomalidomide|mesh-list
44946307|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44946308|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946309|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
44946310|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
44946311|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946312|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946313|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946314|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
44946315|NCT04045795|Hormones|hormones|mesh-ancestor
44946316|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946317|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946318|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946319|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
44946320|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44946321|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44946322|NCT04045795|Growth Substances|growth substances|mesh-ancestor
44946323|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44946324|NCT04040946|Choline|choline|mesh-list
44946325|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
44946326|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44946327|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
44946328|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946329|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946330|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44946331|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
44946332|NCT03869866|Vaccines|vaccines|mesh-list
44946333|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
44946334|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946335|NCT03703050|Nivolumab|nivolumab|mesh-list
44946336|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946337|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946338|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44946339|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946340|NCT03610711|Nivolumab|nivolumab|mesh-list
44946341|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946342|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946343|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44946344|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946345|NCT03604874|Oxytocin|oxytocin|mesh-list
44946346|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
44946347|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946348|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946349|NCT03575572|Colchicine|colchicine|mesh-list
44946350|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
44946351|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946352|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44946353|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
44946354|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44946355|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946356|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946357|NCT03557359|Nivolumab|nivolumab|mesh-list
44946358|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946359|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946360|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44946361|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946362|NCT03522415|Methotrexate|methotrexate|mesh-list
44946363|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44946364|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
44946365|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946366|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946367|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946368|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
44946369|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946370|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946371|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946372|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946373|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44946374|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946375|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
44946376|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946377|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44946378|NCT03521687|Apremilast|apremilast|mesh-list
44946379|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946380|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946381|NCT03521687|Analgesics|analgesics|mesh-ancestor
44946382|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
44946383|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946384|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946385|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946386|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946387|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44946388|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44946389|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946390|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946391|NCT03498131|Melatonin|melatonin|mesh-list
44946392|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
44946393|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946394|NCT03498131|Protective Agents|protective agents|mesh-ancestor
44946395|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946396|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946397|NCT03410901|Antibodies|antibodies|mesh-list
44946398|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
44946399|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946400|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
44946401|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44946402|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44946403|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946404|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
44946405|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946406|NCT03357939|Adalimumab|adalimumab|mesh-list
44946407|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946408|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946409|NCT03316781|Adalimumab|adalimumab|mesh-list
44946410|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946411|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946412|NCT03256045|Dexamethasone|dexamethasone|mesh-list
44946413|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
44946414|NCT03256045|Panobinostat|panobinostat|mesh-list
44946415|NCT03256045|Ichthammol|ichthammol|mesh-list
44946416|NCT03256045|BB 1101|bb 1101|mesh-list
44475869|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946417|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946418|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
44946419|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
44946420|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946421|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946422|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946423|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
44946424|NCT03256045|Hormones|hormones|mesh-ancestor
44946425|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946426|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946427|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946428|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
44946429|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946430|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946431|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44946432|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946433|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
44946434|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44946435|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
44946436|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946437|NCT03149107|Expectorants|expectorants|mesh-ancestor
44946438|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
44946439|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44946440|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
44946441|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946442|NCT03149107|Protective Agents|protective agents|mesh-ancestor
44946443|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946444|NCT03149107|Antidotes|antidotes|mesh-ancestor
44946445|NCT03135301|Metformin|metformin|mesh-list
44946446|NCT03135301|Letrozole|letrozole|mesh-list
44946447|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44946448|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946449|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946450|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44946451|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44946452|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946453|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946454|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44946455|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
44946456|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946457|NCT03117010|Dexamethasone|dexamethasone|mesh-list
44946458|NCT03117010|Etoposide|etoposide|mesh-list
44946459|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946460|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
44946461|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
44946462|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946463|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946464|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946465|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
44946466|NCT03117010|Hormones|hormones|mesh-ancestor
44946467|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946468|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946469|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946470|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946471|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946472|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44946473|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946474|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946475|NCT03046836|Oxytocin|oxytocin|mesh-list
44946476|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
44946477|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946478|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946479|NCT03038594|Hormones|hormones|mesh-list
44946480|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946481|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946482|NCT03009838|Letrozole|letrozole|mesh-list
44946483|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946484|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44946485|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44946486|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946487|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946488|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44946489|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
44946490|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946491|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946492|NCT02983747|Loxoprofen|loxoprofen|mesh-list
44946493|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946494|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946495|NCT02983747|Analgesics|analgesics|mesh-ancestor
44946496|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
44946497|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946498|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946499|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946500|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946501|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
44946502|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946503|NCT02966119|Aspirin|aspirin|mesh-list
44946504|NCT02966119|Clopidogrel|clopidogrel|mesh-list
44946505|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946506|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946507|NCT02966119|Analgesics|analgesics|mesh-ancestor
44946508|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
44946509|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946510|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946511|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946512|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946513|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44946514|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44946515|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946516|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44946517|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44946518|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946519|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
44946520|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44946521|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44946522|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44946523|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
44946524|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946525|NCT02870738|Triamcinolone|triamcinolone|mesh-list
44946526|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946527|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
44946528|NCT02870738|Hormones|hormones|mesh-ancestor
44946529|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946530|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946531|NCT02859896|Calcitriol|calcitriol|mesh-list
44946532|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44946533|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44946534|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946535|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44946536|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44946537|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946538|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44946539|NCT02859896|Vitamins|vitamins|mesh-ancestor
44946540|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
44946541|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44946542|NCT02832167|Nivolumab|nivolumab|mesh-list
44946543|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946544|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946545|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44946546|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946547|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
44946548|NCT02821026|Sirolimus|sirolimus|mesh-list
44946549|NCT02821026|Etanercept|etanercept|mesh-list
44946550|NCT02821026|Tacrolimus|tacrolimus|mesh-list
44946551|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
44946552|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44946553|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946554|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
44946555|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946556|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44946557|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946558|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946559|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44946560|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946561|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44946562|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
44946563|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44946564|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946565|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
44946566|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946567|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946569|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
44946570|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946571|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946572|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946573|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946574|NCT02787239|Rituximab|rituximab|mesh-list
44946575|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946576|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946577|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
44946578|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946579|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946580|NCT02681237|Olaparib|olaparib|mesh-list
44946581|NCT02681237|Cediranib|cediranib|mesh-list
44946582|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44946583|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946584|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946585|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946586|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44946587|NCT02674529|Citalopram|citalopram|mesh-list
44946588|NCT02674529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44946589|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44946590|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44946591|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946592|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946593|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
44946594|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946595|NCT02674529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44946596|NCT02674529|Antidepressive Agents|antidepressive agents|mesh-ancestor
44946597|NCT02674529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44946598|NCT02659020|Gemcitabine|gemcitabine|mesh-list
44946599|NCT02659020|Docetaxel|docetaxel|mesh-list
44946600|NCT02659020|Olaratumab|olaratumab|mesh-list
44946601|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946602|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
44946603|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946604|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946605|NCT02659020|Antiviral Agents|antiviral agents|mesh-ancestor
44946606|NCT02659020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946607|NCT02659020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946608|NCT02659020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946609|NCT02659020|Immunologic Factors|immunologic factors|mesh-ancestor
44946610|NCT02659020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946611|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
44946612|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
44946613|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
44946614|NCT02584920|Rituximab|rituximab|mesh-list
44946615|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946616|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946617|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
44946618|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946619|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946620|NCT02565914|Ivacaftor|ivacaftor|mesh-list
44946621|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44946622|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44946623|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946624|NCT02535832|Pioglitazone|pioglitazone|mesh-list
44946625|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44946626|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946627|NCT02513186|Dexamethasone|dexamethasone|mesh-list
44946628|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
44946629|NCT02513186|Lenalidomide|lenalidomide|mesh-list
44946630|NCT02513186|Bortezomib|bortezomib|mesh-list
44946631|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946632|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
44946633|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946634|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946635|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44946636|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
44946637|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946638|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946639|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44946640|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946641|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
44946642|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
44946643|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946644|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946645|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
44946646|NCT02513186|Hormones|hormones|mesh-ancestor
44946647|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946648|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946649|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44946650|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44946651|NCT02513186|Growth Substances|growth substances|mesh-ancestor
44946652|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44946653|NCT02373241|Losartan|losartan|mesh-list
44946654|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44946655|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44946656|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44946657|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44946658|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946659|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
44946660|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44946661|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44946662|NCT01941589|Prednisolone|prednisolone|mesh-list
44946663|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
44946664|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
44946665|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44946666|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44946667|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44946668|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44946669|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
44946670|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946671|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
44946672|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
44946673|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946674|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946675|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946676|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
44946677|NCT01941589|Hormones|hormones|mesh-ancestor
44946678|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946679|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44946680|NCT01941589|Protective Agents|protective agents|mesh-ancestor
44946681|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946682|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946683|NCT01845649|Estradiol|estradiol|mesh-list
44946684|NCT01845649|Estrogens|estrogens|mesh-ancestor
44946685|NCT01845649|Hormones|hormones|mesh-ancestor
44946686|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946687|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946688|NCT01816139|Estradiol|estradiol|mesh-list
44946689|NCT01816139|Estrogens|estrogens|mesh-ancestor
44946690|NCT01816139|Hormones|hormones|mesh-ancestor
44946691|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946692|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946693|NCT01453088|Bortezomib|bortezomib|mesh-list
44946694|NCT01453088|Melphalan|melphalan|mesh-list
44946695|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946696|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44946697|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
44946698|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946699|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44946700|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946701|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
44946702|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946703|NCT01400776|Estradiol|estradiol|mesh-list
44946704|NCT01400776|Estrogens|estrogens|mesh-ancestor
44946705|NCT01400776|Hormones|hormones|mesh-ancestor
44946706|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946707|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946708|NCT01182766|Topiramate|topiramate|mesh-list
44946709|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
44946710|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44946711|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946712|NCT00783536|Etanercept|etanercept|mesh-list
44946713|NCT00783536|Methotrexate|methotrexate|mesh-list
44946714|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44946715|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
44946716|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44946717|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946718|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44946719|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
44946720|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946721|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946722|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44946723|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946724|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44946725|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946726|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
44946727|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946728|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44946729|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946730|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946731|NCT00783536|Analgesics|analgesics|mesh-ancestor
44946732|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
44946733|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946734|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946735|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946736|NCT00695214|Propofol|propofol|mesh-list
44946737|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946738|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946739|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946740|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44946741|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
44946742|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
44946743|NCT00511134|Eszopiclone|eszopiclone|mesh-list
44946744|NCT00511134|Bupropion|bupropion|mesh-list
44946745|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44946746|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
44946747|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44946748|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44946749|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44946750|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44946751|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946752|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
44946753|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946754|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946755|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44946756|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44946757|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946758|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946759|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946760|NCT04005209|Ketamine|ketamine|mesh-list
44946761|NCT04005209|Analgesics|analgesics|mesh-ancestor
44946762|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
44946763|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946764|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946765|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44946766|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44946767|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
44946768|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
44946769|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946770|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44946771|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44946772|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946773|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946774|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
44946775|NCT03961789|Narcotics|narcotics|mesh-ancestor
44946776|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946777|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946778|NCT03961789|Analgesics|analgesics|mesh-ancestor
44475895|NCT04023305|Sevoflurane|sevoflurane|mesh-list
44946779|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
44946780|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946781|NCT03873675|Hormones|hormones|mesh-list
44946782|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
44946783|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946784|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946785|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44946787|NCT03728179|Celecoxib|celecoxib|mesh-list
44946788|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
44946789|NCT03728179|Nivolumab|nivolumab|mesh-list
44946790|NCT03728179|Ipilimumab|ipilimumab|mesh-list
44946791|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946792|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
44946793|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946794|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946795|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44946796|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
44946797|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946798|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946799|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44946800|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946801|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44946802|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44946803|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946804|NCT03728179|Analgesics|analgesics|mesh-ancestor
44946805|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
44946806|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946807|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946808|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44946809|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44946810|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44946811|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44946812|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946813|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
44946814|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44946815|NCT03626376|Valacyclovir|valacyclovir|mesh-list
44946816|NCT03626376|Acyclovir|acyclovir|mesh-list
44946817|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44946818|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44946819|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
44946820|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946821|NCT03556358|Paclitaxel|paclitaxel|mesh-list
44946822|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
44946823|NCT03556358|Trastuzumab|trastuzumab|mesh-list
44946824|NCT03556358|Epirubicin|epirubicin|mesh-list
44946825|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44946826|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946827|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44946828|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44946829|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44946830|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946831|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44946832|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
44946833|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946834|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44946835|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44946836|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
44946837|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44946838|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44946839|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44946840|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946841|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946842|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946843|NCT03436108|Bisphenol A|bisphenol a|mesh-list
44946844|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44946845|NCT03436108|Estrogens|estrogens|mesh-ancestor
44946846|NCT03436108|Hormones|hormones|mesh-ancestor
44946847|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946848|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946849|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44946850|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
44946851|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946852|NCT03436108|Protective Agents|protective agents|mesh-ancestor
44946853|NCT03433248|Empagliflozin|empagliflozin|mesh-list
44946854|NCT03433248|Gliclazide|gliclazide|mesh-list
44946855|NCT03433248|Linagliptin|linagliptin|mesh-list
44946856|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44946857|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946858|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44946859|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946860|NCT03433248|Incretins|incretins|mesh-ancestor
44946861|NCT03433248|Hormones|hormones|mesh-ancestor
44946862|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946863|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44946864|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
44946865|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946866|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
44946867|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946868|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946869|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946870|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44946871|NCT03417999|Analgesics|analgesics|mesh-ancestor
44946872|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
44946873|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946874|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44946875|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44946876|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946877|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946878|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946879|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946880|NCT03348670|BCG Vaccine|bcg vaccine|mesh-list
44946881|NCT03348670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44946882|NCT03348670|Immunologic Factors|immunologic factors|mesh-ancestor
44946883|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946884|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44946885|NCT03228680|Hormones|hormones|mesh-ancestor
44946886|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946887|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946888|NCT02914977|Daunorubicin|daunorubicin|mesh-list
44946889|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44946890|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946891|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44946892|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44946893|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946894|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946895|NCT02891798|Dexamethasone|dexamethasone|mesh-list
44946896|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
44946897|NCT02891798|Clonidine|clonidine|mesh-list
44946898|NCT02891798|Buprenorphine|buprenorphine|mesh-list
44946899|NCT02891798|Bupivacaine|bupivacaine|mesh-list
44946900|NCT02891798|BB 1101|bb 1101|mesh-list
44946901|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946902|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
44946903|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
44946904|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946905|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946906|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946907|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
44946908|NCT02891798|Hormones|hormones|mesh-ancestor
44946909|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946910|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44946911|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946912|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
44946913|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946914|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946915|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
44946916|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
44946917|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946918|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
44946919|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44946920|NCT02891798|Narcotics|narcotics|mesh-ancestor
44946921|NCT02891798|Analgesics|analgesics|mesh-ancestor
44946922|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44946923|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44946924|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
44946925|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44946926|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44946927|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44946928|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
44946929|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946930|NCT02870218|Nicotine|nicotine|mesh-list
44946931|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44946932|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
44946933|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946934|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946935|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44946936|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44946937|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
44946938|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946939|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946940|NCT02859961|Leronlimab|leronlimab|mesh-list
44946941|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
44946942|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44946943|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44946944|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946945|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44946946|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44946947|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
44946948|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44946949|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
44946950|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946951|NCT02679781|Midazolam|midazolam|mesh-list
44946952|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44946953|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44946954|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44946955|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946956|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44946957|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44946958|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44946959|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44946960|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
44946961|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
44946962|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
44946963|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
44946964|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44946965|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946966|NCT02624869|Evolocumab|evolocumab|mesh-list
44946967|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44946968|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44946969|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
44946970|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946971|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44946972|NCT02614690|Calpastatin|calpastatin|mesh-list
44946973|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44946974|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
44946975|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44946976|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44946977|NCT02435433|Ramucirumab|ramucirumab|mesh-list
44946978|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44946979|NCT02417142|Exenatide|exenatide|mesh-list
44946980|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44946981|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946982|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44946983|NCT02417142|Incretins|incretins|mesh-ancestor
44946984|NCT02417142|Hormones|hormones|mesh-ancestor
44946985|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946986|NCT02368886|Clobetasol|clobetasol|mesh-list
44946987|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44946988|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
44946989|NCT02368886|Hormones|hormones|mesh-ancestor
44946990|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44946991|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946992|NCT02354703|Ondansetron|ondansetron|mesh-list
44946993|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
44946994|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
44946995|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44946996|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44946997|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44946998|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
44946999|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
44947000|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44947001|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
44947002|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947003|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947004|NCT02354703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44947005|NCT02354703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44947006|NCT02354703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947007|NCT02354703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44947008|NCT02354703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44947009|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44947010|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44947011|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947012|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947013|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
44947014|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947016|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
44947017|NCT00796068|Fludarabine|fludarabine|mesh-list
44947018|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
44947019|NCT00796068|Treosulfan|treosulfan|mesh-list
44947020|NCT00796068|Busulfan|busulfan|mesh-list
44947021|NCT00796068|Cyclosporins|cyclosporins|mesh-list
44947022|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947023|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947024|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
44947025|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947026|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947027|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
44947028|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947029|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947030|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
44947031|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947032|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44947033|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947034|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44947035|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44947036|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44947037|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
44947038|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44947039|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44947040|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
44947041|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44947042|NCT00468130|Aripiprazole|aripiprazole|mesh-list
44947043|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
44947044|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44947045|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44947046|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44947047|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947048|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947049|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
44947050|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
44947051|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947052|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947053|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44947054|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44947055|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
44947056|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44947057|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44947058|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44947059|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44947060|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44947061|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44947062|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
44947063|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947064|NCT05197751|Antacids|antacids|mesh-ancestor
44947065|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947066|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44947067|NCT05197504|Bevacizumab|bevacizumab|mesh-list
44947068|NCT05197504|Atezolizumab|atezolizumab|mesh-list
44947069|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947070|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947071|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44947072|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44947073|NCT05197504|Growth Substances|growth substances|mesh-ancestor
44947074|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947075|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44947076|NCT05197101|Oxytocin|oxytocin|mesh-list
44947077|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
44947078|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44947079|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947080|NCT05197088|Tamsulosin|tamsulosin|mesh-list
44947081|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44947082|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44947083|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44947084|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
44947085|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947086|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947087|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947088|NCT05197088|Urological Agents|urological agents|mesh-ancestor
44478373|NCT03588091|Docetaxel|docetaxel|mesh-list
44947089|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
44947090|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44947091|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947092|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947093|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947094|NCT05196256|Sufentanil|sufentanil|mesh-list
44947095|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
44947096|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44947097|NCT05196256|Narcotics|narcotics|mesh-ancestor
44947098|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947099|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947100|NCT05196256|Analgesics|analgesics|mesh-ancestor
44947101|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
44947102|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947103|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44947104|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44947105|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
44947106|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
44947107|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947108|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
44947109|NCT05195619|Vaccines|vaccines|mesh-list
44947110|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
44947111|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947112|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947113|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947114|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44947115|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
44947116|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947117|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947118|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44947119|NCT05195294|Lenvatinib|lenvatinib|mesh-list
44947120|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947121|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947122|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947123|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947124|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
44947125|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
44947126|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947127|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
44947128|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947129|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947130|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44947131|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
44947132|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947133|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947134|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44947135|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44947136|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44947137|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
44947138|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44947139|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947140|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947141|NCT05194904|Ketorolac|ketorolac|mesh-list
44947142|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
44947143|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44947144|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947145|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947146|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947147|NCT05194904|Analgesics|analgesics|mesh-ancestor
44947148|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
44947149|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947150|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44947151|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44947152|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44947153|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44947154|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947155|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947156|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947157|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947158|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947159|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947160|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947161|NCT05194852|Anesthetics|anesthetics|mesh-list
44947162|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
44478440|NCT03587220|Lidocaine|lidocaine|mesh-list
44947163|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947164|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947165|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
44947166|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947167|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44947168|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947169|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947170|NCT05194046|Amoxicillin|amoxicillin|mesh-list
44947171|NCT05194046|Clarithromycin|clarithromycin|mesh-list
44947172|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44947173|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947174|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44947175|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947176|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947177|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44947178|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44947179|NCT05193838|Allopurinol|allopurinol|mesh-list
44947180|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
44947181|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947182|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947183|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
44947184|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947185|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44947186|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
44947187|NCT05193838|Protective Agents|protective agents|mesh-ancestor
44947188|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947189|NCT05193747|Anesthetics|anesthetics|mesh-list
44947190|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947191|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947192|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
44947193|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
44947194|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
44947195|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947196|NCT05193604|Gemcitabine|gemcitabine|mesh-list
44947197|NCT05193604|Paclitaxel|paclitaxel|mesh-list
44947198|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44947199|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947200|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
44947201|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
44947202|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
44947203|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947204|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947205|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
44947206|NCT05193604|Antiviral Agents|antiviral agents|mesh-ancestor
44947207|NCT05193604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947208|NCT05193604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947209|NCT05193604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947210|NCT05193604|Immunologic Factors|immunologic factors|mesh-ancestor
44947211|NCT05193604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947212|NCT05193253|Liver Extracts|liver extracts|mesh-list
44947213|NCT05193253|Hematinics|hematinics|mesh-ancestor
44947214|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44947215|NCT05173597|Hormones|hormones|mesh-ancestor
44947216|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947217|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947218|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
44947219|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44947220|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
44947221|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44947222|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947223|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44947224|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44947225|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44478515|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
44947226|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44947227|NCT05170464|Caffeine|caffeine|mesh-list
44947228|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44947229|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947230|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44947231|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947232|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947233|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44947234|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44947235|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
44947236|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947237|NCT05165251|Amlodipine|amlodipine|mesh-list
44947238|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44947239|NCT05165251|Atorvastatin|atorvastatin|mesh-list
44947240|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44947241|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44947242|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
44947243|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947244|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44947245|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44947246|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947247|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44947248|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44947249|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947250|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44947251|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947252|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
44947253|NCT05139875|Triamcinolone|triamcinolone|mesh-list
44947254|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44947255|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44947256|NCT05139875|Betamethasone|betamethasone|mesh-list
44947257|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
44947258|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44947259|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
44947260|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
44947261|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44947262|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44947263|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947264|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
44947265|NCT05139875|Hormones|hormones|mesh-ancestor
44947266|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947267|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947268|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947269|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
44947270|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947271|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947272|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44947273|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44947274|NCT05137860|Bortezomib|bortezomib|mesh-list
44947275|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947276|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44947277|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
44947278|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947279|NCT05123170|Lidocaine|lidocaine|mesh-list
44947280|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
44947281|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947282|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
44947283|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947284|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947285|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
44947286|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947287|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44947288|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44947289|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44947290|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947291|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947292|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44947293|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947294|NCT05123170|Analgesics|analgesics|mesh-ancestor
44947295|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44947296|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44947297|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44947299|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947300|NCT05105750|Aspirin|aspirin|mesh-list
44947301|NCT05105750|Indobufen|indobufen|mesh-list
44947302|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947303|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947304|NCT05105750|Analgesics|analgesics|mesh-ancestor
44947305|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
44947306|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947307|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947308|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947309|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947310|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44947311|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44947312|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947313|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44947314|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947315|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947316|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
44947317|NCT05081089|Lumefantrine|lumefantrine|mesh-list
44947318|NCT05081089|Artemether|artemether|mesh-list
44947319|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
44947320|NCT05081089|Primaquine|primaquine|mesh-list
44947321|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
44947322|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44947323|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44947324|NCT05081089|Amodiaquine|amodiaquine|mesh-list
44947325|NCT05081089|Tafenoquine|tafenoquine|mesh-list
44947326|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
44947327|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44947328|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44947329|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947330|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44947331|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947332|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947333|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44947334|NCT05081089|Renal Agents|renal agents|mesh-ancestor
44947335|NCT05064800|Ritonavir|ritonavir|mesh-list
44947336|NCT05064800|Dabigatran|dabigatran|mesh-list
44947337|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44947338|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44947339|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947340|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947341|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947342|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44947343|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44947344|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
44947345|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947346|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44947347|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44947348|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
44947349|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44947350|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
44947351|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44947352|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
44947353|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947354|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947355|NCT05042505|Incretins|incretins|mesh-ancestor
44947356|NCT05042505|Hormones|hormones|mesh-ancestor
44947357|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947358|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44947359|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947360|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947361|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947362|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44947363|NCT05041673|Metformin|metformin|mesh-list
44947364|NCT05041673|Liraglutide|liraglutide|mesh-list
44947365|NCT05041673|Empagliflozin|empagliflozin|mesh-list
44947366|NCT05041673|Vildagliptin|vildagliptin|mesh-list
44947367|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947368|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947369|NCT05041673|Incretins|incretins|mesh-ancestor
44947370|NCT05041673|Hormones|hormones|mesh-ancestor
44947371|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947372|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44478624|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
44947373|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947374|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44947375|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947376|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947378|NCT05032950|Midazolam|midazolam|mesh-list
44947379|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44947380|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44947381|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947382|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947383|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44947384|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44947385|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44947386|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44947387|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
44947388|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
44947389|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
44947390|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
44947391|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947392|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947393|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44947394|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44947395|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947396|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947397|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44947398|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44947399|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
44947400|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947401|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44947402|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44947403|NCT05008276|Dextrans|dextrans|mesh-list
44947404|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
44947405|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
44947406|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
44947407|NCT05005312|Ritonavir|ritonavir|mesh-list
44947408|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44947409|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44947410|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947411|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947412|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947413|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44947414|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44475914|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
44947415|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
44947416|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947417|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44947418|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44947419|NCT04995120|Paclitaxel|paclitaxel|mesh-list
44947420|NCT04995120|Cisplatin|cisplatin|mesh-list
44947421|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44947422|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947423|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44947424|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44947425|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44947426|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947427|NCT04964960|Paclitaxel|paclitaxel|mesh-list
44947428|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44947429|NCT04964960|Carboplatin|carboplatin|mesh-list
44947430|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
44947431|NCT04964960|Pemetrexed|pemetrexed|mesh-list
44947432|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44947433|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947434|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44947435|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44947436|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44947437|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947438|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947439|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947440|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44947441|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44947442|NCT04885881|Lidocaine|lidocaine|mesh-list
44947443|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947444|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
44947445|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947446|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947447|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
44478730|NCT03585140|Adapalene|adapalene|mesh-list
44947448|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947449|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44947450|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44947451|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44947452|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947453|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947454|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44947455|NCT04871360|Laxatives|laxatives|mesh-ancestor
44947456|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44947457|NCT04860804|Aspirin|aspirin|mesh-list
44947458|NCT04860804|Ketamine|ketamine|mesh-list
44947459|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947460|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947461|NCT04860804|Analgesics|analgesics|mesh-ancestor
44947462|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
44947463|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947464|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947465|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947466|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947467|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44947468|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44947469|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947470|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44947471|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947472|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947473|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
44947474|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44947475|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44947476|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
44947477|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
44947478|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947479|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44947480|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44947481|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947482|NCT04856488|Lugol's solution|lugol's solution|mesh-list
44947483|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44947484|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
44947485|NCT04856488|Coagulants|coagulants|mesh-ancestor
44947486|NCT04796948|Leucovorin|leucovorin|mesh-list
44947487|NCT04796948|Fluorouracil|fluorouracil|mesh-list
44947488|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
44947489|NCT04796948|Irinotecan|irinotecan|mesh-list
44947490|NCT04796948|Calcium|calcium|mesh-list
44947491|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
44947492|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44947493|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947494|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
44947495|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947496|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947497|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947498|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947499|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
44947500|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44947501|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44947502|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947503|NCT04796948|Antidotes|antidotes|mesh-ancestor
44947504|NCT04796948|Protective Agents|protective agents|mesh-ancestor
44947505|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
44947506|NCT04796948|Vitamins|vitamins|mesh-ancestor
44947507|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
44947508|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
44478781|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
44947509|NCT04750824|Afatinib|afatinib|mesh-list
44947510|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947511|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947512|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947513|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947514|NCT04726475|Cannabidiol|cannabidiol|mesh-list
44947515|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
44947516|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
44947517|NCT04720976|Osimertinib|osimertinib|mesh-list
44947518|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947519|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947520|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947521|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947522|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947523|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
44947524|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44947525|NCT04717362|Testosterone|testosterone|mesh-list
44947526|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
44947527|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
44947528|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44947529|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947530|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
44947531|NCT04717362|Hormones|hormones|mesh-ancestor
44947532|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947533|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947534|NCT04717362|Androgens|androgens|mesh-ancestor
44947535|NCT04707326|Lamivudine|lamivudine|mesh-list
44947536|NCT04707326|Dolutegravir|dolutegravir|mesh-list
44947537|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44947538|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44947539|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947540|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947541|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
44947542|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947543|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44947544|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44947545|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44947546|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44947547|NCT04690023|Ropivacaine|ropivacaine|mesh-list
44947548|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947549|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
44947550|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947551|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947552|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
44947553|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947554|NCT04646590|Vaccines|vaccines|mesh-list
44947555|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
44947556|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947557|NCT04635254|Histamine|histamine|mesh-list
44947558|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
44947559|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
44947560|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947561|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947562|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947563|NCT04625946|Metformin|metformin|mesh-list
44947564|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947565|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947566|NCT04591002|Osimertinib|osimertinib|mesh-list
44947567|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947568|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947569|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947570|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947571|NCT04589351|Ezetimibe|ezetimibe|mesh-list
44947572|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44947573|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44947574|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
44947575|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947576|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44947577|NCT04583592|Gabexate|gabexate|mesh-list
44947578|NCT04583592|Camostat|camostat|mesh-list
44947579|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
44947580|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947581|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947582|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44947583|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44478854|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
44947585|NCT04523961|Lidocaine|lidocaine|mesh-list
44947586|NCT04523961|Tetracaine|tetracaine|mesh-list
44947587|NCT04523961|Prilocaine|prilocaine|mesh-list
44947588|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44947589|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947590|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
44947591|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947592|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947593|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
44947594|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947595|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44947596|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44947597|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44947598|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947599|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947600|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44947601|NCT04500509|Diclofenac|diclofenac|mesh-list
44947602|NCT04500509|Dinoprostone|dinoprostone|mesh-list
44947603|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947604|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947605|NCT04500509|Analgesics|analgesics|mesh-ancestor
44947606|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
44947607|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947608|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947609|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947610|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947611|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947612|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947613|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947614|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
44947615|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44947616|NCT04500470|Ketoprofen|ketoprofen|mesh-list
44947617|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947618|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947619|NCT04500470|Analgesics|analgesics|mesh-ancestor
44947620|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
44947621|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947622|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947623|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947624|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947625|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947626|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947627|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947628|NCT04441073|Lidocaine|lidocaine|mesh-list
44947629|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947630|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
44947631|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947632|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947633|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
44947634|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947635|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44947636|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44947637|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44947638|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947639|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947640|NCT04409665|Ketamine|ketamine|mesh-list
44947641|NCT04409665|Analgesics|analgesics|mesh-ancestor
44947642|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
44947643|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947644|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947645|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44947646|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44947647|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
44947648|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
44947649|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947650|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44947651|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44947652|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947653|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947654|NCT04382937|Ribavirin|ribavirin|mesh-list
44947655|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44947656|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
44947657|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947658|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
44947659|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947660|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44947661|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44947662|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
44947663|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44947664|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947665|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947666|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947667|NCT04351698|Montelukast|montelukast|mesh-list
44947668|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44947669|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
44947670|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44947671|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
44947672|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947673|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947674|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44947675|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44947676|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947677|NCT04226833|Entrectinib|entrectinib|mesh-list
44947678|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947679|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947680|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947681|NCT04214860|Azacitidine|azacitidine|mesh-list
44947683|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947684|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
44947685|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947686|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947687|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947688|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44947689|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44947690|NCT04165122|Valacyclovir|valacyclovir|mesh-list
44947691|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
44947692|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947693|NCT04103554|Valsartan|valsartan|mesh-list
44947694|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44947695|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44947696|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44947697|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44947698|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947699|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
44947700|NCT04088890|Fludarabine|fludarabine|mesh-list
44947701|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947702|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
44947703|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947704|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947705|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44947706|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
44947707|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947708|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947709|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44947710|NCT04073147|Venetoclax|venetoclax|mesh-list
44947711|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
44947712|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947713|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947714|NCT04054375|Prednisone|prednisone|mesh-list
44947715|NCT04054375|Prednisolone|prednisolone|mesh-list
44947716|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947717|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
44947718|NCT04054375|Hormones|hormones|mesh-ancestor
44947719|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947720|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947721|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44947722|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947723|NCT04032301|Ketamine|ketamine|mesh-list
44947724|NCT04032301|Analgesics|analgesics|mesh-ancestor
44947725|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
44947726|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947727|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947728|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44947729|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44947730|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
44947731|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
44947732|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947733|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44947734|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44947735|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947736|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947737|NCT03998319|Tenecteplase|tenecteplase|mesh-list
44947738|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44947739|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44947740|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947741|NCT03984214|Dronabinol|dronabinol|mesh-list
44947742|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
44947743|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947744|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44947745|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947746|NCT03984214|Analgesics|analgesics|mesh-ancestor
44947747|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
44947748|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947749|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44947750|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44947751|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947752|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947753|NCT03984214|Hormones|hormones|mesh-ancestor
44947754|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947755|NCT03965130|Glucagon|glucagon|mesh-list
44947756|NCT03965130|Hormones|hormones|mesh-ancestor
44947757|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947758|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947759|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44947760|NCT03953079|Sunitinib|sunitinib|mesh-list
44947761|NCT03953079|Aflibercept|aflibercept|mesh-list
44947762|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479016|NCT03581773|Folic Acid|folic acid|mesh-list
44947763|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44947764|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44947765|NCT03953079|Growth Substances|growth substances|mesh-ancestor
44947766|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947767|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
44947768|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947769|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947770|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947771|NCT03931291|Azacitidine|azacitidine|mesh-list
44947772|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947773|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
44947774|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947775|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947776|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947777|NCT03922750|Insulin|insulin|mesh-list
44947778|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44947779|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
44947780|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947781|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947782|NCT03910673|Fosfomycin|fosfomycin|mesh-list
44947783|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44947784|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947785|NCT03882970|Tirzepatide|tirzepatide|mesh-list
44947786|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947787|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947788|NCT03882970|Incretins|incretins|mesh-ancestor
44947789|NCT03882970|Hormones|hormones|mesh-ancestor
44947790|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947791|NCT03867734|Aztreonam|aztreonam|mesh-list
44947792|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44947793|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947794|NCT03796156|Aspirin|aspirin|mesh-list
44947795|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44947796|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947797|NCT03796156|Analgesics|analgesics|mesh-ancestor
44947798|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
44947799|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947800|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947801|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44947802|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44947803|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44947804|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44947805|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947806|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44947807|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44947808|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947809|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
44947810|NCT03794427|Anesthetics|anesthetics|mesh-list
44947811|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947812|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947813|NCT03770676|Selenium|selenium|mesh-list
44947814|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
44947815|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947816|NCT03770676|Protective Agents|protective agents|mesh-ancestor
44947817|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947818|NCT03770676|Trace Elements|trace elements|mesh-ancestor
44947819|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
44947820|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44947821|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44947822|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947823|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
44947824|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
44947825|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947826|NCT03689712|Protective Agents|protective agents|mesh-ancestor
44947827|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947828|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
44947829|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
44947830|NCT03631446|Citric Acid|citric acid|mesh-list
44947831|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
44947832|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
44947833|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44947834|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
44947835|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
44947836|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947837|NCT03631446|Cathartics|cathartics|mesh-ancestor
44947838|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44947839|NCT03631446|Antacids|antacids|mesh-ancestor
44947840|NCT03625388|Dasatinib|dasatinib|mesh-list
44947841|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947842|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947843|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947844|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947845|NCT03567057|Amantadine|amantadine|mesh-list
44947846|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44947847|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44947848|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
44947849|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947850|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
44947851|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947852|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947853|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947854|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44947855|NCT03567057|Analgesics|analgesics|mesh-ancestor
44947856|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
44947857|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947858|NCT03552068|Clonidine|clonidine|mesh-list
44947859|NCT03552068|Analgesics|analgesics|mesh-ancestor
44947860|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
44947861|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947862|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947863|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44947864|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
44947865|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
44947866|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44947867|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44947868|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44947869|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
44947870|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947871|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947872|NCT03548064|Vaccines|vaccines|mesh-list
44947873|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
44947874|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947875|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
44947876|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947877|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947878|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44947879|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
44947880|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947881|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44947882|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
44947883|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44947884|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947885|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44947886|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44947887|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947888|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
44947889|NCT03446456|Vasopressins|vasopressins|mesh-list
44947890|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
44947891|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
44947892|NCT03446456|Coagulants|coagulants|mesh-ancestor
44947893|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44947894|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44947895|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
44947896|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947897|NCT03396692|Morphine|morphine|mesh-list
44947898|NCT03396692|Ropivacaine|ropivacaine|mesh-list
44947899|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44947900|NCT03396692|Narcotics|narcotics|mesh-ancestor
44947901|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947902|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947903|NCT03396692|Analgesics|analgesics|mesh-ancestor
44947904|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
44947905|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44947906|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
44947907|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
44479132|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
44947908|NCT03388190|Leucovorin|leucovorin|mesh-list
44947909|NCT03388190|Fluorouracil|fluorouracil|mesh-list
44947910|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
44947911|NCT03388190|Nivolumab|nivolumab|mesh-list
44947912|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
44947913|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
44947914|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947915|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44947916|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947917|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947918|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
44947919|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947920|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44947921|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44947922|NCT03388190|Antidotes|antidotes|mesh-ancestor
44947923|NCT03388190|Protective Agents|protective agents|mesh-ancestor
44947924|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
44947925|NCT03388190|Vitamins|vitamins|mesh-ancestor
44947926|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
44947927|NCT03382834|Tamoxifen|tamoxifen|mesh-list
44947928|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44947929|NCT03382834|Vorinostat|vorinostat|mesh-list
44947930|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44947931|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
44475958|NCT04022291|Insulin|insulin|mesh-list
44947932|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947933|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947934|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44947935|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947936|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44947937|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44947938|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44947939|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44947940|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947941|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947942|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
44947943|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44947944|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
44947945|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44947946|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947947|NCT03302286|Mannitol|mannitol|mesh-list
44947948|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44947949|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44947950|NCT03302286|Diuretics|diuretics|mesh-ancestor
44947951|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
44947952|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947953|NCT03264352|Amlodipine|amlodipine|mesh-list
44947954|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44947955|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44947956|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947957|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947958|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44947959|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947960|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
44947961|NCT03255083|Osimertinib|osimertinib|mesh-list
44947962|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947963|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44947964|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947965|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947966|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
44947967|NCT03253172|Diuretics|diuretics|mesh-ancestor
44947968|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
44947969|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947970|NCT03253172|Expectorants|expectorants|mesh-ancestor
44947971|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
44947972|NCT03227471|Ivacaftor|ivacaftor|mesh-list
44947973|NCT03227471|Elexacaftor|elexacaftor|mesh-list
44947974|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44947975|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44947976|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947977|NCT03194321|Tacrolimus|tacrolimus|mesh-list
44947978|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44947979|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
44947980|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947981|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44947982|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44947983|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44947984|NCT03189693|Anesthetics|anesthetics|mesh-list
44947985|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44947986|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947987|NCT03085095|Leuprolide|leuprolide|mesh-list
44947988|NCT03085095|Relugolix|relugolix|mesh-list
44947989|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44947990|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
44947991|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44947992|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44947993|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44947994|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44947995|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
44947996|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
44947997|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44947998|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44947999|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44948000|NCT03057431|Diuretics|diuretics|mesh-ancestor
44948001|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
44948002|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948003|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44948004|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948005|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948006|NCT02984800|Anesthetics|anesthetics|mesh-list
44948007|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948008|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948009|NCT02891811|Thalidomide|thalidomide|mesh-list
44948010|NCT02891811|Dexamethasone|dexamethasone|mesh-list
44948011|NCT02891811|Lenalidomide|lenalidomide|mesh-list
44948012|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948013|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
44948014|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
44948015|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948016|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948017|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948018|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
44948019|NCT02891811|Hormones|hormones|mesh-ancestor
44948020|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948021|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948022|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948023|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
44948024|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948025|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948026|NCT02891811|Growth Substances|growth substances|mesh-ancestor
44948027|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948028|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948029|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
44948030|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44948031|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948032|NCT02876510|Aldesleukin|aldesleukin|mesh-list
44948033|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
44948034|NCT02876510|Fludarabine|fludarabine|mesh-list
44948035|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
44948036|NCT02876510|Atezolizumab|atezolizumab|mesh-list
44948037|NCT02876510|Interleukin-2|interleukin-2|mesh-list
44948038|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948039|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
44948040|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948041|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948042|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44948043|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
44948044|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948045|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948046|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44948047|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948048|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
44948049|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
44948050|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948051|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948052|NCT02876510|Analgesics|analgesics|mesh-ancestor
44948053|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
44948054|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948055|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44948056|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44948057|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
44948058|NCT02828761|Calcium|calcium|mesh-list
44948059|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44948060|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948061|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44948062|NCT02815280|Minocycline|minocycline|mesh-list
44948063|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44948064|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948065|NCT02815267|Minocycline|minocycline|mesh-list
44948066|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44948067|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948068|NCT02811783|Naloxone|naloxone|mesh-list
44948069|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44948070|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948071|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
44948072|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948073|NCT02802228|Ifetroban|ifetroban|mesh-list
44948074|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44948075|NCT02801448|Sulforaphane|sulforaphane|mesh-list
44948076|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44948077|NCT02801448|Protective Agents|protective agents|mesh-ancestor
44948078|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948079|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948080|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
44948081|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948082|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
44948083|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948084|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948085|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948086|NCT02661022|Dexamethasone|dexamethasone|mesh-list
44948087|NCT02661022|Pomalidomide|pomalidomide|mesh-list
44948088|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948089|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
44948090|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
44948091|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948092|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948093|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948094|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
44948095|NCT02661022|Hormones|hormones|mesh-ancestor
44948096|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948097|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948098|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948099|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
44948100|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948101|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948102|NCT02661022|Growth Substances|growth substances|mesh-ancestor
44948103|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948104|NCT02652195|Oxytocin|oxytocin|mesh-list
44948105|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
44948106|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44948107|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948108|NCT02649855|Docetaxel|docetaxel|mesh-list
44948109|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948110|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44948111|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44948112|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44948113|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948114|NCT02570984|Omalizumab|omalizumab|mesh-list
44948115|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44948116|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44948117|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
44948118|NCT02539693|Lidocaine|lidocaine|mesh-list
44948119|NCT02539693|Clonidine|clonidine|mesh-list
44948120|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
44948121|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
44948122|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948123|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948124|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
44948125|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948126|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44948127|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44948128|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44948129|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948130|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948131|NCT02539693|Analgesics|analgesics|mesh-ancestor
44948132|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44948133|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
44948134|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
44948135|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44948136|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44948137|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44948138|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948139|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948140|NCT02534012|Anesthetics|anesthetics|mesh-list
44948141|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948142|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948143|NCT02505204|Clonidine|clonidine|mesh-list
44948144|NCT02505204|Analgesics|analgesics|mesh-ancestor
44948145|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
44948146|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948147|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948148|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44948149|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
44948150|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
44948151|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44948152|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44948153|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44948154|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948155|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948156|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948157|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
44948158|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
44948159|NCT02487979|Immunotoxins|immunotoxins|mesh-list
44948160|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44948161|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
44948162|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948163|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44948164|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948165|NCT02310867|Abatacept|abatacept|mesh-list
44948166|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44948167|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948168|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948169|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948170|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
44948171|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948172|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948173|NCT02303431|Edoxaban|edoxaban|mesh-list
44948174|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44948175|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
44948176|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44948177|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
44948178|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948179|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948180|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
44948181|NCT02288897|Temozolomide|temozolomide|mesh-list
44948182|NCT02288897|Dacarbazine|dacarbazine|mesh-list
44948183|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44948184|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44948185|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
44948186|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948187|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948188|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44948189|NCT01898312|Mifepristone|mifepristone|mesh-list
44948190|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44948191|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
44948192|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44948193|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948194|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44948195|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44948196|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44948197|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
44948198|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44948199|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44948200|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
44948201|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948202|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
44948203|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44948204|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44948205|NCT01883804|Methyldopa|methyldopa|mesh-list
44948206|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44948207|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
44948208|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
44948209|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948210|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948211|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44948212|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44948213|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44948214|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948215|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948216|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948218|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44948219|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948220|NCT01881048|Analgesics|analgesics|mesh-ancestor
44948221|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
44948222|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948223|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948224|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948225|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948226|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44948227|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44948228|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948229|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948230|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
44948231|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948232|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44948233|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948234|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948235|NCT01366898|Methotrexate|methotrexate|mesh-list
44948236|NCT01366898|Idarubicin|idarubicin|mesh-list
44948237|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44948238|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
44948239|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44948240|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948241|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948242|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
44948243|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948244|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948245|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
44948246|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948247|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44948248|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948249|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
44948250|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948251|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948252|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44948253|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44948254|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44948255|NCT01358201|Cytarabine|cytarabine|mesh-list
44948256|NCT01358201|Dexamethasone|dexamethasone|mesh-list
44948257|NCT01358201|Methotrexate|methotrexate|mesh-list
44948258|NCT01358201|Vincristine|vincristine|mesh-list
44948259|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948260|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
44948261|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
44948262|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948263|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948264|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948265|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
44948266|NCT01358201|Hormones|hormones|mesh-ancestor
44948267|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948268|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948269|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948270|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44948271|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
44948272|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44948273|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948274|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
44948275|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948276|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44948277|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948278|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44948279|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948280|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
44479489|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
44948281|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948282|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948283|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44948284|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
44948285|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
44948286|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
44948287|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
44948288|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948289|NCT01338636|Ambrisentan|ambrisentan|mesh-list
44948290|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44948291|NCT01308034|Sunitinib|sunitinib|mesh-list
44948292|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476003|NCT04022005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476004|NCT04021433|Ketamine|ketamine|mesh-list
44476005|NCT04021433|Analgesics|analgesics|mesh-ancestor
44476006|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
44476007|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476008|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476009|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44476010|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44476011|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
44476012|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
44476013|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476014|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44476018|NCT04021420|Nivolumab|nivolumab|mesh-list
44948293|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948294|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948295|NCT01308034|Growth Substances|growth substances|mesh-ancestor
44948296|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948297|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948298|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44948299|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948300|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948301|NCT00938912|Lacosamide|lacosamide|mesh-list
44948302|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
44948303|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44948304|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44948305|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948306|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479491|NCT03157310|Gefitinib|gefitinib|mesh-list
44948307|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
44948308|NCT00925652|Bevacizumab|bevacizumab|mesh-list
44948309|NCT00925652|Methotrexate|methotrexate|mesh-list
44948310|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948311|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
44948312|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948313|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948314|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44948315|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
44948316|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948317|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948318|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44948319|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44948320|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948321|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948322|NCT00925652|Growth Substances|growth substances|mesh-ancestor
44948323|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948324|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44948325|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
44948326|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44948327|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948328|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
44948329|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
44948330|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948331|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44948332|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948333|NCT00604617|Interferons|interferons|mesh-list
44948334|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
44948335|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948336|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
44948337|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948338|NCT00579826|Letrozole|letrozole|mesh-list
44948339|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948340|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44948341|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44948342|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948343|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948344|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44948345|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
44948346|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948347|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948348|NCT05200429|Ivacaftor|ivacaftor|mesh-list
44948349|NCT05200429|Elexacaftor|elexacaftor|mesh-list
44948350|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44948351|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948352|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948353|NCT05200299|Leucovorin|leucovorin|mesh-list
44948354|NCT05200299|Fluorouracil|fluorouracil|mesh-list
44948355|NCT05200299|Capecitabine|capecitabine|mesh-list
44948356|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
44948357|NCT05200299|Irinotecan|irinotecan|mesh-list
44948358|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
44948359|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
44948360|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948361|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948362|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948363|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948364|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
44948365|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948366|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44948367|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44948368|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948369|NCT05200299|Antidotes|antidotes|mesh-ancestor
44948370|NCT05200299|Protective Agents|protective agents|mesh-ancestor
44948371|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
44948372|NCT05200299|Vitamins|vitamins|mesh-ancestor
44948373|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
44948374|NCT05200260|Niraparib|niraparib|mesh-list
44948375|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44948376|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948377|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948378|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948379|NCT05199727|Tadalafil|tadalafil|mesh-list
44948380|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
44948381|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44948382|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44948383|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948384|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948385|NCT05199727|Urological Agents|urological agents|mesh-ancestor
44948386|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44948387|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
44948388|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
44948389|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948390|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948391|NCT05198947|Ivermectin|ivermectin|mesh-list
44948392|NCT05198947|Permethrin|permethrin|mesh-list
44948393|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44948394|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948395|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948396|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948397|NCT05198856|Thalidomide|thalidomide|mesh-list
44948398|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948399|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
44948400|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948401|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
44948402|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44948403|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948404|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948405|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948406|NCT05198856|Growth Substances|growth substances|mesh-ancestor
44948407|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948408|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948409|NCT05198609|Apatinib|apatinib|mesh-list
44948410|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948411|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44948412|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948413|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948414|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44948415|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44948416|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44948417|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948418|NCT05198141|Letrozole|letrozole|mesh-list
44948419|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948420|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44948421|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44948422|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948423|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948424|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44948425|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
44948426|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948427|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948428|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44948429|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44948430|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44948431|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
44948432|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948433|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44948434|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44948435|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948436|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
44948437|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44948438|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
44948439|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948440|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
44948441|NCT05188898|Protective Agents|protective agents|mesh-ancestor
44948442|NCT05178225|Ubiquinone|ubiquinone|mesh-list
44948443|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
44948444|NCT05178225|Anticoagulants|anticoagulants|mesh-list
44948445|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
44948446|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948447|NCT05178225|Vitamins|vitamins|mesh-ancestor
44948448|NCT05178173|Ethanol|ethanol|mesh-list
44948449|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
44948450|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44948451|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948452|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948453|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948454|NCT05162443|Adagrasib|adagrasib|mesh-list
44948455|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948456|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
44948457|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
44948458|NCT05139849|Vasopressins|vasopressins|mesh-list
44948459|NCT05139849|Arginine Vasopressin|arginine vasopressin|mesh-list
44948460|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948461|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
44948462|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
44948463|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948464|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948465|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948466|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
44948467|NCT05139849|Hormones|hormones|mesh-ancestor
44948468|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948469|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44948470|NCT05139849|Protective Agents|protective agents|mesh-ancestor
44948471|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
44948472|NCT05139849|Coagulants|coagulants|mesh-ancestor
44948473|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44948474|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44948475|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
44948476|NCT05110781|Atezolizumab|atezolizumab|mesh-list
44948477|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44948478|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948479|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
44948480|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948481|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
44948482|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44948483|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948484|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948485|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
44948486|NCT05099276|Coagulants|coagulants|mesh-ancestor
44948487|NCT05077449|Fulvestrant|fulvestrant|mesh-list
44948488|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948489|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948490|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44948491|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44948492|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
44948493|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948494|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948495|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44948496|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948498|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44948499|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
44948500|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948501|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
44948502|NCT05073575|Protective Agents|protective agents|mesh-ancestor
44948503|NCT05062135|Progesterone|progesterone|mesh-list
44948504|NCT05062135|Progestins|progestins|mesh-ancestor
44948505|NCT05062135|Hormones|hormones|mesh-ancestor
44948506|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948507|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948508|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
44948509|NCT05005182|Luspatercept|luspatercept|mesh-list
44948510|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44948511|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948512|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
44948513|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948514|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948515|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948516|NCT05005182|Hematinics|hematinics|mesh-ancestor
44948517|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
44948518|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948519|NCT04937816|Empagliflozin|empagliflozin|mesh-list
44948520|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44948521|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948522|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948523|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948524|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
44948525|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44948526|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948527|NCT04856293|Crizotinib|crizotinib|mesh-list
44948528|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948529|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44948530|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948531|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948532|NCT04783233|Chitosan|chitosan|mesh-list
44948533|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44948534|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44948535|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44948536|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
44948537|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948538|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44948539|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
44948540|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
44948541|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
44948542|NCT04783233|Coagulants|coagulants|mesh-ancestor
44948543|NCT04707183|Lidocaine|lidocaine|mesh-list
44948544|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
44948545|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
44948546|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948547|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948548|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
44948549|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948550|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44948551|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44948552|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44948553|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948554|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948555|NCT04703205|Ivermectin|ivermectin|mesh-list
44948556|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44948557|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948558|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
44948559|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948560|NCT04676334|Rucaparib|rucaparib|mesh-list
44948561|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44948562|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948563|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948564|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948565|NCT04608903|Sulforaphane|sulforaphane|mesh-list
44948566|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44948567|NCT04608903|Protective Agents|protective agents|mesh-ancestor
44948568|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948569|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948570|NCT04560127|Apatinib|apatinib|mesh-list
44479758|NCT03154983|Apatinib|apatinib|mesh-list
44948571|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948572|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44948573|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948574|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948575|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44948576|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44948577|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948578|NCT04512079|Enoxaparin|enoxaparin|mesh-list
44948579|NCT04512079|Apixaban|apixaban|mesh-list
44948580|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
44948581|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44948582|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948583|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948584|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44948585|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
44948586|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44948587|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
44948588|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948589|NCT05416827|Dexamethasone|dexamethasone|mesh-list
44948590|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948591|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
44948592|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
44948593|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948594|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948595|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948596|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
44948597|NCT05416827|Hormones|hormones|mesh-ancestor
44948598|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948599|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948600|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948601|NCT05416580|Metformin|metformin|mesh-list
44948602|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44948603|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948604|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948605|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44948606|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948607|NCT05416073|Sufentanil|sufentanil|mesh-list
44948608|NCT05416073|Esketamine|esketamine|mesh-list
44948609|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44948610|NCT05416073|Narcotics|narcotics|mesh-ancestor
44948611|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948612|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948613|NCT05416073|Analgesics|analgesics|mesh-ancestor
44948614|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
44948615|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948616|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44948617|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44948618|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
44948619|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
44948620|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
44948621|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44948622|NCT05415826|Dexamethasone|dexamethasone|mesh-list
44948623|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948624|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
44948625|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
44948626|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948627|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948628|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948629|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
44948630|NCT05415826|Hormones|hormones|mesh-ancestor
44948631|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948632|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948633|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948634|NCT05415748|Tamsulosin|tamsulosin|mesh-list
44948635|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44948636|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44948637|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44948638|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948639|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948640|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948641|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948642|NCT05415748|Urological Agents|urological agents|mesh-ancestor
44948643|NCT05415436|Propofol|propofol|mesh-list
44948644|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44948645|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948646|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948647|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44948648|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
44948650|NCT05415254|Calcitriol|calcitriol|mesh-list
44948651|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44948652|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948653|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44948654|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948655|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948656|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44948657|NCT05415254|Vitamins|vitamins|mesh-ancestor
44948658|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
44948659|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44948660|NCT05415228|Edetic Acid|edetic acid|mesh-list
44948661|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44948662|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
44948663|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
44948664|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948665|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
44948666|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44948667|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44948669|NCT05392361|Baclofen|baclofen|mesh-list
44948670|NCT05392361|Analgesics|analgesics|mesh-ancestor
44948671|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
44948672|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948673|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948674|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
44948675|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44948676|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44948677|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948678|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44948679|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44948680|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44948681|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948682|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948683|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
44948684|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44948685|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44948686|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44948687|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
44948688|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
44948689|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
44948690|NCT05370547|Fludarabine|fludarabine|mesh-list
44948691|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948692|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
44948693|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948694|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948695|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44948696|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
44948697|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948698|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948699|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44948700|NCT05348122|Dulaglutide|dulaglutide|mesh-list
44948701|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44948702|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948703|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948704|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
44948705|NCT05338541|Etoposide|etoposide|mesh-list
44948706|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44948707|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948708|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44948709|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735904|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735905|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
44735906|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735907|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735908|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
44735909|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44735910|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948710|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948711|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948712|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
44948713|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44948714|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948715|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948716|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948717|NCT05335655|Analgesics|analgesics|mesh-ancestor
44948718|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
44948719|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948720|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44948721|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44948722|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44948723|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948724|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948725|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948726|NCT05328336|Paclitaxel|paclitaxel|mesh-list
44948727|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44948728|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948729|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44948730|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44948731|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44948732|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948733|NCT05253495|Cytarabine|cytarabine|mesh-list
44948734|NCT05253495|Etoposide|etoposide|mesh-list
44948735|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44948736|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948737|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44948738|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44948739|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948740|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948741|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948742|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
44948743|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
44948744|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948745|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44948746|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
44948747|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948749|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44948750|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948751|NCT05125276|Analgesics|analgesics|mesh-ancestor
44948752|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
44948753|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948754|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948755|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948756|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948757|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44948758|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948759|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948760|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44948761|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44948762|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948763|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
44948764|NCT05054842|Metformin|metformin|mesh-list
44948765|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948766|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948767|NCT05054751|Fulvestrant|fulvestrant|mesh-list
44948768|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948769|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948770|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44948771|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44948772|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
44948773|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948774|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948775|NCT05038618|Somatomedin B|somatomedin b|mesh-list
44948776|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44948777|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44948778|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
44948779|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948780|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948781|NCT05037487|Dronabinol|dronabinol|mesh-list
44948782|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
44948783|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948784|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44948785|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948786|NCT05037487|Analgesics|analgesics|mesh-ancestor
44948787|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
44948788|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948789|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44948790|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44948791|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948792|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948793|NCT05037487|Hormones|hormones|mesh-ancestor
44948794|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948795|NCT04930744|Metformin|metformin|mesh-list
44948796|NCT04930744|Rifampin|rifampin|mesh-list
44948797|NCT04930744|Isoniazid|isoniazid|mesh-list
44948798|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
44948799|NCT04930744|Ethambutol|ethambutol|mesh-list
44948800|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948801|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948802|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44948803|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
44948804|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44948805|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948806|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
44948807|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44948808|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948809|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948810|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44948811|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44948812|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44948813|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44948814|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44948815|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44948816|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44948818|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
44948819|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44948820|NCT04927052|Lidocaine|lidocaine|mesh-list
44948821|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
44948822|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
44948823|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948824|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948825|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
44948826|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948827|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44948828|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44948829|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44948830|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948831|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948832|NCT04892264|Dexamethasone|dexamethasone|mesh-list
44948833|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
44948834|NCT04892264|Lenalidomide|lenalidomide|mesh-list
44948835|NCT04892264|Daratumumab|daratumumab|mesh-list
44948836|NCT04892264|Ichthammol|ichthammol|mesh-list
44948837|NCT04892264|BB 1101|bb 1101|mesh-list
44948838|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948839|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
44948840|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
44948841|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948842|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948843|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44948844|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
44948845|NCT04892264|Hormones|hormones|mesh-ancestor
44948846|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44948847|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44948848|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948849|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
44948850|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948851|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948852|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
44948853|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44948854|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44948855|NCT04892264|Growth Substances|growth substances|mesh-ancestor
44948856|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
44948857|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44948858|NCT04771520|Piperazine|piperazine|mesh-list
44948859|NCT04771520|Mebendazole|mebendazole|mesh-list
44948860|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
44948861|NCT04771520|DMP 777|dmp 777|mesh-list
44948862|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
44948863|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
44948864|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44948865|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948866|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44948867|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44948868|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44948869|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948870|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948871|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948872|NCT04770740|Vitamin K|vitamin k|mesh-list
44948873|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
44948874|NCT04770740|Vitamin MK 7|vitamin mk 7|mesh-list
44948875|NCT04770740|Vitamins|vitamins|mesh-ancestor
44948876|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
44948877|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948878|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44948879|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948880|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948881|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
44948882|NCT04770740|Coagulants|coagulants|mesh-ancestor
44948883|NCT04744831|Camptothecin|camptothecin|mesh-list
44948884|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
44948885|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44948886|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948887|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44948888|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44948889|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948890|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948891|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
44948892|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948894|NCT04721873|Phentermine|phentermine|mesh-list
44948895|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
44948896|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948897|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948898|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44948899|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
44948900|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44948901|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
44948902|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
44948903|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948904|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
44948905|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948906|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948907|NCT04664829|Capecitabine|capecitabine|mesh-list
44948908|NCT04664829|Bexarotene|bexarotene|mesh-list
44948909|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44948910|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
44948911|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948912|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948913|NCT04622709|Furosemide|furosemide|mesh-list
44948914|NCT04622709|Diuretics|diuretics|mesh-list
44948915|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44948916|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
44948917|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948918|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44948919|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948920|NCT04535362|Nicotine|nicotine|mesh-list
44948921|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44948922|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
44948923|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948924|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948925|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44948926|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44948927|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
44948928|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948929|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948930|NCT04499053|Durvalumab|durvalumab|mesh-list
44948931|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44948932|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948933|NCT04456608|Aspirin|aspirin|mesh-list
44948934|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44948935|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44948936|NCT04456608|Analgesics|analgesics|mesh-ancestor
44948937|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
44948938|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948939|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948940|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44948941|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44948942|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44948943|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948944|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948945|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44948946|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44948947|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948948|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
44948950|NCT04450212|Vitamins|vitamins|mesh-ancestor
44948951|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
44948952|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948953|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44948954|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44948955|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948956|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
44948957|NCT04450212|Coagulants|coagulants|mesh-ancestor
44948958|NCT04317300|Varenicline|varenicline|mesh-list
44948959|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44948960|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44948961|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
44948962|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44948963|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948964|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948965|NCT04300231|Hydromorphone|hydromorphone|mesh-list
44948966|NCT04300231|Bupivacaine|bupivacaine|mesh-list
44948967|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
44948968|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
44948969|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948970|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948971|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
44948972|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948973|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44948974|NCT04300231|Narcotics|narcotics|mesh-ancestor
44948975|NCT04300231|Analgesics|analgesics|mesh-ancestor
44948976|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44948977|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44948978|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44948979|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
44948980|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44948981|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44948982|NCT04138277|Miglustat|miglustat|mesh-list
44948983|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44948984|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44948985|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44948986|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44948987|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
44948988|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44948989|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44948990|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44948991|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948992|NCT04096170|Lidocaine|lidocaine|mesh-list
44948993|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
44948994|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
44948995|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44948996|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44948997|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
44948998|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44948999|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44949000|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44949001|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44949002|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949003|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949004|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
44949005|NCT03984578|Capecitabine|capecitabine|mesh-list
44949006|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949007|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949008|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949009|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
44949010|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949011|NCT03930745|TOL-463|tol-463|mesh-list
44949012|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949013|NCT03822975|Heparin|heparin|mesh-list
44949014|NCT03822975|Calcium heparin|calcium heparin|mesh-list
44949015|NCT03822975|Bivalirudin|bivalirudin|mesh-list
44949016|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
44949017|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44949018|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44949019|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949020|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
44949021|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44480223|NCT01670955|Folic Acid|folic acid|mesh-list
44949022|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
44949023|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949024|NCT03792867|Doxorubicin|doxorubicin|mesh-list
44949025|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44949026|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949027|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44949028|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44949029|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949030|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949032|NCT03668041|Trazodone|trazodone|mesh-list
44949033|NCT03668041|Eszopiclone|eszopiclone|mesh-list
44949034|NCT03668041|Analgesics|analgesics|mesh-ancestor
44949035|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
44949036|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949037|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949038|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
44949039|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44949040|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44949041|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949042|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44949043|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44949044|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44949045|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949046|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949047|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
44949048|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44949049|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44949050|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44949051|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949052|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
44949053|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44949054|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
44949055|NCT03663335|Tacrolimus|tacrolimus|mesh-list
44949056|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949057|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
44949058|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949059|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44949060|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949061|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949062|NCT03534947|Imiquimod|imiquimod|mesh-list
44949063|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44949064|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
44949065|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949066|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949067|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
44949068|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
44949069|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44949070|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949071|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
44949072|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44949073|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949074|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949075|NCT03347617|Hematinics|hematinics|mesh-ancestor
44949076|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44949077|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44949078|NCT03315741|Pirfenidone|pirfenidone|mesh-list
44949079|NCT03315741|Analgesics|analgesics|mesh-ancestor
44949080|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
44949081|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949082|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949083|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949084|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44949085|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949086|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949087|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949088|NCT03259425|Nivolumab|nivolumab|mesh-list
44949089|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949090|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949091|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949092|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949093|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
44949094|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949095|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949096|NCT03175978|Methotrexate|methotrexate|mesh-list
44949097|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949098|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44949099|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
44949100|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44949101|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949102|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
44949103|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949104|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949105|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949106|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949107|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44949108|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949109|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
44949110|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949111|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44949112|NCT03129100|Ixekizumab|ixekizumab|mesh-list
44949113|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949114|NCT03100006|Nivolumab|nivolumab|mesh-list
44949115|NCT03100006|Oregovomab|oregovomab|mesh-list
44949116|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949117|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949118|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949119|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949120|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
44949121|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949122|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949123|NCT02959541|Leucovorin|leucovorin|mesh-list
44949124|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
44949125|NCT02959541|Antidotes|antidotes|mesh-ancestor
44949126|NCT02959541|Protective Agents|protective agents|mesh-ancestor
44949127|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949128|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
44949129|NCT02959541|Vitamins|vitamins|mesh-ancestor
44949130|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
44949131|NCT02684006|Sunitinib|sunitinib|mesh-list
44949132|NCT02684006|Avelumab|avelumab|mesh-list
44949133|NCT02684006|Axitinib|axitinib|mesh-list
44949134|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949135|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44949136|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44949137|NCT02684006|Growth Substances|growth substances|mesh-ancestor
44949138|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949139|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44949140|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949141|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949142|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949143|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949144|NCT02675465|Miglustat|miglustat|mesh-list
44949145|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949146|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949147|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44949148|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44949149|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
44949150|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949151|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44476031|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44476032|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
44476033|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44476034|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476035|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
44476036|NCT04020653|Lumefantrine|lumefantrine|mesh-list
44476037|NCT04020653|Artemether|artemether|mesh-list
44476038|NCT04020653|Artemisinins|artemisinins|mesh-list
44476039|NCT04020653|Artemisinin|artemisinin|mesh-list
44476040|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44476041|NCT04020653|Citric Acid|citric acid|mesh-list
44476042|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
44476043|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
43623647|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
44949152|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44949153|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949154|NCT02649673|Topotecan|topotecan|mesh-list
44949155|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44949156|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44949157|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949158|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949159|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949160|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
44949161|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949162|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949163|NCT02454855|Melatonin|melatonin|mesh-list
44949164|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
44949165|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949166|NCT02454855|Protective Agents|protective agents|mesh-ancestor
44949167|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949168|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949169|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
44949170|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44949171|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44949172|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44949173|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949174|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949175|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
44949176|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949177|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949178|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44949179|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949180|NCT02288832|Azithromycin|azithromycin|mesh-list
44949181|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949182|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949183|NCT02142738|Gemcitabine|gemcitabine|mesh-list
44949184|NCT02142738|Paclitaxel|paclitaxel|mesh-list
44949185|NCT02142738|Cisplatin|cisplatin|mesh-list
44949186|NCT02142738|Carboplatin|carboplatin|mesh-list
44949187|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
44949188|NCT02142738|Pemetrexed|pemetrexed|mesh-list
44949189|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44949190|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949191|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949192|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949193|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949194|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949195|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949196|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
44949197|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
44949198|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949199|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949200|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949201|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
44949202|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949203|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949204|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44949205|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44949206|NCT02072148|Cisplatin|cisplatin|mesh-list
44949207|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949208|NCT01667133|Ponatinib|ponatinib|mesh-list
44949209|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949210|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949211|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949212|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949213|NCT01466686|Temozolomide|temozolomide|mesh-list
44949214|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44476044|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44949215|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
44949216|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949217|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949218|NCT00921115|Fulvestrant|fulvestrant|mesh-list
44949219|NCT00921115|Anastrozole|anastrozole|mesh-list
44949220|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44949221|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949222|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44949223|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44949224|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
44949225|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949226|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949227|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44949228|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44949229|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949230|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949231|NCT00913705|Carboplatin|carboplatin|mesh-list
44949232|NCT00913705|Paclitaxel|paclitaxel|mesh-list
44949233|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44949234|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949235|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44949236|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949237|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949238|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949239|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949240|NCT00883480|Gemcitabine|gemcitabine|mesh-list
44949241|NCT00883480|Cisplatin|cisplatin|mesh-list
44949242|NCT00883480|Docetaxel|docetaxel|mesh-list
44949243|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44949244|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949245|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949246|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
44949247|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949248|NCT00883480|Antiviral Agents|antiviral agents|mesh-ancestor
44949249|NCT00883480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949250|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949251|NCT00883480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949252|NCT00883480|Immunologic Factors|immunologic factors|mesh-ancestor
44949253|NCT00883480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949254|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949255|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949256|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949257|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949258|NCT00446225|Gemcitabine|gemcitabine|mesh-list
44949260|NCT00446225|Carboplatin|carboplatin|mesh-list
44949261|NCT00446225|Docetaxel|docetaxel|mesh-list
44949262|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44949263|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949264|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949265|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949266|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949267|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949268|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949269|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949270|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949271|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
44949272|NCT00446225|Antiviral Agents|antiviral agents|mesh-ancestor
44949273|NCT00446225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949274|NCT00446225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949275|NCT00446225|Immunologic Factors|immunologic factors|mesh-ancestor
44949276|NCT00446225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949277|NCT00089245|Iodine|iodine|mesh-list
44949278|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
44949279|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44949280|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949281|NCT00089245|Trace Elements|trace elements|mesh-ancestor
44949282|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
44949283|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949284|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
44949285|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44949286|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949287|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44949288|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949289|NCT05418907|Exenatide|exenatide|mesh-list
44949290|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44949291|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949292|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44949293|NCT05418907|Incretins|incretins|mesh-ancestor
44949294|NCT05418907|Hormones|hormones|mesh-ancestor
44949295|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949296|NCT05418686|Colchicine|colchicine|mesh-list
44949297|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
44949298|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949299|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949300|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949301|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949302|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949303|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949304|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
44949305|NCT05418660|Nivolumab|nivolumab|mesh-list
44949306|NCT05418660|Atezolizumab|atezolizumab|mesh-list
44949307|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949308|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949309|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949310|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949311|NCT05418556|Aspirin|aspirin|mesh-list
44949312|NCT05418556|Clopidogrel|clopidogrel|mesh-list
44949313|NCT05418556|Ticagrelor|ticagrelor|mesh-list
44949314|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44949315|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949316|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480505|NCT01674127|Methyldopa|methyldopa|mesh-list
44949317|NCT05418556|Analgesics|analgesics|mesh-ancestor
44949318|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
44949319|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949320|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949321|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949322|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949323|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44949324|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44949325|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949326|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44949327|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44949328|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949329|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
44949330|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44949331|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44949332|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44949333|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
44949334|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949335|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
44949336|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44949337|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949338|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44949339|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949340|NCT05418452|Metformin|metformin|mesh-list
44949341|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44949342|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949343|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44949344|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44949345|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
44949346|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476055|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
44949347|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949348|NCT05418348|Nimodipine|nimodipine|mesh-list
44949349|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44949350|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44949351|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949352|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949353|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44949354|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949355|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
44949356|NCT05418309|Paclitaxel|paclitaxel|mesh-list
44949357|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44949358|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949359|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949360|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949361|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949362|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949363|NCT05418244|Ondansetron|ondansetron|mesh-list
44949364|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
44949365|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
44949366|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949367|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949368|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949369|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
44949370|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949371|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44949372|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
44949373|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949374|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949375|NCT05418244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44949376|NCT05418244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44949377|NCT05418244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949378|NCT05418244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44949379|NCT05418244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44949380|NCT05418166|Evolocumab|evolocumab|mesh-list
44949381|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44949382|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44949383|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
44949384|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949385|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44949386|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
44949387|NCT05418114|Analgesics|analgesics|mesh-ancestor
44949388|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
44949389|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949390|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949391|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
44949392|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949394|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
44949395|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44949396|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949397|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949398|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44949399|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
44949400|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44949401|NCT05417997|Clarithromycin|clarithromycin|mesh-list
44949402|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
44949403|NCT05417997|Favipiravir|favipiravir|mesh-list
44949404|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
44949405|NCT05417997|Enoxaparin|enoxaparin|mesh-list
44949406|NCT05417997|Lansoprazole|lansoprazole|mesh-list
44949407|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949408|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
44949409|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
44949410|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949411|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949412|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949413|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
44949414|NCT05417997|Hormones|hormones|mesh-ancestor
44949415|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949416|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44949417|NCT05417997|Protective Agents|protective agents|mesh-ancestor
44949418|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949419|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949420|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44949421|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949422|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949423|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44949424|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44949425|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
44949426|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44949427|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44949428|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44949429|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44949430|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
44949431|NCT05417893|Sirolimus|sirolimus|mesh-list
44949432|NCT05417893|Everolimus|everolimus|mesh-list
44949433|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949434|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949435|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
44949436|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949437|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949438|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949439|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44949440|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
44949441|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44949442|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949443|NCT05417308|Minoxidil|minoxidil|mesh-list
44949444|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44949445|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
44949446|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44949447|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949448|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949449|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
44949450|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949451|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
44949452|NCT05417035|Androgens|androgens|mesh-ancestor
44949453|NCT05417035|Hormones|hormones|mesh-ancestor
44949454|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949455|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949456|NCT05416190|Anticoagulants|anticoagulants|mesh-list
44949457|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
44949458|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
44949459|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480647|NCT01674933|Listerine|listerine|mesh-list
44949460|NCT05410496|Tenofovir|tenofovir|mesh-list
44949461|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
44949462|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949463|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44949464|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44949465|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476082|NCT04020445|Insulin|insulin|mesh-list
44949466|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949467|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44949468|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44949469|NCT05378763|Docetaxel|docetaxel|mesh-list
44949470|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949471|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44949472|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44949473|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44949474|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949475|NCT05285566|Lidocaine|lidocaine|mesh-list
44949476|NCT05285566|Bupivacaine|bupivacaine|mesh-list
44949477|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
44949478|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
44949479|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949480|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949481|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
44949482|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949483|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44949484|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44949485|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44949486|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949487|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949488|NCT05212025|Gemcitabine|gemcitabine|mesh-list
44949489|NCT05212025|Adavosertib|adavosertib|mesh-list
44949490|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949491|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
44949492|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949493|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949494|NCT05212025|Antiviral Agents|antiviral agents|mesh-ancestor
44949495|NCT05212025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949496|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949497|NCT05212025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949498|NCT05212025|Immunologic Factors|immunologic factors|mesh-ancestor
44949499|NCT05212025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949500|NCT05166096|Aspirin|aspirin|mesh-list
44949501|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949502|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44949503|NCT05166096|Analgesics|analgesics|mesh-ancestor
44949504|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
44949505|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949506|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949507|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949508|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949509|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44949510|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44949511|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949512|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44949513|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44949514|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949515|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
44949516|NCT05110638|Luliconazole|luliconazole|mesh-list
44949517|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
44949518|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949519|NCT05071703|Carboplatin|carboplatin|mesh-list
44949520|NCT05071703|Etoposide|etoposide|mesh-list
44949521|NCT05071703|Topotecan|topotecan|mesh-list
44949522|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949523|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44949524|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44949525|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44949526|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949527|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949528|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44949529|NCT04961593|Caspofungin|caspofungin|mesh-list
44949530|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
44949531|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949532|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949533|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949534|NCT04961580|Ceftazidime|ceftazidime|mesh-list
44949535|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949536|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949537|NCT04869592|Vaccines|vaccines|mesh-list
44949538|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
44949539|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949540|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
44949541|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44949542|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
44949543|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949544|NCT04793646|Expectorants|expectorants|mesh-ancestor
44949545|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44949546|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44949547|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
44949548|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949549|NCT04793646|Protective Agents|protective agents|mesh-ancestor
44949550|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949551|NCT04793646|Antidotes|antidotes|mesh-ancestor
44949552|NCT04780581|Dexamethasone|dexamethasone|mesh-list
44949553|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
44949554|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44949555|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44949556|NCT04780581|Prednisolone|prednisolone|mesh-list
44949557|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
44949558|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44949559|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
44949560|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949561|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
44949562|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
44949563|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949564|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949565|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949566|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
44949567|NCT04780581|Hormones|hormones|mesh-ancestor
44949568|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949569|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44949570|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949571|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44949572|NCT04780581|Protective Agents|protective agents|mesh-ancestor
44949573|NCT04639115|Ozanimod|ozanimod|mesh-list
44949574|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44949575|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949576|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949577|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
44949578|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949579|NCT04608344|Atorvastatin|atorvastatin|mesh-list
44949580|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44949581|NCT04608344|Pravastatin|pravastatin|mesh-list
44949582|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44949583|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44949584|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
44949585|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949586|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44949587|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44949588|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949589|NCT04564547|Islatravir|islatravir|mesh-list
44949590|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
44949591|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949592|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949593|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949594|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44949595|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44949596|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44949597|NCT04492072|Misoprostol|misoprostol|mesh-list
44949598|NCT04492072|Oxytocin|oxytocin|mesh-list
44949599|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
44949600|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44949601|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949602|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44949603|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
44949604|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44949605|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480763|NCT01675648|Analgesics|analgesics|mesh-ancestor
44949606|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44949607|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44949608|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
44949609|NCT04482803|Hormones|hormones|mesh-ancestor
44949610|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949611|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949612|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949613|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949614|NCT04468776|Zolpidem|zolpidem|mesh-list
44949615|NCT04468776|Trazodone|trazodone|mesh-list
44949616|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44949617|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44949618|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949619|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949620|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44949621|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
44949622|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
44949623|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426797|NCT02208063|Vancomycin|vancomycin|mesh-list
44949624|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949625|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44949626|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44949627|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44949628|NCT04468776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44949629|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44949630|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949631|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
44949632|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44949633|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
44949634|NCT04455815|Gabexate|gabexate|mesh-list
44949635|NCT04455815|Camostat|camostat|mesh-list
44949636|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
44949637|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949638|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949639|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44949640|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44949641|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
44949642|NCT04421248|Methylphenidate|methylphenidate|mesh-list
44949643|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44949644|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949645|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44949646|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44949647|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44949648|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949649|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
44949650|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949651|NCT04352205|Thalidomide|thalidomide|mesh-list
44949652|NCT04352205|Dexamethasone|dexamethasone|mesh-list
44949653|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
44949654|NCT04352205|Lenalidomide|lenalidomide|mesh-list
44949655|NCT04352205|Bortezomib|bortezomib|mesh-list
44949656|NCT04352205|Daratumumab|daratumumab|mesh-list
44949657|NCT04352205|Ichthammol|ichthammol|mesh-list
44949658|NCT04352205|BB 1101|bb 1101|mesh-list
44949659|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949660|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
44949661|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
44949662|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949663|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949664|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949665|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
44949666|NCT04352205|Hormones|hormones|mesh-ancestor
44949667|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949668|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44949669|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949670|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
44949671|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949672|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949673|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
44949674|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44949675|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44949676|NCT04352205|Growth Substances|growth substances|mesh-ancestor
44949677|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44949678|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949679|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
44949680|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949681|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426798|NCT02208063|Cefazolin|cefazolin|mesh-list
44426799|NCT02208063|Daptomycin|daptomycin|mesh-list
44949682|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949683|NCT04303403|Trametinib|trametinib|mesh-list
44949684|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949685|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949686|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949687|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949688|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
44949689|NCT04249310|Olodaterol|olodaterol|mesh-list
44949690|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44949691|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
44949692|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949693|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949694|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44949695|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
44949696|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
44949697|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44949698|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44949699|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949700|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949701|NCT04215471|Antibodies|antibodies|mesh-list
44949702|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
44949703|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
44949704|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949705|NCT04203641|Doxorubicin|doxorubicin|mesh-list
44949706|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44949707|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949708|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44949709|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44949710|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949711|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949712|NCT04188119|Aspirin|aspirin|mesh-list
44949713|NCT04188119|Avelumab|avelumab|mesh-list
44949714|NCT04188119|Lansoprazole|lansoprazole|mesh-list
44949715|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
44949716|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949717|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44949718|NCT04188119|Analgesics|analgesics|mesh-ancestor
44949719|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
44949720|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949721|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949722|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949723|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949724|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44949725|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44949726|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949727|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44949728|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44949729|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949730|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
44949731|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949732|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949733|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44949734|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949735|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44949736|NCT04173338|Pemetrexed|pemetrexed|mesh-list
44949737|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949738|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949739|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949740|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44949741|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44949742|NCT04173325|Nivolumab|nivolumab|mesh-list
44949743|NCT04173325|Irinotecan|irinotecan|mesh-list
44949744|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949745|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949746|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949747|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949748|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44949749|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44949750|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949751|NCT04172597|Loperamide|loperamide|mesh-list
44949752|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
44949753|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949754|NCT04162873|Celecoxib|celecoxib|mesh-list
44949755|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
44949756|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949757|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44949758|NCT04162873|Analgesics|analgesics|mesh-ancestor
44949759|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
44949760|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949761|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949762|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949763|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949764|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44949765|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44949766|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949767|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949768|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44949769|NCT04113538|Aflibercept|aflibercept|mesh-list
44949770|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44949771|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44949772|NCT04113538|Growth Substances|growth substances|mesh-ancestor
44949773|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949774|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
44949775|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949776|NCT04113187|Propranolol|propranolol|mesh-list
44949777|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44949778|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44949779|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44949780|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949781|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949782|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949783|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44949784|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44949785|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44949786|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
44949787|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44949788|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44949789|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
44949790|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949791|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949792|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949793|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
44949794|NCT04011475|Olodaterol|olodaterol|mesh-list
44949795|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44949796|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
44949797|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949798|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949799|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44949800|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
44949801|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
44949802|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44949803|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
44949804|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949805|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949806|NCT03941964|Azacitidine|azacitidine|mesh-list
44949807|NCT03941964|Decitabine|decitabine|mesh-list
44949808|NCT03941964|Venetoclax|venetoclax|mesh-list
44949809|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949810|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
44949811|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949812|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949813|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949814|NCT03912064|Ipilimumab|ipilimumab|mesh-list
44949815|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949816|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949817|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949818|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949819|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
44949820|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949821|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949822|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
44949823|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949824|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44949825|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
44949826|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44949827|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44949828|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44949829|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949830|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949831|NCT03711422|Afatinib|afatinib|mesh-list
44949832|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949833|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44949834|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949835|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949836|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
44949837|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949838|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949839|NCT03639558|Promethazine|promethazine|mesh-list
44949840|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
44949841|NCT03639558|Haloperidol|haloperidol|mesh-list
44949842|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
44949843|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
44949844|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
44949845|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
44949846|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949847|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949848|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949849|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44949850|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44949851|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44949852|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44949853|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44949854|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
44949855|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949856|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949857|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44949858|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
44949859|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949860|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44949861|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
44949862|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
44949863|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44949864|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44949865|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44949866|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
44949867|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
44949868|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
44949869|NCT03566511|Diazoxide|diazoxide|mesh-list
44949870|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44949871|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44949872|NCT03463265|Sirolimus|sirolimus|mesh-list
44949873|NCT03463265|Bevacizumab|bevacizumab|mesh-list
44949874|NCT03463265|Temozolomide|temozolomide|mesh-list
44949875|NCT03463265|Lomustine|lomustine|mesh-list
44949876|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949877|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949878|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44949879|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44949880|NCT03463265|Growth Substances|growth substances|mesh-ancestor
44949881|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949882|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
44949883|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44949884|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
44949885|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949886|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949887|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949888|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44949889|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
44949890|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949891|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
44949892|NCT03439462|Sirolimus|sirolimus|mesh-list
44949893|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949894|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949895|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44949896|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949897|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44949898|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
44949899|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949900|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
44949901|NCT03437005|Ketoconazole|ketoconazole|mesh-list
44949902|NCT03437005|Desonide|desonide|mesh-list
44949903|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
44949904|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44949905|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44949906|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44949907|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949908|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949909|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44949910|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
44949911|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949912|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949913|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44949914|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949915|NCT03422666|Teduglutide|teduglutide|mesh-list
44949916|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949917|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44949918|NCT03422666|Protective Agents|protective agents|mesh-ancestor
44949919|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949920|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
44949921|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949922|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949923|NCT03387852|Fluticasone|fluticasone|mesh-list
44949924|NCT03387852|Xhance|xhance|mesh-list
44949925|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44949926|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44949927|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44949928|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949929|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44949930|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
44949931|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949932|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949933|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44949934|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
44949935|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44949936|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44949937|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44949938|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44949939|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44949940|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
44949941|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949942|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949943|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
44949944|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
44949945|NCT03387852|Hormones|hormones|mesh-ancestor
44949946|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949947|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
44949948|NCT03382574|Denosumab|denosumab|mesh-list
44949949|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44949950|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949951|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
44949952|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44949953|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44949954|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949955|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949956|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44949957|NCT03113643|Azacitidine|azacitidine|mesh-list
44949958|NCT03113643|Venetoclax|venetoclax|mesh-list
44949959|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44949960|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
44949961|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949962|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949963|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44949964|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44949965|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
44949966|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949967|NCT03091491|Nivolumab|nivolumab|mesh-list
44949968|NCT03091491|Ipilimumab|ipilimumab|mesh-list
44949969|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44949970|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949971|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44949972|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44949973|NCT03033095|Etanercept|etanercept|mesh-list
44949974|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44949975|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44949976|NCT03033095|Analgesics|analgesics|mesh-ancestor
44949977|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
44949978|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44949979|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949980|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949981|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44949982|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44949983|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949984|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
44949985|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
44949986|NCT02921789|Prednisone|prednisone|mesh-list
44949987|NCT02921789|Tacrolimus|tacrolimus|mesh-list
44949988|NCT02921789|Basiliximab|basiliximab|mesh-list
44949989|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44949990|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
44949991|NCT02921789|Hormones|hormones|mesh-ancestor
44949992|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44949993|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44949994|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44949995|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44949996|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44949997|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
44949998|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44949999|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950000|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950001|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950002|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44950003|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
44950004|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950005|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950006|NCT02898077|Paclitaxel|paclitaxel|mesh-list
44950007|NCT02898077|Ramucirumab|ramucirumab|mesh-list
44950008|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950009|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950010|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950011|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950012|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950013|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950014|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44950015|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44950016|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950017|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44950018|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44950019|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950020|NCT02653963|Triamcinolone|triamcinolone|mesh-list
44950021|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950022|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
44950023|NCT02653963|Hormones|hormones|mesh-ancestor
44950024|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950025|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950026|NCT02470585|Paclitaxel|paclitaxel|mesh-list
44950027|NCT02470585|Carboplatin|carboplatin|mesh-list
44950028|NCT02470585|Veliparib|veliparib|mesh-list
44950029|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950030|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950031|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950032|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950033|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950034|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950035|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44950036|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950037|NCT02163694|Paclitaxel|paclitaxel|mesh-list
44950038|NCT02163694|Carboplatin|carboplatin|mesh-list
44950039|NCT02163694|Veliparib|veliparib|mesh-list
44950040|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950041|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950042|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950043|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950044|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950045|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950046|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44950047|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950048|NCT02133404|Cinacalcet|cinacalcet|mesh-list
44950049|NCT02133404|ASP7991|asp7991|mesh-list
44950050|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44950051|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950052|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44950053|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
44950054|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950055|NCT01966471|Maytansine|maytansine|mesh-list
44950056|NCT01966471|Docetaxel|docetaxel|mesh-list
44950057|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44950058|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
44950059|NCT01966471|Doxorubicin|doxorubicin|mesh-list
44950060|NCT01966471|Fluorouracil|fluorouracil|mesh-list
44950061|NCT01966471|Trastuzumab|trastuzumab|mesh-list
44950062|NCT01966471|Epirubicin|epirubicin|mesh-list
44950063|NCT01966471|Pertuzumab|pertuzumab|mesh-list
44950064|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950065|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950066|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950067|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950068|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950069|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950070|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950071|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
44950072|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950073|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950074|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950075|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
44950076|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950077|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950078|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44950079|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950080|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950081|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
44950082|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950083|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950084|NCT01536964|Morphine|morphine|mesh-list
44950085|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44950086|NCT01536964|Narcotics|narcotics|mesh-ancestor
44950087|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950088|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950089|NCT01536964|Analgesics|analgesics|mesh-ancestor
44950090|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
44950091|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950092|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44476161|NCT04025658|Oxytocin|oxytocin|mesh-list
44950093|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44950094|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950095|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950096|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
44950097|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950098|NCT01307423|Thalidomide|thalidomide|mesh-list
44481247|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
44950099|NCT01307423|Apremilast|apremilast|mesh-list
44950100|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44950101|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44950102|NCT01307423|Analgesics|analgesics|mesh-ancestor
44950103|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
44950104|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950105|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950106|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950107|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950108|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44950109|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44950110|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950111|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950112|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950113|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
44950114|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
44950115|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950116|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950117|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44950118|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44950119|NCT01307423|Growth Substances|growth substances|mesh-ancestor
44950120|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44950121|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950122|NCT01030575|Inositol|inositol|mesh-list
44950123|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
44950124|NCT01030575|Vitamins|vitamins|mesh-ancestor
44950125|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
44950126|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950127|NCT00911183|Prednisone|prednisone|mesh-list
44950128|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
44950129|NCT00911183|Rituximab|rituximab|mesh-list
44950130|NCT00911183|Doxorubicin|doxorubicin|mesh-list
44950131|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44950132|NCT00911183|Vincristine|vincristine|mesh-list
44950133|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950134|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
44950135|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950136|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950137|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950138|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
44950139|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950140|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950141|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950142|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950143|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950144|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44950145|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950146|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950147|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950148|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
44950149|NCT00911183|Hormones|hormones|mesh-ancestor
44950150|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950151|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44950152|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950153|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950154|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950155|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950156|NCT00655876|Paclitaxel|paclitaxel|mesh-list
44950157|NCT00655876|Cisplatin|cisplatin|mesh-list
44950158|NCT00655876|Cetuximab|cetuximab|mesh-list
44950159|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950160|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950161|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950162|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950163|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950164|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950165|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950166|NCT00602576|Temozolomide|temozolomide|mesh-list
44950167|NCT00602576|Sorafenib|sorafenib|mesh-list
44950168|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950169|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
44950170|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950171|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950172|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950173|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481327|NCT01679795|Tibolone|tibolone|mesh-list
44950174|NCT00265941|Cisplatin|cisplatin|mesh-list
44950175|NCT00265941|Cetuximab|cetuximab|mesh-list
44950176|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950177|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950178|NCT00114140|Temozolomide|temozolomide|mesh-list
44950179|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950180|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
44950181|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950182|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950183|NCT00047008|Cisplatin|cisplatin|mesh-list
44950184|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950185|NCT05420948|Paclitaxel|paclitaxel|mesh-list
44950186|NCT05420948|Carboplatin|carboplatin|mesh-list
44950187|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
44950188|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950189|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950190|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950191|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950192|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950193|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950194|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950195|NCT05420922|Lenvatinib|lenvatinib|mesh-list
44950196|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44950197|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950198|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950199|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950200|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950201|NCT05420441|Chitosan|chitosan|mesh-list
44950202|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44950203|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44950204|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
44950205|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950206|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44950207|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
44950208|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
44950209|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
44950210|NCT05420441|Coagulants|coagulants|mesh-ancestor
44950211|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44950212|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44950213|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44950214|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44950215|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950216|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950217|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44950218|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44950219|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950220|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
43624110|NCT05404061|Hormones|hormones|mesh-list
44950221|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44950222|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
44950223|NCT05598619|Vitamins|vitamins|mesh-ancestor
44950224|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
44950225|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950226|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
44950227|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950228|NCT05598619|Protective Agents|protective agents|mesh-ancestor
44950229|NCT05598593|Cytarabine|cytarabine|mesh-list
44950230|NCT05598593|Fludarabine|fludarabine|mesh-list
44950231|NCT05598593|Busulfan|busulfan|mesh-list
44950232|NCT05598593|Thiotepa|thiotepa|mesh-list
44950233|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950234|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950235|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
44950236|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950237|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950238|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
44950239|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950240|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
44950241|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950242|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
44950243|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950244|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950245|NCT05598580|Lenalidomide|lenalidomide|mesh-list
44950246|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
44950247|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950248|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44950249|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481395|NCT01677754|Rivastigmine|rivastigmine|mesh-list
44950250|NCT05598580|Growth Substances|growth substances|mesh-ancestor
44950251|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
44950252|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950253|NCT05598567|Anesthetics|anesthetics|mesh-list
44950254|NCT05598567|Sevoflurane|sevoflurane|mesh-list
44950255|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950256|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950257|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44950258|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44950259|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
44950260|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
44950261|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
44950262|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950263|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
44950264|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
44950265|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950266|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950267|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950268|NCT05598424|Hormones|hormones|mesh-ancestor
44950269|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950270|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44950271|NCT05598424|Protective Agents|protective agents|mesh-ancestor
44950272|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
44950273|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
44950274|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950275|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
44950276|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
44950277|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950278|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950279|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950280|NCT05598411|Hormones|hormones|mesh-ancestor
44950281|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950282|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44950283|NCT05598411|Protective Agents|protective agents|mesh-ancestor
44950284|NCT05598281|Digoxin|digoxin|mesh-list
44950285|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44950286|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44950287|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950288|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950289|NCT05598281|Protective Agents|protective agents|mesh-ancestor
44950290|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950291|NCT05598255|Dexamethasone|dexamethasone|mesh-list
44950292|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
44950293|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950294|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
44950295|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
44950296|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950297|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950298|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950299|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
44950300|NCT05598255|Hormones|hormones|mesh-ancestor
44950301|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950302|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44950303|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950304|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
44950305|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
44950306|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950307|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
44950308|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44950309|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44950310|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
44950311|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44950312|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950313|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950314|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44950315|NCT05598177|Analgesics|analgesics|mesh-ancestor
44950316|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
44950317|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950318|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44950319|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44950320|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44950321|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
44950322|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44950323|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950324|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
44950325|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44950326|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44950327|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44950328|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44950329|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950330|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
44950331|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44950332|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950333|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44950334|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950335|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
44950336|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44950337|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44950338|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950339|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
44950340|NCT05598086|Coagulants|coagulants|mesh-ancestor
44950341|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
44950342|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44950343|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44950344|NCT05597917|Trabectedin|trabectedin|mesh-list
44950345|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950346|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
44950347|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950348|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950349|NCT05597839|Nivolumab|nivolumab|mesh-list
44950350|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950351|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950352|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950353|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950354|NCT05597813|Timolol|timolol|mesh-list
44950355|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44950356|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44950357|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
44950358|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44950359|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950360|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950361|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44950362|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44950363|NCT05597800|Nivolumab|nivolumab|mesh-list
44950364|NCT05597800|Ipilimumab|ipilimumab|mesh-list
44950365|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950366|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950367|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44236607|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
44950368|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950369|NCT05597709|Insulin|insulin|mesh-list
44950370|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950371|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950372|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44950373|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44950374|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950375|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
44950376|NCT05597527|Apatinib|apatinib|mesh-list
44950377|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950378|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950379|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950380|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950381|NCT05597280|Rifampin|rifampin|mesh-list
44950382|NCT05597280|Bedaquiline|bedaquiline|mesh-list
44950383|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44950384|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
44950385|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950386|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950387|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
44950388|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44950389|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950390|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950391|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44950392|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44950393|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44950394|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44950395|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44950396|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44950397|NCT05597254|Niacin|niacin|mesh-list
44950398|NCT05597254|Niacinamide|niacinamide|mesh-list
44950399|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
44950400|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44950401|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
44950402|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950403|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44950404|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44950405|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
44950406|NCT05597254|Vitamins|vitamins|mesh-ancestor
44950407|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
44950408|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950409|NCT05595772|Mitogens|mitogens|mesh-list
44950410|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950411|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950412|NCT05593055|Eplerenone|eplerenone|mesh-list
44950413|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
44950414|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44950415|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
44950416|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950417|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950418|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44950419|NCT05593055|Diuretics|diuretics|mesh-ancestor
44950420|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
44950421|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44950422|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44950423|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44950424|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950425|NCT05571319|Metformin|metformin|mesh-list
44950426|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950427|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950428|NCT05563116|Calcium|calcium|mesh-list
44950429|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44950430|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950431|NCT05548426|Linezolid|linezolid|mesh-list
44950433|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950434|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950435|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44950436|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950437|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950438|NCT05523609|Vitamin D|vitamin d|mesh-list
44950439|NCT05523609|Letrozole|letrozole|mesh-list
44950440|NCT05523609|Vitamins|vitamins|mesh-ancestor
44950441|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
44950442|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950443|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44950444|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950445|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44950446|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44950447|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950448|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950449|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44950450|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
44950451|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950452|NCT05475717|Alprostadil|alprostadil|mesh-list
44950453|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44950454|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
44950455|NCT05475717|Urological Agents|urological agents|mesh-ancestor
44950456|NCT05460455|Antibodies|antibodies|mesh-list
44950457|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44950458|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
44950459|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481701|NCT00089479|Docetaxel|docetaxel|mesh-list
44950460|NCT05451771|Dexamethasone|dexamethasone|mesh-list
44950461|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
44950462|NCT05451771|Venetoclax|venetoclax|mesh-list
44950463|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44950464|NCT05451771|Daratumumab|daratumumab|mesh-list
44950465|NCT05451771|Pomalidomide|pomalidomide|mesh-list
44950466|NCT05451771|Ixazomib|ixazomib|mesh-list
44950467|NCT05451771|BB 1101|bb 1101|mesh-list
44950468|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950469|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
44950470|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
44950471|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950472|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950473|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950474|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
44950475|NCT05451771|Hormones|hormones|mesh-ancestor
44950476|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950477|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44950478|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950479|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
44950480|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950481|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950482|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950483|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
44950484|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
44950485|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44950486|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44950487|NCT05451771|Growth Substances|growth substances|mesh-ancestor
44950488|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
44950489|NCT05425862|Talazoparib|talazoparib|mesh-list
44950490|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44950491|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950492|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950493|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950494|NCT05420220|Axitinib|axitinib|mesh-list
44950495|NCT05420220|Antibodies|antibodies|mesh-list
44950496|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
44950497|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950498|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950499|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950500|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950501|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950502|NCT05387343|Vaccines|vaccines|mesh-list
44950503|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
44950504|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950505|NCT05383560|Vaccines|vaccines|mesh-list
44950506|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
44950507|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950508|NCT05359835|Edetic Acid|edetic acid|mesh-list
44950509|NCT05359835|Calcium|calcium|mesh-list
44950510|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
44950511|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44950512|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950513|NCT05359835|Antidotes|antidotes|mesh-ancestor
44950514|NCT05359835|Protective Agents|protective agents|mesh-ancestor
44950515|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
44950516|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
44950517|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950518|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44950519|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
44950520|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44950521|NCT05330377|Cytarabine|cytarabine|mesh-list
44950522|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
44950523|NCT05330377|Cladribine|cladribine|mesh-list
44950524|NCT05330377|Lenograstim|lenograstim|mesh-list
44950525|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950526|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
44950527|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950528|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950529|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
44950530|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950531|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950532|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
44950533|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950534|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44950535|NCT05330377|Analgesics|analgesics|mesh-ancestor
44950536|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
44950537|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950538|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44950539|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950540|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950541|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44950542|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
44950543|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44950544|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
44950545|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44950546|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950547|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44950548|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44950549|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950550|NCT05308056|Anesthetics|anesthetics|mesh-list
44950551|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950552|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950553|NCT05301322|Vaccines|vaccines|mesh-list
44950554|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
44950555|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950556|NCT05255107|Riboflavin|riboflavin|mesh-list
44950557|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
44950558|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
44950559|NCT05255107|Vitamins|vitamins|mesh-ancestor
44950560|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
44950561|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950562|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44950563|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
44950564|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44950565|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44950566|NCT05255016|Riboflavin|riboflavin|mesh-list
44950567|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
44950568|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
44950569|NCT05255016|Vitamins|vitamins|mesh-ancestor
44950570|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
44950571|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950572|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44950573|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
44950574|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44950575|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44950576|NCT05212623|Vaccines|vaccines|mesh-list
44950577|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
44950578|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950579|NCT05203510|Treprostinil|treprostinil|mesh-list
44950580|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44950581|NCT05178888|Palbociclib|palbociclib|mesh-list
44950582|NCT05178888|Adagrasib|adagrasib|mesh-list
44950583|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950584|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950585|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950586|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950587|NCT05107219|Linaclotide|linaclotide|mesh-list
44950588|NCT05107219|Plecanatide|plecanatide|mesh-list
44950589|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44950590|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
44950591|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950592|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950593|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
44950594|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44950595|NCT05104762|Antibodies|antibodies|mesh-list
44950596|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
44950597|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44950598|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
44950599|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950600|NCT05084651|Itraconazole|itraconazole|mesh-list
44950601|NCT05084651|Lumefantrine|lumefantrine|mesh-list
44950602|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
44950603|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950604|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44950605|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44950606|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950607|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950608|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44950609|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
44950610|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950611|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481850|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
44950612|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44950613|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
44950614|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44950615|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44950616|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
44950617|NCT05049863|Irinotecan|irinotecan|mesh-list
44950618|NCT05049863|Allopurinol|allopurinol|mesh-list
44950619|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44950620|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950621|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950622|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950623|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950624|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950625|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44950626|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
44950627|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950628|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950629|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
44950630|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
44950631|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950632|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44950633|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
44950634|NCT05049863|Protective Agents|protective agents|mesh-ancestor
44950635|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950636|NCT04941261|Vaccines|vaccines|mesh-list
44950637|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
44950638|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950639|NCT04919382|Temozolomide|temozolomide|mesh-list
44950640|NCT04919382|Atezolizumab|atezolizumab|mesh-list
44950641|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44950642|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950643|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
44950644|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950645|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950646|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
44950647|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950648|NCT04907539|Denosumab|denosumab|mesh-list
44950649|NCT04907539|Nivolumab|nivolumab|mesh-list
44950650|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950651|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950652|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950653|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950654|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44950655|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950656|NCT04871321|Gemcitabine|gemcitabine|mesh-list
44950657|NCT04871321|Paclitaxel|paclitaxel|mesh-list
44950658|NCT04871321|Cisplatin|cisplatin|mesh-list
44950659|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950660|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950661|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950662|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950663|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950664|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950665|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950666|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
44950667|NCT04871321|Antiviral Agents|antiviral agents|mesh-ancestor
44950668|NCT04871321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950669|NCT04871321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950670|NCT04871321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950671|NCT04871321|Immunologic Factors|immunologic factors|mesh-ancestor
44950672|NCT04871321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950673|NCT04863885|Nivolumab|nivolumab|mesh-list
44950674|NCT04863885|Ipilimumab|ipilimumab|mesh-list
44950675|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950676|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950677|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950678|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950679|NCT04833023|Olanzapine|olanzapine|mesh-list
44950680|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
44950681|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
44950682|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950683|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950684|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950685|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44950686|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44950687|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950688|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44950689|NCT04833023|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44950691|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44950692|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950693|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44950694|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
44950695|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44950696|NCT04711122|Cephalosporins|cephalosporins|mesh-list
44950697|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950698|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44950699|NCT04699383|Allopurinol|allopurinol|mesh-list
44950700|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
44950701|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950702|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950703|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
44950704|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950705|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44950706|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
44950707|NCT04699383|Protective Agents|protective agents|mesh-ancestor
44950708|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950709|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44950710|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44950711|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950712|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
44950713|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44950714|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
44950715|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
44950716|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950717|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950718|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
44950719|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950720|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950721|NCT04603365|Temozolomide|temozolomide|mesh-list
44950722|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44950723|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950724|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
44950725|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950726|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950727|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950728|NCT04546620|Prednisolone|prednisolone|mesh-list
44950729|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44950730|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
44950731|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44950732|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
44950733|NCT04546620|Prednisone|prednisone|mesh-list
44950734|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
44950735|NCT04546620|Rituximab|rituximab|mesh-list
44950736|NCT04546620|Doxorubicin|doxorubicin|mesh-list
44950737|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44950738|NCT04546620|Vincristine|vincristine|mesh-list
44950739|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
44950740|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44950741|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
44950742|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950743|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
44950744|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950745|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950746|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950747|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
44950748|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950749|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950750|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950751|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950752|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950753|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44950754|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950755|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950756|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950757|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950758|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950759|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950760|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44950761|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
44950762|NCT04546620|Hormones|hormones|mesh-ancestor
44950763|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950764|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44950765|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
44950766|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
44950767|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950768|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44950769|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44950770|NCT04546620|Protective Agents|protective agents|mesh-ancestor
44950771|NCT04539938|Trastuzumab|trastuzumab|mesh-list
44950772|NCT04539938|Tucatinib|tucatinib|mesh-list
44950773|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950774|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950775|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950776|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950777|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950778|NCT04390399|Leucovorin|leucovorin|mesh-list
44950779|NCT04390399|Gemcitabine|gemcitabine|mesh-list
44950780|NCT04390399|Paclitaxel|paclitaxel|mesh-list
44950781|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
44950782|NCT04390399|Fluorouracil|fluorouracil|mesh-list
44950783|NCT04390399|Irinotecan|irinotecan|mesh-list
44950784|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44950785|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950786|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950787|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950788|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950789|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950790|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950791|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
44950792|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950793|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950794|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950795|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
44950796|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950797|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950798|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
44950799|NCT04390399|Antiviral Agents|antiviral agents|mesh-ancestor
44950800|NCT04390399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950801|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950802|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44950803|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950804|NCT04390399|Antidotes|antidotes|mesh-ancestor
44950805|NCT04390399|Protective Agents|protective agents|mesh-ancestor
44950806|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
44950807|NCT04390399|Vitamins|vitamins|mesh-ancestor
44950808|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
44950809|NCT04367311|Cisplatin|cisplatin|mesh-list
44950810|NCT04367311|Docetaxel|docetaxel|mesh-list
44950811|NCT04367311|Pemetrexed|pemetrexed|mesh-list
44950812|NCT04367311|Atezolizumab|atezolizumab|mesh-list
44950813|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950814|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44950815|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44950816|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44950817|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950818|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950819|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44950820|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44950821|NCT04354012|Gentian Violet|gentian violet|mesh-list
44950822|NCT04354012|Methylene Blue|methylene blue|mesh-list
44950823|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950824|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950825|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44950826|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950827|NCT04220775|Atezolizumab|atezolizumab|mesh-list
44950828|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950829|NCT04211675|Irinotecan|irinotecan|mesh-list
44950830|NCT04211675|Temozolomide|temozolomide|mesh-list
44950831|NCT04211675|Dinutuximab|dinutuximab|mesh-list
44950832|NCT04211675|Sargramostim|sargramostim|mesh-list
44950833|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44950834|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44950835|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950836|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950837|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950838|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950839|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
44950840|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
44950841|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950842|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
44950843|NCT04209660|Lenvatinib|lenvatinib|mesh-list
44950844|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950845|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950846|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950847|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950848|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950849|NCT03970096|Cyclosporine|cyclosporine|mesh-list
44950850|NCT03970096|Sirolimus|sirolimus|mesh-list
44950851|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
44950852|NCT03970096|Busulfan|busulfan|mesh-list
44950853|NCT03970096|Thiotepa|thiotepa|mesh-list
44950854|NCT03970096|Methotrexate|methotrexate|mesh-list
44950855|NCT03970096|Fludarabine|fludarabine|mesh-list
44950856|NCT03970096|Tacrolimus|tacrolimus|mesh-list
44950857|NCT03970096|Cyclosporins|cyclosporins|mesh-list
44950858|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950859|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
44950860|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950861|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950862|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950863|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
44950864|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950865|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950866|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950867|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44950868|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
44950869|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44950870|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950871|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
44950872|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
44950873|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950874|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44950875|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44950876|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44950877|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
44950878|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950879|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44950880|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44950881|NCT03961256|Exenatide|exenatide|mesh-list
44950882|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950883|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950884|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44950885|NCT03961256|Incretins|incretins|mesh-ancestor
44950886|NCT03961256|Hormones|hormones|mesh-ancestor
44950887|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950888|NCT03684447|Propofol|propofol|mesh-list
44950889|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44950890|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44950891|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950892|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44950893|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
44950894|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
44950895|NCT03635892|Nivolumab|nivolumab|mesh-list
44950896|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950897|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950898|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950899|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950900|NCT03575793|Nivolumab|nivolumab|mesh-list
44950901|NCT03575793|Ipilimumab|ipilimumab|mesh-list
44950902|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950903|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950904|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950905|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950906|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44950907|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44950908|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950909|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950910|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950911|NCT03502031|Losartan|losartan|mesh-list
44950912|NCT03502031|Valsartan|valsartan|mesh-list
44950913|NCT03502031|Enalapril|enalapril|mesh-list
44950914|NCT03502031|Enalaprilat|enalaprilat|mesh-list
44950915|NCT03502031|Lisinopril|lisinopril|mesh-list
44950916|NCT03502031|Perindopril|perindopril|mesh-list
44950917|NCT03502031|Spironolactone|spironolactone|mesh-list
44950918|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44950919|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44950920|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44950921|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950922|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44950923|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44482241|NCT00081289|Leucovorin|leucovorin|mesh-list
44950924|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44950925|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44950926|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950927|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44950929|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
44950930|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44950931|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
44950932|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950933|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44950934|NCT03502031|Protective Agents|protective agents|mesh-ancestor
44950935|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
44950936|NCT03318861|Fludarabine|fludarabine|mesh-list
44950937|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950938|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
44950939|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950940|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44950941|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44950942|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
44950943|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950944|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950945|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44950946|NCT03317119|Trifluridine|trifluridine|mesh-list
44950947|NCT03317119|Trametinib|trametinib|mesh-list
44950948|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950949|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44950950|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950951|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950952|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
44950953|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
44950954|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950955|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44950956|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44950957|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950958|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950959|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950960|NCT03148795|Talazoparib|talazoparib|mesh-list
44950961|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44950962|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950963|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950964|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950965|NCT03101566|Gemcitabine|gemcitabine|mesh-list
44950966|NCT03101566|Cisplatin|cisplatin|mesh-list
44950967|NCT03101566|Nivolumab|nivolumab|mesh-list
44950968|NCT03101566|Ipilimumab|ipilimumab|mesh-list
44950969|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950970|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950971|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
44950972|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950973|NCT03101566|Antiviral Agents|antiviral agents|mesh-ancestor
44950974|NCT03101566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950975|NCT03101566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950976|NCT03101566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950977|NCT03101566|Immunologic Factors|immunologic factors|mesh-ancestor
44950978|NCT03101566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950979|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44950980|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44950981|NCT03098654|Metformin|metformin|mesh-list
44950982|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44950983|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950984|NCT03093909|Gemcitabine|gemcitabine|mesh-list
44950985|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44950986|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
44950987|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44950988|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44950989|NCT03093909|Antiviral Agents|antiviral agents|mesh-ancestor
44950990|NCT03093909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44950991|NCT03093909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44950992|NCT03093909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44950993|NCT03093909|Immunologic Factors|immunologic factors|mesh-ancestor
44950994|NCT03093909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950995|NCT03032172|Risdiplam|risdiplam|mesh-list
44482312|NCT00080483|Hormones|hormones|mesh-ancestor
44950996|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44950997|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44950998|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44950999|NCT03011450|Fenofibrate|fenofibrate|mesh-list
44951000|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44951001|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
44951002|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951003|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44951004|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
44951005|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44951006|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951008|NCT02923739|Bevacizumab|bevacizumab|mesh-list
44951009|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44951010|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44951011|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
44951012|NCT02923739|Antibodies|antibodies|mesh-list
44951013|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
44951014|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44951015|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
44951016|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951017|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951018|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951019|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951020|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951021|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951022|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951023|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951024|NCT02923739|Growth Substances|growth substances|mesh-ancestor
44951025|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951026|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951027|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
44482396|NCT00081510|Lonafarnib|lonafarnib|mesh-list
44951028|NCT02660710|Rituximab|rituximab|mesh-list
44951029|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951030|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951031|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
44951032|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951033|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951034|NCT02659540|Nivolumab|nivolumab|mesh-list
44951035|NCT02659540|Ipilimumab|ipilimumab|mesh-list
44951036|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951037|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951038|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44951039|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951040|NCT02460419|Capecitabine|capecitabine|mesh-list
44951041|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951042|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
44951043|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951044|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951045|NCT01097746|Paclitaxel|paclitaxel|mesh-list
44951046|NCT01097746|Bevacizumab|bevacizumab|mesh-list
44951047|NCT01097746|Carboplatin|carboplatin|mesh-list
44951048|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44951049|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44951050|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
44951051|NCT01097746|Antibodies|antibodies|mesh-list
44951052|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
44951053|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44951054|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
44951055|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951056|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951057|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951058|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951059|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951060|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951061|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951062|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951063|NCT01097746|Growth Substances|growth substances|mesh-ancestor
44951064|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951065|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951066|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
44951067|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44951068|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
44951069|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
44951070|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951071|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44951072|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951073|NCT05419674|Amoxicillin|amoxicillin|mesh-list
44951074|NCT05419674|Clarithromycin|clarithromycin|mesh-list
44951075|NCT05419674|Rabeprazole|rabeprazole|mesh-list
44951076|NCT05419674|Bismuth|bismuth|mesh-list
44951077|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951078|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951079|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44951080|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951081|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951082|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44951083|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44951084|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44951085|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44951086|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44951087|NCT05419674|Antacids|antacids|mesh-ancestor
44951088|NCT05419466|Melatonin|melatonin|mesh-list
44951089|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
44951090|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951091|NCT05419466|Protective Agents|protective agents|mesh-ancestor
44951092|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951093|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951094|NCT05419297|Buprenorphine|buprenorphine|mesh-list
44951095|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44951096|NCT05419297|Narcotics|narcotics|mesh-ancestor
44951097|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951098|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951099|NCT05419297|Analgesics|analgesics|mesh-ancestor
44951100|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
44951101|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951102|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44951103|NCT05419193|Ceftriaxone|ceftriaxone|mesh-list
44951104|NCT05419193|Propranolol|propranolol|mesh-list
44951105|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44951106|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44951107|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
44951108|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951109|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951110|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951111|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44951112|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44482496|NCT03088059|Durvalumab|durvalumab|mesh-list
44951113|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
44951114|NCT05419193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951115|NCT05419193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951116|NCT05417841|Insulin|insulin|mesh-list
44951117|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44951118|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
44951119|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
44951120|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44951121|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44951122|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951123|NCT05416840|Amlodipine|amlodipine|mesh-list
44951124|NCT05416840|Clonidine|clonidine|mesh-list
44951125|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44951126|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44951127|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44951128|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951129|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44951130|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951131|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
44951132|NCT05416840|Analgesics|analgesics|mesh-ancestor
44951133|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
44951134|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951135|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
44951136|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
44951137|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44951138|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44951139|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44951140|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
44951141|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951142|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
44951143|NCT05411991|Acetazolamide|acetazolamide|mesh-list
44951144|NCT05411991|Bumetanide|bumetanide|mesh-list
44951145|NCT05411991|Diuretics|diuretics|mesh-list
44951146|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44951147|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
44951148|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951149|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
44951150|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44951151|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951152|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951153|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44951154|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44951155|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44951156|NCT05396690|Sevoflurane|sevoflurane|mesh-list
44951157|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44951158|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44951159|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
44951160|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
44951161|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951162|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951163|NCT05351151|Lidocaine|lidocaine|mesh-list
44951164|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
44951165|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
44951166|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951167|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951168|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
44951169|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951170|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44951171|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44951172|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44951173|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44951174|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951175|NCT05344495|Midazolam|midazolam|mesh-list
44951176|NCT05344495|Bupivacaine|bupivacaine|mesh-list
44951177|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
44951178|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
44951179|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951180|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951181|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
44951182|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951183|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44951184|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44951185|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44951186|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44951187|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44951188|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44951189|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
44951190|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
44951191|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
44951192|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951193|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951194|NCT05337449|Fluorides|fluorides|mesh-list
44951195|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
44951196|NCT05337449|Protective Agents|protective agents|mesh-ancestor
44951197|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951198|NCT05213312|Paclitaxel|paclitaxel|mesh-list
44951199|NCT05213312|Cisplatin|cisplatin|mesh-list
44951200|NCT05213312|Fluorouracil|fluorouracil|mesh-list
44951201|NCT05213312|Nivolumab|nivolumab|mesh-list
44951202|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951203|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951204|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951205|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951206|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951207|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951208|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
44951209|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951210|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951211|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
44951212|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951213|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951214|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44951215|NCT05207644|Letrozole|letrozole|mesh-list
44951216|NCT05207644|Misoprostol|misoprostol|mesh-list
44951217|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951218|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44951219|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44951220|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951221|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951222|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44951223|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951224|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951225|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951226|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44951227|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
44951228|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44951229|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44951230|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44951231|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
44951232|NCT05192850|Metformin|metformin|mesh-list
44951233|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44951234|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951235|NCT05133687|Bupivacaine|bupivacaine|mesh-list
44951236|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
44951237|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
44951238|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951239|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951240|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
44951241|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951242|NCT05131828|Metformin|metformin|mesh-list
44951243|NCT05131828|Clemastine|clemastine|mesh-list
44951244|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44951245|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951246|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
44951247|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951248|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44951249|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
44951250|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
44951251|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951252|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951253|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44951254|NCT05101551|Gemcitabine|gemcitabine|mesh-list
44951255|NCT05101551|Topotecan|topotecan|mesh-list
44951256|NCT05101551|Talazoparib|talazoparib|mesh-list
44951257|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951258|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
44951259|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951260|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951261|NCT05101551|Antiviral Agents|antiviral agents|mesh-ancestor
44951262|NCT05101551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951263|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951264|NCT05101551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951265|NCT05101551|Immunologic Factors|immunologic factors|mesh-ancestor
44951266|NCT05101551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951267|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44951268|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951269|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44951270|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
44951271|NCT05027893|Cefixime|cefixime|mesh-list
44951272|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482699|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
44951273|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951274|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44951275|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951276|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951277|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951278|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951279|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
44951280|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44951281|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
44951282|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951283|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
44951284|NCT04989361|Protective Agents|protective agents|mesh-ancestor
44951285|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44951286|NCT04899193|Hormones|hormones|mesh-ancestor
44951287|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951288|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951289|NCT04877379|Ceftibuten|ceftibuten|mesh-list
44951290|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951291|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951292|NCT04809116|Pimavanserin|pimavanserin|mesh-list
44951293|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44951294|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44951295|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44951296|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44951297|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951298|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951299|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44951300|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44951301|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44951302|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
44951303|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951304|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951305|NCT04799236|Amphotericin B|amphotericin b|mesh-list
44951306|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44951307|NCT04799236|Miltefosine|miltefosine|mesh-list
44951308|NCT04799236|Amebicides|amebicides|mesh-ancestor
44951309|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44951310|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44951311|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951312|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951313|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
44951314|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951315|NCT04687631|Bevacizumab|bevacizumab|mesh-list
44951316|NCT04687631|Cetuximab|cetuximab|mesh-list
44951317|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951318|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951319|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951320|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951321|NCT04687631|Growth Substances|growth substances|mesh-ancestor
44951322|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951323|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951324|NCT04630210|Atezolizumab|atezolizumab|mesh-list
44951325|NCT04630210|Letrozole|letrozole|mesh-list
44951326|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951327|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44951328|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44951329|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951330|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951331|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44951332|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951333|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951334|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951335|NCT04592744|Vasopressins|vasopressins|mesh-list
44951336|NCT04592744|Epinephrine|epinephrine|mesh-list
44951337|NCT04592744|Norepinephrine|norepinephrine|mesh-list
44951338|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
44951339|NCT04592744|Giapreza|giapreza|mesh-list
44951340|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
44951341|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44951342|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44951343|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
44951344|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951345|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951346|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951347|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44951348|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44951349|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
44951350|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951351|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44951352|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
44951353|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
44951354|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
44951355|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44951356|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
44951357|NCT04592744|Coagulants|coagulants|mesh-ancestor
44951358|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44951359|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
44951360|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44951361|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
44951362|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951363|NCT04546828|Gemcitabine|gemcitabine|mesh-list
44951364|NCT04546828|Cisplatin|cisplatin|mesh-list
44951365|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951366|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951367|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
44951368|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951369|NCT04546828|Antiviral Agents|antiviral agents|mesh-ancestor
44951370|NCT04546828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951371|NCT04546828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951372|NCT04546828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951373|NCT04546828|Immunologic Factors|immunologic factors|mesh-ancestor
44951374|NCT04546828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951375|NCT04509193|Warfarin|warfarin|mesh-list
44951376|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
44951377|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
44951378|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44951379|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
44951380|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44951381|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
44951382|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951383|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951384|NCT04429685|Ketamine|ketamine|mesh-list
44951385|NCT04429685|Analgesics|analgesics|mesh-ancestor
44951386|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
44951387|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951388|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951389|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44951390|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44951391|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
44951392|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
44951393|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951394|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44951395|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44951396|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951397|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951398|NCT04401709|Gemcitabine|gemcitabine|mesh-list
44951399|NCT04401709|Capecitabine|capecitabine|mesh-list
44951400|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951401|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
44951402|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951403|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951404|NCT04401709|Antiviral Agents|antiviral agents|mesh-ancestor
44951405|NCT04401709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951406|NCT04401709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951407|NCT04401709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951408|NCT04401709|Immunologic Factors|immunologic factors|mesh-ancestor
44951409|NCT04401709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951410|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
44951411|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
44951412|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482853|NCT03086785|Apatinib|apatinib|mesh-list
44951414|NCT04326439|Etoposide|etoposide|mesh-list
44951415|NCT04326439|Daunorubicin|daunorubicin|mesh-list
44951416|NCT04326439|Sorafenib|sorafenib|mesh-list
44951417|NCT04326439|Asparaginase|asparaginase|mesh-list
44951418|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
44951419|NCT04326439|Calicheamicins|calicheamicins|mesh-list
44951420|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951421|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951422|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44951423|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951424|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951425|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951426|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951427|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
44951428|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
44951429|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951430|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951431|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
44951432|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951433|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951434|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44951435|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951436|NCT04233047|Fostemsavir|fostemsavir|mesh-list
44951437|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44951438|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44951439|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
44951440|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951441|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44951442|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44951443|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951444|NCT04188730|Lofexidine|lofexidine|mesh-list
44951445|NCT04188730|Clonidine|clonidine|mesh-list
44951446|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44951447|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44951448|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951449|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
44951450|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951451|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44951452|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44951453|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44951454|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
44951455|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951456|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951457|NCT04188730|Analgesics|analgesics|mesh-ancestor
44951458|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
44951459|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
44951460|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
44951461|NCT04113083|Provitamins|provitamins|mesh-ancestor
44951462|NCT04113083|Vitamins|vitamins|mesh-ancestor
44951463|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
44951464|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951465|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
44951466|NCT04099641|Bavituximab|bavituximab|mesh-list
44951467|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951468|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951469|NCT04098302|Dutasteride|dutasteride|mesh-list
44951470|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44951471|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44951472|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951473|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951474|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951475|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951476|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951477|NCT03909607|Ketamine|ketamine|mesh-list
44951478|NCT03909607|Analgesics|analgesics|mesh-ancestor
44951479|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
44951480|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951481|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951482|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44951483|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44951484|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
44951485|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
44951486|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951487|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44736722|NCT03725202|Upadacitinib|upadacitinib|mesh-list
44951488|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44951489|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951490|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951492|NCT03902509|Analgesics|analgesics|mesh-ancestor
44951493|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
44951494|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951495|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951496|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44951497|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44951498|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44951499|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951500|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951501|NCT03841565|Dexamethasone|dexamethasone|mesh-list
44951502|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
44951503|NCT03841565|Daratumumab|daratumumab|mesh-list
44951504|NCT03841565|Pomalidomide|pomalidomide|mesh-list
44951505|NCT03841565|Ichthammol|ichthammol|mesh-list
44951506|NCT03841565|BB 1101|bb 1101|mesh-list
44951507|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44951508|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
44951509|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
44951510|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951511|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951512|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44951513|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
44951514|NCT03841565|Hormones|hormones|mesh-ancestor
44951515|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951516|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44951517|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951518|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44951519|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951520|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951521|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
44951522|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951523|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951524|NCT03841565|Growth Substances|growth substances|mesh-ancestor
44951525|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951526|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951527|NCT03780608|Durvalumab|durvalumab|mesh-list
44951528|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951529|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951530|NCT03722849|Adenosine|adenosine|mesh-list
44951531|NCT03722849|Capsaicin|capsaicin|mesh-list
44951532|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
44951533|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951534|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
44951535|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951536|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951537|NCT03722849|Analgesics|analgesics|mesh-ancestor
44951538|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44951539|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
44951540|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44951541|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
44951542|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
44951543|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951544|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951545|NCT03654716|Cytarabine|cytarabine|mesh-list
44951546|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951547|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
44951548|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951549|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951550|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
44951551|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951552|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951553|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
44951554|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951555|NCT03612713|Oxycodone|oxycodone|mesh-list
44951556|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44951557|NCT03612713|Narcotics|narcotics|mesh-ancestor
44951558|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951559|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951560|NCT03612713|Analgesics|analgesics|mesh-ancestor
44951561|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
44951562|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951563|NCT03469284|Methylene Blue|methylene blue|mesh-list
44951565|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951566|NCT03442556|Carboplatin|carboplatin|mesh-list
44951567|NCT03442556|Docetaxel|docetaxel|mesh-list
44951568|NCT03442556|Rucaparib|rucaparib|mesh-list
44951569|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951570|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951571|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951572|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951573|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951574|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44951575|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951576|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44951577|NCT03430531|Lidocaine|lidocaine|mesh-list
44951578|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
44951579|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
44951580|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951581|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951582|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
44951583|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951584|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44951585|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44951586|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44951587|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44951588|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951589|NCT03402841|Olaparib|olaparib|mesh-list
44951590|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44951591|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951592|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951593|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951594|NCT03243058|Aldesleukin|aldesleukin|mesh-list
44951595|NCT03243058|Interleukin-2|interleukin-2|mesh-list
44951596|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951597|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44951598|NCT03243058|Analgesics|analgesics|mesh-ancestor
44951599|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
44951600|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951601|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951602|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44951603|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44951604|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
44951605|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951606|NCT03181386|Warfarin|warfarin|mesh-list
44951607|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
44951608|NCT03181386|Dabigatran|dabigatran|mesh-list
44951609|NCT03181386|Apixaban|apixaban|mesh-list
44951610|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
44951611|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44951612|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
44951613|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44951614|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
44951615|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951616|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951617|NCT03170180|Sunitinib|sunitinib|mesh-list
44951618|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
44951619|NCT03170180|Gefitinib|gefitinib|mesh-list
44951620|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951621|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951622|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951623|NCT03170180|Growth Substances|growth substances|mesh-ancestor
44951624|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951625|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951626|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951627|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951628|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951629|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
44951630|NCT03164993|Doxorubicin|doxorubicin|mesh-list
44951631|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44951632|NCT03164993|Atezolizumab|atezolizumab|mesh-list
44951633|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951634|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
44951635|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951636|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951637|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44951638|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
44483006|NCT03084575|Glycerol|glycerol|mesh-list
44951639|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951640|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951641|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44951642|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44951643|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44951644|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951645|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951646|NCT03110510|Leucovorin|leucovorin|mesh-list
44951647|NCT03110510|Fluorouracil|fluorouracil|mesh-list
44951648|NCT03110510|Irinotecan|irinotecan|mesh-list
44951649|NCT03110510|Calcium|calcium|mesh-list
44951650|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
44951651|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44951652|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951653|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
44951654|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735927|NCT04877522|Dasatinib|dasatinib|mesh-list
44951655|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951656|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951657|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951658|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
44951659|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44951660|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951661|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951662|NCT03110510|Antidotes|antidotes|mesh-ancestor
44951663|NCT03110510|Protective Agents|protective agents|mesh-ancestor
44951664|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
44951665|NCT03110510|Vitamins|vitamins|mesh-ancestor
44951666|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
44951667|NCT03110484|Pemetrexed|pemetrexed|mesh-list
44951668|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44951669|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951670|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951671|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951672|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44951673|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44951674|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951675|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
44951676|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951677|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951678|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
44951679|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44951680|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951681|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951682|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44951683|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951684|NCT02881957|Vitamin D|vitamin d|mesh-list
44951685|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
44951686|NCT02881957|Vitamins|vitamins|mesh-ancestor
44951687|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
44951688|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951689|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44951690|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44951691|NCT02761694|Paclitaxel|paclitaxel|mesh-list
44951692|NCT02761694|Fulvestrant|fulvestrant|mesh-list
44951693|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951694|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951695|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951696|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951697|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951698|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951699|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44951700|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44951701|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44951702|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951703|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951704|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951705|NCT02691793|Sunitinib|sunitinib|mesh-list
44951706|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951707|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951708|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951709|NCT02691793|Growth Substances|growth substances|mesh-ancestor
44951710|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951711|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951712|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483085|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
44951713|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951714|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951716|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951717|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951718|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44951719|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951720|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
44951721|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951722|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
44951723|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951724|NCT02630199|Paclitaxel|paclitaxel|mesh-list
44951725|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951726|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951727|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951728|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951729|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951730|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951731|NCT02588781|Pemetrexed|pemetrexed|mesh-list
44951732|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951733|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951734|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951735|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44951736|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44951737|NCT02574455|Gemcitabine|gemcitabine|mesh-list
44951738|NCT02574455|Capecitabine|capecitabine|mesh-list
44951739|NCT02574455|Vinorelbine|vinorelbine|mesh-list
44951740|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951741|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
44951742|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951743|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951744|NCT02574455|Antiviral Agents|antiviral agents|mesh-ancestor
44951745|NCT02574455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951746|NCT02574455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951747|NCT02574455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951748|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
44951749|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951750|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951751|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951752|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951753|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951754|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
44951755|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
44951756|NCT02566304|Fludarabine|fludarabine|mesh-list
44951757|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
44951758|NCT02566304|Tacrolimus|tacrolimus|mesh-list
44951759|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951760|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
44951761|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951762|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951763|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44951764|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
44951765|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951766|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951767|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44951768|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951769|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
44951770|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951771|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44951772|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951773|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44951774|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44951775|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
44951776|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951777|NCT02467608|Isoniazid|isoniazid|mesh-list
44951778|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
44951779|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44951780|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951781|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44951782|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44951783|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
44951784|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951785|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44951786|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
44951787|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951788|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951789|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951790|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951791|NCT02450123|Sunitinib|sunitinib|mesh-list
44951792|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951793|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44951794|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44951795|NCT02450123|Growth Substances|growth substances|mesh-ancestor
44951796|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951797|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
44951798|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951799|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951800|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951801|NCT02426281|Gemcitabine|gemcitabine|mesh-list
44951802|NCT02426281|Paclitaxel|paclitaxel|mesh-list
44951803|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951804|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951805|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951806|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951807|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951808|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951809|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951810|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
44951811|NCT02426281|Antiviral Agents|antiviral agents|mesh-ancestor
44951812|NCT02426281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951813|NCT02426281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951814|NCT02426281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951815|NCT02426281|Immunologic Factors|immunologic factors|mesh-ancestor
44951816|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951817|NCT02232087|Fluticasone|fluticasone|mesh-list
44951818|NCT02232087|Xhance|xhance|mesh-list
44951819|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44951820|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44951821|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44951822|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44951823|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
44951824|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951825|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951826|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44951827|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44951828|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951829|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44951830|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44951831|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44951832|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44951833|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44951834|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951835|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951836|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
44951837|NCT02232087|Hormones|hormones|mesh-ancestor
44951838|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951839|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
44951840|NCT01560585|Isotretinoin|isotretinoin|mesh-list
44951841|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951842|NCT01376427|Dexamethasone|dexamethasone|mesh-list
44951843|NCT01376427|Methotrexate|methotrexate|mesh-list
44951844|NCT01376427|Vincristine|vincristine|mesh-list
44951845|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44951846|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
44951847|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
44951848|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951849|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951850|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44951851|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
44951852|NCT01376427|Hormones|hormones|mesh-ancestor
44951853|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951854|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44951855|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951856|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44951857|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
44951858|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44951859|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951860|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
44951861|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951862|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44951863|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951864|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44951865|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951866|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
44951867|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951868|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44951869|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951870|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951871|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951872|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951873|NCT01096966|Bupivacaine|bupivacaine|mesh-list
44707247|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44951874|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44951875|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
44951876|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951877|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951878|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
44951879|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951881|NCT00979212|Carboplatin|carboplatin|mesh-list
44951882|NCT00979212|Panitumumab|panitumumab|mesh-list
44951883|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44951884|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951885|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
44951886|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
44951887|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
44951888|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951889|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44951890|NCT00777491|Gemcitabine|gemcitabine|mesh-list
44951891|NCT00777491|Cisplatin|cisplatin|mesh-list
44951892|NCT00777491|Fluorouracil|fluorouracil|mesh-list
44951893|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951894|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44951895|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
44951896|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951897|NCT00777491|Antiviral Agents|antiviral agents|mesh-ancestor
44951898|NCT00777491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951899|NCT00777491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951900|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951901|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
44951902|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951903|NCT00759655|Factor VIII|factor viii|mesh-list
44951904|NCT00759655|Coagulants|coagulants|mesh-ancestor
44951905|NCT00145795|Ritonavir|ritonavir|mesh-list
44951906|NCT00145795|Lopinavir|lopinavir|mesh-list
44951907|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44951908|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44951909|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
44951910|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951911|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951912|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44951913|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44951914|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
44951915|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44951916|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44951917|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44951918|NCT00005044|Bicalutamide|bicalutamide|mesh-list
44951919|NCT00005044|Flutamide|flutamide|mesh-list
44951920|NCT00005044|Hormones|hormones|mesh-list
44951921|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44951922|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951923|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951924|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
44951925|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951926|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951927|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44951928|NCT00002874|Bicalutamide|bicalutamide|mesh-list
44951929|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
44951930|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
44951931|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44951932|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951933|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951934|NCT05422716|Baclofen|baclofen|mesh-list
44951935|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44951936|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951937|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44951938|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951939|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44951940|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
44951941|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
44951942|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951943|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951944|NCT05422183|Lenvatinib|lenvatinib|mesh-list
44951945|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951946|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951947|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951948|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951949|NCT05422131|Clozapine|clozapine|mesh-list
44951950|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44951952|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951953|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951954|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951955|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44951956|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44951957|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951958|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44951959|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
44951960|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
44951961|NCT05422001|Ketamine|ketamine|mesh-list
44951962|NCT05422001|Analgesics|analgesics|mesh-ancestor
44951963|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
44951964|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44951965|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951966|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44951967|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44951968|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
44951969|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
44951970|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44951971|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44951972|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44951973|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44951974|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951975|NCT05421936|Osimertinib|osimertinib|mesh-list
44951976|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951977|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44951978|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951979|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951980|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
44951981|NCT05421897|Temozolomide|temozolomide|mesh-list
44951982|NCT05421897|Irinotecan|irinotecan|mesh-list
44951983|NCT05421897|Topotecan|topotecan|mesh-list
44951984|NCT05421897|Dinutuximab|dinutuximab|mesh-list
44951985|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44951986|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
44951987|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44951988|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44951989|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44951990|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
44951991|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44951992|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44951993|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44951994|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44951995|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44951996|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44951997|NCT05421416|Loratadine|loratadine|mesh-list
44951998|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
44951999|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44952000|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44952001|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44952002|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44952003|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
44952004|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
44952005|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952006|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952007|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952008|NCT05421000|Anesthetics|anesthetics|mesh-list
44952009|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952010|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952011|NCT05419362|Avelumab|avelumab|mesh-list
44952012|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952013|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952014|NCT05418504|Anesthetics|anesthetics|mesh-list
44952015|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952016|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952017|NCT05345249|Ropivacaine|ropivacaine|mesh-list
44952018|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
44952019|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
44952020|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952021|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952022|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
44952023|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483366|NCT03080350|Fentanyl|fentanyl|mesh-list
44952024|NCT05326373|Fluorides|fluorides|mesh-list
44952025|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
44952026|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
44952027|NCT05326373|Protective Agents|protective agents|mesh-ancestor
44952028|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952029|NCT05322902|Propofol|propofol|mesh-list
44952030|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952031|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952032|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952033|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952034|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
44952035|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
44952036|NCT05320627|Edoxaban|edoxaban|mesh-list
44952037|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44952038|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
44952039|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44952040|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
44952041|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952042|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952043|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
44952044|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44952045|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952046|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44952047|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952048|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
44952049|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952050|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952051|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
44952052|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952053|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952054|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
44952055|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44952056|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44952057|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952058|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
44952059|NCT05037162|Coagulants|coagulants|mesh-ancestor
44952060|NCT04884399|Ranibizumab|ranibizumab|mesh-list
44952061|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44952062|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44952063|NCT04884399|Growth Substances|growth substances|mesh-ancestor
44952064|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952065|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
44952066|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952067|NCT04850599|Pomalidomide|pomalidomide|mesh-list
44952068|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44952069|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
44952070|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952071|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44952072|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44476287|NCT04020718|Nicotine|nicotine|mesh-list
44952073|NCT04850599|Growth Substances|growth substances|mesh-ancestor
44952074|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
44476530|NCT04143282|Metformin|metformin|mesh-list
44952075|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952076|NCT04839328|Hemay005|hemay005|mesh-list
44952077|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44476808|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
44952078|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44952079|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44952080|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476856|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44476890|NCT04147481|Anesthetics|anesthetics|mesh-list
44476964|NCT04146116|Povidone|povidone|mesh-list
44477040|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477041|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477042|NCT04145232|Nivolumab|nivolumab|mesh-list
44477043|NCT04145232|Ipilimumab|ipilimumab|mesh-list
44477044|NCT04145232|Atezolizumab|atezolizumab|mesh-list
44477045|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477046|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477047|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44477048|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477049|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
44477050|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44477051|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44477052|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477053|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477054|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477056|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
44477157|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952081|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477373|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
44477515|NCT04146298|Antibodies|antibodies|mesh-list
44952082|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44477630|NCT04146532|Analgesics|analgesics|mesh-ancestor
44952083|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
44952084|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44478000|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44478001|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478002|NCT05587881|Vaccines|vaccines|mesh-list
44478003|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
44478004|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478005|NCT05586204|Vaccines|vaccines|mesh-list
44478006|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
44478007|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736134|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736135|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736157|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
44736158|NCT04485013|Cetuximab|cetuximab|mesh-list
44736159|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736160|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736161|NCT04484532|Vaccines|vaccines|mesh-list
44736162|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
44736163|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736164|NCT04452877|Trametinib|trametinib|mesh-list
44736165|NCT04452877|Dabrafenib|dabrafenib|mesh-list
44736166|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736170|NCT04427709|Oxytocin|oxytocin|mesh-list
44478167|NCT03582774|Edetic Acid|edetic acid|mesh-list
44478244|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44478245|NCT03589027|Ritonavir|ritonavir|mesh-list
44478246|NCT03589027|Darunavir|darunavir|mesh-list
44478247|NCT03589027|Rilpivirine|rilpivirine|mesh-list
44478248|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
44478249|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44478250|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44478251|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
44478252|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478253|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478254|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44478255|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44478256|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
44478257|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478283|NCT03588936|Nivolumab|nivolumab|mesh-list
44952085|NCT04795869|Antibodies|antibodies|mesh-list
44952086|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
44952087|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44952088|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
44952089|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
44952090|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952091|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952092|NCT04644289|Durvalumab|durvalumab|mesh-list
44952093|NCT04644289|Olaparib|olaparib|mesh-list
44952094|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952095|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952096|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44952097|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952098|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952099|NCT04591275|Denosumab|denosumab|mesh-list
44952100|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44952101|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952102|NCT04571645|Heparin|heparin|mesh-list
44952103|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
44952104|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44952105|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44478555|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44952106|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952107|NCT04565847|Albuterol|albuterol|mesh-list
44478787|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44478859|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44478860|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44478861|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478862|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478863|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
44736268|NCT04231877|Prednisone|prednisone|mesh-list
44736269|NCT04231877|Cortisone|cortisone|mesh-list
44736270|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
44952108|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44478969|NCT03582332|Etoricoxib|etoricoxib|mesh-list
44952109|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
44952110|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952111|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952112|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479066|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
44479146|NCT03580239|Everolimus|everolimus|mesh-list
44479291|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
44479292|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479293|NCT03159702|Fludarabine|fludarabine|mesh-list
44479294|NCT03159702|Melphalan|melphalan|mesh-list
44479295|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479296|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479297|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479298|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
44479299|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479300|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44479301|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
44479302|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44479303|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
44479304|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
44479305|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479340|NCT03159754|Tazobactam|tazobactam|mesh-list
44952113|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
44952114|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
44952115|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44479412|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44952116|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44952117|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44952118|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44952119|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952120|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952121|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952122|NCT04504045|Metformin|metformin|mesh-list
44952123|NCT04504045|Efavirenz|efavirenz|mesh-list
44952124|NCT04504045|Losartan|losartan|mesh-list
44952125|NCT04504045|Metoprolol|metoprolol|mesh-list
44952126|NCT04504045|Midazolam|midazolam|mesh-list
44952127|NCT04504045|Caffeine|caffeine|mesh-list
44952128|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44952129|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952130|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44952131|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952132|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479483|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479484|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
44479485|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
44479486|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44479487|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44479488|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479490|NCT03157401|Coagulants|coagulants|mesh-ancestor
44736394|NCT04166435|Temozolomide|temozolomide|mesh-list
44736395|NCT04166435|Olaparib|olaparib|mesh-list
44736396|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736397|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
44736398|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736399|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736400|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44736401|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736402|NCT04162015|Cisplatin|cisplatin|mesh-list
44736403|NCT04162015|Carboplatin|carboplatin|mesh-list
44736404|NCT04162015|Nivolumab|nivolumab|mesh-list
44736405|NCT04162015|Pemetrexed|pemetrexed|mesh-list
44736406|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736407|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736408|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44736409|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736410|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736411|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44952133|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44952134|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44952135|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952136|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952137|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
44952138|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
44952139|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
44952140|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
44952141|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952142|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736496|NCT04009044|Tamoxifen|tamoxifen|mesh-list
44479681|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
44952143|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44952144|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480088|NCT01670084|Methotrexate|methotrexate|mesh-list
44480167|NCT01670240|Adalimumab|adalimumab|mesh-list
44736562|NCT03936153|Abexinostat|abexinostat|mesh-list
44480224|NCT01670955|Hematinics|hematinics|mesh-ancestor
44480225|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
44480226|NCT01670955|Vitamins|vitamins|mesh-ancestor
44480227|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
44480228|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952145|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44952146|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44480496|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
44952147|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44952148|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44952149|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952150|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44480824|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44480972|NCT01677104|Hormones|hormones|mesh-ancestor
44481048|NCT01677884|Bevacizumab|bevacizumab|mesh-list
44481122|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44736653|NCT03802630|Aflibercept|aflibercept|mesh-list
44952151|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44952152|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
44481618|NCT00089999|Lapatinib|lapatinib|mesh-list
44952153|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44952154|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44952155|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
44952156|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952157|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44952158|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44952159|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44952160|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44952161|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44952162|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44952163|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
44952164|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
44952165|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952166|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44952167|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44952168|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44952169|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952170|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
44952171|NCT04469868|Narcotics|narcotics|mesh-ancestor
44482280|NCT00081159|Doxorubicin|doxorubicin|mesh-list
44952172|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44736672|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736673|NCT03785691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44736674|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44736676|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44482546|NCT03086538|Pemetrexed|pemetrexed|mesh-list
44482617|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44482691|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482692|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
44482693|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482694|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44482695|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44482696|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44482697|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482698|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736709|NCT03736863|Apatinib|apatinib|mesh-list
44736710|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736711|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736712|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736713|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952173|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482748|NCT03088384|Ketamine|ketamine|mesh-list
44482825|NCT03086720|Eusol|eusol|mesh-list
44952174|NCT04469868|Analgesics|analgesics|mesh-ancestor
44952175|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
44952177|NCT04108234|Ketamine|ketamine|mesh-list
44952178|NCT04108234|Analgesics|analgesics|mesh-ancestor
44952179|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
44952180|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952181|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952182|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44952183|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952184|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
44952185|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
44952186|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952187|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44952188|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44952189|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952190|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482896|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44482897|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482898|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482899|NCT03085992|Bevacizumab|bevacizumab|mesh-list
44482900|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482901|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482902|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44952191|NCT04093219|Acetaminophen|acetaminophen|mesh-list
44952192|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44952193|NCT04093219|Analgesics|analgesics|mesh-ancestor
44952194|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
44952195|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952196|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952197|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
44952198|NCT04013334|Nivolumab|nivolumab|mesh-list
44952199|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483164|NCT03082339|Cortisone|cortisone|mesh-list
44483231|NCT03081832|Oxytocin|oxytocin|mesh-list
44952200|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952201|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44483477|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483478|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483480|NCT05688813|Anesthetics|anesthetics|mesh-list
44483528|NCT05688475|Dexamethasone|dexamethasone|mesh-list
44483605|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44483705|NCT05688007|Hormones|hormones|mesh-list
44483779|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952202|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483883|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
44952203|NCT03949894|Tolvaptan|tolvaptan|mesh-list
44952204|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44952205|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952206|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
44952207|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952208|NCT03810976|Gemcitabine|gemcitabine|mesh-list
44952209|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952210|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
44952211|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952212|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952213|NCT03810976|Antiviral Agents|antiviral agents|mesh-ancestor
44952214|NCT03810976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952215|NCT03810976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952216|NCT03810976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484088|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
44952217|NCT03810976|Immunologic Factors|immunologic factors|mesh-ancestor
44952218|NCT03810976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952219|NCT03516214|Trametinib|trametinib|mesh-list
44737020|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737021|NCT02987543|Olaparib|olaparib|mesh-list
44737022|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
44737024|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484312|NCT05638932|Tofacitinib|tofacitinib|mesh-list
44484386|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44484387|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44484388|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484389|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484390|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
44484391|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
44484392|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
44484393|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484394|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
44484395|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
44484396|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484397|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44484398|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
44484399|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
44952220|NCT03516214|Nazartinib|nazartinib|mesh-list
44952221|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952222|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44952223|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952224|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952225|NCT03501966|Acetazolamide|acetazolamide|mesh-list
44952226|NCT03501966|Diuretics|diuretics|mesh-list
44952227|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
44952228|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952229|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
44952230|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44952231|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484676|NCT05586815|Minocycline|minocycline|mesh-list
44484822|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
44484823|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484824|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484825|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44484826|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
44484827|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484828|NCT05525858|Bevacizumab|bevacizumab|mesh-list
44484829|NCT05525858|Trastuzumab|trastuzumab|mesh-list
44484830|NCT05525858|Pertuzumab|pertuzumab|mesh-list
44484831|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44484832|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44484833|NCT05525858|Atezolizumab|atezolizumab|mesh-list
44484834|NCT05525858|Vemurafenib|vemurafenib|mesh-list
44303935|NCT00852423|Artesunate|artesunate|mesh-list
44484835|NCT05525858|Maytansine|maytansine|mesh-list
44737078|NCT02979873|Sirolimus|sirolimus|mesh-list
44737111|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737112|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737113|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484915|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44485067|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485195|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44737181|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44485456|NCT05232825|Hormones|hormones|mesh-ancestor
44485649|NCT05145309|Cathartics|cathartics|mesh-ancestor
44737237|NCT02828358|Antidotes|antidotes|mesh-ancestor
44485958|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
44952232|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952233|NCT03492671|Gemcitabine|gemcitabine|mesh-list
44952234|NCT03492671|Paclitaxel|paclitaxel|mesh-list
44952235|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44952236|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952237|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44952238|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44952239|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44952240|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952241|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952242|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
44952243|NCT03492671|Antiviral Agents|antiviral agents|mesh-ancestor
44952244|NCT03492671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952245|NCT03492671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952246|NCT03492671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952247|NCT03492671|Immunologic Factors|immunologic factors|mesh-ancestor
44952248|NCT03492671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952249|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
44952250|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44952251|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
44952252|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952253|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
44952254|NCT03477630|Protective Agents|protective agents|mesh-ancestor
44952255|NCT03426657|Durvalumab|durvalumab|mesh-list
44952256|NCT03426657|Tremelimumab|tremelimumab|mesh-list
44952257|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952258|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483639|NCT05688202|Prilocaine|prilocaine|mesh-list
44483640|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44483641|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483642|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
44483643|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952259|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
44483644|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483645|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
44483646|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483647|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44483648|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44483649|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44483662|NCT05688098|Amlodipine|amlodipine|mesh-list
44952260|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952261|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952263|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
44952264|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952265|NCT03341936|Nivolumab|nivolumab|mesh-list
44952266|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952267|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952268|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44952269|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486172|NCT04857840|Firibastat|firibastat|mesh-list
44486173|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44486174|NCT04853251|Ranibizumab|ranibizumab|mesh-list
44486175|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44486176|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44486177|NCT04853251|Growth Substances|growth substances|mesh-ancestor
44486178|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486179|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
44486224|NCT04820309|Trospium chloride|trospium chloride|mesh-list
44486318|NCT04785924|Imipenem|imipenem|mesh-list
44952270|NCT03246529|Lenograstim|lenograstim|mesh-list
44952271|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44952272|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
44952273|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952274|NCT03174353|Lanreotide|lanreotide|mesh-list
44952275|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952276|NCT03121014|Methotrexate|methotrexate|mesh-list
44952277|NCT03121014|Fludarabine|fludarabine|mesh-list
44952278|NCT03121014|Busulfan|busulfan|mesh-list
44952279|NCT03121014|Tacrolimus|tacrolimus|mesh-list
44952280|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
44952281|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44952282|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
44952283|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44952284|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952285|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952286|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
44952287|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952288|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952289|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
44952290|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952291|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44486892|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44486893|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486894|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
44486895|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
44486896|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486897|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486898|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44486899|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
44486900|NCT04548999|Hormones|hormones|mesh-ancestor
44486901|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486902|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44486908|NCT04543617|Atezolizumab|atezolizumab|mesh-list
44486956|NCT04530565|Cortisone|cortisone|mesh-list
44487034|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487107|NCT04451772|Upadacitinib|upadacitinib|mesh-list
44952292|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952293|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
44952294|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952295|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44952296|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44487258|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
44952297|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
44487595|NCT04198116|Guanfacine|guanfacine|mesh-list
44487596|NCT04198116|Varenicline|varenicline|mesh-list
44487597|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44487598|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44487599|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
44487600|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487601|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487602|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487603|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44487605|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44487672|NCT04176419|Ketamine|ketamine|mesh-list
44487673|NCT04176419|Gabapentin|gabapentin|mesh-list
44487674|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
44487675|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
44487676|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44487677|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487678|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
44487679|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487680|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44487681|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44952298|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44952299|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44952300|NCT03119363|Methamphetamine|methamphetamine|mesh-list
44952301|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44952302|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487824|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487825|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487826|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487827|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487828|NCT04084314|Erenumab|erenumab|mesh-list
44487829|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44487830|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487831|NCT04084314|Analgesics|analgesics|mesh-ancestor
44487832|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
44487833|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952303|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
44952304|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
44952305|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952306|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
44952307|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737496|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
44488138|NCT03836261|Venetoclax|venetoclax|mesh-list
44952308|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952309|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952310|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44952311|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952312|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952313|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44952314|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
44952315|NCT03113617|Bombesin|bombesin|mesh-list
44952316|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952317|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952318|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952319|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952320|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
44952321|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44952322|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44488205|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
44488350|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44488425|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44488499|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
44952323|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952324|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
44952325|NCT02918201|Coagulants|coagulants|mesh-ancestor
44952326|NCT02906007|Bedaquiline|bedaquiline|mesh-list
44952327|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
44952328|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489073|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737538|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
44489196|NCT02307149|Ipilimumab|ipilimumab|mesh-list
44489270|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
44952329|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952330|NCT02884219|Ibuprofen|ibuprofen|mesh-list
44489569|NCT01787409|Vitamin D|vitamin d|mesh-list
44308750|NCT00877123|Vitamin D|vitamin d|mesh-list
44952331|NCT02884219|Indomethacin|indomethacin|mesh-list
44952332|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
44489740|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44489813|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
44489814|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
44489815|NCT00378482|Tremelimumab|tremelimumab|mesh-list
44489816|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489895|NCT03085563|Midazolam|midazolam|mesh-list
44489963|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44490038|NCT05247619|Bevacizumab|bevacizumab|mesh-list
44952333|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44952334|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490474|NCT02391571|Naltrexone|naltrexone|mesh-list
44952335|NCT02884219|Analgesics|analgesics|mesh-ancestor
44490622|NCT00638456|Lansoprazole|lansoprazole|mesh-list
44490695|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
44490919|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952337|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491228|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491533|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
44491609|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491686|NCT01920542|Analgesics|analgesics|mesh-ancestor
44952338|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491884|NCT01922427|RNS60|rns60|mesh-list
44952339|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952340|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952341|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952342|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952343|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
44952344|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
44952345|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44952346|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
44952347|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952348|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952349|NCT02647827|Metformin|metformin|mesh-list
44952350|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44952351|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952352|NCT02532660|Dexetimide|dexetimide|mesh-list
44952353|NCT02532660|Citalopram|citalopram|mesh-list
44952354|NCT02532660|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44952355|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952356|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952357|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952358|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952359|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
44952360|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952361|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44952362|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
44952363|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952364|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44952365|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44952366|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
44491958|NCT01922817|Saxagliptin|saxagliptin|mesh-list
44952367|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
44952368|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952369|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44952370|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44952371|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
44952372|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
44952373|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952374|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952375|NCT02419417|Nivolumab|nivolumab|mesh-list
44952376|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952377|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952378|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44952379|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952380|NCT02342275|Propranolol|propranolol|mesh-list
44952381|NCT02342275|Atenolol|atenolol|mesh-list
44952382|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44952383|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44952384|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952385|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952386|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492163|NCT01923987|Cetuximab|cetuximab|mesh-list
44952387|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952388|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44952389|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44952390|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
44952391|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
44952392|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
44952393|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952394|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44952395|NCT02199236|Capecitabine|capecitabine|mesh-list
44952396|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952397|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
44952398|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952399|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952400|NCT02183870|Crizotinib|crizotinib|mesh-list
44952401|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952402|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44952403|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952404|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952405|NCT02162849|Nicotine|nicotine|mesh-list
44952406|NCT02162849|Varenicline|varenicline|mesh-list
44952407|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44952408|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
44483788|NCT05687253|Bromides|bromides|mesh-list
44952409|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952410|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952411|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44952412|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44952413|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
44952414|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952415|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952416|NCT01970722|Gemcitabine|gemcitabine|mesh-list
44952417|NCT01970722|Paclitaxel|paclitaxel|mesh-list
44952418|NCT01970722|Cisplatin|cisplatin|mesh-list
44952419|NCT01970722|Carboplatin|carboplatin|mesh-list
44952420|NCT01970722|Doxorubicin|doxorubicin|mesh-list
44952421|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44952422|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44952423|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44492783|NCT01928511|Interferons|interferons|mesh-list
44952424|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952425|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
44952426|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
44952427|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
44952428|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952429|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952430|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
44952431|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
44952432|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952433|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952434|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952435|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
44952436|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952437|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44952438|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44952439|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44952440|NCT01827553|Gemcitabine|gemcitabine|mesh-list
44952441|NCT01827553|Folfirinox|folfirinox|mesh-list
44952442|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952443|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
44952444|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493065|NCT01920737|Vitamins|vitamins|mesh-ancestor
44952445|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952446|NCT01827553|Antiviral Agents|antiviral agents|mesh-ancestor
44952447|NCT01827553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952448|NCT01827553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952449|NCT01827553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952450|NCT01827553|Immunologic Factors|immunologic factors|mesh-ancestor
44952451|NCT01827553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952452|NCT01371240|Secretin|secretin|mesh-list
44952453|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952454|NCT01371240|Hormones|hormones|mesh-ancestor
44952455|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44952456|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952457|NCT00979693|Psilocybin|psilocybin|mesh-list
44952458|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
44952459|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952460|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952461|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
44952462|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44952463|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
44952464|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952465|NCT00775476|Expectorants|expectorants|mesh-ancestor
44952466|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44952467|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44952468|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
44952469|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952470|NCT00775476|Protective Agents|protective agents|mesh-ancestor
44952471|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952472|NCT00775476|Antidotes|antidotes|mesh-ancestor
44952473|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
44952474|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
44952475|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44952476|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44952477|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952478|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952479|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952480|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952481|NCT03639948|Carboplatin|carboplatin|mesh-list
44952482|NCT03639948|Docetaxel|docetaxel|mesh-list
44952483|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
44952484|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952485|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
44952486|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
44952487|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44952488|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952489|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952490|NCT03968406|Talazoparib|talazoparib|mesh-list
44952491|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44952492|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952493|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952494|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952495|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
44493247|NCT00988858|Pemetrexed|pemetrexed|mesh-list
44952496|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952497|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952498|NCT04897880|Panobinostat|panobinostat|mesh-list
44952499|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952500|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44952501|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952502|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952503|NCT04437485|Norepinephrine|norepinephrine|mesh-list
44952504|NCT04437485|Bupropion|bupropion|mesh-list
44952505|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
44952506|NCT04437485|Serotonin|serotonin|mesh-list
44493314|NCT00987402|Ethanol|ethanol|mesh-list
44493377|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493450|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
44952507|NCT04437485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44952508|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44952509|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952510|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44952511|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952512|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952513|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952514|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
44952515|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952516|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952517|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44952518|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44952519|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952520|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44952521|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44952522|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952523|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
44952524|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
44952525|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952526|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44952527|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44952528|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
44952529|NCT04436224|Fentanyl|fentanyl|mesh-list
44952530|NCT04436224|Hydromorphone|hydromorphone|mesh-list
44952531|NCT04436224|Butorphanol|butorphanol|mesh-list
44952532|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44952533|NCT04436224|Narcotics|narcotics|mesh-ancestor
44952534|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952535|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952536|NCT04436224|Analgesics|analgesics|mesh-ancestor
44952537|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
44952538|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952539|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44952540|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952541|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
44952542|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
44952543|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
44952544|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
44952545|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44952546|NCT04374019|Artesunate|artesunate|mesh-list
44952547|NCT04374019|Ivermectin|ivermectin|mesh-list
44952548|NCT04374019|Camostat|camostat|mesh-list
44952549|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
44952550|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44952551|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44952552|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952553|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952554|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
44952555|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
44493998|NCT00981656|Cisplatin|cisplatin|mesh-list
44952556|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44952557|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
44952558|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44952559|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952560|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952561|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44952562|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44952563|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44952564|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44952565|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44952566|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952567|NCT04311463|Paroxetine|paroxetine|mesh-list
44952568|NCT04311463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44952569|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952570|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952571|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952572|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952573|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
44952574|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494283|NCT05601817|Vitamin E|vitamin e|mesh-list
44952575|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44952576|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
44952577|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952578|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44952579|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44952580|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952581|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44952582|NCT04295005|Empagliflozin|empagliflozin|mesh-list
44952583|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44494415|NCT05607303|Estrogens|estrogens|mesh-list
44952584|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952585|NCT04295005|Incretins|incretins|mesh-ancestor
44952586|NCT04295005|Hormones|hormones|mesh-ancestor
44952587|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44952588|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44952589|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
44952590|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952591|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952592|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44952593|NCT04179890|Afatinib|afatinib|mesh-list
44494487|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494488|NCT05609942|Azacitidine|azacitidine|mesh-list
44494489|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494490|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
44494491|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494492|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494493|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494494|NCT05609929|Omeprazole|omeprazole|mesh-list
44494495|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44494557|NCT05608642|Lidocaine|lidocaine|mesh-list
44952594|NCT04179890|Mitogens|mitogens|mesh-list
44952595|NCT04179890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44952596|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952597|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952598|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44952599|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952600|NCT04175509|Acetaminophen|acetaminophen|mesh-list
44952601|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44952602|NCT04175509|Analgesics|analgesics|mesh-ancestor
44952603|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
44952604|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952605|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952606|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
44952607|NCT04044209|Nivolumab|nivolumab|mesh-list
44952608|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952609|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952610|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44952611|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952612|NCT03990363|Allopurinol|allopurinol|mesh-list
44952613|NCT03990363|Verinurad|verinurad|mesh-list
44952614|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
44952615|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952616|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952617|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
44952618|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952619|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44952620|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
44952621|NCT03990363|Protective Agents|protective agents|mesh-ancestor
44952622|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952623|NCT03930186|Apremilast|apremilast|mesh-list
44952624|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44952625|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44952626|NCT03930186|Analgesics|analgesics|mesh-ancestor
44952627|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
44952628|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952629|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952630|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952631|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952632|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44952633|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44952634|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952635|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952636|NCT03817463|Empagliflozin|empagliflozin|mesh-list
44952637|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44494827|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952638|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44952639|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952640|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44494892|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
44952641|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952642|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44952643|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952644|NCT03787849|Anesthetics|anesthetics|mesh-list
44952645|NCT03787849|Propofol|propofol|mesh-list
44952646|NCT03787849|Sevoflurane|sevoflurane|mesh-list
44952647|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952648|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952649|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952650|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952651|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
44952652|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44952653|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44952654|NCT03781440|Lidocaine|lidocaine|mesh-list
44952655|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
44952656|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
44952657|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952658|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952659|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
44952660|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952661|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44952662|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44952663|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44952664|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952665|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952666|NCT03777319|Prednisolone|prednisolone|mesh-list
44952667|NCT03777319|Spironolactone|spironolactone|mesh-list
44952668|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952669|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
44952670|NCT03777319|Hormones|hormones|mesh-ancestor
44952671|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44952672|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952673|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44952674|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952675|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44952676|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
44952677|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44952678|NCT03777319|Diuretics|diuretics|mesh-ancestor
44952679|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
44952680|NCT03740100|Sirolimus|sirolimus|mesh-list
44952681|NCT03740100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44952682|NCT03740100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952683|NCT03740100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44952684|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952685|NCT03740100|Antifungal Agents|antifungal agents|mesh-ancestor
44952686|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952687|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
44952688|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952689|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44952690|NCT03687814|Laxatives|laxatives|mesh-ancestor
44952691|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952692|NCT03490513|Anastrozole|anastrozole|mesh-list
44952693|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44952694|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952695|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44952696|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44952697|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952698|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952699|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44952700|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
44952701|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495433|NCT04123392|Decitabine|decitabine|mesh-list
44952702|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952703|NCT03471728|Linaclotide|linaclotide|mesh-list
44952704|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44952705|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
44952706|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952707|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952708|NCT03463057|Atezolizumab|atezolizumab|mesh-list
44952709|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952710|NCT03342027|Bupropion|bupropion|mesh-list
44952711|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44952712|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
44952713|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952714|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44952715|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952716|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952717|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952718|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
44952719|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495741|NCT04124614|Sertraline|sertraline|mesh-list
44952720|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952721|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44952722|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44952723|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952724|NCT03053362|Vortioxetine|vortioxetine|mesh-list
44495791|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
44952725|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
44952726|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952727|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44952728|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44952729|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952730|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952731|NCT03053362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44952732|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44952733|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952734|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952735|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952736|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
44952737|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44952738|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44952739|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44952740|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44952741|NCT02906332|Dexamethasone|dexamethasone|mesh-list
44952742|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
44952743|NCT02906332|Lenalidomide|lenalidomide|mesh-list
44952744|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952745|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
44952746|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
44952747|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952748|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952749|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952750|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
44952751|NCT02906332|Hormones|hormones|mesh-ancestor
44952752|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44952753|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44952754|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952755|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952756|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
44952757|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44952758|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44952759|NCT02906332|Growth Substances|growth substances|mesh-ancestor
44952760|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44952761|NCT05463224|Lazertinib|lazertinib|mesh-list
44952762|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44952763|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952764|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952765|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
44952766|NCT05462938|Propofol|propofol|mesh-list
44952767|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952768|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952769|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952770|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952771|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
44952772|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
44952773|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44952774|NCT05462938|Analgesics|analgesics|mesh-ancestor
44952775|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
44952776|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952777|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44952778|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44952779|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44952780|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
44952781|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952782|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952783|NCT05462613|Aspirin|aspirin|mesh-list
44952784|NCT05462613|Bevacizumab|bevacizumab|mesh-list
44952785|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952786|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952787|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44952788|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44952789|NCT05462613|Growth Substances|growth substances|mesh-ancestor
44952790|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952791|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
44952792|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44952793|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44952794|NCT05462613|Analgesics|analgesics|mesh-ancestor
44952795|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
44952796|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952797|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952798|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44952799|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44952800|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44952801|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952803|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44952804|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952805|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
44952806|NCT05462548|Luspatercept|luspatercept|mesh-list
44952807|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44952808|NCT05462548|Hematinics|hematinics|mesh-ancestor
44952809|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
44952810|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952811|NCT05462535|Losartan|losartan|mesh-list
44952812|NCT05462535|Amlodipine|amlodipine|mesh-list
44496311|NCT03825809|Narcotics|narcotics|mesh-ancestor
44952813|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
44952814|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44952815|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44952816|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952817|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952818|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44952819|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952820|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
44952821|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44952822|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44496607|NCT03822559|Timolol|timolol|mesh-list
44952823|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44496742|NCT03820245|Lycopene|lycopene|mesh-list
44496819|NCT03829007|Durvalumab|durvalumab|mesh-list
44952824|NCT05462535|Diuretics|diuretics|mesh-ancestor
44952825|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
44952826|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44952827|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44952828|NCT05462496|Metronidazole|metronidazole|mesh-list
44952829|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
44952830|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44952831|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
44952832|NCT05462496|Folfirinox|folfirinox|mesh-list
44952833|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952834|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952835|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497042|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
44952836|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
44952837|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44952838|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44497401|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
44497477|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44952839|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44952840|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44952841|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497555|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952842|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952843|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44952844|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44952845|NCT05462093|Liver Extracts|liver extracts|mesh-list
44952846|NCT05462093|Hematinics|hematinics|mesh-ancestor
44952847|NCT05461833|Octylonium|octylonium|mesh-list
44952848|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44952849|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44952850|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952851|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44952852|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952853|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952854|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
44952855|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
44952856|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44952857|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44952858|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44497840|NCT01456611|Diclofenac|diclofenac|mesh-list
44952859|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
44952860|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952861|NCT05461690|Niraparib|niraparib|mesh-list
44952862|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44952863|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952864|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952865|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952866|NCT05461508|Amoxicillin|amoxicillin|mesh-list
44952867|NCT05461508|Fucoidan|fucoidan|mesh-list
44952868|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44952869|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952870|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44952871|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44952872|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
44952873|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952874|NCT05461365|Insulin|insulin|mesh-list
44952875|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44952876|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44952877|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952878|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
44952879|NCT05461235|Nivolumab|nivolumab|mesh-list
44952880|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44952881|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952882|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44952883|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952884|NCT05457647|Riboflavin|riboflavin|mesh-list
44952885|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
44952886|NCT05457647|Vitamins|vitamins|mesh-ancestor
44952887|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
44952888|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952889|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44952890|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
44952891|NCT05456230|Midazolam|midazolam|mesh-list
44952892|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44952893|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952894|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44952895|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498257|NCT01459406|Levan|levan|mesh-list
44952896|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44498347|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
44952897|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44952898|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952899|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44952900|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
44952901|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
44952902|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
44952903|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
44952904|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44952905|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952906|NCT05404048|Atezolizumab|atezolizumab|mesh-list
44952907|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952908|NCT05391230|Permethrin|permethrin|mesh-list
44952909|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952910|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952911|NCT05383482|Paclitaxel|paclitaxel|mesh-list
44952912|NCT05383482|Docetaxel|docetaxel|mesh-list
44498637|NCT04845035|Cytarabine|cytarabine|mesh-list
44498725|NCT04840264|Docetaxel|docetaxel|mesh-list
44952913|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44952914|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952915|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
44952916|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
44952917|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
44952918|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952919|NCT05342584|Cytarabine|cytarabine|mesh-list
44952920|NCT05342584|Daunorubicin|daunorubicin|mesh-list
44952921|NCT05342584|Venetoclax|venetoclax|mesh-list
44952922|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44952923|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
44952924|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952925|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952926|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
44952927|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952928|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44952929|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
44498993|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
44499148|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
44952930|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952931|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44952932|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44952933|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500055|NCT01896518|Nicotine|nicotine|mesh-list
44952934|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952935|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44952936|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44952937|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44952938|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44952939|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500272|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44952940|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952941|NCT05335356|Ustekinumab|ustekinumab|mesh-list
44952942|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
44952943|NCT05320120|Esketamine|esketamine|mesh-list
44500599|NCT01790997|Aspirin|aspirin|mesh-list
44952944|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
44952945|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44952946|NCT05302271|Prednisone|prednisone|mesh-list
44952947|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44952948|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
44500875|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
44952949|NCT05302271|Hormones|hormones|mesh-ancestor
44501394|NCT01797315|Sirolimus|sirolimus|mesh-list
44952950|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501778|NCT01795911|Ribavirin|ribavirin|mesh-list
44501847|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952951|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952952|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502145|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
44952953|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952954|NCT05296278|Lenvatinib|lenvatinib|mesh-list
44952955|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952956|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44952957|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952958|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952959|NCT05278338|Denosumab|denosumab|mesh-list
44952960|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44502445|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44952961|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502744|NCT02990455|Nicotine|nicotine|mesh-list
44952962|NCT05132660|Levodopa|levodopa|mesh-list
44952963|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44952964|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44503271|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
44952965|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44952966|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
44952967|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504013|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
44504090|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44952968|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44952969|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504545|NCT01278394|Tavaborole|tavaborole|mesh-list
44952970|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44952971|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
44952972|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
44952973|NCT05045144|Vaccines|vaccines|mesh-list
44505229|NCT01276379|Antidotes|antidotes|mesh-ancestor
44505317|NCT00249288|Vitamins|vitamins|mesh-ancestor
44952974|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
44505372|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505444|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505673|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44505748|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
44506047|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44506121|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
44952975|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952976|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
44952977|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44506347|NCT03804840|Hormones|hormones|mesh-ancestor
44952978|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952979|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44506648|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
44506719|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44506720|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
44952980|NCT04929080|Antibodies|antibodies|mesh-list
44952981|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
44506868|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
44952982|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44952983|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
44952984|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
44507169|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44952985|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44952986|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44952987|NCT04852224|Leuprolide|leuprolide|mesh-list
44952988|NCT04852224|Goserelin|goserelin|mesh-list
44952989|NCT04852224|Androgens|androgens|mesh-list
44952990|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44952991|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
44952992|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44952993|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507689|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
44507764|NCT03215498|Insulin|insulin|mesh-list
44952994|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44507831|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
44952995|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507983|NCT03213249|Gentamicins|gentamicins|mesh-list
44952996|NCT04852224|Hormones|hormones|mesh-ancestor
44508206|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508357|NCT03215524|Thalidomide|thalidomide|mesh-list
44508647|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
44508648|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44508720|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44508864|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508940|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509017|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509093|NCT01834209|Prednisone|prednisone|mesh-list
44509164|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44509240|NCT01835340|Propofol|propofol|mesh-list
44509315|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
44509399|NCT01836575|Pemetrexed|pemetrexed|mesh-list
44509543|NCT01837810|Ibuprofen|ibuprofen|mesh-list
44509770|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
44952997|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44952998|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
44509929|NCT01838395|Cytarabine|cytarabine|mesh-list
44510004|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44952999|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953000|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
44953001|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510260|NCT01722227|Hormones|hormones|mesh-ancestor
44510399|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44953002|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510635|NCT01724983|Fentanyl|fentanyl|mesh-list
44510705|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
44953003|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44953004|NCT04796922|Rituximab|rituximab|mesh-list
44953005|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
44953006|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44953007|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953008|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
44511522|NCT01048788|Tolvaptan|tolvaptan|mesh-list
44953009|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953010|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953011|NCT04780321|Antibodies|antibodies|mesh-list
44953012|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44953013|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
44332239|NCT00990418|Fentanyl|fentanyl|mesh-list
44953014|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953015|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44953016|NCT04747314|Aripiprazole|aripiprazole|mesh-list
44953017|NCT04747314|Mirtazapine|mirtazapine|mesh-list
44953018|NCT04747314|Citalopram|citalopram|mesh-list
44953019|NCT04747314|Bupropion|bupropion|mesh-list
44512320|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44512404|NCT03406299|Leucovorin|leucovorin|mesh-list
44512545|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
44512791|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953020|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44512963|NCT03401372|Hormones|hormones|mesh-ancestor
44953021|NCT04747314|Sertraline|sertraline|mesh-list
44953022|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
44513111|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44513359|NCT02240238|Antiviral Agents|antiviral agents|mesh-ancestor
44513437|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953023|NCT04747314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44953024|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44953025|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953026|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953027|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953028|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
44953029|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953030|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44953031|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44953032|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513585|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513661|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
44513734|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
44953033|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44953034|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
44953035|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44513955|NCT02243553|Tipranavir|tipranavir|mesh-list
44514046|NCT02243800|Vitamins|vitamins|mesh-ancestor
44953036|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44953037|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953038|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44953039|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44514420|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44514578|NCT02246816|Analgesics|analgesics|mesh-ancestor
44953040|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953041|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514731|NCT02248012|Everolimus|everolimus|mesh-list
44953042|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44953043|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44515316|NCT02246920|Xhance|xhance|mesh-list
44953044|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44953045|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44515497|NCT00558519|Doxorubicin|doxorubicin|mesh-list
44515584|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
44953046|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44515804|NCT00553644|Lenalidomide|lenalidomide|mesh-list
44953047|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44516052|NCT00551759|Docetaxel|docetaxel|mesh-list
44516131|NCT00551161|Memantine|memantine|mesh-list
44516364|NCT00555789|Tacrolimus|tacrolimus|mesh-list
44516514|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
44516588|NCT03023449|Protective Agents|protective agents|mesh-ancestor
44953048|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44953049|NCT04747314|Analgesics|analgesics|mesh-ancestor
44953050|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
44517293|NCT03023982|Morphine|morphine|mesh-list
44953051|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44517370|NCT03022838|Caffeine|caffeine|mesh-list
44953052|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
44953053|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
44517595|NCT03020368|Diclofenac|diclofenac|mesh-list
44517758|NCT04278053|Inositol|inositol|mesh-list
44953054|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44517910|NCT04276545|Midazolam|midazolam|mesh-list
44517983|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44518076|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44953055|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44953056|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44518387|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
44518462|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
44518704|NCT03836703|Iron|iron|mesh-list
44518780|NCT03835442|Baclofen|baclofen|mesh-list
44518853|NCT03833999|Ondansetron|ondansetron|mesh-list
44519078|NCT03830827|Vortioxetine|vortioxetine|mesh-list
44519171|NCT03830034|Iron|iron|mesh-list
44519323|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44953057|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44519564|NCT05441761|Hormones|hormones|mesh-ancestor
44953058|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
44484405|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
44484406|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484407|NCT05626530|Letermovir|letermovir|mesh-list
44520236|NCT01055106|Metronidazole|metronidazole|mesh-list
44953059|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44953060|NCT04724759|Lidocaine|lidocaine|mesh-list
44953061|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
44520477|NCT03279549|Mitogens|mitogens|mesh-list
44953062|NCT04724759|Ketamine|ketamine|mesh-list
44953063|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953064|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
44953065|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953066|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953067|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
44953068|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520645|NCT03278015|Gemcitabine|gemcitabine|mesh-list
44953069|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44520874|NCT03274895|Polihexanide|polihexanide|mesh-list
44953070|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44521102|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
44521179|NCT03270735|Thrombin|thrombin|mesh-list
44521260|NCT03271021|Minocycline|minocycline|mesh-list
44953071|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44521411|NCT01241097|Ezetimibe|ezetimibe|mesh-list
44521483|NCT01241500|ON 01910|on 01910|mesh-list
44953072|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953073|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521704|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
44343193|NCT01042873|Dobutamine|dobutamine|mesh-list
44953074|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44953075|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953076|NCT04724759|Analgesics|analgesics|mesh-ancestor
44953077|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44522016|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44953078|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44953079|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44522400|NCT01248442|Vitamins|vitamins|mesh-ancestor
44953080|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44953081|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522566|NCT01249690|Growth Substances|growth substances|mesh-ancestor
44522634|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953082|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44953083|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44953084|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
44953085|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44953086|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44523559|NCT04515641|Islatravir|islatravir|mesh-list
44953087|NCT04637386|Anesthetics|anesthetics|mesh-list
44953088|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
44524045|NCT02590393|Nicotine|nicotine|mesh-list
44524136|NCT02598895|Docetaxel|docetaxel|mesh-list
44524356|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
44953089|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524760|NCT03459859|Cytarabine|cytarabine|mesh-list
44524835|NCT03459144|Ranibizumab|ranibizumab|mesh-list
44953090|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953091|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
44525395|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
44525714|NCT00195494|Analgesics|analgesics|mesh-ancestor
44525778|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953092|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953093|NCT04573946|Vitamin D|vitamin d|mesh-list
44953094|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
44526084|NCT00191646|Carboplatin|carboplatin|mesh-list
44953095|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
44953096|NCT04573946|Vitamins|vitamins|mesh-list
44953097|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
44526385|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526470|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44526776|NCT00476606|Nevirapine|nevirapine|mesh-list
44526943|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
44953098|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953099|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44527245|NCT00475670|Taxane|taxane|mesh-list
44527251|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527397|NCT00473889|Carboplatin|carboplatin|mesh-list
44527547|NCT00472420|Rituximab|rituximab|mesh-list
44527629|NCT00471315|Analgesics|analgesics|mesh-ancestor
44527690|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953100|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527846|NCT00477412|Cytarabine|cytarabine|mesh-list
44953101|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
44953102|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
44528387|NCT01081626|Hormones|hormones|mesh-ancestor
44528442|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
44953103|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44953104|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953105|NCT04490057|Bupropion|bupropion|mesh-list
44953106|NCT04490057|Nicotine|nicotine|mesh-list
44528926|NCT02210364|Capecitabine|capecitabine|mesh-list
44529089|NCT02211690|Emtricitabine|emtricitabine|mesh-list
44529242|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
44953107|NCT04490057|Varenicline|varenicline|mesh-list
44529392|NCT02213913|Doxorubicin|doxorubicin|mesh-list
44529485|NCT02214602|Epirubicin|epirubicin|mesh-list
44529618|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44953108|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44953109|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
44953110|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530081|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
44953111|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953112|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44953113|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44953114|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
44953115|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531010|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44953116|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531398|NCT01647555|Cetuximab|cetuximab|mesh-list
44531479|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44531556|NCT01648712|Heparin|heparin|mesh-list
44531629|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
44953117|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44531787|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953118|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44953119|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532264|NCT01683292|Apomorphine|apomorphine|mesh-list
44532337|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
44532502|NCT01685502|Acarbose|acarbose|mesh-list
44532649|NCT01686659|Chrysarobin|chrysarobin|mesh-list
44953120|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44953121|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44532975|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44953122|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953123|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
44953124|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44953125|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44953126|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953127|NCT04471233|Pregabalin|pregabalin|mesh-list
44953128|NCT04471233|Analgesics|analgesics|mesh-ancestor
44533451|NCT04823845|Adapalene|adapalene|mesh-list
44533525|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
44953129|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
44953130|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953131|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953132|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
44533917|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
44534066|NCT01603654|Vitamins|vitamins|mesh-ancestor
44357800|NCT01122940|Phenytoin|phenytoin|mesh-list
44534699|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
44953133|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44953134|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535105|NCT02270970|Belimumab|belimumab|mesh-list
44535550|NCT02273505|Dipyridamole|dipyridamole|mesh-list
44535698|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
44535777|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
44535846|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953135|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535991|NCT02276846|Paclitaxel|paclitaxel|mesh-list
44953136|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44953137|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44536387|NCT02279966|Paroxetine|paroxetine|mesh-list
44536452|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
44536453|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
44536454|NCT02279823|Minoxidil|minoxidil|mesh-list
44536455|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44536456|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44536457|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536458|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
44536459|NCT02279602|Combretastatin|combretastatin|mesh-list
44536460|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44536461|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536462|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
44536463|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
44536464|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
44536465|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536466|NCT02278133|Cetuximab|cetuximab|mesh-list
44536467|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44536468|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536470|NCT02271503|Carbidopa|carbidopa|mesh-list
44536536|NCT02271997|Hematinics|hematinics|mesh-ancestor
44536618|NCT02485418|Propofol|propofol|mesh-list
44953138|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44953139|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953140|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44953141|NCT04447781|Citric Acid|citric acid|mesh-list
44953142|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
44537003|NCT01582425|Methadone|methadone|mesh-list
44537260|NCT01584492|Albuterol|albuterol|mesh-list
44537333|NCT01585051|Vitamin D|vitamin d|mesh-list
44953143|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
44537473|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953144|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44953145|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
44953146|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
44953147|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953148|NCT04412096|Timolol|timolol|mesh-list
44953149|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44953150|NCT04412096|Latanoprost|latanoprost|mesh-list
44953151|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44953152|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44537859|NCT01589055|Nicotine|nicotine|mesh-list
44537954|NCT01589549|Hormones|hormones|mesh-ancestor
44953153|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44953154|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538397|NCT01561456|Docetaxel|docetaxel|mesh-list
44538488|NCT01562483|Dronabinol|dronabinol|mesh-list
44538643|NCT01563640|Permethrin|permethrin|mesh-list
44953155|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953156|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538788|NCT01565018|Rotigotine|rotigotine|mesh-list
44538879|NCT01565837|Ipilimumab|ipilimumab|mesh-list
44953157|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539027|NCT01567215|Ethanol|ethanol|mesh-list
44953158|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44539189|NCT01568307|Serotonin|serotonin|mesh-list
44539264|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
44539344|NCT01569919|Hydroxocobalamin|hydroxocobalamin|mesh-list
44539427|NCT01564537|Ixazomib|ixazomib|mesh-list
44539580|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539658|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
44539732|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539814|NCT00107978|Vancomycin|vancomycin|mesh-list
44953159|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44953160|NCT04369937|Cisplatin|cisplatin|mesh-list
44953161|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
44953162|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953163|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44953164|NCT04316390|Vitamins|vitamins|mesh-list
44953165|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
44953166|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
44540831|NCT02033408|Amoxicillin|amoxicillin|mesh-list
44540920|NCT02033798|Urological Agents|urological agents|mesh-ancestor
44953167|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953168|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
44541235|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541403|NCT02037503|Ketamine|ketamine|mesh-list
44541475|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
44541643|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
44541715|NCT02034422|Protective Agents|protective agents|mesh-ancestor
44953169|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953170|NCT04316390|Protective Agents|protective agents|mesh-ancestor
44953171|NCT04313959|Dexamethasone|dexamethasone|mesh-list
44953172|NCT04313959|Ropivacaine|ropivacaine|mesh-list
44953173|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542250|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44542251|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44953174|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
44953175|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
44953176|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953177|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953178|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953179|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
44953180|NCT04313959|Hormones|hormones|mesh-ancestor
44953181|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44953182|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44953183|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953184|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953185|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
44953186|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953187|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
44953188|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44953189|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
44542723|NCT00705666|Ribavirin|ribavirin|mesh-list
44953190|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542798|NCT00705224|Ribavirin|ribavirin|mesh-list
44953191|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44953192|NCT04257500|Etonogestrel|etonogestrel|mesh-list
44953193|NCT04257500|NuvaRing|nuvaring|mesh-list
44953194|NCT04257500|Estradiol|estradiol|mesh-list
44953195|NCT04257500|Estrogens|estrogens|mesh-ancestor
44953196|NCT04257500|Hormones|hormones|mesh-ancestor
44953197|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543279|NCT00707889|Vitamins|vitamins|mesh-ancestor
44953198|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953199|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44953200|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
44953201|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44543574|NCT04057989|Analgesics|analgesics|mesh-ancestor
44543648|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
44543821|NCT04054063|Etomidate|etomidate|mesh-list
44953202|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44543994|NCT04050098|Metformin|metformin|mesh-list
44953203|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44544062|NCT04055844|Decitabine|decitabine|mesh-list
44953204|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44953205|NCT04166942|Belumosudil|belumosudil|mesh-list
44544297|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
44953206|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44544683|NCT01061775|Hormones|hormones|mesh-ancestor
44953207|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545060|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545155|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
44545301|NCT01313377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545387|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44953208|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953209|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
44545543|NCT01315951|Petrolatum|petrolatum|mesh-list
44545865|NCT01318369|Hormones|hormones|mesh-ancestor
44953210|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44546011|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953211|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
44546181|NCT01318499|Nepafenac|nepafenac|mesh-list
44546245|NCT01318070|Incretins|incretins|mesh-ancestor
44546487|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546488|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546489|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44546490|NCT05654064|Narcotics|narcotics|mesh-ancestor
44546639|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
44953212|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44546873|NCT01377389|Ipilimumab|ipilimumab|mesh-list
44547181|NCT01373164|Antiviral Agents|antiviral agents|mesh-ancestor
44953213|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
44953214|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547324|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44547471|NCT01369849|Antibodies|antibodies|mesh-list
44547547|NCT01369342|Ustekinumab|ustekinumab|mesh-list
44547704|NCT01365481|Diuretics|diuretics|mesh-ancestor
44547791|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44548121|NCT01359592|Hormones|hormones|mesh-ancestor
44548340|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
44548412|NCT01354314|Fluconazole|fluconazole|mesh-list
44953215|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953216|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
44953217|NCT03924986|Gemcitabine|gemcitabine|mesh-list
44548723|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
44548796|NCT01348100|Iloperidone|iloperidone|mesh-list
44953218|NCT03924986|Cisplatin|cisplatin|mesh-list
44953219|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549020|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44953220|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44549350|NCT01339923|Vaccines|vaccines|mesh-list
44953221|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
44549837|NCT01332630|Ranitidine|ranitidine|mesh-list
44550470|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550556|NCT01323790|Naloxegol|naloxegol|mesh-list
44550617|NCT01323530|Capecitabine|capecitabine|mesh-list
44953222|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953223|NCT03924986|Antiviral Agents|antiviral agents|mesh-ancestor
44550849|NCT01313858|Golimumab|golimumab|mesh-list
44953224|NCT03924986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550928|NCT01313559|Hormones|hormones|mesh-ancestor
44953225|NCT03924986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953226|NCT03924986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953227|NCT03924986|Immunologic Factors|immunologic factors|mesh-ancestor
44551231|NCT01308749|Oxytocin|oxytocin|mesh-list
44953228|NCT03924986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953229|NCT03911505|Miglustat|miglustat|mesh-list
44953230|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551528|NCT01303627|Remifentanil|remifentanil|mesh-list
44551682|NCT01301066|Pitavastatin|pitavastatin|mesh-list
44551769|NCT01300455|Suvorexant|suvorexant|mesh-list
44953231|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551984|NCT01298193|Droperidol|droperidol|mesh-list
44953232|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44953233|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44953234|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
44552291|NCT01294397|Denosumab|denosumab|mesh-list
44552526|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44552604|NCT01289782|Simeprevir|simeprevir|mesh-list
44552679|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552771|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44953235|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552861|NCT01285323|Reslizumab|reslizumab|mesh-list
44553159|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
44953236|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44553380|NCT01268891|Rasagiline|rasagiline|mesh-list
44953237|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44953238|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953239|NCT03853694|Morphine|morphine|mesh-list
44953240|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44953241|NCT03853694|Narcotics|narcotics|mesh-ancestor
44953242|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953243|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953244|NCT03853694|Analgesics|analgesics|mesh-ancestor
44953245|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
44953246|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953247|NCT03794778|Paclitaxel|paclitaxel|mesh-list
44553608|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
44554008|NCT01260948|Donepezil|donepezil|mesh-list
44953248|NCT03794778|Carboplatin|carboplatin|mesh-list
44953249|NCT03794778|Doxorubicin|doxorubicin|mesh-list
44953250|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44554316|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554396|NCT05136898|Mitomycins|mitomycins|mesh-list
44554466|NCT04935177|Antibodies|antibodies|mesh-list
44554624|NCT04576156|Imetelstat|imetelstat|mesh-list
44953251|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554772|NCT04308785|Atezolizumab|atezolizumab|mesh-list
44554949|NCT03764553|Carboplatin|carboplatin|mesh-list
44953252|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555116|NCT03048825|Diuretics|diuretics|mesh-ancestor
44953253|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555283|NCT01321073|Treprostinil|treprostinil|mesh-list
44555350|NCT00694733|Anastrozole|anastrozole|mesh-list
44953254|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555727|NCT01256398|Hematinics|hematinics|mesh-ancestor
44953255|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43960376|NCT01439815|Xhance|xhance|mesh-list
44556122|NCT01251614|Adalimumab|adalimumab|mesh-list
44953256|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953257|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44556277|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953258|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44556668|NCT01235442|Etanercept|etanercept|mesh-list
44556893|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
44557040|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
44557280|NCT01227629|Warfarin|warfarin|mesh-list
44953259|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44557429|NCT01224431|Lidocaine|lidocaine|mesh-list
44557599|NCT01221350|Vitamins|vitamins|mesh-ancestor
44557768|NCT01218646|Vaccines|vaccines|mesh-list
44557834|NCT01218009|Albuterol|albuterol|mesh-list
44953260|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557994|NCT01217073|Metformin|metformin|mesh-list
44953261|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44953262|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44953263|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44558366|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
44558598|NCT01208038|Hormones|hormones|mesh-ancestor
44558760|NCT01204918|Riluzole|riluzole|mesh-list
44558833|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44559056|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559139|NCT01200589|Rituximab|rituximab|mesh-list
44559213|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44953264|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44953265|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44559529|NCT01196390|Paclitaxel|paclitaxel|mesh-list
44953266|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44953267|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559754|NCT01193517|Decitabine|decitabine|mesh-list
44559902|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
44560138|NCT05657704|Analgesics|analgesics|mesh-ancestor
44560513|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
44560590|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44560669|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44560836|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560908|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561221|NCT01180790|Interferons|interferons|mesh-list
44561222|NCT01180790|Ribavirin|ribavirin|mesh-list
44561295|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
44561682|NCT01173679|Fludarabine|fludarabine|mesh-list
44561833|NCT01172535|Ritonavir|ritonavir|mesh-list
44562004|NCT01169103|Hormones|hormones|mesh-list
44562156|NCT01166763|Vitamin D|vitamin d|mesh-list
44562227|NCT01165307|Naproxen|naproxen|mesh-list
44562341|NCT01164475|Plerixafor|plerixafor|mesh-list
44562382|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562530|NCT01161446|Antibodies|antibodies|mesh-list
44562764|NCT01158118|Plerixafor|plerixafor|mesh-list
44562908|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953268|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953269|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484605|NCT05600426|Methotrexate|methotrexate|mesh-list
44953270|NCT03774810|Zolpidem|zolpidem|mesh-list
44953271|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44953272|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44953273|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564079|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564255|NCT01137071|Antibodies|antibodies|mesh-list
44953274|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564398|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564569|NCT01133665|Cetuximab|cetuximab|mesh-list
44953275|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44564650|NCT01132807|Hormones|hormones|mesh-ancestor
44953276|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
44564943|NCT01128569|Xhance|xhance|mesh-list
44953277|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
44953278|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565096|NCT01126424|Urological Agents|urological agents|mesh-ancestor
44565265|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
44565340|NCT01123395|Colchicine|colchicine|mesh-list
44565578|NCT01120626|Donepezil|donepezil|mesh-list
44565718|NCT01119508|Ipilimumab|ipilimumab|mesh-list
44565794|NCT01118949|Lacosamide|lacosamide|mesh-list
44565865|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566098|NCT01114373|Melatonin|melatonin|mesh-list
44953279|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953280|NCT03703271|Methotrexate|methotrexate|mesh-list
44953281|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44953282|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
44566245|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
44953283|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44566765|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44566840|NCT01104701|Incretins|incretins|mesh-ancestor
44953284|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953285|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44953286|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
44953287|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953288|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953289|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
44953290|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953291|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44953292|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953293|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
44953294|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953295|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44567461|NCT01095666|Metformin|metformin|mesh-list
44567615|NCT01092780|Modafinil|modafinil|mesh-list
44953296|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
44953297|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44953298|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953299|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44953300|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44953301|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567902|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44953302|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953303|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953304|NCT03601806|Thalidomide|thalidomide|mesh-list
44953305|NCT03601806|Pomalidomide|pomalidomide|mesh-list
44953306|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953307|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
44953308|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953309|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
44568286|NCT01076400|Cisplatin|cisplatin|mesh-list
44953310|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44953311|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953312|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44953313|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44953314|NCT03601806|Growth Substances|growth substances|mesh-ancestor
44953315|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44953316|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953317|NCT03295396|TIC10 compound|tic10 compound|mesh-list
44953318|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953319|NCT03284866|Vaccines|vaccines|mesh-list
44953320|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
44953321|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953322|NCT03248297|Amoxicillin|amoxicillin|mesh-list
44953323|NCT03248297|Azithromycin|azithromycin|mesh-list
44953324|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44953325|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953326|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
44953327|NCT03197064|Aprepitant|aprepitant|mesh-list
44953328|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
44953329|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
44569581|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
44953330|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569804|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
44569878|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569951|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44953331|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570114|NCT01029652|Hormones|hormones|mesh-ancestor
44570334|NCT01026220|Etoposide|etoposide|mesh-list
44953332|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570578|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44570652|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953333|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44570796|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
44953334|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571183|NCT01014585|Milnacipran|milnacipran|mesh-list
44571257|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44571331|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44953335|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571490|NCT01010971|Ciclesonide|ciclesonide|mesh-list
44953337|NCT03120624|Interferons|interferons|mesh-list
44953338|NCT03120624|Interferon-beta|interferon-beta|mesh-list
44572110|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953339|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44572190|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44572264|NCT01002547|Vitamins|vitamins|mesh-list
44572344|NCT01001598|Danazol|danazol|mesh-list
44572426|NCT01001208|Analgesics|analgesics|mesh-ancestor
44572489|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572563|NCT00999921|Analgesics|analgesics|mesh-ancestor
44953340|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
44953341|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953342|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
44953343|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953344|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
44953345|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573803|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953346|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44953347|NCT03120624|Trace Elements|trace elements|mesh-ancestor
44953348|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
44574200|NCT00974233|Rituximab|rituximab|mesh-list
44574272|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574273|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44574274|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44574275|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574282|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574283|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574284|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
44574285|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574286|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44574287|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
44574288|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574289|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574290|NCT00972595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44574291|NCT00972595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44574292|NCT00972595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574293|NCT00972595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574294|NCT00972595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44574295|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44574296|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
44574297|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574298|NCT00972504|Cetirizine|cetirizine|mesh-list
44574299|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44574300|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44574301|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44574302|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
44574303|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
44574304|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574305|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574306|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574342|NCT00972283|Insulin|insulin|mesh-list
44574343|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44574344|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
44953349|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953350|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574904|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575008|NCT00963820|Ixazomib|ixazomib|mesh-list
44575060|NCT00962780|Vaccines|vaccines|mesh-list
44575130|NCT00961636|Niacin|niacin|mesh-list
44575201|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575303|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
44575451|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575604|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575702|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
44953351|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575857|NCT00953745|Aripiprazole|aripiprazole|mesh-list
44953352|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44953353|NCT03113422|Venetoclax|venetoclax|mesh-list
44576258|NCT00949702|Vemurafenib|vemurafenib|mesh-list
44576355|NCT00948688|Vorinostat|vorinostat|mesh-list
44953354|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953355|NCT02924038|Poly ICLC|poly iclc|mesh-list
44953356|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
44576651|NCT00944645|Vitamins|vitamins|mesh-ancestor
44576729|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
44953357|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
44953358|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953359|NCT02921022|Gemcitabine|gemcitabine|mesh-list
44953360|NCT02921022|Paclitaxel|paclitaxel|mesh-list
44577117|NCT00938886|Naltrexone|naltrexone|mesh-list
44577183|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577763|NCT00930722|Quinapril|quinapril|mesh-list
44577903|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
44578150|NCT00926328|Triclosan|triclosan|mesh-list
44953361|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44578292|NCT00924950|Vitamins|vitamins|mesh-ancestor
44953362|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578453|NCT00923364|Fludarabine|fludarabine|mesh-list
44578516|NCT00923195|Analgesics|analgesics|mesh-ancestor
44953363|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44953364|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44953365|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44579373|NCT00910273|Etanercept|etanercept|mesh-list
44579587|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
44579845|NCT00905021|Sunitinib|sunitinib|mesh-list
44579910|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953366|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580208|NCT00901394|Analgesics|analgesics|mesh-ancestor
44953367|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580512|NCT00895310|Ketoconazole|ketoconazole|mesh-list
44580662|NCT00892957|Thrombin|thrombin|mesh-list
44953368|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
44580808|NCT00891228|Hormones|hormones|mesh-ancestor
44953369|NCT02921022|Antiviral Agents|antiviral agents|mesh-ancestor
44953370|NCT02921022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953371|NCT02921022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581115|NCT00887068|Azacitidine|azacitidine|mesh-list
44581216|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
44581291|NCT05660382|Miconazole|miconazole|mesh-list
44581365|NCT05659823|Narcotics|narcotics|mesh-ancestor
44581520|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581820|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
44953372|NCT02921022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582193|NCT05484167|Testosterone|testosterone|mesh-list
44582194|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
44582195|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
44953373|NCT02921022|Immunologic Factors|immunologic factors|mesh-ancestor
44953374|NCT02921022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953375|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
44953376|NCT02865850|Hematinics|hematinics|mesh-ancestor
44953377|NCT02826512|Niraparib|niraparib|mesh-list
44953378|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44953379|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953380|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582277|NCT05452772|Niacin|niacin|mesh-list
44582358|NCT05417594|Temozolomide|temozolomide|mesh-list
44582417|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44582418|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44582419|NCT05378750|Diuretics|diuretics|mesh-list
44582420|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
44582421|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983798|NCT02130063|Iron|iron|mesh-list
44582501|NCT05308420|Morphine|morphine|mesh-list
44582656|NCT05221151|Pregabalin|pregabalin|mesh-list
44582882|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44953381|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953382|NCT02764541|Tamoxifen|tamoxifen|mesh-list
44953383|NCT02764541|Letrozole|letrozole|mesh-list
44953384|NCT02764541|Palbociclib|palbociclib|mesh-list
44583270|NCT04875728|Cefazolin|cefazolin|mesh-list
44583340|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
44953385|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953386|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44583493|NCT04756232|Mecamylamine|mecamylamine|mesh-list
44953387|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44583754|NCT04613518|BMS-986165|bms-986165|mesh-list
44583809|NCT04583956|Remdesivir|remdesivir|mesh-list
44953388|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953389|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953390|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44953391|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
44953392|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44953393|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953394|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44953395|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44953396|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44953397|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44953398|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953399|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
44953400|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44953401|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44953402|NCT02591953|Prednisolone|prednisolone|mesh-list
44953403|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
44953404|NCT02591953|Lidocaine|lidocaine|mesh-list
44953405|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44953406|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
44953407|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953408|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
44953409|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953410|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953411|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
44953412|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953413|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44953414|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44953415|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44953416|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953417|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953418|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44953419|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
44953420|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
44584191|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
44953421|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953422|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
44953423|NCT02591953|Hormones|hormones|mesh-ancestor
44953424|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44953425|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44953426|NCT02591953|Protective Agents|protective agents|mesh-ancestor
44953427|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44953428|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953429|NCT02569489|Paclitaxel|paclitaxel|mesh-list
44953430|NCT02569489|Trastuzumab|trastuzumab|mesh-list
44953431|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44953432|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953433|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44953434|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44953435|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44953436|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953437|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44953438|NCT02201381|Metformin|metformin|mesh-list
44953439|NCT02201381|Doxycycline|doxycycline|mesh-list
44953440|NCT02201381|Mebendazole|mebendazole|mesh-list
44953441|NCT02201381|Atorvastatin|atorvastatin|mesh-list
44953442|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44953443|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953444|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44953445|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44953446|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
44584480|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
44584629|NCT03901131|Estradiol|estradiol|mesh-list
44953447|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953448|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44584943|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
44585098|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585099|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
44585100|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585101|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44585102|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44585103|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585104|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
44585105|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44585106|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
44585107|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585108|NCT03596125|Expectorants|expectorants|mesh-ancestor
44953449|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44953450|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585320|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585321|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585469|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44585470|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585474|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44585545|NCT03061474|Niacin|niacin|mesh-list
44953451|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44585718|NCT02860039|Vaccines|vaccines|mesh-list
44585782|NCT02739412|Analgesics|analgesics|mesh-ancestor
44585866|NCT02574728|Analgesics|analgesics|mesh-ancestor
44953452|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586005|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413570|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
44586046|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44586047|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586049|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
44586050|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44586051|NCT02296684|Cisplatin|cisplatin|mesh-list
44586052|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
44586055|NCT02281955|Cisplatin|cisplatin|mesh-list
44586123|NCT02193841|Calcium|calcium|mesh-list
44953453|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
44953454|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44953455|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44953456|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
44953457|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
44953458|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
44953459|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
44953460|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
44953461|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953462|NCT02059499|Fluorouracil|fluorouracil|mesh-list
44586330|NCT01193842|Rituximab|rituximab|mesh-list
44586331|NCT01193842|Doxorubicin|doxorubicin|mesh-list
44586332|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44586333|NCT01193842|Etoposide|etoposide|mesh-list
44586334|NCT01193842|Vincristine|vincristine|mesh-list
44586335|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
44586336|NCT01193842|Vorinostat|vorinostat|mesh-list
44586337|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
44586338|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44586339|NCT01193842|Antibodies|antibodies|mesh-list
44586340|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
44586341|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44586342|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586343|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
44586344|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586345|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586346|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586347|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
44586348|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586350|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586351|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44586352|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44953463|NCT02059499|Imiquimod|imiquimod|mesh-list
44953464|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
44586651|NCT05661669|Ketamine|ketamine|mesh-list
44586795|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
44586867|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953465|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953466|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44953467|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587258|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
44953468|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587559|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
44953469|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
44587641|NCT03797014|Tenofovir|tenofovir|mesh-list
44953470|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587854|NCT03228693|Triamcinolone|triamcinolone|mesh-list
44587943|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
44953471|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44416045|NCT02335983|Hormones|hormones|mesh-ancestor
44953472|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
44588393|NCT05652322|Furosemide|furosemide|mesh-list
44588394|NCT05652322|Diuretics|diuretics|mesh-ancestor
44588395|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
44588396|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588397|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44588398|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44588399|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588400|NCT05644041|Gemcitabine|gemcitabine|mesh-list
44588401|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588402|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
44588403|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588405|NCT05644041|Antiviral Agents|antiviral agents|mesh-ancestor
44953473|NCT01941875|Progesterone|progesterone|mesh-list
44588544|NCT05498766|Tegafur|tegafur|mesh-list
44953474|NCT01941875|Progestins|progestins|mesh-ancestor
44953475|NCT01941875|Hormones|hormones|mesh-ancestor
44588854|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588855|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588856|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588860|NCT05116293|Digoxin|digoxin|mesh-list
44953476|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44953477|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953478|NCT01814657|Lidocaine|lidocaine|mesh-list
44953479|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953480|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
44953481|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953482|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953483|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
44953484|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953485|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44953486|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44953487|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44953488|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44588943|NCT04996004|Doxorubicin|doxorubicin|mesh-list
44953489|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589081|NCT04598477|Prednisone|prednisone|mesh-list
44953490|NCT01773395|Methotrexate|methotrexate|mesh-list
44953491|NCT01773395|Fludarabine|fludarabine|mesh-list
44953492|NCT01773395|Busulfan|busulfan|mesh-list
44953493|NCT01773395|Tacrolimus|tacrolimus|mesh-list
44589375|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589449|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44953494|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44953495|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
44589599|NCT02955823|Hormones|hormones|mesh-ancestor
44589675|NCT02176148|Fluocinonide|fluocinonide|mesh-list
44589845|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
44589919|NCT00885378|Incretins|incretins|mesh-ancestor
44953496|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44953497|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590177|NCT00883051|Lasmiditan|lasmiditan|mesh-list
44953498|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590446|NCT00879970|Vitamin D|vitamin d|mesh-list
44590597|NCT00877890|Exenatide|exenatide|mesh-list
44953499|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
44590753|NCT00875979|Trastuzumab|trastuzumab|mesh-list
44953500|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953501|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953502|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
44953503|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591274|NCT00869089|Apremilast|apremilast|mesh-list
44953504|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591584|NCT00866307|Hormones|hormones|mesh-ancestor
44591660|NCT00865189|Leucovorin|leucovorin|mesh-list
44591761|NCT00864097|Analgesics|analgesics|mesh-ancestor
44953505|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953506|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
44591906|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
44953507|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592073|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44592158|NCT00859456|Growth Substances|growth substances|mesh-ancestor
44592245|NCT00858234|Vorinostat|vorinostat|mesh-list
44592318|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44592393|NCT00857220|Eszopiclone|eszopiclone|mesh-list
44953508|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44953509|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44953510|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
44953511|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592642|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
44953512|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44953513|NCT01704859|Vitamin D|vitamin d|mesh-list
44953514|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
44953515|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
44593141|NCT00849875|Imidazole|imidazole|mesh-list
44953516|NCT01704859|Vitamins|vitamins|mesh-list
44593212|NCT00848965|Xhance|xhance|mesh-list
44953517|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
44593380|NCT00847626|Diuretics|diuretics|mesh-ancestor
44593452|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44593536|NCT00845676|Interferons|interferons|mesh-list
44953518|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953519|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44593693|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953520|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44593914|NCT00840827|Lenalidomide|lenalidomide|mesh-list
44953521|NCT01142284|Cilostazol|cilostazol|mesh-list
44953522|NCT01142284|Probucol|probucol|mesh-list
44594138|NCT00837967|Terbutaline|terbutaline|mesh-list
44953523|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44953524|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
44594511|NCT00833248|Goserelin|goserelin|mesh-list
44953525|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594834|NCT00829283|Orlistat|orlistat|mesh-list
44594985|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
44953526|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953527|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595223|NCT00823979|Etravirine|etravirine|mesh-list
44953528|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
44953529|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44595464|NCT00820170|Paclitaxel|paclitaxel|mesh-list
44953530|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595774|NCT00816166|Aspirin|aspirin|mesh-list
44953531|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596265|NCT00811057|Indomethacin|indomethacin|mesh-list
44953532|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44953533|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
44424899|NCT03155061|Nivolumab|nivolumab|mesh-list
44596629|NCT00808028|Vaccines|vaccines|mesh-list
44953534|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44953535|NCT01142284|Protective Agents|protective agents|mesh-ancestor
44953536|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44953537|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44953538|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953539|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44598045|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
44953540|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44953541|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
44953542|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44953543|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
44953544|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44953545|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44598637|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44598786|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
44599030|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
44599338|NCT00778830|Cetuximab|cetuximab|mesh-list
44953546|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44953547|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953548|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953549|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953550|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953551|NCT01074151|Analgesics|analgesics|mesh-ancestor
44953552|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
44953553|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953554|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
44599567|NCT00775450|Vaccines|vaccines|mesh-list
44953555|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44953556|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
44953557|NCT02795988|Cisplatin|cisplatin|mesh-list
44599862|NCT00772109|Vaccines|vaccines|mesh-list
44600007|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
44953558|NCT02795988|Fluorouracil|fluorouracil|mesh-list
44600149|NCT00769132|Niacin|niacin|mesh-list
44953559|NCT02795988|Capecitabine|capecitabine|mesh-list
44953560|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
44953561|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953562|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
44600377|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44600453|NCT00765817|Hormones|hormones|mesh-ancestor
44953563|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600598|NCT00763958|Narcotics|narcotics|mesh-ancestor
44953564|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600676|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44953565|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953566|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
44953567|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953568|NCT02786329|Lidocaine|lidocaine|mesh-list
44484851|NCT05524246|Pravastatin|pravastatin|mesh-list
44484852|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44484854|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
44953569|NCT02786329|Sevoflurane|sevoflurane|mesh-list
44953570|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953571|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
44953572|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953573|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601516|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601664|NCT00751881|Teriflunomide|teriflunomide|mesh-list
44953574|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
44953575|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953576|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44953577|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44601891|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44953578|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44602298|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
44602374|NCT00742924|Vitamins|vitamins|mesh-ancestor
44953579|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602456|NCT00742326|Pioglitazone|pioglitazone|mesh-list
44953580|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602549|NCT00741013|Protein C|protein c|mesh-list
44953581|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44953582|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44602605|NCT00740714|Vitamins|vitamins|mesh-list
44953583|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
44953584|NCT02731352|Apatinib|apatinib|mesh-list
44602763|NCT00738374|Rituximab|rituximab|mesh-list
44953585|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953586|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953587|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953588|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953589|NCT02726659|Celecoxib|celecoxib|mesh-list
44603060|NCT00734929|Ondansetron|ondansetron|mesh-list
44603135|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44603206|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
44603279|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603357|NCT00732498|Cytarabine|cytarabine|mesh-list
44603431|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
44953590|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44603652|NCT00729833|Sunitinib|sunitinib|mesh-list
44953591|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953592|NCT02726659|Analgesics|analgesics|mesh-ancestor
44603911|NCT00727272|Analgesics|analgesics|mesh-ancestor
44953593|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
44953594|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604139|NCT00724854|Ribavirin|ribavirin|mesh-list
44604237|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953595|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953596|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44953597|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604532|NCT00721110|Analgesics|analgesics|mesh-ancestor
44953598|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44604682|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
44953599|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44953600|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604857|NCT00719472|Antipyretics|antipyretics|mesh-list
44604931|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44953601|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953602|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
44953603|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605082|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
44605151|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
44605226|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44605388|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
44605462|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605463|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44605464|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605467|NCT05683301|Amlodipine|amlodipine|mesh-list
44953604|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953605|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605608|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605787|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
44605862|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
44605863|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605864|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605865|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605866|NCT05429268|Growth Substances|growth substances|mesh-ancestor
44605939|NCT05338502|Ranitidine|ranitidine|mesh-list
44606088|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606090|NCT05218499|Doxorubicin|doxorubicin|mesh-list
44953606|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953607|NCT02600923|Letrozole|letrozole|mesh-list
44953608|NCT02600923|Palbociclib|palbociclib|mesh-list
44953609|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953610|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44953611|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44953612|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953613|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953614|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44953615|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44953616|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44953617|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953618|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953619|NCT02460900|Varenicline|varenicline|mesh-list
44953620|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44953621|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44953622|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44953623|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953624|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953625|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953626|NCT02428647|Zinc|zinc|mesh-list
44953627|NCT02428647|Trace Elements|trace elements|mesh-ancestor
44953628|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
44953629|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953630|NCT02371889|Topiramate|topiramate|mesh-list
44953631|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
44953632|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44606329|NCT04775953|Dalbavancin|dalbavancin|mesh-list
44953633|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953634|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
44953635|NCT02257424|Trametinib|trametinib|mesh-list
44953636|NCT02257424|Dabrafenib|dabrafenib|mesh-list
44953637|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
44953638|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44953639|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44953640|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606951|NCT03326921|Vidarabine|vidarabine|mesh-list
44953641|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607094|NCT02717455|Panobinostat|panobinostat|mesh-list
44607097|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607200|NCT02543983|Ketamine|ketamine|mesh-list
44607201|NCT02543983|Analgesics|analgesics|mesh-ancestor
44607202|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
44607203|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607204|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607205|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44607206|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44607207|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
44607208|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
44607209|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607210|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44607211|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44607212|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607213|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607214|NCT02531126|Ozanimod|ozanimod|mesh-list
44607215|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44607216|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607217|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607218|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
44607219|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607220|NCT02494258|Azacitidine|azacitidine|mesh-list
44607221|NCT02494258|Cc-486|cc-486|mesh-list
44607222|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607223|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
44607224|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607225|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607228|NCT02430077|Cathartics|cathartics|mesh-ancestor
44953642|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607272|NCT02135419|Fluorouracil|fluorouracil|mesh-list
44607335|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44607336|NCT01366144|Veliparib|veliparib|mesh-list
44607337|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607338|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607339|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607340|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607341|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607342|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607343|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44607344|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607345|NCT01327781|Tamoxifen|tamoxifen|mesh-list
44607346|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44607347|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
44607348|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607349|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607350|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44607351|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607352|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44607353|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44607354|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44607385|NCT01139970|Temozolomide|temozolomide|mesh-list
44607386|NCT01139970|Veliparib|veliparib|mesh-list
44607387|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607388|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
44607389|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607390|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953643|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607488|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44953644|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607605|NCT00712335|Xhance|xhance|mesh-list
44953645|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953646|NCT01945775|Talazoparib|talazoparib|mesh-list
44953647|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44953648|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607948|NCT00700115|Ritonavir|ritonavir|mesh-list
44953649|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953650|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608396|NCT00695136|Donepezil|donepezil|mesh-list
44608549|NCT00693017|Zonisamide|zonisamide|mesh-list
44953651|NCT01858922|Cytarabine|cytarabine|mesh-list
44953652|NCT01858922|Dexamethasone|dexamethasone|mesh-list
44953653|NCT01858922|Prednisone|prednisone|mesh-list
44953654|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
44953655|NCT01858922|Cisplatin|cisplatin|mesh-list
44953656|NCT01858922|Doxorubicin|doxorubicin|mesh-list
44953657|NCT01858922|Etoposide|etoposide|mesh-list
44609036|NCT00687440|Docetaxel|docetaxel|mesh-list
44953658|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
44953659|NCT01858922|Vincristine|vincristine|mesh-list
44953660|NCT01858922|Bleomycin|bleomycin|mesh-list
44953661|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953662|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
44953663|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953664|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953665|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609646|NCT00682539|Triamcinolone|triamcinolone|mesh-list
44953666|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
44609818|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609891|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44609966|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
44610041|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44953667|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610189|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610264|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
44953668|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953669|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44610500|NCT00672646|Naproxen|naproxen|mesh-list
44953670|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44953671|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
44610729|NCT00670930|Omalizumab|omalizumab|mesh-list
44953672|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
44953673|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610966|NCT00669071|Tretinoin|tretinoin|mesh-list
44953674|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953675|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
44953676|NCT01858922|Hormones|hormones|mesh-ancestor
44611181|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
44953677|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611251|NCT00666757|Analgesics|analgesics|mesh-ancestor
44953678|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44611328|NCT00666536|Amlodipine|amlodipine|mesh-list
44953679|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953680|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44611489|NCT00665353|Ribavirin|ribavirin|mesh-list
44611569|NCT00663858|Cetrorelix|cetrorelix|mesh-list
44611658|NCT00662558|Celecoxib|celecoxib|mesh-list
44611710|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611862|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44953681|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612008|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612009|NCT00659529|Urological Agents|urological agents|mesh-ancestor
44612010|NCT00659490|Naproxen|naproxen|mesh-list
44612011|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44612031|NCT00659373|Tamoxifen|tamoxifen|mesh-list
44953682|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44953683|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612101|NCT00658788|Vitamins|vitamins|mesh-ancestor
44612173|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
44953684|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44953685|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
44953686|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
44953687|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953688|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44953689|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44953690|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
44953691|NCT01781637|Omalizumab|omalizumab|mesh-list
44953692|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44953693|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44612545|NCT00654732|Antibodies|antibodies|mesh-list
44953694|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44953695|NCT01773278|Antioxidants|antioxidants|mesh-list
44612799|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953696|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953697|NCT01773278|Protective Agents|protective agents|mesh-ancestor
44953698|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953699|NCT01416935|Amiodarone|amiodarone|mesh-list
44953700|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44953701|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
44613013|NCT00650806|Canagliflozin|canagliflozin|mesh-list
44953702|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44613167|NCT00646776|Ritonavir|ritonavir|mesh-list
44613238|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613239|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613240|NCT00645411|Vaccines|vaccines|mesh-list
44613241|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
44613242|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613243|NCT00645099|Olanzapine|olanzapine|mesh-list
44613244|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44613245|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
44613246|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
44613247|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613248|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442414|NCT01882985|Lycopene|lycopene|mesh-list
44953703|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953704|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953705|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44953706|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44953707|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44953708|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953709|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44953710|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44953711|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44953712|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
44953713|NCT01019356|Acarbose|acarbose|mesh-list
44953714|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44953715|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953716|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44953717|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613385|NCT00643162|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44953718|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953719|NCT05202730|Anesthetics|anesthetics|mesh-list
44953720|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
44953721|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953722|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953723|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
44614003|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44953724|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953725|NCT05202665|Fluorides|fluorides|mesh-list
44953726|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
44614175|NCT00626522|Bromides|bromides|mesh-list
44953727|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
44953728|NCT05202665|Protective Agents|protective agents|mesh-ancestor
44953729|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953730|NCT05202496|Calcitriol|calcitriol|mesh-list
44953731|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614614|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44614684|NCT00622388|Ofatumumab|ofatumumab|mesh-list
44953732|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953733|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44953734|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614920|NCT00620555|Gabapentin|gabapentin|mesh-list
44614992|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44615063|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44953735|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615137|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953736|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44953737|NCT05202496|Vitamins|vitamins|mesh-ancestor
44953738|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
44615462|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615615|NCT00614991|Ritonavir|ritonavir|mesh-list
44615688|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
44953739|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44615834|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953740|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
44953741|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
44953742|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953743|NCT05202275|Olanzapine|olanzapine|mesh-list
44953744|NCT05202275|Aprepitant|aprepitant|mesh-list
44953745|NCT05202275|Palonosetron|palonosetron|mesh-list
44953746|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
44953747|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
44953748|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616228|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
44953749|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953750|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953751|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44953752|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616463|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44953753|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616631|NCT00606502|Vitamins|vitamins|mesh-list
44953754|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616906|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
44616981|NCT00603915|Immunologic Factors|immunologic factors|mesh-ancestor
44953755|NCT05202275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44953756|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44953757|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953758|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953759|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953760|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
44953761|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44953762|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44953763|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44953764|NCT05201560|Fentanyl|fentanyl|mesh-list
44953765|NCT05201560|Butorphanol|butorphanol|mesh-list
44953766|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44953767|NCT05201560|Narcotics|narcotics|mesh-ancestor
44617200|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
44617283|NCT00600756|Risperidone|risperidone|mesh-list
44953768|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617569|NCT00597506|Everolimus|everolimus|mesh-list
44953769|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953770|NCT05201560|Analgesics|analgesics|mesh-ancestor
44953771|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
44617837|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953772|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617998|NCT00592319|Celecoxib|celecoxib|mesh-list
44953773|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44953774|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44618132|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
44953775|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
44953776|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
44618281|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
44953777|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
44953778|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
44953779|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44618701|NCT00585351|Ranitidine|ranitidine|mesh-list
44618744|NCT00585169|Memantine|memantine|mesh-list
44953780|NCT05201352|Trifluridine|trifluridine|mesh-list
44953781|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
44618982|NCT00582556|Leuprolide|leuprolide|mesh-list
44448649|NCT01767116|Ribavirin|ribavirin|mesh-list
44619160|NCT00580970|Lovastatin|lovastatin|mesh-list
44953782|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953783|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
44619303|NCT00578786|Ambrisentan|ambrisentan|mesh-list
44953784|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953785|NCT05201326|Bevacizumab|bevacizumab|mesh-list
44953786|NCT05201326|Irinotecan|irinotecan|mesh-list
44619520|NCT00577473|Mesalamine|mesalamine|mesh-list
44953787|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619672|NCT00576823|Alfuzosin|alfuzosin|mesh-list
44619841|NCT00574288|Hormones|hormones|mesh-ancestor
44449430|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
44953788|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620330|NCT00570128|Donepezil|donepezil|mesh-list
44620389|NCT00569127|Octreotide|octreotide|mesh-list
44953789|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44953790|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44620617|NCT00567255|Naltrexone|naltrexone|mesh-list
44620717|NCT00566501|Donepezil|donepezil|mesh-list
44620771|NCT00565448|Cisplatin|cisplatin|mesh-list
44953791|NCT05201326|Growth Substances|growth substances|mesh-ancestor
44953792|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620996|NCT00562965|Hormones|hormones|mesh-ancestor
44621071|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
44953793|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44953794|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44953795|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44621394|NCT00560352|Bortezomib|bortezomib|mesh-list
44953796|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953797|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953798|NCT05200793|Metformin|metformin|mesh-list
44953799|NCT05200793|Empagliflozin|empagliflozin|mesh-list
44953800|NCT05200793|Linagliptin|linagliptin|mesh-list
44953801|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44621935|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953802|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622156|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622235|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
44622304|NCT00545168|Permethrin|permethrin|mesh-list
44622381|NCT00544817|Sorafenib|sorafenib|mesh-list
44622449|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44622532|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
44953803|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44622605|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44622753|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623056|NCT00537823|Fluorouracil|fluorouracil|mesh-list
44623073|NCT00537823|Vitamins|vitamins|mesh-ancestor
44623222|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623371|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953804|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953805|NCT05200793|Incretins|incretins|mesh-ancestor
44953806|NCT05200793|Hormones|hormones|mesh-ancestor
44953807|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623964|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624041|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44624114|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624341|NCT00526097|Laxatives|laxatives|mesh-ancestor
44624415|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953808|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44953809|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
44953810|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953811|NCT05200663|Tamoxifen|tamoxifen|mesh-list
44953812|NCT05200663|Vitamin E|vitamin e|mesh-list
44953813|NCT05200663|Vitamins|vitamins|mesh-ancestor
44953814|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
44625315|NCT00515619|Lacosamide|lacosamide|mesh-list
44625389|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
44625463|NCT00514683|Nintedanib|nintedanib|mesh-list
44953815|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953816|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44625772|NCT00511004|Albendazole|albendazole|mesh-list
44953817|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44625851|NCT00510484|Pancreatin|pancreatin|mesh-list
44626070|NCT00508274|Lapatinib|lapatinib|mesh-list
44626077|NCT00508157|Olanzapine|olanzapine|mesh-list
44953818|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626219|NCT00507416|Hormones|hormones|mesh-ancestor
44626293|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
44626441|NCT00505661|Letrozole|letrozole|mesh-list
44626740|NCT00502671|Capecitabine|capecitabine|mesh-list
44626893|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
44953819|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44953820|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627362|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
44953821|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44627513|NCT00494026|Carboplatin|carboplatin|mesh-list
44627587|NCT00493311|Analgesics|analgesics|mesh-ancestor
44627660|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627682|NCT00492297|Sorafenib|sorafenib|mesh-list
44953822|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44953823|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44953824|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
44627880|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627961|NCT00490490|Iodine|iodine|mesh-list
44628102|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44953825|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628325|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44953826|NCT05200663|Protective Agents|protective agents|mesh-ancestor
44953827|NCT05198531|Gemcitabine|gemcitabine|mesh-list
44953828|NCT05198531|Cisplatin|cisplatin|mesh-list
44628475|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
44953829|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628550|NCT00483717|Ketorolac|ketorolac|mesh-list
44953830|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628714|NCT00482053|Carmustine|carmustine|mesh-list
44953831|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
44628927|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
44629000|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44953832|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953833|NCT05198531|Antiviral Agents|antiviral agents|mesh-ancestor
44953834|NCT05198531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953835|NCT05198531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953836|NCT05198531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953837|NCT05198531|Immunologic Factors|immunologic factors|mesh-ancestor
44953838|NCT05198531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953839|NCT05180214|Ketorolac|ketorolac|mesh-list
44953840|NCT05180214|Bupivacaine|bupivacaine|mesh-list
44629746|NCT00464308|Rabeprazole|rabeprazole|mesh-list
44953841|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
44953842|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
44630199|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44630348|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
44630430|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44953843|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953844|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630647|NCT00455312|Hormones|hormones|mesh-ancestor
44953845|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
44630950|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
44953846|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631097|NCT00451178|Hormones|hormones|mesh-ancestor
44631250|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631343|NCT00449670|Vaccines|vaccines|mesh-list
44631407|NCT00449033|Cisplatin|cisplatin|mesh-list
44631474|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631559|NCT00447902|Ritonavir|ritonavir|mesh-list
44631692|NCT00446797|Analgesics|analgesics|mesh-ancestor
44631772|NCT00446199|Drospirenone|drospirenone|mesh-list
44953847|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44953848|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953849|NCT05180214|Analgesics|analgesics|mesh-ancestor
44953850|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44953851|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953852|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44953853|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631919|NCT00445458|Paclitaxel|paclitaxel|mesh-list
44953854|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953855|NCT05170893|Ubiquinone|ubiquinone|mesh-list
44953856|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
44632060|NCT00444587|Trastuzumab|trastuzumab|mesh-list
44632131|NCT00443781|Anesthetics|anesthetics|mesh-list
44632213|NCT00443430|Prednisone|prednisone|mesh-list
44632321|NCT00442546|Pregabalin|pregabalin|mesh-list
44632363|NCT00441792|Midazolam|midazolam|mesh-list
44953857|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
44953858|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632743|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
44953859|NCT05170893|Vitamins|vitamins|mesh-ancestor
44953860|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
44953861|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44953862|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
44633113|NCT00435409|Capecitabine|capecitabine|mesh-list
44633193|NCT00434642|Gemcitabine|gemcitabine|mesh-list
44633259|NCT00434109|Sunitinib|sunitinib|mesh-list
44633336|NCT00433381|Bevacizumab|bevacizumab|mesh-list
44953863|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953864|NCT05074121|Expectorants|expectorants|mesh-ancestor
44953865|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44953866|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44633784|NCT00428844|Nafcillin|nafcillin|mesh-list
44953867|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
44634008|NCT00425607|Lonafarnib|lonafarnib|mesh-list
44953868|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634270|NCT00424008|Xhance|xhance|mesh-list
44953869|NCT05074121|Protective Agents|protective agents|mesh-ancestor
44634455|NCT00423098|Prednisone|prednisone|mesh-list
44953870|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634529|NCT00422734|Tadalafil|tadalafil|mesh-list
44953871|NCT05074121|Antidotes|antidotes|mesh-ancestor
44953872|NCT05069012|Morphine|morphine|mesh-list
44634925|NCT00419926|Cyclosporine|cyclosporine|mesh-list
44635000|NCT00419562|Insulin|insulin|mesh-list
44953873|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44953874|NCT05069012|Narcotics|narcotics|mesh-ancestor
44635144|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
44635372|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
44953875|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186972|NCT00338754|Adalimumab|adalimumab|mesh-list
44953876|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953877|NCT05069012|Analgesics|analgesics|mesh-ancestor
44636039|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
44636119|NCT00407550|Pemetrexed|pemetrexed|mesh-list
44636186|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
44636406|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953878|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
44953879|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636705|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
44953880|NCT05049343|Ketamine|ketamine|mesh-list
44953881|NCT05049343|Analgesics|analgesics|mesh-ancestor
44637151|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637379|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44953882|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
44637448|NCT00395226|Astringents|astringents|mesh-ancestor
44637523|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44953883|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953884|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637671|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44953885|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44637979|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
44638121|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44953886|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44953887|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
44953888|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
44638198|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638345|NCT00387348|Dexetimide|dexetimide|mesh-list
44953889|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638490|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638639|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953890|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44953891|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44953892|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638865|NCT00381706|Epirubicin|epirubicin|mesh-list
44639090|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
44639318|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44639393|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953893|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639690|NCT00372905|Rituximab|rituximab|mesh-list
44953894|NCT05041322|Buspirone|buspirone|mesh-list
44953895|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44953896|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44953897|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953898|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640319|NCT00367341|Citalopram|citalopram|mesh-list
44953899|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640445|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
44640604|NCT00364286|Dasatinib|dasatinib|mesh-list
44640670|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44953900|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44953901|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
44953902|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641039|NCT00358670|Infliximab|infliximab|mesh-list
44641115|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44641193|NCT00357097|Ropinirole|ropinirole|mesh-list
44641335|NCT00356265|Protective Agents|protective agents|mesh-ancestor
44641409|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44641484|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44953903|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953904|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
44641782|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
44953905|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44641857|NCT00350636|Oxybutynin|oxybutynin|mesh-list
44641929|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44953906|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44953907|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953908|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
44953909|NCT04996368|Coagulants|coagulants|mesh-ancestor
44953910|NCT04941755|Famotidine|famotidine|mesh-list
44953911|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44953912|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953913|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44642528|NCT00337662|Olanzapine|olanzapine|mesh-list
44953914|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
44642759|NCT00336024|Antidotes|antidotes|mesh-ancestor
44953915|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
44642895|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44953916|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953917|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953918|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643118|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
44643199|NCT00332189|Verapamil|verapamil|mesh-list
44953919|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
44953920|NCT04931641|Trace Elements|trace elements|mesh-ancestor
44953921|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
44953922|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953923|NCT04878627|Cannabidiol|cannabidiol|mesh-list
44953924|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
44953925|NCT04872426|Insulin|insulin|mesh-list
44644180|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
44953926|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44644326|NCT00319111|Bosentan|bosentan|mesh-list
44644400|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953927|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953928|NCT04467723|Pirfenidone|pirfenidone|mesh-list
44953929|NCT04467723|Atezolizumab|atezolizumab|mesh-list
44953930|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644625|NCT00314262|Analgesics|analgesics|mesh-ancestor
44953931|NCT04467723|Analgesics|analgesics|mesh-ancestor
44644700|NCT00313313|Metformin|metformin|mesh-list
44953932|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
44953933|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953934|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645535|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
44645677|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
44645756|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646063|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
44646134|NCT00297882|Artesunate|artesunate|mesh-list
44646281|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
44646356|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
44646431|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
44953935|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646517|NCT00294398|Xhance|xhance|mesh-list
44646579|NCT00293397|Doxorubicin|doxorubicin|mesh-list
44646978|NCT00290433|Cytarabine|cytarabine|mesh-list
44647258|NCT00286429|Alogliptin|alogliptin|mesh-list
44647337|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
44953936|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953937|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44953938|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953939|NCT04400838|Vaccines|vaccines|mesh-list
44953940|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
44953941|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953942|NCT04344444|Azithromycin|azithromycin|mesh-list
44953943|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
44953944|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647933|NCT00278148|Paclitaxel|paclitaxel|mesh-list
44648017|NCT00276614|Bortezomib|bortezomib|mesh-list
44953945|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44953946|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
44648158|NCT00275262|Leuprolide|leuprolide|mesh-list
44953947|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44648240|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
44953948|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44648528|NCT00268242|Antiviral Agents|antiviral agents|mesh-ancestor
44953949|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44953950|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953951|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44953952|NCT04324606|Acetaminophen|acetaminophen|mesh-list
44953953|NCT04324606|Vaccines|vaccines|mesh-list
44953954|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
44953955|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953956|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44953957|NCT04324606|Analgesics|analgesics|mesh-ancestor
44953958|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
44648743|NCT00266032|Diuretics|diuretics|mesh-ancestor
44648899|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
44953959|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44953960|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
44953961|NCT04295577|Niraparib|niraparib|mesh-list
44649417|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44649491|NCT00256750|Cyclosporins|cyclosporins|mesh-list
44649566|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44649715|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649787|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649935|NCT00250835|Analgesics|analgesics|mesh-ancestor
44650009|NCT00250432|Caspofungin|caspofungin|mesh-list
44953962|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44953963|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650679|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44953964|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953965|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44953966|NCT04251689|Mannitol|mannitol|mesh-list
44651050|NCT00211081|Diuretics|diuretics|mesh-ancestor
44953967|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44953968|NCT04251689|Diuretics|diuretics|mesh-ancestor
44953969|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
44953970|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953971|NCT04232423|Olanzapine|olanzapine|mesh-list
44953972|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
44651793|NCT00185731|Atorvastatin|atorvastatin|mesh-list
44953973|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
44651869|NCT00185211|Interferons|interferons|mesh-list
44953974|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652017|NCT00183248|Tacrolimus|tacrolimus|mesh-list
44953975|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652316|NCT00166439|Dexamethasone|dexamethasone|mesh-list
44953976|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44953977|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44953978|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44953979|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44953980|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44953981|NCT04232423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44953982|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652912|NCT00147498|Tofacitinib|tofacitinib|mesh-list
44953983|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953984|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44953985|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44953986|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
44953987|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44953988|NCT04178993|Methylphenidate|methylphenidate|mesh-list
44953989|NCT04178993|Methamphetamine|methamphetamine|mesh-list
44953990|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44953991|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44953992|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44953993|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44953994|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44953995|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653133|NCT00142519|Morphine|morphine|mesh-list
44653353|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
44953996|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
44653431|NCT00137111|Cytarabine|cytarabine|mesh-list
44653878|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44953997|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654028|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
44654177|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
44654476|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44654625|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44953998|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44954000|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
44954001|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954002|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
44654850|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
44954003|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44954004|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
44655216|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
44655294|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
44954005|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
44655437|NCT00112502|Analgesics|analgesics|mesh-ancestor
44954006|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
44655591|NCT00110890|Cinacalcet|cinacalcet|mesh-list
44655709|NCT00108485|Niacin|niacin|mesh-list
44655743|NCT00108069|Tamoxifen|tamoxifen|mesh-list
44655819|NCT00105196|Aripiprazole|aripiprazole|mesh-list
44655888|NCT00104247|Verapamil|verapamil|mesh-list
44655964|NCT00099632|Ritonavir|ritonavir|mesh-list
44954007|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44954008|NCT04107727|Cytarabine|cytarabine|mesh-list
44656117|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
44954009|NCT04107727|Idarubicin|idarubicin|mesh-list
44656265|NCT00097591|Clopidogrel|clopidogrel|mesh-list
44656339|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
44656416|NCT00096200|Sorafenib|sorafenib|mesh-list
44656493|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954010|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656718|NCT00094107|Axitinib|axitinib|mesh-list
44954011|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
44656952|NCT00089674|Denosumab|denosumab|mesh-list
44657016|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657237|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
44954012|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954013|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954014|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
44954015|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954016|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954017|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
44657853|NCT00074711|Calcium|calcium|mesh-list
44658005|NCT00073307|Sorafenib|sorafenib|mesh-list
44658074|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954018|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954019|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658475|NCT00066690|Tamoxifen|tamoxifen|mesh-list
44658541|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44658618|NCT00065182|Docetaxel|docetaxel|mesh-list
44954020|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44954021|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954022|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954023|NCT04107077|Cisplatin|cisplatin|mesh-list
44954024|NCT04107077|Mitomycins|mitomycins|mesh-list
44954025|NCT04107077|Mitomycin|mitomycin|mesh-list
44659225|NCT00057811|Methotrexate|methotrexate|mesh-list
44659307|NCT00056160|Dexamethasone|dexamethasone|mesh-list
44954026|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659450|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44659682|NCT00048581|Abatacept|abatacept|mesh-list
44659858|NCT00045630|Paclitaxel|paclitaxel|mesh-list
44954027|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659919|NCT00045032|Trastuzumab|trastuzumab|mesh-list
44954028|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
44954029|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660215|NCT00040664|Ritonavir|ritonavir|mesh-list
44954030|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44954031|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954032|NCT04065074|FX006|fx006|mesh-list
44954033|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954034|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
44954035|NCT04065074|Hormones|hormones|mesh-ancestor
44660595|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660670|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660743|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
44660821|NCT00025155|Epothilones|epothilones|mesh-list
44660972|NCT00021541|Tipifarnib|tipifarnib|mesh-list
44661056|NCT00007345|Romidepsin|romidepsin|mesh-list
44661122|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661199|NCT00006237|Cisplatin|cisplatin|mesh-list
44661278|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661281|NCT00006046|Antibodies|antibodies|mesh-list
44661353|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661582|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661662|NCT00003702|Dactinomycin|dactinomycin|mesh-list
44662223|NCT05625503|Verapamil|verapamil|mesh-list
44662348|NCT05371132|Deferoxamine|deferoxamine|mesh-list
44662349|NCT05371132|Siderophores|siderophores|mesh-ancestor
44662350|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44662351|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
44662352|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
44662425|NCT05215327|Vaccines|vaccines|mesh-list
44662501|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662650|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662651|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662652|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662653|NCT04660812|Growth Substances|growth substances|mesh-ancestor
44662654|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954036|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662728|NCT04537923|Insulin|insulin|mesh-list
44662800|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
44954037|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662949|NCT03187262|Daratumumab|daratumumab|mesh-list
44954038|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954039|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
44663027|NCT01118793|Clopidogrel|clopidogrel|mesh-list
44954040|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
44954041|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663242|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
44954042|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44954043|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44954044|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954045|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954046|NCT03997097|Urological Agents|urological agents|mesh-ancestor
44954047|NCT03979885|Nicotine|nicotine|mesh-list
44954048|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44954049|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
44954050|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954051|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954052|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44664063|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
44954053|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44954054|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
44954055|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954056|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664282|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
44954058|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954059|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954060|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954061|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954062|NCT03947216|Pimavanserin|pimavanserin|mesh-list
44665039|NCT01219153|Hormones|hormones|mesh-ancestor
44954063|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44954064|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44954065|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44954066|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44954067|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954068|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954069|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44954070|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44954071|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44954072|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
44954073|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954074|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954075|NCT03939520|Pirfenidone|pirfenidone|mesh-list
44954076|NCT03939520|Nintedanib|nintedanib|mesh-list
44665316|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
44954077|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665536|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
44665685|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
44954078|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954079|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954080|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954081|NCT03939520|Analgesics|analgesics|mesh-ancestor
44954082|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
44665909|NCT01224457|Phenobarbital|phenobarbital|mesh-list
44954083|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954084|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954085|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44665982|NCT01224769|Rituximab|rituximab|mesh-list
44954086|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666123|NCT01225523|Cisplatin|cisplatin|mesh-list
44666198|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954087|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954088|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954089|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
44954090|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44666645|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
44666719|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44954091|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954092|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
44954093|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
44954094|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666947|NCT01230983|Leucovorin|leucovorin|mesh-list
44954095|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
44667094|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44667172|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
44954096|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954097|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954098|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
44954099|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954100|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954101|NCT03793010|FX006|fx006|mesh-list
44667391|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
44954102|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954103|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
44954104|NCT03793010|Hormones|hormones|mesh-ancestor
44667689|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44954105|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954106|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954107|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954108|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
44954109|NCT03781219|Vemurafenib|vemurafenib|mesh-list
44954110|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954111|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954112|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954113|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485387|NCT05259046|Vitamin K|vitamin k|mesh-list
44954114|NCT03529942|FX006|fx006|mesh-list
44954115|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667981|NCT01237535|Progesterone|progesterone|mesh-list
44954116|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
44954117|NCT03529942|Hormones|hormones|mesh-ancestor
44668134|NCT01238367|Factor VIII|factor viii|mesh-list
44668203|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44954118|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954119|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954120|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954121|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
44954122|NCT03501940|Fluorides|fluorides|mesh-list
44668577|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
44954123|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
44668665|NCT01248299|Cisplatin|cisplatin|mesh-list
44954124|NCT03501940|Protective Agents|protective agents|mesh-ancestor
44669261|NCT01253694|Ranibizumab|ranibizumab|mesh-list
44669404|NCT01255046|Donepezil|donepezil|mesh-list
44954125|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954126|NCT03349775|Metformin|metformin|mesh-list
44670024|NCT01258491|Niacin|niacin|mesh-list
44670401|NCT01260675|Analgesics|analgesics|mesh-ancestor
44954127|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44954128|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954129|NCT03207815|Prednisone|prednisone|mesh-list
44670479|NCT01261078|Epinephrine|epinephrine|mesh-list
44670550|NCT01261286|Verapamil|verapamil|mesh-list
44954130|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954131|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
44954132|NCT03207815|Hormones|hormones|mesh-ancestor
44670623|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670769|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954133|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670919|NCT01263860|Ribavirin|ribavirin|mesh-list
44671068|NCT01264588|Calcium|calcium|mesh-list
44954134|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954135|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954136|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954137|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44954138|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954139|NCT03019640|Cytarabine|cytarabine|mesh-list
44954140|NCT03019640|Rituximab|rituximab|mesh-list
44954141|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44954142|NCT03019640|Etoposide|etoposide|mesh-list
44954143|NCT03019640|Lenalidomide|lenalidomide|mesh-list
44954144|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
44954145|NCT03019640|Melphalan|melphalan|mesh-list
44954146|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
44954147|NCT03019640|Carmustine|carmustine|mesh-list
44954148|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
44954149|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44954150|NCT03019640|Antibodies|antibodies|mesh-list
44672792|NCT01282385|Simvastatin|simvastatin|mesh-list
44954151|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
44672863|NCT01282697|Sirolimus|sirolimus|mesh-list
44954152|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44954153|NCT03019640|Lenograstim|lenograstim|mesh-list
44954154|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
44673231|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
44673380|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673454|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
44954155|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673601|NCT01287715|Etanercept|etanercept|mesh-list
44954156|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954157|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673981|NCT01289496|Interferons|interferons|mesh-list
44954158|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44674057|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
44674133|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674201|NCT01290276|Ondansetron|ondansetron|mesh-list
44954159|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44674580|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
44954160|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954161|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954162|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954163|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44954164|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
44954165|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
44954166|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954167|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954168|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44954169|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44954170|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44674884|NCT01294072|Curcumin|curcumin|mesh-list
44954171|NCT03019640|Growth Substances|growth substances|mesh-ancestor
44954172|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44954173|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954174|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
44954175|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44954176|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
44954177|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44954178|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44485463|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44485464|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485465|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
44485466|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
44485467|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
44485468|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44485469|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
44675161|NCT01295606|Cefazolin|cefazolin|mesh-list
44485470|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
44485471|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675305|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44485472|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675526|NCT05412082|Capecitabine|capecitabine|mesh-list
44485473|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44485474|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
44954179|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954180|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954182|NCT02968563|Idelalisib|idelalisib|mesh-list
44954183|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675755|NCT04961281|Analgesics|analgesics|mesh-ancestor
44675904|NCT04638790|Hormones|hormones|mesh-ancestor
44954184|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954185|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675985|NCT04429516|Morphine|morphine|mesh-list
44954186|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954187|NCT02817659|Glucagon|glucagon|mesh-list
44954188|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954189|NCT02817659|Hormones|hormones|mesh-ancestor
44676579|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954190|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954191|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954192|NCT02796261|Eflornithine|eflornithine|mesh-list
44954193|NCT02796261|Lomustine|lomustine|mesh-list
44954194|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954195|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
44954196|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954197|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954198|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44954199|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44954200|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44954201|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954202|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44954203|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954204|NCT02787044|Vaccines|vaccines|mesh-list
44954205|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
44954206|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954207|NCT02764489|Thrombin|thrombin|mesh-list
44677502|NCT01303094|Trabectedin|trabectedin|mesh-list
44954208|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44954209|NCT02764489|Coagulants|coagulants|mesh-list
44954210|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
44954211|NCT02586675|Tamoxifen|tamoxifen|mesh-list
44954212|NCT02586675|Goserelin|goserelin|mesh-list
44677797|NCT01304342|Fentanyl|fentanyl|mesh-list
44954213|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44954214|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
44954215|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677869|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44954216|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954217|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954218|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954219|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44954220|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44954221|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44954222|NCT02560805|Losartan|losartan|mesh-list
44954223|NCT02560805|Atenolol|atenolol|mesh-list
44954224|NCT02560805|Nitroprusside|nitroprusside|mesh-list
44954225|NCT02560805|Phenylephrine|phenylephrine|mesh-list
44954226|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
44954227|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44954228|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44954229|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44954230|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44954231|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954232|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44954233|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
44954234|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
44954235|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954236|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954237|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
44954238|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44954239|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
44485527|NCT05198050|Letrozole|letrozole|mesh-list
44485528|NCT05198050|Alprostadil|alprostadil|mesh-list
44485529|NCT05198050|Misoprostol|misoprostol|mesh-list
44485530|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485531|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44485532|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44485533|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678141|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
44485534|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485535|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44485536|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485537|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485538|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485539|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44485556|NCT05171816|Olaparib|olaparib|mesh-list
44954240|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
44954241|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44954242|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44954243|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44678237|NCT01306721|Ephedrine|ephedrine|mesh-list
44954244|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954245|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954246|NCT02560805|Protective Agents|protective agents|mesh-ancestor
44954248|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44954249|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44678355|NCT01307527|Riboflavin|riboflavin|mesh-list
44678421|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
44954250|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44954251|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44954252|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44954253|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
44954254|NCT02162420|Fludarabine|fludarabine|mesh-list
44954255|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
44954256|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44954257|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954258|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
44954259|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954260|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954261|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954262|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
44954263|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954264|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954265|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44954266|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954267|NCT01821690|Buspirone|buspirone|mesh-list
44678559|NCT01308541|Propofol|propofol|mesh-list
44954268|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44954269|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44954270|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678777|NCT01309607|Paclitaxel|paclitaxel|mesh-list
44954271|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954272|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679076|NCT01318005|Norinyl|norinyl|mesh-list
44679221|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679227|NCT01320878|Iloprost|iloprost|mesh-list
44679296|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44954273|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44954274|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
44679694|NCT05460377|Vaccines|vaccines|mesh-list
44679824|NCT05200884|Lidocaine|lidocaine|mesh-list
44954275|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954276|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954277|NCT01816165|Acipimox|acipimox|mesh-list
44680268|NCT03395080|Paclitaxel|paclitaxel|mesh-list
44954278|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44954279|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
44680408|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44954280|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954281|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44954282|NCT01813929|Metformin|metformin|mesh-list
44954283|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44954284|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954285|NCT01502085|Dexamethasone|dexamethasone|mesh-list
44954286|NCT01502085|Vorinostat|vorinostat|mesh-list
44681086|NCT01327066|Droxidopa|droxidopa|mesh-list
44954287|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954288|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
44681392|NCT01328834|Tacrolimus|tacrolimus|mesh-list
44954289|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
44954290|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954291|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954292|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954293|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
44954294|NCT01502085|Hormones|hormones|mesh-ancestor
44681831|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954295|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954296|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954297|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954298|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44954299|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954300|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954301|NCT01178814|Lenalidomide|lenalidomide|mesh-list
44954302|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
44954303|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954304|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44954305|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44954306|NCT01178814|Growth Substances|growth substances|mesh-ancestor
44682510|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44682511|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
44682512|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682519|NCT05470881|Atropine|atropine|mesh-list
44682584|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
44682585|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682586|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682587|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
44682588|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682589|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682590|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
44682591|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44682592|NCT05431582|Bevacizumab|bevacizumab|mesh-list
44682593|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
44682594|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954307|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44954308|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954309|NCT01125176|Thalidomide|thalidomide|mesh-list
44954310|NCT01125176|Rituximab|rituximab|mesh-list
44954311|NCT01125176|Lenalidomide|lenalidomide|mesh-list
44954312|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954313|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954314|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
44954315|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954316|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954317|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44954318|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44954319|NCT01125176|Growth Substances|growth substances|mesh-ancestor
44954320|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44954321|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954322|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
44954323|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954324|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954325|NCT00882050|Exenatide|exenatide|mesh-list
44954326|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44954327|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954328|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44954329|NCT00882050|Incretins|incretins|mesh-ancestor
44954330|NCT00882050|Hormones|hormones|mesh-ancestor
44954331|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954332|NCT00790829|Nicotine|nicotine|mesh-list
44236600|NCT00560092|Analgesics|analgesics|mesh-ancestor
43780845|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
44954333|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44954334|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
44954335|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954336|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954337|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44954338|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44954339|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
44954340|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954341|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954342|NCT00070564|Paclitaxel|paclitaxel|mesh-list
44954343|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
44954344|NCT00070564|Doxorubicin|doxorubicin|mesh-list
44159442|NCT00239096|Losartan|losartan|mesh-list
44954345|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44954346|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44954347|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954348|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954349|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954350|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954351|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954352|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954353|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
44954354|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954355|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954356|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954357|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
44954358|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44954359|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44954360|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44954361|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954362|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954363|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
44954364|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44954365|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954366|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
44954367|NCT05206682|Goserelin|goserelin|mesh-list
44954368|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954369|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954370|NCT05206318|Cysteamine|cysteamine|mesh-list
44954371|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44954372|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780846|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954373|NCT05205837|Letrozole|letrozole|mesh-list
44954374|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954375|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44954376|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44954377|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954378|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954379|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44954380|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
44954381|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954382|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954383|NCT05205720|Ropivacaine|ropivacaine|mesh-list
44954384|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
44954385|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
44954386|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954387|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954388|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
44954389|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954390|NCT05205603|Mesalamine|mesalamine|mesh-list
44954391|NCT05205603|Infliximab|infliximab|mesh-list
44954392|NCT05205603|Vedolizumab|vedolizumab|mesh-list
44954393|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44954394|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954395|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954396|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44954397|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44954398|NCT05205603|Analgesics|analgesics|mesh-ancestor
44954399|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
44954400|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954401|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954402|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781008|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44160465|NCT00241371|Clofarabine|clofarabine|mesh-list
44236601|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
44954403|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44954404|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44954405|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954406|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
44954407|NCT05205317|Metformin|metformin|mesh-list
44954408|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44954409|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954410|NCT05205200|Paclitaxel|paclitaxel|mesh-list
44954411|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44954412|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954413|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954414|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954415|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954416|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954417|NCT05205122|Mitomycins|mitomycins|mesh-list
44954418|NCT05205122|Mitomycin|mitomycin|mesh-list
44954419|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44954420|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954421|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
44954422|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954423|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44954424|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954425|NCT05204979|Misoprostol|misoprostol|mesh-list
44163148|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
44954426|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44954427|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
44954428|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44954429|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954430|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44954431|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954432|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
44954433|NCT05204641|Rifaximin|rifaximin|mesh-list
44954434|NCT05204641|Levodopa|levodopa|mesh-list
44954435|NCT05204641|Benserazide|benserazide|mesh-list
44954436|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44954437|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44954438|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
44954439|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954440|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954441|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954442|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870463|NCT04518319|Olanzapine|olanzapine|mesh-list
44954443|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954444|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954445|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954446|NCT05204628|Crizotinib|crizotinib|mesh-list
44954447|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954448|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954449|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954450|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954451|NCT05204524|Temozolomide|temozolomide|mesh-list
44954452|NCT05204524|Epirubicin|epirubicin|mesh-list
44954453|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954454|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
44954455|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954456|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954457|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44954458|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44954459|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954460|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954461|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44954462|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44954463|NCT05204173|Paclitaxel|paclitaxel|mesh-list
44954464|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44954465|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954466|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954467|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954468|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954469|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954470|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
44954471|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44954472|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44954473|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
44954474|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954475|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
44954476|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
44954477|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
44954478|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954479|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954480|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
44954481|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44954482|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44954483|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44954484|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954485|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954486|NCT05204056|Epinephrine|epinephrine|mesh-list
44954487|NCT05204056|Morphine|morphine|mesh-list
44954488|NCT05204056|Ropivacaine|ropivacaine|mesh-list
44233880|NCT00546286|Timolol|timolol|mesh-list
44233881|NCT00546286|Dorzolamide|dorzolamide|mesh-list
44233882|NCT00546286|Maleic acid|maleic acid|mesh-list
44233883|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44233884|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44233885|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
44233886|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233887|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233888|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233889|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44233890|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44233891|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233892|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44233893|NCT00546325|Rimonabant|rimonabant|mesh-list
44233894|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44233895|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44233896|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44233897|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233898|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233899|NCT00546325|Hormones|hormones|mesh-ancestor
44233900|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233901|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233902|NCT00546403|Modafinil|modafinil|mesh-list
44078485|NCT00017225|Melphalan|melphalan|mesh-list
44954489|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
44458641|NCT01592370|Dexamethasone|dexamethasone|mesh-list
44954490|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44935923|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935924|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44935925|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44935926|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44935927|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234594|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
44935928|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893803|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
44935929|NCT03712423|Docetaxel|docetaxel|mesh-list
44935930|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234769|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
44935931|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44935932|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44935933|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44935934|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935935|NCT03712397|Irinotecan|irinotecan|mesh-list
43906576|NCT00256451|Ethanol|ethanol|mesh-list
44954491|NCT05204056|Narcotics|narcotics|mesh-ancestor
44235322|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
43930645|NCT00706836|Pregabalin|pregabalin|mesh-list
44935936|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44935937|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44935938|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157675|NCT00235014|Verapamil|verapamil|mesh-list
44008016|NCT02860845|Miconazole|miconazole|mesh-list
44935939|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935940|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44935941|NCT03712241|Indomethacin|indomethacin|mesh-list
44235735|NCT00556023|Gemcitabine|gemcitabine|mesh-list
44040501|NCT00002700|Leucovorin|leucovorin|mesh-list
44149706|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
44235903|NCT00556413|Leucovorin|leucovorin|mesh-list
44935942|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44935943|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44073166|NCT05080322|Xhance|xhance|mesh-list
44080238|NCT04473950|Naloxone|naloxone|mesh-list
44127975|NCT00142896|Morphine|morphine|mesh-list
44935944|NCT03712241|Analgesics|analgesics|mesh-ancestor
44733315|NCT05584657|Lactams|lactams|mesh-list
44935945|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
44237807|NCT00565123|Renal Agents|renal agents|mesh-ancestor
44935946|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44935947|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935948|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44935949|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236177|NCT00557921|Omeprazole|omeprazole|mesh-list
44935950|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
44082026|NCT01805999|Psyllium|psyllium|mesh-list
44251234|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251235|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
44935951|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
44935952|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151953|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
44935953|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44935954|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44935955|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935956|NCT03712163|Ketotifen|ketotifen|mesh-list
44935957|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
44935958|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
44935959|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44935960|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
44935961|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
44082503|NCT01465113|Vitamin D|vitamin d|mesh-list
44935962|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082648|NCT01280994|Xenon|xenon|mesh-list
44236186|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236187|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44935963|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935964|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935965|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44935966|NCT03712111|Norepinephrine|norepinephrine|mesh-list
44935967|NCT03712111|Bupivacaine|bupivacaine|mesh-list
44935968|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
44935969|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
44935970|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44935971|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152139|NCT00216281|Clozapine|clozapine|mesh-list
44270736|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935972|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
44935973|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083629|NCT00276575|Bevacizumab|bevacizumab|mesh-list
44273645|NCT00693589|Folic Acid|folic acid|mesh-list
44935974|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44935975|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44935976|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
44935977|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44935978|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463161|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44463162|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44084333|NCT00130338|Rivastigmine|rivastigmine|mesh-list
44463228|NCT01517984|Prednisone|prednisone|mesh-list
44276525|NCT00709436|Analgesics|analgesics|mesh-ancestor
44935979|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
44935980|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
44935981|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44935982|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44279009|NCT00723216|Enoxaparin|enoxaparin|mesh-list
44935983|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44935984|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707030|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44707031|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44282546|NCT00740090|Antacids|antacids|mesh-ancestor
44707032|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
44282615|NCT00740389|Etravirine|etravirine|mesh-list
44236206|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707033|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707034|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085538|NCT00019552|Irofulven|irofulven|mesh-list
44085851|NCT00020345|Gemcitabine|gemcitabine|mesh-list
44085924|NCT00020488|Leucovorin|leucovorin|mesh-list
44707035|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086077|NCT00020709|Cisplatin|cisplatin|mesh-list
44707036|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44707037|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
43804564|NCT04944082|Ivermectin|ivermectin|mesh-list
44236209|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44086415|NCT00021320|Paclitaxel|paclitaxel|mesh-list
44287420|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
44707038|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707039|NCT01431612|Phenylephrine|phenylephrine|mesh-list
44707040|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
44707041|NCT01431612|Esmolol|esmolol|mesh-list
44288157|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44707042|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44288409|NCT00768157|Lamivudine|lamivudine|mesh-list
44707043|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
44707044|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
44087015|NCT00022646|Pemetrexed|pemetrexed|mesh-list
44236214|NCT00557934|Protective Agents|protective agents|mesh-ancestor
44707045|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713754|NCT02674139|Copper|copper|mesh-list
44707046|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707047|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
44707048|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44707049|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
44707050|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
44935986|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
44935987|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44935988|NCT03711708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44935989|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44935990|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236222|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
44935991|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44935992|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236226|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
44935993|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
44290279|NCT00777244|Mitotane|mitotane|mesh-list
44935994|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44935995|NCT03711253|Tenofovir|tenofovir|mesh-list
44935996|NCT03711253|Emtricitabine|emtricitabine|mesh-list
44935997|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
44935998|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44935999|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44936000|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44236234|NCT00558077|Metformin|metformin|mesh-list
44936001|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936002|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292271|NCT00787007|Equol|equol|mesh-list
44936003|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44936004|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44936005|NCT03711240|Leucovorin|leucovorin|mesh-list
44936006|NCT03711240|Bevacizumab|bevacizumab|mesh-list
44936007|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
44936008|NCT03711240|Irinotecan|irinotecan|mesh-list
44936009|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936010|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936011|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44936012|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44936013|NCT03711240|Growth Substances|growth substances|mesh-ancestor
44936014|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936015|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
44936016|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44936017|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44936018|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936019|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936020|NCT03711240|Antidotes|antidotes|mesh-ancestor
44936021|NCT03711240|Protective Agents|protective agents|mesh-ancestor
44936022|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
44936023|NCT03711240|Vitamins|vitamins|mesh-ancestor
44936024|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
43950594|NCT01147601|Timolol|timolol|mesh-list
44089992|NCT00028717|Hormones|hormones|mesh-ancestor
44090063|NCT00028795|Temozolomide|temozolomide|mesh-list
44236253|NCT00558090|Analgesics|analgesics|mesh-ancestor
44465066|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
44936025|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
44936026|NCT03710863|Vorolanib|vorolanib|mesh-list
44936027|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936028|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236258|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
44954492|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936029|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090766|NCT00030719|Antibodies|antibodies|mesh-list
44465401|NCT01478048|Bortezomib|bortezomib|mesh-list
44936030|NCT03710811|Insulin|insulin|mesh-list
44299608|NCT00823238|Tobramycin|tobramycin|mesh-list
44936031|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44936032|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936033|NCT03710655|Histamine|histamine|mesh-list
44301093|NCT00832364|Etanercept|etanercept|mesh-list
44301690|NCT00837135|Vaccines|vaccines|mesh-list
44936034|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
44936035|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
44936036|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936037|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936038|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936039|NCT03710434|Lansoprazole|lansoprazole|mesh-list
44936040|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
44936041|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44936042|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936043|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44936044|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954493|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936045|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936046|NCT03710395|Nifedipine|nifedipine|mesh-list
44936047|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44465930|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44936048|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44936049|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305379|NCT00861523|Thiamine|thiamine|mesh-list
44954494|NCT05204056|Analgesics|analgesics|mesh-ancestor
44092509|NCT00034840|Valsartan|valsartan|mesh-list
44305974|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
44092651|NCT00035061|Pemetrexed|pemetrexed|mesh-list
44936050|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236275|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
44092837|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44936051|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936052|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306953|NCT00866762|Vorinostat|vorinostat|mesh-list
43726210|NCT02592915|Clonidine|clonidine|mesh-list
44936053|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
44307371|NCT00869596|Xhance|xhance|mesh-list
44936054|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936055|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
44936056|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
44936057|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44236282|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
44236283|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
44936058|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44936059|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093497|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
44936060|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936061|NCT03710369|Urological Agents|urological agents|mesh-ancestor
44936062|NCT03710356|Danazol|danazol|mesh-list
44936063|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44936064|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
44309186|NCT00879827|PENTA|penta|mesh-list
44936065|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936066|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936067|NCT03710343|Metformin|metformin|mesh-list
44936068|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236287|NCT00558181|Hormones|hormones|mesh-ancestor
44936069|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936070|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
44312099|NCT00894010|Analgesics|analgesics|mesh-ancestor
44936071|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44936072|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936073|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936074|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
44936075|NCT03710330|Coagulants|coagulants|mesh-ancestor
44936076|NCT03710317|Misoprostol|misoprostol|mesh-list
44936077|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
44936078|NCT03710317|Carbetocin|carbetocin|mesh-list
44936079|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44936080|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936081|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936082|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
44936083|NCT03710317|Coagulants|coagulants|mesh-ancestor
44936084|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44936085|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
44936086|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936087|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936088|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44936089|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936090|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
44936091|NCT03710304|Misoprostol|misoprostol|mesh-list
44936092|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
44936093|NCT03710304|Oxytocin|oxytocin|mesh-list
44936094|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
44936095|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936096|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936097|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44936098|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44936099|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936100|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
44936101|NCT03710304|Coagulants|coagulants|mesh-ancestor
44936102|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44936103|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
44936104|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44936105|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936106|NCT03710252|Ritonavir|ritonavir|mesh-list
44936107|NCT03710252|Ribavirin|ribavirin|mesh-list
44936108|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44236322|NCT00558454|Hematinics|hematinics|mesh-ancestor
44936109|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44936110|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44936111|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936112|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936113|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44936114|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44936115|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
44314309|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
44936116|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936117|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44936118|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44936119|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
44936120|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
44936121|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936122|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
44936123|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
44936124|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095007|NCT00039767|Lepirudin|lepirudin|mesh-list
44936125|NCT03710044|Cyclosporine|cyclosporine|mesh-list
44936126|NCT03710044|Cyclosporins|cyclosporins|mesh-list
44936127|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936128|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936129|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458811|NCT01590017|Cisplatin|cisplatin|mesh-list
44936130|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
44936131|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936132|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
44936133|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936134|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
44936135|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936136|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44936137|NCT03709992|Tamsulosin|tamsulosin|mesh-list
44936138|NCT03709992|Trospium chloride|trospium chloride|mesh-list
44936139|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44936140|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44936141|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44936142|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
44936143|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936144|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936145|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936146|NCT03709992|Urological Agents|urological agents|mesh-ancestor
44936147|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
44936148|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
44936149|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936150|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44936151|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44936152|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
44936153|NCT03709953|Apatinib|apatinib|mesh-list
44936154|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936155|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936156|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936157|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936158|NCT03709940|Methylphenidate|methylphenidate|mesh-list
44936159|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44936160|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936161|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44936162|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44936163|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44936164|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318174|NCT04400383|Antibodies|antibodies|mesh-list
44936165|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
44936166|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44936167|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
44936168|NCT03709927|Fosfomycin|fosfomycin|mesh-list
44936169|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44936170|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936171|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44936172|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44936173|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318925|NCT02393248|Antiviral Agents|antiviral agents|mesh-ancestor
44936174|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936175|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936176|NCT03709849|Citric Acid|citric acid|mesh-list
44096299|NCT00043277|Bivalirudin|bivalirudin|mesh-list
44936177|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
44936178|NCT03709849|Clomiphene|clomiphene|mesh-list
44322571|NCT00940524|Cytarabine|cytarabine|mesh-list
44936179|NCT03709849|Enclomiphene|enclomiphene|mesh-list
44936180|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
44936181|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
44936182|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44936183|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
44936184|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
44936185|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936186|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44936187|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
44936188|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936189|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936190|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44936191|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
44936192|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936193|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44936194|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44936195|NCT03709745|Ranibizumab|ranibizumab|mesh-list
44936196|NCT03709745|Aflibercept|aflibercept|mesh-list
44936197|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44936198|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44936199|NCT03709745|Growth Substances|growth substances|mesh-ancestor
44936200|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936201|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
44936202|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323275|NCT00943709|Insulin|insulin|mesh-list
44936203|NCT03709719|Blinatumomab|blinatumomab|mesh-list
44096711|NCT00044525|IDN 5109|idn 5109|mesh-list
44096793|NCT00044694|Exenatide|exenatide|mesh-list
44323989|NCT00947388|Antibodies|antibodies|mesh-list
44096937|NCT00044954|Cyclosporine|cyclosporine|mesh-list
44936204|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936205|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44707051|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44707052|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44707053|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44326410|NCT00959387|Paclitaxel|paclitaxel|mesh-list
44707054|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707055|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707056|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707057|NCT01431612|Protective Agents|protective agents|mesh-ancestor
44707058|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44707059|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44236383|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
44707060|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707062|NCT01431690|Anticoagulants|anticoagulants|mesh-list
44707063|NCT01431729|Propolis|propolis|mesh-list
44097966|NCT00047749|Ziconotide|ziconotide|mesh-list
44707064|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707065|NCT01431742|Buprenorphine|buprenorphine|mesh-list
44707066|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44707067|NCT01431742|Narcotics|narcotics|mesh-ancestor
44707068|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707069|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707070|NCT01431742|Analgesics|analgesics|mesh-ancestor
44707071|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
44707072|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707073|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44707074|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44707075|NCT01431781|Somatostatin|somatostatin|mesh-list
44707076|NCT01431781|Hormones|hormones|mesh-ancestor
44098129|NCT00048594|Aprepitant|aprepitant|mesh-list
44329221|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098185|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
44954495|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
44329844|NCT00976755|Everolimus|everolimus|mesh-list
44954496|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954497|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
44098429|NCT00049348|Cisplatin|cisplatin|mesh-list
44954498|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
44954499|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44954500|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44332616|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332617|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44098835|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098908|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333976|NCT04285866|Durvalumab|durvalumab|mesh-list
44098987|NCT00050895|Ritonavir|ritonavir|mesh-list
44334450|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334960|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099135|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335499|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954501|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954502|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
44954503|NCT05204056|Coagulants|coagulants|mesh-ancestor
43992660|NCT02534129|Petrolatum|petrolatum|mesh-list
44954504|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43747551|NCT05555797|Tazarotene|tazarotene|mesh-list
44954505|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44954506|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954507|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748523|NCT02517372|Pemirolast|pemirolast|mesh-list
44954508|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44099936|NCT00053378|Calcium|calcium|mesh-list
44153029|NCT00218621|Analgesics|analgesics|mesh-ancestor
44954509|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44707077|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707078|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707079|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
44707080|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44707081|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707082|NCT01431924|Fluticasone|fluticasone|mesh-list
44707083|NCT01431924|Xhance|xhance|mesh-list
44344110|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
44707084|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44954510|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
44707085|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345476|NCT01053390|Vitamins|vitamins|mesh-ancestor
44707086|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44345811|NCT01055301|Melphalan|melphalan|mesh-list
44707087|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
44707088|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346373|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346832|NCT01060683|Analgesics|analgesics|mesh-ancestor
44347300|NCT01063179|Thalidomide|thalidomide|mesh-list
44236406|NCT00559312|Fluticasone|fluticasone|mesh-list
44707089|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236407|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44707090|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44707091|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
44707092|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44707093|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44707094|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44707095|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44707096|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44707097|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707098|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707099|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707100|NCT01432028|Drospirenone|drospirenone|mesh-list
44707101|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44707102|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44707103|NCT01432028|Estradiol|estradiol|mesh-list
44707104|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44707105|NCT01432028|Progesterone|progesterone|mesh-list
44707106|NCT01432028|Estrogens|estrogens|mesh-ancestor
44707107|NCT01432028|Hormones|hormones|mesh-ancestor
44236414|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44954511|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44954512|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44954513|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
44954514|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
44954515|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44236680|NCT00560430|Telmisartan|telmisartan|mesh-list
44102186|NCT00060632|Sirolimus|sirolimus|mesh-list
44954516|NCT05203913|Paclitaxel|paclitaxel|mesh-list
44954517|NCT05203913|Cisplatin|cisplatin|mesh-list
44954518|NCT05203913|Nivolumab|nivolumab|mesh-list
44102269|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954519|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102567|NCT00061815|Leucovorin|leucovorin|mesh-list
44102722|NCT00062114|Rituximab|rituximab|mesh-list
44353614|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
44954520|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954521|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954522|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954523|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44356910|NCT01117116|Xhance|xhance|mesh-list
44103109|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44103235|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
44357462|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103311|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44954524|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358604|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
44103543|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
44103597|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
44103670|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44954525|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103821|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362359|NCT01147731|Warfarin|warfarin|mesh-list
44362839|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44954526|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44364146|NCT01157572|Metoprolol|metoprolol|mesh-list
44707108|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364618|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
44365231|NCT01164176|Everolimus|everolimus|mesh-list
44954527|NCT05203744|Tafenoquine|tafenoquine|mesh-list
43547492|NCT03651934|Iron|iron|mesh-list
44707109|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707110|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44104512|NCT00069888|Docetaxel|docetaxel|mesh-list
44104579|NCT00070057|Celecoxib|celecoxib|mesh-list
44707111|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
44707112|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371773|NCT01203618|Farletuzumab|farletuzumab|mesh-list
44707113|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44707114|NCT01432028|Progestins|progestins|mesh-ancestor
44954528|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
44373073|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954529|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44707115|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44707116|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
44373849|NCT00980954|Paclitaxel|paclitaxel|mesh-list
44954530|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44707117|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44707118|NCT01432028|Diuretics|diuretics|mesh-ancestor
44105726|NCT00073593|Heparin|heparin|mesh-list
44375490|NCT04216316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375496|NCT04199117|Nicotine|nicotine|mesh-list
44375773|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
44375774|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375775|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375776|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375777|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
44375778|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375779|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375800|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375801|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376330|NCT01446016|Taxane|taxane|mesh-list
44707119|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
44707120|NCT01432080|Azithromycin|azithromycin|mesh-list
44707121|NCT01432080|Prednisone|prednisone|mesh-list
44707122|NCT01432080|Budesonide|budesonide|mesh-list
44707123|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
44707124|NCT01432080|Montelukast|montelukast|mesh-list
44236437|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954531|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707125|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44936206|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44936207|NCT03709381|Cosyntropin|cosyntropin|mesh-list
44936208|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
44936209|NCT03709381|Hormones|hormones|mesh-ancestor
44936210|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954532|NCT05203588|Vitamin D|vitamin d|mesh-list
44936211|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106998|NCT00077779|Adalimumab|adalimumab|mesh-list
44954533|NCT05203588|Denosumab|denosumab|mesh-list
44954534|NCT05203588|Calcium|calcium|mesh-list
44936212|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385162|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
44385598|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385600|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
44954535|NCT05203588|Vitamins|vitamins|mesh-ancestor
44387090|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
44387091|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954536|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
44236442|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107819|NCT00080275|Niacin|niacin|mesh-list
44936213|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936214|NCT03709160|Bumetanide|bumetanide|mesh-list
44936215|NCT03709160|Diuretics|diuretics|mesh-ancestor
44936216|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
44936217|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936218|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44936219|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44108263|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44393094|NCT03074162|Analgesics|analgesics|mesh-ancestor
44936220|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936221|NCT03709147|Metformin|metformin|mesh-list
44936222|NCT03709147|Cisplatin|cisplatin|mesh-list
44936223|NCT03709147|Carboplatin|carboplatin|mesh-list
44393832|NCT03038620|Liraglutide|liraglutide|mesh-list
44936224|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
44936225|NCT03709147|Pemetrexed|pemetrexed|mesh-list
44936226|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936227|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44936228|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395060|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
44395674|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395676|NCT02964247|Incretins|incretins|mesh-ancestor
44108905|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396451|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396452|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396453|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
44396454|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44396455|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396456|NCT02937571|Growth Substances|growth substances|mesh-ancestor
44396661|NCT02928029|Dexamethasone|dexamethasone|mesh-list
44396839|NCT02923921|Antidotes|antidotes|mesh-ancestor
44397346|NCT02900092|Ganaxolone|ganaxolone|mesh-list
44398036|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936229|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109244|NCT05327530|Avelumab|avelumab|mesh-list
44400021|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44936230|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936231|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109395|NCT04605081|Bupropion|bupropion|mesh-list
44402053|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
44936232|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44402928|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403670|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109720|NCT03784014|Lapatinib|lapatinib|mesh-list
44936233|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44936234|NCT03709082|Trastuzumab|trastuzumab|mesh-list
44109963|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
44936235|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43831290|NCT05317806|Metformin|metformin|mesh-list
44936236|NCT03709082|Letrozole|letrozole|mesh-list
44110412|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
44409084|NCT02501161|Xultophy|xultophy|mesh-list
44936237|NCT03709082|Palbociclib|palbociclib|mesh-list
44936238|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936239|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068702|NCT00000553|Niacin|niacin|mesh-list
44411084|NCT02455050|Laxatives|laxatives|mesh-ancestor
44936240|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44936241|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44936242|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936243|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936244|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44111326|NCT00087802|Paclitaxel|paclitaxel|mesh-list
44936245|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
44954537|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954538|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44954539|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44954540|NCT05203354|Acitretin|acitretin|mesh-list
44954541|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
44954542|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413713|NCT02393209|Docetaxel|docetaxel|mesh-list
44954543|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44954544|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
44954545|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
44954546|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414025|NCT02385799|Sertraline|sertraline|mesh-list
44414154|NCT02380742|Lidocaine|lidocaine|mesh-list
44954547|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
44954548|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954549|NCT05202821|Fluorides|fluorides|mesh-list
44954550|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
44414574|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414610|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
44954551|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
44954552|NCT05202821|Protective Agents|protective agents|mesh-ancestor
44954553|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954554|NCT05198388|Endorphins|endorphins|mesh-list
44112711|NCT00093301|Protective Agents|protective agents|mesh-ancestor
44954555|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112863|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153924|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954556|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415752|NCT02341625|Nivolumab|nivolumab|mesh-list
44936246|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936247|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415917|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415941|NCT02337946|Vitamins|vitamins|mesh-ancestor
44416275|NCT02325739|Spartalizumab|spartalizumab|mesh-list
44416596|NCT02317627|Belumosudil|belumosudil|mesh-list
44936248|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936249|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416984|NCT02305797|Lorazepam|lorazepam|mesh-list
44417080|NCT02302859|Nicotine|nicotine|mesh-list
44417329|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936250|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417547|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44936251|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44936252|NCT03709056|Propofol|propofol|mesh-list
44114428|NCT00099320|Exenatide|exenatide|mesh-list
44418037|NCT02283658|Letrozole|letrozole|mesh-list
44114473|NCT00099554|Etanercept|etanercept|mesh-list
44418129|NCT02280473|Laxatives|laxatives|mesh-ancestor
44936253|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44936254|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936255|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114666|NCT00100100|Modafinil|modafinil|mesh-list
44418495|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418610|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
44114875|NCT00100750|Antiviral Agents|antiviral agents|mesh-ancestor
44936256|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44936257|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
44936258|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
44936259|NCT03708926|Abaloparatide|abaloparatide|mesh-list
44936260|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44936261|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419165|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419166|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
44419167|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419168|NCT02257567|Rituximab|rituximab|mesh-list
44419169|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
44419170|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44419171|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44419253|NCT02256969|Protective Agents|protective agents|mesh-ancestor
44936262|NCT03708861|Ritonavir|ritonavir|mesh-list
44936263|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44936264|NCT03708861|Maraviroc|maraviroc|mesh-list
44936265|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44115352|NCT00102310|Z 338|z 338|mesh-list
44419603|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419604|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
44077351|NCT00015080|Naltrexone|naltrexone|mesh-list
44419605|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44419606|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419607|NCT05648318|Lactulose|lactulose|mesh-list
44419608|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419609|NCT05648266|Analgesics|analgesics|mesh-list
44419610|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
44419611|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419612|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419613|NCT05648071|Pemetrexed|pemetrexed|mesh-list
44419614|NCT05648071|Nedaplatin|nedaplatin|mesh-list
44419615|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936266|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44419805|NCT05646459|Cannabidiol|cannabidiol|mesh-list
44419895|NCT05642182|Vitamin D|vitamin d|mesh-list
44936267|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420565|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44420566|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420567|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
44236462|NCT00559455|Antidotes|antidotes|mesh-ancestor
44420714|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420750|NCT05031494|Paclitaxel|paclitaxel|mesh-list
44936268|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420866|NCT04928703|Ketamine|ketamine|mesh-list
44158157|NCT00236301|Hormones|hormones|mesh-ancestor
44954557|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954558|NCT05180032|Denosumab|denosumab|mesh-list
44954559|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44236465|NCT00559455|Vitamins|vitamins|mesh-ancestor
44236466|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
44954560|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954561|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44116717|NCT00107848|Modafinil|modafinil|mesh-list
44421969|NCT04001647|Vitamins|vitamins|mesh-ancestor
44422099|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44236469|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
44954562|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44954563|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44117048|NCT00109109|Vorinostat|vorinostat|mesh-list
44422466|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
44422468|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117116|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422584|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422585|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422604|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117191|NCT00109603|Tenofovir|tenofovir|mesh-list
44422770|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117267|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
44117343|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
44423102|NCT02456974|Amikacin|amikacin|mesh-list
44423104|NCT02456974|Teicoplanin|teicoplanin|mesh-list
44423292|NCT01747447|Vitamins|vitamins|mesh-list
44423457|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44423458|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
44423459|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423460|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
44423461|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44423462|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423522|NCT00119366|Iodine|iodine|mesh-list
44423523|NCT00119366|Cyclosporine|cyclosporine|mesh-list
44423524|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
44423525|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44423526|NCT00119366|Fludarabine|fludarabine|mesh-list
44423527|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
44423528|NCT00119366|Antibodies|antibodies|mesh-list
44423529|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
44423530|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44423531|NCT00119366|Cyclosporins|cyclosporins|mesh-list
44423532|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
44423533|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423534|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423535|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44423536|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
44423537|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423538|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423539|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423540|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
44423541|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423542|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44936269|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423634|NCT05651750|Xhance|xhance|mesh-list
44423761|NCT05639712|Morphine|morphine|mesh-list
44117883|NCT00111904|Paclitaxel|paclitaxel|mesh-list
44423966|NCT05197426|Azacitidine|azacitidine|mesh-list
44118029|NCT00112528|Gemcitabine|gemcitabine|mesh-list
44118107|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
44424345|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
44424346|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936270|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44424519|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
44936271|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44936272|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
44936273|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936274|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44236473|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425009|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936275|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44936276|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44425234|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44936277|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44936278|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44936279|NCT03708848|Metronidazole|metronidazole|mesh-list
44733712|NCT05065866|Cc-486|cc-486|mesh-list
44936281|NCT03708848|Levofloxacin|levofloxacin|mesh-list
44936282|NCT03708848|Ofloxacin|ofloxacin|mesh-list
44936283|NCT03708848|Tetracycline|tetracycline|mesh-list
44936284|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
44426304|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44936285|NCT03708848|Esomeprazole|esomeprazole|mesh-list
44936286|NCT03708848|Bismuth|bismuth|mesh-list
44119264|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44707331|NCT01433614|Paclitaxel|paclitaxel|mesh-list
44707406|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707488|NCT01434173|Cefuroxime|cefuroxime|mesh-list
44707630|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
44936287|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936288|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936289|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44936290|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44936291|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44936292|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44936293|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936294|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44936295|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936296|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44707855|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44936297|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44936298|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44936299|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44936300|NCT03708848|Renal Agents|renal agents|mesh-ancestor
44708366|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44708441|NCT04922567|Vincristine|vincristine|mesh-list
44708516|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44936301|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44708818|NCT03495960|Procarbazine|procarbazine|mesh-list
44936302|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44936303|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936304|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44936305|NCT03708848|Antacids|antacids|mesh-ancestor
44936306|NCT03708848|Diuretics|diuretics|mesh-ancestor
44936307|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
44708982|NCT02572843|Durvalumab|durvalumab|mesh-list
44709043|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
44709044|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709045|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709046|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
44709047|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709048|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709049|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
44709050|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709052|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
44709053|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44709054|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709055|NCT01781468|Modafinil|modafinil|mesh-list
44709056|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44709057|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709058|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44709059|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44709060|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44709061|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709062|NCT01624142|Evolocumab|evolocumab|mesh-list
44709063|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709064|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709065|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
44709066|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709067|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709068|NCT01375764|Ezetimibe|ezetimibe|mesh-list
44709069|NCT01375764|Evolocumab|evolocumab|mesh-list
44709070|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44709271|NCT01439178|Bevacizumab|bevacizumab|mesh-list
44936308|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709570|NCT01441232|Hormones|hormones|mesh-ancestor
44936309|NCT03708848|Expectorants|expectorants|mesh-ancestor
44709647|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
44936310|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
44936311|NCT03708822|Cisplatin|cisplatin|mesh-list
44936312|NCT03708822|Docetaxel|docetaxel|mesh-list
44936313|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
44936314|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709976|NCT01443195|Iron|iron|mesh-list
44936315|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
44936316|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
44936317|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
44710179|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
44710243|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936318|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710554|NCT01446731|Docetaxel|docetaxel|mesh-list
44710633|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
44936319|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936320|NCT03708718|Prednisolone|prednisolone|mesh-list
44936321|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936322|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
44936323|NCT03708718|Hormones|hormones|mesh-ancestor
44711307|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711380|NCT01460537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711687|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44711838|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
44711999|NCT01467596|Lidocaine|lidocaine|mesh-list
44712067|NCT01468038|Trazodone|trazodone|mesh-list
44712213|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44712285|NCT01469520|Lamivudine|lamivudine|mesh-list
44712361|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712583|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712659|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712733|NCT01472016|Docetaxel|docetaxel|mesh-list
44712958|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44713036|NCT01474460|Vitamin K|vitamin k|mesh-list
44713188|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44713265|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
44936324|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44936325|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936326|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44713861|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
44713937|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714004|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936327|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714153|NCT01481259|Pemetrexed|pemetrexed|mesh-list
44714224|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
44936328|NCT03708536|Bevacizumab|bevacizumab|mesh-list
44714324|NCT01482156|Dactolisib|dactolisib|mesh-list
44714380|NCT01482559|Dopamine|dopamine|mesh-list
44714454|NCT01483248|Interferons|interferons|mesh-list
44714525|NCT01484171|Idarubicin|idarubicin|mesh-list
44936329|NCT03708536|Capecitabine|capecitabine|mesh-list
44714600|NCT01484990|Levodopa|levodopa|mesh-list
44936330|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44714685|NCT01485315|Mannitol|mannitol|mesh-list
44936331|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714746|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44714906|NCT01486433|Aspirin|aspirin|mesh-list
44936332|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44715047|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
44715123|NCT01487512|Hydromorphone|hydromorphone|mesh-list
44715450|NCT01489410|Ethanol|ethanol|mesh-list
44936333|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44936334|NCT03708536|Growth Substances|growth substances|mesh-ancestor
44715728|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715881|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715954|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44716108|NCT01492972|Hormones|hormones|mesh-ancestor
44716265|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
44716402|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716476|NCT01495104|Valproic Acid|valproic acid|mesh-list
44716554|NCT01495338|Cetirizine|cetirizine|mesh-list
44716627|NCT01495806|Cathartics|cathartics|mesh-ancestor
44936335|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936336|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716846|NCT01497093|Hormones|hormones|mesh-ancestor
44936337|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44936338|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
44717071|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
44717373|NCT01500577|Nimesulide|nimesulide|mesh-list
44717450|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
44936339|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717605|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
44936340|NCT03708497|Misoprostol|misoprostol|mesh-list
44936341|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
44936342|NCT03708497|Carbetocin|carbetocin|mesh-list
44936343|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44936344|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44718197|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
44718352|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936345|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936346|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
44718519|NCT01505218|Propofol|propofol|mesh-list
44718799|NCT01506505|Analgesics|analgesics|mesh-ancestor
44718957|NCT01507077|CKD732|ckd732|mesh-list
44719100|NCT01507597|Incretins|incretins|mesh-ancestor
44719309|NCT01508611|Fluorides|fluorides|mesh-list
44936347|NCT03708497|Coagulants|coagulants|mesh-ancestor
44719508|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719582|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719658|NCT01510977|Bisacodyl|bisacodyl|mesh-list
44719737|NCT01511198|Incretins|incretins|mesh-ancestor
44719810|NCT01511367|Fluticasone|fluticasone|mesh-list
44719885|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
44719960|NCT01511822|Diuretics|diuretics|mesh-ancestor
44720034|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720035|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44720036|NCT01512173|Propranolol|propranolol|mesh-list
44720037|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44720038|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44720039|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720040|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720041|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720107|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720180|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
44936348|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44936349|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
44720570|NCT01515228|Paclitaxel|paclitaxel|mesh-list
44720639|NCT01515813|Tenofovir|tenofovir|mesh-list
44936350|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936351|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936352|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44936353|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721314|NCT01519102|Hormones|hormones|mesh-list
44936354|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
44936355|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
44936356|NCT03708458|Indomethacin|indomethacin|mesh-list
44721617|NCT01520896|Naloxegol|naloxegol|mesh-list
44936357|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44721762|NCT01522040|Analgesics|analgesics|mesh-ancestor
44936358|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
44936359|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721910|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
44936361|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
44936362|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44722287|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
44936363|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
44722510|NCT01526005|Nicotine|nicotine|mesh-list
44722659|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722735|NCT01526694|Growth Substances|growth substances|mesh-ancestor
44722883|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722956|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723184|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
44723260|NCT01529229|Prednisolone|prednisolone|mesh-list
44723335|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
44723410|NCT01530022|Lacosamide|lacosamide|mesh-list
44936364|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723712|NCT01531595|Bevacizumab|bevacizumab|mesh-list
44723859|NCT01532544|Eptifibatide|eptifibatide|mesh-list
44723937|NCT01533090|Bisacodyl|bisacodyl|mesh-list
44936365|NCT03708458|Protective Agents|protective agents|mesh-ancestor
44936366|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936367|NCT03708458|Antidotes|antidotes|mesh-ancestor
44724237|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
44724386|NCT01535547|Isavuconazole|isavuconazole|mesh-list
44724461|NCT01536028|Insulin|insulin|mesh-list
44936368|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724605|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
44936369|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44936370|NCT03708458|Analgesics|analgesics|mesh-ancestor
44936371|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
44936372|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936373|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936374|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936375|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
44936376|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
44936377|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44725205|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44936378|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44725351|NCT01540812|Dexamethasone|dexamethasone|mesh-list
44936379|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936380|NCT03708341|Melatonin|melatonin|mesh-list
44936381|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
44936382|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936383|NCT03708341|Protective Agents|protective agents|mesh-ancestor
44725655|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
44725723|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
44936384|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725798|NCT01543386|Curcumin|curcumin|mesh-list
44725870|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936385|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44936386|NCT03708146|Zamicastat|zamicastat|mesh-list
44936387|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726351|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
44726503|NCT01548118|Vaccines|vaccines|mesh-list
44936388|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936389|NCT03708133|Nifurtimox|nifurtimox|mesh-list
44726953|NCT01550770|Propofol|propofol|mesh-list
44936390|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44936391|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44936392|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44936393|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44936394|NCT03708120|Insect Repellents|insect repellents|mesh-list
44936395|NCT03708120|Protective Agents|protective agents|mesh-ancestor
44727479|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
44727552|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
44727701|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727778|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44727859|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
44936396|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936397|NCT03707899|Amlodipine|amlodipine|mesh-list
44936398|NCT03707899|Telmisartan|telmisartan|mesh-list
44936399|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44936400|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44936401|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44936402|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44936403|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728220|NCT01559753|Cefotaxime|cefotaxime|mesh-list
44728369|NCT05561257|Ascorbic Acid|ascorbic acid|mesh-list
44728576|NCT05137080|Hormones|hormones|mesh-ancestor
44280482|NCT00728715|Budesonide|budesonide|mesh-list
44728745|NCT04227483|Prednisolone|prednisolone|mesh-list
44728818|NCT03813121|Analgesics|analgesics|mesh-ancestor
44728969|NCT03104374|Upadacitinib|upadacitinib|mesh-list
44936404|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729191|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729273|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
44936405|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44936406|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936407|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
44936408|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44936409|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44936410|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
44936411|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44936412|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44936413|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936414|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44936415|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44936416|NCT03707847|Etoposide|etoposide|mesh-list
44936417|NCT03707847|Crizotinib|crizotinib|mesh-list
44936418|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44729482|NCT01571050|Antacids|antacids|mesh-ancestor
44936419|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936420|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44729708|NCT01572181|Busulfan|busulfan|mesh-list
44729772|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936421|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44729923|NCT01573377|Metformin|metformin|mesh-list
44936422|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44936423|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936424|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936425|NCT03707808|Nivolumab|nivolumab|mesh-list
44936426|NCT03707808|Ipilimumab|ipilimumab|mesh-list
44936427|NCT03707808|Avelumab|avelumab|mesh-list
44730514|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44730587|NCT01578304|Fesoterodine|fesoterodine|mesh-list
44730664|NCT01578473|Androgens|androgens|mesh-ancestor
44936428|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44730814|NCT01579227|Protective Agents|protective agents|mesh-ancestor
44936429|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936430|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44733808|NCT04969250|Vaccines|vaccines|mesh-list
44731183|NCT01590199|Hormones|hormones|mesh-ancestor
44731258|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
44936431|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936432|NCT03707795|Betamethasone|betamethasone|mesh-list
44936433|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
44731480|NCT01592032|Linezolid|linezolid|mesh-list
44936434|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44731716|NCT01593332|Rituximab|rituximab|mesh-list
44936435|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
44936436|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
44731938|NCT01594346|Vitamin E|vitamin e|mesh-list
44936437|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
44936438|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44936439|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44936440|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
44732157|NCT01595789|Hormones|hormones|mesh-ancestor
44732159|NCT01595815|Calcium|calcium|mesh-list
44732234|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
44936442|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732536|NCT01597206|Cobalt|cobalt|mesh-list
44732616|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
44936443|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732768|NCT01598337|Analgesics|analgesics|mesh-ancestor
44936444|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44936445|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732920|NCT01599078|Paclitaxel|paclitaxel|mesh-list
44733071|NCT05690282|Ibuprofen|ibuprofen|mesh-list
44733295|NCT05610072|Antidotes|antidotes|mesh-ancestor
44733443|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733444|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44733445|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44733446|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44733447|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733448|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733449|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
44733450|NCT05455697|Hormones|hormones|mesh-ancestor
44733451|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733452|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44936446|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44936447|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
44936448|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936449|NCT03707678|Albuterol|albuterol|mesh-list
44936450|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44936451|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
44936452|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44936453|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936454|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44936455|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
44936456|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
44936457|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44936458|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44936459|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44936460|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44733533|NCT05362058|Insulin|insulin|mesh-list
44733596|NCT05251376|Narcotics|narcotics|mesh-ancestor
44733746|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
44733747|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44733748|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733749|NCT05020236|Growth Substances|growth substances|mesh-ancestor
44733750|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733759|NCT04994977|Carboplatin|carboplatin|mesh-list
44733760|NCT04994977|Melphalan|melphalan|mesh-list
44733761|NCT04994977|Topotecan|topotecan|mesh-list
44733773|NCT04994808|Fludarabine|fludarabine|mesh-list
44936461|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
44936462|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733899|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
44734045|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734119|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734198|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734275|NCT04332744|Talazoparib|talazoparib|mesh-list
44734348|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
44734496|NCT03672630|Rifampin|rifampin|mesh-list
44734648|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
44734796|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44734797|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44734798|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44734799|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
44734800|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44734801|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44734802|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734803|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
44734804|NCT05705336|Coagulants|coagulants|mesh-ancestor
44734805|NCT05705258|Aflibercept|aflibercept|mesh-list
44734806|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44734807|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44734808|NCT05705258|Growth Substances|growth substances|mesh-ancestor
44734809|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734871|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44936463|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936464|NCT03707652|Vitamins|vitamins|mesh-list
44936465|NCT03707652|Niacinamide|niacinamide|mesh-list
44936466|NCT03707652|Niacin|niacin|mesh-list
44936467|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
44936468|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
44936469|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
44936470|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44936471|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44936472|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
44936473|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936474|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44936475|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
44936476|NCT03707639|Apatinib|apatinib|mesh-list
44936477|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44936478|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44936479|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735099|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44735172|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735173|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735174|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44735175|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44468682|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
44468828|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468903|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
44468981|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
44469131|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44469132|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44469133|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
44735193|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735194|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735203|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
44735204|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
44735205|NCT05622318|Tacrolimus|tacrolimus|mesh-list
44735206|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735207|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
44469261|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
44469408|NCT01421342|Aripiprazole|aripiprazole|mesh-list
44936480|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733892|NCT04844528|Niacin|niacin|mesh-list
44469701|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
44469702|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469703|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469704|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469705|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
44469707|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735245|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735246|NCT05601440|Antiviral Agents|antiviral agents|mesh-ancestor
44735247|NCT05601440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735258|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
44469806|NCT01415401|Timolol|timolol|mesh-list
44469868|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
44936482|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469949|NCT01412957|Panitumumab|panitumumab|mesh-list
44936483|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44936484|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44936485|NCT03707509|Gemcitabine|gemcitabine|mesh-list
44936486|NCT03707509|Cisplatin|cisplatin|mesh-list
44936487|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470835|NCT01397461|Retapamulin|retapamulin|mesh-list
44470910|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
44470911|NCT01396395|Nicorandil|nicorandil|mesh-list
44470912|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470916|NCT01396395|Vitamins|vitamins|mesh-ancestor
44936488|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44936489|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
44936490|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44936491|NCT03707509|Antiviral Agents|antiviral agents|mesh-ancestor
44707126|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707127|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
44707128|NCT01432080|Hormones|hormones|mesh-ancestor
44707129|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44735324|NCT05505630|Midazolam|midazolam|mesh-list
44735325|NCT05505630|Ketamine|ketamine|mesh-list
44735326|NCT05505630|Analgesics|analgesics|mesh-ancestor
44735327|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
44735328|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735329|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735330|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44471075|NCT01395524|Naloxegol|naloxegol|mesh-list
44707130|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471295|NCT01392560|Empagliflozin|empagliflozin|mesh-list
44471367|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44707131|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471518|NCT01390402|Busulfan|busulfan|mesh-list
44471596|NCT01389323|Interferons|interferons|mesh-list
44707132|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707133|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44707134|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
44707135|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707136|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44707137|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
44707138|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44707139|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707140|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44707141|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44707142|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44707143|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707144|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472158|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735376|NCT05458232|Tadalafil|tadalafil|mesh-list
44472428|NCT05368857|Afamelanotide|afamelanotide|mesh-list
44472503|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472504|NCT05632549|Biotin|biotin|mesh-list
44472505|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
44472506|NCT05632549|Vitamins|vitamins|mesh-ancestor
44472507|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
44472508|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735403|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735411|NCT05403086|Ketamine|ketamine|mesh-list
44735412|NCT05403086|Psilocybin|psilocybin|mesh-list
44472554|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
44707145|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707146|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44472775|NCT05633667|Cisplatin|cisplatin|mesh-list
44472776|NCT05633667|Carboplatin|carboplatin|mesh-list
44472777|NCT05633667|Pemetrexed|pemetrexed|mesh-list
44472778|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472779|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472780|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472781|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472782|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472783|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472784|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472785|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44472786|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44472787|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44472788|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44472789|NCT00214916|Insulin|insulin|mesh-list
44472790|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44472791|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44472792|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472793|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44472794|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707147|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44473065|NCT00215137|Citalopram|citalopram|mesh-list
44707148|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44473201|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
44473274|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44473349|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44473350|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
44473351|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44473352|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44473353|NCT03591731|Nivolumab|nivolumab|mesh-list
44473354|NCT03591731|Ipilimumab|ipilimumab|mesh-list
44473355|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473356|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473357|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44473358|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735472|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
44735473|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735474|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44735475|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735476|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735477|NCT05379595|Antidotes|antidotes|mesh-ancestor
44735478|NCT05379595|Protective Agents|protective agents|mesh-ancestor
44735479|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
44735480|NCT05379595|Vitamins|vitamins|mesh-ancestor
44735481|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
44707149|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44707150|NCT01432106|Valsartan|valsartan|mesh-list
44707151|NCT01432106|Ramipril|ramipril|mesh-list
44707152|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707153|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44707154|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44707155|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707156|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44707157|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44707158|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707159|NCT01432119|Cetuximab|cetuximab|mesh-list
44735530|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44735531|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735532|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735533|NCT05298423|Paclitaxel|paclitaxel|mesh-list
44735534|NCT05298423|Etoposide|etoposide|mesh-list
44735535|NCT05298423|Cisplatin|cisplatin|mesh-list
44473795|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44473796|NCT03596281|Growth Substances|growth substances|mesh-ancestor
44473797|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473798|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44473799|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44473804|NCT03596099|Acetic Acid|acetic acid|mesh-list
44473901|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
44707160|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44473976|NCT03594396|Durvalumab|durvalumab|mesh-list
44474054|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
44735658|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
44474350|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
44474423|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
44735730|NCT05030506|Lenvatinib|lenvatinib|mesh-list
44474531|NCT04198129|Clindamycin|clindamycin|mesh-list
44474606|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735737|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44735738|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
44735739|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474607|NCT04196855|Teriparatide|teriparatide|mesh-list
44474608|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44474609|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474610|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44474611|NCT04196829|Fluorides|fluorides|mesh-list
44474670|NCT04196608|Tazobactam|tazobactam|mesh-list
44474744|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474745|NCT04195321|Protective Agents|protective agents|mesh-ancestor
44474746|NCT04195074|Tenofovir|tenofovir|mesh-list
44474747|NCT04195074|Entecavir|entecavir|mesh-list
44474748|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
44474749|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474750|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44474752|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735761|NCT05007106|Gemcitabine|gemcitabine|mesh-list
44735762|NCT05007106|Docetaxel|docetaxel|mesh-list
44735763|NCT05007106|Bevacizumab|bevacizumab|mesh-list
44735764|NCT05007106|Carboplatin|carboplatin|mesh-list
44735765|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
44756116|NCT01705392|Bevacizumab|bevacizumab|mesh-list
44756117|NCT01705392|Dacarbazine|dacarbazine|mesh-list
44756118|NCT01705392|Propranolol|propranolol|mesh-list
44756119|NCT01705392|Enalapril|enalapril|mesh-list
44756120|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44756121|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756122|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756123|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756124|NCT01705392|Growth Substances|growth substances|mesh-ancestor
44756125|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756126|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
44756127|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44756128|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44756129|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756130|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756131|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756132|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44756133|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44756134|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44236698|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44756135|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44756136|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
44756137|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44756138|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
44756139|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756140|NCT01705457|Vitamin A|vitamin a|mesh-list
44756141|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
44756142|NCT01705457|Vitamins|vitamins|mesh-ancestor
44756143|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
44756144|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756145|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
44533669|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
44533670|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
44533671|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44533672|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533673|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533674|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44533675|NCT01601509|Tramazoline|tramazoline|mesh-list
44756146|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756147|NCT01705457|Protective Agents|protective agents|mesh-ancestor
44756148|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44236719|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
44756149|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756150|NCT01705470|Furosemide|furosemide|mesh-list
44756151|NCT01705470|Diuretics|diuretics|mesh-ancestor
44756152|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
44756153|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756154|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44756155|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756156|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756157|NCT01705483|Paclitaxel|paclitaxel|mesh-list
44756158|NCT01705483|Docetaxel|docetaxel|mesh-list
44756159|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44756160|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756161|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
44756162|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44756163|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
43895687|NCT03363503|Xhance|xhance|mesh-list
44756164|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689267|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
44756165|NCT01705639|Melatonin|melatonin|mesh-list
44756166|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
44756167|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756168|NCT01705639|Protective Agents|protective agents|mesh-ancestor
44756169|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756170|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756171|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
44756172|NCT01705743|Sevoflurane|sevoflurane|mesh-list
44756173|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44756174|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44756175|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
44756176|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
44756177|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756178|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756179|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756180|NCT01705743|Analgesics|analgesics|mesh-ancestor
44756181|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
44756182|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756183|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44756184|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756185|NCT01705769|Micronutrients|micronutrients|mesh-list
44756186|NCT01705769|Trace Elements|trace elements|mesh-list
44756187|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756188|NCT01705795|Antibodies|antibodies|mesh-list
44756189|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
44756190|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236761|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756191|NCT01705808|Protein C|protein c|mesh-list
44756192|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
44756193|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44756194|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756195|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756196|NCT01705938|Dolcanatide|dolcanatide|mesh-list
44756197|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44756198|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
44756199|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756200|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44756201|NCT01705951|Nicotine|nicotine|mesh-list
44756202|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44756203|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
44756204|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756205|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756206|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44756207|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44756208|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
44756209|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756210|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756211|NCT01706055|Interferons|interferons|mesh-list
44756212|NCT01706055|Interferon-beta|interferon-beta|mesh-list
44756213|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
44756214|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756215|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
44756216|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756217|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
44756218|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756219|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44756220|NCT01706120|Paclitaxel|paclitaxel|mesh-list
44756221|NCT01706120|Bevacizumab|bevacizumab|mesh-list
44756222|NCT01706120|Carboplatin|carboplatin|mesh-list
44756223|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44756224|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756225|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44756226|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44756227|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44756228|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756229|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896447|NCT04697693|Citalopram|citalopram|mesh-list
44756230|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756231|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756232|NCT01706120|Growth Substances|growth substances|mesh-ancestor
44756233|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756234|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
44756235|NCT01706172|Lidocaine|lidocaine|mesh-list
44756236|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
44756237|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
44756238|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756239|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756240|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
44756241|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756242|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44756243|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44756244|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44236816|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
44756245|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756246|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756247|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
44756248|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756249|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756250|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44756251|NCT01706354|Anesthetics|anesthetics|mesh-list
44756252|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
44756253|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756254|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756255|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
44756256|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756257|NCT01706367|Vaccines|vaccines|mesh-list
44756258|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
44756259|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756260|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
44756261|NCT01706471|Everolimus|everolimus|mesh-list
44756262|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756263|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44756264|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
44756265|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756266|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44756267|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44756268|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
44756269|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44756270|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756271|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756272|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756273|NCT01706510|Clopidogrel|clopidogrel|mesh-list
44756274|NCT01706510|Ticagrelor|ticagrelor|mesh-list
44756275|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236837|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
44756276|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44756277|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44756278|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44756279|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
44756280|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236845|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
44756281|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756282|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756283|NCT01706562|Itraconazole|itraconazole|mesh-list
44756284|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
44756285|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756286|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44756287|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756288|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756289|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236852|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
44756290|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44756291|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
44756292|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756293|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756294|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44756295|NCT01706627|Melatonin|melatonin|mesh-list
44756296|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
44756297|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756298|NCT01706627|Protective Agents|protective agents|mesh-ancestor
44236862|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
44756299|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756300|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756301|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
44756302|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44756303|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756304|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44756305|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44756306|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756307|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756308|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756309|NCT01706874|Listerine|listerine|mesh-list
44756310|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44756311|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533834|NCT01602523|Budesonide|budesonide|mesh-list
44756313|NCT01706887|Diuretics|diuretics|mesh-ancestor
44756314|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
44756315|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756316|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44756317|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44756318|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236878|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
44756319|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756320|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44756321|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44756322|NCT01707082|Midazolam|midazolam|mesh-list
44756323|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44756324|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44756325|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898003|NCT00005669|Metformin|metformin|mesh-list
44756326|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756327|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44756328|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44756329|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44756330|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44756331|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
44756332|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
44756333|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
44756334|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
44756335|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756336|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756337|NCT01707134|Insulin|insulin|mesh-list
44756338|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44756339|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
44756340|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
44756341|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
44756342|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
44756343|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756344|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756345|NCT01707160|Insulin|insulin|mesh-list
44756346|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44756347|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
44756348|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
44756349|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44756350|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756351|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756352|NCT01707199|Artesunate|artesunate|mesh-list
44756353|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
44756354|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
44756355|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44756356|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
44756357|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44756358|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44756359|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756360|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756361|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
44756362|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
44756363|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44756364|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
44756365|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44756366|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756367|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756368|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44756369|NCT01707199|Renal Agents|renal agents|mesh-ancestor
44756370|NCT01707251|Ibuprofen|ibuprofen|mesh-list
44756371|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756372|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756373|NCT01707251|Analgesics|analgesics|mesh-ancestor
44533900|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44533901|NCT01602861|Diuretics|diuretics|mesh-ancestor
44533902|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
44533903|NCT01602900|Rolipram|rolipram|mesh-list
44533904|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533905|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533906|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44533907|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44533908|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533909|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236939|NCT00561899|Piperaquine|piperaquine|mesh-list
44533910|NCT01602913|Paroxetine|paroxetine|mesh-list
44533911|NCT01602913|Pravastatin|pravastatin|mesh-list
44533912|NCT01602913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44533916|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756374|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
44756375|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756376|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756377|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756378|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756379|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44756380|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756381|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756382|NCT01707316|Canagliflozin|canagliflozin|mesh-list
44756383|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44236956|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44756384|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756385|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756386|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756387|NCT01707342|Simeprevir|simeprevir|mesh-list
44236965|NCT00562068|Prednisolone|prednisolone|mesh-list
44756388|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
44756389|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756390|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
44756391|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756392|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756393|NCT01707394|Apixaban|apixaban|mesh-list
44756394|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44756395|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
44756396|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44756397|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44756398|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756399|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756400|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
44756401|NCT01707407|Ketoconazole|ketoconazole|mesh-list
44756402|NCT01707407|Pomalidomide|pomalidomide|mesh-list
44756403|NCT01707407|Carbamazepine|carbamazepine|mesh-list
44756404|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
44756405|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
44135442|NCT00161421|Androgens|androgens|mesh-ancestor
44756406|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756407|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756408|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756409|NCT01707407|Growth Substances|growth substances|mesh-ancestor
44756410|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899619|NCT02957019|Rituximab|rituximab|mesh-list
44756411|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756412|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
44756413|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756414|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44236987|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44756415|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756416|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756417|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756418|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44756419|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
44756420|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756421|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44756422|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
44756423|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
44756424|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44756425|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756426|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44756427|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756428|NCT01707407|Analgesics|analgesics|mesh-ancestor
44756429|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
44756430|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756431|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44236994|NCT00562133|Insulin|insulin|mesh-list
44756432|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756433|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44756434|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44756435|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44756436|NCT01707407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44756437|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44756438|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756439|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
44756440|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44756441|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
44756442|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44756443|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44756444|NCT01707537|Vaccines|vaccines|mesh-list
44756445|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
44756446|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756447|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
44756448|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
44237026|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756449|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756450|NCT01707615|Protective Agents|protective agents|mesh-ancestor
44756451|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237033|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756452|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44756453|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44756454|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756455|NCT01707732|Enoxaparin|enoxaparin|mesh-list
44756456|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
44756457|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44756458|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756459|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756460|NCT01707745|Bevacizumab|bevacizumab|mesh-list
44756461|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44756462|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756463|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756464|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756465|NCT01707745|Growth Substances|growth substances|mesh-ancestor
44756466|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756467|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
44756468|NCT01707823|Aspirin|aspirin|mesh-list
44756469|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756470|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756471|NCT01707823|Analgesics|analgesics|mesh-ancestor
44756472|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
44756473|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756474|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756475|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756476|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756477|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43900385|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
44756478|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756479|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756480|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44756481|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44756482|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756483|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
44756484|NCT01707849|Everolimus|everolimus|mesh-list
44237058|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756485|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756486|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44756487|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
44756488|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756489|NCT01707940|Ketoconazole|ketoconazole|mesh-list
44756490|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
44756491|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756492|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44756493|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756494|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756495|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756496|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44756497|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
44756498|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756499|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756500|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44756501|NCT01707953|Midodrine|midodrine|mesh-list
44689268|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44689269|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689270|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689271|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
44689272|NCT01348412|Raltitrexed|raltitrexed|mesh-list
44689273|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689274|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689275|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
44689276|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689291|NCT01348724|Naloxegol|naloxegol|mesh-list
44689292|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44689293|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689294|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
44689295|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689296|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44689297|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689298|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44689299|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44534017|NCT01603251|Ivermectin|ivermectin|mesh-list
44756503|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
44756504|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756505|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756506|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44756507|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44756508|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44756509|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44458889|NCT01588990|Vitamins|vitamins|mesh-ancestor
44458890|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
44756510|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756511|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756512|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756513|NCT01708005|Vitamin D|vitamin d|mesh-list
44756514|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
44756515|NCT01708005|Vitamins|vitamins|mesh-ancestor
44756516|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
43874862|NCT04731766|Listerine|listerine|mesh-list
44756517|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756518|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44756519|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44756520|NCT01708044|Pramlintide|pramlintide|mesh-list
44756521|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756522|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756523|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
44756524|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44756525|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756526|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756527|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
44756528|NCT01708239|Coagulants|coagulants|mesh-ancestor
44756529|NCT01708330|Lidocaine|lidocaine|mesh-list
44756530|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
44756531|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
44756532|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756533|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756534|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
44756535|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756536|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44756537|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44756538|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44458914|NCT01588184|Growth Substances|growth substances|mesh-ancestor
44756539|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756540|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756541|NCT01708369|Aspirin|aspirin|mesh-list
44756542|NCT01708369|Ethanol|ethanol|mesh-list
44756543|NCT01708369|Oseltamivir|oseltamivir|mesh-list
44756544|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756545|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756546|NCT01708369|Analgesics|analgesics|mesh-ancestor
44756547|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
44237085|NCT00562419|Irinotecan|irinotecan|mesh-list
44756548|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756549|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756550|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756551|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756552|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44756553|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756554|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756555|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44756556|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43901248|NCT00067028|Cytarabine|cytarabine|mesh-list
44756557|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756558|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
44756559|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44756560|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756561|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756562|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
44756563|NCT01708447|Lidocaine|lidocaine|mesh-list
44756564|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
44756565|NCT01708447|Anesthetics|anesthetics|mesh-list
44756566|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756567|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756568|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
44756569|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756570|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44756571|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44756572|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44756573|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237103|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44534073|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44756574|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756576|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44756577|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
44756578|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756579|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901438|NCT00073073|Antacids|antacids|mesh-ancestor
44756580|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756581|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44756582|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44756583|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756584|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44756585|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44756586|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
44756587|NCT01708642|Epinephrine|epinephrine|mesh-list
44756588|NCT01708642|Racepinephrine|racepinephrine|mesh-list
44756589|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
44756590|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44756591|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44756592|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756593|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756594|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756595|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756596|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44756597|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44756598|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
44756599|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756600|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44756601|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44756602|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
44756603|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
44756604|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44756605|NCT01708707|Morphine|morphine|mesh-list
44756606|NCT01708707|Buprenorphine|buprenorphine|mesh-list
44756607|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44756608|NCT01708707|Narcotics|narcotics|mesh-ancestor
44756609|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756610|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756611|NCT01708707|Analgesics|analgesics|mesh-ancestor
44756612|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
44756613|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756614|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44756615|NCT01708720|Vaccines|vaccines|mesh-list
44756616|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
44756617|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756618|NCT01708798|Eplerenone|eplerenone|mesh-list
44756619|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44756620|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
44756621|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756622|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756623|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44756624|NCT01708798|Diuretics|diuretics|mesh-ancestor
44756625|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
44756626|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44756627|NCT01708837|Propofol|propofol|mesh-list
44756628|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44756629|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756630|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756631|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44756632|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
44756633|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
44756634|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
44756635|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44756636|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
44756637|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44756638|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44756639|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756640|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756641|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
44756642|NCT01708876|Artesunate|artesunate|mesh-list
44756643|NCT01708876|Chloroquine|chloroquine|mesh-list
44756644|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44756645|NCT01708876|Primaquine|primaquine|mesh-list
44756646|NCT01708876|Mefloquine|mefloquine|mesh-list
44756647|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
44756648|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44756649|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44756650|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756651|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756652|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
44756653|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
44756654|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44756655|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
44756656|NCT01708876|Amebicides|amebicides|mesh-ancestor
44756657|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756658|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756659|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756660|NCT01708876|Analgesics|analgesics|mesh-ancestor
44756661|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
44756662|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756663|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756664|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756665|NCT01708876|Filaricides|filaricides|mesh-ancestor
44756666|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
44756667|NCT01708993|Docetaxel|docetaxel|mesh-list
44756668|NCT01708993|Pemetrexed|pemetrexed|mesh-list
44756669|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756670|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44756671|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44237210|NCT00563069|Midazolam|midazolam|mesh-list
44756672|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44756673|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756674|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756675|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44756676|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44756677|NCT01709019|Vaccines|vaccines|mesh-list
44756678|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
44756679|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756680|NCT01709071|Vaccines|vaccines|mesh-list
44756681|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
44756682|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534225|NCT01605344|Antidotes|antidotes|mesh-ancestor
44534226|NCT01605344|Protective Agents|protective agents|mesh-ancestor
44534227|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
44534228|NCT01605344|Vitamins|vitamins|mesh-ancestor
44534229|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
44534230|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44534231|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44534232|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44534233|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44534234|NCT01605357|Mannitol|mannitol|mesh-list
44756683|NCT01709292|Vemurafenib|vemurafenib|mesh-list
44756684|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756685|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44756686|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756687|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756688|NCT01709370|Letrozole|letrozole|mesh-list
44756689|NCT01709370|Palbociclib|palbociclib|mesh-list
44756690|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756691|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44756692|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44756693|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756694|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237242|NCT00563160|Gemcitabine|gemcitabine|mesh-list
44756695|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44756696|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
44756697|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756698|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756699|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44756700|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
44756701|NCT01709630|Analgesics|analgesics|mesh-ancestor
44756702|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
44756703|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756704|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756705|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
44756706|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756707|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44756708|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
44756709|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44689300|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689301|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689302|NCT01348880|Urological Agents|urological agents|mesh-ancestor
44689303|NCT01348984|Fentanyl|fentanyl|mesh-list
44689304|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44689305|NCT01348984|Narcotics|narcotics|mesh-ancestor
44689306|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689307|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689308|NCT01348984|Analgesics|analgesics|mesh-ancestor
44689309|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
44689310|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689311|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44689312|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44689313|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
44689314|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
44689315|NCT01349010|Probucol|probucol|mesh-list
44689316|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44689317|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44689318|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
44689319|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689320|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44689321|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
44689322|NCT01349010|Protective Agents|protective agents|mesh-ancestor
44689323|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689324|NCT01349088|Niacinamide|niacinamide|mesh-list
44689325|NCT01349088|Capecitabine|capecitabine|mesh-list
44689326|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
44689327|NCT01349088|Imetelstat|imetelstat|mesh-list
44689328|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689329|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
44689330|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689331|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237287|NCT00563394|Ofloxacin|ofloxacin|mesh-list
44689332|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44689333|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689334|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
44689335|NCT01349088|Vitamins|vitamins|mesh-ancestor
44689336|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
44689337|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689338|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
44689339|NCT01349127|Vitamin D|vitamin d|mesh-list
44689340|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
44689341|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
44689342|NCT01349127|Vitamins|vitamins|mesh-list
44689343|NCT01349127|Calcium|calcium|mesh-list
44689344|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
44689345|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689346|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44689347|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44689348|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
44237297|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44689349|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
44756710|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756711|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756712|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44756714|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756715|NCT01709656|Celecoxib|celecoxib|mesh-list
44756716|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756717|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756718|NCT01709656|Analgesics|analgesics|mesh-ancestor
44756719|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
44756720|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756721|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756722|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756723|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756724|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44756725|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44756726|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756727|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756728|NCT01709682|Amiodarone|amiodarone|mesh-list
44756729|NCT01709682|Sotalol|sotalol|mesh-list
44756730|NCT01709682|Flecainide|flecainide|mesh-list
44756731|NCT01709682|Propafenone|propafenone|mesh-list
44756732|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44756733|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
44756734|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44756735|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44756736|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756737|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44756738|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44756739|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756740|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756741|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44756742|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44756743|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44756744|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44756745|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44756746|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756747|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756748|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237336|NCT00563485|Urological Agents|urological agents|mesh-ancestor
44756749|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
44756750|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
44756751|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756752|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44756753|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
44756754|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756755|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756756|NCT01709760|Methotrexate|methotrexate|mesh-list
44756757|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44756758|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
44756759|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756760|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756761|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44756762|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
44756763|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756764|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756765|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
44756766|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756767|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44756768|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237373|NCT00563654|Alfuzosin|alfuzosin|mesh-list
44756769|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
44756770|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756771|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44756772|NCT01709825|Sulfalene|sulfalene|mesh-list
44756773|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756774|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44756775|NCT01709825|Renal Agents|renal agents|mesh-ancestor
44756776|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
44756777|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44756778|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44756779|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
44756780|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44689350|NCT01349205|Caffeine|caffeine|mesh-list
44756781|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756783|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44756784|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
44756785|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756786|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756787|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44774281|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756788|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756789|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44756790|NCT01709955|Cathartics|cathartics|mesh-ancestor
44756791|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44756792|NCT01709994|Aspirin|aspirin|mesh-list
44756793|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756794|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756795|NCT01709994|Analgesics|analgesics|mesh-ancestor
44756796|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
44756797|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756798|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756799|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756800|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756801|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44756802|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756803|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756804|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44756805|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44756806|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756807|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
44756808|NCT01710007|Atorvastatin|atorvastatin|mesh-list
44756809|NCT01710007|Pitavastatin|pitavastatin|mesh-list
44756810|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44756811|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44756812|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
44756813|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756814|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44756815|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44756816|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756817|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
44756818|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
44756819|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774282|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
44756820|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756821|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756822|NCT01710072|Aspirin|aspirin|mesh-list
44756823|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44756824|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756825|NCT01710072|Analgesics|analgesics|mesh-ancestor
44756826|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
44756827|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756828|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756829|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756830|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44756831|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44756832|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44756833|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756834|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44756835|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44756836|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756837|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
44756838|NCT01710163|Aripiprazole|aripiprazole|mesh-list
44756839|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
44756840|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44756841|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44756842|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44756843|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458919|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
44756844|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756845|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
44756846|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
44756847|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756848|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756849|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44756850|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44756851|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
44756852|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44756853|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44756854|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44756855|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44756856|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
44756857|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756858|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
44756859|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44756860|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44756861|NCT01710228|Prednisolone|prednisolone|mesh-list
44756862|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
44756863|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44756864|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
44756865|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756866|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
44756867|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
44756868|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756869|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756870|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44756871|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
44756872|NCT01710228|Hormones|hormones|mesh-ancestor
44756873|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756874|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44756875|NCT01710228|Protective Agents|protective agents|mesh-ancestor
44756876|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44756877|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756878|NCT01710384|Betamethasone|betamethasone|mesh-list
44756879|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44756880|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
44756881|NCT01710384|Hormones|hormones|mesh-ancestor
44756882|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756883|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756884|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44756885|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44756886|NCT01710462|Domperidone|domperidone|mesh-list
44756887|NCT01710462|Pantoprazole|pantoprazole|mesh-list
44756888|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44756889|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44756890|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44756891|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756892|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756893|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
44756894|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
44756895|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756896|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756897|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44756898|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
44756899|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756900|NCT01710488|Levofloxacin|levofloxacin|mesh-list
44756901|NCT01710488|Ofloxacin|ofloxacin|mesh-list
44756902|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
44756903|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44756904|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756905|NCT01710488|Renal Agents|renal agents|mesh-ancestor
44756906|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44756907|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44756908|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44756909|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756910|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756911|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756912|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44756913|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756914|NCT01710540|Metformin|metformin|mesh-list
44756915|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756916|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756917|NCT01710553|Metformin|metformin|mesh-list
44756918|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44756919|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756920|NCT01710566|Misoprostol|misoprostol|mesh-list
44756921|NCT01710566|Oxytocin|oxytocin|mesh-list
44756922|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
43903426|NCT00130923|Risperidone|risperidone|mesh-list
44756923|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756924|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756925|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44534415|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44756926|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
44756927|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44756928|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44756929|NCT01710592|Docetaxel|docetaxel|mesh-list
44756930|NCT01710592|Capecitabine|capecitabine|mesh-list
44756931|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
44756932|NCT01710592|Epirubicin|epirubicin|mesh-list
44756933|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756934|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
44756935|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
44756936|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
44756937|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756938|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44756939|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
44756940|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44756941|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237547|NCT00564252|Finasteride|finasteride|mesh-list
44756942|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44756943|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756944|NCT01710631|Eszopiclone|eszopiclone|mesh-list
44756945|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44756946|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774283|NCT01848119|Gabapentin|gabapentin|mesh-list
44756947|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756948|NCT01710670|Ethanol|ethanol|mesh-list
44756949|NCT01710670|Brivaracetam|brivaracetam|mesh-list
44756950|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44756951|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756952|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44756953|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756954|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
44756955|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44756956|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44756957|NCT01710696|Estradiol|estradiol|mesh-list
44756958|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44756959|NCT01710696|Estrogens|estrogens|mesh-ancestor
44756960|NCT01710696|Hormones|hormones|mesh-ancestor
44756961|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756962|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756963|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44756964|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
44756965|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756966|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44756967|NCT01710722|Ephedrine|ephedrine|mesh-list
44756968|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
44756969|NCT01710722|Caffeine|caffeine|mesh-list
44756970|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44756971|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756972|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44756973|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756974|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756975|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44756976|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44756977|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
44756978|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44756979|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
44756980|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
44756981|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756982|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44756983|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
44756984|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44756985|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44756986|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44756987|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
44756988|NCT01710748|Everolimus|everolimus|mesh-list
44756989|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756990|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44756991|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
44756992|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756993|NCT01710761|Caffeine|caffeine|mesh-list
44534488|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534489|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534490|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44534491|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44534492|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534493|NCT01607762|Olanzapine|olanzapine|mesh-list
44534494|NCT01607762|Risperidone|risperidone|mesh-list
44534495|NCT01607762|Aripiprazole|aripiprazole|mesh-list
44534496|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44534497|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44534498|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44756994|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44756995|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756996|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44756997|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756998|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756999|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44774284|NCT01848119|Analgesics|analgesics|mesh-ancestor
44757000|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44757001|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
44757002|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757004|NCT01710904|Naloxone|naloxone|mesh-list
44757005|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44757006|NCT01710904|Narcotics|narcotics|mesh-ancestor
44757007|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757008|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757009|NCT01710904|Analgesics|analgesics|mesh-ancestor
44757010|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
44757011|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757012|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44757013|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44757014|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44757015|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757016|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757017|NCT01711060|Oxytocin|oxytocin|mesh-list
44757018|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
44757019|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757020|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757021|NCT01711073|Plerixafor|plerixafor|mesh-list
44757022|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44757023|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44757024|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
44689351|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44689352|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689353|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44689354|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689355|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689356|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44689357|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44689358|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
44689359|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689360|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
44689361|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689362|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44689363|NCT01349205|Protective Agents|protective agents|mesh-ancestor
44240983|NCT00585156|Celecoxib|celecoxib|mesh-list
44689364|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689365|NCT01349205|Analgesics|analgesics|mesh-ancestor
44689366|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
44689367|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689368|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
44689369|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44689370|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
44689371|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689372|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689373|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44689374|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689375|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44689376|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44237661|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689377|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44689378|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
44689379|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689380|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689381|NCT01349270|Prednisone|prednisone|mesh-list
44689382|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
44689383|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44689384|NCT01349270|Antibodies|antibodies|mesh-list
44689385|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689386|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
44689387|NCT01349270|Hormones|hormones|mesh-ancestor
44689388|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44689389|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689390|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44689391|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689392|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
44757025|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757026|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
44757027|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44757028|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
44757029|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757030|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757031|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44757032|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757033|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44757034|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44757035|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44757036|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44757037|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757038|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757039|NCT01711112|Docetaxel|docetaxel|mesh-list
44757040|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757041|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904132|NCT00170157|Ipilimumab|ipilimumab|mesh-list
44757042|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757043|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757044|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757045|NCT01711125|Baclofen|baclofen|mesh-list
44757046|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44757047|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757048|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44757049|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757050|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44757051|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
44757052|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
44757053|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757054|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757056|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44237717|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44757057|NCT01711229|Analgesics|analgesics|mesh-ancestor
44757058|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
44757059|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757060|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757061|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
44757062|NCT01711320|Omeprazole|omeprazole|mesh-list
44757063|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44757064|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757065|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44757066|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757067|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757068|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
44757069|NCT01711437|Simethicone|simethicone|mesh-list
44757070|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
44757071|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
44757072|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44757073|NCT01711437|Citric Acid|citric acid|mesh-list
44757074|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
44757075|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44757076|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
44757077|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44757078|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
44757079|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
44757080|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757081|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
44757082|NCT01711437|Protective Agents|protective agents|mesh-ancestor
44757083|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757084|NCT01711437|Vitamins|vitamins|mesh-ancestor
44757085|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
44757086|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
44757087|NCT01711437|Emollients|emollients|mesh-ancestor
44237748|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44757088|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757089|NCT01711437|Cathartics|cathartics|mesh-ancestor
44757090|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757091|NCT01711437|Antacids|antacids|mesh-ancestor
44757092|NCT01711437|Laxatives|laxatives|mesh-ancestor
44757093|NCT01711463|Fluticasone|fluticasone|mesh-list
44757094|NCT01711463|Xhance|xhance|mesh-list
44757095|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757096|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44757097|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
44757098|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757099|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757100|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44757101|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757102|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757103|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44757104|NCT01711476|Complement Factor H|complement factor h|mesh-list
44757105|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44757106|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757107|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
44757108|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757109|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
44757110|NCT01711489|Isavuconazole|isavuconazole|mesh-list
44757111|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44757112|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757113|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44757114|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
44757115|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757116|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757117|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757118|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757119|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
44757120|NCT01711515|Cisplatin|cisplatin|mesh-list
44757121|NCT01711515|Ipilimumab|ipilimumab|mesh-list
44757122|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757123|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757124|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44757125|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757126|NCT01711528|Dexamethasone|dexamethasone|mesh-list
44757127|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
44757128|NCT01711528|Bortezomib|bortezomib|mesh-list
44757129|NCT01711528|Ichthammol|ichthammol|mesh-list
44757130|NCT01711528|BB 1101|bb 1101|mesh-list
44534626|NCT01608412|Everolimus|everolimus|mesh-list
44757131|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757132|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
44757133|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
44757134|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757135|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757136|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757137|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
44757138|NCT01711528|Hormones|hormones|mesh-ancestor
44757139|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757140|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757141|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757142|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44757143|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774285|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
44757144|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757145|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757146|NCT01711567|Tenofovir|tenofovir|mesh-list
44757147|NCT01711567|Entecavir|entecavir|mesh-list
44757148|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
44757149|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757150|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44757151|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44757152|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237816|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
44237819|NCT00565175|Famotidine|famotidine|mesh-list
44757153|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757154|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44757155|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44757156|NCT01711593|Dimercaprol|dimercaprol|mesh-list
44757157|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
44757158|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
44757159|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757160|NCT01711671|Dexamethasone|dexamethasone|mesh-list
44757161|NCT01711671|Lenalidomide|lenalidomide|mesh-list
44757162|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757163|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
44757164|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
44757165|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757166|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757167|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757168|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
44757169|NCT01711671|Hormones|hormones|mesh-ancestor
44757170|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757171|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757172|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757173|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
44757174|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44757175|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44757176|NCT01711671|Growth Substances|growth substances|mesh-ancestor
44757177|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
44757178|NCT01711697|Paclitaxel|paclitaxel|mesh-list
44757179|NCT01711697|Carboplatin|carboplatin|mesh-list
44757180|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44757181|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757182|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44757183|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757184|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757185|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757186|NCT01711723|Darapladib|darapladib|mesh-list
44757187|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44757188|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757189|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757190|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44757191|NCT01711749|Calcium|calcium|mesh-list
44757192|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44757193|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757194|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44757195|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44757196|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
44757197|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757198|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44757199|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44757200|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757201|NCT01711814|Peficitinib|peficitinib|mesh-list
44757202|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757203|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757204|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757205|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
44757206|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689393|NCT01349296|Everolimus|everolimus|mesh-list
44757208|NCT01711827|Prednisone|prednisone|mesh-list
44757209|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757210|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
44757211|NCT01711827|Hormones|hormones|mesh-ancestor
44757212|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757213|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757214|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757215|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757216|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
44757217|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757218|NCT01711905|Vitamin D|vitamin d|mesh-list
44757219|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
44757220|NCT01711905|Vitamins|vitamins|mesh-ancestor
44757221|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
44757222|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757223|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44757224|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44757225|NCT01711931|Everolimus|everolimus|mesh-list
44757226|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757227|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757228|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
44757229|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757230|NCT01711957|Liver Extracts|liver extracts|mesh-list
44757231|NCT01711957|Hematinics|hematinics|mesh-ancestor
44757232|NCT01711970|Paclitaxel|paclitaxel|mesh-list
44757233|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44757234|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757235|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44757236|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757237|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757238|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757239|NCT01712100|Irbesartan|irbesartan|mesh-list
44757240|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757241|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44757242|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44757243|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757244|NCT01712113|Irbesartan|irbesartan|mesh-list
44757245|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757246|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44757247|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237907|NCT00565331|Rituximab|rituximab|mesh-list
44757248|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757249|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44757250|NCT01712126|Irbesartan|irbesartan|mesh-list
44757251|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757252|NCT01712126|Diuretics|diuretics|mesh-ancestor
44757253|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
44757254|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757255|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44757256|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757257|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757258|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44757259|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44757260|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44757261|NCT01712139|Irbesartan|irbesartan|mesh-list
44757262|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757263|NCT01712139|Diuretics|diuretics|mesh-ancestor
44757264|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
44757265|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757266|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44237927|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757267|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534772|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44534773|NCT01609491|Phenylephrine|phenylephrine|mesh-list
44534774|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
44534775|NCT01609491|Norepinephrine|norepinephrine|mesh-list
44534776|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44534777|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
44534778|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
44534779|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534780|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534781|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
44534782|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44534783|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
44534784|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757268|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757269|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44757270|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44757272|NCT01712295|Salicylates|salicylates|mesh-list
44757273|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44757274|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44757275|NCT01712295|Analgesics|analgesics|mesh-ancestor
44757276|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
44757277|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757278|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757279|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757280|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44757281|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44757282|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757283|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757284|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757285|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
44757286|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
44757287|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757288|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44757289|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
44757290|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757291|NCT01712321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44757292|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44757293|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43878221|NCT04689412|Resveratrol|resveratrol|mesh-list
44757294|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757295|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757296|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
44757297|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757298|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44757299|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44757300|NCT01712347|Bevacizumab|bevacizumab|mesh-list
44757301|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757302|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689394|NCT01349296|Nintedanib|nintedanib|mesh-list
44689395|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689396|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44689397|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
44689398|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689399|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44689400|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689401|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689402|NCT01349335|Tolvaptan|tolvaptan|mesh-list
44689403|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44689404|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689405|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
44689406|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689407|NCT01349348|Tolvaptan|tolvaptan|mesh-list
43906163|NCT00243061|Cediranib|cediranib|mesh-list
44689408|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44689409|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238006|NCT00565656|Bevacizumab|bevacizumab|mesh-list
44689410|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
44689411|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689412|NCT01349387|Metformin|metformin|mesh-list
44689413|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44689414|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689415|NCT01349413|Esomeprazole|esomeprazole|mesh-list
44138511|NCT00171353|Valsartan|valsartan|mesh-list
44689416|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44689417|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689418|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44689419|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689420|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689421|NCT01349439|Propranolol|propranolol|mesh-list
44689422|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44689423|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44689424|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44689425|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689426|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689427|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689428|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689429|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757303|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44757304|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44757305|NCT01712347|Growth Substances|growth substances|mesh-ancestor
44757306|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757307|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
44757308|NCT01712464|Oxytocin|oxytocin|mesh-list
44757309|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
44757310|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757311|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757312|NCT01712477|Midazolam|midazolam|mesh-list
44757313|NCT01712477|Propofol|propofol|mesh-list
44757314|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44757315|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757316|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757317|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44757318|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
44458933|NCT01587885|Omeprazole|omeprazole|mesh-list
44757319|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
44757320|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44757321|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44757322|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44757323|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757324|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
44757325|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
44757326|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757327|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757328|NCT01712568|Ropinirole|ropinirole|mesh-list
44757329|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44757330|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458935|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757331|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
44757332|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
44757333|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757334|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757335|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757336|NCT01712646|Oxytocin|oxytocin|mesh-list
44757337|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
44757338|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757339|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757340|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
44757341|NCT01712828|Promethazine|promethazine|mesh-list
44757342|NCT01712828|Sirolimus|sirolimus|mesh-list
44757343|NCT01712828|Quinidine|quinidine|mesh-list
44757344|NCT01712828|Lenalidomide|lenalidomide|mesh-list
44757345|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
43878937|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
44757346|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757347|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44757348|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44757349|NCT01712828|Growth Substances|growth substances|mesh-ancestor
44757350|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
44757351|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757352|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757353|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757354|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44757355|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
44757356|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757357|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44757358|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44757359|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757360|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
44757361|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
44757362|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
44757363|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757364|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
44757365|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
44757366|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757367|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44757368|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
44757369|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
44757370|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757371|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757372|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44534861|NCT01609998|Vaccines|vaccines|mesh-list
44534864|NCT01606098|Bevacizumab|bevacizumab|mesh-list
44757373|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
44757374|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757375|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44757376|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44757377|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
44757378|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757379|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
44757380|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44757381|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43907361|NCT00288067|Rituximab|rituximab|mesh-list
44757382|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757383|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44238088|NCT00566241|Mecasermin|mecasermin|mesh-list
44757384|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44757385|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
44757386|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44757387|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44757388|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757389|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44238091|NCT00566267|Simvastatin|simvastatin|mesh-list
44757390|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44757391|NCT01712893|Goserelin|goserelin|mesh-list
44757392|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757393|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757394|NCT01712919|Paclitaxel|paclitaxel|mesh-list
44757395|NCT01712919|Cetuximab|cetuximab|mesh-list
44757396|NCT01712919|Nedaplatin|nedaplatin|mesh-list
44757397|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43891096|NCT04791228|Doxorubicin|doxorubicin|mesh-list
44757398|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757399|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
44757400|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757401|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757402|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757403|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757404|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
44757405|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757406|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757407|NCT01712997|Bosentan|bosentan|mesh-list
44757408|NCT01712997|Iloprost|iloprost|mesh-list
44757409|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757410|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44757411|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757412|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44757413|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44757414|NCT01713049|Alovudine|alovudine|mesh-list
44757415|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
44757416|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757417|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
44757418|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
44757419|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44757420|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44757421|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757422|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
44757423|NCT01713101|Coagulants|coagulants|mesh-ancestor
44757424|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
44757425|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757426|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44757427|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757428|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44757429|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238125|NCT00566592|Ethanol|ethanol|mesh-list
44757430|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757431|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757432|NCT01713127|Remifentanil|remifentanil|mesh-list
44757433|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44757434|NCT01713127|Narcotics|narcotics|mesh-ancestor
44757435|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757436|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908041|NCT05266261|Vitamins|vitamins|mesh-ancestor
44757437|NCT01713127|Analgesics|analgesics|mesh-ancestor
44757438|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
44757439|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757440|NCT01713153|Misoprostol|misoprostol|mesh-list
44757441|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44757442|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
44757443|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757444|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238138|NCT00566683|Meperidine|meperidine|mesh-list
44757445|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44757446|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757447|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
44757448|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
44757449|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44757450|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44757451|NCT01713179|Ambroxol|ambroxol|mesh-list
44757452|NCT01713179|Expectorants|expectorants|mesh-ancestor
44757453|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757454|NCT01713218|Gemcitabine|gemcitabine|mesh-list
44757455|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44757456|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
44757457|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757458|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757459|NCT01713218|Antiviral Agents|antiviral agents|mesh-ancestor
44757460|NCT01713218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757461|NCT01713218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757462|NCT01713218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757463|NCT01713218|Immunologic Factors|immunologic factors|mesh-ancestor
44757464|NCT01713218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757465|NCT01713231|Vitamin D|vitamin d|mesh-list
44757466|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
44757467|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
44757468|NCT01713231|Vitamins|vitamins|mesh-list
44757469|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
44757470|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757471|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44757472|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43908342|NCT04129619|Ether|ether|mesh-list
44757473|NCT01713309|Lenograstim|lenograstim|mesh-list
44757474|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44757475|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
44757476|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757477|NCT01713361|Enoxaparin|enoxaparin|mesh-list
44757478|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
44757479|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44757480|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44757481|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757482|NCT01713387|Gemcitabine|gemcitabine|mesh-list
44757483|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44757484|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
44757485|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757486|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757487|NCT01713387|Antiviral Agents|antiviral agents|mesh-ancestor
44757488|NCT01713387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757489|NCT01713387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757490|NCT01713387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757491|NCT01713387|Immunologic Factors|immunologic factors|mesh-ancestor
44757492|NCT01713387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757493|NCT01713426|Pregabalin|pregabalin|mesh-list
44757494|NCT01713426|Capsaicin|capsaicin|mesh-list
44757495|NCT01713426|Analgesics|analgesics|mesh-ancestor
44757496|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
44757497|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757498|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757499|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
44757500|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44757501|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757502|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757503|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44757504|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44757505|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44757506|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757507|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757508|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
44757509|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
44757510|NCT01713556|Propranolol|propranolol|mesh-list
44757511|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44757512|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44757513|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
44757514|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757515|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757516|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757517|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757518|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757519|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
44757520|NCT01713647|Losartan|losartan|mesh-list
44757521|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757522|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757523|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44757524|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44757525|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757526|NCT01713725|Omalizumab|omalizumab|mesh-list
44757527|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44757528|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44757529|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757530|NCT01713738|Rituximab|rituximab|mesh-list
44238219|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44757531|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757532|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757533|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
44757534|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757535|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44757536|NCT01713777|Lamotrigine|lamotrigine|mesh-list
44757537|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
44757538|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44757539|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757540|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757541|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44757542|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757543|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44757544|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44757545|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757546|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757547|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44757548|NCT01713803|Buprenorphine|buprenorphine|mesh-list
44757549|NCT01713803|Naloxone|naloxone|mesh-list
44757550|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44757551|NCT01713803|Narcotics|narcotics|mesh-ancestor
44757552|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757553|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757554|NCT01713803|Analgesics|analgesics|mesh-ancestor
44757555|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
44757556|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757557|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44757558|NCT01713920|Amlodipine|amlodipine|mesh-list
44757559|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44757560|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44757561|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43908877|NCT00310401|Albuterol|albuterol|mesh-list
44757562|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757563|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44757564|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757565|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
44757566|NCT01713972|Dabrafenib|dabrafenib|mesh-list
44757567|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757568|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44757569|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757570|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757571|NCT01714011|Aripiprazole|aripiprazole|mesh-list
44757572|NCT01714011|Ziprasidone|ziprasidone|mesh-list
44757573|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
44757574|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757575|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44757576|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44757577|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757578|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757579|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
44757580|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
44757581|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757582|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757583|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44757584|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44757585|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
44757586|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44757587|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44757588|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44757589|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44757590|NCT01714037|Gemcitabine|gemcitabine|mesh-list
44757591|NCT01714037|Cisplatin|cisplatin|mesh-list
44757592|NCT01714037|Docetaxel|docetaxel|mesh-list
44535087|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
44535088|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44535089|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44535090|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535091|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535092|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44535093|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44535097|NCT02270918|Apixaban|apixaban|mesh-list
44757593|NCT01714037|Pemetrexed|pemetrexed|mesh-list
44757594|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757595|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44757596|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
44238279|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44757597|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757598|NCT01714037|Antiviral Agents|antiviral agents|mesh-ancestor
44757599|NCT01714037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757600|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757601|NCT01714037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909169|NCT00322101|Busulfan|busulfan|mesh-list
44757602|NCT01714037|Immunologic Factors|immunologic factors|mesh-ancestor
44757603|NCT01714037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757604|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44757605|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757606|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757607|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44757608|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44757609|NCT01714089|Interferons|interferons|mesh-list
44757610|NCT01714089|Interferon-beta|interferon-beta|mesh-list
44757611|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
44757612|NCT01714089|RNS60|rns60|mesh-list
43909302|NCT00324870|Vorinostat|vorinostat|mesh-list
44757613|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757614|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
44757615|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757616|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
43909377|NCT00328614|Bicalutamide|bicalutamide|mesh-list
44757617|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757618|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44757619|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44757620|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44757621|NCT01714089|Analgesics|analgesics|mesh-ancestor
44757622|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
44757623|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757624|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757625|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44757626|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44757627|NCT01714102|Resveratrol|resveratrol|mesh-list
44757628|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
44689430|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689431|NCT01349452|Ganciclovir|ganciclovir|mesh-list
44689432|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44689433|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
44689434|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44689435|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44689436|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
44689437|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689438|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44689439|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241066|NCT00586118|Propofol|propofol|mesh-list
44238342|NCT00567554|Trastuzumab|trastuzumab|mesh-list
44689440|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689441|NCT01349556|Tretinoin|tretinoin|mesh-list
44689442|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689443|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
44689444|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44689445|NCT01349647|Vaccines|vaccines|mesh-list
44689446|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
44689447|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689448|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44689449|NCT01349699|Deferasirox|deferasirox|mesh-list
44689450|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44689451|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
44689452|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
44689453|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689454|NCT01349699|Hematinics|hematinics|mesh-ancestor
44689455|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44689456|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
44689457|NCT01349738|Levofloxacin|levofloxacin|mesh-list
44689458|NCT01349738|Ofloxacin|ofloxacin|mesh-list
44689459|NCT01349738|Gentamicins|gentamicins|mesh-list
44689460|NCT01349738|Cefazolin|cefazolin|mesh-list
44689461|NCT01349738|Tobramycin|tobramycin|mesh-list
44689462|NCT01349738|Ampicillin|ampicillin|mesh-list
44689463|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44689464|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
44689465|NCT01349738|Sulbactam|sulbactam|mesh-list
44689466|NCT01349738|Trimethoprim|trimethoprim|mesh-list
44689467|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
44689468|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757629|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689469|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44535129|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
44757630|NCT01714102|Protective Agents|protective agents|mesh-ancestor
44757631|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757632|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757633|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44757634|NCT01714115|Aflibercept|aflibercept|mesh-list
44757635|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44757636|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44757637|NCT01714115|Growth Substances|growth substances|mesh-ancestor
44757638|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757639|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
44757640|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757641|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44757642|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44757643|NCT01714128|Estradiol|estradiol|mesh-list
44757644|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44757645|NCT01714128|Estrogens|estrogens|mesh-ancestor
44757646|NCT01714128|Hormones|hormones|mesh-ancestor
44757647|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757648|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757649|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44757650|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
44757651|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757652|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44757653|NCT01714154|Ritonavir|ritonavir|mesh-list
44757654|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44757655|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44757656|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44757657|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757658|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757659|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44238402|NCT00567762|Tacrolimus|tacrolimus|mesh-list
44757660|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44757661|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
44757662|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757663|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43910925|NCT00369226|Bortezomib|bortezomib|mesh-list
44757664|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44757665|NCT01714193|Canagliflozin|canagliflozin|mesh-list
44757666|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
44757667|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
44757668|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757669|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757670|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44757671|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757672|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44757673|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44757674|NCT01714206|Canagliflozin|canagliflozin|mesh-list
44757675|NCT01714206|Digoxin|digoxin|mesh-list
44757676|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757677|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44757678|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757679|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757680|NCT01714206|Protective Agents|protective agents|mesh-ancestor
44238413|NCT00567788|Bimatoprost|bimatoprost|mesh-list
44757681|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757682|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44757683|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44757684|NCT01714297|Dalteparin|dalteparin|mesh-list
44757685|NCT01714297|Tinzaparin|tinzaparin|mesh-list
44757686|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44757687|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
44757688|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44757689|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44757690|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757691|NCT01714388|Remifentanil|remifentanil|mesh-list
44757692|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44757693|NCT01714388|Narcotics|narcotics|mesh-ancestor
44757694|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757695|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757696|NCT01714388|Analgesics|analgesics|mesh-ancestor
44458939|NCT01587651|Ticagrelor|ticagrelor|mesh-list
44757697|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
44757698|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757699|NCT01714401|Albuterol|albuterol|mesh-list
44757700|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44757701|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
44458949|NCT01587274|Acetaminophen|acetaminophen|mesh-list
44757702|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757703|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757704|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44458954|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44757705|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
44757706|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
44757707|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757708|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44757709|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44757710|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44757711|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
44757712|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757713|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757714|NCT01714414|Lamivudine|lamivudine|mesh-list
44757715|NCT01714414|Zidovudine|zidovudine|mesh-list
44757716|NCT01714414|Efavirenz|efavirenz|mesh-list
44757717|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44757718|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44757719|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757720|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757721|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
44757722|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757723|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44757724|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44757725|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
44757726|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44458976|NCT01587118|Asenapine|asenapine|mesh-list
44757727|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44757728|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44757729|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44757730|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44757731|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44757732|NCT01714427|Dexamethasone|dexamethasone|mesh-list
44757733|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757734|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
44757735|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
44757736|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757737|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757738|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757739|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
44757740|NCT01714427|Hormones|hormones|mesh-ancestor
44238433|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44757741|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757742|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757743|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757744|NCT01714557|Tazobactam|tazobactam|mesh-list
44757745|NCT01714557|Piperacillin|piperacillin|mesh-list
44774286|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757746|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44757747|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757748|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757749|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44757750|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757751|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757752|NCT01714570|Tazobactam|tazobactam|mesh-list
44757753|NCT01714570|Piperacillin|piperacillin|mesh-list
44757754|NCT01714570|Imipenem|imipenem|mesh-list
44757755|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44757756|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757757|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757758|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44757759|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757760|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757761|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44757762|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757763|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44757764|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
44757765|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44757766|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
44757767|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44757768|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757769|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44757770|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757771|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757772|NCT01714765|Everolimus|everolimus|mesh-list
44757773|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757774|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757775|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
44757776|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757777|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
44757778|NCT01714817|Prednisone|prednisone|mesh-list
44757779|NCT01714817|Abatacept|abatacept|mesh-list
44757780|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44757781|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
44757782|NCT01714817|Hormones|hormones|mesh-ancestor
44757783|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757784|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757785|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44757786|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757787|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44757788|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44757789|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
44757790|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757791|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757792|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757793|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757794|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44757795|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757796|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
44757797|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44757798|NCT01714843|Linaclotide|linaclotide|mesh-list
44757799|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44757800|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
44757801|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757802|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44757803|NCT01714856|Ropinirole|ropinirole|mesh-list
44757804|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44757805|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44757806|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
44757807|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
44757808|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757809|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757810|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757811|NCT01714895|Insulin|insulin|mesh-list
44757812|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44757813|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44757814|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757815|NCT01714908|Etoposide|etoposide|mesh-list
44757816|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44757817|NCT01714908|Cisplatin|cisplatin|mesh-list
43792078|NCT05137964|Vitamins|vitamins|mesh-ancestor
44757818|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44757819|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757820|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44757821|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44757822|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757823|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757824|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44757825|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44757826|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44757827|NCT01715077|Ipilimumab|ipilimumab|mesh-list
44757828|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44757829|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757830|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43883377|NCT04612179|Sirolimus|sirolimus|mesh-list
44757831|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757832|NCT01715090|Insulin|insulin|mesh-list
44757833|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44757834|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757835|NCT01715142|Gemcitabine|gemcitabine|mesh-list
44757836|NCT01715142|Paclitaxel|paclitaxel|mesh-list
44757837|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44757838|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44757839|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757840|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44757841|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44757842|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44757843|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757844|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44757845|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
44757846|NCT01715142|Antiviral Agents|antiviral agents|mesh-ancestor
44757847|NCT01715142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757848|NCT01715142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883587|NCT04609748|Nimesulide|nimesulide|mesh-list
44535384|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44757849|NCT01715142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757850|NCT01715142|Immunologic Factors|immunologic factors|mesh-ancestor
44757851|NCT01715142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757852|NCT01715168|Doxorubicin|doxorubicin|mesh-list
44757853|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44757854|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44757855|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757856|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44757857|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44757858|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757859|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757860|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
44757861|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
44757862|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
44757863|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757864|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44757865|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238571|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
44757866|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757867|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
44757868|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757869|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238579|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44757870|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44757871|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
44757872|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44757873|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
44757874|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757875|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757876|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44535385|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44535386|NCT02272660|Analgesics|analgesics|mesh-ancestor
44535387|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
44535388|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535389|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535390|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535391|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535392|NCT02272699|Paclitaxel|paclitaxel|mesh-list
44535393|NCT02272699|Cisplatin|cisplatin|mesh-list
44535394|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
44535395|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44757877|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238595|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
44757878|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
44757879|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44757880|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44757881|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757882|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757883|NCT01715363|Leucovorin|leucovorin|mesh-list
44757884|NCT01715363|Folic Acid|folic acid|mesh-list
44757885|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
44757886|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
44757887|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757888|NCT01715363|Antidotes|antidotes|mesh-ancestor
44757889|NCT01715363|Protective Agents|protective agents|mesh-ancestor
44757890|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238609|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
44757891|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
44757892|NCT01715363|Vitamins|vitamins|mesh-ancestor
44757893|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
44757894|NCT01715363|Hematinics|hematinics|mesh-ancestor
44757895|NCT01715441|Irinotecan|irinotecan|mesh-list
44757896|NCT01715441|Sorafenib|sorafenib|mesh-list
44757897|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44757898|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44757899|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757900|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757901|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757902|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44757903|NCT01715493|Muramidase|muramidase|mesh-list
44757904|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757905|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44757906|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
44757907|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44757908|NCT01715519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44238612|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
44757909|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44757910|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757911|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757912|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44757913|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
44757914|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757915|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44757916|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44757917|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
44757918|NCT01715584|Sevoflurane|sevoflurane|mesh-list
44757919|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44757920|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44757921|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
44757922|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
44757923|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757924|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757925|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44757926|NCT01715584|Analgesics|analgesics|mesh-ancestor
44757927|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
44757928|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757929|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
44757930|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
44757931|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757932|NCT01715597|Protective Agents|protective agents|mesh-ancestor
44757933|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757934|NCT01715597|Vitamins|vitamins|mesh-ancestor
44757935|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
44757936|NCT01715610|Clindamycin|clindamycin|mesh-list
44757937|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
44757938|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
44757939|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44757940|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44757941|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757942|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44757943|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757944|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757945|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44757946|NCT01715636|Tenofovir|tenofovir|mesh-list
44757947|NCT01715636|Emtricitabine|emtricitabine|mesh-list
44757948|NCT01715636|Rilpivirine|rilpivirine|mesh-list
44757949|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
44757950|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535432|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
44757951|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44757952|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44757953|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757954|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757955|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44757956|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44757957|NCT01715688|Lidocaine|lidocaine|mesh-list
44757958|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
44757959|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
44757960|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44757961|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757962|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
44757963|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44757964|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44757965|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44757966|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44757967|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44757968|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757969|NCT01715701|Iodine|iodine|mesh-list
44757970|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44757971|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757972|NCT01715701|Trace Elements|trace elements|mesh-ancestor
44757973|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
44757974|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44757975|NCT01715909|Oseltamivir|oseltamivir|mesh-list
44757976|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
44757977|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757978|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757979|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757980|NCT01715922|Fluconazole|fluconazole|mesh-list
44757981|NCT01715922|Flucytosine|flucytosine|mesh-list
44757982|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
44757983|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44757984|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44757985|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44757986|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44757987|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44757988|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44757989|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
44757990|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44757991|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689470|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44689471|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689472|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689473|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689474|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44689475|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44689476|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44238706|NCT00569088|Mannitol|mannitol|mesh-list
44689477|NCT01349738|Renal Agents|renal agents|mesh-ancestor
44689478|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44689479|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
44689480|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44689481|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44689482|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44689483|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44689484|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44689485|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44689486|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
44689487|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689488|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
44689489|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689490|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689491|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
44689492|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689493|NCT01349764|Vitamin D|vitamin d|mesh-list
44689494|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
44689495|NCT01349764|Vitamins|vitamins|mesh-ancestor
44689496|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
44689497|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689498|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44689499|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44689500|NCT01349777|Clopidogrel|clopidogrel|mesh-list
44689501|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44689502|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44689503|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44757992|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44757993|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44757995|NCT01715935|Everolimus|everolimus|mesh-list
44757996|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44757997|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44757998|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
44238751|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
44757999|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758000|NCT01715987|Tenofovir|tenofovir|mesh-list
44758001|NCT01715987|Entecavir|entecavir|mesh-list
44758002|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
44758003|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758004|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44758005|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44758006|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758007|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758008|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44758009|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44758010|NCT01716260|Chloroquine|chloroquine|mesh-list
44758011|NCT01716260|Primaquine|primaquine|mesh-list
44758012|NCT01716260|Amebicides|amebicides|mesh-ancestor
44758013|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44758014|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44758015|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758016|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
44758017|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758018|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44758019|NCT01716273|Laxatives|laxatives|mesh-ancestor
44758020|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758021|NCT01716338|Glyburide|glyburide|mesh-list
44758022|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758023|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758024|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44758025|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44758026|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44758027|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758028|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758029|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758030|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758031|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44758032|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44238775|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
44758033|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44758034|NCT01716416|Cetuximab|cetuximab|mesh-list
44238784|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44758035|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758036|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758037|NCT01716442|Rituximab|rituximab|mesh-list
44758038|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758039|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758040|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
44238787|NCT00569712|Hormones|hormones|mesh-ancestor
44758041|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758042|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758043|NCT01716572|Erythromycin|erythromycin|mesh-list
44758044|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
44758045|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44758046|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
44758047|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44758048|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758049|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758050|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44758051|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758052|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758053|NCT01716611|Tolvaptan|tolvaptan|mesh-list
44758054|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44758055|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758056|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
44758057|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758058|NCT01716624|Oxybutynin|oxybutynin|mesh-list
44758059|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
44758060|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44758061|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44758062|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44238804|NCT00569790|Bevacizumab|bevacizumab|mesh-list
44758063|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758064|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758065|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44758066|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758067|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923767|NCT00585650|Etanercept|etanercept|mesh-list
44758068|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44758069|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758070|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
44758071|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
44758072|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44758073|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44758074|NCT01716624|Urological Agents|urological agents|mesh-ancestor
44758075|NCT01716637|Etanercept|etanercept|mesh-list
44758076|NCT01716637|Curcumin|curcumin|mesh-list
44758077|NCT01716637|Resveratrol|resveratrol|mesh-list
44758078|NCT01716637|Quercetin|quercetin|mesh-list
44758079|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44758080|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44758081|NCT01716637|Analgesics|analgesics|mesh-ancestor
44758082|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
44758083|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758084|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758085|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758086|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758087|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758088|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758089|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
44758090|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758091|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758092|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758093|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
44758094|NCT01716637|Protective Agents|protective agents|mesh-ancestor
44758095|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44758096|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
44758097|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758098|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
44758099|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758100|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758101|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44758102|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
44758103|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758104|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758105|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44535617|NCT02273713|Paclitaxel|paclitaxel|mesh-list
44758107|NCT01716767|Menthol|menthol|mesh-list
44758108|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
44758109|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758110|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758111|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
44758112|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44758113|NCT01716858|Sulforaphane|sulforaphane|mesh-list
44758114|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44758115|NCT01716858|Protective Agents|protective agents|mesh-ancestor
44758116|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758117|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758118|NCT01716949|Fluorouracil|fluorouracil|mesh-list
44758119|NCT01716949|Capecitabine|capecitabine|mesh-list
44758120|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
44758121|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
44758122|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758123|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758124|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758125|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758126|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
44459022|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758127|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758128|NCT01717027|Oxycodone|oxycodone|mesh-list
44758129|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758130|NCT01717027|Narcotics|narcotics|mesh-ancestor
44758131|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758132|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758133|NCT01717027|Analgesics|analgesics|mesh-ancestor
44758134|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
44758135|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758136|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
44758137|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44758138|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758139|NCT01717118|Vaccines|vaccines|mesh-list
44758140|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
44459032|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
44758141|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758142|NCT01717157|Fentanyl|fentanyl|mesh-list
44758143|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758144|NCT01717157|Narcotics|narcotics|mesh-ancestor
44238829|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44758145|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758146|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758147|NCT01717157|Analgesics|analgesics|mesh-ancestor
44758148|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
44758149|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758150|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44758151|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44758152|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
44238837|NCT00569920|BB 1101|bb 1101|mesh-list
44758153|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
44758154|NCT01717222|Lidocaine|lidocaine|mesh-list
44758155|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
44758156|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
44758157|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758158|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758159|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
44758160|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758161|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44758162|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44758163|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44758164|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758165|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758166|NCT01717235|Ropinirole|ropinirole|mesh-list
44758167|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44758168|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44758169|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
44758170|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
44758171|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758172|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758173|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758174|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
44758175|NCT01717300|Anacetrapib|anacetrapib|mesh-list
44758176|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44758177|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44758178|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
44758179|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758180|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44758181|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758182|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44758183|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758184|NCT01717404|Mexiletine|mexiletine|mesh-list
44758185|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44758186|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44758187|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44758188|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758189|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758190|NCT01717599|Diclofenac|diclofenac|mesh-list
44758191|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44758192|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44758193|NCT01717599|Analgesics|analgesics|mesh-ancestor
44758194|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
44758195|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758196|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758197|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758198|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758199|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44758200|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774287|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758201|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758202|NCT01717612|Thrombin|thrombin|mesh-list
44758203|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
44758204|NCT01717612|Coagulants|coagulants|mesh-ancestor
44758205|NCT01717625|Montelukast|montelukast|mesh-list
44758206|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44758207|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
44758208|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44758209|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
44758210|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758211|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758212|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44758213|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44758214|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758215|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
43892021|NCT05177731|Cytarabine|cytarabine|mesh-list
44758216|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44758217|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44758218|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758219|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
44758220|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44758221|NCT01717729|Iodine|iodine|mesh-list
44758222|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44758223|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758224|NCT01717729|Trace Elements|trace elements|mesh-ancestor
44758225|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
44758226|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758227|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44774288|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
44758228|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758229|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44758230|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758231|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758232|NCT01717846|Abatacept|abatacept|mesh-list
44758233|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44758234|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758235|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758236|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758237|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
44774289|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44758238|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758239|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758240|NCT01717911|Metformin|metformin|mesh-list
44758241|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44758242|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
44758243|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758244|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758245|NCT01717911|Incretins|incretins|mesh-ancestor
44758246|NCT01717911|Hormones|hormones|mesh-ancestor
44758247|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758248|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44758249|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
44758250|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758251|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758252|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44758253|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44758254|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
44689504|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44758255|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758256|NCT01717950|Antacids|antacids|mesh-ancestor
44758257|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758258|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758259|NCT01717963|Naltrexone|naltrexone|mesh-list
44758260|NCT01717963|Buprenorphine|buprenorphine|mesh-list
44758261|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44758262|NCT01717963|Naloxone|naloxone|mesh-list
44758263|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758264|NCT01717963|Narcotics|narcotics|mesh-ancestor
44758265|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758266|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758267|NCT01717963|Analgesics|analgesics|mesh-ancestor
44758268|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
44758269|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758270|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44758271|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44758272|NCT01718054|Chloroquine|chloroquine|mesh-list
44758273|NCT01718054|Amebicides|amebicides|mesh-ancestor
44689505|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
44689506|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689507|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689508|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689509|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
44689510|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44689511|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689512|NCT01350024|Lidocaine|lidocaine|mesh-list
44689513|NCT01350024|Epinephrine|epinephrine|mesh-list
44689514|NCT01350024|Racepinephrine|racepinephrine|mesh-list
44689515|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
44689516|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689517|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
44689518|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689520|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
44689521|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689522|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689523|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44689524|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44689525|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689526|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689527|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44689528|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44689529|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
44689530|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689531|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44689532|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44689533|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
44689534|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44774290|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44689535|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689536|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
44689537|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
44689538|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44689539|NCT01350037|Remifentanil|remifentanil|mesh-list
44689540|NCT01350037|Alfentanil|alfentanil|mesh-list
44689541|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44689542|NCT01350037|Narcotics|narcotics|mesh-ancestor
44689543|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689544|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689545|NCT01350037|Analgesics|analgesics|mesh-ancestor
44689546|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
44689547|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689548|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44689549|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
44689550|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
44689551|NCT01350050|Carticaine|carticaine|mesh-list
44689552|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689553|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
44689554|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689555|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689556|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
44689557|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689558|NCT01350063|Troclosene|troclosene|mesh-list
44689559|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
44689560|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689561|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
44758274|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44689562|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
44758275|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44758276|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758277|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
44758278|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758279|NCT01718093|Metformin|metformin|mesh-list
44239021|NCT00571129|Mitomycins|mitomycins|mesh-list
44758280|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44758281|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758282|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758283|NCT01718093|Incretins|incretins|mesh-ancestor
44758284|NCT01718093|Hormones|hormones|mesh-ancestor
44758285|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758286|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44758287|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44758288|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758289|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758290|NCT01718223|Temoporfin|temoporfin|mesh-list
44758291|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758292|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44758293|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44758294|NCT01718236|Rocuronium|rocuronium|mesh-list
44758295|NCT01718236|Succinylcholine|succinylcholine|mesh-list
44758296|NCT01718236|Neostigmine|neostigmine|mesh-list
44758297|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44758298|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44758299|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44758300|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758301|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758302|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44758303|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758304|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758305|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
44758306|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758307|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44758308|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
44758309|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44758310|NCT01718288|Aspirin|aspirin|mesh-list
44758311|NCT01718288|Iloprost|iloprost|mesh-list
44758312|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44758313|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44758314|NCT01718288|Analgesics|analgesics|mesh-ancestor
44758315|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
44758316|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931528|NCT00731055|Varenicline|varenicline|mesh-list
44758317|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758318|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758319|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758320|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44758321|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44758322|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758323|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44758324|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44758325|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758326|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
44758327|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
44758328|NCT01718301|Ribavirin|ribavirin|mesh-list
44758329|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44758330|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44758331|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
44758332|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758333|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
44758334|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758335|NCT01718314|Lidocaine|lidocaine|mesh-list
44758336|NCT01718314|Misoprostol|misoprostol|mesh-list
44758337|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44758338|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
44758339|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758340|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758341|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
44758342|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758343|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44758344|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44758345|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44758346|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758347|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758348|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44758349|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
44758350|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44758351|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44758352|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758353|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
44758354|NCT01718327|Sunitinib|sunitinib|mesh-list
44239088|NCT00571298|Antidotes|antidotes|mesh-ancestor
44758355|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758356|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44758357|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44758358|NCT01718327|Growth Substances|growth substances|mesh-ancestor
44758359|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758360|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44758361|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44758362|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758363|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758364|NCT01718340|Metformin|metformin|mesh-list
44758365|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758366|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758367|NCT01718366|Vitamin D|vitamin d|mesh-list
44758368|NCT01718366|Azacitidine|azacitidine|mesh-list
44758369|NCT01718366|Deferasirox|deferasirox|mesh-list
44758370|NCT01718366|Vitamins|vitamins|mesh-ancestor
44758371|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
44140461|NCT00179283|Sertraline|sertraline|mesh-list
44758372|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758373|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44758374|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758375|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
44758376|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758377|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758378|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758379|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44758380|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
44758381|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
44758382|NCT01718379|Lenalidomide|lenalidomide|mesh-list
44758383|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
44239125|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
44758384|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758385|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44758386|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44758387|NCT01718379|Growth Substances|growth substances|mesh-ancestor
44758388|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44758389|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758391|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758392|NCT01718496|Narcotics|narcotics|mesh-ancestor
44758393|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758394|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758395|NCT01718496|Analgesics|analgesics|mesh-ancestor
44758396|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
44758397|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758398|NCT01718587|Lamivudine|lamivudine|mesh-list
44758399|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
44758400|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44758401|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44758402|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774291|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758403|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758404|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758405|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44758406|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44758407|NCT01718613|Vasopressins|vasopressins|mesh-list
44758408|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
44758409|NCT01718613|Norepinephrine|norepinephrine|mesh-list
44758410|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44758411|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44758412|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758413|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758414|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239147|NCT00571740|Leucovorin|leucovorin|mesh-list
44758415|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758416|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
44758417|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
44758418|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758419|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44758420|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
44758421|NCT01718613|Coagulants|coagulants|mesh-ancestor
44758422|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44758423|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
44758424|NCT01718626|Docetaxel|docetaxel|mesh-list
44758425|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758426|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44758427|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44758428|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44758429|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758430|NCT01718652|Canagliflozin|canagliflozin|mesh-list
44758431|NCT01718652|Cyclosporine|cyclosporine|mesh-list
44758432|NCT01718652|Cyclosporins|cyclosporins|mesh-list
44758433|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758434|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758435|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758436|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
44758437|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758438|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
44758439|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758440|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
44758441|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758442|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44758443|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44758444|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758445|NCT01718678|Melatonin|melatonin|mesh-list
44758446|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
44758447|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758448|NCT01718678|Protective Agents|protective agents|mesh-ancestor
44758449|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758450|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758451|NCT01718717|Morphine|morphine|mesh-list
44758452|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758453|NCT01718717|Narcotics|narcotics|mesh-ancestor
44758454|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758455|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758456|NCT01718717|Analgesics|analgesics|mesh-ancestor
44758457|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
44758458|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758459|NCT01718808|Capecitabine|capecitabine|mesh-list
44758460|NCT01718808|Cetuximab|cetuximab|mesh-list
44758461|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758462|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
44758463|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758464|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536017|NCT02276989|Riboflavin|riboflavin|mesh-list
44758465|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758467|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
44758468|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758469|NCT01718873|Leucovorin|leucovorin|mesh-list
44758470|NCT01718873|Folic Acid|folic acid|mesh-list
44758471|NCT01718873|Bevacizumab|bevacizumab|mesh-list
44758472|NCT01718873|Fluorouracil|fluorouracil|mesh-list
44758473|NCT01718873|Capecitabine|capecitabine|mesh-list
44758474|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
44758475|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
44758476|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758477|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758478|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44758479|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44758480|NCT01718873|Growth Substances|growth substances|mesh-ancestor
44758481|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758482|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
44758483|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
44758484|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758485|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758486|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758487|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
44758488|NCT01718873|Antidotes|antidotes|mesh-ancestor
44758489|NCT01718873|Protective Agents|protective agents|mesh-ancestor
44758490|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
44758491|NCT01718873|Vitamins|vitamins|mesh-ancestor
44758492|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
44758493|NCT01718873|Hematinics|hematinics|mesh-ancestor
44758494|NCT01718899|Lenalidomide|lenalidomide|mesh-list
44758495|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
44239215|NCT00572065|Cytarabine|cytarabine|mesh-list
44758496|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758497|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44758498|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44758499|NCT01718899|Growth Substances|growth substances|mesh-ancestor
44758500|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
44758501|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758502|NCT01718912|Metronidazole|metronidazole|mesh-list
44758503|NCT01718912|Nystatin|nystatin|mesh-list
44758504|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758505|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44758506|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44758507|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44758508|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
44758509|NCT01718912|Ionophores|ionophores|mesh-ancestor
44758510|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758511|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758512|NCT01718951|Pamidronate|pamidronate|mesh-list
44758513|NCT01718951|Golimumab|golimumab|mesh-list
44758514|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44758515|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758516|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758517|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
44758518|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758519|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44758520|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
44758521|NCT01718964|Mannitol|mannitol|mesh-list
44758522|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44758523|NCT01718964|Diuretics|diuretics|mesh-ancestor
44758524|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
44758525|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758526|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758527|NCT01719042|Ondansetron|ondansetron|mesh-list
44758528|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
44758529|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
44758530|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160120|NCT00240656|Diuretics|diuretics|mesh-ancestor
44758531|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758532|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758533|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
44758534|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44758535|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44758536|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
44758537|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758538|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689563|NCT01350089|Ethanol|ethanol|mesh-list
44689564|NCT01350089|Caffeine|caffeine|mesh-list
44239256|NCT00572312|Atorvastatin|atorvastatin|mesh-list
44758539|NCT01719042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44758540|NCT01719042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44758541|NCT01719042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758542|NCT01719042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44758543|NCT01719042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44758544|NCT01719133|Histamine|histamine|mesh-list
44758545|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
43805870|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
44758546|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
44758547|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
44758548|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758549|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758550|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758551|NCT01719159|Rituximab|rituximab|mesh-list
44758552|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758553|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758554|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
44758555|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758556|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758557|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
44758558|NCT01719185|Phentermine|phentermine|mesh-list
44758559|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44758560|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758561|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
44758562|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44758563|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
44758564|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
44758565|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758566|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758567|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774292|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44758568|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758569|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
44758570|NCT01719185|Vitamins|vitamins|mesh-ancestor
44758571|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
44758572|NCT01719302|Gemcitabine|gemcitabine|mesh-list
44758573|NCT01719302|Docetaxel|docetaxel|mesh-list
44758574|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758575|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
44758576|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758577|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758578|NCT01719302|Antiviral Agents|antiviral agents|mesh-ancestor
44758579|NCT01719302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758580|NCT01719302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758581|NCT01719302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758582|NCT01719302|Immunologic Factors|immunologic factors|mesh-ancestor
44758583|NCT01719302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239289|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
44758584|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44758585|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44758586|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44758587|NCT01719419|Orlistat|orlistat|mesh-list
44758588|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758589|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758590|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44758591|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44758592|NCT01719588|Tapentadol|tapentadol|mesh-list
44758593|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758594|NCT01719588|Narcotics|narcotics|mesh-ancestor
44758595|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758596|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758597|NCT01719588|Analgesics|analgesics|mesh-ancestor
44758598|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
44758599|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758600|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44758601|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44758602|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758603|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758604|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758605|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758606|NCT01719601|Tapentadol|tapentadol|mesh-list
44758607|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44758608|NCT01719601|Narcotics|narcotics|mesh-ancestor
44536159|NCT02278081|Lansoprazole|lansoprazole|mesh-list
44536160|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
44536161|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44536162|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536163|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44536164|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536165|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536166|NCT02278172|Vitamin D|vitamin d|mesh-list
44536167|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
44536168|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
44758609|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758610|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758611|NCT01719601|Analgesics|analgesics|mesh-ancestor
44758612|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
44758613|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758614|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44239333|NCT00573001|Ritonavir|ritonavir|mesh-list
44758615|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44758616|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758617|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758618|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758619|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758620|NCT01719614|Metformin|metformin|mesh-list
44758621|NCT01719614|Rilpivirine|rilpivirine|mesh-list
44239341|NCT00573001|Efavirenz|efavirenz|mesh-list
44758622|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44758623|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758624|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44758625|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44758626|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758627|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758628|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
44758629|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758630|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44758631|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44758632|NCT01719627|Maraviroc|maraviroc|mesh-list
44758633|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44758634|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44774293|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44758635|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758636|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44758637|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44758638|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
44758639|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758640|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44758641|NCT01719692|Rituximab|rituximab|mesh-list
44758642|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44758643|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758644|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
44758645|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758646|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758647|NCT01719705|Pregabalin|pregabalin|mesh-list
44758648|NCT01719705|Analgesics|analgesics|mesh-ancestor
44758649|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
44758650|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758651|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758652|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
44758653|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44758654|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758655|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758656|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44758657|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44758658|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44758659|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758660|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44758661|NCT01719770|Rocuronium|rocuronium|mesh-list
44758662|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44239378|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758663|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44758664|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44758665|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758666|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758667|NCT01719835|Gemcitabine|gemcitabine|mesh-list
44758668|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
44758669|NCT01719835|Prednisolone|prednisolone|mesh-list
44758670|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
44758671|NCT01719835|Doxorubicin|doxorubicin|mesh-list
44758672|NCT01719835|Vincristine|vincristine|mesh-list
44758673|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758674|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
44239392|NCT00573547|Fluoxetine|fluoxetine|mesh-list
44758675|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758676|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758677|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44758678|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
44758679|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758680|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941056|NCT00948298|Vitamin D|vitamin d|mesh-list
44758681|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44536183|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
44758682|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758683|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
44758684|NCT01719835|Antiviral Agents|antiviral agents|mesh-ancestor
44758685|NCT01719835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758686|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941401|NCT00957359|Niacin|niacin|mesh-list
44758687|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44758688|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44758689|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44758690|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44758691|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44758692|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44758693|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44758694|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758695|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
44758696|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
44758697|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758698|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758699|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
44758701|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758702|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44758703|NCT01719835|Protective Agents|protective agents|mesh-ancestor
44758704|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44758705|NCT01719926|Indomethacin|indomethacin|mesh-list
44758706|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44758707|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44758708|NCT01719926|Analgesics|analgesics|mesh-ancestor
44758709|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
44758710|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758711|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758712|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758713|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758714|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
44758715|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
44758716|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44758717|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44758718|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758719|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758720|NCT01719952|Oxytocin|oxytocin|mesh-list
44758721|NCT01719952|Carbetocin|carbetocin|mesh-list
44758722|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
44758723|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44758724|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758725|NCT01719978|Epinephrine|epinephrine|mesh-list
44758726|NCT01719978|Racepinephrine|racepinephrine|mesh-list
44758727|NCT01719978|Mepivacaine|mepivacaine|mesh-list
44758728|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
44239445|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758729|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44758730|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44758731|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758732|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758733|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758734|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758735|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44758736|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44758737|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
44758738|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758739|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44758740|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44758741|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
44758742|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
44758743|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44758744|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
44758745|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
44758746|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44758747|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
44758748|NCT01720459|Resveratrol|resveratrol|mesh-list
44758749|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
44758750|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758751|NCT01720459|Protective Agents|protective agents|mesh-ancestor
44758752|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758753|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758754|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44758755|NCT01720537|Bococizumab|bococizumab|mesh-list
44758756|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44758757|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44758758|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44758759|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
44758760|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758761|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44758762|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
44758763|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758765|NCT01720719|Atorvastatin|atorvastatin|mesh-list
44758766|NCT01720719|Vitamins|vitamins|mesh-ancestor
44758767|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
44758768|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758769|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44758770|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44239468|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
44758771|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
44758772|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758773|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44774294|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44758774|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44758775|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758776|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
44758777|NCT01720719|Protective Agents|protective agents|mesh-ancestor
44758779|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758780|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758781|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
44758782|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44758783|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44758784|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758785|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239483|NCT00573950|Cilostazol|cilostazol|mesh-list
44758786|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758787|NCT01723852|Vitamin D|vitamin d|mesh-list
44758788|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
44758789|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
44758790|NCT01723852|Vitamins|vitamins|mesh-list
44758791|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
44758792|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758793|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44758794|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44758795|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
44758796|NCT01724229|Clotrimazole|clotrimazole|mesh-list
44758797|NCT01724229|Miconazole|miconazole|mesh-list
44758798|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758799|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44758800|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44758801|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44758802|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758803|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758804|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44758805|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44758806|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758807|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758808|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44758809|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44758810|NCT01724450|Carvedilol|carvedilol|mesh-list
44758811|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44239507|NCT00574015|Acetaminophen|acetaminophen|mesh-list
44758812|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44758813|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
44758814|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44758815|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758816|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758817|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44758818|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
44758819|NCT01724450|Protective Agents|protective agents|mesh-ancestor
44758820|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44758821|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44758822|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44758823|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
44758824|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44758825|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44758826|NCT01724723|Entecavir|entecavir|mesh-list
44758827|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
44758828|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758829|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44758830|NCT01724892|Dexamethasone|dexamethasone|mesh-list
44758831|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758832|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
44758833|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
44689565|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44689566|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689567|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689568|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689569|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44689570|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44689571|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239539|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943316|NCT01007994|Enalapril|enalapril|mesh-list
44689572|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689573|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44689574|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44689575|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
44689576|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689577|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
44689578|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689579|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44689580|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44536417|NCT02272348|Insulin|insulin|mesh-list
44758834|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758835|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758836|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44758837|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
44758838|NCT01724892|Hormones|hormones|mesh-ancestor
44758839|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44758840|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44758841|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758842|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44758843|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44758844|NCT01726400|Interferons|interferons|mesh-list
44758845|NCT01726400|Ribavirin|ribavirin|mesh-list
44758846|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
44758847|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758848|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
44758849|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758850|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
44758851|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758852|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
43943742|NCT01016691|Bimatoprost|bimatoprost|mesh-list
44758853|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758854|NCT01726582|Leucovorin|leucovorin|mesh-list
44758855|NCT01726582|Gemcitabine|gemcitabine|mesh-list
44758856|NCT01726582|Paclitaxel|paclitaxel|mesh-list
44758857|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44758858|NCT01726582|Capecitabine|capecitabine|mesh-list
44758859|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
44758860|NCT01726582|Irinotecan|irinotecan|mesh-list
44758861|NCT01726582|Cisplatin|cisplatin|mesh-list
44758862|NCT01726582|Folfirinox|folfirinox|mesh-list
44758863|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44758864|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758865|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44758866|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44758867|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44758868|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239589|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44758869|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758870|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
44758871|NCT01726582|Antiviral Agents|antiviral agents|mesh-ancestor
44758872|NCT01726582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758873|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758874|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758875|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
44758876|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758877|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44758878|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44758879|NCT01726582|Antidotes|antidotes|mesh-ancestor
44758880|NCT01726582|Protective Agents|protective agents|mesh-ancestor
44758881|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
44758882|NCT01726582|Vitamins|vitamins|mesh-ancestor
44758883|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
44758884|NCT01727427|Aspirin|aspirin|mesh-list
44758885|NCT01727427|Vitamin K|vitamin k|mesh-list
44758886|NCT01727427|Heparin|heparin|mesh-list
44758887|NCT01727427|Enoxaparin|enoxaparin|mesh-list
44758888|NCT01727427|Dalteparin|dalteparin|mesh-list
44758889|NCT01727427|Tinzaparin|tinzaparin|mesh-list
44758890|NCT01727427|PENTA|penta|mesh-list
44758891|NCT01727427|Nadroparin|nadroparin|mesh-list
44758892|NCT01727427|Warfarin|warfarin|mesh-list
44758893|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
44758894|NCT01727427|Dabigatran|dabigatran|mesh-list
44758895|NCT01727427|Apixaban|apixaban|mesh-list
44758896|NCT01727427|Fondaparinux|fondaparinux|mesh-list
44758897|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
44758898|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
44758899|NCT01727427|Bemiparin|bemiparin|mesh-list
44758900|NCT01727427|Vitamins|vitamins|mesh-ancestor
44758901|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
44758902|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758903|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44758904|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44758905|NCT01727427|Analgesics|analgesics|mesh-ancestor
44758906|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
44758907|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44758908|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44758909|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44758910|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44758911|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44758912|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758913|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44758914|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44758915|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758916|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
44758917|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
44758918|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44758919|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
44758920|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44758921|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
44758922|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44758923|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
44758924|NCT01727427|Coagulants|coagulants|mesh-ancestor
44758925|NCT01727778|Antibodies|antibodies|mesh-list
44758926|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
44758927|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
44758928|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758929|NCT01728025|Ranolazine|ranolazine|mesh-list
44758930|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44758931|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44536546|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758932|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758933|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44758934|NCT01728363|Rifampin|rifampin|mesh-list
44758935|NCT01728363|Clindamycin|clindamycin|mesh-list
44758936|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
44758937|NCT01728363|Ticarcillin|ticarcillin|mesh-list
44758938|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44758939|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758940|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44758941|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
44758942|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
44758943|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44758944|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758945|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758946|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44758947|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44758948|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44758949|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44758950|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44758951|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44758952|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44239663|NCT00575302|Hormones|hormones|mesh-ancestor
44758953|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44758954|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
44758955|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44758956|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239680|NCT00575406|Prednisolone|prednisolone|mesh-list
44758957|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44758958|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44758959|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758960|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758961|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758962|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44758963|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44758964|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
44758965|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239683|NCT00575406|Doxorubicin|doxorubicin|mesh-list
44239684|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44758966|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758967|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44758968|NCT01730157|Ipilimumab|ipilimumab|mesh-list
44758969|NCT01730157|Antibodies|antibodies|mesh-list
44758970|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
44758971|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44758972|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
44758973|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758974|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758975|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44758976|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758977|NCT01730209|Everolimus|everolimus|mesh-list
44758978|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536547|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44536548|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44536549|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44536550|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44536551|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44536552|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44536553|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44536557|NCT02279394|Dexamethasone|dexamethasone|mesh-list
44758979|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758980|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
44758981|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44758982|NCT01730222|Gemcitabine|gemcitabine|mesh-list
44758984|NCT01730222|Cisplatin|cisplatin|mesh-list
44758985|NCT01730222|Capecitabine|capecitabine|mesh-list
44758986|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44758987|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44758988|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44758989|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44758990|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44758991|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44758992|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44758993|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
44758994|NCT01730222|Antiviral Agents|antiviral agents|mesh-ancestor
44758995|NCT01730222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44758996|NCT01730222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44758997|NCT01730222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44758998|NCT01730222|Immunologic Factors|immunologic factors|mesh-ancestor
44758999|NCT01730222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759000|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
44759001|NCT01730287|Calcium|calcium|mesh-list
44759002|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759003|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759004|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44759005|NCT01730326|Acetaminophen|acetaminophen|mesh-list
44759006|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44759007|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759008|NCT01730326|Analgesics|analgesics|mesh-ancestor
44759009|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
44759010|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759011|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759012|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
44759013|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759014|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759015|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759016|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44759017|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946228|NCT01795313|Imiquimod|imiquimod|mesh-list
44759018|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759019|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759020|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44759021|NCT01730495|Etanercept|etanercept|mesh-list
44759022|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759023|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759024|NCT01730495|Analgesics|analgesics|mesh-ancestor
44759025|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
44759026|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759027|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759028|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759029|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759030|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759031|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44759032|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
44759033|NCT01730508|Interferons|interferons|mesh-list
44759034|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
44759035|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759036|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
44759037|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239768|NCT00575627|Ribavirin|ribavirin|mesh-list
44759038|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
44759039|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759040|NCT01730612|Histamine|histamine|mesh-list
44759041|NCT01730612|Glycine|glycine|mesh-list
44759042|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
44759043|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
44759044|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759045|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759046|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759047|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
44759048|NCT01730664|Ertapenem|ertapenem|mesh-list
44759049|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44759050|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759051|NCT01730677|Vinorelbine|vinorelbine|mesh-list
44759052|NCT01730677|Lapatinib|lapatinib|mesh-list
44759053|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44759054|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759055|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44759056|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44759057|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44759058|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759059|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44239779|NCT00575640|Hydralazine|hydralazine|mesh-list
44759060|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759062|NCT01730976|Vitamins|vitamins|mesh-list
44759063|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
44759064|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759065|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44759066|NCT01731067|Fexofenadine|fexofenadine|mesh-list
44759067|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
44759068|NCT01731067|Midazolam|midazolam|mesh-list
44759069|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
44759070|NCT01731067|Caffeine|caffeine|mesh-list
44759071|NCT01731067|Bupropion|bupropion|mesh-list
44759072|NCT01731067|Omeprazole|omeprazole|mesh-list
44759073|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44759074|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759075|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759076|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759077|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44759078|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44459090|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44759079|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44759080|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44759081|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
44759082|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
44759083|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
44759084|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
44759085|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759086|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759087|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44759088|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759089|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44759090|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759091|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44759092|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44759093|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44759094|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44759095|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
44759096|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44759097|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
44759098|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44759099|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44759100|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44759101|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
44759102|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44759103|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44759104|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
44759105|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
44759106|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44759107|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44759108|NCT01731067|Analgesics|analgesics|mesh-ancestor
44759109|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
44759110|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759111|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759112|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759113|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759114|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759115|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44759116|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44759117|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44759118|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44759119|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
44759120|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
44759121|NCT01731132|Copper|copper|mesh-list
44759122|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
44759123|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44759124|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
44759125|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44759126|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759127|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44759128|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44759129|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44759130|NCT01731132|Trace Elements|trace elements|mesh-ancestor
44759131|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
44759132|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
44759133|NCT01731158|Bevacizumab|bevacizumab|mesh-list
44759134|NCT01731158|Sunitinib|sunitinib|mesh-list
44689581|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759135|NCT01731158|Everolimus|everolimus|mesh-list
44759136|NCT01731158|Sorafenib|sorafenib|mesh-list
44759137|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759138|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759139|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759140|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44759141|NCT01731158|Growth Substances|growth substances|mesh-ancestor
44689582|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689583|NCT01350154|Urological Agents|urological agents|mesh-ancestor
44689584|NCT01350323|Bevacizumab|bevacizumab|mesh-list
44689585|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44689586|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689587|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948366|NCT01103934|Xhance|xhance|mesh-list
44689588|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44689589|NCT01350323|Growth Substances|growth substances|mesh-ancestor
44689590|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689591|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
44689592|NCT01350570|Loperamide|loperamide|mesh-list
44689593|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
44689594|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689595|NCT01350596|Ibuprofen|ibuprofen|mesh-list
44689596|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44689597|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689598|NCT01350596|Analgesics|analgesics|mesh-ancestor
44689599|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
44689600|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689601|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689602|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689603|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689604|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44689605|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689606|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689607|NCT01350609|Candesartan|candesartan|mesh-list
44689608|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
44689609|NCT01350609|Nifedipine|nifedipine|mesh-list
44239829|NCT00575952|Paclitaxel|paclitaxel|mesh-list
44689610|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44689611|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44689612|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44689613|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689614|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44689615|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689616|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44689617|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689618|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689619|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
44689620|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44689621|NCT01350622|Diclofenac|diclofenac|mesh-list
44689622|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44689623|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44689624|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689625|NCT01350622|Analgesics|analgesics|mesh-ancestor
44689626|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
44689627|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689628|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239861|NCT00576069|Budesonide|budesonide|mesh-list
44689629|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689630|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689631|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44689632|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689633|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689634|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
44689635|NCT01350713|Povidone|povidone|mesh-list
44689636|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
44689637|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
43949657|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44689638|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44689639|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689640|NCT01350817|Docetaxel|docetaxel|mesh-list
44689641|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44689642|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689643|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
44689644|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
44689645|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
44689646|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689647|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44689648|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689649|NCT01350856|Artesunate|artesunate|mesh-list
44689650|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
44759142|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759143|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759144|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44759145|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
44759146|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44759147|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239882|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44759148|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759149|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
44759150|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759152|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44759153|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759154|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759155|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759156|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44759157|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44759158|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44759159|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44759160|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
44759161|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
44759162|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
44759163|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
44759164|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759165|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759166|NCT01731275|Quetmolimab|quetmolimab|mesh-list
44759167|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44759168|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759169|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
44759170|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759171|NCT01731301|Ribavirin|ribavirin|mesh-list
44759172|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
44759173|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759174|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
44759175|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759176|NCT01731327|Tofacitinib|tofacitinib|mesh-list
44759177|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44759178|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759179|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759180|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
44759181|NCT01731340|Calcium|calcium|mesh-list
44774295|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759182|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759183|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759184|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44759185|NCT01731431|Glyburide|glyburide|mesh-list
44759186|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44759187|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759188|NCT01731457|Etanercept|etanercept|mesh-list
44759189|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759190|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759191|NCT01731457|Analgesics|analgesics|mesh-ancestor
44759192|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
44759193|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759194|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759195|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759196|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759197|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759198|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536798|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
44536799|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44536800|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44536801|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536802|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
44536803|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
44536804|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
44536805|NCT01581073|Hematinics|hematinics|mesh-ancestor
44536806|NCT01581151|Dexamethasone|dexamethasone|mesh-list
44536807|NCT01581151|Ranibizumab|ranibizumab|mesh-list
44536808|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536809|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
44536810|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
44536811|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536812|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536813|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536814|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
44536815|NCT01581151|Hormones|hormones|mesh-ancestor
44536817|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759199|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
44759201|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759202|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759203|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
44759204|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759205|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759206|NCT01731574|Dapivirine|dapivirine|mesh-list
44759207|NCT01731574|Miconazole|miconazole|mesh-list
44759208|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44759209|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44759210|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
44759211|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759212|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
44759213|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44759214|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44759215|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759216|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759217|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44759218|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
44759219|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759220|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759221|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44759222|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44759223|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
44759224|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44759225|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
44759226|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759227|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759228|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44759229|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
44759230|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759231|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759232|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44759233|NCT01731652|Imiquimod|imiquimod|mesh-list
44759234|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44239985|NCT00576615|Propofol|propofol|mesh-list
44759235|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
44759236|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759237|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759238|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
44759239|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
44759240|NCT01731756|Salicylates|salicylates|mesh-list
44759241|NCT01731756|Petrolatum|petrolatum|mesh-list
44759242|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239995|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
44759243|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
44759244|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
44759245|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44759246|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759247|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759248|NCT01731756|Analgesics|analgesics|mesh-ancestor
44759249|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
44759250|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759251|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759252|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759253|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759254|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44759255|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759256|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759257|NCT01731756|Emollients|emollients|mesh-ancestor
44759258|NCT01731795|Dexamethasone|dexamethasone|mesh-list
44759259|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
44759260|NCT01731795|BB 1101|bb 1101|mesh-list
44759261|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759262|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
44759263|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
44759264|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759265|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759266|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759267|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
44759268|NCT01731795|Hormones|hormones|mesh-ancestor
44759269|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240013|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44759270|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759271|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759272|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536849|NCT01581411|Plasminogen|plasminogen|mesh-list
44759273|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759274|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759275|NCT01731899|S 20098|s 20098|mesh-list
44759276|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759277|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759278|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759279|NCT01731925|Sunitinib|sunitinib|mesh-list
44759280|NCT01731925|Lanreotide|lanreotide|mesh-list
44759281|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759282|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759283|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44759284|NCT01731925|Growth Substances|growth substances|mesh-ancestor
44759285|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759286|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759287|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44759288|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759289|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759290|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
44759291|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44759292|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44759293|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
44759294|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44759295|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
44759296|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44759297|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759298|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44759299|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759300|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759301|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44759302|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
44759303|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44240031|NCT00577057|Cisplatin|cisplatin|mesh-list
44759304|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
44759305|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44759306|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759307|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44759308|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759309|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759310|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
44759311|NCT01732146|Hematinics|hematinics|mesh-ancestor
44759312|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44759313|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
44759314|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759315|NCT01732224|Tenofovir|tenofovir|mesh-list
44759316|NCT01732224|Telbivudine|telbivudine|mesh-list
44759317|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
44759318|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759319|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44759320|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44759321|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759322|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759323|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44759324|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44759325|NCT01732250|Meropenem|meropenem|mesh-list
44759326|NCT01732250|Colistin|colistin|mesh-list
44759327|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44759328|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759329|NCT01732276|Gefitinib|gefitinib|mesh-list
44759330|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759331|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44759332|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759333|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759334|NCT01732328|Vitamin D|vitamin d|mesh-list
44759335|NCT01732328|Calcium|calcium|mesh-list
44759336|NCT01732328|Vitamins|vitamins|mesh-ancestor
44759337|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
44759338|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759339|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759340|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44759341|NCT01732367|Tenofovir|tenofovir|mesh-list
44759342|NCT01732367|Lamivudine|lamivudine|mesh-list
44759343|NCT01732367|Adefovir|adefovir|mesh-list
44759344|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
44240102|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
44240104|NCT00577369|Desflurane|desflurane|mesh-list
44759345|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759346|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44759347|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44759348|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759349|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759350|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44759351|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44759352|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
44759353|NCT01732380|Raltitrexed|raltitrexed|mesh-list
44759354|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240117|NCT00577668|Thalidomide|thalidomide|mesh-list
44759355|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44759356|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
44759357|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759358|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44759359|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759360|NCT01732393|Quercetin|quercetin|mesh-list
44759361|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
44759362|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759363|NCT01732393|Protective Agents|protective agents|mesh-ancestor
44759364|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759365|NCT01732666|Remifentanil|remifentanil|mesh-list
44759366|NCT01732666|Nefopam|nefopam|mesh-list
44759367|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44759368|NCT01732666|Narcotics|narcotics|mesh-ancestor
44759369|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759370|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759371|NCT01732666|Analgesics|analgesics|mesh-ancestor
44759372|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
44240122|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
44759373|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759374|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759375|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44759376|NCT01732744|Eusol|eusol|mesh-list
44759377|NCT01732744|Castor Oil|castor oil|mesh-list
44759378|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44759379|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
44759380|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167586|NCT00268788|Antibodies|antibodies|mesh-list
44759381|NCT01732744|Cathartics|cathartics|mesh-ancestor
44759382|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759383|NCT01732861|Lenalidomide|lenalidomide|mesh-list
44759384|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
44759385|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759386|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759387|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44759388|NCT01732861|Growth Substances|growth substances|mesh-ancestor
44759389|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759390|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759391|NCT01733017|Lycopene|lycopene|mesh-list
44759392|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759393|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
44759394|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759395|NCT01733017|Protective Agents|protective agents|mesh-ancestor
44240151|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
44759396|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759397|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44759398|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44759399|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759400|NCT01733030|Cycloserine|cycloserine|mesh-list
44759401|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44759402|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759403|NCT01733030|Renal Agents|renal agents|mesh-ancestor
44759404|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44759405|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
44759406|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44759407|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
44689651|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44689652|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44689653|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689654|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689655|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
44759408|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759409|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
44759410|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759411|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759412|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759413|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759414|NCT01733043|Analgesics|analgesics|mesh-ancestor
44759415|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
44759416|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459132|NCT01585038|Rilpivirine|rilpivirine|mesh-list
44759417|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44759418|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44759419|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44759420|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44759421|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689656|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
44689657|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44689658|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
44689659|NCT01350882|Rituximab|rituximab|mesh-list
44689660|NCT01350882|Citric Acid|citric acid|mesh-list
44537072|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44537073|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44537074|NCT01582672|Growth Substances|growth substances|mesh-ancestor
44537075|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459137|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
44537076|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
44537077|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44537078|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537079|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537080|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
44459148|NCT01585025|Cathartics|cathartics|mesh-ancestor
44537081|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44759422|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759423|NCT01733095|Ambrisentan|ambrisentan|mesh-list
44759424|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44759425|NCT01733108|Canagliflozin|canagliflozin|mesh-list
44459152|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44759427|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44759428|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759429|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44759430|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759431|NCT01733134|Tolvaptan|tolvaptan|mesh-list
44759432|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44759433|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759434|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
44759435|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759436|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
44759437|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44759438|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44759439|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44759440|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44759441|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759442|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
44759443|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759444|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759445|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44759446|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759447|NCT01733342|Anesthetics|anesthetics|mesh-list
44759448|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759449|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759450|NCT01733394|Lamotrigine|lamotrigine|mesh-list
44759451|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
44759452|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44759453|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44759454|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759455|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759456|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953921|NCT01235897|Paclitaxel|paclitaxel|mesh-list
44759457|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44759458|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44759459|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759460|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44759461|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44759462|NCT01733459|Metformin|metformin|mesh-list
44759463|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44759464|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759465|NCT01733485|Aspirin|aspirin|mesh-list
44759466|NCT01733485|Indomethacin|indomethacin|mesh-list
44759467|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759468|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759469|NCT01733485|Analgesics|analgesics|mesh-ancestor
44759470|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
44759471|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759472|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759473|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759474|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759475|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44759476|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44759477|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759478|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44759479|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44759480|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759481|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
44759482|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
44759483|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
44759484|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44759485|NCT01733589|Etoposide|etoposide|mesh-list
44759486|NCT01733589|Cisplatin|cisplatin|mesh-list
44759487|NCT01733589|Endostatins|endostatins|mesh-list
44759488|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44759489|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759490|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44759491|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44759492|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759493|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537125|NCT01583244|Abatacept|abatacept|mesh-list
44759494|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759495|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44759496|NCT01733589|Growth Substances|growth substances|mesh-ancestor
44759497|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759498|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759499|NCT01733706|Nicotine|nicotine|mesh-list
44759500|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44759501|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
44759502|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759503|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759504|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44759505|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44759506|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
44759507|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759508|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759509|NCT01733823|Nimorazole|nimorazole|mesh-list
44759510|NCT01733823|Cisplatin|cisplatin|mesh-list
44759511|NCT01733823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759512|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44759513|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44759514|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44759515|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759516|NCT01733836|Metformin|metformin|mesh-list
44759517|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44759518|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759519|NCT01733966|Amoxicillin|amoxicillin|mesh-list
44759520|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
44759521|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
44759522|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44759523|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
44759524|NCT01733966|Secnidazole|secnidazole|mesh-list
44759525|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44759526|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759527|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759528|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759529|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44759530|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44759531|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44759532|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44759533|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44759534|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759535|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44759536|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44759537|NCT01733979|Iron|iron|mesh-list
44759538|NCT01733979|Trace Elements|trace elements|mesh-ancestor
44759539|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
44759540|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759541|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44759542|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44759543|NCT01734044|Dexamethasone|dexamethasone|mesh-list
44759544|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
44759545|NCT01734044|BB 1101|bb 1101|mesh-list
44759546|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759547|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
44759548|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
44759549|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759550|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759551|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759552|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
44759553|NCT01734044|Hormones|hormones|mesh-ancestor
44759554|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759555|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759556|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240268|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759557|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
44759558|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759559|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759560|NCT01734057|Dexamethasone|dexamethasone|mesh-list
44759561|NCT01734057|Rituximab|rituximab|mesh-list
44759562|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759563|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759564|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
44759565|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759566|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759567|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759568|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
44759569|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
44759570|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759571|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759572|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
44759573|NCT01734057|Hormones|hormones|mesh-ancestor
44759574|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759575|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44759576|NCT01734096|Candesartan|candesartan|mesh-list
44759577|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
44759578|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44759579|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44759580|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44759581|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759582|NCT01734252|Argatroban|argatroban|mesh-list
44240302|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
44759583|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
44759584|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44759585|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44759586|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759587|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759588|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
44759589|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44759590|NCT01734330|Nicotine|nicotine|mesh-list
44759591|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44759592|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
44759593|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759594|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759595|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44240318|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
44759596|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44759597|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
44759598|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759599|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759600|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44759601|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
44759602|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44759603|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
44759604|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759605|NCT01734408|Antacids|antacids|mesh-ancestor
44759606|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759607|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759608|NCT01734473|Caseins|caseins|mesh-list
44759609|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
44759610|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
44759611|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759612|NCT01734564|Poly I-C|poly i-c|mesh-list
44759613|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44759614|NCT01734564|Poly ICLC|poly iclc|mesh-list
44759615|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
44759616|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
44759617|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759618|NCT01734564|Laxatives|laxatives|mesh-ancestor
44759619|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759620|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
44759621|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689661|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
44689662|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44689663|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689664|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
44689665|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689666|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689667|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
44689668|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44689669|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
44689670|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
44689671|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689672|NCT01350921|Ticagrelor|ticagrelor|mesh-list
44240339|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759622|NCT01734694|Vancomycin|vancomycin|mesh-list
44759623|NCT01734694|Linezolid|linezolid|mesh-list
44759624|NCT01734694|Daptomycin|daptomycin|mesh-list
44759625|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44240367|NCT00579592|Rituximab|rituximab|mesh-list
44759626|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44759627|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759628|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44759629|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759630|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759631|NCT01734798|Gemcitabine|gemcitabine|mesh-list
44759632|NCT01734798|Cisplatin|cisplatin|mesh-list
44759633|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956186|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
44240376|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
44759634|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44759635|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
44759636|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759637|NCT01734798|Antiviral Agents|antiviral agents|mesh-ancestor
44759638|NCT01734798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759639|NCT01734798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759640|NCT01734798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44759641|NCT01734798|Immunologic Factors|immunologic factors|mesh-ancestor
44759642|NCT01734798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759643|NCT01734824|Denosumab|denosumab|mesh-list
44759644|NCT01734824|Teriparatide|teriparatide|mesh-list
44759645|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
44759646|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44759647|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759648|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759649|NCT01734915|Iproplatin|iproplatin|mesh-list
44759650|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759651|NCT01734954|Midazolam|midazolam|mesh-list
44759652|NCT01734954|Analgesics|analgesics|mesh-list
44759653|NCT01734954|Anesthetics|anesthetics|mesh-list
44759654|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
44759655|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
44759656|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240385|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44759657|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759658|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44759659|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759660|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44759661|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43957221|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
44759662|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44759663|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44759664|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
44759665|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
44759666|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
44759667|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957880|NCT01359007|Leucovorin|leucovorin|mesh-list
43958489|NCT01375140|Growth Substances|growth substances|mesh-ancestor
44171326|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
43958726|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43958900|NCT01389856|Bosentan|bosentan|mesh-list
44759668|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759669|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
44759670|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759671|NCT01735006|Vaccines|vaccines|mesh-list
44759672|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
43960164|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
44759673|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759674|NCT01735019|Remifentanil|remifentanil|mesh-list
43960481|NCT01444924|Bupivacaine|bupivacaine|mesh-list
44759675|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44759676|NCT01735019|Narcotics|narcotics|mesh-ancestor
44759677|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759678|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759679|NCT01735019|Analgesics|analgesics|mesh-ancestor
44759680|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
44759681|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759682|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
44759683|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44759684|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
44759685|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759686|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
44759687|NCT01735058|Protective Agents|protective agents|mesh-ancestor
44759688|NCT01735071|Bevacizumab|bevacizumab|mesh-list
44537338|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44537339|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
44537340|NCT01585350|Poly ICLC|poly iclc|mesh-list
44537341|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44537342|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
44537343|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537344|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
44537345|NCT01585415|Aldesleukin|aldesleukin|mesh-list
44537346|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
44537347|NCT01585415|Fludarabine|fludarabine|mesh-list
44759689|NCT01735071|Carboplatin|carboplatin|mesh-list
44759690|NCT01735071|Trabectedin|trabectedin|mesh-list
44759691|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759692|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759693|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759694|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43960764|NCT01457521|Ibuprofen|ibuprofen|mesh-list
44759695|NCT01735071|Growth Substances|growth substances|mesh-ancestor
44759696|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759697|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759698|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44759699|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
44759700|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759701|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44759702|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
44459194|NCT01584232|Dulaglutide|dulaglutide|mesh-list
44759703|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759705|NCT01735097|Vitamins|vitamins|mesh-ancestor
44759706|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
44759707|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759708|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
44759709|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759710|NCT01735097|Protective Agents|protective agents|mesh-ancestor
44759711|NCT01735123|Caseins|caseins|mesh-list
44759712|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
44759713|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
44759714|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759715|NCT01735227|Omeprazole|omeprazole|mesh-list
44759716|NCT01735227|Pantoprazole|pantoprazole|mesh-list
44759717|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44759718|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759719|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44759720|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759721|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759722|NCT01735240|Ketoconazole|ketoconazole|mesh-list
44759723|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
44759724|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759725|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44759726|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44759727|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759728|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759729|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44759730|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
44759731|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759732|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759733|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44759734|NCT01735318|Lisinopril|lisinopril|mesh-list
44759735|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44759736|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
44759737|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759738|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759739|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44759740|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44759741|NCT01735318|Protective Agents|protective agents|mesh-ancestor
44759742|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759743|NCT01735344|Lisinopril|lisinopril|mesh-list
44759744|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44759745|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
44759746|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759747|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759748|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44759749|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44759750|NCT01735344|Protective Agents|protective agents|mesh-ancestor
44759751|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759752|NCT01735370|Etodolac|etodolac|mesh-list
44759753|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759754|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759755|NCT01735370|Analgesics|analgesics|mesh-ancestor
44759756|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
44759757|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759758|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759759|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759760|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759761|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44759762|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44759763|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759764|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759765|NCT01735383|Etodolac|etodolac|mesh-list
44759766|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44759767|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759768|NCT01735383|Analgesics|analgesics|mesh-ancestor
44759769|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
44759770|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759771|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759772|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759773|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759774|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44759775|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44759776|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759777|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759778|NCT01735487|Nicotine|nicotine|mesh-list
44759779|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44759780|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
44759781|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759782|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759783|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44759784|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44759785|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
44759786|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759787|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759788|NCT01735669|Remifentanil|remifentanil|mesh-list
44759789|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
44759790|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44759791|NCT01735669|Narcotics|narcotics|mesh-ancestor
44759792|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759793|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759794|NCT01735669|Analgesics|analgesics|mesh-ancestor
44759795|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
44759796|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759797|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43961740|NCT01489826|HU 211|hu 211|mesh-list
44759798|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
44759799|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
44759800|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759801|NCT01735747|Vincristine|vincristine|mesh-list
44759802|NCT01735747|Temozolomide|temozolomide|mesh-list
44759803|NCT01735747|Nedaplatin|nedaplatin|mesh-list
44240507|NCT00580619|Methyldopa|methyldopa|mesh-list
44759804|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44759805|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759806|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
44759807|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
44759808|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
44759809|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759810|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44759811|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
44759812|NCT01735864|Indirubin|indirubin|mesh-list
44759813|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44759814|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759815|NCT01735890|Amlodipine|amlodipine|mesh-list
44759816|NCT01735890|Valsartan|valsartan|mesh-list
44759817|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44759818|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43962135|NCT01502306|Nicotine|nicotine|mesh-list
44759819|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44759820|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44759821|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759822|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44759823|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759824|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
44759825|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44759826|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44759827|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
44759828|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
44759829|NCT01736020|Ketamine|ketamine|mesh-list
44759830|NCT01736020|Propofol|propofol|mesh-list
44759831|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759832|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759833|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759834|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44759835|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
44759836|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
44759837|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44759838|NCT01736020|Analgesics|analgesics|mesh-ancestor
44759839|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
44759840|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759841|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44759842|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44759843|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44759844|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
44759845|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759846|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759847|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44759848|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44759849|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44759850|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44759851|NCT01736033|Tamsulosin|tamsulosin|mesh-list
44759852|NCT01736033|Finasteride|finasteride|mesh-list
44759853|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44759854|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44759855|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44759856|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44759857|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759858|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759859|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759860|NCT01736033|Urological Agents|urological agents|mesh-ancestor
44759861|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44759862|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44240536|NCT00580827|Disulfiram|disulfiram|mesh-list
44759863|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759864|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
44759865|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759866|NCT01736150|Sevelamer|sevelamer|mesh-list
44759867|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
44759868|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
44759869|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759870|NCT01736163|Hormones|hormones|mesh-list
44759871|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759872|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759873|NCT01736371|Propofol|propofol|mesh-list
44759874|NCT01736371|Sevoflurane|sevoflurane|mesh-list
44759875|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759876|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759877|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759878|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44759879|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
44759880|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
44759881|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44759882|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44759883|NCT01736410|Cisplatin|cisplatin|mesh-list
44759884|NCT01736410|Trastuzumab|trastuzumab|mesh-list
44759885|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759886|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759887|NCT01736423|Ramosetron|ramosetron|mesh-list
44759888|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
44759889|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
44759890|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240591|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44759891|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759892|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44759893|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44759894|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
44759895|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759896|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537522|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
44759898|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44759899|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759900|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44759901|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44759902|NCT01736449|Growth Substances|growth substances|mesh-ancestor
44759903|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759904|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44759905|NCT01736488|Atenolol|atenolol|mesh-list
44759906|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44759907|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44759908|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
44759909|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
44240617|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
44759910|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759911|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759912|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44759913|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44759914|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44759915|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
44759916|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44759917|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759918|NCT01736514|Allopurinol|allopurinol|mesh-list
44759919|NCT01736514|Febuxostat|febuxostat|mesh-list
44759920|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
44240620|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
44759921|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759922|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759923|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
44759924|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44759925|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44759926|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
44759927|NCT01736514|Protective Agents|protective agents|mesh-ancestor
44759928|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759929|NCT01736670|Triamcinolone|triamcinolone|mesh-list
44759930|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44759931|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44759932|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44759933|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44759934|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
44759935|NCT01736670|Hormones|hormones|mesh-ancestor
44759936|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44759937|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759938|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44759939|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
44759940|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240636|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
44689673|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44689674|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44689675|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44689676|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44689677|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
44689678|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689679|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240660|NCT00581789|Growth Substances|growth substances|mesh-ancestor
44689680|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689681|NCT01351038|Capecitabine|capecitabine|mesh-list
44689682|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
44689683|NCT01351038|Panitumumab|panitumumab|mesh-list
44689684|NCT01351038|Epirubicin|epirubicin|mesh-list
44689685|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689686|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
44689687|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689688|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689689|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44689690|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44689691|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44689692|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44689693|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689694|NCT01351168|Levodopa|levodopa|mesh-list
44689695|NCT01351168|Zolpidem|zolpidem|mesh-list
44689696|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44689697|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44689698|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
44689699|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689700|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689701|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689702|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44759941|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759942|NCT01736761|Ritonavir|ritonavir|mesh-list
44759943|NCT01736761|Darunavir|darunavir|mesh-list
44759944|NCT01736761|Rilpivirine|rilpivirine|mesh-list
44759945|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44759946|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44759947|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44759948|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759949|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759950|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44759951|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44759952|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
44759953|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759954|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44759955|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44759956|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44759957|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44759958|NCT01736800|Temozolomide|temozolomide|mesh-list
44759959|NCT01736800|Topotecan|topotecan|mesh-list
44759960|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44759961|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
44759962|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759963|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759964|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44759965|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44759966|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759967|NCT01736813|Maraviroc|maraviroc|mesh-list
44759968|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44759969|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44759970|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759971|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44759972|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44759973|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
44759974|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44759975|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44759976|NCT01736878|Sorafenib|sorafenib|mesh-list
44759977|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759978|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44759979|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759980|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759981|NCT01736891|Rasagiline|rasagiline|mesh-list
44759982|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44759983|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44759984|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44759985|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44759986|NCT01736891|Protective Agents|protective agents|mesh-ancestor
44759987|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759988|NCT01737008|Cisplatin|cisplatin|mesh-list
44759989|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44759990|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
44759991|NCT01737073|Narcotics|narcotics|mesh-ancestor
44759992|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44759993|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44759994|NCT01737073|Analgesics|analgesics|mesh-ancestor
44759995|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
44759996|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44759997|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
44759998|NCT01737086|Astringents|astringents|mesh-ancestor
44759999|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760000|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760001|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
44240664|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44760002|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44537642|NCT01587638|Metoprolol|metoprolol|mesh-list
44760003|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537643|NCT01587638|Atenolol|atenolol|mesh-list
44537644|NCT01587638|Carvedilol|carvedilol|mesh-list
44537645|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
44537646|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44537647|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44537648|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
44537649|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
44537650|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537651|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537652|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44537653|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44760004|NCT01737177|Rituximab|rituximab|mesh-list
44760005|NCT01737177|Lenalidomide|lenalidomide|mesh-list
44760006|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44760007|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44760008|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760009|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
44760010|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760011|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760012|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44760013|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44760014|NCT01737177|Growth Substances|growth substances|mesh-ancestor
44760015|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240697|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
44760016|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44760017|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
44760018|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760019|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
44240704|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
44760020|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760021|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44760022|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44760023|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44760024|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760025|NCT01737203|Urological Agents|urological agents|mesh-ancestor
44760026|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
44760027|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760028|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760029|NCT01737294|Capsaicin|capsaicin|mesh-list
44760030|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
44760031|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760032|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
44760033|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760034|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760035|NCT01737307|Fluorides|fluorides|mesh-list
44760036|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
44760037|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
44760038|NCT01737307|Protective Agents|protective agents|mesh-ancestor
44760039|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760040|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44760041|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44760042|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760043|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
44760044|NCT01737346|Lomustine|lomustine|mesh-list
44760045|NCT01737346|Procarbazine|procarbazine|mesh-list
44760046|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44760047|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
44760048|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760049|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760050|NCT01737359|Tenofovir|tenofovir|mesh-list
44760051|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
44760052|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760053|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44760054|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44760055|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760056|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760057|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44760058|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44760059|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
44760060|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44760061|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44760062|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
44760063|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760064|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760065|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760066|NCT01737411|Urological Agents|urological agents|mesh-ancestor
44760067|NCT01737541|Fluoxetine|fluoxetine|mesh-list
44760068|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44760069|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44760070|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44760071|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963829|NCT01554488|Xhance|xhance|mesh-list
44760072|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760073|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
44760074|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760075|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44760076|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
44760077|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760078|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44760079|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44760080|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760082|NCT01737671|Methotrexate|methotrexate|mesh-list
44760083|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44760084|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
44760085|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760086|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760087|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44760088|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
44760089|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760090|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760091|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760092|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760093|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44240774|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
44760094|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240783|NCT00583986|Albuterol|albuterol|mesh-list
44760095|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
44760096|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760097|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44760098|NCT01737671|Antidotes|antidotes|mesh-ancestor
44760099|NCT01737671|Protective Agents|protective agents|mesh-ancestor
44760100|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
44760101|NCT01737671|Vitamins|vitamins|mesh-ancestor
44760102|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
44760103|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
44760104|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44760105|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44760106|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
44760107|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760108|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760109|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760110|NCT01737918|Urological Agents|urological agents|mesh-ancestor
44760111|NCT01738035|Budesonide|budesonide|mesh-list
44760112|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760113|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44760114|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
44240799|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44760115|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760116|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760117|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44240806|NCT00584155|Ofloxacin|ofloxacin|mesh-list
44760118|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
44760119|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
44760120|NCT01738035|Hormones|hormones|mesh-ancestor
44760121|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760122|NCT01738087|Fluticasone|fluticasone|mesh-list
44760123|NCT01738087|Xhance|xhance|mesh-list
44760124|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
44760125|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760126|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44760127|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
44760128|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760129|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760130|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44760131|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44760132|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760133|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44760134|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44760135|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44760136|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44760137|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44760138|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240807|NCT00584155|Levofloxacin|levofloxacin|mesh-list
44760139|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760140|NCT01738100|Morphine|morphine|mesh-list
44760141|NCT01738100|Clopidogrel|clopidogrel|mesh-list
44760142|NCT01738100|Ticagrelor|ticagrelor|mesh-list
44760143|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44760144|NCT01738100|Narcotics|narcotics|mesh-ancestor
44760145|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760146|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760147|NCT01738100|Analgesics|analgesics|mesh-ancestor
44760148|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
44760149|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760150|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44760151|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44760152|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44760153|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44760154|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
44760155|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760156|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760158|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44240836|NCT00584376|Analgesics|analgesics|mesh-ancestor
44760159|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760160|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44760161|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760162|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760163|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44760164|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44760165|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
44760166|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760167|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
44760168|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44760169|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
44760170|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760171|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
44760172|NCT01738243|Protective Agents|protective agents|mesh-ancestor
44760173|NCT01738282|Baclofen|baclofen|mesh-list
44760174|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44760175|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760176|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44760177|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760178|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44760179|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
44760180|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
44760181|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760182|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760183|NCT01738295|Donepezil|donepezil|mesh-list
44760184|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44760185|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760186|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760187|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
44760188|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760189|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760190|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
44760191|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
44240873|NCT00584571|Dexetimide|dexetimide|mesh-list
44760192|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760193|NCT01738373|Plerixafor|plerixafor|mesh-list
44760194|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43964514|NCT01578278|Xhance|xhance|mesh-list
44760195|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44760196|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
44760197|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760198|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
44760199|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
44760200|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760201|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760202|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760203|NCT01738451|Dabrafenib|dabrafenib|mesh-list
44760204|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760205|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44760206|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760207|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760208|NCT01738542|Bosentan|bosentan|mesh-list
44760209|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
44760210|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44760211|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760212|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44760213|NCT01738607|Psyllium|psyllium|mesh-list
44760214|NCT01738607|Laxatives|laxatives|mesh-ancestor
44760215|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760216|NCT01738607|Cathartics|cathartics|mesh-ancestor
44760217|NCT01738724|Goserelin|goserelin|mesh-list
44760218|NCT01738724|Dienogest|dienogest|mesh-list
44760219|NCT01738724|Desogestrel|desogestrel|mesh-list
44760220|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44760221|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459307|NCT01582282|Psyllium|psyllium|mesh-list
44760222|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44760223|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
44760224|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760225|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760226|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44760227|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44760228|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44760229|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44760230|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44760231|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760232|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44760233|NCT01738724|Progestins|progestins|mesh-ancestor
44760234|NCT01738724|Hormones|hormones|mesh-ancestor
44760235|NCT01738763|Inositol|inositol|mesh-list
44760236|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
44760237|NCT01738763|Vitamins|vitamins|mesh-ancestor
44760238|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
44760239|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760240|NCT01738802|Micronutrients|micronutrients|mesh-list
44760241|NCT01738802|Trace Elements|trace elements|mesh-list
44760242|NCT01738802|Antioxidants|antioxidants|mesh-list
44760243|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760244|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760245|NCT01738802|Protective Agents|protective agents|mesh-ancestor
44760246|NCT01738815|Valproic Acid|valproic acid|mesh-list
44760247|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
44760248|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760249|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760250|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
44760251|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760252|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760253|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
44760254|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760255|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760256|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760257|NCT01738867|Naltrexone|naltrexone|mesh-list
44760258|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44760259|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44760260|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537913|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44537914|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537915|NCT01589354|Ropivacaine|ropivacaine|mesh-list
44537916|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
44537917|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
44537918|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537922|NCT01589393|Enoxaparin|enoxaparin|mesh-list
44760261|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
44459338|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760262|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760264|NCT01738893|Analgesics|analgesics|mesh-ancestor
44760265|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
44760266|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760267|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689703|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44689704|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689705|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44689706|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
44689707|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
44689708|NCT01351272|Methylphenidate|methylphenidate|mesh-list
44689709|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44689710|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689711|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44689712|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44689713|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689714|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689715|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
44689716|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689717|NCT01351285|Remifentanil|remifentanil|mesh-list
44689718|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44689719|NCT01351285|Narcotics|narcotics|mesh-ancestor
44689720|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689721|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689722|NCT01351285|Analgesics|analgesics|mesh-ancestor
44689723|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
44689724|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689725|NCT01351298|Lidocaine|lidocaine|mesh-list
44689726|NCT01351298|Xylometazoline|xylometazoline|mesh-list
44689727|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689728|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
44689729|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689730|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689731|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
44689732|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689733|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689734|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44689735|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44689736|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689737|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689738|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
44240904|NCT00584636|Budesonide|budesonide|mesh-list
44689739|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44689740|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689741|NCT01351428|Nifedipine|nifedipine|mesh-list
44689742|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44689743|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689744|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689745|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44689746|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689747|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689748|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
44689749|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44689750|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
44689751|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44689752|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
44689753|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689754|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689755|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44689756|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689757|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44689758|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
44689759|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689760|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689761|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44689762|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689763|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
44689764|NCT01351493|Protective Agents|protective agents|mesh-ancestor
44689765|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43965057|NCT01595516|Kininogens|kininogens|mesh-list
44689766|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44689767|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44537982|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760268|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
44760269|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44760270|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760271|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760272|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760273|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44760274|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44760275|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760276|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760278|NCT01738945|Amlodipine|amlodipine|mesh-list
44760279|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44760280|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44760281|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44760282|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760283|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44760284|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760285|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
44760286|NCT01739049|Liraglutide|liraglutide|mesh-list
44760287|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44760288|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760289|NCT01739049|Incretins|incretins|mesh-ancestor
44760290|NCT01739049|Hormones|hormones|mesh-ancestor
44760291|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760292|NCT01739127|Risperidone|risperidone|mesh-list
44760293|NCT01739127|Aripiprazole|aripiprazole|mesh-list
44760294|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44760295|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44760296|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
44760297|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760298|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760299|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760300|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44760301|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760302|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760303|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760304|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44760305|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
44760306|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
44760307|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
44760308|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44760309|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44760310|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44760311|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44760312|NCT01739192|Bupropion|bupropion|mesh-list
44241022|NCT00585520|Progesterone|progesterone|mesh-list
44760313|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44760314|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
44760315|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760316|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44760317|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44760318|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44760319|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760320|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
44760321|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760322|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760323|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44760324|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44760325|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760326|NCT01739218|Paclitaxel|paclitaxel|mesh-list
44760327|NCT01739218|Bevacizumab|bevacizumab|mesh-list
44760328|NCT01739218|Carboplatin|carboplatin|mesh-list
44760329|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44241043|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
44760330|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760331|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44760332|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44760333|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44760334|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760335|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44760336|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44760337|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44760338|NCT01739218|Growth Substances|growth substances|mesh-ancestor
44760339|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537989|NCT01589952|Interferons|interferons|mesh-list
44760340|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
44760341|NCT01739413|Anesthetics|anesthetics|mesh-list
44760342|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760343|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760344|NCT01739439|Gemcitabine|gemcitabine|mesh-list
44760345|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44760346|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
44760347|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760348|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760349|NCT01739439|Antiviral Agents|antiviral agents|mesh-ancestor
44760350|NCT01739439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760351|NCT01739439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760352|NCT01739439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44760353|NCT01739439|Immunologic Factors|immunologic factors|mesh-ancestor
44760354|NCT01739439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760355|NCT01739504|Anesthetics|anesthetics|mesh-list
44760356|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760357|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760358|NCT01739556|Aspirin|aspirin|mesh-list
44760359|NCT01739556|Ticagrelor|ticagrelor|mesh-list
44760360|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760361|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760362|NCT01739556|Analgesics|analgesics|mesh-ancestor
44760363|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
44760364|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760365|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760366|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760367|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760368|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44760369|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44760370|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760371|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44760372|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44760373|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760374|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
44760375|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44760376|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44241089|NCT00586365|Naproxen|naproxen|mesh-list
44760377|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44760378|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
44760379|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760380|NCT01739582|Enclomiphene|enclomiphene|mesh-list
44760381|NCT01739582|Clomiphene|clomiphene|mesh-list
44760382|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
44760383|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44760384|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
44760385|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760386|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760387|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44760388|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
44760389|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760390|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44760391|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44760392|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
44760393|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
44760394|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760395|NCT01739673|Riboflavin|riboflavin|mesh-list
44760396|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
44760397|NCT01739673|Vitamins|vitamins|mesh-ancestor
44760398|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
44760399|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760400|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44760401|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760402|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
44760403|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
44760404|NCT01739855|Calcium|calcium|mesh-list
44760405|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44760406|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760407|NCT01739855|Antacids|antacids|mesh-ancestor
44760408|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760409|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760410|NCT01739855|Vitamins|vitamins|mesh-ancestor
44760411|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
44760412|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760413|NCT01739894|Paclitaxel|paclitaxel|mesh-list
44760414|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44760415|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760416|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
44760417|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
44760418|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
44760419|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760420|NCT01739907|Vitamin D|vitamin d|mesh-list
44760421|NCT01739907|Vitamins|vitamins|mesh-ancestor
44760422|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
44760423|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760424|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760425|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
44760426|NCT01739920|Povidone|povidone|mesh-list
44760427|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
44760428|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
44760429|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44760430|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760431|NCT01739985|Dexamethasone|dexamethasone|mesh-list
44760432|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
44760433|NCT01739985|Droperidol|droperidol|mesh-list
44760434|NCT01739985|Ondansetron|ondansetron|mesh-list
44760435|NCT01739985|BB 1101|bb 1101|mesh-list
44760436|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760437|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
44760438|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
44760439|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760440|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760441|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760442|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
44760443|NCT01739985|Hormones|hormones|mesh-ancestor
44760444|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760445|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44760446|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760447|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
44760448|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760449|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760450|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
44760451|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760452|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44760453|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
44760454|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760455|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44760456|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760457|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760458|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760459|NCT01739985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44760460|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44760461|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44760462|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44760463|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
44538142|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538143|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
44538144|NCT01580007|Vitamin D|vitamin d|mesh-list
44538145|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44538146|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44241157|NCT00586976|Ropivacaine|ropivacaine|mesh-list
44538147|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538148|NCT01580007|Vitamins|vitamins|mesh-ancestor
44538149|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
44538150|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760465|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
44760466|NCT01740245|Polihexanide|polihexanide|mesh-list
44760467|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44760468|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760469|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
44760470|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44760471|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760472|NCT01740271|Epirubicin|epirubicin|mesh-list
44760473|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44760474|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760475|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44760476|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44760477|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760478|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760479|NCT01740336|Paclitaxel|paclitaxel|mesh-list
44760480|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44760481|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760482|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44760483|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44760484|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44760485|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760486|NCT01740453|Ropivacaine|ropivacaine|mesh-list
44760487|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
44760488|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
44760489|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760490|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760491|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
44760492|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760493|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
44760494|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
44760495|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760496|NCT01740518|Protective Agents|protective agents|mesh-ancestor
44760497|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760498|NCT01740518|Vitamins|vitamins|mesh-ancestor
44760499|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
44760500|NCT01740921|Aspirin|aspirin|mesh-list
44760501|NCT01740921|Liraglutide|liraglutide|mesh-list
44760502|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760503|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760504|NCT01740921|Analgesics|analgesics|mesh-ancestor
44760505|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
44760506|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760507|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760508|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760509|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760510|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44760511|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44760512|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760513|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44760514|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44760515|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760516|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
44760517|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44760518|NCT01740921|Incretins|incretins|mesh-ancestor
44760519|NCT01740921|Hormones|hormones|mesh-ancestor
44760520|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760521|NCT01740947|Amphotericin B|amphotericin b|mesh-list
44760522|NCT01740947|Tobramycin|tobramycin|mesh-list
44760523|NCT01740947|Colistin|colistin|mesh-list
44760524|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44760525|NCT01740947|Amebicides|amebicides|mesh-ancestor
44760526|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44760527|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44760528|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760529|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44760530|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
44760531|NCT01740960|Dronabinol|dronabinol|mesh-list
44760532|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
44760533|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760534|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760535|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760536|NCT01740960|Analgesics|analgesics|mesh-ancestor
44760537|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
44760538|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760539|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44760540|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44760541|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760542|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760543|NCT01740960|Hormones|hormones|mesh-ancestor
44760544|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760545|NCT01741038|Cetuximab|cetuximab|mesh-list
44760546|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44760547|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760548|NCT01741077|Folic Acid|folic acid|mesh-list
44760549|NCT01741077|Hematinics|hematinics|mesh-ancestor
44760550|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
44760551|NCT01741077|Vitamins|vitamins|mesh-ancestor
44760552|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
44241217|NCT00587496|Valacyclovir|valacyclovir|mesh-list
44760553|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760554|NCT01741142|Citalopram|citalopram|mesh-list
44760555|NCT01741142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44760556|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44760557|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44760558|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760559|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760560|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
44760561|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760562|NCT01741142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44760563|NCT01741142|Antidepressive Agents|antidepressive agents|mesh-ancestor
44760564|NCT01741142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760565|NCT01741181|Vitamin D|vitamin d|mesh-list
44760566|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
44760567|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
44241240|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
44241241|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241244|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44760568|NCT01741181|Vitamins|vitamins|mesh-list
44760569|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
44760570|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760571|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760572|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44760573|NCT01741285|Fluticasone|fluticasone|mesh-list
44760574|NCT01741285|Beclomethasone|beclomethasone|mesh-list
44760575|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760576|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44760577|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
44760578|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760579|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760580|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44760581|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
44760582|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760583|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44760584|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
44760585|NCT01741285|Hormones|hormones|mesh-ancestor
44760586|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760587|NCT01741324|Vitamin D|vitamin d|mesh-list
44760588|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
44760589|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
44760590|NCT01741324|Vitamins|vitamins|mesh-list
44760591|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
44760592|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760593|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44760594|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44760595|NCT01741376|Progesterone|progesterone|mesh-list
44760596|NCT01741376|Progestins|progestins|mesh-ancestor
44760597|NCT01741376|Hormones|hormones|mesh-ancestor
44760598|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760599|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760600|NCT01741389|Melatonin|melatonin|mesh-list
44760601|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
44760602|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760603|NCT01741389|Protective Agents|protective agents|mesh-ancestor
44760604|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760605|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760606|NCT01741493|Upadacitinib|upadacitinib|mesh-list
44241284|NCT00587873|Vitamins|vitamins|mesh-ancestor
44760607|NCT01741493|Tofacitinib|tofacitinib|mesh-list
44760608|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44760609|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760610|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760611|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44760612|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760613|NCT01741506|Dalteparin|dalteparin|mesh-list
44760614|NCT01741506|Tinzaparin|tinzaparin|mesh-list
44760615|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44760616|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
44760617|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44760618|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44760619|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760620|NCT01741519|Landiolol|landiolol|mesh-list
44760621|NCT01741519|Esmolol|esmolol|mesh-list
44760622|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44760623|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44760624|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44760625|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
44760626|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760627|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760628|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760629|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44760630|NCT01741558|Riboflavin|riboflavin|mesh-list
44760631|NCT01741558|Methotrexate|methotrexate|mesh-list
44760632|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44760633|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
44760634|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760635|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689769|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
44689770|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689771|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44689772|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44689773|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44689774|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689775|NCT01351636|Arotinolol|arotinolol|mesh-list
44689776|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44689777|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44689778|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44689779|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689780|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689781|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689782|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44689783|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44689784|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44689785|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689786|NCT01351818|Hormones|hormones|mesh-list
44689787|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44689788|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689789|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44689790|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44689791|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
44689792|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689793|NCT01351948|Antacids|antacids|mesh-ancestor
44689794|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689795|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689796|NCT01352026|Metformin|metformin|mesh-list
44689797|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44689798|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689799|NCT01352039|Heparin|heparin|mesh-list
44689800|NCT01352039|Calcium heparin|calcium heparin|mesh-list
44689801|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
44689802|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44689803|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44689804|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689805|NCT01352065|Bosentan|bosentan|mesh-list
44689806|NCT01352065|Ambrisentan|ambrisentan|mesh-list
44689807|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44689808|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44689809|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689810|NCT01352091|Goserelin|goserelin|mesh-list
44689811|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44689812|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689813|NCT01352130|Ondansetron|ondansetron|mesh-list
44689814|NCT01352130|Granisetron|granisetron|mesh-list
44241416|NCT00589264|Copper|copper|mesh-list
44689852|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
44689853|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
44689854|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44689855|NCT01352312|Ofatumumab|ofatumumab|mesh-list
44689856|NCT01352312|Pentostatin|pentostatin|mesh-list
44689857|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44689858|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
44689859|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760636|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44760637|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
44760638|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760639|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760640|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760641|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760642|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44760643|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44760644|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
44760645|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760646|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44760647|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44760648|NCT01741558|Vitamins|vitamins|mesh-ancestor
44760649|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
44760650|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44760651|NCT01741623|Bisoprolol|bisoprolol|mesh-list
44760652|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44760653|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
44760654|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
44241390|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760655|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760656|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760657|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44760658|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44760659|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44760660|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
44760661|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760662|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760663|NCT01741649|Povidone|povidone|mesh-list
44760664|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
44760665|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
44760666|NCT01741753|Prednisone|prednisone|mesh-list
44760667|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760668|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
44760669|NCT01741753|Hormones|hormones|mesh-ancestor
44760670|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760671|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760672|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44760673|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760674|NCT01741831|Darunavir|darunavir|mesh-list
44760675|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44760676|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44760677|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
44760678|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760679|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760680|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44241419|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760681|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44760682|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
44760683|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760684|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
44760685|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760686|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760687|NCT01742247|Palmidrol|palmidrol|mesh-list
44760688|NCT01742247|Analgesics|analgesics|mesh-ancestor
44760689|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
44760690|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760691|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760692|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760693|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760694|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760695|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760696|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
44760697|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760698|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44760699|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44760700|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760701|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760702|NCT01742247|Hormones|hormones|mesh-ancestor
44760703|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760704|NCT01742273|Vitamin K|vitamin k|mesh-list
44760705|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
44760706|NCT01742273|Vitamins|vitamins|mesh-ancestor
44760707|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
44760708|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760709|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44760710|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44760711|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760712|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
44760713|NCT01742273|Coagulants|coagulants|mesh-ancestor
44760714|NCT01742338|Prednisone|prednisone|mesh-list
44760715|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
44760716|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44760717|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44760718|NCT01742338|Prednisolone|prednisolone|mesh-list
44760719|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
44241441|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
44760720|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44760721|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
44760722|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241460|NCT00589485|Cobalt|cobalt|mesh-list
44760723|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
44760724|NCT01742338|Hormones|hormones|mesh-ancestor
44760725|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538429|NCT01561911|Antibodies|antibodies|mesh-list
44538430|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44538431|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
44538432|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538433|NCT01561937|Warfarin|warfarin|mesh-list
44538434|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
44538435|NCT01561950|Clopidogrel|clopidogrel|mesh-list
44538436|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44538437|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44538438|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44538439|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44538440|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
44538441|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538442|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538443|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760726|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760727|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44760728|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241462|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
44760729|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
44760730|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
44760731|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760732|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760733|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44760734|NCT01742338|Protective Agents|protective agents|mesh-ancestor
44760735|NCT01742390|Risperidone|risperidone|mesh-list
44760736|NCT01742390|Aripiprazole|aripiprazole|mesh-list
44760737|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44760738|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44760739|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
44760740|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241487|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760741|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760742|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760743|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44760744|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760745|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760746|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241493|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
44760747|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44760748|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
44760749|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
44760750|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
44760751|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44760752|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44760753|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43966122|NCT05199194|Tenecteplase|tenecteplase|mesh-list
44760754|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44760755|NCT01742429|Amoxicillin|amoxicillin|mesh-list
44760756|NCT01742429|Metronidazole|metronidazole|mesh-list
44760757|NCT01742429|Levofloxacin|levofloxacin|mesh-list
44760758|NCT01742429|Ofloxacin|ofloxacin|mesh-list
44760759|NCT01742429|Tetracycline|tetracycline|mesh-list
44760760|NCT01742429|Bismuth|bismuth|mesh-list
44760761|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44760762|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44760763|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44760764|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760765|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44760766|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44760767|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44760768|NCT01742429|Renal Agents|renal agents|mesh-ancestor
44760769|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44760770|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44241508|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
44760771|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760772|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760773|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760774|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44760775|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44760776|NCT01742429|Antacids|antacids|mesh-ancestor
44760777|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44760778|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44760779|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
44760780|NCT01742533|Hormones|hormones|mesh-list
44760781|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760782|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760783|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
44760784|NCT01742624|Tacrolimus|tacrolimus|mesh-list
44760785|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44760786|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
44760787|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760788|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44760789|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760790|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760791|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44760792|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760793|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44760794|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
44760795|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44760796|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760797|NCT01742637|Adapalene|adapalene|mesh-list
44760798|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44760799|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
44538479|NCT01562405|Hormones|hormones|mesh-ancestor
44760800|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760801|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760802|NCT01742637|Analgesics|analgesics|mesh-ancestor
44760803|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
44760804|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760805|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760806|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760807|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760808|NCT01742663|Diclofenac|diclofenac|mesh-list
44760809|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760810|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760811|NCT01742663|Analgesics|analgesics|mesh-ancestor
44760812|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
44760813|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760814|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760815|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760816|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760817|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44760818|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760819|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760820|NCT01742676|Tacrolimus|tacrolimus|mesh-list
44760821|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44760822|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
44760823|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760824|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44760825|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241580|NCT00590408|Ubiquinone|ubiquinone|mesh-list
44760826|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760827|NCT01742689|Indomethacin|indomethacin|mesh-list
44241584|NCT00590408|Vitamins|vitamins|mesh-ancestor
44760828|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44760829|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44760830|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760831|NCT01742689|Analgesics|analgesics|mesh-ancestor
44760832|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
44760833|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760834|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760835|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241585|NCT00590447|Rituximab|rituximab|mesh-list
44241592|NCT00590603|Bortezomib|bortezomib|mesh-list
44760836|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760837|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
44760838|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
44760839|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760840|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44760841|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760842|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760843|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
44760844|NCT01742689|Coagulants|coagulants|mesh-ancestor
44760845|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44760846|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
44760847|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44760848|NCT01742702|Bisoprolol|bisoprolol|mesh-list
44760849|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
44760850|NCT01742702|Albuterol|albuterol|mesh-list
44760851|NCT01742702|Caseins|caseins|mesh-list
44760852|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44760853|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
44760854|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760855|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760856|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44760857|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689860|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689861|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44689862|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689863|NCT01352338|Prednisone|prednisone|mesh-list
44689864|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
44689865|NCT01352338|Lenalidomide|lenalidomide|mesh-list
44689866|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44689867|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
44689868|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689869|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689870|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44689871|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
44689872|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689873|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689874|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44689875|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689876|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
44689877|NCT01352338|Hormones|hormones|mesh-ancestor
44689878|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760858|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
44760859|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760860|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44760861|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44760862|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44760863|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
44760864|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760865|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760866|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
44760867|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
44760868|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
44241643|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44760869|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44760870|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
44760871|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44760872|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44760873|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44241647|NCT00590837|Lomustine|lomustine|mesh-list
44760874|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44760875|NCT01742767|Pemetrexed|pemetrexed|mesh-list
44760876|NCT01742767|Cisplatin|cisplatin|mesh-list
44760877|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760878|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760879|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760880|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44760881|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44760882|NCT01742793|Lenalidomide|lenalidomide|mesh-list
44760883|NCT01742793|Romidepsin|romidepsin|mesh-list
44760884|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
44760885|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760886|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44760887|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44760888|NCT01742793|Growth Substances|growth substances|mesh-ancestor
44760889|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
44760890|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760891|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44760892|NCT01742845|Ropivacaine|ropivacaine|mesh-list
44760893|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
44760894|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
44760895|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760896|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760897|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
44241667|NCT00591162|Tetracycline|tetracycline|mesh-list
44760898|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760899|NCT01742988|Rituximab|rituximab|mesh-list
44760900|NCT01742988|Venetoclax|venetoclax|mesh-list
44760901|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44760902|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760903|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
44760904|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760905|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44760906|NCT01743014|Ramipril|ramipril|mesh-list
44760907|NCT01743014|Clopidogrel|clopidogrel|mesh-list
44760908|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44760909|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44760910|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44760911|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44760912|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
44760913|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760914|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241684|NCT00591201|Infliximab|infliximab|mesh-list
44760915|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760916|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43967781|NCT03386721|Antibodies|antibodies|mesh-list
44760917|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
44760918|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760919|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44459406|NCT01580488|Calcipotriene|calcipotriene|mesh-list
44760920|NCT01743066|Vitamin E|vitamin e|mesh-list
44760921|NCT01743066|Vitamins|vitamins|mesh-ancestor
44760922|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
44760923|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760924|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
44760925|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760926|NCT01743066|Protective Agents|protective agents|mesh-ancestor
44760927|NCT01743079|Lamivudine|lamivudine|mesh-list
44760928|NCT01743079|Telbivudine|telbivudine|mesh-list
44760929|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44760930|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44760931|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44760932|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760933|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
44760934|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44760935|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44760936|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44760937|NCT01743118|Calcipotriene|calcipotriene|mesh-list
44760938|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44760939|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
44760940|NCT01743144|Analgesics|analgesics|mesh-ancestor
44760941|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
44760942|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760943|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760944|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
44760945|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760946|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44760947|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
44760948|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44760949|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459428|NCT01580020|Hormones|hormones|mesh-ancestor
44760950|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760951|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44760952|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
44760953|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44760954|NCT01743157|Bevacizumab|bevacizumab|mesh-list
44760955|NCT01743157|Ipilimumab|ipilimumab|mesh-list
44760956|NCT01743157|Interleukin-2|interleukin-2|mesh-list
44760957|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44760958|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44760959|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44760960|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44760961|NCT01743157|Growth Substances|growth substances|mesh-ancestor
44760962|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760963|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
44760964|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44760965|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760966|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44760967|NCT01743157|Analgesics|analgesics|mesh-ancestor
44760968|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
44760969|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44760970|NCT01743235|Buspirone|buspirone|mesh-list
44760971|NCT01743235|Testosterone|testosterone|mesh-list
44760972|NCT01743235|Androgens|androgens|mesh-ancestor
44760973|NCT01743235|Hormones|hormones|mesh-ancestor
44760974|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44760975|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760976|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44760977|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760978|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760979|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459454|NCT01578850|Analgesics|analgesics|mesh-ancestor
44760980|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44760981|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
44459464|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
44760982|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760983|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44760984|NCT01743300|Sunitinib|sunitinib|mesh-list
44760985|NCT01743300|Midazolam|midazolam|mesh-list
44760986|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44760987|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44760988|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44760989|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44760990|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44760991|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44760992|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44760993|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44760994|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
44760995|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
44760996|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
44760997|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
44760998|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44760999|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241710|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
44761000|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761001|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44761002|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44761003|NCT01743300|Growth Substances|growth substances|mesh-ancestor
44761004|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
44761005|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761006|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761007|NCT01743326|Anesthetics|anesthetics|mesh-list
44761008|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761009|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761010|NCT01743365|Cisplatin|cisplatin|mesh-list
44761011|NCT01743365|Afatinib|afatinib|mesh-list
44761012|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761013|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761014|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241717|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761015|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761016|NCT01743378|Ropivacaine|ropivacaine|mesh-list
44761017|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
44761018|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
44761019|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761020|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761021|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
44761022|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761023|NCT01743456|Anesthetics|anesthetics|mesh-list
44761024|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761025|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761026|NCT01743508|Misoprostol|misoprostol|mesh-list
44761027|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44761028|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
44761029|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44761030|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761031|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44761032|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761033|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
44761034|NCT01743690|Nystatin|nystatin|mesh-list
44761035|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44761036|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761037|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
44761038|NCT01743690|Hormones|hormones|mesh-ancestor
44761039|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241743|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
44761040|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761041|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44761042|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761043|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
44761044|NCT01743690|Ionophores|ionophores|mesh-ancestor
44761045|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761046|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761047|NCT01743755|Dexamethasone|dexamethasone|mesh-list
44761048|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761049|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
44761050|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
44761051|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761052|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761053|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761054|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
44761055|NCT01743755|Hormones|hormones|mesh-ancestor
44761056|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761057|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44761058|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761059|NCT01743794|Ropivacaine|ropivacaine|mesh-list
44761060|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689879|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44689880|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44241763|NCT00591916|Thrombin|thrombin|mesh-list
44689881|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44689882|NCT01352338|Growth Substances|growth substances|mesh-ancestor
44689883|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
44689884|NCT01352494|Gemcitabine|gemcitabine|mesh-list
44689885|NCT01352494|Docetaxel|docetaxel|mesh-list
44689886|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689887|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
44689888|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689889|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689890|NCT01352494|Antiviral Agents|antiviral agents|mesh-ancestor
44689891|NCT01352494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689892|NCT01352494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689893|NCT01352494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44689894|NCT01352494|Immunologic Factors|immunologic factors|mesh-ancestor
44689895|NCT01352494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689896|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44689897|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44689898|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44689899|NCT01352559|Milnacipran|milnacipran|mesh-list
44241782|NCT00592111|Etoposide|etoposide|mesh-list
44761061|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
44761062|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241786|NCT00592111|Bleomycin|bleomycin|mesh-list
44761063|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970033|NCT01669434|Protective Agents|protective agents|mesh-ancestor
44761064|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
44241789|NCT00592111|Mitogens|mitogens|mesh-list
44761065|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761066|NCT01743820|Piperaquine|piperaquine|mesh-list
44761067|NCT01743820|Primaquine|primaquine|mesh-list
44761068|NCT01743820|Artenimol|artenimol|mesh-list
44761069|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
44761070|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761071|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44761072|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761073|NCT01743885|Propranolol|propranolol|mesh-list
44761074|NCT01743885|Acebutolol|acebutolol|mesh-list
43970255|NCT01681095|Tryptophan|tryptophan|mesh-list
44761075|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44761076|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44761077|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761078|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761079|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761080|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761081|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44761082|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761083|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44761084|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
44761085|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
43970402|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761086|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241807|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761087|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44689900|NCT01352559|Mirtazapine|mirtazapine|mesh-list
44761088|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
44241812|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
44761089|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44761090|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
44761091|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44761092|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
44761093|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761094|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761095|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
44761096|NCT01743911|Tadalafil|tadalafil|mesh-list
44761097|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
44761098|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44761099|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44761100|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761101|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761102|NCT01743911|Urological Agents|urological agents|mesh-ancestor
44761103|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
44761104|NCT01744106|Ephedrine|ephedrine|mesh-list
44241813|NCT00592137|Calcium|calcium|mesh-list
44761105|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44761106|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
44761107|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761108|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689901|NCT01352559|Sertraline|sertraline|mesh-list
44689902|NCT01352559|Fluoxetine|fluoxetine|mesh-list
44689903|NCT01352559|Paroxetine|paroxetine|mesh-list
44689904|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44689905|NCT01352559|Nortriptyline|nortriptyline|mesh-list
44241833|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
44689906|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
44689907|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44689908|NCT01352559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44538816|NCT01565512|Bupivacaine|bupivacaine|mesh-list
44538817|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
44538818|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
44538819|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538820|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538821|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
44538822|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538823|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
44538824|NCT01565590|Propofol|propofol|mesh-list
44538825|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44538826|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538827|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538828|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44538829|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
44538830|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
44538831|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538832|NCT01565590|Analgesics|analgesics|mesh-ancestor
44538833|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
44538834|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538835|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44538837|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44761109|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44761110|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44761111|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
44761112|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44761113|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44761114|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
44761115|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761116|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761117|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761118|NCT01744184|Midazolam|midazolam|mesh-list
44761119|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
44761120|NCT01744184|Entonox|entonox|mesh-list
43971236|NCT01716039|Adalimumab|adalimumab|mesh-list
44761121|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44761122|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761123|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761124|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241868|NCT00592410|Insulin|insulin|mesh-list
44761125|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761126|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761127|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761128|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44761129|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
44761130|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
44761131|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
44761132|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
44761133|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761134|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761135|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44761136|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761137|NCT01744184|Analgesics|analgesics|mesh-ancestor
44761138|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
44761139|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761140|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44761141|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44761142|NCT01744236|Liraglutide|liraglutide|mesh-list
44761143|NCT01744236|Exenatide|exenatide|mesh-list
44761144|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44761145|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761146|NCT01744236|Incretins|incretins|mesh-ancestor
44761147|NCT01744236|Hormones|hormones|mesh-ancestor
44761148|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761149|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44761150|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
44761151|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761152|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761153|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44761154|NCT01744249|Axitinib|axitinib|mesh-list
44761155|NCT01744249|Octreotide|octreotide|mesh-list
44761156|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241890|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44761157|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761158|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761159|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761160|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761161|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44761162|NCT01744262|Anesthetics|anesthetics|mesh-list
44241902|NCT00592618|Expectorants|expectorants|mesh-ancestor
44761163|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761164|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761165|NCT01744288|Clopidogrel|clopidogrel|mesh-list
44761166|NCT01744288|Ticagrelor|ticagrelor|mesh-list
44761167|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44761168|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44241907|NCT00592618|Protective Agents|protective agents|mesh-ancestor
44761169|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44761170|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44761171|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
44761172|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761173|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761174|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761175|NCT01744314|Indomethacin|indomethacin|mesh-list
44761176|NCT01744314|Pantoprazole|pantoprazole|mesh-list
44761177|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44761178|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761179|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44761180|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761181|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761182|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44761183|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761184|NCT01744314|Analgesics|analgesics|mesh-ancestor
44761185|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
44761186|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241915|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761187|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761188|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761189|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761190|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
44761191|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
44761192|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44761193|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44761194|NCT01744366|Goserelin|goserelin|mesh-list
44761195|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44761196|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761197|NCT01744379|Lesinurad|lesinurad|mesh-list
44761198|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
44761199|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761200|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
44761201|NCT01744379|Renal Agents|renal agents|mesh-ancestor
44761202|NCT01744444|Gabapentin|gabapentin|mesh-list
44761203|NCT01744444|Memantine|memantine|mesh-list
44761204|NCT01744444|Analgesics|analgesics|mesh-ancestor
44761205|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
44761206|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761207|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761208|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
44761209|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761210|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761211|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761212|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761213|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44761214|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44761215|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761216|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761217|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
44761218|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44761219|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44761220|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
44761221|NCT01744470|Tacrolimus|tacrolimus|mesh-list
44761222|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44761223|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
44761224|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761225|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44761226|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761227|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761228|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44761229|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
44241945|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761230|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761231|NCT01744587|Protective Agents|protective agents|mesh-ancestor
44761232|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761233|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44761234|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44761235|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761236|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44761237|NCT01744756|Bevacizumab|bevacizumab|mesh-list
44761238|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761239|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761240|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44761241|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44761242|NCT01744756|Growth Substances|growth substances|mesh-ancestor
44761243|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761244|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44761245|NCT01744873|Bisoprolol|bisoprolol|mesh-list
44761246|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761247|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
44761248|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
44761249|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761250|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761251|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44761252|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44761253|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44761254|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761255|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761256|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761257|NCT01744886|Benzocaine|benzocaine|mesh-list
44689909|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44761258|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
44761259|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
44761260|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761261|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761262|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
44761263|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761264|NCT01744626|Rituximab|rituximab|mesh-list
44761265|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761266|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761267|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
44761268|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761269|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761270|NCT01744964|Apomorphine|apomorphine|mesh-list
44761271|NCT01744964|Emetics|emetics|mesh-ancestor
44761272|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761273|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
43972016|NCT04826692|Metformin|metformin|mesh-list
44761274|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761275|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761276|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
44761277|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
44157556|NCT00234871|Verapamil|verapamil|mesh-list
44761278|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761279|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761280|NCT01745081|Mannitol|mannitol|mesh-list
44761281|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44761282|NCT01745081|Diuretics|diuretics|mesh-ancestor
44761283|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
44242027|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
44761284|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761285|NCT01745159|Tacrolimus|tacrolimus|mesh-list
44761286|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44761287|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
44761288|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761289|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44761290|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242034|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
44761291|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689910|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143643|NCT00190463|Amebicides|amebicides|mesh-ancestor
44689911|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689912|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689913|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
44689914|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689915|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44539014|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
44761293|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
44761294|NCT01745263|Vitamins|vitamins|mesh-ancestor
44761295|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
44761296|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761297|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44761298|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44761299|NCT01745302|Gefitinib|gefitinib|mesh-list
44761300|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242052|NCT00593294|Diuretics|diuretics|mesh-ancestor
44242053|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
44242054|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44242055|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44761301|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761302|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761303|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761304|NCT01745328|Amoxicillin|amoxicillin|mesh-list
44761305|NCT01745328|Levofloxacin|levofloxacin|mesh-list
44761306|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44761307|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761308|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44761309|NCT01745328|Renal Agents|renal agents|mesh-ancestor
44761310|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44761311|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44761312|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761313|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761314|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761315|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44761316|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44761317|NCT01745549|Insulin|insulin|mesh-list
44761318|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44761319|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44761320|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761321|NCT01745562|Alprazolam|alprazolam|mesh-list
44761322|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761323|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459476|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761324|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242062|NCT00593463|Cycloserine|cycloserine|mesh-list
44761325|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761326|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761327|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761328|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
44761329|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
44761330|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761331|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761332|NCT01745575|Alprazolam|alprazolam|mesh-list
44761333|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761334|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761335|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761336|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761337|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761338|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761339|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
44761340|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
44761341|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761342|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761343|NCT01745601|Dexetimide|dexetimide|mesh-list
44761344|NCT01745601|Citalopram|citalopram|mesh-list
44761345|NCT01745601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44761346|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44761347|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761348|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761349|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761350|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
44761351|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761352|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44761353|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
44761354|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761355|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43972828|NCT02620865|Vitamins|vitamins|mesh-ancestor
44761356|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44761357|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
44761358|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
44761359|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761360|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44761361|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44761362|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
44761363|NCT01745614|Nimesulide|nimesulide|mesh-list
44761364|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44761365|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44539079|NCT01567618|Docetaxel|docetaxel|mesh-list
43972942|NCT01641055|Caseins|caseins|mesh-list
44761366|NCT01745614|Analgesics|analgesics|mesh-ancestor
44761367|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
44761368|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761369|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761370|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761371|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973060|NCT01734161|Hormones|hormones|mesh-ancestor
44761372|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44761373|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761374|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761375|NCT01745640|Dexamethasone|dexamethasone|mesh-list
44761376|NCT01745640|Pomalidomide|pomalidomide|mesh-list
44761377|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761378|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
44761379|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
44761380|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539155|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539156|NCT01568125|Hormones|hormones|mesh-ancestor
44539157|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761381|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761382|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761383|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
44761384|NCT01745640|Hormones|hormones|mesh-ancestor
44761385|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761386|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44761387|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761388|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
44761389|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44761390|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44761391|NCT01745640|Growth Substances|growth substances|mesh-ancestor
44761392|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44761393|NCT01745666|Epinephrine|epinephrine|mesh-list
44761394|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44761395|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44761396|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761397|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761398|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761399|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761400|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44761401|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44761402|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
44761403|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761404|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44761405|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44761406|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
44761407|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
44761408|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44761409|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
44761410|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44761411|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761412|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44761413|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44761414|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44761415|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761416|NCT01745770|Mesalamine|mesalamine|mesh-list
44761417|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44761418|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761419|NCT01745770|Analgesics|analgesics|mesh-ancestor
44761420|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
44761421|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761422|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761423|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761424|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761425|NCT01745809|Dimercaprol|dimercaprol|mesh-list
44761426|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
44761427|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
44539158|NCT01568268|Palonosetron|palonosetron|mesh-list
44539159|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
44539160|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
44539161|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539162|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539163|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242155|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44539164|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44242158|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
44539165|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44761428|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761429|NCT01745835|Bisacodyl|bisacodyl|mesh-list
44761430|NCT01745835|Cathartics|cathartics|mesh-ancestor
44761431|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761432|NCT01745835|Laxatives|laxatives|mesh-ancestor
44761433|NCT01745965|Trastuzumab|trastuzumab|mesh-list
43974189|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44761434|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761435|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761436|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
44761437|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
44761438|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44242167|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
44761439|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44761440|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
44761441|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
44761442|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761443|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44761444|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761445|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44761446|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761447|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761448|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44761449|NCT01746199|Renal Agents|renal agents|mesh-ancestor
44761450|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44761451|NCT01746251|Afatinib|afatinib|mesh-list
44761452|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761453|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761454|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761455|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761456|NCT01746277|Docetaxel|docetaxel|mesh-list
44761457|NCT01746277|Pemetrexed|pemetrexed|mesh-list
44761458|NCT01746277|Gefitinib|gefitinib|mesh-list
44761459|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761460|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44761461|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761462|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44761463|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761464|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761465|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44761466|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44761467|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242196|NCT00594191|Simvastatin|simvastatin|mesh-list
44761468|NCT01746485|Treprostinil|treprostinil|mesh-list
44761469|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761470|NCT01746563|Ranibizumab|ranibizumab|mesh-list
44761471|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44761472|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44761473|NCT01746563|Growth Substances|growth substances|mesh-ancestor
44761474|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761475|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44761476|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761477|NCT01746602|Timolol|timolol|mesh-list
44761478|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44761479|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44761480|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761481|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761482|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761483|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761484|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44761485|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761486|NCT01746641|Remifentanil|remifentanil|mesh-list
44761487|NCT01746641|Propofol|propofol|mesh-list
44761488|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761489|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761490|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761491|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44761492|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
44761493|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
43974766|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
44761494|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44761495|NCT01746641|Narcotics|narcotics|mesh-ancestor
44761496|NCT01746641|Analgesics|analgesics|mesh-ancestor
44761497|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
44761498|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761499|NCT01746680|Methotrexate|methotrexate|mesh-list
44761500|NCT01746680|Tacrolimus|tacrolimus|mesh-list
44761501|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44761502|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44761503|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44761504|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761505|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44761507|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761508|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761509|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761510|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761511|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44761512|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44761513|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
44761514|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761515|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44242235|NCT00594373|Tenofovir|tenofovir|mesh-list
44761516|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44761517|NCT01746719|Etodolac|etodolac|mesh-list
44761518|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44761519|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761520|NCT01746719|Analgesics|analgesics|mesh-ancestor
44761521|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
43975297|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
44761522|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761523|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761524|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761525|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761526|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44761527|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44761528|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761529|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761530|NCT01746771|Paclitaxel|paclitaxel|mesh-list
44761531|NCT01746771|Trastuzumab|trastuzumab|mesh-list
44761532|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44761533|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761534|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44761535|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761536|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44761537|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761538|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761539|NCT01746823|Cyclosporine|cyclosporine|mesh-list
44761540|NCT01746823|Cyclosporins|cyclosporins|mesh-list
44761541|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761542|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761543|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44761544|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
44761545|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761546|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
44761547|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761548|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761549|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761550|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44761551|NCT01746875|Aflibercept|aflibercept|mesh-list
44761552|NCT01746875|Verteporfin|verteporfin|mesh-list
44761553|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44761554|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44761555|NCT01746875|Growth Substances|growth substances|mesh-ancestor
44761556|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761557|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242256|NCT00594555|Cytarabine|cytarabine|mesh-list
44761558|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761559|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44761560|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761561|NCT01746992|Prednisone|prednisone|mesh-list
44761562|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
44761563|NCT01746992|Ifosfamide|ifosfamide|mesh-list
44761564|NCT01746992|Doxorubicin|doxorubicin|mesh-list
44761565|NCT01746992|Methotrexate|methotrexate|mesh-list
44761566|NCT01746992|Etoposide|etoposide|mesh-list
44761567|NCT01746992|Vincristine|vincristine|mesh-list
44761568|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
44761569|NCT01746992|Pirarubicin|pirarubicin|mesh-list
44761570|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44761571|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
44761572|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761573|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761574|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44761575|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
44761576|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761577|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761578|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539255|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
44539256|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
44242288|NCT00594867|Acetaminophen|acetaminophen|mesh-list
44242300|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44761579|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44761580|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44761581|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44761582|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761583|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761584|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
44761585|NCT01746992|Hormones|hormones|mesh-ancestor
44761586|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761587|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44689916|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44689917|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44689918|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689919|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44689920|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44689921|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
44689922|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
44689923|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44689924|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44689925|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689926|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44689927|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44689928|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44689929|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
44689930|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44689931|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44689932|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44689933|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689934|NCT01352559|Analgesics|analgesics|mesh-ancestor
44689935|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
44689936|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689937|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44689938|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44689939|NCT01352572|Milnacipran|milnacipran|mesh-list
44689940|NCT01352572|Mirtazapine|mirtazapine|mesh-list
44689941|NCT01352572|Sertraline|sertraline|mesh-list
44689942|NCT01352572|Fluoxetine|fluoxetine|mesh-list
44689943|NCT01352572|Paroxetine|paroxetine|mesh-list
44689944|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44689945|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
44689946|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
44689947|NCT01352572|Nortriptyline|nortriptyline|mesh-list
44689948|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44689949|NCT01352572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44689950|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44689951|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689952|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689953|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689954|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
44689955|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689956|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44689957|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44689958|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44689959|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689960|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44689961|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44689962|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
44689963|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
44689964|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44689965|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242340|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
44242360|NCT00595569|Insulin|insulin|mesh-list
44689966|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689967|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44689968|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44689969|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44539329|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539330|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539331|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761588|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44761589|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
44761590|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44761591|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44761592|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
44539332|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539333|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761593|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761594|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44761595|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44761596|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44761597|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44761598|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761599|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44761600|NCT01747044|Milnacipran|milnacipran|mesh-list
44761601|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
44761602|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44761603|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44761604|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761605|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761606|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761607|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761608|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761609|NCT01747044|Analgesics|analgesics|mesh-ancestor
44761610|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
44761611|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761612|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
44761613|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761614|NCT01747083|Metformin|metformin|mesh-list
44761615|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44761616|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761617|NCT01747135|Betadex|betadex|mesh-list
44761618|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
44242391|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44761619|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761620|NCT01747148|Radavirsen|radavirsen|mesh-list
44761621|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
44761622|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761623|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
44761624|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44761625|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761626|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761627|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
44761628|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761629|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761630|NCT01747174|Adenosine|adenosine|mesh-list
44761631|NCT01747174|Nitroprusside|nitroprusside|mesh-list
44761632|NCT01747174|Analgesics|analgesics|mesh-ancestor
44761633|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
44761634|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761635|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761636|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44761637|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
44761638|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44761639|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
44761640|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
44761641|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761642|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761643|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761644|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44761645|NCT01747226|Fluorides|fluorides|mesh-list
44761646|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
44761647|NCT01747226|Protective Agents|protective agents|mesh-ancestor
44761648|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761649|NCT01747252|Resveratrol|resveratrol|mesh-list
44761650|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
44761651|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761652|NCT01747252|Protective Agents|protective agents|mesh-ancestor
44761653|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761654|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761655|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44761656|NCT01747278|Trimethoprim|trimethoprim|mesh-list
44761657|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
44761658|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44761659|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761660|NCT01747278|Renal Agents|renal agents|mesh-ancestor
44761661|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
44761662|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761663|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44761664|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44761665|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761666|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761667|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44761668|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44761669|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44761670|NCT01747564|Mirabegron|mirabegron|mesh-list
44761671|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44761672|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44761673|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44761674|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761675|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761676|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761677|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761678|NCT01747564|Urological Agents|urological agents|mesh-ancestor
44761679|NCT01747590|Zolpidem|zolpidem|mesh-list
44761680|NCT01747590|Alprazolam|alprazolam|mesh-list
44761681|NCT01747590|Caffeine|caffeine|mesh-list
44761682|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44761683|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761684|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44761685|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761686|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761687|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44761688|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44761689|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
44761690|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242473|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44761691|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44761692|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761693|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761694|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44761695|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
44761696|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
44761697|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761698|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761699|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761700|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
44761701|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
44761702|NCT01747616|Chitosan|chitosan|mesh-list
44761703|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44761704|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44761705|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44242486|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44761706|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
44761707|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761708|NCT01747616|Expectorants|expectorants|mesh-ancestor
44761709|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
44761710|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44761711|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
44761712|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761713|NCT01747616|Protective Agents|protective agents|mesh-ancestor
44761714|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761715|NCT01747616|Antidotes|antidotes|mesh-ancestor
44761716|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44761717|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44761718|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
44761719|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44761720|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
44761721|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
44761722|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
44761723|NCT01747616|Coagulants|coagulants|mesh-ancestor
44761724|NCT01747642|Sorafenib|sorafenib|mesh-list
44761725|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761726|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761727|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761728|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761729|NCT01747668|Tocopherols|tocopherols|mesh-list
44761730|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
44761731|NCT01747668|Vitamin E|vitamin e|mesh-list
44761732|NCT01747668|Vitamins|vitamins|mesh-ancestor
44761733|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
44761734|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761735|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
44761736|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761737|NCT01747668|Protective Agents|protective agents|mesh-ancestor
44761738|NCT01747707|Cisplatin|cisplatin|mesh-list
44761739|NCT01747707|Docetaxel|docetaxel|mesh-list
44761740|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761741|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44242503|NCT00596414|Midazolam|midazolam|mesh-list
44761742|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761743|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242520|NCT00596414|Narcotics|narcotics|mesh-ancestor
44761744|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242528|NCT00596531|Acamprosate|acamprosate|mesh-list
44761745|NCT01747720|Vitamin D|vitamin d|mesh-list
44761746|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
44761747|NCT01747720|Vitamins|vitamins|mesh-ancestor
44761748|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
44761749|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761750|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44761751|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44761752|NCT01747746|Enoxaparin|enoxaparin|mesh-list
44761753|NCT01747746|Warfarin|warfarin|mesh-list
44761754|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
44761755|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
44761756|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44761757|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
44761758|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44761759|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
44761760|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761761|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761762|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44761763|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44761764|NCT01747798|Auranofin|auranofin|mesh-list
44761765|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761766|NCT01747993|Tamsulosin|tamsulosin|mesh-list
44761767|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44761768|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44761769|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44761770|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761771|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761772|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761773|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761774|NCT01747993|Urological Agents|urological agents|mesh-ancestor
44761775|NCT01748019|Namitecan|namitecan|mesh-list
44761776|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44761777|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761778|NCT01748084|Rituximab|rituximab|mesh-list
44761779|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761780|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761781|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
44761782|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761783|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44761784|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44761785|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
44761786|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44761787|NCT01748123|Diuretics|diuretics|mesh-ancestor
44761788|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
44761789|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761790|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44761791|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761792|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761793|NCT01748253|Amlodipine|amlodipine|mesh-list
44761794|NCT01748253|Telmisartan|telmisartan|mesh-list
44761795|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44761796|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44242557|NCT00596804|Veltuzumab|veltuzumab|mesh-list
44761797|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44761798|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761799|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761800|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44761801|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761802|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44761803|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44761804|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44761805|NCT01748279|Atorvastatin|atorvastatin|mesh-list
44761806|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
44761807|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44761808|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44761809|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
44761810|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242589|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44761811|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44761812|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44761813|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761814|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44761815|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
44761816|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539567|NCT00109668|Beclomethasone|beclomethasone|mesh-list
44539568|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539569|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
44539570|NCT00109668|Hormones|hormones|mesh-ancestor
44539571|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539572|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539573|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44539574|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
44539575|NCT00102648|Temozolomide|temozolomide|mesh-list
44539576|NCT00102648|Lonafarnib|lonafarnib|mesh-list
44539578|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
44761817|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761818|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44242610|NCT00597415|Celecoxib|celecoxib|mesh-list
44761819|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
44761820|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44761821|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44761822|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44761823|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761824|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761825|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44761826|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44761827|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761828|NCT01748318|Renal Agents|renal agents|mesh-ancestor
44761829|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44761830|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
44761831|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761832|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44761834|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44761835|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44761836|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44761837|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
44761838|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
44761839|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761840|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761841|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761842|NCT01748370|Vitamin D|vitamin d|mesh-list
44761843|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
44761844|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
44761845|NCT01748370|Vitamins|vitamins|mesh-list
44761846|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
44761847|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761848|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44761849|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44761850|NCT01748396|Calcitriol|calcitriol|mesh-list
44761851|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
44761852|NCT01748396|Calcium|calcium|mesh-list
44761853|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44761854|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761855|NCT01748396|Antacids|antacids|mesh-ancestor
44761856|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761857|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761858|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44761859|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44761860|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44761861|NCT01748396|Vitamins|vitamins|mesh-ancestor
44761862|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
44761863|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44761864|NCT01748422|Capsaicin|capsaicin|mesh-list
44761865|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
44761866|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761867|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
44761868|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761869|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761870|NCT01748435|Capsaicin|capsaicin|mesh-list
44761871|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
44761872|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761873|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
44459510|NCT01578486|Analgesics|analgesics|mesh-ancestor
44761874|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761875|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761876|NCT01748487|Dexamethasone|dexamethasone|mesh-list
44761877|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
44761878|NCT01748487|BB 1101|bb 1101|mesh-list
44761879|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44761880|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
44761881|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
44761882|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761883|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761884|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761885|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
44761886|NCT01748487|Hormones|hormones|mesh-ancestor
44761887|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242628|NCT00597623|Adalimumab|adalimumab|mesh-list
44761888|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44761889|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761890|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
44761891|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539629|NCT00109837|Leucovorin|leucovorin|mesh-list
44761892|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761893|NCT01748500|Pantoprazole|pantoprazole|mesh-list
44761894|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44761895|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44761896|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44761897|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761898|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761899|NCT01748526|Canagliflozin|canagliflozin|mesh-list
44761900|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44761901|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761902|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44761903|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761904|NCT01748539|Brodalumab|brodalumab|mesh-list
44761905|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44761906|NCT01748630|Fentanyl|fentanyl|mesh-list
44761907|NCT01748630|Midazolam|midazolam|mesh-list
44761908|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
44761909|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44761910|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44761911|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761912|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761913|NCT01748630|Analgesics|analgesics|mesh-ancestor
44761914|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
44761915|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44761916|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44761917|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44761918|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44761919|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
44761920|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44761921|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761922|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44761923|NCT01748630|Narcotics|narcotics|mesh-ancestor
44761924|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44761925|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44761926|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
44761927|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
44761928|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44761929|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44761930|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44761931|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
44761932|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
44761933|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
44761934|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
44761935|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761936|NCT01748669|Protective Agents|protective agents|mesh-ancestor
44242687|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
44242691|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
44761937|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761938|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44761939|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761940|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44761941|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761942|NCT01748721|Antibodies|antibodies|mesh-list
44761943|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44761944|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
44242692|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
44761945|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761946|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44761947|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44761948|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
44761949|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761950|NCT01748773|Capecitabine|capecitabine|mesh-list
44761951|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
44761952|NCT01748773|Trastuzumab|trastuzumab|mesh-list
44242700|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44761953|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44761954|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
44761955|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761956|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761957|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44761958|NCT01748838|Mannitol|mannitol|mesh-list
44761959|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44761960|NCT01748838|Diuretics|diuretics|mesh-ancestor
44761961|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
44761962|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761963|NCT01748929|Albendazole|albendazole|mesh-list
44761964|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
44761965|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44761966|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761967|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
44761968|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44242722|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44761969|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44761970|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
44761971|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761972|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44761973|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761974|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761975|NCT01749072|Vinorelbine|vinorelbine|mesh-list
44761976|NCT01749072|Ifosfamide|ifosfamide|mesh-list
44761977|NCT01749072|Gefitinib|gefitinib|mesh-list
44761978|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44761979|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44761980|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
44761981|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
44761982|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242734|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44761983|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761984|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44761985|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
44761986|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44761987|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761988|NCT01749085|Ketoconazole|ketoconazole|mesh-list
44761989|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
44242745|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44761990|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44761991|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44761992|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44761993|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44761994|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44761995|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44761996|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
44761997|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44761998|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44761999|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44762000|NCT01749098|Ketamine|ketamine|mesh-list
44762001|NCT01749098|Analgesics|analgesics|mesh-ancestor
44762002|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
44762003|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762004|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762005|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44242760|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44762006|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44762007|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
44762008|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
44762009|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762010|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44762011|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44762012|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762013|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762014|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
44762015|NCT01749111|Methotrexate|methotrexate|mesh-list
44762016|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44762017|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762018|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
44762019|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762020|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762021|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44762022|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
44762023|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762024|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762025|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44762026|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44762027|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
44762028|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44762029|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44762030|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
44762031|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
44762032|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762033|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44762034|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44762035|NCT01749150|Ritonavir|ritonavir|mesh-list
44762036|NCT01749150|Ribavirin|ribavirin|mesh-list
44762037|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44762038|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
44762039|NCT01749150|Lactams|lactams|mesh-list
44762040|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44762041|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44762042|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44762043|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762044|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762045|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44762046|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44762047|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
44762048|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762049|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44762050|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44762051|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
44762052|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
44762053|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762054|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44762055|NCT01749228|Etodolac|etodolac|mesh-list
44762056|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44762057|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44762058|NCT01749228|Analgesics|analgesics|mesh-ancestor
44762059|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
44762060|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762061|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762062|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762063|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762064|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44762065|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44762066|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762067|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762068|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44762069|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44762070|NCT01749319|Baclofen|baclofen|mesh-list
44762071|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44762072|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762073|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44762074|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762075|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44762076|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
44762077|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
44762078|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762079|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762080|NCT01749371|Vitamins|vitamins|mesh-list
44762081|NCT01749371|Vitamin E|vitamin e|mesh-list
44762082|NCT01749371|Tocopherols|tocopherols|mesh-list
44762083|NCT01749371|Tocotrienols|tocotrienols|mesh-list
44762084|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
44762085|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
44762086|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762087|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
44762088|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762089|NCT01749371|Protective Agents|protective agents|mesh-ancestor
44762090|NCT01749384|Bevacizumab|bevacizumab|mesh-list
44762091|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44762092|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
44762093|NCT01749384|Antibodies|antibodies|mesh-list
44762094|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
44762095|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44762096|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
44762097|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762098|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44762099|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44762100|NCT01749384|Growth Substances|growth substances|mesh-ancestor
44689970|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44242860|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
44689971|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44689972|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44689973|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44689974|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689975|NCT01352572|Analgesics|analgesics|mesh-ancestor
44689976|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
44689977|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689978|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44689979|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44689980|NCT01352611|Baclofen|baclofen|mesh-list
44689981|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44689982|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689983|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44689984|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689985|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44689986|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
44689987|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
44689988|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689989|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689990|NCT01352650|Plerixafor|plerixafor|mesh-list
44689991|NCT01352650|Decitabine|decitabine|mesh-list
44242876|NCT00598923|Topiramate|topiramate|mesh-list
44689992|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689993|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
44689994|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689995|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689996|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689997|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44689998|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44689999|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
44690000|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690001|NCT01352663|Insulin|insulin|mesh-list
44690002|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
44690003|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690004|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690005|NCT01352702|Dabigatran|dabigatran|mesh-list
44690006|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
44690007|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
44690008|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44690009|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
44690010|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690011|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690012|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
44690013|NCT01352728|Axitinib|axitinib|mesh-list
44690014|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690015|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44690016|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690017|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690018|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44690019|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690020|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690021|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
44690022|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690023|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
44690024|NCT01353170|Calcium|calcium|mesh-list
44690025|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690026|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690027|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44690028|NCT01353209|Letrozole|letrozole|mesh-list
44690029|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690030|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44690031|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44690032|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690033|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690034|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44690035|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44690036|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690037|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690038|NCT01353235|Prednisolone|prednisolone|mesh-list
44690039|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690040|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
44690041|NCT01353235|Hormones|hormones|mesh-ancestor
44539930|NCT00106184|Rituximab|rituximab|mesh-list
44762101|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762102|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
44762103|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
44762104|NCT01749397|Fluorouracil|fluorouracil|mesh-list
44762105|NCT01749397|Floxuridine|floxuridine|mesh-list
44762106|NCT01749397|Veliparib|veliparib|mesh-list
44762107|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
44762108|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
44762109|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762110|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44762111|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762112|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762113|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
44762114|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242931|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44242932|NCT00599287|Haloperidol|haloperidol|mesh-list
44762115|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44762116|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762117|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
44762118|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44762119|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44762120|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44762121|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762122|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762123|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
44762124|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144328|NCT00191672|Paclitaxel|paclitaxel|mesh-list
44762125|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762126|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44762127|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762128|NCT01749475|Midazolam|midazolam|mesh-list
44762129|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44762130|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44762131|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762132|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762133|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44762134|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44762135|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762136|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43978272|NCT01906658|Hormones|hormones|mesh-ancestor
44762137|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
44762138|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
44762139|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
44762140|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
44762141|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762142|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762143|NCT01749514|Luspatercept|luspatercept|mesh-list
44762144|NCT01749514|Hematinics|hematinics|mesh-ancestor
44762145|NCT01749540|Luspatercept|luspatercept|mesh-list
44762146|NCT01749540|Hematinics|hematinics|mesh-ancestor
44762147|NCT01749566|Maraviroc|maraviroc|mesh-list
44762148|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44762149|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44762150|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762151|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44762152|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44762153|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
44762154|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762155|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44762156|NCT01749579|Fentanyl|fentanyl|mesh-list
44539931|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242986|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539932|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539933|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
44539934|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539935|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539936|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
44539937|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44539938|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539939|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539940|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44539941|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242996|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539942|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44539943|NCT00106002|Pemetrexed|pemetrexed|mesh-list
44539944|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539945|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539946|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609572|NCT03187223|Melphalan|melphalan|mesh-list
44762157|NCT01749579|Midazolam|midazolam|mesh-list
44762158|NCT01749579|Propofol|propofol|mesh-list
44762159|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44762160|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762161|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762162|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44762163|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
44762164|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
44762165|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762166|NCT01749579|Narcotics|narcotics|mesh-ancestor
44762167|NCT01749579|Analgesics|analgesics|mesh-ancestor
44762168|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
44762169|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762170|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44762171|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44762172|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44762173|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762174|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
44762175|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
44762176|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762177|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762178|NCT01750060|Fentanyl|fentanyl|mesh-list
44762179|NCT01750060|Naltrexone|naltrexone|mesh-list
44243014|NCT00599807|Vitamin D|vitamin d|mesh-list
44762180|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762181|NCT01750060|Narcotics|narcotics|mesh-ancestor
44762182|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762183|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762184|NCT01750060|Analgesics|analgesics|mesh-ancestor
44762185|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
44762186|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762187|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44762188|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44762189|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
44762190|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
44762191|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44762192|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44762193|NCT01750099|Lidocaine|lidocaine|mesh-list
44762194|NCT01750099|Epinephrine|epinephrine|mesh-list
44762195|NCT01750099|Fentanyl|fentanyl|mesh-list
44762196|NCT01750099|Bupivacaine|bupivacaine|mesh-list
44762197|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
44762198|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
44762199|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762200|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762201|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
44762202|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762203|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44762204|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44762205|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44762206|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762207|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762208|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762209|NCT01750099|Narcotics|narcotics|mesh-ancestor
44762210|NCT01750099|Analgesics|analgesics|mesh-ancestor
44762211|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44762212|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44762213|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
44762214|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44762215|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44762216|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
44762217|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762218|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44762219|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44762220|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
44762221|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44762222|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
44762223|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
44762224|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
44762225|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44762226|NCT01750359|Curcumin|curcumin|mesh-list
44243057|NCT00599911|Analgesics|analgesics|mesh-ancestor
44762227|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44762228|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44762229|NCT01750359|Analgesics|analgesics|mesh-ancestor
44762230|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
44539947|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44762231|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762232|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762233|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762234|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762235|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762236|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762237|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762238|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44762239|NCT01750385|Cephalosporins|cephalosporins|mesh-list
44762240|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762241|NCT01750437|Esomeprazole|esomeprazole|mesh-list
44762242|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44762243|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762244|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44762245|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762246|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762247|NCT01750463|Chrysarobin|chrysarobin|mesh-list
44762248|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44762249|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44762250|NCT01750463|Analgesics|analgesics|mesh-ancestor
44762251|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
44762252|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762253|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762254|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762255|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762256|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44762257|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
44762258|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44762259|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
44762260|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44762261|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762262|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44762263|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44762264|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44762265|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44762266|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44762267|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762268|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44690042|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690043|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690044|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690045|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690046|NCT01353339|Levofloxacin|levofloxacin|mesh-list
44690048|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44690049|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690050|NCT01353339|Renal Agents|renal agents|mesh-ancestor
44243092|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690051|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44690052|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690053|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690054|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690055|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690056|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690057|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44690058|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44690059|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
44690060|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44690061|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690062|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690063|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690064|NCT01353378|Analgesics|analgesics|mesh-ancestor
44690065|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
44690066|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690067|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44690068|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44690069|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690070|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690071|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690072|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690073|NCT01353391|Metformin|metformin|mesh-list
44690074|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690075|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762269|NCT01750541|Valproic Acid|valproic acid|mesh-list
44762270|NCT01750541|Haloperidol|haloperidol|mesh-list
44762271|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
44762272|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
44762273|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
44762274|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762275|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762276|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762277|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44762278|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44762279|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762280|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762281|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44762282|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
44762283|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762284|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762285|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44762286|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
44762287|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762288|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
44762289|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
44762290|NCT01750580|Ipilimumab|ipilimumab|mesh-list
44762291|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44762292|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762293|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44762294|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762295|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
44762296|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44762297|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762298|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762299|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
44762300|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762301|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762302|NCT01750723|Acetazolamide|acetazolamide|mesh-list
44762303|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
44762304|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44762305|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762306|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762307|NCT01750723|Diuretics|diuretics|mesh-ancestor
44762308|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
44762309|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762310|NCT01750762|Lenalidomide|lenalidomide|mesh-list
44762311|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
44762312|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762313|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44762314|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44762315|NCT01750762|Growth Substances|growth substances|mesh-ancestor
44762316|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
44762317|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762318|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
44762319|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44762320|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
44762321|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44762322|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
44762323|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762324|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762325|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
44762326|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
44762327|NCT01750801|Propolis|propolis|mesh-list
44762328|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44762329|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762330|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
44762331|NCT01750866|Prednisone|prednisone|mesh-list
44762332|NCT01750866|Lenograstim|lenograstim|mesh-list
44762333|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762334|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
44762335|NCT01750866|Hormones|hormones|mesh-ancestor
44762336|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762337|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762338|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44762339|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762340|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44762341|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
44762342|NCT01750983|Lenalidomide|lenalidomide|mesh-list
44762343|NCT01750983|Ipilimumab|ipilimumab|mesh-list
44762344|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
44762345|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762346|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44762347|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44762348|NCT01750983|Growth Substances|growth substances|mesh-ancestor
44762349|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
44762350|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762351|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44762352|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44762353|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762354|NCT01751009|Vitamins|vitamins|mesh-list
44762355|NCT01751009|Vitamin A|vitamin a|mesh-list
44762356|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
44762357|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
44762358|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762359|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
44762360|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762361|NCT01751009|Protective Agents|protective agents|mesh-ancestor
44762362|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44762363|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762364|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44762365|NCT01751074|Darapladib|darapladib|mesh-list
44762366|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44762367|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44762368|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
44762369|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762370|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44762371|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44762372|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762373|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44762374|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
44762375|NCT01751204|Calcium|calcium|mesh-list
44762376|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44762377|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762378|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44762379|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44762380|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762381|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762382|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44762383|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762384|NCT01751295|Atorvastatin|atorvastatin|mesh-list
44762385|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44762386|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44762387|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
44762388|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762389|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44762390|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44762391|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762392|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44762393|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44762394|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762395|NCT01751321|Incretins|incretins|mesh-ancestor
44762396|NCT01751321|Hormones|hormones|mesh-ancestor
44762397|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762398|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44762399|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
44762400|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762401|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762402|NCT01751347|Lidocaine|lidocaine|mesh-list
44762403|NCT01751347|Bupivacaine|bupivacaine|mesh-list
44762404|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44762405|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
44762406|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762407|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762408|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
44762409|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762410|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44762411|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44762412|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44762413|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762414|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762415|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
44762416|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44762417|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44762418|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762419|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762420|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44762421|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762422|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762423|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44762424|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762425|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
44762426|NCT01751425|Dasatinib|dasatinib|mesh-list
44762427|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44762428|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762429|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44762430|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762431|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762432|NCT01751763|Sorafenib|sorafenib|mesh-list
44762433|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762434|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44144406|NCT00191828|Olanzapine|olanzapine|mesh-list
44762435|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762436|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762437|NCT01751828|Sertraline|sertraline|mesh-list
44762438|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
44762439|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762440|NCT01751828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44762441|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44762442|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762443|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762444|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762445|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
44762446|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762447|NCT01751854|Citalopram|citalopram|mesh-list
44762448|NCT01751854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44762449|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44762450|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762451|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762452|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762453|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
44762454|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762455|NCT01751854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44762456|NCT01751854|Antidepressive Agents|antidepressive agents|mesh-ancestor
44762457|NCT01751854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762458|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
44243329|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
44762459|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762460|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44762461|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762462|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762463|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
44762464|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762465|NCT01752075|Lenalidomide|lenalidomide|mesh-list
44762466|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
44762467|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762468|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44762469|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243340|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
44762470|NCT01752075|Growth Substances|growth substances|mesh-ancestor
44762471|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
44762472|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762473|NCT01752153|Silymarin|silymarin|mesh-list
44762474|NCT01752153|Deferoxamine|deferoxamine|mesh-list
44762475|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
44762476|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762477|NCT01752153|Protective Agents|protective agents|mesh-ancestor
44762478|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762479|NCT01752153|Siderophores|siderophores|mesh-ancestor
44762480|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44762481|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
44762482|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
44762483|NCT01752205|Paclitaxel|paclitaxel|mesh-list
44762484|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44762485|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44762486|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762487|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
44762488|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
44762489|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540219|NCT00102960|Didanosine|didanosine|mesh-list
44762490|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762491|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44762492|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762493|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
44540294|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762494|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44762495|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44762496|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762497|NCT01752244|Vitamins|vitamins|mesh-ancestor
44762498|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
44762499|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
44762500|NCT01752270|Cyproterone|cyproterone|mesh-list
44243352|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762501|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
44762502|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
44762503|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
44243370|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
44762504|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762505|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762506|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762507|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44762508|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
43979954|NCT01973205|Aspirin|aspirin|mesh-list
44762509|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44762510|NCT01752322|Lidocaine|lidocaine|mesh-list
44762511|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
44762512|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
44762513|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762514|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762515|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
44762516|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762517|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44762518|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44762519|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44762520|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762521|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540295|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44540296|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540297|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540298|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540299|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
44540300|NCT00101582|Cisplatin|cisplatin|mesh-list
44540301|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540302|NCT00101452|Citalopram|citalopram|mesh-list
44540303|NCT00101452|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44540304|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44540305|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540306|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762522|NCT01752517|Vinorelbine|vinorelbine|mesh-list
44762523|NCT01752517|Ifosfamide|ifosfamide|mesh-list
44762524|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44762525|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762526|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44762527|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44762528|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44762529|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762530|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44762531|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
44762532|NCT01752543|Conivaptan|conivaptan|mesh-list
44762533|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44762534|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762535|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
44762536|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762537|NCT01752686|Carboplatin|carboplatin|mesh-list
44762538|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762539|NCT01752699|Methadone|methadone|mesh-list
44762540|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762541|NCT01752699|Narcotics|narcotics|mesh-ancestor
44762542|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762543|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762544|NCT01752699|Analgesics|analgesics|mesh-ancestor
44762545|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
44762546|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762547|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
44762548|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
44762549|NCT01752790|Azathioprine|azathioprine|mesh-list
44762550|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762551|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
44762552|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762553|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44762554|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762555|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762556|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
44762557|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762558|NCT01752881|Vaccines|vaccines|mesh-list
44762559|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
44762560|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762561|NCT01752959|Remifentanil|remifentanil|mesh-list
44762562|NCT01752959|Esmolol|esmolol|mesh-list
44762563|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762564|NCT01752959|Narcotics|narcotics|mesh-ancestor
44762565|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762566|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762567|NCT01752959|Analgesics|analgesics|mesh-ancestor
44762568|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
44762569|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762570|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44762571|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44762572|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44762573|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44762574|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762575|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762576|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
44762577|NCT01752998|Narcotics|narcotics|mesh-ancestor
44762578|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762579|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762580|NCT01752998|Analgesics|analgesics|mesh-ancestor
44762581|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
44762582|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762583|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44762584|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44762585|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
44762586|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762587|NCT01753102|Estradiol|estradiol|mesh-list
44762588|NCT01753102|Estrogens|estrogens|mesh-ancestor
44762589|NCT01753102|Hormones|hormones|mesh-ancestor
44762590|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762591|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762592|NCT01753128|Imipramine|imipramine|mesh-list
44762593|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44762594|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44762595|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459541|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762596|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44762597|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44762598|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762599|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762600|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
44762601|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762602|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762603|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44762604|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
44762605|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44762606|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44459552|NCT01576718|Albuterol|albuterol|mesh-list
44762607|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44762608|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762609|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762610|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
44762611|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762612|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762613|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44762614|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762615|NCT01753375|Vitamin D|vitamin d|mesh-list
44762616|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
44762617|NCT01753375|Vitamins|vitamins|mesh-ancestor
44762618|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
44762619|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762620|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44459579|NCT01576705|Vitamins|vitamins|mesh-ancestor
44762621|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44762622|NCT01753453|Plerixafor|plerixafor|mesh-list
44762623|NCT01753453|Lenograstim|lenograstim|mesh-list
44762624|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44762625|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
44762626|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762627|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44762628|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44762629|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
44762630|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762631|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44762632|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44762633|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
44762634|NCT01753752|Chitosan|chitosan|mesh-list
44762635|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44762636|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44762637|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44762638|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
44762639|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762640|NCT01753752|Expectorants|expectorants|mesh-ancestor
44762641|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
44762642|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44762643|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
44762644|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762645|NCT01753752|Protective Agents|protective agents|mesh-ancestor
44762646|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762647|NCT01753752|Antidotes|antidotes|mesh-ancestor
44762648|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44762649|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44762650|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
44762651|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44762652|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
44762653|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
44762654|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
44762655|NCT01753752|Coagulants|coagulants|mesh-ancestor
44762656|NCT01753882|Citalopram|citalopram|mesh-list
44762657|NCT01753882|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44762658|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44762659|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762660|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762661|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762662|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
44762663|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762664|NCT01753882|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44762665|NCT01753882|Antidepressive Agents|antidepressive agents|mesh-ancestor
44762666|NCT01753882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44540404|NCT00101010|Hormones|hormones|mesh-ancestor
44762667|NCT01754116|Cabotegravir|cabotegravir|mesh-list
44762668|NCT01754116|Midazolam|midazolam|mesh-list
44762669|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44762670|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44243477|NCT00601562|Zidovudine|zidovudine|mesh-list
44243478|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
44762671|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762672|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762673|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44762674|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44762675|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762676|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44762677|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
44762678|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
44762679|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
44762680|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
44762681|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762682|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762683|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44762684|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44762685|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762686|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44762687|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44762688|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
44762689|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762690|NCT01754181|Insulin|insulin|mesh-list
44762691|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44762692|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762693|NCT01754220|Montelukast|montelukast|mesh-list
44762694|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44762695|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
44762696|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44762697|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
44762698|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762699|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762700|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44762701|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44762702|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243501|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44762703|NCT01754285|Octreotide|octreotide|mesh-list
44762704|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762705|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44762706|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762707|NCT01754324|Methadone|methadone|mesh-list
44762708|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44762709|NCT01754324|Narcotics|narcotics|mesh-ancestor
44762710|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243511|NCT00601666|Zolpidem|zolpidem|mesh-list
44762711|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762712|NCT01754324|Analgesics|analgesics|mesh-ancestor
44762713|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
44762714|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762715|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
44762716|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44762717|NCT01754649|Misoprostol|misoprostol|mesh-list
44762718|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44762719|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
44762720|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44762721|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762722|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44762723|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762724|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
44762725|NCT01754701|Iron|iron|mesh-list
44762726|NCT01754701|Trace Elements|trace elements|mesh-ancestor
44762727|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
44762728|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762729|NCT01754792|Inositol|inositol|mesh-list
44762730|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
44762731|NCT01754792|Vitamins|vitamins|mesh-ancestor
44762732|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
44762733|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762734|NCT01754805|Methotrexate|methotrexate|mesh-list
44762735|NCT01754805|Peficitinib|peficitinib|mesh-list
44762736|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44762737|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
44762738|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44762739|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762740|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44762741|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
44762742|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762743|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762744|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44762745|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762746|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44762747|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762748|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
44762749|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762750|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44762751|NCT01754831|Fluorides|fluorides|mesh-list
44762752|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
44762753|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
44762754|NCT01754831|Protective Agents|protective agents|mesh-ancestor
44762755|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762756|NCT01754844|AZD7624|azd7624|mesh-list
44762757|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44762758|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762759|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762760|NCT01754870|Rituximab|rituximab|mesh-list
44762761|NCT01754870|Lenalidomide|lenalidomide|mesh-list
44762762|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44762763|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44762764|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762765|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
44762766|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762767|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762768|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44762769|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44762770|NCT01754870|Growth Substances|growth substances|mesh-ancestor
44762771|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
44762772|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44762773|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
44762774|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762775|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
44762776|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
44762777|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44762778|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762779|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981173|NCT02021942|Hormones|hormones|mesh-ancestor
44762780|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
44762781|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44762782|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762783|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762784|NCT01754961|Vitamin D|vitamin d|mesh-list
44762785|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
44762786|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
44762787|NCT01754961|Vitamins|vitamins|mesh-list
44762788|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
44762789|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243584|NCT00602004|Losartan|losartan|mesh-list
44762790|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44762791|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44762792|NCT01754974|Ribavirin|ribavirin|mesh-list
44762793|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44762794|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
44762795|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762796|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
44762797|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762798|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
44762799|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
44762800|NCT01755078|Calcium|calcium|mesh-list
44762801|NCT01755078|Sevelamer|sevelamer|mesh-list
44762802|NCT01755078|Calcium acetate|calcium acetate|mesh-list
44762803|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44762804|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762805|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44762806|NCT01755078|Antacids|antacids|mesh-ancestor
44762807|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157571|NCT00234897|Adalimumab|adalimumab|mesh-list
44762808|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762809|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
44540538|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540539|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540540|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
44540541|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540542|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44540543|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
44540544|NCT00108745|Paclitaxel|paclitaxel|mesh-list
44540545|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44540546|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44762810|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
44762811|NCT01755117|Ropivacaine|ropivacaine|mesh-list
44762812|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
44762813|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
44762814|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44762815|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762816|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
44762817|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762818|NCT01755182|Somatostatin|somatostatin|mesh-list
44762819|NCT01755182|Hormones|hormones|mesh-ancestor
44762820|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762821|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762822|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
44762823|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44762824|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762825|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44762826|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44762827|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762828|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762829|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762830|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44762831|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44762832|NCT01755299|Caffeine|caffeine|mesh-list
44762833|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44762834|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762835|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44762836|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762837|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243646|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762838|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44762839|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44762840|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
44762841|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762842|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
44762843|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44762844|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44762845|NCT01755338|Prednisolone|prednisolone|mesh-list
44762846|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
44762847|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44762848|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
44762849|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762850|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
44762851|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
44762852|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762853|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762854|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44762855|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
44762856|NCT01755338|Hormones|hormones|mesh-ancestor
44762857|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762858|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44762859|NCT01755338|Protective Agents|protective agents|mesh-ancestor
44762860|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44762861|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762862|NCT01755377|Benzonidazole|benzonidazole|mesh-list
44762863|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762864|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
44762865|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762866|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44762867|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44762868|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44762869|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762870|NCT01755403|Benzonidazole|benzonidazole|mesh-list
44762871|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762872|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
44762873|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762874|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44762875|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44762876|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44762877|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762878|NCT01755468|Insulin|insulin|mesh-list
44762879|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44762880|NCT01755468|Metformin|metformin|mesh-list
44762881|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
44762882|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
44690076|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
44241680|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
44690077|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44540580|NCT02030483|Hormones|hormones|mesh-ancestor
44762883|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44243688|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44762884|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762886|NCT01755494|Saxagliptin|saxagliptin|mesh-list
44762887|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44762888|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762889|NCT01755494|Incretins|incretins|mesh-ancestor
44762890|NCT01755494|Hormones|hormones|mesh-ancestor
44762891|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762892|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44762893|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
44762894|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762895|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762896|NCT01755520|Aspirin|aspirin|mesh-list
44243711|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
44762897|NCT01755520|Ticagrelor|ticagrelor|mesh-list
44762898|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44762899|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44762900|NCT01755520|Analgesics|analgesics|mesh-ancestor
44762901|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
44762902|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762903|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762904|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762905|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762906|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44762907|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44762908|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762909|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44762910|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44762911|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762912|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
44762913|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44762914|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44762915|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44762916|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
44762917|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762918|NCT01755559|Artesunate|artesunate|mesh-list
44762919|NCT01755559|Lumefantrine|lumefantrine|mesh-list
44762920|NCT01755559|Artemether|artemether|mesh-list
44762921|NCT01755559|Piperaquine|piperaquine|mesh-list
44762922|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44762923|NCT01755559|Amodiaquine|amodiaquine|mesh-list
44762924|NCT01755559|Artenimol|artenimol|mesh-list
44762925|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
44762926|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44762927|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44762928|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762929|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762930|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
44762931|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
44762932|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44762933|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
44762934|NCT01755572|Liraglutide|liraglutide|mesh-list
44762935|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44762936|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762937|NCT01755572|Incretins|incretins|mesh-ancestor
44762938|NCT01755572|Hormones|hormones|mesh-ancestor
44762939|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44762940|NCT01755611|Minocycline|minocycline|mesh-list
44762941|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44762942|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762943|NCT01755663|Metoprolol|metoprolol|mesh-list
44762944|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44762945|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44762946|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
44762947|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
44762948|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762949|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762950|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44762951|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44243763|NCT05644587|Buprenorphine|buprenorphine|mesh-list
44762952|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44762953|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
44762954|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44762955|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762956|NCT01755676|Orlistat|orlistat|mesh-list
44762957|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762958|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762959|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44762960|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44762961|NCT01755728|Acetaminophen|acetaminophen|mesh-list
44762962|NCT01755728|Ibuprofen|ibuprofen|mesh-list
44459596|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44762963|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44762964|NCT01755728|Analgesics|analgesics|mesh-ancestor
44762965|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
44762966|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44762967|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762968|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
44762969|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44762970|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44762971|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44762972|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44762973|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44762974|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762975|NCT01755845|Paclitaxel|paclitaxel|mesh-list
44762976|NCT01755845|Cisplatin|cisplatin|mesh-list
44762977|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44762978|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762979|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44762980|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44762981|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44762982|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459613|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44762983|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44762984|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44762985|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762986|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44762987|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
44762988|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44762989|NCT01755897|Paclitaxel|paclitaxel|mesh-list
44762990|NCT01755897|Cisplatin|cisplatin|mesh-list
44762991|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44762992|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44762993|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44762994|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44762995|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44762996|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44762997|NCT01755923|Docetaxel|docetaxel|mesh-list
44762998|NCT01755923|Gefitinib|gefitinib|mesh-list
44762999|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763000|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763001|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
44763002|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
44763003|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763004|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44763005|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763006|NCT01756040|Lactulose|lactulose|mesh-list
44763007|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44763008|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763009|NCT01756105|Insulin|insulin|mesh-list
44763010|NCT01756105|Metformin|metformin|mesh-list
44763011|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
44763012|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
44763013|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
44763014|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763015|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763016|NCT01756118|Dactolisib|dactolisib|mesh-list
44763017|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763018|NCT01756131|Cabotegravir|cabotegravir|mesh-list
44763019|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44763020|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44763021|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763022|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763023|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44763024|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44763025|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
44763026|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690078|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690079|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243789|NCT05644496|Analgesics|analgesics|mesh-ancestor
44690080|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690081|NCT01353456|Analgesics|analgesics|mesh-ancestor
44690082|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
44690083|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690084|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44690085|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44690086|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690087|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690088|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690089|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690090|NCT01353469|Insulin|insulin|mesh-list
44690091|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44690092|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690093|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690094|NCT01353482|Cisplatin|cisplatin|mesh-list
44690095|NCT01353482|Pemetrexed|pemetrexed|mesh-list
44690096|NCT01353482|Vorinostat|vorinostat|mesh-list
44690097|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690098|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690099|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690100|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44690101|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44690102|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44690103|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
44690104|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690105|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690106|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44690107|NCT01353716|Dolutegravir|dolutegravir|mesh-list
44690108|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44690109|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44690110|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690111|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690112|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44690113|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44690114|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
44690115|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690116|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
44690117|NCT01353729|Zanamivir|zanamivir|mesh-list
44243834|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690118|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44690119|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44690120|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690121|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690122|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690123|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690124|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690125|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690126|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44690127|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
44690128|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44690129|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690130|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44763027|NCT01756170|Paclitaxel|paclitaxel|mesh-list
44763028|NCT01756170|Cisplatin|cisplatin|mesh-list
44763029|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44243850|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763030|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763031|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763032|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44763033|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44763034|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763035|NCT01756183|Paclitaxel|paclitaxel|mesh-list
44763036|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44763037|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243859|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763038|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763039|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44763040|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44763041|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763042|NCT01756261|Aflibercept|aflibercept|mesh-list
44763043|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44763044|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44763045|NCT01756261|Growth Substances|growth substances|mesh-ancestor
44763046|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763047|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44763048|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763049|NCT01756404|Canagliflozin|canagliflozin|mesh-list
44763050|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44763051|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763052|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763053|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763054|NCT01756417|Metformin|metformin|mesh-list
44763055|NCT01756417|Canagliflozin|canagliflozin|mesh-list
44763056|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763057|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763058|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44763059|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763060|NCT01756430|Carvedilol|carvedilol|mesh-list
44763061|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44763062|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44763063|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763064|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243886|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763065|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763066|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763067|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44763068|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
44763069|NCT01756430|Protective Agents|protective agents|mesh-ancestor
44763070|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44763071|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44763072|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44763073|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
44763074|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44763075|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44763076|NCT01756443|Lidocaine|lidocaine|mesh-list
44763077|NCT01756443|Epinephrine|epinephrine|mesh-list
44763078|NCT01756443|Racepinephrine|racepinephrine|mesh-list
44763079|NCT01756443|Bupivacaine|bupivacaine|mesh-list
44763080|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
44763081|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763082|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
44763083|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763084|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763085|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
44763086|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763087|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44763088|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44763089|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44763090|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44763091|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763092|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44763093|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44243901|NCT05643586|Ticagrelor|ticagrelor|mesh-list
44243918|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
44763094|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763095|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763096|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44763097|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44763098|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
44763099|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44763100|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44540816|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44763101|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
44763102|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
44763103|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44243928|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763104|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
44763105|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44763106|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763107|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763108|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44763109|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44763110|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763111|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763112|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763113|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44763114|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
44763115|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44763116|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763117|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44763118|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44763119|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44763120|NCT01756508|Eculizumab|eculizumab|mesh-list
44763121|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44763122|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763123|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
44763124|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763125|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
44763126|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763127|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763128|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44763129|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44763130|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763131|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763132|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763133|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
44763134|NCT01756547|Diuretics|diuretics|mesh-ancestor
44763135|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
44763136|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763137|NCT01756547|Expectorants|expectorants|mesh-ancestor
44763138|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44763139|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
44763140|NCT01756612|Hematinics|hematinics|mesh-ancestor
44763141|NCT01756638|Prednisolone|prednisolone|mesh-list
44763142|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763143|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
44763144|NCT01756638|Hormones|hormones|mesh-ancestor
44763145|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763146|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763147|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763148|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763149|NCT01756651|Fentanyl|fentanyl|mesh-list
44763150|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44763151|NCT01756651|Narcotics|narcotics|mesh-ancestor
44459657|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763152|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763153|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763154|NCT01756651|Analgesics|analgesics|mesh-ancestor
44763155|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
44763156|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763157|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763158|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44540891|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540892|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44540893|NCT02033707|Scopolamine|scopolamine|mesh-list
44540894|NCT02033707|Hallucinogens|hallucinogens|mesh-list
44540895|NCT02033707|Nicotine|nicotine|mesh-list
44459678|NCT01575899|Renal Agents|renal agents|mesh-ancestor
44540896|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44540897|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
44540898|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540899|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540900|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44540901|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44540902|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44540903|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459687|NCT01575873|Denosumab|denosumab|mesh-list
44540904|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540905|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44540906|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
44763159|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
44763160|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
44763161|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
44763162|NCT01756664|Petrolatum|petrolatum|mesh-list
44763163|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44763164|NCT01756664|Protective Agents|protective agents|mesh-ancestor
44763165|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763166|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763167|NCT01756664|Emollients|emollients|mesh-ancestor
44763168|NCT01756768|Palbociclib|palbociclib|mesh-list
44763169|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763170|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44763171|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763172|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763173|NCT01756781|Palbociclib|palbociclib|mesh-list
44763174|NCT01756781|Midazolam|midazolam|mesh-list
44763175|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763176|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763177|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763178|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763179|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44763180|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44763181|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44763182|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44763183|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
44763184|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
44763185|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
44763186|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
44763187|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763188|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763189|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763190|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459691|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
44763191|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763192|NCT01756989|Thalidomide|thalidomide|mesh-list
44763193|NCT01756989|Celecoxib|celecoxib|mesh-list
44763194|NCT01756989|Etoposide|etoposide|mesh-list
44763195|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
44763196|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44763197|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763198|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44763199|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44763200|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763201|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243979|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44763202|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44763203|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44763204|NCT01756989|Analgesics|analgesics|mesh-ancestor
43983961|NCT02138006|Insulin|insulin|mesh-list
44763205|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
44763206|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763207|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763208|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763209|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763210|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44763211|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243990|NCT05642078|Vaccines|vaccines|mesh-list
44763212|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763213|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
44763214|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
44763215|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763216|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243995|NCT05642026|Ropivacaine|ropivacaine|mesh-list
44763217|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44763218|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44763219|NCT01756989|Growth Substances|growth substances|mesh-ancestor
44763220|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
44763221|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
44763222|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763223|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44763224|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44763225|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
44763226|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763227|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244006|NCT05641909|Remifentanil|remifentanil|mesh-list
44763228|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763229|NCT01757106|Sevoflurane|sevoflurane|mesh-list
44763230|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44763231|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44763232|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
44763233|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
44763234|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763235|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763236|NCT01757236|Vancomycin|vancomycin|mesh-list
44763237|NCT01757236|Rifampin|rifampin|mesh-list
44763238|NCT01757236|Clindamycin|clindamycin|mesh-list
44763239|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
44763240|NCT01757236|Linezolid|linezolid|mesh-list
44763241|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44763242|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
44763243|NCT01757236|Trimethoprim|trimethoprim|mesh-list
44763244|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
44763245|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763246|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763247|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44763248|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
44763249|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
44244027|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
44763250|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44763251|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244032|NCT05641649|Valproic Acid|valproic acid|mesh-list
44763252|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763253|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44763254|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44763255|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44763256|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44763257|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44763258|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44763259|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44763260|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44763261|NCT01757236|Renal Agents|renal agents|mesh-ancestor
44763262|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
44763263|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44763264|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44763265|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44763266|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44244055|NCT05640830|Paclitaxel|paclitaxel|mesh-list
44763267|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44763268|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44763269|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
44763270|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44763271|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44763272|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
44763273|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44763274|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44244056|NCT05640830|Bevacizumab|bevacizumab|mesh-list
44763275|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763276|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44763277|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44763278|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44763279|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44763280|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44763281|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44763282|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44763283|NCT01757262|Clopidogrel|clopidogrel|mesh-list
44763284|NCT01757262|Ticagrelor|ticagrelor|mesh-list
44244069|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44763285|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44763286|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44763287|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44763288|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44763289|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
44763290|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763291|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763292|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690131|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44244070|NCT05640804|Dasatinib|dasatinib|mesh-list
44690132|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44690133|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
44690134|NCT01353742|Lamivudine|lamivudine|mesh-list
44690135|NCT01353742|Adefovir|adefovir|mesh-list
44690136|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44690137|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44690138|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44690139|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690140|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690141|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
44690142|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690143|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44690144|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44690145|NCT01353794|Sorafenib|sorafenib|mesh-list
44690146|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763294|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44763295|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763296|NCT01757431|Eculizumab|eculizumab|mesh-list
44763297|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44763298|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763299|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
44763300|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763301|NCT01757457|Abciximab|abciximab|mesh-list
44763302|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
44763303|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44763304|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
44763305|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763306|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763307|NCT01757587|Insulin|insulin|mesh-list
44763308|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44763309|NCT01757587|Metformin|metformin|mesh-list
44763310|NCT01757587|Vildagliptin|vildagliptin|mesh-list
44763311|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763312|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763313|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43985069|NCT02179671|Docetaxel|docetaxel|mesh-list
44763314|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
44763315|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763316|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763317|NCT01757639|Ipilimumab|ipilimumab|mesh-list
44763318|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763319|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763320|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44763321|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763322|NCT01757756|Midazolam|midazolam|mesh-list
44763323|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763324|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763325|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763326|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763327|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44763328|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44763329|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44763330|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44763331|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
44763332|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
44763333|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
44763334|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
44763335|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763336|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763337|NCT01757769|Silodosin|silodosin|mesh-list
44763338|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44763339|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44763340|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44763341|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763342|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763343|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763344|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763345|NCT01757769|Urological Agents|urological agents|mesh-ancestor
44763346|NCT01757795|Otaplimastat|otaplimastat|mesh-list
44763347|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44763348|NCT01757795|Protective Agents|protective agents|mesh-ancestor
44763349|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763350|NCT01757808|Ranolazine|ranolazine|mesh-list
44763351|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44541048|NCT02035371|Insulin|insulin|mesh-list
44541049|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44541050|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
44541051|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
44541052|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44541053|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44541054|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541055|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44541056|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44541057|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541058|NCT02035488|Tobramycin|tobramycin|mesh-list
44541059|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44541060|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541061|NCT02035527|Cisplatin|cisplatin|mesh-list
44541062|NCT02035527|Docetaxel|docetaxel|mesh-list
44541063|NCT02035527|Sorafenib|sorafenib|mesh-list
44541071|NCT02035800|Adalimumab|adalimumab|mesh-list
44763352|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44763353|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763354|NCT01757860|Vitamin D|vitamin d|mesh-list
44763355|NCT01757860|Vitamins|vitamins|mesh-ancestor
44763356|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
44763357|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763358|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44763359|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
44763360|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44763361|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44763362|NCT01757899|Prednisolone|prednisolone|mesh-list
44763363|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
44763364|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44763365|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
44763366|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763367|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
44763368|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
44763369|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763370|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763371|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763372|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
44763373|NCT01757899|Hormones|hormones|mesh-ancestor
44763374|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763375|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44763376|NCT01757899|Protective Agents|protective agents|mesh-ancestor
44763377|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763378|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763380|NCT01758029|Testosterone|testosterone|mesh-list
44763381|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
44763382|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
44763383|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44763384|NCT01758029|Androgens|androgens|mesh-ancestor
44763385|NCT01758029|Hormones|hormones|mesh-ancestor
44763386|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763387|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763388|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763389|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763390|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
44763391|NCT01758094|Testosterone|testosterone|mesh-list
44763392|NCT01758094|Androgens|androgens|mesh-ancestor
44763393|NCT01758094|Hormones|hormones|mesh-ancestor
44763394|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763395|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763396|NCT01758107|Cyclosporine|cyclosporine|mesh-list
44763397|NCT01758107|Cyclosporins|cyclosporins|mesh-list
44763398|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244192|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44244207|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44763399|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763400|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763401|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
44763402|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763403|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
44763404|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763405|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763406|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763407|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44763408|NCT01758120|Prednisone|prednisone|mesh-list
44763409|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
44763410|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763411|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
44763412|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763413|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763414|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44763415|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
44763416|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763417|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763418|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44763419|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763420|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
44763421|NCT01758120|Hormones|hormones|mesh-ancestor
44763422|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763423|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763424|NCT01758146|Tamoxifen|tamoxifen|mesh-list
44763425|NCT01758146|Letrozole|letrozole|mesh-list
44763426|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763427|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44763428|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44763429|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763430|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763431|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44763432|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
44763433|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763434|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763435|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763436|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44763437|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44763438|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44763439|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44763440|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
44763441|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
44763442|NCT01758185|Vaccines|vaccines|mesh-list
44763443|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
44763444|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763445|NCT01758198|Methotrexate|methotrexate|mesh-list
44763446|NCT01758198|Abatacept|abatacept|mesh-list
44763447|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44763448|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
44763449|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44763450|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763451|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44763452|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
44763453|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763454|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763455|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763456|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763457|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44763458|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763459|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
44763460|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763461|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44763462|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44763463|NCT01758263|Metoprolol|metoprolol|mesh-list
44763464|NCT01758263|Nebivolol|nebivolol|mesh-list
44763465|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44763466|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44763467|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
44763468|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
44763469|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763470|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763471|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44763472|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44763473|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44763474|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763475|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763476|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763477|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
44763478|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44763479|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44763480|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44763481|NCT01758367|Decitabine|decitabine|mesh-list
44763482|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44763483|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
44763484|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763485|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763486|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763487|NCT01758380|Metformin|metformin|mesh-list
44763488|NCT01758380|Vildagliptin|vildagliptin|mesh-list
44763489|NCT01758380|Gliclazide|gliclazide|mesh-list
44763490|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763491|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763492|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44763493|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
44763494|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459730|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
44459731|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459741|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
44763495|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763496|NCT01758393|Prednisone|prednisone|mesh-list
44763497|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763498|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
44763499|NCT01758393|Hormones|hormones|mesh-ancestor
44763500|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763501|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763502|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763503|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763504|NCT01758471|Acarbose|acarbose|mesh-list
44763505|NCT01758471|Glipizide|glipizide|mesh-list
44763506|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44763507|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763508|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763509|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763510|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763511|NCT01758627|Icodextrin|icodextrin|mesh-list
44763512|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
44763513|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44763514|NCT01758640|Warfarin|warfarin|mesh-list
44763515|NCT01758640|Phenindione|phenindione|mesh-list
44763516|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
44763517|NCT01758666|Leucovorin|leucovorin|mesh-list
44763518|NCT01758666|Methotrexate|methotrexate|mesh-list
44763519|NCT01758666|Calcium|calcium|mesh-list
44763520|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
44763521|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44763522|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763523|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44763524|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
44763525|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44763526|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44763527|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
44763528|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763529|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763530|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763531|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763532|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44763533|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763534|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
44763535|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763536|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44763537|NCT01758666|Antidotes|antidotes|mesh-ancestor
44763538|NCT01758666|Protective Agents|protective agents|mesh-ancestor
44763539|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
44763540|NCT01758666|Vitamins|vitamins|mesh-ancestor
44763541|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
44763542|NCT01758744|Treprostinil|treprostinil|mesh-list
44763543|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44763544|NCT01758809|Bupivacaine|bupivacaine|mesh-list
44763545|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763546|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
44690147|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44690148|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690149|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690150|NCT01353833|Aldesleukin|aldesleukin|mesh-list
44690151|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690191|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44690192|NCT01354262|Vitamin D|vitamin d|mesh-list
44690193|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
44690194|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
44690195|NCT01354262|Vitamins|vitamins|mesh-list
44690196|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
44690197|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690198|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44690199|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690200|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44690201|NCT01354275|Hormones|hormones|mesh-ancestor
44690202|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690203|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690204|NCT01354405|Lanreotide|lanreotide|mesh-list
44690205|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690206|NCT01354418|Phenylephrine|phenylephrine|mesh-list
44690207|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
44690208|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44690209|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
44690210|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
44690211|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690212|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690213|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
44690214|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44690215|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
44690216|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
44690217|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44690218|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44690219|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690220|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690221|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690222|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690223|NCT01354418|Protective Agents|protective agents|mesh-ancestor
44690224|NCT01354457|Epratuzumab|epratuzumab|mesh-list
44690225|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44690226|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690227|NCT01354470|Modafinil|modafinil|mesh-list
44690228|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44244343|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690229|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690230|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44690231|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44690232|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44690233|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690234|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
44690235|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44690236|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44690237|NCT01354483|Prednisolone|prednisolone|mesh-list
44690238|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
44690239|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
44690240|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44763547|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763548|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763549|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
44763550|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763551|NCT01758835|Calpastatin|calpastatin|mesh-list
44244373|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763552|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44763553|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44763554|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763555|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763556|NCT01758913|Ibuprofen|ibuprofen|mesh-list
44763557|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44763558|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44763559|NCT01758913|Analgesics|analgesics|mesh-ancestor
44763560|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
44763561|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763562|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763563|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763564|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763565|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44763566|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763567|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763568|NCT01758978|Hydrocodone|hydrocodone|mesh-list
44541359|NCT02037191|Methotrexate|methotrexate|mesh-list
44541360|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44763569|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44763570|NCT01758978|Narcotics|narcotics|mesh-ancestor
44763571|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763572|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763573|NCT01758978|Analgesics|analgesics|mesh-ancestor
44763574|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
44763575|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763576|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
44763577|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44763578|NCT01759030|Rituximab|rituximab|mesh-list
44763579|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763580|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763581|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
44763582|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244399|NCT05414201|Adalimumab|adalimumab|mesh-list
44763583|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763584|NCT01759108|Rebamipide|rebamipide|mesh-list
44763585|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44763586|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763587|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
44763588|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763589|NCT01759108|Protective Agents|protective agents|mesh-ancestor
44763590|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763591|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763592|NCT01759394|Maleic acid|maleic acid|mesh-list
44763593|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763594|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763595|NCT01759485|Vitamin D|vitamin d|mesh-list
44763596|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
44763597|NCT01759485|Vitamins|vitamins|mesh-ancestor
44763598|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
44763599|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763600|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44763601|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44763602|NCT01759524|Lidocaine|lidocaine|mesh-list
44763603|NCT01759524|Clonidine|clonidine|mesh-list
44763604|NCT01759524|Bupivacaine|bupivacaine|mesh-list
44459747|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763605|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763606|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
44763607|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763608|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763609|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
44541361|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
44541362|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44541363|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541364|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541365|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
44541366|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541367|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541368|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44541369|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541370|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44541371|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541372|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
44763610|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763611|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44763612|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44763613|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44763614|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44763615|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763616|NCT01759524|Analgesics|analgesics|mesh-ancestor
44763617|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44763618|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
44763619|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
44763620|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44763621|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44763622|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44763623|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
44763624|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763625|NCT01759576|Canagliflozin|canagliflozin|mesh-list
44763626|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44763627|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763628|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763629|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763630|NCT01759589|Remifentanil|remifentanil|mesh-list
44763631|NCT01759589|Propofol|propofol|mesh-list
44459792|NCT01574612|Acyclovir|acyclovir|mesh-list
44763632|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44763633|NCT01759589|Anesthetics|anesthetics|mesh-list
44763634|NCT01759589|Sevoflurane|sevoflurane|mesh-list
44763635|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763636|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763637|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763638|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
44763639|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44763640|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44763641|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44763642|NCT01759589|Narcotics|narcotics|mesh-ancestor
44763643|NCT01759589|Analgesics|analgesics|mesh-ancestor
44763644|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
44763645|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541393|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
44763646|NCT01759706|Dexamethasone|dexamethasone|mesh-list
44763647|NCT01759706|Sufentanil|sufentanil|mesh-list
44763648|NCT01759706|Diazepam|diazepam|mesh-list
44763649|NCT01759706|Ondansetron|ondansetron|mesh-list
44763650|NCT01759706|Anesthetics|anesthetics|mesh-list
44763651|NCT01759706|Ropivacaine|ropivacaine|mesh-list
44763652|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763653|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
44763654|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
44763655|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763656|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763657|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763658|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
44763659|NCT01759706|Hormones|hormones|mesh-ancestor
44763660|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763661|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763662|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763663|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763664|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
44763665|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763666|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44763667|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
44763668|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763669|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763670|NCT01759706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44763671|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44763672|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44763673|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44763674|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44763675|NCT01759706|Narcotics|narcotics|mesh-ancestor
44763676|NCT01759706|Analgesics|analgesics|mesh-ancestor
44763677|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
44763678|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763679|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44763680|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
44763681|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763682|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
44763683|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763684|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44763685|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44763686|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
44763687|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
44763688|NCT01759719|Chromium|chromium|mesh-list
44763689|NCT01759719|Trace Elements|trace elements|mesh-ancestor
44763690|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
44763691|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763692|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
44763693|NCT01759732|Fludarabine|fludarabine|mesh-list
44763694|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44763695|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763696|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
44763697|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763698|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763699|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44763700|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
44763701|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763702|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763703|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44763704|NCT01759771|Vitamin D|vitamin d|mesh-list
44763705|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
44763706|NCT01759771|Vitamins|vitamins|mesh-ancestor
44763707|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
44763708|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244464|NCT05378100|Midazolam|midazolam|mesh-list
44763709|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44763710|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44763711|NCT01759810|Vaccines|vaccines|mesh-list
44763712|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
44763713|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763714|NCT01759875|Ritonavir|ritonavir|mesh-list
44763715|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44763716|NCT01759875|Rabeprazole|rabeprazole|mesh-list
44763717|NCT01759875|Betaine|betaine|mesh-list
44763718|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44763719|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44763720|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723126|NCT02612207|Bilirubin|bilirubin|mesh-list
44763721|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763722|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763723|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44763724|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44763725|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
44763726|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763727|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44763728|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44763729|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44763730|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763731|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44763732|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
44763733|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44763734|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
44763735|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44244489|NCT05376852|Decitabine|decitabine|mesh-list
44763736|NCT01759940|Ropivacaine|ropivacaine|mesh-list
44763737|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763738|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
44763739|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763740|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987924|NCT02311933|Tamoxifen|tamoxifen|mesh-list
44244495|NCT05373901|Tretinoin|tretinoin|mesh-list
44763741|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
44763742|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763743|NCT01760018|Desflurane|desflurane|mesh-list
44763744|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44763745|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
44763746|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
44763747|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763748|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763749|NCT01760096|Cyclosporine|cyclosporine|mesh-list
44763750|NCT01760096|Levamisole|levamisole|mesh-list
44763751|NCT01760096|Cyclosporins|cyclosporins|mesh-list
44763752|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
44244501|NCT05368441|Midazolam|midazolam|mesh-list
44763753|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763754|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763755|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690241|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
44690242|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690243|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
44690244|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
44690245|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690246|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244507|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44690247|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690248|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
44690249|NCT01354483|Hormones|hormones|mesh-ancestor
44690250|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690251|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44690252|NCT01354483|Protective Agents|protective agents|mesh-ancestor
44690253|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690254|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690255|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
44690256|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44690257|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244517|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44690258|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690259|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
44690260|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44690261|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690262|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
44690263|NCT01354522|Docetaxel|docetaxel|mesh-list
44690264|NCT01354522|Doxorubicin|doxorubicin|mesh-list
44690265|NCT01354522|Capecitabine|capecitabine|mesh-list
44690266|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690267|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
44690268|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690269|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690270|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44690271|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
44690272|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690273|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988279|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
44690274|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44690275|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
44690276|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690277|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690278|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44763756|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
44244546|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
44690279|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44541546|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44541547|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
44541548|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
44541549|NCT02038842|Vaccines|vaccines|mesh-list
44541550|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
44541552|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
44763757|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763758|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
44763759|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763760|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763761|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763762|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44763763|NCT01760096|Hormones|hormones|mesh-ancestor
44763764|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763765|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44244560|NCT05335928|Abatacept|abatacept|mesh-list
44244568|NCT05335915|Nicotine|nicotine|mesh-list
44763766|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
44763767|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
44763768|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44763769|NCT01760109|Piperacillin|piperacillin|mesh-list
44763770|NCT01760109|Sulbactam|sulbactam|mesh-list
44763771|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763772|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763773|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44763774|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763775|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763776|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44763777|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
44763778|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763779|NCT01760148|Interferons|interferons|mesh-list
44763780|NCT01760148|Ribavirin|ribavirin|mesh-list
44763781|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
44763782|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
44763783|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763784|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
44763785|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763786|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
44244584|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763787|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988720|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
44763788|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
44763789|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763790|NCT01760161|Ropivacaine|ropivacaine|mesh-list
44763791|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763792|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
44763793|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763794|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244589|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244595|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763795|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
44763796|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763797|NCT01760174|Bupivacaine|bupivacaine|mesh-list
44763798|NCT01760174|Ropivacaine|ropivacaine|mesh-list
44763799|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
44763800|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
44763801|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763802|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763803|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
44763804|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763805|NCT01760226|Prednisone|prednisone|mesh-list
44763806|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
44763807|NCT01760226|Rituximab|rituximab|mesh-list
44763808|NCT01760226|Doxorubicin|doxorubicin|mesh-list
44763809|NCT01760226|Methotrexate|methotrexate|mesh-list
44763810|NCT01760226|Etoposide|etoposide|mesh-list
44763811|NCT01760226|Vincristine|vincristine|mesh-list
44763812|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44763813|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
44763814|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763815|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244606|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44763816|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44763817|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
44763818|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763819|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763820|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44763821|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763822|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44763823|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44763824|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44541581|NCT02039323|Tenofovir|tenofovir|mesh-list
44541582|NCT02039323|Maraviroc|maraviroc|mesh-list
44541583|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
44541584|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541585|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44541586|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541587|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541588|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763825|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244633|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763826|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44763827|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
44763828|NCT01760226|Hormones|hormones|mesh-ancestor
44763829|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763830|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44763831|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44763832|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
44763833|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44763834|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44763835|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
44763836|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763837|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44763838|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44763839|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44763840|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
44763841|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
44763842|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
44763843|NCT01760252|Capecitabine|capecitabine|mesh-list
44763844|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
44244651|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44763845|NCT01760252|Irinotecan|irinotecan|mesh-list
44763846|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44763847|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
44763848|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763849|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763850|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44763851|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44763852|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763853|NCT01760278|Cetrorelix|cetrorelix|mesh-list
44763854|NCT01760278|Hormones|hormones|mesh-list
44763855|NCT01760278|Progesterone|progesterone|mesh-list
44763856|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44763857|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244661|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
44763858|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763859|NCT01760278|Progestins|progestins|mesh-ancestor
44763860|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44763861|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
44763862|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44763863|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
44763864|NCT01760330|Acetaminophen|acetaminophen|mesh-list
44763865|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44763866|NCT01760330|Analgesics|analgesics|mesh-ancestor
44763867|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
44763868|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763869|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763870|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
44763871|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
44763872|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
44244662|NCT05241288|Albuterol|albuterol|mesh-list
44244675|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763873|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44763874|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44763875|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763876|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763877|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763878|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44763879|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
44763880|NCT01760460|Anacetrapib|anacetrapib|mesh-list
44763881|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44763882|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44763883|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
44763884|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763885|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44763886|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763887|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44763888|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763889|NCT01760564|Miglustat|miglustat|mesh-list
44763890|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763891|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763892|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44763893|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44763894|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
44763895|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763896|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44763897|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44763898|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763899|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
44763900|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44763901|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44763902|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
44763903|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44763904|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44763905|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763906|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44763907|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763908|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763909|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44763910|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44763911|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44763912|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
44763913|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
44763914|NCT01760577|Protective Agents|protective agents|mesh-ancestor
44763915|NCT01760642|Rifampin|rifampin|mesh-list
44763916|NCT01760642|Ketoconazole|ketoconazole|mesh-list
44763917|NCT01760642|Midazolam|midazolam|mesh-list
44763918|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44763919|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763920|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44763921|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763922|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44763923|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44763924|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44763925|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44763926|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
44763927|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
44763928|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
44763929|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
44763930|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44763931|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763932|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44763933|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
44763934|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763935|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763936|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
44763937|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44763938|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763939|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44763940|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44763941|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44763942|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44763943|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44763944|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44763945|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
44763946|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44763947|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44763948|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44763949|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
44244711|NCT05157464|Losartan|losartan|mesh-list
44763950|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44763951|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44763952|NCT01760694|Leucovorin|leucovorin|mesh-list
44763953|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
44763954|NCT01760694|Irinotecan|irinotecan|mesh-list
44763955|NCT01760694|Folfirinox|folfirinox|mesh-list
44763956|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763957|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44763958|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44763959|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763960|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763961|NCT01760694|Antidotes|antidotes|mesh-ancestor
44763962|NCT01760694|Protective Agents|protective agents|mesh-ancestor
44763963|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244766|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44763964|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
44763965|NCT01760694|Vitamins|vitamins|mesh-ancestor
44763966|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
44763967|NCT01760746|Bevacizumab|bevacizumab|mesh-list
44763968|NCT01760746|Ranibizumab|ranibizumab|mesh-list
44763969|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763970|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763971|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44763972|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44763973|NCT01760746|Growth Substances|growth substances|mesh-ancestor
44763974|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763975|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
44763976|NCT01760798|Teriparatide|teriparatide|mesh-list
44763977|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44763978|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44763979|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44763980|NCT01760811|Cetuximab|cetuximab|mesh-list
44763981|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44763982|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44763983|NCT01760824|Amoxicillin|amoxicillin|mesh-list
44763984|NCT01760824|Metronidazole|metronidazole|mesh-list
44763985|NCT01760824|Clarithromycin|clarithromycin|mesh-list
44763986|NCT01760824|Tetracycline|tetracycline|mesh-list
44763987|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44763988|NCT01760824|Esomeprazole|esomeprazole|mesh-list
44763989|NCT01760824|Bismuth|bismuth|mesh-list
44763990|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44763991|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44763992|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44763993|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44763994|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44763995|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44763996|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44763997|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44763998|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44763999|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44764000|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44764001|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44764002|NCT01760824|Antacids|antacids|mesh-ancestor
44764003|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44764004|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764005|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
44764006|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44764007|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764008|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764009|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764010|NCT01760967|Analgesics|analgesics|mesh-ancestor
44764011|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
44764012|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764013|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44764014|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44764015|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44764016|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764017|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764018|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764019|NCT01760980|Exemestane|exemestane|mesh-list
44764020|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764021|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44764022|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44764023|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764024|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764025|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44764026|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
44764027|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764028|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764029|NCT01761071|Diclofenac|diclofenac|mesh-list
44764030|NCT01761071|Ketorolac|ketorolac|mesh-list
44764031|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764032|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764033|NCT01761071|Analgesics|analgesics|mesh-ancestor
44764034|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
44764035|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764036|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764037|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764038|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764039|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764040|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764041|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764042|NCT01761110|Buprenorphine|buprenorphine|mesh-list
44764043|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44764044|NCT01761110|Narcotics|narcotics|mesh-ancestor
44764045|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764046|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764047|NCT01761110|Analgesics|analgesics|mesh-ancestor
44764048|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
44764049|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764050|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44764051|NCT01761149|Remifentanil|remifentanil|mesh-list
44764052|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44764053|NCT01761149|Narcotics|narcotics|mesh-ancestor
44764054|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764055|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764056|NCT01761149|Analgesics|analgesics|mesh-ancestor
44764057|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
44764058|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764059|NCT01761201|Levofloxacin|levofloxacin|mesh-list
44764061|NCT01761201|Isoniazid|isoniazid|mesh-list
44764062|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44764063|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764064|NCT01761201|Renal Agents|renal agents|mesh-ancestor
44764065|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764066|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44764067|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44764068|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764069|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764070|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764071|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44764072|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44764073|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
44764074|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44764075|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764076|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
44764077|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764078|NCT01761214|Amoxicillin|amoxicillin|mesh-list
44764079|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
44764080|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
44764081|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
44764082|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44764083|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44764084|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764085|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764086|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44764087|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44764088|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764089|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764090|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764091|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44764092|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44541930|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44764093|NCT01761318|Liraglutide|liraglutide|mesh-list
44764094|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44764095|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764096|NCT01761318|Incretins|incretins|mesh-ancestor
44764098|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764099|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
44764100|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764101|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
44764102|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764103|NCT01761487|Gentamicins|gentamicins|mesh-list
44764104|NCT01761487|Polymyxins|polymyxins|mesh-list
44764105|NCT01761487|Colistin|colistin|mesh-list
44764106|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764107|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764108|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44764109|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764110|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764111|NCT01761513|Esomeprazole|esomeprazole|mesh-list
44764112|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44764113|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764114|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44764115|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764116|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764117|NCT01761526|Rotigotine|rotigotine|mesh-list
44764118|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
44764119|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
44764120|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764121|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764122|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764123|NCT01761552|Atropine|atropine|mesh-list
44764124|NCT01761552|Neostigmine|neostigmine|mesh-list
44764125|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244839|NCT05062031|Atropine|atropine|mesh-list
44244852|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44764126|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44764127|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44764128|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
44764129|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764130|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764131|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44764132|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
44764133|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
44764134|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
44764135|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44764136|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44764137|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
44764138|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764139|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764140|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44764141|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764142|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44764143|NCT01761656|Atorvastatin|atorvastatin|mesh-list
44764144|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44764145|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764146|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
44764147|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764148|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764149|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44764150|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764151|NCT01761669|Vitamin D|vitamin d|mesh-list
44764152|NCT01761669|Vitamins|vitamins|mesh-ancestor
44764153|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
44541931|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541932|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541933|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44541934|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44541935|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541936|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541937|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764154|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764155|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44764156|NCT01761877|Sulindac|sulindac|mesh-list
44764157|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44244886|NCT05046522|Palmidrol|palmidrol|mesh-list
44764158|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764159|NCT01761877|Analgesics|analgesics|mesh-ancestor
44764160|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
44764161|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764162|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764163|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764164|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764165|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764166|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764167|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764168|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764169|NCT01761916|Clonidine|clonidine|mesh-list
44764170|NCT01761916|Captopril|captopril|mesh-list
44764171|NCT01761916|Analgesics|analgesics|mesh-ancestor
44244901|NCT05046522|Hormones|hormones|mesh-ancestor
44244904|NCT05036278|Coagulants|coagulants|mesh-ancestor
44764172|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
44764173|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764174|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764175|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44764176|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
44764177|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
44764178|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44764179|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44764180|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44764181|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764182|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764183|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764184|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44764185|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
44764186|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244905|NCT05034952|Acetaminophen|acetaminophen|mesh-list
44244922|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
44764187|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44764188|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44764189|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764190|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764191|NCT01761994|Nafamostat|nafamostat|mesh-list
44764192|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764193|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764194|NCT01761994|Analgesics|analgesics|mesh-ancestor
44764195|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
44764196|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764197|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764198|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764199|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764200|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
44764201|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
44764202|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764203|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764204|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44764205|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44764206|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44764207|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764208|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
44764209|NCT01762046|Metformin|metformin|mesh-list
44764210|NCT01762046|Glipizide|glipizide|mesh-list
44764211|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44764212|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764213|NCT01762150|Gemcitabine|gemcitabine|mesh-list
44764214|NCT01762150|Cisplatin|cisplatin|mesh-list
44764215|NCT01762150|Sorafenib|sorafenib|mesh-list
44764216|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764217|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44764218|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
44764219|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764220|NCT01762150|Antiviral Agents|antiviral agents|mesh-ancestor
44764221|NCT01762150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764222|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764223|NCT01762150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764224|NCT01762150|Immunologic Factors|immunologic factors|mesh-ancestor
44764225|NCT01762150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764226|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44764227|NCT01762163|Aspirin|aspirin|mesh-list
44764228|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764229|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764230|NCT01762163|Analgesics|analgesics|mesh-ancestor
44764231|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
44764232|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764233|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541939|NCT00159432|Bevacizumab|bevacizumab|mesh-list
44764234|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764235|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764236|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44764237|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44764238|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764239|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44764240|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764241|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764242|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
44764243|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
44764244|NCT01762202|Fludarabine|fludarabine|mesh-list
44764245|NCT01762202|Ofatumumab|ofatumumab|mesh-list
44764246|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764247|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
44764248|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764249|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764250|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44764251|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
44764252|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764253|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764254|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44764255|NCT01762306|Folic Acid|folic acid|mesh-list
44764256|NCT01762306|Diclofenac|diclofenac|mesh-list
44764257|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764258|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764259|NCT01762306|Analgesics|analgesics|mesh-ancestor
44764260|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
44764261|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764262|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764263|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764264|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764265|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764266|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764267|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245004|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44764268|NCT01762306|Hematinics|hematinics|mesh-ancestor
44764269|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
44764270|NCT01762306|Vitamins|vitamins|mesh-ancestor
44764271|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
44764272|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
44764273|NCT01762319|Pyridoxal|pyridoxal|mesh-list
44764274|NCT01762319|Pyridoxine|pyridoxine|mesh-list
44764275|NCT01762319|Misoprostol|misoprostol|mesh-list
44764276|NCT01762319|Vitamins|vitamins|mesh-ancestor
44764277|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
44764278|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764279|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44764280|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
44764281|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44764282|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44764283|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764284|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
44764285|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
44764286|NCT01762332|Remifentanil|remifentanil|mesh-list
44764287|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44764288|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44764289|NCT01762332|Narcotics|narcotics|mesh-ancestor
44459888|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44764290|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764291|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764292|NCT01762332|Analgesics|analgesics|mesh-ancestor
44764293|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
44764294|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764295|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44764296|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764297|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764298|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764299|NCT01762436|Atenolol|atenolol|mesh-list
44764300|NCT01762436|Bisoprolol|bisoprolol|mesh-list
44764301|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44764302|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44764303|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
44245031|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
44764304|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
44764305|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764306|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764307|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44764308|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44764309|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44690280|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44764310|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764311|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764312|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764313|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
44764314|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
44764315|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44764316|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44764317|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245032|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
44245046|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44764318|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764319|NCT01762475|Urological Agents|urological agents|mesh-ancestor
44764320|NCT01762514|Amifostine|amifostine|mesh-list
44764321|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44764322|NCT01762514|Protective Agents|protective agents|mesh-ancestor
44764323|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764324|NCT01762540|Prednisolone|prednisolone|mesh-list
44764325|NCT01762540|Calcium|calcium|mesh-list
44764326|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
44764327|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44764328|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764329|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764330|NCT01762540|Hormones|hormones|mesh-ancestor
44245047|NCT04954287|Vaccines|vaccines|mesh-list
44245060|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764331|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764332|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44764333|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764334|NCT01762644|Cyclosporine|cyclosporine|mesh-list
44764335|NCT01762644|Omeprazole|omeprazole|mesh-list
44764336|NCT01762644|Cyclosporins|cyclosporins|mesh-list
44764337|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764338|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764339|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764340|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
44764341|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764342|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
44764343|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764344|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
44764345|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764346|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44764347|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44764348|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764349|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44764350|NCT01762657|Cyclosporine|cyclosporine|mesh-list
44764351|NCT01762657|Lansoprazole|lansoprazole|mesh-list
44764352|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
44764353|NCT01762657|Cyclosporins|cyclosporins|mesh-list
44764354|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764355|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764356|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764357|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
44764358|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764359|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
44764360|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764361|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44764362|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764363|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44764364|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44764365|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764366|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44764367|NCT01762670|Metronidazole|metronidazole|mesh-list
44764368|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764369|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764370|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44764371|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44764373|NCT01762787|Prednisolone|prednisolone|mesh-list
44764374|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44245098|NCT04904978|Protective Agents|protective agents|mesh-ancestor
44764375|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
44764376|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44764377|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
44764378|NCT01762787|Cantharidin|cantharidin|mesh-list
44764379|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44764380|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
44764381|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764382|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764383|NCT01762787|Analgesics|analgesics|mesh-ancestor
44764384|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
44764385|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764386|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764387|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764388|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690281|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690282|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44690283|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
44690284|NCT01354613|Amlodipine|amlodipine|mesh-list
44690285|NCT01354613|Dobutamine|dobutamine|mesh-list
44690286|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44690287|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44690288|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690289|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690290|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690291|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690292|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
44245124|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
44690293|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44690294|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
44690295|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
44690296|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690297|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44690298|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44690299|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690300|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690301|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690302|NCT01354613|Protective Agents|protective agents|mesh-ancestor
44690303|NCT01354665|Interferons|interferons|mesh-list
44690304|NCT01354665|Interferon-beta|interferon-beta|mesh-list
44690305|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
44690306|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690307|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
44690308|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690309|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
44690310|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690311|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44690312|NCT01354704|Enoxaparin|enoxaparin|mesh-list
44690313|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
44690314|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44690315|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44690316|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690317|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44690318|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44690319|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690320|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690321|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
44690322|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690323|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690324|NCT01354860|Lobeline|lobeline|mesh-list
44690325|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44690326|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
44690327|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690328|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690329|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44690330|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44690331|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
44690332|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690333|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690334|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
44690335|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44690336|NCT01354886|Hormones|hormones|mesh-ancestor
44690337|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764389|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44764390|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44245151|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44764391|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764392|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44764393|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764394|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764395|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
44764396|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
44764397|NCT01762787|Hormones|hormones|mesh-ancestor
44764398|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764399|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44764400|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764401|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
44764402|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
44764403|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764404|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44764405|NCT01762787|Protective Agents|protective agents|mesh-ancestor
44764406|NCT01762826|Inositol|inositol|mesh-list
44764407|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
44764408|NCT01762826|Vitamins|vitamins|mesh-ancestor
44764409|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
44764410|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764411|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
44764412|NCT01762839|Oritavancin|oritavancin|mesh-list
44764413|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764414|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764415|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44764416|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44764417|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764418|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764419|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764420|NCT01762852|Belimumab|belimumab|mesh-list
44764421|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764422|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
44764423|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764424|NCT01762878|Nemiralisib|nemiralisib|mesh-list
44764425|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44764426|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764427|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764428|NCT01762891|Acetaminophen|acetaminophen|mesh-list
44764429|NCT01762891|Celecoxib|celecoxib|mesh-list
44764430|NCT01762891|Rofecoxib|rofecoxib|mesh-list
44764431|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764432|NCT01762891|Analgesics|analgesics|mesh-ancestor
44764433|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
44764434|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764435|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764436|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
44764437|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764438|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764439|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764440|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44764441|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764442|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764443|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764444|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
44764445|NCT01762995|Dolutegravir|dolutegravir|mesh-list
44764446|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
44764447|NCT01762995|Calcium|calcium|mesh-list
44764448|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44764449|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764450|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44764451|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44764452|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764453|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764454|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44764455|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44764456|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
44764457|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764458|NCT01762995|Antacids|antacids|mesh-ancestor
44764459|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764460|NCT01762995|Trace Elements|trace elements|mesh-ancestor
44764461|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
44764462|NCT01763021|Rifampin|rifampin|mesh-list
44764463|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44542182|NCT00150618|Guanfacine|guanfacine|mesh-list
44542183|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542199|NCT00150462|Hormones|hormones|mesh-ancestor
44764464|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
44764466|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764467|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
44764468|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44764469|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764470|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764471|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44764472|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44764473|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44764474|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44764475|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44764476|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44764477|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44764478|NCT01763281|Hormones|hormones|mesh-ancestor
44764479|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764480|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764481|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44764482|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764483|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44764484|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764485|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764486|NCT01763424|Calcitriol|calcitriol|mesh-list
44764487|NCT01763424|Niacinamide|niacinamide|mesh-list
44764488|NCT01763424|Niacin|niacin|mesh-list
44764489|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
44764490|NCT01763424|Calcipotriene|calcipotriene|mesh-list
44764491|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
44764492|NCT01763424|Vitamins|vitamins|mesh-ancestor
44764493|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
44764494|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764495|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764496|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
44764497|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764498|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764499|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
44764500|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44764501|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44764502|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44764503|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764504|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44764505|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44764506|NCT01763437|Tetracycline|tetracycline|mesh-list
44764507|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764508|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764509|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44764510|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764511|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764512|NCT01763450|Bevacizumab|bevacizumab|mesh-list
44764513|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44764514|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764515|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44764516|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44764517|NCT01763450|Growth Substances|growth substances|mesh-ancestor
44764518|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764519|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44764520|NCT01763463|Fluticasone|fluticasone|mesh-list
44764521|NCT01763463|Xhance|xhance|mesh-list
44764522|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44764523|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44764524|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
44764525|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764526|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
44764527|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764528|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764529|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44764530|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44764531|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
44764532|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44764533|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44764534|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44764535|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44764536|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764537|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764538|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764540|NCT01763463|Hormones|hormones|mesh-ancestor
44245218|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44764541|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764542|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
44764543|NCT01763476|Paclitaxel|paclitaxel|mesh-list
44764544|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44764545|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764546|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
44764547|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
44764548|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245284|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764549|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764550|NCT01763541|Anastrozole|anastrozole|mesh-list
44764551|NCT01763541|Leuprolide|leuprolide|mesh-list
44764552|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44764553|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764554|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44764555|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44764556|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764557|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990846|NCT02454283|Vanoxerine|vanoxerine|mesh-list
44245295|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
44764558|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44764559|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
44764560|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764561|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764562|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44764563|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
44764564|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44764565|NCT01763658|Dexamethasone|dexamethasone|mesh-list
44764566|NCT01763658|Prednisolone|prednisolone|mesh-list
44764567|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44764568|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
44764569|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44764570|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
44764571|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44764572|NCT01763658|Antioxidants|antioxidants|mesh-list
44764573|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764574|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
44764575|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
44245306|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44764576|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764577|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764578|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764579|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
44764580|NCT01763658|Hormones|hormones|mesh-ancestor
44764581|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764582|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44764583|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764584|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764585|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44764586|NCT01763658|Protective Agents|protective agents|mesh-ancestor
44764587|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
44764588|NCT01763671|Paclitaxel|paclitaxel|mesh-list
44764589|NCT01763671|Docetaxel|docetaxel|mesh-list
44764590|NCT01763671|Bevacizumab|bevacizumab|mesh-list
44764591|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44764592|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764593|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44764594|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44764595|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44764596|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764597|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44764598|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44764599|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44764600|NCT01763671|Growth Substances|growth substances|mesh-ancestor
44764601|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764602|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
44764603|NCT01763710|Paclitaxel|paclitaxel|mesh-list
43684422|NCT02842931|Prednisone|prednisone|mesh-list
44764604|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44764605|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44764606|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764607|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
44764608|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
44764609|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
44764610|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764611|NCT01763749|Clopidogrel|clopidogrel|mesh-list
44764612|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44764613|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44764614|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44764615|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44764616|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
44764617|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764618|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764619|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764620|NCT01763788|Gemcitabine|gemcitabine|mesh-list
44764621|NCT01763788|Cisplatin|cisplatin|mesh-list
44764622|NCT01763788|Necitumumab|necitumumab|mesh-list
44764623|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764624|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44764625|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
44764626|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764627|NCT01763788|Antiviral Agents|antiviral agents|mesh-ancestor
44764628|NCT01763788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764629|NCT01763788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764630|NCT01763788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764631|NCT01763788|Immunologic Factors|immunologic factors|mesh-ancestor
44764632|NCT01763788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764633|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44764634|NCT01764087|Paclitaxel|paclitaxel|mesh-list
44764635|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
44245357|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764636|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44764637|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764638|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44764639|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44764640|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44764641|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764642|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764643|NCT01764126|Vaccines|vaccines|mesh-list
44764644|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
44764645|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764646|NCT01764139|Vitamin D|vitamin d|mesh-list
44764647|NCT01764139|Vitamins|vitamins|mesh-ancestor
44764648|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
44764649|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245370|NCT04655755|Decitabine|decitabine|mesh-list
44764650|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44764651|NCT01764178|Valsartan|valsartan|mesh-list
44764652|NCT01764178|Pitavastatin|pitavastatin|mesh-list
44245378|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764653|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44764654|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44764655|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44764656|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764657|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44764658|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44764659|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764660|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
44764661|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764662|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764663|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44764664|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
44764665|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44764666|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
44764667|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44764668|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764669|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44764670|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44764671|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764672|NCT01764295|Olmesartan|olmesartan|mesh-list
44764673|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44764674|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44764675|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764676|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
44764677|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764678|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764679|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44764680|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764681|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44764682|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44764683|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44764684|NCT01764451|Simvastatin|simvastatin|mesh-list
44764685|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44764686|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764687|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
44764688|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764689|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764690|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44764691|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764692|NCT01764555|Acetaminophen|acetaminophen|mesh-list
44764693|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764694|NCT01764555|Analgesics|analgesics|mesh-ancestor
44764695|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
44764696|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764697|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764698|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
44764699|NCT01764581|Tacrolimus|tacrolimus|mesh-list
44764700|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764701|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
44764702|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764703|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44764704|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764705|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992015|NCT02508077|Vitamins|vitamins|mesh-ancestor
44764706|NCT01764672|Methylphenidate|methylphenidate|mesh-list
44764707|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44764708|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764709|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44764710|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44764711|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764712|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764713|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
44764714|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764715|NCT01764750|Vancomycin|vancomycin|mesh-list
44764716|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764717|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764718|NCT01764828|Gemcitabine|gemcitabine|mesh-list
44764719|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44764720|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
44764721|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764722|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764723|NCT01764828|Antiviral Agents|antiviral agents|mesh-ancestor
44764724|NCT01764828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764725|NCT01764828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764726|NCT01764828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44764727|NCT01764828|Immunologic Factors|immunologic factors|mesh-ancestor
44764728|NCT01764828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764729|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44764730|NCT01764867|Dexetimide|dexetimide|mesh-list
44764731|NCT01764867|Mirtazapine|mirtazapine|mesh-list
44764732|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
44764733|NCT01764867|Trazodone|trazodone|mesh-list
44245459|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
44764734|NCT01764867|Citalopram|citalopram|mesh-list
44764735|NCT01764867|Bupropion|bupropion|mesh-list
44764736|NCT01764867|Fluoxetine|fluoxetine|mesh-list
44764737|NCT01764867|Paroxetine|paroxetine|mesh-list
44764738|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44764739|NCT01764867|Sertraline|sertraline|mesh-list
44764740|NCT01764867|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44764741|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44764742|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764743|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764744|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764745|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
44764746|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764747|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44764748|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
44764749|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44764750|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44764751|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44764752|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
44764753|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
44764754|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764755|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44764756|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44764757|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
44245469|NCT04589325|Ixekizumab|ixekizumab|mesh-list
44764758|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44542484|NCT00709098|Iloprost|iloprost|mesh-list
44764759|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
44764760|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44764761|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44764762|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764763|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44764764|NCT01764867|Analgesics|analgesics|mesh-ancestor
44764765|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
44245489|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764766|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44764767|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
44764768|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
44764769|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44542557|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44764770|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44764771|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764772|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44764773|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44764774|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44764775|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
44764776|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44764777|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44245494|NCT04570410|Cisplatin|cisplatin|mesh-list
44764778|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44764779|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44764780|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44764781|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
44764782|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44764783|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43992414|NCT02525549|Analgesics|analgesics|mesh-ancestor
44764784|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
44764785|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764786|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764787|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764788|NCT01764893|Urological Agents|urological agents|mesh-ancestor
44764789|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
44764791|NCT01765010|Calcitriol|calcitriol|mesh-list
44764792|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
44764793|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44764794|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44764795|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764796|NCT01765010|Vitamins|vitamins|mesh-ancestor
44764797|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
44764798|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44764799|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44764800|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764801|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245505|NCT04566328|Dexamethasone|dexamethasone|mesh-list
44764802|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44764803|NCT01765023|Metformin|metformin|mesh-list
44764804|NCT01765023|Atorvastatin|atorvastatin|mesh-list
44245527|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
44764805|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44764806|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764807|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44764808|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44764809|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
44764810|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764811|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44764812|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44245533|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
44764813|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764814|NCT01765088|Temozolomide|temozolomide|mesh-list
44542558|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
44542559|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542560|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44542561|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44542562|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542563|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542564|NCT00707993|Alogliptin|alogliptin|mesh-list
44542565|NCT00707993|Glipizide|glipizide|mesh-list
44542566|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44245536|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542567|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542568|NCT00707993|Incretins|incretins|mesh-ancestor
44542569|NCT00707993|Hormones|hormones|mesh-ancestor
44542570|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542571|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44542572|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
44366732|NCT01172756|Riociguat|riociguat|mesh-list
44764815|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44764816|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
44764817|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764818|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764819|NCT01765231|Entecavir|entecavir|mesh-list
44764820|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
44764821|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764822|NCT01765257|Rasagiline|rasagiline|mesh-list
44764823|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44764824|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764825|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764826|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44764827|NCT01765257|Protective Agents|protective agents|mesh-ancestor
44764828|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764829|NCT01765296|Celecoxib|celecoxib|mesh-list
44764830|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44764831|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44764832|NCT01765296|Analgesics|analgesics|mesh-ancestor
44764833|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
44764834|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44764835|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764836|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44764837|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764838|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44764839|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44764840|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764841|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764842|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
44764843|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44764844|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764845|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764846|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
44764847|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764848|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764849|NCT01765374|Rituximab|rituximab|mesh-list
44764850|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44764851|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764852|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
44245591|NCT04542148|Insulin|insulin|mesh-list
44764853|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764854|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764855|NCT01765452|Clopidogrel|clopidogrel|mesh-list
44764856|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44764857|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44764858|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44764859|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44764860|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
44764861|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245606|NCT04527991|Paclitaxel|paclitaxel|mesh-list
44764862|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764863|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764864|NCT01765556|Ketoconazole|ketoconazole|mesh-list
44764865|NCT01765556|Vemurafenib|vemurafenib|mesh-list
44764866|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
44764867|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764868|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44764869|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44764870|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764871|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764872|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44764873|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
44764874|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44764875|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764876|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44764877|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764878|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44764879|NCT01765608|Zonisamide|zonisamide|mesh-list
44764880|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
44764881|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44764882|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44245614|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
44764883|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764884|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44542584|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764885|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764886|NCT01765738|Minocycline|minocycline|mesh-list
44764887|NCT01765738|Rifampin|rifampin|mesh-list
44764888|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44764889|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764890|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44764891|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
44764892|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
44764893|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44764894|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764895|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764896|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44764897|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44764898|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44764899|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44764900|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44764901|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44764902|NCT01765790|Antibodies|antibodies|mesh-list
44764903|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
44764904|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
44764905|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764906|NCT01765829|Droperidol|droperidol|mesh-list
44764907|NCT01765829|Haloperidol|haloperidol|mesh-list
44764908|NCT01765829|Pimozide|pimozide|mesh-list
44764909|NCT01765829|Olanzapine|olanzapine|mesh-list
44764910|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
44764911|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
44764912|NCT01765829|Risperidone|risperidone|mesh-list
44764913|NCT01765829|Aripiprazole|aripiprazole|mesh-list
44764914|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44764915|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44764916|NCT01765829|Ziprasidone|ziprasidone|mesh-list
44764917|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
44764918|NCT01765829|Clozapine|clozapine|mesh-list
44764919|NCT01765829|Asenapine|asenapine|mesh-list
44764920|NCT01765829|Amisulpride|amisulpride|mesh-list
44764921|NCT01765829|Perphenazine|perphenazine|mesh-list
44764922|NCT01765829|Sertindole|sertindole|mesh-list
44764923|NCT01765829|Sulpiride|sulpiride|mesh-list
44764924|NCT01765829|Clopenthixol|clopenthixol|mesh-list
44764925|NCT01765829|Clothiapine|clothiapine|mesh-list
44764926|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44764927|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
44764928|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44764929|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764930|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764931|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44764932|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44764933|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44764934|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44764935|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
44764936|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
44764937|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
44764938|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690338|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690339|NCT01354925|Insulin|insulin|mesh-list
44690340|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690341|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690342|NCT01355120|Ipilimumab|ipilimumab|mesh-list
44690343|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44690344|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690345|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44690346|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690347|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
44690348|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44690349|NCT01355198|Glycine|glycine|mesh-list
44690350|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
44690351|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690352|NCT01355198|Expectorants|expectorants|mesh-ancestor
44690353|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
44690354|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44245683|NCT04443348|Paclitaxel|paclitaxel|mesh-list
44690355|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
44690356|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690357|NCT01355198|Protective Agents|protective agents|mesh-ancestor
44764939|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764940|NCT01765829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44764941|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44764942|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44764943|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
44764944|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
44764945|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44764946|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44764947|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44764948|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44764949|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44764950|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
44764951|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
44764952|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44764953|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44764955|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44764956|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764957|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
44764958|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764959|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44764960|NCT01765855|Betrixaban|betrixaban|mesh-list
44764961|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44764962|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
44764963|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44764964|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44764965|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764966|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764967|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
44764968|NCT01765868|Betrixaban|betrixaban|mesh-list
44764969|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44764970|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
44764971|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44764972|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
44764973|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44764974|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44764975|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
44764976|NCT01765881|Misoprostol|misoprostol|mesh-list
44764977|NCT01765881|Dinoprostone|dinoprostone|mesh-list
44764978|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44764979|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
44764980|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44764981|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764982|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44764983|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44764984|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
44764985|NCT01765946|Metformin|metformin|mesh-list
44764986|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44764987|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764988|NCT01766063|Interferons|interferons|mesh-list
44764989|NCT01766063|Interferon-beta|interferon-beta|mesh-list
44764990|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
44764991|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44764992|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
44764993|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44764994|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
44764995|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44764996|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44764997|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
44764998|NCT01766089|Remifentanil|remifentanil|mesh-list
44764999|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44765000|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765001|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765002|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44765003|NCT01766089|Analgesics|analgesics|mesh-ancestor
44765004|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
44765005|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765006|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44765007|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44765008|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44765009|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
44765010|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765011|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765012|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44765013|NCT01766089|Narcotics|narcotics|mesh-ancestor
44765014|NCT01766154|Tirofiban|tirofiban|mesh-list
44765015|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44765016|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44765017|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765018|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44765019|NCT01766180|Resveratrol|resveratrol|mesh-list
44765020|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
44765021|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765022|NCT01766180|Protective Agents|protective agents|mesh-ancestor
44765023|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765024|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765025|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44765027|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44765028|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44765029|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
44765030|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765031|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765032|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765033|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44765034|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765035|NCT01766323|Modafinil|modafinil|mesh-list
44765036|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43993724|NCT05249153|Dsuvia|dsuvia|mesh-list
44765037|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765038|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44765039|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44765040|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44765041|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765042|NCT01766375|Cyclosporine|cyclosporine|mesh-list
44765043|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
44765044|NCT01766375|Methotrexate|methotrexate|mesh-list
44765045|NCT01766375|Cyclosporins|cyclosporins|mesh-list
44765046|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44765047|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
44765048|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44765049|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765050|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765051|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
44765052|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765053|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765054|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765055|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765056|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44765057|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765058|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
44765059|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44765060|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44765061|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
44765062|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765063|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44765064|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44765065|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44245822|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44765066|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
44765067|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765068|NCT01766414|Complement C1s|complement c1s|mesh-list
44765069|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44765070|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44765071|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
44765072|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765073|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44765074|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765075|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
44765076|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44765077|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765078|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44765079|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
44765080|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765081|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765082|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245831|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44765083|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765084|NCT01766583|Lenalidomide|lenalidomide|mesh-list
44765085|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
44765086|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765087|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44765088|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765089|NCT01766583|Growth Substances|growth substances|mesh-ancestor
44765090|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765091|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765092|NCT01766609|Triamcinolone|triamcinolone|mesh-list
44765093|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44765094|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44765095|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44765096|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542863|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542864|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44542865|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44542866|NCT00703846|Ketoconazole|ketoconazole|mesh-list
44459957|NCT01571362|Naltrexone|naltrexone|mesh-list
44542867|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
44542868|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542869|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44542870|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44542871|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542872|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542873|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44765097|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
44765098|NCT01766609|Hormones|hormones|mesh-ancestor
44765099|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765100|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765101|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765102|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
44765103|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765104|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765105|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
44765106|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
44765107|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
44765108|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765109|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44765110|NCT01766843|Charcoal|charcoal|mesh-list
44765111|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44765112|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
44765113|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765114|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765115|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44765116|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765117|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
44765118|NCT01766843|Hormones|hormones|mesh-ancestor
44765119|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765120|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
44765121|NCT01766843|Antidotes|antidotes|mesh-ancestor
44765122|NCT01766843|Protective Agents|protective agents|mesh-ancestor
44765123|NCT01766960|Morphine|morphine|mesh-list
44765124|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44765125|NCT01766960|Narcotics|narcotics|mesh-ancestor
44765126|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765127|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765128|NCT01766960|Analgesics|analgesics|mesh-ancestor
44765129|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
44765130|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765131|NCT01767025|Oxytocin|oxytocin|mesh-list
44765132|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
44765133|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44765134|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765135|NCT01767090|Leuprolide|leuprolide|mesh-list
44765136|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44765137|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
44765138|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44765139|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765140|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44765141|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765142|NCT01767259|Valsartan|valsartan|mesh-list
44765143|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44765144|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44765145|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44765146|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44765147|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765148|NCT01767259|Diuretics|diuretics|mesh-ancestor
44765149|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
44765150|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765151|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44765152|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765153|NCT01767272|Fexofenadine|fexofenadine|mesh-list
44765154|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44765155|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44765156|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44765157|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
44765158|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
44765159|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765160|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765161|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765162|NCT01767298|Valsartan|valsartan|mesh-list
44765163|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44765164|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44765165|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44765166|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44765167|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765168|NCT01767298|Diuretics|diuretics|mesh-ancestor
44765169|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
44542888|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44765170|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765171|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44765172|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765173|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44765174|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
44765175|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44765176|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
44765177|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765178|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765179|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765180|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44765181|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765182|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765183|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765184|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44765185|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
44765186|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765187|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765188|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44765189|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765190|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44765191|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
44765192|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765193|NCT01767428|Acetaminophen|acetaminophen|mesh-list
44765194|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44765195|NCT01767428|Analgesics|analgesics|mesh-ancestor
44765196|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
44765197|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765198|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765199|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
44765200|NCT01767454|Ipilimumab|ipilimumab|mesh-list
44765201|NCT01767454|Trametinib|trametinib|mesh-list
44765202|NCT01767454|Dabrafenib|dabrafenib|mesh-list
44765203|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44765204|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765205|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44765206|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765207|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44765208|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765209|NCT01767532|Cephalexin|cephalexin|mesh-list
44765210|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765211|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765212|NCT01767545|Dexamethasone|dexamethasone|mesh-list
44765213|NCT01767545|Bevacizumab|bevacizumab|mesh-list
44765214|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44765215|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765216|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245935|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44765217|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765218|NCT01767545|Growth Substances|growth substances|mesh-ancestor
44765219|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765220|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765221|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765222|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
44765223|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
44765224|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245950|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
44765225|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765226|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
44765227|NCT01767545|Hormones|hormones|mesh-ancestor
44765228|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765229|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44765230|NCT01767571|Cephalexin|cephalexin|mesh-list
44765231|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765232|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765233|NCT01767584|Cephalexin|cephalexin|mesh-list
44765234|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765235|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765236|NCT01767610|Infliximab|infliximab|mesh-list
44765237|NCT01767610|Fenofibrate|fenofibrate|mesh-list
44765238|NCT01767610|Pitavastatin|pitavastatin|mesh-list
44765239|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765240|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
44765241|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765242|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765243|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44765244|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44765245|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765246|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765247|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765248|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44765250|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765251|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44765252|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765253|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765254|NCT01767714|Plerixafor|plerixafor|mesh-list
44765255|NCT01767714|Lenograstim|lenograstim|mesh-list
44765256|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44765257|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
44765258|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765259|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44765260|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44245966|NCT04205643|Infliximab|infliximab|mesh-list
44765261|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
44765262|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765263|NCT01767896|Vaccines|vaccines|mesh-list
44765264|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
44765265|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765266|NCT01768039|Vitamin D|vitamin d|mesh-list
44765267|NCT01768039|Vitamins|vitamins|mesh-ancestor
44765268|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
44765269|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765270|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44765271|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44765272|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44765273|NCT01768078|Betamethasone|betamethasone|mesh-list
44765274|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765275|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
44765276|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765277|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
44765278|NCT01768078|Hormones|hormones|mesh-ancestor
44765279|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765280|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765281|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44765282|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765283|NCT01768182|Leucovorin|leucovorin|mesh-list
44765284|NCT01768182|Folic Acid|folic acid|mesh-list
44765285|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
44543106|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
44543107|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44765286|NCT01768182|Antidotes|antidotes|mesh-ancestor
44246015|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
44765287|NCT01768182|Protective Agents|protective agents|mesh-ancestor
44765288|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765289|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
44765290|NCT01768182|Vitamins|vitamins|mesh-ancestor
44765291|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
44765292|NCT01768182|Hematinics|hematinics|mesh-ancestor
44765293|NCT01768195|Entecavir|entecavir|mesh-list
44765294|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
44765295|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765296|NCT01768208|Saxagliptin|saxagliptin|mesh-list
44765297|NCT01768208|Incretins|incretins|mesh-ancestor
44765298|NCT01768208|Hormones|hormones|mesh-ancestor
44765299|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765300|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765301|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44765302|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
44765303|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765304|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246024|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
44765305|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44765306|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44765307|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44765308|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765309|NCT01768260|Aspirin|aspirin|mesh-list
44765310|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44765311|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44765312|NCT01768260|Analgesics|analgesics|mesh-ancestor
44765313|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
44765314|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765315|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765316|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765317|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44765318|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44765319|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44765320|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765321|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44765322|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44765323|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765324|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
44765325|NCT01768273|Midazolam|midazolam|mesh-list
44765326|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44765327|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44765328|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765329|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765330|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44543108|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543109|NCT00700570|Bevacizumab|bevacizumab|mesh-list
44543110|NCT00700570|Capecitabine|capecitabine|mesh-list
44543111|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
44543112|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543113|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543114|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44543115|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44543116|NCT00700570|Growth Substances|growth substances|mesh-ancestor
44543117|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543118|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246071|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
44543119|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543120|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
44543121|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543122|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44543123|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44543124|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44543125|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543126|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543127|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
44543128|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543129|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765331|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44765332|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765333|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44765334|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
44765335|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
44765336|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
44765337|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
44765338|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765339|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765340|NCT01768299|Misoprostol|misoprostol|mesh-list
44765341|NCT01768299|Mifepristone|mifepristone|mesh-list
44765342|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44765343|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
44765344|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44765345|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765346|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44765347|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765348|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
44765349|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44765350|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44765351|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44246094|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246095|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
44246097|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765352|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44765353|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
44765354|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44765355|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44765356|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765357|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765358|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
44765359|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44765360|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44765361|NCT01768312|Cyclosporine|cyclosporine|mesh-list
44765362|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44765363|NCT01768312|Cyclosporins|cyclosporins|mesh-list
44765364|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765365|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765366|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765367|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
44765368|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765369|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
44765370|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765371|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765372|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246118|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
44765373|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44765374|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44765375|NCT01768338|Ofatumumab|ofatumumab|mesh-list
44765376|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765377|NCT01768351|Calcitriol|calcitriol|mesh-list
44765378|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44765379|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765380|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44765381|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246129|NCT04104672|Paclitaxel|paclitaxel|mesh-list
44765382|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765383|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44765384|NCT01768351|Vitamins|vitamins|mesh-ancestor
44765385|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
44765386|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44765387|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44765388|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44765389|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765390|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44765391|NCT01768364|Renal Agents|renal agents|mesh-ancestor
44765392|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
44765393|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44765394|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44765395|NCT01768377|Lidocaine|lidocaine|mesh-list
44765396|NCT01768377|Fentanyl|fentanyl|mesh-list
44765397|NCT01768377|Midazolam|midazolam|mesh-list
44765398|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
44765399|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
44765400|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459985|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
44765401|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765402|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
44765403|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765404|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44765405|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44765406|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44765407|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765408|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765409|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44765410|NCT01768377|Narcotics|narcotics|mesh-ancestor
44765411|NCT01768377|Analgesics|analgesics|mesh-ancestor
44765412|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44765413|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44765414|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
44765415|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44765416|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44765417|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460006|NCT01570387|Dexamethasone|dexamethasone|mesh-list
44765418|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765419|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
44765420|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
44765421|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765422|NCT01768390|Fluorides|fluorides|mesh-list
44765423|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
44765424|NCT01768390|Protective Agents|protective agents|mesh-ancestor
44765425|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765426|NCT01768455|Glimepiride|glimepiride|mesh-list
44765427|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44765428|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44765429|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765430|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765431|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
44765432|NCT01768481|Atorvastatin|atorvastatin|mesh-list
44765433|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44765434|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765435|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
44765436|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765437|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765438|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44765439|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765440|NCT01768507|Resveratrol|resveratrol|mesh-list
44765441|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
44765442|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765443|NCT01768507|Protective Agents|protective agents|mesh-ancestor
44765444|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765445|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765446|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44765447|NCT01768663|Itraconazole|itraconazole|mesh-list
44765448|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
44765449|NCT01768663|Rifampin|rifampin|mesh-list
44765450|NCT01768663|Ivacaftor|ivacaftor|mesh-list
44765451|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
44765452|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765453|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44765454|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44765455|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765456|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765457|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44460037|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
44765458|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765459|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765460|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765461|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44765462|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765463|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44765464|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44765465|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765466|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44765467|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44765468|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
44765469|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
44765470|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44765471|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44765472|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44765473|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44765474|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44765475|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44765476|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44765477|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44765478|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765479|NCT01768741|Liver Extracts|liver extracts|mesh-list
44765480|NCT01768741|Hematinics|hematinics|mesh-ancestor
44543209|NCT00702338|Hormones|hormones|mesh-list
44765481|NCT01768767|Ketamine|ketamine|mesh-list
44765482|NCT01768767|Analgesics|analgesics|mesh-ancestor
44765483|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
44765484|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765485|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246163|NCT04082442|Evolocumab|evolocumab|mesh-list
44765486|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44765487|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44765488|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
44765489|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
44765490|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765491|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44765492|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44246177|NCT04074330|Rituximab|rituximab|mesh-list
44765493|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765494|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765495|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
44765496|NCT01768780|Bupivacaine|bupivacaine|mesh-list
44765497|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44765498|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
44765499|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
44765500|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765501|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765502|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
44690358|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690359|NCT01355198|Antidotes|antidotes|mesh-ancestor
44690360|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
44690361|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690362|NCT01355263|Vitamin A|vitamin a|mesh-list
44690363|NCT01355263|Vitamins|vitamins|mesh-ancestor
44690364|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
44690365|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690366|NCT01355276|Domperidone|domperidone|mesh-list
44690367|NCT01355276|Cinitapride|cinitapride|mesh-list
44690368|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
44690369|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
44690370|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690371|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690372|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690373|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44690374|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
44690375|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690376|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246203|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
44690377|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44690378|NCT01355354|Digoxin|digoxin|mesh-list
44690379|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44690380|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44690381|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690382|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690383|NCT01355354|Protective Agents|protective agents|mesh-ancestor
44690384|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690385|NCT01355367|Nifedipine|nifedipine|mesh-list
44690386|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44690387|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690388|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690389|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690390|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690391|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
44690392|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
44690393|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44690394|NCT01355380|Iloprost|iloprost|mesh-list
44690395|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44690396|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
44690397|NCT01355445|Irinotecan|irinotecan|mesh-list
44690398|NCT01355445|Vincristine|vincristine|mesh-list
44690399|NCT01355445|Temozolomide|temozolomide|mesh-list
44690400|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44690401|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690402|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690403|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690404|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690405|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44690406|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44145790|NCT00195910|Morphine|morphine|mesh-list
44690407|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690408|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690409|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44690410|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
44690411|NCT01355562|Interleukin-2|interleukin-2|mesh-list
44690412|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765503|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765504|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44765505|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44765506|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
44765507|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765508|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765509|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
44765510|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44765511|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
44765512|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765513|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765514|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44765515|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765516|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44765517|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
44765518|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765519|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246259|NCT04047576|Sirolimus|sirolimus|mesh-list
44765520|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44765521|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
44765522|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
44765523|NCT01768884|Protective Agents|protective agents|mesh-ancestor
44765524|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
44765525|NCT01768897|Cytarabine|cytarabine|mesh-list
44765526|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
44765527|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765528|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
44765529|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765530|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765531|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
44765532|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765533|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765534|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
44765535|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765536|NCT01768897|Analgesics|analgesics|mesh-ancestor
44765537|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
44765538|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765539|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44765540|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44765541|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765542|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
44765543|NCT01768897|Protective Agents|protective agents|mesh-ancestor
44765544|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
44765545|NCT01768897|Vitamins|vitamins|mesh-ancestor
44765546|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
44765547|NCT01768988|Pregabalin|pregabalin|mesh-list
44765548|NCT01768988|Analgesics|analgesics|mesh-ancestor
44765549|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
44765550|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765551|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765552|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
44765553|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44246289|NCT04001621|Capecitabine|capecitabine|mesh-list
44765554|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765555|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765556|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44765557|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44765558|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44765559|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765560|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765561|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44765562|NCT01769027|Azithromycin|azithromycin|mesh-list
43996840|NCT04507841|Niraparib|niraparib|mesh-list
44765563|NCT01769027|Penicillins|penicillins|mesh-list
44765564|NCT01769027|Sertraline|sertraline|mesh-list
44765565|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44765566|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765567|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
44765568|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765569|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44765570|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44765571|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765572|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765573|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765574|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
44765575|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765576|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
44765577|NCT01769040|Rifaximin|rifaximin|mesh-list
44543303|NCT00703820|Cytarabine|cytarabine|mesh-list
44765578|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765579|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765580|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765581|NCT01769066|Pemetrexed|pemetrexed|mesh-list
44765582|NCT01769066|Gefitinib|gefitinib|mesh-list
44765583|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765584|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765585|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765586|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44765587|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44246320|NCT03946878|Venetoclax|venetoclax|mesh-list
44765588|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44765589|NCT01769079|Isosorbide|isosorbide|mesh-list
44765590|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44765591|NCT01769079|Diuretics|diuretics|mesh-ancestor
44765592|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
44765593|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765594|NCT01769118|Caffeine|caffeine|mesh-list
44765595|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44765596|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765597|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44765598|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765599|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765600|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44765601|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44765602|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
44765603|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765604|NCT01769183|Squalamine|squalamine|mesh-list
44765605|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44765606|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44765607|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765608|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765609|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44765610|NCT01769183|Protective Agents|protective agents|mesh-ancestor
44765611|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765612|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765613|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44765614|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765615|NCT01769183|Growth Substances|growth substances|mesh-ancestor
44765616|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765617|NCT01769235|Clindamycin|clindamycin|mesh-list
44765618|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
44765619|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
44765620|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44765621|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765622|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765623|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44765624|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765625|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765626|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765627|NCT01769482|Udenafil|udenafil|mesh-list
44765628|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44765629|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44765630|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765631|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765632|NCT01769625|Vitamin D|vitamin d|mesh-list
44765633|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
44765634|NCT01769625|Celecoxib|celecoxib|mesh-list
44765635|NCT01769625|Vitamins|vitamins|mesh-ancestor
44246365|NCT03937635|Growth Substances|growth substances|mesh-ancestor
44246366|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246367|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
44246368|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246369|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246370|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
44246371|NCT03933163|Resveratrol|resveratrol|mesh-list
44246372|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
44246373|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899503|NCT01855607|Menthol|menthol|mesh-list
44246374|NCT03933163|Protective Agents|protective agents|mesh-ancestor
43997199|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997200|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
43997201|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997202|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997203|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43997204|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
43997205|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997206|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997207|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43997208|NCT02578641|Gemcitabine|gemcitabine|mesh-list
43997209|NCT02578641|Carboplatin|carboplatin|mesh-list
43997210|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997211|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765636|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
44765637|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765638|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44765639|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44765640|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44765641|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543379|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543380|NCT04057131|Analgesics|analgesics|mesh-ancestor
44543381|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
44246376|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543382|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543383|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543384|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543385|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543386|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44543387|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44543388|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765642|NCT01769625|Analgesics|analgesics|mesh-ancestor
44765643|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
44765644|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765645|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765646|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44765647|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44765648|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44765649|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765650|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765651|NCT01769651|Methadone|methadone|mesh-list
44765652|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44765653|NCT01769651|Narcotics|narcotics|mesh-ancestor
44246391|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765654|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765655|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765656|NCT01769651|Analgesics|analgesics|mesh-ancestor
44765657|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
44246403|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765658|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765659|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
44765660|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765661|NCT01769664|Clindamycin|clindamycin|mesh-list
44765662|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
44765663|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
44765664|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44765665|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765666|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765667|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44765668|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765669|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765670|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765671|NCT01769677|Hydrocodone|hydrocodone|mesh-list
44765672|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44765673|NCT01769677|Narcotics|narcotics|mesh-ancestor
43997629|NCT02658240|Epinephrine|epinephrine|mesh-list
44765674|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765675|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765676|NCT01769677|Analgesics|analgesics|mesh-ancestor
44765677|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
44765678|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765679|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
44765680|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765681|NCT01769703|Dabigatran|dabigatran|mesh-list
44765682|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
44765683|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44765684|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
44765685|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765686|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765687|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
44765688|NCT01769768|Bupropion|bupropion|mesh-list
44246429|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765689|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44765690|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
44765691|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765692|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44765693|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44765694|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765695|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765696|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
44765697|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765698|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765699|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44765700|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44765701|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765702|NCT01769781|Anastrozole|anastrozole|mesh-list
44765703|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44765704|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765705|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44765706|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44765707|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246442|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765708|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765709|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44765710|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765711|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765712|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765713|NCT01769820|Dexamethasone|dexamethasone|mesh-list
44765714|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765715|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
44765716|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
44765717|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765718|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765719|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765720|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
44765721|NCT01769820|Hormones|hormones|mesh-ancestor
44765722|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765723|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44765724|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765725|NCT01769833|Interferons|interferons|mesh-list
44765726|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
44765727|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
44765728|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44765729|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765730|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
44765731|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765732|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
44765733|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690413|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690414|NCT01355562|Analgesics|analgesics|mesh-ancestor
44690415|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
44690416|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690417|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690418|NCT01355614|Infliximab|infliximab|mesh-list
44543495|NCT04059536|Aspirin|aspirin|mesh-list
44765734|NCT01769898|Budesonide|budesonide|mesh-list
44765735|NCT01769898|Theophylline|theophylline|mesh-list
44765736|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
44765737|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765738|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44765739|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
44765740|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765741|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765742|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44765743|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765744|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
44765745|NCT01769898|Hormones|hormones|mesh-ancestor
44765746|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44765747|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44765748|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44765749|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44765750|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
44765751|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765752|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765753|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44765754|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765755|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
44460066|NCT01569464|Rotigotine|rotigotine|mesh-list
44765756|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44765757|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44765758|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
44765759|NCT01769911|Cytarabine|cytarabine|mesh-list
44765760|NCT01769911|Etoposide|etoposide|mesh-list
44765761|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
44765762|NCT01769911|Melphalan|melphalan|mesh-list
44765763|NCT01769911|Carmustine|carmustine|mesh-list
44765764|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44765765|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44765766|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765767|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44765768|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44765769|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765770|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765771|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765772|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
44765773|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
44765774|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765775|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765776|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
44765777|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765778|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44765779|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
44765780|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44765781|NCT01769950|Choline|choline|mesh-list
44765782|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
44765783|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765784|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
44765785|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765786|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765787|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765788|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
44765789|NCT01770041|Acetaminophen|acetaminophen|mesh-list
44765790|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44765791|NCT01770041|Analgesics|analgesics|mesh-ancestor
44765792|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
44765793|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765794|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765795|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
44765796|NCT01770080|Peppermint oil|peppermint oil|mesh-list
44765797|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44765798|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
44765799|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
44765800|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765801|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765802|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44765803|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
44765804|NCT01770106|Denosumab|denosumab|mesh-list
44765805|NCT01770106|Alendronate|alendronate|mesh-list
44765806|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44765807|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765808|NCT01770132|Gemcitabine|gemcitabine|mesh-list
44765809|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44765810|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44765811|NCT01770132|Trioxsalen|trioxsalen|mesh-list
44765812|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765813|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
44246521|NCT03814005|Paclitaxel|paclitaxel|mesh-list
44765814|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765815|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765816|NCT01770132|Antiviral Agents|antiviral agents|mesh-ancestor
44765817|NCT01770132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765818|NCT01770132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765819|NCT01770132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765820|NCT01770132|Immunologic Factors|immunologic factors|mesh-ancestor
44765821|NCT01770132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765822|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
44765823|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44765824|NCT01770171|Paclitaxel|paclitaxel|mesh-list
44765825|NCT01770171|Bevacizumab|bevacizumab|mesh-list
44765826|NCT01770171|Carboplatin|carboplatin|mesh-list
44765827|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44765828|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765829|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
44765830|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
44765831|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
44765832|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765833|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44765834|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44765835|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765836|NCT01770171|Growth Substances|growth substances|mesh-ancestor
44765837|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765838|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765839|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44765840|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44765841|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44765842|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765843|NCT01770210|Atorvastatin|atorvastatin|mesh-list
44765844|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44765845|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765846|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
44765847|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765848|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765849|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44765850|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765851|NCT01770223|Ribavirin|ribavirin|mesh-list
44765852|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44765853|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
44765854|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765855|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
44765856|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765857|NCT01770236|Acetaminophen|acetaminophen|mesh-list
44765858|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44765859|NCT01770236|Analgesics|analgesics|mesh-ancestor
44765860|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
44765861|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765862|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765863|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
44765864|NCT01770301|Paclitaxel|paclitaxel|mesh-list
44765865|NCT01770301|Bevacizumab|bevacizumab|mesh-list
44765866|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44765867|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765868|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
44765869|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44765870|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246563|NCT03762564|Paclitaxel|paclitaxel|mesh-list
44765871|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765872|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44765873|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44765874|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765875|NCT01770301|Growth Substances|growth substances|mesh-ancestor
44765876|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765877|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765878|NCT01770444|Cytarabine|cytarabine|mesh-list
44765879|NCT01770444|Thioguanine|thioguanine|mesh-list
44765880|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765881|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
44765882|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765883|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765884|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
44543637|NCT04056650|Caffeine|caffeine|mesh-list
44765885|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765886|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765887|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
44765888|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765889|NCT01770470|Chitosan|chitosan|mesh-list
44765890|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44765891|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765892|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
44765893|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765894|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765895|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
44765896|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
44765897|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
44765898|NCT01770470|Coagulants|coagulants|mesh-ancestor
44765899|NCT01770600|Risperidone|risperidone|mesh-list
44765900|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44765901|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
44765902|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44765903|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765904|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765905|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44765906|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44765907|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765908|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765909|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44765910|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
44246598|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246599|NCT03698552|Epratuzumab|epratuzumab|mesh-list
44246600|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246601|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246602|NCT03695445|Norepinephrine|norepinephrine|mesh-list
44246603|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44246604|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44246605|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
44246606|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246607|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246608|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645634|NCT03880019|Temozolomide|temozolomide|mesh-list
43999819|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999820|NCT04553367|Meropenem|meropenem|mesh-list
43999839|NCT04545151|Verapamil|verapamil|mesh-list
44765911|NCT01770769|Cloxacillin|cloxacillin|mesh-list
44765912|NCT01770769|Cephalothin|cephalothin|mesh-list
44765913|NCT01770769|Dalteparin|dalteparin|mesh-list
44765914|NCT01770769|Tinzaparin|tinzaparin|mesh-list
44765915|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44765916|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
44765917|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44765918|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44765919|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765920|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44765921|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765922|NCT01770795|Gemcitabine|gemcitabine|mesh-list
44765923|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44765924|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
44765925|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765926|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765927|NCT01770795|Antiviral Agents|antiviral agents|mesh-ancestor
44246613|NCT03692065|Apixaban|apixaban|mesh-list
44765928|NCT01770795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44765929|NCT01770795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765930|NCT01770795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44765931|NCT01770795|Immunologic Factors|immunologic factors|mesh-ancestor
44765932|NCT01770795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765933|NCT01770899|Montelukast|montelukast|mesh-list
44765934|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44765935|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
44765936|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44765937|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
44765938|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543712|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
44543713|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543714|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543715|NCT04055506|Ritonavir|ritonavir|mesh-list
44543716|NCT04055506|BMS-986165|bms-986165|mesh-list
44543717|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44543718|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44543719|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543720|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543721|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543722|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44543723|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44543724|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
44543725|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543726|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44543727|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44543728|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
44543729|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543730|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
44543731|NCT04055415|Expectorants|expectorants|mesh-list
44543732|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
44543733|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765939|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765940|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44765941|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44690437|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690438|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44690439|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690440|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690441|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690442|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44690443|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44690444|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
44690445|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44690446|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690448|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690449|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
44690450|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44690451|NCT01355939|Protective Agents|protective agents|mesh-ancestor
44690452|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690453|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
44690454|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
44690455|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690456|NCT01355952|Protective Agents|protective agents|mesh-ancestor
44690457|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690458|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
44690459|NCT01355952|Vitamins|vitamins|mesh-ancestor
44690460|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
44690461|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
44690462|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44690463|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44690464|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
44690465|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690466|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690467|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44690468|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
44690469|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
44690470|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44690471|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
44690472|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690473|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690474|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44690475|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44690476|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690477|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690478|NCT01356017|Amlodipine|amlodipine|mesh-list
44690479|NCT01356017|Telmisartan|telmisartan|mesh-list
44690480|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44690481|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44690482|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246677|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690483|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690484|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690485|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690486|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
44690487|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44690488|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44690489|NCT01356043|Niacin|niacin|mesh-list
44690490|NCT01356043|Amlodipine|amlodipine|mesh-list
44690491|NCT01356043|Telmisartan|telmisartan|mesh-list
44690492|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44690493|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44690494|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690495|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690496|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690497|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690498|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
44690499|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44690500|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44690501|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44690502|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
44690503|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44690504|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
44690505|NCT01356043|Vitamins|vitamins|mesh-ancestor
44690506|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
44690507|NCT01356121|Midazolam|midazolam|mesh-list
44690508|NCT01356121|Propofol|propofol|mesh-list
44765942|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765943|NCT01770964|Pregabalin|pregabalin|mesh-list
44765944|NCT01770964|Analgesics|analgesics|mesh-ancestor
44765945|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
44765946|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44765947|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765948|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
44765949|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44765950|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44765951|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765952|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44765953|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44765954|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44765955|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44765956|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44765957|NCT01771081|Ranibizumab|ranibizumab|mesh-list
44246743|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
44765958|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44765959|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44765960|NCT01771081|Growth Substances|growth substances|mesh-ancestor
44765961|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765962|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
44765963|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765964|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
44765965|NCT01771146|Irinotecan|irinotecan|mesh-list
44765966|NCT01771146|Folfirinox|folfirinox|mesh-list
44246755|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
44765967|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765968|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44765969|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44765970|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765971|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765972|NCT01771185|Metformin|metformin|mesh-list
44765973|NCT01771185|Gliclazide|gliclazide|mesh-list
44765974|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44000144|NCT03915769|Ozanimod|ozanimod|mesh-list
44765975|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765976|NCT01771198|Simvastatin|simvastatin|mesh-list
44765977|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44765978|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44765979|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
44765980|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765981|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44765982|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44246771|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
44765983|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44765984|NCT01771289|Cisplatin|cisplatin|mesh-list
44765985|NCT01771289|Docetaxel|docetaxel|mesh-list
44765986|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44765987|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
44765988|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
44765989|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
44765990|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44765991|NCT01771302|Calcium|calcium|mesh-list
44246781|NCT03557918|Tremelimumab|tremelimumab|mesh-list
44765992|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44765993|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44765994|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
44765995|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44765996|NCT01771328|Cortisone|cortisone|mesh-list
44765997|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44765998|NCT01771406|Nebivolol|nebivolol|mesh-list
44765999|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44766000|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000321|NCT03333616|Nivolumab|nivolumab|mesh-list
44766001|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44766002|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44766003|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44766004|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
44766005|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766006|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766007|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766008|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44766009|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766010|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44766011|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766012|NCT01771458|Tamoxifen|tamoxifen|mesh-list
44766013|NCT01771458|Trastuzumab|trastuzumab|mesh-list
44766014|NCT01771458|Everolimus|everolimus|mesh-list
44766015|NCT01771458|Sorafenib|sorafenib|mesh-list
44766016|NCT01771458|Letrozole|letrozole|mesh-list
44543737|NCT04054960|Levodopa|levodopa|mesh-list
44766017|NCT01771458|Dasatinib|dasatinib|mesh-list
44766018|NCT01771458|Lapatinib|lapatinib|mesh-list
44766019|NCT01771458|Vemurafenib|vemurafenib|mesh-list
44246817|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766020|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44766021|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766022|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766023|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
44766024|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766025|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44766026|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766027|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766028|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44766029|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44766030|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44766031|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
44766032|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766033|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766034|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44766035|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44766036|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44766037|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44766038|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766039|NCT05318365|Laxatives|laxatives|mesh-ancestor
44766040|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44766041|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44766042|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44766043|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766044|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44766045|NCT01771822|Ibuprofen|ibuprofen|mesh-list
44766046|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766047|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766048|NCT01771822|Analgesics|analgesics|mesh-ancestor
44766049|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
44766050|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766051|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766052|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766053|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766054|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44766055|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766056|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766057|NCT01771874|Bupropion|bupropion|mesh-list
44246830|NCT03528642|Temozolomide|temozolomide|mesh-list
44766058|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44766059|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44766060|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
44766061|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44766062|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44766063|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44766064|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690509|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44690510|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690511|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690512|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44690513|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
44690514|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
44246844|NCT03493425|Cisplatin|cisplatin|mesh-list
44690515|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44690516|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44690517|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44690518|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44690519|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
44690520|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
44690521|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690522|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690523|NCT01356212|Ketorolac|ketorolac|mesh-list
44690524|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44690525|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690526|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690527|NCT01356212|Analgesics|analgesics|mesh-ancestor
44690528|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
44690529|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690530|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690531|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690532|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690533|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44766065|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766066|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
44766067|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766068|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766069|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44766070|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766071|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766072|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
44690534|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543887|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543888|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543889|NCT04051853|Sorafenib|sorafenib|mesh-list
44543890|NCT04051853|Midazolam|midazolam|mesh-list
44543891|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44543892|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44543893|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543894|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543895|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44543896|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44543897|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44766073|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
44766074|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44766075|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44766076|NCT01771978|Diltiazem|diltiazem|mesh-list
44766077|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44766078|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44766079|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766080|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766081|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44766082|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766083|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44766084|NCT01772056|Fluticasone|fluticasone|mesh-list
44766085|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766086|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44766087|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
44766088|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246898|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
44766089|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766090|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44766091|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44766092|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44766093|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44766094|NCT01772212|Terbinafine|terbinafine|mesh-list
44766095|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
44766096|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766097|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766098|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766099|NCT01772238|Amoxicillin|amoxicillin|mesh-list
44766100|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44766101|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
44766102|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
44766103|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766104|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766105|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44766106|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900032|NCT00030147|Estradiol|estradiol|mesh-list
44766107|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766108|NCT01772251|Insulin|insulin|mesh-list
44766109|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766110|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766111|NCT01772290|Itraconazole|itraconazole|mesh-list
44766112|NCT01772290|Fluconazole|fluconazole|mesh-list
44766113|NCT01772290|Rabeprazole|rabeprazole|mesh-list
44766114|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
44766115|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766116|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44766117|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766118|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766119|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766120|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44246923|NCT03365609|Bismuth|bismuth|mesh-list
44766121|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
44766122|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766123|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766124|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44766125|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44766126|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766127|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44766128|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44766129|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44766130|NCT01772381|Dexamethasone|dexamethasone|mesh-list
44766131|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766132|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
44766133|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
44766134|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766135|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766136|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766137|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
44766138|NCT01772381|Hormones|hormones|mesh-ancestor
44766139|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766140|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766141|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766142|NCT01772420|Lenalidomide|lenalidomide|mesh-list
44766143|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
44766144|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766145|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44766146|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44766147|NCT01772420|Growth Substances|growth substances|mesh-ancestor
44766148|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
44766149|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766150|NCT01772563|Itraconazole|itraconazole|mesh-list
44766151|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
44766152|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766153|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44766154|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766155|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766156|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766157|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44766158|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
44766159|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766160|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766161|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44766162|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
44766163|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
44766164|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44766165|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
44766166|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44246968|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246969|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44246970|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246971|NCT03296033|Enoxaparin|enoxaparin|mesh-list
44246972|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
44246973|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
44246974|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44246975|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44246976|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246977|NCT03288675|Serotonin|serotonin|mesh-list
44766167|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766168|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44766169|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44766170|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001536|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
44766171|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766172|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766173|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44766174|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766175|NCT01772641|Varenicline|varenicline|mesh-list
44766176|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44766177|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44766178|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
44246986|NCT03263650|Prednisone|prednisone|mesh-list
44766179|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766180|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766181|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766182|NCT01772797|Ceritinib|ceritinib|mesh-list
44766183|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690535|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690536|NCT01356225|Ketorolac|ketorolac|mesh-list
44690537|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44690538|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44246999|NCT03262116|Insulin|insulin|mesh-list
44690539|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690540|NCT01356225|Analgesics|analgesics|mesh-ancestor
44690541|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
44690542|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690543|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690544|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690545|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690546|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44247003|NCT03262116|Pancrelipase|pancrelipase|mesh-list
44247004|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44247005|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247006|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247007|NCT03248479|Azacitidine|azacitidine|mesh-list
44247008|NCT03248479|Magrolimab|magrolimab|mesh-list
44247009|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44001661|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44001666|NCT04964466|Becaplermin|becaplermin|mesh-list
44690547|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690548|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690549|NCT01356303|Cisplatin|cisplatin|mesh-list
44690550|NCT01356303|Docetaxel|docetaxel|mesh-list
44690551|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690552|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
44690553|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690554|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690555|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690556|NCT01356329|Heparin|heparin|mesh-list
44690557|NCT01356329|Enoxaparin|enoxaparin|mesh-list
44690558|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
44247010|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
44247011|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247012|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247013|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247014|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247015|NCT03248063|Cefazolin|cefazolin|mesh-list
44247016|NCT03248063|Cloxacillin|cloxacillin|mesh-list
44247017|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44247018|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247019|NCT03245840|Budesonide|budesonide|mesh-list
44247020|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646011|NCT03614494|Piroxicam|piroxicam|mesh-list
44001754|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44001755|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44001756|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44001757|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
44001758|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001759|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44001760|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44001761|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001762|NCT04900623|Paclitaxel|paclitaxel|mesh-list
44001763|NCT04900623|Cisplatin|cisplatin|mesh-list
44001764|NCT04900623|Carboplatin|carboplatin|mesh-list
44001765|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44001766|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001767|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
44001768|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
44001769|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
44001770|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001771|NCT04895410|Dexamethasone|dexamethasone|mesh-list
44690559|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44690560|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44690561|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690562|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44690563|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44690564|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44690565|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44690566|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247021|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44690567|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690568|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544012|NCT04052932|Allopurinol|allopurinol|mesh-list
44766184|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44766185|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766186|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766187|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44766188|NCT01772836|Biapenem|biapenem|mesh-list
44766189|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766190|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766191|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766192|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766193|NCT01772940|Ritonavir|ritonavir|mesh-list
44766194|NCT01772940|Lopinavir|lopinavir|mesh-list
44247044|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766195|NCT01772940|Tenofovir|tenofovir|mesh-list
44766196|NCT01772940|Lamivudine|lamivudine|mesh-list
44766197|NCT01772940|Zidovudine|zidovudine|mesh-list
44766198|NCT01772940|Emtricitabine|emtricitabine|mesh-list
44766199|NCT01772940|Nevirapine|nevirapine|mesh-list
44766200|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44766201|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44766202|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
44766203|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766204|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766205|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44766206|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44766207|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
44766208|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766209|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44766210|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766211|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44766212|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44766213|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
44766214|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44766215|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44766216|NCT01772953|Treosulfan|treosulfan|mesh-list
44766217|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44766218|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
44766219|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766220|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766221|NCT01772979|Trabectedin|trabectedin|mesh-list
44766222|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44766223|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
44766224|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766225|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766226|NCT01773005|Acetaminophen|acetaminophen|mesh-list
44766227|NCT01773005|Ibuprofen|ibuprofen|mesh-list
44766228|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766229|NCT01773005|Analgesics|analgesics|mesh-ancestor
44766230|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
44766231|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766232|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766233|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
44766234|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766235|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766236|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766237|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44766238|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766239|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766240|NCT01773044|Lidocaine|lidocaine|mesh-list
44766241|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
44766242|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
44766243|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766244|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766245|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
44766246|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766247|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44247089|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
44766248|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44766249|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44766250|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766251|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766252|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
44766253|NCT01773096|Bisacodyl|bisacodyl|mesh-list
44766254|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44766255|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44766256|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44766257|NCT01773096|Cathartics|cathartics|mesh-ancestor
44766258|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766259|NCT01773096|Laxatives|laxatives|mesh-ancestor
44766260|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44766261|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766262|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
44766263|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766264|NCT01773096|Antacids|antacids|mesh-ancestor
44766265|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766266|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
44766267|NCT01773174|Dabigatran|dabigatran|mesh-list
44766268|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
44766269|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44766270|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
44766271|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766272|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766273|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
44544118|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544119|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544120|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544121|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544122|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44247113|NCT03082209|Bevacizumab|bevacizumab|mesh-list
44544123|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44544124|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544125|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544126|NCT04058054|Histamine|histamine|mesh-list
44544127|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
44544128|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
44544129|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544132|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44766275|NCT01773408|Daunorubicin|daunorubicin|mesh-list
44766276|NCT01773408|Idarubicin|idarubicin|mesh-list
44766277|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44766278|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
44766279|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766280|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766281|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
44766282|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766283|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002811|NCT03233347|Nivolumab|nivolumab|mesh-list
44766284|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
44766285|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766286|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44766287|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44766288|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44766289|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766290|NCT01773460|Everolimus|everolimus|mesh-list
44766291|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766292|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766293|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
44766294|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766295|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44766296|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44766297|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44766298|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
44766299|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766300|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44247149|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766301|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44766302|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766303|NCT01773538|Rifaximin|rifaximin|mesh-list
44766304|NCT01773538|Lactulose|lactulose|mesh-list
44766305|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766306|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766307|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766308|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
44766309|NCT01773616|Prednisolone|prednisolone|mesh-list
44766310|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44766311|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
44766312|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44766313|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
44766314|NCT01773616|Rituximab|rituximab|mesh-list
44766315|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44766316|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
44766317|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44766318|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766319|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
44766320|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766321|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766322|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44766323|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44766324|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
44766325|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766326|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766327|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766328|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766329|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766330|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
44766331|NCT01773616|Hormones|hormones|mesh-ancestor
44766332|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766333|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766334|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
44766335|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
44766336|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766337|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766338|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44766339|NCT01773616|Protective Agents|protective agents|mesh-ancestor
44766340|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
44766341|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766342|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
44766343|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766344|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766345|NCT01773772|Progesterone|progesterone|mesh-list
44766346|NCT01773772|Progestins|progestins|mesh-ancestor
44544153|NCT01061515|Bevacizumab|bevacizumab|mesh-list
44766347|NCT01773772|Hormones|hormones|mesh-ancestor
44766348|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766349|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766351|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44766352|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
44766353|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
44766354|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44766355|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766356|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766357|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44766358|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766359|NCT01773837|Methylphenidate|methylphenidate|mesh-list
44766360|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44766361|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766362|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44766363|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44766364|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766365|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766366|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
44766367|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766368|NCT01773876|Micafungin|micafungin|mesh-list
44247216|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
44766369|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
44766370|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766371|NCT01774370|Dabigatran|dabigatran|mesh-list
44766372|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
44766373|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44766374|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44766375|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766376|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766377|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
44766378|NCT01774396|Lidocaine|lidocaine|mesh-list
44766379|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
44766380|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
44003512|NCT05453435|Entecavir|entecavir|mesh-list
44766381|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766382|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766383|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
44766384|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766385|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44766386|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44766387|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44766388|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766389|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766390|NCT01774474|Dexamethasone|dexamethasone|mesh-list
44766391|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
44766392|NCT01774474|Triamcinolone|triamcinolone|mesh-list
44766393|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44766394|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44766395|NCT01774474|Bromfenac|bromfenac|mesh-list
44766396|NCT01774474|Bevacizumab|bevacizumab|mesh-list
44766397|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44766398|NCT01774474|BB 1101|bb 1101|mesh-list
44766399|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44766400|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44766401|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766402|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44766403|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44766404|NCT01774474|Growth Substances|growth substances|mesh-ancestor
44766405|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766406|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
44766407|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766408|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
44766409|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
44766410|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766411|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766412|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
44766413|NCT01774474|Hormones|hormones|mesh-ancestor
44766414|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766415|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766416|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
44766417|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766418|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766419|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44766420|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766421|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
44766422|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766423|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766424|NCT01774474|Analgesics|analgesics|mesh-ancestor
44766425|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
44766426|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766427|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
44766428|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44766429|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460172|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
44766430|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766431|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766432|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44766433|NCT01774487|Protective Agents|protective agents|mesh-ancestor
44766434|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766435|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44766436|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44766437|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
44766438|NCT01774565|Insulin|insulin|mesh-list
44766439|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44766440|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766441|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766442|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
44766443|NCT01774812|Vitamin D|vitamin d|mesh-list
44766444|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
44766445|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44766446|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44766447|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766448|NCT01774812|Vitamins|vitamins|mesh-ancestor
44766449|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
44766450|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44766451|NCT01774838|Clopidogrel|clopidogrel|mesh-list
44766452|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44766453|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766454|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44766455|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44766456|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44766457|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
44766458|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766459|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766460|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766461|NCT01774864|Udenafil|udenafil|mesh-list
44766462|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44766463|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44766464|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766465|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766466|NCT01774877|Leflunomide|leflunomide|mesh-list
44766467|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766468|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766469|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766470|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
44766471|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766472|NCT01775098|Allopurinol|allopurinol|mesh-list
44766473|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
44766474|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766475|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766476|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
44766477|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766478|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44766479|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
44766480|NCT01775098|Protective Agents|protective agents|mesh-ancestor
44766481|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690569|NCT01356355|Urological Agents|urological agents|mesh-ancestor
44766482|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44247241|NCT02946996|Metformin|metformin|mesh-list
44766483|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
44766484|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766485|NCT01775397|Vancomycin|vancomycin|mesh-list
44766486|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
44766487|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766488|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766489|NCT01775540|Dexamethasone|dexamethasone|mesh-list
44766490|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
44766491|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766492|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
44766493|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
44766494|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766495|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766496|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766497|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
44766498|NCT01775540|Hormones|hormones|mesh-ancestor
44766499|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766500|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766501|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766502|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44766503|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44766504|NCT01775579|Metformin|metformin|mesh-list
44766505|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44766506|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766507|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766508|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44766509|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44766510|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
44766511|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766512|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44766513|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44003958|NCT04674462|Vaccines|vaccines|mesh-list
44766514|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766515|NCT01775618|Factor VIII|factor viii|mesh-list
44766516|NCT01775618|Coagulants|coagulants|mesh-ancestor
44766517|NCT01775631|Rituximab|rituximab|mesh-list
44766518|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44766519|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766520|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
44766521|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766522|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766523|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
44766524|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766525|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766526|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44766527|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44766528|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766529|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766530|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766531|NCT01775839|Aspirin|aspirin|mesh-list
44766532|NCT01775839|Digoxin|digoxin|mesh-list
44766533|NCT01775839|Clopidogrel|clopidogrel|mesh-list
44766534|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766535|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766536|NCT01775839|Analgesics|analgesics|mesh-ancestor
44766537|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
44766538|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247321|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766539|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766540|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766541|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766542|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44766543|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44766544|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766545|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766546|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44766547|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766548|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
44766549|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44766550|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44766551|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44766552|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
44766553|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766554|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44766555|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44766556|NCT01775839|Protective Agents|protective agents|mesh-ancestor
44766557|NCT01775891|Flecainide|flecainide|mesh-list
44544449|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766558|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44766560|NCT01775891|Pilsicainide|pilsicainide|mesh-list
44766561|NCT01775891|Lidocaine|lidocaine|mesh-list
44766562|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44766563|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44766564|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766565|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766566|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
44766567|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
44766568|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766569|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766570|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
44766571|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766572|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44766573|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44766574|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44766575|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
44766576|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44766577|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44766578|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44766579|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
44766580|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44766581|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766582|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44766583|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44766584|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44766585|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44766586|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766587|NCT01776320|Alprostadil|alprostadil|mesh-list
44766588|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766589|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
44766590|NCT01776320|Urological Agents|urological agents|mesh-ancestor
44766591|NCT01776437|Talazoparib|talazoparib|mesh-list
44766592|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44766593|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766594|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766595|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766596|NCT01776515|Acetaminophen|acetaminophen|mesh-list
44766597|NCT01776515|Tramadol|tramadol|mesh-list
44766598|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766599|NCT01776515|Analgesics|analgesics|mesh-ancestor
44766600|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
44766601|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766602|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766603|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
44766604|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44766605|NCT01776515|Narcotics|narcotics|mesh-ancestor
44766606|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766607|NCT01776567|Everolimus|everolimus|mesh-list
44766608|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766609|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766610|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
44766611|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766612|NCT01776671|Gabapentin|gabapentin|mesh-list
44766613|NCT01776671|Analgesics|analgesics|mesh-ancestor
44766614|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
44766615|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766616|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766617|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
44544450|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44544451|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44544452|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44544453|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544454|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544455|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544456|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
44544457|NCT01066000|Hematinics|hematinics|mesh-ancestor
44544458|NCT01065844|Nelfinavir|nelfinavir|mesh-list
44544459|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44544460|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44544461|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
44544462|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766618|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44766619|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44766620|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766621|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44766622|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44766623|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44766624|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766625|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766626|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
44766627|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44766628|NCT01776684|Gefitinib|gefitinib|mesh-list
44766629|NCT01776684|Afatinib|afatinib|mesh-list
44766630|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766631|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44766632|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766633|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766634|NCT01776788|Insulin|insulin|mesh-list
44766635|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44766636|NCT01776788|Exenatide|exenatide|mesh-list
44766637|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
44766638|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766639|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766640|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44766641|NCT01776788|Incretins|incretins|mesh-ancestor
44766642|NCT01776788|Hormones|hormones|mesh-ancestor
44766643|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766644|NCT01776853|Levan|levan|mesh-list
44766645|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766646|NCT01776970|Nabiximols|nabiximols|mesh-list
44766647|NCT01776970|Analgesics|analgesics|mesh-ancestor
44766648|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
44766649|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766650|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766651|NCT01777087|Capsaicin|capsaicin|mesh-list
44766652|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
44766653|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44766654|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
44766655|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766656|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766657|NCT01777100|Sufentanil|sufentanil|mesh-list
44766658|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44766659|NCT01777100|Narcotics|narcotics|mesh-ancestor
44766660|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766661|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766662|NCT01777100|Analgesics|analgesics|mesh-ancestor
44766663|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
44766664|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766665|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44766666|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44247434|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
44766667|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
44766668|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
44766669|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44766670|NCT01777464|Histamine|histamine|mesh-list
44766671|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
44766672|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
44766673|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766674|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766675|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766676|NCT01777477|Gemcitabine|gemcitabine|mesh-list
44766677|NCT01777477|Chloroquine|chloroquine|mesh-list
44766678|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44766679|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
44766680|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766681|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766682|NCT01777477|Antiviral Agents|antiviral agents|mesh-ancestor
44766683|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766684|NCT01777477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766685|NCT01777477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44766686|NCT01777477|Immunologic Factors|immunologic factors|mesh-ancestor
44766687|NCT01777477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766688|NCT01777477|Amebicides|amebicides|mesh-ancestor
44766689|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44766690|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44766691|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
44766692|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766693|NCT01777503|Clopidogrel|clopidogrel|mesh-list
44766694|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44766695|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766696|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44766697|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44766698|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44766699|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
44766700|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766701|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766702|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766703|NCT01777685|Sulpiride|sulpiride|mesh-list
44766704|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44766705|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44766706|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766707|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766708|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44766709|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44766710|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
44766711|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766712|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247502|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
44766713|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44766714|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44766715|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44766716|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44766717|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766718|NCT01777737|Renal Agents|renal agents|mesh-ancestor
44766719|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766720|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
44766721|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44766722|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44766723|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
44766724|NCT01777867|Miotics|miotics|mesh-ancestor
44766725|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
44766726|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766727|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766728|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44766729|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44766730|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
44766731|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44766732|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44766733|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
44766734|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766735|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766736|NCT01777919|Copper|copper|mesh-list
44766737|NCT01777919|Temozolomide|temozolomide|mesh-list
44766738|NCT01777919|Disulfiram|disulfiram|mesh-list
44766739|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44766740|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
44766741|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766742|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766743|NCT01777919|Trace Elements|trace elements|mesh-ancestor
44766744|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
44766745|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766746|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44766747|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44766748|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766749|NCT01778075|Acetaminophen|acetaminophen|mesh-list
44766750|NCT01778075|Tramadol|tramadol|mesh-list
44766751|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766752|NCT01778075|Analgesics|analgesics|mesh-ancestor
44766753|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
44766754|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766755|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766756|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
44766757|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44766758|NCT01778075|Narcotics|narcotics|mesh-ancestor
44766759|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766760|NCT01778101|Lansoprazole|lansoprazole|mesh-list
44766761|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
44766762|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44766763|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766764|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44766765|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766766|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766767|NCT01778114|Vitamin D|vitamin d|mesh-list
44766768|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
44766769|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
44766770|NCT01778114|Vitamins|vitamins|mesh-list
44766771|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
44766772|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766773|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44766774|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44766775|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
44766776|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
44766777|NCT01778192|Citric Acid|citric acid|mesh-list
44766778|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
44766779|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
44766780|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44766781|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
44766782|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
44766783|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766784|NCT01778192|Cathartics|cathartics|mesh-ancestor
44766785|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44766786|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
44766787|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
44766788|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766789|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
44766790|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766791|NCT01778244|Metformin|metformin|mesh-list
44766792|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766793|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766794|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
44766795|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44766796|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
44766797|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44766798|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
44766799|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766800|NCT01778309|Expectorants|expectorants|mesh-ancestor
44766801|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
44766802|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44766803|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
44766804|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766805|NCT01778309|Protective Agents|protective agents|mesh-ancestor
44766806|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766807|NCT01778309|Antidotes|antidotes|mesh-ancestor
44766808|NCT01778400|Ethanol|ethanol|mesh-list
44247608|NCT02007044|Antibodies|antibodies|mesh-list
44766809|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44766810|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766811|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766812|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766813|NCT01778413|Tenofovir|tenofovir|mesh-list
44766814|NCT01778413|Emtricitabine|emtricitabine|mesh-list
44766815|NCT01778413|Efavirenz|efavirenz|mesh-list
44766816|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44766817|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
44766818|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766819|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44766820|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44766821|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766822|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766823|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44766824|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44766825|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44766826|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44766827|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44766828|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44766829|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44766830|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44766831|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
44766832|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766833|NCT01778686|Pindolol|pindolol|mesh-list
44766834|NCT01778686|Citalopram|citalopram|mesh-list
44766835|NCT01778686|Tryptophan|tryptophan|mesh-list
44766836|NCT01778686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44766837|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44766838|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44766839|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247642|NCT01962415|Melphalan|melphalan|mesh-list
44766840|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766841|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
44766842|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766843|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44766844|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
44766845|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44766846|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44766847|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44766848|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
44766849|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44766850|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44766851|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44766852|NCT01778803|Paclitaxel|paclitaxel|mesh-list
44766853|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44766854|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766855|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
44766856|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
44766857|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
44766858|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766859|NCT01778842|Clopidogrel|clopidogrel|mesh-list
44766860|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44766861|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766862|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44766863|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44766864|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44766865|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
44766866|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766867|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766868|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544688|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
44766869|NCT01779089|Minocycline|minocycline|mesh-list
44766870|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44766871|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766872|NCT01779206|Paclitaxel|paclitaxel|mesh-list
44766873|NCT01779206|Docetaxel|docetaxel|mesh-list
44766874|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
44766875|NCT01779206|Epirubicin|epirubicin|mesh-list
44766876|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44766877|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766878|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44766879|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44766880|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44766881|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766882|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44005612|NCT04826133|Calcitriol|calcitriol|mesh-list
44766883|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
44766884|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766885|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766886|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44766887|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
44766888|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44766889|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44766890|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44766891|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44766892|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766893|NCT01779232|Danazol|danazol|mesh-list
44766894|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44766895|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
44766896|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766897|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766898|NCT01779245|Calcium|calcium|mesh-list
44766899|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44766900|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766901|NCT01779258|Desonide|desonide|mesh-list
44766902|NCT01779258|Glycerol|glycerol|mesh-list
44766903|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44766904|NCT01779258|Protective Agents|protective agents|mesh-ancestor
44766905|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766906|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766907|NCT01779271|Loxoprofen|loxoprofen|mesh-list
44766908|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766909|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766910|NCT01779271|Analgesics|analgesics|mesh-ancestor
44766911|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
44766912|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766913|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766914|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247708|NCT01740427|Letrozole|letrozole|mesh-list
44766915|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766916|NCT01779284|Timolol|timolol|mesh-list
44766917|NCT01779284|Travoprost|travoprost|mesh-list
44766918|NCT01779284|Latanoprost|latanoprost|mesh-list
44766919|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44766920|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44766921|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
44766922|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766923|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766924|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766925|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44766926|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44766927|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44766928|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44766929|NCT01779362|Metformin|metformin|mesh-list
44766930|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
44247721|NCT01735825|Paclitaxel|paclitaxel|mesh-list
44766931|NCT01779362|Liraglutide|liraglutide|mesh-list
44766932|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44766933|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766934|NCT01779362|Incretins|incretins|mesh-ancestor
44766935|NCT01779362|Hormones|hormones|mesh-ancestor
44766936|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44766937|NCT01779401|Aspirin|aspirin|mesh-list
44766938|NCT01779401|Cilostazol|cilostazol|mesh-list
44766939|NCT01779401|Clopidogrel|clopidogrel|mesh-list
44766940|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44766941|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44766942|NCT01779401|Analgesics|analgesics|mesh-ancestor
44766943|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
44766944|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766945|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766946|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44766947|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44766948|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44766949|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44766950|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766951|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44766952|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44766953|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44766954|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
44766955|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44766956|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44766957|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44766958|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
44766959|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44766960|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44766961|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
44766962|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44766963|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
44766964|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
44766965|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44766966|NCT01779401|Protective Agents|protective agents|mesh-ancestor
44766967|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44766968|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44766969|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44766970|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
44766971|NCT01779466|Coagulants|coagulants|mesh-ancestor
44766972|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44766973|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
44766974|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766975|NCT01779479|Paclitaxel|paclitaxel|mesh-list
44766976|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44766977|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766978|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
44766979|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
44766980|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
44766981|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766982|NCT01779492|Oxycodone|oxycodone|mesh-list
44766983|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44766984|NCT01779492|Narcotics|narcotics|mesh-ancestor
44766985|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44766986|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44766987|NCT01779492|Analgesics|analgesics|mesh-ancestor
43646698|NCT02861898|Cetuximab|cetuximab|mesh-list
44766988|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
44766989|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44766990|NCT01779518|Interferons|interferons|mesh-list
44766991|NCT01779518|Ribavirin|ribavirin|mesh-list
44766992|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
44766993|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44766994|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
44247752|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
44766995|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44766996|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
44766997|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44766998|NCT01779596|Bosentan|bosentan|mesh-list
44766999|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44767000|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44247759|NCT01723774|Palbociclib|palbociclib|mesh-list
44767001|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767002|NCT01779609|Bosentan|bosentan|mesh-list
44767003|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44767004|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44767005|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767006|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
44767007|NCT01779687|Atorvastatin|atorvastatin|mesh-list
44767008|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44767009|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44767010|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
44767011|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767012|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44767013|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44767014|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767015|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44767016|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44767017|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
44767018|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767019|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44544839|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767020|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44767021|NCT01779830|Zolpidem|zolpidem|mesh-list
44247781|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44767022|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44767023|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44767024|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767025|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767026|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44767027|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
44767028|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
44767029|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767030|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767031|NCT01779843|Cytarabine|cytarabine|mesh-list
44767032|NCT01779843|Idarubicin|idarubicin|mesh-list
44767033|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767034|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
44767035|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767036|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767037|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
44767038|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767039|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767040|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
44767041|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767042|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44767043|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44767044|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44767045|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767046|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
44767047|NCT01779882|Busulfan|busulfan|mesh-list
44767048|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767049|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
44767050|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767051|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767052|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44767053|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
44767054|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767055|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007130|NCT01685814|Bortezomib|bortezomib|mesh-list
44767056|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44767057|NCT01779908|Vitamin D|vitamin d|mesh-list
44767058|NCT01779908|Vitamins|vitamins|mesh-ancestor
44767059|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
44767060|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767061|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44767062|NCT01779921|Thrombin|thrombin|mesh-list
44767063|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
44767064|NCT01779921|Coagulants|coagulants|mesh-ancestor
44767065|NCT01780051|Metformin|metformin|mesh-list
44767066|NCT01780051|Repaglinide|repaglinide|mesh-list
44767067|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767068|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767069|NCT01780181|Gemcitabine|gemcitabine|mesh-list
44767070|NCT01780181|Docetaxel|docetaxel|mesh-list
44767071|NCT01780181|Vinorelbine|vinorelbine|mesh-list
44767072|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767073|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
44767074|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767075|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767076|NCT01780181|Antiviral Agents|antiviral agents|mesh-ancestor
44767077|NCT01780181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767078|NCT01780181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767079|NCT01780181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767080|NCT01780181|Immunologic Factors|immunologic factors|mesh-ancestor
44767081|NCT01780181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767082|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44767083|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44767084|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44767085|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44767086|NCT01780233|Fentanyl|fentanyl|mesh-list
44767087|NCT01780233|Naltrexone|naltrexone|mesh-list
44767088|NCT01780233|Citric Acid|citric acid|mesh-list
44767089|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
44767090|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44767091|NCT01780233|Narcotics|narcotics|mesh-ancestor
44767092|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767093|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767094|NCT01780233|Analgesics|analgesics|mesh-ancestor
44767095|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
44767096|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767097|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44767098|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44767099|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
44767100|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
44767101|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
44767102|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44767103|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
44767104|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
44767105|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767106|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44767107|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44767108|NCT01780259|Triazolam|triazolam|mesh-list
44767109|NCT01780259|Esketamine|esketamine|mesh-list
44767110|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44767111|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44767112|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44767113|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44767114|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44247866|NCT01410344|Vidarabine|vidarabine|mesh-list
44247872|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767115|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767116|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767117|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
44767118|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
44767119|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767120|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767121|NCT01780311|Sotalol|sotalol|mesh-list
44767122|NCT01780311|Flecainide|flecainide|mesh-list
44767123|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44767124|NCT01780311|Propafenone|propafenone|mesh-list
44147156|NCT00199979|Nevirapine|nevirapine|mesh-list
44767125|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44767126|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44767127|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
44767128|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247881|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767129|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767130|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767131|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
44767132|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
44767133|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007637|NCT02812238|Niacin|niacin|mesh-list
44767134|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44767135|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44767136|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44767137|NCT01780467|Dopamine|dopamine|mesh-list
44767138|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44767139|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
44767140|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
44767141|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767142|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767143|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
44767144|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767145|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767146|NCT01780467|Protective Agents|protective agents|mesh-ancestor
44767147|NCT01780519|Lorazepam|lorazepam|mesh-list
44767148|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
44767149|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
44767150|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
44767151|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247909|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
44767152|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767153|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767154|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44767155|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767156|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44767157|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44767158|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44767159|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
44767160|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
44767161|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247912|NCT01254864|Hormones|hormones|mesh-ancestor
44767162|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767163|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44767164|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44767165|NCT01780558|Hormones|hormones|mesh-list
44767166|NCT01780558|Estradiol|estradiol|mesh-list
44767167|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44767168|NCT01780558|Progesterone|progesterone|mesh-list
44774296|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767169|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767170|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767171|NCT01780558|Estrogens|estrogens|mesh-ancestor
44767172|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44767173|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
44767174|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44767175|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44767176|NCT01780558|Progestins|progestins|mesh-ancestor
44767177|NCT01780610|Letrozole|letrozole|mesh-list
44767178|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44247927|NCT01120249|Everolimus|everolimus|mesh-list
44767179|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44767180|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44767181|NCT01780610|Hormones|hormones|mesh-list
44690570|NCT01356368|Cisplatin|cisplatin|mesh-list
44690571|NCT01356368|Docetaxel|docetaxel|mesh-list
44690572|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247939|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
44690573|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44690574|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690575|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690576|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690577|NCT01356381|Vildagliptin|vildagliptin|mesh-list
44690578|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690579|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690580|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44690581|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44690582|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690583|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690584|NCT01356433|Vitamins|vitamins|mesh-list
44690585|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
44690586|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
44690587|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690588|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
44690589|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690590|NCT01356433|Protective Agents|protective agents|mesh-ancestor
44690591|NCT01356472|Imipenem|imipenem|mesh-list
44690592|NCT01356472|Cilastatin|cilastatin|mesh-list
44690593|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44690594|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690595|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
44690596|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690597|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690598|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44690599|NCT01356511|Dexamethasone|dexamethasone|mesh-list
44690600|NCT01356511|Prednisone|prednisone|mesh-list
44690601|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690602|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
44690603|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
44690604|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690605|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690606|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690607|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
44690608|NCT01356511|Hormones|hormones|mesh-ancestor
44774297|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
44690609|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690610|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690611|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690612|NCT01356524|Progesterone|progesterone|mesh-list
44690613|NCT01356524|Progestins|progestins|mesh-ancestor
44690614|NCT01356524|Hormones|hormones|mesh-ancestor
44690615|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690616|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690617|NCT01356615|Heparin|heparin|mesh-list
44690618|NCT01356615|Calcium heparin|calcium heparin|mesh-list
44690619|NCT01356615|Enoxaparin|enoxaparin|mesh-list
44690620|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44690621|NCT01356615|Tinzaparin|tinzaparin|mesh-list
44690622|NCT01356615|Dalteparin|dalteparin|mesh-list
44690623|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
44690624|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
44690625|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44690626|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44690627|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690628|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44247992|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
44690629|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690630|NCT01356680|Prednisone|prednisone|mesh-list
44690631|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
44690632|NCT01356680|Dacarbazine|dacarbazine|mesh-list
44690633|NCT01356680|Etoposide|etoposide|mesh-list
44690634|NCT01356680|Vincristine|vincristine|mesh-list
44690635|NCT01356680|Doxorubicin|doxorubicin|mesh-list
44767182|NCT01780610|Estradiol|estradiol|mesh-list
44690636|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44690637|NCT01356680|Bleomycin|bleomycin|mesh-list
44690638|NCT01356680|Vinblastine|vinblastine|mesh-list
44690639|NCT01356680|Procarbazine|procarbazine|mesh-list
44690640|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690641|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
44369380|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
44767184|NCT01780610|Progesterone|progesterone|mesh-list
44767185|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767186|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767187|NCT01780610|Estrogens|estrogens|mesh-ancestor
44767188|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44767189|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
44767190|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44774298|NCT01848132|Prednisone|prednisone|mesh-list
44767191|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44767192|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767193|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44767194|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44767195|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008429|NCT02896907|Antidotes|antidotes|mesh-ancestor
44767196|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767197|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44767198|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
44767199|NCT01780610|Progestins|progestins|mesh-ancestor
44767201|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44767202|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44767203|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
44767204|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767205|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44767206|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44767207|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767208|NCT01780753|Primaquine|primaquine|mesh-list
44767209|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
44767210|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767211|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44767212|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767213|NCT01780883|Melatonin|melatonin|mesh-list
44767214|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
44767215|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767216|NCT01780883|Protective Agents|protective agents|mesh-ancestor
44767217|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767218|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767219|NCT01780909|Paromomycin|paromomycin|mesh-list
44767220|NCT01780909|Domperidone|domperidone|mesh-list
44767221|NCT01780909|Loperamide|loperamide|mesh-list
44767222|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
44767223|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767224|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
44767225|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
44767226|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767227|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767228|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44767229|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
44767230|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767231|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767232|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767233|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767234|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767235|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44767236|NCT01780948|Everolimus|everolimus|mesh-list
44767237|NCT01780948|Atorvastatin|atorvastatin|mesh-list
44767238|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44767239|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44767240|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
44767241|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767242|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44767243|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44767244|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767245|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767246|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767247|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
44767248|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767249|NCT01781052|Iloprost|iloprost|mesh-list
44767250|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44767251|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
44767252|NCT01781273|Ethanol|ethanol|mesh-list
44767253|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44767254|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767255|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767256|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767257|NCT01781377|Metoclopramide|metoclopramide|mesh-list
44767258|NCT01781377|Propofol|propofol|mesh-list
44767259|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44767260|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767261|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545072|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44248085|NCT00329043|Sunitinib|sunitinib|mesh-list
44545073|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44545074|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
44545075|NCT01311570|Buprenorphine|buprenorphine|mesh-list
44545076|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545077|NCT01311570|Narcotics|narcotics|mesh-ancestor
44545078|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545079|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545080|NCT01311570|Analgesics|analgesics|mesh-ancestor
44545081|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
44545082|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545083|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44545084|NCT01311622|Warfarin|warfarin|mesh-list
44767262|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44767263|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
44767264|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
44767265|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
44767266|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
44767267|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767268|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767269|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44767270|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44767271|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
44767272|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767273|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767274|NCT01781442|Sirolimus|sirolimus|mesh-list
44767275|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767276|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767277|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44767278|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767279|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
44767280|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767281|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
44767282|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767283|NCT01781507|Cetirizine|cetirizine|mesh-list
44767284|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44767285|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44767286|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44767287|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
44767288|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
44767289|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767290|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767291|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767292|NCT01781663|Petrolatum|petrolatum|mesh-list
44767293|NCT01781663|Emollients|emollients|mesh-ancestor
44767294|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
44767295|NCT01781702|Celecoxib|celecoxib|mesh-list
44767296|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767297|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767298|NCT01781702|Analgesics|analgesics|mesh-ancestor
44767299|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
44767300|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767301|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767302|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767303|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767304|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44767305|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44767306|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767307|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774299|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
44248142|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44767308|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44767309|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
44767310|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767311|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44767312|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
44767313|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767314|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767315|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767316|NCT01781897|Mosapride|mosapride|mesh-list
44767317|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767318|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44767319|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
44767320|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767321|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767322|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767323|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44767324|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767325|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
44767326|NCT01781936|Hormones|hormones|mesh-ancestor
44767327|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767328|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767329|NCT01781988|Gemcitabine|gemcitabine|mesh-list
44767330|NCT01781988|Carboplatin|carboplatin|mesh-list
44767331|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767332|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767333|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
44767334|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767335|NCT01781988|Antiviral Agents|antiviral agents|mesh-ancestor
44767336|NCT01781988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767337|NCT01781988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767338|NCT01781988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767339|NCT01781988|Immunologic Factors|immunologic factors|mesh-ancestor
44767340|NCT01781988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767341|NCT01782001|Vitamins|vitamins|mesh-list
44767342|NCT01782001|Vitamin A|vitamin a|mesh-list
44767343|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
44767344|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
44009310|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
44767345|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767346|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
44767347|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767348|NCT01782001|Protective Agents|protective agents|mesh-ancestor
44767349|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44767350|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767351|NCT01782261|Liraglutide|liraglutide|mesh-list
44767352|NCT01782261|Saxagliptin|saxagliptin|mesh-list
44767353|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767354|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767355|NCT01782261|Incretins|incretins|mesh-ancestor
44767356|NCT01782261|Hormones|hormones|mesh-ancestor
44767357|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767358|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44767359|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
44767360|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767361|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767362|NCT01782274|Vaccines|vaccines|mesh-list
44767363|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
44767364|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767365|NCT01782287|Vaccines|vaccines|mesh-list
44767366|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
44767367|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767368|NCT01782300|Vaccines|vaccines|mesh-list
44767369|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
44767370|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767371|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
44767372|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44767373|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767374|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
44767375|NCT01782508|Interferons|interferons|mesh-list
44248192|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
44767376|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
44767377|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767378|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
44767379|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767380|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767381|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767382|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767383|NCT01782560|Omeprazole|omeprazole|mesh-list
44767384|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44767385|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767386|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44767387|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774300|NCT01848132|Rituximab|rituximab|mesh-list
44767388|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767389|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
44767390|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44767391|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44767392|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767393|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
44767394|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
44767395|NCT01782599|Nicotine|nicotine|mesh-list
44767396|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44767397|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
44767398|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147328|NCT00200564|Ketamine|ketamine|mesh-list
44767399|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767400|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44767401|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44767402|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
44767403|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767404|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767405|NCT01782612|Analgesics|analgesics|mesh-list
44767406|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
44767407|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767408|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767409|NCT01782651|Capecitabine|capecitabine|mesh-list
44767410|NCT01782651|Lapatinib|lapatinib|mesh-list
44767411|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767412|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
44767413|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767414|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767415|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44460185|NCT01567826|Atorvastatin|atorvastatin|mesh-list
44767416|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767417|NCT01782781|Epinephrine|epinephrine|mesh-list
44767418|NCT01782781|Ropivacaine|ropivacaine|mesh-list
44767419|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
44767420|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
44767421|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767422|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767423|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
44767424|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767425|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44690642|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690643|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460207|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
44690644|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44690645|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
44690646|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690647|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690648|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44690649|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690650|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
44690651|NCT01356680|Hormones|hormones|mesh-ancestor
44690652|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690653|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690654|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44010028|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44690655|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690656|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690657|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690658|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
44690659|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690660|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690661|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44690662|NCT01356732|Sufentanil|sufentanil|mesh-list
44690663|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44690664|NCT01356732|Narcotics|narcotics|mesh-ancestor
44690665|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690666|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690667|NCT01356732|Analgesics|analgesics|mesh-ancestor
44690668|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
44690669|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690670|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44690671|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44690672|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
44690673|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
44690674|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
44690675|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44690676|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
44690677|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
44690678|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690679|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690680|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690681|NCT01356745|Analgesics|analgesics|mesh-ancestor
44690682|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
44690683|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690684|NCT01356758|Adalimumab|adalimumab|mesh-list
44690685|NCT01356758|Etanercept|etanercept|mesh-list
44690686|NCT01356758|Infliximab|infliximab|mesh-list
44690687|NCT01356758|Ustekinumab|ustekinumab|mesh-list
44690688|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690689|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690690|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690691|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690692|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690693|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690694|NCT01356758|Analgesics|analgesics|mesh-ancestor
44690695|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
44690696|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767426|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44767427|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
44767428|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767429|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767430|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44767431|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44767432|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
44767433|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44767434|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44767435|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
44767436|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
44767437|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44767438|NCT01782846|Codeine|codeine|mesh-list
44248271|NCT00602615|Torsemide|torsemide|mesh-list
44767439|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44767440|NCT01782846|Narcotics|narcotics|mesh-ancestor
44767441|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767442|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767443|NCT01782846|Analgesics|analgesics|mesh-ancestor
44767444|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
44767445|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767446|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
44767447|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
44767448|NCT01782911|Resveratrol|resveratrol|mesh-list
44767449|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
44767450|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767451|NCT01782911|Protective Agents|protective agents|mesh-ancestor
44767452|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767453|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774301|NCT01848132|Doxorubicin|doxorubicin|mesh-list
44767454|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44767455|NCT01782924|Brodalumab|brodalumab|mesh-list
44767456|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44767457|NCT01782937|Brodalumab|brodalumab|mesh-list
44767458|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44767459|NCT01782950|Rifampin|rifampin|mesh-list
44767460|NCT01782950|Isoniazid|isoniazid|mesh-list
44767461|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
44767462|NCT01782950|Ethambutol|ethambutol|mesh-list
44767463|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44767464|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
44767465|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767466|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767467|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
44767468|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44767469|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774302|NCT01848132|Vincristine|vincristine|mesh-list
44767470|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767471|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44767472|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44767473|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44767474|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44767475|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44767476|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44767477|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44767478|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44767479|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
44767480|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44767481|NCT01782976|Bevacizumab|bevacizumab|mesh-list
44767482|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44767483|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248313|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44767484|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44767485|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44767486|NCT01782976|Growth Substances|growth substances|mesh-ancestor
44767487|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767488|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44767489|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
44767490|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44774303|NCT01848132|Bortezomib|bortezomib|mesh-list
44248324|NCT00602706|Analgesics|analgesics|mesh-ancestor
44767491|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767492|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
44767493|NCT01783106|Doxycycline|doxycycline|mesh-list
44767494|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
44767495|NCT01783106|Budesonide|budesonide|mesh-list
44767496|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767497|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44767498|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
44767499|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767500|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767501|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44767502|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44767503|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
44767504|NCT01783106|Hormones|hormones|mesh-ancestor
44767505|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011332|NCT03096730|Dsuvia|dsuvia|mesh-list
44767506|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
44767507|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767508|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44248337|NCT00602849|Sertraline|sertraline|mesh-list
44767509|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767510|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767511|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767512|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767513|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43647092|NCT02465736|Cisplatin|cisplatin|mesh-list
44248348|NCT00602862|Sorafenib|sorafenib|mesh-list
44767514|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44767515|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44767516|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767517|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44767518|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44767519|NCT01783197|Paclitaxel|paclitaxel|mesh-list
44767520|NCT01783197|Cisplatin|cisplatin|mesh-list
44767521|NCT01783197|Carboplatin|carboplatin|mesh-list
44767522|NCT01783197|Pemetrexed|pemetrexed|mesh-list
44767523|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44767524|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767525|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44767526|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44767527|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44767528|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767529|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767530|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44248355|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
44767531|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44767532|NCT01783340|Azithromycin|azithromycin|mesh-list
44767533|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767534|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767535|NCT01783379|Micafungin|micafungin|mesh-list
44767536|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
44767537|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767538|NCT01783431|Poly ICLC|poly iclc|mesh-list
44767539|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
44767540|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
44767541|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767542|NCT01783587|Docetaxel|docetaxel|mesh-list
44545355|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767543|NCT01783587|Afatinib|afatinib|mesh-list
44767544|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767545|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44767546|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44767547|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44767548|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767549|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767550|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767551|NCT01783717|Exenatide|exenatide|mesh-list
44767552|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767553|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767554|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44767555|NCT01783717|Incretins|incretins|mesh-ancestor
44767556|NCT01783717|Hormones|hormones|mesh-ancestor
44767557|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767558|NCT01783756|Capecitabine|capecitabine|mesh-list
44767559|NCT01783756|Everolimus|everolimus|mesh-list
44767560|NCT01783756|Lapatinib|lapatinib|mesh-list
44767561|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767562|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
44767563|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767564|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767565|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767566|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
44545356|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44248393|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545357|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44545358|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44545359|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44545360|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545361|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545362|NCT01314274|Bevacizumab|bevacizumab|mesh-list
44545370|NCT01314339|Desloratadine|desloratadine|mesh-list
44767567|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767568|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767569|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767570|NCT01783834|Pemetrexed|pemetrexed|mesh-list
44767571|NCT01783834|Gefitinib|gefitinib|mesh-list
44767572|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767573|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767574|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767575|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44767576|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44767577|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767578|NCT01783925|Aflibercept|aflibercept|mesh-list
44767579|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44767580|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44767581|NCT01783925|Growth Substances|growth substances|mesh-ancestor
44767582|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767583|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
44767584|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767585|NCT01783951|Cisplatin|cisplatin|mesh-list
44767586|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767587|NCT01783964|Cytarabine|cytarabine|mesh-list
44767588|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767589|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
44767590|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767591|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767592|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
44767593|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767594|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767595|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
44767596|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767597|NCT01783977|Vaccines|vaccines|mesh-list
44767598|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
44767599|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767600|NCT01784107|Ifosfamide|ifosfamide|mesh-list
44767601|NCT01784107|Belotecan|belotecan|mesh-list
44767602|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44767603|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
44767604|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767605|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767606|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44767607|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44767608|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767609|NCT01784120|Doxorubicin|doxorubicin|mesh-list
44767610|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44767611|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767612|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44767613|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44767614|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767615|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767616|NCT01784250|Propranolol|propranolol|mesh-list
44767617|NCT01784250|Clonidine|clonidine|mesh-list
44767618|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44767619|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44767620|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
44767621|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767622|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767623|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767624|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44767625|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44767626|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
44767627|NCT01784250|Analgesics|analgesics|mesh-ancestor
44767628|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
44767629|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248462|NCT00603824|PENTA|penta|mesh-list
44767630|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
44767631|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
44767632|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44767633|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44767634|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44767635|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
44767636|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44767637|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44767638|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
44767639|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767640|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44767641|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44767642|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767643|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545408|NCT01314586|Hormones|hormones|mesh-ancestor
44767644|NCT01784315|Chloroquine|chloroquine|mesh-list
44248476|NCT00604006|Spironolactone|spironolactone|mesh-list
44767645|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44767646|NCT01784315|Primaquine|primaquine|mesh-list
44767647|NCT01784315|Artemisinins|artemisinins|mesh-list
44767648|NCT01784315|Artemisinin|artemisinin|mesh-list
44767649|NCT01784315|Amebicides|amebicides|mesh-ancestor
44767650|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767651|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44767652|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767653|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
44767654|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767655|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767656|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767657|NCT01784315|Analgesics|analgesics|mesh-ancestor
44767658|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
44767659|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767660|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767661|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767662|NCT01784315|Filaricides|filaricides|mesh-ancestor
44767663|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
44767664|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
44767665|NCT01784380|Metformin|metformin|mesh-list
44767666|NCT01784380|Clomiphene|clomiphene|mesh-list
44767667|NCT01784380|Enclomiphene|enclomiphene|mesh-list
44767668|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
44767669|NCT01784380|Menotropins|menotropins|mesh-list
44690697|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690698|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690699|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
44690700|NCT01356797|Fentanyl|fentanyl|mesh-list
44690701|NCT01356797|Bupivacaine|bupivacaine|mesh-list
44690702|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
44690703|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
44690704|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
44690705|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690706|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690707|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
44690708|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690709|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44690710|NCT01356797|Narcotics|narcotics|mesh-ancestor
44690711|NCT01356797|Analgesics|analgesics|mesh-ancestor
44690712|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44690713|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44690714|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
44690715|NCT01356862|Pasireotide|pasireotide|mesh-list
44690716|NCT01356862|Hormones|hormones|mesh-ancestor
44690717|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690718|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690719|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44690720|NCT01356927|Etonogestrel|etonogestrel|mesh-list
44690721|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44690722|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
44690723|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44690724|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690725|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44690726|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44690727|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690728|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690729|NCT01356992|Enoxaparin|enoxaparin|mesh-list
44690730|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
44690731|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44690732|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44690733|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690734|NCT01357031|Amitriptyline|amitriptyline|mesh-list
44690735|NCT01357031|Melatonin|melatonin|mesh-list
44690736|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
44690737|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690738|NCT01357031|Protective Agents|protective agents|mesh-ancestor
44690739|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690740|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690741|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44248507|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
44690742|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
44690743|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44690744|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690745|NCT01357031|Analgesics|analgesics|mesh-ancestor
44690746|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
44767670|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
44767671|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767672|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767673|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44767674|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
44767675|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767676|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44767678|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44767679|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44248559|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767680|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44767681|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
44767682|NCT01784445|Ceftazidime|ceftazidime|mesh-list
44767683|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767684|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767685|NCT01784536|Oritavancin|oritavancin|mesh-list
44767686|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767687|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767688|NCT01784549|Gemcitabine|gemcitabine|mesh-list
44767689|NCT01784549|Cisplatin|cisplatin|mesh-list
44767690|NCT01784549|Docetaxel|docetaxel|mesh-list
44767691|NCT01784549|Pemetrexed|pemetrexed|mesh-list
44767692|NCT01784549|Vinorelbine|vinorelbine|mesh-list
44767693|NCT01784549|Gefitinib|gefitinib|mesh-list
44767694|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767695|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767696|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
44767697|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767698|NCT01784549|Antiviral Agents|antiviral agents|mesh-ancestor
44767699|NCT01784549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767700|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248566|NCT00604682|Apremilast|apremilast|mesh-list
44767701|NCT01784549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767702|NCT01784549|Immunologic Factors|immunologic factors|mesh-ancestor
44767703|NCT01784549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767704|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44767705|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44767706|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44767707|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44767708|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44767709|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44767710|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767711|NCT01784562|Riociguat|riociguat|mesh-list
44767712|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
44767713|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767714|NCT01784640|Pemetrexed|pemetrexed|mesh-list
44767715|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767716|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767717|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767718|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44767719|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44460249|NCT01566435|Paclitaxel|paclitaxel|mesh-list
44767720|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44767721|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767722|NCT01784900|Catumaxomab|catumaxomab|mesh-list
44767723|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44767724|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767725|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
44767726|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767727|NCT01784913|Sargramostim|sargramostim|mesh-list
44767728|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
44767729|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767730|NCT01784978|Everolimus|everolimus|mesh-list
44767731|NCT01784978|Sunitinib|sunitinib|mesh-list
44767732|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767733|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767734|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
44767735|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767736|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44767737|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44767738|NCT01784978|Growth Substances|growth substances|mesh-ancestor
44767739|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44767740|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44767741|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767742|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767743|NCT01785004|Vitamin D|vitamin d|mesh-list
44767744|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
44767745|NCT01785004|Vitamins|vitamins|mesh-ancestor
44767746|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
44767747|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767748|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44767749|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44767750|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
44767751|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44767752|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
44767753|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
44767754|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248593|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248594|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
44248595|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
44248596|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248597|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248598|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44248599|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
44248600|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248601|NCT00604955|Paromomycin|paromomycin|mesh-list
44767755|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767756|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767757|NCT01785030|Analgesics|analgesics|mesh-ancestor
44767758|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
44248615|NCT00605098|Ritonavir|ritonavir|mesh-list
44767759|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767760|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44767761|NCT01785043|Liraglutide|liraglutide|mesh-list
44767762|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767763|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767764|NCT01785043|Incretins|incretins|mesh-ancestor
44767765|NCT01785043|Hormones|hormones|mesh-ancestor
44767766|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767767|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44767768|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
44767769|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767770|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767771|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44767772|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
44767773|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767774|NCT01785108|Vitamin D|vitamin d|mesh-list
44767775|NCT01785108|Ibuprofen|ibuprofen|mesh-list
44767776|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
44767777|NCT01785108|Vitamins|vitamins|mesh-ancestor
44767778|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
44767779|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767780|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44767781|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767782|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767783|NCT01785108|Analgesics|analgesics|mesh-ancestor
44767784|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
44767785|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767786|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545586|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767787|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767788|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44767789|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767790|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767791|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44248654|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767792|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
44767793|NCT01785290|Haloperidol|haloperidol|mesh-list
44767794|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
44767795|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
44767796|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
44767797|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767798|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767799|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44767800|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44767801|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44767802|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767803|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44767804|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44767805|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
44767806|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767807|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767808|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44767809|NCT01785446|Sufentanil|sufentanil|mesh-list
44767810|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
44767811|NCT01785446|Dsuvia|dsuvia|mesh-list
44767812|NCT01785446|Atracurium|atracurium|mesh-list
44767813|NCT01785446|Cisatracurium|cisatracurium|mesh-list
44767814|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44767815|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767816|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767817|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767818|NCT01785446|Analgesics|analgesics|mesh-ancestor
44767819|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
44767820|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767821|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44767822|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44248667|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767823|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44767824|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
44767825|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767826|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767827|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44767828|NCT01785446|Narcotics|narcotics|mesh-ancestor
44767829|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44767830|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44767831|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
44767832|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
44767833|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44767834|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44767835|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44767836|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44767837|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44767838|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
44767839|NCT01785589|Adenosine|adenosine|mesh-list
44767840|NCT01785589|Analgesics|analgesics|mesh-ancestor
44767841|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
44767842|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767843|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767844|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44767845|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
44767846|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44767847|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
44767848|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
44767849|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767850|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767851|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44767852|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
44767853|NCT01785641|Gentamicins|gentamicins|mesh-list
44767854|NCT01785641|Cefazolin|cefazolin|mesh-list
44545658|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545659|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545660|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248715|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
44545661|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44545662|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545663|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545664|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
44545665|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
44545666|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545667|NCT01317069|Fluorouracil|fluorouracil|mesh-list
44767855|NCT01785641|Ceftazidime|ceftazidime|mesh-list
44248721|NCT00605787|Protective Agents|protective agents|mesh-ancestor
44767856|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44767857|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767858|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44767859|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44767860|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44767861|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767862|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767863|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767864|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44767865|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44767866|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44767867|NCT01785693|Clonidine|clonidine|mesh-list
44690747|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690748|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44690749|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44690750|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690751|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690752|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690753|NCT01357109|Bosentan|bosentan|mesh-list
44690754|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44690755|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44690756|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690757|NCT01357252|Vildagliptin|vildagliptin|mesh-list
44690758|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690759|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690760|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44690761|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44690762|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690763|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690764|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
44690765|NCT01357317|Calcium|calcium|mesh-list
44690766|NCT01357317|Calcium acetate|calcium acetate|mesh-list
44690767|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690768|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690769|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44690770|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
44690771|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
44690772|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690773|NCT01357486|Sorafenib|sorafenib|mesh-list
44690774|NCT01357486|Pravastatin|pravastatin|mesh-list
44690775|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690776|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44690777|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248738|NCT00605930|Niacin|niacin|mesh-list
44690778|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690779|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44690780|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44690781|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
44690782|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44690797|NCT01357759|Gimsilumab|gimsilumab|mesh-list
44690798|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690799|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
44690800|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690801|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
44690802|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44690803|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44690804|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44690805|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690806|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690807|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
44690808|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44690809|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690810|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44690811|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690812|NCT01357811|Digoxin|digoxin|mesh-list
44690813|NCT01357811|Eliglustat|eliglustat|mesh-list
44690814|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44690815|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44690816|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690817|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690818|NCT01357811|Protective Agents|protective agents|mesh-ancestor
44690819|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690820|NCT01357876|Metformin|metformin|mesh-list
44690821|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44767868|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
44767870|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
44248797|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767871|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767872|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767873|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44767874|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
44767875|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
44767876|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44767877|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44767878|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44767879|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44767880|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44767881|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767882|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
44767883|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
44767884|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44767885|NCT01785797|Silicon|silicon|mesh-list
44767886|NCT01785797|Trace Elements|trace elements|mesh-ancestor
44767887|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
44767888|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767889|NCT01785836|Dapsone|dapsone|mesh-list
44767890|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767891|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
44767892|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767893|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44767894|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44767895|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767896|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767897|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
44767898|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44767899|NCT01785862|Ibuprofen|ibuprofen|mesh-list
44767900|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767901|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767902|NCT01785862|Analgesics|analgesics|mesh-ancestor
44767903|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
44767904|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767905|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767906|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767907|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767908|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44767909|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767910|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767911|NCT01785979|Chloroquine|chloroquine|mesh-list
44767912|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44767913|NCT01785979|Prednisone|prednisone|mesh-list
44767914|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767915|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
44767916|NCT01785979|Hormones|hormones|mesh-ancestor
44767917|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767918|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767919|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44767920|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767921|NCT01785979|Amebicides|amebicides|mesh-ancestor
44767922|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44767923|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44767924|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767925|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
44767926|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767927|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767928|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767929|NCT01785979|Analgesics|analgesics|mesh-ancestor
44767930|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
44767931|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767932|NCT01785979|Filaricides|filaricides|mesh-ancestor
44767933|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
44767934|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
44767935|NCT01786018|Cyclosporine|cyclosporine|mesh-list
44767936|NCT01786018|Methotrexate|methotrexate|mesh-list
44767937|NCT01786018|Busulfan|busulfan|mesh-list
44767938|NCT01786018|Thiotepa|thiotepa|mesh-list
44767939|NCT01786018|Cyclosporins|cyclosporins|mesh-list
44767940|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44767941|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
44767942|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44767943|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545734|NCT01317849|Vitamins|vitamins|mesh-list
44767944|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44767946|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767947|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44767948|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
44767949|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767950|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44767951|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44767952|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
44767953|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767954|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44767955|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
44767956|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44767957|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44767958|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
44767959|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44767960|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44767961|NCT01786070|Budesonide|budesonide|mesh-list
44767962|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767963|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44767964|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
44767965|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767966|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767967|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248882|NCT00606814|Docetaxel|docetaxel|mesh-list
44767968|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
44767969|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
44767970|NCT01786070|Hormones|hormones|mesh-ancestor
44767971|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44767972|NCT01786200|Aspirin|aspirin|mesh-list
44767973|NCT01786200|Ibuprofen|ibuprofen|mesh-list
44248888|NCT00606866|Sorafenib|sorafenib|mesh-list
44767974|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44767975|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44767976|NCT01786200|Analgesics|analgesics|mesh-ancestor
44767977|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
44767978|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44767979|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647599|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
44767980|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44767981|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44767982|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44767983|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44767984|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44767985|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44767986|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44767987|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44767988|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
44767989|NCT01786226|Mifepristone|mifepristone|mesh-list
44767990|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44767991|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
44767992|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44767993|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44767994|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44767995|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44767996|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44767997|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
44767998|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44014191|NCT03226457|Furosemide|furosemide|mesh-list
44767999|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44768000|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
44768001|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768002|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
44768003|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44768004|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44768005|NCT01786382|Midazolam|midazolam|mesh-list
44768006|NCT01786382|Omeprazole|omeprazole|mesh-list
44545811|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44545812|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44545813|NCT01318148|Caspofungin|caspofungin|mesh-list
44545814|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
44545815|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545816|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545817|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545818|NCT01318161|Morphine|morphine|mesh-list
44545819|NCT01318161|Ropivacaine|ropivacaine|mesh-list
44545820|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545821|NCT01318161|Narcotics|narcotics|mesh-ancestor
44768008|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44768009|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768010|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768011|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44768012|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44768013|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768014|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44768015|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
44768016|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
44768017|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
44768018|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
44768019|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768020|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768021|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44768022|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768023|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44768024|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768025|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
44768026|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44768027|NCT01786538|Leucovorin|leucovorin|mesh-list
44768028|NCT01786538|Fluorouracil|fluorouracil|mesh-list
44768029|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
44768030|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
44768031|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768032|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768033|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768034|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768035|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
44768036|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768037|NCT01786538|Antidotes|antidotes|mesh-ancestor
44768038|NCT01786538|Protective Agents|protective agents|mesh-ancestor
44768039|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
44768040|NCT01786538|Vitamins|vitamins|mesh-ancestor
44014381|NCT03242590|Hormones|hormones|mesh-ancestor
44768041|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
44768042|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
44768043|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44768044|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
44768045|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768046|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768047|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44768048|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248940|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768049|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44768050|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44768051|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44768052|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44768053|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768054|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768055|NCT01786655|Epinephrine|epinephrine|mesh-list
44768056|NCT01786655|Bupivacaine|bupivacaine|mesh-list
44768057|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
44768058|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
44768059|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
44768060|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768061|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768062|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
44768063|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768064|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44768065|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44768066|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44768067|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768068|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768069|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44768070|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44768071|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
44768072|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44768073|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768074|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
44768075|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
44768076|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44768077|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44768078|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44768079|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44768080|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44768081|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44768082|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44768083|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
44768084|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44768085|NCT01787123|Protective Agents|protective agents|mesh-ancestor
44768086|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768087|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
44768088|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
44768089|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
44768090|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768091|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44768092|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44768093|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768094|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768095|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768096|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
44768097|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44768098|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44768099|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44768100|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768101|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014740|NCT03296072|Listerine|listerine|mesh-list
44768102|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
44768103|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768104|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768105|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44768106|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768107|NCT01787357|Canagliflozin|canagliflozin|mesh-list
44768108|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
44768109|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44768110|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768111|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44768112|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44768113|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768114|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768115|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768116|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768117|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44768118|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768119|NCT01787396|Metformin|metformin|mesh-list
44768120|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768121|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768122|NCT01787474|Cytarabine|cytarabine|mesh-list
44768123|NCT01787474|Fludarabine|fludarabine|mesh-list
44768124|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
44768125|NCT01787474|Lenograstim|lenograstim|mesh-list
44768126|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768127|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768128|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
44768129|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768130|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768131|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
44768132|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768133|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
44768134|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768135|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44768136|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
44768137|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44768138|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
44768139|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768140|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
44768141|NCT01787630|Protective Agents|protective agents|mesh-ancestor
44768142|NCT01787669|Dexamethasone|dexamethasone|mesh-list
44768143|NCT01787669|Bevacizumab|bevacizumab|mesh-list
44768144|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44768145|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768146|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44768147|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44768148|NCT01787669|Growth Substances|growth substances|mesh-ancestor
44768149|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768150|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44768151|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768152|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
44768153|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
44768154|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768155|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768156|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
44768157|NCT01787669|Hormones|hormones|mesh-ancestor
44768158|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768159|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768160|NCT01788007|Imiquimod|imiquimod|mesh-list
44249053|NCT00607750|Mecamylamine|mecamylamine|mesh-list
44768161|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44768162|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
44768163|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768164|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768165|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
44768166|NCT01788072|Oxytocin|oxytocin|mesh-list
44768167|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
44768168|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768169|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768170|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
44249056|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
44768171|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44768172|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768173|NCT01788189|Lenalidomide|lenalidomide|mesh-list
44768174|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
44768175|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690822|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768176|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44768177|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44768178|NCT01788189|Growth Substances|growth substances|mesh-ancestor
44768179|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44768180|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768181|NCT01788254|Talinolol|talinolol|mesh-list
44768182|NCT01788254|Torsemide|torsemide|mesh-list
44768183|NCT01788254|Midazolam|midazolam|mesh-list
44768184|NCT01788254|Codeine|codeine|mesh-list
44768185|NCT01788254|Pravastatin|pravastatin|mesh-list
44768186|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44768187|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44768188|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768189|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768190|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44768191|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44768192|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768193|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44768194|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
44768195|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
44768196|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
44768197|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
44768198|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768199|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768200|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44249094|NCT00607984|Melphalan|melphalan|mesh-list
44768201|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44768202|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
44768203|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44768204|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44768205|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768206|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44768207|NCT01788254|Narcotics|narcotics|mesh-ancestor
44768208|NCT01788254|Analgesics|analgesics|mesh-ancestor
44768209|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
44768210|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768211|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
44768212|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768213|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44768214|NCT01788254|Diuretics|diuretics|mesh-ancestor
44768215|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
44768216|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44768217|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768218|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44768219|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44768220|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
44768221|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44768222|NCT01788280|Bevacizumab|bevacizumab|mesh-list
44768223|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44768224|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768225|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44768226|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44768227|NCT01788280|Growth Substances|growth substances|mesh-ancestor
44768228|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768229|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
44768230|NCT01788332|Olaparib|olaparib|mesh-list
44768231|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44768232|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768233|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768234|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768235|NCT01788371|Lamivudine|lamivudine|mesh-list
44768236|NCT01788371|Telbivudine|telbivudine|mesh-list
44768237|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44768238|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44768239|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768240|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768241|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
44249129|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768242|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768243|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44546075|NCT01319734|Ascorbic Acid|ascorbic acid|mesh-list
44546076|NCT01319734|Glyburide|glyburide|mesh-list
44546077|NCT01319734|Vitamins|vitamins|mesh-ancestor
44546078|NCT01319734|Micronutrients|micronutrients|mesh-ancestor
44546079|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546080|NCT01319734|Antioxidants|antioxidants|mesh-ancestor
44546081|NCT01319734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546082|NCT01319734|Protective Agents|protective agents|mesh-ancestor
44546083|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546084|NCT01319825|Milnacipran|milnacipran|mesh-list
44768244|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44768245|NCT01788384|Clindamycin|clindamycin|mesh-list
44768246|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
44768247|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
44768248|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44768249|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44768250|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768251|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44768252|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768253|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768254|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
44768255|NCT01788462|Tesamorelin|tesamorelin|mesh-list
44768256|NCT01788462|Growth Substances|growth substances|mesh-ancestor
44768257|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768258|NCT01788501|Cyclosporine|cyclosporine|mesh-list
44768259|NCT01788501|Methotrexate|methotrexate|mesh-list
44768260|NCT01788501|Tacrolimus|tacrolimus|mesh-list
44768261|NCT01788501|Cyclosporins|cyclosporins|mesh-list
44768262|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44768263|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
44768264|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44249153|NCT00608335|Micafungin|micafungin|mesh-list
44768265|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768266|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768267|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
44768268|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768269|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768270|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
43824157|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
44768271|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768272|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44768273|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768274|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
44768275|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768276|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44768277|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44768278|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
44768279|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768280|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44768281|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44768282|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44768283|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44768284|NCT01788605|Ramosetron|ramosetron|mesh-list
44768285|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
44768286|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
44249180|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768287|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768288|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768289|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768290|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44249186|NCT00608673|Betamethasone|betamethasone|mesh-list
44768291|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
44768292|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768293|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768294|NCT01788670|Ethanol|ethanol|mesh-list
44768295|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44768296|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768297|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768298|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768299|NCT01788722|Dienogest|dienogest|mesh-list
44768300|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44768301|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
44768302|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768303|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768304|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44768305|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44768306|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44768307|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44768308|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
44768309|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768310|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768311|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768312|NCT01788774|Risperidone|risperidone|mesh-list
44768313|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44768314|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
44768315|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768316|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768317|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768318|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44768319|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44768320|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768321|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768322|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44768323|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
44768324|NCT01788969|Citalopram|citalopram|mesh-list
44768325|NCT01788969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44768326|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44768327|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768328|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768329|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768330|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
44768331|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768332|NCT01788969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44768333|NCT01788969|Antidepressive Agents|antidepressive agents|mesh-ancestor
44768334|NCT01788969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768335|NCT01788982|Nintedanib|nintedanib|mesh-list
44768336|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768337|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44768338|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768339|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768340|NCT01789086|Liraglutide|liraglutide|mesh-list
44768341|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768342|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768343|NCT01789086|Incretins|incretins|mesh-ancestor
44768344|NCT01789086|Hormones|hormones|mesh-ancestor
44768345|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768346|NCT01789099|Sargramostim|sargramostim|mesh-list
44768347|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
44768348|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768349|NCT01789125|Nicotine|nicotine|mesh-list
44768350|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44768351|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
44768352|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768353|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768354|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44768355|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44768356|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
44768357|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768358|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768359|NCT01789216|Ketorolac|ketorolac|mesh-list
44768360|NCT01789216|Meloxicam|meloxicam|mesh-list
44768361|NCT01789216|Pregabalin|pregabalin|mesh-list
44768362|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44768363|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768364|NCT01789216|Analgesics|analgesics|mesh-ancestor
44768365|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
44768366|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768367|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768368|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768369|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768370|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44768371|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768372|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768373|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
44768374|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44768375|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768376|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44768377|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44768378|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44768379|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768380|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768381|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44768382|NCT01789242|Dexamethasone|dexamethasone|mesh-list
44768383|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768384|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
44768385|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
44768386|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768387|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768388|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768389|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
44768390|NCT01789242|Hormones|hormones|mesh-ancestor
44768391|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768392|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768393|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768394|NCT01789294|Mesalamine|mesalamine|mesh-list
44768395|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44768396|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768397|NCT01789294|Analgesics|analgesics|mesh-ancestor
44768398|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
44768399|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768400|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768401|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768402|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768403|NCT01789333|Riboflavin|riboflavin|mesh-list
44768404|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44768405|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44768406|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
44768407|NCT01789333|Vitamins|vitamins|mesh-ancestor
44768408|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
44768409|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768410|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44768411|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
44768412|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
44768413|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44768414|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768415|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768416|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768417|NCT01789385|Analgesics|analgesics|mesh-ancestor
44768418|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
44768419|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768420|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44768421|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44768422|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44768423|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
44768424|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768425|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768426|NCT01789437|Dexamethasone|dexamethasone|mesh-list
44768427|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768428|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
44768429|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
44768430|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768431|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768432|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768433|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
44768434|NCT01789437|Hormones|hormones|mesh-ancestor
44768435|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460327|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460332|NCT01565694|Urological Agents|urological agents|mesh-ancestor
44768436|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768437|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768438|NCT01789619|Tacrolimus|tacrolimus|mesh-list
44768439|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768440|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
44768441|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768442|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44768443|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768444|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768445|NCT01789710|Bupropion|bupropion|mesh-list
44768446|NCT01789710|Nicotine|nicotine|mesh-list
44768447|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44768448|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
44768449|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768450|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768451|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44768452|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44768453|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
44768454|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768455|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018291|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
44768456|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44768457|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
44768458|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44768459|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44768460|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249292|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768461|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768462|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
44768463|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44768464|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44768465|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768466|NCT01789723|Leucovorin|leucovorin|mesh-list
44768467|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
44768468|NCT01789723|Antidotes|antidotes|mesh-ancestor
44768469|NCT01789723|Protective Agents|protective agents|mesh-ancestor
44768470|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768471|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
44768472|NCT01789723|Vitamins|vitamins|mesh-ancestor
44768473|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
44768474|NCT01789827|Interleukin-2|interleukin-2|mesh-list
44768475|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768476|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768477|NCT01789827|Analgesics|analgesics|mesh-ancestor
44768478|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
44768479|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768480|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768481|NCT01789879|Efavirenz|efavirenz|mesh-list
44768482|NCT01789879|Nevirapine|nevirapine|mesh-list
44768483|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
44768484|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44768485|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44768486|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249318|NCT00609375|Cefepime|cefepime|mesh-list
44768487|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768488|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
44768489|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768490|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44768491|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44249321|NCT00609388|Tacrolimus|tacrolimus|mesh-list
44768492|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44768493|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44768494|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44768495|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44768496|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44768497|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
44768498|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768499|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768500|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44768501|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44768502|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44768503|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44768504|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44768505|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
44768506|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44768507|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44768508|NCT01789892|Prednisolone|prednisolone|mesh-list
44768509|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
44768510|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44768511|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
44768512|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44768513|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768514|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
44768515|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
44768516|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768517|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768518|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44768519|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
44768520|NCT01789892|Hormones|hormones|mesh-ancestor
44768521|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768522|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44768523|NCT01789892|Protective Agents|protective agents|mesh-ancestor
44768524|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768525|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768526|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44768527|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768528|NCT01789957|Exenatide|exenatide|mesh-list
44768529|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768530|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768531|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44768532|NCT01789957|Incretins|incretins|mesh-ancestor
44768533|NCT01789957|Hormones|hormones|mesh-ancestor
44768534|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768535|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44768536|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44690823|NCT01357902|Lamotrigine|lamotrigine|mesh-list
44690824|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
44690825|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44690826|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690827|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690828|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690829|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690830|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44690831|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44690832|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690833|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44546391|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
44768537|NCT01792063|Sevoflurane|sevoflurane|mesh-list
44768538|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44768539|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44768540|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
44768541|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
44768542|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768543|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768544|NCT01792570|Darunavir|darunavir|mesh-list
44768545|NCT01792570|Rilpivirine|rilpivirine|mesh-list
44768546|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44768547|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44768548|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
44768549|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768550|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768551|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44768552|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44768553|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
44768554|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768555|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44768556|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44768557|NCT01792804|Vancomycin|vancomycin|mesh-list
44768558|NCT01792804|Clindamycin|clindamycin|mesh-list
44768559|NCT01792804|Cefazolin|cefazolin|mesh-list
44768560|NCT01792804|Linezolid|linezolid|mesh-list
44768561|NCT01792804|Daptomycin|daptomycin|mesh-list
44768562|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44768563|NCT01792804|Floxacillin|floxacillin|mesh-list
44768564|NCT01792804|Cloxacillin|cloxacillin|mesh-list
44768565|NCT01792804|Trimethoprim|trimethoprim|mesh-list
44768566|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
44768567|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44768568|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768569|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44768570|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768571|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768572|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44768573|NCT01792804|Renal Agents|renal agents|mesh-ancestor
44768574|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
44768575|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44768576|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44768577|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44768578|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44768579|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44768580|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44768581|NCT01793038|Clomiphene|clomiphene|mesh-list
44768582|NCT01793038|Enclomiphene|enclomiphene|mesh-list
44768583|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
44768584|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44774304|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768585|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768586|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44768587|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
44768588|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768589|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249431|NCT00610077|Enclomiphene|enclomiphene|mesh-list
44768590|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44768591|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
44768592|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768593|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44768594|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44768595|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44768596|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768597|NCT01794182|Glyburide|glyburide|mesh-list
44768598|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546456|NCT05654194|Azacitidine|azacitidine|mesh-list
44546457|NCT05654194|Venetoclax|venetoclax|mesh-list
44546458|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44546459|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
44546460|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546461|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546462|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546463|NCT05654090|Sulbactam|sulbactam|mesh-list
44546464|NCT05654090|Cefoperazone|cefoperazone|mesh-list
44546465|NCT05654090|Sulperazone|sulperazone|mesh-list
44546466|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546467|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546468|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44546469|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546471|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44768599|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768600|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44768602|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768603|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768604|NCT01794247|Lidocaine|lidocaine|mesh-list
44768605|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
44768606|NCT01794247|Fentanyl|fentanyl|mesh-list
44768607|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
44768608|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
44768609|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768610|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768611|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
44768612|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768613|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44768614|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44768615|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44768616|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768617|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768618|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44768619|NCT01794247|Narcotics|narcotics|mesh-ancestor
44768620|NCT01794247|Analgesics|analgesics|mesh-ancestor
44249462|NCT00610142|Analgesics|analgesics|mesh-ancestor
44249473|NCT00610246|Sorafenib|sorafenib|mesh-list
44768621|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44768622|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44768623|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
44768624|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
44768625|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44768626|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44768627|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
44768628|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768629|NCT01794429|Exenatide|exenatide|mesh-list
44768630|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768631|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768632|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44768633|NCT01794429|Incretins|incretins|mesh-ancestor
44768634|NCT01794429|Hormones|hormones|mesh-ancestor
44768635|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768636|NCT01795248|Liraglutide|liraglutide|mesh-list
44768637|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768638|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768639|NCT01795248|Incretins|incretins|mesh-ancestor
44768640|NCT01795248|Hormones|hormones|mesh-ancestor
44768641|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768642|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44768643|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
44768644|NCT01796132|Citalopram|citalopram|mesh-list
44768645|NCT01796132|Fluoxetine|fluoxetine|mesh-list
44768646|NCT01796132|Paroxetine|paroxetine|mesh-list
44768647|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44768648|NCT01796132|Sertraline|sertraline|mesh-list
44768649|NCT01796132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44768650|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44768651|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768652|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768653|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768654|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
44768655|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768656|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44768657|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
44768658|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249512|NCT00610506|Citalopram|citalopram|mesh-list
44768659|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768660|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44768661|NCT01796132|Analgesics|analgesics|mesh-ancestor
44768662|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
44768663|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
44768664|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44768665|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44768666|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768667|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44021990|NCT01397695|Bevacizumab|bevacizumab|mesh-list
44768668|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44768669|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768670|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44768671|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44768672|NCT01796418|Beraprost|beraprost|mesh-list
44768673|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44768674|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
44768675|NCT01796522|Nifedipine|nifedipine|mesh-list
44768676|NCT01796522|Progesterone|progesterone|mesh-list
44768677|NCT01796522|Progestins|progestins|mesh-ancestor
44768678|NCT01796522|Hormones|hormones|mesh-ancestor
44768679|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768680|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768681|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44768682|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44768683|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768684|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44768685|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
44768686|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
44768687|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768688|NCT01796730|Bambuterol|bambuterol|mesh-list
44768689|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44768690|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
44768691|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768692|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768693|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44768694|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768695|NCT01796808|Lidocaine|lidocaine|mesh-list
44768696|NCT01796808|Epinephrine|epinephrine|mesh-list
44768697|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
44768698|NCT01796808|Anesthetics|anesthetics|mesh-list
44768699|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44768700|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249548|NCT00610584|Cetirizine|cetirizine|mesh-list
44768701|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
44768702|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023254|NCT00843310|Hormones|hormones|mesh-ancestor
44768703|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44768704|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44768705|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44768706|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774305|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
44768707|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768708|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44768709|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44768710|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
44768711|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768712|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44768713|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44768714|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
44768715|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44768716|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768717|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
44768718|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
44768719|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44768720|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
44768721|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44768722|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44768723|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768724|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
44768725|NCT01797289|Coagulants|coagulants|mesh-ancestor
44768726|NCT01797718|Letrozole|letrozole|mesh-list
44768727|NCT01797718|Testosterone|testosterone|mesh-list
44768728|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768729|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44768730|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44768731|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768732|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768733|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44768734|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44768735|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768736|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768737|NCT01797718|Androgens|androgens|mesh-ancestor
44768738|NCT01797718|Hormones|hormones|mesh-ancestor
44768739|NCT01797796|Capsaicin|capsaicin|mesh-list
44768740|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
44768741|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
44768742|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
44768743|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768744|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768745|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44768746|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768747|NCT01798446|Axitinib|axitinib|mesh-list
44546585|NCT05653193|Interferons|interferons|mesh-list
44768748|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768749|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44768750|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768751|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768752|NCT01798680|Vitamin D|vitamin d|mesh-list
44768753|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
44768754|NCT01798680|Vitamins|vitamins|mesh-ancestor
44768755|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
44768756|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690834|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44690835|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44690836|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44690837|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44690838|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44690839|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44690840|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690841|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690842|NCT01358045|Calcitriol|calcitriol|mesh-list
44690843|NCT01358045|Diclofenac|diclofenac|mesh-list
44690844|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690845|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690846|NCT01358045|Analgesics|analgesics|mesh-ancestor
44690847|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
44690848|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690849|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690850|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690851|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690852|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44690853|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690854|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690855|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690856|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44690857|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44690858|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44690859|NCT01358045|Vitamins|vitamins|mesh-ancestor
44249623|NCT00610948|Antidotes|antidotes|mesh-ancestor
44690860|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
44690861|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44690862|NCT01358071|Doxorubicin|doxorubicin|mesh-list
44690863|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44690864|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44690865|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690866|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690867|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690868|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249629|NCT00611000|Folic Acid|folic acid|mesh-list
44690869|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690870|NCT01358240|Econazole|econazole|mesh-list
44690871|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
44690872|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690873|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44690874|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44690875|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690876|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690877|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44690878|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
44690879|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690880|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690881|NCT01358253|Cytarabine|cytarabine|mesh-list
44690882|NCT01358253|Dexamethasone|dexamethasone|mesh-list
44690883|NCT01358253|Prednisone|prednisone|mesh-list
44690884|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
44690885|NCT01358253|Rituximab|rituximab|mesh-list
44690886|NCT01358253|Doxorubicin|doxorubicin|mesh-list
44690887|NCT01358253|Methotrexate|methotrexate|mesh-list
44690888|NCT01358253|Vincristine|vincristine|mesh-list
44690889|NCT01358253|Asparaginase|asparaginase|mesh-list
44690890|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
44690891|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44690892|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
44690893|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690894|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690895|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44690896|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
44690897|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690898|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44690899|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44768757|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44768758|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44768759|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44768760|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44768761|NCT01798836|Estradiol|estradiol|mesh-list
44768762|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44768763|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44768764|NCT01798836|Estrogens|estrogens|mesh-ancestor
44768765|NCT01798836|Hormones|hormones|mesh-ancestor
44249648|NCT05331469|Insulin|insulin|mesh-list
44768766|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768767|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768768|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44768769|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
44768770|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44768771|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44768772|NCT01798901|Decitabine|decitabine|mesh-list
44768773|NCT01798901|Azacitidine|azacitidine|mesh-list
44768774|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44768775|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768776|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
44768777|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768778|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768779|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768780|NCT01799863|Ketorolac|ketorolac|mesh-list
44768781|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44768782|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44768783|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
44768784|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44768785|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768786|NCT01799863|Analgesics|analgesics|mesh-ancestor
44768787|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
44768788|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768789|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768790|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768791|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768792|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44249673|NCT05330065|Bevacizumab|bevacizumab|mesh-list
44768793|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768794|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768795|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44768796|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44768797|NCT01799863|Laxatives|laxatives|mesh-ancestor
44768798|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44026197|NCT04051996|Decitabine|decitabine|mesh-list
44768799|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
44768800|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44768801|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
44768802|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44768803|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
44768804|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768805|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768806|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
44768807|NCT01800019|Nicotine|nicotine|mesh-list
44768808|NCT01800019|Varenicline|varenicline|mesh-list
44768809|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44768810|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
44768811|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768812|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768813|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44768814|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44768815|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
44768816|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44768817|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768818|NCT01800097|Modafinil|modafinil|mesh-list
44768819|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44768820|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546667|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
44546668|NCT05634785|Fludarabine|fludarabine|mesh-list
44546669|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546670|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
44546671|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546672|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546673|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44546674|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
44546675|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546678|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44768821|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44768822|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44768823|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44768824|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768825|NCT01800227|Metformin|metformin|mesh-list
44768826|NCT01800227|Pioglitazone|pioglitazone|mesh-list
44768827|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768828|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768829|NCT01800240|Metformin|metformin|mesh-list
44768830|NCT01800240|Pioglitazone|pioglitazone|mesh-list
44768831|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44768832|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768833|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
44768834|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026500|NCT00000201|Selegiline|selegiline|mesh-list
44768835|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
44768836|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44768837|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44249728|NCT05329454|Ibuprofen|ibuprofen|mesh-list
44249730|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768838|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768839|NCT01800292|Urological Agents|urological agents|mesh-ancestor
44768840|NCT01800357|Aspirin|aspirin|mesh-list
44768841|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
44768842|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44768843|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768844|NCT01800357|Analgesics|analgesics|mesh-ancestor
44768845|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
44768846|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768847|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768848|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768849|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768850|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44768851|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44768852|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768853|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44768854|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44768855|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768856|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
44768857|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44768858|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
44768859|NCT01800396|Caseins|caseins|mesh-list
44768860|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
44768861|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
44768862|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768863|NCT01800422|Progesterone|progesterone|mesh-list
44768864|NCT01800422|Progestins|progestins|mesh-ancestor
44768865|NCT01800422|Hormones|hormones|mesh-ancestor
44768866|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768867|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768868|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
44768869|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44768870|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44768871|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44768872|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768873|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
44768874|NCT01800435|Coagulants|coagulants|mesh-ancestor
44768875|NCT01800487|Silymarin|silymarin|mesh-list
44768876|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
44768877|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768878|NCT01800487|Protective Agents|protective agents|mesh-ancestor
44768879|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768880|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
44768881|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44768882|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
44768883|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768884|NCT01800526|Expectorants|expectorants|mesh-ancestor
44768885|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
44768886|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44768887|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
44768888|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768889|NCT01800526|Protective Agents|protective agents|mesh-ancestor
44768890|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768891|NCT01800526|Antidotes|antidotes|mesh-ancestor
44768892|NCT01800630|Gemcitabine|gemcitabine|mesh-list
44768893|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768894|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
44768895|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768896|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768897|NCT01800630|Antiviral Agents|antiviral agents|mesh-ancestor
44768898|NCT01800630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768899|NCT01800630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768900|NCT01800630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768901|NCT01800630|Immunologic Factors|immunologic factors|mesh-ancestor
44768902|NCT01800630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768903|NCT01800643|Busulfan|busulfan|mesh-list
44768904|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
44768905|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768906|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768907|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
44249771|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
44249776|NCT05188508|Olaparib|olaparib|mesh-list
44768908|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768909|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44768910|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768911|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44768912|NCT01800695|Temozolomide|temozolomide|mesh-list
44768913|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44768914|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
44768915|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768916|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768917|NCT01800708|Prednisolone|prednisolone|mesh-list
44768918|NCT01800708|Triamcinolone|triamcinolone|mesh-list
44768919|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44768920|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44768921|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44768922|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44768923|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
44768924|NCT01800708|Hormones|hormones|mesh-ancestor
44768925|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768926|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768927|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44768928|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768929|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768930|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
44768931|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768932|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768933|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44768934|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768935|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
44768936|NCT01800799|Celecoxib|celecoxib|mesh-list
44768937|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44768938|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44768939|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44768940|NCT01800799|Analgesics|analgesics|mesh-ancestor
44768941|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
44768942|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768943|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768944|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44768945|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44768946|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44768947|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768948|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768949|NCT01800825|Clindamycin|clindamycin|mesh-list
44768950|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
44768951|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
44027006|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
44768952|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44768953|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768954|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44768955|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768956|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768957|NCT01800942|Azithromycin|azithromycin|mesh-list
44768958|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44768959|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768960|NCT01801046|Cytarabine|cytarabine|mesh-list
44768961|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
44768962|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44768963|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
44768964|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768965|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768966|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
44768967|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44768968|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768969|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
44768970|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768971|NCT01801046|Analgesics|analgesics|mesh-ancestor
44768972|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
44768973|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44768974|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44768975|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44768976|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768977|NCT01801137|Everolimus|everolimus|mesh-list
44768978|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249842|NCT04939467|Pirfenidone|pirfenidone|mesh-list
44768979|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44768980|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
44768981|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768982|NCT01801163|Sorafenib|sorafenib|mesh-list
44768983|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44768984|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44768985|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44768986|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44768987|NCT01801228|Eplerenone|eplerenone|mesh-list
44768988|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44768989|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
44768990|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44768991|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44768992|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44768993|NCT01801228|Diuretics|diuretics|mesh-ancestor
44768994|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
44768995|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44768996|NCT01801410|Misoprostol|misoprostol|mesh-list
44768997|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44768998|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
44768999|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44769000|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249856|NCT04938232|Nivolumab|nivolumab|mesh-list
44769001|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44769002|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769003|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
44769004|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
44769005|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769006|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
44769007|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769008|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249870|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769009|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769010|NCT01801644|Gemcitabine|gemcitabine|mesh-list
44769012|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769013|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769014|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
44027618|NCT00000335|Morphine|morphine|mesh-list
44769015|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769016|NCT01801644|Antiviral Agents|antiviral agents|mesh-ancestor
44769017|NCT01801644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769018|NCT01801644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769019|NCT01801644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769020|NCT01801644|Immunologic Factors|immunologic factors|mesh-ancestor
44769021|NCT01801644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769022|NCT01801774|Triamcinolone|triamcinolone|mesh-list
44769023|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44769024|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44769025|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44769026|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769027|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
44769028|NCT01801774|Hormones|hormones|mesh-ancestor
44769029|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769030|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769031|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769032|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
44769033|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769034|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769035|NCT01801904|Panitumumab|panitumumab|mesh-list
44769036|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769037|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546934|NCT01376245|Xhance|xhance|mesh-list
44249885|NCT04901689|Leronlimab|leronlimab|mesh-list
44769038|NCT01802255|Midazolam|midazolam|mesh-list
44769039|NCT01802255|Sevoflurane|sevoflurane|mesh-list
44769040|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44769041|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44769042|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769043|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769044|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44769045|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44769046|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769047|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44769048|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
44769049|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
44769050|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
44769051|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
44769052|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769053|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769054|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44769055|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44769056|NCT01802268|Sirolimus|sirolimus|mesh-list
44769057|NCT01802268|Tacrolimus|tacrolimus|mesh-list
44769058|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769059|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
44769060|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769061|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44769062|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769063|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769064|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769065|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769066|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44249917|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769067|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769068|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
44769069|NCT01802450|Dasatinib|dasatinib|mesh-list
44769070|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769071|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249929|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
44769072|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769073|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769074|NCT01802476|Palbociclib|palbociclib|mesh-list
44769075|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769076|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249934|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
44769077|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769078|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769079|NCT01802489|Amiloride|amiloride|mesh-list
44769080|NCT01802489|Diuretics|diuretics|mesh-ancestor
44769081|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
44769082|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769083|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44769084|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769085|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769086|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769087|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44769088|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44769089|NCT01802502|Rifampin|rifampin|mesh-list
44769090|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44769091|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
44769092|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769093|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769094|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
44769095|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769096|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769097|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769098|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44769099|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44769100|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44769101|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44769102|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44547000|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44547001|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44547002|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547003|NCT01375049|Aztreonam|aztreonam|mesh-list
44547004|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547005|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547006|NCT01375010|Vitamin D|vitamin d|mesh-list
44547007|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
44769103|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44769104|NCT01802593|Methotrexate|methotrexate|mesh-list
44030507|NCT00000916|Lamivudine|lamivudine|mesh-list
44249977|NCT04607460|Coal Tar|coal tar|mesh-list
44769105|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
44769106|NCT01802593|Azathioprine|azathioprine|mesh-list
44769107|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44769108|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
44769109|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44769110|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769111|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769112|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
44769113|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769114|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769115|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769116|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769117|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44769118|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769119|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
44769120|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769121|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769122|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
44769123|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44769124|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
44769125|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769126|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769127|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44769128|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769129|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44769130|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
44769131|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769132|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769133|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44769134|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44769135|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
44769136|NCT01802619|Protective Agents|protective agents|mesh-ancestor
44769137|NCT01802645|Leucovorin|leucovorin|mesh-list
44769138|NCT01802645|Folic Acid|folic acid|mesh-list
44769139|NCT01802645|Bevacizumab|bevacizumab|mesh-list
44769140|NCT01802645|Cetuximab|cetuximab|mesh-list
44769141|NCT01802645|Fluorouracil|fluorouracil|mesh-list
44769142|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
44769143|NCT01802645|Irinotecan|irinotecan|mesh-list
44769144|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
44769145|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769146|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769147|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44769148|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44769149|NCT01802645|Growth Substances|growth substances|mesh-ancestor
44769150|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769151|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
44769152|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
44460398|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769153|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769154|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769155|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769156|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
44769157|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44769158|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44460407|NCT01564277|Allopurinol|allopurinol|mesh-list
44769159|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769160|NCT01802645|Antidotes|antidotes|mesh-ancestor
44769161|NCT01802645|Protective Agents|protective agents|mesh-ancestor
44769162|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
44769163|NCT01802645|Vitamins|vitamins|mesh-ancestor
44769164|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
44769165|NCT01802645|Hematinics|hematinics|mesh-ancestor
44769166|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
44769167|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44769168|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769169|NCT01802684|Aflibercept|aflibercept|mesh-list
44769170|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460411|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769171|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44769172|NCT01802684|Growth Substances|growth substances|mesh-ancestor
44769173|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769174|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44769175|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769176|NCT01802749|Gemcitabine|gemcitabine|mesh-list
44769177|NCT01802749|Paclitaxel|paclitaxel|mesh-list
44769178|NCT01802749|Bevacizumab|bevacizumab|mesh-list
44769179|NCT01802749|Carboplatin|carboplatin|mesh-list
44769180|NCT01802749|Doxorubicin|doxorubicin|mesh-list
44769181|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44769182|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44769183|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769184|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
44769185|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
44769186|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460432|NCT01563354|Everolimus|everolimus|mesh-list
44769187|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769188|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769189|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44769190|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44769191|NCT01802749|Growth Substances|growth substances|mesh-ancestor
44769192|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769193|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
44769194|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769195|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
44769196|NCT01802749|Antiviral Agents|antiviral agents|mesh-ancestor
44769197|NCT01802749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769198|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769199|NCT01802749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769200|NCT01802749|Immunologic Factors|immunologic factors|mesh-ancestor
44769201|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44769202|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44769203|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44769204|NCT01802814|Epratuzumab|epratuzumab|mesh-list
44769205|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769206|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769207|NCT01802892|Plerixafor|plerixafor|mesh-list
44769208|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44769209|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769210|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
44769211|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769212|NCT01802918|Ritonavir|ritonavir|mesh-list
44769213|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
44769214|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44769215|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44769216|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44769217|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769218|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769219|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44769220|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769221|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
44769222|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769223|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44769224|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44769225|NCT01802931|Ketoconazole|ketoconazole|mesh-list
44769226|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
44769227|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769228|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44769229|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44769230|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769231|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769232|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44769233|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
44769234|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769235|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769236|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44769237|NCT01802944|Insulin|insulin|mesh-list
44769238|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44769239|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769240|NCT01802970|Paclitaxel|paclitaxel|mesh-list
44769241|NCT01802970|Vinorelbine|vinorelbine|mesh-list
44769242|NCT01802970|Capecitabine|capecitabine|mesh-list
44769243|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44769244|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44769245|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769246|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44769247|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44769248|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44769249|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769250|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769251|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
44769252|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769253|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
44769254|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44769255|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
44769256|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769257|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769258|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44769259|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769260|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44769261|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44769262|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44769263|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44769264|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769265|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769266|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
44769267|NCT01803191|Fosfomycin|fosfomycin|mesh-list
44769268|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769269|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769270|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44769271|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44769272|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769273|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769274|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250065|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250066|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769275|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44769276|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44769277|NCT01803321|Rilonacept|rilonacept|mesh-list
44769278|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903451|NCT00131677|Tenofovir|tenofovir|mesh-list
44769279|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44769280|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
44769281|NCT01803347|Coagulants|coagulants|mesh-ancestor
44769282|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
44769283|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769284|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769285|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44769286|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44769287|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769288|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769289|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769290|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44769291|NCT01803503|Docetaxel|docetaxel|mesh-list
44769292|NCT01803503|Sunitinib|sunitinib|mesh-list
44769293|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769294|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
44769295|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250092|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769296|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
44769297|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769298|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44769299|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44769300|NCT01803503|Growth Substances|growth substances|mesh-ancestor
44769301|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769302|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44769303|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44769304|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769305|NCT01803659|Vitamin A|vitamin a|mesh-list
44769306|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
44769307|NCT01803659|Carotenoids|carotenoids|mesh-list
44769308|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
44769309|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769310|NCT01803659|Protective Agents|protective agents|mesh-ancestor
44769311|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769312|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44769313|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769314|NCT01803659|Vitamins|vitamins|mesh-ancestor
44769315|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
44769316|NCT01803763|Omalizumab|omalizumab|mesh-list
44769317|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44769318|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44769319|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769320|NCT01803828|Tadalafil|tadalafil|mesh-list
44769321|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
44769322|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44769323|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44769324|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769325|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769326|NCT01803828|Urological Agents|urological agents|mesh-ancestor
44769328|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769329|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769330|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
44769331|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769332|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769333|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
44769334|NCT01804205|Analgesics|analgesics|mesh-ancestor
44769335|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
44769336|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769337|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769338|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
44769339|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769340|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769341|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
44769342|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44769343|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250134|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769344|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769345|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44769346|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
44769347|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44769348|NCT01804218|Nadolol|nadolol|mesh-list
44769349|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44769350|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44250136|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
44769351|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
44769352|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769353|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769354|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769355|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769356|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44769357|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
44769358|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
44250141|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
44769359|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769360|NCT01804244|Rilpivirine|rilpivirine|mesh-list
44769361|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44769362|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769363|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769364|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769365|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
44769366|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769367|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44769368|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769369|NCT01804335|Trifarotene|trifarotene|mesh-list
44769370|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769371|NCT01804361|Cyclosporine|cyclosporine|mesh-list
44769372|NCT01804361|Cyclosporins|cyclosporins|mesh-list
44769373|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769374|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769375|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769376|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
44769377|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769378|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
44769379|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769380|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769381|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769382|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44769383|NCT01804374|Everolimus|everolimus|mesh-list
44769384|NCT01804374|Sorafenib|sorafenib|mesh-list
44769385|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769386|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769387|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
44769388|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769389|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44769390|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769391|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769392|NCT01804387|Lamivudine|lamivudine|mesh-list
44769393|NCT01804387|Adefovir|adefovir|mesh-list
44769394|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44769395|NCT01804387|Telbivudine|telbivudine|mesh-list
44769396|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44769397|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769398|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769399|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769400|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
44769401|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769402|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44250190|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44690900|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44690901|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690902|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
44690903|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
44690904|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250193|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
44690905|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690906|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
44690907|NCT01358253|Hormones|hormones|mesh-ancestor
44690908|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44690909|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44690910|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44690911|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44690912|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44690913|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690914|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44690915|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
44690916|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44690917|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44690918|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
44690919|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
44690920|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44690921|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44690922|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
44690923|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44690924|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44690925|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44690926|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44690927|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44690928|NCT01358344|Pantoprazole|pantoprazole|mesh-list
44690929|NCT01358344|Vorapaxar|vorapaxar|mesh-list
44690930|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44690931|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690932|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44690933|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690934|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690935|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44690936|NCT01358383|Naproxen|naproxen|mesh-list
44690937|NCT01358383|Esomeprazole|esomeprazole|mesh-list
44690938|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44690939|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690940|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44690941|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44690942|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690943|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690944|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690945|NCT01358383|Analgesics|analgesics|mesh-ancestor
44690946|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
44690947|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690948|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690949|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690950|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690951|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
44690952|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44690953|NCT01358396|Chrysarobin|chrysarobin|mesh-list
44690954|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44690955|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690956|NCT01358396|Analgesics|analgesics|mesh-ancestor
44690957|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
44690958|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690959|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690960|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690961|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44690962|NCT01358409|Nebivolol|nebivolol|mesh-list
44690963|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44690964|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44250248|NCT03539952|Protective Agents|protective agents|mesh-ancestor
44690965|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44690966|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44690967|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44690968|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
44690969|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250258|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44690970|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250263|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44690971|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690972|NCT01358435|Insulin|insulin|mesh-list
44769403|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769404|NCT01804400|Montelukast|montelukast|mesh-list
44769405|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44769406|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769407|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44769408|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
44769409|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769410|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769411|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44769412|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44769413|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769414|NCT01804413|Insulin|insulin|mesh-list
44769415|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44769416|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44769417|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769418|NCT01804543|Ranolazine|ranolazine|mesh-list
44769419|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769420|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769421|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769422|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
44769423|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44769424|NCT01804595|Protective Agents|protective agents|mesh-ancestor
44769425|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250284|NCT03421288|Fluorouracil|fluorouracil|mesh-list
44769426|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769427|NCT01804712|Rituximab|rituximab|mesh-list
44769428|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769429|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769430|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
44769431|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769432|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769433|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44769434|NCT01804777|Amiloride|amiloride|mesh-list
44769435|NCT01804777|Diuretics|diuretics|mesh-ancestor
44769436|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
44769437|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769438|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44769439|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769440|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769441|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769442|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44769443|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44769444|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44769445|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44769446|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
44769447|NCT01804985|Dasatinib|dasatinib|mesh-list
44250297|NCT03421288|Antidotes|antidotes|mesh-ancestor
44769448|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769449|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44769450|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769451|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769452|NCT01805115|Misoprostol|misoprostol|mesh-list
44769453|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44769454|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
44769455|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44250315|NCT03245892|Nivolumab|nivolumab|mesh-list
44769456|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690973|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44690974|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
44769457|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44769458|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769459|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
44690975|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
44690976|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
44690977|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44690978|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690979|NCT01358500|Fentanyl|fentanyl|mesh-list
44690980|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44690981|NCT01358500|Narcotics|narcotics|mesh-ancestor
44690982|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44690983|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690984|NCT01358500|Analgesics|analgesics|mesh-ancestor
44547317|NCT01370694|Prednisolone|prednisolone|mesh-list
44547318|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
44547319|NCT01370694|Vincristine|vincristine|mesh-list
44547320|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547321|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
44547334|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
44769461|NCT01805232|Quinine|quinine|mesh-list
44769462|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
44769463|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44769464|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44769465|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769466|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769467|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
44769468|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
44769469|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44769470|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
44769471|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44769472|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769473|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44769474|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769475|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44769476|NCT01805232|Analgesics|analgesics|mesh-ancestor
44769477|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
44769478|NCT01805258|Efavirenz|efavirenz|mesh-list
44769479|NCT01805258|Nevirapine|nevirapine|mesh-list
44769480|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44769481|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769482|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769483|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769484|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
44769485|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769486|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44769487|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44769488|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44769489|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44769490|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44769491|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44769492|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44769493|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769494|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
44769495|NCT01805310|Cathartics|cathartics|mesh-ancestor
44769496|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769497|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44769498|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769499|NCT01807741|Asenapine|asenapine|mesh-list
44769500|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44769501|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44769502|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769503|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769504|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769505|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
44769506|NCT01807767|Everolimus|everolimus|mesh-list
44769507|NCT01807767|Tacrolimus|tacrolimus|mesh-list
44769508|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769509|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
44769510|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769511|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44769512|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769513|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250335|NCT03007329|Hormones|hormones|mesh-ancestor
44250339|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769514|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769515|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44769516|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44769517|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
44769518|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769519|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769520|NCT01807832|Capsaicin|capsaicin|mesh-list
44769521|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
44769522|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44250343|NCT02973542|Ethosuximide|ethosuximide|mesh-list
44769523|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
44769524|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769525|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769526|NCT01807910|Choline|choline|mesh-list
44769527|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
44769528|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44769529|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
44769530|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769531|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769532|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44769533|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
44769534|NCT01807962|Lidocaine|lidocaine|mesh-list
44769535|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
44769536|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
44250360|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769537|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769538|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769539|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
44769540|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769541|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769542|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44769543|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769544|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250361|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250362|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769545|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769547|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44769548|NCT01808014|Analgesics|analgesics|mesh-ancestor
44769549|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
44769550|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250371|NCT02437279|Nivolumab|nivolumab|mesh-list
44769551|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769552|NCT01808131|Lesinurad|lesinurad|mesh-list
44769553|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
44769554|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769555|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
44769556|NCT01808131|Renal Agents|renal agents|mesh-ancestor
44769557|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
44769558|NCT01808300|Pregabalin|pregabalin|mesh-list
44769559|NCT01808300|Analgesics|analgesics|mesh-ancestor
44769560|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
44769561|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769562|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769563|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
44769564|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44769565|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769566|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769567|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44769568|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44769569|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44769570|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769571|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769572|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
44769573|NCT01808300|Protective Agents|protective agents|mesh-ancestor
44769574|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
44769575|NCT01808300|Vitamins|vitamins|mesh-ancestor
44769576|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
44769577|NCT01808469|Antibodies|antibodies|mesh-list
44769578|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44769579|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
44769580|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769581|NCT01808495|Mitomycins|mitomycins|mesh-list
44769582|NCT01808495|Mitomycin|mitomycin|mesh-list
44769583|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44769584|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769585|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
44769586|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769587|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769588|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769589|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
44769590|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44769591|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
44769592|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769593|NCT01808521|Expectorants|expectorants|mesh-ancestor
44769594|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769595|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44769596|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
44769597|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769598|NCT01808521|Protective Agents|protective agents|mesh-ancestor
44769599|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769600|NCT01808521|Antidotes|antidotes|mesh-ancestor
44769601|NCT01808586|Dexamethasone|dexamethasone|mesh-list
44769602|NCT01808586|Betamethasone|betamethasone|mesh-list
44769603|NCT01808586|Lidocaine|lidocaine|mesh-list
44769604|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769605|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
44769606|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
44769607|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765521|NCT02412813|Cobalt|cobalt|mesh-list
44769608|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769609|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769610|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
44769611|NCT01808586|Hormones|hormones|mesh-ancestor
44769612|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250432|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769613|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44769614|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769615|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44769616|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
44769617|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769618|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
44769619|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769620|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44769621|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769622|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769623|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769624|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44769625|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44769626|NCT01808638|Gemcitabine|gemcitabine|mesh-list
44769627|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769628|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
44769629|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769630|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769631|NCT01808638|Antiviral Agents|antiviral agents|mesh-ancestor
44769632|NCT01808638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769633|NCT01808638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769634|NCT01808638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769635|NCT01808638|Immunologic Factors|immunologic factors|mesh-ancestor
44769636|NCT01808638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769637|NCT01808768|Alcaftadine|alcaftadine|mesh-list
44769638|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44769639|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
44769640|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
44769641|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769642|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769643|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769644|NCT01808898|Bupivacaine|bupivacaine|mesh-list
44769645|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
44769646|NCT01808898|Mepivacaine|mepivacaine|mesh-list
44769647|NCT01808898|Anesthetics|anesthetics|mesh-list
44769648|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769649|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769650|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
44769651|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769652|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
44769653|NCT01808911|Rituximab|rituximab|mesh-list
44250467|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769654|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769655|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
44769656|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250473|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
44769657|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769658|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44769659|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
44769660|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769661|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769662|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44769663|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769664|NCT01809041|Remifentanil|remifentanil|mesh-list
44769665|NCT01809041|Propofol|propofol|mesh-list
44769666|NCT01809041|Sevoflurane|sevoflurane|mesh-list
44769667|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44769668|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769669|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769670|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44769671|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
44769672|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
44769673|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44769674|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44769675|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44769676|NCT01809041|Narcotics|narcotics|mesh-ancestor
44769677|NCT01809041|Analgesics|analgesics|mesh-ancestor
44769678|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
44769679|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769680|NCT01809158|Minocycline|minocycline|mesh-list
44769681|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769682|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769683|NCT01809171|Vitamin D|vitamin d|mesh-list
44769684|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
44769685|NCT01809171|Vitamins|vitamins|mesh-ancestor
44769686|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
44769687|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769688|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44769689|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44769690|NCT01809184|Insulin|insulin|mesh-list
44769691|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44769692|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
44769693|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44769694|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769695|NCT01809301|Niacin|niacin|mesh-list
44769696|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
44769697|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44769698|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
44769699|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769700|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44769701|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44769702|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
44769703|NCT01809301|Vitamins|vitamins|mesh-ancestor
44769704|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
44769705|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769706|NCT01809340|Minocycline|minocycline|mesh-list
44769707|NCT01809340|Ketamine|ketamine|mesh-list
44769708|NCT01809340|Analgesics|analgesics|mesh-ancestor
44769709|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
44769710|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769711|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769712|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44769713|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44769714|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
44769715|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
44769716|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769717|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44250524|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44250526|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
44769718|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44769719|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769720|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769721|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769722|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769723|NCT01809392|Decitabine|decitabine|mesh-list
44037207|NCT00002462|Vincristine|vincristine|mesh-list
44769724|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769725|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
44769726|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769727|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769728|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769729|NCT01809444|Doxycycline|doxycycline|mesh-list
44769730|NCT01809444|Prednisone|prednisone|mesh-list
44769731|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769732|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
44769733|NCT01809444|Hormones|hormones|mesh-ancestor
44769734|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769735|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769736|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44769737|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769738|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769739|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769740|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
44769741|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44769742|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44769743|NCT01809626|Zolpidem|zolpidem|mesh-list
44769744|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44769745|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44769746|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769747|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769748|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44769749|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
44769750|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
44769751|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769752|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769753|NCT01809743|Adenosine|adenosine|mesh-list
44769754|NCT01809743|Regadenoson|regadenoson|mesh-list
44769755|NCT01809743|Analgesics|analgesics|mesh-ancestor
44769756|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
44769757|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769758|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769759|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769760|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
44769761|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44769762|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
44769763|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
44769764|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769765|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769766|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44769767|NCT01809847|Ofatumumab|ofatumumab|mesh-list
44769768|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769769|NCT01809860|Sirolimus|sirolimus|mesh-list
44769770|NCT01809860|Isavuconazole|isavuconazole|mesh-list
44250546|NCT05332314|Ibuprofen|ibuprofen|mesh-list
44769771|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769772|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769773|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44769774|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769775|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
44769776|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769777|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
44769778|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547750|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250593|NCT05332028|Narcotics|narcotics|mesh-ancestor
44547751|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
44547752|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
44547753|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547754|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547755|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547757|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547758|NCT01364649|Vortioxetine|vortioxetine|mesh-list
44547759|NCT01364649|Citalopram|citalopram|mesh-list
44547760|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44547761|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44547762|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547763|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460501|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
44547764|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547765|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
44547766|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547767|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44547768|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
44547777|NCT01364597|Brivaracetam|brivaracetam|mesh-list
44769779|NCT01809886|Neostigmine|neostigmine|mesh-list
44769780|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44769781|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460504|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
44769782|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769783|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44769784|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769785|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769786|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44769787|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
44769788|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769789|NCT01809925|Psyllium|psyllium|mesh-list
44769790|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
44769791|NCT01809925|Cathartics|cathartics|mesh-ancestor
44769792|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769793|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
44769794|NCT01810185|Naltrexone|naltrexone|mesh-list
44769795|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44769796|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44769797|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769798|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
44769799|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769800|NCT01810237|Dabigatran|dabigatran|mesh-list
44769801|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
44769802|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44769803|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
44769804|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769805|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769806|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
44769807|NCT01810315|Estradiol|estradiol|mesh-list
44769808|NCT01810315|Estrogens|estrogens|mesh-ancestor
44769809|NCT01810315|Hormones|hormones|mesh-ancestor
44769810|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769811|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769812|NCT01810354|Cefazolin|cefazolin|mesh-list
44769813|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44769814|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769815|NCT01810367|Gemcitabine|gemcitabine|mesh-list
44769816|NCT01810367|Cisplatin|cisplatin|mesh-list
44769817|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769818|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769819|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
44769820|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769821|NCT01810367|Antiviral Agents|antiviral agents|mesh-ancestor
44769822|NCT01810367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769823|NCT01810367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769824|NCT01810367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769825|NCT01810367|Immunologic Factors|immunologic factors|mesh-ancestor
44769826|NCT01810367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769827|NCT01810393|Trastuzumab|trastuzumab|mesh-list
44769828|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769829|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769830|NCT01810458|Acetaminophen|acetaminophen|mesh-list
44769831|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44769832|NCT01810458|Lidocaine|lidocaine|mesh-list
44769833|NCT01810458|Fentanyl|fentanyl|mesh-list
44769834|NCT01810458|Midazolam|midazolam|mesh-list
44769835|NCT01810458|Oxycodone|oxycodone|mesh-list
44769836|NCT01810458|Lorazepam|lorazepam|mesh-list
44769837|NCT01810458|Ondansetron|ondansetron|mesh-list
44769838|NCT01810458|Liver Extracts|liver extracts|mesh-list
44769839|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
44769840|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
44769841|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769842|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769843|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
44769844|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769845|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44769846|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44769847|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769848|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769849|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250669|NCT05242874|Hormones|hormones|mesh-ancestor
44769850|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44769851|NCT01810458|Narcotics|narcotics|mesh-ancestor
44769852|NCT01810458|Analgesics|analgesics|mesh-ancestor
44769853|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44547797|NCT01364428|Insulin|insulin|mesh-list
44769854|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44769855|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
44769856|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44769857|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44769858|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44769859|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769860|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
44769861|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
44769862|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44769863|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44769864|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
44769865|NCT01810458|Hematinics|hematinics|mesh-ancestor
44769866|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
44769867|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
44769868|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44769869|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
44769870|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769871|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44769872|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
44769873|NCT01810458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44769874|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
44769875|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44769876|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769877|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769878|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44769879|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769880|NCT01810601|Progesterone|progesterone|mesh-list
44769881|NCT01810601|Progestins|progestins|mesh-ancestor
44769882|NCT01810601|Hormones|hormones|mesh-ancestor
44769883|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769884|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769885|NCT01810640|Liver Extracts|liver extracts|mesh-list
44769886|NCT01810640|Hematinics|hematinics|mesh-ancestor
44769887|NCT01810731|Vaccines|vaccines|mesh-list
44250709|NCT04986605|Methoxsalen|methoxsalen|mesh-list
44769888|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
44769889|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769890|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44769891|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769892|NCT01810796|Ranolazine|ranolazine|mesh-list
44769893|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44769894|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769895|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769896|NCT01810809|Hylan|hylan|mesh-list
44769897|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
44769898|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
44769899|NCT01810809|Protective Agents|protective agents|mesh-ancestor
44769900|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769901|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44769902|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
44769903|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
44769904|NCT01810848|Hylan|hylan|mesh-list
44769905|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44769906|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
44769907|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769908|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
44690985|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
44690986|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44690987|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44690988|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44690989|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
44690990|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
44690991|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
44690992|NCT01358591|Calcium|calcium|mesh-list
44690993|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44690994|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44690995|NCT01358591|Antacids|antacids|mesh-ancestor
44690996|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44690997|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44690998|NCT01358812|Panitumumab|panitumumab|mesh-list
44690999|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691000|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691001|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44691002|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691003|NCT01359020|Acetaminophen|acetaminophen|mesh-list
44769909|NCT01810848|Protective Agents|protective agents|mesh-ancestor
44691004|NCT01359020|Dipyrone|dipyrone|mesh-list
44769910|NCT01810887|Ritonavir|ritonavir|mesh-list
44769911|NCT01810887|Darunavir|darunavir|mesh-list
44769912|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44769913|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44769914|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
44769915|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769916|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769917|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44769918|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44769919|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
44769920|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769921|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44769922|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44769923|NCT01810926|Cyclosporine|cyclosporine|mesh-list
44769924|NCT01810926|Rituximab|rituximab|mesh-list
44769925|NCT01810926|Methotrexate|methotrexate|mesh-list
44769926|NCT01810926|Fludarabine|fludarabine|mesh-list
44769927|NCT01810926|Thiotepa|thiotepa|mesh-list
44250748|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769928|NCT01810926|Treosulfan|treosulfan|mesh-list
44769929|NCT01810926|Antibodies|antibodies|mesh-list
44769930|NCT01810926|Cyclosporins|cyclosporins|mesh-list
44769931|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
44250764|NCT04286529|Calcitriol|calcitriol|mesh-list
44769932|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769933|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44769934|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769935|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44769936|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44769937|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
44769938|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44769939|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44769940|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
44769941|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769942|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
44769943|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44769944|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44769945|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44769946|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44769947|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
44769948|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44769949|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44769950|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44769951|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
44769952|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44769953|NCT01811056|Mifepristone|mifepristone|mesh-list
44769954|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44769955|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
44769956|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44769957|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769958|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44769959|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44460517|NCT01561989|Vitamin D|vitamin d|mesh-list
44769960|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44769961|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
44769962|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44769963|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44769964|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
44769965|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769966|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
44460536|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
44769967|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44769968|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44769969|NCT01811160|Melatonin|melatonin|mesh-list
44769970|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
44769971|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769972|NCT01811160|Protective Agents|protective agents|mesh-ancestor
44769973|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769974|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769975|NCT01811251|Dexamethasone|dexamethasone|mesh-list
44769976|NCT01811251|Pregabalin|pregabalin|mesh-list
44769977|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769978|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
44769979|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
44769980|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44769981|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44769982|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547918|NCT01362608|Triamcinolone|triamcinolone|mesh-list
44547919|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44547920|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44547921|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44547922|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372708|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44547923|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
44547924|NCT01362608|Hormones|hormones|mesh-ancestor
44769983|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
44769984|NCT01811251|Hormones|hormones|mesh-ancestor
44769985|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44769986|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44769987|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44769988|NCT01811251|Analgesics|analgesics|mesh-ancestor
44769989|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
44769990|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
44769991|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44769992|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44769993|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44769994|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44769995|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44769996|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460555|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44769997|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44769998|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44769999|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
44038700|NCT00002555|Cisplatin|cisplatin|mesh-list
44770000|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770001|NCT01811381|Curcumin|curcumin|mesh-list
44770002|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44770003|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770004|NCT01811381|Analgesics|analgesics|mesh-ancestor
44770005|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
44770006|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770007|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770008|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770009|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770010|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770011|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774306|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770012|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770013|NCT01811459|Haloperidol|haloperidol|mesh-list
44770014|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44770015|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
44770016|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
44770017|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770018|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44770019|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44770020|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44038945|NCT00002571|Hormones|hormones|mesh-ancestor
44770021|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770022|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
44770023|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
44770024|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770025|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770026|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44770027|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
44770028|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770029|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770030|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44770031|NCT01811615|Ethanol|ethanol|mesh-list
44770032|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44770033|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770034|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770035|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770036|NCT01811667|Sirolimus|sirolimus|mesh-list
44770037|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770038|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770039|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44770040|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770041|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
44770042|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770043|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
44770044|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547931|NCT01362530|Ondansetron|ondansetron|mesh-list
44770045|NCT01811810|Androgens|androgens|mesh-list
44250799|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770046|NCT01811810|Hormones|hormones|mesh-ancestor
44770047|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770048|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770050|NCT01811836|Trace Elements|trace elements|mesh-ancestor
44770051|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
44250825|NCT03936192|Meloxicam|meloxicam|mesh-list
44770052|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770053|NCT01811849|Insulin|insulin|mesh-list
44770054|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44770055|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
44770056|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44770057|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770058|NCT01812018|Gemcitabine|gemcitabine|mesh-list
44770059|NCT01812018|Docetaxel|docetaxel|mesh-list
44770060|NCT01812018|Endostar protein|endostar protein|mesh-list
44770061|NCT01812018|Endostatins|endostatins|mesh-list
44770062|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770063|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
44770064|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770065|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770066|NCT01812018|Antiviral Agents|antiviral agents|mesh-ancestor
44770067|NCT01812018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770068|NCT01812018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770069|NCT01812018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770070|NCT01812018|Immunologic Factors|immunologic factors|mesh-ancestor
44770071|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770072|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44250833|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770073|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770074|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770075|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44770076|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44770077|NCT01812018|Growth Substances|growth substances|mesh-ancestor
44770078|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44770079|NCT01812096|Bortezomib|bortezomib|mesh-list
44770080|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770081|NCT01812122|Glimepiride|glimepiride|mesh-list
44770082|NCT01812122|Vildagliptin|vildagliptin|mesh-list
44770083|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44770084|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44770085|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770086|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770087|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
44770088|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44770089|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
44770090|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770091|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770092|NCT01812135|Vaccines|vaccines|mesh-list
44770093|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
44770094|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770095|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
44770096|NCT01812200|Dabigatran|dabigatran|mesh-list
44250869|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770097|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
44770098|NCT01812200|Ticagrelor|ticagrelor|mesh-list
44770099|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44770100|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44770101|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44770102|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44770103|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
44770104|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770105|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770106|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770107|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44770108|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
44770109|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44770110|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
44770111|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770112|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
44770113|NCT01812239|Progesterone|progesterone|mesh-list
44770114|NCT01812239|Progestins|progestins|mesh-list
44770115|NCT01812239|Hormones|hormones|mesh-ancestor
44770116|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770117|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548001|NCT01361308|Paroxetine|paroxetine|mesh-list
44770118|NCT01812330|Clopidogrel|clopidogrel|mesh-list
44770119|NCT01812330|Ticagrelor|ticagrelor|mesh-list
44770120|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44770121|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44770122|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44770123|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44770124|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
44770125|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774307|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770126|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770127|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770128|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
44548073|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
44770129|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44770130|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
44770131|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
44770132|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770133|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770134|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770135|NCT01812356|Analgesics|analgesics|mesh-ancestor
44770136|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
44770137|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770138|NCT01812369|Gemcitabine|gemcitabine|mesh-list
44770139|NCT01812369|Doxorubicin|doxorubicin|mesh-list
44770140|NCT01812369|Vinblastine|vinblastine|mesh-list
44770141|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770142|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
44770143|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770144|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770145|NCT01812369|Antiviral Agents|antiviral agents|mesh-ancestor
44250907|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770146|NCT01812369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770147|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770148|NCT01812369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770149|NCT01812369|Immunologic Factors|immunologic factors|mesh-ancestor
44770150|NCT01812369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770151|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44770152|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44770153|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44770154|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770155|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44770156|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770157|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770158|NCT01812382|Retapamulin|retapamulin|mesh-list
44770159|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770160|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770161|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
44770162|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44250918|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44770163|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44770164|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44770165|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770166|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770167|NCT01812434|Urological Agents|urological agents|mesh-ancestor
44770168|NCT01812538|Diclofenac|diclofenac|mesh-list
44250935|NCT03561376|Petrolatum|petrolatum|mesh-list
44770169|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44770170|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770171|NCT01812538|Analgesics|analgesics|mesh-ancestor
44770172|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
44770173|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770174|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770175|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770176|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770177|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44770178|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770179|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770180|NCT01812551|Alendronate|alendronate|mesh-list
44770181|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44770182|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770183|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
44770184|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44548074|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
44548075|NCT01360021|Hormones|hormones|mesh-ancestor
44548076|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548077|NCT01359956|Interferons|interferons|mesh-list
44548078|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
44548079|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
44548080|NCT01359956|Dacarbazine|dacarbazine|mesh-list
44548081|NCT01359956|Fotemustine|fotemustine|mesh-list
44548082|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548083|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
44770185|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44770186|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
44770187|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770188|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770189|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770190|NCT01812720|Dexamethasone|dexamethasone|mesh-list
44770191|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770192|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
44770193|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
44770194|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770195|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770196|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770197|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
44770198|NCT01812720|Hormones|hormones|mesh-ancestor
44770199|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770200|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44770201|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770202|NCT01812889|TOL-463|tol-463|mesh-list
44770203|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770204|NCT01812928|Diclofenac|diclofenac|mesh-list
44770205|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44770206|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44770207|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770208|NCT01812928|Analgesics|analgesics|mesh-ancestor
44770209|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
44770210|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770211|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770212|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770213|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44770214|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770215|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770216|NCT01812954|Cyclosporine|cyclosporine|mesh-list
44770217|NCT01812954|Adalimumab|adalimumab|mesh-list
44770218|NCT01812954|Etanercept|etanercept|mesh-list
44770219|NCT01812954|Methotrexate|methotrexate|mesh-list
44770220|NCT01812954|Infliximab|infliximab|mesh-list
44770221|NCT01812954|Ustekinumab|ustekinumab|mesh-list
44770222|NCT01812954|Acitretin|acitretin|mesh-list
44770223|NCT01812954|Cyclosporins|cyclosporins|mesh-list
44770224|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44770225|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
44770226|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44770227|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770228|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770229|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
44770230|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770231|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770232|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44770233|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770234|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44770235|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770236|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
44770237|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770238|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44770239|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
44770240|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770241|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44770242|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770243|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770244|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44770245|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770246|NCT01812954|Analgesics|analgesics|mesh-ancestor
44770247|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
44770248|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770249|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
44770250|NCT01812967|Caseins|caseins|mesh-list
44770251|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
44770252|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
44770253|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770254|NCT01813162|Tenofovir|tenofovir|mesh-list
44770255|NCT01813162|Metronidazole|metronidazole|mesh-list
44770256|NCT01813162|Terconazole|terconazole|mesh-list
44770257|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
44770258|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
44770259|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770260|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44770261|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44770262|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770263|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770264|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44770265|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44770266|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770267|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44770268|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44770269|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44770270|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770271|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
44770272|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
44770273|NCT01813201|Testosterone|testosterone|mesh-list
44770274|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
44770275|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
44770276|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44770277|NCT01813201|Androgens|androgens|mesh-ancestor
44770278|NCT01813201|Hormones|hormones|mesh-ancestor
44770279|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770280|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770281|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44770282|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770283|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
44770284|NCT01813240|Minocycline|minocycline|mesh-list
44770285|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770286|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770287|NCT01813253|Irinotecan|irinotecan|mesh-list
44770288|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
44770289|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44770290|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44770291|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770292|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770293|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770294|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44770295|NCT01813318|Acamprosate|acamprosate|mesh-list
44770296|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44770297|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
44770298|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770299|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770300|NCT01813461|Isavuconazole|isavuconazole|mesh-list
44770301|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
44770302|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770303|NCT01813487|Entecavir|entecavir|mesh-list
44770304|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
44770305|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770306|NCT01813513|Simeprevir|simeprevir|mesh-list
44770307|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
44770308|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770309|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
44770310|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770311|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770312|NCT01813552|Ritonavir|ritonavir|mesh-list
44770313|NCT01813552|Omeprazole|omeprazole|mesh-list
44770314|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44770315|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44770316|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44770317|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770318|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770319|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44770320|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44770321|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
44770322|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770323|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44770324|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44770325|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44770326|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770327|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44770328|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
44770329|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44770330|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
44770331|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770332|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
44770333|NCT01813565|Protective Agents|protective agents|mesh-ancestor
44770334|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44770335|NCT01813591|Hormones|hormones|mesh-ancestor
44770336|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770337|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770338|NCT01813604|Vaccines|vaccines|mesh-list
44770339|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
44770340|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770341|NCT01813617|Prednisone|prednisone|mesh-list
44770342|NCT01813617|Methotrexate|methotrexate|mesh-list
44770343|NCT01813617|Azathioprine|azathioprine|mesh-list
44770344|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44770345|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770346|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
44770347|NCT01813617|Hormones|hormones|mesh-ancestor
44770348|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770349|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770350|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44770351|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770352|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44770353|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
44770354|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44460603|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770355|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770356|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
44770357|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770358|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44770359|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770360|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44770361|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
44770362|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770363|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44770364|NCT01813643|Risperidone|risperidone|mesh-list
44770365|NCT01813643|Aripiprazole|aripiprazole|mesh-list
44770366|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44770367|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
44770368|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770369|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770370|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770371|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44770372|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44770373|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770374|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770375|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44770376|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
44770377|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
44770378|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
44770379|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44770380|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44770381|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44770382|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44770383|NCT01813656|Aripiprazole|aripiprazole|mesh-list
44770384|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
44770385|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770386|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44770387|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44770388|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770389|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770390|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
44770391|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
44770392|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770393|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770394|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44770395|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44770396|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
44770397|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44040535|NCT00002700|Hormones|hormones|mesh-ancestor
44770398|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44770399|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44770400|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44770401|NCT01813773|Aflibercept|aflibercept|mesh-list
44770402|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44770403|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44770404|NCT01813773|Growth Substances|growth substances|mesh-ancestor
44770405|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770406|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
44770407|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770408|NCT01813812|Rebamipide|rebamipide|mesh-list
44770409|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44770410|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770411|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
44770412|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770413|NCT01813812|Protective Agents|protective agents|mesh-ancestor
44770414|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770415|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770416|NCT01813955|Papaverine|papaverine|mesh-list
44770417|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44770418|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770419|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770420|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
44770421|NCT01813955|Urological Agents|urological agents|mesh-ancestor
44770422|NCT01813981|Caffeine|caffeine|mesh-list
44770423|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44770424|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770425|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44770426|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251153|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
44770427|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770428|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43605844|NCT03224208|Vemurafenib|vemurafenib|mesh-list
44770429|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44770430|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
44770431|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770432|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44770433|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44770434|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44770435|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
44770436|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770437|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770438|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44770439|NCT01814059|Sirolimus|sirolimus|mesh-list
44770440|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770441|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770442|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44770443|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770444|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
44770445|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770446|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
44770447|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770448|NCT01814085|Citalopram|citalopram|mesh-list
44770449|NCT01814085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44770450|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44770451|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44770452|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770453|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770454|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
44770455|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770456|NCT01814085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44770457|NCT01814085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44770458|NCT01814085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770459|NCT01814098|Citalopram|citalopram|mesh-list
44770460|NCT01814098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44770461|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44770462|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44770463|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770464|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770465|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
44548317|NCT01356407|Cathartics|cathartics|mesh-ancestor
44548318|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44548319|NCT01355575|Rifaximin|rifaximin|mesh-list
44548320|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548321|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548322|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44548323|NCT01355523|Melatonin|melatonin|mesh-list
44548324|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
44548325|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770466|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770467|NCT01814098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44770468|NCT01814098|Antidepressive Agents|antidepressive agents|mesh-ancestor
44770469|NCT01814098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770470|NCT01814163|Paclitaxel|paclitaxel|mesh-list
44770471|NCT01814163|Bevacizumab|bevacizumab|mesh-list
44770472|NCT01814163|Carboplatin|carboplatin|mesh-list
44770473|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770474|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770475|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44770476|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460645|NCT01559935|Clarithromycin|clarithromycin|mesh-list
44460648|NCT01559935|Lenalidomide|lenalidomide|mesh-list
44770477|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770478|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770479|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44770480|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44770481|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44770482|NCT01814163|Growth Substances|growth substances|mesh-ancestor
44770483|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770484|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44770485|NCT01814189|Promethazine|promethazine|mesh-list
44770486|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
44770487|NCT01814189|Sumatriptan|sumatriptan|mesh-list
44770488|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44770489|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44770490|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44770491|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
44770492|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770493|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770494|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770495|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
44770496|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44770497|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44770498|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
44770499|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
44770500|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44770501|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44770502|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44770503|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770504|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
44770505|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
44770506|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
44770507|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770508|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
44770509|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
44770510|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770511|NCT01814319|Probenecid|probenecid|mesh-list
44770512|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
44770513|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
44770514|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770515|NCT01814319|Renal Agents|renal agents|mesh-ancestor
44770516|NCT01814410|Ethanol|ethanol|mesh-list
44770517|NCT01814410|Nicotine|nicotine|mesh-list
44770518|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44770519|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
44770520|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770521|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770522|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44770523|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44770524|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
44770525|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770526|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770527|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44770528|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770529|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770530|NCT01814423|Chloroquine|chloroquine|mesh-list
44770531|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44770532|NCT01814423|Amebicides|amebicides|mesh-ancestor
44770533|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44770534|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44770535|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548389|NCT01354431|Nivolumab|nivolumab|mesh-list
44770536|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
44770537|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770538|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44770539|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770540|NCT01814423|Analgesics|analgesics|mesh-ancestor
44770541|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
44770542|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770543|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770544|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770545|NCT01814423|Filaricides|filaricides|mesh-ancestor
44770546|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
44770547|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
44770548|NCT01814449|Letrozole|letrozole|mesh-list
44770549|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770550|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44770551|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44770552|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770553|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770554|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44770555|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
44770556|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770557|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770558|NCT01814475|Vidarabine|vidarabine|mesh-list
44770559|NCT01814475|Fludarabine|fludarabine|mesh-list
44770560|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
44770561|NCT01814475|Busulfan|busulfan|mesh-list
44770562|NCT01814475|Thiotepa|thiotepa|mesh-list
44770563|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770564|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770565|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
44770566|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770567|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770568|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
44770569|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770570|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
44770571|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770572|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
44770573|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44770574|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44770575|NCT01814501|Leucovorin|leucovorin|mesh-list
44770576|NCT01814501|Fluorouracil|fluorouracil|mesh-list
44770577|NCT01814501|Irinotecan|irinotecan|mesh-list
44770578|NCT01814501|Panitumumab|panitumumab|mesh-list
44770579|NCT01814501|Calcium|calcium|mesh-list
44770580|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
44770581|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44770582|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770583|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
44770584|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691005|NCT01359020|Ibuprofen|ibuprofen|mesh-list
44691006|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691007|NCT01359020|Analgesics|analgesics|mesh-ancestor
44691008|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
44691009|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691010|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691011|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
44691012|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691013|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691014|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691015|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691016|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774308|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44691017|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691018|NCT01359059|Pregabalin|pregabalin|mesh-list
44691019|NCT01359059|Analgesics|analgesics|mesh-ancestor
44691020|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
44691021|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691022|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691023|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
44691024|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44691025|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691026|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691027|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691028|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44691029|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44691030|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691031|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691032|NCT01359085|Pregabalin|pregabalin|mesh-list
44691033|NCT01359085|Analgesics|analgesics|mesh-ancestor
44691034|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
44691035|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770585|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770586|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770587|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770588|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
44770589|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44770590|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44770591|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770592|NCT01814501|Antidotes|antidotes|mesh-ancestor
44770593|NCT01814501|Protective Agents|protective agents|mesh-ancestor
44770594|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44770595|NCT01814501|Vitamins|vitamins|mesh-ancestor
44770596|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
44770597|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44770598|NCT01814514|Timolol|timolol|mesh-list
44770599|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44770600|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44770601|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
44770602|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770603|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770604|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770605|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44770606|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44770607|NCT01814618|Budesonide|budesonide|mesh-list
44770608|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770609|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44770610|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
44770611|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770612|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770613|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44770614|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
44770615|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
44770616|NCT01814618|Hormones|hormones|mesh-ancestor
44251301|NCT05323708|Denosumab|denosumab|mesh-list
44770617|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770618|NCT01814683|Primaquine|primaquine|mesh-list
44770619|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
44770620|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44770621|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44770622|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770623|NCT01814709|Itraconazole|itraconazole|mesh-list
44770624|NCT01814709|Rifampin|rifampin|mesh-list
44770625|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
44770626|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770627|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44770628|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44770629|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770630|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251348|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
44770631|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44770632|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44770633|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770634|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770635|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44770636|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44770637|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
44770638|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770639|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
44770640|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44770641|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44770642|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44770643|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44770644|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44770645|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44770646|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44770647|NCT01814826|Azacitidine|azacitidine|mesh-list
44770648|NCT01814826|Pevonedistat|pevonedistat|mesh-list
44770649|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770650|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
44770651|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251362|NCT05243940|Lidocaine|lidocaine|mesh-list
44770652|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770653|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770654|NCT01814865|Prednisone|prednisone|mesh-list
44770655|NCT01814865|Anastrozole|anastrozole|mesh-list
44770656|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
44770657|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44770658|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770659|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
44770660|NCT01814865|Hormones|hormones|mesh-ancestor
44548496|NCT01352741|Pregabalin|pregabalin|mesh-list
44770661|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770662|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770663|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041672|NCT00002786|Aldesleukin|aldesleukin|mesh-list
44770664|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770665|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44770666|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770667|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770668|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44770669|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
44770670|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44770671|NCT01814891|Vitamin A|vitamin a|mesh-list
44770672|NCT01814891|Vitamins|vitamins|mesh-ancestor
44770673|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
44770674|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770675|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
44770676|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770677|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
44770678|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44770679|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770680|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
44770681|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
44770682|NCT01815021|Calcium|calcium|mesh-list
44770683|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44770684|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770685|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44770686|NCT01815021|Antacids|antacids|mesh-ancestor
44770687|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770688|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770689|NCT01815047|Vitamin D|vitamin d|mesh-list
44770690|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
44770691|NCT01815047|Vitamins|vitamins|mesh-ancestor
44770692|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
44770693|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770694|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44770695|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44460687|NCT01559675|Prednisolone|prednisolone|mesh-list
44770696|NCT01815073|Vaccines|vaccines|mesh-list
44770697|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
44770698|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770699|NCT01815125|Ondansetron|ondansetron|mesh-list
44770700|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
44770701|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
44770702|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770703|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770704|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770705|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
44770706|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
44770707|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44770708|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
44770709|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770710|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770711|NCT01815125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44770712|NCT01815125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44770713|NCT01815125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770714|NCT01815125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44770715|NCT01815125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44770716|NCT01815203|Caffeine|caffeine|mesh-list
44770717|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44770718|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770719|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44770720|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770721|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770722|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44770723|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44770724|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
44770725|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44042032|NCT00002805|Cytarabine|cytarabine|mesh-list
44770726|NCT01815242|Gemcitabine|gemcitabine|mesh-list
44770727|NCT01815242|Paclitaxel|paclitaxel|mesh-list
44770728|NCT01815242|Carboplatin|carboplatin|mesh-list
44770729|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770730|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770731|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44770732|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770733|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770734|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251431|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
44770735|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770736|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
44770737|NCT01815242|Antiviral Agents|antiviral agents|mesh-ancestor
44770738|NCT01815242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770739|NCT01815242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770740|NCT01815242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770741|NCT01815242|Immunologic Factors|immunologic factors|mesh-ancestor
44770742|NCT01815242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770744|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
44770745|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770746|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44770747|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44770748|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770749|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770750|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44770751|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44770752|NCT01815268|Vaccines|vaccines|mesh-list
44770753|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
44770754|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770755|NCT01815294|Doxorubicin|doxorubicin|mesh-list
44770756|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44770757|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44770758|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770759|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44770760|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44770761|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770762|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548645|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44548646|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44548647|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
44548648|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548649|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44548650|NCT01350128|Bromides|bromides|mesh-list
44548651|NCT01350128|Ipratropium|ipratropium|mesh-list
44548652|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
44548653|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44548654|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
44548655|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548656|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548657|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44548658|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
44770763|NCT01815307|Gemcitabine|gemcitabine|mesh-list
44770764|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44770765|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
44770766|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770767|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770768|NCT01815307|Antiviral Agents|antiviral agents|mesh-ancestor
44770769|NCT01815307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770770|NCT01815307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770771|NCT01815307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770772|NCT01815307|Immunologic Factors|immunologic factors|mesh-ancestor
44770773|NCT01815307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770774|NCT01815437|Vitamin D|vitamin d|mesh-list
44770775|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
44770776|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
44770777|NCT01815437|Vitamins|vitamins|mesh-list
44770778|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
44770779|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770780|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44774309|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
44770781|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44770782|NCT01815528|Catumaxomab|catumaxomab|mesh-list
44770783|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770784|NCT01815541|Teicoplanin|teicoplanin|mesh-list
44770785|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44770786|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770787|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
44770788|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44770789|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770790|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44770791|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
44770792|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770793|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
44770794|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770795|NCT01815892|Furosemide|furosemide|mesh-list
44770796|NCT01815892|Diuretics|diuretics|mesh-ancestor
44770797|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
44770798|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770799|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44770800|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44770801|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770802|NCT01815944|Ropivacaine|ropivacaine|mesh-list
44770803|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
44770804|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
44770805|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770806|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770807|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
44770808|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770809|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44770810|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770811|NCT01816035|Trastuzumab|trastuzumab|mesh-list
44770812|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44770813|NCT01816035|Maytansine|maytansine|mesh-list
44770814|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
44770815|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44770816|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770817|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770818|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44770819|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770820|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770821|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770822|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
44770823|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770824|NCT01816191|Diltiazem|diltiazem|mesh-list
44770825|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44770826|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44770827|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251492|NCT05104554|Folic Acid|folic acid|mesh-list
44770828|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770829|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44770830|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770831|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44770832|NCT01816321|Ganirelix|ganirelix|mesh-list
44770833|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44770834|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770835|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770836|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
44770837|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44770838|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44770839|NCT01816334|Prednisolone|prednisolone|mesh-list
44770840|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
44770841|NCT01816334|Ketoprofen|ketoprofen|mesh-list
44770842|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44770843|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
44770844|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770845|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
44770846|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
44770847|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770848|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770849|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770850|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
44770851|NCT01816334|Hormones|hormones|mesh-ancestor
44770852|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770853|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44770854|NCT01816334|Protective Agents|protective agents|mesh-ancestor
44770855|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44770856|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770857|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44770858|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44770859|NCT01816334|Analgesics|analgesics|mesh-ancestor
44770860|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
44770861|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770862|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44770863|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770864|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770865|NCT01816412|Paclitaxel|paclitaxel|mesh-list
44770866|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770867|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770868|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
44770869|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
44770870|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
44770871|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770872|NCT01816490|Silybin|silybin|mesh-list
44770873|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44770874|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770875|NCT01816490|Protective Agents|protective agents|mesh-ancestor
44770876|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770877|NCT01816529|Diltiazem|diltiazem|mesh-list
44770878|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44770879|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44770880|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44770881|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770882|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44770883|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770884|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
44770885|NCT01816555|Vitamin D|vitamin d|mesh-list
44770886|NCT01816555|Vitamins|vitamins|mesh-ancestor
44770887|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
44770888|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770889|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44770890|NCT01816581|Morphine|morphine|mesh-list
44770891|NCT01816581|Naloxone|naloxone|mesh-list
44770892|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44770893|NCT01816581|Narcotics|narcotics|mesh-ancestor
44770894|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770895|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770896|NCT01816581|Analgesics|analgesics|mesh-ancestor
44770897|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
44460721|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
44770898|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770899|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44770900|NCT01816620|Dexamethasone|dexamethasone|mesh-list
44770901|NCT01816620|Lenalidomide|lenalidomide|mesh-list
44770902|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770903|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
44770904|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
44770905|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770906|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770907|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44770908|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
44770909|NCT01816620|Hormones|hormones|mesh-ancestor
44548748|NCT01349192|Renal Agents|renal agents|mesh-ancestor
44770910|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44770911|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44770912|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770913|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
44770914|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44770915|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44770916|NCT01816620|Growth Substances|growth substances|mesh-ancestor
44770917|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
44770918|NCT01816646|Cidofovir|cidofovir|mesh-list
44770919|NCT01816646|Probenecid|probenecid|mesh-list
44770920|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
44770921|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
44770922|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44770923|NCT01816646|Renal Agents|renal agents|mesh-ancestor
44770924|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
44770925|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44770926|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770927|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770928|NCT01816659|Metformin|metformin|mesh-list
44770929|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44770930|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770931|NCT01816789|Buserelin|buserelin|mesh-list
44770932|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44770933|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
44770934|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44770935|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770936|NCT01816958|Ketamine|ketamine|mesh-list
44770937|NCT01816958|Analgesics|analgesics|mesh-ancestor
44770938|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
44770939|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44770940|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043140|NCT00002896|Cobalt|cobalt|mesh-list
44770941|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44770942|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44770943|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
44770944|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
44770945|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44770946|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44770947|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44770948|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44770949|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770950|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44770951|NCT01816997|Pravastatin|pravastatin|mesh-list
44770952|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44770953|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44770954|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
44770955|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770956|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44770957|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44770958|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44770959|NCT01817023|Cisplatin|cisplatin|mesh-list
44770960|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251627|NCT04848597|Paclitaxel|paclitaxel|mesh-list
44770961|NCT01817036|Vitamin D|vitamin d|mesh-list
44770962|NCT01817036|Vitamins|vitamins|mesh-ancestor
44770963|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
44770964|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770965|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44770967|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44770968|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44770969|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44770970|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44770971|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
44770972|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44770973|NCT01817257|Heparin|heparin|mesh-list
44770974|NCT01817257|Enoxaparin|enoxaparin|mesh-list
44770975|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44770976|NCT01817257|Tinzaparin|tinzaparin|mesh-list
44770977|NCT01817257|Dalteparin|dalteparin|mesh-list
44770978|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
44770979|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44770980|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44770981|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770982|NCT01817283|Triptolide|triptolide|mesh-list
44770983|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44770984|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44770985|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44770986|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
44770987|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44770988|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44770989|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
44770990|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44770991|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
44770992|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44770993|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44770994|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
44770995|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
44770996|NCT01817322|Prednisolone|prednisolone|mesh-list
44770997|NCT01817322|Deflazacort|deflazacort|mesh-list
44770998|NCT01817322|Basiliximab|basiliximab|mesh-list
44770999|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44771000|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
44771001|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
44251657|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
44771002|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771003|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771004|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771005|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
44771006|NCT01817322|Hormones|hormones|mesh-ancestor
44771007|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771008|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44771009|NCT01817322|Protective Agents|protective agents|mesh-ancestor
44771010|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44771011|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771012|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44771013|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44771014|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
44771015|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771016|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771017|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771018|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771019|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771020|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
44771021|NCT01817348|Lidocaine|lidocaine|mesh-list
44771022|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
44771023|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
44771024|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251675|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44771025|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771026|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
44771027|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771028|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771029|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44771030|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44771031|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771032|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771033|NCT01817400|Aspirin|aspirin|mesh-list
44771034|NCT01817400|Pioglitazone|pioglitazone|mesh-list
44771035|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44771036|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44771037|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44771038|NCT01817400|Analgesics|analgesics|mesh-ancestor
44771039|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
44771040|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771041|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771042|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44771043|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44771044|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44251692|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771045|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44771046|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771047|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44771048|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44771049|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771050|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
44771051|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44251711|NCT04745728|Hormones|hormones|mesh-ancestor
44771052|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44771053|NCT01817439|Amiodarone|amiodarone|mesh-list
44771054|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771055|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771056|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44043747|NCT00002972|Paclitaxel|paclitaxel|mesh-list
44771057|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771058|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771059|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44771060|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44771061|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44771062|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771063|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44771064|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44771065|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44771066|NCT01817452|Paclitaxel|paclitaxel|mesh-list
44771067|NCT01817452|Trastuzumab|trastuzumab|mesh-list
44771068|NCT01817452|Pertuzumab|pertuzumab|mesh-list
44771069|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771070|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771071|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771072|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771073|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44771074|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771075|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44771076|NCT01817699|Vitamin D|vitamin d|mesh-list
44771077|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
44771078|NCT01817699|Vitamins|vitamins|mesh-ancestor
44771079|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
44771080|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771081|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44771082|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771083|NCT01817803|Metolazone|metolazone|mesh-list
44771084|NCT01817803|Furosemide|furosemide|mesh-list
44771085|NCT01817803|Spironolactone|spironolactone|mesh-list
44771086|NCT01817803|Diuretics|diuretics|mesh-ancestor
44771087|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771088|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771089|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44251722|NCT04690322|Factor VIII|factor viii|mesh-list
44771090|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771091|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771092|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44771093|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
44771094|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771095|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44771096|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771097|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44771098|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44771099|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44771100|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44771101|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771102|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771103|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44771104|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771105|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771106|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771107|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548971|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44548972|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44548973|NCT01344824|Growth Substances|growth substances|mesh-ancestor
44548974|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548975|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
44251764|NCT04637594|Avelumab|avelumab|mesh-list
44771109|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44771110|NCT01817829|Analgesics|analgesics|mesh-ancestor
44771111|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
44771112|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771113|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771114|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
44771115|NCT01817868|Factor VIII|factor viii|mesh-list
44771116|NCT01817868|Coagulants|coagulants|mesh-ancestor
44771117|NCT01817894|Eflornithine|eflornithine|mesh-list
44771118|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771119|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44771120|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44771121|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44771122|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771123|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44771124|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771125|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771126|NCT01817972|Azathioprine|azathioprine|mesh-list
44771127|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
44771128|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
44771129|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771130|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771131|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771132|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771133|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
44771134|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771135|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251798|NCT04622904|Lidocaine|lidocaine|mesh-list
44691036|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691037|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
44691038|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44691039|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691040|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691041|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691042|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44691043|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44691044|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691045|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691046|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
44691047|NCT01359098|Dexamethasone|dexamethasone|mesh-list
44691048|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691049|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
44691050|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
44691051|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691052|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691053|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691054|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
44691055|NCT01359098|Hormones|hormones|mesh-ancestor
44691056|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691057|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44691058|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691059|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691060|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691061|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691062|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691063|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44691064|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44691065|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44691066|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44691067|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
44691068|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44691069|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44691070|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44691071|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
44691072|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691073|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691074|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44691075|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44691076|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44691077|NCT01359228|Rifaximin|rifaximin|mesh-list
44691078|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691079|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771136|NCT01817985|Velpatasvir|velpatasvir|mesh-list
44771137|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
44771138|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771139|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44771140|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
44771141|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774310|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771142|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44771143|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44771144|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771145|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771146|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771147|NCT01818648|Exenatide|exenatide|mesh-list
44771148|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771149|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771150|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44771151|NCT01818648|Incretins|incretins|mesh-ancestor
44771152|NCT01818648|Hormones|hormones|mesh-ancestor
44771153|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771154|NCT01818713|Doxorubicin|doxorubicin|mesh-list
44771155|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44771156|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44771157|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771158|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44771159|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44771160|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771161|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771162|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
44771163|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
44771164|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771165|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
44771166|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771167|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771168|NCT01818856|Ritonavir|ritonavir|mesh-list
44771169|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44771170|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44771171|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44771172|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
44771173|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771174|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771175|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44771176|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44771177|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
44771178|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771179|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44771180|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44771181|NCT01818869|Adenosine|adenosine|mesh-list
44771182|NCT01818869|Analgesics|analgesics|mesh-ancestor
44771183|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
44771184|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771185|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771186|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771187|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771188|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44771189|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
44771190|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
44771191|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771192|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771193|NCT01818908|Prednisone|prednisone|mesh-list
44771194|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
44771195|NCT01818908|Doxorubicin|doxorubicin|mesh-list
44771196|NCT01818908|Etoposide|etoposide|mesh-list
44771197|NCT01818908|Vincristine|vincristine|mesh-list
44771198|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771199|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
44771200|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771201|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44771202|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44771203|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
44771204|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771205|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771206|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44771207|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44771208|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44771209|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44549005|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44771210|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771211|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44771212|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
44771213|NCT01818908|Hormones|hormones|mesh-ancestor
44771214|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771215|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44771216|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771217|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771218|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771219|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
44771221|NCT01818973|Capecitabine|capecitabine|mesh-list
44251880|NCT04533451|Pemetrexed|pemetrexed|mesh-list
44771222|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
44771223|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44771224|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771225|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44771226|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44771227|NCT01818973|Growth Substances|growth substances|mesh-ancestor
44771228|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771229|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44771230|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771231|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
44771232|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549154|NCT01342484|Incretins|incretins|mesh-ancestor
44549155|NCT01342484|Hormones|hormones|mesh-ancestor
44771233|NCT01819012|Isoflurane|isoflurane|mesh-list
44771234|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44771235|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
44771236|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
44251887|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
44771237|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771238|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771239|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
44771240|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44771241|NCT01819064|Atropine|atropine|mesh-list
44771242|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44771243|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771244|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44771245|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
44771246|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771247|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771248|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44771249|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
44771250|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
44771251|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
44771252|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44771253|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44771254|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771255|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771256|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771257|NCT01819155|Vaccines|vaccines|mesh-list
44771258|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
44771259|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771260|NCT01819220|Amlodipine|amlodipine|mesh-list
44771261|NCT01819220|Valsartan|valsartan|mesh-list
44771262|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44771263|NCT01819220|Telmisartan|telmisartan|mesh-list
44771264|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44771265|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44771266|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771267|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771268|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771269|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771270|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771271|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771272|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771273|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44771274|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44771275|NCT01819220|Diuretics|diuretics|mesh-ancestor
44771276|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771277|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44771278|NCT01819259|Nicotine|nicotine|mesh-list
44771279|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44771280|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
44771281|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549156|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549157|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44549158|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549159|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549160|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549161|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44549162|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44549163|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549170|NCT01342367|Bicalutamide|bicalutamide|mesh-list
44771282|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771283|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44771284|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44771285|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771286|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771287|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771288|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44771290|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771291|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771292|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
44771293|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771294|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44771295|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771296|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771297|NCT01819402|Pioglitazone|pioglitazone|mesh-list
44771298|NCT01819402|Glimepiride|glimepiride|mesh-list
44771299|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771300|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771301|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771302|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771303|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
44771304|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44771305|NCT01819441|Perindopril|perindopril|mesh-list
44771306|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771307|NCT01819441|Diuretics|diuretics|mesh-ancestor
44771308|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771309|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771310|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44771311|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771312|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771313|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44771314|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44771315|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771316|NCT01819610|Ketorolac|ketorolac|mesh-list
44771317|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44771318|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44771319|NCT01819610|Analgesics|analgesics|mesh-ancestor
44771320|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
44771321|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771322|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771323|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44771324|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44771325|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44771326|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771327|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771328|NCT01819649|Selenium|selenium|mesh-list
44771329|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
44771330|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771331|NCT01819649|Protective Agents|protective agents|mesh-ancestor
44771332|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771333|NCT01819649|Trace Elements|trace elements|mesh-ancestor
44771334|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
44771335|NCT01819701|Ubiquinone|ubiquinone|mesh-list
44771336|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
44771337|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
44771338|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771339|NCT01819701|Vitamins|vitamins|mesh-ancestor
44771340|NCT01819779|Amlodipine|amlodipine|mesh-list
44771341|NCT01819779|Valsartan|valsartan|mesh-list
44771342|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44252020|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44771343|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771344|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771345|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771346|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771347|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771348|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771349|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771350|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44771351|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44771352|NCT01819857|Ondansetron|ondansetron|mesh-list
44771353|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
44771354|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
44374103|NCT05543629|Taxane|taxane|mesh-list
44771355|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771356|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771357|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771358|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
44771359|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
44771360|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44771361|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
44771362|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771363|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252038|NCT04371952|Doxycycline|doxycycline|mesh-list
44771364|NCT01819857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44771365|NCT01819857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44771366|NCT01819857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771367|NCT01819857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44771368|NCT01819857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44771369|NCT01819870|Carvedilol|carvedilol|mesh-list
44771370|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44771371|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44771372|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
44771373|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771374|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771375|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771376|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43905669|NCT00223821|Oxybutynin|oxybutynin|mesh-list
44252053|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44252055|NCT04340882|Docetaxel|docetaxel|mesh-list
44771377|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
44771378|NCT01819870|Protective Agents|protective agents|mesh-ancestor
44771379|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771380|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771381|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771382|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771383|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44771384|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44771385|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44771386|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44771387|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44771388|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44771389|NCT01820026|Amoxicillin|amoxicillin|mesh-list
44771390|NCT01820026|Azithromycin|azithromycin|mesh-list
44771391|NCT01820026|Vancomycin|vancomycin|mesh-list
44771392|NCT01820026|Imipenem|imipenem|mesh-list
44252056|NCT04340882|Ramucirumab|ramucirumab|mesh-list
44252057|NCT04340882|Antibodies|antibodies|mesh-list
44771393|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44771394|NCT01820026|Cefotaxime|cefotaxime|mesh-list
44771395|NCT01820026|Cefoxitin|cefoxitin|mesh-list
44771396|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771397|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771398|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44771399|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771400|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771401|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
44771402|NCT01820091|Antidotes|antidotes|mesh-ancestor
44771403|NCT01820091|Protective Agents|protective agents|mesh-ancestor
44771404|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549250|NCT01341457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549251|NCT01341457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549252|NCT01341457|Immunologic Factors|immunologic factors|mesh-ancestor
44549253|NCT01341457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549254|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44549255|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
44549256|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549257|NCT01340872|Ferric maltol|ferric maltol|mesh-list
44549258|NCT01340872|Hematinics|hematinics|mesh-ancestor
44549259|NCT01340768|Metformin|metformin|mesh-list
44549260|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44549261|NCT01340768|Glimepiride|glimepiride|mesh-list
44549262|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549263|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549264|NCT01340768|Incretins|incretins|mesh-ancestor
44549265|NCT01340768|Hormones|hormones|mesh-ancestor
44549266|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252095|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
44549267|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44549268|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549269|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549270|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549271|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549272|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650109|NCT03016806|Melphalan|melphalan|mesh-list
44549273|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
44771405|NCT01820104|Lansoprazole|lansoprazole|mesh-list
44771406|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
44771407|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44771408|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771409|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44771410|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771411|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771412|NCT01820143|Esomeprazole|esomeprazole|mesh-list
44771413|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44771414|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771415|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44771416|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771417|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771418|NCT01820299|Vitamin D|vitamin d|mesh-list
44771419|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
44771420|NCT01820299|Vitamins|vitamins|mesh-ancestor
44771421|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
44771422|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771423|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44771424|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771425|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771426|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
44771427|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771428|NCT01820299|Protective Agents|protective agents|mesh-ancestor
44771429|NCT01820312|Paclitaxel|paclitaxel|mesh-list
44771430|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771431|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771432|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771433|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771434|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44771435|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771436|NCT01820325|Paclitaxel|paclitaxel|mesh-list
44771437|NCT01820325|Carboplatin|carboplatin|mesh-list
44771438|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771439|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771440|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771441|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771442|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
44771443|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771444|NCT01820442|Lofexidine|lofexidine|mesh-list
44771445|NCT01820442|Clonidine|clonidine|mesh-list
44771446|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771447|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44771448|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771449|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
44771450|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771451|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44771452|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44771453|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44771454|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44771455|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774311|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771456|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771457|NCT01820442|Analgesics|analgesics|mesh-ancestor
44771458|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
44771459|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
44771460|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
44771461|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44771462|NCT01820455|Mupirocin|mupirocin|mesh-list
44771463|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44771464|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771465|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
44771466|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
44771467|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771468|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44771469|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771470|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771472|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
44771473|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
44771474|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44771475|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771476|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771477|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
44771478|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44771479|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771480|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771481|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771482|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
44771483|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
44771484|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
44771485|NCT01820767|Atorvastatin|atorvastatin|mesh-list
44771486|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44771487|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44771488|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
44771489|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771490|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44771491|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44771492|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771493|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771494|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771495|NCT01820767|Vitamins|vitamins|mesh-ancestor
44771496|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
44771497|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44771498|NCT01820793|Cefoxitin|cefoxitin|mesh-list
44771499|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771500|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771501|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
44771502|NCT01820832|Calcitriol|calcitriol|mesh-list
44771503|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771504|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771505|NCT01820832|Vitamins|vitamins|mesh-ancestor
44771506|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
44771507|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44771508|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44771509|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771510|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771511|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44771512|NCT01820858|Paclitaxel|paclitaxel|mesh-list
44771513|NCT01820858|Carboplatin|carboplatin|mesh-list
44771514|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771515|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771516|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771517|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771518|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
44771519|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771520|NCT01820897|Trimethoprim|trimethoprim|mesh-list
44771521|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44771522|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
44771523|NCT01820897|Fosfomycin|fosfomycin|mesh-list
44771524|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44771525|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771526|NCT01820897|Renal Agents|renal agents|mesh-ancestor
44771527|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
44771528|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44771529|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44771530|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44771531|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771532|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771533|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44771534|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44771535|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44771536|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771537|NCT01820962|Heparin|heparin|mesh-list
44771538|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
44771539|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771540|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44771541|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44771542|NCT01821001|Bromocriptine|bromocriptine|mesh-list
44771543|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44771544|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44771545|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
44771546|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771547|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771549|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
44771550|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771551|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771552|NCT01821027|Canagliflozin|canagliflozin|mesh-list
44771553|NCT01821027|Simvastatin|simvastatin|mesh-list
44771554|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44771555|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44771556|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
44771557|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771558|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44771559|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44771560|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771561|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44771562|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771563|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771564|NCT01821040|Prednisone|prednisone|mesh-list
44771565|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44771566|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
44771567|NCT01821040|Hormones|hormones|mesh-ancestor
44771568|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252150|NCT04081831|Analgesics|analgesics|mesh-ancestor
44771569|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771570|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44771571|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771572|NCT01821066|Tamoxifen|tamoxifen|mesh-list
44771573|NCT01821066|Palbociclib|palbociclib|mesh-list
44771574|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44771575|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
44771576|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771577|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771578|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44771579|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771580|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44771581|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44771582|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44252198|NCT03994796|Entrectinib|entrectinib|mesh-list
44771583|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44771584|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771585|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771586|NCT01821170|Methylphenidate|methylphenidate|mesh-list
44771587|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44771588|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771589|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44771590|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44771591|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549447|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44549448|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44549449|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44549450|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44549451|NCT01338025|Lamivudine|lamivudine|mesh-list
44549452|NCT01338025|Emtricitabine|emtricitabine|mesh-list
44549453|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44549454|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44549455|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549456|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549457|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
44549458|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549459|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44549460|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44549461|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
44549462|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44549463|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549464|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549465|NCT01337674|Metoprolol|metoprolol|mesh-list
44549466|NCT01337674|Amlodipine|amlodipine|mesh-list
44549467|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549468|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44549469|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549475|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
44771592|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771593|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
44771594|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771596|NCT01821235|Analgesics|analgesics|mesh-ancestor
44771597|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
44771598|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771599|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771600|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
44771601|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44771602|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44771603|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771604|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44771605|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44771606|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44771607|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771608|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771609|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
44771610|NCT01821248|Gemcitabine|gemcitabine|mesh-list
44771611|NCT01821248|Cisplatin|cisplatin|mesh-list
44771612|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771613|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771614|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
44771615|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771616|NCT01821248|Antiviral Agents|antiviral agents|mesh-ancestor
44771617|NCT01821248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771618|NCT01821248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771619|NCT01821248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771620|NCT01821248|Immunologic Factors|immunologic factors|mesh-ancestor
44771621|NCT01821248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771622|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
44771623|NCT01821261|Fluorides|fluorides|mesh-list
44771624|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
44771625|NCT01821261|Protective Agents|protective agents|mesh-ancestor
44771626|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771627|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44771628|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771629|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
44771630|NCT01821274|Diltiazem|diltiazem|mesh-list
44771631|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44252279|NCT03853044|Hormones|hormones|mesh-ancestor
44771632|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771633|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771634|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771635|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771636|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771637|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771638|NCT01821404|Atorvastatin|atorvastatin|mesh-list
44771639|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44771640|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44771641|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
44252288|NCT03847857|Coagulants|coagulants|mesh-ancestor
44771642|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771643|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44771644|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44771645|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771646|NCT01821430|Pregabalin|pregabalin|mesh-list
44771647|NCT01821430|Analgesics|analgesics|mesh-ancestor
44771648|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
44771649|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771650|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771651|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
44771652|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771653|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771654|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771655|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771656|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44771657|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44771658|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771659|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44771660|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
44771661|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
44771662|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
44771663|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44771664|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44771665|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44771666|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771667|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771668|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771669|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771670|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771671|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44771672|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771673|NCT01821612|Leucovorin|leucovorin|mesh-list
44771674|NCT01821612|Gemcitabine|gemcitabine|mesh-list
44771675|NCT01821612|Fluorouracil|fluorouracil|mesh-list
44771676|NCT01821612|Capecitabine|capecitabine|mesh-list
44771677|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
44771678|NCT01821612|Irinotecan|irinotecan|mesh-list
44771679|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771680|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
44771681|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771682|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771683|NCT01821612|Antiviral Agents|antiviral agents|mesh-ancestor
44771684|NCT01821612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771685|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771686|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771687|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
44771688|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771689|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44771690|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44771691|NCT01821612|Antidotes|antidotes|mesh-ancestor
44771692|NCT01821612|Protective Agents|protective agents|mesh-ancestor
44771693|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
44771694|NCT01821612|Vitamins|vitamins|mesh-ancestor
44771695|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
44771696|NCT01821664|Heparin|heparin|mesh-list
44771697|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
44771698|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44771699|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44771700|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771701|NCT01821703|Spironolactone|spironolactone|mesh-list
44771702|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44771703|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44771704|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460894|NCT01556997|Amlodipine|amlodipine|mesh-list
44771705|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771706|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44771707|NCT01821703|Diuretics|diuretics|mesh-ancestor
44771708|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771709|NCT01821846|Liraglutide|liraglutide|mesh-list
44771710|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771711|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047021|NCT00003335|Melphalan|melphalan|mesh-list
44771712|NCT01821846|Incretins|incretins|mesh-ancestor
44771713|NCT01821846|Hormones|hormones|mesh-ancestor
44771714|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771715|NCT01821872|Acetaminophen|acetaminophen|mesh-list
44771716|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44771717|NCT01821872|Analgesics|analgesics|mesh-ancestor
44771718|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
44771719|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252325|NCT03651011|Aflibercept|aflibercept|mesh-list
44771720|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771721|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
44771722|NCT01821989|Lactoferrin|lactoferrin|mesh-list
44771723|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771724|NCT01822015|Cytarabine|cytarabine|mesh-list
44771725|NCT01822015|Sirolimus|sirolimus|mesh-list
44771726|NCT01822015|Idarubicin|idarubicin|mesh-list
44771727|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771728|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
44771729|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771730|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771731|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
44771732|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252340|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771733|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771734|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
44252347|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
44771735|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771736|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771737|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44771738|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
44771739|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44771740|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44771741|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771742|NCT01822028|Miglustat|miglustat|mesh-list
44549553|NCT01336023|Xultophy|xultophy|mesh-list
44771743|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44771744|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771745|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691080|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691081|NCT01359241|Insulin|insulin|mesh-list
44691082|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44691083|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691084|NCT01359397|Bevacizumab|bevacizumab|mesh-list
44691085|NCT01359397|Trastuzumab|trastuzumab|mesh-list
44691086|NCT01359397|Docetaxel|docetaxel|mesh-list
44691087|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
44691088|NCT01359397|Capecitabine|capecitabine|mesh-list
44047586|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44691089|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691090|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691091|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44691092|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44691093|NCT01359397|Growth Substances|growth substances|mesh-ancestor
44691094|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691095|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
44691096|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
44691123|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44691124|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691125|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
44691126|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691127|NCT01359488|Hormones|hormones|mesh-list
44691128|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44691129|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691130|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691131|NCT01359514|Pregabalin|pregabalin|mesh-list
44691132|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
44691133|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44691134|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691135|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691136|NCT01359514|Analgesics|analgesics|mesh-ancestor
44691137|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
44691138|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691139|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
44691140|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691141|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691142|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44691143|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44691144|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691145|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691146|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44691147|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691148|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691149|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
44691150|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
44691151|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
44691152|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44691153|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691154|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691155|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
44691156|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44691157|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691158|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691159|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
44691160|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44691161|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691162|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691163|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44691164|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44691165|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691166|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691167|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691168|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44691169|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
44691170|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691171|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691172|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44691173|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44374526|NCT05664061|Hormones|hormones|mesh-ancestor
44771746|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44771747|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44771748|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
44771749|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771750|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44771751|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44771752|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771753|NCT01822080|Dienogest|dienogest|mesh-list
44252435|NCT03254654|Apatinib|apatinib|mesh-list
44771754|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44771755|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
44771756|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44771757|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771758|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44771759|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44771760|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44771761|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44771762|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44771763|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44771764|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44771765|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771766|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
44771767|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44771768|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771769|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771770|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771771|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252448|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
44771772|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549631|NCT01334918|Regadenoson|regadenoson|mesh-list
44549632|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44549633|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44549634|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44549635|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
44549636|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
44549637|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549638|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549639|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549640|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44549641|NCT01334710|Sorafenib|sorafenib|mesh-list
44549642|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549643|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44549644|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549645|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771773|NCT01822405|Tocopherols|tocopherols|mesh-list
44771774|NCT01822405|Vitamin E|vitamin e|mesh-list
44771775|NCT01822405|Tocotrienols|tocotrienols|mesh-list
44771776|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
44771777|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
44771778|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44771779|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771780|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771781|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44252473|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44252474|NCT03110822|Prednisolone|prednisolone|mesh-list
44771782|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44771783|NCT01822405|Protective Agents|protective agents|mesh-ancestor
44771784|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771785|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771786|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44771787|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
44771788|NCT01822405|Vitamins|vitamins|mesh-ancestor
44771789|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
44771790|NCT01822418|S 20098|s 20098|mesh-list
44771791|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44771792|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771793|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771794|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44771795|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771796|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771797|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771798|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44771799|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
44771800|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44771801|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771802|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44771803|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
44771804|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771805|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771806|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771807|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771808|NCT01822509|Nivolumab|nivolumab|mesh-list
44771809|NCT01822509|Ipilimumab|ipilimumab|mesh-list
44771810|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44771811|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771812|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44771813|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771814|NCT01822600|Omeprazole|omeprazole|mesh-list
44771815|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44771816|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771817|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44771818|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771819|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771820|NCT01822613|Paclitaxel|paclitaxel|mesh-list
44771821|NCT01822613|Docetaxel|docetaxel|mesh-list
44771822|NCT01822613|Irinotecan|irinotecan|mesh-list
44771823|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44771824|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771825|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44771826|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44771827|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252519|NCT03103750|Vitamins|vitamins|mesh-ancestor
44771828|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771829|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44771830|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44771831|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771832|NCT01822639|Amlodipine|amlodipine|mesh-list
44771833|NCT01822639|Enalapril|enalapril|mesh-list
44771834|NCT01822639|Enalaprilat|enalaprilat|mesh-list
44771835|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771836|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771837|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252532|NCT03102047|Durvalumab|durvalumab|mesh-list
44771838|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771839|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771840|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771841|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771842|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771843|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44771844|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
44771845|NCT01822730|Risperidone|risperidone|mesh-list
44771846|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44771847|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44771848|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
44771849|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771850|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771851|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771852|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44771853|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44771854|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44771855|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44771856|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44771857|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
44771858|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44771859|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44771861|NCT01822808|Isosorbide|isosorbide|mesh-list
44771862|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44771863|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44771864|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44771865|NCT01822808|Diuretics|diuretics|mesh-ancestor
44771866|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771867|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771868|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771869|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44771870|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771871|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771872|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44771873|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
44771874|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44771875|NCT01822860|Diuretics|diuretics|mesh-ancestor
44771876|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
44771877|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771878|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44771879|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771880|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771881|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
44771882|NCT01822951|Donepezil|donepezil|mesh-list
44771883|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44771884|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460919|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
44771885|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771886|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
44771887|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771888|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771889|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
44771890|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44771891|NCT01822951|Protective Agents|protective agents|mesh-ancestor
44771892|NCT01822977|Omeprazole|omeprazole|mesh-list
44771893|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44771894|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44771895|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44771896|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771897|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771898|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
44771899|NCT01823029|Hematinics|hematinics|mesh-ancestor
44771900|NCT01823042|Azathioprine|azathioprine|mesh-list
44771901|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
44460944|NCT01556438|Dexamethasone|dexamethasone|mesh-list
44771902|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771903|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44771904|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771905|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44771906|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
44771907|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771908|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44771909|NCT01823081|Bevacizumab|bevacizumab|mesh-list
44771910|NCT01823081|Fasudil|fasudil|mesh-list
44771911|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460953|NCT01556438|Hormones|hormones|mesh-ancestor
44771912|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771913|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44771914|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44771915|NCT01823081|Growth Substances|growth substances|mesh-ancestor
44771916|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771917|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
44771918|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44771919|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44771920|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771921|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44771922|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771923|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44771924|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771925|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44771926|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44771927|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44771929|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771930|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44771931|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44771932|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771933|NCT01823159|Ezogabine|ezogabine|mesh-list
44771934|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
44771935|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252561|NCT03028519|Vitamin D|vitamin d|mesh-list
44771936|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771937|NCT01823172|Methylene Blue|methylene blue|mesh-list
44771938|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771939|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771940|NCT01823185|Clopidogrel|clopidogrel|mesh-list
44771941|NCT01823185|Ticagrelor|ticagrelor|mesh-list
44771942|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44771943|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44771944|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44771945|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44771946|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44771947|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
44771948|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771949|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771950|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771951|NCT01823393|Heparin|heparin|mesh-list
44771952|NCT01823393|Calcium heparin|calcium heparin|mesh-list
44771953|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
44771954|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44771955|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44771956|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771957|NCT01823523|Clindamycin|clindamycin|mesh-list
44771958|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
44771959|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
44771960|NCT01823523|Cefazolin|cefazolin|mesh-list
44771961|NCT01823523|Cephalexin|cephalexin|mesh-list
44771962|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44771963|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44771964|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44771965|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44771966|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771967|NCT01823744|Micronutrients|micronutrients|mesh-list
44771968|NCT01823744|Trace Elements|trace elements|mesh-list
44771969|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771970|NCT01823770|Rotigotine|rotigotine|mesh-list
44771971|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
44771972|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
44771973|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771974|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771975|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771976|NCT01823809|Adenosine|adenosine|mesh-list
44771977|NCT01823809|Analgesics|analgesics|mesh-ancestor
44771978|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
44771979|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44771980|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771981|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44771982|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
44771983|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44771984|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
44771985|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
44771986|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44771987|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44771988|NCT01823848|Mineral Oil|mineral oil|mesh-list
44771989|NCT01823848|Emollients|emollients|mesh-ancestor
44771990|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
44771991|NCT01823965|Ranibizumab|ranibizumab|mesh-list
44771992|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44771993|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44771994|NCT01823965|Growth Substances|growth substances|mesh-ancestor
44771995|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44771996|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44549798|NCT01332968|Rituximab|rituximab|mesh-list
44771997|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44771998|NCT01824043|Ranibizumab|ranibizumab|mesh-list
44771999|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772000|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772001|NCT01824043|Growth Substances|growth substances|mesh-ancestor
44772002|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772003|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772004|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772005|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44772006|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44772007|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772008|NCT01824199|Omeprazole|omeprazole|mesh-list
44772009|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44772010|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772011|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44772012|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772013|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549873|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
44549874|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44549875|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549876|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549877|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549878|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44549879|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44549880|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252642|NCT02897050|Capecitabine|capecitabine|mesh-list
44549881|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549882|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
44549886|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
44772015|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772016|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772017|NCT01824225|Growth Substances|growth substances|mesh-ancestor
44772018|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772019|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772020|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772021|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
44772022|NCT01824238|Anacetrapib|anacetrapib|mesh-list
44772023|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44772024|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44772025|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
44772026|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772027|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44772028|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772029|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44772030|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772031|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
44772032|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44772033|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
44772034|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44772035|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
44772036|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772037|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44772038|NCT01824264|Licogliflozin|licogliflozin|mesh-list
44772039|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44772040|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772041|NCT01824264|Incretins|incretins|mesh-ancestor
44772042|NCT01824264|Hormones|hormones|mesh-ancestor
44772043|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772044|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44772045|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772046|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772047|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772048|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44772049|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
44772050|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44772051|NCT01824420|Oxybutynin|oxybutynin|mesh-list
44772052|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44772053|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44772054|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
44772055|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772056|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772057|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772058|NCT01824420|Urological Agents|urological agents|mesh-ancestor
44772059|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
44772060|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
44772061|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772062|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44772063|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772064|NCT01824420|Renal Agents|renal agents|mesh-ancestor
44772065|NCT01824433|Fluoxetine|fluoxetine|mesh-list
44772066|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44772067|NCT01824433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44772068|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44772069|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772070|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772071|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772072|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
44772073|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252698|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772074|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44772075|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
44772076|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772077|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44772078|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44772079|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772080|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44772081|NCT01824459|Cisplatin|cisplatin|mesh-list
44772082|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
44772083|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772084|NCT01824524|Hydromorphone|hydromorphone|mesh-list
44772085|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44772086|NCT01824524|Narcotics|narcotics|mesh-ancestor
44772087|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772088|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772090|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
44772091|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772092|NCT01824615|Sunitinib|sunitinib|mesh-list
44772093|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772094|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772095|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772096|NCT01824615|Growth Substances|growth substances|mesh-ancestor
44772097|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772098|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44252722|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772099|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44772100|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772101|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772102|NCT01824758|Lidocaine|lidocaine|mesh-list
44772103|NCT01824758|Rocuronium|rocuronium|mesh-list
44772104|NCT01824758|Esmolol|esmolol|mesh-list
44772105|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772106|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
44772107|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772108|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772109|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
44772110|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772111|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772112|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44772113|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44772114|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772115|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772116|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44772117|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44772118|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44772119|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44772120|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44772121|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44772122|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44772123|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772124|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
44772125|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44772126|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44772127|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44772128|NCT01824992|Interferons|interferons|mesh-list
44772129|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772130|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
44772131|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772132|NCT01825031|Azithromycin|azithromycin|mesh-list
44772133|NCT01825031|Isoniazid|isoniazid|mesh-list
44772134|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
44772135|NCT01825031|Fluconazole|fluconazole|mesh-list
44772136|NCT01825031|Albendazole|albendazole|mesh-list
44772137|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772138|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772139|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44772140|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44772141|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
44772142|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44772143|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44772144|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772145|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772146|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
44772147|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44252771|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252772|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772148|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44772149|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44772150|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44772151|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772152|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772153|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44772154|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44772155|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
44772156|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44772157|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44772158|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
44772159|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44772160|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
44772161|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44772162|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
44772163|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44772164|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44772165|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44772166|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44772167|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44772168|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772169|NCT01825044|Cyclosporine|cyclosporine|mesh-list
44772170|NCT01825044|Cyclosporins|cyclosporins|mesh-list
44772171|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772172|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772173|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772174|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
44772175|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772176|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
44772177|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772178|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
44772179|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44772180|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44772181|NCT01825083|Ketamine|ketamine|mesh-list
44252825|NCT02066220|Vincristine|vincristine|mesh-list
44252826|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252827|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
44252828|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252829|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252830|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252831|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
44252832|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252833|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252834|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252835|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252836|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44772182|NCT01825083|Analgesics|analgesics|mesh-ancestor
44772183|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
44772184|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772185|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772186|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44772187|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44772188|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
44772189|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
44772190|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772191|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44772192|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44772193|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772194|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772195|NCT01825109|Vaccines|vaccines|mesh-list
44772196|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
44772197|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772198|NCT01825395|Amifampridine|amifampridine|mesh-list
44772199|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44772200|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772201|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772202|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44772203|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772204|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772205|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44772206|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772207|NCT01825447|Naltrexone|naltrexone|mesh-list
44772208|NCT01825447|Oxycodone|oxycodone|mesh-list
44772209|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44772210|NCT01825447|Narcotics|narcotics|mesh-ancestor
44772211|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772212|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772213|NCT01825447|Analgesics|analgesics|mesh-ancestor
44772214|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
44772215|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772216|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44772217|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44772218|NCT01825473|Erythromycin|erythromycin|mesh-list
44252864|NCT01716312|Omalizumab|omalizumab|mesh-list
44252865|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44252866|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44252867|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44252886|NCT01503606|Clarithromycin|clarithromycin|mesh-list
44049932|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049933|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049934|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44049935|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44049948|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049949|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44049950|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44049951|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
44049952|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44049953|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049955|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
44049956|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44049957|NCT00003687|Narcotics|narcotics|mesh-ancestor
44049958|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44049959|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772219|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
44772220|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44772221|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
44772222|NCT01825473|Phenobarbital|phenobarbital|mesh-list
44772223|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772224|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772225|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772226|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44772227|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772228|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772229|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
44772230|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44772231|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772232|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772233|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44772234|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44772235|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550049|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
44772236|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
44772237|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
44772238|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44772239|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44772240|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44772241|NCT01825551|Lenograstim|lenograstim|mesh-list
44772242|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44772243|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
44772244|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772245|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
44772246|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44772247|NCT01825603|Gemcitabine|gemcitabine|mesh-list
44772248|NCT01825603|Cisplatin|cisplatin|mesh-list
44772249|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772250|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44772251|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
44772252|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772253|NCT01825603|Antiviral Agents|antiviral agents|mesh-ancestor
44772254|NCT01825603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772255|NCT01825603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772256|NCT01825603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772257|NCT01825603|Immunologic Factors|immunologic factors|mesh-ancestor
44772258|NCT01825603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772259|NCT01825616|Vitamin D|vitamin d|mesh-list
44772260|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
44772261|NCT01825616|Vitamins|vitamins|mesh-ancestor
44772262|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
44772263|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772264|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44772265|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772266|NCT01825720|Insulin|insulin|mesh-list
44772267|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44252887|NCT01503606|Cefazolin|cefazolin|mesh-list
44772268|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772269|NCT01825733|Palonosetron|palonosetron|mesh-list
44772270|NCT01825733|Ramosetron|ramosetron|mesh-list
44772271|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
44772272|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
44772273|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772274|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772275|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772276|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44772277|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44772278|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
44772279|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772280|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772281|NCT01825850|Irbesartan|irbesartan|mesh-list
44772282|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772283|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44772284|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44772285|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772286|NCT01825863|Ropivacaine|ropivacaine|mesh-list
44772287|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772288|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
44772289|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772290|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772291|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
44772292|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772293|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44772294|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44772295|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252931|NCT00867321|Sorafenib|sorafenib|mesh-list
44772296|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44772297|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44772298|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44772299|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772300|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772301|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772302|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44772303|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44772304|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
44772305|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772306|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772307|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44772308|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44772309|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
44772310|NCT01825993|Morphine|morphine|mesh-list
44772311|NCT01825993|Bupivacaine|bupivacaine|mesh-list
44772312|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772313|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
44772314|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772315|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772316|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
44772317|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772318|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44772319|NCT01825993|Narcotics|narcotics|mesh-ancestor
44772320|NCT01825993|Analgesics|analgesics|mesh-ancestor
44550196|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44550197|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550198|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550199|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44550200|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44460968|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550201|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
44550202|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550203|NCT01328002|Milnacipran|milnacipran|mesh-list
44550204|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
44772321|NCT01826149|Propofol|propofol|mesh-list
44772322|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44772323|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772324|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772325|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44772326|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
44772327|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
44772328|NCT01826175|Clopidogrel|clopidogrel|mesh-list
44772329|NCT01826175|Ticagrelor|ticagrelor|mesh-list
44772330|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44772331|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44772332|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44772333|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44772334|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
44772335|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772336|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772337|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772338|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44772339|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
44772340|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
44772341|NCT01826279|Resveratrol|resveratrol|mesh-list
44772342|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
44772343|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772344|NCT01826279|Protective Agents|protective agents|mesh-ancestor
44772345|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772346|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772347|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44772348|NCT01826396|Irinotecan|irinotecan|mesh-list
44772349|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44772350|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44772351|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772352|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772353|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772354|NCT01826526|Taurolidine|taurolidine|mesh-list
44772355|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772356|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44772357|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772358|NCT01826747|Progesterone|progesterone|mesh-list
44772359|NCT01826747|Progestins|progestins|mesh-ancestor
44772360|NCT01826747|Hormones|hormones|mesh-ancestor
44772361|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772362|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772363|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
44772364|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772365|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772366|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
44772367|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772368|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772369|NCT01826864|Sargramostim|sargramostim|mesh-list
44772370|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
44772371|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772372|NCT01826916|Ecallantide|ecallantide|mesh-list
44772373|NCT01826916|Analgesics|analgesics|mesh-ancestor
44772374|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
44772375|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772376|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772377|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44772378|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44772379|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772380|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44772381|NCT01827007|Polygeline|polygeline|mesh-list
44772382|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
44772383|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
44772384|NCT01827020|Lidocaine|lidocaine|mesh-list
44772385|NCT01827020|Ketamine|ketamine|mesh-list
44772386|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772387|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
44772388|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772389|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772390|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
44772391|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772392|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772393|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44772394|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44550212|NCT01328002|Analgesics|analgesics|mesh-ancestor
44772395|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772396|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772397|NCT01827020|Analgesics|analgesics|mesh-ancestor
44772398|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44772399|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44772400|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
44772401|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44772402|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44772403|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772404|NCT01827059|Bosentan|bosentan|mesh-list
44772405|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772406|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44772407|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772408|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
44772409|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
44772410|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772411|NCT01827124|Oxytocin|oxytocin|mesh-list
44772412|NCT01827124|Carbetocin|carbetocin|mesh-list
44772413|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
44772414|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253047|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
44772415|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772416|NCT01827137|Lenalidomide|lenalidomide|mesh-list
44772417|NCT01827137|Molgramostim|molgramostim|mesh-list
44772418|NCT01827137|Sargramostim|sargramostim|mesh-list
44772419|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
44772420|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772421|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772422|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772423|NCT01827137|Growth Substances|growth substances|mesh-ancestor
44772424|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772425|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772426|NCT01827202|Candesartan|candesartan|mesh-list
44772427|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772428|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44772429|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44772430|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772431|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
44772432|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
44772433|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772434|NCT01827280|Vildagliptin|vildagliptin|mesh-list
44772435|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44772436|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772437|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44772438|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772439|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772440|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772441|NCT01827293|Promethazine|promethazine|mesh-list
44772442|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
44772443|NCT01827293|Lorazepam|lorazepam|mesh-list
44772444|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
44772445|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
44772446|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
44772447|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772448|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772449|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772450|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44253080|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
44772451|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772452|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44772453|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44772454|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772455|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
44772456|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
44772457|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772458|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772459|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
44772460|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44772461|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44772462|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
44772463|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
44772464|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44772465|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44772466|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772467|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
44772468|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
44772469|NCT01827345|Vitamin D|vitamin d|mesh-list
44772470|NCT01827345|Vitamins|vitamins|mesh-ancestor
44772471|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
44772472|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772473|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44772474|NCT01827397|Vaccines|vaccines|mesh-list
44772475|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
44772476|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772477|NCT01827540|Dolutegravir|dolutegravir|mesh-list
44772478|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
44691174|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44691175|NCT01359657|Dexamethasone|dexamethasone|mesh-list
44691176|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
44691177|NCT01359657|Lenalidomide|lenalidomide|mesh-list
44691178|NCT01359657|Bortezomib|bortezomib|mesh-list
44691179|NCT01359657|BB 1101|bb 1101|mesh-list
44691180|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44691181|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691182|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
44691183|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
44691184|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691185|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691186|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691187|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
44691188|NCT01359657|Hormones|hormones|mesh-ancestor
44691189|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691190|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44691191|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691192|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
44691193|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691195|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
44691196|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44691197|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44691198|NCT01359657|Growth Substances|growth substances|mesh-ancestor
44691199|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44691200|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
44691201|NCT01359670|Tadalafil|tadalafil|mesh-list
44691202|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253134|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
44691203|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44691204|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44691205|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691206|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691207|NCT01359670|Urological Agents|urological agents|mesh-ancestor
44691208|NCT01359696|Gemcitabine|gemcitabine|mesh-list
44691209|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44691210|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
44691211|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691212|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691213|NCT01359696|Antiviral Agents|antiviral agents|mesh-ancestor
44691214|NCT01359696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691215|NCT01359696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691216|NCT01359696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691217|NCT01359696|Immunologic Factors|immunologic factors|mesh-ancestor
44691218|NCT01359696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691219|NCT01359709|Nicotine|nicotine|mesh-list
44691220|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44691221|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
44691222|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691223|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691224|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44691225|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44691226|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
44691227|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691228|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691229|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
44691230|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44691231|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
44691232|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691233|NCT01359722|Expectorants|expectorants|mesh-ancestor
44691234|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691235|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44691236|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
44691237|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691238|NCT01359722|Protective Agents|protective agents|mesh-ancestor
44691239|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460972|NCT01555671|Meperidine|meperidine|mesh-list
44691240|NCT01359722|Antidotes|antidotes|mesh-ancestor
44691241|NCT01359826|Milnacipran|milnacipran|mesh-list
44691242|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
44691243|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44550359|NCT01326026|Insulin|insulin|mesh-list
44772479|NCT01827540|Midazolam|midazolam|mesh-list
44772480|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44772481|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44772482|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772483|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772484|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44772485|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44772486|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772487|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44772488|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
44772489|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
44772490|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
44772491|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
44772492|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772493|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772494|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44772495|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44772496|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772497|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44772498|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44772499|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
44772500|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772501|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44772502|NCT01827618|Sirolimus|sirolimus|mesh-list
44772503|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772504|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772505|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44772506|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772507|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
44772508|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772509|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
44772510|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772511|NCT01827722|Dexamethasone|dexamethasone|mesh-list
44772512|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
44772513|NCT01827722|Ranibizumab|ranibizumab|mesh-list
44772514|NCT01827722|BB 1101|bb 1101|mesh-list
44772515|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772516|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
44772517|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
44461017|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
44772518|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772519|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772520|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772521|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
44772522|NCT01827722|Hormones|hormones|mesh-ancestor
44772523|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772524|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149764|NCT00208819|Valproic Acid|valproic acid|mesh-list
44772525|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772526|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772527|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774312|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44772528|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772529|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772530|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772531|NCT01827722|Growth Substances|growth substances|mesh-ancestor
44772532|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772533|NCT01827735|Aldesleukin|aldesleukin|mesh-list
44772534|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772535|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44772536|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44772537|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
44772538|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550364|NCT01325493|Ketamine|ketamine|mesh-list
44772540|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44772541|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44772542|NCT01827865|Analgesics|analgesics|mesh-ancestor
44772543|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
44772544|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772545|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772546|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772547|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44772548|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44772549|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44772550|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772551|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772552|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44772553|NCT01827878|Lisinopril|lisinopril|mesh-list
44772554|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
44772555|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772556|NCT01827878|Diuretics|diuretics|mesh-ancestor
44772557|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
44772558|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772559|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44772560|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772561|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772562|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44772563|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772564|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772565|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44772566|NCT01827878|Protective Agents|protective agents|mesh-ancestor
44772567|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44772568|NCT01828125|Glucagon|glucagon|mesh-list
44772569|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772570|NCT01828125|Hormones|hormones|mesh-ancestor
44772571|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772572|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772573|NCT01828203|Minocycline|minocycline|mesh-list
44772574|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772575|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772576|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
44772577|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44772578|NCT01828294|Antibodies|antibodies|mesh-list
44772579|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
44772580|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772581|NCT01828346|Azacitidine|azacitidine|mesh-list
44772582|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44772583|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
44772584|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772585|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772586|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772587|NCT01828359|Losartan|losartan|mesh-list
44772588|NCT01828359|Amlodipine|amlodipine|mesh-list
44772589|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772590|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44772591|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772592|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772593|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772594|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772595|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
44772596|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772597|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44772598|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44772599|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
44772600|NCT01828385|Analgesics|analgesics|mesh-ancestor
44772601|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
44772602|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772603|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772604|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
44772605|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772606|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44550440|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44550441|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44550442|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550443|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44375479|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
44772608|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44772609|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772610|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772611|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772612|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
44772613|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44772614|NCT01828437|Pyridoxine|pyridoxine|mesh-list
44772615|NCT01828437|Prednisolone|prednisolone|mesh-list
44772616|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44772617|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
44772618|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44772619|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
44772620|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44772621|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
44772622|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772623|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
44772624|NCT01828437|Hormones|hormones|mesh-ancestor
44253271|NCT05338190|Rituximab|rituximab|mesh-list
44772625|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772626|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772627|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44772628|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772629|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
44772630|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
44772631|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772632|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772633|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44772634|NCT01828437|Protective Agents|protective agents|mesh-ancestor
44772635|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
44772636|NCT01828437|Vitamins|vitamins|mesh-ancestor
44772637|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
44772638|NCT01828463|Nitisinone|nitisinone|mesh-list
44772639|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772640|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772641|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
44772642|NCT01828489|Analgesics|analgesics|mesh-ancestor
44772643|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
44772644|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772645|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772646|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772647|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44772648|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44772649|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772650|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772651|NCT01828606|Monensin|monensin|mesh-list
44772652|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
44772653|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772654|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44772655|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44772656|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
44772657|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
44772658|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
44772659|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772660|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772661|NCT01828606|Ionophores|ionophores|mesh-ancestor
44772662|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772663|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
44772664|NCT01828736|Gemcitabine|gemcitabine|mesh-list
44772665|NCT01828736|Cisplatin|cisplatin|mesh-list
44772666|NCT01828736|Carboplatin|carboplatin|mesh-list
44772667|NCT01828736|Trastuzumab|trastuzumab|mesh-list
44772668|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772669|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44772670|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
44772671|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772672|NCT01828736|Antiviral Agents|antiviral agents|mesh-ancestor
44772673|NCT01828736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772674|NCT01828736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772675|NCT01828736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772676|NCT01828736|Immunologic Factors|immunologic factors|mesh-ancestor
44772677|NCT01828736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772678|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44772679|NCT01828788|Ropivacaine|ropivacaine|mesh-list
44772680|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772681|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
44772682|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772683|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772684|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
44772685|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772686|NCT01828879|Tacrolimus|tacrolimus|mesh-list
44772687|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772688|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
44772689|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772690|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44772691|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772692|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772693|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44772694|NCT01828892|Vancomycin|vancomycin|mesh-list
44772695|NCT01828892|Meropenem|meropenem|mesh-list
44772696|NCT01828892|Ceftazidime|ceftazidime|mesh-list
44772697|NCT01828892|Cefotaxime|cefotaxime|mesh-list
44772698|NCT01828892|Cefoxitin|cefoxitin|mesh-list
44772699|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772700|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
44772701|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44772702|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772703|NCT01829178|Cisplatin|cisplatin|mesh-list
44772704|NCT01829178|Docetaxel|docetaxel|mesh-list
44772705|NCT01829178|Fluorouracil|fluorouracil|mesh-list
44772706|NCT01829178|Silymarin|silymarin|mesh-list
44772707|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772708|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44772709|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
44253333|NCT05279833|Sotalol|sotalol|mesh-list
44772710|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
44772711|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772712|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
44772713|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44772714|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772715|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
44772716|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772717|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
44772718|NCT01829178|Protective Agents|protective agents|mesh-ancestor
44772719|NCT01829334|Listerine|listerine|mesh-list
44772720|NCT01829334|Fluorides|fluorides|mesh-list
44772721|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
44772722|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
44772723|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
44772724|NCT01829334|Protective Agents|protective agents|mesh-ancestor
44772725|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772726|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44772727|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772728|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
44772729|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44772730|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
44772731|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772732|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
44772733|NCT01829451|Protective Agents|protective agents|mesh-ancestor
44772734|NCT01829529|Amoxicillin|amoxicillin|mesh-list
44772735|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44772736|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772737|NCT01829659|Ticagrelor|ticagrelor|mesh-list
44772738|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44772739|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44772740|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44772741|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44772742|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
44772743|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772744|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772745|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772746|NCT01829685|Entecavir|entecavir|mesh-list
44772747|NCT01829685|Adefovir|adefovir|mesh-list
44772748|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
44772749|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772750|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44772751|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44772752|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772753|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772754|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44772755|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44772756|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772757|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
44772758|NCT01829711|Protective Agents|protective agents|mesh-list
44772759|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772760|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772761|NCT01829802|Ritonavir|ritonavir|mesh-list
44772762|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44772763|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
44772764|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44772765|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44772766|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772767|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772768|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772769|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44772770|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44772771|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
44772772|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772773|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44772774|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44772775|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44772776|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44772777|NCT01829841|Sunitinib|sunitinib|mesh-list
44772778|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772779|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772780|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772781|NCT01829841|Growth Substances|growth substances|mesh-ancestor
44772782|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772783|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772784|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44772785|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772786|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253368|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44772787|NCT01829893|Tamsulosin|tamsulosin|mesh-list
44772788|NCT01829893|Finasteride|finasteride|mesh-list
44772789|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44772790|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44772791|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44772792|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
44772793|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772794|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772795|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772796|NCT01829893|Urological Agents|urological agents|mesh-ancestor
44772797|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44772798|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44772799|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772800|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
44772801|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772802|NCT01830153|Everolimus|everolimus|mesh-list
44253403|NCT05170685|Nivolumab|nivolumab|mesh-list
44772803|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772804|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44772805|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
44772806|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772807|NCT01830244|Paclitaxel|paclitaxel|mesh-list
44772808|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44772809|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772810|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
44772811|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
44772812|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
44772813|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772814|NCT01830270|Paclitaxel|paclitaxel|mesh-list
44772815|NCT01830270|Cisplatin|cisplatin|mesh-list
44772816|NCT01830270|Epirubicin|epirubicin|mesh-list
44772817|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44772818|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772819|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44772820|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44772821|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44772822|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772823|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44772824|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44772825|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44772826|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772827|NCT01830530|Telmisartan|telmisartan|mesh-list
44772828|NCT01830530|Nifedipine|nifedipine|mesh-list
44772829|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772830|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44772831|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44772832|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772833|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44772834|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772835|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772836|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772837|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
44772838|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
44772839|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44772841|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
44772842|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772843|NCT01831050|Vaccines|vaccines|mesh-list
44772844|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
44772845|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772846|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
44772847|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772848|NCT01832311|Ketorolac|ketorolac|mesh-list
44772849|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44772850|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44772851|NCT01832311|Analgesics|analgesics|mesh-ancestor
44772852|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
44772853|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772854|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772855|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772856|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44772857|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44772858|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772859|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772860|NCT01832350|Quinidine|quinidine|mesh-list
44772861|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
44772862|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
44772863|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
44772864|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44772865|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44772866|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772867|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772868|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772869|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44772870|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44772871|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
44772872|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772873|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
44772874|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44772875|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44772876|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44772877|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772878|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44772879|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44772880|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
44772881|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44772882|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44772883|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772884|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44772885|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44772886|NCT01833221|Lidocaine|lidocaine|mesh-list
44772887|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772888|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
44772889|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772890|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772891|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
44772892|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772893|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772894|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44772895|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44772896|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772897|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772898|NCT01834820|Dexamethasone|dexamethasone|mesh-list
44772899|NCT01834820|Epinephrine|epinephrine|mesh-list
44772900|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772901|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
44772902|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
44772903|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772904|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772905|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44772906|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
44772907|NCT01834820|Hormones|hormones|mesh-ancestor
44772908|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772909|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44772910|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253490|NCT04954742|Riociguat|riociguat|mesh-list
44772911|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44772912|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44772913|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
44772914|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772915|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772916|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44772917|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44772918|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44772919|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
44772920|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
44772921|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
44772922|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44772923|NCT01835197|Abrocitinib|abrocitinib|mesh-list
44772924|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44772925|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772926|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772927|NCT01835418|Amlodipine|amlodipine|mesh-list
44772928|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44772929|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44772930|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772931|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772932|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44772933|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772934|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
44772935|NCT01835678|Linagliptin|linagliptin|mesh-list
44772936|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44772937|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772938|NCT01835678|Incretins|incretins|mesh-ancestor
44772939|NCT01835678|Hormones|hormones|mesh-ancestor
44772940|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772941|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44772942|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
44772943|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44772944|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772945|NCT01836614|Lidocaine|lidocaine|mesh-list
44772946|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772947|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
44772948|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772949|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461129|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
44772950|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
44772951|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772952|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44772953|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44772954|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44772955|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44772956|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772957|NCT01837251|Bevacizumab|bevacizumab|mesh-list
44772958|NCT01837251|Carboplatin|carboplatin|mesh-list
44772959|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44772960|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44772961|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44772962|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44772963|NCT01837251|Growth Substances|growth substances|mesh-ancestor
44772964|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461143|NCT01552915|Methylphenidate|methylphenidate|mesh-list
44772965|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
44772966|NCT01837290|Midazolam|midazolam|mesh-list
44772967|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
44772968|NCT01837290|Bupivacaine|bupivacaine|mesh-list
44772969|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
44772970|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
44772971|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44772972|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44772973|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
44772974|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44772975|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44772976|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44772977|NCT01837290|Analgesics|analgesics|mesh-ancestor
44550810|NCT01315249|Xhance|xhance|mesh-list
44772978|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44772979|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44772980|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44772981|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
44772982|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44772983|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44772984|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44772985|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44772986|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44772987|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44772988|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44772989|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
44772990|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
44772992|NCT01837433|Prednisone|prednisone|mesh-list
44772993|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
44772994|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44772995|NCT01837433|Hormones|hormones|mesh-ancestor
44772996|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44772997|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461153|NCT01552902|Methylphenidate|methylphenidate|mesh-list
44772998|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44772999|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773000|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
44773001|NCT01837446|Promethazine|promethazine|mesh-list
44773002|NCT01837446|Lidocaine|lidocaine|mesh-list
44773003|NCT01837446|Morphine|morphine|mesh-list
44773004|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44773005|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
44773006|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773007|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
44773008|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773009|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773010|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
44773011|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773012|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773013|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44773014|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44773015|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773016|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773017|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44773018|NCT01837446|Narcotics|narcotics|mesh-ancestor
44773019|NCT01837446|Analgesics|analgesics|mesh-ancestor
44773020|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44773021|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44773022|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
44773023|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
44773024|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773025|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44773026|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
44773027|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
44773028|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773029|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44773030|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
44773031|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44773032|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44773033|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
44773034|NCT01837446|Antacids|antacids|mesh-ancestor
44773035|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44773036|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773037|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44773038|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44773039|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773040|NCT01839344|Acarbose|acarbose|mesh-list
44773041|NCT01839344|Quercetin|quercetin|mesh-list
44773042|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44773043|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773044|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773045|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44773046|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773047|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
44773048|NCT01839344|Protective Agents|protective agents|mesh-ancestor
44773049|NCT01839578|Heparin|heparin|mesh-list
44773050|NCT01839578|Calcium heparin|calcium heparin|mesh-list
44550824|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44550825|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44550834|NCT01315249|Hormones|hormones|mesh-ancestor
44773051|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
44773052|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773053|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44773054|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44773055|NCT01839994|Androgens|androgens|mesh-list
44773056|NCT01839994|Hormones|hormones|mesh-ancestor
44773057|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773058|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550897|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44773059|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
44773060|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44773061|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44773062|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44773063|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773064|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
44773065|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44773066|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773067|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773068|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44773069|NCT01840254|Analgesics|analgesics|mesh-ancestor
44773070|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
44773071|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773072|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44773073|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44773074|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44773075|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
44773076|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773077|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773078|NCT01840384|Micronutrients|micronutrients|mesh-list
44773079|NCT01840384|Trace Elements|trace elements|mesh-list
44773080|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773081|NCT01840423|Levodopa|levodopa|mesh-list
44773082|NCT01840423|Carbidopa|carbidopa|mesh-list
44773083|NCT01840423|Entacapone|entacapone|mesh-list
44773084|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44773085|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44773086|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
44773087|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773088|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773089|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253597|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253611|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
44773090|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44773091|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773092|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44773093|NCT01840449|Lanreotide|lanreotide|mesh-list
44773094|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773095|NCT01840683|Heparin|heparin|mesh-list
44773096|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
44773097|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44773098|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44773099|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773100|NCT01840696|Regadenoson|regadenoson|mesh-list
44773101|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44773102|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44773103|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
44773104|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
44253626|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44773105|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773106|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773107|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773108|NCT01840774|Ketamine|ketamine|mesh-list
44773109|NCT01840774|Analgesics|analgesics|mesh-list
44773110|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
44773111|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773112|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773113|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44773114|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44773115|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
44773116|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
44773117|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773118|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44773119|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44773120|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773121|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773122|NCT01840800|Ropivacaine|ropivacaine|mesh-list
44773123|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773124|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
44773125|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773126|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773127|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
44773128|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773129|NCT01840813|Misoprostol|misoprostol|mesh-list
44773130|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44773131|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
44773132|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44773133|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773134|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44773135|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773136|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
44773137|NCT01841008|Tacrolimus|tacrolimus|mesh-list
44773138|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773139|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
44773140|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773141|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44773142|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773143|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773144|NCT01841099|Mesalamine|mesalamine|mesh-list
44773145|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44773146|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44773147|NCT01841099|Analgesics|analgesics|mesh-ancestor
44773148|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
44773149|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773150|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253662|NCT04504734|Analgesics|analgesics|mesh-ancestor
44773151|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773152|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773153|NCT01841112|BI 409306|bi 409306|mesh-list
44773154|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44773155|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773156|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773157|NCT01841125|Citalopram|citalopram|mesh-list
44773158|NCT01841125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44773159|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44773160|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773161|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773162|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773163|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
44773164|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773165|NCT01841125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44773166|NCT01841125|Antidepressive Agents|antidepressive agents|mesh-ancestor
44773167|NCT01841125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44773168|NCT01841164|Montelukast|montelukast|mesh-list
44773169|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44773170|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773171|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44773172|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
44773173|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773174|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773175|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44773176|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44253671|NCT04500236|Anesthetics|anesthetics|mesh-list
44773177|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773178|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
44773179|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
44773180|NCT01841242|Povidone|povidone|mesh-list
44773181|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44773182|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773183|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
44773184|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
44773185|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
44773186|NCT01841294|Lidocaine|lidocaine|mesh-list
44773187|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773188|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
44773189|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773190|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773191|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
44773192|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773193|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773194|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44773195|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44773196|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773197|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773198|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
44773199|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44773200|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
44773201|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253703|NCT04403698|Alendronate|alendronate|mesh-list
44773202|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773203|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44773204|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691244|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44773205|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44773206|NCT01841320|Methadone|methadone|mesh-list
44773207|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44773208|NCT01841320|Narcotics|narcotics|mesh-ancestor
44773209|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773210|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773211|NCT01841320|Analgesics|analgesics|mesh-ancestor
44773212|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
44773213|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773214|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
44773215|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773216|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
44773217|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773218|NCT01841411|Metronidazole|metronidazole|mesh-list
44773219|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
44773220|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44773221|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773222|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773223|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44773224|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44773225|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
44773226|NCT01841411|Expectorants|expectorants|mesh-ancestor
44461169|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773227|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773228|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44773229|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
44773230|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773231|NCT01841411|Protective Agents|protective agents|mesh-ancestor
44773232|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773233|NCT01841411|Antidotes|antidotes|mesh-ancestor
44773234|NCT01841424|Benzocaine|benzocaine|mesh-list
44773235|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773236|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
44773237|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773238|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773239|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
44773240|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773241|NCT01841463|Vemurafenib|vemurafenib|mesh-list
44773242|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773243|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44773244|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773245|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773246|NCT01841502|Paroxetine|paroxetine|mesh-list
44773247|NCT01841502|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44773248|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461181|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44461182|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44773249|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773250|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773251|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773252|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
44773253|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773254|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44773255|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
44773256|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44773257|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44773258|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44773259|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773260|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44773261|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
44773262|NCT01841515|Coagulants|coagulants|mesh-ancestor
44773263|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44773264|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
44773265|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773266|NCT01841658|Folic Acid|folic acid|mesh-list
44773267|NCT01841658|Hematinics|hematinics|mesh-ancestor
44773268|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
44773269|NCT01841658|Vitamins|vitamins|mesh-ancestor
44773270|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
44773271|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773272|NCT01841684|Anacetrapib|anacetrapib|mesh-list
44773273|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44773274|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44773275|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
44773276|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773277|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44551124|NCT01310777|Brinzolamide|brinzolamide|mesh-list
44773279|NCT01841775|Ribavirin|ribavirin|mesh-list
44773280|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773281|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
44773282|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773283|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
44461203|NCT01552369|Valganciclovir|valganciclovir|mesh-list
44773284|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773285|NCT01841827|Cilostazol|cilostazol|mesh-list
44773286|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44773287|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
44773288|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773289|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773290|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44773291|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773292|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44773293|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44773294|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773295|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44773296|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
44773297|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44773298|NCT01841827|Protective Agents|protective agents|mesh-ancestor
44773299|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44773300|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44773301|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773302|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44773303|NCT01842074|Bortezomib|bortezomib|mesh-list
44773304|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773305|NCT01842087|Iproplatin|iproplatin|mesh-list
44773306|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773307|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44773308|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773309|NCT01842113|Rifaximin|rifaximin|mesh-list
44773310|NCT01842113|Lactulose|lactulose|mesh-list
44773311|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773312|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773313|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773314|NCT01842139|Poly I-C|poly i-c|mesh-list
44773315|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44773316|NCT01842139|Poly ICLC|poly iclc|mesh-list
44773317|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44773318|NCT01842139|Basiliximab|basiliximab|mesh-list
44773319|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
44773320|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
44773321|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773322|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44773323|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773324|NCT01842139|Laxatives|laxatives|mesh-ancestor
44773325|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773326|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
44773327|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773328|NCT01842230|Niacin|niacin|mesh-list
44773329|NCT01842230|Amlodipine|amlodipine|mesh-list
44773330|NCT01842230|Telmisartan|telmisartan|mesh-list
44773331|NCT01842230|Atorvastatin|atorvastatin|mesh-list
44773332|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44773333|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44773334|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
44773335|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773336|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44773337|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44773338|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773339|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773340|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44773341|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773342|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44773343|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773344|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
44773345|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44773346|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44773347|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
44773348|NCT01842230|Vitamins|vitamins|mesh-ancestor
44773349|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
44773350|NCT01842256|Amlodipine|amlodipine|mesh-list
44773351|NCT01842256|Telmisartan|telmisartan|mesh-list
44773352|NCT01842256|Atorvastatin|atorvastatin|mesh-list
44773353|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44773354|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44773355|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
44773356|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773357|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44773358|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44773359|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773360|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773361|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44773362|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773363|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44551268|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44551269|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44773364|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773365|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
44773366|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44773367|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44773368|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
44773369|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44773370|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773371|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44773372|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
44773373|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773374|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773375|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773376|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773377|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
44773378|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773379|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44773380|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773381|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773382|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44773383|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773384|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253823|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44253847|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773385|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44773386|NCT01842373|Lidocaine|lidocaine|mesh-list
44773387|NCT01842373|Tetracaine|tetracaine|mesh-list
44773388|NCT01842373|Benzocaine|benzocaine|mesh-list
44773389|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773390|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
44773391|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773392|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773393|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
44773394|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773395|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773396|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44773397|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44773398|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773399|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773400|NCT01842516|Delpazolid|delpazolid|mesh-list
44773401|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
44773402|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773403|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773404|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44773405|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773406|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773407|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
44773408|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44773409|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773410|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773411|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
44773412|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773413|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773414|NCT01842893|Fentanyl|fentanyl|mesh-list
44551270|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
44551271|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551272|NCT01307579|Fluconazole|fluconazole|mesh-list
44551273|NCT01307579|Caspofungin|caspofungin|mesh-list
44551274|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
44551275|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551276|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44551277|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44551278|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551280|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44773415|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44253866|NCT04115644|Hormones|hormones|mesh-ancestor
44773416|NCT01842893|Narcotics|narcotics|mesh-ancestor
44773417|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773418|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773419|NCT01842893|Analgesics|analgesics|mesh-ancestor
44773420|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
44253889|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
44773421|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773422|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44773423|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44773424|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
44773425|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
44773426|NCT01842932|Bromides|bromides|mesh-list
44773427|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44773428|NCT01842932|Cimetropium|cimetropium|mesh-list
44773429|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
44773430|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
43549132|NCT03635411|Niacin|niacin|mesh-list
44773431|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773432|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773433|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773434|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
44773435|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
44773436|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773437|NCT01843010|Parecoxib|parecoxib|mesh-list
44773438|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44773439|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44773440|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773441|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773442|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44773443|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44773444|NCT01843010|Analgesics|analgesics|mesh-ancestor
44773445|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
44773446|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773447|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773448|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773449|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773450|NCT01843075|Liraglutide|liraglutide|mesh-list
44773451|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44773452|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773453|NCT01843075|Incretins|incretins|mesh-ancestor
44773454|NCT01843075|Hormones|hormones|mesh-ancestor
44773455|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773456|NCT01843088|Mannitol|mannitol|mesh-list
44773457|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44773458|NCT01843088|Diuretics|diuretics|mesh-ancestor
44773459|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
44773460|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773461|NCT01843127|Exenatide|exenatide|mesh-list
44773462|NCT01843127|Ranolazine|ranolazine|mesh-list
44773463|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44773464|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773465|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44773466|NCT01843127|Incretins|incretins|mesh-ancestor
44773467|NCT01843127|Hormones|hormones|mesh-ancestor
44774313|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44773468|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773469|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44773470|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773471|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773472|NCT01843153|Ropivacaine|ropivacaine|mesh-list
44773473|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773474|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
44773475|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773476|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773477|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
44773478|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253941|NCT03879135|Factor VIII|factor viii|mesh-list
44773479|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44773480|NCT01843166|Estrogens|estrogens|mesh-ancestor
44773481|NCT01843166|Hormones|hormones|mesh-ancestor
44773482|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773483|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773484|NCT01843179|Cytarabine|cytarabine|mesh-list
44773485|NCT01843179|Sulindac|sulindac|mesh-list
44773486|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773487|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
44773488|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773489|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773490|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
44773491|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773492|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773493|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
44773494|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773495|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44773496|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44773497|NCT01843179|Analgesics|analgesics|mesh-ancestor
44773498|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
44773499|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773500|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773501|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773502|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44773503|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773504|NCT01843257|Ethanol|ethanol|mesh-list
44773505|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44773506|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773507|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773508|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773509|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
44773510|NCT01843296|Fentanyl|fentanyl|mesh-list
44773511|NCT01843296|Bupivacaine|bupivacaine|mesh-list
44773512|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773513|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
44773514|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773515|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773516|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
44773517|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773518|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44773519|NCT01843296|Narcotics|narcotics|mesh-ancestor
44773520|NCT01843296|Analgesics|analgesics|mesh-ancestor
44773521|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44773522|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44773523|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
44773524|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773525|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
44773526|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44773527|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773528|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773529|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44773530|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
44773531|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44773532|NCT01843309|Spironolactone|spironolactone|mesh-list
44773533|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44773534|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
44773535|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773536|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773537|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44773538|NCT01843309|Diuretics|diuretics|mesh-ancestor
44773539|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
44773540|NCT01843439|Pyridoxine|pyridoxine|mesh-list
44773541|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
44773542|NCT01843439|Vitamins|vitamins|mesh-ancestor
44773543|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
44254002|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44773544|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773545|NCT01843452|Capecitabine|capecitabine|mesh-list
44773546|NCT01843452|Mitomycins|mitomycins|mesh-list
44773547|NCT01843452|Mitomycin|mitomycin|mesh-list
44773548|NCT01843452|Panitumumab|panitumumab|mesh-list
44773549|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773550|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
44773551|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773552|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773553|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44773554|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
44773555|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44773556|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773557|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44773558|NCT01843530|Cortisone|cortisone|mesh-list
44773559|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773560|NCT01843556|Donepezil|donepezil|mesh-list
44773561|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44773562|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551363|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44773563|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773564|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44773565|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773566|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773567|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
44773568|NCT01843647|Cisplatin|cisplatin|mesh-list
44773569|NCT01843647|Vinorelbine|vinorelbine|mesh-list
44773570|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773571|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44461233|NCT01551212|Everolimus|everolimus|mesh-list
44773572|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
44773573|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
44773574|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
44773575|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773576|NCT01843699|Topiramate|topiramate|mesh-list
44773577|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
44773578|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44773579|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773580|NCT01843725|Capecitabine|capecitabine|mesh-list
44773581|NCT01843725|Aflibercept|aflibercept|mesh-list
44773582|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773583|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
44773584|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773585|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773586|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44773587|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44773588|NCT01843725|Growth Substances|growth substances|mesh-ancestor
44773589|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773590|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
44773591|NCT01843738|Vemurafenib|vemurafenib|mesh-list
44773592|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773593|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44773594|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773595|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773596|NCT01843829|Paclitaxel|paclitaxel|mesh-list
44773597|NCT01843829|Carboplatin|carboplatin|mesh-list
44773598|NCT01843829|Capecitabine|capecitabine|mesh-list
44773599|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
44773600|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44773601|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773602|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44773603|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44773604|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44461268|NCT01549886|Rituximab|rituximab|mesh-list
44773605|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773606|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773607|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
44773608|NCT01843868|Prednisolone|prednisolone|mesh-list
44773609|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
44773610|NCT01843868|Doxorubicin|doxorubicin|mesh-list
44773611|NCT01843868|Vincristine|vincristine|mesh-list
44773612|NCT01843868|Lorazepam|lorazepam|mesh-list
44773613|NCT01843868|Ondansetron|ondansetron|mesh-list
44773614|NCT01843868|Aprepitant|aprepitant|mesh-list
44773615|NCT01843868|Palonosetron|palonosetron|mesh-list
44773616|NCT01843868|Metoclopramide|metoclopramide|mesh-list
44773617|NCT01843868|Granisetron|granisetron|mesh-list
44773618|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
44773619|NCT01843868|Tropisetron|tropisetron|mesh-list
44773620|NCT01843868|Antiemetics|antiemetics|mesh-list
44773621|NCT01843868|Emetics|emetics|mesh-list
44773622|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773623|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
44773624|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773625|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773626|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44773627|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
44773628|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773629|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773630|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44773631|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44773632|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44773633|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44773634|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773635|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44773636|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
44773637|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
44773638|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44773639|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44773640|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
44773641|NCT01843868|Hormones|hormones|mesh-ancestor
44773642|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773643|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44773644|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
44773645|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773646|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773647|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
44773648|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44773649|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44773650|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
44773651|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773652|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44773653|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44773654|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254044|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
44773655|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44773656|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44773657|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44773658|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44773659|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44773660|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44773661|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
44773662|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
44773663|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44773664|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
44773665|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
44773667|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773668|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773669|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44773670|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773671|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
44773672|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773673|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
44773674|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773675|NCT01844024|Misoprostol|misoprostol|mesh-list
44773676|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44254051|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44773677|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
44773678|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44773679|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773680|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44773681|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773682|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
44773683|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
44773684|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773685|NCT01844141|Ethanol|ethanol|mesh-list
44773686|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
44773687|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44773688|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44773689|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773690|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773691|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773692|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
44773693|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
44773694|NCT01844323|Palbociclib|palbociclib|mesh-list
44773695|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773696|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44773697|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254085|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773698|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773699|NCT01844401|Albuterol|albuterol|mesh-list
44773700|NCT01844401|Procaterol|procaterol|mesh-list
44773701|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44773702|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
44773703|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773704|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773705|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44773706|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773707|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
44773708|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44773709|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44254098|NCT03521102|Acetaminophen|acetaminophen|mesh-list
44254100|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44773710|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44773711|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44551582|NCT01302938|Urological Agents|urological agents|mesh-ancestor
44551583|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44551584|NCT01302899|Ramipril|ramipril|mesh-list
44551585|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551586|NCT01302899|Diuretics|diuretics|mesh-ancestor
44551587|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
44551588|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551589|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44551590|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551592|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44773712|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
44773713|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773714|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773715|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
44773716|NCT01844427|Memantine|memantine|mesh-list
44773717|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44773718|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44773719|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
44773720|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774314|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44773721|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773722|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773723|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44773724|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44773725|NCT01844622|Domperidone|domperidone|mesh-list
44773726|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
44773727|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
44773728|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773729|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773730|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254125|NCT03364868|Insulin|insulin|mesh-list
44773731|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44773732|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
44773733|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774315|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44773734|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773735|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
44773736|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
44773737|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773738|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773739|NCT01844648|Tropicamide|tropicamide|mesh-list
44773740|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
44773741|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
44773742|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773743|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773744|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44773745|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44773746|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
44773747|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773748|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773749|NCT01844674|Vemurafenib|vemurafenib|mesh-list
44773750|NCT01844674|Tizanidine|tizanidine|mesh-list
44773751|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773752|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44773753|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773754|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773755|NCT01844674|Analgesics|analgesics|mesh-ancestor
44773756|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
44773757|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773758|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773759|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
44773760|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44773761|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44773762|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
44773763|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
44773764|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44773765|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44773766|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44773767|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
44773768|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773769|NCT01844791|Gemcitabine|gemcitabine|mesh-list
44773770|NCT01844791|Pentamidine|pentamidine|mesh-list
44773771|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773772|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
44773773|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773774|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691245|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691246|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691247|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691248|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691249|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691250|NCT01359826|Analgesics|analgesics|mesh-ancestor
44691251|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
44254176|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44691252|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691253|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551612|NCT01302691|Diuretics|diuretics|mesh-ancestor
44773775|NCT01844791|Antiviral Agents|antiviral agents|mesh-ancestor
44773776|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773777|NCT01844791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773778|NCT01844791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44773779|NCT01844791|Immunologic Factors|immunologic factors|mesh-ancestor
44773780|NCT01844791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773781|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
44773782|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44773783|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44773784|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44773786|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
44773787|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773788|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773789|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
43651974|NCT03003884|Propofol|propofol|mesh-list
44773790|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44773791|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773792|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44773793|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773794|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773795|NCT01844947|Sorafenib|sorafenib|mesh-list
44773796|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254200|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773797|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44773798|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773799|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773800|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
44773801|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44773802|NCT01845038|Timolol|timolol|mesh-list
44773803|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44773804|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44773805|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
44773806|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44773807|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773808|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773809|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44254210|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
44773810|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773811|NCT01845064|Kallikreins|kallikreins|mesh-list
44773812|NCT01845064|Coagulants|coagulants|mesh-ancestor
44773813|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44773814|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
44773815|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44773816|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773817|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
44773818|NCT01845090|Calcium|calcium|mesh-list
44773819|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44773820|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773821|NCT01845090|Antacids|antacids|mesh-ancestor
44773822|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773823|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44773824|NCT01845142|Vitamin D|vitamin d|mesh-list
44773825|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
44773826|NCT01845142|Vitamins|vitamins|mesh-ancestor
44773827|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
44773828|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773829|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44773830|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44773831|NCT01845194|Metoprolol|metoprolol|mesh-list
44773832|NCT01845194|Talinolol|talinolol|mesh-list
44773833|NCT01845194|Torsemide|torsemide|mesh-list
44773834|NCT01845194|Midazolam|midazolam|mesh-list
44773835|NCT01845194|Codeine|codeine|mesh-list
44773836|NCT01845194|Caffeine|caffeine|mesh-list
44773837|NCT01845194|Pravastatin|pravastatin|mesh-list
44773838|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44773839|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44773840|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773841|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773842|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44773843|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44773844|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44773845|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44773846|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
44773847|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
44773848|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
44773849|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
44773850|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774316|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44773851|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773852|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44773853|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44773854|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773855|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44773856|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44773857|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
44773858|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773859|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44254267|NCT03013504|Trastuzumab|trastuzumab|mesh-list
44773860|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
44773861|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
44773862|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773863|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44773864|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44773865|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44773866|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
44773867|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44773868|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44773869|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
44773870|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44773871|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44773872|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44773873|NCT01845194|Narcotics|narcotics|mesh-ancestor
44773874|NCT01845194|Analgesics|analgesics|mesh-ancestor
44773875|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
44773876|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
44773877|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
44773878|NCT01845194|Diuretics|diuretics|mesh-ancestor
44773879|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
44774317|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773880|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44773881|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773882|NCT01845246|Colistin|colistin|mesh-list
44773883|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773884|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773885|NCT01845259|Liraglutide|liraglutide|mesh-list
44773886|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44055057|NCT00004446|Fluoxetine|fluoxetine|mesh-list
44773887|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773888|NCT01845259|Incretins|incretins|mesh-ancestor
44773889|NCT01845259|Hormones|hormones|mesh-ancestor
44773890|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44773891|NCT01845272|Amlodipine|amlodipine|mesh-list
44773892|NCT01845272|Candesartan|candesartan|mesh-list
44773893|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
44773894|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773895|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44773896|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44773897|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773898|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44773899|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773900|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
44773901|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44773902|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44773903|NCT01845298|Rifampin|rifampin|mesh-list
44773904|NCT01845298|Rifamycins|rifamycins|mesh-list
44773905|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44773906|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
44773907|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44773908|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773909|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
44773910|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44773911|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44773912|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773913|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44773914|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055258|NCT00004489|Antacids|antacids|mesh-ancestor
44773915|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44773916|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44773917|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44773918|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44773919|NCT01845337|Capecitabine|capecitabine|mesh-list
44773920|NCT01845337|Tegafur|tegafur|mesh-list
44773921|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44773922|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
44551740|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551741|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
44551742|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551743|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44551744|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44773923|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773924|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773926|NCT01845363|Cefazolin|cefazolin|mesh-list
44773927|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44773928|NCT01845376|Anesthetics|anesthetics|mesh-list
44773929|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773930|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773931|NCT01845428|Pravastatin|pravastatin|mesh-list
44773932|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44773933|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44773934|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
44773935|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773936|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44773937|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44773938|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551810|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44773939|NCT01845493|Sulforaphane|sulforaphane|mesh-list
44773940|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44773941|NCT01845493|Protective Agents|protective agents|mesh-ancestor
44773942|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773943|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773944|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44773945|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
44773946|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
44773947|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44773948|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773949|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
44773950|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44773951|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44773952|NCT01845558|Wobenzym|wobenzym|mesh-list
44773953|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44773954|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
44773955|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773956|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
44773957|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44773958|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
44773959|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44773960|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
44773961|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773962|NCT01845610|Manganese|manganese|mesh-list
44773963|NCT01845610|Trace Elements|trace elements|mesh-ancestor
44773964|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
44773965|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773966|NCT01845675|Temozolomide|temozolomide|mesh-list
44773967|NCT01845675|Dacarbazine|dacarbazine|mesh-list
44773968|NCT01845675|Endostatins|endostatins|mesh-list
44773969|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44773970|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
44773971|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773972|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773973|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44254370|NCT02757872|Vitamin D|vitamin d|mesh-list
44773974|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44773975|NCT01845675|Growth Substances|growth substances|mesh-ancestor
44773976|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44773977|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
44773978|NCT01845688|Losartan|losartan|mesh-list
44773979|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44773980|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44773981|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44773982|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44773983|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44773984|NCT01845701|Artesunate|artesunate|mesh-list
44773985|NCT01845701|Lumefantrine|lumefantrine|mesh-list
44773986|NCT01845701|Artemether|artemether|mesh-list
44773987|NCT01845701|Piperaquine|piperaquine|mesh-list
44773988|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44773989|NCT01845701|Amodiaquine|amodiaquine|mesh-list
44254391|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
44773990|NCT01845701|Artenimol|artenimol|mesh-list
44773991|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
44773992|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44773993|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44773994|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44773995|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44773996|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
44773997|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
44773998|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44773999|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
44774000|NCT01845727|Amphotericin B|amphotericin b|mesh-list
44774001|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44774002|NCT01845727|Amebicides|amebicides|mesh-ancestor
44774003|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44774004|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44774005|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774006|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774007|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
44774008|NCT01845844|Ranibizumab|ranibizumab|mesh-list
44774009|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44774010|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44774011|NCT01845844|Growth Substances|growth substances|mesh-ancestor
44774012|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774013|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
44774014|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774015|NCT01846026|Vitamin D|vitamin d|mesh-list
44774016|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
44774017|NCT01846026|Vitamins|vitamins|mesh-ancestor
44774018|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
44774019|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774020|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44774021|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774022|NCT01846117|Vitamin D|vitamin d|mesh-list
44774023|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
44774024|NCT01846117|Vitamins|vitamins|mesh-ancestor
44774025|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
44774026|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774027|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44774028|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
44774029|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44774030|NCT01846117|Estrogens|estrogens|mesh-ancestor
44774031|NCT01846117|Hormones|hormones|mesh-ancestor
44774032|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774033|NCT01846143|Poly ICLC|poly iclc|mesh-list
44774034|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
44774035|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774036|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
44774037|NCT01846273|Ranibizumab|ranibizumab|mesh-list
44774038|NCT01846273|Verteporfin|verteporfin|mesh-list
44774039|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44774040|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44774041|NCT01846273|Growth Substances|growth substances|mesh-ancestor
44774042|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774043|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
44774044|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774045|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44774046|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774047|NCT01846325|Vitamin E|vitamin e|mesh-list
44774048|NCT01846325|Vitamins|vitamins|mesh-ancestor
44774049|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
44774050|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774051|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
44774052|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774053|NCT01846325|Protective Agents|protective agents|mesh-ancestor
44774054|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44774055|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44774056|NCT01846364|Protective Agents|protective agents|mesh-ancestor
44774057|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774058|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774059|NCT01846390|Gemcitabine|gemcitabine|mesh-list
44774060|NCT01846390|Dexamethasone|dexamethasone|mesh-list
44774061|NCT01846390|Cisplatin|cisplatin|mesh-list
44774062|NCT01846390|Romidepsin|romidepsin|mesh-list
44774063|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774064|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
44774065|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
44774066|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774067|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774068|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44774069|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
44774070|NCT01846390|Hormones|hormones|mesh-ancestor
44774071|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774072|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44774073|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774074|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774075|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
44774076|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774077|NCT01846390|Antiviral Agents|antiviral agents|mesh-ancestor
44254457|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774078|NCT01846390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774079|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774080|NCT01846390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774081|NCT01846390|Immunologic Factors|immunologic factors|mesh-ancestor
44774082|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44774083|NCT01846559|Clopidogrel|clopidogrel|mesh-list
44774084|NCT01846559|Ticagrelor|ticagrelor|mesh-list
44774085|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44774086|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44774087|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44774088|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44774089|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
44774090|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774091|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774092|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774093|NCT01846650|Capecitabine|capecitabine|mesh-list
44552030|NCT01297517|Brinzolamide|brinzolamide|mesh-list
44774094|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774095|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
44774096|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774097|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774098|NCT01846806|Rifaximin|rifaximin|mesh-list
44774099|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774100|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774101|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44774102|NCT01846832|Interferons|interferons|mesh-list
44774103|NCT01846832|Ribavirin|ribavirin|mesh-list
44774104|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
44774105|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
44774106|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44774107|NCT01846832|Simeprevir|simeprevir|mesh-list
44774108|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774109|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
44774110|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774111|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
44774112|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774113|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
44774114|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774115|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44774116|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774117|NCT01846962|Fluticasone|fluticasone|mesh-list
44774118|NCT01846962|Budesonide|budesonide|mesh-list
44774119|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774120|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44774121|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
44774122|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774123|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774124|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44774125|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774126|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774127|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44774128|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
44774129|NCT01846962|Hormones|hormones|mesh-ancestor
44774130|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774131|NCT01846975|Abatacept|abatacept|mesh-list
44774132|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44774133|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774134|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774135|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774136|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
44774137|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774138|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774139|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44774140|NCT01847144|Gliclazide|gliclazide|mesh-list
44774141|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44774142|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44774143|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774144|NCT01847144|Incretins|incretins|mesh-ancestor
44774145|NCT01847144|Hormones|hormones|mesh-ancestor
44774146|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254519|NCT01188096|Poly ICLC|poly iclc|mesh-list
44774147|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
44774148|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774149|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774150|NCT01847157|Anesthetics|anesthetics|mesh-list
44774151|NCT01847157|Prilocaine|prilocaine|mesh-list
44774152|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774153|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774154|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
44774155|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
44552031|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44552032|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44552033|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44552034|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44552035|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44552036|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
44552037|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552038|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552039|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552040|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44552041|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254565|NCT00302744|Vitamins|vitamins|mesh-ancestor
44552042|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44774156|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774157|NCT01847235|Temozolomide|temozolomide|mesh-list
44774158|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44774159|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
44774160|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774161|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774162|NCT01847326|Paclitaxel|paclitaxel|mesh-list
44774163|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44774164|NCT01847326|Carboplatin|carboplatin|mesh-list
44774165|NCT01847326|Fluorouracil|fluorouracil|mesh-list
44774166|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
44774167|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774168|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774169|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774170|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774171|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774172|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774173|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
44774174|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774175|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774176|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
44774177|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774178|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
44774179|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774180|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552044|NCT01297465|Hormones|hormones|mesh-ancestor
44774181|NCT01847339|Bupivacaine|bupivacaine|mesh-list
44774182|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
44774183|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
44254566|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
44254597|NCT00611143|Atorvastatin|atorvastatin|mesh-list
44254598|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44774184|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774185|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774186|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
44774187|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774188|NCT01847404|Pantoprazole|pantoprazole|mesh-list
44774189|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774190|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774191|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44774192|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44774193|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44774194|NCT01847417|Pantoprazole|pantoprazole|mesh-list
44774195|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44774196|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254599|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44774197|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44774198|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774199|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774201|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44774202|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44774203|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774204|NCT01847495|Irinotecan|irinotecan|mesh-list
44774205|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44774206|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44774207|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774208|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254611|NCT00611195|Propofol|propofol|mesh-list
44774209|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774210|NCT01847521|Quercetin|quercetin|mesh-list
44774211|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
44774212|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774213|NCT01847521|Protective Agents|protective agents|mesh-ancestor
44774214|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774215|NCT01847599|Capecitabine|capecitabine|mesh-list
44774216|NCT01847599|Lapatinib|lapatinib|mesh-list
44774217|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774218|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
44774219|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774220|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774221|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44774222|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774223|NCT01847612|Methylene Blue|methylene blue|mesh-list
44774224|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774225|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774226|NCT01847664|Rifamycins|rifamycins|mesh-list
44774227|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
44774228|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774229|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774230|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774231|NCT01847677|Paclitaxel|paclitaxel|mesh-list
44774232|NCT01847677|Bevacizumab|bevacizumab|mesh-list
44774233|NCT01847677|Carboplatin|carboplatin|mesh-list
44774234|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774235|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774236|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774237|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774238|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774239|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774240|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774241|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44774242|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461328|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
44954564|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954565|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954566|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44954567|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44954568|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44954569|NCT05167370|Amifostine|amifostine|mesh-list
44954570|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44954571|NCT05167370|Protective Agents|protective agents|mesh-ancestor
44954572|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954573|NCT05156879|Aspirin|aspirin|mesh-list
44954574|NCT05156879|Drospirenone|drospirenone|mesh-list
44954575|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44954576|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44954577|NCT05156879|Estradiol|estradiol|mesh-list
44954578|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44954579|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44954580|NCT05156879|Analgesics|analgesics|mesh-ancestor
44954581|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
44954582|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954583|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954584|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954585|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954586|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44954587|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44954588|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954589|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44954590|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44954591|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954592|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
44954593|NCT05156879|Estrogens|estrogens|mesh-ancestor
44954594|NCT05156879|Hormones|hormones|mesh-ancestor
44954595|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954596|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44954597|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
44954598|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44954599|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44954600|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44954601|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44954602|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44954603|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
44954604|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44954605|NCT05156879|Diuretics|diuretics|mesh-ancestor
44954606|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
44954607|NCT05136560|Dexamethasone|dexamethasone|mesh-list
44954608|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
44954609|NCT05136560|BB 1101|bb 1101|mesh-list
44954610|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954611|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
44954612|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
44954613|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954614|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954615|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954616|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
44954617|NCT05136560|Hormones|hormones|mesh-ancestor
44954618|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954619|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954620|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954621|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
44954622|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954623|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954624|NCT05125523|Sirolimus|sirolimus|mesh-list
44954625|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954626|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954627|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44954628|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954629|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
44954630|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954631|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
44954632|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954633|NCT05124678|Isoniazid|isoniazid|mesh-list
44954634|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
44954635|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954636|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954637|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44954638|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44254626|NCT00611286|Everolimus|everolimus|mesh-list
44954639|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
44954640|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954641|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44954642|NCT05083910|Misoprostol|misoprostol|mesh-list
44954643|NCT05083910|Oxytocin|oxytocin|mesh-list
44954644|NCT05083910|Carbetocin|carbetocin|mesh-list
44954645|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
44707248|NCT01432717|Luspatercept|luspatercept|mesh-list
44954646|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44954647|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954648|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44954649|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
44954650|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44954651|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954652|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
44954653|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
44954654|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
44954655|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44954656|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44954657|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954658|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954659|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954660|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954661|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44954662|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954663|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44954664|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954665|NCT05079841|Oxytocin|oxytocin|mesh-list
44954666|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
44954667|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44954668|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954669|NCT05055999|Atezolizumab|atezolizumab|mesh-list
44954670|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954671|NCT05055947|Atezolizumab|atezolizumab|mesh-list
44954672|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954673|NCT05055908|Atezolizumab|atezolizumab|mesh-list
44954674|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954675|NCT05003076|Methamphetamine|methamphetamine|mesh-list
44954676|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44954677|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954678|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
44954679|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
44954680|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954681|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
44954682|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954683|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954684|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954685|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44954686|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44954687|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44954688|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44954689|NCT04949022|Insulin|insulin|mesh-list
44954690|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44954691|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954692|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
44954693|NCT04917029|Bupivacaine|bupivacaine|mesh-list
44954694|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
44954695|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
44954696|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954697|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954698|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
44954699|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954700|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44954701|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44954702|NCT04917029|Analgesics|analgesics|mesh-ancestor
44954703|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44954704|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44954705|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44954706|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954707|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954708|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954709|NCT04892420|Dexamethasone|dexamethasone|mesh-list
44954710|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
44954711|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
44954712|NCT04892420|Bupivacaine|bupivacaine|mesh-list
44954713|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954714|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
44954715|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
44954716|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954717|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954718|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954719|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
44954720|NCT04892420|Hormones|hormones|mesh-ancestor
44954721|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954722|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954723|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954724|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
44954725|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
44954726|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954727|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
44954728|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44486005|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
44486006|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44486007|NCT04962126|Atezolizumab|atezolizumab|mesh-list
44486008|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
44486009|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44486010|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486011|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486012|NCT04958785|Paclitaxel|paclitaxel|mesh-list
44486013|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44486014|NCT04958785|Magrolimab|magrolimab|mesh-list
44486015|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486016|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486017|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486018|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486019|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486022|NCT04957095|Levodopa|levodopa|mesh-list
44954729|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44954730|NCT04892420|Analgesics|analgesics|mesh-ancestor
44954731|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44954732|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44954733|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44954734|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954735|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954736|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954737|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44954738|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
44954739|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44954740|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44954741|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44954742|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
44954743|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44954744|NCT04876677|Beclomethasone|beclomethasone|mesh-list
44954745|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
44954746|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
44954747|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44954748|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
44954749|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954750|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954751|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44954752|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
44954753|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44954754|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44954755|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44954756|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954757|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954758|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954759|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954760|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
44954761|NCT04876677|Hormones|hormones|mesh-ancestor
44954762|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954763|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44954764|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44954765|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44954766|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
44954767|NCT04716699|Lidocaine|lidocaine|mesh-list
44954768|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
44954769|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
44954770|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954771|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954772|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
44954773|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954774|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44954775|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44954776|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44774243|NCT01847677|Growth Substances|growth substances|mesh-ancestor
44954777|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44954778|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954779|NCT04708145|Aflibercept|aflibercept|mesh-list
44954780|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44954781|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44954782|NCT04708145|Growth Substances|growth substances|mesh-ancestor
44954783|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954784|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
44954785|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954786|NCT04688177|Nicotine|nicotine|mesh-list
44954787|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
44954788|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44954789|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
44954790|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44954791|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954792|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44954793|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44954794|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
44954795|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954796|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954797|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
44954798|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
44954799|NCT04671810|Eculizumab|eculizumab|mesh-list
44954800|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44954801|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954802|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
44254803|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
44954803|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954804|NCT04671615|Palbociclib|palbociclib|mesh-list
44954805|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954806|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954807|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954808|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954810|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
44954811|NCT04668365|Rituximab|rituximab|mesh-list
44954812|NCT04668365|Vincristine|vincristine|mesh-list
44954813|NCT04668365|Epirubicin|epirubicin|mesh-list
44954814|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
44954815|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44954816|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
44954817|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954818|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954819|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954820|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
44954821|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954822|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954823|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44954824|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954825|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954826|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
44954827|NCT04668365|Hormones|hormones|mesh-ancestor
44954828|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44954829|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44954830|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44954831|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954832|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954833|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954834|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44954835|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44954836|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954837|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954838|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44954839|NCT04629378|Amoxicillin|amoxicillin|mesh-list
44954840|NCT04629378|Meropenem|meropenem|mesh-list
44954841|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
44954842|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
44954843|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
44954844|NCT04629378|Bedaquiline|bedaquiline|mesh-list
44954845|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44954846|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954847|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954848|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44954849|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954850|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954851|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
44954852|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44954853|NCT04616183|Cetuximab|cetuximab|mesh-list
44954854|NCT04616183|Antibodies|antibodies|mesh-list
44954855|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
44954856|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44954857|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
44954858|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954859|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954860|NCT04608318|Venetoclax|venetoclax|mesh-list
44954861|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
44954862|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954863|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954864|NCT04606069|Regadenoson|regadenoson|mesh-list
44954865|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44954866|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44954867|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
44954868|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
44954869|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44954870|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954871|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954872|NCT04603846|Paclitaxel|paclitaxel|mesh-list
44954873|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44954874|NCT04603846|Antibodies|antibodies|mesh-list
44954875|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44954876|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954877|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44954878|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44954879|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44954880|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954881|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
44954882|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954883|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44954884|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954885|NCT04578106|Trastuzumab|trastuzumab|mesh-list
44954886|NCT04578106|Pertuzumab|pertuzumab|mesh-list
44954887|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954888|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954889|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
44954890|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
44954891|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44954892|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44954893|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
44954894|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954895|NCT04549376|Iodine|iodine|mesh-list
44954896|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
44954897|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
44954898|NCT04549376|Povidone|povidone|mesh-list
44954899|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44954900|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954901|NCT04549376|Trace Elements|trace elements|mesh-ancestor
44954902|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
44954903|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954904|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
44954905|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
44954906|NCT04528134|Listerine|listerine|mesh-list
44954907|NCT04528134|Fluorides|fluorides|mesh-list
44954908|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
44954909|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
44954910|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
44954911|NCT04528134|Protective Agents|protective agents|mesh-ancestor
44954912|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954913|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44954914|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954915|NCT04502381|Amphotericin B|amphotericin b|mesh-list
44954916|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44954917|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
44954918|NCT04502381|Amebicides|amebicides|mesh-ancestor
44954919|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44954920|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44954921|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954922|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954923|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
44954924|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44954925|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44954926|NCT04472182|Calcium|calcium|mesh-list
44954927|NCT04472182|Fluorides|fluorides|mesh-list
44954928|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
44954929|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44954930|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954931|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
44954932|NCT04472182|Protective Agents|protective agents|mesh-ancestor
44954933|NCT04462965|Temozolomide|temozolomide|mesh-list
44954934|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44954935|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
44954936|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954937|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954938|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
44954939|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44954940|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954941|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44954942|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44954943|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954944|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954945|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954946|NCT04409509|Antibodies|antibodies|mesh-list
44954947|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44954948|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
44954949|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954950|NCT04401865|Riboflavin|riboflavin|mesh-list
44954951|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
44954952|NCT04401865|Vitamins|vitamins|mesh-ancestor
44954953|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
44954954|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954955|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44954956|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
44954957|NCT04349371|Chloroquine|chloroquine|mesh-list
44954958|NCT04349371|Amebicides|amebicides|mesh-ancestor
44954959|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44954960|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44954961|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44954962|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
44954963|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954964|NCT04284657|Citric Acid|citric acid|mesh-list
44486289|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
44486290|NCT04790903|Rituximab|rituximab|mesh-list
44486291|NCT04790903|Doxorubicin|doxorubicin|mesh-list
44486292|NCT04790903|Venetoclax|venetoclax|mesh-list
44486293|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486294|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
44486295|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486296|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44486297|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44486298|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
44486299|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486300|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486301|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44486302|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486303|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44486304|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44486305|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44486309|NCT04790903|Hormones|hormones|mesh-ancestor
44954965|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
44954966|NCT04284657|Pravastatin|pravastatin|mesh-list
44954967|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
44954968|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44954969|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
44954970|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
44954971|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954972|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44954973|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44954974|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
44954975|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44954976|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44954977|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44954978|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
44954979|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
44954980|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44954981|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774244|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954982|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44954983|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
44954984|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44954985|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44954986|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954987|NCT04161248|Gemcitabine|gemcitabine|mesh-list
44954988|NCT04161248|Dexamethasone|dexamethasone|mesh-list
44954989|NCT04161248|Rituximab|rituximab|mesh-list
44954990|NCT04161248|Cisplatin|cisplatin|mesh-list
44954991|NCT04161248|Venetoclax|venetoclax|mesh-list
44954992|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44954993|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44954994|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
44954995|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44954996|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44954997|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44954998|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
44954999|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
44955000|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955001|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44955002|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
44955003|NCT04161248|Hormones|hormones|mesh-ancestor
44955004|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955005|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44955006|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955007|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
44955008|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955009|NCT04161248|Antiviral Agents|antiviral agents|mesh-ancestor
44955010|NCT04161248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955011|NCT04161248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955012|NCT04161248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255047|NCT00613145|Capecitabine|capecitabine|mesh-list
44955013|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44955014|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44955015|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
44955016|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955017|NCT04136548|Fentanyl|fentanyl|mesh-list
44955018|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44955019|NCT04136548|Narcotics|narcotics|mesh-ancestor
44955020|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955021|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955022|NCT04136548|Analgesics|analgesics|mesh-ancestor
44955023|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
44955024|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955025|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44955026|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955027|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
44955028|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
44955029|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44955030|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44955031|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44955032|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955033|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955034|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955035|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955036|NCT04111627|Analgesics|analgesics|mesh-ancestor
44774245|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44955037|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
44955038|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955039|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
44955040|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44486367|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
44955041|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
44955042|NCT04087395|Lidocaine|lidocaine|mesh-list
44955043|NCT04087395|Anesthetics|anesthetics|mesh-list
44955044|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955045|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955046|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955047|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
44955048|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955049|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955050|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44255077|NCT00613457|Cytarabine|cytarabine|mesh-list
44955051|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44955052|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955053|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955054|NCT04074785|Bevacizumab|bevacizumab|mesh-list
44955055|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955056|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955057|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44955058|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44955059|NCT04074785|Growth Substances|growth substances|mesh-ancestor
44955060|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955061|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
44955062|NCT04069585|Lidocaine|lidocaine|mesh-list
44955063|NCT04069585|Anesthetics|anesthetics|mesh-list
44255090|NCT00613457|Vindesine|vindesine|mesh-list
44955064|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955065|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955066|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955067|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
44955068|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955069|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955070|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44955071|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44955072|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955073|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955074|NCT03911713|Ivacaftor|ivacaftor|mesh-list
44955075|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44955076|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955077|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955078|NCT03852459|Ibuprofen|ibuprofen|mesh-list
44955079|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44955080|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44955081|NCT03852459|Analgesics|analgesics|mesh-ancestor
44955082|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
44955083|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955084|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955085|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955086|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955087|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44955088|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955089|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955090|NCT03849768|Gefitinib|gefitinib|mesh-list
44955091|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955092|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955093|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955094|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955095|NCT03824808|Lidocaine|lidocaine|mesh-list
44955096|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955097|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
44955098|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955099|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955100|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
44955101|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955102|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955103|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44955104|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44955105|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955106|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955107|NCT03740919|Insulin|insulin|mesh-list
44955108|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44955109|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
44955110|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
44955111|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955112|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955113|NCT03737565|Tryptophan|tryptophan|mesh-list
44955114|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44955115|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
44955116|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955117|NCT03700970|Bupivacaine|bupivacaine|mesh-list
44955118|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955119|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
44955120|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955121|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955122|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
44955123|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955124|NCT03686345|Midostaurin|midostaurin|mesh-list
44955125|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955126|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955127|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955128|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955129|NCT03647488|Docetaxel|docetaxel|mesh-list
44955130|NCT03647488|Spartalizumab|spartalizumab|mesh-list
44955131|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955132|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955133|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955134|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955135|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955136|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955137|NCT03632759|Liraglutide|liraglutide|mesh-list
44955138|NCT03632759|Golimumab|golimumab|mesh-list
44955139|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955140|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955141|NCT03632759|Incretins|incretins|mesh-ancestor
44955142|NCT03632759|Hormones|hormones|mesh-ancestor
44955143|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955144|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44955145|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955146|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955147|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
44955148|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
44955149|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955150|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44955151|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44955152|NCT03579160|Timolol|timolol|mesh-list
44955153|NCT03579160|Petrolatum|petrolatum|mesh-list
44955154|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44955155|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44955156|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
44255184|NCT00613743|Narcotics|narcotics|mesh-ancestor
44955157|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955158|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955159|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955160|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955161|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44955162|NCT03579160|Emollients|emollients|mesh-ancestor
44955163|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
44955164|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
44955165|NCT03531736|Fludarabine|fludarabine|mesh-list
44955166|NCT03531736|Rituximab|rituximab|mesh-list
44955167|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44955168|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
44955169|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955170|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
44486512|NCT04731467|Gemcitabine|gemcitabine|mesh-list
44955171|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955172|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955173|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44955174|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
44955175|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955176|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955177|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44955178|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955179|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
44955180|NCT03498014|Narcotics|narcotics|mesh-ancestor
44955181|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955182|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955183|NCT03498014|Analgesics|analgesics|mesh-ancestor
44955184|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
44955185|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955186|NCT03447262|Ivacaftor|ivacaftor|mesh-list
44955187|NCT03447262|VX-659|vx-659|mesh-list
44955188|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44955189|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955190|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955191|NCT03417180|Remifentanil|remifentanil|mesh-list
44955192|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44955193|NCT03417180|Narcotics|narcotics|mesh-ancestor
44955194|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955195|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955196|NCT03417180|Analgesics|analgesics|mesh-ancestor
44955197|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
44955198|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955199|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
44955200|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955201|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955202|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
44955203|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955204|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955205|NCT03321188|Paclitaxel|paclitaxel|mesh-list
44955206|NCT03321188|Carboplatin|carboplatin|mesh-list
44955207|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44955208|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955209|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955210|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955211|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955212|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955213|NCT03311308|Metformin|metformin|mesh-list
44955214|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
44955215|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955216|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955217|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955218|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955219|NCT03292133|Gefitinib|gefitinib|mesh-list
44955220|NCT03292133|Nazartinib|nazartinib|mesh-list
44955221|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955222|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955223|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955224|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955225|NCT03267589|Durvalumab|durvalumab|mesh-list
44955226|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955227|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955228|NCT03255096|Rituximab|rituximab|mesh-list
44955229|NCT03255096|Venetoclax|venetoclax|mesh-list
44255236|NCT00613847|Trastuzumab|trastuzumab|mesh-list
44955230|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955231|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955232|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
44955233|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955234|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955235|NCT03191084|Dronabinol|dronabinol|mesh-list
44955236|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
44955237|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955238|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955239|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44955240|NCT03191084|Analgesics|analgesics|mesh-ancestor
44955241|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
44955242|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955243|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44955244|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44955245|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486591|NCT04702880|Nivolumab|nivolumab|mesh-list
44955246|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955247|NCT03191084|Hormones|hormones|mesh-ancestor
44955248|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955249|NCT03189719|Cisplatin|cisplatin|mesh-list
44955250|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
44955251|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955252|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955253|NCT03184155|Nicardipine|nicardipine|mesh-list
44955254|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44955255|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44955256|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955257|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955258|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44955259|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955260|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
44955261|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
44955262|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44955263|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44955264|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
44955265|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955266|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955267|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955268|NCT03149809|Urological Agents|urological agents|mesh-ancestor
44955269|NCT03072043|Azacitidine|azacitidine|mesh-list
44955270|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955271|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
44955272|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955273|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955274|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955275|NCT03016013|Methotrexate|methotrexate|mesh-list
44955276|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43777097|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
44955277|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
44955278|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44955279|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955280|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955281|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
44955282|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955283|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955284|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
44955285|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955286|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44955287|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955288|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
44955289|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955290|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44955291|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
44058769|NCT00005765|Nicotine|nicotine|mesh-list
44955292|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
44955293|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44955294|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44955295|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955296|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955297|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955298|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955299|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
44955300|NCT02909452|Entinostat|entinostat|mesh-list
44955301|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955302|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955303|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44955304|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955305|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955306|NCT02898506|Liraglutide|liraglutide|mesh-list
44955307|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955308|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955309|NCT02898506|Incretins|incretins|mesh-ancestor
44955310|NCT02898506|Hormones|hormones|mesh-ancestor
44955311|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955312|NCT02842827|Tretinoin|tretinoin|mesh-list
44955313|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955314|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
44955315|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44955316|NCT02837029|Nivolumab|nivolumab|mesh-list
44955317|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774246|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
44955318|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955319|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955320|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955321|NCT02740127|Dexamethasone|dexamethasone|mesh-list
44955323|NCT02740127|Epinephrine|epinephrine|mesh-list
44955324|NCT02740127|Propofol|propofol|mesh-list
44955325|NCT02740127|Ropivacaine|ropivacaine|mesh-list
44955326|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955327|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
44955328|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
44955329|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955330|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955331|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44955332|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
44955333|NCT02740127|Hormones|hormones|mesh-ancestor
44955334|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955335|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44955336|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955337|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955338|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955339|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955340|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955341|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
44955342|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
44955343|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955344|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
44955345|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44955346|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44955347|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
44955348|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955349|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44955350|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44955351|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44955352|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
44955353|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
44955354|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
44955355|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44955356|NCT02740127|Analgesics|analgesics|mesh-ancestor
44955357|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44955358|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
44955359|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44955360|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
44955361|NCT02737475|Nivolumab|nivolumab|mesh-list
44955362|NCT02737475|Ipilimumab|ipilimumab|mesh-list
44955363|NCT02737475|Vaccines|vaccines|mesh-list
44955364|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
44955365|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955366|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955367|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255387|NCT00615160|Dacarbazine|dacarbazine|mesh-list
44955368|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44955369|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
44955370|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955371|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955372|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44955373|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955374|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955375|NCT02642965|Cytarabine|cytarabine|mesh-list
44955376|NCT02642965|Fludarabine|fludarabine|mesh-list
44955377|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
44955378|NCT02642965|Daunorubicin|daunorubicin|mesh-list
44955379|NCT02642965|Lenograstim|lenograstim|mesh-list
44955380|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955381|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955382|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
44955383|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955384|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955385|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
44955386|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955387|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
44955388|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955389|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44955390|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44955391|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44955392|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44955393|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486697|NCT04630145|Rifampin|rifampin|mesh-list
44955394|NCT02632175|Adalimumab|adalimumab|mesh-list
44955395|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955396|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955397|NCT02611232|Liraglutide|liraglutide|mesh-list
44955398|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955399|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955400|NCT02611232|Incretins|incretins|mesh-ancestor
44955401|NCT02611232|Hormones|hormones|mesh-ancestor
44955402|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955403|NCT02604433|Luspatercept|luspatercept|mesh-list
44955404|NCT02604433|Hematinics|hematinics|mesh-ancestor
44955405|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
44955406|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
44955407|NCT02582775|Busulfan|busulfan|mesh-list
44955408|NCT02582775|Fludarabine|fludarabine|mesh-list
44955409|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
44955410|NCT02582775|Tacrolimus|tacrolimus|mesh-list
44955411|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
44955412|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44955413|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955414|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
44255417|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
44955415|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955416|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955417|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44955418|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
44955419|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955420|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955421|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44955422|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955423|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
44955424|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955425|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44955426|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955427|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44955428|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44955429|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
44255444|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
44955430|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44955431|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
44955432|NCT02519738|Triamcinolone|triamcinolone|mesh-list
44955433|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44955434|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955435|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
44955436|NCT02519738|Hormones|hormones|mesh-ancestor
44955437|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955438|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955439|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955440|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
44955441|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44955442|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955443|NCT02410343|Hormones|hormones|mesh-list
44955444|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955445|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486770|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
44955446|NCT02343224|Interferons|interferons|mesh-list
44955447|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
44955448|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
44955449|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44955450|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955451|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
44955452|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955453|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
44955454|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955455|NCT02291445|Peppermint oil|peppermint oil|mesh-list
44955456|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
44955457|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
44955458|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955459|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955460|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44955461|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
44955462|NCT02262026|Saracatinib|saracatinib|mesh-list
44955463|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955464|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955465|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955466|NCT02113878|Cisplatin|cisplatin|mesh-list
44955467|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955468|NCT02097680|Letrozole|letrozole|mesh-list
44955469|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955470|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44955471|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44955472|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955473|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955474|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44955475|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44955476|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955477|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955478|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44955479|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
44955480|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955481|NCT01986075|Amphetamine|amphetamine|mesh-list
44955482|NCT01986075|Adderall|adderall|mesh-list
44955483|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44955484|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955485|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
44955486|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
44955487|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955488|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
44955489|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955490|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955491|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
44955492|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44955493|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44955494|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955495|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44955496|NCT01935466|Pioglitazone|pioglitazone|mesh-list
44955497|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44955498|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955499|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44955500|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44955501|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955502|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461445|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955503|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955504|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44955505|NCT01759836|Atorvastatin|atorvastatin|mesh-list
44955506|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44955507|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44955508|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
44955509|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955510|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44955511|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44955512|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955513|NCT00958737|Leucovorin|leucovorin|mesh-list
44955514|NCT00958737|Fluorouracil|fluorouracil|mesh-list
44955515|NCT00958737|Capecitabine|capecitabine|mesh-list
44955516|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
44955517|NCT00958737|Calcium|calcium|mesh-list
44955518|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
44955519|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44955520|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955521|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
44955522|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955523|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955524|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955525|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955526|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
44955527|NCT00958737|Antidotes|antidotes|mesh-ancestor
44955528|NCT00958737|Protective Agents|protective agents|mesh-ancestor
44955529|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
44955530|NCT00958737|Vitamins|vitamins|mesh-ancestor
44955531|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
44955532|NCT00826462|Triamcinolone|triamcinolone|mesh-list
44955533|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44955534|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44955535|NCT00826462|Naproxen|naproxen|mesh-list
44955536|NCT00826462|Lidocaine|lidocaine|mesh-list
44955537|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44955538|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955539|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
44955540|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955541|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955542|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
44955543|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955544|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955545|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44955546|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44255471|NCT00615524|Exemestane|exemestane|mesh-list
44955547|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955548|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955549|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44955550|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
44955551|NCT00826462|Hormones|hormones|mesh-ancestor
44955552|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955553|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955554|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
44955555|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955556|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44955557|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44955558|NCT00826462|Analgesics|analgesics|mesh-ancestor
44955559|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955560|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
44955561|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44955562|NCT00710970|Tamoxifen|tamoxifen|mesh-list
44955563|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44955564|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44955565|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
44955566|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44955567|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955568|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44955569|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255521|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955570|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44955571|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44955572|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44955573|NCT00685919|Carbidopa|carbidopa|mesh-list
44955574|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44955575|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44955576|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
44955577|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955578|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955579|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955580|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44955581|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955582|NCT00344487|Ritonavir|ritonavir|mesh-list
44955583|NCT00344487|Lopinavir|lopinavir|mesh-list
44955584|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44955585|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44955586|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
44955587|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955588|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955589|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44955590|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44955591|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
44955592|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955593|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44955594|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44955595|NCT00281658|Paclitaxel|paclitaxel|mesh-list
44955596|NCT00281658|Lapatinib|lapatinib|mesh-list
44955597|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44955598|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955599|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955600|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955601|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955602|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955603|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955604|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955605|NCT05209529|Durvalumab|durvalumab|mesh-list
44955606|NCT05209529|Olaparib|olaparib|mesh-list
44955607|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955608|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955609|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44955610|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955611|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955612|NCT05209295|Azacitidine|azacitidine|mesh-list
44955613|NCT05209295|Cc-486|cc-486|mesh-list
44955614|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955615|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
44955616|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955617|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955618|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955619|NCT05209256|Pemetrexed|pemetrexed|mesh-list
44955620|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955621|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955622|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955623|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44955624|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44955625|NCT05208931|Mitogens|mitogens|mesh-list
44955626|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
44955627|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955628|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955629|NCT05208931|Growth Substances|growth substances|mesh-ancestor
44955630|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955631|NCT05208879|Carotenoids|carotenoids|mesh-list
44955632|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
44955633|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955634|NCT05208879|Protective Agents|protective agents|mesh-ancestor
44955635|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955636|NCT05208827|Vitamin D|vitamin d|mesh-list
44955637|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
44955638|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
44955639|NCT05208827|Vitamins|vitamins|mesh-list
44955640|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
44955641|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955642|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44955643|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44955644|NCT05208801|Morphine|morphine|mesh-list
44955645|NCT05208801|Bupivacaine|bupivacaine|mesh-list
44955646|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
44955647|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
44955648|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955649|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955650|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
44955651|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955652|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44955653|NCT05208801|Narcotics|narcotics|mesh-ancestor
44955654|NCT05208801|Analgesics|analgesics|mesh-ancestor
44955655|NCT05208398|Warfarin|warfarin|mesh-list
44955656|NCT05208398|Apixaban|apixaban|mesh-list
44955657|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
44255609|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955658|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44955659|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
44955660|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44955661|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
44955662|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955663|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955664|NCT05208294|Sulpiride|sulpiride|mesh-list
44955665|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44955666|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44955667|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955668|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955669|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955670|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44955671|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
44955672|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955673|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955674|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44955675|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
44955676|NCT05207904|Paclitaxel|paclitaxel|mesh-list
44955677|NCT05207904|Carboplatin|carboplatin|mesh-list
44955678|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44955679|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955680|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955681|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955682|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955683|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955684|NCT05207774|Oxytocin|oxytocin|mesh-list
44955685|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
44955686|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44955687|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955688|NCT05207735|Capecitabine|capecitabine|mesh-list
44955689|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955690|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
44955691|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955692|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955693|NCT05207683|Antibodies|antibodies|mesh-list
44955694|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
44955695|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
44955696|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955697|NCT05207514|Ethanol|ethanol|mesh-list
44955698|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
44955699|NCT05207514|Docetaxel|docetaxel|mesh-list
44955700|NCT05207514|Doxorubicin|doxorubicin|mesh-list
44955701|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955702|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
44955703|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955704|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255644|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059890|NCT00005925|Muscimol|muscimol|mesh-list
44955705|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44955706|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
44955707|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955708|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955709|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44955710|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955711|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955712|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955713|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44955714|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44955715|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44955716|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955717|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44955718|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955719|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955720|NCT05207436|Oxytocin|oxytocin|mesh-list
44955721|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
44955722|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44955723|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955724|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
44955725|NCT05187338|Ipilimumab|ipilimumab|mesh-list
44955726|NCT05187338|Durvalumab|durvalumab|mesh-list
44955727|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955728|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955729|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955730|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955731|NCT05187208|Niraparib|niraparib|mesh-list
44955732|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44955733|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955734|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955735|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955736|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
44955737|NCT05186467|Analgesics|analgesics|mesh-ancestor
44955738|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
44255664|NCT00616408|Octreotide|octreotide|mesh-list
44955739|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955740|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955741|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
44955742|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955743|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955744|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
44955745|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44955746|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44955747|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955748|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44955749|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
44955750|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44955751|NCT05166239|Lenvatinib|lenvatinib|mesh-list
44955752|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955753|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955754|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955755|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955756|NCT05122130|Melatonin|melatonin|mesh-list
44955757|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
44955758|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955759|NCT05122130|Protective Agents|protective agents|mesh-ancestor
44955760|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955761|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955762|NCT05081206|Propofol|propofol|mesh-list
44955763|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955764|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955765|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955766|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955767|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
44955768|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
44955769|NCT05047939|Propofol|propofol|mesh-list
44255721|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
44955770|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955771|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955772|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955773|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955774|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
44955775|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
44955776|NCT04947059|Gemcitabine|gemcitabine|mesh-list
44955777|NCT04947059|Epirubicin|epirubicin|mesh-list
44955778|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955779|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
44955780|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955781|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955782|NCT04947059|Antiviral Agents|antiviral agents|mesh-ancestor
44955783|NCT04947059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955784|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955785|NCT04947059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955786|NCT04947059|Immunologic Factors|immunologic factors|mesh-ancestor
44955787|NCT04947059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955788|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44955789|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44955790|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44955791|NCT04921735|Cisatracurium|cisatracurium|mesh-list
44955792|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44955793|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44955794|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955795|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955796|NCT04879368|Trifluridine|trifluridine|mesh-list
44955797|NCT04879368|Paclitaxel|paclitaxel|mesh-list
44955798|NCT04879368|Docetaxel|docetaxel|mesh-list
44955799|NCT04879368|Nivolumab|nivolumab|mesh-list
44955800|NCT04879368|Irinotecan|irinotecan|mesh-list
44955801|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44955802|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955803|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44955804|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44955805|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44955806|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955807|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955808|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955809|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44955810|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44955811|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955812|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
44955813|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
44955814|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955815|NCT04739865|Psilocybin|psilocybin|mesh-list
44955816|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
44955817|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955818|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955819|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
44955820|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955821|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955822|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955823|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44955824|NCT04720963|Analgesics|analgesics|mesh-ancestor
44955825|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
44955826|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955827|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44955828|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44955829|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44955830|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
44955831|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955832|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955833|NCT04699357|Atropine|atropine|mesh-list
44955834|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44955835|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955836|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44955837|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
44955838|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955839|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955840|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44955841|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44955842|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
44955843|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
44955844|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44955845|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44955846|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
44955847|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955848|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955849|NCT04690192|Gemcitabine|gemcitabine|mesh-list
44955850|NCT04690192|Melphalan|melphalan|mesh-list
44255779|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
44955851|NCT04690192|Busulfan|busulfan|mesh-list
44955852|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44955853|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
44955854|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955855|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955856|NCT04690192|Antiviral Agents|antiviral agents|mesh-ancestor
44955857|NCT04690192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955858|NCT04690192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955859|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44955860|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
44255797|NCT00617045|Analgesics|analgesics|mesh-ancestor
44955861|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955862|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44955863|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
44955864|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44955865|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
44955866|NCT04626024|Dasatinib|dasatinib|mesh-list
44955867|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955868|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44955869|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060910|NCT00006015|Leucovorin|leucovorin|mesh-list
44955870|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955871|NCT04577638|Nivolumab|nivolumab|mesh-list
44955872|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44955873|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955874|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44955875|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955876|NCT04503148|Propofol|propofol|mesh-list
44955877|NCT04503148|Anesthetics|anesthetics|mesh-list
44955878|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
44955879|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
44955880|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955881|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955882|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955883|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955884|NCT04400799|Enoxaparin|enoxaparin|mesh-list
44955885|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
44955886|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44955887|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44955888|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955889|NCT04368910|Artesunate|artesunate|mesh-list
44955890|NCT04368910|Chloroquine|chloroquine|mesh-list
44955891|NCT04368910|Pyronaridine|pyronaridine|mesh-list
44461464|NCT01546883|Dabigatran|dabigatran|mesh-list
44955892|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
44955893|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44955894|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44955895|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44955896|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461470|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
44955897|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
44955898|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
44955899|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44955900|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
44955901|NCT04368910|Amebicides|amebicides|mesh-ancestor
44955902|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44955903|NCT04365985|Naltrexone|naltrexone|mesh-list
44955904|NCT04365985|Ketamine|ketamine|mesh-list
44955905|NCT04365985|Analgesics|analgesics|mesh-ancestor
44955906|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
44955907|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955908|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955909|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44955910|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955911|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
44955912|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
44955913|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955914|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44955915|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44955916|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955917|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955918|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44955919|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44955920|NCT04249258|Dobutamine|dobutamine|mesh-list
44955921|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44955922|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
44955923|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
44955924|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44955925|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955926|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44955927|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44955928|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44955929|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
44955930|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44955931|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955932|NCT04249258|Protective Agents|protective agents|mesh-ancestor
44955933|NCT04235608|Propofol|propofol|mesh-list
44955934|NCT04235608|Sevoflurane|sevoflurane|mesh-list
44955935|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44955936|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44955937|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955938|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44955939|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
44955940|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
44461506|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44955941|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44955942|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44955943|NCT04094519|Digoxin|digoxin|mesh-list
44955944|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44955945|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44955946|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44955947|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
44955948|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955949|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44955950|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44955951|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955952|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44955953|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44955954|NCT04094519|Protective Agents|protective agents|mesh-ancestor
44955955|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955956|NCT04080531|Vaccines|vaccines|mesh-list
44955957|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
44955958|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955959|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
44955960|NCT03938584|Vitamins|vitamins|mesh-ancestor
44955961|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
44255838|NCT00617500|Hormones|hormones|mesh-list
44955962|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955963|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
44955964|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955965|NCT03938584|Protective Agents|protective agents|mesh-ancestor
44955966|NCT03775200|Psilocybin|psilocybin|mesh-list
44955967|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
44955968|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955969|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44955970|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
44955971|NCT03753555|Atorvastatin|atorvastatin|mesh-list
44955972|NCT03753555|Probucol|probucol|mesh-list
44955973|NCT03753555|Calcium|calcium|mesh-list
44955974|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44955975|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44955976|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44955977|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44955978|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44955979|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
44955980|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955981|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44955982|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44955983|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44955984|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
44955985|NCT03753555|Protective Agents|protective agents|mesh-ancestor
44955986|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
44955987|NCT03716609|Citric Acid|citric acid|mesh-list
44955988|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
44955989|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
44955990|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44955991|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
44955992|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
44487298|NCT04362761|Ivacaftor|ivacaftor|mesh-list
44955993|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44955994|NCT03716609|Cathartics|cathartics|mesh-ancestor
44955995|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44955996|NCT03709355|Clarithromycin|clarithromycin|mesh-list
44955997|NCT03709355|Rifampin|rifampin|mesh-list
44955998|NCT03709355|Rifabutin|rifabutin|mesh-list
44955999|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
44956000|NCT03709355|Omeprazole|omeprazole|mesh-list
44956001|NCT03709355|Atorvastatin|atorvastatin|mesh-list
44956002|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
44956003|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44956004|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44255874|NCT00617656|Antiviral Agents|antiviral agents|mesh-ancestor
44956005|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44956006|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44956007|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
44956008|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956009|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44255883|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
44956010|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44956011|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956012|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44956013|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956014|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44956015|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44956016|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956017|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44956018|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44956019|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44956020|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44956021|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
44255884|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44255885|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44255886|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
44255887|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255888|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255889|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255890|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
44255891|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44956022|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44956023|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956024|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44956025|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44255897|NCT00617760|Vaccines|vaccines|mesh-list
44956026|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44956027|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44956028|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
44956029|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
44956030|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44956031|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44956032|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44956033|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44956034|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44956035|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44956036|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44956037|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44956038|NCT03709355|Estrogens|estrogens|mesh-ancestor
44956039|NCT03709355|Hormones|hormones|mesh-ancestor
44956040|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956041|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44956042|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44956043|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
44956044|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44956045|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44956046|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
44956047|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44956048|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44956049|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44956050|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
44956051|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44956052|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956053|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44956054|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44956055|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44956056|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956057|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956058|NCT03669133|Vitamin E|vitamin e|mesh-list
44956059|NCT03669133|Vitamins|vitamins|mesh-ancestor
44956060|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
44956061|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487372|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44487373|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
44487374|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487375|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44487376|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
44487377|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44487378|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487379|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
44956062|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
44956063|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956064|NCT03669133|Protective Agents|protective agents|mesh-ancestor
44956065|NCT03637491|Avelumab|avelumab|mesh-list
44956066|NCT03637491|Talazoparib|talazoparib|mesh-list
44956067|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956068|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956069|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44255951|NCT00618111|Granisetron|granisetron|mesh-list
44956070|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956071|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956072|NCT03498391|Ketamine|ketamine|mesh-list
44956073|NCT03498391|Propofol|propofol|mesh-list
44956074|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44956075|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956076|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956077|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44956078|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
44956079|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
44956080|NCT03498391|Analgesics|analgesics|mesh-ancestor
44956081|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
44956082|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956083|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44956084|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44956085|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44956086|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956087|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956088|NCT03477162|Metformin|metformin|mesh-list
44956089|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956090|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956091|NCT03461952|Nivolumab|nivolumab|mesh-list
44956092|NCT03461952|Ipilimumab|ipilimumab|mesh-list
44956093|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956094|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956095|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44956096|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956097|NCT03420508|Ensartinib|ensartinib|mesh-list
44956098|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956099|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956100|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956101|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956102|NCT03340727|Caffeine|caffeine|mesh-list
44956103|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
44062186|NCT04743661|Antipyretics|antipyretics|mesh-list
44956104|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956105|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44956106|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956107|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44956108|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956109|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44956110|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44956111|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
44956112|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956113|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44956114|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44956115|NCT03269344|Gabapentin|gabapentin|mesh-list
44956116|NCT03269344|Analgesics|analgesics|mesh-ancestor
44956117|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
44956118|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956119|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956120|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
44956121|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44956122|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44956123|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956124|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956125|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44956126|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44956127|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956128|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487455|NCT04303325|Esketamine|esketamine|mesh-list
44487456|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
44487457|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487458|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
44487459|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44487460|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
44487461|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956129|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
44956130|NCT02966093|Lenvatinib|lenvatinib|mesh-list
44956131|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956132|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956133|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956134|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956135|NCT02953093|Acarbose|acarbose|mesh-list
44956136|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44956137|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956138|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956139|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956140|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956141|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
44956142|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956143|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956144|NCT02921997|Vaccines|vaccines|mesh-list
44956145|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
44255987|NCT00618176|Lamivudine|lamivudine|mesh-list
44956146|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956147|NCT02879162|Durvalumab|durvalumab|mesh-list
44956148|NCT02879162|Tremelimumab|tremelimumab|mesh-list
44956149|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956150|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956151|NCT02822092|Risperidone|risperidone|mesh-list
44956152|NCT02822092|Aripiprazole|aripiprazole|mesh-list
44956153|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44956154|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
44956155|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956156|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956157|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956158|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44956159|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44956160|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956161|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956162|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44956163|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
44956164|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
44956165|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
44956166|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44956167|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44956168|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44956169|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44956170|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
44956171|NCT02717416|Hemostatics|hemostatics|mesh-list
44956172|NCT02717416|Coagulants|coagulants|mesh-ancestor
44956173|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
44956174|NCT02675946|Cetuximab|cetuximab|mesh-list
43653473|NCT02984176|Emollients|emollients|mesh-ancestor
44956175|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956176|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956177|NCT02660827|Insulin|insulin|mesh-list
44956178|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956179|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956180|NCT02627963|Sorafenib|sorafenib|mesh-list
44256063|NCT00618345|Everolimus|everolimus|mesh-list
44956181|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956182|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956183|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956184|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956185|NCT02133573|Progesterone|progesterone|mesh-list
44956186|NCT02133573|Progestins|progestins|mesh-ancestor
44956187|NCT02133573|Hormones|hormones|mesh-ancestor
44956188|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956189|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956190|NCT02054104|Celecoxib|celecoxib|mesh-list
44956191|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
44956192|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956193|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
44956194|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956195|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44956196|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44256077|NCT00618397|Ketamine|ketamine|mesh-list
44956197|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
44956198|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956199|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956200|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44956201|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44956202|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44956203|NCT02054104|Analgesics|analgesics|mesh-ancestor
44956204|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
44956205|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956206|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956207|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44256085|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
43653513|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
44956208|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44956209|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956210|NCT01468831|Minocycline|minocycline|mesh-list
44956211|NCT01468831|Bevacizumab|bevacizumab|mesh-list
44956212|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956213|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956214|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44956215|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44956216|NCT01468831|Growth Substances|growth substances|mesh-ancestor
44956217|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956218|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
44956219|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44956220|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956221|NCT01383109|Pyronaridine|pyronaridine|mesh-list
44956222|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
44256106|NCT00618501|Cytarabine|cytarabine|mesh-list
44956223|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44956224|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44956225|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956226|NCT00603954|Fludarabine|fludarabine|mesh-list
44956227|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
44956228|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44956229|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956230|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256112|NCT00618501|Methotrexate|methotrexate|mesh-list
44956231|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
44956232|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956233|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956234|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
44956235|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956236|NCT00003777|Cisplatin|cisplatin|mesh-list
44956237|NCT00003777|Fluorouracil|fluorouracil|mesh-list
44956238|NCT00003777|Amifostine|amifostine|mesh-list
44956239|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956240|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
44956241|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956242|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44956243|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956244|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
44956245|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956246|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44956247|NCT00003777|Protective Agents|protective agents|mesh-ancestor
44487608|NCT04197713|Olaparib|olaparib|mesh-list
44956248|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
44956249|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956250|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956251|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956252|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956253|NCT05214157|Bupivacaine|bupivacaine|mesh-list
44956254|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
44956255|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
44956256|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956257|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956258|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
44956259|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956260|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
44956261|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44956262|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44956263|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
44956264|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956265|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44956266|NCT05213884|Cisplatin|cisplatin|mesh-list
44956267|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956268|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
44956269|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44956270|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
44956271|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956272|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956273|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44956274|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44956275|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44956276|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
44774247|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956277|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956278|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956279|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44956280|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
44956281|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
44956282|NCT05213676|Protective Agents|protective agents|mesh-ancestor
44956283|NCT05213585|Ivermectin|ivermectin|mesh-list
44956284|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44956285|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956286|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44956287|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44956288|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44956289|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956290|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956291|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956292|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44956293|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44956294|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44956295|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
44956296|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956297|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956298|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44956299|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44956300|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
44956301|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44956302|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44956303|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
44956304|NCT05213065|Bupivacaine|bupivacaine|mesh-list
44956305|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
44956306|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
44956307|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956308|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956309|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
44956310|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956311|NCT05212662|Cysteamine|cysteamine|mesh-list
44956312|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44774248|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
44956313|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956314|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
44956315|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956316|NCT05212597|Losartan|losartan|mesh-list
44956317|NCT05212597|Amlodipine|amlodipine|mesh-list
44956318|NCT05212597|Valsartan|valsartan|mesh-list
44956319|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44956320|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44956321|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44956322|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44956323|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956324|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43653561|NCT02983084|Nickel|nickel|mesh-list
44956325|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956326|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
44956327|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44956328|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44956329|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44956330|NCT05212337|Denosumab|denosumab|mesh-list
44956331|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44956332|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956333|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
44956334|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
44956335|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44956336|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44956337|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44956338|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956339|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
44956340|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44956341|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
44956342|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956343|NCT05211622|Protective Agents|protective agents|mesh-ancestor
44956344|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956345|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
44956346|NCT05211622|Vitamins|vitamins|mesh-ancestor
44956347|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
44956348|NCT05211583|Progesterone|progesterone|mesh-list
44956349|NCT05211583|Progestins|progestins|mesh-ancestor
44956350|NCT05211583|Hormones|hormones|mesh-ancestor
44956351|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956352|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956353|NCT05211050|Cromakalim|cromakalim|mesh-list
44956354|NCT05211050|Sumatriptan|sumatriptan|mesh-list
44956355|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44956356|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44956357|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44956358|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
44956359|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956360|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956361|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956362|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44956363|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44956364|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
44956365|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956366|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44956367|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44956368|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
44956369|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44956370|NCT05211011|Fosfomycin|fosfomycin|mesh-list
44956371|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44956372|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956373|NCT05210595|Clopidogrel|clopidogrel|mesh-list
44956374|NCT05210595|Ticagrelor|ticagrelor|mesh-list
44956375|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44774249|NCT01847768|Dimercaprol|dimercaprol|mesh-list
44956376|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44956377|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44956378|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44956379|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
44956380|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956381|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956382|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956383|NCT05210517|Empagliflozin|empagliflozin|mesh-list
44956384|NCT05210517|Benzbromarone|benzbromarone|mesh-list
44956385|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44956386|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956387|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956388|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956389|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
44956390|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
44956391|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44956392|NCT05210517|Renal Agents|renal agents|mesh-ancestor
44956393|NCT05210465|Dobutamine|dobutamine|mesh-list
44956394|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44956395|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
44956396|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
44956397|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956398|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956399|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44956400|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44956401|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44956402|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44956403|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956404|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956405|NCT05210465|Protective Agents|protective agents|mesh-ancestor
44956406|NCT05210192|Lidocaine|lidocaine|mesh-list
44956407|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
44956408|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
44956409|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956410|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956411|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
44956412|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256290|NCT00619268|Sirolimus|sirolimus|mesh-list
44956413|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44956414|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44956415|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44956416|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44956417|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956418|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
44956419|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
44774250|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
44956420|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956421|NCT05210166|Protective Agents|protective agents|mesh-ancestor
44956422|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956423|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44956424|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956425|NCT05209217|Ketamine|ketamine|mesh-list
44956426|NCT05209217|Analgesics|analgesics|mesh-ancestor
44956427|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
44774251|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
44956428|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956429|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956430|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44956431|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44956432|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
44956433|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
44956434|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956435|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44956436|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44956437|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956438|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956439|NCT05191264|Analgesics|analgesics|mesh-list
44956440|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
44956441|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956442|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956443|NCT05190627|Loratadine|loratadine|mesh-list
44956444|NCT05190627|Sirolimus|sirolimus|mesh-list
44956445|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44956446|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256323|NCT00619398|Tacrolimus|tacrolimus|mesh-list
44956447|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44956448|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956449|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
44956450|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956451|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
44956452|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956453|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
44956454|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
44956455|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44956456|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44956457|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44956458|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
44956459|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
44956460|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956461|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956462|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44956463|NCT05188417|Tirofiban|tirofiban|mesh-list
44956464|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44956465|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44956466|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256340|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956467|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44956468|NCT05188326|Azacitidine|azacitidine|mesh-list
44956469|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44956470|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
44956471|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956472|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956473|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956474|NCT05186454|Dexamethasone|dexamethasone|mesh-list
44956475|NCT05186454|Midazolam|midazolam|mesh-list
44956476|NCT05186454|Morphine|morphine|mesh-list
44956477|NCT05186454|Bupivacaine|bupivacaine|mesh-list
44956478|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956479|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
44956480|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
44956481|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956482|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956483|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956484|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
44956485|NCT05186454|Hormones|hormones|mesh-ancestor
44956486|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956487|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956488|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956489|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
44956490|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
44956491|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956492|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
44956493|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44956494|NCT05186454|Narcotics|narcotics|mesh-ancestor
44956495|NCT05186454|Analgesics|analgesics|mesh-ancestor
44956496|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44956497|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44956498|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44956499|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44956500|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956501|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44956502|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
44956503|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
44956504|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
44956505|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956506|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956507|NCT05176080|Fulvestrant|fulvestrant|mesh-list
44956508|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956509|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956510|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44956511|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44956512|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44956513|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956514|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956515|NCT05162898|Lenvatinib|lenvatinib|mesh-list
44956516|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956517|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956518|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487902|NCT04012931|Rilpivirine|rilpivirine|mesh-list
44956519|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956520|NCT05134857|Zonisamide|zonisamide|mesh-list
44956521|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
44956523|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44956524|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956525|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44956526|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956527|NCT05113290|Sorafenib|sorafenib|mesh-list
44956528|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956529|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956530|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956531|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956532|NCT05107778|Entecavir|entecavir|mesh-list
44064729|NCT00006258|Cisplatin|cisplatin|mesh-list
44956533|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
44956534|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956535|NCT05097716|Tolbutamide|tolbutamide|mesh-list
44256410|NCT00619996|Docetaxel|docetaxel|mesh-list
44956536|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956537|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956538|NCT05095857|Ketamine|ketamine|mesh-list
44956539|NCT05095857|Esketamine|esketamine|mesh-list
44956540|NCT05095857|Analgesics|analgesics|mesh-ancestor
44956541|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
44956542|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956543|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956544|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44956545|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44956546|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
44956547|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
44956548|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956549|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44956550|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44956551|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956552|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956553|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
44956554|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956555|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
44956556|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44956557|NCT05058872|Estradiol|estradiol|mesh-list
44956558|NCT05058872|Estrogens|estrogens|mesh-ancestor
44956559|NCT05058872|Hormones|hormones|mesh-ancestor
44956560|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956561|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956562|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44956563|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
44956564|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44956565|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44956566|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44956567|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44956568|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44487958|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44487959|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44487960|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487961|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487962|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
44487963|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487964|NCT03939767|Aflibercept|aflibercept|mesh-list
44487965|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487966|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487967|NCT03939767|Growth Substances|growth substances|mesh-ancestor
44487968|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956570|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44956571|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
44956572|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956573|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956574|NCT04789304|Midazolam|midazolam|mesh-list
44956575|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44956576|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44956577|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956578|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956579|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44956580|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44956581|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956582|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44956583|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
44956584|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
44956585|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
44956586|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
44956587|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956588|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956589|NCT04780724|Nitrox|nitrox|mesh-list
44956590|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44956591|NCT04780724|Protective Agents|protective agents|mesh-ancestor
44956592|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956593|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
44956594|NCT04700007|Promethazine|promethazine|mesh-list
44956595|NCT04700007|Morphine|morphine|mesh-list
44956596|NCT04700007|Capsaicin|capsaicin|mesh-list
44956597|NCT04700007|Histamine|histamine|mesh-list
44956598|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44956599|NCT04700007|Narcotics|narcotics|mesh-ancestor
44956600|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956601|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956602|NCT04700007|Analgesics|analgesics|mesh-ancestor
44956603|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
44956604|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956605|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
44956606|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256483|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956607|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44956608|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44956609|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44956610|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
44956611|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
44956612|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
44956613|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956614|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44956615|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-ancestor
44956616|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
44956617|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956618|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956619|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44956620|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
44956621|NCT04681079|Albuterol|albuterol|mesh-list
44956622|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44956623|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
44956624|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956625|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956626|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44956627|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44956628|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
44956629|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44956630|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44956631|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44956632|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44956633|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
44956634|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256509|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256512|NCT00620581|Paroxetine|paroxetine|mesh-list
44956635|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956636|NCT04643405|Gemcitabine|gemcitabine|mesh-list
44956637|NCT04643405|Paclitaxel|paclitaxel|mesh-list
44956638|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44956639|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956640|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44956641|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44956642|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488031|NCT03910452|Sirolimus|sirolimus|mesh-list
44488032|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
44956643|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956644|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44956645|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
44956646|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
44956647|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956648|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956649|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956650|NCT04643405|Immunologic Factors|immunologic factors|mesh-ancestor
44956651|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956652|NCT04623567|Metformin|metformin|mesh-list
44956653|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956654|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956655|NCT04617821|Gemcitabine|gemcitabine|mesh-list
44956656|NCT04617821|Paclitaxel|paclitaxel|mesh-list
44956657|NCT04617821|Folfirinox|folfirinox|mesh-list
44956658|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44956659|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956660|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
44956661|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
44956662|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
44956663|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956664|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44956665|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
44956666|NCT04617821|Antiviral Agents|antiviral agents|mesh-ancestor
44956667|NCT04617821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956668|NCT04617821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956669|NCT04617821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956670|NCT04617821|Immunologic Factors|immunologic factors|mesh-ancestor
44956671|NCT04617821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956672|NCT04581148|Antibodies|antibodies|mesh-list
44956673|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
44956674|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
44956675|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956676|NCT04574232|Triamcinolone|triamcinolone|mesh-list
44956677|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44956678|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44956679|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44956680|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956681|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
44956682|NCT04574232|Hormones|hormones|mesh-ancestor
44256552|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44956683|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956684|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956685|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44956686|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
44956687|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956688|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956689|NCT04548973|Esketamine|esketamine|mesh-list
44956690|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
44956691|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44956692|NCT04539548|Prednisolone|prednisolone|mesh-list
44956693|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956694|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
44956695|NCT04539548|Hormones|hormones|mesh-ancestor
44956696|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956697|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956698|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956699|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956700|NCT04538040|Tenofovir|tenofovir|mesh-list
44956701|NCT04538040|Emtricitabine|emtricitabine|mesh-list
44956702|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44956703|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
44956704|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956705|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44956706|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44956707|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774318|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956708|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956709|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44956710|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44956712|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44956713|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956714|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956715|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956716|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44956717|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
44956718|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44956719|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44956720|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
44956721|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956722|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956723|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956724|NCT04477265|Urological Agents|urological agents|mesh-ancestor
44956725|NCT04360980|Colchicine|colchicine|mesh-list
44956726|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
44956727|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44956728|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
44956729|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
44956730|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
44956731|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956732|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956733|NCT04331704|Tenofovir|tenofovir|mesh-list
44956734|NCT04331704|Emtricitabine|emtricitabine|mesh-list
44956735|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
44956736|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956737|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44774319|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
44956738|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44956739|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956740|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956741|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44956742|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44956743|NCT04313075|Leronlimab|leronlimab|mesh-list
44956744|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44956745|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44956746|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956747|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44956748|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256624|NCT00620919|Secretin|secretin|mesh-list
44956749|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
44956750|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956751|NCT04305756|Enoxaparin|enoxaparin|mesh-list
44956752|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
44956753|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44956754|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44956755|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956756|NCT04301934|Estradiol|estradiol|mesh-list
44956757|NCT04301934|Estrogens|estrogens|mesh-list
44956758|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44956759|NCT04301934|Hormones|hormones|mesh-ancestor
44956760|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956761|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956762|NCT04233840|Nivolumab|nivolumab|mesh-list
44956763|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956764|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956765|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43653934|NCT02980757|Gliclazide|gliclazide|mesh-list
44956766|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956767|NCT04229290|Dolutegravir|dolutegravir|mesh-list
44956768|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44956769|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44956770|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956771|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956772|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44956773|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44956774|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
44956775|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956776|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
44956777|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44956778|NCT04181476|Protective Agents|protective agents|mesh-ancestor
44956779|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956780|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
44956781|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
44956782|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
44956783|NCT04129723|Protective Agents|protective agents|mesh-ancestor
44956784|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956785|NCT04066751|Ivacaftor|ivacaftor|mesh-list
44956786|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44956787|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44956788|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956789|NCT04065789|Dexamethasone|dexamethasone|mesh-list
44956790|NCT04065789|Lenalidomide|lenalidomide|mesh-list
44956791|NCT04065789|Daratumumab|daratumumab|mesh-list
44956792|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956793|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
44956794|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
44956795|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956796|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956797|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956798|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
44774320|NCT01848132|Hormones|hormones|mesh-ancestor
44956800|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956801|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956802|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956803|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
44956804|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44956805|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44956806|NCT04065789|Growth Substances|growth substances|mesh-ancestor
44956807|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44956808|NCT04047953|Paclitaxel|paclitaxel|mesh-list
44956809|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44956810|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
44956811|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44956812|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956813|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44956814|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44956815|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44956816|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956817|NCT04031599|Hormones|hormones|mesh-list
44956818|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956819|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956820|NCT04019821|Insulin|insulin|mesh-list
44956821|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44956822|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
44956823|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
44956824|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
44956825|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44956826|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956827|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44956828|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44956829|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956830|NCT03911661|Warfarin|warfarin|mesh-list
44956831|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
44956832|NCT03908255|Vitamins|vitamins|mesh-list
44956833|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
44956834|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956835|NCT03900754|Oxytocin|oxytocin|mesh-list
44956836|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
44956837|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44956838|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956839|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44956840|NCT03897244|Amoxicillin|amoxicillin|mesh-list
44956841|NCT03897244|Metronidazole|metronidazole|mesh-list
44956842|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44956843|NCT03897244|Rabeprazole|rabeprazole|mesh-list
44956844|NCT03897244|Bismuth|bismuth|mesh-list
44956845|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44956846|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956847|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
44956848|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44956849|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44956850|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44956851|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956852|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956853|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956854|NCT03897244|Antacids|antacids|mesh-ancestor
44956855|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44956856|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44956857|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956858|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956859|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44956860|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44956861|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956862|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
44956863|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956864|NCT03854110|Gemcitabine|gemcitabine|mesh-list
44956865|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44956866|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
44256732|NCT00621387|Ofloxacin|ofloxacin|mesh-list
44956867|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956868|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956869|NCT03854110|Antiviral Agents|antiviral agents|mesh-ancestor
44956870|NCT03854110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956871|NCT03854110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956872|NCT03854110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256745|NCT00621400|Dexamethasone|dexamethasone|mesh-list
44956873|NCT03854110|Immunologic Factors|immunologic factors|mesh-ancestor
44956874|NCT03854110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956875|NCT03851081|Vincristine|vincristine|mesh-list
44956876|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44956877|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44956878|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956879|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44956880|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44956881|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44956882|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956883|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956884|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44956885|NCT03737136|Bortezomib|bortezomib|mesh-list
44256750|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
44956886|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956887|NCT03667716|Nivolumab|nivolumab|mesh-list
44956888|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956889|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956890|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44956891|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956892|NCT03665129|Avdoralimab|avdoralimab|mesh-list
44956893|NCT03665129|Durvalumab|durvalumab|mesh-list
44956894|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956895|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956896|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956897|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
44956898|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956899|NCT03617731|Dexamethasone|dexamethasone|mesh-list
44956900|NCT03617731|Lenalidomide|lenalidomide|mesh-list
44956901|NCT03617731|Bortezomib|bortezomib|mesh-list
44956902|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956903|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
44956904|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
44956905|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956906|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956907|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44956908|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
44956909|NCT03617731|Hormones|hormones|mesh-ancestor
44956910|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956911|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956912|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956913|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
44956914|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44956915|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44956916|NCT03617731|Growth Substances|growth substances|mesh-ancestor
44956917|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
44956918|NCT03505710|Trastuzumab|trastuzumab|mesh-list
44956919|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956920|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956921|NCT03446157|Cetuximab|cetuximab|mesh-list
44956922|NCT03446157|Palbociclib|palbociclib|mesh-list
44956923|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44956924|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956925|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44956926|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956927|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067326|NCT05637671|Paroxetine|paroxetine|mesh-list
44956928|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44956929|NCT03296553|Valganciclovir|valganciclovir|mesh-list
44956930|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
44956931|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956932|NCT03077243|Cisplatin|cisplatin|mesh-list
44956933|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956934|NCT03000569|Levodopa|levodopa|mesh-list
44956935|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
44956936|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44956937|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
44956938|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956939|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256799|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44956940|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956941|NCT02964507|Fulvestrant|fulvestrant|mesh-list
44956942|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956943|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956944|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44956945|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44956946|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44956947|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956948|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956949|NCT02955394|Fulvestrant|fulvestrant|mesh-list
44956950|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44956951|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44956952|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44956953|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44956954|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
44461548|NCT01544920|Interferons|interferons|mesh-list
44956955|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44956956|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461551|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
44956957|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44956958|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
44956959|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44956960|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44956961|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956962|NCT02942017|Brexanolone|brexanolone|mesh-list
44461560|NCT01544491|Everolimus|everolimus|mesh-list
44956963|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
44956964|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956965|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956966|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956967|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
44956968|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
44956969|NCT02942004|Pregnanolone|pregnanolone|mesh-list
44956970|NCT02942004|Brexanolone|brexanolone|mesh-list
44067912|NCT00000248|Pergolide|pergolide|mesh-list
44956971|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
44956972|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44956973|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956974|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956975|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
44956976|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
44956977|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
44461569|NCT01544309|Atorvastatin|atorvastatin|mesh-list
44956978|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44956979|NCT02929589|Ibuprofen|ibuprofen|mesh-list
44956980|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
44956981|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44956982|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44956983|NCT02929589|Analgesics|analgesics|mesh-ancestor
44956984|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
44956985|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44956986|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44956987|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44956988|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461587|NCT01544153|Nicotine|nicotine|mesh-list
44956989|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44956990|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44956991|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44956992|NCT02929589|Narcotics|narcotics|mesh-ancestor
44956993|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068390|NCT00000499|Metoprolol|metoprolol|mesh-list
44956994|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
44956995|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44956996|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44956997|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44956998|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44956999|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957000|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957001|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957002|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
44957003|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
44488407|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
44957004|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957005|NCT02840227|Anesthetics|anesthetics|mesh-list
44957006|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957007|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957009|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957010|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957011|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44957012|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44957013|NCT02737306|Leronlimab|leronlimab|mesh-list
44957014|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44957015|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44957016|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957017|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44957018|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44957019|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
44957020|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957021|NCT02728648|Oxycodone|oxycodone|mesh-list
44957022|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44957023|NCT02728648|Narcotics|narcotics|mesh-ancestor
44957024|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957025|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957026|NCT02728648|Analgesics|analgesics|mesh-ancestor
44957027|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
44957028|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957029|NCT02614547|Brexanolone|brexanolone|mesh-list
44957030|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
44957031|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957032|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957033|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068843|NCT00000569|Hormones|hormones|mesh-ancestor
44957034|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
44957035|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
44957036|NCT02589691|Rocuronium|rocuronium|mesh-list
44957037|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44957038|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44957039|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44957040|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957041|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957042|NCT02583048|Dolutegravir|dolutegravir|mesh-list
44957043|NCT02583048|Bedaquiline|bedaquiline|mesh-list
44957044|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44957045|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44957046|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957047|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957048|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44957049|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44957050|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
44957051|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957052|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
44957053|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957054|NCT02539160|Ticagrelor|ticagrelor|mesh-list
44957055|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44957056|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44957057|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44957058|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44957059|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
44957060|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256880|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44957061|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957062|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957063|NCT02477618|Brexanolone|brexanolone|mesh-list
44957064|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
44957065|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957066|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957067|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957068|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
44957069|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
44957070|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
44957071|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44957072|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957073|NCT02424851|Thalidomide|thalidomide|mesh-list
44957074|NCT02424851|Dexamethasone|dexamethasone|mesh-list
44957075|NCT02424851|Bortezomib|bortezomib|mesh-list
44957076|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44957077|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957078|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
44957079|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
44957080|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957081|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957082|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957083|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
44957084|NCT02424851|Hormones|hormones|mesh-ancestor
44957085|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957086|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44957087|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957088|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44957089|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
44957090|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957091|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957092|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
44957093|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
44957094|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957095|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957096|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44957097|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44957098|NCT02424851|Growth Substances|growth substances|mesh-ancestor
44957099|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957100|NCT02285504|Brexanolone|brexanolone|mesh-list
44957101|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
44957102|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957103|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957104|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957105|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
44957106|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
44957107|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44957108|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44957109|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957110|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
44957111|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44957112|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
44957113|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44957114|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
44957115|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957116|NCT01971970|Adalimumab|adalimumab|mesh-list
44957117|NCT01971970|Infliximab|infliximab|mesh-list
44957118|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957119|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957120|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44069583|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
44957121|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957122|NCT01969409|Rituximab|rituximab|mesh-list
44957123|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44957124|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957125|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
44957126|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957127|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957128|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
44957129|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44957130|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957131|NCT01942122|Analgesics|analgesics|mesh-ancestor
44256961|NCT00622349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957132|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
44957133|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957134|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957135|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957136|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957137|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44957138|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957139|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957140|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
44957141|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957142|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
44957143|NCT01869829|Clotrimazole|clotrimazole|mesh-list
44957144|NCT01869829|Miconazole|miconazole|mesh-list
44957145|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256974|NCT00622375|Analgesics|analgesics|mesh-ancestor
44957146|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44957147|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44957148|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44957149|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957150|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957151|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44957152|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44957153|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957154|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957155|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44957156|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44957157|NCT01754779|Indapamide|indapamide|mesh-list
44957158|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
44957159|NCT01754779|Citric Acid|citric acid|mesh-list
44957160|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
44957161|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
44957162|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44957163|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
44957164|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
44256987|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957165|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957166|NCT01754779|Diuretics|diuretics|mesh-ancestor
44957167|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
44957168|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957169|NCT01754779|Expectorants|expectorants|mesh-ancestor
44957170|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957171|NCT01754779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44957172|NCT01754779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44957173|NCT01754779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44957174|NCT01578954|Lenalidomide|lenalidomide|mesh-list
44957175|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
44957176|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957177|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44957178|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44957179|NCT01578954|Growth Substances|growth substances|mesh-ancestor
44957180|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957181|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957182|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44957183|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957184|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957185|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957186|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44957187|NCT01218555|Lenalidomide|lenalidomide|mesh-list
44957188|NCT01218555|Everolimus|everolimus|mesh-list
44957189|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
44957190|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957191|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44957192|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44957193|NCT01218555|Growth Substances|growth substances|mesh-ancestor
44957194|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957195|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957196|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957197|NCT01161394|Pioglitazone|pioglitazone|mesh-list
44957198|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44957199|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957200|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
44957201|NCT01111305|Reslizumab|reslizumab|mesh-list
44957202|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44957203|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957204|NCT01111305|Filaricides|filaricides|mesh-ancestor
44957205|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
44957206|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
44957207|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44957208|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957209|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44957210|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957211|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488633|NCT03412565|Hormones|hormones|mesh-ancestor
44488634|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957213|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
44957214|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44257040|NCT00622817|Epinephrine|epinephrine|mesh-list
44957215|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
44957216|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957217|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957218|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957219|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44957220|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44957221|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957222|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957223|NCT00659646|Levofloxacin|levofloxacin|mesh-list
44957224|NCT00659646|Ofloxacin|ofloxacin|mesh-list
44957225|NCT00659646|Gentamicins|gentamicins|mesh-list
44957226|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44957227|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070637|NCT00000966|Vitamins|vitamins|mesh-ancestor
44957228|NCT00659646|Renal Agents|renal agents|mesh-ancestor
44957229|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957230|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44957231|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44957232|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957233|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957234|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257062|NCT00622843|Vaccines|vaccines|mesh-list
44957235|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44957236|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44957237|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44257066|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
44957238|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44957239|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44957240|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957241|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957242|NCT00369317|Cytarabine|cytarabine|mesh-list
44957243|NCT00369317|Etoposide|etoposide|mesh-list
44957244|NCT00369317|Daunorubicin|daunorubicin|mesh-list
44957245|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
44957246|NCT00369317|Asparaginase|asparaginase|mesh-list
44957247|NCT00369317|Thioguanine|thioguanine|mesh-list
44957248|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44957249|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957250|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44957251|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44957252|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957253|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957254|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44957255|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
44957256|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
44957257|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957258|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957259|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
44957260|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957261|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44957262|NCT00261807|Daptomycin|daptomycin|mesh-list
44957263|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957264|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957265|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
44957266|NCT05216419|Vitamin D|vitamin d|mesh-list
44957267|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44957268|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957269|NCT05216419|Vitamins|vitamins|mesh-ancestor
44957270|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
44957271|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44957272|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
44957273|NCT05216237|Apatinib|apatinib|mesh-list
44957274|NCT05216237|Tegafur|tegafur|mesh-list
44957275|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957276|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957277|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957278|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957279|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44957280|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
44957281|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
44957282|NCT05215743|Antioxidants|antioxidants|mesh-list
44957283|NCT05215743|Deferoxamine|deferoxamine|mesh-list
44957284|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
44957285|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957286|NCT05215743|Expectorants|expectorants|mesh-ancestor
44957287|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957288|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44957289|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957290|NCT05215743|Protective Agents|protective agents|mesh-ancestor
44957291|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957293|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44957294|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
44957295|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
44957296|NCT05215730|Copper|copper|mesh-list
44957297|NCT05215730|Trace Elements|trace elements|mesh-ancestor
44957298|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
44957299|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957300|NCT05215665|Lenvatinib|lenvatinib|mesh-list
44957301|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957302|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957303|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957304|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957305|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
44957306|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
44957307|NCT05215366|Coagulants|coagulants|mesh-ancestor
44957308|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44957309|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44957310|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
44957311|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957312|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44957313|NCT05214872|Calcium|calcium|mesh-list
44957314|NCT05214872|Mitogens|mitogens|mesh-list
44957315|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44957316|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957317|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257141|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
44957318|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957319|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
44957320|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44957321|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44957322|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957323|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44957324|NCT05193487|Anesthetics|anesthetics|mesh-list
44957325|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957326|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957327|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44957328|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44957329|NCT05189145|Hormones|hormones|mesh-list
44957330|NCT05189145|Estradiol|estradiol|mesh-list
44957331|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44957332|NCT05189145|Progesterone|progesterone|mesh-list
44957333|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
44957334|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957335|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957336|NCT05189145|Estrogens|estrogens|mesh-ancestor
44957337|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44957338|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
44957339|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44957340|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44957341|NCT05189145|Progestins|progestins|mesh-ancestor
44957342|NCT05114915|Docetaxel|docetaxel|mesh-list
44957343|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957344|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44957345|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44957346|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44957347|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957348|NCT04967079|Trametinib|trametinib|mesh-list
44957349|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957350|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957351|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957352|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257187|NCT00623402|Sorafenib|sorafenib|mesh-list
44957353|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
44957354|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44957355|NCT04964193|Cyproterone|cyproterone|mesh-list
44957356|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
44957357|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44957358|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44957359|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44957360|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
44957361|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44957362|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957363|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44957364|NCT04964193|Estrogens|estrogens|mesh-ancestor
44957365|NCT04964193|Hormones|hormones|mesh-ancestor
44957366|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957367|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
44957368|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44957369|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957370|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44957371|NCT04958876|Naltrexone|naltrexone|mesh-list
44957372|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44957373|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44957374|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957375|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
44957376|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957377|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
44957378|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44957379|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957380|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
44957381|NCT04865796|Lactoferrin|lactoferrin|mesh-list
44957382|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957383|NCT04811118|Docetaxel|docetaxel|mesh-list
44957384|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957385|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44957386|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44957387|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44957388|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957389|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
44957390|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44957391|NCT04703036|Glycine|glycine|mesh-list
44957392|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
44957393|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957394|NCT04703036|Expectorants|expectorants|mesh-ancestor
44957395|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957396|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44957397|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
44957398|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957399|NCT04703036|Protective Agents|protective agents|mesh-ancestor
44957400|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957401|NCT04703036|Antidotes|antidotes|mesh-ancestor
44957402|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
44957403|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957404|NCT04695652|Somatomedin B|somatomedin b|mesh-list
44957405|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44957406|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44957407|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
44957408|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957409|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957410|NCT04647084|Lidocaine|lidocaine|mesh-list
44957411|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
44957412|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
44957413|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957414|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957415|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
44957416|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957417|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44957418|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44957419|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44957420|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44957421|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957423|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
44957424|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957425|NCT04576078|Nefopam|nefopam|mesh-list
44957426|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957427|NCT04576078|Analgesics|analgesics|mesh-ancestor
44957428|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
44957429|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957430|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957431|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
44957432|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44957433|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44957434|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957435|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
44957436|NCT04489108|Coagulants|coagulants|mesh-ancestor
44957437|NCT04471675|Docetaxel|docetaxel|mesh-list
44957438|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957439|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
44957440|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
44957441|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
44957442|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957443|NCT04439513|Hemostatics|hemostatics|mesh-list
44957444|NCT04439513|Coagulants|coagulants|mesh-ancestor
44957445|NCT04431375|Tenofovir|tenofovir|mesh-list
44957446|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
44957447|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957448|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44957449|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44957450|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957451|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957452|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44957453|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44957454|NCT04315038|Anesthetics|anesthetics|mesh-list
44957455|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257277|NCT00624182|Gemcitabine|gemcitabine|mesh-list
44957456|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957457|NCT04256629|Allopurinol|allopurinol|mesh-list
44957458|NCT04256629|Verinurad|verinurad|mesh-list
44957459|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
44957460|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957461|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957462|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
44957463|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957464|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44957465|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
44957466|NCT04256629|Protective Agents|protective agents|mesh-ancestor
44957467|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957468|NCT04231084|Epoprostenol|epoprostenol|mesh-list
44957469|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
44957470|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
44957471|NCT04231084|Tezosentan|tezosentan|mesh-list
44957472|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44957473|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
44957474|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957475|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957476|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44957477|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
44488927|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488928|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488929|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
44488930|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257298|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
44488931|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488932|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44488933|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
44488934|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488951|NCT02944071|Paclitaxel|paclitaxel|mesh-list
44488952|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488953|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488954|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488955|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488956|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488958|NCT02941783|Factor VIII|factor viii|mesh-list
44957478|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44957479|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
44957480|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957481|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957482|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44957483|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
44957484|NCT04231084|Protective Agents|protective agents|mesh-ancestor
44957485|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44957486|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44957487|NCT04186494|Liraglutide|liraglutide|mesh-list
44957488|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44257306|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44957489|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957490|NCT04186494|Incretins|incretins|mesh-ancestor
44957491|NCT04186494|Hormones|hormones|mesh-ancestor
44257331|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957492|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957493|NCT04180995|Axitinib|axitinib|mesh-list
44957494|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957495|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957496|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957497|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957498|NCT04083963|Paclitaxel|paclitaxel|mesh-list
44957499|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
44957500|NCT04083963|Carboplatin|carboplatin|mesh-list
44957501|NCT04083963|Doxorubicin|doxorubicin|mesh-list
44957502|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44957503|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957504|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44957505|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44957506|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44957507|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957508|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957509|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
44957510|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957511|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957512|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44957513|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
44957514|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44957515|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44957516|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44957517|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44957518|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957519|NCT03790111|Gemcitabine|gemcitabine|mesh-list
44957520|NCT03790111|Cisplatin|cisplatin|mesh-list
44957521|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957522|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44957523|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
44957524|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957525|NCT03790111|Antiviral Agents|antiviral agents|mesh-ancestor
44957526|NCT03790111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957527|NCT03790111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957528|NCT03790111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957529|NCT03790111|Immunologic Factors|immunologic factors|mesh-ancestor
44957530|NCT03790111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957531|NCT03771586|Ketamine|ketamine|mesh-list
44957532|NCT03771586|Analgesics|analgesics|mesh-ancestor
44957533|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
44957534|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957535|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957536|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44957537|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44957538|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
44957539|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
44957540|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957541|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44489002|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
44257362|NCT00624546|Lansoprazole|lansoprazole|mesh-list
44489003|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489004|NCT02758665|Venetoclax|venetoclax|mesh-list
44489005|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
44489006|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489007|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489008|NCT02736149|Ubenimex|ubenimex|mesh-list
44489009|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44489010|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
44489011|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489012|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957542|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44257383|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957543|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957544|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957545|NCT03767582|Nivolumab|nivolumab|mesh-list
44957546|NCT03767582|Vaccines|vaccines|mesh-list
44957547|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
44957548|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957549|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44957550|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957551|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44957552|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957553|NCT03706885|Efavirenz|efavirenz|mesh-list
44957554|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44957555|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44957556|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957557|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957558|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
44957559|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957560|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44957561|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44957562|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44957563|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44957564|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44957565|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44957566|NCT03284853|Latanoprost|latanoprost|mesh-list
44957567|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44957568|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44957569|NCT03206463|Dronabinol|dronabinol|mesh-list
44957570|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
44957571|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257394|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44957572|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957573|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957574|NCT03206463|Analgesics|analgesics|mesh-ancestor
44957575|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
44957576|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957577|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44957578|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44957579|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957580|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957581|NCT03206463|Hormones|hormones|mesh-ancestor
44957582|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957583|NCT03166761|Dexamethasone|dexamethasone|mesh-list
44957584|NCT03166761|Triamcinolone|triamcinolone|mesh-list
44957585|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44257436|NCT00624871|Analgesics|analgesics|mesh-ancestor
44957586|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44957587|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44957588|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957589|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
44957590|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
44957591|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957592|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957593|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957594|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
44957595|NCT03166761|Hormones|hormones|mesh-ancestor
44957596|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957597|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44957598|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957599|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957600|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
44957601|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957602|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957603|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
44957604|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957605|NCT02947165|Spartalizumab|spartalizumab|mesh-list
44957606|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44957607|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957608|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957609|NCT02721069|Diazepam|diazepam|mesh-list
44957610|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44957611|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
44957612|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
44957613|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
44957614|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957615|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957616|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957617|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44957618|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957619|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44957620|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44957621|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44957622|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44957623|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957624|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44957625|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
44957626|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
44957627|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
44957628|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
44957629|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957630|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957631|NCT02389465|Celecoxib|celecoxib|mesh-list
44957632|NCT02389465|Dexetimide|dexetimide|mesh-list
44957633|NCT02389465|Citalopram|citalopram|mesh-list
44957634|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44957635|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957636|NCT02389465|Analgesics|analgesics|mesh-ancestor
44957637|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
44957638|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957639|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957640|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707249|NCT01432717|Hematinics|hematinics|mesh-ancestor
44957641|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957642|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44957643|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44957644|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957645|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957646|NCT02389465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44957647|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44957648|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44957649|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957650|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
44957651|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44957652|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
44957653|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957654|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44957655|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44957656|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
44957657|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
44957658|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44957659|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44957660|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
44957661|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
44957662|NCT02335060|Dronabinol|dronabinol|mesh-list
44957663|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44957664|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
44957665|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957666|NCT02335060|Expectorants|expectorants|mesh-ancestor
44957667|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
44957668|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44957669|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
44957670|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957671|NCT02335060|Protective Agents|protective agents|mesh-ancestor
44957672|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957673|NCT02335060|Antidotes|antidotes|mesh-ancestor
44957674|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
44957675|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957676|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957677|NCT02335060|Analgesics|analgesics|mesh-ancestor
44957678|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
44957679|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957680|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44957681|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44257516|NCT00625196|Xhance|xhance|mesh-list
44957682|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957683|NCT02335060|Hormones|hormones|mesh-ancestor
44957684|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957685|NCT02297438|Letrozole|letrozole|mesh-list
44957686|NCT02297438|Palbociclib|palbociclib|mesh-list
44957687|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957688|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44957689|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44957690|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957691|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957692|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44957693|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
44957694|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957695|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957696|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957697|NCT02297412|Minocycline|minocycline|mesh-list
44957698|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44257539|NCT00625248|Anticoagulants|anticoagulants|mesh-list
44957699|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957700|NCT02292758|Bevacizumab|bevacizumab|mesh-list
44957701|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44957702|NCT02292758|Cetuximab|cetuximab|mesh-list
44957703|NCT02292758|Irinotecan|irinotecan|mesh-list
44957704|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
44957705|NCT02292758|Antibodies|antibodies|mesh-list
44957706|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
44957707|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44957708|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
44957709|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957710|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44957711|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44957712|NCT02292758|Growth Substances|growth substances|mesh-ancestor
44957713|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957714|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957715|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
44957716|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44957717|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44957718|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957719|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957720|NCT02250326|Paclitaxel|paclitaxel|mesh-list
44957721|NCT02250326|Azacitidine|azacitidine|mesh-list
44957722|NCT02250326|Cc-486|cc-486|mesh-list
44957723|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44957724|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957725|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44957726|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44957727|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44957728|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957729|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44957730|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
44957731|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957732|NCT01856270|Amitriptyline|amitriptyline|mesh-list
44957733|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44957734|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
44957735|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957736|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957737|NCT01856270|Analgesics|analgesics|mesh-ancestor
44957738|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
44957739|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957740|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957741|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44957742|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44957743|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257584|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957744|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957745|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
44957746|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957747|NCT01503515|Fluconazole|fluconazole|mesh-list
44957748|NCT01503515|Voriconazole|voriconazole|mesh-list
44957749|NCT01503515|Caspofungin|caspofungin|mesh-list
44957750|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
44957751|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957752|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44957753|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44957754|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957755|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957756|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44957757|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
44957758|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957759|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957760|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44957761|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44957762|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44957763|NCT01491893|Vaccines|vaccines|mesh-list
44957764|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
44957765|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957766|NCT01180374|Dronabinol|dronabinol|mesh-list
44957767|NCT01180374|Cannabidiol|cannabidiol|mesh-list
44957768|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
44957769|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
44957770|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957771|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957772|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957773|NCT01180374|Analgesics|analgesics|mesh-ancestor
44957774|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
44957775|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957776|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44957777|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44957778|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957779|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957780|NCT01180374|Hormones|hormones|mesh-ancestor
44957781|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957782|NCT00357565|Cyclosporine|cyclosporine|mesh-list
44957783|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
44957784|NCT00357565|Fludarabine|fludarabine|mesh-list
44957785|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
44957786|NCT00357565|Melphalan|melphalan|mesh-list
44957787|NCT00357565|Busulfan|busulfan|mesh-list
44957788|NCT00357565|Cyclosporins|cyclosporins|mesh-list
44957789|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461618|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
44957790|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44957791|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
44957792|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957793|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957794|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
44957795|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957796|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957797|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
44957798|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957799|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44957800|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957801|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44957802|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44957803|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44957804|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
44957805|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957806|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44957807|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
44461623|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
44957808|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44957809|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
44957810|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957811|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
44957812|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957813|NCT00245960|Etanercept|etanercept|mesh-list
44957814|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44957815|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957816|NCT00245960|Analgesics|analgesics|mesh-ancestor
44957817|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
44257622|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44957818|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957819|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957820|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957821|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957822|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957823|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957824|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
44957825|NCT00136903|Cyclosporine|cyclosporine|mesh-list
44957826|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
44957827|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
44957828|NCT00136903|Prednisone|prednisone|mesh-list
44957829|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
44957830|NCT00136903|Tacrolimus|tacrolimus|mesh-list
44957831|NCT00136903|Cyclosporins|cyclosporins|mesh-list
44957832|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957833|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
44957834|NCT00136903|Hormones|hormones|mesh-ancestor
44957835|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957836|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957837|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44957838|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957839|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957840|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
44957841|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44957842|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957843|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957844|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
44957845|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957846|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44957847|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957848|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44957849|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44957850|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
44957851|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957852|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
44957853|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
44957854|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957855|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957856|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44957857|NCT00136903|Protective Agents|protective agents|mesh-ancestor
44957858|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
44957859|NCT05218616|Sunitinib|sunitinib|mesh-list
44957860|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957861|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44957862|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44957863|NCT05218616|Growth Substances|growth substances|mesh-ancestor
44957864|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957865|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44957866|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44957867|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489388|NCT02067416|Taxane|taxane|mesh-list
44957868|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957869|NCT05218577|Selenium|selenium|mesh-list
44957870|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
44957871|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957872|NCT05218577|Protective Agents|protective agents|mesh-ancestor
44957873|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957874|NCT05218577|Trace Elements|trace elements|mesh-ancestor
44957875|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
44957876|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
44957877|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44957878|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957879|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957880|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957881|NCT05218161|Analgesics|analgesics|mesh-ancestor
44957882|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
44957883|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957884|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44957885|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44957886|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44957887|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44957888|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957889|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957890|NCT05217836|Hepcidins|hepcidins|mesh-list
44957891|NCT05217836|Chrysarobin|chrysarobin|mesh-list
44957892|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44957893|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44957894|NCT05217836|Analgesics|analgesics|mesh-ancestor
44957895|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
44957896|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957897|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957898|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957899|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44957900|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957901|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
44957902|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44957903|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44957904|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44957905|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44957906|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957907|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44957908|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957909|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957910|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44257694|NCT00625911|Narcotics|narcotics|mesh-ancestor
44957911|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957912|NCT05217238|Remifentanil|remifentanil|mesh-list
44957913|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44957914|NCT05217238|Narcotics|narcotics|mesh-ancestor
44957915|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957916|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957917|NCT05217238|Analgesics|analgesics|mesh-ancestor
44957918|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
44257709|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957919|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957920|NCT05217160|Morphine|morphine|mesh-list
44957921|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44957922|NCT05217160|Narcotics|narcotics|mesh-ancestor
44957923|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44957924|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957925|NCT05217160|Analgesics|analgesics|mesh-ancestor
44957926|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
44957927|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957928|NCT05217069|Leucovorin|leucovorin|mesh-list
44957929|NCT05217069|Folic Acid|folic acid|mesh-list
44957930|NCT05217069|Irinotecan|irinotecan|mesh-list
44957931|NCT05217069|Cetuximab|cetuximab|mesh-list
44957932|NCT05217069|Avelumab|avelumab|mesh-list
44957933|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
44957934|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44957935|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44957936|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957937|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957938|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957939|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44957940|NCT05217069|Antidotes|antidotes|mesh-ancestor
44957941|NCT05217069|Protective Agents|protective agents|mesh-ancestor
44957942|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489436|NCT01998971|Hormones|hormones|mesh-ancestor
44151363|NCT00213694|Celecoxib|celecoxib|mesh-list
44957943|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
44957944|NCT05217069|Vitamins|vitamins|mesh-ancestor
44957945|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
44957946|NCT05217069|Hematinics|hematinics|mesh-ancestor
44489522|NCT01858740|Thiotepa|thiotepa|mesh-list
44957947|NCT05216822|Racecadotril|racecadotril|mesh-list
44957948|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
44257735|NCT00626223|Folic Acid|folic acid|mesh-list
44957949|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44957950|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44957951|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957952|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957953|NCT05215470|Nivolumab|nivolumab|mesh-list
44957954|NCT05215470|Ipilimumab|ipilimumab|mesh-list
44957955|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44957956|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957957|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44957958|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957959|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
44957960|NCT05193565|Sirolimus|sirolimus|mesh-list
44957961|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44957962|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44957963|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44957964|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
44074122|NCT03991130|Nivolumab|nivolumab|mesh-list
44957965|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44957966|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44957967|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44957968|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957969|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
44957970|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44957971|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
44957972|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957973|NCT05192460|Vaccines|vaccines|mesh-list
44957974|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
44957975|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957976|NCT05186779|Progestins|progestins|mesh-list
44957977|NCT05186779|Hormones|hormones|mesh-ancestor
44957978|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44957979|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957980|NCT05065294|Psilocybin|psilocybin|mesh-list
44957981|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44957982|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
44957983|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44957984|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44957985|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44957986|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
44957987|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44957988|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44957989|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44957990|NCT05052970|Dexamethasone|dexamethasone|mesh-list
44957991|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
44957992|NCT05052970|Bortezomib|bortezomib|mesh-list
44957993|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
44957994|NCT05052970|BB 1101|bb 1101|mesh-list
44957995|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44957996|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
44957997|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
44957998|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44957999|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958000|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958001|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
44958002|NCT05052970|Hormones|hormones|mesh-ancestor
44958003|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958004|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958005|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958006|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
44958007|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958008|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958009|NCT05052970|Analgesics|analgesics|mesh-ancestor
44958010|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
44958011|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44958012|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44958013|NCT05008783|Capecitabine|capecitabine|mesh-list
44958014|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
44958015|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44958016|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
44958017|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958018|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958019|NCT04986579|Trastuzumab|trastuzumab|mesh-list
44257801|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
44958020|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44958021|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958022|NCT04930315|Apatinib|apatinib|mesh-list
44958023|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958024|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44958025|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958026|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958028|NCT04903210|Niacin|niacin|mesh-list
44958029|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
44958030|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
44958031|NCT04903210|Vitamins|vitamins|mesh-ancestor
44958032|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
44958033|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958034|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44958035|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
44958036|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958037|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44958038|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
44958039|NCT04896658|Dexamethasone|dexamethasone|mesh-list
44958040|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
44257811|NCT00626678|Prednisone|prednisone|mesh-list
44958041|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958042|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
44958043|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958044|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958045|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44958046|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
44958047|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958048|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257824|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
44958049|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44958050|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958051|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
44958052|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
44958053|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958054|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958055|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
44958056|NCT04896658|Hormones|hormones|mesh-ancestor
44958057|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958058|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958059|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44958060|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958061|NCT04769401|Progesterone|progesterone|mesh-list
44958062|NCT04769401|Progestins|progestins|mesh-ancestor
44958063|NCT04769401|Hormones|hormones|mesh-ancestor
44958064|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958065|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958066|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
44958067|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44958068|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958069|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958070|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
44958071|NCT04733157|Coagulants|coagulants|mesh-ancestor
44958072|NCT04724252|Gabapentin|gabapentin|mesh-list
44958073|NCT04724252|Analgesics|analgesics|mesh-ancestor
44958074|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
44958075|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958076|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958077|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
44958078|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44958079|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44958080|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958081|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958082|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44958083|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44958084|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958085|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958086|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
44958087|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
44958088|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44958089|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44257850|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
44958090|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
44958091|NCT04719208|Listerine|listerine|mesh-list
44958092|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44958093|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44958094|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958095|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
44958096|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44958097|NCT04706715|Cemiplimab|cemiplimab|mesh-list
44958098|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44958099|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958100|NCT04701190|Norepinephrine|norepinephrine|mesh-list
44958101|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958102|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44958103|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44958104|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44958105|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958106|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958107|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
44958108|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
44958109|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958110|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44958111|NCT04700423|Ivermectin|ivermectin|mesh-list
44958112|NCT04700423|Albendazole|albendazole|mesh-list
44958113|NCT04700423|Moxidectin|moxidectin|mesh-list
44958114|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44958115|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958116|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
44958117|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
44958118|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44958119|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44958120|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44958121|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44958122|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44958123|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958124|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958125|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
44958126|NCT04666454|Adenosine|adenosine|mesh-list
44958127|NCT04666454|Dipyridamole|dipyridamole|mesh-list
44958128|NCT04666454|Apixaban|apixaban|mesh-list
44958129|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44958130|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
44958131|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44958132|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
44958133|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958134|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958135|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
44958136|NCT04666454|Analgesics|analgesics|mesh-ancestor
44958137|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
44958138|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958139|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958140|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44958141|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
44958142|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44958143|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
44958144|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
44958145|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958146|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44958147|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958148|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
44958149|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44958150|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958151|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44958152|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958153|NCT04573777|Evolocumab|evolocumab|mesh-list
44958154|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44958155|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44958156|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
44257905|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958157|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958158|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44958159|NCT04538352|Insulin|insulin|mesh-list
44958160|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44958161|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
44958162|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44958163|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958164|NCT04496362|Heparin|heparin|mesh-list
44958165|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
44958166|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958167|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958168|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958169|NCT04465266|Tolperisone|tolperisone|mesh-list
44958170|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44958171|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958172|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44958173|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958174|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
44958175|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44958176|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44958177|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257929|NCT00627471|Insulin|insulin|mesh-list
44958178|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958179|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958180|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958181|NCT04437108|Urological Agents|urological agents|mesh-ancestor
44958182|NCT04434300|Daptomycin|daptomycin|mesh-list
44958183|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44958184|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958185|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
44958186|NCT04423588|Lansoprazole|lansoprazole|mesh-list
44958187|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44958188|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958189|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44958190|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257944|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44958191|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958192|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
44958193|NCT04407377|Tolperisone|tolperisone|mesh-list
44958194|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44958195|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44958196|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958197|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44958198|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958199|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44958200|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958201|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44958202|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958203|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
44958204|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
44958205|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44958206|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44958207|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958208|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958209|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958210|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958211|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
44257974|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958212|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
44958213|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44958214|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44958215|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958216|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958217|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958218|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958219|NCT04307797|Exenatide|exenatide|mesh-list
44958220|NCT04307797|Glucagon|glucagon|mesh-list
44958221|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44958222|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44958223|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958224|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44958225|NCT04307797|Incretins|incretins|mesh-ancestor
44958226|NCT04307797|Hormones|hormones|mesh-ancestor
44958227|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958228|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958229|NCT04249323|Prednisone|prednisone|mesh-list
44958230|NCT04249323|Cortisone|cortisone|mesh-list
44958231|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958232|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
44958233|NCT04249323|Hormones|hormones|mesh-ancestor
44958234|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958235|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958236|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958237|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958238|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44958239|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44958240|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44958241|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958242|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958243|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44958244|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44958245|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958246|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958247|NCT04218357|Probenecid|probenecid|mesh-list
44958248|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
44958249|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
44958250|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958251|NCT04218357|Renal Agents|renal agents|mesh-ancestor
44958252|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
44958253|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958254|NCT04112641|Niacinamide|niacinamide|mesh-list
44958255|NCT04112641|Niacin|niacin|mesh-list
44958256|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
44958257|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
44958258|NCT04112641|Vitamins|vitamins|mesh-ancestor
44958259|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
44958260|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958261|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44958262|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
44958263|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958264|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44958265|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
44958266|NCT04108962|Benralizumab|benralizumab|mesh-list
44958267|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44958268|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
44958269|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
44958270|NCT04090684|Celecoxib|celecoxib|mesh-list
44958271|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44958272|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44958273|NCT04090684|Analgesics|analgesics|mesh-ancestor
44958274|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
44958275|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958276|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076303|NCT00011921|Paclitaxel|paclitaxel|mesh-list
44958277|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958278|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958279|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44958280|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44958281|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958282|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958283|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44958284|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958285|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44958286|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44958287|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461652|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958288|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44958289|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44958290|NCT04045301|Omalizumab|omalizumab|mesh-list
44958291|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44958292|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44958293|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44958294|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
44958295|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
44958296|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958297|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
44958298|NCT04033107|Metformin|metformin|mesh-list
44958299|NCT04033107|Vitamins|vitamins|mesh-ancestor
44958300|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
44958301|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958302|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44958303|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
44958304|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958305|NCT04033107|Protective Agents|protective agents|mesh-ancestor
44958306|NCT03950245|Glucagon|glucagon|mesh-list
44958307|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44958308|NCT03950245|Incretins|incretins|mesh-ancestor
44958309|NCT03950245|Hormones|hormones|mesh-ancestor
44958310|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958311|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912067|NCT00370838|Clonidine|clonidine|mesh-list
44958312|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958313|NCT03939104|Artesunate|artesunate|mesh-list
44958314|NCT03939104|Lumefantrine|lumefantrine|mesh-list
44958315|NCT03939104|Artemether|artemether|mesh-list
44958316|NCT03939104|Piperaquine|piperaquine|mesh-list
44958317|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44958318|NCT03939104|Amodiaquine|amodiaquine|mesh-list
44958319|NCT03939104|Mefloquine|mefloquine|mesh-list
44958320|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
44958321|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44958322|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44958323|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958324|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958325|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
44958326|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
44958327|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44958328|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
44958329|NCT03913091|Bupivacaine|bupivacaine|mesh-list
44958330|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
44958331|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
44958332|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958333|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958334|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
44958335|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958336|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44958337|NCT03889249|Tenecteplase|tenecteplase|mesh-list
44958338|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958339|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958340|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958341|NCT03858322|Paclitaxel|paclitaxel|mesh-list
44958342|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
44958343|NCT03858322|Carboplatin|carboplatin|mesh-list
44958344|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44958345|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958346|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44958347|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44958348|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
43654749|NCT02973958|Ibuprofen|ibuprofen|mesh-list
44958349|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958350|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958351|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
44076910|NCT00014196|Cisplatin|cisplatin|mesh-list
44958352|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958353|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958354|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44958355|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
44958356|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44958357|NCT03763422|Temozolomide|temozolomide|mesh-list
44958358|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44958359|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
44958360|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958361|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958362|NCT03752307|Prednisone|prednisone|mesh-list
44958363|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
44958364|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
44958365|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958366|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
44958367|NCT03752307|Hormones|hormones|mesh-ancestor
44958368|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958369|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958370|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958371|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958372|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
44958373|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
44958374|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958375|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958376|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44958377|NCT03752307|Protective Agents|protective agents|mesh-ancestor
44958378|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44958379|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44958380|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
44958381|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958382|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958383|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
44958384|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
44958385|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
44958386|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44958387|NCT03740334|Dexamethasone|dexamethasone|mesh-list
44958388|NCT03740334|Everolimus|everolimus|mesh-list
44958389|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958390|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
44958391|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
44958392|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958393|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958394|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958395|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
44958396|NCT03740334|Hormones|hormones|mesh-ancestor
44958397|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958398|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958399|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958400|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958401|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
44958402|NCT03637556|Deferasirox|deferasirox|mesh-list
44958403|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44958404|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
44958405|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
44958406|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958407|NCT03627897|Bupivacaine|bupivacaine|mesh-list
44958408|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
44958409|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
44958410|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958411|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958412|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
44958413|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958414|NCT03603184|Paclitaxel|paclitaxel|mesh-list
44958415|NCT03603184|Carboplatin|carboplatin|mesh-list
44958416|NCT03603184|Atezolizumab|atezolizumab|mesh-list
44958417|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44958418|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958419|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44958420|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44958421|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44958422|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489987|NCT03080441|Midodrine|midodrine|mesh-list
44958423|NCT03441555|Venetoclax|venetoclax|mesh-list
44958424|NCT03441555|Alvocidib|alvocidib|mesh-list
44958425|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958426|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
44958427|NCT03441555|Growth Substances|growth substances|mesh-ancestor
44958428|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958429|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44958430|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958431|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958432|NCT03438526|Melatonin|melatonin|mesh-list
44958433|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
44958434|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958435|NCT03438526|Protective Agents|protective agents|mesh-ancestor
44958436|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958437|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958438|NCT03416179|Cytarabine|cytarabine|mesh-list
44077204|NCT00014586|Goserelin|goserelin|mesh-list
44958439|NCT03416179|Azacitidine|azacitidine|mesh-list
44958440|NCT03416179|Daunorubicin|daunorubicin|mesh-list
44958441|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44958442|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
44958443|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258154|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
44958444|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958445|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
44958446|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958447|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958448|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
44958449|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958450|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958451|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44958452|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44958453|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44958454|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
44958455|NCT03353922|Tolperisone|tolperisone|mesh-list
44958456|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44958457|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
44958458|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958459|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44958460|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958461|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44958462|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958463|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44958464|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958465|NCT03346239|Citalopram|citalopram|mesh-list
44958466|NCT03346239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44958467|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258176|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958468|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44958469|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958470|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958471|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
44958472|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958473|NCT03346239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44958474|NCT03346239|Antidepressive Agents|antidepressive agents|mesh-ancestor
44958475|NCT03346239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958476|NCT03188705|Aspirin|aspirin|mesh-list
44958477|NCT03188705|Clopidogrel|clopidogrel|mesh-list
44958478|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44958479|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44958480|NCT03188705|Analgesics|analgesics|mesh-ancestor
44958481|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
44958482|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958483|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958484|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958485|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958486|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958487|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958488|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958489|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958490|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44958491|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958492|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
44958493|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44958494|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44958495|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44958496|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
44958497|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958498|NCT03173456|Acetaminophen|acetaminophen|mesh-list
44958499|NCT03173456|Ibuprofen|ibuprofen|mesh-list
44958500|NCT03173456|Oxycodone|oxycodone|mesh-list
44958501|NCT03173456|Hydrocodone|hydrocodone|mesh-list
44958502|NCT03173456|Codeine|codeine|mesh-list
44958503|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44958504|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44958505|NCT03173456|Analgesics|analgesics|mesh-ancestor
44958506|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
44958507|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958508|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077777|NCT00016094|Antibodies|antibodies|mesh-list
44958509|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958510|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958511|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44958512|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958513|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958514|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44958515|NCT03173456|Narcotics|narcotics|mesh-ancestor
44958516|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958517|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
44958518|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
44258221|NCT00628550|Coagulants|coagulants|mesh-ancestor
44958519|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44958520|NCT03161678|Clopidogrel|clopidogrel|mesh-list
44958521|NCT03161678|Ticagrelor|ticagrelor|mesh-list
44958522|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958523|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44958524|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44958525|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44958526|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
44958527|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958528|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958529|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958530|NCT03006068|Upadacitinib|upadacitinib|mesh-list
44958531|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44958532|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44958533|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958534|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958535|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958536|NCT02918370|Aripiprazole|aripiprazole|mesh-list
44958537|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
44958538|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958539|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44958540|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44958541|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958542|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958543|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
44958544|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
44958545|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958546|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958547|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44958548|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44958549|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
44958550|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44958551|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44958552|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44958553|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44958554|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44958555|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
44958556|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
44958557|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958558|NCT02575144|Clarithromycin|clarithromycin|mesh-list
44958559|NCT02575144|Dexamethasone|dexamethasone|mesh-list
44958560|NCT02575144|Lenalidomide|lenalidomide|mesh-list
44958561|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958562|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
44958563|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
44958564|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958565|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958566|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958567|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
44958568|NCT02575144|Hormones|hormones|mesh-ancestor
44958569|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707250|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
44958570|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958571|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958572|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
44958573|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44958574|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44958575|NCT02575144|Growth Substances|growth substances|mesh-ancestor
44958576|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44958577|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44958578|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958579|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44958580|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958581|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958582|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44958583|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44958584|NCT02574286|Vitamin D|vitamin d|mesh-list
44958585|NCT02574286|Vitamins|vitamins|mesh-ancestor
44958586|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
44958587|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958588|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44958589|NCT02542956|Bupivacaine|bupivacaine|mesh-list
44958590|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
44958591|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
44958592|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958593|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958594|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
44958595|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958596|NCT02471144|Etanercept|etanercept|mesh-list
44958597|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44958598|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44958599|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44958600|NCT02471144|Analgesics|analgesics|mesh-ancestor
44958601|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
44958602|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258271|NCT00628732|Topotecan|topotecan|mesh-list
44958603|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958604|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958605|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958606|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958607|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958608|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
44958609|NCT02366728|Temozolomide|temozolomide|mesh-list
44958610|NCT02366728|Basiliximab|basiliximab|mesh-list
44958611|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
44958612|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958613|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44958614|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
44958615|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958616|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958617|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958618|NCT02313870|Clobetasol|clobetasol|mesh-list
44958619|NCT02313870|Methotrexate|methotrexate|mesh-list
44258332|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44958620|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44958621|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
44958622|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44958623|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958624|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44958625|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
44958626|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958627|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958628|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44958629|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958630|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44958631|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958632|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
44958633|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958634|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44958635|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958636|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
44958637|NCT02313870|Hormones|hormones|mesh-ancestor
44958638|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958639|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44958640|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958641|NCT02236806|Ramipril|ramipril|mesh-list
44958642|NCT02236806|Bisoprolol|bisoprolol|mesh-list
44958643|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44490165|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44958644|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44958645|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958646|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958647|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44958648|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
44958649|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
44958650|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958651|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958652|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44958653|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44958654|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44958655|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
44958656|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958657|NCT02236572|Everolimus|everolimus|mesh-list
44958658|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958659|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958660|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
44958661|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958662|NCT02220452|Anesthetics|anesthetics|mesh-list
44958663|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958664|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958665|NCT02083354|Trametinib|trametinib|mesh-list
44958666|NCT02083354|Dabrafenib|dabrafenib|mesh-list
44958667|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958668|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44958669|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958670|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958671|NCT02065635|Propofol|propofol|mesh-list
44958672|NCT02065635|Sevoflurane|sevoflurane|mesh-list
44958673|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44958674|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958675|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258389|NCT00629213|Acarbose|acarbose|mesh-list
44958676|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44958677|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
44958678|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
44958679|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958680|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44958681|NCT02061514|Propofol|propofol|mesh-list
44958682|NCT02061514|Desflurane|desflurane|mesh-list
44958683|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44958684|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958685|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958686|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44958687|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
44958688|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
44958689|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44958690|NCT01775813|Metformin|metformin|mesh-list
44958691|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44958692|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958693|NCT01694069|Tazobactam|tazobactam|mesh-list
44958694|NCT01694069|Piperacillin|piperacillin|mesh-list
44958695|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44958696|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44958697|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258410|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44958698|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44958699|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958700|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958701|NCT01399918|Bevacizumab|bevacizumab|mesh-list
44958702|NCT01399918|Everolimus|everolimus|mesh-list
44958703|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44958704|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958705|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44958706|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44958707|NCT01399918|Growth Substances|growth substances|mesh-ancestor
44958708|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958709|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
44958710|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958711|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
44958712|NCT01078454|Dexamethasone|dexamethasone|mesh-list
44958713|NCT01078454|Bortezomib|bortezomib|mesh-list
44958714|NCT01078454|Melphalan|melphalan|mesh-list
44958715|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958716|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
44958717|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
44958718|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958719|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958720|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958721|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
44958722|NCT01078454|Hormones|hormones|mesh-ancestor
44958723|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958724|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44958725|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958726|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44958727|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
44958728|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958729|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44958730|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958731|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
44958732|NCT00472654|Vitamin D|vitamin d|mesh-list
44958733|NCT00472654|Vitamins|vitamins|mesh-ancestor
44958734|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
44958735|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958736|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44958737|NCT00112840|Bevacizumab|bevacizumab|mesh-list
44958738|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44958739|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958740|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44958741|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44958742|NCT00112840|Growth Substances|growth substances|mesh-ancestor
44958743|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958744|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
44958745|NCT05223244|Triamcinolone|triamcinolone|mesh-list
44958746|NCT05223244|Heparin|heparin|mesh-list
44958747|NCT05223244|Bupivacaine|bupivacaine|mesh-list
44958748|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44958749|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
44958750|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
44958751|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958752|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958753|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
44958754|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958755|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
44958756|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958757|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958758|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958759|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958760|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
44958761|NCT05223244|Hormones|hormones|mesh-ancestor
44958762|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958763|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44258474|NCT00629447|Tinzaparin|tinzaparin|mesh-list
44958764|NCT05223244|Protective Agents|protective agents|mesh-ancestor
44958765|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44958766|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
44958767|NCT05223010|Sevoflurane|sevoflurane|mesh-list
44958768|NCT05223010|Melatonin|melatonin|mesh-list
44958769|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44958770|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958771|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44958772|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
44958773|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
44958774|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461689|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44958775|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958776|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
44958777|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958778|NCT05223010|Protective Agents|protective agents|mesh-ancestor
44958779|NCT05222646|Metoclopramide|metoclopramide|mesh-list
44958780|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
44958781|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
44958782|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958783|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958784|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958785|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44958786|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44958787|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
44958788|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461709|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958789|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958790|NCT05222633|Ranibizumab|ranibizumab|mesh-list
44958791|NCT05222633|Aflibercept|aflibercept|mesh-list
44958792|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461714|NCT01540487|Incretins|incretins|mesh-ancestor
44958793|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44958794|NCT05222633|Growth Substances|growth substances|mesh-ancestor
44958795|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490309|NCT05245786|Copper|copper|mesh-list
44958796|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
44958797|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958798|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44958799|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44958800|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958801|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958802|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44958803|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44958804|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958805|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
44958806|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490377|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490378|NCT05242081|Narcotics|narcotics|mesh-ancestor
44461721|NCT01539837|Deferiprone|deferiprone|mesh-list
44490379|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44490380|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
44490381|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44490383|NCT05249309|Analgesics|analgesics|mesh-ancestor
44490384|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
44490385|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490386|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490387|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44958807|NCT05222334|Bupivacaine|bupivacaine|mesh-list
44958808|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
44958809|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
44958810|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958811|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958812|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
44958813|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958814|NCT05222243|Calcium|calcium|mesh-list
44958815|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44958816|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958817|NCT05222204|Gemcitabine|gemcitabine|mesh-list
44958818|NCT05222204|Paclitaxel|paclitaxel|mesh-list
44958819|NCT05222204|Cisplatin|cisplatin|mesh-list
44958820|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44958821|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958822|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44958823|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44958824|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44958825|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461751|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
44958826|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44958827|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
44958828|NCT05222204|Antiviral Agents|antiviral agents|mesh-ancestor
44958829|NCT05222204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958830|NCT05222204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958831|NCT05222204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958832|NCT05222204|Immunologic Factors|immunologic factors|mesh-ancestor
44958833|NCT05222204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958834|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
44958835|NCT05222191|Spironolactone|spironolactone|mesh-list
44958836|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44958837|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
44958838|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258488|NCT00629473|Hormones|hormones|mesh-ancestor
44958839|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958840|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44958841|NCT05222191|Diuretics|diuretics|mesh-ancestor
44958842|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
44958843|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44958844|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44958845|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44958846|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958847|NCT05222113|Favipiravir|favipiravir|mesh-list
44958848|NCT05222113|Remdesivir|remdesivir|mesh-list
44958849|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
44958850|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958851|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
44258499|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958852|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958853|NCT05221892|Thiamine|thiamine|mesh-list
44958854|NCT05221892|Pyridoxine|pyridoxine|mesh-list
44958855|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
44958856|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
44958857|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44958858|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958859|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
44958860|NCT05221892|Vitamins|vitamins|mesh-ancestor
44958861|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
44958862|NCT05221892|Hematinics|hematinics|mesh-ancestor
44958863|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
44958864|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958865|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958866|NCT05221879|Enoxaparin|enoxaparin|mesh-list
44958867|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
44958868|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958869|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958870|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958871|NCT05221775|Lenvatinib|lenvatinib|mesh-list
44958872|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958873|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44958874|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958875|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958876|NCT05221736|Ethanol|ethanol|mesh-list
44958877|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44958878|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490457|NCT02398500|Ranibizumab|ranibizumab|mesh-list
44490458|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490459|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490460|NCT02398500|Growth Substances|growth substances|mesh-ancestor
44958879|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44958881|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44958882|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958883|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
44958884|NCT05221411|Tacrolimus|tacrolimus|mesh-list
44958885|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958886|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
44958887|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958888|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44958889|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958890|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958891|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44958892|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958893|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44958894|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
44958895|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44958896|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958897|NCT05221164|Aspirin|aspirin|mesh-list
44958898|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44958899|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44958900|NCT05221164|Analgesics|analgesics|mesh-ancestor
44958901|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
44958902|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958903|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958904|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958905|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958906|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958907|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958908|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958909|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44958910|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44258558|NCT00629824|Interferons|interferons|mesh-list
44958911|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958912|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
44958913|NCT05220527|Triamcinolone|triamcinolone|mesh-list
44958914|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
44958915|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44958916|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
44958917|NCT05220527|Hormones|hormones|mesh-ancestor
44958918|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958919|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958920|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
44958921|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44958922|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
44958923|NCT05220527|Protective Agents|protective agents|mesh-ancestor
44958924|NCT05220228|Prucalopride|prucalopride|mesh-list
44958925|NCT05220228|Laxatives|laxatives|mesh-ancestor
44958926|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44958927|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44958928|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44958929|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
44958930|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958931|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958932|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958933|NCT05219656|Cyclosporine|cyclosporine|mesh-list
44958934|NCT05219656|Cyclosporins|cyclosporins|mesh-list
44958935|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958936|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958937|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958938|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
44958939|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958940|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
44958941|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958942|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
44958943|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44958944|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44490531|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
44958945|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44958946|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44958948|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44958949|NCT05197374|Estrogens|estrogens|mesh-ancestor
44958950|NCT05197374|Hormones|hormones|mesh-ancestor
44958951|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44958952|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958953|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44958954|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
44958955|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44958956|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44958957|NCT05191290|Heparin|heparin|mesh-list
44958958|NCT05191290|Calcium heparin|calcium heparin|mesh-list
44958959|NCT05191290|Citric Acid|citric acid|mesh-list
44958960|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
44958961|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
44958962|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44958963|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
44958964|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
44958965|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958966|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44958967|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44958968|NCT05189028|Gemcitabine|gemcitabine|mesh-list
44958969|NCT05189028|Cisplatin|cisplatin|mesh-list
44258612|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
44958970|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44958971|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44958972|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
44958973|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958974|NCT05189028|Antiviral Agents|antiviral agents|mesh-ancestor
44958975|NCT05189028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958976|NCT05189028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44958977|NCT05189028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44958978|NCT05189028|Immunologic Factors|immunologic factors|mesh-ancestor
44958979|NCT05189028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958980|NCT05179499|Norepinephrine|norepinephrine|mesh-list
44958981|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44958982|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44958983|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44958984|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44958985|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44958986|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44958987|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
44958988|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
44958989|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44958990|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44958991|NCT05168644|Niclosamide|niclosamide|mesh-list
44958992|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
44958993|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44958994|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
44958995|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44958996|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44958997|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
44958998|NCT05126264|Ibuprofen|ibuprofen|mesh-list
44958999|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44959000|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44959001|NCT05126264|Analgesics|analgesics|mesh-ancestor
44959002|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
44959003|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959004|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959005|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959006|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959007|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44959008|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959009|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959010|NCT05095311|Cetirizine|cetirizine|mesh-list
44959011|NCT05095311|Nedocromil|nedocromil|mesh-list
44959012|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44959013|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44959014|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44959015|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
44959016|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
44959017|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490604|NCT00638508|Ketorolac|ketorolac|mesh-list
44959018|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258646|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
44959019|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959020|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44959021|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
44959022|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959023|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44959024|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959025|NCT05052827|Caseins|caseins|mesh-list
44959026|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
44959027|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
44959028|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959029|NCT05049278|Phenylephrine|phenylephrine|mesh-list
44959030|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
44959031|NCT05049278|Norepinephrine|norepinephrine|mesh-list
44959032|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44959033|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
44959034|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
44959035|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959036|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959037|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
44258669|NCT00630149|Pemetrexed|pemetrexed|mesh-list
44258670|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959038|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44959039|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
44959040|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44258679|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959041|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44959042|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959043|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959044|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44258685|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
44959045|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959046|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959047|NCT05049278|Protective Agents|protective agents|mesh-ancestor
44959048|NCT05011357|Phenylephrine|phenylephrine|mesh-list
44959049|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
44959050|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44959051|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
44959052|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
44959053|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959054|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959055|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
44959056|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44959057|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
44959058|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959059|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44959060|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959061|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959062|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959063|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258701|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
44959064|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959065|NCT05011357|Protective Agents|protective agents|mesh-ancestor
44959066|NCT04963816|Dexamethasone|dexamethasone|mesh-list
44959067|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
44959068|NCT04963816|Bupivacaine|bupivacaine|mesh-list
44959069|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44959070|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44959071|NCT04963816|BB 1101|bb 1101|mesh-list
44959072|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959073|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
44959074|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
44959075|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959076|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959077|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44959078|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
44959079|NCT04963816|Hormones|hormones|mesh-ancestor
44959080|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959081|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959082|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959083|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
44959084|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959085|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959086|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959087|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
44959088|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959089|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
44959090|NCT04933240|Tamoxifen|tamoxifen|mesh-list
44959091|NCT04933240|Estradiol|estradiol|mesh-list
44959092|NCT04933240|Estrogens|estrogens|mesh-ancestor
44959093|NCT04933240|Hormones|hormones|mesh-ancestor
44959094|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959095|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959096|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44959097|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959098|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959099|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959100|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44959101|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44959102|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44959104|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44959105|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959106|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
44959107|NCT04889703|Salicylates|salicylates|mesh-list
44258739|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44959108|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959109|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
44959110|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
44959111|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
44959112|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44959113|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44959114|NCT04889703|Analgesics|analgesics|mesh-ancestor
44959115|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
44959116|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959117|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959118|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959119|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959120|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44959121|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959122|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959123|NCT04873375|Cemiplimab|cemiplimab|mesh-list
44959124|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959125|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959126|NCT04789499|Theophylline|theophylline|mesh-list
44959127|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44959128|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
44959129|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258765|NCT00630708|Benazepril|benazepril|mesh-list
44959130|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959131|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44959132|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959133|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44959134|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959135|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959136|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44959137|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44959138|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44959139|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
44959140|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959141|NCT04765644|Celecoxib|celecoxib|mesh-list
44959142|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44959143|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44959144|NCT04765644|Analgesics|analgesics|mesh-ancestor
44959145|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
44959146|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959147|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959148|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959149|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959150|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44959151|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44959152|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959153|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490758|NCT00636636|Gabapentin|gabapentin|mesh-list
44959154|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
44959155|NCT05707377|Tacrolimus|tacrolimus|mesh-list
44959156|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959157|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
44959158|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959159|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44959160|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959161|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959162|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258781|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
44959163|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44959164|NCT05707351|Factor VIII|factor viii|mesh-list
44959165|NCT05707351|BAX 855|bax 855|mesh-list
44959166|NCT05707351|Coagulants|coagulants|mesh-ancestor
44959167|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
44959168|NCT05707273|Fludarabine|fludarabine|mesh-list
44959169|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959170|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
44959171|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959172|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959173|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959174|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
44959175|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959176|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959177|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44959178|NCT05707234|Midazolam|midazolam|mesh-list
44959179|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44959180|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44258808|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
44959181|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959182|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959183|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44959184|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44959185|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959186|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44959187|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
44959188|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
44959189|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
44959190|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
44959191|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959192|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959193|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
44959194|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44959195|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959196|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
44959197|NCT05707208|Lidocaine|lidocaine|mesh-list
44959198|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959199|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
44959200|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959201|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959202|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
44959203|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959204|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44959205|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44959206|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44959207|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959208|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959209|NCT05707169|Lidocaine|lidocaine|mesh-list
44959210|NCT05707169|Epinephrine|epinephrine|mesh-list
44959211|NCT05707169|Racepinephrine|racepinephrine|mesh-list
44959212|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
44959213|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
44959214|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959215|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
44959216|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959217|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959218|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
44959219|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959220|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44959221|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44959222|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44959223|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959224|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959225|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959226|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959227|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959228|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959229|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44959230|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44959231|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
44959232|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44959233|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959234|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
44959235|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
44959236|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44959237|NCT05706987|Lidocaine|lidocaine|mesh-list
44959238|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959239|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
44959240|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959241|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959242|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
44959243|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959244|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44959245|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44959246|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44959247|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959248|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959249|NCT05706870|Clobetasol|clobetasol|mesh-list
44959250|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959251|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
44959252|NCT05706870|Hormones|hormones|mesh-ancestor
44959253|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959254|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959255|NCT05706844|Anesthetics|anesthetics|mesh-list
44959256|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959257|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959258|NCT05706779|Cetuximab|cetuximab|mesh-list
44959259|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959260|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959261|NCT05706753|Drospirenone|drospirenone|mesh-list
44959262|NCT05706753|Midazolam|midazolam|mesh-list
44959263|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44959264|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44959265|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959266|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959267|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959268|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44959269|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44959270|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959271|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44959272|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
44959273|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
44959274|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
44959275|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
44959276|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959277|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959278|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44959279|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44959280|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44959281|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
44959282|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44959283|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44959284|NCT05706753|Estrogens|estrogens|mesh-ancestor
44959285|NCT05706753|Hormones|hormones|mesh-ancestor
44461814|NCT01538472|Cytarabine|cytarabine|mesh-list
44959286|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959287|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44959288|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959289|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44959290|NCT05706753|Diuretics|diuretics|mesh-ancestor
44959291|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
44959292|NCT05706727|Phenylephrine|phenylephrine|mesh-list
44959293|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
44959294|NCT05706727|Mephentermine|mephentermine|mesh-list
44959295|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44959296|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
44959297|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
44959298|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959299|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959300|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
44959301|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44959302|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
44959303|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959304|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44959305|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959306|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959307|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959308|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959309|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959310|NCT05706727|Protective Agents|protective agents|mesh-ancestor
44959312|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44959313|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
44959314|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959315|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959316|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44959317|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44959318|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
44959319|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959320|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959321|NCT05706688|Anesthetics|anesthetics|mesh-list
44959322|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959323|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959324|NCT05706506|Tirzepatide|tirzepatide|mesh-list
44959325|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44959326|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959327|NCT05706506|Incretins|incretins|mesh-ancestor
44959328|NCT05706506|Hormones|hormones|mesh-ancestor
44959329|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959330|NCT05706454|Ramatroban|ramatroban|mesh-list
44959331|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44959332|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
44959333|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44959334|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
44959335|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959336|NCT05706402|Expectorants|expectorants|mesh-ancestor
44959337|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959338|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44959339|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
44959340|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959341|NCT05706402|Protective Agents|protective agents|mesh-ancestor
44959342|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959343|NCT05706402|Antidotes|antidotes|mesh-ancestor
44959344|NCT05706337|Propofol|propofol|mesh-list
44258921|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
44959345|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959346|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959347|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959348|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44959349|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
44959350|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
44959351|NCT05706259|Vitamin D|vitamin d|mesh-list
44959352|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
44959353|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
44959354|NCT05706259|Vitamins|vitamins|mesh-list
44959355|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
44959356|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959357|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44959358|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44959359|NCT05706233|Analgesics|analgesics|mesh-list
44959360|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
44959361|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959362|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959363|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44959364|NCT05706207|Antibodies|antibodies|mesh-list
44959365|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
44959366|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44959367|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
44959368|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959369|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959370|NCT05706090|Fentanyl|fentanyl|mesh-list
44959371|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
44959372|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959373|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959374|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44959375|NCT05706090|Narcotics|narcotics|mesh-ancestor
44959376|NCT05706090|Analgesics|analgesics|mesh-ancestor
44959377|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
44959378|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959379|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44959380|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44959381|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
44959382|NCT05706038|Adalimumab|adalimumab|mesh-list
44959383|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959384|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959385|NCT05705856|Ustekinumab|ustekinumab|mesh-list
44959386|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
44959387|NCT05705843|Vancomycin|vancomycin|mesh-list
44959388|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959389|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959390|NCT05705830|Serotonin|serotonin|mesh-list
44959391|NCT05705830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44959392|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44959393|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
44959394|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959395|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959396|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959397|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44959398|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959399|NCT05705804|Atorvastatin|atorvastatin|mesh-list
44959400|NCT05705804|Pitavastatin|pitavastatin|mesh-list
44959401|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44959402|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44959403|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
44258976|NCT00631995|Vaccines|vaccines|mesh-list
44959404|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959405|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44959406|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44959407|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959408|NCT05705700|Dutasteride|dutasteride|mesh-list
44959409|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44959410|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44959411|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959412|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959413|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959414|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959415|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959416|NCT05705635|Docetaxel|docetaxel|mesh-list
44959417|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959418|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959419|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959420|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44959421|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959422|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
44959423|NCT05705570|Fludarabine|fludarabine|mesh-list
44959424|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959425|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
44959426|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959427|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959428|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959429|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
44959430|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959431|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959432|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44959433|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
44959434|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959435|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959436|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959437|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44959438|NCT05705128|Analgesics|analgesics|mesh-ancestor
44959439|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
44959440|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959441|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44259010|NCT00632268|Leucovorin|leucovorin|mesh-list
44959442|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959443|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959444|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959445|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959446|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959447|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
44959448|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
44959449|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44959450|NCT05702671|Antibodies|antibodies|mesh-list
44959451|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
44959452|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959453|NCT05702333|Simendan|simendan|mesh-list
44959454|NCT05702333|Dobutamine|dobutamine|mesh-list
44959455|NCT05702333|Dopamine|dopamine|mesh-list
44259033|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
44959456|NCT05702333|Epinephrine|epinephrine|mesh-list
44491059|NCT00634114|Omeprazole|omeprazole|mesh-list
44959457|NCT05702333|Norepinephrine|norepinephrine|mesh-list
44959458|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959459|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959460|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959461|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959462|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959463|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959464|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44959465|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44959466|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
44959467|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959468|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44959469|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959470|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
44959471|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
44959472|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44959473|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44959474|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
44959475|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44959476|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44259052|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
44959477|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959478|NCT05702333|Protective Agents|protective agents|mesh-ancestor
44084243|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959479|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44959480|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
44959481|NCT05699811|Paclitaxel|paclitaxel|mesh-list
44959482|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
44959483|NCT05699811|Antibodies|antibodies|mesh-list
44959484|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44959485|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44259058|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
44959486|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959487|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959488|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959489|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259062|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44959490|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959491|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959492|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
44959493|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959494|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959495|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959496|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
44959497|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44959498|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
44959499|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959500|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959501|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959502|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44959503|NCT05698758|Analgesics|analgesics|mesh-ancestor
44259077|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
44959504|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
44959505|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959506|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44959507|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44959508|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44959509|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44959510|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959511|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959512|NCT05698381|Acetic Acid|acetic acid|mesh-list
44959513|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959514|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959515|NCT05692154|Fexofenadine|fexofenadine|mesh-list
44959516|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44959517|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44959518|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44959519|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
44959520|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
44959521|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959522|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959523|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959524|NCT05689177|Vaccines|vaccines|mesh-list
44959525|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
44959526|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959527|NCT05681039|Cisplatin|cisplatin|mesh-list
44959528|NCT05681039|Carboplatin|carboplatin|mesh-list
44959529|NCT05681039|Atezolizumab|atezolizumab|mesh-list
44959530|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959531|NCT05675462|Lenvatinib|lenvatinib|mesh-list
44491131|NCT00633360|Drospirenone|drospirenone|mesh-list
44959532|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959533|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44959534|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959535|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959536|NCT05672927|Vaccines|vaccines|mesh-list
44259114|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44959537|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
44959538|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959539|NCT05670379|Exenatide|exenatide|mesh-list
44959540|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44959541|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959542|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44959543|NCT05670379|Incretins|incretins|mesh-ancestor
44959544|NCT05670379|Hormones|hormones|mesh-ancestor
44959545|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959546|NCT05670236|Lidocaine|lidocaine|mesh-list
44959547|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959548|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
44959549|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959550|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959551|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
44959552|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959553|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44959554|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44959555|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44959556|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959557|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959558|NCT05660538|Pregabalin|pregabalin|mesh-list
44959559|NCT05660538|Analgesics|analgesics|mesh-ancestor
44259125|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44959560|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
44959561|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959562|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959563|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
44959564|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44959565|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959566|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959567|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44959568|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44959569|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44959570|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959571|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959572|NCT05654623|Fulvestrant|fulvestrant|mesh-list
44959573|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959574|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959575|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44959576|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44959577|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959578|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959579|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959580|NCT05653713|Lenograstim|lenograstim|mesh-list
44959581|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44959582|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
44959583|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959584|NCT05652478|Tenofovir|tenofovir|mesh-list
44959585|NCT05652478|Dolutegravir|dolutegravir|mesh-list
44959586|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
44959587|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959588|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44959589|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44959590|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085449|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44959591|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959592|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44959593|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44959594|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44959595|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44959596|NCT05651074|Omeprazole|omeprazole|mesh-list
44959597|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44959598|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44959599|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44959600|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259166|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44959601|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959602|NCT05648006|Bevacizumab|bevacizumab|mesh-list
44959603|NCT05648006|Capecitabine|capecitabine|mesh-list
44959604|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491210|NCT00632827|Etoposide|etoposide|mesh-list
44959605|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959606|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44959607|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44959608|NCT05648006|Growth Substances|growth substances|mesh-ancestor
44959609|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959610|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44959611|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44959612|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
44259184|NCT00633347|Cetrorelix|cetrorelix|mesh-list
44959613|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959615|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959616|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959617|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44959618|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44959619|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959620|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959621|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959622|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44959623|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44959624|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
44959625|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959626|NCT05630781|Suvorexant|suvorexant|mesh-list
44959627|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44959628|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959629|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959630|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959631|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44959632|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959633|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959634|NCT05617521|Caffeine|caffeine|mesh-list
44959635|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44959636|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959637|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44959638|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959639|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959640|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44959641|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44959642|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
44959643|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959644|NCT05613777|BI 425809|bi 425809|mesh-list
44959645|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44959646|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44959647|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44461833|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
44959648|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
44959649|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44959650|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959651|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44959652|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44959653|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44959654|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44959655|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44959656|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44959657|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44959658|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44959659|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
44959660|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44959661|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959662|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959663|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
44959664|NCT05609656|Calcium|calcium|mesh-list
44959665|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44461857|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
44959666|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959667|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959668|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959669|NCT05609370|Bevacizumab|bevacizumab|mesh-list
44959670|NCT05609370|Capecitabine|capecitabine|mesh-list
44959671|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959672|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959673|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44959674|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44959675|NCT05609370|Growth Substances|growth substances|mesh-ancestor
44959676|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959677|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44959678|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44959679|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
44259217|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959680|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959681|NCT05607004|Exemestane|exemestane|mesh-list
44959682|NCT05607004|Goserelin|goserelin|mesh-list
44959683|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959684|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44959685|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44959686|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959687|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959688|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44959689|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259224|NCT00633412|Esomeprazole|esomeprazole|mesh-list
44959690|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959691|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959692|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959693|NCT05601882|Upadacitinib|upadacitinib|mesh-list
44959694|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44959695|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44959696|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959697|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959698|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959699|NCT05582694|UB-421|ub-421|mesh-list
44959700|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44959701|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
44959702|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959703|NCT05578976|Prednisone|prednisone|mesh-list
44959704|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
44959705|NCT05578976|Rituximab|rituximab|mesh-list
44959706|NCT05578976|Doxorubicin|doxorubicin|mesh-list
44959707|NCT05578976|Vincristine|vincristine|mesh-list
44959708|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259246|NCT00633438|Analgesics|analgesics|mesh-ancestor
44959709|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
44959710|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959711|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959712|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959713|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
44959714|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959715|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959716|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44959717|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959718|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44959719|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44959720|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44959721|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959722|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959723|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
44959724|NCT05578976|Hormones|hormones|mesh-ancestor
44959725|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959726|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959727|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44959728|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959729|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959730|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
44959731|NCT05570526|Melatonin|melatonin|mesh-list
44959732|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
44959733|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959734|NCT05570526|Protective Agents|protective agents|mesh-ancestor
44959735|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959736|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959737|NCT05555706|Paclitaxel|paclitaxel|mesh-list
44959738|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44959739|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959740|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959741|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959742|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44959743|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959744|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
44959745|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959746|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44959747|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959748|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959749|NCT05545137|Fosfomycin|fosfomycin|mesh-list
44959750|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
44959751|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959752|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959753|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44959754|NCT05545137|Renal Agents|renal agents|mesh-ancestor
44959755|NCT05538910|Nicotine|nicotine|mesh-list
44959756|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44959757|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
44959758|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959759|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959760|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44959761|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44087596|NCT00023868|Leucovorin|leucovorin|mesh-list
44959762|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
44959763|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44959764|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959765|NCT05538897|Megestrol|megestrol|mesh-list
44959766|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
44959767|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44959768|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44959769|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44959770|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
44959771|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44959772|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959773|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44959774|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44959775|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959776|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959777|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
44959778|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44959779|NCT05532358|Midazolam|midazolam|mesh-list
44959780|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
44959781|NCT05532358|Caffeine|caffeine|mesh-list
44959782|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44959783|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44959784|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959785|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959786|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44959787|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44959788|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959789|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44959790|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
44959791|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
44959792|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
44959793|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
44959794|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259320|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959795|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959796|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44959797|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44959798|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959799|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44959800|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44959801|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
44959802|NCT05532358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44959803|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44959804|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44959805|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
44959806|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44959807|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
44959808|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44959809|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44959810|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44959811|NCT05524168|Gemcitabine|gemcitabine|mesh-list
44959812|NCT05524168|Cisplatin|cisplatin|mesh-list
44959813|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959814|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44959815|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
44959816|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959817|NCT05524168|Antiviral Agents|antiviral agents|mesh-ancestor
44959818|NCT05524168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959819|NCT05524168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959820|NCT05524168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959821|NCT05524168|Immunologic Factors|immunologic factors|mesh-ancestor
44959822|NCT05524168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959823|NCT05522673|Rolipram|rolipram|mesh-list
44959824|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
44959825|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959826|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44959827|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44959828|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959829|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959830|NCT05501860|Carticaine|carticaine|mesh-list
44959831|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
44959832|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
44959833|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44959834|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959835|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
44959836|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959837|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
44959838|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959839|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959840|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44959841|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44959842|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959843|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959844|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959845|NCT05476926|Ranibizumab|ranibizumab|mesh-list
44959846|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44959847|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44959848|NCT05476926|Growth Substances|growth substances|mesh-ancestor
44959849|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959850|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
44959851|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959852|NCT05470491|Maraviroc|maraviroc|mesh-list
44959853|NCT05470491|Plerixafor|plerixafor|mesh-list
44959854|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44959855|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44959856|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959857|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44959858|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44959859|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
44959860|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259395|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959861|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44959862|NCT05459129|Paclitaxel|paclitaxel|mesh-list
44959863|NCT05459129|Carboplatin|carboplatin|mesh-list
44959864|NCT05459129|Atezolizumab|atezolizumab|mesh-list
44959865|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44959866|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959867|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959868|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959869|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
44959870|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959871|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
44959872|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
44959873|NCT05457556|Melphalan|melphalan|mesh-list
44959874|NCT05457556|Busulfan|busulfan|mesh-list
44959875|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
44959876|NCT05457556|Thiotepa|thiotepa|mesh-list
44959877|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44959878|NCT05457556|Rituximab|rituximab|mesh-list
44959879|NCT05457556|Methotrexate|methotrexate|mesh-list
44959880|NCT05457556|Fludarabine|fludarabine|mesh-list
44959881|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44959882|NCT05457556|Tacrolimus|tacrolimus|mesh-list
44959883|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
44959884|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44959885|NCT05457556|Antibodies|antibodies|mesh-list
44959886|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
44959887|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44959888|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
44959889|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44959890|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44959891|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959892|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
44959893|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959894|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44959895|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959896|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
44959897|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259404|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44959898|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491436|NCT00630331|Vaccines|vaccines|mesh-list
44491465|NCT00637130|Travoprost|travoprost|mesh-list
44959899|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44959900|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44959901|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
44959902|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44959903|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44959904|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
44959905|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44959906|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959907|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44959908|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44959909|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44959910|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44959911|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44959912|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
44959913|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959914|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959915|NCT05453825|Paclitaxel|paclitaxel|mesh-list
44959916|NCT05453825|Irinotecan|irinotecan|mesh-list
44959917|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44959918|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959919|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959920|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959921|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259448|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
44959922|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959923|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44959924|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44959925|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959926|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44959927|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44959928|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959929|NCT05438979|Calcium|calcium|mesh-list
44959930|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44959931|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959932|NCT05432414|Dexamethasone|dexamethasone|mesh-list
44959933|NCT05432414|Bortezomib|bortezomib|mesh-list
44959934|NCT05432414|Pomalidomide|pomalidomide|mesh-list
44959935|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44959936|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
44959937|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
44959938|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44959939|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959940|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44959941|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
44959942|NCT05432414|Hormones|hormones|mesh-ancestor
44959943|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959944|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44959945|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959946|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
44959947|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44959948|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44959949|NCT05432414|Growth Substances|growth substances|mesh-ancestor
44959950|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
44959951|NCT05432115|Amoxicillin|amoxicillin|mesh-list
44959952|NCT05432115|Tetracycline|tetracycline|mesh-list
44959953|NCT05432115|Esomeprazole|esomeprazole|mesh-list
44959954|NCT05432115|Bismuth|bismuth|mesh-list
44959955|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44959956|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44959957|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44959958|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44959959|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44959960|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44959961|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959962|NCT05432115|Antacids|antacids|mesh-ancestor
44959963|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44959964|NCT05430399|Docetaxel|docetaxel|mesh-list
44959965|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959966|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44959967|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44959968|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44959969|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959970|NCT05413304|Temozolomide|temozolomide|mesh-list
44959971|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
44959972|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44959973|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
44959974|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44959975|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44959976|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44959977|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44959978|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
44959979|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
44959980|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959981|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959982|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44959983|NCT05407662|Diuretics|diuretics|mesh-ancestor
44959984|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
44959985|NCT05407662|Hormones|hormones|mesh-ancestor
44959986|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44959987|NCT05403476|Hormones|hormones|mesh-ancestor
44959988|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44959989|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44959990|NCT05389423|Prednisone|prednisone|mesh-list
44959991|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
44959992|NCT05389423|Rituximab|rituximab|mesh-list
44259492|NCT00634634|Sorafenib|sorafenib|mesh-list
44959993|NCT05389423|Doxorubicin|doxorubicin|mesh-list
44959994|NCT05389423|Etoposide|etoposide|mesh-list
44959995|NCT05389423|Vincristine|vincristine|mesh-list
44959996|NCT05389423|Pomalidomide|pomalidomide|mesh-list
44959997|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44959998|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
44959999|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960000|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960001|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960002|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
44960003|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960004|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960005|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44960006|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960007|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960008|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44960009|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44960010|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259541|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
44960011|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960012|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
44960013|NCT05389423|Hormones|hormones|mesh-ancestor
44960014|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960015|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44960016|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960017|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960018|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960019|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960020|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960021|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960022|NCT05389423|Growth Substances|growth substances|mesh-ancestor
44960023|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44960024|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
44960025|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
44960026|NCT05382338|Lomustine|lomustine|mesh-list
44960027|NCT05382338|Cisplatin|cisplatin|mesh-list
44960028|NCT05382338|Vincristine|vincristine|mesh-list
44960030|NCT05382338|Antidotes|antidotes|mesh-list
44960031|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960032|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
44960033|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960034|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960035|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960036|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
44960037|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960038|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960039|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44960040|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960041|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960042|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
44259576|NCT00635037|Bupivacaine|bupivacaine|mesh-list
44960043|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960044|NCT05382338|Protective Agents|protective agents|mesh-ancestor
44960045|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
44960046|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
44960047|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960048|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960049|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
44960050|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
44960051|NCT05377242|Curcumin|curcumin|mesh-list
44960052|NCT05377242|Resveratrol|resveratrol|mesh-list
44960053|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44960054|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960055|NCT05377242|Analgesics|analgesics|mesh-ancestor
44960056|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
44960057|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960058|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960059|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960060|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960061|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960062|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960063|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960064|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
44960065|NCT05377242|Protective Agents|protective agents|mesh-ancestor
44960066|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44960067|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
44960068|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44960069|NCT05371054|Prednisone|prednisone|mesh-list
44960070|NCT05371054|Venetoclax|venetoclax|mesh-list
44960071|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960072|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
44960073|NCT05371054|Hormones|hormones|mesh-ancestor
44960074|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960075|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960076|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44960077|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960078|NCT05370911|Psilocybin|psilocybin|mesh-list
44960079|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
44960080|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960081|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44960082|NCT05352815|Insulin|insulin|mesh-list
44960083|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960084|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960085|NCT05350774|Methylprednisolone|methylprednisolone|mesh-list
44960086|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
44960087|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44960088|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
44960089|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44960090|NCT05350774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960091|NCT05350774|Antiemetics|antiemetics|mesh-ancestor
44960092|NCT05350774|Autonomic Agents|autonomic agents|mesh-ancestor
44960093|NCT05350774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960094|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960095|NCT05350774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960096|NCT05350774|Glucocorticoids|glucocorticoids|mesh-ancestor
44960097|NCT05350774|Hormones|hormones|mesh-ancestor
44960098|NCT05350774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960099|NCT05350774|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44960100|NCT05350774|Protective Agents|protective agents|mesh-ancestor
44960101|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
44960102|NCT05347238|Dopamine|dopamine|mesh-list
44960103|NCT05347238|Norepinephrine|norepinephrine|mesh-list
44960104|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44960105|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44960106|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960107|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960108|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960109|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960110|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
44960111|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
44960112|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960113|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44960114|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44960115|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
44461877|NCT01537120|Vildagliptin|vildagliptin|mesh-list
44960116|NCT05347238|Protective Agents|protective agents|mesh-ancestor
44960117|NCT05333458|Atezolizumab|atezolizumab|mesh-list
44960118|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44960119|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960120|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
44960121|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960122|NCT05330429|Leucovorin|leucovorin|mesh-list
44960123|NCT05330429|Bevacizumab|bevacizumab|mesh-list
44960124|NCT05330429|Magrolimab|magrolimab|mesh-list
44960125|NCT05330429|Fluorouracil|fluorouracil|mesh-list
44960126|NCT05330429|Irinotecan|irinotecan|mesh-list
44960127|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960128|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960129|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960130|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960135|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960137|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960138|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
44960139|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44960140|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44960141|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960142|NCT05330429|Antidotes|antidotes|mesh-ancestor
44960143|NCT05330429|Protective Agents|protective agents|mesh-ancestor
44960144|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
44960145|NCT05330429|Vitamins|vitamins|mesh-ancestor
44960146|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
44960147|NCT05324163|Celecoxib|celecoxib|mesh-list
44259626|NCT00635401|Varenicline|varenicline|mesh-list
44960148|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44960149|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960150|NCT05324163|Analgesics|analgesics|mesh-ancestor
44960151|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
44259645|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44960152|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960153|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960154|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960155|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960156|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44960157|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44960158|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960159|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960160|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44960161|NCT05308446|Nivolumab|nivolumab|mesh-list
44960162|NCT05308446|Cetuximab|cetuximab|mesh-list
44960163|NCT05308446|Antibodies|antibodies|mesh-list
44960164|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
44960165|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44960166|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
44960167|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960168|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960169|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44960170|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960171|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44960172|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960173|NCT05288153|Metformin|metformin|mesh-list
44960174|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960175|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960176|NCT05286827|Olaparib|olaparib|mesh-list
44960177|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44960178|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960179|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960180|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960181|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44960182|NCT05280028|Tibolone|tibolone|mesh-list
44960183|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44960184|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44960185|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
44960186|NCT05280028|Estradiol|estradiol|mesh-list
44960187|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44960188|NCT05280028|Estrogens|estrogens|mesh-ancestor
44960189|NCT05280028|Hormones|hormones|mesh-ancestor
44682625|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
44682626|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44682627|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44682628|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682629|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
44682630|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44682631|NCT05408585|Anesthetics|anesthetics|mesh-list
44682632|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259685|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682633|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960190|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960191|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960192|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44960193|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
44960194|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44960195|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44960196|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44960197|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44960198|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44960199|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44960200|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44960201|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960202|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
44960203|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
44960204|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960205|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44960206|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
44960207|NCT05278676|Dotinurad|dotinurad|mesh-list
44960208|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
44960209|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
44259694|NCT00635791|Sorafenib|sorafenib|mesh-list
44960210|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960211|NCT05278676|Renal Agents|renal agents|mesh-ancestor
44960212|NCT05256225|Paclitaxel|paclitaxel|mesh-list
44960213|NCT05256225|Carboplatin|carboplatin|mesh-list
44960214|NCT05256225|Trastuzumab|trastuzumab|mesh-list
44960215|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44960216|NCT05256225|Pertuzumab|pertuzumab|mesh-list
44960217|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960218|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960219|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960220|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960221|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960222|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960223|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960224|NCT05255991|Treprostinil|treprostinil|mesh-list
44960225|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960226|NCT05254002|Empagliflozin|empagliflozin|mesh-list
44960227|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44960228|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960229|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960230|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960231|NCT05249101|Capecitabine|capecitabine|mesh-list
44960232|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44960233|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
44960234|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960235|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960236|NCT05233566|Ketamine|ketamine|mesh-list
44960237|NCT05233566|Analgesics|analgesics|mesh-ancestor
44960238|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
44960239|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960240|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960241|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44960242|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44259717|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
44960243|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
44960244|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
44960245|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960246|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44960247|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44960248|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960249|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960250|NCT05230368|Decitabine|decitabine|mesh-list
44960251|NCT05230368|Romidepsin|romidepsin|mesh-list
44960252|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44960253|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
44259753|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44960254|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960255|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960256|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960257|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960258|NCT05211336|Prednisone|prednisone|mesh-list
44960259|NCT05211336|Lenalidomide|lenalidomide|mesh-list
44960260|NCT05211336|Venetoclax|venetoclax|mesh-list
44960261|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
44960262|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960263|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
44960264|NCT05211336|Hormones|hormones|mesh-ancestor
44960265|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960266|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960267|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44960268|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960269|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
44960270|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960271|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960272|NCT05211336|Growth Substances|growth substances|mesh-ancestor
44960273|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089673|NCT00027976|Celecoxib|celecoxib|mesh-list
44960274|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960275|NCT05185947|Paclitaxel|paclitaxel|mesh-list
44960276|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960277|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960278|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960279|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960280|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089725|NCT00028171|Tacrolimus|tacrolimus|mesh-list
44960281|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960282|NCT05174455|Niraparib|niraparib|mesh-list
44960283|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44960284|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960285|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960286|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960287|NCT05162053|Clopidogrel|clopidogrel|mesh-list
44960288|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44960289|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44960290|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44960291|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44960292|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
44960293|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960294|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960295|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960296|NCT05150938|Vitamin K|vitamin k|mesh-list
44960297|NCT05150938|Heparin|heparin|mesh-list
44960298|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44960299|NCT05150938|Tinzaparin|tinzaparin|mesh-list
44960300|NCT05150938|Dalteparin|dalteparin|mesh-list
44960301|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
44960302|NCT05150938|Vitamins|vitamins|mesh-ancestor
44960303|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
44960304|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259800|NCT00636311|Bortezomib|bortezomib|mesh-list
44960305|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
44960306|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44960307|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44960308|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960309|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44960310|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
44960311|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44960312|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
44960313|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960314|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44960315|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
44960316|NCT05150938|Coagulants|coagulants|mesh-ancestor
44960317|NCT05130515|Niraparib|niraparib|mesh-list
44960318|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44960319|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960320|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960321|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960322|NCT05120895|Pravastatin|pravastatin|mesh-list
44960323|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44960324|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44960325|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
44960326|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960327|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44960328|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44960329|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960330|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
44960331|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960332|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960333|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
44960334|NCT05103735|Remifentanil|remifentanil|mesh-list
44960335|NCT05103735|Propofol|propofol|mesh-list
44960336|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44960337|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960338|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960339|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44960340|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
44960341|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
44960342|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960343|NCT05103735|Analgesics|analgesics|mesh-ancestor
44259848|NCT00636519|Antitoxins|antitoxins|mesh-list
44960344|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
44960345|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914054|NCT00416494|Bevacizumab|bevacizumab|mesh-list
44960346|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44960347|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44960348|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44960349|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960350|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960351|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960352|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44960353|NCT05103735|Narcotics|narcotics|mesh-ancestor
44960354|NCT05096442|Paclitaxel|paclitaxel|mesh-list
44960355|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44960356|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960357|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960358|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960359|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960360|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960361|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960362|NCT05087212|Plerixafor|plerixafor|mesh-list
44960363|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44960364|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44960365|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
44960366|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960367|NCT05071794|Propofol|propofol|mesh-list
44960368|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44960369|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960370|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960371|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44960372|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
44960373|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
44960374|NCT05053828|Clopidogrel|clopidogrel|mesh-list
44960375|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44960376|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44960377|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44960378|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44960379|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
44960380|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960381|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960382|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960383|NCT05047172|Aspirin|aspirin|mesh-list
44960384|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
44960385|NCT05047172|Clopidogrel|clopidogrel|mesh-list
44960386|NCT05047172|Ticagrelor|ticagrelor|mesh-list
44960387|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44960388|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960389|NCT05047172|Analgesics|analgesics|mesh-ancestor
44960390|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
44960391|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960392|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960393|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960394|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960395|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44960396|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44960397|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960398|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44960399|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44960400|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960401|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
44960402|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44960403|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44960404|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44960405|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
44960406|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960407|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44960408|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
44960409|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44960410|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
44960411|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
44960412|NCT05039619|Acetaminophen|acetaminophen|mesh-list
44960413|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
44960414|NCT05039619|Promethazine|promethazine|mesh-list
44960415|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
44960416|NCT05039619|Prednisone|prednisone|mesh-list
44960417|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
44960418|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
44960419|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960420|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
44960421|NCT05039619|Hormones|hormones|mesh-ancestor
44090351|NCT00029523|Cytarabine|cytarabine|mesh-list
44960425|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960426|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960427|NCT05039619|Analgesics|analgesics|mesh-ancestor
44960428|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
44960429|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960430|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
44960431|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960432|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44960433|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
44960434|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090461|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
44090543|NCT00030368|Paclitaxel|paclitaxel|mesh-list
44960435|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960436|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960437|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960438|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
44960439|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
44960440|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960441|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44960442|NCT05039619|Protective Agents|protective agents|mesh-ancestor
44960443|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960444|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44960445|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44960446|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960447|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
44960448|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
44960449|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44960450|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
44960451|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
44960452|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960453|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44960454|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
44960455|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
44960456|NCT05029050|Clonidine|clonidine|mesh-list
44960457|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
44960458|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44960459|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960460|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960461|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960462|NCT05029050|Analgesics|analgesics|mesh-ancestor
44960463|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
44960464|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960465|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44960466|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44960467|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44960468|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960469|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960470|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960471|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960472|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
44960473|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
44960474|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
44960475|NCT05027945|Sirolimus|sirolimus|mesh-list
44960476|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
44960477|NCT05027945|Busulfan|busulfan|mesh-list
44960478|NCT05027945|Fludarabine|fludarabine|mesh-list
44960479|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960480|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
44960481|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682643|NCT05399498|Psilocybin|psilocybin|mesh-list
44682644|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
44682645|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682646|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682647|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
44682648|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
44682649|NCT05395052|Nivolumab|nivolumab|mesh-list
44682650|NCT05395052|Trastuzumab|trastuzumab|mesh-list
44682651|NCT05395052|Fludarabine|fludarabine|mesh-list
44682652|NCT05395052|Cetuximab|cetuximab|mesh-list
44682653|NCT05395052|Atezolizumab|atezolizumab|mesh-list
44682654|NCT05395052|Interleukin-2|interleukin-2|mesh-list
44682655|NCT05395052|Avelumab|avelumab|mesh-list
44960482|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960483|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44259993|NCT00636974|Anesthetics|anesthetics|mesh-list
44960485|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960486|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960487|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44259999|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960488|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960489|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44960490|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
44960491|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960492|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960493|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960494|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
44960495|NCT05026606|Nivolumab|nivolumab|mesh-list
44960496|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960497|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960498|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44960499|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960500|NCT05020899|Nicotine|nicotine|mesh-list
44960501|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44960502|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
44960503|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960504|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960505|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44960506|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44960507|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
44960508|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960509|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960510|NCT05018273|Atezolizumab|atezolizumab|mesh-list
44960511|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960512|NCT05017545|Abatacept|abatacept|mesh-list
44960513|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44960514|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960515|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960516|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960517|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
44960518|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960519|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960520|NCT05014334|Amoxicillin|amoxicillin|mesh-list
44960521|NCT05014334|Clarithromycin|clarithromycin|mesh-list
44960522|NCT05014334|Rabeprazole|rabeprazole|mesh-list
44960523|NCT05014334|Bismuth|bismuth|mesh-list
44960524|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960525|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960526|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44960527|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960528|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960529|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44960530|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44960531|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44960532|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960533|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44960534|NCT05014334|Antacids|antacids|mesh-ancestor
44960535|NCT05009082|Paclitaxel|paclitaxel|mesh-list
44960536|NCT05009082|Bevacizumab|bevacizumab|mesh-list
44960537|NCT05009082|Carboplatin|carboplatin|mesh-list
44960538|NCT05009082|Niraparib|niraparib|mesh-list
44960539|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960540|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960541|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960542|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960543|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960544|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960545|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960546|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960547|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960548|NCT05009082|Growth Substances|growth substances|mesh-ancestor
44960549|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960550|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
44960551|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44960552|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960553|NCT04998006|Ethanol|ethanol|mesh-list
44960554|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44091635|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960555|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960556|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960557|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960559|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
44960560|NCT04994132|Vincristine|vincristine|mesh-list
44960561|NCT04994132|Vinorelbine|vinorelbine|mesh-list
44960562|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960563|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
44960564|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960565|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960566|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960567|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
44960568|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960569|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960570|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44960571|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960572|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960573|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960574|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960575|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960576|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960577|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960578|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44960579|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960580|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44960581|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
44960582|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960583|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960584|NCT04939597|Memantine|memantine|mesh-list
44960585|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44960586|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44960587|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
44960588|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960589|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960590|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960591|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44960592|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44960593|NCT04931017|Metformin|metformin|mesh-list
44260071|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
44960594|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960595|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960596|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44960597|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44960598|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44960599|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960600|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960601|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
44960602|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960603|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44960604|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44960605|NCT04920838|Acetaminophen|acetaminophen|mesh-list
44960606|NCT04920838|Ciclesonide|ciclesonide|mesh-list
44960607|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
44960608|NCT04920838|Budesonide|budesonide|mesh-list
44960609|NCT04920838|Telmisartan|telmisartan|mesh-list
44960610|NCT04920838|Fluoxetine|fluoxetine|mesh-list
44960611|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44960612|NCT04920838|Analgesics|analgesics|mesh-ancestor
44960613|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
44960614|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960615|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960616|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
44960617|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960618|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44960619|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
44960620|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44960621|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
44960622|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
44960623|NCT04920838|Hormones|hormones|mesh-ancestor
44152443|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
44960624|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960625|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960626|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44960627|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44092160|NCT00034086|Ritonavir|ritonavir|mesh-list
44960628|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960629|NCT04920838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44682656|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44960630|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461948|NCT01536574|Ropinirole|ropinirole|mesh-list
44960631|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44960632|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960633|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
44960634|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44960635|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
44960636|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44960637|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44960638|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44960639|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960640|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44960641|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092352|NCT00034606|Pemetrexed|pemetrexed|mesh-list
44960642|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44960643|NCT04918758|Sucralfate|sucralfate|mesh-list
44960644|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44960645|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960646|NCT04915183|Atorvastatin|atorvastatin|mesh-list
44960647|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44960648|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44960649|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
44260084|NCT00637403|Megestrol|megestrol|mesh-list
44960650|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960651|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44960652|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44960653|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960654|NCT04908202|BMS-986165|bms-986165|mesh-list
44960655|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44960656|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44960657|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960658|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960659|NCT04905693|Treprostinil|treprostinil|mesh-list
44960660|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960661|NCT04893655|Dobutamine|dobutamine|mesh-list
44960662|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44960663|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
44960664|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
44960665|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960666|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960667|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44960668|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44960669|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44960670|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960671|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960672|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960673|NCT04893655|Protective Agents|protective agents|mesh-ancestor
44960674|NCT04893109|Paclitaxel|paclitaxel|mesh-list
44960675|NCT04893109|Maytansine|maytansine|mesh-list
44960676|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44960677|NCT04893109|Trastuzumab|trastuzumab|mesh-list
44960678|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960679|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960680|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
44260118|NCT00637468|Aspirin|aspirin|mesh-list
44960681|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960682|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960683|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960684|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960685|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
44960686|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960687|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960688|NCT04890093|Vincristine|vincristine|mesh-list
44960689|NCT04890093|Temozolomide|temozolomide|mesh-list
44960690|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960691|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960692|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960693|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960694|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960695|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960696|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960697|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
44960698|NCT04887194|Nivolumab|nivolumab|mesh-list
44960699|NCT04887194|Digoxin|digoxin|mesh-list
44960700|NCT04887194|Midazolam|midazolam|mesh-list
44960701|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
44960702|NCT04887194|Warfarin|warfarin|mesh-list
44960703|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44960704|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960705|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960706|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44960707|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960708|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44960709|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44960710|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960711|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960712|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44960713|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44960714|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44960715|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44960716|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
44960717|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
44960718|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
44960719|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
44960720|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960721|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44960722|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44960723|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
44960724|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44960725|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44960726|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960727|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
44960728|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44960729|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44960730|NCT04887194|Protective Agents|protective agents|mesh-ancestor
44960731|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
44960732|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
44960733|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44960734|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44960735|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
44960736|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
44960737|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960739|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44960740|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960741|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960742|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960743|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
44960744|NCT04847063|Cisplatin|cisplatin|mesh-list
44960745|NCT04847063|Doxorubicin|doxorubicin|mesh-list
44960746|NCT04847063|Fluorouracil|fluorouracil|mesh-list
44960747|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
44960748|NCT04847063|Mitomycins|mitomycins|mesh-list
44960749|NCT04847063|Mitomycin|mitomycin|mesh-list
44960750|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960751|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44960752|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44960753|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44960754|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960755|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960756|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
44960757|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44960758|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960759|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
44960760|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960761|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
44960762|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44960763|NCT04847063|Antidotes|antidotes|mesh-ancestor
44960764|NCT04847063|Protective Agents|protective agents|mesh-ancestor
44960765|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
44960766|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
44960767|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960768|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960769|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
44960770|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
44960771|NCT04843111|Vaccines|vaccines|mesh-list
44960772|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
44960773|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960774|NCT04825223|Vaccines|vaccines|mesh-list
44960775|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
44960776|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960777|NCT04824599|Ropivacaine|ropivacaine|mesh-list
44960778|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
44960779|NCT04824599|Anesthetics|anesthetics|mesh-list
44960780|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960781|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960782|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
44260178|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
44960783|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960785|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960786|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960787|NCT04766437|Ticagrelor|ticagrelor|mesh-list
44960788|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44960789|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44960790|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44960791|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44960792|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44960793|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
44960794|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960795|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960796|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960797|NCT04712097|Rituximab|rituximab|mesh-list
44960798|NCT04712097|Lenalidomide|lenalidomide|mesh-list
44960799|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960800|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960801|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
44960802|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960803|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960804|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960805|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960806|NCT04712097|Growth Substances|growth substances|mesh-ancestor
44960807|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
44960808|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
44960809|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960810|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960811|NCT04697186|Amoxicillin|amoxicillin|mesh-list
44960812|NCT04697186|Clarithromycin|clarithromycin|mesh-list
44960813|NCT04697186|Rabeprazole|rabeprazole|mesh-list
44960814|NCT04697186|Bismuth|bismuth|mesh-list
44960815|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960816|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960817|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44960818|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960819|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960820|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44960821|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44960822|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44960823|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960824|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44960825|NCT04697186|Antacids|antacids|mesh-ancestor
44960826|NCT04693507|Antarelix|antarelix|mesh-list
44960827|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44960828|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44960829|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960830|NCT04684368|Carboplatin|carboplatin|mesh-list
44960831|NCT04684368|Etoposide|etoposide|mesh-list
44960832|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
44960833|NCT04684368|Ifosfamide|ifosfamide|mesh-list
44960834|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
44960835|NCT04684368|Thiotepa|thiotepa|mesh-list
44960836|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
44960837|NCT04684368|Lenograstim|lenograstim|mesh-list
44960838|NCT04684368|Mesna|mesna|mesh-list
44960839|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960840|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960841|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44960842|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44960843|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260247|NCT00637845|Esomeprazole|esomeprazole|mesh-list
44960844|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960845|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44960846|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
44960847|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960848|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960849|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
44960850|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960851|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44960852|NCT04684368|Protective Agents|protective agents|mesh-ancestor
44960853|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
44960854|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44960855|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960856|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960857|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960858|NCT04682366|Tamsulosin|tamsulosin|mesh-list
44960859|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44960860|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44960861|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44960862|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960863|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960864|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960865|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260276|NCT00637884|Fexofenadine|fexofenadine|mesh-list
44960866|NCT04682366|Urological Agents|urological agents|mesh-ancestor
44960867|NCT04680910|Propofol|propofol|mesh-list
44960868|NCT04680910|Anesthetics|anesthetics|mesh-list
44960869|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44260299|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960870|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44960871|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960872|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44960873|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
44960874|NCT04678492|Amoxicillin|amoxicillin|mesh-list
44960875|NCT04678492|Tetracycline|tetracycline|mesh-list
44960876|NCT04678492|Furazolidone|furazolidone|mesh-list
44960877|NCT04678492|Esomeprazole|esomeprazole|mesh-list
44960878|NCT04678492|Bismuth|bismuth|mesh-list
44960879|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44960880|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960881|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44960882|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960883|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44960884|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960885|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960886|NCT04678492|Antacids|antacids|mesh-ancestor
44093694|NCT00038220|Ritonavir|ritonavir|mesh-list
44960887|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44960888|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44960889|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44960890|NCT04678492|Renal Agents|renal agents|mesh-ancestor
44960891|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44960892|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44960893|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44960894|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44960895|NCT04660123|Bismuth|bismuth|mesh-list
44960896|NCT04660123|Antacids|antacids|mesh-ancestor
44960897|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960898|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960899|NCT04629651|Captopril|captopril|mesh-list
44960900|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44960901|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
44960902|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960903|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960904|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44960905|NCT04620733|Seladelpar|seladelpar|mesh-list
44960906|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44960907|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
44960908|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960909|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44960910|NCT04580394|Oxybutynin|oxybutynin|mesh-list
44960911|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44960912|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44960913|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44960914|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44960915|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960916|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44960917|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960918|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960919|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
44960920|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
44960921|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960922|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44960923|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44960924|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44960925|NCT04580394|Urological Agents|urological agents|mesh-ancestor
44960926|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44960927|NCT04579367|Ezetimibe|ezetimibe|mesh-list
44960928|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44682657|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682658|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
44682659|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682660|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682661|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960929|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44960931|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960932|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44960933|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960934|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44960935|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960936|NCT04579224|Gemcitabine|gemcitabine|mesh-list
44960937|NCT04579224|Paclitaxel|paclitaxel|mesh-list
44960938|NCT04579224|Docetaxel|docetaxel|mesh-list
44960939|NCT04579224|Halichondrin B|halichondrin b|mesh-list
44960940|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44960941|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960942|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960943|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960944|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960945|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960946|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960947|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44960948|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
44960949|NCT04579224|Antiviral Agents|antiviral agents|mesh-ancestor
44960950|NCT04579224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44960951|NCT04579224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960952|NCT04579224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960953|NCT04579224|Immunologic Factors|immunologic factors|mesh-ancestor
44960954|NCT04579224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960955|NCT04565236|Factor VIII|factor viii|mesh-list
44960956|NCT04565236|Coagulants|coagulants|mesh-ancestor
44960957|NCT04551950|Paclitaxel|paclitaxel|mesh-list
44960958|NCT04551950|Bevacizumab|bevacizumab|mesh-list
44960959|NCT04551950|Cisplatin|cisplatin|mesh-list
44960960|NCT04551950|Carboplatin|carboplatin|mesh-list
44960961|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44960962|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960963|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
44960964|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
44960965|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
44960966|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960967|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960968|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44960969|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44960970|NCT04551950|Growth Substances|growth substances|mesh-ancestor
44960971|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960972|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44960973|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
44960974|NCT04548752|Olaparib|olaparib|mesh-list
44960975|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44260398|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44960976|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44960977|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960978|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44960979|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960980|NCT04512235|Dexamethasone|dexamethasone|mesh-list
44960981|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
44960982|NCT04512235|Bortezomib|bortezomib|mesh-list
44960983|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44960984|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
44960985|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44960986|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44960987|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44960988|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
44960989|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44960990|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44960991|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44260413|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
44260415|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44960992|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44960993|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
44960994|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
44960995|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44960996|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44960997|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
44960998|NCT04512235|Hormones|hormones|mesh-ancestor
44960999|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961000|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961001|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44961002|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44961003|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44961004|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44961005|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961006|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961007|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961008|NCT04504812|Analgesics|analgesics|mesh-ancestor
44961009|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
44961010|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961011|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
44961012|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44961013|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
44260418|NCT00638326|Clopidogrel|clopidogrel|mesh-list
44961014|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
44961015|NCT04503616|Abatacept|abatacept|mesh-list
44961016|NCT04503616|Tacrolimus|tacrolimus|mesh-list
44961017|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961018|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
43593712|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
44961019|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961020|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961021|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961022|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
44961023|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961024|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961025|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961026|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44961027|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961028|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961029|NCT04493320|Levodopa|levodopa|mesh-list
44961030|NCT04493320|Carbidopa|carbidopa|mesh-list
44961031|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44961032|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44961033|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44961034|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
44961035|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961036|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961037|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961038|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44961039|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961040|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44961041|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
44961042|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
44961043|NCT04493164|Cytarabine|cytarabine|mesh-list
44961044|NCT04493164|Daunorubicin|daunorubicin|mesh-list
44961045|NCT04493164|Ivosidenib|ivosidenib|mesh-list
44961046|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961047|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
44961048|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961049|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961050|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
44961051|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961052|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961053|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
44961054|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961055|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961056|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961057|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961058|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961059|NCT04444921|Paclitaxel|paclitaxel|mesh-list
44961060|NCT04444921|Carboplatin|carboplatin|mesh-list
44961061|NCT04444921|Nivolumab|nivolumab|mesh-list
44961062|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44961063|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094681|NCT00038961|PENTA|penta|mesh-list
44961064|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961065|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961066|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961067|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961068|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961069|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961070|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961071|NCT04423718|Aflibercept|aflibercept|mesh-list
44961072|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44961073|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44961074|NCT04423718|Growth Substances|growth substances|mesh-ancestor
44961075|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961076|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
44961077|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961078|NCT04418167|Dabrafenib|dabrafenib|mesh-list
44961079|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961080|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961081|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961082|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961083|NCT04414475|Dexamethasone|dexamethasone|mesh-list
44961084|NCT04414475|Bortezomib|bortezomib|mesh-list
44961085|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44961086|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
44961087|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
44961088|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961089|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961090|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44961091|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
44961092|NCT04414475|Hormones|hormones|mesh-ancestor
44961093|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961094|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961095|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961096|NCT04408638|Gemcitabine|gemcitabine|mesh-list
44961097|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
44961098|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
44961099|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961100|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
44961101|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961102|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961103|NCT04408638|Antiviral Agents|antiviral agents|mesh-ancestor
44961104|NCT04408638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961105|NCT04408638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961106|NCT04408638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961107|NCT04408638|Immunologic Factors|immunologic factors|mesh-ancestor
44961108|NCT04408638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961109|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961110|NCT04370795|Sirolimus|sirolimus|mesh-list
44961111|NCT04370795|Busulfan|busulfan|mesh-list
44961112|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44961113|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961114|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961115|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961116|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
44961117|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260499|NCT00638807|Celecoxib|celecoxib|mesh-list
44961118|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
44961119|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094988|NCT00039611|Antidotes|antidotes|mesh-ancestor
44961120|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
44961121|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961122|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961123|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961124|NCT04365257|Prazosin|prazosin|mesh-list
44961125|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
44961126|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44961127|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44961128|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44961129|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
44961130|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961131|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961132|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961133|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
44961134|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44461963|NCT01536535|Prednisone|prednisone|mesh-list
44961135|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
44961136|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44961137|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
44961138|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961139|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961140|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
44961141|NCT04339751|Vorinostat|vorinostat|mesh-list
44961142|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961143|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44961144|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961145|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961146|NCT04334941|Atezolizumab|atezolizumab|mesh-list
44961147|NCT04334941|Talazoparib|talazoparib|mesh-list
44961148|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961149|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961150|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
44961151|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961152|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44682662|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
44961153|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961154|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961155|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
44961156|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
44961157|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44961158|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44961159|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961160|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961161|NCT04325243|Urological Agents|urological agents|mesh-ancestor
44961162|NCT04310007|Gemcitabine|gemcitabine|mesh-list
44961163|NCT04310007|Paclitaxel|paclitaxel|mesh-list
44961164|NCT04310007|Docetaxel|docetaxel|mesh-list
44961165|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44961166|NCT04310007|Nivolumab|nivolumab|mesh-list
44461992|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44682663|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682664|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682665|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44682666|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682667|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44682668|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682669|NCT05395052|Analgesics|analgesics|mesh-ancestor
44462000|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
44682670|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
44682671|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682672|NCT05389813|Pregabalin|pregabalin|mesh-list
44260553|NCT00639249|SA 4503|sa 4503|mesh-list
44682673|NCT05389813|Oxycodone|oxycodone|mesh-list
44682674|NCT05389813|Analgesics|analgesics|mesh-ancestor
44682675|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
44682676|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682677|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682678|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
44682679|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44682680|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260554|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
44682681|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682682|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44682683|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44682684|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44682685|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682686|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682687|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44682688|NCT05389813|Narcotics|narcotics|mesh-ancestor
44682689|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
44682690|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682691|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44682692|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682693|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682694|NCT05378464|Trastuzumab|trastuzumab|mesh-list
44682695|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682696|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682697|NCT05376579|Siponimod|siponimod|mesh-list
44682698|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44682699|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682700|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260575|NCT00639483|Celecoxib|celecoxib|mesh-list
44682701|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
44682702|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682703|NCT05364099|Triamcinolone|triamcinolone|mesh-list
44682704|NCT05364099|Lidocaine|lidocaine|mesh-list
44682705|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
44682706|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
44682707|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682708|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682709|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
44682710|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682711|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44682712|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44682713|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44682714|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44682715|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682716|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682717|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
44682718|NCT05364099|Hormones|hormones|mesh-ancestor
44682719|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682720|NCT05361486|Primaquine|primaquine|mesh-list
44682721|NCT05361486|Tafenoquine|tafenoquine|mesh-list
44961167|NCT04310007|Ramucirumab|ramucirumab|mesh-list
44961168|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44961170|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
44961171|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961172|NCT04310007|Lexatumumab|lexatumumab|mesh-list
44961173|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961174|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961175|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961176|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961177|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961178|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961179|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
44961180|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961181|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961182|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
44961183|NCT04310007|Antiviral Agents|antiviral agents|mesh-ancestor
44961184|NCT04310007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961185|NCT04310007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961186|NCT04310007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961187|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961188|NCT04305691|Ixazomib|ixazomib|mesh-list
44961189|NCT04305691|Glycine|glycine|mesh-list
44961190|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961191|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961192|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
44961193|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961194|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
44961195|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961196|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961197|NCT04300556|Farletuzumab|farletuzumab|mesh-list
44961198|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961199|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
44961200|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44961201|NCT04285567|Rituximab|rituximab|mesh-list
44961202|NCT04285567|Fludarabine|fludarabine|mesh-list
44961203|NCT04285567|Venetoclax|venetoclax|mesh-list
44961204|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
44961205|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961206|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
44961207|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961208|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961209|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961210|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
44961211|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961212|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961213|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44260637|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
44961214|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961215|NCT04269902|Venetoclax|venetoclax|mesh-list
44961216|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
44961217|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961218|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961219|NCT04267848|Gemcitabine|gemcitabine|mesh-list
44961220|NCT04267848|Paclitaxel|paclitaxel|mesh-list
44961221|NCT04267848|Cisplatin|cisplatin|mesh-list
44961222|NCT04267848|Carboplatin|carboplatin|mesh-list
44961223|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
44961224|NCT04267848|Pemetrexed|pemetrexed|mesh-list
44961225|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44961226|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961227|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961228|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961229|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961230|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961231|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961232|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961233|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
44961234|NCT04267848|Antiviral Agents|antiviral agents|mesh-ancestor
44961235|NCT04267848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961236|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961237|NCT04267848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961238|NCT04267848|Immunologic Factors|immunologic factors|mesh-ancestor
44961239|NCT04267848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961240|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961241|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44492756|NCT01928160|Cisplatin|cisplatin|mesh-list
44961242|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961243|NCT04256707|Docetaxel|docetaxel|mesh-list
44961244|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
44961245|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961246|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961247|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961248|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961249|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961250|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961251|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
44961252|NCT04239872|Calcium|calcium|mesh-list
44961253|NCT04239872|Fluorides|fluorides|mesh-list
44961254|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44961255|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961256|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44961257|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
44961258|NCT04239872|Protective Agents|protective agents|mesh-ancestor
44961259|NCT04232306|Bupivacaine|bupivacaine|mesh-list
44961260|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
44961261|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
44961262|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44961263|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961264|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
44961265|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961266|NCT04221503|Niraparib|niraparib|mesh-list
44961267|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44961268|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961269|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961270|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961271|NCT04194944|Cisplatin|cisplatin|mesh-list
44961272|NCT04194944|Carboplatin|carboplatin|mesh-list
44961273|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
44961274|NCT04194944|Pemetrexed|pemetrexed|mesh-list
44961275|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961276|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961277|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961278|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961279|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44961280|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961281|NCT04181060|Bevacizumab|bevacizumab|mesh-list
44961282|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44961283|NCT04181060|Osimertinib|osimertinib|mesh-list
44961284|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
44961285|NCT04181060|Antibodies|antibodies|mesh-list
44961286|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
44961287|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961288|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
44961289|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961290|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44961291|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44961292|NCT04181060|Growth Substances|growth substances|mesh-ancestor
44961293|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961294|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
44961295|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
44961296|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961297|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961298|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961299|NCT04175912|Paclitaxel|paclitaxel|mesh-list
44961300|NCT04175912|Carboplatin|carboplatin|mesh-list
44961301|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44961302|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44961303|NCT04175912|Pevonedistat|pevonedistat|mesh-list
44961304|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44260705|NCT00640029|Meloxicam|meloxicam|mesh-list
44961305|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961306|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961307|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961308|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961309|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961310|NCT04164082|Gemcitabine|gemcitabine|mesh-list
44961311|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
44961312|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961313|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
44961314|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961315|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961316|NCT04164082|Antiviral Agents|antiviral agents|mesh-ancestor
44961317|NCT04164082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961318|NCT04164082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961319|NCT04164082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961320|NCT04164082|Immunologic Factors|immunologic factors|mesh-ancestor
44961321|NCT04164082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961322|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961323|NCT04145115|Nivolumab|nivolumab|mesh-list
44961324|NCT04145115|Ipilimumab|ipilimumab|mesh-list
44961325|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961326|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961327|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961328|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961329|NCT04136353|Hormones|hormones|mesh-list
44961330|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44961331|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961332|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961333|NCT04102436|Aldesleukin|aldesleukin|mesh-list
44961334|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
44961335|NCT04102436|Fludarabine|fludarabine|mesh-list
44961336|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961337|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
44961338|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961339|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961340|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961341|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
44961342|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961343|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260745|NCT00640159|Selegiline|selegiline|mesh-list
44961344|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961345|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44961346|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44961347|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
44961348|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961349|NCT04093024|Nintedanib|nintedanib|mesh-list
44961350|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961351|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961352|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961353|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961354|NCT04092283|Paclitaxel|paclitaxel|mesh-list
44961355|NCT04092283|Etoposide|etoposide|mesh-list
44961356|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
44961357|NCT04092283|Cisplatin|cisplatin|mesh-list
44961358|NCT04092283|Carboplatin|carboplatin|mesh-list
44961359|NCT04092283|Pemetrexed|pemetrexed|mesh-list
44961360|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44961361|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
44961362|NCT04092283|Durvalumab|durvalumab|mesh-list
44961363|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
44961364|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961365|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
44961366|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961367|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961368|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961369|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961370|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961371|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961372|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961373|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961374|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961375|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44260798|NCT00640432|Celecoxib|celecoxib|mesh-list
44961376|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961377|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961378|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
44961379|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961380|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
44961381|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44961382|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
44961383|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961384|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961385|NCT04072952|Palbociclib|palbociclib|mesh-list
44961386|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961387|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961388|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961389|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961390|NCT04062448|Rituximab|rituximab|mesh-list
44961391|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961392|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961393|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
44961394|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961395|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961396|NCT04054752|Vaccines|vaccines|mesh-list
44961397|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
44961398|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961399|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
44961400|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961401|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961402|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
44961403|NCT04030195|Fludarabine|fludarabine|mesh-list
44961404|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961405|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
44961406|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961407|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961408|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961409|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
44961410|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961411|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961412|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961413|NCT04025879|Paclitaxel|paclitaxel|mesh-list
44961414|NCT04025879|Docetaxel|docetaxel|mesh-list
44961415|NCT04025879|Cisplatin|cisplatin|mesh-list
44961416|NCT04025879|Carboplatin|carboplatin|mesh-list
44961417|NCT04025879|Nivolumab|nivolumab|mesh-list
44961418|NCT04025879|Pemetrexed|pemetrexed|mesh-list
44961419|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961420|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961421|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961422|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961423|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961424|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961425|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961426|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961427|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961428|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44961429|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961430|NCT04024436|Fulvestrant|fulvestrant|mesh-list
44961431|NCT04024436|Futibatinib|futibatinib|mesh-list
44260852|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961432|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961433|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961434|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44961435|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44961436|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
44961437|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961438|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961439|NCT04022980|Nivolumab|nivolumab|mesh-list
44961440|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961441|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961442|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961443|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961444|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
44961445|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44961446|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44961447|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44961448|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44961449|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44961450|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961451|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44961452|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961453|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961454|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44961455|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961456|NCT03984448|Prednisone|prednisone|mesh-list
44961457|NCT03984448|Cortisone|cortisone|mesh-list
44961458|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
44961459|NCT03984448|Rituximab|rituximab|mesh-list
44961460|NCT03984448|Doxorubicin|doxorubicin|mesh-list
44961461|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44961462|NCT03984448|Etoposide|etoposide|mesh-list
44961463|NCT03984448|Vincristine|vincristine|mesh-list
44961464|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
44961465|NCT03984448|Venetoclax|venetoclax|mesh-list
44961466|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
44961467|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44961468|NCT03984448|Antibodies|antibodies|mesh-list
44961469|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
44961470|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961471|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961472|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
44961473|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682722|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
44961474|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961475|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961476|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
44961477|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961478|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961479|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961480|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961481|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44260870|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961482|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961483|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961484|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44961485|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
44961486|NCT03984448|Hormones|hormones|mesh-ancestor
44961487|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961488|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961489|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961490|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961491|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961492|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961493|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
44961494|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
44961495|NCT03953833|Antibodies|antibodies|mesh-list
44961496|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961497|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
44961498|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961499|NCT03952585|Cisplatin|cisplatin|mesh-list
44961500|NCT03952585|Nivolumab|nivolumab|mesh-list
44961501|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961502|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961503|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961504|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961505|NCT03941860|Lenalidomide|lenalidomide|mesh-list
44961506|NCT03941860|Ixazomib|ixazomib|mesh-list
44961507|NCT03941860|Glycine|glycine|mesh-list
44961508|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
44961509|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961510|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44961511|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44961512|NCT03941860|Growth Substances|growth substances|mesh-ancestor
44961513|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
44961514|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961515|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961516|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
44961517|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961518|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
44961519|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961520|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
44961521|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44961522|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
44961523|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961524|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
44961525|NCT03889925|Protective Agents|protective agents|mesh-ancestor
44961526|NCT03866382|Nivolumab|nivolumab|mesh-list
44961527|NCT03866382|Ipilimumab|ipilimumab|mesh-list
44961528|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961529|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961530|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961531|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961532|NCT03857321|Insulin|insulin|mesh-list
44961533|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44961534|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
44961535|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44961536|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961537|NCT03850574|Venetoclax|venetoclax|mesh-list
44961538|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961539|NCT03841617|Hormones|hormones|mesh-list
44961540|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961541|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961542|NCT03816163|Gemcitabine|gemcitabine|mesh-list
44961543|NCT03816163|Paclitaxel|paclitaxel|mesh-list
44961544|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961545|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961546|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961547|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44260952|NCT00640861|Vaccines|vaccines|mesh-list
44961548|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961549|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961550|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961551|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
44961552|NCT03816163|Antiviral Agents|antiviral agents|mesh-ancestor
44961553|NCT03816163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961554|NCT03816163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961555|NCT03816163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682723|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44682724|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44260987|NCT00640939|Analgesics|analgesics|mesh-ancestor
44682725|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682726|NCT05351801|Dronabinol|dronabinol|mesh-list
44682727|NCT05351801|Nabiximols|nabiximols|mesh-list
44682728|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
44682729|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682730|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682731|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682732|NCT05351801|Analgesics|analgesics|mesh-ancestor
44682733|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
44682734|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682735|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44682736|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44682737|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682738|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682739|NCT05351801|Hormones|hormones|mesh-ancestor
44682740|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682741|NCT05343325|Paclitaxel|paclitaxel|mesh-list
44682742|NCT05343325|Cisplatin|cisplatin|mesh-list
44682743|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44682744|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44682745|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682746|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682747|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682748|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682749|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682750|NCT05332821|Bevacizumab|bevacizumab|mesh-list
44682751|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44682752|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682753|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682754|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682755|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682756|NCT05332821|Growth Substances|growth substances|mesh-ancestor
44682757|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682758|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682759|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682760|NCT05332496|Bevacizumab|bevacizumab|mesh-list
44682761|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44682762|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682763|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682764|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682765|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682766|NCT05332496|Growth Substances|growth substances|mesh-ancestor
44682767|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682768|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
44260996|NCT00640952|Acamprosate|acamprosate|mesh-list
44682769|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682770|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
44682771|NCT05331651|Tropisetron|tropisetron|mesh-list
44682772|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44682773|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44682774|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44682776|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682777|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682778|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682779|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
44682780|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
44682781|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682782|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682783|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44682784|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44682785|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
44682786|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
44682787|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44682788|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44682789|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682790|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
44682791|NCT05326997|Coagulants|coagulants|mesh-ancestor
44961556|NCT03816163|Immunologic Factors|immunologic factors|mesh-ancestor
44961557|NCT03816163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961558|NCT03811015|Cisplatin|cisplatin|mesh-list
44961559|NCT03811015|Nivolumab|nivolumab|mesh-list
44961560|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961561|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961562|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961563|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961564|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44961565|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961566|NCT03793179|Carboplatin|carboplatin|mesh-list
44961567|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
44961568|NCT03793179|Pemetrexed|pemetrexed|mesh-list
44961569|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961570|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961571|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961572|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961573|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44961574|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961575|NCT03793166|Nivolumab|nivolumab|mesh-list
44961576|NCT03793166|Ipilimumab|ipilimumab|mesh-list
44961577|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961578|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961579|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961580|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961581|NCT03773107|Dexamethasone|dexamethasone|mesh-list
44961582|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44961583|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
44961584|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
44961585|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961586|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961587|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44961588|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
44961589|NCT03773107|Hormones|hormones|mesh-ancestor
44961590|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961591|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961592|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961593|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
44961594|NCT03742505|Vitamin D|vitamin d|mesh-list
44961595|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44961596|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961597|NCT03742505|Vitamins|vitamins|mesh-ancestor
44961598|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
44961599|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44961600|NCT03737994|Cisplatin|cisplatin|mesh-list
44961601|NCT03737994|Carboplatin|carboplatin|mesh-list
44961602|NCT03737994|Pemetrexed|pemetrexed|mesh-list
44961603|NCT03737994|Crizotinib|crizotinib|mesh-list
44961604|NCT03737994|Ceritinib|ceritinib|mesh-list
44961605|NCT03737994|Ensartinib|ensartinib|mesh-list
44961606|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961607|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961608|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961609|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44961610|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961611|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961612|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
44961613|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961614|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961615|NCT03733067|Abatacept|abatacept|mesh-list
44961616|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961617|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961618|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961619|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961620|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
44961621|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961622|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961623|NCT03717129|Tenofovir|tenofovir|mesh-list
44961624|NCT03717129|Emtricitabine|emtricitabine|mesh-list
44961625|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44961626|NCT03717129|Cobicistat|cobicistat|mesh-list
44961627|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44961628|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44961629|NCT03717129|Elvitegravir|elvitegravir|mesh-list
44493140|NCT01921868|Vitamins|vitamins|mesh-ancestor
44961630|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
44961631|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961632|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44961633|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44961634|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961635|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961636|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44961637|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44961638|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44961639|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44961640|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44961641|NCT03713580|Venetoclax|venetoclax|mesh-list
44961642|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961643|NCT03701308|Cytarabine|cytarabine|mesh-list
44961644|NCT03701308|Daunorubicin|daunorubicin|mesh-list
44961645|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961646|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
44961647|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961648|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961649|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
44961650|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961651|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961652|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
44961653|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961654|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961655|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961656|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961657|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961658|NCT03701282|Venetoclax|venetoclax|mesh-list
44961659|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
44961660|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961661|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961662|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
44961663|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961664|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961665|NCT03660826|Durvalumab|durvalumab|mesh-list
44961666|NCT03660826|Olaparib|olaparib|mesh-list
44961667|NCT03660826|Cediranib|cediranib|mesh-list
44961668|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44961669|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
44961670|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961671|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
44961672|NCT03660826|Maleic acid|maleic acid|mesh-list
44961673|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961674|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961675|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
44961676|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961677|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961678|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961679|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961680|NCT03624985|Lidocaine|lidocaine|mesh-list
44961681|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
44961682|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
44961683|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44961684|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961685|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
44961686|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961687|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44961688|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44961689|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44961690|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44961691|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961692|NCT03620669|Durvalumab|durvalumab|mesh-list
44961693|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961694|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961695|NCT03611738|Docetaxel|docetaxel|mesh-list
44961696|NCT03611738|Ceritinib|ceritinib|mesh-list
44961697|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961698|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961699|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961700|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961701|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961702|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961703|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961704|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
44961705|NCT03577431|Everolimus|everolimus|mesh-list
44961706|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961707|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
44961708|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961709|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961710|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961711|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
44961712|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961713|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961714|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961715|NCT03568422|Paclitaxel|paclitaxel|mesh-list
44961716|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961717|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961718|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961719|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961720|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961721|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961722|NCT03535688|Cycloserine|cycloserine|mesh-list
44961723|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44961724|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961725|NCT03535688|Renal Agents|renal agents|mesh-ancestor
44961726|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44961727|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
44961728|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44961729|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
44961730|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961731|NCT03535350|Temozolomide|temozolomide|mesh-list
44961732|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961733|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
44961734|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961735|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961736|NCT03533582|Gemcitabine|gemcitabine|mesh-list
44961737|NCT03533582|Cisplatin|cisplatin|mesh-list
44961738|NCT03533582|Carboplatin|carboplatin|mesh-list
44961739|NCT03533582|Doxorubicin|doxorubicin|mesh-list
44961740|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44961741|NCT03533582|Fluorouracil|fluorouracil|mesh-list
44961742|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
44961743|NCT03533582|Irinotecan|irinotecan|mesh-list
44961744|NCT03533582|Etoposide|etoposide|mesh-list
44961745|NCT03533582|Vincristine|vincristine|mesh-list
44961746|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
44961747|NCT03533582|Sorafenib|sorafenib|mesh-list
44961748|NCT03533582|Daunorubicin|daunorubicin|mesh-list
44961749|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
44961750|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961751|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961752|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
44961753|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961754|NCT03533582|Antiviral Agents|antiviral agents|mesh-ancestor
44961755|NCT03533582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961756|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961757|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961758|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
44961759|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961760|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961761|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961762|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961763|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44961764|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961765|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961766|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961767|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961768|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961769|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
44961770|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44961771|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
44961772|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961773|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
44961774|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961775|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961776|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961777|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
44961778|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961779|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961780|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44682792|NCT05320380|Cytarabine|cytarabine|mesh-list
44961781|NCT03462719|Venetoclax|venetoclax|mesh-list
44961782|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
44961783|NCT03462719|Chlorambucil|chlorambucil|mesh-list
44961784|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961785|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961786|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961787|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
44961788|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961790|NCT03444298|Tocopherols|tocopherols|mesh-list
44961791|NCT03444298|Tocotrienols|tocotrienols|mesh-list
44961792|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
44961793|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
44961794|NCT03444298|Vitamins|vitamins|mesh-ancestor
44961795|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
44961796|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961797|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
44261197|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44961798|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961799|NCT03444298|Protective Agents|protective agents|mesh-ancestor
44961800|NCT03436745|Zolpidem|zolpidem|mesh-list
44961801|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44961802|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44961803|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44961804|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961805|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44961806|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
44961807|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
44961808|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44961809|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961810|NCT03365687|Vitamin D|vitamin d|mesh-list
44961811|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
44961812|NCT03365687|Vitamins|vitamins|mesh-ancestor
44961813|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
44961814|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961815|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44961816|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44961817|NCT03339128|Eluxadoline|eluxadoline|mesh-list
44961818|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44961819|NCT03332667|Vorinostat|vorinostat|mesh-list
44961820|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44961821|NCT03332667|Dinutuximab|dinutuximab|mesh-list
44961822|NCT03332667|Sargramostim|sargramostim|mesh-list
44961823|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
44261241|NCT00641979|Hormones|hormones|mesh-ancestor
44961824|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961825|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961826|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44961827|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961828|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961829|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44961830|NCT03323463|Cisplatin|cisplatin|mesh-list
44961831|NCT03323463|Carboplatin|carboplatin|mesh-list
44961832|NCT03323463|Fluorouracil|fluorouracil|mesh-list
44961833|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961834|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
44961835|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961836|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44961837|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961838|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
44961839|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961840|NCT03318393|Heparin|heparin|mesh-list
44961841|NCT03318393|Calcium heparin|calcium heparin|mesh-list
44961842|NCT03318393|Bivalirudin|bivalirudin|mesh-list
44961843|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
44961844|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44961845|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44261262|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
44961846|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961847|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
44961848|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44961849|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
44961850|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961851|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
44961852|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961853|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961854|NCT03290287|Bromides|bromides|mesh-list
44961855|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
44961856|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44961857|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
44961858|NCT03278782|Romidepsin|romidepsin|mesh-list
44961859|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961860|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961861|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44961862|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961864|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44961865|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961866|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961867|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
44961868|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961869|NCT03269669|Prednisone|prednisone|mesh-list
44961870|NCT03269669|Cortisone|cortisone|mesh-list
44961871|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
44961872|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44961873|NCT03269669|Doxorubicin|doxorubicin|mesh-list
44961874|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44961875|NCT03269669|Vincristine|vincristine|mesh-list
44961876|NCT03269669|Lenalidomide|lenalidomide|mesh-list
44961877|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
44961878|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961879|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
44961880|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961881|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961882|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961883|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
44961884|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961885|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961886|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961887|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44961888|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961889|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961890|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961891|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44961892|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
44961893|NCT03269669|Hormones|hormones|mesh-ancestor
44961894|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961895|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961896|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961897|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961898|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961899|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961900|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44961901|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44961902|NCT03269669|Growth Substances|growth substances|mesh-ancestor
44961903|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44961904|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961905|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
44961906|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961907|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961908|NCT03240835|Cisplatin|cisplatin|mesh-list
44961909|NCT03240835|Docetaxel|docetaxel|mesh-list
44961910|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961911|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961912|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961913|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961914|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961915|NCT03233711|Nivolumab|nivolumab|mesh-list
44961916|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961917|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961918|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44961919|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961920|NCT03201965|Dexamethasone|dexamethasone|mesh-list
44961921|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
44961922|NCT03201965|Bortezomib|bortezomib|mesh-list
44961923|NCT03201965|Daratumumab|daratumumab|mesh-list
44961924|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961925|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
44961926|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961927|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961928|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961929|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
44961930|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961931|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961932|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961933|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44961934|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
44961935|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
44961936|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44961937|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44961938|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
44961939|NCT03201965|Hormones|hormones|mesh-ancestor
44961940|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44961941|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44961942|NCT03196986|Bevacizumab|bevacizumab|mesh-list
44961943|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961944|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961945|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44961946|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44961947|NCT03196986|Growth Substances|growth substances|mesh-ancestor
44961948|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961949|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
44961950|NCT03194893|Crizotinib|crizotinib|mesh-list
44961951|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961952|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961953|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961954|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961955|NCT03191149|Osimertinib|osimertinib|mesh-list
44961956|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961957|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44961958|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961959|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961960|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44961961|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44961962|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961963|NCT03141359|Paclitaxel|paclitaxel|mesh-list
44961964|NCT03141359|Etoposide|etoposide|mesh-list
44961965|NCT03141359|Carboplatin|carboplatin|mesh-list
44961966|NCT03141359|Durvalumab|durvalumab|mesh-list
44961967|NCT03141359|Cisplatin|cisplatin|mesh-list
44961968|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44961969|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961970|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44961971|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44961972|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44961973|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961974|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44961975|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961976|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961977|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961978|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
44961979|NCT03107988|Topotecan|topotecan|mesh-list
44961980|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44961981|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
44961982|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44961983|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44961984|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44961985|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
44961986|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44961987|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44961988|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44961989|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44961990|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44961991|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44961992|NCT03092674|Cytarabine|cytarabine|mesh-list
44961993|NCT03092674|Nivolumab|nivolumab|mesh-list
44961994|NCT03092674|Azacitidine|azacitidine|mesh-list
44961995|NCT03092674|Decitabine|decitabine|mesh-list
44961996|NCT03092674|Midostaurin|midostaurin|mesh-list
44961997|NCT03092674|Staurosporine|staurosporine|mesh-list
44961998|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44961999|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962000|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962001|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962002|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962003|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
44962004|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
44962005|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962006|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962007|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
44962008|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962009|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962010|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962011|NCT03067181|Cisplatin|cisplatin|mesh-list
44962012|NCT03067181|Carboplatin|carboplatin|mesh-list
44962013|NCT03067181|Etoposide|etoposide|mesh-list
44962014|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
44962015|NCT03067181|Bleomycin|bleomycin|mesh-list
44962016|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
44962017|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962018|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962019|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962020|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962021|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962022|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962023|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962024|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962025|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962026|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44261426|NCT00642512|Hormones|hormones|mesh-ancestor
44962027|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962028|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962029|NCT03058757|Mitomycins|mitomycins|mesh-list
44962030|NCT03058757|Mitomycin|mitomycin|mesh-list
44962031|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962032|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962033|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
44962034|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962035|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962036|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962037|NCT03049462|Ascorbic Acid|ascorbic acid|mesh-list
44962038|NCT03049462|Mirabegron|mirabegron|mesh-list
44962039|NCT03049462|Vitamins|vitamins|mesh-ancestor
44962040|NCT03049462|Micronutrients|micronutrients|mesh-ancestor
44962041|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962042|NCT03049462|Antioxidants|antioxidants|mesh-ancestor
44962043|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962044|NCT03049462|Protective Agents|protective agents|mesh-ancestor
44962045|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44962046|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44962047|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44962048|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261462|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44962049|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44962050|NCT03049462|Urological Agents|urological agents|mesh-ancestor
44962051|NCT03024996|Atezolizumab|atezolizumab|mesh-list
44962052|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962053|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
44962054|NCT02981628|Leucovorin|leucovorin|mesh-list
44962055|NCT02981628|Folic Acid|folic acid|mesh-list
44962056|NCT02981628|Cytarabine|cytarabine|mesh-list
44962057|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
44962058|NCT02981628|Methotrexate|methotrexate|mesh-list
44962059|NCT02981628|Vincristine|vincristine|mesh-list
44962060|NCT02981628|Asparaginase|asparaginase|mesh-list
44962061|NCT02981628|Pegaspargase|pegaspargase|mesh-list
44962062|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44962063|NCT02981628|Calcium|calcium|mesh-list
44962064|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
44962065|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962066|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
44962067|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962068|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962069|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962070|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
44962071|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962072|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962073|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962074|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44962075|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962076|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44962077|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
44962078|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962079|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962080|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
44962081|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962082|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962083|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44962084|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962085|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
44962086|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962087|NCT02981628|Antidotes|antidotes|mesh-ancestor
44962088|NCT02981628|Protective Agents|protective agents|mesh-ancestor
44962089|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
44962090|NCT02981628|Vitamins|vitamins|mesh-ancestor
44962092|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962093|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962094|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962095|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962096|NCT02981628|Hematinics|hematinics|mesh-ancestor
44962097|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962098|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962099|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
44962100|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962101|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962102|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
44962103|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962104|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962105|NCT02947347|Rituximab|rituximab|mesh-list
44962106|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962107|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962108|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
44962109|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962110|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962111|NCT02928224|Leucovorin|leucovorin|mesh-list
44962112|NCT02928224|Folic Acid|folic acid|mesh-list
44962113|NCT02928224|Fluorouracil|fluorouracil|mesh-list
44962114|NCT02928224|Irinotecan|irinotecan|mesh-list
44962115|NCT02928224|Cetuximab|cetuximab|mesh-list
44962116|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
44962117|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
44962118|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962119|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962120|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962121|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462085|NCT01535053|Antidotes|antidotes|mesh-ancestor
44962122|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
44962123|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962124|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44962125|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962126|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962127|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962128|NCT02928224|Antidotes|antidotes|mesh-ancestor
44962129|NCT02928224|Protective Agents|protective agents|mesh-ancestor
44962130|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
44962131|NCT02928224|Vitamins|vitamins|mesh-ancestor
44962132|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
44962133|NCT02928224|Hematinics|hematinics|mesh-ancestor
44962134|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
44962135|NCT02912559|Leucovorin|leucovorin|mesh-list
44962136|NCT02912559|Folic Acid|folic acid|mesh-list
44962137|NCT02912559|Fluorouracil|fluorouracil|mesh-list
44962138|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
44962139|NCT02912559|Atezolizumab|atezolizumab|mesh-list
44962140|NCT02912559|Calcium|calcium|mesh-list
44962141|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962142|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
44261520|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962143|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44962144|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962145|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962146|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
44962147|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962148|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962149|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962150|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962151|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
44962152|NCT02912559|Antidotes|antidotes|mesh-ancestor
44962153|NCT02912559|Protective Agents|protective agents|mesh-ancestor
44962154|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
44962155|NCT02912559|Vitamins|vitamins|mesh-ancestor
44962156|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
44962157|NCT02912559|Hematinics|hematinics|mesh-ancestor
44962158|NCT02905318|Palbociclib|palbociclib|mesh-list
44962159|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962160|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962161|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962162|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962163|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
44962164|NCT02890355|Leucovorin|leucovorin|mesh-list
44962165|NCT02890355|Folic Acid|folic acid|mesh-list
44962166|NCT02890355|Fluorouracil|fluorouracil|mesh-list
44962167|NCT02890355|Irinotecan|irinotecan|mesh-list
44962168|NCT02890355|Veliparib|veliparib|mesh-list
44962169|NCT02890355|Camptothecin|camptothecin|mesh-list
44962170|NCT02890355|Calcium|calcium|mesh-list
44962171|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
44962174|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962175|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
44962176|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962177|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44261557|NCT00643292|Amoxicillin|amoxicillin|mesh-list
44261572|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962178|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962179|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962180|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
44962181|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44962182|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962183|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962184|NCT02890355|Antidotes|antidotes|mesh-ancestor
44962185|NCT02890355|Protective Agents|protective agents|mesh-ancestor
44962186|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
44962187|NCT02890355|Vitamins|vitamins|mesh-ancestor
44962188|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
44962189|NCT02890355|Hematinics|hematinics|mesh-ancestor
44962190|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44962191|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962192|NCT02886065|Lenalidomide|lenalidomide|mesh-list
44962193|NCT02886065|Poly ICLC|poly iclc|mesh-list
44261574|NCT00643357|Analgesics|analgesics|mesh-ancestor
44962194|NCT02886065|Citarinostat|citarinostat|mesh-list
44962195|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
44962196|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962197|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44096792|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
44962198|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962199|NCT02886065|Growth Substances|growth substances|mesh-ancestor
44682793|NCT05320380|Prednisolone|prednisolone|mesh-list
44682794|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
44682795|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44682796|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44682797|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44682798|NCT05320380|Methotrexate|methotrexate|mesh-list
44682799|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
44682800|NCT05320380|Fludarabine|fludarabine|mesh-list
44682801|NCT05320380|Daunorubicin|daunorubicin|mesh-list
44682802|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44682803|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
44682804|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682805|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261591|NCT00643500|Levetiracetam|levetiracetam|mesh-list
44261605|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682806|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682807|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
44682808|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682809|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682810|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
44682811|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682812|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44682813|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682814|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
44682815|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682816|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682817|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
44682818|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682819|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682820|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
44682821|NCT05320380|Hormones|hormones|mesh-ancestor
44682822|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682823|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682824|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44682825|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44682826|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44682827|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
44682828|NCT05319015|Lenvatinib|lenvatinib|mesh-list
44682829|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682830|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682831|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44682832|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682833|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682836|NCT05296603|Lenvatinib|lenvatinib|mesh-list
44682837|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682838|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962200|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962201|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962202|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
44962203|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44962204|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261625|NCT00643799|Analgesics|analgesics|mesh-ancestor
44962205|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962206|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
44962207|NCT02883049|Leucovorin|leucovorin|mesh-list
44962208|NCT02883049|Folic Acid|folic acid|mesh-list
44962209|NCT02883049|Cytarabine|cytarabine|mesh-list
44962210|NCT02883049|Dexamethasone|dexamethasone|mesh-list
44962211|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
44962212|NCT02883049|Prednisone|prednisone|mesh-list
44962213|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
44962214|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44962215|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44962216|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44962217|NCT02883049|Cortisone|cortisone|mesh-list
44962218|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
44962219|NCT02883049|Doxorubicin|doxorubicin|mesh-list
44962220|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44962221|NCT02883049|Methotrexate|methotrexate|mesh-list
44962222|NCT02883049|Etoposide|etoposide|mesh-list
44962223|NCT02883049|Vincristine|vincristine|mesh-list
44962224|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
44962225|NCT02883049|Daunorubicin|daunorubicin|mesh-list
44962226|NCT02883049|Asparaginase|asparaginase|mesh-list
44962227|NCT02883049|Dasatinib|dasatinib|mesh-list
44962228|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
44962229|NCT02883049|Clofarabine|clofarabine|mesh-list
44962230|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
44962231|NCT02883049|Pegaspargase|pegaspargase|mesh-list
44962232|NCT02883049|Thioguanine|thioguanine|mesh-list
44962233|NCT02883049|BB 1101|bb 1101|mesh-list
44962234|NCT02883049|Calcium|calcium|mesh-list
44962235|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
44962236|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
44962237|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962238|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
44962239|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962240|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962241|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962242|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
44962243|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962244|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962245|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962246|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44962247|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
44962248|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
44962249|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44962250|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44962251|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
44962252|NCT02883049|Hormones|hormones|mesh-ancestor
44962253|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44962254|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44962255|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44962256|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962257|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962258|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962259|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962260|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44962261|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962262|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44962263|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
44962264|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962265|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962266|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
44962267|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962268|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44962269|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962270|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962271|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
44962272|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962273|NCT02883049|Antidotes|antidotes|mesh-ancestor
44962274|NCT02883049|Protective Agents|protective agents|mesh-ancestor
44962275|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44962276|NCT02883049|Vitamins|vitamins|mesh-ancestor
44962277|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
44962278|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962279|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962280|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962281|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962282|NCT02883049|Hematinics|hematinics|mesh-ancestor
44962283|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962284|NCT02839707|Bevacizumab|bevacizumab|mesh-list
44962285|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962286|NCT02839707|Doxorubicin|doxorubicin|mesh-list
44962287|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44962288|NCT02839707|Atezolizumab|atezolizumab|mesh-list
44962289|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
44962290|NCT02839707|Antibodies|antibodies|mesh-list
44962291|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
44962292|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962293|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
44962294|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962295|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44962296|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962297|NCT02839707|Growth Substances|growth substances|mesh-ancestor
44962298|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962299|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962300|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
44962301|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962302|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962303|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962304|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962305|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962306|NCT02834013|Nivolumab|nivolumab|mesh-list
44962307|NCT02834013|Ipilimumab|ipilimumab|mesh-list
44962308|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962309|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962310|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962311|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962312|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
44962313|NCT02782546|Tacrolimus|tacrolimus|mesh-list
44962314|NCT02782546|Lenograstim|lenograstim|mesh-list
44962315|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962316|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
44962317|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962318|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44962319|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261748|NCT00644319|Ibuprofen|ibuprofen|mesh-list
44962320|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962321|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962322|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962323|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44962324|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
44962325|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44962326|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962327|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44962328|NCT02780804|Entinostat|entinostat|mesh-list
44962329|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962330|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44962331|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962332|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962333|NCT02767661|Capecitabine|capecitabine|mesh-list
44962334|NCT02767661|Letrozole|letrozole|mesh-list
44962335|NCT02767661|Anastrozole|anastrozole|mesh-list
44962336|NCT02767661|Exemestane|exemestane|mesh-list
44962337|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44962338|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962339|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
44962340|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962341|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962342|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44962343|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962344|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44962345|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
44962346|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44962347|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962348|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44962349|NCT02754856|Durvalumab|durvalumab|mesh-list
44962350|NCT02754856|Ipilimumab|ipilimumab|mesh-list
44962351|NCT02754856|Tremelimumab|tremelimumab|mesh-list
44962352|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
44962353|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962354|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
44962355|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962356|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962357|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
44962358|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962359|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962360|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962361|NCT02642042|Docetaxel|docetaxel|mesh-list
44962362|NCT02642042|Trametinib|trametinib|mesh-list
44962363|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962364|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962365|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962366|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962367|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962368|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962369|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962370|NCT02595944|Nivolumab|nivolumab|mesh-list
44962371|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962372|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962373|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962374|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962375|NCT02595905|Cisplatin|cisplatin|mesh-list
44962376|NCT02595905|Veliparib|veliparib|mesh-list
44962377|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962378|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44962379|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962380|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962381|NCT02587325|Sirolimus|sirolimus|mesh-list
44962382|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44962383|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962384|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962385|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962386|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
44962387|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962388|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
44962389|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962390|NCT02573896|Lenalidomide|lenalidomide|mesh-list
44962391|NCT02573896|Dinutuximab|dinutuximab|mesh-list
44962392|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
44962393|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962394|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44962395|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962396|NCT02573896|Growth Substances|growth substances|mesh-ancestor
44962397|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962398|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962399|NCT02567435|Sirolimus|sirolimus|mesh-list
44962400|NCT02567435|Dactinomycin|dactinomycin|mesh-list
44962401|NCT02567435|Cactinomycin|cactinomycin|mesh-list
44962402|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
44962403|NCT02567435|Irinotecan|irinotecan|mesh-list
44962404|NCT02567435|Vincristine|vincristine|mesh-list
44462128|NCT01534520|Lidocaine|lidocaine|mesh-list
44962405|NCT02567435|Vinorelbine|vinorelbine|mesh-list
44962406|NCT02567435|Camptothecin|camptothecin|mesh-list
44962407|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962408|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
44962409|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962410|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962411|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962412|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
44962413|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962414|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962415|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962416|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44962417|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962418|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962419|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962420|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962421|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962422|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962423|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44962424|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962425|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962426|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
44962427|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44962428|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962429|NCT02537418|Durvalumab|durvalumab|mesh-list
44962430|NCT02537418|Tremelimumab|tremelimumab|mesh-list
44962431|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962432|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493913|NCT00986882|Analgesics|analgesics|mesh-ancestor
44962433|NCT02521493|Cytarabine|cytarabine|mesh-list
44962435|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
44962436|NCT02521493|Daunorubicin|daunorubicin|mesh-list
44962437|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
44962438|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
44962439|NCT02521493|Asparaginase|asparaginase|mesh-list
44962440|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
44962441|NCT02521493|Thioguanine|thioguanine|mesh-list
44962442|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
44962443|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962444|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962445|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962446|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962447|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962448|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962449|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962450|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
44962451|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
44962452|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962453|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962454|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
44962455|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962456|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962457|NCT02521493|Analgesics|analgesics|mesh-ancestor
44962458|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
44962459|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44962460|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962461|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962462|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962463|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962464|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962465|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962466|NCT02506153|Interferons|interferons|mesh-list
44962467|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
44962468|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
44962469|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
44962470|NCT02506153|Ipilimumab|ipilimumab|mesh-list
44962471|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962472|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962473|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
44962474|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962475|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962476|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962477|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
44261844|NCT00644696|Cefixime|cefixime|mesh-list
44962478|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962479|NCT02466971|Cisplatin|cisplatin|mesh-list
44962480|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962481|NCT02446457|Rituximab|rituximab|mesh-list
44962482|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962483|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
44962484|NCT02446457|Lenalidomide|lenalidomide|mesh-list
44962485|NCT02446457|Antibodies|antibodies|mesh-list
44962486|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
44962487|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962488|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
44962489|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962490|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962491|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962492|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44962493|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962494|NCT02446457|Growth Substances|growth substances|mesh-ancestor
44962495|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962496|NCT02443077|Cytarabine|cytarabine|mesh-list
44962497|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
44962498|NCT02443077|Melphalan|melphalan|mesh-list
44962499|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
44962500|NCT02443077|Carmustine|carmustine|mesh-list
44962501|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44962502|NCT02443077|Etoposide|etoposide|mesh-list
44962503|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
44962504|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
44962505|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962506|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
44962507|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962508|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962509|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962510|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
44962511|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962512|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962513|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962514|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962515|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962516|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962517|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962518|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962519|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
44962520|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
44962521|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962522|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962523|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962524|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962525|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962526|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962527|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
44962528|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44962529|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
44962530|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962531|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962532|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44962534|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44962535|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
44962536|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44962537|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962538|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962539|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44962540|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44962541|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44962542|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44962543|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
44962544|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
44962545|NCT02392429|Cytarabine|cytarabine|mesh-list
44962546|NCT02392429|Alovudine|alovudine|mesh-list
44962547|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962548|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
44962549|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962550|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962551|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
44962552|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962553|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962554|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
44962555|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962556|NCT02372409|Doxorubicin|doxorubicin|mesh-list
44962557|NCT02372409|Etoposide|etoposide|mesh-list
44962558|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
44962559|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962560|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962561|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962562|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962563|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962564|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962565|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962566|NCT02365597|Metformin|metformin|mesh-list
44962567|NCT02365597|Midazolam|midazolam|mesh-list
44962568|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44962569|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962570|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44962571|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44962572|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44962573|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44962574|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44962575|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682839|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682840|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682841|NCT05288335|Methamphetamine|methamphetamine|mesh-list
44682842|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44682843|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682844|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
44682845|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
44682846|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682847|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
44682848|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682849|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682850|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44962576|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44962577|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
44962578|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
44962579|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
44962580|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
44962581|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44962582|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962583|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
44962584|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44962585|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
44962586|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962587|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962588|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44962589|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44962590|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44962591|NCT02339571|Nivolumab|nivolumab|mesh-list
44962592|NCT02339571|Ipilimumab|ipilimumab|mesh-list
44962593|NCT02339571|Sargramostim|sargramostim|mesh-list
44962594|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962595|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962596|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962597|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962598|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
44962599|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962600|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
44962601|NCT02306161|Ifosfamide|ifosfamide|mesh-list
44962602|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
44962603|NCT02306161|Doxorubicin|doxorubicin|mesh-list
44962604|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44962605|NCT02306161|Etoposide|etoposide|mesh-list
44962606|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
44962607|NCT02306161|Vincristine|vincristine|mesh-list
44962608|NCT02306161|Daunorubicin|daunorubicin|mesh-list
44962609|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
44962610|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962611|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962612|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
44962613|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962614|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962615|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44261957|NCT00645060|Antibodies|antibodies|mesh-list
44962616|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
44962617|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962618|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962619|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962620|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962621|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962622|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962623|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962624|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962625|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962626|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962627|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962628|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962629|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962630|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
44962631|NCT02298348|Sorafenib|sorafenib|mesh-list
44962632|NCT02298348|Topotecan|topotecan|mesh-list
44962633|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962634|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
44962635|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962636|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962637|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962638|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
44962639|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962640|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962641|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962642|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962643|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962644|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44962645|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962646|NCT02278120|Tamoxifen|tamoxifen|mesh-list
44962647|NCT02278120|Letrozole|letrozole|mesh-list
44962648|NCT02278120|Anastrozole|anastrozole|mesh-list
44962649|NCT02278120|Goserelin|goserelin|mesh-list
44962650|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962651|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44962652|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44962653|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962654|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962655|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44962656|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
44962657|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261997|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
44962658|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962659|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44962660|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44962661|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44962662|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44962663|NCT02272790|Gemcitabine|gemcitabine|mesh-list
44962664|NCT02272790|Paclitaxel|paclitaxel|mesh-list
44962665|NCT02272790|Carboplatin|carboplatin|mesh-list
44962666|NCT02272790|Adavosertib|adavosertib|mesh-list
44962667|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962668|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962669|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962670|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962671|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962672|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962673|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962674|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
44962675|NCT02272790|Antiviral Agents|antiviral agents|mesh-ancestor
44962676|NCT02272790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962677|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962678|NCT02272790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962679|NCT02272790|Immunologic Factors|immunologic factors|mesh-ancestor
44962680|NCT02272790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962681|NCT02257528|Nivolumab|nivolumab|mesh-list
44962682|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962683|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962684|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962685|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962686|NCT02224781|Nivolumab|nivolumab|mesh-list
44962687|NCT02224781|Ipilimumab|ipilimumab|mesh-list
44962688|NCT02224781|Trametinib|trametinib|mesh-list
44962689|NCT02224781|Dabrafenib|dabrafenib|mesh-list
44962690|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44962691|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962692|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962693|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962694|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962695|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962696|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962697|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44962698|NCT02224781|Protective Agents|protective agents|mesh-ancestor
44962699|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962700|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44962701|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
44962702|NCT02196181|Trametinib|trametinib|mesh-list
44962703|NCT02196181|Dabrafenib|dabrafenib|mesh-list
44962704|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44962705|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962706|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962707|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962708|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962709|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44962710|NCT02196181|Protective Agents|protective agents|mesh-ancestor
44962711|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962712|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44962713|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
44962714|NCT02194738|Gemcitabine|gemcitabine|mesh-list
44962715|NCT02194738|Paclitaxel|paclitaxel|mesh-list
44962716|NCT02194738|Cisplatin|cisplatin|mesh-list
44962717|NCT02194738|Carboplatin|carboplatin|mesh-list
44962718|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
44962719|NCT02194738|Nivolumab|nivolumab|mesh-list
44962720|NCT02194738|Pemetrexed|pemetrexed|mesh-list
44962721|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44962722|NCT02194738|Crizotinib|crizotinib|mesh-list
44962723|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962724|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962725|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962726|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962727|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962728|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962729|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962730|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
44962731|NCT02194738|Antiviral Agents|antiviral agents|mesh-ancestor
44962732|NCT02194738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962733|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962734|NCT02194738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962735|NCT02194738|Immunologic Factors|immunologic factors|mesh-ancestor
44962736|NCT02194738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962737|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962738|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962739|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44962740|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962741|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962742|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44962743|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962744|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962745|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962746|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962747|NCT02180867|Doxorubicin|doxorubicin|mesh-list
44962748|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44962749|NCT02180867|Daunorubicin|daunorubicin|mesh-list
44962750|NCT02180867|Ifosfamide|ifosfamide|mesh-list
44962751|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
44962752|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962753|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962754|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962755|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962756|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962757|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962758|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962759|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
44962760|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962761|NCT02154490|Nivolumab|nivolumab|mesh-list
44962762|NCT02154490|Ipilimumab|ipilimumab|mesh-list
44962763|NCT02154490|Durvalumab|durvalumab|mesh-list
44962764|NCT02154490|Rilotumumab|rilotumumab|mesh-list
44962765|NCT02154490|Docetaxel|docetaxel|mesh-list
44962766|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44962767|NCT02154490|Palbociclib|palbociclib|mesh-list
44962768|NCT02154490|Tremelimumab|tremelimumab|mesh-list
44962769|NCT02154490|Talazoparib|talazoparib|mesh-list
44962770|NCT02154490|Antibodies|antibodies|mesh-list
44962771|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
44962772|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962773|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
44962774|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
44962775|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962776|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962777|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962778|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962779|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962780|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262113|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
44962781|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962782|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44962783|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962784|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44962785|NCT02125461|Durvalumab|durvalumab|mesh-list
44962786|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962787|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962788|NCT02101944|Dexamethasone|dexamethasone|mesh-list
44962789|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
44962790|NCT02101944|Ichthammol|ichthammol|mesh-list
44962791|NCT02101944|BB 1101|bb 1101|mesh-list
44962792|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44962793|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
44962794|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
44962795|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44962796|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962797|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44962798|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
44962799|NCT02101944|Hormones|hormones|mesh-ancestor
44962800|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262165|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262166|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44962801|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44962802|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962803|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44962804|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962805|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962806|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962807|NCT02051218|Denosumab|denosumab|mesh-list
44962814|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962816|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
44962817|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962818|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962819|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
44262179|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
44962820|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962821|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962822|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44682851|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44682852|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44682853|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44682854|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44682855|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
44682856|NCT05280444|Idarubicin|idarubicin|mesh-list
44682857|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44682858|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682859|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44682860|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44682861|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682862|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682863|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
44682864|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44682865|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44682866|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682867|NCT05266846|Bevacizumab|bevacizumab|mesh-list
44682868|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
44682869|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682870|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682871|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682872|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682873|NCT05266846|Growth Substances|growth substances|mesh-ancestor
44682874|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682875|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682876|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
44682877|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44262207|NCT00645632|Ifosfamide|ifosfamide|mesh-list
44682878|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682879|NCT05259839|Dexamethasone|dexamethasone|mesh-list
44682880|NCT05259839|Lenalidomide|lenalidomide|mesh-list
44682881|NCT05259839|Daratumumab|daratumumab|mesh-list
44682882|NCT05259839|Pomalidomide|pomalidomide|mesh-list
44262215|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
44682883|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682884|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
44682885|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
44682886|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682887|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682888|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682889|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
44682890|NCT05259839|Hormones|hormones|mesh-ancestor
44682891|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262218|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152989|NCT00218517|Selegiline|selegiline|mesh-list
44682892|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682893|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682894|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
44682895|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682896|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682897|NCT05259839|Growth Substances|growth substances|mesh-ancestor
44682898|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682904|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
44682905|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44682906|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44682907|NCT05252754|Indomethacin|indomethacin|mesh-list
44682908|NCT05252754|Tacrolimus|tacrolimus|mesh-list
44494350|NCT05600894|Decitabine|decitabine|mesh-list
44962823|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
44962824|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962825|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962826|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962827|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962828|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
44962829|NCT02030964|Eflornithine|eflornithine|mesh-list
44962830|NCT02030964|Celecoxib|celecoxib|mesh-list
44962831|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
44962832|NCT02030964|Topotecan|topotecan|mesh-list
44962833|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962834|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
44962835|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962836|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962837|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962838|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
44962839|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962840|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962841|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962842|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44962843|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44962844|NCT02030964|Analgesics|analgesics|mesh-ancestor
44962845|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
44262256|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962846|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44962847|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44962848|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44962849|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44962850|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962851|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44962852|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962853|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44962854|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44962855|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44262261|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
44962856|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962857|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44962858|NCT02003222|Cytarabine|cytarabine|mesh-list
44962859|NCT02003222|Dexamethasone|dexamethasone|mesh-list
44962860|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
44962861|NCT02003222|Prednisone|prednisone|mesh-list
44962862|NCT02003222|Cortisone|cortisone|mesh-list
44962863|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
44962864|NCT02003222|Rituximab|rituximab|mesh-list
44962865|NCT02003222|Methotrexate|methotrexate|mesh-list
44962866|NCT02003222|Etoposide|etoposide|mesh-list
44962867|NCT02003222|Vincristine|vincristine|mesh-list
44962868|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
44962869|NCT02003222|Daunorubicin|daunorubicin|mesh-list
44962870|NCT02003222|Asparaginase|asparaginase|mesh-list
44962871|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
44962872|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
44962873|NCT02003222|Pegaspargase|pegaspargase|mesh-list
44962874|NCT02003222|Blinatumomab|blinatumomab|mesh-list
44962875|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962876|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
44962877|NCT02003222|Antibodies|antibodies|mesh-list
44962878|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
44962879|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962880|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44962881|NCT02003222|BB 1101|bb 1101|mesh-list
44962882|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962883|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
44962884|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962885|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962886|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962887|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
44962888|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962889|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962890|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44962891|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44962892|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
44962893|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
44962894|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44962895|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44962896|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
44962897|NCT02003222|Hormones|hormones|mesh-ancestor
44962898|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44962899|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44962900|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
44962901|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962902|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44962903|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
44962904|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962905|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962906|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
44962907|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962908|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44962909|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962910|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44962911|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44962912|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44962913|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
44262325|NCT00646087|Ketamine|ketamine|mesh-list
44962914|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962915|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44962916|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44962917|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44962918|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962919|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
44962920|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
44962921|NCT01951885|Methotrexate|methotrexate|mesh-list
44962922|NCT01951885|Tacrolimus|tacrolimus|mesh-list
44962923|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44962924|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
44962925|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44962926|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962927|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44962928|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
44962929|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962930|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962931|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44962932|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44962933|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44962934|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44962935|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
44682909|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682910|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
44682911|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682912|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44100032|NCT00053820|Interferons|interferons|mesh-list
44682913|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100117|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
44682914|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682915|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44682916|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682917|NCT05252754|Analgesics|analgesics|mesh-ancestor
44682918|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
44682919|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682920|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682921|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682922|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
44682948|NCT05236972|Capecitabine|capecitabine|mesh-list
44682949|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
44682950|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682951|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
44682952|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682953|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682954|NCT05235191|Methadone|methadone|mesh-list
44682955|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44682956|NCT05235191|Narcotics|narcotics|mesh-ancestor
44262369|NCT00646230|Fenretinide|fenretinide|mesh-list
44682957|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682958|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682959|NCT05235191|Analgesics|analgesics|mesh-ancestor
44682960|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
44682961|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682962|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
44682963|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682964|NCT05234697|Remifentanil|remifentanil|mesh-list
44682965|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44682966|NCT05234697|Narcotics|narcotics|mesh-ancestor
44262374|NCT00646321|Budesonide|budesonide|mesh-list
44262385|NCT00646321|Hormones|hormones|mesh-ancestor
44682967|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682968|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682969|NCT05234697|Analgesics|analgesics|mesh-ancestor
44682970|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
44682971|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682972|NCT05220410|Psilocybin|psilocybin|mesh-list
44682973|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
44682974|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682975|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44962936|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962937|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44962938|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44962939|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44962940|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44962941|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
44462163|NCT01534208|Enclomiphene|enclomiphene|mesh-list
44962942|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44962943|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44962944|NCT01950390|Bevacizumab|bevacizumab|mesh-list
44962945|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962946|NCT01950390|Ipilimumab|ipilimumab|mesh-list
44962947|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
44962948|NCT01950390|Antibodies|antibodies|mesh-list
44962949|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
44962950|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962951|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
44962952|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962953|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44962954|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962955|NCT01950390|Growth Substances|growth substances|mesh-ancestor
44962956|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962957|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962958|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
44962959|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44962960|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962961|NCT01886872|Rituximab|rituximab|mesh-list
44962962|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44962963|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44962964|NCT01886872|Antibodies|antibodies|mesh-list
44962965|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
44962966|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44962967|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
44962968|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962969|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962970|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962971|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962972|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
44962973|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962974|NCT01776840|Rituximab|rituximab|mesh-list
44962975|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44962976|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962977|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962978|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
44962979|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962980|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962981|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962982|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
44962983|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962984|NCT01754857|Rituximab|rituximab|mesh-list
44962985|NCT01754857|Lenalidomide|lenalidomide|mesh-list
44962986|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44962987|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44962988|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44962989|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
44962990|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44962991|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44962992|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44962993|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44962994|NCT01754857|Growth Substances|growth substances|mesh-ancestor
44962995|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
44962996|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44962997|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
44962998|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44962999|NCT01661400|Thalidomide|thalidomide|mesh-list
44963000|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
44963001|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963002|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
44963003|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963004|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963005|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963006|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
44963007|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963008|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963009|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963010|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
44963011|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44963012|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963013|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963014|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963015|NCT01661400|Growth Substances|growth substances|mesh-ancestor
44963016|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963017|NCT01522976|Lenalidomide|lenalidomide|mesh-list
44963018|NCT01522976|Azacitidine|azacitidine|mesh-list
44963019|NCT01522976|Vorinostat|vorinostat|mesh-list
44963020|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
44963021|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963022|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963023|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963024|NCT01522976|Growth Substances|growth substances|mesh-ancestor
44963025|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963026|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262467|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44963027|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44963028|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
44963029|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963030|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963031|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44963032|NCT01512316|Cycloserine|cycloserine|mesh-list
44963033|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44963034|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963035|NCT01512316|Renal Agents|renal agents|mesh-ancestor
44963036|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44963037|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
44963038|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44963039|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
44963040|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963041|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
44963042|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44262481|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
44963043|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44963044|NCT01465334|Prednisolone|prednisolone|mesh-list
44963045|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
44963046|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
44963047|NCT01465334|Ofatumumab|ofatumumab|mesh-list
44963048|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44963049|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
44963050|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44963051|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
44963052|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
44963053|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44963054|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963055|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44963056|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
44963057|NCT01465334|Hormones|hormones|mesh-ancestor
44963058|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963059|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44963060|NCT01465334|Protective Agents|protective agents|mesh-ancestor
44963061|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963062|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963063|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44963064|NCT01358877|Paclitaxel|paclitaxel|mesh-list
44682976|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
44682977|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682978|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682979|NCT05215431|Antioxidants|antioxidants|mesh-list
44682980|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682981|NCT05215431|Protective Agents|protective agents|mesh-ancestor
44682982|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682983|NCT05205447|Itraconazole|itraconazole|mesh-list
44682984|NCT05205447|Carbamazepine|carbamazepine|mesh-list
44682985|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
44682986|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682987|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44682988|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44682989|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682990|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682991|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44682992|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
44682993|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682994|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682995|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44963065|NCT01358877|Docetaxel|docetaxel|mesh-list
44963066|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
44963067|NCT01358877|Carboplatin|carboplatin|mesh-list
44963068|NCT01358877|Doxorubicin|doxorubicin|mesh-list
44963069|NCT01358877|Fluorouracil|fluorouracil|mesh-list
44963070|NCT01358877|Trastuzumab|trastuzumab|mesh-list
44963072|NCT01358877|Pertuzumab|pertuzumab|mesh-list
44262532|NCT00646711|Valproic Acid|valproic acid|mesh-list
44963073|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963074|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963075|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963076|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963077|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963078|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963079|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963080|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
44963081|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963082|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963083|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963084|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
44963085|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963086|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963087|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44963088|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963089|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963090|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
44963091|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44963092|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44963093|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
44963094|NCT01286272|Bortezomib|bortezomib|mesh-list
44963095|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44963096|NCT01286272|Ofatumumab|ofatumumab|mesh-list
44963097|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44963098|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963099|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963100|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963101|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
44963102|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963103|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44963104|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
44963105|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
44963106|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963107|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
44963108|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963109|NCT01275677|Paclitaxel|paclitaxel|mesh-list
44963110|NCT01275677|Docetaxel|docetaxel|mesh-list
44963111|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
44963112|NCT01275677|Doxorubicin|doxorubicin|mesh-list
44963113|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44963114|NCT01275677|Trastuzumab|trastuzumab|mesh-list
44963115|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44963116|NCT01275677|Daunorubicin|daunorubicin|mesh-list
44963117|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44963118|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963119|NCT01275677|Antibodies|antibodies|mesh-list
44963120|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
44963121|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963122|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963123|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963124|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963125|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963126|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963127|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963128|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963129|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
44963130|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963131|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963132|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963133|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
44963134|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963135|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963136|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44963137|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963138|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963139|NCT01272037|Tamoxifen|tamoxifen|mesh-list
44963140|NCT01272037|Letrozole|letrozole|mesh-list
44963141|NCT01272037|Anastrozole|anastrozole|mesh-list
44963142|NCT01272037|Exemestane|exemestane|mesh-list
44963143|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963144|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963145|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44963146|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44963147|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963148|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44963149|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44262605|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963150|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963151|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963152|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963153|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44963154|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44963155|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44963156|NCT01255891|Androgens|androgens|mesh-list
44963157|NCT01255891|Hormones|hormones|mesh-ancestor
44963158|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963159|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963160|NCT01167712|Paclitaxel|paclitaxel|mesh-list
44963161|NCT01167712|Bevacizumab|bevacizumab|mesh-list
44963162|NCT01167712|Carboplatin|carboplatin|mesh-list
44963163|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44963164|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963165|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
44963166|NCT01167712|Antibodies|antibodies|mesh-list
44963167|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
44963168|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963169|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
44963170|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963171|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963172|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963173|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963174|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963175|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963176|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963177|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44262631|NCT00646945|Analgesics|analgesics|mesh-ancestor
44963178|NCT01167712|Growth Substances|growth substances|mesh-ancestor
44963179|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963180|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963181|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
44963182|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
44963183|NCT01162109|Astringents|astringents|mesh-ancestor
44963184|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262641|NCT00647049|Rituximab|rituximab|mesh-list
44963185|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
44963186|NCT01065519|Umirolimus|umirolimus|mesh-list
44963187|NCT01065519|Everolimus|everolimus|mesh-list
44963188|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963189|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963190|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
44963191|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963192|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44963193|NCT01048138|Biperiden|biperiden|mesh-list
44963194|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
44963195|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44963196|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44963197|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
44963198|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
44963199|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44963200|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963201|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44963202|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44963203|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44963204|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44963205|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963206|NCT00972478|Prednisone|prednisone|mesh-list
44963207|NCT00972478|Cortisone|cortisone|mesh-list
44963208|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
44963209|NCT00972478|Rituximab|rituximab|mesh-list
44963210|NCT00972478|Doxorubicin|doxorubicin|mesh-list
44963211|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44963212|NCT00972478|Vincristine|vincristine|mesh-list
44963213|NCT00972478|Vorinostat|vorinostat|mesh-list
44262673|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963214|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963215|NCT00972478|Antibodies|antibodies|mesh-list
44963216|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
44963217|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963218|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963219|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
44963220|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963221|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963222|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963223|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
44963224|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963225|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963226|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963227|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963228|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44963229|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963230|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963231|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44963232|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
44963234|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963235|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963236|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963237|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963238|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963239|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963240|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44963241|NCT00823342|Tenofovir|tenofovir|mesh-list
44963242|NCT00823342|Clevudine|clevudine|mesh-list
44963243|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
44963244|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963245|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44963246|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44963247|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963248|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963249|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44963250|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44963251|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963252|NCT00769379|Trastuzumab|trastuzumab|mesh-list
44963253|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44963254|NCT00769379|Antibodies|antibodies|mesh-list
44963255|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
44963256|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963257|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
44963258|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963259|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963260|NCT00658814|Azacitidine|azacitidine|mesh-list
44963261|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
44963262|NCT00658814|Calicheamicins|calicheamicins|mesh-list
44963263|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44963264|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
44963265|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963266|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963267|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963268|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44963269|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963270|NCT00644228|Dexamethasone|dexamethasone|mesh-list
44963271|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
44963272|NCT00644228|Lenalidomide|lenalidomide|mesh-list
44963273|NCT00644228|Bortezomib|bortezomib|mesh-list
44963274|NCT00644228|Ichthammol|ichthammol|mesh-list
44963275|NCT00644228|BB 1101|bb 1101|mesh-list
44963276|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44963277|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
44963278|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
44963279|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44963280|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682996|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
44682997|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
44682998|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44682999|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683000|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44683001|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683002|NCT05205447|Analgesics|analgesics|mesh-ancestor
44683003|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
44683004|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683005|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44683006|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44683007|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44683008|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44683009|NCT05203172|Cetuximab|cetuximab|mesh-list
44963281|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683010|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494747|NCT05605002|Serotonin|serotonin|mesh-list
44963282|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
44963283|NCT00644228|Hormones|hormones|mesh-ancestor
44963284|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963285|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963286|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963287|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44963288|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963289|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963290|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
44963291|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963292|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963293|NCT00644228|Growth Substances|growth substances|mesh-ancestor
44963294|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963295|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44963296|NCT00618098|Thrombin|thrombin|mesh-list
44963297|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
44963298|NCT00618098|Coagulants|coagulants|mesh-ancestor
44963299|NCT00601900|Tamoxifen|tamoxifen|mesh-list
44963300|NCT00601900|Bevacizumab|bevacizumab|mesh-list
44963301|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963302|NCT00601900|Letrozole|letrozole|mesh-list
44963303|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
44963304|NCT00601900|Antibodies|antibodies|mesh-list
44963305|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
44963306|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963307|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
44963308|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963309|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963310|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963311|NCT00601900|Growth Substances|growth substances|mesh-ancestor
44963312|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963313|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963314|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
44963315|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963316|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44963317|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44963318|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963319|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44963320|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
44963321|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963322|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963323|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44963324|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44963325|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44963326|NCT00588770|Bevacizumab|bevacizumab|mesh-list
44963327|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963328|NCT00588770|Cisplatin|cisplatin|mesh-list
44963329|NCT00588770|Carboplatin|carboplatin|mesh-list
44963330|NCT00588770|Docetaxel|docetaxel|mesh-list
44963331|NCT00588770|Fluorouracil|fluorouracil|mesh-list
44963332|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
44963333|NCT00588770|Antibodies|antibodies|mesh-list
44963334|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
44963335|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963336|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
44963337|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963338|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963339|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963340|NCT00588770|Growth Substances|growth substances|mesh-ancestor
44963341|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963342|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963343|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
44963344|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963345|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963346|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963347|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963348|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
44963349|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44963350|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963351|NCT00433511|Paclitaxel|paclitaxel|mesh-list
44963352|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
44963353|NCT00433511|Bevacizumab|bevacizumab|mesh-list
44963354|NCT00433511|Doxorubicin|doxorubicin|mesh-list
44963355|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44963356|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44494807|NCT05604261|Rabeprazole|rabeprazole|mesh-list
44963357|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963358|NCT00433511|Antibodies|antibodies|mesh-list
44963359|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
44963360|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963361|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
44963362|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
44963363|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963364|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963365|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963366|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963367|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963368|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963369|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963370|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
44963371|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963372|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963373|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963374|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
44963375|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963376|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44963377|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963378|NCT00433511|Growth Substances|growth substances|mesh-ancestor
44963379|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963380|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963381|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44963382|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963383|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963384|NCT00359684|Cysteamine|cysteamine|mesh-list
44963385|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44963386|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963387|NCT00354835|Dactinomycin|dactinomycin|mesh-list
44963388|NCT00354835|Cactinomycin|cactinomycin|mesh-list
44963389|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
44963390|NCT00354835|Irinotecan|irinotecan|mesh-list
44963391|NCT00354835|Vincristine|vincristine|mesh-list
44963392|NCT00354835|Camptothecin|camptothecin|mesh-list
44963393|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963394|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
44963395|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963396|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963397|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963398|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
44963399|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963400|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963401|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963402|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44963403|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963404|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963405|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963406|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963407|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963408|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963409|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44963410|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963411|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963412|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44963413|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44963414|NCT00324805|Gemcitabine|gemcitabine|mesh-list
44963415|NCT00324805|Bevacizumab|bevacizumab|mesh-list
44963416|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44963417|NCT00324805|Cisplatin|cisplatin|mesh-list
44963418|NCT00324805|Docetaxel|docetaxel|mesh-list
44963419|NCT00324805|Pemetrexed|pemetrexed|mesh-list
44963420|NCT00324805|Vinorelbine|vinorelbine|mesh-list
44963421|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
44963422|NCT00324805|Antibodies|antibodies|mesh-list
44963423|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
44963424|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44963425|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
44963426|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963427|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44262858|NCT00647777|Olanzapine|olanzapine|mesh-list
44963428|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44963429|NCT00324805|Growth Substances|growth substances|mesh-ancestor
44963430|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963431|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
44963432|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
44963433|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44963434|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
44963435|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963436|NCT00324805|Antiviral Agents|antiviral agents|mesh-ancestor
44963437|NCT00324805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44963438|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963439|NCT00324805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963440|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963441|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963442|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
44963443|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44963444|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44963445|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963446|NCT00310180|Tamoxifen|tamoxifen|mesh-list
44963447|NCT00310180|Letrozole|letrozole|mesh-list
44963448|NCT00310180|Anastrozole|anastrozole|mesh-list
44963449|NCT00310180|Exemestane|exemestane|mesh-list
44963450|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963451|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963452|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44963453|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44963454|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963455|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44963456|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
44963457|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963458|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963459|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963460|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44963461|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44963462|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44963463|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
44963464|NCT00070499|Dasatinib|dasatinib|mesh-list
44963465|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963466|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44963467|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963468|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963469|NCT00005780|Prednisone|prednisone|mesh-list
44963470|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
44963471|NCT00005780|Doxorubicin|doxorubicin|mesh-list
44963472|NCT00005780|Etoposide|etoposide|mesh-list
44963473|NCT00005780|Vincristine|vincristine|mesh-list
44963474|NCT00005780|Sargramostim|sargramostim|mesh-list
44963475|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44963476|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
44963477|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44963478|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44963479|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44963480|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
44963481|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44963482|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44963483|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44963484|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44963485|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44963486|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44963487|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44963488|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44963489|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
44963490|NCT00005780|Hormones|hormones|mesh-ancestor
44963491|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44963492|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44963493|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44963494|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
44963495|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
44963496|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
44494958|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683028|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44683029|NCT05183646|Proxigermanium|proxigermanium|mesh-list
44683030|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683031|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
44683032|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
44683033|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683034|NCT05171231|Hemostatics|hemostatics|mesh-list
44683035|NCT05171231|Coagulants|coagulants|mesh-ancestor
44683036|NCT05170334|Belinostat|belinostat|mesh-list
44683037|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683038|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44683039|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683040|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683041|NCT05163561|Vaccines|vaccines|mesh-list
44683042|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
44262951|NCT00647920|Adalimumab|adalimumab|mesh-list
44462194|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683043|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683065|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44683066|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683067|NCT05090280|Nafamostat|nafamostat|mesh-list
44683068|NCT05090280|Naltrexone|naltrexone|mesh-list
44683069|NCT05090280|Oxycodone|oxycodone|mesh-list
44683070|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44683071|NCT05090280|Narcotics|narcotics|mesh-ancestor
44683072|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683073|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683074|NCT05090280|Analgesics|analgesics|mesh-ancestor
44683075|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
44683076|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683077|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44683078|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44683079|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44683080|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683081|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683082|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683083|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
44683084|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
44683085|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683086|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683087|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44683088|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44683089|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44683090|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683091|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
44683092|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
44683093|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683094|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683095|NCT05082285|Vaccines|vaccines|mesh-list
44683096|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
44683097|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683098|NCT05075161|Pirfenidone|pirfenidone|mesh-list
44683099|NCT05075161|Analgesics|analgesics|mesh-ancestor
44683100|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
44683124|NCT05053633|Anesthetics|anesthetics|mesh-list
44683125|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683126|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683127|NCT05029999|Doxorubicin|doxorubicin|mesh-list
44683128|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44683129|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44683130|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683131|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44683132|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44683133|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683134|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683135|NCT05024032|Tirzepatide|tirzepatide|mesh-list
44683136|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44683137|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683138|NCT05024032|Incretins|incretins|mesh-ancestor
44683139|NCT05024032|Hormones|hormones|mesh-ancestor
44683140|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683141|NCT05022004|Brinzolamide|brinzolamide|mesh-list
44683142|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44683143|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683144|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683145|NCT05005507|Tenofovir|tenofovir|mesh-list
44683146|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44683147|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
44683148|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683149|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44683150|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44683151|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683152|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683153|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44683154|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44683155|NCT04998786|Dexamethasone|dexamethasone|mesh-list
44683156|NCT04998786|Ixazomib|ixazomib|mesh-list
44683157|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683158|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
44683159|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
44683160|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683161|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683162|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683163|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
44683164|NCT04998786|Hormones|hormones|mesh-ancestor
44683165|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683166|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683167|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683168|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44683169|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683170|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683171|NCT04975308|Fulvestrant|fulvestrant|mesh-list
44683172|NCT04975308|Exemestane|exemestane|mesh-list
44683173|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683174|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683175|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44683176|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44683177|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
44683178|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683179|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683180|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44683181|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44683182|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683183|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683184|NCT04973254|Rilpivirine|rilpivirine|mesh-list
44683185|NCT04973254|Cabotegravir|cabotegravir|mesh-list
44314655|NCT00909337|Bosentan|bosentan|mesh-list
44495492|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
44683186|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44683187|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44683188|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683189|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683191|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683192|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44683193|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44683194|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44683195|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44683196|NCT04959591|Acetaminophen|acetaminophen|mesh-list
44683197|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683198|NCT04959591|Analgesics|analgesics|mesh-ancestor
44683199|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
44683200|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683201|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683202|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
44683203|NCT04952753|Leucovorin|leucovorin|mesh-list
44683204|NCT04952753|Bevacizumab|bevacizumab|mesh-list
44683205|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
44683206|NCT04952753|Irinotecan|irinotecan|mesh-list
44683207|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
44683208|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683209|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683210|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44683211|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683212|NCT04952753|Growth Substances|growth substances|mesh-ancestor
44683213|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683214|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683215|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44683216|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44683217|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683218|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683219|NCT04952753|Antidotes|antidotes|mesh-ancestor
44683220|NCT04952753|Protective Agents|protective agents|mesh-ancestor
44683221|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
44683222|NCT04952753|Vitamins|vitamins|mesh-ancestor
44683223|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
44683224|NCT04943445|Paclitaxel|paclitaxel|mesh-list
44683225|NCT04943445|Carboplatin|carboplatin|mesh-list
44683226|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
44683227|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
44683228|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44683229|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683230|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683231|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683232|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683233|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683234|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683235|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683236|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44683237|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44683238|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
44683239|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683240|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263103|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683241|NCT04939636|Vitamin D|vitamin d|mesh-list
44683242|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
44683243|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
44683244|NCT04939636|Vitamins|vitamins|mesh-list
44683245|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
44683246|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683247|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44683248|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44683267|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44683268|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
44683269|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683270|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683271|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44234580|NCT00550095|Valsartan|valsartan|mesh-list
44683272|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683273|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
44683275|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683276|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683277|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
44683278|NCT04923893|Hormones|hormones|mesh-ancestor
44683279|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683280|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683281|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44683282|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683283|NCT04923893|Growth Substances|growth substances|mesh-ancestor
44683284|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683285|NCT04908787|Paclitaxel|paclitaxel|mesh-list
44683286|NCT04908787|Doxorubicin|doxorubicin|mesh-list
44683287|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44683288|NCT04908787|Topotecan|topotecan|mesh-list
44683289|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44683290|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683291|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683292|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683293|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683294|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683295|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44683296|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44683297|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44683298|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683299|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44496204|NCT03826615|Gabapentin|gabapentin|mesh-list
44496279|NCT03825861|Folfirinox|folfirinox|mesh-list
44496446|NCT03824834|Morphine|morphine|mesh-list
44683300|NCT04907084|Fenofibrate|fenofibrate|mesh-list
44683301|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44683302|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
44683303|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683304|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44683305|NCT04879225|Menthol|menthol|mesh-list
44683306|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
44683307|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683308|NCT04869371|Prednisone|prednisone|mesh-list
44683309|NCT04869371|Docetaxel|docetaxel|mesh-list
44683310|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44683311|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683312|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683313|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683314|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683315|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683316|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683317|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
44683318|NCT04869371|Hormones|hormones|mesh-ancestor
44683319|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683320|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683321|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683322|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
44683323|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44683324|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
44683325|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44683326|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44683327|NCT04859296|Dronabinol|dronabinol|mesh-list
44683328|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
44683329|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683330|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44683331|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683332|NCT04859296|Analgesics|analgesics|mesh-ancestor
44683333|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
44683334|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683335|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44683336|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44683337|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683338|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683339|NCT04859296|Hormones|hormones|mesh-ancestor
44683340|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683341|NCT04857931|Colchicine|colchicine|mesh-list
44683342|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
44683343|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683344|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683345|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683346|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234631|NCT00550329|Glipizide|glipizide|mesh-list
44683347|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683383|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
44683384|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496510|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
44496532|NCT03823950|Lenograstim|lenograstim|mesh-list
44683385|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683386|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683387|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683388|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44683389|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683390|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
44683391|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44683392|NCT04800627|Pevonedistat|pevonedistat|mesh-list
44683393|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683394|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263171|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
44683395|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683396|NCT04777357|Cariprazine|cariprazine|mesh-list
44683397|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44683398|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44683399|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683400|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683401|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44683402|NCT04761159|Ketamine|ketamine|mesh-list
44683403|NCT04761159|Analgesics|analgesics|mesh-ancestor
44683404|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
44683405|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683406|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683407|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44683408|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44683409|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
44683410|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
44683411|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683412|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44683413|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44683414|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496682|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
44496724|NCT03820622|Paclitaxel|paclitaxel|mesh-list
44683415|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683417|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
44683418|NCT04745780|Inositol|inositol|mesh-list
44683419|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
44683420|NCT04745780|Vitamins|vitamins|mesh-ancestor
44683421|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
44683422|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683423|NCT04741139|Acetaminophen|acetaminophen|mesh-list
44683424|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
44683425|NCT04741139|Promethazine|promethazine|mesh-list
44683426|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44683427|NCT04741139|Analgesics|analgesics|mesh-ancestor
44683428|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
44683429|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683430|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683431|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
44683432|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44683433|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44683434|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683435|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
44683436|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
44683437|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
44683438|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
44683439|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683440|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44683441|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
44683442|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
44683443|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683444|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683445|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44683446|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
44683447|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683448|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
44683449|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44683450|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683451|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44683452|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683453|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
44683454|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44683455|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683456|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44683457|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683458|NCT04707196|Fulvestrant|fulvestrant|mesh-list
44683459|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44683460|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683461|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683462|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44683463|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44683464|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
44234793|NCT00551005|Celecoxib|celecoxib|mesh-list
44683465|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683466|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683467|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44683468|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683469|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683470|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
44683471|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44683472|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
44683473|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683474|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
44683475|NCT04704531|Protective Agents|protective agents|mesh-ancestor
44683476|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
44683477|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44683478|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
44683479|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683481|NCT04704518|Protective Agents|protective agents|mesh-ancestor
44683482|NCT04702789|Timolol|timolol|mesh-list
44683483|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44683484|NCT04702789|Dorzolamide|dorzolamide|mesh-list
44683485|NCT04702789|Latanoprost|latanoprost|mesh-list
44683486|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44683487|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44683488|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44683489|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683490|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683491|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683492|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44683493|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44683494|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44497262|NCT01451840|Narcotics|narcotics|mesh-ancestor
44683518|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683519|NCT04700176|Growth Substances|growth substances|mesh-ancestor
44683520|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683521|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
44683522|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44497548|NCT01454180|Leucovorin|leucovorin|mesh-list
44497647|NCT01455246|Daptomycin|daptomycin|mesh-list
44683554|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683555|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
44683556|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
44683557|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683558|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683559|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683560|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
44683561|NCT04661137|Hormones|hormones|mesh-ancestor
44683562|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683563|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497800|NCT01456351|Rituximab|rituximab|mesh-list
44497936|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
44497937|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497938|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44497939|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
44497940|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44497941|NCT01457690|Tocopherols|tocopherols|mesh-list
44497942|NCT01457690|Vitamin E|vitamin e|mesh-list
44497943|NCT01457690|Tocotrienols|tocotrienols|mesh-list
44497944|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
44683564|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683565|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
44683566|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44683567|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683568|NCT04661137|Growth Substances|growth substances|mesh-ancestor
44683569|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683570|NCT04658862|Gemcitabine|gemcitabine|mesh-list
44683571|NCT04658862|Cisplatin|cisplatin|mesh-list
44683572|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683573|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683574|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
44683575|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683576|NCT04658862|Antiviral Agents|antiviral agents|mesh-ancestor
44683577|NCT04658862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683578|NCT04658862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683579|NCT04658862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683580|NCT04658862|Immunologic Factors|immunologic factors|mesh-ancestor
44683581|NCT04658862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683582|NCT04649229|Aprepitant|aprepitant|mesh-list
44683583|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44683584|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
44683585|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
44683586|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683587|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683588|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683589|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44683590|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683591|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683592|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44683593|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44683594|NCT04648696|Vancomycin|vancomycin|mesh-list
44498149|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44498314|NCT01459887|Hormones|hormones|mesh-ancestor
44683595|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44683596|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683597|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
44683598|NCT04640623|Gemcitabine|gemcitabine|mesh-list
44683599|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498451|NCT01459679|Riboflavin|riboflavin|mesh-list
44683600|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
44683601|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683602|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683603|NCT04640623|Antiviral Agents|antiviral agents|mesh-ancestor
44683604|NCT04640623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683605|NCT04640623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683606|NCT04640623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683607|NCT04640623|Immunologic Factors|immunologic factors|mesh-ancestor
44683608|NCT04640623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683610|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
44683611|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683612|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44683613|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44683614|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683615|NCT04586426|Daratumumab|daratumumab|mesh-list
44683616|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683617|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44683622|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44683623|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44683624|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44683625|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44683627|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44683628|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44683629|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683630|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
44498747|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
44683631|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683632|NCT04527003|Cannabidiol|cannabidiol|mesh-list
44683633|NCT04527003|Norethindrone|norethindrone|mesh-list
44683634|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
44683635|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
44683636|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44683637|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44683638|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44683639|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
44683640|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44683641|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683642|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44683643|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44683644|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
44683645|NCT04526509|Fludarabine|fludarabine|mesh-list
44683646|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683647|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
44683648|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683649|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683650|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44683651|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
44263398|NCT00648778|Loxapine|loxapine|mesh-list
44683652|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683653|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683654|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44683655|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
44683656|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44683657|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
44683658|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683659|NCT04520139|Expectorants|expectorants|mesh-ancestor
44683660|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44683661|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44683662|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
44683663|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683664|NCT04520139|Protective Agents|protective agents|mesh-ancestor
44263413|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44683665|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683666|NCT04520139|Antidotes|antidotes|mesh-ancestor
44683667|NCT04491968|Methadone|methadone|mesh-list
44683668|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44683669|NCT04491968|Narcotics|narcotics|mesh-ancestor
44683670|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683671|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683672|NCT04491968|Analgesics|analgesics|mesh-ancestor
44683673|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
44683674|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683675|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
44683676|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
44683677|NCT04480372|Gemcitabine|gemcitabine|mesh-list
44683678|NCT04480372|Atezolizumab|atezolizumab|mesh-list
44499050|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
44499051|NCT05021315|Povidone|povidone|mesh-list
44499052|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
44499053|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
44499054|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44683685|NCT04480372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683686|NCT04480372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683687|NCT04480372|Immunologic Factors|immunologic factors|mesh-ancestor
44683688|NCT04480372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683689|NCT04462276|Atezolizumab|atezolizumab|mesh-list
44683690|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683691|NCT04439136|Afatinib|afatinib|mesh-list
44683692|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683693|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44683694|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683695|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683696|NCT04431193|Oxytocin|oxytocin|mesh-list
44683697|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
44683698|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44683699|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683701|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683702|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
44263434|NCT00648817|Tenofovir|tenofovir|mesh-list
44683703|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683704|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683705|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683713|NCT04417257|Fenretinide|fenretinide|mesh-list
44683714|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683715|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44683716|NCT04417257|Protective Agents|protective agents|mesh-ancestor
44683717|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683718|NCT04385173|Temozolomide|temozolomide|mesh-list
44683733|NCT04345718|Narcotics|narcotics|mesh-ancestor
44683734|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683735|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683737|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
44683738|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683739|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44683740|NCT04339738|Paclitaxel|paclitaxel|mesh-list
44683741|NCT04339738|Nivolumab|nivolumab|mesh-list
44683742|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44263462|NCT00648856|Sertraline|sertraline|mesh-list
44683743|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44683744|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683745|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683746|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683747|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683748|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683749|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683750|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44683751|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
44683752|NCT04322318|Ifosfamide|ifosfamide|mesh-list
44683753|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
44683754|NCT04322318|Carboplatin|carboplatin|mesh-list
44683755|NCT04322318|Doxorubicin|doxorubicin|mesh-list
44683756|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44683757|NCT04322318|Irinotecan|irinotecan|mesh-list
44683758|NCT04322318|Etoposide|etoposide|mesh-list
44683759|NCT04322318|Vincristine|vincristine|mesh-list
44683760|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
44683761|NCT04322318|Daunorubicin|daunorubicin|mesh-list
44683762|NCT04322318|Topotecan|topotecan|mesh-list
44683763|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
44683764|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683765|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
44499756|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
44683766|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683767|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683768|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44683769|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
44683770|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683771|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683772|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44683773|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44683774|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44683775|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44683776|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683777|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44683778|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44683779|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683780|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683781|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683782|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
44683783|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683784|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44683785|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44683786|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683787|NCT04276233|Prednisone|prednisone|mesh-list
44683788|NCT04276233|Prednisolone|prednisolone|mesh-list
44683789|NCT04276233|Albuterol|albuterol|mesh-list
44683790|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683791|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
44683792|NCT04276233|Hormones|hormones|mesh-ancestor
44683793|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263495|NCT00648947|Clopidogrel|clopidogrel|mesh-list
44683794|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683795|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683796|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683797|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
44683798|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683799|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44683800|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44683801|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
44683802|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
44683803|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500101|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
44683804|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44683805|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44683806|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44683807|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
44683808|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683809|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683810|NCT04270877|Naltrexone|naltrexone|mesh-list
44683811|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44683812|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44683813|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683814|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
44683815|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683816|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
44500286|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44683818|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683819|NCT04255433|Dulaglutide|dulaglutide|mesh-list
44683820|NCT04255433|Tirzepatide|tirzepatide|mesh-list
44683821|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44683822|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683823|NCT04255433|Incretins|incretins|mesh-ancestor
44683824|NCT04255433|Hormones|hormones|mesh-ancestor
44683825|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683826|NCT04250142|Methamphetamine|methamphetamine|mesh-list
44683827|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44263548|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44263550|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
44683828|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683829|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
44683830|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
44683831|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683832|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
44683833|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683834|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683835|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
44683836|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44683837|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44683838|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44683839|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44683840|NCT04237649|Spartalizumab|spartalizumab|mesh-list
44683841|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44683842|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683843|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683844|NCT04185883|Bevacizumab|bevacizumab|mesh-list
44683845|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
44683846|NCT04185883|Panitumumab|panitumumab|mesh-list
44683847|NCT04185883|Carboplatin|carboplatin|mesh-list
44683848|NCT04185883|Docetaxel|docetaxel|mesh-list
44683849|NCT04185883|Pemetrexed|pemetrexed|mesh-list
44683860|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683861|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683862|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683863|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44683864|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683865|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683866|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683867|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44683868|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44683869|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683870|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
44683871|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44683872|NCT04182204|Gemcitabine|gemcitabine|mesh-list
44683873|NCT04182204|Rituximab|rituximab|mesh-list
44683874|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
44683875|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683876|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683877|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
44683878|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683879|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44683880|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683881|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
44683882|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683883|NCT04182204|Antiviral Agents|antiviral agents|mesh-ancestor
44683884|NCT04182204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44683885|NCT04182204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683886|NCT04182204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500591|NCT01790971|Morphine|morphine|mesh-list
44683887|NCT04180397|Furosemide|furosemide|mesh-list
44683888|NCT04180397|Diuretics|diuretics|mesh-ancestor
44683889|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
44683890|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683891|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44683892|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44683893|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683894|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
44683895|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44683896|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
44683897|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44263582|NCT00649064|Ziprasidone|ziprasidone|mesh-list
44683898|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44683899|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683900|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683901|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
44683902|NCT04173247|Mineral Oil|mineral oil|mesh-list
44683903|NCT04173247|Emollients|emollients|mesh-ancestor
44683904|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
44683905|NCT04170348|Vitamin D|vitamin d|mesh-list
44683906|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
44683907|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
44683908|NCT04170348|Vitamins|vitamins|mesh-list
44683909|NCT04170348|Trientine|trientine|mesh-list
44683910|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
44683911|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683912|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44683913|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44683914|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
44683915|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
44683916|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235254|NCT00553943|Cytarabine|cytarabine|mesh-list
44683918|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44683919|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44683920|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44683921|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44683922|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683923|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44683924|NCT04163952|Panitumumab|panitumumab|mesh-list
44683925|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44683926|NCT04163952|Antibodies|antibodies|mesh-list
44683927|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
44500929|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
44683929|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
44683930|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683931|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683932|NCT04150887|Azacitidine|azacitidine|mesh-list
44683933|NCT04150887|Venetoclax|venetoclax|mesh-list
44683934|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683935|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
44683936|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683937|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683938|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44683939|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
44683940|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44683941|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683942|NCT04133636|Dexamethasone|dexamethasone|mesh-list
44683943|NCT04133636|Lenalidomide|lenalidomide|mesh-list
44683944|NCT04133636|Bortezomib|bortezomib|mesh-list
44683945|NCT04133636|Daratumumab|daratumumab|mesh-list
44683946|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683947|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
44683948|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
44683949|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44683950|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683951|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44683952|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
44683953|NCT04133636|Hormones|hormones|mesh-ancestor
44683954|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683955|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44683956|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683957|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
44683958|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44683959|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44683960|NCT04133636|Growth Substances|growth substances|mesh-ancestor
44683961|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
44683962|NCT04105231|Cannabidiol|cannabidiol|mesh-list
44683963|NCT04105231|Risperidone|risperidone|mesh-list
44683964|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44683965|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
44683966|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44683967|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683968|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683969|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44683970|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44683971|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44683972|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44683973|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44683974|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
44683975|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
44683976|NCT04094298|FX006|fx006|mesh-list
44683977|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44683978|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
44683979|NCT04094298|Hormones|hormones|mesh-ancestor
44683980|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44683981|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44683982|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44683983|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
44683984|NCT04083599|Gemcitabine|gemcitabine|mesh-list
44683985|NCT04083599|Paclitaxel|paclitaxel|mesh-list
44683986|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44683987|NCT04083599|Cisplatin|cisplatin|mesh-list
44683988|NCT04083599|Carboplatin|carboplatin|mesh-list
44683989|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
44683990|NCT04083599|Pemetrexed|pemetrexed|mesh-list
44683991|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44683992|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44683993|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44683995|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44683996|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44683997|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44683998|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
44683999|NCT04083599|Antiviral Agents|antiviral agents|mesh-ancestor
44684000|NCT04083599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684001|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684002|NCT04083599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684003|NCT04083599|Immunologic Factors|immunologic factors|mesh-ancestor
44684004|NCT04083599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684005|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684006|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44684007|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44684008|NCT04083235|Leucovorin|leucovorin|mesh-list
44684009|NCT04083235|Gemcitabine|gemcitabine|mesh-list
44684010|NCT04083235|Paclitaxel|paclitaxel|mesh-list
44684011|NCT04083235|Fluorouracil|fluorouracil|mesh-list
44684012|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
44684013|NCT04083235|Irinotecan|irinotecan|mesh-list
44684014|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684015|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684016|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684017|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684018|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684019|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684020|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684021|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
44684022|NCT04083235|Antiviral Agents|antiviral agents|mesh-ancestor
44684023|NCT04083235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684024|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684025|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684026|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
44684027|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684028|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44684029|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684030|NCT04083235|Antidotes|antidotes|mesh-ancestor
44684031|NCT04083235|Protective Agents|protective agents|mesh-ancestor
44684032|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
44684033|NCT04083235|Vitamins|vitamins|mesh-ancestor
44684034|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
44684035|NCT04077866|Temozolomide|temozolomide|mesh-list
44684036|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684037|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
44684038|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684039|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684040|NCT04064294|Levodopa|levodopa|mesh-list
44684041|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44684042|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44684043|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
44684044|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684045|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684046|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684047|NCT04060758|Latanoprost|latanoprost|mesh-list
44684048|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44684049|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44501487|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
44501560|NCT01798537|Vancomycin|vancomycin|mesh-list
44501634|NCT01799057|Metformin|metformin|mesh-list
44684050|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44684051|NCT04057456|Nabilone|nabilone|mesh-list
44684052|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
44684053|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
44684054|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684055|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684056|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684057|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44684058|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44684059|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44684060|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44684061|NCT04035486|Cisplatin|cisplatin|mesh-list
44684062|NCT04035486|Carboplatin|carboplatin|mesh-list
44684063|NCT04035486|Pemetrexed|pemetrexed|mesh-list
44684064|NCT04035486|Osimertinib|osimertinib|mesh-list
44235362|NCT00554346|Etoricoxib|etoricoxib|mesh-list
44684065|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684066|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684067|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684068|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44684069|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44684071|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
44684072|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684073|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684074|NCT04025359|Dronabinol|dronabinol|mesh-list
44684075|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
44684076|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684077|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44684078|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684079|NCT04025359|Analgesics|analgesics|mesh-ancestor
44684080|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
44684081|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684082|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44684083|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44684084|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684085|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684086|NCT04025359|Hormones|hormones|mesh-ancestor
44263792|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
44684087|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684097|NCT04023526|Azacitidine|azacitidine|mesh-list
44684098|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684099|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
44684100|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684101|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684102|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684103|NCT04010539|Azithromycin|azithromycin|mesh-list
44684104|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
44684105|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44684106|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684107|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44684108|NCT03995641|Bupivacaine|bupivacaine|mesh-list
44684109|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
44684110|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
44684111|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44684112|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684113|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
44684114|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684115|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684116|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
44684117|NCT03995641|Hormones|hormones|mesh-ancestor
44684118|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684119|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684120|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
44684121|NCT03993457|Citalopram|citalopram|mesh-list
44684122|NCT03993457|Bupropion|bupropion|mesh-list
44684123|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44684124|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44684125|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44684126|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684127|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684128|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
44684129|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684130|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44684131|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
44684132|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44684133|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44684134|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
44684135|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44684136|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44684137|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684138|NCT03981614|Trifluridine|trifluridine|mesh-list
44684139|NCT03981614|Palbociclib|palbociclib|mesh-list
44684140|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684141|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684142|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684143|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684144|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
44684145|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
44684146|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684147|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
44684148|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
44684149|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684150|NCT03970447|Temozolomide|temozolomide|mesh-list
44684151|NCT03970447|Lomustine|lomustine|mesh-list
44684152|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
44684153|NCT03970447|GDC-0084|gdc-0084|mesh-list
44684154|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684155|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
44684156|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684157|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684158|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684159|NCT03948646|Bromides|bromides|mesh-list
44684160|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
44684161|NCT03941093|Leucovorin|leucovorin|mesh-list
44684162|NCT03941093|Gemcitabine|gemcitabine|mesh-list
44684163|NCT03941093|Paclitaxel|paclitaxel|mesh-list
44684164|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44684165|NCT03941093|Irinotecan|irinotecan|mesh-list
44684166|NCT03941093|Fluorouracil|fluorouracil|mesh-list
44684167|NCT03941093|Folfirinox|folfirinox|mesh-list
44684168|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
44684169|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684170|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684171|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684172|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684173|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684174|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684175|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684176|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
44684177|NCT03941093|Antiviral Agents|antiviral agents|mesh-ancestor
44684178|NCT03941093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684179|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684180|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684181|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
44684182|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684183|NCT03941093|Antidotes|antidotes|mesh-ancestor
44684184|NCT03941093|Protective Agents|protective agents|mesh-ancestor
44684185|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
44684186|NCT03941093|Vitamins|vitamins|mesh-ancestor
44684187|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
44684188|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44684189|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684190|NCT03935685|Mirtazapine|mirtazapine|mesh-list
44684191|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44684192|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44684193|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44684194|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
44684195|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
44684196|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684197|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684198|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684199|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44684200|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44684201|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44684202|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44684203|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44684204|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44684205|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44684206|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44684207|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44684208|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
44684209|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44684210|NCT03934216|BMS-986165|bms-986165|mesh-list
44684211|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44684212|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684213|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684214|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684215|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44684216|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44684217|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684218|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44684219|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44684255|NCT03810807|Osimertinib|osimertinib|mesh-list
44684256|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684257|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684258|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684259|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684260|NCT03794349|Eflornithine|eflornithine|mesh-list
44684261|NCT03794349|Irinotecan|irinotecan|mesh-list
44684262|NCT03794349|Camptothecin|camptothecin|mesh-list
44684263|NCT03794349|Temozolomide|temozolomide|mesh-list
44684264|NCT03794349|Dinutuximab|dinutuximab|mesh-list
44684265|NCT03794349|Sargramostim|sargramostim|mesh-list
44684266|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44684267|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684268|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684269|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684270|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684271|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684272|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
44684273|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
44684274|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684275|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684276|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44502356|NCT02994173|Ketamine|ketamine|mesh-list
44502453|NCT02993588|Melatonin|melatonin|mesh-list
44684278|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44684279|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684280|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44684281|NCT03785210|Vancomycin|vancomycin|mesh-list
44684282|NCT03785210|Nivolumab|nivolumab|mesh-list
44684283|NCT03785210|Tadalafil|tadalafil|mesh-list
44684284|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684285|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684286|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44684287|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684288|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44684289|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684290|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
44684291|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44684292|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44684293|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684294|NCT03785210|Urological Agents|urological agents|mesh-ancestor
44684295|NCT03782532|Prednisone|prednisone|mesh-list
44684296|NCT03782532|Prednisolone|prednisolone|mesh-list
44684297|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684298|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
44684299|NCT03782532|Hormones|hormones|mesh-ancestor
44684300|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684301|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684302|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684303|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684304|NCT03735121|Atezolizumab|atezolizumab|mesh-list
44684305|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263928|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263958|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44684306|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44684307|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
44684308|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
44684309|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684310|NCT03719326|Paclitaxel|paclitaxel|mesh-list
44684311|NCT03719326|Doxorubicin|doxorubicin|mesh-list
44684312|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44684313|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44684314|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684315|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684316|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684317|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684318|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684319|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684320|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44684321|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44684322|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684323|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684324|NCT03690947|Ranibizumab|ranibizumab|mesh-list
44684325|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44684326|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44684327|NCT03690947|Growth Substances|growth substances|mesh-ancestor
44684328|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684329|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
44684330|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684331|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44684332|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
44684333|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684334|NCT03667326|Aspirin|aspirin|mesh-list
44684335|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44502499|NCT02992925|Vaccines|vaccines|mesh-list
44684336|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684337|NCT03667326|Analgesics|analgesics|mesh-ancestor
44263978|NCT00649688|Metoprolol|metoprolol|mesh-list
44684338|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
44684339|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684340|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684341|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684342|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684343|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44684344|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44684345|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684346|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44684347|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44684348|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684349|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
44684350|NCT03665545|Poly I-C|poly i-c|mesh-list
44684351|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
44684352|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44684353|NCT03665545|Poly ICLC|poly iclc|mesh-list
44684354|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684355|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684356|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
44684357|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
44264007|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684358|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684359|NCT03665545|Laxatives|laxatives|mesh-ancestor
44684360|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684361|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
44684362|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684363|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
44684364|NCT03662711|Olodaterol|olodaterol|mesh-list
44684365|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
44684366|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684367|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684368|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44684369|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
44684370|NCT03649711|Aspirin|aspirin|mesh-list
44684371|NCT03649711|Clopidogrel|clopidogrel|mesh-list
44684372|NCT03649711|Ticagrelor|ticagrelor|mesh-list
44684373|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44684374|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684375|NCT03649711|Analgesics|analgesics|mesh-ancestor
44684376|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
44684377|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684378|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264026|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44684379|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684380|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684381|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44684382|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44684383|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502997|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684401|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684402|NCT03580369|Omalizumab|omalizumab|mesh-list
44684403|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44684404|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44684405|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
44684406|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
44684407|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684408|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684409|NCT03564691|Paclitaxel|paclitaxel|mesh-list
44684410|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44684411|NCT03564691|Cisplatin|cisplatin|mesh-list
44684412|NCT03564691|Carboplatin|carboplatin|mesh-list
44684413|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
44684414|NCT03564691|Pemetrexed|pemetrexed|mesh-list
44684415|NCT03564691|Lenvatinib|lenvatinib|mesh-list
44684416|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684417|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684418|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684419|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44264028|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44684420|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684421|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684422|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684423|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684424|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44684425|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44684426|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684427|NCT03560960|Pramlintide|pramlintide|mesh-list
44684428|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44684429|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503162|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
44684479|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684480|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44684481|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
44684483|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
44684484|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684485|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44684486|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
44684487|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
44684488|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684489|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684490|NCT03484520|Venetoclax|venetoclax|mesh-list
44684491|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684492|NCT03473743|Cisplatin|cisplatin|mesh-list
44684493|NCT03473743|Carboplatin|carboplatin|mesh-list
44684494|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684495|NCT03464448|Teriflunomide|teriflunomide|mesh-list
44684496|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44684497|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684498|NCT03464448|Analgesics|analgesics|mesh-ancestor
44684499|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
44684500|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684501|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684502|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684503|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684504|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684505|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
44503646|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
44684521|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
44684523|NCT03457142|Ixazomib|ixazomib|mesh-list
44684524|NCT03457142|Ichthammol|ichthammol|mesh-list
44684525|NCT03457142|BB 1101|bb 1101|mesh-list
44684526|NCT03457142|Glycine|glycine|mesh-list
44684527|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684528|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
44684529|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
44264073|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
44264095|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684530|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684531|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684532|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684533|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
44684534|NCT03457142|Hormones|hormones|mesh-ancestor
44684535|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684536|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684537|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684538|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684539|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
44684540|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684541|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44684542|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684543|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
44684544|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684545|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44684546|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
44684547|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684548|NCT03452865|Esomeprazole|esomeprazole|mesh-list
44684549|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44684550|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684551|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44503787|NCT01275274|Tretinoin|tretinoin|mesh-list
44503963|NCT01276548|Carboplatin|carboplatin|mesh-list
44684552|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684553|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684554|NCT03452839|Meropenem|meropenem|mesh-list
44684555|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44684556|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684557|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
44684558|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
44684559|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44684560|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44684561|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684562|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684598|NCT03315832|Valsartan|valsartan|mesh-list
44684599|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44684600|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44684601|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44684602|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684603|NCT03290950|Dexamethasone|dexamethasone|mesh-list
44684604|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
44684605|NCT03290950|Lenalidomide|lenalidomide|mesh-list
44684606|NCT03290950|Daratumumab|daratumumab|mesh-list
44684607|NCT03290950|BB 1101|bb 1101|mesh-list
44684608|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684609|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
44684610|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
44684611|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684612|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684613|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684614|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
44684615|NCT03290950|Hormones|hormones|mesh-ancestor
44684616|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684617|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684618|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684619|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
44684620|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684621|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684622|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
44684623|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44684624|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44684625|NCT03290950|Growth Substances|growth substances|mesh-ancestor
44684626|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44684627|NCT03289962|Atezolizumab|atezolizumab|mesh-list
44684628|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684629|NCT03268954|Azacitidine|azacitidine|mesh-list
44684630|NCT03268954|Pevonedistat|pevonedistat|mesh-list
44684631|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684632|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
44684633|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684634|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684635|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684636|NCT03253679|Adavosertib|adavosertib|mesh-list
44684637|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684638|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684639|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
44684640|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44684641|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44684642|NCT03229538|Prednisolone|prednisolone|mesh-list
44684643|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
44684644|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44684645|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
44684646|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684647|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
44684648|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
44684649|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684650|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684651|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684652|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
44684653|NCT03229538|Hormones|hormones|mesh-ancestor
44504196|NCT01278238|Protective Agents|protective agents|mesh-ancestor
44504277|NCT01279096|Hormones|hormones|mesh-ancestor
44707251|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44684658|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684660|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684661|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684662|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684663|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684686|NCT03193333|Timolol|timolol|mesh-list
44684687|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44684688|NCT03193333|Dorzolamide|dorzolamide|mesh-list
44684689|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44684690|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44684691|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44684692|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44684693|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
44684694|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684695|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684696|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684697|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44684698|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44684699|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44684700|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44684701|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44684702|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44684703|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684709|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
44684710|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684711|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
44684712|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684713|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684714|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44684715|NCT03152786|Propranolol|propranolol|mesh-list
44684716|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44684717|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44684718|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
44684719|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684720|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684721|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684722|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44684723|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44504426|NCT01279876|Melatonin|melatonin|mesh-list
44504504|NCT01279057|Xhance|xhance|mesh-list
44684724|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
44684726|NCT03139370|Fludarabine|fludarabine|mesh-list
44684727|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684728|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
44684729|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684730|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684731|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684732|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
44684733|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684734|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684735|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44684736|NCT03136055|Paclitaxel|paclitaxel|mesh-list
44684737|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
44684738|NCT03136055|Irinotecan|irinotecan|mesh-list
44684739|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684740|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684741|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684742|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684743|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684744|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684745|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684746|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44684747|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684748|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684749|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
44684750|NCT03126630|Maytansine|maytansine|mesh-list
44707252|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44505083|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684768|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684769|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
44684770|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684771|NCT03093922|Antiviral Agents|antiviral agents|mesh-ancestor
44684772|NCT03093922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684773|NCT03093922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684774|NCT03093922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684775|NCT03093922|Immunologic Factors|immunologic factors|mesh-ancestor
44684776|NCT03093922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684777|NCT03087448|Trametinib|trametinib|mesh-list
44684778|NCT03087448|Ceritinib|ceritinib|mesh-list
44684779|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684780|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44684781|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684782|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684801|NCT03063619|Tamoxifen|tamoxifen|mesh-list
44684802|NCT03063619|Afimoxifene|afimoxifene|mesh-list
44684803|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44684804|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
44684805|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684806|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505686|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44684807|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684808|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684809|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44684810|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44684811|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44684812|NCT03054766|Ranibizumab|ranibizumab|mesh-list
44684813|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44684814|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44684815|NCT03054766|Growth Substances|growth substances|mesh-ancestor
44684816|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684817|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
44684818|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684819|NCT03040141|Oseltamivir|oseltamivir|mesh-list
44684820|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
44684821|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236176|NCT00557921|Aspirin|aspirin|mesh-list
44684822|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684823|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684824|NCT03036748|Amiloride|amiloride|mesh-list
44684825|NCT03036748|Diuretics|diuretics|mesh-ancestor
44684826|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
44684827|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684828|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44684829|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44684830|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44684831|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684832|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44684833|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44684834|NCT03034304|Gemcitabine|gemcitabine|mesh-list
44684835|NCT03034304|Cisplatin|cisplatin|mesh-list
44684836|NCT03034304|Carboplatin|carboplatin|mesh-list
44684837|NCT03034304|Doxorubicin|doxorubicin|mesh-list
44684838|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44684839|NCT03034304|Ifosfamide|ifosfamide|mesh-list
44684840|NCT03034304|Antibodies|antibodies|mesh-list
44684841|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
44684842|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684843|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684844|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684845|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
44684846|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684847|NCT03034304|Antiviral Agents|antiviral agents|mesh-ancestor
44684848|NCT03034304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684849|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684850|NCT03034304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684851|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44684852|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44684853|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684854|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684855|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
44684856|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
44684857|NCT03018288|Temozolomide|temozolomide|mesh-list
44684858|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44264308|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44684859|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684860|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684861|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
44684862|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684863|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
44684864|NCT03016377|Fludarabine|fludarabine|mesh-list
44684865|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684866|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
44684867|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684868|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684869|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684870|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
44264326|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44684871|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684872|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684873|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44684874|NCT03011034|Daratumumab|daratumumab|mesh-list
44684875|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684876|NCT03005522|Dexamethasone|dexamethasone|mesh-list
44684877|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684878|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
44684879|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
44684880|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684881|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684882|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684883|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
44684884|NCT03005522|Hormones|hormones|mesh-ancestor
44684885|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658404|NCT02945280|Apixaban|apixaban|mesh-list
44684886|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44506298|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44506299|NCT03804931|Prednisone|prednisone|mesh-list
44684887|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684888|NCT02998736|Tadalafil|tadalafil|mesh-list
44684889|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44684890|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44684891|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44684892|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684893|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684894|NCT02998736|Urological Agents|urological agents|mesh-ancestor
44684895|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
44684896|NCT02996474|Decitabine|decitabine|mesh-list
44684897|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684898|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684899|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684900|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
44684901|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684902|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684903|NCT02987257|Cyclosporine|cyclosporine|mesh-list
44684904|NCT02987257|Etanercept|etanercept|mesh-list
44684905|NCT02987257|Cyclosporins|cyclosporins|mesh-list
44684906|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684907|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684908|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684909|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
44684910|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684911|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
44684912|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684913|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44684914|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44684915|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44684916|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44684917|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684918|NCT02987257|Analgesics|analgesics|mesh-ancestor
44684919|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
44684920|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684921|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684922|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684923|NCT02985957|Prednisone|prednisone|mesh-list
44684924|NCT02985957|Nivolumab|nivolumab|mesh-list
44684925|NCT02985957|Ipilimumab|ipilimumab|mesh-list
44684926|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684927|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
44684928|NCT02985957|Hormones|hormones|mesh-ancestor
44684929|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44684930|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684931|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44684932|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684933|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684934|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44684935|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684936|NCT02978495|Paclitaxel|paclitaxel|mesh-list
44684937|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
44684938|NCT02978495|Carboplatin|carboplatin|mesh-list
44684939|NCT02978495|Doxorubicin|doxorubicin|mesh-list
44684940|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44684941|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684942|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44684943|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44684944|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44684945|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684946|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684947|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
44684948|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684949|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264395|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684950|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44684951|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
44684952|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44684953|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44684954|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44506525|NCT03802552|Cephalexin|cephalexin|mesh-list
44506529|NCT03802318|Amoxicillin|amoxicillin|mesh-list
44506603|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44684955|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44684956|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684957|NCT02968212|Clofazimine|clofazimine|mesh-list
44684958|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44684959|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
44684960|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44684961|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44684962|NCT02960113|Scopolamine|scopolamine|mesh-list
44684963|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44684964|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44684965|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
44684966|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
44684967|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44684968|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684969|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44684970|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
44684971|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44684972|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
44684973|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44684974|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684975|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44684976|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
44684977|NCT02954536|Cisplatin|cisplatin|mesh-list
44684978|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
44684979|NCT02954536|Fluorouracil|fluorouracil|mesh-list
44684980|NCT02954536|Capecitabine|capecitabine|mesh-list
44684981|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
44684982|NCT02954536|Trastuzumab|trastuzumab|mesh-list
44684983|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44684984|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44684985|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
44684986|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684987|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44684988|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44684989|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
44684990|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44684991|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44684992|NCT02924389|Dolutegravir|dolutegravir|mesh-list
44684993|NCT02924389|Triumeq|triumeq|mesh-list
44684994|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44684995|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44684996|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44684997|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44684998|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
44684999|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685000|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44685001|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44685002|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44685003|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44685004|NCT02923531|Nivolumab|nivolumab|mesh-list
44685005|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685006|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685007|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44685008|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685009|NCT02918019|Astegolimab|astegolimab|mesh-list
44685010|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44685011|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685012|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
44685013|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685014|NCT02913274|Paclitaxel|paclitaxel|mesh-list
44685015|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685016|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685017|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685018|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685019|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685020|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685021|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
44685022|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44685023|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
44685024|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685025|NCT02871297|Vortioxetine|vortioxetine|mesh-list
44685026|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
44685027|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44685028|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44685029|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44685030|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685031|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685032|NCT02871297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44685033|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44685034|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44685035|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685036|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685037|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
44685038|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44685039|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44685040|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44264489|NCT00650637|Calcium|calcium|mesh-list
44685041|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44685043|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
44685044|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44685045|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
44685046|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685047|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44685048|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44685049|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
44685051|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
44685052|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685053|NCT02843451|Protective Agents|protective agents|mesh-ancestor
44685054|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685055|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
44685056|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44685057|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44685058|NCT02836925|Ledipasvir|ledipasvir|mesh-list
44685059|NCT02836925|Velpatasvir|velpatasvir|mesh-list
44685060|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
44685061|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685062|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44685063|NCT02752191|Hematinics|hematinics|mesh-ancestor
44685064|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44685065|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44685066|NCT02737046|Interferons|interferons|mesh-list
44685067|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
44685068|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
44685069|NCT02737046|Zidovudine|zidovudine|mesh-list
44685070|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44685071|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44685072|NCT02737046|Belinostat|belinostat|mesh-list
44685073|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685074|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
44685075|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685076|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
44264545|NCT00650910|Lapatinib|lapatinib|mesh-list
44685077|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685078|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
44685079|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685080|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44685081|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685082|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685083|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44685084|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44685085|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44685086|NCT02668653|Cytarabine|cytarabine|mesh-list
44685087|NCT02668653|Daunorubicin|daunorubicin|mesh-list
44685088|NCT02668653|Idarubicin|idarubicin|mesh-list
44685089|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44685090|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
44685091|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685092|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685093|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
44685094|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685095|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685096|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
44685097|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685098|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685099|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44506983|NCT05310305|Antibodies|antibodies|mesh-list
44507060|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
44685100|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685101|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685102|NCT02667587|Nivolumab|nivolumab|mesh-list
44685103|NCT02667587|Temozolomide|temozolomide|mesh-list
44685104|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685105|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685106|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44685107|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685108|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685109|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
44685110|NCT02659384|Aspirin|aspirin|mesh-list
44685111|NCT02659384|Bevacizumab|bevacizumab|mesh-list
44685112|NCT02659384|Atezolizumab|atezolizumab|mesh-list
44685113|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685114|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685115|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44685116|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44685117|NCT02659384|Growth Substances|growth substances|mesh-ancestor
44685118|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685119|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
44685120|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44685121|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44685122|NCT02659384|Analgesics|analgesics|mesh-ancestor
44236425|NCT00559312|Hormones|hormones|mesh-ancestor
44685123|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
44685134|NCT02639273|Nalmefene|nalmefene|mesh-list
44685135|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44685136|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685137|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
44685138|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685139|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
44685140|NCT02623972|Doxorubicin|doxorubicin|mesh-list
44685141|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44685142|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685143|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
44685144|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685145|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685146|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685147|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
44685148|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685149|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685150|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685151|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685152|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685153|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685154|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685155|NCT02598661|Imetelstat|imetelstat|mesh-list
44685156|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
44685157|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462243|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
44685158|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685159|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44685160|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
44685161|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685162|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685163|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
44685164|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685165|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685166|NCT02591615|Paclitaxel|paclitaxel|mesh-list
44685167|NCT02591615|Carboplatin|carboplatin|mesh-list
44685168|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
44685169|NCT02591615|Pemetrexed|pemetrexed|mesh-list
44685170|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685171|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685172|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685173|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685174|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685175|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685176|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685177|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685178|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44685179|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685180|NCT02576444|Olaparib|olaparib|mesh-list
44685181|NCT02576444|Adavosertib|adavosertib|mesh-list
44685182|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44685183|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507296|NCT03219853|Selenium|selenium|mesh-list
44685185|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685186|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
44685187|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44685188|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685189|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685190|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44685191|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44685192|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44685193|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44685194|NCT02461927|Midazolam|midazolam|mesh-list
44685195|NCT02461927|Naltrexone|naltrexone|mesh-list
44685196|NCT02461927|Ketamine|ketamine|mesh-list
44685197|NCT02461927|Analgesics|analgesics|mesh-ancestor
44685198|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
44685199|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685200|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685201|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44685202|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44685203|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
44685204|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
44685205|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685206|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44685207|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44685208|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685241|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685242|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44685243|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685244|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
44685245|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685246|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685247|NCT02422498|Cisplatin|cisplatin|mesh-list
44685248|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236647|NCT00560300|Calcitriol|calcitriol|mesh-list
44685249|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
44685250|NCT02379520|Nivolumab|nivolumab|mesh-list
44685251|NCT02379520|Fludarabine|fludarabine|mesh-list
44685252|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685253|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
44685254|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685255|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685256|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685257|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
44685258|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685259|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685260|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685261|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685262|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44507366|NCT03219671|Nivolumab|nivolumab|mesh-list
44685294|NCT02332850|Hormones|hormones|mesh-ancestor
44685295|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685296|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685297|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685298|NCT02288247|Prednisolone|prednisolone|mesh-list
44685299|NCT02288247|Docetaxel|docetaxel|mesh-list
44685300|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685301|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685302|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685303|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
44507609|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507720|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
44507839|NCT03214627|Iron|iron|mesh-list
44507921|NCT03213977|Hormones|hormones|mesh-ancestor
44685338|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44685339|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
44685340|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685341|NCT02177695|Antiviral Agents|antiviral agents|mesh-ancestor
44685342|NCT02177695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685343|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685344|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685345|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
44685346|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685347|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685348|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685349|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685350|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44685351|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
44685352|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44685353|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685354|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44685355|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685356|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685357|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685358|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685359|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685360|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685361|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
44685362|NCT02158091|Rituximab|rituximab|mesh-list
44685363|NCT02158091|Fludarabine|fludarabine|mesh-list
44685364|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685365|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
44685366|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685367|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685368|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685369|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
44508181|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685370|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685371|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685372|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685373|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685375|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
44685376|NCT02152995|Trametinib|trametinib|mesh-list
44685377|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44685378|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685379|NCT02152995|Trace Elements|trace elements|mesh-ancestor
44685380|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
44685381|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685382|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685383|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44685384|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685385|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685386|NCT02125513|Paclitaxel|paclitaxel|mesh-list
44685387|NCT02125513|Carboplatin|carboplatin|mesh-list
44685388|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685389|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685390|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685391|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685392|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685393|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685394|NCT02120352|Rilpivirine|rilpivirine|mesh-list
44685395|NCT02120352|Cabotegravir|cabotegravir|mesh-list
44685396|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44685397|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685398|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685399|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685400|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
44685401|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685402|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44685403|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44685404|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44685405|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44685406|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
44685407|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44685408|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44685409|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44685410|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264666|NCT00651352|Nicotine|nicotine|mesh-list
44685411|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685412|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
44685413|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685414|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685415|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44685416|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685417|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44508576|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
44685418|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44685419|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685420|NCT02038634|Betamethasone|betamethasone|mesh-list
44685421|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685422|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
44685424|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685425|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685426|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44685427|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44685428|NCT02023905|Everolimus|everolimus|mesh-list
44685429|NCT02023905|Temozolomide|temozolomide|mesh-list
44685430|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685431|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685432|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
44685433|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685434|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685435|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
44685436|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685437|NCT02004522|Ofatumumab|ofatumumab|mesh-list
44264724|NCT00651599|Drospirenone|drospirenone|mesh-list
44685438|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685439|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
44685440|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685441|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44685442|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685443|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685444|NCT01974440|Prednisone|prednisone|mesh-list
44685445|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
44685446|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44685447|NCT01974440|Rituximab|rituximab|mesh-list
44685448|NCT01974440|Doxorubicin|doxorubicin|mesh-list
44685449|NCT01974440|Vincristine|vincristine|mesh-list
44685450|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685451|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
44685452|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685453|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685454|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685455|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
44685456|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685457|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685458|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685459|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685460|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685461|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685462|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685463|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685464|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685465|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
44685466|NCT01974440|Hormones|hormones|mesh-ancestor
44264759|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
44685467|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685468|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685469|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685470|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685471|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685472|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236843|NCT00561223|Iloprost|iloprost|mesh-list
44685473|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
44685474|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44685475|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685476|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685477|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44685478|NCT01973452|Analgesics|analgesics|mesh-ancestor
44685479|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
44685480|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685481|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44685482|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44685483|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264779|NCT00651703|Imiquimod|imiquimod|mesh-list
44685484|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
44685485|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685486|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685487|NCT01969578|Paclitaxel|paclitaxel|mesh-list
44685488|NCT01969578|Cisplatin|cisplatin|mesh-list
44685489|NCT01969578|Carboplatin|carboplatin|mesh-list
44685490|NCT01969578|Doxorubicin|doxorubicin|mesh-list
44685491|NCT01969578|Bicalutamide|bicalutamide|mesh-list
44685492|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44685493|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685494|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685495|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685496|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685497|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685498|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685499|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685500|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685501|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685502|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685503|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
44685504|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685505|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685506|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685507|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
44685508|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44685509|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
44685510|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44685511|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44685512|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685513|NCT01946074|Paclitaxel|paclitaxel|mesh-list
44685514|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44685515|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685516|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
44685517|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
44685518|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
44685519|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685520|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44264808|NCT00651768|Hormones|hormones|mesh-ancestor
44685521|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44685522|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685523|NCT01928199|Incretins|incretins|mesh-ancestor
44685524|NCT01928199|Hormones|hormones|mesh-ancestor
44685525|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685526|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44685527|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
44685528|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685529|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685530|NCT01882816|Doxorubicin|doxorubicin|mesh-list
44685531|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685532|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685533|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685534|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685535|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685536|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685537|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
44685538|NCT01860170|Bortezomib|bortezomib|mesh-list
44685539|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685540|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
44685541|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685542|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685543|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685544|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
44685545|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685546|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685547|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685548|NCT01845441|Fentanyl|fentanyl|mesh-list
44685549|NCT01845441|Midazolam|midazolam|mesh-list
44685550|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
44685551|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44685552|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685553|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685554|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44685555|NCT01845441|Analgesics|analgesics|mesh-ancestor
44685556|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
44685557|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685558|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44685559|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44685560|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44685561|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
44685562|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685563|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685564|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44685566|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44685567|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44685568|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
44685569|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
44685570|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44685571|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44685572|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44685573|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
44685574|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
44685575|NCT01822275|Temozolomide|temozolomide|mesh-list
44685576|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685577|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
44685578|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685579|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685580|NCT01730950|Bevacizumab|bevacizumab|mesh-list
44685581|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44685582|NCT01730950|Antibodies|antibodies|mesh-list
44685583|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
44685584|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44685585|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685586|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44685587|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44685588|NCT01730950|Growth Substances|growth substances|mesh-ancestor
44685589|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685590|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44685591|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
44685592|NCT01659606|Cyclosporine|cyclosporine|mesh-list
44685593|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
44685594|NCT01659606|Fludarabine|fludarabine|mesh-list
44685595|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
44685596|NCT01659606|Tacrolimus|tacrolimus|mesh-list
44685597|NCT01659606|Cyclosporins|cyclosporins|mesh-list
44685598|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685599|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685600|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685601|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
44685602|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685603|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44685604|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685605|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
44685606|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685607|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685608|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685609|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685610|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44685611|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
44685612|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44685613|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685614|NCT01642186|Everolimus|everolimus|mesh-list
44685615|NCT01642186|Letrozole|letrozole|mesh-list
44685616|NCT01642186|Leuprolide|leuprolide|mesh-list
44685617|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685618|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685619|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
44685620|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264897|NCT00652119|Paclitaxel|paclitaxel|mesh-list
44685621|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44685622|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44685623|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685650|NCT01439802|Trace Elements|trace elements|mesh-ancestor
44685651|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
44685652|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685653|NCT01412333|Interferons|interferons|mesh-list
44685654|NCT01412333|Interferon-beta|interferon-beta|mesh-list
44685655|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
44685656|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
44685657|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685658|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
44685659|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685660|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
44685661|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685662|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44685663|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
44685664|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685665|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
44685666|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685667|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685668|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44685669|NCT01342952|Ambrisentan|ambrisentan|mesh-list
44685670|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44685671|NCT01341080|Varenicline|varenicline|mesh-list
44685672|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44685673|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44685674|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
44685675|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685676|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685677|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685678|NCT01339689|Ganaxolone|ganaxolone|mesh-list
44685679|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
44685680|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264941|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685681|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685682|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685683|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
44685684|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
44685685|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44685686|NCT01336803|Hematinics|hematinics|mesh-ancestor
44685687|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44685688|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44685689|NCT01297764|Dexamethasone|dexamethasone|mesh-list
44685690|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
44685691|NCT01297764|Lenalidomide|lenalidomide|mesh-list
44685692|NCT01297764|Vorinostat|vorinostat|mesh-list
44685693|NCT01297764|BB 1101|bb 1101|mesh-list
44685694|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685695|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
44685696|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
44685697|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685698|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685699|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44685700|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
44685701|NCT01297764|Hormones|hormones|mesh-ancestor
44685702|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685703|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685704|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685705|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
44685706|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685707|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685708|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
44685709|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44685710|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44685711|NCT01297764|Growth Substances|growth substances|mesh-ancestor
44685712|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
44685713|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44685714|NCT01241708|Bortezomib|bortezomib|mesh-list
44264979|NCT00652392|Hormones|hormones|mesh-ancestor
44685715|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685716|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
44685717|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
44685718|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685719|NCT01130519|Bevacizumab|bevacizumab|mesh-list
44685720|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44685721|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685722|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685723|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44685724|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44685725|NCT01130519|Growth Substances|growth substances|mesh-ancestor
44685726|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685727|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
44685728|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44685729|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685730|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685731|NCT01112306|Selexipag|selexipag|mesh-list
44685732|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44685733|NCT01071395|Amantadine|amantadine|mesh-list
44685734|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44509865|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509866|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44509867|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509868|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509869|NCT01839955|Quinacrine|quinacrine|mesh-list
44509870|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44509871|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509872|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509873|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509891|NCT01839981|Vitamins|vitamins|mesh-ancestor
44685735|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44685736|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
44685737|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685738|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
44685739|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685740|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685741|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685742|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44685743|NCT01071395|Analgesics|analgesics|mesh-ancestor
44685744|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
44685745|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685746|NCT00936390|Leuprolide|leuprolide|mesh-list
44685747|NCT00936390|Goserelin|goserelin|mesh-list
44685748|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44685749|NCT00936390|Flutamide|flutamide|mesh-list
44685750|NCT00936390|Bicalutamide|bicalutamide|mesh-list
44685751|NCT00936390|Buserelin|buserelin|mesh-list
44685752|NCT00936390|Androgens|androgens|mesh-list
44685753|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
44685754|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44685755|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
44510199|NCT01721694|Azithromycin|azithromycin|mesh-list
44510200|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510201|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510202|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44510203|NCT01721707|Latanoprost|latanoprost|mesh-list
44510204|NCT01721707|Brinzolamide|brinzolamide|mesh-list
44510205|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44510206|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44510207|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44510208|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510209|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510210|NCT01721798|Copper|copper|mesh-list
44510211|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
44510212|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44510213|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
44510214|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510215|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510216|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44510219|NCT01721798|Trace Elements|trace elements|mesh-ancestor
44510327|NCT01722539|Albendazole|albendazole|mesh-list
44685756|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44685757|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685758|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685759|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685760|NCT00936390|Hormones|hormones|mesh-ancestor
44685761|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685762|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685763|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
44685764|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44685765|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
44685766|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44685767|NCT00908076|Lubiprostone|lubiprostone|mesh-list
44685768|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44685769|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44685770|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685771|NCT00904046|Pioglitazone|pioglitazone|mesh-list
44685772|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44685773|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44685774|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685775|NCT00849667|Carboplatin|carboplatin|mesh-list
44685776|NCT00849667|Taxane|taxane|mesh-list
44685777|NCT00849667|Farletuzumab|farletuzumab|mesh-list
44685778|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685779|NCT00840177|Cytarabine|cytarabine|mesh-list
44685780|NCT00840177|Idarubicin|idarubicin|mesh-list
44685781|NCT00840177|Pravastatin|pravastatin|mesh-list
44685782|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44685783|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
44685784|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685785|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685786|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
44685787|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685788|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685789|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
44685790|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685791|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685792|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685793|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685794|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685795|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44685796|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44685797|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44685798|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44237152|NCT00562835|Hormones|hormones|mesh-ancestor
44685799|NCT00719888|Cyclosporine|cyclosporine|mesh-list
44685800|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
44685801|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
44685802|NCT00719888|Thiotepa|thiotepa|mesh-list
44685803|NCT00719888|Fludarabine|fludarabine|mesh-list
44510402|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44510427|NCT01723371|Carvedilol|carvedilol|mesh-list
44510503|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
44510504|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510505|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44510506|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44510507|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
44510508|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510509|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510510|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44685804|NCT00719888|Cyclosporins|cyclosporins|mesh-list
44685805|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685806|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
44685807|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685808|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685809|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685810|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
44685811|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685812|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685813|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685814|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685815|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
44685816|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685817|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685818|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44685819|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685820|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44685821|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
44685822|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44685823|NCT00533468|Lidocaine|lidocaine|mesh-list
44685824|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
44685825|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
44685826|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685827|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685828|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
44685829|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685830|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44685831|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44685832|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44510716|NCT01725204|Dasatinib|dasatinib|mesh-list
44510791|NCT01725620|Analgesics|analgesics|mesh-ancestor
44510792|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
44510793|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510794|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510795|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510796|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44510797|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510798|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44510799|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
44510800|NCT01725672|Metformin|metformin|mesh-list
44510801|NCT01725672|Glimepiride|glimepiride|mesh-list
44685833|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510907|NCT01726465|Expectorants|expectorants|mesh-ancestor
44510987|NCT01727271|Tenofovir|tenofovir|mesh-list
44511076|NCT01728272|Metoprolol|metoprolol|mesh-list
44685834|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685835|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
44685836|NCT00423514|Melphalan|melphalan|mesh-list
44685837|NCT00423514|Thiotepa|thiotepa|mesh-list
44685838|NCT00423514|Clofarabine|clofarabine|mesh-list
44685839|NCT00423514|Tacrolimus|tacrolimus|mesh-list
44685840|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44685841|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
44685842|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685843|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44685844|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685845|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685846|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44685847|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685848|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44685849|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
44685850|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44685851|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685852|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44685853|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
44685854|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44685855|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44685856|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
44685857|NCT00364637|Anesthetics|anesthetics|mesh-list
44685858|NCT00364637|Sevoflurane|sevoflurane|mesh-list
44685859|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685860|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685861|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44685862|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44511135|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
44685863|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
44511415|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44511485|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511486|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511487|NCT01048944|Bupropion|bupropion|mesh-list
44511488|NCT01048944|Nicotine|nicotine|mesh-list
44511489|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44511490|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
44511491|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511492|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511493|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44511494|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44685865|NCT00120952|Chromium|chromium|mesh-list
44685866|NCT00120952|Trace Elements|trace elements|mesh-ancestor
44685867|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
44685868|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685869|NCT00004124|Prednisone|prednisone|mesh-list
44685870|NCT00004124|Goserelin|goserelin|mesh-list
44685871|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
44685872|NCT00004124|Bicalutamide|bicalutamide|mesh-list
44685873|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685874|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
44685875|NCT00004124|Hormones|hormones|mesh-ancestor
44685876|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685877|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685878|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44685879|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685880|NCT00004124|Analgesics|analgesics|mesh-ancestor
44685881|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
44685882|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685883|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44685884|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44685885|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685886|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685887|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
44685888|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685889|NCT01329809|Molgramostim|molgramostim|mesh-list
44685890|NCT01329809|Sargramostim|sargramostim|mesh-list
44685891|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
44685892|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685893|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685894|NCT01329887|Ketanserin|ketanserin|mesh-list
44685895|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44685896|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44685897|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44685898|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
44685899|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685900|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685901|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685902|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
44685903|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685904|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
44685905|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44685906|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685907|NCT01330472|Alprazolam|alprazolam|mesh-list
44685908|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44685909|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44685910|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685911|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44685912|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44685913|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44685914|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
44685915|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
44685916|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44685917|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685918|NCT01330524|Triamcinolone|triamcinolone|mesh-list
44685919|NCT01330524|Bevacizumab|bevacizumab|mesh-list
44685920|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44685921|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685922|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44685923|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44685924|NCT01330524|Growth Substances|growth substances|mesh-ancestor
44511755|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511756|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511757|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511758|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
44511759|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44511760|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511761|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44511762|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
44685925|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685926|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44685927|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685928|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
44685929|NCT01330524|Hormones|hormones|mesh-ancestor
44685930|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685931|NCT01330563|Ketoconazole|ketoconazole|mesh-list
44685932|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
44685933|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44685934|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43658805|NCT02942732|Vitamin D|vitamin d|mesh-list
44685935|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44685936|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685937|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685938|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44685939|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
44685940|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44685941|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685942|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44685943|NCT01330615|Lidocaine|lidocaine|mesh-list
44685944|NCT01330615|Prilocaine|prilocaine|mesh-list
44685945|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44685946|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
44685947|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
44685948|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512129|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512130|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512131|NCT03401320|Letrozole|letrozole|mesh-list
44512132|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512133|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44685949|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685950|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
44685951|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237312|NCT00563446|Hematinics|hematinics|mesh-ancestor
44685983|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44685984|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44685985|NCT01330810|Analgesics|analgesics|mesh-ancestor
44685986|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
44685987|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44685988|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44685989|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44685990|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44685991|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44685992|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44685993|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44685994|NCT01330901|Ustekinumab|ustekinumab|mesh-list
44685995|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44685996|NCT01331122|Droxidopa|droxidopa|mesh-list
44685997|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44685998|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44685999|NCT01331135|Sirolimus|sirolimus|mesh-list
44686000|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686001|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686002|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44686003|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686004|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
44686005|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686006|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
44686007|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686008|NCT01331382|Resveratrol|resveratrol|mesh-list
44686009|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
44686010|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686011|NCT01331382|Protective Agents|protective agents|mesh-ancestor
44686012|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686013|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686014|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44686015|NCT01331421|Exemestane|exemestane|mesh-list
44686016|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686017|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44686018|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44686019|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686020|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686021|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44265307|NCT00653458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44686022|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686023|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686024|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686025|NCT01331434|Exemestane|exemestane|mesh-list
44686026|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686027|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44686028|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44686029|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686030|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686031|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44686032|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686033|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686034|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686035|NCT01331447|Exemestane|exemestane|mesh-list
44686036|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686037|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44686038|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44686039|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686040|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686041|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44512259|NCT03407703|Grazoprevir|grazoprevir|mesh-list
44512335|NCT03406793|Iron|iron|mesh-list
44686042|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686043|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686044|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686045|NCT01331525|Ipilimumab|ipilimumab|mesh-list
44686046|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512558|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
44512559|NCT03404635|Apixaban|apixaban|mesh-list
44512560|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44512561|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
44512562|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44512563|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
44512564|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512565|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512566|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
44512567|NCT03404479|Celecoxib|celecoxib|mesh-list
44512568|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
44512569|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44512570|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512571|NCT03404479|Analgesics|analgesics|mesh-ancestor
44686047|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686048|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44686049|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686050|NCT01331590|Dexamethasone|dexamethasone|mesh-list
44686051|NCT01331590|Etoposide|etoposide|mesh-list
44686052|NCT01331590|Ifosfamide|ifosfamide|mesh-list
44686053|NCT01331590|Lenograstim|lenograstim|mesh-list
44686054|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686055|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
44686056|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
44686057|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686058|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686059|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44686060|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
44686061|NCT01331590|Hormones|hormones|mesh-ancestor
44686062|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686063|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44686064|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686065|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686066|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44686067|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44686068|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686069|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686070|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44686071|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
44686072|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44686073|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
44686074|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
44686075|NCT01331655|Drospirenone|drospirenone|mesh-list
44686076|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44105122|NCT00071266|Lovastatin|lovastatin|mesh-list
44686077|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686078|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686079|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686080|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44686081|NCT01331655|Diuretics|diuretics|mesh-ancestor
44686082|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44686083|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
44686084|NCT01331655|Vitamins|vitamins|mesh-ancestor
44686085|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
44686086|NCT01331707|Everolimus|everolimus|mesh-list
44686087|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686088|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686089|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
44686090|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686091|NCT01331785|Midodrine|midodrine|mesh-list
44686092|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
44686093|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
44686094|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686095|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686096|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44686097|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44686098|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44686099|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686100|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512712|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
44512714|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512715|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512716|NCT03402698|Vitamins|vitamins|mesh-ancestor
44512717|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
44512718|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44512719|NCT03402438|Fulacimstat|fulacimstat|mesh-list
44512723|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
44512900|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
44512901|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512902|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44512903|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44512904|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
44512905|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
44512906|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512907|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44512908|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512909|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512910|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
44512911|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
44512912|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512913|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512914|NCT03401541|Vitamin D|vitamin d|mesh-list
44512960|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686101|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686102|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686104|NCT01331902|Adenosine|adenosine|mesh-list
44686105|NCT01331902|Analgesics|analgesics|mesh-ancestor
44686106|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
44686107|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686108|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686109|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44686110|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
44686111|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44686112|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
44686113|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
44686114|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686115|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686116|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44686117|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
44686118|NCT01331902|Vitamins|vitamins|mesh-ancestor
44686119|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
44686120|NCT01331928|Docetaxel|docetaxel|mesh-list
44686121|NCT01331928|Capecitabine|capecitabine|mesh-list
44686122|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
44265449|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686123|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686124|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686125|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686126|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686127|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686128|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686129|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
44686130|NCT01331941|Paclitaxel|paclitaxel|mesh-list
44686131|NCT01331941|Trebananib|trebananib|mesh-list
44686132|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686133|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686134|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686135|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686136|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686137|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686138|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44686139|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44686140|NCT01331941|Growth Substances|growth substances|mesh-ancestor
44686141|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686142|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
44265483|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
44686143|NCT01331967|Pioglitazone|pioglitazone|mesh-list
44686144|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686145|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686146|NCT01331993|Naproxen|naproxen|mesh-list
44686147|NCT01331993|Esomeprazole|esomeprazole|mesh-list
44686148|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44686149|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44686150|NCT01331993|Analgesics|analgesics|mesh-ancestor
44686151|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
44686152|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686153|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686154|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686155|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686156|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
44686157|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44686158|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686159|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686160|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44686161|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44686162|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44686163|NCT01332097|Prednisone|prednisone|mesh-list
44686164|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686165|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
44686166|NCT01332097|Hormones|hormones|mesh-ancestor
44686167|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686168|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265484|NCT00654173|Atorvastatin|atorvastatin|mesh-list
44686169|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44686170|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686171|NCT01332201|Tacrolimus|tacrolimus|mesh-list
44686172|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686173|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
44513035|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513114|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44513115|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
44513116|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513117|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513118|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44513119|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
44513120|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44513121|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44513122|NCT03408574|Mecamylamine|mecamylamine|mesh-list
44513123|NCT03408574|Nicotine|nicotine|mesh-list
44513124|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44513125|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
44513126|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513127|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513128|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44513129|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44513130|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513304|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686174|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686175|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44686176|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686177|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686178|NCT01332279|Everolimus|everolimus|mesh-list
44686179|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44686180|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686181|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513377|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513378|NCT02240459|Urological Agents|urological agents|mesh-ancestor
44513379|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
44513380|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
44513381|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686182|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
44513467|NCT02241174|Eusol|eusol|mesh-list
44513607|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513608|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513609|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
44513610|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513611|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513612|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
44513613|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44513614|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513615|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
44513616|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513617|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513618|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513619|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686183|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686184|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44686185|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686186|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686187|NCT01332344|Fluticasone|fluticasone|mesh-list
44686188|NCT01332344|Xhance|xhance|mesh-list
44686189|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44686190|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686191|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44686192|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
44686193|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686194|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686195|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44686196|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686197|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
44686198|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44686199|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44686200|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44686201|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686202|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265540|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44686203|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686204|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686205|NCT01332370|Metformin|metformin|mesh-list
44686206|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44686207|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
44686208|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686209|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686210|NCT01332370|Incretins|incretins|mesh-ancestor
44686211|NCT01332370|Hormones|hormones|mesh-ancestor
44686212|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686213|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44686214|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44686215|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686216|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686217|NCT01332383|Naratriptan|naratriptan|mesh-list
44686218|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44686219|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44686220|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44686221|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
44686222|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686223|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686224|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686225|NCT01332396|Lapatinib|lapatinib|mesh-list
44686226|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686227|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44686228|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686229|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686230|NCT01332409|Fluticasone|fluticasone|mesh-list
44513750|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
44513751|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513752|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513753|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
44513754|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513755|NCT02242656|Opium|opium|mesh-list
44513756|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44513757|NCT02242656|Narcotics|narcotics|mesh-ancestor
44513758|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513817|NCT02242864|Telmisartan|telmisartan|mesh-list
44514043|NCT02243800|Vitamin D|vitamin d|mesh-list
44686231|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44265601|NCT00654537|Atorvastatin|atorvastatin|mesh-list
44686232|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44686233|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686234|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44686235|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
44686236|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686237|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686238|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44686239|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686240|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44686241|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44686242|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44686243|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44686244|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686245|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
44686246|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686247|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686248|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
44686249|NCT01332409|Hormones|hormones|mesh-ancestor
44686250|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686251|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
44686252|NCT01332422|Fluticasone|fluticasone|mesh-list
44686253|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44686254|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44686255|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686256|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44686257|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
44686258|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686259|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686260|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44686261|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686262|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
44686263|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44686264|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44686265|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44686266|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686267|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
44686268|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265629|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
44686269|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686270|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
44686271|NCT01332422|Hormones|hormones|mesh-ancestor
44686272|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686273|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
44686274|NCT01332448|Orlistat|orlistat|mesh-list
44686275|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686276|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686277|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44686278|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44237672|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
44686313|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
44686314|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44686315|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44686316|NCT01332617|Prednisolone|prednisolone|mesh-list
44686317|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
44686318|NCT01332617|Diclofenac|diclofenac|mesh-list
44686319|NCT01332617|Bortezomib|bortezomib|mesh-list
44686320|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44686321|NCT01332617|Simvastatin|simvastatin|mesh-list
44686322|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44686323|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
44265667|NCT00654758|Paclitaxel|paclitaxel|mesh-list
44686324|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686325|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514207|NCT02244437|Acetaminophen|acetaminophen|mesh-list
44514208|NCT02244437|Ibuprofen|ibuprofen|mesh-list
44514209|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44514210|NCT02244437|Analgesics|analgesics|mesh-ancestor
44514211|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
44514212|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462319|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44514213|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514214|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
44514215|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44514216|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514217|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44514218|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44514219|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514220|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514221|NCT02244489|Capecitabine|capecitabine|mesh-list
44514222|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
44514223|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44514224|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514225|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
44514226|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462335|NCT01531998|Hormones|hormones|mesh-ancestor
44514248|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686326|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
44686327|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
44686328|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686329|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686330|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44686331|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
44686332|NCT01332617|Hormones|hormones|mesh-ancestor
44686333|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686334|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44686335|NCT01332617|Protective Agents|protective agents|mesh-ancestor
44686336|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44686337|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44686338|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44686339|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
44686340|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686341|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44686342|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44686343|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686344|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44686345|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44686346|NCT01332617|Analgesics|analgesics|mesh-ancestor
44686347|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
44686348|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686349|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44686350|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44686351|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
44686352|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44686353|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
44686354|NCT01332734|Analgesics|analgesics|mesh-ancestor
44686355|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
44686356|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686357|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686358|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
44686359|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686360|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44686361|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
44686362|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44686363|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44686364|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686365|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44686366|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
44686367|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44686368|NCT01332747|Atorvastatin|atorvastatin|mesh-list
44686369|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44686370|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44686371|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
44265690|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686372|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686373|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44686374|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44686375|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686376|NCT01332786|Tigecycline|tigecycline|mesh-list
44686377|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686378|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686379|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44686380|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686381|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514560|NCT02246595|Vilobelimab|vilobelimab|mesh-list
44514561|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44514562|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514563|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
44514564|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514565|NCT02246712|Tramadol|tramadol|mesh-list
44514566|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44514567|NCT02246712|Narcotics|narcotics|mesh-ancestor
44514568|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514613|NCT02247258|Azathioprine|azathioprine|mesh-list
44686382|NCT01332929|Bevacizumab|bevacizumab|mesh-list
44686383|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44686384|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686385|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44686386|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44686387|NCT01332929|Growth Substances|growth substances|mesh-ancestor
44686388|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686389|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
44686390|NCT01332955|Ribavirin|ribavirin|mesh-list
44686391|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44686392|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
44686393|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686394|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
44686395|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686396|NCT01333085|Paclitaxel|paclitaxel|mesh-list
44686397|NCT01333085|Carboplatin|carboplatin|mesh-list
44686398|NCT01333085|Everolimus|everolimus|mesh-list
44686399|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686400|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686401|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686402|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686403|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686404|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686405|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686406|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
44686407|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686408|NCT01333124|Gemcitabine|gemcitabine|mesh-list
44686409|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686410|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
44686411|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686412|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686413|NCT01333124|Antiviral Agents|antiviral agents|mesh-ancestor
44686414|NCT01333124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686415|NCT01333124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686416|NCT01333124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686417|NCT01333124|Immunologic Factors|immunologic factors|mesh-ancestor
44686418|NCT01333124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686419|NCT01333137|Gemcitabine|gemcitabine|mesh-list
44686420|NCT01333137|Carboplatin|carboplatin|mesh-list
44686421|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514840|NCT02248428|Clarithromycin|clarithromycin|mesh-list
44514947|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44514948|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514949|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44514950|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44514951|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44514952|NCT02248792|Methotrexate|methotrexate|mesh-list
44514953|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44514954|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
44514955|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43608686|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
43611365|NCT03172533|Estradiol|estradiol|mesh-list
44737735|NCT03187769|Olanzapine|olanzapine|mesh-list
44737736|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
44737737|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
44737738|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737739|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737740|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44737741|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44737742|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44737743|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44737744|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44737745|NCT03187769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44737746|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44737747|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44737748|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737749|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737750|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
44737751|NCT03164616|Gemcitabine|gemcitabine|mesh-list
44737752|NCT03164616|Cisplatin|cisplatin|mesh-list
44737753|NCT03164616|Carboplatin|carboplatin|mesh-list
44737754|NCT03164616|Pemetrexed|pemetrexed|mesh-list
44737755|NCT03164616|Durvalumab|durvalumab|mesh-list
44737756|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44737757|NCT03164616|Tremelimumab|tremelimumab|mesh-list
44737758|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737759|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737760|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
44737761|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265791|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
44737762|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
44737763|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737764|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737765|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737766|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
44737767|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737768|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44737769|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737770|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737771|NCT03161353|Tamoxifen|tamoxifen|mesh-list
44737772|NCT03161353|Carboplatin|carboplatin|mesh-list
44737773|NCT03161353|Docetaxel|docetaxel|mesh-list
44737774|NCT03161353|Trastuzumab|trastuzumab|mesh-list
44737775|NCT03161353|Letrozole|letrozole|mesh-list
44737776|NCT03161353|Pertuzumab|pertuzumab|mesh-list
44737777|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737778|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737779|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737780|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737781|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737782|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737783|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44737784|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44737785|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737786|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44737787|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
44737788|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737789|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737790|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44737791|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44737792|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44737793|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44737794|NCT03136731|Antibodies|antibodies|mesh-list
44737795|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
44737796|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737797|NCT03134196|Valacyclovir|valacyclovir|mesh-list
44737798|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
44737799|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737800|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
44737801|NCT03092518|Cisplatin|cisplatin|mesh-list
44737802|NCT03092518|Mitomycins|mitomycins|mesh-list
44737803|NCT03092518|Mitomycin|mitomycin|mesh-list
44737804|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737805|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737806|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
44737807|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514979|NCT02248870|Dexamethasone|dexamethasone|mesh-list
44737808|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737809|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737810|NCT03092518|Antidotes|antidotes|mesh-ancestor
44737811|NCT03092518|Protective Agents|protective agents|mesh-ancestor
44737812|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737813|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
44737814|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
44737815|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44737816|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737817|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
44737818|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
44737819|NCT02956382|Venetoclax|venetoclax|mesh-list
44737820|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737821|NCT02939573|Dapsone|dapsone|mesh-list
44737822|NCT02939573|Colchicine|colchicine|mesh-list
44737823|NCT02939573|Azathioprine|azathioprine|mesh-list
44737824|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
44737825|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737826|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737827|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737828|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737829|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737830|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737831|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
44737832|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737833|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737834|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
44737835|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737836|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737837|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
44737838|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44737839|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44737840|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44106052|NCT00074438|Rituximab|rituximab|mesh-list
44737841|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737842|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
44737843|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44737844|NCT02894398|Letrozole|letrozole|mesh-list
44737845|NCT02894398|Fulvestrant|fulvestrant|mesh-list
44737846|NCT02894398|Palbociclib|palbociclib|mesh-list
44737847|NCT02894398|Anastrozole|anastrozole|mesh-list
44737848|NCT02894398|Exemestane|exemestane|mesh-list
44737849|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737850|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44737851|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44737852|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737853|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737854|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44737855|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
44737856|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737857|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737858|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265899|NCT00655837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737859|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44737860|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737861|NCT02891603|Sirolimus|sirolimus|mesh-list
44737862|NCT02891603|Tacrolimus|tacrolimus|mesh-list
44737863|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737864|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
44737865|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737866|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44737867|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737868|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737869|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44737870|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737871|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737872|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737873|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
44737874|NCT02876107|Paclitaxel|paclitaxel|mesh-list
44737875|NCT02876107|Carboplatin|carboplatin|mesh-list
44737876|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44737877|NCT02876107|Panitumumab|panitumumab|mesh-list
44265900|NCT00655915|Betamethasone|betamethasone|mesh-list
44737878|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44737879|NCT02876107|Antibodies|antibodies|mesh-list
44737880|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
44737881|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737882|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737883|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737884|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737885|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515029|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
44737886|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737887|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737888|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
44737889|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737890|NCT02855229|Methylphenidate|methylphenidate|mesh-list
44737891|NCT02855229|Modafinil|modafinil|mesh-list
44737892|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44737893|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737894|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44737895|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44737896|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44737897|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737898|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
44737899|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737900|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44737901|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44737902|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44737903|NCT02829931|Bevacizumab|bevacizumab|mesh-list
44737904|NCT02829931|Nivolumab|nivolumab|mesh-list
44737905|NCT02829931|Ipilimumab|ipilimumab|mesh-list
44737906|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737907|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737908|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44737909|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44737910|NCT02829931|Growth Substances|growth substances|mesh-ancestor
44737911|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737912|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44737913|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44737914|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737915|NCT02815566|Tenofovir|tenofovir|mesh-list
44737916|NCT02815566|Emtricitabine|emtricitabine|mesh-list
44737917|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
44737918|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737919|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44737920|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737921|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737922|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737923|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44737924|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44737925|NCT02769962|Olaparib|olaparib|mesh-list
44737926|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44737927|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737928|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737929|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737930|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
44737931|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737932|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
44737933|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737934|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737935|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737936|NCT02743806|Vedolizumab|vedolizumab|mesh-list
44737937|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44737938|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
44737939|NCT02727803|Melphalan|melphalan|mesh-list
44737940|NCT02727803|Busulfan|busulfan|mesh-list
44737941|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
44737942|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44737943|NCT02727803|Rituximab|rituximab|mesh-list
44737944|NCT02727803|Fludarabine|fludarabine|mesh-list
44737945|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
44737946|NCT02727803|Clofarabine|clofarabine|mesh-list
44737947|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44737948|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44737949|NCT02727803|Antibodies|antibodies|mesh-list
44737950|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
44737951|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737952|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737953|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
44737954|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737955|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737956|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737957|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
44737958|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737959|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265989|NCT00656214|Protective Agents|protective agents|mesh-ancestor
44737960|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737961|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686422|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737962|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
44737964|NCT02702492|Nivolumab|nivolumab|mesh-list
44737965|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737966|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737967|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44737968|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737969|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44737970|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
44737971|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44737972|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
44737973|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
44737974|NCT02702492|Vitamins|vitamins|mesh-ancestor
44737975|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
44737976|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737977|NCT02652455|Aldesleukin|aldesleukin|mesh-list
44737978|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
44737979|NCT02652455|Nivolumab|nivolumab|mesh-list
44737980|NCT02652455|Fludarabine|fludarabine|mesh-list
44737981|NCT02652455|Interleukin-2|interleukin-2|mesh-list
44737982|NCT02652455|Antibodies|antibodies|mesh-list
44737983|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
44737984|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
44737985|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737986|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
44737987|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737988|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737989|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737990|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
44737991|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737992|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266011|NCT00656331|Amlodipine|amlodipine|mesh-list
44737993|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737994|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737995|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44737996|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44737997|NCT02652455|Analgesics|analgesics|mesh-ancestor
44737998|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
44737999|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738000|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44738001|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44738002|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
44738003|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738004|NCT02578680|Folic Acid|folic acid|mesh-list
44738005|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
44738006|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
44738007|NCT02578680|Dexamethasone|dexamethasone|mesh-list
44738008|NCT02578680|Carboplatin|carboplatin|mesh-list
44738009|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
44738010|NCT02578680|Pemetrexed|pemetrexed|mesh-list
44738011|NCT02578680|Vitamins|vitamins|mesh-ancestor
44738012|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
44738013|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738014|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738015|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
44738016|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
44738017|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738018|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738019|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
44738020|NCT02578680|Hormones|hormones|mesh-ancestor
44738021|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738022|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738023|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738024|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738025|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738026|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738027|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44738028|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44738029|NCT02578680|Hematinics|hematinics|mesh-ancestor
44738030|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
44738031|NCT02562235|Riociguat|riociguat|mesh-list
44738032|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
44738033|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738034|NCT02520791|Antibodies|antibodies|mesh-list
44686423|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
44738035|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44738036|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
44738037|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738038|NCT02491983|Letrozole|letrozole|mesh-list
44738039|NCT02491983|Fulvestrant|fulvestrant|mesh-list
44738040|NCT02491983|Palbociclib|palbociclib|mesh-list
44738041|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266058|NCT00656591|Methotrexate|methotrexate|mesh-list
44738042|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44738043|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44738044|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738045|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738046|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44738047|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
44515252|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515253|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738048|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738049|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738050|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738051|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44738052|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738053|NCT02467478|Linagliptin|linagliptin|mesh-list
44738054|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738055|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738056|NCT02467478|Incretins|incretins|mesh-ancestor
44738057|NCT02467478|Hormones|hormones|mesh-ancestor
44738058|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738059|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44738060|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
44738061|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738062|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738063|NCT02466243|Lenabasum|lenabasum|mesh-list
44738064|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44738065|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44738066|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738067|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738068|NCT02466243|Hormones|hormones|mesh-ancestor
44738069|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738070|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738071|NCT02386800|Panobinostat|panobinostat|mesh-list
44738072|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738073|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44738074|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738075|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738076|NCT02321098|Amorolfine|amorolfine|mesh-list
44738077|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
44738078|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738079|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
44738080|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738081|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44738082|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
44738083|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44738084|NCT02185417|Diuretics|diuretics|mesh-ancestor
44738085|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
44738086|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738087|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44462372|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
44738088|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738089|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738090|NCT02158234|Cisplatin|cisplatin|mesh-list
44738091|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
44738092|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738093|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738094|NCT02123758|Prednisone|prednisone|mesh-list
44738095|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
44515254|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44515255|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44515256|NCT02245308|Bupropion|bupropion|mesh-list
44515257|NCT02245308|Nicotine|nicotine|mesh-list
44515258|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44515259|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
44515260|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515261|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515262|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44515263|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44515264|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
44515265|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515269|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738096|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738097|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
44738098|NCT02123758|Hormones|hormones|mesh-ancestor
44738099|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738100|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738101|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738102|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738103|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44738104|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738105|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738106|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
44462384|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738107|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44738108|NCT02043678|Prednisone|prednisone|mesh-list
44738109|NCT02043678|Prednisolone|prednisolone|mesh-list
44738110|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44738111|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738112|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
44738113|NCT02043678|Hormones|hormones|mesh-ancestor
44738114|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738115|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738116|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738117|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738118|NCT02035787|Metformin|metformin|mesh-list
44738119|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738120|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738121|NCT02019641|beta-Aminoethyl Isothiourea|beta-aminoethyl isothiourea|mesh-list
44738122|NCT02019641|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44738123|NCT02019641|Protective Agents|protective agents|mesh-ancestor
44738124|NCT02019641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738125|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
44738126|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738127|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
44738128|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738129|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738130|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44738131|NCT01953926|Trastuzumab|trastuzumab|mesh-list
44738132|NCT01953926|Fulvestrant|fulvestrant|mesh-list
44738133|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738134|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738135|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462431|NCT01529346|Ibuprofen|ibuprofen|mesh-list
44738136|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44738137|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44738138|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
44738139|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738140|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738141|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44738142|NCT01859026|Mitogens|mitogens|mesh-list
44738143|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738144|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738145|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738146|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738147|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44738148|NCT01843374|Tremelimumab|tremelimumab|mesh-list
44738149|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738150|NCT01657591|Vemurafenib|vemurafenib|mesh-list
44738151|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738152|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462434|NCT01529346|Analgesics|analgesics|mesh-ancestor
44738153|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738154|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738155|NCT01517100|Dronabinol|dronabinol|mesh-list
44738156|NCT01517100|Nabilone|nabilone|mesh-list
44738157|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
44738158|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
44738159|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738160|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738161|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738162|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44738163|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44738164|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738165|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738166|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
44738167|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44686424|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686425|NCT01333137|Antiviral Agents|antiviral agents|mesh-ancestor
44515280|NCT02242409|Gemcitabine|gemcitabine|mesh-list
44738168|NCT01517100|Analgesics|analgesics|mesh-ancestor
44738169|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
44738170|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44738171|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44738172|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738173|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738174|NCT01517100|Hormones|hormones|mesh-ancestor
44738175|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738176|NCT00967785|Plerixafor|plerixafor|mesh-list
44738177|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44738178|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44738179|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
44738180|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738181|NCT00565851|Gemcitabine|gemcitabine|mesh-list
44738182|NCT00565851|Paclitaxel|paclitaxel|mesh-list
44738183|NCT00565851|Docetaxel|docetaxel|mesh-list
44738184|NCT00565851|Bevacizumab|bevacizumab|mesh-list
44738185|NCT00565851|Carboplatin|carboplatin|mesh-list
44738186|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44738187|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44738188|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
44738189|NCT00565851|Antibodies|antibodies|mesh-list
44738190|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
44738191|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44738192|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
44738193|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266167|NCT00657059|Prednisone|prednisone|mesh-list
44738194|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738195|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
44738196|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
44738197|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
44738198|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738199|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44738200|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44738201|NCT00565851|Growth Substances|growth substances|mesh-ancestor
44738202|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738203|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44738204|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
44266183|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266184|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
44738205|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44738206|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
44738207|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
44738208|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738209|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738210|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738211|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44738212|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44738213|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738214|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
44738215|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44738216|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44738217|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738218|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
44738219|NCT01599468|Coagulants|coagulants|mesh-ancestor
44738220|NCT01599572|Zinc|zinc|mesh-list
44738221|NCT01599572|Trace Elements|trace elements|mesh-ancestor
44738222|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
44738223|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738224|NCT01599598|Imidacloprid|imidacloprid|mesh-list
44738225|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
44738226|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738227|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738228|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266205|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738229|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44738230|NCT01599702|Hematinics|hematinics|mesh-ancestor
44738231|NCT01599728|Substance P|substance p|mesh-list
44738232|NCT01599728|Neurokinin A|neurokinin a|mesh-list
44738233|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738234|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738235|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738236|NCT01599819|Factor VIII|factor viii|mesh-list
44738237|NCT01599819|BAX 855|bax 855|mesh-list
44738238|NCT01599819|Coagulants|coagulants|mesh-ancestor
44738239|NCT01599858|Omeprazole|omeprazole|mesh-list
44738240|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44738241|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738242|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44738243|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738244|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738245|NCT01599871|Theophylline|theophylline|mesh-list
44738246|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44738247|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
44738248|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738249|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738250|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44738251|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738252|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44738253|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738254|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738255|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738256|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44738257|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44738258|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
44738259|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738260|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
44738261|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44738262|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
44738263|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738264|NCT01599884|Expectorants|expectorants|mesh-ancestor
44738265|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738266|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44738267|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
44738268|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738269|NCT01599884|Protective Agents|protective agents|mesh-ancestor
44738270|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738271|NCT01599884|Antidotes|antidotes|mesh-ancestor
44738272|NCT01599923|Antivenins|antivenins|mesh-list
44738273|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
44738274|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738275|NCT01599936|Antivenins|antivenins|mesh-list
44738276|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
44738277|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738278|NCT01599962|Cinacalcet|cinacalcet|mesh-list
44738279|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44738280|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738281|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44738282|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
44738283|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738284|NCT01599975|Methylphenidate|methylphenidate|mesh-list
44738285|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44738286|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738287|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44738288|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44738289|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738290|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738291|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
44738292|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738293|NCT01599988|Caseins|caseins|mesh-list
44738294|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
44738295|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
44266267|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266285|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738296|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738297|NCT01600430|Vitamin D|vitamin d|mesh-list
44738298|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
44738299|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
44738300|NCT01600430|Vitamins|vitamins|mesh-list
44738301|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
44738302|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738303|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44738304|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44738305|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
44738306|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44738307|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44738308|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738309|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
44266286|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266299|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44738310|NCT01600599|Coagulants|coagulants|mesh-ancestor
44738311|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
44738312|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
44738313|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44738314|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44738315|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738316|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738317|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738318|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738319|NCT01602029|Ondansetron|ondansetron|mesh-list
44738320|NCT01602029|Simvastatin|simvastatin|mesh-list
44738321|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44738322|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44738323|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
44738324|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738325|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44738326|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44738327|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515499|NCT00558519|Methotrexate|methotrexate|mesh-list
44738328|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
44738329|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
44738330|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738331|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738332|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738333|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
44738334|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738335|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44738336|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
44738337|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738338|NCT01602029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44738339|NCT01602029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44738340|NCT01602029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738341|NCT01602029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738342|NCT01602029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44738343|NCT01602874|Metronidazole|metronidazole|mesh-list
44738344|NCT01602874|Clarithromycin|clarithromycin|mesh-list
44738345|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
44738346|NCT01602874|Tigecycline|tigecycline|mesh-list
44738347|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738348|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44738349|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44738350|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44738351|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44738352|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738353|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738354|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44738355|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44738356|NCT01602887|Palbociclib|palbociclib|mesh-list
44738357|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515571|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
44515572|NCT00558272|Saracatinib|saracatinib|mesh-list
44738358|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738359|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738360|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738361|NCT01603264|Trastuzumab|trastuzumab|mesh-list
44738362|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738363|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738364|NCT01603680|Anesthetics|anesthetics|mesh-list
44738365|NCT01603680|Mepivacaine|mepivacaine|mesh-list
44738366|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
44738367|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738368|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738369|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
44738370|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515573|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44515574|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515575|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515576|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515577|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515578|NCT00558259|Dabigatran|dabigatran|mesh-list
44515579|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
44738372|NCT01604135|Dextrans|dextrans|mesh-list
44738373|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
44738374|NCT01604135|Vitamins|vitamins|mesh-ancestor
44738375|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
44738376|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738377|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44738378|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738379|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
44738380|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
44266375|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738381|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
44738382|NCT01604213|Metformin|metformin|mesh-list
44738383|NCT01604213|Vildagliptin|vildagliptin|mesh-list
44738384|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738385|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738386|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44738387|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
44738388|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738389|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738390|NCT01605240|Acetaminophen|acetaminophen|mesh-list
44738391|NCT01605240|Ibuprofen|ibuprofen|mesh-list
44738392|NCT01605240|Codeine|codeine|mesh-list
44738393|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738394|NCT01605240|Analgesics|analgesics|mesh-ancestor
44738395|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
44738396|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738397|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738398|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
44738399|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44738400|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738401|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738402|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44738403|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266376|NCT00657865|Ramipril|ramipril|mesh-list
44738404|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738405|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44738406|NCT01605240|Narcotics|narcotics|mesh-ancestor
44738407|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738408|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
44738409|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738410|NCT01605279|Dobutamine|dobutamine|mesh-list
44738411|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44738412|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
44738413|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
44738414|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738415|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738416|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44738417|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44738418|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44738419|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44738420|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738421|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738422|NCT01605279|Protective Agents|protective agents|mesh-ancestor
44738423|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44738424|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
44738425|NCT01606072|Coagulants|coagulants|mesh-ancestor
44738426|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44738427|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
44738428|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738429|NCT01606722|Ritonavir|ritonavir|mesh-list
44738430|NCT01606722|Darunavir|darunavir|mesh-list
44738431|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44738432|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44738433|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
44738434|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738435|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738436|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44738437|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44738438|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
44738439|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738440|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44738441|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44738442|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
44515610|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
44738443|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44738444|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
44738445|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738446|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738447|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44738448|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738449|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44738450|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
44738451|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738452|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738453|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44738454|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738455|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
44738456|NCT01607983|Protective Agents|protective agents|mesh-ancestor
44738457|NCT01608217|Acetaminophen|acetaminophen|mesh-list
44738458|NCT01608217|Dronabinol|dronabinol|mesh-list
44738459|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738460|NCT01608217|Analgesics|analgesics|mesh-ancestor
44738461|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
44738462|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738463|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738464|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
44738465|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
44738466|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738467|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44738468|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44738469|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738470|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738471|NCT01608217|Hormones|hormones|mesh-ancestor
44738472|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738473|NCT01608594|Ipilimumab|ipilimumab|mesh-list
44738474|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738475|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738476|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44738477|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738478|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44738479|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738480|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
44738481|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738482|NCT01608958|Oxytocin|oxytocin|mesh-list
44738483|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
44738484|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44738485|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738486|NCT01609153|Olanzapine|olanzapine|mesh-list
44738487|NCT01609153|Amisulpride|amisulpride|mesh-list
44738488|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
44738489|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
44738490|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738491|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738492|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738493|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44738494|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44738495|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738496|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738497|NCT01609153|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44738498|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44738499|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738500|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738501|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738502|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
44738503|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44738504|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
44738505|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44738506|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
44738507|NCT01610141|Warfarin|warfarin|mesh-list
44738508|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
44738509|NCT01610310|Interferon-beta|interferon-beta|mesh-list
44738510|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738511|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
44738512|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738513|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
44738514|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738515|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
44738516|NCT01610362|Antibodies|antibodies|mesh-list
44738517|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
44738518|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44738519|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44738520|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
44738521|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
44738522|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738523|NCT01610401|Metformin|metformin|mesh-list
44738524|NCT01610401|Caffeine|caffeine|mesh-list
44738525|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266505|NCT00658593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428126|NCT02176291|Narcotics|narcotics|mesh-ancestor
44738526|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738527|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44738528|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44738529|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738530|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738531|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44738532|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44738533|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
44738534|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738535|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
44738536|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738537|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44738538|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44738539|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738540|NCT01610869|Nintedanib|nintedanib|mesh-list
44738541|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738542|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738543|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738544|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738545|NCT01610921|Adenosine|adenosine|mesh-list
44738546|NCT01610921|Analgesics|analgesics|mesh-ancestor
44738547|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
44738548|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738549|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738550|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44738551|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738552|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44738553|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
44738554|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
44738555|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738556|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738557|NCT01610934|Liraglutide|liraglutide|mesh-list
44738558|NCT01610934|Glimepiride|glimepiride|mesh-list
44738559|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738560|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738561|NCT01610934|Incretins|incretins|mesh-ancestor
44738562|NCT01610934|Hormones|hormones|mesh-ancestor
44738563|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738564|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44738565|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738566|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
44738567|NCT01610947|Adalimumab|adalimumab|mesh-list
44738568|NCT01610947|Etanercept|etanercept|mesh-list
44738569|NCT01610947|Golimumab|golimumab|mesh-list
44738570|NCT01610947|Infliximab|infliximab|mesh-list
44738571|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44738572|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738573|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738574|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738575|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738576|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44738577|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738578|NCT01610947|Analgesics|analgesics|mesh-ancestor
44738579|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
44738580|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738581|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738582|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738583|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
44738584|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44738585|NCT01610999|Plerixafor|plerixafor|mesh-list
44738586|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44738587|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44462494|NCT01527487|Docetaxel|docetaxel|mesh-list
44738588|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
44738589|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738590|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
44738591|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44738592|NCT01611038|Protective Agents|protective agents|mesh-ancestor
44738593|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738594|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738595|NCT01611077|Amlodipine|amlodipine|mesh-list
44738596|NCT01611077|Candesartan|candesartan|mesh-list
44738597|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
44738598|NCT01611077|Olmesartan|olmesartan|mesh-list
44738599|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44738600|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44738601|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44738602|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738603|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738604|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44738605|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738606|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738607|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44738608|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44738609|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
44738610|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515834|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515835|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515836|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515837|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515838|NCT00553319|Amphetamine|amphetamine|mesh-list
44515839|NCT00553319|Adderall|adderall|mesh-list
44515840|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44515841|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515842|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
44515843|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
44515844|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515845|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
44515846|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515847|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738611|NCT01611311|BI 409306|bi 409306|mesh-list
44738612|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44738613|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738614|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738615|NCT01611324|Epinephrine|epinephrine|mesh-list
44738616|NCT01611324|Mepivacaine|mepivacaine|mesh-list
44738617|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44738618|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44738619|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
44266549|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
44738620|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738621|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738622|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738623|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44738624|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44738625|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
44738626|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738627|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44738628|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738629|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
44738630|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
44738631|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44738632|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
44738633|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
44738634|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738635|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
44738636|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
44738637|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44738638|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738639|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738640|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738641|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
44738642|NCT01611415|Furosemide|furosemide|mesh-list
44738643|NCT01611415|Diuretics|diuretics|mesh-ancestor
44738644|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
44738645|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738646|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44738647|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738648|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738649|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44738650|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738651|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
44738652|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44738653|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738654|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738655|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738656|NCT01611480|Imiquimod|imiquimod|mesh-list
44738657|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44738658|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
44738659|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738660|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738661|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
44738662|NCT01611506|Cisplatin|cisplatin|mesh-list
44738663|NCT01611506|Capecitabine|capecitabine|mesh-list
44738664|NCT01611506|Cetuximab|cetuximab|mesh-list
44738665|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738666|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44738667|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
44738668|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738669|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738670|NCT01611675|Vemurafenib|vemurafenib|mesh-list
44738671|NCT01611675|Leflunomide|leflunomide|mesh-list
44738672|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738673|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738674|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738675|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738676|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738677|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
44738678|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738679|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44738680|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
44738681|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738682|NCT01611727|Cisplatin|cisplatin|mesh-list
44738683|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738684|NCT01611896|Selenium|selenium|mesh-list
44515869|NCT00553202|Prednisolone|prednisolone|mesh-list
44738685|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
44738686|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738687|NCT01611896|Protective Agents|protective agents|mesh-ancestor
44738688|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738689|NCT01611896|Trace Elements|trace elements|mesh-ancestor
44738690|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
44266615|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738691|NCT01611909|Terpin|terpin|mesh-list
44738692|NCT01611909|Expectorants|expectorants|mesh-ancestor
44738693|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
44738694|NCT01611961|Docetaxel|docetaxel|mesh-list
44738695|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738696|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44738697|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44738698|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44738699|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738700|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44738701|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738702|NCT01612065|Misoprostol|misoprostol|mesh-list
44738703|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44738704|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
44738705|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44266636|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44738706|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738707|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44738708|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738709|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
44738710|NCT01612078|Droxidopa|droxidopa|mesh-list
44738711|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44738712|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44738713|NCT01612247|Aspirin|aspirin|mesh-list
44738714|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
44738715|NCT01612247|Methotrexate|methotrexate|mesh-list
44738716|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738717|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
44738718|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738719|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738720|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44738721|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
44738722|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738723|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738724|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44738725|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44738726|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
44738727|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44738728|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44738729|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
44738730|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738731|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738732|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44738733|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44738734|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44738735|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738736|NCT01612247|Analgesics|analgesics|mesh-ancestor
44738737|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
44738738|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738739|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738740|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44266682|NCT00659503|Ciclesonide|ciclesonide|mesh-list
44738741|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44738742|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44738743|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44738744|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
44738745|NCT01612273|Aspirin|aspirin|mesh-list
44738746|NCT01612273|Triflusal|triflusal|mesh-list
44738747|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44738748|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738749|NCT01612273|Analgesics|analgesics|mesh-ancestor
44738750|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
44738751|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738752|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738753|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738754|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738755|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44738756|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44738757|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515947|NCT00552617|Rocuronium|rocuronium|mesh-list
44738758|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44738759|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44738761|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
44738762|NCT01612286|Endostatins|endostatins|mesh-list
44738763|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44738764|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44738765|NCT01612286|Growth Substances|growth substances|mesh-ancestor
44738766|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738767|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
44738768|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738769|NCT01612299|Everolimus|everolimus|mesh-list
44738770|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738771|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738772|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
44738773|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738774|NCT01612377|Prednisone|prednisone|mesh-list
44738775|NCT01612377|Prednisolone|prednisolone|mesh-list
44738776|NCT01612377|Dipyridamole|dipyridamole|mesh-list
44738777|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738778|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
44738779|NCT01612377|Hormones|hormones|mesh-ancestor
44738780|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738781|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738782|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738783|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738784|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44738785|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738786|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738787|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44738788|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738789|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
44738790|NCT01612403|Astringents|astringents|mesh-ancestor
44738791|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266700|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
44738792|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738793|NCT01612468|Liraglutide|liraglutide|mesh-list
44738794|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738795|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738796|NCT01612468|Incretins|incretins|mesh-ancestor
44738797|NCT01612468|Hormones|hormones|mesh-ancestor
44738798|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738799|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44738800|NCT01612507|Cephalosporins|cephalosporins|mesh-list
44738801|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44738802|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738803|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44738804|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44738805|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738806|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738807|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44738808|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44738809|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738810|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738811|NCT01612741|Acarbose|acarbose|mesh-list
44738812|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44738813|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738814|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738815|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738816|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516017|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516018|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
44516019|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266736|NCT00659776|Hematinics|hematinics|mesh-ancestor
44516020|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
44516021|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
44516022|NCT00552110|Phenylephrine|phenylephrine|mesh-list
44516023|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
44516024|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516025|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516026|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44516027|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44516028|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44516029|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516030|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44738818|NCT01612832|Analgesics|analgesics|mesh-ancestor
44738819|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
44738820|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738821|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738822|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
44738823|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44738824|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44738825|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738826|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44738827|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44738828|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44738829|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44738830|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44738831|NCT01612871|Tamoxifen|tamoxifen|mesh-list
44738832|NCT01612871|Letrozole|letrozole|mesh-list
44738833|NCT01612871|Anastrozole|anastrozole|mesh-list
44738834|NCT01612871|Exemestane|exemestane|mesh-list
44738835|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738836|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44738837|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44738838|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738839|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738840|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44738841|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
44738842|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738843|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738844|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44738845|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44738846|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44738847|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44738848|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44738849|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44738850|NCT01612910|Protective Agents|protective agents|mesh-ancestor
44738851|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738852|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738853|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44738854|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44738855|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738856|NCT01612975|Naproxen|naproxen|mesh-list
44738857|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44738858|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44738859|NCT01612975|Analgesics|analgesics|mesh-ancestor
44738860|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
44738861|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44738862|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738863|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44738864|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738865|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
44738866|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44738867|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738868|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738869|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
44738870|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44429211|NCT02154529|XL647|xl647|mesh-list
44738871|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44738872|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738873|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44738874|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44738875|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738876|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738877|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738878|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44738879|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
44738880|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44738881|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738882|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44738883|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44738884|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44738885|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
44738886|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738887|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44738888|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738889|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738890|NCT01613079|Methotrexate|methotrexate|mesh-list
44738891|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44738892|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
44266827|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266828|NCT00660140|Antiviral Agents|antiviral agents|mesh-ancestor
44738893|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44738894|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738895|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44738896|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
44738897|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738898|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738899|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738900|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738901|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44738902|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44738903|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
44738904|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44738905|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44738906|NCT01613092|Vancomycin|vancomycin|mesh-list
44738907|NCT01613092|Clindamycin|clindamycin|mesh-list
44738908|NCT01613092|Cefazolin|cefazolin|mesh-list
44738909|NCT01613092|Cephalexin|cephalexin|mesh-list
44738910|NCT01613092|Bacitracin|bacitracin|mesh-list
44738911|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44738912|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738913|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44738914|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738915|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738916|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44738917|NCT01613105|Acarbose|acarbose|mesh-list
44738918|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44738919|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738920|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738921|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738922|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738923|NCT01613170|Estrogens|estrogens|mesh-list
44266860|NCT00660270|Gemcitabine|gemcitabine|mesh-list
44738924|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44738925|NCT01613170|Hormones|hormones|mesh-ancestor
44738926|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738927|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738928|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
44738929|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
44738930|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738931|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
44738932|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738933|NCT01613209|Candesartan|candesartan|mesh-list
44738934|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
44738935|NCT01613209|Olmesartan|olmesartan|mesh-list
44266883|NCT00660335|Hormones|hormones|mesh-ancestor
44738936|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44738937|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44738938|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44738939|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738940|NCT01613300|Ofatumumab|ofatumumab|mesh-list
44738941|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738942|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
44738943|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44738944|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44738945|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738946|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
44738947|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
44738948|NCT01613469|Leucovorin|leucovorin|mesh-list
44738949|NCT01613469|Antidotes|antidotes|mesh-ancestor
44738950|NCT01613469|Protective Agents|protective agents|mesh-ancestor
44738951|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738952|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
44266895|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
44738953|NCT01613469|Vitamins|vitamins|mesh-ancestor
44738954|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
44738955|NCT01613482|Trastuzumab|trastuzumab|mesh-list
44738956|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44738957|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44738958|NCT01613534|Sucralfate|sucralfate|mesh-list
44738959|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44738960|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44738961|NCT01613547|Amoxicillin|amoxicillin|mesh-list
44738962|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44738963|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44738964|NCT01613573|Hormones|hormones|mesh-list
44738965|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44738966|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738967|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44738968|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
44738969|NCT01613664|Coagulants|coagulants|mesh-ancestor
44738970|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
44738971|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44738972|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44738973|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44738974|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
44738975|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266921|NCT00660582|Vitamins|vitamins|mesh-ancestor
44738976|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738977|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738978|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44738979|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44738980|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44738981|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
44738982|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738983|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44738984|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44738985|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738986|NCT01613755|Metformin|metformin|mesh-list
44738987|NCT01613755|Dipyridamole|dipyridamole|mesh-list
44738988|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44738989|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44738990|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44738991|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44738992|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44738993|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44738994|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
44738995|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44738996|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44738997|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44738998|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
44738999|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739000|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44739001|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44739002|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739003|NCT01613807|Insulin|insulin|mesh-list
44739004|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44739005|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
44686426|NCT01333137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686427|NCT01333137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686428|NCT01333137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686429|NCT01333137|Immunologic Factors|immunologic factors|mesh-ancestor
44686430|NCT01333137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266958|NCT00660751|Analgesics|analgesics|mesh-ancestor
44686431|NCT01333150|Propranolol|propranolol|mesh-list
44686432|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44686433|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44686434|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
44686435|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686436|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686437|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686438|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44686439|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44686440|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
44686441|NCT01333267|Hormones|hormones|mesh-list
44686442|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
44686443|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
44686444|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44686445|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
44686446|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686447|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686448|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44686449|NCT01333332|Capecitabine|capecitabine|mesh-list
44686450|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686451|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
44686452|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686453|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686454|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
44686455|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44686456|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686457|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
44739006|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44739007|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
44739008|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739009|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739010|NCT01613820|Scopolamine|scopolamine|mesh-list
44739011|NCT01613820|Ketamine|ketamine|mesh-list
44739012|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44739013|NCT01613820|Analgesics|analgesics|mesh-ancestor
44739014|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
44739015|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739016|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739017|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44739018|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44266994|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739019|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
44739020|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
44739021|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739022|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44739023|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44739024|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739025|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739026|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44739027|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
44739028|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
44739029|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739030|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
44739031|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44739032|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
44739033|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44739034|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
44739035|NCT01613846|Sorafenib|sorafenib|mesh-list
44739036|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739037|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44739038|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739039|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739040|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44739041|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739042|NCT01613963|Cyclosporine|cyclosporine|mesh-list
44739043|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
44739044|NCT01613963|Prednisolone|prednisolone|mesh-list
44739045|NCT01613963|Adalimumab|adalimumab|mesh-list
44739046|NCT01613963|Etanercept|etanercept|mesh-list
44739047|NCT01613963|Methotrexate|methotrexate|mesh-list
44739048|NCT01613963|Azathioprine|azathioprine|mesh-list
44739049|NCT01613963|Infliximab|infliximab|mesh-list
44739050|NCT01613963|Cyclosporins|cyclosporins|mesh-list
44739051|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44739052|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739053|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
44739054|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739055|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739056|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739057|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739058|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739059|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739060|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
44739061|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739062|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739063|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739064|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44739065|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739066|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
44739067|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739068|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44739069|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44739070|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44739071|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
44739072|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44739073|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739074|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
44739075|NCT01613963|Hormones|hormones|mesh-ancestor
44739076|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739077|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44739078|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739079|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739080|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739081|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739083|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
44739084|NCT01613976|Panobinostat|panobinostat|mesh-list
44739085|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739086|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44739087|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739088|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739089|NCT01614041|Tandospirone|tandospirone|mesh-list
44739090|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44739091|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739092|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739093|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739094|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739095|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44739096|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
44739097|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739098|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739099|NCT01614132|Cisplatin|cisplatin|mesh-list
44739100|NCT01614132|Vincristine|vincristine|mesh-list
44516343|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516344|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739101|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739102|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739103|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44739104|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739105|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739106|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44739107|NCT01614197|Cytarabine|cytarabine|mesh-list
44739108|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
44739109|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44739110|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44739111|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44739112|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
44739113|NCT01614197|Methotrexate|methotrexate|mesh-list
44739114|NCT01614197|Etoposide|etoposide|mesh-list
44739115|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
44739116|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739117|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
44739118|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739119|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739120|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44739121|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
44739122|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739123|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739124|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44739125|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739126|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739127|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739128|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739129|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
44739130|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739131|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739132|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44739133|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739134|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44739135|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44739136|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44739137|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
44739138|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739139|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739140|NCT01614223|Betamethasone|betamethasone|mesh-list
44739141|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516345|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44739142|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
44739143|NCT01614223|Hormones|hormones|mesh-ancestor
44516346|NCT00557128|Protective Agents|protective agents|mesh-ancestor
44516347|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267109|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267135|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516348|NCT00556920|Carvedilol|carvedilol|mesh-list
44516349|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44516350|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44516351|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516352|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516353|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516355|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739144|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739145|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739146|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44739147|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
44739148|NCT01614236|Pregabalin|pregabalin|mesh-list
44739149|NCT01614236|Analgesics|analgesics|mesh-ancestor
44739150|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
44739151|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739152|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739153|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
44739154|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44739155|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739156|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739157|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44739158|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44739159|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739160|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739161|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739162|NCT01614301|Pioglitazone|pioglitazone|mesh-list
44739163|NCT01614301|Sirolimus|sirolimus|mesh-list
44739164|NCT01614301|Etoricoxib|etoricoxib|mesh-list
44739165|NCT01614301|Dacarbazine|dacarbazine|mesh-list
44739166|NCT01614301|Trofosfamide|trofosfamide|mesh-list
44739167|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739168|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739169|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44739170|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739171|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44267153|NCT00661349|Ritonavir|ritonavir|mesh-list
44739172|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739173|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
44739174|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739175|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
44739176|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44739177|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
44739178|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739179|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739180|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739181|NCT01614301|Analgesics|analgesics|mesh-ancestor
44739182|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
44739183|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739184|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739185|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739186|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44739187|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44739188|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739189|NCT01614366|Amlodipine|amlodipine|mesh-list
44739190|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44267170|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44267171|NCT00661375|Sorafenib|sorafenib|mesh-list
44267172|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739191|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44739192|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739193|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739194|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44739195|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739196|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
44739197|NCT01614405|Ritonavir|ritonavir|mesh-list
44739198|NCT01614405|Lopinavir|lopinavir|mesh-list
44739199|NCT01614405|Tenofovir|tenofovir|mesh-list
44739200|NCT01614405|Emtricitabine|emtricitabine|mesh-list
44739201|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44739202|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44739203|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44739204|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
44739205|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739206|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739207|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44739208|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44739209|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
44739210|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739211|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44739212|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44739213|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44739214|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739215|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
44739216|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44739217|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
44739218|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739219|NCT01614431|Expectorants|expectorants|mesh-ancestor
44739220|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
44739221|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44739222|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
44739223|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739224|NCT01614431|Protective Agents|protective agents|mesh-ancestor
44739225|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739226|NCT01614431|Antidotes|antidotes|mesh-ancestor
44739227|NCT01614496|Insulin|insulin|mesh-list
44739228|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739229|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739230|NCT01614535|Remifentanil|remifentanil|mesh-list
44739231|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44739232|NCT01614535|Narcotics|narcotics|mesh-ancestor
44739233|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739234|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739235|NCT01614535|Analgesics|analgesics|mesh-ancestor
44739236|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
44739237|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516462|NCT00550459|Tolvaptan|tolvaptan|mesh-list
44739238|NCT01614938|Cisplatin|cisplatin|mesh-list
44739239|NCT01614938|Docetaxel|docetaxel|mesh-list
44739240|NCT01614938|Cetuximab|cetuximab|mesh-list
44739241|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739242|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739243|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739244|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44739245|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739246|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44739247|NCT01614964|Lumefantrine|lumefantrine|mesh-list
44739248|NCT01614964|Artemether|artemether|mesh-list
44739249|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44739250|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
44739251|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44739252|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44739253|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739254|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44739255|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44739256|NCT01615042|Lenalidomide|lenalidomide|mesh-list
44739257|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
44739258|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739259|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44739260|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44739261|NCT01615042|Growth Substances|growth substances|mesh-ancestor
44739262|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
44739263|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739264|NCT01615055|Fluoxetine|fluoxetine|mesh-list
44739265|NCT01615055|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44267250|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
44739266|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44739267|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739268|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739269|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739270|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
44739271|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739272|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44739273|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
44739274|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739275|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44739276|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44739277|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739278|NCT01615081|Insulin|insulin|mesh-list
44739279|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739280|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739281|NCT01615107|Oxytocin|oxytocin|mesh-list
44739282|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
44739283|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44267265|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267280|NCT00662272|Vaccines|vaccines|mesh-list
44739284|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739285|NCT01615185|Amisulpride|amisulpride|mesh-list
44739286|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44739287|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739288|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739289|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739290|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739291|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44739292|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
44739293|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739294|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739295|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44739296|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
44739297|NCT01615211|Letrozole|letrozole|mesh-list
44739298|NCT01615211|Trilostane|trilostane|mesh-list
44739299|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739300|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44739301|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44739302|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739303|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739304|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44739305|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44739306|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739307|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739308|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44739309|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739310|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739311|NCT01615224|Misoprostol|misoprostol|mesh-list
44739312|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739313|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739314|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739315|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739316|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44739317|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739318|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
44739319|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44739320|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44267283|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
44739321|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44739322|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44739323|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
44739324|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739325|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739326|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44739327|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44739328|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44739329|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44686458|NCT01333410|Tacrolimus|tacrolimus|mesh-list
44686459|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686460|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
44686461|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686462|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44686463|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686464|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686465|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686466|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
44686467|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44686468|NCT01333423|Roscovitine|roscovitine|mesh-list
44686469|NCT01333423|Doxorubicin|doxorubicin|mesh-list
44686470|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44686471|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44686472|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686473|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44686474|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44267340|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267341|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44686475|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516602|NCT03023631|Vaccines|vaccines|mesh-list
44516603|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
44516604|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516605|NCT03022097|Bromides|bromides|mesh-list
44516606|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
44516607|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44516608|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
44516609|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516610|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516611|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516612|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516613|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44516614|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44516615|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44516616|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516617|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516618|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516619|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
44516620|NCT03025256|Nivolumab|nivolumab|mesh-list
43608980|NCT03192878|Infliximab|infliximab|mesh-list
43608981|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
43608982|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608983|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608984|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
43849301|NCT03943537|Insulin|insulin|mesh-list
43849302|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43849303|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849304|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
43849305|NCT03942653|Goserelin|goserelin|mesh-list
43849306|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849311|NCT03941730|Estradiol|estradiol|mesh-list
43608985|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608986|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608987|NCT03193073|Mitogens|mitogens|mesh-list
43608988|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
43608989|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608990|NCT03192943|Nivolumab|nivolumab|mesh-list
43608991|NCT03192943|Linrodostat|linrodostat|mesh-list
43608992|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44739330|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44739331|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44739332|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44739333|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44739334|NCT01615393|Ribavirin|ribavirin|mesh-list
44739335|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
44739336|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739337|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
44739338|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739339|NCT01615445|Resveratrol|resveratrol|mesh-list
44739340|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
44739341|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739342|NCT01615445|Protective Agents|protective agents|mesh-ancestor
44739343|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739344|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739345|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267388|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44267389|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
44739346|NCT01615601|Ritonavir|ritonavir|mesh-list
44739347|NCT01615601|Darunavir|darunavir|mesh-list
44739348|NCT01615601|Etravirine|etravirine|mesh-list
44739349|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44739350|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44739351|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44739352|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
44739353|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739354|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739355|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44739356|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
44739357|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739358|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44739359|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44739360|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44739361|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739362|NCT01615614|Rilpivirine|rilpivirine|mesh-list
44739363|NCT01615614|Rifabutin|rifabutin|mesh-list
44739364|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44739365|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739366|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739367|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739368|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
44739369|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739370|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44739371|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44739372|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44739373|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44739374|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
44739375|NCT01615627|Treprostinil|treprostinil|mesh-list
44739376|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44739377|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739378|NCT01615757|Cytarabine|cytarabine|mesh-list
44739379|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739380|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
44739381|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739382|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739383|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
44739384|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739385|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739386|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
44739387|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739388|NCT01615913|Ketoconazole|ketoconazole|mesh-list
44739389|NCT01615913|Terbinafine|terbinafine|mesh-list
44739390|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
44739391|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739392|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44739393|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44739394|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739395|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739396|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44739397|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
44739398|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739399|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739400|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44739401|NCT01615978|Liraglutide|liraglutide|mesh-list
44739402|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739403|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739404|NCT01615978|Incretins|incretins|mesh-ancestor
44739405|NCT01615978|Hormones|hormones|mesh-ancestor
44739406|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739407|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
44739408|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44739409|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
44739410|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
44739411|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739412|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739413|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739414|NCT01616004|Analgesics|analgesics|mesh-ancestor
44739415|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
44739416|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739417|NCT01616069|Simendan|simendan|mesh-list
44739418|NCT01616069|Epinephrine|epinephrine|mesh-list
44739419|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44739420|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44739421|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
44739422|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739423|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739424|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739425|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44739426|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44739427|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
44739428|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739429|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44739430|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44739431|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
44739432|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
44739433|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44739434|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44739435|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
44739436|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44739437|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44739438|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739439|NCT01616069|Protective Agents|protective agents|mesh-ancestor
44739440|NCT01616108|Bupivacaine|bupivacaine|mesh-list
44739441|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
44739442|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
44739443|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739444|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739445|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
44739446|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739447|NCT01616186|Everolimus|everolimus|mesh-list
44739448|NCT01616186|Sorafenib|sorafenib|mesh-list
44739449|NCT01616186|Sunitinib|sunitinib|mesh-list
44739450|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739451|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739452|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
44739453|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739454|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44739455|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267441|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739456|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739457|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44739458|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44739459|NCT01616186|Growth Substances|growth substances|mesh-ancestor
44739460|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44739461|NCT01616225|Hormones|hormones|mesh-list
44739462|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739463|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686476|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686477|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
44686478|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686479|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44686480|NCT01333449|Decitabine|decitabine|mesh-list
44686481|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686482|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
44516699|NCT03020030|Protective Agents|protective agents|mesh-ancestor
44739464|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44739465|NCT01616355|Eusol|eusol|mesh-list
44739466|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
44739467|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739468|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
44739469|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
44739470|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44739471|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44739472|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739473|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739474|NCT01616381|Urological Agents|urological agents|mesh-ancestor
44739475|NCT01616407|Methylphenidate|methylphenidate|mesh-list
44739476|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44739477|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44267457|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
44739478|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739479|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44739480|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44739481|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739482|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739483|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
44739484|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739485|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
44739486|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739487|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
44739488|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44739489|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44739490|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
44739491|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
44739492|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739493|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
44739494|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44739495|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44739496|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739497|NCT01616485|Urological Agents|urological agents|mesh-ancestor
44739498|NCT01616615|Aspirin|aspirin|mesh-list
44739499|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739500|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739501|NCT01616615|Analgesics|analgesics|mesh-ancestor
44739502|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
44739503|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739504|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739505|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739506|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739507|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44739508|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44267504|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431976|NCT02094937|Xhance|xhance|mesh-list
44739509|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739510|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44739511|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44739512|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739513|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
44739514|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44739515|NCT01616680|Antibodies|antibodies|mesh-list
44739516|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
44739517|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44739518|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
44739519|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
44739520|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739521|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44739522|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739523|NCT01616732|Testosterone|testosterone|mesh-list
44739524|NCT01616732|Androgens|androgens|mesh-ancestor
44739525|NCT01616732|Hormones|hormones|mesh-ancestor
44739526|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739527|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739528|NCT01616784|Insulin|insulin|mesh-list
44739529|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44739530|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
44739531|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739532|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739533|NCT01616849|Cisplatin|cisplatin|mesh-list
44739534|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
44739535|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739536|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44739537|NCT01616875|Cisplatin|cisplatin|mesh-list
44739538|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739539|NCT01616888|Paclitaxel|paclitaxel|mesh-list
44739540|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44739541|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739542|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739543|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739544|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44739545|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739546|NCT01616927|Lanreotide|lanreotide|mesh-list
44739547|NCT01616927|Somatostatin|somatostatin|mesh-list
44739548|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739549|NCT01616927|Hormones|hormones|mesh-ancestor
44739550|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739551|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739552|NCT01616966|Remifentanil|remifentanil|mesh-list
44739553|NCT01616966|Propofol|propofol|mesh-list
44739554|NCT01616966|Sevoflurane|sevoflurane|mesh-list
44739555|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44739556|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739557|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267541|NCT00663455|Cyclosporine|cyclosporine|mesh-list
44267542|NCT00663455|Cyclosporins|cyclosporins|mesh-list
44739558|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44739559|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
44739560|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
44739561|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44739562|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44739563|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44739564|NCT01616966|Narcotics|narcotics|mesh-ancestor
44739565|NCT01616966|Analgesics|analgesics|mesh-ancestor
44739566|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
44739567|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739568|NCT01616992|Bupivacaine|bupivacaine|mesh-list
44739569|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
44739570|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
44739571|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739572|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739573|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
44739574|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739575|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
44739576|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44739577|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739578|NCT01617135|Levodopa|levodopa|mesh-list
44739579|NCT01617135|Carbidopa|carbidopa|mesh-list
44739580|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44739581|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44739582|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44739583|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
44739584|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739585|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267574|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267575|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739586|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739587|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44739588|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739589|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44739590|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
44739591|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
44739592|NCT01617200|Olanzapine|olanzapine|mesh-list
44739593|NCT01617200|Asenapine|asenapine|mesh-list
44739594|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
44739595|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
44739596|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739597|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739598|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739599|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44739600|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739601|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739602|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739603|NCT01617200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44739604|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44739605|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739606|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739607|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739608|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
44739609|NCT01617213|Lenalidomide|lenalidomide|mesh-list
44739610|NCT01617213|Melphalan|melphalan|mesh-list
44739611|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
44739612|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739613|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44739614|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44739615|NCT01617213|Growth Substances|growth substances|mesh-ancestor
44739616|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44739617|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739618|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44739619|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
44739620|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739621|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44739622|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739623|NCT01617226|Azacitidine|azacitidine|mesh-list
44739624|NCT01617226|Vorinostat|vorinostat|mesh-list
44739625|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739626|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
44739627|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739628|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739629|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739630|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44739631|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
44739632|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44739633|NCT01617317|Antibodies|antibodies|mesh-list
44739634|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
44739635|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44739636|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
44267591|NCT00663728|Urological Agents|urological agents|mesh-ancestor
44739637|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739638|NCT01617356|Lidocaine|lidocaine|mesh-list
44739639|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
44739640|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
44739641|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739642|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739643|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
44739644|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739645|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44739646|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44739647|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44739648|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739649|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739650|NCT01617538|Atorvastatin|atorvastatin|mesh-list
44739651|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44739652|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44739653|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
44739654|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739655|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44739656|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44739657|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739658|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44739659|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739660|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739661|NCT01617564|Bupivacaine|bupivacaine|mesh-list
44739662|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
44686483|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686484|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686485|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686486|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
44686487|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
44686488|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44686489|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686490|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686491|NCT01333631|Valproic Acid|valproic acid|mesh-list
44686492|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
44686493|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686494|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686495|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
44686496|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686497|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686498|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
44686499|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44267677|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686500|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686501|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44686502|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44686503|NCT01333696|Pemetrexed|pemetrexed|mesh-list
44686504|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686505|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686506|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686507|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44686508|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739663|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
44739664|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739665|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739666|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
44739667|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739668|NCT01617590|Methotrexate|methotrexate|mesh-list
44739669|NCT01617590|Leflunomide|leflunomide|mesh-list
44739670|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739671|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739672|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739673|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739674|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739675|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
44739676|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739677|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739678|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739679|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739680|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44739681|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44739682|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
44739683|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739684|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44739685|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
44739686|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44739687|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739688|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739689|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739690|NCT01617694|Analgesics|analgesics|mesh-ancestor
44739691|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
44739692|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739693|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44739694|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44739695|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44739696|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
44739697|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739698|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739699|NCT01617707|Midazolam|midazolam|mesh-list
44739700|NCT01617707|Propofol|propofol|mesh-list
44739701|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44739702|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739703|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739704|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44739705|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
44739706|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
44739707|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44739708|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44739709|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739710|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739711|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
44739712|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
44739713|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739714|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739715|NCT01617733|Pasireotide|pasireotide|mesh-list
44739716|NCT01617733|Hormones|hormones|mesh-ancestor
44739717|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267738|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44267751|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
44739718|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739719|NCT01617746|Bosentan|bosentan|mesh-list
44739720|NCT01617746|Ambrisentan|ambrisentan|mesh-list
44739721|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739722|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44739723|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739724|NCT01617772|Atorvastatin|atorvastatin|mesh-list
44739725|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44739726|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44739727|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
44739728|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739729|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44739730|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44739731|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739732|NCT01617798|Metolazone|metolazone|mesh-list
44739733|NCT01617798|Furosemide|furosemide|mesh-list
44516966|NCT03027115|Tamsulosin|tamsulosin|mesh-list
44516967|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44516968|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44739734|NCT01617798|Diuretics|diuretics|mesh-ancestor
44739735|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
44739736|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739737|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44739738|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739739|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462575|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462586|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
44739740|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739741|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44739742|NCT01617811|Anesthetics|anesthetics|mesh-list
44739743|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739744|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739745|NCT01617824|Linagliptin|linagliptin|mesh-list
44739746|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739747|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739748|NCT01617824|Incretins|incretins|mesh-ancestor
44739749|NCT01617824|Hormones|hormones|mesh-ancestor
44739750|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739751|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44739752|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44739753|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739754|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739755|NCT01617928|Paclitaxel|paclitaxel|mesh-list
44739756|NCT01617928|Carboplatin|carboplatin|mesh-list
44739757|NCT01617928|Veliparib|veliparib|mesh-list
44739758|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44739759|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739760|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739761|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739762|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462587|NCT01526057|Rituximab|rituximab|mesh-list
44462588|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44462589|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462593|NCT01525901|Mitogens|mitogens|mesh-list
44267759|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44739763|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739764|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44739765|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739766|NCT01618006|Aspirin|aspirin|mesh-list
44739767|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739768|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739769|NCT01618006|Analgesics|analgesics|mesh-ancestor
44739770|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
44739771|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739772|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739773|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739774|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739775|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44739776|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44739777|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739778|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44739779|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44739780|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739781|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
44739782|NCT01618136|Paclitaxel|paclitaxel|mesh-list
44739783|NCT01618136|Carboplatin|carboplatin|mesh-list
44739784|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44739785|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739786|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739787|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739788|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
44739789|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739790|NCT01618188|Insulin|insulin|mesh-list
44739791|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44739792|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
44739793|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
44739794|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44739795|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44739796|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739797|NCT01618253|Sorafenib|sorafenib|mesh-list
44739798|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739799|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44739800|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739801|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739802|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44739803|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739804|NCT01618396|Midazolam|midazolam|mesh-list
44739805|NCT01618396|Propofol|propofol|mesh-list
44739806|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44739807|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739808|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739809|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44739810|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
44739811|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
44739812|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44739813|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44739814|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739815|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739816|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
44739817|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
44739818|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739819|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739820|NCT01618448|Tolvaptan|tolvaptan|mesh-list
44739821|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44739822|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739823|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
44739824|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739825|NCT01618474|Docetaxel|docetaxel|mesh-list
44739826|NCT01618474|Capecitabine|capecitabine|mesh-list
44739827|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739828|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
44739829|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
44739830|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
44739831|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739832|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44739833|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
44739834|NCT01618513|Octreotide|octreotide|mesh-list
44739835|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739836|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44739837|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739838|NCT01618539|Propofol|propofol|mesh-list
44739839|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44739840|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739841|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739842|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44739843|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
44739844|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
44739845|NCT01618591|Azithromycin|azithromycin|mesh-list
44739846|NCT01618591|Levofloxacin|levofloxacin|mesh-list
44739847|NCT01618591|Ofloxacin|ofloxacin|mesh-list
44739848|NCT01618591|Rifaximin|rifaximin|mesh-list
44739849|NCT01618591|Loperamide|loperamide|mesh-list
44739850|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
44739851|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44739852|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739853|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44739854|NCT01618591|Renal Agents|renal agents|mesh-ancestor
44739855|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44739856|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44739857|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739858|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739859|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739860|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44739861|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44739862|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739864|NCT01618643|Retinol acetate|retinol acetate|mesh-list
44739865|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44739866|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739867|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44739868|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
44739869|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739870|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44739871|NCT01618643|Protective Agents|protective agents|mesh-ancestor
44739872|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739873|NCT01618760|Risperidone|risperidone|mesh-list
44739874|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44686509|NCT01333709|Folfirinox|folfirinox|mesh-list
44686510|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686511|NCT01333774|Acarbose|acarbose|mesh-list
44686512|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44686513|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686514|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686515|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686516|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686517|NCT01333800|Ciclesonide|ciclesonide|mesh-list
44686518|NCT01333800|Beclomethasone|beclomethasone|mesh-list
44686519|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686520|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
44686521|NCT01333800|Hormones|hormones|mesh-ancestor
44686522|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686523|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686524|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44686525|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686526|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44686527|NCT01333852|Metformin|metformin|mesh-list
44686528|NCT01333852|Paclitaxel|paclitaxel|mesh-list
44686529|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686530|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686531|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44237971|NCT00565539|Interferons|interferons|mesh-list
44686532|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686533|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686534|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686536|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686537|NCT01333878|Abatacept|abatacept|mesh-list
44686538|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44686539|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686540|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267881|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
44267882|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686541|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686542|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
44686543|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686544|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686545|NCT01333891|Nitroprusside|nitroprusside|mesh-list
44686546|NCT01333891|Phenylephrine|phenylephrine|mesh-list
44686547|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
44686548|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44686549|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
44686550|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
44686551|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686552|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686553|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
44686554|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44686555|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
44686556|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686557|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44686558|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44686559|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686560|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44686561|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686562|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686563|NCT01333891|Protective Agents|protective agents|mesh-ancestor
44686564|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44686565|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
44686566|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44686567|NCT01333917|Curcumin|curcumin|mesh-list
44739875|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
44739876|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739877|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739878|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739879|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44739880|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739881|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739882|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739883|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44739884|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
44739885|NCT01618773|Adapalene|adapalene|mesh-list
44739886|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44739887|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
44739888|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739889|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739890|NCT01618773|Analgesics|analgesics|mesh-ancestor
44739891|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
44739892|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739893|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739894|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739895|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739896|NCT01618799|Lamotrigine|lamotrigine|mesh-list
44739897|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
44739898|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44739899|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739900|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739901|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44739902|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739903|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44739904|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739905|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739906|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739907|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44739908|NCT01618825|Lamotrigine|lamotrigine|mesh-list
44739909|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
44739910|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44739911|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44739912|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739913|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44739914|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739915|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44739916|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44739917|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44739918|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44739919|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44739920|NCT01618877|Levetiracetam|levetiracetam|mesh-list
44739921|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
44739922|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
44739923|NCT01618890|Propranolol|propranolol|mesh-list
44739924|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44739925|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44739926|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44739927|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44739928|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739929|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739930|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44739931|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44739932|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
44739933|NCT01618903|Levetiracetam|levetiracetam|mesh-list
44739934|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
44739935|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
44739936|NCT01618929|Montelukast|montelukast|mesh-list
44739937|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44739938|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
44739939|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44739940|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
44739941|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739942|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739943|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44739944|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44739945|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739946|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
44739947|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44739948|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
44517205|NCT03024840|Propofol|propofol|mesh-list
44739949|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44739950|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44739951|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739952|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739953|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
44739954|NCT01619046|Factor VIII|factor viii|mesh-list
44739955|NCT01619046|Coagulants|coagulants|mesh-ancestor
44739956|NCT01619072|Misoprostol|misoprostol|mesh-list
44739957|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739958|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
44739959|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739960|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739961|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44739962|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44739963|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
44739964|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
44739965|NCT01619137|Povidone|povidone|mesh-list
44739966|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
44739967|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
44739968|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44739969|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44739970|NCT01619150|Etoricoxib|etoricoxib|mesh-list
44739971|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44739972|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44739973|NCT01619150|Analgesics|analgesics|mesh-ancestor
44739974|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
44739975|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44739976|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739977|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739978|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44739979|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44739980|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44739981|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739982|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44739983|NCT01619163|Prednisolone|prednisolone|mesh-list
44739984|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44739985|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
44739986|NCT01619163|Hormones|hormones|mesh-ancestor
44739987|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44739988|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739989|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44739990|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44739991|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44739992|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44739993|NCT01619176|Methotrexate|methotrexate|mesh-list
44739994|NCT01619176|Leflunomide|leflunomide|mesh-list
44739995|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44739996|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
44268009|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44739997|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44739998|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44739999|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740000|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
44740001|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740002|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740003|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44740004|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740005|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44740006|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740007|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
44740008|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740009|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44740010|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44740011|NCT01619176|Analgesics|analgesics|mesh-ancestor
44740012|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
44740013|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740014|NCT01619280|Nitroprusside|nitroprusside|mesh-list
44740015|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740016|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
44740017|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44268046|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
44740018|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740019|NCT01619436|Clonidine|clonidine|mesh-list
44740020|NCT01619436|Analgesics|analgesics|mesh-ancestor
44740021|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
44740022|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707253|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44740023|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740024|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740025|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
44740026|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
44740027|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44740028|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44740029|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44740030|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740031|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740032|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740033|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44740034|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
44740035|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740036|NCT01619527|Darunavir|darunavir|mesh-list
44740037|NCT01619527|Cobicistat|cobicistat|mesh-list
44740038|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44740039|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44740040|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
44740041|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740042|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740043|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44740044|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44740045|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
44740046|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740047|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44740048|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44740049|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44740050|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44740051|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44740052|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740053|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740054|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740055|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740056|NCT01619566|Analgesics|analgesics|mesh-ancestor
44740057|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
44740058|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740059|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
44740060|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740061|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
44740062|NCT01619644|Valproic Acid|valproic acid|mesh-list
44740063|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
44740064|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740065|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740066|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
44740067|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740068|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740069|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
44740070|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44740071|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740072|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740073|NCT01619683|Enclomiphene|enclomiphene|mesh-list
44740074|NCT01619683|Clomiphene|clomiphene|mesh-list
44268110|NCT00666055|Etravirine|etravirine|mesh-list
44740075|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
44740076|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44740077|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44740078|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740079|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740080|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44740081|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
44740082|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44740083|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44740084|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44517354|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517355|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517356|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44517357|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44517358|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268126|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44517359|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44517360|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517363|NCT03023358|Hormones|hormones|mesh-ancestor
44740086|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
44740087|NCT01619761|Melphalan|melphalan|mesh-list
44740088|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
44740089|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44740090|NCT01619761|Rituximab|rituximab|mesh-list
44740091|NCT01619761|Fludarabine|fludarabine|mesh-list
44740092|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
44740093|NCT01619761|Lenalidomide|lenalidomide|mesh-list
44740094|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44740095|NCT01619761|Tacrolimus|tacrolimus|mesh-list
44740096|NCT01619761|Antibodies|antibodies|mesh-list
44740097|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
44740098|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44740099|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740100|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
44740101|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740102|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268143|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
44740103|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44740104|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
44740105|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740106|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740107|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44740108|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740109|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
44740110|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44740111|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740112|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44740113|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44740114|NCT01619761|Growth Substances|growth substances|mesh-ancestor
44740115|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
44740116|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740117|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44740118|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
44740119|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740120|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740121|NCT01619813|Prednisone|prednisone|mesh-list
44740122|NCT01619813|Docetaxel|docetaxel|mesh-list
44686568|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44686569|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44686570|NCT01333917|Analgesics|analgesics|mesh-ancestor
44686571|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
44686572|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686573|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686574|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686575|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686576|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686577|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686578|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686579|NCT01333982|Amoxicillin|amoxicillin|mesh-list
44686580|NCT01333982|Gentamicins|gentamicins|mesh-list
44686581|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686582|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686583|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44686584|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686585|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686586|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
44686587|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686588|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686589|NCT01334047|Vaccines|vaccines|mesh-list
44686590|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
44686591|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686592|NCT01334060|Vaccines|vaccines|mesh-list
44686593|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
44686594|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686595|NCT01334073|Everolimus|everolimus|mesh-list
44686596|NCT01334073|Axitinib|axitinib|mesh-list
44686597|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686598|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686599|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
44686600|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686601|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44686602|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686603|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686604|NCT01334099|Tremelimumab|tremelimumab|mesh-list
44686605|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740123|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740124|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
44740125|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740126|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
44740127|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740128|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740129|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
44740130|NCT01619813|Hormones|hormones|mesh-ancestor
44740131|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740132|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740133|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740134|NCT01619891|Vitamin D|vitamin d|mesh-list
44740135|NCT01619891|Vitamins|vitamins|mesh-ancestor
44740136|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
44740137|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740138|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44740139|NCT01620112|Lidocaine|lidocaine|mesh-list
44740140|NCT01620112|Clonidine|clonidine|mesh-list
44740141|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
44740142|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
44740143|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740144|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740145|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
44462620|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
44462621|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740146|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740147|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44740148|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44740149|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44740150|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740151|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740152|NCT01620112|Analgesics|analgesics|mesh-ancestor
44740153|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740154|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
44740155|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
44740156|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44740157|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44740158|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44740159|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740160|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740161|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44740162|NCT01620229|Antibodies|antibodies|mesh-list
44740163|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
44740164|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44740165|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
44740166|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
44740167|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740168|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44740169|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740170|NCT01620268|Leflunomide|leflunomide|mesh-list
44740171|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740172|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740173|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740174|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
44740175|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740176|NCT01620307|Sirolimus|sirolimus|mesh-list
44740177|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740178|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740179|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44462661|NCT01525602|Paclitaxel|paclitaxel|mesh-list
44740180|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740181|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
44740182|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740183|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
44740184|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740185|NCT01620320|Dobutamine|dobutamine|mesh-list
44740186|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44740187|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
44740188|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
44740189|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740190|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740191|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44740192|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44740193|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44462671|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44740194|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740195|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740196|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740197|NCT01620320|Protective Agents|protective agents|mesh-ancestor
44740198|NCT01620333|Insulin|insulin|mesh-list
44740199|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44740200|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
44740201|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
44740202|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44740203|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
44740204|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740205|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740206|NCT01620424|Insulin|insulin|mesh-list
44740207|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44740208|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
44740209|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
44740210|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44740211|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
44268222|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44740212|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44740213|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740214|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740215|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
44740216|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
44740217|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740218|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740219|NCT01620450|Insulin|insulin|mesh-list
44740220|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44740221|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740222|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740223|NCT01620463|Liraglutide|liraglutide|mesh-list
44740224|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44268241|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740225|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740226|NCT01620463|Incretins|incretins|mesh-ancestor
44740227|NCT01620463|Hormones|hormones|mesh-ancestor
44740228|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740229|NCT01620476|Liraglutide|liraglutide|mesh-list
44740230|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740231|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740232|NCT01620476|Incretins|incretins|mesh-ancestor
44740233|NCT01620476|Hormones|hormones|mesh-ancestor
44740234|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740235|NCT01620684|Metyrapone|metyrapone|mesh-list
44740236|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
44740237|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740238|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740239|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
44740240|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44740241|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44740242|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
44740243|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740244|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44740245|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44740246|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740247|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740248|NCT01620814|Misoprostol|misoprostol|mesh-list
44740249|NCT01620814|Dinoprostone|dinoprostone|mesh-list
44740250|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44740251|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
44740252|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44740253|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740254|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44740255|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44740256|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
44740257|NCT01620840|Lacosamide|lacosamide|mesh-list
44740258|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
44740259|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44740260|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44740261|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740262|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740263|NCT01620944|Ritonavir|ritonavir|mesh-list
44740264|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44740265|NCT01620944|Tenofovir|tenofovir|mesh-list
44740266|NCT01620944|Lamivudine|lamivudine|mesh-list
44740267|NCT01620944|Emtricitabine|emtricitabine|mesh-list
44740268|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44740269|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44740270|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44740271|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740272|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740273|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44740274|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44740275|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
44740276|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740277|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44740278|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44740279|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44740280|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44740282|NCT01621022|Nicotine|nicotine|mesh-list
44740283|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44740284|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
44740285|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740286|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740287|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44740288|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44740289|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
44268308|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
44740290|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740291|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740292|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44740293|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44740294|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740295|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44740296|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44740297|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740298|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
44740299|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44740300|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44740301|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740302|NCT01621100|Hydromorphone|hydromorphone|mesh-list
44740303|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44740304|NCT01621100|Narcotics|narcotics|mesh-ancestor
44740305|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740306|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740307|NCT01621100|Analgesics|analgesics|mesh-ancestor
44740308|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
44740309|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740310|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
44740311|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44740312|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740313|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740314|NCT01621165|Prazosin|prazosin|mesh-list
44740315|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740316|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44740317|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44740318|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44740319|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740320|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740321|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740322|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740323|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
44740324|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44740325|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
44740326|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44740327|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
44740328|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740329|NCT01621217|Cetuximab|cetuximab|mesh-list
44740330|NCT01621217|Mitomycins|mitomycins|mesh-list
44740331|NCT01621217|Mitomycin|mitomycin|mesh-list
44740332|NCT01621217|Fluorouracil|fluorouracil|mesh-list
44740333|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44740334|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740335|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740336|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
44740337|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740338|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44740339|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740340|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
44740341|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740342|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740343|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
44740344|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740345|NCT01621256|Ancrod|ancrod|mesh-list
44740346|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
44740347|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44740348|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44740349|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740351|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44740352|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740353|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740354|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
44740355|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740356|NCT01621308|Insulin|insulin|mesh-list
44740357|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740358|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740359|NCT01621321|Voriconazole|voriconazole|mesh-list
44740360|NCT01621321|Prednisolone|prednisolone|mesh-list
44740361|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740362|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
44740363|NCT01621321|Hormones|hormones|mesh-ancestor
44740364|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740365|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740366|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740367|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740368|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
44740369|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740370|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44740371|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44740372|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740373|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740374|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44740375|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44740376|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44740377|NCT01621373|Propofol|propofol|mesh-list
44740378|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44740379|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740380|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740381|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44740382|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
44740383|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
44740384|NCT01621386|Prednisone|prednisone|mesh-list
44740385|NCT01621386|Montelukast|montelukast|mesh-list
44740386|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740387|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
44740388|NCT01621386|Hormones|hormones|mesh-ancestor
44686606|NCT01334112|Axitinib|axitinib|mesh-list
44686607|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686608|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238027|NCT00565708|Aspirin|aspirin|mesh-list
44686609|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686642|NCT01334424|Propofol|propofol|mesh-list
44686643|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44686644|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686645|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686646|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44686647|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
44686648|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
44686649|NCT01334502|Prednisone|prednisone|mesh-list
44686650|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
44686651|NCT01334502|Rituximab|rituximab|mesh-list
44686652|NCT01334502|Doxorubicin|doxorubicin|mesh-list
44686653|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44686654|NCT01334502|Vincristine|vincristine|mesh-list
44686655|NCT01334502|Everolimus|everolimus|mesh-list
44686656|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686657|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
44686658|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686659|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686660|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44686661|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
44686662|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686663|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686664|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44686665|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44686666|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44686667|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44686668|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44686669|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686670|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922815|NCT00570700|Dasatinib|dasatinib|mesh-list
44686671|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
44686672|NCT01334502|Hormones|hormones|mesh-ancestor
44517663|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740389|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740390|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740391|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740392|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740393|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44740394|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
44740395|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44740396|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
44740397|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44740398|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44740399|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740400|NCT01621451|Aspirin|aspirin|mesh-list
44740401|NCT01621451|Clopidogrel|clopidogrel|mesh-list
44740402|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44740403|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44740404|NCT01621451|Analgesics|analgesics|mesh-ancestor
44740405|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
44740406|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740407|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740408|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740409|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740410|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44740411|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44740412|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740413|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44740414|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44740415|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740416|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
44268461|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740417|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44740418|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44740419|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44740420|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
44740421|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517703|NCT03025594|Ketorolac|ketorolac|mesh-list
44517704|NCT03025594|Epinephrine|epinephrine|mesh-list
44517705|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
44517706|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44517707|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44517708|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44517709|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517710|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517711|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517712|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44517713|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44517714|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
44517715|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517716|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44740422|NCT01621620|Yohimbine|yohimbine|mesh-list
44740423|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
44740424|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
44740425|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740426|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740427|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44740428|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44740429|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44740430|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740431|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740432|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740433|NCT01621620|Urological Agents|urological agents|mesh-ancestor
44740434|NCT01621698|Fentanyl|fentanyl|mesh-list
44740435|NCT01621698|Bupivacaine|bupivacaine|mesh-list
44740436|NCT01621698|Propofol|propofol|mesh-list
44740437|NCT01621698|Atracurium|atracurium|mesh-list
44740438|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
44740439|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
44740440|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740441|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740442|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
44740443|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740444|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44740445|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44740446|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
44740447|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44740448|NCT01621698|Narcotics|narcotics|mesh-ancestor
44740449|NCT01621698|Analgesics|analgesics|mesh-ancestor
44740450|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44740451|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44740452|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44740453|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44740454|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44740455|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44740456|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
44740457|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740458|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740459|NCT01621750|Clopidogrel|clopidogrel|mesh-list
44740460|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44740461|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44740462|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44740463|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44740464|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
44740465|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740466|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740467|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740468|NCT01621763|Clopidogrel|clopidogrel|mesh-list
44740469|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44740470|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44740471|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44740472|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44268534|NCT00667641|Paclitaxel|paclitaxel|mesh-list
44740473|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
44740474|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740475|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740476|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740477|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
44740478|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44740479|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44740480|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740481|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44740482|NCT01621893|Calcium|calcium|mesh-list
44740483|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44740484|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740485|NCT01621971|Milrinone|milrinone|mesh-list
44740486|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44740487|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44740488|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
44740489|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44740490|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44740491|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740492|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740493|NCT01621971|Protective Agents|protective agents|mesh-ancestor
44740494|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517803|NCT04278599|Zinc|zinc|mesh-list
44740495|NCT01622075|Paclitaxel|paclitaxel|mesh-list
44740496|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44740497|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44740498|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740499|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
44740500|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740501|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
44740502|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740503|NCT01622283|Cetirizine|cetirizine|mesh-list
44740504|NCT01622283|Levocetirizine|levocetirizine|mesh-list
44740505|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44740506|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44740507|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44740508|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
44740509|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
44740510|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740511|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268575|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740512|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740513|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
44740514|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44740515|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
44740516|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
44740517|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740518|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740519|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44740520|NCT01622322|Analgesics|analgesics|mesh-ancestor
44740521|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
44740522|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740523|NCT01622361|Tamoxifen|tamoxifen|mesh-list
44740524|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
44740525|NCT01622361|Docetaxel|docetaxel|mesh-list
44740526|NCT01622361|Doxorubicin|doxorubicin|mesh-list
44740527|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44740528|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740529|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
44740530|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268597|NCT00667966|Urological Agents|urological agents|mesh-ancestor
44686673|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686674|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44686675|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686676|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686677|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686678|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686679|NCT01334567|Tenofovir|tenofovir|mesh-list
44686680|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
44686681|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686682|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44686683|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44686684|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686685|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686686|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44686687|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44686688|NCT01334580|Methadone|methadone|mesh-list
44686689|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44686690|NCT01334580|Narcotics|narcotics|mesh-ancestor
44686691|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686692|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686693|NCT01334580|Analgesics|analgesics|mesh-ancestor
44686694|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
44686695|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686696|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
44686697|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44686698|NCT01334619|Ropivacaine|ropivacaine|mesh-list
44686699|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
44686700|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
44686701|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686702|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686703|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
44686704|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686705|NCT01334632|Morphine|morphine|mesh-list
44686706|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44686707|NCT01334632|Narcotics|narcotics|mesh-ancestor
44686708|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44686709|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686710|NCT01334632|Analgesics|analgesics|mesh-ancestor
44686711|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
44686712|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740531|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740532|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44740533|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
44740534|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740535|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740536|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44740537|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
44740538|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740539|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
44740540|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740541|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44740542|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44740543|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740544|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44740545|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
44740546|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740547|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740548|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44740549|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44740550|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44740551|NCT01622439|Prednisone|prednisone|mesh-list
44740552|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
44740553|NCT01622439|Rituximab|rituximab|mesh-list
44268659|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
44740554|NCT01622439|Doxorubicin|doxorubicin|mesh-list
44740555|NCT01622439|Vincristine|vincristine|mesh-list
44740556|NCT01622439|Valproic Acid|valproic acid|mesh-list
44740557|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740558|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
44740559|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740560|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740561|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44740562|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
44740563|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740564|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740565|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44740566|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44740567|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740568|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44740569|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44740570|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740571|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740572|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
44740573|NCT01622439|Hormones|hormones|mesh-ancestor
44740574|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740575|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740576|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44740577|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
44740578|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740579|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
44740580|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
44740581|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
44740582|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740583|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
44740584|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44740585|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740586|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740587|NCT01622504|Naloxone|naloxone|mesh-list
44740588|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44740589|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740590|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
44740591|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740592|NCT01622556|Fludarabine|fludarabine|mesh-list
44740593|NCT01622556|Busulfan|busulfan|mesh-list
44740594|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
44740595|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740596|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740597|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740598|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
44740599|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740600|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
44268698|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
44268699|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
44740601|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44740602|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44740603|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44740604|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44740605|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44740606|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
44740607|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740608|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44740609|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44740610|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740612|NCT01622790|Abacavir|abacavir|mesh-list
44740613|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
44740614|NCT01622790|Dolutegravir|dolutegravir|mesh-list
44740615|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44740616|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44740617|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740618|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740619|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
44740620|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740621|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44740622|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44740623|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44740624|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44740625|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
44740626|NCT01622881|Nefopam|nefopam|mesh-list
44740627|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44740628|NCT01622881|Analgesics|analgesics|mesh-ancestor
44740629|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
44740630|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740631|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740632|NCT01622933|Interferons|interferons|mesh-list
44740633|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
44740634|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740635|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
44740636|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740637|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
44268746|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44740638|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740639|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
44740640|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44740641|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44740642|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740643|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
44740644|NCT01622946|Coagulants|coagulants|mesh-ancestor
44740645|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44740646|NCT01622972|Laxatives|laxatives|mesh-ancestor
44740647|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44740648|NCT01623024|Vitamin D|vitamin d|mesh-list
44740649|NCT01623024|Vitamins|vitamins|mesh-ancestor
44740650|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
44740651|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740652|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44740653|NCT01623102|Gemcitabine|gemcitabine|mesh-list
44740654|NCT01623102|Bevacizumab|bevacizumab|mesh-list
44740655|NCT01623102|Cisplatin|cisplatin|mesh-list
44740656|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44740657|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740658|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44740659|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44740660|NCT01623102|Growth Substances|growth substances|mesh-ancestor
44740661|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740662|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44740663|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740664|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
44740665|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740666|NCT01623102|Antiviral Agents|antiviral agents|mesh-ancestor
44740667|NCT01623102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740668|NCT01623102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740669|NCT01623102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740670|NCT01623102|Immunologic Factors|immunologic factors|mesh-ancestor
44740671|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44740672|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
44740673|NCT01623206|Coagulants|coagulants|mesh-ancestor
44740674|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44740675|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
44740676|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740677|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44740678|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44740679|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740680|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44740681|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44686713|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
44740682|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
44740683|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
44740684|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740685|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
44740686|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740687|NCT01623349|Olaparib|olaparib|mesh-list
44740688|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44740689|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740690|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740691|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740692|NCT01623362|Fluorides|fluorides|mesh-list
44740693|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
44740694|NCT01623362|Protective Agents|protective agents|mesh-ancestor
44740695|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686714|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
44686715|NCT01334645|Coagulants|coagulants|mesh-ancestor
44686716|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44686717|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44686718|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
44686719|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686720|NCT01334671|Atorvastatin|atorvastatin|mesh-list
44686721|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44686722|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44686723|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
44686724|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686725|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44686726|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44686727|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686728|NCT01334684|Metformin|metformin|mesh-list
44686729|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686730|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686731|NCT01334762|Letrozole|letrozole|mesh-list
44686732|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686733|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44686734|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44686735|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686736|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686737|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44517992|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44517993|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
44517994|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517995|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517996|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
44268773|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517997|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44517998|NCT04274933|Capecitabine|capecitabine|mesh-list
44517999|NCT04274933|Venetoclax|venetoclax|mesh-list
44518000|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44518001|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
44518002|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518003|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518004|NCT04275245|Meplazumab|meplazumab|mesh-list
44518005|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
44518006|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518007|NCT04274920|Calcium|calcium|mesh-list
44518013|NCT04274907|Venetoclax|venetoclax|mesh-list
44740696|NCT01623375|Insulin|insulin|mesh-list
44740697|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44740698|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
44740699|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740700|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740701|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
44740702|NCT01623401|Tedizolid|tedizolid|mesh-list
44740703|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740704|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740705|NCT01623440|Naltrexone|naltrexone|mesh-list
44740706|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44740707|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44740708|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740709|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
44740710|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740711|NCT01623505|Varenicline|varenicline|mesh-list
44740712|NCT01623505|Nicotine|nicotine|mesh-list
44740713|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44740714|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44740715|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
44740716|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740717|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740718|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740719|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44740720|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
44740721|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740722|NCT01623570|Menotropins|menotropins|mesh-list
44740723|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44740724|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
44740725|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44740726|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740727|NCT01623609|Naloxegol|naloxegol|mesh-list
44740728|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44740729|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740730|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
44740731|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740732|NCT01623635|Ropivacaine|ropivacaine|mesh-list
44740733|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
44740734|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
44740735|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740736|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740737|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
44740738|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740739|NCT01623713|Risperidone|risperidone|mesh-list
44740740|NCT01623713|Iloperidone|iloperidone|mesh-list
44740741|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44740742|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
44268828|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44740743|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740744|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740745|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740746|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44740747|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44740748|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740749|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740750|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44740751|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
44740752|NCT01623778|Interferons|interferons|mesh-list
44740753|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
44740754|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
44740755|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740756|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
44740757|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740758|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
44740759|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740760|NCT01623817|Vancomycin|vancomycin|mesh-list
44740761|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740762|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740763|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
44740764|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44268845|NCT00669149|Analgesics|analgesics|mesh-ancestor
44740765|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740766|NCT01623921|Celecoxib|celecoxib|mesh-list
44740767|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44740768|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44740769|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44740770|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
44740771|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518040|NCT04274257|Rituximab|rituximab|mesh-list
44740772|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44740773|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44740774|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740775|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44740776|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44740777|NCT01623921|Analgesics|analgesics|mesh-ancestor
44740778|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
44740779|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740780|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740781|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740782|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268866|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268867|NCT00669344|Rivastigmine|rivastigmine|mesh-list
44268885|NCT00669435|Losartan|losartan|mesh-list
44740783|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44740784|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44740785|NCT01624025|Docetaxel|docetaxel|mesh-list
44740786|NCT01624025|Epirubicin|epirubicin|mesh-list
44740787|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740788|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
44740789|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
44740790|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
44740791|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740792|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740793|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44740794|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44740795|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740796|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
44740797|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740798|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
44740799|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740800|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740801|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44740802|NCT01624051|Cisplatin|cisplatin|mesh-list
44740803|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740804|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
44740805|NCT01624064|Enalapril|enalapril|mesh-list
44740806|NCT01624064|Calcium|calcium|mesh-list
44740807|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44740808|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44740809|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44740810|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740811|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44268899|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44740812|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
44740813|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740814|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44740815|NCT01624103|Lidocaine|lidocaine|mesh-list
44740816|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
44740817|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
44740818|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
44740819|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740820|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740821|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
44740822|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740823|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44740824|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44740825|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44740826|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740827|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740828|NCT01624116|Metformin|metformin|mesh-list
44740829|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44740830|NCT01624116|Acarbose|acarbose|mesh-list
44740831|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44740832|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740833|NCT01624116|Incretins|incretins|mesh-ancestor
44740834|NCT01624116|Hormones|hormones|mesh-ancestor
44740835|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740836|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44740837|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
44740838|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740839|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740840|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44740841|NCT01624129|Fluticasone|fluticasone|mesh-list
44740842|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740843|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44740844|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
44740845|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518106|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
44740846|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740847|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44740848|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
44740849|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44740850|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44268939|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
44740852|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44740853|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44740854|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
44740855|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740856|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44740857|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44740858|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740859|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44740860|NCT01624246|Avibactam|avibactam|mesh-list
44740861|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740862|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740863|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44740864|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268954|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740865|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740866|NCT01624337|Piperaquine|piperaquine|mesh-list
44740867|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
44740868|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44740869|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44740870|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740871|NCT01624428|Varenicline|varenicline|mesh-list
44686738|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686739|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686740|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686741|NCT01334879|Ranibizumab|ranibizumab|mesh-list
44686742|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44686743|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44686744|NCT01334879|Growth Substances|growth substances|mesh-ancestor
44686745|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686746|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
44686747|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686748|NCT01334892|Cyclosporine|cyclosporine|mesh-list
44686749|NCT01334892|Cyclosporins|cyclosporins|mesh-list
44686750|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686751|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686752|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686753|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
44686754|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686755|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
44686756|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686757|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
44686758|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44686759|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44686760|NCT01334905|Mirabegron|mirabegron|mesh-list
44686761|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44686762|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44686763|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44686764|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
44686765|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686766|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686767|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686768|NCT01334905|Urological Agents|urological agents|mesh-ancestor
44686769|NCT01335035|Deferasirox|deferasirox|mesh-list
44686770|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44686771|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
44686772|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
44686773|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686774|NCT01335048|Clopidogrel|clopidogrel|mesh-list
44686775|NCT01335048|Atorvastatin|atorvastatin|mesh-list
44686776|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44686777|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44686778|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
44686779|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686780|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44686781|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44686782|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686783|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44686784|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44518179|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
44740872|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44740873|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44740874|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
44740875|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740876|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740877|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740879|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740880|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740881|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44740882|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44740883|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740884|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740885|NCT01624493|Gemcitabine|gemcitabine|mesh-list
44740886|NCT01624493|Carboplatin|carboplatin|mesh-list
44740887|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740888|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740889|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
44740890|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740891|NCT01624493|Antiviral Agents|antiviral agents|mesh-ancestor
44740892|NCT01624493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740893|NCT01624493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740894|NCT01624493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740895|NCT01624493|Immunologic Factors|immunologic factors|mesh-ancestor
44740896|NCT01624493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740897|NCT01624649|Methylphenidate|methylphenidate|mesh-list
44740898|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44740899|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44740900|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740901|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44740902|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44740903|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44740904|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740905|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
44740906|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740907|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44740908|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44740909|NCT01624675|Risperidone|risperidone|mesh-list
44740910|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44740911|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
44740912|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44740913|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740914|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740915|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44740916|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44740917|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44740918|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44740919|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44740920|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
44740921|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
44740922|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44740923|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740924|NCT01624766|Denosumab|denosumab|mesh-list
44740925|NCT01624766|Everolimus|everolimus|mesh-list
44740926|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44740927|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740928|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740929|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
44740930|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740931|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44740932|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740933|NCT01624805|Cyclosporine|cyclosporine|mesh-list
44740934|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
44740935|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44740936|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44740937|NCT01624805|Prednisolone|prednisolone|mesh-list
44740938|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
44740939|NCT01624805|Lenograstim|lenograstim|mesh-list
44740940|NCT01624805|Cyclosporins|cyclosporins|mesh-list
44740941|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
44740942|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44740943|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44740944|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
44740945|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44740946|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
44740947|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740948|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740949|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740950|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740951|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
44740952|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740953|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44740954|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44740955|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44740956|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44740957|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
44740958|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
44740959|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44740960|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44740961|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
44740962|NCT01624805|Hormones|hormones|mesh-ancestor
44740963|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44740964|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44740965|NCT01624805|Protective Agents|protective agents|mesh-ancestor
44740966|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44740967|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740968|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44740969|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44740970|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44740971|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
44740972|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740973|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44740974|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44740975|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740976|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44740977|NCT01625026|Cathartics|cathartics|mesh-ancestor
44740978|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269113|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518277|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44518278|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44518279|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44518280|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
44518281|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518282|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44518283|NCT04270318|Pemetrexed|pemetrexed|mesh-list
44518284|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518285|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518286|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518287|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44518288|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44518289|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44740979|NCT01625156|Sirolimus|sirolimus|mesh-list
44740980|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44740981|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740982|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44740983|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740984|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
44740985|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740986|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
44740987|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740988|NCT01625260|Gemcitabine|gemcitabine|mesh-list
44740989|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44740990|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
44740991|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44740992|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44740993|NCT01625260|Antiviral Agents|antiviral agents|mesh-ancestor
44740994|NCT01625260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44740995|NCT01625260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44740996|NCT01625260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44740997|NCT01625260|Immunologic Factors|immunologic factors|mesh-ancestor
44740998|NCT01625260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44740999|NCT01625351|Sirolimus|sirolimus|mesh-list
44741000|NCT01625351|Fludarabine|fludarabine|mesh-list
44741001|NCT01625351|Melphalan|melphalan|mesh-list
44741002|NCT01625351|Busulfan|busulfan|mesh-list
44741003|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
44741004|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
44741005|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741006|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269161|NCT00670436|Paclitaxel|paclitaxel|mesh-list
44741007|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741008|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
44741009|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741010|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44741011|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741012|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44741013|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
44741014|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44741015|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
44741016|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44741017|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741018|NCT01625429|Paclitaxel|paclitaxel|mesh-list
44741019|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44741020|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741021|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44741022|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44741023|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44741024|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741025|NCT01625494|Amlodipine|amlodipine|mesh-list
44741026|NCT01625494|Irbesartan|irbesartan|mesh-list
44741027|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741028|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44269171|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741029|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741030|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741031|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741032|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741033|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
44741034|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44741035|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44741036|NCT01625520|Everolimus|everolimus|mesh-list
44741037|NCT01625520|Pasireotide|pasireotide|mesh-list
44741038|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741039|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741040|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
44741041|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741042|NCT01625520|Hormones|hormones|mesh-ancestor
44741043|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741044|NCT01625572|Morphine|morphine|mesh-list
44741045|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44741046|NCT01625572|Narcotics|narcotics|mesh-ancestor
44741047|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741048|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741049|NCT01625572|Analgesics|analgesics|mesh-ancestor
44741050|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
44741051|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741052|NCT01625715|Ketotifen|ketotifen|mesh-list
44741053|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
44741054|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44741055|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44741056|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
44741057|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
44741058|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741059|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462725|NCT01524991|Cisplatin|cisplatin|mesh-list
44269217|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
44741060|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741061|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44741062|NCT01625741|Rituximab|rituximab|mesh-list
44741063|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741064|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741065|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
44741066|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741067|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741068|NCT01625793|Interferons|interferons|mesh-list
44741069|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
44741070|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741071|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
44741072|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741073|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
44741074|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686785|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44686786|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44686787|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
44686788|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686789|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686790|NCT01335074|Sirolimus|sirolimus|mesh-list
44686791|NCT01335074|Sorafenib|sorafenib|mesh-list
44686792|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686793|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44686795|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686796|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686797|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686798|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44686799|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
44686800|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686801|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
44686802|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686803|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
44686804|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44686805|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44686806|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
44686807|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686808|NCT01335321|Triamcinolone|triamcinolone|mesh-list
44686809|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
44686810|NCT01335321|Hylan|hylan|mesh-list
44686811|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686812|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
44686813|NCT01335321|Hormones|hormones|mesh-ancestor
44686814|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686815|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686816|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
44686817|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
44686818|NCT01335321|Protective Agents|protective agents|mesh-ancestor
44686819|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44686820|NCT01335334|Metronidazole|metronidazole|mesh-list
44269251|NCT00670787|Losartan|losartan|mesh-list
44686821|NCT01335334|Tetracycline|tetracycline|mesh-list
44686822|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44686823|NCT01335334|Omeprazole|omeprazole|mesh-list
44686824|NCT01335334|Bismuth|bismuth|mesh-list
44686825|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686826|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686827|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44686828|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44686829|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44686830|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44686831|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44686832|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686833|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686834|NCT01335334|Antacids|antacids|mesh-ancestor
44686835|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44686836|NCT01335360|Nevirapine|nevirapine|mesh-list
44686837|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44686838|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44686839|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686840|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686841|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
44741075|NCT01625806|Ketoconazole|ketoconazole|mesh-list
44741076|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
44741077|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741078|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44741079|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44741080|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741081|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741082|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44741083|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
44741084|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741085|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741086|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44741088|NCT01625871|Artemether|artemether|mesh-list
44741089|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44741090|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
44741091|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44741092|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44741093|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741094|NCT01625936|Bevacizumab|bevacizumab|mesh-list
44741095|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741096|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741097|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44741098|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44741099|NCT01625936|Growth Substances|growth substances|mesh-ancestor
44741100|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741101|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44741102|NCT01626222|Everolimus|everolimus|mesh-list
44741103|NCT01626222|Exemestane|exemestane|mesh-list
44741104|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741105|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741106|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
44741107|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741108|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44741109|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44741110|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741111|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741112|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44741113|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
44741114|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741115|NCT01626339|Bevacizumab|bevacizumab|mesh-list
44741116|NCT01626339|Ranibizumab|ranibizumab|mesh-list
44741117|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741118|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741119|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44741120|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44741121|NCT01626339|Growth Substances|growth substances|mesh-ancestor
44741122|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741123|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
44741124|NCT01626443|Folic Acid|folic acid|mesh-list
44741125|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
44741126|NCT01626443|Inositol|inositol|mesh-list
44741127|NCT01626443|Hematinics|hematinics|mesh-ancestor
44741128|NCT01626443|Vitamins|vitamins|mesh-ancestor
44741129|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
44741130|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741131|NCT01626469|Captopril|captopril|mesh-list
44741132|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44741133|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
44741134|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741135|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741136|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741137|NCT01626534|Clopidogrel|clopidogrel|mesh-list
44741138|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44741139|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44741140|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44741141|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44269331|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
44741142|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
44741143|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741144|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741145|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741146|NCT01626560|Vancomycin|vancomycin|mesh-list
44741147|NCT01626560|Daptomycin|daptomycin|mesh-list
44741148|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44741149|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741150|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
44741151|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44741152|NCT01626651|Ketoconazole|ketoconazole|mesh-list
44741153|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
44741154|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741155|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44741156|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44741157|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269352|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44741158|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741159|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44741160|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
44741161|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741162|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741163|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44518481|NCT03831113|Analgesics|analgesics|mesh-ancestor
44518482|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
44518483|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518484|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44518485|NCT03834506|Dexamethasone|dexamethasone|mesh-list
44518486|NCT03834506|Prednisone|prednisone|mesh-list
44518487|NCT03834506|Docetaxel|docetaxel|mesh-list
44518488|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
44518489|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741164|NCT01626911|Heparin|heparin|mesh-list
44741165|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44741166|NCT01626911|Tinzaparin|tinzaparin|mesh-list
44741167|NCT01626911|Dalteparin|dalteparin|mesh-list
44741168|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
44741169|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44741170|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44741171|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741172|NCT01627041|Cytarabine|cytarabine|mesh-list
44741173|NCT01627041|Decitabine|decitabine|mesh-list
44741174|NCT01627041|Daunorubicin|daunorubicin|mesh-list
44741175|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741176|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
44741177|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741178|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741179|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
44741180|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269370|NCT00671476|Doxorubicin|doxorubicin|mesh-list
44741181|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741182|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
44741183|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741184|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44741185|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44741186|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44741187|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741188|NCT01627106|Amiodarone|amiodarone|mesh-list
44741189|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44741190|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
44741191|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44741192|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741193|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741194|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44269398|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44269404|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
44741195|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44741196|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44741197|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741198|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44741199|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44741200|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44741201|NCT01627132|Dasatinib|dasatinib|mesh-list
44741202|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741203|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44741204|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741205|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741206|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
44741207|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44741208|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44741209|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741210|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741211|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741212|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741213|NCT01627145|Urological Agents|urological agents|mesh-ancestor
44741214|NCT01627158|Budesonide|budesonide|mesh-list
44741215|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
44741216|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44741217|NCT01627158|Charcoal|charcoal|mesh-list
44741218|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741219|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44741220|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
44741221|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741222|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741223|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44741224|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
44741225|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
44741226|NCT01627158|Hormones|hormones|mesh-ancestor
44741227|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269434|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741228|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44741229|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44741230|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44741231|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741232|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741233|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741234|NCT01627158|Antidotes|antidotes|mesh-ancestor
44741235|NCT01627158|Protective Agents|protective agents|mesh-ancestor
44741236|NCT01627171|Bisacodyl|bisacodyl|mesh-list
44741237|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
44741238|NCT01627171|Cathartics|cathartics|mesh-ancestor
44741239|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741240|NCT01627171|Laxatives|laxatives|mesh-ancestor
44741241|NCT01627223|Lamivudine|lamivudine|mesh-list
44741242|NCT01627223|Entecavir|entecavir|mesh-list
44741243|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44741244|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44741245|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269448|NCT00672022|Miglustat|miglustat|mesh-list
44741246|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741247|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
44741248|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741249|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44741250|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44741251|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
44741252|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44741253|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44741254|NCT01627236|Prednisolone|prednisolone|mesh-list
44741255|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
44741256|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44741257|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
44741258|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741259|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
44741260|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
44741261|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741262|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741263|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741264|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
44741265|NCT01627236|Hormones|hormones|mesh-ancestor
44741266|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741267|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44741268|NCT01627236|Protective Agents|protective agents|mesh-ancestor
44741269|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44741270|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741271|NCT01627262|Mesalamine|mesalamine|mesh-list
44741272|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44741273|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741274|NCT01627262|Analgesics|analgesics|mesh-ancestor
44741275|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
44741276|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741277|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686842|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686843|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44686844|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44686845|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44686846|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44686847|NCT01335373|Metronidazole|metronidazole|mesh-list
44686848|NCT01335373|Miconazole|miconazole|mesh-list
44686849|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686850|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686851|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44686852|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44686853|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
44686854|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44686855|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44686856|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686857|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686858|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44686859|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
44686860|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686861|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269504|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44269510|NCT00672360|Folic Acid|folic acid|mesh-list
44686862|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44686863|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44686864|NCT01335386|Glycerol|glycerol|mesh-list
44686865|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44686866|NCT01335386|Protective Agents|protective agents|mesh-ancestor
44238325|NCT00567528|Ibuprofen|ibuprofen|mesh-list
44686885|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
44686886|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686887|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686888|NCT01335685|Prednisone|prednisone|mesh-list
44686889|NCT01335685|Melphalan|melphalan|mesh-list
44686890|NCT01335685|Ixazomib|ixazomib|mesh-list
44686891|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44686892|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
44686893|NCT01335685|Hormones|hormones|mesh-ancestor
44686894|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741278|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741279|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741280|NCT01627353|Dexamethasone|dexamethasone|mesh-list
44741281|NCT01627353|Lidocaine|lidocaine|mesh-list
44741282|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
44741283|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741284|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
44741285|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
44741286|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741287|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741288|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741289|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
44741290|NCT01627353|Hormones|hormones|mesh-ancestor
44741291|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741292|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44741293|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741294|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741295|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
44741296|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
44741297|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741298|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
44741299|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660868|NCT02928575|Sunitinib|sunitinib|mesh-list
44741300|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44741301|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44741302|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741303|NCT01627353|Analgesics|analgesics|mesh-ancestor
44741304|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
44741305|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741306|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741307|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
44741308|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44741309|NCT01627379|Cisplatin|cisplatin|mesh-list
44741310|NCT01627379|Panitumumab|panitumumab|mesh-list
44741311|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741312|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741313|NCT01627431|Aspirin|aspirin|mesh-list
44741314|NCT01627431|Clopidogrel|clopidogrel|mesh-list
44741315|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44741316|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741317|NCT01627431|Analgesics|analgesics|mesh-ancestor
44741318|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
44741319|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741320|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741321|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741322|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741323|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44741324|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44741325|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741326|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44741327|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44741328|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741329|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
44741330|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44741331|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44741332|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44741333|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
44741334|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741335|NCT01627587|Ketoconazole|ketoconazole|mesh-list
44741336|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
44741337|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741338|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44741339|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44741340|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741341|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741342|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44269564|NCT00672659|Citalopram|citalopram|mesh-list
44741343|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
44741344|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741345|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741346|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44741347|NCT01627626|Pilocarpine|pilocarpine|mesh-list
44741348|NCT01627626|Miotics|miotics|mesh-ancestor
44741349|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
44741350|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741351|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741353|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44741354|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741355|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741356|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741357|NCT01627639|Acetazolamide|acetazolamide|mesh-list
44741358|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
44741359|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44741360|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741361|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741362|NCT01627639|Diuretics|diuretics|mesh-ancestor
44741363|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
44741364|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741365|NCT01627678|Molgramostim|molgramostim|mesh-list
44741366|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44741367|NCT01627678|Sargramostim|sargramostim|mesh-list
44741368|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
44741369|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741370|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741371|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44741372|NCT01627678|Antacids|antacids|mesh-ancestor
44741373|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741374|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741375|NCT01627717|Maraviroc|maraviroc|mesh-list
44741376|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44741377|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44741378|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741379|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44741380|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44741381|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
44741382|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741383|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44741384|NCT01627834|Ropinirole|ropinirole|mesh-list
44741385|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44741386|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44741387|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
44741388|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
44741389|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741390|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741391|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741392|NCT01627847|Ropinirole|ropinirole|mesh-list
44741393|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44741394|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44741395|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
44741396|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
44741397|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741398|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269624|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741399|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741400|NCT01627873|Fentanyl|fentanyl|mesh-list
44741401|NCT01627873|Remifentanil|remifentanil|mesh-list
44741402|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44686895|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686896|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44686897|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686898|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44686899|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
44686900|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686901|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44686902|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686903|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
44686904|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
44686905|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686906|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
44269647|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44686907|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686908|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686909|NCT01336010|Ribavirin|ribavirin|mesh-list
44686910|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44686911|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
44686912|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686913|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
44686914|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686915|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
44686916|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44686917|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741403|NCT01627873|Narcotics|narcotics|mesh-ancestor
44741404|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741405|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741406|NCT01627873|Analgesics|analgesics|mesh-ancestor
44741407|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
44741408|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741409|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44741410|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44741411|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
44741412|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
44741413|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
44741414|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44741415|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741416|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
44741417|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
44741418|NCT01627938|Razoxane|razoxane|mesh-list
44741419|NCT01627938|Analgesics|analgesics|mesh-ancestor
44741420|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
44741421|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741422|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741423|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741424|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44741425|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44741426|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741427|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741428|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44741429|NCT01627938|Protective Agents|protective agents|mesh-ancestor
44741430|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44741431|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44741432|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
44741433|NCT01628055|Antibodies|antibodies|mesh-list
44741434|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
44741435|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44741436|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44741437|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
44741438|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
44741439|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741440|NCT01628211|Leucovorin|leucovorin|mesh-list
44741441|NCT01628211|Folic Acid|folic acid|mesh-list
44741442|NCT01628211|Fluorouracil|fluorouracil|mesh-list
44741443|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
44741444|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
44741445|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
44269699|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
44741446|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741447|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741448|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741449|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741450|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
44741451|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741452|NCT01628211|Antidotes|antidotes|mesh-ancestor
44741453|NCT01628211|Protective Agents|protective agents|mesh-ancestor
44741454|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
44741455|NCT01628211|Vitamins|vitamins|mesh-ancestor
44741456|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
44741457|NCT01628211|Hematinics|hematinics|mesh-ancestor
44741458|NCT01628341|Insulin|insulin|mesh-list
44741459|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741460|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741461|NCT01628354|Ranibizumab|ranibizumab|mesh-list
44741462|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44741463|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44741464|NCT01628354|Growth Substances|growth substances|mesh-ancestor
44269718|NCT00673621|Miotics|miotics|mesh-ancestor
44741465|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741466|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
44741467|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741468|NCT01628445|Liraglutide|liraglutide|mesh-list
44741469|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741470|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518790|NCT03835871|Beclomethasone|beclomethasone|mesh-list
44518791|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518792|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
44518793|NCT03835871|Hormones|hormones|mesh-ancestor
44518794|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518795|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518796|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518797|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
44741471|NCT01628445|Incretins|incretins|mesh-ancestor
44741472|NCT01628445|Hormones|hormones|mesh-ancestor
44774252|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269735|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269752|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44741473|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741475|NCT01628471|Genistein|genistein|mesh-list
44741476|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741477|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
44741478|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741479|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741480|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741481|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44741482|NCT01628471|Protective Agents|protective agents|mesh-ancestor
44741483|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741484|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44741485|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
44269753|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
44741486|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44741487|NCT01628471|Estrogens|estrogens|mesh-ancestor
44741488|NCT01628471|Hormones|hormones|mesh-ancestor
44741489|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741490|NCT01628562|Remifentanil|remifentanil|mesh-list
44741491|NCT01628562|Esmolol|esmolol|mesh-list
44741492|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44741493|NCT01628562|Narcotics|narcotics|mesh-ancestor
44741494|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741495|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741496|NCT01628562|Analgesics|analgesics|mesh-ancestor
44741497|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
44741498|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741499|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44741500|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44741501|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44741502|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741503|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741504|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518855|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
44518871|NCT03834012|Beclomethasone|beclomethasone|mesh-list
44741505|NCT01628666|Vancomycin|vancomycin|mesh-list
44741506|NCT01628666|Cefazolin|cefazolin|mesh-list
44741507|NCT01628666|Cephalexin|cephalexin|mesh-list
44741508|NCT01628666|Bacitracin|bacitracin|mesh-list
44741509|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44741510|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741511|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44741512|NCT01628731|Furosemide|furosemide|mesh-list
44741513|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
44741514|NCT01628731|Diuretics|diuretics|mesh-ancestor
44741515|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
44741516|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741517|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44741518|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741519|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741520|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741521|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44741522|NCT01628770|Hematinics|hematinics|mesh-ancestor
44741523|NCT01628783|Citalopram|citalopram|mesh-list
44741524|NCT01628783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44741525|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44741526|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741527|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741528|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741529|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
44741530|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741531|NCT01628783|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44741532|NCT01628783|Antidepressive Agents|antidepressive agents|mesh-ancestor
44741533|NCT01628783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44741534|NCT01628952|Curare|curare|mesh-list
44741535|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44741536|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44741537|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44741538|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741539|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741540|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44741541|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44741542|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741543|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741544|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741545|NCT01629082|Lenalidomide|lenalidomide|mesh-list
44741546|NCT01629082|Clofarabine|clofarabine|mesh-list
44741547|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
44269815|NCT00674414|Trastuzumab|trastuzumab|mesh-list
44741548|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741549|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44741550|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44741551|NCT01629082|Growth Substances|growth substances|mesh-ancestor
44741552|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
44741553|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741554|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741555|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
44741556|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741557|NCT01629173|Ethylene|ethylene|mesh-list
44741558|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44741559|NCT01629173|Growth Substances|growth substances|mesh-ancestor
44741560|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741561|NCT01629199|Mitogens|mitogens|mesh-list
44741562|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44741563|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741564|NCT01629212|Octylonium|octylonium|mesh-list
44741565|NCT01629212|Bromides|bromides|mesh-list
44741566|NCT01629212|Tiropramide|tiropramide|mesh-list
44741567|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
44741568|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
44741569|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
44741570|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741571|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741572|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741573|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741574|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741575|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741576|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741577|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44741578|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44741579|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741580|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741581|NCT01629225|Candesartan|candesartan|mesh-list
44741582|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741583|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44741584|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44741585|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741586|NCT01629251|Insulin|insulin|mesh-list
44741587|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741588|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741589|NCT01629277|Insulin|insulin|mesh-list
44741590|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741591|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741592|NCT01629368|Carbamazepine|carbamazepine|mesh-list
44741593|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
44741594|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
44741595|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44686918|NCT01336062|Paclitaxel|paclitaxel|mesh-list
44686919|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44686920|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686921|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686922|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44686923|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
44686924|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
44686925|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686927|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
44686928|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686929|NCT01336192|Gemcitabine|gemcitabine|mesh-list
44269857|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44686930|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686931|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
44686932|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686933|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686934|NCT01336192|Antiviral Agents|antiviral agents|mesh-ancestor
44686935|NCT01336192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686936|NCT01336192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686937|NCT01336192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686938|NCT01336192|Immunologic Factors|immunologic factors|mesh-ancestor
44686939|NCT01336192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686940|NCT01336218|Rifampin|rifampin|mesh-list
44686941|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44686942|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
44686943|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44686944|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686945|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
44686946|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44686947|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686948|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686949|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44686950|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44686951|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44269873|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
44686952|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44686953|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44686954|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44686955|NCT01336322|Metformin|metformin|mesh-list
44686956|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44686957|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44686958|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686959|NCT01336322|Incretins|incretins|mesh-ancestor
44686960|NCT01336322|Hormones|hormones|mesh-ancestor
44686961|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44686962|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44686963|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44686964|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686965|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686966|NCT01336348|Tirofiban|tirofiban|mesh-list
44686967|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44686968|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44686969|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44686970|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44686971|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686972|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
44686973|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44686974|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44519006|NCT03832465|Levofloxacin|levofloxacin|mesh-list
44741596|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741597|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741599|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741600|NCT01629368|Analgesics|analgesics|mesh-ancestor
44741601|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
44741602|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741603|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44741604|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269893|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44741605|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741606|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44741607|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44741608|NCT01629394|Neostigmine|neostigmine|mesh-list
44741609|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44741610|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741611|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741612|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741613|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741614|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741615|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44741616|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
44741617|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741618|NCT01629446|Lofexidine|lofexidine|mesh-list
44741619|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741620|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44741621|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741622|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
44741623|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741624|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44741625|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44741626|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44741627|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741628|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741629|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741630|NCT01629511|Gemcitabine|gemcitabine|mesh-list
44741631|NCT01629511|Methotrexate|methotrexate|mesh-list
44741632|NCT01629511|Clofarabine|clofarabine|mesh-list
44741633|NCT01629511|Busulfan|busulfan|mesh-list
44741634|NCT01629511|Tacrolimus|tacrolimus|mesh-list
44741635|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
44741636|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44741637|NCT01629511|Lenograstim|lenograstim|mesh-list
44741638|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741639|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
44741640|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741641|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741642|NCT01629511|Antiviral Agents|antiviral agents|mesh-ancestor
44741643|NCT01629511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741644|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741645|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741646|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
44741647|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741648|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44741649|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
44741650|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44741651|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
44741652|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44741653|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741654|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44741655|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44741656|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44741657|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
44741658|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44741659|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44741660|NCT01629628|Adalimumab|adalimumab|mesh-list
44741661|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
44741662|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741663|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741664|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
44741665|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741666|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741667|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741668|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741669|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
44741670|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741671|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44741672|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741673|NCT01629680|Moxaverine|moxaverine|mesh-list
44741674|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
44741675|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
44741676|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741677|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269983|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741678|NCT01629732|Ribavirin|ribavirin|mesh-list
44741679|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
44741680|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741681|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
44741682|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741683|NCT01629758|Nivolumab|nivolumab|mesh-list
44741684|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44741685|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741686|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44741687|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741688|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44741689|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44741690|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44741691|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741692|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741693|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44741694|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741695|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741696|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741697|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741698|NCT01630018|Topotecan|topotecan|mesh-list
44741699|NCT01630018|Belotecan|belotecan|mesh-list
44741700|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44741701|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44741702|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741703|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741704|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741705|NCT01630057|Zonisamide|zonisamide|mesh-list
44741706|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
44741707|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741708|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741709|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741710|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741711|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741712|NCT01630070|Paclitaxel|paclitaxel|mesh-list
44741713|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44741714|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269999|NCT00675649|Golimumab|golimumab|mesh-list
44741715|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44741716|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44741717|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44741718|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741719|NCT01630083|Capecitabine|capecitabine|mesh-list
44741720|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
44741721|NCT01630083|Epirubicin|epirubicin|mesh-list
44741722|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741723|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
44741724|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741725|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741726|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44519094|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44519095|NCT03830957|Metoprolol|metoprolol|mesh-list
44519096|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44519097|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44519098|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
44519099|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
44519100|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519101|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519102|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44519103|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44519104|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44519105|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519106|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519107|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519108|NCT03830684|Baicalein|baicalein|mesh-list
44519109|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
44519110|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741727|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44741728|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44741729|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741730|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44741731|NCT01630096|Laxatives|laxatives|mesh-ancestor
44741732|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741733|NCT01630148|Bemiparin|bemiparin|mesh-list
44741734|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
44741735|NCT01630187|Carbetocin|carbetocin|mesh-list
44741736|NCT01630187|Oxytocin|oxytocin|mesh-list
44741737|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
44741738|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44741739|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741740|NCT01630226|Cisplatin|cisplatin|mesh-list
44741741|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741742|NCT01630278|Ibuprofen|ibuprofen|mesh-list
44741743|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44741744|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741745|NCT01630278|Analgesics|analgesics|mesh-ancestor
44741746|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
44741747|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741748|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741749|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741750|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741751|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44741752|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741753|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519150|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
44741754|NCT01630343|Acetaminophen|acetaminophen|mesh-list
44741755|NCT01630343|Tramadol|tramadol|mesh-list
44741756|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741757|NCT01630343|Analgesics|analgesics|mesh-ancestor
44741758|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
44741759|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741760|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741761|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
44741762|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44741763|NCT01630343|Narcotics|narcotics|mesh-ancestor
44741764|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741765|NCT01630369|Insulin|insulin|mesh-list
44741766|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44741767|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741768|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741769|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
44741770|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741771|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
44741772|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741773|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741774|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44741775|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
44741776|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741777|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741778|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44741779|NCT01630564|Aldesleukin|aldesleukin|mesh-list
44741780|NCT01630564|Interleukin-2|interleukin-2|mesh-list
44741781|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741782|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741783|NCT01630564|Analgesics|analgesics|mesh-ancestor
44741784|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
44741785|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741786|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741787|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44741788|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44741789|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
44741790|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741791|NCT01630642|Clopidogrel|clopidogrel|mesh-list
44741792|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44741793|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44741794|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44741795|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44741796|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
44741797|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741798|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741799|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741800|NCT01630655|Felodipine|felodipine|mesh-list
44741801|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44741802|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741803|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44270139|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
44741804|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741805|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741806|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741807|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741808|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
44741809|NCT01630720|Vitamin D|vitamin d|mesh-list
44741810|NCT01630720|Vitamins|vitamins|mesh-list
44741811|NCT01630720|Ascorbic Acid|ascorbic acid|mesh-list
44741812|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
44741813|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741814|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44741815|NCT01630720|Antioxidants|antioxidants|mesh-ancestor
44741816|NCT01630720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741817|NCT01630720|Protective Agents|protective agents|mesh-ancestor
44741818|NCT01630733|Docetaxel|docetaxel|mesh-list
44741819|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741820|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
44741821|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
44741822|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
44741823|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741824|NCT01630902|Felodipine|felodipine|mesh-list
44741825|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44741826|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741827|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741828|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741829|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741830|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741831|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741833|NCT01630915|Clopidogrel|clopidogrel|mesh-list
44741834|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44741835|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44741836|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44741837|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44741838|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
44741839|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741840|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741841|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741842|NCT01630941|Denosumab|denosumab|mesh-list
44741843|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44686975|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44686976|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44686977|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686978|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44686979|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44686980|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686981|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44686982|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44686983|NCT01336543|Gemcitabine|gemcitabine|mesh-list
44686984|NCT01336543|Cisplatin|cisplatin|mesh-list
44686985|NCT01336543|Etoposide|etoposide|mesh-list
44686986|NCT01336543|Pemetrexed|pemetrexed|mesh-list
44686987|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44686988|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44686989|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
44686990|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44686991|NCT01336543|Antiviral Agents|antiviral agents|mesh-ancestor
44686992|NCT01336543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44686993|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44686994|NCT01336543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44686995|NCT01336543|Immunologic Factors|immunologic factors|mesh-ancestor
44686996|NCT01336543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44686997|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44686998|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44686999|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44687000|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44687001|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687002|NCT01336582|Docetaxel|docetaxel|mesh-list
44687003|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687004|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44687005|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44687006|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44687007|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687008|NCT01336595|Cobalt|cobalt|mesh-list
44687009|NCT01336595|Triamcinolone|triamcinolone|mesh-list
44687010|NCT01336595|Trace Elements|trace elements|mesh-ancestor
44687011|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
44687012|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687013|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687014|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
44687015|NCT01336595|Hormones|hormones|mesh-ancestor
44687016|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687017|NCT01336621|Ezogabine|ezogabine|mesh-list
44687018|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
44687019|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44687020|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687021|NCT01336660|Antivenins|antivenins|mesh-list
44687022|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
44687023|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687024|NCT01336751|Insulin|insulin|mesh-list
44687025|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44687026|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
44687027|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
44687028|NCT01336751|Protamines|protamines|mesh-list
44687029|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687030|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687031|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
44687032|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687033|NCT01336751|Coagulants|coagulants|mesh-ancestor
44741844|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741845|NCT01631058|Prednisone|prednisone|mesh-list
44741846|NCT01631058|Everolimus|everolimus|mesh-list
44741847|NCT01631058|Lactitol|lactitol|mesh-list
44741848|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741849|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
44741850|NCT01631058|Hormones|hormones|mesh-ancestor
44741851|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44741852|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741853|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44741854|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741855|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741856|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
44741857|NCT01631058|Cathartics|cathartics|mesh-ancestor
44741858|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741859|NCT01631136|Gemcitabine|gemcitabine|mesh-list
44741860|NCT01631136|Cisplatin|cisplatin|mesh-list
44741861|NCT01631136|Pemetrexed|pemetrexed|mesh-list
44741862|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741863|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741864|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
44741865|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741866|NCT01631136|Antiviral Agents|antiviral agents|mesh-ancestor
44741867|NCT01631136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741868|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741869|NCT01631136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741870|NCT01631136|Immunologic Factors|immunologic factors|mesh-ancestor
44741871|NCT01631136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741872|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44741873|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44741874|NCT01631201|Azithromycin|azithromycin|mesh-list
44741875|NCT01631201|KRM 1648|krm 1648|mesh-list
44741876|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44741877|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741878|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44741879|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
44741880|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
44741881|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
44741882|NCT01631305|Calcium|calcium|mesh-list
44741883|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741884|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741885|NCT01631305|Antacids|antacids|mesh-ancestor
44741886|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741887|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44741888|NCT01631357|Gemcitabine|gemcitabine|mesh-list
44741889|NCT01631357|Cisplatin|cisplatin|mesh-list
44741890|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44741891|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44741892|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
44741893|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741894|NCT01631357|Antiviral Agents|antiviral agents|mesh-ancestor
44741895|NCT01631357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44741896|NCT01631357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741897|NCT01631357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44741898|NCT01631357|Immunologic Factors|immunologic factors|mesh-ancestor
44741899|NCT01631357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741900|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
44774253|NCT01847768|Miotics|miotics|mesh-ancestor
44741901|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44741902|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741903|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741904|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741905|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741906|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741907|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741908|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44741909|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44741910|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741911|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44741912|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44741913|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
44741914|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741915|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741916|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741917|NCT01631383|Analgesics|analgesics|mesh-ancestor
44741918|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
44741919|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270286|NCT00677027|Lentinan|lentinan|mesh-list
44741920|NCT01631396|Neostigmine|neostigmine|mesh-list
44741921|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44741922|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741923|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741924|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
44741925|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741926|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741927|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44741928|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
44741929|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741931|NCT01631409|Atenolol|atenolol|mesh-list
44741932|NCT01631409|Enalapril|enalapril|mesh-list
44741933|NCT01631409|Enalaprilat|enalaprilat|mesh-list
44741934|NCT01631409|Amlodipine|amlodipine|mesh-list
44741935|NCT01631409|Isosorbide|isosorbide|mesh-list
44741936|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44741937|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44741938|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
44741939|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44270303|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
44270320|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741940|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44741941|NCT01631409|Analgesics|analgesics|mesh-ancestor
44741942|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
44741943|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741944|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741945|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44741946|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44741947|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44741948|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44741949|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741950|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44741951|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44741952|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44741953|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
44270321|NCT00677300|Ritonavir|ritonavir|mesh-list
44270322|NCT00677300|Darunavir|darunavir|mesh-list
44741954|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44741955|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
44741956|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44741957|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44741958|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
44741959|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
44741960|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44741961|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44741962|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44741963|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741964|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44741965|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44741966|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741967|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44741968|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44741969|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44741970|NCT01631409|Diuretics|diuretics|mesh-ancestor
44741971|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
44741972|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44741973|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44741974|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
44741975|NCT01631448|Coagulants|coagulants|mesh-ancestor
44741976|NCT01631513|Tapentadol|tapentadol|mesh-list
44741977|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44741978|NCT01631513|Narcotics|narcotics|mesh-ancestor
44741979|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44741980|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741981|NCT01631513|Analgesics|analgesics|mesh-ancestor
44741982|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
44741983|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44741984|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44741985|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44741986|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44741987|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44741988|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
44741989|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519391|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44519392|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44519393|NCT05444569|Liraglutide|liraglutide|mesh-list
44519394|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44741990|NCT01631526|Vitamin D|vitamin d|mesh-list
44741991|NCT01631526|Vitamins|vitamins|mesh-ancestor
44741992|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
44741993|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44741994|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44741996|NCT01631539|Cetuximab|cetuximab|mesh-list
44741997|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44741998|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44741999|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742000|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742001|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742002|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742003|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
44742004|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44742005|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742006|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742007|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
44742008|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742009|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742010|NCT01631669|Celecoxib|celecoxib|mesh-list
44742011|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44742012|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742013|NCT01631669|Analgesics|analgesics|mesh-ancestor
44742014|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
44742015|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742016|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742017|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742018|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742019|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44742020|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44742021|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742022|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742023|NCT01631838|Tocotrienols|tocotrienols|mesh-list
44742024|NCT01631838|Vitamin E|vitamin e|mesh-list
44742025|NCT01631838|Tocopherols|tocopherols|mesh-list
44742026|NCT01631838|Tocovid|tocovid|mesh-list
44742027|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
44742028|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742029|NCT01631838|Protective Agents|protective agents|mesh-ancestor
44742030|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742031|NCT01631838|Vitamins|vitamins|mesh-ancestor
44742032|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
44742033|NCT01631877|Enoxaparin|enoxaparin|mesh-list
44742034|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
44742035|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
44742036|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44742037|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44742038|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742039|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44742040|NCT01631968|Colistin|colistin|mesh-list
44742041|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742042|NCT01631994|Metoclopramide|metoclopramide|mesh-list
44742043|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
44742044|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
44742045|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742046|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742047|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44742048|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44742049|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44742050|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
44270399|NCT00677755|Misoprostol|misoprostol|mesh-list
44742051|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742052|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742053|NCT01632007|Alogliptin|alogliptin|mesh-list
44742054|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44742055|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742056|NCT01632007|Incretins|incretins|mesh-ancestor
44742057|NCT01632007|Hormones|hormones|mesh-ancestor
44742058|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44742059|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44742060|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44742061|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742062|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742063|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
44742064|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44742065|NCT01632163|Lixisenatide|lixisenatide|mesh-list
44742066|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44742067|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742068|NCT01632189|Varenicline|varenicline|mesh-list
44742069|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44742070|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44742071|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
44270435|NCT00678132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742072|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742073|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742074|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742075|NCT01632371|Paclitaxel|paclitaxel|mesh-list
44742076|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44742077|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44742078|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742079|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
44742080|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
44742081|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
44742082|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742083|NCT01632436|Pixantrone|pixantrone|mesh-list
44742084|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44742085|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44742086|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742087|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742088|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742089|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
44742090|NCT01632514|Vitamin D|vitamin d|mesh-list
44742091|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742092|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742093|NCT01632514|Vitamins|vitamins|mesh-ancestor
44742094|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
44742095|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742096|NCT01632540|Beclomethasone|beclomethasone|mesh-list
44742097|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742098|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
44742099|NCT01632540|Hormones|hormones|mesh-ancestor
44742100|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44742101|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742102|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44742103|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44742104|NCT01632592|Tesamorelin|tesamorelin|mesh-list
44742105|NCT01632592|Growth Substances|growth substances|mesh-ancestor
44742106|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742107|NCT01632605|Sirolimus|sirolimus|mesh-list
44742108|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44742109|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742110|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44742111|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742112|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
44742113|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742114|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
44742115|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742116|NCT01632722|Bevacizumab|bevacizumab|mesh-list
44742117|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742118|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742119|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742120|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742121|NCT01632722|Growth Substances|growth substances|mesh-ancestor
44742122|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742123|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742124|NCT01632761|Vitamin D|vitamin d|mesh-list
44742125|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
44742126|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
44742127|NCT01632761|Vitamins|vitamins|mesh-list
44742128|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
44742129|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742130|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742131|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742132|NCT01632826|Pomalidomide|pomalidomide|mesh-list
44742133|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
44742134|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742135|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742136|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742137|NCT01632826|Growth Substances|growth substances|mesh-ancestor
44742138|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742139|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742140|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
44742141|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44742142|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
44742143|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742144|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742145|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44742146|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
44742147|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44742148|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
44742149|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687034|NCT01336829|Rilpivirine|rilpivirine|mesh-list
44687035|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44687036|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687037|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687038|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687039|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
44687040|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687041|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687042|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687043|NCT01336842|Cisplatin|cisplatin|mesh-list
44687044|NCT01336842|Pemetrexed|pemetrexed|mesh-list
44687045|NCT01336842|Panobinostat|panobinostat|mesh-list
44687046|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687047|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687048|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687049|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44687050|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687051|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44687052|NCT01336985|Irinotecan|irinotecan|mesh-list
44687053|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44687054|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44687055|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687056|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687057|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687058|NCT01337219|Tobramycin|tobramycin|mesh-list
44687059|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687060|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687061|NCT01337258|Dutasteride|dutasteride|mesh-list
44687062|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44687063|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44687064|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687065|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687066|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
44687067|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687068|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687069|NCT01337323|Fluticasone|fluticasone|mesh-list
44687070|NCT01337323|Xhance|xhance|mesh-list
44687071|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687072|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44687073|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
44687074|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687076|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44687077|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44687078|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44687079|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44687080|NCT01337362|Insulin|insulin|mesh-list
44687081|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44687082|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687083|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687084|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44687085|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
44687086|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
44687087|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687088|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
44687089|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687090|NCT01337401|Cediranib|cediranib|mesh-list
44687091|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687092|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687093|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687094|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687095|NCT01337427|Interferons|interferons|mesh-list
44687096|NCT01337427|Interferon-beta|interferon-beta|mesh-list
44687097|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
44687098|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687099|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
44687100|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462797|NCT01524289|Anacetrapib|anacetrapib|mesh-list
44687101|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
44742150|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742151|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44742152|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
44742154|NCT01633086|Protective Agents|protective agents|mesh-ancestor
44742155|NCT01633099|Decitabine|decitabine|mesh-list
44742156|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742157|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
44742158|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742159|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742160|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742161|NCT01633177|Vitamin D|vitamin d|mesh-list
44742162|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
44742163|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
44742164|NCT01633177|Vitamins|vitamins|mesh-list
44742165|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
44742166|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742167|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742168|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742169|NCT01633203|Cisplatin|cisplatin|mesh-list
44742170|NCT01633203|Capecitabine|capecitabine|mesh-list
44742171|NCT01633203|Epirubicin|epirubicin|mesh-list
44742172|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742173|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742174|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
44742175|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742176|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44742177|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44742178|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44742179|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742180|NCT01633294|Gentamicins|gentamicins|mesh-list
44742181|NCT01633294|Ampicillin|ampicillin|mesh-list
44742182|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44742183|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742184|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44742185|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742186|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742187|NCT01633359|Atorvastatin|atorvastatin|mesh-list
44742188|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44742189|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44742190|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44742191|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
44742192|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742193|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44742194|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742195|NCT01633450|Zinc|zinc|mesh-list
44742196|NCT01633450|Trace Elements|trace elements|mesh-ancestor
44742197|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
44742198|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742199|NCT01633476|Valacyclovir|valacyclovir|mesh-list
44742200|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
44742201|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742202|NCT01633593|Donepezil|donepezil|mesh-list
44742203|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44742204|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742205|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742206|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
44742207|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742208|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742209|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
44742210|NCT01633645|Gemcitabine|gemcitabine|mesh-list
44742211|NCT01633645|Cisplatin|cisplatin|mesh-list
44742212|NCT01633645|Bortezomib|bortezomib|mesh-list
44742213|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742214|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742215|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
44742216|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742217|NCT01633645|Antiviral Agents|antiviral agents|mesh-ancestor
44742218|NCT01633645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742219|NCT01633645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742220|NCT01633645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742221|NCT01633645|Immunologic Factors|immunologic factors|mesh-ancestor
44742222|NCT01633645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742223|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
44742224|NCT01633658|Vitamin D|vitamin d|mesh-list
44742225|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44519555|NCT05441761|Cisplatin|cisplatin|mesh-list
44742226|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742227|NCT01633658|Vitamins|vitamins|mesh-ancestor
44742228|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
44742229|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742230|NCT01633749|Vaccines|vaccines|mesh-list
44742231|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
44742232|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742233|NCT01633762|Vancomycin|vancomycin|mesh-list
44742234|NCT01633762|Gentamicins|gentamicins|mesh-list
44742235|NCT01633762|Meropenem|meropenem|mesh-list
44742236|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44742237|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742238|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44742239|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742240|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742241|NCT01633957|Warfarin|warfarin|mesh-list
44742242|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
44519629|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
44742243|NCT01633970|Leucovorin|leucovorin|mesh-list
44742244|NCT01633970|Paclitaxel|paclitaxel|mesh-list
44742245|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44742246|NCT01633970|Bevacizumab|bevacizumab|mesh-list
44742247|NCT01633970|Carboplatin|carboplatin|mesh-list
44742248|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
44742249|NCT01633970|Pemetrexed|pemetrexed|mesh-list
44742250|NCT01633970|Atezolizumab|atezolizumab|mesh-list
44742251|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44742252|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742253|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44742254|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44742255|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44742256|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742257|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742258|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742259|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742260|NCT01633970|Growth Substances|growth substances|mesh-ancestor
44742261|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742262|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742263|NCT01633970|Antidotes|antidotes|mesh-ancestor
44742264|NCT01633970|Protective Agents|protective agents|mesh-ancestor
44742265|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
44742266|NCT01633970|Vitamins|vitamins|mesh-ancestor
44742267|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
44742268|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742269|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44742270|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44742271|NCT01633983|Methotrexate|methotrexate|mesh-list
44742272|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44742273|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
44742274|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44742275|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742276|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742277|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
44742278|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742279|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742280|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44742281|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742282|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44742283|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742284|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
44742285|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742286|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44742287|NCT01634061|Dactolisib|dactolisib|mesh-list
44742288|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742289|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
44742290|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742291|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
44742292|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742293|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742294|NCT01634295|Niacin|niacin|mesh-list
44742295|NCT01634295|Amlodipine|amlodipine|mesh-list
44742296|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44742297|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44270694|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742298|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742299|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742300|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742301|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742302|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
44742303|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44742304|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
44742305|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44742306|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
44742307|NCT01634295|Vitamins|vitamins|mesh-ancestor
44742308|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
44742309|NCT01634321|Leuprolide|leuprolide|mesh-list
44519705|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519706|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519707|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519708|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519709|NCT01056159|Albuterol|albuterol|mesh-list
44519710|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44519711|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
44742310|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44742311|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
44742312|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44742313|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742314|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44742315|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742316|NCT01634347|Propranolol|propranolol|mesh-list
44742317|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44742318|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44742319|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44742320|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742321|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742322|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742323|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44742324|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44742325|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
44742326|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44742327|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
44742328|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742329|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44742330|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742331|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742332|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742333|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44742334|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
44742335|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742336|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44742337|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742338|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742339|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742340|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44742341|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
44742342|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742343|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44742344|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742345|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742346|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742347|NCT01634412|Amitriptyline|amitriptyline|mesh-list
44742348|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
44742349|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44742350|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
44742351|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742352|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44742353|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742354|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44742355|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742356|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742357|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742358|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742359|NCT01634412|Analgesics|analgesics|mesh-ancestor
44742360|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
44742361|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44742362|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44742363|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742364|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742365|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44742366|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742367|NCT01634438|Heparin|heparin|mesh-list
44742368|NCT01634438|Calcium heparin|calcium heparin|mesh-list
44742369|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
44742370|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44742371|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44742372|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742373|NCT01634594|Nicardipine|nicardipine|mesh-list
44742374|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
44742375|NCT01634594|Remifentanil|remifentanil|mesh-list
44742376|NCT01634594|Sevoflurane|sevoflurane|mesh-list
44742377|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44742378|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270761|NCT00679536|Fludarabine|fludarabine|mesh-list
44742379|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742380|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742381|NCT01634594|Analgesics|analgesics|mesh-ancestor
44742382|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
44742383|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742384|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44742385|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44742386|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44742387|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44742388|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742389|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742390|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44742391|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44742392|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
44742393|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
44742394|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44742395|NCT01634594|Narcotics|narcotics|mesh-ancestor
44742396|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44742397|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44742398|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742399|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742400|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44270785|NCT00679614|Narcotics|narcotics|mesh-ancestor
44742401|NCT01634685|Capecitabine|capecitabine|mesh-list
44742402|NCT01634685|Bavituximab|bavituximab|mesh-list
44742403|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742404|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
44742405|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742406|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687102|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687103|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44687104|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44687105|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44687106|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687107|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687108|NCT01337440|Incretins|incretins|mesh-ancestor
44687109|NCT01337440|Hormones|hormones|mesh-ancestor
44270808|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687110|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687111|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44687112|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
44687113|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687114|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687115|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44687116|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687117|NCT01337466|Fialuridine|fialuridine|mesh-list
44687118|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
44687119|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687120|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687121|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687122|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687123|NCT01337492|Sorafenib|sorafenib|mesh-list
44687124|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687125|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687126|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687127|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687128|NCT01337518|Androgens|androgens|mesh-list
44687129|NCT01337518|Hormones|hormones|mesh-ancestor
44687130|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687131|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687132|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
44687133|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44687134|NCT01337570|Dapivirine|dapivirine|mesh-list
44687135|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687136|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687137|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
44687138|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687139|NCT01337583|Dapivirine|dapivirine|mesh-list
44687140|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687141|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687142|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
44687143|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687144|NCT01337765|Dactolisib|dactolisib|mesh-list
44687145|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687146|NCT01337791|Telbivudine|telbivudine|mesh-list
44687147|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
44687148|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687149|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687150|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687159|NCT01338077|Omeprazole|omeprazole|mesh-list
44687160|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44687161|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687162|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44742407|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44687163|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519786|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742408|NCT01634698|Vitamin A|vitamin a|mesh-list
44742409|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
44742410|NCT01634698|Vitamins|vitamins|mesh-ancestor
44742411|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
44742412|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742413|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
44774254|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
44742414|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742415|NCT01634698|Protective Agents|protective agents|mesh-ancestor
44742416|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44742417|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742418|NCT01634763|Ceritinib|ceritinib|mesh-list
44742419|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742420|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44742421|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742422|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742423|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
44742424|NCT01634789|Estrogens|estrogens|mesh-list
44742425|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44742426|NCT01634789|Hormones|hormones|mesh-ancestor
44742427|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44742428|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742429|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44742430|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44742431|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
44742432|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742433|NCT01634880|Panitumumab|panitumumab|mesh-list
44691254|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742434|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742435|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742436|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
44742437|NCT01634893|Sorafenib|sorafenib|mesh-list
44742438|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742439|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44742440|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742441|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742442|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
44742443|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742444|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742445|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742446|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742447|NCT01634906|Atorvastatin|atorvastatin|mesh-list
44742448|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44742449|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44742450|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44742451|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
44742452|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742453|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44742454|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44742455|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742456|NCT01634932|Iron|iron|mesh-list
44742457|NCT01634932|Trace Elements|trace elements|mesh-ancestor
44270902|NCT00680212|Beta Carotene|beta carotene|mesh-list
44742458|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
44742459|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742460|NCT01634945|Amodiaquine|amodiaquine|mesh-list
44742461|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
44742462|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742463|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742464|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742465|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44742466|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44742467|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
44742468|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742469|NCT01634958|Antacids|antacids|mesh-ancestor
44742470|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742471|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44742472|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
44742473|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742474|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
44270928|NCT00680355|Carotenoids|carotenoids|mesh-list
44742475|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44742476|NCT01635114|Resveratrol|resveratrol|mesh-list
44742477|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
44742478|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742479|NCT01635114|Protective Agents|protective agents|mesh-ancestor
44742480|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742481|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742482|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44742483|NCT01635205|Anesthetics|anesthetics|mesh-list
44742484|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742485|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742487|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742488|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
44742489|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742490|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742491|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
44742492|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742493|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742494|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
44742495|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742496|NCT01635400|Irinotecan|irinotecan|mesh-list
44462821|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742497|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44742498|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44742499|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742500|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742501|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742502|NCT01635426|Aspirin|aspirin|mesh-list
44742503|NCT01635426|Clopidogrel|clopidogrel|mesh-list
44742504|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44742505|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742506|NCT01635426|Analgesics|analgesics|mesh-ancestor
44742507|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
44742508|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742509|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742510|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742511|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742512|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44742513|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44742514|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742515|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44742516|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44742517|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742518|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
44742519|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44742520|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44742521|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44742522|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
44742523|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742524|NCT01635530|Doxycycline|doxycycline|mesh-list
44742525|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
44742526|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44742527|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742528|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
44742529|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742530|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742531|NCT01635608|Acetaminophen|acetaminophen|mesh-list
44742532|NCT01635608|Amoxicillin|amoxicillin|mesh-list
44742533|NCT01635608|Talinolol|talinolol|mesh-list
44742534|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742535|NCT01635608|Analgesics|analgesics|mesh-ancestor
44742536|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
44742537|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742538|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742539|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
44742540|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44742541|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742542|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44742543|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44742544|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
44742545|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742546|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742547|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44742548|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44742549|NCT01635686|Etanercept|etanercept|mesh-list
44742550|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44742551|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742552|NCT01635686|Analgesics|analgesics|mesh-ancestor
44742553|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
44742554|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742555|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742556|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742557|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742558|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44742559|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742560|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
44742561|NCT01635751|Pregabalin|pregabalin|mesh-list
44742562|NCT01635751|Analgesics|analgesics|mesh-ancestor
44742563|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
44742564|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742565|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742566|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
44742567|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44742568|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742569|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271005|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742570|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742571|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44742572|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742573|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742574|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742575|NCT01635777|Miltefosine|miltefosine|mesh-list
44742576|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
44742577|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742578|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742579|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742580|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742581|NCT01635790|Bevacizumab|bevacizumab|mesh-list
44742582|NCT01635790|Ranibizumab|ranibizumab|mesh-list
44742583|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742584|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742585|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742586|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742587|NCT01635790|Growth Substances|growth substances|mesh-ancestor
44742588|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742589|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742590|NCT01635803|Bevacizumab|bevacizumab|mesh-list
44742591|NCT01635803|Ranibizumab|ranibizumab|mesh-list
44742592|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44742593|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742594|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742595|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742596|NCT01635803|Growth Substances|growth substances|mesh-ancestor
44742597|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742598|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742599|NCT01635816|Vaccines|vaccines|mesh-list
44742600|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
44742601|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742602|NCT01635829|Carbamazepine|carbamazepine|mesh-list
44742603|NCT01635829|Phenytoin|phenytoin|mesh-list
44742604|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
44742605|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
44742606|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742607|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742608|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742609|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742610|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742611|NCT01635829|Analgesics|analgesics|mesh-ancestor
44742612|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
44742613|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742614|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44742615|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742616|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519959|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519960|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519961|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519962|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44271049|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
44519963|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519964|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519965|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
44742617|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44742618|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44742619|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44742620|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44742621|NCT01635946|Isavuconazole|isavuconazole|mesh-list
44742622|NCT01635946|Atorvastatin|atorvastatin|mesh-list
44742623|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44742624|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44742625|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
44742626|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742627|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44742628|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44742629|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742630|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
44742631|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742632|NCT01635972|Isavuconazole|isavuconazole|mesh-list
44742633|NCT01635972|Bupropion|bupropion|mesh-list
44271073|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
44742634|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44742635|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
44742636|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742637|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44742638|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44742639|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44742640|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742641|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
44742642|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742643|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742644|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44271095|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44742645|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44742646|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742647|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
44742648|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742649|NCT01636037|Levodopa|levodopa|mesh-list
44742650|NCT01636037|Carbidopa|carbidopa|mesh-list
44742651|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44742652|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44742653|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44742654|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
44742655|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742656|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742657|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742658|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44742659|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742660|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44742661|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
44742662|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
44742663|NCT01636128|Eflornithine|eflornithine|mesh-list
44742664|NCT01636128|Sulindac|sulindac|mesh-list
44742665|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742666|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44742667|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742668|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742669|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742670|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44742671|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742672|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742673|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44742674|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742675|NCT01636128|Analgesics|analgesics|mesh-ancestor
44742676|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
44742677|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742678|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742679|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742680|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742681|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44742682|NCT01636141|Dapansutrile|dapansutrile|mesh-list
44742683|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742684|NCT01636180|Clopidogrel|clopidogrel|mesh-list
44742685|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44742686|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44742687|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44742688|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44519985|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742689|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
44742690|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742691|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742692|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742693|NCT01636245|Vaccines|vaccines|mesh-list
44742694|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
44742695|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742696|NCT01636271|Darapladib|darapladib|mesh-list
44742697|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44742698|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742699|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742700|NCT01636310|Nicotine|nicotine|mesh-list
44742701|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44742702|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
44742703|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742704|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742705|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44742706|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44742707|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44742708|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742709|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742710|NCT01636323|Nicotine|nicotine|mesh-list
44742711|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44742712|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
44742713|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742714|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742715|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44742716|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44742717|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
44742718|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742719|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742720|NCT01636336|Nicotine|nicotine|mesh-list
44742721|NCT01636336|Progesterone|progesterone|mesh-list
44742722|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44742723|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
44742724|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742725|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742726|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44742727|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44742728|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
44742729|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742730|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742731|NCT01636336|Progestins|progestins|mesh-ancestor
44742732|NCT01636336|Hormones|hormones|mesh-ancestor
44742733|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44742734|NCT01636401|Bromides|bromides|mesh-list
44742735|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
44742736|NCT01636505|Cetrorelix|cetrorelix|mesh-list
44742737|NCT01636505|Buserelin|buserelin|mesh-list
44742738|NCT01636505|Ganirelix|ganirelix|mesh-list
44742739|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44742740|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
44742741|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44742742|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742743|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
44742744|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44742745|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44742746|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
44742747|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742748|NCT01636557|Vitamin K|vitamin k|mesh-list
44742749|NCT01636557|Midazolam|midazolam|mesh-list
44742750|NCT01636557|Caffeine|caffeine|mesh-list
44742751|NCT01636557|Omeprazole|omeprazole|mesh-list
44742752|NCT01636557|Warfarin|warfarin|mesh-list
44742753|NCT01636557|Vitamins|vitamins|mesh-ancestor
44742754|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
44742755|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742756|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44742757|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44742758|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742759|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44742760|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44742761|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44742762|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44742763|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
44742764|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
44742765|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
44271208|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44742766|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
44742768|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742769|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
44742770|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44742771|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44742772|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44742773|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742774|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44742775|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44742776|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44742777|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44742778|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
44742779|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44742780|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44742781|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
44742782|NCT01636557|Coagulants|coagulants|mesh-ancestor
44742783|NCT01636570|Vitamin D|vitamin d|mesh-list
44742784|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
44742785|NCT01636570|Vitamins|vitamins|mesh-ancestor
44742786|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
44742787|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742788|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742789|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742790|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
44742791|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44742792|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742793|NCT01636609|Cytarabine|cytarabine|mesh-list
44742794|NCT01636609|Azacitidine|azacitidine|mesh-list
44742795|NCT01636609|Tosedostat|tosedostat|mesh-list
44742796|NCT01636609|Glycine|glycine|mesh-list
44742797|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44742798|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
44742799|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742800|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742801|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
44742802|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742803|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742804|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
44742805|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742806|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742807|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
44742808|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742809|NCT01636622|Paclitaxel|paclitaxel|mesh-list
44742810|NCT01636622|Carboplatin|carboplatin|mesh-list
44742811|NCT01636622|Vemurafenib|vemurafenib|mesh-list
44742812|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44742813|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742814|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44742815|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44742816|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44742817|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742818|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44742819|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742820|NCT01636700|Tramadol|tramadol|mesh-list
44742821|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44742822|NCT01636700|Narcotics|narcotics|mesh-ancestor
44742823|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742824|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742825|NCT01636700|Analgesics|analgesics|mesh-ancestor
44742826|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
44742827|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742828|NCT01636869|Bupivacaine|bupivacaine|mesh-list
44742829|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
44742830|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
44742831|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742832|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742833|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
44742834|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742835|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
44742836|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44742837|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
44742838|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
44742839|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44742840|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44742841|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742842|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44742843|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742844|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742845|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44742847|NCT01636908|Everolimus|everolimus|mesh-list
44742848|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44742849|NCT01636908|Sorafenib|sorafenib|mesh-list
44742850|NCT01636908|Sunitinib|sunitinib|mesh-list
44742851|NCT01636908|Dasatinib|dasatinib|mesh-list
44742852|NCT01636908|Lapatinib|lapatinib|mesh-list
44742853|NCT01636908|Vemurafenib|vemurafenib|mesh-list
44742854|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742855|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742856|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
44742857|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742858|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44742859|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742860|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742861|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44742862|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44742863|NCT01636908|Growth Substances|growth substances|mesh-ancestor
44742864|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
44742865|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
44742866|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44742867|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
44742868|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
44742869|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44742870|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742871|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44742872|NCT01636999|Analgesics|analgesics|mesh-ancestor
44742873|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
44742874|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742875|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
44742876|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
44742877|NCT01637025|Coagulants|coagulants|mesh-ancestor
44742878|NCT01637155|Vitamin D|vitamin d|mesh-list
44742879|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
44742880|NCT01637155|Vitamins|vitamins|mesh-ancestor
44742881|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
44742882|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742883|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44742884|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44742885|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44742886|NCT01637194|Cetuximab|cetuximab|mesh-list
44742887|NCT01637194|Everolimus|everolimus|mesh-list
44742888|NCT01637194|Antibodies|antibodies|mesh-list
44742889|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
44742890|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44742891|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
44742892|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742893|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742894|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44742895|NCT01637233|Ritonavir|ritonavir|mesh-list
44742896|NCT01637233|Lopinavir|lopinavir|mesh-list
44742897|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44742898|NCT01637233|Darunavir|darunavir|mesh-list
44742899|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
44742900|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44742901|NCT01637233|Tenofovir|tenofovir|mesh-list
44742902|NCT01637233|Lamivudine|lamivudine|mesh-list
44742903|NCT01637233|Zidovudine|zidovudine|mesh-list
44742904|NCT01637233|Emtricitabine|emtricitabine|mesh-list
44742905|NCT01637233|Maraviroc|maraviroc|mesh-list
44462824|NCT01523886|Rocuronium|rocuronium|mesh-list
44742906|NCT01637233|Abacavir|abacavir|mesh-list
44742907|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
44742908|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44742909|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
44742910|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44742911|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742912|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742913|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44742914|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44742915|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
44742916|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742917|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44742918|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44742919|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44742920|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
44520215|NCT01056393|Ibalizumab|ibalizumab|mesh-list
44742921|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44742922|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44687164|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687165|NCT01338090|Bevacizumab|bevacizumab|mesh-list
44742923|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44742924|NCT01637259|Ritonavir|ritonavir|mesh-list
44742925|NCT01637259|Lopinavir|lopinavir|mesh-list
44742926|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44742927|NCT01637259|Darunavir|darunavir|mesh-list
44742928|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
44742929|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44742930|NCT01637259|Tenofovir|tenofovir|mesh-list
44742931|NCT01637259|Lamivudine|lamivudine|mesh-list
44742932|NCT01637259|Zidovudine|zidovudine|mesh-list
44742933|NCT01637259|Emtricitabine|emtricitabine|mesh-list
44742934|NCT01637259|Maraviroc|maraviroc|mesh-list
44742935|NCT01637259|Abacavir|abacavir|mesh-list
44742936|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
44742937|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44742938|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
44742939|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44742940|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742941|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742942|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44742943|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44742944|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
44742945|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742946|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44742947|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44742948|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44742949|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
44742950|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44742951|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44742952|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44742953|NCT01637376|Temoporfin|temoporfin|mesh-list
44742954|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742955|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44742956|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
44687166|NCT01338090|Everolimus|everolimus|mesh-list
44687167|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44687168|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44687169|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687170|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687171|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687172|NCT01338090|Growth Substances|growth substances|mesh-ancestor
44687173|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687174|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520285|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520286|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520287|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44520288|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44520289|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
44520290|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520291|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520292|NCT03274375|Rituximab|rituximab|mesh-list
44520293|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520294|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520295|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
44520296|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520297|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44742957|NCT01637454|Terlipressin|terlipressin|mesh-list
44742958|NCT01637454|Norepinephrine|norepinephrine|mesh-list
44742959|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44742960|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44742961|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44742962|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44742963|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
44742964|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44742965|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742966|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742967|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
44742968|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
44742969|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742970|NCT01637532|Interferons|interferons|mesh-list
44742971|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
44742972|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
44742973|NCT01637532|Carboplatin|carboplatin|mesh-list
44742974|NCT01637532|Doxorubicin|doxorubicin|mesh-list
44742975|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44742976|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44742977|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44742978|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44742979|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44742980|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742981|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
44742982|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44742983|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
44742984|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742986|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
44742987|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
44742988|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44742989|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44742990|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44742991|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44742992|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
44742993|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271371|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44742994|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44742995|NCT01637558|Ritonavir|ritonavir|mesh-list
44742996|NCT01637558|Lopinavir|lopinavir|mesh-list
44742997|NCT01637558|Nevirapine|nevirapine|mesh-list
44742998|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44742999|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44743000|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44743001|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743002|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743003|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44743004|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44743005|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
44743006|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743007|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44743008|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44743009|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44271421|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743010|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743011|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44743012|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44743013|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
44743014|NCT01637571|Lansoprazole|lansoprazole|mesh-list
44743015|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44743016|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743017|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44743018|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743019|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743020|NCT01637636|Rifampin|rifampin|mesh-list
44743021|NCT01637636|Ketoconazole|ketoconazole|mesh-list
44743022|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44743023|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
44743024|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44743025|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743026|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
44743027|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743028|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743029|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743030|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44743031|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44743032|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44743033|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44271439|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743034|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44743035|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44743036|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
44743037|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44743038|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44743039|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44743040|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
44743041|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743042|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743043|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44743045|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
44743046|NCT01637675|Citric Acid|citric acid|mesh-list
44743047|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
44743048|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
44743049|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44743050|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
44743051|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
44743052|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743053|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
44743054|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44743055|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44743056|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743057|NCT01637675|Urological Agents|urological agents|mesh-ancestor
44743058|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743059|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44743060|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44743061|NCT01637675|Analgesics|analgesics|mesh-ancestor
44743062|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
44743063|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743064|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743065|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743066|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743067|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44743068|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271470|NCT00683137|Valdecoxib|valdecoxib|mesh-list
44743069|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743070|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
44743071|NCT01637753|Carmustine|carmustine|mesh-list
44743072|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44743073|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
44743074|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743075|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743076|NCT01637766|Melphalan|melphalan|mesh-list
44743077|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44743078|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
44743079|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743080|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743081|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44743082|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271510|NCT00683267|Capsaicin|capsaicin|mesh-list
44743083|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
44743084|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743085|NCT01637818|Acetaminophen|acetaminophen|mesh-list
44743086|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44743087|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44743088|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44743089|NCT01637818|Analgesics|analgesics|mesh-ancestor
44743090|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
44743091|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743092|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743093|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
44743094|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743095|NCT01637844|Telbivudine|telbivudine|mesh-list
44743096|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
44743097|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743098|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743099|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271514|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743100|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743101|NCT01637883|Benzydamine|benzydamine|mesh-list
44743102|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743103|NCT01637948|Listerine|listerine|mesh-list
44743104|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44743105|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743106|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44743107|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
44743108|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44743109|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
44743110|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743111|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743112|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44743113|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44743114|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743115|NCT01638078|Thalidomide|thalidomide|mesh-list
44743116|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743117|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
44743118|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743119|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
44743120|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44743121|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743122|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44743123|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44743124|NCT01638078|Growth Substances|growth substances|mesh-ancestor
44743125|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44743126|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743127|NCT01638182|Vitamins|vitamins|mesh-list
44743128|NCT01638182|Vitamin K|vitamin k|mesh-list
44743129|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
44743130|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
44743131|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
44743132|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743133|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44743134|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44743135|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743136|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
44743137|NCT01638182|Coagulants|coagulants|mesh-ancestor
44743138|NCT01638234|Melatonin|melatonin|mesh-list
44743139|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
44743140|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743141|NCT01638234|Protective Agents|protective agents|mesh-ancestor
44743142|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743143|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743144|NCT01638247|Tamoxifen|tamoxifen|mesh-list
44743145|NCT01638247|Goserelin|goserelin|mesh-list
44743146|NCT01638247|Exemestane|exemestane|mesh-list
44743147|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44743148|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44743149|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
44743150|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743151|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743152|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44743153|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743154|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44743155|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44743156|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44743157|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44743158|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44743159|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743160|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743161|NCT01638247|Hormones|hormones|mesh-ancestor
44743162|NCT01638260|Liraglutide|liraglutide|mesh-list
44743163|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743164|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743165|NCT01638260|Incretins|incretins|mesh-ancestor
44743166|NCT01638260|Hormones|hormones|mesh-ancestor
44743167|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743168|NCT01638273|Pregabalin|pregabalin|mesh-list
44743169|NCT01638273|Analgesics|analgesics|mesh-ancestor
44743170|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
44743171|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743172|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743173|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
44743174|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44743175|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44743176|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743177|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44743178|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44743179|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44743180|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743181|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44743183|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743184|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271611|NCT00683865|Renal Agents|renal agents|mesh-ancestor
44743185|NCT01638325|Insulin|insulin|mesh-list
44743186|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44743187|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
44743188|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743189|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743190|NCT01638364|Ethanol|ethanol|mesh-list
44743191|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44743192|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743193|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743194|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743195|NCT01638377|Naltrexone|naltrexone|mesh-list
44743196|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44743197|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44743198|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743199|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
44743200|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743201|NCT01638403|Modafinil|modafinil|mesh-list
44743202|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44743203|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743204|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44743205|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44743206|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44743207|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743208|NCT01638442|Tosedostat|tosedostat|mesh-list
44743209|NCT01638442|Glycine|glycine|mesh-list
44743210|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743211|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743212|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
44743213|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743214|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743215|NCT01638624|Propofol|propofol|mesh-list
44743216|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44743217|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743218|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743219|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44743220|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
44743221|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
44743222|NCT01638650|Ritonavir|ritonavir|mesh-list
44743223|NCT01638650|Saquinavir|saquinavir|mesh-list
44743224|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44743225|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44271635|NCT00683956|Propofol|propofol|mesh-list
44743226|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44743227|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
44743228|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743229|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743230|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44743231|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44743232|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
44743233|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743234|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44743235|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44743236|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743237|NCT01638663|Tolvaptan|tolvaptan|mesh-list
44743238|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44743239|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743240|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
44743241|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743242|NCT01638676|Metformin|metformin|mesh-list
44743243|NCT01638676|Vemurafenib|vemurafenib|mesh-list
44520527|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520528|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44520529|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44520530|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44520531|NCT03278938|Bupropion|bupropion|mesh-list
44520532|NCT03278938|Citalopram|citalopram|mesh-list
44520533|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44520534|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
44520535|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520536|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44743244|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743245|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743246|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743247|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44743248|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743249|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743250|NCT01638689|Citalopram|citalopram|mesh-list
44743251|NCT01638689|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44743252|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44743253|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44743254|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743255|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743256|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
44743257|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743258|NCT01638689|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44743259|NCT01638689|Antidepressive Agents|antidepressive agents|mesh-ancestor
44743260|NCT01638689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44743261|NCT01638715|Rituximab|rituximab|mesh-list
44743262|NCT01638715|Abatacept|abatacept|mesh-list
44743263|NCT01638715|Infliximab|infliximab|mesh-list
44743264|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44743265|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743266|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
44687175|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687176|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
44687177|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44687178|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687179|NCT01338103|Rituximab|rituximab|mesh-list
44687180|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44687181|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687182|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
44687183|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687184|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687185|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44271705|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
44687186|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687187|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
44687188|NCT01338129|Vitamins|vitamins|mesh-ancestor
44687189|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
44687190|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687191|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
44687192|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687193|NCT01338129|Protective Agents|protective agents|mesh-ancestor
44687194|NCT01338311|Albuterol|albuterol|mesh-list
44687195|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44687196|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
44687197|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687198|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687199|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44687200|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
44687201|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
44687202|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44687203|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44445046|NCT01834586|Anesthetics|anesthetics|mesh-list
44687204|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44687205|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44687206|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687207|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687208|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687209|NCT01338324|Simvastatin|simvastatin|mesh-list
44687210|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44687211|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44687212|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
44687213|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687214|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44687215|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44687216|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687217|NCT01338337|Azacitidine|azacitidine|mesh-list
44687218|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44687219|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
44687220|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687221|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687222|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687223|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44687224|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
44687225|NCT01338441|Erythromycin|erythromycin|mesh-list
44743267|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743268|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743269|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44743270|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743271|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44462888|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44743272|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743273|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743274|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
44743276|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
44743277|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743278|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743279|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44743280|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44743281|NCT01638780|Resveratrol|resveratrol|mesh-list
44743282|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
44743283|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743284|NCT01638780|Protective Agents|protective agents|mesh-ancestor
44743285|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743286|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743287|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44743288|NCT01638858|Ranibizumab|ranibizumab|mesh-list
44743289|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44743290|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44743291|NCT01638858|Growth Substances|growth substances|mesh-ancestor
44743292|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462921|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
44743293|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
44743294|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743295|NCT01638936|Maytansine|maytansine|mesh-list
44743296|NCT01638936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44743297|NCT01638936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743298|NCT01638936|Tubulin Modulators|tubulin modulators|mesh-ancestor
44743299|NCT01638936|Antimitotic Agents|antimitotic agents|mesh-ancestor
44743300|NCT01638936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44743301|NCT01638936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743302|NCT01638962|Acetaminophen|acetaminophen|mesh-list
44743303|NCT01638962|Aspirin|aspirin|mesh-list
44743304|NCT01638962|Ibuprofen|ibuprofen|mesh-list
44743305|NCT01638962|Celecoxib|celecoxib|mesh-list
44743306|NCT01638962|Diclofenac|diclofenac|mesh-list
44743307|NCT01638962|Naproxen|naproxen|mesh-list
44743308|NCT01638962|Indomethacin|indomethacin|mesh-list
44743309|NCT01638962|Etoricoxib|etoricoxib|mesh-list
44271734|NCT00684268|Protective Agents|protective agents|mesh-ancestor
44271745|NCT00684385|Gefitinib|gefitinib|mesh-list
44743310|NCT01638962|Meloxicam|meloxicam|mesh-list
44743311|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44743312|NCT01638962|Etodolac|etodolac|mesh-list
44743313|NCT01638962|Lornoxicam|lornoxicam|mesh-list
44743314|NCT01638962|Nabumetone|nabumetone|mesh-list
44743315|NCT01638962|Tenoxicam|tenoxicam|mesh-list
44743316|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
44743317|NCT01638962|Analgesics|analgesics|mesh-list
44743318|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44743319|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
44743320|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743321|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743322|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
44743323|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44743324|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743325|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743326|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44743327|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743328|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743329|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44743330|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
44743331|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44271750|NCT00684450|Protamines|protamines|mesh-list
44743332|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44743333|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44743334|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
44743335|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743336|NCT01638988|Metformin|metformin|mesh-list
44743337|NCT01638988|Clomiphene|clomiphene|mesh-list
44743338|NCT01638988|Enclomiphene|enclomiphene|mesh-list
44743339|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
44743340|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743341|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743342|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44743343|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
44743344|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743345|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44743346|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
44743347|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743348|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44743349|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44743351|NCT01639027|Analgesics|analgesics|mesh-ancestor
44743352|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
44743353|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743354|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743355|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
44743356|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
44743357|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
44743358|NCT01639066|Tenofovir|tenofovir|mesh-list
44743359|NCT01639066|Entecavir|entecavir|mesh-list
44743360|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
44271769|NCT00684528|Metformin|metformin|mesh-list
44743361|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743362|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44743363|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743364|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743365|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743366|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44743367|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44743368|NCT01639092|Tenofovir|tenofovir|mesh-list
44743369|NCT01639092|Entecavir|entecavir|mesh-list
44743370|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
44743371|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743372|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44743373|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743374|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743375|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743376|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44743377|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44743378|NCT01639261|Interferons|interferons|mesh-list
44743379|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
44743380|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743381|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
44743382|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743383|NCT01639326|Irinotecan|irinotecan|mesh-list
44743384|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44271799|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44743385|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44743386|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743387|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743388|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743389|NCT01639456|Aldesleukin|aldesleukin|mesh-list
44743390|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
44743391|NCT01639456|Fludarabine|fludarabine|mesh-list
44743392|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743393|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
44743394|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743395|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743396|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44743397|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
44743398|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743399|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743400|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44743401|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44743402|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44743403|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
44743404|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743405|NCT01639521|Gemcitabine|gemcitabine|mesh-list
44743406|NCT01639521|Cisplatin|cisplatin|mesh-list
44743407|NCT01639521|Doxorubicin|doxorubicin|mesh-list
44743408|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44743409|NCT01639521|Methotrexate|methotrexate|mesh-list
44743410|NCT01639521|Vinblastine|vinblastine|mesh-list
44743411|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743412|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44743413|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
44743414|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743415|NCT01639521|Antiviral Agents|antiviral agents|mesh-ancestor
44743416|NCT01639521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743417|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743418|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743419|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
44743420|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743421|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44743422|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44743423|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44520742|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520743|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520744|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520745|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
44520746|NCT03276325|Hormones|hormones|mesh-ancestor
44520747|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520748|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44520749|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520750|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44743424|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44743425|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
44743426|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743427|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
44743428|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44743429|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743430|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743431|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44743432|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
44743433|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
44743434|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
44743435|NCT01639547|Ribavirin|ribavirin|mesh-list
44743436|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44687226|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
44687227|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44687228|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
44687229|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687230|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687231|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687232|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44687233|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687234|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687235|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
44687236|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44687237|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44687238|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687240|NCT01338454|Coagulants|coagulants|mesh-ancestor
44687241|NCT01338558|Bevacizumab|bevacizumab|mesh-list
44687242|NCT01338558|Cetuximab|cetuximab|mesh-list
44687243|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44687244|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687245|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687246|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687247|NCT01338558|Growth Substances|growth substances|mesh-ancestor
44687248|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687249|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44687250|NCT01338675|Busulfan|busulfan|mesh-list
44687251|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
44687252|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687253|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687254|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
44687255|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687256|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687257|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687258|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687259|NCT01338753|Bevacizumab|bevacizumab|mesh-list
44687260|NCT01338753|Docetaxel|docetaxel|mesh-list
44687261|NCT01338753|Doxorubicin|doxorubicin|mesh-list
44687262|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271888|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687263|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687264|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687265|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687266|NCT01338753|Growth Substances|growth substances|mesh-ancestor
44687267|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687268|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44687269|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44687270|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44687271|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44687272|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687273|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44687274|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44687275|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44687276|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687277|NCT01338844|Inositol|inositol|mesh-list
44687278|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
44687279|NCT01338844|Vitamins|vitamins|mesh-ancestor
44687280|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
44687281|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687282|NCT01338896|Rotigotine|rotigotine|mesh-list
44687283|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
44687284|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
44687285|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687286|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687287|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687288|NCT01338909|Clopidogrel|clopidogrel|mesh-list
44687289|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44520760|NCT03276143|Enoxaparin|enoxaparin|mesh-list
44743437|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
44743438|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743439|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
44743440|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743441|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
44743442|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44743443|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743444|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
44743445|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44743446|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44743447|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
44743448|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743449|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743450|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743451|NCT01639794|Urological Agents|urological agents|mesh-ancestor
44743452|NCT01639807|Latanoprost|latanoprost|mesh-list
44743453|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44743454|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44743455|NCT01639885|Interferons|interferons|mesh-list
44743456|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
44743457|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
44743458|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743459|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
44743460|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743461|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
44743462|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743463|NCT01639898|Dexamethasone|dexamethasone|mesh-list
44743464|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
44743465|NCT01639898|Lenalidomide|lenalidomide|mesh-list
44743466|NCT01639898|BB 1101|bb 1101|mesh-list
44743467|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743468|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
44743469|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
44743470|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743471|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743472|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743473|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
44743474|NCT01639898|Hormones|hormones|mesh-ancestor
44743475|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743476|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44743477|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743478|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
44743479|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743480|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743481|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
44743482|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44743483|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44743484|NCT01639898|Growth Substances|growth substances|mesh-ancestor
44271968|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743485|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44743486|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
44743487|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44743488|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44743489|NCT01640743|Prednisolone|prednisolone|mesh-list
44743490|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
44743491|NCT01640743|Everolimus|everolimus|mesh-list
44743492|NCT01640743|Tacrolimus|tacrolimus|mesh-list
44743493|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44743494|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
44743495|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743496|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
44743497|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743498|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44743499|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743500|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743501|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743502|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743503|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
44743504|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
44743505|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743506|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743507|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
44743508|NCT01640743|Hormones|hormones|mesh-ancestor
44743509|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743510|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44743511|NCT01640743|Protective Agents|protective agents|mesh-ancestor
44743512|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44743513|NCT01641016|Efavirenz|efavirenz|mesh-list
44743514|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44743515|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44743516|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743517|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743518|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
44743519|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743520|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44743521|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44272011|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44272012|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44743522|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44743523|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44743524|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44743525|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44743526|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44743527|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
44743528|NCT01641718|Coagulants|coagulants|mesh-ancestor
44743530|NCT01642771|Fluorouracil|fluorouracil|mesh-list
44743531|NCT01642771|Capecitabine|capecitabine|mesh-list
44743532|NCT01642771|Epirubicin|epirubicin|mesh-list
44743533|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743534|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44743535|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44743536|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44743537|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743538|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
44743539|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44743540|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743541|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
44743542|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743543|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44743544|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44743545|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44743546|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743547|NCT01642979|Cyclosporine|cyclosporine|mesh-list
44743548|NCT01642979|Levamisole|levamisole|mesh-list
44743549|NCT01642979|Cyclosporins|cyclosporins|mesh-list
44743550|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
44743551|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743552|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743553|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743554|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
44743555|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743556|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
44743557|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743558|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
44743559|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743560|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44743561|NCT01642979|Hormones|hormones|mesh-ancestor
44743562|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743563|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44743564|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
44743565|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
44743566|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44743567|NCT01643031|Clopidogrel|clopidogrel|mesh-list
44743568|NCT01643031|Ticagrelor|ticagrelor|mesh-list
44272032|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
44743569|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44743570|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44743571|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44743572|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44743573|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
44743574|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743575|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743576|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743577|NCT01643434|Clonidine|clonidine|mesh-list
44743578|NCT01643434|Spironolactone|spironolactone|mesh-list
44743579|NCT01643434|Analgesics|analgesics|mesh-ancestor
44272072|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44272081|NCT00685958|Enoxaparin|enoxaparin|mesh-list
44743580|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
44743581|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743582|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743583|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44743584|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
44743585|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
44743586|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44743587|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44743588|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44743589|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44743590|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743591|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743592|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44743593|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
44743594|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743595|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44743596|NCT01643434|Diuretics|diuretics|mesh-ancestor
44743597|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
44743598|NCT01643941|Vaccines|vaccines|mesh-list
44743599|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
44743600|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743601|NCT01643980|Progesterone|progesterone|mesh-list
44743602|NCT01643980|Progestins|progestins|mesh-ancestor
44743603|NCT01643980|Hormones|hormones|mesh-ancestor
44743604|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743605|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743606|NCT01645228|Calcium|calcium|mesh-list
44743607|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44743608|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743609|NCT01645839|Cytarabine|cytarabine|mesh-list
44743610|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44743611|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
44743612|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743613|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743614|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
44687290|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44687291|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44687292|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44687293|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44687294|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
44687295|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687296|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687297|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687298|NCT01338922|Insulin|insulin|mesh-list
44687299|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687300|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687301|NCT01339026|Clopidogrel|clopidogrel|mesh-list
44687302|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44687303|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44687304|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44687305|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44687306|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44687307|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
44687308|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272117|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687309|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687310|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687311|NCT01339039|Plerixafor|plerixafor|mesh-list
44687312|NCT01339039|Bevacizumab|bevacizumab|mesh-list
44687313|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44687314|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687315|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687316|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687317|NCT01339039|Growth Substances|growth substances|mesh-ancestor
44687318|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687319|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44687320|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687321|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687322|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
44687323|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687324|NCT01339065|Ketamine|ketamine|mesh-list
44687325|NCT01339065|Analgesics|analgesics|mesh-ancestor
44687326|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
44687327|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687328|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687329|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44687330|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44687331|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
44687332|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
44687333|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687334|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44687335|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44520933|NCT03274102|Vaccines|vaccines|mesh-list
44743615|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743616|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743617|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
44743618|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743619|NCT01646437|Aspirin|aspirin|mesh-list
44743620|NCT01646437|Vitamin D|vitamin d|mesh-list
44743621|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
44743622|NCT01646437|Vitamins|vitamins|mesh-ancestor
44743623|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
44743624|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743625|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44743626|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44743627|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44743628|NCT01646437|Analgesics|analgesics|mesh-ancestor
44743629|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
44743630|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743631|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743632|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743633|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44743634|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44743635|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743636|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44743637|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44272149|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743638|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743639|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
44743640|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44743641|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
44743642|NCT01646619|Analgesics|analgesics|mesh-ancestor
44743643|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
44743644|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743645|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743646|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
44743647|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743648|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44743649|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
44743650|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44743651|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44743652|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743653|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44743654|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
44743655|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743656|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44743657|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44743658|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272159|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743659|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743660|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
44743661|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743662|NCT01648218|Insulin|insulin|mesh-list
44743663|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44743664|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
44743665|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
44743666|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
44743667|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
44743668|NCT01648218|Protamines|protamines|mesh-list
44743669|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743670|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743671|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
44743672|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743673|NCT01648218|Coagulants|coagulants|mesh-ancestor
44743674|NCT01648465|Everolimus|everolimus|mesh-list
44743675|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743676|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743677|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
44743678|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520949|NCT03273634|Lansoprazole|lansoprazole|mesh-list
44520950|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
44520951|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44743679|NCT01648777|Bupivacaine|bupivacaine|mesh-list
44743680|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
44743681|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
44743682|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44743683|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743684|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
44743685|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743686|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
44743687|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743688|NCT01649024|Tremelimumab|tremelimumab|mesh-list
44743689|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743691|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44743692|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743693|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44743694|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743695|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
44743696|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743697|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
44743698|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743699|NCT01650012|Eplerenone|eplerenone|mesh-list
44743700|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44743701|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
44774255|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272228|NCT00687011|Palonosetron|palonosetron|mesh-list
44743702|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743703|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743704|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44743705|NCT01650012|Diuretics|diuretics|mesh-ancestor
44743706|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
44743707|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44743708|NCT01650090|Cisplatin|cisplatin|mesh-list
44743709|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743710|NCT01650129|Insulin|insulin|mesh-list
44743711|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44743712|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
44743713|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
44743714|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743715|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743716|NCT01650181|Selenium|selenium|mesh-list
44743717|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
44743718|NCT01650181|Metformin|metformin|mesh-list
44743719|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743720|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743721|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
44743722|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743723|NCT01650181|Protective Agents|protective agents|mesh-ancestor
44743724|NCT01650181|Trace Elements|trace elements|mesh-ancestor
44743725|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
44743726|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
44743727|NCT01650181|Vitamins|vitamins|mesh-ancestor
44743728|NCT01650272|Minoxidil|minoxidil|mesh-list
44743729|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44743730|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44743731|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
44743732|NCT01650376|Paclitaxel|paclitaxel|mesh-list
44743733|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44743734|NCT01650376|Carboplatin|carboplatin|mesh-list
44743735|NCT01650376|Olaparib|olaparib|mesh-list
44743736|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44743737|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743738|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44743739|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44743740|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44743741|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743742|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44743743|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743744|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
44272251|NCT00687206|Valsartan|valsartan|mesh-list
44743745|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44743746|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
44743747|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743748|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
44743749|NCT01650415|Hematinics|hematinics|mesh-ancestor
44743750|NCT01650428|Bevacizumab|bevacizumab|mesh-list
44743751|NCT01650428|Fluorouracil|fluorouracil|mesh-list
44743752|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
44743753|NCT01650428|Irinotecan|irinotecan|mesh-list
44743754|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44743755|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743756|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44743757|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44743758|NCT01650428|Growth Substances|growth substances|mesh-ancestor
44743759|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743760|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
44743761|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
44743762|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743763|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44743764|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743765|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
44743766|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44743767|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44743768|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743769|NCT01650441|Beclomethasone|beclomethasone|mesh-list
44743770|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
44743771|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44743772|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
44743773|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743774|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743775|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44743776|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
44743777|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44743778|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44743779|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44743780|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
44743781|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743782|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743783|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743784|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
44743785|NCT01650441|Hormones|hormones|mesh-ancestor
44743786|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743787|NCT01650493|Listerine|listerine|mesh-list
44743788|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
44743789|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
44743790|NCT01650493|Protective Agents|protective agents|mesh-ancestor
44743791|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743792|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44743793|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743794|NCT01650506|Metformin|metformin|mesh-list
44743795|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44743796|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44743797|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743798|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272269|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
44743799|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44743800|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743801|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743802|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
44743803|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743804|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743805|NCT01650649|Lofexidine|lofexidine|mesh-list
44743806|NCT01650649|Clonidine|clonidine|mesh-list
44743807|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44743808|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44743809|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743810|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
44743811|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743812|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44743813|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44743814|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44743815|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44743816|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743817|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743818|NCT01650649|Analgesics|analgesics|mesh-ancestor
44743819|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
44743820|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
44743821|NCT01650662|Cyclosporine|cyclosporine|mesh-list
44743822|NCT01650662|Cyclosporins|cyclosporins|mesh-list
44743823|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743824|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743825|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743826|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
44743827|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743828|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
44743829|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743830|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44743831|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521031|NCT03273036|Hormones|hormones|mesh-ancestor
44743832|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44743833|NCT01650727|Rituximab|rituximab|mesh-list
44743834|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44743835|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743836|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
44743837|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743838|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743839|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44743840|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44743841|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44743842|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44743843|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743844|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743845|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743846|NCT01650740|Analgesics|analgesics|mesh-ancestor
44743847|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
44743848|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743849|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
44743850|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44743851|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
44743852|NCT01650792|Aspirin|aspirin|mesh-list
44272357|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743853|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44743854|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44743855|NCT01650792|Analgesics|analgesics|mesh-ancestor
44743856|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
44743857|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743858|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743859|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44743860|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743861|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44743862|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44743863|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743864|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44743865|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44743866|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743867|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
44743868|NCT01650870|Lactulose|lactulose|mesh-list
44743869|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743870|NCT01650883|Vitamin D|vitamin d|mesh-list
44743871|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
44687336|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687337|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687338|NCT01339143|Pioglitazone|pioglitazone|mesh-list
44687339|NCT01339143|Vildagliptin|vildagliptin|mesh-list
44687340|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687341|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687342|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44687343|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
44687344|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687345|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687346|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44687347|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44687348|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44687349|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44687350|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687351|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687352|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687353|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687354|NCT01339312|Vaccines|vaccines|mesh-list
44687355|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
44687356|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687357|NCT01339442|Fulvestrant|fulvestrant|mesh-list
44687358|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44687359|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687360|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44687361|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44687362|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
44687363|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687364|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687365|NCT01339468|Tacrolimus|tacrolimus|mesh-list
44687366|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687367|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
44687368|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743872|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
44743873|NCT01650883|Vitamins|vitamins|mesh-list
44743874|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
44743875|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743876|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44743877|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44743878|NCT01650961|Palonosetron|palonosetron|mesh-list
44743879|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
44743880|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
44743881|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44743882|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743883|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44743884|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44743885|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44743886|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
44743887|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743888|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743889|NCT01651130|Carbetocin|carbetocin|mesh-list
44743890|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
44743891|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44743892|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743893|NCT01651156|Tolvaptan|tolvaptan|mesh-list
44743894|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44743895|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743896|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
44743897|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743898|NCT01651169|Methylphenidate|methylphenidate|mesh-list
44743899|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44743900|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743901|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44743902|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44743903|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44743904|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743905|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
44272457|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44743906|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743907|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
44743908|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44743909|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44743910|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743911|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
44743912|NCT01651182|Coagulants|coagulants|mesh-ancestor
44743913|NCT01651312|Mirabegron|mirabegron|mesh-list
44743914|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44743915|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44743916|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44743917|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44743918|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743919|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743920|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743921|NCT01651312|Urological Agents|urological agents|mesh-ancestor
44743922|NCT01651325|Isavuconazole|isavuconazole|mesh-list
44743923|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
44743924|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
44743925|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
44743926|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44272471|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743927|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44743928|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743929|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743930|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743931|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
44743932|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743933|NCT01651364|Cabergoline|cabergoline|mesh-list
44743934|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44743935|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44743936|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
44743937|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
44743938|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743939|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743940|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743941|NCT01651377|Pramipexole|pramipexole|mesh-list
44743942|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
44743943|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743944|NCT01651377|Protective Agents|protective agents|mesh-ancestor
44743945|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743946|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44743947|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44743948|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
44743949|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
44743950|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44743952|NCT01651390|Paclitaxel|paclitaxel|mesh-list
44272505|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743953|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44743954|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44743955|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
44743956|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
44743957|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
44447664|NCT01783821|Budesonide|budesonide|mesh-list
44743958|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743959|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44743960|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743961|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44743962|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
44743963|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743964|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
44743965|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743966|NCT01651416|Lumefantrine|lumefantrine|mesh-list
44743967|NCT01651416|Artemether|artemether|mesh-list
44743968|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
44743969|NCT01651416|Piperaquine|piperaquine|mesh-list
44743970|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
44743971|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44743972|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44743973|NCT01651416|Amodiaquine|amodiaquine|mesh-list
44743974|NCT01651416|Artenimol|artenimol|mesh-list
44743975|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
44272523|NCT00688857|Diazoxide|diazoxide|mesh-list
44447896|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
44447897|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44743976|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44743977|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44743978|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44743979|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44743980|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44743981|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743982|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44743983|NCT01651416|Renal Agents|renal agents|mesh-ancestor
44743984|NCT01651481|Montelukast|montelukast|mesh-list
44743985|NCT01651481|Levocetirizine|levocetirizine|mesh-list
44743986|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272540|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44743987|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44743988|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44743989|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
44743990|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44743991|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44743992|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44743993|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44743994|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44743995|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44743996|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44743997|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
44743998|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
44743999|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744000|NCT01651520|Flumazenil|flumazenil|mesh-list
44744001|NCT01651520|Antidotes|antidotes|mesh-ancestor
44744002|NCT01651520|Protective Agents|protective agents|mesh-ancestor
44744003|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744004|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
44744005|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
44744006|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744007|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744008|NCT01651572|Rocuronium|rocuronium|mesh-list
44744009|NCT01651572|Cisatracurium|cisatracurium|mesh-list
44744010|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44744011|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44744012|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44744013|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744014|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744015|NCT01651585|Valacyclovir|valacyclovir|mesh-list
44744016|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
44521221|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521222|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997782|NCT02665728|Laxatives|laxatives|mesh-list
44521223|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
44744017|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744018|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44744019|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44687369|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44687370|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687371|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687372|NCT01339481|Abatacept|abatacept|mesh-list
44687373|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44687374|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687375|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687376|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687377|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
44687378|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687379|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687380|NCT01339572|Plerixafor|plerixafor|mesh-list
44687381|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687382|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687383|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
44687384|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687385|NCT01339624|Ketorolac|ketorolac|mesh-list
44687386|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44687387|NCT01339624|Fentanyl|fentanyl|mesh-list
44687388|NCT01339624|Morphine|morphine|mesh-list
44687389|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44687390|NCT01339624|Narcotics|narcotics|mesh-ancestor
44687391|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687392|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687393|NCT01339624|Analgesics|analgesics|mesh-ancestor
44687394|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
44744020|NCT01651715|Antibodies|antibodies|mesh-list
44744021|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
44744022|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744023|NCT01651728|Simvastatin|simvastatin|mesh-list
44744024|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44744025|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44744026|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
44744027|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744028|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44744029|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44744030|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744031|NCT01651923|Heparin|heparin|mesh-list
44744032|NCT01651923|Calcium heparin|calcium heparin|mesh-list
44744033|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
44744034|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44744035|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44744036|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744037|NCT01651962|Fentanyl|fentanyl|mesh-list
44744038|NCT01651962|Terbutaline|terbutaline|mesh-list
44744039|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44744040|NCT01651962|Narcotics|narcotics|mesh-ancestor
44744041|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744042|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744043|NCT01651962|Analgesics|analgesics|mesh-ancestor
44744044|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
44744045|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744046|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44744047|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44744048|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
44744049|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
44744050|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44744051|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
44744052|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44744053|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
44744054|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
44744055|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
44744056|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44744057|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44744058|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44744059|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44744060|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744061|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744062|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744063|NCT01651988|Propofol|propofol|mesh-list
44744064|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44744065|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744066|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744067|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44744068|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
44744069|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
44744070|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
44744071|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
44744072|NCT01652014|Fludarabine|fludarabine|mesh-list
44744073|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
44744074|NCT01652014|Tacrolimus|tacrolimus|mesh-list
44744075|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744076|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
44744077|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744078|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44744079|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44744080|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
44744081|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744082|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744083|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44744084|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744085|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
44744086|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44744087|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744088|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44744089|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44744090|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
44521301|NCT01240148|Lidocaine|lidocaine|mesh-list
44744091|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744092|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744093|NCT01652118|Clarithromycin|clarithromycin|mesh-list
44744094|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744095|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744096|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44744097|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744098|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744099|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44272669|NCT00689208|Miotics|miotics|mesh-ancestor
44744100|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44744101|NCT01652157|Pancrelipase|pancrelipase|mesh-list
44744102|NCT01652157|Pancreatin|pancreatin|mesh-list
44744103|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744104|NCT01652183|Acetaminophen|acetaminophen|mesh-list
44744105|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44744106|NCT01652183|Analgesics|analgesics|mesh-ancestor
44744107|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
44744108|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744109|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744110|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
44744111|NCT01652196|Leucovorin|leucovorin|mesh-list
44744112|NCT01652196|Fluorouracil|fluorouracil|mesh-list
44744113|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
44744114|NCT01652196|Aflibercept|aflibercept|mesh-list
44272692|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44744115|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
44744116|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44744117|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
44744118|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744119|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744120|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744121|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744122|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
44744123|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744124|NCT01652196|Antidotes|antidotes|mesh-ancestor
44744125|NCT01652196|Protective Agents|protective agents|mesh-ancestor
44744126|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
44744127|NCT01652196|Vitamins|vitamins|mesh-ancestor
44744128|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
44744129|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44744130|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44744131|NCT01652196|Growth Substances|growth substances|mesh-ancestor
44744132|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
44744133|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44744134|NCT01652313|Rasagiline|rasagiline|mesh-list
44744135|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44744136|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744137|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272706|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
44272707|NCT00689520|Coagulants|coagulants|mesh-ancestor
44744138|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44744139|NCT01652313|Protective Agents|protective agents|mesh-ancestor
44744140|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744141|NCT01652326|Diazepam|diazepam|mesh-list
44744142|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44744143|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
44744144|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
44744145|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
44744146|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744147|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744148|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744149|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44272728|NCT00689585|Ethosuximide|ethosuximide|mesh-list
44744150|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744151|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44744152|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44744153|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44744154|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44744155|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44744156|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44744157|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
44744158|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
44744159|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
44744160|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
44744161|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744162|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744163|NCT01652339|Amlodipine|amlodipine|mesh-list
44744164|NCT01652339|Valsartan|valsartan|mesh-list
44744165|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44744166|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44744167|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44744168|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521346|NCT01240642|Vadimezan|vadimezan|mesh-list
44744169|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744170|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744171|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744172|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
44744173|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44744174|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44744176|NCT01652378|Ondansetron|ondansetron|mesh-list
44744177|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
44744178|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
44744179|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744180|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744181|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
44744182|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744183|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44272755|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
44272756|NCT00689624|Vitamins|vitamins|mesh-ancestor
44744184|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44744185|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44449571|NCT01746901|Naltrexone|naltrexone|mesh-list
44744186|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744187|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744188|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
44744189|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
44744190|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744191|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
44744192|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
44744193|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44744194|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
44744195|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744196|NCT01652378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44744197|NCT01652378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44744198|NCT01652378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44744199|NCT01652378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44521417|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44744200|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
44744201|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44744202|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44744203|NCT01652417|Prednisolone|prednisolone|mesh-list
44744204|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
44744205|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44744206|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
44744207|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44744208|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
44744209|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
44744210|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744211|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744212|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744213|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
44744214|NCT01652417|Hormones|hormones|mesh-ancestor
44744215|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744216|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44744217|NCT01652417|Protective Agents|protective agents|mesh-ancestor
44744218|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44744219|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744220|NCT01652534|Amantadine|amantadine|mesh-list
44744221|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44744222|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44744223|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
44744224|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744225|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
44744226|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744227|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744228|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744229|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44744230|NCT01652534|Analgesics|analgesics|mesh-ancestor
44744231|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
44744232|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744233|NCT01652547|Pasireotide|pasireotide|mesh-list
44744234|NCT01652547|Somatostatin|somatostatin|mesh-list
44521418|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521419|NCT01241110|Ofloxacin|ofloxacin|mesh-list
44521420|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44521421|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521422|NCT01241110|Renal Agents|renal agents|mesh-ancestor
44521423|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521424|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44521425|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44521426|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744235|NCT01652547|Hormones|hormones|mesh-ancestor
44744236|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744237|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744238|NCT01652560|Bevacizumab|bevacizumab|mesh-list
44744239|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44744240|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744241|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44744242|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44744243|NCT01652560|Growth Substances|growth substances|mesh-ancestor
44744244|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744245|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
44744246|NCT01652586|Midazolam|midazolam|mesh-list
44744247|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
44744248|NCT01652586|Remifentanil|remifentanil|mesh-list
44744249|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44744250|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744251|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272836|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744252|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44744253|NCT01652586|Analgesics|analgesics|mesh-ancestor
44744254|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
44744255|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744256|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44744257|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44744258|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44744259|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744260|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744261|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744262|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44744263|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44744264|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44744265|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44744266|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44744267|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
44744268|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
44744269|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
44744270|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
44744271|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44744272|NCT01652586|Narcotics|narcotics|mesh-ancestor
44744273|NCT01652599|Dexamethasone|dexamethasone|mesh-list
44744274|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44744275|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
44744276|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
44744277|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272869|NCT00689858|Cilostazol|cilostazol|mesh-list
44744278|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744279|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744280|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
44744281|NCT01652599|Hormones|hormones|mesh-ancestor
44744282|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744283|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44744284|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744285|NCT01652638|Heparin|heparin|mesh-list
44744286|NCT01652638|Calcium heparin|calcium heparin|mesh-list
44744287|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
44744288|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44744289|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44744290|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744291|NCT01652781|Azacitidine|azacitidine|mesh-list
44744292|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744293|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
44744294|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744295|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744296|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744297|NCT01652794|Gemcitabine|gemcitabine|mesh-list
44744298|NCT01652794|Carboplatin|carboplatin|mesh-list
44744299|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744300|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744301|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
44744302|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744303|NCT01652794|Antiviral Agents|antiviral agents|mesh-ancestor
44744304|NCT01652794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744305|NCT01652794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744306|NCT01652794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521456|NCT01241409|Rabeprazole|rabeprazole|mesh-list
44744307|NCT01652794|Immunologic Factors|immunologic factors|mesh-ancestor
44744308|NCT01652794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744309|NCT01652820|Gemcitabine|gemcitabine|mesh-list
44744310|NCT01652820|Carboplatin|carboplatin|mesh-list
44744311|NCT01652820|Docetaxel|docetaxel|mesh-list
44744312|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744313|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744314|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
44744315|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744316|NCT01652820|Antiviral Agents|antiviral agents|mesh-ancestor
44744317|NCT01652820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744318|NCT01652820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744319|NCT01652820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744320|NCT01652820|Immunologic Factors|immunologic factors|mesh-ancestor
44744321|NCT01652820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744322|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
44744323|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
44744324|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
44744325|NCT01652859|Amphotericin B|amphotericin b|mesh-list
44744326|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44744327|NCT01652859|Amebicides|amebicides|mesh-ancestor
44744328|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44744329|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44744330|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744331|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744332|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
44744333|NCT01652898|Esmolol|esmolol|mesh-list
44744334|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44744335|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44744336|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44744337|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744338|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744339|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744340|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744341|NCT01652924|Anesthetics|anesthetics|mesh-list
44744342|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744343|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687395|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687396|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44687397|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44687398|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
44687399|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
44687400|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44687401|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687402|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687403|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687404|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44687405|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687406|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687407|NCT01339663|Aldesleukin|aldesleukin|mesh-list
44687408|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
44687409|NCT01339663|Interleukin-2|interleukin-2|mesh-list
44687410|NCT01339663|Vaccines|vaccines|mesh-list
44687411|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
44687412|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687413|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687414|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687415|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687416|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
44687417|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687418|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687419|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687420|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687421|NCT01339663|Analgesics|analgesics|mesh-ancestor
44687422|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
44687423|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687424|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687425|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44462978|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44687426|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
44687427|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687428|NCT01339676|Vitamin D|vitamin d|mesh-list
44687429|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
44687430|NCT01339676|Vitamins|vitamins|mesh-ancestor
44687431|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
44687432|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687433|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44687434|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44687435|NCT01339741|Vitamin D|vitamin d|mesh-list
44687436|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
44687437|NCT01339741|Vitamins|vitamins|mesh-ancestor
44687438|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
44687439|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744344|NCT01653015|Vaccines|vaccines|mesh-list
44744345|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
44744346|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744347|NCT01653041|Everolimus|everolimus|mesh-list
44744348|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744349|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744350|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
44744351|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744352|NCT01653067|Cytarabine|cytarabine|mesh-list
44744353|NCT01653067|Sirolimus|sirolimus|mesh-list
44744354|NCT01653067|Dexamethasone|dexamethasone|mesh-list
44744355|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
44744356|NCT01653067|Rituximab|rituximab|mesh-list
44744357|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44744358|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744359|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
44744360|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744361|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44744362|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44744363|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
44744364|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
44744365|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744366|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744367|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
44744368|NCT01653067|Hormones|hormones|mesh-ancestor
44744369|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744370|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44744371|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744372|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744373|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
44744374|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
44744375|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744376|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744377|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744378|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44744379|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
44744380|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44744381|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272963|NCT00690417|Vitamin D|vitamin d|mesh-list
44744382|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44744383|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
44744384|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744385|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44744386|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44744387|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744388|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
44744389|NCT01653171|Simethicone|simethicone|mesh-list
44744390|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44744391|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
44744392|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744393|NCT01653171|Expectorants|expectorants|mesh-ancestor
44744394|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44744395|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44744396|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
44744397|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744398|NCT01653171|Protective Agents|protective agents|mesh-ancestor
44744399|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744400|NCT01653171|Antidotes|antidotes|mesh-ancestor
44744401|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
44744402|NCT01653171|Emollients|emollients|mesh-ancestor
44744403|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
44744404|NCT01653236|Ribavirin|ribavirin|mesh-list
44744405|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44744406|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
44744407|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744408|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
44272989|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
44744409|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744410|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
44744411|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744412|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44744413|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744414|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744415|NCT01653457|Memantine|memantine|mesh-list
44744416|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44744417|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44744418|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
44744419|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744420|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744421|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744422|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44744423|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44744424|NCT01653470|Leucovorin|leucovorin|mesh-list
44744425|NCT01653470|Paclitaxel|paclitaxel|mesh-list
44744426|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44744427|NCT01653470|Carboplatin|carboplatin|mesh-list
44744428|NCT01653470|Fluorouracil|fluorouracil|mesh-list
44744429|NCT01653470|Irinotecan|irinotecan|mesh-list
44744430|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44744431|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744432|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44744433|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44744434|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44744435|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744436|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
44744437|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744438|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744439|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
44744440|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744441|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44744442|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44744443|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744444|NCT01653470|Antidotes|antidotes|mesh-ancestor
44744445|NCT01653470|Protective Agents|protective agents|mesh-ancestor
44744446|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
44744447|NCT01653470|Vitamins|vitamins|mesh-ancestor
44744448|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
44744449|NCT01653522|Doxycycline|doxycycline|mesh-list
44744450|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744451|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744452|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
44744453|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44273058|NCT00690911|Adalimumab|adalimumab|mesh-list
44744454|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44744455|NCT01653561|Apatinib|apatinib|mesh-list
44744456|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744457|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44744458|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744459|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744460|NCT01653639|Factor VIII|factor viii|mesh-list
44744461|NCT01653639|Coagulants|coagulants|mesh-ancestor
44744462|NCT01653665|Sargramostim|sargramostim|mesh-list
44744463|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
44744464|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744465|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
44744466|NCT01653717|Fludarabine|fludarabine|mesh-list
44744467|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
44744468|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744469|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
44744470|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744471|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44744472|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44744473|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
44744474|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744475|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744476|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44744477|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744478|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
44744479|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44744480|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
44744481|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44744482|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744483|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744484|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44744485|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44744486|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744487|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744488|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744489|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44744490|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
44744491|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44744492|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744493|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44744495|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44744496|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44744497|NCT01654081|Irinotecan|irinotecan|mesh-list
44744498|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44744499|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44744500|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744501|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744502|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744503|NCT01654120|Liraglutide|liraglutide|mesh-list
44744504|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44744505|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744506|NCT01654120|Incretins|incretins|mesh-ancestor
44744507|NCT01654120|Hormones|hormones|mesh-ancestor
44744508|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744509|NCT01654146|Paclitaxel|paclitaxel|mesh-list
44744510|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44744511|NCT01654146|Carboplatin|carboplatin|mesh-list
44744512|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44744513|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744514|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44744515|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273085|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44744516|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44744517|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744518|NCT01654185|Letrozole|letrozole|mesh-list
44744519|NCT01654185|Exemestane|exemestane|mesh-list
44744520|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44744521|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744522|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44744523|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744524|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744525|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44744526|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
44744527|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744528|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744529|NCT01654211|Ritonavir|ritonavir|mesh-list
44744530|NCT01654211|Lactams|lactams|mesh-list
44744531|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44744532|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44744533|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44744534|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744535|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744536|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44744537|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44744538|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
44744539|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744540|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44744541|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44744542|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744543|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
44744544|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44744545|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44744546|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744547|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44744548|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744549|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744550|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44744551|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
44744552|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744553|NCT01654497|HU 211|hu 211|mesh-list
44744554|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44744555|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
44744556|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
44744557|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744558|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521708|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44521709|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
44521710|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521711|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521712|NCT01243632|Antiviral Agents|antiviral agents|mesh-ancestor
44744559|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744560|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44744561|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44744562|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744563|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744564|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44744565|NCT01654497|Protective Agents|protective agents|mesh-ancestor
44744566|NCT01654562|Simvastatin|simvastatin|mesh-list
44744567|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44744568|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44744569|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
44744570|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744571|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44744572|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44744573|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744574|NCT01654575|Methotrexate|methotrexate|mesh-list
44744575|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44744576|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
44744577|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44744578|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744579|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744580|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
44744581|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744582|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744583|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
44744584|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744585|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44744586|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744587|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
44744588|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44744589|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44744590|NCT01654640|Metformin|metformin|mesh-list
44744591|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44744592|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744593|NCT01654692|Ipilimumab|ipilimumab|mesh-list
44744594|NCT01654692|Fotemustine|fotemustine|mesh-list
44744595|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44744596|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744597|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44744598|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744599|NCT01654705|Pantoprazole|pantoprazole|mesh-list
44273179|NCT00691470|Warfarin|warfarin|mesh-list
44273214|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744600|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44744601|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744602|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44744603|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744604|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744605|NCT01654718|Pantoprazole|pantoprazole|mesh-list
44744606|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44744607|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744608|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44744609|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744610|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744611|NCT01654731|Bezafibrate|bezafibrate|mesh-list
44744612|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44744613|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
44744614|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744615|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44744616|NCT01654809|Vaccines|vaccines|mesh-list
44744617|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
44744618|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744619|NCT01654913|Chrysarobin|chrysarobin|mesh-list
44744620|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44744621|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44744622|NCT01654913|Analgesics|analgesics|mesh-ancestor
44744623|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
44744624|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744625|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744626|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44744627|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44744628|NCT01654939|Rifaximin|rifaximin|mesh-list
44744629|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744630|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744631|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744632|NCT01654965|Topotecan|topotecan|mesh-list
44744633|NCT01654965|Lenograstim|lenograstim|mesh-list
44744634|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44744635|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
44744636|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744637|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44744638|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44744639|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744640|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744641|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744642|NCT01655004|Exemestane|exemestane|mesh-list
44744643|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744644|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44744645|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44744646|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744647|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744648|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44744649|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44273257|NCT00692016|Naproxen|naproxen|mesh-list
44744650|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744651|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744652|NCT01655056|Darexaban|darexaban|mesh-list
44744653|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44744654|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
44744655|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44744656|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
44744657|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744658|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744659|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
44744660|NCT01655082|Nicotine|nicotine|mesh-list
44744661|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44744662|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
44744663|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744664|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744665|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44744666|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44744667|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
44744668|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744669|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744670|NCT01655095|Prucalopride|prucalopride|mesh-list
44744671|NCT01655095|Bisacodyl|bisacodyl|mesh-list
44744672|NCT01655095|Laxatives|laxatives|mesh-ancestor
44744673|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744674|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44744675|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44744676|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
44744677|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744678|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744679|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744680|NCT01655095|Cathartics|cathartics|mesh-ancestor
44744681|NCT01655108|Minoxidil|minoxidil|mesh-list
44744682|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44744683|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
44744684|NCT01655147|Rifampin|rifampin|mesh-list
44744685|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
44744686|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744687|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44744688|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744689|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744690|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
44744691|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744692|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744693|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44744694|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44744695|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
44744696|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44744697|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744698|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
44744699|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44744700|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44744701|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44744702|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44744703|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44744704|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44744705|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44744707|NCT01655199|Ipratropium|ipratropium|mesh-list
44744708|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44744709|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
44744710|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744711|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744712|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44744713|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
44744714|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
44744715|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44744716|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44744717|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44744718|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44744719|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744720|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744721|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273293|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744722|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44744723|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
44744724|NCT01655212|Valganciclovir|valganciclovir|mesh-list
44744725|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
44744726|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687440|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44687441|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44687442|NCT01339754|Trabectedin|trabectedin|mesh-list
44687443|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687444|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
44687445|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687446|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687447|NCT01339819|Dabigatran|dabigatran|mesh-list
44687448|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
44687449|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
44687450|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44687451|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
44687452|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687453|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687454|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
44687455|NCT01339871|Vorinostat|vorinostat|mesh-list
44687456|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687457|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44687458|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687468|NCT01339988|Busulfan|busulfan|mesh-list
44687469|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687470|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
44687471|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687472|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687473|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687474|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
44687475|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687476|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687477|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687478|NCT01340118|Budesonide|budesonide|mesh-list
44687479|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687480|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44687481|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
44687482|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687483|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687484|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44687485|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44687486|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
44687487|NCT01340118|Hormones|hormones|mesh-ancestor
44687488|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687489|NCT01340235|Erythromycin|erythromycin|mesh-list
44687490|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
44687491|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44687492|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
44744727|NCT01655303|Propranolol|propranolol|mesh-list
44744729|NCT01655303|Verapamil|verapamil|mesh-list
44744730|NCT01655303|Diltiazem|diltiazem|mesh-list
44744731|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44744732|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44744733|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744734|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744735|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744736|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744737|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44744738|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44744739|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
44744740|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
44273355|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
44744741|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
44744742|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744743|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44744744|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44744745|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744746|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744747|NCT01655316|Verapamil|verapamil|mesh-list
44521891|NCT01244360|Resveratrol|resveratrol|mesh-list
44744748|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44744749|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44744750|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744751|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744752|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744753|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744754|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
44744755|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
44744756|NCT01655524|Aminophylline|aminophylline|mesh-list
44744757|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44744758|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
44744759|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744760|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744761|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44744762|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
44744763|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44744764|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44744765|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744766|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744767|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44744768|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44744769|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
44744770|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744771|NCT01655524|Protective Agents|protective agents|mesh-ancestor
44744772|NCT01655628|Gemcitabine|gemcitabine|mesh-list
44744773|NCT01655628|Cisplatin|cisplatin|mesh-list
44744774|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744775|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744776|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
44744777|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744778|NCT01655628|Antiviral Agents|antiviral agents|mesh-ancestor
44744779|NCT01655628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744780|NCT01655628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744781|NCT01655628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44744782|NCT01655628|Immunologic Factors|immunologic factors|mesh-ancestor
44744783|NCT01655628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744784|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
44521892|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
44521893|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521894|NCT01244360|Protective Agents|protective agents|mesh-ancestor
44521895|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521896|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521897|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44521898|NCT01244581|Amoxicillin|amoxicillin|mesh-list
44521899|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
44521900|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
44521901|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44521902|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521903|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521904|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44521905|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521907|NCT01244659|Tacrolimus|tacrolimus|mesh-list
44744785|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44744786|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44744787|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744788|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
44744789|NCT01655641|Coagulants|coagulants|mesh-ancestor
44744790|NCT01655706|Aripiprazole|aripiprazole|mesh-list
44744791|NCT01655706|Citalopram|citalopram|mesh-list
44744792|NCT01655706|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44744793|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44744794|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744795|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744796|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744797|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
44744798|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744799|NCT01655706|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44744800|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
44744801|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44744802|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44744803|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44744804|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44744805|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
44744806|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
44744807|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44744808|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44744809|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44744810|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44744811|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44744812|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44744813|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44744814|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44744815|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744816|NCT01655758|Timolol|timolol|mesh-list
44744817|NCT01655758|Bimatoprost|bimatoprost|mesh-list
44744818|NCT01655758|Travoprost|travoprost|mesh-list
44744819|NCT01655758|Dorzolamide|dorzolamide|mesh-list
44744820|NCT01655758|Latanoprost|latanoprost|mesh-list
44744821|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44744822|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44744823|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744824|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744825|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744826|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744827|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44744828|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44744829|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44744830|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44744831|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44744832|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744833|NCT01655810|Vitamin D|vitamin d|mesh-list
44744834|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
44744835|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
44744836|NCT01655810|Vitamins|vitamins|mesh-list
44744837|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
44744838|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
44744839|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744840|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744841|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44744842|NCT01655810|Antacids|antacids|mesh-ancestor
44744843|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744844|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44744845|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
44744846|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44744847|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44744848|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44744849|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744850|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744851|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
44744852|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744853|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744854|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44744855|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744856|NCT01655875|Plerixafor|plerixafor|mesh-list
44744857|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44744858|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44744859|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
44744860|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744862|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744863|NCT01655914|Flumazenil|flumazenil|mesh-list
44744864|NCT01655914|Antidotes|antidotes|mesh-ancestor
44744865|NCT01655914|Protective Agents|protective agents|mesh-ancestor
44744866|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744867|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
44744868|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
44744869|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744870|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744871|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
44744872|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44744873|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44744874|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744875|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
44744876|NCT01655927|Coagulants|coagulants|mesh-ancestor
44744877|NCT01655966|Vitamin D|vitamin d|mesh-list
44744878|NCT01655966|Interferons|interferons|mesh-list
44744879|NCT01655966|Ribavirin|ribavirin|mesh-list
44744880|NCT01655966|Vitamins|vitamins|mesh-ancestor
44744881|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
44744882|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744883|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44744884|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744885|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
44744886|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744887|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
44744888|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744889|NCT01655992|Capecitabine|capecitabine|mesh-list
44744890|NCT01655992|Tegafur|tegafur|mesh-list
44273522|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744891|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44744892|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
44744893|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744894|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44744895|NCT01656005|Beclomethasone|beclomethasone|mesh-list
44744896|NCT01656005|Carvedilol|carvedilol|mesh-list
44744897|NCT01656005|Bisoprolol|bisoprolol|mesh-list
44744898|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
44744899|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
44744900|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44744901|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
44744902|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744903|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744904|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44744905|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
44744906|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44744907|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44744908|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44744909|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
44744910|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44744911|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744912|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
44273545|NCT00693355|Butyric Acid|butyric acid|mesh-list
44744913|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44744914|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
44744915|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44744916|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44744917|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44744918|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
44744919|NCT01656005|Protective Agents|protective agents|mesh-ancestor
44744920|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44744921|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744922|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744923|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
44273558|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744924|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44744925|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44744926|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
44744927|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44744928|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44744929|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
44744930|NCT01656005|Hormones|hormones|mesh-ancestor
44744931|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44744932|NCT01656018|Rilpivirine|rilpivirine|mesh-list
44744933|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44744934|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44744935|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744936|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744937|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
44744938|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744939|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44744940|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44744942|NCT01656057|Metformin|metformin|mesh-list
44744943|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
44273572|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
44744944|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44744945|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44744946|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744947|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44744948|NCT01656057|Analgesics|analgesics|mesh-ancestor
44744949|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
44744950|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744951|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
44744952|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44744953|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44744954|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
44744955|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744956|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44744957|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44744958|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273589|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44744959|NCT01656070|Vitamin D|vitamin d|mesh-list
44744960|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
44744961|NCT01656070|Vitamins|vitamins|mesh-ancestor
44744962|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
44744963|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744964|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44744965|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44744966|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44744967|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44744968|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44744969|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
44744970|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744971|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744972|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44744973|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44744974|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
44744975|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744976|NCT01656122|Abacavir|abacavir|mesh-list
44744977|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44744978|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44744979|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44744980|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744981|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
44744982|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44744983|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44744984|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44744985|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
44744986|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44744987|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44744988|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44744989|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
44744990|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44744991|NCT01656226|Protective Agents|protective agents|mesh-ancestor
44744992|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44744993|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44744994|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
44744995|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44744996|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
44744997|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44744998|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
44744999|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745000|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745001|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
44745002|NCT01656512|Vitamin D|vitamin d|mesh-list
44745003|NCT01656512|Diphosphonates|diphosphonates|mesh-list
44745004|NCT01656512|Calcium|calcium|mesh-list
44745005|NCT01656512|Vitamins|vitamins|mesh-ancestor
44745006|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
44745007|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745008|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44745009|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44273604|NCT00693446|Tacrolimus|tacrolimus|mesh-list
44745010|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44745011|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
44745012|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745013|NCT01656538|Paclitaxel|paclitaxel|mesh-list
44745014|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44745015|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745016|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745017|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745018|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745019|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745020|NCT01656551|Gemcitabine|gemcitabine|mesh-list
44745021|NCT01656551|Cisplatin|cisplatin|mesh-list
44745022|NCT01656551|Pemetrexed|pemetrexed|mesh-list
44745023|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745024|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44745025|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
44745026|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745027|NCT01656551|Antiviral Agents|antiviral agents|mesh-ancestor
44745028|NCT01656551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745029|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745030|NCT01656551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745031|NCT01656551|Immunologic Factors|immunologic factors|mesh-ancestor
44745032|NCT01656551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745033|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44745034|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44745035|NCT01656616|Antidotes|antidotes|mesh-list
44745036|NCT01656616|Protective Agents|protective agents|mesh-ancestor
44273656|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44451859|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44745037|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745038|NCT01656642|Atezolizumab|atezolizumab|mesh-list
44745039|NCT01656642|Vemurafenib|vemurafenib|mesh-list
44745040|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745041|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44745042|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745043|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745044|NCT01656668|Theobromine|theobromine|mesh-list
44745045|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44745046|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
44745047|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745048|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745049|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745050|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273682|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745051|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
44745052|NCT01656720|Methoxamine|methoxamine|mesh-list
44745053|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
44745054|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
44745055|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745056|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745057|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44745058|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44745059|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44745060|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44745061|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745062|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745063|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745064|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
44745065|NCT01656798|Citric Acid|citric acid|mesh-list
44745066|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
44745067|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
44745068|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44745069|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
44745070|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
44745071|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745072|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
44745073|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44745074|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44745075|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745076|NCT01656798|Urological Agents|urological agents|mesh-ancestor
44745077|NCT01656811|Albuterol|albuterol|mesh-list
44745078|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44745079|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
44745080|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745081|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745082|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44687493|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687494|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687495|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687496|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44522156|NCT01246440|Catumaxomab|catumaxomab|mesh-list
44745083|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745084|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
44745085|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44745086|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44745087|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44745088|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44745089|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745090|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745091|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745092|NCT01656980|Carmustine|carmustine|mesh-list
44745093|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44745094|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
44745095|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745096|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522219|NCT01246921|Fluticasone|fluticasone|mesh-list
44522220|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522221|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44522222|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
44522223|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522224|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522225|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44522226|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
44522227|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745097|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
44745098|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
44745099|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
44745100|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745101|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745102|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745103|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44745104|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
44745105|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
44745106|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745107|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745108|NCT01657071|Aspirin|aspirin|mesh-list
44745109|NCT01657071|Clopidogrel|clopidogrel|mesh-list
44273735|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44745110|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745111|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745112|NCT01657071|Analgesics|analgesics|mesh-ancestor
44745113|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
44745114|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745115|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745116|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745117|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745118|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44745119|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745120|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273758|NCT00694044|Varenicline|varenicline|mesh-list
44745121|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44745122|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44745123|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745124|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
44745125|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44745126|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44745127|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44745128|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
44745129|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745130|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
44745131|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44745132|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745133|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44745134|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44745135|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745136|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745137|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745138|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745139|NCT01657201|Voriconazole|voriconazole|mesh-list
44745140|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
44745141|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745142|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44745143|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44745144|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745145|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745146|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44745147|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745148|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745149|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745150|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44745151|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44745152|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44745153|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44745154|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745155|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745156|NCT01657240|Analgesics|analgesics|mesh-ancestor
44745157|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
44745158|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745159|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745160|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745161|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745162|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44745163|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44745164|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44745165|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
44745166|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
44745167|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687497|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522249|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
44745168|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745169|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44745170|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745171|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44745172|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44745173|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44745174|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
44745175|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745176|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745177|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44745179|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44745180|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745181|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
44745182|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
44745183|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44745184|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44745185|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44745186|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44745187|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44745188|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745189|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
44745190|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745191|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745192|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44745193|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745194|NCT01657448|Methenamine|methenamine|mesh-list
44745195|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
44745196|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
44745197|NCT01657448|Methylene Blue|methylene blue|mesh-list
44745198|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44745199|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745200|NCT01657448|Renal Agents|renal agents|mesh-ancestor
44745201|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44745202|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745203|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745204|NCT01657487|Fluticasone|fluticasone|mesh-list
44745205|NCT01657487|Xhance|xhance|mesh-list
44745206|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44745207|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44745208|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745209|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44745210|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
44745211|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745212|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745213|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745214|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745215|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745216|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44745217|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44745218|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44745219|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44745220|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745221|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745222|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745223|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
44745224|NCT01657487|Hormones|hormones|mesh-ancestor
44745225|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745226|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
44745227|NCT01657578|Omeprazole|omeprazole|mesh-list
44745228|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44745229|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745230|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44745231|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745232|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745233|NCT01657656|Vitamin D|vitamin d|mesh-list
44745234|NCT01657656|Vitamins|vitamins|mesh-ancestor
44745235|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
44745236|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745237|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44745238|NCT01657669|Aflibercept|aflibercept|mesh-list
44745239|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44745240|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522326|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
44745241|NCT01657669|Growth Substances|growth substances|mesh-ancestor
44745242|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745243|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44745244|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745246|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745247|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44745248|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
44745249|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
44745250|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745251|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745252|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44745253|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44745254|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
44745255|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745256|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745257|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
44745258|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44745259|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44745260|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745261|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745262|NCT01657812|Analgesics|analgesics|mesh-ancestor
44745263|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
44745264|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273900|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
44745265|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44745266|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44745267|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44745268|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745269|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745270|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745271|NCT01657825|Isavuconazole|isavuconazole|mesh-list
44745272|NCT01657825|Warfarin|warfarin|mesh-list
44745273|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
44745274|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
44745275|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745276|NCT01657838|Ketoconazole|ketoconazole|mesh-list
44745277|NCT01657838|Isavuconazole|isavuconazole|mesh-list
44745278|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
44745279|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745280|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44745281|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44745282|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745283|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745284|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44745285|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745286|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745287|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745288|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44745289|NCT01657851|Tamsulosin|tamsulosin|mesh-list
44745290|NCT01657851|Dutasteride|dutasteride|mesh-list
44745291|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44745292|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44745293|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44745294|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745295|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745296|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745297|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745298|NCT01657851|Urological Agents|urological agents|mesh-ancestor
44745299|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44745300|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44745301|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745302|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745303|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745304|NCT01657864|Lamotrigine|lamotrigine|mesh-list
44745305|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
44745306|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44745307|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44745308|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745309|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44745310|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745311|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44745312|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44745313|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44745314|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44745315|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44687498|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687499|NCT01340248|Carvedilol|carvedilol|mesh-list
44687500|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44687501|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44687502|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687503|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687504|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687505|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687506|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44687507|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
44687508|NCT01340248|Protective Agents|protective agents|mesh-ancestor
44687509|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44687510|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44687511|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44687512|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
44687513|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44687514|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44687515|NCT01340326|Valsartan|valsartan|mesh-list
44687516|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44687517|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44687518|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44687519|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687520|NCT01340417|Melatonin|melatonin|mesh-list
44687521|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
44687522|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687523|NCT01340417|Protective Agents|protective agents|mesh-ancestor
44687524|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687525|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687526|NCT01340456|Rifampin|rifampin|mesh-list
44687527|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44687528|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
44687529|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687530|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687531|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
44687532|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687533|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687534|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687535|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44687536|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44687537|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44239051|NCT00571246|Lamotrigine|lamotrigine|mesh-list
44687538|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44687539|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44687540|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44687542|NCT01340521|Enclomiphene|enclomiphene|mesh-list
44687543|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
44687544|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44687545|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
44687546|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687547|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687548|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44687549|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
44687550|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44687551|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44687552|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44687553|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
44687554|NCT01340547|Ifosfamide|ifosfamide|mesh-list
44687555|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687556|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
44687557|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687558|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687559|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44687560|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
44687561|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687562|NCT01340599|Protective Agents|protective agents|mesh-ancestor
44687563|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687564|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44687565|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44745317|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
44745318|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745319|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44745320|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44274028|NCT00695994|Carboplatin|carboplatin|mesh-list
44745321|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
44745322|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745323|NCT01657929|Antacids|antacids|mesh-ancestor
44745324|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745325|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745326|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44745327|NCT01657955|Chlorambucil|chlorambucil|mesh-list
44745328|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44745329|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
44745330|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745331|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745332|NCT01657513|Adalimumab|adalimumab|mesh-list
44745333|NCT01657513|Etanercept|etanercept|mesh-list
44745334|NCT01657513|Infliximab|infliximab|mesh-list
44274044|NCT00696007|Cisplatin|cisplatin|mesh-list
44745335|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745336|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745337|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745338|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745339|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745340|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745341|NCT01657513|Analgesics|analgesics|mesh-ancestor
44745342|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
44745343|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745344|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745345|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745346|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
44745347|NCT01657981|Darexaban|darexaban|mesh-list
44745348|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44745349|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
44745350|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44745351|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745352|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745353|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745354|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
44745355|NCT01658007|Sirolimus|sirolimus|mesh-list
44745356|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44745357|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745358|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44745359|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745360|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
44745361|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745362|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
44745363|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745364|NCT01658033|Leucovorin|leucovorin|mesh-list
44745365|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
44745366|NCT01658033|Bevacizumab|bevacizumab|mesh-list
44745367|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745368|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44745369|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44745370|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44745371|NCT01658033|Growth Substances|growth substances|mesh-ancestor
44745372|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745373|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
44745374|NCT01658033|Antidotes|antidotes|mesh-ancestor
44745375|NCT01658033|Protective Agents|protective agents|mesh-ancestor
44745376|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
44745377|NCT01658033|Vitamins|vitamins|mesh-ancestor
44745378|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
44745379|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
44745380|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44745381|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745382|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745383|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
44745384|NCT01658124|Coagulants|coagulants|mesh-ancestor
44745385|NCT01658176|Exemestane|exemestane|mesh-list
44745386|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745387|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44745388|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44745389|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745390|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745391|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44745392|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745393|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745394|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745396|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44745397|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
44745398|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745399|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745400|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44745401|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44745402|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
44745403|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745404|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745405|NCT01658215|Nicotine|nicotine|mesh-list
44745406|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44745407|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
44745408|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745409|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745410|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44745411|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44745412|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
44745413|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745414|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745415|NCT01658319|Fludarabine|fludarabine|mesh-list
44745416|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
44745417|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274119|NCT00696475|Diazoxide|diazoxide|mesh-list
44745418|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44745419|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
44745420|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745421|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745422|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
44745423|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745424|NCT01658358|Doxorubicin|doxorubicin|mesh-list
44745425|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44745426|NCT01658358|Lapatinib|lapatinib|mesh-list
44745427|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44745428|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745429|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44745430|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44745431|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745432|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745433|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44745434|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44745435|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44745436|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44745437|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745438|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
44745439|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44745440|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
44745441|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745442|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
44745443|NCT01658449|Protective Agents|protective agents|mesh-ancestor
44745444|NCT01658462|Docetaxel|docetaxel|mesh-list
44745445|NCT01658462|Nintedanib|nintedanib|mesh-list
44745446|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745447|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745448|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745449|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745450|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745451|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44745452|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745453|NCT01658527|Bicalutamide|bicalutamide|mesh-list
44745454|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
44745455|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745456|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522555|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522556|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
44522557|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522558|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522559|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522560|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
44522561|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
44522562|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522563|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745457|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745458|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745459|NCT01658553|Trametinib|trametinib|mesh-list
44745460|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745461|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44745462|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745463|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745464|NCT01658774|Ascorbic Acid|ascorbic acid|mesh-list
44745465|NCT01658774|Albendazole|albendazole|mesh-list
44745466|NCT01658774|Vitamins|vitamins|mesh-ancestor
44745467|NCT01658774|Micronutrients|micronutrients|mesh-ancestor
44745468|NCT01658774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745469|NCT01658774|Antioxidants|antioxidants|mesh-ancestor
44745470|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745471|NCT01658774|Protective Agents|protective agents|mesh-ancestor
44745472|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
44745473|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44745474|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745475|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
44745476|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44745477|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44745478|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745479|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745480|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745481|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522577|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745482|NCT01658852|Metronidazole|metronidazole|mesh-list
44745483|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745484|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44745485|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44745486|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44745488|NCT01658878|Ipilimumab|ipilimumab|mesh-list
44745489|NCT01658878|Sorafenib|sorafenib|mesh-list
44745490|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44745491|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745492|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44745493|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745494|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44745495|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745496|NCT01658891|Beclomethasone|beclomethasone|mesh-list
44745497|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
44745498|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44745499|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
44745500|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745501|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745502|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745503|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745504|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44745505|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44745506|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44745507|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745508|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745509|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745510|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745511|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
44745512|NCT01658891|Hormones|hormones|mesh-ancestor
44745513|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745514|NCT01659008|Estradiol|estradiol|mesh-list
44745515|NCT01659008|Estrogens|estrogens|mesh-ancestor
44745516|NCT01659008|Hormones|hormones|mesh-ancestor
44745517|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745518|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745519|NCT01659047|Idelalisib|idelalisib|mesh-list
44745520|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745521|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745522|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745523|NCT01659086|Vaccines|vaccines|mesh-list
44745524|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
44745525|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745526|NCT01659099|Prednisone|prednisone|mesh-list
44745527|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
44745528|NCT01659099|Rituximab|rituximab|mesh-list
44745529|NCT01659099|Doxorubicin|doxorubicin|mesh-list
44745530|NCT01659099|Vincristine|vincristine|mesh-list
44745531|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
44745532|NCT01659099|Bleomycin|bleomycin|mesh-list
44745533|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745534|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
44745535|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745536|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745537|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44745538|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
44745539|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745540|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745541|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44745542|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44745543|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44745544|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44745545|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44745546|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745547|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745548|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
44745549|NCT01659099|Hormones|hormones|mesh-ancestor
44745550|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274215|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44274271|NCT00696982|Hormones|hormones|mesh-ancestor
44745551|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44745552|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44745553|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745554|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745555|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745556|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
44745557|NCT01659190|Antacids|antacids|mesh-ancestor
44745558|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745559|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745561|NCT01659242|Methotrexate|methotrexate|mesh-list
44745562|NCT01659242|Leflunomide|leflunomide|mesh-list
44745563|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44745564|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
44745565|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44745566|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745567|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44745568|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
44745569|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745570|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745571|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745572|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745573|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44745574|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745575|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
44745576|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745577|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44745578|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274274|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745579|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745580|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745581|NCT01659242|Analgesics|analgesics|mesh-ancestor
44745582|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
44745583|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745584|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745585|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745586|NCT01659281|Artesunate|artesunate|mesh-list
44745587|NCT01659281|Mefloquine|mefloquine|mesh-list
44745588|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
44745589|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44745590|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44745591|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745592|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745593|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
44745594|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
44745595|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44745596|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
44745597|NCT01659346|Carvedilol|carvedilol|mesh-list
44745598|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44745599|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44745600|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745601|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745602|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745603|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745604|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44745605|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
44745606|NCT01659346|Protective Agents|protective agents|mesh-ancestor
44745607|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44745608|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44745609|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44745610|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
44745611|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44745612|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44745613|NCT01659359|Lidocaine|lidocaine|mesh-list
44745614|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44745615|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
44745616|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274319|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
44745617|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745618|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
44745619|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745620|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44745621|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44745622|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44745623|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44745624|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745625|NCT01659372|Naproxen|naproxen|mesh-list
44745626|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745627|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745628|NCT01659372|Analgesics|analgesics|mesh-ancestor
44745629|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
44745630|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522727|NCT01248468|Analgesics|analgesics|mesh-ancestor
44745631|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745632|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745633|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745634|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
44745635|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44274336|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44745636|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745637|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745638|NCT01659437|Clarithromycin|clarithromycin|mesh-list
44745639|NCT01659437|Streptomycin|streptomycin|mesh-list
44745640|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44745641|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745642|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44745643|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745644|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745645|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44745646|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44745647|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
44745648|NCT01659476|Miotics|miotics|mesh-ancestor
44745649|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
44745650|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274358|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44274361|NCT00697372|Sirolimus|sirolimus|mesh-list
44745651|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745652|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44745653|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44745654|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745655|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44745656|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44745657|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
44745658|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745659|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745660|NCT01659515|Arbekacin|arbekacin|mesh-list
44745661|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745662|NCT01659619|Erythromycin|erythromycin|mesh-list
44745663|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
44745664|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44745665|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
44745666|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44745667|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745668|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745669|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44687566|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687567|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44687568|NCT01340677|Canagliflozin|canagliflozin|mesh-list
44687569|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44687570|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687571|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687572|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687573|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
44687574|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44687575|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
44687576|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687577|NCT01340833|Dabrafenib|dabrafenib|mesh-list
44687578|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687579|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687580|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687581|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687582|NCT01340846|Ketoconazole|ketoconazole|mesh-list
44687583|NCT01340846|Dabrafenib|dabrafenib|mesh-list
44687584|NCT01340846|Warfarin|warfarin|mesh-list
44687585|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
44687586|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
44687587|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
44687588|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687589|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44687590|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44687591|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687592|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687593|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44687594|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44687595|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687596|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687597|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44687598|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687599|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687600|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44274401|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745670|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745671|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745672|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
44745673|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44745674|NCT01659684|Antibodies|antibodies|mesh-list
44745675|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
44745676|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44745677|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
44745678|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745679|NCT01659775|Ondansetron|ondansetron|mesh-list
44745680|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
44745681|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
44745682|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745683|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745684|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745685|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
44745686|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745687|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44745688|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
44745689|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745690|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745691|NCT01659775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44745692|NCT01659775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44745693|NCT01659775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44745694|NCT01659775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44745695|NCT01659775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44745696|NCT01659788|Ubiquinone|ubiquinone|mesh-list
44745697|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
44745698|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
44745699|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745700|NCT01659788|Vitamins|vitamins|mesh-ancestor
44745701|NCT01659827|Bupivacaine|bupivacaine|mesh-list
44745702|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
44745703|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
44745704|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44745705|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745706|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
44745707|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745708|NCT01659892|Montelukast|montelukast|mesh-list
44745709|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745710|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745711|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44745712|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745713|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745714|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745715|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44745716|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44745717|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274426|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745718|NCT01659905|Montelukast|montelukast|mesh-list
44745719|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745720|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745721|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44745722|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745723|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745724|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745725|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44745726|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44745727|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745728|NCT01659918|Montelukast|montelukast|mesh-list
44745729|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745730|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745731|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44745732|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
44745733|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745734|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745735|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44745736|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44745737|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745738|NCT01659931|Montelukast|montelukast|mesh-list
44745739|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44745740|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
44745741|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44687601|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
44745742|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
44274453|NCT00697775|Vaccines|vaccines|mesh-list
44745743|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745744|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745745|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44745746|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44745747|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745749|NCT01659944|Eliglustat|eliglustat|mesh-list
44745750|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44745751|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44745752|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
44745753|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
44745754|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745755|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745756|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44745757|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44745758|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44745759|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745760|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745761|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745762|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745763|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44745764|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
44745765|NCT01660295|Certoparin|certoparin|mesh-list
44745766|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
44745767|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44745768|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745769|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745770|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44745771|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
44745772|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
44745773|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745774|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745775|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745776|NCT01660295|Analgesics|analgesics|mesh-ancestor
44745777|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
44745778|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745779|NCT01660373|Tirofiban|tirofiban|mesh-list
44745780|NCT01660373|Ticagrelor|ticagrelor|mesh-list
44745781|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44745782|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44745783|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44745784|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44745785|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
44745786|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745787|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745788|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745789|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44745790|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745791|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44745792|NCT01660386|Glimepiride|glimepiride|mesh-list
44745793|NCT01660386|Saxagliptin|saxagliptin|mesh-list
44745794|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44745795|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745796|NCT01660386|Incretins|incretins|mesh-ancestor
44745797|NCT01660386|Hormones|hormones|mesh-ancestor
44745798|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745799|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44745800|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745801|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745802|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745803|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44745804|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745805|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
44745806|NCT01660399|Docetaxel|docetaxel|mesh-list
44745807|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745808|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745809|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745810|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745811|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745812|NCT01660477|Ritonavir|ritonavir|mesh-list
44745813|NCT01660477|Lopinavir|lopinavir|mesh-list
44745814|NCT01660477|Isavuconazole|isavuconazole|mesh-list
44745815|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44745816|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44745817|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745818|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745819|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745820|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44745821|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44745822|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
44745823|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745824|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44745825|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44745826|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
44745827|NCT01660542|Docetaxel|docetaxel|mesh-list
44745828|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745829|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
44745830|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
44745831|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44745832|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745833|NCT01660594|Calcium|calcium|mesh-list
44745834|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44745835|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522987|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44522988|NCT01240811|Trace Elements|trace elements|mesh-ancestor
44522989|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
44522990|NCT01240746|Vaccines|vaccines|mesh-list
44522991|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
44522992|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522993|NCT01240590|Cisplatin|cisplatin|mesh-list
44522994|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522995|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44522996|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44522997|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
44745836|NCT01660620|Betaxolol|betaxolol|mesh-list
44745837|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44745838|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
44745839|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
44745840|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745841|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745842|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44745843|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44745844|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44745845|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
44745846|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745847|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745848|NCT01660750|Dexamethasone|dexamethasone|mesh-list
44274553|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44274559|NCT00698425|Citric Acid|citric acid|mesh-list
44745849|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
44745850|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44745851|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
44745852|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745853|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745854|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44745855|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
44745856|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745857|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745858|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44745859|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745860|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
44745861|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
44745862|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745863|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745864|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
44745865|NCT01660750|Hormones|hormones|mesh-ancestor
44745866|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745867|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44274573|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274575|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
44745868|NCT01660854|Proguanil|proguanil|mesh-list
44745869|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44745870|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
44745871|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44745872|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44745873|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745874|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
44745875|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745876|NCT01660867|Dexamethasone|dexamethasone|mesh-list
44745877|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745878|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
44745879|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
44745880|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745881|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745882|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745883|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
44745884|NCT01660867|Hormones|hormones|mesh-ancestor
44745885|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745886|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44745887|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745888|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44745889|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44745890|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44745891|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
44745892|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745893|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44745894|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44745895|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745896|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44745897|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44745898|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44745899|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
44745900|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745901|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44745902|NCT01660997|Dexamethasone|dexamethasone|mesh-list
44745903|NCT01660997|Ixazomib|ixazomib|mesh-list
44745904|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745905|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
44745906|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
44745907|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745908|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745909|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745910|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
44745911|NCT01660997|Hormones|hormones|mesh-ancestor
44745912|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745913|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44745914|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44745915|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745916|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745917|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745918|NCT01661101|Omeprazole|omeprazole|mesh-list
44745919|NCT01661101|Dabigatran|dabigatran|mesh-list
44745920|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44745921|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745922|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44745923|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274592|NCT00698724|Prednisolone|prednisolone|mesh-list
44745924|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745925|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
44745926|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44745927|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745928|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
44745929|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44745930|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
44745931|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44745932|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44745933|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745934|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745935|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745936|NCT01661257|Infliximab|infliximab|mesh-list
44745937|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745938|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745939|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745940|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44745941|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44745942|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44745943|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44745944|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
44274648|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44274649|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44745945|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44745946|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
44745947|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
44745948|NCT01661309|Vitamins|vitamins|mesh-ancestor
44745949|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
44745950|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745951|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
44745952|NCT01661322|Aspirin|aspirin|mesh-list
44745953|NCT01661322|Clopidogrel|clopidogrel|mesh-list
44745954|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44745955|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44745956|NCT01661322|Analgesics|analgesics|mesh-ancestor
44745957|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
44745958|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745959|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745960|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745961|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44745962|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44745963|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44745964|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745965|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44745966|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44745967|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745968|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
44745969|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44745970|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44745971|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44274668|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44745972|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
44745973|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745974|NCT01661335|Dexamethasone|dexamethasone|mesh-list
44745975|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
44745976|NCT01661335|Ondansetron|ondansetron|mesh-list
44745977|NCT01661335|Aprepitant|aprepitant|mesh-list
44745978|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
44745979|NCT01661335|BB 1101|bb 1101|mesh-list
44745980|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44745981|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
44745982|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
44523075|NCT01241006|Prednisone|prednisone|mesh-list
44523078|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
44745983|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44745984|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745985|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44745987|NCT01661335|Hormones|hormones|mesh-ancestor
44745988|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44745989|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44745990|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274693|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44745991|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
44745992|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44745993|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44745994|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
44745995|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44745996|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44745997|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
44745998|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44745999|NCT01661335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44746000|NCT01661335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44746001|NCT01661335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746002|NCT01661335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44746003|NCT01661335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44746004|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44746005|NCT01661439|Heparin|heparin|mesh-list
44746006|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44746007|NCT01661439|Tinzaparin|tinzaparin|mesh-list
44746008|NCT01661439|Dalteparin|dalteparin|mesh-list
44746009|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
44746010|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44746011|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44746012|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746013|NCT01661530|Vitamin E|vitamin e|mesh-list
44746014|NCT01661530|Vitamins|vitamins|mesh-ancestor
44746015|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
44746016|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746017|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
44746018|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746019|NCT01661530|Protective Agents|protective agents|mesh-ancestor
44746020|NCT01661556|Miconazole|miconazole|mesh-list
44746021|NCT01661556|Hydroquinone|hydroquinone|mesh-list
44746022|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
44746023|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274724|NCT00699322|Hormones|hormones|mesh-ancestor
44746024|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44746025|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44746026|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746027|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746028|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44746029|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
44746030|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746031|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746032|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44746033|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44746034|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
44746035|NCT01661556|Protective Agents|protective agents|mesh-ancestor
44746036|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44746037|NCT01661751|Vaccines|vaccines|mesh-list
44746038|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
44746039|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746040|NCT01661777|Diuretics|diuretics|mesh-list
44746041|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
44746042|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44746043|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
44746044|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746045|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
44746046|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746047|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746048|NCT01661855|Riluzole|riluzole|mesh-list
44746049|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
44746050|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44746051|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44746052|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746053|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746054|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746055|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44746056|NCT01661855|Protective Agents|protective agents|mesh-ancestor
44746057|NCT01661868|Olaparib|olaparib|mesh-list
44746058|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44746059|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746060|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746061|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746062|NCT01661985|Azithromycin|azithromycin|mesh-list
44746063|NCT01661985|Doxycycline|doxycycline|mesh-list
44746064|NCT01661985|Lymecycline|lymecycline|mesh-list
44746065|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746066|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746067|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
44746068|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44746069|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44746070|NCT01662037|Bosentan|bosentan|mesh-list
44746071|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44746072|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44746073|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746074|NCT01662089|Zinc|zinc|mesh-list
44746075|NCT01662089|Trace Elements|trace elements|mesh-ancestor
44746076|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
44746077|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746078|NCT01662128|Capecitabine|capecitabine|mesh-list
44746079|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44746080|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
44746081|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746082|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746083|NCT01662180|Hormones|hormones|mesh-list
44746084|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44746085|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746086|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746087|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
44746088|NCT01662193|Vitamin D|vitamin d|mesh-list
44746089|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
44746090|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
44746091|NCT01662193|Vitamins|vitamins|mesh-list
44746092|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
44746093|NCT01662193|Calcium|calcium|mesh-list
44746094|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
44746095|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746096|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44746097|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44746098|NCT01662193|Antacids|antacids|mesh-ancestor
44687602|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44687603|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44687604|NCT01340950|Tenofovir|tenofovir|mesh-list
44687605|NCT01340950|Lamivudine|lamivudine|mesh-list
44687606|NCT01340950|Zidovudine|zidovudine|mesh-list
44687607|NCT01340950|Efavirenz|efavirenz|mesh-list
44687608|NCT01340950|Nevirapine|nevirapine|mesh-list
44687609|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44687610|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
44687611|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687612|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44687613|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687614|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687615|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687616|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44687617|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44687618|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
44687619|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44687620|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44687621|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44687622|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44687623|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44687624|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44687625|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
44687626|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
44687627|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
44687628|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687629|NCT01341106|Entecavir|entecavir|mesh-list
44687630|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
44687631|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687632|NCT01341158|Interferons|interferons|mesh-list
44687633|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274800|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44687634|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
44687635|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687636|NCT01341184|Rifampin|rifampin|mesh-list
44687637|NCT01341184|Rifabutin|rifabutin|mesh-list
44687638|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44687639|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
44746099|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746100|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746101|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
44746102|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44746103|NCT01662401|Bupivacaine|bupivacaine|mesh-list
44746104|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
44746105|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
44746106|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746107|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746108|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
44746109|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746110|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
44746111|NCT01662466|Testosterone|testosterone|mesh-list
44746112|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
44746113|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
44746114|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44274821|NCT00699894|Ondansetron|ondansetron|mesh-list
44746115|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44746116|NCT01662466|Androgens|androgens|mesh-ancestor
44746117|NCT01662466|Hormones|hormones|mesh-ancestor
44746118|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746119|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746120|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44746121|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746122|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
44746123|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44746124|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
44746125|NCT01662518|Dexamethasone|dexamethasone|mesh-list
44746126|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746127|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
44746128|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
44746129|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746130|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746131|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746132|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
44746133|NCT01662518|Hormones|hormones|mesh-ancestor
44746134|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746135|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44746136|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746138|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44746139|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44746140|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
44746141|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
44746142|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746143|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746144|NCT01662674|Metformin|metformin|mesh-list
44746145|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746146|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746147|NCT01662687|Granisetron|granisetron|mesh-list
44746148|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
44746149|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
44746150|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746151|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746152|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746153|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44746154|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
44746155|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746156|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746157|NCT01662700|Artesunate|artesunate|mesh-list
44746158|NCT01662700|Chloroquine|chloroquine|mesh-list
44746159|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
44746160|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44746161|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44746162|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746163|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746164|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
44746165|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
44746166|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44746167|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
44746168|NCT01662700|Amebicides|amebicides|mesh-ancestor
44746169|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746170|NCT01662804|Interleukin-2|interleukin-2|mesh-list
44746171|NCT01662804|Antibodies|antibodies|mesh-list
44746172|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44746173|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
44746174|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746175|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746176|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746177|NCT01662804|Analgesics|analgesics|mesh-ancestor
44746178|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
44746179|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746180|NCT01662869|Leucovorin|leucovorin|mesh-list
44746181|NCT01662869|Folic Acid|folic acid|mesh-list
44746182|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
44746183|NCT01662869|Fluorouracil|fluorouracil|mesh-list
44746184|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
44746185|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746186|NCT01662869|Antidotes|antidotes|mesh-ancestor
44746187|NCT01662869|Protective Agents|protective agents|mesh-ancestor
44746188|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746189|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
44746190|NCT01662869|Vitamins|vitamins|mesh-ancestor
44746191|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
44746192|NCT01662869|Hematinics|hematinics|mesh-ancestor
44746193|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
44746194|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746195|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44746196|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44746197|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
44746198|NCT01662921|Insulin|insulin|mesh-list
44746199|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44746200|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
44746201|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
44523339|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523340|NCT04518618|Analgesics|analgesics|mesh-ancestor
44523341|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
44523342|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523343|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44523344|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44523345|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
44523346|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
44523347|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44523348|NCT04518982|Lenalidomide|lenalidomide|mesh-list
44746202|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
44746203|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746204|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746205|NCT01663038|Aspirin|aspirin|mesh-list
44746206|NCT01663038|Clopidogrel|clopidogrel|mesh-list
44746207|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746208|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746209|NCT01663038|Analgesics|analgesics|mesh-ancestor
44746210|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
44746211|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746212|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746213|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746214|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746215|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44746216|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44746217|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746218|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44746219|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44746220|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746221|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
44746222|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44746223|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44746224|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44746225|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
44746226|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746227|NCT01663077|Clozapine|clozapine|mesh-list
44746228|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44746229|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
44746230|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746231|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746232|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746233|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44746234|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44746235|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746236|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44746237|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
44746238|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
44746239|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44746240|NCT01663090|Hematinics|hematinics|mesh-ancestor
44746241|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44746242|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44746243|NCT01663168|Rifabutin|rifabutin|mesh-list
44746244|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746245|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746246|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44746247|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
44746248|NCT01663441|Oprelvekin|oprelvekin|mesh-list
44746249|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746250|NCT01663558|Imiquimod|imiquimod|mesh-list
44746251|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44746252|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
44746253|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746254|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746255|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
44746256|NCT01663662|Tolvaptan|tolvaptan|mesh-list
44746257|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44746258|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746259|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
44746260|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746261|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44746262|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44746263|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746264|NCT01663805|Everolimus|everolimus|mesh-list
44746265|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746266|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44746267|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
44746268|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746269|NCT01663961|Digoxin|digoxin|mesh-list
44746270|NCT01663961|Mirabegron|mirabegron|mesh-list
44746271|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44746272|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44746273|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746274|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274988|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
44746275|NCT01663961|Protective Agents|protective agents|mesh-ancestor
44746276|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746277|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44746278|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44746279|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44746280|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746281|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746282|NCT01663961|Urological Agents|urological agents|mesh-ancestor
44746283|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
44746284|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44746285|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44746286|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44746287|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44746288|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746289|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
44746290|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746291|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746292|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44746293|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746294|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44746295|NCT01664065|Cephalosporins|cephalosporins|mesh-list
44746296|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746297|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746298|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
44746299|NCT01664195|Hematinics|hematinics|mesh-ancestor
44746300|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
44746301|NCT01664221|Hematinics|hematinics|mesh-ancestor
44746302|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
44746303|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44746304|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
44687640|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687641|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687642|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
44687643|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44687644|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687645|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687646|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44687647|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44687648|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44687649|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44687650|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44687651|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44687652|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
44687653|NCT01341262|Thalidomide|thalidomide|mesh-list
44687654|NCT01341262|Dexamethasone|dexamethasone|mesh-list
44687655|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
44687656|NCT01341262|Melphalan|melphalan|mesh-list
44687657|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687658|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
44687659|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687660|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687661|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687662|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
44687663|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687664|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687665|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687666|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687667|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
44687668|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
44687669|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687670|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687671|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
44687672|NCT01341262|Hormones|hormones|mesh-ancestor
44275070|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44687673|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687674|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44687675|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
44687676|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687677|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687678|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687679|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687680|NCT01341262|Growth Substances|growth substances|mesh-ancestor
44687681|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44687682|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44687683|NCT01341275|Vaccines|vaccines|mesh-list
44687684|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
44275072|NCT00701337|Hormones|hormones|mesh-ancestor
44687685|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687686|NCT01341340|Everolimus|everolimus|mesh-list
44687687|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687688|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687689|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
44523449|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746305|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746306|NCT01664260|Expectorants|expectorants|mesh-ancestor
44746307|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
44746308|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44746309|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
44746310|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746311|NCT01664260|Protective Agents|protective agents|mesh-ancestor
44746312|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746313|NCT01664260|Antidotes|antidotes|mesh-ancestor
44746314|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
44746315|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44746316|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746317|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746318|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746319|NCT01664520|Analgesics|analgesics|mesh-ancestor
44746320|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
44746321|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746322|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44746323|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44746324|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44746325|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746326|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746327|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746329|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44746330|NCT01664650|Protective Agents|protective agents|mesh-ancestor
44746331|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746332|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746333|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44746334|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746335|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746336|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
44746337|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44746338|NCT01664650|Estrogens|estrogens|mesh-ancestor
44746339|NCT01664650|Hormones|hormones|mesh-ancestor
44746340|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746341|NCT01664676|Liraglutide|liraglutide|mesh-list
44746342|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746343|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746344|NCT01664676|Incretins|incretins|mesh-ancestor
44746345|NCT01664676|Hormones|hormones|mesh-ancestor
44746346|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746347|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
44746348|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
44746349|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746350|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44746351|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746352|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746353|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44746354|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746355|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746356|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44746357|NCT01664728|Hormones|hormones|mesh-ancestor
44746358|NCT01664754|Carboplatin|carboplatin|mesh-list
44746359|NCT01664754|Pemetrexed|pemetrexed|mesh-list
44746360|NCT01664754|Exemestane|exemestane|mesh-list
44746361|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746362|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746363|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746364|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44746365|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44746366|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44746367|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44746368|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44746369|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44746370|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746371|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746372|NCT01664819|Antioxidants|antioxidants|mesh-list
44746373|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746374|NCT01664819|Protective Agents|protective agents|mesh-ancestor
44746375|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746376|NCT01664845|Metformin|metformin|mesh-list
44746377|NCT01664845|Ribavirin|ribavirin|mesh-list
44746378|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746379|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746380|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
44746381|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746382|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
44746383|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746384|NCT01664871|Fluorides|fluorides|mesh-list
44746385|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
44746386|NCT01664871|Protective Agents|protective agents|mesh-ancestor
44746387|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746388|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44746389|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44746390|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746391|NCT01665066|Nicotine|nicotine|mesh-list
44746392|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44746393|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
44746394|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746395|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746396|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44746397|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44746398|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
44746399|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746400|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746401|NCT01665079|Propofol|propofol|mesh-list
44746402|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44746403|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746404|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746405|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44746406|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
44746407|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
44746408|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
44746409|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44746410|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44746411|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746412|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
44746413|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
44746414|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746415|NCT01665209|Morphine|morphine|mesh-list
44746416|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44746417|NCT01665209|Narcotics|narcotics|mesh-ancestor
44746418|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746419|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746420|NCT01665209|Analgesics|analgesics|mesh-ancestor
44746421|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
44746422|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746423|NCT01665222|Morphine|morphine|mesh-list
44746424|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44746425|NCT01665222|Narcotics|narcotics|mesh-ancestor
44746426|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746427|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746428|NCT01665222|Analgesics|analgesics|mesh-ancestor
44746429|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
44746430|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746431|NCT01665235|Aspirin|aspirin|mesh-list
44746432|NCT01665235|Amlodipine|amlodipine|mesh-list
44746433|NCT01665235|Clopidogrel|clopidogrel|mesh-list
44746434|NCT01665235|Atorvastatin|atorvastatin|mesh-list
44746435|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746436|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746437|NCT01665235|Analgesics|analgesics|mesh-ancestor
44746438|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
44746439|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746440|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746441|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746442|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746443|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44746444|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44746445|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746446|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44746447|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44746448|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746449|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
44746450|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44746451|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44746452|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
44746453|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44746454|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44746455|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44746456|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44746457|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44746458|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
44746459|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746460|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44746461|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44746462|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44746463|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44746464|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
44746465|NCT01665248|Listerine|listerine|mesh-list
44746466|NCT01665248|Fluorides|fluorides|mesh-list
44746467|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
44746468|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
44746469|NCT01665248|Protective Agents|protective agents|mesh-ancestor
44746470|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746471|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44746472|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746473|NCT01665378|Folic Acid|folic acid|mesh-list
44746474|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
44746475|NCT01665378|Micronutrients|micronutrients|mesh-list
44746476|NCT01665378|Trace Elements|trace elements|mesh-list
44746477|NCT01665378|Hematinics|hematinics|mesh-ancestor
44746478|NCT01665378|Vitamins|vitamins|mesh-ancestor
44746479|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746480|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
44746481|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44746482|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44746483|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746484|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746485|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44746486|NCT01665404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44746487|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44746488|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44746489|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746490|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746491|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
44746492|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44746493|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
44746494|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44746495|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44746496|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746497|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44746498|NCT01665417|Docetaxel|docetaxel|mesh-list
44746499|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746500|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44746501|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44746502|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44746503|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746504|NCT01665469|Lycopene|lycopene|mesh-list
44687690|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687692|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
44687693|NCT01341353|Calcium|calcium|mesh-list
44687694|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44687695|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687696|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44687697|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
44687698|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44687699|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44687700|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687701|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44687702|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44687703|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44687704|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687705|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44687706|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44687707|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44687708|NCT01341392|Amlodipine|amlodipine|mesh-list
44687709|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44687710|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44275221|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687711|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44746505|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746506|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
44746507|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746508|NCT01665469|Protective Agents|protective agents|mesh-ancestor
44746509|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746510|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44746511|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44746512|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746513|NCT01664507|Epinephrine|epinephrine|mesh-list
44746514|NCT01664507|Racepinephrine|racepinephrine|mesh-list
44746515|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
44746516|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44746517|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44746518|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746519|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746520|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275276|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44746521|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746522|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44746523|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44746524|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
44746525|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746526|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44746527|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44746528|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
44746529|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
44746530|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44746531|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
44746532|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44746533|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746534|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746535|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746536|NCT01665586|Analgesics|analgesics|mesh-ancestor
44746537|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
44746538|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746539|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44746540|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44746541|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44746542|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746543|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746544|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746545|NCT01665638|Canagliflozin|canagliflozin|mesh-list
44746546|NCT01665638|Somatostatin|somatostatin|mesh-list
44746547|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44746548|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746549|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746550|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746551|NCT01665638|Hormones|hormones|mesh-ancestor
44746552|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746553|NCT01665677|Atorvastatin|atorvastatin|mesh-list
44746554|NCT01665677|Calcium|calcium|mesh-list
44746555|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44746556|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746557|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44746558|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44746559|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
44746560|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746561|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44746562|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44746563|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746564|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44746565|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44746566|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746567|NCT01665742|Tocopherols|tocopherols|mesh-list
44746568|NCT01665742|Vitamin E|vitamin e|mesh-list
44746569|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
44746570|NCT01665742|Lycopene|lycopene|mesh-list
44523677|NCT04513340|Levodopa|levodopa|mesh-list
44523678|NCT04513340|Carbidopa|carbidopa|mesh-list
44523679|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44523680|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44746571|NCT01665742|Vitamins|vitamins|mesh-ancestor
44746572|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
44746573|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746574|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
44275332|NCT00703066|Vaccines|vaccines|mesh-list
44746575|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746576|NCT01665742|Protective Agents|protective agents|mesh-ancestor
44746577|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746578|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44746579|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44746580|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746581|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
44746582|NCT01665781|Hematinics|hematinics|mesh-ancestor
44746583|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44746584|NCT01665846|Hematinics|hematinics|mesh-ancestor
44746585|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44746586|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44746587|NCT01666041|Fenofibrate|fenofibrate|mesh-list
44746588|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44746589|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
44746590|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746591|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44746592|NCT01666067|Simvastatin|simvastatin|mesh-list
44746593|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44746594|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44746595|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44746596|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
44746597|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746598|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44746599|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44746600|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746602|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746603|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746604|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44746605|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44746606|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44746607|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44746608|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
44746609|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746610|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44746611|NCT01666223|Cathartics|cathartics|mesh-ancestor
44746612|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746613|NCT01666236|Triamcinolone|triamcinolone|mesh-list
44746614|NCT01666236|Ranibizumab|ranibizumab|mesh-list
44746615|NCT01666236|Verteporfin|verteporfin|mesh-list
44746616|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44746617|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44746618|NCT01666236|Growth Substances|growth substances|mesh-ancestor
44746619|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746620|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
44746621|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746622|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746623|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
44746624|NCT01666236|Hormones|hormones|mesh-ancestor
44746625|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746626|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44746627|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746628|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
44746629|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44746630|NCT01666249|Antibodies|antibodies|mesh-list
44746631|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
44746632|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746633|NCT01666262|Vaccines|vaccines|mesh-list
44746634|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
44746635|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746636|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
44746637|NCT01666301|Hematinics|hematinics|mesh-ancestor
44746638|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44746639|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44746640|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746641|NCT01666379|Fentanyl|fentanyl|mesh-list
44746642|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44746643|NCT01666379|Narcotics|narcotics|mesh-ancestor
44746644|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746645|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746646|NCT01666379|Analgesics|analgesics|mesh-ancestor
44746647|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
44746648|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746649|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44746650|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44746651|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
44746652|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
44746653|NCT01666418|Paclitaxel|paclitaxel|mesh-list
44746654|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44746655|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746656|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44746657|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44746658|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44746659|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746660|NCT01666431|Lapatinib|lapatinib|mesh-list
44746661|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746662|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44746663|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746664|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746665|NCT01666522|Vitamin D|vitamin d|mesh-list
44746666|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
44746667|NCT01666522|Vitamins|vitamins|mesh-ancestor
44746668|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
44746669|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746670|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44746671|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44746672|NCT01666587|Ibuprofen|ibuprofen|mesh-list
44746673|NCT01666587|Antioxidants|antioxidants|mesh-list
44746674|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
44746675|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746676|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746677|NCT01666587|Analgesics|analgesics|mesh-ancestor
44746678|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
44746679|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746680|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746681|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746682|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746683|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44746684|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746685|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746686|NCT01666587|Protective Agents|protective agents|mesh-ancestor
44746687|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
44746688|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275441|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
44687712|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687713|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44687714|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687715|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44687716|NCT01341405|Celecoxib|celecoxib|mesh-list
44687717|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44687718|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687719|NCT01341405|Analgesics|analgesics|mesh-ancestor
44687720|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
44687721|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687722|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687723|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687724|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687725|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44687726|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44687727|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687728|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687729|NCT01341496|Celecoxib|celecoxib|mesh-list
44687730|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
44687731|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687732|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
44687733|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687734|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687735|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687736|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
44687737|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687738|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687739|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687740|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44687741|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687742|NCT01341496|Analgesics|analgesics|mesh-ancestor
44687743|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
44687744|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746689|NCT01666600|Nintedanib|nintedanib|mesh-list
44746690|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746691|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44746692|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746693|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746694|NCT01666665|Metformin|metformin|mesh-list
44746695|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44746696|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746697|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
44746698|NCT01666678|Promethazine|promethazine|mesh-list
44746699|NCT01666678|Naproxen|naproxen|mesh-list
44746700|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746701|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746702|NCT01666678|Analgesics|analgesics|mesh-ancestor
44746703|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
44746704|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746705|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746706|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746707|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746708|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
44746709|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44746710|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746711|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746712|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44746713|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44746714|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746715|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
44746716|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
44746717|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
44746718|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
44746719|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746720|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44746721|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
44746722|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
44746723|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746724|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44746725|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
44746726|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746727|NCT01666691|CKD732|ckd732|mesh-list
44746728|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44746729|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44746730|NCT01666691|Growth Substances|growth substances|mesh-ancestor
44746731|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746732|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
44746733|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746734|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44746735|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746736|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746737|NCT01666756|Sorafenib|sorafenib|mesh-list
44746738|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746739|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44746740|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746741|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746742|NCT01666769|Micafungin|micafungin|mesh-list
44746743|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
44746744|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746745|NCT01667094|Meropenem|meropenem|mesh-list
44746746|NCT01667094|Tazobactam|tazobactam|mesh-list
44746747|NCT01667094|Piperacillin|piperacillin|mesh-list
44746748|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
44746749|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
44746750|NCT01667094|Ceftazidime|ceftazidime|mesh-list
44746751|NCT01667094|Cefepime|cefepime|mesh-list
44746752|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44746753|NCT01667094|Ticarcillin|ticarcillin|mesh-list
44746754|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44746755|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746756|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746757|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44746758|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746759|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746760|NCT01667211|Paclitaxel|paclitaxel|mesh-list
44746761|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44746762|NCT01667211|Nedaplatin|nedaplatin|mesh-list
44746763|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44746764|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746765|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44746766|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44746767|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44746768|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746769|NCT01667263|Tretinoin|tretinoin|mesh-list
44746770|NCT01667263|Danazol|danazol|mesh-list
44746771|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746772|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
44746773|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746774|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44746775|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
44746776|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746777|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746778|NCT01667315|Bupivacaine|bupivacaine|mesh-list
44746779|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
44746780|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
44746781|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746782|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746783|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
44746784|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746785|NCT01667445|Morphine|morphine|mesh-list
44746786|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44746787|NCT01667445|Narcotics|narcotics|mesh-ancestor
44746788|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746789|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746790|NCT01667445|Analgesics|analgesics|mesh-ancestor
44746791|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
44746792|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746793|NCT01667484|Adderall|adderall|mesh-list
44746794|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44746795|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746796|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
44275573|NCT00704145|Paclitaxel|paclitaxel|mesh-list
44746797|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44746798|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44746799|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746800|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
44746801|NCT01667523|Capsaicin|capsaicin|mesh-list
44746802|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
44746803|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746804|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
44746805|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746806|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746807|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44746808|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746809|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44746810|NCT01667523|Protective Agents|protective agents|mesh-ancestor
44746811|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44746812|NCT01667575|Amoxicillin|amoxicillin|mesh-list
44275585|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44746813|NCT01667575|Clarithromycin|clarithromycin|mesh-list
44746814|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44746815|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
44746816|NCT01667575|Esomeprazole|esomeprazole|mesh-list
44746817|NCT01667575|Bismuth|bismuth|mesh-list
44746818|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44746819|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746820|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523937|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44523938|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
44523939|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
44523940|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523941|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44523942|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
44523943|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523944|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523945|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523946|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523947|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44523948|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523949|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523950|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523951|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44523952|NCT04515576|Dulaglutide|dulaglutide|mesh-list
44523953|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275601|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
44523954|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523955|NCT04511832|Diclofenac|diclofenac|mesh-list
44523956|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746821|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
44746822|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44746823|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746824|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746825|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44746826|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44746827|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44746828|NCT01667575|Antacids|antacids|mesh-ancestor
44746829|NCT01667575|Diuretics|diuretics|mesh-ancestor
44746830|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
44746831|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746832|NCT01667575|Expectorants|expectorants|mesh-ancestor
44746833|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44746834|NCT01667614|Losartan|losartan|mesh-list
44746835|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44746836|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44746837|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44746838|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44746839|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746840|NCT01667692|Azithromycin|azithromycin|mesh-list
44746841|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746842|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746843|NCT01667718|Amoxicillin|amoxicillin|mesh-list
44746844|NCT01667718|Levofloxacin|levofloxacin|mesh-list
44746845|NCT01667718|Ofloxacin|ofloxacin|mesh-list
44746846|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
44746847|NCT01667718|Lansoprazole|lansoprazole|mesh-list
44746848|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
44746849|NCT01667718|Bismuth|bismuth|mesh-list
44746850|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44746851|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746852|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275660|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
44746853|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746854|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44746855|NCT01667718|Renal Agents|renal agents|mesh-ancestor
44746856|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44746857|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44746858|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746859|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746860|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44746861|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44746862|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44746863|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746864|NCT01667718|Antacids|antacids|mesh-ancestor
44746865|NCT01667718|Diuretics|diuretics|mesh-ancestor
44746866|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
44746867|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746868|NCT01667718|Expectorants|expectorants|mesh-ancestor
44746869|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
44746870|NCT01667874|Gentamicins|gentamicins|mesh-list
44746871|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746872|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746873|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44746874|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275667|NCT00704639|Carboplatin|carboplatin|mesh-list
44746875|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746876|NCT01668043|UB-421|ub-421|mesh-list
44746877|NCT01668043|Antibodies|antibodies|mesh-list
44746878|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
44746879|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746880|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44746881|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
44746882|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746883|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44746884|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44746885|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746886|NCT01668069|Ondansetron|ondansetron|mesh-list
44746887|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
44746888|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
44746889|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746890|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746891|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746892|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
44746893|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746894|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44687745|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687746|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44746895|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
44746896|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746897|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746898|NCT01668069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44746899|NCT01668069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44746900|NCT01668069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44746901|NCT01668069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44746902|NCT01668069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44746904|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
44746905|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44746906|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746907|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44746908|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
44746909|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746910|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746911|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44746912|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44746913|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
44746914|NCT01668121|Hormones|hormones|mesh-ancestor
44746915|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44746916|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44746917|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44746918|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44746919|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746920|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44746921|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524084|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
44524085|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44524086|NCT02591199|Lidocaine|lidocaine|mesh-list
44524087|NCT02591199|Heparin|heparin|mesh-list
44524088|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524089|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
44524090|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524091|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524092|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
44524093|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524094|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524096|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44746922|NCT01668433|Primaquine|primaquine|mesh-list
44746923|NCT01668433|Methylene Blue|methylene blue|mesh-list
44746924|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
44746925|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44746926|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44746927|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746928|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746929|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746930|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
44746931|NCT01668446|Estradiol|estradiol|mesh-list
44746932|NCT01668446|Estrogens|estrogens|mesh-ancestor
44746933|NCT01668446|Hormones|hormones|mesh-ancestor
44746934|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275735|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44746935|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746936|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
44746937|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44746938|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44746939|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746940|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746941|NCT01668446|Urological Agents|urological agents|mesh-ancestor
44746942|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44746943|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746944|NCT01668498|Doxycycline|doxycycline|mesh-list
44746945|NCT01668498|Erythromycin|erythromycin|mesh-list
44746946|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
44746947|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44275752|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275753|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746948|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
44746949|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44746950|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44746951|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
44746952|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44746953|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44746954|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44746955|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44746956|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746957|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746958|NCT01668550|AZD-0424|azd-0424|mesh-list
44746959|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44746960|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746961|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746962|NCT01668615|Tretinoin|tretinoin|mesh-list
44746963|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746964|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
44746965|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746966|NCT01668680|Celecoxib|celecoxib|mesh-list
44746967|NCT01668680|Capecitabine|capecitabine|mesh-list
44746968|NCT01668680|Methotrexate|methotrexate|mesh-list
44746969|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44746970|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
44746971|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44746972|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44746973|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44746974|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44746975|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44746976|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44746977|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44746978|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44746979|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44746980|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44746981|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
44746982|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44746983|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44746984|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746985|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746986|NCT01668680|Analgesics|analgesics|mesh-ancestor
44746987|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
44746988|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44746989|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44746990|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44746991|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44746992|NCT01668901|Aspirin|aspirin|mesh-list
44746993|NCT01668901|Warfarin|warfarin|mesh-list
44746994|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44746995|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44746996|NCT01668901|Analgesics|analgesics|mesh-ancestor
44746997|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
44746998|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275785|NCT00705120|Busulfan|busulfan|mesh-list
44275786|NCT00705120|Cyclosporins|cyclosporins|mesh-list
44746999|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747000|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747001|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747002|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44747003|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44747004|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747005|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44747006|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44747007|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747008|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
44747009|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
44747010|NCT01668927|Amoxicillin|amoxicillin|mesh-list
44747011|NCT01668927|Metronidazole|metronidazole|mesh-list
44747012|NCT01668927|Tetracycline|tetracycline|mesh-list
44747013|NCT01668927|Furazolidone|furazolidone|mesh-list
44747014|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
44747015|NCT01668927|Lansoprazole|lansoprazole|mesh-list
44747016|NCT01668927|Bismuth|bismuth|mesh-list
44747017|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44747018|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747019|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44747020|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747021|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44747022|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44747023|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44747024|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747025|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747026|NCT01668927|Antacids|antacids|mesh-ancestor
44747027|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44747028|NCT01668927|Diuretics|diuretics|mesh-ancestor
44747029|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
44747030|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747031|NCT01668927|Expectorants|expectorants|mesh-ancestor
44747032|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747033|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44747034|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44747035|NCT01668927|Renal Agents|renal agents|mesh-ancestor
44747036|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44747037|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44747038|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
44747039|NCT01669044|Propofol|propofol|mesh-list
44747040|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747041|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747042|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747043|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747044|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
44747045|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
44747046|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747047|NCT01669044|Analgesics|analgesics|mesh-ancestor
44747048|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
44747049|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747050|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44747051|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44747052|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44747053|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747054|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747055|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747056|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
44747057|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44747058|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747059|NCT01669135|Anesthetics|anesthetics|mesh-list
44747060|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747061|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747062|NCT01669213|Ondansetron|ondansetron|mesh-list
44747063|NCT01669213|Ramosetron|ramosetron|mesh-list
44747064|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
44747065|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
44747066|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747067|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747068|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747069|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
44747070|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
44747071|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44747072|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
44747073|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747074|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747075|NCT01669213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44747076|NCT01669213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747077|NCT01669213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747078|NCT01669213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747079|NCT01669213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44747080|NCT01669226|Taxane|taxane|mesh-list
44747081|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747082|NCT01669239|Doxorubicin|doxorubicin|mesh-list
44747083|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44747084|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44747085|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747086|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44747087|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44747088|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747089|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747090|NCT01669291|Leuprolide|leuprolide|mesh-list
44747091|NCT01669291|Cetrorelix|cetrorelix|mesh-list
44747092|NCT01669291|Menotropins|menotropins|mesh-list
44747093|NCT01669291|Ganirelix|ganirelix|mesh-list
44687747|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44687748|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687749|NCT01341717|Metformin|metformin|mesh-list
44687750|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44687751|NCT01341717|Glimepiride|glimepiride|mesh-list
44687752|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687753|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687754|NCT01341717|Incretins|incretins|mesh-ancestor
44687755|NCT01341717|Hormones|hormones|mesh-ancestor
44687756|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687757|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44687758|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44687773|NCT01341834|Everolimus|everolimus|mesh-list
44687774|NCT01341834|Panobinostat|panobinostat|mesh-list
44687775|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275905|NCT00705770|Anecortave|anecortave|mesh-list
44275913|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
44687776|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687777|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
44687778|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687779|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44687780|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687781|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687782|NCT01341886|Metformin|metformin|mesh-list
44687783|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687784|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687785|NCT01341938|Nicotine|nicotine|mesh-list
44687786|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44687787|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
44687788|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687789|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687790|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44687791|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44687792|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
44687793|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774256|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687794|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687795|NCT01341951|Lenograstim|lenograstim|mesh-list
44687796|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44687797|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
44687798|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687799|NCT01341964|Aspirin|aspirin|mesh-list
44687800|NCT01341964|Clopidogrel|clopidogrel|mesh-list
44687801|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44687802|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687803|NCT01341964|Analgesics|analgesics|mesh-ancestor
44687804|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
44687805|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687806|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687807|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687808|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687809|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44687810|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44687811|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687812|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44687813|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44687814|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687815|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
44687816|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44747094|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44747095|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
44747097|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747098|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44747099|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747100|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
44747101|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747102|NCT01669304|Verapamil|verapamil|mesh-list
44747103|NCT01669304|Sertraline|sertraline|mesh-list
44747104|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
44747105|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747106|NCT01669304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44747107|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44747108|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747109|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747110|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747111|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
44747112|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747113|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44747114|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44747115|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44747116|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
44747117|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
44747118|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
44747119|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747120|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747121|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747122|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
44747123|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747124|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747125|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747126|NCT01669447|Ranibizumab|ranibizumab|mesh-list
44747127|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44747128|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44747129|NCT01669447|Growth Substances|growth substances|mesh-ancestor
44747130|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747131|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
44747132|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747133|NCT01669499|Dexamethasone|dexamethasone|mesh-list
44747134|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
44747135|NCT01669499|BB 1101|bb 1101|mesh-list
44747136|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747137|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
44747138|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
44747139|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747140|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747141|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747142|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
44747143|NCT01669499|Hormones|hormones|mesh-ancestor
44747144|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747145|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44747146|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747147|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
44747148|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747149|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747150|NCT01669707|Endostar protein|endostar protein|mesh-list
44747151|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44747152|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44747153|NCT01669707|Growth Substances|growth substances|mesh-ancestor
44747154|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747155|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44747156|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747157|NCT01669824|Aspirin|aspirin|mesh-list
44747158|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44747159|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747160|NCT01669824|Analgesics|analgesics|mesh-ancestor
44747161|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
44747162|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747163|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747164|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747165|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747166|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44747167|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44524285|NCT05145634|Anticoagulants|anticoagulants|mesh-list
44747168|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747169|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44747170|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44747171|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747172|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
44747173|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44747174|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
44747175|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44747176|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44747177|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747178|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
44747179|NCT01669967|Promethazine|promethazine|mesh-list
44747180|NCT01669967|Lidocaine|lidocaine|mesh-list
44747181|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
44747182|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
44747183|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747184|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747185|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
44747186|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747187|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44747188|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44747189|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44747190|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747191|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747192|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44747193|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747194|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
44747195|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
44747196|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747197|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44747198|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
44747199|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
44747200|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747201|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44747202|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
44747203|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
44747204|NCT01670149|Rifaximin|rifaximin|mesh-list
44747205|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44747206|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747207|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747208|NCT01670370|Gemcitabine|gemcitabine|mesh-list
44747209|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
44747210|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747211|NCT01670370|Immunologic Factors|immunologic factors|mesh-ancestor
44747212|NCT01670370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747213|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44747214|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
44747215|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747216|NCT01670370|Antiviral Agents|antiviral agents|mesh-ancestor
44747217|NCT01670370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747218|NCT01670370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747219|NCT01670370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44747220|NCT01670552|Naproxen|naproxen|mesh-list
44747221|NCT01670552|Nimesulide|nimesulide|mesh-list
44747222|NCT01670552|Esomeprazole|esomeprazole|mesh-list
44747223|NCT01670552|Pantoprazole|pantoprazole|mesh-list
44747224|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44747225|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747226|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44747227|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747228|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747229|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44524362|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524363|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524364|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44524365|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44524366|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524367|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524368|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44524369|NCT05149378|Azacitidine|azacitidine|mesh-list
44524370|NCT05149378|Venetoclax|venetoclax|mesh-list
44524371|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524372|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
44524373|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524374|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747230|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276072|NCT00706953|Bortezomib|bortezomib|mesh-list
44747231|NCT01670552|Analgesics|analgesics|mesh-ancestor
44747232|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
44747233|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747234|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747235|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747236|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747237|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
44747238|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44747239|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
44747240|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44747241|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
44747242|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747243|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
44747244|NCT01670578|Protective Agents|protective agents|mesh-ancestor
44747245|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
44747246|NCT01670812|Rituximab|rituximab|mesh-list
44747247|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747248|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747249|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
44747250|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747251|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747252|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276095|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
44276096|NCT00707083|Hormones|hormones|mesh-ancestor
44747253|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
44747254|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
44747255|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747256|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747257|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
44747258|NCT01670812|Hormones|hormones|mesh-ancestor
44747259|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747260|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44747261|NCT01670812|Protective Agents|protective agents|mesh-ancestor
44687817|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44687818|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44687819|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
44687820|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687821|NCT01342016|Prednisone|prednisone|mesh-list
44687822|NCT01342016|Tacrolimus|tacrolimus|mesh-list
44687823|NCT01342016|Leflunomide|leflunomide|mesh-list
44276117|NCT00707135|Sirolimus|sirolimus|mesh-list
44687824|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687825|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
44687826|NCT01342016|Hormones|hormones|mesh-ancestor
44687827|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687828|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687829|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44687830|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687831|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687832|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
44687833|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44687834|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687835|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687836|NCT01342146|Hormones|hormones|mesh-list
44687837|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44687838|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687839|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44687840|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44687841|NCT01342198|Erythromycin|erythromycin|mesh-list
44687842|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
44687843|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44687844|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
44687845|NCT01342198|Pregabalin|pregabalin|mesh-list
44239407|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
44687846|NCT01342198|Analgesics|analgesics|mesh-ancestor
44687847|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
44687848|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687849|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687850|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
44687851|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44687852|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44687853|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687854|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44276131|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276164|NCT00707421|Ketorolac|ketorolac|mesh-list
44687855|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44687856|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44687857|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687858|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524434|NCT05148442|Decitabine|decitabine|mesh-list
44747262|NCT01671449|Cisplatin|cisplatin|mesh-list
44747263|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
44747264|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524443|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
44747265|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44747266|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44747267|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44747268|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747269|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747270|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
44747271|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747272|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747273|NCT01672359|Choline|choline|mesh-list
44747274|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
44747275|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44747276|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
44747277|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747278|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747279|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44747280|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
44747281|NCT01673308|Lenalidomide|lenalidomide|mesh-list
44747282|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
44747283|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747284|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44747285|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44747286|NCT01673308|Growth Substances|growth substances|mesh-ancestor
44747287|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
44747288|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747289|NCT01673737|Vemurafenib|vemurafenib|mesh-list
44747290|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747291|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747292|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747293|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747294|NCT01674556|Gemcitabine|gemcitabine|mesh-list
44747295|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44747296|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
44747297|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747298|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747299|NCT01674556|Antiviral Agents|antiviral agents|mesh-ancestor
44276198|NCT00707551|Verapamil|verapamil|mesh-list
44747300|NCT01674556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747301|NCT01674556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747302|NCT01674556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44747303|NCT01674556|Immunologic Factors|immunologic factors|mesh-ancestor
44747304|NCT01674556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747305|NCT01675115|Aspirin|aspirin|mesh-list
44747306|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44747307|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747308|NCT01675115|Analgesics|analgesics|mesh-ancestor
44747309|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
44747310|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747311|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747312|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747313|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747314|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44747315|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44747316|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747317|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44747318|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44276205|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44747319|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747320|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
44747321|NCT01675310|Metformin|metformin|mesh-list
44747322|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44747323|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747324|NCT01676649|Paclitaxel|paclitaxel|mesh-list
44747325|NCT01676649|Carboplatin|carboplatin|mesh-list
44747326|NCT01676649|Ipilimumab|ipilimumab|mesh-list
44747327|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44747328|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747329|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44747330|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44747331|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44747332|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747333|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747334|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44747335|NCT01676987|Budesonide|budesonide|mesh-list
44747336|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
44747337|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747338|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44747339|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
44747340|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747341|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747342|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44774257|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44276228|NCT00707772|Ribavirin|ribavirin|mesh-list
44747343|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747344|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
44747345|NCT01676987|Hormones|hormones|mesh-ancestor
44747346|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747347|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44747348|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44747349|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44747350|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747351|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747352|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747353|NCT01677039|Ethanol|ethanol|mesh-list
44747354|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44747355|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747356|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747357|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747358|NCT01677065|Oxycodone|oxycodone|mesh-list
44747359|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747360|NCT01677065|Narcotics|narcotics|mesh-ancestor
44747361|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747362|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747363|NCT01677065|Analgesics|analgesics|mesh-ancestor
44747364|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
44747365|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747366|NCT01677247|Glimepiride|glimepiride|mesh-list
44747367|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44747368|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44747369|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747370|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44747371|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
44747372|NCT01677260|Metformin|metformin|mesh-list
44747373|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44747374|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747375|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
44747376|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
44747377|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747378|NCT01677650|Methadone|methadone|mesh-list
44747379|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747380|NCT01677650|Narcotics|narcotics|mesh-ancestor
44747381|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747382|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747383|NCT01677650|Analgesics|analgesics|mesh-ancestor
44747384|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
44747385|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747386|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
44747387|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747388|NCT01678053|Omeprazole|omeprazole|mesh-list
44747389|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
44747390|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44747391|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44747392|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44747393|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44747394|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747395|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747396|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
44747397|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747398|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524592|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
44524593|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44524594|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44524595|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524596|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524597|NCT05146674|Urological Agents|urological agents|mesh-ancestor
44524598|NCT05146635|Epirubicin|epirubicin|mesh-list
44524599|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44524600|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524601|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44524602|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44524603|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524604|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524605|NCT05148546|Nivolumab|nivolumab|mesh-list
44524606|NCT05148546|Ipilimumab|ipilimumab|mesh-list
44747399|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44747400|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276302|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747401|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747402|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44747403|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747404|NCT01678937|Cyclosporine|cyclosporine|mesh-list
44747405|NCT01678937|Sirolimus|sirolimus|mesh-list
44747406|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
44747407|NCT01678937|Tacrolimus|tacrolimus|mesh-list
44747408|NCT01678937|Cyclosporins|cyclosporins|mesh-list
44747409|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44747410|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
44747411|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747412|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44747413|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747414|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747415|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
44687859|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687860|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687861|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44687862|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44687863|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687865|NCT01342224|Tadalafil|tadalafil|mesh-list
44687866|NCT01342224|Sargramostim|sargramostim|mesh-list
44687867|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
44687868|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687869|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44687870|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
44687871|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687872|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687873|NCT01342224|Antiviral Agents|antiviral agents|mesh-ancestor
44687874|NCT01342224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687875|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687876|NCT01342224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687877|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
44687878|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44687879|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44687880|NCT01342224|Urological Agents|urological agents|mesh-ancestor
44687881|NCT01342237|Carboplatin|carboplatin|mesh-list
44687882|NCT01342237|Etoposide|etoposide|mesh-list
44687883|NCT01342237|Melphalan|melphalan|mesh-list
44687884|NCT01342237|Topotecan|topotecan|mesh-list
44687885|NCT01342237|Thiotepa|thiotepa|mesh-list
44687886|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687887|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44687888|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44687889|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44687890|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774258|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44463229|NCT01517984|Tacrolimus|tacrolimus|mesh-list
44687891|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687892|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687893|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
44687894|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687895|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687896|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
44687897|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687898|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44687899|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
44687900|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
44687901|NCT01342289|Fludarabine|fludarabine|mesh-list
44687902|NCT01342289|Tacrolimus|tacrolimus|mesh-list
44687903|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44687904|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
44687905|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687906|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44687907|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44687908|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
44687909|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687910|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687911|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44687912|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44687913|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687914|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44687915|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44687916|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
44747416|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747417|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44747418|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747419|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44747420|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747421|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44747422|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
44747423|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463230|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
44747424|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
44747425|NCT01679041|Fludarabine|fludarabine|mesh-list
44747426|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
44747427|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44747428|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
44747429|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747430|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747431|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44747432|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
44747433|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747434|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747435|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44747436|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747437|NCT01679093|Dexamethasone|dexamethasone|mesh-list
44747438|NCT01679093|Droperidol|droperidol|mesh-list
44747439|NCT01679093|Ondansetron|ondansetron|mesh-list
44747440|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747441|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
44747442|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
44747443|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747444|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747445|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747446|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
44747447|NCT01679093|Hormones|hormones|mesh-ancestor
44747448|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747449|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44747450|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747451|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
44747452|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
44747453|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44747454|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
44747455|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747456|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463265|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747457|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44747458|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747459|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747460|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747461|NCT01679093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44747462|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747463|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44747464|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44747465|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
44747466|NCT01679743|Trastuzumab|trastuzumab|mesh-list
44747467|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747468|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747469|NCT01680094|Panobinostat|panobinostat|mesh-list
44747470|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747471|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44747472|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747473|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747474|NCT01680120|Anesthetics|anesthetics|mesh-list
44747475|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747476|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747477|NCT01680198|Vitamin D|vitamin d|mesh-list
44747478|NCT01680198|Vitamins|vitamins|mesh-ancestor
44747479|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
44747480|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747481|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44747482|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44747483|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44747484|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747485|NCT05596981|Sorafenib|sorafenib|mesh-list
44747486|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747487|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747488|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747489|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747490|NCT05596968|Sorafenib|sorafenib|mesh-list
44747491|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747492|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747493|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747494|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747495|NCT05596890|Paclitaxel|paclitaxel|mesh-list
44747496|NCT05596890|Cisplatin|cisplatin|mesh-list
44747497|NCT05596890|Carboplatin|carboplatin|mesh-list
44747498|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44747499|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747500|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44747501|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44747502|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44747503|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747504|NCT05596786|Rituximab|rituximab|mesh-list
44747505|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747506|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747507|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
44747508|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747509|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747510|NCT05596669|Ketamine|ketamine|mesh-list
44747511|NCT05596669|Morphine|morphine|mesh-list
44747512|NCT05596669|Analgesics|analgesics|mesh-ancestor
44747513|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
44747514|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747515|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747516|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44747517|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747518|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
44747519|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
44747520|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747521|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44747522|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44747523|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747524|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747525|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747526|NCT05596669|Narcotics|narcotics|mesh-ancestor
44747527|NCT05596617|Melatonin|melatonin|mesh-list
44747528|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
44747529|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747530|NCT05596617|Protective Agents|protective agents|mesh-ancestor
44747531|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747532|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747533|NCT05596552|Fentanyl|fentanyl|mesh-list
44747534|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
44747535|NCT05596552|Bupivacaine|bupivacaine|mesh-list
44747536|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
44747537|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
44747538|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747539|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747540|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
44747541|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747542|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747543|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747544|NCT05596552|Analgesics|analgesics|mesh-ancestor
44747545|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44747546|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44747547|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44747548|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747549|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747550|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747551|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747552|NCT05596552|Narcotics|narcotics|mesh-ancestor
44747553|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747554|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747555|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
44747556|NCT05596383|Vitamin D|vitamin d|mesh-list
44747557|NCT05596383|Vitamins|vitamins|mesh-ancestor
44747558|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
44747559|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747560|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44747561|NCT05596227|Fentanyl|fentanyl|mesh-list
44747562|NCT05596227|Narcotics|narcotics|mesh-list
44747563|NCT05596227|Propofol|propofol|mesh-list
44747564|NCT05596227|Anesthetics|anesthetics|mesh-list
44747565|NCT05596227|Sevoflurane|sevoflurane|mesh-list
44747566|NCT05596227|Rocuronium|rocuronium|mesh-list
44747567|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747568|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747569|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687917|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687918|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687919|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
44687920|NCT01342328|Propofol|propofol|mesh-list
44687921|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44687922|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687923|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687924|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44687925|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
44687926|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
44687927|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44687928|NCT01342328|Analgesics|analgesics|mesh-ancestor
44276453|NCT00709189|Folic Acid|folic acid|mesh-list
44687929|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
44687930|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44687931|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44687932|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44687933|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44687934|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44687935|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687936|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687937|NCT01342562|Anesthetics|anesthetics|mesh-list
44687938|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687939|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687940|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44687941|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44687943|NCT01342614|Fosinopril|fosinopril|mesh-list
44687944|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687945|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687946|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44687947|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
44687948|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687949|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687950|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44687951|NCT01342627|Sorafenib|sorafenib|mesh-list
44687952|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687953|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687954|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687955|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687956|NCT01342679|Dasatinib|dasatinib|mesh-list
44687957|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687958|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44687959|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687960|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687961|NCT01342692|Lenalidomide|lenalidomide|mesh-list
44687962|NCT01342692|Azacitidine|azacitidine|mesh-list
44687963|NCT01342692|Idarubicin|idarubicin|mesh-list
44687964|NCT01342692|Valproic Acid|valproic acid|mesh-list
44687965|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
44687966|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687967|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44687968|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44687969|NCT01342692|Growth Substances|growth substances|mesh-ancestor
44687970|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
44687971|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44687972|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44687973|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
44687974|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276483|NCT00709254|Analgesics|analgesics|mesh-ancestor
44687975|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687976|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
44687977|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
44687978|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44687979|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
44747570|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747571|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
44747572|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747573|NCT05596227|Analgesics|analgesics|mesh-ancestor
44747574|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
44747575|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747576|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747577|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44747578|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44747579|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44747580|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44747581|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44747582|NCT05596214|Curcumin|curcumin|mesh-list
44747583|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44747584|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747585|NCT05596214|Analgesics|analgesics|mesh-ancestor
44747586|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
44747587|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747588|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276538|NCT00709449|Papaverine|papaverine|mesh-list
44747589|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747590|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747591|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747592|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747593|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747594|NCT05596149|Listerine|listerine|mesh-list
44747595|NCT05596149|Fluorides|fluorides|mesh-list
44747596|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
44747597|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
44747598|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
44747599|NCT05596149|Protective Agents|protective agents|mesh-ancestor
44747600|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747601|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44747602|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747603|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
44747604|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747605|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747606|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747607|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747608|NCT05596071|Sufentanil|sufentanil|mesh-list
44747610|NCT05596071|Ropivacaine|ropivacaine|mesh-list
44747611|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
44747612|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
44747613|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747614|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747615|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
44747616|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747617|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747618|NCT05596071|Narcotics|narcotics|mesh-ancestor
44747619|NCT05596071|Analgesics|analgesics|mesh-ancestor
44747620|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747621|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747622|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
44747623|NCT05596006|Domperidone|domperidone|mesh-list
44747624|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
44747625|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
44747626|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747627|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747628|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747629|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44747630|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
44747631|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747632|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747633|NCT05595993|Cilostazol|cilostazol|mesh-list
44276573|NCT00709644|Norgestimate|norgestimate|mesh-list
44747634|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44747635|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
44747636|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747637|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747638|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44747639|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747640|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44747641|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44747642|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747643|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44747644|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44747645|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44276604|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
44747646|NCT05595993|Protective Agents|protective agents|mesh-ancestor
44747658|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44747659|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44747660|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44747661|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747662|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747663|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747664|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747665|NCT05557253|Anesthetics|anesthetics|mesh-list
44747666|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747667|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747668|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
44747669|NCT05539924|Pregabalin|pregabalin|mesh-list
44747670|NCT05539924|Gabapentin|gabapentin|mesh-list
44747671|NCT05539924|Vitamins|vitamins|mesh-ancestor
44747672|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
44276616|NCT00709982|Folic Acid|folic acid|mesh-list
44747673|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747674|NCT05539924|Analgesics|analgesics|mesh-ancestor
44747675|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
44747676|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747677|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
44747678|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44747679|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747680|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747681|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44747682|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44747683|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747684|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747685|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747686|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44747687|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44747688|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747689|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
44747690|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
44747703|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
44747704|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44747705|NCT05514782|Protective Agents|protective agents|mesh-ancestor
44747706|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747707|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
44747708|NCT05488847|Acetaminophen|acetaminophen|mesh-list
44747709|NCT05488847|Dexamethasone|dexamethasone|mesh-list
44747710|NCT05488847|Ibuprofen|ibuprofen|mesh-list
44747711|NCT05488847|Celecoxib|celecoxib|mesh-list
44747712|NCT05488847|Ketorolac|ketorolac|mesh-list
44524909|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524910|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
44524911|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
44524912|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524913|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44524914|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44524915|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524916|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747713|NCT05488847|Pregabalin|pregabalin|mesh-list
44747714|NCT05488847|Epinephrine|epinephrine|mesh-list
44747716|NCT05488847|Tramadol|tramadol|mesh-list
44747717|NCT05488847|Tizanidine|tizanidine|mesh-list
44747718|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
44747719|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747720|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
44747721|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
44747722|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747723|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747724|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747725|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
44747726|NCT05488847|Hormones|hormones|mesh-ancestor
44747727|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747728|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44747729|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747730|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44747731|NCT05488847|Analgesics|analgesics|mesh-ancestor
44747732|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
44747733|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
44747734|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44747735|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44747736|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44747737|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747738|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747739|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
44747740|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44747741|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747742|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44747743|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44747744|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747745|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747746|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747747|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44747748|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44747749|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747750|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747751|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44747752|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44747753|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44747754|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747755|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
44747756|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
44747757|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44747758|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44747759|NCT05488847|Narcotics|narcotics|mesh-ancestor
44747760|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44747761|NCT05488847|Antacids|antacids|mesh-ancestor
44747762|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44747763|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44747764|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
44747765|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44747766|NCT05479370|Vaccines|vaccines|mesh-list
44747767|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
44747768|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747769|NCT05468242|Bevacizumab|bevacizumab|mesh-list
44747770|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747771|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747772|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44747773|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44747774|NCT05468242|Growth Substances|growth substances|mesh-ancestor
44747775|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747776|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44747777|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
44747778|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
44747779|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
44747780|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747781|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747782|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44747783|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44747784|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747785|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747786|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463289|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
44747787|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44747788|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
44747789|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747790|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747792|NCT05423951|Propofol|propofol|mesh-list
44747793|NCT05423951|Rocuronium|rocuronium|mesh-list
44747794|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747795|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747796|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747797|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747798|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
44747799|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
44747800|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44747801|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44747802|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44747803|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747804|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44687980|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44687981|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44687982|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44687983|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44687984|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44687985|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44687986|NCT01342731|Tigecycline|tigecycline|mesh-list
44687987|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44687988|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44687989|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44687990|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44687991|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44687992|NCT01342744|Metformin|metformin|mesh-list
44687993|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44687994|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44687995|NCT01342835|Propofol|propofol|mesh-list
44687996|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44687997|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276740|NCT00710788|Antacids|antacids|mesh-ancestor
44688035|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688036|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44688037|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44688038|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44688039|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
44688040|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688041|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688042|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688043|NCT05250245|Urological Agents|urological agents|mesh-ancestor
44688044|NCT05249933|Benzocaine|benzocaine|mesh-list
44688045|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
44688046|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
44688047|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688048|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688049|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
44688050|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688051|NCT05226442|Heparin|heparin|mesh-list
44688052|NCT05226442|Calcium heparin|calcium heparin|mesh-list
44688053|NCT05226442|Argatroban|argatroban|mesh-list
44688054|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
44688055|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44688056|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44688057|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688058|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
44688059|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44688060|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688061|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688062|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44688063|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
44688064|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
44688065|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688066|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44688067|NCT05211024|Penicillins|penicillins|mesh-list
44688068|NCT05211024|Penicillin G|penicillin g|mesh-list
44688069|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44688070|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
44688071|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44688072|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688073|NCT05198128|Calcium|calcium|mesh-list
44688074|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44688075|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688076|NCT05164549|Buprenorphine|buprenorphine|mesh-list
44688077|NCT05164549|Methadone|methadone|mesh-list
44525002|NCT03457233|Menotropins|menotropins|mesh-list
44525005|NCT03457233|Hormones|hormones|mesh-ancestor
44747805|NCT05423951|Narcotics|narcotics|mesh-ancestor
44747806|NCT05423951|Analgesics|analgesics|mesh-ancestor
44747807|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
44747808|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747809|NCT05419089|Cisplatin|cisplatin|mesh-list
44747810|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747811|NCT05418972|Nivolumab|nivolumab|mesh-list
44747812|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44276765|NCT00711204|Donepezil|donepezil|mesh-list
44276804|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747813|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747814|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44747815|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747816|NCT05416957|Vortioxetine|vortioxetine|mesh-list
44747817|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
44747818|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747819|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44747820|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747821|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747822|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747823|NCT05416957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44747824|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44747825|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747826|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747827|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747828|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
44747829|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44747830|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44747831|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44747832|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44747833|NCT05416762|Vortioxetine|vortioxetine|mesh-list
44747834|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
44747835|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747836|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44276829|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44747837|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44747838|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747839|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747840|NCT05416762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44747841|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44747842|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747843|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747844|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747845|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
44747846|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44747847|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44747848|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44747849|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44747850|NCT05405621|Exatecan|exatecan|mesh-list
44747851|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44747852|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44747853|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747854|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747855|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747856|NCT05389722|Itraconazole|itraconazole|mesh-list
44747857|NCT05389722|Rifampin|rifampin|mesh-list
44747858|NCT05389722|Digoxin|digoxin|mesh-list
44747859|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44747860|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44747861|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44747862|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
44747863|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747864|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44747865|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44747866|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747867|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
44747868|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747869|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44747870|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44747871|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44747872|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
44747873|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747874|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747875|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44747876|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44747877|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
44747878|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44747879|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
44747880|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44747881|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44747882|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44747883|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44747884|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44747885|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44747886|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44747887|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44747888|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44747889|NCT05389722|Protective Agents|protective agents|mesh-ancestor
44747890|NCT05383196|Paclitaxel|paclitaxel|mesh-list
44747891|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44747892|NCT05383196|Onvansertib|onvansertib|mesh-list
44747893|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44747894|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747895|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
44747896|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
44747897|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
44747898|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747899|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747900|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747901|NCT05351541|Zolpidem|zolpidem|mesh-list
44747902|NCT05351541|Modafinil|modafinil|mesh-list
44747903|NCT05351541|Psilocybin|psilocybin|mesh-list
44747904|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44747905|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44747906|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747907|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44747908|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44747909|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44747910|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747911|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44747912|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44747913|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747914|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44747915|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
44747916|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
44747917|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747918|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
44747919|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44747920|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44747921|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
44747922|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44747923|NCT05350696|Morphine|morphine|mesh-list
44747924|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276893|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44747925|NCT05350696|Narcotics|narcotics|mesh-ancestor
44747926|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747927|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747928|NCT05350696|Analgesics|analgesics|mesh-ancestor
44747929|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
44747930|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747931|NCT05301361|Methylphenidate|methylphenidate|mesh-list
44747932|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44747933|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747934|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44747935|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44747936|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44747937|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747938|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
44525092|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525093|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44525094|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774259|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
44276920|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44525095|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525096|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44525097|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44525098|NCT03456401|Growth Substances|growth substances|mesh-ancestor
44525099|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525100|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
44525101|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
44525102|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747939|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747940|NCT05291156|Cetuximab|cetuximab|mesh-list
44747941|NCT05291156|Avelumab|avelumab|mesh-list
44747942|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44747943|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747944|NCT05271292|Chiauranib|chiauranib|mesh-list
44747945|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747946|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44747947|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747948|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747949|NCT05253118|Pemetrexed|pemetrexed|mesh-list
44747950|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44747951|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44747952|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747953|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44747954|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44747955|NCT05226923|Meropenem|meropenem|mesh-list
44747956|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44747957|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44747958|NCT05098327|Pioglitazone|pioglitazone|mesh-list
44747959|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44747960|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747961|NCT05086250|Ketamine|ketamine|mesh-list
44747962|NCT05086250|Analgesics|analgesics|mesh-ancestor
44747963|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
44747964|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747965|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747966|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44747967|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44747968|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
44747969|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
44747970|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44747971|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44747972|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44747973|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747974|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747975|NCT05084222|Budesonide|budesonide|mesh-list
44747976|NCT05084222|Albuterol|albuterol|mesh-list
44747977|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
44747978|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44747979|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44747980|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
44747981|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44747982|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44747983|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44747984|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
44747985|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
44747986|NCT05084222|Hormones|hormones|mesh-ancestor
44747987|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44747988|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44747989|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44747990|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44747991|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
44747992|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44747993|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44747994|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
44747995|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44747996|NCT05076838|Diazepam|diazepam|mesh-list
44747997|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44747998|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
44747999|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
44748000|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
44748001|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748002|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748003|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748004|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44748005|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748006|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44748007|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44748008|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44748009|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44748010|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748011|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44748012|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
44525149|NCT03455049|Analgesics|analgesics|mesh-ancestor
44748013|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
44748015|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
44748016|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748017|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748018|NCT05057949|Itraconazole|itraconazole|mesh-list
44748019|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44748020|NCT05057949|Rifampin|rifampin|mesh-list
44748021|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
44748022|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688078|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44688079|NCT05164549|Narcotics|narcotics|mesh-ancestor
44688080|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276975|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44688081|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688082|NCT05164549|Analgesics|analgesics|mesh-ancestor
44688083|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
44688084|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688085|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44688086|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
44688087|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
44688088|NCT05162274|Lazertinib|lazertinib|mesh-list
44688089|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688090|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688091|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688092|NCT05157698|Naltrexone|naltrexone|mesh-list
44688093|NCT05157698|Bupropion|bupropion|mesh-list
44688094|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44688095|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44688096|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688097|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
44688098|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688099|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44688100|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
44688101|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44688102|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44688103|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44688104|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688105|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688106|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
44688107|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688108|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44688109|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44688110|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239702|NCT00575406|Hormones|hormones|mesh-ancestor
44688111|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
44688112|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688113|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688114|NCT05119101|Analgesics|analgesics|mesh-ancestor
44688115|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
44688116|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688117|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688118|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
44688119|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44688120|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
44688121|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44688122|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688123|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44688124|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
44688125|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44688126|NCT05073250|Rituximab|rituximab|mesh-list
44688127|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688128|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688129|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
44688130|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688131|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688132|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
44688133|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44688134|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
44688135|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688136|NCT04983407|Gemcitabine|gemcitabine|mesh-list
44688137|NCT04983407|Paclitaxel|paclitaxel|mesh-list
44688138|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44688139|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688140|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44688141|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525213|NCT03454620|Irinotecan|irinotecan|mesh-list
44748023|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44748024|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44748025|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748026|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748027|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44748028|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748029|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748030|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748031|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44748032|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44748033|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
44748034|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748035|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
44748036|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44748037|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44748038|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44748039|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44748040|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44748041|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44748042|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44748043|NCT05047640|Vaccines|vaccines|mesh-list
44748044|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
44748045|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525224|NCT03454217|Oxycodone|oxycodone|mesh-list
44748046|NCT04932434|Psilocybin|psilocybin|mesh-list
44748047|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44748048|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
44748049|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748050|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44688142|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44688143|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688144|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44688145|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
44688146|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
44688147|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688148|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688149|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44688150|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
44688151|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688152|NCT04920331|Erenumab|erenumab|mesh-list
44688153|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44688154|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688155|NCT04920331|Analgesics|analgesics|mesh-ancestor
44688156|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
44688157|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688158|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688159|NCT04861987|Capecitabine|capecitabine|mesh-list
44688160|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44688161|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
44688162|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688163|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688164|NCT04832438|Carboplatin|carboplatin|mesh-list
44688165|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688166|NCT04832087|Teduglutide|teduglutide|mesh-list
44688167|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44688168|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44688169|NCT04832087|Protective Agents|protective agents|mesh-ancestor
44688170|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688171|NCT04736394|Epirubicin|epirubicin|mesh-list
44688172|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44688173|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688174|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44688175|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44688176|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688177|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688178|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44688179|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44688180|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
44688181|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688182|NCT04693689|Vaccines|vaccines|mesh-list
44688183|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
44688184|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688185|NCT04490993|Epirubicin|epirubicin|mesh-list
44688192|NCT04409964|Lidocaine|lidocaine|mesh-list
44688193|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
44688194|NCT04409964|Remifentanil|remifentanil|mesh-list
44688195|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
44688196|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
44688197|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688198|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688199|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
44688200|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688201|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44688202|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44688203|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44688204|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688205|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688206|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44688207|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688208|NCT04409964|Analgesics|analgesics|mesh-ancestor
44688209|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44688210|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44688211|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44688212|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688213|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688214|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44688215|NCT04409964|Narcotics|narcotics|mesh-ancestor
44748051|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44748052|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
44748053|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748054|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748055|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44748056|NCT04925960|Epalrestat|epalrestat|mesh-list
44748057|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748058|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748059|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
44748060|NCT04901312|Narcotics|narcotics|mesh-ancestor
44748061|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748062|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748063|NCT04901312|Analgesics|analgesics|mesh-ancestor
44748064|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
44748065|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748066|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44748067|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748068|NCT04886297|Resveratrol|resveratrol|mesh-list
44748069|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
44748070|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748071|NCT04886297|Protective Agents|protective agents|mesh-ancestor
44748072|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748073|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748074|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44748075|NCT04830410|Levan|levan|mesh-list
44748076|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748077|NCT04818216|Niacinamide|niacinamide|mesh-list
44748078|NCT04818216|Niacin|niacin|mesh-list
44748079|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
44748080|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44748081|NCT04818216|Vitamins|vitamins|mesh-ancestor
44748082|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
44748083|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748084|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44748085|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
44748086|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748087|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44748088|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
44748089|NCT04810793|Amoxicillin|amoxicillin|mesh-list
44748090|NCT04810793|Levofloxacin|levofloxacin|mesh-list
44748091|NCT04810793|Ofloxacin|ofloxacin|mesh-list
44748092|NCT04810793|Tetracycline|tetracycline|mesh-list
44748093|NCT04810793|Furazolidone|furazolidone|mesh-list
44748094|NCT04810793|Esomeprazole|esomeprazole|mesh-list
44748095|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748096|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748097|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44748098|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748099|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44748100|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748101|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748102|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44748103|NCT04810793|Renal Agents|renal agents|mesh-ancestor
44748104|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44748105|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277179|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44748106|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748107|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44748108|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44748109|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44748110|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44748111|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44748112|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44748113|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44748114|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44748115|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
44748116|NCT04797832|Hematinics|hematinics|mesh-ancestor
44748117|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
44748118|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748119|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748120|NCT04731974|Melatonin|melatonin|mesh-list
44748121|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
44748122|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748123|NCT04731974|Protective Agents|protective agents|mesh-ancestor
44748124|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748125|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748126|NCT04711824|Gemcitabine|gemcitabine|mesh-list
44748127|NCT04711824|Paclitaxel|paclitaxel|mesh-list
44748128|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44748129|NCT04711824|Cisplatin|cisplatin|mesh-list
44748130|NCT04711824|Carboplatin|carboplatin|mesh-list
44748131|NCT04711824|Capecitabine|capecitabine|mesh-list
44748132|NCT04711824|Durvalumab|durvalumab|mesh-list
44748133|NCT04711824|Olaparib|olaparib|mesh-list
44748134|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748135|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277203|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
44748136|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748137|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748138|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748139|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748140|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748141|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
44748142|NCT04711824|Antiviral Agents|antiviral agents|mesh-ancestor
44748143|NCT04711824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748144|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748145|NCT04711824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748146|NCT04711824|Immunologic Factors|immunologic factors|mesh-ancestor
44748147|NCT04711824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748148|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748149|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44748150|NCT04708054|Fludarabine|fludarabine|mesh-list
44748151|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
44748152|NCT04708054|Busulfan|busulfan|mesh-list
44748153|NCT04708054|Venetoclax|venetoclax|mesh-list
44748154|NCT04708054|Thiotepa|thiotepa|mesh-list
44748155|NCT04708054|Cladribine|cladribine|mesh-list
44748156|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44748157|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748158|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748159|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
44748160|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748161|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748162|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
44748163|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748164|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
44748165|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748166|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748167|NCT04684511|Rofecoxib|rofecoxib|mesh-list
44748168|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44748169|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44748170|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748171|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277233|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748172|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44748173|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44748174|NCT04684511|Analgesics|analgesics|mesh-ancestor
44748175|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
44748176|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748177|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748178|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748179|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748180|NCT04650841|Naloxone|naloxone|mesh-list
44748181|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44748182|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748183|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
44748184|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748185|NCT04624854|Aspirin|aspirin|mesh-list
44748186|NCT04624854|Clopidogrel|clopidogrel|mesh-list
44748187|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44748188|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44748189|NCT04624854|Analgesics|analgesics|mesh-ancestor
44525377|NCT03451110|Famotidine|famotidine|mesh-list
44525378|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44525379|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
44525380|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525381|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44525382|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44525383|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525384|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525385|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44525386|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748190|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
44748191|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748192|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748193|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748194|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748195|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44748196|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44748197|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748198|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44748199|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44748200|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748201|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
44748202|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44748203|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44277276|NCT00713739|Prazosin|prazosin|mesh-list
44748204|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44748205|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
44748206|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748207|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
44748208|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748209|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748210|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748211|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748212|NCT04565171|Yimitasvir|yimitasvir|mesh-list
44748213|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
44748214|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748215|NCT04504331|Tamoxifen|tamoxifen|mesh-list
44748216|NCT04504331|Infigratinib|infigratinib|mesh-list
44748217|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44748218|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748219|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748220|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748221|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748222|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748223|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44748224|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44748225|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44748226|NCT04463368|Nivolumab|nivolumab|mesh-list
44748227|NCT04463368|Ipilimumab|ipilimumab|mesh-list
44748228|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748229|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748230|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748231|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748232|NCT04452344|Analgesics|analgesics|mesh-list
44748233|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748234|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
44748235|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748236|NCT04450407|Insulin|insulin|mesh-list
44748237|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44748238|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748239|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
44748240|NCT04441034|Convulsants|convulsants|mesh-list
44748241|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
44748242|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748243|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44748244|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748245|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
44748246|NCT04432506|Fludarabine|fludarabine|mesh-list
44748247|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44748248|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748249|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
44748250|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748251|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748252|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748253|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
44748254|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748255|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748256|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748257|NCT04408508|Amoxicillin|amoxicillin|mesh-list
44748258|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748259|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748260|NCT04385368|Durvalumab|durvalumab|mesh-list
44748261|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748262|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525391|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44748263|NCT04338269|Atezolizumab|atezolizumab|mesh-list
44748264|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748265|NCT04281017|Anesthetics|anesthetics|mesh-list
44748266|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748267|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748268|NCT04256941|Letrozole|letrozole|mesh-list
44748269|NCT04256941|Fulvestrant|fulvestrant|mesh-list
44748270|NCT04256941|Palbociclib|palbociclib|mesh-list
44748271|NCT04256941|Anastrozole|anastrozole|mesh-list
44748272|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748273|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44748274|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44748275|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748276|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277362|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748277|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44748278|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748279|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748280|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688216|NCT04377997|Heparin|heparin|mesh-list
44688217|NCT04377997|Calcium heparin|calcium heparin|mesh-list
44688218|NCT04377997|Enoxaparin|enoxaparin|mesh-list
44688219|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44688220|NCT04377997|Tinzaparin|tinzaparin|mesh-list
44688221|NCT04377997|Dalteparin|dalteparin|mesh-list
44688222|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
44688223|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44688224|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44688225|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688226|NCT04346394|Yohimbine|yohimbine|mesh-list
44688227|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
44688228|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
44688229|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688230|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688231|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44688232|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44688233|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44688234|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688235|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688236|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688237|NCT04346394|Urological Agents|urological agents|mesh-ancestor
44688238|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
44688239|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688240|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688241|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688242|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688243|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
44688244|NCT04179110|Ramucirumab|ramucirumab|mesh-list
44688245|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688246|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688247|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
44688248|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
44688249|NCT03740958|Argatroban|argatroban|mesh-list
44688250|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
44688251|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44688252|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688253|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688254|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688255|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
44688256|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44688257|NCT03685188|Sufentanil|sufentanil|mesh-list
44688258|NCT03685188|Oxycodone|oxycodone|mesh-list
44688259|NCT03685188|Dsuvia|dsuvia|mesh-list
44688260|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44688261|NCT03685188|Narcotics|narcotics|mesh-ancestor
44688262|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688263|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688264|NCT03685188|Analgesics|analgesics|mesh-ancestor
44688265|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
44239857|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
44688266|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688267|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44688268|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44688269|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
44688270|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
44688271|NCT03649880|Misonidazole|misonidazole|mesh-list
44688272|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688273|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44688274|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44748281|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748282|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44748283|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748284|NCT04242238|Avelumab|avelumab|mesh-list
44748285|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748286|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748287|NCT04231838|Nicotine|nicotine|mesh-list
44748288|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44748289|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
44748290|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748291|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748292|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44748293|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44748294|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748295|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748296|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748297|NCT04218266|Apixaban|apixaban|mesh-list
44748298|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44748299|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
44748300|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44748301|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
44748302|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748303|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748304|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
44748305|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
44748306|NCT04207086|Lenvatinib|lenvatinib|mesh-list
44748307|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748308|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748309|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748310|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748311|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748312|NCT04172363|Octenidine|octenidine|mesh-list
44748313|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748314|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44748315|NCT04113018|Dexamethasone|dexamethasone|mesh-list
44748316|NCT04113018|Lenalidomide|lenalidomide|mesh-list
44748317|NCT04113018|Daratumumab|daratumumab|mesh-list
44748318|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748319|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
44748320|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
44748321|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748322|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748323|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748324|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
44748325|NCT04113018|Hormones|hormones|mesh-ancestor
44748326|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748327|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748328|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748329|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
44748330|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44748331|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44748332|NCT04113018|Growth Substances|growth substances|mesh-ancestor
44748333|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44748334|NCT04074603|Insulin|insulin|mesh-list
44748335|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44748336|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748337|NCT04068246|Metformin|metformin|mesh-list
44748338|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44748339|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748340|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
44748341|NCT04063033|Hematinics|hematinics|mesh-ancestor
44748342|NCT04038255|Nicotine|nicotine|mesh-list
44748343|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44748344|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
44748345|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774260|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44748346|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748347|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44748348|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44748349|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748350|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748351|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748352|NCT04037605|Ketoconazole|ketoconazole|mesh-list
44748353|NCT04037605|Dexamethasone|dexamethasone|mesh-list
44748354|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
44748355|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
44748356|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44748357|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44748358|NCT04037605|Hormones|hormones|mesh-list
44748359|NCT04037605|Cosyntropin|cosyntropin|mesh-list
44748360|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44748361|NCT04037605|BB 1101|bb 1101|mesh-list
44748362|NCT04037605|Ganirelix|ganirelix|mesh-list
44748363|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748364|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
44748365|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
44748366|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748367|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748368|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748369|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
44748370|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748371|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748372|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748373|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
44748374|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748375|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748376|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
44748377|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748378|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44748379|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44748380|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44748381|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748382|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44748383|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
44748384|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44748385|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748386|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748387|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748388|NCT03960008|Doxorubicin|doxorubicin|mesh-list
44748389|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44748390|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44748391|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748392|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44748393|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44748394|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748395|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748396|NCT03929666|Leucovorin|leucovorin|mesh-list
44748397|NCT03929666|Gemcitabine|gemcitabine|mesh-list
44748398|NCT03929666|Bevacizumab|bevacizumab|mesh-list
44748399|NCT03929666|Cisplatin|cisplatin|mesh-list
44748400|NCT03929666|Fluorouracil|fluorouracil|mesh-list
44748401|NCT03929666|Capecitabine|capecitabine|mesh-list
44748402|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
44748403|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748404|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748405|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44748406|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44748407|NCT03929666|Growth Substances|growth substances|mesh-ancestor
44748408|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748409|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
44748410|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748411|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
44748412|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748413|NCT03929666|Antiviral Agents|antiviral agents|mesh-ancestor
44748414|NCT03929666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748415|NCT03929666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748416|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748417|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
44748418|NCT03929666|Antidotes|antidotes|mesh-ancestor
44748419|NCT03929666|Protective Agents|protective agents|mesh-ancestor
44748420|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
44748421|NCT03929666|Vitamins|vitamins|mesh-ancestor
44748422|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
44748423|NCT03928093|Pregabalin|pregabalin|mesh-list
44748424|NCT03928093|Analgesics|analgesics|mesh-ancestor
44748425|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
44748426|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748427|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748428|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
44748429|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44748430|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44748431|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748432|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44748433|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44748434|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44748435|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748436|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748438|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44748439|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44748440|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748441|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
44277541|NCT00715273|Niacin|niacin|mesh-list
44748442|NCT03923959|Coagulants|coagulants|mesh-ancestor
44748443|NCT03907800|Paclitaxel|paclitaxel|mesh-list
44748444|NCT03907800|Carboplatin|carboplatin|mesh-list
44748445|NCT03907800|Trastuzumab|trastuzumab|mesh-list
44748446|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748447|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748448|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748449|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748450|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748451|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748452|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748453|NCT03894904|Heparin|heparin|mesh-list
44748454|NCT03894904|Papaverine|papaverine|mesh-list
44748455|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
44748456|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44748457|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44748458|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748459|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44748460|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748461|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
44748462|NCT03894904|Urological Agents|urological agents|mesh-ancestor
44748463|NCT03856216|Rituximab|rituximab|mesh-list
44748464|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44748465|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44748466|NCT03856216|Methotrexate|methotrexate|mesh-list
44748467|NCT03856216|Fludarabine|fludarabine|mesh-list
44748468|NCT03856216|Melphalan|melphalan|mesh-list
44748469|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44748470|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
44748471|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44748472|NCT03856216|Antibodies|antibodies|mesh-list
44748473|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
44748474|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44748475|NCT03856216|Tacrolimus|tacrolimus|mesh-list
44748476|NCT03856216|Lenograstim|lenograstim|mesh-list
44748477|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44748478|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
44748479|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748480|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748481|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748482|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44748483|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
44748484|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44748485|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748486|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
44748487|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774261|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44525630|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525631|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44748488|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44748489|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748490|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44748491|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748492|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44748493|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44748494|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44748495|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748496|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
44748497|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748498|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44748499|NCT03797833|Anesthetics|anesthetics|mesh-list
44748500|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525632|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
44525633|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44525634|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
44525635|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44525636|NCT00196326|Estradiol|estradiol|mesh-list
44525637|NCT00196326|Estrogens|estrogens|mesh-ancestor
44525638|NCT00196326|Hormones|hormones|mesh-ancestor
44525640|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748501|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748502|NCT03749174|Anesthetics|anesthetics|mesh-list
44748503|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748504|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748505|NCT03722927|Bupivacaine|bupivacaine|mesh-list
44748506|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
44748507|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
44748508|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748509|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748510|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
44748511|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748512|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44748513|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
44748514|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748515|NCT03681652|Azathioprine|azathioprine|mesh-list
44748516|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748517|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
44748518|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748519|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748520|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748521|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748522|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
44748523|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748524|NCT03671525|Nimodipine|nimodipine|mesh-list
44748525|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44748526|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44748527|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44748528|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748529|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44748530|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748531|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
44748532|NCT03600155|Nivolumab|nivolumab|mesh-list
44748533|NCT03600155|Ipilimumab|ipilimumab|mesh-list
44748534|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748535|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748536|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748537|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748538|NCT03578198|Rituximab|rituximab|mesh-list
44748539|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748540|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748541|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
44748542|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748543|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748544|NCT03575195|Rifaximin|rifaximin|mesh-list
44748545|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748546|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748547|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748548|NCT03571308|Prednisolone|prednisolone|mesh-list
44748549|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
44748550|NCT03571308|Doxorubicin|doxorubicin|mesh-list
44748551|NCT03571308|Vincristine|vincristine|mesh-list
44748552|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
44748553|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748554|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
44748555|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748556|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748557|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748558|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
44748559|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748560|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748561|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748562|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44748563|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44748564|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44748565|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748566|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748567|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748568|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748569|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748570|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748571|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
44748572|NCT03571308|Hormones|hormones|mesh-ancestor
44748573|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748574|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748575|NCT03554200|Empagliflozin|empagliflozin|mesh-list
44748576|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44748577|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748578|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44748579|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748581|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44748582|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44748583|NCT03518086|Analgesics|analgesics|mesh-ancestor
44748584|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
44748585|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748586|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748587|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748588|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748589|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44748590|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748591|NCT03517176|Gemcitabine|gemcitabine|mesh-list
44748592|NCT03517176|Paclitaxel|paclitaxel|mesh-list
44748593|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748594|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748595|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748596|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748597|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748598|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748599|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748600|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
44748601|NCT03517176|Antiviral Agents|antiviral agents|mesh-ancestor
44748602|NCT03517176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748603|NCT03517176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748604|NCT03517176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748605|NCT03517176|Immunologic Factors|immunologic factors|mesh-ancestor
44748606|NCT03517176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748607|NCT03512964|Tenofovir|tenofovir|mesh-list
44748608|NCT03512964|Emtricitabine|emtricitabine|mesh-list
44748609|NCT03512964|Dolutegravir|dolutegravir|mesh-list
44748610|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44748611|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
44748612|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748613|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44748614|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44748615|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748616|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748617|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44748618|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44748619|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44748620|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44748621|NCT03507608|Flutamide|flutamide|mesh-list
44748622|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
44748623|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748624|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748625|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748626|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44748627|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748628|NCT03476109|Omalizumab|omalizumab|mesh-list
44748629|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44748630|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44748631|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
44748632|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
44748633|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44748634|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
44748635|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748636|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
44748637|NCT03463499|Protective Agents|protective agents|mesh-ancestor
44525771|NCT00194987|Antibodies|antibodies|mesh-list
44748638|NCT03404193|Decitabine|decitabine|mesh-list
44748639|NCT03404193|Venetoclax|venetoclax|mesh-list
44748640|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748641|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
44748642|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748643|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748644|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748645|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
44748646|NCT03391466|Fludarabine|fludarabine|mesh-list
44748647|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748648|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
44277688|NCT00716170|Glucagon|glucagon|mesh-list
44748649|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748650|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748651|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748652|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
44748653|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748654|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748655|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748656|NCT03366974|Clarithromycin|clarithromycin|mesh-list
44748657|NCT03366974|Midazolam|midazolam|mesh-list
44748658|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44748659|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44748660|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748661|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748662|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44748663|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44748664|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44748665|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44748666|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
44748667|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
44748668|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
44748669|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
44748670|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748671|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748672|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748673|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748674|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44748675|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748676|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44748677|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44748678|NCT03362515|Furosemide|furosemide|mesh-list
44748679|NCT03362515|Diuretics|diuretics|mesh-ancestor
44748680|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
44748681|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748682|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44748683|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44748684|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748685|NCT03340129|Nivolumab|nivolumab|mesh-list
44748686|NCT03340129|Ipilimumab|ipilimumab|mesh-list
44748687|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748688|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748689|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748690|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748691|NCT03307746|Rituximab|rituximab|mesh-list
44748692|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44277750|NCT00716547|Celecoxib|celecoxib|mesh-list
44748693|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748694|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
44748695|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748696|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748697|NCT03294083|Cemiplimab|cemiplimab|mesh-list
44748698|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748699|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748700|NCT03222076|Nivolumab|nivolumab|mesh-list
44748701|NCT03222076|Ipilimumab|ipilimumab|mesh-list
44748702|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748703|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748704|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748705|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748706|NCT03128398|Domperidone|domperidone|mesh-list
44748707|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
44748708|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
44748709|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748710|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748711|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44748712|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44748714|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748715|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748716|NCT03125902|Paclitaxel|paclitaxel|mesh-list
44748717|NCT03125902|Atezolizumab|atezolizumab|mesh-list
44748718|NCT03125902|Antibodies|antibodies|mesh-list
44748719|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44748720|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748721|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748722|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748723|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277782|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44748724|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748725|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748726|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
44748727|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748728|NCT03119038|Ketorolac|ketorolac|mesh-list
44748729|NCT03119038|Clonidine|clonidine|mesh-list
44748730|NCT03119038|Epinephrine|epinephrine|mesh-list
44748731|NCT03119038|Bupivacaine|bupivacaine|mesh-list
44748732|NCT03119038|Ropivacaine|ropivacaine|mesh-list
44748733|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44748734|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
44748735|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44748736|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748737|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
44748738|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748739|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44748740|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44277797|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277799|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748741|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
44748742|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748743|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748744|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44748745|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44748746|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
44748747|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44748748|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
44748749|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
44748750|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
44748751|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44277815|NCT00717210|Temozolomide|temozolomide|mesh-list
44748752|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44748753|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44748754|NCT03119038|Analgesics|analgesics|mesh-ancestor
44748755|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748756|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748757|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44748758|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748759|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44748760|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
44748761|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44748762|NCT03099265|Leucovorin|leucovorin|mesh-list
44748763|NCT03099265|Fluorouracil|fluorouracil|mesh-list
44748764|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
44748765|NCT03099265|Irinotecan|irinotecan|mesh-list
44748766|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
44748767|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748768|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748769|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748770|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748771|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
44748772|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748773|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44748774|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44748775|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748776|NCT03099265|Antidotes|antidotes|mesh-ancestor
44748777|NCT03099265|Protective Agents|protective agents|mesh-ancestor
44748778|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
44748779|NCT03099265|Vitamins|vitamins|mesh-ancestor
44277822|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277849|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
44748780|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
44748781|NCT03065387|Everolimus|everolimus|mesh-list
44748782|NCT03065387|Palbociclib|palbociclib|mesh-list
44748783|NCT03065387|Trametinib|trametinib|mesh-list
44748784|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748785|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748786|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
44748787|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748788|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748789|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525921|NCT00193180|Docetaxel|docetaxel|mesh-list
44748790|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748791|NCT03063749|Sirolimus|sirolimus|mesh-list
44748792|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748793|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748794|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44748795|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748796|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
44748797|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748798|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
44748799|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748800|NCT03016312|Atezolizumab|atezolizumab|mesh-list
44748801|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748802|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
44748803|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44748804|NCT03007589|Protective Agents|protective agents|mesh-ancestor
44748805|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748806|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44748807|NCT02975037|Clarithromycin|clarithromycin|mesh-list
44748808|NCT02975037|Itraconazole|itraconazole|mesh-list
44748809|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
44748810|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
44748811|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44748812|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44748813|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277870|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748814|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748815|NCT02975037|Urological Agents|urological agents|mesh-ancestor
44748816|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44748817|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748818|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44748819|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44748820|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44748821|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
44748822|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44748823|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44748824|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44748825|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748826|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748827|NCT02931890|Paclitaxel|paclitaxel|mesh-list
44748828|NCT02931890|Docetaxel|docetaxel|mesh-list
44748829|NCT02931890|Carboplatin|carboplatin|mesh-list
44748830|NCT02931890|Capecitabine|capecitabine|mesh-list
44748831|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
44748832|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748833|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748834|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748835|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748836|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748837|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277883|NCT00717561|Azithromycin|azithromycin|mesh-list
44748838|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748839|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
44748840|NCT02914405|Nivolumab|nivolumab|mesh-list
44748841|NCT02914405|Dinutuximab|dinutuximab|mesh-list
44748842|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
44748843|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
44748844|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748845|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748846|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748847|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748848|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
44748849|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748850|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
44748851|NCT02812862|Olodaterol|olodaterol|mesh-list
44748852|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44748853|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
44748854|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748855|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748856|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44748857|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44748858|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
44748859|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44748860|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748861|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748862|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748863|NCT02587312|Nicotine|nicotine|mesh-list
44748864|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44748865|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
44748866|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748867|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748868|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44748869|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44748870|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748871|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748872|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748873|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
44748874|NCT02549677|Docetaxel|docetaxel|mesh-list
44748875|NCT02549677|Epirubicin|epirubicin|mesh-list
44277936|NCT00717704|Dasatinib|dasatinib|mesh-list
44748876|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748877|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
44748878|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748879|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748880|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748881|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
44748882|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748883|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748884|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44748885|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748886|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748887|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748888|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44748889|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44748890|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277945|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
44748891|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748892|NCT02536300|Idelalisib|idelalisib|mesh-list
44748893|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748894|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748895|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748896|NCT02450253|Tadalafil|tadalafil|mesh-list
44748897|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44748898|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44748899|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44748900|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748901|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748902|NCT02450253|Urological Agents|urological agents|mesh-ancestor
44748903|NCT02370329|Interferons|interferons|mesh-list
44748904|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
44748905|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
44748906|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44748907|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44748908|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748909|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
44748910|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44748911|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
44748912|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748913|NCT02320292|Rituximab|rituximab|mesh-list
44277960|NCT00717808|Analgesics|analgesics|mesh-ancestor
44748914|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44748915|NCT02320292|Antibodies|antibodies|mesh-list
44748916|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
44748917|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44748918|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
44748919|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748920|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748921|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748922|NCT02257970|Ketoprofen|ketoprofen|mesh-list
44748923|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44748924|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44748925|NCT02257970|Analgesics|analgesics|mesh-ancestor
44748926|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
44526072|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44526073|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44748927|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748928|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277988|NCT00717938|Etoposide|etoposide|mesh-list
44748929|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44748930|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44748931|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44748932|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526074|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44526075|NCT00191724|Enoxaparin|enoxaparin|mesh-list
44526076|NCT00191724|Protein C|protein c|mesh-list
44526077|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
44526078|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44748933|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748934|NCT02177578|Temozolomide|temozolomide|mesh-list
44748935|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44748936|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
44774262|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748937|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748938|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748939|NCT02151981|Osimertinib|osimertinib|mesh-list
44748940|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748941|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748942|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748943|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748944|NCT02135042|Gemcitabine|gemcitabine|mesh-list
44748945|NCT02135042|Paclitaxel|paclitaxel|mesh-list
44748946|NCT02135042|Cisplatin|cisplatin|mesh-list
44748947|NCT02135042|Fluorouracil|fluorouracil|mesh-list
44748948|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44748949|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44748950|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748951|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44748952|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44748953|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44748954|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748955|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44748956|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
44748957|NCT02135042|Antiviral Agents|antiviral agents|mesh-ancestor
44748958|NCT02135042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688275|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688277|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
44688278|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44688279|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
44688280|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44688281|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688282|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688283|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688284|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
44688285|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44688286|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44688287|NCT03246958|Nivolumab|nivolumab|mesh-list
44688288|NCT03246958|Ipilimumab|ipilimumab|mesh-list
44688289|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688290|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688291|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44688292|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688293|NCT03160521|Risperidone|risperidone|mesh-list
44688294|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44688295|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
44688296|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688297|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688298|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688299|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44688300|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44688301|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688302|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44688303|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44688304|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
44688305|NCT03143816|Insulin|insulin|mesh-list
44688306|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44688307|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688308|NCT03133988|Margetuximab|margetuximab|mesh-list
44688309|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688310|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
44688311|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44688312|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44688313|NCT03122847|Prednisolone|prednisolone|mesh-list
44688314|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
44688315|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44688316|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
44688317|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688318|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
44688319|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
44688320|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688321|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688322|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44688323|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
44688324|NCT03122847|Hormones|hormones|mesh-ancestor
44688325|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526141|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44526143|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
44748959|NCT02135042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44748960|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44748961|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
44748962|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748963|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44748964|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748965|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748967|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44748968|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748969|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44748970|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748971|NCT02036086|Vemurafenib|vemurafenib|mesh-list
44748972|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44748973|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44748974|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278029|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
44748975|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748976|NCT01517451|Androgens|androgens|mesh-list
44748977|NCT01517451|Hormones|hormones|mesh-ancestor
44748978|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44748979|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748980|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
44748981|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44748982|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44748983|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44748984|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44748985|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44748986|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
44748987|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44748988|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44748989|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44748990|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44748991|NCT01415882|Dexamethasone|dexamethasone|mesh-list
44748992|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
44748993|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
44748994|NCT01415882|Daratumumab|daratumumab|mesh-list
44748995|NCT01415882|Ixazomib|ixazomib|mesh-list
44748996|NCT01415882|Ichthammol|ichthammol|mesh-list
44748997|NCT01415882|BB 1101|bb 1101|mesh-list
44748998|NCT01415882|Glycine|glycine|mesh-list
44748999|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749000|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
44749001|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749002|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749003|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749004|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
44749005|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749006|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749007|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44749008|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749009|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
44749010|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
44749011|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749012|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749013|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
44749014|NCT01415882|Hormones|hormones|mesh-ancestor
44749015|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749016|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44749017|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
44749018|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749019|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
44749020|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
44749021|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749022|NCT01299480|Vaccines|vaccines|mesh-list
44749023|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
44749024|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749025|NCT01681446|Interferons|interferons|mesh-list
44749026|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
44749027|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749028|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
44749029|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749030|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
44749031|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749032|NCT01681875|Nicotine|nicotine|mesh-list
44749033|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44749034|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
44749035|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749036|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749038|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44749039|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
44749040|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749041|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526246|NCT00190671|Pemetrexed|pemetrexed|mesh-list
44749042|NCT01682577|Perindopril|perindopril|mesh-list
44749043|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44749044|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
44749045|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749046|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749047|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44749048|NCT01683760|Fluconazole|fluconazole|mesh-list
44749049|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
44278121|NCT00718757|Dexamethasone|dexamethasone|mesh-list
44749050|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749051|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44749052|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44749053|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749054|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749055|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44749056|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749057|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749058|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749059|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44749060|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44749061|NCT01684813|Clopidogrel|clopidogrel|mesh-list
44749062|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44749063|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44749064|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44749065|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44749066|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44749067|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
44749068|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749069|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749070|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749071|NCT01684982|Sirolimus|sirolimus|mesh-list
44749072|NCT01684982|Everolimus|everolimus|mesh-list
44749073|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749074|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749075|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
44749076|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749077|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749078|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749079|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749080|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
44749081|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
44749082|NCT01685489|Docetaxel|docetaxel|mesh-list
44278184|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749083|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749084|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749085|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749086|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749087|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749088|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44749089|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
44749090|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749091|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749092|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
44749093|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749094|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
44278194|NCT00719095|Buprenorphine|buprenorphine|mesh-list
44749095|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44749096|NCT01685489|Protective Agents|protective agents|mesh-ancestor
44749097|NCT01686126|Metformin|metformin|mesh-list
44749098|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
44749099|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44749100|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749101|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44749102|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
44749103|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44749104|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44749105|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44749106|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44749107|NCT01686386|Dexamethasone|dexamethasone|mesh-list
44749108|NCT01686386|Lenalidomide|lenalidomide|mesh-list
44749109|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44749110|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749111|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
44749112|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
44749113|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749114|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749115|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749116|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
44749118|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749119|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44749120|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749121|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
44749122|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44749123|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44749124|NCT01686386|Growth Substances|growth substances|mesh-ancestor
44749125|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
44749126|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749127|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
44749128|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749129|NCT01686594|Methoxsalen|methoxsalen|mesh-list
44749130|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44749131|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
44749132|NCT01687517|Vaccines|vaccines|mesh-list
44749133|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
44749134|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749135|NCT01687751|Midazolam|midazolam|mesh-list
44749136|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
44749137|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44749138|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749139|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749140|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749141|NCT01687751|Analgesics|analgesics|mesh-ancestor
44749142|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
44749143|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749144|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44749145|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44749146|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44749147|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44749148|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749149|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749150|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44749151|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44749152|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44749153|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44749154|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44749155|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
44749156|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
44749157|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
44749158|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
44749159|NCT01688362|Dexamethasone|dexamethasone|mesh-list
44749160|NCT01688362|Bupivacaine|bupivacaine|mesh-list
44749161|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749162|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
44749163|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
44749164|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749165|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749166|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749167|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
44749168|NCT01688362|Hormones|hormones|mesh-ancestor
44749169|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749170|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44749171|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749172|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
44749173|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
44749174|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526392|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526393|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526394|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526395|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526396|NCT00179010|Adenosine|adenosine|mesh-list
44526397|NCT00179010|Analgesics|analgesics|mesh-ancestor
44526398|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
44526399|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526400|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526401|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44526402|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44526403|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44526404|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
44526405|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
44749175|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
44749176|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44749177|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44749178|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749180|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
44749181|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
44749182|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44749183|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
44749184|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
44749185|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749186|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
44749187|NCT01690039|Furosemide|furosemide|mesh-list
44749188|NCT01690039|Diuretics|diuretics|mesh-ancestor
44749189|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
44749190|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749191|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44749192|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749193|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749194|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749195|NCT01690091|Metformin|metformin|mesh-list
44749196|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44749197|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749198|NCT01690104|Rifampin|rifampin|mesh-list
44749199|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44749200|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
44749201|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749202|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749203|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
44749204|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44749205|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749206|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749207|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44749208|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44749209|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44749210|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44749211|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44749212|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44749213|NCT01690221|Diltiazem|diltiazem|mesh-list
44749214|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44278315|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44278317|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749215|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44749216|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749217|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749218|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44749219|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749220|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
44749221|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44749222|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
44749223|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749224|NCT01690286|Ketoconazole|ketoconazole|mesh-list
44749225|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
44749226|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749227|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44749228|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44749229|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749230|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749231|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44749232|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749233|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749234|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749235|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44749236|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
44749237|NCT01690325|Bevacizumab|bevacizumab|mesh-list
44749238|NCT01690325|Docetaxel|docetaxel|mesh-list
44749239|NCT01690325|Trastuzumab|trastuzumab|mesh-list
44749240|NCT01690325|Epirubicin|epirubicin|mesh-list
44749241|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749242|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
44749243|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749244|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278341|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44749245|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749246|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
44749247|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749248|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749249|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44749250|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44749251|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44749252|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44749253|NCT01690325|Growth Substances|growth substances|mesh-ancestor
44749254|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
44749255|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749256|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749257|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749258|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749259|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44749260|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749261|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749262|NCT01690338|Bromides|bromides|mesh-list
44749263|NCT01690338|Rocuronium|rocuronium|mesh-list
44749264|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
44749265|NCT01690338|Cisatracurium|cisatracurium|mesh-list
44749266|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
44749267|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44463452|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463453|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749268|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44749269|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44749270|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749271|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749272|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44749273|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44749274|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
44749275|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749276|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749277|NCT01690364|Anesthetics|anesthetics|mesh-list
44749278|NCT01690364|Cisatracurium|cisatracurium|mesh-list
44749279|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
44749280|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749281|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749282|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44749283|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44278370|NCT00720018|Sumatriptan|sumatriptan|mesh-list
44749284|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749285|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44749286|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44749287|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44749288|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
44749289|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749290|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749291|NCT01690403|Rifapentine|rifapentine|mesh-list
44749292|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44278386|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278387|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749293|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
44749294|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749295|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749296|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
44749297|NCT01690468|Carboplatin|carboplatin|mesh-list
44749298|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749299|NCT01690507|Cytarabine|cytarabine|mesh-list
44749300|NCT01690507|Decitabine|decitabine|mesh-list
44749301|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
44749302|NCT01690507|Lenograstim|lenograstim|mesh-list
44749303|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749304|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
44749305|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749306|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749307|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
44749308|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749309|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749310|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
44278396|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44749311|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749312|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749313|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44749314|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749315|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
44749316|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44749317|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749318|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749319|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44749320|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749321|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749322|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749323|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749324|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44749325|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
44749326|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44749327|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749328|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44749329|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44749330|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44749331|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
44749332|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44749333|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749334|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44749335|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749336|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749337|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749338|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749339|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44749340|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44749341|NCT01690572|Paclitaxel|paclitaxel|mesh-list
44749342|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
44749343|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44749344|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749345|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749346|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749347|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749348|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278440|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749349|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44749350|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
44749351|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749352|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
44749353|NCT01690572|Protective Agents|protective agents|mesh-ancestor
44749354|NCT01690598|Topotecan|topotecan|mesh-list
44749355|NCT01690598|Veliparib|veliparib|mesh-list
44749356|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44749357|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749358|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749359|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749360|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749361|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44749362|NCT01690637|Oseltamivir|oseltamivir|mesh-list
44749363|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
44749364|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749365|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749366|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749367|NCT01690702|Paclitaxel|paclitaxel|mesh-list
44749368|NCT01690702|Docetaxel|docetaxel|mesh-list
44749369|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
44749370|NCT01690702|Epirubicin|epirubicin|mesh-list
44749371|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44749372|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749373|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749374|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749375|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749376|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749377|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749378|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
44749379|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749380|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749381|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749382|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
44278452|NCT00720421|Lorazepam|lorazepam|mesh-list
44749383|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44749384|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749385|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44749386|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749387|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526587|NCT00176254|Paclitaxel|paclitaxel|mesh-list
44526588|NCT00176254|Carboplatin|carboplatin|mesh-list
44749388|NCT01690767|Lidocaine|lidocaine|mesh-list
44749389|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
44749390|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
44749391|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749392|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749393|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
44749394|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749395|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44749396|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44749397|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44749398|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749399|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749400|NCT01690780|Ibuprofen|ibuprofen|mesh-list
44749401|NCT01690780|Morphine|morphine|mesh-list
44749402|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44749403|NCT01690780|Narcotics|narcotics|mesh-ancestor
44749404|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749405|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749406|NCT01690780|Analgesics|analgesics|mesh-ancestor
44749407|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
44749408|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749409|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44749410|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749411|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749412|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749413|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44749414|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749415|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749416|NCT01690832|Fenoldopam|fenoldopam|mesh-list
44749417|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44749418|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
44749419|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
44749420|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
44749421|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749422|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749423|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749424|NCT01690871|Dactolisib|dactolisib|mesh-list
44749425|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749426|NCT01690884|Adenosine|adenosine|mesh-list
44749427|NCT01690884|Analgesics|analgesics|mesh-ancestor
44749428|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
44749429|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749430|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749431|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44749432|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
44749433|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44749434|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
44749435|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
44749436|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749437|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749438|NCT01690962|Vitamins|vitamins|mesh-list
44749439|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
44749440|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
44749441|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
44749442|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
44749443|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749444|NCT01690962|Hematinics|hematinics|mesh-ancestor
44749445|NCT01690975|Benzonatate|benzonatate|mesh-list
44749446|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
44749447|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44749448|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
44749449|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44749450|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749451|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749452|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749453|NCT01691001|Analgesics|analgesics|mesh-ancestor
44749454|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
44749455|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749456|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44749457|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44749458|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44749459|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526666|NCT00171834|Epothilones|epothilones|mesh-list
44749460|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749461|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749462|NCT01691053|Spironolactone|spironolactone|mesh-list
44749463|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44749464|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749465|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749466|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749467|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44749468|NCT01691053|Diuretics|diuretics|mesh-ancestor
44749469|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
44749470|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
44749471|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
44749472|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749473|NCT01691365|Vitamins|vitamins|mesh-list
44749474|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
44749475|NCT01691365|Antioxidants|antioxidants|mesh-list
44749476|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
44749477|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749478|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749479|NCT01691365|Protective Agents|protective agents|mesh-ancestor
44749480|NCT01691404|Quercetin|quercetin|mesh-list
44749481|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
44749482|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749483|NCT01691404|Protective Agents|protective agents|mesh-ancestor
44749484|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749485|NCT01691456|Montelukast|montelukast|mesh-list
44749486|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44749487|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44749488|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44749489|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749490|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749491|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749492|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44749493|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44749494|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749495|NCT01691469|Montelukast|montelukast|mesh-list
44749496|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44749497|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
44749498|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44749499|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749500|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749501|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749502|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44749503|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44749504|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749505|NCT01691495|PENTA|penta|mesh-list
44749506|NCT01691495|Fondaparinux|fondaparinux|mesh-list
44749507|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44749508|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
44749509|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44749510|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44749511|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749512|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749513|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
44749514|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44749515|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44749516|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
44749517|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44749518|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44749519|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44749520|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749521|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749522|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
44278603|NCT00720824|Anesthetics|anesthetics|mesh-list
44749523|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749524|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749525|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44749526|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749527|NCT01691677|Beclomethasone|beclomethasone|mesh-list
44749528|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749529|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
44749530|NCT01691677|Hormones|hormones|mesh-ancestor
44749531|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749532|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749533|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44749534|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
44749535|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44749537|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749538|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44749539|NCT01691807|Ofatumumab|ofatumumab|mesh-list
44749540|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749541|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
44749542|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749543|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749544|NCT01691872|Ezogabine|ezogabine|mesh-list
44749545|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
44278633|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278634|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749546|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749547|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749548|NCT01691937|Sufentanil|sufentanil|mesh-list
44749549|NCT01691937|Ropivacaine|ropivacaine|mesh-list
44749550|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
44749551|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
44749552|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749553|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749554|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
44749555|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749556|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44749557|NCT01691937|Narcotics|narcotics|mesh-ancestor
44749558|NCT01691937|Analgesics|analgesics|mesh-ancestor
44749559|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44749560|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44749561|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
44749562|NCT01691976|Estrogens|estrogens|mesh-list
44749563|NCT01691976|Hormones|hormones|mesh-ancestor
44749564|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749565|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749566|NCT01692132|Prucalopride|prucalopride|mesh-list
44749567|NCT01692132|Laxatives|laxatives|mesh-ancestor
44749568|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749569|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44749570|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44749571|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
44749572|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749573|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749574|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749575|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
44749576|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44749577|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749578|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749579|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749580|NCT01692210|Analgesics|analgesics|mesh-ancestor
44749581|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
44749582|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749583|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44749584|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44749585|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44749586|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
44749587|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749588|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749589|NCT01692457|Golimumab|golimumab|mesh-list
44749590|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44749591|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749592|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749593|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
44749594|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749595|NCT01692483|Prednisone|prednisone|mesh-list
44749596|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
44526813|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526814|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526815|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526816|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526817|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526818|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526819|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526820|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
44526821|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44526822|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526823|NCT00479765|Paclitaxel|paclitaxel|mesh-list
44526824|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44749597|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749598|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
44749599|NCT01692483|Hormones|hormones|mesh-ancestor
44749600|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749601|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749602|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44749603|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749604|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44749605|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749606|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749607|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749608|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44749609|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44749610|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44749611|NCT01692678|Dacarbazine|dacarbazine|mesh-list
44749612|NCT01692678|Trabectedin|trabectedin|mesh-list
44749613|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44749614|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
44749615|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278708|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
44749616|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749617|NCT01692704|Gemcitabine|gemcitabine|mesh-list
44749619|NCT01692704|Floxuridine|floxuridine|mesh-list
44749620|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749621|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749622|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
44749623|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749624|NCT01692704|Antiviral Agents|antiviral agents|mesh-ancestor
44749625|NCT01692704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749626|NCT01692704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749627|NCT01692704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749628|NCT01692704|Immunologic Factors|immunologic factors|mesh-ancestor
44749629|NCT01692704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749630|NCT01692808|Vitamin D|vitamin d|mesh-list
44749631|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
44749632|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
44749633|NCT01692808|Vitamins|vitamins|mesh-list
44749634|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
44749635|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749636|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44749637|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44749638|NCT01692834|Cyclosporine|cyclosporine|mesh-list
44749639|NCT01692834|Cyclosporins|cyclosporins|mesh-list
44749640|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749641|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749642|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749643|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
44749644|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749645|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
44749646|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749647|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44278739|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
44749648|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749649|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44749650|NCT01692886|Vaccines|vaccines|mesh-list
44749651|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44749652|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
44749653|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749654|NCT01692925|Factor VIII|factor viii|mesh-list
44749655|NCT01692925|Coagulants|coagulants|mesh-ancestor
44749656|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
44749657|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44749658|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
44749659|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749660|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749661|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44749662|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
44749663|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
44749664|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44749665|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
44278764|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44278765|NCT00721552|Protective Agents|protective agents|mesh-ancestor
44749666|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749667|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749668|NCT01693081|Apomorphine|apomorphine|mesh-list
44749669|NCT01693081|Emetics|emetics|mesh-ancestor
44749670|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749671|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
44749672|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749673|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749674|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
44749675|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
44749676|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749677|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749678|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
44749679|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
44749680|NCT01693159|Coagulants|coagulants|mesh-ancestor
44749681|NCT01693276|Gemcitabine|gemcitabine|mesh-list
44749682|NCT01693276|Paclitaxel|paclitaxel|mesh-list
44749683|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44749684|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44749685|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749686|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749687|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749688|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749689|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749690|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749691|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
44749692|NCT01693276|Antiviral Agents|antiviral agents|mesh-ancestor
44749693|NCT01693276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749694|NCT01693276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749695|NCT01693276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749696|NCT01693276|Immunologic Factors|immunologic factors|mesh-ancestor
44749697|NCT01693276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749698|NCT01693289|Metformin|metformin|mesh-list
44749699|NCT01693289|Letrozole|letrozole|mesh-list
44749700|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44749701|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749702|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749703|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44749704|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44749705|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749706|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749707|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44749708|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
44749709|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749710|NCT01693302|Insulin|insulin|mesh-list
44749711|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44749712|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44749713|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749714|NCT01693328|Fentanyl|fentanyl|mesh-list
44749715|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44749716|NCT01693328|Narcotics|narcotics|mesh-ancestor
44749717|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749718|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749719|NCT01693328|Analgesics|analgesics|mesh-ancestor
44749720|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
44749721|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749722|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44749723|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44749724|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
44749725|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
44749726|NCT01693380|Vaccines|vaccines|mesh-list
44749727|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
44749728|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749729|NCT01693393|Cyclosporine|cyclosporine|mesh-list
44749730|NCT01693393|Cyclosporins|cyclosporins|mesh-list
44749731|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749732|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749733|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749734|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
44749735|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749736|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
44749737|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749738|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44749739|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749740|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44749741|NCT01693419|Gemcitabine|gemcitabine|mesh-list
44749742|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44749743|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749744|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
44749745|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749746|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278823|NCT00722033|Analgesics|analgesics|mesh-ancestor
44749747|NCT01693419|Antiviral Agents|antiviral agents|mesh-ancestor
44749748|NCT01693419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749749|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749750|NCT01693419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749751|NCT01693419|Immunologic Factors|immunologic factors|mesh-ancestor
44749752|NCT01693419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749753|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44749754|NCT01693432|Docetaxel|docetaxel|mesh-list
44749755|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749756|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
44749757|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
44749758|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
44749759|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749760|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
44749761|NCT01693445|Irinotecan|irinotecan|mesh-list
44749762|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749763|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44749764|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749765|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749766|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749768|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749769|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44278868|NCT00722215|Nifedipine|nifedipine|mesh-list
44749770|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749771|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749772|NCT01693640|Abatacept|abatacept|mesh-list
44749773|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44749774|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749775|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749776|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749777|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
44749778|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749779|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749780|NCT01693679|Lamivudine|lamivudine|mesh-list
44749781|NCT01693679|Adefovir|adefovir|mesh-list
44749782|NCT01693679|Telbivudine|telbivudine|mesh-list
44749783|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44749784|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44749785|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749786|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688326|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44688327|NCT03122847|Protective Agents|protective agents|mesh-ancestor
44688328|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688329|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688330|NCT03078192|Xenon|xenon|mesh-list
44688331|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44688332|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
44688333|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
44688334|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688335|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688336|NCT03004131|Fluticasone|fluticasone|mesh-list
44688337|NCT03004131|Xhance|xhance|mesh-list
44688338|NCT03004131|Loratadine|loratadine|mesh-list
44688339|NCT03004131|Azelastine|azelastine|mesh-list
44688340|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688341|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44688342|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
44688343|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688344|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688345|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44688346|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
44688347|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
44688348|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688349|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
44688350|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44688351|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44278898|NCT00722579|Cobalt|cobalt|mesh-list
44688352|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
44688353|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
44688354|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688355|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688356|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44688357|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688358|NCT02959944|Prednisone|prednisone|mesh-list
44688359|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688360|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
44688361|NCT02959944|Hormones|hormones|mesh-ancestor
44688362|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688363|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688364|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688365|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688366|NCT02903823|Baclofen|baclofen|mesh-list
44688367|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44688368|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688369|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44688370|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688371|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44688372|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
44688373|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
44688374|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688375|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688376|NCT02855697|Olaparib|olaparib|mesh-list
44749787|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
44749788|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749789|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44749790|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44749791|NCT01693718|Cisplatin|cisplatin|mesh-list
44749792|NCT01693718|Fluorouracil|fluorouracil|mesh-list
44749793|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
44749794|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749795|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
44749796|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749797|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749798|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749799|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
44749800|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749801|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
44749802|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749803|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44749804|NCT01693809|Caffeine|caffeine|mesh-list
44749805|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44749806|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749807|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44749808|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749809|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749810|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44749811|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44749812|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
44749813|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749814|NCT01693822|Axitinib|axitinib|mesh-list
44749815|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749816|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44749817|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749818|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749819|NCT01694017|Tenofovir|tenofovir|mesh-list
44749820|NCT01694017|Zidovudine|zidovudine|mesh-list
44749821|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
44749822|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749823|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44749824|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44749825|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749826|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749827|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44749828|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44749829|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
44527124|NCT00476957|Sirolimus|sirolimus|mesh-list
44527125|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44527126|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527127|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44527128|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527129|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
44527130|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527131|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
44527132|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527133|NCT00476593|Dexamethasone|dexamethasone|mesh-list
44527134|NCT00476593|Diclofenac|diclofenac|mesh-list
44527135|NCT00476593|Lactitol|lactitol|mesh-list
44527136|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44527137|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527138|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
44527139|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
44527140|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527141|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749830|NCT05288829|Ravulizumab|ravulizumab|mesh-list
44749831|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44749832|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749833|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
44749834|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749835|NCT05288816|Ravulizumab|ravulizumab|mesh-list
44749836|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44749837|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749838|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
44749839|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749840|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
44749841|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44749842|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749843|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749844|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749845|NCT05288738|Analgesics|analgesics|mesh-ancestor
44749846|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
44749847|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749848|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44749849|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44749850|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44749851|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
44279012|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44279014|NCT00723242|Ribavirin|ribavirin|mesh-list
44749852|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749853|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749854|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44749855|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749856|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
44749857|NCT05288725|Hormones|hormones|mesh-ancestor
44749858|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749859|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749860|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749861|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
44749862|NCT05288673|Ravulizumab|ravulizumab|mesh-list
44749863|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44749864|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749865|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
44749866|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749867|NCT05288660|Ravulizumab|ravulizumab|mesh-list
44749868|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44749869|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749870|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
44749871|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749872|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
44749873|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44749874|NCT05288465|Protective Agents|protective agents|mesh-ancestor
44749875|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749876|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
44749877|NCT05288374|Celecoxib|celecoxib|mesh-list
44749878|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44749879|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749880|NCT05288374|Analgesics|analgesics|mesh-ancestor
44749881|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
44749882|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749883|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749884|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749885|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749886|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44749887|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44749888|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749889|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749890|NCT05288192|Triamcinolone|triamcinolone|mesh-list
44749891|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44749892|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44749893|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44749894|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749895|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
44749896|NCT05288192|Hormones|hormones|mesh-ancestor
44749897|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44749898|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749899|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44749900|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
44749901|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749902|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527209|NCT00476008|Memantine|memantine|mesh-list
44749906|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44749907|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749908|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44749909|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44749910|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749912|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749916|NCT05288127|Talazoparib|talazoparib|mesh-list
44749917|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44749918|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749919|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749920|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749921|NCT05291455|Lacosamide|lacosamide|mesh-list
44749922|NCT05291455|Phenobarbital|phenobarbital|mesh-list
44749923|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
44749924|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44749925|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44749926|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44749927|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749928|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44749929|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44749930|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749931|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44749932|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44749933|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44749934|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
44749935|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
44749936|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44749937|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44749938|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44749939|NCT05291338|Doxorubicin|doxorubicin|mesh-list
44749940|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
44749941|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44749942|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749943|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44749944|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44749945|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749946|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749947|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44749948|NCT05291195|Eusol|eusol|mesh-list
44749949|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
44749950|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749951|NCT05291130|Vitamin E|vitamin e|mesh-list
44749952|NCT05291130|Vitamins|vitamins|mesh-ancestor
44749953|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
44749954|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749955|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
44749956|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749957|NCT05291130|Protective Agents|protective agents|mesh-ancestor
44749958|NCT05291104|Folic Acid|folic acid|mesh-list
44749959|NCT05291104|Choline|choline|mesh-list
44749960|NCT05291104|Hematinics|hematinics|mesh-ancestor
44749961|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
44749962|NCT05291104|Vitamins|vitamins|mesh-ancestor
44749963|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
44749964|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749965|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
44749966|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44749967|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
44749968|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749969|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749970|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44749971|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
44749972|NCT05291052|Capecitabine|capecitabine|mesh-list
44749973|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
44749974|NCT05291052|Lenvatinib|lenvatinib|mesh-list
44749975|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44749976|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
44749977|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44749978|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749979|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44749980|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749981|NCT05291039|Adalimumab|adalimumab|mesh-list
44749982|NCT05291039|Infliximab|infliximab|mesh-list
44749983|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44749984|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44749985|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
44749986|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44749987|NCT05290948|Bevacizumab|bevacizumab|mesh-list
44749988|NCT05290948|Acetazolamide|acetazolamide|mesh-list
44749989|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44749990|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44749991|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44749992|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44279139|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44749993|NCT05290948|Growth Substances|growth substances|mesh-ancestor
44749994|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44749995|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
44749996|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
44749997|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44749998|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44749999|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750000|NCT05290948|Diuretics|diuretics|mesh-ancestor
44750001|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
44750002|NCT05290935|Paclitaxel|paclitaxel|mesh-list
44750003|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44750004|NCT05290935|Antibodies|antibodies|mesh-list
44750005|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44750006|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750007|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750008|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750009|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750010|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750011|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
44279170|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
44279189|NCT00724022|Tacrolimus|tacrolimus|mesh-list
44750012|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750013|NCT05290857|Hemostatics|hemostatics|mesh-list
44750014|NCT05290857|Coagulants|coagulants|mesh-ancestor
44750015|NCT05290506|Linagliptin|linagliptin|mesh-list
44750016|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44750017|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750018|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750019|NCT05290506|Incretins|incretins|mesh-ancestor
44750020|NCT05290506|Hormones|hormones|mesh-ancestor
44750021|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750022|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
44750023|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750024|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750025|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
44750026|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750027|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44750028|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750029|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750030|NCT05290324|Midazolam|midazolam|mesh-list
44750031|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44750032|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44750033|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750034|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750035|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44750036|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750037|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750038|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750039|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
44750040|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
44750041|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
44750042|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
44750043|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750044|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750045|NCT05290090|Rituximab|rituximab|mesh-list
44750046|NCT05290090|Lenalidomide|lenalidomide|mesh-list
44750047|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
44750048|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750049|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750050|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
44750051|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750052|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750053|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44750054|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44750055|NCT05290090|Growth Substances|growth substances|mesh-ancestor
44750056|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
44750057|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44750058|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750059|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750060|NCT05292742|Capecitabine|capecitabine|mesh-list
44750061|NCT05292742|Trastuzumab|trastuzumab|mesh-list
44750062|NCT05292742|Pertuzumab|pertuzumab|mesh-list
44750063|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44750064|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
44750065|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750066|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750067|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750068|NCT05292677|Anesthetics|anesthetics|mesh-list
44750069|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750070|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750071|NCT05292586|Beclomethasone|beclomethasone|mesh-list
44750072|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
44750073|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44750074|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
44750075|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750076|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750077|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44750078|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750079|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44750080|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44750081|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44750082|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750083|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750084|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750085|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750086|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
44750087|NCT05292586|Hormones|hormones|mesh-ancestor
44750088|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750089|NCT05292573|Metformin|metformin|mesh-list
44750090|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750091|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750092|NCT05291910|Paclitaxel|paclitaxel|mesh-list
44750093|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44750094|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44750095|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750096|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750097|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750098|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750099|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750100|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
44750101|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44750102|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44750103|NCT05291793|Prednisolone|prednisolone|mesh-list
44750104|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
44750105|NCT05291793|Tenoxicam|tenoxicam|mesh-list
44750106|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44750107|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
44750108|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750109|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
44750110|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
44750111|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750112|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750113|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750114|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
44750115|NCT05291793|Hormones|hormones|mesh-ancestor
44750116|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750117|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44750118|NCT05291793|Protective Agents|protective agents|mesh-ancestor
44750119|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44750120|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750121|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44750122|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750123|NCT05291793|Analgesics|analgesics|mesh-ancestor
44750124|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
44750125|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750126|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44750127|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750128|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750129|NCT05294926|Rocuronium|rocuronium|mesh-list
44750130|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44750131|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44750132|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44750133|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750134|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750135|NCT05294887|Bisoprolol|bisoprolol|mesh-list
44750136|NCT05294887|Diltiazem|diltiazem|mesh-list
44750137|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44750138|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44750139|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750140|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750141|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750142|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750143|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44750144|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
44750145|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
44279251|NCT00724178|Vitamin D|vitamin d|mesh-list
44750146|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750147|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44750148|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44750149|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750150|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750151|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
44750152|NCT05294822|Insulin|insulin|mesh-list
44750153|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750154|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750155|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
44750156|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44750157|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
44750158|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750159|NCT05294744|Expectorants|expectorants|mesh-ancestor
44750160|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750161|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44750162|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
44750163|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750164|NCT05294744|Protective Agents|protective agents|mesh-ancestor
44750165|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750166|NCT05294744|Antidotes|antidotes|mesh-ancestor
44750167|NCT05294679|Propofol|propofol|mesh-list
44750168|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44750169|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750170|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750171|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750172|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
44750173|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
44750174|NCT05294666|Cyclosporine|cyclosporine|mesh-list
44750175|NCT05294666|Tacrolimus|tacrolimus|mesh-list
44750176|NCT05294666|Cyclosporins|cyclosporins|mesh-list
44750177|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750178|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
44750179|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750180|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44750181|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750182|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750183|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
44750184|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750185|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750186|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750187|NCT05294640|Lidocaine|lidocaine|mesh-list
44750188|NCT05294640|Epinephrine|epinephrine|mesh-list
44750189|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
44750190|NCT05294640|Anesthetics|anesthetics|mesh-list
44750191|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750192|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750193|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
44750194|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750195|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44750196|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44750197|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44750198|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750199|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750200|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44750201|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44750202|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750203|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750204|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44750205|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44750206|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
44750207|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44750208|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750209|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
44750210|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
44750211|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44750213|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750214|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750215|NCT05294536|Incretins|incretins|mesh-ancestor
44750216|NCT05294536|Hormones|hormones|mesh-ancestor
44750217|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750218|NCT05294484|Indapamide|indapamide|mesh-list
44750219|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44750220|NCT05294484|Diuretics|diuretics|mesh-ancestor
44750221|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
44750222|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750223|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44750224|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750225|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750226|NCT05294406|Piperaquine|piperaquine|mesh-list
44750227|NCT05294406|Artenimol|artenimol|mesh-list
44750228|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
44750229|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44750230|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44750231|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750232|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
44750233|NCT05294393|Ropivacaine|ropivacaine|mesh-list
44750234|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
44750235|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
44750236|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750237|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750238|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
44750239|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750240|NCT05294393|Analgesics|analgesics|mesh-ancestor
44750241|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44750242|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
44750243|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44750244|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750245|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750246|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750247|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
44750248|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44750249|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44750250|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750251|NCT05293808|Aspirin|aspirin|mesh-list
44750252|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44750253|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750254|NCT05293808|Analgesics|analgesics|mesh-ancestor
44750255|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
44750256|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750257|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750258|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750259|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750260|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44750261|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44750262|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750263|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44750264|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44750265|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750266|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
44750267|NCT05293704|Mizoribine|mizoribine|mesh-list
44750268|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44750269|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750270|NCT05293704|Analgesics|analgesics|mesh-ancestor
44750271|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
44750272|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750273|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750274|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750275|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750276|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750277|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750278|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44750279|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750280|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
44750281|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44750282|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44527624|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44750283|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750284|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750285|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750286|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
44750287|NCT05293574|Norethindrone|norethindrone|mesh-list
44750288|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
44279416|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44750289|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44750290|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44750291|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44750292|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
44750293|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44750294|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750295|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44750296|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44750297|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
44750298|NCT05293132|Ubiquinone|ubiquinone|mesh-list
44750299|NCT05293132|Montelukast|montelukast|mesh-list
44750300|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44750301|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750302|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44750303|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
44750304|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750305|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750306|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44750307|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44750308|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750309|NCT05293132|Vitamins|vitamins|mesh-ancestor
44750310|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
44750311|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
44750312|NCT05293119|Tofacitinib|tofacitinib|mesh-list
44750313|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750314|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750315|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44750316|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44750317|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750318|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750319|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44750320|NCT05296863|Minoxidil|minoxidil|mesh-list
44750321|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44750322|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
44750323|NCT05296564|Aldesleukin|aldesleukin|mesh-list
44750324|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
44750325|NCT05296564|Interleukin-2|interleukin-2|mesh-list
44750326|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750327|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
44750328|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750329|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279448|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
44750330|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44750331|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
44750332|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750333|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750334|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44750335|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750336|NCT05296564|Analgesics|analgesics|mesh-ancestor
44750337|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
44750338|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750339|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44750340|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44750341|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
44750342|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750343|NCT05296369|Folic Acid|folic acid|mesh-list
44750344|NCT05296369|Hematinics|hematinics|mesh-ancestor
44750345|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
44750346|NCT05296369|Vitamins|vitamins|mesh-ancestor
44750347|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
44750348|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750349|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
44750350|NCT05296317|Epirubicin|epirubicin|mesh-list
44750351|NCT05296317|Lenograstim|lenograstim|mesh-list
44750352|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750353|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
44750354|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750355|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750356|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44750357|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
44750358|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750359|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750360|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44750361|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44750362|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44750363|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44750364|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44750365|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750366|NCT05296005|Leucovorin|leucovorin|mesh-list
44750367|NCT05296005|Docetaxel|docetaxel|mesh-list
44750368|NCT05296005|Fluorouracil|fluorouracil|mesh-list
44750369|NCT05296005|Capecitabine|capecitabine|mesh-list
44750370|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
44750371|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750372|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750373|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750374|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750375|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750376|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
44750377|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44750378|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750379|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
44750380|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750381|NCT05296005|Antidotes|antidotes|mesh-ancestor
44750382|NCT05296005|Protective Agents|protective agents|mesh-ancestor
44750383|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
44750384|NCT05296005|Vitamins|vitamins|mesh-ancestor
44750385|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
44750386|NCT05295836|Glycerol|glycerol|mesh-list
44750387|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44750388|NCT05295836|Protective Agents|protective agents|mesh-ancestor
44750389|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750390|NCT05295537|Liver Extracts|liver extracts|mesh-list
44750391|NCT05295537|Hematinics|hematinics|mesh-ancestor
44750392|NCT05294900|Paclitaxel|paclitaxel|mesh-list
44750393|NCT05294900|Carboplatin|carboplatin|mesh-list
44750394|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44750395|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750396|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750397|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750398|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750399|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750401|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750402|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750403|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750404|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44750405|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44750406|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750407|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463520|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44750408|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44750409|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750410|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750411|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
44750412|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750413|NCT05275491|Calcium|calcium|mesh-list
44750414|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
44750415|NCT05275491|Hormones|hormones|mesh-list
44750416|NCT05275491|Mitogens|mitogens|mesh-list
44750417|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750418|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750419|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750420|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750421|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750422|NCT05273996|Bupropion|bupropion|mesh-list
44750423|NCT05273996|Sertraline|sertraline|mesh-list
44750424|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44750425|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44750426|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44750427|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750428|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44750429|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44750430|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750431|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750432|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
44750433|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750434|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750435|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44750436|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44750437|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750438|NCT05273996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44750439|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
44279515|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750440|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44750441|NCT05273242|Artesunate|artesunate|mesh-list
44750442|NCT05273242|Infliximab|infliximab|mesh-list
44750443|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750444|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750445|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750446|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750447|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
44750448|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44750449|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44750450|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750451|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
44750452|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
44750453|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44750454|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
44750455|NCT05269095|Anesthetics|anesthetics|mesh-list
44750456|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750457|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750458|NCT05267938|Lidocaine|lidocaine|mesh-list
44750459|NCT05267938|Epinephrine|epinephrine|mesh-list
44750460|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
44750461|NCT05267938|Anesthetics|anesthetics|mesh-list
44750462|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750463|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750464|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
44750465|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750466|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44750467|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44750468|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44750469|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750470|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750471|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44750473|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750474|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750475|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44750476|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44750477|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
44279530|NCT00726700|Prednisone|prednisone|mesh-list
44750478|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44750479|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750480|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
44750481|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
44750482|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44750483|NCT05267431|Methotrexate|methotrexate|mesh-list
44750484|NCT05267431|Hydroquinone|hydroquinone|mesh-list
44750485|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44750486|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
44750487|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44750488|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750489|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44750490|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
44750491|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750492|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750493|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750494|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750495|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44750496|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750497|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
44750498|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750499|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44750500|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
44750501|NCT05267431|Protective Agents|protective agents|mesh-ancestor
44750502|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44750503|NCT05266248|Caffeine|caffeine|mesh-list
44750504|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44750505|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750506|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44750507|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750508|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750509|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44750510|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44750511|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
44750512|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750513|NCT05264896|Leucovorin|leucovorin|mesh-list
44750514|NCT05264896|Docetaxel|docetaxel|mesh-list
44750515|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
44750516|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750517|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750518|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750519|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750520|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750521|NCT05264896|Antidotes|antidotes|mesh-ancestor
44750522|NCT05264896|Protective Agents|protective agents|mesh-ancestor
44750523|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750524|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
44750525|NCT05264896|Vitamins|vitamins|mesh-ancestor
44750526|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
44750527|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
44750528|NCT05264584|Febuxostat|febuxostat|mesh-list
44750529|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44750530|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
44750531|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750532|NCT05264584|Expectorants|expectorants|mesh-ancestor
44750533|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750534|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44750535|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
44750536|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750537|NCT05264584|Protective Agents|protective agents|mesh-ancestor
44750538|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750539|NCT05264584|Antidotes|antidotes|mesh-ancestor
44750540|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
44750541|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750542|NCT05262686|Aldesleukin|aldesleukin|mesh-list
44750543|NCT05262686|Interleukin-2|interleukin-2|mesh-list
44750544|NCT05262686|Belimumab|belimumab|mesh-list
44750545|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750546|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750547|NCT05262686|Analgesics|analgesics|mesh-ancestor
44750548|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
44527850|NCT00477412|Rituximab|rituximab|mesh-list
44750549|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750550|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750551|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750552|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
44750553|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44750554|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44750555|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
44750556|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688377|NCT02855697|Cediranib|cediranib|mesh-list
44688378|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44688379|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688380|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688381|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688382|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688383|NCT02607319|Bemiparin|bemiparin|mesh-list
44688384|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
44688385|NCT02562599|Cisplatin|cisplatin|mesh-list
44688386|NCT02562599|Raltitrexed|raltitrexed|mesh-list
44688387|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688388|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44688389|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
44688390|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688391|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44688392|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688393|NCT02456012|Esomeprazole|esomeprazole|mesh-list
44688394|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44688395|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44688396|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44688397|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688398|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688399|NCT02250157|Irinotecan|irinotecan|mesh-list
44688400|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44688401|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44688402|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688403|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688404|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688405|NCT02225405|Cisplatin|cisplatin|mesh-list
44688406|NCT02225405|Docetaxel|docetaxel|mesh-list
44688407|NCT02225405|Nintedanib|nintedanib|mesh-list
44688408|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688409|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44688410|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44688411|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774263|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688412|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688413|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688414|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688415|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
44688416|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
44688417|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688418|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
44688419|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688420|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688421|NCT01431508|Losartan|losartan|mesh-list
44688422|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44688423|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44688424|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44688425|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44688426|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688427|NCT00871351|Atorvastatin|atorvastatin|mesh-list
44688428|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44688429|NCT00871351|Ezetimibe|ezetimibe|mesh-list
44688430|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688431|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688432|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
44688433|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688434|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688435|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688436|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688437|NCT00832455|Montelukast|montelukast|mesh-list
44688438|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44688439|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
44527923|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44750557|NCT05238506|Lidocaine|lidocaine|mesh-list
44750558|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
44463559|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750559|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
44750560|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750561|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750562|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
44750563|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750564|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44750565|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44750566|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44750567|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750568|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750569|NCT05236608|Nivolumab|nivolumab|mesh-list
44750570|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750571|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750572|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44750573|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750574|NCT05225402|Norepinephrine|norepinephrine|mesh-list
44750575|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44750576|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44750577|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750578|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750579|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750580|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750581|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
44750582|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
44750583|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750584|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44750585|NCT05220826|Ethanol|ethanol|mesh-list
44750586|NCT05220826|Ethylene|ethylene|mesh-list
44750587|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44750588|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750589|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750590|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750591|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44750592|NCT05220826|Growth Substances|growth substances|mesh-ancestor
44750593|NCT05215548|Afatinib|afatinib|mesh-list
44750594|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750595|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44750596|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750597|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750598|NCT05210413|Spartalizumab|spartalizumab|mesh-list
44750599|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44750600|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750601|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750602|NCT05203705|Enoxaparin|enoxaparin|mesh-list
44750603|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
44750604|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44750605|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44750606|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750607|NCT05202561|Vaccines|vaccines|mesh-list
44750608|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
44750609|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750610|NCT05192629|Midazolam|midazolam|mesh-list
44750611|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
44750612|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44750613|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750614|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750615|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750616|NCT05192629|Analgesics|analgesics|mesh-ancestor
44750617|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
44750618|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750619|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44750620|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44750621|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44750622|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44750623|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750624|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750625|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44750626|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44750627|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750628|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750629|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750630|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
44750631|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
44750632|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
44750633|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
44750634|NCT05189444|Amoxicillin|amoxicillin|mesh-list
44750635|NCT05189444|Clarithromycin|clarithromycin|mesh-list
44186560|NCT00337051|Propofol|propofol|mesh-list
44750636|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
44750637|NCT05189444|Esomeprazole|esomeprazole|mesh-list
44750638|NCT05189444|Bismuth|bismuth|mesh-list
44750639|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750640|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750641|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750642|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44750643|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750644|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44750645|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750646|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44750647|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44750648|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44750649|NCT05189444|Antacids|antacids|mesh-ancestor
44750650|NCT05189444|Diuretics|diuretics|mesh-ancestor
44750651|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
44750652|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750653|NCT05189444|Expectorants|expectorants|mesh-ancestor
44750654|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750655|NCT05180006|Bevacizumab|bevacizumab|mesh-list
44750656|NCT05180006|Trastuzumab|trastuzumab|mesh-list
44750657|NCT05180006|Pertuzumab|pertuzumab|mesh-list
44750658|NCT05180006|Atezolizumab|atezolizumab|mesh-list
44750659|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750660|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750661|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44750662|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44750663|NCT05180006|Growth Substances|growth substances|mesh-ancestor
44750664|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750665|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44750666|NCT05175274|Colchicine|colchicine|mesh-list
44750667|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
44750668|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750669|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750670|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750671|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750672|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750673|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750674|NCT05169268|Aripiprazole|aripiprazole|mesh-list
44750675|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
44750676|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44750677|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750678|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44750679|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750680|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750681|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750682|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
44750683|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
44750684|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750685|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279787|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44750686|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44750687|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44750688|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
44750689|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44750690|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44750691|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44750692|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44750693|NCT05217706|Ketamine|ketamine|mesh-list
44750694|NCT05217706|Analgesics|analgesics|mesh-ancestor
44750695|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
44750696|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750697|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750698|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44750699|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750700|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
44750701|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
44750702|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750703|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44750704|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44750705|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750706|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750707|NCT05159427|Glipizide|glipizide|mesh-list
44750709|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750710|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750711|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750712|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750713|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750714|NCT05150795|Pregabalin|pregabalin|mesh-list
44750715|NCT05150795|Fentanyl|fentanyl|mesh-list
44279803|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44279805|NCT04406727|UB-421|ub-421|mesh-list
44750716|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44750717|NCT05150795|Narcotics|narcotics|mesh-ancestor
44750718|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750719|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750720|NCT05150795|Analgesics|analgesics|mesh-ancestor
44750721|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
44750722|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750723|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44750724|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750725|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
44750726|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
44750727|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
44750728|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44750729|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750730|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750731|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750732|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44279836|NCT04254627|Analgesics|analgesics|mesh-ancestor
44750733|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750734|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750735|NCT05129137|Acetaminophen|acetaminophen|mesh-list
44750736|NCT05129137|Nefopam|nefopam|mesh-list
44750737|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750738|NCT05129137|Analgesics|analgesics|mesh-ancestor
44750739|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
44750740|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750741|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750742|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
44750743|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
44750744|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750745|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750746|NCT05110898|Olmesartan|olmesartan|mesh-list
44750747|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44750748|NCT05110898|Indapamide|indapamide|mesh-list
44750749|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44750750|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44750751|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44750752|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750753|NCT05110898|Diuretics|diuretics|mesh-ancestor
44750754|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
44750755|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750756|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44750757|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750758|NCT05103696|Propofol|propofol|mesh-list
44750759|NCT05103696|Etomidate|etomidate|mesh-list
44750760|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44750761|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750762|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750763|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44750764|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
44750765|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
44750766|NCT05098041|Rifampin|rifampin|mesh-list
44750767|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44750768|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
44750769|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750770|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750771|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
44750772|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44750773|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750774|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750775|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44279881|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
44750776|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44750777|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44750778|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44750779|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44750780|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44750781|NCT05096325|Insulin|insulin|mesh-list
44750782|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750783|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750784|NCT05096065|Leuprolide|leuprolide|mesh-list
44750785|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44750786|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
44750787|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44750788|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750789|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279893|NCT04213794|Protective Agents|protective agents|mesh-ancestor
44750790|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528155|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44528156|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44528157|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528158|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528159|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528160|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
44528161|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44528163|NCT01085812|Analgesics|analgesics|mesh-ancestor
44750791|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44750792|NCT05083572|Rifaximin|rifaximin|mesh-list
44750793|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750794|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750795|NCT05057273|Adalimumab|adalimumab|mesh-list
44750796|NCT05057273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750797|NCT05057273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750798|NCT05039476|Vitamin A|vitamin a|mesh-list
44750799|NCT05039476|Vitamins|vitamins|mesh-ancestor
44750800|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
44750801|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934365|NCT00796705|Adalimumab|adalimumab|mesh-list
44750802|NCT05033743|Secnidazole|secnidazole|mesh-list
44750803|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44750804|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44750805|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750806|NCT05030025|Lamivudine|lamivudine|mesh-list
44750807|NCT05030025|Abacavir|abacavir|mesh-list
44750808|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
44750809|NCT05030025|Dolutegravir|dolutegravir|mesh-list
44750810|NCT05030025|Triumeq|triumeq|mesh-list
44750811|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44750812|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44750813|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750814|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750815|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
44750816|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750817|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44750818|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44750819|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44750820|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44750821|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
44750822|NCT05013567|Ibuprofen|ibuprofen|mesh-list
44750823|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44750824|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750825|NCT05013567|Analgesics|analgesics|mesh-ancestor
44750826|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
44750827|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750828|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750829|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750830|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750831|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44750832|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750833|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750834|NCT05008926|Naloxegol|naloxegol|mesh-list
44750835|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44750836|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463611|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44463612|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750837|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
44750838|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750839|NCT04989621|Rituximab|rituximab|mesh-list
44750840|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750841|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750842|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
44750843|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750844|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750845|NCT04989049|Folic Acid|folic acid|mesh-list
44750846|NCT04989049|Hematinics|hematinics|mesh-ancestor
44750847|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44750848|NCT04989049|Vitamins|vitamins|mesh-ancestor
44750849|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
44750850|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750851|NCT04984044|Vitamin D|vitamin d|mesh-list
44750852|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
44750853|NCT04984044|Vitamins|vitamins|mesh-ancestor
44750854|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
44750855|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750856|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44750857|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44750858|NCT04981912|Rituximab|rituximab|mesh-list
44750859|NCT04981912|Venetoclax|venetoclax|mesh-list
44750860|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44750861|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750862|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
44750863|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750864|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44750865|NCT04975802|Caffeine|caffeine|mesh-list
44750866|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44750867|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750868|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44750869|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750870|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750871|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44750873|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
44187301|NCT00343265|Hormones|hormones|mesh-ancestor
44750874|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750875|NCT04973930|Citalopram|citalopram|mesh-list
44750876|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44750877|NCT04973930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44750878|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44750879|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750880|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750881|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750882|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
44750883|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750884|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44750885|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
44750886|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750887|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44750888|NCT04972552|Ubiquinone|ubiquinone|mesh-list
44750889|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
44750890|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
44279944|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
44750891|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750892|NCT04972552|Vitamins|vitamins|mesh-ancestor
44750893|NCT04964700|Natalizumab|natalizumab|mesh-list
44750894|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
44750895|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750896|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44750897|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
44750898|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750899|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44750900|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44750901|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44750902|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750903|NCT04940767|Minocycline|minocycline|mesh-list
44279951|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750904|NCT04940767|Isotretinoin|isotretinoin|mesh-list
44750905|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750906|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750907|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750908|NCT04936854|Sirolimus|sirolimus|mesh-list
44750909|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
44750910|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44750911|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44750912|NCT04936854|Prednisolone|prednisolone|mesh-list
44750913|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
44750914|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44750915|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
44750916|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44750917|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44750918|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44750919|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750920|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
44750921|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44750922|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
44750923|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279982|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44750924|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44750925|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
44750926|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
44750927|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750928|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44750929|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
44750930|NCT04936854|Hormones|hormones|mesh-ancestor
44750931|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750932|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44750933|NCT04936854|Protective Agents|protective agents|mesh-ancestor
44750934|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528286|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
44750935|NCT04926181|Androgens|androgens|mesh-list
44750936|NCT04926181|Hormones|hormones|mesh-ancestor
44750937|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750938|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750939|NCT04921527|Paclitaxel|paclitaxel|mesh-list
44750940|NCT04921527|Chiauranib|chiauranib|mesh-list
44750941|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44750942|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750943|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44750944|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44750945|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44750946|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750947|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44750948|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750949|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
44750950|NCT04899843|Astringents|astringents|mesh-ancestor
44750951|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750952|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
44750953|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
44750954|NCT04899687|Fluoxetine|fluoxetine|mesh-list
44750955|NCT04899687|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44750956|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44750957|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44750958|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44750959|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44750960|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
44750961|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750962|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44750963|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
44750964|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44750965|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44750966|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44750967|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44750968|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
44750969|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44750970|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44750971|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44750972|NCT04897802|Exenatide|exenatide|mesh-list
44750973|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44750974|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280004|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
44750975|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44750976|NCT04897802|Incretins|incretins|mesh-ancestor
44750977|NCT04897802|Hormones|hormones|mesh-ancestor
44750978|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44750979|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
44750980|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44750981|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
44750982|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
44750983|NCT04882332|Vitamins|vitamins|mesh-ancestor
44750984|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
44750985|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750986|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
44750987|NCT04882332|Hematinics|hematinics|mesh-ancestor
44750988|NCT04882202|Acetaminophen|acetaminophen|mesh-list
44750989|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44750990|NCT04882202|Analgesics|analgesics|mesh-ancestor
44750991|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
44750992|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44750993|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44750994|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
44750995|NCT04871425|Fentanyl|fentanyl|mesh-list
44750996|NCT04871425|Ketamine|ketamine|mesh-list
44750997|NCT04871425|Analgesics|analgesics|mesh-ancestor
44750998|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
44750999|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751000|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751001|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44751002|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44751003|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
44751004|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
44751005|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751006|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44528363|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
44751007|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44751008|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454798|NCT01658943|Fluorouracil|fluorouracil|mesh-list
44751009|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751010|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44751011|NCT04871425|Narcotics|narcotics|mesh-ancestor
44751012|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44751013|NCT04869605|Chrysarobin|chrysarobin|mesh-list
44751014|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44751015|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751016|NCT04869605|Analgesics|analgesics|mesh-ancestor
44751017|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
44751018|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751019|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751020|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280075|NCT03491540|Gentamicins|gentamicins|mesh-list
44751021|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751023|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751024|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751025|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751026|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751027|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44751028|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
44751029|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44751030|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44751031|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44751032|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751033|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751034|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44751035|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751036|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751037|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44751038|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751039|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44751040|NCT04800107|Curcumin|curcumin|mesh-list
44751041|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44751042|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751043|NCT04800107|Analgesics|analgesics|mesh-ancestor
44751044|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
44751045|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751046|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280093|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751047|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751048|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751049|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751050|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751051|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751052|NCT04793867|Xenon|xenon|mesh-list
44751053|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44751054|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
44751055|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
44751056|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751057|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751058|NCT04774315|Omalizumab|omalizumab|mesh-list
44751059|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44751060|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44751061|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
44751062|NCT04767503|Propofol|propofol|mesh-list
44751063|NCT04767503|Desflurane|desflurane|mesh-list
44751064|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44751065|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751066|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751067|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44751068|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
44751069|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
44751070|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44751071|NCT04763564|Liraglutide|liraglutide|mesh-list
44751072|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44751073|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751074|NCT04763564|Incretins|incretins|mesh-ancestor
44751075|NCT04763564|Hormones|hormones|mesh-ancestor
44751076|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751077|NCT04762888|Edetic Acid|edetic acid|mesh-list
44751078|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44751079|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
44751080|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
44751081|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751082|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
44751083|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44751084|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44751085|NCT04762199|Osimertinib|osimertinib|mesh-list
44751086|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751087|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751088|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751089|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751090|NCT04760496|Oxytocin|oxytocin|mesh-list
44751091|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
44751092|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44751093|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751094|NCT04750967|Lidocaine|lidocaine|mesh-list
44751095|NCT04750967|Amitriptyline|amitriptyline|mesh-list
44751096|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751097|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
44751098|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751099|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751100|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
44751101|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751102|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44751103|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44751104|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44751105|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751106|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751107|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44751108|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44751109|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44751110|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751111|NCT04750967|Analgesics|analgesics|mesh-ancestor
44751112|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44751113|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44751114|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
44751115|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751116|NCT04733547|Furosemide|furosemide|mesh-list
44751117|NCT04733547|Diuretics|diuretics|mesh-ancestor
44751118|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
44751119|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751120|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44751121|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751122|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528509|NCT01089790|Incretins|incretins|mesh-ancestor
44528510|NCT01089790|Hormones|hormones|mesh-ancestor
44774264|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44528511|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528512|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44528513|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528514|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528515|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006008|NCT02415712|Fomepizole|fomepizole|mesh-list
44751123|NCT04722679|Anticoagulants|anticoagulants|mesh-list
44751124|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
44751125|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751126|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
44751127|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751128|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751129|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44751130|NCT04696380|Nicotine|nicotine|mesh-list
44751131|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44751132|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
44280183|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751133|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751134|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751135|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44751136|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44751137|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44751138|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751139|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751140|NCT04672772|Paclitaxel|paclitaxel|mesh-list
44751141|NCT04672772|Cetuximab|cetuximab|mesh-list
44751142|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44751143|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751144|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44751145|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44751146|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44751147|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751148|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751149|NCT04671082|Tolperisone|tolperisone|mesh-list
44751150|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44751151|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751152|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44751153|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751154|NCT04669587|Palbociclib|palbociclib|mesh-list
44751155|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751156|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751157|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751158|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751159|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
44751160|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44751161|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
44751162|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751163|NCT04659382|Bevacizumab|bevacizumab|mesh-list
44751164|NCT04659382|Atezolizumab|atezolizumab|mesh-list
44751165|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751166|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751167|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44751168|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751169|NCT04659382|Growth Substances|growth substances|mesh-ancestor
44751170|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751171|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
44751172|NCT04658823|Vitamin E|vitamin e|mesh-list
44751173|NCT04658823|Tocopherols|tocopherols|mesh-list
44751174|NCT04658823|Tocotrienols|tocotrienols|mesh-list
44751175|NCT04658823|Tocovid|tocovid|mesh-list
44751176|NCT04658823|Vitamins|vitamins|mesh-ancestor
44751177|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
44751178|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751179|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
44751180|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751181|NCT04658823|Protective Agents|protective agents|mesh-ancestor
44751182|NCT04657016|Tirzepatide|tirzepatide|mesh-list
44751183|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44751184|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751185|NCT04657016|Incretins|incretins|mesh-ancestor
44751186|NCT04657016|Hormones|hormones|mesh-ancestor
44751187|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751188|NCT04655144|Dexamethasone|dexamethasone|mesh-list
44751189|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751190|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
44751191|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
44751192|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751193|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751194|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751195|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
44751196|NCT04655144|Hormones|hormones|mesh-ancestor
44751197|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751198|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688440|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44751199|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751200|NCT04648241|Vaccines|vaccines|mesh-list
44751201|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
44751202|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751203|NCT04640818|Rituximab|rituximab|mesh-list
44751204|NCT04640818|Cladribine|cladribine|mesh-list
44751205|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
44751206|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751207|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751208|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
44280214|NCT00727077|Interferons|interferons|mesh-list
44751209|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751210|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751211|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44688441|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
44688442|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688443|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688444|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44688445|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44688446|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688447|NCT00812006|Rizatriptan|rizatriptan|mesh-list
44688448|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44688449|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
44688450|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688451|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688452|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688453|NCT00739050|Simvastatin|simvastatin|mesh-list
44688454|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688455|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688456|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
44688457|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688458|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688459|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688460|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688461|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
44688462|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688463|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44688464|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688465|NCT00654628|Simvastatin|simvastatin|mesh-list
44688466|NCT00654628|Ezetimibe|ezetimibe|mesh-list
44688467|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688468|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688469|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
44688470|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688471|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688472|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688473|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688474|NCT00604812|Rizatriptan|rizatriptan|mesh-list
44688475|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44688476|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
44688477|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688478|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688479|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688480|NCT00536380|Loratadine|loratadine|mesh-list
44688481|NCT00536380|Desloratadine|desloratadine|mesh-list
44688482|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44688483|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44688484|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688485|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280260|NCT00727727|Piribedil|piribedil|mesh-list
44688486|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688487|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44688488|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44688489|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
44688490|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
44688491|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
44688492|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
44688493|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688494|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
44688495|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688497|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688498|NCT00496834|Losartan|losartan|mesh-list
44688499|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44688500|NCT00496834|Carvedilol|carvedilol|mesh-list
44688501|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44280282|NCT00727831|Leucovorin|leucovorin|mesh-list
44688502|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44688503|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44751212|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
44751213|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44751214|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751215|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44751216|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751217|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
44751218|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44751219|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751220|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751221|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751222|NCT04635098|Analgesics|analgesics|mesh-ancestor
44751223|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
44751224|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751225|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44751226|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44751227|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44751228|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44751229|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751230|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528602|NCT01086540|Acetaminophen|acetaminophen|mesh-list
44751231|NCT04602078|Gemcitabine|gemcitabine|mesh-list
44751232|NCT04602078|Cisplatin|cisplatin|mesh-list
44751233|NCT04602078|Atezolizumab|atezolizumab|mesh-list
44751234|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751235|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44751236|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
44751237|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751238|NCT04602078|Antiviral Agents|antiviral agents|mesh-ancestor
44751239|NCT04602078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751240|NCT04602078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751241|NCT04602078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751242|NCT04602078|Immunologic Factors|immunologic factors|mesh-ancestor
44751243|NCT04602078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751244|NCT04588857|Dexamethasone|dexamethasone|mesh-list
44751245|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751246|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
44751247|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
44751248|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751249|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751250|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751251|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
44751252|NCT04588857|Hormones|hormones|mesh-ancestor
44774265|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
44751253|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751254|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44751255|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751256|NCT04577001|Letrozole|letrozole|mesh-list
44751257|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751258|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44751259|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44751260|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751261|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751262|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44751263|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
44751264|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751265|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751266|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
44751267|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
44751268|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280340|NCT00727987|Golimumab|golimumab|mesh-list
44751269|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751270|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751271|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
44751272|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
44751273|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
44751274|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751275|NCT04564885|Meloxicam|meloxicam|mesh-list
44751276|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44751277|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751278|NCT04564885|Analgesics|analgesics|mesh-ancestor
44751279|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
44751280|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751281|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751282|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751283|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751284|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44751285|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44751286|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751287|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751288|NCT04564443|Calcium|calcium|mesh-list
44751289|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44751290|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751291|NCT04562831|Niacinamide|niacinamide|mesh-list
44751292|NCT04562831|Niacin|niacin|mesh-list
44751293|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
44751294|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
44751295|NCT04562831|Vitamins|vitamins|mesh-ancestor
44751296|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
44280359|NCT00728000|Gemcitabine|gemcitabine|mesh-list
44751297|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751298|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44751299|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
44751300|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751301|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44751302|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
44751303|NCT04561375|Fentanyl|fentanyl|mesh-list
44751304|NCT04561375|Sufentanil|sufentanil|mesh-list
44751305|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44528683|NCT04997759|Neostigmine|neostigmine|mesh-list
44751306|NCT04561375|Narcotics|narcotics|mesh-ancestor
44751307|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751308|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751309|NCT04561375|Analgesics|analgesics|mesh-ancestor
44751310|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
44751311|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751312|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44280384|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751313|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44751314|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
44751315|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
44751316|NCT04560972|Carboplatin|carboplatin|mesh-list
44751317|NCT04560972|Etoposide|etoposide|mesh-list
44751318|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
44751319|NCT04560972|Atezolizumab|atezolizumab|mesh-list
44751320|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
44751321|NCT04560972|LB100|lb100|mesh-list
44751322|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44751323|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751324|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44751325|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44751326|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44751327|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751328|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751329|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
44751330|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751331|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
44751332|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
44751333|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
44751334|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
44751335|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
44751336|NCT04548648|Isavuconazole|isavuconazole|mesh-list
44751337|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
44751338|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751339|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
44751340|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751341|NCT04545242|Dexamethasone|dexamethasone|mesh-list
44751342|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751343|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
44751344|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
44751345|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751346|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751347|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751348|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
44751349|NCT04545242|Hormones|hormones|mesh-ancestor
44751350|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751351|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44751352|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751353|NCT04542980|Autoantibodies|autoantibodies|mesh-list
44751354|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
44751355|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751356|NCT04529499|Favipiravir|favipiravir|mesh-list
44751357|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
44751358|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751359|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
44751360|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44751361|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751362|NCT04526132|Analgesics|analgesics|mesh-ancestor
44751363|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
44751364|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751365|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751366|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751367|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751368|NCT04523428|Venetoclax|venetoclax|mesh-list
44688504|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44688505|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688506|NCT00496834|Diuretics|diuretics|mesh-ancestor
44688507|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
44688508|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688509|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44688510|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688511|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44688512|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44688513|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688514|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688515|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
44688516|NCT00496834|Protective Agents|protective agents|mesh-ancestor
44688517|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44528755|NCT04991103|Dexamethasone|dexamethasone|mesh-list
44751369|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
44751370|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751371|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44751372|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44751373|NCT04521920|Narcotics|narcotics|mesh-ancestor
44751374|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751375|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751376|NCT04521920|Analgesics|analgesics|mesh-ancestor
44751377|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
44751378|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751379|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44751380|NCT04520776|Meloxicam|meloxicam|mesh-list
44751381|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44751382|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751383|NCT04520776|Analgesics|analgesics|mesh-ancestor
44751384|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
44751385|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751386|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751387|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751388|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751389|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44751390|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44751391|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751392|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751393|NCT04508504|Ropivacaine|ropivacaine|mesh-list
44751394|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
44528815|NCT04996823|Ipilimumab|ipilimumab|mesh-list
44751395|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
44751396|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751397|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751398|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
44751399|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751400|NCT04505280|Lidocaine|lidocaine|mesh-list
44280499|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751401|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751402|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
44751403|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751404|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751405|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
44751406|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751407|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44751408|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44751409|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44751410|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751411|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751412|NCT04490707|Lenalidomide|lenalidomide|mesh-list
44751413|NCT04490707|Azacitidine|azacitidine|mesh-list
44751414|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
44751415|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751416|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44751417|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751418|NCT04490707|Growth Substances|growth substances|mesh-ancestor
44751419|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528816|NCT04996823|Axitinib|axitinib|mesh-list
44528817|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528818|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528819|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44528820|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528821|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44528822|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528823|NCT04996771|Cisplatin|cisplatin|mesh-list
44528824|NCT04996771|Etoposide|etoposide|mesh-list
44528825|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
44528826|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528827|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44528828|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44528829|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44463719|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
44190021|NCT00353145|Antiviral Agents|antiviral agents|mesh-ancestor
44528830|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528831|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528832|NCT04995653|Vancomycin|vancomycin|mesh-list
44528833|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44528834|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528835|NCT04993677|Carboplatin|carboplatin|mesh-list
44528836|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
44528837|NCT04993677|Pemetrexed|pemetrexed|mesh-list
44751420|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751421|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44751422|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
44751423|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751424|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751425|NCT04484350|Enalapril|enalapril|mesh-list
44751426|NCT04484350|Labetalol|labetalol|mesh-list
44751427|NCT04484350|Hydralazine|hydralazine|mesh-list
44751428|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44751429|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
44751430|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751431|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751432|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44751433|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44463731|NCT01506609|Paclitaxel|paclitaxel|mesh-list
44751434|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44751435|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
44751436|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751437|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751438|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
44751439|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
44751440|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751441|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44751442|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44463750|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
44280503|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
44751443|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
44751444|NCT04464577|Itraconazole|itraconazole|mesh-list
44751445|NCT04464577|Fluconazole|fluconazole|mesh-list
44751446|NCT04464577|Bupropion|bupropion|mesh-list
44751447|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44751448|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
44751449|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44751450|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44751451|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44751452|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751453|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751454|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
44751455|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751456|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751457|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44751458|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44751459|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751460|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
44751461|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751462|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44751463|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44751464|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
44751465|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751466|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44751467|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44751468|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44751469|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
44751470|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751471|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751472|NCT04430855|Upadacitinib|upadacitinib|mesh-list
44751473|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44751474|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751475|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751476|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751477|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751478|NCT04430517|Niacinamide|niacinamide|mesh-list
44751479|NCT04430517|Niacin|niacin|mesh-list
44751480|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
44751481|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
44751482|NCT04430517|Vitamins|vitamins|mesh-ancestor
44751483|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
44751484|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751485|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44751486|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
44751487|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751488|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44751489|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
44751490|NCT04417361|Erenumab|erenumab|mesh-list
44751491|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44751492|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751493|NCT04417361|Analgesics|analgesics|mesh-ancestor
44751494|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
44751495|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751496|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528941|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44751497|NCT04402658|Albuterol|albuterol|mesh-list
44751498|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44751499|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
44751500|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751501|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751502|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44751503|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
44751504|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
44751505|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44751506|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44751507|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44751508|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44751509|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280566|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751510|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751511|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751512|NCT04391179|Dipyridamole|dipyridamole|mesh-list
44751513|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44751514|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751515|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751516|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44751517|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
44751518|NCT04375683|HH-GV-678|hh-gv-678|mesh-list
44751519|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751520|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774266|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751521|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751522|NCT04356742|Metformin|metformin|mesh-list
44751523|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
44751524|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44751525|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751526|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44751527|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751528|NCT04353284|Gabexate|gabexate|mesh-list
44280586|NCT00729404|Progestins|progestins|mesh-ancestor
44751529|NCT04353284|Camostat|camostat|mesh-list
44751530|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44751531|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751532|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751533|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44751534|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44751535|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
44751536|NCT04348864|Antibodies|antibodies|mesh-list
44751537|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
44751538|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751539|NCT04344262|Atracurium|atracurium|mesh-list
44751540|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44751541|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44688518|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44688519|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
44688520|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44774267|NCT01847872|Vaccines|vaccines|mesh-list
44688521|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44688522|NCT00442897|Atorvastatin|atorvastatin|mesh-list
44688523|NCT00442897|Simvastatin|simvastatin|mesh-list
44688524|NCT00442897|Ezetimibe|ezetimibe|mesh-list
44688525|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688526|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688527|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
44688528|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688529|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688530|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688531|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688532|NCT00423579|Simvastatin|simvastatin|mesh-list
44688533|NCT00423579|Ezetimibe|ezetimibe|mesh-list
44280607|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44688534|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44688535|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44688536|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44688537|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
44688538|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688539|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44688540|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44688541|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688542|NCT00394355|Fluticasone|fluticasone|mesh-list
44688543|NCT00394355|Xhance|xhance|mesh-list
44688544|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
44688545|NCT00394355|Montelukast|montelukast|mesh-list
44688546|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751542|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44751543|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751544|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751545|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44751546|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44751547|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
44751548|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751549|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751550|NCT04328012|Losartan|losartan|mesh-list
44751551|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44751552|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44751553|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44751554|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44280638|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280646|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
44751555|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751556|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
44751557|NCT04321993|Remdesivir|remdesivir|mesh-list
44751558|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44751559|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751560|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
44751561|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751562|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751563|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751564|NCT04310150|Hemostatics|hemostatics|mesh-list
44751565|NCT04310150|Coagulants|coagulants|mesh-ancestor
44751566|NCT04305444|Everolimus|everolimus|mesh-list
44751567|NCT04305444|Pomalidomide|pomalidomide|mesh-list
44751568|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751569|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751570|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
44751571|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751572|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44751573|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751574|NCT04305444|Growth Substances|growth substances|mesh-ancestor
44751575|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
44751576|NCT04298983|Androgens|androgens|mesh-list
44751577|NCT04298983|Hormones|hormones|mesh-ancestor
44751578|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751579|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751580|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44751581|NCT04294147|Erenumab|erenumab|mesh-list
44751582|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44751583|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751584|NCT04294147|Analgesics|analgesics|mesh-ancestor
44751585|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
44751586|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751587|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751588|NCT04292873|Vitamin D|vitamin d|mesh-list
44751589|NCT04292873|Vitamins|vitamins|mesh-ancestor
44751590|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
44751591|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751592|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44751593|NCT04264637|Azelastine|azelastine|mesh-list
44751594|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44751595|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
44751596|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751597|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751598|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44774268|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
44280685|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
44751599|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44751600|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44751601|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751602|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751603|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44751604|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44529062|NCT02211482|Lamivudine|lamivudine|mesh-list
44529063|NCT02211482|Dolutegravir|dolutegravir|mesh-list
44529064|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44529065|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529066|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529067|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529068|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
44529069|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529070|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44529071|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44529072|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44529073|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44751605|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44751606|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
44751607|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
44751608|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751609|NCT04262687|Bevacizumab|bevacizumab|mesh-list
44751610|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
44280710|NCT00729950|Ipilimumab|ipilimumab|mesh-list
44751611|NCT04262687|Capecitabine|capecitabine|mesh-list
44751612|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
44751613|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751614|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751615|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44751616|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751617|NCT04262687|Growth Substances|growth substances|mesh-ancestor
44751618|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751619|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
44751620|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44751621|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
44751622|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751623|NCT04238546|Sirolimus|sirolimus|mesh-list
44280712|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751624|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44751625|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751626|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44751627|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751628|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
44751629|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751630|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
44751631|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751632|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44751633|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751634|NCT04233801|Empagliflozin|empagliflozin|mesh-list
44751635|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44751636|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751637|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44280725|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280726|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751638|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751639|NCT04233112|Melatonin|melatonin|mesh-list
44751640|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
44751641|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751642|NCT04233112|Protective Agents|protective agents|mesh-ancestor
44751643|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751644|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751645|NCT04224558|Acetaminophen|acetaminophen|mesh-list
44280742|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
44751646|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
44751647|NCT04224558|Promethazine|promethazine|mesh-list
44751648|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
44751649|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44751650|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
44751651|NCT04224558|Fludarabine|fludarabine|mesh-list
44751652|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
44751653|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44751654|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
44751655|NCT04224558|Antibodies|antibodies|mesh-list
44751656|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
44751657|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44751658|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44751659|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751660|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
44751661|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751662|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751663|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44751664|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
44751665|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751666|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751667|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44751668|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44751669|NCT04224558|Analgesics|analgesics|mesh-ancestor
44751670|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
44751671|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751672|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
44751673|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751674|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
44751675|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
44751676|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751677|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
44751678|NCT04224558|Hormones|hormones|mesh-ancestor
44751679|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751680|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44751681|NCT04224558|Protective Agents|protective agents|mesh-ancestor
44751682|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44751683|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44751684|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44751685|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280771|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
44751686|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751687|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
44751688|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44751689|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
44751690|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
44751691|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751692|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44751693|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
44751694|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44751695|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
44751696|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44751697|NCT04223570|Levulinic acid|levulinic acid|mesh-list
44751698|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44751699|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
44751700|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751701|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751702|NCT04200651|Dexamethasone|dexamethasone|mesh-list
44751703|NCT04200651|Prednisolone|prednisolone|mesh-list
44751704|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44751705|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
44751706|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44751707|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
44751708|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44751709|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
44751710|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751711|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
44751712|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
44751713|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751714|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751715|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280805|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
44751716|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
44751717|NCT04200651|Hormones|hormones|mesh-ancestor
44751718|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751719|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44751720|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751721|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44751722|NCT04200651|Protective Agents|protective agents|mesh-ancestor
44751723|NCT04187833|Nivolumab|nivolumab|mesh-list
44751724|NCT04187833|Talazoparib|talazoparib|mesh-list
44280811|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
44751725|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751726|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751727|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44751728|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751729|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44751730|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751731|NCT04183205|Sertraline|sertraline|mesh-list
44751732|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
44751733|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44751734|NCT04183205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44751735|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44751736|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751737|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751738|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751739|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
44751740|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751741|NCT04180085|Abatacept|abatacept|mesh-list
44193399|NCT00367874|Buprenorphine|buprenorphine|mesh-list
44751742|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44751743|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751744|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751745|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751746|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
44751747|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751748|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751749|NCT04169451|Letrozole|letrozole|mesh-list
44751750|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751751|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44751752|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44751753|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751754|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751755|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44751756|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
44751757|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751758|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751759|NCT04169438|Petrolatum|petrolatum|mesh-list
44751760|NCT04169438|Emollients|emollients|mesh-ancestor
44751761|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
44751762|NCT04160494|Atezolizumab|atezolizumab|mesh-list
44751763|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
44751764|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751765|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
44280853|NCT00730509|Vitamins|vitamins|mesh-ancestor
44751766|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751767|NCT04159818|Cisplatin|cisplatin|mesh-list
44751768|NCT04159818|Doxorubicin|doxorubicin|mesh-list
44751769|NCT04159818|Nivolumab|nivolumab|mesh-list
44751770|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751771|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44751772|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44751773|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44751774|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751775|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751776|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751777|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44751778|NCT04157881|Rabeprazole|rabeprazole|mesh-list
44751779|NCT04157881|Dabigatran|dabigatran|mesh-list
44751780|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
44280860|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44280866|NCT00730574|Vitamins|vitamins|mesh-list
44751781|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44751782|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
44751783|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751784|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751785|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
44751786|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44751787|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751788|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44463753|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751789|NCT04151563|Docetaxel|docetaxel|mesh-list
44751790|NCT04151563|Nivolumab|nivolumab|mesh-list
44751791|NCT04151563|Ipilimumab|ipilimumab|mesh-list
44751792|NCT04151563|Ramucirumab|ramucirumab|mesh-list
44751793|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751794|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44751795|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44751796|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44751797|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751798|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751799|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44751800|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
44751801|NCT04150900|Bavituximab|bavituximab|mesh-list
44751802|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751803|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751804|NCT04136262|Methotrexate|methotrexate|mesh-list
44751805|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44751806|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
44751807|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44751808|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751809|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44751810|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
44751811|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751812|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463777|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
44751813|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
44751814|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751815|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44751816|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751817|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
44751818|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751819|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44751820|NCT04133922|Insulin|insulin|mesh-list
44751821|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44751822|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751823|NCT04115059|Dasatinib|dasatinib|mesh-list
44751824|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751825|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44751826|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751827|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751828|NCT04114890|Tenofovir|tenofovir|mesh-list
44751829|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
44751830|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751831|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44751832|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44751833|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751834|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751835|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44751836|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44751837|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44751838|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
44751839|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44751840|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44751841|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44751842|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751843|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751844|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
44751845|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751846|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751847|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44751848|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751849|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44751850|NCT04096066|Dexamethasone|dexamethasone|mesh-list
44751851|NCT04096066|Lenalidomide|lenalidomide|mesh-list
44751852|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751853|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
44751854|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
44751855|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751856|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751857|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751858|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
44751859|NCT04096066|Hormones|hormones|mesh-ancestor
44751860|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751861|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44751862|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751863|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
44751864|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44751865|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751866|NCT04096066|Growth Substances|growth substances|mesh-ancestor
44751867|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280888|NCT00730938|Cefuroxime|cefuroxime|mesh-list
44751868|NCT04084548|Lidocaine|lidocaine|mesh-list
44751869|NCT04084548|Ketamine|ketamine|mesh-list
44751870|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751871|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
44751872|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751873|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751874|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
44751875|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751876|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44751877|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44751878|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44280892|NCT00730977|Mannitol|mannitol|mesh-list
44751879|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751880|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751881|NCT04084548|Analgesics|analgesics|mesh-ancestor
44751882|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44751883|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44751884|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
44751885|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44751886|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44751887|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751888|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
44751889|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44751890|NCT04083495|Fludarabine|fludarabine|mesh-list
44751891|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751892|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
44751893|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280908|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
44751894|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751895|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44751896|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
44751897|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751898|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751899|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44751900|NCT04082676|Bupivacaine|bupivacaine|mesh-list
44751901|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751902|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
44280919|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
44751903|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751904|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529422|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44751905|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
44751906|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751907|NCT04012177|Niacinamide|niacinamide|mesh-list
44751908|NCT04012177|Niacin|niacin|mesh-list
44751909|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
44751910|NCT04012177|Azithromycin|azithromycin|mesh-list
44751911|NCT04012177|Choline|choline|mesh-list
44751912|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44751913|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44751914|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
44751915|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44751916|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
44751917|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751918|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529423|NCT02213913|Growth Substances|growth substances|mesh-ancestor
44529424|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
44529425|NCT02214004|Trastuzumab|trastuzumab|mesh-list
44529426|NCT02214004|Letrozole|letrozole|mesh-list
44529427|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44529428|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529429|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44529430|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44529438|NCT02214368|Propofol|propofol|mesh-list
44751919|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44751920|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
44751921|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
44751922|NCT04012177|Vitamins|vitamins|mesh-ancestor
44751923|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
44751924|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751925|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
44751926|NCT04007289|Apixaban|apixaban|mesh-list
44751927|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44751928|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
44751929|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44751930|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
44751931|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751932|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280958|NCT00731302|Aspirin|aspirin|mesh-list
44280966|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44751933|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
44751934|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
44751935|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
44751936|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44751937|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44751938|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
44751939|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44751940|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751941|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44751942|NCT04002518|Cimetidine|cimetidine|mesh-list
44751943|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44751944|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44751945|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44751946|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
44751947|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
44751948|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44751949|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751950|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751951|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44751952|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44751953|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751954|NCT03993249|Nivolumab|nivolumab|mesh-list
44751955|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751956|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751957|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44751958|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751959|NCT03990883|Lidocaine|lidocaine|mesh-list
44280977|NCT00731367|Laxatives|laxatives|mesh-ancestor
44751960|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
44751961|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
44751962|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44751963|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751964|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
44751965|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44751966|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44751967|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44751968|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44751969|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44751970|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751971|NCT03984890|Vitamin D|vitamin d|mesh-list
44751972|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
44751973|NCT03984890|Vitamins|vitamins|mesh-ancestor
44751974|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
44751975|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751976|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44751977|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44751978|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
44751979|NCT03969446|Decitabine|decitabine|mesh-list
44751980|NCT03969446|Venetoclax|venetoclax|mesh-list
44751981|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44751982|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751983|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44751984|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
44751985|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751986|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44751987|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
44751988|NCT03926091|Docetaxel|docetaxel|mesh-list
44751989|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44751990|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
44751991|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44751992|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44751993|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44751994|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
44751995|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44751996|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44751997|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44751998|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
44751999|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
44752000|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
44752001|NCT03924427|BMS-986165|bms-986165|mesh-list
44752002|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44752003|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752004|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752005|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752006|NCT03922451|Cefazolin|cefazolin|mesh-list
44752007|NCT03922451|Tazobactam|tazobactam|mesh-list
44752008|NCT03922451|Piperacillin|piperacillin|mesh-list
44752009|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44752010|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752011|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752012|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44752013|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752014|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752015|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44752016|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
44752017|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752018|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44752019|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44752020|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44752021|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
44752022|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752023|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44752024|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44752025|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752026|NCT03884998|Nivolumab|nivolumab|mesh-list
44752027|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752029|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44281050|NCT00731952|Vorinostat|vorinostat|mesh-list
44752030|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752031|NCT03870880|Risperidone|risperidone|mesh-list
44752032|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44752033|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
44752034|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752035|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752036|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752037|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44752038|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44752039|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752040|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752041|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44752042|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
44752043|NCT03861377|Remifentanil|remifentanil|mesh-list
44752044|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44752045|NCT03861377|Narcotics|narcotics|mesh-ancestor
44752046|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752047|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752048|NCT03861377|Analgesics|analgesics|mesh-ancestor
44752049|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
44752050|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752051|NCT03846570|Beclomethasone|beclomethasone|mesh-list
44752052|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
44752053|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44752054|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
44752055|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752056|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752057|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44752058|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281079|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752059|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44752060|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44752061|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44752062|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752063|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752064|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281095|NCT00732290|Fluoxetine|fluoxetine|mesh-list
44752065|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752066|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
44752067|NCT03846570|Hormones|hormones|mesh-ancestor
44752068|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752069|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44752070|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44752071|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752072|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
44752073|NCT03836144|Diuretics|diuretics|mesh-ancestor
44752074|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
44752075|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752076|NCT03836144|Expectorants|expectorants|mesh-ancestor
44752077|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44752078|NCT03825536|Methamphetamine|methamphetamine|mesh-list
44752079|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44752080|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752081|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
44752082|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
44752083|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752084|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
44752085|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688547|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44688548|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
44688549|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688550|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688551|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44688552|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
44688553|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
44688554|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688555|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44688556|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
44281121|NCT00732420|Topotecan|topotecan|mesh-list
44688557|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688558|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44688559|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44688560|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688561|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
44752086|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752087|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752088|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44752089|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752090|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752091|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44752092|NCT03816397|Adalimumab|adalimumab|mesh-list
44752093|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752094|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752095|NCT03796416|Misoprostol|misoprostol|mesh-list
44752096|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44752097|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
44752098|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281131|NCT00732446|BB 1101|bb 1101|mesh-list
44752099|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752100|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44752101|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752102|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
44752103|NCT03785106|Vitamins|vitamins|mesh-list
44752104|NCT03785106|Pyridoxine|pyridoxine|mesh-list
44752105|NCT03785106|Pyridoxal|pyridoxal|mesh-list
44752106|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
44752107|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
44752108|NCT03785106|Isoniazid|isoniazid|mesh-list
44752109|NCT03785106|Rifapentine|rifapentine|mesh-list
44752110|NCT03785106|Rifampin|rifampin|mesh-list
44752111|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
44752112|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752113|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
44752114|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752115|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752116|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44752117|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44752118|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
44752119|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752120|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44752121|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44752122|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
44752123|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752124|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752125|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44752126|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44752127|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44752128|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44752129|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44281156|NCT00732485|Fenofibrate|fenofibrate|mesh-list
44752130|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44752131|NCT03782142|Tenofovir|tenofovir|mesh-list
44752132|NCT03782142|Dolutegravir|dolutegravir|mesh-list
44752133|NCT03782142|Rilpivirine|rilpivirine|mesh-list
44752134|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44752135|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
44752136|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752137|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44752138|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752139|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752140|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752141|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44752142|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44752143|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44752144|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44752145|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752146|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44752147|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44752148|NCT03770299|Gemcitabine|gemcitabine|mesh-list
44752149|NCT03770299|Paclitaxel|paclitaxel|mesh-list
44752150|NCT03770299|Vinorelbine|vinorelbine|mesh-list
44752151|NCT03770299|Docetaxel|docetaxel|mesh-list
44752152|NCT03770299|Cisplatin|cisplatin|mesh-list
44752153|NCT03770299|Carboplatin|carboplatin|mesh-list
44752154|NCT03770299|Nivolumab|nivolumab|mesh-list
44752155|NCT03770299|Pemetrexed|pemetrexed|mesh-list
44752156|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44752157|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752158|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
44752159|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
44752160|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
44752161|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752162|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752163|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
44752164|NCT03770299|Antiviral Agents|antiviral agents|mesh-ancestor
44752165|NCT03770299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752166|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752167|NCT03770299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752168|NCT03770299|Immunologic Factors|immunologic factors|mesh-ancestor
44752169|NCT03770299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752170|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752171|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44281205|NCT00732576|Vitamin K|vitamin k|mesh-list
44752172|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44752173|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752174|NCT03760835|Dexamethasone|dexamethasone|mesh-list
44752175|NCT03760835|Prednisone|prednisone|mesh-list
44752176|NCT03760835|Prednisolone|prednisolone|mesh-list
44752177|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
44752178|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44752179|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44752180|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44752181|NCT03760835|Cortisone|cortisone|mesh-list
44752182|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
44752183|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752184|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
44752185|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
44752186|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752187|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752188|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752189|NCT03760835|Hormones|hormones|mesh-ancestor
44752190|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752191|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752192|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752193|NCT03759496|Durvalumab|durvalumab|mesh-list
44752194|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752195|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752196|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
44752197|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752198|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752199|NCT03748784|Aflibercept|aflibercept|mesh-list
44752200|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44752201|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752202|NCT03748784|Growth Substances|growth substances|mesh-ancestor
44752203|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752204|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752205|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752206|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
44752207|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752208|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752209|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
44752210|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752211|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752212|NCT03724409|Octreotide|octreotide|mesh-list
44752213|NCT03724409|Edotreotide|edotreotide|mesh-list
44752214|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752215|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752216|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752217|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44752218|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752219|NCT03715829|PF-06700841|pf-06700841|mesh-list
44752220|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463826|NCT01504971|Rabeprazole|rabeprazole|mesh-list
44752221|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752222|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752223|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
44752224|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
44752225|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44752226|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752227|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752228|NCT03704441|Bupivacaine|bupivacaine|mesh-list
44752229|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
44752230|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
44752231|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752232|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752233|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
44752234|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752235|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
44752236|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752237|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752238|NCT03693677|Gemcitabine|gemcitabine|mesh-list
44752239|NCT03693677|Paclitaxel|paclitaxel|mesh-list
44752240|NCT03693677|Irinotecan|irinotecan|mesh-list
44752241|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44752242|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752243|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44752244|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44752245|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44752246|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752247|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752248|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
44752249|NCT03693677|Antiviral Agents|antiviral agents|mesh-ancestor
44752250|NCT03693677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752251|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752252|NCT03693677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752253|NCT03693677|Immunologic Factors|immunologic factors|mesh-ancestor
44752254|NCT03693677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752255|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44752256|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44752257|NCT03673826|Dexamethasone|dexamethasone|mesh-list
44752258|NCT03673826|Lenalidomide|lenalidomide|mesh-list
44752259|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752260|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
44752261|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
44752262|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752263|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752264|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752265|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
44752266|NCT03673826|Hormones|hormones|mesh-ancestor
44752267|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752268|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752269|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752270|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
44752271|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44752272|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752273|NCT03673826|Growth Substances|growth substances|mesh-ancestor
44752274|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752275|NCT03662685|Coal Tar|coal tar|mesh-list
44752276|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
44752277|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
44752278|NCT03660839|Artefenomel|artefenomel|mesh-list
44752279|NCT03660839|Ferroquine|ferroquine|mesh-list
44281296|NCT00732927|Aspirin|aspirin|mesh-list
44752280|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
44752281|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44752282|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44752283|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752284|NCT03660241|Abrocitinib|abrocitinib|mesh-list
44752285|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752286|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752287|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752288|NCT03651102|Thalidomide|thalidomide|mesh-list
44752289|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
44752290|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752291|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
44752292|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752293|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
44752294|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752295|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752296|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44752297|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752298|NCT03651102|Growth Substances|growth substances|mesh-ancestor
44752299|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752300|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752301|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
44752302|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752303|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752304|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752305|NCT03649802|Vitamin D|vitamin d|mesh-list
44752306|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
44752307|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
44752308|NCT03649802|Vitamins|vitamins|mesh-list
44752309|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
44752310|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752311|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44752312|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44752313|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44752314|NCT03643198|Metronidazole|metronidazole|mesh-list
44752315|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
44752316|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752317|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44752318|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44281327|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44752319|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44752320|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44752321|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752322|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752323|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752324|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44752325|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44752326|NCT03606980|Dexamethasone|dexamethasone|mesh-list
44752327|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
44752328|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44752329|NCT03606980|BB 1101|bb 1101|mesh-list
44752330|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752331|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
44752332|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
44281345|NCT00733083|Dexamethasone|dexamethasone|mesh-list
44752333|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752334|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752335|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752336|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
44752337|NCT03606980|Hormones|hormones|mesh-ancestor
44752338|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752339|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752340|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281362|NCT00733083|Analgesics|analgesics|mesh-ancestor
44752341|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752342|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752343|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281375|NCT00733239|Gabapentin|gabapentin|mesh-list
44752344|NCT03576417|Cisplatin|cisplatin|mesh-list
44529911|NCT02217007|Calcium|calcium|mesh-list
44529912|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529913|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529914|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44529915|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44529916|NCT02217163|Dexamethasone|dexamethasone|mesh-list
44529917|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
44529918|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529919|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
44529920|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281376|NCT00733239|Naloxone|naloxone|mesh-list
44529921|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529922|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44529923|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
44752346|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752347|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752348|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752349|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752350|NCT03573115|Adapalene|adapalene|mesh-list
44752351|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44752352|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44752353|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44752354|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44752355|NCT03573115|Analgesics|analgesics|mesh-ancestor
44752356|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
44752357|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752358|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752359|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752360|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752361|NCT03569475|Milnacipran|milnacipran|mesh-list
44281405|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44752362|NCT03569475|Fluoxetine|fluoxetine|mesh-list
44752363|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
44752364|NCT03569475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44752365|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752366|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752367|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752368|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752369|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
44752370|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281407|NCT00733265|Ticagrelor|ticagrelor|mesh-list
44752371|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44752372|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
44752373|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752374|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44752375|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44752376|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752377|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44688562|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688563|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44688564|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688565|NCT00189280|Imiquimod|imiquimod|mesh-list
44688566|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44688567|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
44688568|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688582|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688583|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44688584|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688585|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688586|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44688587|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
44688588|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
44688589|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688590|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
44688591|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688592|NCT01343225|Ritonavir|ritonavir|mesh-list
44688593|NCT01343225|Darunavir|darunavir|mesh-list
44688594|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
44688595|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44688596|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44688597|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44688598|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688599|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688600|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688601|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44688602|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44688603|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
44688604|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688605|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44688606|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44688607|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44281439|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
44688608|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44688609|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44688610|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44688611|NCT01343290|Canagliflozin|canagliflozin|mesh-list
44688612|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44688613|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752378|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44752379|NCT03569475|Analgesics|analgesics|mesh-ancestor
44752380|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
44752381|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752382|NCT03546556|Alovudine|alovudine|mesh-list
44752383|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
44752384|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
44752385|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752386|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
44752387|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752388|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44752389|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752390|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752391|NCT03533712|Folic Acid|folic acid|mesh-list
44752392|NCT03533712|Hematinics|hematinics|mesh-ancestor
44752393|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
44752394|NCT03533712|Vitamins|vitamins|mesh-ancestor
44752395|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
44752396|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752397|NCT03529396|Chloroquine|chloroquine|mesh-list
44752398|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44752399|NCT03529396|Primaquine|primaquine|mesh-list
44752400|NCT03529396|Amebicides|amebicides|mesh-ancestor
44752401|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44752402|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44752403|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752404|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
44752405|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752406|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44752407|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44752408|NCT03529396|Analgesics|analgesics|mesh-ancestor
44752409|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
44752410|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752411|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752412|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752413|NCT03529396|Filaricides|filaricides|mesh-ancestor
44752414|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
44752415|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
44752416|NCT03523520|Naltrexone|naltrexone|mesh-list
44752417|NCT03523520|Bromides|bromides|mesh-list
44752418|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
44752419|NCT03523520|Naloxegol|naloxegol|mesh-list
44752420|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
44752421|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44752422|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752423|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
44752424|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752425|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44752426|NCT03521830|Nivolumab|nivolumab|mesh-list
44752427|NCT03521830|Ipilimumab|ipilimumab|mesh-list
44752428|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752429|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752430|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752431|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752432|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
44752433|NCT03518242|Capecitabine|capecitabine|mesh-list
44752434|NCT03518242|Methotrexate|methotrexate|mesh-list
44752435|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752436|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
44752437|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752438|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752439|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44752440|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
44752441|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752442|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752443|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44752444|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752445|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
44752446|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44752447|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
44752448|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44752449|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44752450|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752451|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44752452|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752453|NCT03500549|Eculizumab|eculizumab|mesh-list
44752454|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44752455|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752456|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
44752457|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752458|NCT03469960|Nivolumab|nivolumab|mesh-list
44752459|NCT03469960|Ipilimumab|ipilimumab|mesh-list
44752460|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752461|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752462|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752463|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752464|NCT03460379|Citalopram|citalopram|mesh-list
44752465|NCT03460379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44752466|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752467|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752468|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752469|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752470|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
44752471|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752472|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44752473|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
44752474|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752475|NCT03460366|Enalapril|enalapril|mesh-list
44752476|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44752477|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752478|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752479|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752480|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44752481|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
44752482|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44752483|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752484|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44752485|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752486|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752487|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752488|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
44752489|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752490|NCT03460327|Candesartan|candesartan|mesh-list
44752491|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44752492|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44752493|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44752494|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752495|NCT03460314|Buprenorphine|buprenorphine|mesh-list
44752496|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44752497|NCT03460314|Narcotics|narcotics|mesh-ancestor
44752498|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752499|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752500|NCT03460314|Analgesics|analgesics|mesh-ancestor
44752501|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
44752502|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752503|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44752504|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44752505|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44752506|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752507|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752508|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752509|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752510|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752511|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752512|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44752513|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
44752514|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752515|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44752516|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44752517|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752518|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752519|NCT03435185|Lidocaine|lidocaine|mesh-list
44752520|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
44752521|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
44752522|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752523|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752524|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
44752525|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752526|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44752527|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44752528|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44752529|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752530|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752531|NCT03426293|Heparin|heparin|mesh-list
44752532|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
44752533|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44752534|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44752535|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752536|NCT03383380|Sirolimus|sirolimus|mesh-list
44752537|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752538|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752539|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44752540|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752541|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
44752542|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752543|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
44752544|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752545|NCT03325439|Brivaracetam|brivaracetam|mesh-list
44752546|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
44752547|NCT03251924|Nivolumab|nivolumab|mesh-list
44752548|NCT03251924|Ipilimumab|ipilimumab|mesh-list
44752549|NCT03251924|Antibodies|antibodies|mesh-list
44752550|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
44752551|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
44752552|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
44752553|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752554|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752555|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752556|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752557|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752558|NCT03242772|Amphetamine|amphetamine|mesh-list
44752559|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44752560|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752561|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
44752562|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
44752563|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752564|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
44752565|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774269|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752566|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752567|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752568|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44752569|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752570|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752571|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44752572|NCT03236311|Adenosine|adenosine|mesh-list
44752573|NCT03236311|Regadenoson|regadenoson|mesh-list
44752574|NCT03236311|Analgesics|analgesics|mesh-ancestor
44752575|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
44752576|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752577|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752578|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44752579|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44752580|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44752581|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
44752582|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
44752583|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530126|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44530127|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44530128|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530129|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44530130|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44530131|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44530132|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530133|NCT02218762|Fluticasone|fluticasone|mesh-list
44752584|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752585|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44752586|NCT03234686|Deferiprone|deferiprone|mesh-list
44752587|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44752588|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
44752589|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
44752590|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752592|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44752593|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752594|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
44752595|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
44752596|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
44752597|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752598|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
44752599|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44752600|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752601|NCT03190369|Hylan|hylan|mesh-list
44752602|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
44752603|NCT03190369|Protective Agents|protective agents|mesh-ancestor
44752604|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752605|NCT05438316|Ramipril|ramipril|mesh-list
44199481|NCT00394368|Xhance|xhance|mesh-list
44752606|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44752607|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
44281656|NCT00734773|Cytarabine|cytarabine|mesh-list
44752608|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752609|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752610|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44752611|NCT05438108|Bevacizumab|bevacizumab|mesh-list
44752612|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752613|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752614|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44752615|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752616|NCT05438108|Growth Substances|growth substances|mesh-ancestor
44752617|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752618|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752619|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44752620|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752621|NCT05437783|Azithromycin|azithromycin|mesh-list
44752622|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752623|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752624|NCT05437718|Ropivacaine|ropivacaine|mesh-list
44752625|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
44752626|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
44752627|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752628|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667194|NCT05455424|Niraparib|niraparib|mesh-list
44752629|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
44752630|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752631|NCT05437497|Propofol|propofol|mesh-list
44752632|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44752633|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752634|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752635|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44752636|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
44752637|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
44752638|NCT05437471|Letrozole|letrozole|mesh-list
44752639|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
44752640|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752641|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44752642|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44752643|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752644|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752645|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44752646|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
44752647|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752648|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752649|NCT05437471|Progestins|progestins|mesh-ancestor
44752650|NCT05437471|Hormones|hormones|mesh-ancestor
44752651|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
44752652|NCT05437432|Methamphetamine|methamphetamine|mesh-list
44752653|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44752654|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455868|NCT01639729|Dsuvia|dsuvia|mesh-list
44752655|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
44752656|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
44752657|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688614|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44752658|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
44752659|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752660|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752661|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752662|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44752663|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752664|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752665|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44752666|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
44752667|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752668|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752669|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
44752670|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44752671|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281722|NCT00735241|Fluorouracil|fluorouracil|mesh-list
44688615|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688616|NCT01343303|Naproxen|naproxen|mesh-list
44688617|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688618|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688619|NCT01343303|Analgesics|analgesics|mesh-ancestor
44688620|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
44688621|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688622|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688623|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688624|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688625|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
44688626|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44688627|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688628|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688629|NCT01343329|Propranolol|propranolol|mesh-list
44688630|NCT01343329|Esmolol|esmolol|mesh-list
44688631|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44688632|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44688633|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688634|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688635|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688636|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688637|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44688638|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44688639|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
44688640|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44688641|NCT01343381|Heparin|heparin|mesh-list
44688642|NCT01343381|Calcium heparin|calcium heparin|mesh-list
44688643|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
44688644|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44688645|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44688646|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688647|NCT01343498|Dactolisib|dactolisib|mesh-list
44688648|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688649|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44688650|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44688651|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44688652|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688653|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688654|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688655|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688656|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281754|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281768|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44688657|NCT01343680|Heparin|heparin|mesh-list
44688658|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
44688659|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44688660|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44688661|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688662|NCT01343706|BI 409306|bi 409306|mesh-list
44688663|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44688664|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688665|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688666|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
44688667|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44688668|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
44688669|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688670|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688671|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44688672|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
44688673|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44752674|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
44752675|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752676|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752677|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
44752678|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44752679|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44752680|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752681|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44752682|NCT05436964|Analgesics|analgesics|mesh-ancestor
44752683|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
44752684|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752685|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44752686|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44752687|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44752688|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752689|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752690|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752691|NCT05432518|Everolimus|everolimus|mesh-list
44752692|NCT05432518|Dasatinib|dasatinib|mesh-list
44752693|NCT05432518|Olaparib|olaparib|mesh-list
44752694|NCT05432518|Palbociclib|palbociclib|mesh-list
44752695|NCT05432518|Afatinib|afatinib|mesh-list
44752696|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774270|NCT01847976|Doxycycline|doxycycline|mesh-list
44752697|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752698|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
44752699|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752700|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752701|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752702|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281814|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
44752703|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44752704|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
44752705|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44202026|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752706|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44752707|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752708|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
44752709|NCT05427513|Coagulants|coagulants|mesh-ancestor
44752710|NCT05426811|Raltitrexed|raltitrexed|mesh-list
44752711|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752712|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
44752713|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752714|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752715|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44752716|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752717|NCT05357859|Vitamin D|vitamin d|mesh-list
44281826|NCT00736294|Ramipril|ramipril|mesh-list
44752718|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
44752719|NCT05357859|Vitamins|vitamins|mesh-ancestor
44752720|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
44281829|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752721|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752722|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44752723|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44752724|NCT05265286|Factor VIII|factor viii|mesh-list
44752725|NCT05265286|Coagulants|coagulants|mesh-ancestor
44752726|NCT05239169|Capecitabine|capecitabine|mesh-list
44752727|NCT05239169|Durvalumab|durvalumab|mesh-list
44752728|NCT05239169|Tremelimumab|tremelimumab|mesh-list
44281838|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752729|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752730|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
44752731|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752732|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752733|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752734|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
44752735|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752736|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752737|NCT05006079|Morphine|morphine|mesh-list
44752738|NCT05006079|Alprazolam|alprazolam|mesh-list
44752739|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44752740|NCT05006079|Narcotics|narcotics|mesh-ancestor
44530340|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530341|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530342|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44530343|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530344|NCT02219867|Ketamine|ketamine|mesh-list
44530345|NCT02219867|Analgesics|analgesics|mesh-ancestor
44530346|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
44530347|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752741|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281855|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
44752742|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752743|NCT05006079|Analgesics|analgesics|mesh-ancestor
44752744|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
44752745|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752746|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44752747|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44752748|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44752749|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281869|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44752750|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
44752751|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
44752752|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752753|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752754|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
44752755|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44752756|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
44752757|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44752758|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752759|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752760|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752761|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
44752762|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
44752763|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
44752764|NCT04950270|Coagulants|coagulants|mesh-ancestor
44752765|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44752766|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44752767|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
44752768|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752769|NCT04895046|Niraparib|niraparib|mesh-list
44752770|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44752771|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281878|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
44752772|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752773|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752774|NCT04765514|Temozolomide|temozolomide|mesh-list
44752775|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44752776|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
44752777|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752778|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752779|NCT04590586|Thalidomide|thalidomide|mesh-list
44752780|NCT04590586|Apremilast|apremilast|mesh-list
44752781|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44752782|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44752783|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44752784|NCT04590586|Analgesics|analgesics|mesh-ancestor
44752785|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
44752786|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44752787|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752788|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752789|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752790|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44203576|NCT00410215|Bisacodyl|bisacodyl|mesh-list
44752791|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44752792|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752793|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752794|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752795|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
44752796|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
44752797|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44752798|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752799|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44752800|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752801|NCT04590586|Growth Substances|growth substances|mesh-ancestor
44752802|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752803|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752805|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44752806|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
44752807|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204023|NCT00411541|Hormones|hormones|mesh-ancestor
44752808|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752809|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
44752810|NCT04427293|Lenvatinib|lenvatinib|mesh-list
44752811|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752812|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281930|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44752813|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752814|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752815|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752816|NCT04312009|Losartan|losartan|mesh-list
44752817|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44752818|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44752819|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44752820|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44752821|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752822|NCT04201262|Ravulizumab|ravulizumab|mesh-list
44752823|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44752824|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44752825|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
44752826|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752827|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
44752828|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
44752829|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752830|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752831|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752832|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
44752833|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
44752834|NCT03850483|PF-06700841|pf-06700841|mesh-list
44752835|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752836|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752837|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752838|NCT03819296|Prednisone|prednisone|mesh-list
44752839|NCT03819296|Cortisone|cortisone|mesh-list
44752840|NCT03819296|Infliximab|infliximab|mesh-list
44752841|NCT03819296|Vedolizumab|vedolizumab|mesh-list
44752842|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
44752843|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
44752844|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44752845|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
44752846|NCT03819296|Hormones|hormones|mesh-ancestor
44752847|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752848|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752849|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752850|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752851|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
44752852|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
44752853|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44752854|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752855|NCT03563742|Tenofovir|tenofovir|mesh-list
44752856|NCT03563742|Lamivudine|lamivudine|mesh-list
44752857|NCT03563742|Rilpivirine|rilpivirine|mesh-list
44752858|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
44752859|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752860|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44752861|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44752862|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752863|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752864|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44752865|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44752866|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44752867|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
44752868|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752869|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752870|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
44752871|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752872|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752873|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44752874|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752875|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752876|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752877|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44752878|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
44752879|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752880|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44752881|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
44752882|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44752883|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752884|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44281992|NCT00736970|Sirolimus|sirolimus|mesh-list
44752885|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44752886|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44752887|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
44752888|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
44752889|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752890|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752891|NCT03435640|Nivolumab|nivolumab|mesh-list
44752892|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752893|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752894|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752895|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752896|NCT03424122|Rituximab|rituximab|mesh-list
44752897|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44752898|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752899|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752900|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
44752901|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752902|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44752903|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44752904|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
44752905|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752906|NCT03230097|BI 409306|bi 409306|mesh-list
44752907|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44752908|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752909|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752910|NCT03065621|Palbociclib|palbociclib|mesh-list
44752911|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752912|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44752913|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752914|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752915|NCT02968940|Avelumab|avelumab|mesh-list
44752916|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752917|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752918|NCT02679144|Eflornithine|eflornithine|mesh-list
44752919|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752920|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44752921|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44752922|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44752923|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752924|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44752925|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752926|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752927|NCT02663908|Leuprolide|leuprolide|mesh-list
44752928|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44752929|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
44752930|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44752931|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752932|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44752933|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752934|NCT02333292|Ritonavir|ritonavir|mesh-list
44752935|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
44752936|NCT02333292|Grazoprevir|grazoprevir|mesh-list
44752937|NCT02333292|Ledipasvir|ledipasvir|mesh-list
44752938|NCT02333292|Velpatasvir|velpatasvir|mesh-list
44752939|NCT02333292|Simeprevir|simeprevir|mesh-list
44752940|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44752941|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44752942|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
44752943|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752944|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752945|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44752946|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44752947|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
44752948|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752949|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44752950|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44752951|NCT02203773|Posaconazole|posaconazole|mesh-list
44752952|NCT02203773|Azacitidine|azacitidine|mesh-list
44752953|NCT02203773|Decitabine|decitabine|mesh-list
44752954|NCT02203773|Venetoclax|venetoclax|mesh-list
44752955|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44752956|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
44282053|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44752957|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752958|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752959|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44752960|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
44752961|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44752962|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44752963|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44752964|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44752965|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44752966|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44752967|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44752968|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206310|NCT00421694|Bicalutamide|bicalutamide|mesh-list
44752969|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44752970|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752971|NCT02175030|Copper|copper|mesh-list
44752972|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
44752973|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44752974|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
44752975|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44752976|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752977|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44752978|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44752979|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44752980|NCT02175030|Trace Elements|trace elements|mesh-ancestor
44752981|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
44752982|NCT02017717|Bevacizumab|bevacizumab|mesh-list
44752983|NCT02017717|Nivolumab|nivolumab|mesh-list
44752984|NCT02017717|Ipilimumab|ipilimumab|mesh-list
44752985|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44752986|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752987|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282092|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
44752988|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44752989|NCT02017717|Growth Substances|growth substances|mesh-ancestor
44752990|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752991|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
44752992|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44752993|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44752994|NCT01734512|Everolimus|everolimus|mesh-list
44752995|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44752996|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282100|NCT00737373|Vitamins|vitamins|mesh-ancestor
44752997|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
44752998|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44752999|NCT01555541|Cytarabine|cytarabine|mesh-list
44753000|NCT01555541|Etoposide|etoposide|mesh-list
44753001|NCT01555541|Ofatumumab|ofatumumab|mesh-list
44753002|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44753003|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753004|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44753005|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44753006|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753007|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753008|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753009|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
44753010|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
44753011|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753012|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753013|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
44753014|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753015|NCT01398852|Riboflavin|riboflavin|mesh-list
44688674|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44688675|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44688676|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688677|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688678|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753016|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
44753017|NCT01398852|Vitamins|vitamins|mesh-ancestor
44753018|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
44688679|NCT01343862|Cycloserine|cycloserine|mesh-list
44688680|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44688681|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530591|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207010|NCT00424853|Gemcitabine|gemcitabine|mesh-list
44530592|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44753019|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753020|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44753021|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753022|NCT01398839|Riboflavin|riboflavin|mesh-list
44753023|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
44753024|NCT01398839|Vitamins|vitamins|mesh-ancestor
44753025|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
44753026|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753027|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44753028|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753029|NCT00496795|Docetaxel|docetaxel|mesh-list
44753030|NCT00496795|Epirubicin|epirubicin|mesh-list
44753031|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753032|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
44753033|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
44753034|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
44753035|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753036|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44753037|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44753038|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44753039|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753040|NCT00316888|Cisplatin|cisplatin|mesh-list
44753041|NCT00316888|Fluorouracil|fluorouracil|mesh-list
44753042|NCT00316888|Cetuximab|cetuximab|mesh-list
44282157|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44753043|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753044|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
44753045|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753046|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753047|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753048|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
44753049|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753050|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753051|NCT03178487|Upadacitinib|upadacitinib|mesh-list
44753052|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44753053|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753054|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753055|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753056|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753057|NCT03164889|Entecavir|entecavir|mesh-list
44753058|NCT03164889|Molgramostim|molgramostim|mesh-list
44753059|NCT03164889|Sargramostim|sargramostim|mesh-list
44753060|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
44753061|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753062|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
44753063|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753064|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753065|NCT03133260|Aspirin|aspirin|mesh-list
44753066|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44753067|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753068|NCT03133260|Analgesics|analgesics|mesh-ancestor
44753069|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
44753070|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753071|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753072|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753073|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753074|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44753075|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44753076|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753077|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44753078|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44753079|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753080|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
44753081|NCT03126812|Paclitaxel|paclitaxel|mesh-list
44753082|NCT03126812|Carboplatin|carboplatin|mesh-list
44753083|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
44753084|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44282181|NCT00737867|Vinorelbine|vinorelbine|mesh-list
44753085|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753086|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44753087|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44753088|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44753089|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753090|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753091|NCT03096834|Erenumab|erenumab|mesh-list
44753092|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44753093|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530656|NCT01640782|Leucovorin|leucovorin|mesh-list
44753094|NCT03096834|Analgesics|analgesics|mesh-ancestor
44753095|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
44753096|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753097|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753098|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
44753099|NCT03089203|Fludarabine|fludarabine|mesh-list
44753100|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753101|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
44753102|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753103|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753104|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753105|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
44753106|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753107|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753108|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753109|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
44753111|NCT03070392|Dacarbazine|dacarbazine|mesh-list
44753112|NCT03070392|Imidazole|imidazole|mesh-list
44753113|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753114|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753115|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753116|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753117|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753118|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
44753119|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753120|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
44282212|NCT00737971|Hormones|hormones|mesh-ancestor
44753121|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44753122|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
44753123|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753124|NCT03056014|Expectorants|expectorants|mesh-ancestor
44753125|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
44753126|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44753127|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
44753128|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753129|NCT03056014|Protective Agents|protective agents|mesh-ancestor
44753130|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753131|NCT03056014|Antidotes|antidotes|mesh-ancestor
44753132|NCT03054363|Letrozole|letrozole|mesh-list
44753133|NCT03054363|Palbociclib|palbociclib|mesh-list
44753134|NCT03054363|Tucatinib|tucatinib|mesh-list
44753135|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753136|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44753137|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44753138|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753139|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753140|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44753141|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
44753142|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753143|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753144|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753145|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
44753146|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
44753147|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753149|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
44753150|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753151|NCT03015792|Dexamethasone|dexamethasone|mesh-list
44753152|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
44753153|NCT03015792|Lenalidomide|lenalidomide|mesh-list
44753154|NCT03015792|Ichthammol|ichthammol|mesh-list
44753155|NCT03015792|BB 1101|bb 1101|mesh-list
44753156|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753157|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
44753158|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
44753159|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753160|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753161|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753162|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
44753163|NCT03015792|Hormones|hormones|mesh-ancestor
44753164|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753165|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753166|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753167|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
44753168|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44753169|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44753170|NCT03015792|Growth Substances|growth substances|mesh-ancestor
44753171|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
44753172|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753173|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753174|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753175|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753176|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
44753177|NCT03012815|Gabapentin|gabapentin|mesh-list
44753178|NCT03012815|Lorazepam|lorazepam|mesh-list
44753179|NCT03012815|Valproic Acid|valproic acid|mesh-list
44753180|NCT03012815|Analgesics|analgesics|mesh-ancestor
44753181|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
44753182|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753183|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753184|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
44753185|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44753186|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208924|NCT00432315|Cisplatin|cisplatin|mesh-list
44753187|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753188|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753189|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44753190|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44753191|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753192|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753193|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
44753194|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
44753195|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
44753196|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753197|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44209408|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
44753198|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
44753199|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
44753200|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753201|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44753202|NCT03006432|Leucovorin|leucovorin|mesh-list
44753203|NCT03006432|Folic Acid|folic acid|mesh-list
44753204|NCT03006432|Docetaxel|docetaxel|mesh-list
44753205|NCT03006432|Fluorouracil|fluorouracil|mesh-list
44753206|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
44753207|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
44753208|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753209|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
44753210|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
44753211|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
44753212|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753213|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
44753214|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753215|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753216|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
44753217|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753218|NCT03006432|Antidotes|antidotes|mesh-ancestor
44753219|NCT03006432|Protective Agents|protective agents|mesh-ancestor
44753220|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
44753221|NCT03006432|Vitamins|vitamins|mesh-ancestor
44753222|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
44530813|NCT01641666|Ribavirin|ribavirin|mesh-list
44753223|NCT03006432|Hematinics|hematinics|mesh-ancestor
44753224|NCT03003065|Temoporfin|temoporfin|mesh-list
44753225|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753226|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44753227|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753229|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
44753230|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
44753231|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753232|NCT02993757|Vaccines|vaccines|mesh-list
44753233|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
44753234|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753235|NCT02979535|Vaccines|vaccines|mesh-list
44753236|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
44753237|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753238|NCT02978716|Gemcitabine|gemcitabine|mesh-list
44753239|NCT02978716|Carboplatin|carboplatin|mesh-list
44753240|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210263|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44753241|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753242|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
44753243|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753244|NCT02978716|Antiviral Agents|antiviral agents|mesh-ancestor
44753245|NCT02978716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753246|NCT02978716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753247|NCT02978716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753248|NCT02978716|Immunologic Factors|immunologic factors|mesh-ancestor
44753249|NCT02978716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753250|NCT02973321|Metformin|metformin|mesh-list
44753251|NCT02973321|Liraglutide|liraglutide|mesh-list
44753252|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753253|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753254|NCT02973321|Incretins|incretins|mesh-ancestor
44753255|NCT02973321|Hormones|hormones|mesh-ancestor
44753256|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753257|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44753258|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44753259|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753260|NCT02943785|Edoxaban|edoxaban|mesh-list
44753261|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44753262|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
44753263|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44753264|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753265|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753266|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753267|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
44753268|NCT02908334|Sertraline|sertraline|mesh-list
44753269|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
44753270|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753271|NCT02908334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44753272|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44753273|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44753274|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753275|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753276|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
44753277|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753278|NCT02901067|Aspirin|aspirin|mesh-list
44753279|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44688682|NCT01343862|Renal Agents|renal agents|mesh-ancestor
44688683|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44688684|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
44688685|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44688686|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
44688687|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688688|NCT01344031|Fulvestrant|fulvestrant|mesh-list
44688689|NCT01344031|Anastrozole|anastrozole|mesh-list
44463903|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
44688690|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688691|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688692|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44688693|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44688694|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44688695|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688696|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688697|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44688698|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44688699|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688700|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688701|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44530886|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
44753280|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44530935|NCT01642966|Ticagrelor|ticagrelor|mesh-list
44753281|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753282|NCT02901067|Analgesics|analgesics|mesh-ancestor
44753283|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
44753284|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753285|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753286|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753287|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753288|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44753289|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44753290|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753291|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44753292|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44753293|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753294|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
44753295|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44753296|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44753297|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
44753298|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44753299|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44753300|NCT02886286|Fentanyl|fentanyl|mesh-list
44753301|NCT02886286|Morphine|morphine|mesh-list
44753302|NCT02886286|Hydromorphone|hydromorphone|mesh-list
44753303|NCT02886286|Bupivacaine|bupivacaine|mesh-list
44753304|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
44753305|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
44753306|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753307|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753308|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
44753309|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753310|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44753311|NCT02886286|Narcotics|narcotics|mesh-ancestor
44753312|NCT02886286|Analgesics|analgesics|mesh-ancestor
44753313|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44753314|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44282390|NCT00738829|Fludarabine|fludarabine|mesh-list
44753315|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
44753316|NCT02865187|Vitamin D|vitamin d|mesh-list
44753317|NCT02865187|Vitamins|vitamins|mesh-ancestor
44753318|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
44753319|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753320|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44753321|NCT02821754|Durvalumab|durvalumab|mesh-list
44753322|NCT02821754|Tremelimumab|tremelimumab|mesh-list
44210958|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210995|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
44753323|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753324|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753325|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
44753326|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753327|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
44753328|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753329|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753330|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753331|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
44282410|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44753332|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753333|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753334|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753335|NCT02787551|Metformin|metformin|mesh-list
44753336|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
44753337|NCT02787551|Pioglitazone|pioglitazone|mesh-list
44753338|NCT02787551|Liraglutide|liraglutide|mesh-list
44753339|NCT02787551|Exenatide|exenatide|mesh-list
44282419|NCT00738985|Ezetimibe|ezetimibe|mesh-list
44530936|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44530937|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44530938|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44530939|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44530940|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44530941|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
44530942|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530943|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530944|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530945|NCT01643083|Rifaximin|rifaximin|mesh-list
44530946|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530947|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530948|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753340|NCT02787551|Dulaglutide|dulaglutide|mesh-list
44753341|NCT02787551|Lixisenatide|lixisenatide|mesh-list
44753342|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44753343|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44753344|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
44753345|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753346|NCT02787551|Incretins|incretins|mesh-ancestor
44753347|NCT02787551|Hormones|hormones|mesh-ancestor
44753348|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753349|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44753350|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753351|NCT02736656|Viloxazine|viloxazine|mesh-list
44753352|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44282428|NCT00739128|Vaccines|vaccines|mesh-list
44753353|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
44753354|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753355|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44753356|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44753357|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44753358|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753359|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
44753360|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753361|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753362|NCT02735044|Insulin|insulin|mesh-list
44211411|NCT00443144|Hormones|hormones|mesh-list
44753363|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44753364|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
44753365|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753366|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753367|NCT02713867|Nivolumab|nivolumab|mesh-list
44753368|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753369|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753370|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753371|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753372|NCT02692651|Vancomycin|vancomycin|mesh-list
44753373|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
44753374|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44753375|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753376|NCT02678572|Melphalan|melphalan|mesh-list
44753377|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753378|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
44753379|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753380|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282474|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
44753381|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753382|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753383|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
44753384|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753385|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
44753386|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753387|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753388|NCT02656706|Nivolumab|nivolumab|mesh-list
44753389|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753390|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753391|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753392|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753393|NCT02654314|Melatonin|melatonin|mesh-list
44753394|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
44753395|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753396|NCT02654314|Protective Agents|protective agents|mesh-ancestor
44753397|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753398|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753399|NCT02626962|Nivolumab|nivolumab|mesh-list
44753400|NCT02626962|Ipilimumab|ipilimumab|mesh-list
44753401|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753402|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753403|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753404|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753405|NCT02623998|Metformin|metformin|mesh-list
44753406|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
44753407|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44753408|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753409|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753410|NCT02623998|Incretins|incretins|mesh-ancestor
44753411|NCT02623998|Hormones|hormones|mesh-ancestor
44753412|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753413|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44753414|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753415|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753416|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753417|NCT02608684|Gemcitabine|gemcitabine|mesh-list
44753418|NCT02608684|Cisplatin|cisplatin|mesh-list
44753419|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
44753420|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753421|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753422|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
44753423|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753424|NCT02608684|Antiviral Agents|antiviral agents|mesh-ancestor
44753425|NCT02608684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753426|NCT02608684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753427|NCT02608684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753428|NCT02608684|Immunologic Factors|immunologic factors|mesh-ancestor
44753429|NCT02608684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753430|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753431|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
44753432|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753433|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753434|NCT02587520|Vaccines|vaccines|mesh-list
44753435|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
44753436|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753437|NCT02584829|Interferons|interferons|mesh-list
44753438|NCT02584829|Interferon-beta|interferon-beta|mesh-list
44753439|NCT02584829|Avelumab|avelumab|mesh-list
44753440|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44753441|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753442|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
44753443|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753444|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753445|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
44753446|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753447|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
44753448|NCT02559856|Apixaban|apixaban|mesh-list
44753449|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44753450|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
44753451|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44753452|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753453|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753454|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753455|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
44753456|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
44753457|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753458|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753459|NCT02514083|Fludarabine|fludarabine|mesh-list
44753460|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753461|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
44753462|NCT02512172|Azacitidine|azacitidine|mesh-list
44753463|NCT02512172|Romidepsin|romidepsin|mesh-list
44753464|NCT02512172|Cc-486|cc-486|mesh-list
44753465|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753466|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753467|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753468|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
44753469|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753470|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753471|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44753472|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
44753473|NCT02499367|Cisplatin|cisplatin|mesh-list
44753474|NCT02499367|Doxorubicin|doxorubicin|mesh-list
44753475|NCT02499367|Nivolumab|nivolumab|mesh-list
44753476|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753477|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
44753478|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753479|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753480|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753481|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
44753482|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753483|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753484|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753485|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44753486|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44753487|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44753488|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753489|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753490|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753491|NCT02497612|Artefenomel|artefenomel|mesh-list
44753492|NCT02497612|Ferroquine|ferroquine|mesh-list
44753493|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
44753494|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44753495|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44753496|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753497|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44753498|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753499|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753500|NCT02491333|Metformin|metformin|mesh-list
44753501|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753502|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753503|NCT02469987|Bevacizumab|bevacizumab|mesh-list
44753504|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753505|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753506|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44753507|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44688702|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688703|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688704|NCT01344083|Analgesics|analgesics|mesh-ancestor
44688705|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
44688706|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688707|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688708|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688709|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688710|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44688711|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44688712|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44688713|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
44688714|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
44688715|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753508|NCT02469987|Growth Substances|growth substances|mesh-ancestor
44753509|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753510|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44753511|NCT02452268|Spartalizumab|spartalizumab|mesh-list
44753512|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44753513|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753514|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753515|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44753516|NCT02439307|Rifaximin|rifaximin|mesh-list
44753517|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753518|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753519|NCT02381652|Triamcinolone|triamcinolone|mesh-list
44753520|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44753521|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44753522|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
44753523|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44753524|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753525|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
44753526|NCT02381652|Hormones|hormones|mesh-ancestor
44753527|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753528|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753529|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753530|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
44753531|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753532|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753533|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44753534|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
44753535|NCT02381652|Protective Agents|protective agents|mesh-ancestor
44753536|NCT02368301|Dexamethasone|dexamethasone|mesh-list
44753537|NCT02368301|Lenalidomide|lenalidomide|mesh-list
44753538|NCT02368301|Elotuzumab|elotuzumab|mesh-list
44753539|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753540|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
44753541|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
44753542|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753543|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753544|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753545|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
44753546|NCT02368301|Hormones|hormones|mesh-ancestor
44753547|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753548|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753549|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753550|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
44753551|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44753552|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44753553|NCT02368301|Growth Substances|growth substances|mesh-ancestor
44753554|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
44753555|NCT02367794|Paclitaxel|paclitaxel|mesh-list
44282595|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
44753556|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44753557|NCT02367794|Carboplatin|carboplatin|mesh-list
44753558|NCT02367794|Atezolizumab|atezolizumab|mesh-list
44753559|NCT02367794|Antibodies|antibodies|mesh-list
44753560|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44753561|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753562|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
44753563|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
44753564|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
44753565|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753566|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
44753567|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753568|NCT02363998|Lofexidine|lofexidine|mesh-list
44753569|NCT02363998|Clonidine|clonidine|mesh-list
44753570|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44753571|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44753572|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753573|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
44753574|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753575|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44753576|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44753577|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44753578|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44753579|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753580|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753581|NCT02363998|Analgesics|analgesics|mesh-ancestor
44753582|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
44753583|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
44753584|NCT02355379|Capecitabine|capecitabine|mesh-list
44753585|NCT02355379|Fluorouracil|fluorouracil|mesh-list
44753586|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753588|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753589|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753590|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753591|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
44753592|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753593|NCT02325466|Aspirin|aspirin|mesh-list
44753594|NCT02325466|Ticagrelor|ticagrelor|mesh-list
44753595|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44753596|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753597|NCT02325466|Analgesics|analgesics|mesh-ancestor
44753598|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
44753599|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753600|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753601|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753602|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753603|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44753604|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44753605|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753606|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44753607|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44753608|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753609|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
44753610|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44753611|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44753612|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44753613|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
44753614|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753615|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44753616|NCT02323100|Glycerol|glycerol|mesh-list
44753617|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44753618|NCT02323100|Protective Agents|protective agents|mesh-ancestor
44753619|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753620|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753621|NCT02322710|Petrolatum|petrolatum|mesh-list
44753622|NCT02322710|Emollients|emollients|mesh-ancestor
44753623|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753624|NCT02283281|Dronabinol|dronabinol|mesh-list
44753625|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
44753626|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753627|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753628|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753629|NCT02283281|Analgesics|analgesics|mesh-ancestor
44753630|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
44753631|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753632|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44753633|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44753634|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753635|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753636|NCT02283281|Hormones|hormones|mesh-ancestor
44753637|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753638|NCT02204241|Dexamethasone|dexamethasone|mesh-list
44753639|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
44753640|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753641|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
44753642|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753643|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753644|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753645|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
44753646|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753647|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753648|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753649|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753650|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
44753651|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
44531237|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774271|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531238|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531239|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531240|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
44531241|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
44531242|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531243|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
44531244|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44531246|NCT01645800|Muramidase|muramidase|mesh-list
44753652|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753653|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753654|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
44753656|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753657|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753658|NCT02185820|Dexamethasone|dexamethasone|mesh-list
44753659|NCT02185820|Pomalidomide|pomalidomide|mesh-list
44753660|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753661|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
44753662|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
44753663|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753664|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753665|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753666|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
44753667|NCT02185820|Hormones|hormones|mesh-ancestor
44753668|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753669|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753670|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753671|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
44753672|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44753673|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44753674|NCT02185820|Growth Substances|growth substances|mesh-ancestor
44753675|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44753676|NCT02168829|Aspirin|aspirin|mesh-list
44753677|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
44753678|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44753679|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753680|NCT02168829|Analgesics|analgesics|mesh-ancestor
44753681|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
44282711|NCT00740948|Rituximab|rituximab|mesh-list
44753682|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753683|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753684|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753685|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753686|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44753687|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44753688|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753689|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44753690|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44753691|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753692|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
44753693|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44753694|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
44753695|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44753696|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753697|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
44753698|NCT02162563|Leucovorin|leucovorin|mesh-list
44753699|NCT02162563|Bevacizumab|bevacizumab|mesh-list
44753700|NCT02162563|Panitumumab|panitumumab|mesh-list
44753701|NCT02162563|Fluorouracil|fluorouracil|mesh-list
44753702|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
44753703|NCT02162563|Irinotecan|irinotecan|mesh-list
44753704|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
44753705|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44753706|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753707|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44753708|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44753709|NCT02162563|Growth Substances|growth substances|mesh-ancestor
44753710|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753711|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44753712|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
44753713|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753714|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753715|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753716|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
44753717|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44753718|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44753719|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753720|NCT02162563|Antidotes|antidotes|mesh-ancestor
44753721|NCT02162563|Protective Agents|protective agents|mesh-ancestor
44753722|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
44753723|NCT02162563|Vitamins|vitamins|mesh-ancestor
44753724|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
44531255|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
44753725|NCT02127086|Analgesics|analgesics|mesh-list
44753726|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
44753727|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753728|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753729|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44753730|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44753731|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
44753732|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44753733|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44753734|NCT02106195|Belumosudil|belumosudil|mesh-list
44753735|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753736|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753737|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753738|NCT02102243|Insulin|insulin|mesh-list
44753739|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44753740|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753741|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753742|NCT02075177|Ketoconazole|ketoconazole|mesh-list
44753743|NCT02075177|Fenretinide|fenretinide|mesh-list
44753744|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
44753745|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753746|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44753747|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44753748|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753749|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753750|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44753751|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
44753752|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753753|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753754|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44753755|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753756|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44753757|NCT02075177|Protective Agents|protective agents|mesh-ancestor
44753758|NCT02050919|Sorafenib|sorafenib|mesh-list
44753759|NCT02050919|Epirubicin|epirubicin|mesh-list
44753760|NCT02050919|Ifosfamide|ifosfamide|mesh-list
44753761|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
44753762|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753763|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753764|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753765|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753766|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44753767|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44753768|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44753769|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753770|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
44753771|NCT02040857|Tamoxifen|tamoxifen|mesh-list
44753772|NCT02040857|Letrozole|letrozole|mesh-list
44753773|NCT02040857|Palbociclib|palbociclib|mesh-list
44753774|NCT02040857|Anastrozole|anastrozole|mesh-list
44753775|NCT02040857|Exemestane|exemestane|mesh-list
44753776|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44753777|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753778|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44753779|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753780|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753781|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44753782|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44753783|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753784|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753785|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753786|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44753787|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44753788|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44753789|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753790|NCT01997463|Albuterol|albuterol|mesh-list
44753791|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44753792|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
44753793|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753794|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753795|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44753796|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44753797|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
44753798|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44753799|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44753800|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44531325|NCT01646775|Analgesics|analgesics|mesh-ancestor
44753801|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44753802|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688716|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688717|NCT01344174|Lamivudine|lamivudine|mesh-list
44688718|NCT01344174|Dexamethasone|dexamethasone|mesh-list
44688719|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688720|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
44688721|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
44688722|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688723|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688724|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44688725|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
44688727|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688728|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688729|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688730|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44688731|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44688732|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688733|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688734|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
44688735|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688736|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44688737|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44688738|NCT01344213|Celecoxib|celecoxib|mesh-list
44688739|NCT01344213|Pregabalin|pregabalin|mesh-list
44688740|NCT01344213|Analgesics|analgesics|mesh-ancestor
44688741|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
44688742|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688743|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688744|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
44688745|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44688746|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688747|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688748|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44688749|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44688750|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44688751|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688752|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44688753|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688754|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688755|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688756|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688757|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44688758|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44688759|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688760|NCT01344252|Lidocaine|lidocaine|mesh-list
44688761|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
44688762|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
44688763|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688764|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688765|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
44688766|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688767|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44688768|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44688769|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44688770|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688771|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688772|NCT01344291|Curcumin|curcumin|mesh-list
44688773|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688774|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688775|NCT01344291|Analgesics|analgesics|mesh-ancestor
44688776|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
44688777|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688778|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688779|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688780|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688781|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688782|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688783|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688784|NCT01344304|Aprepitant|aprepitant|mesh-list
44688785|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
44688786|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
44688787|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
44753803|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753804|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753805|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
44753806|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44753807|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753808|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753809|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44753810|NCT01976754|Analgesics|analgesics|mesh-ancestor
44753811|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
44753812|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753813|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44753814|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44753815|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44753816|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44753817|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753818|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753819|NCT01943825|Vaccines|vaccines|mesh-list
44753820|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
44753821|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753822|NCT01916317|Lidocaine|lidocaine|mesh-list
44753823|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
44753824|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
44753825|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753826|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753827|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
44753828|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753829|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44753830|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44753831|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44753832|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44753833|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753834|NCT01913951|Azacitidine|azacitidine|mesh-list
44753835|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44753836|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
44753837|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753838|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753839|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753840|NCT01913730|Dexamethasone|dexamethasone|mesh-list
44753841|NCT01913730|Bortezomib|bortezomib|mesh-list
44753842|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753843|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
44753844|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
44753845|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753846|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753847|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753848|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
44753849|NCT01913730|Hormones|hormones|mesh-ancestor
44753850|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753851|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753852|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753853|NCT01904123|Tyrphostins|tyrphostins|mesh-list
44753854|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753855|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753856|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753857|NCT01863186|Lofexidine|lofexidine|mesh-list
44753858|NCT01863186|Clonidine|clonidine|mesh-list
44753859|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44753860|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44753861|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753862|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
44753863|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753864|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44753865|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44753866|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44753867|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44531401|NCT01647633|Calcium|calcium|mesh-list
44531402|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531403|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531404|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44531405|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44531406|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44531407|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44531408|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
44531412|NCT01647646|Hormones|hormones|mesh-ancestor
44753869|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753870|NCT01863186|Analgesics|analgesics|mesh-ancestor
44753871|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
44753872|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
44753873|NCT01857115|Dexamethasone|dexamethasone|mesh-list
44753874|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
44753875|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44753876|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
44753877|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753878|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753879|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44753880|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
44753881|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753882|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753883|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44753884|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44753885|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
44753886|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
44753887|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753888|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753889|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
44753890|NCT01857115|Hormones|hormones|mesh-ancestor
44753891|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753892|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44753893|NCT01828840|Fentanyl|fentanyl|mesh-list
44753894|NCT01828840|Morphine|morphine|mesh-list
44753895|NCT01828840|Methadone|methadone|mesh-list
44753896|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44753897|NCT01828840|Narcotics|narcotics|mesh-ancestor
44753898|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282989|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753899|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753900|NCT01828840|Analgesics|analgesics|mesh-ancestor
44753901|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
44753902|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753903|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44753904|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44753905|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
44753906|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
44753907|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
44753908|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44753909|NCT01817751|Sorafenib|sorafenib|mesh-list
44753910|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
44753911|NCT01817751|Valproic Acid|valproic acid|mesh-list
44753912|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753913|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753914|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753915|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753916|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
44753917|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44753918|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44753919|NCT01817751|Urological Agents|urological agents|mesh-ancestor
44753920|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
44753921|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
44753922|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753923|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753924|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
44753925|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44753926|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753927|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753928|NCT01817426|Infliximab|infliximab|mesh-list
44753929|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753930|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753931|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44753932|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44753933|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753934|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753935|NCT01741103|Incretins|incretins|mesh-ancestor
44753936|NCT01741103|Hormones|hormones|mesh-ancestor
44753937|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753938|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44753939|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
44753940|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753941|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753942|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44753943|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
44753944|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753946|NCT01630590|Hormones|hormones|mesh-ancestor
44753947|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44753948|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753949|NCT01619085|Nintedanib|nintedanib|mesh-list
44753950|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44753951|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44753952|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44753953|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753954|NCT01499095|Insulin|insulin|mesh-list
44753955|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44753956|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
44753957|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753958|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753959|NCT01499082|Insulin|insulin|mesh-list
44753960|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44753961|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
44753962|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44753963|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753964|NCT01488890|Vaccines|vaccines|mesh-list
44753965|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
44753966|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753967|NCT01436396|Vaccines|vaccines|mesh-list
44753968|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
44753969|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753970|NCT01414777|Ondansetron|ondansetron|mesh-list
44753971|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
44753972|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
44753973|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44753974|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753975|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44753976|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
44753977|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44753978|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44753979|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
44753980|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44753981|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753982|NCT01414777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44753983|NCT01414777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44753984|NCT01414777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44753985|NCT01414777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44753986|NCT01414777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44753987|NCT01411241|Vaccines|vaccines|mesh-list
44753988|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44753989|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
44753990|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44753991|NCT01380938|Ribavirin|ribavirin|mesh-list
44753992|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44753993|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
44753994|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
44753995|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44753996|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
44753997|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44753998|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
44753999|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754000|NCT01374516|Vaccines|vaccines|mesh-list
44754001|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
44754002|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754003|NCT01373281|Vaccines|vaccines|mesh-list
44754004|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
44754005|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754006|NCT01346787|Dexamethasone|dexamethasone|mesh-list
44754007|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
44754008|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754009|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
44754010|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754011|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754012|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754013|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
44754014|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754015|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754016|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754017|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754018|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
44754019|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
44754020|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754021|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754022|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
44754023|NCT01346787|Hormones|hormones|mesh-ancestor
44754024|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754025|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754026|NCT01254422|Vaccines|vaccines|mesh-list
44531593|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44754027|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
44754028|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754029|NCT01204242|Lidocaine|lidocaine|mesh-list
44754030|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
44754032|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754033|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754034|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
44754035|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754036|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44754037|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44754038|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44754039|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44754040|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754041|NCT01190787|Prednisone|prednisone|mesh-list
44754042|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
44754043|NCT01190787|Melphalan|melphalan|mesh-list
44754044|NCT01190787|Bortezomib|bortezomib|mesh-list
44754045|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754046|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
44754047|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754048|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754049|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754050|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
44754051|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754052|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688788|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688789|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688790|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44688791|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44688792|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688793|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688794|NCT01344395|Ketorolac|ketorolac|mesh-list
44688795|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44688796|NCT01344395|Ropivacaine|ropivacaine|mesh-list
44688797|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
44688798|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
44688799|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688800|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688802|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688803|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688804|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688805|NCT01344395|Analgesics|analgesics|mesh-ancestor
44688806|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688807|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688808|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44688809|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688810|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688811|NCT01344473|Caseins|caseins|mesh-list
44688812|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
44688813|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
44688814|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688815|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
44688816|NCT01344512|Ceftazidime|ceftazidime|mesh-list
44688817|NCT01344512|Voriconazole|voriconazole|mesh-list
44688818|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44688819|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688820|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44688821|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44688822|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688823|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688824|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688825|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44688826|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44688827|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
44688828|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44688829|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44688830|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
44688831|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688832|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688833|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44688834|NCT01344564|Leuprolide|leuprolide|mesh-list
44688835|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44688836|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
44688837|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44688838|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754053|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754054|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754055|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
44754056|NCT01190787|Hormones|hormones|mesh-ancestor
44754057|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754058|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754059|NCT01187433|Vaccines|vaccines|mesh-list
44754060|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
44754061|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754062|NCT01166113|Prednisone|prednisone|mesh-list
44754063|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
44754064|NCT01166113|Pomalidomide|pomalidomide|mesh-list
44754065|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754066|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
44754067|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754068|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754069|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754070|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
44754071|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754072|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754073|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754074|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754075|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
44754076|NCT01166113|Hormones|hormones|mesh-ancestor
44754077|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754078|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754079|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44754080|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44754081|NCT01166113|Growth Substances|growth substances|mesh-ancestor
44754082|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
44754083|NCT01160107|Prednisone|prednisone|mesh-list
44754084|NCT01160107|Melphalan|melphalan|mesh-list
44754085|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754086|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
44754087|NCT01160107|Hormones|hormones|mesh-ancestor
44754088|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754089|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754090|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754091|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754092|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754093|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
44754094|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754095|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754096|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754097|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
44754098|NCT01150045|Leucovorin|leucovorin|mesh-list
44754099|NCT01150045|Celecoxib|celecoxib|mesh-list
44754100|NCT01150045|Fluorouracil|fluorouracil|mesh-list
44754101|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
44754102|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
44754103|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754104|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44754105|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754106|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754107|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
44754108|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754109|NCT01150045|Antidotes|antidotes|mesh-ancestor
44754110|NCT01150045|Protective Agents|protective agents|mesh-ancestor
44754111|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
44754112|NCT01150045|Vitamins|vitamins|mesh-ancestor
44754113|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
44754114|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44754115|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44754116|NCT01150045|Analgesics|analgesics|mesh-ancestor
44531689|NCT01649895|Cycloserine|cycloserine|mesh-list
44531690|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44531691|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531692|NCT01649895|Renal Agents|renal agents|mesh-ancestor
44531693|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44531694|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
44531695|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531696|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
44531697|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531698|NCT01649921|Interferons|interferons|mesh-list
44531699|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
44531700|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754117|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
44754118|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754119|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754120|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754121|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44754122|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44754123|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754124|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
44754125|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
44754126|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754127|NCT01098032|Expectorants|expectorants|mesh-ancestor
44754128|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
44754129|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44754130|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
44754131|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754132|NCT01098032|Protective Agents|protective agents|mesh-ancestor
44754133|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754134|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
44754135|NCT01096368|Cisplatin|cisplatin|mesh-list
44754136|NCT01096368|Carboplatin|carboplatin|mesh-list
44754137|NCT01096368|Etoposide|etoposide|mesh-list
44754138|NCT01096368|Vincristine|vincristine|mesh-list
44754139|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
44754140|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
44754141|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754142|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
44754143|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754144|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754145|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754146|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
44754147|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754148|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754149|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754150|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754151|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44754152|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44754153|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754154|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754155|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754156|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754157|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
44754158|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44754159|NCT01093196|Dexamethasone|dexamethasone|mesh-list
44754160|NCT01093196|Prednisone|prednisone|mesh-list
44754161|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
44754162|NCT01093196|Melphalan|melphalan|mesh-list
44754163|NCT01093196|Lenalidomide|lenalidomide|mesh-list
44754164|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754165|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
44754166|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754167|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754168|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754169|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
44754170|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754171|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754172|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754173|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754174|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
44754175|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
44754176|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754177|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754178|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
44754179|NCT01093196|Hormones|hormones|mesh-ancestor
44754180|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754181|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754182|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44754183|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44754184|NCT01093196|Growth Substances|growth substances|mesh-ancestor
44754185|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
44754186|NCT00945009|Dactinomycin|dactinomycin|mesh-list
44754187|NCT00945009|Cactinomycin|cactinomycin|mesh-list
44754188|NCT00945009|Doxorubicin|doxorubicin|mesh-list
44754189|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44754190|NCT00945009|Vincristine|vincristine|mesh-list
44754191|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44531704|NCT01648751|Hormones|hormones|mesh-ancestor
44754192|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754193|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44754194|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44754195|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754196|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754197|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754198|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754199|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754200|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754201|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754202|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754203|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44754204|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44754205|NCT00942877|Cediranib|cediranib|mesh-list
44754206|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754207|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44754208|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754209|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754210|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44754211|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44754212|NCT00896389|Diuretics|diuretics|mesh-ancestor
44754213|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
44754214|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754215|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44754216|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44754217|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754218|NCT00887146|Vincristine|vincristine|mesh-list
44754219|NCT00887146|Temozolomide|temozolomide|mesh-list
44754220|NCT00887146|Procarbazine|procarbazine|mesh-list
44754221|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754222|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754223|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754224|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754225|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754226|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754227|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754228|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
44754229|NCT00880893|Vaccines|vaccines|mesh-list
44754230|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
44754231|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754232|NCT00579527|Cyclosporine|cyclosporine|mesh-list
44754233|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
44754234|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
44754235|NCT00579527|Prednisolone|prednisolone|mesh-list
44754236|NCT00579527|Tacrolimus|tacrolimus|mesh-list
44754237|NCT00579527|Cyclosporins|cyclosporins|mesh-list
44754238|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
44754239|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44754240|NCT00579527|Daclizumab|daclizumab|mesh-list
44754241|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
44754242|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754243|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
44754244|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754245|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44754246|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754247|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754248|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
44754249|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754250|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
44754251|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754252|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44754253|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754254|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44754255|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
44754256|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754257|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754258|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
44754259|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
44754260|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754261|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754262|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
44754263|NCT00579527|Hormones|hormones|mesh-ancestor
44754264|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754265|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44754266|NCT00579527|Protective Agents|protective agents|mesh-ancestor
44754267|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754268|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531850|NCT02757898|Biotin|biotin|mesh-list
44754269|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
44754270|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44754271|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754272|NCT00551928|Prednisone|prednisone|mesh-list
44754273|NCT00551928|Lenalidomide|lenalidomide|mesh-list
44754274|NCT00551928|Melphalan|melphalan|mesh-list
44754275|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754276|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
44754277|NCT00551928|Hormones|hormones|mesh-ancestor
44754278|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754279|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754280|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754281|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754282|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
44754283|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44754284|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44754285|NCT00551928|Growth Substances|growth substances|mesh-ancestor
44754286|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
44754287|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754288|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
44754289|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754290|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754291|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754292|NCT00531232|Clofarabine|clofarabine|mesh-list
44754293|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44754294|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
44754295|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754296|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754297|NCT00379340|Dactinomycin|dactinomycin|mesh-list
44754298|NCT00379340|Cactinomycin|cactinomycin|mesh-list
44754299|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
44754300|NCT00379340|Doxorubicin|doxorubicin|mesh-list
44754301|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44754302|NCT00379340|Etoposide|etoposide|mesh-list
44754303|NCT00379340|Vincristine|vincristine|mesh-list
44754304|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
44754305|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754306|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
44754307|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754308|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754309|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754310|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
44754311|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754312|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754313|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754314|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44754315|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44754316|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44754317|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754318|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754319|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754320|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754321|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754322|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754323|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754324|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44754325|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44754326|NCT00304070|Cisplatin|cisplatin|mesh-list
44754327|NCT00304070|Doxorubicin|doxorubicin|mesh-list
44754328|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44754329|NCT00304070|Etoposide|etoposide|mesh-list
44754330|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
44754331|NCT00304070|Mitotane|mitotane|mesh-list
44754332|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754333|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44754334|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44754335|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44754336|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754337|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754338|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754339|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754340|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
44754341|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44754342|NCT00066950|Fluorides|fluorides|mesh-list
44754343|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
44754344|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
44754345|NCT00066950|Protective Agents|protective agents|mesh-ancestor
44754346|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754347|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44754348|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754349|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
44754350|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44754351|NCT00004935|Trastuzumab|trastuzumab|mesh-list
44754352|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44754353|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754354|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44754355|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
44754356|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44754357|NCT01694134|Prednisolone|prednisolone|mesh-list
44754358|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
44754359|NCT01694134|Lidocaine|lidocaine|mesh-list
44754360|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44754361|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
44754362|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
44754363|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
44754364|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754365|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754366|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
44754367|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754368|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44754369|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44754370|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44754371|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44754372|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754373|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754374|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
44754375|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
44754376|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754377|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
44754378|NCT01694134|Hormones|hormones|mesh-ancestor
44754379|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754380|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44754381|NCT01694134|Protective Agents|protective agents|mesh-ancestor
44754382|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754383|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754384|NCT01694212|Diclofenac|diclofenac|mesh-list
44754385|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44754386|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44754387|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44754388|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44754389|NCT01694212|Analgesics|analgesics|mesh-ancestor
44754390|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
44754391|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754392|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754393|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754394|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754395|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44754396|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754397|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754398|NCT01694264|Entecavir|entecavir|mesh-list
44754399|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
44754400|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754401|NCT01694355|Vitamin D|vitamin d|mesh-list
44754402|NCT01694355|Vitamins|vitamins|mesh-ancestor
44754403|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
44754404|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754405|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754406|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44754407|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44754408|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754409|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
44754410|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754411|NCT01694407|Tenofovir|tenofovir|mesh-list
44754412|NCT01694407|Emtricitabine|emtricitabine|mesh-list
44754413|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
44754414|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754415|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44754416|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44754417|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754418|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754419|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44688839|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688840|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688841|NCT01344590|Ethanol|ethanol|mesh-list
44688842|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44688843|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688844|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688845|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688846|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44688847|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44688848|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
44688849|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688850|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688851|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44688852|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44688853|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44688854|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44688855|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44688856|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688857|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688858|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688859|NCT01344681|Itraconazole|itraconazole|mesh-list
44688860|NCT01344681|Micafungin|micafungin|mesh-list
44688861|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
44688862|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688863|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44688864|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44688865|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688866|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688867|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44532009|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754420|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44754421|NCT01694459|Heparin|heparin|mesh-list
44754422|NCT01694459|Calcium heparin|calcium heparin|mesh-list
44754423|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
44754424|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44754425|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44754426|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754427|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44754428|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
44754429|NCT01694498|Coagulants|coagulants|mesh-ancestor
44754430|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44754431|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
44754432|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754433|NCT01694576|Paclitaxel|paclitaxel|mesh-list
44754434|NCT01694576|Nedaplatin|nedaplatin|mesh-list
44754435|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754436|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754437|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754438|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754439|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754440|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532010|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532011|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44532012|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532013|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44532014|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
44532015|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44532016|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532017|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
44354835|NCT01103817|Vitamin D|vitamin d|mesh-list
44754441|NCT01694693|Abatacept|abatacept|mesh-list
44754442|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44754443|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754444|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754445|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754446|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
44754447|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754448|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754449|NCT01694732|Varenicline|varenicline|mesh-list
44754450|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44754451|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44754452|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
44754453|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754454|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754455|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754456|NCT01694797|Metoprolol|metoprolol|mesh-list
44754457|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44754458|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44754459|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
44754460|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
44754461|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754462|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754463|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44754464|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44754465|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44754466|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44754467|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754468|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754469|NCT01695005|Prednisone|prednisone|mesh-list
44754470|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754471|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
44754472|NCT01695005|Hormones|hormones|mesh-ancestor
44754473|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754474|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754475|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754476|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754477|NCT01695057|Vorinostat|vorinostat|mesh-list
44754478|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754479|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44754480|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283604|NCT00745511|Bevacizumab|bevacizumab|mesh-list
44754481|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754482|NCT01695070|Melatonin|melatonin|mesh-list
44754483|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
44754484|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754485|NCT01695070|Protective Agents|protective agents|mesh-ancestor
44754486|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754487|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754488|NCT01695109|Liraglutide|liraglutide|mesh-list
44754489|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754490|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754491|NCT01695109|Incretins|incretins|mesh-ancestor
44754492|NCT01695109|Hormones|hormones|mesh-ancestor
44754493|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754494|NCT01695122|Valproic Acid|valproic acid|mesh-list
44754495|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
44754496|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754497|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754498|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
44754499|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754500|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754501|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
44754502|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44754503|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754504|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44754505|NCT01695148|Carotenoids|carotenoids|mesh-list
44754506|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
44754507|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754508|NCT01695148|Protective Agents|protective agents|mesh-ancestor
44754509|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754510|NCT01695174|Rifaximin|rifaximin|mesh-list
44754511|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754512|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754513|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754514|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
44754515|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
44754516|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754517|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754518|NCT01695226|Celecoxib|celecoxib|mesh-list
44754519|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44754520|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44754521|NCT01695226|Analgesics|analgesics|mesh-ancestor
44754522|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
44754523|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754524|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754525|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754526|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754527|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44754528|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44754529|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754530|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754531|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
44754532|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
44754533|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
44754534|NCT01695356|Avobenzone|avobenzone|mesh-list
44754535|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
44754536|NCT01695356|Benzophenone|benzophenone|mesh-list
44754537|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44754538|NCT01695356|Protective Agents|protective agents|mesh-ancestor
44754539|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754540|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
44754541|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44754542|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
44754543|NCT01695460|Vitamins|vitamins|mesh-list
44754544|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
44754545|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754546|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44754547|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754548|NCT01695707|Pioglitazone|pioglitazone|mesh-list
44754549|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754550|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754551|NCT01695733|Vaccines|vaccines|mesh-list
44754552|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
44754553|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754554|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
44754555|NCT01695759|Hematinics|hematinics|mesh-ancestor
44754556|NCT01695798|Vaccines|vaccines|mesh-list
44754557|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
44754558|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754559|NCT01695824|Warfarin|warfarin|mesh-list
44754560|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
44754561|NCT01695850|Sennosides|sennosides|mesh-list
44754562|NCT01695850|Laxatives|laxatives|mesh-ancestor
44754563|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754564|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
44754565|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44754566|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
44754567|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44754568|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754569|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44754570|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44754571|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44754572|NCT01696110|Heparin|heparin|mesh-list
44754573|NCT01696110|Calcium heparin|calcium heparin|mesh-list
44754574|NCT01696110|Tirofiban|tirofiban|mesh-list
44754575|NCT01696110|Bivalirudin|bivalirudin|mesh-list
44754576|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
44754577|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44754578|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44754579|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754580|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
44754581|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44754582|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
44754583|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754584|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44754585|NCT01696240|Udenafil|udenafil|mesh-list
44754586|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44754587|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44754588|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754589|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754590|NCT01696370|Trimetazidine|trimetazidine|mesh-list
44754591|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
44754592|NCT01696383|Timolol|timolol|mesh-list
44754593|NCT01696383|Travoprost|travoprost|mesh-list
44754594|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44754595|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44754596|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
44754597|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754598|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754599|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754600|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44754601|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44532193|NCT01682746|Trioxsalen|trioxsalen|mesh-list
44754602|NCT01696409|Vitamin D|vitamin d|mesh-list
44754603|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
44754604|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
44754605|NCT01696409|Vitamins|vitamins|mesh-list
44754606|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
44754607|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754608|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754609|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44754610|NCT01696422|Vaccines|vaccines|mesh-list
44754611|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
44754612|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754613|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
44754614|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
44754615|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754616|NCT01696448|Protective Agents|protective agents|mesh-ancestor
44754617|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754618|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
44754619|NCT01696448|Vitamins|vitamins|mesh-ancestor
44754620|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
44754621|NCT01696461|Plerixafor|plerixafor|mesh-list
44754622|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44754623|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44754624|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
44754625|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754626|NCT01696474|Bortezomib|bortezomib|mesh-list
44754627|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754628|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
44754629|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44754630|NCT01696500|Antibodies|antibodies|mesh-list
44754631|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
44754632|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44754633|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
44754634|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754635|NCT01696526|Vitamin D|vitamin d|mesh-list
44754636|NCT01696526|Vitamins|vitamins|mesh-ancestor
44754637|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
44754638|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754639|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754640|NCT01696552|Cimetidine|cimetidine|mesh-list
44754641|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44754642|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754643|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44754644|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
44754645|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
44754646|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754647|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754648|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754649|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44754650|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44754651|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754652|NCT01696617|Aripiprazole|aripiprazole|mesh-list
44754653|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
44754654|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44754655|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44754656|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44754657|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754658|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754659|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
44754660|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
44754661|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754662|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754663|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44754664|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44532241|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532242|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532243|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532244|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532245|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
44532246|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532247|NCT01683253|Dopamine|dopamine|mesh-list
44532248|NCT01683253|Levodopa|levodopa|mesh-list
44532249|NCT01683253|Carbidopa|carbidopa|mesh-list
44532250|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
44532251|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44532252|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44754665|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
44754666|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44754667|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44754668|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44754669|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44754670|NCT01696630|Desflurane|desflurane|mesh-list
44754671|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44754672|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
44754673|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
44754674|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754675|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754676|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44754677|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
44754678|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754679|NCT01696799|Econazole|econazole|mesh-list
44754680|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
44754681|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754682|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44754683|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44754684|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754685|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754686|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44688868|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
44688869|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688889|NCT01344863|Trastuzumab|trastuzumab|mesh-list
44688890|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688891|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688892|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
44688893|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44688894|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44688895|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
44688896|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44688897|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44688898|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688899|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688900|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
44688901|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
44688902|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688903|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
44688904|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44688905|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688906|NCT01345084|Cisplatin|cisplatin|mesh-list
44688907|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
44688908|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688909|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688910|NCT01345240|Vaccines|vaccines|mesh-list
44688911|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
44688912|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688913|NCT01345279|Paclitaxel|paclitaxel|mesh-list
44688914|NCT01345279|Cisplatin|cisplatin|mesh-list
44688915|NCT01345279|Topotecan|topotecan|mesh-list
44688916|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44688917|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688918|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
44688919|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
44688920|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
44688921|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688922|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44688923|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44688924|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688925|NCT01345357|Gemcitabine|gemcitabine|mesh-list
44688926|NCT01345357|Cisplatin|cisplatin|mesh-list
44688927|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688928|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44688929|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
44688930|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688931|NCT01345357|Antiviral Agents|antiviral agents|mesh-ancestor
44688932|NCT01345357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44688933|NCT01345357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688934|NCT01345357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44688935|NCT01345357|Immunologic Factors|immunologic factors|mesh-ancestor
44688936|NCT01345357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688937|NCT01345370|Temozolomide|temozolomide|mesh-list
44688938|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44688939|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
44707254|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44754687|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
44532253|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
44754688|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754689|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754690|NCT01696825|Diazepam|diazepam|mesh-list
44754691|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44754692|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
44754693|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
44754694|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
44754695|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754696|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754697|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754698|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44754699|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754700|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44754701|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44754702|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44754703|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44754704|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44754705|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44754706|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
44754707|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
44754708|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
44754709|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
44754710|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754711|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754712|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
44754713|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
44754714|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754715|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44754716|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754717|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754718|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
44754719|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754720|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44754721|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754722|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44754723|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
44754724|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44754725|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44754726|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754727|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754728|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
44754729|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754730|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44754731|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44754732|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44754733|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44754734|NCT01697059|Amoxicillin|amoxicillin|mesh-list
44754735|NCT01697059|Piperacillin|piperacillin|mesh-list
44754736|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44754737|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754738|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754739|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44754740|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754741|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754742|NCT01697098|Dexamethasone|dexamethasone|mesh-list
44754743|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
44754744|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
44754745|NCT01697098|BB 1101|bb 1101|mesh-list
44754746|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754747|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
44754748|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
44754749|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754750|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754751|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754752|NCT01697098|Hormones|hormones|mesh-ancestor
44754753|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754754|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754755|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754756|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
44754757|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754758|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754759|NCT01697111|Dienogest|dienogest|mesh-list
44754760|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44532274|NCT01683552|Fexofenadine|fexofenadine|mesh-list
44283976|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
44754761|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
44754762|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44754763|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754764|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44754765|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44754766|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44754767|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44754768|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
44754769|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754770|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44754771|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754772|NCT01697150|Pancrelipase|pancrelipase|mesh-list
44754773|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44754774|NCT01697228|Vitamin D|vitamin d|mesh-list
44754775|NCT01697228|Vitamins|vitamins|mesh-ancestor
44754776|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
44754777|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754778|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754779|NCT01697293|Paclitaxel|paclitaxel|mesh-list
44754780|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
44754781|NCT01697293|Doxorubicin|doxorubicin|mesh-list
44754782|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44754783|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44754784|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44754785|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754786|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44754787|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44754788|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44754789|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754790|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754791|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
44754792|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754793|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44754794|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44754795|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
44754796|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44754797|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44754798|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44754799|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44754800|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754801|NCT01697306|Gemcitabine|gemcitabine|mesh-list
44754802|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
44754803|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44754804|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
44754805|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754806|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754807|NCT01697306|Antiviral Agents|antiviral agents|mesh-ancestor
44754808|NCT01697306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754809|NCT01697306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754810|NCT01697306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754811|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
44754812|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754813|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44754814|NCT01697410|Terlipressin|terlipressin|mesh-list
44754815|NCT01697410|Norepinephrine|norepinephrine|mesh-list
44754816|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44754817|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44754818|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
44754819|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754820|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754821|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754822|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
44754823|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
44754824|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754825|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44754826|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44754827|NCT01697436|Ribavirin|ribavirin|mesh-list
44754828|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
44754829|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754830|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
44754831|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754832|NCT01697605|Infigratinib|infigratinib|mesh-list
44754833|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754834|NCT01697618|Insulin|insulin|mesh-list
44754835|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44754836|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
44754837|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
44754838|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44754839|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754840|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754841|NCT01697631|Insulin|insulin|mesh-list
44754842|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44754843|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
44754844|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
44754845|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44754846|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
44754847|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44754848|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754849|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754850|NCT01697657|Insulin|insulin|mesh-list
44754851|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44754852|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
44754853|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
44754854|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
44754855|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
44754856|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
44754857|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754858|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754859|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44754860|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44754861|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44754862|NCT01697722|Beclomethasone|beclomethasone|mesh-list
44754863|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44754864|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
44754865|NCT01697722|Hormones|hormones|mesh-ancestor
44754866|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754867|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754868|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44754869|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44754870|NCT01697735|Atorvastatin|atorvastatin|mesh-list
44754871|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44754872|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44754873|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44754874|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
44754875|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754876|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44754877|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44754878|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754879|NCT01697787|Artesunate|artesunate|mesh-list
44754880|NCT01697787|Lumefantrine|lumefantrine|mesh-list
44754881|NCT01697787|Artemether|artemether|mesh-list
44754882|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44754883|NCT01697787|Amodiaquine|amodiaquine|mesh-list
44754884|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
44754885|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44754886|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44754887|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754888|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754889|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
44754890|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
44754891|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44754892|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
44754893|NCT01697826|Clindamycin|clindamycin|mesh-list
44754894|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
44754895|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
44754896|NCT01697826|Clotrimazole|clotrimazole|mesh-list
44754897|NCT01697826|Miconazole|miconazole|mesh-list
44754898|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44754899|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532425|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532426|NCT01684787|Ribavirin|ribavirin|mesh-list
44532427|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44532428|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
44532429|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
44532430|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532431|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
44532432|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532433|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
44532434|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532435|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44355339|NCT01107639|Cisplatin|cisplatin|mesh-list
44754900|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44754901|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754902|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754904|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
44754905|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44754906|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44754907|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44754908|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
44754909|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754910|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754911|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44754912|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44754913|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44754914|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44754915|NCT01698164|Estradiol|estradiol|mesh-list
44754916|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44754917|NCT01698164|Progesterone|progesterone|mesh-list
44754918|NCT01698164|Estrogens|estrogens|mesh-ancestor
44754919|NCT01698164|Hormones|hormones|mesh-ancestor
44754920|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44754921|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754922|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44754923|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
44754924|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44754925|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44754926|NCT01698164|Progestins|progestins|mesh-ancestor
44754927|NCT01698177|Vaccines|vaccines|mesh-list
44754928|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
44754929|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754930|NCT01698203|Ropivacaine|ropivacaine|mesh-list
44754931|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
44754932|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
44754933|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754934|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284097|NCT00748891|Cediranib|cediranib|mesh-list
44754935|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
44754936|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754937|NCT01698476|Vitamin D|vitamin d|mesh-list
44754938|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
44754939|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44754940|NCT01698476|Vitamins|vitamins|mesh-ancestor
44754941|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
44754942|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754943|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44754944|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44754945|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44754946|NCT01698541|Tacrolimus|tacrolimus|mesh-list
44754947|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44754948|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
44754949|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754950|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44754951|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754952|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754953|NCT01698567|Antithrombins|antithrombins|mesh-list
44688940|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688941|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688942|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44688943|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44688944|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44688945|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44688946|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44688947|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
44688948|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688949|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688950|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688951|NCT01345604|Ropivacaine|ropivacaine|mesh-list
44688952|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
44688953|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
44688954|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44688955|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688956|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
44688957|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688958|NCT01345643|Chrysarobin|chrysarobin|mesh-list
44688959|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44688960|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44688961|NCT01345643|Analgesics|analgesics|mesh-ancestor
44688962|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
44688963|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240586|NCT00581139|Midazolam|midazolam|mesh-list
44688964|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688965|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688966|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688967|NCT01345708|Prednisone|prednisone|mesh-list
44688968|NCT01345708|Rituximab|rituximab|mesh-list
44688969|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44688970|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44688971|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
44284200|NCT00749619|Taurolidine|taurolidine|mesh-list
44688972|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688973|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44688974|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44688975|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
44688976|NCT01345708|Hormones|hormones|mesh-ancestor
44688977|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688978|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44688979|NCT01345734|Liraglutide|liraglutide|mesh-list
44688980|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44688981|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688982|NCT01345734|Incretins|incretins|mesh-ancestor
44688983|NCT01345734|Hormones|hormones|mesh-ancestor
44688984|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44688985|NCT01345864|Scopolamine|scopolamine|mesh-list
44688986|NCT01345864|Donepezil|donepezil|mesh-list
44688987|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44688988|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44688989|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44688990|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44688991|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
44688992|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44688993|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44688994|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
44688995|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44754954|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
44754955|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44754956|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
44754957|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44754958|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754959|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
44754960|NCT01698593|Epinephrine|epinephrine|mesh-list
44754961|NCT01698593|Bupivacaine|bupivacaine|mesh-list
44754962|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
44754963|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
44754964|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44754965|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754966|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
44754967|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754968|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44754969|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44754970|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
44754971|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44754972|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754973|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44754974|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44754975|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
44754976|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44754977|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
44754978|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
44754979|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
44284259|NCT00749853|Buserelin|buserelin|mesh-list
44754980|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44754981|NCT01698645|Fentanyl|fentanyl|mesh-list
44754982|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44754983|NCT01698645|Narcotics|narcotics|mesh-ancestor
44754984|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284269|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44754985|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754986|NCT01698645|Analgesics|analgesics|mesh-ancestor
44754987|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
44754988|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44754989|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44754990|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44754991|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
44754992|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
44754993|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
44754994|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44754995|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44754996|NCT01698723|Ribavirin|ribavirin|mesh-list
44754997|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
44754998|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44754999|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
44755000|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755001|NCT01698749|Dexamethasone|dexamethasone|mesh-list
44755002|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755003|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
44755004|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
44755005|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755006|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755007|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755008|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
44755009|NCT01698749|Hormones|hormones|mesh-ancestor
44755010|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755011|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44755012|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755013|NCT01698788|Dexamethasone|dexamethasone|mesh-list
44755014|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
44755015|NCT01698788|BB 1101|bb 1101|mesh-list
44755016|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755017|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
44755018|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
44284292|NCT00750113|Telmisartan|telmisartan|mesh-list
44755019|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755020|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755021|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755022|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
44755023|NCT01698788|Hormones|hormones|mesh-ancestor
44755024|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755025|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44755026|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755027|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755028|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755029|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755030|NCT01698931|Glyburide|glyburide|mesh-list
44755031|NCT01698931|Repaglinide|repaglinide|mesh-list
44755032|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44755033|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755034|NCT01699113|Rabeprazole|rabeprazole|mesh-list
44755035|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44755036|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755037|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44755038|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755039|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755040|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44755041|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44755042|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44755043|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
44755044|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755045|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44755046|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44755047|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755048|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
44755049|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44755050|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
44284330|NCT00750334|Clofarabine|clofarabine|mesh-list
44755051|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755052|NCT01699204|Expectorants|expectorants|mesh-ancestor
44755053|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755054|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44755055|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
44755056|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755057|NCT01699204|Protective Agents|protective agents|mesh-ancestor
44755058|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755059|NCT01699204|Antidotes|antidotes|mesh-ancestor
44755060|NCT01699282|Antivitamins K|antivitamins k|mesh-list
44755061|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
44755062|NCT01699347|Picibanil|picibanil|mesh-list
44755063|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755064|NCT01699360|Cyclosporine|cyclosporine|mesh-list
44755065|NCT01699360|Sirolimus|sirolimus|mesh-list
44755066|NCT01699360|Tacrolimus|tacrolimus|mesh-list
44755067|NCT01699360|Cyclosporins|cyclosporins|mesh-list
44755068|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755069|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
44755070|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755071|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44755072|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284348|NCT00750347|Hormones|hormones|mesh-ancestor
44755073|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755074|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
44755075|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755076|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755077|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44755078|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755079|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44755080|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755081|NCT01699412|Dexamethasone|dexamethasone|mesh-list
44755082|NCT01699412|Clobetasol|clobetasol|mesh-list
44755083|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755084|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
44755085|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
44755086|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755087|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755088|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284365|NCT00750425|Cediranib|cediranib|mesh-list
44755089|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
44755090|NCT01699412|Hormones|hormones|mesh-ancestor
44284370|NCT00750451|Heparin|heparin|mesh-list
44755091|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755092|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44755093|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755094|NCT01699438|Mesalamine|mesalamine|mesh-list
44755095|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44755096|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44755097|NCT01699438|Analgesics|analgesics|mesh-ancestor
44755098|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
44755099|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755100|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755101|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755102|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44755103|NCT01699490|Valsartan|valsartan|mesh-list
44755104|NCT01699490|Fluoxetine|fluoxetine|mesh-list
44755105|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44755106|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44532605|NCT01686464|Hormones|hormones|mesh-ancestor
44755107|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44755108|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755109|NCT01699490|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44755110|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44755111|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755112|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755113|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
44755114|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755115|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44755116|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
44755117|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755118|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44755119|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44755120|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755121|NCT01699594|Mannitol|mannitol|mesh-list
44755122|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
44755123|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44215398|NCT00462696|Docetaxel|docetaxel|mesh-list
44755124|NCT01699594|Diuretics|diuretics|mesh-ancestor
44755125|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
44755126|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755127|NCT01699594|Miotics|miotics|mesh-ancestor
44755128|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
44215494|NCT00463021|Vitamins|vitamins|mesh-ancestor
44755129|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755130|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44755131|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44755132|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755133|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44755134|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44755135|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
44755136|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755137|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755138|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44755139|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
44755140|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755141|NCT01699711|Protective Agents|protective agents|mesh-ancestor
44755142|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755143|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44755144|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44755145|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755146|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44755147|NCT01699724|Sertraline|sertraline|mesh-list
44755148|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
44755149|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755150|NCT01699724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44755151|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44755152|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44688996|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
44688997|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
44688998|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44688999|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689000|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
44689001|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44689002|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44689003|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
44689004|NCT01345981|Lidocaine|lidocaine|mesh-list
44532681|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532682|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532683|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44532684|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284428|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
44532685|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532686|NCT01687049|Red yeast rice|red yeast rice|mesh-list
44532687|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44532688|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44532689|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44532690|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
44532691|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532692|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532693|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44532694|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44532695|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44532696|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
44532697|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
44532698|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284457|NCT00751062|Timolol|timolol|mesh-list
44532699|NCT01687127|Folic Acid|folic acid|mesh-list
44755153|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755154|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755155|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
44755156|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755157|NCT01699776|Digoxin|digoxin|mesh-list
44755158|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44755159|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44755160|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755161|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755162|NCT01699776|Protective Agents|protective agents|mesh-ancestor
44755163|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755164|NCT01699802|Anesthetics|anesthetics|mesh-list
44755165|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755166|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755167|NCT01699828|Buspirone|buspirone|mesh-list
44755168|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44755169|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44755170|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755171|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755172|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755173|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44755174|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
44755175|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755176|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755177|NCT01699854|Capsaicin|capsaicin|mesh-list
44755178|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
44755179|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755180|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
44755181|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755182|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755183|NCT01699919|Lidocaine|lidocaine|mesh-list
44217100|NCT00471393|Analgesics|analgesics|mesh-ancestor
44755184|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755185|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
44755186|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755187|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755188|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
44755189|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755190|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44755191|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44755192|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44755193|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755194|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755195|NCT01699932|Metformin|metformin|mesh-list
44755196|NCT01699932|Glimepiride|glimepiride|mesh-list
44457151|NCT01616693|Zinc|zinc|mesh-list
44755197|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44755198|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755199|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44755200|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755201|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
44755202|NCT01699997|Oxytocin|oxytocin|mesh-list
44755203|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
44755204|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44755205|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755206|NCT01700010|Paclitaxel|paclitaxel|mesh-list
44755207|NCT01700010|Lapatinib|lapatinib|mesh-list
44284512|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
44755208|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44755209|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755210|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44284513|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
44755211|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44755212|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44755213|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755214|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44755215|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689005|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755217|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44755218|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44755219|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284526|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
44755220|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755221|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755222|NCT01700270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44755223|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44755224|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755225|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755226|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755227|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
44284529|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755228|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44755229|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
44755230|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44689006|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
44284538|NCT00751270|Valacyclovir|valacyclovir|mesh-list
44689007|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689008|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689009|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
44689010|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689011|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689012|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44689013|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44284547|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689014|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689015|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689016|NCT01346007|Vaccines|vaccines|mesh-list
44689017|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44689018|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
44689019|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689020|NCT01346137|Meloxicam|meloxicam|mesh-list
44689021|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44689022|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689023|NCT01346137|Analgesics|analgesics|mesh-ancestor
44689024|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
44689025|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689026|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689027|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689028|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689029|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44689030|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44689031|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689032|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689033|NCT01346215|Heparin|heparin|mesh-list
44689034|NCT01346215|Calcium heparin|calcium heparin|mesh-list
44689035|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
44689036|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44689037|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44774272|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689038|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689055|NCT01346800|Ritonavir|ritonavir|mesh-list
44689056|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44689057|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44689058|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44689059|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
44689060|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689061|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689062|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44689063|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44689064|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
44689065|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689066|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44457387|NCT01611090|Rituximab|rituximab|mesh-list
44689067|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44689068|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44689069|NCT01346826|Infliximab|infliximab|mesh-list
44689070|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44689071|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689072|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689073|NCT01346865|Cilostazol|cilostazol|mesh-list
44689074|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44689075|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
44689076|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689077|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689078|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44755231|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44755233|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44755234|NCT01700322|Clopidogrel|clopidogrel|mesh-list
44755235|NCT01700322|Ticagrelor|ticagrelor|mesh-list
44755236|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44755237|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44755238|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43539114|NCT03783403|Cetuximab|cetuximab|mesh-list
44755239|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44755240|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44755241|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
44755242|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755243|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774273|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
44755244|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755245|NCT01700400|Bevacizumab|bevacizumab|mesh-list
44755246|NCT01700400|Carboplatin|carboplatin|mesh-list
44755247|NCT01700400|Pemetrexed|pemetrexed|mesh-list
44755248|NCT01700400|Everolimus|everolimus|mesh-list
44755249|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755250|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755251|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44755252|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44755253|NCT01700400|Growth Substances|growth substances|mesh-ancestor
44755254|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755255|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
44755256|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755257|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755258|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44755259|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44755260|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755261|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
44755262|NCT01700413|Idarubicin|idarubicin|mesh-list
44755263|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44755264|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755265|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44755266|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44755267|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755268|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755269|NCT01700426|Vitamins|vitamins|mesh-list
44755270|NCT01700426|Vitamin E|vitamin e|mesh-list
44755271|NCT01700426|Tocopherols|tocopherols|mesh-list
44755272|NCT01700426|Tocotrienols|tocotrienols|mesh-list
44755273|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
44755274|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
44755275|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755276|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
44755277|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755278|NCT01700426|Protective Agents|protective agents|mesh-ancestor
43668245|NCT03736616|Cytarabine|cytarabine|mesh-list
44755279|NCT01700478|Vasopressins|vasopressins|mesh-list
44755280|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
44755281|NCT01700478|Misoprostol|misoprostol|mesh-list
44755282|NCT01700478|Diuretics|diuretics|mesh-list
44755283|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755284|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44755285|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
44755286|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44755287|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44755288|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755289|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
44755290|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
44755291|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
44755292|NCT01700478|Coagulants|coagulants|mesh-ancestor
44755293|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44755294|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44755295|NCT01700491|Ropivacaine|ropivacaine|mesh-list
44755296|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755297|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
44755298|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755299|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755300|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
44774274|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44755301|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755302|NCT01700504|Gentamicins|gentamicins|mesh-list
44774275|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44755303|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755304|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755305|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44755306|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755307|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755309|NCT01700569|Folic Acid|folic acid|mesh-list
44755310|NCT01700569|Temozolomide|temozolomide|mesh-list
44755311|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
44755312|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774276|NCT01848106|Bivalirudin|bivalirudin|mesh-list
44755313|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44755314|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
44755315|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755316|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755317|NCT01700569|Antidotes|antidotes|mesh-ancestor
44755318|NCT01700569|Protective Agents|protective agents|mesh-ancestor
44755319|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
44755320|NCT01700569|Vitamins|vitamins|mesh-ancestor
44755321|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
44755322|NCT01700569|Hematinics|hematinics|mesh-ancestor
44755323|NCT01700608|Plerixafor|plerixafor|mesh-list
44755324|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44755325|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44284675|NCT00752024|Coagulants|coagulants|mesh-ancestor
44755326|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
44755327|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755328|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44755329|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755330|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755331|NCT01700790|Ritonavir|ritonavir|mesh-list
44755332|NCT01700790|Lopinavir|lopinavir|mesh-list
44284684|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44755333|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44755334|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44755335|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755336|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755337|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755338|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43541007|NCT01965132|Adalimumab|adalimumab|mesh-list
44755339|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44755340|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
44755341|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755342|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44774277|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
44755343|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44755344|NCT01700803|Iodine|iodine|mesh-list
44755345|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
44228348|NCT00524381|Etanercept|etanercept|mesh-list
44755346|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
44755347|NCT01700803|Povidone|povidone|mesh-list
44755348|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44755349|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284701|NCT00752115|Paclitaxel|paclitaxel|mesh-list
44755350|NCT01700803|Trace Elements|trace elements|mesh-ancestor
44755351|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
44755352|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755353|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
44755354|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
44755355|NCT01700881|Vitamin E|vitamin e|mesh-list
44755356|NCT01700881|Vitamins|vitamins|mesh-ancestor
44755357|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
44229093|NCT00527215|Hematinics|hematinics|mesh-ancestor
44755358|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755359|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
44755360|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755361|NCT01700881|Protective Agents|protective agents|mesh-ancestor
44755362|NCT01701076|Dexamethasone|dexamethasone|mesh-list
44229403|NCT00528983|Cc-486|cc-486|mesh-list
44755363|NCT01701076|Lenalidomide|lenalidomide|mesh-list
44755364|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44755365|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755366|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
44755367|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
44755368|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284716|NCT00752141|Oxybutynin|oxybutynin|mesh-list
44755369|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755370|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532891|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
44532892|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
44532893|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
44532894|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532895|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44532896|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
44532897|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
43541755|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
44532898|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44532899|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
44532900|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44532901|NCT01688583|Fentanyl|fentanyl|mesh-list
44532902|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44755371|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
44755372|NCT01701076|Hormones|hormones|mesh-ancestor
44755373|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755374|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44755375|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755376|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755377|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
44755378|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44755379|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44755380|NCT01701076|Growth Substances|growth substances|mesh-ancestor
44755381|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
44755382|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44755383|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
44755384|NCT01701089|Selegiline|selegiline|mesh-list
44464080|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
44755385|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
44755386|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755387|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44755388|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44755389|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44755390|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755391|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755392|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44755393|NCT01701089|Protective Agents|protective agents|mesh-ancestor
44755394|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755395|NCT01701180|Oxytocin|oxytocin|mesh-list
44755396|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
44755397|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44755398|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755399|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44755400|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755401|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755402|NCT01701232|Rituximab|rituximab|mesh-list
44755403|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755404|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755405|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
44755406|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755407|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44755408|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44755409|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44755410|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755411|NCT01701297|Renal Agents|renal agents|mesh-ancestor
44755412|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755413|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
44755414|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44755415|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44755416|NCT01701323|Cytarabine|cytarabine|mesh-list
44755417|NCT01701323|Fludarabine|fludarabine|mesh-list
44755418|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
44755419|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755420|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44755421|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
44755422|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755423|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755424|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
44755425|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755426|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
44755427|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755428|NCT01701336|Cloricromen|cloricromen|mesh-list
44755429|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44755430|NCT01701349|Paclitaxel|paclitaxel|mesh-list
44755431|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
44755432|NCT01701349|Combretastatin|combretastatin|mesh-list
44755433|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44755434|NCT01701349|Carboplatin|carboplatin|mesh-list
44755435|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44755436|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755437|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44755438|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44755439|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44755440|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755441|NCT01701453|Clopidogrel|clopidogrel|mesh-list
44755442|NCT01701453|Ticagrelor|ticagrelor|mesh-list
44755443|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44755444|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44284777|NCT00752401|Vitamins|vitamins|mesh-ancestor
44755445|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44755446|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44755447|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44755448|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
44755449|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755450|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232991|NCT00542152|Infliximab|infliximab|mesh-list
44755451|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755453|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44755454|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755455|NCT01701479|Aldesleukin|aldesleukin|mesh-list
44755456|NCT01701479|Interleukin-2|interleukin-2|mesh-list
44755457|NCT01701479|Dinutuximab|dinutuximab|mesh-list
44755458|NCT01701479|Isotretinoin|isotretinoin|mesh-list
44755459|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755460|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44755461|NCT01701479|Analgesics|analgesics|mesh-ancestor
44755462|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
44755463|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755464|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755465|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44755466|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44755467|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
44755468|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755469|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755470|NCT01701518|Dexamethasone|dexamethasone|mesh-list
44755471|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755472|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
44755473|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
44755474|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755475|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755476|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755477|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
44755478|NCT01701518|Hormones|hormones|mesh-ancestor
44755479|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755480|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44755481|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755482|NCT01701583|Omalizumab|omalizumab|mesh-list
44755483|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44755484|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44755485|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755486|NCT01701739|Digoxin|digoxin|mesh-list
44755487|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44755488|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44755489|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755490|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755491|NCT01701739|Protective Agents|protective agents|mesh-ancestor
44755492|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755493|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
44755494|NCT01701778|Sevoflurane|sevoflurane|mesh-list
44755495|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
44755496|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44755497|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755498|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755499|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44755500|NCT01701778|Analgesics|analgesics|mesh-ancestor
44755501|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
44755502|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755503|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44755504|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44755505|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44755506|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44755507|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774278|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44284832|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
44284833|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44284834|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
44284835|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284836|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284837|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755508|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755509|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44755510|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44755511|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
44755512|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
44755513|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755514|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
44755515|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44755516|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
44755517|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755518|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284851|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
44755519|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44755520|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755521|NCT01701856|Interferons|interferons|mesh-list
44755522|NCT01701856|Interferon-beta|interferon-beta|mesh-list
44755523|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
44755524|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755525|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
44755526|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755527|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
44755528|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755529|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44755530|NCT01701882|Tenofovir|tenofovir|mesh-list
44755531|NCT01701882|Emtricitabine|emtricitabine|mesh-list
44755532|NCT01701882|Rilpivirine|rilpivirine|mesh-list
44755533|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
44755534|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755535|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44755536|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44755537|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755538|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755539|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44755540|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44755541|NCT01701921|Pregabalin|pregabalin|mesh-list
44755542|NCT01701921|Analgesics|analgesics|mesh-ancestor
44755543|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
44755544|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755545|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755546|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
44755547|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44755548|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755549|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284876|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
44755550|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44755551|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44755552|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44755553|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755554|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755555|NCT01702038|Rituximab|rituximab|mesh-list
44755556|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755557|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755558|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
44755559|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755560|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44755561|NCT01702090|Ritonavir|ritonavir|mesh-list
44755562|NCT01702090|Darunavir|darunavir|mesh-list
44755563|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44755564|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44755565|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755566|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755567|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755568|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44284908|NCT00752648|Simeprevir|simeprevir|mesh-list
44755569|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44689079|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
44689080|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44689081|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44689082|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284914|NCT00752661|Tramadol|tramadol|mesh-list
44689083|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44689084|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689085|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44689086|NCT01346865|Protective Agents|protective agents|mesh-ancestor
44689087|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44689088|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44689089|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689090|NCT01346917|Lidocaine|lidocaine|mesh-list
44689091|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689092|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
44689093|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689094|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689095|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
44689096|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689097|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689098|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44689099|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44689100|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689101|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689102|NCT01346930|Macitentan|macitentan|mesh-list
44689103|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44689104|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44284922|NCT00752739|Selenium|selenium|mesh-list
44689105|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689106|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44689107|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44689108|NCT01347268|Hormones|hormones|mesh-ancestor
44689109|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44689110|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689111|NCT01347294|Bleomycin|bleomycin|mesh-list
44689112|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44689113|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689114|NCT01347424|Paclitaxel|paclitaxel|mesh-list
44689115|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44284939|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44689116|NCT01347424|Carboplatin|carboplatin|mesh-list
44689117|NCT01347424|Endostatins|endostatins|mesh-list
44689118|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44689119|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689120|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44689121|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44689122|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44689123|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689124|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44689125|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44689126|NCT01347424|Growth Substances|growth substances|mesh-ancestor
44689127|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689128|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
44689130|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44689131|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689132|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
44774279|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44689133|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
44689134|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44689135|NCT01347814|Domperidone|domperidone|mesh-list
44689136|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
44689137|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
44755570|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
44755571|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755572|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44284965|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44284966|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44755573|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44755574|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
44755575|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755576|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755577|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44755578|NCT01702129|Doxorubicin|doxorubicin|mesh-list
44755579|NCT01702129|Cetuximab|cetuximab|mesh-list
44755580|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44755581|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755582|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44755583|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44755584|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755585|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755586|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755587|NCT01702181|Tacrolimus|tacrolimus|mesh-list
44755588|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755589|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
44755590|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755591|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44755592|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755593|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755594|NCT01702207|Tacrolimus|tacrolimus|mesh-list
44755595|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755596|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
44755597|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755598|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44755599|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755600|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755601|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
44755602|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755603|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755604|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44755605|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44755606|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755607|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755608|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755609|NCT01702389|Remifentanil|remifentanil|mesh-list
44755610|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44755611|NCT01702389|Narcotics|narcotics|mesh-ancestor
44755612|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755613|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755614|NCT01702389|Analgesics|analgesics|mesh-ancestor
44755615|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
44755616|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284996|NCT00753038|Paclitaxel|paclitaxel|mesh-list
44755617|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
44755618|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44755619|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755620|NCT01702506|Antacids|antacids|mesh-list
44755621|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755622|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755623|NCT01702610|Temozolomide|temozolomide|mesh-list
44533175|NCT01684397|Bevacizumab|bevacizumab|mesh-list
44533176|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44533177|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
44533178|NCT01684397|Antibodies|antibodies|mesh-list
44533179|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
44533180|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44533181|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
44533182|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533183|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44533184|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285016|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44533185|NCT01684397|Growth Substances|growth substances|mesh-ancestor
44533186|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533187|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
44533188|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
44533189|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
44533190|NCT01685359|Hematinics|hematinics|mesh-ancestor
44533191|NCT01689246|Methylene Blue|methylene blue|mesh-list
44533192|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533193|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533194|NCT01687985|Laxatives|laxatives|mesh-list
44533195|NCT01687985|Cathartics|cathartics|mesh-list
44533196|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755624|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44755626|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755627|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755628|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
44755629|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
44755630|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44755631|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44755632|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755633|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285038|NCT00753103|Azathioprine|azathioprine|mesh-list
44755634|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44755635|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44755636|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
44755637|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44755638|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44755639|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755640|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
44755641|NCT01702636|Coagulants|coagulants|mesh-ancestor
44755642|NCT01702649|Biapenem|biapenem|mesh-list
44755643|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755644|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
44755645|NCT01702688|Giapreza|giapreza|mesh-list
44755646|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
44285052|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44755647|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44755648|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44755649|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755650|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755651|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755652|NCT01702701|Fluticasone|fluticasone|mesh-list
44755653|NCT01702701|Montelukast|montelukast|mesh-list
44755654|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755655|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44755656|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
44755657|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755658|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755659|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44755660|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755661|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755662|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44755663|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44755664|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
44755665|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755666|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44755667|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44755668|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755669|NCT01702714|Gemcitabine|gemcitabine|mesh-list
44755670|NCT01702714|Paclitaxel|paclitaxel|mesh-list
44755671|NCT01702714|Cisplatin|cisplatin|mesh-list
44755672|NCT01702714|Carboplatin|carboplatin|mesh-list
44755673|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44755674|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755675|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44755676|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44755677|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44755678|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755679|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44755680|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
44755681|NCT01702714|Antiviral Agents|antiviral agents|mesh-ancestor
44755682|NCT01702714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755683|NCT01702714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755684|NCT01702714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755685|NCT01702714|Immunologic Factors|immunologic factors|mesh-ancestor
44755686|NCT01702714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755687|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44755688|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44755689|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
44755690|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755691|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44755692|NCT01702857|Vaccines|vaccines|mesh-list
44755693|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
44755694|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
44755695|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755696|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44755697|NCT01702857|Antacids|antacids|mesh-ancestor
44533225|NCT01680965|Ofatumumab|ofatumumab|mesh-list
44755698|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755699|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44755700|NCT01702974|Vitamin D|vitamin d|mesh-list
44755701|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
44285117|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
44755702|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44755703|NCT01702974|Vitamins|vitamins|mesh-ancestor
44755704|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
44755705|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755706|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44755707|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44755708|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755709|NCT01703104|Folic Acid|folic acid|mesh-list
44755710|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
44755711|NCT01703104|Proguanil|proguanil|mesh-list
44755712|NCT01703104|Hematinics|hematinics|mesh-ancestor
44755713|NCT01703104|Vitamins|vitamins|mesh-ancestor
44285119|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44755714|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
44755715|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755716|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
44755717|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44755718|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44755719|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755720|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
44755721|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755722|NCT01703130|Ropivacaine|ropivacaine|mesh-list
44755723|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755724|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
44755725|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755726|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755727|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
44755728|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755729|NCT01703234|Ramipril|ramipril|mesh-list
44755730|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44755731|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755732|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755733|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755734|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44755735|NCT01703312|Omalizumab|omalizumab|mesh-list
44755736|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44755737|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44755738|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755739|NCT01703325|Triamcinolone|triamcinolone|mesh-list
44755740|NCT01703325|Clobetasol|clobetasol|mesh-list
44755741|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44755742|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
44755743|NCT01703325|Hormones|hormones|mesh-ancestor
44755744|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755745|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755746|NCT01703351|Fentanyl|fentanyl|mesh-list
44755747|NCT01703351|Ropivacaine|ropivacaine|mesh-list
44755748|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755749|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
44755750|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774280|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755751|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755752|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
44755753|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755754|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44755755|NCT01703351|Narcotics|narcotics|mesh-ancestor
44755756|NCT01703351|Analgesics|analgesics|mesh-ancestor
44755757|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44755758|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44755759|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
44755760|NCT01703364|Lenalidomide|lenalidomide|mesh-list
44755761|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
44755762|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755763|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44755764|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44755765|NCT01703364|Growth Substances|growth substances|mesh-ancestor
44755766|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
44755767|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755768|NCT01703390|Cetuximab|cetuximab|mesh-list
44755769|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755770|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755771|NCT01703455|Sorafenib|sorafenib|mesh-list
44755772|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755773|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44755774|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755775|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755776|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
44755777|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
44755778|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44755779|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44755780|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755781|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755782|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44755783|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44755784|NCT01703559|Phentolamine|phentolamine|mesh-list
44755785|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44755786|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44755787|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44755788|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44755789|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
44755790|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755791|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755792|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755793|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44755794|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
44755795|NCT01703624|Bromides|bromides|mesh-list
44755796|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
44755797|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44755798|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44755799|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44755800|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44755801|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755802|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755803|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755804|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44755805|NCT01703637|Vildagliptin|vildagliptin|mesh-list
44755806|NCT01703637|Saxagliptin|saxagliptin|mesh-list
44755807|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44285212|NCT00753909|Bevacizumab|bevacizumab|mesh-list
44755808|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755809|NCT01703637|Incretins|incretins|mesh-ancestor
44755810|NCT01703637|Hormones|hormones|mesh-ancestor
44755811|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755812|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44755813|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44755814|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755815|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755816|NCT01703728|Menotropins|menotropins|mesh-list
44755817|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44755818|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
44755819|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44755820|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755821|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
44533367|NCT04829799|Lidocaine|lidocaine|mesh-list
44533368|NCT04829799|Phenylephrine|phenylephrine|mesh-list
44755822|NCT01703754|Ifosfamide|ifosfamide|mesh-list
44755823|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44755824|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
44755825|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755826|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533369|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
44533370|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
44533371|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
44533372|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533373|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533374|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
44464096|NCT01499849|Dexamethasone|dexamethasone|mesh-list
44533375|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533376|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44533377|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44533378|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44533379|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755827|NCT01703910|Gemcitabine|gemcitabine|mesh-list
44755828|NCT01703910|Paclitaxel|paclitaxel|mesh-list
44755829|NCT01703910|Etoposide|etoposide|mesh-list
44755830|NCT01703910|Vinorelbine|vinorelbine|mesh-list
44755831|NCT01703910|Docetaxel|docetaxel|mesh-list
44755832|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44755833|NCT01703910|Cisplatin|cisplatin|mesh-list
44755834|NCT01703910|Doxorubicin|doxorubicin|mesh-list
44464105|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
44755835|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44755836|NCT01703910|Fluorouracil|fluorouracil|mesh-list
44755837|NCT01703910|Capecitabine|capecitabine|mesh-list
44755838|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
44464116|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44755839|NCT01703910|Irinotecan|irinotecan|mesh-list
44755840|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
44689138|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689139|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689140|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44689141|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44689142|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
44689143|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689144|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689145|NCT01347853|Ketorolac|ketorolac|mesh-list
44689146|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44689147|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44689148|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689149|NCT01347853|Analgesics|analgesics|mesh-ancestor
44689150|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
44689151|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689152|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689153|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44689154|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689155|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44689156|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689157|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689158|NCT01347944|Lenalidomide|lenalidomide|mesh-list
44689159|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
44689160|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689161|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44689162|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44689163|NCT01347944|Growth Substances|growth substances|mesh-ancestor
44689164|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
44689165|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689166|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
44689167|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44689168|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
44689169|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689170|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689171|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44689172|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
44285262|NCT00754403|Metformin|metformin|mesh-list
44285263|NCT00754403|Pioglitazone|pioglitazone|mesh-list
44285264|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44285265|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285266|NCT00754429|Losartan|losartan|mesh-list
44285267|NCT00754429|Amlodipine|amlodipine|mesh-list
44285268|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285269|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44285270|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44689173|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44689174|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
44689175|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689176|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689177|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44689178|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
44689179|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
44689180|NCT01347957|Protective Agents|protective agents|mesh-ancestor
44689181|NCT01347983|Methotrexate|methotrexate|mesh-list
44689182|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44689183|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
44689184|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44689185|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689186|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689187|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
44689188|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285286|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689189|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689190|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44689191|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689192|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44689193|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44689194|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
44689195|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44689196|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44689197|NCT01347996|Interleukin-2|interleukin-2|mesh-list
44755841|NCT01703910|Pemetrexed|pemetrexed|mesh-list
44755842|NCT01703910|Cetuximab|cetuximab|mesh-list
44755843|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44755844|NCT01703910|Sorafenib|sorafenib|mesh-list
44755845|NCT01703910|Topotecan|topotecan|mesh-list
44755846|NCT01703910|Dasatinib|dasatinib|mesh-list
44755847|NCT01703910|Mitomycins|mitomycins|mesh-list
44755848|NCT01703910|Mitomycin|mitomycin|mesh-list
44755849|NCT01703910|Raltitrexed|raltitrexed|mesh-list
44755850|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285297|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755851|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755852|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44755853|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44755854|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44755855|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755856|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44755857|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
44755858|NCT01703910|Antiviral Agents|antiviral agents|mesh-ancestor
44755859|NCT01703910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755860|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755861|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755862|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
44755863|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755864|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44755865|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44755866|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44755867|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44755868|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44755869|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44755870|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755871|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44755872|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
44755873|NCT01704027|Androgens|androgens|mesh-list
44755874|NCT01704027|Hormones|hormones|mesh-ancestor
44755875|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44755876|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755877|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
44755878|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44755879|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755880|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755881|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44755882|NCT01704092|Analgesics|analgesics|mesh-ancestor
44755883|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
44755884|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755885|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44755886|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44755887|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44755888|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
44755889|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755890|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755891|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44755892|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44755893|NCT01704339|Capsaicin|capsaicin|mesh-list
44755894|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
44755895|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755896|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
44285348|NCT00754871|Hormones|hormones|mesh-ancestor
44755897|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755898|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755899|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
44755900|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
44755901|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44755902|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755903|NCT01704417|Insulin|insulin|mesh-list
44755904|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44755905|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
44755906|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44755907|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755908|NCT01704469|Anesthetics|anesthetics|mesh-list
44755909|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
44755910|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755911|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755912|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
44755913|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755914|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
44755915|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44755916|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
44755917|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755918|NCT01704482|Expectorants|expectorants|mesh-ancestor
44755919|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
44755920|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44755921|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
44755922|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755923|NCT01704482|Protective Agents|protective agents|mesh-ancestor
44755924|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755925|NCT01704482|Antidotes|antidotes|mesh-ancestor
44755926|NCT01704508|Lumefantrine|lumefantrine|mesh-list
44755927|NCT01704508|Artemether|artemether|mesh-list
44755928|NCT01704508|Piperaquine|piperaquine|mesh-list
44755929|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44755930|NCT01704508|Artenimol|artenimol|mesh-list
44755931|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
44755932|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44755933|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44755934|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44755935|NCT01704534|Ustekinumab|ustekinumab|mesh-list
44755936|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
44755937|NCT01704612|Ropivacaine|ropivacaine|mesh-list
44755938|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
44755939|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
44755940|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755941|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755942|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
44755943|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44755944|NCT01704638|Digoxin|digoxin|mesh-list
44755945|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
44755946|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44755947|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44755948|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44755949|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755950|NCT01704638|Protective Agents|protective agents|mesh-ancestor
44755951|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755952|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44755953|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44755954|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44755955|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44755956|NCT01704638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44755957|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44755958|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44755959|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44755960|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
44755961|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44755962|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
44755963|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44755964|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44755965|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44755966|NCT01704690|Paclitaxel|paclitaxel|mesh-list
44755967|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44755968|NCT01704690|Cisplatin|cisplatin|mesh-list
44755969|NCT01704690|Fluorouracil|fluorouracil|mesh-list
44755970|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44755971|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755972|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44755973|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44755974|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44755975|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44755976|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
44755977|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44755978|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44755979|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
44755980|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44755981|NCT01704703|Panitumumab|panitumumab|mesh-list
44755982|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44755983|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44755984|NCT01704716|Aldesleukin|aldesleukin|mesh-list
44755985|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
44755986|NCT01704716|Melphalan|melphalan|mesh-list
44755987|NCT01704716|Busulfan|busulfan|mesh-list
44755988|NCT01704716|Carboplatin|carboplatin|mesh-list
44755989|NCT01704716|Doxorubicin|doxorubicin|mesh-list
44755990|NCT01704716|Etoposide|etoposide|mesh-list
44755991|NCT01704716|Vincristine|vincristine|mesh-list
44755992|NCT01704716|Interleukin-2|interleukin-2|mesh-list
44755993|NCT01704716|Dinutuximab|dinutuximab|mesh-list
44755994|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533528|NCT01600274|Androgens|androgens|mesh-ancestor
44755995|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
44755996|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285439|NCT00755118|Vitamins|vitamins|mesh-ancestor
44755997|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44755998|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44755999|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
44756000|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756001|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756002|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44756003|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44756004|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44756005|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44756006|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756007|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285454|NCT00755170|Bevacizumab|bevacizumab|mesh-list
44756008|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44756009|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44756010|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44756011|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44756012|NCT01704716|Analgesics|analgesics|mesh-ancestor
44756013|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
44756014|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44756015|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44756016|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44756017|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
44756018|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756019|NCT01704794|Folic Acid|folic acid|mesh-list
44756020|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
44756021|NCT01704794|Proguanil|proguanil|mesh-list
44756022|NCT01704794|Hematinics|hematinics|mesh-ancestor
44756023|NCT01704794|Vitamins|vitamins|mesh-ancestor
44756024|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
44756025|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756026|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
44756027|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44756028|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44756029|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756030|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
44756031|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756032|NCT01704872|Dinutuximab|dinutuximab|mesh-list
44756033|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756034|NCT01704898|Efavirenz|efavirenz|mesh-list
44756035|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44756036|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44756037|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756038|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756039|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
44756040|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44756041|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44756042|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44756043|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44756044|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44756045|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44756046|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44756047|NCT01705002|Bevacizumab|bevacizumab|mesh-list
44756048|NCT01705002|Capecitabine|capecitabine|mesh-list
44756049|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44756050|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756051|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756052|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756053|NCT01705002|Growth Substances|growth substances|mesh-ancestor
44756054|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756055|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
44756056|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44756057|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
44756058|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756059|NCT01705041|Liver Extracts|liver extracts|mesh-list
44756060|NCT01705041|Hematinics|hematinics|mesh-ancestor
44756061|NCT01705158|Carboplatin|carboplatin|mesh-list
44756062|NCT01705158|Doxorubicin|doxorubicin|mesh-list
44756063|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44756064|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756065|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44756066|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44756067|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44756068|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756069|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756070|NCT01705184|Bevacizumab|bevacizumab|mesh-list
44756071|NCT01705184|Cisplatin|cisplatin|mesh-list
44756072|NCT01705184|Pemetrexed|pemetrexed|mesh-list
44756073|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44756074|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756075|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44756076|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44756077|NCT01705184|Growth Substances|growth substances|mesh-ancestor
44756078|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689199|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
44689200|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689201|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44689202|NCT01347996|Analgesics|analgesics|mesh-ancestor
44689203|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
44689204|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689205|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689206|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
44689207|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
44689208|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689209|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689210|NCT01348009|Cisplatin|cisplatin|mesh-list
44689211|NCT01348009|Capecitabine|capecitabine|mesh-list
44689212|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689213|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44689214|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
44689215|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689216|NCT01348126|Docetaxel|docetaxel|mesh-list
44689217|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44689218|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
44689219|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
44689220|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
44689221|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689222|NCT01348204|Quercetin|quercetin|mesh-list
44689223|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
44689224|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689225|NCT01348204|Protective Agents|protective agents|mesh-ancestor
44689226|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689227|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
44689228|NCT01348243|Lidocaine|lidocaine|mesh-list
44689229|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
44689230|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
44689231|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44689232|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689233|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
44689234|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44689235|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44689236|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44689237|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44689238|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285553|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689239|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689240|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44689241|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
44689242|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44689243|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689244|NCT01348282|Rivastigmine|rivastigmine|mesh-list
44689245|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44689246|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689247|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689248|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44689249|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
44689250|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44689251|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44689252|NCT01348282|Protective Agents|protective agents|mesh-ancestor
44689253|NCT01348308|Maraviroc|maraviroc|mesh-list
44689254|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44689255|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44689256|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44689257|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44689258|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44689259|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
44689260|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44689261|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44689262|NCT01348321|Levamisole|levamisole|mesh-list
44689263|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44689264|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
44689265|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44689266|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
44285577|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285579|NCT00755573|Pregabalin|pregabalin|mesh-list
44285589|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44756079|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
44756080|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756081|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756082|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44756083|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44756084|NCT01705223|Vaccines|vaccines|mesh-list
44756085|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
44756086|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756087|NCT01705249|Norethindrone|norethindrone|mesh-list
44756088|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
44756089|NCT01705249|Estradiol|estradiol|mesh-list
44756090|NCT01705249|Estrogens|estrogens|mesh-ancestor
44756091|NCT01705249|Hormones|hormones|mesh-ancestor
44756092|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44756093|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756094|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44756095|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
44756096|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44756097|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44756098|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44756099|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44756100|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44756101|NCT01705314|Vitamin D|vitamin d|mesh-list
44756102|NCT01705314|Vitamins|vitamins|mesh-ancestor
44756103|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
44756104|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44756105|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44756106|NCT01705340|Trastuzumab|trastuzumab|mesh-list
44756107|NCT01705340|Lapatinib|lapatinib|mesh-list
44756108|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44756109|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44756110|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44756111|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44756112|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44756113|NCT01705379|Lactitol|lactitol|mesh-list
44756114|NCT01705379|Cathartics|cathartics|mesh-ancestor
44756115|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799984|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
44799985|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799986|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799987|NCT02017639|Simvastatin|simvastatin|mesh-list
44799988|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44799989|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44799990|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
44799991|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799992|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44799993|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44799994|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799995|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
44799996|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44799997|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799998|NCT02018055|Aspirin|aspirin|mesh-list
44799999|NCT02018055|Clopidogrel|clopidogrel|mesh-list
44800000|NCT02018055|Ticagrelor|ticagrelor|mesh-list
44800001|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44800002|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44800003|NCT02018055|Analgesics|analgesics|mesh-ancestor
44800004|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
44800005|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800006|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800007|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800008|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800009|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44800010|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44800011|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800012|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44800013|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44800014|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800015|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
44800016|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44800017|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44800018|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44800019|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
44800020|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800021|NCT02018081|Levofloxacin|levofloxacin|mesh-list
44800022|NCT02018081|Ofloxacin|ofloxacin|mesh-list
44800023|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44800024|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800025|NCT02018081|Renal Agents|renal agents|mesh-ancestor
44800026|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800027|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44800028|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44800029|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800030|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800031|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800032|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44800033|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44800035|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
44800036|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
44800037|NCT02018094|Metronidazole|metronidazole|mesh-list
44800038|NCT02018094|Clindamycin|clindamycin|mesh-list
44800039|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44800040|NCT02018094|Teicoplanin|teicoplanin|mesh-list
44800041|NCT02018094|Povidone|povidone|mesh-list
44800042|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44800043|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800044|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
44800045|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800046|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44800047|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44800048|NCT02018094|Trace Elements|trace elements|mesh-ancestor
44800049|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
44800050|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800051|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44800052|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800053|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800054|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
44800055|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
44800056|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44800058|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
44800059|NCT02018133|Vitamins|vitamins|mesh-ancestor
44800060|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
44800061|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800062|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800063|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800064|NCT02018159|Menotropins|menotropins|mesh-list
44800065|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44800066|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
44800067|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800068|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800069|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
44800070|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800071|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
44800072|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800073|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800074|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
44800075|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800076|NCT02018263|Cocaine|cocaine|mesh-list
44800077|NCT02018263|Nicotine|nicotine|mesh-list
44800078|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44800079|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
44800080|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800081|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800082|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44800083|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44800084|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800085|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800086|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800087|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800088|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
44800089|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800090|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
44800091|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44285736|NCT00756184|Travoprost|travoprost|mesh-list
44800092|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44800093|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800094|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800095|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
44800096|NCT02018276|Lidocaine|lidocaine|mesh-list
44800097|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800098|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
44800099|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800100|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800101|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
44800102|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800103|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44800104|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44800105|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44800106|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800107|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800108|NCT02018289|Triclosan|triclosan|mesh-list
44800109|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44800110|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800111|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44800112|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44800113|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
44800114|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800115|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44800116|NCT02018328|Curcumin|curcumin|mesh-list
44800117|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44800118|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44800119|NCT02018328|Analgesics|analgesics|mesh-ancestor
44800120|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
44800121|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800122|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800123|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800124|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800125|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800126|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800127|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800129|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44800130|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800131|NCT02018419|Vaccines|vaccines|mesh-list
44800132|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
44800133|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800134|NCT02018523|Lenalidomide|lenalidomide|mesh-list
44800135|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
44800136|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800137|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44800138|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44800139|NCT02018523|Growth Substances|growth substances|mesh-ancestor
44800140|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
44800141|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800143|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
44800144|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800145|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
44800146|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800147|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800148|NCT02018588|Tryptophan|tryptophan|mesh-list
44800149|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44800150|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44800151|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800152|NCT02018601|Acetaminophen|acetaminophen|mesh-list
44800153|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44800154|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44800155|NCT02018601|Analgesics|analgesics|mesh-ancestor
44800156|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
44800157|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800158|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800159|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
44800160|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44800161|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800162|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800163|NCT02018731|Metformin|metformin|mesh-list
44800164|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44800165|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800166|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
44800167|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
44800168|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44800169|NCT02018757|Estrogens|estrogens|mesh-ancestor
44800170|NCT02018757|Hormones|hormones|mesh-ancestor
44800171|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800172|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800173|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44800174|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800175|NCT02018783|Listerine|listerine|mesh-list
44800176|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
44800177|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
44800178|NCT02018783|Protective Agents|protective agents|mesh-ancestor
44800179|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800180|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44800181|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800182|NCT02018796|Misoprostol|misoprostol|mesh-list
44800183|NCT02018796|Mifepristone|mifepristone|mesh-list
44800184|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44800185|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
44800186|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800187|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800188|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44800189|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800190|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
44800191|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44800192|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44800193|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44800194|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44800195|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
44800196|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44800197|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44800198|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
44800199|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800200|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
44800201|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44800202|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44800203|NCT02018874|Gemcitabine|gemcitabine|mesh-list
44800204|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800205|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
44800206|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800207|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800208|NCT02018874|Antiviral Agents|antiviral agents|mesh-ancestor
44800209|NCT02018874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800210|NCT02018874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800211|NCT02018874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800212|NCT02018874|Immunologic Factors|immunologic factors|mesh-ancestor
44800213|NCT02018874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800214|NCT02018965|Vitamins|vitamins|mesh-list
44800215|NCT02018965|Niacin|niacin|mesh-list
44800216|NCT02018965|Niacinamide|niacinamide|mesh-list
44800217|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
44800218|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
44800219|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
44800220|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800221|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44800222|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
44800223|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800224|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44800225|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
44800226|NCT02018991|Everolimus|everolimus|mesh-list
44800227|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800228|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800229|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
44800230|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800231|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
44800232|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44800233|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44800234|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44285833|NCT00757185|Testosterone|testosterone|mesh-list
44800235|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800236|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800237|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800238|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800239|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800240|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44800241|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800242|NCT02019056|Pyridoxine|pyridoxine|mesh-list
44800243|NCT02019056|Metadoxine|metadoxine|mesh-list
44800244|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44800245|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
44800246|NCT02019056|Vitamins|vitamins|mesh-ancestor
44800247|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
44800248|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800249|NCT02019095|Dimercaprol|dimercaprol|mesh-list
44800250|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
44800251|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
44800252|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800253|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
44800254|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44800255|NCT02019160|Fluorides|fluorides|mesh-list
44800256|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
44800257|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
44800258|NCT02019160|Protective Agents|protective agents|mesh-ancestor
44800259|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800260|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44800261|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800262|NCT02019186|Vitamins|vitamins|mesh-list
44800263|NCT02019186|Ascorbic Acid|ascorbic acid|mesh-list
44800264|NCT02019186|Vitamin E|vitamin e|mesh-list
44800265|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
44800266|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800267|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
44800268|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800269|NCT02019186|Protective Agents|protective agents|mesh-ancestor
44800270|NCT02019290|Midazolam|midazolam|mesh-list
44800271|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44800272|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44800273|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800274|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800275|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44800276|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800277|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800278|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44800279|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
44800280|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
44800281|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
44800282|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
44800283|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800284|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800285|NCT02019329|Risperidone|risperidone|mesh-list
44800286|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44800287|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
44800288|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800289|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800290|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800291|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44800292|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800293|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800294|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800295|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44800296|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
44800297|NCT02019355|Fluorouracil|fluorouracil|mesh-list
44800298|NCT02019355|Calcipotriene|calcipotriene|mesh-list
44800299|NCT02019355|Petrolatum|petrolatum|mesh-list
44800300|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
44800301|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800302|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800303|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800304|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800305|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
44800306|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800307|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800308|NCT02019355|Emollients|emollients|mesh-ancestor
44800309|NCT02019381|Vitamin D|vitamin d|mesh-list
44800310|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
44800311|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
44800312|NCT02019381|Vitamins|vitamins|mesh-list
44285949|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44800313|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
44800314|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800315|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800316|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800317|NCT02019446|Terbinafine|terbinafine|mesh-list
44800318|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
44800319|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800320|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800321|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800322|NCT02019459|Nicotine|nicotine|mesh-list
44800323|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44800324|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
44800325|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800326|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800327|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44800328|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44800329|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800330|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800331|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800332|NCT02019485|Tapentadol|tapentadol|mesh-list
44800333|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44800334|NCT02019485|Narcotics|narcotics|mesh-ancestor
44800335|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800336|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800337|NCT02019485|Analgesics|analgesics|mesh-ancestor
44800338|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
44285963|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44800339|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800340|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44800341|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800342|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800343|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800344|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44800345|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800346|NCT02019524|Folic Acid|folic acid|mesh-list
44800347|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
44800348|NCT02019524|Molgramostim|molgramostim|mesh-list
44800349|NCT02019524|Vaccines|vaccines|mesh-list
44800350|NCT02019524|Sargramostim|sargramostim|mesh-list
44800351|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
44800352|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800353|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800354|NCT02019524|Hematinics|hematinics|mesh-ancestor
44800355|NCT02019524|Vitamins|vitamins|mesh-ancestor
44800356|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
44800357|NCT02019784|Rifaximin|rifaximin|mesh-list
44800358|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800359|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800360|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800361|NCT02019797|Desflurane|desflurane|mesh-list
44800362|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44800363|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
44800364|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
44800365|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800366|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800367|NCT02019810|Dobutamine|dobutamine|mesh-list
44800368|NCT02019810|Norepinephrine|norepinephrine|mesh-list
44800369|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44800370|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44800371|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
44800372|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800373|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800374|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800375|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
44800376|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
44800377|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800378|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44800379|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44800380|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44800381|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44800382|NCT02019810|Protective Agents|protective agents|mesh-ancestor
44800383|NCT02019836|Vitamin D|vitamin d|mesh-list
44800384|NCT02019836|Vitamins|vitamins|mesh-ancestor
44800385|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
44800386|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800387|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800388|NCT02019875|Clarithromycin|clarithromycin|mesh-list
44800389|NCT02019875|Rifampin|rifampin|mesh-list
44800390|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800391|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800392|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44800393|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800394|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800395|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44800396|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693162|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44693163|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44693164|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693165|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
44693166|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693167|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
44693168|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44693169|NCT01372904|Dexamethasone|dexamethasone|mesh-list
44693170|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
44693171|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44693172|NCT01372904|BB 1101|bb 1101|mesh-list
44693173|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693174|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
44693175|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
44693176|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693177|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244803|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
44693179|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
44693180|NCT01372904|Hormones|hormones|mesh-ancestor
44693181|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693182|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44693183|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693184|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
44693185|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693186|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693187|NCT01372930|Etanercept|etanercept|mesh-list
44693188|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44693189|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693190|NCT01372930|Analgesics|analgesics|mesh-ancestor
44693191|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
44693192|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693193|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693194|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693195|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693196|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44693197|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693198|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
44693199|NCT01372982|Letrozole|letrozole|mesh-list
44693200|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693201|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44693202|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44693203|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580358|NCT00898443|Anesthetics|anesthetics|mesh-list
44800397|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44800398|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
44800399|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
44800400|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44800401|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44800402|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44800403|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44800404|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44800405|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44286042|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800406|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44800407|NCT02020005|Nicotine|nicotine|mesh-list
44800408|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44800409|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
44800410|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800411|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800412|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44800413|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44800414|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800415|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800416|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800417|NCT02020122|Pregabalin|pregabalin|mesh-list
44800418|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44800419|NCT02020122|Analgesics|analgesics|mesh-ancestor
44800420|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
44800421|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800422|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800423|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
44800424|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44800425|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286055|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44800426|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800427|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800428|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44800429|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800430|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800431|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800432|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44800433|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800434|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800435|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
44800436|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
44800437|NCT02020161|Methotrexate|methotrexate|mesh-list
44286089|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
44800438|NCT02020161|Idarubicin|idarubicin|mesh-list
44800439|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44800440|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
44800441|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800442|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800443|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800444|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
44800445|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800446|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800447|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800448|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800449|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44800450|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800451|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
44800452|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800453|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44800454|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44800455|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44800456|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44800457|NCT02020200|Methylphenidate|methylphenidate|mesh-list
44800458|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44800459|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800460|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44800461|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800462|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800463|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800464|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
44800465|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800466|NCT02020213|Posaconazole|posaconazole|mesh-list
44800467|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
44800468|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800469|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44800470|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44800471|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44800472|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44800473|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44800474|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800475|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800476|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44800477|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
44800478|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800479|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800480|NCT02020330|Lumefantrine|lumefantrine|mesh-list
44800481|NCT02020330|Artemether|artemether|mesh-list
44800482|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44800483|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
44800484|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44800485|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44800486|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580465|NCT00895661|Rituximab|rituximab|mesh-list
44800487|NCT02020499|Lanreotide|lanreotide|mesh-list
44800488|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800489|NCT02020551|Lidocaine|lidocaine|mesh-list
44800490|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800491|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
44800492|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800493|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800494|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
44800495|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800496|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44800497|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44800498|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44800499|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800500|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800501|NCT02020603|Epinephrine|epinephrine|mesh-list
44800502|NCT02020603|Racepinephrine|racepinephrine|mesh-list
44800503|NCT02020603|Hemostatics|hemostatics|mesh-list
44800504|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
44800505|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44800506|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44800507|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
44800508|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800509|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800510|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800511|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44800512|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44800513|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
44800514|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800515|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44800516|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
44800517|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
44800518|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
44800519|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44800520|NCT02020603|Coagulants|coagulants|mesh-ancestor
44800521|NCT02020629|Lixisenatide|lixisenatide|mesh-list
44800522|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44800523|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800524|NCT02020681|Fluorides|fluorides|mesh-list
44800525|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
44800526|NCT02020681|Protective Agents|protective agents|mesh-ancestor
44800527|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800528|NCT02020694|Vitamin D|vitamin d|mesh-list
44800529|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
44800530|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
44800531|NCT02020694|Vitamins|vitamins|mesh-list
44800532|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
44800533|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800534|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800535|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800536|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
44800537|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44286162|NCT05428293|Ibuprofen|ibuprofen|mesh-list
44286193|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
44800538|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44800539|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44800540|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800541|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800542|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800543|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800544|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800545|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44800546|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800547|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44800548|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44800549|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
44800550|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44800551|NCT02021097|Estradiol|estradiol|mesh-list
44800552|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44800553|NCT02021097|Estrogens|estrogens|mesh-ancestor
44800554|NCT02021097|Hormones|hormones|mesh-ancestor
44800555|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800556|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800557|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44800558|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
44800559|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44580537|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
44800560|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44800561|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44800562|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44800563|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44800564|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44800565|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44800566|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800568|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
44800569|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800570|NCT02021201|Risperidone|risperidone|mesh-list
44800571|NCT02021201|Sertindole|sertindole|mesh-list
44800572|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44800573|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
44800574|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800575|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800576|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800577|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44800578|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800579|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800580|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800581|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44800582|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
44800583|NCT02021214|Methylphenidate|methylphenidate|mesh-list
44800584|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44800585|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800586|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44800587|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800588|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800589|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800590|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
44800591|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800592|NCT02021240|Dexamethasone|dexamethasone|mesh-list
44800593|NCT02021240|Ketamine|ketamine|mesh-list
44464173|NCT01499160|Everolimus|everolimus|mesh-list
44800594|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800595|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
44800596|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
44800597|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800598|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800599|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800600|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
44800601|NCT02021240|Hormones|hormones|mesh-ancestor
44800602|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800603|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44800604|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800605|NCT02021240|Analgesics|analgesics|mesh-ancestor
44800606|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
44800607|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44800608|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44800609|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
44800610|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
44800611|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800612|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44800613|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44800614|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800615|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800616|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
44800617|NCT02021409|Hematinics|hematinics|mesh-ancestor
44800618|NCT02021422|Fluorouracil|fluorouracil|mesh-list
44800619|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
44800620|NCT02021422|Irinotecan|irinotecan|mesh-list
44800621|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44800622|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
44800623|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800624|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800625|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800626|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800627|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
44800628|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800629|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44800630|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44800631|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800632|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800633|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44580628|NCT00893737|Naproxen|naproxen|mesh-list
44800634|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800635|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
44800636|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800637|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800638|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
44800639|NCT02021825|Analgesics|analgesics|mesh-ancestor
44800640|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
44800641|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800642|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800643|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800644|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44800645|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44800646|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800647|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800648|NCT02021851|Dexamethasone|dexamethasone|mesh-list
44800649|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
44800650|NCT02021851|Ondansetron|ondansetron|mesh-list
44800651|NCT02021851|Aprepitant|aprepitant|mesh-list
44800652|NCT02021851|BB 1101|bb 1101|mesh-list
44800653|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800654|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
44800655|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
44800656|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800657|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800658|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800659|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
44800660|NCT02021851|Hormones|hormones|mesh-ancestor
44800661|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800662|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44800663|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800664|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
44800665|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800666|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800667|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
44800668|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800669|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44800670|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
44800671|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800672|NCT02021851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44800673|NCT02021851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800674|NCT02021851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800675|NCT02021851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800676|NCT02021851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44800677|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44800678|NCT02021864|Vitamin D|vitamin d|mesh-list
44800679|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
44800680|NCT02021864|Vitamins|vitamins|mesh-ancestor
44800681|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
44800682|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800683|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800684|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800685|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44800686|NCT02022163|Vaccines|vaccines|mesh-list
44800687|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
44800688|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800689|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44800690|NCT02022163|Antacids|antacids|mesh-ancestor
44800691|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800692|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800693|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44800694|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44800695|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
44800696|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44800697|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
44800698|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800699|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800700|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44800701|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44800702|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800703|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44800704|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
44800705|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44800706|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
44800707|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800708|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580694|NCT00892177|Dasatinib|dasatinib|mesh-list
44800709|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44800710|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44800711|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800713|NCT02022254|Warfarin|warfarin|mesh-list
44800714|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44800715|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800716|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
44800717|NCT02022293|Atorvastatin|atorvastatin|mesh-list
44800718|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44800719|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44800720|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
44800721|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800722|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44800723|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44800724|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800725|NCT02022358|Leucovorin|leucovorin|mesh-list
44800726|NCT02022358|Folic Acid|folic acid|mesh-list
44800727|NCT02022358|Methotrexate|methotrexate|mesh-list
44800728|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
44800729|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44800730|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
44800731|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800732|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800733|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800734|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
44800735|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800736|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800737|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800738|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800739|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44800740|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800741|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
44800742|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800743|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44800744|NCT02022358|Antidotes|antidotes|mesh-ancestor
44800745|NCT02022358|Protective Agents|protective agents|mesh-ancestor
44800746|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
44800747|NCT02022358|Vitamins|vitamins|mesh-ancestor
44800748|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
44800749|NCT02022358|Hematinics|hematinics|mesh-ancestor
44800750|NCT02022475|Vitamin D|vitamin d|mesh-list
44800751|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
44800752|NCT02022475|Vitamins|vitamins|mesh-ancestor
44800753|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
44800754|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800755|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44800756|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800757|NCT02022488|Midazolam|midazolam|mesh-list
44800758|NCT02022488|Ketamine|ketamine|mesh-list
44800759|NCT02022488|Alfentanil|alfentanil|mesh-list
44800760|NCT02022488|Analgesics|analgesics|mesh-ancestor
44800761|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
44800762|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800763|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800764|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44800765|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44800766|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
44800767|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
44800768|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800769|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44800770|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44800771|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800772|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800773|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44800774|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44800775|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44800776|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44800777|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44800778|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
44800779|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
44800780|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44800781|NCT02022488|Narcotics|narcotics|mesh-ancestor
44800782|NCT02022527|Aspirin|aspirin|mesh-list
44800783|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
44800784|NCT02022527|Salicylates|salicylates|mesh-list
44800785|NCT02022527|Warfarin|warfarin|mesh-list
44800786|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44800787|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44800788|NCT02022527|Analgesics|analgesics|mesh-ancestor
44800789|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
44800790|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800791|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800792|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800793|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800794|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44800795|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44286398|NCT04767061|Protective Agents|protective agents|mesh-ancestor
44286399|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44800796|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800797|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44580831|NCT00890825|Docetaxel|docetaxel|mesh-list
44286412|NCT04757584|Atenolol|atenolol|mesh-list
44800798|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44800799|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800800|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
44800801|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
44800802|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800803|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
44800804|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
44800805|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800806|NCT02022540|Ranibizumab|ranibizumab|mesh-list
44800807|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44800808|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44800809|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44800810|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44800811|NCT02022540|Growth Substances|growth substances|mesh-ancestor
44800812|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800813|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
44800814|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800815|NCT02022722|Triamcinolone|triamcinolone|mesh-list
44800816|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44800817|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44800818|NCT02022722|Bupivacaine|bupivacaine|mesh-list
44800819|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44800820|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800821|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
44800822|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800823|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800824|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
44800825|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800826|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800827|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
44800828|NCT02022722|Hormones|hormones|mesh-ancestor
44800829|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800830|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800831|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
44800832|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800833|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800834|NCT02022761|Laninamivir|laninamivir|mesh-list
44800835|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
44800836|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800837|NCT02022852|Capecitabine|capecitabine|mesh-list
44800838|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800839|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
44800840|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800841|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800842|NCT02022917|Bevacizumab|bevacizumab|mesh-list
44800843|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44800844|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800845|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44800846|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44800847|NCT02022917|Growth Substances|growth substances|mesh-ancestor
44800848|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800849|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44800850|NCT02022930|Triamcinolone|triamcinolone|mesh-list
44800851|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44800852|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44800853|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44800854|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44800855|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
44800856|NCT02022930|Hormones|hormones|mesh-ancestor
44800857|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800858|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800859|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800860|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
44800861|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800862|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800863|NCT02023021|Gemcitabine|gemcitabine|mesh-list
44800864|NCT02023021|Paclitaxel|paclitaxel|mesh-list
44800865|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44800866|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800867|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44800868|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44580904|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44580905|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580906|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580907|NCT00889252|Ketotifen|ketotifen|mesh-list
44580908|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
44580909|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
44580910|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44580911|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
44580912|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
44800869|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44800870|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800871|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800872|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
44800873|NCT02023021|Antiviral Agents|antiviral agents|mesh-ancestor
44800874|NCT02023021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800875|NCT02023021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800876|NCT02023021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800877|NCT02023021|Immunologic Factors|immunologic factors|mesh-ancestor
44800878|NCT02023021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800879|NCT02023047|Nifedipine|nifedipine|mesh-list
44800880|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44800881|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800882|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800883|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44800884|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800885|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
44800886|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
44800887|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44800888|NCT02023086|Tropicamide|tropicamide|mesh-list
44800889|NCT02023086|Mydriatics|mydriatics|mesh-list
44800890|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
44800891|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800892|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800893|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44800894|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44800895|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
44800896|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800897|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800898|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
44800899|NCT02023164|Promethazine|promethazine|mesh-list
44800900|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44800901|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44800902|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44800903|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800904|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
44800905|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
44800906|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
44800907|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800908|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
44800909|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
44800910|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44800911|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44800912|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
44800913|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
44800914|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800915|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800916|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44800917|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
44800918|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
44800919|NCT02023359|Everolimus|everolimus|mesh-list
44800920|NCT02023359|Exemestane|exemestane|mesh-list
44800921|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800922|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800923|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
44800924|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800925|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44800926|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44800927|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800928|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800929|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44286499|NCT03897348|Lacosamide|lacosamide|mesh-list
44800930|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
44800931|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44800932|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
44800933|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
44800934|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44800935|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
44800936|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800937|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800938|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44800939|NCT02023450|Ritonavir|ritonavir|mesh-list
44800940|NCT02023450|Saquinavir|saquinavir|mesh-list
44800941|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44800942|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44800943|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44800944|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800945|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800946|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44800947|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44800948|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
44800949|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800950|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44800951|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44800952|NCT02023554|Azithromycin|azithromycin|mesh-list
44800953|NCT02023554|Theophylline|theophylline|mesh-list
44800954|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44800955|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44800956|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44800957|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
44800958|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44800959|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800960|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44800961|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
44800962|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44800963|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800964|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800965|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44800966|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44800967|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44800968|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
44800969|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800970|NCT02023567|Serotonin|serotonin|mesh-list
44800971|NCT02023567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44800972|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44800973|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
44800974|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44800975|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800976|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800977|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44800978|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44800979|NCT02023593|Leucovorin|leucovorin|mesh-list
44800980|NCT02023593|Fluorouracil|fluorouracil|mesh-list
44800981|NCT02023593|Irinotecan|irinotecan|mesh-list
44800982|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
44800983|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44800984|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44800985|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44800986|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44800987|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
44800988|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44800989|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44800990|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44800991|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44800992|NCT02023593|Antidotes|antidotes|mesh-ancestor
44800993|NCT02023593|Protective Agents|protective agents|mesh-ancestor
44800994|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
44800995|NCT02023593|Vitamins|vitamins|mesh-ancestor
44800996|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
44800997|NCT02023684|Lidocaine|lidocaine|mesh-list
44800998|NCT02023684|Ropivacaine|ropivacaine|mesh-list
44800999|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
44801000|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
44801001|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801002|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801003|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
44801004|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801005|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801006|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44801007|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44801008|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801009|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801010|NCT02023710|Paclitaxel|paclitaxel|mesh-list
44801011|NCT02023710|Bevacizumab|bevacizumab|mesh-list
44801012|NCT02023710|Carboplatin|carboplatin|mesh-list
44801013|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44801014|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801015|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
44286576|NCT03168256|Apremilast|apremilast|mesh-list
44801016|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
44801017|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
44580988|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801018|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801019|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44801020|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44801021|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44801022|NCT02023710|Growth Substances|growth substances|mesh-ancestor
44693204|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693205|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44693206|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
44693207|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693208|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693209|NCT01373008|Beclomethasone|beclomethasone|mesh-list
44693210|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693211|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
44693212|NCT01373008|Hormones|hormones|mesh-ancestor
44693213|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693214|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693215|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44693216|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44693217|NCT01373021|Fentanyl|fentanyl|mesh-list
44693218|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
44693219|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44693220|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693221|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693222|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693223|NCT01373021|Analgesics|analgesics|mesh-ancestor
44693224|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
44693225|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693226|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44693227|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44693228|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44693229|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
44693230|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693231|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693232|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44693233|NCT01373021|Narcotics|narcotics|mesh-ancestor
44693234|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44693235|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44693236|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
44693237|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
44693238|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
44693239|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44693240|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693241|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44693242|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693243|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
44693244|NCT01373138|Ephedrine|ephedrine|mesh-list
44693245|NCT01373138|Desloratadine|desloratadine|mesh-list
44693246|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44693247|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44693248|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693249|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693250|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693251|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44693252|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44693253|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
44693254|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
44693255|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44693256|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
44693257|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693258|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44286651|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
44693259|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
44693260|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
44693261|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44693262|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44693263|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
44693264|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44693265|NCT01373216|Exenatide|exenatide|mesh-list
44693266|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44693267|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693268|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44693269|NCT01373216|Incretins|incretins|mesh-ancestor
44693270|NCT01373216|Hormones|hormones|mesh-ancestor
44286657|NCT02726997|Paclitaxel|paclitaxel|mesh-list
44693271|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801023|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801024|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
44801025|NCT02023840|Metronidazole|metronidazole|mesh-list
44801026|NCT02023840|Erythritol|erythritol|mesh-list
44801027|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801028|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801029|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44801030|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44801031|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801032|NCT02023853|Metronidazole|metronidazole|mesh-list
44801033|NCT02023853|Erythritol|erythritol|mesh-list
44801034|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801035|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801036|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44801037|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44801038|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801039|NCT02023892|Atorvastatin|atorvastatin|mesh-list
44801040|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44801041|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44801042|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
44801043|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801044|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801045|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44801046|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801047|NCT02023931|Sulforaphane|sulforaphane|mesh-list
44801048|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44801049|NCT02023931|Protective Agents|protective agents|mesh-ancestor
44801050|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801051|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801052|NCT02024009|Gemcitabine|gemcitabine|mesh-list
44801053|NCT02024009|Nelfinavir|nelfinavir|mesh-list
44801054|NCT02024009|Paclitaxel|paclitaxel|mesh-list
44801055|NCT02024009|Capecitabine|capecitabine|mesh-list
44801056|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44801057|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801058|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44801059|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44801060|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44801061|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801062|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801063|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
44801064|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
44801065|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801066|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801067|NCT02024009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801068|NCT02024009|Immunologic Factors|immunologic factors|mesh-ancestor
44801069|NCT02024009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801070|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44801071|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44801072|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
44801073|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44801074|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44801075|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
44801076|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
44801077|NCT02024022|Cathartics|cathartics|mesh-ancestor
44801078|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801079|NCT02024152|Cetirizine|cetirizine|mesh-list
44801080|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44801081|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44801082|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44801083|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
44801084|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
44801085|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286706|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
44801086|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801087|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801088|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
44801089|NCT02024217|Tegafur|tegafur|mesh-list
44801090|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801091|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801092|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
44801093|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801094|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
44801095|NCT02024256|Analgesics|analgesics|mesh-ancestor
44801096|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
44801097|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801098|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801099|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
44801100|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801101|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801102|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
44801103|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44801104|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111655|NCT00089037|Sirolimus|sirolimus|mesh-list
44801105|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801106|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44801107|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
44801108|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44801109|NCT02024295|Choline|choline|mesh-list
44801110|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
44801111|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
44801112|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44801113|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
44801114|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801115|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801116|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801117|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
44801118|NCT02024308|Cytarabine|cytarabine|mesh-list
44801119|NCT02024308|Fludarabine|fludarabine|mesh-list
44801120|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801121|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581141|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581142|NCT00886379|Vitamin D|vitamin d|mesh-list
44581143|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
44581144|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
44581145|NCT00886379|Vitamins|vitamins|mesh-list
44581146|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
44581147|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581148|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44581149|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581150|NCT05660993|Nivolumab|nivolumab|mesh-list
44581151|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581152|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581153|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44581154|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581155|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
44581156|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44581157|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581158|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44581159|NCT05660785|Cyclosporine|cyclosporine|mesh-list
44581160|NCT05660785|Cyclosporins|cyclosporins|mesh-list
44581161|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581162|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581163|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581164|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
44581165|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581166|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
44581167|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581168|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581169|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581170|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44408151|NCT02528188|Tanezumab|tanezumab|mesh-list
44801122|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
44801123|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801124|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801125|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
44801126|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801127|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
44801128|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801129|NCT02024334|Leflunomide|leflunomide|mesh-list
44801130|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801131|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801132|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801133|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
44801134|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801135|NCT02024373|Atorvastatin|atorvastatin|mesh-list
44801136|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44801137|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44801138|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
44801139|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464263|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
44801140|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801141|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44801142|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801143|NCT02024425|Antioxidants|antioxidants|mesh-list
44801144|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801145|NCT02024425|Protective Agents|protective agents|mesh-ancestor
44801146|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801147|NCT02024555|Azithromycin|azithromycin|mesh-list
44801148|NCT02024555|Levofloxacin|levofloxacin|mesh-list
44801150|NCT02024555|Rifampin|rifampin|mesh-list
44801151|NCT02024555|Ethambutol|ethambutol|mesh-list
44801152|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801153|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801154|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44801155|NCT02024555|Renal Agents|renal agents|mesh-ancestor
44801156|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44801157|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44801158|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801159|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464277|NCT01498120|Rotigotine|rotigotine|mesh-list
44801160|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801161|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44801162|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44801163|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44801164|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
44801165|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
44801166|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44801167|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44801168|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44801169|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44801170|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44801171|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44801172|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44801173|NCT02024568|Pregabalin|pregabalin|mesh-list
44801174|NCT02024568|Analgesics|analgesics|mesh-ancestor
44801175|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
44801176|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801177|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801178|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
44801179|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44801180|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801181|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801182|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44801183|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44801184|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44801185|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801186|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801187|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
44801188|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44801189|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
44801190|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
44801191|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801192|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801193|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44801194|NCT02024594|Analgesics|analgesics|mesh-ancestor
44801195|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
44801196|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801197|NCT02024633|Gemcitabine|gemcitabine|mesh-list
44801198|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801199|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
44286809|NCT00758433|Capsaicin|capsaicin|mesh-list
44801200|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801201|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801202|NCT02024633|Antiviral Agents|antiviral agents|mesh-ancestor
44801203|NCT02024633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801204|NCT02024633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801205|NCT02024633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801206|NCT02024633|Immunologic Factors|immunologic factors|mesh-ancestor
44801207|NCT02024633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801208|NCT02024659|Budesonide|budesonide|mesh-list
44801209|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801210|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44801211|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
44801212|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801213|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801214|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44801215|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
44801216|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
44801217|NCT02024659|Hormones|hormones|mesh-ancestor
44801218|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801219|NCT02024841|Docetaxel|docetaxel|mesh-list
44801220|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801221|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
44801222|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
44801223|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
44801224|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801225|NCT02024906|Caseins|caseins|mesh-list
44801226|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
44801227|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
44801228|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801229|NCT02024919|Diltiazem|diltiazem|mesh-list
44801230|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44801231|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44801232|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801233|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801234|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44801235|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801236|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801237|NCT02024945|Propiverine|propiverine|mesh-list
44801238|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
44801239|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
44801240|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801241|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801242|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44801243|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44801244|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
44801245|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801246|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801247|NCT02024945|Urological Agents|urological agents|mesh-ancestor
44801248|NCT02024984|Clomiphene|clomiphene|mesh-list
44801249|NCT02024984|Enclomiphene|enclomiphene|mesh-list
44801250|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
44801251|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44801252|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801253|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801254|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801255|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44801256|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
44801257|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44801258|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44801259|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44801260|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
44801261|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801262|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44801263|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801264|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801265|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801266|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801267|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801268|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44801269|NCT02025023|Triamcinolone|triamcinolone|mesh-list
44801270|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44801271|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44801272|NCT02025023|Fluorouracil|fluorouracil|mesh-list
44801273|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44801274|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
44801275|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801276|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801277|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801278|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801279|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
44801280|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801281|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801282|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
44801283|NCT02025023|Hormones|hormones|mesh-ancestor
44801284|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801285|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801286|NCT02025036|Capecitabine|capecitabine|mesh-list
44801287|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
44801288|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801289|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
44801290|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801291|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286909|NCT00759226|Leucovorin|leucovorin|mesh-list
44801292|NCT02025140|Anesthetics|anesthetics|mesh-list
44801293|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801294|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801295|NCT02025166|Acetaminophen|acetaminophen|mesh-list
44801296|NCT02025166|Lornoxicam|lornoxicam|mesh-list
44801297|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44801298|NCT02025166|Analgesics|analgesics|mesh-ancestor
44801299|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
44801300|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801301|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801302|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
44801303|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44801304|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801305|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801306|NCT02025192|Capecitabine|capecitabine|mesh-list
44801307|NCT02025192|Trastuzumab|trastuzumab|mesh-list
44801308|NCT02025192|Tucatinib|tucatinib|mesh-list
44801309|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801310|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
44801311|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801312|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801313|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44801314|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44801315|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801316|NCT02025218|Gefitinib|gefitinib|mesh-list
44801317|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693272|NCT01373333|Amifampridine|amifampridine|mesh-list
44693273|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44693274|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693275|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693276|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44693277|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693278|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693279|NCT01373359|Misoprostol|misoprostol|mesh-list
44693280|NCT01373359|Oxytocin|oxytocin|mesh-list
44693281|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
44693282|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44693283|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693284|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44693285|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
44693286|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44693287|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44693288|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44693289|NCT01373372|Hormones|hormones|mesh-ancestor
44693290|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693291|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693292|NCT01373398|Apaziquone|apaziquone|mesh-list
44693293|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693294|NCT01373411|Ticagrelor|ticagrelor|mesh-list
44693295|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44693296|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44801318|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44801319|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801320|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801321|NCT02025348|Metoprolol|metoprolol|mesh-list
44801322|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801323|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44801324|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
44801325|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
44801326|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801327|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801328|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44801329|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44801330|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44801331|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44801332|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801333|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801334|NCT02025361|Lidocaine|lidocaine|mesh-list
44801335|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
44801336|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
44801337|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801338|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801339|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
44801340|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801341|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801342|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44801343|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44801344|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801345|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801346|NCT02025374|Bupivacaine|bupivacaine|mesh-list
44801347|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
44801348|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
44801349|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
44801350|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801351|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801352|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
44801353|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801354|NCT02025465|Metoprolol|metoprolol|mesh-list
44801355|NCT02025465|Diltiazem|diltiazem|mesh-list
44801356|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801357|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44801358|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
44801359|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
44801360|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286990|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
44801361|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801362|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44801363|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44801364|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44801365|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44801366|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801367|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801368|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44801369|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801370|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44801371|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801372|NCT02025491|Amphotericin B|amphotericin b|mesh-list
44801373|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44801374|NCT02025491|Amebicides|amebicides|mesh-ancestor
44801375|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44801376|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44801377|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801378|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801379|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
44801380|NCT02025608|Pramipexole|pramipexole|mesh-list
44801381|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
44801382|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801383|NCT02025608|Protective Agents|protective agents|mesh-ancestor
44801384|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801385|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44801386|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44801387|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
44801388|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
44801389|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801390|NCT02025712|Everolimus|everolimus|mesh-list
44801391|NCT02025712|Exemestane|exemestane|mesh-list
44801392|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801393|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801394|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
44801395|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801396|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44801397|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44801398|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801399|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801400|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44801401|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801402|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801403|NCT02025803|Capecitabine|capecitabine|mesh-list
44801404|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801405|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
44801406|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801407|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801408|NCT02025855|Methadone|methadone|mesh-list
44801409|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44801410|NCT02025855|Narcotics|narcotics|mesh-ancestor
44801411|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801412|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801413|NCT02025855|Analgesics|analgesics|mesh-ancestor
44801414|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
44801415|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801416|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
44801417|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
44801418|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
44801419|NCT02025868|Darunavir|darunavir|mesh-list
44801420|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44801421|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44801422|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
44801423|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801424|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44801425|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44801426|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801427|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801428|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44801429|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44801430|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
44801431|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
44801432|NCT02025881|Thiotepa|thiotepa|mesh-list
44801433|NCT02025881|Carboplatin|carboplatin|mesh-list
44801434|NCT02025881|Etoposide|etoposide|mesh-list
44801435|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801436|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
44801437|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801438|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801439|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44801440|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
44801441|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801442|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801443|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44801444|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44801445|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44801446|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44801447|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801448|NCT02025998|Ibudilast|ibudilast|mesh-list
44801449|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44801450|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
44287075|NCT00760175|Vaccines|vaccines|mesh-list
44801451|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801452|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801453|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44801454|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
44801455|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44801456|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801457|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801458|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44801459|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801460|NCT02026050|Dexamethasone|dexamethasone|mesh-list
44801461|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
44801462|NCT02026050|BB 1101|bb 1101|mesh-list
44801463|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801464|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
44801465|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
44801466|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801467|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801468|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801469|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
44801470|NCT02026050|Hormones|hormones|mesh-ancestor
44801471|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801472|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44801473|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801474|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
44801475|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801476|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801477|NCT02026219|Clopidogrel|clopidogrel|mesh-list
44801478|NCT02026219|Ticagrelor|ticagrelor|mesh-list
44801479|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44801480|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44801481|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44801482|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44801483|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
44801484|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801485|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801486|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801487|NCT02026310|Metformin|metformin|mesh-list
44801488|NCT02026310|Glimepiride|glimepiride|mesh-list
44801489|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801490|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801491|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801492|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801493|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
44801494|NCT02026479|Dexamethasone|dexamethasone|mesh-list
44801495|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
44801496|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44801497|NCT02026479|BB 1101|bb 1101|mesh-list
44464328|NCT01496976|Ofatumumab|ofatumumab|mesh-list
44801498|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801499|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
44801500|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
44801501|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801502|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801503|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801504|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
44801505|NCT02026479|Hormones|hormones|mesh-ancestor
44801506|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801507|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44801508|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801509|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
44801510|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801511|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801512|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
44801513|NCT02026492|Miotics|miotics|mesh-ancestor
44801514|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
44801515|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801516|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801517|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44801518|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44801519|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44801520|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44801521|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44801522|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
44801523|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801524|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801525|NCT02026505|Bortezomib|bortezomib|mesh-list
44801526|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693297|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44693298|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44693299|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
44693300|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693301|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693302|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693303|NCT01373463|Cisplatin|cisplatin|mesh-list
44693304|NCT01373463|Carboplatin|carboplatin|mesh-list
44693305|NCT01373463|Pemetrexed|pemetrexed|mesh-list
44693306|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693307|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693308|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693309|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44693310|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44693311|NCT01373528|Budesonide|budesonide|mesh-list
44693312|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693313|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44693314|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
44693315|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693316|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693317|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44693318|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
44693319|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
44693320|NCT01373528|Hormones|hormones|mesh-ancestor
44693321|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693322|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
44693323|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693324|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693326|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
44693327|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693328|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
44693329|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44801527|NCT02026518|Vitamin D|vitamin d|mesh-list
44801528|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
44801529|NCT02026518|Vitamins|vitamins|mesh-ancestor
44801530|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
44801531|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801532|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44801533|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44801534|NCT02026583|Simvastatin|simvastatin|mesh-list
44801535|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44801536|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44693330|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
44693331|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44693332|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44693333|NCT01373554|Protective Agents|protective agents|mesh-ancestor
44693334|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693335|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693336|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44693337|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44693338|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693339|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693340|NCT01373593|Lidocaine|lidocaine|mesh-list
44693341|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
44693342|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
44693343|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693344|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693345|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
44693346|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693347|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44693348|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44693349|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44693350|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693351|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693352|NCT01373606|Terlipressin|terlipressin|mesh-list
44693353|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44693354|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44693355|NCT01373632|Sirolimus|sirolimus|mesh-list
44693356|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693357|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693358|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44693359|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693360|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
44693361|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693362|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
44693363|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693364|NCT01373684|Tenofovir|tenofovir|mesh-list
44693365|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44693366|NCT01373684|Entecavir|entecavir|mesh-list
44693367|NCT01373684|Adefovir|adefovir|mesh-list
44693368|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
44693369|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693370|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44693371|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44693372|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693373|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693374|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44693375|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44693376|NCT01373697|Ibuprofen|ibuprofen|mesh-list
44287184|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
44693377|NCT01373697|Ketoprofen|ketoprofen|mesh-list
44693378|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44693379|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693380|NCT01373697|Analgesics|analgesics|mesh-ancestor
44693381|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
44693382|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693383|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693384|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693385|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693386|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44693387|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693388|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693389|NCT01373710|Trastuzumab|trastuzumab|mesh-list
44693390|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581647|NCT05648708|Bupivacaine|bupivacaine|mesh-list
44581648|NCT05648708|Prilocaine|prilocaine|mesh-list
44801537|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
44801538|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801539|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801540|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44801541|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801542|NCT02026765|Heparin|heparin|mesh-list
44801543|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
44801544|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44801545|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44801546|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801547|NCT02026778|Betahistine|betahistine|mesh-list
44801548|NCT02026778|Ondansetron|ondansetron|mesh-list
44801549|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
44801550|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
44801551|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801552|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801553|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801554|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
44801555|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
44801556|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44801557|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
44801558|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801559|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801560|NCT02026778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44801561|NCT02026778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44801562|NCT02026778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801563|NCT02026778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801564|NCT02026778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44801565|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801566|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
44801567|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
44801568|NCT02026817|Metformin|metformin|mesh-list
44801569|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44801570|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801571|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801572|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44801573|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44801574|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
44287239|NCT00761644|Bevacizumab|bevacizumab|mesh-list
44801575|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801576|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801577|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44801578|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801579|NCT02026856|Selenious Acid|selenious acid|mesh-list
44801580|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
44801581|NCT02026856|Trace Elements|trace elements|mesh-ancestor
44801582|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
44801583|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801584|NCT02026869|Metformin|metformin|mesh-list
44801585|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801586|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801587|NCT02026921|Carboplatin|carboplatin|mesh-list
44801588|NCT02026921|Docetaxel|docetaxel|mesh-list
44801589|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801590|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44801591|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44801592|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44801593|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801594|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
44801595|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
44801596|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801597|NCT02026973|Fulvestrant|fulvestrant|mesh-list
44801598|NCT02026973|Anastrozole|anastrozole|mesh-list
44801599|NCT02026973|Somatostatin|somatostatin|mesh-list
44801600|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44801601|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801602|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44801603|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44801604|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801605|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801606|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801607|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44801608|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44581657|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44801609|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801610|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801611|NCT02026973|Hormones|hormones|mesh-ancestor
44801612|NCT02027064|Interferons|interferons|mesh-list
44801613|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
44801614|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801615|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
44801616|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801617|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
44801618|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801619|NCT02027103|Metformin|metformin|mesh-list
44801620|NCT02027103|Pioglitazone|pioglitazone|mesh-list
44801621|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801622|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801623|NCT02027220|Dexamethasone|dexamethasone|mesh-list
44801624|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
44801625|NCT02027220|Bortezomib|bortezomib|mesh-list
44801626|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801627|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
44801628|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801629|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801630|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44801631|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
44801632|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801633|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801634|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44801635|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801636|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
44801637|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
44801638|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801639|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801640|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
44801641|NCT02027220|Hormones|hormones|mesh-ancestor
44801642|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801643|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44801644|NCT02027298|Abatacept|abatacept|mesh-list
44801645|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44801646|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801647|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801648|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801649|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
44801650|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801651|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801652|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
44801653|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
44801654|NCT02027324|Povidone|povidone|mesh-list
44801655|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44801656|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801657|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
44801658|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
44801659|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
44801660|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
44801661|NCT02027337|Drospirenone|drospirenone|mesh-list
44801662|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44801663|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44801664|NCT02027337|Cyproterone|cyproterone|mesh-list
44801665|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
44801666|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44801667|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44801668|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44801669|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
44801670|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44801671|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801672|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44801673|NCT02027337|Estrogens|estrogens|mesh-ancestor
44801674|NCT02027337|Hormones|hormones|mesh-ancestor
44801675|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801676|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44801677|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801678|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44801679|NCT02027337|Diuretics|diuretics|mesh-ancestor
44801680|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
44801681|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
44801682|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801683|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44801684|NCT02027363|Capecitabine|capecitabine|mesh-list
44801685|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801686|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
44801687|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801688|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801689|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
44801690|NCT02027454|Cabotegravir|cabotegravir|mesh-list
44801691|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801692|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801693|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44801694|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44801695|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801696|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801697|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801698|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44801699|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44801700|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44801701|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44801702|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
44801703|NCT02027493|Interferons|interferons|mesh-list
44801704|NCT02027493|Ribavirin|ribavirin|mesh-list
44801705|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
44801706|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
44801707|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44801708|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801709|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
44801710|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801711|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
44801712|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801713|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
44801714|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801715|NCT02027532|Vancomycin|vancomycin|mesh-list
44801716|NCT02027532|Cefazolin|cefazolin|mesh-list
44801717|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801718|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801719|NCT02027675|Micronutrients|micronutrients|mesh-list
44801720|NCT02027675|Trace Elements|trace elements|mesh-list
44801721|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801722|NCT02027753|Metformin|metformin|mesh-list
44801723|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
44801724|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44693391|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693392|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44693393|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693394|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693395|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693396|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44693397|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
44693398|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244953|NCT04989166|Curcumin|curcumin|mesh-list
44693422|NCT01374126|Azithromycin|azithromycin|mesh-list
44693423|NCT01374126|Artesunate|artesunate|mesh-list
44693424|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693425|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693426|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
44693427|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44693428|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44693429|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693430|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
44693431|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
44693432|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44693433|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
44693434|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
44693435|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44693436|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44693437|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44693438|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693439|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693440|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
44693441|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693442|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693443|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44693444|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693445|NCT01374282|Penicillamine|penicillamine|mesh-list
44693446|NCT01374282|Antidotes|antidotes|mesh-ancestor
44693447|NCT01374282|Protective Agents|protective agents|mesh-ancestor
44693448|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693449|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
44693450|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
44693451|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693452|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693453|NCT01374308|Interferons|interferons|mesh-list
44693454|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
44693455|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
44693456|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44693457|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693458|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
44693459|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693460|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
44693461|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693462|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
44693463|NCT01374373|Hematinics|hematinics|mesh-ancestor
44693464|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
44693465|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
44693466|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
44693467|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693468|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693469|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
44693470|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693471|NCT01374581|Artesunate|artesunate|mesh-list
44693472|NCT01374581|Lumefantrine|lumefantrine|mesh-list
44693473|NCT01374581|Artemether|artemether|mesh-list
44693474|NCT01374581|Amodiaquine|amodiaquine|mesh-list
44693475|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44693476|NCT01374581|Quinine|quinine|mesh-list
44693477|NCT01374581|Clindamycin|clindamycin|mesh-list
44693478|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
44693479|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
44693480|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
44801725|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801726|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801727|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
44801728|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801729|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801731|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44801732|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44801733|NCT02027792|Analgesics|analgesics|mesh-ancestor
44801734|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
44801735|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801736|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801737|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801738|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801739|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44801740|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801741|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801742|NCT02027870|Sirolimus|sirolimus|mesh-list
44801743|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44801744|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801745|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44801746|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801747|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
44801748|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801749|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
44801750|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801751|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44801752|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
44801753|NCT02027922|Protective Agents|protective agents|mesh-ancestor
44801754|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801755|NCT02027961|Durvalumab|durvalumab|mesh-list
44801756|NCT02027961|Trametinib|trametinib|mesh-list
44801757|NCT02027961|Dabrafenib|dabrafenib|mesh-list
44801758|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44801759|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801760|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44801761|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801762|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801763|NCT02027987|Valproic Acid|valproic acid|mesh-list
44801764|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
44801765|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801766|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801767|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
44801768|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801769|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801770|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
44801771|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44801772|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801773|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801774|NCT02028026|Citalopram|citalopram|mesh-list
44801775|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44801776|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44801777|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44801778|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801779|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801780|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801781|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
44464386|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801782|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801783|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44801784|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
44801785|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801786|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44801787|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44801788|NCT02028078|Insulin|insulin|mesh-list
44801789|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44801790|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801791|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801792|NCT02028234|Omeprazole|omeprazole|mesh-list
44801793|NCT02028234|Pantoprazole|pantoprazole|mesh-list
44801794|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44801795|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801796|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44801797|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801798|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801799|NCT02028260|Modafinil|modafinil|mesh-list
44801800|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44801801|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801802|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44801803|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44801804|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44801805|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801806|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44801807|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44801808|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
44801809|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44801810|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44801811|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44801812|NCT02028403|BMS-936559|bms-936559|mesh-list
44801813|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44801814|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44801815|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801816|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
44801817|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801818|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
44801819|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
44801820|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801821|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44801822|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
44801823|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801824|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44801825|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44801826|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801827|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801828|NCT02028429|Urological Agents|urological agents|mesh-ancestor
44801829|NCT02028494|Capecitabine|capecitabine|mesh-list
44801830|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801831|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
44801832|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801833|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801834|NCT02028507|Capecitabine|capecitabine|mesh-list
44801835|NCT02028507|Fulvestrant|fulvestrant|mesh-list
44801836|NCT02028507|Palbociclib|palbociclib|mesh-list
44801837|NCT02028507|Exemestane|exemestane|mesh-list
44801838|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44801839|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
44801840|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801841|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801842|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44801843|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44801844|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44801845|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44801846|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44801847|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801848|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44801849|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801850|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44801851|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44801852|NCT02028533|Oxytocin|oxytocin|mesh-list
44801853|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
44801854|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44801855|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801856|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
44801857|NCT02028598|Clomipramine|clomipramine|mesh-list
44801858|NCT02028598|Citric Acid|citric acid|mesh-list
44801859|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
44801860|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
44801861|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44801862|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
44801863|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
44801864|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801865|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44801866|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44801867|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44801868|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801869|NCT02028598|Urological Agents|urological agents|mesh-ancestor
44801870|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44801871|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
44801872|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801873|NCT02028598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44801874|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44801875|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801876|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801877|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
44801878|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801879|NCT02028663|Esomeprazole|esomeprazole|mesh-list
44801880|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44801881|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801882|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44801883|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801884|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801885|NCT02028689|Metformin|metformin|mesh-list
44801886|NCT02028689|Lesinurad|lesinurad|mesh-list
44801887|NCT02028689|Furosemide|furosemide|mesh-list
44801888|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44801889|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801890|NCT02028689|Diuretics|diuretics|mesh-ancestor
44801891|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
44801892|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44801893|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44801894|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801895|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
44801896|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801897|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
44801898|NCT02028689|Renal Agents|renal agents|mesh-ancestor
44801899|NCT02028806|Leucovorin|leucovorin|mesh-list
44801900|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
44801901|NCT02028806|Irinotecan|irinotecan|mesh-list
44801902|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801903|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44287544|NCT00763646|Cisplatin|cisplatin|mesh-list
44801904|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44801905|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801906|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801907|NCT02028806|Antidotes|antidotes|mesh-ancestor
44801908|NCT02028806|Protective Agents|protective agents|mesh-ancestor
44801909|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801910|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
44801911|NCT02028806|Vitamins|vitamins|mesh-ancestor
44801912|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
44801913|NCT02028819|Dolutegravir|dolutegravir|mesh-list
44801914|NCT02028819|Ibalizumab|ibalizumab|mesh-list
44801915|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44801916|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44801917|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693481|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44801918|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801919|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44693482|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44693483|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693484|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693485|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
44693486|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
44693487|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44693488|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
44693489|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693490|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44693491|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693492|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693493|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44693494|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693495|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44693496|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693497|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693498|NCT01374581|Analgesics|analgesics|mesh-ancestor
44693499|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
44693500|NCT01374620|Paclitaxel|paclitaxel|mesh-list
44693501|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44693502|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
44693503|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44693504|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693505|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
44693506|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
44693507|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
44693508|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693509|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693510|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
44693511|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801920|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44801921|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
44801922|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44801923|NCT02028910|Ondansetron|ondansetron|mesh-list
44801924|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
44801925|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
44801926|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801927|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801928|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44801929|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
44801930|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44801931|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44801932|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
44801933|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801934|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801935|NCT02028910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44801936|NCT02028910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44801937|NCT02028910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801938|NCT02028910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44801939|NCT02028910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44801941|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44801942|NCT02028923|Narcotics|narcotics|mesh-ancestor
44801943|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44801944|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801945|NCT02028923|Analgesics|analgesics|mesh-ancestor
44801946|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
44801947|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801948|NCT02028949|Idarubicin|idarubicin|mesh-list
44801949|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44801950|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44801951|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44801952|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44801953|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801954|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801955|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
44801956|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44801957|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
44801958|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801959|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
44801960|NCT02029105|Protective Agents|protective agents|mesh-ancestor
44801961|NCT02029118|Aspirin|aspirin|mesh-list
44801962|NCT02029118|Metoprolol|metoprolol|mesh-list
44801963|NCT02029118|Ramipril|ramipril|mesh-list
44801964|NCT02029118|Atorvastatin|atorvastatin|mesh-list
44801965|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44801966|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44801967|NCT02029118|Analgesics|analgesics|mesh-ancestor
44801968|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
44801969|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44801970|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44801971|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44801972|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44801973|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44801974|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44801975|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44801976|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44801977|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44801978|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801979|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
44801980|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44801981|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44801982|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
44801983|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44801984|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44801985|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44801986|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44801987|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
44801988|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
44801989|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44801990|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44801991|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44801992|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
44801993|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44801994|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44582089|NCT05514132|Durvalumab|durvalumab|mesh-list
44693512|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693513|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44693514|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
44693515|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44693517|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44693518|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44693519|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
44693520|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
44693521|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287680|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
44693522|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693523|NCT01374698|Aspirin|aspirin|mesh-list
44693524|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44693525|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693526|NCT01374698|Analgesics|analgesics|mesh-ancestor
44693527|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
44693528|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693529|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693530|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693531|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693532|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44693533|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44693534|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693535|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44693536|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44693537|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693538|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
44693539|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
44693540|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44693541|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693542|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693543|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693544|NCT01374737|Analgesics|analgesics|mesh-ancestor
44693545|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
44693546|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693547|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44693548|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44693549|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44693550|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44693551|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693552|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693553|NCT01374750|Cyclosporine|cyclosporine|mesh-list
44693554|NCT01374750|Sirolimus|sirolimus|mesh-list
44693555|NCT01374750|Tacrolimus|tacrolimus|mesh-list
44693556|NCT01374750|Cyclosporins|cyclosporins|mesh-list
44693557|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693558|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
44693559|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693560|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44693561|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582156|NCT05502250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44801996|NCT02029313|Montelukast|montelukast|mesh-list
44801997|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44801998|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
44801999|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44802000|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
44802001|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802002|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802003|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44802004|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44802005|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802006|NCT02029378|Eculizumab|eculizumab|mesh-list
44802007|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44802008|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802009|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
44802010|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802011|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44802012|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44802013|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44802014|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802015|NCT02029482|Ponesimod|ponesimod|mesh-list
44802016|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44802017|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802018|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802019|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
44802020|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802021|NCT02029534|Atorvastatin|atorvastatin|mesh-list
44802022|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44802023|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802024|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
44802025|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802026|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802027|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44802028|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802029|NCT02029573|Temozolomide|temozolomide|mesh-list
44802030|NCT02029573|Atorvastatin|atorvastatin|mesh-list
44802031|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44802032|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802033|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
44287743|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802034|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802035|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802036|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44802037|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802038|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44802039|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
44802040|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802041|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
44802042|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802043|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44802044|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44802045|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802046|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802047|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
44802048|NCT02029599|Acetaminophen|acetaminophen|mesh-list
44802049|NCT02029599|Methotrexate|methotrexate|mesh-list
44802050|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44802051|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
44802052|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44802053|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802054|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802055|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
44802056|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802057|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802058|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44802059|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802060|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44802061|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802062|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
44802063|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44802064|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44802065|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44802066|NCT02029599|Analgesics|analgesics|mesh-ancestor
44802067|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
44802068|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802069|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
44802070|NCT02029612|Nicotine|nicotine|mesh-list
44802071|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44802072|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
44802073|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802074|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802075|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44802076|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44802077|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
44802078|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802079|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802080|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44802081|NCT02029625|Ezetimibe|ezetimibe|mesh-list
44802082|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44802083|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802084|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
44802085|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802086|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802087|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44802088|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802089|NCT02029794|Acetic Acid|acetic acid|mesh-list
44802090|NCT02029794|Retinol acetate|retinol acetate|mesh-list
44802091|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802092|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802093|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44802094|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
44802095|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802096|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44802097|NCT02029794|Protective Agents|protective agents|mesh-ancestor
44802098|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802099|NCT02029898|Remifentanil|remifentanil|mesh-list
44802100|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44802101|NCT02029898|Narcotics|narcotics|mesh-ancestor
44802102|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802103|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802104|NCT02029898|Analgesics|analgesics|mesh-ancestor
44802105|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
44802106|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802107|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
44802108|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802109|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802110|NCT02029937|Proflavine|proflavine|mesh-list
44802111|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44802112|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802113|NCT02029950|Cytarabine|cytarabine|mesh-list
44802114|NCT02029950|Etoposide|etoposide|mesh-list
44802115|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
44802116|NCT02029950|Daunorubicin|daunorubicin|mesh-list
44802117|NCT02029950|Idarubicin|idarubicin|mesh-list
44802118|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
44802119|NCT02029950|Pomalidomide|pomalidomide|mesh-list
44802120|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44802121|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802122|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44802123|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802124|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802125|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802126|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802127|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
44802128|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
44802129|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802130|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802131|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
44802132|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802133|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44802134|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44802135|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44802136|NCT02029950|Growth Substances|growth substances|mesh-ancestor
44802137|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44802138|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
44802139|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44802140|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802141|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802142|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802143|NCT02030561|Trastuzumab|trastuzumab|mesh-list
44802144|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44802145|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802147|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44802148|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44802149|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44802150|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802151|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
44802152|NCT02031367|Hormones|hormones|mesh-ancestor
44802153|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802154|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802155|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802156|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
44802157|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802158|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802159|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
44802160|NCT02031692|Vitamin D|vitamin d|mesh-list
44802161|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
44802162|NCT02031692|Calcium|calcium|mesh-list
44802163|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44802164|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802165|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44802166|NCT02031692|Vitamins|vitamins|mesh-ancestor
44802167|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
44802168|NCT02031692|Antacids|antacids|mesh-ancestor
44802169|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802170|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802171|NCT02031991|Bevacizumab|bevacizumab|mesh-list
44802172|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44802173|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802174|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44802175|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44802176|NCT02031991|Growth Substances|growth substances|mesh-ancestor
44802177|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802178|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
44802179|NCT02032043|Ivermectin|ivermectin|mesh-list
44802180|NCT02032043|Albendazole|albendazole|mesh-list
44802181|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44802182|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802183|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
44802184|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
44802185|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44802186|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44802187|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802188|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802189|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802190|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802191|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802192|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44802193|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44802194|NCT02032134|Protective Agents|protective agents|mesh-ancestor
44802195|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802196|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44802197|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
44802198|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802199|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
44802200|NCT02032186|Cathartics|cathartics|mesh-ancestor
44802201|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802202|NCT02033356|Lidocaine|lidocaine|mesh-list
44802203|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
44802204|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
44802205|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802206|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802207|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
44802208|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802209|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44802210|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44802211|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44802212|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44802213|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802214|NCT02033733|Cisatracurium|cisatracurium|mesh-list
44802215|NCT02033733|Atracurium|atracurium|mesh-list
44802216|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44802217|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44802218|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802219|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802220|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44802221|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44802222|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44802223|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
44802224|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802225|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802226|NCT02034253|Risperidone|risperidone|mesh-list
44802227|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44802228|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
44802229|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802230|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802231|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693562|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693563|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
44693564|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693565|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44693566|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287947|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
44693567|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693568|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44693569|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693570|NCT01374763|Oxycodone|oxycodone|mesh-list
44693571|NCT01374763|Naloxone|naloxone|mesh-list
44693572|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44693573|NCT01374763|Narcotics|narcotics|mesh-ancestor
44693574|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245172|NCT04823052|Sulindac|sulindac|mesh-list
44693575|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693576|NCT01374763|Analgesics|analgesics|mesh-ancestor
44693577|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
44693578|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693579|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44693580|NCT01374789|Panitumumab|panitumumab|mesh-list
44693581|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44693582|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693583|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44693584|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44693585|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693586|NCT01374828|Analgesics|analgesics|mesh-ancestor
44693587|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
44693588|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693589|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693590|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693591|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693592|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44693593|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693594|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693595|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
44693596|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693597|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
44693598|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693599|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693600|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44693601|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
44693602|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693603|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693604|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44693605|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
44693606|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44693607|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
44693608|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693609|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693610|NCT01375088|Propolis|propolis|mesh-list
44693611|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693612|NCT01375101|Quercetin|quercetin|mesh-list
44693613|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
44693614|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693615|NCT01375101|Protective Agents|protective agents|mesh-ancestor
44693616|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693617|NCT01375244|Lisinopril|lisinopril|mesh-list
44693618|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44693619|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
44693620|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693621|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693622|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44802232|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44802233|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44802234|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802235|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802236|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44802237|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
44802238|NCT02035020|Interferons|interferons|mesh-list
44802239|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
44802240|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802241|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
44802242|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802243|NCT02035709|Hydromorphone|hydromorphone|mesh-list
44802244|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44802245|NCT02035709|Narcotics|narcotics|mesh-ancestor
44802246|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802247|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802248|NCT02035709|Analgesics|analgesics|mesh-ancestor
44802249|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
44802250|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802251|NCT02035891|Colchicine|colchicine|mesh-list
44802252|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
44802253|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44802254|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802255|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802256|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802257|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802258|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802259|NCT02035956|Vaccines|vaccines|mesh-list
44802260|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
44802261|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802262|NCT02036151|Fluorides|fluorides|mesh-list
44802263|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
44802264|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
44802265|NCT02036151|Protective Agents|protective agents|mesh-ancestor
44802266|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802267|NCT02036255|Taurolidine|taurolidine|mesh-list
44802268|NCT02036255|Heparin|heparin|mesh-list
44802269|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
44802270|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44802271|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44802272|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802273|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802274|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44802275|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693623|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44802276|NCT02038062|Sevoflurane|sevoflurane|mesh-list
44802277|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802278|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44802279|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
44802280|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
44802281|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802282|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802283|NCT02039453|Fentanyl|fentanyl|mesh-list
44802284|NCT02039453|Meperidine|meperidine|mesh-list
44802285|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44802286|NCT02039453|Narcotics|narcotics|mesh-ancestor
44802287|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802288|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802289|NCT02039453|Analgesics|analgesics|mesh-ancestor
44802290|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
44802291|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802292|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44802293|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44802294|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
44802295|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
44802296|NCT02039492|Spironolactone|spironolactone|mesh-list
44802297|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44802298|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
44802299|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802300|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802301|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44802302|NCT02039492|Diuretics|diuretics|mesh-ancestor
44802303|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
44802304|NCT02039869|Omeprazole|omeprazole|mesh-list
44802305|NCT02039869|Sucralfate|sucralfate|mesh-list
44802306|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44802307|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44802308|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802309|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802310|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802311|NCT02040064|Gefitinib|gefitinib|mesh-list
44288090|NCT00766441|Hormones|hormones|mesh-ancestor
44802312|NCT02040064|Tremelimumab|tremelimumab|mesh-list
44802313|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802314|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44802315|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802316|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802317|NCT02040142|Mitomycins|mitomycins|mesh-list
44802318|NCT02040142|Mitomycin|mitomycin|mesh-list
44802319|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44802320|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802321|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
44802322|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802323|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44802324|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802325|NCT02040220|Aflibercept|aflibercept|mesh-list
44802326|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44802327|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44802328|NCT02040220|Growth Substances|growth substances|mesh-ancestor
44802329|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802330|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
44802331|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802332|NCT02040246|Metformin|metformin|mesh-list
44802333|NCT02040246|Repaglinide|repaglinide|mesh-list
44802334|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802335|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802336|NCT02040285|Metoclopramide|metoclopramide|mesh-list
44802337|NCT02040285|Bisacodyl|bisacodyl|mesh-list
44802338|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
44802339|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
44802340|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802341|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802342|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802343|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44802344|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44582493|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582494|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44582495|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
44582496|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44582497|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
44582498|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
44582499|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802345|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
44802347|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802348|NCT02040285|Cathartics|cathartics|mesh-ancestor
44802349|NCT02040285|Laxatives|laxatives|mesh-ancestor
44802350|NCT02040311|Topiramate|topiramate|mesh-list
44802351|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
44802352|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802353|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802354|NCT02040350|Pralidoxime|pralidoxime|mesh-list
44802355|NCT02040350|Antidotes|antidotes|mesh-ancestor
44802356|NCT02040350|Protective Agents|protective agents|mesh-ancestor
44802357|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802358|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
44802359|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
44802360|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802361|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
44802362|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802363|NCT02040402|Vaccines|vaccines|mesh-list
44802364|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
44802365|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802366|NCT02040415|Eperisone|eperisone|mesh-list
44802367|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
44802368|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44802369|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44802370|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802371|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44802372|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802373|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44802374|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44802375|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802376|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
44802377|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
44802378|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
44802379|NCT02040441|Spironolactone|spironolactone|mesh-list
44802380|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44802381|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
44802382|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802383|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802384|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44802385|NCT02040441|Diuretics|diuretics|mesh-ancestor
44802386|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
44802387|NCT02040454|Paclitaxel|paclitaxel|mesh-list
44693624|NCT01375244|Protective Agents|protective agents|mesh-ancestor
44693625|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693626|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44693627|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44693628|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693629|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
44693630|NCT01375322|Amlodipine|amlodipine|mesh-list
44693631|NCT01375322|Valsartan|valsartan|mesh-list
44693632|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44693633|NCT01375322|Benazepril|benazepril|mesh-list
44693634|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44693635|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44693636|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693637|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693638|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44693639|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693640|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
44693641|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44693642|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44693643|NCT01375322|Diuretics|diuretics|mesh-ancestor
44693644|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
44693645|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44693646|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44693647|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44693648|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693649|NCT01375335|Dobutamine|dobutamine|mesh-list
44693650|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44693651|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
44693652|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
44693653|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693654|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693655|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44802388|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44802389|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802390|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802391|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802392|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802393|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802394|NCT02040571|Insulin|insulin|mesh-list
44802395|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802396|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802397|NCT02040597|Beclomethasone|beclomethasone|mesh-list
44802398|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
44802399|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
44802400|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44802401|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
44802402|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802403|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802404|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44802405|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
44802406|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44802407|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44802408|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44802409|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
44802410|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802411|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802412|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44802413|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44802414|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44802415|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
44802416|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802417|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
44802418|NCT02040597|Hormones|hormones|mesh-ancestor
44802419|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802420|NCT02040636|Vaccines|vaccines|mesh-list
44802421|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
44802422|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802423|NCT02040649|Midazolam|midazolam|mesh-list
44802424|NCT02040649|Propofol|propofol|mesh-list
44802425|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44802426|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802427|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802428|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44802429|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
44802430|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
44802431|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44802432|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44802433|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44802434|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802435|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
44802436|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
44802437|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802438|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802439|NCT02040662|Morphine|morphine|mesh-list
44288238|NCT00767169|Pamidronate|pamidronate|mesh-list
44802440|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44802441|NCT02040662|Narcotics|narcotics|mesh-ancestor
44802442|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802443|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802444|NCT02040662|Analgesics|analgesics|mesh-ancestor
44802445|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
44802446|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802447|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
44802448|NCT02040818|Tigecycline|tigecycline|mesh-list
44802449|NCT02040818|Heparin|heparin|mesh-list
44802450|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44802451|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
44802452|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44802453|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44802454|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802455|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
44802456|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802457|NCT02040818|Expectorants|expectorants|mesh-ancestor
44802458|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
44802459|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44802460|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
44802461|NCT02040818|Protective Agents|protective agents|mesh-ancestor
44802462|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802463|NCT02040818|Antidotes|antidotes|mesh-ancestor
44802464|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802465|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44802466|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802467|NCT02040831|Vaccines|vaccines|mesh-list
44802468|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
44802469|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802470|NCT02040883|Olanzapine|olanzapine|mesh-list
44802471|NCT02040883|Risperidone|risperidone|mesh-list
44802472|NCT02040883|Aripiprazole|aripiprazole|mesh-list
44802473|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44802474|NCT02040883|Ziprasidone|ziprasidone|mesh-list
44802475|NCT02040883|Tandospirone|tandospirone|mesh-list
44802476|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44802477|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
44802478|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802479|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802480|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802481|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44802482|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288277|NCT00767494|Travoprost|travoprost|mesh-list
44802483|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802484|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802485|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44802486|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
44802487|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
44802488|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
44802489|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802490|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802491|NCT02040883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44802492|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44802493|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44802494|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
44802495|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
44802496|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44802497|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44802498|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44802499|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44802500|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44802501|NCT02040909|Propofol|propofol|mesh-list
44802502|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44802503|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802504|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802505|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44802506|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
44802507|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
44802508|NCT02040935|Trastuzumab|trastuzumab|mesh-list
44802509|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44802510|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802511|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
44802512|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802513|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802514|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44802515|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802516|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802517|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802518|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802519|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44802520|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44802521|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802522|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
44802523|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802524|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802525|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44802526|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802527|NCT02041143|Caseins|caseins|mesh-list
44802528|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
44802529|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
44802530|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802531|NCT02041273|Palbociclib|palbociclib|mesh-list
44802532|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802533|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44802534|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802535|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802536|NCT02041338|Paclitaxel|paclitaxel|mesh-list
44802537|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44802538|NCT02041338|Carboplatin|carboplatin|mesh-list
44582681|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582683|NCT05206448|Letrozole|letrozole|mesh-list
44802539|NCT02041338|Epirubicin|epirubicin|mesh-list
44802540|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44802541|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802542|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802543|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802544|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802545|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802546|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44802547|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44802548|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802549|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802550|NCT02041351|Docetaxel|docetaxel|mesh-list
44802551|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802552|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802553|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802554|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802555|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802556|NCT02041455|Amitriptyline|amitriptyline|mesh-list
44802557|NCT02041455|Melatonin|melatonin|mesh-list
44802558|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
44802559|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802560|NCT02041455|Protective Agents|protective agents|mesh-ancestor
44802561|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802562|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802563|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44802564|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44802565|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802566|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44802567|NCT02041455|Analgesics|analgesics|mesh-ancestor
44802568|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
44802569|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802570|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44802571|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44802572|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44802573|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
44802574|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802575|NCT02041481|Leucovorin|leucovorin|mesh-list
44802576|NCT02041481|Fluorouracil|fluorouracil|mesh-list
44802577|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
44802578|NCT02041481|Calcium|calcium|mesh-list
44802579|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
44802580|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44802581|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802582|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
44802583|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802584|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802585|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802586|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802587|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
44802588|NCT02041481|Antidotes|antidotes|mesh-ancestor
44802589|NCT02041481|Protective Agents|protective agents|mesh-ancestor
44802590|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
44802591|NCT02041481|Vitamins|vitamins|mesh-ancestor
44802592|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
44802593|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44802594|NCT02041546|Poractant alfa|poractant alfa|mesh-list
44802595|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44802596|NCT02041650|Ticagrelor|ticagrelor|mesh-list
44802597|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802598|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44802599|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44802600|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44802601|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
44802602|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802603|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802604|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802605|NCT02041767|Ertapenem|ertapenem|mesh-list
44802606|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802607|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802608|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
44802609|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44802610|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802611|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44802612|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
44802613|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802614|NCT02042170|Hormones|hormones|mesh-list
44802615|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802616|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802617|NCT02042196|Cetrorelix|cetrorelix|mesh-list
44802618|NCT02042196|Estradiol|estradiol|mesh-list
44802619|NCT02042196|Estrogens|estrogens|mesh-ancestor
44802620|NCT02042196|Hormones|hormones|mesh-ancestor
44802621|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802622|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802623|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44802624|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44802625|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
44802626|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
44802627|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
44802628|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802629|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
44802630|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288419|NCT00768183|Ethanol|ethanol|mesh-list
44802631|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802632|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44802633|NCT02042326|Sirolimus|sirolimus|mesh-list
44802634|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802635|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802636|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44802637|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802638|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
44802639|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802640|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
44802641|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802642|NCT02042482|Ubiquinone|ubiquinone|mesh-list
44802643|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
44802644|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
44802645|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802646|NCT02042482|Vitamins|vitamins|mesh-ancestor
44802647|NCT02042495|Metformin|metformin|mesh-list
44802648|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802649|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802650|NCT02042573|Sertraline|sertraline|mesh-list
44802651|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
44802652|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802653|NCT02042573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44802654|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44802655|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44802656|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802657|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802658|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
44802659|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802660|NCT02042599|Sevoflurane|sevoflurane|mesh-list
44802661|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802662|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44802663|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
44802664|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
44802665|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802666|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802667|NCT02042612|Sevoflurane|sevoflurane|mesh-list
44582844|NCT05152147|Cisplatin|cisplatin|mesh-list
44802668|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802669|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44802670|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
44802672|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802673|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802674|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44802675|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44802676|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802677|NCT02042664|Metformin|metformin|mesh-list
44802678|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802679|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693656|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44693657|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44693658|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44693659|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693660|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693661|NCT01375335|Protective Agents|protective agents|mesh-ancestor
44693662|NCT01375348|Remifentanil|remifentanil|mesh-list
44693663|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44693664|NCT01375348|Narcotics|narcotics|mesh-ancestor
44693665|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693666|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693667|NCT01375348|Analgesics|analgesics|mesh-ancestor
44693668|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
44693669|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693670|NCT01375361|Albuterol|albuterol|mesh-list
44693671|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44693672|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
44693673|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693674|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693675|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44693676|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
44693677|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
44693678|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44693679|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44693680|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44693681|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44693682|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
44693683|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693684|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693685|NCT01375387|Lacosamide|lacosamide|mesh-list
44693686|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
44693687|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44693688|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44693689|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693690|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693691|NCT01375400|Aspirin|aspirin|mesh-list
44693692|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44693693|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44693694|NCT01375400|Analgesics|analgesics|mesh-ancestor
44693695|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
44693696|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693697|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693698|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693699|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44693700|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44693701|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44693702|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693703|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44693704|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44693705|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693706|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
44693707|NCT01375426|Amoxicillin|amoxicillin|mesh-list
44693708|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693709|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693710|NCT01375452|Letrozole|letrozole|mesh-list
44693711|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693712|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44693713|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44693714|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693715|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693716|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44802680|NCT02042690|Dexamethasone|dexamethasone|mesh-list
44802681|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
44802682|NCT02042690|Methotrexate|methotrexate|mesh-list
44802683|NCT02042690|Epirubicin|epirubicin|mesh-list
44802684|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
44802685|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802686|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
44802687|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802688|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44802689|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44802690|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
44802691|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802692|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802693|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44802694|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802695|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
44802696|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
44802697|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802698|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802699|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
44802700|NCT02042690|Hormones|hormones|mesh-ancestor
44802701|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802702|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44802703|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802704|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44802705|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
44802706|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44802707|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802708|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
44802709|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44802710|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44802711|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44802712|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44802713|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44802714|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802715|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44802716|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
44802717|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802718|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
44802719|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802720|NCT02042742|Protective Agents|protective agents|mesh-ancestor
44802721|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802722|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802723|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44802724|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
44802725|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44802726|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44802727|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802728|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44802729|NCT02043054|Liraglutide|liraglutide|mesh-list
44802730|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802731|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802732|NCT02043054|Incretins|incretins|mesh-ancestor
44802733|NCT02043054|Hormones|hormones|mesh-ancestor
44802734|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802735|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44802736|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
44802737|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802738|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802739|NCT02043171|Vitamin D|vitamin d|mesh-list
44802740|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
44802741|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
44802742|NCT02043171|Vitamins|vitamins|mesh-list
44802743|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
44802744|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802745|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44802746|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44802747|NCT02043223|Vitamins|vitamins|mesh-list
44802748|NCT02043223|Vitamin A|vitamin a|mesh-list
44802749|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
44802750|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
44802751|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802752|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
44802753|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802754|NCT02043223|Protective Agents|protective agents|mesh-ancestor
44802755|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44802756|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802757|NCT02043288|Gemcitabine|gemcitabine|mesh-list
44802758|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802759|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
44802760|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802761|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802762|NCT02043288|Antiviral Agents|antiviral agents|mesh-ancestor
44802763|NCT02043288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802764|NCT02043288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802765|NCT02043288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802766|NCT02043288|Immunologic Factors|immunologic factors|mesh-ancestor
44802767|NCT02043288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802768|NCT02043314|Isoniazid|isoniazid|mesh-list
44802769|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
44802770|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44802771|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802772|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44802773|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802774|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
44802775|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802776|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802777|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
44802778|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
44802779|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
44802780|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44802781|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802782|NCT02043717|Vitamin D|vitamin d|mesh-list
44802783|NCT02043717|Vitamins|vitamins|mesh-ancestor
44802784|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
44802785|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802786|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44802787|NCT02043730|Gemcitabine|gemcitabine|mesh-list
44802788|NCT02043730|Paclitaxel|paclitaxel|mesh-list
44802789|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44802790|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802791|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802792|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802793|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802794|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288607|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
44802795|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802796|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
44802797|NCT02043730|Antiviral Agents|antiviral agents|mesh-ancestor
44802798|NCT02043730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802799|NCT02043730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802800|NCT02043730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802801|NCT02043730|Immunologic Factors|immunologic factors|mesh-ancestor
44802802|NCT02043730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802803|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
44802804|NCT02043756|Analgesics|analgesics|mesh-ancestor
44802805|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
44802806|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802807|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802808|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802809|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44802810|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802811|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802812|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802813|NCT02043821|Capecitabine|capecitabine|mesh-list
44802814|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44802815|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
44802816|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802817|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802818|NCT02043886|Acarbose|acarbose|mesh-list
44802819|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44802820|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802821|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802822|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802823|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802824|NCT02043912|Haloperidol|haloperidol|mesh-list
44802825|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
44802826|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
44802827|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
44802828|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802829|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802830|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802831|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44802832|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44802833|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802834|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44802835|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44802836|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
44802837|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802838|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802839|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44802840|NCT02043977|Propofol|propofol|mesh-list
44802841|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44802842|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802843|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802844|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44802845|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
44802846|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
44802847|NCT02044120|Irinotecan|irinotecan|mesh-list
44802848|NCT02044120|Temozolomide|temozolomide|mesh-list
44802849|NCT02044120|Niraparib|niraparib|mesh-list
44802850|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44802851|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44802852|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802853|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802854|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802855|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44802856|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
44802857|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44802858|NCT02044133|Vitamin D|vitamin d|mesh-list
44802859|NCT02044133|Vitamins|vitamins|mesh-ancestor
44802860|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
44802861|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802862|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44802863|NCT02044146|Clopidogrel|clopidogrel|mesh-list
44802864|NCT02044146|Ticagrelor|ticagrelor|mesh-list
44802865|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44802866|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802867|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44802868|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44802869|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44802870|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
44802871|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802872|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802873|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802874|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
44802875|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44802876|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44802877|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802878|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44802879|NCT02044224|Analgesics|analgesics|mesh-ancestor
44802880|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
44802881|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802882|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44802883|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44802884|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44802885|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
44802886|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802887|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802888|NCT02044250|Aspirin|aspirin|mesh-list
44802889|NCT02044250|Clopidogrel|clopidogrel|mesh-list
44802890|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44802891|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44802892|NCT02044250|Analgesics|analgesics|mesh-ancestor
44802893|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
44802894|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802895|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802896|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802897|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44802898|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44802899|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44802900|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802901|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44802902|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44802903|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802904|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
44802905|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44802906|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44802907|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44802908|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
44802909|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44802910|NCT02044354|Docetaxel|docetaxel|mesh-list
44802911|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802912|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802913|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802914|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802915|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802916|NCT02044549|Oxytocin|oxytocin|mesh-list
44802917|NCT02044549|Carbetocin|carbetocin|mesh-list
44802918|NCT02044549|Methylergonovine|methylergonovine|mesh-list
44802919|NCT02044549|Syntometrine|syntometrine|mesh-list
44802920|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
44802921|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44802922|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802923|NCT02044601|Paclitaxel|paclitaxel|mesh-list
44802924|NCT02044601|Carboplatin|carboplatin|mesh-list
44802925|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44802926|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44802927|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802928|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44802929|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44802930|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44802931|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802932|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44802933|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802934|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44802935|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44802936|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
44802937|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802938|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44802939|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802940|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44802941|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802942|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
44802943|NCT02044653|Hematinics|hematinics|mesh-ancestor
44802944|NCT02044809|Cannabidiol|cannabidiol|mesh-list
44802945|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
44802946|NCT02044952|Mesalamine|mesalamine|mesh-list
44802947|NCT02044952|Triptolide|triptolide|mesh-list
44288763|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44802948|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44802949|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44802950|NCT02044952|Analgesics|analgesics|mesh-ancestor
44802951|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
44802952|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802953|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802954|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802955|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44802956|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802957|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44802958|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44802959|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
44802960|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44583146|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44583147|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
44583148|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583149|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44583150|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44583151|NCT04985604|Niacinamide|niacinamide|mesh-list
44583152|NCT04985604|Vitamin B Complex|vitamin b complex|mesh-ancestor
44583153|NCT04985604|Vitamins|vitamins|mesh-ancestor
44583154|NCT04985604|Micronutrients|micronutrients|mesh-ancestor
44583155|NCT04985604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583156|NCT04975555|Siltuximab|siltuximab|mesh-list
44802961|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44802962|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
44802963|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44802964|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
44802965|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802966|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44802967|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44802969|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
44802970|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44802971|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44802972|NCT02044965|Renal Agents|renal agents|mesh-ancestor
44288819|NCT00770497|Ramipril|ramipril|mesh-list
44802973|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
44802974|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44802975|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44802976|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44802977|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44802978|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44802979|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44693717|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
44693718|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693719|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693720|NCT01375556|Ethanol|ethanol|mesh-list
44693721|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44693722|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693741|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44693742|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
44693743|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44693744|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693745|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44693746|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44693747|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693748|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693749|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
44693750|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44693751|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44693752|NCT01375699|Urological Agents|urological agents|mesh-ancestor
44693753|NCT01375816|Leucovorin|leucovorin|mesh-list
44693754|NCT01375816|Bevacizumab|bevacizumab|mesh-list
44693755|NCT01375816|Fluorouracil|fluorouracil|mesh-list
44693756|NCT01375816|Irinotecan|irinotecan|mesh-list
44693757|NCT01375816|Calcium|calcium|mesh-list
44693758|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
44693759|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44693760|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693761|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44693762|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44693763|NCT01375816|Growth Substances|growth substances|mesh-ancestor
44693764|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693765|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
44693766|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44693767|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
44693768|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693769|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44693770|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693771|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
44693772|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44693773|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44693774|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693775|NCT01375816|Antidotes|antidotes|mesh-ancestor
44693776|NCT01375816|Protective Agents|protective agents|mesh-ancestor
44693777|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
44693778|NCT01375816|Vitamins|vitamins|mesh-ancestor
44693779|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
44693780|NCT01375842|Atezolizumab|atezolizumab|mesh-list
44693781|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693782|NCT01375881|Ritonavir|ritonavir|mesh-list
44693783|NCT01375881|Darunavir|darunavir|mesh-list
44693784|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44693785|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44693786|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
44693787|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693788|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693789|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44693790|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44693791|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
44693792|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583158|NCT04973345|Terbutaline|terbutaline|mesh-list
44802980|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44802981|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44802982|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
44802983|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44802984|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802985|NCT02045017|Dexamethasone|dexamethasone|mesh-list
44802986|NCT02045017|Pomalidomide|pomalidomide|mesh-list
44802987|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44802988|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
44802989|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
44802990|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44802991|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44802992|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44802993|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
44802994|NCT02045017|Hormones|hormones|mesh-ancestor
44802995|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44802996|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44802997|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44802998|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
44802999|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44803000|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44803001|NCT02045017|Growth Substances|growth substances|mesh-ancestor
44803002|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
44803003|NCT02045030|Aflibercept|aflibercept|mesh-list
44803004|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44803005|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44803006|NCT02045030|Growth Substances|growth substances|mesh-ancestor
44803007|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288893|NCT00770731|Bortezomib|bortezomib|mesh-list
44803008|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
44803009|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583174|NCT04967508|Ustekinumab|ustekinumab|mesh-list
44803010|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
44803011|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44803012|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
44803013|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803014|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44803015|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44803016|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44803017|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803019|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44803020|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803021|NCT02045290|Metformin|metformin|mesh-list
44803022|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803023|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803024|NCT02045368|Methotrexate|methotrexate|mesh-list
44803025|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44803026|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
44803027|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803028|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803029|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803030|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
44803031|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803032|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803033|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44803034|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803035|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44803036|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803037|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
44803038|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803039|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44803040|NCT02045589|Gemcitabine|gemcitabine|mesh-list
44803041|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44803042|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803043|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
44803044|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803045|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803046|NCT02045589|Antiviral Agents|antiviral agents|mesh-ancestor
44803047|NCT02045589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803048|NCT02045589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803049|NCT02045589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803050|NCT02045589|Immunologic Factors|immunologic factors|mesh-ancestor
44803051|NCT02045589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803052|NCT02045602|Gemcitabine|gemcitabine|mesh-list
44803053|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44803054|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803055|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
44803056|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803057|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803058|NCT02045602|Antiviral Agents|antiviral agents|mesh-ancestor
44803059|NCT02045602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803060|NCT02045602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803061|NCT02045602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803062|NCT02045602|Immunologic Factors|immunologic factors|mesh-ancestor
44803063|NCT02045602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803064|NCT02045667|Mexiletine|mexiletine|mesh-list
44803065|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44803066|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44803067|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44803068|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803069|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803070|NCT02045693|Buprenorphine|buprenorphine|mesh-list
44803071|NCT02045693|Methadone|methadone|mesh-list
44803072|NCT02045693|Naloxone|naloxone|mesh-list
44803073|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44803074|NCT02045693|Narcotics|narcotics|mesh-ancestor
44803075|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803076|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803077|NCT02045693|Analgesics|analgesics|mesh-ancestor
44803078|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
44803079|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803080|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44803081|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
44803082|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44803083|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
44803084|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
44803085|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
44803086|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803087|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803088|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
44803089|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803090|NCT02045849|Itraconazole|itraconazole|mesh-list
44803091|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
44803092|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803093|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44803094|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44803095|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803096|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803097|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44803098|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803099|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803100|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464512|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
44803101|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44803102|NCT02045914|Calcium|calcium|mesh-list
44803103|NCT02045914|Ionophores|ionophores|mesh-list
44803104|NCT02045914|Ionomycin|ionomycin|mesh-list
44803105|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
44803106|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803107|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803108|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803109|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803110|NCT02045940|GSK2881078|gsk2881078|mesh-list
44803111|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
44803112|NCT02045940|Hormones|hormones|mesh-ancestor
44803113|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803114|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803115|NCT02045953|Albuterol|albuterol|mesh-list
44803116|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44803117|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
44803118|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803119|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803120|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44803121|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
44803122|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
44803123|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803124|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44803125|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44803126|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44803127|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803128|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803129|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803130|NCT02045992|Caffeine|caffeine|mesh-list
44803131|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44803132|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803133|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44803134|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803135|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803136|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44803137|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44803138|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
44803139|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803140|NCT02046044|Digoxin|digoxin|mesh-list
44803141|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44803142|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44803143|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803144|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803145|NCT02046044|Protective Agents|protective agents|mesh-ancestor
44803146|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803147|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
44803148|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44803149|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803150|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
44803151|NCT02046187|Temozolomide|temozolomide|mesh-list
44803152|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44803153|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
44803154|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803155|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803156|NCT02046304|Gemcitabine|gemcitabine|mesh-list
44803157|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803158|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
44803159|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803160|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803161|NCT02046304|Antiviral Agents|antiviral agents|mesh-ancestor
44803162|NCT02046304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803163|NCT02046304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803164|NCT02046304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803165|NCT02046304|Immunologic Factors|immunologic factors|mesh-ancestor
44803166|NCT02046304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803167|NCT02046421|Gemcitabine|gemcitabine|mesh-list
44803168|NCT02046421|Carboplatin|carboplatin|mesh-list
44803169|NCT02046421|Mifepristone|mifepristone|mesh-list
44803170|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803171|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803172|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
44803173|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803174|NCT02046421|Antiviral Agents|antiviral agents|mesh-ancestor
44803175|NCT02046421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803176|NCT02046421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803177|NCT02046421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803178|NCT02046421|Immunologic Factors|immunologic factors|mesh-ancestor
44803179|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803180|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44803181|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
44803182|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803183|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44803184|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44693793|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44693794|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693795|NCT01375920|Metyrapone|metyrapone|mesh-list
44693796|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
44289027|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44693797|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693798|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693799|NCT01375972|Gemcitabine|gemcitabine|mesh-list
44693800|NCT01375972|Cisplatin|cisplatin|mesh-list
44693801|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693802|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44693803|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
44693804|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693805|NCT01375972|Antiviral Agents|antiviral agents|mesh-ancestor
44693806|NCT01375972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693807|NCT01375972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693808|NCT01375972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693809|NCT01375972|Immunologic Factors|immunologic factors|mesh-ancestor
44693810|NCT01375972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693811|NCT01375985|Radavirsen|radavirsen|mesh-list
44693812|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
44693813|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693814|NCT01376011|Quercetin|quercetin|mesh-list
44693815|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
44693816|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693817|NCT01376011|Protective Agents|protective agents|mesh-ancestor
44693818|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693819|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
44693820|NCT01376076|Risperidone|risperidone|mesh-list
44693821|NCT01376076|Cariprazine|cariprazine|mesh-list
44693822|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44693823|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693824|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693825|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44693826|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44693827|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693828|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693829|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693830|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44693831|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
44693832|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44693833|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693834|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44693835|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44693836|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44693837|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44693838|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
44693839|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803185|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44803186|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
44803187|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44803188|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44803189|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803190|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803191|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
44803192|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44803193|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44803194|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
44803195|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44803196|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44803197|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44803198|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44803199|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
44803200|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803201|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803202|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803203|NCT02046460|Aspirin|aspirin|mesh-list
44803204|NCT02046460|Vitamin K|vitamin k|mesh-list
44803205|NCT02046460|Warfarin|warfarin|mesh-list
44803206|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
44803207|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
44803208|NCT02046460|Vitamins|vitamins|mesh-ancestor
44803209|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
44803210|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803211|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
44803212|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803213|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803214|NCT02046460|Analgesics|analgesics|mesh-ancestor
44803215|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
44803216|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803217|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803218|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803219|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44803220|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44803221|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803222|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803223|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44803224|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803225|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
44803226|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44803227|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
44803228|NCT02046460|Coagulants|coagulants|mesh-ancestor
44803229|NCT02046486|Ticagrelor|ticagrelor|mesh-list
44803230|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803231|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44803232|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44803233|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44803234|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
44289114|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44803235|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803236|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803237|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803238|NCT02046499|Oxytocin|oxytocin|mesh-list
44803239|NCT02046499|Ergonovine|ergonovine|mesh-list
44803240|NCT02046499|Syntometrine|syntometrine|mesh-list
44803241|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
44803242|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803243|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803244|NCT02046538|Leucovorin|leucovorin|mesh-list
44803245|NCT02046538|Fluorouracil|fluorouracil|mesh-list
44803246|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
44803247|NCT02046538|Irinotecan|irinotecan|mesh-list
44803248|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
44803249|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803250|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803251|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803252|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803253|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
44803254|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803255|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44803256|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44803257|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803258|NCT02046538|Antidotes|antidotes|mesh-ancestor
44803259|NCT02046538|Protective Agents|protective agents|mesh-ancestor
44803260|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
44583433|NCT04783194|Dexamethasone|dexamethasone|mesh-list
44803262|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
44803263|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44803264|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44803265|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44803266|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803267|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803268|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803269|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803270|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803271|NCT02046577|Vitamin D|vitamin d|mesh-list
44803272|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
44803273|NCT02046577|Vitamins|vitamins|mesh-ancestor
44803274|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
44803275|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803276|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44803277|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803278|NCT02046590|Propofol|propofol|mesh-list
44803279|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
44803280|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803281|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803282|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44803283|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44803284|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
44803285|NCT02046629|Teriflunomide|teriflunomide|mesh-list
44803286|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
44803287|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803288|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803289|NCT02046629|Analgesics|analgesics|mesh-ancestor
44803290|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
44803291|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803292|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803293|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803294|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803295|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803296|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
44803297|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44803298|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44803299|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
44803300|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803301|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44803302|NCT02046668|Spironolactone|spironolactone|mesh-list
44803303|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44803304|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803305|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803306|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803307|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44803308|NCT02046668|Diuretics|diuretics|mesh-ancestor
44803309|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
44803310|NCT02046720|Propofol|propofol|mesh-list
44803311|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44803312|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803313|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803314|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44803315|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
44803316|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
44803317|NCT02046733|Nivolumab|nivolumab|mesh-list
44803318|NCT02046733|Ipilimumab|ipilimumab|mesh-list
44583509|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583510|NCT04756063|Protective Agents|protective agents|mesh-ancestor
44583511|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44583512|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44583513|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583514|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583515|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
44583516|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583517|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583518|NCT04750070|Dopamine|dopamine|mesh-list
44583519|NCT04750070|Epinephrine|epinephrine|mesh-list
44583520|NCT04750070|Racepinephrine|racepinephrine|mesh-list
44583521|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
44583522|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44583523|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44583524|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803319|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44803320|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803321|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44803322|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803323|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44803324|NCT02046850|Rifampin|rifampin|mesh-list
44803325|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44803326|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
44803327|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44803328|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803329|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
44803330|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44803331|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803332|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803333|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44803334|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44803335|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44289239|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803336|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44803337|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44803338|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44803339|NCT02046915|Dexamethasone|dexamethasone|mesh-list
44803340|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
44803341|NCT02046915|Pomalidomide|pomalidomide|mesh-list
44803342|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803343|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
44803344|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803345|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803346|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44803347|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
44803348|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803349|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803350|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44803351|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803352|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
44803353|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
44803354|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803355|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44803356|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
44803357|NCT02046915|Hormones|hormones|mesh-ancestor
44803358|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803359|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44803360|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44803361|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44803362|NCT02046915|Growth Substances|growth substances|mesh-ancestor
44803363|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
44803364|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
44803365|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44803366|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
44803367|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44803368|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
44803369|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803370|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803371|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
44803372|NCT02047019|Candesartan|candesartan|mesh-list
44803373|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
44803374|NCT02047019|Nifedipine|nifedipine|mesh-list
44803375|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44803376|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44803377|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44803378|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803379|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44803380|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803381|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803382|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803383|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
44803384|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
44803385|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803386|NCT02047136|Histamine|histamine|mesh-list
44803387|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
44803388|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
44803389|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803390|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803391|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803392|NCT02047149|Zileuton|zileuton|mesh-list
44803393|NCT02047149|Dasatinib|dasatinib|mesh-list
44803394|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
44803395|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803396|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44803397|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803398|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803399|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803400|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803401|NCT02047149|Analgesics|analgesics|mesh-ancestor
44803402|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
44803403|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803404|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803405|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803406|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803407|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44803408|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44803409|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803410|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803411|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
44803412|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44803413|NCT02047162|Bismuth|bismuth|mesh-list
44803414|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44803415|NCT02047162|Antacids|antacids|mesh-ancestor
44803416|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803417|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44803418|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
44803419|NCT02047175|Niacin|niacin|mesh-list
44803420|NCT02047175|Amlodipine|amlodipine|mesh-list
44803421|NCT02047175|Telmisartan|telmisartan|mesh-list
44803422|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44803423|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44803424|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44803425|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803426|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803427|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803428|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803429|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44803430|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44803431|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44803432|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
44803433|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44803434|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44803435|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803436|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44803437|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44803438|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
44803440|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
44803441|NCT02047201|Cisplatin|cisplatin|mesh-list
44803442|NCT02047201|Docetaxel|docetaxel|mesh-list
44803443|NCT02047201|Fluorouracil|fluorouracil|mesh-list
44803444|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803445|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
44803446|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
44803447|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
44803448|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803449|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
44803450|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803451|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803452|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
44803453|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803454|NCT02047292|Tacrine|tacrine|mesh-list
44803455|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44803456|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803457|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803458|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
44803459|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803460|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803461|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44803462|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
44803463|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803464|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
44803465|NCT02047422|Metolazone|metolazone|mesh-list
44803466|NCT02047422|Furosemide|furosemide|mesh-list
44803467|NCT02047422|Spironolactone|spironolactone|mesh-list
44803468|NCT02047422|Diuretics|diuretics|mesh-ancestor
44803469|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
44803470|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803471|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44803472|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803473|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803474|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44803475|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803476|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803477|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44803478|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44803479|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44803480|NCT02047539|Aspirin|aspirin|mesh-list
44803481|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803482|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803483|NCT02047539|Analgesics|analgesics|mesh-ancestor
44803484|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
44803485|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803486|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803487|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803488|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803489|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44803490|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44803491|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803492|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803493|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44803494|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803495|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
44803496|NCT02047552|Iron|iron|mesh-list
44803497|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44803498|NCT02047552|Oxandrolone|oxandrolone|mesh-list
44803499|NCT02047552|Trace Elements|trace elements|mesh-ancestor
44803500|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
44803501|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803502|NCT02047552|Hematinics|hematinics|mesh-ancestor
44803503|NCT02047552|Androgens|androgens|mesh-ancestor
44803504|NCT02047552|Hormones|hormones|mesh-ancestor
44803505|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803506|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
44803507|NCT02047565|Edoxaban|edoxaban|mesh-list
44803508|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44803509|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
44803510|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44693840|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44803511|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44803512|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803513|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803514|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
44803515|NCT02047578|Busulfan|busulfan|mesh-list
44803516|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
44803517|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803518|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803519|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
44803520|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803521|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44803522|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803523|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44803524|NCT02047630|Latanoprost|latanoprost|mesh-list
44803525|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44803526|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44803527|NCT02047773|Meropenem|meropenem|mesh-list
44803528|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44803529|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803530|NCT02047799|Calcitriol|calcitriol|mesh-list
44803531|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803532|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803533|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44803534|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803535|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803536|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44803537|NCT02047799|Vitamins|vitamins|mesh-ancestor
44803538|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
44803539|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44803540|NCT02047838|Hormones|hormones|mesh-list
44803541|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44803542|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803543|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803544|NCT02048007|Azithromycin|azithromycin|mesh-list
44803545|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44803546|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803547|NCT02048020|Paclitaxel|paclitaxel|mesh-list
44803548|NCT02048020|Carboplatin|carboplatin|mesh-list
44803549|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44803550|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803551|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
44803552|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
44803553|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
44803554|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803555|NCT02048085|Clopidogrel|clopidogrel|mesh-list
44803556|NCT02048085|Ticagrelor|ticagrelor|mesh-list
44803557|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803558|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44803559|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44803560|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44803561|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
44803562|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803563|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803564|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803565|NCT02048098|Misoprostol|misoprostol|mesh-list
44803566|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44803567|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
44803568|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803569|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803570|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44803571|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44803572|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
44803573|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
44803574|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803575|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803576|NCT02048215|Ephedrine|ephedrine|mesh-list
44803577|NCT02048215|Caffeine|caffeine|mesh-list
44803578|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44803579|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693841|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44693842|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693843|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693844|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44693845|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
44693846|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
44583752|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
44803580|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44803581|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803582|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803583|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44803584|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44803585|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
44803586|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803587|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
44803588|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
44803589|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803590|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44803591|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803592|NCT02048228|Clopidogrel|clopidogrel|mesh-list
44803594|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803595|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44289471|NCT00773812|Mecamylamine|mecamylamine|mesh-list
44803596|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44803597|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44803598|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
44803599|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803600|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803601|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803602|NCT02048293|Remifentanil|remifentanil|mesh-list
44803603|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44803604|NCT02048293|Narcotics|narcotics|mesh-ancestor
44803605|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803606|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803607|NCT02048293|Analgesics|analgesics|mesh-ancestor
44803608|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
44803609|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803610|NCT02048319|Ethanol|ethanol|mesh-list
44803611|NCT02048319|Pasireotide|pasireotide|mesh-list
44803612|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44803613|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803614|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803615|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803616|NCT02048319|Hormones|hormones|mesh-ancestor
44803617|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803618|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44803619|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
44803620|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44803621|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44803622|NCT02048358|Prednisolone|prednisolone|mesh-list
44803623|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
44803624|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44803625|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
44803626|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803627|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
44803628|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
44803629|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803630|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803631|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44803632|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
44803633|NCT02048358|Hormones|hormones|mesh-ancestor
44803634|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803635|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44803636|NCT02048358|Protective Agents|protective agents|mesh-ancestor
44803637|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44803638|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803639|NCT02048384|Metformin|metformin|mesh-list
44803640|NCT02048384|Sirolimus|sirolimus|mesh-list
44803641|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803642|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803643|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44803644|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803645|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44803646|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803647|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
44803648|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944233|NCT03115047|Meperidine|meperidine|mesh-list
44803649|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
44803650|NCT02048423|Ketamine|ketamine|mesh-list
44803651|NCT02048423|Analgesics|analgesics|mesh-ancestor
44803652|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
44803653|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803654|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803655|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44803656|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44803657|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
44803658|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
44803659|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803660|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44803661|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44803662|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803663|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803664|NCT02048475|Desflurane|desflurane|mesh-list
44803665|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44803666|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
44803667|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
44803668|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803669|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803670|NCT02048488|Belizatinib|belizatinib|mesh-list
44803671|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44803672|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803673|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803674|NCT02048540|Bevacizumab|bevacizumab|mesh-list
44803675|NCT02048540|Docetaxel|docetaxel|mesh-list
44803676|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
44803677|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44803678|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803679|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44803680|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44803681|NCT02048540|Growth Substances|growth substances|mesh-ancestor
44803682|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803683|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
44803684|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
44803685|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
44803686|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
44289551|NCT00774358|Interleukin-2|interleukin-2|mesh-list
44803687|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803688|NCT02048644|Beclomethasone|beclomethasone|mesh-list
44803689|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
44803690|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44803691|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
44803692|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803693|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803694|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44803695|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
44803696|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44803697|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44803698|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44803699|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803700|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803701|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803702|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803703|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
44803704|NCT02048644|Hormones|hormones|mesh-ancestor
44803705|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803706|NCT02048683|Sevoflurane|sevoflurane|mesh-list
44803707|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803708|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44803709|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
44803710|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
44583967|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44583968|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44803711|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803712|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803713|NCT02048761|Metformin|metformin|mesh-list
44803714|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803715|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803716|NCT02048800|Treosulfan|treosulfan|mesh-list
44803717|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44803718|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
44803719|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803720|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803721|NCT02048852|Menthol|menthol|mesh-list
44803722|NCT02048852|Nicotine|nicotine|mesh-list
44803723|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44803724|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
44803725|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803726|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803727|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44803728|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44803729|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
44803730|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803731|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803732|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
44803733|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44803734|NCT02048865|Apixaban|apixaban|mesh-list
44803735|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44583969|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44583970|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583971|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44583972|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44583973|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583974|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
44583975|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44583976|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289589|NCT00774488|Hormones|hormones|mesh-ancestor
44583977|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583978|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583979|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44583980|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
44583981|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583982|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583983|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
44583984|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583985|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583986|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
44583987|NCT04438213|Metolazone|metolazone|mesh-list
44583988|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44583989|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583990|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44583991|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583993|NCT04438213|Diuretics|diuretics|mesh-ancestor
44803736|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
44803737|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44803738|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
44803739|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803740|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803741|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
44803742|NCT02048917|Bupropion|bupropion|mesh-list
44803743|NCT02048917|Varenicline|varenicline|mesh-list
44803744|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44803745|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
44803746|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44803747|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44803748|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44803749|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803750|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803751|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
44803752|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803753|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803754|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44803755|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44803756|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803757|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44803758|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44803759|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
44803760|NCT02048930|Budesonide|budesonide|mesh-list
44803761|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803762|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44803763|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
44803764|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289648|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803765|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803766|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44803767|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44803768|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
44803769|NCT02048930|Hormones|hormones|mesh-ancestor
44803770|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803771|NCT02048943|Gemcitabine|gemcitabine|mesh-list
44803772|NCT02048943|Paclitaxel|paclitaxel|mesh-list
44803773|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44803774|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44803775|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803776|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44803777|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44803778|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44803779|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803780|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803781|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
44803782|NCT02048943|Antiviral Agents|antiviral agents|mesh-ancestor
44803783|NCT02048943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803784|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803785|NCT02048943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803786|NCT02048943|Immunologic Factors|immunologic factors|mesh-ancestor
44803787|NCT02048943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803788|NCT02048969|Flumazenil|flumazenil|mesh-list
44803789|NCT02048969|Antidotes|antidotes|mesh-ancestor
44803790|NCT02048969|Protective Agents|protective agents|mesh-ancestor
44803791|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693847|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44693848|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693849|NCT01376128|Paroxetine|paroxetine|mesh-list
44693850|NCT01376128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44693851|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44693852|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693853|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693854|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693855|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
44693856|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693857|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44693858|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44693859|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693860|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44693861|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693862|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693863|NCT01376141|Sumatriptan|sumatriptan|mesh-list
44584018|NCT04417062|Olaparib|olaparib|mesh-list
44803792|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
44803793|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
44803794|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803795|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803796|NCT02049034|Lixisenatide|lixisenatide|mesh-list
44803797|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803798|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803799|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
44803800|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44803801|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44803802|NCT02049073|Prednisolone|prednisolone|mesh-list
44803803|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
44803804|NCT02049073|Zonisamide|zonisamide|mesh-list
44803805|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44803806|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
44803807|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803808|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
44803809|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
44803810|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803811|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803812|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44803813|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
44803814|NCT02049073|Hormones|hormones|mesh-ancestor
44803815|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803816|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44803817|NCT02049073|Protective Agents|protective agents|mesh-ancestor
44803818|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44803819|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803820|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
44803821|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44803822|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44803823|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803824|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44803825|NCT02049190|Onapristone|onapristone|mesh-list
44803826|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803827|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44803828|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
44803829|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44803830|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803831|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
44803832|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803833|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
44803834|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
44803835|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803836|NCT02049229|Everolimus|everolimus|mesh-list
44803837|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803838|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803839|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
44803840|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803841|NCT02049255|Bupivacaine|bupivacaine|mesh-list
44803842|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
44803843|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
44803844|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
44803845|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803846|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803847|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
44803848|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803849|NCT02049268|Ethanol|ethanol|mesh-list
44803850|NCT02049268|Nicotine|nicotine|mesh-list
44803851|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44803852|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
44803853|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803854|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803855|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44803856|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44803857|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
44803858|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803859|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803860|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44289707|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
44803861|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803862|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803863|NCT02049294|Omalizumab|omalizumab|mesh-list
44803864|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44803865|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44803866|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44803867|NCT02049320|Remifentanil|remifentanil|mesh-list
44803868|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44803869|NCT02049320|Narcotics|narcotics|mesh-ancestor
44803870|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803871|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803872|NCT02049320|Analgesics|analgesics|mesh-ancestor
44803873|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
44803874|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803875|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
44803876|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
44803877|NCT02049346|Hematinics|hematinics|mesh-ancestor
44803878|NCT02049411|Ketamine|ketamine|mesh-list
44803879|NCT02049411|Analgesics|analgesics|mesh-ancestor
44803880|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
44803881|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803882|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803883|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44803884|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44803885|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
44803886|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
44803887|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803888|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44803889|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44803890|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803891|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803892|NCT02049515|Ofatumumab|ofatumumab|mesh-list
44803893|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803894|NCT02049541|Rituximab|rituximab|mesh-list
44803895|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44803896|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803897|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
44803898|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803899|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803900|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
44803901|NCT02049580|Thiotepa|thiotepa|mesh-list
44803902|NCT02049580|Fludarabine|fludarabine|mesh-list
44803903|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803904|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
44803905|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803906|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803907|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44803908|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
44803909|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803910|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803911|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44803912|NCT02049606|Nabumetone|nabumetone|mesh-list
44803913|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803914|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803915|NCT02049606|Analgesics|analgesics|mesh-ancestor
44803916|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
44803917|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803918|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803919|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803920|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803921|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44803922|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44803923|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803924|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803925|NCT02049671|Hormones|hormones|mesh-list
44803926|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44803927|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803928|NCT02049736|Telbivudine|telbivudine|mesh-list
44803929|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
44803930|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803931|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44803932|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803933|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803934|NCT02049762|Aspirin|aspirin|mesh-list
44803935|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44803936|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803937|NCT02049762|Analgesics|analgesics|mesh-ancestor
44803938|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
44803939|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584150|NCT04298567|Analgesics|analgesics|mesh-ancestor
44803940|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803941|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44803942|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44803943|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44803944|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44803945|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803946|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44803947|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44803948|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803949|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
44803950|NCT02049801|Cytarabine|cytarabine|mesh-list
44803951|NCT02049801|Idarubicin|idarubicin|mesh-list
44803952|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44803953|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
44803954|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803955|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803956|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
44803957|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44803958|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44803959|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
44803960|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803961|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44803962|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44803963|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44803964|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44803965|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
44803966|NCT02049970|Bupivacaine|bupivacaine|mesh-list
44803967|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
44803968|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
44803969|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44803970|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803971|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
44803972|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44803973|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44803974|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44803975|NCT02049970|Analgesics|analgesics|mesh-ancestor
44803976|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44803977|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44803978|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44803979|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
44803980|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44803981|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803982|NCT02050009|Metformin|metformin|mesh-list
44803983|NCT02050009|Paclitaxel|paclitaxel|mesh-list
44803984|NCT02050009|Carboplatin|carboplatin|mesh-list
44803985|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44803986|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44803987|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44803988|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44803989|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44803990|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44803991|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803992|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803993|NCT02050074|Metformin|metformin|mesh-list
44803994|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44803995|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44803996|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44803997|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44803998|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44803999|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
44804000|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804001|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44804002|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
44804003|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44804004|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
44804005|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
44804006|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804007|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804008|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804009|NCT02050152|Analgesics|analgesics|mesh-ancestor
44804010|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
44804011|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804012|NCT02050178|Gemcitabine|gemcitabine|mesh-list
44804013|NCT02050178|Paclitaxel|paclitaxel|mesh-list
44804014|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804015|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804016|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804017|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804018|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804019|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804020|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44804021|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
44804022|NCT02050178|Antiviral Agents|antiviral agents|mesh-ancestor
44804023|NCT02050178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804024|NCT02050178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804025|NCT02050178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804026|NCT02050178|Immunologic Factors|immunologic factors|mesh-ancestor
44804027|NCT02050178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804028|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
44804029|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
44804030|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44804031|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44804032|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804033|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804034|NCT02050360|Urological Agents|urological agents|mesh-ancestor
44584296|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
44693864|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44693865|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44693866|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44693867|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
44693868|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693869|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693870|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693871|NCT01376154|Lamivudine|lamivudine|mesh-list
44693872|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44693873|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44693874|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693875|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693876|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
44693877|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693878|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44693879|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44693880|NCT01376180|Lamotrigine|lamotrigine|mesh-list
44693881|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
44693882|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44693883|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693884|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584368|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584369|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
44804035|NCT02050529|Hydralazine|hydralazine|mesh-list
44804036|NCT02050529|Labetalol|labetalol|mesh-list
44804037|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44804038|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
44804039|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44804040|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44804041|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804042|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804043|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804044|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804045|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
44804046|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
44804047|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804048|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44804049|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44804050|NCT02050594|Ipilimumab|ipilimumab|mesh-list
44804051|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44804052|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804053|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44804054|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804055|NCT02050672|Inositol|inositol|mesh-list
44804056|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
44804057|NCT02050672|Vitamins|vitamins|mesh-ancestor
44804058|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
44804059|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804060|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
44584370|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584371|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44584372|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44584373|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44584374|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44584375|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584376|NCT04153136|Valsartan|valsartan|mesh-list
44584377|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44584378|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44584379|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44584380|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44584381|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584382|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44584383|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
44584384|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584385|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44584386|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584387|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584388|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584389|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44584390|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44804061|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44804062|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804063|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
44804064|NCT02050802|Macitentan|macitentan|mesh-list
44804065|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804066|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804067|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44804068|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44804069|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804070|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804071|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804072|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44804073|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44804074|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44804075|NCT02050893|Midazolam|midazolam|mesh-list
44804076|NCT02050893|Propofol|propofol|mesh-list
44804077|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44804078|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804079|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804080|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44804081|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
44804082|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
44804083|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44804084|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44804085|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44804086|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804087|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
44804088|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
44804089|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804090|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804091|NCT02050958|Ibuprofen|ibuprofen|mesh-list
44804092|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44804093|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804094|NCT02050958|Analgesics|analgesics|mesh-ancestor
44804095|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
44804096|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804097|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804098|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804099|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804100|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44804101|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804102|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804103|NCT02051023|Fluorometholone|fluorometholone|mesh-list
44804104|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
44804105|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44804106|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44804107|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804108|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
44804109|NCT02051023|Hormones|hormones|mesh-ancestor
44804110|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804111|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804112|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44804113|NCT02051153|Modafinil|modafinil|mesh-list
44804114|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44804115|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804116|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44804117|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44804118|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44804119|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804120|NCT02051231|Oxytocin|oxytocin|mesh-list
44804121|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
44804122|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804123|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804124|NCT02051387|Cannabidiol|cannabidiol|mesh-list
44804125|NCT02051387|Olanzapine|olanzapine|mesh-list
44804126|NCT02051387|Risperidone|risperidone|mesh-list
44804127|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44804128|NCT02051387|Amisulpride|amisulpride|mesh-list
44290009|NCT00776113|Carvedilol|carvedilol|mesh-list
44804129|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44804130|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
44804131|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804132|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804133|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804134|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44804135|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44804136|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804137|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804138|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44804139|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
44804140|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
44804141|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
44804142|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804143|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804144|NCT02051387|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44804145|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44804146|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804147|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804148|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
44804149|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44804150|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44804151|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44804152|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44804153|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804154|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804155|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804156|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804157|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44804158|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804159|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804160|NCT02051530|Tryptophan|tryptophan|mesh-list
44804161|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44804162|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804163|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804164|NCT02051569|Tryptophan|tryptophan|mesh-list
44804165|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44804166|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804167|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804168|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44804169|NCT02051738|Mebendazole|mebendazole|mesh-list
44804170|NCT02051738|Piperazine|piperazine|mesh-list
44804171|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
44804172|NCT02051738|DMP 777|dmp 777|mesh-list
44804173|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
44804174|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
44804175|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44804176|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804177|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804178|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804179|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804180|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804181|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804182|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804183|NCT02051751|Paclitaxel|paclitaxel|mesh-list
44804184|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804185|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804186|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804187|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804188|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804189|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804190|NCT02051842|Metadoxine|metadoxine|mesh-list
44804191|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44804192|NCT02051868|Paclitaxel|paclitaxel|mesh-list
44804193|NCT02051868|Cisplatin|cisplatin|mesh-list
44804194|NCT02051868|Carboplatin|carboplatin|mesh-list
44804195|NCT02051868|Fluorouracil|fluorouracil|mesh-list
44804196|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804197|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804198|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804199|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804200|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804201|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804202|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
44804203|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44804204|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804205|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
44804206|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804207|NCT02051894|Dobutamine|dobutamine|mesh-list
44804208|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44804209|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
44804210|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
44804211|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804212|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804213|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44804214|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44804216|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804217|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804218|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804219|NCT02051894|Protective Agents|protective agents|mesh-ancestor
44804220|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
44804221|NCT02051946|Diuretics|diuretics|mesh-ancestor
44804222|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
44804223|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804224|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804225|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804226|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44804227|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
44804228|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44804229|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44804230|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44804231|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804232|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804233|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
44804234|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804235|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804236|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44804237|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804238|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44804240|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804241|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44804242|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
44804243|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804244|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804245|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804246|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804247|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44804248|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
44804249|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804250|NCT02052167|Methotrexate|methotrexate|mesh-list
44804251|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44804252|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
44290130|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44804253|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804254|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804255|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44804256|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
44804257|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804258|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804259|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
44804260|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804261|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44804262|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804263|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
44804264|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804265|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44804266|NCT02052180|Bupivacaine|bupivacaine|mesh-list
44804267|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
44804268|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
44804269|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804270|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804271|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
44804272|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804273|NCT02052258|Oxytocin|oxytocin|mesh-list
44804274|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
44804275|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804276|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804277|NCT02052323|Artesunate|artesunate|mesh-list
44804278|NCT02052323|Mefloquine|mefloquine|mesh-list
44804279|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
44804280|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44804281|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44804282|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804283|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804284|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
44804285|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
44804286|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44804287|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
44804288|NCT02052336|Clarithromycin|clarithromycin|mesh-list
44804289|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804290|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804291|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44804292|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804293|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804294|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44804295|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44804296|NCT02052388|Daptomycin|daptomycin|mesh-list
44804297|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804298|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804299|NCT02052492|Vitamin D|vitamin d|mesh-list
44804300|NCT02052492|Vitamins|vitamins|mesh-ancestor
44804301|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
44804302|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804303|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804304|NCT02052609|Brodalumab|brodalumab|mesh-list
44804305|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44804306|NCT02052687|Imiquimod|imiquimod|mesh-list
44804307|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44804308|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
44804309|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804310|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804311|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
44804312|NCT02052713|Tamsulosin|tamsulosin|mesh-list
44804313|NCT02052713|Dutasteride|dutasteride|mesh-list
44804314|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44804315|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44804316|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44804317|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804318|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804319|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804320|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804321|NCT02052713|Urological Agents|urological agents|mesh-ancestor
44693885|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44693886|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693887|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44693888|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44693889|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693890|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693891|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44693892|NCT01376193|Naratriptan|naratriptan|mesh-list
44693893|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44693894|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44693895|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44693896|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
44693897|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693898|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693899|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693900|NCT01376206|Fluticasone|fluticasone|mesh-list
44693901|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693902|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44693903|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
44693904|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693905|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693906|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44693907|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
44693908|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
44693909|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44693910|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
44693911|NCT01376232|Glycine|glycine|mesh-list
44693912|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
44693913|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693914|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693915|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693916|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44693917|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
44693918|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44693919|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44693920|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693921|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693922|NCT01376258|Finasteride|finasteride|mesh-list
44693923|NCT01376258|Dutasteride|dutasteride|mesh-list
44693924|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44693925|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44693926|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693927|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693928|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
44245493|NCT04570410|Gemcitabine|gemcitabine|mesh-list
44693929|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693930|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693931|NCT01376258|Urological Agents|urological agents|mesh-ancestor
44693932|NCT01376271|Paroxetine|paroxetine|mesh-list
44693933|NCT01376271|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44693934|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44693935|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693936|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693937|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693938|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
44693939|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693940|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44693941|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
44693942|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693943|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44693944|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693945|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693946|NCT01376284|Dutasteride|dutasteride|mesh-list
44693947|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44804322|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44804323|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44804324|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804325|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804326|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804328|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
44804329|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804330|NCT02052908|Naproxen|naproxen|mesh-list
44804331|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44804332|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804333|NCT02052908|Analgesics|analgesics|mesh-ancestor
44804334|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
44804335|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804336|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804337|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804338|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804339|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
44804340|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44804341|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804342|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804343|NCT02052934|Vaccines|vaccines|mesh-list
44804344|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
44804345|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804346|NCT02052973|Propolis|propolis|mesh-list
44804347|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804348|NCT02053142|Acyclovir|acyclovir|mesh-list
44804349|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
44804350|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804351|NCT02053298|Timolol|timolol|mesh-list
44804352|NCT02053298|Dorzolamide|dorzolamide|mesh-list
44804353|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44804354|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44804355|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804356|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804357|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804358|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804359|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44804360|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44804361|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44804362|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804363|NCT02053402|Vitamin D|vitamin d|mesh-list
44804364|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
44804365|NCT02053402|Vitamins|vitamins|mesh-ancestor
44804366|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
44804367|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804368|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804369|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44804370|NCT02053519|Vitamin D|vitamin d|mesh-list
44804371|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
44804372|NCT02053519|Vitamins|vitamins|mesh-ancestor
44804373|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
44804374|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804375|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804376|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44804377|NCT02053558|Lidocaine|lidocaine|mesh-list
44804378|NCT02053558|Ropivacaine|ropivacaine|mesh-list
44804379|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
44804380|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
44804381|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804382|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804383|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
44804384|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804385|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44804386|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44804387|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44804388|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804389|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804390|NCT02053597|Paclitaxel|paclitaxel|mesh-list
44804391|NCT02053597|Doxorubicin|doxorubicin|mesh-list
44804392|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804393|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804394|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804395|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804396|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804397|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804398|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44804399|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44804400|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44804401|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804402|NCT02053675|Vasopressins|vasopressins|mesh-list
44804403|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
44804404|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
44804405|NCT02053675|Coagulants|coagulants|mesh-ancestor
44804406|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44804407|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44804408|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
44804409|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804410|NCT02053727|Abatacept|abatacept|mesh-list
44804411|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44804412|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804413|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804414|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804415|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
44804416|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804417|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804418|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
44804419|NCT02053766|Propofol|propofol|mesh-list
44804420|NCT02053766|Sevoflurane|sevoflurane|mesh-list
44804421|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44804422|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804423|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804424|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44804425|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
44804426|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
44804427|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804428|NCT02053766|Analgesics|analgesics|mesh-ancestor
44804429|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
44804430|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804431|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44290330|NCT00777543|Ferulic acid|ferulic acid|mesh-list
44804432|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44804433|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44804434|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804435|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804436|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804437|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44804438|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44804439|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44804440|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
44804441|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44804442|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
44804443|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804444|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804445|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44804446|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44804447|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804448|NCT02053818|Sufentanil|sufentanil|mesh-list
44804449|NCT02053818|Remifentanil|remifentanil|mesh-list
44804450|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44804451|NCT02053818|Narcotics|narcotics|mesh-ancestor
44804452|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804453|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804454|NCT02053818|Analgesics|analgesics|mesh-ancestor
44804455|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
44804456|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804457|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44804458|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44804459|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
44804460|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
44804461|NCT02053857|Amoxicillin|amoxicillin|mesh-list
44804462|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804463|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584773|NCT03822468|Anastrozole|anastrozole|mesh-list
44804464|NCT02053922|Misoprostol|misoprostol|mesh-list
44804465|NCT02053922|Oxytocin|oxytocin|mesh-list
44804466|NCT02053922|Carbetocin|carbetocin|mesh-list
44804467|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44804468|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
44804469|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804470|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804471|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44804472|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804473|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
44804474|NCT02053935|Dopamine|dopamine|mesh-list
44804475|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44804476|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
44804477|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
44804478|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804479|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804480|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
44804481|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804482|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804483|NCT02053935|Protective Agents|protective agents|mesh-ancestor
44804484|NCT02053974|Spironolactone|spironolactone|mesh-list
44584846|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
44584847|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584848|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584849|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584850|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584851|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584852|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584853|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584854|NCT03767348|Nivolumab|nivolumab|mesh-list
44584855|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584856|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584857|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44584858|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584859|NCT03764540|Prednisone|prednisone|mesh-list
44584860|NCT03764540|Docetaxel|docetaxel|mesh-list
44584861|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584862|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584863|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584864|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
43609821|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
43609822|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
43609823|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609824|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609825|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
43609857|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43609858|NCT03184844|Growth Substances|growth substances|mesh-ancestor
43609859|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
43609860|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609861|NCT03185143|Acetaminophen|acetaminophen|mesh-list
43609862|NCT03185143|Sumatriptan|sumatriptan|mesh-list
43609863|NCT03185143|Naltrexone|naltrexone|mesh-list
43609864|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609865|NCT03185143|Analgesics|analgesics|mesh-ancestor
43609866|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
43609867|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609868|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609869|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
43609870|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43609871|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43609872|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43609873|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43609874|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43609875|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
43609876|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609877|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609878|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43609879|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
43609880|NCT03185130|Promethazine|promethazine|mesh-list
43609881|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
43609882|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43609883|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43609886|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
43609907|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609908|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804485|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44804486|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804487|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804488|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804489|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44804490|NCT02053974|Diuretics|diuretics|mesh-ancestor
44804491|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
44804492|NCT02054000|Tirofiban|tirofiban|mesh-list
44804493|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44804494|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44804495|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804496|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44804497|NCT02054052|Bevacizumab|bevacizumab|mesh-list
44804498|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44804499|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804500|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44804501|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44804502|NCT02054052|Growth Substances|growth substances|mesh-ancestor
44804503|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804504|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
44804505|NCT02054078|Bevacizumab|bevacizumab|mesh-list
44804506|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44804507|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804508|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44804509|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44804510|NCT02054078|Growth Substances|growth substances|mesh-ancestor
44804511|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804512|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44804513|NCT02054143|Sevoflurane|sevoflurane|mesh-list
44804514|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44804515|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44804516|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
44804517|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
44804518|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804519|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804520|NCT02054182|Vitamin D|vitamin d|mesh-list
44804521|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
44804522|NCT02054182|Vitamins|vitamins|mesh-ancestor
44804523|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
44804524|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804525|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804526|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44804527|NCT02054299|Thiamine|thiamine|mesh-list
44804528|NCT02054299|Proguanil|proguanil|mesh-list
44804529|NCT02054299|Sumatriptan|sumatriptan|mesh-list
44804530|NCT02054299|Amitriptyline|amitriptyline|mesh-list
44804531|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44804532|NCT02054299|Fenoterol|fenoterol|mesh-list
44804533|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44804534|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44804535|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44804536|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
44804537|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804538|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804539|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290494|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44804540|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44804541|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804542|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804543|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804544|NCT02054299|Analgesics|analgesics|mesh-ancestor
44804545|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
44804546|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804547|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44804548|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44804549|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804550|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804551|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
44804552|NCT02054299|Vitamins|vitamins|mesh-ancestor
44804553|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
44804554|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44804555|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
44804556|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44804557|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44584867|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
44804558|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804560|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44804561|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
44804562|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44804563|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
44804564|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
44804565|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
44804566|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804567|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44804568|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44804569|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44804570|NCT02054429|Insulin|insulin|mesh-list
44804571|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44804572|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44804573|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804574|NCT02054442|Methotrexate|methotrexate|mesh-list
44804575|NCT02054442|Cetuximab|cetuximab|mesh-list
44804576|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44804577|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
44804578|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44804579|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804580|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44804581|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
44804582|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804583|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804584|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
44804585|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804586|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44804587|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804588|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
44804589|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804590|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44804591|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44804592|NCT02054468|Remifentanil|remifentanil|mesh-list
44804593|NCT02054468|Propofol|propofol|mesh-list
44804594|NCT02054468|Rocuronium|rocuronium|mesh-list
44804595|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44804596|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804597|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804598|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44804599|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
44804600|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
44804601|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44804602|NCT02054468|Narcotics|narcotics|mesh-ancestor
44804603|NCT02054468|Analgesics|analgesics|mesh-ancestor
44804604|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
44804605|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804606|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44804607|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44804608|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44804609|NCT02054637|Lanreotide|lanreotide|mesh-list
44804610|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804611|NCT02054663|Clopidogrel|clopidogrel|mesh-list
44804612|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44804613|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44804614|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44804615|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44804616|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
44804617|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804618|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804619|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804620|NCT02054676|Ibuprofen|ibuprofen|mesh-list
44804621|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44804622|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804623|NCT02054676|Analgesics|analgesics|mesh-ancestor
44804624|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
44804625|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804626|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804627|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804628|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804629|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44804630|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804631|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804632|NCT02054793|Itraconazole|itraconazole|mesh-list
44804633|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
44804634|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804635|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44804636|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44804637|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804638|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804639|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44804640|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804641|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804642|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804643|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44804644|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
44804645|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44804646|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804647|NCT02054884|Paclitaxel|paclitaxel|mesh-list
44804648|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44804649|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804650|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804651|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44804652|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44804653|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44804654|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804655|NCT02054936|Warfarin|warfarin|mesh-list
44804656|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
44804657|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
44804658|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44804659|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
44290608|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804660|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44804661|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
44804662|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804663|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804664|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
44804665|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44804666|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
44804667|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804668|NCT02054949|Expectorants|expectorants|mesh-ancestor
44804669|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
44804670|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44804671|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
44804672|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804673|NCT02054949|Protective Agents|protective agents|mesh-ancestor
44804674|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804675|NCT02054949|Antidotes|antidotes|mesh-ancestor
44804676|NCT02054975|Vitamin D|vitamin d|mesh-list
44804677|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
44804678|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
44804679|NCT02054975|Vitamins|vitamins|mesh-list
44804680|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
44804681|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804682|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804683|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44804684|NCT02054988|Caffeine|caffeine|mesh-list
44804685|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44804686|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804687|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44804688|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804689|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804690|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44804691|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44804692|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
44804693|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804694|NCT02055014|Liraglutide|liraglutide|mesh-list
44804695|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44804696|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804697|NCT02055014|Incretins|incretins|mesh-ancestor
44804698|NCT02055014|Hormones|hormones|mesh-ancestor
44804699|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804700|NCT02055079|Sirolimus|sirolimus|mesh-list
44804701|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804702|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804703|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44804704|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804705|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
44804706|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804707|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
44585017|NCT03711838|Antidotes|antidotes|mesh-ancestor
44804708|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804709|NCT02055131|Aspirin|aspirin|mesh-list
44804710|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44804711|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804712|NCT02055131|Analgesics|analgesics|mesh-ancestor
44804713|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
44804714|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804715|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804716|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804717|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804718|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44804719|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44804720|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804721|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44804722|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44804723|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804724|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
44804725|NCT02055170|Finasteride|finasteride|mesh-list
44804726|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44804727|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44804728|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804729|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804730|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804731|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804732|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804733|NCT02055170|Urological Agents|urological agents|mesh-ancestor
44804734|NCT02055183|Antitoxins|antitoxins|mesh-list
44804735|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
44804736|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
44804737|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804738|NCT02055196|Irinotecan|irinotecan|mesh-list
44804739|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44804740|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44804741|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804742|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804743|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804744|NCT02055274|Rotigotine|rotigotine|mesh-list
44804745|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
44693948|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44693949|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693950|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693951|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
44693952|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693953|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693954|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44693955|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44693956|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693957|NCT01376323|Incretins|incretins|mesh-ancestor
44693958|NCT01376323|Hormones|hormones|mesh-ancestor
44693959|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693960|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44693961|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
44693962|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693963|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693964|NCT01376401|Prednisone|prednisone|mesh-list
44693965|NCT01376401|Bortezomib|bortezomib|mesh-list
44693966|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44693967|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44693968|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
44693969|NCT01376401|Hormones|hormones|mesh-ancestor
44693970|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693971|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693972|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44693973|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693974|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44693975|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
44693976|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693977|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44693978|NCT01376440|Eusol|eusol|mesh-list
44693979|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
44693980|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585091|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804746|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
44804747|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804748|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804749|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804750|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44804751|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44804752|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44804753|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44804754|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804755|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804756|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804757|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
44804758|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804759|NCT02055378|Atropine|atropine|mesh-list
44804760|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44804761|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44804762|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44804763|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
44804764|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804765|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804766|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44804767|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
44804768|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
44804769|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
44804770|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44804771|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44804772|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
44804773|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804774|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804775|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44804776|NCT02055456|Nandrolone|nandrolone|mesh-list
44804777|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44804778|NCT02055456|Androgens|androgens|mesh-ancestor
44804779|NCT02055456|Hormones|hormones|mesh-ancestor
44804780|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804781|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804782|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
44804783|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44804784|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
44804785|NCT02055482|Hematinics|hematinics|mesh-ancestor
44804786|NCT02055586|Alovudine|alovudine|mesh-list
44804787|NCT02055586|Fluorides|fluorides|mesh-list
44804788|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
44804789|NCT02055586|Protective Agents|protective agents|mesh-ancestor
44804790|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804791|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
44804792|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804793|NCT02055664|Ropivacaine|ropivacaine|mesh-list
44804794|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
44804795|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
44804796|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804797|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804798|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
44804799|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804800|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
44804801|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44804802|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804803|NCT02055703|Itraconazole|itraconazole|mesh-list
44804804|NCT02055703|Rifampin|rifampin|mesh-list
44804805|NCT02055703|Digoxin|digoxin|mesh-list
44804806|NCT02055703|Donepezil|donepezil|mesh-list
44804807|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
44804808|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804809|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44804810|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44804811|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804812|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804813|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44804814|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44804815|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804816|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804817|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44804818|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44804819|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
44804820|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804821|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
44804822|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44804823|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
44804824|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804825|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
44804826|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44804827|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44804828|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44804829|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44804830|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44804831|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44804832|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44804833|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44804834|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44804835|NCT02055703|Protective Agents|protective agents|mesh-ancestor
44804836|NCT02055716|Sulforaphane|sulforaphane|mesh-list
44804837|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44804838|NCT02055716|Protective Agents|protective agents|mesh-ancestor
44804839|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804840|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804841|NCT02055911|Ranibizumab|ranibizumab|mesh-list
44804842|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44804843|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44804844|NCT02055911|Growth Substances|growth substances|mesh-ancestor
44804845|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804846|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44804847|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804848|NCT02056041|Liver Extracts|liver extracts|mesh-list
44804849|NCT02056041|Hematinics|hematinics|mesh-ancestor
44804850|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
44804851|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804852|NCT02056184|Adalimumab|adalimumab|mesh-list
44804853|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804854|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804855|NCT02056210|Plerixafor|plerixafor|mesh-list
44804856|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44804857|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44804858|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
44804859|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804860|NCT02056223|Acetaminophen|acetaminophen|mesh-list
44804861|NCT02056223|Ibuprofen|ibuprofen|mesh-list
44804862|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44804863|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804864|NCT02056223|Analgesics|analgesics|mesh-ancestor
44804865|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
44804866|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804867|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804868|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804869|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44804870|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44804871|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804872|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804873|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
44804874|NCT02056249|Norepinephrine|norepinephrine|mesh-list
44804875|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44804876|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44804877|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44804878|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804879|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804880|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804881|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
44804882|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
44804883|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804884|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44804885|NCT02056353|Insulin|insulin|mesh-list
44804886|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44804887|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804888|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
44804889|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
44804890|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804891|NCT02056366|Protective Agents|protective agents|mesh-ancestor
44804892|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804893|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
44804894|NCT02056366|Vitamins|vitamins|mesh-ancestor
44804895|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
44804896|NCT02056379|Dexamethasone|dexamethasone|mesh-list
44804897|NCT02056379|Budesonide|budesonide|mesh-list
44804898|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804899|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
44804900|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
44804901|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804902|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804903|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804904|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
44804905|NCT02056379|Hormones|hormones|mesh-ancestor
44804906|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804907|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44804908|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804909|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44804910|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44804911|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
44804912|NCT02056405|Mosapride|mosapride|mesh-list
44804913|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804914|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44804915|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
44804916|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804917|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804918|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804919|NCT02056418|Prednisone|prednisone|mesh-list
44804920|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
44804921|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804922|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
44804923|NCT02056418|Hormones|hormones|mesh-ancestor
44804924|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804925|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804926|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44804927|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804928|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
44804929|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44804930|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44804931|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804932|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
44804933|NCT02056444|Coagulants|coagulants|mesh-ancestor
44804934|NCT02056587|Everolimus|everolimus|mesh-list
44585279|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804935|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804936|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44804937|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
44804938|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804939|NCT02056600|Metformin|metformin|mesh-list
44804940|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44804941|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804942|NCT02056665|Minocycline|minocycline|mesh-list
44804943|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44804944|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44804945|NCT02056678|Acetaminophen|acetaminophen|mesh-list
44804946|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44804947|NCT02056678|Analgesics|analgesics|mesh-ancestor
44804948|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
44804949|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804950|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804951|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
44804952|NCT02056717|Dexamethasone|dexamethasone|mesh-list
44804953|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44804954|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
44804955|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
44804956|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44804957|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804958|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804959|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
44804960|NCT02056717|Hormones|hormones|mesh-ancestor
44804961|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44804962|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44804963|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44804964|NCT02056730|Calcium|calcium|mesh-list
44804965|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44804966|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804967|NCT02056743|Fexofenadine|fexofenadine|mesh-list
44804968|NCT02056743|Losartan|losartan|mesh-list
44804969|NCT02056743|Midazolam|midazolam|mesh-list
44804970|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
44804971|NCT02056743|Caffeine|caffeine|mesh-list
44804972|NCT02056743|Omeprazole|omeprazole|mesh-list
44804973|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44804974|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44804975|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44804976|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44804977|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44804978|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44804979|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44804980|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44804981|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
44804982|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
44804983|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
44804984|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
44804985|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44804986|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44804987|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44804988|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44804989|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44804990|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44804991|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44804992|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44804993|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44804994|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44804995|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44804996|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44804997|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44804998|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44804999|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
44805000|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
44805001|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805002|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44805003|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44805004|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44805005|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44805006|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44805007|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
44805008|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
44805009|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
44805010|NCT02056847|Pitavastatin|pitavastatin|mesh-list
44585356|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44805011|NCT02056847|Calcium|calcium|mesh-list
44805012|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44805013|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805014|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44805015|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44805016|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44805017|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44805018|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
44805019|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805020|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805021|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44805022|NCT02056899|Gabapentin|gabapentin|mesh-list
44805023|NCT02056899|Analgesics|analgesics|mesh-ancestor
44805024|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
44805025|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805026|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805027|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
44805028|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44805029|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44805030|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805031|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44805032|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44805033|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44805034|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805035|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805036|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
44805037|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44805038|NCT02056938|Basiliximab|basiliximab|mesh-list
44291061|NCT00780325|Celecoxib|celecoxib|mesh-list
44805039|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
44805040|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805041|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805042|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
44805043|NCT02057003|Grazoprevir|grazoprevir|mesh-list
44805044|NCT02057003|Ledipasvir|ledipasvir|mesh-list
44805045|NCT02057003|Velpatasvir|velpatasvir|mesh-list
44805046|NCT02057003|Simeprevir|simeprevir|mesh-list
44805047|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
44805048|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805049|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44805050|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805051|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805052|NCT02057094|Caseins|caseins|mesh-list
44805053|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
44805054|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
44805055|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805056|NCT02057107|Docetaxel|docetaxel|mesh-list
44805057|NCT02057107|Cetuximab|cetuximab|mesh-list
44805058|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805059|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805060|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805061|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805062|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805063|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805064|NCT02057263|Alendronate|alendronate|mesh-list
44805065|NCT02057263|Diphosphonates|diphosphonates|mesh-list
44805066|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44805067|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585431|NCT03236805|Ketamine|ketamine|mesh-list
44805068|NCT02057289|Micafungin|micafungin|mesh-list
44805069|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
44805070|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805071|NCT02057328|Telmisartan|telmisartan|mesh-list
44805072|NCT02057328|Nebivolol|nebivolol|mesh-list
44805073|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805074|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44805075|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44805076|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805077|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805078|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44805079|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44805080|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44805081|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44805082|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805083|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805084|NCT02057367|Bupivacaine|bupivacaine|mesh-list
44805085|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805086|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
44693981|NCT01376453|Fluorouracil|fluorouracil|mesh-list
44693982|NCT01376453|Sorafenib|sorafenib|mesh-list
44693983|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
44693984|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693985|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44693986|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693987|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44693988|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
44693989|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693990|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44693991|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693992|NCT01376713|Dacarbazine|dacarbazine|mesh-list
44693993|NCT01376713|Ofatumumab|ofatumumab|mesh-list
44693994|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44693995|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44693996|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
44693997|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693998|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693999|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
44694000|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694002|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44694003|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
44694004|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694005|NCT01376765|Antacids|antacids|mesh-ancestor
44694006|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694007|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44694008|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44694009|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44694010|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44694011|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44694012|NCT01376882|Caffeine|caffeine|mesh-list
44805087|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805088|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805089|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
44291112|NCT00780728|Urological Agents|urological agents|mesh-ancestor
44805090|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805091|NCT02057484|Tacrolimus|tacrolimus|mesh-list
44805092|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805093|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
44805094|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805095|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44805096|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694013|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44585501|NCT03170882|Growth Substances|growth substances|mesh-ancestor
44585502|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
44585503|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
44585504|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585505|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585506|NCT03151681|Propranolol|propranolol|mesh-list
44585507|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44585508|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44585509|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
44585510|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585511|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585513|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44805097|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805098|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
44805099|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805100|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
44805101|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805102|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805103|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
44805104|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805105|NCT02057679|Amoxicillin|amoxicillin|mesh-list
44805106|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805107|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805108|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
44805109|NCT02057770|Busulfan|busulfan|mesh-list
44805110|NCT02057770|Fludarabine|fludarabine|mesh-list
44805111|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
44805112|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805113|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
44805114|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805115|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805116|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44805117|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
44805118|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805119|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805120|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44805121|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44805122|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
44805123|NCT02057796|Efavirenz|efavirenz|mesh-list
44805124|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44805125|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44805126|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44805127|NCT02057796|Rifampin|rifampin|mesh-list
44805128|NCT02057796|Isoniazid|isoniazid|mesh-list
44805129|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
44805130|NCT02057796|Ethambutol|ethambutol|mesh-list
44805131|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44805132|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44805133|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805134|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805135|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
44805136|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805137|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44805138|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44805139|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44805140|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44805141|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44805142|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44291200|NCT00781196|Vitamins|vitamins|mesh-ancestor
44805143|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44805144|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44805145|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44805146|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
44805147|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805148|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
44805149|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44805150|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44805151|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44805152|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44805153|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44805154|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
44805155|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44805156|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44805157|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
44805158|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805159|NCT02057926|Tetracycline|tetracycline|mesh-list
44805160|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805161|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805162|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44805163|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805164|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805165|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
44805166|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44805167|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44805168|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805169|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
44805170|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44805171|NCT02058173|Chloroquine|chloroquine|mesh-list
44805172|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44805173|NCT02058173|Amebicides|amebicides|mesh-ancestor
44805174|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44805175|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44805176|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805177|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
44805178|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805179|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44805180|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805181|NCT02058173|Analgesics|analgesics|mesh-ancestor
44805182|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
44805183|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805184|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805185|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805186|NCT02058173|Filaricides|filaricides|mesh-ancestor
44805187|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
44805188|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
44805189|NCT02058186|Vitamin D|vitamin d|mesh-list
44805190|NCT02058186|Vitamins|vitamins|mesh-ancestor
44805191|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
44805192|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805193|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44805194|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
44805195|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44805196|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
44805197|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44805198|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
44805199|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805200|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805201|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
44805202|NCT02058212|Vitamin E|vitamin e|mesh-list
44805203|NCT02058212|Selenium|selenium|mesh-list
44805204|NCT02058212|Vitamins|vitamins|mesh-ancestor
44805205|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
44805206|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805207|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
44805208|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805209|NCT02058212|Protective Agents|protective agents|mesh-ancestor
44805210|NCT02058212|Trace Elements|trace elements|mesh-ancestor
44805211|NCT02058277|Aprepitant|aprepitant|mesh-list
44805212|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
44805213|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
44805214|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805215|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805216|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805217|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44805218|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805219|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805220|NCT02058303|Bupivacaine|bupivacaine|mesh-list
44805221|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805222|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
44805223|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805224|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805225|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
44805226|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805227|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44805228|NCT02058433|Paclitaxel|paclitaxel|mesh-list
44805229|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44805230|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44805231|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805232|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805233|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805234|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805235|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805236|NCT02058446|Amlodipine|amlodipine|mesh-list
44805237|NCT02058446|Valsartan|valsartan|mesh-list
44805238|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44805239|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805240|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44805241|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805242|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805243|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44585606|NCT02939287|Olanzapine|olanzapine|mesh-list
44805244|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805245|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805246|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44805247|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44805248|NCT02058485|Midazolam|midazolam|mesh-list
44805249|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
44805250|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44805251|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805252|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805253|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805254|NCT02058485|Analgesics|analgesics|mesh-ancestor
44805255|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
44805256|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805257|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44805258|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44805259|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44805260|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291316|NCT00781755|Varenicline|varenicline|mesh-list
44805261|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805262|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805263|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44805264|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44805265|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44805266|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44805267|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44805268|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
44805269|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
44805270|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
44805271|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
44805272|NCT02058576|Tamsulosin|tamsulosin|mesh-list
44805273|NCT02058576|Dutasteride|dutasteride|mesh-list
44805274|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44805275|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44805276|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44805277|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
44805278|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805279|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805280|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805281|NCT02058576|Urological Agents|urological agents|mesh-ancestor
44805282|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44805283|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44805284|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805285|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
44805286|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805287|NCT02058641|Darapladib|darapladib|mesh-list
44805288|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44805289|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291337|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805290|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805291|NCT02058667|Paclitaxel|paclitaxel|mesh-list
44805292|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44805293|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805294|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805295|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805296|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805297|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805298|NCT02058693|Amphetamine|amphetamine|mesh-list
44805299|NCT02058693|Adderall|adderall|mesh-list
44805300|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44805301|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805302|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
44805303|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
44805304|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805305|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
44805306|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805307|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805308|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44805309|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44805310|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44805311|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805312|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44805313|NCT02058706|Leuprolide|leuprolide|mesh-list
44805314|NCT02058706|Goserelin|goserelin|mesh-list
44805315|NCT02058706|Bicalutamide|bicalutamide|mesh-list
44805316|NCT02058706|Androgens|androgens|mesh-list
44805317|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44805318|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
44805319|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44585686|NCT02873598|Gemcitabine|gemcitabine|mesh-list
44805320|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805321|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44805322|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805323|NCT02058706|Hormones|hormones|mesh-ancestor
44805324|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805325|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
44805326|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
44805327|NCT02058823|Amlodipine|amlodipine|mesh-list
44805328|NCT02058823|Valsartan|valsartan|mesh-list
44805329|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805330|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44805331|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44291386|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44805332|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805333|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44805334|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805335|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805336|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44805337|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44805338|NCT02058875|Cyclosporine|cyclosporine|mesh-list
44805339|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
44805340|NCT02058875|Prednisone|prednisone|mesh-list
44805341|NCT02058875|Cyclosporins|cyclosporins|mesh-list
44805342|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805343|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
44291395|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291409|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44805344|NCT02058875|Hormones|hormones|mesh-ancestor
44805345|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805346|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805347|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44805348|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805349|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805350|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805351|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805352|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
44805353|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
44805354|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805355|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44805356|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805357|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44805358|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44805359|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44805360|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
44805361|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805362|NCT02058901|Sunitinib|sunitinib|mesh-list
44805363|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805364|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805365|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805366|NCT02058901|Growth Substances|growth substances|mesh-ancestor
44805367|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805368|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805369|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44805370|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805371|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805372|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44805373|NCT02058979|Cefazolin|cefazolin|mesh-list
44805374|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805375|NCT02059018|Diclofenac|diclofenac|mesh-list
44805376|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
44805377|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
44805378|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44805379|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44805380|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44291441|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
44805381|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805382|NCT02059018|Analgesics|analgesics|mesh-ancestor
44805383|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
44805384|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805385|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805386|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805387|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805388|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805389|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805390|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805391|NCT02059031|Cabotegravir|cabotegravir|mesh-list
44805392|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44805393|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44805394|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805395|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805396|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44805397|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44805398|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
44805399|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805400|NCT02059330|Palbociclib|palbociclib|mesh-list
44805401|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805402|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44805403|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805404|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805405|NCT02059460|Terlipressin|terlipressin|mesh-list
44805406|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805407|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44805408|NCT02059564|Liraglutide|liraglutide|mesh-list
44805409|NCT02059564|Exenatide|exenatide|mesh-list
44805410|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44805411|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805412|NCT02059564|Incretins|incretins|mesh-ancestor
44805413|NCT02059564|Hormones|hormones|mesh-ancestor
44805414|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805415|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44805416|NCT02059590|Isavuconazole|isavuconazole|mesh-list
44805417|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
44805418|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805419|NCT02059616|Amlodipine|amlodipine|mesh-list
44805420|NCT02059616|Candesartan|candesartan|mesh-list
44805421|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
44805422|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805423|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44805424|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805425|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805426|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44805427|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805428|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805429|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44805430|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44805431|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44805432|NCT02059655|Bimatoprost|bimatoprost|mesh-list
44805433|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44805434|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44805435|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805436|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44805437|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805438|NCT02059694|Lidocaine|lidocaine|mesh-list
44805439|NCT02059694|Epinephrine|epinephrine|mesh-list
44805440|NCT02059694|Racepinephrine|racepinephrine|mesh-list
44805441|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
44805442|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805443|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
44805444|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805445|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805446|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
44805447|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805448|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44805449|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44805450|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44805451|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805452|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805453|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44805454|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44805455|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
44805456|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805457|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44805458|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44805459|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
44805460|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44805461|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805462|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
44805463|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
44805464|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44805465|NCT02059759|Aldesleukin|aldesleukin|mesh-list
44805466|NCT02059759|Interleukin-2|interleukin-2|mesh-list
44805467|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805468|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805469|NCT02059759|Analgesics|analgesics|mesh-ancestor
44805470|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
44805471|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805472|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805473|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44805474|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44805475|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
44585914|NCT02489318|Androgens|androgens|mesh-list
44805476|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291526|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805477|NCT02059772|Ranibizumab|ranibizumab|mesh-list
44805478|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805479|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805480|NCT02059772|Growth Substances|growth substances|mesh-ancestor
44805481|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805482|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805483|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805484|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
44805485|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805486|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
44805487|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805488|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805489|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44805490|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
44805491|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805492|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805493|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44805494|NCT02059876|Paclitaxel|paclitaxel|mesh-list
44805495|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44805496|NCT02059876|Carboplatin|carboplatin|mesh-list
44805497|NCT02059876|Trastuzumab|trastuzumab|mesh-list
44805498|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44805499|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805500|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805501|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805502|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805503|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805504|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805505|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
44805506|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44805507|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44805508|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805509|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
44694014|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694015|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44694016|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694017|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694018|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44694019|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44694020|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
44694021|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694022|NCT01376999|Hormones|hormones|mesh-list
44694023|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694024|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694025|NCT01377025|Sorafenib|sorafenib|mesh-list
44694026|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694027|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44694028|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694029|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694030|NCT01377051|Maleic acid|maleic acid|mesh-list
44694031|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694032|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694033|NCT01377103|Testosterone|testosterone|mesh-list
44694034|NCT01377103|Androgens|androgens|mesh-ancestor
44694035|NCT01377103|Hormones|hormones|mesh-ancestor
44694036|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694037|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694038|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
44694039|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44694040|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694041|NCT01377168|Naltrexone|naltrexone|mesh-list
44694042|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44694043|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44694044|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694045|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
44291581|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44694046|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694047|NCT01377220|Choline|choline|mesh-list
44694048|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
44694049|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694050|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
44694051|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694052|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805510|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
44805511|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805512|NCT02059915|Oxycodone|oxycodone|mesh-list
44805513|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44805514|NCT02059915|Narcotics|narcotics|mesh-ancestor
44805515|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805516|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805517|NCT02059915|Analgesics|analgesics|mesh-ancestor
44805518|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
44805519|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805520|NCT02059967|Paclitaxel|paclitaxel|mesh-list
44805521|NCT02059967|Carboplatin|carboplatin|mesh-list
44805522|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44805523|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805524|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805525|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805526|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805527|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805528|NCT02060006|Meloxicam|meloxicam|mesh-list
44805529|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
44805530|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44805531|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805532|NCT02060006|Analgesics|analgesics|mesh-ancestor
44805533|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
44805534|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805535|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805536|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805537|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805538|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44805539|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805540|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805541|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44805542|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44586014|NCT02325011|Fluconazole|fluconazole|mesh-list
44586015|NCT02325011|Nabiximols|nabiximols|mesh-list
44586016|NCT02325011|Dronabinol|dronabinol|mesh-list
44586017|NCT02325011|Cannabidiol|cannabidiol|mesh-list
44586018|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
44586019|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586020|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44291618|NCT00783731|Midazolam|midazolam|mesh-list
44586021|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586022|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586023|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586024|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586025|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586026|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586027|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586028|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44586029|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44586030|NCT02325011|Analgesics|analgesics|mesh-ancestor
44586031|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
44586032|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586033|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
44586034|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
44586035|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586036|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44586037|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44586038|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44586039|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586040|NCT02325011|Hormones|hormones|mesh-ancestor
44586041|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
44586042|NCT02299414|Nifedipine|nifedipine|mesh-list
44586043|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44586044|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44586045|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610367|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
43610368|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
43610369|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610370|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610371|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
43610372|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610373|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
43610374|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
43610375|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44805543|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44805544|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44805545|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
44805546|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805547|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44291656|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
44464698|NCT01490697|Renal Agents|renal agents|mesh-ancestor
44805548|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44805549|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805550|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805551|NCT02060032|Atorvastatin|atorvastatin|mesh-list
44805552|NCT02060032|Simvastatin|simvastatin|mesh-list
44805553|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44805554|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44805555|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
44805556|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805557|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44805558|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44805559|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805560|NCT02060149|Minocycline|minocycline|mesh-list
44805561|NCT02060149|Sulbactam|sulbactam|mesh-list
44805562|NCT02060149|Cefoperazone|cefoperazone|mesh-list
44805563|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44805564|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805565|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805566|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44805567|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805568|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805569|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
44805570|NCT02060201|Saxagliptin|saxagliptin|mesh-list
44805571|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44805572|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805573|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44805574|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805575|NCT02060201|Incretins|incretins|mesh-ancestor
44805576|NCT02060201|Hormones|hormones|mesh-ancestor
44805577|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805578|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44805579|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44805580|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805581|NCT02060253|Paclitaxel|paclitaxel|mesh-list
44805582|NCT02060253|Trastuzumab|trastuzumab|mesh-list
44805583|NCT02060253|Pertuzumab|pertuzumab|mesh-list
44805584|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44464725|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
44805585|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805586|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805587|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805588|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805589|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805590|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805591|NCT02060279|Carotenoids|carotenoids|mesh-list
44805592|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
44805593|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464736|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44805594|NCT02060279|Protective Agents|protective agents|mesh-ancestor
44805595|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805596|NCT02060305|Bevacizumab|bevacizumab|mesh-list
44805597|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805598|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805599|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805600|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805601|NCT02060305|Growth Substances|growth substances|mesh-ancestor
44805602|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805603|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805604|NCT02060318|Infliximab|infliximab|mesh-list
44805605|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44805606|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805607|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805608|NCT02060396|Aspirin|aspirin|mesh-list
44805609|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44464742|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
44805610|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805611|NCT02060396|Analgesics|analgesics|mesh-ancestor
44805612|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
44805613|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805614|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805615|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805616|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586048|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805617|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44805618|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44805619|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805620|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44805621|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44805622|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805623|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
44805624|NCT02060552|Diacetylrhein|diacetylrhein|mesh-list
44805625|NCT02060552|Colchicine|colchicine|mesh-list
44805626|NCT02060552|Febuxostat|febuxostat|mesh-list
44805627|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
44805628|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805629|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805630|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805631|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44464757|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805632|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805633|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805634|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805635|NCT02060591|Bupivacaine|bupivacaine|mesh-list
44805636|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805637|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
44805638|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805639|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805640|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
44805641|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805642|NCT02060604|Ketorolac|ketorolac|mesh-list
44805643|NCT02060604|Ranibizumab|ranibizumab|mesh-list
44805644|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805645|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805646|NCT02060604|Growth Substances|growth substances|mesh-ancestor
44805647|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805648|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805649|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805650|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44805651|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805652|NCT02060604|Analgesics|analgesics|mesh-ancestor
44805653|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
44805654|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805655|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805656|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805657|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44805658|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805659|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805660|NCT02060656|Gemcitabine|gemcitabine|mesh-list
44805661|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
44805662|NCT02060656|Rituximab|rituximab|mesh-list
44805663|NCT02060656|Lenalidomide|lenalidomide|mesh-list
44805664|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805665|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805666|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
44291741|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805667|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805668|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805669|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44805670|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
44805671|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805672|NCT02060656|Antiviral Agents|antiviral agents|mesh-ancestor
44805673|NCT02060656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805674|NCT02060656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805675|NCT02060656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805676|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805677|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805678|NCT02060656|Growth Substances|growth substances|mesh-ancestor
44805679|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805680|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805681|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
44805682|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
44805683|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805684|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805685|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
44805686|NCT02060656|Hormones|hormones|mesh-ancestor
44805687|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805688|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44805689|NCT02060656|Protective Agents|protective agents|mesh-ancestor
44805690|NCT02060669|Capecitabine|capecitabine|mesh-list
44805691|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44805692|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
44805693|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805694|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805695|NCT02060734|Lidocaine|lidocaine|mesh-list
44805696|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805697|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
44805698|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805699|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805700|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
44805701|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805702|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44805703|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44805704|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44805705|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805706|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805707|NCT02060786|Clopidogrel|clopidogrel|mesh-list
44805708|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44805709|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44805710|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44805711|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44805712|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
44805713|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805714|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805715|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805716|NCT02060851|Iron|iron|mesh-list
44805717|NCT02060851|Trace Elements|trace elements|mesh-ancestor
44805718|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
44805719|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805720|NCT02060916|PAZ320|paz320|mesh-list
44805721|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44805722|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805723|NCT02060929|Esketamine|esketamine|mesh-list
44805724|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
44805725|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44805726|NCT02060955|Bevacizumab|bevacizumab|mesh-list
44805727|NCT02060955|Irinotecan|irinotecan|mesh-list
44805728|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805729|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805730|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44805731|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44805732|NCT02060955|Growth Substances|growth substances|mesh-ancestor
44805733|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805734|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
44805735|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44805736|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44805737|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805738|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805739|NCT02061007|Misonidazole|misonidazole|mesh-list
44805740|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805741|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44805742|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44805743|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805744|NCT02061124|Sevelamer|sevelamer|mesh-list
44805745|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
44805746|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
44805747|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805748|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44805749|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44805750|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805751|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805752|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
44805753|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805754|NCT02061267|Niacin|niacin|mesh-list
44805755|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
44805756|NCT02061267|Vitamins|vitamins|mesh-ancestor
44805757|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
44805758|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805759|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
44805760|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44805761|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
44805762|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805763|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44805764|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
44805765|NCT02061449|Romidepsin|romidepsin|mesh-list
44805766|NCT02061449|Poly ICLC|poly iclc|mesh-list
44805767|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
44805768|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
44805769|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805770|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44805771|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805772|NCT02061475|Lidocaine|lidocaine|mesh-list
44805773|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
44805774|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
44805775|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805776|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805777|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
44805778|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805779|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44805780|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44805781|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44805782|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44805783|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805784|NCT02061631|Dexamethasone|dexamethasone|mesh-list
44805785|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
44805786|NCT02061631|Cisplatin|cisplatin|mesh-list
44805787|NCT02061631|Docetaxel|docetaxel|mesh-list
44805788|NCT02061631|BB 1101|bb 1101|mesh-list
44805789|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805790|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
44805791|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
44805792|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805793|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805794|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805795|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
44805796|NCT02061631|Hormones|hormones|mesh-ancestor
44805797|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805798|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44805799|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805800|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
44805801|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805802|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805803|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
44805804|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
44805805|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
44805806|NCT02061644|Anesthetics|anesthetics|mesh-list
44805807|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805808|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805809|NCT02061657|Misoprostol|misoprostol|mesh-list
44805810|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44805811|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
44805812|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44805813|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805814|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44805815|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805816|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
44805817|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
44805818|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44586276|NCT01370512|Droxidopa|droxidopa|mesh-list
44805820|NCT02061800|Melphalan|melphalan|mesh-list
44805821|NCT02061800|Busulfan|busulfan|mesh-list
44805822|NCT02061800|Thiotepa|thiotepa|mesh-list
44805823|NCT02061800|Fludarabine|fludarabine|mesh-list
44805824|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
44805825|NCT02061800|Tacrolimus|tacrolimus|mesh-list
44805826|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805827|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
44805828|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805829|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805830|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44805831|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
44805832|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805833|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805834|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44805835|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44805836|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805837|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805838|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
44805839|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
44805840|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805841|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805842|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
44805843|NCT02061800|Hormones|hormones|mesh-ancestor
44805844|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805845|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44805846|NCT02061800|Protective Agents|protective agents|mesh-ancestor
44805847|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44805848|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805849|NCT02061878|Bexarotene|bexarotene|mesh-list
44805850|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805851|NCT02061917|Lobeline|lobeline|mesh-list
44805852|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44805853|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
44291913|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44114726|NCT00100464|Paroxetine|paroxetine|mesh-list
44805854|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805855|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805856|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44805857|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44805858|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
44805859|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805860|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805861|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805862|NCT02062034|Vitamins|vitamins|mesh-list
44805863|NCT02062034|Vitamin E|vitamin e|mesh-list
44805864|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
44694053|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44694054|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
44694055|NCT01377246|Octreotide|octreotide|mesh-list
44694056|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44694057|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44694058|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694059|NCT01377259|Anesthetics|anesthetics|mesh-list
44694060|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694061|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694062|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
44694063|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44694064|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44694065|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694066|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694067|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694068|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44694069|NCT01377285|Protective Agents|protective agents|mesh-ancestor
44694070|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694071|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694072|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44694073|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
44694104|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
44694105|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44694106|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44694107|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44694108|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44694109|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805865|NCT02062034|Ubiquinone|ubiquinone|mesh-list
44586349|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805866|NCT02062034|Antioxidants|antioxidants|mesh-list
44805867|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
44805868|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805869|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805870|NCT02062034|Protective Agents|protective agents|mesh-ancestor
44805871|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
44805872|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44805873|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805874|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
44805875|NCT02062112|Laxatives|laxatives|mesh-list
44805876|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44805877|NCT02062190|Resveratrol|resveratrol|mesh-list
44805878|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
44805879|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805880|NCT02062190|Protective Agents|protective agents|mesh-ancestor
44805881|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805882|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805883|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44805884|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
44805885|NCT02062203|Glycine|glycine|mesh-list
44805886|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805887|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805888|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44805889|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44805890|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805891|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805892|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805893|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805894|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
44805895|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805896|NCT02062255|Aspirin|aspirin|mesh-list
44805897|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44805898|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805899|NCT02062255|Analgesics|analgesics|mesh-ancestor
44805900|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
44805901|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805902|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805903|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805904|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44805905|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44805906|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44805907|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805908|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44805909|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44805910|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805911|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
44805912|NCT02062281|Vaccines|vaccines|mesh-list
44805913|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44805914|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
44805915|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805916|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
44805917|NCT02062333|Esmolol|esmolol|mesh-list
44805918|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44805919|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44805920|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805921|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44805922|NCT02062333|Analgesics|analgesics|mesh-ancestor
44805923|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
44805924|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805925|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44805926|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44805927|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44805928|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
44805929|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805930|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805931|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44805932|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44805933|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44805934|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
44805935|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805936|NCT02062892|Sirolimus|sirolimus|mesh-list
44805937|NCT02062892|Everolimus|everolimus|mesh-list
44805938|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805939|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44805940|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
44805941|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805942|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44805943|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44805944|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44805945|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
44805946|NCT02062983|Trastuzumab|trastuzumab|mesh-list
44805947|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44805948|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44805949|NCT02062996|Phenylephrine|phenylephrine|mesh-list
44805950|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
44805951|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44805952|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44805953|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44586471|NCT00379431|Protective Agents|protective agents|mesh-ancestor
44586472|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586473|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44586474|NCT00343824|Laxatives|laxatives|mesh-ancestor
44586475|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586476|NCT00278915|Fulvestrant|fulvestrant|mesh-list
44586477|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586478|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586479|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44586480|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44586481|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611290|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
43611291|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43611292|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43611294|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611295|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
43611296|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
43611297|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611298|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611299|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43611300|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
43611301|NCT03172988|Hormones|hormones|mesh-ancestor
43611302|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611303|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611304|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611305|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
43611306|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611324|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611325|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611326|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43611327|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611328|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611329|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43611330|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43611331|NCT03172793|Telavancin|telavancin|mesh-list
43611332|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611333|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611334|NCT03172741|Dronabinol|dronabinol|mesh-list
43611335|NCT03172741|Cannabidiol|cannabidiol|mesh-list
43611336|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
43611337|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
44292063|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
43611338|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611339|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43611340|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611341|NCT03172741|Analgesics|analgesics|mesh-ancestor
43611342|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
43611343|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611344|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43611345|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43611346|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611347|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611349|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611350|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43611351|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43611352|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43611353|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
43611354|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611355|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611356|NCT03172299|Aflibercept|aflibercept|mesh-list
43611363|NCT03172533|Dienogest|dienogest|mesh-list
43611364|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44805954|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805955|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805956|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805957|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
44805958|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
44805959|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805960|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
44805961|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44805962|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805963|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44805964|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
44805965|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44805966|NCT02062996|Protective Agents|protective agents|mesh-ancestor
44586483|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805967|NCT02063100|Losartan|losartan|mesh-list
44805968|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44805969|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44805970|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44805971|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44805972|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805973|NCT02063139|Fluticasone|fluticasone|mesh-list
44805974|NCT02063139|Beclomethasone|beclomethasone|mesh-list
44805975|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44805976|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44805977|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
44805978|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44805979|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805980|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44805981|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44805982|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
44805983|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44805984|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
44805985|NCT02063139|Hormones|hormones|mesh-ancestor
44292097|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44805986|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44805987|NCT02063269|Rivastigmine|rivastigmine|mesh-list
44805988|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44805989|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44805990|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44805991|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
44805992|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44805993|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44805994|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44805995|NCT02063269|Protective Agents|protective agents|mesh-ancestor
44805996|NCT02063334|Vitamin D|vitamin d|mesh-list
44805997|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
44805998|NCT02063334|Vitamins|vitamins|mesh-ancestor
44805999|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
44806000|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806001|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44806002|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806003|NCT02063360|Ritonavir|ritonavir|mesh-list
44806004|NCT02063360|Darunavir|darunavir|mesh-list
44806005|NCT02063360|Fostemsavir|fostemsavir|mesh-list
44806006|NCT02063360|Etravirine|etravirine|mesh-list
44806007|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44806008|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44806009|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
44806010|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806011|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806012|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806013|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806014|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
44806015|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806016|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44806017|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806018|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44806019|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44806020|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44806021|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44806022|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
44806023|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44806024|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
44806025|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806026|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
44806027|NCT02063373|Protective Agents|protective agents|mesh-ancestor
44806028|NCT02063425|Fluoxetine|fluoxetine|mesh-list
44806029|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44806030|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44806031|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44694110|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694111|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44694112|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694113|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694114|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694115|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44245729|NCT04420936|Benzocaine|benzocaine|mesh-list
44694116|NCT01377545|Anesthetics|anesthetics|mesh-list
44694117|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
44694118|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806032|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806033|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806034|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
44806035|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806036|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44806037|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
44806038|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806039|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44806040|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806041|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806042|NCT02063529|Leucovorin|leucovorin|mesh-list
44806043|NCT02063529|Fluorouracil|fluorouracil|mesh-list
44806044|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
44806045|NCT02063529|Irinotecan|irinotecan|mesh-list
44806046|NCT02063529|Cetuximab|cetuximab|mesh-list
44806047|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
44806048|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
44806049|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806050|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44806051|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806052|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806053|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
44806054|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806055|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44806056|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44806057|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806058|NCT02063529|Antidotes|antidotes|mesh-ancestor
44806059|NCT02063529|Protective Agents|protective agents|mesh-ancestor
44806060|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
44806061|NCT02063529|Vitamins|vitamins|mesh-ancestor
44806062|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
44806063|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44806064|NCT02063568|Oxytocin|oxytocin|mesh-list
44806065|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
44806066|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44806067|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806068|NCT02063620|Ketamine|ketamine|mesh-list
44806069|NCT02063620|Analgesics|analgesics|mesh-ancestor
44806070|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
44806071|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806072|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806073|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44806074|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806075|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
44806076|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
44806077|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806078|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44806079|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44806080|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806081|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806082|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
44806083|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44806084|NCT02063789|Antibodies|antibodies|mesh-list
44806085|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
44806086|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806087|NCT02063802|Metformin|metformin|mesh-list
44806088|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44806089|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806090|NCT02063841|Bismuth|bismuth|mesh-list
44806091|NCT02063841|Antacids|antacids|mesh-ancestor
44806092|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806093|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806094|NCT02063945|Risperidone|risperidone|mesh-list
44806095|NCT02063945|Methylphenidate|methylphenidate|mesh-list
44806096|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44806097|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
44806098|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806099|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806100|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806101|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44806102|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44806103|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806104|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806105|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44806106|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
44806107|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44806108|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44806109|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44806110|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806111|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
44806112|NCT02064010|Acamprosate|acamprosate|mesh-list
44806113|NCT02064010|Calcium|calcium|mesh-list
44806114|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806115|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806116|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44806117|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44806118|NCT02064023|Insulin|insulin|mesh-list
44806119|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44806120|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44806121|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806122|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
44806123|NCT02064049|Velpatasvir|velpatasvir|mesh-list
44806124|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44806125|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
44806126|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806127|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
44806128|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
44292226|NCT00786669|Irinotecan|irinotecan|mesh-list
44806129|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
44806130|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806131|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806132|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
44806133|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806134|NCT02064140|Rocuronium|rocuronium|mesh-list
44806135|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44806136|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44806137|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44806138|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806139|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806140|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
44806141|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44806142|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
44806143|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
44806144|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44806145|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806146|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44806147|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44806148|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806149|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806150|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806151|NCT02064374|Metformin|metformin|mesh-list
44806152|NCT02064374|Dolutegravir|dolutegravir|mesh-list
44806153|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44806154|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806155|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44806156|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44806157|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806158|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806159|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806160|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806161|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
44806162|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806163|NCT02064465|Lamotrigine|lamotrigine|mesh-list
44806164|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
44806165|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44806166|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806167|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806168|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806169|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806170|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44806171|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44806172|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806173|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806174|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44806175|NCT02064491|Paclitaxel|paclitaxel|mesh-list
44806176|NCT02064491|Docetaxel|docetaxel|mesh-list
44806177|NCT02064491|Cisplatin|cisplatin|mesh-list
44806178|NCT02064491|Carboplatin|carboplatin|mesh-list
44806179|NCT02064491|Pemetrexed|pemetrexed|mesh-list
44806180|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44806181|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44806182|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806183|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
44806184|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
44806185|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44806186|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806187|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806188|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44806189|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44806190|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806191|NCT02064504|Fluticasone|fluticasone|mesh-list
44806192|NCT02064504|Xhance|xhance|mesh-list
44806193|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44806194|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44806195|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
44806196|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806197|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806198|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44806199|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
44806200|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44806201|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44806202|NCT02064517|Calcium|calcium|mesh-list
44806203|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806204|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806205|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
44806206|NCT02064530|Bupivacaine|bupivacaine|mesh-list
44806207|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806208|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
44806209|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806210|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806211|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
44806212|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806213|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806214|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44806215|NCT02064530|Analgesics|analgesics|mesh-ancestor
44806216|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44806217|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44806218|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44806219|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
44806220|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806221|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806222|NCT02064556|Amlodipine|amlodipine|mesh-list
44806223|NCT02064556|Candesartan|candesartan|mesh-list
44806224|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44806225|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44806226|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806227|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806228|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806229|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806230|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
44292344|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44806231|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44806232|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44806233|NCT02064621|Amlodipine|amlodipine|mesh-list
44694119|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694120|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
44694121|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694122|NCT01377597|Ranibizumab|ranibizumab|mesh-list
44694123|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44694124|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44694125|NCT01377597|Growth Substances|growth substances|mesh-ancestor
44694126|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694127|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
44694128|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694129|NCT01377610|Naltrexone|naltrexone|mesh-list
44694130|NCT01377610|Buprenorphine|buprenorphine|mesh-list
44694131|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44694132|NCT01377610|Narcotics|narcotics|mesh-ancestor
44694133|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694134|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694135|NCT01377610|Analgesics|analgesics|mesh-ancestor
44694136|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
44694137|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694138|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44694139|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44694140|NCT01377961|Lycopene|lycopene|mesh-list
44694141|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694142|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
44694143|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806234|NCT02064621|Candesartan|candesartan|mesh-list
44806235|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
44806236|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44806237|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44806238|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806239|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806240|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806241|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806242|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
44806243|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44806244|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44806245|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
44806246|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
44806247|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
44806248|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806249|NCT02064777|Tacrolimus|tacrolimus|mesh-list
44806250|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806251|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
44806252|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806253|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44806254|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806255|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806256|NCT02064829|Paclitaxel|paclitaxel|mesh-list
44806257|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44806258|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44806259|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806260|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44806261|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44806262|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44806263|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806264|NCT02064842|Ritonavir|ritonavir|mesh-list
44806265|NCT02064842|Simeprevir|simeprevir|mesh-list
44806266|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44806267|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44806268|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
44806269|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806270|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806271|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806272|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806273|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
44806274|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806275|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44806276|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806277|NCT02064881|Metformin|metformin|mesh-list
44806278|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44806279|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806280|NCT02064946|Vitamin D|vitamin d|mesh-list
44806281|NCT02064946|Vitamins|vitamins|mesh-ancestor
44806282|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
44806283|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806284|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44806285|NCT02065063|Palbociclib|palbociclib|mesh-list
44806286|NCT02065063|Trametinib|trametinib|mesh-list
44806287|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806288|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806289|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806290|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806291|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44806292|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
44806293|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
44806294|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806295|NCT02065128|Capsaicin|capsaicin|mesh-list
44806296|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
44806297|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
44806298|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
44806299|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806300|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806301|NCT02065219|Bupivacaine|bupivacaine|mesh-list
44806302|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806303|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
44806304|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806305|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806306|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
44806307|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806308|NCT02065349|ASP8477|asp8477|mesh-list
44806309|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806310|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806311|NCT02065388|Warfarin|warfarin|mesh-list
44806312|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
44806313|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44806314|NCT02065401|Antacids|antacids|mesh-ancestor
44806315|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694144|NCT01377961|Protective Agents|protective agents|mesh-ancestor
44694145|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806316|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806317|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
44694146|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44694147|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44694148|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694149|NCT01377974|Miltefosine|miltefosine|mesh-list
44694150|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44694151|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
44694152|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694153|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694154|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694155|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694156|NCT01378039|Budesonide|budesonide|mesh-list
44694157|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586898|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
44806318|NCT02065414|Listerine|listerine|mesh-list
44806319|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44806320|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806321|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
44806322|NCT02065466|Paclitaxel|paclitaxel|mesh-list
44806323|NCT02065466|Bevacizumab|bevacizumab|mesh-list
44806324|NCT02065466|Temozolomide|temozolomide|mesh-list
44806325|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44806326|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806327|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
44806328|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
44806329|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
44806330|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806331|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44806332|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44806333|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44806334|NCT02065466|Growth Substances|growth substances|mesh-ancestor
44806335|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806336|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
44806337|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44806338|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
44806339|NCT02065492|Amlodipine|amlodipine|mesh-list
44806340|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
44806341|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806342|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806343|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44806344|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806345|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806346|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
44806347|NCT02065739|Itraconazole|itraconazole|mesh-list
44806348|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
44806349|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
44806350|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806351|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44806352|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806353|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806354|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806355|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44806356|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44806357|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44806358|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806359|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44806360|NCT02065752|Metformin|metformin|mesh-list
44806361|NCT02065752|Canagliflozin|canagliflozin|mesh-list
44806362|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44806363|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806364|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44806365|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806366|NCT02065804|Bupivacaine|bupivacaine|mesh-list
44806367|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806368|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
44806369|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806370|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806371|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
44806372|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806373|NCT02065843|Midazolam|midazolam|mesh-list
44806374|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44806375|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806376|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806377|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806378|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44806379|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44806380|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806381|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806382|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
44806383|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
44806384|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
44806385|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
44806386|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806387|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806388|NCT02065947|Lidocaine|lidocaine|mesh-list
44806389|NCT02065947|Epinephrine|epinephrine|mesh-list
44806390|NCT02065947|Racepinephrine|racepinephrine|mesh-list
44806391|NCT02065947|Fentanyl|fentanyl|mesh-list
44586960|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
44806392|NCT02065947|Midazolam|midazolam|mesh-list
44806393|NCT02065947|Ketamine|ketamine|mesh-list
44806394|NCT02065947|Bupivacaine|bupivacaine|mesh-list
44806395|NCT02065947|Propofol|propofol|mesh-list
44806396|NCT02065947|Sevoflurane|sevoflurane|mesh-list
44806397|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
44806398|NCT02065947|Atracurium|atracurium|mesh-list
44806399|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806400|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
44806401|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694158|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44694159|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
44694160|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694161|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694162|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44694163|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44694164|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
44694165|NCT01378039|Hormones|hormones|mesh-ancestor
44694166|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694167|NCT01378091|Prednisone|prednisone|mesh-list
44694168|NCT01378091|Docetaxel|docetaxel|mesh-list
44694169|NCT01378091|Lenalidomide|lenalidomide|mesh-list
44694170|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694171|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694172|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694173|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
44694174|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694175|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694176|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
44694177|NCT01378091|Hormones|hormones|mesh-ancestor
44694178|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694179|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694180|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44694181|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
44694182|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44694183|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44694184|NCT01378091|Growth Substances|growth substances|mesh-ancestor
44694185|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
44694186|NCT01378143|Pentamidine|pentamidine|mesh-list
44694187|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
44694188|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694189|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694190|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694191|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44694192|NCT01378156|Vaccines|vaccines|mesh-list
44694193|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
44694194|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694195|NCT01378286|Artesunate|artesunate|mesh-list
44694196|NCT01378286|Chloroquine|chloroquine|mesh-list
44694197|NCT01378286|Amodiaquine|amodiaquine|mesh-list
44694198|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
44694199|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694200|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694201|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694202|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694203|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
44694204|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
44694205|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44694206|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
44694207|NCT01378286|Amebicides|amebicides|mesh-ancestor
44694208|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694209|NCT01378481|Vorinostat|vorinostat|mesh-list
44694210|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694211|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44694212|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694213|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694214|NCT01378533|Paclitaxel|paclitaxel|mesh-list
44694215|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
44694216|NCT01378533|Carboplatin|carboplatin|mesh-list
44694217|NCT01378533|Epirubicin|epirubicin|mesh-list
44694218|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44694219|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694220|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694221|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694222|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44694223|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694224|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44694225|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
44806402|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806403|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
44806404|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806405|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44806406|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44806407|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44806408|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806409|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806410|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806411|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806412|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
44806413|NCT02065947|Analgesics|analgesics|mesh-ancestor
44806414|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44806415|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44806416|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44806417|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806418|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806419|NCT02065947|Narcotics|narcotics|mesh-ancestor
44806420|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44806421|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44806422|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292644|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
44292645|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44292646|NCT00789308|Basiliximab|basiliximab|mesh-list
44292647|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806423|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806424|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
44806425|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
44806426|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44806427|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44806428|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44806429|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44806430|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44806431|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44806432|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44806433|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
44806434|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44806435|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
44806436|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
44806437|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
44806438|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44806439|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44806440|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44806441|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44806442|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44806443|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44292673|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
44292674|NCT00789386|Midazolam|midazolam|mesh-list
44292675|NCT00789386|Remifentanil|remifentanil|mesh-list
44292676|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44292677|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44292678|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292679|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292680|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44114830|NCT00100646|Ritonavir|ritonavir|mesh-list
44806444|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
44806445|NCT02065986|Tenofovir|tenofovir|mesh-list
44806446|NCT02065986|Emtricitabine|emtricitabine|mesh-list
44806447|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44806448|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
44806449|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806450|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44806451|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44806452|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806453|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806454|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806455|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806456|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44806457|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806458|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806459|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806460|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806461|NCT02066077|Propofol|propofol|mesh-list
44806462|NCT02066077|Etomidate|etomidate|mesh-list
44806463|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806464|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806465|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806466|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806467|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
44806468|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
44806469|NCT02066103|Paclitaxel|paclitaxel|mesh-list
44806470|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44806471|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806472|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44806473|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44806474|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44806475|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806476|NCT02066207|Atorvastatin|atorvastatin|mesh-list
44806477|NCT02066207|Fenofibrate|fenofibrate|mesh-list
44806478|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44806479|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44806480|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
44806481|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806482|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44806483|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44806484|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806486|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806487|NCT02066454|Apixaban|apixaban|mesh-list
44806488|NCT02066454|Anticoagulants|anticoagulants|mesh-list
44806489|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44806490|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
44806491|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44806492|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
44806493|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806494|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806495|NCT02066532|Trastuzumab|trastuzumab|mesh-list
44806496|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44806497|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806498|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
44806499|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
44806500|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806501|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
44806502|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806503|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806504|NCT02066571|Droxidopa|droxidopa|mesh-list
44806505|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44806506|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44806507|NCT02066610|Selenium|selenium|mesh-list
44806508|NCT02066610|Selenious Acid|selenious acid|mesh-list
44292745|NCT00789646|Lidocaine|lidocaine|mesh-list
44806509|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
44806510|NCT02066610|Selenic Acid|selenic acid|mesh-list
44806511|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
44806512|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806513|NCT02066610|Protective Agents|protective agents|mesh-ancestor
44806514|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806515|NCT02066610|Trace Elements|trace elements|mesh-ancestor
44806516|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
44806517|NCT02066649|Carvedilol|carvedilol|mesh-list
44806518|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44806519|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44806520|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44806521|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806522|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806523|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806524|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44806525|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
44806526|NCT02066649|Protective Agents|protective agents|mesh-ancestor
44806527|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44806528|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806529|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806530|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
44806531|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44806532|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44806533|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
44806534|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
44806535|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44806536|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
44806537|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44806538|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
44806539|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806540|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806541|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
44806542|NCT02066675|Trabectedin|trabectedin|mesh-list
44806543|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44806544|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
44806545|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806546|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806547|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
44806548|NCT02066688|Vitamin D|vitamin d|mesh-list
44806549|NCT02066688|Folic Acid|folic acid|mesh-list
44587123|NCT05167409|Cetuximab|cetuximab|mesh-list
44806550|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
44806551|NCT02066688|Calcium|calcium|mesh-list
44806552|NCT02066688|Vitamins|vitamins|mesh-ancestor
44806553|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
44806554|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806555|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806556|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44806557|NCT02066688|Hematinics|hematinics|mesh-ancestor
44806558|NCT02066818|Lidocaine|lidocaine|mesh-list
44806559|NCT02066818|Tetracaine|tetracaine|mesh-list
44806560|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806561|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
44806562|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806563|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806564|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
44806565|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806566|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44806567|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44806568|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44806569|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806570|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806571|NCT02066844|Betamethasone|betamethasone|mesh-list
44806572|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
44806573|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44806574|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
44806575|NCT02066844|Lidocaine|lidocaine|mesh-list
44806576|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44806577|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806578|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
44806579|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806580|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806581|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
44806582|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806583|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44806584|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44806585|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44806586|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806587|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806588|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44806589|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
44806590|NCT02066844|Hormones|hormones|mesh-ancestor
44806591|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44806592|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44806593|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292811|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694226|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694227|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694228|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44694229|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
44694230|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44694231|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44694232|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44694233|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44694234|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694235|NCT01378546|Amifampridine|amifampridine|mesh-list
44694236|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44694237|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694238|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694239|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44694240|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44694241|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694242|NCT01378650|Cilostazol|cilostazol|mesh-list
44694243|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44694244|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
44694245|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694246|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806594|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
44806595|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806596|NCT02067013|Ranibizumab|ranibizumab|mesh-list
44806597|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44806598|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44806599|NCT02067013|Growth Substances|growth substances|mesh-ancestor
44806600|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806601|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
44806602|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806603|NCT02067065|Propofol|propofol|mesh-list
44806604|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806605|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806606|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806607|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806608|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
44806609|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
44806610|NCT02067078|Dexamethasone|dexamethasone|mesh-list
44806611|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
44806612|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44806613|NCT02067078|Clonidine|clonidine|mesh-list
44806614|NCT02067078|Epinephrine|epinephrine|mesh-list
44806615|NCT02067078|Racepinephrine|racepinephrine|mesh-list
44806616|NCT02067078|Ropivacaine|ropivacaine|mesh-list
44806617|NCT02067078|Bupivacaine|bupivacaine|mesh-list
44806618|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
44806619|NCT02067078|BB 1101|bb 1101|mesh-list
44806620|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44806621|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
44806622|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
44806623|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806624|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806625|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806626|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
44806627|NCT02067078|Hormones|hormones|mesh-ancestor
44806628|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44806629|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44806630|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806631|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
44806632|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806633|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806634|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
44806635|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
44806636|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806637|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
44806638|NCT02067078|Analgesics|analgesics|mesh-ancestor
44806639|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44464801|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
44806640|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
44806641|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44806642|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44806643|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44806644|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
44806645|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806646|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44806647|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44806648|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44806649|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44806650|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
44806651|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
44806652|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44806653|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44806654|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44806655|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44806656|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44806657|NCT02067143|Cytarabine|cytarabine|mesh-list
44806658|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44806659|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
44806660|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806661|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806662|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
44806663|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806664|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806665|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
44806666|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806667|NCT02067338|Morphine|morphine|mesh-list
44587247|NCT04865939|Gemcitabine|gemcitabine|mesh-list
44806668|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
44806669|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806670|NCT02067338|Narcotics|narcotics|mesh-ancestor
44806671|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806672|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806673|NCT02067338|Analgesics|analgesics|mesh-ancestor
44806674|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
44806675|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806676|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
44806677|NCT02067338|Coagulants|coagulants|mesh-ancestor
44806678|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
44806679|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44806680|NCT02067377|Antibodies|antibodies|mesh-list
44806681|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
44806682|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806683|NCT02067442|Acetaminophen|acetaminophen|mesh-list
44806684|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44806685|NCT02067442|Analgesics|analgesics|mesh-ancestor
44806686|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
44806687|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806688|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806689|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
44806690|NCT02067520|Hydromorphone|hydromorphone|mesh-list
44806691|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806692|NCT02067520|Narcotics|narcotics|mesh-ancestor
44806693|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806694|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806695|NCT02067520|Analgesics|analgesics|mesh-ancestor
44806696|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
44806697|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806698|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44806699|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44806700|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806701|NCT02067767|Lamivudine|lamivudine|mesh-list
44806702|NCT02067767|Abacavir|abacavir|mesh-list
44806703|NCT02067767|Dolutegravir|dolutegravir|mesh-list
44806704|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44806705|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44806706|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806707|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806708|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
44806709|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806710|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806711|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806712|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44806713|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44806714|NCT02067780|Levofloxacin|levofloxacin|mesh-list
44806715|NCT02067780|Ofloxacin|ofloxacin|mesh-list
44806716|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44806717|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806718|NCT02067780|Renal Agents|renal agents|mesh-ancestor
44806719|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44806720|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44806721|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44806722|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806723|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806724|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806725|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44806726|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806727|NCT02067910|Abatacept|abatacept|mesh-list
44806728|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44806729|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806730|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806731|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806732|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
44806733|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806734|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44806735|NCT02067936|Remifentanil|remifentanil|mesh-list
44806736|NCT02067936|Propofol|propofol|mesh-list
44806737|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44806738|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806739|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806740|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44806741|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
44806742|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
44806743|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806744|NCT02067936|Narcotics|narcotics|mesh-ancestor
44806745|NCT02067936|Analgesics|analgesics|mesh-ancestor
44806746|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
44806747|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806748|NCT02067949|Simvastatin|simvastatin|mesh-list
44806749|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44806750|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44806751|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
44806752|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806753|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44806754|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44806755|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806756|NCT02068079|Vemurafenib|vemurafenib|mesh-list
44806757|NCT02068079|Trientine|trientine|mesh-list
44806758|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806759|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806760|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806761|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806762|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
44806763|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
44806764|NCT02068131|Capecitabine|capecitabine|mesh-list
44806765|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44806766|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
44806767|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806768|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806769|NCT02068170|Azithromycin|azithromycin|mesh-list
44806770|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
44806771|NCT02068170|Clarithromycin|clarithromycin|mesh-list
44806772|NCT02068170|Levofloxacin|levofloxacin|mesh-list
44806773|NCT02068170|Erythromycin|erythromycin|mesh-list
44806774|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
44806775|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44806776|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
44806777|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44806778|NCT02068170|Itraconazole|itraconazole|mesh-list
44806779|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44806780|NCT02068170|Fluconazole|fluconazole|mesh-list
44806781|NCT02068170|Ketoconazole|ketoconazole|mesh-list
44806782|NCT02068170|Voriconazole|voriconazole|mesh-list
44806783|NCT02068170|Sunitinib|sunitinib|mesh-list
44806784|NCT02068170|Methadone|methadone|mesh-list
44806785|NCT02068170|Haloperidol|haloperidol|mesh-list
44806786|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
44806787|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44806788|NCT02068170|Tacrolimus|tacrolimus|mesh-list
44806789|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806790|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
44806791|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806792|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44806793|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806794|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806795|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44806796|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806797|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44806798|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44806799|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806800|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44806801|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
44806802|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44806803|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44806804|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44806805|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44806806|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44806807|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44806808|NCT02068170|Growth Substances|growth substances|mesh-ancestor
44806809|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44806810|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806811|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44587400|NCT04521946|Antibodies|antibodies|mesh-list
44587401|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
44587402|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44587403|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44587404|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587405|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587406|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
44587407|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587408|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587409|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
44587410|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806812|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44806813|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806814|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
44806815|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44806816|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44806817|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44806818|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44806819|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44806820|NCT02068170|Renal Agents|renal agents|mesh-ancestor
44806821|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44806822|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806823|NCT02068170|Narcotics|narcotics|mesh-ancestor
44806824|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806825|NCT02068170|Analgesics|analgesics|mesh-ancestor
44806826|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
44806827|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806828|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
44806829|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
44806830|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44806831|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44806832|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
44806833|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
44806834|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806835|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44806836|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44806837|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806838|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44806839|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
44806840|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806841|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44806842|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
44806843|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44806844|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44806845|NCT02068196|Ipilimumab|ipilimumab|mesh-list
44806846|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44806847|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806848|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44806849|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806850|NCT02068209|Tramadol|tramadol|mesh-list
44806851|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44806852|NCT02068209|Narcotics|narcotics|mesh-ancestor
44806853|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44806854|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806855|NCT02068209|Analgesics|analgesics|mesh-ancestor
44806856|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
44806857|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806858|NCT02068235|Ponesimod|ponesimod|mesh-list
44806859|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44806860|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806861|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44806862|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
44806863|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806864|NCT02068287|Esmolol|esmolol|mesh-list
44806865|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44806866|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44806867|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44806868|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
44806869|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806870|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806871|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806872|NCT02068339|Oltipraz|oltipraz|mesh-list
44806873|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
44806874|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806875|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
44806876|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44806877|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
44806878|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44806879|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44806880|NCT02068339|Protective Agents|protective agents|mesh-ancestor
44806881|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806882|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806883|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44806884|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44806885|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806886|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806887|NCT02068404|Nifedipine|nifedipine|mesh-list
44806888|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44806889|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293112|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806890|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806891|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44806892|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806893|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
44806894|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
44806895|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44806896|NCT02068430|Riboflavin|riboflavin|mesh-list
44806897|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
44806898|NCT02068430|Vitamins|vitamins|mesh-ancestor
44806899|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
44806900|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806901|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44806902|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
44806903|NCT02068482|Rifaximin|rifaximin|mesh-list
44806904|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694247|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44694248|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
44694249|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44694250|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44694251|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694252|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694253|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694254|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44694255|NCT01378650|Protective Agents|protective agents|mesh-ancestor
44694256|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44694257|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44694258|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694259|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44694260|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44694261|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694262|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
44694263|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694264|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44694265|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44694266|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694267|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
44694268|NCT01378741|Propofol|propofol|mesh-list
44694269|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44694270|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694271|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694272|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44694273|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
44694274|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
44694275|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694276|NCT01378741|Analgesics|analgesics|mesh-ancestor
44694277|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
44694278|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694279|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44694280|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44694281|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44694282|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
44694283|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694284|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694285|NCT01378754|Fospropofol|fospropofol|mesh-list
44694286|NCT01378754|Propofol|propofol|mesh-list
44694287|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44694288|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694289|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694290|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44694291|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
44694292|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
44694293|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44694294|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694295|NCT01378845|Bosentan|bosentan|mesh-list
44694296|NCT01378845|Alprostadil|alprostadil|mesh-list
44694297|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44694298|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44587488|NCT04203160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806905|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806906|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44806907|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44806908|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
44806909|NCT02068560|Coagulants|coagulants|mesh-ancestor
44806910|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44806911|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
44806912|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806913|NCT02068625|Rasagiline|rasagiline|mesh-list
44806914|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44806915|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806916|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806917|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44806918|NCT02068625|Protective Agents|protective agents|mesh-ancestor
44806919|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587518|NCT04082754|Antibodies|antibodies|mesh-list
44806920|NCT02068690|BI 425809|bi 425809|mesh-list
44806921|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
44806922|NCT02068859|Diclofenac|diclofenac|mesh-list
44806923|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44806924|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44806925|NCT02068859|Analgesics|analgesics|mesh-ancestor
44806926|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
44806927|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44806928|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806929|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44806930|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44806931|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44806932|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806933|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806934|NCT02068937|Furosemide|furosemide|mesh-list
44806935|NCT02068937|Diuretics|diuretics|mesh-ancestor
44806936|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
44806937|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806938|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44806939|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806940|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806941|NCT02069080|Plerixafor|plerixafor|mesh-list
44806942|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44806943|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44806944|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
44806945|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806946|NCT02069132|Warfarin|warfarin|mesh-list
44806947|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
44806948|NCT02069145|Sorafenib|sorafenib|mesh-list
44806949|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44806950|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806951|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806952|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806953|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806954|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
44806955|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806956|NCT02069158|Paclitaxel|paclitaxel|mesh-list
44806957|NCT02069158|Carboplatin|carboplatin|mesh-list
44806958|NCT02069158|Gedatolisib|gedatolisib|mesh-list
44806959|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44806960|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44806961|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44806962|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44806963|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44806964|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806965|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44806966|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806967|NCT02069197|Orlistat|orlistat|mesh-list
44806968|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806969|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806970|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44806971|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44806972|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
44806973|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44806974|NCT02069301|Fluoxetine|fluoxetine|mesh-list
44806975|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
44806976|NCT02069301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44806977|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44806978|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44806979|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806980|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44806981|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
44806982|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806983|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44806984|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44806985|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44806986|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44806987|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44806988|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
44806989|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44806990|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44806991|NCT02069418|Alovudine|alovudine|mesh-list
44806992|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44806993|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44806994|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44806995|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
44806996|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44806997|NCT02069431|Oxytocin|oxytocin|mesh-list
44806998|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
44806999|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807000|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807001|NCT02069522|Carotenoids|carotenoids|mesh-list
44807002|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
44807003|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807004|NCT02069522|Protective Agents|protective agents|mesh-ancestor
44807005|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807006|NCT02069665|Ribavirin|ribavirin|mesh-list
44807007|NCT02069665|Ibuprofen|ibuprofen|mesh-list
44807008|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
44807009|NCT02069665|Albuterol|albuterol|mesh-list
44807010|NCT02069665|Guaifenesin|guaifenesin|mesh-list
44807011|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44807012|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
44807013|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807014|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
44807015|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807016|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44807017|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807018|NCT02069665|Analgesics|analgesics|mesh-ancestor
44807019|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
44807020|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807021|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807022|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807023|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807024|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44807025|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807026|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44807027|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
44807028|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44807029|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
44807030|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
44807031|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807032|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44807033|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44807034|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44807035|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
44807036|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807037|NCT02069665|Expectorants|expectorants|mesh-ancestor
44807038|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44807039|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
44807040|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44807041|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
44807042|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
44807043|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44807044|NCT02069808|Leuprolide|leuprolide|mesh-list
44807045|NCT02069808|Menotropins|menotropins|mesh-list
44807046|NCT02069808|Ganirelix|ganirelix|mesh-list
44807047|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44807048|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
44807049|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807050|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807051|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807052|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807053|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
44807054|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807055|NCT02069886|Deferasirox|deferasirox|mesh-list
44807056|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44807057|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
44807058|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
44293322|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807059|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807060|NCT02069977|Aripiprazole|aripiprazole|mesh-list
44807061|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
44807062|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44807063|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44807064|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44807065|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807066|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807067|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
44807068|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
44587652|NCT03785587|Bromides|bromides|mesh-list
44807069|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807070|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807071|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44807072|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44807073|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
44807074|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44807075|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44807076|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44807077|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44807078|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
44807079|NCT02069990|Vitamin D|vitamin d|mesh-list
44807080|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44807081|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807082|NCT02069990|Vitamins|vitamins|mesh-ancestor
44807083|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
44807084|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44807085|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
44807086|NCT02070003|Narcotics|narcotics|mesh-ancestor
44807087|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807088|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807089|NCT02070003|Analgesics|analgesics|mesh-ancestor
44807090|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
44807091|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807092|NCT02070120|Mitomycins|mitomycins|mesh-list
44807093|NCT02070120|Mitomycin|mitomycin|mesh-list
44807094|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44807095|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807096|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
44293333|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807097|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807098|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44807099|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807100|NCT02070133|Simvastatin|simvastatin|mesh-list
44807101|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44807102|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44807103|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
44807104|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807105|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44807106|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44807107|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807108|NCT02070159|Clopidogrel|clopidogrel|mesh-list
44807109|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44807110|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807111|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44807112|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44807113|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44807114|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
44807115|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807116|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807117|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807118|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44807119|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44807120|NCT02070198|Hormones|hormones|mesh-ancestor
44807121|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807122|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807123|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
44807124|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44807125|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
44807126|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807127|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44807128|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807129|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807130|NCT02070289|PF-06372865|pf-06372865|mesh-list
44807131|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
44807132|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
44807133|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807134|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807135|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807136|NCT02070406|Aldesleukin|aldesleukin|mesh-list
44807137|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
44807138|NCT02070406|Fludarabine|fludarabine|mesh-list
44807139|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
44807140|NCT02070406|Interleukin-2|interleukin-2|mesh-list
44807141|NCT02070406|Vaccines|vaccines|mesh-list
44807142|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44807143|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807144|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
44807145|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807146|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807147|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44807148|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
44807149|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807150|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807151|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44807152|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807153|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
44807154|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807155|NCT02070406|Analgesics|analgesics|mesh-ancestor
44807156|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
44807157|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807158|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44807159|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44807160|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
44807161|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807162|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44807163|NCT02070458|Cytarabine|cytarabine|mesh-list
44807164|NCT02070458|Etoposide|etoposide|mesh-list
44807165|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
44807166|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
44807167|NCT02070458|Ixazomib|ixazomib|mesh-list
44807168|NCT02070458|Glycine|glycine|mesh-list
44807169|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44807170|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44807171|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807172|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44807173|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44807174|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807175|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807176|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807177|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
44807178|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
44807179|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807180|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807181|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
44807182|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807183|NCT02070458|Analgesics|analgesics|mesh-ancestor
44807184|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
44807185|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807186|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
44807187|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
44807188|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807189|NCT02070510|Lisinopril|lisinopril|mesh-list
44807190|NCT02070510|Warfarin|warfarin|mesh-list
44807191|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
44807192|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44807193|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
44807194|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807195|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807196|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44807197|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44807198|NCT02070510|Protective Agents|protective agents|mesh-ancestor
44807199|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807200|NCT02070653|Ticagrelor|ticagrelor|mesh-list
44807201|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807202|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44807203|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44807204|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44807205|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
44807206|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807207|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807208|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807209|NCT02070679|Vitamin E|vitamin e|mesh-list
44807210|NCT02070679|Tocopherols|tocopherols|mesh-list
44807211|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
44807212|NCT02070679|Vitamins|vitamins|mesh-ancestor
44587809|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
44807213|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
44807214|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807215|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
44807216|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807217|NCT02070679|Protective Agents|protective agents|mesh-ancestor
44807218|NCT02070718|Pentazocine|pentazocine|mesh-list
44807219|NCT02070718|Naloxone|naloxone|mesh-list
44807220|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44807221|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807222|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
44807223|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807224|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44807225|NCT02070718|Narcotics|narcotics|mesh-ancestor
44807226|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807227|NCT02070718|Analgesics|analgesics|mesh-ancestor
44807228|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44807229|NCT02070796|Rotigotine|rotigotine|mesh-list
44807230|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
44807231|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
44807232|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807233|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807234|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807235|NCT02071004|Aspirin|aspirin|mesh-list
44807236|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44807237|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807238|NCT02071004|Analgesics|analgesics|mesh-ancestor
44807239|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
44807240|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694299|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694300|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694301|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694302|NCT01378845|Urological Agents|urological agents|mesh-ancestor
44694303|NCT01378884|Domperidone|domperidone|mesh-list
44694304|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
44694305|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
44694306|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115059|NCT00101179|Entinostat|entinostat|mesh-list
44694307|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694308|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44694309|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44694310|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
44694311|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694312|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694313|NCT01378949|Morphine|morphine|mesh-list
44694314|NCT01378949|Bupivacaine|bupivacaine|mesh-list
44694315|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
44694316|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
44694317|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694318|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694319|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
44694320|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694321|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44694322|NCT01378949|Narcotics|narcotics|mesh-ancestor
44694323|NCT01378949|Analgesics|analgesics|mesh-ancestor
44694324|NCT01379001|Scopolamine|scopolamine|mesh-list
44694325|NCT01379001|Donepezil|donepezil|mesh-list
44694326|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44694327|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44694328|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694329|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694330|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44694331|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694332|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694333|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
44293522|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44694334|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44694335|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
44694336|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
44694337|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694338|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44694339|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
44694340|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44694341|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44694342|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
44694343|NCT01379079|Aspirin|aspirin|mesh-list
44694344|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
44245911|NCT04223661|Dexamethasone|dexamethasone|mesh-list
44694374|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
44694375|NCT01379300|Dabigatran|dabigatran|mesh-list
44694376|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44807241|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807242|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807243|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807244|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44807245|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44807246|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807247|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807248|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44807249|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807250|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
44807251|NCT02071043|Capecitabine|capecitabine|mesh-list
44807252|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
44807253|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807254|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
44807255|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807256|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807257|NCT02071069|Fluorouracil|fluorouracil|mesh-list
44807258|NCT02071069|Irinotecan|irinotecan|mesh-list
44807259|NCT02071069|Cetuximab|cetuximab|mesh-list
44807260|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
44807261|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293548|NCT00793663|Dexamethasone|dexamethasone|mesh-list
44807262|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807263|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807264|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807265|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
44807266|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807267|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44807268|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44807269|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807270|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807271|NCT02071160|Melatonin|melatonin|mesh-list
44807272|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
44807273|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807274|NCT02071160|Protective Agents|protective agents|mesh-ancestor
44807275|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807276|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807277|NCT02071212|Ticagrelor|ticagrelor|mesh-list
44807278|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807279|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44807280|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44807281|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44293581|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807282|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
44807283|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807284|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807285|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807286|NCT02071303|Celecoxib|celecoxib|mesh-list
44807287|NCT02071303|Tramadol|tramadol|mesh-list
44807288|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44807289|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807290|NCT02071303|Analgesics|analgesics|mesh-ancestor
44807291|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
44807292|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807293|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807294|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807295|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807296|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44807297|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44807298|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587908|NCT03073967|Foscarnet|foscarnet|mesh-list
44587909|NCT03073967|Pritelivir|pritelivir|mesh-list
44587910|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
44587911|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587912|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44587913|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587914|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587915|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587916|NCT02976935|Xenon|xenon|mesh-list
44587917|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44587918|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
44587919|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
44587920|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44587921|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587922|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
44807299|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807300|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44807301|NCT02071303|Narcotics|narcotics|mesh-ancestor
44807302|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807303|NCT02071316|Esomeprazole|esomeprazole|mesh-list
44807304|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
44807305|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44807306|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44807307|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807308|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
44807309|NCT02071316|Coagulants|coagulants|mesh-ancestor
44807310|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44807311|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807312|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44807313|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807315|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807316|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807317|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
44807318|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807319|NCT02071355|Simeprevir|simeprevir|mesh-list
44807320|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
44807321|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807322|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
44807323|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807324|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807325|NCT02071368|Metformin|metformin|mesh-list
44807326|NCT02071368|Canagliflozin|canagliflozin|mesh-list
44807327|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44807328|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807329|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44293638|NCT00793923|Dexamethasone|dexamethasone|mesh-list
44807330|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807331|NCT02071407|Midazolam|midazolam|mesh-list
44807332|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44807333|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44807334|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807335|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807336|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44807337|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44807338|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44807339|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44807340|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
44807341|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
44807342|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
44807343|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
44807344|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293662|NCT00794209|Narcotics|narcotics|mesh-ancestor
44807345|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807346|NCT02071433|Iodine|iodine|mesh-list
44807347|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44807348|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807349|NCT02071433|Trace Elements|trace elements|mesh-ancestor
44807350|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
44807351|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807352|NCT02071459|Droxidopa|droxidopa|mesh-list
44807353|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44807354|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44807355|NCT02071537|Gemcitabine|gemcitabine|mesh-list
44807356|NCT02071537|Chloroquine|chloroquine|mesh-list
44807357|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44807358|NCT02071537|Carboplatin|carboplatin|mesh-list
44807359|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807360|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807361|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
44807362|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807363|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
44807364|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807365|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807366|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807367|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
44807368|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807369|NCT02071537|Amebicides|amebicides|mesh-ancestor
44807370|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44807371|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44807372|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
44807373|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807374|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44807375|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807376|NCT02071537|Analgesics|analgesics|mesh-ancestor
44807377|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
44807378|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807379|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807380|NCT02071537|Filaricides|filaricides|mesh-ancestor
44807381|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
44807382|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
44807384|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44807385|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807386|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807387|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44807388|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807389|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
44807390|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
44807391|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807392|NCT02071615|Methylphenidate|methylphenidate|mesh-list
44807393|NCT02071615|Caffeine|caffeine|mesh-list
44807394|NCT02071615|Modafinil|modafinil|mesh-list
44807395|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44807396|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807397|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44807398|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44807399|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807400|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807401|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
44807402|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807403|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44807404|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807405|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44807406|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44807407|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
44807408|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44807409|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44807410|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44807411|NCT02071641|Sunitinib|sunitinib|mesh-list
44807412|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807413|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807414|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807415|NCT02071641|Growth Substances|growth substances|mesh-ancestor
44807416|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807417|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807418|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807419|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807420|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807421|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44807422|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807423|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807424|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807425|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44807426|NCT02071888|Dexamethasone|dexamethasone|mesh-list
44807427|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
44807428|NCT02071888|Pomalidomide|pomalidomide|mesh-list
44807429|NCT02071888|BB 1101|bb 1101|mesh-list
44807430|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807431|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
44807432|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
44807433|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807434|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807435|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807436|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
44807437|NCT02071888|Hormones|hormones|mesh-ancestor
44807438|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807439|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807440|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807441|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44807442|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807443|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807444|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
44807445|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807446|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807447|NCT02071888|Growth Substances|growth substances|mesh-ancestor
44807448|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807449|NCT02071927|Azacitidine|azacitidine|mesh-list
44807450|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807451|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
44807452|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807453|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807454|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807455|NCT02071966|Clopidogrel|clopidogrel|mesh-list
44807456|NCT02071966|Ticagrelor|ticagrelor|mesh-list
44807457|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807458|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44807459|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44807460|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44807461|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
44807462|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807463|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807464|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807465|NCT02072031|Sunitinib|sunitinib|mesh-list
44807466|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807467|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807468|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807469|NCT02072031|Growth Substances|growth substances|mesh-ancestor
44807470|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807471|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807472|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807473|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807474|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807476|NCT02072083|Ketamine|ketamine|mesh-list
44807477|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44807478|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807479|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293753|NCT00794885|Folic Acid|folic acid|mesh-list
44293754|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
44807480|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44807481|NCT02072083|Analgesics|analgesics|mesh-ancestor
44807482|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
44807483|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807484|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44807485|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44807486|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44807487|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44807488|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807489|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807490|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44807491|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44807492|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
44807493|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
44807494|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44807495|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44807496|NCT02072135|Bupivacaine|bupivacaine|mesh-list
44807497|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
44807498|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
44694377|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
44694378|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44694379|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44694380|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694381|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694382|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
44694383|NCT01379326|Mebendazole|mebendazole|mesh-list
44694384|NCT01379326|Piperazine|piperazine|mesh-list
44694385|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
44694386|NCT01379326|DMP 777|dmp 777|mesh-list
44694387|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
44694388|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
44694389|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694390|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694391|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694392|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694393|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44694394|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694395|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694396|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694397|NCT01379482|Paclitaxel|paclitaxel|mesh-list
44694398|NCT01379482|Docetaxel|docetaxel|mesh-list
44694399|NCT01379482|Cisplatin|cisplatin|mesh-list
44694400|NCT01379482|Doxorubicin|doxorubicin|mesh-list
44694401|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
44694402|NCT01379482|Irinotecan|irinotecan|mesh-list
44694403|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44694404|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694405|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694406|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694407|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
44293810|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44694408|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694409|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44694410|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44694411|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44694412|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694413|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44694414|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44694415|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694416|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
44694417|NCT01379560|Dinoprost|dinoprost|mesh-list
44694418|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44694419|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44694420|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
44694421|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44694422|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694423|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
44694424|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
44694425|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44694426|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694427|NCT01379807|Docetaxel|docetaxel|mesh-list
44694428|NCT01379807|Panitumumab|panitumumab|mesh-list
44694429|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807499|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807500|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807501|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
44807502|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807503|NCT02072213|Tamsulosin|tamsulosin|mesh-list
44807504|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44807505|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44807506|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44807507|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
44807508|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807509|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807510|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807511|NCT02072213|Urological Agents|urological agents|mesh-ancestor
44807512|NCT02072278|Vortioxetine|vortioxetine|mesh-list
44807513|NCT02072278|Citalopram|citalopram|mesh-list
44807514|NCT02072278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44807515|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44807516|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807517|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807518|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807519|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
44807520|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807521|NCT02072278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44807522|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
44807523|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44807524|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44807525|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44807526|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807527|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44807528|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44807529|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44807530|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44807531|NCT02072291|Nifedipine|nifedipine|mesh-list
44807532|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44807533|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807534|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807535|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44807536|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807537|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44807538|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
44807539|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807540|NCT02072317|Raltitrexed|raltitrexed|mesh-list
44807541|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807542|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
44807543|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807544|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807545|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44807546|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807547|NCT02072330|Amlodipine|amlodipine|mesh-list
44807548|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44807549|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44807550|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44807551|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44807552|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807553|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807554|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44807555|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807556|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
44807557|NCT02072330|Diuretics|diuretics|mesh-ancestor
44807558|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
44807559|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44807560|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44807561|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44807562|NCT02072382|Metformin|metformin|mesh-list
44807563|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44807564|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807565|NCT02072408|Aflibercept|aflibercept|mesh-list
44807566|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807567|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807568|NCT02072408|Growth Substances|growth substances|mesh-ancestor
44807569|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807570|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807571|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807572|NCT02072512|Fulvestrant|fulvestrant|mesh-list
44807573|NCT02072512|Anastrozole|anastrozole|mesh-list
44807574|NCT02072512|Goserelin|goserelin|mesh-list
44807575|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807576|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807577|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44807578|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44807579|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
44807580|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807581|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807582|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44807583|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44807584|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807585|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807586|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44807587|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
44293910|NCT00795613|Doxorubicin|doxorubicin|mesh-list
44807588|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807589|NCT02072720|Bevacizumab|bevacizumab|mesh-list
44807590|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807591|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807592|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807593|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807594|NCT02072720|Growth Substances|growth substances|mesh-ancestor
44807595|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807596|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807597|NCT02072746|Zinc|zinc|mesh-list
44807598|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
44807599|NCT02072746|Trace Elements|trace elements|mesh-ancestor
44807600|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
44807601|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807602|NCT02072746|Astringents|astringents|mesh-ancestor
44807603|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44807604|NCT02072785|Vincristine|vincristine|mesh-list
44807605|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44807606|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807607|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
44807608|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
44807609|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
44807610|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807611|NCT02072798|Cefuroxime|cefuroxime|mesh-list
44807612|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
44807613|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44807614|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807615|NCT02072811|Cytarabine|cytarabine|mesh-list
44807616|NCT02072811|Daunorubicin|daunorubicin|mesh-list
44807617|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
44807618|NCT02072811|Cladribine|cladribine|mesh-list
44807619|NCT02072811|Lenograstim|lenograstim|mesh-list
44807620|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807621|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
44293957|NCT00795756|Cytarabine|cytarabine|mesh-list
44807622|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807623|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807624|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
44807625|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807626|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807627|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
44807628|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807629|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44807630|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44807631|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44807632|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807633|NCT02072811|Analgesics|analgesics|mesh-ancestor
44807634|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
44807635|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807636|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44807637|NCT02072967|Rituximab|rituximab|mesh-list
44293986|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
44807638|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44807639|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807640|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807641|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
44807642|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807643|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807644|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44807645|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
44807646|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807647|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
44807648|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44807649|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807650|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44807651|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44807652|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807653|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807654|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807655|NCT02073149|Iron|iron|mesh-list
44807656|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44807657|NCT02073149|Trace Elements|trace elements|mesh-ancestor
44807658|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
44807659|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807660|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44694430|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694431|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694432|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44694433|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694434|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44694435|NCT01379846|Vaccines|vaccines|mesh-list
44694436|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
44694437|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694438|NCT01379898|Doxazosin|doxazosin|mesh-list
44694439|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
44694440|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44694441|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44694442|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44694443|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44694444|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
44694445|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694446|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694447|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694448|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694449|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
44694450|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
44694451|NCT01379976|Vitamins|vitamins|mesh-ancestor
44694452|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
44694453|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694454|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
44694455|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
44694456|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694457|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694458|NCT01380015|Analgesics|analgesics|mesh-ancestor
44694459|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
44694460|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694461|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694462|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694463|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694464|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
44694465|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694466|NCT01380015|Protective Agents|protective agents|mesh-ancestor
44694467|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694468|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44694469|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
44694470|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694471|NCT01380249|Bromides|bromides|mesh-list
44694472|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
44694473|NCT01380275|Docetaxel|docetaxel|mesh-list
44694474|NCT01380275|Irinotecan|irinotecan|mesh-list
44694475|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694476|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694477|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694478|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44694479|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694480|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44694481|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44694482|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694483|NCT01380288|Rivastigmine|rivastigmine|mesh-list
44694484|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44694485|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694486|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694487|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
44694488|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588324|NCT05663268|Infliximab|infliximab|mesh-list
44807661|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
44807662|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
44807663|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807665|NCT02073227|Canagliflozin|canagliflozin|mesh-list
44807666|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44807667|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807668|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44807669|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807670|NCT02073357|Anesthetics|anesthetics|mesh-list
44807671|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807672|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807673|NCT02073526|Adalimumab|adalimumab|mesh-list
44807674|NCT02073526|Infliximab|infliximab|mesh-list
44807675|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
44807676|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807677|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807678|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294074|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
44807679|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807680|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807681|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
44807682|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807683|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
44807684|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44807685|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
44807686|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807687|NCT02073552|Protective Agents|protective agents|mesh-ancestor
44807688|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807689|NCT02073552|Vitamins|vitamins|mesh-ancestor
44807690|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
44807691|NCT02073552|Laxatives|laxatives|mesh-ancestor
44807692|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807693|NCT02073669|Interferons|interferons|mesh-list
44807694|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
44807695|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807696|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
44807697|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807698|NCT02073734|Dexamethasone|dexamethasone|mesh-list
44807699|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807700|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
44807701|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
44807702|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807703|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807704|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807705|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
44807706|NCT02073734|Hormones|hormones|mesh-ancestor
44807707|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807708|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807709|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807710|NCT02073773|Levodopa|levodopa|mesh-list
44807711|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44807712|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44807713|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
44294097|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44807714|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807715|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807716|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694489|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694490|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44694491|NCT01380288|Protective Agents|protective agents|mesh-ancestor
44807718|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44807719|NCT02073916|Trastuzumab|trastuzumab|mesh-list
44807720|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44807721|NCT02073916|Lapatinib|lapatinib|mesh-list
44807722|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44807723|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807724|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
44807725|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
44807726|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294131|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807727|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807728|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807729|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807730|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807731|NCT02074137|Prednisone|prednisone|mesh-list
44807732|NCT02074137|Prednisolone|prednisolone|mesh-list
44807733|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807734|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
44807735|NCT02074137|Hormones|hormones|mesh-ancestor
44807736|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807737|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807738|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44807739|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807740|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44807741|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44807742|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44807743|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807744|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807745|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44807746|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807747|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807748|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
44807749|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807750|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44807751|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44807752|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44807753|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807754|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807755|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44807756|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807757|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807758|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
44807759|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807760|NCT02074189|Gemcitabine|gemcitabine|mesh-list
44807761|NCT02074189|Cisplatin|cisplatin|mesh-list
44807762|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807763|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807764|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
44807765|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807766|NCT02074189|Antiviral Agents|antiviral agents|mesh-ancestor
44807767|NCT02074189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807768|NCT02074189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807769|NCT02074189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807770|NCT02074189|Immunologic Factors|immunologic factors|mesh-ancestor
44807771|NCT02074189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807772|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44807773|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44807774|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807775|NCT02074228|Methylphenidate|methylphenidate|mesh-list
44807776|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44807777|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807778|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44807779|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44807780|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807781|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807782|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
44807783|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807784|NCT02074267|Gabapentin|gabapentin|mesh-list
44807785|NCT02074267|Analgesics|analgesics|mesh-ancestor
44807786|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
44807787|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807788|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807789|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
44807790|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44807791|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44807792|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807793|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44807794|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44807795|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44807796|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807797|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807799|NCT02074280|Rifaximin|rifaximin|mesh-list
44807800|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44807801|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807802|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44807803|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44807804|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44807805|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44807806|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807807|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807808|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44807809|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807810|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807811|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
44807812|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807813|NCT02074319|Methotrexate|methotrexate|mesh-list
44807814|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44807815|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
44807816|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44807817|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807818|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807819|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
44807820|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807821|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807822|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
44807823|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807824|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44807825|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807826|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
44294173|NCT00796458|Docetaxel|docetaxel|mesh-list
44807827|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44807828|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44807829|NCT02074605|Interferons|interferons|mesh-list
44807830|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
44807831|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807832|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
44807833|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807834|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
44807835|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807836|NCT02074800|Siltuximab|siltuximab|mesh-list
44807837|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44807838|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807839|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
44807840|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807841|NCT02074878|Sunitinib|sunitinib|mesh-list
44807842|NCT02074878|Crizotinib|crizotinib|mesh-list
44807843|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807844|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807845|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807846|NCT02074878|Growth Substances|growth substances|mesh-ancestor
44807847|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807848|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807849|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807850|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807851|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807852|NCT02074891|Tenofovir|tenofovir|mesh-list
44807853|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
44807854|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807855|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44807856|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44807857|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807858|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807859|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44807860|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44807861|NCT02075034|ON 01910|on 01910|mesh-list
44807862|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807863|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807864|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807865|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807866|NCT02075086|Bevacizumab|bevacizumab|mesh-list
44807867|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807868|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807869|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44807870|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44807871|NCT02075086|Growth Substances|growth substances|mesh-ancestor
44807872|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807873|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
44807874|NCT02075112|Cisplatin|cisplatin|mesh-list
44807875|NCT02075112|Genistein|genistein|mesh-list
44807876|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807877|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44807878|NCT02075112|Protective Agents|protective agents|mesh-ancestor
44807879|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807880|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44807881|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807882|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807883|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
44807884|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44807885|NCT02075112|Estrogens|estrogens|mesh-ancestor
44807886|NCT02075112|Hormones|hormones|mesh-ancestor
44807887|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807888|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
44807889|NCT02075242|Tacrolimus|tacrolimus|mesh-list
44807890|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807891|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
44807892|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807893|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44807894|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294272|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44807895|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807896|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44807897|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807898|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44807899|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
44807900|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44807901|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807902|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44807903|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44807904|NCT02075294|Entecavir|entecavir|mesh-list
44807905|NCT02075294|Adefovir|adefovir|mesh-list
44807906|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44807907|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
44807908|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807909|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44807910|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44807911|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294290|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807912|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807913|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44807914|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44807915|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44807916|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44807917|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44807918|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807919|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44807920|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44807921|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44807922|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
44807923|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44807924|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807925|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44807926|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44807927|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
44807928|NCT02075619|Amlodipine|amlodipine|mesh-list
44807929|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44807930|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44807931|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44807932|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44807933|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807934|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44807935|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807936|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44807937|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44807939|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
44807940|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44807941|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44807942|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694492|NCT01380301|Miltefosine|miltefosine|mesh-list
44807943|NCT02075749|Triamcinolone|triamcinolone|mesh-list
44807944|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44807945|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44807946|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44807947|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44807948|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
44807949|NCT02075749|Hormones|hormones|mesh-ancestor
44807950|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44807951|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807952|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44807953|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
44807954|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807955|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807956|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
44807957|NCT02075970|Hematinics|hematinics|mesh-ancestor
44807958|NCT02076191|Decitabine|decitabine|mesh-list
44807959|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44807960|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
44807961|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807962|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807963|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807964|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
44807965|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44807966|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
44807967|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807968|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807969|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
44807970|NCT02076373|Hematinics|hematinics|mesh-ancestor
44807971|NCT02076386|Dolutegravir|dolutegravir|mesh-list
44807972|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44807973|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44807974|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807975|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807976|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44807977|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44807978|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
44807979|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44807980|NCT02076451|DS-8273a|ds-8273a|mesh-list
44807981|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44807982|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807983|NCT02076477|Cisplatin|cisplatin|mesh-list
44807984|NCT02076477|Docetaxel|docetaxel|mesh-list
44807985|NCT02076477|Pemetrexed|pemetrexed|mesh-list
44807986|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44807987|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694493|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
44694494|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694495|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694496|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694497|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694498|NCT01380314|Miltefosine|miltefosine|mesh-list
44694499|NCT01380314|Imiquimod|imiquimod|mesh-list
44694500|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44694501|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
44694502|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694503|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694504|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
44694505|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
44694506|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694507|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694508|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694509|NCT01380353|Diclofenac|diclofenac|mesh-list
44694510|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44694511|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694512|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694513|NCT01380353|Analgesics|analgesics|mesh-ancestor
44694514|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
44694515|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694516|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694517|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694518|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694519|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694520|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694521|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694522|NCT01380431|Lisinopril|lisinopril|mesh-list
44694523|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44694524|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
44807988|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44807989|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44807990|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44807991|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44807992|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44807993|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44807994|NCT02076529|Ramosetron|ramosetron|mesh-list
44807995|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
44807996|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
44807997|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44807998|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44807999|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808000|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44808001|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
44808002|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808003|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808004|NCT02076594|Docetaxel|docetaxel|mesh-list
44808005|NCT02076594|Capecitabine|capecitabine|mesh-list
44808006|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
44808007|NCT02076594|Epirubicin|epirubicin|mesh-list
44808008|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808009|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
44808010|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
44808011|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
44808012|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808013|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44808014|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
44808015|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44808016|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294414|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
44808017|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44808018|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808019|NCT02076659|Methotrexate|methotrexate|mesh-list
44808020|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44808021|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
44808022|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44808023|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808024|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44808025|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
44808026|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808027|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808028|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
44808029|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808030|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44808031|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808032|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
44808033|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808034|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44808035|NCT02076685|Isoniazid|isoniazid|mesh-list
44808036|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
44808037|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808038|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808039|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44808040|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808041|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
44808042|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808043|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808044|NCT02076750|Vitamin D|vitamin d|mesh-list
44808045|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
44808046|NCT02076750|Vitamins|vitamins|mesh-ancestor
44294445|NCT00797810|Cytarabine|cytarabine|mesh-list
44808047|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
44808048|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808049|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44808050|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44808051|NCT02076815|Anagrelide|anagrelide|mesh-list
44808052|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44808053|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44588760|NCT05252546|Loperamide|loperamide|mesh-list
44588761|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
44588762|NCT05252546|Bentonite|bentonite|mesh-list
44588763|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588764|NCT05252546|Antidotes|antidotes|mesh-ancestor
44588765|NCT05252546|Protective Agents|protective agents|mesh-ancestor
44588766|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588767|NCT05251948|Capecitabine|capecitabine|mesh-list
44588768|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
44588769|NCT05251948|Atezolizumab|atezolizumab|mesh-list
44808054|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808055|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44808056|NCT02076828|Zinc|zinc|mesh-list
44808057|NCT02076828|Glycine|glycine|mesh-list
44808058|NCT02076828|Trace Elements|trace elements|mesh-ancestor
44808059|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
44294476|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44808060|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808061|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
44808062|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808063|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808064|NCT02076841|Interferons|interferons|mesh-list
44808065|NCT02076841|Interferon-beta|interferon-beta|mesh-list
44808066|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
44808067|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808068|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
44808069|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808070|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
44808071|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808072|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44808073|NCT02076893|Ibuprofen|ibuprofen|mesh-list
44808074|NCT02076893|Gabapentin|gabapentin|mesh-list
44808075|NCT02076893|Tramadol|tramadol|mesh-list
44808076|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808077|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808078|NCT02076893|Analgesics|analgesics|mesh-ancestor
44808079|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
44808080|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808081|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808082|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808083|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808084|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44808085|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808086|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808087|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
44808088|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44808089|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808090|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808091|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808092|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44808093|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44808094|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808095|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
44808096|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808097|NCT02076893|Narcotics|narcotics|mesh-ancestor
44808098|NCT02076945|Lidocaine|lidocaine|mesh-list
44808099|NCT02076945|Bupivacaine|bupivacaine|mesh-list
44808100|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
44808101|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
44808102|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808103|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808104|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
44808105|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808106|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44808107|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44808108|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44808109|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44808110|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808111|NCT02077010|Milrinone|milrinone|mesh-list
44808112|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44808113|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44808114|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44808115|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44808116|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44808117|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808118|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808119|NCT02077010|Protective Agents|protective agents|mesh-ancestor
44808120|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808121|NCT02077231|Vitamins|vitamins|mesh-list
44808122|NCT02077231|Vitamin A|vitamin a|mesh-list
44808123|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
44808124|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
44808125|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808126|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
44808127|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808128|NCT02077231|Protective Agents|protective agents|mesh-ancestor
44808129|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44808130|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808131|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44808132|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808133|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808134|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
44808135|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808136|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808137|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44808138|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808139|NCT02077309|Linagliptin|linagliptin|mesh-list
44808140|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44808141|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808142|NCT02077309|Incretins|incretins|mesh-ancestor
44808143|NCT02077309|Hormones|hormones|mesh-ancestor
44808144|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808145|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44808146|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
44808147|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808148|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808149|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
44808150|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
44808151|NCT02077322|Coagulants|coagulants|mesh-ancestor
44808152|NCT02077348|Hormones|hormones|mesh-list
44808153|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808154|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808155|NCT02077400|Cefazolin|cefazolin|mesh-list
44808156|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808157|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808158|NCT02077478|Remifentanil|remifentanil|mesh-list
44808159|NCT02077478|Propofol|propofol|mesh-list
44808160|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808161|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808162|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808163|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808164|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
44808165|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
44808166|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808167|NCT02077478|Narcotics|narcotics|mesh-ancestor
44808168|NCT02077478|Analgesics|analgesics|mesh-ancestor
44808169|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
44808170|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808171|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
44808172|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
44808173|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44808174|NCT02077556|Prednisolone|prednisolone|mesh-list
44808175|NCT02077556|Everolimus|everolimus|mesh-list
44808176|NCT02077556|Tacrolimus|tacrolimus|mesh-list
44808177|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808178|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
44808179|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808180|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44808181|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808182|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808183|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808184|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44808185|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44808186|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
44808187|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808188|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808189|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808190|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
44808191|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
44808192|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808193|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808194|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
44808195|NCT02077556|Hormones|hormones|mesh-ancestor
44808196|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808197|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44808198|NCT02077556|Protective Agents|protective agents|mesh-ancestor
44808199|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44808200|NCT02077634|Prednisone|prednisone|mesh-list
44808201|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
44808202|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808203|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
44808204|NCT02077634|Hormones|hormones|mesh-ancestor
44808205|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808206|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808207|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44808208|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808209|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44808210|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808211|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808212|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
44808213|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44808214|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
44808215|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808216|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808217|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808218|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808219|NCT02077712|Analgesics|analgesics|mesh-ancestor
44808220|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
44808221|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808222|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44808223|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44808224|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44808225|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
44808226|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808227|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808228|NCT02077751|Biotin|biotin|mesh-list
44808229|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
44808230|NCT02077751|Vitamins|vitamins|mesh-ancestor
44808231|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
44808232|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808233|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44808234|NCT02077777|Mesalamine|mesalamine|mesh-list
44808235|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808236|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808237|NCT02077777|Analgesics|analgesics|mesh-ancestor
44808238|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
44808239|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808240|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808241|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808242|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808243|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
44808244|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808245|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808246|NCT02077803|Metformin|metformin|mesh-list
44808247|NCT02077803|Canagliflozin|canagliflozin|mesh-list
44808248|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44808249|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808250|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44808251|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808252|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
44808253|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44808254|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808255|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
44808256|NCT02077933|Everolimus|everolimus|mesh-list
44808257|NCT02077933|Exemestane|exemestane|mesh-list
44808258|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808259|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808260|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
44808261|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808262|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44808263|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44294614|NCT00798525|Lepirudin|lepirudin|mesh-list
44808264|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808265|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808266|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44808267|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
44808268|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808269|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44808270|NCT02077946|Liraglutide|liraglutide|mesh-list
44808271|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44808272|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808273|NCT02077946|Incretins|incretins|mesh-ancestor
44808274|NCT02077946|Hormones|hormones|mesh-ancestor
44808275|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808276|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44808277|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
44808278|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808279|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808280|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
44808281|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808282|NCT02078063|Mepivacaine|mepivacaine|mesh-list
44808283|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
44808284|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
44808285|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808286|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808287|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
44694525|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694526|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694527|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44694528|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44294667|NCT00798915|Hormones|hormones|mesh-ancestor
44694529|NCT01380431|Protective Agents|protective agents|mesh-ancestor
44694530|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694532|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
44694533|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694534|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44694535|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694536|NCT01380457|Analgesics|analgesics|mesh-ancestor
44694537|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
44694538|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694539|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44694540|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44694541|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694542|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694543|NCT01380457|Hormones|hormones|mesh-ancestor
44694544|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694545|NCT01380483|Doxycycline|doxycycline|mesh-list
44808288|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294685|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
44808289|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
44808290|NCT02078089|Morphine|morphine|mesh-list
44808291|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808292|NCT02078089|Narcotics|narcotics|mesh-ancestor
44808293|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808294|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808295|NCT02078089|Analgesics|analgesics|mesh-ancestor
44808296|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
44808297|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808298|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
44808299|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44808300|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44808301|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44808302|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294694|NCT00798993|Vitamin D|vitamin d|mesh-list
44808303|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44808304|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44808305|NCT02078167|Policosanol|policosanol|mesh-list
44808306|NCT02078167|Red yeast rice|red yeast rice|mesh-list
44808307|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808308|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808309|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
44808310|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808311|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808312|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44808313|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44808314|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808315|NCT02078232|Pancrelipase|pancrelipase|mesh-list
44294711|NCT00799071|Posaconazole|posaconazole|mesh-list
44808316|NCT02078232|Pancreatin|pancreatin|mesh-list
44808317|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808318|NCT02078323|Linaclotide|linaclotide|mesh-list
44808319|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44808320|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
44808321|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808322|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808323|NCT02078336|Atropine|atropine|mesh-list
44808324|NCT02078336|Midazolam|midazolam|mesh-list
44808325|NCT02078336|Droperidol|droperidol|mesh-list
44808326|NCT02078336|Lorazepam|lorazepam|mesh-list
44294722|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
44808327|NCT02078336|Biperiden|biperiden|mesh-list
44808328|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808329|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808330|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43555334|NCT03563235|Vitamins|vitamins|mesh-ancestor
44808331|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808332|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44808333|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808334|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808335|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808336|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
44808337|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
44808338|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
44808339|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
44808340|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808341|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808342|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44808343|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44808344|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
44808345|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808346|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44808347|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
44808348|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
44808349|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
44808350|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44808351|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44808352|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
44808353|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
44808354|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
44808355|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808356|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44808357|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44808358|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44808359|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44808360|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44808361|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
44808362|NCT02078388|Doxorubicin|doxorubicin|mesh-list
44808363|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44808364|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808365|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44808366|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44808367|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808368|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808370|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44808371|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44808372|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
44808373|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808374|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808375|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
44808376|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
44808377|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808378|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808379|NCT02078583|Fentanyl|fentanyl|mesh-list
44808380|NCT02078583|Remifentanil|remifentanil|mesh-list
44808381|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808382|NCT02078583|Narcotics|narcotics|mesh-ancestor
44808383|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808384|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808385|NCT02078583|Analgesics|analgesics|mesh-ancestor
44808386|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
44808387|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808388|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808389|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808390|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
44808391|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
44808392|NCT02078596|Valproic Acid|valproic acid|mesh-list
44808393|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
44808394|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808395|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808396|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
44808397|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808398|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808399|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
44808400|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808401|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808402|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808403|NCT02078609|Midostaurin|midostaurin|mesh-list
44808404|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808405|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44808406|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808407|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808408|NCT02078648|Poly I-C|poly i-c|mesh-list
44808409|NCT02078648|Bevacizumab|bevacizumab|mesh-list
44808410|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44808411|NCT02078648|Poly ICLC|poly iclc|mesh-list
44808412|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44808413|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808414|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44808415|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44808416|NCT02078648|Growth Substances|growth substances|mesh-ancestor
44808417|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808418|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44808419|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
44808420|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
44808421|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
44808422|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808423|NCT02078648|Laxatives|laxatives|mesh-ancestor
44808424|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808425|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44808426|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44808427|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44808428|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808429|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808430|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44808431|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44808432|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808433|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
44808434|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808435|NCT02078869|Progesterone|progesterone|mesh-list
44808436|NCT02078869|Progestins|progestins|mesh-ancestor
44808437|NCT02078869|Hormones|hormones|mesh-ancestor
44808438|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589137|NCT04558866|Hormones|hormones|mesh-ancestor
44808439|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808440|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
44808441|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44808442|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44808443|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44808444|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44808445|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808446|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
44808447|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808448|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808449|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44808450|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808451|NCT02078973|Tolvaptan|tolvaptan|mesh-list
44808452|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44808453|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808454|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
44808455|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808456|NCT02079064|Propofol|propofol|mesh-list
44808457|NCT02079064|Desflurane|desflurane|mesh-list
44808458|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808459|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808460|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808461|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808462|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
44808463|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
44808464|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44694546|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694547|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694548|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
44694549|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694550|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694551|NCT01380496|Doxycycline|doxycycline|mesh-list
44694552|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694553|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694554|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
44694555|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694556|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694557|NCT01380509|Metronidazole|metronidazole|mesh-list
44694558|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694559|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694560|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694561|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44808465|NCT02079194|Aspirin|aspirin|mesh-list
44808466|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808467|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808468|NCT02079194|Analgesics|analgesics|mesh-ancestor
44808469|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
44808470|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808471|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808472|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808473|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808474|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44808475|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44808476|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808477|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44808478|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44808479|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808480|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
44808481|NCT02079220|Capecitabine|capecitabine|mesh-list
44808482|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
44808483|NCT02079220|Aflibercept|aflibercept|mesh-list
44808484|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44808485|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
44808486|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808487|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808488|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44808489|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44808490|NCT02079220|Growth Substances|growth substances|mesh-ancestor
44808491|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808492|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
44808493|NCT02079298|Fluconazole|fluconazole|mesh-list
44808494|NCT02079298|Ibuprofen|ibuprofen|mesh-list
44808495|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808496|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808497|NCT02079298|Analgesics|analgesics|mesh-ancestor
44808498|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
44808499|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808500|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808501|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808502|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808503|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44808504|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808505|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808506|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
44808507|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808508|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44808509|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44808510|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44808511|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
44808512|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808513|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44808514|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44808515|NCT02079337|Rocuronium|rocuronium|mesh-list
44808516|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44294889|NCT00800137|Heparin|heparin|mesh-list
44808517|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44694562|NCT01380522|Metronidazole|metronidazole|mesh-list
44694563|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589272|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589273|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589274|NCT03968653|Carboplatin|carboplatin|mesh-list
44589275|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808518|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44808519|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808520|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808521|NCT02079350|Polygeline|polygeline|mesh-list
44808522|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
44808523|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
44808524|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44808525|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44808526|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
44808527|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808528|NCT02079506|Candesartan|candesartan|mesh-list
44808529|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44808530|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808531|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808532|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
44808533|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808534|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808535|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44808536|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808537|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44808538|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44808539|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44808540|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44808541|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
44808542|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808543|NCT02079558|Oxytocin|oxytocin|mesh-list
44808544|NCT02079558|Carbetocin|carbetocin|mesh-list
44808545|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
44808546|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44808547|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808548|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44808549|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
44808550|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808551|NCT02079727|Celecoxib|celecoxib|mesh-list
44808552|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808553|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808554|NCT02079727|Analgesics|analgesics|mesh-ancestor
44808555|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
44808556|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808557|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808558|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808559|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808560|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44808561|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44808562|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808563|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808564|NCT02079961|Micronutrients|micronutrients|mesh-list
44808565|NCT02079961|Trace Elements|trace elements|mesh-list
44808566|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808567|NCT02079974|Pravastatin|pravastatin|mesh-list
44808568|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808569|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808570|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
44808571|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808572|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808573|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44808574|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808575|NCT02080026|Chloroquine|chloroquine|mesh-list
44808576|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44808577|NCT02080026|Atovaquone|atovaquone|mesh-list
44808578|NCT02080026|Proguanil|proguanil|mesh-list
44808579|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44808580|NCT02080026|Amebicides|amebicides|mesh-ancestor
44808581|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44808582|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44808583|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808584|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
44808585|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808586|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808587|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808588|NCT02080026|Analgesics|analgesics|mesh-ancestor
44808589|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
44808590|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808591|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808592|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808593|NCT02080026|Filaricides|filaricides|mesh-ancestor
44808594|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
44808595|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
44808596|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808597|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808598|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
44808599|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44808600|NCT02080078|Theophylline|theophylline|mesh-list
44808601|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808602|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44808603|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808604|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808605|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44808606|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
44808607|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808608|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808609|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44808610|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44808611|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44808612|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44808613|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44808614|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44808615|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
44808616|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808618|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
44808619|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44808620|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808621|NCT02080169|Fentanyl|fentanyl|mesh-list
44808622|NCT02080169|Midazolam|midazolam|mesh-list
44808623|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
44808624|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808625|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808626|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808627|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808628|NCT02080169|Analgesics|analgesics|mesh-ancestor
44808629|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
44808630|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808631|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44808632|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44808633|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44808634|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
44808635|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808636|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808637|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808638|NCT02080169|Narcotics|narcotics|mesh-ancestor
44808639|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808640|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808641|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
44808642|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
44808643|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44808644|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808645|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808646|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
44808647|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
44808648|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
44808649|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44808650|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
44808651|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808652|NCT02080182|Expectorants|expectorants|mesh-ancestor
44808653|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44808654|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44808655|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
44808656|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808657|NCT02080182|Protective Agents|protective agents|mesh-ancestor
44808658|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808659|NCT02080182|Antidotes|antidotes|mesh-ancestor
44808660|NCT02080234|Gemcitabine|gemcitabine|mesh-list
44808661|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
44808662|NCT02080234|Asparaginase|asparaginase|mesh-list
44808663|NCT02080234|Pegaspargase|pegaspargase|mesh-list
44808664|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44808665|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
44808666|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808667|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808668|NCT02080234|Antiviral Agents|antiviral agents|mesh-ancestor
44808669|NCT02080234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808670|NCT02080234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808671|NCT02080234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808672|NCT02080234|Immunologic Factors|immunologic factors|mesh-ancestor
44808673|NCT02080234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808674|NCT02080377|Glyburide|glyburide|mesh-list
44808675|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44808676|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808677|NCT02080416|Nelfinavir|nelfinavir|mesh-list
44808678|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44808679|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44808680|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
44808681|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808682|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808683|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44808684|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44808685|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
44808686|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808687|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
44808688|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44808689|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44808690|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808691|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
44808692|NCT02080494|Coagulants|coagulants|mesh-ancestor
44808693|NCT02080624|Sirolimus|sirolimus|mesh-list
44808694|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808695|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808696|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44808697|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808698|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
44808699|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808700|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
44808701|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808702|NCT02080715|Tolcapone|tolcapone|mesh-list
44808703|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44808704|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44808705|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44808706|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808707|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808708|NCT02080728|Ropivacaine|ropivacaine|mesh-list
44808709|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
44808710|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
44808711|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808712|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808713|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
44808714|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808715|NCT02080845|Theobromine|theobromine|mesh-list
44808716|NCT02080845|Caffeine|caffeine|mesh-list
44808717|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44808718|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808719|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44808720|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808721|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808722|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44808723|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44808724|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
44808725|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808726|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44808727|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
44808728|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808729|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44808730|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
44808731|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44589425|NCT03431350|Hormones|hormones|mesh-ancestor
44808733|NCT02080858|Ticagrelor|ticagrelor|mesh-list
44808734|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44808735|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44808736|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44808737|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44808738|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
44808739|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808740|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808741|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808742|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44808743|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
44808744|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44808745|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
44808746|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808747|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
44808748|NCT02081027|Riluzole|riluzole|mesh-list
44808749|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
44808750|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44808751|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44808752|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808753|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808754|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808755|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44808756|NCT02081027|Protective Agents|protective agents|mesh-ancestor
44808757|NCT02081144|Nicotine|nicotine|mesh-list
44808758|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44808759|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
44808760|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808761|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808762|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44808763|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44808764|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
44808765|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808766|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808767|NCT02081287|Inositol|inositol|mesh-list
44808768|NCT02081287|Lamotrigine|lamotrigine|mesh-list
44808769|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
44808770|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44808771|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44808772|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808773|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44808774|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808775|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44808776|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808777|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295159|NCT00801086|Tempol|tempol|mesh-list
44808778|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808779|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44808780|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
44808781|NCT02081287|Vitamins|vitamins|mesh-ancestor
44808782|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
44808783|NCT02081339|Ranibizumab|ranibizumab|mesh-list
44808784|NCT02081339|Aflibercept|aflibercept|mesh-list
44808785|NCT02081339|Verteporfin|verteporfin|mesh-list
44808786|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44808787|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44808788|NCT02081339|Growth Substances|growth substances|mesh-ancestor
44808789|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808790|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
44808791|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808792|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44808793|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
44808794|NCT02081391|Tapentadol|tapentadol|mesh-list
44808795|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44808796|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808797|NCT02081391|Narcotics|narcotics|mesh-ancestor
44808798|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808799|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808800|NCT02081391|Analgesics|analgesics|mesh-ancestor
44808801|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
44808802|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808803|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44808804|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44808805|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44589501|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44808806|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808807|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44808808|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808810|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44808811|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808812|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44808813|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808814|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808815|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44808816|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44808817|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808818|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44808819|NCT02081495|Doxorubicin|doxorubicin|mesh-list
44808820|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44808821|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808822|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44808823|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44808824|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808825|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808826|NCT02081560|Colistin|colistin|mesh-list
44808827|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44808828|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694564|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694565|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44694566|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44694567|NCT01380548|Iron|iron|mesh-list
44694568|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44295216|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44694569|NCT01380548|Trace Elements|trace elements|mesh-ancestor
44694570|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
44694571|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694572|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44694573|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
44694574|NCT01380600|Molgramostim|molgramostim|mesh-list
44694575|NCT01380600|Sargramostim|sargramostim|mesh-list
44694576|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
44694577|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694578|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694579|NCT01380678|Bevacizumab|bevacizumab|mesh-list
44694580|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44694581|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
44694582|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44694583|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44694584|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694585|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44694586|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44694587|NCT01380678|Growth Substances|growth substances|mesh-ancestor
44694588|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694589|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
44694590|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
44694591|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694592|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694593|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
44694594|NCT01380717|Calcium|calcium|mesh-list
44694595|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44694596|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44694597|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44694598|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694599|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44694600|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
44694601|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694602|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694603|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44694637|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
44694638|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44694639|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808829|NCT02081885|Chitosan|chitosan|mesh-list
44808830|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808831|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808832|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
44808833|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808834|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808835|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
44808836|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
44808837|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
44808838|NCT02081885|Coagulants|coagulants|mesh-ancestor
44808839|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
44808840|NCT02082054|Atropine|atropine|mesh-list
44808841|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
44808842|NCT02082054|Ephedrine|ephedrine|mesh-list
44808843|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808844|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44808845|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44808846|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
44808847|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808848|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808849|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44808850|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
44808851|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
44808852|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
44808853|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44808854|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44808855|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
44808856|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808857|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808858|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
44808859|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44808860|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44808861|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
44808862|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
44808863|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
44808864|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44808865|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44808866|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
44808867|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
44808868|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44808869|NCT02082067|Ketorolac|ketorolac|mesh-list
44808870|NCT02082067|Morphine|morphine|mesh-list
44808871|NCT02082067|Anesthetics|anesthetics|mesh-list
44808872|NCT02082067|Ropivacaine|ropivacaine|mesh-list
44808873|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
44808874|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
44808875|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808876|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808877|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808878|NCT02082067|Narcotics|narcotics|mesh-ancestor
44808879|NCT02082067|Analgesics|analgesics|mesh-ancestor
44808880|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
44808881|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808882|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44808883|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808884|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808885|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808886|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44808887|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808888|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808889|NCT02082236|Sufentanil|sufentanil|mesh-list
44808890|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44808891|NCT02082236|Narcotics|narcotics|mesh-ancestor
44808892|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808893|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808894|NCT02082236|Analgesics|analgesics|mesh-ancestor
44808895|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
44808896|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808897|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808898|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808899|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
44808900|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
44808901|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44808902|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
44589609|NCT02734290|Paclitaxel|paclitaxel|mesh-list
44808903|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808904|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808905|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808906|NCT02082405|Dexamethasone|dexamethasone|mesh-list
44808907|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
44808908|NCT02082405|Bortezomib|bortezomib|mesh-list
44808909|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44808910|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
44808911|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808912|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44808913|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44808914|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
44808915|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808916|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808917|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44808918|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44808919|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
44808920|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
44808921|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808922|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44808923|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
44808924|NCT02082405|Hormones|hormones|mesh-ancestor
44808925|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808926|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44808927|NCT02082418|Caseins|caseins|mesh-list
44808928|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
44808929|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
44808930|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808931|NCT02082496|Liraglutide|liraglutide|mesh-list
44808932|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44808933|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808934|NCT02082496|Incretins|incretins|mesh-ancestor
44808935|NCT02082496|Hormones|hormones|mesh-ancestor
44808936|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44808937|NCT02082613|Polidocanol|polidocanol|mesh-list
44808938|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44808939|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44808940|NCT02082652|Etonogestrel|etonogestrel|mesh-list
44808941|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44808942|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
44808943|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44808944|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808945|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44808946|NCT02082665|Dabrafenib|dabrafenib|mesh-list
44808947|NCT02082665|Midazolam|midazolam|mesh-list
44808948|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44808949|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44808950|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808951|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808952|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808953|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44808954|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44808955|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44808956|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44808957|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
44808958|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
44808959|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
44808960|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
44808961|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808962|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808963|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44808964|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44808965|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
44808966|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44808967|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44808968|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44808969|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808970|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44808971|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
44808972|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
44808973|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44808974|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44808975|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808976|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44808977|NCT02083055|Analgesics|analgesics|mesh-ancestor
44808978|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
44808979|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44808980|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44808981|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44808982|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44808983|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44808984|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44808985|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44808986|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
44808987|NCT02083068|Vaccines|vaccines|mesh-list
44808988|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44808989|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
44808990|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44808991|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44808992|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
44808993|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44808994|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44808995|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
44808996|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44808997|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44808998|NCT02083276|Renal Agents|renal agents|mesh-ancestor
44808999|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809000|NCT02083315|Morphine|morphine|mesh-list
44809001|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44809002|NCT02083315|Narcotics|narcotics|mesh-ancestor
44809003|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809004|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809005|NCT02083315|Analgesics|analgesics|mesh-ancestor
44809006|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
44809007|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809008|NCT02083328|Mannitol|mannitol|mesh-list
44809009|NCT02083328|Caffeine|caffeine|mesh-list
44809010|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44809011|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809012|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44809013|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809014|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809015|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44809016|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44809017|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
44809018|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809019|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44809020|NCT02083328|Diuretics|diuretics|mesh-ancestor
44809021|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
44809022|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
44809023|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44809024|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809025|NCT02083510|Colchicine|colchicine|mesh-list
44589756|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44589757|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589758|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589759|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589760|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
44589761|NCT00602667|Cisplatin|cisplatin|mesh-list
44589762|NCT00602667|Carboplatin|carboplatin|mesh-list
44589763|NCT00602667|Methotrexate|methotrexate|mesh-list
44589764|NCT00602667|Etoposide|etoposide|mesh-list
44589765|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
44589766|NCT00602667|Vincristine|vincristine|mesh-list
44589767|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44589768|NCT00602667|Topotecan|topotecan|mesh-list
44589769|NCT00602667|Vinblastine|vinblastine|mesh-list
44589770|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589771|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
44589772|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589773|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589774|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589775|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
44809026|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
44809027|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809028|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
44809029|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
44809030|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
44809031|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809032|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809033|NCT02083536|Docetaxel|docetaxel|mesh-list
44809034|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809035|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
44809036|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
44809037|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
44809038|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809039|NCT02083575|Vitamins|vitamins|mesh-list
44809040|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
44809041|NCT02083575|Deferiprone|deferiprone|mesh-list
44809042|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
44809043|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809044|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
44809045|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809046|NCT02083575|Protective Agents|protective agents|mesh-ancestor
44809047|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44809048|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
44809049|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
44809050|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
44809051|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44809052|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44809053|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44809054|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
44809055|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809056|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44809057|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44809058|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809059|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809060|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809061|NCT02083640|Palbociclib|palbociclib|mesh-list
44809062|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809063|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44809064|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809065|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809066|NCT02083692|Metformin|metformin|mesh-list
44809067|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44809068|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809069|NCT02083874|Cannabidiol|cannabidiol|mesh-list
44809070|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
44809071|NCT02083991|Prednisolone|prednisolone|mesh-list
44809072|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
44809073|NCT02083991|Basiliximab|basiliximab|mesh-list
44809074|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809075|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
44809076|NCT02083991|Hormones|hormones|mesh-ancestor
44809077|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809078|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809079|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809080|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809081|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
44809082|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809083|NCT02084043|Amikacin|amikacin|mesh-list
44809084|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809085|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809086|NCT02084225|Lidocaine|lidocaine|mesh-list
44809087|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809088|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
44809089|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809090|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809091|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
44809092|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809093|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44809094|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44809095|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44809096|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809097|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809098|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44809099|NCT02084303|Hematinics|hematinics|mesh-ancestor
44809100|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44809101|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44809102|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44589816|NCT00577278|Sirolimus|sirolimus|mesh-list
44809103|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
44809104|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44809105|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44809106|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809107|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
44809108|NCT02084342|Coagulants|coagulants|mesh-ancestor
44809109|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44809110|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
44809111|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809112|NCT02084355|Fentanyl|fentanyl|mesh-list
44809113|NCT02084355|Oxycodone|oxycodone|mesh-list
44809114|NCT02084355|Hydromorphone|hydromorphone|mesh-list
44809115|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44809116|NCT02084355|Narcotics|narcotics|mesh-ancestor
44809117|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809118|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809119|NCT02084355|Analgesics|analgesics|mesh-ancestor
44809120|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
44809121|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809122|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44809123|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44809124|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
44809125|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
44809126|NCT02084368|Bupivacaine|bupivacaine|mesh-list
44809127|NCT02084368|Ropivacaine|ropivacaine|mesh-list
44809128|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809129|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
44809130|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809131|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809132|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
44809133|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809134|NCT02084420|Pantoprazole|pantoprazole|mesh-list
44809135|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44809136|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809137|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44809138|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809139|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589902|NCT00885482|Ritonavir|ritonavir|mesh-list
44809140|NCT02084433|Anesthetics|anesthetics|mesh-list
44809141|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809142|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809143|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
44809144|NCT02084446|Prednisone|prednisone|mesh-list
44809145|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
44809146|NCT02084446|Everolimus|everolimus|mesh-list
44809147|NCT02084446|Tacrolimus|tacrolimus|mesh-list
44809148|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
44809149|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44809150|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809151|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
44809152|NCT02084446|Hormones|hormones|mesh-ancestor
44809153|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809154|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809155|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809156|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809157|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809158|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
44809159|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44809160|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809161|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809162|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44809163|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44809164|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
44809165|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809166|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809167|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
44809168|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
44809169|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809170|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809171|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44809172|NCT02084446|Protective Agents|protective agents|mesh-ancestor
44809173|NCT02084472|Petrolatum|petrolatum|mesh-list
44809174|NCT02084472|Mineral Oil|mineral oil|mesh-list
44809175|NCT02084472|Glycerol|glycerol|mesh-list
44809176|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44809177|NCT02084472|Protective Agents|protective agents|mesh-ancestor
44809178|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809179|NCT02084472|Emollients|emollients|mesh-ancestor
44809180|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
44809181|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44809182|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44809183|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44809184|NCT02084563|Cytarabine|cytarabine|mesh-list
44809185|NCT02084563|Decitabine|decitabine|mesh-list
44809186|NCT02084563|Daunorubicin|daunorubicin|mesh-list
44809187|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809188|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
44809189|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809190|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809191|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
44809192|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809193|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809194|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
44809195|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809196|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44809197|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44809198|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44809199|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809200|NCT02084576|Ketorolac|ketorolac|mesh-list
44809201|NCT02084576|Nepafenac|nepafenac|mesh-list
44809202|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44809203|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809204|NCT02084576|Analgesics|analgesics|mesh-ancestor
44809205|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
44809206|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809207|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809208|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809209|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809210|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44809211|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809212|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809213|NCT02084589|Fentanyl|fentanyl|mesh-list
44809214|NCT02084589|Ropivacaine|ropivacaine|mesh-list
44809215|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809216|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
44809217|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809218|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809219|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
44809220|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809221|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44809223|NCT02084589|Analgesics|analgesics|mesh-ancestor
44809224|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44809225|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44809226|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
44809227|NCT02084602|Artesunate|artesunate|mesh-list
44809228|NCT02084602|Mefloquine|mefloquine|mesh-list
44809229|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
44809230|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44809231|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44809232|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809233|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809234|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
44809235|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
44809236|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44809237|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
44809238|NCT02084615|Aspirin|aspirin|mesh-list
44809239|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44809240|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809241|NCT02084615|Analgesics|analgesics|mesh-ancestor
44809242|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
44809243|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809244|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809245|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809246|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809247|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44809248|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44809249|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809250|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44809251|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44809252|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809253|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
44809254|NCT02084654|Exenatide|exenatide|mesh-list
44809255|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44809256|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809257|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44809258|NCT02084654|Incretins|incretins|mesh-ancestor
44809259|NCT02084654|Hormones|hormones|mesh-ancestor
44809260|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809261|NCT02084719|Antibodies|antibodies|mesh-list
44809262|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
44809263|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809264|NCT02084732|Sorafenib|sorafenib|mesh-list
44809265|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809266|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44809267|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809268|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809269|NCT02084784|Methylene Blue|methylene blue|mesh-list
44809270|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809271|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809272|NCT02084875|Tofacitinib|tofacitinib|mesh-list
44809273|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44809274|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809275|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809276|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
44809277|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809278|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809279|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44809280|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44809281|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809282|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809283|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809284|NCT02085005|Capecitabine|capecitabine|mesh-list
44809285|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
44809286|NCT02085005|Aflibercept|aflibercept|mesh-list
44809287|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809288|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
44809289|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809290|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809291|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590038|NCT00884273|Goserelin|goserelin|mesh-list
44809292|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44809293|NCT02085005|Growth Substances|growth substances|mesh-ancestor
44809294|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809295|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
44809296|NCT02085018|Omeprazole|omeprazole|mesh-list
44809297|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44809298|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809299|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44809300|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809301|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809302|NCT02085109|Theobromine|theobromine|mesh-list
44809303|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44809304|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
44809305|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809306|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809307|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44809308|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
44809309|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809310|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
44809311|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809312|NCT02085239|Lidocaine|lidocaine|mesh-list
44809313|NCT02085239|Ropivacaine|ropivacaine|mesh-list
44809314|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809315|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
44809316|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809317|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809318|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
44809319|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809320|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44809321|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44809322|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44809323|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809324|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809325|NCT02085291|Norepinephrine|norepinephrine|mesh-list
44809326|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44809327|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44809328|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
44809329|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809330|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809331|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809332|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
44809333|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
44809334|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809335|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44809336|NCT02085304|Temozolomide|temozolomide|mesh-list
44809337|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44809338|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
44809339|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809340|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809341|NCT02085317|Nitroprusside|nitroprusside|mesh-list
44809342|NCT02085317|Acetylcholine|acetylcholine|mesh-list
44809343|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809344|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809345|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44809346|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809347|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44809348|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
44809349|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809350|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809351|NCT02085408|Cytarabine|cytarabine|mesh-list
44809352|NCT02085408|Decitabine|decitabine|mesh-list
44809353|NCT02085408|Clofarabine|clofarabine|mesh-list
44809354|NCT02085408|Azacitidine|azacitidine|mesh-list
44809355|NCT02085408|Daunorubicin|daunorubicin|mesh-list
44809356|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809357|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
44809358|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809359|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809360|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
44809361|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809362|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809363|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
44809364|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809365|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590160|NCT00883116|Paclitaxel|paclitaxel|mesh-list
44295736|NCT00803699|Selenium|selenium|mesh-list
44809366|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44809367|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44809368|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809370|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809371|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44809372|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809373|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809374|NCT02085577|Acetaminophen|acetaminophen|mesh-list
44809375|NCT02085577|Sufentanil|sufentanil|mesh-list
44809376|NCT02085577|Ketamine|ketamine|mesh-list
44809377|NCT02085577|Morphine|morphine|mesh-list
44809378|NCT02085577|Dsuvia|dsuvia|mesh-list
44809379|NCT02085577|Ondansetron|ondansetron|mesh-list
44809380|NCT02085577|Analgesics|analgesics|mesh-ancestor
44809381|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
44809382|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809383|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809384|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44809385|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44809386|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
44809387|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
44809388|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809389|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44809390|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44809391|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809392|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809393|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44809394|NCT02085577|Narcotics|narcotics|mesh-ancestor
44809395|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809396|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
44809397|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
44809398|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
44809399|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809400|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
44809401|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
44809402|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44809403|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
44809404|NCT02085577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44809405|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809406|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44809407|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44809408|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44809409|NCT02085590|Vaccines|vaccines|mesh-list
44809410|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
44809411|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
44809412|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809413|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44809414|NCT02085603|Saracatinib|saracatinib|mesh-list
44809415|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809416|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809417|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809418|NCT02085655|Gemcitabine|gemcitabine|mesh-list
44809419|NCT02085655|Thalidomide|thalidomide|mesh-list
44809420|NCT02085655|Dexamethasone|dexamethasone|mesh-list
44809421|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
44809422|NCT02085655|Methotrexate|methotrexate|mesh-list
44809423|NCT02085655|Pegaspargase|pegaspargase|mesh-list
44809424|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809425|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
44809426|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
44809427|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809428|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809429|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809430|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
44809431|NCT02085655|Hormones|hormones|mesh-ancestor
44809432|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809433|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809434|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809435|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809436|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
44809437|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809438|NCT02085655|Antiviral Agents|antiviral agents|mesh-ancestor
44809439|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809440|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809441|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809442|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
44809443|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44809444|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
44809445|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44809446|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44809447|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44809448|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809449|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44694640|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694641|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694642|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44694643|NCT01381055|Protective Agents|protective agents|mesh-ancestor
44694644|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694645|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694646|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44694647|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
44694648|NCT01381185|Aspirin|aspirin|mesh-list
44694649|NCT01381185|Clopidogrel|clopidogrel|mesh-list
44694650|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694651|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694652|NCT01381185|Analgesics|analgesics|mesh-ancestor
44694653|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
44694654|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694655|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694656|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694657|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694658|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44694659|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44694660|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694661|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694662|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694663|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694664|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
44694665|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44694666|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44694667|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44694668|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
44694669|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694670|NCT01381276|Beta Carotene|beta carotene|mesh-list
44694671|NCT01381276|Vitamin A|vitamin a|mesh-list
44694672|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
44694673|NCT01381276|Carotenoids|carotenoids|mesh-list
44694674|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
44694675|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694676|NCT01381276|Protective Agents|protective agents|mesh-ancestor
44694677|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694678|NCT01381276|Provitamins|provitamins|mesh-ancestor
44694679|NCT01381276|Vitamins|vitamins|mesh-ancestor
44694680|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
44465036|NCT01484977|Lacosamide|lacosamide|mesh-list
44694681|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44694682|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694683|NCT01381289|Ivacaftor|ivacaftor|mesh-list
44694684|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44694685|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44694686|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694687|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
44694688|NCT01381354|Riboflavin|riboflavin|mesh-list
44694689|NCT01381354|Thiamine|thiamine|mesh-list
44694690|NCT01381354|Niacinamide|niacinamide|mesh-list
44694691|NCT01381354|Niacin|niacin|mesh-list
44694692|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
44694693|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
44694694|NCT01381354|Ubiquinone|ubiquinone|mesh-list
44694695|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
44694696|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44694697|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44694698|NCT01381354|Vitamins|vitamins|mesh-ancestor
44694699|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
44694700|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694701|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
44694702|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694703|NCT01381354|Expectorants|expectorants|mesh-ancestor
44694704|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
44694705|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44694706|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
44694707|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694708|NCT01381354|Protective Agents|protective agents|mesh-ancestor
44694709|NCT01381354|Antidotes|antidotes|mesh-ancestor
44809450|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
44809451|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809452|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44809453|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44809454|NCT02085655|Growth Substances|growth substances|mesh-ancestor
44809455|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
44809456|NCT02085824|Enoxaparin|enoxaparin|mesh-list
44809457|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
44809458|NCT02085824|Dabigatran|dabigatran|mesh-list
44809459|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44809460|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
44809461|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44809462|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44809463|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809464|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809465|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
44809466|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44809467|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44809468|NCT02085902|Ropivacaine|ropivacaine|mesh-list
44809469|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809470|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
44809471|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809472|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809473|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
44809474|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809475|NCT02085967|Itraconazole|itraconazole|mesh-list
44809476|NCT02085967|Rifampin|rifampin|mesh-list
44809477|NCT02085967|Midazolam|midazolam|mesh-list
44809478|NCT02085967|Bupropion|bupropion|mesh-list
44809479|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44809480|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44809481|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809482|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809483|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44809484|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809485|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44809486|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44809487|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
44809488|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
44809489|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
44809490|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
44809491|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809492|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809493|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44809494|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44809495|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44809496|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44809497|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809498|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
44809499|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44809500|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44809501|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809502|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
44809503|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295892|NCT00804336|Pasireotide|pasireotide|mesh-list
44809504|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44809505|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44809506|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
44809507|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809508|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44809509|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44809510|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
44809511|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809512|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
44809513|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44809514|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44809515|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44809516|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44809517|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44809518|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44809519|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44809520|NCT02086019|Ramipril|ramipril|mesh-list
44809521|NCT02086019|Bisoprolol|bisoprolol|mesh-list
44809522|NCT02086019|Heparin|heparin|mesh-list
44809523|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44809524|NCT02086019|Tinzaparin|tinzaparin|mesh-list
44809525|NCT02086019|Dalteparin|dalteparin|mesh-list
44809526|NCT02086019|Clopidogrel|clopidogrel|mesh-list
44809527|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44809528|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809529|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809530|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44809531|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44809532|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809533|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44809534|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809535|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44809536|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44809537|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44809538|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
44809539|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809540|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
44809541|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44809542|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809543|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44809544|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44809545|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44809546|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
44809547|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
44809548|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44809549|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44809550|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44809551|NCT02086032|Estradiol|estradiol|mesh-list
44809552|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44809553|NCT02086032|Estrogens|estrogens|mesh-list
44809554|NCT02086032|Progesterone|progesterone|mesh-list
44809555|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
44809556|NCT02086032|Hormones|hormones|mesh-ancestor
44809557|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809558|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809559|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44809560|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
44809561|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44809562|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44809563|NCT02086032|Progestins|progestins|mesh-ancestor
44809564|NCT02086097|Ibuprofen|ibuprofen|mesh-list
44809565|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44809566|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44809567|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809568|NCT02086097|Analgesics|analgesics|mesh-ancestor
44809569|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
44809570|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809571|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809572|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809573|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809574|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44809575|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809576|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809577|NCT02086188|Mirabegron|mirabegron|mesh-list
44809578|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44809579|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44809580|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44809581|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
44809582|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809583|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809584|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809585|NCT02086188|Urological Agents|urological agents|mesh-ancestor
44809586|NCT02086227|Glucagon|glucagon|mesh-list
44809587|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44809588|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809589|NCT02086227|Hormones|hormones|mesh-ancestor
44809590|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809591|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809592|NCT02086227|Incretins|incretins|mesh-ancestor
44809593|NCT02086253|BQ 788|bq 788|mesh-list
44809594|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809595|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44809596|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809597|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44809598|NCT02086279|Hormones|hormones|mesh-list
44809599|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809600|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809601|NCT02086292|Lidocaine|lidocaine|mesh-list
44809602|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809603|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
44809604|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809605|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809606|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
44295985|NCT00804830|Growth Substances|growth substances|mesh-ancestor
44809607|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809608|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44809609|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44809610|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44809611|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809612|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809613|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
44809614|NCT02086409|Vitamin D|vitamin d|mesh-list
44809615|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
44809616|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
44809617|NCT02086409|Vitamins|vitamins|mesh-list
44809618|NCT02086409|Calcium|calcium|mesh-list
44809619|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
44809620|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809621|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44809622|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44809623|NCT02086474|Bupivacaine|bupivacaine|mesh-list
44809624|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
44809625|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
44809626|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
44809627|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809628|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809629|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
44809630|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809631|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44809632|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
44809633|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
44809634|NCT02086474|Protective Agents|protective agents|mesh-ancestor
44809635|NCT02086526|Metformin|metformin|mesh-list
44809636|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44809637|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809638|NCT02086656|Bevacizumab|bevacizumab|mesh-list
44809639|NCT02086656|Capecitabine|capecitabine|mesh-list
44809640|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
44809641|NCT02086656|Irinotecan|irinotecan|mesh-list
44809642|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44809643|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809644|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44809645|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296033|NCT00804921|Diuretics|diuretics|mesh-ancestor
44809646|NCT02086656|Growth Substances|growth substances|mesh-ancestor
44809647|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809648|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44809649|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809650|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
44809651|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809652|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44809653|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44809654|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809655|NCT02086747|Acetaminophen|acetaminophen|mesh-list
44809656|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809657|NCT02086747|Analgesics|analgesics|mesh-ancestor
44809658|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
44809659|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809660|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809661|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
44809662|NCT02086825|Rifaximin|rifaximin|mesh-list
44809663|NCT02086825|Lactulose|lactulose|mesh-list
44809664|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809665|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809666|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809667|NCT02086838|Dextrans|dextrans|mesh-list
44809668|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
44809669|NCT02086838|Hematinics|hematinics|mesh-list
44809670|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
44809671|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
44809672|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
44809673|NCT02086903|Clopidogrel|clopidogrel|mesh-list
44809674|NCT02086903|Ticagrelor|ticagrelor|mesh-list
44809675|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44809676|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44809677|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44809678|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44809679|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
44809680|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809681|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809682|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809683|NCT02086929|Trazodone|trazodone|mesh-list
44809684|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44809685|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44809686|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44809687|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809688|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809689|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809690|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809691|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44809692|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
44809693|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44809694|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44809695|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809696|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809697|NCT02086929|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44809698|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
44809699|NCT02086942|Dexamethasone|dexamethasone|mesh-list
44809700|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
44809701|NCT02086942|Bortezomib|bortezomib|mesh-list
44809702|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809703|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
44809704|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809705|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809706|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44809707|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
44809708|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809709|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809710|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44809711|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809712|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
44809713|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
44590497|NCT00879437|Growth Substances|growth substances|mesh-ancestor
44809714|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809715|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809716|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
44809717|NCT02086942|Hormones|hormones|mesh-ancestor
44809718|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809719|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809720|NCT02086994|Misoprostol|misoprostol|mesh-list
44809721|NCT02086994|Carbetocin|carbetocin|mesh-list
44809722|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44809723|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
44809724|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44809725|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809726|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44809727|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809728|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
44809729|NCT02087007|Cilostazol|cilostazol|mesh-list
44809730|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44809731|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
44809732|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809733|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809734|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44809735|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
44809736|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44809737|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44809738|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809739|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44809740|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809741|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44809742|NCT02087007|Protective Agents|protective agents|mesh-ancestor
44809743|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44809744|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44809745|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809746|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44809747|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809748|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
44809749|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44809750|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44809751|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
44809752|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809753|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809754|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809755|NCT02087098|Urological Agents|urological agents|mesh-ancestor
44809756|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
44809757|NCT02087202|Ketamine|ketamine|mesh-list
44809758|NCT02087202|Analgesics|analgesics|mesh-ancestor
44809759|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
44809760|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809761|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809762|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44809763|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44809764|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
44809765|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
44809766|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809767|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44809768|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44809769|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809770|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809771|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44809772|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
44809773|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44809774|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809775|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44809776|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
44809777|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44809778|NCT02087215|Boron|boron|mesh-list
44809779|NCT02087215|Trace Elements|trace elements|mesh-ancestor
44809780|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
44809781|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809782|NCT02087332|Torsemide|torsemide|mesh-list
44809783|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809784|NCT02087332|Diuretics|diuretics|mesh-ancestor
44809785|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
44809786|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590586|NCT00877929|Amlodipine|amlodipine|mesh-list
44809787|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44809788|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809789|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809791|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
44809792|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809793|NCT02087462|Vitamins|vitamins|mesh-list
44809794|NCT02087462|Thiamine|thiamine|mesh-list
44809795|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
44809796|NCT02087462|Diclofenac|diclofenac|mesh-list
44809797|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
44809798|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809799|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44809800|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809801|NCT02087462|Analgesics|analgesics|mesh-ancestor
44809802|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
44809803|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809804|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809805|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809806|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44809807|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809808|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809809|NCT02087475|Fluorouracil|fluorouracil|mesh-list
44809810|NCT02087475|Irinotecan|irinotecan|mesh-list
44809811|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
44809812|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809813|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44809814|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809815|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44809816|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
44809817|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809818|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44809819|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44809820|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809821|NCT02087488|Eszopiclone|eszopiclone|mesh-list
44809822|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44809823|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296184|NCT00805519|Chloroquine|chloroquine|mesh-list
44809824|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809825|NCT02087527|Dexamethasone|dexamethasone|mesh-list
44809826|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809827|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
44809828|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
44809829|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809830|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809831|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809832|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
44809833|NCT02087527|Hormones|hormones|mesh-ancestor
44809834|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809835|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809836|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809837|NCT02087540|Telmisartan|telmisartan|mesh-list
44809838|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44809839|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44809840|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44809841|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
44809842|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809843|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44809844|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44809845|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809846|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809847|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44809848|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44809849|NCT02087566|Linezolid|linezolid|mesh-list
44809850|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44809851|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809852|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44809853|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809854|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809855|NCT02087579|Olanzapine|olanzapine|mesh-list
44809856|NCT02087579|Risperidone|risperidone|mesh-list
44809857|NCT02087579|Aripiprazole|aripiprazole|mesh-list
44809858|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44809859|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44809860|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44809861|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
44694710|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
44809862|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809863|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809864|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809865|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44809866|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809867|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809868|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44809869|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44809870|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
44809872|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
44809873|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809874|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809875|NCT02087579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44809876|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44809877|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809878|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
44809879|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
44809880|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44809881|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44809882|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44809883|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44809884|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44809885|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
44809886|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44809887|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44809888|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809889|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809890|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809891|NCT02087683|Vitamin D|vitamin d|mesh-list
44809892|NCT02087683|Vitamins|vitamins|mesh-ancestor
44809893|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
44809894|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809895|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44809896|NCT02087722|Melatonin|melatonin|mesh-list
44809897|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
44809898|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809899|NCT02087722|Protective Agents|protective agents|mesh-ancestor
44809900|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809901|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809902|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
44809903|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44809904|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
44809905|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44809906|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
44809907|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809908|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
44809909|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
44590717|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44809910|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809911|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809912|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809913|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
44809914|NCT02087813|Hormones|hormones|mesh-ancestor
44809915|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44809916|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44809917|NCT02087813|Protective Agents|protective agents|mesh-ancestor
44809918|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44809919|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44809920|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809921|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590718|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590719|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
44590720|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590721|NCT00876343|Aripiprazole|aripiprazole|mesh-list
44590722|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
44590723|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590724|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44590725|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590726|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590727|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590728|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
44590729|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
44809922|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44809923|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44809925|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809926|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44809927|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44809928|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809929|NCT02088060|Cannabidiol|cannabidiol|mesh-list
44809930|NCT02088060|Olanzapine|olanzapine|mesh-list
44809931|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
44809932|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
44809933|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809934|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809935|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44809936|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44809937|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44809938|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44809939|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465089|NCT01484275|Siltuximab|siltuximab|mesh-list
44809940|NCT02088060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44809941|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44809942|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809943|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809944|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809945|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
44809946|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
44809947|NCT02088398|Ricolinostat|ricolinostat|mesh-list
44809948|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694711|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44246301|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
44694712|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
44694713|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694714|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
44694715|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44694716|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694717|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694718|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
44694719|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44694720|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
44694721|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694722|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
44694723|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44694724|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694725|NCT01381432|Azathioprine|azathioprine|mesh-list
44694726|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
44694727|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694728|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44694729|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694730|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44694731|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
44694732|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694733|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694734|NCT01381445|Clobetasol|clobetasol|mesh-list
44694735|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694736|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
44694737|NCT01381445|Hormones|hormones|mesh-ancestor
44694738|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694739|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694740|NCT01381497|Naproxen|naproxen|mesh-list
44694741|NCT01381497|Sumatriptan|sumatriptan|mesh-list
44694742|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694743|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694744|NCT01381497|Analgesics|analgesics|mesh-ancestor
44694745|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
44694746|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694747|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694748|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694749|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694750|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
44694751|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694752|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694753|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694754|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44694755|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44694756|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44694757|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
44694758|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44809949|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44809950|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809951|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809953|NCT02088411|Wobenzym|wobenzym|mesh-list
44809954|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44809955|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44809956|NCT02088411|Analgesics|analgesics|mesh-ancestor
44809957|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
44809958|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809959|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809960|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44809961|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44809962|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44809963|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809964|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809965|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44809966|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
44809967|NCT02088424|Insulin|insulin|mesh-list
44809968|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44809969|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809970|NCT02088450|Nitrendipine|nitrendipine|mesh-list
44809971|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44809972|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44809973|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44809974|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809975|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44809976|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809977|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809978|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
44809979|NCT02088502|Theophylline|theophylline|mesh-list
44809980|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44809981|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
44809982|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44809983|NCT02088502|Expectorants|expectorants|mesh-ancestor
44809984|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
44809985|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44809986|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
44809987|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44809988|NCT02088502|Protective Agents|protective agents|mesh-ancestor
44809989|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44809990|NCT02088502|Antidotes|antidotes|mesh-ancestor
44809991|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44809992|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
44809993|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44809994|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44809995|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44809996|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44809997|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
44809998|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44809999|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44810000|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
44810001|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810002|NCT02088515|Cisplatin|cisplatin|mesh-list
44810003|NCT02088515|Docetaxel|docetaxel|mesh-list
44810004|NCT02088515|Nedaplatin|nedaplatin|mesh-list
44810005|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810006|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
44810007|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
44810008|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
44810009|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810010|NCT02088528|Mitomycins|mitomycins|mesh-list
44810011|NCT02088528|Mitomycin|mitomycin|mesh-list
44810012|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44810013|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810014|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
44810015|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810016|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44810017|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810018|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
44810019|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44810020|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810021|NCT02088671|Propofol|propofol|mesh-list
44810022|NCT02088671|Desflurane|desflurane|mesh-list
44810023|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44590883|NCT00873730|Etanercept|etanercept|mesh-list
44810024|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810025|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810026|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44810027|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
44810028|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
44810029|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44810030|NCT02088684|Fulvestrant|fulvestrant|mesh-list
44810031|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44810032|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810033|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44810034|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44810035|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
44810036|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810037|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810038|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
44810039|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
44810040|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810042|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
44810043|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
44810044|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810045|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810046|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
44810047|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810048|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44810049|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44810050|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44810051|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44810052|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810053|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
44810054|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44810055|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
44810056|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810057|NCT02088918|Metformin|metformin|mesh-list
44810058|NCT02088918|Nateglinide|nateglinide|mesh-list
44810059|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810060|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810061|NCT02088944|Infliximab|infliximab|mesh-list
44810062|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810063|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810064|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810065|NCT02088970|Riboflavin|riboflavin|mesh-list
44810066|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44810067|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810068|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
44810069|NCT02088970|Vitamins|vitamins|mesh-ancestor
44810070|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
44810071|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810072|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44810073|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810074|NCT02088983|Choline|choline|mesh-list
44810075|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44810076|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
44810077|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44810078|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
44810079|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810080|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810081|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44810082|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
44810083|NCT02089048|Auranofin|auranofin|mesh-list
44810084|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810085|NCT02089061|Atorvastatin|atorvastatin|mesh-list
44810086|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44810087|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44810088|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44810089|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
44810090|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810091|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44810092|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44810093|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810094|NCT02089126|Glimepiride|glimepiride|mesh-list
44810095|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44810096|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810097|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810098|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810099|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
44810100|NCT02089178|Remifentanil|remifentanil|mesh-list
44810101|NCT02089178|Anesthetics|anesthetics|mesh-list
44810102|NCT02089178|Propofol|propofol|mesh-list
44810103|NCT02089178|Sevoflurane|sevoflurane|mesh-list
44810104|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810105|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810106|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44810107|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44810108|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
44810109|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44810110|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44810111|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810112|NCT02089178|Narcotics|narcotics|mesh-ancestor
44810113|NCT02089178|Analgesics|analgesics|mesh-ancestor
44810114|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
44810115|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810116|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
44810117|NCT02089204|Fluorides|fluorides|mesh-list
44810118|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
44810119|NCT02089204|Protective Agents|protective agents|mesh-ancestor
44810120|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810121|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
44810122|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810123|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
44810124|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810125|NCT02089256|Liraglutide|liraglutide|mesh-list
44810126|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810127|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810128|NCT02089256|Incretins|incretins|mesh-ancestor
44810129|NCT02089256|Hormones|hormones|mesh-ancestor
44810130|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810131|NCT02089295|Oxycodone|oxycodone|mesh-list
44810132|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810133|NCT02089295|Narcotics|narcotics|mesh-ancestor
44810134|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810135|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810136|NCT02089295|Analgesics|analgesics|mesh-ancestor
44810137|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
44810138|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810139|NCT02089308|Nicotine|nicotine|mesh-list
44810140|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44810141|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
44810142|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810143|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810144|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44810145|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44810146|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
44810147|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810148|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810149|NCT02089386|Tamoxifen|tamoxifen|mesh-list
44810150|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44810151|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
44810152|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810153|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810154|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44810155|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810156|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44810157|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44810158|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810159|NCT02089399|Olmesartan|olmesartan|mesh-list
44810160|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44810161|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44810162|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44810163|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
44810164|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810165|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44810166|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44810167|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810168|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44810169|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44810170|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44810171|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44810172|NCT02089438|Vildagliptin|vildagliptin|mesh-list
44591030|NCT00871858|Fulvestrant|fulvestrant|mesh-list
44810173|NCT02089438|Saxagliptin|saxagliptin|mesh-list
44810174|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810175|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810176|NCT02089438|Incretins|incretins|mesh-ancestor
44810177|NCT02089438|Hormones|hormones|mesh-ancestor
44810178|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810179|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44810180|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
44810181|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810182|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810183|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
44810184|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810185|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810186|NCT02089503|Ranibizumab|ranibizumab|mesh-list
44810187|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810188|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44810189|NCT02089503|Growth Substances|growth substances|mesh-ancestor
44810190|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810191|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44810192|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810193|NCT02089529|Ibuprofen|ibuprofen|mesh-list
44810194|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44810195|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810196|NCT02089529|Analgesics|analgesics|mesh-ancestor
44810197|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
44810198|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810199|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810200|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810201|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810202|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44810203|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810204|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810205|NCT02089542|Methylene Blue|methylene blue|mesh-list
44810206|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810207|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810208|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44810209|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810210|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810211|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44810212|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810213|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810214|NCT02089633|BCT-100|bct-100|mesh-list
44810215|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810216|NCT02089763|BCT-100|bct-100|mesh-list
44810217|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810218|NCT02089841|Lumefantrine|lumefantrine|mesh-list
44810219|NCT02089841|Artemether|artemether|mesh-list
44810220|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44810221|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
44810222|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44810223|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44810224|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810225|NCT02089854|Toremifene|toremifene|mesh-list
44810226|NCT02089854|Anastrozole|anastrozole|mesh-list
44810227|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44810228|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810229|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44810230|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44810231|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810232|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810233|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44810234|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
44810235|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810236|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810237|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44810238|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44810239|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810240|NCT02089867|Ezetimibe|ezetimibe|mesh-list
44810241|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44810242|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44810243|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
44810244|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810245|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44810246|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
44810247|NCT02089932|Bupivacaine|bupivacaine|mesh-list
44810248|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
44810249|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
44810250|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810251|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810252|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
44810253|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810254|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44810255|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810256|NCT02089932|Analgesics|analgesics|mesh-ancestor
44810257|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44810258|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44810259|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44810260|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
44810261|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810262|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810263|NCT02090036|Lumefantrine|lumefantrine|mesh-list
44810264|NCT02090036|Artemether|artemether|mesh-list
44810265|NCT02090036|Primaquine|primaquine|mesh-list
44810266|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44810267|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
44810268|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44810269|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44810270|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810271|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44810272|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810273|NCT02090153|Leucovorin|leucovorin|mesh-list
44810274|NCT02090153|Tegafur|tegafur|mesh-list
44810275|NCT02090153|Antidotes|antidotes|mesh-ancestor
44810276|NCT02090153|Protective Agents|protective agents|mesh-ancestor
44810277|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810278|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
44810279|NCT02090153|Vitamins|vitamins|mesh-ancestor
44810280|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
44810281|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44810282|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
44810283|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810284|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810285|NCT02090244|Teriparatide|teriparatide|mesh-list
44810286|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810287|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810288|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810289|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
44810290|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810291|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
44810292|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810293|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810294|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44810295|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
44810296|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810297|NCT02090322|Bevacizumab|bevacizumab|mesh-list
44810298|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44810299|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810300|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810301|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44810302|NCT02090322|Growth Substances|growth substances|mesh-ancestor
44810303|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810304|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44810305|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44810306|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810307|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810308|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
44810309|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810310|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
44810311|NCT02090400|Calcium|calcium|mesh-list
44810312|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810313|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810314|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44810315|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44810316|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
44810317|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810318|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810319|NCT02090439|Silodosin|silodosin|mesh-list
44810320|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44810321|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44810322|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44810323|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44810324|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810325|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810326|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694759|NCT01381510|Finasteride|finasteride|mesh-list
44694760|NCT01381510|Dutasteride|dutasteride|mesh-list
44694761|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
44694762|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44694763|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694764|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694765|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
44694766|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44694767|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694768|NCT01381510|Urological Agents|urological agents|mesh-ancestor
44694769|NCT01381523|Naproxen|naproxen|mesh-list
44694770|NCT01381523|Sumatriptan|sumatriptan|mesh-list
44694771|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694772|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694773|NCT01381523|Analgesics|analgesics|mesh-ancestor
44694774|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
44694775|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694776|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694777|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694778|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694779|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
44694780|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694781|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694782|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694783|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44694784|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44694785|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44694786|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
44694787|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694788|NCT01381536|Belimumab|belimumab|mesh-list
44694789|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44694790|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
44694791|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694792|NCT01381601|Bevacizumab|bevacizumab|mesh-list
44694793|NCT01381601|Sunitinib|sunitinib|mesh-list
44694794|NCT01381601|Sorafenib|sorafenib|mesh-list
44694795|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44810327|NCT02090439|Urological Agents|urological agents|mesh-ancestor
44810328|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
44810329|NCT02090504|Oxazepam|oxazepam|mesh-list
44810330|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44810331|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44810332|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
44810333|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
44810334|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810335|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810336|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44810337|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44810338|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44810339|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810340|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
44810341|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
44810342|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810343|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810344|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
44810345|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
44810346|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44810347|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
44810348|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44810349|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44810350|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810351|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810352|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
44810353|NCT02090673|Exenatide|exenatide|mesh-list
44810354|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810355|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810356|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44810357|NCT02090673|Incretins|incretins|mesh-ancestor
44810358|NCT02090673|Hormones|hormones|mesh-ancestor
44810359|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810360|NCT02090738|Amoxicillin|amoxicillin|mesh-list
44810361|NCT02090738|Clarithromycin|clarithromycin|mesh-list
44810362|NCT02090738|Acetazolamide|acetazolamide|mesh-list
44810363|NCT02090738|Esomeprazole|esomeprazole|mesh-list
44810364|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810365|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810366|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44810367|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296763|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44810368|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44810369|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810370|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810371|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44810372|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44810373|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44810374|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
44810375|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44810376|NCT02090738|Diuretics|diuretics|mesh-ancestor
44810377|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
44810378|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810379|NCT02090790|Dexamethasone|dexamethasone|mesh-list
44810380|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
44810381|NCT02090790|BB 1101|bb 1101|mesh-list
44810382|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810383|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
44810384|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
44810385|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810386|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810387|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810388|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
44810389|NCT02090790|Hormones|hormones|mesh-ancestor
44810390|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810391|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44810392|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810393|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44810394|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810395|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810396|NCT02090829|Oxytocin|oxytocin|mesh-list
44810397|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
44810398|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44810399|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810400|NCT02090920|Nifedipine|nifedipine|mesh-list
44591297|NCT00868998|Docetaxel|docetaxel|mesh-list
44810401|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44810402|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44810403|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810404|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810405|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810406|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
44810407|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
44810408|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44810409|NCT02090933|Celecoxib|celecoxib|mesh-list
44810410|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44810411|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810412|NCT02090933|Analgesics|analgesics|mesh-ancestor
44810413|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
44810414|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810415|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810416|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810417|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810418|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44810419|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44810420|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810421|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810422|NCT02091063|Ricolinostat|ricolinostat|mesh-list
44810423|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810424|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44810425|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810426|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810427|NCT02091180|Mannitol|mannitol|mesh-list
44810428|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44810429|NCT02091180|Diuretics|diuretics|mesh-ancestor
44810430|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
44810431|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810432|NCT02091219|Vitamin D|vitamin d|mesh-list
44810433|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
44810434|NCT02091219|Calcifediol|calcifediol|mesh-list
44810435|NCT02091219|Vitamins|vitamins|mesh-ancestor
44810436|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
44810437|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810438|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810439|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810440|NCT02091297|Acetaminophen|acetaminophen|mesh-list
44810441|NCT02091297|Morphine|morphine|mesh-list
44810442|NCT02091297|Ropivacaine|ropivacaine|mesh-list
44810443|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810444|NCT02091297|Narcotics|narcotics|mesh-ancestor
44810445|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810446|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810447|NCT02091297|Analgesics|analgesics|mesh-ancestor
44810448|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
44810449|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810450|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
44810451|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
44810452|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810453|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
44810454|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
44810455|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810456|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810457|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44810458|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44810459|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810460|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810461|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810462|NCT02091336|Metformin|metformin|mesh-list
44810463|NCT02091336|Glyburide|glyburide|mesh-list
44810464|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810465|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810466|NCT02091388|Risperidone|risperidone|mesh-list
44591363|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591364|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591365|NCT00867490|Amlodipine|amlodipine|mesh-list
44591366|NCT00867490|Candesartan|candesartan|mesh-list
44810467|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44810468|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
44810469|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810470|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810471|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810472|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44810473|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44810474|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810475|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810476|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44810477|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
44810478|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
44810479|NCT02091401|Analgesics|analgesics|mesh-ancestor
44810480|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
44810481|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810482|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810483|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
44810484|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296876|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
44810485|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44810486|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
44810487|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44810488|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44810489|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810490|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810491|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
44810492|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44591431|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44810493|NCT02091492|Teriparatide|teriparatide|mesh-list
44810494|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810495|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810496|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810497|NCT02091505|Ranibizumab|ranibizumab|mesh-list
44810498|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810499|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44810500|NCT02091505|Growth Substances|growth substances|mesh-ancestor
44810501|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810502|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44810503|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296900|NCT00809198|Laxatives|laxatives|mesh-ancestor
44810504|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
44810505|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44810506|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
44810507|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810508|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
44810509|NCT02091674|Protective Agents|protective agents|mesh-ancestor
44810510|NCT02091817|Oxytocin|oxytocin|mesh-list
44810511|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
44810512|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44810513|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810514|NCT02091830|Acetaminophen|acetaminophen|mesh-list
44810515|NCT02091830|Cortisone|cortisone|mesh-list
44810516|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44810517|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44810518|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810519|NCT02091830|Analgesics|analgesics|mesh-ancestor
44810520|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
44810521|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810522|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810523|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
44810524|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810525|NCT02091908|Lactitol|lactitol|mesh-list
44810526|NCT02091908|Vaccines|vaccines|mesh-list
44810527|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
44810528|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810529|NCT02091908|Cathartics|cathartics|mesh-ancestor
44810530|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810531|NCT02091973|Everolimus|everolimus|mesh-list
44810532|NCT02091973|Tacrolimus|tacrolimus|mesh-list
44810533|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810534|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
44810535|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810536|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44810537|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810538|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810539|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810540|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44810541|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
44296942|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
44810542|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44810543|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810544|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810545|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810546|NCT02092012|Analgesics|analgesics|mesh-ancestor
44810547|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
44810548|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810549|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44810550|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44810551|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44810552|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
44810553|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810554|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810555|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44810556|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810557|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810558|NCT02092038|Temozolomide|temozolomide|mesh-list
44810559|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44810560|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
44810561|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810562|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810563|NCT02092142|Vaccines|vaccines|mesh-list
44810564|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
44810565|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810566|NCT02092363|Paclitaxel|paclitaxel|mesh-list
44810567|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44810568|NCT02092363|Carboplatin|carboplatin|mesh-list
44810569|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44810570|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44810571|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810572|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
44810573|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
44810574|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
44810575|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810576|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
44810577|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810578|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
44810579|NCT02092376|Vitamin D|vitamin d|mesh-list
44810580|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44810581|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810582|NCT02092376|Vitamins|vitamins|mesh-ancestor
44810583|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
44810584|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810585|NCT02092428|Adenosine|adenosine|mesh-list
44810586|NCT02092428|Regadenoson|regadenoson|mesh-list
44810587|NCT02092428|Analgesics|analgesics|mesh-ancestor
44810588|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
44810589|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810590|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810591|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44810592|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
44810593|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44810594|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
44810595|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
44810596|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296981|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810597|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810598|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44810599|NCT02092506|Amoxicillin|amoxicillin|mesh-list
44810600|NCT02092506|Metronidazole|metronidazole|mesh-list
44810601|NCT02092506|Clarithromycin|clarithromycin|mesh-list
44810602|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44810603|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810604|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810605|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44810606|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44810607|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44810608|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810609|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810610|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44810611|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44810612|NCT02092532|Aflibercept|aflibercept|mesh-list
44810613|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810614|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44810615|NCT02092532|Growth Substances|growth substances|mesh-ancestor
44810616|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810617|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
44810618|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810619|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
44810620|NCT02092558|Cephalosporins|cephalosporins|mesh-list
44810621|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44810622|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810623|NCT02092558|Renal Agents|renal agents|mesh-ancestor
44810624|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810625|NCT02092597|Exenatide|exenatide|mesh-list
44810626|NCT02092597|Linagliptin|linagliptin|mesh-list
44810627|NCT02092597|Gliclazide|gliclazide|mesh-list
44810628|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810629|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810630|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44810631|NCT02092597|Incretins|incretins|mesh-ancestor
44810632|NCT02092597|Hormones|hormones|mesh-ancestor
44810633|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810634|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44810635|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44810636|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810637|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810638|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
44810639|NCT02092701|Vitamin D|vitamin d|mesh-list
44694796|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694797|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810640|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44694798|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591606|NCT00866294|Paroxetine|paroxetine|mesh-list
44810641|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810642|NCT02092701|Vitamins|vitamins|mesh-ancestor
44810643|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
44297019|NCT00810121|Ketoprofen|ketoprofen|mesh-list
44810644|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44810645|NCT02092766|Artesunate|artesunate|mesh-list
44810646|NCT02092766|Quinine|quinine|mesh-list
44810647|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
44810648|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44810649|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44810650|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810651|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810652|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
44810653|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
44810654|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44810655|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
44810656|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44810657|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810658|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44810659|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810660|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810661|NCT02092766|Analgesics|analgesics|mesh-ancestor
44810662|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
44810663|NCT02092818|Riociguat|riociguat|mesh-list
44297041|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810664|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
44810665|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810666|NCT02092896|Liraglutide|liraglutide|mesh-list
44810667|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44810668|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810669|NCT02092896|Incretins|incretins|mesh-ancestor
44810670|NCT02092896|Hormones|hormones|mesh-ancestor
44810671|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810672|NCT02092974|Citalopram|citalopram|mesh-list
44810673|NCT02092974|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44810674|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44810675|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44810676|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810677|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810678|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
44810679|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810680|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44810681|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
44297062|NCT00810524|Lamivudine|lamivudine|mesh-list
44694799|NCT01381601|Growth Substances|growth substances|mesh-ancestor
44694800|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694801|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
44694802|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44694803|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694804|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694805|NCT01381614|Bevacizumab|bevacizumab|mesh-list
44694806|NCT01381614|Sunitinib|sunitinib|mesh-list
44694807|NCT01381614|Sorafenib|sorafenib|mesh-list
44694808|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44694809|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694810|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44694811|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44694812|NCT01381614|Growth Substances|growth substances|mesh-ancestor
44694813|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694814|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
44694815|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44694816|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694817|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694818|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
44694819|NCT01381627|Remifentanil|remifentanil|mesh-list
44694820|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44694821|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694822|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694823|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694824|NCT01381627|Analgesics|analgesics|mesh-ancestor
44297081|NCT00810589|Insulin|insulin|mesh-list
44694825|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
44694826|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694827|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44694828|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44694829|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44694830|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44694831|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591658|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810682|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810683|NCT02093000|Bevacizumab|bevacizumab|mesh-list
44810684|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44810685|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810686|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44810687|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44810688|NCT02093000|Growth Substances|growth substances|mesh-ancestor
44810689|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810690|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591697|NCT00865098|Cetuximab|cetuximab|mesh-list
44810691|NCT02093091|Vitremer|vitremer|mesh-list
44810692|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
44810693|NCT02093091|Protective Agents|protective agents|mesh-ancestor
44810694|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810695|NCT02093143|Remifentanil|remifentanil|mesh-list
44810696|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810697|NCT02093143|Narcotics|narcotics|mesh-ancestor
44810698|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810699|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810700|NCT02093143|Analgesics|analgesics|mesh-ancestor
44810701|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
44810702|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810703|NCT02093195|Bosentan|bosentan|mesh-list
44810704|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44810705|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44810706|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
44810707|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44810708|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44810709|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810710|NCT02093299|Clopidogrel|clopidogrel|mesh-list
44810711|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44810712|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44810713|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44297127|NCT00810862|Analgesics|analgesics|mesh-ancestor
44810714|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44810715|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
44810716|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810717|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810718|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810719|NCT02093403|Decitabine|decitabine|mesh-list
44810720|NCT02093403|Azacitidine|azacitidine|mesh-list
44810721|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591698|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591699|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591700|NCT00865020|Telmisartan|telmisartan|mesh-list
44591701|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44591702|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44591703|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44591704|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591705|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44591706|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
44591707|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44591708|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591709|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591710|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44591711|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44591712|NCT00864916|Protective Agents|protective agents|mesh-ancestor
44591713|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591714|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
44591715|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44591716|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
44591717|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
44591718|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591719|NCT00864721|Sunitinib|sunitinib|mesh-list
44591720|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591721|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44591722|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591723|NCT00864721|Growth Substances|growth substances|mesh-ancestor
44591724|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591725|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591726|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591727|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591728|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810722|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
44810723|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810724|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810725|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591745|NCT00864513|Pemetrexed|pemetrexed|mesh-list
44810726|NCT02093533|Eculizumab|eculizumab|mesh-list
44810727|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44810728|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810729|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
44810730|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810731|NCT02093585|Tenofovir|tenofovir|mesh-list
44810732|NCT02093585|Abacavir|abacavir|mesh-list
44810733|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
44810734|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810735|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44810736|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44810737|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810738|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810739|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44810740|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44810741|NCT02093598|Sirolimus|sirolimus|mesh-list
44810742|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810743|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810744|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44810745|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810746|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
44810747|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810748|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
44810749|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810750|NCT02093728|Itraconazole|itraconazole|mesh-list
44810751|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44810752|NCT02093728|Fluconazole|fluconazole|mesh-list
44810753|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
44810754|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810755|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44810756|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44810757|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810758|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810759|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44810760|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44810761|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297216|NCT00811226|Olmesartan|olmesartan|mesh-list
44810762|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810763|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44810764|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44810765|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44810766|NCT02093741|Factor VIII|factor viii|mesh-list
44810767|NCT02093741|Coagulants|coagulants|mesh-ancestor
44810768|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44810769|NCT02093845|Everolimus|everolimus|mesh-list
44810770|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810771|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44810772|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
44810773|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810774|NCT02093910|Dexamethasone|dexamethasone|mesh-list
44810775|NCT02093910|Bortezomib|bortezomib|mesh-list
44810776|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810777|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
44810778|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
44810779|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810780|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810781|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44810782|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
44810783|NCT02093910|Hormones|hormones|mesh-ancestor
44810784|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810785|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44810786|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810787|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44810788|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44297248|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
44810789|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810790|NCT02094053|Donepezil|donepezil|mesh-list
44810791|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44810792|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810793|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810794|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
44810795|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810796|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810797|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
44810798|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
44810799|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44810800|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44810801|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810802|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
44810803|NCT02094066|Coagulants|coagulants|mesh-ancestor
44810804|NCT02094157|Heparin|heparin|mesh-list
44810805|NCT02094157|Calcium heparin|calcium heparin|mesh-list
44810806|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44810807|NCT02094157|Tinzaparin|tinzaparin|mesh-list
44810808|NCT02094157|Dalteparin|dalteparin|mesh-list
44810809|NCT02094157|Warfarin|warfarin|mesh-list
44810810|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
44810811|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44810812|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44810813|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810814|NCT02094196|Ethanol|ethanol|mesh-list
44810815|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44810816|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810817|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810818|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810819|NCT02094222|Glycerol|glycerol|mesh-list
44810820|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44810821|NCT02094222|Protective Agents|protective agents|mesh-ancestor
44810822|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810823|NCT02094274|Fluticasone|fluticasone|mesh-list
44810824|NCT02094274|Xhance|xhance|mesh-list
44810825|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44297286|NCT00811421|Renal Agents|renal agents|mesh-ancestor
44810826|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810827|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44810828|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
44810829|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810830|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810831|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44810832|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
44810833|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810834|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44810835|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44810836|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44810837|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44810838|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
44810839|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810840|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810841|NCT02094287|Dimethindene|dimethindene|mesh-list
44810842|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
44810843|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
44810844|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44810845|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
44810846|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
44810847|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810848|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810849|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810850|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44810851|NCT02094313|Atorvastatin|atorvastatin|mesh-list
44810852|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
44810853|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44810854|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
44810855|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810856|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44810857|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44810858|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810859|NCT02094339|Analgesics|analgesics|mesh-list
44810860|NCT02094339|Ropivacaine|ropivacaine|mesh-list
44810861|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
44810862|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
44810863|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810864|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810865|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
44810866|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810867|NCT02094378|Esketamine|esketamine|mesh-list
44810868|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44810869|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810870|NCT02094391|Ipilimumab|ipilimumab|mesh-list
44810871|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44810872|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810873|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44810874|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810875|NCT02094469|Cilostazol|cilostazol|mesh-list
44810876|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44810877|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
44810878|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810879|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810880|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44810881|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
44810882|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44810883|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44118454|NCT00114010|Antacids|antacids|mesh-ancestor
44810884|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810885|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44810886|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
44810887|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44810888|NCT02094469|Protective Agents|protective agents|mesh-ancestor
44810889|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44810890|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44810891|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810893|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
44810894|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810895|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810896|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810897|NCT02094599|Analgesics|analgesics|mesh-ancestor
44810898|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
44810899|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44810900|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44810901|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44810902|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810903|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810904|NCT02094599|Hormones|hormones|mesh-ancestor
44810905|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44810906|NCT02094651|Valproic Acid|valproic acid|mesh-list
44810907|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
44810908|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810909|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810910|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
44810911|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810912|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810913|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
44810914|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44810915|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810916|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44810917|NCT02094703|Levofloxacin|levofloxacin|mesh-list
44810918|NCT02094703|Ofloxacin|ofloxacin|mesh-list
44810919|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
44810920|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44810921|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810922|NCT02094703|Renal Agents|renal agents|mesh-ancestor
44810923|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44810924|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44810925|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44810926|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810927|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591956|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44591957|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591958|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
44591959|NCT00862654|Hormones|hormones|mesh-ancestor
44591960|NCT00862641|Regadenoson|regadenoson|mesh-list
44591961|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44591962|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44591963|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
44591964|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
44591965|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591966|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591967|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591968|NCT00862134|Docetaxel|docetaxel|mesh-list
44591969|NCT00862134|Lenograstim|lenograstim|mesh-list
44591970|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591971|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
44591972|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
44591973|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
44591974|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591975|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44591976|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
44591977|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591978|NCT00862121|Mesalamine|mesalamine|mesh-list
44810928|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810929|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44810930|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44810931|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44810932|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44810933|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
44810934|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810935|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810936|NCT02094703|Urological Agents|urological agents|mesh-ancestor
44810937|NCT02094807|Acetaminophen|acetaminophen|mesh-list
44810938|NCT02094807|Diclofenac|diclofenac|mesh-list
44810939|NCT02094807|Oxycodone|oxycodone|mesh-list
44810940|NCT02094807|Tramadol|tramadol|mesh-list
44810941|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44810942|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810943|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44810944|NCT02094807|Analgesics|analgesics|mesh-ancestor
44810945|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
44810946|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297370|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810947|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
44810948|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810949|NCT02094807|Narcotics|narcotics|mesh-ancestor
44810950|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44810951|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44810952|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44810953|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44810954|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810955|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810956|NCT02094833|Vaccines|vaccines|mesh-list
44810957|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
44810958|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810959|NCT02094924|Candesartan|candesartan|mesh-list
44810960|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
44810961|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44810962|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44810963|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44810964|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810965|NCT02094963|Clopidogrel|clopidogrel|mesh-list
44297398|NCT00811993|Irinotecan|irinotecan|mesh-list
44810966|NCT02094963|Ticagrelor|ticagrelor|mesh-list
44810967|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44810968|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44810969|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44810970|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44810971|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
44810972|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44810973|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810974|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810975|NCT02095054|Cetuximab|cetuximab|mesh-list
44810976|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44810977|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810978|NCT02095119|Gemcitabine|gemcitabine|mesh-list
44810979|NCT02095119|Cisplatin|cisplatin|mesh-list
44810980|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
44810981|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44810982|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44810983|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
44810984|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44810985|NCT02095119|Antiviral Agents|antiviral agents|mesh-ancestor
44810986|NCT02095119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44810987|NCT02095119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44810988|NCT02095119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297412|NCT00811993|Growth Substances|growth substances|mesh-ancestor
44810989|NCT02095119|Immunologic Factors|immunologic factors|mesh-ancestor
44810990|NCT02095119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810991|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591981|NCT00862121|Analgesics|analgesics|mesh-ancestor
44810992|NCT02095314|Vaccines|vaccines|mesh-list
44810993|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
44810994|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44810995|NCT02095366|Sufentanil|sufentanil|mesh-list
44810996|NCT02095366|Morphine|morphine|mesh-list
44810997|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44810998|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44810999|NCT02095366|Narcotics|narcotics|mesh-ancestor
44811000|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811001|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811002|NCT02095366|Analgesics|analgesics|mesh-ancestor
44811003|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
44811004|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811005|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44811006|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44811007|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
44811008|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
44297431|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811009|NCT02095405|Caffeine|caffeine|mesh-list
44811010|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44811011|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811012|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44811013|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811014|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811015|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44811016|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44811017|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
44811018|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811019|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
44811020|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44811021|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811022|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44297451|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297458|NCT00812175|Sorafenib|sorafenib|mesh-list
44297466|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811023|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
44811024|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811025|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811026|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811027|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811028|NCT02095509|Enoxaparin|enoxaparin|mesh-list
44811029|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
44811030|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44811031|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44811032|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811033|NCT02095522|Colchicine|colchicine|mesh-list
44811034|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
44811035|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811036|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811037|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44811038|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297467|NCT00812266|Cisplatin|cisplatin|mesh-list
44297483|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
44811039|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811040|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811041|NCT02095548|Lorecivivint|lorecivivint|mesh-list
44811042|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811043|NCT02095574|Venetoclax|venetoclax|mesh-list
44811044|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811045|NCT02095665|Acetaminophen|acetaminophen|mesh-list
44811046|NCT02095665|Tamsulosin|tamsulosin|mesh-list
44811047|NCT02095665|Mirabegron|mirabegron|mesh-list
44811048|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44811049|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44811050|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44811051|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811052|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811053|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811054|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811055|NCT02095665|Urological Agents|urological agents|mesh-ancestor
44811056|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811057|NCT02095665|Analgesics|analgesics|mesh-ancestor
44811058|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
44811059|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811060|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
44297491|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811061|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44811062|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44811063|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44811064|NCT02095704|Acetaminophen|acetaminophen|mesh-list
44811065|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811066|NCT02095704|Analgesics|analgesics|mesh-ancestor
44811067|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
44811068|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811069|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811070|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
44811071|NCT02095717|Curcumin|curcumin|mesh-list
44811072|NCT02095717|Docetaxel|docetaxel|mesh-list
44811073|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811074|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811075|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44811076|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44811077|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811078|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44811079|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811080|NCT02095717|Analgesics|analgesics|mesh-ancestor
44811081|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
44811082|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811083|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811084|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811085|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811086|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811087|NCT02095730|Vitamins|vitamins|mesh-list
44811088|NCT02095730|Riboflavin|riboflavin|mesh-list
44811089|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
44811090|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
44297531|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
44811091|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811092|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44811093|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811094|NCT02095782|Paclitaxel|paclitaxel|mesh-list
44811095|NCT02095782|Carboplatin|carboplatin|mesh-list
44811096|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44811097|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44811098|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811099|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811100|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44811101|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44811102|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811103|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44811104|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811105|NCT02095834|Dexamethasone|dexamethasone|mesh-list
44118954|NCT00115726|Furosemide|furosemide|mesh-list
44811106|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
44811107|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44811108|NCT02095834|Ichthammol|ichthammol|mesh-list
44811109|NCT02095834|BB 1101|bb 1101|mesh-list
44811110|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811111|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
44811112|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
44811113|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811114|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811115|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811116|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
44811117|NCT02095834|Hormones|hormones|mesh-ancestor
44811118|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44811119|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44811120|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811121|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44811122|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
44811123|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811124|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
44811125|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811126|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811127|NCT02095847|Proflavine|proflavine|mesh-list
44811128|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44811129|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811130|NCT02095886|BMS-955176|bms-955176|mesh-list
44811131|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44811132|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44811133|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
44592128|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592129|NCT00859898|Metformin|metformin|mesh-list
44592130|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
44592131|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592132|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592133|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44592134|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592135|NCT00859573|Modafinil|modafinil|mesh-list
44592136|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44592137|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811134|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811135|NCT02095899|Rufinamide|rufinamide|mesh-list
44811136|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
44811137|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44811138|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44811139|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44297546|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44811140|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811141|NCT02095938|Amisulpride|amisulpride|mesh-list
44811142|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44811143|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44811144|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811145|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811146|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44811147|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44811148|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
44811149|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811150|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811151|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44811152|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
44811153|NCT02095990|Hydroquinone|hydroquinone|mesh-list
44811154|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
44811155|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811156|NCT02095990|Protective Agents|protective agents|mesh-ancestor
44811157|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811158|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44811159|NCT02096055|Idarubicin|idarubicin|mesh-list
44811160|NCT02096055|Cladribine|cladribine|mesh-list
44811161|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44811162|NCT02096055|Guadecitabine|guadecitabine|mesh-list
44811163|NCT02096055|Azacitidine|azacitidine|mesh-list
44811164|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44811165|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811166|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44811167|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44811168|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811169|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811170|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44811171|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
44811172|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811173|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44811174|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
44811175|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
44811176|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44811177|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811178|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811179|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811180|NCT02096068|Analgesics|analgesics|mesh-ancestor
44811181|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
44811182|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811183|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44811184|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44811185|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44811186|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811187|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811188|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811189|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
44811190|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44811191|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811192|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
44811193|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
44811194|NCT02096133|Vitamin D|vitamin d|mesh-list
44811195|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44811196|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811197|NCT02096133|Vitamins|vitamins|mesh-ancestor
44811198|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
44811199|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811200|NCT02096224|Sevoflurane|sevoflurane|mesh-list
44811201|NCT02096224|Desflurane|desflurane|mesh-list
44811202|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44811203|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44811204|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
44811205|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
44811206|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811207|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811208|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
44811209|NCT02096250|Edetic Acid|edetic acid|mesh-list
44811210|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
44811211|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44811212|NCT02096250|Trace Elements|trace elements|mesh-ancestor
44811213|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
44811214|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811215|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44811216|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
44811217|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
44811218|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811219|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
44811220|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44811221|NCT02096250|Hematinics|hematinics|mesh-ancestor
44811222|NCT02096289|Thioridazine|thioridazine|mesh-list
44811223|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44811224|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44811225|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811226|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811227|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44811228|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44811229|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
44811230|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811231|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811232|NCT02096315|Murepavadin|murepavadin|mesh-list
44811233|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811234|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811235|NCT02096328|Murepavadin|murepavadin|mesh-list
44811236|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811237|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811238|NCT02096380|Cisplatin|cisplatin|mesh-list
44811239|NCT02096380|Docetaxel|docetaxel|mesh-list
44811240|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811241|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811242|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
44811243|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
44811244|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811245|NCT02096419|Clopidogrel|clopidogrel|mesh-list
44811246|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44811247|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44811248|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44811249|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44811250|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
44811251|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811252|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811253|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811254|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
44811255|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44811256|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44811257|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44811258|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811259|NCT02096536|Vancomycin|vancomycin|mesh-list
44811260|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811261|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811262|NCT02096601|Levodopa|levodopa|mesh-list
44811263|NCT02096601|Carbidopa|carbidopa|mesh-list
44811264|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44811265|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44811266|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
44811267|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811268|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297684|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811269|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811270|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44592213|NCT00858780|Analgesics|analgesics|mesh-ancestor
44592214|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
44592215|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592216|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592217|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592218|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592219|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44592220|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592221|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
44592222|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
44592223|NCT00858637|Simvastatin|simvastatin|mesh-list
44592224|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44592225|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44592226|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
44811271|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811272|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
44811273|NCT02096614|Fludarabine|fludarabine|mesh-list
44811274|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44811275|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
44811276|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811277|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811278|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44811279|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
44811280|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811281|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811282|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44811283|NCT02096913|Ibuprofen|ibuprofen|mesh-list
44811284|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44811285|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811286|NCT02096913|Analgesics|analgesics|mesh-ancestor
44811287|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
44811288|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811289|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811290|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811291|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811292|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44811293|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811294|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811295|NCT02096926|Ibuprofen|ibuprofen|mesh-list
44811296|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44811297|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811298|NCT02096926|Analgesics|analgesics|mesh-ancestor
44811299|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
44811300|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811301|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811302|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811303|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811304|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44811305|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811306|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811307|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
44811308|NCT02096965|Tolvaptan|tolvaptan|mesh-list
44811309|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44811310|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811311|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
44811312|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811313|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44811314|NCT02097004|Entecavir|entecavir|mesh-list
44811315|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
44811316|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811317|NCT02097017|Lidocaine|lidocaine|mesh-list
44811318|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
44811319|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
44811320|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811321|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811322|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
44811323|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811324|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44811325|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44811326|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44811327|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44811328|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811329|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
44811330|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811331|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811332|NCT02097069|Folic Acid|folic acid|mesh-list
44811333|NCT02097069|Inositol|inositol|mesh-list
44811334|NCT02097069|Hematinics|hematinics|mesh-ancestor
44811335|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
44811336|NCT02097069|Vitamins|vitamins|mesh-ancestor
44811337|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
44811338|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811339|NCT02097082|Paclitaxel|paclitaxel|mesh-list
44811340|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44811341|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811342|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811343|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44811344|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44811345|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811346|NCT02097147|Paroxetine|paroxetine|mesh-list
44811347|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44811348|NCT02097147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44811349|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44811350|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44811351|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811352|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811353|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
44811354|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811355|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44811356|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
44811357|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44811358|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44811359|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44811360|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811361|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44811362|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44811363|NCT02097160|Vitamin D|vitamin d|mesh-list
44811364|NCT02097160|Vitamins|vitamins|mesh-ancestor
44811365|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
44811366|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297796|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44811367|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811368|NCT02097173|Methotrexate|methotrexate|mesh-list
44811369|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44811370|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
44811371|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44811372|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811373|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44811374|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
44811375|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811376|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811377|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811378|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811379|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44811380|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44811381|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
44811382|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811383|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44694832|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694833|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44694834|NCT01381627|Narcotics|narcotics|mesh-ancestor
44694835|NCT01381640|Acetaminophen|acetaminophen|mesh-list
44694836|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694837|NCT01381640|Analgesics|analgesics|mesh-ancestor
44694838|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
44694839|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694840|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694841|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
44694842|NCT01381705|Rituximab|rituximab|mesh-list
44694843|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44694844|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694845|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
44694846|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694847|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694848|NCT01381796|Sumatriptan|sumatriptan|mesh-list
44694849|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44694850|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44694851|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44694852|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
44694853|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44694854|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694855|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694856|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
44694857|NCT01381809|Hematinics|hematinics|mesh-ancestor
44694858|NCT01381835|Simeprevir|simeprevir|mesh-list
44694859|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
44694860|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694861|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44694862|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694863|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246455|NCT03853187|Durvalumab|durvalumab|mesh-list
44694865|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694866|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811384|NCT02097264|Adalimumab|adalimumab|mesh-list
44811385|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811386|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811387|NCT02097316|Insulin|insulin|mesh-list
44811388|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44811389|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811390|NCT02097329|Palbociclib|palbociclib|mesh-list
44811391|NCT02097329|Rabeprazole|rabeprazole|mesh-list
44811392|NCT02097329|Famotidine|famotidine|mesh-list
44811393|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
44811394|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
44811395|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44811396|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44811397|NCT02097329|Antacids|antacids|mesh-list
44811398|NCT02097329|TEMPO|tempo|mesh-list
44811399|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811400|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44297867|NCT00814216|Xhance|xhance|mesh-list
44811401|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811402|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811403|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811404|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44811405|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44811406|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
44811407|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
44811408|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811409|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811410|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
44811411|NCT02097329|Protective Agents|protective agents|mesh-ancestor
44811412|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44811413|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
44811414|NCT02097342|Linagliptin|linagliptin|mesh-list
44811415|NCT02097342|Voglibose|voglibose|mesh-list
44811416|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44811417|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811418|NCT02097342|Incretins|incretins|mesh-ancestor
44811419|NCT02097342|Hormones|hormones|mesh-ancestor
44811420|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44811421|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44811422|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
44811423|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811424|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811425|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44811426|NCT02097381|Ritonavir|ritonavir|mesh-list
44811427|NCT02097381|Lopinavir|lopinavir|mesh-list
44811428|NCT02097381|Darunavir|darunavir|mesh-list
44811429|NCT02097381|Tenofovir|tenofovir|mesh-list
44811430|NCT02097381|Emtricitabine|emtricitabine|mesh-list
44811431|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44811432|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44811433|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44811434|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811435|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811436|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44811437|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44811438|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
44811439|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811440|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44811441|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44811442|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44811443|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44811444|NCT02097394|Pancreatin|pancreatin|mesh-list
44811445|NCT02097394|Pancrelipase|pancrelipase|mesh-list
44811446|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811447|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
44811448|NCT02097407|Propofol|propofol|mesh-list
44811449|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44811450|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811451|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811452|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44811453|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
44811454|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
44811455|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811456|NCT02097407|Analgesics|analgesics|mesh-ancestor
44811457|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
44811458|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811459|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44811460|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44811461|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44811462|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811463|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811464|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811465|NCT02097459|Tamoxifen|tamoxifen|mesh-list
44811466|NCT02097459|Toremifene|toremifene|mesh-list
44811467|NCT02097459|Anastrozole|anastrozole|mesh-list
44811468|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44811469|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
44811470|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44811471|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811472|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44811473|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811474|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44811475|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44811476|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811477|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44811478|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44811479|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811480|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811481|NCT02097511|Metoprolol|metoprolol|mesh-list
44811482|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
44811483|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44811484|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44811485|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
44811486|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
44811487|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811488|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811489|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44811490|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44811491|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44811492|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811493|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811494|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811495|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44811496|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44811497|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44811498|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44811499|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
44811500|NCT02097589|Atorvastatin|atorvastatin|mesh-list
44297971|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811501|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44811502|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
44811503|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811504|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44811505|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44811506|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
44811507|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811508|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44811509|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44811510|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811511|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
44811512|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44811513|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44811514|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811515|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
44811516|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811517|NCT02097810|Entrectinib|entrectinib|mesh-list
44811518|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44811519|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811520|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811521|NCT02097953|Rifampin|rifampin|mesh-list
44811522|NCT02097953|Daptomycin|daptomycin|mesh-list
44811523|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44811524|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
44811525|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811526|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811527|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
44811528|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44811529|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811530|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811531|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44811532|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44811533|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44694867|NCT01381887|Canagliflozin|canagliflozin|mesh-list
44811534|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44811535|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44811536|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44811537|NCT02097966|Ribavirin|ribavirin|mesh-list
44811538|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
44811539|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
44811540|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811541|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
44811542|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811543|NCT02098148|Xenon|xenon|mesh-list
44811544|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44811545|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
44811546|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
44297991|NCT00814866|Adalimumab|adalimumab|mesh-list
44811547|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811548|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811549|NCT02098317|Vitamin D|vitamin d|mesh-list
44811550|NCT02098317|Vitamins|vitamins|mesh-ancestor
44811551|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
44811552|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811553|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811554|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
44811555|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44811556|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44811557|NCT02098330|Prednisolone|prednisolone|mesh-list
44811558|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
44811559|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44811560|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
44811561|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811562|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
44811563|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
44811564|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811565|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811566|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811567|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
44811568|NCT02098330|Hormones|hormones|mesh-ancestor
44811569|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44811570|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44811571|NCT02098330|Protective Agents|protective agents|mesh-ancestor
44811572|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44811573|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811574|NCT02098421|Oxytocin|oxytocin|mesh-list
44811575|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
44811576|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44811577|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811578|NCT02098460|Cilostazol|cilostazol|mesh-list
44811579|NCT02098460|Atorvastatin|atorvastatin|mesh-list
44811580|NCT02098460|Probucol|probucol|mesh-list
44811581|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44811582|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44592567|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592568|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592569|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44592570|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44298044|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
44592571|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592572|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592573|NCT00856180|Growth Substances|growth substances|mesh-ancestor
44592574|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592575|NCT00855959|Budesonide|budesonide|mesh-list
44592576|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592577|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44592578|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
44592579|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592580|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592581|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44592582|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44592583|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
44592584|NCT00855959|Hormones|hormones|mesh-ancestor
44592585|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592586|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
44592587|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44592588|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592589|NCT00855920|Indomethacin|indomethacin|mesh-list
44592590|NCT00855920|Rilonacept|rilonacept|mesh-list
44592591|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44592592|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811583|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
44811584|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811585|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44811586|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44811587|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811588|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44811589|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
44298084|NCT00815269|Enflurane|enflurane|mesh-list
44811590|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811591|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811592|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44811593|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44811594|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44811595|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44811596|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44811597|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
44811598|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44811599|NCT02098460|Protective Agents|protective agents|mesh-ancestor
44811600|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44811601|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44811602|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
44811603|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
44811604|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
44811605|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44811606|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811607|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44811608|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44811609|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811610|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811611|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811612|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
44811613|NCT02098499|Promethazine|promethazine|mesh-list
44811614|NCT02098499|Haloperidol|haloperidol|mesh-list
44811615|NCT02098499|Metoclopramide|metoclopramide|mesh-list
44811616|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
44298115|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811617|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44811618|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44811619|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811620|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811621|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
44811622|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
44811623|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
44811624|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811625|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
44811626|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
44811627|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811628|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44811629|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
44811630|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
44811631|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811632|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811633|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44811634|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
44811635|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811636|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44811637|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44811638|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44811639|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44811640|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
44811641|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44811642|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44811643|NCT02098590|Chloroquine|chloroquine|mesh-list
44811644|NCT02098590|Atovaquone|atovaquone|mesh-list
44811645|NCT02098590|Proguanil|proguanil|mesh-list
44811646|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44811647|NCT02098590|Amebicides|amebicides|mesh-ancestor
44465253|NCT01479868|Interferons|interferons|mesh-list
44811648|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44811649|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44811650|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811651|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
44811652|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811653|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811654|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811655|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
44811656|NCT02098616|Asunaprevir|asunaprevir|mesh-list
44811657|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
44811658|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811659|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811660|NCT02098629|Milrinone|milrinone|mesh-list
44811662|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44811663|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44811664|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44811665|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811666|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811667|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811668|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811669|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44811670|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44811671|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44811672|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44811673|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44811674|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465264|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
44811675|NCT02098629|Protective Agents|protective agents|mesh-ancestor
44811676|NCT02098785|Caffeine|caffeine|mesh-list
44811677|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
44811678|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811679|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44811680|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811681|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44811682|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811683|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44811684|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44811685|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
44811686|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811687|NCT02098824|Methylphenidate|methylphenidate|mesh-list
44811688|NCT02098824|Galantamine|galantamine|mesh-list
44811689|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44811690|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811691|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44811692|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44811693|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44811694|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811695|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
44811696|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811697|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44811698|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811699|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
44811700|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44811701|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
44811702|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811703|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
44811704|NCT02098837|Dolutegravir|dolutegravir|mesh-list
44811705|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44811706|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44811707|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811708|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811709|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44811710|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44811711|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
44811712|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811713|NCT02098889|Scopolamine|scopolamine|mesh-list
44811714|NCT02098889|Bromides|bromides|mesh-list
44811715|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44811716|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
44811717|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44811718|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
44811719|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
44811720|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811721|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811722|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811723|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
44811724|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44811725|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
44811726|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811727|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811728|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44811729|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
44811730|NCT02098915|Metoclopramide|metoclopramide|mesh-list
44811731|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
44811732|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
44811733|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811734|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811735|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811736|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44811737|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44811738|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
44811739|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811740|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811741|NCT02098980|Vitamin D|vitamin d|mesh-list
44811742|NCT02098980|Vitamins|vitamins|mesh-ancestor
44811743|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
44811744|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811745|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811746|NCT02099136|Celecoxib|celecoxib|mesh-list
44811747|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44811748|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811749|NCT02099136|Analgesics|analgesics|mesh-ancestor
44811750|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
44811751|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811752|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811753|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811754|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811755|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44811756|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44811757|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298209|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
44811758|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811759|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44811760|NCT02099240|Amoxicillin|amoxicillin|mesh-list
44811761|NCT02099240|Azithromycin|azithromycin|mesh-list
44811762|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
44811763|NCT02099240|Vancomycin|vancomycin|mesh-list
44811764|NCT02099240|Clarithromycin|clarithromycin|mesh-list
44811765|NCT02099240|Doxycycline|doxycycline|mesh-list
44811766|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
44811767|NCT02099240|Levofloxacin|levofloxacin|mesh-list
44811768|NCT02099240|Ofloxacin|ofloxacin|mesh-list
44811769|NCT02099240|Minocycline|minocycline|mesh-list
44811770|NCT02099240|Rifampin|rifampin|mesh-list
44811771|NCT02099240|Clindamycin|clindamycin|mesh-list
44811772|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
44811773|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
44811774|NCT02099240|Gentamicins|gentamicins|mesh-list
44811775|NCT02099240|Isoniazid|isoniazid|mesh-list
44811776|NCT02099240|Meropenem|meropenem|mesh-list
44811777|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
44811778|NCT02099240|Tazobactam|tazobactam|mesh-list
44811779|NCT02099240|Linezolid|linezolid|mesh-list
44811780|NCT02099240|Cycloserine|cycloserine|mesh-list
44811781|NCT02099240|Piperacillin|piperacillin|mesh-list
44811782|NCT02099240|Metronidazole|metronidazole|mesh-list
44592765|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592766|NCT00854100|Cariprazine|cariprazine|mesh-list
44592767|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
44592768|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592769|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592770|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592771|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592772|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592773|NCT00853970|Bromfenac|bromfenac|mesh-list
44592774|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44592775|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44592776|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44592777|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44592778|NCT00853970|Analgesics|analgesics|mesh-ancestor
44592779|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
44592780|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592781|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592782|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592783|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592784|NCT00853957|Amlodipine|amlodipine|mesh-list
44592785|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44592786|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44811783|NCT02099240|Penicillins|penicillins|mesh-list
44811784|NCT02099240|Imipenem|imipenem|mesh-list
44811785|NCT02099240|Amikacin|amikacin|mesh-list
44811786|NCT02099240|Erythromycin|erythromycin|mesh-list
44811787|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
44811788|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44811789|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
44811790|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
44811791|NCT02099240|Ceftazidime|ceftazidime|mesh-list
44811792|NCT02099240|Colistin|colistin|mesh-list
44811793|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44811794|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
44811795|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
44811796|NCT02099240|Ampicillin|ampicillin|mesh-list
44811797|NCT02099240|Rifabutin|rifabutin|mesh-list
44811798|NCT02099240|Rifapentine|rifapentine|mesh-list
44811799|NCT02099240|Cefuroxime|cefuroxime|mesh-list
44811800|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
44811801|NCT02099240|Mupirocin|mupirocin|mesh-list
44811802|NCT02099240|Fosfomycin|fosfomycin|mesh-list
44811803|NCT02099240|Cefepime|cefepime|mesh-list
44811804|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44811805|NCT02099240|Paromomycin|paromomycin|mesh-list
44811806|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
44811807|NCT02099240|Polymyxins|polymyxins|mesh-list
44811808|NCT02099240|Aztreonam|aztreonam|mesh-list
44811809|NCT02099240|Neomycin|neomycin|mesh-list
44811810|NCT02099240|Sulbactam|sulbactam|mesh-list
44811811|NCT02099240|Bacitracin|bacitracin|mesh-list
44811812|NCT02099240|Cefotaxime|cefotaxime|mesh-list
44811813|NCT02099240|Cefoxitin|cefoxitin|mesh-list
44811814|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
44811815|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
44811816|NCT02099240|Polymyxin B|polymyxin b|mesh-list
44811817|NCT02099240|Cefixime|cefixime|mesh-list
44811818|NCT02099240|Cefdinir|cefdinir|mesh-list
44811819|NCT02099240|Penicillin G|penicillin g|mesh-list
44298317|NCT00816634|Paclitaxel|paclitaxel|mesh-list
44811820|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44811821|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
44811822|NCT02099240|Cloxacillin|cloxacillin|mesh-list
44811823|NCT02099240|Norfloxacin|norfloxacin|mesh-list
44811824|NCT02099240|Cefprozil|cefprozil|mesh-list
44811825|NCT02099240|Cephalosporins|cephalosporins|mesh-list
44811826|NCT02099240|Oxacillin|oxacillin|mesh-list
44811827|NCT02099240|Streptomycin|streptomycin|mesh-list
44811828|NCT02099240|Nafcillin|nafcillin|mesh-list
44811829|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
44811830|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
44811831|NCT02099240|Ticarcillin|ticarcillin|mesh-list
44811832|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
44811833|NCT02099240|Cefoperazone|cefoperazone|mesh-list
44811834|NCT02099240|Sultamicillin|sultamicillin|mesh-list
44811835|NCT02099240|Penicillin V|penicillin v|mesh-list
44811836|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
44811837|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
44811838|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
44811839|NCT02099240|Ethionamide|ethionamide|mesh-list
44811840|NCT02099240|Kanamycin|kanamycin|mesh-list
44811841|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44811842|NCT02099240|Ceftibuten|ceftibuten|mesh-list
44811843|NCT02099240|Lincomycin|lincomycin|mesh-list
44811844|NCT02099240|Dirithromycin|dirithromycin|mesh-list
44811845|NCT02099240|Cefotetan|cefotetan|mesh-list
44811846|NCT02099240|Demeclocycline|demeclocycline|mesh-list
44811847|NCT02099240|Capreomycin|capreomycin|mesh-list
44811848|NCT02099240|Cefaclor|cefaclor|mesh-list
44811849|NCT02099240|Mafenide|mafenide|mesh-list
44811850|NCT02099240|Tobramycin|tobramycin|mesh-list
44811851|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
44811852|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44811853|NCT02099240|Netilmicin|netilmicin|mesh-list
44811854|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
44811855|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
44811856|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
44811857|NCT02099240|Novobiocin|novobiocin|mesh-list
44811858|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
44811859|NCT02099240|Virginiamycin|virginiamycin|mesh-list
44811860|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44811861|NCT02099240|Methicillin|methicillin|mesh-list
44811862|NCT02099240|Enoxacin|enoxacin|mesh-list
44811863|NCT02099240|Bacampicillin|bacampicillin|mesh-list
44811864|NCT02099240|Carbenicillin|carbenicillin|mesh-list
44811865|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
44811866|NCT02099240|Mezlocillin|mezlocillin|mesh-list
44811867|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
44811868|NCT02099240|Cefamandole|cefamandole|mesh-list
44811869|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
44811870|NCT02099240|Cefonicid|cefonicid|mesh-list
44811871|NCT02099240|Cefmetazole|cefmetazole|mesh-list
44811872|NCT02099240|Loracarbef|loracarbef|mesh-list
44811873|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
44811874|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
44811875|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
44811876|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
44811877|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
44811878|NCT02099240|Methacycline|methacycline|mesh-list
44811879|NCT02099240|Tetracycline|tetracycline|mesh-list
44811880|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
44298345|NCT00816712|Hormones|hormones|mesh-ancestor
44811881|NCT02099240|Dalfopristin|dalfopristin|mesh-list
44811882|NCT02099240|Spectinomycin|spectinomycin|mesh-list
44811883|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44811884|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
44811885|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
44811886|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44811887|NCT02099240|Methenamine|methenamine|mesh-list
44811888|NCT02099240|Sulperazone|sulperazone|mesh-list
44811889|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
44811890|NCT02099240|Cinoxacin|cinoxacin|mesh-list
44811891|NCT02099240|Trimethoprim|trimethoprim|mesh-list
44811892|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
44811893|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
44811894|NCT02099240|Procaine|procaine|mesh-list
44811895|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44811896|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44811897|NCT02099240|Cilastatin|cilastatin|mesh-list
44811898|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811899|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
44811900|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44811901|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44811902|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811903|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811904|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811905|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44811906|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
44811907|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44811908|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811909|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44811910|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44811911|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44811912|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44811913|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44811914|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44811915|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
44811916|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44811917|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44811918|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44811919|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44811920|NCT02099240|Renal Agents|renal agents|mesh-ancestor
44811921|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
44811922|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44811923|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44811924|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44811925|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44811926|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44811927|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44811928|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44811929|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44811930|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44811931|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
44811932|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44811933|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44811934|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44811935|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44811936|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811937|NCT02099240|Analgesics|analgesics|mesh-ancestor
44811938|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
44811939|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811940|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44811941|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811942|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
44811943|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44811944|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44811945|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44811946|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
44811947|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
44811948|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
44811949|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811950|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44811951|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44811952|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44811953|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44811954|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
44811955|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
44811956|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44811957|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811958|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811959|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44811960|NCT02099253|Analgesics|analgesics|mesh-ancestor
44811961|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
44811962|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44811963|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44811964|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44811965|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44811966|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44811967|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44811968|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811969|NCT02099292|Rituximab|rituximab|mesh-list
44811970|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44811971|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811972|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
44811973|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811974|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44811975|NCT02099331|Melatonin|melatonin|mesh-list
44811976|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
44298429|NCT00817011|Sertraline|sertraline|mesh-list
44811977|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811978|NCT02099331|Protective Agents|protective agents|mesh-ancestor
44811979|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811980|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44811981|NCT02099357|Vitamin D|vitamin d|mesh-list
44811982|NCT02099357|Vitamins|vitamins|mesh-ancestor
44811983|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
44811984|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811985|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44811986|NCT02099396|Gemcitabine|gemcitabine|mesh-list
44811987|NCT02099396|Docetaxel|docetaxel|mesh-list
44811988|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44811989|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
44811990|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44811991|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44811992|NCT02099396|Antiviral Agents|antiviral agents|mesh-ancestor
44811993|NCT02099396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44811994|NCT02099396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44811995|NCT02099396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44811996|NCT02099396|Immunologic Factors|immunologic factors|mesh-ancestor
44811997|NCT02099396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44811998|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
44811999|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
44812000|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
44812001|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
44812002|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44812003|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44812004|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
44812005|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812006|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44812007|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44812008|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812009|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592936|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592937|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592938|NCT00852397|Apixaban|apixaban|mesh-list
44592939|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44592940|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
44592941|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44592942|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592943|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592944|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592945|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
44592946|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
44592947|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44592948|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
44592949|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592950|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
44592951|NCT00852241|Protective Agents|protective agents|mesh-ancestor
44592952|NCT00852202|Cariprazine|cariprazine|mesh-list
44592953|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592954|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592955|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592956|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592958|NCT00851903|Metformin|metformin|mesh-list
44812011|NCT02099604|Interferons|interferons|mesh-list
44812012|NCT02099604|Ribavirin|ribavirin|mesh-list
44812013|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
44812014|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
44812015|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44812016|NCT02099604|Vitamins|vitamins|mesh-ancestor
44812017|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
44812018|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812019|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44812020|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812021|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
44812022|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298496|NCT00817284|Irinotecan|irinotecan|mesh-list
44812023|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
44812024|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812025|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
44812026|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
44812027|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44812028|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44812029|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812030|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812031|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812032|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812033|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
44812034|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
44812035|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812036|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
44812037|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44812038|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812039|NCT02099695|Oxybutynin|oxybutynin|mesh-list
44812040|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
44812041|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
44812042|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812043|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812044|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44812045|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44812046|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
44812047|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812048|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812049|NCT02099695|Urological Agents|urological agents|mesh-ancestor
44812050|NCT02099825|Cycloserine|cycloserine|mesh-list
44812051|NCT02099825|Mifepristone|mifepristone|mesh-list
44812052|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44812053|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
44812054|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812055|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812056|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44812057|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812058|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812059|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812060|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44812061|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44812062|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
44812063|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812064|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
44812065|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812066|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44812067|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44812068|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812069|NCT02099825|Renal Agents|renal agents|mesh-ancestor
44812070|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44812071|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
44812072|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44812073|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
44812074|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812075|NCT02099877|Fentanyl|fentanyl|mesh-list
44812076|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44812077|NCT02099877|Narcotics|narcotics|mesh-ancestor
44812078|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812079|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812080|NCT02099877|Analgesics|analgesics|mesh-ancestor
44812081|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
44812082|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812083|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44812084|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44812085|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
44812086|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
44812087|NCT02099890|Curcumin|curcumin|mesh-list
44812088|NCT02099890|Antioxidants|antioxidants|mesh-list
44812089|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812090|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812091|NCT02099890|Analgesics|analgesics|mesh-ancestor
44812092|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
44812093|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812094|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465302|NCT01479530|Rasagiline|rasagiline|mesh-list
44812095|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812096|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812097|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812098|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812099|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812100|NCT02099890|Protective Agents|protective agents|mesh-ancestor
44812101|NCT02099916|Menotropins|menotropins|mesh-list
44812102|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812103|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44812104|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
44812105|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812106|NCT02099955|Vitamin D|vitamin d|mesh-list
44812107|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
44812108|NCT02099955|Vitamins|vitamins|mesh-ancestor
44812109|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
44812110|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812111|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44694868|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44694869|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694870|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44694871|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694872|NCT01382004|Azithromycin|azithromycin|mesh-list
44694873|NCT01382004|Penicillins|penicillins|mesh-list
44694874|NCT01382004|Penicillin G|penicillin g|mesh-list
44694875|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44694876|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
44694877|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44694878|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694879|NCT01382017|Lacosamide|lacosamide|mesh-list
44694880|NCT01382017|Carbamazepine|carbamazepine|mesh-list
44694881|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
44694882|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44694883|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44694884|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44694885|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694886|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
44694887|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44694888|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44694889|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694890|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44694891|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694892|NCT01382017|Analgesics|analgesics|mesh-ancestor
44694893|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
44694894|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694895|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44694896|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44694897|NCT01382134|Aspirin|aspirin|mesh-list
44694898|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44694899|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44694900|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44694901|NCT01382134|Analgesics|analgesics|mesh-ancestor
44298553|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
44694902|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
44694903|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694904|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694905|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694906|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694907|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44694908|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44694909|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694910|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44694911|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44694912|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694913|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
44694914|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
44694915|NCT01382134|Coagulants|coagulants|mesh-ancestor
44812112|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812113|NCT02099981|Pimagedine|pimagedine|mesh-list
44812114|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812115|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812116|NCT02100046|Ethosuximide|ethosuximide|mesh-list
44812117|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
44812118|NCT02100176|Dopamine|dopamine|mesh-list
44812119|NCT02100176|Rotigotine|rotigotine|mesh-list
44812120|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
44812121|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
44812122|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812123|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298606|NCT00817661|Vitamins|vitamins|mesh-ancestor
44298607|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
44812124|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812125|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44812126|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
44812127|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
44812128|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812129|NCT02100176|Protective Agents|protective agents|mesh-ancestor
44812130|NCT02100202|Turmeric extract|turmeric extract|mesh-list
44812131|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
44812132|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812133|NCT02100202|Protective Agents|protective agents|mesh-ancestor
44812134|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812135|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
44812136|NCT02100267|Miotics|miotics|mesh-ancestor
44812137|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
44812138|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812139|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812140|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44812141|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44812142|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812143|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44812144|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44812145|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
44812146|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812147|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812148|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
44812149|NCT02100293|Analgesics|analgesics|mesh-ancestor
44812150|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
44812151|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812152|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812153|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
44812154|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812155|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44812156|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
44812157|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298633|NCT00817739|Flutamide|flutamide|mesh-list
44298634|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44812158|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812159|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812160|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812161|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
44812162|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812163|NCT02100423|Vitamin D|vitamin d|mesh-list
44812164|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
44812165|NCT02100423|Curcumin|curcumin|mesh-list
44812166|NCT02100423|Vitamins|vitamins|mesh-ancestor
44812167|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
44812168|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812169|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44812170|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812171|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812172|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812173|NCT02100423|Analgesics|analgesics|mesh-ancestor
44812174|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
44812175|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812176|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812177|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812178|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812179|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812180|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812181|NCT02100462|Aspirin|aspirin|mesh-list
44593095|NCT00850460|Atorvastatin|atorvastatin|mesh-list
44812182|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44812183|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
44812184|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812185|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812186|NCT02100462|Analgesics|analgesics|mesh-ancestor
44812187|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
44812188|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812189|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812190|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812191|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812192|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44812193|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44812194|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298668|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812195|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44812196|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44812197|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812198|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
44812199|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44812200|NCT02100462|Diuretics|diuretics|mesh-ancestor
44812201|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
44812202|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44812203|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812204|NCT02100488|Insulin|insulin|mesh-list
44812205|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44812206|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44812207|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812208|NCT02100553|Itraconazole|itraconazole|mesh-list
44812209|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44812210|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
44812211|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812212|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44812213|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44812214|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812215|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812216|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44812217|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44812218|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812219|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812220|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44812221|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
44812222|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
44812223|NCT02100605|Ephedrine|ephedrine|mesh-list
44812224|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44812225|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812226|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44812227|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812228|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
44812229|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
44812230|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812231|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812232|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812233|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812234|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44812235|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44812236|NCT02100761|Voriconazole|voriconazole|mesh-list
44812237|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
44812238|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812239|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44812240|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44812241|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812242|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812243|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44812244|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44812245|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812246|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812247|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44812248|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44812249|NCT02100787|Laxatives|laxatives|mesh-ancestor
44812250|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812251|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
44812252|NCT02100852|Chlorambucil|chlorambucil|mesh-list
44812253|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44812254|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812255|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44812256|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
44812257|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812258|NCT02100917|Trastuzumab|trastuzumab|mesh-list
44812259|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44812260|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812261|NCT02101047|Phenylephrine|phenylephrine|mesh-list
44812262|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
44812263|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44812264|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
44812265|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
44812266|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812267|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812268|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
44812269|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44812270|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
44812271|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812272|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44812273|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44812274|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44812275|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812276|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812277|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593242|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812278|NCT02101047|Protective Agents|protective agents|mesh-ancestor
44812279|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44812280|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44812281|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44812282|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
44298776|NCT00818610|Amoxicillin|amoxicillin|mesh-list
44812283|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812284|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44812285|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44812286|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812287|NCT02101138|Pramipexole|pramipexole|mesh-list
44812288|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
44812289|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812290|NCT02101138|Protective Agents|protective agents|mesh-ancestor
44812291|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812292|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44812293|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44812294|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
44812295|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
44812296|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812297|NCT02101151|Vitamin D|vitamin d|mesh-list
44812298|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
44812299|NCT02101151|Vitamins|vitamins|mesh-ancestor
44812300|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
44593243|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812301|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593244|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593245|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593246|NCT00848549|Analgesics|analgesics|mesh-ancestor
44593247|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
44593248|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593249|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44593250|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593251|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593252|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44593253|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44593254|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44593255|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44593256|NCT00848536|Travoprost|travoprost|mesh-list
44593257|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44593258|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44593259|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593260|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
44593261|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
44593262|NCT00848497|Testosterone|testosterone|mesh-list
44593263|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
44593264|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
44812302|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44812303|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812305|NCT02101164|Pamidronate|pamidronate|mesh-list
44812306|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44812307|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812308|NCT02101203|Buspirone|buspirone|mesh-list
44812309|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44812310|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44812311|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812312|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812313|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812314|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44812315|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
44812316|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812317|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812318|NCT02101216|Abacavir|abacavir|mesh-list
44812319|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
44812320|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44812321|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44812322|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812323|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812324|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
44812325|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812326|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44812327|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44812328|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
44812329|NCT02101229|Insulin|insulin|mesh-list
44812330|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44812331|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44812332|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812333|NCT02101255|Fluorides|fluorides|mesh-list
44812334|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
44812335|NCT02101255|Protective Agents|protective agents|mesh-ancestor
44298842|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812336|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812337|NCT02101476|Acetaminophen|acetaminophen|mesh-list
44812338|NCT02101476|Oxycodone|oxycodone|mesh-list
44812339|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812340|NCT02101476|Analgesics|analgesics|mesh-ancestor
44812341|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
44812342|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812343|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812344|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
44812345|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44812346|NCT02101476|Narcotics|narcotics|mesh-ancestor
44812347|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812348|NCT02101567|Oxytocin|oxytocin|mesh-list
44812349|NCT02101567|Carbetocin|carbetocin|mesh-list
44812350|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
44812351|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812352|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812353|NCT02101606|Tenecteplase|tenecteplase|mesh-list
44812354|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44812355|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44812356|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812357|NCT02101632|Petrolatum|petrolatum|mesh-list
44812358|NCT02101632|Emollients|emollients|mesh-ancestor
44812359|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
44812360|NCT02101710|Isosorbide|isosorbide|mesh-list
44812361|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44812362|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44812363|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44812364|NCT02101710|Diuretics|diuretics|mesh-ancestor
44812365|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
44812366|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812367|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
44812368|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44812369|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812370|NCT02101840|Oxycodone|oxycodone|mesh-list
44812371|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44812372|NCT02101840|Narcotics|narcotics|mesh-ancestor
44812373|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298873|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812374|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812375|NCT02101840|Analgesics|analgesics|mesh-ancestor
44593297|NCT00848393|Narcotics|narcotics|mesh-ancestor
44812376|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
44812377|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812378|NCT02101892|Amitriptyline|amitriptyline|mesh-list
44812379|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44812380|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44812381|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812382|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812383|NCT02101892|Analgesics|analgesics|mesh-ancestor
44812384|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
44812385|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812386|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812387|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44812388|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44812389|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812390|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812391|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812392|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812393|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44812394|NCT02101931|Levulinic acid|levulinic acid|mesh-list
44812395|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44812396|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44812397|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812398|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812399|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44812400|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44812401|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44812402|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44812403|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812404|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812405|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44812406|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44812407|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
44812408|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812409|NCT02102139|Propofol|propofol|mesh-list
44812410|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44812411|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812412|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812413|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44812414|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
44812415|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
44812416|NCT02102152|Tobramycin|tobramycin|mesh-list
44812417|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44812418|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812419|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
44812420|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
44812421|NCT02102295|Fluorides|fluorides|mesh-list
44812422|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
44812423|NCT02102295|Protective Agents|protective agents|mesh-ancestor
44812424|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812425|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
44812426|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812427|NCT02102295|Vitamins|vitamins|mesh-ancestor
44812428|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
44812429|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812430|NCT02102321|Albendazole|albendazole|mesh-list
44812431|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
44812432|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44812433|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812434|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
44812435|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44812436|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44812437|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
44812438|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
44812439|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
44812440|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812441|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812442|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44812443|NCT02102373|Laxatives|laxatives|mesh-ancestor
44812444|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812445|NCT02102438|Paclitaxel|paclitaxel|mesh-list
44812446|NCT02102438|Carboplatin|carboplatin|mesh-list
44812447|NCT02102438|Trastuzumab|trastuzumab|mesh-list
44812448|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44812449|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812450|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
44812451|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
44812452|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
44812453|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812454|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44812456|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44812457|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812458|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812459|NCT02102516|Analgesics|analgesics|mesh-ancestor
44812460|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
44812461|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812462|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812463|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812464|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812465|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44812466|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298942|NCT00819754|Bevacizumab|bevacizumab|mesh-list
44812467|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812468|NCT02102555|Acetaminophen|acetaminophen|mesh-list
44812469|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812470|NCT02102555|Analgesics|analgesics|mesh-ancestor
44812471|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
44812472|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812473|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812474|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
44812475|NCT02102594|Bortezomib|bortezomib|mesh-list
44812476|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812477|NCT02102620|Lidocaine|lidocaine|mesh-list
44812478|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44812479|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
44812480|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812481|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812482|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
44812483|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812484|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44812485|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44812486|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44812487|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812488|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812489|NCT02102633|Dabigatran|dabigatran|mesh-list
44812490|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
44812491|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44812492|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
44812493|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812494|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812495|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
44812496|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44812497|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
44812498|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812499|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812500|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812501|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812502|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812503|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812504|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812505|NCT02102672|Trimetazidine|trimetazidine|mesh-list
44812506|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
44812507|NCT02102698|Ecopipam|ecopipam|mesh-list
44812508|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44812509|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44812510|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812511|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812512|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812513|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44812514|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
44812515|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812516|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812517|NCT02102711|Vitamin A|vitamin a|mesh-list
44812518|NCT02102711|Vitamins|vitamins|mesh-ancestor
44812519|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
44812520|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812521|NCT02102776|Mitomycins|mitomycins|mesh-list
44812522|NCT02102776|Mitomycin|mitomycin|mesh-list
44812523|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44812524|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812525|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
44812526|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812527|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44812528|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812529|NCT02102789|Leucovorin|leucovorin|mesh-list
44812530|NCT02102789|Dexamethasone|dexamethasone|mesh-list
44812531|NCT02102789|Fluorouracil|fluorouracil|mesh-list
44812532|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
44812533|NCT02102789|Floxuridine|floxuridine|mesh-list
44812534|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812535|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
44812536|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
44812537|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812538|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812539|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812540|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
44812541|NCT02102789|Hormones|hormones|mesh-ancestor
44812542|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812543|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812544|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812545|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812546|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
44812547|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44812548|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44812549|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
44812550|NCT02102789|Antidotes|antidotes|mesh-ancestor
44812551|NCT02102789|Protective Agents|protective agents|mesh-ancestor
44812552|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
44812553|NCT02102789|Vitamins|vitamins|mesh-ancestor
44812554|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
44812555|NCT02102815|Dexamethasone|dexamethasone|mesh-list
44812556|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812557|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
44812558|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
44812559|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812560|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299060|NCT00820417|Cetuximab|cetuximab|mesh-list
44812561|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812562|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
44812563|NCT02102815|Hormones|hormones|mesh-ancestor
44812564|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812565|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812566|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812567|NCT02102828|Aspirin|aspirin|mesh-list
44812568|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812569|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812570|NCT02102828|Analgesics|analgesics|mesh-ancestor
44812571|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
44812572|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812573|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812574|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812575|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812576|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44812577|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44812578|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812579|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44812580|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44812581|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812582|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
44593518|NCT00845832|Rituximab|rituximab|mesh-list
44812584|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44812585|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
44812586|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812587|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44812588|NCT02102971|Liver Extracts|liver extracts|mesh-list
44812589|NCT02102971|Hematinics|hematinics|mesh-ancestor
44812590|NCT02103023|Imiquimod|imiquimod|mesh-list
44812591|NCT02103023|Vaccines|vaccines|mesh-list
44812592|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
44812593|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812594|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44812595|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812596|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
44812597|NCT02103049|Ezetimibe|ezetimibe|mesh-list
44812598|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44812599|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44812600|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
44812601|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812602|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44812603|NCT02103166|Scopolamine|scopolamine|mesh-list
44812604|NCT02103166|Bromides|bromides|mesh-list
44812605|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
44812606|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44812607|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
44812608|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
44812609|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812610|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812611|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812612|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
44812613|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44812614|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
44812615|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812616|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812617|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44812618|NCT02103192|Antioxidants|antioxidants|mesh-list
44812619|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812620|NCT02103192|Protective Agents|protective agents|mesh-ancestor
44812621|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812622|NCT02103205|Iron|iron|mesh-list
44812623|NCT02103205|Lactoferrin|lactoferrin|mesh-list
44812624|NCT02103205|Trace Elements|trace elements|mesh-ancestor
44812625|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
44812626|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299106|NCT00820690|Paclitaxel|paclitaxel|mesh-list
44812627|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812628|NCT02103244|Carboplatin|carboplatin|mesh-list
44812629|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812630|NCT02103335|Dexamethasone|dexamethasone|mesh-list
44812631|NCT02103335|Pomalidomide|pomalidomide|mesh-list
44812632|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812633|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
44812634|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
44812635|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812636|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812637|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812638|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
44812639|NCT02103335|Hormones|hormones|mesh-ancestor
44812640|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812641|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812642|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593589|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593590|NCT00844857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44593591|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44593592|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593593|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079814|NCT05051891|Prednisone|prednisone|mesh-list
44593594|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593595|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
44593596|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44593597|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
44593598|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44593599|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44593600|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593601|NCT00844844|Eculizumab|eculizumab|mesh-list
44593602|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44593603|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44812643|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
44812644|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44812645|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44812646|NCT02103335|Growth Substances|growth substances|mesh-ancestor
44812647|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
44812648|NCT02103361|Ustekinumab|ustekinumab|mesh-list
44812649|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44812650|NCT02103374|Terbutaline|terbutaline|mesh-list
44812651|NCT02103374|Ipratropium|ipratropium|mesh-list
44812652|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44812653|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
44812654|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812655|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812656|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44812657|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812658|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44812659|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
44812660|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812661|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812662|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
44812663|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
44812664|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812665|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44812666|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44812667|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44812668|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812669|NCT02103465|Rotigotine|rotigotine|mesh-list
44812670|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
44812671|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
44812672|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812673|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812674|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812675|NCT02103556|Mineral Oil|mineral oil|mesh-list
44812676|NCT02103556|Emollients|emollients|mesh-ancestor
44812677|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44812678|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44812679|NCT02103569|Norethindrone|norethindrone|mesh-list
44812680|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
44812681|NCT02103569|Estradiol|estradiol|mesh-list
44812682|NCT02103569|Asunaprevir|asunaprevir|mesh-list
44812683|NCT02103569|Estrogens|estrogens|mesh-ancestor
44812684|NCT02103569|Hormones|hormones|mesh-ancestor
44812685|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812686|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812687|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812688|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812689|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812690|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812691|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44812692|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812693|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44812694|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44812695|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812696|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812697|NCT02103647|Pregabalin|pregabalin|mesh-list
44812698|NCT02103647|Analgesics|analgesics|mesh-ancestor
44812699|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
44812700|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812701|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812702|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
44812703|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44812704|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812705|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812706|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812707|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44812708|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44812709|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812710|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812711|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44812712|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
44812713|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
44812714|NCT02103660|Progestins|progestins|mesh-list
44812715|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812716|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593606|NCT00844831|Lubiprostone|lubiprostone|mesh-list
44812717|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44812718|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812719|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812720|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812721|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44812722|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44812723|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812724|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812725|NCT02103660|Hormones|hormones|mesh-ancestor
44812726|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812727|NCT02103686|Pregabalin|pregabalin|mesh-list
44812728|NCT02103686|Analgesics|analgesics|mesh-ancestor
44812729|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
44812730|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812731|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812732|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
44812733|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44812734|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812735|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812736|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44812737|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44812738|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44812739|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812740|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812741|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
44812742|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44812743|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44812744|NCT02103725|Analgesics|analgesics|mesh-ancestor
44812745|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
44812746|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812747|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812748|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812749|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44812750|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44812751|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44812752|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
44812753|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44812754|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812755|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812756|NCT02103738|Ranibizumab|ranibizumab|mesh-list
44812757|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44812758|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44812759|NCT02103738|Growth Substances|growth substances|mesh-ancestor
44812760|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812761|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
44812762|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812763|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44812764|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
44812765|NCT02103764|Desogestrel|desogestrel|mesh-list
44812766|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44694916|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44694917|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
44694918|NCT01382147|Daunorubicin|daunorubicin|mesh-list
44694919|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
44694920|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44694921|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694922|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44694923|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44694924|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694925|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694926|NCT01382147|Analgesics|analgesics|mesh-ancestor
44694927|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
44694928|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44694929|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694930|NCT01382160|Adalimumab|adalimumab|mesh-list
44694931|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44694932|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44694933|NCT01382199|Lactoferrin|lactoferrin|mesh-list
44694934|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44694935|NCT01382238|Dolutegravir|dolutegravir|mesh-list
44694936|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44694937|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44694938|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246486|NCT03832998|Erenumab|erenumab|mesh-list
44694942|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
44694943|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812767|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812768|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812769|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812770|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812771|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812772|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812773|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44812774|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44812775|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812776|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812777|NCT02103764|Progestins|progestins|mesh-ancestor
44812778|NCT02103764|Hormones|hormones|mesh-ancestor
44812779|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812780|NCT02103777|Caffeine|caffeine|mesh-list
44812781|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
44812782|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299211|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
44812783|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44812784|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812785|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44812786|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812787|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44812788|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44812789|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
44812790|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812791|NCT02103881|Ketamine|ketamine|mesh-list
44812792|NCT02103881|Haloperidol|haloperidol|mesh-list
44812793|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
44812794|NCT02103881|Analgesics|analgesics|mesh-ancestor
44812795|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
44812796|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812797|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812798|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44812799|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44812800|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
44812801|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
44812802|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812803|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44812804|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44812805|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812806|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812807|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
44812808|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
44812809|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812810|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44812811|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44812812|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812813|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44812814|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
44812815|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44812816|NCT02103998|Iodine|iodine|mesh-list
44812817|NCT02103998|Hormones|hormones|mesh-list
44812818|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812819|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812820|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44812821|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812822|NCT02103998|Trace Elements|trace elements|mesh-ancestor
44812823|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
44812824|NCT02104011|Propranolol|propranolol|mesh-list
44812825|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44812826|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44812827|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812828|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812829|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812830|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812831|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44812832|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44812833|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44812834|NCT02104128|Bupropion|bupropion|mesh-list
44812835|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44812836|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44812837|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44812838|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44812839|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44812840|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812841|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812842|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
44812843|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812844|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812845|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44812846|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44812847|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812848|NCT02104193|Simvastatin|simvastatin|mesh-list
44812849|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44812850|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44812851|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
44812852|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812853|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44812854|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44812855|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812856|NCT02104284|Mannitol|mannitol|mesh-list
44812857|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
44812858|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44812859|NCT02104284|Diuretics|diuretics|mesh-ancestor
44812860|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
44812861|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812862|NCT02104284|Miotics|miotics|mesh-ancestor
44812863|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
44812864|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812865|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44812866|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44812867|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812868|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44812869|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44812870|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
44812871|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812872|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812873|NCT02104297|Remifentanil|remifentanil|mesh-list
44812874|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44812875|NCT02104297|Narcotics|narcotics|mesh-ancestor
44812876|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812877|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812878|NCT02104297|Analgesics|analgesics|mesh-ancestor
44812879|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
44812880|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812881|NCT02104323|Endostatins|endostatins|mesh-list
44812882|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812883|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44812884|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44812885|NCT02104323|Growth Substances|growth substances|mesh-ancestor
44812886|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812887|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593803|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
44593804|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593805|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44593808|NCT00842985|Hormones|hormones|mesh-ancestor
44812888|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
44812889|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812890|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812891|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812892|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812893|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812894|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44812895|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812896|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
44812897|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44299326|NCT00822029|Alendronate|alendronate|mesh-list
44812898|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44812899|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812900|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44812901|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44812902|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812903|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812904|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812905|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44812906|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
44812907|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44812908|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812909|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44812910|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44812911|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44812912|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
44812913|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
44812914|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44812915|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44812916|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44812917|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812918|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44812919|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44812920|NCT02104674|Montelukast|montelukast|mesh-list
44812921|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44812922|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812923|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44812924|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
44812925|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812926|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812927|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44812928|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44812929|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812930|NCT02104700|Tenofovir|tenofovir|mesh-list
44812931|NCT02104700|Emtricitabine|emtricitabine|mesh-list
44812932|NCT02104700|Rilpivirine|rilpivirine|mesh-list
44812933|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
44812934|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44812935|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44812936|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44812937|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812938|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812939|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44812940|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44812941|NCT02104778|Dexamethasone|dexamethasone|mesh-list
44812942|NCT02104778|Epinephrine|epinephrine|mesh-list
44812943|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44812944|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
44812945|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
44812946|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812947|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812948|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44812949|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
44812950|NCT02104778|Hormones|hormones|mesh-ancestor
44812951|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44812952|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44812953|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44812954|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44812955|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44812956|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44812957|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44812958|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593876|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
44812959|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44812960|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44812961|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44812962|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
44812963|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
44812964|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
44812965|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44812966|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44812967|NCT02104843|Asunaprevir|asunaprevir|mesh-list
44812968|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44812969|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44812970|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
44299403|NCT00822263|Antidotes|antidotes|mesh-ancestor
44812971|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812972|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44812973|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44812974|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812975|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
44812976|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
44812977|NCT02105077|Anesthetics|anesthetics|mesh-list
44812978|NCT02105077|Xenon|xenon|mesh-list
44812979|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812980|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812981|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44812982|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
44812983|NCT02105090|Anesthetics|anesthetics|mesh-list
44812984|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
44812985|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44812986|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812987|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44812988|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
44812989|NCT02105103|Insulin|insulin|mesh-list
44812990|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44812991|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812992|NCT02105155|Tacrolimus|tacrolimus|mesh-list
44812993|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44812994|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
44812995|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44812996|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44812997|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44812998|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44812999|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44813000|NCT02105311|Travoprost|travoprost|mesh-list
44813001|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44813002|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44813003|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813004|NCT02105350|Gemcitabine|gemcitabine|mesh-list
44813005|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
44813006|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44813007|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
44813008|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813009|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813010|NCT02105350|Antiviral Agents|antiviral agents|mesh-ancestor
44299445|NCT00822419|Ketamine|ketamine|mesh-list
44813011|NCT02105350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813012|NCT02105350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813013|NCT02105350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813014|NCT02105350|Immunologic Factors|immunologic factors|mesh-ancestor
44813015|NCT02105350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813016|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
44813017|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
44813018|NCT02105610|Anesthetics|anesthetics|mesh-list
44813019|NCT02105610|Sevoflurane|sevoflurane|mesh-list
44813020|NCT02105610|Desflurane|desflurane|mesh-list
44813021|NCT02105610|Isoflurane|isoflurane|mesh-list
44813022|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44813023|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813024|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813025|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813026|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44813027|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
44813028|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44813029|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44813030|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694944|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44813031|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
44813032|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813033|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44813034|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44813035|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813037|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813038|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813039|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813040|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813041|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813042|NCT02105714|Formaldehyde|formaldehyde|mesh-list
44813043|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
44813044|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813045|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44813046|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44813047|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813048|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44299484|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
44813049|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813050|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
44813051|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813052|NCT02105870|Abciximab|abciximab|mesh-list
44813053|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
44813054|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813055|NCT02106104|Glimepiride|glimepiride|mesh-list
44813056|NCT02106104|Linagliptin|linagliptin|mesh-list
44813057|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813058|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44813059|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813060|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813061|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
44813062|NCT02106104|Incretins|incretins|mesh-ancestor
44813063|NCT02106104|Hormones|hormones|mesh-ancestor
44813064|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813065|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44813066|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
44813067|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813068|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813069|NCT02106130|Rebamipide|rebamipide|mesh-list
44813070|NCT02106130|Mosapride|mosapride|mesh-list
44813071|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813072|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44813073|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813074|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
44813075|NCT02106130|Protective Agents|protective agents|mesh-ancestor
44813076|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813077|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813078|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44813079|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
44813080|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813081|NCT02106182|Silodosin|silodosin|mesh-list
44813082|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44813083|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44813084|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44813085|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813086|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299523|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813087|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813088|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813089|NCT02106182|Urological Agents|urological agents|mesh-ancestor
44594020|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813090|NCT02106286|Bisoprolol|bisoprolol|mesh-list
44813091|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44813092|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
44813093|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
44813094|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813095|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813096|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44813097|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44813098|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44813099|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813100|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813101|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813102|NCT02106364|Insulin|insulin|mesh-list
44813103|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44813104|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
44813105|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44813106|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813107|NCT02106468|Prednisone|prednisone|mesh-list
44813108|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813109|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
44813110|NCT02106468|Hormones|hormones|mesh-ancestor
44813111|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813112|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813113|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44813114|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813115|NCT02106481|Ropivacaine|ropivacaine|mesh-list
44813116|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813117|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
44813118|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813119|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813120|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
44813121|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813122|NCT02106507|Everolimus|everolimus|mesh-list
44813123|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813124|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813125|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
44813126|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813127|NCT02106520|Bevacizumab|bevacizumab|mesh-list
44299565|NCT00823004|Letrozole|letrozole|mesh-list
44813128|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44813129|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813130|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44813131|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44813132|NCT02106520|Growth Substances|growth substances|mesh-ancestor
44813133|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813134|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
44813135|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44813136|NCT02106559|Trioxsalen|trioxsalen|mesh-list
44813137|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813138|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813139|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44813140|NCT02106637|Varenicline|varenicline|mesh-list
44813141|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44813142|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44813143|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44813144|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813145|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813146|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813147|NCT02106650|Leucovorin|leucovorin|mesh-list
44813148|NCT02106650|Folic Acid|folic acid|mesh-list
44813149|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
44813150|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
44813151|NCT02106650|Vitamins|vitamins|mesh-ancestor
44813152|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
44813153|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813154|NCT02106650|Antidotes|antidotes|mesh-ancestor
44813155|NCT02106650|Protective Agents|protective agents|mesh-ancestor
44813156|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
44813157|NCT02106650|Hematinics|hematinics|mesh-ancestor
44813158|NCT02106767|Rifampin|rifampin|mesh-list
44813159|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44813160|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44813161|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44813162|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
44594094|NCT00838578|Irinotecan|irinotecan|mesh-list
44813163|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813164|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44813165|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44813166|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813167|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44813168|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
44813169|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813170|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813171|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
44813172|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44813173|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44813174|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44813175|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44813176|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44813177|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44813178|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44813179|NCT02106793|Mitomycins|mitomycins|mesh-list
44813180|NCT02106793|Mitomycin|mitomycin|mesh-list
44813181|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44813182|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813183|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
44813184|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813185|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44813186|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813187|NCT02106806|Zinc|zinc|mesh-list
44813188|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
44813189|NCT02106806|Trace Elements|trace elements|mesh-ancestor
44813190|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
44813191|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813192|NCT02106806|Astringents|astringents|mesh-ancestor
44813193|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813194|NCT02106845|Digoxin|digoxin|mesh-list
44813195|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44813196|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44813197|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44813198|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
44813199|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299613|NCT00823290|Panobinostat|panobinostat|mesh-list
44299614|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299615|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44299616|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299617|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299618|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44299629|NCT00823381|Resveratrol|resveratrol|mesh-list
44299630|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
44299631|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299632|NCT00823381|Protective Agents|protective agents|mesh-ancestor
44813200|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44813201|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44813202|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813203|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813204|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44813205|NCT02106845|Protective Agents|protective agents|mesh-ancestor
44813206|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813207|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
44813208|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44813209|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44813210|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44813211|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813212|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813213|NCT02106871|Urological Agents|urological agents|mesh-ancestor
44813214|NCT02107079|Melatonin|melatonin|mesh-list
44813215|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
44813216|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813217|NCT02107079|Protective Agents|protective agents|mesh-ancestor
44813218|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813219|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813220|NCT02107118|Complement Factor H|complement factor h|mesh-list
44813221|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44813222|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813223|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
44813224|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813225|NCT02107144|Trimetazidine|trimetazidine|mesh-list
44813226|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44813227|NCT02107170|Remifentanil|remifentanil|mesh-list
44813228|NCT02107170|Propofol|propofol|mesh-list
44813229|NCT02107170|Sevoflurane|sevoflurane|mesh-list
44813230|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44813231|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813232|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813233|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813234|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
44813235|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
44813236|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813237|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44813238|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44813239|NCT02107170|Narcotics|narcotics|mesh-ancestor
44813240|NCT02107170|Analgesics|analgesics|mesh-ancestor
44594169|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
44813241|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
44813242|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813244|NCT02107235|ON 01910|on 01910|mesh-list
44813245|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813246|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44813247|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813248|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813249|NCT02107365|Interferons|interferons|mesh-list
44813250|NCT02107365|Ribavirin|ribavirin|mesh-list
44813251|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
44813252|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
44813253|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44813254|NCT02107365|Asunaprevir|asunaprevir|mesh-list
44813255|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813256|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
44813257|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813258|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
44813259|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813260|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
44813261|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813262|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
44813263|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813264|NCT02107378|Paclitaxel|paclitaxel|mesh-list
44813265|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44813266|NCT02107378|Doxorubicin|doxorubicin|mesh-list
44813267|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44813268|NCT02107378|Topotecan|topotecan|mesh-list
44813269|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44813270|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813271|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813272|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813273|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813274|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813275|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44813276|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44813277|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44813278|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813279|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44813280|NCT02107391|Leuprolide|leuprolide|mesh-list
44694945|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44694946|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694947|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
44694948|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694949|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44813281|NCT02107391|Goserelin|goserelin|mesh-list
44813282|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44813283|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
44694950|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44694951|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694952|NCT01382342|Rasagiline|rasagiline|mesh-list
44694953|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44694954|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694955|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694956|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44694957|NCT01382342|Protective Agents|protective agents|mesh-ancestor
44694958|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694959|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
44694960|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
44694961|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44694962|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44694963|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694964|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694965|NCT01382368|Urological Agents|urological agents|mesh-ancestor
44694966|NCT01382407|Cetuximab|cetuximab|mesh-list
44694967|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44694968|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694969|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44694970|NCT01382472|Simvastatin|simvastatin|mesh-list
44694971|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44694972|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694973|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
44694974|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694975|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44594262|NCT00836810|Prednisone|prednisone|mesh-list
44813284|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44813285|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813286|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44813287|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813288|NCT02107690|Lidocaine|lidocaine|mesh-list
44813289|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813290|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
44813291|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813292|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813293|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
44813294|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813295|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813296|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813297|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813298|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813299|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813300|NCT02107716|Lidocaine|lidocaine|mesh-list
44813301|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813302|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
44813303|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813304|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813305|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
44813306|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813307|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813308|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813309|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813310|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813311|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813312|NCT02107729|Lidocaine|lidocaine|mesh-list
44813313|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813314|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
44813315|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813316|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813317|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
44813318|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813319|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813320|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813321|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813322|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813323|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813324|NCT02107742|Lidocaine|lidocaine|mesh-list
44813325|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813326|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
44813327|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813328|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813329|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
44813330|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813331|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813332|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813333|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813334|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813335|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813336|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44813337|NCT02107755|Ipilimumab|ipilimumab|mesh-list
44813338|NCT02107755|Antibodies|antibodies|mesh-list
44813339|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
44813340|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44813341|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
44813342|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813343|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813344|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44813345|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813346|NCT02107807|Lactitol|lactitol|mesh-list
44694976|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44694977|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694978|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
44694979|NCT01382498|Calcium|calcium|mesh-list
44694980|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44694981|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44694982|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
44694983|NCT01382498|Coagulants|coagulants|mesh-ancestor
44694984|NCT01382511|Simvastatin|simvastatin|mesh-list
44813347|NCT02107807|Vaccines|vaccines|mesh-list
44813348|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
44813349|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813350|NCT02107807|Cathartics|cathartics|mesh-ancestor
44813351|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813352|NCT02107924|Vancomycin|vancomycin|mesh-list
44813353|NCT02107924|Tobramycin|tobramycin|mesh-list
44813354|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813355|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813356|NCT02107950|Gemcitabine|gemcitabine|mesh-list
44813357|NCT02107950|Carboplatin|carboplatin|mesh-list
44813358|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813359|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44813360|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
44813361|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813362|NCT02107950|Antiviral Agents|antiviral agents|mesh-ancestor
44813363|NCT02107950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813364|NCT02107950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813365|NCT02107950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813366|NCT02107950|Immunologic Factors|immunologic factors|mesh-ancestor
44299793|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44813367|NCT02107950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813368|NCT02108002|Vorinostat|vorinostat|mesh-list
44813369|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813370|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44813371|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813372|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594350|NCT00834366|Tramadol|tramadol|mesh-list
44813373|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44813374|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813375|NCT02108301|Cyclosporine|cyclosporine|mesh-list
44813376|NCT02108301|Tacrolimus|tacrolimus|mesh-list
44813377|NCT02108301|Cyclosporins|cyclosporins|mesh-list
44813378|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813379|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
44813380|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813381|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44813382|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813383|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813384|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
44813385|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813386|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813387|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813388|NCT02108353|Melatonin|melatonin|mesh-list
44813389|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
44813390|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813391|NCT02108353|Protective Agents|protective agents|mesh-ancestor
44813392|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813393|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813394|NCT02108366|Oseltamivir|oseltamivir|mesh-list
44813395|NCT02108366|Celecoxib|celecoxib|mesh-list
44813396|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813397|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813398|NCT02108366|Analgesics|analgesics|mesh-ancestor
44813399|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
44813400|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813401|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813402|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813403|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813404|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44813405|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44813406|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813407|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813408|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
44813409|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813410|NCT02108483|Dapsone|dapsone|mesh-list
44813411|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813412|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
44813413|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44813414|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44813415|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44813416|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813417|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813418|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
44813419|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813420|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
44813421|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44813422|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813423|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813424|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44813425|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44813426|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
44813427|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44813428|NCT02108548|Naproxen|naproxen|mesh-list
44813429|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813430|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813431|NCT02108548|Analgesics|analgesics|mesh-ancestor
44813432|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
44813433|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813434|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813435|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813436|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813437|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
44813438|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44813439|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813440|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813441|NCT02108626|Nicotine|nicotine|mesh-list
44813442|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44813443|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
44813444|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813445|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813446|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44813447|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44813448|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44813449|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813450|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813451|NCT02108639|Asunaprevir|asunaprevir|mesh-list
44813452|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
44813453|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813454|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813456|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44813457|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
44813458|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813459|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813460|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44813461|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44813462|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
44813463|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44813464|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44813465|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44813466|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44813467|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813468|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813469|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813470|NCT02108756|Pantoprazole|pantoprazole|mesh-list
44813471|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44813472|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813473|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44813474|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813475|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813476|NCT02108795|Remifentanil|remifentanil|mesh-list
44813477|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44813478|NCT02108795|Narcotics|narcotics|mesh-ancestor
44813479|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813480|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813481|NCT02108795|Analgesics|analgesics|mesh-ancestor
44813482|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
44813483|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813484|NCT02108808|Clopidogrel|clopidogrel|mesh-list
44813485|NCT02108808|Ticagrelor|ticagrelor|mesh-list
44813486|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44813487|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813488|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44813489|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44813490|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44813491|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
44813492|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813493|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813494|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813495|NCT02108847|Ropivacaine|ropivacaine|mesh-list
44813496|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813497|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
44813498|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813499|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813500|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
44813501|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813502|NCT02108886|Montelukast|montelukast|mesh-list
44299896|NCT00825058|Paroxetine|paroxetine|mesh-list
44813503|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44813504|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
44813505|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44813506|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
44813507|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813508|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813509|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44813510|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44813511|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813512|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
44813513|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813514|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813515|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44813516|NCT02109289|Etanercept|etanercept|mesh-list
44813517|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813518|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813519|NCT02109289|Analgesics|analgesics|mesh-ancestor
44813520|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
44594501|NCT00833261|Paclitaxel|paclitaxel|mesh-list
44813521|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813522|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813523|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813525|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813526|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813527|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
44813528|NCT02109315|Ascorbic Acid|ascorbic acid|mesh-list
44813529|NCT02109315|Liraglutide|liraglutide|mesh-list
44813530|NCT02109315|Vitamins|vitamins|mesh-ancestor
44813531|NCT02109315|Micronutrients|micronutrients|mesh-ancestor
44813532|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813533|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44813534|NCT02109315|Incretins|incretins|mesh-ancestor
44813535|NCT02109315|Hormones|hormones|mesh-ancestor
44813536|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813537|NCT02109315|Antioxidants|antioxidants|mesh-ancestor
44813538|NCT02109315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813539|NCT02109315|Protective Agents|protective agents|mesh-ancestor
44813540|NCT02109328|Paclitaxel|paclitaxel|mesh-list
44813541|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44299945|NCT00825123|Metoprolol|metoprolol|mesh-list
44813542|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813543|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813544|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813545|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813546|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813547|NCT02109341|Paclitaxel|paclitaxel|mesh-list
44813548|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44813549|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44813550|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813551|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813552|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813553|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813554|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813555|NCT02109354|Vaccines|vaccines|mesh-list
44813556|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
44813557|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813558|NCT02109510|Lidocaine|lidocaine|mesh-list
44813559|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
44813560|NCT02109510|Ketamine|ketamine|mesh-list
44813561|NCT02109510|Anesthetics|anesthetics|mesh-list
44813562|NCT02109510|Propofol|propofol|mesh-list
44813563|NCT02109510|Sevoflurane|sevoflurane|mesh-list
44813564|NCT02109510|Rocuronium|rocuronium|mesh-list
44813565|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813566|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813567|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594573|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44594574|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
44594575|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594576|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594577|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594578|NCT00832650|Urological Agents|urological agents|mesh-ancestor
44594579|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44594580|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594581|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594582|NCT00832624|Incretins|incretins|mesh-ancestor
44594583|NCT00832624|Hormones|hormones|mesh-ancestor
44594584|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594585|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44594586|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594587|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594588|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594589|NCT00832585|Alefacept|alefacept|mesh-list
44594590|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44594591|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
44299988|NCT00825188|Amlodipine|amlodipine|mesh-list
44594592|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594593|NCT00832416|Tramadol|tramadol|mesh-list
44594594|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594595|NCT00832416|Narcotics|narcotics|mesh-ancestor
44594596|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594597|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594598|NCT00832416|Analgesics|analgesics|mesh-ancestor
44594599|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
44594600|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813568|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
44813569|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813570|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813571|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813572|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813573|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813574|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813575|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44813576|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813577|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
44813578|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813580|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44813581|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44813582|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44813583|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813584|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813585|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44813586|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44813587|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44813588|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813589|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44813590|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44813591|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44813592|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44813593|NCT02109614|Niacin|niacin|mesh-list
44813594|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44813595|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
44813596|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813597|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44813598|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
44813599|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
44813600|NCT02109614|Vitamins|vitamins|mesh-ancestor
44813601|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
44813602|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813603|NCT02109627|Cytarabine|cytarabine|mesh-list
44813604|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44813605|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
44813606|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813607|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813608|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
44813609|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813610|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813611|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
44813612|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813613|NCT02109666|Abatacept|abatacept|mesh-list
44813614|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44813615|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813616|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813617|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813618|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
44300059|NCT00825851|Nicotine|nicotine|mesh-list
44813619|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813620|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813621|NCT02109679|Metformin|metformin|mesh-list
44813622|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44813623|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813624|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
44813625|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44813626|NCT02109718|Petrolatum|petrolatum|mesh-list
44813627|NCT02109718|Emollients|emollients|mesh-ancestor
44813628|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813629|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813630|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813631|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44813632|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44813633|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
44813634|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44813635|NCT02109783|Caffeine|caffeine|mesh-list
44813636|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44813637|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813638|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44813639|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813640|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813641|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44813642|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44813643|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
44813644|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813645|NCT02109861|Dexamethasone|dexamethasone|mesh-list
44813646|NCT02109861|Bortezomib|bortezomib|mesh-list
44813647|NCT02109861|Melphalan|melphalan|mesh-list
44813648|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813649|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
44813650|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
44813651|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813652|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813653|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813654|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
44813655|NCT02109861|Hormones|hormones|mesh-ancestor
44813656|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813657|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44813658|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813659|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44813660|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
44813661|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813662|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44813663|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813664|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
44813665|NCT02109900|Progesterone|progesterone|mesh-list
44813666|NCT02109900|Progestins|progestins|mesh-ancestor
44813667|NCT02109900|Hormones|hormones|mesh-ancestor
44813668|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813669|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813670|NCT02109913|Everolimus|everolimus|mesh-list
44813671|NCT02109913|Exemestane|exemestane|mesh-list
44813672|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813673|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813674|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
44813675|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813676|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44813677|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44813678|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813679|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813680|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44813681|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
44813682|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813683|NCT02109965|Midazolam|midazolam|mesh-list
44813684|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
44813685|NCT02109965|Propofol|propofol|mesh-list
44813686|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44813687|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813688|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813689|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813690|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
44813691|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
44813692|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813693|NCT02109965|Analgesics|analgesics|mesh-ancestor
44813694|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
44813695|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813696|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44813697|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44813698|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44813699|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813700|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813701|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813702|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44813703|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44813704|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44813705|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44813706|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
44813707|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
44813708|NCT02110082|Cetuximab|cetuximab|mesh-list
44813709|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44813710|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813711|NCT02110134|Hydroquinone|hydroquinone|mesh-list
44813712|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
44813713|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813714|NCT02110134|Protective Agents|protective agents|mesh-ancestor
44813715|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813716|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44813717|NCT02110303|Ticagrelor|ticagrelor|mesh-list
44813718|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44813719|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44813720|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44813721|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44813722|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
44813723|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813724|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813725|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813726|NCT02110316|Voriconazole|voriconazole|mesh-list
44813727|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
44813728|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813729|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44813730|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44813731|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813732|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300159|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
44813733|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44813734|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
44813735|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813736|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813737|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44813738|NCT02110355|Trametinib|trametinib|mesh-list
44813739|NCT02110355|Dabrafenib|dabrafenib|mesh-list
44813740|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813741|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44813742|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813743|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813744|NCT02110394|Rituximab|rituximab|mesh-list
44813745|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44813746|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44813747|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813748|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
44813749|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813750|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813751|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44813752|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
44813753|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813754|NCT02110459|Murepavadin|murepavadin|mesh-list
44813755|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44813756|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813757|NCT02110524|Paclitaxel|paclitaxel|mesh-list
44813758|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44813759|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813760|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813761|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813762|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813763|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813764|NCT02110537|Flecainide|flecainide|mesh-list
44813765|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813766|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44813767|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44813768|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813769|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813770|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
44813771|NCT02110654|Montelukast|montelukast|mesh-list
44813772|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44813773|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
44813774|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44813775|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44813776|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813777|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813778|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44813779|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44813780|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813781|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813782|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
44813783|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44813785|NCT02110719|Dexamethasone|dexamethasone|mesh-list
44813786|NCT02110719|Ibuprofen|ibuprofen|mesh-list
44813787|NCT02110719|Celecoxib|celecoxib|mesh-list
44813788|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44813789|NCT02110719|Oxycodone|oxycodone|mesh-list
44813790|NCT02110719|Gabapentin|gabapentin|mesh-list
44813791|NCT02110719|Hydromorphone|hydromorphone|mesh-list
44813792|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813793|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
44813794|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
44813795|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300241|NCT00826852|Carboplatin|carboplatin|mesh-list
44813796|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813797|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813798|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
44813799|NCT02110719|Hormones|hormones|mesh-ancestor
44813800|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813801|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44813802|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813803|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813804|NCT02110719|Analgesics|analgesics|mesh-ancestor
44813805|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
44813806|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
44813807|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813808|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813809|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44813810|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813811|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813812|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44813813|NCT02110719|Narcotics|narcotics|mesh-ancestor
44813814|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813815|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
44813816|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44813817|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44813818|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44813819|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44813820|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44813821|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813822|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
44813823|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44813824|NCT02110745|Propofol|propofol|mesh-list
44813825|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44813826|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813827|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813828|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813829|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
44813830|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
44300272|NCT00827021|Hematinics|hematinics|mesh-list
44813831|NCT02110784|Piperaquine|piperaquine|mesh-list
44813832|NCT02110784|Artenimol|artenimol|mesh-list
44813833|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
44813834|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44813835|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44813836|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813837|NCT02110810|Indomethacin|indomethacin|mesh-list
44813838|NCT02110810|Glycerol|glycerol|mesh-list
44813839|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813840|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813841|NCT02110810|Analgesics|analgesics|mesh-ancestor
44813842|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
44813843|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813844|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813845|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813846|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813847|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
44813848|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
44813849|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44813850|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44813851|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813852|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813853|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44813854|NCT02110810|Protective Agents|protective agents|mesh-ancestor
44813855|NCT02110953|Irinotecan|irinotecan|mesh-list
44813856|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44813857|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44813859|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813860|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813861|NCT02110966|Tramadol|tramadol|mesh-list
44813862|NCT02110966|Mepivacaine|mepivacaine|mesh-list
44813863|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44813864|NCT02110966|Narcotics|narcotics|mesh-ancestor
44813865|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813866|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813867|NCT02110966|Analgesics|analgesics|mesh-ancestor
44813868|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
44813869|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813870|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813871|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
44813872|NCT02110992|Docetaxel|docetaxel|mesh-list
44813873|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813874|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44813875|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44813876|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44813877|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813878|NCT02111044|Octreotide|octreotide|mesh-list
44813879|NCT02111044|Somatostatin|somatostatin|mesh-list
44813880|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44813881|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44813882|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44813883|NCT02111044|Hormones|hormones|mesh-ancestor
44813884|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813885|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813886|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
44813887|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44813888|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813889|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
44813890|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
44813891|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813892|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813893|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
44813894|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44813895|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
44813896|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
44813897|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44813898|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
44813899|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813900|NCT02111265|Sufentanil|sufentanil|mesh-list
44813901|NCT02111265|Remifentanil|remifentanil|mesh-list
44813902|NCT02111265|Cisatracurium|cisatracurium|mesh-list
44813903|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44813904|NCT02111265|Narcotics|narcotics|mesh-ancestor
44813905|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813906|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813907|NCT02111265|Analgesics|analgesics|mesh-ancestor
44813908|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
44813909|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813910|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44813911|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44813912|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
44813913|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
44813914|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44813915|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44813916|NCT02111317|Verapamil|verapamil|mesh-list
44813917|NCT02111317|Peficitinib|peficitinib|mesh-list
44813918|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44813919|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44813920|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44813921|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813922|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44300348|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
44813923|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813924|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
44813925|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813926|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44813927|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
44813928|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
44813929|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44813930|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44813931|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813932|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813933|NCT02111421|Analgesics|analgesics|mesh-ancestor
44813934|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
44813935|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813936|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44813937|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44813938|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44813939|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44813940|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813941|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813942|NCT02111434|Testosterone|testosterone|mesh-list
44813943|NCT02111434|Androgens|androgens|mesh-ancestor
44813945|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813946|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813947|NCT02111473|Testosterone|testosterone|mesh-list
44813948|NCT02111473|Androgens|androgens|mesh-ancestor
44813949|NCT02111473|Hormones|hormones|mesh-ancestor
44813950|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813951|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813952|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
44813953|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44813954|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44813955|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44813956|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44813957|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813958|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813959|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
44813960|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44813961|NCT02111590|Antibodies|antibodies|mesh-list
44813962|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
44813963|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813964|NCT02111629|Fluconazole|fluconazole|mesh-list
44813965|NCT02111629|Secnidazole|secnidazole|mesh-list
44813966|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
44813967|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44813968|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44813969|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44813970|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813971|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44813972|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44813973|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
44813974|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44813975|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813976|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44813977|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44813978|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44813979|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44813980|NCT02111707|Indomethacin|indomethacin|mesh-list
44813981|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44813982|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44813983|NCT02111707|Analgesics|analgesics|mesh-ancestor
44813984|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
44813985|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44813986|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813987|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44813988|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44813989|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
44813990|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
44813991|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44594989|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44594990|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44594991|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
44594992|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594993|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44594994|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44594995|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594996|NCT00827567|Everolimus|everolimus|mesh-list
44594997|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594998|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594999|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
44595000|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44813992|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44813993|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44813994|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694985|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44694986|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44694987|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
44694988|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44694989|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44694990|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44694991|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44694992|NCT01382589|Afamelanotide|afamelanotide|mesh-list
44694993|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44694994|NCT01382706|Docetaxel|docetaxel|mesh-list
44694995|NCT01382706|Lapatinib|lapatinib|mesh-list
44694996|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44694997|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44694998|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44694999|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44695000|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695001|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44695002|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695003|NCT01382732|Oxytocin|oxytocin|mesh-list
44695004|NCT01382732|Carbetocin|carbetocin|mesh-list
44695005|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
44695006|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695007|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695008|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
44695009|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695010|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695011|NCT01382888|Heparin|heparin|mesh-list
44695012|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
44695013|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44695014|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44695015|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695016|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
44695017|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695018|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695019|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
44695020|NCT01383044|Carvedilol|carvedilol|mesh-list
44695021|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44695022|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44695023|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
44695024|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695025|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695026|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695027|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44695028|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
44695029|NCT01383044|Protective Agents|protective agents|mesh-ancestor
44695030|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44695031|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695032|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695033|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695034|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44695035|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44695036|NCT01383148|Gemcitabine|gemcitabine|mesh-list
44695037|NCT01383148|Paclitaxel|paclitaxel|mesh-list
44695038|NCT01383148|Cisplatin|cisplatin|mesh-list
44695039|NCT01383148|Carboplatin|carboplatin|mesh-list
44695040|NCT01383148|Pemetrexed|pemetrexed|mesh-list
44695041|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44695042|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695043|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
44695044|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
44695045|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44695046|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695047|NCT01383148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695048|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695049|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
44813995|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44813996|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44813997|NCT02112006|Bupivacaine|bupivacaine|mesh-list
44813998|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
44813999|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
44814000|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814001|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814002|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
44814003|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814004|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
44814005|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814006|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44814007|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
44814008|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814009|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814010|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
44814011|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814012|NCT02112097|Etanercept|etanercept|mesh-list
44814013|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44814014|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814015|NCT02112097|Analgesics|analgesics|mesh-ancestor
44814016|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
44814017|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814018|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814019|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814020|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814021|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814022|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814023|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
44814024|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
44814025|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44814026|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44814027|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814028|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
44814029|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
44814030|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814031|NCT02112175|Lenalidomide|lenalidomide|mesh-list
44814032|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
44814033|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814034|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44814035|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44814036|NCT02112175|Growth Substances|growth substances|mesh-ancestor
44814037|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
44814038|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814039|NCT02112214|Bismuth|bismuth|mesh-list
44814040|NCT02112214|Antacids|antacids|mesh-ancestor
44814041|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814042|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814043|NCT02112292|Dronabinol|dronabinol|mesh-list
44814044|NCT02112292|Cannabidiol|cannabidiol|mesh-list
44814045|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
44814046|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
44814047|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814048|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814049|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814050|NCT02112292|Analgesics|analgesics|mesh-ancestor
44814051|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
44814052|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814053|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44814054|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44814055|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814056|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814057|NCT02112292|Hormones|hormones|mesh-ancestor
44814058|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814059|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
44814060|NCT02112305|Analgesics|analgesics|mesh-ancestor
44814061|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
44814062|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814063|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814064|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
44814065|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814066|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44814067|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
44814068|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44814069|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44814070|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814071|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44814072|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
44814073|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44814074|NCT02112422|Dexamethasone|dexamethasone|mesh-list
44814075|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
44814076|NCT02112422|BB 1101|bb 1101|mesh-list
44814077|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814078|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
44814079|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
44814080|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814081|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814082|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814083|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
44814084|NCT02112422|Hormones|hormones|mesh-ancestor
44814085|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300540|NCT00828919|Axitinib|axitinib|mesh-list
44814086|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814087|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814088|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
44814089|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814090|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814091|NCT02112487|Macitentan|macitentan|mesh-list
44814092|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44814093|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44814094|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814095|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44814096|NCT02112552|Paclitaxel|paclitaxel|mesh-list
44814097|NCT02112552|Carboplatin|carboplatin|mesh-list
44814098|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44814099|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814100|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44814101|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44814102|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44814103|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814104|NCT02112578|Meclizine|meclizine|mesh-list
44814105|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
44814106|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
44814107|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
44814108|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814109|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814110|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814111|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44814112|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
44814113|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
44814114|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814115|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814116|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44814117|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44814118|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814119|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814120|NCT02112630|Interferons|interferons|mesh-list
44814121|NCT02112630|Ribavirin|ribavirin|mesh-list
44814122|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
44814123|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
44814124|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44814125|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44814126|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44814127|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814128|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
44814129|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814130|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
44814131|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814132|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
44814133|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814134|NCT02112643|Selenium|selenium|mesh-list
44814135|NCT02112643|Selenic Acid|selenic acid|mesh-list
44814136|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
44814137|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814138|NCT02112643|Protective Agents|protective agents|mesh-ancestor
44814139|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814140|NCT02112643|Trace Elements|trace elements|mesh-ancestor
44814141|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
44814142|NCT02112695|Diprenorphine|diprenorphine|mesh-list
44814143|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44595089|NCT00826449|Dasatinib|dasatinib|mesh-list
44814144|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814145|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
44814146|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814147|NCT02112721|Vitamin D|vitamin d|mesh-list
44814148|NCT02112721|Vitamins|vitamins|mesh-ancestor
44814149|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
44814150|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814151|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44814152|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44814153|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
44814154|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814155|NCT02112864|Dexamethasone|dexamethasone|mesh-list
44814156|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814157|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
44814158|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
44814159|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814160|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814161|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814162|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
44814163|NCT02112864|Hormones|hormones|mesh-ancestor
44814164|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814165|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814166|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814167|NCT02112903|Vortioxetine|vortioxetine|mesh-list
44814168|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
44814169|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814170|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44814171|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44814172|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814173|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814174|NCT02112903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44300643|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
44814175|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44814176|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44814177|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814178|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814179|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
44814180|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44814181|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44814182|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44814183|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44814184|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
44814185|NCT02112916|Leucovorin|leucovorin|mesh-list
44814186|NCT02112916|Folic Acid|folic acid|mesh-list
44814187|NCT02112916|Cytarabine|cytarabine|mesh-list
44814188|NCT02112916|Dexamethasone|dexamethasone|mesh-list
44814189|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
44814190|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
44814191|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44814192|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44814193|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44814194|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
44814195|NCT02112916|Ifosfamide|ifosfamide|mesh-list
44814196|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
44814197|NCT02112916|Doxorubicin|doxorubicin|mesh-list
44814198|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44814199|NCT02112916|Methotrexate|methotrexate|mesh-list
44814200|NCT02112916|Etoposide|etoposide|mesh-list
44814201|NCT02112916|Vincristine|vincristine|mesh-list
44814202|NCT02112916|Bortezomib|bortezomib|mesh-list
44814203|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
44814204|NCT02112916|Daunorubicin|daunorubicin|mesh-list
44814205|NCT02112916|Asparaginase|asparaginase|mesh-list
44814206|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
44814207|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
44814208|NCT02112916|Pegaspargase|pegaspargase|mesh-list
44814209|NCT02112916|Thioguanine|thioguanine|mesh-list
44814210|NCT02112916|BB 1101|bb 1101|mesh-list
44814211|NCT02112916|Calcium|calcium|mesh-list
44814212|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
44814213|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
44814214|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814215|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
44814216|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814217|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814218|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44695050|NCT01383148|Antiviral Agents|antiviral agents|mesh-ancestor
44814219|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
44814220|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814221|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814222|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44814223|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814224|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
44814225|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
44814226|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814227|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814228|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
44814230|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814231|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814232|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
44814233|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814234|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44814235|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44814236|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44814237|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44814238|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44814239|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44814240|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
44814241|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44814242|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814243|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
44814244|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
44814245|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44814246|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44814247|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44814248|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
44814249|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814250|NCT02112916|Antidotes|antidotes|mesh-ancestor
44814251|NCT02112916|Protective Agents|protective agents|mesh-ancestor
44814252|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
44814253|NCT02112916|Vitamins|vitamins|mesh-ancestor
44814254|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
44814255|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
44814256|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
44814257|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
44814258|NCT02112916|Hematinics|hematinics|mesh-ancestor
44814259|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
44814260|NCT02112929|Xenon|xenon|mesh-list
44814261|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44814262|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
44814263|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
44814264|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300707|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
44814265|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814266|NCT02112981|Sirolimus|sirolimus|mesh-list
44814267|NCT02112981|Everolimus|everolimus|mesh-list
44814268|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814269|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814270|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
44814271|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814272|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814273|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814274|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44814275|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
44814276|NCT02113072|Beclomethasone|beclomethasone|mesh-list
44814277|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814278|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
44595234|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595235|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595236|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44595237|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595238|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595239|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595240|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
44595241|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595242|NCT00823836|Ropinirole|ropinirole|mesh-list
44595243|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44595244|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44595245|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
44595246|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
44595247|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595248|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595249|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595250|NCT00823823|Calpastatin|calpastatin|mesh-list
44595251|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44595252|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
44814279|NCT02113072|Hormones|hormones|mesh-ancestor
44814280|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814281|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814282|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44814283|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44814284|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
44814285|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
44814286|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
44814287|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814288|NCT02113150|Ketamine|ketamine|mesh-list
44814289|NCT02113150|Remifentanil|remifentanil|mesh-list
44814290|NCT02113150|Analgesics|analgesics|mesh-ancestor
44814291|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
44814292|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814293|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814294|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44814295|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44814296|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
44814297|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
44814298|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814299|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44814300|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44814301|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814302|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814303|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814304|NCT02113150|Narcotics|narcotics|mesh-ancestor
44814305|NCT02113176|Minocycline|minocycline|mesh-list
44814306|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814307|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814308|NCT02113202|Bevacizumab|bevacizumab|mesh-list
44814309|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814310|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814311|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44814312|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44814313|NCT02113202|Growth Substances|growth substances|mesh-ancestor
44814314|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814315|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
44814316|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
44814317|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814318|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44814319|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44814320|NCT02113319|Dasatinib|dasatinib|mesh-list
44814321|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814322|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44814323|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814324|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814325|NCT02113332|Liraglutide|liraglutide|mesh-list
44814326|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44814327|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814328|NCT02113332|Incretins|incretins|mesh-ancestor
44814329|NCT02113332|Hormones|hormones|mesh-ancestor
44814330|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814331|NCT02113397|Tobramycin|tobramycin|mesh-list
44814332|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814333|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814334|NCT02113540|Atorvastatin|atorvastatin|mesh-list
44814335|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44814336|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44814337|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
44814338|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814339|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44814340|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44814341|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814342|NCT02113566|Acetaminophen|acetaminophen|mesh-list
44814343|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814344|NCT02113566|Analgesics|analgesics|mesh-ancestor
44814345|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
44814346|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814347|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814348|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
44814349|NCT02113631|Interferons|interferons|mesh-list
44814350|NCT02113631|Ribavirin|ribavirin|mesh-list
44814351|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
44814352|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
44814353|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44814354|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814355|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
44814356|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814357|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
44814358|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814359|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
44814360|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814361|NCT02113657|Ipilimumab|ipilimumab|mesh-list
44814362|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814363|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814364|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44814365|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814366|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44814367|NCT02113735|Hormones|hormones|mesh-ancestor
44814368|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814369|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814370|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
44814371|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44814372|NCT02113800|Everolimus|everolimus|mesh-list
44814373|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814374|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814375|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
44814376|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814377|NCT02113813|Naquotinib|naquotinib|mesh-list
44814378|NCT02113813|Midazolam|midazolam|mesh-list
44814379|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44814380|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44814381|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814382|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814383|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44814384|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44814385|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814386|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44814387|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
44814388|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
44814389|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
44814390|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
44814391|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814392|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300860|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
44814393|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814394|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44814395|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814396|NCT02113891|Eculizumab|eculizumab|mesh-list
44814397|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44814398|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814399|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
44814400|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814401|NCT02113904|Adalimumab|adalimumab|mesh-list
44814402|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814403|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814404|NCT02113943|Citalopram|citalopram|mesh-list
44814405|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44814406|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44814407|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695051|NCT01383148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814408|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814409|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814410|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
44814411|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814412|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44814413|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44814414|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814415|NCT02114021|Betamethasone|betamethasone|mesh-list
44814416|NCT02114021|Lidocaine|lidocaine|mesh-list
44814417|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
44814418|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
44814419|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814420|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814421|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
44814422|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814423|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44814424|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44814425|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44814426|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465595|NCT01473953|Hormones|hormones|mesh-ancestor
44814427|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814428|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814429|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
44814430|NCT02114021|Hormones|hormones|mesh-ancestor
44814431|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814432|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44814433|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
44814434|NCT02114073|Cyclosporine|cyclosporine|mesh-list
44814435|NCT02114073|Betamethasone|betamethasone|mesh-list
44814436|NCT02114073|Cyclosporins|cyclosporins|mesh-list
44814437|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814438|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814439|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814440|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
44814441|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814442|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
44814443|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814444|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44814445|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814446|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44814447|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814448|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
44814449|NCT02114073|Hormones|hormones|mesh-ancestor
44814450|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814451|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44814452|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
44814453|NCT02114099|Atorvastatin|atorvastatin|mesh-list
44814454|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44814455|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44814456|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
44814457|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814458|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44814459|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44814460|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814461|NCT02114333|Vaccines|vaccines|mesh-list
44814462|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
44814463|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814464|NCT02114346|Atorvastatin|atorvastatin|mesh-list
44814465|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44814466|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44814467|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
44814468|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814469|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44814470|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44814471|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814472|NCT02114359|Cisplatin|cisplatin|mesh-list
44814473|NCT02114359|Fluorouracil|fluorouracil|mesh-list
44814474|NCT02114359|Capecitabine|capecitabine|mesh-list
44814475|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
44814476|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814477|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
44814478|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595439|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595440|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595441|NCT00820898|Antiviral Agents|antiviral agents|mesh-ancestor
44595442|NCT00820898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814479|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814481|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
44814482|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814483|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
44814484|NCT02114463|Analgesics|analgesics|mesh-list
44814485|NCT02114463|Ropivacaine|ropivacaine|mesh-list
44814486|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
44814487|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
44814488|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814489|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814490|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
44814491|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814492|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44814493|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814494|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814495|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814496|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44814497|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814498|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814499|NCT02114476|Progestins|progestins|mesh-list
44814500|NCT02114476|Hormones|hormones|mesh-ancestor
44814501|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814502|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814503|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
44814504|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44814505|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814506|NCT02114502|Pyridoxine|pyridoxine|mesh-list
44814507|NCT02114502|Gemcitabine|gemcitabine|mesh-list
44814508|NCT02114502|Dexamethasone|dexamethasone|mesh-list
44814509|NCT02114502|Melphalan|melphalan|mesh-list
44814510|NCT02114502|Busulfan|busulfan|mesh-list
44814511|NCT02114502|Vorinostat|vorinostat|mesh-list
44814512|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814513|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
44814514|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
44814515|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814516|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814517|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814518|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
44814519|NCT02114502|Hormones|hormones|mesh-ancestor
44814520|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814521|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814522|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814523|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814524|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
44814525|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814526|NCT02114502|Antiviral Agents|antiviral agents|mesh-ancestor
44814527|NCT02114502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814528|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814529|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814530|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
44814531|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44814532|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
44814533|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44814534|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44814535|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
44814536|NCT02114502|Vitamins|vitamins|mesh-ancestor
44814537|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
44814538|NCT02114528|Amiodarone|amiodarone|mesh-list
44814539|NCT02114528|Sotalol|sotalol|mesh-list
44814540|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44814541|NCT02114528|Mexiletine|mexiletine|mesh-list
44814542|NCT02114528|Procainamide|procainamide|mesh-list
44814543|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
44814544|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44814545|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44814546|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814547|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44814548|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44814549|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44814550|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814551|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44814552|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44814553|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44814554|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44814555|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44814556|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
44814557|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814558|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814559|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
44814560|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
44814561|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814562|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44814563|NCT02114645|Leuprolide|leuprolide|mesh-list
44814564|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44814565|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44814566|NCT02114645|Estradiol|estradiol|mesh-list
44814567|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44814568|NCT02114645|Progesterone|progesterone|mesh-list
44814569|NCT02114645|Estrogens|estrogens|mesh-ancestor
44814570|NCT02114645|Hormones|hormones|mesh-ancestor
44814571|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814572|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814573|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44814574|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
44814575|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44814576|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44814577|NCT02114645|Progestins|progestins|mesh-ancestor
44814578|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44814579|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
44814580|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814581|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814582|NCT02114658|Sorafenib|sorafenib|mesh-list
44814583|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814584|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44814585|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814586|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814587|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
44814588|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814589|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814590|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44814591|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44814592|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814593|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814594|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814595|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44814596|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44814597|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44814598|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44814599|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44814600|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
44814601|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814602|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44814603|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44814604|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814605|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
44814606|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814607|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
44814608|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44814609|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44301026|NCT00832013|Propofol|propofol|mesh-list
44814610|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44814611|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814612|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44814613|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814614|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814615|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44814616|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814617|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
44814618|NCT02114775|Hormones|hormones|mesh-list
44814619|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814620|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814621|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
44814622|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44814623|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44814624|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814625|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814626|NCT02114775|Urological Agents|urological agents|mesh-ancestor
44814628|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814629|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44814630|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814631|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814632|NCT02115087|Morphine|morphine|mesh-list
44814633|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814634|NCT02115087|Narcotics|narcotics|mesh-ancestor
44814635|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814636|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814637|NCT02115087|Analgesics|analgesics|mesh-ancestor
44814638|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
44814639|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814640|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
44814641|NCT02115152|Fluorouracil|fluorouracil|mesh-list
44814642|NCT02115152|Capecitabine|capecitabine|mesh-list
44814643|NCT02115152|Epirubicin|epirubicin|mesh-list
44814644|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814645|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
44814646|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814647|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814648|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44814649|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
44814650|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814651|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814652|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44814653|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
44814654|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814655|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44814656|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44814657|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44814658|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814659|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
44814660|NCT02115204|Docetaxel|docetaxel|mesh-list
44814661|NCT02115204|Fluorouracil|fluorouracil|mesh-list
44814662|NCT02115204|Methotrexate|methotrexate|mesh-list
44814663|NCT02115204|Epirubicin|epirubicin|mesh-list
44814664|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814665|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
44814666|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814667|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814668|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44814669|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
44814670|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814671|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814672|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44814673|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44814674|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44814675|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44814676|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
44814677|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814678|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44814679|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
44814680|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44814681|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
44814682|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814683|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44814684|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44814685|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44814686|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44814687|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44814688|NCT02115243|Ipilimumab|ipilimumab|mesh-list
44814689|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814690|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595663|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
44301108|NCT00832442|Metoprolol|metoprolol|mesh-list
44595664|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44595665|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44595666|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595667|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44595668|NCT00818389|Protective Agents|protective agents|mesh-ancestor
44595669|NCT00818259|Dexamethasone|dexamethasone|mesh-list
44595670|NCT00818259|Ondansetron|ondansetron|mesh-list
44595671|NCT00818259|Aprepitant|aprepitant|mesh-list
44595672|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
44423976|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
44595673|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814691|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44814692|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695052|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695053|NCT01383148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695054|NCT01383148|Immunologic Factors|immunologic factors|mesh-ancestor
44695055|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44695056|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44695057|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
44695058|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44695059|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695060|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
44695061|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44695062|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695063|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
44695064|NCT01383343|Leucovorin|leucovorin|mesh-list
44695065|NCT01383343|Folic Acid|folic acid|mesh-list
44695066|NCT01383343|Bevacizumab|bevacizumab|mesh-list
44695067|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44695068|NCT01383343|Fluorouracil|fluorouracil|mesh-list
44695069|NCT01383343|Irinotecan|irinotecan|mesh-list
44695070|NCT01383343|Sorafenib|sorafenib|mesh-list
44695071|NCT01383343|Camptothecin|camptothecin|mesh-list
44695072|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
44695073|NCT01383343|Antibodies|antibodies|mesh-list
44695074|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
44695075|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44695076|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
44695077|NCT01383343|Calcium|calcium|mesh-list
44695078|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
44695079|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695080|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44695081|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44695082|NCT01383343|Growth Substances|growth substances|mesh-ancestor
44695083|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695084|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
44695085|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
44695086|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695087|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44695088|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
44301147|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44695089|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695090|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695091|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695092|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44695093|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695094|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695095|NCT01383343|Antidotes|antidotes|mesh-ancestor
44695096|NCT01383343|Protective Agents|protective agents|mesh-ancestor
44695097|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
44695098|NCT01383343|Vitamins|vitamins|mesh-ancestor
44695099|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
44695100|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44695101|NCT01383343|Hematinics|hematinics|mesh-ancestor
44695102|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44695103|NCT01383395|Cilostazol|cilostazol|mesh-list
44695104|NCT01383395|Simvastatin|simvastatin|mesh-list
44695105|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695106|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695107|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
44814693|NCT02115360|Calcitonin|calcitonin|mesh-list
44814694|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
44814695|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44814696|NCT02115360|Fentanyl|fentanyl|mesh-list
44814697|NCT02115360|Katacalcin|katacalcin|mesh-list
44814698|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814699|NCT02115360|Narcotics|narcotics|mesh-ancestor
44814700|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814701|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814702|NCT02115360|Analgesics|analgesics|mesh-ancestor
44814703|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
44814704|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814705|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44814706|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44814707|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
44814708|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
44814709|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301182|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814710|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44814711|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
44814712|NCT02115464|Metformin|metformin|mesh-list
44814713|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44814714|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814715|NCT02115490|Diphosphonates|diphosphonates|mesh-list
44814716|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44814717|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814718|NCT02115529|Nabilone|nabilone|mesh-list
44814719|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
44814720|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
44814721|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814722|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814723|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814724|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44814725|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44814726|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814727|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814728|NCT02115594|Fulvestrant|fulvestrant|mesh-list
44814729|NCT02115594|Entinostat|entinostat|mesh-list
44814730|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814731|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814732|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44814733|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44814734|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
44814735|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814736|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814737|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44814738|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814739|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814740|NCT02115659|Triptolide|triptolide|mesh-list
44814741|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44814742|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814743|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44814744|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
44814745|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44814746|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814747|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
44814748|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44814749|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
44814750|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814751|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814752|NCT02115763|Caffeine|caffeine|mesh-list
44814753|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44814754|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814755|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44814756|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814757|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814758|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44814759|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44814760|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
44814761|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814762|NCT02115776|Amoxicillin|amoxicillin|mesh-list
44814763|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
44814764|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
44814765|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
44814766|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595696|NCT00818168|Infliximab|infliximab|mesh-list
44814767|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814768|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44814769|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
44814770|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44814771|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814772|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814773|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
44814774|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44814775|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814776|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814777|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44814778|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44814779|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
44814780|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44814781|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
44814782|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44814783|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
44814784|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44814785|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
44814786|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814787|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814788|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
44814789|NCT02116231|Cisplatin|cisplatin|mesh-list
44814790|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814791|NCT02116257|Propacetamol|propacetamol|mesh-list
44814792|NCT02116257|Analgesics|analgesics|mesh-ancestor
44814793|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
44814794|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814795|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814796|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44814797|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814798|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814799|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814800|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
44814801|NCT02116348|Mitogens|mitogens|mesh-list
44814802|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
44814803|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814804|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44814805|NCT02116348|Protective Agents|protective agents|mesh-ancestor
44814806|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814807|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
44814808|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
44814809|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
44814810|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814811|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814812|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814813|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
44814814|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44814815|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814816|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814817|NCT02116465|Levodopa|levodopa|mesh-list
44814818|NCT02116465|Carbidopa|carbidopa|mesh-list
44814819|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44814820|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44814821|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44814822|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
44814823|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814824|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814825|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814826|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44814827|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814828|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44814829|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
44814830|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
44814831|NCT02116556|Rifaximin|rifaximin|mesh-list
44814832|NCT02116556|Prednisone|prednisone|mesh-list
44814833|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814834|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
44814835|NCT02116556|Hormones|hormones|mesh-ancestor
44814836|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44814837|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814838|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44814839|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814840|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44814841|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44814842|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44814843|NCT02116569|Daratumumab|daratumumab|mesh-list
44814844|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814845|NCT02116712|Saracatinib|saracatinib|mesh-list
44814846|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814847|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814848|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814849|NCT02116790|Naproxen|naproxen|mesh-list
44814850|NCT02116790|Levodopa|levodopa|mesh-list
44814851|NCT02116790|Carbidopa|carbidopa|mesh-list
44814852|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44814853|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44814854|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44814855|NCT02116790|Analgesics|analgesics|mesh-ancestor
44814856|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
44814857|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814858|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814859|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44814860|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44814861|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
44814862|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44595850|NCT00815295|Sorafenib|sorafenib|mesh-list
44595851|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595852|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595853|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595854|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595855|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595856|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
44595857|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44595858|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44595859|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44595860|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
44595861|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595862|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44595863|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44595864|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424213|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
43700237|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700238|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700239|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700240|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
43700241|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
43700242|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700243|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
43700244|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43700245|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
43700246|NCT02732522|Misoprostol|misoprostol|mesh-list
43700247|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43700248|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
43700249|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700250|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700251|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43700252|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700254|NCT02732678|Propranolol|propranolol|mesh-list
43700255|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43700256|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43700257|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700258|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700259|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700260|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700261|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700262|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43830473|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43830474|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830475|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43830476|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43830477|NCT05361642|Analgesics|analgesics|mesh-ancestor
44814863|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814864|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814865|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44301381|NCT00834600|Diuretics|diuretics|mesh-ancestor
44814866|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44814867|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
44814868|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814869|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44814870|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44814871|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
44814872|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
44814873|NCT02116842|Fentanyl|fentanyl|mesh-list
44814874|NCT02116842|Bupivacaine|bupivacaine|mesh-list
44814875|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
44814876|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
44814877|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814878|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814879|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
44814880|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814881|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814882|NCT02116842|Narcotics|narcotics|mesh-ancestor
44814883|NCT02116842|Analgesics|analgesics|mesh-ancestor
44814884|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44814885|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44814886|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
44814887|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
44814888|NCT02116868|Nicardipine|nicardipine|mesh-list
44814889|NCT02116868|Urapidil|urapidil|mesh-list
44814890|NCT02116868|Remifentanil|remifentanil|mesh-list
44814891|NCT02116868|Esmolol|esmolol|mesh-list
44814892|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814893|NCT02116868|Narcotics|narcotics|mesh-ancestor
44814894|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814895|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814896|NCT02116868|Analgesics|analgesics|mesh-ancestor
44814897|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
44814898|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814899|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44814900|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44814901|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44814902|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44814903|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814904|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814905|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44814906|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44814907|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44814908|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44814909|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44814910|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
44814911|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44814912|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44814913|NCT02116959|Carboplatin|carboplatin|mesh-list
44814914|NCT02116959|Etoposide|etoposide|mesh-list
44814915|NCT02116959|Vincristine|vincristine|mesh-list
44814916|NCT02116959|Melphalan|melphalan|mesh-list
44814917|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814918|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44814919|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44814920|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44814921|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814922|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814923|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44814924|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44814925|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44814926|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44814927|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
44814928|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44814929|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44814930|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
44814931|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814932|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
44814933|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44814934|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44814935|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814936|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
44814937|NCT02117128|Coagulants|coagulants|mesh-ancestor
44814938|NCT02117219|Azacitidine|azacitidine|mesh-list
44814939|NCT02117219|Durvalumab|durvalumab|mesh-list
44814940|NCT02117219|Tremelimumab|tremelimumab|mesh-list
44814941|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44814942|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
44814943|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814944|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814945|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814946|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814947|NCT02117362|Ipilimumab|ipilimumab|mesh-list
44814948|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814949|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814950|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44814951|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814952|NCT02117401|Midazolam|midazolam|mesh-list
44814953|NCT02117401|Ketamine|ketamine|mesh-list
44814954|NCT02117401|Remifentanil|remifentanil|mesh-list
44814955|NCT02117401|Propofol|propofol|mesh-list
44814956|NCT02117401|Mivacurium|mivacurium|mesh-list
44814957|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44814958|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814959|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814960|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44814961|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
44814962|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
44814963|NCT02117401|Analgesics|analgesics|mesh-ancestor
44814964|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
44814965|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44814966|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44814967|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44814968|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44814969|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44814970|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814971|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44814972|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44814973|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44814974|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44814975|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
44814976|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
44814977|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814978|NCT02117401|Narcotics|narcotics|mesh-ancestor
44814979|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44814980|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44814981|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44814982|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44814983|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44814984|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44814985|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
44814986|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44814987|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44814988|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44814989|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44814990|NCT02117466|Cetuximab|cetuximab|mesh-list
44814991|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44814992|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44814993|NCT02117583|Oxycodone|oxycodone|mesh-list
44814994|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44814995|NCT02117583|Narcotics|narcotics|mesh-ancestor
44814996|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44814997|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44814998|NCT02117583|Analgesics|analgesics|mesh-ancestor
44814999|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
44815000|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815001|NCT02117596|Sirolimus|sirolimus|mesh-list
44815002|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815003|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815004|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44815005|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815006|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
44595938|NCT00814333|Thrombin|thrombin|mesh-list
44815007|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44815008|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
44815009|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815010|NCT02117622|Insulin|insulin|mesh-list
44815011|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44815012|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815013|NCT02117726|Midazolam|midazolam|mesh-list
44815014|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
44815015|NCT02117726|Propofol|propofol|mesh-list
44815016|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815017|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815018|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815019|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44815020|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
44815021|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
44815022|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815023|NCT02117726|Analgesics|analgesics|mesh-ancestor
44815024|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
44815025|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815026|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44815027|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44815028|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815029|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815030|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815031|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815032|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44815033|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815034|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815035|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815036|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
44815037|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
44815038|NCT02117739|Dapsone|dapsone|mesh-list
44815039|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815040|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
44815041|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44815042|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44815043|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44815044|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815045|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815046|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
44815047|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815048|NCT02117752|Dapsone|dapsone|mesh-list
44815049|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815050|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
44815051|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44301483|NCT00835744|Enclomiphene|enclomiphene|mesh-list
44815052|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44815053|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44815054|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815055|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815056|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
44815057|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815058|NCT02117765|Ustekinumab|ustekinumab|mesh-list
44815059|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44815060|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
44815061|NCT02117830|Enclomiphene|enclomiphene|mesh-list
44815062|NCT02117830|Clomiphene|clomiphene|mesh-list
44815063|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
44815064|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815065|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815066|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44815067|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815068|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815069|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815070|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815071|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44815072|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815073|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44815074|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
44815075|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815076|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44815077|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
44815078|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44815079|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44815080|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
44815081|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815082|NCT02117869|Furocoumarins|furocoumarins|mesh-list
44815083|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
44815084|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44815085|NCT02117986|Colistin|colistin|mesh-list
44815086|NCT02117986|Polymyxins|polymyxins|mesh-list
44815087|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815088|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815089|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44815090|NCT02118051|Progesterone|progesterone|mesh-list
44815091|NCT02118051|Ganirelix|ganirelix|mesh-list
44815092|NCT02118051|Progestins|progestins|mesh-ancestor
44815093|NCT02118051|Hormones|hormones|mesh-ancestor
44815094|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815095|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815096|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
44815097|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44815098|NCT02118064|Irinotecan|irinotecan|mesh-list
44815099|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44815100|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815101|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815102|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815103|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815104|NCT02118090|Chloroquine|chloroquine|mesh-list
44815105|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44815106|NCT02118090|Amebicides|amebicides|mesh-ancestor
44815107|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44815108|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44815109|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815110|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
44815111|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44815112|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44815113|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815114|NCT02118090|Analgesics|analgesics|mesh-ancestor
44815115|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
44815116|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815117|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815118|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44815119|NCT02118090|Filaricides|filaricides|mesh-ancestor
44815120|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
44815121|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
44815122|NCT02118142|Betaine|betaine|mesh-list
44815123|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815124|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
44815125|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44815126|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
44815127|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815128|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44815129|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
44815130|NCT02118285|Fludarabine|fludarabine|mesh-list
44815131|NCT02118285|Interleukin-2|interleukin-2|mesh-list
44815132|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44815133|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
44815134|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815135|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44815136|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44815137|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
44815138|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815139|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815140|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44815141|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815142|NCT02118285|Analgesics|analgesics|mesh-ancestor
44815143|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
44301568|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
44815144|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815145|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
44815146|NCT02118311|Fludarabine|fludarabine|mesh-list
44815147|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44815148|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
44815149|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815150|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44815151|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44815152|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
44815153|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815154|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815155|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44815156|NCT02118376|Exenatide|exenatide|mesh-list
44815157|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44815158|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815159|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44815160|NCT02118376|Incretins|incretins|mesh-ancestor
44815161|NCT02118376|Hormones|hormones|mesh-ancestor
44815162|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815164|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44815165|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815166|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
44815167|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
44815168|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
44815169|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815170|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
44815171|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815172|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44815173|NCT02118675|Protective Agents|protective agents|mesh-ancestor
44815174|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815175|NCT02118688|Risperidone|risperidone|mesh-list
44815176|NCT02118688|Trazodone|trazodone|mesh-list
44815177|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44815178|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
44815179|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815180|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815181|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815182|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44815183|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815184|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815185|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815186|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44815187|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
44815188|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815189|NCT02118688|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44815190|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44815191|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815192|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44815193|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
44815194|NCT02118753|Eplerenone|eplerenone|mesh-list
44815195|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44815196|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
44596162|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44815197|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815198|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815199|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44815200|NCT02118753|Diuretics|diuretics|mesh-ancestor
44815201|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
44815202|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44815203|NCT02118844|Rocuronium|rocuronium|mesh-list
44815204|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44815205|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44815206|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44815207|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815208|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815209|NCT02118870|Aspirin|aspirin|mesh-list
44815210|NCT02118870|Clopidogrel|clopidogrel|mesh-list
44815211|NCT02118870|Ticagrelor|ticagrelor|mesh-list
44815212|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44815213|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44815214|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596163|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44596164|NCT00811733|Ofatumumab|ofatumumab|mesh-list
44596165|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596166|NCT00811720|Nalmefene|nalmefene|mesh-list
44596167|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44596168|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596169|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
44596170|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596171|NCT00811642|Posaconazole|posaconazole|mesh-list
44596172|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
44596173|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596174|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44596175|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44596176|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44596177|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44596178|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44596179|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301657|NCT00836849|Sertraline|sertraline|mesh-list
44596180|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596181|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44815215|NCT02118870|Analgesics|analgesics|mesh-ancestor
44815216|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
44815217|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815218|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815219|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44815220|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44815221|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44815222|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44815223|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815224|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815225|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44815226|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815227|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
44815228|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44815229|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44815230|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44815231|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
44815232|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596220|NCT00811252|Analgesics|analgesics|mesh-ancestor
44815233|NCT02118909|Itraconazole|itraconazole|mesh-list
44815234|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
44815235|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
44815236|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815237|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44815238|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44815239|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815240|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815241|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44815242|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
44815243|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815244|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815245|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44815246|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815247|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44815248|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815249|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815250|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44815252|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44815253|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44815254|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44815255|NCT02119000|Bisacodyl|bisacodyl|mesh-list
44815256|NCT02119000|Cathartics|cathartics|mesh-ancestor
44815257|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815258|NCT02119000|Laxatives|laxatives|mesh-ancestor
44815259|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44815260|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44815261|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
44815262|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815263|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815264|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44815265|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815266|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815267|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815268|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815269|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
44815270|NCT02119117|Vitamins|vitamins|mesh-ancestor
44815271|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
44815272|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815273|NCT02119143|Vitamins|vitamins|mesh-list
44815274|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
44815275|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695108|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695109|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695110|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44695111|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695112|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44695113|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
44695114|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695115|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695116|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44695117|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
44695118|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44695119|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44695120|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695121|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695122|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44695123|NCT01383395|Protective Agents|protective agents|mesh-ancestor
44695124|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44695125|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44695126|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
44301745|NCT00837564|Citalopram|citalopram|mesh-list
44695127|NCT01383460|Lenograstim|lenograstim|mesh-list
44695128|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44695129|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
44695130|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695131|NCT01383460|Hematinics|hematinics|mesh-ancestor
44695132|NCT01383538|Leucovorin|leucovorin|mesh-list
44695133|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
44695134|NCT01383538|Irinotecan|irinotecan|mesh-list
44695135|NCT01383538|Folfirinox|folfirinox|mesh-list
44695136|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695137|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44695138|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815276|NCT02119234|Beclomethasone|beclomethasone|mesh-list
44815277|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
44815278|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
44815279|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44815280|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
44815281|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815282|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815283|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44815284|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44815285|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44815286|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44815287|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815288|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815289|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815290|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815291|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44815292|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44815293|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44815294|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
44815295|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44815296|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
44815297|NCT02119234|Hormones|hormones|mesh-ancestor
44815298|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815299|NCT02119273|Prednisone|prednisone|mesh-list
44815300|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44815301|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
44815302|NCT02119273|Hormones|hormones|mesh-ancestor
44815303|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815304|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815305|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44815306|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815307|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44815308|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44815309|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
44815310|NCT02119520|Atorvastatin|atorvastatin|mesh-list
44815311|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44815312|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44815313|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
44815314|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815315|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44815316|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44815317|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815318|NCT02119806|Fentanyl|fentanyl|mesh-list
44815319|NCT02119806|Midazolam|midazolam|mesh-list
44815320|NCT02119806|Propofol|propofol|mesh-list
44815321|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815322|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815323|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815324|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44815325|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
44815326|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
44815327|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815328|NCT02119806|Narcotics|narcotics|mesh-ancestor
44815329|NCT02119806|Analgesics|analgesics|mesh-ancestor
44815330|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
44815331|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815332|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44815333|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815334|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815335|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301811|NCT00837889|Diuretics|diuretics|mesh-list
44815336|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
44815337|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
44815338|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815339|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815340|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44815341|NCT02119884|Octreotide|octreotide|mesh-list
44815342|NCT02119884|Terlipressin|terlipressin|mesh-list
44815343|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815344|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44815345|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815346|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44815347|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44815348|NCT02120066|Plasminogen|plasminogen|mesh-list
44815349|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44815350|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44815351|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44815352|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815353|NCT02120092|Clopidogrel|clopidogrel|mesh-list
44815355|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815356|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44815357|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44815358|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44815359|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
44815360|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815361|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815362|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815363|NCT02120118|Cisplatin|cisplatin|mesh-list
44815364|NCT02120118|Docetaxel|docetaxel|mesh-list
44815365|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815366|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44815367|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44815368|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44815369|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815370|NCT02120196|Rifaximin|rifaximin|mesh-list
44815371|NCT02120196|Norfloxacin|norfloxacin|mesh-list
44815372|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815373|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815374|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815375|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44815376|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815377|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815378|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815379|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815380|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44815381|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44815382|NCT02120274|Vitamin D|vitamin d|mesh-list
44815383|NCT02120274|Vitamins|vitamins|mesh-list
44815384|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
44815385|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
44815386|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
44815387|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815388|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44815389|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
44815390|NCT02120274|Hematinics|hematinics|mesh-ancestor
44815391|NCT02120339|Carvedilol|carvedilol|mesh-list
44815392|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44815393|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44815394|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815395|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815396|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815397|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815398|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44815399|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
44815400|NCT02120339|Protective Agents|protective agents|mesh-ancestor
44815401|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44815402|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815403|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44815404|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
44815405|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44815406|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44815407|NCT02120404|Esmolol|esmolol|mesh-list
44301889|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
44815408|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44815409|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44815410|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44815411|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815412|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815413|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815414|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815415|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
44815416|NCT02120547|Liver Extracts|liver extracts|mesh-list
44815417|NCT02120547|Hematinics|hematinics|mesh-ancestor
44815418|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44815419|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815420|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44815421|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44815422|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
44815423|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815424|NCT02120599|Folic Acid|folic acid|mesh-list
44815425|NCT02120599|Hematinics|hematinics|mesh-ancestor
44815426|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
44815427|NCT02120599|Vitamins|vitamins|mesh-ancestor
44815428|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
44815429|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815431|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44815432|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815433|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
44815434|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815435|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
44815436|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
44815437|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44815438|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815439|NCT02120651|Hemostatics|hemostatics|mesh-list
44815440|NCT02120651|Coagulants|coagulants|mesh-ancestor
44815441|NCT02120677|Itraconazole|itraconazole|mesh-list
44815442|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
44815443|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815444|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44815445|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44815446|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815447|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815448|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44815449|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
44815450|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301924|NCT00838240|Cytarabine|cytarabine|mesh-list
44815451|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815452|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44815453|NCT02120703|Pregabalin|pregabalin|mesh-list
44815454|NCT02120703|Gabapentin|gabapentin|mesh-list
44815455|NCT02120703|Analgesics|analgesics|mesh-ancestor
44815456|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
44815457|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815458|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815459|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
44815460|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44815461|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815462|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815463|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44815464|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815465|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815466|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815467|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815468|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44815469|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44815470|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815471|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
44815473|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44815474|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815475|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44815476|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44815477|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44815478|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815479|NCT02120872|Simvastatin|simvastatin|mesh-list
44815480|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44815481|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44815482|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
44815483|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815484|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44815485|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44815486|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815487|NCT02120911|Trastuzumab|trastuzumab|mesh-list
44815488|NCT02120911|Pertuzumab|pertuzumab|mesh-list
44815489|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44815490|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815491|NCT02121119|Lidocaine|lidocaine|mesh-list
44815492|NCT02121119|Bupivacaine|bupivacaine|mesh-list
44815493|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
44815494|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
44815495|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815496|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815497|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
44815498|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815499|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44815500|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44815501|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44815502|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815503|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815504|NCT02121197|Dexamethasone|dexamethasone|mesh-list
44815505|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44815506|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
44815507|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
44815508|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815509|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815510|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815511|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
44815512|NCT02121197|Hormones|hormones|mesh-ancestor
44815513|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815514|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44815515|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815516|NCT02121288|Clopidogrel|clopidogrel|mesh-list
44815517|NCT02121288|Ticagrelor|ticagrelor|mesh-list
44815518|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815519|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44815520|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44815521|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44815522|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
44815523|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815524|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815525|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815526|NCT02121353|Ranibizumab|ranibizumab|mesh-list
44815527|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44815528|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302014|NCT00838760|Darunavir|darunavir|mesh-list
44815529|NCT02121353|Growth Substances|growth substances|mesh-ancestor
44815530|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815531|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
44815532|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815533|NCT02121366|Ethanol|ethanol|mesh-list
44815534|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44815535|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815536|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815537|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815538|NCT02121444|Interferons|interferons|mesh-list
44815539|NCT02121444|Interferon-beta|interferon-beta|mesh-list
44815540|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
44815541|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815542|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
44815543|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815544|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
44815545|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815546|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44815548|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
44815549|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815550|NCT02121457|Protective Agents|protective agents|mesh-ancestor
44815551|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815552|NCT02121457|Trace Elements|trace elements|mesh-ancestor
44815553|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
44815554|NCT02121613|Tamsulosin|tamsulosin|mesh-list
44815555|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
44815556|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44815557|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44815558|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44815559|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815560|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815561|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815562|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815563|NCT02121613|Urological Agents|urological agents|mesh-ancestor
44815564|NCT02121782|Vaccines|vaccines|mesh-list
44815565|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
44815566|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815567|NCT02121951|Lidocaine|lidocaine|mesh-list
44815568|NCT02121951|Fentanyl|fentanyl|mesh-list
44815569|NCT02121951|Midazolam|midazolam|mesh-list
44815570|NCT02121951|Anesthetics|anesthetics|mesh-list
44815571|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
44815572|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
44815573|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815574|NCT02121951|Narcotics|narcotics|mesh-ancestor
44815575|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815576|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815577|NCT02121951|Analgesics|analgesics|mesh-ancestor
44815578|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
44815579|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815580|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44815581|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44815582|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
44815583|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815584|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815585|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815586|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815587|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
44815588|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
44815589|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815590|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815591|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44815592|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44815593|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44815594|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815595|NCT02121990|Paclitaxel|paclitaxel|mesh-list
44815596|NCT02121990|Bevacizumab|bevacizumab|mesh-list
44815597|NCT02121990|Cisplatin|cisplatin|mesh-list
44815598|NCT02121990|Olaparib|olaparib|mesh-list
44815599|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44815600|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815601|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44815602|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44815603|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44815604|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815605|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44815606|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44815607|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44815608|NCT02121990|Growth Substances|growth substances|mesh-ancestor
44815609|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815610|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44815611|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44815612|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815613|NCT02122003|Sorafenib|sorafenib|mesh-list
44815614|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815615|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44815616|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815617|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815618|NCT02122055|Fentanyl|fentanyl|mesh-list
44815619|NCT02122055|Midazolam|midazolam|mesh-list
44815620|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
44815621|NCT02122055|Propofol|propofol|mesh-list
44815622|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815623|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815624|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815625|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44815626|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
44815627|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
44815628|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815629|NCT02122055|Analgesics|analgesics|mesh-ancestor
44815630|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
44815631|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815632|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44815633|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44815634|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815635|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815636|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815637|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815638|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815639|NCT02122055|Narcotics|narcotics|mesh-ancestor
44815640|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44815641|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815642|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815643|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815644|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
44815645|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
44815646|NCT02122172|Afatinib|afatinib|mesh-list
44302127|NCT00839358|Midodrine|midodrine|mesh-list
44815647|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815648|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44815649|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815650|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815651|NCT02122211|Betaine|betaine|mesh-list
44815652|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815653|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
44815654|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44815655|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
44815656|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815657|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44815658|NCT02122393|Sertraline|sertraline|mesh-list
44815659|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
44815660|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815661|NCT02122393|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44815662|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44815663|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815664|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815665|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815666|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
44815667|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815668|NCT02122484|Colchicine|colchicine|mesh-list
44815669|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
44815670|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44815671|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
44815672|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
44815673|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
44815674|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815675|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815676|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
44815677|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815678|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815679|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815680|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815681|NCT02122510|Analgesics|analgesics|mesh-ancestor
44815682|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
44815683|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815684|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44815685|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44815686|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815687|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815688|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815689|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815690|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44815691|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44815692|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44815693|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44815694|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815695|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596709|NCT00807573|Bevacizumab|bevacizumab|mesh-list
44815696|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44815697|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815698|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815699|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
44815700|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815702|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44815703|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
44815704|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815705|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
44815706|NCT02122601|Protective Agents|protective agents|mesh-ancestor
44815707|NCT02122627|Vitamin D|vitamin d|mesh-list
44815708|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
44815709|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
44815710|NCT02122627|Vitamins|vitamins|mesh-list
44815711|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
44815712|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815713|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44815714|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44596786|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
44815715|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
44815716|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44815717|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44815718|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815719|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
44815720|NCT02122679|Coagulants|coagulants|mesh-ancestor
44815721|NCT02122692|Itraconazole|itraconazole|mesh-list
44815722|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44815723|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
44815724|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815725|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44815726|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44815727|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465710|NCT01472835|Fentanyl|fentanyl|mesh-list
44815728|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815729|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44815730|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
44815731|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815732|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815733|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44815734|NCT02122705|Remifentanil|remifentanil|mesh-list
44815735|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815736|NCT02122705|Narcotics|narcotics|mesh-ancestor
44815737|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815738|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815739|NCT02122705|Analgesics|analgesics|mesh-ancestor
44815740|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
44815741|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815742|NCT02122731|Amiloride|amiloride|mesh-list
44815743|NCT02122731|Diuretics|diuretics|mesh-ancestor
44815744|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
44815745|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815746|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44815747|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44815748|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815749|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815750|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44815751|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44815752|NCT02122809|Chiauranib|chiauranib|mesh-list
44815753|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815754|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44815755|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815756|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815757|NCT02122939|Citalopram|citalopram|mesh-list
44815758|NCT02122939|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44815759|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44815760|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44815761|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815762|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815763|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
44815764|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815765|NCT02122939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44815766|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
44815767|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815768|NCT02123004|Clopidogrel|clopidogrel|mesh-list
44815769|NCT02123004|Ticagrelor|ticagrelor|mesh-list
44815770|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815771|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44815772|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44815773|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44815774|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
44815775|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815776|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815777|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815778|NCT02123056|Metoprolol|metoprolol|mesh-list
44815779|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44815780|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44815781|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
44815782|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
44815783|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815784|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815785|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44695139|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815786|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44815787|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44815788|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815789|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815790|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815791|NCT02123069|Nitroprusside|nitroprusside|mesh-list
44815792|NCT02123069|Phenylephrine|phenylephrine|mesh-list
44815793|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
44815794|NCT02123069|Norepinephrine|norepinephrine|mesh-list
44815795|NCT02123069|Acetylcholine|acetylcholine|mesh-list
44815796|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44815797|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
44815798|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
44815799|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815800|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815801|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
44815802|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44815803|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
44815804|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44815805|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44815806|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44815807|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815808|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815809|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815810|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815811|NCT02123069|Protective Agents|protective agents|mesh-ancestor
44815812|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44815813|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
44815814|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44815815|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44815816|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44815817|NCT02123121|Resveratrol|resveratrol|mesh-list
44815818|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
44815819|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815820|NCT02123121|Protective Agents|protective agents|mesh-ancestor
44815821|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302279|NCT00840229|Hormones|hormones|mesh-ancestor
44815822|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815823|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815824|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
44815825|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44815826|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815827|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
44815828|NCT02123355|Remifentanil|remifentanil|mesh-list
44815829|NCT02123355|Sevoflurane|sevoflurane|mesh-list
44815830|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
44815831|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
44815832|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815833|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815834|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815835|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44815836|NCT02123355|Analgesics|analgesics|mesh-ancestor
44815837|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
44815838|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815839|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44815840|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44815841|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44815842|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44815843|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815844|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815845|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44815846|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44815847|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
44815848|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815849|NCT02123355|Narcotics|narcotics|mesh-ancestor
44815850|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44815851|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44815852|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44815853|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44815854|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44815855|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44815856|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
44815857|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44815858|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
44815859|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815860|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
44596940|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
44815861|NCT02123368|Protective Agents|protective agents|mesh-ancestor
44815862|NCT02123381|Cetuximab|cetuximab|mesh-list
44815863|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44815864|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815865|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44815866|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
44815867|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815868|NCT02123498|Omeprazole|omeprazole|mesh-list
44815869|NCT02123498|Pantoprazole|pantoprazole|mesh-list
44815870|NCT02123498|Ranitidine|ranitidine|mesh-list
44815871|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44815872|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44815873|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44815874|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44815875|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815876|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815877|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44815878|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
44815879|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
44815880|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815881|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815882|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
44815883|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44815884|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
44815885|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44815886|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44815887|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815888|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815889|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
44815890|NCT02123563|Listerine|listerine|mesh-list
44815891|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44815892|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815893|NCT02123589|Fentanyl|fentanyl|mesh-list
44815894|NCT02123589|Midazolam|midazolam|mesh-list
44815895|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44815896|NCT02123589|Narcotics|narcotics|mesh-ancestor
44815897|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815898|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815899|NCT02123589|Analgesics|analgesics|mesh-ancestor
44815900|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
44815901|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815902|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44597014|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44597015|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
44597016|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597017|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597018|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597019|NCT00804193|Ciclopirox|ciclopirox|mesh-list
44597020|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
44597021|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597022|NCT00804141|Bromides|bromides|mesh-list
44597023|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
44597024|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
44597025|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44597026|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597027|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
44597028|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597029|NCT00803738|Terconazole|terconazole|mesh-list
44597030|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
44597031|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597032|NCT00803712|Vitamin D|vitamin d|mesh-list
44597033|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
44597034|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
44597035|NCT00803712|Vitamins|vitamins|mesh-list
44597036|NCT00803712|Cinacalcet|cinacalcet|mesh-list
44597037|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
44597038|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597039|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44597040|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44597041|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44597042|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
44597043|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597044|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
44597045|NCT00803634|Diltiazem|diltiazem|mesh-list
44597046|NCT00803634|Nitroprusside|nitroprusside|mesh-list
44815903|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44815904|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
44815905|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
44815906|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44815907|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44815908|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44815909|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44815910|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
44815911|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
44815912|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815913|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815914|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
44815915|NCT02123615|Antibodies|antibodies|mesh-list
44815916|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
44815917|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44815918|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44815919|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
44815920|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
44815921|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815922|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44815923|NCT02123628|Doxycycline|doxycycline|mesh-list
44815924|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
44815925|NCT02123628|Levofloxacin|levofloxacin|mesh-list
44815926|NCT02123628|Rifampin|rifampin|mesh-list
44815927|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
44815928|NCT02123628|Linezolid|linezolid|mesh-list
44815929|NCT02123628|Cefepime|cefepime|mesh-list
44815930|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44815931|NCT02123628|Cefotaxime|cefotaxime|mesh-list
44815932|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
44815933|NCT02123628|Trimethoprim|trimethoprim|mesh-list
44815934|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
44815935|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44815936|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44815937|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
44815938|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
44815939|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44815940|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44815941|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44815942|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44815943|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815944|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815945|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815946|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44815947|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44815948|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44815949|NCT02123628|Renal Agents|renal agents|mesh-ancestor
44815950|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
44815951|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44815952|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44815953|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44815954|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44815955|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44815956|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44815957|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44815958|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44815959|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44815960|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44815961|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44815962|NCT02123654|Asunaprevir|asunaprevir|mesh-list
44815963|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
44815964|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44815965|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815966|NCT02123979|Rotigotine|rotigotine|mesh-list
44815967|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
44695140|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695141|NCT01383538|Antidotes|antidotes|mesh-ancestor
44695142|NCT01383538|Protective Agents|protective agents|mesh-ancestor
44695143|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695144|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
44695145|NCT01383538|Vitamins|vitamins|mesh-ancestor
44695146|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
44695147|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
44695148|NCT01383655|Analgesics|analgesics|mesh-ancestor
44695149|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
44695150|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695151|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695152|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
44815968|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
44815969|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44815970|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815971|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815972|NCT02124005|Bupivacaine|bupivacaine|mesh-list
44815973|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
44815974|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
44815975|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44815976|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815977|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
44815978|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44815980|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44815981|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815982|NCT02124148|Leucovorin|leucovorin|mesh-list
44815983|NCT02124148|Cisplatin|cisplatin|mesh-list
44815984|NCT02124148|Fluorouracil|fluorouracil|mesh-list
44815985|NCT02124148|Pemetrexed|pemetrexed|mesh-list
44815986|NCT02124148|Cetuximab|cetuximab|mesh-list
44815987|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44815988|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
44815989|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44815990|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44815991|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44815992|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
44815993|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44815994|NCT02124148|Antidotes|antidotes|mesh-ancestor
44815995|NCT02124148|Protective Agents|protective agents|mesh-ancestor
44815996|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
44815997|NCT02124148|Vitamins|vitamins|mesh-ancestor
44815998|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
44815999|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816000|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44816001|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44816002|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44816003|NCT02124174|Azacitidine|azacitidine|mesh-list
44816004|NCT02124174|Valproic Acid|valproic acid|mesh-list
44816005|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816006|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
44816007|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816008|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816009|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816010|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
44816011|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
44816012|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816013|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816014|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
44816015|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44816016|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816017|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816018|NCT02124200|Nicotine|nicotine|mesh-list
44816019|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44816020|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
44816021|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816022|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816023|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44816024|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44816025|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
44816026|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816027|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816028|NCT02124226|Methotrexate|methotrexate|mesh-list
44816029|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44816030|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
44816031|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816032|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816033|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816034|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
44816035|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816036|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816037|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816038|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816039|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44816040|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816041|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
44816042|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816043|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44816044|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
44816045|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816046|NCT02124317|Paclitaxel|paclitaxel|mesh-list
44816047|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44816048|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44816049|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816050|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816051|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816052|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816053|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816054|NCT02124330|Bentonite|bentonite|mesh-list
44816055|NCT02124330|Antidotes|antidotes|mesh-ancestor
44816056|NCT02124330|Protective Agents|protective agents|mesh-ancestor
44816057|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816058|NCT02124369|Gemcitabine|gemcitabine|mesh-list
44816059|NCT02124369|Paclitaxel|paclitaxel|mesh-list
44816060|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44816061|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44816062|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816063|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816064|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816065|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816066|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816067|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816068|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
44816069|NCT02124369|Antiviral Agents|antiviral agents|mesh-ancestor
44816070|NCT02124369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816071|NCT02124369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816072|NCT02124369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816073|NCT02124369|Immunologic Factors|immunologic factors|mesh-ancestor
44816074|NCT02124369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816075|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
44816076|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44816077|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
44816078|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816079|NCT02124525|Expectorants|expectorants|mesh-ancestor
44816080|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816081|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44816082|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
44816083|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816084|NCT02124525|Protective Agents|protective agents|mesh-ancestor
44816085|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816086|NCT02124525|Antidotes|antidotes|mesh-ancestor
44816087|NCT02124642|Folic Acid|folic acid|mesh-list
44816088|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
44816089|NCT02124642|Hematinics|hematinics|mesh-ancestor
44816090|NCT02124642|Vitamins|vitamins|mesh-ancestor
44816091|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
44816092|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816093|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
44816094|NCT02124655|Listerine|listerine|mesh-list
44816095|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44816096|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816097|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
44816098|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
44816099|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
44816100|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44816101|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44816102|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816103|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816104|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816105|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816106|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44816107|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44816108|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816109|NCT02124850|Nivolumab|nivolumab|mesh-list
44816110|NCT02124850|Cetuximab|cetuximab|mesh-list
44816111|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44816112|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816113|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44816114|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816115|NCT02124954|Digoxin|digoxin|mesh-list
44816116|NCT02124954|Midazolam|midazolam|mesh-list
44816117|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816118|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44816119|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816120|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816121|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44816122|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44816123|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816124|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44816125|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
44816126|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
44816127|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
44816128|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
44816129|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816130|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816131|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44816132|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44816133|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816134|NCT02124954|Protective Agents|protective agents|mesh-ancestor
44816135|NCT02125084|Everolimus|everolimus|mesh-list
44816136|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816137|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816138|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
44816139|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816140|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44816141|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
44816142|NCT02125188|Coagulants|coagulants|mesh-ancestor
44816143|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44816144|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
44816145|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816146|NCT02125201|Fentanyl|fentanyl|mesh-list
44816147|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44816148|NCT02125201|Narcotics|narcotics|mesh-ancestor
44816149|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816150|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816151|NCT02125201|Analgesics|analgesics|mesh-ancestor
44816152|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
44816153|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816154|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816155|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44816156|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
44816157|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
44816158|NCT02125227|Metformin|metformin|mesh-list
44816159|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44816160|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816161|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816162|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816163|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816164|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
44816165|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816166|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44816167|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44816168|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816169|NCT02125305|Metformin|metformin|mesh-list
44816170|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816171|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816172|NCT02125318|Anagrelide|anagrelide|mesh-list
44816173|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44816174|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44816175|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816176|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44816177|NCT02125344|Paclitaxel|paclitaxel|mesh-list
44816178|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
44816179|NCT02125344|Carboplatin|carboplatin|mesh-list
44816180|NCT02125344|Doxorubicin|doxorubicin|mesh-list
44816181|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44816182|NCT02125344|Trastuzumab|trastuzumab|mesh-list
44816183|NCT02125344|Epirubicin|epirubicin|mesh-list
44816184|NCT02125344|Pertuzumab|pertuzumab|mesh-list
44816185|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44816186|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816187|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816188|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816189|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816190|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816191|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816192|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
44816193|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816194|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816195|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44816196|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
44816197|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44816198|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44302629|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816199|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816200|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816201|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816202|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44816203|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
44816204|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816205|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44816206|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816207|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816208|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
44816209|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816210|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816211|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44816212|NCT02125409|Aspirin|aspirin|mesh-list
44816213|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44816214|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44816215|NCT02125409|Analgesics|analgesics|mesh-ancestor
44816216|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
44816217|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816218|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816219|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816220|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816221|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44816222|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44816223|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816224|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44816225|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44816226|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816227|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
44816228|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
44816229|NCT02125500|Ledipasvir|ledipasvir|mesh-list
44816230|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
44816231|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816232|NCT02125565|Lidocaine|lidocaine|mesh-list
44816233|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816234|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
44816235|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816236|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816237|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
44816238|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816239|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44816240|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44816241|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44816242|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44816243|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816244|NCT02125578|Interferons|interferons|mesh-list
44816245|NCT02125578|Interferon-beta|interferon-beta|mesh-list
44816246|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
44816247|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816248|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
44816249|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816250|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
44816251|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816252|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44816253|NCT02125617|Prednisolone|prednisolone|mesh-list
44816254|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816255|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
44816256|NCT02125617|Hormones|hormones|mesh-ancestor
44816257|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816258|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816259|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44816260|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816261|NCT02125630|Hormones|hormones|mesh-list
44816262|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816263|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816264|NCT02125643|Caffeine|caffeine|mesh-list
44816265|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44816266|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816267|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44816268|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816269|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816270|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44816271|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44816272|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
44816273|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816274|NCT02125682|Atorvastatin|atorvastatin|mesh-list
44816275|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816276|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816277|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
44816278|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816279|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44816280|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44816281|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816282|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
44816283|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816284|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816285|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816286|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816287|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816288|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816289|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816290|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
44816291|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44816292|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44816293|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816294|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
44816295|NCT02125890|Coagulants|coagulants|mesh-ancestor
44816296|NCT02125903|Ropivacaine|ropivacaine|mesh-list
44816297|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816298|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
44816299|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816300|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597422|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816301|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
44816302|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816303|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
44816304|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44816305|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44816306|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816307|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816308|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816309|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816310|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
44816311|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
44816312|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816313|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
44816314|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44816315|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816316|NCT02126020|Infliximab|infliximab|mesh-list
44816317|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816318|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44816319|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816320|NCT02126137|Ezetimibe|ezetimibe|mesh-list
44816321|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816322|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816323|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
44816324|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816325|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44597493|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44597494|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597495|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44597496|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
44597497|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
44597498|NCT00797862|Amlodipine|amlodipine|mesh-list
44597499|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44597500|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44816327|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44816328|NCT02126267|Azithromycin|azithromycin|mesh-list
44816329|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44816330|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816331|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
44816332|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816333|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816334|NCT02126293|Zinc|zinc|mesh-list
44816335|NCT02126293|Trace Elements|trace elements|mesh-ancestor
44816336|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
44816337|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816338|NCT02126332|Acetaminophen|acetaminophen|mesh-list
44816339|NCT02126332|Sufentanil|sufentanil|mesh-list
44816340|NCT02126332|Nefopam|nefopam|mesh-list
44816341|NCT02126332|Tramadol|tramadol|mesh-list
44816342|NCT02126332|Ropivacaine|ropivacaine|mesh-list
44816343|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816344|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
44816345|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816346|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816347|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
44816348|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816349|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44816350|NCT02126332|Analgesics|analgesics|mesh-ancestor
44816351|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
44816352|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44816353|NCT02126332|Narcotics|narcotics|mesh-ancestor
44816354|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816355|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44816356|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
44816357|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44816358|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816359|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816360|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
44816361|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816362|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44816363|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44816364|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816365|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44816366|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
44816367|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816368|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44816369|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44816370|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
44816371|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816372|NCT02126462|Antacids|antacids|mesh-ancestor
44816373|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816374|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44816375|NCT02126527|Sirolimus|sirolimus|mesh-list
44816376|NCT02126527|Auranofin|auranofin|mesh-list
44816377|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816378|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816379|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44816380|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816381|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
44816382|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816383|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
44816384|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816385|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816386|NCT02126579|Poly ICLC|poly iclc|mesh-list
44816387|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
44816388|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
44816389|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816390|NCT02126644|Glycolic acid|glycolic acid|mesh-list
44816391|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
44816392|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816393|NCT02126657|Glycolic acid|glycolic acid|mesh-list
44816394|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
44816395|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44816396|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
44816397|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
44816398|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44816399|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44816400|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816401|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302841|NCT00843063|Pantoprazole|pantoprazole|mesh-list
44816402|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816403|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816404|NCT02126761|Vaccines|vaccines|mesh-list
44816405|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
44816406|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816407|NCT02126943|Macitentan|macitentan|mesh-list
44816408|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44816409|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44816410|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816411|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44816412|NCT02126956|Ponesimod|ponesimod|mesh-list
44816413|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44816414|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816415|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816416|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
44816417|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816418|NCT02126995|Metadoxine|metadoxine|mesh-list
44816419|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44816420|NCT02127034|Digoxin|digoxin|mesh-list
44816421|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
44816422|NCT02127034|Mirabegron|mirabegron|mesh-list
44816423|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44816424|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44816425|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816426|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816427|NCT02127034|Protective Agents|protective agents|mesh-ancestor
44816428|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816429|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44816430|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44816431|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
44816432|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816433|NCT02127034|Urological Agents|urological agents|mesh-ancestor
44816434|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44816435|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44816436|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44816437|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816438|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44816439|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816440|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816441|NCT02127047|Incretins|incretins|mesh-ancestor
44816442|NCT02127047|Hormones|hormones|mesh-ancestor
44816443|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816444|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44816445|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44816446|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465800|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
44816447|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816448|NCT02127060|Ascorbic Acid|ascorbic acid|mesh-list
44816449|NCT02127060|Vitamins|vitamins|mesh-ancestor
44816450|NCT02127060|Micronutrients|micronutrients|mesh-ancestor
44816451|NCT02127060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816452|NCT02127060|Antioxidants|antioxidants|mesh-ancestor
44816453|NCT02127060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816454|NCT02127060|Protective Agents|protective agents|mesh-ancestor
44816455|NCT02127138|Sirolimus|sirolimus|mesh-list
44816456|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816457|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816458|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44816459|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816460|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
44816461|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816462|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
44816463|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816464|NCT02127151|Talazoparib|talazoparib|mesh-list
44816465|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44816466|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816467|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816468|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816469|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44816470|NCT02127164|Eusol|eusol|mesh-list
44816471|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
44816472|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816473|NCT02127190|CXA-10|cxa-10|mesh-list
44816474|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816475|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44816476|NCT02127320|Ezetimibe|ezetimibe|mesh-list
44816477|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816478|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816479|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
44816480|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816481|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44816482|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44816483|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816485|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816486|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44816487|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44816488|NCT02127489|Bupivacaine|bupivacaine|mesh-list
44816489|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816490|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
44816491|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816492|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816493|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
44816494|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816495|NCT02127541|Exenatide|exenatide|mesh-list
44816496|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816497|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816498|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44816499|NCT02127541|Incretins|incretins|mesh-ancestor
44816500|NCT02127541|Hormones|hormones|mesh-ancestor
44816501|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816502|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
44816503|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44816504|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44816505|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44816506|NCT02127593|Norgestimate|norgestimate|mesh-list
44816507|NCT02127593|Norgestrel|norgestrel|mesh-list
44816508|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44816509|NCT02127593|Estradiol|estradiol|mesh-list
44816510|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44816511|NCT02127593|Estrogens|estrogens|mesh-ancestor
44816512|NCT02127593|Hormones|hormones|mesh-ancestor
44816513|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816514|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816515|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44816516|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
44816517|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816518|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44816519|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44816520|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44816521|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44816522|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816523|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816524|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816525|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816526|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816527|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816528|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816529|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44816530|NCT02127684|Ranibizumab|ranibizumab|mesh-list
44816531|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44816532|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44816533|NCT02127684|Growth Substances|growth substances|mesh-ancestor
44816534|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816535|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44816536|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816537|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
44816538|NCT02127697|Albuterol|albuterol|mesh-list
44816539|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44816540|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
44816541|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816542|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816543|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44816544|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816545|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
44816546|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816547|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44816548|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44816549|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44816550|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816551|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816552|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816553|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816554|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44816555|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44816556|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
44816557|NCT02127736|Amitriptyline|amitriptyline|mesh-list
44816558|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44816559|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
44816560|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816561|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303013|NCT00844350|Letrozole|letrozole|mesh-list
44816562|NCT02127736|Analgesics|analgesics|mesh-ancestor
44816563|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
44816564|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816565|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816566|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44816567|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44816568|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44816569|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816570|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816571|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597733|NCT00795600|Insulin|insulin|mesh-list
44816572|NCT02127749|Metronidazole|metronidazole|mesh-list
44816573|NCT02127749|Vancomycin|vancomycin|mesh-list
44816574|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
44816575|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816576|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816577|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44816578|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44816579|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816580|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816581|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816582|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816583|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816584|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44816585|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44816586|NCT02127775|Lesinurad|lesinurad|mesh-list
44816587|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
44816588|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816589|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
44816590|NCT02127775|Renal Agents|renal agents|mesh-ancestor
44816591|NCT02127788|Micafungin|micafungin|mesh-list
44816592|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
44816593|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816594|NCT02127840|Epinephrine|epinephrine|mesh-list
44816595|NCT02127840|Racepinephrine|racepinephrine|mesh-list
44816596|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
44816597|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44816598|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44816599|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816600|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816601|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816602|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816603|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44816604|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44816605|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
44816606|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816607|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44816608|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816609|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
44816610|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
44816611|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44816612|NCT02127853|Gabapentin|gabapentin|mesh-list
44816613|NCT02127853|Analgesics|analgesics|mesh-ancestor
44816614|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
44816615|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695153|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44695154|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44695155|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
44695156|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44695157|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695158|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695159|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695160|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
44695161|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695162|NCT01383668|Sirolimus|sirolimus|mesh-list
44695163|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
44695164|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44246713|NCT03657797|Latanoprost|latanoprost|mesh-list
44695165|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695166|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44695167|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695168|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
44695169|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695170|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
44695171|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695172|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44695173|NCT01383694|Piperine|piperine|mesh-list
44695174|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44695175|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695176|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695177|NCT01383785|Abciximab|abciximab|mesh-list
44695178|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
44695179|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695180|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
44695181|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44695182|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44816616|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816617|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
44816618|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44816619|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44816620|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816621|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816622|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44816623|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44816624|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816625|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816626|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
44816627|NCT02127866|Beclomethasone|beclomethasone|mesh-list
44816628|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
44816629|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
44816630|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44816631|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
44816632|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816633|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816634|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44816635|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44816636|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44816637|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44816638|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44816639|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44816640|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816641|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816642|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816643|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44816644|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44816645|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
44816646|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816647|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
44816648|NCT02127866|Hormones|hormones|mesh-ancestor
44816649|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816650|NCT02127918|Clobazam|clobazam|mesh-list
44816651|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
44816652|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44816653|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44816654|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816655|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816656|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816657|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44816658|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
44816659|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
44816660|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816661|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816662|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44816663|NCT02127996|Incretins|incretins|mesh-ancestor
44816664|NCT02127996|Hormones|hormones|mesh-ancestor
44816665|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816666|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816667|NCT02128022|Glyburide|glyburide|mesh-list
44816668|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816669|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816670|NCT02128061|Rituximab|rituximab|mesh-list
44816671|NCT02128061|Lenalidomide|lenalidomide|mesh-list
44816672|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44816673|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816674|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
44816675|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816676|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816677|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44816678|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44816679|NCT02128061|Growth Substances|growth substances|mesh-ancestor
44816680|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
44816681|NCT02128100|Leucovorin|leucovorin|mesh-list
44816682|NCT02128100|Fluorouracil|fluorouracil|mesh-list
44816683|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
44816684|NCT02128100|Irinotecan|irinotecan|mesh-list
44816685|NCT02128100|Folfirinox|folfirinox|mesh-list
44816686|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
44816687|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816688|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816689|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597844|NCT00794365|Varenicline|varenicline|mesh-list
44816690|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816691|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
44816692|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816693|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44816694|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816695|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816696|NCT02128100|Antidotes|antidotes|mesh-ancestor
44816697|NCT02128100|Protective Agents|protective agents|mesh-ancestor
44816698|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
44816699|NCT02128100|Vitamins|vitamins|mesh-ancestor
44816700|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
44816701|NCT02128126|Vaccines|vaccines|mesh-list
44816702|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
44816703|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816704|NCT02128178|Enoxaparin|enoxaparin|mesh-list
44816705|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
44816706|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
44816707|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44816708|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44816709|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816710|NCT02128191|Ibuprofen|ibuprofen|mesh-list
44816711|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44816712|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44816713|NCT02128191|Analgesics|analgesics|mesh-ancestor
44816714|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
44816715|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816716|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816717|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816718|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816719|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44816720|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816721|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816722|NCT02128204|Lidocaine|lidocaine|mesh-list
44816723|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816724|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
44816725|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816726|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816727|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
44816728|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816729|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44816730|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44816731|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44816732|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44816733|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816734|NCT02128243|Leucovorin|leucovorin|mesh-list
44816735|NCT02128243|Cisplatin|cisplatin|mesh-list
44816736|NCT02128243|Docetaxel|docetaxel|mesh-list
44816737|NCT02128243|Fluorouracil|fluorouracil|mesh-list
44816738|NCT02128243|Capecitabine|capecitabine|mesh-list
44816739|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
44816740|NCT02128243|Epirubicin|epirubicin|mesh-list
44816741|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
44816742|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816743|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816744|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816745|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816746|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816747|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
44816748|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816749|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816750|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
44816751|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816752|NCT02128243|Antidotes|antidotes|mesh-ancestor
44816753|NCT02128243|Protective Agents|protective agents|mesh-ancestor
44816754|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
44816755|NCT02128243|Vitamins|vitamins|mesh-ancestor
44816756|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
44816757|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44816758|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816759|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816760|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816761|NCT02128282|Gemcitabine|gemcitabine|mesh-list
44816762|NCT02128282|Cisplatin|cisplatin|mesh-list
44816763|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816764|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816765|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
44816766|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816767|NCT02128282|Antiviral Agents|antiviral agents|mesh-ancestor
44816768|NCT02128282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816769|NCT02128282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816770|NCT02128282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597997|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816771|NCT02128282|Immunologic Factors|immunologic factors|mesh-ancestor
44816772|NCT02128282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816773|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
44816774|NCT02128308|Levofloxacin|levofloxacin|mesh-list
44816776|NCT02128308|Cycloserine|cycloserine|mesh-list
44816777|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
44816778|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44816779|NCT02128308|Streptomycin|streptomycin|mesh-list
44816780|NCT02128308|Kanamycin|kanamycin|mesh-list
44816781|NCT02128308|Prothionamide|prothionamide|mesh-list
44816782|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44816783|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44816784|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816785|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44816786|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816787|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816788|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816789|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816790|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44816791|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
44816792|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816793|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816794|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44816795|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44816796|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44816797|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44816798|NCT02128308|Renal Agents|renal agents|mesh-ancestor
44816799|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44816800|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44816801|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44816802|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
44816803|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
44816804|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44816805|NCT02128321|Repaglinide|repaglinide|mesh-list
44816806|NCT02128321|Isavuconazole|isavuconazole|mesh-list
44816807|NCT02128321|Caffeine|caffeine|mesh-list
44816808|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44816809|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816810|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44816811|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816812|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816813|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44816814|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44816815|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
44816816|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44816817|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44816818|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
44816819|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816820|NCT02128334|Leuprolide|leuprolide|mesh-list
44816821|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44816822|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
44816823|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816824|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816825|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44816826|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597998|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44597999|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44598000|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44598001|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598002|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44598003|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44598004|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
44598005|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44598006|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44598007|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
44598008|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
44598009|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44303281|NCT00845819|Povidone|povidone|mesh-list
44598010|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44598011|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44426434|NCT02219477|Ritonavir|ritonavir|mesh-list
44816827|NCT02128360|Letrozole|letrozole|mesh-list
44816828|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816829|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44816830|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44816831|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816832|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816833|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44816834|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44816835|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816836|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816837|NCT02128425|Leucovorin|leucovorin|mesh-list
44816838|NCT02128425|Fluorouracil|fluorouracil|mesh-list
44816839|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
44816840|NCT02128425|Irinotecan|irinotecan|mesh-list
44816841|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
44816842|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
44816843|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816844|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816845|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816846|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44816847|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
44816848|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816849|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44816850|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44816851|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816852|NCT02128425|Antidotes|antidotes|mesh-ancestor
44816853|NCT02128425|Protective Agents|protective agents|mesh-ancestor
44816854|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
44816855|NCT02128425|Vitamins|vitamins|mesh-ancestor
44816856|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
44816857|NCT02128451|Fentanyl|fentanyl|mesh-list
44816858|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44816859|NCT02128451|Narcotics|narcotics|mesh-ancestor
44816860|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816861|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816862|NCT02128451|Analgesics|analgesics|mesh-ancestor
44816863|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
44816864|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816865|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44816866|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44816867|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
44816868|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
44816869|NCT02128633|Listerine|listerine|mesh-list
44816870|NCT02128633|Fluorides|fluorides|mesh-list
44816871|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
44816872|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
44816873|NCT02128633|Protective Agents|protective agents|mesh-ancestor
44816874|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816875|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44816876|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816877|NCT02128646|Ketorolac|ketorolac|mesh-list
44816878|NCT02128646|Bupivacaine|bupivacaine|mesh-list
44816879|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44816880|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
44816881|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44816882|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816883|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
44816884|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44816885|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44816886|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44816887|NCT02128646|Analgesics|analgesics|mesh-ancestor
44816888|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44816889|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44816890|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44816891|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816892|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816893|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
44816894|NCT02128685|Progestins|progestins|mesh-ancestor
44816895|NCT02128685|Hormones|hormones|mesh-ancestor
44816896|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816897|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816898|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
44816899|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44816900|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
44816901|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44816902|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
44816903|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816904|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695183|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44816905|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
44816906|NCT02128893|Isavuconazole|isavuconazole|mesh-list
44816907|NCT02128893|Esomeprazole|esomeprazole|mesh-list
44816908|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44816909|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44816910|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44816911|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816912|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816913|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
44816914|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44816915|NCT02128906|Cisplatin|cisplatin|mesh-list
44816916|NCT02128906|Docetaxel|docetaxel|mesh-list
44816917|NCT02128906|Cetuximab|cetuximab|mesh-list
44816918|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816919|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816920|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816921|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816922|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816923|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44816924|NCT02128945|Fludarabine|fludarabine|mesh-list
44816925|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816926|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
44816927|NCT02128971|Trace Elements|trace elements|mesh-ancestor
44816928|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
44816929|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816930|NCT02128984|Antioxidants|antioxidants|mesh-list
44816931|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816932|NCT02128984|Protective Agents|protective agents|mesh-ancestor
44303398|NCT00848796|Calcium heparin|calcium heparin|mesh-list
44816933|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816934|NCT02129088|Esketamine|esketamine|mesh-list
44816935|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
44816936|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44816937|NCT02129101|Azacitidine|azacitidine|mesh-list
44816938|NCT02129101|Decitabine|decitabine|mesh-list
44816939|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816940|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
44816941|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816942|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816943|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816944|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44816945|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44816946|NCT02129114|Estradiol|estradiol|mesh-list
44816947|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44816948|NCT02129114|Estrogens|estrogens|mesh-ancestor
44816949|NCT02129114|Hormones|hormones|mesh-ancestor
44816950|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816951|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816952|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44816953|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
44816954|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44816955|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44816956|NCT02129127|Paclitaxel|paclitaxel|mesh-list
44816957|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44816958|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816959|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44816960|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44816961|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44816962|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816963|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
44816964|NCT02129166|Dasatinib|dasatinib|mesh-list
44816965|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44816966|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44816967|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816968|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816969|NCT02129179|Glucagon|glucagon|mesh-list
44816970|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44816971|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44816972|NCT02129179|Hormones|hormones|mesh-ancestor
44816973|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44816974|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44816975|NCT02129179|Incretins|incretins|mesh-ancestor
44816976|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
44816977|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44816978|NCT02129231|Simvastatin|simvastatin|mesh-list
44816979|NCT02129231|Ezetimibe|ezetimibe|mesh-list
44816980|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44816981|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44816982|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44816983|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
44816984|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816985|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44816986|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44816987|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44816988|NCT02129231|Antacids|antacids|mesh-ancestor
44816989|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44816990|NCT02129257|Leucovorin|leucovorin|mesh-list
44816991|NCT02129257|Folic Acid|folic acid|mesh-list
44816992|NCT02129257|Fluorouracil|fluorouracil|mesh-list
44816993|NCT02129257|Irinotecan|irinotecan|mesh-list
44816994|NCT02129257|Aflibercept|aflibercept|mesh-list
44816995|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
44816996|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
44816997|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44816998|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44816999|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817000|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817001|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
44817002|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817003|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44817004|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44817005|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817006|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44817007|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44817008|NCT02129257|Growth Substances|growth substances|mesh-ancestor
44817009|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
44817010|NCT02129257|Antidotes|antidotes|mesh-ancestor
44817011|NCT02129257|Protective Agents|protective agents|mesh-ancestor
44817012|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
44817013|NCT02129257|Vitamins|vitamins|mesh-ancestor
44817014|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
44817015|NCT02129257|Hematinics|hematinics|mesh-ancestor
44817016|NCT02129270|Lidocaine|lidocaine|mesh-list
44817017|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
44817018|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
44817019|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817020|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817021|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
44817022|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817023|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44817024|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44817025|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44817026|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817027|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817028|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
44817029|NCT02129322|Sorafenib|sorafenib|mesh-list
44817030|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817031|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44817032|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817033|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817034|NCT02129400|Anesthetics|anesthetics|mesh-list
44817035|NCT02129400|Xenon|xenon|mesh-list
44817036|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817037|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817038|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44817039|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
44695184|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817040|NCT02129582|Methotrexate|methotrexate|mesh-list
44817041|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
44817042|NCT02129582|Fludarabine|fludarabine|mesh-list
44817043|NCT02129582|Busulfan|busulfan|mesh-list
44817044|NCT02129582|Tacrolimus|tacrolimus|mesh-list
44817045|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
44817046|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44817047|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
44817048|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44817049|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
44817050|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44817051|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817052|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44817053|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
44817054|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817055|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817056|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44817057|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817058|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44817059|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817060|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
44817061|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817062|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44817063|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44817064|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
44817065|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44817066|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44817067|NCT02129595|Resveratrol|resveratrol|mesh-list
44817068|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
44817069|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817070|NCT02129595|Protective Agents|protective agents|mesh-ancestor
44817071|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817072|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817073|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44817074|NCT02129621|Spironolactone|spironolactone|mesh-list
44817075|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44817076|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817077|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817078|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817079|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44817080|NCT02129621|Diuretics|diuretics|mesh-ancestor
44817081|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
44817082|NCT02129634|Paclitaxel|paclitaxel|mesh-list
44817083|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44817084|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817085|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44817086|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44817087|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44817088|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817089|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44817090|NCT02129673|Latanoprost|latanoprost|mesh-list
44817091|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44817092|NCT02129699|Denosumab|denosumab|mesh-list
44817093|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817094|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817095|NCT02129764|Prednisone|prednisone|mesh-list
44817096|NCT02129764|Allopurinol|allopurinol|mesh-list
44817097|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817098|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
44817099|NCT02129764|Hormones|hormones|mesh-ancestor
44817100|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817101|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817102|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44817103|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817104|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
44817105|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817106|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817107|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
44817108|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817109|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44817110|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
44817111|NCT02129764|Protective Agents|protective agents|mesh-ancestor
44817112|NCT02129829|Tenofovir|tenofovir|mesh-list
44817113|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
44817114|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817115|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44817116|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44817117|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817118|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817119|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44817120|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44817121|NCT02129933|Bevacizumab|bevacizumab|mesh-list
44817122|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44817123|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817124|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44817125|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44817126|NCT02129933|Growth Substances|growth substances|mesh-ancestor
44817127|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817128|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
44817129|NCT02129985|Metformin|metformin|mesh-list
44817130|NCT02129985|Exenatide|exenatide|mesh-list
44817131|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44817132|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817133|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44817134|NCT02129985|Incretins|incretins|mesh-ancestor
44817135|NCT02129985|Hormones|hormones|mesh-ancestor
44817136|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817137|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44817138|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44817139|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817140|NCT02130167|Atropine|atropine|mesh-list
44817141|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817142|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44817143|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44817144|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
44817145|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817146|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817147|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44817148|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
44817149|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
44817150|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
44817151|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44817152|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44817153|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44817154|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817155|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817156|NCT02130323|Imiquimod|imiquimod|mesh-list
44817157|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44817158|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
44817159|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817160|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817161|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
44817162|NCT02130414|Cyclosporine|cyclosporine|mesh-list
44817163|NCT02130414|Cyclosporins|cyclosporins|mesh-list
44817164|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817165|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817166|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817167|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
44817168|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817169|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
44817170|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817171|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
44817172|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817173|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44817174|NCT02130440|Resveratrol|resveratrol|mesh-list
44817175|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
44817176|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817177|NCT02130440|Protective Agents|protective agents|mesh-ancestor
44817178|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817179|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817180|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44817181|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44817182|NCT02130661|Itraconazole|itraconazole|mesh-list
44817183|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
44817184|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817185|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44817186|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44817187|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817188|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817189|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44817190|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817191|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817192|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817193|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44817194|NCT02130700|Seviteronel|seviteronel|mesh-list
44817195|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817196|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44817197|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817198|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817199|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
44817200|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817201|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817202|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44817203|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817204|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817205|NCT02130739|Fentanyl|fentanyl|mesh-list
44817206|NCT02130739|Propofol|propofol|mesh-list
44817207|NCT02130739|Ropivacaine|ropivacaine|mesh-list
44817208|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
44817209|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817210|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817211|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817212|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817213|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
44817214|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
44817215|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
44817216|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817217|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817218|NCT02130739|Narcotics|narcotics|mesh-ancestor
44817219|NCT02130739|Analgesics|analgesics|mesh-ancestor
44817220|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817221|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44817222|NCT02130804|Salicylates|salicylates|mesh-list
44817223|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817224|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817225|NCT02130804|Analgesics|analgesics|mesh-ancestor
44817226|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
44817227|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817228|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817229|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817230|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817231|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44817232|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817233|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817234|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
44817235|NCT02130817|Dexamethasone|dexamethasone|mesh-list
44817236|NCT02130817|Prednisone|prednisone|mesh-list
44817237|NCT02130817|Abatacept|abatacept|mesh-list
44817238|NCT02130817|Tacrolimus|tacrolimus|mesh-list
44817239|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
44817240|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44303688|NCT00850382|Dasatinib|dasatinib|mesh-list
44817241|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
44817242|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44817243|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
44817244|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
44817245|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44817246|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817247|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
44817248|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
44817249|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817250|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817251|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817252|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
44817253|NCT02130817|Hormones|hormones|mesh-ancestor
44817254|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817255|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44817256|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817257|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817258|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817259|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817260|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
44817261|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44817262|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44817263|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44817264|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
44817265|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817266|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817267|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44817268|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817269|NCT02130830|Lidocaine|lidocaine|mesh-list
44817270|NCT02130830|Prilocaine|prilocaine|mesh-list
44817271|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
44817272|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
44817273|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817274|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817275|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
44817276|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817277|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44817278|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44817279|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44817280|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817281|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817282|NCT02130869|Cytarabine|cytarabine|mesh-list
44817283|NCT02130869|Aldesleukin|aldesleukin|mesh-list
44817284|NCT02130869|Carboplatin|carboplatin|mesh-list
44817285|NCT02130869|Etoposide|etoposide|mesh-list
44817286|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
44817287|NCT02130869|Melphalan|melphalan|mesh-list
44817288|NCT02130869|Busulfan|busulfan|mesh-list
44817289|NCT02130869|Interleukin-2|interleukin-2|mesh-list
44817290|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44817291|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
44817292|NCT02130869|Sargramostim|sargramostim|mesh-list
44817293|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817294|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44817295|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44817296|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44817297|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817298|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817299|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44817300|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
44817301|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
44817302|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817303|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817304|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
44817305|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817306|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44817307|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
44817308|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44817309|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817310|NCT02130869|Analgesics|analgesics|mesh-ancestor
44817311|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
44817312|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817313|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44817314|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44817315|NCT02130973|Denosumab|denosumab|mesh-list
44817316|NCT02130973|Teriparatide|teriparatide|mesh-list
44817317|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817318|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303764|NCT00851461|Goserelin|goserelin|mesh-list
44817319|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44817320|NCT02131012|Celecoxib|celecoxib|mesh-list
44817321|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817322|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817323|NCT02131012|Analgesics|analgesics|mesh-ancestor
44817324|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
44817325|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817326|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817327|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817328|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817329|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44817330|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44817331|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817332|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598460|NCT00788710|Etoricoxib|etoricoxib|mesh-list
44598461|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817333|NCT02131220|Tirofiban|tirofiban|mesh-list
44817334|NCT02131220|Saruplase|saruplase|mesh-list
44817335|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44817336|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44817337|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817338|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44817339|NCT02131246|Insulin|insulin|mesh-list
44817340|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44817341|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
44817342|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
44817343|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44817344|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44817345|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817346|NCT02131298|Itraconazole|itraconazole|mesh-list
44817347|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44817348|NCT02131298|Palbociclib|palbociclib|mesh-list
44817349|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
44817350|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817351|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44817352|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44817353|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817354|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817355|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44817356|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817357|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817358|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817359|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44817360|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817361|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44817362|NCT02131350|Ranibizumab|ranibizumab|mesh-list
44817363|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44817364|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44817365|NCT02131350|Growth Substances|growth substances|mesh-ancestor
44817366|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817367|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44817368|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817369|NCT02131480|Doxorubicin|doxorubicin|mesh-list
44817370|NCT02131480|Trabectedin|trabectedin|mesh-list
44817371|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44817372|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817373|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44817374|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44817375|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817376|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817377|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44817378|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
44817379|NCT02131506|Lapatinib|lapatinib|mesh-list
44817380|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44817381|NCT02131506|Doxorubicin|doxorubicin|mesh-list
44817382|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817383|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44817384|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817385|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817386|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44817387|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44817388|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44817389|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44817390|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
44817391|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817392|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44817393|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817394|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817395|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817396|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
44817397|NCT02131688|Analgesics|analgesics|mesh-ancestor
44817398|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
44817399|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817400|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817401|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817402|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44817403|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44817404|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695185|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598533|NCT00787891|Rabeprazole|rabeprazole|mesh-list
44817405|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817406|NCT02131818|Amoxicillin|amoxicillin|mesh-list
44817407|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817408|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817409|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
44817410|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44817411|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817412|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
44817414|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
44817415|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44817416|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817417|NCT02132000|Tamoxifen|tamoxifen|mesh-list
44817418|NCT02132000|Toremifene|toremifene|mesh-list
44817419|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44817420|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817421|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817422|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817423|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44817424|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817425|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44817426|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44817427|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817428|NCT02132026|Denosumab|denosumab|mesh-list
44817429|NCT02132026|Alendronate|alendronate|mesh-list
44817430|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817431|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817432|NCT02132091|Vitamins|vitamins|mesh-list
44817433|NCT02132091|Ascorbic Acid|ascorbic acid|mesh-list
44817434|NCT02132091|Vitamin E|vitamin e|mesh-list
44817435|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
44817436|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817437|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
44817438|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817439|NCT02132091|Protective Agents|protective agents|mesh-ancestor
44817440|NCT02132104|Hormones|hormones|mesh-list
44817441|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817442|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817443|NCT02132234|Adalimumab|adalimumab|mesh-list
44817444|NCT02132234|Etanercept|etanercept|mesh-list
44817445|NCT02132234|Infliximab|infliximab|mesh-list
44817446|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
44817447|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817448|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817449|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
44817450|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817451|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817452|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817453|NCT02132234|Analgesics|analgesics|mesh-ancestor
44817454|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
44817455|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817456|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817457|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817458|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
44817459|NCT02132260|Naftifine|naftifine|mesh-list
44817460|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
44817461|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817462|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44817463|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
44817464|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817465|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44817466|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817467|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817468|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817469|NCT02132390|Toremifene|toremifene|mesh-list
44817470|NCT02132390|Goserelin|goserelin|mesh-list
44817471|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44817472|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817473|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44817474|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44817475|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817476|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817477|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817478|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817479|NCT02132403|Gemcitabine|gemcitabine|mesh-list
44817480|NCT02132403|Milk fat globule|milk fat globule|mesh-list
44817481|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44817482|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
44817483|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817484|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817485|NCT02132403|Antiviral Agents|antiviral agents|mesh-ancestor
44817486|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817487|NCT02132403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817488|NCT02132403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817489|NCT02132403|Immunologic Factors|immunologic factors|mesh-ancestor
44817490|NCT02132403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817492|NCT02132416|Ibuprofen|ibuprofen|mesh-list
44817493|NCT02132416|Diclofenac|diclofenac|mesh-list
44817494|NCT02132416|Morphine|morphine|mesh-list
44817495|NCT02132416|Oxycodone|oxycodone|mesh-list
44817496|NCT02132416|Tramadol|tramadol|mesh-list
44817497|NCT02132416|Anesthetics|anesthetics|mesh-list
44303881|NCT00852332|Analgesics|analgesics|mesh-ancestor
44817498|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817499|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817500|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817501|NCT02132416|Narcotics|narcotics|mesh-ancestor
44817502|NCT02132416|Analgesics|analgesics|mesh-ancestor
44817503|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
44817504|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817505|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817506|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817507|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817508|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817509|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44817510|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817511|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817512|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
44817513|NCT02132442|Vitamin D|vitamin d|mesh-list
44817514|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
44817515|NCT02132442|Vitamins|vitamins|mesh-ancestor
44817516|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
44817517|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817518|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44817519|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44817520|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
44817521|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44817522|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817523|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
44817524|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44817525|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44817526|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
44817527|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817528|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44817529|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44817530|NCT02132689|Heparin|heparin|mesh-list
44817531|NCT02132689|Calcium heparin|calcium heparin|mesh-list
44817532|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44817533|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817534|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
44817535|NCT02132897|Carbamazepine|carbamazepine|mesh-list
44817536|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
44817537|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
44817538|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817539|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817540|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817541|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817542|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817543|NCT02132897|Analgesics|analgesics|mesh-ancestor
44817544|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
44817545|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817546|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44817547|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817548|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817549|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44817550|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44817551|NCT02133014|Fluorouracil|fluorouracil|mesh-list
44817552|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
44817553|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817554|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44817555|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817556|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817558|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817559|NCT02133053|Beclomethasone|beclomethasone|mesh-list
44817560|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817561|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
44817562|NCT02133053|Hormones|hormones|mesh-ancestor
44817563|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817564|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817565|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44817566|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
44817567|NCT02133105|Simendan|simendan|mesh-list
44817568|NCT02133105|Dobutamine|dobutamine|mesh-list
44817569|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44817570|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
44817571|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44817572|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44817573|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817574|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817575|NCT02133105|Protective Agents|protective agents|mesh-ancestor
44817576|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817577|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
44817578|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
44817579|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817580|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44817581|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44817582|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44817583|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
44817584|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817585|NCT02133118|Pioglitazone|pioglitazone|mesh-list
44817586|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44817587|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817588|NCT02133287|Sirolimus|sirolimus|mesh-list
44817589|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
44817590|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817591|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817592|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44817593|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817594|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
44817595|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817596|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
44817597|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817598|NCT02133326|Acetaminophen|acetaminophen|mesh-list
44817599|NCT02133326|Ibuprofen|ibuprofen|mesh-list
44817600|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817601|NCT02133326|Analgesics|analgesics|mesh-ancestor
44817602|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
44817603|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817604|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817605|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
44817606|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44817607|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817608|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817609|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44817610|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817611|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817612|NCT02133378|Hemostatics|hemostatics|mesh-list
44817613|NCT02133378|Coagulants|coagulants|mesh-ancestor
44817614|NCT02133469|Vaccines|vaccines|mesh-list
44817615|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44817616|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
44817617|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817618|NCT02133612|Paclitaxel|paclitaxel|mesh-list
44817619|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44817620|NCT02133612|Cisplatin|cisplatin|mesh-list
44817621|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44817622|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817623|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44817624|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44817625|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44817626|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817627|NCT02133625|Pioglitazone|pioglitazone|mesh-list
44817628|NCT02133625|Carboplatin|carboplatin|mesh-list
44817629|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817630|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44817631|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817632|NCT02133638|Propofol|propofol|mesh-list
44817633|NCT02133638|Sevoflurane|sevoflurane|mesh-list
44817634|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817635|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817636|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817637|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817638|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
44817639|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
44817640|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44817641|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44817642|NCT02133677|Temozolomide|temozolomide|mesh-list
44817643|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44817644|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
44817645|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817646|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817648|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44817649|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44817650|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817651|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817652|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817653|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
44817654|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
44817655|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817656|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817657|NCT02133820|Analgesics|analgesics|mesh-list
44817658|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
44817659|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817660|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817661|NCT02133885|Minocycline|minocycline|mesh-list
44817662|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817663|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817664|NCT02133911|Ranolazine|ranolazine|mesh-list
44817665|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44817666|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817667|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817668|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44817669|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
44817670|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817671|NCT02133989|Ticlopidine|ticlopidine|mesh-list
44817672|NCT02133989|Clopidogrel|clopidogrel|mesh-list
44817673|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44817674|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44817675|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44817676|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44817677|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
44817678|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817679|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817680|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817681|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44817682|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44817683|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44817684|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44817685|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817686|NCT02134002|Disulfiram|disulfiram|mesh-list
44817687|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44817688|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44817689|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817690|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817691|NCT02134067|Paclitaxel|paclitaxel|mesh-list
44817692|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44817693|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817694|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
44817695|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
44817696|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
44817697|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817698|NCT02134093|Midazolam|midazolam|mesh-list
44817699|NCT02134093|Sufentanil|sufentanil|mesh-list
44817700|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
44817701|NCT02134093|Remifentanil|remifentanil|mesh-list
44817702|NCT02134093|Anesthetics|anesthetics|mesh-list
44817703|NCT02134093|Propofol|propofol|mesh-list
44817704|NCT02134093|Etomidate|etomidate|mesh-list
44817705|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
44817706|NCT02134093|Rocuronium|rocuronium|mesh-list
44817707|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817708|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817709|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817710|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817711|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
44817712|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817713|NCT02134093|Analgesics|analgesics|mesh-ancestor
44817714|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
44817715|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817716|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44817717|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44817718|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44817719|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44817720|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817721|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817722|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817723|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44817724|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817725|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817726|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
44817727|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
44817728|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817729|NCT02134093|Narcotics|narcotics|mesh-ancestor
44817730|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44817731|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44817732|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44817733|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44817734|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44817735|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
44817736|NCT02134106|Polymyxins|polymyxins|mesh-list
44817737|NCT02134106|Doripenem|doripenem|mesh-list
44817738|NCT02134106|Polymyxin B|polymyxin b|mesh-list
44817739|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44817740|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817741|NCT02134249|Cabergoline|cabergoline|mesh-list
44817742|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44817743|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44817744|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
44817745|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
44817746|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817747|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817748|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817749|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
44817750|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44817751|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817752|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
44817753|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817754|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817755|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44817756|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
44817757|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817758|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817759|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44817760|NCT02134288|Everolimus|everolimus|mesh-list
44817761|NCT02134288|Abatacept|abatacept|mesh-list
44817762|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817763|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817764|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
44817765|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817766|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44817767|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817768|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44817769|NCT02134327|Midazolam|midazolam|mesh-list
44817770|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
44817771|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817772|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817773|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817774|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44817775|NCT02134327|Analgesics|analgesics|mesh-ancestor
44817776|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
44598984|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598985|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598986|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44598987|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44598988|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44598989|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598990|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598991|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44598992|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44598993|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44598994|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
44598995|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
44598996|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598997|NCT00783289|Benralizumab|benralizumab|mesh-list
44598998|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44598999|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
44817777|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817778|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44817779|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44817780|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44817781|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
44817782|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817783|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817784|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817785|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44817786|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817787|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817788|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817789|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
44817791|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
44817792|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
44817793|NCT02134366|Lorazepam|lorazepam|mesh-list
44817794|NCT02134366|Clonazepam|clonazepam|mesh-list
44817795|NCT02134366|Clobazam|clobazam|mesh-list
44817796|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
44817797|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
44817798|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
44817799|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817800|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817801|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817802|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817803|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817804|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44817805|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817806|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817807|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
44817808|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
44817809|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817810|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817811|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44817812|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
44817813|NCT02134379|Clotrimazole|clotrimazole|mesh-list
44817814|NCT02134379|Miconazole|miconazole|mesh-list
44817815|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44817816|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817817|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
44817818|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44817819|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44817820|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817821|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817822|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44817823|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
44817824|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817825|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817826|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44817827|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44817828|NCT02134405|Esomeprazole|esomeprazole|mesh-list
44817829|NCT02134405|Rebamipide|rebamipide|mesh-list
44817830|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44817831|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817832|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44817833|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817834|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817835|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
44817836|NCT02134405|Protective Agents|protective agents|mesh-ancestor
44817837|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817838|NCT02134457|Ranibizumab|ranibizumab|mesh-list
44817839|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44817840|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44817841|NCT02134457|Growth Substances|growth substances|mesh-ancestor
44817842|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817843|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
44817844|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817845|NCT02134470|Testosterone|testosterone|mesh-list
44817846|NCT02134470|Androgens|androgens|mesh-ancestor
44817847|NCT02134470|Hormones|hormones|mesh-ancestor
44817848|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44817849|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817850|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
44817851|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44817852|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817853|NCT02134626|Simvastatin|simvastatin|mesh-list
44817854|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44817855|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44817856|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
44817857|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817858|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44817859|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44817860|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817861|NCT02134639|Edotreotide|edotreotide|mesh-list
44817862|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44817863|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817864|NCT02134717|Maraviroc|maraviroc|mesh-list
44817865|NCT02134717|Dimercaprol|dimercaprol|mesh-list
44817866|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44817867|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44817868|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817869|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44817870|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44817871|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
44817872|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817873|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44817874|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
44817875|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
44695186|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
44817876|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44817877|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817878|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44817879|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817880|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817881|NCT02134899|Everolimus|everolimus|mesh-list
44817882|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44817883|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817884|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44817885|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
44817886|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817887|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304282|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44817888|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817889|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44817890|NCT02134938|Cathartics|cathartics|mesh-ancestor
44817891|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817892|NCT02134964|Dapansutrile|dapansutrile|mesh-list
44817893|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44817894|NCT02134990|Docetaxel|docetaxel|mesh-list
44817895|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44817896|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44817897|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44817898|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44817899|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817900|NCT02135029|Atorvastatin|atorvastatin|mesh-list
44817901|NCT02135029|Bococizumab|bococizumab|mesh-list
44817902|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44817903|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44817904|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
44817905|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817906|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44817907|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44817908|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817909|NCT02135055|Midazolam|midazolam|mesh-list
44817910|NCT02135055|Morphine|morphine|mesh-list
44817911|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817912|NCT02135055|Narcotics|narcotics|mesh-ancestor
44817913|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817914|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817915|NCT02135055|Analgesics|analgesics|mesh-ancestor
44817916|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
44817917|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817918|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817919|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44817920|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44817921|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44817922|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44817923|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817924|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
44817925|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
44817926|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
44817927|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
44817928|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817929|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817930|NCT02135120|Morphine|morphine|mesh-list
44817931|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817932|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817933|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817934|NCT02135120|Narcotics|narcotics|mesh-ancestor
44817935|NCT02135120|Analgesics|analgesics|mesh-ancestor
44817936|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
44817937|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817938|NCT02135224|Fentanyl|fentanyl|mesh-list
44817939|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44817940|NCT02135224|Narcotics|narcotics|mesh-ancestor
44817941|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44817942|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817943|NCT02135224|Analgesics|analgesics|mesh-ancestor
44817944|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
44817945|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817946|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44817947|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44817948|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
44817949|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
44817950|NCT02135263|Enalapril|enalapril|mesh-list
44817951|NCT02135263|Methylphenidate|methylphenidate|mesh-list
44599197|NCT00780143|Cytarabine|cytarabine|mesh-list
44817952|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44817953|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817954|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44817955|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44817956|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817957|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817958|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
44817959|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817960|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44817961|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
44817962|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44817963|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44817964|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
44817965|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44817966|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44817967|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44817968|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44817969|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44817970|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817971|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
44817972|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817973|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817974|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44817975|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817976|NCT02135354|Azithromycin|azithromycin|mesh-list
44817977|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44695187|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695188|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695189|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44695190|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695191|NCT01384227|Proflavine|proflavine|mesh-list
44695192|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695193|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695194|NCT01384240|Proflavine|proflavine|mesh-list
44695195|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695196|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695197|NCT01384253|Trastuzumab|trastuzumab|mesh-list
44304373|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695198|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695199|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695200|NCT01384058|Simvastatin|simvastatin|mesh-list
44695201|NCT01384058|Ezetimibe|ezetimibe|mesh-list
44695202|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695203|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695204|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
44695205|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695206|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695207|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44695208|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695209|NCT01384279|Metformin|metformin|mesh-list
44695210|NCT01384279|Topiramate|topiramate|mesh-list
44695211|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44695212|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695213|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
44695214|NCT01384331|NuvaRing|nuvaring|mesh-list
44695215|NCT01384331|Desogestrel|desogestrel|mesh-list
44695216|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44695217|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
44695218|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695219|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695220|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44695221|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44695222|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44695223|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44695224|NCT01384331|Progestins|progestins|mesh-ancestor
44695225|NCT01384331|Hormones|hormones|mesh-ancestor
44695226|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695227|NCT01384448|Dobutamine|dobutamine|mesh-list
44695228|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44695229|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
44695230|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
44695231|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695232|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695233|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44695234|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44599271|NCT00779259|Quinine|quinine|mesh-list
44817978|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44817979|NCT02135393|Folic Acid|folic acid|mesh-list
44817980|NCT02135393|Hematinics|hematinics|mesh-ancestor
44817981|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
44817982|NCT02135393|Vitamins|vitamins|mesh-ancestor
44817983|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
44817984|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817985|NCT02135510|Palonosetron|palonosetron|mesh-list
44817986|NCT02135510|Metoclopramide|metoclopramide|mesh-list
44817987|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
44817988|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
44817989|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44817990|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44817991|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44817992|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44817993|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44817994|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
44817995|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44817996|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44817997|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44817998|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44817999|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
44818000|NCT02135588|Plasminogen|plasminogen|mesh-list
44818001|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44818002|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44818003|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44818004|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818005|NCT02135627|Epinephrine|epinephrine|mesh-list
44818006|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44818007|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818008|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818009|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818010|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818011|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818012|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44818013|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44818014|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
44818015|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818016|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44818017|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44818018|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
44818019|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
44818020|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44818021|NCT02135640|Denosumab|denosumab|mesh-list
44818022|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44818023|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818024|NCT02135770|Heparin|heparin|mesh-list
44818025|NCT02135770|Calcium heparin|calcium heparin|mesh-list
44818026|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
44818027|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44818028|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44818029|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818030|NCT02135822|Gemcitabine|gemcitabine|mesh-list
44818031|NCT02135822|Paclitaxel|paclitaxel|mesh-list
44818032|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44818033|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44818034|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818035|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818036|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818037|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818038|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818039|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44818040|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
44818041|NCT02135822|Antiviral Agents|antiviral agents|mesh-ancestor
44818042|NCT02135822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818043|NCT02135822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818044|NCT02135822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818045|NCT02135822|Immunologic Factors|immunologic factors|mesh-ancestor
44818046|NCT02135822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818047|NCT02135887|Leucovorin|leucovorin|mesh-list
44818048|NCT02135887|Folic Acid|folic acid|mesh-list
44818049|NCT02135887|Fluorouracil|fluorouracil|mesh-list
44818050|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
44818051|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
44818052|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
44818053|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818054|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44818055|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818056|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818057|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
44818058|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818059|NCT02135887|Antidotes|antidotes|mesh-ancestor
44818060|NCT02135887|Protective Agents|protective agents|mesh-ancestor
44818061|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
44818062|NCT02135887|Vitamins|vitamins|mesh-ancestor
44818063|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
44818064|NCT02135887|Hematinics|hematinics|mesh-ancestor
44818065|NCT02135913|Vitamin D|vitamin d|mesh-list
44818066|NCT02135913|Vitamins|vitamins|mesh-ancestor
44818067|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
44818068|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818069|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44818070|NCT02135965|Caffeine|caffeine|mesh-list
44818071|NCT02135965|Albuterol|albuterol|mesh-list
44818072|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44818073|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818074|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44818075|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818076|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818077|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44818078|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44818079|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
44818080|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818081|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44818082|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
44818083|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818084|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44818085|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44818086|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
44818087|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44818088|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44818089|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44818090|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818091|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818092|NCT02136030|Amphotericin B|amphotericin b|mesh-list
44818093|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44818094|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44818095|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
44818096|NCT02136030|Amebicides|amebicides|mesh-ancestor
44818097|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44818098|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44818099|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818100|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818101|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
44818102|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44818103|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818104|NCT02136147|Guanfacine|guanfacine|mesh-list
44818105|NCT02136147|Methylphenidate|methylphenidate|mesh-list
44818106|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44818107|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44818108|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44818109|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818110|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44818111|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44818112|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818113|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818114|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
44818115|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818116|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44818117|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818118|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818119|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44818120|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44818121|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818122|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44818123|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
44818124|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
44818125|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44818126|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44818127|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818128|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818129|NCT02136329|Urological Agents|urological agents|mesh-ancestor
44818130|NCT02136511|Rituximab|rituximab|mesh-list
44818131|NCT02136511|Idelalisib|idelalisib|mesh-list
44818132|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44818133|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818134|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
44818135|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818136|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818137|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818138|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599448|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
44599449|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599450|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599451|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44599452|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599453|NCT00777049|Panobinostat|panobinostat|mesh-list
44599454|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599455|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44599456|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599457|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599458|NCT00777023|Gabapentin|gabapentin|mesh-list
44599459|NCT00777023|Analgesics|analgesics|mesh-ancestor
44599460|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
44599463|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
44818139|NCT02136589|Diclofenac|diclofenac|mesh-list
44818140|NCT02136589|Travoprost|travoprost|mesh-list
44818141|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818142|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44818143|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818144|NCT02136589|Analgesics|analgesics|mesh-ancestor
44818145|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
44818146|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818147|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818148|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818149|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818150|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44818151|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818152|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818153|NCT02136641|Fentanyl|fentanyl|mesh-list
44818154|NCT02136641|Midazolam|midazolam|mesh-list
44818155|NCT02136641|Ketamine|ketamine|mesh-list
44818156|NCT02136641|Analgesics|analgesics|mesh-ancestor
44818157|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
44818158|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818159|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818160|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44818161|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818162|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
44818163|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
44818164|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818165|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44818166|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44818167|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818168|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818169|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818170|NCT02136641|Narcotics|narcotics|mesh-ancestor
44818171|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44818172|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44818173|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44818174|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818175|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818176|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
44818177|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
44818178|NCT02136693|Psyllium|psyllium|mesh-list
44818179|NCT02136693|Cathartics|cathartics|mesh-ancestor
44818180|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818181|NCT02136771|Vitamin D|vitamin d|mesh-list
44818182|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
44818183|NCT02136771|Vitamins|vitamins|mesh-ancestor
44818184|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
44818185|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818186|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44818187|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44818188|NCT02136784|Morphine|morphine|mesh-list
44818189|NCT02136784|Oxycodone|oxycodone|mesh-list
44304623|NCT00856505|Everolimus|everolimus|mesh-list
44818190|NCT02136784|Buprenorphine|buprenorphine|mesh-list
44818191|NCT02136784|Hydromorphone|hydromorphone|mesh-list
44818192|NCT02136784|Hydrocodone|hydrocodone|mesh-list
44818193|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818194|NCT02136784|Narcotics|narcotics|mesh-ancestor
44818195|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818196|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818197|NCT02136784|Analgesics|analgesics|mesh-ancestor
44818198|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
44818199|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818200|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44818201|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
44818202|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44818203|NCT02136823|Isradipine|isradipine|mesh-list
44818204|NCT02136823|Riluzole|riluzole|mesh-list
44818205|NCT02136823|Memantine|memantine|mesh-list
44818206|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44818207|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44818208|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
44818209|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818210|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818211|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818212|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44818213|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44818214|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
44818215|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44818216|NCT02136823|Protective Agents|protective agents|mesh-ancestor
44818217|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818218|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44818219|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818220|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44818221|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
44818222|NCT02136875|Fluticasone|fluticasone|mesh-list
44818224|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44818225|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818226|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44818227|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
44818228|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818229|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818230|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44818231|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44818232|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44818233|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44818234|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44818235|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44818236|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818237|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818238|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818239|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818240|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
44818241|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44818242|NCT02136888|Ponesimod|ponesimod|mesh-list
44818243|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818244|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818245|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44818246|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44818247|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304658|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818248|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818249|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818250|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44818251|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
44818252|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44818253|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818254|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44818255|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44818256|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44818257|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44818258|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818259|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
44818260|NCT02136979|Propofol|propofol|mesh-list
44818261|NCT02136979|Sevoflurane|sevoflurane|mesh-list
44818262|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44818263|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818264|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818265|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818266|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
44818267|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
44818268|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44818269|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44818270|NCT02136992|Pirfenidone|pirfenidone|mesh-list
44818271|NCT02136992|Analgesics|analgesics|mesh-ancestor
44818272|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
44818273|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818274|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818275|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44818276|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818277|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818278|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818279|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818280|NCT02137083|Docetaxel|docetaxel|mesh-list
44818281|NCT02137083|Fulvestrant|fulvestrant|mesh-list
44818282|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818283|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818284|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818285|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818286|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818287|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818288|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44818289|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44818290|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
44599590|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
44818291|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304719|NCT00857116|Albendazole|albendazole|mesh-list
44818292|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818293|NCT02137109|Natalizumab|natalizumab|mesh-list
44818294|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
44818295|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818296|NCT02137161|Tobramycin|tobramycin|mesh-list
44818297|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44818298|NCT02137161|Dexamethasone|dexamethasone|mesh-list
44818299|NCT02137161|Bromfenac|bromfenac|mesh-list
44818300|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44818301|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818302|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
44818303|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
44818304|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818305|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818306|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818307|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
44818308|NCT02137161|Hormones|hormones|mesh-ancestor
44818309|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818310|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818311|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818312|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44818313|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818314|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818315|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44818316|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818317|NCT02137161|Analgesics|analgesics|mesh-ancestor
44818318|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
44818319|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818320|NCT02137213|Naloxone|naloxone|mesh-list
44818321|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44818322|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818323|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
44818324|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818325|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
44818326|NCT02137239|Prednisone|prednisone|mesh-list
44818327|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
44818328|NCT02137239|Everolimus|everolimus|mesh-list
44818329|NCT02137239|Abatacept|abatacept|mesh-list
44818330|NCT02137239|Tacrolimus|tacrolimus|mesh-list
44818331|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
44818332|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818333|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
44818334|NCT02137239|Hormones|hormones|mesh-ancestor
44818335|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818336|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818337|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818338|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818339|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818340|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
44818341|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44818342|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818343|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818344|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44818345|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44818346|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
44818347|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818348|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818349|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
44818350|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
44818351|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818352|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818353|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44818354|NCT02137239|Protective Agents|protective agents|mesh-ancestor
44818355|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44818356|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818357|NCT02137265|Clomiphene|clomiphene|mesh-list
44818358|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44818359|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
44818360|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818361|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818362|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44818363|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
44818364|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44818365|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44818366|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44818367|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
44818368|NCT02137278|Levodopa|levodopa|mesh-list
44818369|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
44818370|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
44818371|NCT02137278|Diuretics|diuretics|mesh-list
44818372|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818373|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
44818374|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818375|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
44818376|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818377|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818378|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44818379|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44818380|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818381|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818382|NCT02137356|Capecitabine|capecitabine|mesh-list
44818383|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44818384|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
44818385|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818386|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818387|NCT02137395|Dexamethasone|dexamethasone|mesh-list
44818388|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818389|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
44818390|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
44818391|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818392|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818393|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818394|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
44818395|NCT02137395|Hormones|hormones|mesh-ancestor
44818396|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818397|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818398|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818399|NCT02137421|Resveratrol|resveratrol|mesh-list
44818400|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
44818401|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818402|NCT02137421|Protective Agents|protective agents|mesh-ancestor
44818403|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818404|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818405|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44818406|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
44818407|NCT02137434|Calcium|calcium|mesh-list
44818408|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44818409|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818410|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44818411|NCT02137525|Fentanyl|fentanyl|mesh-list
44818412|NCT02137525|Morphine|morphine|mesh-list
44818413|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818414|NCT02137525|Narcotics|narcotics|mesh-ancestor
44818415|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818416|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818417|NCT02137525|Analgesics|analgesics|mesh-ancestor
44818418|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
44818419|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818420|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44818421|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818422|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
44818423|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
44818424|NCT02137616|Olanzapine|olanzapine|mesh-list
44818425|NCT02137616|Risperidone|risperidone|mesh-list
44818426|NCT02137616|Aripiprazole|aripiprazole|mesh-list
44818427|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44818428|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44818429|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
44818430|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818431|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818432|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818433|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44818434|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818435|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818436|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818437|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44818438|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
44818439|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
44818440|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
44818441|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818442|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818443|NCT02137616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44818444|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44818445|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818446|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
44818447|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
44818448|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44818449|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44818450|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44818451|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44818452|NCT02137629|Azacitidine|azacitidine|mesh-list
44818453|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44818454|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
44818455|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818456|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818457|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818458|NCT02137668|Vancomycin|vancomycin|mesh-list
44818459|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818460|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818461|NCT02137681|Rituximab|rituximab|mesh-list
44818462|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44818463|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818464|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
44818465|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818466|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818467|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44818468|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44818469|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818470|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818471|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
44818472|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818473|NCT02137733|Carvedilol|carvedilol|mesh-list
44818474|NCT02137733|Bisoprolol|bisoprolol|mesh-list
44818475|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44818476|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44818477|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818478|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818479|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818480|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818481|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818482|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
44818483|NCT02137733|Protective Agents|protective agents|mesh-ancestor
44818484|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44818485|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818486|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44818487|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
44818488|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44818489|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44818490|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
44818491|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
44818492|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818493|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44818494|NCT02137759|Temozolomide|temozolomide|mesh-list
44818495|NCT02137759|Belinostat|belinostat|mesh-list
44818496|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44818497|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
44818498|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818499|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818500|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44818501|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818502|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
44818503|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44818504|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818505|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818506|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818507|NCT02137863|Analgesics|analgesics|mesh-ancestor
44818508|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
44818509|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818510|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44818511|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44818512|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818513|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818514|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599816|NCT00772668|Hormones|hormones|mesh-ancestor
44818515|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818516|NCT02137928|Carboplatin|carboplatin|mesh-list
44818517|NCT02137928|Etoposide|etoposide|mesh-list
44818518|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
44818519|NCT02137928|Vincristine|vincristine|mesh-list
44818520|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818521|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44818522|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44818523|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44818524|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818525|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818526|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818527|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818528|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818529|NCT02137954|Lidocaine|lidocaine|mesh-list
44818530|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
44818531|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
44818532|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818533|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818534|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
44818535|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818536|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44818537|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44818538|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44818539|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818540|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818541|NCT02137993|Olanzapine|olanzapine|mesh-list
44818542|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
44818543|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
44818544|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818545|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818546|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818547|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44818548|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818549|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818550|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818551|NCT02137993|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44818552|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44818553|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818554|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818555|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818556|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
44818557|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44818558|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
44818559|NCT02138019|Coagulants|coagulants|mesh-ancestor
44818560|NCT02138045|Liraglutide|liraglutide|mesh-list
44818561|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44818562|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818563|NCT02138045|Incretins|incretins|mesh-ancestor
44818564|NCT02138045|Hormones|hormones|mesh-ancestor
44818565|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818566|NCT02138058|Topiramate|topiramate|mesh-list
44818567|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
44818568|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44818569|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818570|NCT02138084|Ritonavir|ritonavir|mesh-list
44818571|NCT02138084|Fostemsavir|fostemsavir|mesh-list
44818572|NCT02138084|Rifabutin|rifabutin|mesh-list
44818573|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44818574|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44818575|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44818576|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818577|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818578|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44818579|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44818580|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
44818581|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818582|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44818583|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44818584|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44695235|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44695236|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
44246794|NCT03554317|Hormones|hormones|mesh-ancestor
44695237|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695238|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818585|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44818586|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
44818587|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44818588|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44818589|NCT02138292|Trametinib|trametinib|mesh-list
44818590|NCT02138292|Digoxin|digoxin|mesh-list
44818591|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818592|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44818593|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818594|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818595|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44818596|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44818597|NCT02138292|Protective Agents|protective agents|mesh-ancestor
44818598|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818599|NCT02138357|Buprenorphine|buprenorphine|mesh-list
44818600|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818601|NCT02138357|Narcotics|narcotics|mesh-ancestor
44818602|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818603|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818604|NCT02138357|Analgesics|analgesics|mesh-ancestor
44818605|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
44818606|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818607|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44818608|NCT02138383|Gemcitabine|gemcitabine|mesh-list
44818609|NCT02138383|Paclitaxel|paclitaxel|mesh-list
44818610|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44818611|NCT02138383|Androgens|androgens|mesh-list
44818612|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44818613|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818614|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818615|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818616|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818617|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818618|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44818619|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
44818620|NCT02138383|Antiviral Agents|antiviral agents|mesh-ancestor
44818621|NCT02138383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818622|NCT02138383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818623|NCT02138383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818624|NCT02138383|Immunologic Factors|immunologic factors|mesh-ancestor
44818625|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818626|NCT02138383|Hormones|hormones|mesh-ancestor
44818627|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818628|NCT02138396|Fentanyl|fentanyl|mesh-list
44818629|NCT02138396|Naltrexone|naltrexone|mesh-list
44818630|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818631|NCT02138396|Narcotics|narcotics|mesh-ancestor
44818632|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818633|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818634|NCT02138396|Analgesics|analgesics|mesh-ancestor
44818635|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
44818636|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818637|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44818638|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818639|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
44818640|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
44818641|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44818642|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44818643|NCT02138409|Fentanyl|fentanyl|mesh-list
44818644|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44818645|NCT02138409|Narcotics|narcotics|mesh-ancestor
44818646|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818647|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818648|NCT02138409|Analgesics|analgesics|mesh-ancestor
44818649|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
44818650|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818651|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44818652|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818653|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
44818654|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
44818655|NCT02138500|PF-06372865|pf-06372865|mesh-list
44818656|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
44818657|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
44818658|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818659|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818660|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818661|NCT02138539|Hydroquinone|hydroquinone|mesh-list
44818662|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
44818663|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818664|NCT02138539|Protective Agents|protective agents|mesh-ancestor
44818665|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818666|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44818667|NCT02138552|Octenidine|octenidine|mesh-list
44818668|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818669|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44818670|NCT02138708|Adenosine|adenosine|mesh-list
44818671|NCT02138708|Acetylcholine|acetylcholine|mesh-list
44818672|NCT02138708|Analgesics|analgesics|mesh-ancestor
44818673|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
44818674|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818675|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818676|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44818677|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
44818678|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44818679|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
44818680|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
44818681|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818682|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818683|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44818684|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
44818685|NCT02138773|Tamsulosin|tamsulosin|mesh-list
44818686|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44818687|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44818688|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44818689|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818690|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818691|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818692|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818693|NCT02138773|Urological Agents|urological agents|mesh-ancestor
44818694|NCT02138799|Rifampin|rifampin|mesh-list
44818695|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44818696|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
44818697|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818698|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818699|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
44818700|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44818701|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818702|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818703|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44818704|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44818705|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44818706|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44818707|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44818708|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44818709|NCT02138812|Paclitaxel|paclitaxel|mesh-list
44818710|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44818711|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818712|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818713|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818714|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818715|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818716|NCT02138929|Everolimus|everolimus|mesh-list
44818717|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818718|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44818719|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
44695239|NCT01384448|Protective Agents|protective agents|mesh-ancestor
44695240|NCT01384578|Vitamins|vitamins|mesh-list
44695241|NCT01384578|Vitamin E|vitamin e|mesh-list
44695242|NCT01384578|Tocopherols|tocopherols|mesh-list
44695243|NCT01384578|Tocotrienols|tocotrienols|mesh-list
44695244|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
44695245|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
44695246|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
44695247|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695248|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
44695249|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695250|NCT01384578|Protective Agents|protective agents|mesh-ancestor
44695251|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44695252|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695253|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695254|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44695255|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695256|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44695257|NCT01384643|Propofol|propofol|mesh-list
44695258|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44695259|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44695260|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305128|NCT00860340|Diuretics|diuretics|mesh-ancestor
44695261|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44695262|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
44695263|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
44695264|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44695265|NCT01384682|Maraviroc|maraviroc|mesh-list
44695266|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44695267|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44695268|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695269|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44695270|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44695271|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
44695272|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695273|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44695274|NCT01384695|Proflavine|proflavine|mesh-list
44695275|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695276|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695277|NCT01384708|Proflavine|proflavine|mesh-list
44695278|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44818720|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818721|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44818722|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
44818723|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818724|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44818725|NCT02139098|Amitriptyline|amitriptyline|mesh-list
44818726|NCT02139098|Zolpidem|zolpidem|mesh-list
44818727|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44818728|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44305163|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818729|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818730|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818731|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44818732|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
44818733|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
44818734|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818735|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818736|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44818737|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
44818738|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818739|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818740|NCT02139098|Analgesics|analgesics|mesh-ancestor
44818741|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
44818742|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818743|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44818744|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44818745|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818746|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818747|NCT02139241|Ramosetron|ramosetron|mesh-list
44818748|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
44818749|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
44818750|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818751|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818752|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818753|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44818754|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
44818755|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818756|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818757|NCT02139267|Vaccines|vaccines|mesh-list
44818758|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
44818759|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818760|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44818761|NCT02139579|Bevacizumab|bevacizumab|mesh-list
44818762|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44818763|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818764|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44818765|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44818766|NCT02139579|Growth Substances|growth substances|mesh-ancestor
44818767|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818768|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
44818769|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44818770|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44818771|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44818772|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
44818773|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
44818774|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
44818775|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818776|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
44818777|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44818778|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818779|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44818780|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44818781|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818782|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44818783|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818784|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44818785|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818786|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818787|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818788|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44818789|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
44818790|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818791|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818792|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600136|NCT00769483|Antiviral Agents|antiviral agents|mesh-ancestor
44818794|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
44818795|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818796|NCT02139904|Vinorelbine|vinorelbine|mesh-list
44818797|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44818798|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818799|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44818800|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44818801|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44818802|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818803|NCT02139930|Nicotine|nicotine|mesh-list
44818804|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44818805|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
44818806|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818807|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818808|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44818809|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44818810|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
44818811|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818812|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818813|NCT02140047|Vaccines|vaccines|mesh-list
44818814|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
44818815|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818816|NCT02140073|Domperidone|domperidone|mesh-list
44818817|NCT02140073|Omeprazole|omeprazole|mesh-list
44818818|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44818819|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818820|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44818821|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818822|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818823|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
44818824|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
44818825|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818826|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818827|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44818828|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
44818829|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600217|NCT00768469|Paclitaxel|paclitaxel|mesh-list
44818830|NCT02140242|Daunorubicin|daunorubicin|mesh-list
44818831|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44818832|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818833|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44818834|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44818835|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818836|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818837|NCT02140268|Midazolam|midazolam|mesh-list
44818838|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44818839|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44818840|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818841|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818842|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44818843|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44818844|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44818845|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44818846|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
44818847|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
44818848|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
44818849|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
44818850|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818851|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818852|NCT02140281|Cefadroxil|cefadroxil|mesh-list
44818853|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44818854|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44818855|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44818856|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818857|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44818858|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818859|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818860|NCT02140437|Fulvestrant|fulvestrant|mesh-list
44818861|NCT02140437|Anastrozole|anastrozole|mesh-list
44818862|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818863|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818864|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44818865|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44818866|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
44818867|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818868|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818869|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44818870|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44818871|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818872|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818873|NCT02140450|Timolol|timolol|mesh-list
44818874|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44818875|NCT02140450|Mannitol|mannitol|mesh-list
44818876|NCT02140450|Acetazolamide|acetazolamide|mesh-list
44818877|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44818878|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44818879|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
44818880|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44818881|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818882|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818883|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44818884|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44818885|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44818886|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44818887|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44818888|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44818889|NCT02140450|Diuretics|diuretics|mesh-ancestor
44818890|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
44818891|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
44818892|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44818893|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818894|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44818895|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44818896|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44818897|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
44818898|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818899|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44818900|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44818901|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818902|NCT02140515|Hormones|hormones|mesh-list
44818903|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44600288|NCT00767819|Everolimus|everolimus|mesh-list
44818904|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818905|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818906|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44818907|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44818908|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
44818909|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44818910|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44818911|NCT02140632|Prednisolone|prednisolone|mesh-list
44818912|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
44818913|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44818914|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
44818915|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818916|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
44818917|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
44818918|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818919|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818920|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44818921|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
44818922|NCT02140632|Hormones|hormones|mesh-ancestor
44818923|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818924|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44818925|NCT02140632|Protective Agents|protective agents|mesh-ancestor
44818926|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818927|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818928|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
44818929|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44818930|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
44818931|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818932|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
44818933|NCT05579522|Protective Agents|protective agents|mesh-ancestor
44818934|NCT05579418|Evolocumab|evolocumab|mesh-list
44305354|NCT00861419|Imetelstat|imetelstat|mesh-list
44818935|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44818936|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44818937|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
44818938|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818939|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44818940|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
44818941|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44818942|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
44818943|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
44818944|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44818945|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818946|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818947|NCT05579288|Analgesics|analgesics|mesh-ancestor
44818948|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
44818949|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818950|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44818951|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44818952|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818953|NCT05579119|Incretins|incretins|mesh-ancestor
44818954|NCT05579119|Hormones|hormones|mesh-ancestor
44818955|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818956|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44818957|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
44818958|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818959|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818960|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
44818961|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44818962|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818963|NCT05578456|Aspirin|aspirin|mesh-list
44818964|NCT05578456|Prednisone|prednisone|mesh-list
44818965|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44818966|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
44818967|NCT05578456|Hormones|hormones|mesh-ancestor
44818968|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44818969|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818970|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44818971|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44818972|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44818973|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44818974|NCT05578456|Analgesics|analgesics|mesh-ancestor
44818975|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
44818976|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44818977|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44818978|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44818979|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44818980|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44818981|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44818982|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44818983|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44818984|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
44818985|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
44818986|NCT05578404|Vitamin D|vitamin d|mesh-list
44818987|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44466001|NCT01469000|Pemetrexed|pemetrexed|mesh-list
44818988|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44818989|NCT05578404|Vitamins|vitamins|mesh-ancestor
44818990|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
44818991|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44818992|NCT05578378|Cytarabine|cytarabine|mesh-list
44818993|NCT05578378|Methotrexate|methotrexate|mesh-list
44818994|NCT05578378|Fludarabine|fludarabine|mesh-list
44818995|NCT05578378|Cladribine|cladribine|mesh-list
44818996|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44818997|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
44818998|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44818999|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819000|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819001|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
44819002|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819003|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819004|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
44819005|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819006|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44819007|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819008|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
44819009|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819010|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819011|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
44819012|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819013|NCT05578352|Insulin|insulin|mesh-list
44819014|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44819015|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819016|NCT05578287|Celecoxib|celecoxib|mesh-list
44819017|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44819018|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819019|NCT05578287|Analgesics|analgesics|mesh-ancestor
44819020|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
44819021|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819022|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819023|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819024|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819025|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44819026|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44819027|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819028|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819029|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
44819030|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819031|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819032|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44819033|NCT05578001|Pilocarpine|pilocarpine|mesh-list
44819034|NCT05578001|Miotics|miotics|mesh-ancestor
44819035|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
44819036|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819037|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819038|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44819039|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44819040|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44819041|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819042|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819043|NCT05577923|Trastuzumab|trastuzumab|mesh-list
44819044|NCT05577923|Fulvestrant|fulvestrant|mesh-list
44819045|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819046|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819047|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819048|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44819049|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44819050|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44819051|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819052|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819053|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
44819054|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819055|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819056|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819057|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819058|NCT05577871|Analgesics|analgesics|mesh-ancestor
44819059|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
44819060|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819061|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44819062|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44819063|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819064|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819065|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819066|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819067|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
44819068|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44819069|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819070|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
44819071|NCT05577806|Progestins|progestins|mesh-ancestor
44695279|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695280|NCT01384773|Riboflavin|riboflavin|mesh-list
44695281|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44695282|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44695283|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
44695284|NCT01384773|Vitamins|vitamins|mesh-ancestor
44695285|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
44695286|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695287|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44695288|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
44695289|NCT01384799|Cisplatin|cisplatin|mesh-list
44695290|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695291|NCT01384812|Dinoprostone|dinoprostone|mesh-list
44695292|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
44695293|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695294|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695295|NCT01384864|Proflavine|proflavine|mesh-list
44695296|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695297|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695298|NCT01384903|Antithrombins|antithrombins|mesh-list
44695299|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
44695300|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44695301|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44695302|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695303|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695304|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
44695305|NCT01384994|Folic Acid|folic acid|mesh-list
44695306|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
44695307|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
44695308|NCT01384994|Fluorouracil|fluorouracil|mesh-list
44695309|NCT01384994|Panitumumab|panitumumab|mesh-list
44695310|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695311|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
44695312|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695313|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695314|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819072|NCT05577806|Hormones|hormones|mesh-ancestor
44695315|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
44819073|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819074|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819075|NCT05577676|Triamcinolone|triamcinolone|mesh-list
44819076|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44819077|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44819078|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44819079|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819080|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
44819081|NCT05577676|Hormones|hormones|mesh-ancestor
44819082|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819083|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819084|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819085|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
44819086|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819087|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819088|NCT05577624|Rifampin|rifampin|mesh-list
44305493|NCT00861939|Bupropion|bupropion|mesh-list
44819089|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44819090|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
44819091|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44819092|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819093|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
44819094|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819095|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819096|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819097|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44819098|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44819099|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44819100|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44819101|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44819102|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44819103|NCT05577585|Midazolam|midazolam|mesh-list
44819104|NCT05577585|Ketamine|ketamine|mesh-list
44819105|NCT05577585|Analgesics|analgesics|mesh-ancestor
44819106|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
44819107|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819108|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819109|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44819110|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819111|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
44819112|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
44819113|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819114|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44819115|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44819116|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819117|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819118|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819119|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819120|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44819121|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44819122|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819123|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
44819124|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
44819125|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
44819126|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
44819127|NCT05577507|Calcium|calcium|mesh-list
44819128|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44819129|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819130|NCT05577507|Antacids|antacids|mesh-ancestor
44819131|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819132|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819133|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44819134|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44819135|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
44819136|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44819137|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
44819138|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819139|NCT05577273|Trimethoprim|trimethoprim|mesh-list
44819140|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
44819141|NCT05577273|Penicillins|penicillins|mesh-list
44819142|NCT05577273|Cefuroxime|cefuroxime|mesh-list
44819143|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
44819144|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44819145|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819146|NCT05577273|Renal Agents|renal agents|mesh-ancestor
44819147|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
44819148|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44819149|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44819150|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44819151|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819152|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819153|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44819154|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44819155|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44819156|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44819157|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
44819158|NCT05577260|Bupivacaine|bupivacaine|mesh-list
44819159|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
44819160|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
44819161|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819162|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819163|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
44819164|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819165|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819166|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819167|NCT05577260|Analgesics|analgesics|mesh-ancestor
44819168|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44819169|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44819170|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819171|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819172|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819173|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819174|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
44305594|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819175|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819176|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819177|NCT05575973|Rituximab|rituximab|mesh-list
44819178|NCT05575973|Lenalidomide|lenalidomide|mesh-list
44819179|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
44819180|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819181|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819182|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
44819183|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819184|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819185|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819186|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819187|NCT05575973|Growth Substances|growth substances|mesh-ancestor
44819188|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819189|NCT05575973|Analgesics|analgesics|mesh-ancestor
44819190|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
44819191|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819192|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44819193|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44819194|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819195|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819196|NCT05575739|Antioxidants|antioxidants|mesh-list
44819197|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
44819198|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819199|NCT05575739|Protective Agents|protective agents|mesh-ancestor
44819200|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819201|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44819202|NCT05575544|Morphine|morphine|mesh-list
44819203|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44819204|NCT05575544|Narcotics|narcotics|mesh-ancestor
44819205|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819206|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819207|NCT05575544|Analgesics|analgesics|mesh-ancestor
44819208|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
44819209|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819210|NCT05575518|Rifamycins|rifamycins|mesh-list
44819211|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
44819212|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44819213|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819214|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819215|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819216|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819217|NCT05575297|Rifampin|rifampin|mesh-list
44819218|NCT05575297|Methotrexate|methotrexate|mesh-list
44819219|NCT05575297|Febuxostat|febuxostat|mesh-list
44819220|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44819221|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
44819222|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44819223|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819224|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819225|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
44819226|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819227|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819228|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
44819229|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819230|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44819231|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819232|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
44819233|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819234|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819235|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44819236|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
44819237|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44819238|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819239|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
44819240|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44600699|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819241|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44819242|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44819243|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44819244|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44819245|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44819246|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
44819247|NCT05575271|Norepinephrine|norepinephrine|mesh-list
44819248|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44819249|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819250|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819251|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819252|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819253|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819254|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
44819255|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
44819256|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819257|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44819258|NCT05575180|Acetazolamide|acetazolamide|mesh-list
44819259|NCT05575180|Methazolamide|methazolamide|mesh-list
44819260|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
44819261|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44819262|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819263|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819264|NCT05575180|Diuretics|diuretics|mesh-ancestor
44819265|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
44819266|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600700|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600701|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600702|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44600703|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44600704|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44600705|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44600706|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44600707|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44600708|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
44600709|NCT00762762|Triclosan|triclosan|mesh-list
44600710|NCT00762762|Fluorides|fluorides|mesh-list
44600711|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
44600712|NCT00762762|Protective Agents|protective agents|mesh-ancestor
44600713|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600714|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44600715|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600716|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44600717|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600718|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
44600719|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600720|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600721|NCT00762463|Celecoxib|celecoxib|mesh-list
44600722|NCT00762463|Diclofenac|diclofenac|mesh-list
44600723|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44600724|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600725|NCT00762463|Analgesics|analgesics|mesh-ancestor
44600726|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
44600729|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819267|NCT05575167|Vitamin D|vitamin d|mesh-list
44819268|NCT05575167|Alendronate|alendronate|mesh-list
44819269|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
44819270|NCT05575167|Vitamins|vitamins|mesh-ancestor
44819271|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
44819272|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819273|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44819274|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44819275|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
44819276|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819278|NCT05574998|Cisplatin|cisplatin|mesh-list
44819279|NCT05574998|Carboplatin|carboplatin|mesh-list
44819280|NCT05574998|Pemetrexed|pemetrexed|mesh-list
44819281|NCT05574998|Endostar protein|endostar protein|mesh-list
44819282|NCT05574998|Endostatins|endostatins|mesh-list
44819283|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44819284|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819285|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44819286|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44819287|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44819288|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819289|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819290|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44819291|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819292|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819293|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819294|NCT05574998|Growth Substances|growth substances|mesh-ancestor
44819295|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819296|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819297|NCT05574894|Hormones|hormones|mesh-list
44819298|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819299|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819300|NCT05574881|Trastuzumab|trastuzumab|mesh-list
44819301|NCT05574881|Pertuzumab|pertuzumab|mesh-list
44819302|NCT05574881|Fulvestrant|fulvestrant|mesh-list
44819303|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819304|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819305|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819306|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44819307|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44819308|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
44819309|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819310|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819311|NCT05574101|Cemiplimab|cemiplimab|mesh-list
44819312|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819313|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819314|NCT05574036|Vitamin E|vitamin e|mesh-list
44819315|NCT05574036|Febuxostat|febuxostat|mesh-list
44819316|NCT05574036|Vitamins|vitamins|mesh-ancestor
44819317|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
44819318|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819319|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
44819320|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819321|NCT05574036|Protective Agents|protective agents|mesh-ancestor
44819322|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
44819323|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819324|NCT05573802|Dexamethasone|dexamethasone|mesh-list
44819325|NCT05573802|Lenalidomide|lenalidomide|mesh-list
44819326|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819327|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
44819328|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
44819329|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819330|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819331|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819332|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
44819333|NCT05573802|Hormones|hormones|mesh-ancestor
44819334|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819335|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819336|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819337|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
44819338|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819339|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819340|NCT05573802|Growth Substances|growth substances|mesh-ancestor
44819341|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819342|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
44819343|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44819344|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44819345|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44600819|NCT00761735|Ribavirin|ribavirin|mesh-list
44819346|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44819347|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819348|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
44819349|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819350|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819351|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44819352|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819353|NCT05573425|Tazarotene|tazarotene|mesh-list
44819354|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
44819355|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
44819356|NCT05572749|Metformin|metformin|mesh-list
44819357|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44819358|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819359|NCT05572190|Hydrocodone|hydrocodone|mesh-list
44819360|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44819361|NCT05572190|Narcotics|narcotics|mesh-ancestor
44819362|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819363|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819364|NCT05572190|Analgesics|analgesics|mesh-ancestor
44819365|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
44819366|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819367|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
44819368|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44819369|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
44819370|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819371|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819372|NCT05567523|Midazolam|midazolam|mesh-list
44819373|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
44819374|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819375|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819376|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819377|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819378|NCT05567523|Analgesics|analgesics|mesh-ancestor
44819379|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
44819380|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819381|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44819382|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44819383|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819384|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819385|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819386|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819387|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819388|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44819389|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44819390|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819391|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819392|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
44819393|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
44819394|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
44819395|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
44819396|NCT05567094|Dexamethasone|dexamethasone|mesh-list
44819397|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819398|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
44819399|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
44819400|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819401|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819402|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819403|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
44819404|NCT05567094|Hormones|hormones|mesh-ancestor
44819405|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819406|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819407|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819408|NCT05561738|Niacinamide|niacinamide|mesh-list
44819409|NCT05561738|Niacin|niacin|mesh-list
44819410|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
44819411|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44819412|NCT05561738|Vitamins|vitamins|mesh-ancestor
44819413|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
44819414|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819415|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44819416|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
44819417|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819418|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44819419|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819420|NCT05557240|Poly I-C|poly i-c|mesh-list
44819421|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44819422|NCT05557240|Vaccines|vaccines|mesh-list
44819423|NCT05557240|Poly ICLC|poly iclc|mesh-list
44819424|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
44819425|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819426|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
44819427|NCT05557240|Laxatives|laxatives|mesh-ancestor
44819428|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819429|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
44819430|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819431|NCT05524038|Dexamethasone|dexamethasone|mesh-list
44819432|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
44819433|NCT05524038|Bupivacaine|bupivacaine|mesh-list
44819434|NCT05524038|BB 1101|bb 1101|mesh-list
44819435|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819436|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
44819437|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
44819438|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819439|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819440|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819441|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
44819442|NCT05524038|Hormones|hormones|mesh-ancestor
44819443|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819444|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819445|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819446|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44819447|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819448|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819449|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44819450|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
44819451|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819452|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
44819453|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
44819454|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819455|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819456|NCT05505279|Nicotine|nicotine|mesh-list
44819457|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44819458|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
44819459|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819460|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819461|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44819462|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44819463|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
44819464|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819465|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819466|NCT05494190|Cisplatin|cisplatin|mesh-list
44819467|NCT05494190|Docetaxel|docetaxel|mesh-list
44819468|NCT05494190|Capecitabine|capecitabine|mesh-list
44819469|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819470|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
44819471|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
44819472|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
44819473|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819474|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819475|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
44819476|NCT05479578|Dexamethasone|dexamethasone|mesh-list
44819477|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
44819478|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
44819479|NCT05479578|Ichthammol|ichthammol|mesh-list
44819480|NCT05479578|BB 1101|bb 1101|mesh-list
44819481|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819482|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
44819483|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819484|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819485|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44819486|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
44819487|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819488|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819489|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44819490|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819491|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
44819492|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
44819493|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819494|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819495|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
44819496|NCT05479578|Hormones|hormones|mesh-ancestor
44600965|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819497|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305912|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
44819498|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819499|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
44819500|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819501|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44819502|NCT05478993|Dexamethasone|dexamethasone|mesh-list
44819503|NCT05478993|Pomalidomide|pomalidomide|mesh-list
44819504|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819505|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
44819506|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
44819507|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819508|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819509|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819510|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
44819511|NCT05478993|Hormones|hormones|mesh-ancestor
44819512|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819513|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819514|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819515|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
44819516|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819517|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819518|NCT05478993|Growth Substances|growth substances|mesh-ancestor
44819519|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819520|NCT05478850|Anesthetics|anesthetics|mesh-list
44819521|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819522|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819523|NCT05477576|Everolimus|everolimus|mesh-list
44819524|NCT05477576|Sunitinib|sunitinib|mesh-list
44819525|NCT05477576|Octreotide|octreotide|mesh-list
44819526|NCT05477576|Lanreotide|lanreotide|mesh-list
44819527|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819528|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819529|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
44819530|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819531|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819532|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819533|NCT05477576|Growth Substances|growth substances|mesh-ancestor
44819534|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819535|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819536|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819537|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819538|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819539|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819540|NCT05434104|Metronidazole|metronidazole|mesh-list
44819541|NCT05434104|Fluconazole|fluconazole|mesh-list
44819542|NCT05434104|Lactoferrin|lactoferrin|mesh-list
44819543|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44819544|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44819545|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44819546|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44819547|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
44819548|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44819549|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44819550|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305949|NCT00864058|Gabapentin|gabapentin|mesh-list
44819551|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819552|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44819553|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
44819554|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44819555|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819556|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44819557|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44819558|NCT05430698|Antibodies|antibodies|mesh-list
44819559|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
44819560|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819561|NCT05425420|Methadone|methadone|mesh-list
44819562|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44819563|NCT05425420|Narcotics|narcotics|mesh-ancestor
44819564|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819565|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819566|NCT05425420|Analgesics|analgesics|mesh-ancestor
44819567|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
44819568|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819569|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
44819570|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
44819571|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
44819572|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
44819573|NCT05424263|Calcium|calcium|mesh-list
44819574|NCT05424263|Calcium acetate|calcium acetate|mesh-list
44819575|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44819576|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819577|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44819578|NCT05424263|Antacids|antacids|mesh-ancestor
44819579|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819580|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819581|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
44695316|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695317|NCT01384994|Hematinics|hematinics|mesh-ancestor
44695318|NCT01384994|Vitamins|vitamins|mesh-ancestor
44695319|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
44695320|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695321|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
44695322|NCT01385020|Red yeast rice|red yeast rice|mesh-list
44695323|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695324|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
44695325|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695326|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695327|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44695328|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44695329|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695330|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44695331|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695332|NCT01385059|Axitinib|axitinib|mesh-list
44695333|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695334|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44695335|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695336|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695337|NCT01385124|Cannabidiol|cannabidiol|mesh-list
44695338|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
44695339|NCT01385228|Prednisone|prednisone|mesh-list
44695340|NCT01385228|Docetaxel|docetaxel|mesh-list
44695341|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695342|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
44695343|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
44695344|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
44695345|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695346|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695347|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
44819582|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
44819583|NCT05423379|Everolimus|everolimus|mesh-list
44819584|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819585|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819586|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
44819587|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819589|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
44819590|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819591|NCT05420324|Paclitaxel|paclitaxel|mesh-list
44819592|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
44819593|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44819594|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819595|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
44819596|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
44819597|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
44819598|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819599|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819600|NCT05417659|Niacin|niacin|mesh-list
44819601|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44819602|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
44819603|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819604|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44819605|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819606|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
44819607|NCT05417659|Vitamins|vitamins|mesh-ancestor
44819608|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
44819609|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819610|NCT05400889|Tofacitinib|tofacitinib|mesh-list
44819611|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819612|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819613|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819614|NCT05398757|Midazolam|midazolam|mesh-list
44819615|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
44819616|NCT05398757|Propofol|propofol|mesh-list
44819617|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819618|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819619|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819620|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819621|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
44819622|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
44819623|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819624|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44819625|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44819626|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819627|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
44819628|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
44819629|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819630|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819631|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819632|NCT05398757|Analgesics|analgesics|mesh-ancestor
44819633|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
44819634|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819635|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44819636|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44819637|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819638|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819639|NCT05395117|Digoxin|digoxin|mesh-list
44819640|NCT05395117|Midazolam|midazolam|mesh-list
44819641|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44819642|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819643|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819644|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819645|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819646|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601155|NCT00758394|Listerine|listerine|mesh-list
44601156|NCT00758394|Triclosan|triclosan|mesh-list
44601157|NCT00758394|Fluorides|fluorides|mesh-list
44601158|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
44601159|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
44601160|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
44601161|NCT00758394|Protective Agents|protective agents|mesh-ancestor
44601162|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601163|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44601164|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601165|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44819647|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44819648|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819649|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819650|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
44819651|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
44819652|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
44819653|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
44819654|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819655|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819656|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44819657|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44819658|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
44819659|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44819660|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44819661|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819662|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44819663|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44819664|NCT05395117|Protective Agents|protective agents|mesh-ancestor
44819665|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44819666|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
44819667|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819668|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819669|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44819670|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
44819671|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819672|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819673|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44819674|NCT05325229|Bevacizumab|bevacizumab|mesh-list
44819675|NCT05325229|Docetaxel|docetaxel|mesh-list
44819676|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819677|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819678|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44819679|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44819680|NCT05325229|Growth Substances|growth substances|mesh-ancestor
44819681|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819682|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44819683|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
44819684|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
44819685|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
44819686|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819687|NCT05306301|Ponatinib|ponatinib|mesh-list
44819688|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819689|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819690|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819691|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819692|NCT05279183|Erythritol|erythritol|mesh-list
44819693|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819694|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44819695|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
44819696|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819697|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819698|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
44819699|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819700|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819701|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44819702|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44819703|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44819704|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819705|NCT05266586|Ezetimibe|ezetimibe|mesh-list
44819706|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44819707|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44819708|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
44819709|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819710|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44819711|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
44819712|NCT05264168|Apixaban|apixaban|mesh-list
44819713|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44819714|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
44819715|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44819716|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
44819717|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819718|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819719|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
44819720|NCT05260684|Trametinib|trametinib|mesh-list
44819721|NCT05260684|Vemurafenib|vemurafenib|mesh-list
44819722|NCT05260684|Dabrafenib|dabrafenib|mesh-list
44601170|NCT00758264|Vaccines|vaccines|mesh-list
44819723|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819724|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819725|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819726|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819727|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
44819728|NCT05256797|Apixaban|apixaban|mesh-list
44819729|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44819730|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
44819731|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44819732|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
44819733|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819734|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819735|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
44819736|NCT05229445|Insulin|insulin|mesh-list
44819737|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44819738|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819740|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819741|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44819742|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44819743|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819744|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819745|NCT05206955|Urological Agents|urological agents|mesh-ancestor
44819746|NCT05203432|Atropine|atropine|mesh-list
44819747|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819748|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44819749|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44819750|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
44819751|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306198|NCT00864617|Nifedipine|nifedipine|mesh-list
44819752|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819753|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44819754|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44819755|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
44819756|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
44819757|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44819758|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44819759|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
44819760|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819761|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819762|NCT05198804|Niraparib|niraparib|mesh-list
44819763|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44819764|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819765|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819766|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819767|NCT05180799|Nivolumab|nivolumab|mesh-list
44819768|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819769|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819770|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44819771|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819772|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
44819773|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819774|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819775|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44819776|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44819777|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44819778|NCT05176158|Analgesics|analgesics|mesh-ancestor
44819779|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
44819780|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819781|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819782|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44819783|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819784|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
44819785|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819786|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819787|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44819788|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44819789|NCT05159453|Insulin|insulin|mesh-list
44819790|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44819791|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44819792|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819793|NCT05132231|Brodalumab|brodalumab|mesh-list
44819794|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44819795|NCT05125055|Paclitaxel|paclitaxel|mesh-list
44819796|NCT05125055|Docetaxel|docetaxel|mesh-list
44819797|NCT05125055|Cisplatin|cisplatin|mesh-list
44819798|NCT05125055|Fluorouracil|fluorouracil|mesh-list
44819799|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44819800|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819801|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44819802|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44819803|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44819804|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819805|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
44819806|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819807|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819808|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
44819809|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819810|NCT05118854|Cisplatin|cisplatin|mesh-list
44819811|NCT05118854|Carboplatin|carboplatin|mesh-list
44819812|NCT05118854|Pemetrexed|pemetrexed|mesh-list
44601321|NCT00756444|Cisplatin|cisplatin|mesh-list
44819813|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819814|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819815|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819816|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44819817|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44819818|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
44819820|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
44819821|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44819822|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44819823|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819824|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819825|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44819826|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44819827|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44819828|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44819829|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
44819830|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
44819831|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
44819832|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
44819833|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819834|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819835|NCT05084521|Famotidine|famotidine|mesh-list
44819836|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44819837|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44819838|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44819839|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
44819840|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
44819841|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819842|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819843|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819844|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
44819845|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
44819846|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819847|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
44819848|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306282|NCT00864812|Hormones|hormones|mesh-ancestor
44819849|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819850|NCT05069857|Apatinib|apatinib|mesh-list
44819851|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44819852|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819853|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819854|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819855|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819856|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
44819857|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819858|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819859|NCT05063851|Memantine|memantine|mesh-list
44819860|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44819861|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44819862|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
44819863|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819864|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819865|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819866|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44819867|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44819868|NCT05051436|Tadalafil|tadalafil|mesh-list
44819869|NCT05051436|Mirabegron|mirabegron|mesh-list
44819870|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819871|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44819872|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44819873|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819874|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819875|NCT05051436|Urological Agents|urological agents|mesh-ancestor
44819876|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44819877|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44819878|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44819879|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44819880|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819881|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819882|NCT05037123|Ketamine|ketamine|mesh-list
44819883|NCT05037123|Analgesics|analgesics|mesh-ancestor
44819884|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
44819885|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819886|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819887|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44819889|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
44819890|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
44819891|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44819892|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44819893|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44819894|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819895|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819896|NCT05030623|Tadalafil|tadalafil|mesh-list
44819897|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
44819898|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44819899|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44819900|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819901|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819902|NCT05030623|Urological Agents|urological agents|mesh-ancestor
44819903|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44819904|NCT05017103|Antibodies|antibodies|mesh-list
44819905|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
44819906|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44819907|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
44819908|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819909|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819910|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
44819911|NCT05005559|Paraproteins|paraproteins|mesh-list
44819912|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
44819913|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819914|NCT04986631|Topiramate|topiramate|mesh-list
44819915|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
44819916|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44819917|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819918|NCT04980885|Azacitidine|azacitidine|mesh-list
44819919|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819920|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
44819921|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819922|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819923|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819924|NCT04976543|Nadroparin|nadroparin|mesh-list
44819925|NCT04976543|Warfarin|warfarin|mesh-list
44819926|NCT04976543|Calcium|calcium|mesh-list
44819927|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44819928|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819929|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
44819930|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44819931|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44819932|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819933|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
44819934|NCT04944368|Paraproteins|paraproteins|mesh-list
44819935|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
44819936|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819937|NCT04940299|Nivolumab|nivolumab|mesh-list
44819938|NCT04940299|Ipilimumab|ipilimumab|mesh-list
44819939|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
44819940|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
44819941|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819942|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819943|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44819944|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819945|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
44819946|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819948|NCT04925557|Siponimod|siponimod|mesh-list
44819949|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
44819950|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819951|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44819952|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819953|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44819954|NCT04900350|Azacitidine|azacitidine|mesh-list
44819955|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44819956|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
44819957|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819958|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819959|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819960|NCT04894994|Ipilimumab|ipilimumab|mesh-list
44819961|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819962|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819963|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44819964|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819965|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44819966|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
44819967|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44819968|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44819969|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44819970|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
44819971|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44819972|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819973|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44819974|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44819975|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44819976|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44819977|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819978|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44819979|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44819980|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44819981|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44819982|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819983|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44819984|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44819985|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819986|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44819987|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44819988|NCT04876781|Tofacitinib|tofacitinib|mesh-list
44819989|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44819990|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44819991|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44819992|NCT04871191|Rituximab|rituximab|mesh-list
44819993|NCT04871191|Abatacept|abatacept|mesh-list
44819994|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44819995|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44819996|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
44819997|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44819998|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44819999|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44820000|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820001|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820002|NCT04862663|Fulvestrant|fulvestrant|mesh-list
44820003|NCT04862663|Palbociclib|palbociclib|mesh-list
44820004|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820005|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820006|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44820007|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44820008|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44820009|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820010|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820011|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820012|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820013|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820014|NCT04853628|Ethanol|ethanol|mesh-list
44820015|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44820016|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820017|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820018|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820019|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
44820020|NCT04818177|Antibodies|antibodies|mesh-list
44820021|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
44820022|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44820023|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44820024|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
44820025|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820026|NCT04802837|Vancomycin|vancomycin|mesh-list
44820027|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44820028|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820029|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44820030|NCT04792580|Lifitegrast|lifitegrast|mesh-list
44820031|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44820032|NCT04768504|Tofacitinib|tofacitinib|mesh-list
44820033|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820034|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820035|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820036|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
44820037|NCT04767984|Atorvastatin|atorvastatin|mesh-list
44820038|NCT04767984|Calcium|calcium|mesh-list
44820039|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44820040|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820041|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44820042|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44820043|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44820044|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
44820045|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820046|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44820047|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44820048|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820049|NCT04765137|Atorvastatin|atorvastatin|mesh-list
44820050|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44820051|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44820052|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
44820053|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820054|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44820055|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44820056|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820057|NCT04762758|Naltrexone|naltrexone|mesh-list
44820058|NCT04762758|Baclofen|baclofen|mesh-list
44820059|NCT04762758|Sorbitol|sorbitol|mesh-list
44820060|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44820061|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44820062|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820063|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
44820064|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820065|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44820066|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44820067|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44820068|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
44820069|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
44820070|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820071|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820072|NCT04762758|Cathartics|cathartics|mesh-ancestor
44820073|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820074|NCT04756427|Citric Acid|citric acid|mesh-list
44820075|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
44820076|NCT04756427|Anticoagulants|anticoagulants|mesh-list
44820077|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44820078|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
44820079|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
44820080|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820081|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
44820082|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44820083|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820084|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
44820085|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820086|NCT04727034|Propofol|propofol|mesh-list
44820087|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44820088|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820089|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820090|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820091|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
44820092|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
44820093|NCT04723134|Leucovorin|leucovorin|mesh-list
44820094|NCT04723134|Folic Acid|folic acid|mesh-list
44820096|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
44820097|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44820098|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820099|NCT04723134|Antidotes|antidotes|mesh-ancestor
44820100|NCT04723134|Protective Agents|protective agents|mesh-ancestor
44820101|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
44820102|NCT04723134|Vitamins|vitamins|mesh-ancestor
44820103|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
44820104|NCT04723134|Hematinics|hematinics|mesh-ancestor
44820105|NCT04721132|Bevacizumab|bevacizumab|mesh-list
44820106|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44820107|NCT04721132|Atezolizumab|atezolizumab|mesh-list
44820108|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
44820109|NCT04721132|Antibodies|antibodies|mesh-list
44820110|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
44820111|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44820112|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
44820113|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820114|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44820115|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44820116|NCT04721132|Growth Substances|growth substances|mesh-ancestor
44820117|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820118|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44820119|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
44820120|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
44820121|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
44820122|NCT04703673|Ephedrine|ephedrine|mesh-list
44820123|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
44820124|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44820125|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44820126|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44820127|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820128|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
44820129|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820130|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
44820131|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820132|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820133|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44820134|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44820135|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
44820136|NCT04703426|Sargramostim|sargramostim|mesh-list
44820137|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820138|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820139|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
44820140|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820141|NCT04675983|Cisplatin|cisplatin|mesh-list
44820142|NCT04675983|Fluorouracil|fluorouracil|mesh-list
44820143|NCT04675983|Capecitabine|capecitabine|mesh-list
44820144|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
44820145|NCT04675983|Ramucirumab|ramucirumab|mesh-list
44820146|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820147|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
44820148|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820149|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820150|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820151|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
44820152|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820153|NCT04667637|Edaravone|edaravone|mesh-list
44820154|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44820155|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
44820156|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820157|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44601684|NCT00751400|Naproxen|naproxen|mesh-list
44601685|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44601686|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44601687|NCT00751400|Analgesics|analgesics|mesh-ancestor
44601688|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
44601689|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601690|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601691|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44601692|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601693|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
44601694|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820158|NCT04667637|Protective Agents|protective agents|mesh-ancestor
44820159|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820160|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
44820161|NCT04664946|Protective Agents|protective agents|mesh-ancestor
44820162|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820163|NCT04644237|Trastuzumab|trastuzumab|mesh-list
44820164|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820165|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820166|NCT04634877|Paclitaxel|paclitaxel|mesh-list
44820167|NCT04634877|Docetaxel|docetaxel|mesh-list
44820168|NCT04634877|Cisplatin|cisplatin|mesh-list
44820169|NCT04634877|Carboplatin|carboplatin|mesh-list
44820170|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
44820171|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44820172|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820173|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44820174|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44820175|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44820176|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820177|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820178|NCT04629495|Sirolimus|sirolimus|mesh-list
44820179|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44820180|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820181|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44820182|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820183|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
44820184|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820185|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
44820186|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820187|NCT04622839|Acetaminophen|acetaminophen|mesh-list
44820188|NCT04622839|Ibuprofen|ibuprofen|mesh-list
44820189|NCT04622839|Diclofenac|diclofenac|mesh-list
44820190|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820191|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820192|NCT04622839|Analgesics|analgesics|mesh-ancestor
44820193|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
44820194|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820195|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820196|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820197|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820198|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820199|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820200|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820201|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
44820202|NCT04602065|Antibodies|antibodies|mesh-list
44820203|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44820204|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
44820205|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820206|NCT04599777|Sorafenib|sorafenib|mesh-list
44820207|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820208|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820209|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820210|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820211|NCT04589728|Venetoclax|venetoclax|mesh-list
44695348|NCT01385228|Hormones|hormones|mesh-ancestor
44695349|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695350|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695351|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44695352|NCT01385345|Vitamin D|vitamin d|mesh-list
44695353|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
44695354|NCT01385345|Vitamins|vitamins|mesh-ancestor
44695355|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
44695356|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695357|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44695358|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695359|NCT01385527|Triamcinolone|triamcinolone|mesh-list
44695360|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695361|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
44695362|NCT01385527|Hormones|hormones|mesh-ancestor
44695363|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695364|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695365|NCT01385631|Ezetimibe|ezetimibe|mesh-list
44695366|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695367|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695368|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
44695369|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695370|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695371|NCT01385683|Clarithromycin|clarithromycin|mesh-list
44695372|NCT01385683|Dabigatran|dabigatran|mesh-list
44695373|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44695374|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695375|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44695376|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695377|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695378|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44695379|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44695380|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
44695381|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44695382|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44695383|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
44695384|NCT01385735|Rasagiline|rasagiline|mesh-list
44695385|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44695386|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695387|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695388|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44695389|NCT01385735|Protective Agents|protective agents|mesh-ancestor
44695390|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695391|NCT01385826|Antibodies|antibodies|mesh-list
44695392|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44695393|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
44695394|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695427|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
44695428|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820212|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820213|NCT04586504|Midazolam|midazolam|mesh-list
44820214|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44820215|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44820216|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820217|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820218|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44820219|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44820220|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820221|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820222|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
44820223|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
44820224|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
44820225|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
44820226|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820227|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820228|NCT04586335|Olaparib|olaparib|mesh-list
44820229|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44820230|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820231|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820232|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820233|NCT04585711|Etanercept|etanercept|mesh-list
44820234|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820235|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820236|NCT04585711|Analgesics|analgesics|mesh-ancestor
44820237|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
44820238|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820239|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820240|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820241|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820242|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820243|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820244|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
44820245|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44820246|NCT04538092|Analgesics|analgesics|mesh-list
44820247|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820248|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
44820249|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820250|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820251|NCT04527380|Adalimumab|adalimumab|mesh-list
44820252|NCT04527380|Ixekizumab|ixekizumab|mesh-list
44820253|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820254|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820255|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820256|NCT04522336|Docetaxel|docetaxel|mesh-list
44820257|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
44820258|NCT04522336|Fluorouracil|fluorouracil|mesh-list
44820259|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
44820260|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820261|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44820262|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44820263|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44820264|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820265|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820266|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
44820267|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820268|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820269|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
44820270|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820271|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
44820272|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820273|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820274|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
44820275|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820276|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820277|NCT04481724|Analgesics|analgesics|mesh-ancestor
44820278|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
44820279|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820280|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820281|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820282|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820283|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44820284|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
44820285|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820286|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44820287|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820288|NCT04465916|Tenofovir|tenofovir|mesh-list
44820289|NCT04465916|Entecavir|entecavir|mesh-list
44820290|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
44820291|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820292|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44820293|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44820294|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820295|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820296|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44820297|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44820298|NCT04465760|Antibodies|antibodies|mesh-list
44820299|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
44820300|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
44820301|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820302|NCT04459377|Ketamine|ketamine|mesh-list
44820303|NCT04459377|Esketamine|esketamine|mesh-list
44820304|NCT04459377|Analgesics|analgesics|mesh-ancestor
44820305|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
44820306|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820307|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820308|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44820309|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820310|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
44820311|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
44820312|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820313|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44820314|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44820315|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820316|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820317|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44820318|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820319|NCT04447755|Lenvatinib|lenvatinib|mesh-list
44820320|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820321|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820322|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820323|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820324|NCT04424303|Tofacitinib|tofacitinib|mesh-list
44820325|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820326|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820327|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820328|NCT04414943|Ketamine|ketamine|mesh-list
44820329|NCT04414943|Esketamine|esketamine|mesh-list
44820330|NCT04414943|Analgesics|analgesics|mesh-ancestor
44820331|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
44820332|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820333|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820334|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44820335|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820336|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
44820337|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
44820338|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820339|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44820340|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44820341|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820342|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820343|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44820344|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820345|NCT04410796|Carboplatin|carboplatin|mesh-list
44820346|NCT04410796|Pemetrexed|pemetrexed|mesh-list
44820347|NCT04410796|Osimertinib|osimertinib|mesh-list
44820348|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820349|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820350|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820351|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44820352|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44820353|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820354|NCT04408586|Topiramate|topiramate|mesh-list
44820355|NCT04408586|Phentermine|phentermine|mesh-list
44820356|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
44820357|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44820358|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820359|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44820360|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
44820361|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44820362|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
44820363|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
44820364|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820365|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44820366|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820367|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820368|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
44820370|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
44820371|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820372|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
44820373|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820374|NCT04404387|Protective Agents|protective agents|mesh-ancestor
44820375|NCT04401800|Lenvatinib|lenvatinib|mesh-list
44820376|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820377|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820378|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820379|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820380|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
44820381|NCT04398524|Cemiplimab|cemiplimab|mesh-list
44820382|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820383|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820384|NCT04392037|Dexamethasone|dexamethasone|mesh-list
44820385|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
44820386|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820387|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
44820388|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820389|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820390|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44820391|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
44820392|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820393|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820394|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44820395|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820396|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
44820397|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
44820398|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820399|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820400|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
44820401|NCT04392037|Hormones|hormones|mesh-ancestor
44820402|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820403|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820404|NCT04354155|Enoxaparin|enoxaparin|mesh-list
44820405|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
44820406|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44820407|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44820408|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820409|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44820410|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
44820411|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820412|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820413|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44820414|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
44820415|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820416|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820417|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44820418|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
44820419|NCT04350021|Capecitabine|capecitabine|mesh-list
44820420|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820421|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
44820422|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820423|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820424|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44820425|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
44820426|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820427|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820428|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44820429|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820430|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
44820431|NCT04340193|Nivolumab|nivolumab|mesh-list
44820432|NCT04340193|Ipilimumab|ipilimumab|mesh-list
44820433|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820434|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820435|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44820436|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820437|NCT04337177|Temozolomide|temozolomide|mesh-list
44820438|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44820439|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
44306908|NCT00866645|Haloperidol|haloperidol|mesh-list
44820440|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820441|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820442|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44820443|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820444|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820445|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602042|NCT00745901|Estradiol|estradiol|mesh-list
44820447|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44820448|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44820449|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
44820450|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820451|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820452|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820453|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44820454|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44820455|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
44820456|NCT04268498|Acetaminophen|acetaminophen|mesh-list
44820457|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
44820458|NCT04268498|Promethazine|promethazine|mesh-list
44820459|NCT04268498|Dexamethasone|dexamethasone|mesh-list
44820460|NCT04268498|Lenalidomide|lenalidomide|mesh-list
44820461|NCT04268498|Bortezomib|bortezomib|mesh-list
44820462|NCT04268498|Daratumumab|daratumumab|mesh-list
44820463|NCT04268498|Montelukast|montelukast|mesh-list
44820464|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820465|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
44820466|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
44820467|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820468|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820469|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820470|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
44820471|NCT04268498|Hormones|hormones|mesh-ancestor
44820472|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820473|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820474|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820475|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
44820476|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44820477|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44820478|NCT04268498|Growth Substances|growth substances|mesh-ancestor
44820479|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
44820480|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820481|NCT04268498|Analgesics|analgesics|mesh-ancestor
44820482|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
44820483|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
44602090|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602091|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
44602092|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
44602093|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44602094|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44602095|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
44602096|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602097|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44602098|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44602099|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602100|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602101|NCT00745095|Neostigmine|neostigmine|mesh-list
44602102|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44602103|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602104|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602105|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
44602106|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602107|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602108|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44602109|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
44602110|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602111|NCT00744978|Varenicline|varenicline|mesh-list
44602112|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44602113|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44602114|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
44602115|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602116|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602117|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602118|NCT00744757|Decitabine|decitabine|mesh-list
44602119|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602120|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
44602121|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602122|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602123|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602124|NCT00744653|Bleomycin|bleomycin|mesh-list
44602125|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44820484|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44820485|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
44820486|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44820487|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
44820488|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44820489|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44820490|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820491|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44820492|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44820493|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820494|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820495|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
44820496|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44820497|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
44820498|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
44820499|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820500|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44820501|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
44820502|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820503|NCT04260464|PF-06700841|pf-06700841|mesh-list
44820504|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44820505|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820506|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820507|NCT04251715|Leucovorin|leucovorin|mesh-list
44820508|NCT04251715|Dexamethasone|dexamethasone|mesh-list
44820509|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
44820510|NCT04251715|Fluorouracil|fluorouracil|mesh-list
44820511|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
44820512|NCT04251715|Irinotecan|irinotecan|mesh-list
44820513|NCT04251715|Floxuridine|floxuridine|mesh-list
44820514|NCT04251715|BB 1101|bb 1101|mesh-list
44820515|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
44820516|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820517|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
44307011|NCT00867061|ON 01910|on 01910|mesh-list
44820518|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
44820519|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820520|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820521|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820522|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
44820523|NCT04251715|Hormones|hormones|mesh-ancestor
44820524|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820525|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820526|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820527|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
44820528|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820529|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820530|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
44820531|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820532|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820533|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
44820534|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44820535|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44820536|NCT04251715|Antidotes|antidotes|mesh-ancestor
44820537|NCT04251715|Protective Agents|protective agents|mesh-ancestor
44820538|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
44820539|NCT04251715|Vitamins|vitamins|mesh-ancestor
44820540|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
44820541|NCT04249882|Naltrexone|naltrexone|mesh-list
44820542|NCT04249882|Varenicline|varenicline|mesh-list
44820543|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44820544|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44820545|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820546|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
44820547|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820548|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44820549|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44820550|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
44820551|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820552|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820553|NCT04245280|Ropivacaine|ropivacaine|mesh-list
44820554|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44820555|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820556|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
44820557|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820558|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820559|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
44820560|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820561|NCT04239703|Antibodies|antibodies|mesh-list
44820562|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
44820563|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820564|NCT04216953|Atezolizumab|atezolizumab|mesh-list
44820565|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820566|NCT04203056|Aripiprazole|aripiprazole|mesh-list
44820567|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
44820568|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
44820569|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820570|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44307039|NCT00867295|Cefazolin|cefazolin|mesh-list
44820571|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44820572|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820573|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820574|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
44820575|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
44820576|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820577|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820578|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44820579|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44820580|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
44820581|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44820582|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44820583|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44820584|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44820585|NCT04184505|Azacitidine|azacitidine|mesh-list
44820586|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820587|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
44820588|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820589|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820590|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820591|NCT04158739|Cytarabine|cytarabine|mesh-list
44820592|NCT04158739|Antibodies|antibodies|mesh-list
44820593|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
44820594|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44820595|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
44820596|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820597|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820598|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
44820599|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820600|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820601|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
44820602|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820603|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820604|NCT04152473|Proglumide|proglumide|mesh-list
44820605|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44820606|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820607|NCT04139434|Azacitidine|azacitidine|mesh-list
44820608|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820609|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
44820610|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820611|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820612|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820613|NCT04130464|Ketorolac|ketorolac|mesh-list
44820614|NCT04130464|Ropivacaine|ropivacaine|mesh-list
44820615|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820616|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
44820617|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820618|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820619|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
44820620|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820621|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820622|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820623|NCT04130464|Analgesics|analgesics|mesh-ancestor
44820624|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820625|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820626|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820627|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820628|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820629|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
44820630|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820631|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820632|NCT04099355|Dronabinol|dronabinol|mesh-list
44820633|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
44820634|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820635|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820636|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820637|NCT04099355|Analgesics|analgesics|mesh-ancestor
44820638|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
44820639|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820640|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44820641|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44820642|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820643|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820645|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820646|NCT04069819|Cilostazol|cilostazol|mesh-list
44820647|NCT04069819|Citalopram|citalopram|mesh-list
44820648|NCT04069819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44820649|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44820650|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44820651|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820652|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820653|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
44820654|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820655|NCT04069819|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44820656|NCT04069819|Antidepressive Agents|antidepressive agents|mesh-ancestor
44820657|NCT04069819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820658|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
44820659|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820660|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44820661|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44820662|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
44820663|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44820664|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44820665|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44820666|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
44820667|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44820668|NCT04069819|Protective Agents|protective agents|mesh-ancestor
44820669|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44820670|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44820671|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820672|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
44820673|NCT04060017|Leucovorin|leucovorin|mesh-list
44820674|NCT04060017|Calcium|calcium|mesh-list
44820675|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
44820676|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44820677|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820678|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44820679|NCT04060017|Antidotes|antidotes|mesh-ancestor
44820680|NCT04060017|Protective Agents|protective agents|mesh-ancestor
44820681|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
44820682|NCT04060017|Vitamins|vitamins|mesh-ancestor
44820683|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
44820684|NCT04044534|Insulin|insulin|mesh-list
44820685|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44820686|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820687|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
44820688|NCT04039022|Bupropion|bupropion|mesh-list
44820689|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44820690|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44820691|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44820692|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44820693|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44820694|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44820695|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820696|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
44820697|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44820698|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820699|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44820700|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44820701|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820702|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
44820703|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44820704|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44820705|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44820706|NCT04012996|Meloxicam|meloxicam|mesh-list
44820707|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820708|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820709|NCT04012996|Analgesics|analgesics|mesh-ancestor
44820710|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
44820711|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820712|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820713|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820714|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820715|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44820716|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820717|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820718|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820719|NCT04003506|Bupivacaine|bupivacaine|mesh-list
44820720|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820721|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
44820722|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820723|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820724|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
44820725|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820726|NCT04002271|Propofol|propofol|mesh-list
44820727|NCT04002271|Sevoflurane|sevoflurane|mesh-list
44820728|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
44820729|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820730|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820731|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44820732|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820733|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
44820734|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44820735|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44820736|NCT03998813|Ropivacaine|ropivacaine|mesh-list
44820737|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820738|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
44820739|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820740|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820741|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
44820742|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820743|NCT03979131|Avelumab|avelumab|mesh-list
44820744|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820745|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820746|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
44820747|NCT03978624|Entinostat|entinostat|mesh-list
44820748|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820749|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820750|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44820751|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820752|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820753|NCT03931161|Evolocumab|evolocumab|mesh-list
44820754|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44820755|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44820756|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
44820757|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820758|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44820759|NCT03900637|Letrozole|letrozole|mesh-list
44820760|NCT03900637|Leuprolide|leuprolide|mesh-list
44820761|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820762|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44820763|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44820764|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820765|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820766|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44820767|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
44820768|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820769|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820770|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44820771|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
44820772|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44820773|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820774|NCT03899987|Aspirin|aspirin|mesh-list
44820775|NCT03899987|Interferons|interferons|mesh-list
44820776|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
44820777|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
44820778|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44820779|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820780|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
44820781|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820782|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820783|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820784|NCT03899987|Analgesics|analgesics|mesh-ancestor
44820785|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
44820786|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820787|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820788|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820789|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820790|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44820791|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44820792|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820793|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44820794|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820795|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820796|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
44820797|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
44820798|NCT03885089|Infliximab|infliximab|mesh-list
44820799|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820800|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820801|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820802|NCT03885037|Infliximab|infliximab|mesh-list
44820803|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820804|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820805|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820806|NCT03877965|Digoxin|digoxin|mesh-list
44820807|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44820808|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44820809|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820810|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820811|NCT03877965|Protective Agents|protective agents|mesh-ancestor
44820812|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820813|NCT03875872|Propofol|propofol|mesh-list
44820814|NCT03875872|Anesthetics|anesthetics|mesh-list
44820815|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
44820816|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44820817|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820818|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820819|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44820820|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
44820821|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44820822|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
44820823|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695429|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695430|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44695431|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44695432|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
44695433|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44695434|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44695435|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44695436|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44695437|NCT01386151|Mitogens|mitogens|mesh-list
44695438|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
44695439|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695440|NCT01386164|Vaccines|vaccines|mesh-list
44695441|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
44695442|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695443|NCT01386177|Doxazosin|doxazosin|mesh-list
44695444|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44695445|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
44695446|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695447|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44695448|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
44695449|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307241|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695450|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695451|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44695452|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44695453|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695454|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
44695455|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44695456|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44695457|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44695458|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44695459|NCT01386229|Ketamine|ketamine|mesh-list
44695460|NCT01386229|Etomidate|etomidate|mesh-list
44695461|NCT01386229|Analgesics|analgesics|mesh-ancestor
44695462|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
44695463|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695464|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820825|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44820826|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820827|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
44820828|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44820829|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44820830|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820831|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
44820832|NCT03868956|Coagulants|coagulants|mesh-ancestor
44820833|NCT03866980|Carboplatin|carboplatin|mesh-list
44820834|NCT03866980|Pemetrexed|pemetrexed|mesh-list
44820835|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820836|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820837|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820838|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44820839|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44820840|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44820841|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44820842|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820843|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
44820844|NCT03810495|Naltrexone|naltrexone|mesh-list
44820845|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44820846|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44820847|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820848|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
44820849|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820850|NCT03776656|Allopurinol|allopurinol|mesh-list
44820851|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
44820852|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820853|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820854|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
44820855|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820856|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44820857|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
44820858|NCT03776656|Protective Agents|protective agents|mesh-ancestor
44820859|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820860|NCT03776071|Temozolomide|temozolomide|mesh-list
44820861|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44820862|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
44820863|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820864|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820865|NCT03767075|Atezolizumab|atezolizumab|mesh-list
44820866|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820867|NCT03756896|Dexamethasone|dexamethasone|mesh-list
44820868|NCT03756896|Pomalidomide|pomalidomide|mesh-list
44820869|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820870|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
44820871|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
44820872|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820873|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820874|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820875|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
44820876|NCT03756896|Hormones|hormones|mesh-ancestor
44820877|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820878|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820879|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820880|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
44820881|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44820882|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44820883|NCT03756896|Growth Substances|growth substances|mesh-ancestor
44820884|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44820885|NCT03742921|Romidepsin|romidepsin|mesh-list
44820886|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44820887|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820888|NCT03733535|Benralizumab|benralizumab|mesh-list
44820889|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44820890|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44820891|NCT03713879|Indomethacin|indomethacin|mesh-list
44820892|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44820893|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44820894|NCT03713879|Analgesics|analgesics|mesh-ancestor
44820895|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
44820896|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820897|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820898|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820899|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820900|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
44820901|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
44820902|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44820903|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44820904|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820905|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820906|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
44820907|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44820908|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44820909|NCT03704584|Prednisolone|prednisolone|mesh-list
44820910|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
44820912|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44820913|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
44820914|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820915|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
44820916|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820917|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820918|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
44820919|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820920|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44820921|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44820922|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44820923|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44820924|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820925|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44820926|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
44820927|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
44820928|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44820929|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
44820930|NCT03704584|Hormones|hormones|mesh-ancestor
44820931|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820932|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44820933|NCT03704584|Protective Agents|protective agents|mesh-ancestor
44820934|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820935|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820936|NCT03691935|Ropivacaine|ropivacaine|mesh-list
44820937|NCT03691935|Anesthetics|anesthetics|mesh-list
44820938|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
44820939|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820940|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820941|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
44820942|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44820943|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44820944|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
44820945|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820946|NCT03661307|Decitabine|decitabine|mesh-list
44820947|NCT03661307|Venetoclax|venetoclax|mesh-list
44820948|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820949|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
44820950|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820951|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820952|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820953|NCT03652428|Gemcitabine|gemcitabine|mesh-list
44820954|NCT03652428|Paclitaxel|paclitaxel|mesh-list
44820955|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44820956|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820957|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44820958|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44820959|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44820960|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44820961|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44820962|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
44820963|NCT03652428|Antiviral Agents|antiviral agents|mesh-ancestor
44820964|NCT03652428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44820965|NCT03652428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44820966|NCT03652428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44820967|NCT03652428|Immunologic Factors|immunologic factors|mesh-ancestor
44820968|NCT03652428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820969|NCT03651518|Rituximab|rituximab|mesh-list
44820970|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44820971|NCT03651518|Ustekinumab|ustekinumab|mesh-list
44820972|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820973|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602544|NCT00741039|Vaccines|vaccines|mesh-list
44820974|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
44820975|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820976|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44820977|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
44820978|NCT03643510|Fulvestrant|fulvestrant|mesh-list
44820979|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44820980|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820981|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44820982|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44820983|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
44820984|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44820985|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820986|NCT03635021|Bevacizumab|bevacizumab|mesh-list
44820987|NCT03635021|Panitumumab|panitumumab|mesh-list
44820988|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44820989|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44820990|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44820991|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44820992|NCT03635021|Growth Substances|growth substances|mesh-ancestor
44820993|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820994|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44820995|NCT03621748|Anesthetics|anesthetics|mesh-list
44820996|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44820997|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44820998|NCT03595553|Vancomycin|vancomycin|mesh-list
44820999|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44821000|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821001|NCT03568994|Cytarabine|cytarabine|mesh-list
44821002|NCT03568994|Atovaquone|atovaquone|mesh-list
44821003|NCT03568994|Etoposide|etoposide|mesh-list
44821004|NCT03568994|Daunorubicin|daunorubicin|mesh-list
44821005|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
44821006|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821007|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821008|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821009|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821010|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821011|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821012|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821013|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
44821014|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
44821015|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821016|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821017|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
44821018|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821019|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821020|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821021|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
44821022|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44821023|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44821024|NCT03535883|Anticoagulants|anticoagulants|mesh-list
44821025|NCT03535883|Coagulants|coagulants|mesh-list
44602618|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602619|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
44602620|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602621|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602622|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
44602623|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44602624|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44602625|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602626|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
44602627|NCT00740116|Coagulants|coagulants|mesh-ancestor
44602628|NCT00740051|Glimepiride|glimepiride|mesh-list
44602629|NCT00740051|Linagliptin|linagliptin|mesh-list
44602630|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44602631|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44602632|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602633|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602634|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
44602635|NCT00740051|Incretins|incretins|mesh-ancestor
44602636|NCT00740051|Hormones|hormones|mesh-ancestor
44602637|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431301|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
44602638|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44602639|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
44821026|NCT03502785|Atezolizumab|atezolizumab|mesh-list
44821027|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821028|NCT03491683|Temozolomide|temozolomide|mesh-list
44821029|NCT03491683|Cemiplimab|cemiplimab|mesh-list
44821030|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821031|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
44821032|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821033|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821034|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821035|NCT03396952|Aspirin|aspirin|mesh-list
44821036|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
44821037|NCT03396952|Ipilimumab|ipilimumab|mesh-list
44821038|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821039|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821040|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44821041|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44821042|NCT03396952|Analgesics|analgesics|mesh-ancestor
44821043|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
44821044|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821045|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821046|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821047|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821048|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44821049|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44821050|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821051|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44821052|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44821053|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821054|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
44821055|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821056|NCT03378934|Aspirin|aspirin|mesh-list
44821057|NCT03378934|Clopidogrel|clopidogrel|mesh-list
44821058|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44821059|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44821060|NCT03378934|Analgesics|analgesics|mesh-ancestor
44821061|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
44821062|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821063|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821064|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821065|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821066|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44821067|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44821068|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821069|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44821070|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44821071|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821072|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
44821073|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44821074|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44821075|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44821076|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
44821077|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821078|NCT03359161|Furosemide|furosemide|mesh-list
44821079|NCT03359161|Diuretics|diuretics|mesh-ancestor
44821080|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
44821081|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821082|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44821083|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821084|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821085|NCT03318770|Dasatinib|dasatinib|mesh-list
44821086|NCT03318770|Blinatumomab|blinatumomab|mesh-list
44821087|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821088|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821089|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821090|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821091|NCT03292146|Denosumab|denosumab|mesh-list
44821092|NCT03292146|Alendronate|alendronate|mesh-list
44821093|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44821094|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821095|NCT03277339|Paroxetine|paroxetine|mesh-list
44821096|NCT03277339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44821097|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44821098|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821099|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821100|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821102|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821103|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44821104|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44821105|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44821106|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44821107|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44821108|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821109|NCT03210558|Testosterone|testosterone|mesh-list
44821110|NCT03210558|Androgens|androgens|mesh-ancestor
44821111|NCT03210558|Hormones|hormones|mesh-ancestor
44307561|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821112|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821113|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821114|NCT03207958|Belimumab|belimumab|mesh-list
44821115|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821116|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
44821117|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821118|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
44821119|NCT03184194|Nivolumab|nivolumab|mesh-list
44821120|NCT03184194|Daratumumab|daratumumab|mesh-list
44821121|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821122|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821123|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
44821124|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821125|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821126|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821127|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
44821128|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821129|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821130|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44821131|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821132|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821133|NCT03173560|Everolimus|everolimus|mesh-list
44821134|NCT03173560|Lenvatinib|lenvatinib|mesh-list
44821135|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821136|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821137|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
44821138|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821139|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821140|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821141|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821142|NCT03145675|Enoxaparin|enoxaparin|mesh-list
44821143|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
44821144|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
44821145|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44821146|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44821147|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821148|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
44821149|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821150|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821151|NCT03058354|Propofol|propofol|mesh-list
44821152|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
44821153|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821154|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821155|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44821156|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44821157|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
44821158|NCT02994927|Prednisone|prednisone|mesh-list
44821159|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
44821160|NCT02994927|Rituximab|rituximab|mesh-list
44821161|NCT02994927|Azathioprine|azathioprine|mesh-list
44821162|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821163|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
44821164|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821165|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821166|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821167|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
44821168|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821169|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307605|NCT00870961|Vitamin D|vitamin d|mesh-list
44821170|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44821171|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821172|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821173|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
44821174|NCT02994927|Hormones|hormones|mesh-ancestor
44821175|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821176|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44821177|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
44821178|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821179|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44821180|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44821181|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821182|NCT02924441|Lidocaine|lidocaine|mesh-list
44821183|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
44821184|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
44821185|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821186|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821187|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
44821188|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821189|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44821190|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44821191|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44821192|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821193|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821195|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
44821196|NCT02911792|Glipizide|glipizide|mesh-list
44821197|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44821198|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821199|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44821200|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821201|NCT02900352|Zonisamide|zonisamide|mesh-list
44821202|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
44821203|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44821204|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821205|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821206|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44821207|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821208|NCT02790853|Proflavine|proflavine|mesh-list
44821209|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44821210|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821211|NCT02782104|Esketamine|esketamine|mesh-list
44821212|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
44821213|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44821214|NCT02777190|Misoprostol|misoprostol|mesh-list
44821215|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44821216|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
44821217|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44821218|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821219|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44821220|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44821221|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
44821222|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44821223|NCT02718066|Nivolumab|nivolumab|mesh-list
44821224|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821225|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821226|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821227|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821228|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
44821229|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821230|NCT02716805|Melphalan|melphalan|mesh-list
44821231|NCT02716805|Durvalumab|durvalumab|mesh-list
44821232|NCT02716805|Tremelimumab|tremelimumab|mesh-list
44821233|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821234|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
44821235|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821236|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821237|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44821238|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821239|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
44821240|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821241|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821242|NCT02716038|Paclitaxel|paclitaxel|mesh-list
44821243|NCT02716038|Carboplatin|carboplatin|mesh-list
44821244|NCT02716038|Atezolizumab|atezolizumab|mesh-list
44821245|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821246|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821247|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821248|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821249|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821250|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821251|NCT02690558|Gemcitabine|gemcitabine|mesh-list
44821252|NCT02690558|Cisplatin|cisplatin|mesh-list
44821253|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
44821254|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821255|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821256|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
44821257|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602867|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
44821258|NCT02690558|Antiviral Agents|antiviral agents|mesh-ancestor
44821259|NCT02690558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821260|NCT02690558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821261|NCT02690558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821262|NCT02690558|Immunologic Factors|immunologic factors|mesh-ancestor
44821263|NCT02690558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821264|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821265|NCT02647554|Urinastatin|urinastatin|mesh-list
44821266|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
44821267|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44821268|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
44821269|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821270|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821271|NCT02630459|Erenumab|erenumab|mesh-list
44821272|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821273|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44821274|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821275|NCT02630459|Analgesics|analgesics|mesh-ancestor
44821276|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
44821277|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821278|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307702|NCT00871442|Fentanyl|fentanyl|mesh-list
44821279|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
44821280|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
44821281|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44821282|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44821283|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821284|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
44821285|NCT02620748|Coagulants|coagulants|mesh-ancestor
44821286|NCT02576509|Nivolumab|nivolumab|mesh-list
44821287|NCT02576509|Sorafenib|sorafenib|mesh-list
44821288|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821289|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821290|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821291|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821292|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821293|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821294|NCT02564900|Camptothecin|camptothecin|mesh-list
44821295|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
44821296|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821297|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821298|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44821299|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821300|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821301|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821302|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
44821303|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821304|NCT02558010|Morphine|morphine|mesh-list
44821305|NCT02558010|Methadone|methadone|mesh-list
44821306|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44821307|NCT02558010|Narcotics|narcotics|mesh-ancestor
44821308|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821309|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821310|NCT02558010|Analgesics|analgesics|mesh-ancestor
44821311|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
44821312|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821313|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
44821314|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
44821315|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44821316|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821317|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307736|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
44821318|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821319|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821320|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
44821321|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44821322|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44821323|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
44821324|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821325|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44821326|NCT02484248|Ketotifen|ketotifen|mesh-list
44821327|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
44821328|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44821329|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44821330|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
44821331|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
44602941|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821332|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821333|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821334|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821335|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44821336|NCT02425943|Mannitol|mannitol|mesh-list
44821337|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44821338|NCT02425943|Diuretics|diuretics|mesh-ancestor
44821339|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
44821340|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821341|NCT02419742|Paclitaxel|paclitaxel|mesh-list
44821342|NCT02419742|Docetaxel|docetaxel|mesh-list
44821343|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
44821344|NCT02419742|Carboplatin|carboplatin|mesh-list
44821345|NCT02419742|Doxorubicin|doxorubicin|mesh-list
44821346|NCT02419742|Trastuzumab|trastuzumab|mesh-list
44821347|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821348|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821349|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821350|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821351|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821352|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821353|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821354|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
44821355|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821356|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821357|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821358|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
44821359|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44307785|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
44821360|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821361|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821362|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821363|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821364|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821365|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
44821366|NCT02409290|Levofloxacin|levofloxacin|mesh-list
44821367|NCT02409290|Isoniazid|isoniazid|mesh-list
44821368|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
44821369|NCT02409290|Ethambutol|ethambutol|mesh-list
44821370|NCT02409290|Bedaquiline|bedaquiline|mesh-list
44821371|NCT02409290|Clofazimine|clofazimine|mesh-list
44821372|NCT02409290|Kanamycin|kanamycin|mesh-list
44821373|NCT02409290|Prothionamide|prothionamide|mesh-list
44821374|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44821375|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821376|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821377|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821378|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821379|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821380|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821381|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44821382|NCT02409290|Renal Agents|renal agents|mesh-ancestor
44821383|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44821384|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44821385|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
44821386|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44821387|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44821388|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
44821389|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44821390|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821391|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
44821392|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44821393|NCT02174861|Erenumab|erenumab|mesh-list
44821394|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44821395|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821396|NCT02174861|Analgesics|analgesics|mesh-ancestor
44821397|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
44821398|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821399|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821400|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44821401|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821402|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
44821403|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821404|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821405|NCT02098343|Carboplatin|carboplatin|mesh-list
44821406|NCT02098343|Doxorubicin|doxorubicin|mesh-list
44821407|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44821408|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821409|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821410|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821411|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821412|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821413|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821415|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44821416|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821417|NCT02066415|Analgesics|analgesics|mesh-ancestor
44821418|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
44821419|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821420|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695465|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44695466|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44695467|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
44695468|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
44695469|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44695470|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44695471|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44695472|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603088|NCT00734851|Docetaxel|docetaxel|mesh-list
44603089|NCT00734851|Sunitinib|sunitinib|mesh-list
44821421|NCT01975831|Durvalumab|durvalumab|mesh-list
44821422|NCT01975831|Tremelimumab|tremelimumab|mesh-list
44821423|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821424|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821425|NCT01952574|Erenumab|erenumab|mesh-list
44821426|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821427|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44821428|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821429|NCT01952574|Analgesics|analgesics|mesh-ancestor
44821430|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
44821431|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821432|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821433|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
44821434|NCT01810016|Poly I-C|poly i-c|mesh-list
44821435|NCT01810016|Ipilimumab|ipilimumab|mesh-list
44821436|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44821437|NCT01810016|Vaccines|vaccines|mesh-list
44821438|NCT01810016|Poly ICLC|poly iclc|mesh-list
44821439|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44821440|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
44821441|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821442|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821443|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821444|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821445|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821446|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
44821447|NCT01810016|Laxatives|laxatives|mesh-ancestor
44821448|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44821449|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
44821450|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821451|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44821452|NCT01722266|Liraglutide|liraglutide|mesh-list
44821453|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44821454|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821455|NCT01722266|Incretins|incretins|mesh-ancestor
44821456|NCT01722266|Hormones|hormones|mesh-ancestor
44821457|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821458|NCT01590069|Aldesleukin|aldesleukin|mesh-list
44821459|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821460|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44821461|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44821462|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
44821463|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821464|NCT01529593|Metformin|metformin|mesh-list
44821465|NCT01529593|Sirolimus|sirolimus|mesh-list
44821466|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44821467|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821468|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44821469|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821470|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821471|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821472|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
44821473|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821474|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
44821475|NCT01464593|Doxorubicin|doxorubicin|mesh-list
44821476|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44821477|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821478|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821479|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821480|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821481|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821482|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821483|NCT01446133|Rituximab|rituximab|mesh-list
44821484|NCT01446133|Lenalidomide|lenalidomide|mesh-list
44821485|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821486|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821487|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
44821488|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821489|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821490|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821491|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821492|NCT01446133|Growth Substances|growth substances|mesh-ancestor
44821493|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821494|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44821495|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
44821496|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821497|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44821498|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
44821499|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821500|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821501|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44821502|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44821503|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821504|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44821505|NCT01369212|Tenofovir|tenofovir|mesh-list
44821506|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44821507|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
44821508|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821509|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44821510|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44821511|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821512|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821513|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44821514|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44821515|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44821516|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
44821517|NCT01361711|Ofatumumab|ofatumumab|mesh-list
44821518|NCT01361711|Antibodies|antibodies|mesh-list
44821519|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
44821520|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821521|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
44821522|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821523|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821524|NCT01351805|Vitamin D|vitamin d|mesh-list
44821525|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
44821526|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
44821527|NCT01351805|Vitamins|vitamins|mesh-list
44821528|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
44821529|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821530|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44821531|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44821532|NCT01295645|Cidofovir|cidofovir|mesh-list
44821533|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
44821534|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821535|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821536|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821537|NCT01217931|Bevacizumab|bevacizumab|mesh-list
44821538|NCT01217931|Everolimus|everolimus|mesh-list
44821539|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821540|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821541|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821542|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821543|NCT01217931|Growth Substances|growth substances|mesh-ancestor
44821544|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821545|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821546|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821547|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
44821548|NCT01198067|Pomalidomide|pomalidomide|mesh-list
44821549|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
44821550|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821551|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821552|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821553|NCT01198067|Growth Substances|growth substances|mesh-ancestor
44821554|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821555|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821556|NCT01187199|Sirolimus|sirolimus|mesh-list
44821557|NCT01187199|Paclitaxel|paclitaxel|mesh-list
44821558|NCT01187199|Bevacizumab|bevacizumab|mesh-list
44821559|NCT01187199|Carboplatin|carboplatin|mesh-list
44821560|NCT01187199|Sorafenib|sorafenib|mesh-list
44821561|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821562|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821563|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821564|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821565|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821566|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821567|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821568|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821569|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821570|NCT01187199|Growth Substances|growth substances|mesh-ancestor
44821571|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821572|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821573|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821574|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821575|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44821576|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821577|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821578|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
44821579|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821580|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
44821581|NCT01081951|Paclitaxel|paclitaxel|mesh-list
44821582|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44821583|NCT01081951|Carboplatin|carboplatin|mesh-list
44821584|NCT01081951|Olaparib|olaparib|mesh-list
44821585|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821586|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821587|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821588|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821589|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821590|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821591|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44821592|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821593|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
44821594|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821595|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821596|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821597|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821598|NCT00972309|Vaccines|vaccines|mesh-list
44821599|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
44821600|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821601|NCT00842348|Lanreotide|lanreotide|mesh-list
44821602|NCT00842348|Somatostatin|somatostatin|mesh-list
44821603|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821604|NCT00842348|Hormones|hormones|mesh-ancestor
44821605|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821606|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821607|NCT00803569|Sargramostim|sargramostim|mesh-list
44821608|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
44821609|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821610|NCT00715442|Sunitinib|sunitinib|mesh-list
44821611|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821612|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821613|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821614|NCT00715442|Growth Substances|growth substances|mesh-ancestor
44821615|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821616|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821617|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821618|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821619|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821620|NCT00616941|Poly ICLC|poly iclc|mesh-list
44821621|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44821622|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
44821623|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
44821624|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821625|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44821626|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44821627|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
44821628|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44821629|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
44821630|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44821631|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821632|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44821633|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44821634|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821635|NCT00520533|Sunitinib|sunitinib|mesh-list
44821636|NCT00520533|Antibodies|antibodies|mesh-list
44821637|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821638|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
44821639|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821640|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821641|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821642|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821643|NCT00520533|Growth Substances|growth substances|mesh-ancestor
44821644|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821645|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821646|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821647|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821648|NCT00482833|Methotrexate|methotrexate|mesh-list
44821649|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
44603307|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
44821650|NCT00482833|Idarubicin|idarubicin|mesh-list
44821651|NCT00482833|Tretinoin|tretinoin|mesh-list
44821652|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
44821653|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44821654|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
44821655|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44821656|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821657|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821658|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
44821659|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821660|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821661|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
44821662|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821663|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44821664|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821665|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
44821666|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821667|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44821668|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821669|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821670|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821671|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
44821672|NCT00390793|Cytarabine|cytarabine|mesh-list
44821673|NCT00390793|Dexamethasone|dexamethasone|mesh-list
44821674|NCT00390793|Prednisone|prednisone|mesh-list
44821675|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
44821676|NCT00390793|Cortisone|cortisone|mesh-list
44821677|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
44821678|NCT00390793|Doxorubicin|doxorubicin|mesh-list
44821679|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44821680|NCT00390793|Methotrexate|methotrexate|mesh-list
44821681|NCT00390793|Vincristine|vincristine|mesh-list
44821682|NCT00390793|Daunorubicin|daunorubicin|mesh-list
44821683|NCT00390793|Dasatinib|dasatinib|mesh-list
44821684|NCT00390793|BB 1101|bb 1101|mesh-list
44821685|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821686|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
44821687|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308086|NCT00873535|Varenicline|varenicline|mesh-list
44821688|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821689|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44821690|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
44821691|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821692|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821693|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44821694|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821695|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
44821696|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
44821697|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821698|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44821699|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
44821700|NCT00390793|Hormones|hormones|mesh-ancestor
44821701|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821702|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44821703|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44821704|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44821705|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44821706|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821707|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44821708|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
44821709|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44821710|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821711|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
44821712|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
44821713|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44821714|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44821715|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
44821716|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821717|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821718|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821719|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821720|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821721|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821722|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603384|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
44821723|NCT00353496|Lanreotide|lanreotide|mesh-list
44821724|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821725|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44821726|NCT00140855|Ipilimumab|ipilimumab|mesh-list
44821728|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
44821729|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44821730|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
44821731|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821732|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821733|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821734|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821735|NCT00112957|Vaccines|vaccines|mesh-list
44821736|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
44821737|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821738|NCT00006256|Paclitaxel|paclitaxel|mesh-list
44821739|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821740|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821741|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821742|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821743|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821744|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821745|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
44821746|NCT02140736|Hematinics|hematinics|mesh-ancestor
44821747|NCT02140801|Clopidogrel|clopidogrel|mesh-list
44821748|NCT02140801|Ticagrelor|ticagrelor|mesh-list
44821749|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44821750|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44821751|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44821752|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44821753|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
44821754|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821755|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821756|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821757|NCT02140814|Niacinamide|niacinamide|mesh-list
44821758|NCT02140814|Niacin|niacin|mesh-list
44821759|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
44821760|NCT02140814|Vitamins|vitamins|mesh-ancestor
44821761|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
44821762|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821763|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
44821764|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44821765|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
44821766|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821767|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44821768|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
44821769|NCT02140840|Trametinib|trametinib|mesh-list
44821770|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821771|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821772|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821773|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821774|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
44821775|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821776|NCT02140983|Liraglutide|liraglutide|mesh-list
44821777|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44821778|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821779|NCT02140983|Incretins|incretins|mesh-ancestor
44821780|NCT02140983|Hormones|hormones|mesh-ancestor
44821781|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44821782|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44308170|NCT00873834|Fluoxetine|fluoxetine|mesh-list
44821783|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
44821784|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821785|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
44821786|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
44821787|NCT02141035|Vitamins|vitamins|mesh-ancestor
44821788|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
44821789|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821790|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
44821791|NCT02141087|Pirfenidone|pirfenidone|mesh-list
44821792|NCT02141087|Analgesics|analgesics|mesh-ancestor
44821793|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
44821794|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821795|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821796|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44821797|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44821798|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821799|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821800|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821801|NCT02141100|Thioguanine|thioguanine|mesh-list
44821802|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821804|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821805|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821806|NCT02141113|Guanfacine|guanfacine|mesh-list
44821807|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44821808|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44821809|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44821810|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44821811|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44821812|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821813|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821814|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821815|NCT02141139|Ibuprofen|ibuprofen|mesh-list
44821816|NCT02141139|Ketorolac|ketorolac|mesh-list
44821817|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44821818|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44821819|NCT02141139|Analgesics|analgesics|mesh-ancestor
44821820|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
44821821|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821822|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821823|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821824|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44821825|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44821826|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821827|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821828|NCT02141178|Bupivacaine|bupivacaine|mesh-list
44821829|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
44821830|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
44821831|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821832|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821833|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
44821834|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821835|NCT02141321|Alprostadil|alprostadil|mesh-list
44821836|NCT02141321|Misoprostol|misoprostol|mesh-list
44821837|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44821838|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
44821839|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44821840|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821841|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44821842|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44821843|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
44821844|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44821845|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
44821846|NCT02141321|Urological Agents|urological agents|mesh-ancestor
44821847|NCT02141347|Durvalumab|durvalumab|mesh-list
44821848|NCT02141347|Tremelimumab|tremelimumab|mesh-list
44821849|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821850|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821851|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
44821852|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44821853|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821854|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821855|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44821856|NCT02141412|Analgesics|analgesics|mesh-ancestor
44821857|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
44821858|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821859|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44821860|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44821861|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44821862|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44821863|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821864|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821865|NCT02141425|Peficitinib|peficitinib|mesh-list
44821866|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821867|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821868|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821869|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
44821870|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821871|NCT02141477|Decitabine|decitabine|mesh-list
44821872|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
44821873|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44821874|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
44821875|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821876|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821877|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821878|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821879|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44821880|NCT02141698|Esomeprazole|esomeprazole|mesh-list
44821881|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44821882|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44821883|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44821884|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821885|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821886|NCT02141737|Lidocaine|lidocaine|mesh-list
44821887|NCT02141737|Fentanyl|fentanyl|mesh-list
44821888|NCT02141737|Midazolam|midazolam|mesh-list
44821889|NCT02141737|Etomidate|etomidate|mesh-list
44821890|NCT02141737|Rocuronium|rocuronium|mesh-list
44821891|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
44821892|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
44821893|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44821894|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821895|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
44821896|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44821897|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44821898|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44821899|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44821900|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821901|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821902|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44821903|NCT02141737|Narcotics|narcotics|mesh-ancestor
44821904|NCT02141737|Analgesics|analgesics|mesh-ancestor
44821905|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44821906|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44821907|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
44821908|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44821909|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44821910|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44821911|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44821912|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
44821913|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
44821914|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821915|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44821916|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44821917|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44821918|NCT02141958|Fenretinide|fenretinide|mesh-list
44821919|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821920|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44821921|NCT02141958|Protective Agents|protective agents|mesh-ancestor
44821922|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821923|NCT02142010|Paclitaxel|paclitaxel|mesh-list
44821924|NCT02142010|Cisplatin|cisplatin|mesh-list
44821925|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44821926|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821927|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44821928|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44821929|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44821930|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466266|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
44466298|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308297|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
44308298|NCT00874393|Dopamine|dopamine|mesh-list
44308299|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44821931|NCT02142036|Trastuzumab|trastuzumab|mesh-list
44821932|NCT02142036|Cetuximab|cetuximab|mesh-list
44821933|NCT02142036|Panitumumab|panitumumab|mesh-list
44821934|NCT02142036|Everolimus|everolimus|mesh-list
44821935|NCT02142036|Sunitinib|sunitinib|mesh-list
44821936|NCT02142036|Dasatinib|dasatinib|mesh-list
44821937|NCT02142036|Lapatinib|lapatinib|mesh-list
44821938|NCT02142036|Gefitinib|gefitinib|mesh-list
44821939|NCT02142036|Afatinib|afatinib|mesh-list
44821940|NCT02142036|Vemurafenib|vemurafenib|mesh-list
44821941|NCT02142036|Dabrafenib|dabrafenib|mesh-list
44821942|NCT02142036|Crizotinib|crizotinib|mesh-list
44821943|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821944|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821945|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44821946|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
44821947|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821948|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44821949|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44821950|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821951|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821952|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821953|NCT02142036|Growth Substances|growth substances|mesh-ancestor
44821954|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821955|NCT02142075|Daptomycin|daptomycin|mesh-list
44821956|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44821957|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44821958|NCT02142140|Methylphenidate|methylphenidate|mesh-list
44308300|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44821959|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44821960|NCT02142140|Adderall|adderall|mesh-list
44821961|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
44821962|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
44821963|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44821964|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821965|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44821966|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44821967|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44821968|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821969|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
44821970|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44821971|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44821972|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44821973|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
44821974|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44821975|NCT02142192|Natalizumab|natalizumab|mesh-list
44821976|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
44821977|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821978|NCT02142205|Natalizumab|natalizumab|mesh-list
44821979|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
44821980|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821981|NCT02142218|Nivolumab|nivolumab|mesh-list
44821982|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44821983|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821984|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44821985|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44821986|NCT02142296|Aflibercept|aflibercept|mesh-list
44821987|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44821988|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44821989|NCT02142296|Growth Substances|growth substances|mesh-ancestor
44308319|NCT00874406|Antidotes|antidotes|mesh-ancestor
44821990|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821991|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44821992|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44821993|NCT02142309|Pioglitazone|pioglitazone|mesh-list
44821994|NCT02142309|Glimepiride|glimepiride|mesh-list
44821995|NCT02142309|Vildagliptin|vildagliptin|mesh-list
44821996|NCT02142309|Canagliflozin|canagliflozin|mesh-list
44821997|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44821998|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44821999|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44822000|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822001|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
44822002|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44822003|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
44822004|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822005|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822006|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44822007|NCT02142335|Rituximab|rituximab|mesh-list
44822008|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44822009|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822010|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
44822011|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822012|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44822013|NCT02142530|Belinostat|belinostat|mesh-list
44822014|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822015|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44822016|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822017|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822018|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
44308356|NCT00874562|Sirolimus|sirolimus|mesh-list
44822019|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44822020|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
44822021|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44822022|NCT02142543|Protective Agents|protective agents|mesh-ancestor
44822023|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822024|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44822025|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
44822026|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822027|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44822028|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822029|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822030|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822031|NCT02142569|Tocotrienols|tocotrienols|mesh-list
44822032|NCT02142569|Vitamin E|vitamin e|mesh-list
44822033|NCT02142569|Tocopherols|tocopherols|mesh-list
44822034|NCT02142569|Red yeast rice|red yeast rice|mesh-list
44822035|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
44822036|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822037|NCT02142569|Protective Agents|protective agents|mesh-ancestor
44822038|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822039|NCT02142569|Vitamins|vitamins|mesh-ancestor
44822040|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
44822041|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44822042|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44603743|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603744|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603745|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603746|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44603747|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
44603748|NCT00729183|Vitamin D|vitamin d|mesh-list
44603749|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
44603750|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
44603751|NCT00729183|Calcium|calcium|mesh-list
44603752|NCT00729183|Vitamins|vitamins|mesh-ancestor
44603753|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
44603754|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603755|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44603756|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44603757|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603758|NCT00729183|Antacids|antacids|mesh-ancestor
44603759|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603760|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
44603761|NCT00729157|Aflibercept|aflibercept|mesh-list
44603762|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
44603763|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44603764|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603765|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44603766|NCT00729157|Growth Substances|growth substances|mesh-ancestor
44603767|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603768|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603769|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603770|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603771|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44603772|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
44603773|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
44603774|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603775|NCT00728988|Atorvastatin|atorvastatin|mesh-list
44603776|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44603777|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44603778|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
44603779|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822043|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44822044|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
44822045|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822046|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44822047|NCT02142595|Midazolam|midazolam|mesh-list
44822048|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
44822049|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822050|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822051|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822052|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44822053|NCT02142595|Analgesics|analgesics|mesh-ancestor
44822054|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
44822055|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822056|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44822057|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44822058|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44822059|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822060|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822061|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822062|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44822063|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44822064|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822065|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822066|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822067|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
44822068|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
44822069|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
44822070|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
44822071|NCT02142634|Budesonide|budesonide|mesh-list
44822072|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44822073|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44822074|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
44822075|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822076|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822077|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44822078|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44822079|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
44822080|NCT02142634|Hormones|hormones|mesh-ancestor
44822081|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822082|NCT02142751|Meropenem|meropenem|mesh-list
44822083|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
44822084|NCT02142751|Fosfomycin|fosfomycin|mesh-list
44822085|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44822086|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822087|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822088|NCT02142777|Equol|equol|mesh-list
44822089|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
44822090|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44822091|NCT02142777|Estrogens|estrogens|mesh-ancestor
44822092|NCT02142777|Hormones|hormones|mesh-ancestor
44822093|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822094|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822095|NCT02142790|Paclitaxel|paclitaxel|mesh-list
44822096|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44822097|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822098|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44822099|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44822100|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44822101|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822102|NCT02142829|Bupivacaine|bupivacaine|mesh-list
44822103|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
44822104|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
44822105|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822106|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822107|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
44822108|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822109|NCT02142868|Letrozole|letrozole|mesh-list
44822110|NCT02142868|Palbociclib|palbociclib|mesh-list
44822111|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822112|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44822113|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44822114|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822115|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695473|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695474|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822116|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44822117|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
44822118|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822119|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822120|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822121|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
44822123|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822124|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822125|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822126|NCT02143050|Metformin|metformin|mesh-list
44822127|NCT02143050|Trametinib|trametinib|mesh-list
44822128|NCT02143050|Dabrafenib|dabrafenib|mesh-list
44822129|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822130|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822131|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822132|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822133|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822134|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822135|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
44822136|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44822137|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822138|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822139|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44822140|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822141|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822142|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44822143|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822144|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822145|NCT02143362|Remifentanil|remifentanil|mesh-list
44822146|NCT02143362|Anesthetics|anesthetics|mesh-list
44822147|NCT02143362|Propofol|propofol|mesh-list
44822148|NCT02143362|Cisatracurium|cisatracurium|mesh-list
44822149|NCT02143362|Atracurium|atracurium|mesh-list
44822150|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822151|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822152|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822153|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822154|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
44822155|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44822156|NCT02143362|Narcotics|narcotics|mesh-ancestor
44822157|NCT02143362|Analgesics|analgesics|mesh-ancestor
44822158|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
44822159|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822160|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44822161|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44822162|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44822163|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44822164|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44822165|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
44822166|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822167|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822168|NCT02143440|Insulin|insulin|mesh-list
44822169|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822170|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822171|NCT02143479|Tacrolimus|tacrolimus|mesh-list
44822172|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822173|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
44822174|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822175|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44822176|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822177|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822178|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44822179|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
44822180|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44822181|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
44822182|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822183|NCT02143518|Antacids|antacids|mesh-ancestor
44822184|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822185|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822186|NCT02143531|Haloperidol|haloperidol|mesh-list
44822187|NCT02143531|Ondansetron|ondansetron|mesh-list
44822188|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
44822189|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
44822190|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
44822191|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308551|NCT00875927|Zinc|zinc|mesh-list
44308586|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308587|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308588|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
44822192|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822193|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822194|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
44822195|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44822196|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44822197|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
44822198|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822199|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822200|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44822201|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822202|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822203|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822204|NCT02143531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44822205|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44822206|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
44822207|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44822208|NCT02143570|Darifenacin|darifenacin|mesh-list
44822209|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44822210|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44822211|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
44822212|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822213|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822214|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822215|NCT02143570|Urological Agents|urological agents|mesh-ancestor
44822216|NCT02143622|Cetuximab|cetuximab|mesh-list
44822217|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44822218|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822219|NCT02143687|Sevoflurane|sevoflurane|mesh-list
44822220|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44822221|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44822222|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
44822223|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
44822224|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822225|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822226|NCT02143765|Acarbose|acarbose|mesh-list
44822227|NCT02143765|Mitiglinide|mitiglinide|mesh-list
44822228|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44822229|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822230|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822231|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822232|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822233|NCT02143804|Molgramostim|molgramostim|mesh-list
44822234|NCT02143804|Sargramostim|sargramostim|mesh-list
44822235|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
44822236|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822237|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822238|NCT02143934|Chloroquine|chloroquine|mesh-list
44822239|NCT02143934|Lumefantrine|lumefantrine|mesh-list
44822240|NCT02143934|Artemether|artemether|mesh-list
44822241|NCT02143934|Primaquine|primaquine|mesh-list
44822242|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44822243|NCT02143934|Amebicides|amebicides|mesh-ancestor
44822244|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44822245|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44822246|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822247|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
44822248|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44822249|NCT02144025|Cyclosporine|cyclosporine|mesh-list
44822250|NCT02144025|Cyclosporins|cyclosporins|mesh-list
44822251|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822252|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822253|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822254|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
44822255|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822256|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
44822257|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822258|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
44822259|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44822260|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44822261|NCT02144064|Heparin|heparin|mesh-list
44822262|NCT02144064|Calcium heparin|calcium heparin|mesh-list
44822263|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
44822264|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44822265|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44822266|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822267|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
44822268|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44822269|NCT02144194|Docetaxel|docetaxel|mesh-list
44822270|NCT02144194|Vinorelbine|vinorelbine|mesh-list
44822271|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822272|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44822273|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44822274|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44822275|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822276|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44822277|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
44822278|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44822279|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44822280|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44822281|NCT02144246|Norgestimate|norgestimate|mesh-list
44822282|NCT02144246|Norgestrel|norgestrel|mesh-list
44822283|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44822284|NCT02144246|Estradiol|estradiol|mesh-list
44822285|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44822286|NCT02144246|Estrogens|estrogens|mesh-ancestor
44822287|NCT02144246|Hormones|hormones|mesh-ancestor
44822288|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822289|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822290|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44822291|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
44822292|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822293|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44822294|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44822295|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44822296|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44822297|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822298|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822299|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44822300|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44822301|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822302|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822303|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822304|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44822305|NCT02144376|Psyllium|psyllium|mesh-list
44822306|NCT02144376|Cathartics|cathartics|mesh-ancestor
44822307|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822308|NCT02144389|Praziquantel|praziquantel|mesh-list
44822309|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
44822310|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44822311|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822312|NCT02144415|Amphetamine|amphetamine|mesh-list
44822313|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44822314|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
44822315|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44822316|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822317|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
44822318|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
44822319|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822320|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
44822321|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822322|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822323|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822324|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44822325|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44822326|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822327|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44822328|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
44822329|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822330|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822331|NCT02144623|Valproic Acid|valproic acid|mesh-list
44822332|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
44822333|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822334|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822335|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
44822336|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822337|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822338|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
44822339|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822340|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822341|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822342|NCT02144662|Ranibizumab|ranibizumab|mesh-list
44822343|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44822344|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44822345|NCT02144662|Growth Substances|growth substances|mesh-ancestor
44822346|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822347|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44822348|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822349|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44822350|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
44822351|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822352|NCT02144753|Psyllium|psyllium|mesh-list
44822353|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
44822354|NCT02144753|Cathartics|cathartics|mesh-ancestor
44822355|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822356|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
44822357|NCT02144766|Ropivacaine|ropivacaine|mesh-list
44822358|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
44822359|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
44822360|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822361|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822362|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
44822363|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822364|NCT02144792|Verapamil|verapamil|mesh-list
44822365|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44822366|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44822367|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822368|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822369|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44822370|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822371|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
44822372|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44822373|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
44822374|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44822375|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
44822376|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822377|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822378|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44822379|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44822380|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604160|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
44604161|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604162|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44604163|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44604164|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604165|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604166|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44604167|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44604168|NCT00724451|Ribavirin|ribavirin|mesh-list
44604169|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44604170|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604171|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
44604172|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604173|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
44604174|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604175|NCT00724373|Ribavirin|ribavirin|mesh-list
44604176|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604177|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
44604178|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604179|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
44604180|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604181|NCT00724282|Eszopiclone|eszopiclone|mesh-list
44604182|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44604185|NCT00724243|Infliximab|infliximab|mesh-list
44822381|NCT02144922|Pitavastatin|pitavastatin|mesh-list
44822382|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44822383|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44822384|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44822385|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
44822386|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822387|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822388|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44822389|NCT02145065|Paclitaxel|paclitaxel|mesh-list
44822390|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44822391|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822392|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
44822393|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
44308774|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44822394|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
44822395|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822396|NCT02145091|Psilocybin|psilocybin|mesh-list
44822397|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44822398|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
44822399|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822400|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822401|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44822402|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
44822403|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822404|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822405|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44822406|NCT02145104|Valsartan|valsartan|mesh-list
44822407|NCT02145104|Cilnidipine|cilnidipine|mesh-list
44822408|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44822409|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44822410|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44822411|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822412|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44822413|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822414|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44822415|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822416|NCT02145195|Vitamin D|vitamin d|mesh-list
44822417|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
44822418|NCT02145195|Vitamins|vitamins|mesh-ancestor
44822419|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
44822420|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822421|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44822422|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44822423|NCT02145338|Trimethoprim|trimethoprim|mesh-list
44822424|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
44822425|NCT02145338|Cephalexin|cephalexin|mesh-list
44822426|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44822427|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822428|NCT02145338|Renal Agents|renal agents|mesh-ancestor
44822429|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
44822430|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44822431|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44822432|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44308810|NCT00877539|Fluticasone|fluticasone|mesh-list
44822433|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822434|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822435|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44822436|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44822437|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822438|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822439|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
44822440|NCT02145520|Analgesics|analgesics|mesh-ancestor
44822441|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
44822442|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822443|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822444|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
44822445|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822446|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44822447|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
44822448|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44822449|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822450|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822451|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44822452|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
44604213|NCT00723892|Ribavirin|ribavirin|mesh-list
44604214|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44822453|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822455|NCT02145546|Sotalol|sotalol|mesh-list
44822456|NCT02145546|Propafenone|propafenone|mesh-list
44822457|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44822458|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44308857|NCT00877656|Zanolimumab|zanolimumab|mesh-list
44308879|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308880|NCT00877955|Alprazolam|alprazolam|mesh-list
44308881|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44308882|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308887|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
44822459|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44822460|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822461|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822462|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44822463|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44822464|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822465|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822466|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44822467|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44822468|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44822469|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44822470|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44822471|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822472|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822473|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822474|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
44822475|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
44822476|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822477|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44822478|NCT02145559|Metformin|metformin|mesh-list
44822479|NCT02145559|Sirolimus|sirolimus|mesh-list
44822480|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822481|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822482|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822483|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822484|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44822485|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822486|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
44822487|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822488|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
44822489|NCT02145585|Anesthetics|anesthetics|mesh-list
44822490|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822491|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822492|NCT02145598|Lenalidomide|lenalidomide|mesh-list
44822493|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
44822494|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822495|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44822496|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44822497|NCT02145598|Growth Substances|growth substances|mesh-ancestor
44822498|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
44822499|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822500|NCT02145611|Vildagliptin|vildagliptin|mesh-list
44822501|NCT02145611|Glyburide|glyburide|mesh-list
44822502|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822503|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822504|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44822505|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
44822506|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822507|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822508|NCT02145624|Vaccines|vaccines|mesh-list
44822509|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
44822510|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822511|NCT02145637|Afatinib|afatinib|mesh-list
44822512|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822513|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822514|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822515|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822516|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
44822517|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44822518|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44822519|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44822520|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822521|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822522|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
44822523|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822524|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695475|NCT01386242|Interferons|interferons|mesh-list
44604289|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822525|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44822526|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822527|NCT02145715|Thalidomide|thalidomide|mesh-list
44822528|NCT02145715|Dexamethasone|dexamethasone|mesh-list
44822530|NCT02145715|Panobinostat|panobinostat|mesh-list
44822531|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44822532|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
44822533|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
44822534|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822535|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822536|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822537|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
44822538|NCT02145715|Hormones|hormones|mesh-ancestor
44822539|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822540|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44822541|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822542|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822543|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
44822544|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
44822545|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822546|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822547|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44822548|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44822549|NCT02145715|Growth Substances|growth substances|mesh-ancestor
44822550|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44822551|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44822552|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822553|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822554|NCT02145767|Progesterone|progesterone|mesh-list
44822555|NCT02145767|Progestins|progestins|mesh-ancestor
44822556|NCT02145767|Hormones|hormones|mesh-ancestor
44822557|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822558|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822559|NCT02145832|Fluconazole|fluconazole|mesh-list
44822560|NCT02145832|Micafungin|micafungin|mesh-list
44822561|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
44822562|NCT02145832|Clotrimazole|clotrimazole|mesh-list
44822563|NCT02145832|Miconazole|miconazole|mesh-list
44822564|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822565|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44822566|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822567|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822568|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822569|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44308949|NCT00878449|Cisplatin|cisplatin|mesh-list
44822570|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
44822571|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822572|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822573|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44822574|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44822575|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44822576|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44822577|NCT02145884|Timolol|timolol|mesh-list
44822578|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44822579|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44822580|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822581|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822582|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822583|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822584|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44822585|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44822586|NCT02145910|Vemurafenib|vemurafenib|mesh-list
44822587|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822588|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822589|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822590|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822591|NCT02145949|Tryptophan|tryptophan|mesh-list
44822592|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44822593|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
44822594|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822595|NCT02145975|Fentanyl|fentanyl|mesh-list
44822596|NCT02145975|Morphine|morphine|mesh-list
44822597|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
44822598|NCT02145975|Narcotics|narcotics|mesh-ancestor
44604363|NCT00723021|Zileuton|zileuton|mesh-list
44822599|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822600|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822602|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
44822603|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822604|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44822605|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822606|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
44822607|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
44822608|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44822609|NCT02146118|Silybin|silybin|mesh-list
44822610|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822611|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822612|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308985|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44822613|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822614|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44822615|NCT02146118|Protective Agents|protective agents|mesh-ancestor
44822616|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822617|NCT02146209|Metronidazole|metronidazole|mesh-list
44822618|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822619|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822620|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44822621|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44822622|NCT02146222|Docetaxel|docetaxel|mesh-list
44822623|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822624|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44822625|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44822626|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44822627|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822628|NCT02146261|Quetmolimab|quetmolimab|mesh-list
44822629|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44822630|NCT02146300|Xylometazoline|xylometazoline|mesh-list
44822631|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
44822632|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44822633|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
44822634|NCT02146391|Enclomiphene|enclomiphene|mesh-list
44822635|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44822636|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
44822637|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822638|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822639|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44822640|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
44822641|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822642|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44822643|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44822644|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
44822645|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44822646|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44822647|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822648|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
44822649|NCT02146456|Coagulants|coagulants|mesh-ancestor
44822650|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
44822651|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44822652|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822653|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822654|NCT02146547|Aripiprazole|aripiprazole|mesh-list
44822655|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44822656|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44822657|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822658|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44822659|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822660|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822661|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822662|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
44822663|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
44822664|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822665|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822666|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44822667|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44822668|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
44822669|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44604450|NCT00722137|Hormones|hormones|mesh-ancestor
44822670|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44822671|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44822672|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44822673|NCT02146638|Fentanyl|fentanyl|mesh-list
44822674|NCT02146638|Morphine|morphine|mesh-list
44822675|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44822676|NCT02146638|Narcotics|narcotics|mesh-ancestor
44822677|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822678|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822679|NCT02146638|Analgesics|analgesics|mesh-ancestor
44822680|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
44822681|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822682|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44822683|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822684|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
44822685|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
44822686|NCT02146651|Insulin|insulin|mesh-list
44822687|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44822688|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
44822689|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822690|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695476|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695477|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
44695478|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695479|NCT01386255|Baclofen|baclofen|mesh-list
44695480|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44695481|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309078|NCT00879021|Pregabalin|pregabalin|mesh-list
44695482|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44695483|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695484|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44695485|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
44695486|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
44695487|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695488|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695489|NCT01386268|Factor VIII|factor viii|mesh-list
44695490|NCT01386268|Coagulants|coagulants|mesh-ancestor
44695491|NCT01386294|Tenofovir|tenofovir|mesh-list
44695492|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
44695493|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695494|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44695495|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44695496|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695497|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695498|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44695499|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44695500|NCT01386333|Oxytocin|oxytocin|mesh-list
44695501|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
44695502|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695503|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695504|NCT01386346|Capecitabine|capecitabine|mesh-list
44695505|NCT01386346|Azacitidine|azacitidine|mesh-list
44695506|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
44695507|NCT01386346|Epirubicin|epirubicin|mesh-list
44695508|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44822691|NCT02146703|Gemcitabine|gemcitabine|mesh-list
44822692|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44822693|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
44822694|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822695|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822696|NCT02146703|Antiviral Agents|antiviral agents|mesh-ancestor
44822697|NCT02146703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822698|NCT02146703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822699|NCT02146703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822700|NCT02146703|Immunologic Factors|immunologic factors|mesh-ancestor
44822701|NCT02146703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822702|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
44822703|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822704|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822705|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822706|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822707|NCT02146911|Bupropion|bupropion|mesh-list
44822708|NCT02146911|Varenicline|varenicline|mesh-list
44822709|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44822710|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
44822711|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822712|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44822713|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44822714|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822715|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822716|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
44822717|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822718|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822719|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44822720|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822721|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822722|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44822723|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44822724|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
44822725|NCT02146937|Bicalutamide|bicalutamide|mesh-list
44822726|NCT02146937|Finasteride|finasteride|mesh-list
44822727|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
44822728|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44822729|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822730|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822731|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822732|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44822733|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44822734|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822735|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822736|NCT02146937|Urological Agents|urological agents|mesh-ancestor
44822737|NCT02146976|Propofol|propofol|mesh-list
44822738|NCT02146976|Sevoflurane|sevoflurane|mesh-list
44822739|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822740|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822741|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822742|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822743|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
44822744|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
44822745|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44822746|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44822747|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44822748|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
44822749|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
44466322|NCT01465230|Lenalidomide|lenalidomide|mesh-list
44466323|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
44466324|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466325|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44466326|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44466327|NCT01465230|Growth Substances|growth substances|mesh-ancestor
44466328|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
44466329|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822750|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
44822751|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44822752|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822753|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44822754|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
44822755|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
44822756|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822757|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822758|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822759|NCT02147015|Hormones|hormones|mesh-ancestor
44822760|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822761|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44822762|NCT02147015|Protective Agents|protective agents|mesh-ancestor
44822763|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822764|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822765|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44822766|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44822767|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
44822768|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822769|NCT02147041|Protective Agents|protective agents|mesh-ancestor
44822770|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822771|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44822772|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44822773|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822774|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44822775|NCT02147054|Rocuronium|rocuronium|mesh-list
44822776|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44822777|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44822778|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44466330|NCT01465191|Morphine|morphine|mesh-list
44822779|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822780|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822781|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44822782|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822783|NCT02147262|Doxycycline|doxycycline|mesh-list
44822784|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822785|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822786|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
44822787|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44822788|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44822789|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44822790|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44822791|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822792|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822793|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822794|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822795|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44822796|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44822797|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44822798|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822799|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822800|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822801|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44822802|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44822803|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
44822804|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44822805|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44822806|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
44822807|NCT02147535|Methylphenidate|methylphenidate|mesh-list
44822808|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44822809|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822810|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44822811|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44822812|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44822813|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822814|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
44822815|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822816|NCT02147548|Lorazepam|lorazepam|mesh-list
44822817|NCT02147548|Etifoxine|etifoxine|mesh-list
44822818|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
44822819|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
44822820|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
44822821|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822822|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822823|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822824|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822825|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822826|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44822827|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822828|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822829|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
44822830|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
44822831|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822832|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822833|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
44822834|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44822835|NCT02147678|Remifentanil|remifentanil|mesh-list
44822836|NCT02147678|Propofol|propofol|mesh-list
44822837|NCT02147678|Etomidate|etomidate|mesh-list
44822838|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
44822839|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604703|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604704|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44822840|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822841|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822842|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822843|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
44822844|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44822845|NCT02147678|Narcotics|narcotics|mesh-ancestor
44822846|NCT02147678|Analgesics|analgesics|mesh-ancestor
44822847|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
44822848|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822849|NCT02147730|Anesthetics|anesthetics|mesh-list
44822850|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822851|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822852|NCT02147808|Midazolam|midazolam|mesh-list
44822853|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44822854|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822855|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822856|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822857|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44822858|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44822859|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822860|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44822861|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
44822862|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
44822863|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
44822864|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
44309197|NCT00879918|Nicotine|nicotine|mesh-list
44822865|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822866|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822867|NCT02147873|Azacitidine|azacitidine|mesh-list
44822868|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44822869|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
44822870|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822871|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822872|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822873|NCT02147925|Metformin|metformin|mesh-list
44822874|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
44822875|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44822876|NCT02147925|Liraglutide|liraglutide|mesh-list
44822877|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44822878|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822879|NCT02147925|Incretins|incretins|mesh-ancestor
44822880|NCT02147925|Hormones|hormones|mesh-ancestor
44822881|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822882|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44822883|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
44822884|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822885|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822886|NCT02147938|Tacrolimus|tacrolimus|mesh-list
44822887|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44822888|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
44822889|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822890|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44822891|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604705|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604706|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
44604707|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309245|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
44604708|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604709|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44604710|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604711|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
44604712|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
44604713|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604714|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604715|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
44604716|NCT00720109|Hormones|hormones|mesh-ancestor
44604717|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604718|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44604719|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
44604720|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604721|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44604722|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44604723|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44822892|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822893|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44822894|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44822895|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822896|NCT02147964|Ketoconazole|ketoconazole|mesh-list
44822897|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
44822898|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44822899|NCT02147964|Testosterone|testosterone|mesh-list
44822900|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
44822901|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
44822902|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44822903|NCT02147964|Dutasteride|dutasteride|mesh-list
44822905|NCT02147964|Androgens|androgens|mesh-ancestor
44822906|NCT02147964|Hormones|hormones|mesh-ancestor
44822907|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822908|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822909|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44822910|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822911|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
44822912|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
44822913|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822914|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44822915|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822916|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822917|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822918|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44822919|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
44822920|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44822921|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44822922|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822923|NCT02148016|Levofloxacin|levofloxacin|mesh-list
44822924|NCT02148016|Ofloxacin|ofloxacin|mesh-list
44822925|NCT02148016|Betamethasone|betamethasone|mesh-list
44822926|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44822927|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822928|NCT02148016|Renal Agents|renal agents|mesh-ancestor
44822929|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44822930|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44822931|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44822932|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822933|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822934|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822935|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44822936|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44822937|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44822938|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
44822939|NCT02148016|Hormones|hormones|mesh-ancestor
44309313|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309315|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44822940|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822941|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822942|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44822943|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44822944|NCT02148094|Tenofovir|tenofovir|mesh-list
44822945|NCT02148094|Emtricitabine|emtricitabine|mesh-list
44822946|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44822947|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
44822948|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44822949|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44822950|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44822951|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822952|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822953|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44822954|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44822955|NCT02148120|Beclomethasone|beclomethasone|mesh-list
44822956|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
44822957|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44822958|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
44822959|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44822960|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822961|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44822962|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44822963|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44822964|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44822965|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44822966|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44822967|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44822968|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822969|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44822970|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
44822971|NCT02148120|Hormones|hormones|mesh-ancestor
44822972|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822973|NCT02148328|Vaccines|vaccines|mesh-list
44822974|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
44822975|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822976|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
44822977|NCT02148367|Hematinics|hematinics|mesh-ancestor
44822978|NCT02148380|Carboplatin|carboplatin|mesh-list
44822979|NCT02148380|Pemetrexed|pemetrexed|mesh-list
44822980|NCT02148380|Gefitinib|gefitinib|mesh-list
44822981|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44822982|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44822983|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44822984|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44822985|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44822986|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44822987|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44822988|NCT02148393|Estradiol|estradiol|mesh-list
44822989|NCT02148393|Progesterone|progesterone|mesh-list
44822990|NCT02148393|Estrogens|estrogens|mesh-ancestor
44822991|NCT02148393|Hormones|hormones|mesh-ancestor
44822992|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44822993|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44822994|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44822995|NCT02148393|Progestins|progestins|mesh-ancestor
44822996|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
44822997|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44822998|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44822999|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823000|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823001|NCT02148432|Analgesics|analgesics|mesh-ancestor
44823002|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
44823003|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823004|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44823005|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44823006|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44823007|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823008|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823009|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823010|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
44823011|NCT02148549|Irinotecan|irinotecan|mesh-list
44823012|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823013|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44823014|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44823015|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823016|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823017|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44823018|NCT02148601|Vancomycin|vancomycin|mesh-list
44823019|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823020|NCT02148640|Infliximab|infliximab|mesh-list
44823021|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44823022|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823023|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823024|NCT02148783|Methylphenidate|methylphenidate|mesh-list
44823025|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44823026|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823027|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44823028|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44823029|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823030|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823031|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
44823032|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823033|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
44823034|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44823035|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823036|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823037|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823038|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823039|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44823040|NCT02148861|Insulin|insulin|mesh-list
44823041|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44823042|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823043|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823044|NCT02148913|Melphalan|melphalan|mesh-list
44823045|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44823046|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44823047|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
44823048|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823049|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823050|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44823051|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823052|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
44823053|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823054|NCT02148978|Saxagliptin|saxagliptin|mesh-list
44823055|NCT02148978|Incretins|incretins|mesh-ancestor
44823056|NCT02148978|Hormones|hormones|mesh-ancestor
44823057|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823058|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823059|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44823060|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823061|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823062|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823063|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823064|NCT02149095|Treprostinil|treprostinil|mesh-list
44823065|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823066|NCT02149212|Aminaftone|aminaftone|mesh-list
44823067|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
44823068|NCT02149212|Coagulants|coagulants|mesh-ancestor
44695509|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
44823069|NCT02149225|Poly I-C|poly i-c|mesh-list
44823070|NCT02149225|Molgramostim|molgramostim|mesh-list
44823071|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44823072|NCT02149225|Vaccines|vaccines|mesh-list
44823073|NCT02149225|Sargramostim|sargramostim|mesh-list
44823074|NCT02149225|Poly ICLC|poly iclc|mesh-list
44823075|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
44823076|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823077|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823078|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
44823079|NCT02149225|Laxatives|laxatives|mesh-ancestor
44823080|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823081|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
44823082|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823083|NCT02149329|Meropenem|meropenem|mesh-list
44823084|NCT02149329|Imipenem|imipenem|mesh-list
44823085|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44823086|NCT02149329|Cilastatin|cilastatin|mesh-list
44823087|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44823088|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823089|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823090|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823091|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823092|NCT02149407|Glycerol|glycerol|mesh-list
44823093|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44823094|NCT02149407|Protective Agents|protective agents|mesh-ancestor
44823095|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823096|NCT02149433|Prednisone|prednisone|mesh-list
44823097|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823098|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
44823099|NCT02149433|Hormones|hormones|mesh-ancestor
44823100|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823101|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823102|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44823103|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823104|NCT02149459|Metformin|metformin|mesh-list
44823105|NCT02149459|Biguanides|biguanides|mesh-list
44823106|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44823107|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823108|NCT02149628|Propofol|propofol|mesh-list
44823109|NCT02149628|Desflurane|desflurane|mesh-list
44823110|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44823111|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823112|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823113|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823114|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
44823115|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
44823116|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823117|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
44823118|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44823119|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
44823120|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823121|NCT02149758|Etoricoxib|etoricoxib|mesh-list
44823122|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823123|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823124|NCT02149758|Analgesics|analgesics|mesh-ancestor
44823125|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
44823126|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823127|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823128|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823129|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823130|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44823131|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44823132|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823133|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823134|NCT02149888|Tenofovir|tenofovir|mesh-list
44823135|NCT02149888|Emtricitabine|emtricitabine|mesh-list
44823136|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
44823137|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823138|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44823139|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44823140|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823141|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823142|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44823143|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44604956|NCT00718640|Hormones|hormones|mesh-ancestor
44823144|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
44823145|NCT02149901|Ephedrine|ephedrine|mesh-list
44823146|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44823147|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
44823148|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823149|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823150|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44823151|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44823152|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
44823153|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44823154|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44823155|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
44823156|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823157|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823158|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823159|NCT02149914|Rabeprazole|rabeprazole|mesh-list
44823160|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44823161|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44823162|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823163|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823164|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823165|NCT02149927|Sevoflurane|sevoflurane|mesh-list
44823166|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44823167|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823168|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
44823169|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
44823170|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823171|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823172|NCT02149953|Glycine|glycine|mesh-list
44823173|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
44823174|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823175|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823176|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823177|NCT02149992|Inositol|inositol|mesh-list
44823178|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
44823179|NCT02149992|Vitamins|vitamins|mesh-ancestor
44823180|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
44823181|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823182|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
44823183|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44823184|NCT02150031|Lidocaine|lidocaine|mesh-list
44823185|NCT02150031|Epinephrine|epinephrine|mesh-list
44823186|NCT02150031|Racepinephrine|racepinephrine|mesh-list
44823187|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
44823188|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
44823189|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
44823190|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823191|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823192|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
44823193|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823194|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823195|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44823196|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44823197|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823198|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823199|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44823200|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823201|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
44823202|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
44823203|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44823204|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44823205|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823206|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823207|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44823208|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44823209|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
44823210|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44823211|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
44823212|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
44823213|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
44823214|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44605065|NCT00717067|Ritonavir|ritonavir|mesh-list
44823215|NCT02150122|Vitamin D|vitamin d|mesh-list
44823216|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
44823217|NCT02150122|Vitamins|vitamins|mesh-ancestor
44823218|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
44823219|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823220|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44823221|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823222|NCT02150161|Lidocaine|lidocaine|mesh-list
44823223|NCT02150161|Fentanyl|fentanyl|mesh-list
44823224|NCT02150161|Ketamine|ketamine|mesh-list
44823225|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
44823226|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
44823227|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823228|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823229|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
44823230|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823231|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823232|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44823233|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44823234|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309638|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823235|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823236|NCT02150161|Analgesics|analgesics|mesh-ancestor
44823237|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44823238|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823239|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
44823240|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44823241|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44823242|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823243|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823244|NCT02150161|Narcotics|narcotics|mesh-ancestor
44823245|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44823246|NCT02150291|Folic Acid|folic acid|mesh-list
44823247|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
44823248|NCT02150291|Hematinics|hematinics|mesh-ancestor
44823249|NCT02150291|Vitamins|vitamins|mesh-ancestor
44823250|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
44823251|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823252|NCT02150317|Sorafenib|sorafenib|mesh-list
44823253|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
44823254|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823255|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44823256|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823257|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823258|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44823259|NCT02150317|Estrogens|estrogens|mesh-ancestor
44823260|NCT02150317|Hormones|hormones|mesh-ancestor
44823261|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823262|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823263|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44823264|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44823265|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44823266|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
44823267|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823268|NCT02150447|Lansoprazole|lansoprazole|mesh-list
44823269|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44823270|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44823271|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823272|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823273|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823274|NCT02150473|Adalimumab|adalimumab|mesh-list
44823275|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823276|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823277|NCT02150616|Sevoflurane|sevoflurane|mesh-list
44823278|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44823279|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823280|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
44823281|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
44823282|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823283|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823284|NCT02150707|Liraglutide|liraglutide|mesh-list
44823285|NCT02150707|Exenatide|exenatide|mesh-list
44605101|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823286|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44823287|NCT02150707|Glucagon|glucagon|mesh-list
44823288|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44823289|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823290|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823291|NCT02150707|Incretins|incretins|mesh-ancestor
44823292|NCT02150707|Hormones|hormones|mesh-ancestor
44823293|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823294|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44823295|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823296|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823297|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823298|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823299|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
44823300|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44823301|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44823302|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44823303|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823304|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
44823305|NCT02150720|Coagulants|coagulants|mesh-ancestor
44823306|NCT02150928|Asparaginase|asparaginase|mesh-list
44823307|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823308|NCT02150993|Ritonavir|ritonavir|mesh-list
44823309|NCT02150993|Lopinavir|lopinavir|mesh-list
44823310|NCT02150993|Tenofovir|tenofovir|mesh-list
44823311|NCT02150993|Lamivudine|lamivudine|mesh-list
44823312|NCT02150993|Zidovudine|zidovudine|mesh-list
44823313|NCT02150993|Emtricitabine|emtricitabine|mesh-list
44309675|NCT00881725|Metformin|metformin|mesh-list
44823314|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
44823315|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44823316|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44823317|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44823318|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823319|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823320|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823321|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44823322|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44823323|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
44823324|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823325|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44823326|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44823327|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44823328|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44823329|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
44823330|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44823331|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44823332|NCT02151084|Gemcitabine|gemcitabine|mesh-list
44823333|NCT02151084|Cisplatin|cisplatin|mesh-list
44823334|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823335|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44823336|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
44823337|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823338|NCT02151084|Antiviral Agents|antiviral agents|mesh-ancestor
44823339|NCT02151084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823340|NCT02151084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823341|NCT02151084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823342|NCT02151084|Immunologic Factors|immunologic factors|mesh-ancestor
44823343|NCT02151084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823344|NCT02151240|Acyclovir|acyclovir|mesh-list
44823345|NCT02151240|Foscarnet|foscarnet|mesh-list
44823346|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44823347|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
44823348|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466397|NCT01463982|Capecitabine|capecitabine|mesh-list
44823349|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44823350|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44823351|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823352|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823353|NCT02151279|Chitosan|chitosan|mesh-list
44823354|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44823355|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44823356|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
44823357|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823358|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44823359|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
44823360|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
44823361|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
44823362|NCT02151279|Coagulants|coagulants|mesh-ancestor
44823363|NCT02151305|Remifentanil|remifentanil|mesh-list
44823364|NCT02151305|Propofol|propofol|mesh-list
44823365|NCT02151305|Sevoflurane|sevoflurane|mesh-list
44605174|NCT00715520|Levodopa|levodopa|mesh-list
44823366|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44823367|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823368|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823369|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823370|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
44823372|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44823373|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823374|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823375|NCT02151305|Narcotics|narcotics|mesh-ancestor
44823376|NCT02151305|Analgesics|analgesics|mesh-ancestor
44823377|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
44823378|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823379|NCT02151344|Vaccines|vaccines|mesh-list
44823380|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
44823381|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823382|NCT02151604|Xenon|xenon|mesh-list
44823383|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823384|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
44823385|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
44823386|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823387|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823388|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
44823389|NCT02151630|Salicylates|salicylates|mesh-list
44823390|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823391|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
44823392|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
44823393|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
44823394|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823395|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823396|NCT02151630|Analgesics|analgesics|mesh-ancestor
44823397|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
44823398|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823399|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823400|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823401|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823402|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44823403|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823404|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823405|NCT02151695|Aflibercept|aflibercept|mesh-list
44823406|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44823407|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44823408|NCT02151695|Growth Substances|growth substances|mesh-ancestor
44823409|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823410|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44823411|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823412|NCT02151721|Gefitinib|gefitinib|mesh-list
44823413|NCT02151721|Vorinostat|vorinostat|mesh-list
44823414|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823415|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44823416|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823417|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823418|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44823419|NCT02151812|Paclitaxel|paclitaxel|mesh-list
44823420|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44823421|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44823422|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695510|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695511|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695512|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695513|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44695514|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44695515|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695516|NCT01386372|Tolvaptan|tolvaptan|mesh-list
44695517|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44695518|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695519|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
44695520|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695521|NCT01386398|Bortezomib|bortezomib|mesh-list
44695522|NCT01386398|Vorinostat|vorinostat|mesh-list
44695523|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695524|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44695525|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695526|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695527|NCT01386502|Pidilizumab|pidilizumab|mesh-list
44695528|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605255|NCT00714714|Adapalene|adapalene|mesh-list
44823423|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44823424|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44823425|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44823426|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605302|NCT05684913|Hemostatics|hemostatics|mesh-list
44605303|NCT05684913|Coagulants|coagulants|mesh-ancestor
44605304|NCT05684861|Isotretinoin|isotretinoin|mesh-list
44605305|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605306|NCT05684744|Methotrexate|methotrexate|mesh-list
44605307|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44605308|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
44605309|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44605310|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605311|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605312|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
44823427|NCT02151916|Fluorides|fluorides|mesh-list
44823428|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
44823429|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
44823430|NCT02151916|Protective Agents|protective agents|mesh-ancestor
44823431|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823432|NCT02151929|Everolimus|everolimus|mesh-list
44823433|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823434|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823435|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
44823436|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823437|NCT02151968|Anesthetics|anesthetics|mesh-list
44823438|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
44823439|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823440|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823441|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
44823442|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823443|NCT02152059|Nintedanib|nintedanib|mesh-list
44823444|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823445|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44823446|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823447|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823448|NCT02152176|Morphine|morphine|mesh-list
44823449|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823450|NCT02152176|Narcotics|narcotics|mesh-ancestor
44823451|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823452|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823453|NCT02152176|Analgesics|analgesics|mesh-ancestor
44823454|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
44823455|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823456|NCT02152228|Teriparatide|teriparatide|mesh-list
44823457|NCT02152228|Hormones|hormones|mesh-list
44823458|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
44823459|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823460|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823461|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823462|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44823463|NCT02152306|Amlodipine|amlodipine|mesh-list
44823464|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823465|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44823466|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823467|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823468|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823469|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823470|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823471|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
44823472|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44823473|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44823474|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823475|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44823476|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44823477|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823478|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823479|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823480|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44823481|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
44823482|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44823483|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823484|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44823485|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44823486|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44823487|NCT02152358|Acyclovir|acyclovir|mesh-list
44823488|NCT02152358|Ganciclovir|ganciclovir|mesh-list
44823489|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44823490|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
44823491|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823492|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44823493|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823494|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823495|NCT02152410|Morphine|morphine|mesh-list
44823496|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823497|NCT02152410|Narcotics|narcotics|mesh-ancestor
44823498|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823499|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823500|NCT02152410|Analgesics|analgesics|mesh-ancestor
44823501|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
44823502|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823504|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
44823505|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44823506|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44823507|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823508|NCT02152475|Curcumin|curcumin|mesh-list
44823509|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823510|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823511|NCT02152475|Analgesics|analgesics|mesh-ancestor
44823512|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
44823513|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823514|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823515|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823516|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823517|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823518|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823519|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823520|NCT02152514|Sufentanil|sufentanil|mesh-list
44823521|NCT02152514|Morphine|morphine|mesh-list
44823522|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823523|NCT02152514|Narcotics|narcotics|mesh-ancestor
44823524|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823525|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823526|NCT02152514|Analgesics|analgesics|mesh-ancestor
44823527|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
44823528|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823529|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44823530|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823531|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
44823532|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
44823533|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
44823534|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44695529|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695530|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
44695531|NCT01386567|Citric Acid|citric acid|mesh-list
44695532|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
44695533|NCT01386567|Enclomiphene|enclomiphene|mesh-list
44695534|NCT01386567|Clomiphene|clomiphene|mesh-list
44695535|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
44695536|NCT01386567|Testosterone|testosterone|mesh-list
44695537|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
44695538|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
44695539|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44695540|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
44695541|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44695542|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
44695543|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
44695544|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695545|NCT01386567|Androgens|androgens|mesh-ancestor
44695546|NCT01386567|Hormones|hormones|mesh-ancestor
44695547|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695548|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695549|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44695550|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695551|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
44695552|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44695553|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
44695554|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44695555|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
44695556|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695557|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44695558|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44695559|NCT01386580|Doxorubicin|doxorubicin|mesh-list
44695560|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44695561|NCT01386580|Trastuzumab|trastuzumab|mesh-list
44695562|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44695563|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695564|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44695565|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695566|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695567|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695568|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695569|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
44695570|NCT01386593|Rifampin|rifampin|mesh-list
44695571|NCT01386593|Fluconazole|fluconazole|mesh-list
44823535|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823536|NCT02152579|Isosorbide|isosorbide|mesh-list
44823537|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44823538|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44823539|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44823540|NCT02152579|Diuretics|diuretics|mesh-ancestor
44823541|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
44309952|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
44823542|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823543|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823544|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44823545|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823546|NCT02152709|Vaccines|vaccines|mesh-list
44823547|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
44823548|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823549|NCT02152787|Propofol|propofol|mesh-list
44823550|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44823551|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823552|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823553|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823554|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
44823555|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
44823556|NCT02152800|Valacyclovir|valacyclovir|mesh-list
44823557|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
44823558|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823559|NCT02152865|Lupeol|lupeol|mesh-list
44823560|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823561|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
44823562|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44823563|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44823564|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823565|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
44823566|NCT02152917|Coagulants|coagulants|mesh-ancestor
44823567|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44823568|NCT02152943|Trastuzumab|trastuzumab|mesh-list
44823569|NCT02152943|Everolimus|everolimus|mesh-list
44823570|NCT02152943|Letrozole|letrozole|mesh-list
44823571|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44823572|NCT02152943|Antibodies|antibodies|mesh-list
44823573|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
44823574|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44823575|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
44823576|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823577|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823578|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823579|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44823580|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44823581|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823582|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823583|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44823584|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
44823585|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823586|NCT02152969|Amlodipine|amlodipine|mesh-list
44823587|NCT02152969|Telmisartan|telmisartan|mesh-list
44823588|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
44823589|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823590|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44823591|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823592|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823593|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823594|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823595|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823596|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44823597|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44823598|NCT02152969|Diuretics|diuretics|mesh-ancestor
44823599|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
44823600|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44823601|NCT02153060|Dexamethasone|dexamethasone|mesh-list
44823602|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
44823603|NCT02153060|BB 1101|bb 1101|mesh-list
44823604|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823605|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
44823606|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
44823607|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823608|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823609|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44695572|NCT01386593|Paroxetine|paroxetine|mesh-list
44823610|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
44823611|NCT02153060|Hormones|hormones|mesh-ancestor
44823612|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823613|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44823614|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823615|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823616|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823617|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823618|NCT02153125|Eplerenone|eplerenone|mesh-list
44823619|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44823620|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44823621|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823622|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823623|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44823624|NCT02153125|Diuretics|diuretics|mesh-ancestor
44823625|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
44823626|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823627|NCT02153177|Acetaminophen|acetaminophen|mesh-list
44823628|NCT02153177|Ibuprofen|ibuprofen|mesh-list
44823629|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44823630|NCT02153177|Hydrocodone|hydrocodone|mesh-list
44823631|NCT02153177|Oxycodone|oxycodone|mesh-list
44823632|NCT02153177|Omeprazole|omeprazole|mesh-list
44823633|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823634|NCT02153177|Analgesics|analgesics|mesh-ancestor
44823635|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
44823636|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823637|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823638|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
44823639|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823640|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823641|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823642|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44823643|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823644|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823645|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44823646|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823647|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44823648|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44823649|NCT02153177|Narcotics|narcotics|mesh-ancestor
44823650|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823651|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
44823652|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
44823653|NCT02153281|Phenelzine|phenelzine|mesh-list
44823654|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
44823655|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44823656|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44823657|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823658|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823659|NCT02153424|Apixaban|apixaban|mesh-list
44823660|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44823661|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
44823662|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44823663|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44823664|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823665|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823666|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
44823667|NCT02153437|Sotalol|sotalol|mesh-list
44823668|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44823669|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44823670|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823671|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823672|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823673|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823674|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823675|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
44823676|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
44823677|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823678|NCT02153450|Metformin|metformin|mesh-list
44823679|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823680|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823681|NCT02153541|Antipyrine|antipyrine|mesh-list
44823682|NCT02153541|Benzocaine|benzocaine|mesh-list
44823683|NCT02153541|Mineral Oil|mineral oil|mesh-list
44823684|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
44605500|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
44823685|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
44823686|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823687|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823688|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
44823689|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823690|NCT02153541|Emollients|emollients|mesh-ancestor
44823691|NCT02153541|Dermatologic Agents|dermatologic agents|mesh-ancestor
44823692|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823693|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823694|NCT02153541|Analgesics|analgesics|mesh-ancestor
44823695|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823696|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823697|NCT02153567|Citalopram|citalopram|mesh-list
44823698|NCT02153567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44823699|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44823700|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823701|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823702|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823703|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
44823704|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823705|NCT02153567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44823706|NCT02153567|Antidepressive Agents|antidepressive agents|mesh-ancestor
44823707|NCT02153567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44823708|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
44823709|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44823710|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44823711|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44823712|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823713|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
44823714|NCT02153593|Coagulants|coagulants|mesh-ancestor
44823715|NCT02153606|Glycerol|glycerol|mesh-list
44823716|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44823717|NCT02153606|Protective Agents|protective agents|mesh-ancestor
44823718|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823719|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
44823720|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44823721|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823722|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
44823723|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
44823724|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44823725|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44823726|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44823727|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695573|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44695574|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695575|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44695576|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695577|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695578|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695579|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695580|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44695581|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44695582|NCT01386593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44695583|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44695584|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695585|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695586|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
44695587|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695589|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44695590|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44695591|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44695592|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
44695593|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44695594|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44695595|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
44695596|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695597|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44695598|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44695599|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44695600|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
44695601|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
44695602|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44823728|NCT02153866|Vaccines|vaccines|mesh-list
44823729|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
44823730|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823731|NCT02153879|Niacin|niacin|mesh-list
44823732|NCT02153879|Fenofibrate|fenofibrate|mesh-list
44823733|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44823734|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
44823735|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823736|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44823737|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823738|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
44823739|NCT02153879|Vitamins|vitamins|mesh-ancestor
44823740|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
44823741|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823742|NCT02153944|Propranolol|propranolol|mesh-list
44823743|NCT02153944|Methylphenidate|methylphenidate|mesh-list
44823744|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44823745|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823746|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44823747|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44823748|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823749|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823750|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
44823751|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823752|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44823753|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44823754|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823755|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823756|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823757|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823758|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
44823759|NCT02154074|Isoflurane|isoflurane|mesh-list
44823760|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
44823761|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823762|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823763|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44823764|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823765|NCT02154074|Analgesics|analgesics|mesh-ancestor
44823766|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
44823767|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823768|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44823769|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44823770|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44823771|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823772|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823773|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823774|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44823775|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
44823776|NCT02154217|Timolol|timolol|mesh-list
44823777|NCT02154217|Bimatoprost|bimatoprost|mesh-list
44823778|NCT02154217|Latanoprost|latanoprost|mesh-list
44823779|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44823780|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44823781|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823782|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823783|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823784|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823785|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823786|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823787|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44823788|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44823789|NCT02154230|Calcium|calcium|mesh-list
44823790|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44823791|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823792|NCT02154269|Lenograstim|lenograstim|mesh-list
44823793|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44823794|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
44823795|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823796|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
44823797|NCT02154334|Phenylephrine|phenylephrine|mesh-list
44823798|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
44823799|NCT02154334|Esketamine|esketamine|mesh-list
44310271|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44823800|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823801|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605613|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
44605614|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823802|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44823803|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
44823804|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44823805|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44823806|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44823807|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
44823808|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823809|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823810|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823811|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
44823812|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
44823813|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823814|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
44823815|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44823816|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
44823817|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44823818|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
44823819|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44823820|NCT02154334|Protective Agents|protective agents|mesh-ancestor
44823821|NCT02154360|Aprepitant|aprepitant|mesh-list
44823822|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
44823823|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
44823824|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823825|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823826|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823827|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44823828|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823829|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605688|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
44823830|NCT02154438|Ketamine|ketamine|mesh-list
44823831|NCT02154438|Analgesics|analgesics|mesh-ancestor
44823832|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
44823833|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823834|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823835|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44823836|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823837|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
44823838|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
44823839|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823840|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44823841|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44823842|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44823843|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823844|NCT02154464|Acetaminophen|acetaminophen|mesh-list
44823845|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823846|NCT02154464|Analgesics|analgesics|mesh-ancestor
44823847|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
44823848|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823849|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823850|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
44823851|NCT02154503|Minoxidil|minoxidil|mesh-list
44823852|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44605689|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605690|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44310284|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
44310312|NCT00885820|Tacrolimus|tacrolimus|mesh-list
44605691|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605692|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605693|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605694|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44605695|NCT05509816|Midazolam|midazolam|mesh-list
44605696|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44605697|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44605698|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605699|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605700|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44605701|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44605702|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44605703|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44605704|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
44605705|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
44605706|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
44605707|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
44605708|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605709|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605710|NCT05508867|Gemcitabine|gemcitabine|mesh-list
44605711|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
44605726|NCT05487599|Sirolimus|sirolimus|mesh-list
44823853|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
44823854|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
44823855|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44823856|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44823857|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823858|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
44823859|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
44823860|NCT02154646|Gemcitabine|gemcitabine|mesh-list
44823861|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44823862|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
44823863|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823864|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823865|NCT02154646|Antiviral Agents|antiviral agents|mesh-ancestor
44310313|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823866|NCT02154646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823867|NCT02154646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823868|NCT02154646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823869|NCT02154646|Immunologic Factors|immunologic factors|mesh-ancestor
44823870|NCT02154646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823871|NCT02154737|Gemcitabine|gemcitabine|mesh-list
44823872|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44823873|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44823874|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
44823875|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823876|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823877|NCT02154737|Antiviral Agents|antiviral agents|mesh-ancestor
44823878|NCT02154737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823879|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823880|NCT02154737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823881|NCT02154737|Immunologic Factors|immunologic factors|mesh-ancestor
44823882|NCT02154737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823883|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44823884|NCT02154776|Letrozole|letrozole|mesh-list
44823885|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823886|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44823887|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44823888|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823889|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823890|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44823891|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
44823892|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823893|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823894|NCT02154789|Polidocanol|polidocanol|mesh-list
44823895|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44823896|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44823897|NCT02154854|Tacrolimus|tacrolimus|mesh-list
44823898|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823899|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
44823900|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823901|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44823902|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823903|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823904|NCT02154932|Misoprostol|misoprostol|mesh-list
44823905|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44823906|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
44823907|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44823908|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823909|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44823910|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44823911|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
44823912|NCT02155023|Insulin|insulin|mesh-list
44823913|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44310350|NCT00885885|Panitumumab|panitumumab|mesh-list
44823914|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823915|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823916|NCT02155049|Bimatoprost|bimatoprost|mesh-list
44823917|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44823918|NCT02155088|Gemcitabine|gemcitabine|mesh-list
44823919|NCT02155088|Paclitaxel|paclitaxel|mesh-list
44823920|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44823921|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823922|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44823923|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44823924|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44823925|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823926|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695603|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44823927|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
44823928|NCT02155088|Antiviral Agents|antiviral agents|mesh-ancestor
44823929|NCT02155088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823930|NCT02155088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823931|NCT02155088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823932|NCT02155088|Immunologic Factors|immunologic factors|mesh-ancestor
44823933|NCT02155088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823934|NCT02155166|Ibuprofen|ibuprofen|mesh-list
44823935|NCT02155166|Lidocaine|lidocaine|mesh-list
44823936|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
44823937|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
44823938|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823939|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823940|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
44823941|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44823942|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44823943|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44823944|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44823945|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44823946|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823947|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44823948|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44823949|NCT02155166|Analgesics|analgesics|mesh-ancestor
44823950|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823951|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44823952|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44823953|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823954|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
44823955|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44823956|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823957|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44823958|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44823959|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823960|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823961|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823962|NCT02155374|Insulin|insulin|mesh-list
44823963|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44823964|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
44823965|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
44823966|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44823967|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823968|NCT02155439|Triamcinolone|triamcinolone|mesh-list
44823969|NCT02155439|Fluorouracil|fluorouracil|mesh-list
44823970|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
44823971|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823972|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44823973|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44823974|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44823975|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
44823976|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823977|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44823978|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
44823979|NCT02155439|Hormones|hormones|mesh-ancestor
44823980|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823981|NCT02155504|Itraconazole|itraconazole|mesh-list
44823982|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
44823983|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44823984|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44823985|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44823986|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44823987|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44823988|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44823989|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
44823990|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44823991|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823992|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44823993|NCT02155517|Propofol|propofol|mesh-list
44823994|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44823995|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44823996|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44823997|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44823998|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
44823999|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
44824000|NCT02155530|Atorvastatin|atorvastatin|mesh-list
44824001|NCT02155530|Pravastatin|pravastatin|mesh-list
44824002|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44824003|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44824004|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
44824005|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824006|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44824007|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44824008|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695604|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44695605|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44695606|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44695607|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44695608|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44695609|NCT01386658|Icatibant|icatibant|mesh-list
44695610|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44695611|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44695612|NCT01386658|Analgesics|analgesics|mesh-ancestor
44695613|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
44695614|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695615|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695616|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695617|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44695618|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44695619|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44695620|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310473|NCT00886496|Coagulants|coagulants|mesh-ancestor
44695621|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44695622|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695623|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
44695624|NCT01386671|Metformin|metformin|mesh-list
44695625|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44695626|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695627|NCT01386736|Vitamin D|vitamin d|mesh-list
44695628|NCT01386736|Vitamins|vitamins|mesh-ancestor
44695629|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
44605892|NCT05382286|Gemcitabine|gemcitabine|mesh-list
44824009|NCT02155634|Lenalidomide|lenalidomide|mesh-list
44824010|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
44824011|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824012|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44824013|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44824014|NCT02155634|Growth Substances|growth substances|mesh-ancestor
44824015|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
44824016|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824017|NCT02155777|Norinyl|norinyl|mesh-list
44824018|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44824019|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44824020|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824021|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824022|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824023|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824024|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44824025|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824026|NCT02155803|Hormones|hormones|mesh-list
44824027|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44824028|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44824029|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
44824030|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824031|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824032|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824033|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824034|NCT02156336|Ranolazine|ranolazine|mesh-list
44824035|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44824036|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44824037|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824038|NCT02156375|Ustekinumab|ustekinumab|mesh-list
44824039|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
44824040|NCT02156570|Ribavirin|ribavirin|mesh-list
44824041|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
44824042|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
44824043|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824044|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
44824045|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824046|NCT02156596|Ketoprofen|ketoprofen|mesh-list
44824047|NCT02156596|Morphine|morphine|mesh-list
44824048|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44824049|NCT02156596|Narcotics|narcotics|mesh-ancestor
44824050|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824051|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824052|NCT02156596|Analgesics|analgesics|mesh-ancestor
44824053|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
44824054|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824055|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824056|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824057|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824058|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824059|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44824060|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824061|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824062|NCT02156661|Oxytocin|oxytocin|mesh-list
44824063|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
44824064|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824065|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824066|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
44824067|NCT02156726|Fludarabine|fludarabine|mesh-list
44824068|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824069|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
44824070|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824071|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824072|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44824073|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
44824074|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824075|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824076|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44824077|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
44824078|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
44824079|NCT02156843|Vitamins|vitamins|mesh-ancestor
44824080|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
44824081|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605938|NCT05338502|Omeprazole|omeprazole|mesh-list
44824082|NCT02156960|Denosumab|denosumab|mesh-list
44824083|NCT02156960|Teriparatide|teriparatide|mesh-list
44824084|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44824085|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824086|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44824087|NCT02156999|Vitamin D|vitamin d|mesh-list
44824088|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
44824089|NCT02156999|Vitamins|vitamins|mesh-ancestor
44824090|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
44824091|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824092|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44824093|NCT02157012|Tofacitinib|tofacitinib|mesh-list
44824094|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44824095|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824096|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824097|NCT02157181|Rituximab|rituximab|mesh-list
44824098|NCT02157181|Cladribine|cladribine|mesh-list
44824099|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44824100|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824101|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
44824102|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824103|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824104|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824105|NCT02157207|Vitamins|vitamins|mesh-list
44824106|NCT02157207|Vitamin E|vitamin e|mesh-list
44824107|NCT02157207|Antioxidants|antioxidants|mesh-list
44824108|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
44824109|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824110|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824111|NCT02157207|Protective Agents|protective agents|mesh-ancestor
44824112|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
44824113|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44824114|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
44824115|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44824116|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
44824117|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310596|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44824118|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824119|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
44824120|NCT02157311|Tenofovir|tenofovir|mesh-list
44824121|NCT02157311|Lamivudine|lamivudine|mesh-list
44824122|NCT02157311|Emtricitabine|emtricitabine|mesh-list
44824123|NCT02157311|Efavirenz|efavirenz|mesh-list
44824124|NCT02157311|Lopinavir|lopinavir|mesh-list
44824125|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44824126|NCT02157311|Darunavir|darunavir|mesh-list
44824127|NCT02157311|Abacavir|abacavir|mesh-list
44824128|NCT02157311|Rilpivirine|rilpivirine|mesh-list
44824129|NCT02157311|Etravirine|etravirine|mesh-list
44824130|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
44824131|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824132|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44824133|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44824134|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824135|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824136|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44824137|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44824138|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44824139|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44824140|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44824141|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44824142|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44824143|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44824144|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44824145|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44824146|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
44824147|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44824148|NCT02157337|Atorvastatin|atorvastatin|mesh-list
44824149|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44824150|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44824151|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
44824152|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824153|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44824154|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44824155|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606018|NCT05266469|Ofatumumab|ofatumumab|mesh-list
44824156|NCT02157415|Polihexanide|polihexanide|mesh-list
44824157|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
44824158|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824159|NCT02157428|Flumazenil|flumazenil|mesh-list
44824160|NCT02157428|Antidotes|antidotes|mesh-ancestor
44824161|NCT02157428|Protective Agents|protective agents|mesh-ancestor
44824162|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824163|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
44824164|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
44824165|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824166|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824167|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
44824168|NCT02157467|BMS-955176|bms-955176|mesh-list
44824169|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44824170|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44824171|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824172|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44824173|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44824174|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824175|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824176|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824177|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824178|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824179|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824180|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824181|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44824182|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44824183|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824184|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44824185|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44824186|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
44824187|NCT02157558|Fexofenadine|fexofenadine|mesh-list
44824188|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44824189|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44824190|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44824191|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
44824192|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
44824193|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824194|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824195|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824196|NCT02157571|Levofloxacin|levofloxacin|mesh-list
44824197|NCT02157571|Ofloxacin|ofloxacin|mesh-list
44824198|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
44824199|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
44824200|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44824201|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824202|NCT02157571|Renal Agents|renal agents|mesh-ancestor
44824203|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44824204|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44824205|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44824206|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824207|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824208|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824209|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44824210|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44824211|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44824212|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
44824213|NCT02157649|Codeine|codeine|mesh-list
44824214|NCT02157649|Guaifenesin|guaifenesin|mesh-list
44824215|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44824216|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44824217|NCT02157649|Narcotics|narcotics|mesh-ancestor
44824218|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824219|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824220|NCT02157649|Analgesics|analgesics|mesh-ancestor
44824221|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
44824222|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824223|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
44824224|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
44824225|NCT02157649|Expectorants|expectorants|mesh-ancestor
44824226|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44824227|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44824228|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44824229|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606089|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824239|NCT02157792|Carboplatin|carboplatin|mesh-list
44824240|NCT02157792|Irinotecan|irinotecan|mesh-list
44824241|NCT02157792|Etoposide|etoposide|mesh-list
44824242|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824243|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44824244|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
44824245|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824246|NCT02157792|Antiviral Agents|antiviral agents|mesh-ancestor
44824247|NCT02157792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824248|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824249|NCT02157792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824250|NCT02157792|Immunologic Factors|immunologic factors|mesh-ancestor
44824251|NCT02157792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824252|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44824253|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695630|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695631|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44695632|NCT01386853|Atorvastatin|atorvastatin|mesh-list
44695633|NCT01386853|Pitavastatin|pitavastatin|mesh-list
44695634|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695635|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695636|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
44695637|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695638|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695639|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44695640|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695641|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
44695642|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44695643|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606161|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824254|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44824255|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44824256|NCT02157818|Midazolam|midazolam|mesh-list
44824257|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
44824258|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44824259|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824260|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824261|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824262|NCT02157818|Analgesics|analgesics|mesh-ancestor
44824263|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
44824264|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824265|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44824266|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44824267|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44824268|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
44824269|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310725|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824270|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824271|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44606162|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
44606163|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606164|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606165|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44606166|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606167|NCT05054140|Calcium|calcium|mesh-list
44606168|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44606169|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606199|NCT05035927|Psilocybin|psilocybin|mesh-list
44824272|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44824273|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44824274|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44824275|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44824276|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
44824277|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
44824278|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
44824279|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
44824280|NCT02158013|Diltiazem|diltiazem|mesh-list
44824281|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44824282|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44824283|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44824284|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824285|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44824286|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824287|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
44824288|NCT02158078|Insulin|insulin|mesh-list
44824289|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44824290|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824291|NCT02158117|Naloxone|naloxone|mesh-list
44824292|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44824293|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824294|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
44824295|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824296|NCT02158143|Vitamin D|vitamin d|mesh-list
44824297|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
44824298|NCT02158143|Vitamins|vitamins|mesh-ancestor
44824299|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
44824300|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824301|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44824302|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44824303|NCT02158182|Rifaximin|rifaximin|mesh-list
44824304|NCT02158182|Lactulose|lactulose|mesh-list
44824305|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
44824306|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44824307|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824308|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824309|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44824310|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44824311|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824312|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824313|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824314|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44824315|NCT02158221|Growth Substances|growth substances|mesh-ancestor
44824316|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824317|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
44824318|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824319|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824320|NCT02158286|Acetaminophen|acetaminophen|mesh-list
44824321|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824322|NCT02158286|Analgesics|analgesics|mesh-ancestor
44824323|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
44824324|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824325|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824326|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
44824327|NCT02158481|Carotenoids|carotenoids|mesh-list
44824328|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
44824329|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824330|NCT02158481|Protective Agents|protective agents|mesh-ancestor
44824331|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824332|NCT02158598|Vitamin D|vitamin d|mesh-list
44824333|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
44824334|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
44824335|NCT02158598|Vitamins|vitamins|mesh-list
44824336|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
44824337|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824338|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44824339|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44824340|NCT02158624|Ranibizumab|ranibizumab|mesh-list
44824341|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44824342|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44824343|NCT02158624|Growth Substances|growth substances|mesh-ancestor
44824344|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824345|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
44606204|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824346|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824348|NCT02158689|Menotropins|menotropins|mesh-list
44824349|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824350|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44824351|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44824352|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824353|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824354|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44824355|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
44824356|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824357|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824358|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44824359|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
44824360|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824361|NCT02158702|Dexamethasone|dexamethasone|mesh-list
44824362|NCT02158702|Pomalidomide|pomalidomide|mesh-list
44824363|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824364|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
44824365|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
44824366|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824367|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824368|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824369|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
44824370|NCT02158702|Hormones|hormones|mesh-ancestor
44824371|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824372|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824373|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824374|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
44824375|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44824376|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44824377|NCT02158702|Growth Substances|growth substances|mesh-ancestor
44824378|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
44824379|NCT02158845|Leuprolide|leuprolide|mesh-list
44824380|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
44824381|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44824382|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
44824383|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824384|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824385|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824386|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824387|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824388|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824389|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824390|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44824391|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44824392|NCT02158910|Donepezil|donepezil|mesh-list
44824393|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44824394|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824395|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824396|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824397|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824398|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824399|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
44824400|NCT02159027|Maraviroc|maraviroc|mesh-list
44824401|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44824402|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44824403|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824404|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44824405|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44824406|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
44824407|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824408|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44824409|NCT02159105|Chrysarobin|chrysarobin|mesh-list
44824410|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824411|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824412|NCT02159105|Analgesics|analgesics|mesh-ancestor
44824413|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
44824414|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824415|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824416|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824417|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824418|NCT02159131|Cabotegravir|cabotegravir|mesh-list
44824419|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
44824420|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824421|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824423|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824424|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824425|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44824426|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44824427|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44824428|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44824429|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824430|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824431|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44824432|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44824433|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
44824434|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824435|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
44824436|NCT02159196|Albuterol|albuterol|mesh-list
44824437|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44824438|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
44824439|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824440|NCT02159196|Expectorants|expectorants|mesh-ancestor
44824441|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
44824442|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44824443|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
44824444|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824445|NCT02159196|Protective Agents|protective agents|mesh-ancestor
44824446|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824447|NCT02159196|Antidotes|antidotes|mesh-ancestor
44824448|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44824449|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
44824450|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824451|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44824452|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
44824453|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824454|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44824455|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44824456|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44824457|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
44824458|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824459|NCT02159248|Gemcitabine|gemcitabine|mesh-list
44824460|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
44824461|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44824462|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
44824463|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965744|NCT05633381|Olaparib|olaparib|mesh-list
44824464|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824465|NCT02159248|Antiviral Agents|antiviral agents|mesh-ancestor
44824466|NCT02159248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824467|NCT02159248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824468|NCT02159248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824469|NCT02159248|Immunologic Factors|immunologic factors|mesh-ancestor
44824470|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824471|NCT02159248|Analgesics|analgesics|mesh-ancestor
44824472|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
44824473|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824474|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824475|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824476|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824477|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824478|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44824479|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44824480|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44824481|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44824482|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
44824483|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824484|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44824485|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
44824486|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824487|NCT02159287|Heparin|heparin|mesh-list
44824488|NCT02159287|Calcium heparin|calcium heparin|mesh-list
44824489|NCT02159287|Enoxaparin|enoxaparin|mesh-list
44824490|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
44824491|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
44824492|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44824493|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44824494|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824495|NCT02159313|Riociguat|riociguat|mesh-list
44824496|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
44824497|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824498|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44310986|NCT00889434|Vitamin E|vitamin e|mesh-list
44824499|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44824500|NCT02159326|Riociguat|riociguat|mesh-list
44824501|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
44824502|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824503|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824504|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824505|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824506|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824507|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44824508|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44824509|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824510|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44824511|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44824512|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44824513|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44824514|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44695644|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695645|NCT01386879|Methylene Blue|methylene blue|mesh-list
44695646|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695647|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695648|NCT01386996|Budesonide|budesonide|mesh-list
44695649|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
44695650|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44695651|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695652|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44695653|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
44695654|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695655|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695656|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44695657|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44695658|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
44695659|NCT01386996|Hormones|hormones|mesh-ancestor
44695660|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695661|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44695662|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44695663|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44695664|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44695665|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695666|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695667|NCT01387048|Adapalene|adapalene|mesh-list
44695668|NCT01387048|Azelaic acid|azelaic acid|mesh-list
44695669|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824515|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44824517|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
44824518|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824519|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
44824520|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824521|NCT02159599|Ritonavir|ritonavir|mesh-list
44824522|NCT02159599|Darunavir|darunavir|mesh-list
44824523|NCT02159599|Tenofovir|tenofovir|mesh-list
44824524|NCT02159599|Lamivudine|lamivudine|mesh-list
44824525|NCT02159599|Emtricitabine|emtricitabine|mesh-list
44824526|NCT02159599|Abacavir|abacavir|mesh-list
44824527|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44824528|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44824529|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
44824530|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824531|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824532|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44824533|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44824534|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
44824535|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824536|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44824537|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44824538|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44824539|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44824540|NCT02159651|Tacrolimus|tacrolimus|mesh-list
44824541|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824542|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
44824543|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824544|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44824545|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824546|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824547|NCT02159690|Prednisone|prednisone|mesh-list
44824548|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
44824549|NCT02159690|Dutasteride|dutasteride|mesh-list
44824550|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824551|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
44824552|NCT02159690|Hormones|hormones|mesh-ancestor
44824553|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824554|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824555|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824556|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824557|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44824558|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824559|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824560|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44824561|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44824562|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44824563|NCT02159820|Paclitaxel|paclitaxel|mesh-list
44824564|NCT02159820|Carboplatin|carboplatin|mesh-list
44824565|NCT02159820|Decitabine|decitabine|mesh-list
44824566|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44824567|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824568|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
44824569|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
44824570|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
44824571|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824572|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44824573|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
44824574|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824575|NCT02159911|Misoprostol|misoprostol|mesh-list
44824576|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44824577|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
44824578|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824579|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824580|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44824581|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824582|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
44824583|NCT02160028|Anesthetics|anesthetics|mesh-list
44824584|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824585|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824586|NCT02160054|Tacrolimus|tacrolimus|mesh-list
44824587|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824588|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
44824589|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824590|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44824591|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824592|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824593|NCT02160080|Interferons|interferons|mesh-list
44824594|NCT02160080|Ribavirin|ribavirin|mesh-list
44824595|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
44824596|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824597|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
44824598|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824599|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
44824600|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824601|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
44824602|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824603|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
44824604|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44824605|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44824606|NCT02160132|Prednisolone|prednisolone|mesh-list
44824607|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
44824608|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44824609|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
44824610|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824611|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
44824612|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
44824613|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824614|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824615|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824616|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
44824617|NCT02160132|Hormones|hormones|mesh-ancestor
44824618|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824619|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44824620|NCT02160132|Protective Agents|protective agents|mesh-ancestor
44824621|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824622|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824623|NCT02160158|Fesoterodine|fesoterodine|mesh-list
44824624|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44824625|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44824626|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824627|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824628|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824629|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824630|NCT02160158|Urological Agents|urological agents|mesh-ancestor
44824631|NCT02160184|Pancrelipase|pancrelipase|mesh-list
44824632|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824633|NCT02160223|Neostigmine|neostigmine|mesh-list
44824634|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44824635|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824636|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824637|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824638|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824639|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824640|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44824641|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
44824642|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824643|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44824644|NCT02160236|Tenoxicam|tenoxicam|mesh-list
44824645|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824646|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824647|NCT02160236|Analgesics|analgesics|mesh-ancestor
44824648|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
44824649|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824650|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824651|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824652|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824653|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44824654|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824655|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824656|NCT02160275|Insulin|insulin|mesh-list
44824657|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44824658|NCT02160275|Pancrelipase|pancrelipase|mesh-list
44824659|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44824660|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824661|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824662|NCT02160301|Acetaminophen|acetaminophen|mesh-list
44824663|NCT02160301|Dexamethasone|dexamethasone|mesh-list
44824664|NCT02160301|Celecoxib|celecoxib|mesh-list
44824665|NCT02160301|Oxycodone|oxycodone|mesh-list
44824666|NCT02160301|Gabapentin|gabapentin|mesh-list
44824667|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824669|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
44824670|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824671|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824672|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824673|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
44824674|NCT02160301|Hormones|hormones|mesh-ancestor
44824675|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824676|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824677|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824678|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824679|NCT02160301|Analgesics|analgesics|mesh-ancestor
44824680|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
44824681|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
44824682|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44824683|NCT02160301|Narcotics|narcotics|mesh-ancestor
44824684|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824685|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824686|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824687|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44824688|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44824689|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824690|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824691|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
44824692|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44824693|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44824694|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44824695|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44824696|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44824697|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824698|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
44824699|NCT02160353|Prednisolone|prednisolone|mesh-list
44824700|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
44824701|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824702|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
44824703|NCT02160353|Hormones|hormones|mesh-ancestor
44824704|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824705|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824706|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824707|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824708|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44824709|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824710|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824711|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
44824712|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44824713|NCT02160548|Atropine|atropine|mesh-list
44824714|NCT02160548|Albuterol|albuterol|mesh-list
44824715|NCT02160548|Pralidoxime|pralidoxime|mesh-list
44824716|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44824717|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44824718|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44695670|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44695671|NCT01387048|Analgesics|analgesics|mesh-ancestor
44695672|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
44695673|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695674|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695675|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695676|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44695677|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
44695678|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695679|NCT01387087|Peficitinib|peficitinib|mesh-list
44695680|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695681|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695682|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695683|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
44695684|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695685|NCT01387191|Epoprostenol|epoprostenol|mesh-list
44695686|NCT01387191|Tezosentan|tezosentan|mesh-list
44695687|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44695688|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695689|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695690|NCT01387204|Trametinib|trametinib|mesh-list
44824719|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
44695691|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606629|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44824720|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824721|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824722|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44824723|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
44824725|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
44824726|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44824727|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44824728|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824729|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824730|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824731|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
44824732|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824733|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44824734|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44824735|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44824736|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44824737|NCT02160548|Antidotes|antidotes|mesh-ancestor
44824738|NCT02160548|Protective Agents|protective agents|mesh-ancestor
44824739|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
44824740|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
44824741|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
44824742|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44824743|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44824744|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824745|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
44824746|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44824747|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
44824748|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44824749|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44824750|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824751|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
44824752|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44824753|NCT02160704|Enclomiphene|enclomiphene|mesh-list
44824754|NCT02160704|Clomiphene|clomiphene|mesh-list
44824755|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
44824756|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44824757|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
44824758|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824759|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824760|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44824761|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
44824762|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824763|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44824764|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44824765|NCT02160743|Metformin|metformin|mesh-list
44824766|NCT02160743|Atorvastatin|atorvastatin|mesh-list
44824767|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44824768|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824769|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44824770|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44824771|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
44824772|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606681|NCT03992456|Trifluridine|trifluridine|mesh-list
44606682|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44606683|NCT03992456|Panitumumab|panitumumab|mesh-list
44606684|NCT03992456|Antibodies|antibodies|mesh-list
44606685|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
44606686|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606687|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
44606688|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606689|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606690|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
44606691|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606692|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
44606693|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606694|NCT03909165|Atropine|atropine|mesh-list
44606695|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
44606696|NCT03909165|Neostigmine|neostigmine|mesh-list
44606697|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44606698|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44606699|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44606700|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
44606701|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435609|NCT02009384|Ipilimumab|ipilimumab|mesh-list
44606702|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824773|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44824774|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44824776|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44824777|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44824778|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824779|NCT02161055|Insulin|insulin|mesh-list
44824780|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44824781|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44824782|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824783|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
44824784|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44824785|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44824786|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44824787|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44824788|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824789|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824790|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824791|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824792|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44824793|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824794|NCT02161237|Tacrolimus|tacrolimus|mesh-list
44824795|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824796|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
44824797|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824798|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44824799|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824800|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824802|NCT02161354|Naloxone|naloxone|mesh-list
44824803|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44824804|NCT02161354|Narcotics|narcotics|mesh-ancestor
44824805|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824806|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824807|NCT02161354|Analgesics|analgesics|mesh-ancestor
44824808|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
44824809|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824810|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44824811|NCT02161367|Simethicone|simethicone|mesh-list
44824812|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
44824813|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824814|NCT02161367|Emollients|emollients|mesh-ancestor
44824815|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
44824816|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44824817|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44824818|NCT02161614|Estradiol|estradiol|mesh-list
44824819|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44824820|NCT02161614|Estrogens|estrogens|mesh-ancestor
44824821|NCT02161614|Hormones|hormones|mesh-ancestor
44824822|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824823|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824824|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44824825|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
44824826|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44824827|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44824828|NCT02161653|Pyridoxine|pyridoxine|mesh-list
44824829|NCT02161653|Prednisone|prednisone|mesh-list
44824830|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
44824831|NCT02161653|Metadoxine|metadoxine|mesh-list
44824832|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824833|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
44824834|NCT02161653|Hormones|hormones|mesh-ancestor
44824835|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44824836|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824837|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44824838|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824839|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44824840|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824841|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824842|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44824843|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44824844|NCT02161653|Protective Agents|protective agents|mesh-ancestor
44824845|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
44824846|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44824847|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
44824848|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44824849|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
44824850|NCT02161653|Vitamins|vitamins|mesh-ancestor
44824851|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
44824852|NCT02161679|Carboplatin|carboplatin|mesh-list
44824853|NCT02161679|Camptothecin|camptothecin|mesh-list
44824854|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
44824855|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824856|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44824857|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44824858|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44824859|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824860|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824861|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
44824862|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824863|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
44824864|NCT02161692|Cisplatin|cisplatin|mesh-list
44824865|NCT02161692|Carboplatin|carboplatin|mesh-list
44824866|NCT02161692|Etoposide|etoposide|mesh-list
44824867|NCT02161692|Bleomycin|bleomycin|mesh-list
44824868|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44824869|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
44824870|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824871|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824872|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44824873|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
44824874|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824875|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824876|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606784|NCT03768063|Atezolizumab|atezolizumab|mesh-list
44824877|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44824878|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44824879|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44824880|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824881|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44824882|NCT02161770|Osimertinib|osimertinib|mesh-list
44824883|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824884|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44824885|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824886|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824887|NCT02161822|Simvastatin|simvastatin|mesh-list
44824888|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44824889|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44824890|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
44824891|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824892|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44824893|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44824894|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824895|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
44824896|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
44824897|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824898|NCT02161952|Pirfenidone|pirfenidone|mesh-list
44824899|NCT02161952|Analgesics|analgesics|mesh-ancestor
44824900|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
44824901|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824902|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824903|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824904|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824905|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824906|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824907|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44824908|NCT02161965|Warfarin|warfarin|mesh-list
44824909|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
44824910|NCT02161965|Fluindione|fluindione|mesh-list
44824911|NCT02161965|Phenindione|phenindione|mesh-list
44824912|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
44824913|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44824914|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
44824915|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44824916|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
44824917|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824918|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824919|NCT02161991|Aprepitant|aprepitant|mesh-list
44824920|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
44824921|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
44824922|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824923|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824924|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44824925|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44824926|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824927|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824928|NCT02162121|Ketorolac|ketorolac|mesh-list
44824929|NCT02162121|Buprenorphine|buprenorphine|mesh-list
44824930|NCT02162121|Anesthetics|anesthetics|mesh-list
44824931|NCT02162121|Ropivacaine|ropivacaine|mesh-list
44824932|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
44824933|NCT02162121|Mepivacaine|mepivacaine|mesh-list
44824934|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
44824935|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824936|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824937|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
44824938|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824939|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44824940|NCT02162121|Narcotics|narcotics|mesh-ancestor
44824941|NCT02162121|Analgesics|analgesics|mesh-ancestor
44824942|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44824943|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824944|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824945|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824946|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824947|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44824948|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824949|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824950|NCT02162134|Cefuroxime|cefuroxime|mesh-list
44824951|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
44824952|NCT02162134|Ketorolac|ketorolac|mesh-list
44824953|NCT02162134|Midazolam|midazolam|mesh-list
44824954|NCT02162134|Propofol|propofol|mesh-list
44824955|NCT02162134|Sevoflurane|sevoflurane|mesh-list
44824956|NCT02162134|Atracurium|atracurium|mesh-list
44824957|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44824958|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44824959|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824960|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44824961|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
44824962|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
44824963|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44824964|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44824965|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44824966|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44824967|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
44824968|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
44824969|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824970|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824971|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44824972|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44824973|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44824974|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44824975|NCT02162134|Analgesics|analgesics|mesh-ancestor
44824976|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
44824977|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44824978|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44824979|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44824980|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44824981|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824982|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44824983|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44824984|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44824985|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44824986|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44824987|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44824988|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44824989|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824990|NCT02162251|Donepezil|donepezil|mesh-list
44824991|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44824992|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44824993|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44824994|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
44824995|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44824996|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44824997|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
44824998|NCT02162264|Donepezil|donepezil|mesh-list
44824999|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44825000|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825001|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825002|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
44825003|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825004|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825005|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
44825006|NCT02162303|Colchicine|colchicine|mesh-list
44825007|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
44825008|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825009|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
44825010|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
44825011|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
44825012|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825013|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825014|NCT02162381|Methylphenidate|methylphenidate|mesh-list
44825015|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44825016|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825017|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44825018|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44825019|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825020|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825021|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
44825022|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825023|NCT02162407|Insulin|insulin|mesh-list
44825024|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44825025|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
44825026|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825027|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825028|NCT02162485|Fluticasone|fluticasone|mesh-list
44606928|NCT03371017|Immunologic Factors|immunologic factors|mesh-ancestor
44825030|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44825031|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44825032|NCT02162485|Charcoal|charcoal|mesh-list
44825033|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825034|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44825035|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
44695692|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44695693|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695694|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695695|NCT01387243|Orlistat|orlistat|mesh-list
44695696|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695697|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695698|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44695699|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44695700|NCT01387295|Capecitabine|capecitabine|mesh-list
44695701|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
44695702|NCT01387295|Trastuzumab|trastuzumab|mesh-list
44695703|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695704|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
44695705|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695706|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695707|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695708|NCT01387373|Capecitabine|capecitabine|mesh-list
44695709|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
44695710|NCT01387373|Trastuzumab|trastuzumab|mesh-list
44695711|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695712|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
44695713|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695714|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695715|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695716|NCT01387399|Cisplatin|cisplatin|mesh-list
44695717|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695718|NCT01387425|Varenicline|varenicline|mesh-list
44695719|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44695720|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44695721|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
44695722|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695723|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695724|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695725|NCT01387568|Lidocaine|lidocaine|mesh-list
44695726|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
44695727|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
44695728|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44695729|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695730|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
44695731|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695732|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44695749|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44695750|NCT01387997|Antibodies|antibodies|mesh-list
44695751|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
44695752|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695753|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
44695754|NCT01388023|Listerine|listerine|mesh-list
44695755|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44695756|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695757|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
44695758|NCT01388036|Esmolol|esmolol|mesh-list
44695759|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44695760|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44695761|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44695762|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
44695763|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311539|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44695764|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695765|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695766|NCT01388049|Antibodies|antibodies|mesh-list
44695767|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
44695768|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695769|NCT01388062|Antibodies|antibodies|mesh-list
44695770|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
44695771|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695772|NCT01388075|Rifampin|rifampin|mesh-list
44695773|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44695774|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
44607005|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825036|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825037|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825038|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44825039|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44825040|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44825041|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44825042|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44825043|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44825044|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825045|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825046|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825047|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825049|NCT02162485|Hormones|hormones|mesh-ancestor
44825050|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825051|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
44825052|NCT02162485|Antidotes|antidotes|mesh-ancestor
44825053|NCT02162485|Protective Agents|protective agents|mesh-ancestor
44825054|NCT02162537|Bevacizumab|bevacizumab|mesh-list
44825055|NCT02162537|Cisplatin|cisplatin|mesh-list
44825056|NCT02162537|Pemetrexed|pemetrexed|mesh-list
44825057|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44825058|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825059|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44825060|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44825061|NCT02162537|Growth Substances|growth substances|mesh-ancestor
44825062|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825063|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
44825064|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825065|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825066|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44825067|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44825068|NCT02162550|Exenatide|exenatide|mesh-list
44825069|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825070|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825071|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44825072|NCT02162550|Incretins|incretins|mesh-ancestor
44825073|NCT02162550|Hormones|hormones|mesh-ancestor
44825074|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825075|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
44825076|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825077|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
44825078|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825079|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
44311612|NCT00892307|Adenosine|adenosine|mesh-list
44825080|NCT02162693|Protective Agents|protective agents|mesh-ancestor
44825081|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44825082|NCT02162784|Budesonide|budesonide|mesh-list
44825083|NCT02162784|Albuterol|albuterol|mesh-list
44825084|NCT02162784|Procaterol|procaterol|mesh-list
44825085|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825086|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44825087|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
44825088|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825089|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825090|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44825091|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44825092|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
44825093|NCT02162784|Hormones|hormones|mesh-ancestor
44825094|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825095|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
44825096|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825097|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44825098|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44825099|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825100|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825101|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825102|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825103|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
44825104|NCT02162797|Zinc|zinc|mesh-list
44825105|NCT02162797|Trace Elements|trace elements|mesh-ancestor
44825106|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
44825107|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825108|NCT02162875|Praziquantel|praziquantel|mesh-list
44825109|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
44825110|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44825111|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825112|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44825113|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44825114|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
44825115|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825116|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825117|NCT02162966|Colistin|colistin|mesh-list
44825118|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44825119|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825120|NCT02163070|Vitamins|vitamins|mesh-list
44825121|NCT02163070|Vitamin E|vitamin e|mesh-list
44825122|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
44825123|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825124|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
44825125|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825126|NCT02163070|Protective Agents|protective agents|mesh-ancestor
44607110|NCT02628405|Rituximab|rituximab|mesh-list
44825127|NCT02163161|Abrocitinib|abrocitinib|mesh-list
44825128|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44825129|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825130|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825131|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
44825132|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44825133|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825134|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825135|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825136|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44825137|NCT02163174|Protective Agents|protective agents|mesh-ancestor
44825138|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825139|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
44825140|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44825141|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
44825142|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
44311658|NCT00892385|Temozolomide|temozolomide|mesh-list
44825143|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44825144|NCT02163213|Antibodies|antibodies|mesh-list
44825145|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
44825146|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825147|NCT02163291|Paclitaxel|paclitaxel|mesh-list
44825148|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44825149|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825150|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44825151|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44825152|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44825153|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825154|NCT02163330|Acetazolamide|acetazolamide|mesh-list
44825155|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
44825156|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44825157|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825158|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825159|NCT02163330|Diuretics|diuretics|mesh-ancestor
44825160|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
44825161|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825162|NCT02163616|Misoprostol|misoprostol|mesh-list
44825163|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44825164|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
44825165|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825166|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825167|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44825168|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825169|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
44825170|NCT02163655|Furosemide|furosemide|mesh-list
44825171|NCT02163655|Diuretics|diuretics|mesh-ancestor
44825172|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44825173|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825174|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44825175|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825176|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825177|NCT02163707|Psilocybin|psilocybin|mesh-list
44825178|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
44825179|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825180|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44825181|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44825182|NCT02163720|Doxorubicin|doxorubicin|mesh-list
44825183|NCT02163720|Trabectedin|trabectedin|mesh-list
44825184|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44825185|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825186|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44825187|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44825188|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825189|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825190|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44825191|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
44825192|NCT02163954|Clopidogrel|clopidogrel|mesh-list
44825193|NCT02163954|Ticagrelor|ticagrelor|mesh-list
44825194|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825195|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44825196|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44825197|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44825198|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
44825199|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825200|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825201|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825202|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
44825203|NCT02163980|Ropivacaine|ropivacaine|mesh-list
44825204|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825205|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825206|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825207|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825208|NCT02163980|Analgesics|analgesics|mesh-ancestor
44825209|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
44825210|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825211|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44825212|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44825213|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825214|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825215|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825216|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825217|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
44825218|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
44825219|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44825220|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44825221|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44825222|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825223|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
44825224|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825225|NCT02164032|Insulin|insulin|mesh-list
44825226|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44825227|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825228|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825229|NCT02164045|Fostemsavir|fostemsavir|mesh-list
44825230|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44825231|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44825232|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
44825233|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825234|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44825235|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44825236|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825237|NCT02164097|Heparin|heparin|mesh-list
44825238|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
44825239|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44825240|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44825241|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825242|NCT02164110|Vaccines|vaccines|mesh-list
44825243|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
44825244|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825245|NCT02164214|Etanercept|etanercept|mesh-list
44825246|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44825247|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825248|NCT02164214|Analgesics|analgesics|mesh-ancestor
44825249|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
44825250|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825251|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825252|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825253|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825254|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825255|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44825256|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
44825257|NCT02164253|Deferiprone|deferiprone|mesh-list
44825258|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44825259|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
44825260|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
44825261|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607238|NCT02341014|Lenalidomide|lenalidomide|mesh-list
44607239|NCT02341014|Romidepsin|romidepsin|mesh-list
44607240|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
44607241|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607242|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607243|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607244|NCT02341014|Growth Substances|growth substances|mesh-ancestor
44607245|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607246|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607247|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44607248|NCT02253316|Dexamethasone|dexamethasone|mesh-list
44607249|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
44607250|NCT02253316|Lenalidomide|lenalidomide|mesh-list
44607251|NCT02253316|Ixazomib|ixazomib|mesh-list
44825262|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44825263|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44825264|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825266|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825267|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825268|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825269|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825270|NCT02164448|Analgesics|analgesics|mesh-ancestor
44825271|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
44825272|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825273|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44311794|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
44825274|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44825275|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825276|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825277|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825278|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825279|NCT02164552|Vitamin D|vitamin d|mesh-list
44825280|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
44825281|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
44825282|NCT02164552|Vitamins|vitamins|mesh-list
44825283|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
44825284|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825285|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44825286|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44825287|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
44825288|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44825289|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44825290|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825291|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
44825292|NCT02164565|Coagulants|coagulants|mesh-ancestor
44825293|NCT02164578|Aspirin|aspirin|mesh-list
44825294|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
44825295|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44825296|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825297|NCT02164578|Analgesics|analgesics|mesh-ancestor
44825298|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
44825299|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825300|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825301|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825302|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825303|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44825304|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44825305|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825306|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825307|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44825308|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825309|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
44825310|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44825311|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
44825312|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44825313|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
44825314|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
44825315|NCT02164604|Ranibizumab|ranibizumab|mesh-list
44825316|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44825317|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44825318|NCT02164604|Growth Substances|growth substances|mesh-ancestor
44825319|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825320|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44825321|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825322|NCT02164734|Remifentanil|remifentanil|mesh-list
44825323|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44825324|NCT02164734|Narcotics|narcotics|mesh-ancestor
44825325|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825326|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825327|NCT02164734|Analgesics|analgesics|mesh-ancestor
44825328|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
44825329|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825330|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
44825331|NCT02164773|Analgesics|analgesics|mesh-ancestor
44825332|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
44825333|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825334|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825335|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
44825336|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607252|NCT02253316|BB 1101|bb 1101|mesh-list
44825337|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44825338|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
44825339|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44825340|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825341|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825342|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44825343|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
44825344|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825345|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
44825346|NCT02164812|Efavirenz|efavirenz|mesh-list
44825347|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44825348|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825349|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44825350|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44825351|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825352|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825353|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825354|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44825355|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44825356|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
44825357|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44825358|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44825359|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44825360|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44825361|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44825362|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44825363|NCT02164825|Morphine|morphine|mesh-list
44825364|NCT02164825|Ropivacaine|ropivacaine|mesh-list
44825365|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44825366|NCT02164825|Narcotics|narcotics|mesh-ancestor
44825367|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825368|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825369|NCT02164825|Analgesics|analgesics|mesh-ancestor
44825370|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
44825371|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825372|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
44825373|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
44825374|NCT02164838|Axitinib|axitinib|mesh-list
44825375|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825376|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44825377|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825378|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607333|NCT01366144|Paclitaxel|paclitaxel|mesh-list
44825379|NCT02164890|Micafungin|micafungin|mesh-list
44825380|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
44825381|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825382|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
44825383|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825384|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
44825385|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825386|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
44825387|NCT02165020|Protective Agents|protective agents|mesh-ancestor
44825388|NCT02165033|Budesonide|budesonide|mesh-list
44825389|NCT02165033|Procaterol|procaterol|mesh-list
44825390|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825391|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44825392|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
44825393|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825394|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825395|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44825396|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
44825397|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
44825398|NCT02165033|Hormones|hormones|mesh-ancestor
44825399|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825400|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
44825401|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44825402|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44825403|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825404|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825405|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825406|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825407|NCT02165046|Budesonide|budesonide|mesh-list
44825408|NCT02165046|Procaterol|procaterol|mesh-list
44825409|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311929|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825410|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44825411|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
44825412|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825413|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825414|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44825415|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
44825416|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
44825417|NCT02165046|Hormones|hormones|mesh-ancestor
44825418|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825419|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
44825420|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44825421|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44825422|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825423|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825424|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825425|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825426|NCT02165098|Cariprazine|cariprazine|mesh-list
44825427|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44825428|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44825429|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825430|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825431|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44825432|NCT02165189|Ribavirin|ribavirin|mesh-list
44825433|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
44825434|NCT02165189|Simeprevir|simeprevir|mesh-list
44825435|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
44825436|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825437|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
44825438|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825439|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
44825440|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825441|NCT02165215|Etrolizumab|etrolizumab|mesh-list
44825442|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825443|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
44825444|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825445|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
44311959|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44825446|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44825447|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44825448|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825449|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44825450|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44825451|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825452|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825453|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825454|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44825455|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
44825456|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825457|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825458|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44825459|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44825460|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44825461|NCT02165449|Ketamine|ketamine|mesh-list
44825462|NCT02165449|Analgesics|analgesics|mesh-ancestor
44825463|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
44825464|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825465|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825466|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44825467|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44825468|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
44825469|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
44825470|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825471|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44311997|NCT00893724|Niacin|niacin|mesh-list
44825472|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44825473|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825474|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825475|NCT02165475|Loperamide|loperamide|mesh-list
44825476|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
44825477|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825478|NCT02165566|Insulin|insulin|mesh-list
44825479|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44825480|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
44825481|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825482|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825483|NCT02165644|Nimodipine|nimodipine|mesh-list
44825484|NCT02165644|Acetazolamide|acetazolamide|mesh-list
44825485|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
44825486|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44825487|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825488|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825489|NCT02165644|Diuretics|diuretics|mesh-ancestor
44825490|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
44825491|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825492|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44825493|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44825494|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825495|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44825496|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44825497|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44825498|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825499|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825500|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
44825501|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44825502|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825503|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
44825504|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825505|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
44825506|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825507|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
44825508|NCT02165917|Protective Agents|protective agents|mesh-ancestor
44825509|NCT02165930|Naltrexone|naltrexone|mesh-list
44825510|NCT02165930|Oxycodone|oxycodone|mesh-list
44825511|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44825512|NCT02165930|Narcotics|narcotics|mesh-ancestor
44825513|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825514|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825515|NCT02165930|Analgesics|analgesics|mesh-ancestor
44825516|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
44825517|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825518|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44825519|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44825520|NCT02166229|Valproic Acid|valproic acid|mesh-list
44825521|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
44825522|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825523|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825524|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
44825525|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825526|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825527|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
44825528|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44825529|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825530|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44825531|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44825532|NCT02166359|Icodextrin|icodextrin|mesh-list
44825533|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
44695775|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44695776|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695777|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
44695778|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44695779|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695780|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695781|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44695782|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44695783|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44695784|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44695785|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44695786|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44695787|NCT01388088|Amiloride|amiloride|mesh-list
44695788|NCT01388088|Spironolactone|spironolactone|mesh-list
44695789|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44695790|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
44695791|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312061|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
44695792|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695793|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44695794|NCT01388088|Diuretics|diuretics|mesh-ancestor
44695795|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
44695796|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44695797|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44695798|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695799|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695800|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44695801|NCT01388101|Antibodies|antibodies|mesh-list
44695802|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
44695803|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695804|NCT01388114|Antibodies|antibodies|mesh-list
44695805|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
44695806|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695807|NCT01388153|Acarbose|acarbose|mesh-list
44695808|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44695809|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695810|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695811|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44695812|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695813|NCT01388270|Heparin|heparin|mesh-list
44695814|NCT01388270|Calcium heparin|calcium heparin|mesh-list
44695815|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
44695816|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44695817|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44695818|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695819|NCT01388322|Enoxaparin|enoxaparin|mesh-list
44695820|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
44695821|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44695822|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44695823|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695824|NCT01388387|Tacrolimus|tacrolimus|mesh-list
44695825|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695826|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
44695827|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695828|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44695829|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695830|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695831|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44695832|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695833|NCT01388439|Oseltamivir|oseltamivir|mesh-list
44695834|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
44695835|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695836|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695837|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695838|NCT01388517|Vitamin D|vitamin d|mesh-list
44695839|NCT01388517|Calcitriol|calcitriol|mesh-list
44695840|NCT01388517|Petrolatum|petrolatum|mesh-list
44695841|NCT01388517|Tacrolimus|tacrolimus|mesh-list
44695842|NCT01388517|Vitamins|vitamins|mesh-ancestor
44695843|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
44695844|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695845|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44825534|NCT02166450|Nystatin|nystatin|mesh-list
44825535|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44825536|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825537|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
44825538|NCT02166450|Ionophores|ionophores|mesh-ancestor
44825539|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825540|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825541|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
44825542|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825543|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
44825544|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825545|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
44825546|NCT02166554|Protective Agents|protective agents|mesh-ancestor
44607556|NCT00713219|Docetaxel|docetaxel|mesh-list
44607557|NCT00713219|Cetuximab|cetuximab|mesh-list
44607558|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607559|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607560|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607561|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607563|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44825547|NCT02166593|Atorvastatin|atorvastatin|mesh-list
44825548|NCT02166593|Pravastatin|pravastatin|mesh-list
44825549|NCT02166593|Fenofibrate|fenofibrate|mesh-list
44825550|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44825551|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44825552|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
44825553|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825554|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44312154|NCT00894439|Piperacillin|piperacillin|mesh-list
44825555|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44825556|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825557|NCT02166632|Bupivacaine|bupivacaine|mesh-list
44825558|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
44825559|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
44825560|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825561|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825562|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
44825563|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825564|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44825565|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44825566|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44825567|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
44825568|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825569|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44825570|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44825571|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825572|NCT02166853|Midazolam|midazolam|mesh-list
44825573|NCT02166853|Sevoflurane|sevoflurane|mesh-list
44825574|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44825575|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825576|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825577|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825578|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44825579|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44825580|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44825581|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44825582|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
44825583|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
44825584|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
44825585|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
44825586|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825587|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825588|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825589|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44825590|NCT02166905|Poly I-C|poly i-c|mesh-list
44825591|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44825592|NCT02166905|Poly ICLC|poly iclc|mesh-list
44825593|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
44825594|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
44825595|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825596|NCT02166905|Laxatives|laxatives|mesh-ancestor
44825597|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825598|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
44825599|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825600|NCT02166944|Tamoxifen|tamoxifen|mesh-list
44825601|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44825602|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
44825603|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825604|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825605|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44825606|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825607|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44825608|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44825609|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44825610|NCT02167061|Metformin|metformin|mesh-list
44825611|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825612|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825613|NCT02167165|Digoxin|digoxin|mesh-list
44825614|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44825615|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44825616|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825617|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825618|NCT02167165|Protective Agents|protective agents|mesh-ancestor
44825619|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607626|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44825620|NCT02167178|Polygeline|polygeline|mesh-list
44607647|NCT00712010|Caseins|caseins|mesh-list
44825621|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
44825622|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
44825623|NCT02167321|Leucovorin|leucovorin|mesh-list
44825624|NCT02167321|Fluorouracil|fluorouracil|mesh-list
44825625|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
44825626|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
44825627|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825628|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44825629|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825630|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44825631|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
44825632|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825633|NCT02167321|Antidotes|antidotes|mesh-ancestor
44825634|NCT02167321|Protective Agents|protective agents|mesh-ancestor
44825635|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
44825636|NCT02167321|Vitamins|vitamins|mesh-ancestor
44825637|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
44825638|NCT02167425|Methadone|methadone|mesh-list
44825639|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44825640|NCT02167425|Narcotics|narcotics|mesh-ancestor
44825641|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825642|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825643|NCT02167425|Analgesics|analgesics|mesh-ancestor
44825644|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
44825645|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825646|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
44825647|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
44825648|NCT02167464|Coal Tar|coal tar|mesh-list
44825649|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44825650|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
44825651|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44825652|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
44825653|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825654|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825655|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44825656|NCT02167464|Diuretics|diuretics|mesh-ancestor
44825657|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
44825658|NCT02167620|Metformin|metformin|mesh-list
44825659|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44825660|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825661|NCT02167633|Pantoprazole|pantoprazole|mesh-list
44825662|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44825663|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
44825664|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44825665|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825666|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825667|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825668|NCT02167633|Hormones|hormones|mesh-ancestor
44825669|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825670|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825671|NCT02167685|Brincidofovir|brincidofovir|mesh-list
44825672|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
44825673|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825674|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
44825675|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44825676|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44825677|NCT02167698|Prednisolone|prednisolone|mesh-list
44825678|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
44825679|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44825680|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
44825681|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825682|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
44825683|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
44825684|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825685|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825686|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825687|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
44825688|NCT02167698|Hormones|hormones|mesh-ancestor
44825689|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825690|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44825691|NCT02167698|Protective Agents|protective agents|mesh-ancestor
44825692|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44825693|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695846|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44825694|NCT02167854|Trastuzumab|trastuzumab|mesh-list
44825695|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44825696|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825697|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
44825698|NCT02167958|Fludarabine|fludarabine|mesh-list
44825700|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44825701|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
44825702|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825703|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825704|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44825705|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
44825706|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825707|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825708|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44825709|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44825710|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825711|NCT02168010|Neurotropin|neurotropin|mesh-list
44825712|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825713|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
44825714|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825715|NCT02168010|Analgesics|analgesics|mesh-ancestor
44825716|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
44825717|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825718|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
44825719|NCT02168075|Mannitol|mannitol|mesh-list
44825720|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44825721|NCT02168075|Diuretics|diuretics|mesh-ancestor
44825722|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
44825723|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825724|NCT02168127|Methylphenidate|methylphenidate|mesh-list
44825725|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44825726|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825727|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44312356|NCT00895570|Modafinil|modafinil|mesh-list
44825728|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44825729|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825730|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825731|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
44825732|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825733|NCT02168205|Pomalidomide|pomalidomide|mesh-list
44825734|NCT02168205|Caffeine|caffeine|mesh-list
44825735|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44825736|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825737|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44825738|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825739|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825740|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44825741|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44825742|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
44825743|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825744|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
44825745|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44825746|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44825747|NCT02168205|Growth Substances|growth substances|mesh-ancestor
44825748|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44825749|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695847|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
44825751|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44825752|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
44825753|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825754|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
44825755|NCT02168426|Protective Agents|protective agents|mesh-ancestor
44825756|NCT02168543|Alendronate|alendronate|mesh-list
44825757|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44825758|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825759|NCT02168569|Artesunate|artesunate|mesh-list
44825760|NCT02168569|Lumefantrine|lumefantrine|mesh-list
44825761|NCT02168569|Artemether|artemether|mesh-list
44825762|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44825763|NCT02168569|Amodiaquine|amodiaquine|mesh-list
44825764|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
44825765|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44825766|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44825767|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825768|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825769|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
44825770|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
44825771|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44825772|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
44825773|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
44825774|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44825775|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44825776|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825777|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
44825778|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825779|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825780|NCT02168751|Propofol|propofol|mesh-list
44825781|NCT02168751|Sevoflurane|sevoflurane|mesh-list
44825782|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825783|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825784|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825785|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44825786|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
44825787|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
44825788|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825789|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44825790|NCT02168881|Misoprostol|misoprostol|mesh-list
44825791|NCT02168881|Dinoprostone|dinoprostone|mesh-list
44825792|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44825793|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
44825794|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825795|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825796|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44825797|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825798|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
44825799|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
44825800|NCT02168907|Rituximab|rituximab|mesh-list
44825801|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44825802|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44825803|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825804|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
44825805|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825806|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825807|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44825808|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
44825809|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825810|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
44825811|NCT02168907|Protective Agents|protective agents|mesh-ancestor
44825812|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
44825813|NCT02168907|Vitamins|vitamins|mesh-ancestor
44825814|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
44825815|NCT02168959|Bupivacaine|bupivacaine|mesh-list
44825816|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
44825817|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
44825818|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825819|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825820|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
44825821|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825822|NCT02169063|Listerine|listerine|mesh-list
44825823|NCT02169063|Fluorides|fluorides|mesh-list
44825824|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
44825825|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
44825826|NCT02169063|Protective Agents|protective agents|mesh-ancestor
44607849|NCT00708708|Analgesics|analgesics|mesh-ancestor
44825827|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825828|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44825829|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825830|NCT02169154|Diclofenac|diclofenac|mesh-list
44825831|NCT02169154|Menthol|menthol|mesh-list
44825832|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44825833|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825834|NCT02169154|Analgesics|analgesics|mesh-ancestor
44825835|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
44825836|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825837|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825838|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825839|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825840|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44825841|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825842|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825843|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
44825844|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
44825845|NCT02169167|Octenidine|octenidine|mesh-list
44825846|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825847|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44825848|NCT02169544|Abatacept|abatacept|mesh-list
44825849|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44825850|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825851|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825852|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44825853|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
44825854|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825855|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825856|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
44825857|NCT02169570|Vitamin D|vitamin d|mesh-list
44825858|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
44825859|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
44825860|NCT02169570|Vitamins|vitamins|mesh-list
44825861|NCT02169570|Calcium|calcium|mesh-list
44825862|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
44825863|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825864|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44825865|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44825866|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44825867|NCT02169596|Ticagrelor|ticagrelor|mesh-list
44825868|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825869|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44825870|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44825871|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44825872|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
44825873|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825874|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825875|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825876|NCT02169609|Interleukin-2|interleukin-2|mesh-list
44825877|NCT02169609|Dinutuximab|dinutuximab|mesh-list
44825878|NCT02169609|Isotretinoin|isotretinoin|mesh-list
44825879|NCT02169609|Sargramostim|sargramostim|mesh-list
44825880|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825881|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825882|NCT02169609|Analgesics|analgesics|mesh-ancestor
44825883|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
44825884|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825885|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825886|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
44825887|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44825888|NCT02169648|Ranibizumab|ranibizumab|mesh-list
44825889|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44825890|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44825891|NCT02169648|Growth Substances|growth substances|mesh-ancestor
44825892|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825893|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44825894|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825895|NCT02169713|Tamsulosin|tamsulosin|mesh-list
44825896|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
44825897|NCT02169713|Mirabegron|mirabegron|mesh-list
44825898|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44825899|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44825900|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44607934|NCT00704184|Ribavirin|ribavirin|mesh-list
44825901|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825902|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825903|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825904|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825905|NCT02169713|Urological Agents|urological agents|mesh-ancestor
44825906|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44825907|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44825908|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
44825909|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44825910|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44825911|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825913|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44825914|NCT02169804|Enclomiphene|enclomiphene|mesh-list
44825915|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44825916|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
44825917|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825918|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825919|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44825920|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
44825921|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44825922|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44825923|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44825924|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
44825925|NCT02169843|Sevoflurane|sevoflurane|mesh-list
44825926|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825927|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825928|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825929|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825930|NCT02169843|Analgesics|analgesics|mesh-ancestor
44825931|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
44825932|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825933|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44825934|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44312527|NCT00896519|Hormones|hormones|mesh-ancestor
44825935|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44825936|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
44825937|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825938|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825939|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825940|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44825941|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
44825942|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
44825943|NCT02169856|Cefuroxime|cefuroxime|mesh-list
44825944|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
44825945|NCT02169856|Ketorolac|ketorolac|mesh-list
44825946|NCT02169856|Midazolam|midazolam|mesh-list
44825947|NCT02169856|Propofol|propofol|mesh-list
44825948|NCT02169856|Sevoflurane|sevoflurane|mesh-list
44825949|NCT02169856|Atracurium|atracurium|mesh-list
44825950|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44825951|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44825952|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825953|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44825954|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
44825955|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
44825956|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44825957|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44825958|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44825959|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44825960|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
44825961|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
44825962|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825963|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44825964|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44825965|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44825966|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44825967|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44825968|NCT02169856|Analgesics|analgesics|mesh-ancestor
44825969|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
44825970|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825971|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825972|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44825973|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44825974|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44825975|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44607999|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44825976|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44825977|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44825978|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44825979|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44825980|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44825981|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44825982|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
44825983|NCT02169882|Rifampin|rifampin|mesh-list
44825984|NCT02169882|Dexamethasone|dexamethasone|mesh-list
44825985|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44825986|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
44825987|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
44825988|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44825989|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44825990|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44825991|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
44825992|NCT02169882|Hormones|hormones|mesh-ancestor
44825993|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44825994|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44825995|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44825996|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44825997|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
44825998|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44825999|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826000|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
44826001|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44826002|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826003|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826004|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44826005|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44826006|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44826007|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44826008|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44826009|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44826010|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
44826011|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826012|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826013|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44826014|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44826015|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44826016|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
44826017|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44826018|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826019|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44826020|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44826021|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44826022|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44826023|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44826024|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44826025|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44826026|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44826027|NCT02170116|Dabigatran|dabigatran|mesh-list
44826028|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
44826029|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826030|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826031|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826032|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826033|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
44826034|NCT02170246|Telmisartan|telmisartan|mesh-list
44826035|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44826036|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44826037|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44826038|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826039|NCT02170324|Exenatide|exenatide|mesh-list
44826040|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826041|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826042|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44826043|NCT02170324|Incretins|incretins|mesh-ancestor
44826044|NCT02170324|Hormones|hormones|mesh-ancestor
44826045|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44826046|NCT02170402|Factor VIII|factor viii|mesh-list
44826047|NCT02170402|Coagulants|coagulants|mesh-ancestor
44826048|NCT02170415|Pregabalin|pregabalin|mesh-list
44826049|NCT02170415|Anesthetics|anesthetics|mesh-list
44826050|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
44826051|NCT02170415|Analgesics|analgesics|mesh-ancestor
44826052|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
44312590|NCT00896987|Analgesics|analgesics|mesh-ancestor
44826053|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826054|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826055|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
44826056|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44826057|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44826058|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826059|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44826060|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44695848|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44695849|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695850|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695851|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695852|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44695853|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44695854|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44695855|NCT01388517|Emollients|emollients|mesh-ancestor
44695856|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
44695857|NCT01388582|Copper|copper|mesh-list
44695858|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
44695859|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
44695860|NCT01388582|Etonogestrel|etonogestrel|mesh-list
44695861|NCT01388582|Desogestrel|desogestrel|mesh-list
44695862|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
44695863|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44695864|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695865|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44695866|NCT01388582|Trace Elements|trace elements|mesh-ancestor
44695867|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
44695868|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44695869|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44695870|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44695871|NCT01388582|Progestins|progestins|mesh-ancestor
44695872|NCT01388582|Hormones|hormones|mesh-ancestor
44695873|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44695874|NCT01388595|Fluticasone|fluticasone|mesh-list
44695875|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44695876|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44695877|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44695878|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
44695879|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826061|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44826062|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44826063|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44826064|NCT02170571|Dabigatran|dabigatran|mesh-list
44826065|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
44826066|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826067|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
44608147|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608148|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608149|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
44608150|NCT00698009|Fludarabine|fludarabine|mesh-list
44608151|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
44608152|NCT00698009|Interleukin-2|interleukin-2|mesh-list
44608153|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608154|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
44826068|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826069|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826070|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
44826071|NCT02170584|Dabigatran|dabigatran|mesh-list
44826072|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
44826073|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826074|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826075|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826076|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826077|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
44826078|NCT02170597|Dabigatran|dabigatran|mesh-list
44826079|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
44826080|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826081|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826082|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826083|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826084|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
44826085|NCT02170610|Pantoprazole|pantoprazole|mesh-list
44826086|NCT02170610|Dabigatran|dabigatran|mesh-list
44826087|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826088|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826089|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826090|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826091|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826092|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
44826093|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826094|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826095|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
44826096|NCT02170623|Pantoprazole|pantoprazole|mesh-list
44826097|NCT02170623|Dabigatran|dabigatran|mesh-list
44826098|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826099|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826100|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826101|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826102|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826103|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
44826104|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826105|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826106|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
44826107|NCT02170636|Pantoprazole|pantoprazole|mesh-list
44826108|NCT02170636|Dabigatran|dabigatran|mesh-list
44826109|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826110|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826111|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826112|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826113|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826114|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
44826115|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826116|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826117|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
44826118|NCT02170675|Ketoconazole|ketoconazole|mesh-list
44826119|NCT02170675|Dabigatran|dabigatran|mesh-list
44826120|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
44826121|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826122|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826123|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826124|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826125|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
44826126|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
44826127|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826128|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44826129|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826130|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44826131|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
44826132|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44826133|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826134|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44826135|NCT02170701|Dabigatran|dabigatran|mesh-list
44826136|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
44826137|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826138|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826139|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826140|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826141|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
44826142|NCT02170740|Pantoprazole|pantoprazole|mesh-list
44608185|NCT00697593|Antibodies|antibodies|mesh-list
44826143|NCT02170740|Dabigatran|dabigatran|mesh-list
44826144|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826145|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826146|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826147|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826148|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826149|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
44826150|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826151|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826152|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
44826154|NCT02170766|Dabigatran|dabigatran|mesh-list
44826155|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826156|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826157|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826158|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826159|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826160|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
44826161|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826162|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826163|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
44826164|NCT02170792|Ranitidine|ranitidine|mesh-list
44826165|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44826166|NCT02170792|Dabigatran|dabigatran|mesh-list
44826167|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826168|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826169|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44826170|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
44826171|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
44826172|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826173|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826174|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826175|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
44826176|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826177|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826178|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826179|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
44826180|NCT02170805|Pantoprazole|pantoprazole|mesh-list
44826181|NCT02170805|Dabigatran|dabigatran|mesh-list
44826182|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826183|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826184|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826185|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826186|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826187|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
44826188|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826189|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826190|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
44826191|NCT02170831|Dabigatran|dabigatran|mesh-list
44826192|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
44826193|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826194|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826195|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826196|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826197|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
44826198|NCT02170844|Dabigatran|dabigatran|mesh-list
44826199|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
44826200|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826201|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826202|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826203|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826204|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
44826205|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
44826206|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44826207|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
44826208|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826209|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
44826210|NCT02170857|Protective Agents|protective agents|mesh-ancestor
44826211|NCT02170896|Pantoprazole|pantoprazole|mesh-list
44826212|NCT02170896|Dabigatran|dabigatran|mesh-list
44826213|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826214|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826215|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44826216|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826217|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826218|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
44826219|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826220|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826221|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
44826222|NCT02170909|Dabigatran|dabigatran|mesh-list
44826223|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
44826224|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826225|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826226|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826227|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826228|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
44826229|NCT02170922|Dabigatran|dabigatran|mesh-list
44826230|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
44826231|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826232|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826233|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826234|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826235|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
44826236|NCT02170935|Dabigatran|dabigatran|mesh-list
44826237|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
44826238|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826239|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826240|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826241|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826242|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
44826243|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
44826244|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44826245|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312737|NCT00898846|Tegafur|tegafur|mesh-list
44826246|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826247|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44826248|NCT02170948|Analgesics|analgesics|mesh-ancestor
44826249|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
44826250|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826251|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44826252|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44826253|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44826254|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
44826255|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826256|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826257|NCT02170974|Dabigatran|dabigatran|mesh-list
44826258|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
44826259|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826260|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826261|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826262|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826263|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
44826264|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
44826265|NCT02170987|Dabigatran|dabigatran|mesh-list
44826266|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44826267|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826268|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44826269|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44826270|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826271|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826272|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826273|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
44826274|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826275|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826276|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
44826277|NCT02171000|Dabigatran|dabigatran|mesh-list
44826278|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
44826279|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826280|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826281|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826282|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826283|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
44826284|NCT02171013|Dabigatran|dabigatran|mesh-list
44826285|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
44826286|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826287|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826288|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826289|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826290|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
44826291|NCT02171026|Amiodarone|amiodarone|mesh-list
44826292|NCT02171026|Dabigatran|dabigatran|mesh-list
44826293|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
44826294|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826295|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826296|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826297|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826298|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
44826299|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826300|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608339|NCT00695903|Vancomycin|vancomycin|mesh-list
44826301|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44826302|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44826303|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44826304|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44826305|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826306|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44826307|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44826308|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44826309|NCT02171039|Dabigatran|dabigatran|mesh-list
44826310|NCT02171039|Atorvastatin|atorvastatin|mesh-list
44826311|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44826312|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44826313|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
44826314|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826315|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44826316|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44826317|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826318|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
44826319|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826320|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826321|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
44826322|NCT02171052|Digoxin|digoxin|mesh-list
44826323|NCT02171052|Dabigatran|dabigatran|mesh-list
44826324|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
44826325|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826326|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826327|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826328|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312835|NCT00900445|Cortisone|cortisone|mesh-list
44826329|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
44826330|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826331|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44826332|NCT02171052|Protective Agents|protective agents|mesh-ancestor
44826333|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826334|NCT02171156|Nintedanib|nintedanib|mesh-list
44826335|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826336|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826337|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826338|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826339|NCT02171182|Capsaicin|capsaicin|mesh-list
44826340|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
44826341|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
44826342|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
44826343|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826344|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826345|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44826346|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44826347|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44826348|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
44826349|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826350|NCT02171221|DFP-11207|dfp-11207|mesh-list
44826351|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44826352|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
44826353|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826354|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826355|NCT02171299|Ropivacaine|ropivacaine|mesh-list
44826356|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
44826357|NCT02171299|Anesthetics|anesthetics|mesh-list
44826358|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44826359|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826360|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
44826361|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826362|NCT02171325|Irinotecan|irinotecan|mesh-list
44826363|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44826364|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44826365|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826366|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826367|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826368|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44826369|NCT02171338|Azithromycin|azithromycin|mesh-list
44826370|NCT02171338|Clarithromycin|clarithromycin|mesh-list
44826371|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
44826372|NCT02171338|Tazobactam|tazobactam|mesh-list
44826373|NCT02171338|Piperacillin|piperacillin|mesh-list
44826374|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44826375|NCT02171338|Penicillin G|penicillin g|mesh-list
44826376|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826377|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44826378|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826379|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826380|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44826381|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826382|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44826383|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44826384|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826385|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44826386|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44826387|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
44826388|NCT02171390|Testosterone|testosterone|mesh-list
44826389|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
44826390|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
44826391|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44826392|NCT02171390|Androgens|androgens|mesh-ancestor
44826393|NCT02171390|Hormones|hormones|mesh-ancestor
44826394|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44826395|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826396|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44826397|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826398|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
44826399|NCT02171416|Rilonacept|rilonacept|mesh-list
44826400|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44826401|NCT02171442|Dabigatran|dabigatran|mesh-list
44826402|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
44826403|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826404|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826405|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826406|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826407|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
44826408|NCT02171455|Dabigatran|dabigatran|mesh-list
44826409|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
44826410|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826411|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826412|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826413|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826414|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
44826415|NCT02171468|Dabigatran|dabigatran|mesh-list
44826416|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
44826417|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826418|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
44312904|NCT00900887|Ketorolac|ketorolac|mesh-list
44826419|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826420|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826421|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
44826422|NCT02171481|Dabigatran|dabigatran|mesh-list
44826423|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
44826424|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826425|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826426|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826427|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826428|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
44826429|NCT02171494|Warfarin|warfarin|mesh-list
44826430|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
44826431|NCT02171507|Diclofenac|diclofenac|mesh-list
44826432|NCT02171507|Dabigatran|dabigatran|mesh-list
44826433|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44826434|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44826435|NCT02171507|Analgesics|analgesics|mesh-ancestor
44826436|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
44826437|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826438|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826439|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44826440|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44826441|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44826442|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826443|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826444|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
44826445|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826446|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826447|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
44826448|NCT02171520|Dabigatran|dabigatran|mesh-list
44826449|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
44826450|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44608491|NCT00694109|Mipomersen|mipomersen|mesh-list
44826451|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826452|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826453|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826454|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
44826455|NCT02171533|Verapamil|verapamil|mesh-list
44826456|NCT02171533|Dabigatran|dabigatran|mesh-list
44826457|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
44826458|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826459|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826460|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826461|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826462|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
44826463|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826464|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44826465|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44826466|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44826467|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826468|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
44826469|NCT02171546|Fexofenadine|fexofenadine|mesh-list
44826470|NCT02171546|Quinidine|quinidine|mesh-list
44826471|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
44826472|NCT02171546|Dabigatran|dabigatran|mesh-list
44826473|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
44826474|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826475|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826476|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826477|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826478|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
44826479|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44826480|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44826481|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44826482|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
44826483|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
44826484|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826485|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826486|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44826487|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44826488|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44826489|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826490|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
44826491|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44826492|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44826493|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826494|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44826495|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826496|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826497|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44826498|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44826499|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44826500|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44826501|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826502|NCT02171559|Enoxaparin|enoxaparin|mesh-list
44826503|NCT02171559|Dabigatran|dabigatran|mesh-list
44826504|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
44826505|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44826506|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44826507|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826508|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
44826509|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826510|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826511|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826512|NCT02171572|Dabigatran|dabigatran|mesh-list
44826513|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
44826514|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826515|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826516|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826517|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826518|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
44826519|NCT02171585|Clarithromycin|clarithromycin|mesh-list
44826520|NCT02171585|Dabigatran|dabigatran|mesh-list
44826521|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44826522|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826523|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44826524|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826525|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826526|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44826527|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44608557|NCT00692913|Vitamin D|vitamin d|mesh-list
44826528|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
44826529|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826530|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826531|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
44826532|NCT02171598|Dabigatran|dabigatran|mesh-list
44826533|NCT02171598|Clopidogrel|clopidogrel|mesh-list
44826534|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44826535|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44826536|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44826537|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44826538|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
44826539|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826540|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826541|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826542|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
44826543|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826544|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826545|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826546|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
44826547|NCT02171624|Quinidine|quinidine|mesh-list
44826548|NCT02171624|Dabigatran|dabigatran|mesh-list
44826549|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
44826550|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44826551|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826552|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826553|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826554|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
44826555|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44826556|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44826557|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44826558|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826559|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826560|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826561|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
44826562|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44826563|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44826564|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826565|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44826566|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826567|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826568|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44826569|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44826570|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44826571|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44826572|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826573|NCT02171637|Afatinib|afatinib|mesh-list
44826574|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826575|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826576|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826577|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826578|NCT02171650|Afatinib|afatinib|mesh-list
44826579|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826580|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826581|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826582|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826583|NCT02171663|Afatinib|afatinib|mesh-list
44826584|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826585|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826586|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826587|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826588|NCT02171676|Docetaxel|docetaxel|mesh-list
44826589|NCT02171676|Afatinib|afatinib|mesh-list
44826590|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826591|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44826592|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44826593|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44826594|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313111|NCT00901875|Naloxone|naloxone|mesh-list
44826595|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826596|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826597|NCT02171689|Afatinib|afatinib|mesh-list
44826598|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826599|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826600|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826601|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608640|NCT00691210|Vitamins|vitamins|mesh-ancestor
44826602|NCT02171702|Afatinib|afatinib|mesh-list
44826603|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826604|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826605|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826606|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826607|NCT02171715|Afatinib|afatinib|mesh-list
44826608|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826609|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826610|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826611|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826612|NCT02171728|Afatinib|afatinib|mesh-list
44826613|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826614|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826615|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826616|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826617|NCT02171741|Docetaxel|docetaxel|mesh-list
44826618|NCT02171741|Afatinib|afatinib|mesh-list
44826619|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826620|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
44826621|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
44826622|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
44826623|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826624|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826625|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826626|NCT02171754|Ritonavir|ritonavir|mesh-list
44826627|NCT02171754|Afatinib|afatinib|mesh-list
44826628|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44826629|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44826630|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826631|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826632|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826633|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44826634|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44826635|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
44826636|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826637|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44826638|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826639|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826640|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826641|NCT02171767|Afatinib|afatinib|mesh-list
44826642|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313138|NCT00902070|Rocuronium|rocuronium|mesh-list
44826643|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44826644|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608709|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44608710|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608711|NCT00690612|Candesartan|candesartan|mesh-list
44608712|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
44608713|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608714|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608715|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608716|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608717|NCT00690573|Adalimumab|adalimumab|mesh-list
44608718|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608719|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608720|NCT00690443|Atorvastatin|atorvastatin|mesh-list
44608721|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44608722|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44608723|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
44608724|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608725|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44608726|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44608727|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608728|NCT00690430|Octreotide|octreotide|mesh-list
44608729|NCT00690430|Pasireotide|pasireotide|mesh-list
44608730|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608731|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44608732|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608733|NCT00690430|Hormones|hormones|mesh-ancestor
44608734|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608735|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608736|NCT00690378|Imipenem|imipenem|mesh-list
44608737|NCT00690378|Ceftazidime|ceftazidime|mesh-list
44608738|NCT00690378|Avibactam|avibactam|mesh-list
44608739|NCT00690378|Cilastatin|cilastatin|mesh-list
44608740|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44826645|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826646|NCT02171780|Olodaterol|olodaterol|mesh-list
44826647|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826648|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
44826649|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826650|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826651|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826652|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
44608752|NCT00689936|BB 1101|bb 1101|mesh-list
44826654|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826655|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
44826656|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826657|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826658|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826659|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826660|NCT02171806|Olodaterol|olodaterol|mesh-list
44826661|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826662|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
44826663|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826664|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826665|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826666|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826667|NCT02171832|Olodaterol|olodaterol|mesh-list
44826668|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826669|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
44826670|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826671|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826672|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826673|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826674|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
44826675|NCT02171910|Doxapram|doxapram|mesh-list
44826676|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44826677|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826678|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826679|NCT02171975|Anesthetics|anesthetics|mesh-list
44826680|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44826681|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826682|NCT02171988|Propranolol|propranolol|mesh-list
44826683|NCT02171988|Bisoprolol|bisoprolol|mesh-list
44826684|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44826685|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44826686|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44826687|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44826688|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826689|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826690|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826691|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826692|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44826693|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
44826694|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
44826695|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
44826696|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826697|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44826698|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44826699|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826700|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826701|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44826702|NCT02172001|Hematinics|hematinics|mesh-ancestor
44826703|NCT02172014|Fentanyl|fentanyl|mesh-list
44826704|NCT02172014|Midazolam|midazolam|mesh-list
44826705|NCT02172014|Citric Acid|citric acid|mesh-list
44826706|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
44826707|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44826708|NCT02172014|Narcotics|narcotics|mesh-ancestor
44826709|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44826710|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826711|NCT02172014|Analgesics|analgesics|mesh-ancestor
44826712|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
44826713|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826714|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44826715|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44826716|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
44826717|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
44826718|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44826719|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44826720|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44826721|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44826722|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
44826723|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
44826724|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826725|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313217|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
44826726|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
44608828|NCT00689117|Clindamycin|clindamycin|mesh-list
44826727|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44826728|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
44826729|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
44826730|NCT02172105|Olodaterol|olodaterol|mesh-list
44826731|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826732|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
44826733|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826734|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826735|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826736|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826737|NCT02172131|Olodaterol|olodaterol|mesh-list
44826738|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826739|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
44826740|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826741|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826742|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826743|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826744|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
44826745|NCT02172144|Olodaterol|olodaterol|mesh-list
44826746|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44826747|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44826748|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44826749|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44826750|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826751|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826752|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44826753|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826754|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826755|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
44826756|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826757|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826758|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826759|NCT02172157|Olodaterol|olodaterol|mesh-list
44826760|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826761|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
44826762|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826763|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826764|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826765|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826766|NCT02172170|Empagliflozin|empagliflozin|mesh-list
44826767|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826768|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826769|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826770|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826771|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44826772|NCT02172196|Empagliflozin|empagliflozin|mesh-list
44826773|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826774|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826775|NCT02172196|Incretins|incretins|mesh-ancestor
44826776|NCT02172196|Hormones|hormones|mesh-ancestor
44826777|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44826778|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44826779|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826780|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695880|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695881|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44695882|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
44695883|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44695884|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44695885|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44313278|NCT00902811|Artesunate|artesunate|mesh-list
44695886|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44695887|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44695888|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
44695889|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695890|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695891|NCT01388621|Gemcitabine|gemcitabine|mesh-list
44695892|NCT01388621|Carboplatin|carboplatin|mesh-list
44695893|NCT01388621|Doxorubicin|doxorubicin|mesh-list
44695894|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44695895|NCT01388621|Panitumumab|panitumumab|mesh-list
44695896|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695897|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44695898|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
44695899|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695900|NCT01388621|Antiviral Agents|antiviral agents|mesh-ancestor
44695901|NCT01388621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695902|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826781|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826782|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826784|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826785|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826786|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826787|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826788|NCT02172222|Linagliptin|linagliptin|mesh-list
44826789|NCT02172222|Empagliflozin|empagliflozin|mesh-list
44826790|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826791|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826792|NCT02172222|Incretins|incretins|mesh-ancestor
44826793|NCT02172222|Hormones|hormones|mesh-ancestor
44826794|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44826795|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44826796|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
44826797|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826798|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826799|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826800|NCT02172235|Pioglitazone|pioglitazone|mesh-list
44826801|NCT02172235|Empagliflozin|empagliflozin|mesh-list
44826802|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826803|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826804|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44313299|NCT00902915|Dexamethasone|dexamethasone|mesh-list
44826805|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826806|NCT02172248|Metformin|metformin|mesh-list
44826807|NCT02172248|Empagliflozin|empagliflozin|mesh-list
44826808|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826809|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826810|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826811|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826812|NCT02172261|Glimepiride|glimepiride|mesh-list
44826813|NCT02172261|Empagliflozin|empagliflozin|mesh-list
44826814|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44826815|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826816|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826817|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44826818|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
44826819|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826820|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826821|NCT02172274|Empagliflozin|empagliflozin|mesh-list
44826822|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44826823|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826824|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44826825|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826826|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
44826827|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44826828|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826829|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
44826830|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826831|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826832|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826833|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826834|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
44826835|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826836|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313345|NCT00903045|Propiverine|propiverine|mesh-list
44826837|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826838|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826839|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44826840|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44826841|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44826842|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
44826843|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
44826844|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826845|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
44826846|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826847|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826848|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826849|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826850|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
44826851|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826852|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826853|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826854|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826855|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
44826856|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826857|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
44826858|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826859|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826860|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826861|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826862|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
44826863|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826864|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826865|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826866|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826867|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
44826868|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826869|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
44826870|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826871|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826872|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826873|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826874|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
44826875|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826876|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826877|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826878|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826879|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
44826880|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826881|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
44826882|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826883|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826884|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826885|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826886|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
44826887|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826888|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826889|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826890|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826891|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
44826892|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826893|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
44826894|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826895|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826896|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826897|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826898|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
44826899|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826900|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826901|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826902|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826903|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
44826904|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826905|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
44826906|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826907|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826908|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826909|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826910|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
44826911|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826912|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826913|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826914|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826915|NCT02172404|Ipratropium|ipratropium|mesh-list
44826916|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826917|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
44826918|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826919|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826920|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826921|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826922|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826923|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826924|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826925|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826926|NCT02172417|Ranitidine|ranitidine|mesh-list
44826927|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44826928|NCT02172417|Cimetidine|cimetidine|mesh-list
44826929|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
44826930|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826931|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
44826932|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826933|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826934|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826935|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826936|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
44826937|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826938|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826939|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826940|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826941|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44826942|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44826943|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44826944|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
44826945|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
44826946|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44826947|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44826948|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44826949|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
44826950|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826951|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
44826952|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826953|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826954|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826955|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826956|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
44826957|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826958|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826959|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826960|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826961|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
44826962|NCT02172443|Ipratropium|ipratropium|mesh-list
44826963|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826964|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
44826965|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826966|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826967|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826968|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826969|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
44826970|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826971|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826972|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826973|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826974|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
44826975|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826976|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
44826977|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826978|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826979|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826980|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826981|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
44826982|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826983|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826984|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44826985|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44826986|NCT02172469|Bromides|bromides|mesh-list
44826987|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
44826988|NCT02172469|Ipratropium|ipratropium|mesh-list
44826989|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44826990|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
44826991|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44826992|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44826993|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44826994|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
44826995|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
44826996|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44826997|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
44826998|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609107|NCT00686972|Glucagon|glucagon|mesh-list
44826999|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827000|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
44827001|NCT02172482|Bromides|bromides|mesh-list
44827002|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
44827003|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827004|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
44827005|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827006|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827007|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827008|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827009|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
44827010|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827011|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827012|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827013|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827014|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
44827015|NCT02172495|Bromides|bromides|mesh-list
44827016|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
44827017|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827018|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
44827019|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827020|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827021|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827022|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827023|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
44827024|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827025|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827026|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827027|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827028|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
44827029|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
44827030|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827031|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
44827032|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827033|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827034|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827035|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827036|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
44827037|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827038|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827039|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827040|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827041|NCT02172521|Bromides|bromides|mesh-list
44827042|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
44313552|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827043|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827044|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
44827045|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827046|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609174|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609175|NCT00686777|Interferons|interferons|mesh-list
44609176|NCT00686777|Ribavirin|ribavirin|mesh-list
44609177|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
44609178|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
44609179|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44609180|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609181|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
44609182|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609183|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
44609184|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609185|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
44609186|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609187|NCT00686725|Temozolomide|temozolomide|mesh-list
44609188|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609189|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
44609190|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609191|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609192|NCT00686712|Insulin|insulin|mesh-list
44609193|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44609194|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
44609195|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
44609196|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
44609197|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
44609198|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609199|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609200|NCT00686686|Infliximab|infliximab|mesh-list
44827047|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827048|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827049|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
44827050|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827051|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827052|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827053|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827054|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
44827055|NCT02172534|Bromides|bromides|mesh-list
44827056|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
44827057|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827058|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
44827059|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827060|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827061|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827062|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827063|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
44827064|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827065|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827066|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827067|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827068|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
44827069|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
44827070|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827071|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
44827072|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827073|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827074|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827075|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827076|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
44827077|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827078|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827079|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827080|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827081|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
44827082|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827083|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
44827084|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827085|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827086|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827087|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827088|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
44827089|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827090|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827091|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827092|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827093|NCT02172573|Pramipexole|pramipexole|mesh-list
44827094|NCT02172573|Bromocriptine|bromocriptine|mesh-list
44827095|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
44827096|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827097|NCT02172573|Protective Agents|protective agents|mesh-ancestor
44827098|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827099|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44827100|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44827101|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
44827102|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
44827103|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827104|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
44827105|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827106|NCT02172586|Losartan|losartan|mesh-list
44827107|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44827108|NCT02172586|Telmisartan|telmisartan|mesh-list
44827109|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44827110|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44827111|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44827112|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44827113|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827114|NCT02172586|Diuretics|diuretics|mesh-ancestor
44827115|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
44827116|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827117|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44827118|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827119|NCT02172729|Lidocaine|lidocaine|mesh-list
44827120|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
44827121|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
44827122|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827123|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827124|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
44827125|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827126|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44827127|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44827128|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44827129|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827130|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827131|NCT02172768|Micafungin|micafungin|mesh-list
44827132|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
44827133|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827134|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
44827135|NCT02172781|Ipratropium|ipratropium|mesh-list
44827136|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827137|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
44827138|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827139|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827140|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827141|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827142|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
44827143|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827144|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827145|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827146|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827147|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
44827148|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44827149|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827150|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
44827151|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827152|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827153|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827154|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827155|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
44827156|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827157|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827158|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827159|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827160|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827161|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827162|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827163|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827164|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
44827165|NCT02172807|Oxitropium|oxitropium|mesh-list
44827166|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827167|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
44827168|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827169|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827170|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827171|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827172|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
44827173|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827174|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827175|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827176|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827177|NCT02172846|Paclitaxel|paclitaxel|mesh-list
44827178|NCT02172846|Carboplatin|carboplatin|mesh-list
44827179|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44827180|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827181|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44827182|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44827183|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44827184|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827185|NCT02172976|Gemcitabine|gemcitabine|mesh-list
44827186|NCT02172976|Fluorouracil|fluorouracil|mesh-list
44827187|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
44827188|NCT02172976|Irinotecan|irinotecan|mesh-list
44827189|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44827190|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
44827191|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827192|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827193|NCT02172976|Antiviral Agents|antiviral agents|mesh-ancestor
44827194|NCT02172976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827195|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827196|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44827197|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
44827198|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827199|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44827200|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44827201|NCT02173093|Aldesleukin|aldesleukin|mesh-list
44827202|NCT02173093|Interleukin-2|interleukin-2|mesh-list
44827203|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827204|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44827205|NCT02173093|Analgesics|analgesics|mesh-ancestor
44827206|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
44827207|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827208|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827209|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44827210|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44827211|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
44827212|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827213|NCT02173106|Cyclosporine|cyclosporine|mesh-list
44827214|NCT02173106|Cyclosporins|cyclosporins|mesh-list
44827215|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827216|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827217|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44827218|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
44827219|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827220|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
44827221|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827222|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44827223|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827224|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44827225|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
44827226|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
44827227|NCT02173132|Vitamins|vitamins|mesh-ancestor
44827228|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
44827229|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827230|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
44827231|NCT02173145|Azithromycin|azithromycin|mesh-list
44827232|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827233|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120823|NCT00122226|Ritonavir|ritonavir|mesh-list
44827234|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
44827235|NCT02173262|Lenograstim|lenograstim|mesh-list
44827236|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827237|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827238|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44827239|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44827240|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827241|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827242|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827243|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44827244|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44827245|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44827246|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
44827247|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827248|NCT02173288|Furosemide|furosemide|mesh-list
44827249|NCT02173288|Spironolactone|spironolactone|mesh-list
44827250|NCT02173288|Tolvaptan|tolvaptan|mesh-list
44827251|NCT02173288|Midodrine|midodrine|mesh-list
44827252|NCT02173288|Diuretics|diuretics|mesh-ancestor
44827253|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
44827254|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827255|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44827256|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827257|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827258|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44827259|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
44827260|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827261|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44827262|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44827263|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
44827264|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
44827265|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827266|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44827267|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44827268|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44827269|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44609376|NCT00684996|Antibodies|antibodies|mesh-list
44827270|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827271|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827272|NCT02173418|Ropivacaine|ropivacaine|mesh-list
44827273|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
44827274|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
44827275|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827276|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827277|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
44827278|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827279|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44827280|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44313758|NCT00904852|Growth Substances|growth substances|mesh-ancestor
44827281|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827282|NCT02173457|Incretins|incretins|mesh-ancestor
44827283|NCT02173457|Hormones|hormones|mesh-ancestor
44827284|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827285|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44827286|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827287|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827288|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827289|NCT02173639|Metformin|metformin|mesh-list
44827290|NCT02173639|Linagliptin|linagliptin|mesh-list
44827291|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44827292|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827293|NCT02173639|Incretins|incretins|mesh-ancestor
44827294|NCT02173639|Hormones|hormones|mesh-ancestor
44827295|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827296|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44827297|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827298|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827299|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827300|NCT02173652|Linagliptin|linagliptin|mesh-list
44827301|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44827302|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827303|NCT02173652|Incretins|incretins|mesh-ancestor
44827304|NCT02173652|Hormones|hormones|mesh-ancestor
44827305|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827306|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44827307|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827308|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827309|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827310|NCT02173665|Linagliptin|linagliptin|mesh-list
44827311|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44827312|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827313|NCT02173665|Incretins|incretins|mesh-ancestor
44827314|NCT02173665|Hormones|hormones|mesh-ancestor
44827315|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827316|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44827317|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827318|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827319|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827320|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
44827321|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44827322|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827323|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
44827324|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827325|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827326|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827327|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827328|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
44827329|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827330|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827331|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827332|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827333|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827334|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827335|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827336|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827337|NCT02173717|Rifampin|rifampin|mesh-list
44827338|NCT02173717|Dabigatran|dabigatran|mesh-list
44827339|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
44827340|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44827341|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827342|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827343|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827344|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
44609528|NCT00683787|Docetaxel|docetaxel|mesh-list
44827345|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44827346|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
44827347|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313849|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
44827348|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827349|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
44827350|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44827351|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44827352|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44827353|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44827354|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44827355|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44827356|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44827357|NCT02173730|Pantoprazole|pantoprazole|mesh-list
44827358|NCT02173730|Dabigatran|dabigatran|mesh-list
44827359|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44827360|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44827361|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44827362|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827363|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827364|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
44827365|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44827366|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827367|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
44827368|NCT02173756|Morphine|morphine|mesh-list
44827369|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44827370|NCT02173756|Narcotics|narcotics|mesh-ancestor
44827371|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827372|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827373|NCT02173756|Analgesics|analgesics|mesh-ancestor
44827374|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
44827375|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827376|NCT02173782|Fenoterol|fenoterol|mesh-list
44827377|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44827378|NCT02173782|Ipratropium|ipratropium|mesh-list
44827379|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827380|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
44827381|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827382|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827383|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827384|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827385|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
44827386|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
44827387|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827388|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827389|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827390|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827391|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827392|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827393|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827394|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827395|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827396|NCT02173795|Fenoterol|fenoterol|mesh-list
44827397|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44827398|NCT02173795|Ipratropium|ipratropium|mesh-list
44827399|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827400|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
44827401|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827402|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827403|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827404|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827405|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
44827406|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
44827407|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827408|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827409|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827410|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827411|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827412|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827413|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827414|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827415|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827416|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
44827417|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
44827418|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44609636|NCT00682643|Xhance|xhance|mesh-list
44827419|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
44827420|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827421|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827422|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44827423|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44827424|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44827425|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44827426|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44827427|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44827428|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44827429|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827430|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827431|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827432|NCT02173873|Aflibercept|aflibercept|mesh-list
44827433|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827434|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827435|NCT02173873|Growth Substances|growth substances|mesh-ancestor
44827436|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827437|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
44827438|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827439|NCT02173886|Bupropion|bupropion|mesh-list
44827440|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44827441|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
44827442|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44695903|NCT01388621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44695904|NCT01388621|Immunologic Factors|immunologic factors|mesh-ancestor
44695905|NCT01388621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695906|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44695907|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44695908|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44695909|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695910|NCT01388660|Clopidogrel|clopidogrel|mesh-list
44695911|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695912|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44609670|NCT00682448|Metformin|metformin|mesh-list
44827443|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44313963|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44827444|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44827445|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827446|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827447|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
44827448|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827449|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827450|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44827451|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44827452|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827453|NCT02173912|Amlodipine|amlodipine|mesh-list
44827454|NCT02173912|Candesartan|candesartan|mesh-list
44827455|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
44827456|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44827457|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44827458|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827459|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609671|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609672|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609673|NCT00682435|Hydromorphone|hydromorphone|mesh-list
44609674|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44609675|NCT00682435|Narcotics|narcotics|mesh-ancestor
44609676|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609677|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609678|NCT00682435|Analgesics|analgesics|mesh-ancestor
44609679|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
44609680|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609681|NCT00681863|Pramipexole|pramipexole|mesh-list
44609682|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
44609683|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609684|NCT00681863|Protective Agents|protective agents|mesh-ancestor
44609685|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609686|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44609687|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44609688|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
44609689|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
44609690|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827460|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44827461|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827462|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
44827463|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44827464|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44827465|NCT02173951|Deferiprone|deferiprone|mesh-list
44827466|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44827467|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
44827468|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
44827469|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827470|NCT02173964|Pinaverium|pinaverium|mesh-list
44827471|NCT02173964|Bromides|bromides|mesh-list
44827472|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
44827473|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44827474|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827475|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827476|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44827477|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827478|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
44827479|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
44827480|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827481|NCT02173990|Aflibercept|aflibercept|mesh-list
44827482|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827483|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827484|NCT02173990|Growth Substances|growth substances|mesh-ancestor
44827485|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827486|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314010|NCT00906113|Melphalan|melphalan|mesh-list
44827487|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827488|NCT02174068|Acetaminophen|acetaminophen|mesh-list
44827489|NCT02174068|Nefopam|nefopam|mesh-list
44827490|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44827491|NCT02174068|Analgesics|analgesics|mesh-ancestor
44827492|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
44827493|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827494|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827495|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
44827496|NCT02174094|Clobazam|clobazam|mesh-list
44827497|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
44827498|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44827499|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44827500|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827501|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827502|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44827503|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44827504|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
44827505|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
44827506|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827507|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827508|NCT02174120|Propofol|propofol|mesh-list
44827509|NCT02174120|Etomidate|etomidate|mesh-list
44827510|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44827511|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827512|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827513|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44827514|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
44827515|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
44827516|NCT02174172|Interferons|interferons|mesh-list
44827517|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
44827518|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
44827519|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44827520|NCT02174172|Bevacizumab|bevacizumab|mesh-list
44827521|NCT02174172|Ipilimumab|ipilimumab|mesh-list
44827522|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
44827523|NCT02174172|Atezolizumab|atezolizumab|mesh-list
44827524|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44827525|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827526|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827527|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827528|NCT02174172|Growth Substances|growth substances|mesh-ancestor
44827529|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827530|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44827531|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
44827532|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827533|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44827534|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827535|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
44827536|NCT02174211|Ranibizumab|ranibizumab|mesh-list
44827538|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827539|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827540|NCT02174211|Growth Substances|growth substances|mesh-ancestor
44827541|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827542|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
44827543|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827544|NCT02174250|Rifampin|rifampin|mesh-list
44827545|NCT02174250|Istradefylline|istradefylline|mesh-list
44827546|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44827547|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
44827548|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827549|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827550|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
44827551|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44827552|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827553|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827554|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44827555|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44827556|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44827557|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44827558|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44827559|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44827560|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44827561|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44827562|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44827563|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
44827564|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827565|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827566|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
44827567|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
44827568|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
44827569|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827570|NCT02174328|Aspirin|aspirin|mesh-list
44827571|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44827572|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44827573|NCT02174328|Analgesics|analgesics|mesh-ancestor
44827574|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
44827575|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827576|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827577|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44827578|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827579|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44827580|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44827581|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827582|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44827583|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44827584|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827585|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
44827586|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
44827587|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827588|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44827589|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827590|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827591|NCT02174575|Sevoflurane|sevoflurane|mesh-list
44827592|NCT02174575|Desflurane|desflurane|mesh-list
44827593|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44827594|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44827595|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
44827596|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
44827597|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314096|NCT00906516|Bevacizumab|bevacizumab|mesh-list
44827598|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827599|NCT02174588|Midazolam|midazolam|mesh-list
44827600|NCT02174588|Propofol|propofol|mesh-list
44827601|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44827602|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827603|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827604|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44827605|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
44827606|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
44827607|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44827608|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44827609|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44827610|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44827611|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
44827612|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
44827613|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827614|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827615|NCT02174666|Vitamin D|vitamin d|mesh-list
44827616|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
44827617|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
44827618|NCT02174666|Vitamins|vitamins|mesh-list
44827619|NCT02174666|Genistein|genistein|mesh-list
44827620|NCT02174666|Biochanin A|biochanin a|mesh-list
44827621|NCT02174666|Daidzein|daidzein|mesh-list
44827622|NCT02174666|Formononetin|formononetin|mesh-list
44827623|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
44827624|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827625|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44827626|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44827627|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44827628|NCT02174666|Protective Agents|protective agents|mesh-ancestor
44827629|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827630|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44827631|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827632|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827633|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
44827634|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44827635|NCT02174666|Estrogens|estrogens|mesh-ancestor
44827636|NCT02174666|Hormones|hormones|mesh-ancestor
44827637|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827638|NCT02174718|Vitamin D|vitamin d|mesh-list
44827639|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
44827640|NCT02174718|Vitamins|vitamins|mesh-ancestor
44827641|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
44827642|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314119|NCT00906724|Insulin|insulin|mesh-list
44827643|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44827644|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44827645|NCT02174757|Doxycycline|doxycycline|mesh-list
44827646|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827647|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827648|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
44827649|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44827650|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44827651|NCT02174887|Gemcitabine|gemcitabine|mesh-list
44827652|NCT02174887|Paclitaxel|paclitaxel|mesh-list
44827653|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44827654|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827655|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44827656|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44827657|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44827658|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827659|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44827660|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
44827661|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
44827662|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827663|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827664|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44827665|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
44827666|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827667|NCT02174900|Lumefantrine|lumefantrine|mesh-list
44827668|NCT02174900|Artemether|artemether|mesh-list
44827669|NCT02174900|Primaquine|primaquine|mesh-list
44827670|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44827671|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
44827672|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44827673|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44827674|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827675|NCT02174939|Cilostazol|cilostazol|mesh-list
44827676|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827677|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
44827678|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827679|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827680|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827681|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827682|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44827683|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44314163|NCT00907036|Cyclosporins|cyclosporins|mesh-list
44827684|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827685|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44827686|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
44827687|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44827688|NCT02174939|Protective Agents|protective agents|mesh-ancestor
44827689|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44827690|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44827691|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827693|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44827694|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827695|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44827696|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827697|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44827698|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827699|NCT02175069|Ropivacaine|ropivacaine|mesh-list
44827700|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
44827701|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
44827702|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827703|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827704|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
44827705|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827706|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
44827707|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827708|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
44827709|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827710|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827711|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827712|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827713|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
44827714|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827715|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827716|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827717|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827718|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44827719|NCT02175355|Telmisartan|telmisartan|mesh-list
44827720|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44827721|NCT02175355|Diuretics|diuretics|mesh-ancestor
44827722|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
44827723|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827724|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44827725|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827726|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827727|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44827728|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44827729|NCT02175381|Gemcitabine|gemcitabine|mesh-list
44827730|NCT02175381|Carboplatin|carboplatin|mesh-list
44827731|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827732|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44827733|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
44827734|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827735|NCT02175381|Antiviral Agents|antiviral agents|mesh-ancestor
44827736|NCT02175381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827737|NCT02175381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827738|NCT02175381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44827739|NCT02175381|Immunologic Factors|immunologic factors|mesh-ancestor
44827740|NCT02175381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827741|NCT02175394|Linagliptin|linagliptin|mesh-list
44827742|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44827743|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44827744|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44827745|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827746|NCT02175394|Incretins|incretins|mesh-ancestor
44827747|NCT02175394|Hormones|hormones|mesh-ancestor
44827748|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827749|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44827750|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44827751|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827752|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827753|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44827754|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
44827755|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827756|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44827757|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44827758|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44827759|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44827760|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44827761|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44827762|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44827763|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44827764|NCT02175407|Itraconazole|itraconazole|mesh-list
44827765|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
44827766|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827767|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44827768|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44827769|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827770|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827771|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44827772|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
44827773|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827774|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827775|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44827776|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
44827777|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
44827778|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827779|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44827780|NCT02175446|Bevacizumab|bevacizumab|mesh-list
44827781|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44827782|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827783|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827784|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827785|NCT02175446|Growth Substances|growth substances|mesh-ancestor
44827786|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827787|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44827788|NCT02175485|Fexofenadine|fexofenadine|mesh-list
44827789|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44827790|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44827791|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44827792|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
44827793|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
44827794|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827795|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827796|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827797|NCT02175589|Colchicine|colchicine|mesh-list
44827798|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
44827799|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827800|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44827801|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44827802|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44827803|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827804|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44827805|NCT02175602|Citalopram|citalopram|mesh-list
44827806|NCT02175602|Sertraline|sertraline|mesh-list
44827807|NCT02175602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44827808|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44827809|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827810|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827811|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827812|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
44827813|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827814|NCT02175602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44827815|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
44827816|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44827817|NCT02175680|Leronlimab|leronlimab|mesh-list
44827818|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44827819|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44827820|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827821|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44827822|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44827823|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
44314312|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
44827824|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827825|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
44827826|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44827827|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827828|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44827829|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827830|NCT02175888|Iron|iron|mesh-list
44827831|NCT02175888|Trace Elements|trace elements|mesh-ancestor
44827832|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
44827833|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827834|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44827835|NCT02175901|Amoxicillin|amoxicillin|mesh-list
44827837|NCT02175901|Clarithromycin|clarithromycin|mesh-list
44827838|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44827839|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
44827840|NCT02175901|Lansoprazole|lansoprazole|mesh-list
44827841|NCT02175901|Bismuth|bismuth|mesh-list
44827842|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44827843|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827844|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827845|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
44827846|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44827847|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44827848|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44827849|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827850|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44827851|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44827852|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44827853|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44827854|NCT02175901|Antacids|antacids|mesh-ancestor
44827855|NCT02175901|Diuretics|diuretics|mesh-ancestor
44827856|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
44827857|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827858|NCT02175901|Expectorants|expectorants|mesh-ancestor
44827859|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827860|NCT02175914|Erythromycin|erythromycin|mesh-list
44827861|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
44827862|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44827863|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
44827864|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827865|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827866|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44827867|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44827868|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827869|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827870|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44827871|NCT02175927|Amoxicillin|amoxicillin|mesh-list
44827872|NCT02175927|Metronidazole|metronidazole|mesh-list
44827873|NCT02175927|Tetracycline|tetracycline|mesh-list
44827874|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44827875|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
44827876|NCT02175927|Lansoprazole|lansoprazole|mesh-list
44827877|NCT02175927|Bismuth|bismuth|mesh-list
44827878|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44827879|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827880|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827881|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
44827882|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44827883|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44827884|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44827885|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44827886|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827887|NCT02175927|Antacids|antacids|mesh-ancestor
44827888|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44827889|NCT02175927|Diuretics|diuretics|mesh-ancestor
44827890|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
44827891|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827892|NCT02175927|Expectorants|expectorants|mesh-ancestor
44827893|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827894|NCT02176044|Nitroprusside|nitroprusside|mesh-list
44827895|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44827896|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
44827897|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44827898|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827899|NCT02176057|Azithromycin|azithromycin|mesh-list
44827900|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827901|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827902|NCT02176122|Meropenem|meropenem|mesh-list
44827903|NCT02176122|Tazobactam|tazobactam|mesh-list
44827904|NCT02176122|Piperacillin|piperacillin|mesh-list
44827905|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44827906|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44827907|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44827908|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44827909|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44827910|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827911|NCT02176135|Auranofin|auranofin|mesh-list
44827912|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827913|NCT02176187|Fenoterol|fenoterol|mesh-list
44827914|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44827915|NCT02176187|Ipratropium|ipratropium|mesh-list
44827916|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827917|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
44827918|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827919|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827920|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827921|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827922|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
44827923|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
44827924|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827925|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827926|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827927|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827928|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827929|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827930|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827931|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827932|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827933|NCT02176200|Fenoterol|fenoterol|mesh-list
44827934|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44827935|NCT02176200|Ipratropium|ipratropium|mesh-list
44827936|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44827937|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
44827938|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827939|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827940|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44827941|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44827942|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
44827943|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
44827944|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44827945|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44827946|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44827947|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44827948|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
44827949|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44827950|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827951|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44827952|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
44827953|NCT02176213|Dexamethasone|dexamethasone|mesh-list
44827954|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
44827955|NCT02176213|Pomalidomide|pomalidomide|mesh-list
44827956|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44827957|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
44827958|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827959|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44827960|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44827961|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
44827962|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827963|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466833|NCT01458210|Dulaglutide|dulaglutide|mesh-list
44314457|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44827964|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44827965|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44827966|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
44827967|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
44827968|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827969|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44827970|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
44827971|NCT02176213|Hormones|hormones|mesh-ancestor
44827972|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44827973|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44827974|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44827975|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44827976|NCT02176213|Growth Substances|growth substances|mesh-ancestor
44827977|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44827978|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44827979|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
44827980|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44827981|NCT02176304|Prednisolone|prednisolone|mesh-list
44827982|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
44827983|NCT02176304|Lidocaine|lidocaine|mesh-list
44827984|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44827985|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
44827986|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
44827987|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
44827988|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44827989|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44827990|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
44827991|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44827992|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44827993|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44827994|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44827995|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44827996|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44827997|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44827998|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
44827999|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
44828000|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828001|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
44828002|NCT02176304|Hormones|hormones|mesh-ancestor
44828003|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828004|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44828005|NCT02176304|Protective Agents|protective agents|mesh-ancestor
44828006|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44828007|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828008|NCT02176369|Vinorelbine|vinorelbine|mesh-list
44828009|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44828010|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828011|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44828012|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44828013|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44828014|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828015|NCT02176460|Colchicine|colchicine|mesh-list
44828016|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
44828017|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828018|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
44828019|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
44828020|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
44828021|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828022|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828023|NCT02176499|Telmisartan|telmisartan|mesh-list
44828024|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828025|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828026|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828027|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828028|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44828029|NCT02176512|Telmisartan|telmisartan|mesh-list
44828030|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828031|NCT02176512|Diuretics|diuretics|mesh-ancestor
44828032|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
44828033|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828034|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44828035|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828036|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828037|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828038|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828039|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
44828040|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
44828041|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828042|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828043|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44610319|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44610320|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
44610321|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610322|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44610323|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
44610324|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610325|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
44610326|NCT00673816|Sunitinib|sunitinib|mesh-list
44610327|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610328|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610329|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610330|NCT00673816|Growth Substances|growth substances|mesh-ancestor
44610331|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610332|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439453|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610333|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610334|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828044|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828045|NCT02176681|Vildagliptin|vildagliptin|mesh-list
44828046|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44828047|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828048|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44828049|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828050|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828051|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828052|NCT02176720|Fluorides|fluorides|mesh-list
44828053|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44828054|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
44828055|NCT02176720|Protective Agents|protective agents|mesh-ancestor
44828056|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828057|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
44828058|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828059|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828060|NCT02176733|Cyclosporine|cyclosporine|mesh-list
44828061|NCT02176733|Cyclosporins|cyclosporins|mesh-list
44828062|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828063|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828064|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828065|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
44828066|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828067|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
44828068|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828069|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828070|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828071|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44828072|NCT02176759|Citric Acid|citric acid|mesh-list
44828073|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
44828074|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
44828075|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44828076|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
44828077|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
44314541|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
44828078|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695913|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44695914|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44695915|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
44695916|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695917|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695918|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695919|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
44695920|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44695921|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
44695922|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44695923|NCT01388738|Protective Agents|protective agents|mesh-ancestor
44695924|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695925|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
44695926|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828079|NCT02176850|Telmisartan|telmisartan|mesh-list
44828080|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828081|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828082|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828083|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828084|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44828085|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
44828086|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828087|NCT02177253|Bromides|bromides|mesh-list
44828088|NCT02177253|Albuterol|albuterol|mesh-list
44828089|NCT02177253|Ipratropium|ipratropium|mesh-list
44828090|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
44828091|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828092|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
44828093|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828094|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828095|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828096|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828097|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
44828098|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44828099|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44828100|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44828101|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828102|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828103|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828104|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828105|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828106|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828107|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44828108|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
44314589|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
44828109|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828110|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
44828111|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828112|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828113|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828114|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828115|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
44828116|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828117|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828118|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828119|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828120|NCT02177318|Bromides|bromides|mesh-list
44828121|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
44828122|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828123|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
44828124|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828125|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828126|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828127|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828128|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
44828129|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828130|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828131|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828132|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314643|NCT00909311|Ritonavir|ritonavir|mesh-list
44828133|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
44828134|NCT02177331|Lacidipine|lacidipine|mesh-list
44828135|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828136|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44828137|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828138|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828139|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44828140|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828141|NCT02177344|Bromides|bromides|mesh-list
44828142|NCT02177344|Ipratropium|ipratropium|mesh-list
44828143|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
44828144|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828145|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
44828146|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828147|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828148|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828149|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828150|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828151|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
44610394|NCT00673361|Temozolomide|temozolomide|mesh-list
44828152|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828153|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828154|NCT02177357|Pramipexole|pramipexole|mesh-list
44828155|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
44828156|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828157|NCT02177357|Protective Agents|protective agents|mesh-ancestor
44828158|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828159|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44828160|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44828161|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
44828162|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
44828163|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828164|NCT02177370|Fenoterol|fenoterol|mesh-list
44828165|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828166|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
44828167|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828168|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828169|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828170|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828171|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
44828172|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
44828173|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44828174|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44828175|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44828176|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828177|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828178|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828179|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828180|NCT02177396|Valsartan|valsartan|mesh-list
44828181|NCT02177396|Telmisartan|telmisartan|mesh-list
44828182|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828183|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828184|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828185|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828186|NCT02177409|Amlodipine|amlodipine|mesh-list
44828187|NCT02177409|Telmisartan|telmisartan|mesh-list
44828188|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828189|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44828190|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828191|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828192|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44828193|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828194|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44828195|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828196|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828197|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44828198|NCT02177422|Telmisartan|telmisartan|mesh-list
44828199|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828200|NCT02177422|Diuretics|diuretics|mesh-ancestor
44828201|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
44828202|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828203|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44828204|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828205|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828206|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828207|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828208|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44828209|NCT02177435|Telmisartan|telmisartan|mesh-list
44828210|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44828211|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828212|NCT02177435|Diuretics|diuretics|mesh-ancestor
44828213|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
44828214|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828215|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44828216|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828217|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828218|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828219|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828220|NCT02177448|Enalapril|enalapril|mesh-list
44828221|NCT02177448|Enalaprilat|enalaprilat|mesh-list
44828222|NCT02177448|Telmisartan|telmisartan|mesh-list
44828223|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44828224|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828225|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828226|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828227|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828228|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828229|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828231|NCT02177461|Clonidine|clonidine|mesh-list
44828232|NCT02177461|Enalapril|enalapril|mesh-list
44828233|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828234|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828235|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828236|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828237|NCT02177461|Analgesics|analgesics|mesh-ancestor
44828238|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
44828239|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828240|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828241|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
44828242|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
44828243|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44828244|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44828245|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828246|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828247|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828248|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44828249|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314752|NCT00909974|Trace Elements|trace elements|mesh-list
44828250|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828251|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44828252|NCT02177487|Telmisartan|telmisartan|mesh-list
44828253|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44828254|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828255|NCT02177487|Diuretics|diuretics|mesh-ancestor
44828256|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
44828257|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828258|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44828259|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828260|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828261|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828262|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828263|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44828264|NCT02177500|Telmisartan|telmisartan|mesh-list
44828265|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44828266|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828267|NCT02177500|Diuretics|diuretics|mesh-ancestor
44828268|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
44828269|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828270|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44828271|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828272|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828273|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828274|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828275|NCT02177539|Phenylephrine|phenylephrine|mesh-list
44828276|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
44828277|NCT02177539|Tropicamide|tropicamide|mesh-list
44828278|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
44828279|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44828280|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
44828281|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
44828282|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828283|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828284|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
44828285|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44828286|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
44828287|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828288|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44828289|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44828290|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828291|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828292|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828293|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828294|NCT02177539|Protective Agents|protective agents|mesh-ancestor
44828295|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44828296|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828297|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828298|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
44828299|NCT02177552|Carboplatin|carboplatin|mesh-list
44828300|NCT02177552|Docetaxel|docetaxel|mesh-list
44828301|NCT02177552|Capecitabine|capecitabine|mesh-list
44828302|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
44828303|NCT02177552|Epirubicin|epirubicin|mesh-list
44828304|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828305|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44828306|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44828307|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44828308|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828309|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44828310|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
44828311|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44828312|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44828313|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44828314|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828315|NCT02177643|Diacetylrhein|diacetylrhein|mesh-list
44828316|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828317|NCT02177734|Vaccines|vaccines|mesh-list
44828318|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
44828319|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828320|NCT02177760|Sirolimus|sirolimus|mesh-list
44828321|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828322|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828323|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44828324|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828325|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
44828326|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828327|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
44828328|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828329|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
44828330|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828331|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44828332|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828333|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828334|NCT02177851|Iron|iron|mesh-list
44828335|NCT02177851|Trace Elements|trace elements|mesh-ancestor
44828336|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
44828337|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828338|NCT02177955|Midazolam|midazolam|mesh-list
44828339|NCT02177955|Diazepam|diazepam|mesh-list
44828340|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44828341|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44828342|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828343|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828344|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44828345|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44828346|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44828347|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44828348|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
44828349|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
44828350|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
44828351|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
44828352|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828353|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828354|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
44828355|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
44828356|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
44828357|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828358|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828359|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44828360|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44828361|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
44828362|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828363|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828364|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44828365|NCT02178124|Donepezil|donepezil|mesh-list
44828366|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44828367|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828368|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828369|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828370|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828371|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828372|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
44828373|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
44828374|NCT02178137|Astringents|astringents|mesh-ancestor
44828375|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828377|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
44828378|NCT02178150|Antacids|antacids|mesh-ancestor
44828379|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828380|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828381|NCT02178254|Fosfomycin|fosfomycin|mesh-list
44828382|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828383|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828384|NCT02178293|Ketoprofen|ketoprofen|mesh-list
44828385|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
44828386|NCT02178293|Benzydamine|benzydamine|mesh-list
44828387|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828388|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828389|NCT02178293|Analgesics|analgesics|mesh-ancestor
44828390|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
44828391|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828392|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828393|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828394|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828395|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828396|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828397|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828398|NCT02178306|Telmisartan|telmisartan|mesh-list
44828399|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828400|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44828401|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44828402|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828403|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44828404|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828405|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44828406|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828407|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828408|NCT02178449|Dexamethasone|dexamethasone|mesh-list
44828409|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
44828410|NCT02178449|Ropivacaine|ropivacaine|mesh-list
44828411|NCT02178449|BB 1101|bb 1101|mesh-list
44828412|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828413|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
44828414|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
44828415|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828416|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828417|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828418|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
44828419|NCT02178449|Hormones|hormones|mesh-ancestor
44828420|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828421|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44828422|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828423|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
44828424|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
44828425|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828426|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
44828427|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828428|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828429|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828430|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
44828431|NCT02178488|Vitamin D|vitamin d|mesh-list
44828432|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44828433|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828434|NCT02178488|Vitamins|vitamins|mesh-ancestor
44828435|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
44828436|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44828437|NCT02178644|Capecitabine|capecitabine|mesh-list
44828438|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44828439|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
44828440|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828441|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828442|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
44828443|NCT02178683|Tacrolimus|tacrolimus|mesh-list
44828444|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828445|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
44828446|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828447|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44828448|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828449|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828450|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44828451|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828452|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44828453|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
44828454|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828455|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828456|NCT02178761|Chromium|chromium|mesh-list
44828457|NCT02178761|Everolimus|everolimus|mesh-list
44828458|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828459|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828460|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
44828461|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828462|NCT02178761|Trace Elements|trace elements|mesh-ancestor
44828463|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
44314891|NCT00910637|Hormones|hormones|mesh-ancestor
44828464|NCT02178813|Minocycline|minocycline|mesh-list
44828465|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828466|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828467|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44828468|NCT02179008|Latanoprost|latanoprost|mesh-list
44828469|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44828470|NCT02179034|Menthol|menthol|mesh-list
44828471|NCT02179034|Nicotine|nicotine|mesh-list
44828472|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44828473|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
44828474|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828475|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828476|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44828477|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44828478|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828479|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828480|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828481|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
44828482|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828483|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
44828484|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44828485|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44828486|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828487|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828488|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828489|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828490|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828491|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44828492|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828493|NCT02179255|Hormones|hormones|mesh-list
44314923|NCT00910780|Olanzapine|olanzapine|mesh-list
44828494|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44828495|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828496|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828497|NCT02179268|Sertraline|sertraline|mesh-list
44828498|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44828499|NCT02179268|Citalopram|citalopram|mesh-list
44828500|NCT02179268|Reboxetine|reboxetine|mesh-list
44828501|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44828502|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44828503|NCT02179268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44828504|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44828505|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828506|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828507|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828508|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
44828509|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828510|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44828511|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44828512|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44828513|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828515|NCT02179294|Remifentanil|remifentanil|mesh-list
44828516|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44828517|NCT02179294|Narcotics|narcotics|mesh-ancestor
44828518|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828519|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828520|NCT02179294|Analgesics|analgesics|mesh-ancestor
44828521|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
44828522|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828523|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44828524|NCT02179528|Etoposide|etoposide|mesh-list
44828525|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44828526|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828527|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44828528|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44828529|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828530|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828531|NCT02179567|Bevacizumab|bevacizumab|mesh-list
44828532|NCT02179567|Docetaxel|docetaxel|mesh-list
44828533|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44828534|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828535|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44828536|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44828537|NCT02179567|Growth Substances|growth substances|mesh-ancestor
44828538|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828539|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44828540|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44828541|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44828542|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44828543|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828544|NCT02179645|Celecoxib|celecoxib|mesh-list
44828545|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828546|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828547|NCT02179645|Analgesics|analgesics|mesh-ancestor
44828548|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
44828549|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828550|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828551|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828552|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828553|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44828554|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828555|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828556|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828557|NCT02179658|Vancomycin|vancomycin|mesh-list
44828558|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
44828559|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828560|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828561|NCT02179775|Propranolol|propranolol|mesh-list
44828562|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44828563|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44828564|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828565|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828566|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828567|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828568|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44828569|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828570|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
44828571|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
44828572|NCT02179814|Promethazine|promethazine|mesh-list
44828573|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44828574|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44828575|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828576|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828577|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
44828578|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
44828579|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
44828580|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828581|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
44828582|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
44828583|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828584|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44610846|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610847|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44828585|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
44828586|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
44828587|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828588|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828589|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44828590|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
44828591|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828592|NCT02179931|Flupenthixol|flupenthixol|mesh-list
44828593|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44828594|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44828595|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44828596|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828597|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828598|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44828599|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44828600|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
44828601|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828602|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828603|NCT02179970|Plerixafor|plerixafor|mesh-list
44828604|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44828605|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44828606|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
44828607|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828608|NCT02179996|Vaccines|vaccines|mesh-list
44828609|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
44828610|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828611|NCT02180048|Caffeine|caffeine|mesh-list
44828612|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44828613|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828614|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44828615|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828616|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828617|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44828618|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44828619|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
44828620|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828621|NCT02180087|Ketoprofen|ketoprofen|mesh-list
44828622|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828623|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828624|NCT02180087|Analgesics|analgesics|mesh-ancestor
44828625|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
44828626|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828627|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828628|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828629|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828630|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828631|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828632|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828633|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44828634|NCT02180204|Tenecteplase|tenecteplase|mesh-list
44828635|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44828636|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828637|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828638|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
44828639|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44828640|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828641|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828642|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
44828643|NCT02180321|Coagulants|coagulants|mesh-ancestor
44828644|NCT02180334|Acetaminophen|acetaminophen|mesh-list
44828645|NCT02180334|Linagliptin|linagliptin|mesh-list
44828646|NCT02180334|Mosapride|mosapride|mesh-list
44828647|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828648|NCT02180334|Analgesics|analgesics|mesh-ancestor
44828649|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
44828650|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828651|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828652|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
44828653|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828654|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44828655|NCT02180334|Incretins|incretins|mesh-ancestor
44828656|NCT02180334|Hormones|hormones|mesh-ancestor
44828657|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828658|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44315083|NCT00911651|Bromides|bromides|mesh-list
44828659|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828660|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828661|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828662|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44828663|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
44828664|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828665|NCT02180425|Adapalene|adapalene|mesh-list
44828666|NCT02180425|Tretinoin|tretinoin|mesh-list
44828667|NCT02180425|Isotretinoin|isotretinoin|mesh-list
44828668|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828669|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828670|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828671|NCT02180425|Analgesics|analgesics|mesh-ancestor
44828672|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
44828673|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828674|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828675|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828676|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828677|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828678|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
44828679|NCT02180503|Linagliptin|linagliptin|mesh-list
44828680|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44828681|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828682|NCT02180503|Incretins|incretins|mesh-ancestor
44828683|NCT02180503|Hormones|hormones|mesh-ancestor
44828684|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828685|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44828686|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828687|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828688|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828689|NCT02180516|Meloxicam|meloxicam|mesh-list
44828690|NCT02180516|Etodolac|etodolac|mesh-list
44828691|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44828692|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44828693|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828694|NCT02180516|Analgesics|analgesics|mesh-ancestor
44828695|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
44828696|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828697|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828698|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828699|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44828700|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828701|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828702|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828703|NCT02180529|Methylphenidate|methylphenidate|mesh-list
44828704|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44828705|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828706|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44828707|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44828708|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828709|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828710|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
44828711|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828712|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
44828713|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828714|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
44828715|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44828716|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828717|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828718|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828719|NCT02180737|Analgesics|analgesics|mesh-ancestor
44828720|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
44828721|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828722|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44828723|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44828724|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828725|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828726|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828727|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828728|NCT02180789|Tamsulosin|tamsulosin|mesh-list
44828729|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44828730|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44828731|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44828732|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828733|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828734|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828735|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828736|NCT02180789|Urological Agents|urological agents|mesh-ancestor
44828737|NCT02180880|Pregabalin|pregabalin|mesh-list
44828738|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
44828739|NCT02180880|Analgesics|analgesics|mesh-ancestor
44828740|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
44828741|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828742|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828743|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
44828744|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44828745|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44828746|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828747|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44828748|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44828749|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44828750|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828751|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44828752|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44828753|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44828754|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44828755|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44828756|NCT02180997|Tamsulosin|tamsulosin|mesh-list
44828757|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
44828758|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44828759|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44828760|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44828761|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828762|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828763|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828764|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828765|NCT02180997|Urological Agents|urological agents|mesh-ancestor
44828766|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44695927|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
44695928|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695929|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695930|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44695931|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
44695932|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44695933|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
44695934|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695935|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44695936|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44695937|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695938|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
44695939|NCT01388842|Protective Agents|protective agents|mesh-ancestor
44695940|NCT01388855|Vitamin D|vitamin d|mesh-list
44695941|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
44695942|NCT01388855|Vitamins|vitamins|mesh-ancestor
44695943|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
44695944|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695945|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44695946|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44695947|NCT01388959|Rituximab|rituximab|mesh-list
44695948|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44695949|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44695950|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
44695951|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828767|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828768|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828769|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
44828770|NCT02181023|Bromides|bromides|mesh-list
44828771|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
44828772|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44828773|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44828774|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44828775|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
44828776|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828777|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828778|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828779|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
44828780|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44828781|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828782|NCT02181205|Bupivacaine|bupivacaine|mesh-list
44828783|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
44828784|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
44828785|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44828786|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828787|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
44828788|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828789|NCT02181218|Gemcitabine|gemcitabine|mesh-list
44828790|NCT02181218|Dexamethasone|dexamethasone|mesh-list
44828791|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
44828792|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
44828793|NCT02181218|Romidepsin|romidepsin|mesh-list
44828794|NCT02181218|BB 1101|bb 1101|mesh-list
44828795|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828796|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
44828797|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
44828798|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828799|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828800|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44828801|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
44828802|NCT02181218|Hormones|hormones|mesh-ancestor
44828803|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828804|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44828805|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828806|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828807|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828808|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828809|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44828810|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
44828811|NCT02181218|Antiviral Agents|antiviral agents|mesh-ancestor
44315267|NCT00912639|Paclitaxel|paclitaxel|mesh-list
44828812|NCT02181218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828813|NCT02181218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828814|NCT02181218|Immunologic Factors|immunologic factors|mesh-ancestor
44828815|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44828816|NCT02181309|Meloxicam|meloxicam|mesh-list
44828817|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828818|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828819|NCT02181309|Analgesics|analgesics|mesh-ancestor
44828820|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
44828821|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828822|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828823|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828824|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828825|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44828826|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828827|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828828|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828829|NCT02181322|Meloxicam|meloxicam|mesh-list
44828830|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828831|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828832|NCT02181322|Analgesics|analgesics|mesh-ancestor
44828833|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
44828834|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828835|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828836|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828837|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828838|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44828839|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828840|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611120|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
44611126|NCT00667446|Leuprolide|leuprolide|mesh-list
44828841|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828842|NCT02181335|Budesonide|budesonide|mesh-list
44828843|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828844|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44828845|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
44828846|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828847|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828848|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44828849|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
44828850|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
44828851|NCT02181335|Hormones|hormones|mesh-ancestor
44828852|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828853|NCT02181348|Vitamin E|vitamin e|mesh-list
44828854|NCT02181348|Vitamins|vitamins|mesh-ancestor
44828855|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
44828856|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828857|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
44828858|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828859|NCT02181348|Protective Agents|protective agents|mesh-ancestor
44828860|NCT02181361|Aspirin|aspirin|mesh-list
44828861|NCT02181361|Hirudins|hirudins|mesh-list
44828862|NCT02181361|Warfarin|warfarin|mesh-list
44828863|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828864|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828865|NCT02181361|Analgesics|analgesics|mesh-ancestor
44828866|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
44828867|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828868|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828869|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828870|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828871|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44828872|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828873|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828874|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44828875|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828876|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828877|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
44828878|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
44828879|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
44828880|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44828881|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
44828882|NCT02181478|Cyclosporine|cyclosporine|mesh-list
44828883|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
44828884|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
44828885|NCT02181478|Fludarabine|fludarabine|mesh-list
44828886|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
44828887|NCT02181478|Cyclosporins|cyclosporins|mesh-list
44828888|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44828889|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
44828890|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828891|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828892|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44828893|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
44828894|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828895|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44828896|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44828897|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44828898|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
44828899|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828900|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
44828901|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828902|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44828903|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44828904|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44828905|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44828906|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
44828907|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44828908|NCT02181543|Clonidine|clonidine|mesh-list
44828909|NCT02181543|Analgesics|analgesics|mesh-ancestor
44828910|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
44828911|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828912|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828913|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44828914|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
44828915|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
44828916|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44828917|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44828918|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44828919|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
44828920|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44828921|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828922|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
44828923|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44828924|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828925|NCT02181920|Dipyrone|dipyrone|mesh-list
44828926|NCT02181920|Diclofenac|diclofenac|mesh-list
44828927|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44828928|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44828929|NCT02181920|Analgesics|analgesics|mesh-ancestor
44828930|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
44828931|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44828932|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828933|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44828934|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44828935|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44828936|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828937|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828938|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
44828939|NCT02181933|Lamivudine|lamivudine|mesh-list
44828940|NCT02181933|Zidovudine|zidovudine|mesh-list
44828941|NCT02181933|Nevirapine|nevirapine|mesh-list
44828942|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44828943|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44828944|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828945|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828946|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
44828947|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828948|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44828949|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44828950|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
44828951|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44828952|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44828953|NCT02181946|Fluconazole|fluconazole|mesh-list
44828954|NCT02181946|Nevirapine|nevirapine|mesh-list
44828955|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
44828956|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44828957|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44828958|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44828959|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44828960|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828961|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44828962|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
44828963|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44828964|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44828965|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44828966|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44828967|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44828968|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44828969|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
44828970|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44828971|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44828972|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44828973|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44828974|NCT02181985|Heparin|heparin|mesh-list
44828975|NCT02181985|Enoxaparin|enoxaparin|mesh-list
44828976|NCT02181985|Tenecteplase|tenecteplase|mesh-list
44828977|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44828978|NCT02181985|Abciximab|abciximab|mesh-list
44828979|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
44828980|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44828981|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828982|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828983|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44828984|NCT02181998|Heparin|heparin|mesh-list
44828985|NCT02181998|Enoxaparin|enoxaparin|mesh-list
44828986|NCT02181998|Tenecteplase|tenecteplase|mesh-list
44828987|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
44828988|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44695952|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44695953|NCT01389063|Maraviroc|maraviroc|mesh-list
44828989|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828990|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828991|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44828992|NCT02182011|Tenecteplase|tenecteplase|mesh-list
44828993|NCT02182011|Streptokinase|streptokinase|mesh-list
44828994|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44828995|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44828996|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44828997|NCT02182024|Dabigatran|dabigatran|mesh-list
44828998|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
44828999|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44829000|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829001|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829002|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829003|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
44829004|NCT02182050|Nintedanib|nintedanib|mesh-list
44829005|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829006|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829007|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829008|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829009|NCT02182063|Nintedanib|nintedanib|mesh-list
44829010|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829011|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829012|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829013|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829014|NCT02182076|Nintedanib|nintedanib|mesh-list
44829015|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829016|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829017|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829018|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695954|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44695955|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44695956|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695957|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44695958|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44695959|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
44695960|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44695961|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44695962|NCT01389167|Naltrexone|naltrexone|mesh-list
44695963|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44695964|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44695965|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695966|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
44695967|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695968|NCT01389193|Ibudilast|ibudilast|mesh-list
44695969|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44695970|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
44695971|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44695972|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44695973|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44695974|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44695975|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44695976|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44695977|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695978|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695979|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695980|NCT01389206|Bosentan|bosentan|mesh-list
44695981|NCT01389206|Selexipag|selexipag|mesh-list
44695982|NCT01389206|Iloprost|iloprost|mesh-list
44695983|NCT01389206|Macitentan|macitentan|mesh-list
44695984|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695985|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695986|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44695987|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44695988|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695989|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44695990|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44695991|NCT01389271|Iloprost|iloprost|mesh-list
44829019|NCT02182102|Pemetrexed|pemetrexed|mesh-list
44829020|NCT02182102|Nintedanib|nintedanib|mesh-list
44829021|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829022|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829023|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829024|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44829025|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44829026|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829027|NCT02182128|Nintedanib|nintedanib|mesh-list
44829028|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829029|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829030|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829031|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829032|NCT02182141|Nintedanib|nintedanib|mesh-list
44829033|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829034|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829035|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829036|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829037|NCT02182154|Nintedanib|nintedanib|mesh-list
44829038|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829039|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829040|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829041|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829042|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
44829043|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44829044|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
44829045|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829046|NCT02182167|Expectorants|expectorants|mesh-ancestor
44829047|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829048|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44829049|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
44829050|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829051|NCT02182167|Protective Agents|protective agents|mesh-ancestor
44829052|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829053|NCT02182167|Antidotes|antidotes|mesh-ancestor
44829054|NCT02182193|Nintedanib|nintedanib|mesh-list
44829055|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829056|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829057|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829058|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829059|NCT02182206|Nintedanib|nintedanib|mesh-list
44829060|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829061|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829062|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829063|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829064|NCT02182219|Nintedanib|nintedanib|mesh-list
44829065|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829066|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829067|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829068|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829069|NCT02182232|Paclitaxel|paclitaxel|mesh-list
44829070|NCT02182232|Carboplatin|carboplatin|mesh-list
44829071|NCT02182232|Nintedanib|nintedanib|mesh-list
44829072|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44829073|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611379|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
44611380|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
44611381|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44611382|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
44611383|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611384|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611385|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611386|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
44611387|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
44611388|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44611389|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44611390|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611391|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611392|NCT00666198|Urological Agents|urological agents|mesh-ancestor
44611393|NCT00665847|Etravirine|etravirine|mesh-list
44611394|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44611395|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44611396|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611397|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829074|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44829075|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44829076|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44829077|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829078|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829079|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829080|NCT02182245|Paclitaxel|paclitaxel|mesh-list
44829081|NCT02182245|Carboplatin|carboplatin|mesh-list
44829082|NCT02182245|Nintedanib|nintedanib|mesh-list
44829083|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44829084|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829085|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
44829086|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
44829087|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
44829088|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829089|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829090|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829091|NCT02182258|Nintedanib|nintedanib|mesh-list
44829092|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829093|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44829094|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829095|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829096|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
44315605|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
44829097|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44829098|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829099|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44829100|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44829101|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829102|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829103|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829104|NCT02182336|Vitamin K|vitamin k|mesh-list
44829105|NCT02182336|Digoxin|digoxin|mesh-list
44829106|NCT02182336|Midazolam|midazolam|mesh-list
44829107|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
44829108|NCT02182336|Caffeine|caffeine|mesh-list
44829109|NCT02182336|Omeprazole|omeprazole|mesh-list
44829110|NCT02182336|Warfarin|warfarin|mesh-list
44829111|NCT02182336|Vitamins|vitamins|mesh-ancestor
44829112|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
44829113|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829114|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44829115|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44829116|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315634|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829117|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44829118|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44829119|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44829120|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44829121|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
44829122|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
44829123|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
44829124|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
44829125|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829126|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829127|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
44829128|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44829129|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44829130|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44829131|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829132|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44829133|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44829134|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44829135|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44829136|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
44829137|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44829138|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44829139|NCT02182336|Protective Agents|protective agents|mesh-ancestor
44829140|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44829141|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44829142|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
44829143|NCT02182336|Coagulants|coagulants|mesh-ancestor
44829144|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
44829145|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829146|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44829147|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44829148|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
44829149|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44829150|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44829151|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
44829152|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829153|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44829154|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44829155|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829156|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829157|NCT02182401|Tolbutamide|tolbutamide|mesh-list
44829158|NCT02182401|Midazolam|midazolam|mesh-list
44829159|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44829160|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44315667|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315668|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829161|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44829162|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829163|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44829164|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44829165|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44829166|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44829167|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
44829168|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
44829169|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
44829170|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
44829171|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829172|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829173|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829174|NCT02182453|Empagliflozin|empagliflozin|mesh-list
44829175|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44829176|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829177|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829178|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829179|NCT02182479|Fenoterol|fenoterol|mesh-list
44829180|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44829181|NCT02182479|Ipratropium|ipratropium|mesh-list
44829182|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829183|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
44829184|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829185|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829186|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829187|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829188|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
44829189|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829190|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829191|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44829192|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44829193|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44829194|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829195|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829196|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829197|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44829198|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
44829199|NCT02182505|Fenoterol|fenoterol|mesh-list
44829200|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44829201|NCT02182505|Ipratropium|ipratropium|mesh-list
44829202|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829203|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
44829204|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829205|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829206|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829207|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829208|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
44829209|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829210|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829211|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44829212|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44829213|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44829214|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829215|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829216|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829217|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44829218|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
44829219|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
44829220|NCT02182518|Ephedrine|ephedrine|mesh-list
44829221|NCT02182518|Epinastine|epinastine|mesh-list
44829222|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829223|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
44829224|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829225|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829226|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829227|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829228|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
44829229|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44829230|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44829231|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
44829232|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829233|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829234|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829235|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44829236|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
44829237|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
44829238|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
44829239|NCT02182531|Ephedrine|ephedrine|mesh-list
44829240|NCT02182531|Epinastine|epinastine|mesh-list
44829241|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829242|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
44829243|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829244|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829245|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829246|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829247|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
44829248|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44829249|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44829250|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
44829251|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829252|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829253|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829254|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44829255|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
44829256|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
44829257|NCT02182544|Ketotifen|ketotifen|mesh-list
44829258|NCT02182544|Epinastine|epinastine|mesh-list
44829259|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
44829260|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
44829261|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44829262|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
44829263|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
44829264|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829265|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829266|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829267|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44829268|NCT02182557|Ketotifen|ketotifen|mesh-list
44829269|NCT02182557|Epinastine|epinastine|mesh-list
44829270|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
44829271|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44829272|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44829273|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
44829274|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
44829275|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829276|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829277|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829278|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44829279|NCT02182570|Epinastine|epinastine|mesh-list
44829280|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44315772|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
44829281|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
44829282|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
44829283|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829284|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829285|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829286|NCT02182583|Oxitropium|oxitropium|mesh-list
44829287|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
44829288|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
44829289|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829290|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829291|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
44829292|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44829293|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829294|NCT02182622|Prednisone|prednisone|mesh-list
44829295|NCT02182622|Docetaxel|docetaxel|mesh-list
44829296|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829297|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315797|NCT00914576|Vitamins|vitamins|mesh-list
44829298|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44829299|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611553|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
44829300|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829301|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829302|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
44829304|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829305|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829306|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44829307|NCT02182635|Oxitropium|oxitropium|mesh-list
44829308|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
44829309|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
44829310|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829311|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829312|NCT02182648|Propofol|propofol|mesh-list
44829313|NCT02182648|Etomidate|etomidate|mesh-list
44829314|NCT02182648|Sevoflurane|sevoflurane|mesh-list
44829315|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44829316|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44829317|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829318|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44829319|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
44829320|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
44829321|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44829322|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44829323|NCT02182661|Oxitropium|oxitropium|mesh-list
44829324|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
44829325|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
44829326|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829327|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829328|NCT02182700|Bromides|bromides|mesh-list
44829329|NCT02182700|Albuterol|albuterol|mesh-list
44829330|NCT02182700|Ipratropium|ipratropium|mesh-list
44829331|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
44829332|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829333|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
44829334|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829335|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829336|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829337|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829338|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829339|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829340|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44829341|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44829342|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44829343|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829344|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829345|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829346|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44829347|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
44829348|NCT02182713|Bromides|bromides|mesh-list
44829349|NCT02182713|Albuterol|albuterol|mesh-list
44829350|NCT02182713|Ipratropium|ipratropium|mesh-list
44829351|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
44829352|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829353|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
44829354|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829355|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829356|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315846|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44829357|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829358|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829359|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829360|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44829361|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44829362|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44829363|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829364|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829365|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829366|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44829367|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
44829368|NCT02182739|Meloxicam|meloxicam|mesh-list
44829369|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829370|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829371|NCT02182739|Analgesics|analgesics|mesh-ancestor
44829372|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
44829373|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829374|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829375|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611623|NCT00662909|Urological Agents|urological agents|mesh-ancestor
44829376|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829377|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829378|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829379|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829380|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829381|NCT02182752|Tramadol|tramadol|mesh-list
44829382|NCT02182752|Ropivacaine|ropivacaine|mesh-list
44829383|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
44829384|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
44829385|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44829386|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829387|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
44829388|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829389|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44829390|NCT02182752|Narcotics|narcotics|mesh-ancestor
44829391|NCT02182752|Analgesics|analgesics|mesh-ancestor
44829392|NCT02182765|Nevirapine|nevirapine|mesh-list
44829393|NCT02182765|Abacavir|abacavir|mesh-list
44829394|NCT02182765|Amprenavir|amprenavir|mesh-list
44829395|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44829396|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44829397|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829398|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829399|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
44829400|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829401|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44829402|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44829403|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44829404|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44829405|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44829406|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
44829407|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44829408|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44829409|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44829410|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829411|NCT02182778|Gemcitabine|gemcitabine|mesh-list
44829412|NCT02182778|Cisplatin|cisplatin|mesh-list
44829413|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829414|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44829415|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
44829416|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829417|NCT02182778|Antiviral Agents|antiviral agents|mesh-ancestor
44829418|NCT02182778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829419|NCT02182778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829420|NCT02182778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44829421|NCT02182778|Immunologic Factors|immunologic factors|mesh-ancestor
44829422|NCT02182778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829423|NCT02182791|Nevirapine|nevirapine|mesh-list
44829424|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44829425|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44829426|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829427|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829428|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
44829429|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829430|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44829431|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44829432|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44829433|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44829434|NCT02182856|Bromides|bromides|mesh-list
44829435|NCT02182856|Albuterol|albuterol|mesh-list
44829436|NCT02182856|Ipratropium|ipratropium|mesh-list
44829437|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
44829438|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44829439|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
44829440|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829441|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829442|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44829443|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829444|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829445|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829446|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44829447|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44829448|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44829449|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
44829450|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829451|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829452|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44611700|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
44829453|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
44829454|NCT02182960|Ibuprofen|ibuprofen|mesh-list
44829455|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829456|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829457|NCT02182960|Analgesics|analgesics|mesh-ancestor
44829458|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
44829459|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829460|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829461|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829462|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829463|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829464|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829465|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829466|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44829467|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
44829468|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829469|NCT02183012|Ibuprofen|ibuprofen|mesh-list
44829470|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829471|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829472|NCT02183012|Analgesics|analgesics|mesh-ancestor
44829473|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
44829474|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829475|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829476|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829477|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829478|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829479|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829480|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829481|NCT02183025|Meloxicam|meloxicam|mesh-list
44829482|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
44829483|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829484|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829485|NCT02183025|Analgesics|analgesics|mesh-ancestor
44315972|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44829486|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
44829487|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829488|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829489|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829490|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829491|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829492|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829493|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829494|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829495|NCT02183038|Naproxen|naproxen|mesh-list
44829496|NCT02183038|Meloxicam|meloxicam|mesh-list
44829497|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829498|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829499|NCT02183038|Analgesics|analgesics|mesh-ancestor
44829500|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
44829501|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829502|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829503|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829504|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829505|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
44829506|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829507|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316002|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44829508|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829509|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829510|NCT02183051|Ibuprofen|ibuprofen|mesh-list
44829511|NCT02183051|Meloxicam|meloxicam|mesh-list
44829512|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829513|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829514|NCT02183051|Analgesics|analgesics|mesh-ancestor
44829515|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
44829516|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829517|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829518|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829519|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829520|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829521|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829522|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829523|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829524|NCT02183064|Meloxicam|meloxicam|mesh-list
44829525|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829526|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829527|NCT02183064|Analgesics|analgesics|mesh-ancestor
44829528|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
44829529|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829530|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829531|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829532|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829533|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829534|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829535|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829536|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829537|NCT02183077|Meloxicam|meloxicam|mesh-list
44829538|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829539|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829540|NCT02183077|Analgesics|analgesics|mesh-ancestor
44829541|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
44829542|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829543|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829544|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829545|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829546|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829547|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829548|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829549|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829550|NCT02183090|Meloxicam|meloxicam|mesh-list
44829551|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829552|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829553|NCT02183090|Analgesics|analgesics|mesh-ancestor
44829554|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
44829555|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829556|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829557|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829558|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829559|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829560|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829561|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829562|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829563|NCT02183103|Meloxicam|meloxicam|mesh-list
44829564|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829565|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829566|NCT02183103|Analgesics|analgesics|mesh-ancestor
44829567|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
44829568|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829569|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829570|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829571|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829572|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829573|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829574|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829575|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829576|NCT02183116|Meloxicam|meloxicam|mesh-list
44829577|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829578|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829579|NCT02183116|Analgesics|analgesics|mesh-ancestor
44829580|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
44829581|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829582|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829583|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829584|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829585|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829586|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829587|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829588|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829589|NCT02183129|Diclofenac|diclofenac|mesh-list
44829590|NCT02183129|Meloxicam|meloxicam|mesh-list
44829591|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829592|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829593|NCT02183129|Analgesics|analgesics|mesh-ancestor
44829594|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
44829595|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829596|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829597|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829598|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829599|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829600|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829601|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829602|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829603|NCT02183142|Meloxicam|meloxicam|mesh-list
44829604|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829605|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829606|NCT02183142|Analgesics|analgesics|mesh-ancestor
44829607|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
44829608|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829609|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829610|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829611|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829612|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829613|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829614|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829615|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829616|NCT02183155|Indomethacin|indomethacin|mesh-list
44829617|NCT02183155|Meloxicam|meloxicam|mesh-list
44829618|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829619|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829620|NCT02183155|Analgesics|analgesics|mesh-ancestor
44829621|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
44829622|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829623|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829624|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829625|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829626|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
44829627|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829628|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44829629|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829630|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829631|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829632|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829633|NCT02183168|Indomethacin|indomethacin|mesh-list
44829634|NCT02183168|Meloxicam|meloxicam|mesh-list
44829635|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829636|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829637|NCT02183168|Analgesics|analgesics|mesh-ancestor
44829638|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
44829639|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829640|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829641|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829642|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829643|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
44829644|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
44829645|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316136|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44829646|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829647|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829648|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829649|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829650|NCT02183181|Meloxicam|meloxicam|mesh-list
44829651|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829652|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829653|NCT02183181|Analgesics|analgesics|mesh-ancestor
44829654|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
44829655|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829656|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829657|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829658|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829659|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44829660|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829661|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829662|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829663|NCT02183194|Paclitaxel|paclitaxel|mesh-list
44829664|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44829665|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829666|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44829667|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44829668|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44829669|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829670|NCT02183220|Aspirin|aspirin|mesh-list
44829671|NCT02183220|Dipyrone|dipyrone|mesh-list
44829672|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44829673|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829674|NCT02183220|Analgesics|analgesics|mesh-ancestor
44829675|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
44829676|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829677|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829678|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44829679|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44829680|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44829681|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44829682|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829683|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44829684|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44829685|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829686|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
44829687|NCT02183246|Porfiromycin|porfiromycin|mesh-list
44829688|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44829689|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829691|NCT02183272|Analgesics|analgesics|mesh-ancestor
44829692|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
44829693|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829694|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829695|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44829696|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44829697|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
44829698|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
44829699|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44829700|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44829701|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44829702|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466977|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
44829703|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829704|NCT02183298|Linagliptin|linagliptin|mesh-list
44829705|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829706|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829707|NCT02183298|Incretins|incretins|mesh-ancestor
44829708|NCT02183298|Hormones|hormones|mesh-ancestor
44829709|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829710|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829711|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829712|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829713|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829714|NCT02183311|Linagliptin|linagliptin|mesh-list
44829715|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829716|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829717|NCT02183311|Incretins|incretins|mesh-ancestor
44829718|NCT02183311|Hormones|hormones|mesh-ancestor
44829719|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829720|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829721|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829722|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829723|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829724|NCT02183324|Linagliptin|linagliptin|mesh-list
44829725|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829726|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829727|NCT02183324|Incretins|incretins|mesh-ancestor
44829728|NCT02183324|Hormones|hormones|mesh-ancestor
44829729|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829730|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829731|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829732|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829733|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829734|NCT02183337|Pioglitazone|pioglitazone|mesh-list
44829735|NCT02183337|Linagliptin|linagliptin|mesh-list
44829736|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829737|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829738|NCT02183337|Incretins|incretins|mesh-ancestor
44829739|NCT02183337|Hormones|hormones|mesh-ancestor
44829740|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829741|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829742|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829743|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829744|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829745|NCT02183350|Linagliptin|linagliptin|mesh-list
44829746|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829752|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829753|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829754|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829755|NCT02183363|Linagliptin|linagliptin|mesh-list
44829756|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829757|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829758|NCT02183363|Incretins|incretins|mesh-ancestor
44829759|NCT02183363|Hormones|hormones|mesh-ancestor
44829760|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829761|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829762|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829763|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829764|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829765|NCT02183376|Linagliptin|linagliptin|mesh-list
44829766|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829767|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829768|NCT02183376|Incretins|incretins|mesh-ancestor
44829769|NCT02183376|Hormones|hormones|mesh-ancestor
44829770|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829771|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829772|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829773|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829774|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829775|NCT02183389|Linagliptin|linagliptin|mesh-list
44829776|NCT02183389|Warfarin|warfarin|mesh-list
44829777|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
44829778|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829779|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829780|NCT02183389|Incretins|incretins|mesh-ancestor
44829781|NCT02183389|Hormones|hormones|mesh-ancestor
44829782|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316214|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44829783|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829784|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829785|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829786|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829787|NCT02183402|Linagliptin|linagliptin|mesh-list
44829788|NCT02183402|Digoxin|digoxin|mesh-list
44829789|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44829790|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44829791|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829792|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829793|NCT02183402|Protective Agents|protective agents|mesh-ancestor
44829794|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829795|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829796|NCT02183402|Incretins|incretins|mesh-ancestor
44829797|NCT02183402|Hormones|hormones|mesh-ancestor
44829798|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829799|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829800|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829801|NCT02183415|Linagliptin|linagliptin|mesh-list
44829802|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829803|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612072|NCT00659269|Hematinics|hematinics|mesh-ancestor
44612073|NCT00659230|Dopamine|dopamine|mesh-list
44612074|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44612075|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
44612076|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
44612077|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612078|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612079|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
44612080|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612081|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612082|NCT00659230|Protective Agents|protective agents|mesh-ancestor
44829804|NCT02183415|Incretins|incretins|mesh-ancestor
44829806|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829807|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829808|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829809|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829810|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829811|NCT02183428|Glyburide|glyburide|mesh-list
44829812|NCT02183428|Linagliptin|linagliptin|mesh-list
44829813|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829814|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829815|NCT02183428|Incretins|incretins|mesh-ancestor
44829816|NCT02183428|Hormones|hormones|mesh-ancestor
44829817|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829818|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829819|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829820|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829821|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829822|NCT02183441|Linagliptin|linagliptin|mesh-list
44829823|NCT02183441|Ritonavir|ritonavir|mesh-list
44829824|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44829825|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44829826|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829827|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829828|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44695992|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44695993|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
44695994|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44695995|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44695996|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44695997|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
44695998|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316288|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
44695999|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44696000|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44696001|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696002|NCT01389401|Omeprazole|omeprazole|mesh-list
44696003|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44696004|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696005|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44696006|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696007|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696008|NCT01389414|Gemcitabine|gemcitabine|mesh-list
44696009|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
44696010|NCT01389414|Panitumumab|panitumumab|mesh-list
44696011|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696012|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
44696013|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696014|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696015|NCT01389414|Antiviral Agents|antiviral agents|mesh-ancestor
44696016|NCT01389414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696017|NCT01389414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696018|NCT01389414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696019|NCT01389414|Immunologic Factors|immunologic factors|mesh-ancestor
44696020|NCT01389414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696021|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696022|NCT01389427|Sirolimus|sirolimus|mesh-list
44696023|NCT01389427|Prednisone|prednisone|mesh-list
44696024|NCT01389427|Doxorubicin|doxorubicin|mesh-list
44696025|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
44696026|NCT01389427|Vincristine|vincristine|mesh-list
44696027|NCT01389427|Rituximab|rituximab|mesh-list
44696028|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44696029|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696030|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44696031|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696032|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
44696033|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696034|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
44696035|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696036|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44696037|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44696038|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
44696039|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696040|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612093|NCT00658788|Calcitriol|calcitriol|mesh-list
44829829|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44829830|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44829831|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
44829832|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829833|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44829834|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44316335|NCT00917241|Methimazole|methimazole|mesh-list
44829835|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829836|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829837|NCT02183441|Incretins|incretins|mesh-ancestor
44829838|NCT02183441|Hormones|hormones|mesh-ancestor
44829839|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829840|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829841|NCT02183467|Linagliptin|linagliptin|mesh-list
44829842|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
44829843|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44829844|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829845|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44829846|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44829847|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829848|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829849|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44829850|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829851|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829852|NCT02183467|Incretins|incretins|mesh-ancestor
44829853|NCT02183467|Hormones|hormones|mesh-ancestor
44829854|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829855|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829856|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829857|NCT02183480|Linagliptin|linagliptin|mesh-list
44829858|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829859|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829860|NCT02183480|Incretins|incretins|mesh-ancestor
44829861|NCT02183480|Hormones|hormones|mesh-ancestor
44829862|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829863|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829864|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829865|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829866|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829867|NCT02183493|Linagliptin|linagliptin|mesh-list
44829868|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829869|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829870|NCT02183493|Incretins|incretins|mesh-ancestor
44829871|NCT02183493|Hormones|hormones|mesh-ancestor
44829872|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829873|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829874|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829875|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829876|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829877|NCT02183506|Metformin|metformin|mesh-list
44829878|NCT02183506|Linagliptin|linagliptin|mesh-list
44829879|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829880|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829881|NCT02183506|Incretins|incretins|mesh-ancestor
44829882|NCT02183506|Hormones|hormones|mesh-ancestor
44829883|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829884|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829885|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829886|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829887|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829888|NCT02183532|Linagliptin|linagliptin|mesh-list
44829889|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829890|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829891|NCT02183532|Incretins|incretins|mesh-ancestor
44829892|NCT02183532|Hormones|hormones|mesh-ancestor
44829893|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829894|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829895|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829896|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829897|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829898|NCT02183571|Metformin|metformin|mesh-list
44829899|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829900|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829901|NCT02183584|Linagliptin|linagliptin|mesh-list
44829902|NCT02183584|Rifampin|rifampin|mesh-list
44829903|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829904|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829905|NCT02183584|Incretins|incretins|mesh-ancestor
44829906|NCT02183584|Hormones|hormones|mesh-ancestor
44829907|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829908|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829909|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467000|NCT01455220|Natalizumab|natalizumab|mesh-list
44829910|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829911|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829912|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44829913|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
44829914|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44829915|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829916|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
44829917|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44829918|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44829919|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44829920|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44829921|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44829922|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44829923|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44829924|NCT02183610|Linagliptin|linagliptin|mesh-list
44829925|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44829926|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829927|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829928|NCT02183610|Incretins|incretins|mesh-ancestor
44829929|NCT02183610|Hormones|hormones|mesh-ancestor
44829930|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829931|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829932|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829933|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829934|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829935|NCT02183623|Linagliptin|linagliptin|mesh-list
44829936|NCT02183623|Simvastatin|simvastatin|mesh-list
44829937|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44829938|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44829939|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
44829940|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829941|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44829942|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44829943|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829944|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829945|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829946|NCT02183623|Incretins|incretins|mesh-ancestor
44829947|NCT02183623|Hormones|hormones|mesh-ancestor
44829948|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829949|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829950|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829951|NCT02183636|Pioglitazone|pioglitazone|mesh-list
44829952|NCT02183636|Linagliptin|linagliptin|mesh-list
44829953|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44829954|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829955|NCT02183636|Incretins|incretins|mesh-ancestor
44829956|NCT02183636|Hormones|hormones|mesh-ancestor
44829957|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44829958|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44829959|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
44829960|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829961|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829962|NCT02183649|Carbetapentane|carbetapentane|mesh-list
44829963|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
44829964|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
44829965|NCT02183688|Acetaminophen|acetaminophen|mesh-list
44829966|NCT02183688|Caffeine|caffeine|mesh-list
44829967|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44829968|NCT02183688|Analgesics|analgesics|mesh-ancestor
44829969|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
44829970|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44829971|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829972|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
44829973|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44829974|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44829975|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44829976|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829977|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44829978|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44829979|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
44829980|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44829981|NCT02183701|Losartan|losartan|mesh-list
44829982|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44829983|NCT02183701|Telmisartan|telmisartan|mesh-list
44316426|NCT00917878|Calcium|calcium|mesh-list
44829984|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44829985|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44829986|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44829987|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44829988|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44829989|NCT02183701|Diuretics|diuretics|mesh-ancestor
44829990|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
44829991|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44829992|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44829993|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44829994|NCT02183779|Fluconazole|fluconazole|mesh-list
44829995|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
44829996|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44829997|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44829998|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44829999|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830000|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830001|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44830002|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
44830003|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830004|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830005|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44830006|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44830007|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
44830008|NCT02183805|Carboplatin|carboplatin|mesh-list
44830009|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44830010|NCT02183805|Paclitaxel|paclitaxel|mesh-list
44830011|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44830012|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
44830013|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830014|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830015|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44830016|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
44316454|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
44830017|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830018|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830019|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44830020|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44830021|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
44830022|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
44830023|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
44830024|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44830025|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830026|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830027|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
44830028|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830029|NCT02183948|Oxytocin|oxytocin|mesh-list
44830030|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
44830031|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44830032|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830033|NCT02184052|Meloxicam|meloxicam|mesh-list
44830034|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830035|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830036|NCT02184052|Analgesics|analgesics|mesh-ancestor
44830037|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
44830038|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830039|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830040|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830041|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830042|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44612270|NCT00656851|Pioglitazone|pioglitazone|mesh-list
44830043|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830044|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830045|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830046|NCT02184065|Meloxicam|meloxicam|mesh-list
44830047|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830048|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830049|NCT02184065|Analgesics|analgesics|mesh-ancestor
44830050|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
44830051|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830052|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830053|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830054|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830055|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44830056|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830057|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830058|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830059|NCT02184078|Nevirapine|nevirapine|mesh-list
44830060|NCT02184078|Rifabutin|rifabutin|mesh-list
44830061|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830062|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830063|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830064|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830065|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
44830066|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830067|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830068|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830069|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44830070|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44830071|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830072|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44830073|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
44830074|NCT02184091|Nevirapine|nevirapine|mesh-list
44830075|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830076|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830077|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830078|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830079|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
44830080|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830081|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830082|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830083|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44830084|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44830085|NCT02184104|Caffeine|caffeine|mesh-list
44830086|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44830087|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830088|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44830089|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830090|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830091|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44830092|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44830093|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
44830094|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830095|NCT02184117|Adenosine|adenosine|mesh-list
44830096|NCT02184117|Analgesics|analgesics|mesh-ancestor
44830097|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
44830098|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316532|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
44830099|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830100|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44830101|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
44830102|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44830103|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
44830104|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
44830105|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830106|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830107|NCT02184247|Theophylline|theophylline|mesh-list
44830108|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44830109|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
44830110|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830111|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830112|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44830113|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
44830114|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44830115|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830116|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830117|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
44830118|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44830119|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44830120|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
44830121|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830122|NCT02184260|Dipyrone|dipyrone|mesh-list
44830123|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830124|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830125|NCT02184260|Analgesics|analgesics|mesh-ancestor
44830126|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
44830127|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830128|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830129|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830130|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830131|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
44830132|NCT02184273|Dipyrone|dipyrone|mesh-list
44830133|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830134|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830135|NCT02184273|Analgesics|analgesics|mesh-ancestor
44830136|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
44830137|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830138|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830139|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830140|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830141|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
44830142|NCT02184286|Nevirapine|nevirapine|mesh-list
44830143|NCT02184286|Saquinavir|saquinavir|mesh-list
44830144|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830145|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830146|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830147|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830148|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
44830149|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830150|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830151|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830152|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44830153|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44830154|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44830155|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44830156|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
44830157|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44830158|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44830159|NCT02184299|Nevirapine|nevirapine|mesh-list
44830160|NCT02184299|Prednisone|prednisone|mesh-list
44830161|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830162|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
44830163|NCT02184299|Hormones|hormones|mesh-ancestor
44830164|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830165|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830166|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44830167|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830168|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830169|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830170|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830171|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830172|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
44830173|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830174|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830175|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830176|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44830177|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44830178|NCT02184312|Nevirapine|nevirapine|mesh-list
44830179|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830180|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830181|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830182|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830183|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
44830184|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830185|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830186|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830187|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44830188|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44830189|NCT02184351|Clotrimazole|clotrimazole|mesh-list
44830190|NCT02184351|Miconazole|miconazole|mesh-list
44830191|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44830192|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830193|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
44830194|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44830195|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44830196|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830197|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830198|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44830199|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
44830200|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830201|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830202|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44830203|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44830204|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44830205|NCT02184364|Estrogens|estrogens|mesh-ancestor
44830206|NCT02184364|Hormones|hormones|mesh-ancestor
44830207|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830208|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830209|NCT02184429|PF-06669571|pf-06669571|mesh-list
44830210|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
44830211|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
44830212|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830213|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830214|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830215|NCT02184533|Selenious Acid|selenious acid|mesh-list
44830216|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
44830217|NCT02184533|Trace Elements|trace elements|mesh-ancestor
44830218|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
44830219|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830220|NCT02184559|Ropivacaine|ropivacaine|mesh-list
44830221|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
44830222|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
44830223|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830224|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830225|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
44830226|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830227|NCT02184637|Lumefantrine|lumefantrine|mesh-list
44830228|NCT02184637|Artemether|artemether|mesh-list
44830229|NCT02184637|Piperaquine|piperaquine|mesh-list
44830230|NCT02184637|Artenimol|artenimol|mesh-list
44830231|NCT02184637|Tafenoquine|tafenoquine|mesh-list
44830232|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44830233|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
44830234|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44830235|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44830236|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830237|NCT02184819|Riboflavin|riboflavin|mesh-list
44830238|NCT02184819|Simendan|simendan|mesh-list
44830239|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
44830240|NCT02184819|Vitamins|vitamins|mesh-ancestor
44830241|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
44830242|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830243|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44830244|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44830245|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44830246|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
44830247|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44830248|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44830249|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830250|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830251|NCT02184819|Protective Agents|protective agents|mesh-ancestor
44830252|NCT02184832|Metformin|metformin|mesh-list
44830253|NCT02184832|Tryptophan|tryptophan|mesh-list
44830254|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830255|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830256|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44830257|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
44830258|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44830259|NCT02184858|Lisinopril|lisinopril|mesh-list
44830260|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44830261|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
44830262|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830263|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830264|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830265|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44830266|NCT02184858|Protective Agents|protective agents|mesh-ancestor
44830267|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830268|NCT02184897|Lenograstim|lenograstim|mesh-list
44830269|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44830270|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
44830271|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830272|NCT02184910|Gastrins|gastrins|mesh-list
44830273|NCT02184910|Hormones|hormones|mesh-ancestor
44830274|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830275|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830276|NCT02184975|Hemostatics|hemostatics|mesh-list
44830277|NCT02184975|Coagulants|coagulants|mesh-ancestor
44830278|NCT02185066|Metformin|metformin|mesh-list
44830279|NCT02185066|Atorvastatin|atorvastatin|mesh-list
44830280|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830281|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830282|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44830283|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44830284|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
44830285|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830286|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44316735|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467062|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
44830287|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44830288|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830289|NCT02185118|Sevoflurane|sevoflurane|mesh-list
44830290|NCT02185118|Isoflurane|isoflurane|mesh-list
44830291|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44830292|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44830293|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
44830294|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
44830295|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830296|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830297|NCT02185196|Vitamin D|vitamin d|mesh-list
44830298|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
44830299|NCT02185196|Vitamins|vitamins|mesh-ancestor
44830300|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
44830301|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830302|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830303|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830304|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
44830305|NCT02185222|Vitamin D|vitamin d|mesh-list
44830306|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830307|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830308|NCT02185222|Vitamins|vitamins|mesh-ancestor
44830309|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
44830310|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830311|NCT02185261|Interferons|interferons|mesh-list
44830312|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
44830313|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
44830314|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830315|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
44830316|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830317|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
44830318|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830319|NCT02185300|Dolutegravir|dolutegravir|mesh-list
44830320|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44830321|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44830322|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830323|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830324|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830325|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830326|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
44830327|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830328|NCT02185326|Hormones|hormones|mesh-list
44830329|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830330|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830331|NCT02185352|Cisplatin|cisplatin|mesh-list
44830332|NCT02185352|Etoposide|etoposide|mesh-list
44830333|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830334|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44830335|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44830336|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44830337|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830338|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830339|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
44830340|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44830341|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830342|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830343|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830344|NCT02185430|Analgesics|analgesics|mesh-ancestor
44830345|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
44830346|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830347|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44830348|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44830349|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44830350|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
44830351|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830352|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830353|NCT02185456|Metronidazole|metronidazole|mesh-list
44830354|NCT02185456|Miconazole|miconazole|mesh-list
44830355|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830356|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830357|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44830358|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44830359|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
44612644|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612645|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44612646|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44612647|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612648|NCT00653939|Paclitaxel|paclitaxel|mesh-list
44612649|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
44612650|NCT00653939|Combretastatin|combretastatin|mesh-list
44612651|NCT00653939|Bevacizumab|bevacizumab|mesh-list
44612652|NCT00653939|Carboplatin|carboplatin|mesh-list
44612653|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612654|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612655|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612656|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612657|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612658|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612659|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612660|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44612661|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44612662|NCT00653939|Growth Substances|growth substances|mesh-ancestor
44612663|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612664|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44612665|NCT00653523|Simvastatin|simvastatin|mesh-list
44612666|NCT00653523|Ezetimibe|ezetimibe|mesh-list
44612667|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44612668|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44830361|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44830362|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830363|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830364|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44830365|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
44830366|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830367|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830368|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44830369|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44830370|NCT02185547|Sertraline|sertraline|mesh-list
44830371|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44830372|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44830373|NCT02185547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44830374|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44830375|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830376|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830377|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830378|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
44830379|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830380|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
44830381|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44830382|NCT02185651|Miglustat|miglustat|mesh-list
44830383|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830384|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830385|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830386|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830387|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
44830388|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830389|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44830390|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830391|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830392|NCT02185690|Carboplatin|carboplatin|mesh-list
44830393|NCT02185690|Pemetrexed|pemetrexed|mesh-list
44830394|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830395|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830396|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830397|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44830398|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830399|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
44830400|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
44830401|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
44830402|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830403|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830404|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
44830405|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830406|NCT02185768|Idarubicin|idarubicin|mesh-list
44830407|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44830408|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830409|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44830410|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44830411|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830412|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830413|NCT02185833|Dirithromycin|dirithromycin|mesh-list
44830414|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830415|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830416|NCT02185846|Dirithromycin|dirithromycin|mesh-list
44830417|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830418|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830419|NCT02185859|Lidocaine|lidocaine|mesh-list
44830420|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
44830421|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
44830422|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
44830423|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830424|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830425|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
44830426|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830427|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44830428|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44830429|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44830430|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612669|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
44830431|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830432|NCT02185859|Analgesics|analgesics|mesh-ancestor
44830433|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
44830434|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44830435|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830436|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
44830437|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44830438|NCT02185898|Menthol|menthol|mesh-list
44830439|NCT02185898|Nicotine|nicotine|mesh-list
44830440|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44830441|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
44830442|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830443|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830444|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43561856|NCT02471222|Amantadine|amantadine|mesh-list
44830445|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44830446|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
44830447|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830448|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830449|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
44830450|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
44830451|NCT02185924|Parecoxib|parecoxib|mesh-list
44830452|NCT02185924|Ropivacaine|ropivacaine|mesh-list
44830453|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
44830454|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
44830455|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830456|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830457|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
44830458|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830459|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44830460|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830461|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830462|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830463|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830464|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830465|NCT02185924|Analgesics|analgesics|mesh-ancestor
44830466|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830467|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830468|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44830469|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44830470|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44830471|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
44830472|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830473|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44830474|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44830475|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830476|NCT02186028|Vitamin D|vitamin d|mesh-list
44830477|NCT02186028|Vitamins|vitamins|mesh-ancestor
44830478|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
44316940|NCT00920283|Cobalt|cobalt|mesh-list
44830479|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830480|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830481|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
44830482|NCT02186106|Vitamin D|vitamin d|mesh-list
44830483|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830484|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830485|NCT02186106|Vitamins|vitamins|mesh-ancestor
44830486|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
44830487|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830488|NCT02186119|Ranibizumab|ranibizumab|mesh-list
44830489|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44830490|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44830491|NCT02186119|Growth Substances|growth substances|mesh-ancestor
44830492|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830493|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
44830494|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830495|NCT02186132|Atropine|atropine|mesh-list
44830496|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44830497|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44830498|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44830499|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
44830500|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830501|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830502|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44830503|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44830504|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
44830505|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
44830506|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44830507|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44830508|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
44830509|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830510|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830512|NCT02186145|Nystatin|nystatin|mesh-list
44830513|NCT02186145|Dexamethasone|dexamethasone|mesh-list
44830514|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830515|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
44830516|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
44830517|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830518|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830519|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44830520|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
44830521|NCT02186145|Hormones|hormones|mesh-ancestor
44830522|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830523|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44830524|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830525|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830526|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830527|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44830528|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44830529|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
44830530|NCT02186145|Ionophores|ionophores|mesh-ancestor
44830531|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830532|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830533|NCT02186158|Ascorbic Acid|ascorbic acid|mesh-list
44830534|NCT02186158|Vitamins|vitamins|mesh-ancestor
44830535|NCT02186158|Micronutrients|micronutrients|mesh-ancestor
44830536|NCT02186158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830537|NCT02186158|Antioxidants|antioxidants|mesh-ancestor
44830538|NCT02186158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830539|NCT02186158|Protective Agents|protective agents|mesh-ancestor
44830540|NCT02186249|Nivolumab|nivolumab|mesh-list
44830541|NCT02186249|Ipilimumab|ipilimumab|mesh-list
44830542|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44830543|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830544|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44830545|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830546|NCT02186275|Vitamin D|vitamin d|mesh-list
44830547|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
44830548|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
44830549|NCT02186275|Vitamins|vitamins|mesh-list
44830550|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
44830551|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830552|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830553|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830554|NCT02186366|Buspirone|buspirone|mesh-list
44830555|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44830556|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44830557|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830558|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830559|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44830560|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44830561|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
44830562|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830563|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830564|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44830565|NCT02186457|Polymyxins|polymyxins|mesh-list
44830566|NCT02186457|Polymyxin B|polymyxin b|mesh-list
44830567|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830568|NCT02186483|Metformin|metformin|mesh-list
44830569|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44830570|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830571|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830572|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44830573|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44830574|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
44830575|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830576|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44830577|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44830578|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830579|NCT02186496|Amlodipine|amlodipine|mesh-list
44830580|NCT02186496|Candesartan|candesartan|mesh-list
44830581|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830582|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44830583|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830584|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830585|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830586|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830587|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44830588|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830589|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830590|NCT02186535|Vitamin D|vitamin d|mesh-list
44830591|NCT02186535|Calcium|calcium|mesh-list
44830592|NCT02186535|Vitamins|vitamins|mesh-ancestor
44830593|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
44830594|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830595|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830596|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830597|NCT02186574|Tenofovir|tenofovir|mesh-list
44317062|NCT05674656|Dolutegravir|dolutegravir|mesh-list
44830598|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
44830599|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830600|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44830601|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44830602|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830603|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830604|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830605|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830606|NCT02186600|Vitamin D|vitamin d|mesh-list
44830607|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
44830608|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
44830609|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
44830610|NCT02186600|Calcium|calcium|mesh-list
44830611|NCT02186600|Vitamins|vitamins|mesh-ancestor
44830612|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
44830613|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830614|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44830615|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44830616|NCT02186600|Antacids|antacids|mesh-ancestor
44830617|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830618|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44830619|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44830620|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830621|NCT02186769|Risperidone|risperidone|mesh-list
44830622|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44830623|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
44830624|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830625|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830626|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830627|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44830628|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44830629|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830630|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44830631|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44830632|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
44830633|NCT02186782|Citric Acid|citric acid|mesh-list
44830634|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
44830635|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44830636|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44830637|NCT02186782|Clomiphene|clomiphene|mesh-list
44830638|NCT02186782|Enclomiphene|enclomiphene|mesh-list
44830639|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
44830640|NCT02186782|Estradiol|estradiol|mesh-list
44830641|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44830642|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
44830643|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44830644|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
44830645|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
44830646|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830647|NCT02186782|Estrogens|estrogens|mesh-ancestor
44830648|NCT02186782|Hormones|hormones|mesh-ancestor
44830649|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830650|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830651|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44830652|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
44830653|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44830654|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44830655|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44830656|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
44830657|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44830658|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
44830659|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44830660|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44830661|NCT02186886|Golimumab|golimumab|mesh-list
44830662|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44830663|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830664|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44830665|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
44830666|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830667|NCT02186899|Anesthetics|anesthetics|mesh-list
44830668|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830669|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696041|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696042|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
44696043|NCT01389427|Hormones|hormones|mesh-ancestor
44696044|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696045|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696046|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247606|NCT02007044|Rituximab|rituximab|mesh-list
44696071|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44696072|NCT01389505|Growth Substances|growth substances|mesh-ancestor
44612990|NCT00651118|Xhance|xhance|mesh-list
44830671|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
44830672|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
44830673|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830674|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830675|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830676|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830677|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44830678|NCT02186990|Propofol|propofol|mesh-list
44830679|NCT02186990|Etomidate|etomidate|mesh-list
44830680|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44830681|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830682|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830683|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44830684|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
44830685|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
44830686|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
44830687|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44830688|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830689|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830690|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830691|NCT02187068|Analgesics|analgesics|mesh-ancestor
44830692|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
44830693|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830694|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44830695|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44830696|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44830697|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
44830698|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830699|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830700|NCT02187081|Sorafenib|sorafenib|mesh-list
44830701|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830702|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44830703|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830704|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830705|NCT02187107|Darunavir|darunavir|mesh-list
44830706|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44830707|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44830708|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
44830709|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830710|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467132|NCT01453855|Travoprost|travoprost|mesh-list
44830711|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44830712|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44830713|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
44830714|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830715|NCT02187133|Rituximab|rituximab|mesh-list
44830716|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44830717|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44830718|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830719|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
44830720|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830721|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830722|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44830723|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
44830724|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830725|NCT02187211|Minocycline|minocycline|mesh-list
44830726|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830727|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830728|NCT02187250|Metformin|metformin|mesh-list
44830729|NCT02187250|Liraglutide|liraglutide|mesh-list
44830730|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830731|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830732|NCT02187250|Incretins|incretins|mesh-ancestor
44830733|NCT02187250|Hormones|hormones|mesh-ancestor
44830734|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830735|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44830736|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830737|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830738|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
44830739|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830740|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830741|NCT02187315|Cisplatin|cisplatin|mesh-list
44830742|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830743|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
44613038|NCT00649389|Amlodipine|amlodipine|mesh-list
44830744|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44830745|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
44830746|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830747|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830748|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44830749|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
44830750|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830751|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830752|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44830753|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44830754|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830755|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830756|NCT02187445|Budesonide|budesonide|mesh-list
44830757|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830758|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44830759|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
44830760|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830761|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830762|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44830763|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
44830764|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
44830765|NCT02187445|Hormones|hormones|mesh-ancestor
44830766|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830767|NCT02187484|Telmisartan|telmisartan|mesh-list
44830768|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830769|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830770|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830771|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830772|NCT02187497|Telmisartan|telmisartan|mesh-list
44830773|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830774|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830775|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830776|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830777|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44830778|NCT02187523|Telmisartan|telmisartan|mesh-list
44830779|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830780|NCT02187523|Diuretics|diuretics|mesh-ancestor
44830781|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
44830782|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830783|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44830784|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830785|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830786|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830787|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830788|NCT02187536|Telmisartan|telmisartan|mesh-list
44830789|NCT02187536|Simvastatin|simvastatin|mesh-list
44830790|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44830791|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44830792|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
44830793|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830794|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44830795|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44830796|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830797|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830798|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830799|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830800|NCT02187562|Aspirin|aspirin|mesh-list
44830801|NCT02187562|Meloxicam|meloxicam|mesh-list
44830802|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830803|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830804|NCT02187562|Analgesics|analgesics|mesh-ancestor
44830805|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
44830806|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830807|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830808|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830809|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830810|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44830811|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44830812|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830813|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44613120|NCT00647348|Simvastatin|simvastatin|mesh-list
44830814|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830816|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
44830817|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44830818|NCT02187588|Ibuprofen|ibuprofen|mesh-list
44830819|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830820|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830821|NCT02187588|Analgesics|analgesics|mesh-ancestor
44830822|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
44830823|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830824|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830825|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830826|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830827|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830828|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830829|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830830|NCT02187614|Acetaminophen|acetaminophen|mesh-list
44830831|NCT02187614|Diclofenac|diclofenac|mesh-list
44830832|NCT02187614|Morphine|morphine|mesh-list
44830833|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44830834|NCT02187614|Narcotics|narcotics|mesh-ancestor
44830835|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830836|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830837|NCT02187614|Analgesics|analgesics|mesh-ancestor
44830838|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
44830839|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830840|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44830841|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
44830842|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44830843|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830844|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830845|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44830846|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830847|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830848|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44830849|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44830850|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44830851|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830852|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830853|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
44830854|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830855|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830856|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44830857|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830858|NCT02187705|Telmisartan|telmisartan|mesh-list
44830859|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44830860|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44830861|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44830862|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830863|NCT02187718|Anesthetics|anesthetics|mesh-list
44830864|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830865|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830866|NCT02187822|Taxane|taxane|mesh-list
44830867|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830868|NCT02187874|Oxytocin|oxytocin|mesh-list
44830869|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
44830870|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44830871|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830872|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
44830873|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
44830874|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44830875|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830876|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44830877|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
44830878|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830879|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830880|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830881|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830882|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44830883|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44830884|NCT02187900|Protective Agents|protective agents|mesh-ancestor
44830885|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613189|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
44830886|NCT02188173|Dexamethasone|dexamethasone|mesh-list
44830887|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830888|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
44830889|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
44830890|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830891|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830892|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44830893|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
44830894|NCT02188173|Hormones|hormones|mesh-ancestor
44830895|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830896|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44830897|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830898|NCT02188186|Metformin|metformin|mesh-list
44830899|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44830900|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44830901|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830902|NCT02188186|Incretins|incretins|mesh-ancestor
44830903|NCT02188186|Hormones|hormones|mesh-ancestor
44830904|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830905|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44830906|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44830907|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830908|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830909|NCT02188225|Fluoxetine|fluoxetine|mesh-list
44830910|NCT02188225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44830911|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44830912|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830913|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830914|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830915|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
44830916|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830917|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44830918|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
44830919|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44830920|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44830921|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44830922|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830923|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
44317305|NCT05601531|Vitamins|vitamins|mesh-ancestor
44830924|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44830925|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44830926|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44830927|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44830928|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44830929|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830930|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
44830931|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44830932|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830933|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44830934|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830935|NCT02188368|Clarithromycin|clarithromycin|mesh-list
44830936|NCT02188368|Dexamethasone|dexamethasone|mesh-list
44830937|NCT02188368|Prednisone|prednisone|mesh-list
44830938|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
44830939|NCT02188368|Bortezomib|bortezomib|mesh-list
44830940|NCT02188368|Pomalidomide|pomalidomide|mesh-list
44830941|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44830942|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
44830943|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830944|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44830945|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44830946|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
44830947|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830948|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44830949|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44830950|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44830951|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
44830952|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
44830953|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317344|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
44830954|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44830955|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
44830956|NCT02188368|Hormones|hormones|mesh-ancestor
44830957|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44830958|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44830959|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830960|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44830961|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830962|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44830963|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44830964|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44830965|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44830966|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44830967|NCT02188368|Growth Substances|growth substances|mesh-ancestor
44830968|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
44830969|NCT02188394|Bupivacaine|bupivacaine|mesh-list
44830970|NCT02188394|Anesthetics|anesthetics|mesh-list
44830971|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
44830972|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830973|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830974|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
44830975|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44830976|NCT02188407|Propofol|propofol|mesh-list
44830977|NCT02188407|Sevoflurane|sevoflurane|mesh-list
44830978|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44830979|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44830980|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44830981|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44830982|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
44830983|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
44830984|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44830985|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44830986|NCT02188472|Trimethoprim|trimethoprim|mesh-list
44830987|NCT02188472|Penicillins|penicillins|mesh-list
44830988|NCT02188472|Penicillin V|penicillin v|mesh-list
44830989|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44830990|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44830991|NCT02188472|Renal Agents|renal agents|mesh-ancestor
44830992|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
44830993|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44830994|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44317373|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
44830995|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44830996|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44830997|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44830998|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44830999|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44831000|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44831001|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44831002|NCT02188511|Nicotine|nicotine|mesh-list
44831003|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44831004|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
44831005|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831006|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831007|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44831008|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44831009|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
44831010|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831011|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831012|NCT02188537|Nelfinavir|nelfinavir|mesh-list
44831013|NCT02188537|Dexamethasone|dexamethasone|mesh-list
44831014|NCT02188537|Bortezomib|bortezomib|mesh-list
44831015|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831016|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
44831017|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
44831018|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831019|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831020|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831021|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
44831022|NCT02188537|Hormones|hormones|mesh-ancestor
44831023|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831024|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831025|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831026|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44831027|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44831028|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831029|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831030|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831031|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831032|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831033|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
44831034|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831035|NCT02188550|Everolimus|everolimus|mesh-list
44831036|NCT02188550|Letrozole|letrozole|mesh-list
44831037|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831038|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831039|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
44831040|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831041|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44831042|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44831043|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831044|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831045|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44831046|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
44831047|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831049|NCT02188615|Vinorelbine|vinorelbine|mesh-list
44831050|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831051|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44831052|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44831053|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44831054|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831055|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831057|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831058|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831059|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
44831060|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44831061|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
44831062|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831063|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
44831064|NCT02188771|Protective Agents|protective agents|mesh-ancestor
44831065|NCT02188810|Vaccines|vaccines|mesh-list
44831066|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
44831067|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831068|NCT02188888|Esmolol|esmolol|mesh-list
44831069|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44831070|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44831071|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44831072|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831073|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831074|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831075|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831076|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
44831077|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
44831078|NCT02188953|Calcium|calcium|mesh-list
44831079|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44831080|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831081|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44831082|NCT02188953|Antacids|antacids|mesh-ancestor
44831083|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831084|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831085|NCT02189304|Budesonide|budesonide|mesh-list
44831086|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
44831087|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
44831088|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44831089|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831090|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44831091|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
44831092|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831093|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831094|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44831095|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831096|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
44831097|NCT02189304|Hormones|hormones|mesh-ancestor
44831098|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831099|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44831100|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44831101|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44831102|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831103|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831104|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831105|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44831106|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44831107|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44831108|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
44831109|NCT02189343|Thalidomide|thalidomide|mesh-list
44831110|NCT02189343|Dexamethasone|dexamethasone|mesh-list
44831111|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
44831112|NCT02189343|Pomalidomide|pomalidomide|mesh-list
44831113|NCT02189343|Ricolinostat|ricolinostat|mesh-list
44831114|NCT02189343|BB 1101|bb 1101|mesh-list
44831115|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831116|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
44831117|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
44831118|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831119|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831120|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831121|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
44831122|NCT02189343|Hormones|hormones|mesh-ancestor
44831123|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831124|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831125|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831126|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831127|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831128|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831129|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
44831130|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44831131|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44831132|NCT02189343|Growth Substances|growth substances|mesh-ancestor
44831133|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
44831134|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831135|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
44831136|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44831137|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831138|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44831139|NCT02189395|Insulin|insulin|mesh-list
44831140|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
44831141|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44831142|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831143|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831144|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
44831145|NCT02189577|Bromides|bromides|mesh-list
44831146|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
44831147|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44831148|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44831149|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44831150|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44831151|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831152|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831153|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831154|NCT02189655|Bupivacaine|bupivacaine|mesh-list
44831155|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
44831156|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
44831157|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831158|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831159|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
44831160|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831161|NCT02189681|Anesthetics|anesthetics|mesh-list
44831162|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831163|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831164|NCT02189694|Hormones|hormones|mesh-list
44831165|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831166|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831167|NCT02189720|Amifampridine|amifampridine|mesh-list
44831168|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44831169|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831170|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467192|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
44831171|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44831172|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831173|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831174|NCT02189772|Metadoxine|metadoxine|mesh-list
44831175|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44831176|NCT02190058|DS-1971a|ds-1971a|mesh-list
44831177|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44831178|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44831179|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831180|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831181|NCT02190149|Factor VIII|factor viii|mesh-list
44831182|NCT02190149|Coagulants|coagulants|mesh-ancestor
44831183|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44831184|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
44831185|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831186|NCT02190318|Losartan|losartan|mesh-list
44831187|NCT02190318|Spironolactone|spironolactone|mesh-list
44831188|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44831189|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44831190|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44831191|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44831192|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831193|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44831194|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
44831195|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831196|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831197|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44831198|NCT02190318|Diuretics|diuretics|mesh-ancestor
44831199|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
44831200|NCT02190357|Rifaximin|rifaximin|mesh-list
44831201|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44831202|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831203|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831204|NCT02190526|Mesalamine|mesalamine|mesh-list
44831205|NCT02190526|Amitriptyline|amitriptyline|mesh-list
44831206|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44831207|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44831208|NCT02190526|Analgesics|analgesics|mesh-ancestor
44831209|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
44831210|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831211|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831212|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831213|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831214|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44831215|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
44831216|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831217|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44831218|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44831219|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831220|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831221|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831222|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831223|NCT02190695|Carboplatin|carboplatin|mesh-list
44831224|NCT02190695|Decitabine|decitabine|mesh-list
44831225|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
44831226|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831227|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44831228|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
44831229|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831230|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831231|NCT02190708|Midazolam|midazolam|mesh-list
44831232|NCT02190708|Omeprazole|omeprazole|mesh-list
44831233|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44831234|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44831235|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44831236|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831237|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831238|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44831239|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831240|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831241|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44831242|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
44831243|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
44831244|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
44831245|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
44831246|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831247|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831248|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44831249|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831250|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831251|NCT02190760|Dexamethasone|dexamethasone|mesh-list
44831252|NCT02190760|Bupivacaine|bupivacaine|mesh-list
44831253|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831254|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
44831255|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
44831256|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831257|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831258|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831259|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
44831260|NCT02190760|Hormones|hormones|mesh-ancestor
44831261|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831262|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831263|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831264|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
44831265|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
44831266|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831267|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
44831268|NCT02190838|Metformin|metformin|mesh-list
44831269|NCT02190838|Dacarbazine|dacarbazine|mesh-list
44831270|NCT02190838|Melatonin|melatonin|mesh-list
44831271|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831272|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831273|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
44831274|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831275|NCT02190838|Protective Agents|protective agents|mesh-ancestor
44831276|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831277|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44831278|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
44831279|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831280|NCT02190994|Prednisone|prednisone|mesh-list
44831281|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
44831282|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831283|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
44831284|NCT02190994|Hormones|hormones|mesh-ancestor
44831285|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831286|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831287|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831288|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831289|NCT02191007|Calcitriol|calcitriol|mesh-list
44831290|NCT02191007|Betamethasone|betamethasone|mesh-list
44831291|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
44831292|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44831293|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
44831294|NCT02191007|Calcipotriene|calcipotriene|mesh-list
44831295|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44831296|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831297|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
44831298|NCT02191007|Hormones|hormones|mesh-ancestor
44831299|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831300|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831301|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44831302|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831303|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831304|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44831305|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44831306|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831307|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831308|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44831309|NCT02191007|Vitamins|vitamins|mesh-ancestor
44831310|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
44831311|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44831312|NCT02191020|Acitretin|acitretin|mesh-list
44831313|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
44831314|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831315|NCT02191059|Docetaxel|docetaxel|mesh-list
44831316|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831317|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44831318|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44831319|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831320|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831321|NCT02191072|Omalizumab|omalizumab|mesh-list
44831322|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44831323|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44831324|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831325|NCT02191124|Mirtazapine|mirtazapine|mesh-list
44831326|NCT02191124|Paroxetine|paroxetine|mesh-list
44831327|NCT02191124|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613715|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613716|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613717|NCT00640510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613718|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613719|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613720|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613721|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613722|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
44613723|NCT00640393|Etanercept|etanercept|mesh-list
44613724|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44613725|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613726|NCT00640393|Analgesics|analgesics|mesh-ancestor
44613727|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
44613728|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613729|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613730|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613731|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613732|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613733|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44613734|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
44613735|NCT00640328|Ofatumumab|ofatumumab|mesh-list
44613736|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44613737|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831328|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44831329|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831330|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831331|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831332|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
44831333|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831334|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44831335|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
44831336|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831337|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44831338|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44831339|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831340|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44831341|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
44831342|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
44831343|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44831344|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831345|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831346|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44831347|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44831348|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44831349|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831350|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44831351|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44831352|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44831353|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
44831354|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
44831355|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831356|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44831357|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44831358|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831359|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831360|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831361|NCT02191189|Nevirapine|nevirapine|mesh-list
44831362|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831363|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831364|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831365|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831366|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
44831367|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831368|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831369|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831370|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831371|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831372|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44831373|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831374|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317723|NCT05141721|Ipilimumab|ipilimumab|mesh-list
44831375|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831376|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
44831377|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831378|NCT02191215|Nevirapine|nevirapine|mesh-list
44831379|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831380|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831381|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831382|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831383|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
44831384|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831385|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831386|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831387|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831388|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831389|NCT02191228|Linagliptin|linagliptin|mesh-list
44831390|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831391|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831392|NCT02191228|Incretins|incretins|mesh-ancestor
44831393|NCT02191228|Hormones|hormones|mesh-ancestor
44831394|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831395|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44831396|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831397|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831398|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831399|NCT02191280|Quercetin|quercetin|mesh-list
44831400|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
44831401|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831402|NCT02191280|Protective Agents|protective agents|mesh-ancestor
44831403|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831404|NCT02191293|Nevirapine|nevirapine|mesh-list
44831405|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831406|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831407|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831408|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831409|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
44831410|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831411|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831412|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831413|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44317771|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
44696073|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696074|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44696075|NCT01389544|Ritonavir|ritonavir|mesh-list
44696076|NCT01389544|Methadone|methadone|mesh-list
44696077|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44696078|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44696079|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696080|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696081|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696082|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44696083|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44696084|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
44696085|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696086|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44696087|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44696088|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44696089|NCT01389544|Narcotics|narcotics|mesh-ancestor
44696090|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696091|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696092|NCT01389544|Analgesics|analgesics|mesh-ancestor
44696093|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
44696094|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696095|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
44696096|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696097|NCT01389557|Piperaquine|piperaquine|mesh-list
44696098|NCT01389557|Primaquine|primaquine|mesh-list
44696099|NCT01389557|Artenimol|artenimol|mesh-list
44696100|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
44696101|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44696102|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44696103|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696104|NCT01389609|Doxazosin|doxazosin|mesh-list
44696105|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44696106|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44696107|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44696108|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44696109|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44696110|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696111|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696112|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696113|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44696114|NCT01389713|Clomiphene|clomiphene|mesh-list
44696115|NCT01389713|Enclomiphene|enclomiphene|mesh-list
44696116|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
44696117|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44696118|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696119|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696120|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696121|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44696122|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
44696123|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696124|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44696125|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44696126|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
44696127|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44696128|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
44696129|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44696130|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613820|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
44831414|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831416|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831417|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831418|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831419|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831420|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
44831421|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831422|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831423|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831424|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831425|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831426|NCT02191332|Nevirapine|nevirapine|mesh-list
44831427|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831428|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831429|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831430|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831431|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
44831432|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831433|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831434|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831435|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831436|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831437|NCT02191371|Propofol|propofol|mesh-list
44831438|NCT02191371|Desflurane|desflurane|mesh-list
44831439|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44831440|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831441|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831442|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44831443|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
44831444|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
44831445|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44831446|NCT02191423|Oxytocin|oxytocin|mesh-list
44831447|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
44831448|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44831449|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831450|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44831451|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44831452|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831453|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44831454|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831455|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831456|NCT02191527|Chrysarobin|chrysarobin|mesh-list
44831457|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44831458|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44831459|NCT02191527|Analgesics|analgesics|mesh-ancestor
44831460|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
44831461|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831462|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831463|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831464|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831465|NCT02191657|Deferiprone|deferiprone|mesh-list
44831466|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44831467|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
44831468|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
44831469|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831470|NCT02191670|Tenecteplase|tenecteplase|mesh-list
44831471|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44831472|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44831473|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831474|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
44831475|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
44831476|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831477|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44831478|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44831479|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831480|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831481|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831482|NCT02191748|Triamcinolone|triamcinolone|mesh-list
44831483|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831484|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
44831485|NCT02191748|Hormones|hormones|mesh-ancestor
44831486|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831487|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831489|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44831490|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44831491|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44831492|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831493|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831494|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44831495|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
44831496|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44831497|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44831498|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831499|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831500|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831501|NCT02191891|Afatinib|afatinib|mesh-list
44831502|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831503|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44831504|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831505|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831506|NCT02191943|Fluorides|fluorides|mesh-list
44831507|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
44831508|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44831509|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
44831510|NCT02191943|Protective Agents|protective agents|mesh-ancestor
44831511|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831512|NCT02192060|Triclosan|triclosan|mesh-list
44831513|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44831514|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831515|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44831516|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44831517|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
44831518|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831519|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44831520|NCT02192203|Diclofenac|diclofenac|mesh-list
44831521|NCT02192203|Menthol|menthol|mesh-list
44831522|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44831523|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44831524|NCT02192203|Analgesics|analgesics|mesh-ancestor
44831525|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
44831526|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831527|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831528|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831529|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831530|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44831531|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831532|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831533|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
44831534|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831535|NCT02192229|Vitamin D|vitamin d|mesh-list
44831536|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
44831537|NCT02192229|Vitamins|vitamins|mesh-ancestor
44831538|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
44831539|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831540|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44831541|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44831542|NCT02192320|Dexamethasone|dexamethasone|mesh-list
44831543|NCT02192320|Atorvastatin|atorvastatin|mesh-list
44831544|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831545|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
44831546|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
44831547|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831548|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831549|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831550|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
44831551|NCT02192320|Hormones|hormones|mesh-ancestor
44831552|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831553|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831554|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831555|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44831556|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44831557|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
44317984|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
44831558|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831559|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44831560|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44831561|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831562|NCT02192411|Lidocaine|lidocaine|mesh-list
44831563|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
44831564|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
44831565|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831566|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831567|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
44831568|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831569|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44831570|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44831571|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44831572|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831573|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831574|NCT02192424|Insulin|insulin|mesh-list
44831575|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44831576|NCT02192424|Metformin|metformin|mesh-list
44831577|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
44831578|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
44831579|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831580|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831581|NCT02192450|Insulin|insulin|mesh-list
44831582|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44831583|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
44831584|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
44831585|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44613989|NCT00631371|Interferons|interferons|mesh-list
44831586|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831587|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831588|NCT02192463|Nevirapine|nevirapine|mesh-list
44831589|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831590|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831591|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831592|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831593|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
44831594|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831595|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831596|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831597|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831598|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831599|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44831600|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44831601|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44831602|NCT02192632|Analgesics|analgesics|mesh-ancestor
44831603|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
44831604|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831605|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831606|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831607|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831608|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831609|NCT02192697|Naquotinib|naquotinib|mesh-list
44831610|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831611|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44831612|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831613|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831614|NCT02192710|Midazolam|midazolam|mesh-list
44831615|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44831616|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44831617|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831618|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831619|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44831620|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831621|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831622|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44831623|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
44831624|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
44831625|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
44831626|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
44831627|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831628|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831629|NCT02192723|Olanzapine|olanzapine|mesh-list
44831630|NCT02192723|Risperidone|risperidone|mesh-list
44831631|NCT02192723|Aripiprazole|aripiprazole|mesh-list
44831632|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44831633|NCT02192723|Ziprasidone|ziprasidone|mesh-list
44831634|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
44831635|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44831636|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
44831637|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831638|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831639|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831640|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831641|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831642|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831643|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44831644|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
44831645|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
44831646|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
44831647|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831648|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831649|NCT02192723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44831650|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44831651|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831652|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
44831653|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
44831654|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44831655|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44831656|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44831657|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44831658|NCT02192827|Dexamethasone|dexamethasone|mesh-list
44831659|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
44831660|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44831661|NCT02192827|BB 1101|bb 1101|mesh-list
44318054|NCT04606264|Dexamethasone|dexamethasone|mesh-list
44831662|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831663|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
44831664|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
44831665|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831666|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831667|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831668|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
44831669|NCT02192827|Hormones|hormones|mesh-ancestor
44831670|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831671|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831672|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831673|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831674|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831675|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831676|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44831677|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44831678|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831679|NCT02192853|Incretins|incretins|mesh-ancestor
44831680|NCT02192853|Hormones|hormones|mesh-ancestor
44831681|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831682|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44831683|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44831684|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831685|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831686|NCT02192944|Chloroquine|chloroquine|mesh-list
44831687|NCT02192944|Piperaquine|piperaquine|mesh-list
44831688|NCT02192944|Artenimol|artenimol|mesh-list
44831689|NCT02192944|Amebicides|amebicides|mesh-ancestor
44831690|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44831691|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44831692|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831693|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
44831694|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831695|NCT02193022|Miltefosine|miltefosine|mesh-list
44831696|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
44831697|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831698|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831699|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44831700|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44831701|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44831702|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44614129|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831703|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831704|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831705|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
44831706|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831707|NCT02193256|Prazosin|prazosin|mesh-list
44831708|NCT02193256|Varenicline|varenicline|mesh-list
44831709|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44831710|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44831711|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
44831712|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831713|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831714|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831715|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44831716|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44831717|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44831718|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44614130|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614131|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614132|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
44614133|NCT00627393|Hormones|hormones|mesh-ancestor
44614134|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614135|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44614136|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614137|NCT00627042|Ramucirumab|ramucirumab|mesh-list
44614138|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44614139|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614140|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
44614141|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614142|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
44614143|NCT00627016|Lansoprazole|lansoprazole|mesh-list
44614144|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44614145|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831719|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831720|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44831721|NCT02193269|Minocycline|minocycline|mesh-list
44831722|NCT02193269|Tetracycline|tetracycline|mesh-list
44831723|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831724|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44831725|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831726|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831727|NCT02193308|Amlodipine|amlodipine|mesh-list
44831728|NCT02193308|Telmisartan|telmisartan|mesh-list
44831729|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44831730|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44831731|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44831732|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831733|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831734|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44831735|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831736|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
44831737|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44831738|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44831739|NCT02193334|Mitogens|mitogens|mesh-list
44831740|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831741|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831742|NCT02193568|Anesthetics|anesthetics|mesh-list
44831743|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831744|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831745|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
44831746|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831747|NCT02193620|Nalbuphine|nalbuphine|mesh-list
44831748|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44831749|NCT02193620|Narcotics|narcotics|mesh-ancestor
44831750|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831751|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831752|NCT02193620|Analgesics|analgesics|mesh-ancestor
44831753|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
44831754|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831755|NCT02193633|Paclitaxel|paclitaxel|mesh-list
44831756|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44831757|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44831758|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831759|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44831760|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44831761|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831762|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831763|NCT02193698|Dexamethasone|dexamethasone|mesh-list
44831764|NCT02193698|Lenalidomide|lenalidomide|mesh-list
44831765|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44831766|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
44831767|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
44831768|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831769|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831770|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831771|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
44831772|NCT02193698|Hormones|hormones|mesh-ancestor
44831773|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44831774|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831775|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831776|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
44831777|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44831778|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44831779|NCT02193698|Growth Substances|growth substances|mesh-ancestor
44831780|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614187|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614190|NCT00626405|Paclitaxel|paclitaxel|mesh-list
44831781|NCT02193893|Coal Tar|coal tar|mesh-list
44831782|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
44831783|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831784|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44831785|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44831786|NCT02194049|Cisplatin|cisplatin|mesh-list
44831787|NCT02194049|Etoposide|etoposide|mesh-list
44831788|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
44831789|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831790|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44831791|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44831792|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44831793|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831794|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831795|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
44831796|NCT02194075|Methylphenidate|methylphenidate|mesh-list
44831797|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44831798|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831799|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44831800|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44831801|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831802|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831803|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
44831804|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831805|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44831806|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831807|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831808|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831809|NCT02194075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44831810|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
44831811|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44831812|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
44831813|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44831814|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44831815|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831816|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44831817|NCT02194153|Tenecteplase|tenecteplase|mesh-list
44831818|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44831819|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44831820|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831821|NCT02194166|Paclitaxel|paclitaxel|mesh-list
44831822|NCT02194166|Docetaxel|docetaxel|mesh-list
44831823|NCT02194166|Trastuzumab|trastuzumab|mesh-list
44831824|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44831825|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318224|NCT04368559|Renal Agents|renal agents|mesh-ancestor
44831826|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44831827|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44831828|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831829|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831830|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44831831|NCT02194179|Nevirapine|nevirapine|mesh-list
44831832|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831833|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831834|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831835|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831836|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
44831837|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831838|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831839|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831840|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831841|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831842|NCT02194192|Ephedrine|ephedrine|mesh-list
44831843|NCT02194192|Ondansetron|ondansetron|mesh-list
44831844|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
44831845|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
44831846|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831847|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831848|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831849|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
44831850|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
44831851|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44831852|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
44831853|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44831854|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831855|NCT02194192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44831856|NCT02194192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44831857|NCT02194192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44831858|NCT02194192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44831859|NCT02194192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44831860|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44831861|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
44831862|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44831863|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
44831864|NCT02194218|Nevirapine|nevirapine|mesh-list
44318264|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831865|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44831866|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44831867|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831868|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831869|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
44831870|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831871|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44831872|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44831873|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44831874|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44831875|NCT02194231|Trabectedin|trabectedin|mesh-list
44831876|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44831877|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
44831878|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831879|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831880|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44831881|NCT02194257|Ambroxol|ambroxol|mesh-list
44831882|NCT02194257|Expectorants|expectorants|mesh-ancestor
44831883|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831884|NCT02194270|Ambroxol|ambroxol|mesh-list
44831885|NCT02194270|Expectorants|expectorants|mesh-ancestor
44831886|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831887|NCT02194283|Ambroxol|ambroxol|mesh-list
44831888|NCT02194283|Expectorants|expectorants|mesh-ancestor
44831889|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831890|NCT02194296|Ambroxol|ambroxol|mesh-list
44831891|NCT02194296|Expectorants|expectorants|mesh-ancestor
44831892|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831893|NCT02194309|Amlodipine|amlodipine|mesh-list
44831894|NCT02194309|Telmisartan|telmisartan|mesh-list
44831895|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44831896|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44831897|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831898|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831899|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44831900|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831901|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
44831902|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44831903|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44831904|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
44831905|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44831906|NCT02194374|Rituximab|rituximab|mesh-list
44831907|NCT02194374|Fludarabine|fludarabine|mesh-list
44831908|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
44831909|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831910|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
44831911|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831912|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44831913|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44831914|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
44831915|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831916|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831917|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44831918|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44831919|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44831920|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
44831921|NCT02194452|Octreotide|octreotide|mesh-list
44831922|NCT02194452|Edotreotide|edotreotide|mesh-list
44831923|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44831924|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44831925|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831926|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44831927|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831928|NCT02194491|AS2471907|as2471907|mesh-list
44831929|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44614338|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
44831930|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831931|NCT02194556|Gemcitabine|gemcitabine|mesh-list
44831932|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44831933|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
44831934|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831935|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831936|NCT02194556|Antiviral Agents|antiviral agents|mesh-ancestor
44831937|NCT02194556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831938|NCT02194556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831939|NCT02194556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831940|NCT02194556|Immunologic Factors|immunologic factors|mesh-ancestor
44831941|NCT02194556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831942|NCT02194686|Cilostazol|cilostazol|mesh-list
44831943|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44831944|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
44831945|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831946|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831947|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44831948|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
44831949|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44831950|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44831951|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831952|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44831953|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44831954|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44831955|NCT02194686|Protective Agents|protective agents|mesh-ancestor
44831956|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44831957|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44831958|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831959|NCT02194764|Naltrexone|naltrexone|mesh-list
44831960|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44831961|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44831962|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831963|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
44831964|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831965|NCT02194829|Gemcitabine|gemcitabine|mesh-list
44831966|NCT02194829|Paclitaxel|paclitaxel|mesh-list
44831967|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44831968|NCT02194829|Adavosertib|adavosertib|mesh-list
44831969|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44831970|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44831971|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44831972|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44831973|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44831974|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831975|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44831976|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
44831977|NCT02194829|Antiviral Agents|antiviral agents|mesh-ancestor
44831978|NCT02194829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44831979|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44831980|NCT02194829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44831981|NCT02194829|Immunologic Factors|immunologic factors|mesh-ancestor
44831982|NCT02194829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831983|NCT02194855|Rocuronium|rocuronium|mesh-list
44831984|NCT02194855|Cisatracurium|cisatracurium|mesh-list
44831985|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44831986|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44831987|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44831988|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831989|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44831990|NCT02194881|Ivacaftor|ivacaftor|mesh-list
44831991|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44831992|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44831993|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44831994|NCT02194894|Acetaminophen|acetaminophen|mesh-list
44831995|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44831996|NCT02194894|Analgesics|analgesics|mesh-ancestor
44831997|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
44831998|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44831999|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832000|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
44832001|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
44832002|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44832003|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832004|NCT02195089|Vaccines|vaccines|mesh-list
44832005|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
44832006|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832007|NCT02195115|Amitriptyline|amitriptyline|mesh-list
44832008|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44832009|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
44832010|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44832011|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832012|NCT02195115|Analgesics|analgesics|mesh-ancestor
44832013|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
44832014|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832015|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832016|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44832017|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44832018|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44832019|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832020|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
44832021|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832023|NCT02195180|Gemcitabine|gemcitabine|mesh-list
44832024|NCT02195180|Fluorouracil|fluorouracil|mesh-list
44832025|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
44832026|NCT02195180|Asparaginase|asparaginase|mesh-list
44832027|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44832028|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
44832029|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832030|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832031|NCT02195180|Antiviral Agents|antiviral agents|mesh-ancestor
44832032|NCT02195180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832033|NCT02195180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832034|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44832035|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
44832036|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832037|NCT02195180|Antidotes|antidotes|mesh-ancestor
44832038|NCT02195180|Protective Agents|protective agents|mesh-ancestor
44832039|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
44832040|NCT02195180|Vitamins|vitamins|mesh-ancestor
44832041|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
44832042|NCT02195271|Melatonin|melatonin|mesh-list
44832043|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
44832044|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832045|NCT02195271|Protective Agents|protective agents|mesh-ancestor
44832046|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832047|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832048|NCT02195336|Paclitaxel|paclitaxel|mesh-list
44832049|NCT02195336|Bevacizumab|bevacizumab|mesh-list
44832050|NCT02195336|Carboplatin|carboplatin|mesh-list
44832051|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44832052|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832053|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44832054|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44832055|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44832056|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832057|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832058|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44832059|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44832060|NCT02195336|Growth Substances|growth substances|mesh-ancestor
44832061|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832062|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44832063|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44832064|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44832065|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
44832066|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832067|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832068|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44832069|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
44832070|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
44832071|NCT02195375|Hormones|hormones|mesh-ancestor
44832072|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832073|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
44832074|NCT02195466|Ritonavir|ritonavir|mesh-list
44832075|NCT02195466|Tipranavir|tipranavir|mesh-list
44832076|NCT02195466|Fluconazole|fluconazole|mesh-list
44832077|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44832078|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44832079|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614489|NCT00623766|Ipilimumab|ipilimumab|mesh-list
44832080|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832081|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832082|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44832083|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44832084|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
44832085|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832086|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44832087|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832088|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
44832089|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44832090|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44832091|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
44832092|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832093|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832094|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44832095|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44832097|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
44832098|NCT02195492|Protective Agents|protective agents|mesh-ancestor
44832099|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696131|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696132|NCT01389778|Metformin|metformin|mesh-list
44696133|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44696134|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696135|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
44696136|NCT01389791|Rocuronium|rocuronium|mesh-list
44696137|NCT01389791|Analgesics|analgesics|mesh-ancestor
44696138|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
44696139|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696140|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696141|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
44696142|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696143|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44696144|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
44696145|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44696146|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696147|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696148|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44696149|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
44696150|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696151|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44696152|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44696153|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44696154|NCT01389908|Olanzapine|olanzapine|mesh-list
44696155|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
44696156|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
44696157|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696158|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696159|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696160|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44696161|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44696162|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318449|NCT04005339|Antidotes|antidotes|mesh-ancestor
44318502|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
44696163|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44696164|NCT01389908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44696165|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44696166|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696167|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696168|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696169|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
44696170|NCT01390012|Dexamethasone|dexamethasone|mesh-list
44696171|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
44696172|NCT01390012|BB 1101|bb 1101|mesh-list
44696173|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832100|NCT02195544|Hylan|hylan|mesh-list
44832101|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
44832102|NCT02195544|Protective Agents|protective agents|mesh-ancestor
44832103|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832104|NCT02195557|Hylan|hylan|mesh-list
44832105|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
44832106|NCT02195557|Protective Agents|protective agents|mesh-ancestor
44832107|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832108|NCT02195635|Octreotide|octreotide|mesh-list
44832109|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832110|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44832111|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832112|NCT02195661|Melatonin|melatonin|mesh-list
44832113|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
44832114|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
44832115|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832116|NCT02195661|Protective Agents|protective agents|mesh-ancestor
44832117|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832118|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832119|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44832120|NCT02195791|Pioglitazone|pioglitazone|mesh-list
44832121|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832122|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832123|NCT02195804|Ranitidine|ranitidine|mesh-list
44832124|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44832125|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44832126|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832127|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44832128|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
44832129|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
44832130|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832131|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832132|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832133|NCT02195817|Nalmefene|nalmefene|mesh-list
44832134|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44832135|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832136|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
44832137|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832138|NCT02195908|Antiemetics|antiemetics|mesh-list
44832139|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
44832140|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832141|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832142|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832143|NCT02195973|Paclitaxel|paclitaxel|mesh-list
44832144|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44832145|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832146|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
44832147|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
44832148|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
44832149|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832150|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
44832151|NCT02196142|Mannitol|mannitol|mesh-list
44832152|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44832153|NCT02196142|Diuretics|diuretics|mesh-ancestor
44832154|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
44832155|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832156|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832157|NCT02196155|Cortisone|cortisone|mesh-list
44832158|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
44832159|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44832160|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44832161|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44832162|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44832163|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832164|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44832165|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832166|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832167|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832168|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44832169|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832170|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
44832171|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44832172|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
44832173|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832174|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832175|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44832176|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
44832177|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
44832178|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44832179|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
44832180|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832181|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832182|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44832183|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
44832184|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832185|NCT02196285|Vaccines|vaccines|mesh-list
44832186|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
44832187|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832188|NCT02196441|Bupivacaine|bupivacaine|mesh-list
44832189|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
44832190|NCT02196441|Tetracaine|tetracaine|mesh-list
44832191|NCT02196441|Anesthetics|anesthetics|mesh-list
44832192|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832193|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832194|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
44832195|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832196|NCT02196493|Azithromycin|azithromycin|mesh-list
44832197|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832198|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832199|NCT02196662|Mesalamine|mesalamine|mesh-list
44832200|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44832201|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832202|NCT02196662|Analgesics|analgesics|mesh-ancestor
44832203|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
44832204|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832205|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832206|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832207|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832208|NCT02196740|Metronidazole|metronidazole|mesh-list
44832209|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
44832210|NCT02196740|Clindamycin|clindamycin|mesh-list
44832211|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
44832212|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
44832213|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
44832214|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832215|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832216|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832217|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832218|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44832219|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44832220|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832221|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832222|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832223|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44832224|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832225|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44832226|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44832227|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44832228|NCT02196805|Probucol|probucol|mesh-list
44832229|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44832230|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44832231|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
44832232|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832233|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44832234|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
44832235|NCT02196805|Protective Agents|protective agents|mesh-ancestor
44832236|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832237|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44832238|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44832239|NCT02197000|Protective Agents|protective agents|mesh-ancestor
44832240|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832241|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832242|NCT02197026|Hylan|hylan|mesh-list
44832243|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
44832244|NCT02197026|Protective Agents|protective agents|mesh-ancestor
44832245|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832246|NCT02197104|Choline|choline|mesh-list
44832247|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
44832248|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44832249|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
44832250|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832251|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832252|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44832253|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
44614740|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832254|NCT02197143|Esomeprazole|esomeprazole|mesh-list
44832255|NCT02197143|Ranitidine|ranitidine|mesh-list
44832256|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44832257|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44832258|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832259|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44832260|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832261|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832262|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44832263|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
44832264|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
44832265|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832266|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832267|NCT02197169|Interferons|interferons|mesh-list
44832268|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
44832269|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832270|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
44832271|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832272|NCT02197182|Copper|copper|mesh-list
44832273|NCT02197182|Metronidazole|metronidazole|mesh-list
44832274|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832275|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832276|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832277|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832278|NCT02197182|Trace Elements|trace elements|mesh-ancestor
44832279|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
44832280|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832281|NCT02197260|Amoxicillin|amoxicillin|mesh-list
44832282|NCT02197260|Metronidazole|metronidazole|mesh-list
44832283|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832284|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832285|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832286|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832287|NCT02197286|Vitamin D|vitamin d|mesh-list
44832288|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
44832289|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
44832290|NCT02197286|Vitamins|vitamins|mesh-list
44832291|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
44832292|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832293|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44832294|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614741|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614742|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614743|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44614744|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44614745|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614746|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614747|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44614748|NCT00621777|Varenicline|varenicline|mesh-list
44614749|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44614750|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44614751|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
44614752|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614753|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832295|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
44832296|NCT02197403|Propofol|propofol|mesh-list
44832297|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44832298|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832299|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832300|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44832301|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
44832302|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
44832303|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832304|NCT02197403|Analgesics|analgesics|mesh-ancestor
44832305|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
44832306|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832307|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44832308|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44832309|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44832310|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
44832311|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832312|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832313|NCT02197442|Valsartan|valsartan|mesh-list
44832314|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832315|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832316|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832317|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832318|NCT02197494|Valsartan|valsartan|mesh-list
44832319|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832320|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832321|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832322|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832323|NCT02197598|Nalmefene|nalmefene|mesh-list
44832324|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44832325|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832326|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
44832327|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832328|NCT02197637|Vinorelbine|vinorelbine|mesh-list
44318658|NCT03616587|Everolimus|everolimus|mesh-list
44832329|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44832330|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832331|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
44832332|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
44832333|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
44832334|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832335|NCT02197650|Asparaginase|asparaginase|mesh-list
44832336|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832337|NCT02197676|Guadecitabine|guadecitabine|mesh-list
44832338|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832339|NCT02197702|Vitamin D|vitamin d|mesh-list
44832340|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
44832341|NCT02197702|Vitamins|vitamins|mesh-ancestor
44832342|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
44832343|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832344|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44832345|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44832346|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
44832347|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44832348|NCT02197741|Narcotics|narcotics|mesh-ancestor
44832349|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832350|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832351|NCT02197741|Analgesics|analgesics|mesh-ancestor
44832352|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
44832353|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832354|NCT02197884|Clarithromycin|clarithromycin|mesh-list
44832355|NCT02197884|Itraconazole|itraconazole|mesh-list
44832356|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832357|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832358|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44832359|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832360|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832361|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44832362|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832363|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
44832364|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44832365|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44832366|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696174|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
44832367|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832368|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832369|NCT02197988|Fentanyl|fentanyl|mesh-list
44832370|NCT02197988|Bupivacaine|bupivacaine|mesh-list
44832371|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
44832372|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
44832373|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832374|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832375|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
44832376|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832377|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44832378|NCT02197988|Narcotics|narcotics|mesh-ancestor
44832379|NCT02197988|Analgesics|analgesics|mesh-ancestor
44832380|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44832381|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44832382|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
44832383|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44832384|NCT02198001|Amoxicillin|amoxicillin|mesh-list
44832385|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
44832386|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
44832387|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44832388|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832389|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44832390|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832391|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832392|NCT02198027|Bupivacaine|bupivacaine|mesh-list
44832393|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
44832394|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
44832395|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832396|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832397|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
44832398|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832399|NCT02198170|Ketoconazole|ketoconazole|mesh-list
44832400|NCT02198170|Lenvatinib|lenvatinib|mesh-list
44832401|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
44832402|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832403|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44832404|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832405|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832406|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832407|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44832408|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44832409|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832410|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832411|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44832412|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832413|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44832414|NCT02198209|Liraglutide|liraglutide|mesh-list
44832415|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832416|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832417|NCT02198209|Incretins|incretins|mesh-ancestor
44832418|NCT02198209|Hormones|hormones|mesh-ancestor
44832419|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832420|NCT02198248|Prednisolone|prednisolone|mesh-list
44832421|NCT02198248|Rituximab|rituximab|mesh-list
44832422|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
44832423|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832424|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832425|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
44832426|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832427|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832428|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832429|NCT02198248|Hormones|hormones|mesh-ancestor
44832430|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832431|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44832432|NCT02198261|Minoxidil|minoxidil|mesh-list
44832433|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832434|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
44832435|NCT02198300|Clopidogrel|clopidogrel|mesh-list
44832436|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44832437|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44832438|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44832439|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44832440|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
44832441|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696175|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
44832442|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832443|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832444|NCT02198378|Acetaminophen|acetaminophen|mesh-list
44832445|NCT02198378|Morphine|morphine|mesh-list
44832446|NCT02198378|Entonox|entonox|mesh-list
44832447|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44832448|NCT02198378|Narcotics|narcotics|mesh-ancestor
44832449|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832450|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832451|NCT02198378|Analgesics|analgesics|mesh-ancestor
44832452|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
44832453|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832454|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832455|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
44832456|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44832457|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
44832458|NCT02198404|Propofol|propofol|mesh-list
44832459|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44832460|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832461|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832462|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44832463|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
44832464|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
44832465|NCT02198417|Metformin|metformin|mesh-list
44832466|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832467|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832468|NCT02198443|Ritonavir|ritonavir|mesh-list
44318834|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318835|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
44832469|NCT02198443|Lopinavir|lopinavir|mesh-list
44832470|NCT02198443|Tenofovir|tenofovir|mesh-list
44832471|NCT02198443|Emtricitabine|emtricitabine|mesh-list
44832472|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44832473|NCT02198443|Cobicistat|cobicistat|mesh-list
44832474|NCT02198443|Elvitegravir|elvitegravir|mesh-list
44832475|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44832476|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44832477|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44832478|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832479|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832480|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44832481|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44832482|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
44832483|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832484|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44832485|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832486|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44832487|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44832488|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44832489|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44832490|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44832491|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
44832492|NCT02198482|Cytarabine|cytarabine|mesh-list
44832493|NCT02198482|Daunorubicin|daunorubicin|mesh-list
44832494|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
44832495|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44832496|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
44832497|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832498|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832499|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
44832500|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832501|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44832502|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
44832503|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832504|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44832505|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44832506|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44832507|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832508|NCT02198482|Analgesics|analgesics|mesh-ancestor
44832509|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
44832510|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832511|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44832512|NCT02198495|Hematinics|hematinics|mesh-ancestor
44832513|NCT02198508|Deferasirox|deferasirox|mesh-list
44832514|NCT02198508|Deferiprone|deferiprone|mesh-list
44614907|NCT00620750|Naltrexone|naltrexone|mesh-list
44832515|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44832516|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
44832517|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
44832518|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832519|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
44832520|NCT02198547|Ropivacaine|ropivacaine|mesh-list
44832521|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
44832522|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
44832523|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832524|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832525|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
44832526|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832527|NCT02198547|Analgesics|analgesics|mesh-ancestor
44832528|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44832529|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
44832530|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44832531|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44832532|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832533|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44832534|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
44832535|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44832536|NCT02198807|Piperaquine|piperaquine|mesh-list
44832537|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
44832538|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
44832539|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832540|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832541|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832542|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832543|NCT02198820|Anesthetics|anesthetics|mesh-list
44832544|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832545|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832546|NCT02198846|Insulin|insulin|mesh-list
44832547|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832548|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832549|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
44832550|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
44832551|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44832552|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832553|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832554|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
44832555|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44832556|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832557|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832558|NCT02198924|Celecoxib|celecoxib|mesh-list
44832559|NCT02198924|Parecoxib|parecoxib|mesh-list
44832560|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44832561|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832562|NCT02198924|Analgesics|analgesics|mesh-ancestor
44832563|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
44832564|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832565|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832566|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832567|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832568|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44832569|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44832570|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832571|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614975|NCT00620113|Calcium|calcium|mesh-list
44832573|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832574|NCT02199223|Panitumumab|panitumumab|mesh-list
44832575|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832576|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832577|NCT02199327|Interferons|interferons|mesh-list
44832578|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
44832579|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
44832580|NCT02199327|Mitomycins|mitomycins|mesh-list
44832581|NCT02199327|Mitomycin|mitomycin|mesh-list
44832582|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832583|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
44832584|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832585|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
44832586|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832587|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44832588|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
44832589|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832590|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44832591|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832592|NCT02199379|Lenvatinib|lenvatinib|mesh-list
44832593|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832594|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44832595|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832596|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832597|NCT02199392|Lenvatinib|lenvatinib|mesh-list
44832598|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832599|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44832600|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832601|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832602|NCT02199418|Paclitaxel|paclitaxel|mesh-list
44832603|NCT02199418|Cisplatin|cisplatin|mesh-list
44832604|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44832605|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832606|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44832607|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44832608|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44832609|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832610|NCT02199431|Itraconazole|itraconazole|mesh-list
44832611|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
44832612|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832613|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44832614|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44832615|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832616|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832617|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44832618|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
44832619|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832620|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832621|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44832622|NCT02199444|Sevelamer|sevelamer|mesh-list
44832623|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
44832624|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
44832625|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832626|NCT02199522|Propofol|propofol|mesh-list
44832627|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44832628|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832629|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832630|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44832631|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
44832632|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
44832633|NCT02199613|Darunavir|darunavir|mesh-list
44832634|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44832635|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44832636|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
44832637|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832638|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832639|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44832640|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44832641|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
44832642|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832643|NCT02199678|Ketamine|ketamine|mesh-list
44832644|NCT02199678|Analgesics|analgesics|mesh-ancestor
44832645|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
44832646|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832647|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832648|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44832649|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44832650|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
44832651|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
44832652|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832653|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44832654|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44832655|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832656|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832657|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
44832658|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44832659|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44832660|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
44832661|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832662|NCT02199951|Piperaquine|piperaquine|mesh-list
44832663|NCT02199951|Artenimol|artenimol|mesh-list
44832664|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
44832665|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832666|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832667|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832668|NCT02200094|Telmisartan|telmisartan|mesh-list
44832669|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832670|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832671|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832672|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832673|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
44832674|NCT02200146|Prednisone|prednisone|mesh-list
44832675|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832676|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
44832677|NCT02200146|Hormones|hormones|mesh-ancestor
44832678|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832679|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832680|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44832681|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832682|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
44832683|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44832684|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44832685|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832686|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832687|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832688|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832689|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
44832690|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44832691|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832692|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832693|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832694|NCT02200159|Analgesics|analgesics|mesh-ancestor
44832695|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
44832696|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832697|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44832698|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44832699|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44832700|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
44832701|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832702|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832703|NCT02200172|Melatonin|melatonin|mesh-list
44832704|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
44832705|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832706|NCT02200172|Protective Agents|protective agents|mesh-ancestor
44832707|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832708|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832709|NCT02200185|Morphine|morphine|mesh-list
44832710|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44832711|NCT02200185|Narcotics|narcotics|mesh-ancestor
44832712|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832713|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832714|NCT02200185|Analgesics|analgesics|mesh-ancestor
44832715|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
44832716|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832717|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
44832718|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44832719|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
44615120|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
44832720|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832721|NCT02200237|Antacids|antacids|mesh-ancestor
44832722|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832723|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832724|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
44832725|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44832726|NCT02200354|Bevacizumab|bevacizumab|mesh-list
44832727|NCT02200354|Pemetrexed|pemetrexed|mesh-list
44832728|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832729|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832730|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44832731|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44832732|NCT02200354|Growth Substances|growth substances|mesh-ancestor
44832733|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832734|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
44832735|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832736|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832737|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44832738|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44832739|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44832740|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44832741|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44832742|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44832743|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832744|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832745|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832746|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
44832747|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44832748|NCT02200562|Ipilimumab|ipilimumab|mesh-list
44832749|NCT02200562|Dabrafenib|dabrafenib|mesh-list
44832750|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832751|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832752|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44832753|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832754|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44832755|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319074|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44832756|NCT02200575|Telmisartan|telmisartan|mesh-list
44832757|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832758|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832759|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832760|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832761|NCT02200640|Losartan|losartan|mesh-list
44832762|NCT02200640|Telmisartan|telmisartan|mesh-list
44832763|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44832764|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832765|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832766|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832767|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832768|NCT02200653|Losartan|losartan|mesh-list
44832769|NCT02200653|Telmisartan|telmisartan|mesh-list
44832770|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44832771|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44832772|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44832773|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44832774|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832775|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
44832776|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44832777|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
44832778|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615215|NCT00618813|Ifosfamide|ifosfamide|mesh-list
44832779|NCT02200757|Topotecan|topotecan|mesh-list
44832780|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44832781|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44832782|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832783|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832784|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832785|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44832786|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44832787|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44832788|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832789|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832790|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832791|NCT02200848|Rituximab|rituximab|mesh-list
44832792|NCT02200848|Lenalidomide|lenalidomide|mesh-list
44832793|NCT02200848|Glutarimide|glutarimide|mesh-list
44832794|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44832795|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832796|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
44832797|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832798|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832799|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44832800|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44832801|NCT02200848|Growth Substances|growth substances|mesh-ancestor
44832802|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
44832803|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44832804|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319137|NCT00921102|Morphine|morphine|mesh-list
44319138|NCT00921102|Bupivacaine|bupivacaine|mesh-list
44319139|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
44832805|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832806|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
44832807|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44832808|NCT02200991|Lixisenatide|lixisenatide|mesh-list
44832809|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832810|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832811|NCT02200991|Incretins|incretins|mesh-ancestor
44832812|NCT02200991|Hormones|hormones|mesh-ancestor
44832813|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832814|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44832815|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44832816|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832817|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832818|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
44832819|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832820|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832821|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44832822|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832823|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44832824|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
44832825|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832826|NCT02201043|Thalidomide|thalidomide|mesh-list
44832827|NCT02201043|Tolnaftate|tolnaftate|mesh-list
44832828|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44832829|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
44832830|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832831|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
44832832|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832833|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832834|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44832835|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44832836|NCT02201043|Growth Substances|growth substances|mesh-ancestor
44832837|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44832838|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832839|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
44832840|NCT02201082|Amikacin|amikacin|mesh-list
44832841|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832842|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832843|NCT02201121|Phenylephrine|phenylephrine|mesh-list
44832844|NCT02201121|Dopamine|dopamine|mesh-list
44832845|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
44832846|NCT02201121|Ephedrine|ephedrine|mesh-list
44832847|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44832848|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
44832849|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
44832850|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832851|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832852|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
44832853|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44832854|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
44832855|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44832856|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44832857|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44832858|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44832859|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44832860|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832861|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832862|NCT02201121|Protective Agents|protective agents|mesh-ancestor
44832863|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44832864|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
44832865|NCT02201134|Sevoflurane|sevoflurane|mesh-list
44832866|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44832867|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44832868|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
44832869|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
44832870|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44832871|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832872|NCT02201199|Insulin|insulin|mesh-list
44832873|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44832874|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
44832875|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832876|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832877|NCT02201225|Micronutrients|micronutrients|mesh-list
44832878|NCT02201225|Trace Elements|trace elements|mesh-list
44832879|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832880|NCT02201238|Diclofenac|diclofenac|mesh-list
44832881|NCT02201238|Menthol|menthol|mesh-list
44832882|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44832883|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832884|NCT02201238|Analgesics|analgesics|mesh-ancestor
44832885|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
44832886|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832887|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832888|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832889|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832890|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44832891|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832892|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832893|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
44832894|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
44832895|NCT02201316|Mosapride|mosapride|mesh-list
44832896|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832897|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44832898|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44832899|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
44832900|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832901|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832902|NCT02201342|Udenafil|udenafil|mesh-list
44615346|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44615347|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615348|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44615349|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
44615350|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44615351|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615352|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615353|NCT00617591|Dexamethasone|dexamethasone|mesh-list
44615354|NCT00617591|Doxorubicin|doxorubicin|mesh-list
44615355|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44615356|NCT00617591|Lenalidomide|lenalidomide|mesh-list
44615357|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615358|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
44615359|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
44615360|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615361|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615362|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615363|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
44615364|NCT00617591|Hormones|hormones|mesh-ancestor
44615365|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615366|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44615367|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615368|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44615369|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44615370|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44319248|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
44832903|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44832904|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44832905|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832906|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832907|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44832908|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
44832909|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696176|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696177|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696178|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696179|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
44696180|NCT01390012|Hormones|hormones|mesh-ancestor
44696181|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696182|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696183|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696184|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696185|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696186|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696187|NCT01390051|Tinzaparin|tinzaparin|mesh-list
44696188|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44696189|NCT01390051|Dalteparin|dalteparin|mesh-list
44696190|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
44696191|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44696192|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44696193|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696194|NCT01390311|Azacitidine|azacitidine|mesh-list
44696195|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696196|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
44696197|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696198|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696199|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696200|NCT01390324|Naproxen|naproxen|mesh-list
44696201|NCT01390324|Naratriptan|naratriptan|mesh-list
44696202|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44696203|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44696204|NCT01390324|Analgesics|analgesics|mesh-ancestor
44319294|NCT00921674|Ivermectin|ivermectin|mesh-list
44696205|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
44696206|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696207|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696208|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696209|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44696210|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
44696211|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44696212|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696213|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696214|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44696215|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44696216|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44696217|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
44696218|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696219|NCT01390337|Cytarabine|cytarabine|mesh-list
44696220|NCT01390337|Daunorubicin|daunorubicin|mesh-list
44696221|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696222|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
44696223|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696224|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696225|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
44696226|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696227|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696228|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
44696229|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696230|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44696231|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44696232|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44696233|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696234|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
44696235|NCT01390480|Vitamin D|vitamin d|mesh-list
44696236|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44696237|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696238|NCT01390480|Vitamins|vitamins|mesh-ancestor
44696239|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
44696240|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44696241|NCT01390506|Selenious Acid|selenious acid|mesh-list
44696242|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
44696243|NCT01390506|Trace Elements|trace elements|mesh-ancestor
44832910|NCT02201459|Interferons|interferons|mesh-list
44832911|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
44832912|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
44832913|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44832914|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832915|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
44832916|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832917|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
44832918|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832919|NCT02201563|Minocycline|minocycline|mesh-list
44832920|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44832921|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832922|NCT02201576|Bortezomib|bortezomib|mesh-list
44832923|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
44832924|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44832925|NCT02201576|Antibodies|antibodies|mesh-list
44832926|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
44832927|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44832928|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832929|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
44832930|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832931|NCT02201602|Gliclazide|gliclazide|mesh-list
44832932|NCT02201602|Glyburide|glyburide|mesh-list
44832933|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44832934|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832935|NCT02201641|Calcium|calcium|mesh-list
44832936|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44832937|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832938|NCT02201667|Aspirin|aspirin|mesh-list
44832939|NCT02201667|Clopidogrel|clopidogrel|mesh-list
44832940|NCT02201667|Ticagrelor|ticagrelor|mesh-list
44832941|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44832942|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44832943|NCT02201667|Analgesics|analgesics|mesh-ancestor
44832944|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
44832945|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44832946|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832947|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44832948|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44832949|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44832950|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44832951|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832952|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44832953|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44832954|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832955|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
44832956|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44832957|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44832958|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44832959|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
44832960|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44832961|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44832962|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44832963|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44832964|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
44832965|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832966|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44832967|NCT02201914|Clomiphene|clomiphene|mesh-list
44832968|NCT02201914|Enclomiphene|enclomiphene|mesh-list
44832969|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
44832970|NCT02201914|Cetrorelix|cetrorelix|mesh-list
44832971|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
44832972|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44832973|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
44832974|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44832975|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44832976|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44832977|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44832978|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44832979|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44832980|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
44832981|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44832982|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44832983|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
44832984|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44615403|NCT00617344|Vaccines|vaccines|mesh-list
44832985|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44832986|NCT02202005|Nevirapine|nevirapine|mesh-list
44832987|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44832988|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44832989|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44832990|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44832992|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44832993|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44832994|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44832995|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44832996|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44832997|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44832998|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44832999|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44833000|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833001|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833002|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44833003|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833004|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833005|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
44833006|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833007|NCT02202200|Palbociclib|palbociclib|mesh-list
44833008|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833009|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44833010|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833011|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833012|NCT02202239|Fentanyl|fentanyl|mesh-list
44833013|NCT02202239|Midazolam|midazolam|mesh-list
44833014|NCT02202239|Remifentanil|remifentanil|mesh-list
44833015|NCT02202239|Propofol|propofol|mesh-list
44833016|NCT02202239|Etomidate|etomidate|mesh-list
44833017|NCT02202239|Sevoflurane|sevoflurane|mesh-list
44833018|NCT02202239|Cisatracurium|cisatracurium|mesh-list
44833019|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44833020|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833021|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833022|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44833023|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
44833024|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
44833025|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44833026|NCT02202239|Narcotics|narcotics|mesh-ancestor
44833027|NCT02202239|Analgesics|analgesics|mesh-ancestor
44833028|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
44833029|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833030|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44833031|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44833032|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44833033|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44833034|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
44833035|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
44833036|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833037|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833038|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44833039|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44833040|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44833041|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44833042|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
44833043|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44833044|NCT02202304|Thymol|thymol|mesh-list
44833045|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44833046|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833047|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
44833048|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
44833049|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
44615480|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
44833050|NCT02202473|Lamivudine|lamivudine|mesh-list
44833051|NCT02202473|Oxymatrine|oxymatrine|mesh-list
44833052|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44833053|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44833054|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833055|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833056|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
44833057|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833058|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833059|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833060|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44833061|NCT02202512|Naproxen|naproxen|mesh-list
44833062|NCT02202512|Cimetidine|cimetidine|mesh-list
44833063|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44833064|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833065|NCT02202512|Analgesics|analgesics|mesh-ancestor
44833066|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
44833067|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833068|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833069|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833070|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833071|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
44833072|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44319412|NCT00922519|Listerine|listerine|mesh-list
44833073|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833074|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833075|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44833076|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833077|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44833078|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
44833079|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
44833080|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833081|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44833082|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44833083|NCT02202525|Telmisartan|telmisartan|mesh-list
44833084|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833085|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44833086|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44833087|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833088|NCT02202564|Ganciclovir|ganciclovir|mesh-list
44833089|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44833090|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
44833091|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833092|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44833093|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833094|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833095|NCT02202603|Teriparatide|teriparatide|mesh-list
44833096|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833097|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833098|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44833099|NCT02202707|Gabapentin|gabapentin|mesh-list
44833100|NCT02202707|Analgesics|analgesics|mesh-ancestor
44833101|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
44833102|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833103|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833104|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
44833105|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44833106|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44833107|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833108|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44833109|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44833110|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44833111|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974473|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
44833112|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833113|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
44833114|NCT02202720|Sevoflurane|sevoflurane|mesh-list
44833115|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44833116|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44833117|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
44833118|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
44833119|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833120|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833121|NCT02202889|Calcium|calcium|mesh-list
44833122|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833123|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833124|NCT02202967|Misoprostol|misoprostol|mesh-list
44833125|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44833126|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
44833127|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44833128|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833129|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44833130|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833131|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
44833132|NCT02202993|Mibefradil|mibefradil|mesh-list
44833133|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833134|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833135|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833136|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319503|NCT00923390|Aldesleukin|aldesleukin|mesh-list
44833137|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833138|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833139|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44833140|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44833141|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44833142|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833143|NCT02203097|Propofol|propofol|mesh-list
44833144|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44833145|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833146|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833147|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44833148|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
44833149|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
44833150|NCT02203175|Fentanyl|fentanyl|mesh-list
44833151|NCT02203175|Propofol|propofol|mesh-list
44833152|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44833153|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833154|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833155|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44833156|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
44833157|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
44833158|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44833159|NCT02203175|Narcotics|narcotics|mesh-ancestor
44833160|NCT02203175|Analgesics|analgesics|mesh-ancestor
44833161|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
44833162|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833163|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44833164|NCT02203227|Turmeric extract|turmeric extract|mesh-list
44833165|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
44833166|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833167|NCT02203227|Protective Agents|protective agents|mesh-ancestor
44833168|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833169|NCT02203253|Thalidomide|thalidomide|mesh-list
44833170|NCT02203253|Dexamethasone|dexamethasone|mesh-list
44833171|NCT02203253|Palonosetron|palonosetron|mesh-list
44833172|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833173|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
44833174|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
44833175|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833176|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833177|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833178|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
44833179|NCT02203253|Hormones|hormones|mesh-ancestor
44833180|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833181|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833182|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833183|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833184|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
44833185|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
44833186|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833187|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833188|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44833189|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44833190|NCT02203253|Growth Substances|growth substances|mesh-ancestor
44833191|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
44833192|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44833193|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44833194|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
44833195|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833196|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833197|NCT02203396|Cyclosporine|cyclosporine|mesh-list
44833198|NCT02203396|Levamisole|levamisole|mesh-list
44833199|NCT02203396|Cyclosporins|cyclosporins|mesh-list
44833200|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
44833201|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833202|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833203|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833204|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
44833205|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833206|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
44833207|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833208|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
44833209|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833210|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44833211|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44833212|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
44833213|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
44833214|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44833215|NCT02203422|Cyclosporine|cyclosporine|mesh-list
44833216|NCT02203422|Cyclosporins|cyclosporins|mesh-list
44833217|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833218|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833219|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833220|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
44833221|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833222|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
44833223|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833224|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
44833225|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833226|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44833227|NCT02203461|Ritonavir|ritonavir|mesh-list
44833228|NCT02203461|Lopinavir|lopinavir|mesh-list
44833229|NCT02203461|Darunavir|darunavir|mesh-list
44833230|NCT02203461|Tenofovir|tenofovir|mesh-list
44833231|NCT02203461|Emtricitabine|emtricitabine|mesh-list
44319576|NCT00923962|Incretins|incretins|mesh-ancestor
44833232|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44833233|NCT02203461|Cobicistat|cobicistat|mesh-list
44833234|NCT02203461|Elvitegravir|elvitegravir|mesh-list
44833235|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44833236|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44833237|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
44833238|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833239|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833240|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833241|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833242|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
44833243|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833244|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44833245|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44833246|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44833247|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44833248|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44833249|NCT02203500|Telmisartan|telmisartan|mesh-list
44833250|NCT02203500|Lacidipine|lacidipine|mesh-list
44833251|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833252|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44833253|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44833254|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833255|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833256|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833257|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833258|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833259|NCT02203552|Minocycline|minocycline|mesh-list
44833260|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833261|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833262|NCT02203604|Aldesleukin|aldesleukin|mesh-list
44833263|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44833264|NCT02203604|Ipilimumab|ipilimumab|mesh-list
44833265|NCT02203604|Interleukin-2|interleukin-2|mesh-list
44833266|NCT02203604|Antibodies|antibodies|mesh-list
44833267|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
44833268|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44833269|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
44833270|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833271|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833272|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44467494|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833273|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833274|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833275|NCT02203604|Analgesics|analgesics|mesh-ancestor
44833276|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
44833277|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833278|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833279|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833280|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
44833281|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833282|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
44833283|NCT02203656|Testosterone|testosterone|mesh-list
44833284|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
44833285|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
44833286|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44833287|NCT02203656|Androgens|androgens|mesh-ancestor
44833288|NCT02203656|Hormones|hormones|mesh-ancestor
44833289|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833290|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833291|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833292|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833293|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
44833294|NCT02203760|Gemcitabine|gemcitabine|mesh-list
44833295|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44833296|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
44833297|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833298|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833299|NCT02203760|Antiviral Agents|antiviral agents|mesh-ancestor
44833300|NCT02203760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833301|NCT02203760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833302|NCT02203760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833303|NCT02203760|Immunologic Factors|immunologic factors|mesh-ancestor
44833304|NCT02203760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833305|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
44833306|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833307|NCT02204020|Azacitidine|azacitidine|mesh-list
44833308|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44833309|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
44833310|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833311|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833312|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833313|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44833314|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44833315|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833316|NCT02204397|Ustekinumab|ustekinumab|mesh-list
44833317|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
44833318|NCT02204475|Interferons|interferons|mesh-list
44833319|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44833320|NCT02204475|Grazoprevir|grazoprevir|mesh-list
44833321|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44833322|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833323|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
44833324|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833325|NCT02204501|Midazolam|midazolam|mesh-list
44833326|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44833327|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44833328|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833329|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833330|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44833331|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44833332|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44833333|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44833334|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
44833335|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
44833336|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
44833337|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
44833338|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833339|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833340|NCT02204527|Vitamin D|vitamin d|mesh-list
44833341|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
44833342|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
44833343|NCT02204527|Vitamins|vitamins|mesh-list
44833344|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
44833345|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833346|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44833347|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833348|NCT02204553|Panobinostat|panobinostat|mesh-list
44833349|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833350|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44833351|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833352|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615927|NCT00612534|Dsuvia|dsuvia|mesh-list
44833353|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
44833354|NCT02204644|HH-GV-678|hh-gv-678|mesh-list
44833355|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319637|NCT00924742|Tazobactam|tazobactam|mesh-list
44833356|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44833357|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833358|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833359|NCT02204683|Aflibercept|aflibercept|mesh-list
44833360|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44833361|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44833362|NCT02204683|Growth Substances|growth substances|mesh-ancestor
44833363|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833364|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
44833365|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833366|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
44833367|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833368|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44833369|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833370|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833371|NCT02204839|Insulin|insulin|mesh-list
44833372|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
44833373|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
44833374|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44833375|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833376|NCT02204852|Iloprost|iloprost|mesh-list
44833377|NCT02204852|Eptifibatide|eptifibatide|mesh-list
44833378|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44833379|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
44833380|NCT02204878|Parecoxib|parecoxib|mesh-list
44833381|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44833382|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44833383|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833384|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833385|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44833386|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833387|NCT02204878|Analgesics|analgesics|mesh-ancestor
44833388|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
44833389|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833390|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833391|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833392|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833393|NCT02205034|Oxytocin|oxytocin|mesh-list
44833394|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
44833395|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44833396|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833397|NCT02205112|Levofloxacin|levofloxacin|mesh-list
44833398|NCT02205112|Ofloxacin|ofloxacin|mesh-list
44833399|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44833400|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833401|NCT02205112|Renal Agents|renal agents|mesh-ancestor
44833402|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833403|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44833404|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44833405|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615929|NCT00612534|Narcotics|narcotics|mesh-ancestor
44615930|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615931|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615932|NCT00612534|Analgesics|analgesics|mesh-ancestor
44615933|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
44615934|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615935|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44615936|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44615937|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
44615938|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
44615939|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44615940|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44615941|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44615942|NCT00612508|Etonogestrel|etonogestrel|mesh-list
44615943|NCT00612508|Desogestrel|desogestrel|mesh-list
44615944|NCT00612508|NuvaRing|nuvaring|mesh-list
44615945|NCT00612508|Estradiol|estradiol|mesh-list
44615946|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44615947|NCT00612508|Estrogens|estrogens|mesh-ancestor
44615948|NCT00612508|Hormones|hormones|mesh-ancestor
44615949|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615950|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615951|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44833406|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833407|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833408|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44833409|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44833410|NCT02205151|Amlodipine|amlodipine|mesh-list
44833411|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833412|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833413|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833414|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833415|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833416|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833417|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
44833418|NCT02205164|Aprepitant|aprepitant|mesh-list
44833419|NCT02205164|Palonosetron|palonosetron|mesh-list
44833420|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
44833421|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
44833422|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833423|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833424|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833425|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44833426|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833427|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833428|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44833429|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44833430|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
44833431|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44833432|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44833433|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44833434|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
44833435|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833436|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44833437|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44833438|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833439|NCT02205242|Azithromycin|azithromycin|mesh-list
44833440|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833441|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833442|NCT02205255|Azithromycin|azithromycin|mesh-list
44833443|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833444|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833445|NCT02205398|Cetuximab|cetuximab|mesh-list
44833446|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44833447|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833448|NCT02205489|Cetirizine|cetirizine|mesh-list
44833449|NCT02205489|Acyclovir|acyclovir|mesh-list
44833450|NCT02205489|Ibuprofen|ibuprofen|mesh-list
44833451|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
44833452|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44833453|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44833454|NCT02205489|Prednisolone|prednisolone|mesh-list
44833455|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
44833456|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
44833457|NCT02205489|Esomeprazole|esomeprazole|mesh-list
44833458|NCT02205489|Ranitidine|ranitidine|mesh-list
44833459|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44833460|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
44833461|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44833462|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833463|NCT02205489|Analgesics|analgesics|mesh-ancestor
44833464|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
44833465|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833466|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319761|NCT00925977|Insulin|insulin|mesh-list
44833467|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833468|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833469|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44833470|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833471|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833472|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
44833473|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
44833474|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833475|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
44833476|NCT02205489|Hormones|hormones|mesh-ancestor
44833477|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833478|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44833479|NCT02205489|Protective Agents|protective agents|mesh-ancestor
44833480|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833481|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833482|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44833483|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44833484|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44833485|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
44833486|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833487|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44833488|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44833489|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44833490|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
44833491|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
44833492|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833493|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44833495|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
44833496|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
44833497|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833498|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833499|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
44833500|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833501|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319807|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44833502|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44833503|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44833504|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833505|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833506|NCT02205541|Eculizumab|eculizumab|mesh-list
44833507|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44833508|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833509|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
44833510|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833511|NCT02205554|Tramadol|tramadol|mesh-list
44833512|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44833513|NCT02205554|Narcotics|narcotics|mesh-ancestor
44833514|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833515|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833516|NCT02205554|Analgesics|analgesics|mesh-ancestor
44833517|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
44833518|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833519|NCT02205580|Sufentanil|sufentanil|mesh-list
44833520|NCT02205580|Dsuvia|dsuvia|mesh-list
44833521|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44833522|NCT02205580|Narcotics|narcotics|mesh-ancestor
44833523|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833524|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833525|NCT02205580|Analgesics|analgesics|mesh-ancestor
44833526|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
44833527|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833528|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44833529|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44833530|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
44833531|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
44833532|NCT02205619|Glycine|glycine|mesh-list
44833533|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
44833534|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833535|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833536|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833537|NCT02205775|Atorvastatin|atorvastatin|mesh-list
44833538|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44833539|NCT02205775|Ezetimibe|ezetimibe|mesh-list
44833540|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44833541|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44833542|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
44833543|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833544|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44833545|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44833546|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833547|NCT02205879|Pregabalin|pregabalin|mesh-list
44833548|NCT02205879|Analgesics|analgesics|mesh-ancestor
44833549|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
44833550|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833551|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833552|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
44833553|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833554|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833555|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833556|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833557|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44833558|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44833559|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833560|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44833561|NCT02205892|Lupeol|lupeol|mesh-list
44833562|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833563|NCT02205931|Topiramate|topiramate|mesh-list
44833564|NCT02205931|Lamotrigine|lamotrigine|mesh-list
44833565|NCT02205931|Zonisamide|zonisamide|mesh-list
44833566|NCT02205931|Carbamazepine|carbamazepine|mesh-list
44833567|NCT02205931|Phenytoin|phenytoin|mesh-list
44833568|NCT02205931|Rufinamide|rufinamide|mesh-list
44833569|NCT02205931|Levetiracetam|levetiracetam|mesh-list
44833570|NCT02205931|Valproic Acid|valproic acid|mesh-list
44833571|NCT02205931|Clonazepam|clonazepam|mesh-list
44833572|NCT02205931|Vigabatrin|vigabatrin|mesh-list
44833573|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
44833574|NCT02205931|Clobazam|clobazam|mesh-list
44833575|NCT02205931|Ethosuximide|ethosuximide|mesh-list
44833576|NCT02205931|Stiripentol|stiripentol|mesh-list
44833577|NCT02205931|Nitrazepam|nitrazepam|mesh-list
44833578|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44833579|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833580|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
44833581|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833582|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833583|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833584|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833585|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44833586|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44833587|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833588|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44833589|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44833590|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833591|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
44833592|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833593|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
44833594|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833595|NCT02205931|Analgesics|analgesics|mesh-ancestor
44833596|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
44833597|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833598|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44833599|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44833600|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44833601|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44833602|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
44833603|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44833604|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44833605|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
44833606|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44833607|NCT02205996|Insulin|insulin|mesh-list
44833608|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44833609|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44833610|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833611|NCT02206022|Remifentanil|remifentanil|mesh-list
44833612|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44833613|NCT02206022|Narcotics|narcotics|mesh-ancestor
44833614|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833615|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833616|NCT02206022|Analgesics|analgesics|mesh-ancestor
44833617|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
44833618|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833619|NCT02206165|Amlodipine|amlodipine|mesh-list
44833620|NCT02206165|Candesartan|candesartan|mesh-list
44833621|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
44833622|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833623|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44833624|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44833625|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833626|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44833627|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833628|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
44833629|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44833630|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44616100|NCT00610935|Peramivir|peramivir|mesh-list
44833631|NCT02206178|Acetaminophen|acetaminophen|mesh-list
44833632|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
44833633|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44833634|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833635|NCT02206178|Analgesics|analgesics|mesh-ancestor
44833636|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
44833637|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833638|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833639|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
44696244|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
44696245|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247830|NCT01610557|Bevacizumab|bevacizumab|mesh-list
44696248|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696249|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
44696250|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696251|NCT01390571|Temozolomide|temozolomide|mesh-list
44696252|NCT01390571|Olaparib|olaparib|mesh-list
44696253|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44696254|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
44696255|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696256|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696257|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44696258|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696259|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
44696260|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44696261|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696262|NCT01390662|Vitamin D|vitamin d|mesh-list
44696263|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
44696264|NCT01390662|Vitamins|vitamins|mesh-ancestor
44696265|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
44696266|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696267|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44696268|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44696269|NCT01390766|Azathioprine|azathioprine|mesh-list
44696270|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
44696271|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696272|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696273|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696274|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696275|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
44696276|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696277|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44696278|NCT01390792|Zanamivir|zanamivir|mesh-list
44696279|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
44696280|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696281|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696282|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696283|NCT01390805|Valacyclovir|valacyclovir|mesh-list
44696284|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
44696285|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696286|NCT01390883|PENTA|penta|mesh-list
44696287|NCT01390883|Fondaparinux|fondaparinux|mesh-list
44696288|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44696289|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
44696290|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44696291|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696292|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696293|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696294|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
44696295|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44696296|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44696297|NCT01390896|PENTA|penta|mesh-list
44696298|NCT01390896|Fondaparinux|fondaparinux|mesh-list
44696299|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44696300|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
44696301|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44696302|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696303|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696304|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696305|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
44696306|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44696307|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44696308|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
44696309|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44696310|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44696311|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44696312|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696313|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833640|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
44833641|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833642|NCT02206178|Expectorants|expectorants|mesh-ancestor
44833643|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
44833644|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44833645|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
44833646|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833647|NCT02206178|Protective Agents|protective agents|mesh-ancestor
44833648|NCT02206178|Antidotes|antidotes|mesh-ancestor
44833649|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
44833650|NCT02206204|Selexipag|selexipag|mesh-list
44833651|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44833652|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833653|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833654|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44833655|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44833656|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833657|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833658|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833659|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44833660|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
44833661|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44833662|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833663|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44833664|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44833665|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44833666|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44616182|NCT00609869|Rituximab|rituximab|mesh-list
44833667|NCT02206295|Selexipag|selexipag|mesh-list
44833668|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833669|NCT02206308|Antibodies|antibodies|mesh-list
44833670|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44833671|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
44833672|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833673|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
44833674|NCT02206425|Dexamethasone|dexamethasone|mesh-list
44833675|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
44833676|NCT02206425|Prednisone|prednisone|mesh-list
44833677|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
44833678|NCT02206425|Melphalan|melphalan|mesh-list
44833679|NCT02206425|Doxorubicin|doxorubicin|mesh-list
44833680|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44833681|NCT02206425|Lenalidomide|lenalidomide|mesh-list
44833682|NCT02206425|Pomalidomide|pomalidomide|mesh-list
44833683|NCT02206425|BB 1101|bb 1101|mesh-list
44833684|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833685|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
44320047|NCT00927147|Cetuximab|cetuximab|mesh-list
44320069|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833686|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833687|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833688|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44833689|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
44833690|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833691|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833692|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44833693|NCT02206425|Vitamins|vitamins|mesh-ancestor
44833694|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
44833695|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833696|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
44833697|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
44833698|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833699|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833700|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
44833701|NCT02206425|Hormones|hormones|mesh-ancestor
44833702|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833703|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833704|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
44833705|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833706|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44833707|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44833708|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44833709|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44833710|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44833711|NCT02206425|Growth Substances|growth substances|mesh-ancestor
44833712|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
44833713|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
44833714|NCT02206425|Protective Agents|protective agents|mesh-ancestor
44833715|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44833716|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44833717|NCT02206477|Protective Agents|protective agents|mesh-ancestor
44833718|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833719|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44833720|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
44833721|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833722|NCT02206490|Naltrexone|naltrexone|mesh-list
44833723|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
44833724|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44833725|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44833726|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833727|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
44833728|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833729|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
44833730|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
44833731|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44833732|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44833733|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833734|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833735|NCT02206503|Dexamethasone|dexamethasone|mesh-list
44833736|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
44833737|NCT02206503|Lenalidomide|lenalidomide|mesh-list
44833738|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833739|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
44833740|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833741|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833742|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44833743|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
44833744|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833745|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833746|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44833747|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833749|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
44833750|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833751|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833752|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
44833753|NCT02206503|Hormones|hormones|mesh-ancestor
44833754|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833755|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833756|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44833757|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44833758|NCT02206503|Growth Substances|growth substances|mesh-ancestor
44833759|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44833760|NCT02206555|Tenofovir|tenofovir|mesh-list
44833761|NCT02206555|Emtricitabine|emtricitabine|mesh-list
44833762|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44833763|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
44833764|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833765|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44833766|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44833767|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833768|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833769|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833770|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833771|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
44833772|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
44833773|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44833774|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833775|NCT02206646|Tenecteplase|tenecteplase|mesh-list
44833776|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44833777|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44320144|NCT00927654|Iloprost|iloprost|mesh-list
44833778|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833779|NCT02206659|Telmisartan|telmisartan|mesh-list
44833780|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833781|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44833782|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44833783|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833784|NCT02206711|BMS-955176|bms-955176|mesh-list
44833785|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833786|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833787|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
44833788|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833789|NCT02206737|Nicotine|nicotine|mesh-list
44833790|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44833791|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
44833792|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833793|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833794|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44833795|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44833796|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
44833797|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833798|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833799|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44833800|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44833801|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833802|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44833803|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833804|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833805|NCT02206789|Cyclosporine|cyclosporine|mesh-list
44833806|NCT02206789|Prednisolone|prednisolone|mesh-list
44833807|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44833808|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
44833809|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44833810|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
44833811|NCT02206789|Cyclosporins|cyclosporins|mesh-list
44833812|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44833813|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
44833814|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833815|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833816|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696314|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
44833817|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
44833818|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833819|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
44833820|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833821|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44833822|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833823|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44833824|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833825|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
44833826|NCT02206789|Hormones|hormones|mesh-ancestor
44833827|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833828|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44833829|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833830|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
44833831|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
44833832|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833833|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44833834|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44833835|NCT02206789|Protective Agents|protective agents|mesh-ancestor
44833836|NCT02206802|Minoxidil|minoxidil|mesh-list
44833837|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44833838|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
44833839|NCT02206815|Aspirin|aspirin|mesh-list
44833840|NCT02206815|Warfarin|warfarin|mesh-list
44833841|NCT02206815|Clopidogrel|clopidogrel|mesh-list
44833842|NCT02206815|Ticagrelor|ticagrelor|mesh-list
44833843|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44833844|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833845|NCT02206815|Analgesics|analgesics|mesh-ancestor
44833846|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
44833847|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833848|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833849|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833850|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833851|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44833852|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44833853|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833854|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44833855|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44833856|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833857|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
44833858|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44833859|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44833860|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44833861|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
44833862|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833863|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
44833864|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
44833865|NCT02206854|Analgesics|analgesics|mesh-ancestor
44833866|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
44833867|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833868|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833869|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44833870|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44833871|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833872|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833873|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44833874|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833875|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833876|NCT02206867|Adalimumab|adalimumab|mesh-list
44833877|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616410|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44616411|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320244|NCT00928213|Heparin|heparin|mesh-list
44616412|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
44616413|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44616414|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44616415|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44616416|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44616417|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44616418|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44616419|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44616420|NCT00608894|Prednisone|prednisone|mesh-list
44616421|NCT00608894|Azathioprine|azathioprine|mesh-list
44616422|NCT00608894|Tacrolimus|tacrolimus|mesh-list
44616423|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44833878|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44833879|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
44833880|NCT02206932|Simeprevir|simeprevir|mesh-list
44833881|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
44833882|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833883|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44833884|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833885|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833886|NCT02207010|Adavosertib|adavosertib|mesh-list
44833887|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833888|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833889|NCT02207335|Gemcitabine|gemcitabine|mesh-list
44833890|NCT02207335|Carboplatin|carboplatin|mesh-list
44833891|NCT02207335|Capecitabine|capecitabine|mesh-list
44833892|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833893|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44833894|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
44833895|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833896|NCT02207335|Antiviral Agents|antiviral agents|mesh-ancestor
44833897|NCT02207335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833898|NCT02207335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833899|NCT02207335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833900|NCT02207335|Immunologic Factors|immunologic factors|mesh-ancestor
44833901|NCT02207335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833902|NCT02207348|Liraglutide|liraglutide|mesh-list
44833903|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44833904|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833905|NCT02207348|Incretins|incretins|mesh-ancestor
44833906|NCT02207348|Hormones|hormones|mesh-ancestor
44833907|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44833908|NCT02207361|Paclitaxel|paclitaxel|mesh-list
44833909|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44833910|NCT02207361|Carboplatin|carboplatin|mesh-list
44833911|NCT02207361|Epirubicin|epirubicin|mesh-list
44833912|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44833913|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833914|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
44833915|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
44833916|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
44833917|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833918|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44833919|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44833920|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44833921|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833922|NCT02207387|Rasagiline|rasagiline|mesh-list
44833923|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44833924|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320296|NCT00928837|Analgesics|analgesics|mesh-ancestor
44320297|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
44833925|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833926|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44833927|NCT02207387|Protective Agents|protective agents|mesh-ancestor
44833928|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833929|NCT02207426|Tobramycin|tobramycin|mesh-list
44833930|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833931|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833932|NCT02207439|Nelfinavir|nelfinavir|mesh-list
44833933|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44833934|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44833935|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
44833936|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833937|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833938|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44833939|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44833940|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
44833941|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833942|NCT02207452|Albuterol|albuterol|mesh-list
44833943|NCT02207452|Ipratropium|ipratropium|mesh-list
44833944|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44833945|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
44833946|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833947|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833948|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44833949|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44833950|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
44833951|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44833952|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44616425|NCT00608894|Hormones|hormones|mesh-ancestor
44833953|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44833954|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44833955|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
44833956|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44833957|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833958|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44833959|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
44833960|NCT02207660|Cisplatin|cisplatin|mesh-list
44833961|NCT02207660|Fluorouracil|fluorouracil|mesh-list
44833962|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833963|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
44833964|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833965|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44833966|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44833967|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
44833968|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833969|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
44833970|NCT02207699|Benzonatate|benzonatate|mesh-list
44833971|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44833972|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833973|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44833974|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44833975|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44833976|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44833977|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833978|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
44833979|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
44833980|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
44833981|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
44833982|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
44833983|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44833984|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833985|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
44833986|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44833987|NCT02207920|Vaccines|vaccines|mesh-list
44833988|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
44833989|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44833990|NCT02207959|Proflavine|proflavine|mesh-list
44833991|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44833992|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44833993|NCT02208128|Bevacizumab|bevacizumab|mesh-list
44833994|NCT02208128|Sunitinib|sunitinib|mesh-list
44833995|NCT02208128|Everolimus|everolimus|mesh-list
44833996|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44833997|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44833998|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44833999|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44834000|NCT02208128|Growth Substances|growth substances|mesh-ancestor
44834001|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834002|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
44834003|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834004|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
44834005|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44834006|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834007|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834008|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
44834009|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44834010|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44834011|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834012|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
44834013|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
44834014|NCT02208245|Ropivacaine|ropivacaine|mesh-list
44834015|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
44834016|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
44834017|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834018|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834019|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
44834020|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834021|NCT02208427|Isoniazid|isoniazid|mesh-list
44834022|NCT02208427|Rifapentine|rifapentine|mesh-list
44834023|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
44834024|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834025|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834026|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44834027|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44834028|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
44834029|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834030|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44834031|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44834032|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
44834033|NCT02208492|Levetiracetam|levetiracetam|mesh-list
44834034|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
44834035|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
44834036|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
44834037|NCT02208505|Remifentanil|remifentanil|mesh-list
44834038|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834039|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834040|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834041|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834042|NCT02208505|Analgesics|analgesics|mesh-ancestor
44834043|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
44834044|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834045|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44834046|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44834047|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44834048|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44834049|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834050|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834051|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834052|NCT02208505|Narcotics|narcotics|mesh-ancestor
44834053|NCT02208583|Prednisone|prednisone|mesh-list
44834054|NCT02208583|Cisplatin|cisplatin|mesh-list
44834055|NCT02208583|Docetaxel|docetaxel|mesh-list
44834056|NCT02208583|Etoposide|etoposide|mesh-list
44834057|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
44834058|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834059|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44834060|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44834061|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44834062|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834063|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834064|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
44834065|NCT02208583|Hormones|hormones|mesh-ancestor
44834066|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834067|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834068|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44834069|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44834070|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44834071|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44834072|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834073|NCT02208596|Pentazocine|pentazocine|mesh-list
44834074|NCT02208596|Propofol|propofol|mesh-list
44834075|NCT02208596|Etomidate|etomidate|mesh-list
44320427|NCT00930020|Minocycline|minocycline|mesh-list
44834076|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834077|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834078|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834079|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834080|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
44834081|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
44834082|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834083|NCT02208596|Narcotics|narcotics|mesh-ancestor
44834084|NCT02208596|Analgesics|analgesics|mesh-ancestor
44834085|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
44834086|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834087|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44834088|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44834089|NCT02208778|Remifentanil|remifentanil|mesh-list
44616569|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834090|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44834092|NCT02208778|Narcotics|narcotics|mesh-ancestor
44834093|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834094|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320473|NCT00930189|Hormones|hormones|mesh-ancestor
44834095|NCT02208778|Analgesics|analgesics|mesh-ancestor
44834096|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
44834097|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834098|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44834099|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44834100|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834101|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834102|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834103|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
44834104|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834105|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
44834106|NCT02208791|Sirolimus|sirolimus|mesh-list
44834107|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834108|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834109|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44834110|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834111|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
44834112|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834113|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
44834114|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834115|NCT02208882|Midazolam|midazolam|mesh-list
44834116|NCT02208882|BMS-986120|bms-986120|mesh-list
44834117|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44834118|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834119|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834120|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834121|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44834122|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44834123|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834124|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834125|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
44834126|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
44834127|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
44834128|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
44834129|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834130|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834131|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44320490|NCT00930306|Omeprazole|omeprazole|mesh-list
44834132|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44834133|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
44834134|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44834135|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
44834136|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44834137|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834138|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44834139|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44834140|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834141|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44834142|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44834143|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44834144|NCT02209025|Theobromine|theobromine|mesh-list
44834145|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44834146|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
44834147|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834148|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834149|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44834150|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44834151|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
44834152|NCT02209155|Verapamil|verapamil|mesh-list
44834153|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44834154|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44834155|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834156|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834157|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44834158|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834159|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
44834160|NCT02209350|Aspirin|aspirin|mesh-list
44834161|NCT02209350|Clopidogrel|clopidogrel|mesh-list
44616646|NCT00606320|Aripiprazole|aripiprazole|mesh-list
44834162|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44834163|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834164|NCT02209350|Analgesics|analgesics|mesh-ancestor
44834165|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
44834166|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834167|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834168|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834169|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44834170|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44834171|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44834172|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834173|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44834174|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44834175|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834176|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
44834177|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44834178|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44834179|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44834180|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
44834181|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834182|NCT02209428|Temozolomide|temozolomide|mesh-list
44834183|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44834184|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
44834185|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834186|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834187|NCT02209441|Sorafenib|sorafenib|mesh-list
44834188|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834189|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44834190|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834191|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834192|NCT02209649|Telmisartan|telmisartan|mesh-list
44834193|NCT02209649|Lacidipine|lacidipine|mesh-list
44834194|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44834195|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44834196|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44834197|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834198|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44834199|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834200|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44834201|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834202|NCT02209701|Porfiromycin|porfiromycin|mesh-list
44834203|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44834204|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834205|NCT02209740|Tenofovir|tenofovir|mesh-list
44834206|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
44834207|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834208|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44834209|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44834210|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834211|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834212|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44834213|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44834214|NCT02209831|Pantoprazole|pantoprazole|mesh-list
44834215|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44834216|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834217|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44320573|NCT00930670|Omeprazole|omeprazole|mesh-list
44834218|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834219|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834221|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44834222|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834223|NCT02209909|Analgesics|analgesics|mesh-ancestor
44834224|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
44834225|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834226|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834227|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834228|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44834229|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44834230|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44834231|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834232|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44834233|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44834234|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834235|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
44834236|NCT02209974|Fluticasone|fluticasone|mesh-list
44834237|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834238|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44834239|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
44834240|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834241|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834242|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44834243|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44834244|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
44834245|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44834246|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44834247|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
44834248|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834249|NCT02210156|Micronutrients|micronutrients|mesh-list
44834250|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834251|NCT02210169|Vancomycin|vancomycin|mesh-list
44834252|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834253|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834254|NCT02210728|Methylphenidate|methylphenidate|mesh-list
44834255|NCT02210728|Amphetamine|amphetamine|mesh-list
44834256|NCT02210728|Adderall|adderall|mesh-list
44834257|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
44834258|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44834259|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834260|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44834261|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44834262|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834263|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834264|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
44834265|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834266|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
44834267|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
44834268|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834269|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
44834270|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44834271|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
44834272|NCT02210949|Hematinics|hematinics|mesh-ancestor
44834273|NCT02211326|Warfarin|warfarin|mesh-list
44834274|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
44834275|NCT02211729|Azithromycin|azithromycin|mesh-list
44834276|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
44834277|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
44834278|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44834279|NCT02211729|Amodiaquine|amodiaquine|mesh-list
44834280|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834281|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834282|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
44834283|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44834284|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44834285|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44834286|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834287|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834288|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44834289|NCT02211729|Renal Agents|renal agents|mesh-ancestor
44834290|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
44834291|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44834292|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834293|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834294|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616799|NCT00605657|Valproic Acid|valproic acid|mesh-list
44834295|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
44834296|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44834297|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834298|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834299|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
44834300|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834301|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834302|NCT02212392|Meropenem|meropenem|mesh-list
44834303|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834304|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834305|NCT02212535|Plerixafor|plerixafor|mesh-list
44834306|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44834307|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44834308|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
44834309|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834310|NCT02213302|Midazolam|midazolam|mesh-list
44834311|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44834312|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44320669|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44320671|NCT00931021|Nicotine|nicotine|mesh-list
44834313|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834314|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834315|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44834316|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44834317|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834318|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834319|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
44834320|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
44834321|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
44834322|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
44834323|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834324|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834325|NCT02213744|Gemcitabine|gemcitabine|mesh-list
44834326|NCT02213744|Capecitabine|capecitabine|mesh-list
44834327|NCT02213744|Trastuzumab|trastuzumab|mesh-list
44834328|NCT02213744|Vinorelbine|vinorelbine|mesh-list
44834329|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44834330|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
44834331|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834332|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834333|NCT02213744|Antiviral Agents|antiviral agents|mesh-ancestor
44834334|NCT02213744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834335|NCT02213744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834336|NCT02213744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834337|NCT02213744|Immunologic Factors|immunologic factors|mesh-ancestor
44834338|NCT02213744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834339|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44834340|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44834341|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44834342|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44834343|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44834344|NCT02213757|Estrogens|estrogens|mesh-list
44834345|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44834346|NCT02213757|Hormones|hormones|mesh-ancestor
44834347|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834348|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834349|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
44834350|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834351|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834352|NCT02215213|Vitamin D|vitamin d|mesh-list
44834353|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
44834354|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
44834355|NCT02215213|Vitamins|vitamins|mesh-list
44834356|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
44320693|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44834357|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834358|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44834359|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44834360|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
44834361|NCT02217020|Irinotecan|irinotecan|mesh-list
44834362|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834363|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44834364|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44834365|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834366|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834367|NCT02217787|PF-06372865|pf-06372865|mesh-list
44834368|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
44834369|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
44834370|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834371|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834372|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834373|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
44834374|NCT02218476|Vitamins|vitamins|mesh-ancestor
44834375|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
44834376|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834377|NCT02219698|Acetaminophen|acetaminophen|mesh-list
44834378|NCT02219698|Ibuprofen|ibuprofen|mesh-list
44834379|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44834380|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834381|NCT02219698|Analgesics|analgesics|mesh-ancestor
44834382|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
44834383|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834384|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834385|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834386|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44834387|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44834388|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834389|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834390|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
44834391|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
44834392|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44834393|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
44834394|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834395|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834396|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44834397|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44834398|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44834399|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
44834400|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834401|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834402|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44834403|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
44834404|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
44834405|NCT02220023|Protective Agents|protective agents|mesh-ancestor
44834406|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
44834407|NCT02220036|Antacids|antacids|mesh-ancestor
44834408|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834409|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834410|NCT02220049|Bortezomib|bortezomib|mesh-list
44834411|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834412|NCT02220088|Leucovorin|leucovorin|mesh-list
44834413|NCT02220088|Fluorouracil|fluorouracil|mesh-list
44696315|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696316|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696317|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44696318|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696319|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44696320|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696321|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696322|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320771|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
44696323|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44696325|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
44696326|NCT01390961|Pheniramine|pheniramine|mesh-list
44696327|NCT01390961|Naphazoline|naphazoline|mesh-list
44696328|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696329|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44696330|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44696331|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44696332|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696333|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696334|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
44696335|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44696336|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696337|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44696338|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
44696339|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
44696340|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
44696341|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44696342|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44696343|NCT01391052|Norethindrone|norethindrone|mesh-list
44696344|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
44696345|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44696346|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44696347|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44696348|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
44616950|NCT00603980|Alprazolam|alprazolam|mesh-list
44834414|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
44834415|NCT02220088|Sorafenib|sorafenib|mesh-list
44834416|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
44834417|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834418|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44834419|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834420|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834421|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
44834422|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834423|NCT02220088|Antidotes|antidotes|mesh-ancestor
44834424|NCT02220088|Protective Agents|protective agents|mesh-ancestor
44834425|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
44834426|NCT02220088|Vitamins|vitamins|mesh-ancestor
44834427|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
44834428|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44834429|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834430|NCT02220114|Vigabatrin|vigabatrin|mesh-list
44834431|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
44834432|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834433|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834434|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
44834435|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834436|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834437|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
44834438|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834439|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
44320797|NCT00931645|Dexamethasone|dexamethasone|mesh-list
44834440|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834441|NCT02220218|Metformin|metformin|mesh-list
44834442|NCT02220218|Canagliflozin|canagliflozin|mesh-list
44834443|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834444|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834445|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44834446|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616984|NCT00603798|Imiquimod|imiquimod|mesh-list
44616985|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44616986|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
44616987|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616988|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616989|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
44616990|NCT00603733|Mesalamine|mesalamine|mesh-list
44616991|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44616992|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44616993|NCT00603733|Analgesics|analgesics|mesh-ancestor
44616994|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
44834448|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44834449|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
44834450|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834451|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834452|NCT02220335|Digoxin|digoxin|mesh-list
44834453|NCT02220335|Diuretics|diuretics|mesh-list
44834454|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44834455|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44834456|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44834457|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44834458|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834459|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834460|NCT02220335|Protective Agents|protective agents|mesh-ancestor
44834461|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834462|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
44834463|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834464|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44834465|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834466|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44834467|NCT02220348|Linaclotide|linaclotide|mesh-list
44834468|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44834469|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
44834470|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834471|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834472|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
44834473|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834474|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834475|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834476|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834477|NCT02220361|Analgesics|analgesics|mesh-ancestor
44834478|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
44834479|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834480|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44834481|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44834482|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44834483|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
44834484|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834485|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834486|NCT02220400|Ketamine|ketamine|mesh-list
44834487|NCT02220400|Analgesics|analgesics|mesh-ancestor
44834488|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
44834489|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834490|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834491|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44834492|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834493|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
44834494|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
44834495|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834496|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44834497|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44834498|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834499|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834500|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
44834501|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44834502|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834503|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834504|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834505|NCT02220530|Fentanyl|fentanyl|mesh-list
44834506|NCT02220530|Midazolam|midazolam|mesh-list
44834507|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834508|NCT02220530|Narcotics|narcotics|mesh-ancestor
44834509|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834510|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834511|NCT02220530|Analgesics|analgesics|mesh-ancestor
44834512|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
44834513|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834514|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44834515|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834516|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
44834517|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
44834518|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834519|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44834520|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44834521|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834522|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
44834523|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
44834524|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834525|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834526|NCT02220608|Bortezomib|bortezomib|mesh-list
44834527|NCT02220608|Lenograstim|lenograstim|mesh-list
44834528|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44834529|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
44834530|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834531|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834532|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
44834533|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44834534|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
44834535|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834536|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
44834537|NCT02220621|Protective Agents|protective agents|mesh-ancestor
44834538|NCT02220634|Regadenoson|regadenoson|mesh-list
44834539|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44834540|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44834541|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
44834542|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
44834543|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834544|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834545|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834546|NCT02220647|Metformin|metformin|mesh-list
44834547|NCT02220647|Linagliptin|linagliptin|mesh-list
44834548|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834549|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834550|NCT02220647|Incretins|incretins|mesh-ancestor
44834551|NCT02220647|Hormones|hormones|mesh-ancestor
44834552|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834553|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44834554|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834555|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834556|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834557|NCT02220660|Olodaterol|olodaterol|mesh-list
44834558|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44834559|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
44834560|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834561|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834562|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44834563|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
44834564|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
44834565|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
44834566|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834567|NCT02220673|Protective Agents|protective agents|mesh-ancestor
44834568|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834569|NCT02220751|Doxycycline|doxycycline|mesh-list
44834570|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834571|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834572|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
44834573|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44834574|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44834575|NCT02220777|Omeprazole|omeprazole|mesh-list
44834576|NCT02220777|ASP8477|asp8477|mesh-list
44834577|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44834578|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834579|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44834580|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834581|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834582|NCT02220803|Acetazolamide|acetazolamide|mesh-list
44834583|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
44834584|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44834585|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834586|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834587|NCT02220803|Diuretics|diuretics|mesh-ancestor
44834588|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
44834589|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834590|NCT02220829|Silodosin|silodosin|mesh-list
44834591|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44834592|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44834593|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44617075|NCT00602797|Paclitaxel|paclitaxel|mesh-list
44834594|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44834595|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834596|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834597|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834598|NCT02220829|Urological Agents|urological agents|mesh-ancestor
44834599|NCT02220842|Atezolizumab|atezolizumab|mesh-list
44834600|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
44834601|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834602|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44834603|NCT02220868|Ribavirin|ribavirin|mesh-list
44834604|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
44834605|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44834606|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
44834607|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834608|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
44834609|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834610|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44834611|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44834612|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44834613|NCT02221063|Thiamine|thiamine|mesh-list
44834614|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
44834615|NCT02221063|Vitamins|vitamins|mesh-ancestor
44834616|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
44834617|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834618|NCT02221102|Aspirin|aspirin|mesh-list
44834619|NCT02221102|Edoxaban|edoxaban|mesh-list
44834620|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44834621|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834622|NCT02221102|Analgesics|analgesics|mesh-ancestor
44834623|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
44834624|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834625|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834626|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834627|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44834628|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44834629|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44834630|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834631|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44834632|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44834633|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834634|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
44834635|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44834636|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
44834637|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44834638|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834639|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
44834640|NCT02221154|Folic Acid|folic acid|mesh-list
44834641|NCT02221154|Hematinics|hematinics|mesh-ancestor
44834642|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
44834643|NCT02221154|Vitamins|vitamins|mesh-ancestor
44834644|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
44834645|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834646|NCT02221180|Metformin|metformin|mesh-list
44834647|NCT02221180|Canagliflozin|canagliflozin|mesh-list
44834648|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834649|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834650|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44834651|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834652|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
44834653|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834654|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834655|NCT02221375|Ciclesonide|ciclesonide|mesh-list
44834656|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
44834657|NCT02221375|Hormones|hormones|mesh-ancestor
44834658|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834659|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834660|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44834661|NCT02221401|Metformin|metformin|mesh-list
44834662|NCT02221401|Linagliptin|linagliptin|mesh-list
44834663|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834664|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834665|NCT02221401|Incretins|incretins|mesh-ancestor
44834666|NCT02221401|Hormones|hormones|mesh-ancestor
44834667|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834668|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44834669|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834670|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834671|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834673|NCT02221414|Linagliptin|linagliptin|mesh-list
44834674|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834675|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834676|NCT02221414|Incretins|incretins|mesh-ancestor
44834677|NCT02221414|Hormones|hormones|mesh-ancestor
44834678|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834679|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44834680|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834681|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834682|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834683|NCT02221453|Triamcinolone|triamcinolone|mesh-list
44834684|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44834685|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44834686|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44834687|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834688|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
44834689|NCT02221453|Hormones|hormones|mesh-ancestor
44834690|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834691|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834692|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834693|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
44834694|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834695|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834696|NCT02221479|Plerixafor|plerixafor|mesh-list
44834697|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44834698|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44834699|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
44321063|NCT00933023|Hormones|hormones|mesh-ancestor
44834700|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834701|NCT02221492|Plerixafor|plerixafor|mesh-list
44834702|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44834703|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44834704|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
44834705|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834706|NCT02221531|Carbetocin|carbetocin|mesh-list
44834707|NCT02221531|Oxytocin|oxytocin|mesh-list
44834708|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
44834709|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44834710|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834711|NCT02221570|Baclofen|baclofen|mesh-list
44834712|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44834713|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834714|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44834715|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834716|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44834717|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
44834718|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
44834719|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321072|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44834720|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834721|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
44834722|NCT02221583|Tacrolimus|tacrolimus|mesh-list
44834723|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834724|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
44834725|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834726|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44834727|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834728|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834729|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44834730|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834731|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44834732|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
44834733|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834734|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834735|NCT02221596|Vitamin D|vitamin d|mesh-list
44834736|NCT02221596|Vitamins|vitamins|mesh-ancestor
44834737|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
44834738|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834739|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44834740|NCT02221622|Pregnanolone|pregnanolone|mesh-list
44834741|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44834742|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
44834743|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834744|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834745|NCT02221635|Risperidone|risperidone|mesh-list
44834746|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617218|NCT00601172|Dexamethasone|dexamethasone|mesh-list
44834747|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
44834748|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834749|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834750|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834751|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44834752|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44834753|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834754|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834755|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44834756|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
44834757|NCT02221752|Folic Acid|folic acid|mesh-list
44834758|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
44834759|NCT02221752|Hematinics|hematinics|mesh-ancestor
44834760|NCT02221752|Vitamins|vitamins|mesh-ancestor
44834761|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
44834762|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834763|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
44834764|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834765|NCT02221765|Hormones|hormones|mesh-ancestor
44834766|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834767|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834768|NCT02221830|Oxytocin|oxytocin|mesh-list
44834769|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
44834770|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44834771|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834772|NCT02221960|Durvalumab|durvalumab|mesh-list
44834773|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44834774|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834775|NCT02221999|Paclitaxel|paclitaxel|mesh-list
44834776|NCT02221999|Cisplatin|cisplatin|mesh-list
44834777|NCT02221999|Letrozole|letrozole|mesh-list
44834778|NCT02221999|Hormones|hormones|mesh-list
44834779|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44834780|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834781|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44834782|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44834783|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44834784|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834785|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834786|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834787|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44834788|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44834789|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834790|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44834791|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
44834792|NCT02222142|Anesthetics|anesthetics|mesh-list
44834793|NCT02222142|Isoflurane|isoflurane|mesh-list
44834794|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834795|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834796|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44834797|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
44834798|NCT02222168|BI 409306|bi 409306|mesh-list
44834799|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44834800|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834801|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834802|NCT02222220|Metoclopramide|metoclopramide|mesh-list
44834803|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
44834804|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
44834805|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834806|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834807|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834808|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44834809|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44834810|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
44834811|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834812|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834813|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
44834814|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44834815|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44834816|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44834817|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44834818|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834819|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834820|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834821|NCT02222350|Firuglipel|firuglipel|mesh-list
44834822|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834823|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834824|NCT02222376|Pirfenidone|pirfenidone|mesh-list
44834825|NCT02222376|Analgesics|analgesics|mesh-ancestor
44834826|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
44834827|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834828|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834829|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44834830|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834831|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834832|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44834833|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834834|NCT02222428|Olodaterol|olodaterol|mesh-list
44834835|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44834836|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
44834837|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834838|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834839|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44834840|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
44834841|NCT02222441|Pioglitazone|pioglitazone|mesh-list
44834842|NCT02222441|Palbociclib|palbociclib|mesh-list
44834843|NCT02222441|Modafinil|modafinil|mesh-list
44834844|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834845|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834846|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834847|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44834848|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321201|NCT00933439|Analgesics|analgesics|mesh-ancestor
44834849|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834850|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44834851|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44834852|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44834853|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44834854|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44834855|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44834856|NCT02222480|Diuretics|diuretics|mesh-ancestor
44834857|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
44834858|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834859|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44834860|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44834861|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834862|NCT02222519|Bromides|bromides|mesh-list
44834863|NCT02222519|Rocuronium|rocuronium|mesh-list
44834864|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
44834865|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44834866|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44834867|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44834868|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834869|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834870|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
44834871|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834872|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834873|NCT02222636|Fentanyl|fentanyl|mesh-list
44834874|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
44834875|NCT02222636|Anesthetics|anesthetics|mesh-list
44834876|NCT02222636|Sevoflurane|sevoflurane|mesh-list
44834877|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834878|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834879|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44834880|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44834881|NCT02222636|Analgesics|analgesics|mesh-ancestor
44834882|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
44834883|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834884|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44617444|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617445|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617446|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617447|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44617448|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44617449|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44617450|NCT00598832|Adapalene|adapalene|mesh-list
44617451|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617452|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617453|NCT00598832|Analgesics|analgesics|mesh-ancestor
44617454|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
44617455|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617456|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617457|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617458|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617459|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44617460|NCT00598702|Acetaminophen|acetaminophen|mesh-list
44617461|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617462|NCT00598702|Analgesics|analgesics|mesh-ancestor
44617463|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
44617464|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617465|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617466|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
44617467|NCT00598650|Donepezil|donepezil|mesh-list
44617468|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44617469|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617470|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617471|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
44617472|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617473|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617474|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
44617475|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
44617476|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
44617477|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44617478|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44446957|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
44834885|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44834886|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44834887|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44834888|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834889|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834890|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834891|NCT02222636|Narcotics|narcotics|mesh-ancestor
44834892|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44834893|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44834894|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
44834895|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44834896|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44834897|NCT02222649|Vitamin D|vitamin d|mesh-list
44834898|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
44834899|NCT02222649|Vitamins|vitamins|mesh-ancestor
44834900|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
44834901|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834902|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44834903|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44834904|NCT02222727|Donepezil|donepezil|mesh-list
44834905|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44834906|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834907|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834908|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
44834909|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834910|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834911|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
44834912|NCT02222987|Clopidogrel|clopidogrel|mesh-list
44834913|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44834914|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44834915|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44834916|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44834917|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
44834918|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44834919|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834920|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834921|NCT02223026|Metformin|metformin|mesh-list
44834922|NCT02223026|Linagliptin|linagliptin|mesh-list
44834923|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44834924|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834925|NCT02223026|Incretins|incretins|mesh-ancestor
44834926|NCT02223026|Hormones|hormones|mesh-ancestor
44834927|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834928|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44834929|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
44834930|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834931|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834932|NCT02223052|Azacitidine|azacitidine|mesh-list
44834933|NCT02223052|Cc-486|cc-486|mesh-list
44834934|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44834935|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
44834936|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834937|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834938|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834939|NCT02223299|Tryptophan|tryptophan|mesh-list
44834940|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44834941|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
44834942|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44834943|NCT02223377|Morphine|morphine|mesh-list
44834944|NCT02223377|Hydromorphone|hydromorphone|mesh-list
44834945|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834946|NCT02223377|Narcotics|narcotics|mesh-ancestor
44834947|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834948|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834949|NCT02223377|Analgesics|analgesics|mesh-ancestor
44834950|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
44834951|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834952|NCT02223416|Teriparatide|teriparatide|mesh-list
44834953|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44834954|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834955|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44834956|NCT02223533|Morphine|morphine|mesh-list
44834957|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44834958|NCT02223533|Narcotics|narcotics|mesh-ancestor
44834959|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44834960|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834961|NCT02223533|Analgesics|analgesics|mesh-ancestor
44834962|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
44834963|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834964|NCT02223598|Dexamethasone|dexamethasone|mesh-list
44834965|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44834966|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
44834967|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
44834968|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44834969|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834970|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44834971|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
44834972|NCT02223598|Hormones|hormones|mesh-ancestor
44834973|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44834974|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44834975|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834976|NCT02223611|Cisplatin|cisplatin|mesh-list
44834977|NCT02223611|Vinorelbine|vinorelbine|mesh-list
44834978|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834979|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44834980|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44834981|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44834982|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44834983|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617555|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
44834984|NCT02223819|Crizotinib|crizotinib|mesh-list
44834985|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834986|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44834987|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44834988|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834989|NCT02223832|Ponesimod|ponesimod|mesh-list
44834990|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44834991|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44834992|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44834993|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
44834994|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44834995|NCT02223884|Carboplatin|carboplatin|mesh-list
44834996|NCT02223884|Docetaxel|docetaxel|mesh-list
44834997|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44834998|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44834999|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835000|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835001|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835002|NCT02223949|Alprostadil|alprostadil|mesh-list
44835003|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835004|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
44835005|NCT02223949|Urological Agents|urological agents|mesh-ancestor
44835006|NCT02224014|Brotizolam|brotizolam|mesh-list
44835007|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44835008|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835009|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835010|NCT02224040|Azithromycin|azithromycin|mesh-list
44835011|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
44835012|NCT02224040|Cefixime|cefixime|mesh-list
44835013|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44835014|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835015|NCT02224066|Aspirin|aspirin|mesh-list
44835016|NCT02224066|Clopidogrel|clopidogrel|mesh-list
44835017|NCT02224066|Ticagrelor|ticagrelor|mesh-list
44835018|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44835019|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835020|NCT02224066|Analgesics|analgesics|mesh-ancestor
44835021|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
44835022|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835023|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835024|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835025|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835026|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44835027|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835028|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835029|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835030|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44835031|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835032|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
44835033|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44835034|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44835035|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44835036|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
44835037|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835038|NCT02224105|Prednisolone|prednisolone|mesh-list
44835039|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44835040|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
44835041|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44835042|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
44835043|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44835044|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
44835045|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835046|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
44835047|NCT02224105|Hormones|hormones|mesh-ancestor
44835048|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835049|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835050|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44835051|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835052|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
44835053|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
44835054|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835055|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835056|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44835057|NCT02224105|Protective Agents|protective agents|mesh-ancestor
44835058|NCT02224131|Aspirin|aspirin|mesh-list
44835059|NCT02224131|Clopidogrel|clopidogrel|mesh-list
44835060|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44835061|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835062|NCT02224131|Analgesics|analgesics|mesh-ancestor
44835063|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
44835064|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835065|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835066|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835067|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835068|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44835069|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835070|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835071|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835072|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44835073|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835074|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
44835075|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44321395|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
44835076|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44835077|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44835078|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
44835079|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835080|NCT02224170|Dexamethasone|dexamethasone|mesh-list
44835081|NCT02224170|Lidocaine|lidocaine|mesh-list
44835082|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835083|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
44835084|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
44835085|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835086|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835087|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835088|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
44835089|NCT02224170|Hormones|hormones|mesh-ancestor
44835090|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835091|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44835092|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835093|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
44696349|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696350|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696351|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44696352|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44696353|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
44696354|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696355|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44696356|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44696357|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696358|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696359|NCT01391104|Urological Agents|urological agents|mesh-ancestor
44696360|NCT01391156|Minoxidil|minoxidil|mesh-list
44696361|NCT01391156|Finasteride|finasteride|mesh-list
44696362|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44696363|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696364|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44696365|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44696366|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696367|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696368|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696369|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696370|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321439|NCT00934492|Renal Agents|renal agents|mesh-ancestor
44696371|NCT01391156|Urological Agents|urological agents|mesh-ancestor
44696372|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44696373|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44696374|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44696375|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696376|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696377|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696378|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696379|NCT01391221|Analgesics|analgesics|mesh-ancestor
44696380|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
44696381|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696382|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
44696383|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44696384|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
44696385|NCT01391260|Gefitinib|gefitinib|mesh-list
44696386|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617707|NCT00595517|Esomeprazole|esomeprazole|mesh-list
44835094|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
44835095|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835096|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
44835097|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44835098|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44835099|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44835100|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835101|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835102|NCT02224443|Fentanyl|fentanyl|mesh-list
44835103|NCT02224443|Midazolam|midazolam|mesh-list
44835104|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
44835105|NCT02224443|Remifentanil|remifentanil|mesh-list
44835106|NCT02224443|Propofol|propofol|mesh-list
44835107|NCT02224443|Etomidate|etomidate|mesh-list
44835108|NCT02224443|Sevoflurane|sevoflurane|mesh-list
44835109|NCT02224443|Atracurium|atracurium|mesh-list
44835110|NCT02224443|Cisatracurium|cisatracurium|mesh-list
44835111|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44835112|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835113|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835114|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44835115|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
44835116|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
44835117|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835118|NCT02224443|Analgesics|analgesics|mesh-ancestor
44835119|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
44835120|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835121|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44835122|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44835123|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44835124|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835125|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835126|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835127|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44835128|NCT02224443|Narcotics|narcotics|mesh-ancestor
44835129|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44835130|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44835131|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44835132|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44835133|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
44835134|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
44835135|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835136|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44321510|NCT00934739|Analgesics|analgesics|mesh-ancestor
44835137|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44835138|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44835139|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44835140|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44835141|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44835142|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44835143|NCT02224456|Tenofovir|tenofovir|mesh-list
44835144|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
44835145|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835146|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44835147|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44835148|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835149|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835150|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44835151|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44835152|NCT02224534|Clopidogrel|clopidogrel|mesh-list
44835153|NCT02224534|Ticagrelor|ticagrelor|mesh-list
44835154|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835155|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44835156|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44835157|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44835158|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
44835159|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835160|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835161|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835162|NCT02224768|Ipilimumab|ipilimumab|mesh-list
44835163|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835164|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835165|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44835166|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835167|NCT02224937|Melatonin|melatonin|mesh-list
44835168|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
44835169|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835170|NCT02224937|Protective Agents|protective agents|mesh-ancestor
44835171|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835172|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835173|NCT02224950|Emollients|emollients|mesh-list
44835174|NCT02224950|Chitosan|chitosan|mesh-list
44835175|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44835176|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44835177|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
44835178|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835179|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44835180|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
44835181|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
44835182|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
44835183|NCT02224950|Coagulants|coagulants|mesh-ancestor
44835184|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835185|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
44835186|NCT02225054|Ropivacaine|ropivacaine|mesh-list
44835187|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44321522|NCT00934817|Metformin|metformin|mesh-list
44835188|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835189|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835190|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835191|NCT02225054|Analgesics|analgesics|mesh-ancestor
44835192|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
44835193|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835194|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44835195|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44835196|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44835197|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835198|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835199|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835200|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44835201|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
44835202|NCT02225067|Calcium|calcium|mesh-list
44835203|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44835204|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835205|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
44835206|NCT02225093|Caffeine|caffeine|mesh-list
44835207|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44835208|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321573|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835209|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44835210|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835211|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835212|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44835213|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44835214|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
44835215|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835216|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
44835217|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44835218|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44835219|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44835220|NCT02225210|Fentanyl|fentanyl|mesh-list
44835221|NCT02225210|Midazolam|midazolam|mesh-list
44835222|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
44835223|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44835224|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44321596|NCT00935363|Glyburide|glyburide|mesh-list
44835225|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835226|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835227|NCT02225210|Analgesics|analgesics|mesh-ancestor
44835228|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
44835229|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835230|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44835231|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44835232|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44835233|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835234|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835235|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835236|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44835237|NCT02225210|Narcotics|narcotics|mesh-ancestor
44835238|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44835239|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44835240|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
44835241|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
44835242|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44835243|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44835244|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44835245|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
44835246|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
44835247|NCT02225418|Ropivacaine|ropivacaine|mesh-list
44835248|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
44835249|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
44835250|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835251|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835252|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
44835253|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835254|NCT02225470|Vinorelbine|vinorelbine|mesh-list
44321611|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44835255|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835256|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835257|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835258|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835259|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835260|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835261|NCT02225548|Tadalafil|tadalafil|mesh-list
44835262|NCT02225548|Selegiline|selegiline|mesh-list
44835263|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
44835264|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44835265|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44835266|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835267|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835268|NCT02225548|Urological Agents|urological agents|mesh-ancestor
44835269|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
44835270|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44835271|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44835272|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44835273|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44835274|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44835275|NCT02225548|Protective Agents|protective agents|mesh-ancestor
44835276|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617890|NCT00593827|Epothilones|epothilones|mesh-list
44835277|NCT02225652|Paclitaxel|paclitaxel|mesh-list
44835278|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
44835279|NCT02225652|Fluorouracil|fluorouracil|mesh-list
44835280|NCT02225652|Epirubicin|epirubicin|mesh-list
44835281|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835282|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835283|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835284|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835285|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835286|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835287|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835288|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
44835289|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835290|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835291|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835292|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
44835293|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44835294|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
44835295|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44835296|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44835297|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44835298|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44835299|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835300|NCT02225756|Cyclosporine|cyclosporine|mesh-list
44835301|NCT02225756|Cyclosporins|cyclosporins|mesh-list
44835302|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835303|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835304|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835305|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
44835306|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835307|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
44835308|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835309|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835310|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835311|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44835312|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44835313|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44835314|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835315|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835316|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
44835317|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44835318|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
44835319|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835320|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
44835321|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835322|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835323|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835324|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
44835325|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835326|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835327|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44835328|NCT02225834|Atorvastatin|atorvastatin|mesh-list
44835329|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44835330|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44835331|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
44835332|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321693|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835333|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44835334|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44835335|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835336|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
44835337|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
44835338|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835339|NCT02225886|Protective Agents|protective agents|mesh-ancestor
44835340|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835341|NCT02225886|Vitamins|vitamins|mesh-ancestor
44835342|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
44835343|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44835344|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44835345|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835346|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835347|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
44835348|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835349|NCT02226068|Cyclosporine|cyclosporine|mesh-list
44835350|NCT02226068|Cyclosporins|cyclosporins|mesh-list
44835351|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835352|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835354|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
44835355|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835356|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
44835357|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835358|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835359|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835360|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44835361|NCT02226289|Bevacizumab|bevacizumab|mesh-list
44835362|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835363|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835364|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44835365|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44835366|NCT02226289|Growth Substances|growth substances|mesh-ancestor
44835367|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835368|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44835369|NCT02226328|Fentanyl|fentanyl|mesh-list
44835370|NCT02226328|Midazolam|midazolam|mesh-list
44835371|NCT02226328|Propofol|propofol|mesh-list
44835372|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44835373|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835374|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835375|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44835376|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
44835377|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
44835378|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44835379|NCT02226328|Narcotics|narcotics|mesh-ancestor
44835380|NCT02226328|Analgesics|analgesics|mesh-ancestor
44835381|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
44835382|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835383|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44835384|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44835385|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44835386|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44835387|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
44835388|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
44835389|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835390|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835391|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
44835392|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44835393|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44835394|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835395|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44321762|NCT00935961|Cisplatin|cisplatin|mesh-list
44835396|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
44835397|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44835398|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835399|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835400|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835401|NCT02226341|Hormones|hormones|mesh-ancestor
44835402|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835403|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835404|NCT02226367|Prazosin|prazosin|mesh-list
44835405|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44835406|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44835407|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44835408|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44835409|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835410|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835411|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835412|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835413|NCT02226484|Quercetin|quercetin|mesh-list
44835414|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
44835415|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835416|NCT02226484|Protective Agents|protective agents|mesh-ancestor
44618033|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618034|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618035|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618036|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618037|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
44618038|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618039|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618040|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835417|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835419|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44835420|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835421|NCT02226588|Misoprostol|misoprostol|mesh-list
44835422|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44835423|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
44835424|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44835425|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835426|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44835427|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835428|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
44835429|NCT02226601|Aprepitant|aprepitant|mesh-list
44835430|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
44835431|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
44835432|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835433|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835434|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835435|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44835436|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835437|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835438|NCT02226757|Paclitaxel|paclitaxel|mesh-list
44835439|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835440|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835441|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835442|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835443|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835444|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835445|NCT02226783|Omeprazole|omeprazole|mesh-list
44835446|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44835447|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835448|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44835449|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835450|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835451|NCT02226913|Lidocaine|lidocaine|mesh-list
44835452|NCT02226913|Epinephrine|epinephrine|mesh-list
44835453|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
44835454|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
44835455|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835456|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835457|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
44835458|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835459|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44835460|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44835461|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44835462|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835463|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835464|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44835465|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44835466|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835467|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835468|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44835469|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44835470|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
44835471|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44835472|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
44835473|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
44835474|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
44835475|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44835476|NCT02226926|Aspirin|aspirin|mesh-list
44835477|NCT02226926|Dipyridamole|dipyridamole|mesh-list
44835478|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44835479|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44835480|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835481|NCT02226926|Analgesics|analgesics|mesh-ancestor
44835482|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
44835483|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835484|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835485|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835486|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835487|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44835488|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835489|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835490|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835491|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44835492|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835493|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
44835494|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44835495|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
44835496|NCT02226978|Ritonavir|ritonavir|mesh-list
44835497|NCT02226978|Tipranavir|tipranavir|mesh-list
44835498|NCT02226978|Valacyclovir|valacyclovir|mesh-list
44835499|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44835500|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44835501|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44835502|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835503|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835504|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44835505|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44835506|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
44835507|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835508|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44835509|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44835510|NCT02226991|Ritonavir|ritonavir|mesh-list
44835511|NCT02226991|Tipranavir|tipranavir|mesh-list
44835512|NCT02226991|Efavirenz|efavirenz|mesh-list
44835513|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44835514|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44835515|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44835516|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835517|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835518|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321856|NCT00936429|Antacids|antacids|mesh-ancestor
44835519|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44835520|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
44835521|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835522|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44835523|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44835524|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44835525|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44835526|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44835527|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44835528|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44835529|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44835530|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44835531|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44835532|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44835533|NCT02227056|Methylphenidate|methylphenidate|mesh-list
44835534|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44835535|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835536|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44321900|NCT00936650|Cinacalcet|cinacalcet|mesh-list
44835537|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44835538|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835539|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835540|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
44835541|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835542|NCT02227082|Olaparib|olaparib|mesh-list
44835543|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44835544|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835545|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835546|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835547|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
44835548|NCT02227173|Digoxin|digoxin|mesh-list
44835549|NCT02227173|Montelukast|montelukast|mesh-list
44835550|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44835551|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
44835552|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44835553|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
44835554|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835555|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835556|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44835557|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44835558|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835559|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44835560|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44835561|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835562|NCT02227173|Protective Agents|protective agents|mesh-ancestor
44835563|NCT02227173|Analgesics|analgesics|mesh-ancestor
44835564|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
44835565|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835566|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44835567|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835568|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835569|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835570|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44835572|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
44835573|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44835574|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835575|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
44835576|NCT02227264|Cinacalcet|cinacalcet|mesh-list
44835577|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44835578|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835579|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44835580|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
44835581|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835582|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44835583|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
44835584|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
44835585|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835586|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835587|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44835588|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835589|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44835590|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835591|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835592|NCT02227550|Vitamin K|vitamin k|mesh-list
44835593|NCT02227550|Warfarin|warfarin|mesh-list
44835594|NCT02227550|Apixaban|apixaban|mesh-list
44835595|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
44835596|NCT02227550|Fluindione|fluindione|mesh-list
44835597|NCT02227550|Vitamins|vitamins|mesh-ancestor
44835598|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
44835599|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835600|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
44835601|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44835602|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
44835603|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44835604|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
44835605|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835606|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835607|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44835608|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835609|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
44835610|NCT02227550|Coagulants|coagulants|mesh-ancestor
44835611|NCT02227745|Dorzolamide|dorzolamide|mesh-list
44835612|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
44835613|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44835614|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
44835615|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835616|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
44835617|NCT02227745|Protective Agents|protective agents|mesh-ancestor
44835618|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44835619|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44835620|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835621|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835622|NCT02227797|Voriconazole|voriconazole|mesh-list
44835623|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
44835624|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835625|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44835626|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44835627|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835628|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835629|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44835630|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
44835631|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835632|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835633|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44835634|NCT02227823|Bromides|bromides|mesh-list
44835635|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44835636|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
44835637|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44835638|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835639|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835640|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
44835641|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835642|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835643|NCT02227901|Temozolomide|temozolomide|mesh-list
44835644|NCT02227901|Tipifarnib|tipifarnib|mesh-list
44618273|NCT00589914|Risperidone|risperidone|mesh-list
44835645|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835646|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
44835647|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835648|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835650|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835651|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44835652|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835653|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835654|NCT02228005|Sertraline|sertraline|mesh-list
44835655|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
44835656|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44835657|NCT02228005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44835658|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44835659|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321997|NCT00937092|Furosemide|furosemide|mesh-list
44835660|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835661|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835662|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
44835663|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835664|NCT02228031|Oxytocin|oxytocin|mesh-list
44835665|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
44835666|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44835667|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835668|NCT02228083|Lidocaine|lidocaine|mesh-list
44835669|NCT02228083|Epinephrine|epinephrine|mesh-list
44835670|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
44835671|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
44835672|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835673|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835674|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
44835675|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835676|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44835677|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44835678|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44835679|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835680|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835681|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44835682|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44835683|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44835684|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835685|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44835686|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44835687|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
44835688|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44835689|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
44835690|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
44835691|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
44835692|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44835693|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44835694|NCT02228122|Laxatives|laxatives|mesh-ancestor
44835695|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835696|NCT02228135|Dexamethasone|dexamethasone|mesh-list
44835697|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835698|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
44835699|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
44835700|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835701|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835702|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835703|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
44835704|NCT02228135|Hormones|hormones|mesh-ancestor
44835705|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835706|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44835707|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835708|NCT02228239|Mirtazapine|mirtazapine|mesh-list
44835709|NCT02228239|Esketamine|esketamine|mesh-list
44835710|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
44696387|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44696388|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696389|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696390|NCT01391377|Niacin|niacin|mesh-list
44696391|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44835711|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44696392|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
44618339|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
44835712|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44835713|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
44835714|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
44835715|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835716|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835717|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835718|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44835719|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44835720|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835721|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44835722|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44835723|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44835724|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322079|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
44835725|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44835726|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44835727|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
44835728|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44835729|NCT02228252|Caseins|caseins|mesh-list
44835730|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
44835731|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
44835732|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835733|NCT02228369|Osimertinib|osimertinib|mesh-list
44835734|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835735|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44835736|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835737|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835738|NCT02228473|Atropine|atropine|mesh-list
44835739|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
44835740|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44835741|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44835742|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44835743|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
44835744|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835745|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835746|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44835747|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44835748|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
44835749|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
44835750|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44835751|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44835752|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44835753|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835754|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835755|NCT02228512|Prednisone|prednisone|mesh-list
44835756|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
44835757|NCT02228512|Rituximab|rituximab|mesh-list
44835758|NCT02228512|Doxorubicin|doxorubicin|mesh-list
44835759|NCT02228512|Etoposide|etoposide|mesh-list
44835760|NCT02228512|Vincristine|vincristine|mesh-list
44835761|NCT02228512|Pomalidomide|pomalidomide|mesh-list
44835762|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835763|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
44835764|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835765|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835766|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835767|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
44835768|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835769|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835770|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44835771|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835772|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44835773|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44835774|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44835775|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835776|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835777|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
44835778|NCT02228512|Hormones|hormones|mesh-ancestor
44835779|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835780|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44835781|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835782|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835783|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835784|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835785|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44835786|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44835787|NCT02228512|Growth Substances|growth substances|mesh-ancestor
44835788|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
44835789|NCT02228616|Lactulose|lactulose|mesh-list
44835790|NCT02228616|Prucalopride|prucalopride|mesh-list
44835791|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44835792|NCT02228616|Laxatives|laxatives|mesh-ancestor
44835793|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44835794|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44835795|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
44835796|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835797|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835798|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835799|NCT02228772|Cytarabine|cytarabine|mesh-list
44835800|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
44835801|NCT02228772|Doxorubicin|doxorubicin|mesh-list
44835802|NCT02228772|Methotrexate|methotrexate|mesh-list
44835803|NCT02228772|Vincristine|vincristine|mesh-list
44835804|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
44835805|NCT02228772|Ixazomib|ixazomib|mesh-list
44835806|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835807|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
44835808|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835809|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835810|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44835811|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
44835812|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835813|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835814|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44835815|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44835816|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44835817|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44835818|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835819|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44835820|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
44835821|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44835822|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44835823|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
44835824|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835825|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44835826|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44835827|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
44322179|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835828|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835829|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835830|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835831|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835832|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835833|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44835834|NCT02228850|Alprostadil|alprostadil|mesh-list
44835835|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835836|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
44835837|NCT02228850|Urological Agents|urological agents|mesh-ancestor
44835838|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44835839|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44835840|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44835841|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835842|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835843|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44835844|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44835845|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835846|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
44835847|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835848|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
44835849|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
44835850|NCT02228902|Trace Elements|trace elements|mesh-ancestor
44835851|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
44835852|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835853|NCT02228902|Hematinics|hematinics|mesh-ancestor
44835854|NCT02228928|Capsaicin|capsaicin|mesh-list
44835855|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
44835856|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835857|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
44835858|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322197|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44835859|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835860|NCT02229045|Paclitaxel|paclitaxel|mesh-list
44835861|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44835862|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835863|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835864|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835865|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835866|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835867|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835868|NCT02229058|Paclitaxel|paclitaxel|mesh-list
44835869|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44835870|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44835871|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835872|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
44835873|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
44835874|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
44835875|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835876|NCT02229123|Levetiracetam|levetiracetam|mesh-list
44835877|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
44835878|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
44835879|NCT02229175|Bevacizumab|bevacizumab|mesh-list
44835880|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835881|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835882|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44835883|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44835884|NCT02229175|Growth Substances|growth substances|mesh-ancestor
44835885|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835886|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
44835887|NCT02229201|Propofol|propofol|mesh-list
44835888|NCT02229201|Sevoflurane|sevoflurane|mesh-list
44835889|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44835890|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44835891|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835892|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44835893|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
44835894|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
44835895|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44835896|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44835897|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
44835898|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44835899|NCT02229240|Incretins|incretins|mesh-ancestor
44835900|NCT02229240|Hormones|hormones|mesh-ancestor
44835901|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835902|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835903|NCT02229266|Cytarabine|cytarabine|mesh-list
44835904|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44835905|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
44835906|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835907|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835908|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
44835909|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835910|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835911|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
44835912|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835913|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
44618557|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618558|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618559|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44618560|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44618561|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44618562|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
44618563|NCT00586846|Cisplatin|cisplatin|mesh-list
44618564|NCT00586846|Doxorubicin|doxorubicin|mesh-list
44618565|NCT00586846|Methotrexate|methotrexate|mesh-list
44618566|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618567|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44618568|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44618569|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44618570|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618571|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618572|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44618573|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
44618574|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618575|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618576|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44835914|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44835915|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44835916|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835917|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
44835918|NCT02229292|Coagulants|coagulants|mesh-ancestor
44835919|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
44835920|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44835921|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835922|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
44835923|NCT02229617|Testosterone|testosterone|mesh-list
44835924|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
44835925|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
44835926|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44835927|NCT02229617|Androgens|androgens|mesh-ancestor
44835928|NCT02229617|Hormones|hormones|mesh-ancestor
44322279|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835929|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835930|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835931|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44835932|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44835933|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
44835934|NCT02229721|Oxytocin|oxytocin|mesh-list
44835935|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
44835936|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44835937|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835938|NCT02229734|Androgens|androgens|mesh-list
44835939|NCT02229734|Hormones|hormones|mesh-ancestor
44835940|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44835941|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835942|NCT02229747|Diclofenac|diclofenac|mesh-list
44835943|NCT02229747|Meloxicam|meloxicam|mesh-list
44835944|NCT02229747|Nimesulide|nimesulide|mesh-list
44835945|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44835946|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835947|NCT02229747|Analgesics|analgesics|mesh-ancestor
44835948|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
44835949|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835950|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835951|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44835952|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44835953|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44835954|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835955|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835956|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44835957|NCT02229760|Ritonavir|ritonavir|mesh-list
44835958|NCT02229760|Tipranavir|tipranavir|mesh-list
44835959|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44835960|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44835961|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44835962|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835963|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835964|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44835965|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44835966|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
44835967|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44835968|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44835969|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44835970|NCT02229773|Pravastatin|pravastatin|mesh-list
44835971|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44835972|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44835973|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
44835974|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835975|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44835976|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44835977|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44835978|NCT02229786|Acetaminophen|acetaminophen|mesh-list
44835979|NCT02229786|Scopolamine|scopolamine|mesh-list
44835980|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44835981|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44835982|NCT02229786|Analgesics|analgesics|mesh-ancestor
44835983|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
44835984|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44835985|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44835986|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
44835987|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
44835988|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
44835989|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44835990|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44835991|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
44835992|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44835993|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44835994|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44835995|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
44835996|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44322383|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44835997|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
44835998|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44835999|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44836000|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44836001|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836002|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44836003|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44836004|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44836005|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836006|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44836007|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44836008|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44836009|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836010|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836011|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836012|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322393|NCT00939588|Valsartan|valsartan|mesh-list
44836013|NCT02229825|Analgesics|analgesics|mesh-ancestor
44836014|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
44836015|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836016|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44836017|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836018|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
44836019|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44836020|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44836021|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44836022|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836023|NCT02229942|Rituximab|rituximab|mesh-list
44836024|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44836025|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836026|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
44836027|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836028|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44836029|NCT02229955|Cyclosporine|cyclosporine|mesh-list
44836030|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44836031|NCT02229955|Cyclosporins|cyclosporins|mesh-list
44836032|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836033|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836034|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44836035|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
44836036|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836037|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
44836038|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836039|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44836040|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44836041|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44836042|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44836043|NCT02230033|Itraconazole|itraconazole|mesh-list
44836044|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
44836045|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
44836046|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836047|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44836048|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44836049|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836050|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836051|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44836052|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
44836053|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836054|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836055|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44836056|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836057|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
44836058|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836059|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44836060|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
44836061|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836062|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44836063|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836064|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836065|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
44836066|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836067|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836068|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44836069|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
44836070|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44836071|NCT02230163|Antibodies|antibodies|mesh-list
44836072|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
44836073|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836074|NCT02230176|Sunitinib|sunitinib|mesh-list
44836075|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44836076|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836077|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44836078|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44836079|NCT02230176|Growth Substances|growth substances|mesh-ancestor
44836080|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836081|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44836082|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44836083|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836084|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836085|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44836086|NCT02230228|Vitamin A|vitamin a|mesh-list
44836087|NCT02230228|Retinol acetate|retinol acetate|mesh-list
44836088|NCT02230228|Vitamins|vitamins|mesh-ancestor
44836089|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
44836090|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836091|NCT02230228|Protective Agents|protective agents|mesh-ancestor
44836092|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44836093|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836094|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44836095|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
44836096|NCT02230319|Paclitaxel|paclitaxel|mesh-list
44836097|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44836098|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836099|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
44836100|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
44836101|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
44836102|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836103|NCT02230358|Anesthetics|anesthetics|mesh-list
44836104|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836105|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836106|NCT02230371|Granisetron|granisetron|mesh-list
44836107|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
44836108|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
44836109|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836110|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836111|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836112|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44836113|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
44836114|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836115|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836116|NCT02230553|Lapatinib|lapatinib|mesh-list
44836117|NCT02230553|Trametinib|trametinib|mesh-list
44836118|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836119|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44836120|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836121|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836122|NCT02230618|Insulin|insulin|mesh-list
44467731|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
44836123|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
44836124|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44836125|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836126|NCT02230735|Epinephrine|epinephrine|mesh-list
44836127|NCT02230735|Racepinephrine|racepinephrine|mesh-list
44836128|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
44836129|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44836130|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44836131|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
44836132|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836133|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836134|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836135|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44836136|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836137|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
44836138|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836139|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836140|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836141|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
44836142|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
44836143|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44836144|NCT02230800|Tocovid|tocovid|mesh-list
44836145|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
44836146|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44836147|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836148|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836149|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44836150|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44836151|NCT02230800|Protective Agents|protective agents|mesh-ancestor
44836152|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836153|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836154|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44836155|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
44836156|NCT02230800|Vitamins|vitamins|mesh-ancestor
44836157|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
44836158|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
44836159|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44836160|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44836161|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44836162|NCT02230930|Apomorphine|apomorphine|mesh-list
44836163|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44836164|NCT02230930|Emetics|emetics|mesh-ancestor
44836165|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836166|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
44836167|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836168|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836169|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
44836170|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
44836171|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836172|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836173|NCT02230982|Nintedanib|nintedanib|mesh-list
44836174|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836175|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44836176|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836177|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836178|NCT02231021|Pioglitazone|pioglitazone|mesh-list
44836179|NCT02231021|Alogliptin|alogliptin|mesh-list
44836180|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44836181|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836182|NCT02231021|Incretins|incretins|mesh-ancestor
44836183|NCT02231021|Hormones|hormones|mesh-ancestor
44836184|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836185|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44836186|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
44836187|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836188|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836189|NCT02231125|Losartan|losartan|mesh-list
44836190|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836191|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836192|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44836193|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44836194|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836195|NCT02231203|Tocopherols|tocopherols|mesh-list
44836196|NCT02231203|Antioxidants|antioxidants|mesh-list
44836197|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836198|NCT02231203|Protective Agents|protective agents|mesh-ancestor
44836199|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836200|NCT02231203|Vitamins|vitamins|mesh-ancestor
44836201|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
44836202|NCT02231255|Pramipexole|pramipexole|mesh-list
44836203|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
44836204|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836205|NCT02231255|Protective Agents|protective agents|mesh-ancestor
44836206|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836207|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44836208|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44836209|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
44836210|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
44836211|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836212|NCT02231281|Ritonavir|ritonavir|mesh-list
44836213|NCT02231281|Lopinavir|lopinavir|mesh-list
44836214|NCT02231281|Tenofovir|tenofovir|mesh-list
44836215|NCT02231281|Lamivudine|lamivudine|mesh-list
44836216|NCT02231281|Zidovudine|zidovudine|mesh-list
44836217|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44836218|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44836219|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44836220|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836221|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836222|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44836223|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44836224|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
44836225|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836226|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44836227|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44836228|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44836229|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44836230|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
44836231|NCT02231294|Pramipexole|pramipexole|mesh-list
44836232|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
44836233|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836234|NCT02231294|Protective Agents|protective agents|mesh-ancestor
44836235|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836236|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44836237|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44836238|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
44836239|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
44836240|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836241|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836242|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836243|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
44836244|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836245|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836246|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836247|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836249|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44836250|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836251|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836252|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44836253|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44322574|NCT00940524|Etoposide|etoposide|mesh-list
44836254|NCT02231333|Protective Agents|protective agents|mesh-ancestor
44836255|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836256|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836257|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44836258|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
44836259|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836260|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836261|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
44836262|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836263|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836264|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836265|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836266|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836267|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836268|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
44836269|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836270|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836271|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836272|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836273|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836274|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836275|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
44836276|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836277|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836278|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836279|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836280|NCT02231385|Acetic Acid|acetic acid|mesh-list
44836281|NCT02231385|Retinol acetate|retinol acetate|mesh-list
44836282|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44836283|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836284|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44836285|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
44836286|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836287|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44836288|NCT02231385|Protective Agents|protective agents|mesh-ancestor
44836289|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836290|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836291|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836292|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
44836293|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836294|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836295|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836296|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836297|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836298|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836299|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
44836300|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836301|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836302|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836303|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836304|NCT02231606|Methamphetamine|methamphetamine|mesh-list
44836305|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44836306|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836307|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
44836308|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
44836309|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836310|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
44836311|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836312|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836313|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
44836314|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44836315|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44836316|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836317|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44836319|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
44836320|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836321|NCT02231658|Liraglutide|liraglutide|mesh-list
44836322|NCT02231658|Lixisenatide|lixisenatide|mesh-list
44836323|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44836324|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836325|NCT02231658|Incretins|incretins|mesh-ancestor
44836326|NCT02231658|Hormones|hormones|mesh-ancestor
44836327|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836328|NCT02231762|Temozolomide|temozolomide|mesh-list
44836329|NCT02231762|Lanreotide|lanreotide|mesh-list
44836330|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44836331|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
44836332|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836333|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836334|NCT02231788|Amlodipine|amlodipine|mesh-list
44836335|NCT02231788|Telmisartan|telmisartan|mesh-list
44836336|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836337|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44836338|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836339|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836340|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836341|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836342|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836343|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44836344|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44836345|NCT02231879|Plerixafor|plerixafor|mesh-list
44836346|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44836347|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44836348|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
44836349|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836350|NCT02231905|Pramipexole|pramipexole|mesh-list
44836351|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
44836352|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836353|NCT02231905|Protective Agents|protective agents|mesh-ancestor
44836354|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836355|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44836356|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44836357|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
44836358|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
44836359|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836360|NCT02231931|Metformin|metformin|mesh-list
44836361|NCT02231931|Digoxin|digoxin|mesh-list
44836362|NCT02231931|Furosemide|furosemide|mesh-list
44836363|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44836364|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44836365|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836366|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836367|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836368|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
44836369|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836370|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836371|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44836372|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836373|NCT02231931|Diuretics|diuretics|mesh-ancestor
44836374|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
44836375|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44836376|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836377|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836378|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44836379|NCT02231931|Protective Agents|protective agents|mesh-ancestor
44836380|NCT02231957|Vaccines|vaccines|mesh-list
44836381|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
44836382|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836383|NCT02232035|Diazepam|diazepam|mesh-list
44836384|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44836385|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
44836386|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
44836387|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
44836388|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836389|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836390|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836391|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44836392|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836393|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44836394|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44836395|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44696393|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696394|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44696412|NCT01391520|Deferiprone|deferiprone|mesh-list
44696413|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44696414|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
44696415|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
44696416|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696417|NCT01391572|Cisplatin|cisplatin|mesh-list
44696418|NCT01391572|Fluorouracil|fluorouracil|mesh-list
44696419|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696420|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
44696421|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696422|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696423|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696424|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
44696425|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696426|NCT01391598|Lidocaine|lidocaine|mesh-list
44696427|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
44696428|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
44696429|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696430|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696431|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
44696432|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696433|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44696434|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44696435|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44696436|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696437|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696438|NCT01391624|Mineral Oil|mineral oil|mesh-list
44696439|NCT01391624|Emollients|emollients|mesh-ancestor
44696440|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
44696441|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44696442|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44696443|NCT01391689|Protective Agents|protective agents|mesh-ancestor
44696444|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696445|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696446|NCT01391715|Rabeprazole|rabeprazole|mesh-list
44696447|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44696448|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696449|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44696450|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696451|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696452|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
44696453|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44696454|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
44696455|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696456|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696457|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44696458|NCT01392014|Piperaquine|piperaquine|mesh-list
44696459|NCT01392014|Primaquine|primaquine|mesh-list
44696460|NCT01392014|Artenimol|artenimol|mesh-list
44696461|NCT01392014|Artemisinins|artemisinins|mesh-list
44696462|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
44696463|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44696464|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44696465|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696466|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
44696467|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696468|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696469|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
44836396|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836397|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836398|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44836399|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
44836400|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
44836401|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
44836402|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
44836403|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836404|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836405|NCT02232139|Midazolam|midazolam|mesh-list
44836406|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44322832|NCT00941161|Metformin|metformin|mesh-list
44836407|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44836408|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836409|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836410|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44836411|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836412|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836413|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44836414|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
44836415|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
44836416|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
44836417|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
44836418|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836419|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836420|NCT02232269|Felodipine|felodipine|mesh-list
44836421|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836422|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836423|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44836424|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836425|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836426|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836427|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836428|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836429|NCT02232308|Lisinopril|lisinopril|mesh-list
44836430|NCT02232308|Nizatidine|nizatidine|mesh-list
44836431|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44836432|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
44836433|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836434|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836435|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836436|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44836437|NCT02232308|Protective Agents|protective agents|mesh-ancestor
44836438|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836439|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44619117|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
44619118|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44619119|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619120|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619121|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619122|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619123|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619124|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619125|NCT00581360|Doxorubicin|doxorubicin|mesh-list
44619126|NCT00581360|Bortezomib|bortezomib|mesh-list
44619127|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619128|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619129|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619130|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619131|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619132|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619133|NCT00581100|Etanercept|etanercept|mesh-list
44619134|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44619135|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44619136|NCT00581100|Analgesics|analgesics|mesh-ancestor
44619137|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
44619138|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619139|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619140|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619141|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619142|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619143|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619144|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
44619145|NCT00580983|Paclitaxel|paclitaxel|mesh-list
44619146|NCT00580983|Cisplatin|cisplatin|mesh-list
44619147|NCT00580983|Carboplatin|carboplatin|mesh-list
44619148|NCT00580983|Fluorouracil|fluorouracil|mesh-list
44836440|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836441|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44836442|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
44836443|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
44836444|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836445|NCT02232347|Sufentanil|sufentanil|mesh-list
44836446|NCT02232347|Ketamine|ketamine|mesh-list
44836447|NCT02232347|Analgesics|analgesics|mesh-ancestor
44836448|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
44836449|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836450|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836451|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44836452|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44836453|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
44836454|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
44836455|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836456|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44836457|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44836458|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836459|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836460|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44836461|NCT02232347|Narcotics|narcotics|mesh-ancestor
44836462|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44836463|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44836464|NCT02232360|Fenofibrate|fenofibrate|mesh-list
44836465|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836466|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836467|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
44836468|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836469|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836470|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44836471|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836472|NCT02232386|Rituximab|rituximab|mesh-list
44836473|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44836474|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836475|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
44836476|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836477|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44836478|NCT02232399|Simendan|simendan|mesh-list
44836479|NCT02232399|Milrinone|milrinone|mesh-list
44836480|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44836481|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836482|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44836483|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44836484|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836485|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836486|NCT02232399|Protective Agents|protective agents|mesh-ancestor
44836487|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836488|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44836489|NCT02232516|Lenalidomide|lenalidomide|mesh-list
44836490|NCT02232516|Romidepsin|romidepsin|mesh-list
44836491|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
44836492|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836493|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44836494|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44836495|NCT02232516|Growth Substances|growth substances|mesh-ancestor
44836496|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44836497|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836498|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44836499|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44836500|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44836501|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44836502|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836503|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836504|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836505|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836506|NCT02232542|Analgesics|analgesics|mesh-ancestor
44836507|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
44836508|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836509|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
44836510|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836511|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
44836512|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44322954|NCT00941967|Gemcitabine|gemcitabine|mesh-list
44836513|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44836514|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44836515|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836516|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836517|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836518|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836519|NCT02232555|Analgesics|analgesics|mesh-ancestor
44836520|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
44836521|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836522|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
44836523|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836524|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
44836525|NCT02232581|Alovudine|alovudine|mesh-list
44836526|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
44836527|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
44836528|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836529|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
44836530|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836531|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44836532|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44836533|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836534|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44836535|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836536|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
44836537|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836538|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836539|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836540|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619225|NCT00579553|Progestins|progestins|mesh-ancestor
44836541|NCT02232607|Lacidipine|lacidipine|mesh-list
44836542|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836543|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44836544|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836545|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836546|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836547|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836548|NCT02232672|Choline|choline|mesh-list
44836549|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
44836550|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836551|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
44836552|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836553|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836554|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836555|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
44836556|NCT02232685|Choline|choline|mesh-list
44836557|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
44836558|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836559|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
44836560|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836561|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836562|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836563|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
44836564|NCT02232724|Choline|choline|mesh-list
44836565|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
44836566|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836567|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
44836568|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836569|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836570|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836571|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
44836572|NCT02232763|Losartan|losartan|mesh-list
44836573|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836574|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836575|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44836576|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44836577|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836578|NCT02232776|Losartan|losartan|mesh-list
44836579|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836580|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836581|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44836582|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44836583|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836584|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44836585|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
44836586|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836587|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836588|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
44836589|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836590|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836591|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44836592|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44836593|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836594|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44836595|NCT02232932|Capecitabine|capecitabine|mesh-list
44836596|NCT02232932|Liver Extracts|liver extracts|mesh-list
44836597|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44836598|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
44836599|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836600|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836601|NCT02232932|Hematinics|hematinics|mesh-ancestor
44836602|NCT02232945|Oseltamivir|oseltamivir|mesh-list
44836603|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
44836604|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836605|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836606|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836607|NCT02232971|Glucagon|glucagon|mesh-list
44836608|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836609|NCT02232971|Hormones|hormones|mesh-ancestor
44836610|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836611|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836612|NCT02233023|Dopamine|dopamine|mesh-list
44836613|NCT02233023|Pramipexole|pramipexole|mesh-list
44619297|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44836615|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
44836616|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
44836617|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836618|NCT02233023|Protective Agents|protective agents|mesh-ancestor
44836619|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836620|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44836621|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44836622|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
44836623|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836624|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44836625|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
44836626|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
44836627|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836628|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
44836629|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836630|NCT02233049|Everolimus|everolimus|mesh-list
44836631|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44836632|NCT02233049|Dasatinib|dasatinib|mesh-list
44836633|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836634|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44836635|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
44836636|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836637|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44836638|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836639|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836640|NCT02233075|Interferons|interferons|mesh-list
44836641|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
44836642|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
44836643|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44836644|NCT02233075|REP 2139|rep 2139|mesh-list
44836645|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836646|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
44836647|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836648|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
44836649|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836650|NCT02233179|Calpastatin|calpastatin|mesh-list
44836651|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44836652|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
44836653|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836654|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836655|NCT02233205|Gemcitabine|gemcitabine|mesh-list
44836656|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44836657|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
44836658|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836659|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836660|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
44836661|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836662|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836663|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44836664|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
44836665|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836666|NCT02233218|Amlodipine|amlodipine|mesh-list
44836667|NCT02233218|Telmisartan|telmisartan|mesh-list
44836668|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44836669|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44836670|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44836671|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836672|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836673|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836674|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836675|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
44836676|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836677|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836678|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
44836679|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836680|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44836681|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836682|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44836683|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44836684|NCT02233231|Varenicline|varenicline|mesh-list
44836685|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44836686|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44836687|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
44836688|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836689|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836690|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836692|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44836693|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44836694|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836695|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836696|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44836697|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836698|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836699|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44323120|NCT00942682|Sorafenib|sorafenib|mesh-list
44836700|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
44836701|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
44836702|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
44836703|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
44836704|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836705|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836706|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
44836707|NCT02233322|Hematinics|hematinics|mesh-ancestor
44836708|NCT02233387|Imidazole|imidazole|mesh-list
44836709|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836710|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836711|NCT02233400|Acetaminophen|acetaminophen|mesh-list
44836712|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44836713|NCT02233400|Analgesics|analgesics|mesh-ancestor
44836714|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
44836715|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836716|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836717|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
44836718|NCT02233439|Galactogogues|galactogogues|mesh-list
44836719|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836720|NCT02233452|Ketamine|ketamine|mesh-list
44836721|NCT02233452|Methadone|methadone|mesh-list
44836722|NCT02233452|Analgesics|analgesics|mesh-ancestor
44836723|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
44836724|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836725|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836726|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44836727|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44836728|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
44836729|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
44836730|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836731|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44836732|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44836733|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836734|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836735|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44836736|NCT02233452|Narcotics|narcotics|mesh-ancestor
44836737|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
44836738|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836739|NCT02233504|Deferasirox|deferasirox|mesh-list
44836740|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44836741|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
44836742|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
44836743|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836744|NCT02233556|Memantine|memantine|mesh-list
44836745|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44836746|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44836747|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
44836748|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836749|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836750|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836751|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44836752|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44836753|NCT02233582|Ibuprofen|ibuprofen|mesh-list
44836754|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44836755|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44836756|NCT02233582|Analgesics|analgesics|mesh-ancestor
44836757|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
44836758|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836759|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836760|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44836761|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44836762|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44836763|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836764|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836765|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44836766|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44836767|NCT02233621|Estradiol|estradiol|mesh-list
44836768|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44836769|NCT02233621|Estrogens|estrogens|mesh-ancestor
44836770|NCT02233621|Hormones|hormones|mesh-ancestor
44836771|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836772|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836773|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44323202|NCT00943345|Indomethacin|indomethacin|mesh-list
44836774|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
44836775|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44836776|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44836777|NCT02233777|Pregabalin|pregabalin|mesh-list
44836778|NCT02233777|Analgesics|analgesics|mesh-ancestor
44836779|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
44836780|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836781|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836782|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
44836783|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44836784|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836785|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836786|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836787|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44836788|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836789|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836790|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836791|NCT02233790|Clopidogrel|clopidogrel|mesh-list
44836792|NCT02233790|Ticagrelor|ticagrelor|mesh-list
44836793|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44836794|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44836795|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44836796|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44836797|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
44836798|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836799|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836800|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836801|NCT02233816|Vaccines|vaccines|mesh-list
44836802|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
44836803|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836804|NCT02233881|Ipratropium|ipratropium|mesh-list
44836805|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836806|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
44836807|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836808|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836809|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836810|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836811|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44836812|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
44323239|NCT00943540|Lamivudine|lamivudine|mesh-list
44836813|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836814|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836815|NCT02233894|Ipratropium|ipratropium|mesh-list
44836816|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836817|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
44836818|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836819|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836820|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836821|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836822|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44836823|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
44836824|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836825|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836826|NCT02233907|Oxitropium|oxitropium|mesh-list
44836827|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
44836828|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
44836829|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836830|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836831|NCT02233920|Oxitropium|oxitropium|mesh-list
44836832|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
44836833|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
44836834|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836835|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836836|NCT02233972|Midazolam|midazolam|mesh-list
44619539|NCT00577408|Naltrexone|naltrexone|mesh-list
44836837|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44836838|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44836839|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836840|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836841|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44836842|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836843|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836844|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44836845|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
44836846|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
44836847|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
44836848|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
44836849|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836850|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836851|NCT02234037|Decitabine|decitabine|mesh-list
44836852|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44836853|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
44836854|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836855|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836856|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836857|NCT02234050|Trabectedin|trabectedin|mesh-list
44836858|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44836859|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
44836860|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836861|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836862|NCT02234193|Lidocaine|lidocaine|mesh-list
44836863|NCT02234193|Epinephrine|epinephrine|mesh-list
44836864|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
44836865|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
44836866|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836867|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836868|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
44836869|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836870|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44836871|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44836872|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44836873|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44836874|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836875|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44836876|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44836877|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
44836878|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836879|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44836880|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44836881|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
44836882|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44836883|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44836884|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
44836885|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
44836886|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44836887|NCT02234349|Pancrelipase|pancrelipase|mesh-list
44836888|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836889|NCT02234440|Metformin|metformin|mesh-list
44836890|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44836891|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836892|NCT02234466|Dexamethasone|dexamethasone|mesh-list
44836893|NCT02234466|Ondansetron|ondansetron|mesh-list
44836894|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44836895|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
44836896|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
44836897|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44836898|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836899|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44836900|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
44836901|NCT02234466|Hormones|hormones|mesh-ancestor
44836902|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836903|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44836904|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836905|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
44836906|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
44836907|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44836908|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
44836909|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44836910|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836911|NCT02234466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44836912|NCT02234466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44836913|NCT02234466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44836914|NCT02234466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44836915|NCT02234466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44836916|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44836917|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836918|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836919|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
44836920|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836921|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323320|NCT00943943|Plerixafor|plerixafor|mesh-list
44836922|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44836923|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836924|NCT02234544|Vitamin D|vitamin d|mesh-list
44836925|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
44836926|NCT02234544|Ezetimibe|ezetimibe|mesh-list
44836927|NCT02234544|Vitamins|vitamins|mesh-ancestor
44836928|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
44836929|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836930|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44836931|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44836932|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836933|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836934|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
44836935|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836936|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836937|NCT02234739|Voriconazole|voriconazole|mesh-list
44836938|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
44836939|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836940|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44836941|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44836942|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836943|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836944|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44836945|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44619675|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44619676|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
44619677|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619678|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619679|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619680|NCT00576823|Urological Agents|urological agents|mesh-ancestor
44619681|NCT00576758|Rituximab|rituximab|mesh-list
44619682|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
44619683|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619684|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619685|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
44619686|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619687|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619688|NCT00576732|Risperidone|risperidone|mesh-list
44619689|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44619690|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
44619691|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619692|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619693|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836946|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44836947|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836948|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44836949|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
44836950|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44836951|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
44836952|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44836953|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
44836954|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836955|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836956|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
44836957|NCT02234869|Interferons|interferons|mesh-list
44836958|NCT02234869|Interferon-beta|interferon-beta|mesh-list
44836959|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
44836960|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
44836961|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836962|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
44836963|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836964|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
44836965|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836966|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44836967|NCT02234882|Fostemsavir|fostemsavir|mesh-list
44836968|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44836969|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44836970|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44836971|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
44836972|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836973|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44836974|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44836975|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44836976|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44836977|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44836978|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
44836979|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44836980|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44836981|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44836982|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
44836983|NCT02234921|Imiquimod|imiquimod|mesh-list
44836984|NCT02234921|Vaccines|vaccines|mesh-list
44836985|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
44836986|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44836987|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44836988|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44836989|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44836990|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
44836991|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44836992|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44836993|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44836994|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44836995|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
44836996|NCT02235012|Ketamine|ketamine|mesh-list
44836997|NCT02235012|Analgesics|analgesics|mesh-ancestor
44836998|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
44836999|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837000|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837001|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44837002|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44837003|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
44837004|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
44837005|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837006|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44837007|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44837008|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837009|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837010|NCT02235194|Chromium|chromium|mesh-list
44837011|NCT02235194|Picolinic acid|picolinic acid|mesh-list
44837012|NCT02235194|Trace Elements|trace elements|mesh-ancestor
44837013|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
44837014|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837015|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44837016|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
44837017|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
44837018|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837019|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
44837020|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44837021|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837023|NCT02235246|Analgesics|analgesics|mesh-ancestor
44837024|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
44837025|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837026|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837027|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
44837028|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837029|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837030|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
44837031|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44837032|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837033|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837034|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837035|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
44837036|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837037|NCT02235324|Leucovorin|leucovorin|mesh-list
44837038|NCT02235324|Fluorouracil|fluorouracil|mesh-list
44837039|NCT02235324|Aflibercept|aflibercept|mesh-list
44837040|NCT02235324|Calcium|calcium|mesh-list
44837041|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
44837042|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
44837043|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837044|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837045|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
44837046|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837047|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44837048|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837049|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44837050|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
44837051|NCT02235324|Antidotes|antidotes|mesh-ancestor
44837052|NCT02235324|Protective Agents|protective agents|mesh-ancestor
44837053|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
44837054|NCT02235324|Vitamins|vitamins|mesh-ancestor
44837055|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
44837056|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44837057|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44837058|NCT02235324|Growth Substances|growth substances|mesh-ancestor
44837059|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44837060|NCT02235337|Riboflavin|riboflavin|mesh-list
44837061|NCT02235337|Vitamins|vitamins|mesh-ancestor
44837062|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
44837063|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837064|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
44837065|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44837066|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
44837067|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44837068|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44837069|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44837070|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837071|NCT02235402|Lacidipine|lacidipine|mesh-list
44837072|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
44837073|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837074|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44323497|NCT00944814|Zinc|zinc|mesh-list
44837075|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837076|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837077|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837078|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837079|NCT02235402|Diuretics|diuretics|mesh-ancestor
44837080|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
44837081|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44837082|NCT02235415|Lacidipine|lacidipine|mesh-list
44837083|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837084|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44837085|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837086|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837087|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837088|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837089|NCT02235428|Bromides|bromides|mesh-list
44837090|NCT02235428|Albuterol|albuterol|mesh-list
44837091|NCT02235428|Ipratropium|ipratropium|mesh-list
44837092|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
44837093|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837094|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
44696470|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837095|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837096|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837097|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837098|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837099|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
44837100|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837101|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44837102|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44837103|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837104|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837105|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837106|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837107|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837108|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837109|NCT02235480|Tazarotene|tazarotene|mesh-list
44837110|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
44837111|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
44837112|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44837113|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44837114|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44837115|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837116|NCT02235532|Fluorides|fluorides|mesh-list
44837117|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
44837118|NCT02235532|Protective Agents|protective agents|mesh-ancestor
44837119|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837120|NCT02235558|Verapamil|verapamil|mesh-list
44837121|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837122|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44837123|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837124|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837125|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837126|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837127|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
44837128|NCT02235584|Dexamethasone|dexamethasone|mesh-list
44837129|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837130|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
44837131|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
44837132|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837133|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837134|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837135|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
44837136|NCT02235584|Hormones|hormones|mesh-ancestor
44837137|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837138|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837139|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837140|NCT02235662|Tenofovir|tenofovir|mesh-list
44837141|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
44837142|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
44837143|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837144|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44837145|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44837146|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837147|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837148|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44837149|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44837150|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44837151|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
44837152|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837153|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837154|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44837155|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44837156|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44837157|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
44837158|NCT02235805|Cathartics|cathartics|mesh-ancestor
44837159|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837160|NCT02235909|Losartan|losartan|mesh-list
44837161|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44837162|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837163|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837164|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44837165|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44837166|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619848|NCT00574275|Gemcitabine|gemcitabine|mesh-list
44837167|NCT02235948|Folic Acid|folic acid|mesh-list
44837168|NCT02235948|Hematinics|hematinics|mesh-ancestor
44837169|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
44837170|NCT02235948|Vitamins|vitamins|mesh-ancestor
44837171|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
44837172|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837173|NCT02235961|Liraglutide|liraglutide|mesh-list
44837174|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44837175|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837176|NCT02235961|Incretins|incretins|mesh-ancestor
44837177|NCT02235961|Hormones|hormones|mesh-ancestor
44837178|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837179|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
44837180|NCT02236026|ST 1435|st 1435|mesh-list
44837181|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837182|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837183|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44837184|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44837185|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837186|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837187|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837188|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44837189|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
44837190|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837191|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837192|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44837193|NCT02236052|Vaccines|vaccines|mesh-list
44837194|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
44837195|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837196|NCT02236065|Lenograstim|lenograstim|mesh-list
44837197|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44837198|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
44837199|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837200|NCT02236078|Isoniazid|isoniazid|mesh-list
44837201|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
44837202|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837203|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837204|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44837205|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44837206|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
44837207|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837208|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44837209|NCT02236169|Bromides|bromides|mesh-list
44837210|NCT02236169|Norflurane|norflurane|mesh-list
44837211|NCT02236169|Ipratropium|ipratropium|mesh-list
44837212|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
44837213|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837214|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
44837215|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837216|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837217|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837218|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837219|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837220|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837221|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837222|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837223|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
44837224|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837225|NCT02236182|Bromides|bromides|mesh-list
44837226|NCT02236182|Ipratropium|ipratropium|mesh-list
44837227|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
44837228|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837229|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
44837230|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837231|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837232|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837233|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837234|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837235|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837236|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837237|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837238|NCT02236260|Lidocaine|lidocaine|mesh-list
44837239|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
44837240|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
44837241|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837242|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837243|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
44837244|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837245|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837246|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44837247|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44837248|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837249|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837250|NCT02236403|Metronidazole|metronidazole|mesh-list
44837251|NCT02236403|Ivermectin|ivermectin|mesh-list
44837252|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837253|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837254|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44837255|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44837256|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44837257|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837258|NCT02236715|Ipratropium|ipratropium|mesh-list
44837259|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837260|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
44837261|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837262|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837263|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837264|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837265|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837266|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837267|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837268|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837269|NCT02236728|Pramipexole|pramipexole|mesh-list
44837270|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
44837271|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837272|NCT02236728|Protective Agents|protective agents|mesh-ancestor
44837273|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837274|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44837275|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44837276|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
44837277|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
44696471|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
44696472|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696473|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696474|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44696475|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696476|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44696477|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
44696478|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696479|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696480|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44696481|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696482|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
44248135|NCT00602173|Cilostazol|cilostazol|mesh-list
44696483|NCT01392144|Protective Agents|protective agents|mesh-ancestor
44696484|NCT01392157|Copper|copper|mesh-list
44696485|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
44696486|NCT01392157|Trace Elements|trace elements|mesh-ancestor
44696487|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
44696488|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696489|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44696490|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
44696491|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696492|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44696493|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44696494|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44696495|NCT01392209|Bevacizumab|bevacizumab|mesh-list
44696496|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696497|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696498|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44696499|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44696500|NCT01392209|Growth Substances|growth substances|mesh-ancestor
44696501|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696502|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
44837278|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837279|NCT02236741|Pramipexole|pramipexole|mesh-list
44837280|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
44837281|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837282|NCT02236741|Protective Agents|protective agents|mesh-ancestor
44837283|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837284|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44837285|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44837286|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
44837287|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
44837288|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837289|NCT02236793|Becaplermin|becaplermin|mesh-list
44837290|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
44837291|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44837292|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44837293|NCT02236793|Growth Substances|growth substances|mesh-ancestor
44837294|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837295|NCT02236936|Cisplatin|cisplatin|mesh-list
44837296|NCT02236936|Cetuximab|cetuximab|mesh-list
44837297|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837298|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44837299|NCT02236962|Pioglitazone|pioglitazone|mesh-list
44837300|NCT02236962|Ephedrine|ephedrine|mesh-list
44837301|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44837302|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837303|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44837304|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
44837305|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
44837306|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837307|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44837308|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837309|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837310|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837311|NCT02237027|Tenofovir|tenofovir|mesh-list
44837312|NCT02237027|Emtricitabine|emtricitabine|mesh-list
44837313|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44837314|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
44837315|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837316|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44837317|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44837318|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837319|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837320|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44837321|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44837322|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44837323|NCT02237053|Octreotide|octreotide|mesh-list
44837324|NCT02237053|Glucagon|glucagon|mesh-list
44837325|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837326|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837327|NCT02237053|Hormones|hormones|mesh-ancestor
44837328|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837329|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837330|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837331|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
44837332|NCT02237079|Estrogens|estrogens|mesh-list
44837333|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44837334|NCT02237079|Hormones|hormones|mesh-ancestor
44837335|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837336|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837337|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44837338|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44837339|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
44837340|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44837341|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
44837342|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
44837343|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44837344|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837345|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837346|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44837347|NCT02237209|Vaccines|vaccines|mesh-list
44837348|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
44837349|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837350|NCT02237261|Prednisone|prednisone|mesh-list
44837351|NCT02237261|Bortezomib|bortezomib|mesh-list
44837352|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44837353|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620033|NCT00573391|Thalidomide|thalidomide|mesh-list
44620108|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837354|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
44837355|NCT02237261|Hormones|hormones|mesh-ancestor
44837356|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837357|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837358|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837359|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837360|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44837361|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
44837362|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837363|NCT02237326|Acetic Acid|acetic acid|mesh-list
44837364|NCT02237326|Retinol acetate|retinol acetate|mesh-list
44837365|NCT02237326|Lugol's solution|lugol's solution|mesh-list
44837366|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837367|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837368|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44837369|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
44837370|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837371|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44837372|NCT02237326|Protective Agents|protective agents|mesh-ancestor
44837373|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837374|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
44837375|NCT02237326|Coagulants|coagulants|mesh-ancestor
44837376|NCT02237339|Allopurinol|allopurinol|mesh-list
44837377|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
44837378|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837379|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837380|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
44837381|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837382|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44837383|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
44837384|NCT02237339|Protective Agents|protective agents|mesh-ancestor
44837385|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837386|NCT02237365|Aspirin|aspirin|mesh-list
44837387|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44837388|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837389|NCT02237365|Analgesics|analgesics|mesh-ancestor
44837390|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
44837391|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837392|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837393|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837394|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837395|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44837396|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44837397|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837398|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44620109|NCT00572832|Vaccines|vaccines|mesh-list
44620110|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
44620111|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620112|NCT00572728|Alovudine|alovudine|mesh-list
44620113|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
44620114|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
44620115|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620116|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
44620117|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620118|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44620119|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44620120|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620121|NCT00572572|Aprepitant|aprepitant|mesh-list
44620122|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
44620123|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
44620124|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620125|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620126|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620127|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44620128|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620129|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620130|NCT00572455|Latanoprost|latanoprost|mesh-list
44620131|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44620132|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44620133|NCT00572156|Mecasermin|mecasermin|mesh-list
44620134|NCT00572156|Growth Substances|growth substances|mesh-ancestor
44620135|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620136|NCT00571922|Acamprosate|acamprosate|mesh-list
44837399|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44837400|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837401|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
44837402|NCT02237443|Bromides|bromides|mesh-list
44837403|NCT02237443|Rocuronium|rocuronium|mesh-list
44837404|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
44837405|NCT02237443|Succinylcholine|succinylcholine|mesh-list
44837406|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
44837407|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44837408|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44837409|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44837410|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837411|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837412|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44837413|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44837414|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837415|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837416|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837417|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837418|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
44837419|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44837420|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837421|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837422|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837423|NCT02237495|Analgesics|analgesics|mesh-ancestor
44837424|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
44837425|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837426|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44837427|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44837428|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837429|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837430|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837431|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837432|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
44837433|NCT02237534|Calcium|calcium|mesh-list
44837434|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837435|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837436|NCT02237534|Antacids|antacids|mesh-ancestor
44837437|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837438|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837439|NCT02237560|Camphor|camphor|mesh-list
44837440|NCT02237560|Salicylates|salicylates|mesh-list
44837441|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
44837442|NCT02237560|Menthol|menthol|mesh-list
44837443|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44837444|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837445|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
44837446|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
44837447|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44837448|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837449|NCT02237560|Analgesics|analgesics|mesh-ancestor
44837450|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
44837451|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837452|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837453|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837454|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837455|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44323918|NCT00947128|Ondansetron|ondansetron|mesh-list
44837456|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837457|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837458|NCT02237651|Anesthetics|anesthetics|mesh-list
44837459|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837460|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837461|NCT02237690|Doxorubicin|doxorubicin|mesh-list
44837462|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44837463|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44837464|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837465|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44837466|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44837467|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837468|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837469|NCT02237729|Adalimumab|adalimumab|mesh-list
44837470|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837471|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837472|NCT02237755|Citric Acid|citric acid|mesh-list
44837473|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
44837474|NCT02237755|Clomiphene|clomiphene|mesh-list
44837475|NCT02237755|Enclomiphene|enclomiphene|mesh-list
44837476|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
44837477|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
44837478|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44837479|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
44837480|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
44837481|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837482|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44837483|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44837484|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837485|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837486|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44837487|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
44837488|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837489|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44837490|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44837491|NCT02237768|Dirithromycin|dirithromycin|mesh-list
44837492|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837493|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837494|NCT02237807|Dirithromycin|dirithromycin|mesh-list
44837495|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837496|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837497|NCT02237820|Dexamethasone|dexamethasone|mesh-list
44837498|NCT02237820|Prednisone|prednisone|mesh-list
44837499|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837500|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
44837501|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
44837502|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837503|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837504|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837505|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
44837506|NCT02237820|Hormones|hormones|mesh-ancestor
44837507|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837508|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837509|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837510|NCT02237859|Vancomycin|vancomycin|mesh-list
44837511|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44837512|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837513|NCT02237924|Endostar protein|endostar protein|mesh-list
44837514|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44837515|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44837516|NCT02237924|Growth Substances|growth substances|mesh-ancestor
44837517|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837518|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
44837519|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837520|NCT02237937|Amitriptyline|amitriptyline|mesh-list
44837521|NCT02237937|Citalopram|citalopram|mesh-list
44837522|NCT02237937|Paroxetine|paroxetine|mesh-list
44837523|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44837524|NCT02237937|Sertraline|sertraline|mesh-list
44837525|NCT02237937|Nortriptyline|nortriptyline|mesh-list
44837526|NCT02237937|Trimipramine|trimipramine|mesh-list
44837527|NCT02237937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44837528|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44837529|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837530|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837531|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837532|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
44837533|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837534|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44837535|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
44837536|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44837537|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837538|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44837539|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44837540|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837541|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44837542|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44837543|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837544|NCT02237937|Analgesics|analgesics|mesh-ancestor
44837545|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
44837546|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44837547|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837548|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44837549|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837550|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
44837551|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837552|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837553|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837554|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837555|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44837556|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44837557|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837558|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837559|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837560|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837561|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
44837562|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
44837563|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837564|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
44837565|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837566|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837567|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837568|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837569|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44837570|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44837571|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837572|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837573|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837574|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837575|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
44467832|NCT01444742|Cytarabine|cytarabine|mesh-list
44837576|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837577|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837578|NCT02238132|Ipratropium|ipratropium|mesh-list
44837579|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837580|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
44837581|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837582|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837583|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837584|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837585|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837586|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837587|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837588|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837589|NCT02238145|Ipratropium|ipratropium|mesh-list
44837590|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837591|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
44837592|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837593|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837594|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837595|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837596|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837597|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837598|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837599|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837600|NCT02238158|Ipratropium|ipratropium|mesh-list
44837601|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837602|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
44837603|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837604|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837605|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837606|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837607|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837608|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837609|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837610|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837611|NCT02238171|Ipratropium|ipratropium|mesh-list
44837612|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837613|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
44837614|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837615|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837616|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837617|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837618|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837619|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837620|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837621|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837622|NCT02238184|Ipratropium|ipratropium|mesh-list
44837623|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837624|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
44837625|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837626|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837627|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837628|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837629|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837630|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837631|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837632|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837633|NCT02238197|Ipratropium|ipratropium|mesh-list
44837634|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837635|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
44837636|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837637|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837638|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837639|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837640|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837641|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837642|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837643|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837644|NCT02238210|Ipratropium|ipratropium|mesh-list
44837645|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837646|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
44837647|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837648|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837649|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837650|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837651|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44837652|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
44837653|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837654|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837655|NCT02238262|Telmisartan|telmisartan|mesh-list
44837656|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837657|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44837658|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44837659|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837660|NCT02238275|Telmisartan|telmisartan|mesh-list
44837661|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837662|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44837663|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44837664|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837665|NCT02238288|Acetaminophen|acetaminophen|mesh-list
44837666|NCT02238288|Lidocaine|lidocaine|mesh-list
44837667|NCT02238288|Epinephrine|epinephrine|mesh-list
44837668|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
44837669|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
44837670|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
44837671|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837672|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837673|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
44837674|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837675|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837676|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44837677|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44837678|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837679|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837680|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837681|NCT02238288|Analgesics|analgesics|mesh-ancestor
44837682|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
44837683|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44837684|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837685|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837686|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837687|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44837688|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837689|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
44837690|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837691|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837692|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
44837693|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
44837694|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44837695|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44837696|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44837698|NCT02238288|Coagulants|coagulants|mesh-ancestor
44837699|NCT02238314|Ritonavir|ritonavir|mesh-list
44837700|NCT02238314|Tipranavir|tipranavir|mesh-list
44837701|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44837702|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44837703|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44837704|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
44837705|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837706|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837707|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44837708|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44837709|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
44837710|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837711|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44837712|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44837713|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44837714|NCT02238340|Ketoprofen|ketoprofen|mesh-list
44837715|NCT02238340|Morphine|morphine|mesh-list
44837716|NCT02238340|Oxycodone|oxycodone|mesh-list
44837717|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44837718|NCT02238340|Narcotics|narcotics|mesh-ancestor
44837719|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837720|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837721|NCT02238340|Analgesics|analgesics|mesh-ancestor
44837722|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
44837723|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837724|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44837725|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837726|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837727|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837728|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44837729|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837730|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837731|NCT02238353|Fluticasone|fluticasone|mesh-list
44837732|NCT02238353|Azelastine|azelastine|mesh-list
44837733|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837734|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44837735|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
44837736|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837737|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837738|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44837739|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837740|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
44837741|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44837742|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44837743|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837744|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837745|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44837746|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44837747|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
44837748|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
44837749|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837750|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44837751|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
44837752|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44837753|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
44837754|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837755|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837756|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44837757|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837758|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837759|NCT02238392|Adenosine|adenosine|mesh-list
44837760|NCT02238392|Analgesics|analgesics|mesh-ancestor
44837761|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
44837762|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837763|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837764|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837765|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44837766|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44837767|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
44837768|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
44837769|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837770|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837771|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
44837773|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837774|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837775|NCT02238418|Vitamins|vitamins|mesh-ancestor
44837776|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
44837777|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44837778|NCT02238431|Leuprolide|leuprolide|mesh-list
44837779|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44837780|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
44837781|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44837782|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837783|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44837784|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837785|NCT02238444|Aspirin|aspirin|mesh-list
44837786|NCT02238444|Heparin|heparin|mesh-list
44837787|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44837788|NCT02238444|Tinzaparin|tinzaparin|mesh-list
44837789|NCT02238444|Dalteparin|dalteparin|mesh-list
44837790|NCT02238444|Dipyridamole|dipyridamole|mesh-list
44837791|NCT02238444|Warfarin|warfarin|mesh-list
44837792|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44837793|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837794|NCT02238444|Analgesics|analgesics|mesh-ancestor
44837795|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
44837796|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837797|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837798|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44837799|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44837800|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44837801|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44837802|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837803|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44837804|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44837805|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837806|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
44837807|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
44837808|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44837809|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
44837810|NCT02238457|Losartan|losartan|mesh-list
44837811|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44837812|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44837813|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44837814|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44837815|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837816|NCT02238470|Warfarin|warfarin|mesh-list
44837817|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
44837818|NCT02238470|Dabigatran|dabigatran|mesh-list
44837819|NCT02238470|Apixaban|apixaban|mesh-list
44837820|NCT02238470|Anticoagulants|anticoagulants|mesh-list
44837821|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44837822|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
44837823|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44837824|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44837825|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837826|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837827|NCT02238509|Trastuzumab|trastuzumab|mesh-list
44837828|NCT02238509|Lapatinib|lapatinib|mesh-list
44837829|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44837830|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837831|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44837832|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837833|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837834|NCT02238535|Iloprost|iloprost|mesh-list
44837835|NCT02238535|Warfarin|warfarin|mesh-list
44837836|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
44837837|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44837838|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
44837839|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
44837840|NCT02238704|Iron|iron|mesh-list
44837841|NCT02238704|Folic Acid|folic acid|mesh-list
44837842|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
44837843|NCT02238704|Calcium|calcium|mesh-list
44837844|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837845|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620510|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
44837846|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44837847|NCT02238704|Trace Elements|trace elements|mesh-ancestor
44837848|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
44837849|NCT02238704|Hematinics|hematinics|mesh-ancestor
44837850|NCT02238704|Vitamins|vitamins|mesh-ancestor
44837851|NCT02238717|Pregabalin|pregabalin|mesh-list
44837852|NCT02238717|PF-06372865|pf-06372865|mesh-list
44837853|NCT02238717|Analgesics|analgesics|mesh-ancestor
44837854|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
44837855|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837856|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837857|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
44837858|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44837859|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837860|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837861|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837862|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44837863|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44837864|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837865|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44837866|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
44837867|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
44837868|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837869|NCT02238808|Estradiol|estradiol|mesh-list
44837870|NCT02238808|Estrogens|estrogens|mesh-list
44837871|NCT02238808|Hormones|hormones|mesh-ancestor
44837872|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837873|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837874|NCT02238860|Tenofovir|tenofovir|mesh-list
44837875|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
44837876|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837877|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44837878|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44837879|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837880|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837881|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44837882|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44837883|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
44837884|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44837885|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
44837886|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837887|NCT02239107|Expectorants|expectorants|mesh-ancestor
44837888|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
44837889|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44837890|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
44837891|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837892|NCT02239107|Protective Agents|protective agents|mesh-ancestor
44837893|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837894|NCT02239107|Antidotes|antidotes|mesh-ancestor
44837895|NCT02239276|Stiripentol|stiripentol|mesh-list
44837896|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
44837897|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
44837898|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
44837899|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44837900|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837901|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837902|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44837903|NCT02239445|Analgesics|analgesics|mesh-ancestor
44837904|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
44837905|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837906|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44837907|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44837908|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44837909|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837910|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837911|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837912|NCT02239458|Saxagliptin|saxagliptin|mesh-list
44837913|NCT02239458|Incretins|incretins|mesh-ancestor
44837914|NCT02239458|Hormones|hormones|mesh-ancestor
44837915|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44837916|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837917|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44837918|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696503|NCT01392287|Memantine|memantine|mesh-list
44837919|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837920|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837921|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44837922|NCT02239484|Tadalafil|tadalafil|mesh-list
44837923|NCT02239484|Tamsulosin|tamsulosin|mesh-list
44837924|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
44837925|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44837926|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44837927|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837928|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696504|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44696505|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44696506|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
44696507|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696508|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696509|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696510|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44696511|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44696512|NCT01392430|Azithromycin|azithromycin|mesh-list
44696513|NCT01392430|Dapsone|dapsone|mesh-list
44696514|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44696515|NCT01392430|Itraconazole|itraconazole|mesh-list
44696516|NCT01392430|Fluconazole|fluconazole|mesh-list
44696517|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44696518|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696519|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
44696520|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44696521|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44696522|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696523|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696524|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44696525|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696526|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696527|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696528|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44696529|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44696530|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44696531|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
44696532|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44696533|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44696534|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44696535|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
44696536|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44696537|NCT01392430|Renal Agents|renal agents|mesh-ancestor
44696538|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44696539|NCT01392534|Telmisartan|telmisartan|mesh-list
44696540|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44696541|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44696542|NCT01392534|Diuretics|diuretics|mesh-ancestor
44696543|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
44696544|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696545|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44696546|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696547|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696548|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44696549|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44696550|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
44696551|NCT01392612|Hematinics|hematinics|mesh-ancestor
44696552|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
44696553|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696554|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44696555|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44696556|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696557|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696558|NCT01392638|Urological Agents|urological agents|mesh-ancestor
44248217|NCT00602498|Clarithromycin|clarithromycin|mesh-list
44696560|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696561|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696562|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
44696563|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696564|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44696565|NCT01392755|Ritonavir|ritonavir|mesh-list
44837929|NCT02239484|Urological Agents|urological agents|mesh-ancestor
44837930|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44837931|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44837932|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44837933|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837934|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837935|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837936|NCT02239523|Denosumab|denosumab|mesh-list
44837937|NCT02239523|Teriparatide|teriparatide|mesh-list
44837938|NCT02239523|Diphosphonates|diphosphonates|mesh-list
44837939|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44837940|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837941|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44837942|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44837943|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
44837944|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
44837945|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837946|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44837947|NCT02239614|Antacids|antacids|mesh-ancestor
44837948|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837949|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44837950|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44837951|NCT02239731|Doxycycline|doxycycline|mesh-list
44837952|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837953|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
44837954|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44837955|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44696566|NCT01392755|Omeprazole|omeprazole|mesh-list
44696567|NCT01392755|Ranitidine|ranitidine|mesh-list
44324368|NCT00949949|Antiviral Agents|antiviral agents|mesh-ancestor
44696568|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44837957|NCT02239835|Saquinavir|saquinavir|mesh-list
44837958|NCT02239835|Tipranavir|tipranavir|mesh-list
44837959|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44837960|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44837961|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44837962|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44837963|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837964|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44837965|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44837966|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
44837967|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44837968|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44837969|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44837970|NCT02239900|Ipilimumab|ipilimumab|mesh-list
44837971|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44837972|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44837973|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44837974|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837975|NCT02239913|Topiramate|topiramate|mesh-list
44837976|NCT02239913|Phentermine|phentermine|mesh-list
44837977|NCT02239913|Cocaine|cocaine|mesh-list
44837978|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
44837979|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44837980|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44837981|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
44837982|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
44837983|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44837984|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
44837985|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44837986|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44837987|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44837988|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44837989|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44837990|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44837991|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
44837992|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44837993|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44837994|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
44837995|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44837996|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
44837997|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
44837998|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44837999|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44838000|NCT02239952|Sunitinib|sunitinib|mesh-list
44838001|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838002|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838003|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838004|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838005|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44838006|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44838007|NCT02239952|Growth Substances|growth substances|mesh-ancestor
44838008|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838009|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
44838010|NCT02241018|Antibodies|antibodies|mesh-list
44838011|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44838012|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44838013|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
44838014|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838015|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838016|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838017|NCT02241161|Bacteriocins|bacteriocins|mesh-list
44838018|NCT02241161|Antioxidants|antioxidants|mesh-list
44838019|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838020|NCT02241161|Protective Agents|protective agents|mesh-ancestor
44838021|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838022|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838023|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838024|NCT02242799|Artesunate|artesunate|mesh-list
44838025|NCT02242799|Lumefantrine|lumefantrine|mesh-list
44838026|NCT02242799|Artemether|artemether|mesh-list
44838027|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44838028|NCT02242799|Amodiaquine|amodiaquine|mesh-list
44838029|NCT02242799|Dolutegravir|dolutegravir|mesh-list
44838030|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
44838031|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44838032|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44838033|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838034|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838035|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
44838036|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
44838037|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44838038|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
44838039|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44838040|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44838041|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838042|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838043|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44838044|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44838045|NCT02243137|Aspirin|aspirin|mesh-list
44838046|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44838047|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44838048|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44838049|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838050|NCT02243137|Analgesics|analgesics|mesh-ancestor
44324477|NCT00950625|Lidocaine|lidocaine|mesh-list
44838051|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
44838052|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838053|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838054|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838055|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44838056|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44838057|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44838058|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838059|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44838060|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44838061|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838062|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
44838063|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
44838064|NCT02243735|Trace Elements|trace elements|mesh-ancestor
44838065|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
44838066|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838067|NCT02244164|Liraglutide|liraglutide|mesh-list
44838068|NCT02244164|Exenatide|exenatide|mesh-list
44838069|NCT02244164|Lixisenatide|lixisenatide|mesh-list
44838070|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44838071|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44838072|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838073|NCT02244164|Incretins|incretins|mesh-ancestor
44838074|NCT02244164|Hormones|hormones|mesh-ancestor
44838075|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838076|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44838077|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
44838078|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838079|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838080|NCT02244502|Paclitaxel|paclitaxel|mesh-list
44838081|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838082|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838083|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838084|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838085|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838086|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838087|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44838088|NCT02244866|Hormones|hormones|mesh-ancestor
44838089|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838090|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838091|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44838092|NCT02245841|Hormones|hormones|mesh-ancestor
44838093|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838094|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838095|NCT02245867|Antibodies|antibodies|mesh-list
44838096|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44838097|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
44838098|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838099|NCT02245932|Resveratrol|resveratrol|mesh-list
44838100|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
44838101|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838102|NCT02245932|Protective Agents|protective agents|mesh-ancestor
44838103|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838104|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838105|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44838106|NCT02246179|Lidocaine|lidocaine|mesh-list
44838107|NCT02246179|Epinephrine|epinephrine|mesh-list
44838108|NCT02246179|Prilocaine|prilocaine|mesh-list
44838109|NCT02246179|Carticaine|carticaine|mesh-list
44838110|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44838111|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44838112|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
44838113|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838114|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838115|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
44838116|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838117|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44838118|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44838119|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44838120|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838121|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838122|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44838123|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44838124|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
44838125|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838126|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44838127|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44838128|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
44838129|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44838130|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
44838131|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
44838132|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
44838133|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44838134|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44838135|NCT02247128|Aspirin|aspirin|mesh-list
44838136|NCT02247128|Clopidogrel|clopidogrel|mesh-list
44838137|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44838138|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838139|NCT02247128|Analgesics|analgesics|mesh-ancestor
44838140|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
44838141|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324543|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44838142|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838143|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838144|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44838145|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44838146|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44838147|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838148|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44838149|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44838150|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838151|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
44838152|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44838153|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44838154|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44838155|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
44838156|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838157|NCT02247986|Methylphenidate|methylphenidate|mesh-list
44838158|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44838159|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838160|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44838161|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44838162|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838163|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838164|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
44838165|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838166|NCT02248493|Acetaminophen|acetaminophen|mesh-list
44838167|NCT02248493|Ketoprofen|ketoprofen|mesh-list
44838168|NCT02248493|Morphine|morphine|mesh-list
44838169|NCT02248493|Tramadol|tramadol|mesh-list
44838170|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44838171|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44838172|NCT02248493|Narcotics|narcotics|mesh-ancestor
44838173|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838174|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838175|NCT02248493|Analgesics|analgesics|mesh-ancestor
44838176|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
44838177|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838178|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838179|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
44838180|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44838181|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838183|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44838184|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838185|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838186|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44838187|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838188|NCT05354479|Acetaminophen|acetaminophen|mesh-list
44838189|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838190|NCT05354479|Analgesics|analgesics|mesh-ancestor
44838191|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
44838192|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838193|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838194|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
44838195|NCT05354076|Doxorubicin|doxorubicin|mesh-list
44838196|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44838197|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44838198|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838199|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44838200|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44838201|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838202|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838203|NCT05353816|Heparin|heparin|mesh-list
44838204|NCT05353816|Anticoagulants|anticoagulants|mesh-ancestor
44838205|NCT05353816|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44838206|NCT05353816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44838207|NCT05353816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838208|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44838209|NCT05353673|Danazol|danazol|mesh-list
44838210|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44838211|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838212|NCT05353673|Incretins|incretins|mesh-ancestor
44838213|NCT05353673|Hormones|hormones|mesh-ancestor
44838214|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838215|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44838216|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
44838217|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838218|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838219|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44838220|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
44838221|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
44838222|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838223|NCT05353361|Paclitaxel|paclitaxel|mesh-list
44838224|NCT05353361|Pertuzumab|pertuzumab|mesh-list
44838225|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838226|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838227|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838228|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838229|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838230|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838231|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838232|NCT05353283|Tenofovir|tenofovir|mesh-list
44838233|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
44838234|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838235|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44838236|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44838237|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838238|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838239|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44838240|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44838241|NCT05353205|HH-GV-678|hh-gv-678|mesh-list
44838242|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838243|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838244|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838245|NCT05353192|Hormones|hormones|mesh-list
44838246|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838247|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838248|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44838249|NCT05353101|Cyclosporine|cyclosporine|mesh-list
44838250|NCT05353101|Tobramycin|tobramycin|mesh-list
44838251|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44838252|NCT05353101|Cyclosporins|cyclosporins|mesh-list
44838253|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838254|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838255|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838256|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
44838257|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838258|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
44838259|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838260|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
44838261|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44838262|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44838263|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44838264|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838265|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44838266|NCT05353010|Tacrolimus|tacrolimus|mesh-list
44838267|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838268|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
44838269|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838270|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44838271|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838272|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838273|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44838274|NCT05352854|Pilocarpine|pilocarpine|mesh-list
44838275|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44838276|NCT05352854|Miotics|miotics|mesh-ancestor
44838277|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
44838278|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838279|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838280|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44838281|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44838282|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838283|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838284|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838285|NCT05340452|Clarithromycin|clarithromycin|mesh-list
44838286|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838287|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838288|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44838289|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838290|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838291|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44838292|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44838293|NCT05339399|Oxytocin|oxytocin|mesh-list
44838294|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
44838295|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44838296|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838297|NCT05338983|Anesthetics|anesthetics|mesh-list
44838298|NCT05338983|Mepivacaine|mepivacaine|mesh-list
44838299|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
44838300|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838301|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838302|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
44838303|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838304|NCT05335954|Norepinephrine|norepinephrine|mesh-list
44838305|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44838306|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44838307|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
44838308|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838309|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838310|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838311|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
44838312|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
44838313|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838314|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44838315|NCT05330364|Cladribine|cladribine|mesh-list
44838316|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838317|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838318|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
44838319|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838320|NCT05299242|Adalimumab|adalimumab|mesh-list
44838321|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838322|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44838323|NCT05289323|Neostigmine|neostigmine|mesh-list
44324712|NCT00952562|Vitamin D|vitamin d|mesh-list
44838324|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44838325|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838326|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838327|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838328|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838329|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838330|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44838331|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
44838332|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838333|NCT05212610|Vaccines|vaccines|mesh-list
44838334|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
44838335|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838336|NCT05197062|Aticaprant|aticaprant|mesh-list
44838337|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44838338|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838339|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
44838340|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838341|NCT05124457|Insulin|insulin|mesh-list
44838342|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44838343|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
44838344|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
44838345|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
44838346|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
44838347|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44838348|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838349|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
44838350|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
44838351|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44838352|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44838353|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
44838354|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838355|NCT05020327|Amoxicillin|amoxicillin|mesh-list
44838356|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44621125|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838357|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838359|NCT05000736|Palbociclib|palbociclib|mesh-list
44838360|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44838361|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44838362|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838363|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44838364|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44324762|NCT00952952|Mesalamine|mesalamine|mesh-list
44838365|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
44838366|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838367|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838368|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838369|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838370|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838371|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44838372|NCT04876066|Ketamine|ketamine|mesh-list
44838373|NCT04876066|Analgesics|analgesics|mesh-ancestor
44838374|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
44838375|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838376|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838377|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44838378|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44838379|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
44838380|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
44838381|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838382|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44838383|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44838384|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838385|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838386|NCT04856007|Metformin|metformin|mesh-list
44838387|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
44838388|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44838389|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838390|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44838391|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838392|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
44838393|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838394|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838395|NCT04768101|Corticosterone|corticosterone|mesh-list
44838396|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838397|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44838398|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44838399|NCT04736979|Amoxicillin|amoxicillin|mesh-list
44838400|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
44838401|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
44838402|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44838403|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838404|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838405|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44838406|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838407|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838408|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
44838409|NCT04697576|Nivolumab|nivolumab|mesh-list
44838410|NCT04697576|Ipilimumab|ipilimumab|mesh-list
44838411|NCT04697576|Vaccines|vaccines|mesh-list
44838412|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
44838413|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838414|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838415|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838416|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44838417|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838418|NCT04659369|Nivolumab|nivolumab|mesh-list
44838419|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838420|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838421|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44838422|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838423|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
44838424|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
44838425|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838426|NCT04574713|Candesartan|candesartan|mesh-list
44838427|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
44838428|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44838429|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44621205|NCT00561730|Pantoprazole|pantoprazole|mesh-list
44838430|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44838431|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838432|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44838433|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44838435|NCT04509336|Baclofen|baclofen|mesh-list
44838436|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44838437|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838438|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44838439|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838440|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44838441|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
44838442|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
44838443|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838444|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838445|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44838446|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44838447|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
44838448|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
44467978|NCT01442493|Methadone|methadone|mesh-list
44838449|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44838450|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44838451|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838452|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
44838453|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44838454|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838455|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
44838456|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838457|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44838458|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838459|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838460|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44838461|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838462|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838463|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44838464|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
44838465|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
44838466|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
44838467|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838468|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838469|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
44838470|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838471|NCT04368533|Fluorides|fluorides|mesh-list
44838472|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
44838473|NCT04368533|Protective Agents|protective agents|mesh-ancestor
44838474|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838475|NCT04280562|Acetaminophen|acetaminophen|mesh-list
44838476|NCT04280562|Analgesics|analgesics|mesh-list
44838477|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621273|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
44621274|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621275|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621276|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44621277|NCT00561392|Protective Agents|protective agents|mesh-ancestor
44621278|NCT00561353|Ribavirin|ribavirin|mesh-list
44621279|NCT00561353|Simeprevir|simeprevir|mesh-list
44621280|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
44621281|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621282|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
44621283|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621284|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
44621285|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621286|NCT00561080|Vaccines|vaccines|mesh-list
44621287|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
44621288|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621289|NCT00561015|Ribavirin|ribavirin|mesh-list
44621290|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
44324844|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
44621291|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44621292|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
44621293|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621294|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
44621295|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621296|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621297|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44621298|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
44838478|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
44838479|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838480|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838481|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
44838482|NCT04167813|Ondansetron|ondansetron|mesh-list
44838483|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
44838484|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
44838485|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838486|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838487|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44838488|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
44838489|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
44838490|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44838491|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
44838492|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838493|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838494|NCT04167813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44838495|NCT04167813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44838496|NCT04167813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838497|NCT04167813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838498|NCT04167813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44838499|NCT04110080|Anesthetics|anesthetics|mesh-list
44838500|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838501|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838502|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44838504|NCT04079621|Primaquine|primaquine|mesh-list
44838505|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
44838506|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44838507|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44838508|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838509|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
44838510|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44838511|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838512|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838513|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44838514|NCT04042727|Analgesics|analgesics|mesh-ancestor
44838515|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
44838516|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838517|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44838518|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44838519|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44838520|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
44838521|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838522|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838523|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
44838524|NCT04042155|Apixaban|apixaban|mesh-list
44838525|NCT04042155|Edoxaban|edoxaban|mesh-list
44838526|NCT04042155|Dabigatran|dabigatran|mesh-list
44838527|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44838528|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
44838529|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44838530|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
44838531|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838532|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838533|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
44838534|NCT04014387|Zolpidem|zolpidem|mesh-list
44838535|NCT04014387|Suvorexant|suvorexant|mesh-list
44838536|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44838537|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44838538|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838539|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838540|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44838541|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
44838542|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
44838543|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838544|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838545|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44838546|NCT03993912|Dexamethasone|dexamethasone|mesh-list
44838547|NCT03993912|Lenalidomide|lenalidomide|mesh-list
44838548|NCT03993912|Daratumumab|daratumumab|mesh-list
44838549|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838550|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
44838551|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
44838552|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838553|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838554|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44838555|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
44838556|NCT03993912|Hormones|hormones|mesh-ancestor
44838557|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838558|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44838559|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838560|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
44838561|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44838562|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44838563|NCT03993912|Growth Substances|growth substances|mesh-ancestor
44838564|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
44838565|NCT03954379|Dexamethasone|dexamethasone|mesh-list
44838566|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
44838567|NCT03954379|Analgesics|analgesics|mesh-list
44838568|NCT03954379|Anesthetics|anesthetics|mesh-list
44838569|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
44838570|NCT03954379|BB 1101|bb 1101|mesh-list
44838571|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838572|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
44838573|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
44621403|NCT00560352|Hormones|hormones|mesh-ancestor
44838574|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838575|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838576|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44838577|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
44838578|NCT03954379|Hormones|hormones|mesh-ancestor
44838579|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838580|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44838581|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838582|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
44838583|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838584|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838585|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838586|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
44838587|NCT03910387|Gemcitabine|gemcitabine|mesh-list
44838588|NCT03910387|Paclitaxel|paclitaxel|mesh-list
44838589|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44838590|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838591|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838592|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838593|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838594|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838595|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838596|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44838597|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
44838598|NCT03910387|Antiviral Agents|antiviral agents|mesh-ancestor
44838599|NCT03910387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838600|NCT03910387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838601|NCT03910387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838602|NCT03910387|Immunologic Factors|immunologic factors|mesh-ancestor
44838603|NCT03910387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838604|NCT03843463|Dexetimide|dexetimide|mesh-list
44838605|NCT03843463|Citalopram|citalopram|mesh-list
44838606|NCT03843463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44838607|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44838608|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838609|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838610|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838611|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
44838612|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838613|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44838614|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
44838615|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838616|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44838617|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44838618|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
44838619|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
44838620|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838621|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44838622|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44838623|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838624|NCT03842709|Pramipexole|pramipexole|mesh-list
44838625|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
44838626|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838627|NCT03842709|Protective Agents|protective agents|mesh-ancestor
44838628|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838629|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44838630|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44838631|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
44838632|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
44838633|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838634|NCT03796650|Vancomycin|vancomycin|mesh-list
44838635|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838636|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838637|NCT03728361|Nivolumab|nivolumab|mesh-list
44838638|NCT03728361|Temozolomide|temozolomide|mesh-list
44838639|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838640|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838641|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44838642|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838643|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44838644|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
44838645|NCT03715127|Psilocybin|psilocybin|mesh-list
44838646|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
44838647|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838648|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838649|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44838650|NCT03637972|Nicotine|nicotine|mesh-list
44838651|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44838652|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
44838653|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44838654|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838656|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44838657|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838658|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838659|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838660|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44838661|NCT03617328|Poly ICLC|poly iclc|mesh-list
44838662|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
44838663|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838664|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44838665|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
44838666|NCT03573947|Paclitaxel|paclitaxel|mesh-list
44838667|NCT03573947|Nivolumab|nivolumab|mesh-list
44838668|NCT03573947|Ipilimumab|ipilimumab|mesh-list
44838669|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838670|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838671|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838672|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838673|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838674|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838675|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838676|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44838677|NCT03561870|Olaparib|olaparib|mesh-list
44838678|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44838679|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838680|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838681|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838682|NCT03529110|Trastuzumab|trastuzumab|mesh-list
44838683|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44838684|NCT03529110|Maytansine|maytansine|mesh-list
44838685|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838686|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838687|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838688|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838689|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838690|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838691|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838692|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
44838693|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44838694|NCT03524417|Antibodies|antibodies|mesh-list
44838695|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
44838696|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838697|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
44838698|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44838699|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838700|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44838701|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44838702|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
44838703|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838704|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44838705|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44838706|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838707|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44838708|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44838709|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838710|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838711|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
44838712|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838713|NCT03497156|Lercanidipine|lercanidipine|mesh-list
44838714|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44838715|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44838716|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838717|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838718|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44838719|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838720|NCT03497143|Lamotrigine|lamotrigine|mesh-list
44838721|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
44838722|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44838723|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838724|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838725|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44838726|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838727|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44838728|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44838729|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838730|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838731|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44838732|NCT03479684|Warfarin|warfarin|mesh-list
44838733|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
44838734|NCT03440190|Methylphenidate|methylphenidate|mesh-list
44838735|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44838736|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838737|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44838738|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44838739|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838740|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838741|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
44838742|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838743|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
44838744|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838745|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838746|NCT03360721|Prednisone|prednisone|mesh-list
44838747|NCT03360721|Cortisone|cortisone|mesh-list
44838748|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
44838749|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44838750|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
44838751|NCT03360721|Hormones|hormones|mesh-ancestor
44838752|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838753|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838754|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44838755|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838756|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44696569|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44696570|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44696571|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696572|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696573|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696574|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44696575|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44696576|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
44696577|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696578|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44696579|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44696580|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44696581|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696582|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44696583|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44696584|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
44696585|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
44696586|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696587|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696588|NCT01392768|Levetiracetam|levetiracetam|mesh-list
44696589|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
44696590|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
44696591|NCT01392794|Ramosetron|ramosetron|mesh-list
44696592|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
44696593|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
44696594|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696595|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696596|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696597|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44696598|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
44696599|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696600|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696601|NCT01392807|Naloxegol|naloxegol|mesh-list
44696602|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44696603|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696604|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
44696605|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696606|NCT01392833|Prednisone|prednisone|mesh-list
44696607|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
44696608|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44696609|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44696610|NCT01392833|Prednisolone|prednisolone|mesh-list
44696611|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
44696612|NCT01392833|Azathioprine|azathioprine|mesh-list
44838757|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838758|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838760|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44838761|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44838762|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
44838763|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838764|NCT03347331|Befiradol|befiradol|mesh-list
44838765|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44838766|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44838767|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
44838768|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838769|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838770|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838771|NCT03298893|Cisplatin|cisplatin|mesh-list
44838772|NCT03298893|Nivolumab|nivolumab|mesh-list
44838773|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838774|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838775|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44838776|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838777|NCT03289351|Tazobactam|tazobactam|mesh-list
44838778|NCT03289351|Piperacillin|piperacillin|mesh-list
44838779|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44838780|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838781|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838782|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44838783|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838784|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838785|NCT03283488|Megestrol|megestrol|mesh-list
44838786|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
44838787|NCT03283488|Mirtazapine|mirtazapine|mesh-list
44838788|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
44838789|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44838790|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44838791|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
44838792|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
44838793|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838794|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838795|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838796|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44838797|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44838798|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44838799|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44838800|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44838801|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44838802|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
44325155|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44838803|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44838804|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44838805|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
44838806|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44838807|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44838808|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44838809|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44838810|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
44838811|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44838812|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44838813|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44838814|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44838815|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838816|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
44838817|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44838818|NCT03249714|Ofatumumab|ofatumumab|mesh-list
44838819|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44838820|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838821|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
44838822|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838823|NCT03165994|Paclitaxel|paclitaxel|mesh-list
44838824|NCT03165994|Carboplatin|carboplatin|mesh-list
44838825|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838826|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838827|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838828|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838829|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621656|NCT00550615|Dasatinib|dasatinib|mesh-list
44838830|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838831|NCT03126435|Gemcitabine|gemcitabine|mesh-list
44838832|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44838833|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
44838834|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838835|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838836|NCT03126435|Antiviral Agents|antiviral agents|mesh-ancestor
44838837|NCT03126435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838838|NCT03126435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838839|NCT03126435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838840|NCT03126435|Immunologic Factors|immunologic factors|mesh-ancestor
44838841|NCT03126435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838842|NCT03074318|Avelumab|avelumab|mesh-list
44838843|NCT03074318|Trabectedin|trabectedin|mesh-list
44838844|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44838845|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838846|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838847|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44838848|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
44838849|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838850|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
44838851|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838852|NCT02940548|Amlodipine|amlodipine|mesh-list
44838853|NCT02940548|Nifedipine|nifedipine|mesh-list
44838854|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44838855|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44838856|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838857|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838858|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44838859|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838860|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
44838861|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
44838862|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44838863|NCT02915016|Vaccines|vaccines|mesh-list
44838864|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44838865|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
44838866|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838867|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44838868|NCT02871401|Valganciclovir|valganciclovir|mesh-list
44838869|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
44838870|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838871|NCT02801656|Vancomycin|vancomycin|mesh-list
44838872|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838873|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838874|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
44838875|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838876|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838878|NCT02684162|Azacitidine|azacitidine|mesh-list
44838879|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838880|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44838881|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
44838882|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838883|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838884|NCT02621398|Paclitaxel|paclitaxel|mesh-list
44838885|NCT02621398|Carboplatin|carboplatin|mesh-list
44838886|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
44838887|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44838888|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838889|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838890|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838891|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838892|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838893|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838894|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44838895|NCT02533232|Minocycline|minocycline|mesh-list
44838896|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44838897|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838898|NCT02506959|Gemcitabine|gemcitabine|mesh-list
44838899|NCT02506959|Melphalan|melphalan|mesh-list
44838900|NCT02506959|Busulfan|busulfan|mesh-list
44838901|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
44838902|NCT02506959|Panobinostat|panobinostat|mesh-list
44838903|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44838904|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44838905|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
44838906|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838907|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838908|NCT02506959|Antiviral Agents|antiviral agents|mesh-ancestor
44838909|NCT02506959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838910|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838911|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44838912|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
44838913|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838914|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44838915|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
44838916|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44838917|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44838918|NCT02296229|Androgens|androgens|mesh-list
44838919|NCT02296229|Hormones|hormones|mesh-ancestor
44838920|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44838921|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838922|NCT01866111|Cenobamate|cenobamate|mesh-list
44838923|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
44838924|NCT01767129|Quinidine|quinidine|mesh-list
44838925|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
44325292|NCT00956202|Vaccines|vaccines|mesh-list
44838926|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
44838927|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
44838928|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44838929|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44621805|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44621806|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44621807|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621808|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621809|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621810|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621811|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621812|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621813|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
44621814|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621815|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621816|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44621817|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44621818|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
44621819|NCT00549549|Celecoxib|celecoxib|mesh-list
44621820|NCT00549549|Indomethacin|indomethacin|mesh-list
44621821|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44621822|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621823|NCT00549549|Analgesics|analgesics|mesh-ancestor
44621824|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
44621825|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621826|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838930|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44838931|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838932|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838933|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44838934|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44838935|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
44838936|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44838937|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
44838938|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44838939|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44838940|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44838941|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838942|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44838943|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44838944|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
44838945|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44838946|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44838947|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44838948|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44838949|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44838950|NCT01309191|Minoxidil|minoxidil|mesh-list
44838951|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44838952|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44838953|NCT00494182|Paclitaxel|paclitaxel|mesh-list
44838954|NCT00494182|Carboplatin|carboplatin|mesh-list
44838955|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44838956|NCT00494182|Sorafenib|sorafenib|mesh-list
44838957|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838958|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838959|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838960|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838961|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838962|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838963|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838964|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838965|NCT00454753|Dasatinib|dasatinib|mesh-list
44838966|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838967|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838968|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838969|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838970|NCT00358163|Paclitaxel|paclitaxel|mesh-list
44838971|NCT00358163|Vatalanib|vatalanib|mesh-list
44838972|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838973|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838974|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838975|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838976|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44838977|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838978|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44838979|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838980|NCT02249013|Paclitaxel|paclitaxel|mesh-list
44838981|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44838982|NCT02249013|Carboplatin|carboplatin|mesh-list
44838983|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44838984|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44838985|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44838986|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44838987|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325359|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
44838988|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838989|NCT02249871|Omeprazole|omeprazole|mesh-list
44838990|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44838991|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44838992|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44838993|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44838994|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44838995|NCT02249910|Metformin|metformin|mesh-list
44838996|NCT02249910|Digoxin|digoxin|mesh-list
44838997|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44838998|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44838999|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44839000|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44839001|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839002|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839003|NCT02249910|Protective Agents|protective agents|mesh-ancestor
44621827|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839004|NCT02250118|Bevacizumab|bevacizumab|mesh-list
44839005|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44839006|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839007|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44839008|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44839009|NCT02250118|Growth Substances|growth substances|mesh-ancestor
44839010|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839011|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
44839012|NCT02250209|Capecitabine|capecitabine|mesh-list
44839013|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
44839014|NCT02250209|Trastuzumab|trastuzumab|mesh-list
44839015|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44839016|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
44839017|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839018|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839019|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44839020|NCT02250300|Ixazomib|ixazomib|mesh-list
44839021|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839022|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839023|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839024|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839025|NCT02250482|Factor VIII|factor viii|mesh-list
44839026|NCT02250482|Coagulants|coagulants|mesh-ancestor
44839027|NCT02250508|Factor VIII|factor viii|mesh-list
44839028|NCT02250508|Coagulants|coagulants|mesh-ancestor
44839029|NCT02250599|Paclitaxel|paclitaxel|mesh-list
44839030|NCT02250599|Bevacizumab|bevacizumab|mesh-list
44839031|NCT02250599|Carboplatin|carboplatin|mesh-list
44839032|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44839033|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839034|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44839035|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44839036|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44839037|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839038|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44839039|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44839040|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44839041|NCT02250599|Growth Substances|growth substances|mesh-ancestor
44839042|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839043|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
44839044|NCT02250729|Pholcodine|pholcodine|mesh-list
44839045|NCT02250729|Analgesics|analgesics|mesh-ancestor
44839046|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
44839047|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839048|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839049|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
44839050|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839051|NCT02250781|TIC10 compound|tic10 compound|mesh-list
44839052|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839053|NCT02250794|Insulin|insulin|mesh-list
44839054|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44839055|NCT02250794|Metformin|metformin|mesh-list
44839056|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
44839057|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44839058|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
44839059|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44839060|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839061|NCT02250794|Incretins|incretins|mesh-ancestor
44839062|NCT02250794|Hormones|hormones|mesh-ancestor
44839063|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839064|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44839065|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839066|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839067|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839068|NCT02250820|Pentobarbital|pentobarbital|mesh-list
44839069|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
44839070|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44839071|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839072|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839073|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839074|NCT02250820|Analgesics|analgesics|mesh-ancestor
44839075|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
44839076|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839077|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44839078|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44839079|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44839080|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839081|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839082|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839083|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44839084|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
44839085|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
44839086|NCT02250833|Amlodipine|amlodipine|mesh-list
44839087|NCT02250833|Telmisartan|telmisartan|mesh-list
44839088|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44839089|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44839090|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44839091|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839092|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44839093|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839094|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839095|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44839096|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44839097|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44839098|NCT02250859|Minocycline|minocycline|mesh-list
44839099|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839100|NCT02250872|Cisplatin|cisplatin|mesh-list
44839101|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839102|NCT02250924|Caffeine|caffeine|mesh-list
44839103|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44839104|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839105|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44839106|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839107|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839108|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44839109|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44839110|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
44839111|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839112|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
44839113|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839114|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
44839115|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
44839116|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
44839117|NCT02251041|Tocopherols|tocopherols|mesh-list
44839118|NCT02251041|Vitamin E|vitamin e|mesh-list
44839119|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
44839120|NCT02251041|Infliximab|infliximab|mesh-list
44839121|NCT02251041|Epoprostenol|epoprostenol|mesh-list
44839122|NCT02251041|Tezosentan|tezosentan|mesh-list
44839123|NCT02251041|Melatonin|melatonin|mesh-list
44839124|NCT02251041|Antithrombins|antithrombins|mesh-list
44839125|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
44839126|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
44839127|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44839128|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
44839129|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839130|NCT02251041|Protective Agents|protective agents|mesh-ancestor
44839131|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839132|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839133|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
44839134|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839135|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839136|NCT02251041|Hematinics|hematinics|mesh-ancestor
44839137|NCT02251041|Vitamins|vitamins|mesh-ancestor
44839138|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
44839139|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44839140|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839141|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839142|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
44839143|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44839144|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44839145|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839146|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44839147|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44839148|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
44621980|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44839149|NCT02251119|Ritonavir|ritonavir|mesh-list
44839150|NCT02251119|Tipranavir|tipranavir|mesh-list
44839151|NCT02251119|Loperamide|loperamide|mesh-list
44839152|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
44839153|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839154|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839155|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839156|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839157|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839158|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839159|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839160|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
44839161|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839162|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839163|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839164|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839165|NCT02251132|Ritonavir|ritonavir|mesh-list
44839166|NCT02251132|Erythromycin|erythromycin|mesh-list
44839167|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
44839168|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44839169|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
44839170|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839171|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839172|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839173|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325474|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44839174|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839175|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839176|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839177|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
44839178|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839179|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839180|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839181|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44839182|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839183|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44839184|NCT02251145|Ritonavir|ritonavir|mesh-list
44839185|NCT02251145|Tenofovir|tenofovir|mesh-list
44839186|NCT02251145|Tipranavir|tipranavir|mesh-list
44839187|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839188|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839189|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839190|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839191|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839192|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839193|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839194|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
44839195|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839196|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839197|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839198|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44839199|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44839200|NCT02251158|Ritonavir|ritonavir|mesh-list
44839201|NCT02251158|Tipranavir|tipranavir|mesh-list
44839202|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44839203|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839204|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839205|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839206|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839207|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839208|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839209|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839210|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
44839211|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839212|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839213|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839214|NCT02251171|Ritonavir|ritonavir|mesh-list
44839215|NCT02251171|Tipranavir|tipranavir|mesh-list
44839216|NCT02251171|Rifabutin|rifabutin|mesh-list
44839217|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839218|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839219|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839220|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839221|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839222|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839223|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839224|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
44839225|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839226|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839227|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839228|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44839229|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44839230|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
44839232|NCT02251184|Dipyridamole|dipyridamole|mesh-list
44839233|NCT02251184|Lansoprazole|lansoprazole|mesh-list
44839234|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
44839235|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44839236|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44839237|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839238|NCT02251184|Analgesics|analgesics|mesh-ancestor
44839239|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
44839240|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839241|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839242|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839243|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839244|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44839245|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44839246|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839247|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44839248|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44839249|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839250|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
44839251|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44839252|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839253|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44839254|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44839255|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839256|NCT02251223|Ritonavir|ritonavir|mesh-list
44839257|NCT02251223|Tipranavir|tipranavir|mesh-list
44839258|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839259|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839260|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839261|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839262|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839263|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839264|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839265|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
44839266|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839267|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839268|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839269|NCT02251249|Acetaminophen|acetaminophen|mesh-list
44839270|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839271|NCT02251249|Analgesics|analgesics|mesh-ancestor
44839272|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
44839273|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839274|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839275|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
44839276|NCT02251288|Vaccines|vaccines|mesh-list
44839277|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
44839278|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839279|NCT02251431|Exenatide|exenatide|mesh-list
44839280|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44839281|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839282|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44839283|NCT02251431|Incretins|incretins|mesh-ancestor
44839284|NCT02251431|Hormones|hormones|mesh-ancestor
44839285|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839286|NCT02251457|Ranolazine|ranolazine|mesh-list
44839287|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44839288|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44839289|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839290|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
44839291|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44839292|NCT02251483|Antibodies|antibodies|mesh-list
44839293|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
44839294|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839295|NCT02251509|Metoprolol|metoprolol|mesh-list
44839296|NCT02251509|Carvedilol|carvedilol|mesh-list
44839297|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44839298|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44839299|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
44839300|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
44839301|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839302|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839303|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44839304|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44839305|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44839306|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839307|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839308|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839309|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
44839310|NCT02251509|Protective Agents|protective agents|mesh-ancestor
44839311|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44839312|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44839313|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44839314|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839315|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44839316|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44839317|NCT02251600|Deflazacort|deflazacort|mesh-list
44839318|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839319|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44839320|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
44839321|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839322|NCT02251626|Ubiquinone|ubiquinone|mesh-list
44839323|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
44839324|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
44839325|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839326|NCT02251626|Vitamins|vitamins|mesh-ancestor
44839327|NCT02251691|Tacrolimus|tacrolimus|mesh-list
44839328|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44839329|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
44839330|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839331|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44839332|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839333|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839334|NCT02251769|Ritonavir|ritonavir|mesh-list
44839335|NCT02251769|Tipranavir|tipranavir|mesh-list
44839336|NCT02251769|Clarithromycin|clarithromycin|mesh-list
44839337|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839338|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839339|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839340|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839341|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839342|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839343|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839344|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
44839345|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839346|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839347|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839348|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44839349|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44839350|NCT02251795|Aspirin|aspirin|mesh-list
44839351|NCT02251795|Ritonavir|ritonavir|mesh-list
44839352|NCT02251795|Darunavir|darunavir|mesh-list
44839353|NCT02251795|Tipranavir|tipranavir|mesh-list
44839354|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44839355|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839356|NCT02251795|Analgesics|analgesics|mesh-ancestor
44839357|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
44839358|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839359|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839360|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839361|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839362|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44839363|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44839364|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839365|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44839366|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44839367|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839368|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
44839369|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839370|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839371|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839372|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839373|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839374|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
44839375|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622202|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839376|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839377|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839378|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44839379|NCT02251847|Ezetimibe|ezetimibe|mesh-list
44839380|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44839381|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44839382|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
44839383|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839384|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44839385|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44839386|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839387|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44839388|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44839389|NCT02251925|Estradiol|estradiol|mesh-list
44839390|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44839391|NCT02251925|Estrogens|estrogens|mesh-ancestor
44839392|NCT02251925|Hormones|hormones|mesh-ancestor
44839393|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839394|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839395|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44839396|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
44839397|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44839398|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44839399|NCT02251951|Paclitaxel|paclitaxel|mesh-list
44839400|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44839401|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839402|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
44839403|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
44839404|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325705|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
44839405|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839406|NCT02251964|Rituximab|rituximab|mesh-list
44839407|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44839408|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839409|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
44839410|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839411|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839412|NCT02251977|Leucovorin|leucovorin|mesh-list
44839413|NCT02251977|Fluorouracil|fluorouracil|mesh-list
44839414|NCT02251977|Capecitabine|capecitabine|mesh-list
44839415|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839416|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
44839417|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839418|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44839419|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839420|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44839421|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
44839422|NCT02251977|Antidotes|antidotes|mesh-ancestor
44839423|NCT02251977|Protective Agents|protective agents|mesh-ancestor
44839424|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
44839425|NCT02251977|Vitamins|vitamins|mesh-ancestor
44839426|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
44839427|NCT02252107|Decitabine|decitabine|mesh-list
44839428|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44839429|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
44839430|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839431|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839432|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839433|NCT02252263|Elotuzumab|elotuzumab|mesh-list
44839434|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839435|NCT02252302|Albuterol|albuterol|mesh-list
44839436|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44839437|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
44839438|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839439|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839440|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44839441|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839442|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
44839443|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44839444|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44839445|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44839446|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44839447|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839448|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839449|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839450|NCT02252328|Simvastatin|simvastatin|mesh-list
44839451|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44839452|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44839453|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
44839454|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839455|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44839456|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44839457|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839459|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44839460|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
44839461|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839462|NCT02252341|Expectorants|expectorants|mesh-ancestor
44839463|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839464|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44839465|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
44839466|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839467|NCT02252341|Protective Agents|protective agents|mesh-ancestor
44839468|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839469|NCT02252341|Antidotes|antidotes|mesh-ancestor
44839470|NCT02252367|Tadalafil|tadalafil|mesh-list
44839471|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839472|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44839473|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44839474|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839475|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839476|NCT02252367|Urological Agents|urological agents|mesh-ancestor
44839477|NCT02252419|Acetaminophen|acetaminophen|mesh-list
44839478|NCT02252419|Dexamethasone|dexamethasone|mesh-list
44839479|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839480|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
44839481|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
44839482|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839483|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839484|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839485|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
44839486|NCT02252419|Hormones|hormones|mesh-ancestor
44839487|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839488|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44839489|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839490|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839491|NCT02252419|Analgesics|analgesics|mesh-ancestor
44839492|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
44839493|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
44839494|NCT02252458|Fentanyl|fentanyl|mesh-list
44839495|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44839496|NCT02252458|Narcotics|narcotics|mesh-ancestor
44839497|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839498|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839499|NCT02252458|Analgesics|analgesics|mesh-ancestor
44839500|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
44839501|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839502|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44839503|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44839504|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
44839505|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
44839506|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
44839507|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44839508|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44839509|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839510|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
44839511|NCT02252497|Coagulants|coagulants|mesh-ancestor
44839512|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
44839513|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44839514|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839515|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839516|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839517|NCT02252523|Analgesics|analgesics|mesh-ancestor
44839518|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
44839519|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839520|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44839521|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44839522|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44839523|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839524|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839525|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839526|NCT02252614|Acetaminophen|acetaminophen|mesh-list
44839527|NCT02252614|Naproxen|naproxen|mesh-list
44839528|NCT02252614|Codeine|codeine|mesh-list
44839529|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839530|NCT02252614|Analgesics|analgesics|mesh-ancestor
44839531|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
44839532|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839533|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839534|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
44325828|NCT05100654|Renal Agents|renal agents|mesh-ancestor
44839535|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44839536|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839537|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839538|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
44839539|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44839540|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839541|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839542|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44839543|NCT02252614|Narcotics|narcotics|mesh-ancestor
44839544|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839545|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
44839546|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839547|NCT02252627|Phenylephrine|phenylephrine|mesh-list
44839548|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
44839549|NCT02252627|Ephedrine|ephedrine|mesh-list
44839550|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44839551|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
44839552|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
44839553|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839554|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839555|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
44839556|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44839557|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
44839558|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839559|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44839560|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44839561|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44839562|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839563|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839564|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839565|NCT02252627|Protective Agents|protective agents|mesh-ancestor
44839566|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44839567|NCT02252692|Enalapril|enalapril|mesh-list
44839568|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44839569|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839570|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839571|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839572|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44839573|NCT02252731|Warfarin|warfarin|mesh-list
44839574|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
44839575|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
44839576|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44839577|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
44325841|NCT05003245|Ranibizumab|ranibizumab|mesh-list
44839578|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839579|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839580|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44839581|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839582|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44839583|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
44839584|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839585|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839586|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44839587|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839588|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
44839589|NCT02252770|Protective Agents|protective agents|mesh-ancestor
44839590|NCT02252796|Paclitaxel|paclitaxel|mesh-list
44839591|NCT02252796|Carboplatin|carboplatin|mesh-list
44839592|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44839593|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839594|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44839595|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44839596|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44839597|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839598|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
44839599|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44839600|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44839601|NCT02252809|Prednisolone|prednisolone|mesh-list
44839602|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
44839603|NCT02252809|Adalimumab|adalimumab|mesh-list
44839604|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44839605|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
44839606|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839607|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
44839608|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
44839609|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839610|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839611|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839612|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
44839613|NCT02252809|Hormones|hormones|mesh-ancestor
44839614|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839615|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44839616|NCT02252809|Protective Agents|protective agents|mesh-ancestor
44839617|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44839618|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839619|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839620|NCT02252913|Docetaxel|docetaxel|mesh-list
44839621|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839622|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44839623|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44839624|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44839625|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839626|NCT02252926|Acetaminophen|acetaminophen|mesh-list
44839627|NCT02252926|Lidocaine|lidocaine|mesh-list
44839628|NCT02252926|Morphine|morphine|mesh-list
44839629|NCT02252926|Gabapentin|gabapentin|mesh-list
44696613|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44696614|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
44696615|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696616|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
44696617|NCT01392833|Hormones|hormones|mesh-ancestor
44696618|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696619|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696620|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696621|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696622|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
44696623|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
44696624|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696625|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696626|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44696627|NCT01392833|Protective Agents|protective agents|mesh-ancestor
44696628|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
44696629|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696630|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44696631|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696632|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
44696633|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248226|NCT00602511|Bortezomib|bortezomib|mesh-list
44696634|NCT01392898|Liraglutide|liraglutide|mesh-list
44696651|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44696652|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44696653|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44696654|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44696655|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
44696656|NCT01393080|Cisplatin|cisplatin|mesh-list
44696657|NCT01393080|Paclitaxel|paclitaxel|mesh-list
44696658|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696659|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696660|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44696661|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44696662|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44696663|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44696664|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696665|NCT01393145|Fluticasone|fluticasone|mesh-list
44696666|NCT01393145|Xhance|xhance|mesh-list
44696667|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
44696668|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44696669|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44696670|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696671|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44696672|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
44696673|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696674|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696675|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44696676|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839630|NCT02252926|Bupivacaine|bupivacaine|mesh-list
44839631|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
44839632|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
44839633|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839634|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839635|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
44839636|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839637|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44839638|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44839639|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44839640|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44839641|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839642|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44839643|NCT02252926|Narcotics|narcotics|mesh-ancestor
44839644|NCT02252926|Analgesics|analgesics|mesh-ancestor
44839645|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839646|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
44839647|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
44839648|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44839649|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44839650|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44839651|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44839652|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44839653|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839654|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
44622521|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
44622522|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
44622523|NCT00543062|Loxapine|loxapine|mesh-list
44622524|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622525|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622526|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44622527|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44622528|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622529|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839655|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
44325979|NCT04577014|Docetaxel|docetaxel|mesh-list
44839656|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44839657|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839658|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44839659|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44839660|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839661|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839662|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839663|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44839664|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839665|NCT02253004|Cilostazol|cilostazol|mesh-list
44839666|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44839667|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
44839668|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839669|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839670|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44839671|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
44839672|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44839673|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44839674|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839675|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44839676|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839677|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44839678|NCT02253004|Protective Agents|protective agents|mesh-ancestor
44839679|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44839680|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44839681|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839682|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44839683|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839684|NCT02253095|Micronutrients|micronutrients|mesh-list
44839685|NCT02253095|Trace Elements|trace elements|mesh-list
44839686|NCT02253095|Albendazole|albendazole|mesh-list
44839687|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
44839688|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44839689|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839690|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
44839691|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44839692|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44839693|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44839694|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44839695|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44839696|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839697|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839698|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839699|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
44839700|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44839701|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839702|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839703|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839704|NCT02253199|Analgesics|analgesics|mesh-ancestor
44839705|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
44839706|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839707|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44839708|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44839709|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44839710|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44839711|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839712|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839713|NCT02253212|Carboplatin|carboplatin|mesh-list
44839714|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839715|NCT02253264|Rituximab|rituximab|mesh-list
44839716|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44839717|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839718|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
44839719|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839720|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839721|NCT02253121|Insulin|insulin|mesh-list
44839722|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44839723|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
44839724|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44839725|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839726|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44839727|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696677|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44839729|NCT02253420|Rifampin|rifampin|mesh-list
44839730|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
44839731|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839732|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44839733|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839734|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839735|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839736|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44839737|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
44839738|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839739|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839740|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839741|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44839742|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
44839743|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44839744|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
44839745|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44839746|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44839747|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44839748|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44839749|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44839750|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44839751|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44839752|NCT02253446|Diclofenac|diclofenac|mesh-list
44839753|NCT02253446|Piroxicam|piroxicam|mesh-list
44839754|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44839755|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44839756|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839757|NCT02253446|Analgesics|analgesics|mesh-ancestor
44839758|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
44839759|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839760|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839761|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839762|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44839763|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44839764|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839765|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839766|NCT02253459|Capecitabine|capecitabine|mesh-list
44839767|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44839768|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
44839769|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839770|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839771|NCT02253485|Telbivudine|telbivudine|mesh-list
44839772|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
44839773|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839774|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44839775|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839776|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839777|NCT02253524|Metoclopramide|metoclopramide|mesh-list
44839778|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
44839779|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
44839780|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
44839781|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839782|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839783|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839784|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44839785|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44839786|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
44839787|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44839788|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839789|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44839790|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
44839791|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
44839792|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
44839793|NCT02253550|Simeprevir|simeprevir|mesh-list
44839794|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
44839795|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839796|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839797|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839798|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839799|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44839800|NCT02253602|Hematinics|hematinics|mesh-ancestor
44839801|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44839802|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44839803|NCT02253758|Propofol|propofol|mesh-list
44839804|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44839805|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839806|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839807|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44839808|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
44839809|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
44839810|NCT02253784|Dexamethasone|dexamethasone|mesh-list
44839811|NCT02253784|Bupivacaine|bupivacaine|mesh-list
44839812|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44839813|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
44839814|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
44839815|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839816|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839817|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839818|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
44839819|NCT02253784|Hormones|hormones|mesh-ancestor
44839820|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44839821|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44839822|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44839823|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
44839824|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
44839825|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839826|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
44839827|NCT02253797|Ritonavir|ritonavir|mesh-list
44839828|NCT02253797|Tipranavir|tipranavir|mesh-list
44839829|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839830|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839831|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839832|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839833|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839834|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839835|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839836|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
44839837|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839838|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839839|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839840|NCT02253836|Ritonavir|ritonavir|mesh-list
44839841|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44839842|NCT02253836|Tipranavir|tipranavir|mesh-list
44839843|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839844|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839845|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839846|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839847|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839848|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839849|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839850|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
44839851|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839852|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839853|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839854|NCT02253849|Ritonavir|ritonavir|mesh-list
44839855|NCT02253849|Tipranavir|tipranavir|mesh-list
44839856|NCT02253849|Carbamazepine|carbamazepine|mesh-list
44839857|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839858|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839859|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839860|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839861|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839862|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839863|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839864|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
44839865|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839866|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839867|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839868|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
44839869|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
44839870|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44326176|NCT03040778|Vitamin E|vitamin e|mesh-list
44839871|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44839872|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839873|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44622678|NCT00541450|Hormones|hormones|mesh-ancestor
44839874|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44839875|NCT02253849|Analgesics|analgesics|mesh-ancestor
44839876|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
44839877|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44839878|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44839879|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44839880|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44839881|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44839882|NCT02253862|Ritonavir|ritonavir|mesh-list
44839883|NCT02253862|Tipranavir|tipranavir|mesh-list
44839884|NCT02253862|Tadalafil|tadalafil|mesh-list
44839885|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839886|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839887|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839888|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839889|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839890|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839891|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839892|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
44839893|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839894|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839895|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839896|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
44839897|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44839898|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44839899|NCT02253862|Urological Agents|urological agents|mesh-ancestor
44839900|NCT02253875|Ritonavir|ritonavir|mesh-list
44839901|NCT02253875|Tipranavir|tipranavir|mesh-list
44839902|NCT02253875|Omeprazole|omeprazole|mesh-list
44839903|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839904|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839905|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839906|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839907|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839908|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839909|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839910|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
44839911|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839912|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839913|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839914|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44839915|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44839916|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44839917|NCT02253888|Ritonavir|ritonavir|mesh-list
44839918|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839919|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839920|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839921|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839922|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839923|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839924|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839925|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
44839926|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839927|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839928|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839929|NCT02253901|Ritonavir|ritonavir|mesh-list
44839930|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44839931|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839932|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839933|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839934|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839935|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839936|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839937|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839938|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
44839939|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839940|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839941|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839942|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44839943|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44839944|NCT02253914|Ritonavir|ritonavir|mesh-list
44839945|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839946|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839947|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839948|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839949|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839950|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839951|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839952|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
44839953|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839954|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839955|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839956|NCT02253927|Ritonavir|ritonavir|mesh-list
44839957|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839958|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839959|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839960|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839961|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839962|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839963|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839964|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
44839965|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839966|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839967|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839968|NCT02253940|Ritonavir|ritonavir|mesh-list
44839969|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839970|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839971|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839972|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44839973|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839974|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839975|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839976|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
44839977|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839978|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839979|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839980|NCT02253953|Ritonavir|ritonavir|mesh-list
44839981|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44839982|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44839983|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
44839984|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326276|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44839985|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44839986|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44839987|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44839988|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
44839989|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44839990|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44839991|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44839992|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44839993|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
44839994|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44839995|NCT02253966|Prednisolone|prednisolone|mesh-list
44839996|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
44839997|NCT02253966|Lidocaine|lidocaine|mesh-list
44839998|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44839999|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
44840000|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44840001|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
44840002|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840003|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840004|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
44840005|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840006|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44840007|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44840008|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44840009|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840010|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840011|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840012|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
44840013|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
44840014|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840015|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
44840016|NCT02253966|Hormones|hormones|mesh-ancestor
44840017|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840018|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44840019|NCT02253966|Protective Agents|protective agents|mesh-ancestor
44840020|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44840021|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840022|NCT02254005|Maytansine|maytansine|mesh-list
44840023|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
44840024|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44840025|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840026|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44840027|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44840028|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44840029|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840030|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44840031|NCT02254018|Maytansine|maytansine|mesh-list
44840032|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
44840033|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44840034|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840035|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44840036|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44840037|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44840038|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840039|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44840040|NCT02254031|Maytansine|maytansine|mesh-list
44840041|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
44840042|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44840043|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840044|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44840045|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44840046|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44840047|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840048|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44840049|NCT02254044|Maytansine|maytansine|mesh-list
44840050|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
44840051|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44840052|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840053|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
44840054|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
44840055|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
44840056|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840057|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44840058|NCT02254148|Metoprolol|metoprolol|mesh-list
44840059|NCT02254148|Digoxin|digoxin|mesh-list
44840060|NCT02254148|Midazolam|midazolam|mesh-list
44840061|NCT02254148|Caffeine|caffeine|mesh-list
44840062|NCT02254148|Omeprazole|omeprazole|mesh-list
44840063|NCT02254148|Warfarin|warfarin|mesh-list
44840064|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44840065|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44840066|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840067|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840068|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44840069|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44840070|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840071|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840072|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
44840073|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
44840074|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
44840075|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
44840076|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840077|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840078|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
44840079|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44840080|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840081|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44840082|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840083|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44840084|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44840085|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44840086|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44840087|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
44840088|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44840089|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44840090|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
44840091|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
44840092|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840093|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44840094|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44840095|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44840096|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840097|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44840098|NCT02254148|Protective Agents|protective agents|mesh-ancestor
44840099|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
44840100|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44840101|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44840102|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
44840103|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840104|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840105|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840106|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840107|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
44840108|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44840109|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44840110|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840111|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840112|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44840113|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840114|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840115|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840116|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44840117|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44840118|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
44840119|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840120|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840121|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840122|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840123|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44840124|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840125|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840126|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840127|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840128|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840129|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44840130|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44840131|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
44840132|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840133|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840134|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840135|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840136|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44840137|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840138|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840139|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840140|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840141|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840142|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44840143|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44840144|NCT02254239|Everolimus|everolimus|mesh-list
44840145|NCT02254239|Antibodies|antibodies|mesh-list
44840146|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
44840147|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44840148|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
44840149|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
44840150|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840151|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840152|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840153|NCT02254447|Candesartan|candesartan|mesh-list
44840154|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
44840155|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44840156|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44840157|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44840158|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840159|NCT02254525|Ibuprofen|ibuprofen|mesh-list
44840160|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840161|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840162|NCT02254525|Analgesics|analgesics|mesh-ancestor
44326464|NCT00959517|Amebicides|amebicides|mesh-ancestor
44840163|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
44840164|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840165|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840166|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840167|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840168|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44840169|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840170|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840171|NCT02254577|Progesterone|progesterone|mesh-list
44840172|NCT02254577|Progestins|progestins|mesh-ancestor
44840173|NCT02254577|Hormones|hormones|mesh-ancestor
44840174|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840175|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623055|NCT00537823|Cetuximab|cetuximab|mesh-list
44840177|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840178|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
44840179|NCT02254655|Puerarin|puerarin|mesh-list
44840180|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
44840181|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
44840182|NCT02254668|Everolimus|everolimus|mesh-list
44840183|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840184|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840185|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
44840186|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840187|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44840188|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44840189|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
44840190|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840191|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840192|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840193|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840194|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44840195|NCT02254759|Midazolam|midazolam|mesh-list
44840196|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44840197|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44840198|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840199|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840200|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44840201|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44840202|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840203|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840204|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
44840205|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
44840206|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
44840207|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
44840208|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840209|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840210|NCT02254824|Atorvastatin|atorvastatin|mesh-list
44840211|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44840212|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44840213|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
44840214|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840215|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44840216|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44840217|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840218|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44840219|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840220|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840221|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
44840222|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44840223|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
44840224|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840225|NCT02254954|Temozolomide|temozolomide|mesh-list
44840226|NCT02254954|Macitentan|macitentan|mesh-list
44840227|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44840228|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
44840229|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840230|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840231|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44840232|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44623131|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623132|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
44623133|NCT00537381|Hormones|hormones|mesh-ancestor
44623134|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623135|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623136|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44623137|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623138|NCT00537329|Anidulafungin|anidulafungin|mesh-list
44623139|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
44623140|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623141|NCT00537316|Azathioprine|azathioprine|mesh-list
44623142|NCT00537316|Infliximab|infliximab|mesh-list
44623143|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
44623144|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44623145|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623146|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
44623147|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840233|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44840235|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
44840236|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840237|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840238|NCT02254980|Vitamin E|vitamin e|mesh-list
44840239|NCT02254980|Vitamins|vitamins|mesh-ancestor
44840240|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
44840241|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840242|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
44840243|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840244|NCT02254980|Protective Agents|protective agents|mesh-ancestor
44840245|NCT02255006|Glyburide|glyburide|mesh-list
44840246|NCT02255006|Celecoxib|celecoxib|mesh-list
44840247|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840248|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840249|NCT02255006|Analgesics|analgesics|mesh-ancestor
44840250|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
44840251|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840252|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840253|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840254|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840255|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44840256|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44840257|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840258|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840259|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44840260|NCT02255045|Diclofenac|diclofenac|mesh-list
44840261|NCT02255045|Meloxicam|meloxicam|mesh-list
44840262|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840263|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840264|NCT02255045|Analgesics|analgesics|mesh-ancestor
44840265|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
44840266|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840267|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840268|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840269|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840270|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44840271|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840272|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840273|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44840274|NCT02255084|Menthol|menthol|mesh-list
44840275|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
44840276|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
44840277|NCT02255162|Cytarabine|cytarabine|mesh-list
44840278|NCT02255162|Lenalidomide|lenalidomide|mesh-list
44326536|NCT00959972|Varenicline|varenicline|mesh-list
44840279|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44840280|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
44840281|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840282|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840283|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
44840284|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840285|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840286|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
44840287|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840288|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44840289|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44840290|NCT02255162|Growth Substances|growth substances|mesh-ancestor
44840291|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
44840292|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44840293|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
44840294|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840295|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44840296|NCT02255253|Telmisartan|telmisartan|mesh-list
44840297|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44840298|NCT02255253|Diuretics|diuretics|mesh-ancestor
44840299|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
44840300|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840301|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44840302|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840303|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840304|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44840305|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44840306|NCT02255266|Liraglutide|liraglutide|mesh-list
44840307|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44840308|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840309|NCT02255266|Incretins|incretins|mesh-ancestor
44840310|NCT02255266|Hormones|hormones|mesh-ancestor
44840311|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840312|NCT02255292|Cannabidiol|cannabidiol|mesh-list
44840313|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
44840314|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
44840315|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44840316|NCT02255370|Curcumin|curcumin|mesh-list
44840317|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840318|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840319|NCT02255370|Analgesics|analgesics|mesh-ancestor
44840320|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
44840321|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840322|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840323|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840324|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840325|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840326|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840327|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840328|NCT02255396|Estradiol|estradiol|mesh-list
44840329|NCT02255396|Estrogens|estrogens|mesh-ancestor
44840330|NCT02255396|Hormones|hormones|mesh-ancestor
44840331|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840332|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840333|NCT02255578|Clomiphene|clomiphene|mesh-list
44840334|NCT02255578|Enclomiphene|enclomiphene|mesh-list
44840335|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
44840336|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44840337|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44840338|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840339|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840340|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44840341|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
44840342|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44840343|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44840344|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44840345|NCT02255591|Lidocaine|lidocaine|mesh-list
44840346|NCT02255591|Epinephrine|epinephrine|mesh-list
44840347|NCT02255591|Racepinephrine|racepinephrine|mesh-list
44840348|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
44840349|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44840350|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
44840351|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840352|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840353|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
44840354|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840355|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44840356|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44840357|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44840358|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840359|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840360|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44840361|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840362|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840363|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840364|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840365|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44840366|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
44840367|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840368|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840369|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
44840370|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
44840371|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44840372|NCT02255682|Simvastatin|simvastatin|mesh-list
44840373|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44840374|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44840375|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
44840376|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840377|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44840378|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44840379|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840380|NCT02255734|Acyclovir|acyclovir|mesh-list
44840381|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
44840382|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840383|NCT02255747|Lactulose|lactulose|mesh-list
44840384|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840386|NCT02255812|Citric Acid|citric acid|mesh-list
44840387|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
44840388|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
44840389|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44840390|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44840391|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840392|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44840393|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840394|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44840395|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840396|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840397|NCT02255812|Analgesics|analgesics|mesh-ancestor
44840398|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
44840399|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
44840400|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44840401|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
44840402|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
44840403|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840404|NCT02255942|Zinc|zinc|mesh-list
44840405|NCT02255942|Iron|iron|mesh-list
44840406|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
44840407|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
44840408|NCT02255942|Trace Elements|trace elements|mesh-ancestor
44840409|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
44840410|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840411|NCT02255942|Astringents|astringents|mesh-ancestor
44840412|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
44840413|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
44840414|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44840415|NCT02255942|Protective Agents|protective agents|mesh-ancestor
44840416|NCT02255955|Acetaminophen|acetaminophen|mesh-list
44840417|NCT02255955|Naproxen|naproxen|mesh-list
44840418|NCT02255955|Codeine|codeine|mesh-list
44840419|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840420|NCT02255955|Analgesics|analgesics|mesh-ancestor
44840421|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
44840422|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840423|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840424|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
44840425|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840426|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840427|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840428|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
44840429|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44840430|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840431|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840432|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44840433|NCT02255955|Narcotics|narcotics|mesh-ancestor
44840434|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840435|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
44840436|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840437|NCT02256033|Istradefylline|istradefylline|mesh-list
44840438|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44840439|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44840440|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44840441|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
44840442|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840443|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840444|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840445|NCT02256124|Lamotrigine|lamotrigine|mesh-list
44840446|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
44840447|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44840448|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840449|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840450|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44840451|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840452|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44840453|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44840454|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840455|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840456|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44840457|NCT02256150|Mizoribine|mizoribine|mesh-list
44696678|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44840458|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
44840459|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840460|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
44840461|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840462|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840463|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44840464|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
44840465|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840466|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840467|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44840468|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840469|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840470|NCT02256150|Analgesics|analgesics|mesh-ancestor
44840471|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
44840472|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840473|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840474|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840475|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840476|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44840477|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
44840478|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44840479|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44840480|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840481|NCT02256215|Vitamin D|vitamin d|mesh-list
44840482|NCT02256215|Vitamins|vitamins|mesh-ancestor
44840483|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
44840484|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840485|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44840486|NCT02256228|Ropivacaine|ropivacaine|mesh-list
44840487|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
44840488|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
44840489|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840490|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840491|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
44840492|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840493|NCT02256254|Simvastatin|simvastatin|mesh-list
44840494|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44840495|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44840496|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
44840497|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840498|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44840499|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44840500|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840501|NCT02256280|Neostigmine|neostigmine|mesh-list
44840502|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44840503|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840504|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840505|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44840506|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840507|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840508|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44840509|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
44840510|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840511|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
44840512|NCT02256319|Propofol|propofol|mesh-list
44840513|NCT02256319|Imidazole|imidazole|mesh-list
44840514|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44840515|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840516|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840517|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840518|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
44840519|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
44840520|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840521|NCT02256319|Analgesics|analgesics|mesh-ancestor
44840522|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
44840523|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696679|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44696680|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44696681|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44696682|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44696683|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696684|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696685|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
44696686|NCT01393145|Hormones|hormones|mesh-ancestor
44696687|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696688|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
44696689|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
44840524|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44840525|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44840526|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840527|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840528|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840529|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840530|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840531|NCT02256423|Ibuprofen|ibuprofen|mesh-list
44840532|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840533|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840534|NCT02256423|Analgesics|analgesics|mesh-ancestor
44840535|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
44840536|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840537|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840538|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840539|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840540|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44840541|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840542|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623435|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44840543|NCT02256462|Adalimumab|adalimumab|mesh-list
44840544|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840545|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840546|NCT02256605|Vitamin D|vitamin d|mesh-list
44840547|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
44840548|NCT02256605|Vitamins|vitamins|mesh-ancestor
44840549|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
44840550|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840551|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44840552|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44840553|NCT02256683|Dabigatran|dabigatran|mesh-list
44840554|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
44840555|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
44840556|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44840557|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326833|NCT00961480|Metformin|metformin|mesh-list
44840558|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840559|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840560|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
44840561|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44840562|NCT02256722|Propranolol|propranolol|mesh-list
44840563|NCT02256722|Bisoprolol|bisoprolol|mesh-list
44840564|NCT02256722|Acipimox|acipimox|mesh-list
44840565|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44840566|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44840567|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
44840568|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840569|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840570|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840571|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840572|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44840573|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840574|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840575|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840576|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840577|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840578|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44840579|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44840580|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44840581|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44840582|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
44840583|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
44840584|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44840585|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44840586|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
44840587|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44840588|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
44840589|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
44840590|NCT02256735|Ritobegron|ritobegron|mesh-list
44840591|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840592|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840593|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44326861|NCT00961857|Metformin|metformin|mesh-list
44840594|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44840595|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840596|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840597|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840598|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840599|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
44840600|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
44840601|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840602|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
44840603|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44840604|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44840605|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44840606|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840607|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840608|NCT02256748|Midazolam|midazolam|mesh-list
44840609|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44840610|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44840611|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840612|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840613|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44840614|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44840615|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840616|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840617|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
44623509|NCT00534313|Abatacept|abatacept|mesh-list
44840618|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
44840619|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
44840620|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
44840621|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840622|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840623|NCT02256774|Ritonavir|ritonavir|mesh-list
44840624|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44840625|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44840626|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44840627|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
44840628|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840629|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840630|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840631|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44840632|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
44840633|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840634|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44840635|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44840636|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44840637|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44840638|NCT02256813|Vitamin K|vitamin k|mesh-list
44840639|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
44840640|NCT02256813|Midazolam|midazolam|mesh-list
44840641|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
44840642|NCT02256813|Caffeine|caffeine|mesh-list
44840643|NCT02256813|Omeprazole|omeprazole|mesh-list
44840644|NCT02256813|Warfarin|warfarin|mesh-list
44840645|NCT02256813|Vitamins|vitamins|mesh-ancestor
44840646|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
44840647|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840648|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44840649|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44840650|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840651|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44840652|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44840653|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840654|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840655|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
44840656|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
44840657|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
44840658|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
44840659|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840660|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840661|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
44840662|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44840663|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840664|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44840665|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840666|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44840667|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44840668|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44840669|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44840670|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
44840671|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44840672|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44840673|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
44840674|NCT02256813|Coagulants|coagulants|mesh-ancestor
44840675|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
44840676|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840677|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44326929|NCT00962533|Telbivudine|telbivudine|mesh-list
44840678|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44840679|NCT02256826|Ritonavir|ritonavir|mesh-list
44840680|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44840681|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44840682|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44840683|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840684|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840685|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840686|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44840687|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
44840688|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840689|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44840690|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44840691|NCT02256878|Amitriptyline|amitriptyline|mesh-list
44840692|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44840693|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
44840694|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840695|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840696|NCT02256878|Analgesics|analgesics|mesh-ancestor
44840697|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
44840698|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840699|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840700|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44840701|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44840702|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840703|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840705|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840706|NCT02256943|Amitriptyline|amitriptyline|mesh-list
44840707|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44840708|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44840709|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44840710|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44840711|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840712|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840713|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840714|NCT02256943|Urological Agents|urological agents|mesh-ancestor
44840715|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44840716|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44840717|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840718|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840719|NCT02256943|Analgesics|analgesics|mesh-ancestor
44840720|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
44840721|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840722|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44840723|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44840724|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840725|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840726|NCT02256956|Amitriptyline|amitriptyline|mesh-list
44840727|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44840728|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44840729|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44840730|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
44840731|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840732|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840733|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840734|NCT02256956|Urological Agents|urological agents|mesh-ancestor
44840735|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44840736|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
44840737|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44840738|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840739|NCT02256956|Analgesics|analgesics|mesh-ancestor
44840740|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
44840741|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840742|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44840743|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44840744|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840745|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
44840746|NCT02257008|Ritonavir|ritonavir|mesh-list
44840747|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44840748|NCT02257008|Nelfinavir|nelfinavir|mesh-list
44840749|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44840750|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44840751|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
44840752|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840753|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840754|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840755|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44623657|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623658|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840756|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
44840757|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840758|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44840759|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44840760|NCT02257021|Ritonavir|ritonavir|mesh-list
44840761|NCT02257021|Tipranavir|tipranavir|mesh-list
44840762|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44623659|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
44623660|NCT00532155|Hormones|hormones|mesh-ancestor
44623661|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623662|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44623672|NCT00532129|Rituximab|rituximab|mesh-list
44840763|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44840764|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
44840765|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840766|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840767|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840768|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44840769|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
44840770|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840771|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44840772|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44840773|NCT02257242|Rituximab|rituximab|mesh-list
44840774|NCT02257242|Vincristine|vincristine|mesh-list
44840775|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44840776|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44840777|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840778|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
44840779|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840780|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840781|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44840782|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44840783|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44840784|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44840785|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840786|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44840787|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
44840788|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44840789|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44840790|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44840791|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840792|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
44840793|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44840794|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840795|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840796|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44840797|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44840798|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840799|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840800|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840801|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44840802|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
44840803|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44840804|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840805|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44840806|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44840807|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44840808|NCT02257463|Theophylline|theophylline|mesh-list
44840809|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
44840810|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
44840811|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840812|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840813|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840814|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840815|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840816|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840817|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44840818|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840819|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
44840820|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44840821|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44840822|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
44840823|NCT02257476|Dexamethasone|dexamethasone|mesh-list
44840824|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840825|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
44840826|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
44840827|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840828|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840829|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840830|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
44840831|NCT02257476|Hormones|hormones|mesh-ancestor
44840832|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840833|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44840834|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840835|NCT02257502|Aflibercept|aflibercept|mesh-list
44840836|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44840837|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44840838|NCT02257502|Growth Substances|growth substances|mesh-ancestor
44840839|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840840|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
44840841|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840842|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
44840843|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
44840844|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44840845|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
44840846|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44840847|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840848|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44840849|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44840850|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44840851|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44840852|NCT02257671|Estrogens|estrogens|mesh-ancestor
44840853|NCT02257671|Hormones|hormones|mesh-ancestor
44840854|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44840855|NCT02257697|Mizoribine|mizoribine|mesh-list
44840856|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
44840857|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840858|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
44840859|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840860|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840861|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44840862|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
44840863|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840864|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840865|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44840866|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840867|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840868|NCT02257697|Analgesics|analgesics|mesh-ancestor
44840869|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
44840870|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840871|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840872|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840873|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840874|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327134|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44840875|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
44840876|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44840877|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44840878|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840879|NCT02257788|Leronlimab|leronlimab|mesh-list
44840880|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44840881|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44840882|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840883|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840884|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44840885|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
44840886|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840887|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
44840888|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840889|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840890|NCT02258009|Ranibizumab|ranibizumab|mesh-list
44840891|NCT02258009|Aflibercept|aflibercept|mesh-list
44840892|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44840893|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44840894|NCT02258009|Growth Substances|growth substances|mesh-ancestor
44840895|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840896|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
44840897|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840898|NCT02258204|Ketamine|ketamine|mesh-list
44840899|NCT02258204|Analgesics|analgesics|mesh-ancestor
44840900|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
44840901|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840902|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840903|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44840904|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44840905|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
44840906|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
44840907|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44840908|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44840909|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44840910|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840911|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840913|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44840914|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44840915|NCT02258282|Analgesics|analgesics|mesh-ancestor
44840916|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
44840917|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840918|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840919|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44840920|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44840921|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44840922|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44840923|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
44840924|NCT02258542|Benralizumab|benralizumab|mesh-list
44840925|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44840926|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
44840927|NCT02258581|Tenofovir|tenofovir|mesh-list
44840928|NCT02258581|Vesatolimod|vesatolimod|mesh-list
44840929|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
44840930|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840931|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44840932|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44840933|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840934|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840935|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44840936|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44840937|NCT02258607|Trametinib|trametinib|mesh-list
44840938|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44840939|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840940|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44840941|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840942|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840943|NCT02258620|Isosorbide|isosorbide|mesh-list
44840944|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44327158|NCT00963846|Huperzine A|huperzine a|mesh-list
44840945|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44840946|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
44840947|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
44840948|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44840949|NCT02258620|Diuretics|diuretics|mesh-ancestor
44840950|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
44840951|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840952|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44840953|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840954|NCT02258763|Amoxicillin|amoxicillin|mesh-list
44840955|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
44840956|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
44840957|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44840958|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44840959|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44840960|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44840961|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840962|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840963|NCT02258815|Dinutuximab|dinutuximab|mesh-list
44840964|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44840965|NCT02258828|Memantine|memantine|mesh-list
44840966|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44840967|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44840968|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
44840969|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840970|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840971|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840972|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44840973|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44840974|NCT02258906|Urinastatin|urinastatin|mesh-list
44840975|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44840976|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44840977|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
44840978|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44840979|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840980|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
44840981|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44840982|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44840983|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44840984|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44840985|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44840986|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
44840987|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44840988|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840989|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44840990|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840991|NCT02259179|Naltrexone|naltrexone|mesh-list
44840992|NCT02259179|Bupropion|bupropion|mesh-list
44840993|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44840994|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44840995|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44840996|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
44623978|NCT00529451|Ramipril|ramipril|mesh-list
44840997|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44840998|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44840999|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
44841000|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44841001|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44841002|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44841003|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841004|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841005|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
44841006|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841007|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44841008|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841009|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841010|NCT02259309|Misoprostol|misoprostol|mesh-list
44841011|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44841012|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
44841013|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44841014|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841015|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44841016|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841017|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
44841018|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
44841019|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44841020|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841021|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841022|NCT02259374|Ropivacaine|ropivacaine|mesh-list
44841023|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
44841024|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
44841025|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841026|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841027|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
44841028|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841029|NCT02259426|Piperaquine|piperaquine|mesh-list
44841030|NCT02259426|Primaquine|primaquine|mesh-list
44841031|NCT02259426|Artenimol|artenimol|mesh-list
44841032|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
44841033|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44841034|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44841035|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841036|NCT02259491|Calcium|calcium|mesh-list
44841037|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841038|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841039|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
44841040|NCT02259543|Tetracycline|tetracycline|mesh-list
44841041|NCT02259543|Citric Acid|citric acid|mesh-list
44841042|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
44841043|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841044|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841045|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44841046|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841047|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841048|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
44841049|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44841050|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
44841051|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
44841052|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
44841053|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44841054|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
44841055|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
44841056|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841057|NCT02259595|Expectorants|expectorants|mesh-ancestor
44841058|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841059|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44841060|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
44841061|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841062|NCT02259595|Protective Agents|protective agents|mesh-ancestor
44841063|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841064|NCT02259595|Antidotes|antidotes|mesh-ancestor
44841065|NCT02259647|Sorafenib|sorafenib|mesh-list
44841066|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841067|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44841068|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841069|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841070|NCT02259738|Kallikreins|kallikreins|mesh-list
44841071|NCT02259738|Coagulants|coagulants|mesh-ancestor
44841072|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44841073|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
44841074|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44841075|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841077|NCT02259777|Telmisartan|telmisartan|mesh-list
44841078|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44841079|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841080|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841081|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841082|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841083|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841084|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841085|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841086|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841087|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841088|NCT02259790|Amlodipine|amlodipine|mesh-list
44841089|NCT02259790|Telmisartan|telmisartan|mesh-list
44841090|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44841091|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841092|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841093|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841094|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841095|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841096|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841097|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841098|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841099|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841100|NCT02259803|Amlodipine|amlodipine|mesh-list
44841101|NCT02259803|Telmisartan|telmisartan|mesh-list
44841102|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44841103|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841104|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841105|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841106|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841107|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841108|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841109|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841110|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841111|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841112|NCT02259816|Amlodipine|amlodipine|mesh-list
44841113|NCT02259816|Telmisartan|telmisartan|mesh-list
44841114|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841115|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841116|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841117|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841118|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841119|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841120|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841121|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841122|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841123|NCT02259829|Amlodipine|amlodipine|mesh-list
44841124|NCT02259829|Telmisartan|telmisartan|mesh-list
44841125|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44841126|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841127|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841128|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841129|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841130|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841131|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841132|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327355|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44841133|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841134|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841135|NCT02259855|Interferons|interferons|mesh-list
44841136|NCT02259855|Ritonavir|ritonavir|mesh-list
44841137|NCT02259855|Ribavirin|ribavirin|mesh-list
44841138|NCT02259855|Tipranavir|tipranavir|mesh-list
44841139|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841140|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
44841141|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841142|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44841143|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44841144|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696690|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696691|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696692|NCT01393288|Lorazepam|lorazepam|mesh-list
44696693|NCT01393288|Ondansetron|ondansetron|mesh-list
44696694|NCT01393288|Aprepitant|aprepitant|mesh-list
44696695|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
44696696|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
44696697|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696698|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696699|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696700|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
44696701|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44696702|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44696703|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
44696704|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696705|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696706|NCT01393288|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44696707|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44696708|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696709|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44696710|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44696711|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44696712|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
44696713|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44327399|NCT00964691|Chloroquine|chloroquine|mesh-list
44696714|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
44696715|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
44696716|NCT01393340|Omalizumab|omalizumab|mesh-list
44696717|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44696718|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44696719|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696720|NCT01393548|Brompheniramine|brompheniramine|mesh-list
44696721|NCT01393548|Phenylephrine|phenylephrine|mesh-list
44696722|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
44696723|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
44696724|NCT01393548|Ephedrine|ephedrine|mesh-list
44696725|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44696726|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
44696727|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
44696728|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696729|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696730|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
44696731|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44696732|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
44696733|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696734|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44696735|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44696736|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44696737|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44696738|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696739|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696740|NCT01393548|Protective Agents|protective agents|mesh-ancestor
44696741|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44696742|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44696743|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44696744|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44696745|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
44696746|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
44696747|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44696748|NCT01393574|Melatonin|melatonin|mesh-list
44696749|NCT01393574|Methylphenidate|methylphenidate|mesh-list
44696750|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
44696751|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696752|NCT01393574|Protective Agents|protective agents|mesh-ancestor
44696753|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696754|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696755|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44696756|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44696757|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44696758|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696759|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
44696760|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696761|NCT01393756|Lenalidomide|lenalidomide|mesh-list
44696762|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
44696763|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696764|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44696765|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44841145|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841146|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841147|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44841148|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44841149|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44841150|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841151|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
44841152|NCT02259868|Ritonavir|ritonavir|mesh-list
44841153|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44841154|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44841155|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
44841156|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841157|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841158|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44841159|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44841160|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
44841161|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841162|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44841163|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841164|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
44841165|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
44841166|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
44841167|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327474|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841168|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841169|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
44841170|NCT02259946|Bromides|bromides|mesh-list
44841171|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
44841172|NCT02259946|Olodaterol|olodaterol|mesh-list
44841173|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44841174|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
44841175|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841176|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841177|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44841178|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841179|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
44841180|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841181|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841182|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841183|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841184|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
44841185|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44841186|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
44841187|NCT02259959|Olodaterol|olodaterol|mesh-list
44841188|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44841189|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
44841190|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841191|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841192|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44841193|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841194|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
44841195|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841196|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841197|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841198|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841199|NCT02259985|Itasetron|itasetron|mesh-list
44841200|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
44841201|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
44841202|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841203|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841204|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841205|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44841206|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44841207|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
44841208|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841209|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841210|NCT02259998|Dipyridamole|dipyridamole|mesh-list
44841211|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44841212|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841213|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841214|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44841215|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841216|NCT02260011|Bromides|bromides|mesh-list
44841217|NCT02260011|Norflurane|norflurane|mesh-list
44624170|NCT00527826|Xhance|xhance|mesh-list
44841218|NCT02260011|Ipratropium|ipratropium|mesh-list
44841219|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
44841221|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
44841222|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841223|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841224|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44841225|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841226|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841227|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841228|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841229|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841230|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
44841231|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841232|NCT02260024|Pramipexole|pramipexole|mesh-list
44841233|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
44841234|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841235|NCT02260024|Protective Agents|protective agents|mesh-ancestor
44841236|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841237|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841238|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44841239|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
44841240|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
44841241|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696766|NCT01393756|Growth Substances|growth substances|mesh-ancestor
44841243|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44841244|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
44841245|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
44841246|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841247|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841248|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841249|NCT02260050|Epinastine|epinastine|mesh-list
44841250|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44841251|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
44841252|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
44841253|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841254|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841255|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841256|NCT02260063|Epinastine|epinastine|mesh-list
44841257|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44841258|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
44841259|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
44841260|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841261|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841262|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841263|NCT02260089|Telmisartan|telmisartan|mesh-list
44841264|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841265|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841266|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841267|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841268|NCT02260206|Colchicine|colchicine|mesh-list
44841269|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
44841270|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841271|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44841272|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44841273|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44841274|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841275|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841276|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
44841277|NCT02260336|Celecoxib|celecoxib|mesh-list
44841278|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44841279|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841280|NCT02260336|Analgesics|analgesics|mesh-ancestor
44841281|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
44327585|NCT00965809|Dronabinol|dronabinol|mesh-list
44841282|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841283|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841284|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44841285|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841286|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44841287|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44841288|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841289|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841290|NCT02260414|Tinzaparin|tinzaparin|mesh-list
44841291|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44841292|NCT02260414|Dalteparin|dalteparin|mesh-list
44841293|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
44841294|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44841295|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44841296|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841297|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
44841298|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841299|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44841300|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841301|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841302|NCT02260544|Doxorubicin|doxorubicin|mesh-list
44841303|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44841304|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44841305|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841306|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841307|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841308|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327613|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44841309|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841310|NCT02260557|Selexipag|selexipag|mesh-list
44841311|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841312|NCT02260570|Tolcapone|tolcapone|mesh-list
44841313|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841314|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44624323|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
44841315|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44841316|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841317|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841318|NCT02260661|Fulvestrant|fulvestrant|mesh-list
44841319|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44841320|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841321|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44841322|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44841323|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
44841324|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44841325|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841326|NCT02260687|Aflibercept|aflibercept|mesh-list
44841327|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44841328|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44841329|NCT02260687|Growth Substances|growth substances|mesh-ancestor
44841330|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841331|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
44841332|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841333|NCT02260908|Enoxaparin|enoxaparin|mesh-list
44841334|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
44841335|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44841336|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44327642|NCT00965926|Urological Agents|urological agents|mesh-ancestor
44841337|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841338|NCT02260947|Ibuprofen|ibuprofen|mesh-list
44841339|NCT02260947|Pregabalin|pregabalin|mesh-list
44841340|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44841341|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841342|NCT02260947|Analgesics|analgesics|mesh-ancestor
44841343|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
44841344|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841345|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841346|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44841347|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841348|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44841349|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841350|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841351|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
44327673|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327688|NCT00966160|Ritonavir|ritonavir|mesh-list
44841352|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841353|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841354|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841355|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44841356|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44841357|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841358|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44841359|NCT02261025|Aspirin|aspirin|mesh-list
44841360|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44841361|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841362|NCT02261025|Analgesics|analgesics|mesh-ancestor
44841363|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
44841364|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841365|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841366|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44841367|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841368|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44841369|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44841370|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841371|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44841372|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44841373|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841374|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
44841375|NCT02261064|Amlodipine|amlodipine|mesh-list
44841376|NCT02261064|Telmisartan|telmisartan|mesh-list
44841377|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44841378|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841379|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44841380|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841381|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841382|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44841383|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841384|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841385|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841386|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841387|NCT02261077|Scopolamine|scopolamine|mesh-list
44841388|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44841389|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44841390|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
44841391|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
44841392|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841393|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841394|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841395|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
44841396|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841397|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841398|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841399|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841400|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44841401|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
44841402|NCT02261090|Pramipexole|pramipexole|mesh-list
44841403|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
44841404|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841405|NCT02261090|Protective Agents|protective agents|mesh-ancestor
44841406|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841407|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841408|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44841409|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
44841410|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
44841411|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841412|NCT02261103|Pramipexole|pramipexole|mesh-list
44841413|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
44841414|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841415|NCT02261103|Protective Agents|protective agents|mesh-ancestor
44841416|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841417|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841418|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44841419|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
44841420|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
44841421|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841422|NCT02261116|Telmisartan|telmisartan|mesh-list
44841423|NCT02261116|Candesartan|candesartan|mesh-list
44841424|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841425|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841426|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841427|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841428|NCT02261129|Telmisartan|telmisartan|mesh-list
44841429|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841430|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841431|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841432|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841433|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44841434|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841435|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841436|NCT02261207|Axitinib|axitinib|mesh-list
44841437|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841438|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44841439|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841440|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841441|NCT02261220|Durvalumab|durvalumab|mesh-list
44841442|NCT02261220|Tremelimumab|tremelimumab|mesh-list
44841443|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44841444|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841445|NCT02261298|Nivolumab|nivolumab|mesh-list
44841446|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44841447|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841448|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44841449|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841450|NCT02261376|DS-1971a|ds-1971a|mesh-list
44841451|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44841452|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44841453|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841454|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841455|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44841456|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44327778|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841457|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841458|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
44841459|NCT02261662|Ribavirin|ribavirin|mesh-list
44841460|NCT02261662|Betamethasone|betamethasone|mesh-list
44841461|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
44841462|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841463|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
44841464|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841465|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44841466|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
44841467|NCT02261662|Hormones|hormones|mesh-ancestor
44841468|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44841469|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841470|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44841471|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841472|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
44841473|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44841474|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841475|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841476|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841477|NCT02261675|Analgesics|analgesics|mesh-ancestor
44841478|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
44841479|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841480|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44841481|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44841482|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44841483|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
44841484|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841485|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841486|NCT02261779|Tretinoin|tretinoin|mesh-list
44841487|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
44841488|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841489|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
44841490|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
44841491|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44841492|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44841493|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44841494|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841495|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841496|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44841497|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44841498|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841499|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841500|NCT02261844|Resveratrol|resveratrol|mesh-list
44841501|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
44841502|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841503|NCT02261844|Protective Agents|protective agents|mesh-ancestor
44841504|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841505|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841506|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44841507|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
44841508|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841509|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841510|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841511|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841512|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841513|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841514|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841515|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44841516|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841517|NCT02261922|Ticagrelor|ticagrelor|mesh-list
44841518|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44841519|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44841520|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44841521|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44841522|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44841523|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
44841524|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841525|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841526|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841527|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44841528|NCT02262143|Fenofibrate|fenofibrate|mesh-list
44841529|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44841530|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44841531|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
44841532|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841533|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44841534|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44841535|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841536|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
44841537|NCT02262156|Serotonin|serotonin|mesh-list
44841538|NCT02262156|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44841539|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44841540|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44841541|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
44841542|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841543|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841544|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841545|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44841546|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841547|NCT02262169|Omeprazole|omeprazole|mesh-list
44841548|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44841549|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841550|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44841551|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841552|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841553|NCT02262299|Pirfenidone|pirfenidone|mesh-list
44841554|NCT02262299|Analgesics|analgesics|mesh-ancestor
44841555|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
44841556|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841557|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841558|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44841559|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841560|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44841561|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841562|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841563|NCT02262325|Cisplatin|cisplatin|mesh-list
44841564|NCT02262325|Etoposide|etoposide|mesh-list
44841565|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
44841566|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841567|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44841568|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841569|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841570|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841571|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624624|NCT00523744|Amlodipine|amlodipine|mesh-list
44841572|NCT02262416|Leuprolide|leuprolide|mesh-list
44841573|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44841574|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
44841575|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44841576|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841577|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44841578|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841579|NCT02262455|Doxorubicin|doxorubicin|mesh-list
44841580|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44841581|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44841582|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841583|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841584|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841585|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841586|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841587|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
44841588|NCT02262481|Progestins|progestins|mesh-ancestor
44841589|NCT02262481|Hormones|hormones|mesh-ancestor
44327884|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841590|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44841591|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841592|NCT02262520|Digoxin|digoxin|mesh-list
44841593|NCT02262520|Apixaban|apixaban|mesh-list
44841594|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44841595|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
44841596|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44841597|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
44841598|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841599|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841600|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
44841601|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44841602|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44841603|NCT02262520|Protective Agents|protective agents|mesh-ancestor
44841604|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841605|NCT02262533|Atenolol|atenolol|mesh-list
44841606|NCT02262533|Apixaban|apixaban|mesh-list
44841607|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44841608|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
44841609|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44841610|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
44841611|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841612|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841613|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
44841614|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44841615|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841616|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
44841617|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
44841618|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982877|NCT02086786|Risperidone|risperidone|mesh-list
44841619|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841620|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44841621|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44841622|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44841623|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44841624|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841625|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
44841626|NCT02262546|Pramipexole|pramipexole|mesh-list
44841627|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44841628|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841629|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841630|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841631|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841632|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841633|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841634|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841635|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44841636|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
44841637|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44841638|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841639|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44841640|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44841641|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44841642|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
44841643|NCT02262546|Protective Agents|protective agents|mesh-ancestor
44841644|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841645|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44841646|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
44841647|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
44841648|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841649|NCT02262559|Telmisartan|telmisartan|mesh-list
44841650|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841651|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841652|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841653|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841654|NCT02262572|Telmisartan|telmisartan|mesh-list
44841655|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44841656|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841657|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841658|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841659|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841660|NCT02262572|Diuretics|diuretics|mesh-ancestor
44841661|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841662|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841663|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44327968|NCT00967252|Atorvastatin|atorvastatin|mesh-list
44841664|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841665|NCT02262585|Telmisartan|telmisartan|mesh-list
44841666|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841667|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841668|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841669|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841670|NCT02262598|Telmisartan|telmisartan|mesh-list
44841671|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44841672|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841673|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841674|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841675|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841676|NCT02262598|Diuretics|diuretics|mesh-ancestor
44841677|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841678|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841679|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44841680|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841681|NCT02262611|Telmisartan|telmisartan|mesh-list
44841682|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44841683|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841684|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841685|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841686|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841687|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44841688|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841689|NCT02262611|Diuretics|diuretics|mesh-ancestor
44841690|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841691|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841692|NCT02262624|Telmisartan|telmisartan|mesh-list
44841693|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44841694|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841695|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841696|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841697|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841698|NCT02262624|Diuretics|diuretics|mesh-ancestor
44841699|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841700|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841701|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44841702|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841703|NCT02262637|Telmisartan|telmisartan|mesh-list
44841704|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44841705|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841706|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841707|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841708|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841709|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44841710|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841711|NCT02262637|Diuretics|diuretics|mesh-ancestor
44841712|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841713|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841714|NCT02262650|Telmisartan|telmisartan|mesh-list
44841715|NCT02262650|Clopidogrel|clopidogrel|mesh-list
44841716|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44841717|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44841718|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44841719|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44841720|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
44841721|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841722|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841723|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841724|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841725|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841726|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841727|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
44841728|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44841729|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
44841730|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44841731|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
44841732|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841733|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841734|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
44841735|NCT02262702|Acetaminophen|acetaminophen|mesh-list
44841736|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44841737|NCT02262702|Analgesics|analgesics|mesh-ancestor
44841738|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
44841739|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841740|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841741|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
44841742|NCT02262715|Oseltamivir|oseltamivir|mesh-list
44841743|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
44841744|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841745|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841746|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841747|NCT02262741|Durvalumab|durvalumab|mesh-list
44841748|NCT02262741|Tremelimumab|tremelimumab|mesh-list
44841749|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44841750|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841751|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
44841752|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
44841753|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
44841754|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841755|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841756|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841757|NCT02262780|Telmisartan|telmisartan|mesh-list
44841758|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841759|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841760|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44328052|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841761|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841762|NCT02262793|Telmisartan|telmisartan|mesh-list
44841763|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841764|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841765|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841766|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841767|NCT02262858|Telmisartan|telmisartan|mesh-list
44841768|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44841769|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841770|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841771|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841772|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841773|NCT02262858|Diuretics|diuretics|mesh-ancestor
44841774|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841775|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841776|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44841777|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841778|NCT02262897|Paclitaxel|paclitaxel|mesh-list
44841779|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44841780|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44841781|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841782|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44841783|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44841784|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44841785|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841786|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44841787|NCT02262936|Fesoterodine|fesoterodine|mesh-list
44841788|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44841789|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841790|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841791|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841792|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841793|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841794|NCT02262936|Urological Agents|urological agents|mesh-ancestor
44841795|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
44841796|NCT02262936|Coagulants|coagulants|mesh-ancestor
44841797|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44841798|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
44841799|NCT02263027|Vaccines|vaccines|mesh-list
44841800|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
44841801|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841802|NCT02263066|Factor VIII|factor viii|mesh-list
44841803|NCT02263066|Coagulants|coagulants|mesh-ancestor
44841804|NCT02263105|Temozolomide|temozolomide|mesh-list
44841805|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44841806|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
44841807|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841808|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841809|NCT02263170|Phenobarbital|phenobarbital|mesh-list
44841810|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
44841811|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44841812|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841813|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841814|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44841815|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44841816|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841817|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841818|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
44841819|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
44841820|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44841821|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44841822|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44841823|NCT02263196|Ethanol|ethanol|mesh-list
44841824|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
44841825|NCT02263196|Povidone|povidone|mesh-list
44841826|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44841827|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841828|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841829|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841830|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
44328133|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
44328152|NCT00968006|Hormones|hormones|mesh-ancestor
44841831|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
44841832|NCT02263248|Buprenorphine|buprenorphine|mesh-list
44841833|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44841834|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44841835|NCT02263248|Narcotics|narcotics|mesh-ancestor
44841836|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841837|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841838|NCT02263248|Analgesics|analgesics|mesh-ancestor
44841839|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
44841840|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841841|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44841842|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44841843|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44841844|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841845|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841846|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841847|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44841848|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
44841849|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44841850|NCT02263352|Carotenoids|carotenoids|mesh-list
44841851|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
44841852|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841853|NCT02263352|Protective Agents|protective agents|mesh-ancestor
44841854|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841855|NCT02263495|Gemcitabine|gemcitabine|mesh-list
44841856|NCT02263495|Paclitaxel|paclitaxel|mesh-list
44841857|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44841858|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841859|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44841860|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44841861|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44841862|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841863|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44841864|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
44841865|NCT02263495|Antiviral Agents|antiviral agents|mesh-ancestor
44841866|NCT02263495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696767|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44696768|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696769|NCT01393769|Melphalan|melphalan|mesh-list
44696770|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44696771|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
44696772|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696773|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696774|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328172|NCT00968331|Rituximab|rituximab|mesh-list
44696775|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44696776|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
44696777|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696778|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
44696779|NCT01393782|Giapreza|giapreza|mesh-list
44696780|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
44696781|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44696782|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44696783|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696784|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696785|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696786|NCT01393795|Capsaicin|capsaicin|mesh-list
44696787|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
44696788|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
44696789|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
44696790|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696791|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696792|NCT01393912|Crenolanib|crenolanib|mesh-list
44696793|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696794|NCT01393925|Parecoxib|parecoxib|mesh-list
44696795|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44696796|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44696797|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696798|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696799|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44696800|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44696801|NCT01393925|Analgesics|analgesics|mesh-ancestor
44696802|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
44696803|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696804|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696805|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696806|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44696807|NCT01394016|Fulvestrant|fulvestrant|mesh-list
44696808|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696809|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696810|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44696811|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44696812|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44696813|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696814|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696815|NCT01394029|Deferasirox|deferasirox|mesh-list
44696816|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44696817|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
44696818|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
44696819|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696820|NCT01394094|Calcium|calcium|mesh-list
44696821|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44696822|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696823|NCT01394133|Ritonavir|ritonavir|mesh-list
44696824|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44696825|NCT01394133|Tenofovir|tenofovir|mesh-list
44696826|NCT01394133|Emtricitabine|emtricitabine|mesh-list
44696827|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44696828|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44696829|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
44696830|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696831|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696832|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44696833|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44696834|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
44696835|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696836|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44696837|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841867|NCT02263495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841868|NCT02263495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44841869|NCT02263495|Immunologic Factors|immunologic factors|mesh-ancestor
44841870|NCT02263495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625001|NCT00519636|Xhance|xhance|mesh-list
44841871|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44841872|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44841873|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44841874|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44841875|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841877|NCT02263677|Hormones|hormones|mesh-ancestor
44841878|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44841879|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44841880|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
44841881|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841882|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841883|NCT02263690|Lidocaine|lidocaine|mesh-list
44841884|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44841885|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
44841886|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44841887|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841888|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
44841889|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841890|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44841891|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44841892|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44841893|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44841894|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841895|NCT02263872|Minocycline|minocycline|mesh-list
44841896|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841897|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841898|NCT02263924|Tocotrienols|tocotrienols|mesh-list
44841899|NCT02263924|Vitamin E|vitamin e|mesh-list
44841900|NCT02263924|Tocopherols|tocopherols|mesh-list
44841901|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
44841902|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841903|NCT02263924|Protective Agents|protective agents|mesh-ancestor
44841904|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841905|NCT02263924|Vitamins|vitamins|mesh-ancestor
44841906|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
44841907|NCT02263950|Artemether|artemether|mesh-list
44841908|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
44841909|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44841910|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44841911|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841912|NCT02263976|Bromides|bromides|mesh-list
44841913|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
44841914|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
44841915|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44841916|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
44841917|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841918|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841919|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44841920|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
44841921|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
44841922|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44841923|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
44841924|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841925|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841926|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
44841927|NCT02263976|Miotics|miotics|mesh-ancestor
44841928|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44841929|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44841930|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44841931|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44841932|NCT02263989|Telmisartan|telmisartan|mesh-list
44841933|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841934|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44841935|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44841936|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841937|NCT02264002|Metoprolol|metoprolol|mesh-list
44841938|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44841939|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841940|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
44841941|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
44841942|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44841943|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841944|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44625084|NCT00518882|Liraglutide|liraglutide|mesh-list
44841945|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44841946|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44841947|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
44841948|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841949|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841950|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
44841951|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44841952|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841953|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44841954|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44841955|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841956|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841957|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44841958|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44841959|NCT02264041|Itraconazole|itraconazole|mesh-list
44841960|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
44841961|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44841962|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44841963|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44841964|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841965|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841966|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44841967|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
44841968|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44841969|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841970|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44841971|NCT02264093|Propranolol|propranolol|mesh-list
44841972|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44841973|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44841974|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44841975|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44841976|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841977|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841978|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44841979|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44841980|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
44841981|NCT02264106|Pantoprazole|pantoprazole|mesh-list
44841982|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44841983|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841984|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44841985|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841986|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841987|NCT02264119|Pantoprazole|pantoprazole|mesh-list
44841988|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44841989|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44841990|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44841991|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44841992|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841993|NCT02264132|Pramipexole|pramipexole|mesh-list
44841994|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
44841995|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44841996|NCT02264132|Protective Agents|protective agents|mesh-ancestor
44841997|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44841998|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44841999|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44842000|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
44842001|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
44842002|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842003|NCT02264145|Norflurane|norflurane|mesh-list
44842004|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44842005|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
44842006|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842007|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842008|NCT02264158|Telmisartan|telmisartan|mesh-list
44842009|NCT02264158|Lacidipine|lacidipine|mesh-list
44842010|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44842011|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44842012|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44842013|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842014|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44842015|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842016|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44842017|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842019|NCT02264171|Tamsulosin|tamsulosin|mesh-list
44842020|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44842021|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44842022|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842023|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842024|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842025|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842026|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842027|NCT02264171|Urological Agents|urological agents|mesh-ancestor
44842028|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
44842029|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842030|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44842031|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44842032|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842033|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44842034|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
44468373|NCT01437397|Bromides|bromides|mesh-list
44842035|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842036|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44842037|NCT02264184|Paroxetine|paroxetine|mesh-list
44842038|NCT02264184|Tamsulosin|tamsulosin|mesh-list
44842039|NCT02264184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44842040|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44842041|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842042|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842043|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842044|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
44842045|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842046|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44842047|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
44842048|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842049|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44842050|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44842051|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842052|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44842053|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44842054|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842055|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842056|NCT02264184|Urological Agents|urological agents|mesh-ancestor
44842057|NCT02264236|Vaccines|vaccines|mesh-list
44842058|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
44842059|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842060|NCT02264301|Puerarin|puerarin|mesh-list
44842061|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842062|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
44842063|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44842064|NCT02264561|Caffeine|caffeine|mesh-list
44842065|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44842066|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842067|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44842068|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842069|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842070|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44842071|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44842072|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
44842073|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842074|NCT02264587|Domperidone|domperidone|mesh-list
44842075|NCT02264587|Mosapride|mosapride|mesh-list
44842076|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
44842077|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
44842078|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842079|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842080|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44842081|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44842082|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
44842083|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842084|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842085|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44842086|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
44842087|NCT02264626|Remifentanil|remifentanil|mesh-list
44842088|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842089|NCT02264626|Narcotics|narcotics|mesh-ancestor
44842090|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842091|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842092|NCT02264626|Analgesics|analgesics|mesh-ancestor
44842093|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
44842094|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842095|NCT02264665|Everolimus|everolimus|mesh-list
44842096|NCT02264665|Sunitinib|sunitinib|mesh-list
44842097|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842098|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842099|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
44842100|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842101|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44842102|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44842103|NCT02264665|Growth Substances|growth substances|mesh-ancestor
44842104|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
44842105|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44842106|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842107|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842108|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44842109|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44842110|NCT02264743|Estradiol|estradiol|mesh-list
44842111|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44842112|NCT02264743|Estrogens|estrogens|mesh-ancestor
44842113|NCT02264743|Hormones|hormones|mesh-ancestor
44842114|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842115|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842116|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44842117|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
44842118|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842119|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44842120|NCT02264769|Carbetocin|carbetocin|mesh-list
44842121|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
44842122|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842123|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842124|NCT02264795|Lidocaine|lidocaine|mesh-list
44842125|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
44842126|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
44842127|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842128|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842129|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
44842130|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842131|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44842132|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44842133|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44842134|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842135|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842136|NCT02264834|Sufentanil|sufentanil|mesh-list
44842137|NCT02264834|Dsuvia|dsuvia|mesh-list
44842138|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
44842139|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842140|NCT02264834|Narcotics|narcotics|mesh-ancestor
44842141|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842142|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842143|NCT02264834|Analgesics|analgesics|mesh-ancestor
44842144|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
44842145|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842146|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44842147|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842148|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
44842149|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
44842150|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
44842151|NCT02264847|Clomiphene|clomiphene|mesh-list
44842152|NCT02264847|Enclomiphene|enclomiphene|mesh-list
44842153|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
44842154|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44842155|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44842156|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
44842157|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842158|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842159|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44842160|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
44842161|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842162|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44842163|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44842164|NCT02264873|Decitabine|decitabine|mesh-list
44842165|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842166|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
44842167|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842168|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842169|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842170|NCT02264912|Clopidogrel|clopidogrel|mesh-list
44842172|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44842173|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44842174|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44842175|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44842176|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44842177|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
44842178|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842179|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842180|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842181|NCT02264938|Antioxidants|antioxidants|mesh-list
44842182|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842183|NCT02264938|Protective Agents|protective agents|mesh-ancestor
44842184|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842185|NCT02265068|Ticagrelor|ticagrelor|mesh-list
44842186|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842187|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44842188|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44842189|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44842190|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
44842191|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842192|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842193|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842194|NCT02265276|Pioglitazone|pioglitazone|mesh-list
44842195|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44842196|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842197|NCT02265289|Clopidogrel|clopidogrel|mesh-list
44842198|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44328537|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
44842199|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44842200|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44842201|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44842202|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
44842203|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842204|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842205|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842206|NCT02265328|Prednisolone|prednisolone|mesh-list
44842207|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842208|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
44842209|NCT02265328|Hormones|hormones|mesh-ancestor
44842210|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842211|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842212|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44842213|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842214|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
44842215|NCT02265445|beta-Lactams|beta-lactams|mesh-list
44842216|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842217|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842218|NCT02265562|Alprostadil|alprostadil|mesh-list
44842219|NCT02265562|Misoprostol|misoprostol|mesh-list
44842220|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44842221|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
44842222|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842223|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842224|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44842225|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44842226|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
44842227|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842228|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842229|NCT02265562|Urological Agents|urological agents|mesh-ancestor
44842230|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
44842231|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44842232|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
44842233|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842234|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
44842235|NCT02265575|Protective Agents|protective agents|mesh-ancestor
44842236|NCT02265718|Methylphenidate|methylphenidate|mesh-list
44842237|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44842238|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842239|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44842240|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44842241|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842242|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842243|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
44842244|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842245|NCT02265731|Rituximab|rituximab|mesh-list
44842246|NCT02265731|Venetoclax|venetoclax|mesh-list
44842247|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44842248|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842249|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
44842250|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842251|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842252|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
44842253|NCT02265770|Cisplatin|cisplatin|mesh-list
44842254|NCT02265770|Carboplatin|carboplatin|mesh-list
44842255|NCT02265770|Methotrexate|methotrexate|mesh-list
44842256|NCT02265770|Etoposide|etoposide|mesh-list
44842257|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
44842258|NCT02265770|Vincristine|vincristine|mesh-list
44842259|NCT02265770|Valproic Acid|valproic acid|mesh-list
44842260|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842261|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
44842262|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842263|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842264|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44842265|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
44842266|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842267|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842268|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44842269|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44842270|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
44842271|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842272|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842273|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
44842274|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44842275|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842276|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44842277|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44842278|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44842279|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44842280|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44842281|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
44842282|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44842283|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
44842284|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
44842285|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
44842286|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842287|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
44842288|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44842289|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842290|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842291|NCT02265809|Aldesleukin|aldesleukin|mesh-list
44842292|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842293|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44842294|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44842295|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
44842296|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842297|NCT02265822|Midazolam|midazolam|mesh-list
44842298|NCT02265822|Melatonin|melatonin|mesh-list
44842299|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44842300|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44842301|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842302|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842303|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44842304|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44842305|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842306|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842307|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
44842308|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
44328650|NCT00970996|Cisplatin|cisplatin|mesh-list
44842309|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
44842310|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
44842311|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842312|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842313|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
44842314|NCT02265822|Protective Agents|protective agents|mesh-ancestor
44842315|NCT02265874|Nicotine|nicotine|mesh-list
44842316|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44842317|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
44842318|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842319|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842320|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44842321|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44842322|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
44842323|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842324|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842325|NCT02266030|Aspirin|aspirin|mesh-list
44842326|NCT02266030|Cilostazol|cilostazol|mesh-list
44842327|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44842328|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44842329|NCT02266030|Analgesics|analgesics|mesh-ancestor
44842330|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
44328667|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
44328668|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468380|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468381|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44842331|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842332|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842333|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842334|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842335|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44842336|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44842337|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842338|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842339|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44842340|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842341|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
44842342|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44842343|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
44842344|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44625531|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44842345|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842346|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842347|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44842348|NCT02266030|Protective Agents|protective agents|mesh-ancestor
44842349|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44842350|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44842351|NCT02266056|Rocuronium|rocuronium|mesh-list
44842352|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44842353|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44842354|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44842355|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842356|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842357|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44842358|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
44842359|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
44842360|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842361|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842362|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
44842363|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842364|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44842365|NCT02266173|Pertuzumab|pertuzumab|mesh-list
44842366|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44842367|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842368|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
44842369|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44842370|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842371|NCT02266303|Insulin|insulin|mesh-list
44842372|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44842373|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842374|NCT02266355|Omalizumab|omalizumab|mesh-list
44842375|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44842376|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44842377|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842378|NCT02266485|Pravastatin|pravastatin|mesh-list
44842379|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44842380|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44842381|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
44842382|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842383|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44842384|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44842385|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842386|NCT02266511|Tamsulosin|tamsulosin|mesh-list
44842387|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44842388|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44842389|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842390|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842391|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842392|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842393|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842394|NCT02266511|Urological Agents|urological agents|mesh-ancestor
44842395|NCT02266524|Tamsulosin|tamsulosin|mesh-list
44842396|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44842397|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44328717|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328718|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
44328719|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
44328720|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44842398|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842399|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842400|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842401|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842402|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842403|NCT02266524|Urological Agents|urological agents|mesh-ancestor
44842404|NCT02266537|Doxazosin|doxazosin|mesh-list
44842405|NCT02266537|Tamsulosin|tamsulosin|mesh-list
44842406|NCT02266537|Alfuzosin|alfuzosin|mesh-list
44842407|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44842408|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44842409|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842410|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842411|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842412|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842413|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842414|NCT02266537|Urological Agents|urological agents|mesh-ancestor
44842415|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44842416|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
44842417|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625617|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
44842418|NCT02266784|Nicotine|nicotine|mesh-list
44842419|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44842420|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
44842421|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842422|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842423|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44842424|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44842425|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
44842426|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842427|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842428|NCT02266849|Loperamide|loperamide|mesh-list
44842429|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
44842430|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44842431|NCT02265484|Rifaximin|rifaximin|mesh-list
44842432|NCT02265484|Bromocriptine|bromocriptine|mesh-list
44842433|NCT02265484|Lactulose|lactulose|mesh-list
44842434|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842435|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842436|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44842437|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44842438|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44842439|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
44842440|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842441|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842442|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
44842443|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
44842444|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842445|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842446|NCT02266927|Fluticasone|fluticasone|mesh-list
44842447|NCT02266927|Xhance|xhance|mesh-list
44842448|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842449|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44842450|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
44842451|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842452|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842453|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44842454|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842455|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
44842456|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44696838|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44842457|NCT02266940|DS-1971a|ds-1971a|mesh-list
44842458|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44842459|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44842460|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842461|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842462|NCT02267044|Ropivacaine|ropivacaine|mesh-list
44842463|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
44842464|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
44842465|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842466|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842467|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
44842468|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842469|NCT02267057|Acetaminophen|acetaminophen|mesh-list
44842470|NCT02267057|Buprenorphine|buprenorphine|mesh-list
44842471|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44842472|NCT02267057|Analgesics|analgesics|mesh-ancestor
44842473|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
44842474|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842475|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842476|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
44842477|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842478|NCT02267057|Narcotics|narcotics|mesh-ancestor
44842479|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842480|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44842481|NCT02267122|Mupirocin|mupirocin|mesh-list
44328820|NCT00971763|Hormones|hormones|mesh-ancestor
44842482|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842483|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842484|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44842485|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842486|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842487|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
44842488|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44842489|NCT02267239|Listerine|listerine|mesh-list
44842490|NCT02267239|Hexetidine|hexetidine|mesh-list
44842491|NCT02267239|Menthol|menthol|mesh-list
44842492|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
44842493|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44842494|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842495|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
44842496|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44842497|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
44842498|NCT02267239|Protective Agents|protective agents|mesh-ancestor
44842499|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842500|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
44842501|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
44842502|NCT02267304|Morphine|morphine|mesh-list
44842503|NCT02267304|Naloxone|naloxone|mesh-list
44842504|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842505|NCT02267304|Narcotics|narcotics|mesh-ancestor
44842506|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842507|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842508|NCT02267304|Analgesics|analgesics|mesh-ancestor
44842509|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
44842510|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842511|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44842512|NCT02267408|Warfarin|warfarin|mesh-list
44842513|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
44842514|NCT02267616|Etonogestrel|etonogestrel|mesh-list
44842515|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44842516|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
44842517|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842518|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842519|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44842520|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
44842521|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44842522|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
44842523|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842524|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328857|NCT00971893|Hormones|hormones|mesh-ancestor
44842525|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44842526|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842527|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44842528|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
44842529|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842530|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842531|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44842532|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842533|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
44842534|NCT02267655|Protective Agents|protective agents|mesh-ancestor
44842535|NCT02267681|Fentanyl|fentanyl|mesh-list
44842536|NCT02267681|Alfentanil|alfentanil|mesh-list
44842537|NCT02267681|Propofol|propofol|mesh-list
44842538|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44842539|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842540|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842541|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842542|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
44842543|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
44842544|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842545|NCT02267681|Narcotics|narcotics|mesh-ancestor
44842546|NCT02267681|Analgesics|analgesics|mesh-ancestor
44842547|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
44842548|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842549|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44842550|NCT02267707|Gemcitabine|gemcitabine|mesh-list
44842551|NCT02267707|Paclitaxel|paclitaxel|mesh-list
44842552|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44842553|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842554|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44842555|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44842556|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44842557|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842558|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842559|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
44842560|NCT02267707|Antiviral Agents|antiviral agents|mesh-ancestor
44842561|NCT02267707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842562|NCT02267707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842563|NCT02267707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842564|NCT02267707|Immunologic Factors|immunologic factors|mesh-ancestor
44842565|NCT02267707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842566|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
44842567|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842568|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
44842569|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
44842570|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
44842571|NCT02267915|Rituximab|rituximab|mesh-list
44842572|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44842573|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842574|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
44842575|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842576|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842577|NCT02267980|Ketamine|ketamine|mesh-list
44842578|NCT02267980|Sevoflurane|sevoflurane|mesh-list
44842579|NCT02267980|Analgesics|analgesics|mesh-ancestor
44842580|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
44842581|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842582|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842583|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44842584|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842585|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
44842586|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
44842587|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842588|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44842589|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44842590|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842591|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842592|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842593|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44842594|NCT02268006|Capecitabine|capecitabine|mesh-list
44842595|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842596|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
44842597|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842598|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842599|NCT02268019|Epinephrine|epinephrine|mesh-list
44842600|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44328935|NCT00972387|Prednisone|prednisone|mesh-list
44842601|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44842602|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842603|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842604|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842605|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842606|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44842607|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44842608|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
44842609|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842610|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44842611|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842613|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
44842614|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44842615|NCT02268032|Androgens|androgens|mesh-list
44842616|NCT02268032|Hormones|hormones|mesh-ancestor
44842617|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842618|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842619|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
44842620|NCT02268149|Prednisone|prednisone|mesh-list
44842621|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842622|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
44842623|NCT02268149|Hormones|hormones|mesh-ancestor
44842624|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842625|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842626|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44842627|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842628|NCT02268201|Tacrolimus|tacrolimus|mesh-list
44842629|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842630|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
44842631|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842632|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44842633|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842634|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842635|NCT02268279|Solithromycin|solithromycin|mesh-list
44842636|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842637|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842638|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
44842639|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842640|NCT02268357|Propranolol|propranolol|mesh-list
44842641|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44842642|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842643|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842644|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842645|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842646|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842647|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44842648|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44842649|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842650|NCT02268370|Dasatinib|dasatinib|mesh-list
44842651|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842652|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44842653|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842654|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842655|NCT02268383|Luspatercept|luspatercept|mesh-list
44842656|NCT02268383|Hematinics|hematinics|mesh-ancestor
44842657|NCT02268409|Luspatercept|luspatercept|mesh-list
44842658|NCT02268409|Hematinics|hematinics|mesh-ancestor
44842659|NCT02268422|Buprenorphine|buprenorphine|mesh-list
44842660|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44842661|NCT02268422|Narcotics|narcotics|mesh-ancestor
44842662|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842663|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842664|NCT02268422|Analgesics|analgesics|mesh-ancestor
44842665|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
44842666|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842667|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44842668|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
44842669|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842670|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44842671|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842672|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842673|NCT02268487|Sertraline|sertraline|mesh-list
44842674|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
44842675|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842676|NCT02268487|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44842677|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44842678|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842679|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842680|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842681|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
44842682|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842683|NCT02268565|Aspirin|aspirin|mesh-list
44842684|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44842685|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44842686|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44842687|NCT02268565|Analgesics|analgesics|mesh-ancestor
44842688|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
44842689|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842690|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842691|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842692|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44842693|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44842694|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842695|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842696|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44842697|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842698|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
44842700|NCT02268773|Dipyridamole|dipyridamole|mesh-list
44842701|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44842702|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44842703|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44842704|NCT02268773|Analgesics|analgesics|mesh-ancestor
44842705|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
44842706|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842707|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842708|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44842709|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842710|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44842711|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44842712|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842713|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842714|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44842715|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842716|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
44842717|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44842718|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
44842719|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
44842720|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44842721|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842722|NCT02268890|Bortezomib|bortezomib|mesh-list
44842723|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842724|NCT02268903|Furosemide|furosemide|mesh-list
44842725|NCT02268903|Diuretics|diuretics|mesh-list
44842726|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
44842727|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842728|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44842729|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842730|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842731|NCT02268968|Lidocaine|lidocaine|mesh-list
44842732|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
44842733|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
44842734|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842735|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842736|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
44842737|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842738|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44842739|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44842740|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44842741|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842742|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842743|NCT02269046|Simvastatin|simvastatin|mesh-list
44842744|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44842745|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44842746|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
44842747|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842748|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44842749|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44842750|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842751|NCT02269072|Anastrozole|anastrozole|mesh-list
44842752|NCT02269072|Leuprolide|leuprolide|mesh-list
44842753|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44842754|NCT02269072|Testosterone|testosterone|mesh-list
44842755|NCT02269072|Androgens|androgens|mesh-ancestor
44842756|NCT02269072|Hormones|hormones|mesh-ancestor
44329059|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842757|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44842758|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842759|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44842760|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842761|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44842762|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44842763|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842764|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842765|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44842766|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
44842767|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44842768|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
44842769|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842770|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
44842771|NCT02269176|Losartan|losartan|mesh-list
44842772|NCT02269176|Telmisartan|telmisartan|mesh-list
44842773|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44842774|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44842775|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44842776|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44842777|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842779|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44842780|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44842781|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842782|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842783|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44842784|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44842785|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842786|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842787|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
44842788|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
44842789|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
44842790|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
44842791|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842792|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842793|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44842794|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842795|NCT02269280|Azacitidine|azacitidine|mesh-list
44842796|NCT02269280|Decitabine|decitabine|mesh-list
44842797|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842798|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
44842799|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842800|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468450|NCT01436305|Hormones|hormones|mesh-ancestor
44842801|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842802|NCT02269293|Paclitaxel|paclitaxel|mesh-list
44842803|NCT02269293|Carboplatin|carboplatin|mesh-list
44842804|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44842805|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842806|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44842807|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44842808|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44842809|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842810|NCT02269319|Linezolid|linezolid|mesh-list
44842811|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842812|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842813|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44842814|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842815|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842816|NCT02269358|Methotrexate|methotrexate|mesh-list
44842817|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44842818|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
44842819|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44842820|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842821|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842822|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
44842823|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842824|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842825|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44842826|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842827|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44842828|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842829|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
44842830|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44842831|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44842832|NCT02269449|Hemostatics|hemostatics|mesh-list
44842833|NCT02269449|Coagulants|coagulants|mesh-ancestor
44842834|NCT02269462|Efavirenz|efavirenz|mesh-list
44842835|NCT02269462|Nevirapine|nevirapine|mesh-list
44842836|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44842837|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44842838|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842839|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842840|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
44842841|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842842|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44842843|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44842844|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44842845|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44842846|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44842847|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44842848|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44842849|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44842850|NCT02269514|Nicotine|nicotine|mesh-list
44842851|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44842852|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
44842853|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842854|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842855|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44842856|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44842857|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
44842858|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842859|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842860|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
44842861|NCT02269540|Sertraline|sertraline|mesh-list
44842862|NCT02269540|Citalopram|citalopram|mesh-list
44842863|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44842864|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
44842865|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842866|NCT02269540|Expectorants|expectorants|mesh-ancestor
44842867|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44842868|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44842869|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
44842870|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842871|NCT02269540|Protective Agents|protective agents|mesh-ancestor
44842872|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842873|NCT02269540|Antidotes|antidotes|mesh-ancestor
44842874|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
44842875|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842876|NCT02269540|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44842877|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44842878|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44842879|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842880|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
44842881|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44842882|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
44842883|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44842884|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
44842885|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842886|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842887|NCT02269644|Azithromycin|azithromycin|mesh-list
44842888|NCT02269644|Linezolid|linezolid|mesh-list
44842889|NCT02269644|Dalbavancin|dalbavancin|mesh-list
44842890|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842891|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842892|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44842893|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842894|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842895|NCT02269696|Metoprolol|metoprolol|mesh-list
44842896|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44842897|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44842898|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
44842899|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
44842900|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842901|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842902|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44842903|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44842904|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44842905|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842906|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842907|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842908|NCT02269735|Insulin|insulin|mesh-list
44842909|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44842910|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
44842911|NCT02269735|MK-2640|mk-2640|mesh-list
44842912|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44842913|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842914|NCT02269748|Analgesics|analgesics|mesh-list
44842915|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
44842916|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842917|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842918|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44842919|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44842920|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842921|NCT02269904|Fluorouracil|fluorouracil|mesh-list
44842922|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
44842923|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842924|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842925|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842926|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842927|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
44842928|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842929|NCT02269969|Tobramycin|tobramycin|mesh-list
44842930|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44842931|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842932|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
44842933|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44842934|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842935|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842936|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44842937|NCT02270281|Analgesics|analgesics|mesh-ancestor
44842938|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
44842939|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842940|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44842941|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44842942|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44842943|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
44842944|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44842945|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842946|NCT02272166|Propofol|propofol|mesh-list
44842947|NCT02272166|Sevoflurane|sevoflurane|mesh-list
44842948|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44842949|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44842950|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842951|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44842952|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
44842953|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
44842954|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44842955|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44842956|NCT05628623|Cytarabine|cytarabine|mesh-list
44842957|NCT05628623|Azacitidine|azacitidine|mesh-list
44842958|NCT05628623|Daunorubicin|daunorubicin|mesh-list
44842959|NCT05628623|Venetoclax|venetoclax|mesh-list
44842960|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44842961|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
44842962|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842963|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842964|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
44842965|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44842966|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44842967|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
44842968|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842969|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44842970|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44842971|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44842972|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44842973|NCT05628610|Paclitaxel|paclitaxel|mesh-list
44842974|NCT05628610|Cisplatin|cisplatin|mesh-list
44842975|NCT05628610|Carboplatin|carboplatin|mesh-list
44842976|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44842977|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44842978|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44842979|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44842980|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44842981|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44842982|NCT05628584|Metformin|metformin|mesh-list
44842983|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44842984|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842985|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44842986|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
44842987|NCT05628558|Coagulants|coagulants|mesh-ancestor
44842988|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44842989|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
44329224|NCT00973401|Insulin|insulin|mesh-list
44842990|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842991|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
44842992|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44842993|NCT05628389|Nicotine|nicotine|mesh-list
44842994|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44842995|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
44842996|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44842997|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44842998|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44842999|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44843000|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
44843001|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843002|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843003|NCT05628233|Azasetron|azasetron|mesh-list
44843004|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
44843005|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
44843006|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843007|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843008|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843009|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44843010|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
44843011|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843012|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843013|NCT05628038|Capecitabine|capecitabine|mesh-list
44843014|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
44843015|NCT05628038|Antibodies|antibodies|mesh-list
44843016|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
44843017|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843018|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843019|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
44843020|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843021|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843022|NCT05627947|Cyclosporine|cyclosporine|mesh-list
44843023|NCT05627947|Mitomycins|mitomycins|mesh-list
44843024|NCT05627947|Mitomycin|mitomycin|mesh-list
44843025|NCT05627947|Cyclosporins|cyclosporins|mesh-list
44843026|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843027|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843028|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843029|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
44843030|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843031|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
44843032|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843033|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843034|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843035|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44843036|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44843037|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843038|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
44843039|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44843040|NCT05627843|Curcumin|curcumin|mesh-list
44843041|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843042|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843043|NCT05627843|Analgesics|analgesics|mesh-ancestor
44843044|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
44843045|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843046|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843047|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843048|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843049|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843050|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843051|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843052|NCT05627791|Oxytocin|oxytocin|mesh-list
44843053|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
44843054|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44843055|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843056|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44843057|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44843058|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843059|NCT05627752|Docetaxel|docetaxel|mesh-list
44843060|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843061|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
44843062|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
44843063|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
44843064|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843065|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
44843066|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44843067|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843068|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44843069|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
44843070|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44843071|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843072|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843073|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843074|NCT05627557|Acetaminophen|acetaminophen|mesh-list
44843075|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
44843076|NCT05627557|Promethazine|promethazine|mesh-list
44843077|NCT05627557|Prednisone|prednisone|mesh-list
44843078|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
44843079|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
44843080|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843081|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
44843082|NCT05627557|Hormones|hormones|mesh-ancestor
44843083|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843084|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843085|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44843086|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843087|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843088|NCT05627557|Analgesics|analgesics|mesh-ancestor
44843089|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
44843090|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843091|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
44843092|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
44843093|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
44843094|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843095|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44843096|NCT05627557|Protective Agents|protective agents|mesh-ancestor
44843097|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843098|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44843099|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44843100|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843101|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
44843102|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
44843103|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44843104|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
44843105|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
44843106|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843107|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843108|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843109|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
44843110|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843111|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44843112|NCT05627414|Paclitaxel|paclitaxel|mesh-list
44843113|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44329361|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
44843114|NCT05627414|Tegafur|tegafur|mesh-list
44843115|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44843116|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843117|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
44843118|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
44843119|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44843120|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843121|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843122|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
44843123|NCT05627154|Citalopram|citalopram|mesh-list
44843124|NCT05627154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44843125|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44843126|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843127|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843128|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843129|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
44843130|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843131|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44843132|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
44843133|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843134|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
44843135|NCT05626998|Gabapentin|gabapentin|mesh-list
44843136|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44843137|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843138|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843139|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843140|NCT05626998|Analgesics|analgesics|mesh-ancestor
44843141|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
44843142|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843143|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44843144|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44843145|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44843146|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44843147|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843148|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843149|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
44843150|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44843151|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44843152|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843153|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44843154|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44843155|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
44843156|NCT05626972|Tenecteplase|tenecteplase|mesh-list
44843157|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44843158|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44843159|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843160|NCT05626920|Disulfiram|disulfiram|mesh-list
44843161|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44843162|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44843163|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843164|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843165|NCT05626829|Tranilast|tranilast|mesh-list
44843166|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843167|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843168|NCT05626829|Analgesics|analgesics|mesh-ancestor
44843169|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
44843170|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843171|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843172|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843173|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843174|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44843175|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843176|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843177|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44843178|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44843179|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
44843180|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
44843181|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696839|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44696840|NCT01394224|Levetiracetam|levetiracetam|mesh-list
44696841|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
44696842|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
44696843|NCT01394263|Goserelin|goserelin|mesh-list
44696844|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696845|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696847|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44696848|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696849|NCT01394341|Incretins|incretins|mesh-ancestor
44696850|NCT01394341|Hormones|hormones|mesh-ancestor
44696851|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696852|NCT01394354|Dexamethasone|dexamethasone|mesh-list
44696853|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
44696854|NCT01394354|Doxorubicin|doxorubicin|mesh-list
44696855|NCT01394354|Bortezomib|bortezomib|mesh-list
44696856|NCT01394354|Vorinostat|vorinostat|mesh-list
44696857|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696858|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
44696859|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
44696860|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696861|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696862|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696863|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
44696864|NCT01394354|Hormones|hormones|mesh-ancestor
44696865|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44696866|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44696867|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696868|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44696869|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44696870|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44696871|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44696872|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696873|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44696874|NCT01394406|Ketamine|ketamine|mesh-list
44696875|NCT01394406|Analgesics|analgesics|mesh-ancestor
44843182|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44843183|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843184|NCT05626010|Acetaminophen|acetaminophen|mesh-list
44843185|NCT05626010|Ibuprofen|ibuprofen|mesh-list
44843186|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843187|NCT05626010|Analgesics|analgesics|mesh-ancestor
44843188|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
44843189|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843190|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843191|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
44843192|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843193|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843194|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843195|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44843196|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843197|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843198|NCT05625919|Sirolimus|sirolimus|mesh-list
44843199|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44843200|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843201|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44843202|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843203|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
44843204|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843205|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
44843206|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843207|NCT05625373|Vancomycin|vancomycin|mesh-list
44843208|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44843209|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843210|NCT05624840|Ritonavir|ritonavir|mesh-list
44843211|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44843212|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44843213|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
44843214|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843215|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843216|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44843217|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44843218|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
44843219|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843220|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44843221|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44843222|NCT05624138|Leucovorin|leucovorin|mesh-list
44843223|NCT05624138|Ketotifen|ketotifen|mesh-list
44843224|NCT05624138|Fluorouracil|fluorouracil|mesh-list
44843225|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
44843226|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843227|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
44843228|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843229|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843230|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843231|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843232|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
44843233|NCT05624138|Antidotes|antidotes|mesh-ancestor
44843234|NCT05624138|Protective Agents|protective agents|mesh-ancestor
44843235|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
44843236|NCT05624138|Vitamins|vitamins|mesh-ancestor
44843237|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
44843238|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
44843239|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843240|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44843241|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
44843242|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
44843243|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843244|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843245|NCT05622968|Dinoprostone|dinoprostone|mesh-list
44843246|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
44843247|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44843248|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843249|NCT05622201|Rituximab|rituximab|mesh-list
44843250|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843251|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843252|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
44843253|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843254|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843255|NCT05617508|Niacinamide|niacinamide|mesh-list
44843256|NCT05617508|Niacin|niacin|mesh-list
44843257|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
44843258|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
44843259|NCT05617508|Vitamins|vitamins|mesh-ancestor
44843260|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
44843261|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843262|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44843263|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
44843264|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843265|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44843266|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44843267|NCT05613400|Simvastatin|simvastatin|mesh-list
44843268|NCT05613400|Ezetimibe|ezetimibe|mesh-list
44843269|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44843270|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44843271|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
44843272|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843273|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44843274|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44843275|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843276|NCT05573230|Cyclosporine|cyclosporine|mesh-list
44843277|NCT05573230|Midazolam|midazolam|mesh-list
44843278|NCT05573230|Cyclosporins|cyclosporins|mesh-list
44843279|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44843280|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44843281|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843282|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843283|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44843284|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44843285|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843286|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44843287|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
44843288|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
44843289|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
44843290|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
44843291|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843292|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843293|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843294|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843295|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
44626629|NCT00503776|Amifostine|amifostine|mesh-list
44843296|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
44843297|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843298|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843299|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329513|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
44843300|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44843301|NCT05533229|Fentanyl|fentanyl|mesh-list
44843302|NCT05533229|Morphine|morphine|mesh-list
44843303|NCT05533229|Bupivacaine|bupivacaine|mesh-list
44843304|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
44843305|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
44843306|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843307|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843308|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
44843309|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843310|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44843311|NCT05533229|Narcotics|narcotics|mesh-ancestor
44843312|NCT05533229|Analgesics|analgesics|mesh-ancestor
44843313|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44843314|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44843315|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
44843316|NCT05526989|Niraparib|niraparib|mesh-list
44843317|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44843318|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843319|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843320|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843321|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
44843322|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
44843323|NCT05519384|Fludarabine|fludarabine|mesh-list
44843324|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843325|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
44843326|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843327|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843328|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44843329|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
44843330|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843331|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843332|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44843333|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
44843334|NCT05518110|Trametinib|trametinib|mesh-list
44843335|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
44843336|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44843337|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44843338|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843339|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843340|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843341|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843342|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843343|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44843344|NCT05514483|Ondansetron|ondansetron|mesh-list
44843345|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
44843346|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
44843347|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843348|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843349|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843350|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
44843351|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843352|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44843353|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
44843354|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843355|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843356|NCT05514483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44843357|NCT05514483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44843358|NCT05514483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843359|NCT05514483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843360|NCT05514483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44843361|NCT05508074|Riluzole|riluzole|mesh-list
44843362|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
44843363|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44843364|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44843365|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843366|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843367|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843368|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44843369|NCT05508074|Protective Agents|protective agents|mesh-ancestor
44843370|NCT05508061|Insulin|insulin|mesh-list
44843371|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44843372|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
44843373|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44843374|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843375|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
44843376|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843377|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843379|NCT05480878|Citalopram|citalopram|mesh-list
44843380|NCT05480878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44843381|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44843382|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843383|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843384|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843385|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
44843386|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843387|NCT05480878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44843388|NCT05480878|Antidepressive Agents|antidepressive agents|mesh-ancestor
44843389|NCT05480878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843390|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44843391|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843392|NCT05476796|Trifluridine|trifluridine|mesh-list
44843393|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
44843394|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843395|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
44843396|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843397|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
44843398|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843399|NCT05474846|Melatonin|melatonin|mesh-list
44843400|NCT05474846|Methylphenidate|methylphenidate|mesh-list
44843401|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
44843402|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843403|NCT05474846|Protective Agents|protective agents|mesh-ancestor
44843404|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843405|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843406|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44843407|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44843408|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44843409|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843410|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
44843411|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843412|NCT05469126|Clarithromycin|clarithromycin|mesh-list
44843413|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44843414|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843415|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44843416|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843417|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329630|NCT00975572|Vaccines|vaccines|mesh-list
44843418|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44843419|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44843420|NCT05468697|Palbociclib|palbociclib|mesh-list
44843421|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843422|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44843423|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843424|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843425|NCT05468320|Prednisone|prednisone|mesh-list
44843426|NCT05468320|Prednisolone|prednisolone|mesh-list
44843427|NCT05468320|Antibodies|antibodies|mesh-list
44843428|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
44843429|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843430|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843431|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843432|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
44843433|NCT05468320|Hormones|hormones|mesh-ancestor
44843434|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843435|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44843436|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44843437|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
44843438|NCT05467033|Coagulants|coagulants|mesh-ancestor
44843439|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44843440|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
44843441|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843442|NCT05464810|Letrozole|letrozole|mesh-list
44843443|NCT05464810|Simvastatin|simvastatin|mesh-list
44843444|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44843445|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44843446|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
44843447|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843448|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44843449|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44843450|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626780|NCT00501644|Interferons|interferons|mesh-list
44843451|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843452|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44843453|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44843454|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44843455|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
44843456|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843457|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843458|NCT05457855|Fluticasone|fluticasone|mesh-list
44843459|NCT05457855|Montelukast|montelukast|mesh-list
44843460|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843461|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44843462|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
44843463|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843464|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843465|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44843466|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
44843467|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843468|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843469|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44843470|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44843471|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843472|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44843473|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44843474|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843475|NCT05456165|Ipilimumab|ipilimumab|mesh-list
44843476|NCT05456165|Atezolizumab|atezolizumab|mesh-list
44843477|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843478|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843479|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44843480|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843481|NCT05454709|Glucagon|glucagon|mesh-list
44843482|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843483|NCT05454709|Hormones|hormones|mesh-ancestor
44843484|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843485|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843486|NCT05453968|Berotralstat|berotralstat|mesh-list
44843487|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843488|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843489|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
44843490|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
44843491|NCT05451940|Hematinics|hematinics|mesh-list
44843492|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843493|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
44843494|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843495|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843496|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44843497|NCT05436418|Sirolimus|sirolimus|mesh-list
44843498|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
44843499|NCT05436418|Melphalan|melphalan|mesh-list
44843500|NCT05436418|Fludarabine|fludarabine|mesh-list
44843501|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843502|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
44329718|NCT00975936|Ketoconazole|ketoconazole|mesh-list
44843503|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843504|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843505|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44843506|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
44843507|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843508|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843509|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44843510|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44843511|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44843512|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843513|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
44843514|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44843515|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
44843516|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843517|NCT05402397|Losartan|losartan|mesh-list
44843518|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44843519|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44843520|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44843521|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44843522|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843523|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
44843524|NCT05400109|Fludarabine|fludarabine|mesh-list
44843525|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
44843526|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843527|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
44843528|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843529|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843530|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44843531|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
44843532|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843533|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843534|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44843535|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843536|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
44843537|NCT05376878|Copper|copper|mesh-list
44843538|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44843539|NCT05376878|Trastuzumab|trastuzumab|mesh-list
44843540|NCT05376878|Camptothecin|camptothecin|mesh-list
44843541|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44843542|NCT05376878|Antibodies|antibodies|mesh-list
44843543|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
44843544|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44843545|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
44843546|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
44843547|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843548|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843549|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843550|NCT05376878|Trace Elements|trace elements|mesh-ancestor
44843551|NCT05376878|Micronutrients|micronutrients|mesh-ancestor
44843552|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44843553|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44843554|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44843555|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843556|NCT05372588|Vaccines|vaccines|mesh-list
44843557|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
44843558|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843559|NCT05349006|Azathioprine|azathioprine|mesh-list
44843560|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
44843561|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843562|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843563|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843564|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843565|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
44843566|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843567|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843568|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
44843569|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
44843570|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843571|NCT05327348|Protective Agents|protective agents|mesh-ancestor
44843572|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843573|NCT05327348|Vitamins|vitamins|mesh-ancestor
44843574|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
44843575|NCT05283226|Paclitaxel|paclitaxel|mesh-list
44843576|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44843577|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843578|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
44843579|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
44843580|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
44843581|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843582|NCT05272384|Nivolumab|nivolumab|mesh-list
44843583|NCT05272384|Decitabine|decitabine|mesh-list
44843584|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843585|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843586|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44843587|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843588|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843589|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
44843590|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843591|NCT05230303|Caffeine|caffeine|mesh-list
44843592|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44843593|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843594|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44843595|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626937|NCT00499746|Tramadol|tramadol|mesh-list
44843596|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843597|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44843598|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44843599|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
44843600|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843601|NCT05209152|Azacitidine|azacitidine|mesh-list
44843602|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843603|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
44843604|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843605|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843606|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843607|NCT05191784|Bevacizumab|bevacizumab|mesh-list
44843608|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843609|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843610|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44843611|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44843612|NCT05191784|Growth Substances|growth substances|mesh-ancestor
44843613|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843614|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
44843615|NCT05174065|Apremilast|apremilast|mesh-list
44843616|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843617|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843618|NCT05174065|Analgesics|analgesics|mesh-ancestor
44843619|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
44843620|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843621|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843622|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843623|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843624|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44843625|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44843626|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843627|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843628|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44843629|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
44843630|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843631|NCT05151471|Edaravone|edaravone|mesh-list
44843632|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44843633|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
44843634|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843635|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44843636|NCT05151471|Protective Agents|protective agents|mesh-ancestor
44843637|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843638|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
44843639|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843640|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
44843641|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44843642|NCT05122546|Nivolumab|nivolumab|mesh-list
44843643|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843644|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843645|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44843646|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843647|NCT05115903|Adalimumab|adalimumab|mesh-list
44843648|NCT05115903|Etanercept|etanercept|mesh-list
44843649|NCT05115903|Golimumab|golimumab|mesh-list
44843650|NCT05115903|Infliximab|infliximab|mesh-list
44843651|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
44843652|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44843653|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843654|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843655|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843656|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843657|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843658|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843659|NCT05115903|Analgesics|analgesics|mesh-ancestor
44843660|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
44843661|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843662|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843663|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843664|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
44843665|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44843666|NCT05096962|Antibodies|antibodies|mesh-list
44843667|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
44843668|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627000|NCT00499603|Paclitaxel|paclitaxel|mesh-list
44843669|NCT05050162|Cisplatin|cisplatin|mesh-list
44843670|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
44843671|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843672|NCT05047445|Vaccines|vaccines|mesh-list
44843673|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
44843674|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843675|NCT05043116|Vitamin D|vitamin d|mesh-list
44843676|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
44843677|NCT05043116|Vitamins|vitamins|mesh-ancestor
44843678|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
44843679|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843680|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44843681|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44843682|NCT05011058|Valganciclovir|valganciclovir|mesh-list
44843683|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
44843684|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843685|NCT05005689|Fluorides|fluorides|mesh-list
44843686|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
44843687|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843688|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
44843689|NCT05005689|Protective Agents|protective agents|mesh-ancestor
44843690|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44843691|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44843692|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843693|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
44329893|NCT00977028|Lidocaine|lidocaine|mesh-list
44843694|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
44843695|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
44843696|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843697|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843698|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
44843699|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843700|NCT04940052|Trametinib|trametinib|mesh-list
44843701|NCT04940052|Dabrafenib|dabrafenib|mesh-list
44843702|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843703|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44843704|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843705|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843706|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44843707|NCT04895566|Antibodies|antibodies|mesh-list
44843708|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
44843709|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44843710|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
44843711|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843712|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843713|NCT04879966|Infliximab|infliximab|mesh-list
44843714|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843715|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843716|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843717|NCT04875767|Coal Tar|coal tar|mesh-list
44843718|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
44843719|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843720|NCT04874038|Lidocaine|lidocaine|mesh-list
44843721|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44843722|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
44843723|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843724|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843725|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
44843726|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843727|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44843728|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44843729|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44843730|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843731|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843732|NCT04862143|Fulvestrant|fulvestrant|mesh-list
44843733|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44843734|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843735|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44843736|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44843737|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
44843738|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843739|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843740|NCT04809285|Insulin|insulin|mesh-list
44843741|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44843742|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843743|NCT04787965|Opicapone|opicapone|mesh-list
44843744|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44843745|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843746|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843747|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44843748|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44843750|NCT04757363|Nivolumab|nivolumab|mesh-list
44843751|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843752|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843753|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44843754|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843755|NCT04729387|Paclitaxel|paclitaxel|mesh-list
44843756|NCT04729387|Doxorubicin|doxorubicin|mesh-list
44843757|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44843758|NCT04729387|Olaparib|olaparib|mesh-list
44843759|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44843760|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843761|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44843762|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44843763|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44843764|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843765|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44843766|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44843767|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44843768|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843769|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44843770|NCT04718740|Vitamin K|vitamin k|mesh-list
44843771|NCT04718740|Repaglinide|repaglinide|mesh-list
44843772|NCT04718740|Midazolam|midazolam|mesh-list
44843773|NCT04718740|Caffeine|caffeine|mesh-list
44843774|NCT04718740|Bupropion|bupropion|mesh-list
44843775|NCT04718740|Omeprazole|omeprazole|mesh-list
44843776|NCT04718740|Warfarin|warfarin|mesh-list
44843777|NCT04718740|Vitamins|vitamins|mesh-ancestor
44843778|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
44843779|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843780|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44329951|NCT00977223|Aprepitant|aprepitant|mesh-list
44843781|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44843782|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843783|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44843784|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44843785|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44843786|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44843787|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
44843788|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
44843789|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
44843790|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
44843791|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843792|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843793|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
44843794|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44843795|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843796|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44843797|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843798|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44843799|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44843800|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44843801|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44843802|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
44843803|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44843804|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
44843805|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44843806|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44843807|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843808|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
44843809|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44843810|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44843811|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44843812|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44843813|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
44843814|NCT04718740|Coagulants|coagulants|mesh-ancestor
44843815|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44843816|NCT04707703|Isavuconazole|isavuconazole|mesh-list
44843817|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
44843818|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843819|NCT04704050|Dronedarone|dronedarone|mesh-list
44843820|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44843821|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
44843822|NCT04697940|Fludarabine|fludarabine|mesh-list
44843823|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
44843824|NCT04697940|Decitabine|decitabine|mesh-list
44843825|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843826|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
44843827|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843828|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843829|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44843830|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
44843831|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843832|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843833|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44843834|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843835|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
44843836|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843837|NCT04681105|Acetaminophen|acetaminophen|mesh-list
44843838|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
44843839|NCT04681105|Promethazine|promethazine|mesh-list
44843840|NCT04681105|Dexamethasone|dexamethasone|mesh-list
44843841|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
44843842|NCT04681105|Ibuprofen|ibuprofen|mesh-list
44843843|NCT04681105|Ranitidine|ranitidine|mesh-list
44843844|NCT04681105|Antibodies|antibodies|mesh-list
44843845|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
44843846|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44843847|NCT04681105|BB 1101|bb 1101|mesh-list
44843848|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
44843849|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627224|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
44843850|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843851|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
44843852|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
44843853|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843854|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843855|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
44843856|NCT04681105|Hormones|hormones|mesh-ancestor
44843857|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843858|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44843859|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843860|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
44843861|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843862|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843863|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44843864|NCT04681105|Analgesics|analgesics|mesh-ancestor
44843865|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
44843866|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
44843867|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843868|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843869|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44843870|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44843871|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44843872|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627225|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843873|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
44627226|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627227|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627228|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
44627229|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627230|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627231|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627232|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627233|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44627234|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627235|NCT00496782|Maraviroc|maraviroc|mesh-list
44627236|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44627237|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44627238|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627239|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44627240|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44627241|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
44627242|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627243|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44627244|NCT00496769|Aspirin|aspirin|mesh-list
44627245|NCT00496769|Apixaban|apixaban|mesh-list
44627246|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44843874|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
44843875|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44843876|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
44843877|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
44843878|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843879|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843880|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
44843881|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843882|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44843883|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44843884|NCT04666987|Liraglutide|liraglutide|mesh-list
44843885|NCT04666987|Xultophy|xultophy|mesh-list
44843886|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44843887|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843888|NCT04666987|Incretins|incretins|mesh-ancestor
44843889|NCT04666987|Hormones|hormones|mesh-ancestor
44843890|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843891|NCT04648930|Omalizumab|omalizumab|mesh-list
44843892|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44843893|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44843894|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44843895|NCT04642131|Caffeine|caffeine|mesh-list
44843896|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44843897|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843898|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44843899|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843900|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843901|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44843902|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44843903|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
44843904|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843905|NCT04627285|Lacosamide|lacosamide|mesh-list
44843906|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
44843907|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44843908|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44843909|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44843910|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843911|NCT04622228|Cisplatin|cisplatin|mesh-list
44843912|NCT04622228|Carboplatin|carboplatin|mesh-list
44843913|NCT04622228|Etoposide|etoposide|mesh-list
44843914|NCT04622228|Atezolizumab|atezolizumab|mesh-list
44843915|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843916|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44843917|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44843918|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44843919|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843920|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843921|NCT04621318|Denosumab|denosumab|mesh-list
44843922|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44843923|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843924|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44843925|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44843926|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843927|NCT04578938|Ketamine|ketamine|mesh-list
44843928|NCT04578938|Analgesics|analgesics|mesh-ancestor
44843929|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
44330121|NCT00978211|Octreotide|octreotide|mesh-list
44843930|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843931|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843932|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44843933|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44843934|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
44843935|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
44843936|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44843937|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44843938|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44843939|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44843940|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843941|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
44843942|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44696876|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
44696877|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696878|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696879|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44696880|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44696881|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
44696882|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
44696883|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696884|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44696885|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44696886|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696887|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696888|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
44696889|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44696890|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
44696891|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696892|NCT01394419|Expectorants|expectorants|mesh-ancestor
44696893|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696894|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44696895|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
44696896|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696897|NCT01394419|Protective Agents|protective agents|mesh-ancestor
44696898|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696899|NCT01394419|Antidotes|antidotes|mesh-ancestor
44696900|NCT01394445|Physostigmine|physostigmine|mesh-list
44696901|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44696902|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330164|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696903|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696904|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
44696905|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696906|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696907|NCT01394445|Miotics|miotics|mesh-ancestor
44696908|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
44696909|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696910|NCT01394458|Ethanol|ethanol|mesh-list
44696911|NCT01394458|Heparin|heparin|mesh-list
44696912|NCT01394458|Citric Acid|citric acid|mesh-list
44843943|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843944|NCT04540705|Nivolumab|nivolumab|mesh-list
44843945|NCT04540705|Axitinib|axitinib|mesh-list
44843946|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44843947|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843948|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44843949|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843950|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44843951|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843952|NCT04537689|Cyclosporine|cyclosporine|mesh-list
44843953|NCT04537689|Methotrexate|methotrexate|mesh-list
44843954|NCT04537689|Ixekizumab|ixekizumab|mesh-list
44843955|NCT04537689|Acitretin|acitretin|mesh-list
44843956|NCT04537689|Cyclosporins|cyclosporins|mesh-list
44843957|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44843958|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
44843959|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44843960|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843961|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44843962|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
44843963|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330209|NCT00978822|Clevidipine|clevidipine|mesh-list
44843964|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843965|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
44843966|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843967|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44843968|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44843969|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
44843970|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44843971|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44843972|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
44843973|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44843974|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44843975|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
44843976|NCT04537026|Dexamethasone|dexamethasone|mesh-list
44843977|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
44843978|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44843979|NCT04537026|BB 1101|bb 1101|mesh-list
44843980|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44843981|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
44843982|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
44843983|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44843984|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843985|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44843986|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
44843987|NCT04537026|Hormones|hormones|mesh-ancestor
44843988|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44843989|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44843990|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44843991|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
44843992|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44843993|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44843994|NCT04501653|Methylphenidate|methylphenidate|mesh-list
44843995|NCT04501653|Psilocybin|psilocybin|mesh-list
44843996|NCT04501653|Psilocin|psilocin|mesh-list
44843997|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44843998|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44843999|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44844000|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44844001|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44844002|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844003|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
44844004|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844005|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
44844006|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844007|NCT04501614|Ponatinib|ponatinib|mesh-list
44844008|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844009|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844010|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844011|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844012|NCT04496960|Tofacitinib|tofacitinib|mesh-list
44844013|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844014|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844015|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844016|NCT04495257|Nivolumab|nivolumab|mesh-list
44844017|NCT04495257|Ipilimumab|ipilimumab|mesh-list
44844018|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844019|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844020|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844021|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844022|NCT04479072|Aspirin|aspirin|mesh-list
44844023|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44844024|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844025|NCT04479072|Analgesics|analgesics|mesh-ancestor
44844026|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
44844027|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844028|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844029|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844030|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844031|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44844032|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44844033|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844034|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44844035|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44844036|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844037|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
44844038|NCT04476199|Decitabine|decitabine|mesh-list
44844039|NCT04476199|Venetoclax|venetoclax|mesh-list
44844040|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44844041|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
44844042|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844043|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844044|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844045|NCT04464070|Aspirin|aspirin|mesh-list
44844046|NCT04464070|Niacin|niacin|mesh-list
44844047|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44844048|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844049|NCT04464070|Analgesics|analgesics|mesh-ancestor
44844050|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
44844051|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844052|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844053|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844054|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844055|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44844056|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44844057|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844058|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44844059|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44844060|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844061|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
44844062|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44844063|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
44844064|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44844065|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
44844066|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
44844067|NCT04464070|Vitamins|vitamins|mesh-ancestor
44844068|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
44844069|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
44844070|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44844071|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44844072|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
44844073|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844074|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844075|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44844076|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
44844077|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44844078|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
44844079|NCT04460963|Protective Agents|protective agents|mesh-ancestor
44844080|NCT04425018|Paclitaxel|paclitaxel|mesh-list
44844081|NCT04425018|Trastuzumab|trastuzumab|mesh-list
44844082|NCT04425018|Pertuzumab|pertuzumab|mesh-list
44844083|NCT04425018|Margetuximab|margetuximab|mesh-list
44844084|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44844085|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844086|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844087|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844088|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844089|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844090|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844091|NCT04403243|Colchicine|colchicine|mesh-list
44844092|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
44844093|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844094|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844095|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844096|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844097|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844098|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844100|NCT04397484|Epinephrine|epinephrine|mesh-list
44844101|NCT04397484|Racepinephrine|racepinephrine|mesh-list
44844102|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
44844103|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
44844104|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
44844105|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
44844106|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844107|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844108|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
44330353|NCT00979836|Calcium|calcium|mesh-list
44844109|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844110|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44844111|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44844112|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44844113|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44844114|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844115|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44844116|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44844117|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
44844118|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844119|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44844120|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44844121|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
44844122|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44844123|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
44844124|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
44844125|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
44844126|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44844127|NCT04345146|Bevacizumab|bevacizumab|mesh-list
44844128|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844129|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844130|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44844131|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44844132|NCT04345146|Growth Substances|growth substances|mesh-ancestor
44844133|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844134|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
44844135|NCT04305496|Fulvestrant|fulvestrant|mesh-list
44844136|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844137|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844138|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44844139|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44844140|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
44844141|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844142|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844143|NCT04263909|Sufentanil|sufentanil|mesh-list
44844144|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44844145|NCT04263909|Narcotics|narcotics|mesh-ancestor
44844146|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844147|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844148|NCT04263909|Analgesics|analgesics|mesh-ancestor
44844149|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
44844150|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844151|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44844152|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44844153|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
44844154|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
44844155|NCT04249362|Durvalumab|durvalumab|mesh-list
44844156|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844157|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844158|NCT04239859|Cyclosporine|cyclosporine|mesh-list
44844159|NCT04239859|Methotrexate|methotrexate|mesh-list
44844160|NCT04239859|Acitretin|acitretin|mesh-list
44844161|NCT04239859|Cyclosporins|cyclosporins|mesh-list
44844162|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44844163|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
44844164|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44844165|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844166|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44844167|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
44844168|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844169|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44696913|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
44844170|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
44844171|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844172|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44844173|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844174|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
44844175|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844176|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44844177|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
44844178|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844179|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44844180|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
44844181|NCT04232033|Mitogens|mitogens|mesh-list
44844182|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330412|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844183|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844184|NCT04221945|Cisplatin|cisplatin|mesh-list
44844185|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
44844186|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844187|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844188|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44844189|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44844190|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44844191|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44844192|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844193|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844194|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844195|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44844196|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
44844197|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844198|NCT04177706|Ketamine|ketamine|mesh-list
44844199|NCT04177706|Analgesics|analgesics|mesh-ancestor
44844200|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
44844201|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844202|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844203|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44844204|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44844205|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
44844206|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
44844207|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844208|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44844209|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44844210|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844211|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844212|NCT04177654|Albendazole|albendazole|mesh-list
44844213|NCT04177654|Mebendazole|mebendazole|mesh-list
44844214|NCT04177654|Benzimidazole|benzimidazole|mesh-list
44844215|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
44844216|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44844217|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844218|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
44844219|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44844220|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44844221|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844222|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844223|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844224|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844225|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844226|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
44844227|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
44844228|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844229|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844230|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844231|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844232|NCT04161898|Prednisolone|prednisolone|mesh-list
44844233|NCT04161898|Upadacitinib|upadacitinib|mesh-list
44844234|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844235|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
44844236|NCT04161898|Hormones|hormones|mesh-ancestor
44844237|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844238|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844239|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844240|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844241|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44844242|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844243|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844244|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844245|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844246|NCT04158635|Gemcitabine|gemcitabine|mesh-list
44844247|NCT04158635|Paclitaxel|paclitaxel|mesh-list
44844248|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44844249|NCT04158635|Bosentan|bosentan|mesh-list
44844250|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44844251|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844252|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844253|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844254|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844255|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844256|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44844257|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
44844258|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
44844259|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844260|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844261|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844262|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
44844263|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844264|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44844265|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44844266|NCT04134260|Hormones|hormones|mesh-list
44844267|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844268|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696914|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
44844269|NCT04094012|Isoniazid|isoniazid|mesh-list
44844270|NCT04094012|Rifapentine|rifapentine|mesh-list
44844271|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
44844272|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44844273|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844274|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44844275|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44844276|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
44844277|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844278|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44844279|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44844280|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
44844281|NCT04068272|Bosentan|bosentan|mesh-list
44844282|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44844283|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44844284|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844285|NCT04040231|Nivolumab|nivolumab|mesh-list
44844286|NCT04040231|Sargramostim|sargramostim|mesh-list
44844287|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844288|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844289|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844290|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844291|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
44844292|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844293|NCT03980041|Nivolumab|nivolumab|mesh-list
44844294|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844295|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844296|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844297|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844298|NCT03965923|Tenofovir|tenofovir|mesh-list
44844299|NCT03965923|Emtricitabine|emtricitabine|mesh-list
44844300|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44844301|NCT03965923|Dapivirine|dapivirine|mesh-list
44844302|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
44844303|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844304|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44844305|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44844306|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844307|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844308|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44844309|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44844310|NCT03955887|Dimercaprol|dimercaprol|mesh-list
44844311|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
44844312|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
44844313|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844314|NCT03947827|Minocycline|minocycline|mesh-list
44330551|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
44844315|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44844316|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844317|NCT03900715|Luspatercept|luspatercept|mesh-list
44844318|NCT03900715|Hematinics|hematinics|mesh-ancestor
44844319|NCT03899636|Folfirinox|folfirinox|mesh-list
44844320|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844321|NCT03884101|Paclitaxel|paclitaxel|mesh-list
44844322|NCT03884101|Carboplatin|carboplatin|mesh-list
44844323|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
44844324|NCT03884101|Lenvatinib|lenvatinib|mesh-list
44844325|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44844326|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844327|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844328|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844329|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844330|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844331|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844332|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844333|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844334|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
44844335|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
44844336|NCT03854370|Povidone|povidone|mesh-list
44844337|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44844338|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844339|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
44844340|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
44844341|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
44844342|NCT03797222|Vitamin E|vitamin e|mesh-list
44844343|NCT03797222|Tocopherols|tocopherols|mesh-list
44844344|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
44844345|NCT03797222|Vitamins|vitamins|mesh-ancestor
44844346|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
44844347|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844348|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
44844349|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844350|NCT03797222|Protective Agents|protective agents|mesh-ancestor
44844351|NCT03755102|Osimertinib|osimertinib|mesh-list
44844352|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844353|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330601|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
44844354|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844355|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844356|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
44844357|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
44844358|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844359|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
44844360|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844361|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844362|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44844363|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
44844364|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844365|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844366|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44844367|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844368|NCT03728556|Antibodies|antibodies|mesh-list
44844369|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44844370|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
44844371|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844372|NCT03719430|Doxorubicin|doxorubicin|mesh-list
44844373|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44844374|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844375|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44844376|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44844377|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844378|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844379|NCT03715465|Melatonin|melatonin|mesh-list
44844380|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
44844381|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844382|NCT03715465|Protective Agents|protective agents|mesh-ancestor
44844383|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844384|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844385|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
44844386|NCT03710421|Fludarabine|fludarabine|mesh-list
44844387|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844388|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
44844389|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844390|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844391|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44844392|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
44844393|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844394|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844395|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44844396|NCT03679676|Omalizumab|omalizumab|mesh-list
44844397|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44844398|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44844399|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44844400|NCT03675815|Ritonavir|ritonavir|mesh-list
44844401|NCT03675815|Darunavir|darunavir|mesh-list
44844402|NCT03675815|Tenofovir|tenofovir|mesh-list
44844403|NCT03675815|Lamivudine|lamivudine|mesh-list
44844404|NCT03675815|Emtricitabine|emtricitabine|mesh-list
44844405|NCT03675815|Dolutegravir|dolutegravir|mesh-list
44844406|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44844407|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44844408|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44844409|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
44844410|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844411|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844412|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44844413|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44844414|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
44844415|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844416|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44844417|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44844418|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44844419|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44844420|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44844421|NCT03601078|Lenalidomide|lenalidomide|mesh-list
44844422|NCT03601078|Immunologic Factors|immunologic factors|mesh-ancestor
44844423|NCT03601078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844424|NCT03601078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44844425|NCT03601078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44844426|NCT03601078|Growth Substances|growth substances|mesh-ancestor
44844427|NCT03601078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44844428|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844429|NCT03524092|Mirikizumab|mirikizumab|mesh-list
44844430|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44844431|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844432|NCT03524092|Analgesics|analgesics|mesh-ancestor
44844433|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
44844434|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844435|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844436|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844437|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844438|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44844439|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844440|NCT03517449|Paclitaxel|paclitaxel|mesh-list
44844441|NCT03517449|Doxorubicin|doxorubicin|mesh-list
44844442|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
44844443|NCT03517449|Lenvatinib|lenvatinib|mesh-list
44844444|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44844445|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844446|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844447|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844448|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844449|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844450|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44844451|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44844452|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44844453|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844454|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844455|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844456|NCT03479762|Liraglutide|liraglutide|mesh-list
44844457|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44844458|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844459|NCT03479762|Incretins|incretins|mesh-ancestor
44844460|NCT03479762|Hormones|hormones|mesh-ancestor
44844461|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844462|NCT03434379|Bevacizumab|bevacizumab|mesh-list
44844463|NCT03434379|Sorafenib|sorafenib|mesh-list
44844464|NCT03434379|Atezolizumab|atezolizumab|mesh-list
44844465|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844466|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844467|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44844468|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44844469|NCT03434379|Growth Substances|growth substances|mesh-ancestor
44844470|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844471|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44844472|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844473|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844474|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844475|NCT03420521|Nivolumab|nivolumab|mesh-list
44844476|NCT03420521|Ipilimumab|ipilimumab|mesh-list
44844477|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844478|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844479|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844480|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844481|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
44844482|NCT03399773|Thiotepa|thiotepa|mesh-list
44844483|NCT03399773|Fludarabine|fludarabine|mesh-list
44844484|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844485|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
44844486|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844487|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844488|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44844489|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
44844490|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844491|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844492|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44844493|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44844494|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44844495|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44844496|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844497|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844498|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844499|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44844500|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44844501|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44844502|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
44844503|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844504|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844505|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44844506|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44844507|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
44844508|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44844509|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44844510|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
44844511|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
44844512|NCT03388008|Prednisone|prednisone|mesh-list
44844513|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
44844514|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44844515|NCT03388008|Abatacept|abatacept|mesh-list
44844516|NCT03388008|Tacrolimus|tacrolimus|mesh-list
44844517|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
44844518|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844519|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
44844520|NCT03388008|Hormones|hormones|mesh-ancestor
44844521|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844522|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844523|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844524|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844525|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844526|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
44844527|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44844528|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844529|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844530|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44844531|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44844532|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
44844533|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44844534|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844535|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
44844536|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
44844537|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844538|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844539|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44844540|NCT03388008|Protective Agents|protective agents|mesh-ancestor
44844541|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844542|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844543|NCT03386942|Farletuzumab|farletuzumab|mesh-list
44844544|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844545|NCT03382925|Triamcinolone|triamcinolone|mesh-list
44844546|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44844547|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44844548|NCT03382925|Lidocaine|lidocaine|mesh-list
44844549|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44844550|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
44844551|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
44844552|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844553|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844554|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
44844555|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844556|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44844557|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44844558|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44844559|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44844560|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844561|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844562|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
44844563|NCT03382925|Hormones|hormones|mesh-ancestor
44844564|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844565|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844566|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
44844567|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844568|NCT03382821|Dexamethasone|dexamethasone|mesh-list
44844569|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
44844570|NCT03382821|Triamcinolone|triamcinolone|mesh-list
44844571|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44844572|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44844573|NCT03382821|Lidocaine|lidocaine|mesh-list
44844574|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44844575|NCT03382821|BB 1101|bb 1101|mesh-list
44844576|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44844577|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844578|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
44844579|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
44844580|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844581|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844582|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844583|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
44844584|NCT03382821|Hormones|hormones|mesh-ancestor
44844585|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844586|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844587|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844588|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
44844589|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844590|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844591|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
44844592|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
44844593|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330856|NCT00983021|Insulin|insulin|mesh-list
44844594|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
44844595|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44844596|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44844597|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44844598|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44844599|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844600|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
44844601|NCT03377023|Nivolumab|nivolumab|mesh-list
44844602|NCT03377023|Ipilimumab|ipilimumab|mesh-list
44844603|NCT03377023|Nintedanib|nintedanib|mesh-list
44844604|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844605|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844606|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844607|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844608|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844609|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844610|NCT03370263|Belimumab|belimumab|mesh-list
44844611|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844612|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
44844613|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844614|NCT03344536|Fulvestrant|fulvestrant|mesh-list
44844615|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844616|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844617|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44844618|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44844619|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
44844620|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844621|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844622|NCT03331198|Venetoclax|venetoclax|mesh-list
44844623|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844624|NCT03311828|Daratumumab|daratumumab|mesh-list
44844625|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844626|NCT03298061|Prednisolone|prednisolone|mesh-list
44844627|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844628|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
44844629|NCT03298061|Hormones|hormones|mesh-ancestor
44844630|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844631|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844632|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844633|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844634|NCT03256344|Atezolizumab|atezolizumab|mesh-list
44844635|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44844636|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844637|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628059|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844639|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44844640|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330880|NCT00983047|Docetaxel|docetaxel|mesh-list
44844641|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
44844642|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844643|NCT03180502|Temozolomide|temozolomide|mesh-list
44844644|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44844645|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
44844646|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844647|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844648|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
44844649|NCT03105336|Fludarabine|fludarabine|mesh-list
44844650|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844651|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
44844652|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844653|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844654|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44844655|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
44844656|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844657|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844658|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44844659|NCT03072238|Prednisone|prednisone|mesh-list
44844660|NCT03072238|Prednisolone|prednisolone|mesh-list
44844661|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844662|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
44844663|NCT03072238|Hormones|hormones|mesh-ancestor
44844664|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844665|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844666|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844667|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844668|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
44330915|NCT00983164|Antioxidants|antioxidants|mesh-list
44844669|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44844670|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844671|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844672|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844673|NCT03071185|Analgesics|analgesics|mesh-ancestor
44844674|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
44844675|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844676|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44844677|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44844678|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44844679|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
44844680|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844681|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844682|NCT03070522|Prednisone|prednisone|mesh-list
44844683|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844684|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
44844685|NCT03070522|Hormones|hormones|mesh-ancestor
44696915|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44696916|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
44696917|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
44696918|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696919|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44696920|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44696921|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44696922|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696923|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696924|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696925|NCT01394471|Oxytocin|oxytocin|mesh-list
44696926|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
44696927|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44696928|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696929|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
44696930|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
44696931|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696932|NCT01394497|Expectorants|expectorants|mesh-ancestor
44696933|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
44696934|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44696935|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
44696936|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330953|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
44696937|NCT01394497|Protective Agents|protective agents|mesh-ancestor
44696938|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696939|NCT01394640|Vaccines|vaccines|mesh-list
44696940|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
44628150|NCT00488475|Etanercept|etanercept|mesh-list
44844686|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844687|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844688|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44844689|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844690|NCT02989584|Gemcitabine|gemcitabine|mesh-list
44844691|NCT02989584|Cisplatin|cisplatin|mesh-list
44844692|NCT02989584|Atezolizumab|atezolizumab|mesh-list
44844693|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844694|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44844695|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
44844696|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844697|NCT02989584|Antiviral Agents|antiviral agents|mesh-ancestor
44844698|NCT02989584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844699|NCT02989584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844700|NCT02989584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844701|NCT02989584|Immunologic Factors|immunologic factors|mesh-ancestor
44844702|NCT02989584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844703|NCT02923947|Osimertinib|osimertinib|mesh-list
44844704|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844705|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844706|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844707|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844708|NCT02908685|Risdiplam|risdiplam|mesh-list
44844709|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44844710|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330998|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
44844711|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844712|NCT02812667|Nivolumab|nivolumab|mesh-list
44844713|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844714|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844715|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44844716|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844717|NCT02805504|Bupivacaine|bupivacaine|mesh-list
44844718|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
44844719|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
44844720|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844721|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844722|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
44844723|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844724|NCT02802943|Imiquimod|imiquimod|mesh-list
44844725|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44844726|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
44844727|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844728|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844729|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
44844730|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
44844731|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844732|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844733|NCT02783508|Meperidine|meperidine|mesh-list
44844734|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
44844735|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44844736|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
44844737|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
44844738|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844739|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844740|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844741|NCT02783508|Analgesics|analgesics|mesh-ancestor
44844742|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
44844743|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844744|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44844745|NCT02783508|Narcotics|narcotics|mesh-ancestor
44844746|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44844747|NCT02773355|Liraglutide|liraglutide|mesh-list
44844748|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44844749|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844750|NCT02773355|Incretins|incretins|mesh-ancestor
44844751|NCT02773355|Hormones|hormones|mesh-ancestor
44844752|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44844753|NCT02744183|Benzocaine|benzocaine|mesh-list
44844754|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
44844755|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
44331060|NCT00983944|Hormones|hormones|mesh-ancestor
44844756|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844757|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844758|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
44844759|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844760|NCT02713607|Doxycycline|doxycycline|mesh-list
44844761|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44844762|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844763|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
44844764|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44844765|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44844766|NCT02681549|Bevacizumab|bevacizumab|mesh-list
44844767|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
44844768|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844769|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844770|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44844771|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44844772|NCT02681549|Growth Substances|growth substances|mesh-ancestor
44844773|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844774|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
44844775|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
44844776|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844777|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844778|NCT02617277|Durvalumab|durvalumab|mesh-list
44844779|NCT02617277|Adavosertib|adavosertib|mesh-list
44844780|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844781|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844782|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844783|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844784|NCT02503774|Durvalumab|durvalumab|mesh-list
44331067|NCT00983996|Alendronate|alendronate|mesh-list
44844785|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844786|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844787|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
44844788|NCT02403505|Paraproteins|paraproteins|mesh-list
44844789|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
44844790|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
44844791|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844792|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44844793|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
44844794|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44844795|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44844796|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844797|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
44844798|NCT02253810|Coagulants|coagulants|mesh-ancestor
44844799|NCT02094261|Osimertinib|osimertinib|mesh-list
44844800|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844801|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44844802|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844803|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844804|NCT02032823|Olaparib|olaparib|mesh-list
44844805|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44844806|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844807|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844808|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844809|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
44844810|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844811|NCT01950403|Linaclotide|linaclotide|mesh-list
44844812|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44844813|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
44844814|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844815|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844816|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44844817|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
44844818|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844819|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44844820|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44844821|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844822|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844823|NCT01776424|Aspirin|aspirin|mesh-list
44844824|NCT01776424|Pantoprazole|pantoprazole|mesh-list
44844825|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
44844826|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44844827|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844828|NCT01776424|Analgesics|analgesics|mesh-ancestor
44844829|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
44844830|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844831|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844832|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844833|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844834|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44844835|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44628258|NCT00487084|Lidocaine|lidocaine|mesh-list
44844836|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844837|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44844838|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44844839|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844840|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
44844841|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44844842|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
44844843|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44844844|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44844845|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
44844846|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44844847|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844848|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44844850|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844851|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44844852|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44844853|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44844854|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844855|NCT01233297|Azithromycin|azithromycin|mesh-list
44844856|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44844857|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844858|NCT01179009|Clonidine|clonidine|mesh-list
44844859|NCT01179009|Scopolamine|scopolamine|mesh-list
44844860|NCT01179009|Ketamine|ketamine|mesh-list
44844861|NCT01179009|Lorazepam|lorazepam|mesh-list
44844862|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44844863|NCT01179009|Analgesics|analgesics|mesh-ancestor
44844864|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
44844865|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844866|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844867|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44844868|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44844869|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
44844870|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
44844871|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44844872|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44844873|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44844874|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44844875|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844876|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44844877|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
44844878|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
44844879|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44844880|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44844881|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44844882|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44844883|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
44844884|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
44844885|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844886|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44844887|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44844888|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44844889|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44844890|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
44844891|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
44844892|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44844893|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
44844894|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44844895|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
44844896|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44844897|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
44844898|NCT00873275|Leucovorin|leucovorin|mesh-list
44844899|NCT00873275|Bevacizumab|bevacizumab|mesh-list
44844900|NCT00873275|Fluorouracil|fluorouracil|mesh-list
44844901|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
44844902|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44844903|NCT00873275|Calcium|calcium|mesh-list
44844904|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
44844905|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44844906|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844907|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44844908|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44844909|NCT00873275|Growth Substances|growth substances|mesh-ancestor
44844910|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844911|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44844912|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44844913|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
44844914|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844915|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44844916|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844917|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
44844919|NCT00873275|Protective Agents|protective agents|mesh-ancestor
44844920|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
44844921|NCT00873275|Vitamins|vitamins|mesh-ancestor
44844922|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
44844923|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44844924|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44844925|NCT00805129|Everolimus|everolimus|mesh-list
44844926|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44844927|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44844928|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
44844929|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844930|NCT00799864|Tenofovir|tenofovir|mesh-list
44844931|NCT00799864|Lamivudine|lamivudine|mesh-list
44844932|NCT00799864|Zidovudine|zidovudine|mesh-list
44844933|NCT00799864|Emtricitabine|emtricitabine|mesh-list
44844934|NCT00799864|Abacavir|abacavir|mesh-list
44844935|NCT00799864|Rilpivirine|rilpivirine|mesh-list
44844936|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
44844937|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844938|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44844939|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44844940|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44844941|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844942|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44844943|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44844944|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
44844945|NCT02273570|Vitamin D|vitamin d|mesh-list
44844946|NCT02273570|Calcium|calcium|mesh-list
44844947|NCT02273570|Vitamins|vitamins|mesh-ancestor
44844948|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
44844949|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844950|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44844951|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44844952|NCT02273609|Vitamin K|vitamin k|mesh-list
44844953|NCT02273609|Warfarin|warfarin|mesh-list
44844954|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
44844955|NCT02273609|Vitamins|vitamins|mesh-ancestor
44844956|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
44844957|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844958|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
44844959|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44844960|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44844961|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844962|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
44844963|NCT02273609|Coagulants|coagulants|mesh-ancestor
44844964|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44844965|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844966|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
44844967|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44844968|NCT02273622|Protective Agents|protective agents|mesh-ancestor
44844969|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844970|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44844971|NCT02273635|Andrographolide|andrographolide|mesh-list
44844972|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44844973|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44844974|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44844975|NCT02273635|Analgesics|analgesics|mesh-ancestor
44844976|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
44844977|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44844978|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844979|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44844980|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44844981|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44844982|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44844983|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
44844984|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44844985|NCT02273804|Topiramate|topiramate|mesh-list
44844986|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
44844987|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628419|NCT00485472|Lacosamide|lacosamide|mesh-list
44844988|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844989|NCT02273843|Vitamin D|vitamin d|mesh-list
44844990|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
44844991|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
44844992|NCT02273843|Vitamins|vitamins|mesh-list
44844993|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
44844994|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44844995|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44844996|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44844997|NCT02273895|Scopolamine|scopolamine|mesh-list
44844998|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44844999|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44845000|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
44845001|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
44845002|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845003|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845004|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845005|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
44845006|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44845007|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
44845008|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845009|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845010|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44845011|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
44845012|NCT02274077|Bupivacaine|bupivacaine|mesh-list
44845013|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845014|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
44845015|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845016|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845017|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
44845018|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845019|NCT02274142|Methamphetamine|methamphetamine|mesh-list
44845020|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44845021|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845022|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
44845023|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
44845024|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845025|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
44845026|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845027|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845028|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
44845029|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44845030|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44845031|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845032|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44845033|NCT02274259|Ranibizumab|ranibizumab|mesh-list
44845034|NCT02274259|Aflibercept|aflibercept|mesh-list
44845035|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845036|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845037|NCT02274259|Growth Substances|growth substances|mesh-ancestor
44845038|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845039|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845040|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845041|NCT02276014|Beta Carotene|beta carotene|mesh-list
44845042|NCT02276014|Carotenoids|carotenoids|mesh-list
44845043|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
44845044|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845045|NCT02276014|Protective Agents|protective agents|mesh-ancestor
44845046|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845047|NCT02276014|Provitamins|provitamins|mesh-ancestor
44845048|NCT02276014|Vitamins|vitamins|mesh-ancestor
44845049|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
44845050|NCT02276495|Ketorolac|ketorolac|mesh-list
44845051|NCT02276495|Clonidine|clonidine|mesh-list
44845052|NCT02276495|Epinephrine|epinephrine|mesh-list
44845053|NCT02276495|Ropivacaine|ropivacaine|mesh-list
44845054|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845055|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
44845056|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845057|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845058|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
44845059|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845060|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44845061|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44845062|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
44845063|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845064|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845065|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44845066|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44845067|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
44845068|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44845069|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
44845070|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
44845071|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
44845072|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44331344|NCT00985777|Vitamin E|vitamin e|mesh-list
44845073|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845074|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845075|NCT02276495|Analgesics|analgesics|mesh-ancestor
44845076|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845077|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845078|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44845079|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845080|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44845081|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
44845082|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44845083|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
44845084|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44845085|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44845086|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44845087|NCT02277587|Cortisone|cortisone|mesh-list
44845088|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
44845089|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845090|NCT02277587|Hormones|hormones|mesh-ancestor
44845091|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845092|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845093|NCT02277808|Amikacin|amikacin|mesh-list
44845094|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845095|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845096|NCT02277847|Cytarabine|cytarabine|mesh-list
44845097|NCT02277847|Idarubicin|idarubicin|mesh-list
44845098|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845099|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
44845100|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845101|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845102|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
44845103|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845104|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845105|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
44845106|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845107|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44845108|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44845109|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44845110|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845111|NCT02277938|Amantadine|amantadine|mesh-list
44845112|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44845113|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44845114|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
44845115|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845116|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
44845117|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845118|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845119|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845120|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845121|NCT02277938|Analgesics|analgesics|mesh-ancestor
44845122|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
44845123|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845124|NCT02278692|Vitamin K|vitamin k|mesh-list
44845125|NCT02278692|Vitamins|vitamins|mesh-ancestor
44845126|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
44845127|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845128|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44845129|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44845130|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845131|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
44845132|NCT02278692|Coagulants|coagulants|mesh-ancestor
44845133|NCT02279537|Aflibercept|aflibercept|mesh-list
44845134|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845135|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845136|NCT02279537|Growth Substances|growth substances|mesh-ancestor
44845137|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845138|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845139|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845140|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44845141|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
44845142|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845143|NCT02279953|Vortioxetine|vortioxetine|mesh-list
44845144|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
44845145|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845146|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44845147|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44845148|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845149|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845150|NCT02279953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44845151|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44845152|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845153|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845154|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845155|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
44845156|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44845157|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44845158|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44845159|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44845160|NCT02280031|Aspirin|aspirin|mesh-list
44845161|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845162|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845163|NCT02280031|Analgesics|analgesics|mesh-ancestor
44845164|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
44845165|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845166|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845167|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845168|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845169|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44845170|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44845171|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845172|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44845173|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44845174|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845175|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
44845176|NCT02280057|Metformin|metformin|mesh-list
44845177|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44845178|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845179|NCT02280070|Leucovorin|leucovorin|mesh-list
44845180|NCT02280070|Fluorouracil|fluorouracil|mesh-list
44845181|NCT02280070|Tegafur|tegafur|mesh-list
44845182|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
44845183|NCT02280070|Antibodies|antibodies|mesh-list
44845184|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
44845185|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44845186|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
44845187|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845188|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
44845189|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845190|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845191|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845192|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845193|NCT02280070|Antidotes|antidotes|mesh-ancestor
44845194|NCT02280070|Protective Agents|protective agents|mesh-ancestor
44845195|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
44845196|NCT02280070|Vitamins|vitamins|mesh-ancestor
44845197|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
44845198|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
44845199|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44845200|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44845201|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44845202|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845203|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845204|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
44845205|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845206|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845207|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44845208|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845209|NCT02280109|Tenofovir|tenofovir|mesh-list
44845210|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
44845211|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845212|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44845213|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44845214|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845215|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845216|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44845217|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44845218|NCT02280148|Propofol|propofol|mesh-list
44845219|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
44845220|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331484|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845221|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845222|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44845223|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44845224|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
44845225|NCT02280174|Linagliptin|linagliptin|mesh-list
44845226|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44845227|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845228|NCT02280174|Incretins|incretins|mesh-ancestor
44845229|NCT02280174|Hormones|hormones|mesh-ancestor
44845230|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845231|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44845232|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
44845233|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845234|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845235|NCT02280265|Factor VIII|factor viii|mesh-list
44845236|NCT02280265|Coagulants|coagulants|mesh-ancestor
44845237|NCT02280447|Vaccines|vaccines|mesh-list
44845238|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
44845239|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845240|NCT02280486|Glimepiride|glimepiride|mesh-list
44845241|NCT02280486|Saxagliptin|saxagliptin|mesh-list
44845242|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44845243|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44845244|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845245|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845246|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
44845247|NCT02280486|Incretins|incretins|mesh-ancestor
44845248|NCT02280486|Hormones|hormones|mesh-ancestor
44845249|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845250|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44845251|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
44845252|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845253|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845254|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
44845255|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44845256|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
44845257|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845258|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
44845259|NCT02280538|Protective Agents|protective agents|mesh-ancestor
44331555|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845260|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44845261|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44845262|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44845263|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
44845264|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845265|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44845266|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44845267|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845268|NCT02280603|Minoxidil|minoxidil|mesh-list
44845269|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44845270|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
44845272|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845273|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44845274|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
44845275|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845276|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845277|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44845278|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
44845279|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
44845280|NCT02280616|Hormones|hormones|mesh-ancestor
44845281|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845282|NCT02280629|Mesalamine|mesalamine|mesh-list
44845283|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845284|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845285|NCT02280629|Analgesics|analgesics|mesh-ancestor
44845286|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
44845287|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331582|NCT00987207|Cyclosporine|cyclosporine|mesh-list
44845288|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845289|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845290|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845291|NCT02280694|Celecoxib|celecoxib|mesh-list
44845292|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
44845293|NCT02280694|Capecitabine|capecitabine|mesh-list
44845294|NCT02280694|Methotrexate|methotrexate|mesh-list
44845295|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845296|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
44845297|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845298|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845299|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44845300|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
44845301|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845302|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845303|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44845304|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845305|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
44845306|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44845307|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
44845308|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44845309|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
44845310|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845311|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44845312|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44845313|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845314|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845315|NCT02280694|Analgesics|analgesics|mesh-ancestor
44845316|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
44845317|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845318|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845319|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44845320|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44845321|NCT02280720|Tryptophan|tryptophan|mesh-list
44845322|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44845323|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
44845324|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845325|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44845326|NCT02280772|Cathartics|cathartics|mesh-ancestor
44845327|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845328|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44845329|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44845330|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845331|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
44845332|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
44845333|NCT02280876|Andrographolide|andrographolide|mesh-list
44845334|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845335|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845336|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845337|NCT02280876|Analgesics|analgesics|mesh-ancestor
44845338|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
44845339|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845340|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845341|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845342|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44845343|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44845344|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845345|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
44845346|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44845347|NCT02280993|Dexamethasone|dexamethasone|mesh-list
44845348|NCT02280993|Cisplatin|cisplatin|mesh-list
44845349|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44845350|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845351|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
44845352|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
44845353|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845354|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845355|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845356|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
44845357|NCT02280993|Hormones|hormones|mesh-ancestor
44845358|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845359|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44845360|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845361|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44845362|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
44845363|NCT02281006|Antidotes|antidotes|mesh-ancestor
44845364|NCT02281006|Protective Agents|protective agents|mesh-ancestor
44845365|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845366|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
44845367|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845368|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
44845369|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845370|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845371|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
44845372|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
44845373|NCT02281045|Citric Acid|citric acid|mesh-list
44845374|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
44845375|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
44845376|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44845377|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
44845378|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
44845379|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845380|NCT02281058|Abatacept|abatacept|mesh-list
44845381|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44845382|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845383|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845384|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845385|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
44845386|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845387|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845389|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
44845390|NCT02281201|Coagulants|coagulants|mesh-ancestor
44845391|NCT02281240|Oprelvekin|oprelvekin|mesh-list
44845392|NCT02281240|Heparin|heparin|mesh-list
44845393|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
44845394|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44845395|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44845396|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845397|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845398|NCT02281266|Entecavir|entecavir|mesh-list
44845399|NCT02281266|Thymalfasin|thymalfasin|mesh-list
44331668|NCT00987662|Amlodipine|amlodipine|mesh-list
44845400|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
44845401|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845402|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44845403|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
44845404|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845405|NCT02281279|Rituximab|rituximab|mesh-list
44845406|NCT02281279|Lenalidomide|lenalidomide|mesh-list
44845407|NCT02281279|Romidepsin|romidepsin|mesh-list
44845408|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44845409|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845410|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
44845411|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845412|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845413|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845414|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845415|NCT02281279|Growth Substances|growth substances|mesh-ancestor
44845416|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845417|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44845418|NCT02281292|Ranibizumab|ranibizumab|mesh-list
44845419|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44845420|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44845421|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845422|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845423|NCT02281292|Growth Substances|growth substances|mesh-ancestor
44845424|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845425|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845426|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845427|NCT02281305|Colchicine|colchicine|mesh-list
44845428|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
44845429|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845430|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845431|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845432|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845433|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331692|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44845434|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845435|NCT02281370|Cyclosporine|cyclosporine|mesh-list
44845436|NCT02281370|Cyclosporins|cyclosporins|mesh-list
44845437|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845438|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845439|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845440|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
44845441|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845442|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
44845443|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845444|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
44845445|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845446|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44845447|NCT02281396|Vaccines|vaccines|mesh-list
44845448|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
44696941|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696942|NCT01394653|Ramosetron|ramosetron|mesh-list
44696943|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
44696944|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
44696945|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696946|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696947|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44696948|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44696949|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
44696950|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44696951|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696952|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
44696953|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696954|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
44845449|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845450|NCT02281643|Doxycycline|doxycycline|mesh-list
44845451|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845452|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845454|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44845455|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44845456|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44845457|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44845458|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44845459|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845460|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
44845461|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44845462|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
44845463|NCT02281682|Fluorouracil|fluorouracil|mesh-list
44845464|NCT02281682|Imiquimod|imiquimod|mesh-list
44845465|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44845466|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
44845467|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331724|NCT00987844|Prucalopride|prucalopride|mesh-list
44845468|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845469|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845470|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845471|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
44845472|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845473|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44845474|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
44845475|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44845476|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
44845477|NCT02281708|Cisplatin|cisplatin|mesh-list
44845478|NCT02281708|Vinorelbine|vinorelbine|mesh-list
44845479|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845480|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44845481|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845482|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845483|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845484|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845485|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
44845486|NCT02281721|Antacids|antacids|mesh-ancestor
44845487|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845488|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845489|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
44845490|NCT02281799|Azathioprine|azathioprine|mesh-list
44845491|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
44845492|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845493|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845494|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845495|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845496|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
44845497|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845498|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44845499|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845500|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845501|NCT02281929|Amoxicillin|amoxicillin|mesh-list
44845502|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
44845503|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
44845504|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44845505|NCT02281929|Prednisolone|prednisolone|mesh-list
44845506|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845507|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845508|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845509|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
44845510|NCT02281929|Hormones|hormones|mesh-ancestor
44845511|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845512|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845513|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44845514|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845515|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845516|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845517|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44845518|NCT02281968|Naproxen|naproxen|mesh-list
44845519|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44845520|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845521|NCT02281968|Analgesics|analgesics|mesh-ancestor
44845522|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
44845523|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845524|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845525|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44696955|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
44845526|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845527|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
44845528|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44845529|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845530|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845531|NCT02282085|Olanzapine|olanzapine|mesh-list
44845532|NCT02282085|Risperidone|risperidone|mesh-list
44845533|NCT02282085|Aripiprazole|aripiprazole|mesh-list
44845534|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44845535|NCT02282085|Ziprasidone|ziprasidone|mesh-list
44845536|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
44845537|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44845538|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44845539|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
44845540|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845541|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845542|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845543|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44845544|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845545|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845546|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44845547|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
44845548|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
44845549|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
44845550|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845551|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845552|NCT02282085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44845553|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44845554|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845555|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44845556|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
44845557|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44845558|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44845559|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44845560|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44845561|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44845562|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44845563|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44845564|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44845565|NCT02282098|Colchicine|colchicine|mesh-list
44845566|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
44845567|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44845568|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845569|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845570|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845571|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845572|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845573|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44845574|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44845575|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845576|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
44845577|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44845578|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44845579|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44845580|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845581|NCT02282176|Azithromycin|azithromycin|mesh-list
44845582|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845583|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331890|NCT00988806|Simendan|simendan|mesh-list
44845584|NCT02282241|Melatonin|melatonin|mesh-list
44845585|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
44845586|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845587|NCT02282241|Protective Agents|protective agents|mesh-ancestor
44845588|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845589|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845590|NCT02282267|Gefitinib|gefitinib|mesh-list
44845591|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845592|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44845593|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845594|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845595|NCT02282280|Prilocaine|prilocaine|mesh-list
44845596|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845597|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
44845598|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845599|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845600|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
44845601|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845602|NCT02282371|Cetuximab|cetuximab|mesh-list
44845603|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44845604|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845605|NCT02282384|Oseltamivir|oseltamivir|mesh-list
44845606|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
44845607|NCT02282384|Antacids|antacids|mesh-ancestor
44845608|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845609|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845610|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
44845611|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845612|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845613|NCT02282410|Factor VIII|factor viii|mesh-list
44845614|NCT02282410|Coagulants|coagulants|mesh-ancestor
44845615|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44845616|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44845617|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845618|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845619|NCT02282683|Prednisone|prednisone|mesh-list
44845620|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845621|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
44845622|NCT02282683|Hormones|hormones|mesh-ancestor
44845623|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845624|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845625|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44845626|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845627|NCT02282709|Asunaprevir|asunaprevir|mesh-list
44845628|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
44845629|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845630|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845631|NCT02282774|Lidocaine|lidocaine|mesh-list
44845632|NCT02282774|Bupivacaine|bupivacaine|mesh-list
44845633|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845634|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
44845635|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845636|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845637|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
44845638|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845639|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44845640|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44845641|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44845642|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845643|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845644|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
44845645|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44845646|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845647|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845648|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845649|NCT02282787|Analgesics|analgesics|mesh-ancestor
44845650|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
44845651|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845652|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44845653|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44845654|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44845655|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44845656|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845657|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845658|NCT02282800|Vitamin D|vitamin d|mesh-list
44845659|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44845660|NCT02282800|Vitamins|vitamins|mesh-ancestor
44845661|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
44845662|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845663|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44845664|NCT02282826|Acyclovir|acyclovir|mesh-list
44845665|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
44845666|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845667|NCT02282891|Ketamine|ketamine|mesh-list
44845668|NCT02282891|Propofol|propofol|mesh-list
44845669|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44845670|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845671|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845672|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44845673|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
44845674|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
44845675|NCT02282891|Analgesics|analgesics|mesh-ancestor
44845676|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
44845677|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845678|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44845679|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44845680|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44845682|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845683|NCT02282956|Droperidol|droperidol|mesh-list
44845684|NCT02282956|Morphine|morphine|mesh-list
44845685|NCT02282956|Ropivacaine|ropivacaine|mesh-list
44845686|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44845687|NCT02282956|Narcotics|narcotics|mesh-ancestor
44845688|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845689|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845690|NCT02282956|Analgesics|analgesics|mesh-ancestor
44845691|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
44845692|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845693|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845694|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
44845695|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44845696|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
44845697|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
44845698|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845699|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44845700|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44845701|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845702|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44845703|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44845704|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
44845705|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845706|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845707|NCT02283060|Tenofovir|tenofovir|mesh-list
44845708|NCT02283060|Emtricitabine|emtricitabine|mesh-list
44845709|NCT02283060|Efavirenz|efavirenz|mesh-list
44845710|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44845711|NCT02283060|Cobicistat|cobicistat|mesh-list
44845712|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44845713|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44845714|NCT02283060|Elvitegravir|elvitegravir|mesh-list
44845715|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
44845716|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845717|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44845718|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44845719|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845720|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845721|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44845722|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44845723|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44845724|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44845725|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44845726|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44845727|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44845728|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44845729|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44845730|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44845731|NCT02283177|Cytarabine|cytarabine|mesh-list
44845732|NCT02283177|Daunorubicin|daunorubicin|mesh-list
44845733|NCT02283177|Idarubicin|idarubicin|mesh-list
44845734|NCT02283177|Crenolanib|crenolanib|mesh-list
44845735|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845736|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
44845737|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845738|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845739|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
44845740|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845741|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845742|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
44845743|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845744|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44845745|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44845746|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44845747|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845748|NCT02283190|Asparaginase|asparaginase|mesh-list
44845749|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845750|NCT02283203|Acetaminophen|acetaminophen|mesh-list
44845751|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44845752|NCT02283203|Analgesics|analgesics|mesh-ancestor
44845753|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
44845754|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845755|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845756|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
44845757|NCT02283242|Galantamine|galantamine|mesh-list
44845758|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44845759|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845760|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845761|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
44845762|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845763|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845764|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44845765|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
44845766|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845767|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
44845768|NCT02283320|Docetaxel|docetaxel|mesh-list
44845769|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845770|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845771|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845772|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845773|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845774|NCT02283359|Irinotecan|irinotecan|mesh-list
44845775|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44845776|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44845777|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845778|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629301|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44845779|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845780|NCT02283372|Gemcitabine|gemcitabine|mesh-list
44845781|NCT02283372|Paclitaxel|paclitaxel|mesh-list
44845782|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44845783|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44845784|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845785|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845786|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845787|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845788|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845789|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845790|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
44845791|NCT02283372|Antiviral Agents|antiviral agents|mesh-ancestor
44845792|NCT02283372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845793|NCT02283372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845794|NCT02283372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845795|NCT02283372|Immunologic Factors|immunologic factors|mesh-ancestor
44845796|NCT02283372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845797|NCT02283424|Carboplatin|carboplatin|mesh-list
44845798|NCT02283424|Docetaxel|docetaxel|mesh-list
44845799|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845800|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845801|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845802|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845803|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845804|NCT02283476|Gemcitabine|gemcitabine|mesh-list
44845805|NCT02283476|Cisplatin|cisplatin|mesh-list
44845806|NCT02283476|Endostar protein|endostar protein|mesh-list
44845807|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845808|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44845809|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
44845810|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845811|NCT02283476|Antiviral Agents|antiviral agents|mesh-ancestor
44845812|NCT02283476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845813|NCT02283476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845814|NCT02283476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44845815|NCT02283476|Immunologic Factors|immunologic factors|mesh-ancestor
44845816|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845817|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845818|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845819|NCT02283476|Growth Substances|growth substances|mesh-ancestor
44845820|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845821|NCT02283489|Paclitaxel|paclitaxel|mesh-list
44845822|NCT02283489|Cisplatin|cisplatin|mesh-list
44845823|NCT02283489|Endostatins|endostatins|mesh-list
44845824|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44845825|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845826|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44845827|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44845828|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44845829|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845830|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845831|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845832|NCT02283489|Growth Substances|growth substances|mesh-ancestor
44845833|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845834|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845835|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44845836|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44845837|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44845838|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
44845839|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845840|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44845841|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44845842|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845843|NCT02283554|Metformin|metformin|mesh-list
44845844|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332124|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44845845|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845846|NCT02283645|Minoxidil|minoxidil|mesh-list
44845847|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44845848|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
44845849|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
44845850|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44845851|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845852|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845853|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44845854|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44845856|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845857|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
44845858|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44845859|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
44845860|NCT02283775|Dexamethasone|dexamethasone|mesh-list
44845861|NCT02283775|Pomalidomide|pomalidomide|mesh-list
44845862|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44845863|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
44845864|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
44845865|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845866|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845867|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44845868|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
44845869|NCT02283775|Hormones|hormones|mesh-ancestor
44845870|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845871|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44845872|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44845873|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
44845874|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44845875|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44845876|NCT02283775|Growth Substances|growth substances|mesh-ancestor
44845877|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44845878|NCT02283801|Lamotrigine|lamotrigine|mesh-list
44845879|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44845880|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
44845881|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44845882|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845883|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845884|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44845885|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845886|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44845887|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44845888|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845889|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845890|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44845891|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44845892|NCT02283866|Desflurane|desflurane|mesh-list
44845893|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44845894|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
44845895|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
44845896|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845897|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845898|NCT02283905|Voriconazole|voriconazole|mesh-list
44845899|NCT02283905|Amphotericin B|amphotericin b|mesh-list
44845900|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44845901|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
44845902|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845903|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44845904|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44845905|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845906|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845907|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44845908|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
44845909|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845910|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845911|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44845912|NCT02283905|Amebicides|amebicides|mesh-ancestor
44845913|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44845914|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44845915|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44845916|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
44845917|NCT02284035|Lamivudine|lamivudine|mesh-list
44845918|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44845919|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44845920|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
44845921|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44845922|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44845923|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44845924|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845925|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845926|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44629448|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
44629449|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
44845927|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44845929|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44845930|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44845931|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44845932|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44845933|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
44845934|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332244|NCT00990418|Analgesics|analgesics|mesh-ancestor
44845935|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845936|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845937|NCT02284204|Midazolam|midazolam|mesh-list
44845938|NCT02284204|Ketamine|ketamine|mesh-list
44845939|NCT02284204|Sevoflurane|sevoflurane|mesh-list
44845940|NCT02284204|Analgesics|analgesics|mesh-ancestor
44845941|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
44845942|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845943|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845944|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44845945|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44845946|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
44845947|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
44845948|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845949|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44845950|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44845951|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845952|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845953|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44845954|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44845955|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44845956|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44845957|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44845958|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
44845959|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
44845960|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44845961|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44845962|NCT02284230|Liraglutide|liraglutide|mesh-list
44845963|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44845964|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845965|NCT02284230|Incretins|incretins|mesh-ancestor
44845966|NCT02284230|Hormones|hormones|mesh-ancestor
44845967|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44845968|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44845969|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845970|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44845971|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845972|NCT02284282|Lidocaine|lidocaine|mesh-list
44845973|NCT02284282|Morphine|morphine|mesh-list
44845974|NCT02284282|Bupivacaine|bupivacaine|mesh-list
44845975|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
44845976|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
44845977|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44845978|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845979|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
44845980|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845981|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44845982|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44845983|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44845984|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44845985|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845986|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44845987|NCT02284282|Narcotics|narcotics|mesh-ancestor
44845988|NCT02284282|Analgesics|analgesics|mesh-ancestor
44845989|NCT02284412|Neostigmine|neostigmine|mesh-list
44845990|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44845991|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44845992|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44845993|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
44845994|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44845995|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44845996|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44845997|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
44845998|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44845999|NCT02284490|Pemetrexed|pemetrexed|mesh-list
44629537|NCT00467142|Antidotes|antidotes|mesh-ancestor
44846000|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846001|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846002|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846003|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44846004|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846005|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44846006|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44846007|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44846008|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
44846009|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846010|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846011|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44846012|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846013|NCT02284529|Leucovorin|leucovorin|mesh-list
44846014|NCT02284529|Fluorouracil|fluorouracil|mesh-list
44846015|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
44846016|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846017|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44846018|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846019|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846020|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
44846021|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846022|NCT02284529|Antidotes|antidotes|mesh-ancestor
44846023|NCT02284529|Protective Agents|protective agents|mesh-ancestor
44846024|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
44846025|NCT02284529|Vitamins|vitamins|mesh-ancestor
44846026|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
44846027|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
44846028|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44846029|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846030|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846031|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846032|NCT02284672|Analgesics|analgesics|mesh-ancestor
44846033|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
44846034|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846035|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44332314|NCT00990691|Desipramine|desipramine|mesh-list
44846036|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44846037|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44846038|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
44846039|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846040|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846041|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
44846042|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
44846043|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44846044|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44846045|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846046|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846047|NCT02284737|Urological Agents|urological agents|mesh-ancestor
44846048|NCT02284984|Rituximab|rituximab|mesh-list
44846049|NCT02284984|Belimumab|belimumab|mesh-list
44846050|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44846051|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846052|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
44846053|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846054|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846055|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846056|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44846057|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
44846058|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846059|NCT02285075|Temocillin|temocillin|mesh-list
44846060|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44846061|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846062|NCT02285101|BCT-100|bct-100|mesh-list
44846063|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846064|NCT02285309|Enoximone|enoximone|mesh-list
44846065|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44332344|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846066|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
44846067|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44846068|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44846069|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846070|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846071|NCT02285309|Protective Agents|protective agents|mesh-ancestor
44846072|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846073|NCT02285374|Tenofovir|tenofovir|mesh-list
44846074|NCT02285374|Emtricitabine|emtricitabine|mesh-list
44846075|NCT02285374|Efavirenz|efavirenz|mesh-list
44846076|NCT02285374|Dolutegravir|dolutegravir|mesh-list
44846077|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44846078|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
44846079|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846080|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44846081|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846082|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846083|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846084|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44846085|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44846086|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44846087|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846088|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44846089|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44846090|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44846091|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44846092|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44846093|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44846094|NCT02285413|Cisplatin|cisplatin|mesh-list
44846095|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846096|NCT02285491|Bupivacaine|bupivacaine|mesh-list
44846097|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
44846098|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
44846099|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846100|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846101|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
44846102|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846103|NCT02285647|Rolapitant|rolapitant|mesh-list
44846104|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44846105|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332387|NCT00990990|Linezolid|linezolid|mesh-list
44846106|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846107|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846108|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
44846109|NCT02285699|Citalopram|citalopram|mesh-list
44846110|NCT02285699|Fluoxetine|fluoxetine|mesh-list
44846111|NCT02285699|Paroxetine|paroxetine|mesh-list
44846112|NCT02285699|Sertraline|sertraline|mesh-list
44846113|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44846114|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846115|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846116|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846117|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846118|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
44846119|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846120|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44846121|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
44846122|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846123|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44846124|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846125|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846126|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44846127|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44846128|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846129|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44846130|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44846131|NCT02285738|Aspirin|aspirin|mesh-list
44846132|NCT02285738|Simvastatin|simvastatin|mesh-list
44846133|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846134|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846135|NCT02285738|Analgesics|analgesics|mesh-ancestor
44846136|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
44846137|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846138|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846139|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846140|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846141|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44846142|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44846143|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846144|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44846145|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846146|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846147|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
44846148|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44846149|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44846150|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
44846151|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846152|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44846153|NCT02285751|Aspirin|aspirin|mesh-list
44846154|NCT02285751|Clopidogrel|clopidogrel|mesh-list
44846155|NCT02285751|Ticagrelor|ticagrelor|mesh-list
44846156|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44846157|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846158|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846159|NCT02285751|Analgesics|analgesics|mesh-ancestor
44846160|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
44846161|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846162|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846163|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846164|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332458|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44846165|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44846166|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44846167|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846168|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44846169|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846170|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846171|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
44846172|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44846173|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44846174|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44846175|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
44696956|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44696957|NCT01394731|Acetaminophen|acetaminophen|mesh-list
44696958|NCT01394731|Meperidine|meperidine|mesh-list
44696959|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44696960|NCT01394731|Analgesics|analgesics|mesh-ancestor
44696961|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
44696962|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696963|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696964|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
44696965|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44696966|NCT01394731|Narcotics|narcotics|mesh-ancestor
44696967|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696968|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44696969|NCT01394757|Ketamine|ketamine|mesh-list
44696970|NCT01394757|Esketamine|esketamine|mesh-list
44696971|NCT01394757|Analgesics|analgesics|mesh-ancestor
44696972|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
44696973|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44696974|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696975|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44696976|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846176|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846177|NCT02285829|Bromides|bromides|mesh-list
44846178|NCT02285829|Rocuronium|rocuronium|mesh-list
44846179|NCT02285829|Cisatracurium|cisatracurium|mesh-list
44846180|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
44846181|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44846182|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44846183|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44846184|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846185|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846186|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44846187|NCT02285972|Tenoxicam|tenoxicam|mesh-list
44846188|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846189|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846190|NCT02285972|Analgesics|analgesics|mesh-ancestor
44846191|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
44332475|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
44846192|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846193|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846194|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846195|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846196|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846197|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846198|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846199|NCT02285985|Saxagliptin|saxagliptin|mesh-list
44846200|NCT02285985|Incretins|incretins|mesh-ancestor
44846201|NCT02285985|Hormones|hormones|mesh-ancestor
44846202|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846203|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846204|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44846205|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846206|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846207|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846208|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44846209|NCT02286206|Clozapine|clozapine|mesh-list
44846210|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44846211|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
44846212|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846213|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846214|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846215|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44846216|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44846217|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846218|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846219|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
44846220|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
44846221|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
44846222|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
44846223|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
44846224|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846225|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
44846226|NCT02286258|Edetic Acid|edetic acid|mesh-list
44846227|NCT02286258|Calcium|calcium|mesh-list
44846228|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44846229|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846230|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44846231|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
44846232|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
44846233|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846234|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
44846235|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44846236|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44846237|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846238|NCT02286453|Diclofenac|diclofenac|mesh-list
44846239|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846240|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846241|NCT02286453|Analgesics|analgesics|mesh-ancestor
44846242|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
44846243|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846244|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846245|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846246|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846247|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846248|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846249|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846250|NCT02286544|Atorvastatin|atorvastatin|mesh-list
44846251|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44846252|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44846253|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
44846254|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846255|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846256|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44846257|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846258|NCT02286596|Heparin|heparin|mesh-list
44846259|NCT02286596|Dextrans|dextrans|mesh-list
44846260|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
44846261|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44846262|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44846263|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846264|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
44846265|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
44846266|NCT02286609|Deflazacort|deflazacort|mesh-list
44846267|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846268|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846269|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
44846270|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846271|NCT02286622|Deflazacort|deflazacort|mesh-list
44846272|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846273|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846274|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
44846275|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846276|NCT02286635|Clarithromycin|clarithromycin|mesh-list
44846278|NCT02286635|Deflazacort|deflazacort|mesh-list
44846279|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44846280|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846281|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44846282|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846283|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846284|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44846285|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846286|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44846287|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
44846288|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
44846289|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846290|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44846291|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44846292|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44846293|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44846294|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44846295|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44846296|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846297|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846298|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
44846299|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846300|NCT02286687|Talazoparib|talazoparib|mesh-list
44846301|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44846302|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846303|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846304|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846305|NCT02286700|Desonide|desonide|mesh-list
44846306|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846307|NCT02286752|Neostigmine|neostigmine|mesh-list
44846308|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44846309|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846310|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846311|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
44846312|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846313|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846314|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44846315|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
44846316|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846317|NCT02286934|Carvedilol|carvedilol|mesh-list
44846318|NCT02286934|Isoproterenol|isoproterenol|mesh-list
44846319|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44846320|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44846321|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44846322|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846323|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846324|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846325|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44846326|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
44846327|NCT02286934|Protective Agents|protective agents|mesh-ancestor
44846328|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44846329|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846330|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44846331|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
44846332|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44846333|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44846334|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44846335|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44846336|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44846337|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
44846338|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846339|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44846340|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
44846341|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44846342|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
44846343|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
44846344|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44846345|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44846346|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846347|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
44846348|NCT02286973|Coagulants|coagulants|mesh-ancestor
44846350|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
44846351|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
44846352|NCT02287064|Antibodies|antibodies|mesh-list
44846353|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
44846354|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44846355|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44846356|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
44846357|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846358|NCT02287129|Paclitaxel|paclitaxel|mesh-list
44332652|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44846359|NCT02287129|Carboplatin|carboplatin|mesh-list
44846360|NCT02287129|Capecitabine|capecitabine|mesh-list
44846361|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
44846362|NCT02287129|Epirubicin|epirubicin|mesh-list
44846363|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44846364|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846365|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
44846366|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
44846367|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
44846368|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846369|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44846370|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
44846371|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44846372|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44846373|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44846374|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846375|NCT02287181|Remifentanil|remifentanil|mesh-list
44846376|NCT02287181|Propofol|propofol|mesh-list
44846377|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44846378|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846379|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846380|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846381|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
44846382|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
44846383|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846384|NCT02287181|Narcotics|narcotics|mesh-ancestor
44846385|NCT02287181|Analgesics|analgesics|mesh-ancestor
44846386|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
44846387|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846388|NCT02287246|Bupivacaine|bupivacaine|mesh-list
44846389|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
44846390|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
44846391|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846392|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846393|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
44846394|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846395|NCT02287259|Olanzapine|olanzapine|mesh-list
44846396|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
44846397|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
44332684|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846398|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846399|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846400|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846401|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44846402|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44846403|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846404|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846405|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44846406|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846407|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846408|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846409|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846410|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
44846411|NCT02287272|Cimetidine|cimetidine|mesh-list
44846412|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44846413|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846414|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44846415|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
44846416|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
44846417|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846418|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846419|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846420|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44846421|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846422|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846423|NCT02287389|Mitomycins|mitomycins|mesh-list
44846424|NCT02287389|Mitomycin|mitomycin|mesh-list
44846425|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44846426|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846427|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
44846428|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846429|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846430|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846431|NCT02287558|Pomalidomide|pomalidomide|mesh-list
44846432|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
44846433|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846434|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44846435|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44846436|NCT02287558|Growth Substances|growth substances|mesh-ancestor
44846437|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44846438|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846439|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44846440|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44846441|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846442|NCT02287857|Tenofovir|tenofovir|mesh-list
44846443|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
44846444|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846445|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44846446|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846447|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846448|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846449|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44846450|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44846451|NCT02287870|Lidocaine|lidocaine|mesh-list
44846452|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
44846453|NCT02287870|Procaine|procaine|mesh-list
44846454|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
44846455|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
44846456|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846457|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846458|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
44846459|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846460|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44846461|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44846462|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44846463|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846464|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846465|NCT02288000|Memantine|memantine|mesh-list
44846466|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44846467|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44846468|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
44846469|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846470|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332772|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332787|NCT05590260|Iron|iron|mesh-list
44846471|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846472|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44846473|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44846474|NCT02288078|Dexamethasone|dexamethasone|mesh-list
44846475|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44846476|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846477|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
44846478|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
44846479|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846480|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846481|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846482|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
44846483|NCT02288078|Hormones|hormones|mesh-ancestor
44846484|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846485|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44846486|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846487|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846488|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846489|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
44846490|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44846491|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
44846492|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44332798|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
44846493|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846494|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44846495|NCT02288208|Tenofovir|tenofovir|mesh-list
44846496|NCT02288208|Entecavir|entecavir|mesh-list
44846497|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
44846498|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630108|NCT00460603|Bevacizumab|bevacizumab|mesh-list
44846499|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44846500|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44846501|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846502|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846503|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44846504|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44846505|NCT02288234|Telavancin|telavancin|mesh-list
44846506|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44846507|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846508|NCT02288286|Vaccines|vaccines|mesh-list
44846509|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
44846510|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846511|NCT02288338|Atorvastatin|atorvastatin|mesh-list
44846512|NCT02288338|Ezetimibe|ezetimibe|mesh-list
44846513|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44846514|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44846515|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
44846516|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846517|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846518|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44846519|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846520|NCT02288429|Colistin|colistin|mesh-list
44846521|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44846522|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846523|NCT02288507|Sorafenib|sorafenib|mesh-list
44846524|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846525|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44846526|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846527|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630182|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44846528|NCT02288741|Dexamethasone|dexamethasone|mesh-list
44846529|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
44846530|NCT02288741|Melphalan|melphalan|mesh-list
44846531|NCT02288741|BB 1101|bb 1101|mesh-list
44846532|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846533|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
44846534|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
44846535|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846536|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846537|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846538|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
44846539|NCT02288741|Hormones|hormones|mesh-ancestor
44846540|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846541|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44846542|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846543|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846544|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846545|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846546|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44846547|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
44846548|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44846549|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846550|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
44846551|NCT02288923|Acetaminophen|acetaminophen|mesh-list
44846552|NCT02288923|Ibuprofen|ibuprofen|mesh-list
44846553|NCT02288923|Morphine|morphine|mesh-list
44846554|NCT02288923|Antiemetics|antiemetics|mesh-list
44846555|NCT02288923|Anesthetics|anesthetics|mesh-list
44846556|NCT02288923|Emetics|emetics|mesh-list
44846557|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846558|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846559|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846560|NCT02288923|Narcotics|narcotics|mesh-ancestor
44846561|NCT02288923|Analgesics|analgesics|mesh-ancestor
44846562|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
44846563|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846564|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846565|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846566|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846567|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846568|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846569|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332873|NCT05589454|Calcium|calcium|mesh-list
44846570|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846571|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
44846572|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
44846573|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846574|NCT02288962|Cabergoline|cabergoline|mesh-list
44846575|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44846576|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44846577|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
44846578|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
44846579|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846580|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846581|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846582|NCT02289027|Vaccines|vaccines|mesh-list
44846583|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
44846584|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846585|NCT02289144|Ceritinib|ceritinib|mesh-list
44846586|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846587|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44846588|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846589|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846590|NCT02289248|Ketamine|ketamine|mesh-list
44846591|NCT02289248|Analgesics|analgesics|mesh-ancestor
44332902|NCT05589402|Lidocaine|lidocaine|mesh-list
44846592|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
44846593|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846594|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846595|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44846596|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846597|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
44846598|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
44846599|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846600|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44846601|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44846602|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846603|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846604|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
44846606|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44846607|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846608|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846609|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846610|NCT02289261|Analgesics|analgesics|mesh-ancestor
44332921|NCT05589220|Nicotine|nicotine|mesh-list
44846611|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
44846612|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846613|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44846614|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44846615|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44846616|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44846617|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846618|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846619|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846620|NCT02289261|Narcotics|narcotics|mesh-ancestor
44846621|NCT02289274|Aceclofenac|aceclofenac|mesh-list
44846622|NCT02289274|Eperisone|eperisone|mesh-list
44846623|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846624|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846625|NCT02289274|Analgesics|analgesics|mesh-ancestor
44846626|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
44846627|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846628|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846629|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846630|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846631|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
44846632|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44846633|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846634|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846635|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44846636|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44846637|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44846638|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
44846639|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
44332938|NCT05589025|Eugenol|eugenol|mesh-list
44846640|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
44846641|NCT02289378|Docetaxel|docetaxel|mesh-list
44846642|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
44846643|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846644|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44846645|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44846646|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44846647|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846648|NCT02289391|Anesthetics|anesthetics|mesh-list
44846649|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846650|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846651|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44846652|NCT02289430|Ezetimibe|ezetimibe|mesh-list
44846653|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44846654|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44846655|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
44846656|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846657|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44846658|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44846659|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846660|NCT02289482|Ritonavir|ritonavir|mesh-list
44846661|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
44846662|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44846663|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44846664|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846665|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846666|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846667|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44846668|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44332970|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332997|NCT05379959|Methamphetamine|methamphetamine|mesh-list
44846669|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
44846670|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846671|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44846672|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846673|NCT02289495|Ritonavir|ritonavir|mesh-list
44846674|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
44846675|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44846676|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44846677|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846678|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846679|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846680|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44846681|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44846682|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
44846683|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846684|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44846685|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846687|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44846688|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
44846689|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846690|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846691|NCT02289586|Fentanyl|fentanyl|mesh-list
44846692|NCT02289586|Midazolam|midazolam|mesh-list
44846693|NCT02289586|Remifentanil|remifentanil|mesh-list
44846694|NCT02289586|Dezocine|dezocine|mesh-list
44846695|NCT02289586|Propofol|propofol|mesh-list
44846696|NCT02289586|Rocuronium|rocuronium|mesh-list
44846697|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
44846698|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846699|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846700|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44846701|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846702|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
44846703|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846704|NCT02289586|Narcotics|narcotics|mesh-ancestor
44846705|NCT02289586|Analgesics|analgesics|mesh-ancestor
44846706|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
44846707|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846708|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44846709|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44846710|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44846711|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846712|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
44846713|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
44846714|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846715|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846716|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44846717|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44846718|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44846719|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
44846720|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44846721|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
44846722|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44846723|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846724|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846725|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846726|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
44846727|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
44846728|NCT02289768|Salicylates|salicylates|mesh-list
44333051|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
44846729|NCT02289768|Fluorouracil|fluorouracil|mesh-list
44846730|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
44846731|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846732|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44846733|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846734|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846735|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
44846736|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846737|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44846738|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
44846739|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
44846740|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
44846741|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44846742|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846743|NCT02289768|Analgesics|analgesics|mesh-ancestor
44846744|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
44846745|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846746|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846747|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846748|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44846749|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846750|NCT02289807|Cisplatin|cisplatin|mesh-list
44846751|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846752|NCT02289924|Aflibercept|aflibercept|mesh-list
44846753|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630406|NCT00457691|Vitamins|vitamins|mesh-ancestor
44846754|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44846755|NCT02289924|Growth Substances|growth substances|mesh-ancestor
44846756|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846757|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
44846758|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846759|NCT02289937|Ropivacaine|ropivacaine|mesh-list
44846760|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
44846761|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
44846762|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846763|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846764|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
44333075|NCT05183828|Letrozole|letrozole|mesh-list
44846765|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846766|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
44846767|NCT02290002|Calcium|calcium|mesh-list
44846768|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44846769|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846770|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
44846771|NCT02290002|Coagulants|coagulants|mesh-ancestor
44846772|NCT02290054|Anesthetics|anesthetics|mesh-list
44846773|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846774|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846775|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
44846776|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
44846777|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846778|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44846779|NCT02290327|Pantoprazole|pantoprazole|mesh-list
44846780|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44846781|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846782|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44846783|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846784|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846785|NCT02290431|Dexamethasone|dexamethasone|mesh-list
44846786|NCT02290431|Bortezomib|bortezomib|mesh-list
44846787|NCT02290431|Panobinostat|panobinostat|mesh-list
44846788|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846789|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
44846790|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
44846791|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846792|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846793|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846794|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
44846795|NCT02290431|Hormones|hormones|mesh-ancestor
44846796|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846797|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44846798|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846799|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44846800|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846801|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846802|NCT02290470|Dexamethasone|dexamethasone|mesh-list
44846803|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
44846804|NCT02290470|Paclitaxel|paclitaxel|mesh-list
44846805|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44846806|NCT02290470|Carboplatin|carboplatin|mesh-list
44846807|NCT02290470|Olanzapine|olanzapine|mesh-list
44846808|NCT02290470|Palonosetron|palonosetron|mesh-list
44846809|NCT02290470|BB 1101|bb 1101|mesh-list
44846810|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44846811|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846812|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44846813|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44846814|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44846815|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846816|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846817|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
44846818|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
44846819|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846820|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846821|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846822|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
44846823|NCT02290470|Hormones|hormones|mesh-ancestor
44846824|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846825|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44846826|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44846827|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846828|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44846829|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44333145|NCT05053503|Lofexidine|lofexidine|mesh-list
44846830|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846831|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846832|NCT02290470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44846833|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846834|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846835|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846836|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
44846837|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44846838|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44846839|NCT02290717|Fluticasone|fluticasone|mesh-list
44846840|NCT02290717|Xhance|xhance|mesh-list
44846841|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44846842|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44846843|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
44846844|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846845|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846846|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44846847|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
44846848|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
44846849|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44846850|NCT02291055|Durvalumab|durvalumab|mesh-list
44333153|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44846851|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44846852|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846853|NCT02291094|Lidocaine|lidocaine|mesh-list
44696977|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
44846854|NCT02291094|Remifentanil|remifentanil|mesh-list
44846855|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
44846856|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
44846857|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846858|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846859|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
44846860|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846861|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44846862|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44846863|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44846864|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846865|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846866|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846867|NCT02291094|Narcotics|narcotics|mesh-ancestor
44846868|NCT02291094|Analgesics|analgesics|mesh-ancestor
44846869|NCT02291211|Cisplatin|cisplatin|mesh-list
44846870|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846871|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44846872|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44846873|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846874|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846875|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846876|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846877|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846878|NCT02291341|Analgesics|analgesics|mesh-ancestor
44846879|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
44846880|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846881|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
44846882|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846883|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
44846884|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44846885|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44846886|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846887|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846888|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846889|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846890|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846891|NCT02291367|Analgesics|analgesics|mesh-ancestor
44846892|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
44846893|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846894|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
44846895|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846896|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
44846897|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
44846898|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44846899|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44846900|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44846901|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846902|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333195|NCT04912063|Venetoclax|venetoclax|mesh-list
44846903|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44846904|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846905|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846906|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44846907|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846908|NCT02291471|T0001|t0001|mesh-list
44846909|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44846910|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44846911|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
44846912|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846913|NCT02291536|Dronabinol|dronabinol|mesh-list
44846914|NCT02291536|Cannabidiol|cannabidiol|mesh-list
44846915|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
44846916|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
44846917|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846918|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44846919|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846920|NCT02291536|Analgesics|analgesics|mesh-ancestor
44846921|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
44846922|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846923|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44846924|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44846925|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846926|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846927|NCT02291536|Hormones|hormones|mesh-ancestor
44846928|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846929|NCT02291562|Dronabinol|dronabinol|mesh-list
44846930|NCT02291562|Cannabidiol|cannabidiol|mesh-list
44846931|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
44846932|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
44846933|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846934|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44333232|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333264|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44846935|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44846936|NCT02291562|Analgesics|analgesics|mesh-ancestor
44846937|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
44846938|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846939|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44846940|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44846941|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846942|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846943|NCT02291562|Hormones|hormones|mesh-ancestor
44846944|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44846945|NCT02291666|Tolbutamide|tolbutamide|mesh-list
44846946|NCT02291666|Midazolam|midazolam|mesh-list
44846947|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
44846948|NCT02291666|Caffeine|caffeine|mesh-list
44846949|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
44846950|NCT02291666|Bupropion|bupropion|mesh-list
44846951|NCT02291666|Omeprazole|omeprazole|mesh-list
44846952|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44846953|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44846954|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846955|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846956|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44846957|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44846958|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988323|NCT02331095|Warfarin|warfarin|mesh-list
44846959|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44846960|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
44846961|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
44846962|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
44846963|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
44846964|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44846965|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44846966|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44846967|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44846968|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44846969|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44846970|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44846971|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44846972|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44846973|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44846974|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
44846975|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44846976|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
44846977|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44846978|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44846979|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44846980|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
44333286|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
44846981|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44846982|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44846983|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
44846984|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44846985|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44846986|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44846987|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44846988|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44846989|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44846990|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846991|NCT02291705|Tramadol|tramadol|mesh-list
44846992|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44846993|NCT02291705|Narcotics|narcotics|mesh-ancestor
44846994|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44846995|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44846996|NCT02291705|Analgesics|analgesics|mesh-ancestor
44846997|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
44846998|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44846999|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44847000|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44847001|NCT02291796|Bezafibrate|bezafibrate|mesh-list
44847002|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44847003|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
44847004|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847005|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333316|NCT04582435|Insulin|insulin|mesh-list
44847007|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44847008|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847009|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44847010|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847011|NCT02291887|Ranibizumab|ranibizumab|mesh-list
44847012|NCT02291887|Aflibercept|aflibercept|mesh-list
44847013|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44847014|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847015|NCT02291887|Growth Substances|growth substances|mesh-ancestor
44847016|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847017|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847018|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847019|NCT02292069|Amlodipine|amlodipine|mesh-list
44847020|NCT02292069|Atorvastatin|atorvastatin|mesh-list
44847021|NCT02292069|Calcium|calcium|mesh-list
44847022|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847023|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847024|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44847025|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44847026|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
44847027|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847028|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44847029|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44847030|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847031|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44847032|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44847033|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847034|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
44630781|NCT00454194|Pemetrexed|pemetrexed|mesh-list
44847035|NCT02292121|Mannitol|mannitol|mesh-list
44847036|NCT02292121|Lactitol|lactitol|mesh-list
44847037|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44847038|NCT02292121|Diuretics|diuretics|mesh-ancestor
44847039|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
44847040|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847041|NCT02292121|Cathartics|cathartics|mesh-ancestor
44847042|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847043|NCT02292173|Sorafenib|sorafenib|mesh-list
44847044|NCT02292173|Trametinib|trametinib|mesh-list
44847045|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847046|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44847047|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847048|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847049|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
44847050|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847051|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847052|NCT02292277|Ticagrelor|ticagrelor|mesh-list
44847053|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44847054|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44847055|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44847056|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44847057|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
44847058|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847059|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847060|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847061|NCT02292290|Pioglitazone|pioglitazone|mesh-list
44847062|NCT02292290|Liraglutide|liraglutide|mesh-list
44847063|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44847064|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847065|NCT02292290|Incretins|incretins|mesh-ancestor
44847066|NCT02292290|Hormones|hormones|mesh-ancestor
44847067|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847068|NCT02292303|Zinc|zinc|mesh-list
44847069|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
44847070|NCT02292303|Trace Elements|trace elements|mesh-ancestor
44847071|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
44847072|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847073|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
44847074|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
44847075|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44847076|NCT02292303|Protective Agents|protective agents|mesh-ancestor
44847077|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44847078|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44847079|NCT02292459|Laxatives|laxatives|mesh-ancestor
44847080|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847081|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
44333378|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44333410|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44333411|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
44333412|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847082|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44847083|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44847084|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44847085|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847086|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847087|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
44847088|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847089|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847090|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44847091|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847092|NCT02292550|Ceritinib|ceritinib|mesh-list
44847093|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847094|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44847095|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847096|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847097|NCT02292667|Acetaminophen|acetaminophen|mesh-list
44847098|NCT02292667|Morphine|morphine|mesh-list
44847099|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44847100|NCT02292667|Narcotics|narcotics|mesh-ancestor
44847101|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847102|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847103|NCT02292667|Analgesics|analgesics|mesh-ancestor
44847104|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
44847105|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847106|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847107|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
44847108|NCT02292732|Trametinib|trametinib|mesh-list
44847109|NCT02292732|Norinyl|norinyl|mesh-list
44847110|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847111|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630855|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
44847112|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847113|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847114|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44847115|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44847116|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44847117|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
44847118|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44847119|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847120|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44847121|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44847122|NCT02292966|Asunaprevir|asunaprevir|mesh-list
44333455|NCT03925532|Denosumab|denosumab|mesh-list
44333456|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44333457|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847123|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847124|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847125|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847126|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
44847127|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44847128|NCT02293148|Glycine|glycine|mesh-list
44847129|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44847130|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847131|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44847132|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44847133|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847134|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847135|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847136|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44847137|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
44847138|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44847139|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847140|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44847141|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44847142|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44847143|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
44847144|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847145|NCT02293187|Vitamin D|vitamin d|mesh-list
44847146|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
44847147|NCT02293187|Vitamins|vitamins|mesh-ancestor
44847148|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
44847149|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847150|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44847151|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847152|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
44847153|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
44847154|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44847155|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847156|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847157|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
44847158|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44333458|NCT03916263|Metformin|metformin|mesh-list
44847159|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847160|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847161|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
44847162|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
44847163|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
44847164|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847165|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847166|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
44847167|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847168|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
44847169|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847170|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847171|NCT02293447|Lidocaine|lidocaine|mesh-list
44847172|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
44847173|NCT02293447|Anesthetics|anesthetics|mesh-list
44847174|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847175|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847176|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
44847177|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847178|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44847179|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44847180|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44847181|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847182|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847183|NCT02293525|Morphine|morphine|mesh-list
44630930|NCT00452530|Enoxaparin|enoxaparin|mesh-list
44847185|NCT02293525|Ropivacaine|ropivacaine|mesh-list
44847186|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44847187|NCT02293525|Narcotics|narcotics|mesh-ancestor
44847188|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847189|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847190|NCT02293525|Analgesics|analgesics|mesh-ancestor
44847191|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
44847192|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847193|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
44847194|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
44847195|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
44847196|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44847197|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847198|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
44847199|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
44847200|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847201|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
44847202|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847203|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847204|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847205|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847206|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847207|NCT02293590|Analgesics|analgesics|mesh-ancestor
44847208|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
44847209|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847210|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847211|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847212|NCT02293668|Letrozole|letrozole|mesh-list
44847213|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847214|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44847215|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44847216|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847217|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847218|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44847219|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44847220|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847221|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847222|NCT02293681|Infliximab|infliximab|mesh-list
44847223|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
44847224|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847225|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847226|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44847227|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
44847228|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44847229|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44847230|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44847231|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
44847232|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44847233|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847234|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44847235|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44847236|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44847237|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44847238|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847239|NCT02293785|Oxycodone|oxycodone|mesh-list
44847240|NCT02293785|Naloxone|naloxone|mesh-list
44847241|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44847242|NCT02293785|Narcotics|narcotics|mesh-ancestor
44847243|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847244|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847245|NCT02293785|Analgesics|analgesics|mesh-ancestor
44847246|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
44847247|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847248|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44847249|NCT02293824|Caffeine|caffeine|mesh-list
44847250|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
44847251|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847252|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44847253|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847254|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44847255|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847256|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44847257|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44847258|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
44847259|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847260|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44847261|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44847262|NCT02293889|Vitamin D|vitamin d|mesh-list
44847263|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
44847264|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
44847265|NCT02293889|Vitamins|vitamins|mesh-list
44847266|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
44847267|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847268|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44847269|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847270|NCT02294006|Metformin|metformin|mesh-list
44847271|NCT02294006|Everolimus|everolimus|mesh-list
44847272|NCT02294006|Octreotide|octreotide|mesh-list
44847273|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333564|NCT03262935|Lapatinib|lapatinib|mesh-list
44847274|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847275|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847276|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847277|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
44847278|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847279|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44847280|NCT02294071|Acetaminophen|acetaminophen|mesh-list
44847281|NCT02294071|Ibuprofen|ibuprofen|mesh-list
44847282|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847283|NCT02294071|Analgesics|analgesics|mesh-ancestor
44847284|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
44847285|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847286|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847287|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
44847288|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847289|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847290|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847291|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44847292|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847293|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847294|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44847295|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44847296|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847297|NCT02294084|Incretins|incretins|mesh-ancestor
44847298|NCT02294084|Hormones|hormones|mesh-ancestor
44847299|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847300|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44847301|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847302|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847303|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847304|NCT02294110|Anesthetics|anesthetics|mesh-list
44847305|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847306|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847307|NCT02294162|Ketamine|ketamine|mesh-list
44847308|NCT02294162|Analgesics|analgesics|mesh-ancestor
44847309|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
44847310|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847311|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847312|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44847313|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44847314|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
44847315|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
44847316|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847317|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44847318|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44847319|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847320|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847321|NCT02294240|Folic Acid|folic acid|mesh-list
44847322|NCT02294240|Hematinics|hematinics|mesh-ancestor
44847323|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
44847324|NCT02294240|Vitamins|vitamins|mesh-ancestor
44847325|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
44847326|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847327|NCT02294266|Ethanol|ethanol|mesh-list
44847328|NCT02294266|Methamphetamine|methamphetamine|mesh-list
44847329|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44847330|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847331|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847332|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847333|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44847334|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
44847335|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
44847336|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847337|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
44847338|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847339|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847340|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
44847341|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44847342|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44847343|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847344|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44847345|NCT02294279|Beclomethasone|beclomethasone|mesh-list
44847346|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847347|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
44847348|NCT02294279|Hormones|hormones|mesh-ancestor
44847349|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847350|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847351|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44847352|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
44847353|NCT02294292|Carvedilol|carvedilol|mesh-list
44847354|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44847355|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44847356|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
44847357|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847358|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847359|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847360|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44847361|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
44847362|NCT02294292|Protective Agents|protective agents|mesh-ancestor
44847363|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44847364|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847365|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847366|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
44847367|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44847368|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44847369|NCT02294305|Vortioxetine|vortioxetine|mesh-list
44847370|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44847371|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44847372|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44847373|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44847374|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847375|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847376|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44847377|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44847378|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847379|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847380|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847381|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
44847382|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44847383|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44847384|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44847385|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44847386|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
44847387|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847388|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
44847389|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847390|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847391|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44847392|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
44847393|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333683|NCT01306045|Sunitinib|sunitinib|mesh-list
44847394|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847395|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44847396|NCT02294357|Dexamethasone|dexamethasone|mesh-list
44847397|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
44847398|NCT02294357|Prednisone|prednisone|mesh-list
44847399|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
44847400|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44847401|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44847402|NCT02294357|Prednisolone|prednisolone|mesh-list
44847403|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
44847404|NCT02294357|Lenalidomide|lenalidomide|mesh-list
44847405|NCT02294357|Pomalidomide|pomalidomide|mesh-list
44847406|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44847407|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
44847408|NCT02294357|BB 1101|bb 1101|mesh-list
44847409|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847410|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
44847411|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
44847412|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847413|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847414|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847415|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
44847416|NCT02294357|Hormones|hormones|mesh-ancestor
44847417|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847418|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44847419|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847420|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
44333732|NCT05129358|Furosemide|furosemide|mesh-list
44847421|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847422|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847423|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
44847424|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44847425|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847426|NCT02294357|Growth Substances|growth substances|mesh-ancestor
44847427|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847428|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44847429|NCT02294357|Protective Agents|protective agents|mesh-ancestor
44847430|NCT02294539|Losartan|losartan|mesh-list
44847431|NCT02294539|Amlodipine|amlodipine|mesh-list
44847432|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44847433|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44847434|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44847435|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847436|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847437|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847438|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847439|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
44847440|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44847441|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44847442|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44847443|NCT02294539|Diuretics|diuretics|mesh-ancestor
44847444|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
44847445|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44847446|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
44847447|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
44847448|NCT02294552|Busulfan|busulfan|mesh-list
44847449|NCT02294552|Fludarabine|fludarabine|mesh-list
44847450|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
44847451|NCT02294552|Tacrolimus|tacrolimus|mesh-list
44847452|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847453|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
44847454|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847455|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847456|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44847457|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
44847458|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847459|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847460|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44847461|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44847462|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
44847463|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44847464|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847465|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44847466|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44847467|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
44847468|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44847469|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847470|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
44847471|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44847472|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
44847473|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847474|NCT02294591|Expectorants|expectorants|mesh-ancestor
44847475|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
44847476|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44847477|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
44847478|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847479|NCT02294591|Protective Agents|protective agents|mesh-ancestor
44847480|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847481|NCT02294591|Antidotes|antidotes|mesh-ancestor
44847482|NCT02294617|Nicotine|nicotine|mesh-list
44847483|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44847484|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
44847485|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847486|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847487|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44847488|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44847489|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44847490|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847491|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847492|NCT02294643|Aspirin|aspirin|mesh-list
44847493|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
44847494|NCT02294643|Clopidogrel|clopidogrel|mesh-list
44847495|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847496|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847497|NCT02294643|Analgesics|analgesics|mesh-ancestor
44847498|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
44847499|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847500|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847501|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847502|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847503|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44847504|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44847505|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847506|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44847507|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44847508|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847509|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
44847510|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44847511|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44847512|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44847513|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
44847514|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847515|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44847516|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
44847517|NCT02294656|Triamcinolone|triamcinolone|mesh-list
44847518|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44847519|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44847520|NCT02294656|Ranibizumab|ranibizumab|mesh-list
44847521|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44847522|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44847523|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847524|NCT02294656|Growth Substances|growth substances|mesh-ancestor
44847525|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847526|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847527|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847528|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847529|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
44847530|NCT02294656|Hormones|hormones|mesh-ancestor
44847531|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847532|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847533|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
44847534|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847535|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847536|NCT02294838|Citric Acid|citric acid|mesh-list
44847537|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
44847538|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
44696978|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
44847539|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44847540|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
44847541|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
44847542|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847543|NCT02294955|Amiodarone|amiodarone|mesh-list
44847544|NCT02294955|Sotalol|sotalol|mesh-list
44847545|NCT02294955|Flecainide|flecainide|mesh-list
44847546|NCT02294955|Dronedarone|dronedarone|mesh-list
44847547|NCT02294955|Propafenone|propafenone|mesh-list
44847548|NCT02294955|Disopyramide|disopyramide|mesh-list
44847549|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44847550|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
44847551|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44847552|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847553|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847554|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44847555|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44847556|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44847557|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847558|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44847559|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44847560|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44847561|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44847562|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44847563|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
44847564|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847565|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847566|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
44847567|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
44847568|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333878|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333887|NCT04469842|Prednisone|prednisone|mesh-list
44847569|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44847570|NCT02294994|Tirofiban|tirofiban|mesh-list
44847571|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44847572|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44847573|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847574|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44847575|NCT02295046|Amlodipine|amlodipine|mesh-list
44847576|NCT02295046|Atorvastatin|atorvastatin|mesh-list
44847577|NCT02295046|Calcium|calcium|mesh-list
44847578|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847579|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847580|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44847581|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44847582|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
44847583|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847584|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44847585|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44847586|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847587|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44847588|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44847589|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44847590|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
44847591|NCT02295124|Oxycodone|oxycodone|mesh-list
44847592|NCT02295124|Hydromorphone|hydromorphone|mesh-list
44847593|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44847594|NCT02295124|Narcotics|narcotics|mesh-ancestor
44847595|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847596|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847597|NCT02295124|Analgesics|analgesics|mesh-ancestor
44847598|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
44847599|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847600|NCT02295150|Nadroparin|nadroparin|mesh-list
44847601|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
44847602|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44847603|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44847604|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847605|NCT02295189|Triamcinolone|triamcinolone|mesh-list
44847606|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44847607|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44847608|NCT02295189|Ketorolac|ketorolac|mesh-list
44847609|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44847610|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44847611|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847612|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
44847613|NCT02295189|Hormones|hormones|mesh-ancestor
44847614|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847615|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847616|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847617|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
44847618|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847619|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847620|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847621|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847622|NCT02295189|Analgesics|analgesics|mesh-ancestor
44847623|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
44847624|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847625|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847626|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44847627|NCT02295475|Warfarin|warfarin|mesh-list
44847628|NCT02295475|Apixaban|apixaban|mesh-list
44847629|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
44847630|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44847631|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
44847632|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44847633|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847634|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847635|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847636|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
44847637|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44847638|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
44847639|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847640|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847641|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44847642|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
44847643|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44847644|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
44847645|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847646|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847647|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44847648|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
44847649|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
44847650|NCT02295566|Protective Agents|protective agents|mesh-ancestor
44696979|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44696980|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44696981|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44696982|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333954|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44333998|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44696983|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696984|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
44696985|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44696986|NCT01394770|Amlodipine|amlodipine|mesh-list
44696987|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44696988|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44696989|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44696990|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44696991|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847651|NCT02295709|Dexamethasone|dexamethasone|mesh-list
44847652|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
44847653|NCT02295709|BB 1101|bb 1101|mesh-list
44847654|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847655|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
44847656|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
44847657|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847658|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847659|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847660|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
44847661|NCT02295709|Hormones|hormones|mesh-ancestor
44847662|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847663|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44847664|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847665|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847666|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847667|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334023|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334024|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44334025|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44334026|NCT03903640|Nivolumab|nivolumab|mesh-list
44334027|NCT03903640|Ipilimumab|ipilimumab|mesh-list
44334028|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334039|NCT03735979|Argatroban|argatroban|mesh-list
44847668|NCT02295722|Gemcitabine|gemcitabine|mesh-list
44847669|NCT02295722|Melphalan|melphalan|mesh-list
44847670|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44847671|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
44847672|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847673|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847674|NCT02295722|Antiviral Agents|antiviral agents|mesh-ancestor
44847675|NCT02295722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847676|NCT02295722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847677|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847678|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
44847679|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847680|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44847681|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
44847682|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44847683|NCT02295748|Deflazacort|deflazacort|mesh-list
44847684|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847685|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847686|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
44847687|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847688|NCT02295787|Ketamine|ketamine|mesh-list
44847689|NCT02295787|Analgesics|analgesics|mesh-ancestor
44847690|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
44847691|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847692|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847693|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44847694|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44847695|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
44847696|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
44847697|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847698|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44847699|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44847700|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847701|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847702|NCT02295826|Aspirin|aspirin|mesh-list
44847703|NCT02295826|Dabigatran|dabigatran|mesh-list
44847704|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847705|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847706|NCT02295826|Analgesics|analgesics|mesh-ancestor
44847707|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
44847708|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847709|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847710|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847711|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847712|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44847713|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44847714|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847715|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44847716|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44847717|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847718|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
44847719|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
44847720|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44847721|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847722|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
44847723|NCT02295852|Calcium|calcium|mesh-list
44847724|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847725|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847727|NCT02295930|Cetuximab|cetuximab|mesh-list
44847728|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847729|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847730|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334065|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44847731|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847732|NCT02295930|Growth Substances|growth substances|mesh-ancestor
44847733|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847734|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847735|NCT02296021|Amoxicillin|amoxicillin|mesh-list
44847736|NCT02296021|Clarithromycin|clarithromycin|mesh-list
44847737|NCT02296021|Esomeprazole|esomeprazole|mesh-list
44847738|NCT02296021|Bismuth|bismuth|mesh-list
44847739|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44847740|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847741|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44847742|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847743|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44847744|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847745|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847746|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44847747|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44847748|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44847749|NCT02296021|Antacids|antacids|mesh-ancestor
44847750|NCT02296047|Bromides|bromides|mesh-list
44847751|NCT02296047|Albuterol|albuterol|mesh-list
44847752|NCT02296047|Ipratropium|ipratropium|mesh-list
44847753|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
44847754|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44847755|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
44847756|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847757|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847758|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44847759|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44847760|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
44847761|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44847762|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44847763|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44847764|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44847765|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44847766|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847767|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847768|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44847769|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
44847770|NCT02296073|Fentanyl|fentanyl|mesh-list
44847771|NCT02296073|Midazolam|midazolam|mesh-list
44847772|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
44847773|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44847774|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847775|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847776|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847777|NCT02296073|Analgesics|analgesics|mesh-ancestor
44847778|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
44847779|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847780|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44847781|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44847782|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44847783|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
44847784|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847785|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847786|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44847787|NCT02296073|Narcotics|narcotics|mesh-ancestor
44847788|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44847789|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44847790|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
44847791|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
44847792|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44847793|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44847794|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44847795|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
44847796|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
44847797|NCT02296203|Irinotecan|irinotecan|mesh-list
44847798|NCT02296203|Cetuximab|cetuximab|mesh-list
44847799|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44847800|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44847801|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847802|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847803|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847804|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847805|NCT02296281|Pirfenidone|pirfenidone|mesh-list
44847806|NCT02296281|Analgesics|analgesics|mesh-ancestor
44847807|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
44847808|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847809|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847810|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847811|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847812|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44847813|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847814|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847815|NCT02296333|Ondansetron|ondansetron|mesh-list
44847816|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
44847817|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
44847818|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847819|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847820|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847821|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
44847822|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
44847823|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44847824|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
44847825|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847826|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847827|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44847828|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44847829|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847830|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44847831|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44847832|NCT02296398|Romidepsin|romidepsin|mesh-list
44847833|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44847834|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847835|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
44847836|NCT02296411|Bromides|bromides|mesh-list
44847837|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
44847838|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44847839|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44334154|NCT02315326|Rituximab|rituximab|mesh-list
44847840|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44847841|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
44847842|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44847843|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847844|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847845|NCT02296463|Vaccines|vaccines|mesh-list
44847846|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
44847847|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847848|NCT02296567|Bevacizumab|bevacizumab|mesh-list
44847849|NCT02296567|Ranibizumab|ranibizumab|mesh-list
44847850|NCT02296567|Aflibercept|aflibercept|mesh-list
44847851|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847852|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847853|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44847854|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847855|NCT02296567|Growth Substances|growth substances|mesh-ancestor
44847856|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847857|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847858|NCT02296671|Leucovorin|leucovorin|mesh-list
44847859|NCT02296671|Fluorouracil|fluorouracil|mesh-list
44847860|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
44847861|NCT02296671|Pemetrexed|pemetrexed|mesh-list
44847862|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
44847863|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847864|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44847865|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847866|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847867|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
44847868|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847869|NCT02296671|Antidotes|antidotes|mesh-ancestor
44847870|NCT02296671|Protective Agents|protective agents|mesh-ancestor
44847871|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
44847872|NCT02296671|Vitamins|vitamins|mesh-ancestor
44847873|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
44847874|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847875|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334190|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
44847876|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44847877|NCT02296723|Valganciclovir|valganciclovir|mesh-list
44847878|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
44847879|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847880|NCT02296749|Sirolimus|sirolimus|mesh-list
44847881|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44847882|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847883|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44847884|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847885|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
44847886|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847887|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
44847888|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847889|NCT02296762|Sirolimus|sirolimus|mesh-list
44847890|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44847891|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847892|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44847893|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847894|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
44847895|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44847896|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
44847897|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847898|NCT02296996|Trametinib|trametinib|mesh-list
44847899|NCT02296996|Dabrafenib|dabrafenib|mesh-list
44847900|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847901|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44847902|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847903|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847904|NCT02297204|Aflibercept|aflibercept|mesh-list
44847905|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44847906|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44847907|NCT02297204|Growth Substances|growth substances|mesh-ancestor
44847908|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847909|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
44847910|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847911|NCT02297217|Paclitaxel|paclitaxel|mesh-list
44847912|NCT02297217|Carboplatin|carboplatin|mesh-list
44334224|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44847913|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44847914|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847915|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44847916|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44847917|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44847918|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847919|NCT02297386|Testosterone|testosterone|mesh-list
44847920|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
44847921|NCT02297386|Androgens|androgens|mesh-ancestor
44847922|NCT02297386|Hormones|hormones|mesh-ancestor
44847923|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44847924|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847925|NCT02297477|Artesunate|artesunate|mesh-list
44847926|NCT02297477|Atovaquone|atovaquone|mesh-list
44847927|NCT02297477|Proguanil|proguanil|mesh-list
44847928|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44847929|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
44847930|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44847931|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44847932|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847933|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847934|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
44847935|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
44847936|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44847937|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
44847938|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847939|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847940|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
44847941|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44847942|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44847943|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847944|NCT02297568|Vitamin D|vitamin d|mesh-list
44847945|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
44847946|NCT02297568|Vitamins|vitamins|mesh-ancestor
44847947|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
44847948|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847949|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44847950|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44847951|NCT02297594|Ziresovir|ziresovir|mesh-list
44847952|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
44847953|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847954|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
44847955|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44847956|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847957|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44847958|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847959|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44847960|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
44847961|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44847962|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44847963|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44847964|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44847965|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847966|NCT02297854|Valganciclovir|valganciclovir|mesh-list
44847967|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
44847968|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847969|NCT02297906|Ketorolac|ketorolac|mesh-list
44847970|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44847971|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44847972|NCT02297906|Analgesics|analgesics|mesh-ancestor
44847973|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
44847974|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44847975|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44847976|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334284|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
44847977|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847978|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44847979|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847980|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847981|NCT02297945|Metyrapone|metyrapone|mesh-list
44847982|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
44847983|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847984|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44847985|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
44847986|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44847987|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44847988|NCT02298010|Capecitabine|capecitabine|mesh-list
44847989|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
44847990|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44847991|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
44847992|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44847993|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44847994|NCT02298062|Infliximab|infliximab|mesh-list
44334323|NCT00992082|Ketorolac|ketorolac|mesh-list
44847995|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
44847996|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44847997|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44847998|NCT02298088|Clopidogrel|clopidogrel|mesh-list
44847999|NCT02298088|Ticagrelor|ticagrelor|mesh-list
44848000|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44848001|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44848002|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44848003|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44848004|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
44848005|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848006|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848007|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848008|NCT02298101|Edetic Acid|edetic acid|mesh-list
44848009|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
44848010|NCT02298101|Antidotes|antidotes|mesh-ancestor
44848011|NCT02298101|Protective Agents|protective agents|mesh-ancestor
44848012|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848013|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
44848014|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
44848015|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848016|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44848017|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
44848018|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44848019|NCT02298153|Atezolizumab|atezolizumab|mesh-list
44848020|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848021|NCT02298166|Cytarabine|cytarabine|mesh-list
44848022|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
44848023|NCT02298166|Crenolanib|crenolanib|mesh-list
44848024|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44848025|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
44848026|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848027|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848028|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
44848029|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848030|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848031|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
44848032|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848033|NCT02298166|Analgesics|analgesics|mesh-ancestor
44848034|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
44848035|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848036|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44848037|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44848038|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848039|NCT02298205|Beclomethasone|beclomethasone|mesh-list
44848040|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848041|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
44848042|NCT02298205|Hormones|hormones|mesh-ancestor
44848043|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848044|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848045|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44848046|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
44848047|NCT02298218|Meloxicam|meloxicam|mesh-list
44848048|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44848049|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848050|NCT02298218|Analgesics|analgesics|mesh-ancestor
44848051|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
44848052|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848053|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848054|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848055|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44848056|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44848057|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44848058|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848059|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848060|NCT02298283|Prednisone|prednisone|mesh-list
44848061|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
44848062|NCT02298283|Doxorubicin|doxorubicin|mesh-list
44848063|NCT02298283|Etoposide|etoposide|mesh-list
44848064|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44848065|NCT02298283|Vincristine|vincristine|mesh-list
44848066|NCT02298283|Bleomycin|bleomycin|mesh-list
44848067|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44848068|NCT02298283|Procarbazine|procarbazine|mesh-list
44848069|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848070|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
44848071|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848072|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44848073|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44848074|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
44848075|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848076|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848077|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44848078|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44848079|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44848080|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44848081|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848082|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848083|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
44848084|NCT02298283|Hormones|hormones|mesh-ancestor
44848085|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848086|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44848087|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44848088|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
44848089|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
44848090|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
44848091|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44848092|NCT02298335|Prednisone|prednisone|mesh-list
44848093|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848094|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
44848095|NCT02298335|Hormones|hormones|mesh-ancestor
44848096|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848097|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848098|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44848099|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848100|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44848101|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
44848102|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848103|NCT02298530|Caffeine|caffeine|mesh-list
44848104|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44848105|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848106|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44848107|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848108|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848109|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44848110|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44848111|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
44848112|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848113|NCT02298582|Fentanyl|fentanyl|mesh-list
44848114|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44848115|NCT02298582|Narcotics|narcotics|mesh-ancestor
44848116|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848117|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848118|NCT02298582|Analgesics|analgesics|mesh-ancestor
44848119|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
44848120|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848121|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44848122|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44848123|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
44848124|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
44848125|NCT02298595|Cisplatin|cisplatin|mesh-list
44848126|NCT02298595|Cetuximab|cetuximab|mesh-list
44848127|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848128|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44848129|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
44848130|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44848131|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44848132|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44848133|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848134|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848135|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
44848136|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848137|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848138|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44848139|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848140|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
44848141|NCT02298985|Curcumin|curcumin|mesh-list
44848142|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
44848143|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44848144|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848145|NCT02298985|Analgesics|analgesics|mesh-ancestor
44848146|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
44848147|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848148|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334463|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848150|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44848151|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848152|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848153|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848154|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44848155|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848156|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632038|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
44848157|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
44848158|NCT02299024|Narcotics|narcotics|mesh-ancestor
44848159|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848160|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848161|NCT02299024|Analgesics|analgesics|mesh-ancestor
44848162|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
44848163|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848164|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
44848165|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44848166|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848167|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848168|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848169|NCT02299063|Analgesics|analgesics|mesh-ancestor
44848170|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
44848171|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848172|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44848173|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44848174|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44848175|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848176|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848177|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848178|NCT02299115|Prednisolone|prednisolone|mesh-list
44848179|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44848180|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
44848181|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44848182|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
44848183|NCT02299115|Vigabatrin|vigabatrin|mesh-list
44848184|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44848185|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
44848186|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848187|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
44848188|NCT02299115|Hormones|hormones|mesh-ancestor
44848189|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848190|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848191|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44848192|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848193|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
44848194|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
44848195|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848196|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44848197|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44848198|NCT02299115|Protective Agents|protective agents|mesh-ancestor
44848199|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
44848200|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848201|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848202|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
44848203|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848204|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
44848205|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44848206|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848207|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848208|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848209|NCT02299232|Analgesics|analgesics|mesh-ancestor
44848210|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
44848211|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848212|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44848213|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44848214|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44848215|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848216|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848217|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848218|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44848219|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44848220|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44848221|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
44848222|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848223|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44848224|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44848225|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848226|NCT02299271|Ropivacaine|ropivacaine|mesh-list
44848227|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
44848228|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
44848229|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848230|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848231|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
44848232|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848233|NCT02299310|Valsartan|valsartan|mesh-list
44848234|NCT02299310|Perindopril|perindopril|mesh-list
44848235|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44848236|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44848237|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44848238|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848239|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44848240|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44848241|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848242|NCT02299401|Misoprostol|misoprostol|mesh-list
44848243|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44848244|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
44848245|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848246|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848247|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44848248|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44848249|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
44848250|NCT02299440|Ketamine|ketamine|mesh-list
44848251|NCT02299440|Analgesics|analgesics|mesh-ancestor
44848252|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
44848253|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848254|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848255|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44848256|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44848257|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
44848258|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
44848259|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848260|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44848261|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44848262|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848263|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848264|NCT02299518|Cytarabine|cytarabine|mesh-list
44848265|NCT02299518|Etoposide|etoposide|mesh-list
44848266|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
44848267|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
44848268|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44848269|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848270|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44848271|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44848272|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848273|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848274|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44848275|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
44848276|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
44848277|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848278|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848279|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
44848280|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848281|NCT02299518|Analgesics|analgesics|mesh-ancestor
44848282|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
44848283|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848284|NCT02299557|Phenylephrine|phenylephrine|mesh-list
44848285|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
44848286|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44848287|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44848288|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848289|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848290|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848291|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848292|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
44848293|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
44848294|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848295|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
44848296|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44848297|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
44848298|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44848299|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
44848300|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44848301|NCT02299557|Protective Agents|protective agents|mesh-ancestor
44848302|NCT02299687|Omeprazole|omeprazole|mesh-list
44848303|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44848304|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632189|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44848305|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44848306|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848307|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848309|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44848310|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
44848311|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848312|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848313|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44848314|NCT02299726|Diuretics|diuretics|mesh-ancestor
44848315|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
44848316|NCT02299765|Gemcitabine|gemcitabine|mesh-list
44848317|NCT02299765|Carboplatin|carboplatin|mesh-list
44848318|NCT02299765|Gefitinib|gefitinib|mesh-list
44848319|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848320|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44848321|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
44848322|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848323|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
44848324|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848325|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848326|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848327|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
44848328|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848329|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44848330|NCT02299817|Denosumab|denosumab|mesh-list
44848331|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44848332|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848333|NCT02299882|Vancomycin|vancomycin|mesh-list
44848334|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44848335|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848336|NCT02299908|Bupivacaine|bupivacaine|mesh-list
44848337|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
44848338|NCT02299908|Anesthetics|anesthetics|mesh-list
44848339|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44848340|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848341|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848342|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
44848343|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848344|NCT02300038|Lidocaine|lidocaine|mesh-list
44848345|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44848346|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
44848347|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848348|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848349|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
44848350|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848351|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44848352|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44848353|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44848354|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848355|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848356|NCT02300064|Antioxidants|antioxidants|mesh-list
44848357|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848358|NCT02300064|Protective Agents|protective agents|mesh-ancestor
44848359|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848360|NCT02300194|Morphine|morphine|mesh-list
44848361|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44848362|NCT02300194|Narcotics|narcotics|mesh-ancestor
44848363|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848364|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848365|NCT02300194|Analgesics|analgesics|mesh-ancestor
44848366|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
44848367|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848368|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44848369|NCT02300350|Digoxin|digoxin|mesh-list
44848370|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44848371|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44848372|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848373|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848374|NCT02300350|Protective Agents|protective agents|mesh-ancestor
44848375|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848376|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44848377|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848378|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44848379|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44848380|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44848381|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44848382|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
44848383|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848384|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44848385|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44848386|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848387|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44848388|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848389|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848390|NCT02300376|Edetic Acid|edetic acid|mesh-list
44848391|NCT02300376|Calcium|calcium|mesh-list
44848392|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
44848393|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44848394|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848395|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
44848396|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44848397|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
44848398|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
44848399|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848400|NCT02300376|Antidotes|antidotes|mesh-ancestor
44848401|NCT02300376|Protective Agents|protective agents|mesh-ancestor
44848402|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44848403|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
44848404|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
44848405|NCT02300428|Trace Elements|trace elements|mesh-ancestor
44848406|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
44848407|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848408|NCT02300428|Hematinics|hematinics|mesh-ancestor
44848409|NCT02300623|Lamivudine|lamivudine|mesh-list
44848410|NCT02300623|Stavudine|stavudine|mesh-list
44848411|NCT02300623|Indinavir|indinavir|mesh-list
44848412|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44848413|NCT02300623|Interleukin-2|interleukin-2|mesh-list
44848414|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44848415|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44848416|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848417|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848418|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
44848419|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848420|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44848421|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848422|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848423|NCT02300623|Analgesics|analgesics|mesh-ancestor
44696992|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44696993|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
44696994|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44696995|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
44697007|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44697008|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697009|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697010|NCT01394848|Everolimus|everolimus|mesh-list
44697011|NCT01394848|Clopidogrel|clopidogrel|mesh-list
44697012|NCT01394848|Atorvastatin|atorvastatin|mesh-list
44697013|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44697014|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44697015|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
44697016|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697017|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44697018|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44697019|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697020|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697021|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697022|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
44697023|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697024|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44697025|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44697026|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44697027|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44697028|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
44697029|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697030|NCT01394887|Metformin|metformin|mesh-list
44848424|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
44848425|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848426|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848427|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
44848428|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44848429|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44848430|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
44848431|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
44848432|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44848433|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848434|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848435|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848436|NCT02300649|Analgesics|analgesics|mesh-ancestor
44848437|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
44848438|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848439|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44848440|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44848441|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44848442|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848443|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848444|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848445|NCT02300688|Maleic acid|maleic acid|mesh-list
44848446|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848447|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848448|NCT02300701|Omalizumab|omalizumab|mesh-list
44848449|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44848450|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44848451|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44848452|NCT02300740|Niacinamide|niacinamide|mesh-list
44848453|NCT02300740|Niacin|niacin|mesh-list
44848454|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
44848455|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
44848456|NCT02300740|Vitamins|vitamins|mesh-ancestor
44848457|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
44848458|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848459|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44848460|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
44848461|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848462|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44848463|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
44848464|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44848465|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44632385|NCT00441584|Ribavirin|ribavirin|mesh-list
44848466|NCT02300935|Paclitaxel|paclitaxel|mesh-list
44848467|NCT02300935|Trametinib|trametinib|mesh-list
44848468|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44848469|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848470|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44334832|NCT00994396|Vitamin D|vitamin d|mesh-list
44848471|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44848472|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44848473|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848474|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44848475|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848476|NCT02300948|Folic Acid|folic acid|mesh-list
44848477|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
44848478|NCT02300948|Hematinics|hematinics|mesh-ancestor
44848479|NCT02300948|Vitamins|vitamins|mesh-ancestor
44848480|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
44848481|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848482|NCT02301000|Metronidazole|metronidazole|mesh-list
44848483|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848484|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44848485|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44848486|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44848487|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44848488|NCT02301026|Hematinics|hematinics|mesh-ancestor
44848489|NCT02301091|Mitomycins|mitomycins|mesh-list
44848490|NCT02301091|Mitomycin|mitomycin|mesh-list
44848491|NCT02301091|Pirarubicin|pirarubicin|mesh-list
44848492|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44848493|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848494|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
44848495|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848496|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44848497|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848498|NCT02301130|Durvalumab|durvalumab|mesh-list
44848499|NCT02301130|Tremelimumab|tremelimumab|mesh-list
44848500|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
44848501|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44848502|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44848503|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848504|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
44848505|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848506|NCT02301208|Cisplatin|cisplatin|mesh-list
44848507|NCT02301208|Nedaplatin|nedaplatin|mesh-list
44848508|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848509|NCT02301221|Vancomycin|vancomycin|mesh-list
44848510|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44848511|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848512|NCT02301286|Aspirin|aspirin|mesh-list
44848513|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44848514|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848515|NCT02301286|Analgesics|analgesics|mesh-ancestor
44848516|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
44848517|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848518|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848519|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848520|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44848521|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44848522|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44848523|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848524|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44848525|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44848526|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848527|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
44848528|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
44848529|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848530|NCT02301494|Fluocinonide|fluocinonide|mesh-list
44848531|NCT02301494|Imiquimod|imiquimod|mesh-list
44848532|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44848533|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
44848534|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848535|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848536|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
44848537|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848538|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
44848539|NCT02301494|Hormones|hormones|mesh-ancestor
44848540|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848541|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44848542|NCT02301650|Tenofovir|tenofovir|mesh-list
44848543|NCT02301650|Lamivudine|lamivudine|mesh-list
44848544|NCT02301650|Telbivudine|telbivudine|mesh-list
44848545|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
44848546|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848547|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44848548|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44848549|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334882|NCT00994695|Vaccines|vaccines|mesh-list
44848550|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848551|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44848552|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44848553|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
44848555|NCT02301676|Sevoflurane|sevoflurane|mesh-list
44848556|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44848557|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848558|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848559|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44848560|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
44848561|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
44848562|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848563|NCT02301676|Analgesics|analgesics|mesh-ancestor
44848564|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
44848565|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848566|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44848567|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44848568|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44848569|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848570|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848571|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848572|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44848573|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44848574|NCT02301715|Oxytocin|oxytocin|mesh-list
44848575|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
44848576|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848577|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848578|NCT02301780|Aspirin|aspirin|mesh-list
44848579|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44848580|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44848581|NCT02301780|Analgesics|analgesics|mesh-ancestor
44848582|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
44848583|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848584|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848585|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848586|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44848587|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44848588|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44848589|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848590|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44848591|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44848592|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848593|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
44848594|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44848595|NCT02301806|Glimepiride|glimepiride|mesh-list
44848596|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848597|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848598|NCT02301806|Incretins|incretins|mesh-ancestor
44848599|NCT02301806|Hormones|hormones|mesh-ancestor
44848600|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848601|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44848602|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44848603|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848604|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848605|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44848606|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848607|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
44848608|NCT02301910|Tenecteplase|tenecteplase|mesh-list
44848609|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44848610|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44848611|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848612|NCT02301949|Thalidomide|thalidomide|mesh-list
44848613|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848614|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
44848615|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848616|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
44848617|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44848618|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848619|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44848620|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44848621|NCT02301949|Growth Substances|growth substances|mesh-ancestor
44848622|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
44848623|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848624|NCT02301962|Panitumumab|panitumumab|mesh-list
44848625|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44848626|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848627|NCT02302170|Vaccines|vaccines|mesh-list
44848628|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
44848629|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848630|NCT02302209|Oxytocin|oxytocin|mesh-list
44848631|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
44848632|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848633|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848634|NCT02302274|Flecainide|flecainide|mesh-list
44848635|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334963|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848636|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44848637|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44848638|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848639|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848640|NCT02302326|Folic Acid|folic acid|mesh-list
44848641|NCT02302326|Inositol|inositol|mesh-list
44848642|NCT02302326|Metformin|metformin|mesh-list
44848643|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848644|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848645|NCT02302326|Hematinics|hematinics|mesh-ancestor
44848646|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
44848647|NCT02302326|Vitamins|vitamins|mesh-ancestor
44848648|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
44848649|NCT02302378|Bupivacaine|bupivacaine|mesh-list
44848650|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
44848651|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
44848652|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848653|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848654|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
44848655|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848656|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44848657|NCT02302430|Oxytocin|oxytocin|mesh-list
44848658|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
44848659|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848660|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848661|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
44848662|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44848663|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44848664|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848665|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
44848666|NCT02302456|Coagulants|coagulants|mesh-ancestor
44848667|NCT02302469|Lenalidomide|lenalidomide|mesh-list
44848668|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
44848669|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848670|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44848671|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44848672|NCT02302469|Growth Substances|growth substances|mesh-ancestor
44848673|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
44848674|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848675|NCT02302495|Prednisone|prednisone|mesh-list
44848676|NCT02302495|Melphalan|melphalan|mesh-list
44848677|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848678|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
44848679|NCT02302495|Hormones|hormones|mesh-ancestor
44848680|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848681|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335007|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
44848682|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44848683|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848684|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44848685|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
44848686|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848687|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44848688|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848689|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
44848690|NCT02302508|Clopidogrel|clopidogrel|mesh-list
44848691|NCT02302508|Ticagrelor|ticagrelor|mesh-list
44848692|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44848693|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44848694|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44848695|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44848696|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44848697|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
44848698|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848699|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848700|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848701|NCT02302547|Ritonavir|ritonavir|mesh-list
44848702|NCT02302547|Lopinavir|lopinavir|mesh-list
44848703|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44848704|NCT02302547|Darunavir|darunavir|mesh-list
44848705|NCT02302547|Indinavir|indinavir|mesh-list
44848706|NCT02302547|Saquinavir|saquinavir|mesh-list
44848707|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
44848708|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44848709|NCT02302547|Tenofovir|tenofovir|mesh-list
44848710|NCT02302547|Emtricitabine|emtricitabine|mesh-list
44848711|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
44848712|NCT02302547|Nevirapine|nevirapine|mesh-list
44848713|NCT02302547|Maraviroc|maraviroc|mesh-list
44848714|NCT02302547|Dolutegravir|dolutegravir|mesh-list
44848715|NCT02302547|Cobicistat|cobicistat|mesh-list
44848716|NCT02302547|Rilpivirine|rilpivirine|mesh-list
44848717|NCT02302547|Tipranavir|tipranavir|mesh-list
44848718|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
44848719|NCT02302547|Elvitegravir|elvitegravir|mesh-list
44848720|NCT02302547|Efavirenz|efavirenz|mesh-list
44848721|NCT02302547|Etravirine|etravirine|mesh-list
44848722|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44848723|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
44848724|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
44848725|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44848726|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848727|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848728|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44848729|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44848730|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
44848731|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848732|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44848733|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44848734|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44848735|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44848736|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44848737|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44848738|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44848739|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44848740|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44848741|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44848742|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44848743|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44848744|NCT02302586|Morphine|morphine|mesh-list
44848745|NCT02302586|Bupivacaine|bupivacaine|mesh-list
44848746|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44848747|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
44848748|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848749|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848750|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
44848751|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848752|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44848753|NCT02302586|Narcotics|narcotics|mesh-ancestor
44848754|NCT02302586|Analgesics|analgesics|mesh-ancestor
44848755|NCT02302729|Micronutrients|micronutrients|mesh-list
44848756|NCT02302729|Trace Elements|trace elements|mesh-list
44848757|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848758|NCT02302768|Selenium|selenium|mesh-list
44848759|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
44848760|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848761|NCT02302768|Protective Agents|protective agents|mesh-ancestor
44848762|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848763|NCT02302768|Trace Elements|trace elements|mesh-ancestor
44848764|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
44848765|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
44848766|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44848767|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44848768|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
44848769|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848770|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44848771|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44848772|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848773|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848774|NCT02302976|Exenatide|exenatide|mesh-list
44848775|NCT02302976|Cocaine|cocaine|mesh-list
44848776|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848777|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848778|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44848779|NCT02302976|Incretins|incretins|mesh-ancestor
44848780|NCT02302976|Hormones|hormones|mesh-ancestor
44848781|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848782|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
44848783|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
44848784|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335130|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44848785|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
44848786|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848787|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44848788|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44848789|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44848790|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848791|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848792|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
44848793|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848794|NCT02302989|Ranibizumab|ranibizumab|mesh-list
44848795|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44848796|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44848797|NCT02302989|Growth Substances|growth substances|mesh-ancestor
44848798|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848799|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
44848800|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848801|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
44848802|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44848803|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44848804|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44848805|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848806|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848807|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
44848808|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848809|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848810|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44335173|NCT00995917|Vitamin K|vitamin k|mesh-list
44848811|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848812|NCT02303106|Lamotrigine|lamotrigine|mesh-list
44848813|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
44848814|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44848815|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848816|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848817|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44848818|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848819|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44848820|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44848821|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848822|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44848823|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44848824|NCT02303171|Enoxaparin|enoxaparin|mesh-list
44848825|NCT02303171|Warfarin|warfarin|mesh-list
44848826|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
44848827|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44848828|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44848829|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848831|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44848832|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848833|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848834|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44848835|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
44848836|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
44848837|NCT02303327|Androgens|androgens|mesh-list
44848838|NCT02303327|Hormones|hormones|mesh-ancestor
44848839|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848840|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848841|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
44848842|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44848843|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848844|NCT02303418|Oxytocin|oxytocin|mesh-list
44848845|NCT02303418|Carbetocin|carbetocin|mesh-list
44848846|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
44848847|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848848|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848849|NCT02303444|Sorafenib|sorafenib|mesh-list
44848850|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848851|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44848852|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848853|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848854|NCT02303483|Niacinamide|niacinamide|mesh-list
44848855|NCT02303483|Niacin|niacin|mesh-list
44848856|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
44848857|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
44848858|NCT02303483|Vitamins|vitamins|mesh-ancestor
44848859|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
44848860|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848861|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44848862|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
44848863|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848864|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44848865|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
44848866|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
44848867|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44848868|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44848869|NCT02303587|Prednisolone|prednisolone|mesh-list
44848870|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
44848871|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44848872|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
44848873|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44848874|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
44848875|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
44848876|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848877|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848878|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44848879|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
44848880|NCT02303587|Hormones|hormones|mesh-ancestor
44848881|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848882|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44848883|NCT02303587|Protective Agents|protective agents|mesh-ancestor
44848884|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44848885|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848886|NCT02303600|Montelukast|montelukast|mesh-list
44848887|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44848888|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
44848889|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44848890|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
44335224|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848891|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848892|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848893|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44848894|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44848895|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848896|NCT02303639|Amiodarone|amiodarone|mesh-list
44848897|NCT02303639|Sotalol|sotalol|mesh-list
44848898|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44848899|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
44848900|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44848901|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44848902|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848903|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44848904|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44848905|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44848906|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848907|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44848908|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44848909|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44848910|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44848911|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44848912|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848913|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848914|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848915|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
44848916|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
44848917|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848918|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
44848919|NCT02303730|Exenatide|exenatide|mesh-list
44848920|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44848921|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848922|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44848923|NCT02303730|Incretins|incretins|mesh-ancestor
44848924|NCT02303730|Hormones|hormones|mesh-ancestor
44848925|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848926|NCT02303769|Tamsulosin|tamsulosin|mesh-list
44848927|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44848928|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44848929|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44848930|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
44848931|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848932|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848933|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848934|NCT02303769|Urological Agents|urological agents|mesh-ancestor
44848935|NCT02303782|Azacitidine|azacitidine|mesh-list
44848936|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44848937|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
44848938|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848939|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848940|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848941|NCT02303847|Ketamine|ketamine|mesh-list
44848942|NCT02303847|Analgesics|analgesics|mesh-ancestor
44848943|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
44848944|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44848945|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848946|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44848947|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44848948|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
44848949|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
44848950|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44848951|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44848952|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44848953|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44848954|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848955|NCT02303873|Alendronate|alendronate|mesh-list
44848956|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44848957|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848958|NCT02303886|Methylene Blue|methylene blue|mesh-list
44848959|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848960|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848961|NCT02303899|Gemcitabine|gemcitabine|mesh-list
44848962|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
44848963|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44848964|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
44848965|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848966|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848967|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
44848968|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44848969|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848970|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44848971|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
44848972|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848973|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44848974|NCT02303912|Carboplatin|carboplatin|mesh-list
44848975|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848976|NCT02303951|Atezolizumab|atezolizumab|mesh-list
44848977|NCT02303951|Vemurafenib|vemurafenib|mesh-list
44632927|NCT00436826|Cladribine|cladribine|mesh-list
44848978|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44848979|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44848980|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44848981|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44848982|NCT02304042|Oxytocin|oxytocin|mesh-list
44848983|NCT02304042|Carbetocin|carbetocin|mesh-list
44848984|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
44848985|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848986|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848987|NCT02304055|Oxytocin|oxytocin|mesh-list
44848988|NCT02304055|Carbetocin|carbetocin|mesh-list
44848989|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
44848990|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44848991|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848992|NCT02304081|Saxagliptin|saxagliptin|mesh-list
44848993|NCT02304081|Incretins|incretins|mesh-ancestor
44848994|NCT02304081|Hormones|hormones|mesh-ancestor
44848995|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44848996|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44848997|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44848998|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
44848999|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849000|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849001|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849002|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
44849003|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44849004|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44849005|NCT02304094|Prednisolone|prednisolone|mesh-list
44849006|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
44849007|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44849008|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
44849009|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849010|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
44849011|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
44849012|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849013|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849014|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849015|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
44849016|NCT02304094|Hormones|hormones|mesh-ancestor
44849017|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849018|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44849019|NCT02304094|Protective Agents|protective agents|mesh-ancestor
44849020|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849021|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849022|NCT02304107|Letrozole|letrozole|mesh-list
44849023|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849024|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44849025|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44849026|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849027|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849028|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44849029|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44849030|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849031|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849032|NCT02304198|Udenafil|udenafil|mesh-list
44849033|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44849034|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44849035|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849036|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849037|NCT02304211|Insulin|insulin|mesh-list
44849038|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849039|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849040|NCT02304237|Progesterone|progesterone|mesh-list
44849041|NCT02304237|Progestins|progestins|mesh-ancestor
44849042|NCT02304237|Hormones|hormones|mesh-ancestor
44849043|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849044|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849045|NCT02304250|Dexamethasone|dexamethasone|mesh-list
44849046|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849047|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
44849048|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
44849049|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849050|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849051|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849052|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
44633002|NCT00436436|Temozolomide|temozolomide|mesh-list
44849053|NCT02304250|Hormones|hormones|mesh-ancestor
44849054|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849055|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849056|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849057|NCT02304276|Calcium|calcium|mesh-list
44849058|NCT02304276|Fluorides|fluorides|mesh-list
44849059|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44849060|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849061|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
44849062|NCT02304276|Protective Agents|protective agents|mesh-ancestor
44849063|NCT02304289|Artesunate|artesunate|mesh-list
44849064|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
44849065|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44849066|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44849067|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849068|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849069|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
44849070|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
44849071|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44849072|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
44697031|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849074|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849075|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849076|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
44849077|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849078|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849079|NCT02304393|Atezolizumab|atezolizumab|mesh-list
44849080|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849081|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
44849082|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44849083|NCT02304445|Estrogens|estrogens|mesh-ancestor
44849084|NCT02304445|Hormones|hormones|mesh-ancestor
44335423|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849085|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849086|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849087|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849088|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849089|NCT02304627|Insulin|insulin|mesh-list
44849090|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849091|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849092|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
44849093|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849094|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849095|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44849096|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44849097|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849098|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849099|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849100|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44849101|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44849102|NCT02304887|Denosumab|denosumab|mesh-list
44849103|NCT02304887|Teriparatide|teriparatide|mesh-list
44849104|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44849105|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849106|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44849107|NCT02305030|Opicapone|opicapone|mesh-list
44849108|NCT02305030|Warfarin|warfarin|mesh-list
44849109|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
44849110|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44849111|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849112|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849113|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44849114|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44849115|NCT02305069|Pioglitazone|pioglitazone|mesh-list
44849116|NCT02305069|Octreotide|octreotide|mesh-list
44849117|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849118|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849119|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849120|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849121|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849122|NCT02305160|Poractant alfa|poractant alfa|mesh-list
44849123|NCT02305160|Beractant|beractant|mesh-list
44849124|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44849125|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
44849126|NCT02305173|Dexamethasone|dexamethasone|mesh-list
44849127|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849128|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
44849129|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
44849130|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849131|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849132|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849133|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
44849134|NCT02305173|Hormones|hormones|mesh-ancestor
44849135|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849136|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849137|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849138|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
44849139|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849140|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849141|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44849142|NCT02305355|Atorvastatin|atorvastatin|mesh-list
44849143|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44849144|NCT02305355|Simvastatin|simvastatin|mesh-list
44849145|NCT02305355|Pravastatin|pravastatin|mesh-list
44849146|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44849147|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44849148|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
44849149|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849150|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44849151|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44697032|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697033|NCT01394913|Etanercept|etanercept|mesh-list
44697034|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44697035|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44697036|NCT01394913|Analgesics|analgesics|mesh-ancestor
44697037|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
44335502|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44697038|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697039|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697040|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697041|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697042|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697043|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697044|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
44697045|NCT01395069|Ketorolac|ketorolac|mesh-list
44697046|NCT01395069|Nepafenac|nepafenac|mesh-list
44697047|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44697048|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44697049|NCT01395069|Analgesics|analgesics|mesh-ancestor
44697050|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
44697051|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697052|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697053|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697054|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697055|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44697056|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697057|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248656|NCT00605410|Ipratropium|ipratropium|mesh-list
44697059|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
44697060|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697061|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697062|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697063|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697064|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697065|NCT01395147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44697066|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44697067|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44697068|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697069|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697070|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
44697071|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44697072|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44697073|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44697074|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44697075|NCT01395199|Amlodipine|amlodipine|mesh-list
44697076|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44697077|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44697078|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44697079|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697080|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697081|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697082|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
44697083|NCT01395251|Prednisolone|prednisolone|mesh-list
44697084|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
44697085|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697086|NCT01395251|Hormones|hormones|mesh-ancestor
44697087|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697088|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697089|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697090|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697091|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
44697092|NCT01395290|Vitamin D|vitamin d|mesh-list
44697093|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697094|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697095|NCT01395290|Vitamins|vitamins|mesh-ancestor
44697096|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
44697097|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44697098|NCT01395381|Albendazole|albendazole|mesh-list
44697099|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
44697100|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184511|NCT00330304|Renal Agents|renal agents|mesh-ancestor
44849152|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849154|NCT02305394|Propofol|propofol|mesh-list
44849155|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44849156|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849157|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849158|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44849159|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
44849160|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
44849161|NCT02305394|Analgesics|analgesics|mesh-ancestor
44849162|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
44849163|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849164|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44849165|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44849166|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44849167|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849168|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849169|NCT02305485|Everolimus|everolimus|mesh-list
44849170|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849171|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849172|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
44849173|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849174|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
44849175|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44849176|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
44849177|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849178|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849179|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44849180|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44849181|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44849182|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
44849183|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849184|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849185|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44849186|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
44849187|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
44849188|NCT02305550|Protective Agents|protective agents|mesh-ancestor
44849189|NCT02305615|Bevacizumab|bevacizumab|mesh-list
44849190|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849191|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849192|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44849193|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44849194|NCT02305615|Growth Substances|growth substances|mesh-ancestor
44849195|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849196|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44849197|NCT02305654|Paclitaxel|paclitaxel|mesh-list
44849198|NCT02305654|Cisplatin|cisplatin|mesh-list
44849199|NCT02305654|Ifosfamide|ifosfamide|mesh-list
44849200|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44849201|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849202|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
44849203|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
44849204|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
44849205|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849206|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44849207|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
44849208|NCT02305693|Letrozole|letrozole|mesh-list
44849209|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849210|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44849211|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44849212|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849213|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849214|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44335656|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44849215|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
44849216|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849217|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849218|NCT02305810|Everolimus|everolimus|mesh-list
44849219|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849220|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849221|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
44849222|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849223|NCT02305823|Aripiprazole|aripiprazole|mesh-list
44849224|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44849225|NCT02305823|Ziprasidone|ziprasidone|mesh-list
44849226|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
44849227|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849228|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44849229|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44849230|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849231|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849232|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
44849233|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
44849234|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849235|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849236|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44849237|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44849238|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
44849239|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44849240|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44335657|NCT00998192|Paclitaxel|paclitaxel|mesh-list
44335658|NCT00998192|Carboplatin|carboplatin|mesh-list
44849241|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44849242|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44849243|NCT02305836|Donepezil|donepezil|mesh-list
44849244|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44849245|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849246|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849247|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
44849248|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849249|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849250|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
44849251|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44849252|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44849253|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44849254|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
44849255|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849256|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44849257|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44849258|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849259|NCT02305901|Repaglinide|repaglinide|mesh-list
44849260|NCT02305901|Bupropion|bupropion|mesh-list
44849261|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44849262|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
44849263|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849264|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44849265|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44849266|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849267|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849268|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
44849269|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849270|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849271|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44849272|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44849273|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849274|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849275|NCT02305927|Vitamin D|vitamin d|mesh-list
44849276|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
44849277|NCT02305927|Vitamins|vitamins|mesh-ancestor
44849278|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
44849279|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849280|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44849281|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44849282|NCT02305940|Doxycycline|doxycycline|mesh-list
44849283|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849284|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849285|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
44849286|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44849287|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44849288|NCT02305979|Loratadine|loratadine|mesh-list
44849289|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
44849290|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
44849291|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44849292|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44849293|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44849294|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
44849295|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
44849296|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849297|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335683|NCT00998439|Paclitaxel|paclitaxel|mesh-list
44849298|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849299|NCT02305992|Bupivacaine|bupivacaine|mesh-list
44633298|NCT00433537|Dexamethasone|dexamethasone|mesh-list
44849300|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
44849301|NCT02305992|Anesthetics|anesthetics|mesh-list
44849302|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849303|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849304|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
44849305|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633373|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849306|NCT02306031|Diclofenac|diclofenac|mesh-list
44849307|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
44849308|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849309|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849310|NCT02306031|Analgesics|analgesics|mesh-ancestor
44849311|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
44849312|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849313|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849314|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849315|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849316|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44849317|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849318|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849319|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44849320|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44849321|NCT02306070|Metformin|metformin|mesh-list
44849322|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849323|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849324|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
44849325|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44849326|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849327|NCT02306239|Terlipressin|terlipressin|mesh-list
44849328|NCT02306239|Norepinephrine|norepinephrine|mesh-list
44849329|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44849330|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44849331|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
44849332|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849333|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849334|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849335|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
44849336|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
44849337|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849338|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44849339|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44849340|NCT02306278|Gabapentin|gabapentin|mesh-list
44849341|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849342|NCT02306278|Analgesics|analgesics|mesh-ancestor
44849343|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
44849344|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849345|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
44849346|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44849347|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44849348|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849349|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849350|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44849351|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44849352|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849353|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849354|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
44849355|NCT02306473|Mannitol|mannitol|mesh-list
44849356|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44849357|NCT02306473|Diuretics|diuretics|mesh-ancestor
44849358|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
44849359|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849360|NCT02306564|Cabergoline|cabergoline|mesh-list
44849361|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44849362|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44849363|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
44849364|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
44849365|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849366|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849367|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849368|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44849369|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44849370|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44849371|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
44849372|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849373|NCT02306629|Epratuzumab|epratuzumab|mesh-list
44849374|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849375|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849376|NCT02306733|Oxytocin|oxytocin|mesh-list
44849377|NCT02306733|Ergonovine|ergonovine|mesh-list
44849378|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
44849379|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44633450|NCT00432172|Docetaxel|docetaxel|mesh-list
44849380|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849381|NCT02306772|Mesalamine|mesalamine|mesh-list
44849382|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849383|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849384|NCT02306772|Analgesics|analgesics|mesh-ancestor
44849385|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
44849386|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849387|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849388|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849389|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849390|NCT02306785|Mesalamine|mesalamine|mesh-list
44849391|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849392|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849393|NCT02306785|Analgesics|analgesics|mesh-ancestor
44849394|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
44849395|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849396|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849397|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849398|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849399|NCT02306798|Mesalamine|mesalamine|mesh-list
44849400|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849401|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849402|NCT02306798|Analgesics|analgesics|mesh-ancestor
44849403|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
44849404|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849405|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849406|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849407|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849408|NCT02306889|Fenofibrate|fenofibrate|mesh-list
44849409|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44849410|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
44849411|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849412|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44849413|NCT02306902|Fenofibrate|fenofibrate|mesh-list
44849414|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44849415|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
44849416|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849417|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44849418|NCT02306954|Aldesleukin|aldesleukin|mesh-list
44849419|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849420|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44849421|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44849422|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
44849423|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849424|NCT02307006|Vancomycin|vancomycin|mesh-list
44849425|NCT02307006|Cefazolin|cefazolin|mesh-list
44849426|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44849427|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849428|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849429|NCT02307045|Nicotine|nicotine|mesh-list
44849430|NCT02307045|Varenicline|varenicline|mesh-list
44849431|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44849432|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
44849433|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849434|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849435|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44849436|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44849437|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
44849438|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849439|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849440|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
44849441|NCT02307201|Analgesics|analgesics|mesh-ancestor
44849442|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
44849443|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849444|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849445|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
44849446|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849447|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44849448|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
44849449|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44849450|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849451|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849452|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44849453|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
44849454|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44633517|NCT00430781|Lapatinib|lapatinib|mesh-list
44849455|NCT02307227|Paclitaxel|paclitaxel|mesh-list
44849456|NCT02307227|Docetaxel|docetaxel|mesh-list
44849457|NCT02307227|Trastuzumab|trastuzumab|mesh-list
44849458|NCT02307227|Epirubicin|epirubicin|mesh-list
44849459|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44849460|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849461|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44849462|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44849463|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44849464|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849465|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849466|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44849467|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44849468|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44849469|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849470|NCT02307305|Acetaminophen|acetaminophen|mesh-list
44849471|NCT02307305|Celecoxib|celecoxib|mesh-list
44849472|NCT02307305|Naproxen|naproxen|mesh-list
44849473|NCT02307305|Oxycodone|oxycodone|mesh-list
44849474|NCT02307305|Tramadol|tramadol|mesh-list
44849475|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44849476|NCT02307305|Naloxone|naloxone|mesh-list
44849477|NCT02307305|Esomeprazole|esomeprazole|mesh-list
44849478|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849479|NCT02307305|Analgesics|analgesics|mesh-ancestor
44849480|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
44849481|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849482|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849483|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
44849484|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44849485|NCT02307305|Narcotics|narcotics|mesh-ancestor
44849486|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849487|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849488|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849489|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849490|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44849491|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44849492|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849493|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849494|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44849495|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849496|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44849497|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44849498|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44849499|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849500|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849501|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44849502|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849503|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
44849504|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
44849505|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44849506|NCT02307383|Lactitol|lactitol|mesh-list
44849507|NCT02307383|Cathartics|cathartics|mesh-ancestor
44849508|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849509|NCT02307396|Haloperidol|haloperidol|mesh-list
44849510|NCT02307396|Pimozide|pimozide|mesh-list
44849511|NCT02307396|Olanzapine|olanzapine|mesh-list
44849512|NCT02307396|Risperidone|risperidone|mesh-list
44849513|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44849514|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44849515|NCT02307396|Ziprasidone|ziprasidone|mesh-list
44849516|NCT02307396|Amisulpride|amisulpride|mesh-list
44849517|NCT02307396|Perphenazine|perphenazine|mesh-list
44849518|NCT02307396|Sertindole|sertindole|mesh-list
44849519|NCT02307396|Fluphenazine|fluphenazine|mesh-list
44849520|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
44849521|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44849522|NCT02307396|Sulpiride|sulpiride|mesh-list
44849523|NCT02307396|Thioridazine|thioridazine|mesh-list
44849524|NCT02307396|Clopenthixol|clopenthixol|mesh-list
44849525|NCT02307396|Fluspirilene|fluspirilene|mesh-list
44849526|NCT02307396|Benperidol|benperidol|mesh-list
44849527|NCT02307396|Bromperidol|bromperidol|mesh-list
44849528|NCT02307396|Perazine|perazine|mesh-list
44849529|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44849530|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
44849531|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849532|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849533|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849534|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44335949|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849535|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44849536|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849537|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849538|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44849539|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
44849540|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
44849541|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
44849542|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849543|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849544|NCT02307396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44849545|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44335973|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44849546|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849547|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
44849548|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44849549|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44849550|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44849551|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44849552|NCT02307487|Mitomycins|mitomycins|mesh-list
44849553|NCT02307487|Mitomycin|mitomycin|mesh-list
44849554|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44849555|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849556|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
44849557|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849558|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44849559|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849560|NCT02307565|Midodrine|midodrine|mesh-list
44849561|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
44849562|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
44849563|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849564|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849565|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44849566|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44849567|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44849568|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44849569|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
44849570|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849571|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849572|NCT02307591|Amiodarone|amiodarone|mesh-list
44849573|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44849574|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
44849575|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44849576|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849577|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849578|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44849579|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44849580|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44849581|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849582|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44849583|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44849584|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44849585|NCT02307695|Saxagliptin|saxagliptin|mesh-list
44849586|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44849587|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849588|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849589|NCT02307695|Incretins|incretins|mesh-ancestor
44849590|NCT02307695|Hormones|hormones|mesh-ancestor
44849591|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849592|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
44849593|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849594|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849595|NCT02307721|Remifentanil|remifentanil|mesh-list
44849596|NCT02307721|Naloxone|naloxone|mesh-list
44849597|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44849598|NCT02307721|Narcotics|narcotics|mesh-ancestor
44849599|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849600|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849601|NCT02307721|Analgesics|analgesics|mesh-ancestor
44849602|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
44849603|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849604|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44633668|NCT00429364|Losartan|losartan|mesh-list
44849605|NCT02307825|Azithromycin|azithromycin|mesh-list
44849606|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849607|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849608|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
44849609|NCT02307864|Tramadol|tramadol|mesh-list
44849610|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44849611|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849612|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849613|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44849614|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44849615|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849616|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849617|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849618|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44849619|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
44849620|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44849621|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849622|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44849623|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44849624|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44849625|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44849626|NCT02307864|Narcotics|narcotics|mesh-ancestor
44849627|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849628|NCT02307864|Analgesics|analgesics|mesh-ancestor
44849629|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
44849630|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849631|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
44849632|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
44849633|NCT02307955|Protective Agents|protective agents|mesh-ancestor
44849634|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849635|NCT02307968|Insulin|insulin|mesh-list
44849636|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849637|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849638|NCT02308072|Cisplatin|cisplatin|mesh-list
44849639|NCT02308072|Olaparib|olaparib|mesh-list
44849640|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849641|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44849642|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849643|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849644|NCT02308098|Budesonide|budesonide|mesh-list
44849645|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
44849646|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44849647|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849648|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44849649|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
44849650|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849651|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849652|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44849653|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
44849654|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
44849655|NCT02308098|Hormones|hormones|mesh-ancestor
44849656|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849657|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44849658|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44849659|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44849660|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44849661|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849662|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849663|NCT02308137|Domperidone|domperidone|mesh-list
44849664|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849665|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
44849666|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
44849667|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849668|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849669|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849670|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44849671|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
44849672|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849673|NCT02308254|Lixisenatide|lixisenatide|mesh-list
44849674|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44849675|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849676|NCT02308319|Tenofovir|tenofovir|mesh-list
44849677|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
44849678|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633763|NCT00429026|Melphalan|melphalan|mesh-list
44849679|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44849680|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44849681|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849682|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849683|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44849684|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44849685|NCT02308332|Tenofovir|tenofovir|mesh-list
44849686|NCT02308332|Emtricitabine|emtricitabine|mesh-list
44849687|NCT02308332|Rilpivirine|rilpivirine|mesh-list
44849688|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
44849689|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849690|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44849691|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44849692|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849693|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849694|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44849695|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44849696|NCT02308553|Paclitaxel|paclitaxel|mesh-list
44849697|NCT02308553|Nintedanib|nintedanib|mesh-list
44849698|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44849699|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849700|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
44849701|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
44849702|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
44849703|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849704|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44849705|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849706|NCT02308644|Bevacizumab|bevacizumab|mesh-list
44849707|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849708|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849709|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44849710|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44849711|NCT02308644|Growth Substances|growth substances|mesh-ancestor
44849712|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849713|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44849714|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44849715|NCT02308930|Vitamin D|vitamin d|mesh-list
44849716|NCT02308930|Vitamins|vitamins|mesh-list
44336130|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336157|NCT01001247|Omeprazole|omeprazole|mesh-list
44849717|NCT02308930|Vitamin A|vitamin a|mesh-list
44849718|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
44849719|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
44849720|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849721|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
44849722|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849723|NCT02308930|Protective Agents|protective agents|mesh-ancestor
44849724|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44849725|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849726|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44849727|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44849728|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
44849729|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849730|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849731|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44849732|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
44336158|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44336173|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
44849733|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849734|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849735|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44849736|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
44849737|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44849738|NCT02308982|Antibodies|antibodies|mesh-list
44849739|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
44849740|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44849741|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
44849742|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849743|NCT02309177|Gemcitabine|gemcitabine|mesh-list
44849744|NCT02309177|Paclitaxel|paclitaxel|mesh-list
44849745|NCT02309177|Carboplatin|carboplatin|mesh-list
44849746|NCT02309177|Nivolumab|nivolumab|mesh-list
44849747|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44849748|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849749|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44849750|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44849751|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44849752|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849753|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633817|NCT00428220|Sunitinib|sunitinib|mesh-list
44849754|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
44849755|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
44849756|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849757|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849758|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849759|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
44336174|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849760|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849761|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849762|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44849763|NCT02309281|Aflibercept|aflibercept|mesh-list
44849764|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44849765|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44849766|NCT02309281|Growth Substances|growth substances|mesh-ancestor
44849767|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849768|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44336203|NCT01001585|Sevoflurane|sevoflurane|mesh-list
44849769|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849770|NCT02309320|Gontivimab|gontivimab|mesh-list
44849771|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
44849772|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849773|NCT02309346|Clindamycin|clindamycin|mesh-list
44849774|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
44849775|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
44849776|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849777|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849778|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44849779|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849780|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849781|NCT02309385|Dexamethasone|dexamethasone|mesh-list
44849782|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
44849783|NCT02309385|Prednisolone|prednisolone|mesh-list
44849784|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44849785|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
44849786|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44697101|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697102|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
44697103|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44697104|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44697105|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
44697106|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
44697107|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
44697108|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697109|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697110|NCT01395420|Ceftazidime|ceftazidime|mesh-list
44697111|NCT01395420|Avibactam|avibactam|mesh-list
44697112|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697113|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697114|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44697115|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697116|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697117|NCT01395433|Dexetimide|dexetimide|mesh-list
44697118|NCT01395433|Citalopram|citalopram|mesh-list
44697119|NCT01395433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44697120|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44697121|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44697122|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697123|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697124|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
44697125|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697126|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44697127|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
44697128|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697129|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44697130|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44697131|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
44697132|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
44697133|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697134|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44697135|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44697136|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
44697137|NCT01395485|Brodalumab|brodalumab|mesh-list
44697138|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697139|NCT01395589|Vitamin D|vitamin d|mesh-list
44697140|NCT01395589|Vitamins|vitamins|mesh-ancestor
44697141|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
44633890|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44849787|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
44849788|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44849789|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
44849790|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44849792|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849793|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
44849794|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
44849795|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849796|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849797|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849798|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
44849799|NCT02309385|Hormones|hormones|mesh-ancestor
44849800|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849801|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44849802|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849803|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
44849804|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849805|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849806|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44849807|NCT02309385|Protective Agents|protective agents|mesh-ancestor
44849808|NCT02309424|Acetic Acid|acetic acid|mesh-list
44849809|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44849810|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849811|NCT02309437|Oxycodone|oxycodone|mesh-list
44849812|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44849813|NCT02309437|Narcotics|narcotics|mesh-ancestor
44849814|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849815|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849816|NCT02309437|Analgesics|analgesics|mesh-ancestor
44849817|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
44849818|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849819|NCT02309450|Asunaprevir|asunaprevir|mesh-list
44849820|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44849821|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849822|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849823|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
44849824|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849825|NCT02309554|Nonoxynol|nonoxynol|mesh-list
44849826|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44849827|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44849828|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849829|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44849830|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
44849831|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44849832|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44849833|NCT02309658|Gemcitabine|gemcitabine|mesh-list
44849834|NCT02309658|Cisplatin|cisplatin|mesh-list
44849835|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849836|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44849837|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
44849838|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849839|NCT02309658|Antiviral Agents|antiviral agents|mesh-ancestor
44849840|NCT02309658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44849841|NCT02309658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849842|NCT02309658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849843|NCT02309658|Immunologic Factors|immunologic factors|mesh-ancestor
44849844|NCT02309658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849846|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44849847|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849848|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849849|NCT02309879|Lidocaine|lidocaine|mesh-list
44849850|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
44849851|NCT02309879|Remifentanil|remifentanil|mesh-list
44849852|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
44849853|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
44849854|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44849855|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849856|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
44849857|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849858|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44849859|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44849860|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44849861|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44849862|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849863|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44849864|NCT02309879|Narcotics|narcotics|mesh-ancestor
44849865|NCT02309879|Analgesics|analgesics|mesh-ancestor
44849866|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
44849867|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44849868|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44849869|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
44849870|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44849871|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
44849872|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44849873|NCT02309970|Aspirin|aspirin|mesh-list
44849874|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44849875|NCT02309970|Warfarin|warfarin|mesh-list
44849876|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
44849877|NCT02309970|Dabigatran|dabigatran|mesh-list
44849878|NCT02309970|Apixaban|apixaban|mesh-list
44849879|NCT02309970|Clopidogrel|clopidogrel|mesh-list
44849880|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44849881|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849882|NCT02309970|Analgesics|analgesics|mesh-ancestor
44849883|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
44849884|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849885|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849886|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849887|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849888|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44849889|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44849890|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849891|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44849892|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44849893|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849894|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
44849895|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44849896|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44849897|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44849898|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
44849899|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849900|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
44849901|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44849902|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
44849903|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44849904|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
44849905|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44849906|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849907|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44849908|NCT02310074|Hormones|hormones|mesh-list
44849909|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44849910|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849911|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849912|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44849913|NCT02310087|Vitamin E|vitamin e|mesh-list
44849914|NCT02310087|Vitamins|vitamins|mesh-ancestor
44849915|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
44849916|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849917|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
44849918|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849919|NCT02310087|Protective Agents|protective agents|mesh-ancestor
44849920|NCT02310243|Palbociclib|palbociclib|mesh-list
44849921|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849922|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44849923|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849924|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849925|NCT02310295|Triamcinolone|triamcinolone|mesh-list
44849926|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44849927|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44849928|NCT02310295|Bevacizumab|bevacizumab|mesh-list
44849929|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44849930|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44849931|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849932|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44849933|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44849934|NCT02310295|Growth Substances|growth substances|mesh-ancestor
44849935|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336395|NCT01003002|Levodopa|levodopa|mesh-list
44849936|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
44849937|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44849938|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
44849939|NCT02310295|Hormones|hormones|mesh-ancestor
44849940|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849941|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849942|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
44849943|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44849944|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849945|NCT02310347|Dronabinol|dronabinol|mesh-list
44849946|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
44849947|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849948|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44849949|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44849950|NCT02310347|Analgesics|analgesics|mesh-ancestor
44849951|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
44849952|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849953|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44849954|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44849955|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849956|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849957|NCT02310347|Hormones|hormones|mesh-ancestor
44849958|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44849959|NCT02310360|Fallypride|fallypride|mesh-list
44849960|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44849961|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44849962|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
44849963|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849964|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849965|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849966|NCT02310373|Nicotine|nicotine|mesh-list
44849967|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44849968|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
44849969|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44849970|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849971|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44849972|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44849973|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44849974|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44849975|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849976|NCT02310490|Mannitol|mannitol|mesh-list
44849977|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44849978|NCT02310490|Diuretics|diuretics|mesh-ancestor
44849979|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
44849980|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849981|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
44849982|NCT02310997|Melphalan|melphalan|mesh-list
44849983|NCT02310997|Busulfan|busulfan|mesh-list
44849984|NCT02310997|Fludarabine|fludarabine|mesh-list
44849985|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849986|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
44849987|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849988|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44849989|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44849990|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
44849991|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44849992|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44849993|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44849994|NCT02311010|Tacrolimus|tacrolimus|mesh-list
44849995|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44849996|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
44849997|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44849998|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44849999|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850000|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850001|NCT02311088|Caffeine|caffeine|mesh-list
44850002|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44850003|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850004|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44850005|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850006|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850007|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44850008|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44850009|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
44850010|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850011|NCT02311101|Mitomycins|mitomycins|mesh-list
44850012|NCT02311101|Mitomycin|mitomycin|mesh-list
44850013|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44850014|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850015|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
44850016|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850017|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44850018|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850019|NCT02311205|Sorafenib|sorafenib|mesh-list
44850020|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850021|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44850022|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850023|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850024|NCT02311231|Heparin|heparin|mesh-list
44850025|NCT02311231|Calcium heparin|calcium heparin|mesh-list
44850026|NCT02311231|Bivalirudin|bivalirudin|mesh-list
44850027|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
44850028|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44850029|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44850030|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850031|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
44850032|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44850033|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
44336472|NCT01004068|Clomiphene|clomiphene|mesh-list
44850034|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850035|NCT02311439|Folfirinox|folfirinox|mesh-list
44850036|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850037|NCT02311517|Ropivacaine|ropivacaine|mesh-list
44850038|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
44850039|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
44850040|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850041|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850042|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
44850043|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850045|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44850046|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850047|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44850048|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850049|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850050|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44850051|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850052|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
44850053|NCT02311569|Mirabegron|mirabegron|mesh-list
44850054|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44850055|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44850056|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44850057|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44850058|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850059|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850060|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850061|NCT02311569|Urological Agents|urological agents|mesh-ancestor
44850062|NCT02311608|Octreotide|octreotide|mesh-list
44850063|NCT02311608|Terlipressin|terlipressin|mesh-list
44850064|NCT02311608|Somatostatin|somatostatin|mesh-list
44850065|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850066|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850067|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850068|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850069|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44850070|NCT02311608|Hormones|hormones|mesh-ancestor
44850071|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850072|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850073|NCT02311686|Ethanol|ethanol|mesh-list
44850074|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44850075|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850076|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850077|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850078|NCT02311764|Carboplatin|carboplatin|mesh-list
44850079|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850080|NCT02311777|Pregabalin|pregabalin|mesh-list
44850081|NCT02311777|Ketamine|ketamine|mesh-list
44850082|NCT02311777|Analgesics|analgesics|mesh-ancestor
44336510|NCT01004419|Fulvestrant|fulvestrant|mesh-list
44850083|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
44850084|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850085|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850086|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44850087|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44850088|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
44850089|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
44850090|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850091|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44850092|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44850093|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850094|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850095|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
44850096|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44850097|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850098|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44850099|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44336562|NCT01004497|Analgesics|analgesics|mesh-ancestor
44850100|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44850101|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44850102|NCT02311946|Palbociclib|palbociclib|mesh-list
44850103|NCT02311946|Rabeprazole|rabeprazole|mesh-list
44850104|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44850105|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850106|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44850107|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850108|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850109|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44634224|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850110|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850111|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
44850112|NCT02312037|Antibodies|antibodies|mesh-list
44850113|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
44850114|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
44850115|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850116|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850117|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850118|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44850119|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
44850120|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44850121|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
44850122|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850123|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850124|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44850125|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850126|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850127|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44850128|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
44850129|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44850130|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
44850131|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850132|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850133|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44850134|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850135|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850136|NCT02312102|Lenalidomide|lenalidomide|mesh-list
44850137|NCT02312102|Bortezomib|bortezomib|mesh-list
44850138|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
44850139|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850140|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44850141|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44850142|NCT02312102|Growth Substances|growth substances|mesh-ancestor
44850143|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44850144|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850145|NCT02312115|Furosemide|furosemide|mesh-list
44850146|NCT02312115|Diuretics|diuretics|mesh-ancestor
44850147|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
44850148|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850149|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44850150|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850151|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850152|NCT02312180|Plasminogen|plasminogen|mesh-list
44850153|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44850154|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44850155|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850156|NCT02312232|Levodopa|levodopa|mesh-list
44850157|NCT02312232|Carbidopa|carbidopa|mesh-list
44850158|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44850159|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44850160|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
44850161|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850162|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850163|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850164|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44850165|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850166|NCT02312297|Minocycline|minocycline|mesh-list
44850167|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44850168|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850169|NCT02312375|Amlodipine|amlodipine|mesh-list
44850170|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850171|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44850172|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850173|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850174|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44850175|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850176|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
44850177|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44850178|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
44850179|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850180|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850181|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850182|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634301|NCT00423930|Bevacizumab|bevacizumab|mesh-list
44850183|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
44850184|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44850185|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44850186|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850187|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
44850188|NCT02312440|Coagulants|coagulants|mesh-ancestor
44850189|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
44850190|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850191|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850192|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
44850193|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44850194|NCT02312531|Antibodies|antibodies|mesh-list
44850195|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
44850196|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850197|NCT02312544|Timolol|timolol|mesh-list
44850198|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44850199|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44850200|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
44850201|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850202|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850203|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850204|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44850205|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850206|NCT02312609|Minocycline|minocycline|mesh-list
44850207|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44850208|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850209|NCT02312635|Cycloserine|cycloserine|mesh-list
44850210|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44850211|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850212|NCT02312635|Renal Agents|renal agents|mesh-ancestor
44850213|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44850214|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
44850215|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44336693|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44850216|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
44850217|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850218|NCT02312661|Metformin|metformin|mesh-list
44850219|NCT02312661|Paclitaxel|paclitaxel|mesh-list
44850220|NCT02312661|Carboplatin|carboplatin|mesh-list
44850221|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44850222|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850223|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
44850224|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
44850225|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
44850226|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850227|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850228|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850229|NCT02312804|Paclitaxel|paclitaxel|mesh-list
44850230|NCT02312804|Carboplatin|carboplatin|mesh-list
44850231|NCT02312804|Infigratinib|infigratinib|mesh-list
44850232|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44850233|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850234|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44850235|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44850236|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44850237|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850238|NCT02312908|Clonazepam|clonazepam|mesh-list
44850239|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
44850240|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
44850241|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
44850242|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850243|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850244|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850245|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
44850246|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44850247|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44850248|NCT02313051|Everolimus|everolimus|mesh-list
44850249|NCT02313051|Letrozole|letrozole|mesh-list
44850250|NCT02313051|Goserelin|goserelin|mesh-list
44850251|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850252|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44850253|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
44850254|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850255|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44850256|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44850257|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850258|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850259|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44850260|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
44850261|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850262|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850264|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850265|NCT02313103|Lofexidine|lofexidine|mesh-list
44850266|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44336710|NCT01005537|Aldesleukin|aldesleukin|mesh-list
44850267|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44850268|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850269|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
44850270|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850271|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44850272|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44850273|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44850274|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
44850275|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850276|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850277|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
44850278|NCT02313220|Exenatide|exenatide|mesh-list
44850279|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44850280|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850281|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850282|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850283|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44850284|NCT02313220|Incretins|incretins|mesh-ancestor
44850285|NCT02313220|Hormones|hormones|mesh-ancestor
44850286|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850287|NCT02313272|Bevacizumab|bevacizumab|mesh-list
44850288|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
44850289|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850290|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850291|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44850292|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44850293|NCT02313272|Growth Substances|growth substances|mesh-ancestor
44850294|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850295|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
44850296|NCT02313337|Fentanyl|fentanyl|mesh-list
44850297|NCT02313337|Midazolam|midazolam|mesh-list
44850298|NCT02313337|Anesthetics|anesthetics|mesh-list
44850299|NCT02313337|Propofol|propofol|mesh-list
44850300|NCT02313337|Atracurium|atracurium|mesh-list
44850301|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850302|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850303|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44850304|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44850305|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
44850306|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44850307|NCT02313337|Narcotics|narcotics|mesh-ancestor
44850308|NCT02313337|Analgesics|analgesics|mesh-ancestor
44850309|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
44850310|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850311|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44850312|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44850313|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44850314|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44850315|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
44850316|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
44850317|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850318|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850319|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44850320|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44850321|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44850322|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44850323|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44850324|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
44850325|NCT02313584|Dabigatran|dabigatran|mesh-list
44850326|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
44850327|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44850328|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
44850329|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850330|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850331|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
44850332|NCT02313727|Pamidronate|pamidronate|mesh-list
44850333|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44850334|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850335|NCT02313805|Insulin|insulin|mesh-list
44850336|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850337|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850338|NCT02313883|Taurolidine|taurolidine|mesh-list
44850339|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850340|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44850341|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850342|NCT02313922|Etanercept|etanercept|mesh-list
44850343|NCT02313922|Methotrexate|methotrexate|mesh-list
44850344|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44850345|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
44850346|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850347|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850348|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850349|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
44850350|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850351|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850352|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
44850353|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850354|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44850355|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44850356|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
44850357|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850358|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44850359|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44850360|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44850361|NCT02313922|Analgesics|analgesics|mesh-ancestor
44850362|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
44850363|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850364|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850365|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850366|NCT02314013|Metronidazole|metronidazole|mesh-list
44850367|NCT02314013|Cephalosporins|cephalosporins|mesh-list
44850368|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850369|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44850370|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634522|NCT00422799|Rituximab|rituximab|mesh-list
44850371|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44850372|NCT02314182|Bevacizumab|bevacizumab|mesh-list
44850373|NCT02314182|Capecitabine|capecitabine|mesh-list
44850374|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
44850375|NCT02314182|Irinotecan|irinotecan|mesh-list
44850376|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850377|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850378|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44850379|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44850380|NCT02314182|Growth Substances|growth substances|mesh-ancestor
44850381|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850382|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
44850383|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850384|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
44850385|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850386|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44850387|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44850388|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850389|NCT02314195|Serotonin|serotonin|mesh-list
44850390|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44850391|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44336851|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44850392|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
44850393|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850394|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850395|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850396|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44850397|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850398|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44850399|NCT02314208|Resveratrol|resveratrol|mesh-list
44850400|NCT02314208|Atorvastatin|atorvastatin|mesh-list
44850401|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44850402|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44850403|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
44850404|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850405|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44850406|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44336870|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129212|NCT05062356|Ketorolac|ketorolac|mesh-list
44850407|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850408|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
44850409|NCT02314208|Protective Agents|protective agents|mesh-ancestor
44850410|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850411|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44850412|NCT02314208|Cathartics|cathartics|mesh-ancestor
44850413|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850414|NCT02314273|Oprelvekin|oprelvekin|mesh-list
44850415|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850416|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44850417|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44850418|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44850419|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
44336885|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
44850420|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850421|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44850422|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44850423|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850424|NCT02314312|Cyclosporine|cyclosporine|mesh-list
44850425|NCT02314312|Prednisolone|prednisolone|mesh-list
44850426|NCT02314312|Everolimus|everolimus|mesh-list
44850427|NCT02314312|Cyclosporins|cyclosporins|mesh-list
44850428|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850429|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850430|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44850431|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
44850432|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850433|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
44336898|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
44336899|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336907|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
44850434|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850435|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44850436|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850437|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44850438|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850439|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850440|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
44850441|NCT02314312|Hormones|hormones|mesh-ancestor
44850442|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850443|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850444|NCT02314325|Factor VIII|factor viii|mesh-list
44850445|NCT02314325|Coagulants|coagulants|mesh-ancestor
44850446|NCT02314351|Fentanyl|fentanyl|mesh-list
44850447|NCT02314351|Metoclopramide|metoclopramide|mesh-list
44850448|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44850449|NCT02314351|Narcotics|narcotics|mesh-ancestor
44850450|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850451|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850452|NCT02314351|Analgesics|analgesics|mesh-ancestor
44850453|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
44850454|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850455|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44850456|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44850457|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
44850458|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
44850459|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
44850460|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
44850461|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850462|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44850463|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44850464|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
44850465|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850466|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850467|NCT02314377|Bevacizumab|bevacizumab|mesh-list
44850468|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850469|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850470|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44850471|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44850472|NCT02314377|Growth Substances|growth substances|mesh-ancestor
44850473|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850474|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
44850475|NCT02314468|Glycerol|glycerol|mesh-list
44850476|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44850477|NCT02314468|Protective Agents|protective agents|mesh-ancestor
44850478|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850479|NCT02314481|Trastuzumab|trastuzumab|mesh-list
44850480|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44850481|NCT02314481|Atezolizumab|atezolizumab|mesh-list
44850482|NCT02314481|Vemurafenib|vemurafenib|mesh-list
44850483|NCT02314481|Maytansine|maytansine|mesh-list
44850484|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850485|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850486|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44850487|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850488|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850489|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44850490|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
44850491|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
44850492|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
44850493|NCT02314533|Fenofibrate|fenofibrate|mesh-list
44850494|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44850495|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
44850496|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850497|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44850498|NCT02314754|Misoprostol|misoprostol|mesh-list
44850499|NCT02314754|Mifepristone|mifepristone|mesh-list
44850500|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44850501|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
44850502|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850503|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850504|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44850505|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336959|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
44850506|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
44850507|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44850508|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44634674|NCT00421889|Paclitaxel|paclitaxel|mesh-list
44634675|NCT00421889|Carboplatin|carboplatin|mesh-list
44634676|NCT00421889|Belinostat|belinostat|mesh-list
44634677|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44634678|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634679|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44634680|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44634681|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44634682|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634683|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44634684|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634685|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
44634686|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44634687|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634688|NCT00421733|Vitamins|vitamins|mesh-ancestor
44634689|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
44850509|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44850510|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44850511|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
44850512|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44850513|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44850514|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44850515|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850516|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
44850517|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44850518|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44850519|NCT02314806|Clindamycin|clindamycin|mesh-list
44850520|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
44850521|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
44850522|NCT02314806|Gentamicins|gentamicins|mesh-list
44850523|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44850524|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44850525|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850526|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44850527|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850528|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850529|NCT02314871|Morphine|morphine|mesh-list
44850530|NCT02314871|Pirinitramide|pirinitramide|mesh-list
44850531|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44850532|NCT02314871|Narcotics|narcotics|mesh-ancestor
44850533|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850534|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850535|NCT02314871|Analgesics|analgesics|mesh-ancestor
44850536|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
44850537|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850538|NCT02315001|Liraglutide|liraglutide|mesh-list
44850539|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850540|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850541|NCT02315001|Incretins|incretins|mesh-ancestor
44850542|NCT02315001|Hormones|hormones|mesh-ancestor
44850543|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697142|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697143|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44697144|NCT01395602|Cabergoline|cabergoline|mesh-list
44697145|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44697146|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44337028|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44697147|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
44697148|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
44697149|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697150|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697151|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697152|NCT01395654|Rifampin|rifampin|mesh-list
44697153|NCT01395654|Isoniazid|isoniazid|mesh-list
44697154|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
44697155|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44697156|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
44697157|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697158|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697159|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
44337039|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697160|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44697161|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697162|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697163|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44697164|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44697165|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44697166|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44697167|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44697168|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44337052|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
44697169|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44697170|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44697171|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
44850544|NCT02315118|Rituximab|rituximab|mesh-list
44850545|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850546|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850547|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
44850548|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850549|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850550|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44850551|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44850552|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
44850553|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850554|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850555|NCT02315196|Paclitaxel|paclitaxel|mesh-list
44850556|NCT02315196|Carboplatin|carboplatin|mesh-list
44850557|NCT02315196|Doxorubicin|doxorubicin|mesh-list
44850558|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44337063|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850559|NCT02315196|Epirubicin|epirubicin|mesh-list
44850560|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44850561|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850562|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
44850563|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
44850564|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
44850565|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850566|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44850567|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44850568|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44850569|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850570|NCT02315287|Pioglitazone|pioglitazone|mesh-list
44337080|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850571|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850572|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850573|NCT02315391|Glycine|glycine|mesh-list
44850574|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
44850575|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850576|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850577|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850578|NCT02315495|Saxagliptin|saxagliptin|mesh-list
44850579|NCT02315495|Acarbose|acarbose|mesh-list
44850580|NCT02315495|Incretins|incretins|mesh-ancestor
44850581|NCT02315495|Hormones|hormones|mesh-ancestor
44850582|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850583|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850584|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44850585|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44337093|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
44850586|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850587|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850588|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850589|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44850590|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44850591|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850592|NCT02315573|Lidocaine|lidocaine|mesh-list
44850593|NCT02315573|Epinephrine|epinephrine|mesh-list
44850594|NCT02315573|Racepinephrine|racepinephrine|mesh-list
44850595|NCT02315573|Bupivacaine|bupivacaine|mesh-list
44850596|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
44850597|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
44850598|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
44850599|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850600|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850601|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
44850602|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850603|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44850604|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44850605|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44850606|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850607|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850608|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44850609|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44850610|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
44850611|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850612|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44850613|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44850614|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
44850615|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44850616|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44850617|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
44337110|NCT01008046|Metformin|metformin|mesh-list
44850618|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
44850619|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44850620|NCT02315651|Ubiquinone|ubiquinone|mesh-list
44850621|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
44850622|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
44850623|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850624|NCT02315651|Vitamins|vitamins|mesh-ancestor
44850625|NCT02315690|Piperaquine|piperaquine|mesh-list
44850626|NCT02315690|Artenimol|artenimol|mesh-list
44850627|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
44850628|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44850629|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44850630|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850631|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
44850632|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44850633|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850634|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850635|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
44850636|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850637|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850638|NCT02316028|Decitabine|decitabine|mesh-list
44850639|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850640|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
44850641|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850642|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850643|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850644|NCT02316197|Peposertib|peposertib|mesh-list
44850645|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44850646|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850647|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850648|NCT02316249|Estradiol|estradiol|mesh-list
44850649|NCT02316249|Hormones|hormones|mesh-ancestor
44337140|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850650|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850651|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850652|NCT02316249|Estrogens|estrogens|mesh-ancestor
44850653|NCT02316301|Misoprostol|misoprostol|mesh-list
44850654|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44850655|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
44850656|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850657|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850658|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44850659|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850660|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
44850661|NCT02316327|Gemcitabine|gemcitabine|mesh-list
44850662|NCT02316327|Bevacizumab|bevacizumab|mesh-list
44850663|NCT02316327|Cisplatin|cisplatin|mesh-list
44850664|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850665|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850666|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44850667|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44850668|NCT02316327|Growth Substances|growth substances|mesh-ancestor
44850669|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850670|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44850671|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850672|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
44850673|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850674|NCT02316327|Antiviral Agents|antiviral agents|mesh-ancestor
44850675|NCT02316327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850676|NCT02316327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850677|NCT02316327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44850678|NCT02316327|Immunologic Factors|immunologic factors|mesh-ancestor
44850679|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
44850680|NCT02316340|Vorinostat|vorinostat|mesh-list
44850681|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
44850682|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44850683|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44337181|NCT01008631|Antidotes|antidotes|mesh-ancestor
44850684|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850685|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850686|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850687|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850688|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850689|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44850690|NCT02316379|Xenon|xenon|mesh-list
44850691|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44850692|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
44850693|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
44634860|NCT00420238|Etanercept|etanercept|mesh-list
44850694|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850695|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850696|NCT02316496|Irinotecan|irinotecan|mesh-list
44850697|NCT02316496|Cetuximab|cetuximab|mesh-list
44850698|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44337207|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337208|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337209|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337210|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337211|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44850699|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44850700|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850701|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850702|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850703|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850704|NCT02316535|Capecitabine|capecitabine|mesh-list
44850705|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850706|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
44850707|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850708|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850709|NCT02316626|Progesterone|progesterone|mesh-list
44850710|NCT02316626|Progestins|progestins|mesh-ancestor
44850711|NCT02316626|Hormones|hormones|mesh-ancestor
44850712|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850713|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850714|NCT02316704|Tacrine|tacrine|mesh-list
44850715|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44337222|NCT01009021|Diclofenac|diclofenac|mesh-list
44850716|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850717|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850718|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
44850719|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850720|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850721|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44850722|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
44850723|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850724|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
44850725|NCT02316899|Linaclotide|linaclotide|mesh-list
44850726|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44850727|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
44850728|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850729|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850730|NCT02316964|Aldesleukin|aldesleukin|mesh-list
44850731|NCT02316964|Decitabine|decitabine|mesh-list
44850732|NCT02316964|Azacitidine|azacitidine|mesh-list
44850733|NCT02316964|Interleukin-2|interleukin-2|mesh-list
44850734|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850735|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
44850736|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850737|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850738|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850739|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44850740|NCT02316964|Analgesics|analgesics|mesh-ancestor
44850741|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
44850742|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850743|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850744|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44850745|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44850746|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
44850747|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850748|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
44850749|NCT02317146|Analgesics|analgesics|mesh-ancestor
44850750|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
44850751|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850752|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850753|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
44850754|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850755|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44850756|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
44850757|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44850758|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850759|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850760|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44850761|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
44850762|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850763|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
44850764|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850765|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44850766|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850767|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850768|NCT02317198|Clopidogrel|clopidogrel|mesh-list
44850769|NCT02317198|Ticagrelor|ticagrelor|mesh-list
44850770|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44850771|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44850772|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44850773|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44850774|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44850775|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
44850776|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850777|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850778|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850779|NCT02317237|Anesthetics|anesthetics|mesh-list
44850780|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850781|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850782|NCT02317263|Testosterone|testosterone|mesh-list
44850783|NCT02317263|Androgens|androgens|mesh-ancestor
44850784|NCT02317263|Hormones|hormones|mesh-ancestor
44850785|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850786|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850787|NCT02317341|Midazolam|midazolam|mesh-list
44850788|NCT02317341|Ketamine|ketamine|mesh-list
44850789|NCT02317341|Analgesics|analgesics|mesh-ancestor
44850790|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
44850791|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850792|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850793|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44850794|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44850795|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
44850796|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
44850797|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850798|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44850799|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44850800|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850801|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850802|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44850803|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44850804|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44850805|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44850806|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44850807|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
44850808|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
44850809|NCT02317419|Gemcitabine|gemcitabine|mesh-list
44850810|NCT02317419|Paclitaxel|paclitaxel|mesh-list
44850811|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44850812|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850813|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
44850814|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
44850815|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
44850816|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850817|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44850818|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
44850819|NCT02317419|Antiviral Agents|antiviral agents|mesh-ancestor
44850820|NCT02317419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850821|NCT02317419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44850822|NCT02317419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44850823|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
44850824|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850825|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
44850826|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850827|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44850828|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
44850829|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850830|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44850831|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850832|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44850833|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
44850834|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44850835|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44850836|NCT02317601|Prednisolone|prednisolone|mesh-list
44850837|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
44850838|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44850839|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
44850840|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850841|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
44850842|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
44850843|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850844|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850845|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850846|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
44850847|NCT02317601|Hormones|hormones|mesh-ancestor
44850848|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850849|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44850850|NCT02317601|Protective Agents|protective agents|mesh-ancestor
44850851|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850852|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850853|NCT02317640|Testosterone|testosterone|mesh-list
44850854|NCT02317640|Androgens|androgens|mesh-ancestor
44850855|NCT02317640|Hormones|hormones|mesh-ancestor
44850856|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850857|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850858|NCT02317679|Bosentan|bosentan|mesh-list
44850859|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850860|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44850861|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850862|NCT02317770|Lidocaine|lidocaine|mesh-list
44850863|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
44850864|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
44850865|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850866|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850867|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
44850868|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850869|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44850870|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44850871|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44850872|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850873|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850874|NCT02317861|Febuxostat|febuxostat|mesh-list
44850875|NCT02317861|Verinurad|verinurad|mesh-list
44850876|NCT02317861|Benzbromarone|benzbromarone|mesh-list
44850877|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
44850878|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44850879|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
44850880|NCT02317861|Renal Agents|renal agents|mesh-ancestor
44850881|NCT02318017|Methylphenidate|methylphenidate|mesh-list
44850882|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44850883|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850884|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44850885|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44850886|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44850887|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850888|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
44850889|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850890|NCT02318043|Fluticasone|fluticasone|mesh-list
44850891|NCT02318043|Budesonide|budesonide|mesh-list
44850892|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44850893|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44850894|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850895|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44850896|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
44850897|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850898|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850899|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44850900|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
44850901|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
44850902|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44850903|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
44850904|NCT02318043|Hormones|hormones|mesh-ancestor
44850905|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850906|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44850907|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44850908|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44850909|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337390|NCT01009957|Everolimus|everolimus|mesh-list
44850910|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44850911|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44850912|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
44850913|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44850914|NCT02318056|Bacitracin|bacitracin|mesh-list
44850915|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44850916|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850917|NCT02318056|Laxatives|laxatives|mesh-ancestor
44850918|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850919|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44850920|NCT02318082|Aldesleukin|aldesleukin|mesh-list
44850921|NCT02318082|Interleukin-2|interleukin-2|mesh-list
44850922|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850923|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44850924|NCT02318082|Analgesics|analgesics|mesh-ancestor
44850925|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
44850926|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850927|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850928|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44850929|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44850930|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
44850931|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850932|NCT02318121|Oxytocin|oxytocin|mesh-list
44850933|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
44850934|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850935|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850936|NCT02318199|Anesthetics|anesthetics|mesh-list
44850937|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850938|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850939|NCT02318225|Misoprostol|misoprostol|mesh-list
44850940|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44850941|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
44850942|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44850943|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850944|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44850945|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850946|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
44850947|NCT02318290|Analgesics|analgesics|mesh-list
44850948|NCT02318290|Narcotics|narcotics|mesh-list
44850949|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
44337459|NCT01010100|Acarbose|acarbose|mesh-list
44850950|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850951|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850952|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850953|NCT02318433|Dexamethasone|dexamethasone|mesh-list
44850954|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44850955|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
44850956|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
44850957|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850958|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850959|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44850960|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
44850961|NCT02318433|Hormones|hormones|mesh-ancestor
44850962|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44850963|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44850964|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850965|NCT02318446|Folic Acid|folic acid|mesh-list
44850966|NCT02318446|Hematinics|hematinics|mesh-ancestor
44850967|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
44850968|NCT02318446|Vitamins|vitamins|mesh-ancestor
44850969|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
44850970|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850971|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
44850972|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44850973|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
44850974|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850975|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
44850976|NCT02318511|Protective Agents|protective agents|mesh-ancestor
44850978|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44850979|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
44850980|NCT02318563|Cannabidiol|cannabidiol|mesh-list
44850981|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44850982|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
44850983|NCT02318758|Ethanol|ethanol|mesh-list
44850984|NCT02318758|Treprostinil|treprostinil|mesh-list
44850985|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44850986|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44850987|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44850988|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850989|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44850990|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
44850991|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44850992|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44850993|NCT02318810|Rocuronium|rocuronium|mesh-list
44337473|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
44850994|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44850995|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44850996|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44850997|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44850998|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44850999|NCT02318836|Lofexidine|lofexidine|mesh-list
44851000|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44851001|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44851002|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851003|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
44851004|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851005|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44851006|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44851007|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851008|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851009|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851010|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851011|NCT02318888|Icodextrin|icodextrin|mesh-list
44851012|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
44851013|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44851014|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
44851016|NCT02319018|Folic Acid|folic acid|mesh-list
44851017|NCT02319018|Fluorouracil|fluorouracil|mesh-list
44851018|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
44851019|NCT02319018|Calcium|calcium|mesh-list
44851020|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
44851021|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44851022|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851023|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44851024|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
44851025|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851026|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851027|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851028|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337534|NCT01010308|Nadolol|nadolol|mesh-list
44851029|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
44851030|NCT02319018|Antidotes|antidotes|mesh-ancestor
44851031|NCT02319018|Protective Agents|protective agents|mesh-ancestor
44851032|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
44851033|NCT02319018|Vitamins|vitamins|mesh-ancestor
44851034|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
44851035|NCT02319018|Hematinics|hematinics|mesh-ancestor
44851036|NCT02319135|Cytarabine|cytarabine|mesh-list
44851037|NCT02319135|Fludarabine|fludarabine|mesh-list
44851038|NCT02319135|Lenograstim|lenograstim|mesh-list
44851039|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851040|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851041|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
44851042|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851043|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851044|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
44851045|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851046|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
44851047|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851048|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44851049|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
44851050|NCT02319161|Calcium|calcium|mesh-list
44851051|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44851052|NCT02319161|Esmolol|esmolol|mesh-list
44851053|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44851054|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851055|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44851056|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851057|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851058|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851059|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44851060|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44851061|NCT02319187|Irinotecan|irinotecan|mesh-list
44851062|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44851063|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851064|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851065|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851066|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851067|NCT02319200|Metformin|metformin|mesh-list
44851068|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851069|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851070|NCT02319265|Melatonin|melatonin|mesh-list
44851071|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
44851072|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851073|NCT02319265|Protective Agents|protective agents|mesh-ancestor
44851074|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851075|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851076|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44851077|NCT02319278|Hematinics|hematinics|mesh-ancestor
44851078|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44851079|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44851080|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
44851081|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44851082|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44851083|NCT02319343|Prednisolone|prednisolone|mesh-list
44851084|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
44851085|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44851086|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
44851087|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851088|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
44635306|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44851089|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
44851090|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851091|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851092|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851093|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
44851094|NCT02319343|Hormones|hormones|mesh-ancestor
44851095|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851096|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44851097|NCT02319343|Protective Agents|protective agents|mesh-ancestor
44851098|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44851099|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851100|NCT02319460|Thrombin|thrombin|mesh-list
44851101|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
44851102|NCT02319460|Coagulants|coagulants|mesh-ancestor
44851103|NCT02319499|Vitamin A|vitamin a|mesh-list
44851104|NCT02319499|Iron|iron|mesh-list
44851105|NCT02319499|Zinc|zinc|mesh-list
44851106|NCT02319499|Vitamins|vitamins|mesh-ancestor
44851107|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
44851108|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851109|NCT02319499|Trace Elements|trace elements|mesh-ancestor
44851110|NCT02319564|Beclomethasone|beclomethasone|mesh-list
44851111|NCT02319564|Albuterol|albuterol|mesh-list
44851112|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44851113|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
44851114|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851115|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851116|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44851117|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
44851118|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
44851119|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44851120|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44337607|NCT01010581|Vitamins|vitamins|mesh-ancestor
44851121|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44851122|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851123|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851124|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851125|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851126|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851127|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
44851128|NCT02319564|Hormones|hormones|mesh-ancestor
44851129|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851130|NCT02319577|Vinorelbine|vinorelbine|mesh-list
44851131|NCT02319577|Gefitinib|gefitinib|mesh-list
44851132|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44851133|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851134|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44851135|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44851136|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44851137|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851138|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44851139|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851140|NCT02319616|Clobetasol|clobetasol|mesh-list
44851141|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851142|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
44851143|NCT02319616|Hormones|hormones|mesh-ancestor
44851144|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851145|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851146|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44851147|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44851148|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851149|NCT02319707|Oxytocin|oxytocin|mesh-list
44851150|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
44851151|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44851152|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851153|NCT02319772|Galidesivir|galidesivir|mesh-list
44851154|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
44851155|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851156|NCT02319889|Paclitaxel|paclitaxel|mesh-list
44851157|NCT02319889|Carboplatin|carboplatin|mesh-list
44851158|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44851159|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44851160|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851161|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44851162|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44851163|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44851164|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635383|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44851165|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
44851166|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44851168|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851169|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
44851170|NCT02319915|Coagulants|coagulants|mesh-ancestor
44851171|NCT02319941|Clopidogrel|clopidogrel|mesh-list
44851172|NCT02319941|Ticagrelor|ticagrelor|mesh-list
44851173|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851174|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44851175|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44851176|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44851177|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
44851178|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851179|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851180|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851181|NCT02320032|Aripiprazole|aripiprazole|mesh-list
44851182|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
44851183|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
44851184|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851185|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44851186|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44851187|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851188|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851189|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
44851190|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
44851191|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851192|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851193|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44851194|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44851195|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
44851196|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44851197|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44851198|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44851199|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44851200|NCT02320045|Exenatide|exenatide|mesh-list
44851201|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851202|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851203|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44851204|NCT02320045|Incretins|incretins|mesh-ancestor
44851205|NCT02320045|Hormones|hormones|mesh-ancestor
44851206|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851207|NCT02320084|Nitisinone|nitisinone|mesh-list
44851208|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851209|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851210|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44851211|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
44851212|NCT02320240|Citalopram|citalopram|mesh-list
44851213|NCT02320240|Fluoxetine|fluoxetine|mesh-list
44851214|NCT02320240|Paroxetine|paroxetine|mesh-list
44851215|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44851216|NCT02320240|Sertraline|sertraline|mesh-list
44851217|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44851218|NCT02320240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44851219|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44851220|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44851221|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851222|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851223|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
44851224|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851225|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44851226|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
44851227|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851228|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851229|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44851230|NCT02320240|Analgesics|analgesics|mesh-ancestor
44851231|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
44851232|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
44851233|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44851234|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44851235|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851236|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44851237|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44851238|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851239|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44851240|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44851241|NCT02320357|Clopidogrel|clopidogrel|mesh-list
44851242|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851243|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44851244|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44697172|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44697173|NCT01395667|Leucovorin|leucovorin|mesh-list
44697174|NCT01395667|Fluorouracil|fluorouracil|mesh-list
44697175|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
44697176|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697177|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697178|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
44697179|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697180|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697181|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697182|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
44697183|NCT01395667|Antidotes|antidotes|mesh-ancestor
44697184|NCT01395667|Protective Agents|protective agents|mesh-ancestor
44697185|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
44697186|NCT01395667|Vitamins|vitamins|mesh-ancestor
44697187|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
44697188|NCT01395732|Bosentan|bosentan|mesh-list
44697189|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44697190|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44697191|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697192|NCT01395849|Fluticasone|fluticasone|mesh-list
44697193|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44697194|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44697195|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697196|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44697197|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
44697198|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697199|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697200|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44697201|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
44697202|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697203|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44697204|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44697205|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44697206|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44697238|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44697239|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44697240|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697241|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44697242|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
44697243|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697244|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697245|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44697246|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44697247|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697248|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44697249|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44697250|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44697251|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44697252|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
44697253|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697254|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697255|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
44697256|NCT01395927|Canagliflozin|canagliflozin|mesh-list
44697257|NCT01395927|Rifampin|rifampin|mesh-list
44697258|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44337805|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697259|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
44697260|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697261|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697262|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
44697263|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44697264|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697265|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697266|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44697267|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44697268|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44697269|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44697270|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44697271|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44851245|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44851246|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
44851247|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851248|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851249|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851250|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44851251|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
44337820|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851252|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44851253|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
44851254|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851255|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851256|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44851258|NCT02320448|Doxorubicin|doxorubicin|mesh-list
44851259|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
44851260|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851261|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44851262|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851263|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851264|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851265|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851266|NCT02320474|Aflibercept|aflibercept|mesh-list
44851267|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44851268|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44851269|NCT02320474|Growth Substances|growth substances|mesh-ancestor
44851270|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851271|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
44851272|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851273|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44851274|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
44337842|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851275|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851276|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44851277|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44635535|NCT00413218|Voriconazole|voriconazole|mesh-list
44851278|NCT02320734|Rocuronium|rocuronium|mesh-list
44851279|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44851280|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44851281|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44851282|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851283|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851284|NCT02320773|Mirabegron|mirabegron|mesh-list
44851285|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44851286|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44851287|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851288|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851289|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851290|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851291|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851292|NCT02320773|Urological Agents|urological agents|mesh-ancestor
44851293|NCT02320877|Methaqualone|methaqualone|mesh-list
44851294|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851295|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851296|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851297|NCT02321176|Resveratrol|resveratrol|mesh-list
44851298|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
44851299|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851300|NCT02321176|Protective Agents|protective agents|mesh-ancestor
44851301|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851302|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851303|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851304|NCT02321241|Aflibercept|aflibercept|mesh-list
44851305|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44851306|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44851307|NCT02321241|Growth Substances|growth substances|mesh-ancestor
44337865|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44851308|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851309|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
44851310|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851311|NCT02321267|Ranibizumab|ranibizumab|mesh-list
44851312|NCT02321267|Aflibercept|aflibercept|mesh-list
44851313|NCT02321267|Verteporfin|verteporfin|mesh-list
44851314|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44851315|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44851316|NCT02321267|Growth Substances|growth substances|mesh-ancestor
44851317|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851318|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
44851319|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851320|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44851321|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851322|NCT02321280|Denosumab|denosumab|mesh-list
44851323|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44851324|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851325|NCT02321293|Curcumin|curcumin|mesh-list
44851326|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44851327|NCT02321293|Gefitinib|gefitinib|mesh-list
44851328|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851329|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44851330|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851331|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851332|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44851333|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851334|NCT02321293|Analgesics|analgesics|mesh-ancestor
44851335|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
44851336|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851337|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851338|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851339|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851340|NCT02321371|Rifaximin|rifaximin|mesh-list
44851341|NCT02321371|Lactulose|lactulose|mesh-list
44851342|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44851343|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851344|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851345|NCT02321384|Ritonavir|ritonavir|mesh-list
44851346|NCT02321384|Midazolam|midazolam|mesh-list
44851347|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44851348|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851349|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851350|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851351|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44851352|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44851353|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851354|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44851355|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
44851356|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
44851357|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
44851358|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
44851359|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851360|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851361|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44851362|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44851363|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
44851364|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851365|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44851366|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44851367|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
44851368|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851369|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44851370|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44851371|NCT02321397|Oxycodone|oxycodone|mesh-list
44851372|NCT02321397|Naloxone|naloxone|mesh-list
44130142|NCT02008292|Miotics|miotics|mesh-ancestor
44851373|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44851374|NCT02321397|Narcotics|narcotics|mesh-ancestor
44851375|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851376|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851377|NCT02321397|Analgesics|analgesics|mesh-ancestor
44851378|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
44851379|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851380|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44851381|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
44851382|NCT02321579|Pyridoxal|pyridoxal|mesh-list
44851383|NCT02321579|Pyridoxine|pyridoxine|mesh-list
44851384|NCT02321579|Vitamins|vitamins|mesh-ancestor
44851385|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
44851386|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851387|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
44851388|NCT02321761|Amantadine|amantadine|mesh-list
44851389|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44851390|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44851391|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
44851392|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851393|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
44851394|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851395|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851396|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851397|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851398|NCT02321761|Analgesics|analgesics|mesh-ancestor
44851399|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
44851400|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851401|NCT02321839|Ranibizumab|ranibizumab|mesh-list
44851402|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44851403|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44851404|NCT02321839|Growth Substances|growth substances|mesh-ancestor
44337963|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851405|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851406|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44851407|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851408|NCT02321852|Mannitol|mannitol|mesh-list
44851409|NCT02321852|Triflusal|triflusal|mesh-list
44851410|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44851411|NCT02321852|Diuretics|diuretics|mesh-ancestor
44851412|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44851413|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851414|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851415|NCT02321878|Liraglutide|liraglutide|mesh-list
44851416|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851417|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851418|NCT02321878|Incretins|incretins|mesh-ancestor
44851419|NCT02321878|Hormones|hormones|mesh-ancestor
44851420|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851421|NCT02322008|Adalimumab|adalimumab|mesh-list
44851422|NCT02322008|Infliximab|infliximab|mesh-list
44851423|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851424|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851425|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851426|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851427|NCT02322203|Niacin|niacin|mesh-list
44635682|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851428|NCT02322203|Niacinamide|niacinamide|mesh-list
44130200|NCT00144703|Sirolimus|sirolimus|mesh-list
44851429|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
44851430|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44851431|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
44851432|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851433|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44851434|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44851435|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
44851436|NCT02322203|Vitamins|vitamins|mesh-ancestor
44851437|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
44851438|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851439|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
44851440|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
44851441|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
44851442|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851443|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851444|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
44851445|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851446|NCT02322372|Bupivacaine|bupivacaine|mesh-list
44851447|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
44851448|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851449|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851450|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
44851451|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
44851452|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851453|NCT02322502|Propofol|propofol|mesh-list
44851454|NCT02322502|Sevoflurane|sevoflurane|mesh-list
44851455|NCT02322502|Desflurane|desflurane|mesh-list
44338017|NCT01012349|Aspirin|aspirin|mesh-list
44851456|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851457|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851458|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851459|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44851460|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
44851461|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
44851462|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851463|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44851464|NCT02322580|Etanercept|etanercept|mesh-list
44851465|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44851466|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851467|NCT02322580|Analgesics|analgesics|mesh-ancestor
44851468|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
44851469|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851470|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851471|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851472|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851473|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851474|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851475|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
44851476|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
44851477|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44851478|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851479|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851480|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851481|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851482|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851483|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851484|NCT02322645|Eszopiclone|eszopiclone|mesh-list
44851485|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851486|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851487|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851488|NCT02322658|Eszopiclone|eszopiclone|mesh-list
44851489|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851490|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338043|NCT01012479|Diuretics|diuretics|mesh-ancestor
44851491|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851492|NCT02322671|Montelukast|montelukast|mesh-list
44851493|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44851494|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
44851495|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44851496|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
44851497|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851498|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851499|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44851500|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44851501|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851502|NCT02322853|Tamoxifen|tamoxifen|mesh-list
44851503|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44851504|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
44851505|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851506|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851507|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44851508|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851509|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44851510|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44851511|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44851512|NCT02323139|Azacitidine|azacitidine|mesh-list
44851513|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851514|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
44851515|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851516|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851517|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851518|NCT02323191|Atezolizumab|atezolizumab|mesh-list
44851519|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851520|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
44851521|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851522|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
44851523|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851524|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851525|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44851526|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
44851527|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851528|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851529|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44851530|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44851531|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851532|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851533|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
44851534|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851535|NCT02323282|Ropivacaine|ropivacaine|mesh-list
44851536|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
44851537|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
44851538|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851539|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851540|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
44851541|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851542|NCT02323347|Progesterone|progesterone|mesh-list
44851543|NCT02323347|Progestins|progestins|mesh-ancestor
44851544|NCT02323347|Hormones|hormones|mesh-ancestor
44851545|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851546|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851547|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
44851548|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44851549|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44851550|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851551|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
44851552|NCT02323373|Coagulants|coagulants|mesh-ancestor
44851553|NCT02323399|Phenylephrine|phenylephrine|mesh-list
44851554|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
44851555|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44851556|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
44851557|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
44851558|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851559|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851560|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
44851561|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44851562|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
44851563|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
44851564|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44851565|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44851566|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851567|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851568|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851569|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851570|NCT02323399|Protective Agents|protective agents|mesh-ancestor
44851571|NCT02323412|Amoxicillin|amoxicillin|mesh-list
44851572|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44851573|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851574|NCT02323438|Menthol|menthol|mesh-list
44851575|NCT02323438|Nicotine|nicotine|mesh-list
44851576|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44851577|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
44851578|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851579|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851580|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44851581|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44851582|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
44851583|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851584|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851585|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
44851586|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851587|NCT02323451|Chitosan|chitosan|mesh-list
44851588|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
44851589|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44851590|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
44851591|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851592|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
44851593|NCT02323451|Protective Agents|protective agents|mesh-ancestor
44851594|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44851595|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44851596|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
44851597|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635910|NCT00409682|Adalimumab|adalimumab|mesh-list
44851598|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44851599|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
44851600|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
44851601|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
44851602|NCT02323451|Coagulants|coagulants|mesh-ancestor
44851603|NCT02323516|Aspirin|aspirin|mesh-list
44851604|NCT02323516|Loperamide|loperamide|mesh-list
44851605|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
44851606|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44851607|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851608|NCT02323516|Analgesics|analgesics|mesh-ancestor
44851609|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
44851610|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851611|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851612|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44851613|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851614|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44851615|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44851616|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851617|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851618|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44851619|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851620|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
44851621|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851622|NCT02323529|Nitisinone|nitisinone|mesh-list
44851623|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851624|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851625|NCT02323594|Asunaprevir|asunaprevir|mesh-list
44851626|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
44851627|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851628|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851629|NCT02323607|Cytarabine|cytarabine|mesh-list
44851630|NCT02323607|Decitabine|decitabine|mesh-list
44851631|NCT02323607|Daunorubicin|daunorubicin|mesh-list
44851632|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851633|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
44851634|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851635|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851636|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
44851637|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851638|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851639|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
44851640|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851641|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44851642|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851643|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851644|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851645|NCT02323737|Cisplatin|cisplatin|mesh-list
44851646|NCT02323737|Irinotecan|irinotecan|mesh-list
44851647|NCT02323737|Etoposide|etoposide|mesh-list
44851648|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851649|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44851650|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851651|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851652|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851653|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44851654|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851655|NCT02323906|Sorafenib|sorafenib|mesh-list
44851656|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851657|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44851658|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851659|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851660|NCT02323971|Ticagrelor|ticagrelor|mesh-list
44851661|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44851662|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44851663|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44851664|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44851665|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
44851666|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851667|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851668|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851669|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44851670|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851671|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851672|NCT02324010|Incretins|incretins|mesh-ancestor
44851673|NCT02324010|Hormones|hormones|mesh-ancestor
44851674|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851675|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44851676|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
44851678|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851679|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
44851680|NCT02324088|Docetaxel|docetaxel|mesh-list
44851681|NCT02324088|Epirubicin|epirubicin|mesh-list
44851682|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851683|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
44851684|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851685|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851686|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44851687|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
44851688|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851689|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851690|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44851691|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44851692|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44851693|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44851694|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44851695|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851696|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851697|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851698|NCT02324166|Cefazolin|cefazolin|mesh-list
44851699|NCT02324166|Lidocaine|lidocaine|mesh-list
44851700|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
44851701|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
44851702|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851703|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851704|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
44851705|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851706|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44851707|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44851708|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44851709|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44851710|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851711|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44851712|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636073|NCT00408317|Pancreatin|pancreatin|mesh-list
44851713|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
44851714|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44851715|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851716|NCT02324296|Cisplatin|cisplatin|mesh-list
44851717|NCT02324296|Etoposide|etoposide|mesh-list
44851718|NCT02324296|Ifosfamide|ifosfamide|mesh-list
44851719|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851720|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44851721|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44851722|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44851723|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851724|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851725|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44851726|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
44851727|NCT02324413|Clonidine|clonidine|mesh-list
44851728|NCT02324413|Analgesics|analgesics|mesh-ancestor
44851729|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
44851730|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851731|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851732|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44851733|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
44851734|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
44851735|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44851736|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44851737|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851738|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851739|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851740|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851741|NCT02324452|Fluorouracil|fluorouracil|mesh-list
44851742|NCT02324452|Capecitabine|capecitabine|mesh-list
44851743|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
44851744|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851745|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851746|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851747|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851748|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
44851749|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851750|NCT02324491|CKD732|ckd732|mesh-list
44851751|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44851752|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44851753|NCT02324491|Growth Substances|growth substances|mesh-ancestor
44851754|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851755|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44851756|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851757|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
44851758|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44851759|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851760|NCT02324621|TIC10 compound|tic10 compound|mesh-list
44851761|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851762|NCT02324686|Vitamin K|vitamin k|mesh-list
44851763|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
44851764|NCT02324686|Vitamins|vitamins|mesh-ancestor
44851765|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
44851766|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851767|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44851768|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44851769|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851770|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
44851771|NCT02324686|Coagulants|coagulants|mesh-ancestor
44851772|NCT02324738|Piperaquine|piperaquine|mesh-list
44851773|NCT02324738|Artenimol|artenimol|mesh-list
44851774|NCT02324738|Mefloquine|mefloquine|mesh-list
44851775|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
44851776|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44851777|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44851778|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851779|NCT02324933|Fentanyl|fentanyl|mesh-list
44851780|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44851781|NCT02324933|Narcotics|narcotics|mesh-ancestor
44851782|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851783|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636132|NCT00407537|Amlodipine|amlodipine|mesh-list
44851784|NCT02324933|Analgesics|analgesics|mesh-ancestor
44851785|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
44338343|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
44851786|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851787|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44851788|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44851789|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
44851791|NCT02324998|Olaparib|olaparib|mesh-list
44851792|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44851793|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851794|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851795|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851796|NCT02325024|Nabiximols|nabiximols|mesh-list
44851797|NCT02325024|Analgesics|analgesics|mesh-ancestor
44851798|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
44851799|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851800|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851801|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
44851802|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44851803|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44851804|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851805|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
44851806|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851807|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851808|NCT02325180|Lumefantrine|lumefantrine|mesh-list
44851809|NCT02325180|Artemether|artemether|mesh-list
44851810|NCT02325180|Piperaquine|piperaquine|mesh-list
44851811|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44851812|NCT02325180|Artenimol|artenimol|mesh-list
44851813|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
44851814|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44851815|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44851816|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851817|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
44851818|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44851819|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851820|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851821|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851822|NCT02325245|Metformin|metformin|mesh-list
44851823|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851824|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851825|NCT02325362|Miglustat|miglustat|mesh-list
44851826|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44851827|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851828|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851829|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44851830|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44851831|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
44851832|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851833|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44851834|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44851835|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851836|NCT02325440|Natalizumab|natalizumab|mesh-list
44851837|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44851838|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
44851839|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851840|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44851841|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851842|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851843|NCT02325479|Enoxaparin|enoxaparin|mesh-list
44851844|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
44851845|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44851846|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44851847|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851848|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
44851849|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44851850|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851851|NCT02325583|Midazolam|midazolam|mesh-list
44851852|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44851853|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851854|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851855|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851856|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44851857|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44851858|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851859|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44338415|NCT01014520|Gabapentin|gabapentin|mesh-list
44851860|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
44851861|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
44851862|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
44851863|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
44851864|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851865|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851866|NCT02325882|Fentanyl|fentanyl|mesh-list
44851867|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
44851868|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851869|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851870|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851871|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851872|NCT02325882|Analgesics|analgesics|mesh-ancestor
44851873|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
44851874|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851875|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44851876|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44851877|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851878|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851879|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851880|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851881|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44851882|NCT02325882|Narcotics|narcotics|mesh-ancestor
44851883|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44851884|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44851885|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
44851886|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
44851887|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44851888|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44851889|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44851890|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
44851891|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851892|NCT05144100|Cisplatin|cisplatin|mesh-list
44851893|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851894|NCT05118737|Colchicine|colchicine|mesh-list
44851895|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
44851896|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851897|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
44851898|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
44851899|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
44851900|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851901|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851902|NCT05118685|Estrogens|estrogens|mesh-list
44851903|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44851904|NCT05118685|Hormones|hormones|mesh-ancestor
44851905|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44851906|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851907|NCT05037552|Hemostatics|hemostatics|mesh-list
44851908|NCT05037552|Coagulants|coagulants|mesh-ancestor
44851909|NCT04987931|Talazoparib|talazoparib|mesh-list
44851910|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44851911|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851912|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851913|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851914|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
44851915|NCT04929847|Emollients|emollients|mesh-list
44851916|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851917|NCT04929834|Emollients|emollients|mesh-list
44851918|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44851919|NCT04881955|Ecopipam|ecopipam|mesh-list
44851920|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44851921|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44851922|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851923|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338480|NCT01014832|Insulin|insulin|mesh-list
44851924|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44851925|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44851926|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
44851927|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851928|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851929|NCT04722952|Cytarabine|cytarabine|mesh-list
44851930|NCT04722952|Azacitidine|azacitidine|mesh-list
44851931|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
44851932|NCT04722952|Visilizumab|visilizumab|mesh-list
44851933|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851934|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
44851935|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851936|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851937|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
44851938|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851939|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851940|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
44851941|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851942|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851943|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44697272|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44697273|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44697274|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697275|NCT01395953|Buspirone|buspirone|mesh-list
44697276|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697277|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697278|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697279|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697280|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697281|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44697282|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
44697283|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697284|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697285|NCT01395992|Asenapine|asenapine|mesh-list
44697286|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44697287|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697288|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697289|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697290|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697291|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
44697292|NCT01396200|Sirolimus|sirolimus|mesh-list
44697293|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
44697294|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44697295|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44697296|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697297|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44851944|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44851945|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
44851947|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
44851948|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44851949|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
44851950|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851951|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44851952|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44851953|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
44851954|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851955|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44851956|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44851957|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44851958|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
44851959|NCT04703361|Niacin|niacin|mesh-list
44851960|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44851961|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
44851962|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851963|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44851964|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
44851965|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
44851966|NCT04703361|Vitamins|vitamins|mesh-ancestor
44851967|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
44851968|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851969|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
44851970|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44851971|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851972|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851973|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44851974|NCT04674241|Analgesics|analgesics|mesh-ancestor
44851975|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
44851976|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44851977|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44851978|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44851979|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44851980|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
44851981|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44851982|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44851983|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
44851984|NCT04600895|Favipiravir|favipiravir|mesh-list
44851985|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
44851986|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44851987|NCT04532502|Anesthetics|anesthetics|mesh-list
44851988|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
44851989|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44851990|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851991|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
44851992|NCT04496908|Misoprostol|misoprostol|mesh-list
44851993|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44851994|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
44851995|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44851996|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44851997|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44851998|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44851999|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
44852000|NCT04382924|Ifenprodil|ifenprodil|mesh-list
44852001|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44852002|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44852003|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
44852004|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852005|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338578|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
44852006|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852007|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
44852008|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44852009|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44852010|NCT04371640|Sirolimus|sirolimus|mesh-list
44852011|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852012|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852013|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44852014|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852015|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
44852016|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852017|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
44852018|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636396|NCT00404547|Hormones|hormones|mesh-ancestor
44852019|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44852020|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44852021|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44852022|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44852023|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852024|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852025|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852026|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852027|NCT04364997|Analgesics|analgesics|mesh-ancestor
44852028|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
44852029|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130305|NCT00144989|Cisplatin|cisplatin|mesh-list
44852030|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
44852031|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44852032|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
44852033|NCT04356196|Verapamil|verapamil|mesh-list
44852034|NCT04356196|Bisoprolol|bisoprolol|mesh-list
44852035|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44852036|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44852037|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852038|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852039|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44852040|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852041|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
44852042|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44852043|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
44852044|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
44852045|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852046|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44852047|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44852048|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44852049|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
44852050|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852051|NCT04107168|Bevacizumab|bevacizumab|mesh-list
44852052|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
44852053|NCT04107168|Nivolumab|nivolumab|mesh-list
44852054|NCT04107168|Ipilimumab|ipilimumab|mesh-list
44852055|NCT04107168|Durvalumab|durvalumab|mesh-list
44852056|NCT04107168|Atezolizumab|atezolizumab|mesh-list
44852057|NCT04107168|Tremelimumab|tremelimumab|mesh-list
44852058|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852059|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852060|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852061|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852062|NCT04107168|Growth Substances|growth substances|mesh-ancestor
44852063|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852064|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852065|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44852066|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852067|NCT04034459|Leucovorin|leucovorin|mesh-list
44852068|NCT04034459|Folic Acid|folic acid|mesh-list
44852069|NCT04034459|Bevacizumab|bevacizumab|mesh-list
44852070|NCT04034459|Cetuximab|cetuximab|mesh-list
44852071|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
44852072|NCT04034459|Irinotecan|irinotecan|mesh-list
44852073|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
44852074|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852075|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852076|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852077|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852078|NCT04034459|Growth Substances|growth substances|mesh-ancestor
44852079|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852080|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852081|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44852082|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852083|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852084|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852085|NCT04034459|Antidotes|antidotes|mesh-ancestor
44852086|NCT04034459|Protective Agents|protective agents|mesh-ancestor
44852087|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
44852088|NCT04034459|Vitamins|vitamins|mesh-ancestor
44852089|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
44852090|NCT04034459|Hematinics|hematinics|mesh-ancestor
44852091|NCT04030052|Factor VIII|factor viii|mesh-list
44852092|NCT04030052|Coagulants|coagulants|mesh-ancestor
44852093|NCT04005729|Cangrelor|cangrelor|mesh-list
44852094|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44852095|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44852096|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44852097|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44852098|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
44852099|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852100|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852101|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852102|NCT03914885|Fludarabine|fludarabine|mesh-list
44338693|NCT01015547|Analgesics|analgesics|mesh-ancestor
44852103|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44852104|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852105|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852106|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44852107|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
44852108|NCT03812991|Calcitonin|calcitonin|mesh-list
44852109|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
44852110|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44852111|NCT03812991|Katacalcin|katacalcin|mesh-list
44852112|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44852113|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852114|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44852115|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
44852116|NCT03779243|Melatonin|melatonin|mesh-list
44852117|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
44852118|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852119|NCT03779243|Protective Agents|protective agents|mesh-ancestor
44852120|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852121|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852122|NCT03757013|Apremilast|apremilast|mesh-list
44852123|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44852124|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44852125|NCT03757013|Analgesics|analgesics|mesh-ancestor
44852126|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
44852127|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852128|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852129|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852130|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852131|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44852132|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44852133|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852134|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852135|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
44852136|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44852137|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
44852138|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852139|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852140|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44852141|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
44852142|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852143|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44852144|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44852145|NCT03261830|Clindamycin|clindamycin|mesh-list
44852146|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
44852147|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
44852148|NCT03261830|Cefazolin|cefazolin|mesh-list
44852149|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852150|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852151|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44852152|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852153|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852154|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
44852155|NCT03111732|Capecitabine|capecitabine|mesh-list
44852156|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
44852157|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852158|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852159|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44852160|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
44852161|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852162|NCT03065244|Infliximab|infliximab|mesh-list
44852163|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
44852164|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44852165|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
44852166|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44852167|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
44852168|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852169|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852170|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852171|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852172|NCT02934529|Leucovorin|leucovorin|mesh-list
44852173|NCT02934529|Folic Acid|folic acid|mesh-list
44852174|NCT02934529|Bevacizumab|bevacizumab|mesh-list
44852175|NCT02934529|Cetuximab|cetuximab|mesh-list
44852176|NCT02934529|Fluorouracil|fluorouracil|mesh-list
44852177|NCT02934529|Capecitabine|capecitabine|mesh-list
44852178|NCT02934529|Irinotecan|irinotecan|mesh-list
44852179|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
44852180|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852181|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852182|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852183|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852184|NCT02934529|Growth Substances|growth substances|mesh-ancestor
44852185|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852186|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852187|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
44852188|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852189|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44852190|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852191|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
44852192|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44852193|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852194|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852195|NCT02934529|Antidotes|antidotes|mesh-ancestor
44852196|NCT02934529|Protective Agents|protective agents|mesh-ancestor
44852197|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
44852198|NCT02934529|Vitamins|vitamins|mesh-ancestor
44852199|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
44852200|NCT02934529|Hematinics|hematinics|mesh-ancestor
44852201|NCT02816736|Valsartan|valsartan|mesh-list
44852202|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44852203|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44852204|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44852205|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44852206|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852207|NCT02431702|Haloperidol|haloperidol|mesh-list
44852208|NCT02431702|Olanzapine|olanzapine|mesh-list
44852209|NCT02431702|Risperidone|risperidone|mesh-list
44852210|NCT02431702|Aripiprazole|aripiprazole|mesh-list
44852211|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44852212|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44852213|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
44852214|NCT02431702|Perphenazine|perphenazine|mesh-list
44852215|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44852216|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
44852217|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852218|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852219|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852220|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44852221|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44852222|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852223|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44852224|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44852225|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
44852227|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
44852228|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852229|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852230|NCT02431702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44852231|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44852232|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852233|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44852234|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
44852235|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44852236|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44852237|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44852238|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44852239|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44852240|NCT02136069|Infliximab|infliximab|mesh-list
44852241|NCT02136069|Etrolizumab|etrolizumab|mesh-list
44852242|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852243|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852244|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852245|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
44852246|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852247|NCT02096874|Bevacizumab|bevacizumab|mesh-list
44852248|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852249|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852250|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852251|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852252|NCT02096874|Growth Substances|growth substances|mesh-ancestor
44852253|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852254|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852255|NCT02086552|Lenalidomide|lenalidomide|mesh-list
44852256|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
44852257|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852258|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852259|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852260|NCT02086552|Growth Substances|growth substances|mesh-ancestor
44852261|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852262|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852263|NCT01024608|Beclomethasone|beclomethasone|mesh-list
44852264|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852265|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
44852266|NCT01024608|Hormones|hormones|mesh-ancestor
44852267|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852268|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852269|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44852270|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44852271|NCT00838981|Methadone|methadone|mesh-list
44852272|NCT00838981|Modafinil|modafinil|mesh-list
44852273|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44852274|NCT00838981|Narcotics|narcotics|mesh-ancestor
44852275|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852276|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852277|NCT00838981|Analgesics|analgesics|mesh-ancestor
44852278|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
44852279|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852280|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
44852281|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
44852282|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44852283|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44852284|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44852285|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44852286|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852287|NCT00730639|Nivolumab|nivolumab|mesh-list
44852288|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852289|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852290|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44852291|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852292|NCT00363038|Vitamins|vitamins|mesh-list
44852293|NCT00363038|Vitamin K|vitamin k|mesh-list
44852294|NCT00363038|Vitamin A|vitamin a|mesh-list
44852295|NCT00363038|Petrolatum|petrolatum|mesh-list
44636690|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852296|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
44852297|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852298|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44852299|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44852300|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852302|NCT00363038|Coagulants|coagulants|mesh-ancestor
44852303|NCT00363038|Emollients|emollients|mesh-ancestor
44852304|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852305|NCT05131386|Trabectedin|trabectedin|mesh-list
44852306|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44852307|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
44852308|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852309|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852310|NCT05100134|Ceritinib|ceritinib|mesh-list
44852311|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852312|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44852313|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852314|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852315|NCT05079620|Amoxicillin|amoxicillin|mesh-list
44852316|NCT05079620|Vancomycin|vancomycin|mesh-list
44852317|NCT05079620|Levofloxacin|levofloxacin|mesh-list
44852318|NCT05079620|Ofloxacin|ofloxacin|mesh-list
44852319|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
44852320|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44852321|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
44852322|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
44852323|NCT05079620|Cefepime|cefepime|mesh-list
44852324|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852325|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852326|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44852327|NCT05079620|Renal Agents|renal agents|mesh-ancestor
44852328|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44852329|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852330|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852331|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852332|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338920|NCT01017107|Protein C|protein c|mesh-list
44852333|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44852334|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44852335|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44852336|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
44852337|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
44852338|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
44852339|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44852340|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44852341|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852342|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852343|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852344|NCT04987294|Rasburicase|rasburicase|mesh-list
44852345|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
44852346|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852347|NCT04834362|Insulin|insulin|mesh-list
44852348|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44852349|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
44852350|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
44852351|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852352|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852353|NCT04802356|Dexamethasone|dexamethasone|mesh-list
44852354|NCT04802356|Lenalidomide|lenalidomide|mesh-list
44852355|NCT04802356|Bortezomib|bortezomib|mesh-list
44852356|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852357|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
44852358|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
44852359|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852360|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852361|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852362|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
44852363|NCT04802356|Hormones|hormones|mesh-ancestor
44852364|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852365|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338948|NCT01017354|Calcifediol|calcifediol|mesh-list
44852366|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852367|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
44852368|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852369|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852370|NCT04802356|Growth Substances|growth substances|mesh-ancestor
44852371|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636766|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
44852372|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44852373|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44852374|NCT04681482|Apixaban|apixaban|mesh-list
44852375|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44852376|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
44852377|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44852378|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
44852379|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852380|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852381|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
44852382|NCT04635943|Ivermectin|ivermectin|mesh-list
44852383|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44852384|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852385|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
44852386|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
44852387|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852388|NCT04425447|Anesthetics|anesthetics|mesh-list
44852389|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852390|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852391|NCT04355728|Heparin|heparin|mesh-list
44852392|NCT04355728|Calcium heparin|calcium heparin|mesh-list
44852393|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
44852394|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44852395|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44852396|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852397|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
44852398|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852399|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852400|NCT04182997|Dexamethasone|dexamethasone|mesh-list
44852401|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852402|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
44852403|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
44852404|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852405|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852406|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852407|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
44852408|NCT04182997|Hormones|hormones|mesh-ancestor
44852409|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852410|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44852411|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852412|NCT04137354|Vitamins|vitamins|mesh-list
44852413|NCT04137354|Vitamin A|vitamin a|mesh-list
44852414|NCT04137354|Iron|iron|mesh-list
44852415|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
44852416|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
44852417|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852418|NCT04137354|Trace Elements|trace elements|mesh-ancestor
44852419|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
44852420|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852421|NCT04137354|Protective Agents|protective agents|mesh-ancestor
44852422|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44852423|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852424|NCT04002037|Dexamethasone|dexamethasone|mesh-list
44852425|NCT04002037|Triamcinolone|triamcinolone|mesh-list
44852426|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44852427|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44852428|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44852429|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852430|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
44852431|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
44852432|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852433|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852434|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852435|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
44852436|NCT04002037|Hormones|hormones|mesh-ancestor
44852437|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852438|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44852439|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852440|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852441|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
44852442|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852443|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852444|NCT03954938|Cocaine|cocaine|mesh-list
44852445|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852446|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
44852447|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852448|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852449|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
44852450|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852451|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44852452|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44852453|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44852454|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852455|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852456|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
44852457|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852458|NCT03749616|Acetaminophen|acetaminophen|mesh-list
44852459|NCT03749616|Ibuprofen|ibuprofen|mesh-list
44852460|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44852461|NCT03749616|Analgesics|analgesics|mesh-ancestor
44852462|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
44852463|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852464|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852465|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
44852466|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44852467|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852468|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852469|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44852470|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852471|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852472|NCT03546829|Vancomycin|vancomycin|mesh-list
44852473|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852474|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852475|NCT03543839|Belimumab|belimumab|mesh-list
44852476|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852477|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
44852478|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852479|NCT03499119|Erenumab|erenumab|mesh-list
44852480|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44852481|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852482|NCT03499119|Analgesics|analgesics|mesh-ancestor
44852483|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
44852484|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852485|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852486|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44852487|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44852488|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44852489|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852490|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852491|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
44852492|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852493|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44852494|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44852495|NCT03350984|Insulin|insulin|mesh-list
44852496|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44852497|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
44852498|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
44852499|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
44852500|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
44852501|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
44852502|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852503|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852504|NCT03328845|Insulin|insulin|mesh-list
44852505|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44852506|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
44852507|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
44852508|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852509|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852510|NCT03305341|Molgramostim|molgramostim|mesh-list
44852511|NCT03305341|Sargramostim|sargramostim|mesh-list
44852512|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
44852513|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852514|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852515|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
44852516|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44852517|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44852518|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44852519|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852520|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852521|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
44852522|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852523|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852524|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44852525|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852526|NCT03190174|Sirolimus|sirolimus|mesh-list
44852527|NCT03190174|Nivolumab|nivolumab|mesh-list
44852528|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852529|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852530|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44852531|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852532|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852533|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852534|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44852535|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
44852536|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852537|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
44852538|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852539|NCT03148899|Oxytocin|oxytocin|mesh-list
44852540|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
44852541|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852542|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852543|NCT03136627|Nivolumab|nivolumab|mesh-list
44852544|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852545|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852546|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44852547|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852548|NCT02922985|Acetaminophen|acetaminophen|mesh-list
44852549|NCT02922985|Ketorolac|ketorolac|mesh-list
44852550|NCT02922985|Bupivacaine|bupivacaine|mesh-list
44852551|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852552|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
44852553|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852554|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852555|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
44852556|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339121|NCT01018225|Darifenacin|darifenacin|mesh-list
44852557|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44852558|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44852559|NCT02922985|Analgesics|analgesics|mesh-ancestor
44852560|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852561|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852562|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44852563|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852564|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852565|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
44852566|NCT02837783|Linaclotide|linaclotide|mesh-list
44852567|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44852568|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
44852569|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852570|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852571|NCT02786537|Ritonavir|ritonavir|mesh-list
44852572|NCT02786537|Ribavirin|ribavirin|mesh-list
44852573|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
44852574|NCT02786537|Grazoprevir|grazoprevir|mesh-list
44852575|NCT02786537|Ledipasvir|ledipasvir|mesh-list
44852576|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44852577|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44852578|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44852579|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
44852580|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852581|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852582|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44852583|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44852584|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
44852585|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852586|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44852587|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44852588|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
44852589|NCT02710084|Oxytocin|oxytocin|mesh-list
44852590|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
44852591|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852592|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852593|NCT02645474|Ropivacaine|ropivacaine|mesh-list
44852594|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852595|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
44852596|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852597|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852598|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
44852599|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852600|NCT02182687|Doxorubicin|doxorubicin|mesh-list
44852601|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44852602|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44852603|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852604|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44852605|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852606|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852607|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852608|NCT01976273|Glycolic acid|glycolic acid|mesh-list
44852609|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
44852610|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852612|NCT01802086|Prilocaine|prilocaine|mesh-list
44852613|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44852614|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852615|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
44852616|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852617|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852618|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
44852619|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852620|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44852621|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44852622|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44852623|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852624|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852625|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44852626|NCT01525316|Lactoferrin|lactoferrin|mesh-list
44852627|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852628|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44852629|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44852630|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44852631|NCT01388491|Desogestrel|desogestrel|mesh-list
44852632|NCT01388491|Estradiol|estradiol|mesh-list
44852633|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44852634|NCT01388491|Estrogens|estrogens|mesh-ancestor
44852635|NCT01388491|Hormones|hormones|mesh-ancestor
44852636|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852637|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852638|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44852639|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
44852640|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852641|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44852642|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44852643|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44852644|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44852645|NCT01388491|Progestins|progestins|mesh-ancestor
44852646|NCT01373151|Adalimumab|adalimumab|mesh-list
44852647|NCT01373151|Methotrexate|methotrexate|mesh-list
44852648|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44852649|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
44852650|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852651|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852652|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44852653|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
44852654|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852655|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852656|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852657|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852658|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44852659|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852660|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
44852661|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852662|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44852663|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852664|NCT00960297|Paclitaxel|paclitaxel|mesh-list
44852665|NCT00960297|Bevacizumab|bevacizumab|mesh-list
44852666|NCT00960297|Carboplatin|carboplatin|mesh-list
44852667|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44852668|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852669|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44852670|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44852671|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44852672|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852673|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852674|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852675|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852676|NCT00960297|Growth Substances|growth substances|mesh-ancestor
44852677|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852678|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852679|NCT00910650|Aldesleukin|aldesleukin|mesh-list
44852680|NCT00910650|Interleukin-2|interleukin-2|mesh-list
44852681|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852682|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44852683|NCT00910650|Analgesics|analgesics|mesh-ancestor
44852684|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
44852685|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852686|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852687|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44852688|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44852689|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
44852690|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852691|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
44852692|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852693|NCT05118308|Liver Extracts|liver extracts|mesh-list
44852694|NCT05118308|Hematinics|hematinics|mesh-ancestor
44852695|NCT05116800|Gemcitabine|gemcitabine|mesh-list
44852696|NCT05116800|Docetaxel|docetaxel|mesh-list
44852697|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44852698|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
44852699|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852700|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852701|NCT05116800|Antiviral Agents|antiviral agents|mesh-ancestor
44852702|NCT05116800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852703|NCT05116800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852704|NCT05116800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852705|NCT05116800|Immunologic Factors|immunologic factors|mesh-ancestor
44852706|NCT05116800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852707|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44852708|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44852709|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44852710|NCT05112861|Bevacizumab|bevacizumab|mesh-list
44852711|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852712|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852713|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44852714|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44852715|NCT05112861|Growth Substances|growth substances|mesh-ancestor
44852716|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852717|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44852718|NCT05089565|Interferons|interferons|mesh-list
44852719|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
44852720|NCT05089565|Antibodies|antibodies|mesh-list
44852721|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
44852722|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
44852723|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852724|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852725|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
44852726|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852727|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
44852728|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44852729|NCT05085327|Protective Agents|protective agents|mesh-ancestor
44852730|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852731|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44852732|NCT04948463|Vancomycin|vancomycin|mesh-list
44852733|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
44852734|NCT04948463|Tazobactam|tazobactam|mesh-list
44852735|NCT04948463|Piperacillin|piperacillin|mesh-list
44852736|NCT04948463|Amikacin|amikacin|mesh-list
44852737|NCT04948463|Ceftazidime|ceftazidime|mesh-list
44852738|NCT04948463|Cefepime|cefepime|mesh-list
44852739|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852740|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852741|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44852742|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852743|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852744|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852745|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852746|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44852747|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44697298|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697299|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697300|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697301|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44697302|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697303|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
44697304|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697305|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
44852748|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44852749|NCT04939363|Venetoclax|venetoclax|mesh-list
44852750|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
44852751|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852752|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852753|NCT04894721|Ivermectin|ivermectin|mesh-list
44852754|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44852755|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852756|NCT04874311|Doxorubicin|doxorubicin|mesh-list
44852757|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44852758|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852759|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44852760|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852761|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852762|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852763|NCT04825197|Poractant alfa|poractant alfa|mesh-list
44852764|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44852765|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
44852766|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
44852767|NCT04742140|Analgesics|analgesics|mesh-ancestor
44852768|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
44852769|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852770|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852771|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
44852772|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852773|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44852774|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
44852775|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44852776|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852777|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852778|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44852779|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
44852780|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44852781|NCT04590274|Azithromycin|azithromycin|mesh-list
44852782|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
44852783|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44852784|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852785|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
44852786|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44852787|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44852788|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852789|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852790|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852791|NCT04182321|Metformin|metformin|mesh-list
44852792|NCT04182321|Entecavir|entecavir|mesh-list
44852793|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852794|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852795|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
44852796|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852797|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44852798|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852799|NCT04062279|Autoantibodies|autoantibodies|mesh-list
44852800|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
44852801|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852802|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
44852803|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44852804|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
44852805|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852806|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852807|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44852808|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
44852809|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
44852810|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44852811|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
44852812|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852813|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852814|NCT03881020|Fluorides|fluorides|mesh-list
44852815|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
44852816|NCT03881020|Protective Agents|protective agents|mesh-ancestor
44852817|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852818|NCT03797261|Venetoclax|venetoclax|mesh-list
44852819|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852820|NCT03719924|Paclitaxel|paclitaxel|mesh-list
44852821|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44852822|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852823|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
44852824|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44852825|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44852826|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852827|NCT03475953|Avelumab|avelumab|mesh-list
44637356|NCT00395967|Plerixafor|plerixafor|mesh-list
44852828|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44852829|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852830|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852831|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
44852832|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852833|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
44852834|NCT03344341|Acarbose|acarbose|mesh-list
44852835|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44852836|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852837|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852838|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852839|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44852840|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852841|NCT03260881|Liraglutide|liraglutide|mesh-list
44852842|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852843|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852844|NCT03260881|Incretins|incretins|mesh-ancestor
44852845|NCT03260881|Hormones|hormones|mesh-ancestor
44852846|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852847|NCT03238495|Metformin|metformin|mesh-list
44852848|NCT03238495|Carboplatin|carboplatin|mesh-list
44852849|NCT03238495|Docetaxel|docetaxel|mesh-list
44852850|NCT03238495|Trastuzumab|trastuzumab|mesh-list
44852851|NCT03238495|Pertuzumab|pertuzumab|mesh-list
44852852|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852853|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44852854|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852855|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44852856|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44852857|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44852858|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852859|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852860|NCT03135262|Rituximab|rituximab|mesh-list
44852861|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
44852862|NCT03135262|Venetoclax|venetoclax|mesh-list
44852863|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852864|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852865|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
44852866|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339434|NCT01020136|Axitinib|axitinib|mesh-list
44852867|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852868|NCT03104075|Vaccines|vaccines|mesh-list
44852869|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44852870|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
44852871|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852872|NCT03072628|Nicotine|nicotine|mesh-list
44852873|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44852874|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
44852875|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852876|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852877|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44852878|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44852879|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
44852880|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852881|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852882|NCT02907983|Bupivacaine|bupivacaine|mesh-list
44852883|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852884|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
44852885|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852886|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852887|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
44852888|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852889|NCT02880540|Fentanyl|fentanyl|mesh-list
44852890|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
44852891|NCT02880540|Morphine|morphine|mesh-list
44852892|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44852893|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852894|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852895|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44852896|NCT02880540|Analgesics|analgesics|mesh-ancestor
44852897|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
44852898|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852899|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44852900|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44852901|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44852902|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44852903|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852904|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852905|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44852906|NCT02880540|Narcotics|narcotics|mesh-ancestor
44852907|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44852908|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44852909|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
44852910|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
44852911|NCT02841215|Ivermectin|ivermectin|mesh-list
44852912|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44852913|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852914|NCT02802566|Vitamins|vitamins|mesh-list
44852915|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
44852916|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852917|NCT02799641|Lidocaine|lidocaine|mesh-list
44852918|NCT02799641|Diazepam|diazepam|mesh-list
44852919|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
44852920|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
44852921|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44852922|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852923|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
44852924|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852925|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44852926|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44852927|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44852928|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44852929|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852930|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44852931|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
44852932|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
44852933|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
44852934|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852935|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44852936|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44852937|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44852938|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44852939|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44852940|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44852941|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44852942|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
44852943|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
44852944|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
44852945|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44852946|NCT02741388|Gemcitabine|gemcitabine|mesh-list
44852947|NCT02741388|Cytarabine|cytarabine|mesh-list
44852948|NCT02741388|Dexamethasone|dexamethasone|mesh-list
44852949|NCT02741388|Rituximab|rituximab|mesh-list
44852950|NCT02741388|Cisplatin|cisplatin|mesh-list
44852951|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
44852952|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852953|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852954|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
44852955|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852956|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44852957|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44852958|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
44852959|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
44339520|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852960|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852961|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44852962|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
44852963|NCT02741388|Hormones|hormones|mesh-ancestor
44852964|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44852965|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44852966|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44852967|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
44852968|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852969|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
44852970|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44852971|NCT02741388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852972|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44852973|NCT02686346|Etoposide|etoposide|mesh-list
44852974|NCT02686346|Ifosfamide|ifosfamide|mesh-list
44852975|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44852976|NCT02686346|Carboplatin|carboplatin|mesh-list
44852977|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44852978|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852979|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44852980|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44852981|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44852982|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44852983|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44852984|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
44852985|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852986|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44852987|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
44852988|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852989|NCT02536339|Trastuzumab|trastuzumab|mesh-list
44852990|NCT02536339|Pertuzumab|pertuzumab|mesh-list
44852991|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44852992|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44852993|NCT02050308|Nicotine|nicotine|mesh-list
44852994|NCT02050308|Varenicline|varenicline|mesh-list
44852995|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44852996|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
44852997|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44852998|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44852999|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44853000|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44853001|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
44853002|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853003|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853004|NCT01869361|Indomethacin|indomethacin|mesh-list
44853005|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44853006|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853007|NCT01869361|Analgesics|analgesics|mesh-ancestor
44853008|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
44853009|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853010|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853011|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853012|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853013|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
44853014|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
44853015|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853016|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44853017|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853018|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853019|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44853020|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853021|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853022|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
44853023|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44853024|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853025|NCT00943618|Bupropion|bupropion|mesh-list
44853026|NCT00943618|Varenicline|varenicline|mesh-list
44853027|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44853028|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
44853029|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44853030|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44853031|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44853032|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853033|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853034|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
44853035|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853036|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853037|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44853038|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44853039|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853040|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44853041|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44853042|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
44853043|NCT05136040|Bupivacaine|bupivacaine|mesh-list
44853044|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853045|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
44853046|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853047|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853048|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
44853049|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853050|NCT05121298|Upadacitinib|upadacitinib|mesh-list
44853051|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44853052|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853053|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853054|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853055|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853056|NCT05103644|Atorvastatin|atorvastatin|mesh-list
44853057|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44853058|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44853059|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
44339622|NCT01020864|Cetuximab|cetuximab|mesh-list
44853060|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853061|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44853062|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44853063|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853064|NCT05100264|Acetic Acid|acetic acid|mesh-list
44853065|NCT05100264|Retinol acetate|retinol acetate|mesh-list
44853066|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853067|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853068|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44853069|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
44853070|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853071|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44853072|NCT05100264|Protective Agents|protective agents|mesh-ancestor
44853073|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853074|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
44853076|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853077|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853078|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853079|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853080|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853081|NCT05012631|Losartan|losartan|mesh-list
44853082|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44853083|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44853084|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44853085|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44853086|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853087|NCT04989322|Carboplatin|carboplatin|mesh-list
44853088|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
44853089|NCT04989322|Pemetrexed|pemetrexed|mesh-list
44853090|NCT04989322|Lenvatinib|lenvatinib|mesh-list
44853091|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853092|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853093|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853094|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853095|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44853096|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44853097|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853098|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44853099|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44853100|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853101|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853102|NCT04931511|Betamethasone|betamethasone|mesh-list
44853103|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
44853104|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44853105|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
44853106|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44853107|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853108|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
44853109|NCT04931511|Hormones|hormones|mesh-ancestor
44853110|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853111|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853112|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44853113|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853114|NCT04920942|Ivermectin|ivermectin|mesh-list
44853115|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44637658|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
44853116|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853117|NCT04901754|Apatinib|apatinib|mesh-list
44853118|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853119|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853120|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853121|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853122|NCT04804709|Panobinostat|panobinostat|mesh-list
44853123|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853124|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44853125|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853126|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853127|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
44853128|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853129|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853130|NCT04690673|Acetaminophen|acetaminophen|mesh-list
44853131|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853132|NCT04690673|Analgesics|analgesics|mesh-ancestor
44853133|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
44853134|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853135|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853136|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
44853137|NCT04682288|Levofloxacin|levofloxacin|mesh-list
44853138|NCT04682288|Ofloxacin|ofloxacin|mesh-list
44853139|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44853140|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853141|NCT04682288|Renal Agents|renal agents|mesh-ancestor
44853142|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853143|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44853144|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44853145|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853146|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853147|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853148|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44853149|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44853150|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44853151|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44853152|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853153|NCT04580992|Ajmaline|ajmaline|mesh-list
44853154|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44853155|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44853156|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44853157|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853158|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853159|NCT04469634|Antibodies|antibodies|mesh-list
44853160|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
44853161|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853162|NCT04455178|Indapamide|indapamide|mesh-list
44853163|NCT04455178|Spironolactone|spironolactone|mesh-list
44853164|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44853165|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
44853166|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853167|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853168|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44853169|NCT04455178|Diuretics|diuretics|mesh-ancestor
44853170|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
44853171|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44853172|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44853173|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853174|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853175|NCT04400110|Amoxicillin|amoxicillin|mesh-list
44853176|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
44853177|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
44853178|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853179|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853180|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853181|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853182|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44853183|NCT04388501|Atorvastatin|atorvastatin|mesh-list
44853184|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44853185|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44853186|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
44339763|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
44853187|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637732|NCT00393029|Analgesics|analgesics|mesh-ancestor
44853188|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44853189|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44853190|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853191|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
44853192|NCT04308837|Promethazine|promethazine|mesh-list
44853193|NCT04308837|Dexamethasone|dexamethasone|mesh-list
44853194|NCT04308837|Paclitaxel|paclitaxel|mesh-list
44853195|NCT04308837|Carboplatin|carboplatin|mesh-list
44853196|NCT04308837|Palonosetron|palonosetron|mesh-list
44853197|NCT04308837|Famotidine|famotidine|mesh-list
44853198|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44853199|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853200|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
44853201|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
44853202|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
44853203|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853204|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853205|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
44853206|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
44853207|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853208|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853209|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44853210|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
44853211|NCT04308837|Hormones|hormones|mesh-ancestor
44853212|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853213|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44853214|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44853215|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44853216|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853217|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853218|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
44853219|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
44853220|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44853221|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
44853222|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
44853223|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853224|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44853225|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
44853226|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44853227|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44853228|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44853229|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
44853230|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44853231|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44853232|NCT04111419|Amlodipine|amlodipine|mesh-list
44339813|NCT01021943|Spironolactone|spironolactone|mesh-list
44853233|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44853234|NCT04111419|Atorvastatin|atorvastatin|mesh-list
44853235|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44853236|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44853237|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
44853238|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853239|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44853240|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44853241|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853242|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44853243|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44853244|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853245|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44853246|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853247|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
44853248|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44853249|NCT04071613|Plasminogen|plasminogen|mesh-list
44853250|NCT04071613|Tenecteplase|tenecteplase|mesh-list
44853251|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44853252|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853253|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853254|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
44853255|NCT04006769|Entacapone|entacapone|mesh-list
44853256|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853257|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853258|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853259|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853260|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44853261|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44853262|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44853263|NCT03916627|Cemiplimab|cemiplimab|mesh-list
44853264|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853265|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853266|NCT03893318|Lidocaine|lidocaine|mesh-list
44853267|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853268|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
44853269|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853270|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339848|NCT01022151|Aminophylline|aminophylline|mesh-list
44853271|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
44853272|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853273|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44853274|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44853275|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44853276|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853277|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853278|NCT03625466|Ivacaftor|ivacaftor|mesh-list
44853279|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44853280|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853281|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637880|NCT00391846|Valsartan|valsartan|mesh-list
44853282|NCT03417479|Gabapentin|gabapentin|mesh-list
44853283|NCT03417479|Analgesics|analgesics|mesh-ancestor
44853284|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
44853285|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853286|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853287|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
44853288|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44853289|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44853290|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853291|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44853292|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44853293|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44853294|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853295|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853296|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
44853297|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
44853298|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
44853299|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44853300|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853301|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853302|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
44853303|NCT03317795|Coagulants|coagulants|mesh-ancestor
44853304|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44853305|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
44853306|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853307|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339901|NCT01022528|Dexamethasone|dexamethasone|mesh-list
44853308|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44853309|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44853310|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44853311|NCT03115294|Theophylline|theophylline|mesh-list
44853312|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44853313|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
44853314|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853315|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853316|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44853317|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853318|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44853319|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853320|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853321|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
44853322|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44853323|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44853324|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
44853325|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853326|NCT03087656|Levofloxacin|levofloxacin|mesh-list
44853327|NCT03087656|Ofloxacin|ofloxacin|mesh-list
44853328|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
44853329|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44853330|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853331|NCT03087656|Renal Agents|renal agents|mesh-ancestor
44853332|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853333|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44853334|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44853335|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339926|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853336|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853337|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853338|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44853339|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44853340|NCT03033069|Sertraline|sertraline|mesh-list
44853341|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
44853342|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
44853343|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44853344|NCT03033069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44853345|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44853346|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853347|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853348|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853349|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
44853350|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853351|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
44853352|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
44853353|NCT02946424|Simvastatin|simvastatin|mesh-list
44853354|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44853355|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44637971|NCT00391430|Sertraline|sertraline|mesh-list
44853356|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
44853357|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853358|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44853359|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44853360|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853361|NCT02863770|Pancrelipase|pancrelipase|mesh-list
44853362|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44853363|NCT02587598|Cytarabine|cytarabine|mesh-list
44853364|NCT02587598|Azacitidine|azacitidine|mesh-list
44853365|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44853366|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
44853367|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853368|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853369|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
44853370|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853371|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44853372|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
44853373|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853374|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853375|NCT02485574|Calcium|calcium|mesh-list
44853376|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44853377|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853378|NCT02091934|Dipivefrin|dipivefrin|mesh-list
44853379|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44853380|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44853381|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853382|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853383|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853384|NCT01460160|Dasatinib|dasatinib|mesh-list
44853385|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853386|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853387|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853388|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853389|NCT01291004|Drospirenone|drospirenone|mesh-list
44853390|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44853391|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44853392|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
44853393|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44853394|NCT01291004|Desogestrel|desogestrel|mesh-list
44853395|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
44853396|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
44853397|NCT01291004|Estradiol|estradiol|mesh-list
44853398|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44853399|NCT01291004|Estrogens|estrogens|mesh-ancestor
44853400|NCT01291004|Hormones|hormones|mesh-ancestor
44853401|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853402|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853403|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44853404|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853405|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44853406|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44853407|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44339988|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853408|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44853409|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44853410|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44853411|NCT01291004|Diuretics|diuretics|mesh-ancestor
44853412|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
44853413|NCT01291004|Progestins|progestins|mesh-ancestor
44853414|NCT01170702|Ropivacaine|ropivacaine|mesh-list
44853415|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853416|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
44853417|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853418|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853419|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
44853420|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853421|NCT01018563|Farletuzumab|farletuzumab|mesh-list
44853422|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853423|NCT00805961|Bevacizumab|bevacizumab|mesh-list
44853424|NCT00805961|Everolimus|everolimus|mesh-list
44853425|NCT00805961|Temozolomide|temozolomide|mesh-list
44853426|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853427|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853428|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44853429|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44853430|NCT00805961|Growth Substances|growth substances|mesh-ancestor
44853431|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853432|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
44853433|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44853434|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
44853435|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44853436|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
44853437|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853438|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
44853439|NCT00374660|Irofulven|irofulven|mesh-list
44853440|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853441|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44853442|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
44853443|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853444|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
44853445|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
44853446|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853447|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853448|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44340028|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853449|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853450|NCT05152355|Budesonide|budesonide|mesh-list
44853451|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853452|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44853453|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
44853454|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853455|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853456|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44853457|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853458|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
44853459|NCT05152355|Hormones|hormones|mesh-ancestor
44853460|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853461|NCT05152264|Analgesics|analgesics|mesh-list
44853462|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
44853463|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853464|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853465|NCT05152186|Disinfectants|disinfectants|mesh-list
44853466|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853467|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44853468|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44853469|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44853470|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853471|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853472|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
44697306|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697307|NCT01396291|Asenapine|asenapine|mesh-list
44697308|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44697309|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697310|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697311|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697312|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697313|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44697314|NCT01396304|Calcium|calcium|mesh-list
44340071|NCT01023334|Anesthetics|anesthetics|mesh-list
44697315|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697316|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697317|NCT01396304|Laxatives|laxatives|mesh-ancestor
44697318|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697319|NCT01396564|Metformin|metformin|mesh-list
44697320|NCT01396564|Pioglitazone|pioglitazone|mesh-list
44697321|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44697322|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697327|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697328|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
44697329|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
44697330|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
44697331|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697332|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44697333|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44697334|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44697335|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697336|NCT01396668|Gemcitabine|gemcitabine|mesh-list
44697337|NCT01396668|Cisplatin|cisplatin|mesh-list
44697338|NCT01396668|Capecitabine|capecitabine|mesh-list
44697339|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697340|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697341|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
44697342|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697343|NCT01396668|Antiviral Agents|antiviral agents|mesh-ancestor
44853473|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853474|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853475|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44853476|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853477|NCT05151796|Aspirin|aspirin|mesh-list
44853478|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44853479|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853480|NCT05151796|Analgesics|analgesics|mesh-ancestor
44853481|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
44853482|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853483|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853484|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853485|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853486|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44853487|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853488|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853489|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44853490|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44853491|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853492|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
44853493|NCT05151679|Iron|iron|mesh-list
44853494|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44853495|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
44853496|NCT05151679|Trace Elements|trace elements|mesh-ancestor
44853497|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
44853498|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853499|NCT05151679|Hematinics|hematinics|mesh-ancestor
44853500|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
44853501|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
44340124|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
44853502|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853503|NCT05151614|Colchicine|colchicine|mesh-list
44853504|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
44853505|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853506|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
44853507|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
44853508|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
44853509|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853510|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853511|NCT05151549|Cisplatin|cisplatin|mesh-list
44853512|NCT05151549|Carboplatin|carboplatin|mesh-list
44853513|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853514|NCT05151510|Lidocaine|lidocaine|mesh-list
44853515|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853516|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
44853517|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853518|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853519|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
44853520|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853521|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44853522|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44853523|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44853524|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853525|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853526|NCT05151393|Vitamin D|vitamin d|mesh-list
44853527|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
44853528|NCT05151393|Vitamins|vitamins|mesh-ancestor
44853529|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
44853530|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853531|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44853532|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44853533|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
44853534|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853535|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
44853536|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
44853537|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44853538|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44853539|NCT05151016|Mifepristone|mifepristone|mesh-list
44853540|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44853541|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
44853542|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853543|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853544|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44853545|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44340159|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
44853546|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44853547|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
44638149|NCT00390221|Daclizumab|daclizumab|mesh-list
44853548|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44853549|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44853550|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44853551|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853552|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
44853553|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44853554|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44853555|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44853556|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853557|NCT05150899|Fexofenadine|fexofenadine|mesh-list
44853559|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44853560|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44853561|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44853562|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44853563|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853564|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853565|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853566|NCT05150899|Urological Agents|urological agents|mesh-ancestor
44853567|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44853568|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44853569|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44853570|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
44853571|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
44853573|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853574|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44853575|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
44853576|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853577|NCT05076513|Niraparib|niraparib|mesh-list
44853578|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44853579|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853580|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853581|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853582|NCT04991350|Bevacizumab|bevacizumab|mesh-list
44853583|NCT04991350|Ranibizumab|ranibizumab|mesh-list
44853584|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853585|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853586|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44853587|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44853588|NCT04991350|Growth Substances|growth substances|mesh-ancestor
44853589|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853590|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44853591|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44853592|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44340206|NCT01024179|Sirolimus|sirolimus|mesh-list
44853593|NCT04933058|Acetaminophen|acetaminophen|mesh-list
44853594|NCT04933058|Fentanyl|fentanyl|mesh-list
44853595|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44853596|NCT04933058|Narcotics|narcotics|mesh-ancestor
44853597|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853598|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853599|NCT04933058|Analgesics|analgesics|mesh-ancestor
44853600|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
44853601|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853602|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44853603|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44853604|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
44853605|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
44853606|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853607|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
44853608|NCT04891991|Infliximab|infliximab|mesh-list
44853609|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
44853610|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44853611|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853612|NCT04750759|Niclosamide|niclosamide|mesh-list
44853613|NCT04750759|Camostat|camostat|mesh-list
44853614|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
44853615|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853616|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853617|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44340253|NCT01024322|Analgesics|analgesics|mesh-ancestor
44853618|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44853619|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
44853620|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44853621|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
44853622|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44853623|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853624|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
44853625|NCT04574154|Anesthetics|anesthetics|mesh-list
44853626|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853627|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853628|NCT04526821|Lactoferrin|lactoferrin|mesh-list
44853629|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853630|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44853631|NCT04445389|Vaccines|vaccines|mesh-list
44853632|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
44853633|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853634|NCT04365088|Deflazacort|deflazacort|mesh-list
44853635|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853636|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44853637|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
44853638|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853639|NCT04349579|Rifamycins|rifamycins|mesh-list
44853640|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
44853641|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853642|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853643|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853644|NCT04234529|Caffeine|caffeine|mesh-list
44340273|NCT01024348|Tramadol|tramadol|mesh-list
44853645|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44638302|NCT00387881|Analgesics|analgesics|mesh-ancestor
44853646|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853647|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44853648|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853649|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853650|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44853651|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44853652|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
44853653|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853654|NCT04217954|Bevacizumab|bevacizumab|mesh-list
44853655|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853656|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853657|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44853658|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44853659|NCT04217954|Growth Substances|growth substances|mesh-ancestor
44853660|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853661|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
44853662|NCT04182100|Aspirin|aspirin|mesh-list
44853663|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44853664|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853665|NCT04182100|Analgesics|analgesics|mesh-ancestor
44853666|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
44853667|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853668|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853669|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853670|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853671|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44853672|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853673|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853674|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44853675|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44853676|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853677|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
44853678|NCT04179019|Amlodipine|amlodipine|mesh-list
44853679|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44853680|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44853681|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853682|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853683|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44853684|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853685|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
44853686|NCT03966625|Autoantibodies|autoantibodies|mesh-list
44853687|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
44853688|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853689|NCT03961568|Cenobamate|cenobamate|mesh-list
44853690|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
44853691|NCT03954106|Defibrotide|defibrotide|mesh-list
44853692|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44853693|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44853694|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853695|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44853696|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
44853697|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853698|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
44853699|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853700|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853701|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44853702|NCT03930498|Antibodies|antibodies|mesh-list
44853703|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
44853704|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
44853705|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853706|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44853707|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
44853708|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853709|NCT03817554|Dopamine|dopamine|mesh-list
44853710|NCT03817554|Pramipexole|pramipexole|mesh-list
44853711|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
44853712|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
44853713|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853714|NCT03817554|Protective Agents|protective agents|mesh-ancestor
44853715|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853716|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44853717|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44853718|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
44853719|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853720|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44853721|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
44638383|NCT00387010|Fentanyl|fentanyl|mesh-list
44853722|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
44853723|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853724|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
44853725|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853726|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
44853727|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853728|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853729|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44853730|NCT03717896|Thiamine|thiamine|mesh-list
44853731|NCT03717896|Vitamins|vitamins|mesh-ancestor
44853732|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
44853733|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853734|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638446|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44853735|NCT03593252|Metronidazole|metronidazole|mesh-list
44853736|NCT03593252|Cefazolin|cefazolin|mesh-list
44853737|NCT03593252|Neomycin|neomycin|mesh-list
44853738|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
44853739|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
44853740|NCT03593252|Citric Acid|citric acid|mesh-list
44853741|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
44853742|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853743|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44853744|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44853745|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44853746|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
44853747|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44853748|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
44853749|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
44853750|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853751|NCT03593252|Cathartics|cathartics|mesh-ancestor
44853752|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44853753|NCT03593252|Antacids|antacids|mesh-ancestor
44853754|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44853755|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853756|NCT03574792|Oxycodone|oxycodone|mesh-list
44853757|NCT03574792|Methadone|methadone|mesh-list
44853758|NCT03574792|Gabapentin|gabapentin|mesh-list
44853759|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44853760|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44853761|NCT03574792|Narcotics|narcotics|mesh-ancestor
44853762|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853763|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853764|NCT03574792|Analgesics|analgesics|mesh-ancestor
44853765|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
44853766|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853767|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
44853768|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44853769|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44853770|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44853771|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44853772|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44853773|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853774|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853775|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
44853776|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
44853777|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853778|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44853779|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44853780|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853781|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44853782|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
44853783|NCT03368066|Cosyntropin|cosyntropin|mesh-list
44853784|NCT03368066|Hormones|hormones|mesh-ancestor
44853785|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853786|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853788|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
44853789|NCT03356483|Psilocybin|psilocybin|mesh-list
44853790|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44853791|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
44853792|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853793|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44853794|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
44853795|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
44853796|NCT03356483|Vitamins|vitamins|mesh-ancestor
44853797|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
44853798|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853799|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
44853800|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44853801|NCT03042819|Doxorubicin|doxorubicin|mesh-list
44853802|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44853803|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853804|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44853805|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44853806|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638520|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44853807|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853808|NCT03030222|Empagliflozin|empagliflozin|mesh-list
44853809|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44853810|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853811|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44853812|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853813|NCT02892604|Insulin|insulin|mesh-list
44853814|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44853815|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853816|NCT02832687|Acetaminophen|acetaminophen|mesh-list
44853817|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44853818|NCT02832687|Analgesics|analgesics|mesh-ancestor
44853819|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
44340461|NCT01025765|Pioglitazone|pioglitazone|mesh-list
44853820|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853821|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853822|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
44853823|NCT02830477|Factor VIII|factor viii|mesh-list
44853824|NCT02830477|Coagulants|coagulants|mesh-ancestor
44853825|NCT02568449|Nintedanib|nintedanib|mesh-list
44853826|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853827|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853828|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853829|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853830|NCT02546622|Factor VIII|factor viii|mesh-list
44853831|NCT02546622|Coagulants|coagulants|mesh-ancestor
44853832|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
44853833|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
44853834|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44853835|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
44853836|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853837|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44853838|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853839|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
44853840|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853841|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
44853842|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853843|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853844|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44853845|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44853846|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
44853847|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853848|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853849|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44853850|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44853851|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44853852|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
44853853|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853854|NCT01530997|Cisplatin|cisplatin|mesh-list
44853855|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853856|NCT01331616|Bevacizumab|bevacizumab|mesh-list
44853857|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44853858|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853859|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44853860|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44853861|NCT01331616|Growth Substances|growth substances|mesh-ancestor
44853862|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853863|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44853864|NCT01109004|Dexamethasone|dexamethasone|mesh-list
44853865|NCT01109004|Lenalidomide|lenalidomide|mesh-list
44853866|NCT01109004|Bortezomib|bortezomib|mesh-list
44853867|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44853868|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
44853869|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
44853870|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853871|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853872|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44853873|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
44853874|NCT01109004|Hormones|hormones|mesh-ancestor
44340509|NCT01026064|Azithromycin|azithromycin|mesh-list
44853875|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853876|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44853877|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853878|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
44853879|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44853880|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44853881|NCT01109004|Growth Substances|growth substances|mesh-ancestor
44853882|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
44853883|NCT00593905|Bosentan|bosentan|mesh-list
44853884|NCT00593905|Ambrisentan|ambrisentan|mesh-list
44853885|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
44853886|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44853887|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44853888|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853889|NCT00548912|Spironolactone|spironolactone|mesh-list
44853890|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44853891|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
44853892|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853893|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853894|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43748730|NCT02515682|Equol|equol|mesh-list
44853895|NCT00548912|Diuretics|diuretics|mesh-ancestor
44853896|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
44853897|NCT05153928|Norethindrone|norethindrone|mesh-list
44853898|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
44853899|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44853900|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44853901|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44853902|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
44853903|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853904|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853905|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44853906|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44853907|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44853908|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
44853909|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853910|NCT05153785|Lidocaine|lidocaine|mesh-list
44853911|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853912|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
44853913|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853914|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853915|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
44853916|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853917|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44853918|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44853919|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44853920|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44853921|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853922|NCT05153603|Olaparib|olaparib|mesh-list
44853923|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44853924|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853925|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853926|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853927|NCT05153486|Ethanol|ethanol|mesh-list
44853928|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44853929|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44853930|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853931|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853932|NCT05153200|Adalimumab|adalimumab|mesh-list
44853933|NCT05153200|Upadacitinib|upadacitinib|mesh-list
44853934|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340552|NCT01026129|Analgesics|analgesics|mesh-ancestor
44853935|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44853936|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44853937|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44853938|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853939|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853940|NCT05152901|Epinephrine|epinephrine|mesh-list
44853941|NCT05152901|Racepinephrine|racepinephrine|mesh-list
44853942|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
44853943|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44853944|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44853945|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
44853946|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44853947|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853948|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853949|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44853950|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44853951|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
44853952|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44853953|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44853954|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44853955|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
44853956|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
44853957|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44853958|NCT05152667|Dienogest|dienogest|mesh-list
44853959|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
44853960|NCT05152667|Progestins|progestins|mesh-list
44638674|NCT00384033|Analgesics|analgesics|mesh-ancestor
44853961|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44853962|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
44853963|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44853964|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853965|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44853966|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44853967|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44340595|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44853968|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44853969|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44853970|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
44853971|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44853972|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44853973|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853974|NCT05152667|Hormones|hormones|mesh-ancestor
44853975|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
44853976|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44853977|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853978|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853979|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44853980|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44853981|NCT05152511|Protective Agents|protective agents|mesh-ancestor
44853982|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853983|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44853984|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44340628|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
44853985|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
44853986|NCT05132985|Cisplatin|cisplatin|mesh-list
44853987|NCT05132985|Carboplatin|carboplatin|mesh-list
44853988|NCT05132985|Pemetrexed|pemetrexed|mesh-list
44853989|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44853990|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44853991|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44853992|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44853993|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44853994|NCT05118399|Bupivacaine|bupivacaine|mesh-list
44853995|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
44853996|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
44853997|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44853998|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44853999|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
44854000|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854001|NCT04947631|Tadalafil|tadalafil|mesh-list
44854002|NCT04947631|Dutasteride|dutasteride|mesh-list
44854003|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
44854004|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44854005|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44854006|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854007|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854008|NCT04947631|Urological Agents|urological agents|mesh-ancestor
44854009|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44854010|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44854011|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
44854012|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854013|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854014|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
44854015|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44854016|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
44854017|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
44854018|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854019|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854020|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44854021|NCT04884893|Analgesics|analgesics|mesh-ancestor
44854022|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
44854023|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854024|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
44854025|NCT04702256|Prednisone|prednisone|mesh-list
44854026|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
44854027|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44854028|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44854029|NCT04702256|Prednisolone|prednisolone|mesh-list
44854030|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
44854031|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
44854032|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44854033|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
44854034|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44854035|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854036|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
44854037|NCT04702256|Hormones|hormones|mesh-ancestor
44854038|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854039|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854040|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44854041|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854042|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44854043|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44854044|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
44854045|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44854046|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854047|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854048|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854049|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
44854050|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
44854051|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854052|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854053|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44854054|NCT04702256|Protective Agents|protective agents|mesh-ancestor
44854055|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854056|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44854057|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
44854058|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
44854059|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854060|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
44854061|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
44854062|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854063|NCT05259319|Atezolizumab|atezolizumab|mesh-list
44854064|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854065|NCT05259098|Sufentanil|sufentanil|mesh-list
44854066|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44854067|NCT05259098|Narcotics|narcotics|mesh-ancestor
44854068|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854069|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854070|NCT05259098|Analgesics|analgesics|mesh-ancestor
44854071|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
44854072|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854073|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44854074|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44854075|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
44854076|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
44854077|NCT05259007|Amoxicillin|amoxicillin|mesh-list
44854078|NCT05259007|Clarithromycin|clarithromycin|mesh-list
44854079|NCT05259007|Propolis|propolis|mesh-list
44854080|NCT05259007|Lansoprazole|lansoprazole|mesh-list
44854081|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
44854082|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44854083|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854084|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44854085|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854086|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854087|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44854088|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44854089|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44854090|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854091|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44854092|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
44854093|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44854094|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44854095|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854096|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
44854097|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44854098|NCT05258799|Cytarabine|cytarabine|mesh-list
44854099|NCT05258799|Decitabine|decitabine|mesh-list
44854100|NCT05258799|Aclarubicin|aclarubicin|mesh-list
44854101|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854102|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
44854103|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854104|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854105|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
44854106|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854107|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854108|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
44854109|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854110|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854111|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44854112|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44854113|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44854114|NCT05258721|Fluorides|fluorides|mesh-list
44854115|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
44854116|NCT05258721|Protective Agents|protective agents|mesh-ancestor
44854117|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854118|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
44854119|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44854120|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
44854121|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854122|NCT05258682|Expectorants|expectorants|mesh-ancestor
44854123|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
44854124|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44854125|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
44854126|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854127|NCT05258682|Protective Agents|protective agents|mesh-ancestor
44854128|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854129|NCT05258682|Antidotes|antidotes|mesh-ancestor
44854130|NCT05258474|Niacinamide|niacinamide|mesh-list
44854132|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
44854133|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
44854134|NCT05258474|Vitamins|vitamins|mesh-ancestor
44854135|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
44854136|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854137|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44854138|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
44697344|NCT01396668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697345|NCT01396668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697346|NCT01396668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697347|NCT01396668|Immunologic Factors|immunologic factors|mesh-ancestor
44697348|NCT01396668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697349|NCT01396681|Gemcitabine|gemcitabine|mesh-list
44697350|NCT01396681|Cisplatin|cisplatin|mesh-list
44697351|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697352|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697353|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
44697354|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697355|NCT01396681|Antiviral Agents|antiviral agents|mesh-ancestor
44697356|NCT01396681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697357|NCT01396681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697358|NCT01396681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854139|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854140|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44854141|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
44854142|NCT05258136|Antibodies|antibodies|mesh-list
44854143|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44854144|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
44854145|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854146|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44854147|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44340779|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854148|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854149|NCT05257148|Nebivolol|nebivolol|mesh-list
44854150|NCT05257148|Zofenopril|zofenopril|mesh-list
44854151|NCT05257148|Captopril|captopril|mesh-list
44854152|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44854153|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
44854154|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44854155|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44854156|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44854157|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854158|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854159|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854160|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854161|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44854162|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854163|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854164|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
44854165|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
44854166|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44854167|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44854168|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854169|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44854170|NCT05195450|Tenofovir|tenofovir|mesh-list
44854171|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
44854172|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854173|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44854174|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44854175|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854176|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854177|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44854178|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44854179|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
44854180|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854181|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854182|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854183|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854184|NCT05137626|Digoxin|digoxin|mesh-list
44854185|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44854186|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44854187|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854188|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854189|NCT05137626|Protective Agents|protective agents|mesh-ancestor
44854190|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854191|NCT05084599|Metaraminol|metaraminol|mesh-list
44854192|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
44854193|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
44854194|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854195|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854196|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44854197|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44854198|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44854199|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44854200|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854201|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854202|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854204|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
44854205|NCT05008003|Vitamins|vitamins|mesh-ancestor
44854206|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
44854207|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854208|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44854209|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44854210|NCT04859608|Eculizumab|eculizumab|mesh-list
44854211|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44854212|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854213|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
44854214|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854215|NCT04754386|Antibodies|antibodies|mesh-list
44854216|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
44854217|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854218|NCT04660747|Anticoagulants|anticoagulants|mesh-list
44854219|NCT04482673|Vitamin D|vitamin d|mesh-list
44854220|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
44854221|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
44854222|NCT04482673|Vitamins|vitamins|mesh-list
44854223|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
44854224|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854225|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44854226|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44854227|NCT04472299|Ropivacaine|ropivacaine|mesh-list
44854228|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
44854229|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
44854230|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854231|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854232|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
44854233|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854234|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44854235|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44854236|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44854237|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854238|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854239|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854240|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44854241|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44854242|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
44854243|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854244|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44854245|NCT04390646|Hormones|hormones|mesh-ancestor
44854246|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854247|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854248|NCT04370418|Fluorouracil|fluorouracil|mesh-list
44854249|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
44854250|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854251|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854252|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854253|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854254|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
44854255|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854256|NCT04294550|Naloxegol|naloxegol|mesh-list
44854257|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44854258|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854259|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
44854260|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854261|NCT04107038|Anesthetics|anesthetics|mesh-list
44854262|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854263|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854264|NCT03993717|Vaccines|vaccines|mesh-list
44854265|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
44854266|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854267|NCT03951025|Melatonin|melatonin|mesh-list
44854268|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
44854269|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854270|NCT03951025|Protective Agents|protective agents|mesh-ancestor
44854271|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854272|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854273|NCT03908307|Dexamethasone|dexamethasone|mesh-list
44854274|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
44854275|NCT03908307|BB 1101|bb 1101|mesh-list
44854276|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697359|NCT01396681|Immunologic Factors|immunologic factors|mesh-ancestor
44854277|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
44854279|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854280|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854281|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854282|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
44854283|NCT03908307|Hormones|hormones|mesh-ancestor
44854284|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854285|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44854286|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854287|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854288|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854289|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854290|NCT03865940|Lidocaine|lidocaine|mesh-list
44854291|NCT03865940|Guanfacine|guanfacine|mesh-list
44854292|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44854293|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
44854294|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854295|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854296|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
44854297|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854298|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44854299|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44854300|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44854301|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854302|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854303|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44854304|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44854305|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44854306|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44854307|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854308|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854309|NCT03792750|Nivolumab|nivolumab|mesh-list
44854310|NCT03792750|Linrodostat|linrodostat|mesh-list
44854311|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854312|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854313|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44854314|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854315|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854316|NCT03765619|Aspirin|aspirin|mesh-list
44854317|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44854318|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44854319|NCT03765619|Analgesics|analgesics|mesh-ancestor
44854320|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
44854321|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854322|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854323|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854324|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854325|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44854326|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44854327|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854328|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44854329|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44854330|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854331|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
44854332|NCT03739593|Dexamethasone|dexamethasone|mesh-list
44854333|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
44854334|NCT03739593|BB 1101|bb 1101|mesh-list
44854335|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854336|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
44854337|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
44854338|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854339|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854340|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854341|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
44854342|NCT03739593|Hormones|hormones|mesh-ancestor
44854343|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854344|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44854345|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854346|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854347|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854348|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854349|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
44854350|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854351|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854352|NCT03655197|Doxycycline|doxycycline|mesh-list
44854353|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44854354|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854355|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
44854356|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44854357|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44854358|NCT03535272|Bismuth|bismuth|mesh-list
44854359|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44854360|NCT03535272|Antacids|antacids|mesh-ancestor
44854361|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854362|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854363|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
44854364|NCT03520842|Methotrexate|methotrexate|mesh-list
44854365|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44854366|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
44854367|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44854368|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854369|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854370|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
44854371|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854372|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854373|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44854374|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854375|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44854376|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854377|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
44854378|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854379|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44854380|NCT03347123|Nivolumab|nivolumab|mesh-list
44854381|NCT03347123|Ipilimumab|ipilimumab|mesh-list
44854382|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854383|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854384|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44854385|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854386|NCT03309007|Metformin|metformin|mesh-list
44854387|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
44854388|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854389|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854390|NCT03309007|Antacids|antacids|mesh-ancestor
44854391|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854392|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854393|NCT03307616|Nivolumab|nivolumab|mesh-list
44854394|NCT03307616|Ipilimumab|ipilimumab|mesh-list
44854395|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854396|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854397|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44854398|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854399|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
44854400|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44854401|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
44854402|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854403|NCT03306979|Expectorants|expectorants|mesh-ancestor
44854404|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44854405|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44854406|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
44854407|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854408|NCT03306979|Protective Agents|protective agents|mesh-ancestor
44854409|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854410|NCT03306979|Antidotes|antidotes|mesh-ancestor
44854411|NCT03177460|Daratumumab|daratumumab|mesh-list
44854412|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854413|NCT02986269|Anesthetics|anesthetics|mesh-list
44854414|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854415|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854416|NCT02940496|Ribavirin|ribavirin|mesh-list
44854417|NCT02940496|Grazoprevir|grazoprevir|mesh-list
44854418|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44854419|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
44854420|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854421|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854422|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
44854423|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854424|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
44854425|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854426|NCT02553161|Citalopram|citalopram|mesh-list
44854427|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341070|NCT01028547|Dexamethasone|dexamethasone|mesh-list
44854428|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44854429|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854430|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854431|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854432|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
44854433|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854434|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44854435|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
44854436|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44854437|NCT02518555|Vaccines|vaccines|mesh-list
44854438|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
44854439|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854440|NCT02515773|Metformin|metformin|mesh-list
44854441|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854442|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854443|NCT02478788|Amphetamine|amphetamine|mesh-list
44854444|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44854445|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854446|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
44854447|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
44854448|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854449|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
44854450|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854451|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854452|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854453|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44854454|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44854455|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854456|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44854457|NCT02323126|Nivolumab|nivolumab|mesh-list
44854458|NCT02323126|Nazartinib|nazartinib|mesh-list
44854459|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854460|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854461|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44854462|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854463|NCT01712763|Goserelin|goserelin|mesh-list
44854464|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44854465|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44854466|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854467|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
44854468|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44854469|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
44854470|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44854471|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854472|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44854473|NCT01126749|Gemcitabine|gemcitabine|mesh-list
44854474|NCT01126749|Cisplatin|cisplatin|mesh-list
44854475|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854476|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854477|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
44854478|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854479|NCT01126749|Antiviral Agents|antiviral agents|mesh-ancestor
44854480|NCT01126749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854481|NCT01126749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854482|NCT01126749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854483|NCT01126749|Immunologic Factors|immunologic factors|mesh-ancestor
44854484|NCT01126749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854485|NCT00821587|Cyclosporine|cyclosporine|mesh-list
44697360|NCT01396681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854486|NCT00821587|Tacrolimus|tacrolimus|mesh-list
44854487|NCT00821587|Cyclosporins|cyclosporins|mesh-list
44854488|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854489|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
44854490|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854491|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44854492|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854493|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854494|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
44854495|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854496|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44854497|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854498|NCT00585195|Itraconazole|itraconazole|mesh-list
44854499|NCT00585195|Rifampin|rifampin|mesh-list
44854500|NCT00585195|Crizotinib|crizotinib|mesh-list
44854501|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
44854502|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854503|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44854504|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44854505|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854506|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854507|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44854508|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
44854509|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854510|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854511|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44341144|NCT01028963|Pioglitazone|pioglitazone|mesh-list
44854512|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44854513|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
44854514|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44854515|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
44854516|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44854517|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44854518|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44854519|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44854520|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44854521|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44854522|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44854523|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854524|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854525|NCT04457323|Metoprolol|metoprolol|mesh-list
44854526|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44854527|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44854528|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
44854529|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
44854530|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854531|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341189|NCT01029418|Sorafenib|sorafenib|mesh-list
44341210|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44854532|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44854533|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44854534|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44854535|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854536|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854537|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854538|NCT04448431|Vortioxetine|vortioxetine|mesh-list
44854539|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44854540|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
44854541|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44854542|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44854543|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44854544|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854545|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854546|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44854547|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44854548|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854549|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854550|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854551|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
44854552|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44854553|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44854554|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44854555|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44854556|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44854557|NCT04372017|Vitamin D|vitamin d|mesh-list
44854558|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
44854559|NCT04372017|Vitamins|vitamins|mesh-ancestor
44854560|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
44854561|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854562|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44854563|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
44854564|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44854565|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44854566|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854567|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854568|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854569|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854570|NCT04339049|Lidocaine|lidocaine|mesh-list
44854571|NCT04339049|Misoprostol|misoprostol|mesh-list
44854572|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
44854573|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
44854574|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854575|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854576|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
44854577|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854578|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44854579|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44854580|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44854581|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854582|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854583|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44854584|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
44854585|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44854586|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44854587|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854588|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
44854589|NCT04312971|Norepinephrine|norepinephrine|mesh-list
44854590|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44854591|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44854592|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
44854593|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854594|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854595|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854596|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
44854597|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
44854598|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854599|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44854600|NCT04282278|Apatinib|apatinib|mesh-list
44854601|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854602|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854603|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854604|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854605|NCT04243629|Pramlintide|pramlintide|mesh-list
44854606|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
44854607|NCT04243629|Pancrelipase|pancrelipase|mesh-list
44854608|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854609|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854610|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854611|NCT04170998|Metformin|metformin|mesh-list
44854612|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
44854613|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854614|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854615|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44854616|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854617|NCT03990077|Docetaxel|docetaxel|mesh-list
44854618|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854619|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44854620|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44854621|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44854622|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854623|NCT03761277|Morphine|morphine|mesh-list
44854624|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44854625|NCT03761277|Narcotics|narcotics|mesh-ancestor
44854626|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854627|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854628|NCT03761277|Analgesics|analgesics|mesh-ancestor
44854629|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
44854630|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854631|NCT03527238|Tacrolimus|tacrolimus|mesh-list
44854632|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854633|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
44854634|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854635|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44854636|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854637|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854639|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
44854640|NCT03380507|Vitamins|vitamins|mesh-ancestor
44854641|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
44854642|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854643|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854644|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
44854645|NCT03194165|Ritonavir|ritonavir|mesh-list
44854646|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44854647|NCT03194165|Darunavir|darunavir|mesh-list
44854648|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
44854649|NCT03194165|Nevirapine|nevirapine|mesh-list
44854650|NCT03194165|Dolutegravir|dolutegravir|mesh-list
44854651|NCT03194165|Rilpivirine|rilpivirine|mesh-list
44854652|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44854653|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44854654|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854655|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854656|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854657|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44854658|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44854659|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
44854660|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854661|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44854662|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44854663|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44854664|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44854665|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44854666|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44854667|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44854668|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44854669|NCT03179475|Oxycodone|oxycodone|mesh-list
44854670|NCT03179475|Naloxone|naloxone|mesh-list
44854671|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44854672|NCT03179475|Narcotics|narcotics|mesh-ancestor
44854673|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854674|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854675|NCT03179475|Analgesics|analgesics|mesh-ancestor
44854676|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
44854677|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854678|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44854679|NCT03132129|Manganese|manganese|mesh-list
44854680|NCT03132129|Calcium|calcium|mesh-list
44854681|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44854682|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854683|NCT03132129|Trace Elements|trace elements|mesh-ancestor
44854684|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
44854685|NCT02898207|Olaparib|olaparib|mesh-list
44854686|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44854687|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854688|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854689|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854690|NCT02682901|Bromocriptine|bromocriptine|mesh-list
44854691|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44854692|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44854693|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44854694|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854695|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854696|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
44854697|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
44854698|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854699|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854700|NCT02555657|Gemcitabine|gemcitabine|mesh-list
44854701|NCT02555657|Capecitabine|capecitabine|mesh-list
44854702|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
44854703|NCT02555657|Vinorelbine|vinorelbine|mesh-list
44854704|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854705|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
44854706|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854707|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854708|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
44854709|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854710|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697361|NCT01396707|Capecitabine|capecitabine|mesh-list
44854711|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854712|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
44854713|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854714|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854715|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44854716|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44854717|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44854718|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44854719|NCT02457156|Octreotide|octreotide|mesh-list
44854720|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854721|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341377|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341381|NCT01030601|Hormones|hormones|mesh-ancestor
44854722|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854723|NCT02190721|Lenograstim|lenograstim|mesh-list
44854724|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44854725|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
44854726|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854727|NCT00308516|Leucovorin|leucovorin|mesh-list
44854728|NCT00308516|Bevacizumab|bevacizumab|mesh-list
44854729|NCT00308516|Fluorouracil|fluorouracil|mesh-list
44854730|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
44854731|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854732|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854733|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44854734|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44854735|NCT00308516|Growth Substances|growth substances|mesh-ancestor
44854736|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854737|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44854738|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
44854739|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854740|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44854741|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854742|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
44854743|NCT00308516|Antidotes|antidotes|mesh-ancestor
44854744|NCT00308516|Protective Agents|protective agents|mesh-ancestor
44854745|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
44854746|NCT00308516|Vitamins|vitamins|mesh-ancestor
44854747|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
44854748|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
44854749|NCT02325960|Exenatide|exenatide|mesh-list
44854750|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854751|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854752|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44854753|NCT02325960|Incretins|incretins|mesh-ancestor
44854754|NCT02325960|Hormones|hormones|mesh-ancestor
44854755|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854756|NCT05155592|Adalimumab|adalimumab|mesh-list
44854757|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854758|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854759|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
44854760|NCT05155215|Fludarabine|fludarabine|mesh-list
44854761|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44854762|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
44854763|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854764|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854765|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44854766|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
44854767|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854768|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854769|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44854770|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
44854771|NCT05154682|Acetaminophen|acetaminophen|mesh-list
44854772|NCT05154682|Naproxen|naproxen|mesh-list
44854773|NCT05154682|Oxycodone|oxycodone|mesh-list
44854774|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44854775|NCT05154682|Analgesics|analgesics|mesh-ancestor
44854776|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
44854777|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854778|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854779|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
44854780|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44854781|NCT05154682|Narcotics|narcotics|mesh-ancestor
44854782|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854783|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44854784|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854785|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341429|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44854786|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
44854787|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44854788|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854789|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854790|NCT05154396|Loperamide|loperamide|mesh-list
44854791|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
44854793|NCT05134584|Lactulose|lactulose|mesh-list
44854794|NCT05134584|Linaclotide|linaclotide|mesh-list
44854795|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854796|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44854797|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
44854798|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854799|NCT05134415|Menthol|menthol|mesh-list
44854800|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
44854801|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44854802|NCT05052710|Midazolam|midazolam|mesh-list
44854803|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44854804|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44854805|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854806|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854807|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44854808|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44854809|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44854810|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44854811|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
44854812|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
44854813|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
44854814|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
44854815|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854816|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854817|NCT05051293|Testosterone|testosterone|mesh-list
44854818|NCT05051293|Estrogens|estrogens|mesh-list
44854819|NCT05051293|Androgens|androgens|mesh-ancestor
44854820|NCT05051293|Hormones|hormones|mesh-ancestor
44854821|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854822|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854823|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
44854824|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
44854825|NCT05005897|Vitamins|vitamins|mesh-ancestor
44854826|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
44854827|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854828|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
44854829|NCT05005897|Hematinics|hematinics|mesh-ancestor
44639704|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639705|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639706|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639707|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639708|NCT00372697|Octreotide|octreotide|mesh-list
44639709|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639710|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639711|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639712|NCT00372619|Cytarabine|cytarabine|mesh-list
44639713|NCT00372619|Methotrexate|methotrexate|mesh-list
44639714|NCT00372619|Clofarabine|clofarabine|mesh-list
44639715|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44854831|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854832|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854833|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854834|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854835|NCT04285684|Ketamine|ketamine|mesh-list
44854836|NCT04285684|Analgesics|analgesics|mesh-ancestor
44854837|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
44854838|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854839|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854840|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44854841|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44854842|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
44854843|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
44854844|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854845|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44854846|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44854847|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854848|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854849|NCT03884439|Infliximab|infliximab|mesh-list
44854850|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44854851|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44854852|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44854853|NCT03643965|Budesonide|budesonide|mesh-list
44854854|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854855|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44854856|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
44854857|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854858|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854859|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44854860|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44854861|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
44854862|NCT03643965|Hormones|hormones|mesh-ancestor
44854863|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854864|NCT03516292|Mitogens|mitogens|mesh-list
44854865|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
44854866|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854867|NCT03336541|Ketamine|ketamine|mesh-list
44854868|NCT03336541|Analgesics|analgesics|mesh-ancestor
44854869|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
44854870|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854871|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854872|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44854873|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44854874|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
44854875|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
44854876|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854877|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44854878|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44854879|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854880|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854881|NCT03230916|Relebactam|relebactam|mesh-list
44854882|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44854883|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854884|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854885|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44854886|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854887|NCT03202667|Empagliflozin|empagliflozin|mesh-list
44854888|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44854889|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854890|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44854891|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341560|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
44854892|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
44854893|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44854894|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854895|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854896|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
44854897|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854898|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854899|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44854900|NCT02673567|Antibodies|antibodies|mesh-list
44854901|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
44639732|NCT00372593|Cytarabine|cytarabine|mesh-list
44854902|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44854903|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
44854904|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854905|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854907|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44854908|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44697362|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
44697363|NCT01396707|Trastuzumab|trastuzumab|mesh-list
44697364|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697365|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
44697366|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697367|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697368|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44697369|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
44697370|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697371|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697372|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697373|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697374|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697375|NCT01396720|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44697376|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44697377|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44697378|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697379|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697380|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
44697381|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44697382|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
44697383|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44697384|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44697385|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697386|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44697387|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
44697388|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
44697389|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697390|NCT01396733|Protective Agents|protective agents|mesh-ancestor
44697391|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697392|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
44697393|NCT01396733|Vitamins|vitamins|mesh-ancestor
44697394|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
44697395|NCT01397006|Pregabalin|pregabalin|mesh-list
44697396|NCT01397006|Analgesics|analgesics|mesh-ancestor
44697397|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
44697398|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697399|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697400|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
44697401|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44697402|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44697403|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697404|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697405|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697406|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697407|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697408|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697409|NCT01397019|Leucovorin|leucovorin|mesh-list
44697410|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
44697411|NCT01397019|Irinotecan|irinotecan|mesh-list
44697412|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697413|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44697414|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44697415|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697416|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697417|NCT01397019|Antidotes|antidotes|mesh-ancestor
44697418|NCT01397019|Protective Agents|protective agents|mesh-ancestor
44697419|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697420|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
44697421|NCT01397019|Vitamins|vitamins|mesh-ancestor
44697422|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
44697423|NCT01397097|Etonogestrel|etonogestrel|mesh-list
44697424|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44697425|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
44697426|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697427|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697428|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44854909|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854910|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44854911|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44854912|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854913|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854914|NCT02523313|Nivolumab|nivolumab|mesh-list
44854915|NCT02523313|Ipilimumab|ipilimumab|mesh-list
44854916|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854917|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854918|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44854919|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854920|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
44854921|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44854922|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854923|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44854924|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44854925|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854926|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854927|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44854928|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44854929|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854930|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
44854931|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854932|NCT00380653|Sapacitabine|sapacitabine|mesh-list
44854933|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854934|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
44854935|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44854936|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854937|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
44854938|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44854939|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854940|NCT05156970|Cisplatin|cisplatin|mesh-list
44854941|NCT05156970|Carboplatin|carboplatin|mesh-list
44854942|NCT05156970|Docetaxel|docetaxel|mesh-list
44854943|NCT05156970|Apatinib|apatinib|mesh-list
44854944|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854945|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44854946|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44854947|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44854948|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854949|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854950|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854951|NCT05156788|Lenvatinib|lenvatinib|mesh-list
44341671|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
44854952|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854953|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44854954|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854955|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854956|NCT05156749|Calpastatin|calpastatin|mesh-list
44854957|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44854958|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
44854959|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854960|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854961|NCT05156541|Interferons|interferons|mesh-list
44854962|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
44854963|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854964|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
44854965|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44854966|NCT05156450|Prednisone|prednisone|mesh-list
44854967|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
44854968|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44854969|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
44854970|NCT05156450|Hormones|hormones|mesh-ancestor
44854971|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44854972|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854973|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44854974|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44854975|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44854976|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44854977|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854978|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
44854979|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44854980|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
44854981|NCT05155969|Ketamine|ketamine|mesh-list
44854982|NCT05155969|Esketamine|esketamine|mesh-list
44854983|NCT05155969|Analgesics|analgesics|mesh-ancestor
44854984|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
44854985|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44854986|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44854987|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44854988|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44854989|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
44854990|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
44854991|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44854992|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44854993|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44854994|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44854995|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44854996|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
44854997|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44854998|NCT05112913|Vaccines|vaccines|mesh-list
44854999|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
44855000|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855001|NCT04952324|Folic Acid|folic acid|mesh-list
44855002|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
44855003|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
44855004|NCT04952324|Vitamins|vitamins|mesh-ancestor
44855005|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
44855006|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855007|NCT04952324|Hematinics|hematinics|mesh-ancestor
44855008|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
44855009|NCT04774250|Zonisamide|zonisamide|mesh-list
44341741|NCT01033097|Hormones|hormones|mesh-ancestor
44855010|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
44855011|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44855012|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855013|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855014|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44855015|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855016|NCT04768569|Zonisamide|zonisamide|mesh-list
44855017|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
44855018|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44855019|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855020|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855021|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44855022|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855023|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
44855024|NCT04645602|Lenvatinib|lenvatinib|mesh-list
44855025|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855026|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855027|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44855028|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855029|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855030|NCT04560725|Choline|choline|mesh-list
44855031|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
44855032|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44855033|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
44855034|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855035|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855036|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44855037|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
44855038|NCT04506138|Paclitaxel|paclitaxel|mesh-list
44855039|NCT04506138|Carboplatin|carboplatin|mesh-list
44855040|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44855041|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855042|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
44855043|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
44855044|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
44855045|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855046|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44855047|NCT04503707|Hormones|hormones|mesh-ancestor
44855048|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855049|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855050|NCT04456153|Atovaquone|atovaquone|mesh-list
44855051|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855052|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
44855053|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44855054|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855055|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639879|NCT00371566|Lapatinib|lapatinib|mesh-list
44855056|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855057|NCT04455464|Midodrine|midodrine|mesh-list
44855058|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
44855059|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
44855060|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855061|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341772|NCT01033318|Losartan|losartan|mesh-list
44855062|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44855063|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44855064|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44855065|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44855066|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855067|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855068|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855069|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
44855070|NCT04403971|Listerine|listerine|mesh-list
44855071|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44855072|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855073|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
44855074|NCT04351243|Gimsilumab|gimsilumab|mesh-list
44855075|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855076|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
44855077|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855078|NCT04351061|Acetazolamide|acetazolamide|mesh-list
44855079|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
44855080|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44855081|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855082|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855083|NCT04351061|Diuretics|diuretics|mesh-ancestor
44855084|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
44855085|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855086|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44855087|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855088|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855089|NCT04321174|Ritonavir|ritonavir|mesh-list
44855090|NCT04321174|Lopinavir|lopinavir|mesh-list
44855091|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44855092|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44855093|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
44855094|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855095|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855096|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44855097|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44855098|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
44855099|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855100|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44855101|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44855102|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44855103|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
44855104|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
44855105|NCT04206761|Bromides|bromides|mesh-list
44855106|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
44855107|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855108|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855109|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44855110|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44855111|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44855112|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44855113|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
44855114|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855115|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855116|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855117|NCT04194814|Betamethasone|betamethasone|mesh-list
44855118|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
44855119|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44855120|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
44855121|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44855122|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855123|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
44855124|NCT04194814|Hormones|hormones|mesh-ancestor
44855125|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855126|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855127|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44855128|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
44855129|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
44855130|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855131|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855132|NCT03925246|Nivolumab|nivolumab|mesh-list
44341867|NCT01033877|Vaccines|vaccines|mesh-list
44855133|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855134|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855135|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44855136|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855137|NCT03668639|Dexamethasone|dexamethasone|mesh-list
44855138|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855139|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
44855140|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
44855141|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855142|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855143|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855144|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
44855145|NCT03668639|Hormones|hormones|mesh-ancestor
44855146|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855147|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44855148|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855149|NCT03618693|Anesthetics|anesthetics|mesh-list
44855150|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855151|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855152|NCT03600714|Interferons|interferons|mesh-list
44855153|NCT03600714|Ritonavir|ritonavir|mesh-list
44855154|NCT03600714|Lonafarnib|lonafarnib|mesh-list
44855155|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855156|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
44855157|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855158|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44855159|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44855160|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
44855161|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855162|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855163|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44855164|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44855165|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44855166|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44855167|NCT03479307|Ketotifen|ketotifen|mesh-list
44341886|NCT01033981|Sunitinib|sunitinib|mesh-list
44855168|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44855169|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44855170|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
44855171|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855172|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44855173|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
44855174|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
44855175|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855176|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855177|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855178|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44855179|NCT03474640|Antibodies|antibodies|mesh-list
44855180|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44855181|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
44855182|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855183|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44855184|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855185|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44855186|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
44855187|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
44855188|NCT03379389|Methenamine|methenamine|mesh-list
44855189|NCT03379389|Acriflavine|acriflavine|mesh-list
44855190|NCT03379389|Methylene Blue|methylene blue|mesh-list
44855191|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855192|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855193|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855194|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44855195|NCT03379389|Renal Agents|renal agents|mesh-ancestor
44855196|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44855197|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44855198|NCT03377803|Cantharidin|cantharidin|mesh-list
44855199|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855200|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855201|NCT03283371|Natalizumab|natalizumab|mesh-list
44855202|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
44855203|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855204|NCT03257254|Polidocanol|polidocanol|mesh-list
44855205|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44855206|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44855207|NCT03084718|Beclomethasone|beclomethasone|mesh-list
44341922|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
44855208|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855209|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
44855210|NCT03084718|Hormones|hormones|mesh-ancestor
44855211|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855212|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855213|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44855214|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
44855215|NCT03059511|Nalbuphine|nalbuphine|mesh-list
44855216|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44855217|NCT03059511|Narcotics|narcotics|mesh-ancestor
44855218|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855219|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855220|NCT03059511|Analgesics|analgesics|mesh-ancestor
44855221|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
44855222|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855223|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
44855224|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855225|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855226|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
44855227|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44855228|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44855229|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855230|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
44855231|NCT02866838|Coagulants|coagulants|mesh-ancestor
44855232|NCT02824679|Scopolamine|scopolamine|mesh-list
44855233|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44855234|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44855235|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
44855236|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
44855237|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855238|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855239|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855240|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
44855241|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44855242|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
44855243|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855244|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855245|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44855246|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
44855247|NCT02259517|Guanfacine|guanfacine|mesh-list
44855248|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44341963|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
44855249|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44855250|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855251|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44855252|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44855253|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855254|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855255|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
44855256|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855257|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44855258|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44855259|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44855260|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44855261|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855262|NCT02209545|Pyridoxine|pyridoxine|mesh-list
44855263|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
44855264|NCT02209545|Misoprostol|misoprostol|mesh-list
44855265|NCT02209545|Vitamins|vitamins|mesh-ancestor
44855266|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
44855267|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855268|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44855269|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
44855270|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44855271|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44855272|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855273|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
44855274|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
44855275|NCT01147822|Sunitinib|sunitinib|mesh-list
44855276|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855277|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44855278|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44855279|NCT01147822|Growth Substances|growth substances|mesh-ancestor
44855280|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855281|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
44855282|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44855283|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855284|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855285|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
44855286|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855287|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
44855288|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855289|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855290|NCT00328653|Cyclosporine|cyclosporine|mesh-list
44855291|NCT00328653|Cyclosporins|cyclosporins|mesh-list
44855292|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855293|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855294|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855295|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
44855296|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855297|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
44855298|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855299|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855300|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855301|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44855302|NCT05158777|Vaccines|vaccines|mesh-list
44855303|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
44855304|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855305|NCT05158699|Dexamethasone|dexamethasone|mesh-list
44855306|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
44855307|NCT05158699|Triamcinolone|triamcinolone|mesh-list
44855308|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44855309|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44855310|NCT05158699|Ketorolac|ketorolac|mesh-list
44855311|NCT05158699|Bromfenac|bromfenac|mesh-list
44855312|NCT05158699|Phenylephrine|phenylephrine|mesh-list
44855313|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44855314|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44855315|NCT05158699|BB 1101|bb 1101|mesh-list
44855316|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44855317|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855318|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
44855319|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
44855320|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855321|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855322|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855323|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
44855324|NCT05158699|Hormones|hormones|mesh-ancestor
44342040|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855325|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855326|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44855327|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855328|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
44855329|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855330|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855331|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855332|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
44855333|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44855334|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855335|NCT05158699|Analgesics|analgesics|mesh-ancestor
44855336|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
44855337|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855338|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44855339|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44855340|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
44855341|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
44855342|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44855343|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
44855344|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
44855345|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44855346|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44855347|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44855348|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855349|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855350|NCT05158699|Protective Agents|protective agents|mesh-ancestor
44855351|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
44855352|NCT05158647|Analgesics|analgesics|mesh-ancestor
44855353|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
44855354|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855355|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855356|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
44855357|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855358|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44855359|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
44855360|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44855361|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855362|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855363|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44855364|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
44640254|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
44855365|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44855366|NCT05158426|Propofol|propofol|mesh-list
44855367|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44855368|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855369|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855370|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44855371|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
44855372|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
44855373|NCT05158348|Lidocaine|lidocaine|mesh-list
44855374|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
44855375|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
44855376|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
44855377|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855378|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855379|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
44855380|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855381|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44855382|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44855383|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44855384|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855385|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855386|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44855387|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855388|NCT05158348|Analgesics|analgesics|mesh-ancestor
44855389|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44855390|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44855391|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44855392|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855393|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855394|NCT05157893|Analgesics|analgesics|mesh-list
44855395|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
44855396|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855397|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855398|NCT05157542|Paclitaxel|paclitaxel|mesh-list
44855399|NCT05157542|Durvalumab|durvalumab|mesh-list
44855400|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44855401|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44855402|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855403|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
44855404|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
44855405|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44855406|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855407|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855408|NCT05157360|Vitamins|vitamins|mesh-list
44855409|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
44855410|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
44855411|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855412|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855413|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44855414|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44855415|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44855416|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855417|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855418|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44855419|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855420|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855421|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
44855422|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855423|NCT05076253|Ivermectin|ivermectin|mesh-list
44855424|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855425|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855426|NCT04983498|Ondansetron|ondansetron|mesh-list
44855427|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
44855428|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
44855429|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855430|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855431|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44855432|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
44855433|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855434|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44855435|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
44855436|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855437|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855438|NCT04983498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44855439|NCT04983498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44855440|NCT04983498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855441|NCT04983498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44855442|NCT04983498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44855443|NCT04947592|Fluconazole|fluconazole|mesh-list
44855444|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
44855445|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855446|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44342181|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
44855447|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44855448|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855449|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855450|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44855451|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
44855452|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855453|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855454|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44855455|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44855456|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
44342206|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44342207|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44855457|NCT04761614|Leucovorin|leucovorin|mesh-list
44855458|NCT04761614|Folic Acid|folic acid|mesh-list
44855459|NCT04761614|Bevacizumab|bevacizumab|mesh-list
44855460|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44855461|NCT04761614|Fluorouracil|fluorouracil|mesh-list
44855462|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
44855463|NCT04761614|Riluzole|riluzole|mesh-list
44855464|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
44855465|NCT04761614|Antibodies|antibodies|mesh-list
44855466|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
44855467|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44855468|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
44855469|NCT04761614|Calcium|calcium|mesh-list
44855470|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
44855471|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342220|NCT01037140|Vitamin D|vitamin d|mesh-list
44855472|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44855473|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44855474|NCT04761614|Growth Substances|growth substances|mesh-ancestor
44855475|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855476|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
44855477|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
44855478|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44855479|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44855480|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
44855481|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855482|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44855483|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855484|NCT04761614|Antidotes|antidotes|mesh-ancestor
44855485|NCT04761614|Protective Agents|protective agents|mesh-ancestor
44855486|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
44855487|NCT04761614|Vitamins|vitamins|mesh-ancestor
44855488|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
44855489|NCT04761614|Hematinics|hematinics|mesh-ancestor
44855490|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
44855491|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44855492|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44855493|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855494|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44855495|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
44855496|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
44855497|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855498|NCT04694248|Aspirin|aspirin|mesh-list
44855499|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
44855500|NCT04694248|Anticoagulants|anticoagulants|mesh-list
44855501|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44855502|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855503|NCT04694248|Analgesics|analgesics|mesh-ancestor
44855504|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
44855505|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855506|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855507|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855508|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855509|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44855510|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44855511|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855512|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44855513|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44855514|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855515|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
44855516|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44855517|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
44855518|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44855519|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
44855520|NCT04650152|Fenofibrate|fenofibrate|mesh-list
44855521|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44855522|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
44855523|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855524|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44855525|NCT04608955|Bedaquiline|bedaquiline|mesh-list
44855526|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
44855527|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44855528|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855529|NCT04579783|Triamcinolone|triamcinolone|mesh-list
44855530|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44855531|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44855532|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44855533|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855534|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
44855535|NCT04579783|Hormones|hormones|mesh-ancestor
44855536|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855537|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855538|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855539|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
44855540|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855541|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855542|NCT04345861|Azithromycin|azithromycin|mesh-list
44855543|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
44855544|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44855545|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855546|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
44855547|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44855548|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855549|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855550|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855551|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855552|NCT04266379|Insulin|insulin|mesh-list
44855553|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44855554|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44855555|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855556|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
44855557|NCT04240093|Narcotics|narcotics|mesh-ancestor
44855558|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697429|NCT01397175|Everolimus|everolimus|mesh-list
44855559|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855560|NCT04240093|Analgesics|analgesics|mesh-ancestor
44855562|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855563|NCT04234477|Metoprolol|metoprolol|mesh-list
44855564|NCT04234477|Verapamil|verapamil|mesh-list
44855565|NCT04234477|Diltiazem|diltiazem|mesh-list
44855566|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
44855567|NCT04234477|Calcium|calcium|mesh-list
44855568|NCT04234477|Esmolol|esmolol|mesh-list
44855569|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44855570|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44855571|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855572|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44855573|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44855574|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
44855575|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
44855576|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855577|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44855578|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44855579|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855580|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855581|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855582|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855583|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
44855584|NCT04217967|Lenalidomide|lenalidomide|mesh-list
44855585|NCT04217967|Ixazomib|ixazomib|mesh-list
44855586|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
44342300|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
44855587|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855588|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44855589|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44855590|NCT04217967|Growth Substances|growth substances|mesh-ancestor
44855591|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
44855592|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855593|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
44855594|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855595|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855596|NCT04156698|Cisplatin|cisplatin|mesh-list
44855597|NCT04156698|Docetaxel|docetaxel|mesh-list
44855598|NCT04156698|Capecitabine|capecitabine|mesh-list
44855599|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855600|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44855601|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44855602|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44855603|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855604|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44855605|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
44855606|NCT04046614|Nivolumab|nivolumab|mesh-list
44855607|NCT04046614|Nintedanib|nintedanib|mesh-list
44855608|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855609|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855610|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44855611|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855612|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44855613|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855614|NCT03915860|Trifarotene|trifarotene|mesh-list
44855615|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855616|NCT03795233|Vancomycin|vancomycin|mesh-list
44855617|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44855618|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855619|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
44855620|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
44855621|NCT03783091|Hematinics|hematinics|mesh-ancestor
44855622|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
44855623|NCT03783091|Vitamins|vitamins|mesh-ancestor
44855624|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
44855625|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855626|NCT03769376|Salvin|salvin|mesh-list
44855627|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44855628|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855629|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
44855630|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855631|NCT03769376|Protective Agents|protective agents|mesh-ancestor
44855632|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855633|NCT03645863|Iron|iron|mesh-list
44855634|NCT03645863|Trace Elements|trace elements|mesh-ancestor
44855635|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
44855636|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855637|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44855638|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855639|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44855640|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855641|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
44855642|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44855643|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44855644|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855645|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44855646|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855647|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44855648|NCT03423355|Diuretics|diuretics|mesh-ancestor
44855649|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
44855650|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44855651|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855652|NCT03365635|Ribavirin|ribavirin|mesh-list
44855653|NCT03365635|Grazoprevir|grazoprevir|mesh-list
44855654|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44855655|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
44855656|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855657|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
44855658|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855659|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
44855660|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855661|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855662|NCT03254667|Brodalumab|brodalumab|mesh-list
44855663|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855664|NCT03223350|Capsaicin|capsaicin|mesh-list
44855665|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
44855666|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855667|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
44855668|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855669|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855670|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
44855671|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855672|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855673|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
44855674|NCT03193931|Methotrexate|methotrexate|mesh-list
44342392|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44855675|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855676|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855677|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44855678|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
44855679|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44855680|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855681|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44855682|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
44855683|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855684|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855685|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855686|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44855687|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855688|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
44855689|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855690|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44855691|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
44855692|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855693|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855694|NCT03181529|Psilocybin|psilocybin|mesh-list
44855695|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
44855696|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855697|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44855698|NCT02840136|Meropenem|meropenem|mesh-list
44855699|NCT02840136|Tazobactam|tazobactam|mesh-list
44855700|NCT02840136|Piperacillin|piperacillin|mesh-list
44855701|NCT02840136|Ceftazidime|ceftazidime|mesh-list
44855702|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44855703|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44855704|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855705|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44855706|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855707|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855708|NCT02820961|Exemestane|exemestane|mesh-list
44855709|NCT02820961|Entinostat|entinostat|mesh-list
44855710|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855711|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44855712|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44855713|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855714|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855715|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44855716|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
44855717|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855718|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855719|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44855720|NCT02804932|Methamphetamine|methamphetamine|mesh-list
44855721|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44855722|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855723|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
44855724|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
44855725|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855726|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
44855727|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855728|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855729|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855730|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44855731|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44855732|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855733|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44855734|NCT02643381|Ketamine|ketamine|mesh-list
44855735|NCT02643381|Etomidate|etomidate|mesh-list
44855736|NCT02643381|Analgesics|analgesics|mesh-ancestor
44855737|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
44855738|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855739|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855740|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44855741|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44855742|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
44855743|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
44855744|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855745|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44855746|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44855747|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855748|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855749|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44855750|NCT02603900|Bupivacaine|bupivacaine|mesh-list
44855751|NCT02603900|Ropivacaine|ropivacaine|mesh-list
44855752|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
44855753|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
44855754|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855755|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855756|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
44855757|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855758|NCT02334722|Levetiracetam|levetiracetam|mesh-list
44855759|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
44855760|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
44855761|NCT01952288|Simvastatin|simvastatin|mesh-list
44855762|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44855763|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44855764|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
44342508|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44342509|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44855765|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855766|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44855767|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44855768|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855769|NCT01717586|Pravastatin|pravastatin|mesh-list
44855770|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44855771|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44855772|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
44855773|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855774|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44855775|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44855776|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855777|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
44855778|NCT01023737|Vorinostat|vorinostat|mesh-list
44855779|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
44855780|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44855781|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855782|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640701|NCT00363142|Ritonavir|ritonavir|mesh-list
44855783|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855784|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855785|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855786|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855787|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44855788|NCT00741988|Bevacizumab|bevacizumab|mesh-list
44855789|NCT00741988|Carboplatin|carboplatin|mesh-list
44855790|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855791|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855792|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44855793|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44855794|NCT00741988|Growth Substances|growth substances|mesh-ancestor
44855795|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855796|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44855797|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
44855798|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44855799|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855800|NCT00568997|Analgesics|analgesics|mesh-ancestor
44855801|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
44855802|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855803|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342524|NCT01039025|Melphalan|melphalan|mesh-list
44855804|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855805|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855806|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855807|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855808|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
44855809|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44855810|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855811|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855812|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44855813|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
44855814|NCT00563576|Estradiol|estradiol|mesh-list
44855815|NCT00563576|Estrogens|estrogens|mesh-ancestor
44855816|NCT00563576|Hormones|hormones|mesh-ancestor
44855817|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855818|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855819|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44855820|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
44855821|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44855822|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44855823|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44855824|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44855825|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44855826|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44855827|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44855828|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855829|NCT00455403|Chloroquine|chloroquine|mesh-list
44855830|NCT00455403|Amebicides|amebicides|mesh-ancestor
44855831|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44855832|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855833|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855834|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
44855835|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855836|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
44855837|NCT05160623|Povidone|povidone|mesh-list
44855838|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
44855839|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
44855840|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44855841|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855842|NCT05160298|Ropivacaine|ropivacaine|mesh-list
44855843|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
44855844|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
44855845|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855846|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855847|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
44855848|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855849|NCT05160285|Nivolumab|nivolumab|mesh-list
44855850|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855851|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855852|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44855853|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855854|NCT05160220|Psilocybin|psilocybin|mesh-list
44855855|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
44855856|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855857|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44855858|NCT05160051|FAPI-46|fapi-46|mesh-list
44855859|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44855860|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855861|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
44855862|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44855863|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855864|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44855865|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855866|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
44855867|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44855868|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855869|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44855870|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855871|NCT05159674|Analgesics|analgesics|mesh-ancestor
44855872|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
44855873|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855874|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44855875|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44855876|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44855877|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855878|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855879|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855880|NCT05159531|Tenofovir|tenofovir|mesh-list
44855881|NCT05159531|Emtricitabine|emtricitabine|mesh-list
44855882|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
44855883|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855884|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44855885|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44855886|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855887|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855888|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44855889|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44855890|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
44855891|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
44855892|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
44342636|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
44855893|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855894|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44855895|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
44855896|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855897|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
44855898|NCT05159284|Protective Agents|protective agents|mesh-ancestor
44855899|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44855900|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44855901|NCT05157087|Omalizumab|omalizumab|mesh-list
44855902|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44855903|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44855904|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44855905|NCT05150431|Parecoxib|parecoxib|mesh-list
44855906|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44855907|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44855908|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855909|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855910|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44855911|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44855912|NCT05150431|Analgesics|analgesics|mesh-ancestor
44855913|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
44855914|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44855915|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855916|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44855917|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855918|NCT05117450|Heparin|heparin|mesh-list
44855919|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
44855920|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44855921|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44855922|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855923|NCT05096039|Valsartan|valsartan|mesh-list
44855924|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44855925|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44855926|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44855927|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44855928|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855929|NCT04859582|Cisplatin|cisplatin|mesh-list
44855930|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
44855931|NCT04859582|Fluorouracil|fluorouracil|mesh-list
44855932|NCT04859582|Capecitabine|capecitabine|mesh-list
44855933|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
44855934|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855935|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44855936|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
44855937|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855938|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44855939|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44855940|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
44855941|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855942|NCT04713137|Erythritol|erythritol|mesh-list
44855943|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
44855944|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44855945|NCT04682847|Hematinics|hematinics|mesh-ancestor
44855946|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44855947|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44855948|NCT04622553|Mexiletine|mexiletine|mesh-list
44855949|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44855950|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44855951|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44855952|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44855953|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855954|NCT04491526|Tamsulosin|tamsulosin|mesh-list
44855955|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44855956|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44855957|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44855958|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44855959|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44855960|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855961|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855962|NCT04491526|Urological Agents|urological agents|mesh-ancestor
44855963|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
44855964|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
44855965|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
44855966|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44855967|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44855968|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855969|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44855970|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44855971|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44855972|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
44855973|NCT04328961|Protective Agents|protective agents|mesh-ancestor
44855974|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855975|NCT04328961|Vitamins|vitamins|mesh-ancestor
44855976|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
44855977|NCT04259996|Estradiol|estradiol|mesh-list
44855978|NCT04259996|Progesterone|progesterone|mesh-list
44855979|NCT04259996|Estrogens|estrogens|mesh-ancestor
44855980|NCT04259996|Hormones|hormones|mesh-ancestor
44855981|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44855982|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855983|NCT04259996|Progestins|progestins|mesh-ancestor
44855984|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44855985|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
44855986|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44855987|NCT03782636|Aldesleukin|aldesleukin|mesh-list
44855988|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855989|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44855990|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44855991|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
44855992|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44855993|NCT03761810|Tretinoin|tretinoin|mesh-list
44855994|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44855995|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
44855996|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44855997|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
44855998|NCT03761784|Tretinoin|tretinoin|mesh-list
44855999|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44856000|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
44856001|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856002|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
44856003|NCT03739099|Pancrelipase|pancrelipase|mesh-list
44856004|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44856005|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
44856006|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
44856007|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44856008|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44856009|NCT03703778|Androgens|androgens|mesh-list
44856010|NCT03703778|Hormones|hormones|mesh-ancestor
44342753|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44342768|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856011|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856012|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856013|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
44856014|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856015|NCT03703778|Protective Agents|protective agents|mesh-ancestor
44856016|NCT03703778|Vitamins|vitamins|mesh-ancestor
44856017|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
44856018|NCT03703778|Estrogens|estrogens|mesh-ancestor
44856019|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44856020|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856021|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
44856022|NCT03576261|Polygeline|polygeline|mesh-list
44856023|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
44856024|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
44856025|NCT03527186|Risperidone|risperidone|mesh-list
44856026|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44856027|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
44856028|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856029|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856030|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856031|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44856032|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44856033|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856034|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44856035|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44856036|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
44856037|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
44856038|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856039|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856040|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44856041|NCT03320070|Hormones|hormones|mesh-ancestor
44856042|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856043|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856044|NCT03294304|Gemcitabine|gemcitabine|mesh-list
44856045|NCT03294304|Cisplatin|cisplatin|mesh-list
44856046|NCT03294304|Nivolumab|nivolumab|mesh-list
44856047|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856048|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856049|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
44856050|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856051|NCT03294304|Antiviral Agents|antiviral agents|mesh-ancestor
44856052|NCT03294304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856053|NCT03294304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856054|NCT03294304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856055|NCT03294304|Immunologic Factors|immunologic factors|mesh-ancestor
44856056|NCT03294304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856057|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856058|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44856059|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
44856061|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
44856062|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44856063|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44856064|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856065|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856066|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856067|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856068|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856069|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
44856070|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856071|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
44856072|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44856073|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856074|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856075|NCT03122431|Growth Substances|growth substances|mesh-ancestor
44856076|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856077|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856078|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44856079|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44856080|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
44856081|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856082|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856083|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44856084|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44856085|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44856086|NCT02896855|Docetaxel|docetaxel|mesh-list
44856087|NCT02896855|Trastuzumab|trastuzumab|mesh-list
44856088|NCT02896855|Pertuzumab|pertuzumab|mesh-list
44856089|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856090|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856091|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856092|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856093|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856094|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856095|NCT02871778|Ivacaftor|ivacaftor|mesh-list
44856096|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44342825|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
44856097|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856098|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641082|NCT00357903|Etanercept|etanercept|mesh-list
44856100|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
44856101|NCT02421341|Analgesics|analgesics|mesh-list
44856102|NCT02421341|Narcotics|narcotics|mesh-ancestor
44856103|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856104|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856105|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
44856106|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856107|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44856108|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856109|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
44856110|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
44856111|NCT02149121|Rituximab|rituximab|mesh-list
44856112|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856113|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856114|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
44856115|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856116|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856117|NCT01889186|Venetoclax|venetoclax|mesh-list
44856118|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856119|NCT01510184|Rituximab|rituximab|mesh-list
44856120|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44856121|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856122|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856123|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
44856124|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856125|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856126|NCT01471444|Methotrexate|methotrexate|mesh-list
44856127|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
44856128|NCT01471444|Clofarabine|clofarabine|mesh-list
44856129|NCT01471444|Fludarabine|fludarabine|mesh-list
44856130|NCT01471444|Busulfan|busulfan|mesh-list
44856131|NCT01471444|Tacrolimus|tacrolimus|mesh-list
44856132|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
44856133|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44856134|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44856135|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
44856136|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44856137|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856138|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856139|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
44856140|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856141|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856142|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
44856143|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856144|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44856145|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856146|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
44856147|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856148|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44856149|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44856150|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
44856151|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44856152|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44856153|NCT05162872|Niraparib|niraparib|mesh-list
44856154|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44856155|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856156|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856157|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856158|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
44856159|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
44856160|NCT05162625|Cefazolin|cefazolin|mesh-list
44856161|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44856162|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44856163|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44856164|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856165|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44856166|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44856167|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856168|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856169|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856170|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44856171|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44856172|NCT05162456|Antibodies|antibodies|mesh-list
44856173|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
44856174|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
44856175|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
44856176|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856177|NCT05162430|Propofol|propofol|mesh-list
44856178|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856179|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856180|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856181|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856182|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
44856183|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
44856184|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
44856185|NCT05162417|Methylene Blue|methylene blue|mesh-list
44856186|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856187|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856188|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
44856189|NCT05162417|Coagulants|coagulants|mesh-ancestor
44856190|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
44856191|NCT05162183|Liraglutide|liraglutide|mesh-list
44856192|NCT05162183|Glimepiride|glimepiride|mesh-list
44856193|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856194|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856195|NCT05162183|Incretins|incretins|mesh-ancestor
44856196|NCT05162183|Hormones|hormones|mesh-ancestor
44856197|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856198|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44856199|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856200|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
44856201|NCT05162001|Disulfiram|disulfiram|mesh-list
44856202|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44856203|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44856204|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856205|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856206|NCT05161975|Vitamin K|vitamin k|mesh-list
44856207|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
44856208|NCT05161975|Vitamins|vitamins|mesh-ancestor
44856209|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
44856210|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856211|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44856212|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44856213|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856214|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
44856215|NCT05161975|Coagulants|coagulants|mesh-ancestor
44856216|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
44856217|NCT05161572|Tegafur|tegafur|mesh-list
44856218|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856219|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856220|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
44856221|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856222|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
44856223|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44856224|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
44856225|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856226|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
44856227|NCT05161403|Protective Agents|protective agents|mesh-ancestor
44856228|NCT05161221|Acetaminophen|acetaminophen|mesh-list
44856229|NCT05161221|Naproxen|naproxen|mesh-list
44856230|NCT05161221|Oxycodone|oxycodone|mesh-list
44856231|NCT05161221|Bupivacaine|bupivacaine|mesh-list
44856232|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856233|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
44856234|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856235|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856236|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
44856237|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856238|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44856239|NCT05161221|Narcotics|narcotics|mesh-ancestor
44856240|NCT05161221|Analgesics|analgesics|mesh-ancestor
44856241|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44856242|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44856243|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856244|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856245|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
44856246|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44856247|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856248|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856249|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
44856250|NCT05137886|Decitabine|decitabine|mesh-list
44856251|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44342962|NCT01041378|Hormones|hormones|mesh-ancestor
44856252|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856253|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
44856254|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856256|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856257|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44856258|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44856259|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
44856260|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
44856261|NCT05067270|Treprostinil|treprostinil|mesh-list
44856262|NCT05067270|Citric Acid|citric acid|mesh-list
44856263|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
44856264|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
44856265|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44856266|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
44856267|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
44856268|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856269|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856270|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856271|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44856272|NCT04976192|Omalizumab|omalizumab|mesh-list
44856273|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44856274|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44856275|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
44856276|NCT04867798|Tenofovir|tenofovir|mesh-list
44856277|NCT04867798|Lamivudine|lamivudine|mesh-list
44856278|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
44856279|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856280|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44856281|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44856282|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856283|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856284|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44856285|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44856286|NCT04729621|Denosumab|denosumab|mesh-list
44856287|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44856288|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856289|NCT04648826|Azacitidine|azacitidine|mesh-list
44856290|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856291|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
44856292|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856293|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856294|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856296|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44856297|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
44856298|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856299|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856300|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44856301|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
44856302|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
44856303|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697430|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697431|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697432|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
44697433|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697434|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
44697435|NCT01397214|Megestrol|megestrol|mesh-list
44697436|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697437|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697438|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
44697439|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44697440|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697441|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44697442|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44697443|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44697444|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
44697445|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697446|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44697447|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44697448|NCT01397305|Pemetrexed|pemetrexed|mesh-list
44697449|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697450|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697451|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697452|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44697453|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44697454|NCT01397331|Propofol|propofol|mesh-list
44697455|NCT01397331|Isoflurane|isoflurane|mesh-list
44697456|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44697457|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697458|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697459|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44697460|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
44697461|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
44697462|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44697463|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
44697464|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
44697465|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697466|NCT05268835|Clindamycin|clindamycin|mesh-list
44697467|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697468|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697469|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44697470|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697471|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697473|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44697474|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44697475|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
44697476|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697477|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44697478|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44697479|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697480|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697481|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44697482|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44343056|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697483|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697484|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697485|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44697486|NCT05268627|Liraglutide|liraglutide|mesh-list
44697487|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44697488|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697489|NCT05268627|Incretins|incretins|mesh-ancestor
44697490|NCT05268627|Hormones|hormones|mesh-ancestor
44697491|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697492|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
44697493|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
44697494|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856304|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44856305|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44856306|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44856307|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44856308|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856309|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856310|NCT04577690|Epinephrine|epinephrine|mesh-list
44856311|NCT04577690|Racepinephrine|racepinephrine|mesh-list
44856312|NCT04577690|Bupivacaine|bupivacaine|mesh-list
44856313|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
44856314|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856315|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
44856316|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856317|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856318|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
44856319|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856320|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44856321|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44856322|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
44856323|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856324|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856325|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44856326|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44856327|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
44856328|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44856329|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
44856330|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
44856331|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
44856332|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44856334|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
44856335|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
44856336|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44856337|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856338|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856339|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44856340|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44856341|NCT04447053|Belimumab|belimumab|mesh-list
44856342|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856343|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
44856344|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856345|NCT04361799|Insulin|insulin|mesh-list
44856346|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856347|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856348|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
44856349|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
44856350|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
44856351|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44856352|NCT04101890|Protective Agents|protective agents|mesh-ancestor
44856353|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856354|NCT03993314|Bupivacaine|bupivacaine|mesh-list
44856355|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
44856356|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856357|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
44856358|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856359|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856360|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
44856361|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856362|NCT03856359|Rifaximin|rifaximin|mesh-list
44856363|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44856364|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856365|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44856366|NCT03691584|Dimercaprol|dimercaprol|mesh-list
44856367|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
44856368|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
44856369|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856370|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44856371|NCT03654729|Edetic Acid|edetic acid|mesh-list
44856372|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
44856373|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44856374|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
44856375|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
44856376|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856377|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
44641402|NCT00355342|Xhance|xhance|mesh-list
44856378|NCT03654729|Vitamins|vitamins|mesh-ancestor
44856379|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
44856380|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856381|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
44856382|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44856383|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44856384|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44856385|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856386|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856387|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
44856388|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856389|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856390|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44856391|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856392|NCT03376763|Aripiprazole|aripiprazole|mesh-list
44856393|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
44856394|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44856395|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44856396|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44856397|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856398|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856399|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
44856400|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
44856401|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856402|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856403|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44856404|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44856405|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
44856406|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44856407|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44856408|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44856409|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44856410|NCT03106688|Carfentanil|carfentanil|mesh-list
44856411|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44856412|NCT03106688|Narcotics|narcotics|mesh-ancestor
44856413|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856414|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856415|NCT03106688|Analgesics|analgesics|mesh-ancestor
44856416|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
44856417|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856418|NCT02631070|Luspatercept|luspatercept|mesh-list
44856419|NCT02631070|Hematinics|hematinics|mesh-ancestor
44856420|NCT02630641|Hormones|hormones|mesh-list
44856421|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856422|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856423|NCT02616185|Tremelimumab|tremelimumab|mesh-list
44856424|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856425|NCT02513329|Bupivacaine|bupivacaine|mesh-list
44856426|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856427|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
44856428|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856429|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856430|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
44856431|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856432|NCT02297139|Dasatinib|dasatinib|mesh-list
44856433|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856434|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856435|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856436|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856437|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
44856438|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44856439|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
44856440|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44856441|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856442|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44856443|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44856444|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44856446|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44856447|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856448|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44856449|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44856450|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44856451|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856452|NCT05164198|Adalimumab|adalimumab|mesh-list
44856453|NCT05164198|Etanercept|etanercept|mesh-list
44856454|NCT05164198|Golimumab|golimumab|mesh-list
44856455|NCT05164198|Infliximab|infliximab|mesh-list
44856456|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856457|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856458|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
44856459|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343239|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
44856460|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44856461|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44856462|NCT05164198|Analgesics|analgesics|mesh-ancestor
44856463|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
44856464|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856465|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856466|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856467|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
44856468|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44856469|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
44856470|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856471|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856472|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856473|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44856474|NCT05163704|Analgesics|analgesics|mesh-ancestor
44856475|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
44856476|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856477|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44856478|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44856479|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44856480|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
44856481|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856482|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856483|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44856484|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
44856485|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856486|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44856487|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44856488|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
44856489|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856490|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856491|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44856492|NCT05163366|Ketamine|ketamine|mesh-list
44856493|NCT05163366|Morphine|morphine|mesh-list
44856494|NCT05163366|Analgesics|analgesics|mesh-ancestor
44856495|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
44856496|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856497|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856498|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44856499|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856500|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
44856501|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
44856502|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856503|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44856504|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44856505|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856506|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856507|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44856508|NCT05163366|Narcotics|narcotics|mesh-ancestor
44856509|NCT05163249|Osimertinib|osimertinib|mesh-list
44856510|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856511|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856512|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856513|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856515|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
44856516|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856517|NCT05160727|Irinotecan|irinotecan|mesh-list
44856518|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44856519|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44856520|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856521|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856522|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856523|NCT05137678|Glyburide|glyburide|mesh-list
44856524|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856525|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856526|NCT05101018|Denosumab|denosumab|mesh-list
44856527|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44856528|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856529|NCT05097651|Cannabidiol|cannabidiol|mesh-list
44856530|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
44856531|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44856532|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
44856533|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856534|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44856535|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44856536|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
44856537|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856538|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856539|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44856540|NCT04658173|Alfentanil|alfentanil|mesh-list
44856541|NCT04658173|Propofol|propofol|mesh-list
44856542|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856543|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856544|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856545|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856546|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
44856547|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
44856548|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44856549|NCT04658173|Narcotics|narcotics|mesh-ancestor
44856550|NCT04658173|Analgesics|analgesics|mesh-ancestor
44856551|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
44856552|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856553|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44856554|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44856555|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44856556|NCT04587687|Antibodies|antibodies|mesh-list
44856557|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
44856558|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44856559|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
44856560|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
44856561|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856562|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856563|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44856564|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
44856565|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856566|NCT04578600|Lenalidomide|lenalidomide|mesh-list
44856567|NCT04578600|Azacitidine|azacitidine|mesh-list
44856568|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
44856569|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
44856570|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856571|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856572|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856573|NCT04578600|Growth Substances|growth substances|mesh-ancestor
44856574|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856575|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856576|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856577|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
44856578|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856579|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856580|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856581|NCT04565392|Famotidine|famotidine|mesh-list
44856582|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44856583|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44856584|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44856585|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
44856586|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
44856587|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856588|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856589|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856590|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
44856591|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856592|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856593|NCT04373707|Enoxaparin|enoxaparin|mesh-list
44856594|NCT04373707|Dalteparin|dalteparin|mesh-list
44856595|NCT04373707|Tinzaparin|tinzaparin|mesh-list
44856596|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44856597|NCT04373707|Nadroparin|nadroparin|mesh-list
44856598|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
44856599|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
44856600|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44856601|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44856602|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856603|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
44856604|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44856605|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856606|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856607|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856608|NCT04218786|Colchicine|colchicine|mesh-list
44856609|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
44856610|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856611|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856612|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856613|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856614|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856615|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856616|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44856617|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856618|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856619|NCT03940690|Bevacizumab|bevacizumab|mesh-list
44856620|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856621|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856622|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856623|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856624|NCT03940690|Growth Substances|growth substances|mesh-ancestor
44856625|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856626|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856628|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44856629|NCT03901144|Protective Agents|protective agents|mesh-ancestor
44856630|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856631|NCT03765632|Busulfan|busulfan|mesh-list
44856632|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
44856633|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856634|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856635|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
44856636|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856637|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44856638|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856639|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44856640|NCT03695250|Nivolumab|nivolumab|mesh-list
44856641|NCT03695250|Linrodostat|linrodostat|mesh-list
44856642|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856643|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856644|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44856645|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856646|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856647|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
44856648|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
44856649|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
44856650|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856651|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856652|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44856653|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856654|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856655|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
44856656|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856657|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856658|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44856659|NCT03519295|Atezolizumab|atezolizumab|mesh-list
44856660|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856661|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
44856662|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44856663|NCT03166085|Paclitaxel|paclitaxel|mesh-list
44856664|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
44856665|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44856666|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856667|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856668|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856669|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856670|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856671|NCT03161054|Prednisone|prednisone|mesh-list
44856672|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
44856673|NCT03161054|Rituximab|rituximab|mesh-list
44856674|NCT03161054|Etoposide|etoposide|mesh-list
44856675|NCT03161054|Vinorelbine|vinorelbine|mesh-list
44856676|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856677|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
44856678|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856679|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856680|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44856681|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
44856682|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856683|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856684|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44856685|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856686|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856687|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
44856688|NCT03161054|Hormones|hormones|mesh-ancestor
44856689|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856690|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44856691|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44856692|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44856693|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44856694|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856695|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856696|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856697|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856699|NCT03050814|Bevacizumab|bevacizumab|mesh-list
44856700|NCT03050814|Avelumab|avelumab|mesh-list
44856701|NCT03050814|Fluorouracil|fluorouracil|mesh-list
44856702|NCT03050814|Capecitabine|capecitabine|mesh-list
44856703|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
44856704|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856705|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856706|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856707|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856708|NCT03050814|Growth Substances|growth substances|mesh-ancestor
44856709|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856710|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856711|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
44856712|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856713|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856714|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856715|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
44856716|NCT03050814|Antidotes|antidotes|mesh-ancestor
44856717|NCT03050814|Protective Agents|protective agents|mesh-ancestor
44856718|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
44856719|NCT03050814|Vitamins|vitamins|mesh-ancestor
44856720|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
44856721|NCT02724241|Nicotine|nicotine|mesh-list
44856722|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44856723|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
44856724|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856725|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856726|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44856727|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44856728|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
44856729|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856730|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856731|NCT02639910|Venetoclax|venetoclax|mesh-list
44856732|NCT02639910|Idelalisib|idelalisib|mesh-list
44856733|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856734|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856735|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856736|NCT02618980|Hemostatics|hemostatics|mesh-list
44856737|NCT02618980|Coagulants|coagulants|mesh-ancestor
44856738|NCT02613598|Bortezomib|bortezomib|mesh-list
44856739|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856740|NCT02595320|Capecitabine|capecitabine|mesh-list
44856741|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44856742|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
44856743|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856744|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856745|NCT02492867|Paclitaxel|paclitaxel|mesh-list
44856746|NCT02492867|Carboplatin|carboplatin|mesh-list
44856747|NCT02492867|Durvalumab|durvalumab|mesh-list
44856748|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44343544|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
44856749|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856750|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856751|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856752|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856753|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856754|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856755|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
44856756|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44856757|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44856758|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
44856759|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856760|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856761|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856762|NCT02426892|Nivolumab|nivolumab|mesh-list
44856763|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856764|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856765|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44856766|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856767|NCT02375555|Dexamethasone|dexamethasone|mesh-list
44856768|NCT02375555|Lenalidomide|lenalidomide|mesh-list
44856769|NCT02375555|Bortezomib|bortezomib|mesh-list
44856770|NCT02375555|Elotuzumab|elotuzumab|mesh-list
44856771|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856772|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
44856773|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
44856774|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856775|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856776|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44856777|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
44856778|NCT02375555|Hormones|hormones|mesh-ancestor
44856779|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856780|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44856781|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856782|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
44856783|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856784|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856785|NCT02375555|Growth Substances|growth substances|mesh-ancestor
44856786|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856787|NCT02322593|Cisplatin|cisplatin|mesh-list
44856788|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
44856789|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856790|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44856791|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44856792|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44856793|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856794|NCT01772004|Avelumab|avelumab|mesh-list
44856795|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856796|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856797|NCT01633541|Cisplatin|cisplatin|mesh-list
44856798|NCT01633541|Carboplatin|carboplatin|mesh-list
44856799|NCT01633541|Docetaxel|docetaxel|mesh-list
44856800|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856801|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856802|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856803|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856804|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856805|NCT01322971|Metronidazole|metronidazole|mesh-list
44856806|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44856807|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44856808|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44856809|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44856810|NCT01285102|Irinotecan|irinotecan|mesh-list
44856811|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44856812|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44856813|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856814|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856815|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856816|NCT00952692|Lapatinib|lapatinib|mesh-list
44856817|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856818|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856819|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856820|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856821|NCT00424099|Methylphenidate|methylphenidate|mesh-list
44856822|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44856823|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856824|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44856825|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44856826|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856827|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856828|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
44856829|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856830|NCT05166083|Testosterone|testosterone|mesh-list
44856831|NCT05166083|Androgens|androgens|mesh-ancestor
44856832|NCT05166083|Hormones|hormones|mesh-ancestor
44856833|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856834|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856835|NCT05166005|Vitamin D|vitamin d|mesh-list
44856836|NCT05166005|Vitamins|vitamins|mesh-ancestor
44856837|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
44856838|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343627|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
44856839|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44856840|NCT05165914|Midazolam|midazolam|mesh-list
44856841|NCT05165914|Anesthetics|anesthetics|mesh-list
44856842|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856843|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856844|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44856845|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856846|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44856847|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44856848|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44856849|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856850|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
44856851|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
44856852|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
44856853|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856854|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856855|NCT05165615|Insulin|insulin|mesh-list
44856856|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856857|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856858|NCT05165303|Lidocaine|lidocaine|mesh-list
44856859|NCT05165303|Propofol|propofol|mesh-list
44856860|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856861|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
44856862|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856863|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856864|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
44856865|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856866|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44856867|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44856868|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44856869|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856870|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856871|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856872|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44856873|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
44856874|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44697495|NCT05268237|Liraglutide|liraglutide|mesh-list
44856875|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
44856876|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44856877|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856879|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856880|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856881|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856882|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856883|NCT05164770|Prednisone|prednisone|mesh-list
44856884|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
44856885|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
44856886|NCT05164770|Vincristine|vincristine|mesh-list
44856887|NCT05164770|Rituximab|rituximab|mesh-list
44856888|NCT05164770|Doxorubicin|doxorubicin|mesh-list
44856889|NCT05164770|Etoposide|etoposide|mesh-list
44856890|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856891|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856892|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856893|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856894|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44856895|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
44856896|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856897|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44856898|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44856899|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
44856900|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44856901|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44856902|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
44856903|NCT05164770|Hormones|hormones|mesh-ancestor
44856904|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44856905|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44856906|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44856907|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
44856908|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44856909|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
44856910|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856911|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44856912|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44856913|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44856914|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
44856915|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
44856916|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44856917|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856918|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856919|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44856920|NCT05164627|Analgesics|analgesics|mesh-ancestor
44856921|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
44856922|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856923|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44856924|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44856925|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44856926|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44856927|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856928|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856929|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
44856930|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44856931|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
44856932|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44856933|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856934|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44856935|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
44856936|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44856937|NCT05164263|Empagliflozin|empagliflozin|mesh-list
44856938|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44856939|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856940|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44856941|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856942|NCT05153135|Palbociclib|palbociclib|mesh-list
44856943|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856944|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44856945|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44856946|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856947|NCT05110209|Bevacizumab|bevacizumab|mesh-list
44642061|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
44856948|NCT05110209|Ranibizumab|ranibizumab|mesh-list
44856949|NCT05110209|Aflibercept|aflibercept|mesh-list
44856950|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44856951|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44856952|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44856953|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44856954|NCT05110209|Growth Substances|growth substances|mesh-ancestor
44856955|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856956|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
44856957|NCT05096143|Valsartan|valsartan|mesh-list
44856958|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44856959|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44856960|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44856961|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44856962|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856963|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
44856964|NCT05697328|Ephedrine|ephedrine|mesh-list
44856965|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44856966|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
44856967|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856968|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856969|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44856970|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44856971|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
44856972|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44856973|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44856974|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
44856975|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44856976|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44856977|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856978|NCT05697276|Lidocaine|lidocaine|mesh-list
44856979|NCT05697276|Bupivacaine|bupivacaine|mesh-list
44856980|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
44856981|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
44856982|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44856983|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44856984|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
44856985|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44856986|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44856987|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44856988|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44856989|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44856990|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856991|NCT05697211|Ferric maltol|ferric maltol|mesh-list
44856992|NCT05697211|Hematinics|hematinics|mesh-ancestor
44856993|NCT05672550|Enoxaparin|enoxaparin|mesh-list
44856994|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
44856995|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
44856996|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44856997|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44856998|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44856999|NCT05661201|Doxorubicin|doxorubicin|mesh-list
44857000|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857001|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857002|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857003|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857004|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857005|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857006|NCT05615311|Vitamin D|vitamin d|mesh-list
44857007|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
44857008|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
44857009|NCT05615311|Vitamins|vitamins|mesh-list
44857010|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
44857011|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857012|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44857013|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44857014|NCT05601154|Listerine|listerine|mesh-list
44857015|NCT05601154|Fluorides|fluorides|mesh-list
44857016|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
44857017|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
44857018|NCT05601154|Protective Agents|protective agents|mesh-ancestor
44857019|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857020|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44857021|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857022|NCT05579249|Liraglutide|liraglutide|mesh-list
44857023|NCT05579249|Topiramate|topiramate|mesh-list
44857024|NCT05579249|Orlistat|orlistat|mesh-list
44857025|NCT05579249|Phentermine|phentermine|mesh-list
44857026|NCT05579249|Naltrexone|naltrexone|mesh-list
44857027|NCT05579249|Bupropion|bupropion|mesh-list
44857028|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44857029|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44857030|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857031|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
44857032|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857033|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44857034|NCT05579249|Incretins|incretins|mesh-ancestor
44857035|NCT05579249|Hormones|hormones|mesh-ancestor
44857036|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857037|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44857038|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
44857039|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44857040|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44857041|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44857042|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44857043|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857044|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
44857045|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857046|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44857047|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44857048|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857049|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
44697496|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44697497|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697498|NCT05268237|Incretins|incretins|mesh-ancestor
44697499|NCT05268237|Hormones|hormones|mesh-ancestor
44697500|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697501|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44697502|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
44697503|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697504|NCT05267977|Cephalosporins|cephalosporins|mesh-list
44697505|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697506|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697507|NCT05186558|Gemcitabine|gemcitabine|mesh-list
44697508|NCT05186558|Rituximab|rituximab|mesh-list
44697509|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
44697510|NCT05186558|Lenalidomide|lenalidomide|mesh-list
44697511|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44697512|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697513|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
44697514|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697515|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697516|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697517|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
44343845|NCT01046630|Ketamine|ketamine|mesh-list
44697518|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697519|NCT05186558|Antiviral Agents|antiviral agents|mesh-ancestor
44697520|NCT05186558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697521|NCT05186558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697522|NCT05186558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697523|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44697524|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44697525|NCT05186558|Growth Substances|growth substances|mesh-ancestor
44697526|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44697527|NCT05092698|Vitamin D|vitamin d|mesh-list
44697528|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
44697529|NCT05092698|Vitamins|vitamins|mesh-ancestor
44697530|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
44697531|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697532|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44697533|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697534|NCT05038592|Decitabine|decitabine|mesh-list
44697535|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697536|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
44697537|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697538|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697539|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697540|NCT05009355|Ascorbic Acid|ascorbic acid|mesh-list
44697541|NCT05009355|Vitamins|vitamins|mesh-ancestor
44697542|NCT05009355|Micronutrients|micronutrients|mesh-ancestor
44697543|NCT05009355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642203|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857050|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44857051|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44857052|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44857053|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
44857054|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
44857055|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
44857056|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44857057|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
44857058|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857059|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857060|NCT05524714|Xanthohumol|xanthohumol|mesh-list
44857061|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857062|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44857063|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44857064|NCT05524714|Growth Substances|growth substances|mesh-ancestor
44857065|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857066|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
44857067|NCT05479045|Nivolumab|nivolumab|mesh-list
44857068|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857069|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857070|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857071|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857072|NCT05405114|Decitabine|decitabine|mesh-list
44857073|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
44857074|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
44857075|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857076|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
44857077|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857078|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857079|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857080|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
44857081|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44857082|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
44857083|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44857084|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44857085|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857086|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
44857087|NCT05370820|Coagulants|coagulants|mesh-ancestor
44857088|NCT05366725|Avelumab|avelumab|mesh-list
44343905|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857089|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857090|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857091|NCT05364424|Rituximab|rituximab|mesh-list
44857092|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
44857093|NCT05364424|Carboplatin|carboplatin|mesh-list
44857094|NCT05364424|Etoposide|etoposide|mesh-list
44857095|NCT05364424|Ifosfamide|ifosfamide|mesh-list
44857096|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857097|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857098|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
44857099|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857100|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857101|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857102|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857103|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857104|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857105|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857106|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857107|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
44857108|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44857109|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857110|NCT05359653|Clemastine|clemastine|mesh-list
44857111|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
44857112|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44857113|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44857114|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
44857115|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
44857116|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343939|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44857117|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857118|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857119|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44857120|NCT05321940|Interferons|interferons|mesh-list
44857121|NCT05321940|Vaccines|vaccines|mesh-list
44857122|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
44857123|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857124|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857125|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
44857126|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857127|NCT05313659|Ketamine|ketamine|mesh-list
44857128|NCT05313659|Analgesics|analgesics|mesh-ancestor
44857129|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
44857130|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857131|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857132|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44857133|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44857134|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
44857135|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
44857136|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857137|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44857138|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44857139|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857140|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857141|NCT05275439|Azacitidine|azacitidine|mesh-list
44857142|NCT05275439|Venetoclax|venetoclax|mesh-list
44857143|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857144|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
44857145|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857146|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857147|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857149|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44857150|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44857151|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
44857152|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857153|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857154|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44857155|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44857156|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
44857157|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857158|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44857159|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44857160|NCT05256745|Paclitaxel|paclitaxel|mesh-list
44857161|NCT05256745|Docetaxel|docetaxel|mesh-list
44857162|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
44857163|NCT05256745|Carboplatin|carboplatin|mesh-list
44857164|NCT05256745|Doxorubicin|doxorubicin|mesh-list
44857165|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44857166|NCT05256745|Trastuzumab|trastuzumab|mesh-list
44857167|NCT05256745|Pertuzumab|pertuzumab|mesh-list
44857168|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857169|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857170|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857171|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857172|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857173|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857174|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857175|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
44857176|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857177|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857178|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857179|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
44857180|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44857181|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857182|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857183|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857184|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857185|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857186|NCT05159219|Colchicine|colchicine|mesh-list
44857187|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
44857188|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857189|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857190|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857191|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857192|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857193|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857194|NCT05148234|Decitabine|decitabine|mesh-list
44857195|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857196|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
44857197|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857198|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857199|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857200|NCT05147805|Treprostinil|treprostinil|mesh-list
44857201|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44857202|NCT05136196|Nivolumab|nivolumab|mesh-list
44857203|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857204|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857205|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857206|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857207|NCT05116202|Nivolumab|nivolumab|mesh-list
44857208|NCT05116202|Ipilimumab|ipilimumab|mesh-list
44857209|NCT05116202|Atezolizumab|atezolizumab|mesh-list
44857210|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857211|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857212|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857213|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857214|NCT05092958|Avelumab|avelumab|mesh-list
44857215|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857216|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857217|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857218|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
44857219|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857220|NCT05089630|Vaccines|vaccines|mesh-list
44857221|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
44857222|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857223|NCT05088876|Acetaminophen|acetaminophen|mesh-list
44857224|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857225|NCT05088876|Analgesics|analgesics|mesh-ancestor
44857226|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
44857227|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857228|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857229|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
44857230|NCT05084508|Vaccines|vaccines|mesh-list
44857231|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44857232|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
44857233|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857234|NCT05058651|Cisplatin|cisplatin|mesh-list
44857235|NCT05058651|Carboplatin|carboplatin|mesh-list
44857236|NCT05058651|Etoposide|etoposide|mesh-list
44857237|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
44857238|NCT05058651|Atezolizumab|atezolizumab|mesh-list
44857239|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
44857240|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857241|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857242|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857243|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857244|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857245|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857246|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857247|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
44857248|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857249|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
44857250|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
44857251|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857252|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857253|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857254|NCT05021991|Pramoxine|pramoxine|mesh-list
44857255|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
44857256|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
44857257|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857258|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857259|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
44857260|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857261|NCT05017012|Paclitaxel|paclitaxel|mesh-list
44857262|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44857263|NCT05017012|Cisplatin|cisplatin|mesh-list
44857264|NCT05017012|Carboplatin|carboplatin|mesh-list
44857265|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
44857266|NCT05017012|Pemetrexed|pemetrexed|mesh-list
44857267|NCT05017012|Axitinib|axitinib|mesh-list
44857268|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857269|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857270|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857271|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857272|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857273|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857274|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857275|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857276|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44857277|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44857278|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44857279|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44857280|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44857281|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857282|NCT04960709|Durvalumab|durvalumab|mesh-list
44857283|NCT04960709|Tremelimumab|tremelimumab|mesh-list
44857284|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857285|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857286|NCT04929041|Paclitaxel|paclitaxel|mesh-list
44857287|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44857288|NCT04929041|Carboplatin|carboplatin|mesh-list
44857289|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
44857290|NCT04929041|Nivolumab|nivolumab|mesh-list
44857291|NCT04929041|Pemetrexed|pemetrexed|mesh-list
44857292|NCT04929041|Ipilimumab|ipilimumab|mesh-list
44857293|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857294|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857295|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857296|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857297|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857298|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857299|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857300|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857301|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857302|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44857303|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44857305|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
44857306|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857307|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857308|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
44857309|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857310|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
44857311|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857312|NCT04853446|Dexamethasone|dexamethasone|mesh-list
44857313|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
44857314|NCT04853446|BB 1101|bb 1101|mesh-list
44857315|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857316|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
44857317|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
44857318|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857319|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857320|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44857321|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
44857322|NCT04853446|Hormones|hormones|mesh-ancestor
44857323|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857324|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857325|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857326|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
44344171|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344172|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344173|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344174|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344175|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
44344176|NCT01048086|Tretinoin|tretinoin|mesh-list
44344177|NCT01048086|Isotretinoin|isotretinoin|mesh-list
44344178|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344179|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
44344180|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44344194|NCT01048190|Vaccines|vaccines|mesh-list
44344195|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
44344196|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857327|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857328|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857329|NCT04818749|Dexamethasone|dexamethasone|mesh-list
44857330|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
44857331|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
44857332|NCT04818749|BB 1101|bb 1101|mesh-list
44857333|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857334|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
44857335|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
44857336|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857337|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857338|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44857339|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
44857340|NCT04818749|Hormones|hormones|mesh-ancestor
44857341|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857342|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857343|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857344|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
44857345|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857346|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857347|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44857348|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857349|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857350|NCT04818749|Analgesics|analgesics|mesh-ancestor
44857351|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
44857352|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44857353|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44857354|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44857355|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
44857356|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857357|NCT04817501|Edetic Acid|edetic acid|mesh-list
44857358|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
44857359|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44857360|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
44857361|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
44857362|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857363|NCT04799275|Prednisone|prednisone|mesh-list
44857364|NCT04799275|Cortisone|cortisone|mesh-list
44857365|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
44857366|NCT04799275|Rituximab|rituximab|mesh-list
44857367|NCT04799275|Doxorubicin|doxorubicin|mesh-list
44857368|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44857369|NCT04799275|Vincristine|vincristine|mesh-list
44857370|NCT04799275|Azacitidine|azacitidine|mesh-list
44857371|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44857372|NCT04799275|Antibodies|antibodies|mesh-list
44857373|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
44857374|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857375|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857376|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
44857377|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857378|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857379|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857380|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
44857381|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857382|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857383|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44857384|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857385|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857386|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857387|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857388|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857389|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
44857391|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857392|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857393|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857394|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857395|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857396|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857397|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857398|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
44857399|NCT04751370|Nivolumab|nivolumab|mesh-list
44857400|NCT04751370|Ipilimumab|ipilimumab|mesh-list
44857401|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857402|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857403|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857404|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857405|NCT04666688|Gemcitabine|gemcitabine|mesh-list
44857406|NCT04666688|Paclitaxel|paclitaxel|mesh-list
44857407|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857408|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857409|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857410|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857411|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857412|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857413|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857414|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
44857415|NCT04666688|Antiviral Agents|antiviral agents|mesh-ancestor
44857416|NCT04666688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344230|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
44344232|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
44857417|NCT04666688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857418|NCT04666688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857419|NCT04666688|Immunologic Factors|immunologic factors|mesh-ancestor
44857420|NCT04666688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857421|NCT04607772|Gemcitabine|gemcitabine|mesh-list
44857422|NCT04607772|Rituximab|rituximab|mesh-list
44857423|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
44857424|NCT04607772|Lenalidomide|lenalidomide|mesh-list
44857425|NCT04607772|Venetoclax|venetoclax|mesh-list
44857426|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44857427|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857428|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857429|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
44857430|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857431|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857432|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857433|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
44857434|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857435|NCT04607772|Antiviral Agents|antiviral agents|mesh-ancestor
44857436|NCT04607772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857437|NCT04607772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857438|NCT04607772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857439|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44857440|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44857441|NCT04607772|Growth Substances|growth substances|mesh-ancestor
44857442|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
44857443|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857444|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
44857445|NCT04577755|Pomalidomide|pomalidomide|mesh-list
44857446|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
44857447|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857448|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44857449|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44857450|NCT04577755|Growth Substances|growth substances|mesh-ancestor
44857451|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
44857452|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697544|NCT05009355|Antioxidants|antioxidants|mesh-ancestor
44857453|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44857454|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
44857455|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857457|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
44857458|NCT04534218|Capecitabine|capecitabine|mesh-list
44857459|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857460|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
44857461|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857462|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857463|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857464|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
44857465|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857466|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857467|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44857468|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857469|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
44857470|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44857471|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857472|NCT04534218|Analgesics|analgesics|mesh-ancestor
44857473|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
44857474|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857475|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857476|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44857477|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44857478|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44857479|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44857480|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857481|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
44857482|NCT04513314|Valproic Acid|valproic acid|mesh-list
44857483|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44857484|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
44857485|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44857486|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44857487|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44857488|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857489|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857490|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
44857491|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857492|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857493|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
44857494|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857495|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
44857496|NCT04450173|Venetoclax|venetoclax|mesh-list
44857497|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
44857498|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857499|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857500|NCT04396860|Nivolumab|nivolumab|mesh-list
44857501|NCT04396860|Ipilimumab|ipilimumab|mesh-list
44857502|NCT04396860|Temozolomide|temozolomide|mesh-list
44857503|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857504|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857505|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857506|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857507|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857508|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
44857509|NCT04328727|Cyclosporine|cyclosporine|mesh-list
44857510|NCT04328727|Cyclosporins|cyclosporins|mesh-list
44857511|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44857512|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
44857513|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857514|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857515|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857516|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
44857517|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857518|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
44857519|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857520|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
44857521|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857522|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44857523|NCT04303858|Atezolizumab|atezolizumab|mesh-list
44857524|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857525|NCT04301843|Eflornithine|eflornithine|mesh-list
44857526|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857527|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44857528|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44857529|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44857530|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857531|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44857532|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344336|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857533|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857534|NCT04216290|Gemcitabine|gemcitabine|mesh-list
44857535|NCT04216290|Cisplatin|cisplatin|mesh-list
44857536|NCT04216290|Fluorouracil|fluorouracil|mesh-list
44857537|NCT04216290|Durvalumab|durvalumab|mesh-list
44857538|NCT04216290|Mitomycins|mitomycins|mesh-list
44857539|NCT04216290|Mitomycin|mitomycin|mesh-list
44857540|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
44857541|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857542|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
44857543|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857544|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857545|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
44857546|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857547|NCT04216290|Antiviral Agents|antiviral agents|mesh-ancestor
44857548|NCT04216290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857549|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857550|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857551|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
44857552|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857553|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857554|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857555|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
44857556|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44857557|NCT04214249|Cytarabine|cytarabine|mesh-list
44857558|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
44857559|NCT04214249|Daunorubicin|daunorubicin|mesh-list
44857560|NCT04214249|Idarubicin|idarubicin|mesh-list
44857561|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857562|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857563|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857564|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
44857565|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857566|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
44857567|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857568|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857569|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
44857570|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857571|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857572|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857573|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857574|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857575|NCT04120246|Acetic Acid|acetic acid|mesh-list
44857576|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44857577|NCT04120246|Trastuzumab|trastuzumab|mesh-list
44857578|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44857579|NCT04120246|Antibodies|antibodies|mesh-list
44857580|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
44857581|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857582|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
44857583|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857584|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857585|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44857586|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857587|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44857588|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857589|NCT04062669|Vaccines|vaccines|mesh-list
44857590|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
44857591|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857592|NCT03854903|Fulvestrant|fulvestrant|mesh-list
44857593|NCT03854903|Palbociclib|palbociclib|mesh-list
44857594|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857595|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857596|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44857597|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44857598|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
44857599|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857600|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857601|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44857602|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857603|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857604|NCT03811002|Cisplatin|cisplatin|mesh-list
44857605|NCT03811002|Carboplatin|carboplatin|mesh-list
44857606|NCT03811002|Etoposide|etoposide|mesh-list
44857607|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
44857608|NCT03811002|Atezolizumab|atezolizumab|mesh-list
44857609|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
44857610|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44344413|NCT01049425|Docetaxel|docetaxel|mesh-list
44857611|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857612|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857613|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857614|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857615|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857616|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857617|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
44857618|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857619|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
44857620|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44857621|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857622|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857623|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857624|NCT03775265|Gemcitabine|gemcitabine|mesh-list
44857625|NCT03775265|Cisplatin|cisplatin|mesh-list
44857626|NCT03775265|Fluorouracil|fluorouracil|mesh-list
44857627|NCT03775265|Atezolizumab|atezolizumab|mesh-list
44857628|NCT03775265|Mitomycins|mitomycins|mesh-list
44857629|NCT03775265|Mitomycin|mitomycin|mesh-list
44857630|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857631|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857632|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857633|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
44857634|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857635|NCT03775265|Antiviral Agents|antiviral agents|mesh-ancestor
44857636|NCT03775265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857637|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857638|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857639|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
44857640|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857641|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857642|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
44857643|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44857644|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
44857645|NCT03761056|Fludarabine|fludarabine|mesh-list
44857646|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857647|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
44857648|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857649|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44857650|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857651|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
44857652|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857653|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857654|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44857655|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44857656|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44857657|NCT03739814|Blinatumomab|blinatumomab|mesh-list
44857658|NCT03739814|Antibodies|antibodies|mesh-list
44857659|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
44857660|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44857661|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
44857662|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44857663|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
44857664|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857665|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857666|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857667|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857668|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
44857669|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857670|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857671|NCT03604991|Paclitaxel|paclitaxel|mesh-list
44857672|NCT03604991|Carboplatin|carboplatin|mesh-list
44857673|NCT03604991|Nivolumab|nivolumab|mesh-list
44857674|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44857675|NCT03604991|Ipilimumab|ipilimumab|mesh-list
44857676|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857677|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857678|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857679|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857680|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857681|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857682|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857683|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857684|NCT03578367|Niacinamide|niacinamide|mesh-list
44857685|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
44857686|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857687|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44857688|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857689|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857690|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
44857691|NCT03578367|Vitamins|vitamins|mesh-ancestor
44857692|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
44857693|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857694|NCT03535506|Palbociclib|palbociclib|mesh-list
44344502|NCT01049633|Aspirin|aspirin|mesh-list
44857695|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857696|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44857697|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857698|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857699|NCT03530683|Dexamethasone|dexamethasone|mesh-list
44857700|NCT03530683|Azacitidine|azacitidine|mesh-list
44857701|NCT03530683|Venetoclax|venetoclax|mesh-list
44857702|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857703|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
44857704|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
44857705|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857706|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857707|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44857708|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
44857709|NCT03530683|Hormones|hormones|mesh-ancestor
44857710|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857711|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857712|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857713|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857714|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
44857715|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857716|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857717|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
44857718|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44857719|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857720|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
44857721|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
44857722|NCT03417193|Anesthetics|anesthetics|mesh-list
44857723|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857724|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857725|NCT03417193|Narcotics|narcotics|mesh-ancestor
44857726|NCT03417193|Analgesics|analgesics|mesh-ancestor
44857727|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
44857728|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857729|NCT03402503|Montelukast|montelukast|mesh-list
44857730|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44857731|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
44857732|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44857733|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
44857734|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857735|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857736|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44857737|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44857738|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857739|NCT03366142|Ustekinumab|ustekinumab|mesh-list
44857740|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44857741|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
44857742|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857743|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857744|NCT03298087|Leuprolide|leuprolide|mesh-list
44857745|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44857746|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
44857747|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44857748|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857749|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857750|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857751|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44857752|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
44857753|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857754|NCT03278925|Protective Agents|protective agents|mesh-ancestor
44857755|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857756|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44857757|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44857758|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857759|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44857760|NCT03258567|Nivolumab|nivolumab|mesh-list
44857761|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857762|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857763|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857764|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857765|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
44857766|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857767|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857768|NCT02989402|Rivastigmine|rivastigmine|mesh-list
44857769|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44857770|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857771|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857772|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
44857773|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857774|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857775|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44857776|NCT02989402|Protective Agents|protective agents|mesh-ancestor
44857777|NCT02861950|Bupivacaine|bupivacaine|mesh-list
44857778|NCT02861950|Ropivacaine|ropivacaine|mesh-list
44857779|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
44857780|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
44857781|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857782|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857783|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
44857784|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857785|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
44857786|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857787|NCT02659930|Doxorubicin|doxorubicin|mesh-list
44857788|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44857789|NCT02659930|Pomalidomide|pomalidomide|mesh-list
44857790|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44857791|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857792|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44857793|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857794|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857795|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344592|NCT01049815|Calcium|calcium|mesh-list
44857796|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
44857797|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857798|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44857799|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44857800|NCT02659930|Growth Substances|growth substances|mesh-ancestor
44857801|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44249122|NCT00608101|Hormones|hormones|mesh-ancestor
44857802|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
44857803|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
44857804|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857805|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857806|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
44857807|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857808|NCT02087423|Durvalumab|durvalumab|mesh-list
44857809|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857810|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857811|NCT01351103|Spartalizumab|spartalizumab|mesh-list
44857812|NCT01351103|LGK974|lgk974|mesh-list
44857813|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44857814|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857815|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857816|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857817|NCT00001309|Ascorbic Acid|ascorbic acid|mesh-list
44857818|NCT00001309|Vitamins|vitamins|mesh-ancestor
44857819|NCT00001309|Micronutrients|micronutrients|mesh-ancestor
44857820|NCT00001309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857821|NCT00001309|Antioxidants|antioxidants|mesh-ancestor
44857822|NCT00001309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857823|NCT00001309|Protective Agents|protective agents|mesh-ancestor
44857824|NCT05007145|Paclitaxel|paclitaxel|mesh-list
44857825|NCT05007145|Cisplatin|cisplatin|mesh-list
44857826|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44857827|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44857828|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857829|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857830|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857831|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857832|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857833|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857834|NCT04952857|Vitamin D|vitamin d|mesh-list
44857835|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
44857836|NCT04952857|Vitamins|vitamins|mesh-ancestor
44857837|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
44857838|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857839|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44857840|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44857841|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
44857842|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44857843|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857844|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44857845|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857846|NCT04803994|Bevacizumab|bevacizumab|mesh-list
44857847|NCT04803994|Atezolizumab|atezolizumab|mesh-list
44857848|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44857849|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857850|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44857851|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44857852|NCT04803994|Growth Substances|growth substances|mesh-ancestor
44857853|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857854|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
44857855|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44857856|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44857857|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857858|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
44857859|NCT04527289|Amantadine|amantadine|mesh-list
44857860|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44857861|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44857862|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
44857863|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857864|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
44857865|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857866|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857867|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857868|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857869|NCT04527289|Analgesics|analgesics|mesh-ancestor
44857870|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
44857871|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857872|NCT04525898|Methadone|methadone|mesh-list
44857873|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44857874|NCT04525898|Narcotics|narcotics|mesh-ancestor
44857875|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857876|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857877|NCT04525898|Analgesics|analgesics|mesh-ancestor
44857878|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
44857879|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857880|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
44857881|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44857882|NCT04282070|Gemcitabine|gemcitabine|mesh-list
44857883|NCT04282070|Paclitaxel|paclitaxel|mesh-list
44857884|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44857885|NCT04282070|Cisplatin|cisplatin|mesh-list
44857886|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44857887|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857888|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44857889|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44857890|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44857891|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857892|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857893|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
44857894|NCT04282070|Antiviral Agents|antiviral agents|mesh-ancestor
44857895|NCT04282070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857896|NCT04282070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857897|NCT04282070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857898|NCT04282070|Immunologic Factors|immunologic factors|mesh-ancestor
44857899|NCT04282070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857900|NCT04246554|Acetaminophen|acetaminophen|mesh-list
44857901|NCT04246554|Ketorolac|ketorolac|mesh-list
44857902|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44857903|NCT04246554|Oxycodone|oxycodone|mesh-list
44857904|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857905|NCT04246554|Analgesics|analgesics|mesh-ancestor
44857906|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
44857907|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857908|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857909|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
44857910|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44857911|NCT04246554|Narcotics|narcotics|mesh-ancestor
44857912|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857913|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44697575|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
44697576|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44697577|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44697578|NCT04941937|Growth Substances|growth substances|mesh-ancestor
44697579|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
44697580|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697581|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
44697582|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44697583|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697584|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
44697585|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44697586|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697587|NCT04893096|Felzartamab|felzartamab|mesh-list
44697588|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697589|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
44697590|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697591|NCT04835129|Dexamethasone|dexamethasone|mesh-list
44697592|NCT04835129|Pomalidomide|pomalidomide|mesh-list
44697593|NCT04835129|Elotuzumab|elotuzumab|mesh-list
44697594|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44697595|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697596|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
44697597|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
44697598|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697599|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697600|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697601|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
44697602|NCT04835129|Hormones|hormones|mesh-ancestor
44697603|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697604|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697605|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697606|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
44697607|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44697608|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44697609|NCT04835129|Growth Substances|growth substances|mesh-ancestor
44697610|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
44697611|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44697612|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
44697613|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697614|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44697615|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643135|NCT00332696|Octreotide|octreotide|mesh-list
44857914|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857915|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344773|NCT01050452|Albendazole|albendazole|mesh-list
44857916|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44857917|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857918|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857919|NCT03934671|Antioxidants|antioxidants|mesh-list
44857920|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857921|NCT03934671|Protective Agents|protective agents|mesh-ancestor
44857922|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857923|NCT03679091|Clopidogrel|clopidogrel|mesh-list
44857924|NCT03679091|Ticagrelor|ticagrelor|mesh-list
44857925|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44857926|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44857927|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44857928|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44857929|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
44857930|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857931|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857932|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857933|NCT03475381|Ivacaftor|ivacaftor|mesh-list
44857934|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44857935|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44857936|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857937|NCT03465540|Dexamethasone|dexamethasone|mesh-list
44857938|NCT03465540|Azacitidine|azacitidine|mesh-list
44857939|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44857940|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
44857941|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
44857942|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857943|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857944|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44857945|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
44857946|NCT03465540|Hormones|hormones|mesh-ancestor
44857947|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44857948|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44857949|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857950|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44857951|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
44857952|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857953|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857954|NCT03436199|Amantadine|amantadine|mesh-list
44857955|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44857956|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44857957|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
44857958|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44857959|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
44857960|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44857961|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857962|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857963|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44857964|NCT03436199|Analgesics|analgesics|mesh-ancestor
44857965|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
44857966|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857967|NCT03353233|Ropivacaine|ropivacaine|mesh-list
44857968|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
44857969|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
44857970|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44857971|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857972|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
44857973|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44857974|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
44857975|NCT05400603|Irinotecan|irinotecan|mesh-list
44857976|NCT05400603|Temozolomide|temozolomide|mesh-list
44857977|NCT05400603|Dinutuximab|dinutuximab|mesh-list
44857978|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44857979|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44857980|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857981|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857982|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857983|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44857984|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
44857985|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44857986|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344842|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
44857987|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44857988|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857989|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44857990|NCT05399732|Cyclosporine|cyclosporine|mesh-list
44857991|NCT05399732|Luspatercept|luspatercept|mesh-list
44857992|NCT05399732|Cyclosporins|cyclosporins|mesh-list
44857993|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44857994|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44857995|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44857996|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
44857997|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44857998|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
44857999|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858000|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858001|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858002|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44858003|NCT05399732|Hematinics|hematinics|mesh-ancestor
44858004|NCT05399576|Nicorandil|nicorandil|mesh-list
44858005|NCT05399576|Verapamil|verapamil|mesh-list
44858006|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44858007|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44858008|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858009|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858010|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858011|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858012|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858013|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44858014|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
44858015|NCT05399576|Vitamins|vitamins|mesh-ancestor
44858016|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
44858017|NCT05398861|Bevacizumab|bevacizumab|mesh-list
44858018|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858019|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858020|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44858021|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44858022|NCT05398861|Growth Substances|growth substances|mesh-ancestor
44858023|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858024|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44858025|NCT05398770|Vitamin D|vitamin d|mesh-list
44858026|NCT05398770|Vitamins|vitamins|mesh-ancestor
44858027|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
44858028|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858029|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858030|NCT05398679|Amoxicillin|amoxicillin|mesh-list
44858031|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
44858032|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
44858033|NCT05398679|Levofloxacin|levofloxacin|mesh-list
44858034|NCT05398679|Ofloxacin|ofloxacin|mesh-list
44858035|NCT05398679|Clindamycin|clindamycin|mesh-list
44858036|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
44858037|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
44858038|NCT05398679|Rifampin|rifampin|mesh-list
44858039|NCT05398679|Linezolid|linezolid|mesh-list
44858040|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44858041|NCT05398679|Tedizolid|tedizolid|mesh-list
44858042|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
44858043|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
44858044|NCT05398679|Cefaclor|cefaclor|mesh-list
44858045|NCT05398679|Trimethoprim|trimethoprim|mesh-list
44858046|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
44858047|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
44858048|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44858049|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858050|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858051|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44858052|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44858053|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858054|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858055|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858056|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44858057|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
44858058|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44858059|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858060|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44858061|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44858062|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44858063|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44858064|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44858065|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44858066|NCT05398679|Renal Agents|renal agents|mesh-ancestor
44858067|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44858068|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44858069|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
44858070|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
44858071|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44858072|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44858073|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44858074|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44858075|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44858076|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44858077|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44858078|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
44858079|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44858080|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44858081|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44858082|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44858083|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44858084|NCT05398653|Cyclosporine|cyclosporine|mesh-list
44858085|NCT05398653|Cyclosporins|cyclosporins|mesh-list
44858086|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858087|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858088|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858089|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
44858090|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858091|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
44858092|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858093|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858094|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858095|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44858096|NCT05398393|Tenofovir|tenofovir|mesh-list
44858097|NCT05398393|Amlodipine|amlodipine|mesh-list
44858098|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44858099|NCT05398393|Atorvastatin|atorvastatin|mesh-list
44858100|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
44858101|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44858102|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
44858103|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858104|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44858105|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44858106|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858107|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
44858108|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858109|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44858110|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44858111|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44858112|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44858113|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44858114|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44858115|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858116|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858117|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858118|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858119|NCT05398367|Galactogogues|galactogogues|mesh-list
44858120|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858121|NCT05398224|Rituximab|rituximab|mesh-list
44858122|NCT05398224|Methotrexate|methotrexate|mesh-list
44858123|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
44858124|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858125|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858126|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
44858127|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858128|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858129|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44858130|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
44858131|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44858132|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858133|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
44858134|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858135|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858136|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858137|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44858138|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858139|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44858140|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858141|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
44858142|NCT05398081|Cefuroxime|cefuroxime|mesh-list
44858143|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
44858144|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858145|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858146|NCT05398055|Azithromycin|azithromycin|mesh-list
44858147|NCT05398055|Doxycycline|doxycycline|mesh-list
44858148|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858149|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858150|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
44858151|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44858152|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44858153|NCT05397938|Alendronate|alendronate|mesh-list
44858154|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858155|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858156|NCT05397834|Fluticasone|fluticasone|mesh-list
44858157|NCT05397834|Xhance|xhance|mesh-list
44858158|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858159|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44858160|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
44858161|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858162|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858163|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44858164|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
44858165|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858166|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44858167|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44858168|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44858169|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
44858170|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44858171|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
44858172|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44858173|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858174|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44858175|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44858176|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643395|NCT00329641|Carboplatin|carboplatin|mesh-list
44858177|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
44858178|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44858179|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44858180|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858181|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
44858182|NCT05397652|Coagulants|coagulants|mesh-ancestor
44858183|NCT05397262|Cisplatin|cisplatin|mesh-list
44858184|NCT05397262|Fluorouracil|fluorouracil|mesh-list
44858185|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858186|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
44858187|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858188|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858189|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858190|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
44858191|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858192|NCT05397236|Dexamethasone|dexamethasone|mesh-list
44858193|NCT05397236|Bupivacaine|bupivacaine|mesh-list
44858194|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858195|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
44858196|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
44858197|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858198|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858199|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858200|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
44858201|NCT05397236|Hormones|hormones|mesh-ancestor
44858202|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858203|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44858204|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858205|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
44858206|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
44858207|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858208|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
44858209|NCT05396937|Bevacizumab|bevacizumab|mesh-list
44858210|NCT05396937|Atezolizumab|atezolizumab|mesh-list
44858211|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858212|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858213|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44858214|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44858215|NCT05396937|Growth Substances|growth substances|mesh-ancestor
44858216|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858217|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
44858218|NCT05396742|Ravulizumab|ravulizumab|mesh-list
44858219|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44858220|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858221|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
44858222|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858223|NCT05396677|Acetaminophen|acetaminophen|mesh-list
44858224|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858225|NCT05396677|Analgesics|analgesics|mesh-ancestor
44858226|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
44858227|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858228|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858229|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
44858230|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
44858231|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858232|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
44858233|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
44858234|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
44858235|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858236|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858237|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858238|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44858239|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
44858240|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
44858241|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858242|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858243|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
44858244|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44858245|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
44858246|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
44858247|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858248|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858249|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858250|NCT05396144|Analgesics|analgesics|mesh-ancestor
44643476|NCT00328926|Hormones|hormones|mesh-list
44858251|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
44858252|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858253|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44858254|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44858255|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858256|NCT05392634|Amoxicillin|amoxicillin|mesh-list
44858257|NCT05392634|Meropenem|meropenem|mesh-list
44858258|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
44858259|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
44858260|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44858261|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858262|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858263|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858264|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858265|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44858266|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
44858267|NCT05389527|Lenvatinib|lenvatinib|mesh-list
44858268|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858269|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858270|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858271|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858272|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858273|NCT05387200|Alendronate|alendronate|mesh-list
44858274|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858275|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858276|NCT05386810|Vaccines|vaccines|mesh-list
44858277|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
44858278|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858279|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
44858280|NCT05385705|Trastuzumab|trastuzumab|mesh-list
44858281|NCT05385705|Interleukin-2|interleukin-2|mesh-list
44858282|NCT05385705|Pertuzumab|pertuzumab|mesh-list
44858283|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858284|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
44858285|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858286|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858287|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44858288|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
44858289|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858290|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858291|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44858292|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858293|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858294|NCT05385705|Analgesics|analgesics|mesh-ancestor
44858295|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
44858296|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858297|NCT05385523|Dexamethasone|dexamethasone|mesh-list
44858298|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858299|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
44858300|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
44858301|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858302|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858303|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858304|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
44858305|NCT05385523|Hormones|hormones|mesh-ancestor
44858306|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858307|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44858308|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858309|NCT05376228|Vancomycin|vancomycin|mesh-list
44858310|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858311|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858312|NCT05374954|Vaccines|vaccines|mesh-list
44858313|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
44858314|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858315|NCT05370716|Pregabalin|pregabalin|mesh-list
44858316|NCT05370716|Analgesics|analgesics|mesh-ancestor
44858317|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
44858318|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858319|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858320|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
44858321|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44858322|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345175|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858323|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858324|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858325|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858326|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858327|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858328|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858329|NCT05359315|Interferons|interferons|mesh-list
44858330|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
44858331|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858332|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
44858333|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858334|NCT05341180|Lactulose|lactulose|mesh-list
44858335|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44858336|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858337|NCT05309460|Labetalol|labetalol|mesh-list
44858338|NCT05309460|Nifedipine|nifedipine|mesh-list
44858339|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44858340|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858341|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858342|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858343|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858344|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858345|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
44858346|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44858347|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44858348|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44858349|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
44858350|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858351|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44858352|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
44858353|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
44858354|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858355|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44858356|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44858357|NCT05293548|Vaccines|vaccines|mesh-list
44858358|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
44858359|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858360|NCT05271331|Anesthetics|anesthetics|mesh-list
44858361|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
44858362|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858363|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858364|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
44858365|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858366|NCT05238844|Tenofovir|tenofovir|mesh-list
44858367|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
44858368|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858369|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44858370|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44858371|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858372|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858373|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44858374|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44858375|NCT05232734|Caffeine|caffeine|mesh-list
44858376|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
44858377|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858378|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44858379|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858380|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44858381|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858382|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44858383|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44858384|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
44858385|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858386|NCT05226897|Metformin|metformin|mesh-list
44858387|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
44858388|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44858389|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858390|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44858391|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858392|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
44858393|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44858394|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858395|NCT05439798|Dexamethasone|dexamethasone|mesh-list
44858396|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
44858397|NCT05439798|Ondansetron|ondansetron|mesh-list
44858398|NCT05439798|Palonosetron|palonosetron|mesh-list
44858400|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858401|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
44858402|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
44858403|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858404|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858405|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858406|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
44858407|NCT05439798|Hormones|hormones|mesh-ancestor
44858408|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858409|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44858410|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858411|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
44858412|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858413|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858414|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
44858415|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858416|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44858417|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
44858418|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858419|NCT05439798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44858420|NCT05439798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858421|NCT05439798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858422|NCT05439798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858423|NCT05439798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858424|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44858425|NCT05439772|Ondansetron|ondansetron|mesh-list
44858426|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
44858427|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
44858428|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858429|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858430|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858431|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
44858432|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858433|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44858434|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
44858435|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858436|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858437|NCT05439772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44858438|NCT05439772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858439|NCT05439772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858440|NCT05439772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858441|NCT05439772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858442|NCT05439629|Ranibizumab|ranibizumab|mesh-list
44858443|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44858444|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44858445|NCT05439629|Growth Substances|growth substances|mesh-ancestor
44858446|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858447|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
44858448|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858449|NCT05439577|Heparinoids|heparinoids|mesh-list
44858450|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
44858451|NCT05439577|Hormones|hormones|mesh-ancestor
44858452|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858453|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858454|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858455|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
44858456|NCT05439408|Dasatinib|dasatinib|mesh-list
44858457|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858458|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858459|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858460|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858461|NCT05439278|Temozolomide|temozolomide|mesh-list
44858462|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44858463|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
44858464|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858465|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858466|NCT05439213|Epinephrine|epinephrine|mesh-list
44858467|NCT05439213|Racepinephrine|racepinephrine|mesh-list
44858468|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44858469|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
44858470|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44858471|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44858472|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
44858473|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858474|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858475|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858476|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44858477|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44858478|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
44858479|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858480|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44858481|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
44858482|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
44858483|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
44858484|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44858485|NCT05438992|Bupivacaine|bupivacaine|mesh-list
44858486|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
44858487|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
44858488|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858489|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858490|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
44858491|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858492|NCT05438875|Tretinoin|tretinoin|mesh-list
44858493|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345338|NCT01052987|Tranilast|tranilast|mesh-list
44858494|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
44858495|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858496|NCT05438706|Carboplatin|carboplatin|mesh-list
44858497|NCT05438706|Capecitabine|capecitabine|mesh-list
44858498|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858499|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858500|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
44858501|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858502|NCT05438550|Amoxicillin|amoxicillin|mesh-list
44858503|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44858504|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858505|NCT05434624|Midazolam|midazolam|mesh-list
44858506|NCT05434624|Propofol|propofol|mesh-list
44858507|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44858508|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858509|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858510|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44858511|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
44858512|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
44858513|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44858514|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858515|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858516|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858517|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
44858518|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
44858519|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858520|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858521|NCT05431920|Vitamin D|vitamin d|mesh-list
44858522|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
44858523|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
44858524|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44858525|NCT05431920|Calcifediol|calcifediol|mesh-list
44858526|NCT05431920|Vitamins|vitamins|mesh-list
44858527|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
44858528|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858529|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858530|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858531|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
44858532|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44858533|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44858534|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44858535|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643775|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858536|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858537|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
44858538|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858539|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858540|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44858541|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858543|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44858544|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858545|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44858546|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858547|NCT05391971|Bupivacaine|bupivacaine|mesh-list
44858548|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
44858549|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
44858550|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858551|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345401|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858552|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
44858553|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858554|NCT05382715|Ozanimod|ozanimod|mesh-list
44858555|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44858556|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858557|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858558|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
44858559|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858560|NCT05339334|Ritonavir|ritonavir|mesh-list
44858561|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44858562|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44858563|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44858564|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858565|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858566|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44858567|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44858568|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
44858569|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858570|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44858571|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44858572|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44858573|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
44858574|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858575|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44858576|NCT05330130|Hormones|hormones|mesh-ancestor
44858577|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858578|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858579|NCT05328154|Diphosphonates|diphosphonates|mesh-list
44697616|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697617|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697618|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44697619|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44697620|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44697621|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44697622|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
44697623|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697624|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697625|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
44697626|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697627|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44697628|NCT04604353|Calcium|calcium|mesh-list
44697629|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44697630|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697631|NCT04500756|Metformin|metformin|mesh-list
44345461|NCT01053390|Leucovorin|leucovorin|mesh-list
44697632|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44697633|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697634|NCT04472416|Analgesics|analgesics|mesh-list
44697635|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
44697636|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697637|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697638|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
44697639|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
44697640|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44697641|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44697642|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697643|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643849|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44858580|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858581|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858582|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
44858583|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44858584|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858585|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858586|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858587|NCT05274789|Analgesics|analgesics|mesh-ancestor
44858588|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
44858589|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858590|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44858591|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44858592|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44858593|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44858594|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858595|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858596|NCT05263895|Ritonavir|ritonavir|mesh-list
44858597|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44858598|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44858599|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44858600|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858601|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858602|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44858603|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44858604|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
44858605|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858606|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44858607|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44858608|NCT05251090|Factor VIII|factor viii|mesh-list
44858609|NCT05251090|Coagulants|coagulants|mesh-ancestor
44858610|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44858611|NCT05222828|Mepivacaine|mepivacaine|mesh-list
44858612|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
44858613|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
44858614|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858615|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858616|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
44858617|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858618|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
44858619|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44858620|NCT05215236|Narcotics|narcotics|mesh-ancestor
44858621|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858622|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858623|NCT05215236|Analgesics|analgesics|mesh-ancestor
44858624|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
44858625|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858626|NCT05181124|Naproxen|naproxen|mesh-list
44858627|NCT05181124|Meloxicam|meloxicam|mesh-list
44858628|NCT05181124|Aceclofenac|aceclofenac|mesh-list
44858629|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44858630|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858631|NCT05181124|Analgesics|analgesics|mesh-ancestor
44858632|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
44858633|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858634|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858635|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858636|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858637|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
44858638|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44858639|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858640|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858641|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44858642|NCT05118776|Bevacizumab|bevacizumab|mesh-list
44858643|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858644|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858645|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44858646|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44858647|NCT05118776|Growth Substances|growth substances|mesh-ancestor
44858648|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858649|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
44858650|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
44858651|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858652|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858653|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
44858654|NCT05049213|Povidone|povidone|mesh-list
44858655|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
44858656|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
44643977|NCT00322348|Goserelin|goserelin|mesh-list
44858657|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44858658|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858659|NCT05033769|Paclitaxel|paclitaxel|mesh-list
44858660|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44858661|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44858662|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858663|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44858664|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44858665|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44858666|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858667|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
44858668|NCT05033756|Olaparib|olaparib|mesh-list
44858669|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858670|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858671|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44858672|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858673|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858674|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
44858675|NCT05030155|Azathioprine|azathioprine|mesh-list
44858676|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858677|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
44345604|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
44858678|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858679|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858680|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44858681|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
44858682|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858683|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858684|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44858685|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
44858686|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858687|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
44858688|NCT05015387|Procyanidin|procyanidin|mesh-list
44858689|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
44858690|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858691|NCT05015387|Protective Agents|protective agents|mesh-ancestor
44858692|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858693|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44858694|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44858695|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858696|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44858697|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
44858698|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858699|NCT04975347|Naloxone|naloxone|mesh-list
44858700|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858701|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44858702|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
44858703|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858704|NCT04975334|Naloxone|naloxone|mesh-list
44858705|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44858706|NCT04975334|Hormones|hormones|mesh-ancestor
44858707|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858708|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858709|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44858710|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
44858711|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858712|NCT04971837|Cannabidiol|cannabidiol|mesh-list
44858713|NCT04971837|Sorbitol|sorbitol|mesh-list
44858714|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
44858715|NCT04971837|Cathartics|cathartics|mesh-ancestor
44858716|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858717|NCT04960618|Gemcitabine|gemcitabine|mesh-list
44858718|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
44858719|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858720|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
44858721|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858722|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858723|NCT04960618|Antiviral Agents|antiviral agents|mesh-ancestor
44858724|NCT04960618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858725|NCT04960618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858726|NCT04960618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858727|NCT04960618|Immunologic Factors|immunologic factors|mesh-ancestor
44858728|NCT04960618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858729|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858730|NCT04864743|Factor VIII|factor viii|mesh-list
44858731|NCT04864743|Coagulants|coagulants|mesh-ancestor
44858732|NCT04857385|Hemostatics|hemostatics|mesh-list
44858733|NCT04857385|Coagulants|coagulants|mesh-ancestor
44858734|NCT04857307|Alprazolam|alprazolam|mesh-list
44858735|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44858736|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858737|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858738|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858739|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858740|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858741|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
44858742|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
44858743|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858744|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858745|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
44345626|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858746|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858747|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858748|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
44858749|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
44858750|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858751|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858752|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858753|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
44858754|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
44858755|NCT04777994|Mitogens|mitogens|mesh-list
44858756|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
44858757|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44858758|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858759|NCT04777994|Growth Substances|growth substances|mesh-ancestor
44858760|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858761|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
44858762|NCT04774965|Promethazine|promethazine|mesh-list
44858763|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44858764|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44858765|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858766|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858767|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
44858768|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
44858769|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
44858770|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858771|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
44858772|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
44858773|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858774|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44858775|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
44858776|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
44858777|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858778|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858779|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44858780|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
44858781|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858782|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44858783|NCT04751500|Metronidazole|metronidazole|mesh-list
44858784|NCT04751500|Clindamycin|clindamycin|mesh-list
44858785|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44858786|NCT04751500|Misoprostol|misoprostol|mesh-list
44858787|NCT04751500|Mifepristone|mifepristone|mesh-list
44858788|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858789|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44858790|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44858791|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44858792|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
44858793|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44858794|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858795|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44858796|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44858797|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
44858798|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44858799|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858800|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858801|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44858802|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44858803|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44858804|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44858805|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
44858806|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44858807|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44858808|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
44858809|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858810|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
44858811|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44858812|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44858813|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44858814|NCT04750616|Niacinamide|niacinamide|mesh-list
44858816|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
44858817|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
44858818|NCT04750616|Vitamins|vitamins|mesh-ancestor
44858819|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
44858820|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858821|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44858822|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
44858823|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858824|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44858825|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858826|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
44858827|NCT04740307|Lenvatinib|lenvatinib|mesh-list
44858828|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858829|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858830|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858831|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858832|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858833|NCT04722822|Vaccines|vaccines|mesh-list
44858834|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
44858835|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858836|NCT04673422|Montelukast|montelukast|mesh-list
44858837|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44858838|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44858839|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44858840|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44858841|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858842|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858843|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44858844|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44858845|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858846|NCT04657666|Nabiximols|nabiximols|mesh-list
44858847|NCT04657666|Analgesics|analgesics|mesh-ancestor
44858848|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
44858849|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858850|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858851|NCT04645966|Acetaminophen|acetaminophen|mesh-list
44858852|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44858853|NCT04645966|Analgesics|analgesics|mesh-ancestor
44858854|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
44858855|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858856|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858857|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
44858858|NCT04592809|Midazolam|midazolam|mesh-list
44858859|NCT04592809|Ketamine|ketamine|mesh-list
44858860|NCT04592809|Analgesics|analgesics|mesh-ancestor
44858861|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
44858862|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858863|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858864|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44858865|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44858866|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
44858867|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
44858868|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858869|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44858870|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44858871|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44858872|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858873|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44858874|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44858875|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44858876|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44858877|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44858878|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
44858879|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
44858880|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
44858881|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858882|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858883|NCT04563507|Letrozole|letrozole|mesh-list
44858884|NCT04563507|Palbociclib|palbociclib|mesh-list
44858885|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858886|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44858887|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44858888|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858889|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858890|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44858891|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44858892|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858893|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858894|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858895|NCT04534582|Denosumab|denosumab|mesh-list
44858896|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44858897|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858898|NCT04508803|Trastuzumab|trastuzumab|mesh-list
44858899|NCT04508803|Niraparib|niraparib|mesh-list
44858900|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858901|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858902|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44858903|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858904|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858905|NCT04497584|Prednisone|prednisone|mesh-list
44858906|NCT04497584|Afatinib|afatinib|mesh-list
44858907|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44858908|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
44858909|NCT04497584|Hormones|hormones|mesh-ancestor
44858910|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44858911|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858912|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44858913|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858914|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44858915|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858916|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858917|NCT04492033|Paclitaxel|paclitaxel|mesh-list
44858918|NCT04492033|Irinotecan|irinotecan|mesh-list
44858919|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44858920|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858921|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44858922|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44858923|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44858924|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858925|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44858926|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44858927|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858928|NCT04491032|Anesthetics|anesthetics|mesh-list
44858929|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44858930|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858931|NCT04488978|Amlodipine|amlodipine|mesh-list
44858932|NCT04488978|Irbesartan|irbesartan|mesh-list
44858933|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44858934|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44858935|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858936|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858937|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44858938|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858939|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44858940|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44858941|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44858942|NCT04487756|Carboplatin|carboplatin|mesh-list
44858943|NCT04487756|Atezolizumab|atezolizumab|mesh-list
44858944|NCT04487756|Vaccines|vaccines|mesh-list
44858945|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
44858946|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858947|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858948|NCT04481204|Leucovorin|leucovorin|mesh-list
44858949|NCT04481204|Gemcitabine|gemcitabine|mesh-list
44858950|NCT04481204|Paclitaxel|paclitaxel|mesh-list
44858951|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44858952|NCT04481204|Cisplatin|cisplatin|mesh-list
44858953|NCT04481204|Fluorouracil|fluorouracil|mesh-list
44858954|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
44858955|NCT04481204|Irinotecan|irinotecan|mesh-list
44858956|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644275|NCT00319956|Azithromycin|azithromycin|mesh-list
44858957|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858958|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44858959|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44858960|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44858961|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858962|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44858963|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
44858964|NCT04481204|Antiviral Agents|antiviral agents|mesh-ancestor
44858965|NCT04481204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858966|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44858967|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44858968|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
44858969|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858970|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44858971|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44858972|NCT04481204|Antidotes|antidotes|mesh-ancestor
44858973|NCT04481204|Protective Agents|protective agents|mesh-ancestor
44858974|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
44858975|NCT04481204|Vitamins|vitamins|mesh-ancestor
44858976|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
44858977|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
44858978|NCT04460456|Cemiplimab|cemiplimab|mesh-list
44858979|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858980|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44858981|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
44858982|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858983|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
44858984|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
44858985|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44858986|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
44858987|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44858988|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644352|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
44858990|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44345902|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44858991|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44858992|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44858993|NCT04316702|Analgesics|analgesics|mesh-ancestor
44858994|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
44858995|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44858996|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44858997|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44858998|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44858999|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44859000|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44859001|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44859002|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859003|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44859004|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
44859005|NCT04222595|Vaccines|vaccines|mesh-list
44859006|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
44859007|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859008|NCT04220827|Paclitaxel|paclitaxel|mesh-list
44859009|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44859010|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44859011|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859012|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859013|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859014|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44859015|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859016|NCT04220008|Gemcitabine|gemcitabine|mesh-list
44859017|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
44859018|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
44859019|NCT04220008|Busulfan|busulfan|mesh-list
44859020|NCT04220008|Rituximab|rituximab|mesh-list
44859021|NCT04220008|Vorinostat|vorinostat|mesh-list
44859022|NCT04220008|Clofarabine|clofarabine|mesh-list
44859023|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44859024|NCT04220008|Tacrolimus|tacrolimus|mesh-list
44859025|NCT04220008|Antibodies|antibodies|mesh-list
44859026|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
44859027|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44859028|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859029|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
44859030|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859031|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859032|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859033|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
44859034|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859035|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859036|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44859037|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859038|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
44859039|NCT04220008|Antiviral Agents|antiviral agents|mesh-ancestor
44859040|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859041|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859042|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44859043|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44859044|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44859045|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
44859046|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859047|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44859048|NCT04176848|Durvalumab|durvalumab|mesh-list
44859049|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859050|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859051|NCT04163978|Budesonide|budesonide|mesh-list
44859052|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
44859053|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859054|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44859055|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
44859056|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859057|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859058|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44859059|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44859060|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
44859061|NCT04163978|Hormones|hormones|mesh-ancestor
44859062|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859063|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44859064|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
44859065|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859066|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859067|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44859068|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44859069|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
44859070|NCT04163978|Protective Agents|protective agents|mesh-ancestor
44859071|NCT04116320|Poly ICLC|poly iclc|mesh-list
44859072|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
44859073|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
44859074|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859075|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44859076|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44859077|NCT04108897|Doxycycline|doxycycline|mesh-list
44859078|NCT04108897|Ivermectin|ivermectin|mesh-list
44697644|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697645|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697646|NCT04453449|Midazolam|midazolam|mesh-list
44697647|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44697648|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44697649|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697650|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697651|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697652|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697653|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697654|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44697655|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
44697656|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
44697657|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
44697658|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
44697659|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697660|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697661|NCT04415333|Butyric Acid|butyric acid|mesh-list
44697662|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
44697663|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
44697664|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249267|NCT00608946|Copper|copper|mesh-list
44697665|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697667|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44697668|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44697669|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697670|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
44697671|NCT04093596|Fludarabine|fludarabine|mesh-list
44697672|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697673|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
44697674|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697675|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697676|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44697677|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
44697678|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697679|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697680|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44697681|NCT03982693|Edetic Acid|edetic acid|mesh-list
44697682|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
44697683|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
44697684|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44697685|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
44697686|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
44697687|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697688|NCT03982693|Antidotes|antidotes|mesh-ancestor
44697689|NCT03982693|Protective Agents|protective agents|mesh-ancestor
44697690|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697691|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44697692|NCT03524170|Atezolizumab|atezolizumab|mesh-list
44697693|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697694|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
44697695|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44697696|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697697|NCT03308578|Atorvastatin|atorvastatin|mesh-list
44697698|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44697699|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44697700|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
44697701|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697702|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44644503|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859079|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859080|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859081|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
44859082|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44859083|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44859084|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44859085|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44859086|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859087|NCT03982030|Dalbavancin|dalbavancin|mesh-list
44859088|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859089|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859090|NCT03905603|Cosyntropin|cosyntropin|mesh-list
44859091|NCT03905603|Hormones|hormones|mesh-ancestor
44859092|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859093|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859094|NCT03896269|Cytarabine|cytarabine|mesh-list
44859095|NCT03896269|Daunorubicin|daunorubicin|mesh-list
44859096|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859097|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
44859098|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859099|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859100|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
44859101|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859102|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859103|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
44859104|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859105|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44859106|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44859107|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44859108|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859109|NCT03866525|Irinotecan|irinotecan|mesh-list
44859110|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44859111|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44859112|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859113|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859114|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859115|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
44859116|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859117|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859118|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
44859119|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859120|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859121|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859122|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859123|NCT03813147|Cytarabine|cytarabine|mesh-list
44859124|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
44859125|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44859126|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44859127|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44859128|NCT03813147|Methotrexate|methotrexate|mesh-list
44859129|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
44859130|NCT03813147|Azacitidine|azacitidine|mesh-list
44859131|NCT03813147|Fludarabine|fludarabine|mesh-list
44859132|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44859133|NCT03813147|Pevonedistat|pevonedistat|mesh-list
44859134|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44859135|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
44859136|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44859137|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859138|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859139|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
44859140|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859141|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859142|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
44859143|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44859144|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859145|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
44859146|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859147|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44859148|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
44859149|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859150|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859151|NCT03776812|Paclitaxel|paclitaxel|mesh-list
44859152|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44859153|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44859154|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859155|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859156|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859157|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346092|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859158|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859159|NCT03761095|Dacarbazine|dacarbazine|mesh-list
44859160|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859161|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
44859162|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859163|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859164|NCT03745352|Azacitidine|azacitidine|mesh-list
44859165|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44859166|NCT03745352|Pevonedistat|pevonedistat|mesh-list
44859167|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859168|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
44859169|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859170|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859171|NCT03730649|Sulforaphane|sulforaphane|mesh-list
44859172|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44859173|NCT03730649|Protective Agents|protective agents|mesh-ancestor
44859174|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859175|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859176|NCT03728881|Vaccines|vaccines|mesh-list
44859177|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
44859178|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859179|NCT03722680|Riluzole|riluzole|mesh-list
44859180|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
44859181|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44859182|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44859183|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859184|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859185|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859186|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44859187|NCT03722680|Protective Agents|protective agents|mesh-ancestor
44859188|NCT03719001|Clevidipine|clevidipine|mesh-list
44859189|NCT03719001|Phenylephrine|phenylephrine|mesh-list
44859190|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
44859191|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
44859192|NCT03719001|Calcium|calcium|mesh-list
44859193|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44859194|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859195|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44859196|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859197|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44859198|NCT03719001|Analgesics|analgesics|mesh-ancestor
44859199|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
44859200|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859201|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44346141|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
44859202|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44859203|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44859204|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
44859205|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859206|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859207|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44859208|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
44859209|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
44859210|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
44859211|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44859212|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
44859213|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
44859214|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44859215|NCT03719001|Protective Agents|protective agents|mesh-ancestor
44859216|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44859217|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859218|NCT03678688|Bedaquiline|bedaquiline|mesh-list
44859219|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
44859220|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
44859221|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859222|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859223|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
44859224|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44859225|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859226|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
44859227|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859228|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
44859229|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644601|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
44859230|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859231|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859232|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
44859233|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859234|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859235|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44859236|NCT03595982|Nifedipine|nifedipine|mesh-list
44859237|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44859238|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859239|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859240|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44859241|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859242|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
44859243|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
44859244|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44859245|NCT03579446|Oxymorphone|oxymorphone|mesh-list
44859246|NCT03579446|Morphine|morphine|mesh-list
44859247|NCT03579446|Oxycodone|oxycodone|mesh-list
44859248|NCT03579446|Hydromorphone|hydromorphone|mesh-list
44859249|NCT03579446|Hydrocodone|hydrocodone|mesh-list
44859250|NCT03579446|Levorphanol|levorphanol|mesh-list
44859251|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44859252|NCT03579446|Narcotics|narcotics|mesh-ancestor
44859253|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859254|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859255|NCT03579446|Analgesics|analgesics|mesh-ancestor
44859256|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
44859257|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859258|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
44859259|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
44859260|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44859261|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44859262|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44859263|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859264|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859265|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44859266|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859267|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859268|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
44859269|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859270|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
44859271|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
44859272|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859273|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859274|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859275|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
44859276|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
44859277|NCT03512756|Gemcitabine|gemcitabine|mesh-list
44859278|NCT03512756|Sirolimus|sirolimus|mesh-list
44859279|NCT03512756|Capecitabine|capecitabine|mesh-list
44859280|NCT03512756|Phenytoin|phenytoin|mesh-list
44859281|NCT03512756|Methoxsalen|methoxsalen|mesh-list
44859282|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859283|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
44859284|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859285|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859286|NCT03512756|Antiviral Agents|antiviral agents|mesh-ancestor
44859287|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859288|NCT03512756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859289|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859290|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
44859291|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859292|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859293|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44859294|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
44859295|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
44859296|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44859297|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44859298|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859299|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44859300|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44859301|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44859302|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44859303|NCT03463876|Apatinib|apatinib|mesh-list
44859304|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859305|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859306|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859307|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859308|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
44859309|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859310|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859311|NCT03436654|Prednisone|prednisone|mesh-list
44859312|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
44859313|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859314|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
44859315|NCT03436654|Hormones|hormones|mesh-ancestor
44859316|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859317|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859318|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44859319|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859320|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44859321|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859322|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859323|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44859324|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44859325|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44859326|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44859327|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44859328|NCT03413202|Protective Agents|protective agents|mesh-ancestor
44859329|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859330|NCT03378479|Posaconazole|posaconazole|mesh-list
44859331|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
44859332|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859333|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44859334|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44859335|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44859336|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44859337|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44859338|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859339|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859340|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44859341|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
44859342|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859343|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859344|NCT03367741|Nivolumab|nivolumab|mesh-list
44859345|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859346|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859347|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44859348|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859349|NCT03355118|Anesthetics|anesthetics|mesh-list
44859350|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859351|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859352|NCT03344965|Olaparib|olaparib|mesh-list
44859353|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44859354|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859355|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859356|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859357|NCT03263078|Propofol|propofol|mesh-list
44859358|NCT03263078|Sevoflurane|sevoflurane|mesh-list
44859359|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44859360|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859361|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859362|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44346317|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859363|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
44859364|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
44859365|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44859366|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44859367|NCT03126539|Sulforaphane|sulforaphane|mesh-list
44859368|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44859369|NCT03126539|Protective Agents|protective agents|mesh-ancestor
44859370|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859371|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859372|NCT03102320|Gemcitabine|gemcitabine|mesh-list
44859373|NCT03102320|Cisplatin|cisplatin|mesh-list
44859374|NCT03102320|Maytansine|maytansine|mesh-list
44859375|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859376|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859377|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
44859378|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859379|NCT03102320|Antiviral Agents|antiviral agents|mesh-ancestor
44859380|NCT03102320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859381|NCT03102320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859382|NCT03102320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859383|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
44859384|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859385|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44859386|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859387|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859388|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
44859389|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
44859390|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859391|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859392|NCT02974621|Bevacizumab|bevacizumab|mesh-list
44644819|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859393|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44859395|NCT02974621|Cediranib|cediranib|mesh-list
44859396|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
44859397|NCT02974621|Antibodies|antibodies|mesh-list
44859398|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
44859399|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44859400|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
44859401|NCT02974621|Maleic acid|maleic acid|mesh-list
44859402|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859403|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44859404|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44859405|NCT02974621|Growth Substances|growth substances|mesh-ancestor
44859406|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859407|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
44859408|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
44859409|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859410|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44859411|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859412|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859413|NCT02953834|Insulin|insulin|mesh-list
44859414|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44859415|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859416|NCT02935205|Indomethacin|indomethacin|mesh-list
44859417|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44859418|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44859419|NCT02935205|Analgesics|analgesics|mesh-ancestor
44859420|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
44859421|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859422|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859423|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859424|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859425|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
44859426|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
44859427|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44859428|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44859429|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859430|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859431|NCT02922777|Docetaxel|docetaxel|mesh-list
44859432|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859433|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859434|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859435|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
44859436|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859437|NCT02897648|Lactams|lactams|mesh-list
44859438|NCT02897648|beta-Lactams|beta-lactams|mesh-list
44859439|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859440|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859441|NCT02856451|Nivolumab|nivolumab|mesh-list
44859442|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859443|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859444|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44859445|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859446|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
44859447|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859448|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859449|NCT02819635|Upadacitinib|upadacitinib|mesh-list
44859450|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44859451|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859452|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859453|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859454|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859455|NCT02798471|Heparin|heparin|mesh-list
44859456|NCT02798471|Enoxaparin|enoxaparin|mesh-list
44859457|NCT02798471|Warfarin|warfarin|mesh-list
44859458|NCT02798471|Edoxaban|edoxaban|mesh-list
44859459|NCT02798471|Fondaparinux|fondaparinux|mesh-list
44859460|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
44859461|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44859462|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44859463|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859464|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44859465|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
44859466|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44859467|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
44859468|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859469|NCT02718404|Analgesics|analgesics|mesh-list
44859470|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
44859471|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859472|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859473|NCT02712905|Nivolumab|nivolumab|mesh-list
44859474|NCT02712905|Azacitidine|azacitidine|mesh-list
44859475|NCT02712905|Tretinoin|tretinoin|mesh-list
44859476|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859477|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859478|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44859479|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859480|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859481|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
44859482|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859483|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
44859484|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
44859485|NCT02692339|Dexamethasone|dexamethasone|mesh-list
44859486|NCT02692339|Lenalidomide|lenalidomide|mesh-list
44859487|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859488|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
44859489|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
44859490|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859491|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859492|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44859493|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
44859494|NCT02692339|Hormones|hormones|mesh-ancestor
44859495|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859496|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44859497|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859498|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
44859499|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44859500|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44859501|NCT02692339|Growth Substances|growth substances|mesh-ancestor
44859502|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
44859503|NCT02620150|Citalopram|citalopram|mesh-list
44859504|NCT02620150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44859505|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44859506|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859507|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859508|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859509|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
44859510|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859511|NCT02620150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44859512|NCT02620150|Antidepressive Agents|antidepressive agents|mesh-ancestor
44859513|NCT02620150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44859514|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44859515|NCT02535325|Cisplatin|cisplatin|mesh-list
44859516|NCT02535325|Pemetrexed|pemetrexed|mesh-list
44859517|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859518|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859519|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859520|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44859521|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44859522|NCT02535078|Durvalumab|durvalumab|mesh-list
44859523|NCT02535078|Tremelimumab|tremelimumab|mesh-list
44859524|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859525|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859526|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
44859527|NCT02529813|Fludarabine|fludarabine|mesh-list
44859528|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
44859529|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859530|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
44859531|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859532|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859533|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859534|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
44859535|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859536|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859537|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44859538|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859539|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
44859540|NCT02473042|Promethazine|promethazine|mesh-list
44859541|NCT02473042|Dexamethasone|dexamethasone|mesh-list
44859542|NCT02473042|Ondansetron|ondansetron|mesh-list
44859543|NCT02473042|Famotidine|famotidine|mesh-list
44859544|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859545|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
44859547|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859548|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859549|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44859550|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
44859551|NCT02473042|Hormones|hormones|mesh-ancestor
44859552|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859553|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44859554|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859555|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
44859556|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44859557|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44346504|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
44859558|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
44859559|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859560|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859561|NCT02473042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44859562|NCT02473042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44859563|NCT02473042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859564|NCT02473042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44859565|NCT02473042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44859566|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44859567|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44859568|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
44859569|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
44859570|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44859571|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44859572|NCT02460588|Prednisolone|prednisolone|mesh-list
44859573|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
44859574|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859575|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
44859576|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859577|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859578|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859579|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
44859580|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859581|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859582|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44859583|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859584|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
44859585|NCT02460588|Hormones|hormones|mesh-ancestor
44859586|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859587|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44859588|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44859589|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44859590|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44859591|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859592|NCT02417103|Liraglutide|liraglutide|mesh-list
44859593|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44859594|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859595|NCT02417103|Incretins|incretins|mesh-ancestor
44859596|NCT02417103|Hormones|hormones|mesh-ancestor
44859597|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859598|NCT02382549|Vaccines|vaccines|mesh-list
44859599|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
44859600|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859601|NCT02237183|Iloprost|iloprost|mesh-list
44859602|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44859603|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44859604|NCT02181413|Ixazomib|ixazomib|mesh-list
44859605|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859606|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859607|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
44859608|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859609|NCT02142803|Bevacizumab|bevacizumab|mesh-list
44859610|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44859611|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
44859612|NCT02142803|Antibodies|antibodies|mesh-list
44859613|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
44859614|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44859615|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
44859616|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859617|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44859618|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44859619|NCT02142803|Growth Substances|growth substances|mesh-ancestor
44859620|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859621|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
44859622|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
44859623|NCT02097225|Trametinib|trametinib|mesh-list
44859624|NCT02097225|Dabrafenib|dabrafenib|mesh-list
44859625|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859626|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859627|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859628|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859629|NCT01998529|Cisplatin|cisplatin|mesh-list
44859630|NCT01998529|Amifostine|amifostine|mesh-list
44859631|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859632|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44859633|NCT01998529|Protective Agents|protective agents|mesh-ancestor
44859634|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859635|NCT01915810|Nicotine|nicotine|mesh-list
44859636|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44859637|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
44859638|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859639|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859640|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44859641|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44859642|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
44859643|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859644|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859645|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44859646|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44859647|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44859648|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
44859649|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859650|NCT01744652|Dasatinib|dasatinib|mesh-list
44859651|NCT01744652|Crizotinib|crizotinib|mesh-list
44859652|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859653|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859654|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859655|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859656|NCT01709123|Chromium|chromium|mesh-list
44859657|NCT01709123|Trace Elements|trace elements|mesh-ancestor
44859658|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
44859659|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859660|NCT01479842|Rituximab|rituximab|mesh-list
44859661|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44859662|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859663|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859664|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
44859665|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859666|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859667|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859668|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
44859669|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859670|NCT01434316|Veliparib|veliparib|mesh-list
44859671|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44859672|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859673|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859674|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859676|NCT01425541|Estradiol|estradiol|mesh-list
44859677|NCT01425541|Estrogens|estrogens|mesh-list
44859678|NCT01425541|Progestins|progestins|mesh-ancestor
44859679|NCT01425541|Hormones|hormones|mesh-ancestor
44859680|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859681|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859682|NCT01410942|Methylphenidate|methylphenidate|mesh-list
44859683|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44859684|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859685|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44859686|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44859687|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44859688|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859689|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
44859690|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859691|NCT01301807|Panobinostat|panobinostat|mesh-list
44859692|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859693|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44859694|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859695|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859696|NCT01283997|Minocycline|minocycline|mesh-list
44859697|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859698|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859699|NCT01160211|Trastuzumab|trastuzumab|mesh-list
44859700|NCT01160211|Lapatinib|lapatinib|mesh-list
44859701|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44859702|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859703|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859704|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859705|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859706|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859707|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44859708|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44859709|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44859710|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859711|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859712|NCT01093573|Azacitidine|azacitidine|mesh-list
44859713|NCT01093573|Midostaurin|midostaurin|mesh-list
44859714|NCT01093573|Staurosporine|staurosporine|mesh-list
44859715|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859716|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
44859717|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859718|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859719|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859720|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859721|NCT00828854|Entinostat|entinostat|mesh-list
44859722|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44859723|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44859724|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859725|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859726|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44859727|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
44859728|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859729|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859730|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859731|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44859732|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
44859733|NCT00740805|Doxorubicin|doxorubicin|mesh-list
44859734|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44859735|NCT00740805|Veliparib|veliparib|mesh-list
44859736|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859737|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
44859738|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859739|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859740|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859741|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
44859742|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859743|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859744|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44859745|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44859746|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44859747|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44859748|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859749|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44859750|NCT05183880|Vitamins|vitamins|mesh-list
44859751|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
44859752|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
44859753|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859754|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
44859755|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859756|NCT05183880|Protective Agents|protective agents|mesh-ancestor
44859757|NCT05174858|Hemostatics|hemostatics|mesh-list
44859758|NCT05174858|Coagulants|coagulants|mesh-ancestor
44859759|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
44859760|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
44859761|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859762|NCT05174845|Protective Agents|protective agents|mesh-ancestor
44859763|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859764|NCT05174845|Vitamins|vitamins|mesh-ancestor
44859765|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
44859766|NCT05171374|Trametinib|trametinib|mesh-list
44859767|NCT05171374|Dabrafenib|dabrafenib|mesh-list
44859768|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859769|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859770|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859771|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859772|NCT05112848|Vaccines|vaccines|mesh-list
44346721|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
44859773|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
44859774|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859775|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44859776|NCT05105633|Tenecteplase|tenecteplase|mesh-list
44859777|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44859778|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44859779|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859780|NCT05102071|Metformin|metformin|mesh-list
44859781|NCT05102071|Empagliflozin|empagliflozin|mesh-list
44859782|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44859783|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859784|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44859785|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859786|NCT05089370|Nivolumab|nivolumab|mesh-list
44859787|NCT05089370|Decitabine|decitabine|mesh-list
44859788|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859789|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859790|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44859791|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859792|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859793|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
44859794|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859795|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
44859796|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859797|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859798|NCT05082155|Bupivacaine|bupivacaine|mesh-list
44859799|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
44859800|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
44859801|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859802|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859803|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
44859804|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859805|NCT05054868|Ketorolac|ketorolac|mesh-list
44859806|NCT05054868|Oxycodone|oxycodone|mesh-list
44859807|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44859808|NCT05054868|Narcotics|narcotics|mesh-ancestor
44859809|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859810|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859811|NCT05054868|Analgesics|analgesics|mesh-ancestor
44859812|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
44697703|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44697704|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697705|NCT03283813|Inositol|inositol|mesh-list
44697706|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
44697707|NCT03283813|Vitamins|vitamins|mesh-ancestor
44697708|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
44697709|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697710|NCT03283384|Letrozole|letrozole|mesh-list
44697711|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697712|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44859813|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859814|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44859815|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44859816|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859817|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44859818|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44859819|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859820|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645338|NCT00306189|Denosumab|denosumab|mesh-list
44859821|NCT05016518|Propofol|propofol|mesh-list
44859822|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44859823|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859824|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859825|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44859826|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
44859827|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
44859828|NCT05006599|Insulin|insulin|mesh-list
44859829|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44859830|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44859831|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859832|NCT04985500|Bupivacaine|bupivacaine|mesh-list
44859833|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
44859834|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
44859835|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859836|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859837|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
44859838|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859839|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
44859840|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
44859841|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44859842|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859843|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859844|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
44859845|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44859846|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859847|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859848|NCT04962893|Vaccines|vaccines|mesh-list
44859849|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
44859850|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859851|NCT04956042|Cytarabine|cytarabine|mesh-list
44859852|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859853|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
44859854|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859855|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859856|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
44859857|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859858|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859859|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
44859860|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859861|NCT04937543|Beclomethasone|beclomethasone|mesh-list
44859862|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
44859863|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
44859864|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44859865|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
44859866|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859867|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859868|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44859869|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
44859870|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44859871|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44859872|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44859873|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
44859874|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859875|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859876|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44859877|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
44859878|NCT04937543|Hormones|hormones|mesh-ancestor
44859879|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44859880|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44859881|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44859882|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44859883|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
44859884|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
44859885|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44859886|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859887|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859888|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44859889|NCT04923737|Analgesics|analgesics|mesh-ancestor
44859890|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
44859891|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859892|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44859893|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44859894|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44859895|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44859896|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859897|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859898|NCT04921943|Azithromycin|azithromycin|mesh-list
44859899|NCT04921943|Rifampin|rifampin|mesh-list
44859900|NCT04921943|Ethambutol|ethambutol|mesh-list
44859901|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44859902|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859903|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44859904|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
44859905|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
44859906|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44859907|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859908|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859909|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44859910|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44859911|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44859912|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44859913|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44859914|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44859915|NCT04920032|Irinotecan|irinotecan|mesh-list
44859916|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44859917|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44859918|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859919|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859920|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859921|NCT04901208|Nicotine|nicotine|mesh-list
44859922|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44859923|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
44859924|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44859925|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859926|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44859927|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44859928|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
44859929|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44859930|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859931|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
44859932|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44859933|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859934|NCT04884412|Anesthetics|anesthetics|mesh-list
44859935|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44859936|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859937|NCT04807673|Paclitaxel|paclitaxel|mesh-list
44859938|NCT04807673|Cisplatin|cisplatin|mesh-list
44859939|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
44859940|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44859941|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859942|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859943|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859944|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44859945|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859946|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859947|NCT04796454|Gemcitabine|gemcitabine|mesh-list
44859948|NCT04796454|Cisplatin|cisplatin|mesh-list
44859949|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
44859950|NCT04796454|Temozolomide|temozolomide|mesh-list
44859951|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859952|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44859953|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
44859954|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859955|NCT04796454|Antiviral Agents|antiviral agents|mesh-ancestor
44859956|NCT04796454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44859957|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859958|NCT04796454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44859959|NCT04796454|Immunologic Factors|immunologic factors|mesh-ancestor
44859960|NCT04796454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859961|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859962|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
44859963|NCT04788420|Sorafenib|sorafenib|mesh-list
44859964|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859965|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44859966|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859967|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859968|NCT04765709|Cisplatin|cisplatin|mesh-list
44859969|NCT04765709|Carboplatin|carboplatin|mesh-list
44859970|NCT04765709|Pemetrexed|pemetrexed|mesh-list
44859972|NCT04765709|Vinorelbine|vinorelbine|mesh-list
44859973|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44859974|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859975|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44859976|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859977|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44859978|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44859979|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44859980|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
44859981|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859982|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44859983|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44859984|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44859985|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44859986|NCT04752813|Vitamin K|vitamin k|mesh-list
44859987|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
44859988|NCT04752813|Temozolomide|temozolomide|mesh-list
44859989|NCT04752813|Vitamins|vitamins|mesh-ancestor
44859990|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
44859991|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44859992|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44859993|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
44859994|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44859995|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44859996|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44859997|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44859998|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
44859999|NCT04752813|Coagulants|coagulants|mesh-ancestor
44860000|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
44860001|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44860002|NCT04740580|Glycine|glycine|mesh-list
44860003|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
44860004|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860005|NCT04740580|Expectorants|expectorants|mesh-ancestor
44860006|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44860007|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44860008|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
44860009|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860010|NCT04740580|Protective Agents|protective agents|mesh-ancestor
44860011|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860012|NCT04740580|Antidotes|antidotes|mesh-ancestor
44860013|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
44860014|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860015|NCT04727229|Bupivacaine|bupivacaine|mesh-list
44860016|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
44860017|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
44860018|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860019|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860020|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
44346989|NCT01061216|Insulin|insulin|mesh-list
44860021|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860022|NCT04715633|Apatinib|apatinib|mesh-list
44860023|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44860024|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860025|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860026|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860027|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860028|NCT04705818|Durvalumab|durvalumab|mesh-list
44860029|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860030|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860031|NCT04701424|Insulin|insulin|mesh-list
44860032|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44860033|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860034|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
44860035|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
44860036|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860037|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
44860038|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860039|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860040|NCT04673786|Ustekinumab|ustekinumab|mesh-list
44860041|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
44860042|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44860043|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44860044|NCT04640402|Vaccines|vaccines|mesh-list
44860045|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
44860046|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860047|NCT04613206|Vaccines|vaccines|mesh-list
44860048|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
44860049|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860050|NCT04594005|Paclitaxel|paclitaxel|mesh-list
44860051|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860052|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860053|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860054|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44860055|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860056|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860057|NCT04580277|Tofacitinib|tofacitinib|mesh-list
44860058|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860059|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860060|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860061|NCT04560660|Midazolam|midazolam|mesh-list
44860062|NCT04560660|Ketamine|ketamine|mesh-list
44860063|NCT04560660|Analgesics|analgesics|mesh-ancestor
44860064|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
44860065|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860066|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860067|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44860068|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860069|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
44860070|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
44860071|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860072|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44860073|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44860074|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860075|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860076|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44860077|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860078|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44860079|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44860080|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860081|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
44860082|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
44860083|NCT04530656|Vaccines|vaccines|mesh-list
44860084|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
44860085|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860086|NCT04509596|Capecitabine|capecitabine|mesh-list
44860087|NCT04509596|Trastuzumab|trastuzumab|mesh-list
44860088|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860089|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
44860090|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860091|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860092|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860093|NCT04489433|Trametinib|trametinib|mesh-list
44860094|NCT04489433|Dabrafenib|dabrafenib|mesh-list
44860095|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347048|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44860096|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860097|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860098|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860099|NCT04422652|Bupropion|bupropion|mesh-list
44860100|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44860101|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
44860102|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860103|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44645679|NCT00302081|Ribavirin|ribavirin|mesh-list
44860104|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44860105|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44860106|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860107|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
44860108|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860109|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860110|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44860111|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44860112|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860113|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44860114|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
44860115|NCT04420585|Coagulants|coagulants|mesh-ancestor
44860116|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44860117|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
44860118|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860119|NCT04380311|Tacrolimus|tacrolimus|mesh-list
44860120|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44860121|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
44860122|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860123|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44860124|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860125|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860126|NCT04369014|Anesthetics|anesthetics|mesh-list
44860127|NCT04369014|Propofol|propofol|mesh-list
44860128|NCT04369014|Etomidate|etomidate|mesh-list
44860129|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860130|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860131|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860132|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860133|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
44860134|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
44860135|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44860136|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44347082|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44860137|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860138|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
44860139|NCT04360629|Coagulants|coagulants|mesh-ancestor
44860140|NCT04360421|Bupivacaine|bupivacaine|mesh-list
44860141|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
44860142|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
44860143|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860144|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860145|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
44860146|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860147|NCT04339270|Azithromycin|azithromycin|mesh-list
44860148|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860149|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860150|NCT04327024|Allopurinol|allopurinol|mesh-list
44860151|NCT04327024|Verinurad|verinurad|mesh-list
44860152|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
44860153|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860154|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860155|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
44860156|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44860157|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44860158|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
44860159|NCT04327024|Protective Agents|protective agents|mesh-ancestor
44860160|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860161|NCT04326478|Azithromycin|azithromycin|mesh-list
44860162|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860163|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860164|NCT04294225|Letrozole|letrozole|mesh-list
44860165|NCT04294225|Anastrozole|anastrozole|mesh-list
44860166|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860167|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44860168|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44860169|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860170|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860171|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44860172|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860173|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860174|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860175|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860176|NCT04266795|Azacitidine|azacitidine|mesh-list
44860177|NCT04266795|Venetoclax|venetoclax|mesh-list
44860178|NCT04266795|Pevonedistat|pevonedistat|mesh-list
44860179|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860180|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
44860181|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860182|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860183|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860185|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645795|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860187|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860188|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860189|NCT04178460|Niraparib|niraparib|mesh-list
44860190|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44860191|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860192|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860193|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860194|NCT04175925|Famotidine|famotidine|mesh-list
44860195|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44860196|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44860197|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44860198|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
44860199|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
44860200|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860201|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860202|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860203|NCT04116203|Metformin|metformin|mesh-list
44860204|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44860205|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860206|NCT04072770|Caseins|caseins|mesh-list
44860207|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
44860208|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
44860209|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860210|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44860211|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
44860212|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347163|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
44860213|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44860214|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44860215|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44860216|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44860217|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
44860218|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44860219|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860220|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44860221|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44860222|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44860223|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44860224|NCT03986996|Amoxicillin|amoxicillin|mesh-list
44860225|NCT03986996|Metronidazole|metronidazole|mesh-list
44860226|NCT03986996|Doxycycline|doxycycline|mesh-list
44860227|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860228|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860229|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44860230|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44860231|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
44860232|NCT03943173|Olaparib|olaparib|mesh-list
44860233|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44860234|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860235|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860236|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860237|NCT03902418|Tenofovir|tenofovir|mesh-list
44860238|NCT03902418|Emtricitabine|emtricitabine|mesh-list
44860239|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
44860240|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860241|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44860242|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44860243|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860244|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860245|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44860246|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44860247|NCT03897998|Naloxone|naloxone|mesh-list
44860248|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44860249|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860250|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
44860251|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860252|NCT03874325|Durvalumab|durvalumab|mesh-list
44860253|NCT03874325|Letrozole|letrozole|mesh-list
44860254|NCT03874325|Anastrozole|anastrozole|mesh-list
44860255|NCT03874325|Exemestane|exemestane|mesh-list
44860256|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860257|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860258|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44860259|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44645869|NCT00300495|Amiodarone|amiodarone|mesh-list
44860260|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860261|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860262|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44860263|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860264|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860265|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860266|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860268|NCT03861611|Diclofenac|diclofenac|mesh-list
44860269|NCT03861611|Ketorolac|ketorolac|mesh-list
44860270|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44860271|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860272|NCT03861611|Analgesics|analgesics|mesh-ancestor
44860273|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
44860274|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860275|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860276|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860277|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44860278|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44860279|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860280|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347246|NCT01062945|Doxazosin|doxazosin|mesh-list
44860281|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
44860282|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860283|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860284|NCT03799835|Atezolizumab|atezolizumab|mesh-list
44860285|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
44860286|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860287|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44860288|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
44860289|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860290|NCT03784066|Durvalumab|durvalumab|mesh-list
44860291|NCT03784066|Tremelimumab|tremelimumab|mesh-list
44860292|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44860293|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860294|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860295|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
44860296|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860297|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
44860298|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860299|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860300|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860301|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860302|NCT03757897|Analgesics|analgesics|mesh-ancestor
44860303|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
44860304|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860305|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44860306|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44860307|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44860308|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
44860309|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860310|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860311|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44860312|NCT03735095|Trioxsalen|trioxsalen|mesh-list
44860313|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860314|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44860315|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44860316|NCT03712098|Liraglutide|liraglutide|mesh-list
44860317|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44860318|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860319|NCT03712098|Incretins|incretins|mesh-ancestor
44860320|NCT03712098|Hormones|hormones|mesh-ancestor
44860321|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860322|NCT03654274|Norethindrone|norethindrone|mesh-list
44860323|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
44860324|NCT03654274|Estradiol|estradiol|mesh-list
44860325|NCT03654274|Relugolix|relugolix|mesh-list
44860326|NCT03654274|Estrogens|estrogens|mesh-ancestor
44860327|NCT03654274|Hormones|hormones|mesh-ancestor
44860328|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860329|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347270|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
44860330|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44860331|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
44860332|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44860333|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44860334|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44860335|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44860336|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44860337|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
44860338|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860339|NCT03621553|Vitamin D|vitamin d|mesh-list
44860340|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
44860341|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
44860342|NCT03621553|Vitamins|vitamins|mesh-list
44860343|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
44860344|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860345|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44860346|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44860347|NCT03608358|Metformin|metformin|mesh-list
44860348|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
44860349|NCT03608358|Saxagliptin|saxagliptin|mesh-list
44860350|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44860351|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860352|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44860353|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860354|NCT03608358|Incretins|incretins|mesh-ancestor
44860355|NCT03608358|Hormones|hormones|mesh-ancestor
44860356|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860357|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44860358|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
44860359|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860360|NCT03605719|Dexamethasone|dexamethasone|mesh-list
44860361|NCT03605719|Nivolumab|nivolumab|mesh-list
44860362|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860363|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
44860364|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
44860365|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860366|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860367|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44860368|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
44860369|NCT03605719|Hormones|hormones|mesh-ancestor
44860370|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860371|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860372|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860373|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860374|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44860375|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860376|NCT03569839|Propofol|propofol|mesh-list
44860377|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860378|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860379|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860380|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860381|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
44860382|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
44860383|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
44860384|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860385|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860386|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860387|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860388|NCT03564093|Analgesics|analgesics|mesh-ancestor
44646018|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860389|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
44860390|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860391|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44860392|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44860393|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44860394|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44860395|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860396|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860397|NCT03560934|Dronabinol|dronabinol|mesh-list
44860398|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
44860399|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860400|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860401|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860402|NCT03560934|Analgesics|analgesics|mesh-ancestor
44860403|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
44860404|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860405|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44860406|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44860407|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860408|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860409|NCT03560934|Hormones|hormones|mesh-ancestor
44860410|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860411|NCT03557840|Temocillin|temocillin|mesh-list
44860412|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860413|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860414|NCT03529422|Durvalumab|durvalumab|mesh-list
44860415|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860416|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860417|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
44860418|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
44860419|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44860420|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860421|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860422|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860423|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
44860424|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860425|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860426|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
44860427|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
44860428|NCT03525002|Bromocriptine|bromocriptine|mesh-list
44860429|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44860430|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44860431|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860432|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860433|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860434|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
44860435|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
44860436|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860437|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860438|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
44860439|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44860440|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44860441|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44860442|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44860443|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860444|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
44860445|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860446|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860447|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44860448|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860449|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
44860450|NCT03463993|Oxytocin|oxytocin|mesh-list
44860451|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
44860452|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44860453|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860454|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44860455|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44860456|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860457|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
44860458|NCT03463993|Coagulants|coagulants|mesh-ancestor
44860459|NCT03395314|Midazolam|midazolam|mesh-list
44860460|NCT03395314|Ketamine|ketamine|mesh-list
44860461|NCT03395314|Analgesics|analgesics|mesh-ancestor
44860462|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
44860463|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860464|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860465|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44860466|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860467|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
44860468|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
44860469|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860470|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44860471|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44860472|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860473|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860474|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44860475|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860476|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44860477|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44860478|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860479|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
44860480|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
44860481|NCT03344419|Ketamine|ketamine|mesh-list
44860482|NCT03344419|Analgesics|analgesics|mesh-ancestor
44860483|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
44860484|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860485|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860486|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44860487|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860488|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
44860489|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
44860490|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860491|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44860492|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44860493|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860494|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860495|NCT03336398|Ketamine|ketamine|mesh-list
44860496|NCT03336398|Analgesics|analgesics|mesh-ancestor
44860497|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
44860498|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860499|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860500|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44860501|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44860502|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
44860503|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
44860504|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860505|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44860506|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44860507|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860508|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860509|NCT03274752|Paroxetine|paroxetine|mesh-list
44860510|NCT03274752|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44860511|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44860512|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44860513|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860514|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860515|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
44860516|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860517|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44860518|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
44860519|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860520|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44860521|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44347484|NCT01063933|Peramivir|peramivir|mesh-list
44860522|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860523|NCT03242382|Palbociclib|palbociclib|mesh-list
44860524|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860525|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860526|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860527|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860528|NCT03238196|Fulvestrant|fulvestrant|mesh-list
44860529|NCT03238196|Palbociclib|palbociclib|mesh-list
44860530|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860531|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860532|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44860533|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44860534|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860535|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860536|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860537|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860538|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860539|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860541|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44860542|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
44860543|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860544|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860545|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
44860546|NCT03221257|Pirfenidone|pirfenidone|mesh-list
44860547|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44860548|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860549|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44860550|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
44860551|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860552|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860553|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860554|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860555|NCT03221257|Analgesics|analgesics|mesh-ancestor
44860556|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
44860557|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860558|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860559|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44860560|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860561|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860562|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44860563|NCT03203642|XL647|xl647|mesh-list
44860564|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860565|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860566|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860567|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860568|NCT03179904|Paclitaxel|paclitaxel|mesh-list
44860569|NCT03179904|Trastuzumab|trastuzumab|mesh-list
44860570|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44860571|NCT03179904|Letrozole|letrozole|mesh-list
44860572|NCT03179904|Fulvestrant|fulvestrant|mesh-list
44860573|NCT03179904|Anastrozole|anastrozole|mesh-list
44860574|NCT03179904|Exemestane|exemestane|mesh-list
44860575|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44860576|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44860577|NCT03179904|Antibodies|antibodies|mesh-list
44860578|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
44860579|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44860580|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860581|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860582|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860583|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44860584|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860585|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860586|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
44860587|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860588|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44860589|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44860590|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860591|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44860592|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860593|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860594|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860595|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44860596|NCT03179605|Clobetasol|clobetasol|mesh-list
44860597|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860598|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
44860599|NCT03179605|Hormones|hormones|mesh-ancestor
44860600|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860601|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860602|NCT03174275|Paclitaxel|paclitaxel|mesh-list
44860603|NCT03174275|Cisplatin|cisplatin|mesh-list
44860604|NCT03174275|Carboplatin|carboplatin|mesh-list
44860605|NCT03174275|Durvalumab|durvalumab|mesh-list
44860606|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860607|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860608|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860609|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44860610|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860611|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860612|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860613|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
44860614|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
44860615|NCT03173053|Clarithromycin|clarithromycin|mesh-list
44860616|NCT03173053|Doxycycline|doxycycline|mesh-list
44860617|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
44860618|NCT03173053|Rifampin|rifampin|mesh-list
44860619|NCT03173053|Clindamycin|clindamycin|mesh-list
44860620|NCT03173053|Trimethoprim|trimethoprim|mesh-list
44860621|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
44860622|NCT03173053|Mupirocin|mupirocin|mesh-list
44860623|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
44860624|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44860625|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44860626|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860627|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
44860628|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860629|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44860630|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860631|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860632|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44860633|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44860634|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
44860635|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44860636|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44860637|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44860638|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44860639|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860640|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44860641|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44860642|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
44860643|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
44860644|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44860645|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44860646|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44860647|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44860648|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44860649|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44347603|NCT01064752|Minocycline|minocycline|mesh-list
44860650|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44860651|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44860652|NCT03173053|Renal Agents|renal agents|mesh-ancestor
44860653|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44860654|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44860655|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44860656|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44860657|NCT03109795|Clonidine|clonidine|mesh-list
44860658|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44860659|NCT03109795|Diuretics|diuretics|mesh-ancestor
44860660|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
44860661|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860662|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44860663|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44860664|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860665|NCT03109795|Analgesics|analgesics|mesh-ancestor
44860666|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
44860667|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860668|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
44860669|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
44860670|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44860671|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44860672|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44860673|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
44860674|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860675|NCT03101475|Durvalumab|durvalumab|mesh-list
44860676|NCT03101475|Tremelimumab|tremelimumab|mesh-list
44860677|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860678|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860679|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
44860680|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44860681|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860682|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860683|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44860684|NCT03069638|Analgesics|analgesics|mesh-ancestor
44860685|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
44860686|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860687|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44860688|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44860689|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44860690|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
44860691|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860692|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860693|NCT03052608|Crizotinib|crizotinib|mesh-list
44860694|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860695|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860696|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860697|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860698|NCT03015610|Lansoprazole|lansoprazole|mesh-list
44860699|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
44860700|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44860701|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44860702|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44860703|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860704|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860705|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
44860706|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
44860707|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44860708|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44860709|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860710|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860711|NCT02983461|Urological Agents|urological agents|mesh-ancestor
44860712|NCT02977494|Dexamethasone|dexamethasone|mesh-list
44860713|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
44860714|NCT02977494|Bortezomib|bortezomib|mesh-list
44697713|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44697714|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697715|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697716|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44697717|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
44697718|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697719|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697720|NCT03245827|Clomiphene|clomiphene|mesh-list
44697721|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44697722|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
44697723|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697724|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697725|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44697726|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
44697727|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697728|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44697729|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44697730|NCT03129321|Econazole|econazole|mesh-list
44697731|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
44697732|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697733|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44697734|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44697735|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697736|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697737|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44697738|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44697756|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44697757|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347700|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44347742|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44347743|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347744|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347752|NCT01065545|Clofarabine|clofarabine|mesh-list
44347753|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347754|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
44697758|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697759|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
44697760|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697761|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697762|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44697764|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697765|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44697766|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44697767|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44697768|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
44697769|NCT03107611|Tacrolimus|tacrolimus|mesh-list
44697770|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44697771|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44697772|NCT03107611|Analgesics|analgesics|mesh-ancestor
44697773|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
44646399|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
44860715|NCT02977494|Daratumumab|daratumumab|mesh-list
44860716|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860717|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
44860718|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
44860719|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860720|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860721|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44860722|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
44860724|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860725|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860726|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860727|NCT02948660|Zolpidem|zolpidem|mesh-list
44860728|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44860729|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44860730|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860731|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860732|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44860733|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
44860734|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
44860735|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860736|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860737|NCT02944019|Edoxaban|edoxaban|mesh-list
44860738|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44860739|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
44860740|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44860741|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44860742|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860743|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860744|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
44860745|NCT02935309|Capecitabine|capecitabine|mesh-list
44860746|NCT02935309|Lenvatinib|lenvatinib|mesh-list
44860747|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860748|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
44860749|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860750|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860751|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860752|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860753|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44860754|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44860755|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
44860756|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44860757|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
44860758|NCT02900443|Azathioprine|azathioprine|mesh-list
44860759|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44860760|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860761|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44860762|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
44860763|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860764|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860765|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860766|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860767|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
44860768|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860769|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44860770|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
44860771|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860772|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44860773|NCT02841995|Belumosudil|belumosudil|mesh-list
44860774|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860775|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860776|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860777|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
44860778|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860779|NCT02805257|Mitomycins|mitomycins|mesh-list
44860780|NCT02805257|Mitomycin|mitomycin|mesh-list
44860781|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44860782|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860783|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
44860784|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860785|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44860786|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860787|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
44860788|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44860789|NCT02774239|Antibodies|antibodies|mesh-list
44860790|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
44860791|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
44860792|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860793|NCT02696564|Losartan|losartan|mesh-list
44860794|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44860795|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44860796|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44860797|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44860798|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860799|NCT02639065|Durvalumab|durvalumab|mesh-list
44860800|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860801|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860802|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44860803|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
44860804|NCT02636387|Coagulants|coagulants|mesh-ancestor
44860805|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44860806|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
44860807|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860808|NCT02564263|Paclitaxel|paclitaxel|mesh-list
44860809|NCT02564263|Docetaxel|docetaxel|mesh-list
44860810|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
44860811|NCT02564263|Irinotecan|irinotecan|mesh-list
44860812|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860813|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860814|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860815|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
44347817|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
44860816|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860817|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860818|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860819|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44860820|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44860821|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860822|NCT02546232|Paclitaxel|paclitaxel|mesh-list
44860823|NCT02546232|Carboplatin|carboplatin|mesh-list
44860824|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860825|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860826|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860827|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44860828|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860829|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860830|NCT02537197|Naltrexone|naltrexone|mesh-list
44860831|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44646498|NCT00294658|Prednisone|prednisone|mesh-list
44860832|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44860833|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860834|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
44860835|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860837|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860838|NCT02432547|Aflibercept|aflibercept|mesh-list
44860839|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44860840|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44860841|NCT02432547|Growth Substances|growth substances|mesh-ancestor
44860842|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860843|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
44860844|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860845|NCT02367456|Azacitidine|azacitidine|mesh-list
44860846|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860847|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
44860848|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860849|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860850|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860851|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44860852|NCT02345733|Amoxicillin|amoxicillin|mesh-list
44860853|NCT02345733|Metronidazole|metronidazole|mesh-list
44860854|NCT02345733|Doxycycline|doxycycline|mesh-list
44860855|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860856|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44860857|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44860858|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
44860859|NCT02260102|Temocillin|temocillin|mesh-list
44860860|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860861|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860862|NCT02204254|Doxycycline|doxycycline|mesh-list
44860863|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860864|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860865|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
44860866|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44860867|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44860868|NCT02065596|Fludarabine|fludarabine|mesh-list
44860869|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
44860870|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860871|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860872|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
44860873|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860874|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44860875|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
44860876|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860877|NCT02022059|Lidocaine|lidocaine|mesh-list
44860878|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
44860879|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
44860880|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44860881|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860882|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
44860883|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860884|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44860885|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44860886|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44860887|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44860888|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860889|NCT01918644|Capecitabine|capecitabine|mesh-list
44860890|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44860891|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
44860892|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860893|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860894|NCT01912651|Cephalexin|cephalexin|mesh-list
44860895|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44860896|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44860897|NCT01887522|Vinblastine|vinblastine|mesh-list
44860898|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44860899|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860900|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
44860901|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44860902|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44860903|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860904|NCT01559363|XL647|xl647|mesh-list
44860905|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860906|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860907|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646590|NCT00293384|Aprepitant|aprepitant|mesh-list
44860908|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860909|NCT01504919|Nicotine|nicotine|mesh-list
44860910|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44860911|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
44860912|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860913|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860914|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44860915|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44860916|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
44860917|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44860918|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860919|NCT01434602|Everolimus|everolimus|mesh-list
44860920|NCT01434602|Sorafenib|sorafenib|mesh-list
44860921|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860922|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44860923|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
44860924|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860925|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44860926|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860927|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860928|NCT01239797|Dexamethasone|dexamethasone|mesh-list
44860929|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
44860930|NCT01239797|Lenalidomide|lenalidomide|mesh-list
44860931|NCT01239797|Elotuzumab|elotuzumab|mesh-list
44860932|NCT01239797|BB 1101|bb 1101|mesh-list
44860933|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860934|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
44860935|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
44860936|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860937|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860938|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44860939|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
44860940|NCT01239797|Hormones|hormones|mesh-ancestor
44347933|NCT01066429|Dexamethasone|dexamethasone|mesh-list
44860941|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860942|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44860943|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860944|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
44860945|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860946|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860947|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
44860948|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44860949|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44860950|NCT01239797|Growth Substances|growth substances|mesh-ancestor
44860951|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44860952|NCT01236521|Analgesics|analgesics|mesh-list
44860953|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
44860954|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860955|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860956|NCT01103349|Montelukast|montelukast|mesh-list
44860957|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44860958|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
44860959|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44860960|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860961|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44860962|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860963|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44860964|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44860965|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860966|NCT01092143|Fluticasone|fluticasone|mesh-list
44860967|NCT01092143|Xhance|xhance|mesh-list
44860968|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44860969|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44860970|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
44860971|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44860972|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860973|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44860974|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
44860975|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44860976|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44860977|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
44860978|NCT01025089|Cisplatin|cisplatin|mesh-list
44860979|NCT01025089|Doxorubicin|doxorubicin|mesh-list
44860980|NCT01025089|Cetuximab|cetuximab|mesh-list
44860981|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44860982|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
44646650|NCT00293059|Dienogest|dienogest|mesh-list
44860983|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44860984|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44860985|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44860986|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
44860987|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44860988|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44860989|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44860990|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44860991|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44860992|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44860993|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44860994|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44860995|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44860996|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44860997|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44860998|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
44860999|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861000|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861001|NCT01004029|Progestins|progestins|mesh-ancestor
44861002|NCT01004029|Hormones|hormones|mesh-ancestor
44861003|NCT00940940|Vaccines|vaccines|mesh-list
44861004|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
44861005|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861006|NCT00754260|Caffeine|caffeine|mesh-list
44861007|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44861008|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861009|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44861010|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861011|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861012|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44861013|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44861014|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
44861015|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861016|NCT00715988|Methadone|methadone|mesh-list
44861017|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44861018|NCT00715988|Narcotics|narcotics|mesh-ancestor
44861019|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861020|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861021|NCT00715988|Analgesics|analgesics|mesh-ancestor
44861022|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
44861023|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861024|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
44861025|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
44861026|NCT00593567|Levofloxacin|levofloxacin|mesh-list
44861027|NCT00593567|Ofloxacin|ofloxacin|mesh-list
44861028|NCT00593567|Gentamicins|gentamicins|mesh-list
44861029|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44861030|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861031|NCT00593567|Renal Agents|renal agents|mesh-ancestor
44861032|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44861033|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44861034|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44861035|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861036|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861037|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861038|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44861039|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44861040|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44861041|NCT00389870|Cyclosporine|cyclosporine|mesh-list
44861042|NCT00389870|Irinotecan|irinotecan|mesh-list
44861043|NCT00389870|Panitumumab|panitumumab|mesh-list
44861044|NCT00389870|Cyclosporins|cyclosporins|mesh-list
44861045|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44861046|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44861047|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861048|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861049|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861050|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861051|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
44861052|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861053|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
44861054|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861055|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861056|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861057|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44861058|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861059|NCT00295646|Tamoxifen|tamoxifen|mesh-list
44861060|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
44861061|NCT00295646|Anastrozole|anastrozole|mesh-list
44861062|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44861063|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44861064|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861065|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861066|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44861067|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861068|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44861069|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44861070|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44861071|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44861072|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44861073|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861074|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861075|NCT00006455|Leucovorin|leucovorin|mesh-list
44861076|NCT00006455|Cytarabine|cytarabine|mesh-list
44861077|NCT00006455|Dexamethasone|dexamethasone|mesh-list
44861078|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
44861079|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44861080|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44861081|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44861082|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
44861083|NCT00006455|Ifosfamide|ifosfamide|mesh-list
44861084|NCT00006455|Doxorubicin|doxorubicin|mesh-list
44861085|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44861086|NCT00006455|Methotrexate|methotrexate|mesh-list
44861087|NCT00006455|Etoposide|etoposide|mesh-list
44861088|NCT00006455|Vinblastine|vinblastine|mesh-list
44861089|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
44861090|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861091|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
44861092|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861093|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861094|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44348109|NCT01067066|Temozolomide|temozolomide|mesh-list
44861095|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
44861096|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861097|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861098|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44861099|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861100|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
44861101|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
44861102|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861103|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861104|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
44861105|NCT00006455|Hormones|hormones|mesh-ancestor
44861106|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861107|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44861108|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44861109|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44861110|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44861111|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861112|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44861113|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
44861114|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646802|NCT00291486|Capecitabine|capecitabine|mesh-list
44861115|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861116|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
44861117|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861118|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861119|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861120|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44861121|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
44861122|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861123|NCT00006455|Antidotes|antidotes|mesh-ancestor
44861124|NCT00006455|Protective Agents|protective agents|mesh-ancestor
44861125|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
44861127|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
44861128|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861129|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861130|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861131|NCT00003716|Rituximab|rituximab|mesh-list
44861132|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861133|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861134|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
44861135|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861136|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861137|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
44861138|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861139|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861140|NCT02975492|Vitamin D|vitamin d|mesh-list
44861141|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
44861142|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
44861143|NCT02975492|Vitamins|vitamins|mesh-list
44861144|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
44861145|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861146|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44861147|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861148|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44861149|NCT02827526|Ketamine|ketamine|mesh-list
44861150|NCT02827526|Analgesics|analgesics|mesh-ancestor
44861151|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
44861152|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861153|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861154|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44861155|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44861156|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
44861157|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
44861158|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861159|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44861160|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44861161|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861162|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861163|NCT02743923|Paclitaxel|paclitaxel|mesh-list
44861164|NCT02743923|Bevacizumab|bevacizumab|mesh-list
44861165|NCT02743923|Cisplatin|cisplatin|mesh-list
44861166|NCT02743923|Carboplatin|carboplatin|mesh-list
44861167|NCT02743923|Pemetrexed|pemetrexed|mesh-list
44861168|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44861169|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861170|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861171|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861172|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861173|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861174|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861175|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44861176|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44861177|NCT02743923|Growth Substances|growth substances|mesh-ancestor
44861178|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861179|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44861180|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861181|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861182|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861183|NCT02735707|Aspirin|aspirin|mesh-list
44861184|NCT02735707|Vitamins|vitamins|mesh-list
44861185|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
44861186|NCT02735707|Interferons|interferons|mesh-list
44861187|NCT02735707|Ritonavir|ritonavir|mesh-list
44861188|NCT02735707|Lopinavir|lopinavir|mesh-list
44861189|NCT02735707|Interferon-beta|interferon-beta|mesh-list
44861190|NCT02735707|Oseltamivir|oseltamivir|mesh-list
44861191|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
44861192|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
44861193|NCT02735707|Amoxicillin|amoxicillin|mesh-list
44861194|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
44861195|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
44861196|NCT02735707|Levofloxacin|levofloxacin|mesh-list
44861197|NCT02735707|Ivermectin|ivermectin|mesh-list
44861198|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
44861199|NCT02735707|Tazobactam|tazobactam|mesh-list
44861200|NCT02735707|Piperacillin|piperacillin|mesh-list
44861201|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
44861202|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44861203|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44861204|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44861205|NCT02735707|Apremilast|apremilast|mesh-list
44861206|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
44861207|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44861208|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44861209|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44861210|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44861211|NCT02735707|Losartan|losartan|mesh-list
44861212|NCT02735707|Valsartan|valsartan|mesh-list
44861213|NCT02735707|Telmisartan|telmisartan|mesh-list
44861214|NCT02735707|Candesartan|candesartan|mesh-list
44861215|NCT02735707|Ramipril|ramipril|mesh-list
44861216|NCT02735707|Olmesartan|olmesartan|mesh-list
44861217|NCT02735707|Enalapril|enalapril|mesh-list
44861218|NCT02735707|Lisinopril|lisinopril|mesh-list
44861219|NCT02735707|Irbesartan|irbesartan|mesh-list
44861220|NCT02735707|Perindopril|perindopril|mesh-list
44861221|NCT02735707|Captopril|captopril|mesh-list
44861222|NCT02735707|Trandolapril|trandolapril|mesh-list
44861223|NCT02735707|Clopidogrel|clopidogrel|mesh-list
44861224|NCT02735707|Ticagrelor|ticagrelor|mesh-list
44861225|NCT02735707|Simvastatin|simvastatin|mesh-list
44861226|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44861227|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
44861228|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44861229|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44861230|NCT02735707|Cysteamine|cysteamine|mesh-list
44861231|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
44861232|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861233|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861234|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861235|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44861236|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44861237|NCT02735707|Analgesics|analgesics|mesh-ancestor
44861238|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
44861239|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861240|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861241|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861242|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44861243|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44861244|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861245|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44861246|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44861247|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
44861248|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44861249|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44861250|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44861251|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44861252|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44861253|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44861254|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44861255|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44861256|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44861257|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44861258|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
44861259|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861260|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44861261|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44861262|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44861263|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
44861264|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44348262|NCT01067677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44861265|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44861266|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44861267|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44861268|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
44861269|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44861270|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44861271|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
44861272|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44861273|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44861274|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44861275|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
44861276|NCT02735707|Protective Agents|protective agents|mesh-ancestor
44861277|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44861278|NCT02735707|Renal Agents|renal agents|mesh-ancestor
44861279|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44861280|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44861281|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44861282|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44861283|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44861284|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44861285|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44861286|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
44861287|NCT02345850|Methotrexate|methotrexate|mesh-list
44861288|NCT02345850|Tacrolimus|tacrolimus|mesh-list
44861289|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861290|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
44861291|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861292|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861293|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44861294|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
44861295|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861296|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861297|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44861298|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44861299|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
44861300|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861301|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861302|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
44861303|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861304|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348304|NCT01067950|Pancrelipase|pancrelipase|mesh-list
44861305|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861306|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861307|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44861308|NCT02109081|Dexamethasone|dexamethasone|mesh-list
44861309|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861310|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
44861311|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
44861312|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861313|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861314|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861315|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
44861316|NCT02109081|Hormones|hormones|mesh-ancestor
44861317|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861318|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44861319|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861320|NCT01962792|Dexamethasone|dexamethasone|mesh-list
44861321|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861322|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
44861323|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
44861324|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861325|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861326|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861327|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
44861328|NCT01962792|Hormones|hormones|mesh-ancestor
44861329|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861330|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44861331|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861332|NCT01546948|Methadone|methadone|mesh-list
44861333|NCT01546948|Hydromorphone|hydromorphone|mesh-list
44861334|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44861335|NCT01546948|Narcotics|narcotics|mesh-ancestor
44861336|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861337|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861338|NCT01546948|Analgesics|analgesics|mesh-ancestor
44861339|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
44861340|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861341|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
44861342|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
44861343|NCT01464164|Prednisone|prednisone|mesh-list
44861344|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647024|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
44861345|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
44861346|NCT01464164|Hormones|hormones|mesh-ancestor
44861347|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861348|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861349|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44861350|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861352|NCT01111565|Citalopram|citalopram|mesh-list
44861353|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44861354|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44861355|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861356|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861357|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861358|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
44861359|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861360|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44861361|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
44861362|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44861363|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44861364|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44861365|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861366|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
44861367|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
44861368|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44861369|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44861370|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44861371|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44861372|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44861373|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44861374|NCT00950989|Folic Acid|folic acid|mesh-list
44861375|NCT00950989|Methotrexate|methotrexate|mesh-list
44861376|NCT00950989|Brodalumab|brodalumab|mesh-list
44861377|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44861378|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
44861379|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861380|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861381|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861382|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
44861383|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861384|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861385|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861386|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861387|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861388|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861389|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
44861390|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861391|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861392|NCT00950989|Hematinics|hematinics|mesh-ancestor
44861393|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
44861394|NCT00950989|Vitamins|vitamins|mesh-ancestor
44861395|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
44861396|NCT05171400|Insulin|insulin|mesh-list
44861397|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44861398|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861399|NCT05171309|Apatinib|apatinib|mesh-list
44861400|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861401|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44861402|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861403|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861404|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
44861405|NCT05170828|Sirolimus|sirolimus|mesh-list
44861406|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
44861407|NCT05170828|Busulfan|busulfan|mesh-list
44861408|NCT05170828|Fludarabine|fludarabine|mesh-list
44861409|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861410|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
44861411|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861412|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861413|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44861414|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
44861415|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861416|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861417|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44861418|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44861419|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44861420|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
44861421|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647098|NCT00288704|Rilonacept|rilonacept|mesh-list
44861422|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861424|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
44861425|NCT05170607|Antibodies|antibodies|mesh-list
44861426|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
44861427|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861428|NCT05170594|Bevacizumab|bevacizumab|mesh-list
44861429|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44861430|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861431|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861432|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44861433|NCT05170594|Growth Substances|growth substances|mesh-ancestor
44861434|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861435|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44861436|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44861437|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861438|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861439|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44861440|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
44861441|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44861442|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861443|NCT05170217|Cannabidiol|cannabidiol|mesh-list
44861444|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
44861445|NCT05170061|Valsartan|valsartan|mesh-list
44861446|NCT05170061|Nebivolol|nebivolol|mesh-list
44861447|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44861448|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44861449|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44861450|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861451|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
44861452|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44861453|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44861454|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44861455|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
44861456|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861457|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861458|NCT05169801|Paclitaxel|paclitaxel|mesh-list
44861459|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44861460|NCT05169801|Carboplatin|carboplatin|mesh-list
44861461|NCT05169801|Bevacizumab|bevacizumab|mesh-list
44861462|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44861463|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861464|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861465|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861466|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861467|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861468|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861469|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44861470|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44861471|NCT05169801|Growth Substances|growth substances|mesh-ancestor
44861472|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861473|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
44861474|NCT05169554|Amoxicillin|amoxicillin|mesh-list
44861475|NCT05169554|Clarithromycin|clarithromycin|mesh-list
44861476|NCT05169554|Rifampin|rifampin|mesh-list
44861477|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
44861478|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
44861479|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44861480|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44861481|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861482|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44861483|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861484|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861485|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44697774|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697775|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697776|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697777|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697778|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697779|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697780|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
44697781|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44697782|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647172|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44348487|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44861486|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44861487|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44861488|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
44861490|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861491|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44861492|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44861493|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44861494|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44861495|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44861496|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44861497|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44647235|NCT00286455|Alogliptin|alogliptin|mesh-list
44861498|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44861499|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861500|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
44861501|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44861502|NCT05169021|Folic Acid|folic acid|mesh-list
44861503|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
44861504|NCT05169021|Amlodipine|amlodipine|mesh-list
44861505|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
44861506|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44861507|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861508|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861509|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861510|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861511|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
44861512|NCT05169021|Hematinics|hematinics|mesh-ancestor
44861513|NCT05169021|Vitamins|vitamins|mesh-ancestor
44861514|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
44861515|NCT05168787|Valsartan|valsartan|mesh-list
44861516|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44861517|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44861518|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44861519|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44861520|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861521|NCT05168475|Rituximab|rituximab|mesh-list
44861522|NCT05168475|Infliximab|infliximab|mesh-list
44861523|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861524|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861525|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
44861526|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861527|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861528|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861529|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861530|NCT05168176|Dolutegravir|dolutegravir|mesh-list
44861531|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44861532|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44861533|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861534|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861535|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44861536|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44861537|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
44861538|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861539|NCT05168137|Colchicine|colchicine|mesh-list
44861540|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
44861541|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861542|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861543|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861544|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861545|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861546|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861547|NCT05168059|Clevidipine|clevidipine|mesh-list
44861548|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44861549|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861550|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861551|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861552|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861553|NCT05168007|Cariprazine|cariprazine|mesh-list
44861554|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44861555|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44861556|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861557|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861558|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44861559|NCT05167851|Lazertinib|lazertinib|mesh-list
44861560|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44861561|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861562|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647311|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44647312|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647313|NCT00285818|Mifepristone|mifepristone|mesh-list
44647329|NCT00285584|Bupropion|bupropion|mesh-list
44861563|NCT05167123|Calcium|calcium|mesh-list
44861564|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861565|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861566|NCT05166668|Letrozole|letrozole|mesh-list
44861567|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861568|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44861569|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44861570|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861571|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861572|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44861573|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44861574|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861575|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861576|NCT05166538|Clopidogrel|clopidogrel|mesh-list
44861577|NCT05166538|Ticagrelor|ticagrelor|mesh-list
44861578|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44861579|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44861580|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44861581|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44861582|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
44861583|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861584|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861585|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861586|NCT05161429|Insulin|insulin|mesh-list
44861587|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348614|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
44861588|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861589|NCT05111912|Liraglutide|liraglutide|mesh-list
44861590|NCT05111912|Glucagon|glucagon|mesh-list
44861591|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44861592|NCT05111912|Incretins|incretins|mesh-ancestor
44861593|NCT05111912|Hormones|hormones|mesh-ancestor
44861594|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861595|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861596|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861597|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44861598|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
44861599|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44861600|NCT05105672|Cisplatin|cisplatin|mesh-list
44861601|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861602|NCT05067920|Antibodies|antibodies|mesh-list
44861603|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
44861604|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861605|NCT05051189|Fentanyl|fentanyl|mesh-list
44861606|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44861607|NCT05051189|Narcotics|narcotics|mesh-ancestor
44861608|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861609|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861610|NCT05051189|Analgesics|analgesics|mesh-ancestor
44861611|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
44861612|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861613|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44861614|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44861615|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
44861616|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
44861617|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44861618|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44861619|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44861620|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44861621|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
44861622|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861623|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44861624|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44861625|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861626|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44861627|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44647379|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861628|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44861629|NCT04929600|Amlodipine|amlodipine|mesh-list
44861630|NCT04929600|Valsartan|valsartan|mesh-list
44861631|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44861632|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44861633|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44861634|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861635|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861636|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861637|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861638|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
44861639|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44861640|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44861641|NCT04928521|Bupivacaine|bupivacaine|mesh-list
44861642|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
44861643|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
44861644|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861645|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861646|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
44861647|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861648|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44861649|NCT04757090|Trastuzumab|trastuzumab|mesh-list
44861650|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861651|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861652|NCT04726969|Ivermectin|ivermectin|mesh-list
44861653|NCT04726969|Albendazole|albendazole|mesh-list
44861654|NCT04726969|Moxidectin|moxidectin|mesh-list
44861655|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44861656|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861657|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
44861658|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
44861659|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44861660|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44861661|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861662|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348706|NCT01069965|BGP 15|bgp 15|mesh-list
44861663|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861664|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861665|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861666|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
44861667|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44861668|NCT04645212|Aflibercept|aflibercept|mesh-list
44861669|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44861670|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44861671|NCT04645212|Growth Substances|growth substances|mesh-ancestor
44861672|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861673|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
44861674|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861675|NCT04632706|Ivermectin|ivermectin|mesh-list
44861676|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44861677|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861678|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44861679|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861680|NCT04588818|Adalimumab|adalimumab|mesh-list
44861681|NCT04588818|Methotrexate|methotrexate|mesh-list
44861682|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44861683|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
44861684|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861685|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861686|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861687|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
44861688|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861689|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861690|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861691|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861692|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861693|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861694|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
44861695|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861696|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861697|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861698|NCT04579510|Vaccines|vaccines|mesh-list
44861699|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
44861700|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861701|NCT04539730|Bupivacaine|bupivacaine|mesh-list
44861702|NCT04539730|Ropivacaine|ropivacaine|mesh-list
44861703|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
44861704|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
44861705|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348722|NCT01070108|Analgesics|analgesics|mesh-ancestor
44861706|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861707|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
44861708|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861709|NCT04535791|Vitamin D|vitamin d|mesh-list
44861710|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
44861711|NCT04535791|Vitamins|vitamins|mesh-ancestor
44861712|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
44861713|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861714|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44861715|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861716|NCT04523246|Vaccines|vaccines|mesh-list
44861717|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
44861718|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861719|NCT04452383|Ketamine|ketamine|mesh-list
44861720|NCT04452383|Propofol|propofol|mesh-list
44861721|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44861722|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861723|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861724|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44861725|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
44861726|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
44861727|NCT04452383|Analgesics|analgesics|mesh-ancestor
44861728|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
44861729|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861730|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44861731|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44861732|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44861733|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861734|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861735|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44861736|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44861737|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44861738|NCT04363840|Aspirin|aspirin|mesh-list
44861739|NCT04363840|Vitamin D|vitamin d|mesh-list
44861740|NCT04363840|Vitamins|vitamins|mesh-ancestor
44861741|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
44861742|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861743|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44861744|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44861745|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44861746|NCT04363840|Analgesics|analgesics|mesh-ancestor
44861747|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
44861748|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861749|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44861750|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861751|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44861752|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44861753|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861754|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44861755|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44861756|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861757|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
44861758|NCT04337060|Lidocaine|lidocaine|mesh-list
44861759|NCT04337060|Morphine|morphine|mesh-list
44861760|NCT04337060|Bupivacaine|bupivacaine|mesh-list
44861761|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
44861762|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
44861763|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861764|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861765|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
44861766|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861767|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44861768|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44861769|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44861770|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861771|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861772|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44861773|NCT04337060|Narcotics|narcotics|mesh-ancestor
44861774|NCT04337060|Analgesics|analgesics|mesh-ancestor
44861775|NCT04330183|Ketamine|ketamine|mesh-list
44861776|NCT04330183|Analgesics|analgesics|mesh-ancestor
44861777|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
44861778|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861779|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861780|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44861781|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44861782|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
44861783|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
44861784|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861785|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44861786|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44861787|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861788|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861789|NCT04300595|Anesthetics|anesthetics|mesh-list
44861790|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861791|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861792|NCT04297293|Ramosetron|ramosetron|mesh-list
44861793|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
44861794|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
44861795|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861796|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861797|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44861798|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44861799|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
44861800|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861801|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861802|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
44861803|NCT04295863|Nivolumab|nivolumab|mesh-list
44861804|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861805|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861806|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44861807|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647613|NCT00282256|Tacrolimus|tacrolimus|mesh-list
44861808|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
44861809|NCT04249297|Progestins|progestins|mesh-ancestor
44861810|NCT04249297|Hormones|hormones|mesh-ancestor
44861811|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861812|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861813|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
44861814|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44861815|NCT04167761|Glipizide|glipizide|mesh-list
44861816|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861817|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44861818|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861819|NCT04147546|Artenimol|artenimol|mesh-list
44861820|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
44861821|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44861822|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44861823|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861824|NCT04035837|Interferons|interferons|mesh-list
44861825|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
44861826|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861827|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
44861828|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861829|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
44861830|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861831|NCT03991403|Paclitaxel|paclitaxel|mesh-list
44861832|NCT03991403|Bevacizumab|bevacizumab|mesh-list
44861833|NCT03991403|Cisplatin|cisplatin|mesh-list
44861834|NCT03991403|Carboplatin|carboplatin|mesh-list
44861835|NCT03991403|Pemetrexed|pemetrexed|mesh-list
44861836|NCT03991403|Atezolizumab|atezolizumab|mesh-list
44861837|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44861838|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861839|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861840|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861841|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861842|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861843|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861844|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44861845|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44861846|NCT03991403|Growth Substances|growth substances|mesh-ancestor
44861847|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861848|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
44861849|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861850|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861851|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44861852|NCT03905902|Vaccines|vaccines|mesh-list
44861853|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
44861854|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861855|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
44861856|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861857|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861858|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
44861859|NCT03858049|Progestins|progestins|mesh-ancestor
44861860|NCT03858049|Hormones|hormones|mesh-ancestor
44861861|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861862|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861863|NCT03852888|Methotrexate|methotrexate|mesh-list
44861864|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
44861865|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44861866|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
44861867|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861868|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861869|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861870|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
44861871|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861872|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861873|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44861874|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861875|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44861876|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861877|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
44861878|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861879|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44647679|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44861880|NCT03823365|Blinatumomab|blinatumomab|mesh-list
44861881|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861882|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
44861883|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44861884|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
44861885|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861886|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348927|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861887|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44861888|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44861889|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44861890|NCT05239390|Dronabinol|dronabinol|mesh-list
44861891|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
44861892|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861893|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44861894|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44861895|NCT05239390|Analgesics|analgesics|mesh-ancestor
44861896|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
44861897|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861898|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44861899|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44861900|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44861901|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861902|NCT05239390|Hormones|hormones|mesh-ancestor
44861903|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44861904|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
44861905|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44861906|NCT05239078|Anesthetics|anesthetics|mesh-list
44861907|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
44861908|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861909|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861910|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
44861911|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861912|NCT05238727|Mepivacaine|mepivacaine|mesh-list
44861913|NCT05238727|Carticaine|carticaine|mesh-list
44861914|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
44861915|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
44861916|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861917|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861918|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
44861919|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861920|NCT05238467|Antibodies|antibodies|mesh-list
44861921|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
44861922|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861923|NCT05238220|Valganciclovir|valganciclovir|mesh-list
44861924|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
44861925|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861926|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
44861927|NCT05238064|Doxorubicin|doxorubicin|mesh-list
44861928|NCT05238064|Vincristine|vincristine|mesh-list
44861929|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861930|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
44861931|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861932|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348944|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44861933|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44861934|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
44861935|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861936|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861937|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44861938|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44861939|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44861940|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44861941|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861942|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44861943|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
44861944|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
44861945|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
44861946|NCT05238012|Atorvastatin|atorvastatin|mesh-list
44861947|NCT05238012|Calcium|calcium|mesh-list
44861948|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861949|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861950|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44861951|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44861952|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
44861953|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861954|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44861955|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44861956|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861957|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
44861959|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861960|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861961|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
44861962|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44861963|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44861964|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861965|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
44861966|NCT05237791|Analgesics|analgesics|mesh-ancestor
44861967|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
44861968|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44861969|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861970|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
44861971|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44861972|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44861973|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
44861974|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44861975|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44861976|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861977|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44861978|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
44861979|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44861980|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
44861981|NCT05237323|Azathioprine|azathioprine|mesh-list
44861982|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44861983|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44861984|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44861985|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
44861986|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44861987|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44861988|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44861989|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44861990|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
44861991|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44861992|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44861993|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
44861994|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861995|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44861996|NCT05215990|Metformin|metformin|mesh-list
44861997|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44861998|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44861999|NCT05215834|Remifentanil|remifentanil|mesh-list
44862000|NCT05215834|Propofol|propofol|mesh-list
44862001|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44862002|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862003|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862004|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44862005|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
44862006|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
44862007|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44862008|NCT05215834|Narcotics|narcotics|mesh-ancestor
44862009|NCT05215834|Analgesics|analgesics|mesh-ancestor
44862010|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
44862011|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862012|NCT05214183|Rituximab|rituximab|mesh-list
44862013|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
44862014|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862015|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862016|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
44862017|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862018|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862019|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
44862020|NCT05181527|Serotonin|serotonin|mesh-list
44862021|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44862022|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
44862023|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862024|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44862025|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44862026|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862027|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862028|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862029|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44862030|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
44862031|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44862032|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862033|NCT05097768|Dexamethasone|dexamethasone|mesh-list
44862034|NCT05097768|Ibuprofen|ibuprofen|mesh-list
44862035|NCT05097768|Ketorolac|ketorolac|mesh-list
44862036|NCT05097768|Meloxicam|meloxicam|mesh-list
44862037|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862038|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
44862039|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
44862040|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862041|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862042|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44862043|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
44862044|NCT05097768|Hormones|hormones|mesh-ancestor
44862045|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862046|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44862047|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862048|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44862049|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44862050|NCT05097768|Analgesics|analgesics|mesh-ancestor
44862051|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
44862052|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862053|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44862054|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862055|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862056|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44862057|NCT05093582|Cromakalim|cromakalim|mesh-list
44862058|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44862059|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862060|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
44862061|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862062|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862063|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862064|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862065|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
44862066|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
44862067|NCT05040282|Etonogestrel|etonogestrel|mesh-list
44862068|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44862069|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
44862070|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44862071|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862072|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44862073|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
44862074|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44862075|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
44862076|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862077|NCT04982172|Infliximab|infliximab|mesh-list
44862078|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44862079|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44862080|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862081|NCT04978272|Piperaquine|piperaquine|mesh-list
44862082|NCT04978272|Artenimol|artenimol|mesh-list
44862083|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
44862084|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44862085|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44862086|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862087|NCT04817410|Naltrexone|naltrexone|mesh-list
44862088|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44862089|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44862090|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862091|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
44862092|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862093|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
44862094|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
44862095|NCT04770012|Aspirin|aspirin|mesh-list
44862096|NCT04770012|Clopidogrel|clopidogrel|mesh-list
44862097|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44862098|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44862099|NCT04770012|Analgesics|analgesics|mesh-ancestor
44862100|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
44862101|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862102|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862103|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862104|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862105|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44862106|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44862107|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862108|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44862109|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44862110|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862111|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
44862112|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44862113|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44862114|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44862115|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
44862116|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862117|NCT04760626|Insulin|insulin|mesh-list
44862118|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44862119|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
44862120|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44862121|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862122|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
44862123|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44862124|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
44862125|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862126|NCT04755972|Expectorants|expectorants|mesh-ancestor
44862127|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862128|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44862129|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
44862130|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862131|NCT04755972|Protective Agents|protective agents|mesh-ancestor
44862132|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862134|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44862135|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44862136|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862137|NCT04709250|Bupivacaine|bupivacaine|mesh-list
44862138|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
44862139|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
44862140|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862141|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862142|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
44862143|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862144|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44862145|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44862146|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862147|NCT04652245|Fluticasone|fluticasone|mesh-list
44862148|NCT04652245|Xhance|xhance|mesh-list
44862149|NCT04652245|Azelastine|azelastine|mesh-list
44862150|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862151|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862152|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
44862153|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862154|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862155|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862156|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
44349190|NCT01072071|Furosemide|furosemide|mesh-list
44862157|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
44862158|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44862159|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44862160|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862161|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862162|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44862163|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44862164|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
44862165|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
44862166|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862167|NCT04647643|Paclitaxel|paclitaxel|mesh-list
44862168|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44862169|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862170|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44862171|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44862172|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44862173|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862174|NCT04631536|Folic Acid|folic acid|mesh-list
44862175|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
44862176|NCT04631536|Nicorandil|nicorandil|mesh-list
44862177|NCT04631536|Nebivolol|nebivolol|mesh-list
44862178|NCT04631536|Atorvastatin|atorvastatin|mesh-list
44862179|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862180|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862181|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
44862182|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862183|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862184|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862185|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862186|NCT04631536|Hematinics|hematinics|mesh-ancestor
44862187|NCT04631536|Vitamins|vitamins|mesh-ancestor
44862188|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
44862189|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862190|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44862191|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
44862192|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44862193|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44862194|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44862195|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44862196|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862197|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44862198|NCT04567992|Bupivacaine|bupivacaine|mesh-list
44862199|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
44862200|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
44862201|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862202|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862203|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
44862204|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862205|NCT04565600|Etoricoxib|etoricoxib|mesh-list
44862206|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44862207|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44862208|NCT04565600|Analgesics|analgesics|mesh-ancestor
44862209|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
44862210|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862211|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862212|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862213|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862214|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44862215|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44862216|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862217|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862218|NCT04501211|Granisetron|granisetron|mesh-list
44862219|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
44862220|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
44862221|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862222|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862223|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44862224|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44862225|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
44862226|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862227|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862228|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
44862229|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
44862230|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44862231|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44862232|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862233|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862234|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862235|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862236|NCT04409262|Remdesivir|remdesivir|mesh-list
44862237|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
44697783|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697784|NCT03040726|Palonosetron|palonosetron|mesh-list
44697785|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
44697786|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
44697787|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349257|NCT01072786|Vaccines|vaccines|mesh-list
44697788|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697789|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697790|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44697791|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44697792|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
44697793|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697794|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249358|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
44697795|NCT02607956|Dolutegravir|dolutegravir|mesh-list
44697796|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44697797|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44697798|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44697799|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697800|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697801|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44697802|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44697803|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
44697804|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697805|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44697806|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44697807|NCT02499666|Clopidogrel|clopidogrel|mesh-list
44697808|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44697809|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44697810|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44697811|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44697812|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
44697813|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697814|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697815|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697816|NCT02420912|Nivolumab|nivolumab|mesh-list
44697817|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44697818|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697819|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44697820|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697821|NCT02094716|Permethrin|permethrin|mesh-list
44697822|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697823|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697824|NCT01460810|Silicon|silicon|mesh-list
44862238|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862239|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
44862240|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862241|NCT04330430|Nivolumab|nivolumab|mesh-list
44862242|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862243|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862244|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44862245|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862246|NCT03994146|Remifentanil|remifentanil|mesh-list
44862247|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44862248|NCT03994146|Narcotics|narcotics|mesh-ancestor
44862249|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862250|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862251|NCT03994146|Analgesics|analgesics|mesh-ancestor
44862252|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
44862253|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862254|NCT03987919|Tirzepatide|tirzepatide|mesh-list
44862255|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44862256|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862257|NCT03987919|Incretins|incretins|mesh-ancestor
44862259|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862260|NCT03861039|Tirzepatide|tirzepatide|mesh-list
44862261|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44862262|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862263|NCT03861039|Incretins|incretins|mesh-ancestor
44862264|NCT03861039|Hormones|hormones|mesh-ancestor
44862265|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862266|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
44862267|NCT03730662|Tirzepatide|tirzepatide|mesh-list
44862268|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44862269|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862270|NCT03730662|Incretins|incretins|mesh-ancestor
44862271|NCT03730662|Hormones|hormones|mesh-ancestor
44862272|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862273|NCT03717623|Posaconazole|posaconazole|mesh-list
44862274|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
44862275|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862276|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44862277|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44862278|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44862279|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44862280|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44862281|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862282|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862283|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44862284|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44349357|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
44862285|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862286|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862287|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44862288|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44862289|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862290|NCT03613506|Captopril|captopril|mesh-list
44862291|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44862292|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
44862293|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862294|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862295|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44862296|NCT03537833|Pemetrexed|pemetrexed|mesh-list
44862297|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862298|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862299|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862300|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44862301|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44862302|NCT03439085|Durvalumab|durvalumab|mesh-list
44862303|NCT03439085|Interleukin-12|interleukin-12|mesh-list
44862304|NCT03439085|Vaccines|vaccines|mesh-list
44862305|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
44862306|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44862307|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
44862308|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
44862309|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862310|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862311|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862312|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44862313|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44862314|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44862315|NCT03439085|Growth Substances|growth substances|mesh-ancestor
44862316|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
44862317|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
44862318|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44862319|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
44862320|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862322|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862323|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44862324|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
44862325|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862326|NCT03252925|Protective Agents|protective agents|mesh-ancestor
44862327|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862328|NCT03252925|Antidotes|antidotes|mesh-ancestor
44862329|NCT02976337|Naloxone|naloxone|mesh-list
44862330|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44862331|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862332|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
44862333|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862334|NCT02963714|Vaccines|vaccines|mesh-list
44862335|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
44862336|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862337|NCT02959918|Sirolimus|sirolimus|mesh-list
44862338|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44862339|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862340|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44862341|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862342|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
44862343|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44862344|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
44862345|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862346|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
44862347|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
44862348|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862349|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
44862350|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862351|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862352|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44862353|NCT02817789|Clopidogrel|clopidogrel|mesh-list
44862354|NCT02817789|Ticagrelor|ticagrelor|mesh-list
44862355|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44862356|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44862357|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44862358|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44862359|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
44862360|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862361|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862362|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862363|NCT02817789|Analgesics|analgesics|mesh-ancestor
44862364|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
44862365|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862366|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44862367|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44862368|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862369|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862370|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44862371|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862372|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
44862373|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44862374|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862375|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
44862376|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862377|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862378|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862379|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862380|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
44862381|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44862382|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349448|NCT01073683|Cisplatin|cisplatin|mesh-list
44862383|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862384|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862385|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
44862386|NCT02813200|Hormones|hormones|mesh-ancestor
44862387|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862388|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
44862389|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
44862390|NCT02744742|Busulfan|busulfan|mesh-list
44862391|NCT02744742|Decitabine|decitabine|mesh-list
44648310|NCT00272987|Paclitaxel|paclitaxel|mesh-list
44862392|NCT02744742|Lenograstim|lenograstim|mesh-list
44862393|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44862394|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
44862395|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862396|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862397|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44862398|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
44862399|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862400|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862401|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44862402|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44862403|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
44862404|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862405|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44862406|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
44862407|NCT02687386|Analgesics|analgesics|mesh-ancestor
44862408|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
44862409|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862410|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862411|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862412|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44862413|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44862414|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862415|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862416|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
44862417|NCT02678143|Sirolimus|sirolimus|mesh-list
44862418|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
44862419|NCT02678143|Fludarabine|fludarabine|mesh-list
44862420|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
44862421|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44862422|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
44862423|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862424|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862425|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44862426|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
44862427|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862428|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862429|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44862430|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44862431|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44862432|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
44862433|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44862434|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862435|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862436|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
44862437|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862438|NCT02479646|Lenograstim|lenograstim|mesh-list
44862439|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44862440|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
44862441|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862442|NCT02472964|Paclitaxel|paclitaxel|mesh-list
44862443|NCT02472964|Docetaxel|docetaxel|mesh-list
44862444|NCT02472964|Trastuzumab|trastuzumab|mesh-list
44862445|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44862446|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862447|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44862448|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44862449|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44862450|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862451|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862452|NCT02467868|Lenograstim|lenograstim|mesh-list
44862453|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44862454|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
44862455|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862456|NCT02421263|Psilocybin|psilocybin|mesh-list
44862457|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
44862458|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862459|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44862460|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
44862461|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862462|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862463|NCT01889303|Docetaxel|docetaxel|mesh-list
44862464|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862465|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
44862466|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
44862467|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
44862468|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862469|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
44862470|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
44862471|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862472|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
44862473|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862474|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862475|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862476|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862477|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44862478|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44862479|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44862480|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
44862481|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862482|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862483|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862484|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
44862485|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44862486|NCT01104922|Cetuximab|cetuximab|mesh-list
44862487|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862488|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862489|NCT00862251|Atorvastatin|atorvastatin|mesh-list
44862490|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44862491|NCT00862251|Simvastatin|simvastatin|mesh-list
44862492|NCT00862251|Ezetimibe|ezetimibe|mesh-list
44862493|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862494|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862495|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
44862496|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862497|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862498|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862499|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862500|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44862501|NCT00783263|Ezetimibe|ezetimibe|mesh-list
44862502|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862503|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862504|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
44862505|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862506|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862507|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862508|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862509|NCT00782184|Atorvastatin|atorvastatin|mesh-list
44862510|NCT00782184|Simvastatin|simvastatin|mesh-list
44862511|NCT00782184|Ezetimibe|ezetimibe|mesh-list
44862512|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44862513|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862514|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862515|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
44862516|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862517|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862518|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862519|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862520|NCT00664937|Montelukast|montelukast|mesh-list
44862521|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862522|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862523|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862524|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862525|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862526|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862527|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862528|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862529|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862530|NCT00586391|Ipilimumab|ipilimumab|mesh-list
44862531|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862532|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862533|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44862534|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862535|NCT00545324|Fluticasone|fluticasone|mesh-list
44862536|NCT00545324|Montelukast|montelukast|mesh-list
44862537|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862538|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862539|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
44862540|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862541|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862542|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862543|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862544|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
44862545|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44862546|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862547|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862548|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862549|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862550|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862551|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862552|NCT00540839|Fluticasone|fluticasone|mesh-list
44862553|NCT00540839|Xhance|xhance|mesh-list
44862554|NCT00540839|Montelukast|montelukast|mesh-list
44862555|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862556|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862557|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
44862558|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862559|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862560|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862561|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862562|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44862563|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44862564|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862565|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862566|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862567|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862568|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862569|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862570|NCT00535405|Atorvastatin|atorvastatin|mesh-list
44862571|NCT00535405|Simvastatin|simvastatin|mesh-list
44862572|NCT00535405|Ezetimibe|ezetimibe|mesh-list
44862573|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862574|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862575|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
44862576|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862577|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862578|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862579|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862580|NCT00496730|Atorvastatin|atorvastatin|mesh-list
44862581|NCT00496730|Simvastatin|simvastatin|mesh-list
44862582|NCT00496730|Ezetimibe|ezetimibe|mesh-list
44862583|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862584|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862585|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
44862586|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862587|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862588|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862589|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862590|NCT00462748|Atorvastatin|atorvastatin|mesh-list
44862591|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44862592|NCT00462748|Simvastatin|simvastatin|mesh-list
44862593|NCT00462748|Ezetimibe|ezetimibe|mesh-list
44862594|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862595|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862596|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
44862597|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862598|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862599|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862600|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862601|NCT00446186|Montelukast|montelukast|mesh-list
44349664|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44862602|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862603|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862604|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862605|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862606|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862607|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862608|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862609|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862610|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862611|NCT00445107|Montelukast|montelukast|mesh-list
44862612|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862613|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862614|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862615|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862616|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862617|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862618|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862619|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862620|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862621|NCT00418834|Atorvastatin|atorvastatin|mesh-list
44862622|NCT00418834|Ezetimibe|ezetimibe|mesh-list
44862623|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862624|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862625|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
44862626|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862627|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862628|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862629|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862630|NCT00409773|Atorvastatin|atorvastatin|mesh-list
44862631|NCT00409773|Simvastatin|simvastatin|mesh-list
44862632|NCT00409773|Ezetimibe|ezetimibe|mesh-list
44862633|NCT00409773|Calcium|calcium|mesh-list
44862634|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44862635|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862636|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862637|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862638|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
44862639|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862640|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862641|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862642|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862643|NCT00398151|Montelukast|montelukast|mesh-list
44862644|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862645|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862646|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862647|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862648|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862649|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862650|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862651|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862652|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862653|NCT00394160|Montelukast|montelukast|mesh-list
44862654|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862655|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862656|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862657|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862658|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862659|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862660|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862661|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862662|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862663|NCT00380705|Montelukast|montelukast|mesh-list
44862664|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862665|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862666|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862667|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862668|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862669|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862670|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862671|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862672|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862673|NCT00271817|Niacin|niacin|mesh-list
44862674|NCT00271817|Niacinamide|niacinamide|mesh-list
44862675|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
44862676|NCT00271817|Simvastatin|simvastatin|mesh-list
44862677|NCT00271817|Ezetimibe|ezetimibe|mesh-list
44862678|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44862679|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44862680|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44862681|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
44862682|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862683|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44862684|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44862685|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862686|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44862687|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
44862688|NCT00271817|Vitamins|vitamins|mesh-ancestor
44862689|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
44862690|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862691|NCT00127647|Montelukast|montelukast|mesh-list
44862692|NCT00127647|Pranlukast|pranlukast|mesh-list
44648701|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
44862694|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862695|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862696|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862697|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862698|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862699|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862700|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862701|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862702|NCT00092989|Montelukast|montelukast|mesh-list
44862703|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862704|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862705|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862706|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862707|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862708|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862709|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862710|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862711|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862712|NCT00092144|Montelukast|montelukast|mesh-list
44862713|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862714|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862715|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862716|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862717|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44862718|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
44862719|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862720|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44862721|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44862722|NCT03754153|Atropine|atropine|mesh-list
44862723|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44862724|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44862725|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44862726|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
44862727|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862728|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862729|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44862730|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
44862731|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
44862732|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
44862733|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44862734|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44862735|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
44862736|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862737|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862738|NCT03731923|Liver Extracts|liver extracts|mesh-list
44862739|NCT03731923|Hematinics|hematinics|mesh-ancestor
44862740|NCT03727633|Idarubicin|idarubicin|mesh-list
44862741|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
44862742|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44862743|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862744|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44862745|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44862746|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862747|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862748|NCT03713086|Vaccines|vaccines|mesh-list
44862749|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
44862750|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862751|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
44862752|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44349836|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
44862753|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
44862754|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862755|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
44862756|NCT03697876|Protective Agents|protective agents|mesh-ancestor
44862757|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
44862758|NCT03690765|Progestins|progestins|mesh-ancestor
44862759|NCT03690765|Hormones|hormones|mesh-ancestor
44862760|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862761|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862762|NCT03636451|Lidocaine|lidocaine|mesh-list
44862763|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
44862764|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
44862765|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862766|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862767|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
44862768|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862769|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44862770|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44862771|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44862772|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862773|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862774|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44862775|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44862776|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862777|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862778|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44862779|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862780|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862781|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
44862782|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862783|NCT03493126|Estradiol|estradiol|mesh-list
44862784|NCT03493126|Estrogens|estrogens|mesh-ancestor
44862785|NCT03493126|Hormones|hormones|mesh-ancestor
44862786|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862787|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862788|NCT03460015|Propofol|propofol|mesh-list
44862789|NCT03460015|Sevoflurane|sevoflurane|mesh-list
44862790|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44862791|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862792|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862793|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44862794|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
44862795|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
44862796|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44862797|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44862798|NCT03339284|Dexamethasone|dexamethasone|mesh-list
44862799|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
44862800|NCT03339284|Ropivacaine|ropivacaine|mesh-list
44862801|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44862802|NCT03339284|BB 1101|bb 1101|mesh-list
44862803|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862804|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
44862805|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
44862806|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862807|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862808|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44862809|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
44862810|NCT03339284|Hormones|hormones|mesh-ancestor
44862811|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862812|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44862813|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862814|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
44862815|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
44862816|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44862817|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
44862818|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44862819|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862820|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862821|NCT03316586|Nivolumab|nivolumab|mesh-list
44862822|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862823|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862824|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44862825|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862826|NCT03268811|Teduglutide|teduglutide|mesh-list
44862827|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44862828|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44862829|NCT03268811|Protective Agents|protective agents|mesh-ancestor
44862830|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862831|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
44862832|NCT03231085|Trace Elements|trace elements|mesh-ancestor
44862833|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
44862834|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862835|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
44862836|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862837|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648835|NCT00265317|Sunitinib|sunitinib|mesh-list
44862838|NCT03110744|Palbociclib|palbociclib|mesh-list
44862839|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862840|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44862841|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862842|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862843|NCT03093246|Aspirin|aspirin|mesh-list
44862844|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44862845|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44862846|NCT03093246|Analgesics|analgesics|mesh-ancestor
44862847|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
44862848|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862849|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862850|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44862851|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44862852|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44862853|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44862854|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862855|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44862856|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44862857|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862858|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
44862859|NCT03090997|Vitamins|vitamins|mesh-list
44862860|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
44862861|NCT03090997|Resveratrol|resveratrol|mesh-list
44862862|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
44862863|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862864|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
44862865|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862866|NCT03090997|Protective Agents|protective agents|mesh-ancestor
44862867|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862868|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44862869|NCT02970500|Methylphenidate|methylphenidate|mesh-list
44862870|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44862871|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862872|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44862873|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44862874|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862875|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862876|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
44862877|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862878|NCT02969928|Amoxicillin|amoxicillin|mesh-list
44862879|NCT02969928|Metronidazole|metronidazole|mesh-list
44862880|NCT02969928|Clarithromycin|clarithromycin|mesh-list
44862881|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44862882|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862883|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44862884|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44862885|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44862886|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862887|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862888|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44862889|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44862890|NCT02968446|Vitamin D|vitamin d|mesh-list
44862891|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
44862892|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
44862893|NCT02968446|Vitamins|vitamins|mesh-ancestor
44862894|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
44862895|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862896|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44862897|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44862898|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
44697825|NCT01460810|Trace Elements|trace elements|mesh-ancestor
44697826|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
44697827|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697828|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
44697829|NCT01175356|Melphalan|melphalan|mesh-list
44697830|NCT01175356|Busulfan|busulfan|mesh-list
44697831|NCT01175356|Doxorubicin|doxorubicin|mesh-list
44697832|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44697833|NCT01175356|Etoposide|etoposide|mesh-list
44697834|NCT01175356|Vincristine|vincristine|mesh-list
44697835|NCT01175356|Topotecan|topotecan|mesh-list
44697836|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
44697837|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44697838|NCT01175356|Isotretinoin|isotretinoin|mesh-list
44697839|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697840|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
44862899|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862900|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44862901|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862902|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
44862903|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862904|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862905|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
44862906|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
44862907|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862908|NCT02857426|Nivolumab|nivolumab|mesh-list
44862909|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44862910|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862911|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44862912|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862913|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
44862914|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44862915|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44862916|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
44862917|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648969|NCT00264238|Memantine|memantine|mesh-list
44862918|NCT02678533|Plerixafor|plerixafor|mesh-list
44862919|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44862920|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44862921|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
44862922|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862923|NCT02591147|Fluorides|fluorides|mesh-list
44862924|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
44862925|NCT02591147|Protective Agents|protective agents|mesh-ancestor
44862926|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862927|NCT02527798|Furosemide|furosemide|mesh-list
44862928|NCT02527798|Diuretics|diuretics|mesh-ancestor
44862929|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
44862930|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862931|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44862932|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862933|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862934|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44862935|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44862936|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862937|NCT02346630|Levodopa|levodopa|mesh-list
44862938|NCT02346630|Carbidopa|carbidopa|mesh-list
44862939|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44862940|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44862941|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
44862942|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862943|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862944|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862945|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44862946|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862947|NCT02067975|Tryptophan|tryptophan|mesh-list
44862948|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44862949|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
44862950|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44862951|NCT01964807|Nicotine|nicotine|mesh-list
44862952|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44862953|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
44862954|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44862955|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862956|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44862957|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44862958|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44862959|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862960|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862961|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
44862962|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44862963|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44862964|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44862965|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44862966|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44862967|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862968|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862969|NCT01907360|Methylphenidate|methylphenidate|mesh-list
44862970|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44862971|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862972|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44862973|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44862974|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44862975|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44862976|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
44862977|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44862978|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44862979|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
44862980|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
44862981|NCT01873170|Etonogestrel|etonogestrel|mesh-list
44862982|NCT01873170|Desogestrel|desogestrel|mesh-list
44862983|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
44862984|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44862985|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44862986|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44862987|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44862988|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44862989|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44350090|NCT01076478|Cilostazol|cilostazol|mesh-list
44862990|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44862991|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44862992|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44862993|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44862994|NCT01873170|Progestins|progestins|mesh-ancestor
44862995|NCT01873170|Hormones|hormones|mesh-ancestor
44862996|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44862997|NCT01481272|Leucovorin|leucovorin|mesh-list
44862998|NCT01481272|Cytarabine|cytarabine|mesh-list
44862999|NCT01481272|Methotrexate|methotrexate|mesh-list
44863000|NCT01481272|Etoposide|etoposide|mesh-list
44863001|NCT01481272|Ofatumumab|ofatumumab|mesh-list
44863002|NCT01481272|Lenograstim|lenograstim|mesh-list
44863003|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44863004|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
44863005|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44863006|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863007|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863008|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
44863009|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863010|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863011|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
44863012|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863013|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44863014|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863015|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
44863016|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44863017|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44863018|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44863019|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44863020|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44863021|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
44863022|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863023|NCT01481272|Antidotes|antidotes|mesh-ancestor
44863024|NCT01481272|Protective Agents|protective agents|mesh-ancestor
44863025|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
44863026|NCT01481272|Vitamins|vitamins|mesh-ancestor
44863027|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
44863028|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44863029|NCT01380028|Prednisone|prednisone|mesh-list
44863030|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863031|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
44863032|NCT01380028|Hormones|hormones|mesh-ancestor
44863033|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863034|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863035|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863036|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863037|NCT01305460|Azacitidine|azacitidine|mesh-list
44863038|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863039|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
44863040|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863041|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863042|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863043|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
44863044|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44863045|NCT01300143|Estrogens|estrogens|mesh-ancestor
44863046|NCT01300143|Hormones|hormones|mesh-ancestor
44863047|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863048|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863049|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863050|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863051|NCT01199302|Brodalumab|brodalumab|mesh-list
44863052|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44863053|NCT01164995|Carboplatin|carboplatin|mesh-list
44863054|NCT01164995|Adavosertib|adavosertib|mesh-list
44863055|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863056|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863057|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863058|NCT01123707|Aripiprazole|aripiprazole|mesh-list
44863059|NCT01123707|Citalopram|citalopram|mesh-list
44863060|NCT01123707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44863061|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44863062|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863063|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863064|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863065|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
44863066|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863067|NCT01123707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44863068|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44863069|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44863070|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44863071|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44863072|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863073|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
44863074|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
44863075|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44863076|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44863077|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44863078|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44863079|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44863080|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44863081|NCT00999401|Roscovitine|roscovitine|mesh-list
44863082|NCT00999401|Sapacitabine|sapacitabine|mesh-list
44863083|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863084|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
44863085|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863086|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863087|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863088|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863089|NCT00885963|Sapacitabine|sapacitabine|mesh-list
44863090|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863091|NCT00725127|Aspirin|aspirin|mesh-list
44863092|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44863093|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863094|NCT00725127|Analgesics|analgesics|mesh-ancestor
44863095|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
44863096|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863097|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863098|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863099|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44863100|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44863101|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44863102|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863103|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44863104|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44863105|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863106|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
44863107|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
44863108|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44863109|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863110|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44863111|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863112|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863113|NCT00372073|Roscovitine|roscovitine|mesh-list
44863114|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863115|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
44863116|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863117|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863118|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863119|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863120|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
44863121|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44863122|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
44863123|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863124|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
44863125|NCT00225095|Protective Agents|protective agents|mesh-ancestor
44863126|NCT00038727|Metformin|metformin|mesh-list
44863127|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44863128|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863129|NCT05174195|Desogestrel|desogestrel|mesh-list
44863130|NCT05174195|Etonogestrel|etonogestrel|mesh-list
44863131|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44863132|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44863133|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44863134|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
44863135|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44863136|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863137|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44863138|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44863139|NCT05174195|Progestins|progestins|mesh-ancestor
44863140|NCT05174195|Hormones|hormones|mesh-ancestor
44863141|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863142|NCT05173584|Albuterol|albuterol|mesh-list
44863143|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44863144|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
44863145|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863146|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863147|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44863148|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44863149|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
44863150|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44863151|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44863152|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44863153|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863154|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863155|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863156|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863157|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
44863158|NCT05173545|Analgesics|analgesics|mesh-ancestor
44863159|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
44863160|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863161|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863162|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863163|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44863164|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44863165|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350258|NCT01077453|Letrozole|letrozole|mesh-list
44863166|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863167|NCT05173337|Nefopam|nefopam|mesh-list
44863168|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863169|NCT05173337|Analgesics|analgesics|mesh-ancestor
44863170|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
44863171|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863172|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863173|NCT05173246|Paclitaxel|paclitaxel|mesh-list
44863174|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44863175|NCT05173246|Cisplatin|cisplatin|mesh-list
44863176|NCT05173246|Carboplatin|carboplatin|mesh-list
44863177|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44863178|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863179|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863180|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863181|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863182|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863183|NCT05173090|Ropivacaine|ropivacaine|mesh-list
44863184|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
44863185|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
44863186|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863187|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863188|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
44863189|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863190|NCT05172934|Tenecteplase|tenecteplase|mesh-list
44863191|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44863192|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44863193|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649275|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863194|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
44863195|NCT05172739|Anesthetics|anesthetics|mesh-list
44863196|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863197|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863198|NCT05172739|Narcotics|narcotics|mesh-ancestor
44863199|NCT05172739|Analgesics|analgesics|mesh-ancestor
44863200|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
44863201|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863202|NCT05172570|Gabapentin|gabapentin|mesh-list
44863203|NCT05172570|Analgesics|analgesics|mesh-ancestor
44863204|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
44863205|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863206|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863207|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
44863208|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44863209|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44863210|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863211|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44863212|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44863213|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44863214|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863215|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863216|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
44863217|NCT05172518|Capecitabine|capecitabine|mesh-list
44863219|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863220|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
44863221|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863222|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863223|NCT05172440|Axitinib|axitinib|mesh-list
44863224|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863225|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863226|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863227|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863228|NCT05172310|FAPI-46|fapi-46|mesh-list
44863229|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44863230|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863231|NCT05172115|Heparin|heparin|mesh-list
44863232|NCT05172115|Enoxaparin|enoxaparin|mesh-list
44863233|NCT05172115|Plasminogen|plasminogen|mesh-list
44863234|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44863235|NCT05172115|Tinzaparin|tinzaparin|mesh-list
44863236|NCT05172115|Dalteparin|dalteparin|mesh-list
44863237|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44863238|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
44863239|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44863240|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44863241|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863242|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
44863243|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44863244|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863245|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863246|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863247|NCT05171985|Analgesics|analgesics|mesh-ancestor
44863248|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
44863249|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863250|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44863251|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44863252|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863253|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863254|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863255|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863256|NCT05171751|Octreotide|octreotide|mesh-list
44863257|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863258|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863259|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863260|NCT05171660|Capecitabine|capecitabine|mesh-list
44863261|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
44863262|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863263|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863264|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
44863265|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863266|NCT05171530|Lenvatinib|lenvatinib|mesh-list
44863267|NCT05171530|Taxane|taxane|mesh-list
44863268|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863269|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863270|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863271|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863272|NCT05151588|Docetaxel|docetaxel|mesh-list
44863273|NCT05151588|Fluorouracil|fluorouracil|mesh-list
44863274|NCT05151588|Cisplatin|cisplatin|mesh-list
44863275|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863276|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863277|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863278|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863279|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863280|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
44863281|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863282|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863283|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
44863284|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863285|NCT05137938|Ketamine|ketamine|mesh-list
44863286|NCT05137938|Analgesics|analgesics|mesh-ancestor
44863287|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
44863288|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863289|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863290|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44863291|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44863292|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
44863293|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
44863294|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863295|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44863296|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44863297|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350384|NCT01078142|Sirolimus|sirolimus|mesh-list
44863298|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863299|NCT05117307|Bupivacaine|bupivacaine|mesh-list
44863300|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
44863301|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
44863302|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863303|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863304|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
44863305|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863306|NCT04947072|Anesthetics|anesthetics|mesh-list
44863307|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863308|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863309|NCT04942158|Eugenol|eugenol|mesh-list
44863310|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
44863311|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
44863312|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
44863313|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44863314|NCT04942158|Protective Agents|protective agents|mesh-ancestor
44863315|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863316|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863317|NCT04911166|Atezolizumab|atezolizumab|mesh-list
44863318|NCT04911166|Interleukin-12|interleukin-12|mesh-list
44863319|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863320|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44863321|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
44863322|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863323|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44863324|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44863325|NCT04911166|Growth Substances|growth substances|mesh-ancestor
44863326|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
44863327|NCT04810208|Docetaxel|docetaxel|mesh-list
44863328|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863329|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863330|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863331|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863332|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863333|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
44863334|NCT04671030|Neostigmine|neostigmine|mesh-list
44863335|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44863336|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863337|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863338|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863339|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863340|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863341|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44863342|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
44863343|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863344|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44863345|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44863346|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44863347|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
44863348|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44863349|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863350|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863351|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44863352|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44863353|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863354|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863355|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863356|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44863357|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
44863358|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44863359|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863360|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44863361|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44863362|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44863363|NCT04652206|Gemcitabine|gemcitabine|mesh-list
44863364|NCT04652206|Paclitaxel|paclitaxel|mesh-list
44863365|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44863366|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863367|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863368|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863369|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863370|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863371|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863372|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
44863373|NCT04652206|Antiviral Agents|antiviral agents|mesh-ancestor
44863374|NCT04652206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863375|NCT04652206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863376|NCT04652206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863377|NCT04652206|Immunologic Factors|immunologic factors|mesh-ancestor
44863378|NCT04652206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863379|NCT04647903|Amphetamine|amphetamine|mesh-list
44863380|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
44863381|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44863382|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863383|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
44863384|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
44350493|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
44863385|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863386|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
44863387|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863388|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863389|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863390|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44863391|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44863392|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863393|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44863394|NCT04632264|Oxytocin|oxytocin|mesh-list
44863395|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
44863396|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44863397|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863398|NCT04607928|Pirfenidone|pirfenidone|mesh-list
44863399|NCT04607928|Analgesics|analgesics|mesh-ancestor
44863400|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
44863401|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863402|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863403|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44863404|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863405|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863406|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44863407|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863408|NCT04498780|Valsartan|valsartan|mesh-list
44863409|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44863410|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44863411|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44863412|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44863413|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863414|NCT04448717|Antibodies|antibodies|mesh-list
44863415|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
44863416|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863417|NCT04436965|Cisplatin|cisplatin|mesh-list
44863418|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863419|NCT04420741|Iloprost|iloprost|mesh-list
44863420|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44863421|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
44863422|NCT04409041|Naltrexone|naltrexone|mesh-list
44863423|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44863424|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44863425|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863426|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
44863427|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863428|NCT04407286|Vitamin D|vitamin d|mesh-list
44863429|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
44863430|NCT04407286|Vitamins|vitamins|mesh-ancestor
44863431|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
44863432|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863433|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44863434|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44863435|NCT04282239|Lidocaine|lidocaine|mesh-list
44863436|NCT04282239|Epinephrine|epinephrine|mesh-list
44863437|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
44863438|NCT04282239|Ropivacaine|ropivacaine|mesh-list
44863439|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
44863440|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
44863441|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863442|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863443|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
44863444|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863445|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44863446|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44863447|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44863448|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863449|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863450|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44863451|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863452|NCT04282239|Analgesics|analgesics|mesh-ancestor
44863453|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44863454|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44863455|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863456|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863457|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863458|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44863459|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44863460|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
44863461|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44863462|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
44863463|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
44863464|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
44863465|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44863466|NCT04232072|Ibuprofen|ibuprofen|mesh-list
44863467|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44863468|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863469|NCT04232072|Analgesics|analgesics|mesh-ancestor
44863470|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
44863471|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863472|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863473|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863474|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44863475|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44863476|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863477|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863478|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44863479|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863480|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44863481|NCT03857542|Pilocarpine|pilocarpine|mesh-list
44863482|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44863483|NCT03857542|Miotics|miotics|mesh-ancestor
44863484|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
44863485|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863486|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863487|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44863488|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44863489|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863490|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863491|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863492|NCT03700541|Morphine|morphine|mesh-list
44863493|NCT03700541|Pirinitramide|pirinitramide|mesh-list
44863494|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44863495|NCT03700541|Narcotics|narcotics|mesh-ancestor
44863496|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863497|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863498|NCT03700541|Analgesics|analgesics|mesh-ancestor
44863499|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
44863500|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863501|NCT03700411|Morphine|morphine|mesh-list
44863502|NCT03700411|Pirinitramide|pirinitramide|mesh-list
44863503|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44863504|NCT03700411|Narcotics|narcotics|mesh-ancestor
44863505|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863506|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863507|NCT03700411|Analgesics|analgesics|mesh-ancestor
44863508|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
44863509|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863510|NCT03691051|Capecitabine|capecitabine|mesh-list
44863511|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863512|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
44863513|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863514|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863515|NCT03688802|Varenicline|varenicline|mesh-list
44863516|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44863517|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44863518|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863519|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863520|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863521|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863522|NCT03630666|Hormones|hormones|mesh-list
44863523|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44863524|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863525|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863526|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
44863527|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44863528|NCT03541083|Blinatumomab|blinatumomab|mesh-list
44863529|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863530|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
44863531|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44863532|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863533|NCT03446612|Nitroprusside|nitroprusside|mesh-list
44863534|NCT03446612|Acetylcholine|acetylcholine|mesh-list
44863535|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
44863536|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44863537|NCT03446612|Hematinics|hematinics|mesh-ancestor
44863538|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44863539|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
44863540|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44863541|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863542|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44863543|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863544|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863545|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863546|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863547|NCT03436433|Lacosamide|lacosamide|mesh-list
44863548|NCT03436433|Levetiracetam|levetiracetam|mesh-list
44863549|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
44863550|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
44863551|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44863552|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44863553|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863554|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863555|NCT03387774|Cisplatin|cisplatin|mesh-list
44863556|NCT03387774|Urinastatin|urinastatin|mesh-list
44350663|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
44863557|NCT03387774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863558|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44863559|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44863560|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
44863561|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863562|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697841|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697842|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697843|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44697844|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
44697845|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697846|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697847|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44697848|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44697849|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44697850|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44697851|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697852|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44697853|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
44697854|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
44697855|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
44697856|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44697857|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
44697858|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44697859|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
44863563|NCT03255512|Isosorbide|isosorbide|mesh-list
44863564|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44863565|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44863566|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44863567|NCT03255512|Diuretics|diuretics|mesh-ancestor
44863568|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
44863569|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863570|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
44863571|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44863572|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863573|NCT03230266|Insulin|insulin|mesh-list
44863574|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44863575|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863576|NCT03111212|Iloprost|iloprost|mesh-list
44863577|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44863578|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
44863579|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
44863580|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44863581|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863582|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863583|NCT02997358|Doxorubicin|doxorubicin|mesh-list
44863584|NCT02997358|Trabectedin|trabectedin|mesh-list
44863585|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44863586|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863587|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44863588|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44863589|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863590|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863591|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44863592|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
44863593|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
44863594|NCT02963610|Lenalidomide|lenalidomide|mesh-list
44863595|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863596|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863597|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
44863598|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863599|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44863600|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44863601|NCT02963610|Growth Substances|growth substances|mesh-ancestor
44863602|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
44863603|NCT02903160|Prednisone|prednisone|mesh-list
44863604|NCT02903160|Carboplatin|carboplatin|mesh-list
44863605|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
44863606|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44863607|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863608|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863609|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
44863610|NCT02903160|Hormones|hormones|mesh-ancestor
44863611|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863612|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863613|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863614|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44863615|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863616|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863617|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
44863618|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44863619|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
44863620|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
44863621|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863622|NCT02814695|Protective Agents|protective agents|mesh-ancestor
44863623|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863624|NCT02814695|Vitamins|vitamins|mesh-ancestor
44863625|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
44863626|NCT02766335|Docetaxel|docetaxel|mesh-list
44863627|NCT02766335|Durvalumab|durvalumab|mesh-list
44863628|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
44863629|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44863630|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
44863631|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863632|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863633|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863634|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863635|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863636|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863637|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
44863638|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863639|NCT02675439|Ipilimumab|ipilimumab|mesh-list
44863640|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863641|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863642|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44863643|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863644|NCT02651740|Rifaximin|rifaximin|mesh-list
44863645|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863646|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863647|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863648|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
44863649|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
44863650|NCT02606136|Mitogens|mitogens|mesh-list
44863651|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863652|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863653|NCT02051309|Guanfacine|guanfacine|mesh-list
44863654|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44863655|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44863656|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44863657|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863658|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863659|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863660|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863661|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863662|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
44863663|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863664|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863665|NCT01900002|Sorafenib|sorafenib|mesh-list
44863666|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863667|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863668|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863669|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863670|NCT01595061|Gemcitabine|gemcitabine|mesh-list
44863671|NCT01595061|Cisplatin|cisplatin|mesh-list
44863672|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863673|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863674|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
44863675|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863676|NCT01595061|Antiviral Agents|antiviral agents|mesh-ancestor
44863677|NCT01595061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863678|NCT01595061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863679|NCT01595061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863680|NCT01595061|Immunologic Factors|immunologic factors|mesh-ancestor
44863681|NCT01595061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863682|NCT00165724|Donepezil|donepezil|mesh-list
44863683|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44863684|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863685|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863686|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863687|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863688|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863689|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
44863690|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
44863691|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44863692|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
44863693|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44863694|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
44863695|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863696|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863697|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
44863698|NCT04527133|Aprotinin|aprotinin|mesh-list
44863699|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
44863700|NCT04527133|Coagulants|coagulants|mesh-ancestor
44863701|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44863702|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44863703|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
44863704|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863705|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863706|NCT04527068|Bevacizumab|bevacizumab|mesh-list
44863707|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863708|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863709|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44863710|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44863711|NCT04527068|Growth Substances|growth substances|mesh-ancestor
44863712|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863713|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
44863715|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44863716|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863717|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44863718|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44863719|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44863720|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863721|NCT04526353|Oxybutynin|oxybutynin|mesh-list
44863722|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
44863723|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
44863724|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863725|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863726|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44863727|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44863728|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
44863729|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863730|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863731|NCT04526353|Urological Agents|urological agents|mesh-ancestor
44863732|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44863733|NCT04526210|Choline|choline|mesh-list
44863734|NCT04526210|Bupropion|bupropion|mesh-list
44863735|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44863736|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44863737|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44863738|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44863739|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44863740|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44863741|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863742|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
44863743|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863744|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863745|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44863746|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44863747|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863748|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
44863749|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44863750|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
44863751|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863752|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44863753|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
44863754|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
44863755|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
44863756|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44863757|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44863758|NCT04526210|Growth Substances|growth substances|mesh-ancestor
44863759|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
44863760|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863761|NCT04526028|Fulvestrant|fulvestrant|mesh-list
44863762|NCT04526028|Palbociclib|palbociclib|mesh-list
44863763|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863764|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863765|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44863766|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44863767|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
44863768|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863769|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863770|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863771|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863772|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863773|NCT04526236|Methadone|methadone|mesh-list
44863774|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44863775|NCT04526236|Narcotics|narcotics|mesh-ancestor
44863776|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863777|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863778|NCT04526236|Analgesics|analgesics|mesh-ancestor
44863779|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
44863780|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863781|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
44863782|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
44863783|NCT04525820|Vitamin D|vitamin d|mesh-list
44863784|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
44863785|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
44863786|NCT04525820|Vitamins|vitamins|mesh-list
44863787|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44863788|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
44863789|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863790|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44863791|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44863792|NCT04525664|Amoxicillin|amoxicillin|mesh-list
44863793|NCT04525664|Clarithromycin|clarithromycin|mesh-list
44863794|NCT04525664|Omeprazole|omeprazole|mesh-list
44863795|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863796|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863797|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44863798|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863799|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44863800|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863801|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863802|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44863803|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44863804|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44863805|NCT04525729|Rituximab|rituximab|mesh-list
44863806|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863807|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863808|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
44863809|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863810|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44863811|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
44863812|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44863813|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863814|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
44863815|NCT04525495|Dopamine|dopamine|mesh-list
44863816|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44863817|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
44863818|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
44863819|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863820|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863821|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
44863822|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863823|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863824|NCT04525495|Protective Agents|protective agents|mesh-ancestor
44863825|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
44863826|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44863827|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
44863828|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863829|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
44863830|NCT04525066|Protective Agents|protective agents|mesh-ancestor
44863832|NCT04525235|Rifampin|rifampin|mesh-list
44863833|NCT04525235|Digoxin|digoxin|mesh-list
44863834|NCT04525235|Midazolam|midazolam|mesh-list
44863835|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
44863836|NCT04525235|Caffeine|caffeine|mesh-list
44863837|NCT04525235|Omeprazole|omeprazole|mesh-list
44863838|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44863839|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44863840|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863841|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863842|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44863843|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44863844|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44863845|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44863846|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
44863847|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
44863848|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
44863849|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
44863850|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863851|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863852|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44863853|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44863854|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44863855|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863856|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44863857|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44863858|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44863859|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44863860|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
44863861|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44863862|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
44863863|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863864|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863865|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
44863866|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44863867|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44863868|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44863869|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44863870|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44863871|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44863872|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44863873|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44863874|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44863875|NCT04525235|Protective Agents|protective agents|mesh-ancestor
44863876|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
44863877|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
44863878|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44863879|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44863880|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44863881|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
44863882|NCT04525274|Ketamine|ketamine|mesh-list
44863883|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44863884|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863885|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863886|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44863887|NCT04525274|Analgesics|analgesics|mesh-ancestor
44863888|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
44863889|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863890|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44863891|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44863892|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863893|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863894|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863895|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863896|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44863897|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44863898|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
44863899|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
44863900|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44351027|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
44863901|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44863902|NCT04525326|Bevacizumab|bevacizumab|mesh-list
44863903|NCT04525326|Cetuximab|cetuximab|mesh-list
44863904|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44863905|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863906|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44863907|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44863908|NCT04525326|Growth Substances|growth substances|mesh-ancestor
44863909|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863910|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44863911|NCT04525300|Liraglutide|liraglutide|mesh-list
44863912|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44863913|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863914|NCT04525300|Incretins|incretins|mesh-ancestor
44863915|NCT04525300|Hormones|hormones|mesh-ancestor
44863916|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863917|NCT04524728|Letrozole|letrozole|mesh-list
44863918|NCT04524728|Fulvestrant|fulvestrant|mesh-list
44863919|NCT04524728|Palbociclib|palbociclib|mesh-list
44863920|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863921|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44863922|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44863923|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863924|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863925|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44863926|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44863927|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863928|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863929|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44863930|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44863931|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44863932|NCT04524897|Triamcinolone|triamcinolone|mesh-list
44863933|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44863934|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44863935|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44863936|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44863937|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
44863938|NCT04524897|Hormones|hormones|mesh-ancestor
44863939|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863940|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863941|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863942|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
44863943|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863944|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863945|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44863946|NCT04524169|Thymalfasin|thymalfasin|mesh-list
44351090|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
44863947|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44863948|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
44863949|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863950|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
44863951|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44863952|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44863953|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44863954|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44863955|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863956|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863957|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863958|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44863959|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44863960|NCT04524026|Letrozole|letrozole|mesh-list
44863961|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44863962|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863963|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44863964|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863965|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863966|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44863967|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44863968|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44863969|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863970|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44863971|NCT04523844|Brinzolamide|brinzolamide|mesh-list
44863972|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44863973|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44863974|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44863975|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44863976|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
44863977|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44863978|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863979|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863980|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44863981|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44863983|NCT04523818|Capecitabine|capecitabine|mesh-list
44863984|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
44863985|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44863986|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44863987|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44863988|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44863989|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
44863990|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863991|NCT04523792|Buprenorphine|buprenorphine|mesh-list
44863992|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44863993|NCT04523792|Narcotics|narcotics|mesh-ancestor
44863994|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44863995|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44863996|NCT04523792|Analgesics|analgesics|mesh-ancestor
44863997|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
44863998|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44863999|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44864000|NCT04523740|Acetaminophen|acetaminophen|mesh-list
44864001|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864002|NCT04523740|Analgesics|analgesics|mesh-ancestor
44864003|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
44864004|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864005|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864006|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
44864007|NCT04523623|Ibuprofen|ibuprofen|mesh-list
44864008|NCT04523623|Oxycodone|oxycodone|mesh-list
44864009|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44864010|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864011|NCT04523623|Analgesics|analgesics|mesh-ancestor
44864012|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
44864013|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864014|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864015|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864016|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864017|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44864018|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864019|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864020|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44864021|NCT04523623|Narcotics|narcotics|mesh-ancestor
44864022|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864023|NCT04523662|Apatinib|apatinib|mesh-list
44864024|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864025|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44864026|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864027|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864028|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
44864029|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44864030|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
44864031|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864032|NCT04523675|Expectorants|expectorants|mesh-ancestor
44864033|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864034|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44864035|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
44864036|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864037|NCT04523675|Protective Agents|protective agents|mesh-ancestor
44864038|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864039|NCT04523675|Antidotes|antidotes|mesh-ancestor
44864040|NCT04523688|Temozolomide|temozolomide|mesh-list
44864041|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44864042|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
44864043|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864044|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864045|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44864046|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
44864047|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44864048|NCT04523467|Growth Substances|growth substances|mesh-ancestor
44864049|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864050|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
44864051|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864052|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44864053|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
44864054|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44864055|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44864056|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864057|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
44864058|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864059|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864061|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
44864062|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864063|NCT04523272|Sunitinib|sunitinib|mesh-list
44864064|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864065|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44864066|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44864067|NCT04523272|Growth Substances|growth substances|mesh-ancestor
44864068|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864069|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
44864070|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44864071|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864072|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864073|NCT04523077|Antibodies|antibodies|mesh-list
44864074|NCT04523077|Hormones|hormones|mesh-list
44864075|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
44864076|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864077|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864078|NCT04522882|Insulin|insulin|mesh-list
44864079|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44864080|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864081|NCT04523064|Empagliflozin|empagliflozin|mesh-list
44864082|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44864083|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864084|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44864085|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864086|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44864087|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864088|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
44864089|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
44864090|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44864091|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44864092|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864093|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864094|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864095|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864096|NCT04522297|Octreotide|octreotide|mesh-list
44864097|NCT04522297|Epinephrine|epinephrine|mesh-list
44864098|NCT04522297|Midodrine|midodrine|mesh-list
44864099|NCT04522297|Norepinephrine|norepinephrine|mesh-list
44864100|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44864101|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44864102|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44864103|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864104|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864105|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864106|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44864107|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44864108|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
44864109|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864110|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44864111|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864112|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
44864113|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
44864114|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44864115|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864116|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44864117|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864118|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44864119|NCT04521868|Sulforaphane|sulforaphane|mesh-list
44864120|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44864121|NCT04521868|Protective Agents|protective agents|mesh-ancestor
44864122|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864123|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864124|NCT04522050|Gemcitabine|gemcitabine|mesh-list
44864125|NCT04522050|Cisplatin|cisplatin|mesh-list
44864126|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864127|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864128|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
44864129|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864130|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
44864131|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864132|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864133|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44864134|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
44864135|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864136|NCT04522037|Morphine|morphine|mesh-list
44864137|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44864138|NCT04522037|Narcotics|narcotics|mesh-ancestor
44864139|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864140|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864141|NCT04522037|Analgesics|analgesics|mesh-ancestor
44864142|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
44864143|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864144|NCT04521400|Interferons|interferons|mesh-list
44864145|NCT04521400|Ritonavir|ritonavir|mesh-list
44864146|NCT04521400|Lopinavir|lopinavir|mesh-list
44864147|NCT04521400|Interferon-beta|interferon-beta|mesh-list
44864148|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
44864149|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864150|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
44864151|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864152|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44864153|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44864154|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44864155|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864156|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864157|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44864158|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44864159|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44864160|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44864161|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
44864162|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864163|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44864164|NCT04521751|Acarbose|acarbose|mesh-list
44864165|NCT04521751|Orlistat|orlistat|mesh-list
44864166|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44864167|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864168|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351308|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
44351310|NCT01083017|Diuretics|diuretics|mesh-ancestor
44864169|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44864170|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864171|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44864172|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44864173|NCT04521517|Imidacloprid|imidacloprid|mesh-list
44864174|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
44864175|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864176|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864177|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864178|NCT04521491|Leucovorin|leucovorin|mesh-list
44864179|NCT04521491|Fluorouracil|fluorouracil|mesh-list
44864180|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
44864181|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
44864182|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864183|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864184|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864185|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44864186|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
44864187|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864188|NCT04521491|Antidotes|antidotes|mesh-ancestor
44864189|NCT04521491|Protective Agents|protective agents|mesh-ancestor
44864190|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
44864191|NCT04521491|Vitamins|vitamins|mesh-ancestor
44864192|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
44864193|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
44864194|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44864195|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
44864196|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864197|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
44864198|NCT04521387|Protective Agents|protective agents|mesh-ancestor
44864199|NCT04521075|Nivolumab|nivolumab|mesh-list
44864200|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864201|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864202|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44864203|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864204|NCT04521309|Antibodies|antibodies|mesh-list
44864205|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
44864206|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864207|NCT04521153|Apatinib|apatinib|mesh-list
44864208|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864209|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44864210|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864211|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864212|NCT04521049|Saxagliptin|saxagliptin|mesh-list
44864213|NCT04521049|Incretins|incretins|mesh-ancestor
44864214|NCT04521049|Hormones|hormones|mesh-ancestor
44864215|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864216|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864217|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44864218|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44864219|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864220|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864221|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44864222|NCT04520646|Empagliflozin|empagliflozin|mesh-list
44864223|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44864224|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864225|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44864226|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864227|NCT04520620|Enoxaparin|enoxaparin|mesh-list
44864228|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
44864229|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44864230|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44864231|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864232|NCT04520880|Antibodies|antibodies|mesh-list
44864233|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
44864234|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
44864235|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
44864236|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864237|NCT04520919|Anesthetics|anesthetics|mesh-list
44864238|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864239|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864240|NCT04520503|Propofol|propofol|mesh-list
44864241|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44864242|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864243|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864244|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44351379|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
44864245|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
44864247|NCT04520230|Budesonide|budesonide|mesh-list
44864248|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
44864249|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
44864250|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44864251|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864252|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44864253|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
44864254|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697860|NCT00667329|Rituximab|rituximab|mesh-list
44697861|NCT00667329|Cladribine|cladribine|mesh-list
44697862|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697863|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
44697864|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697865|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44697866|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44697867|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
44697868|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697869|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697870|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44697871|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44697872|NCT00492167|Antibodies|antibodies|mesh-list
44697873|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44697874|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
44697875|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697876|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44697877|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44697878|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351400|NCT01083537|Paclitaxel|paclitaxel|mesh-list
44351401|NCT01083537|Cisplatin|cisplatin|mesh-list
44697879|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697880|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
44697881|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697882|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697883|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
44697884|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697885|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44697886|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697887|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697888|NCT05274191|Maleic acid|maleic acid|mesh-list
44697889|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697890|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697891|NCT05274139|Cytarabine|cytarabine|mesh-list
44697892|NCT05274139|Dexamethasone|dexamethasone|mesh-list
44697893|NCT05274139|Temozolomide|temozolomide|mesh-list
44697894|NCT05274139|Fotemustine|fotemustine|mesh-list
44697895|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697896|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
44697897|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
44697898|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697899|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697900|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697901|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
44697902|NCT05274139|Hormones|hormones|mesh-ancestor
44697903|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697904|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697905|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697906|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697907|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44697908|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
44697909|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
44697910|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697911|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44697912|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
44697913|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44697914|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
44697915|NCT05274113|Dexamethasone|dexamethasone|mesh-list
44697916|NCT05274113|Ropivacaine|ropivacaine|mesh-list
44697917|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44697918|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
44697919|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
44697920|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864255|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864256|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44864257|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864258|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
44864259|NCT04520230|Hormones|hormones|mesh-ancestor
44864260|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864261|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44864262|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44864263|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44864264|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
44864265|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864266|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864267|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
44864268|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44864269|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44864270|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44864271|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864272|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
44864273|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864274|NCT04520126|Protective Agents|protective agents|mesh-ancestor
44864275|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864276|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44864277|NCT04520035|Paclitaxel|paclitaxel|mesh-list
44864278|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44864279|NCT04520035|Cisplatin|cisplatin|mesh-list
44864280|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44864281|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864282|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44864283|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44864284|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44864285|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864286|NCT04519125|Tenofovir|tenofovir|mesh-list
44864287|NCT04519125|Emtricitabine|emtricitabine|mesh-list
44864288|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
44864289|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864290|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44351470|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44864291|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44864292|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864293|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864294|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44864295|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44864296|NCT04519281|Ascorbic Acid|ascorbic acid|mesh-list
44864297|NCT04519281|Vitamins|vitamins|mesh-ancestor
44864298|NCT04519281|Micronutrients|micronutrients|mesh-ancestor
44864299|NCT04519281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864300|NCT04519281|Antioxidants|antioxidants|mesh-ancestor
44864301|NCT04519281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864302|NCT04519281|Protective Agents|protective agents|mesh-ancestor
44864303|NCT04521556|Morphine|morphine|mesh-list
44864304|NCT04521556|Tramadol|tramadol|mesh-list
44864305|NCT04521556|Anesthetics|anesthetics|mesh-list
44864306|NCT04521556|Ropivacaine|ropivacaine|mesh-list
44864307|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864308|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864309|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44864310|NCT04521556|Narcotics|narcotics|mesh-ancestor
44864311|NCT04521556|Analgesics|analgesics|mesh-ancestor
44864312|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
44864313|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864314|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864315|NCT04518475|Rituximab|rituximab|mesh-list
44864316|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864317|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864318|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
44864319|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864320|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650538|NCT00230178|Allopurinol|allopurinol|mesh-list
44864321|NCT04517162|Povidone|povidone|mesh-list
44864322|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
44864323|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
44864324|NCT04516655|Rituximab|rituximab|mesh-list
44864325|NCT04516655|Methotrexate|methotrexate|mesh-list
44864326|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864327|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864328|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
44864329|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864330|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864331|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44864332|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
44864333|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44864334|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864335|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
44864336|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864337|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44864338|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864339|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44864340|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44864341|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44864342|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44864343|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44864344|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864345|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
44864346|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
44864347|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44864348|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44864349|NCT04515966|Prednisolone|prednisolone|mesh-list
44864350|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
44864351|NCT04515966|Lidocaine|lidocaine|mesh-list
44864352|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44864353|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
44864354|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864355|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
44864356|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864357|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864358|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
44864359|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864360|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44864361|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44864362|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44864363|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44864364|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864365|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864366|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
44864367|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
44864368|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864369|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
44864370|NCT04515966|Hormones|hormones|mesh-ancestor
44864371|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864372|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44864373|NCT04515966|Protective Agents|protective agents|mesh-ancestor
44864374|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44864375|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864376|NCT04511468|Ascorbic Acid|ascorbic acid|mesh-list
44864377|NCT04511468|Copper|copper|mesh-list
44864378|NCT04511468|Chromium|chromium|mesh-list
44864379|NCT04511468|Vitamins|vitamins|mesh-ancestor
44351560|NCT01084486|Metformin|metformin|mesh-list
44864380|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
44864381|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864382|NCT04511468|Antioxidants|antioxidants|mesh-ancestor
44864383|NCT04511468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864384|NCT04511468|Protective Agents|protective agents|mesh-ancestor
44864385|NCT04511468|Trace Elements|trace elements|mesh-ancestor
44864386|NCT04511195|Diclofenac|diclofenac|mesh-list
44864387|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44864388|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864389|NCT04511195|Analgesics|analgesics|mesh-ancestor
44864390|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
44864391|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864392|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864393|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864394|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864395|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44650610|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
44864396|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864397|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864398|NCT04509999|Bicalutamide|bicalutamide|mesh-list
44864399|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
44864400|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
44864401|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864402|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864403|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864404|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
44864405|NCT04509466|Pegaspargase|pegaspargase|mesh-list
44864406|NCT04509466|Asparaginase|asparaginase|mesh-list
44864407|NCT04509466|Analgesics|analgesics|mesh-ancestor
44864408|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
44864409|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864410|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864411|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864412|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44864413|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44864414|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864415|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864416|NCT04509583|Vitamin E|vitamin e|mesh-list
44864417|NCT04509583|Vitamins|vitamins|mesh-ancestor
44864418|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
44864419|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864420|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
44864421|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864422|NCT04509583|Protective Agents|protective agents|mesh-ancestor
44864423|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
44864424|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
44864425|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864426|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864427|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44864428|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864429|NCT04509635|Cetuximab|cetuximab|mesh-list
44864430|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864431|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864432|NCT04509440|Triamcinolone|triamcinolone|mesh-list
44864433|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44864434|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44864435|NCT04509440|Anesthetics|anesthetics|mesh-list
44864436|NCT04509440|Mepivacaine|mepivacaine|mesh-list
44864437|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
44864438|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44864439|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864440|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864441|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864442|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
44864443|NCT04509440|Hormones|hormones|mesh-ancestor
44864444|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864445|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44864446|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
44864447|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864448|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864449|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
44864450|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864451|NCT04509102|Adderall|adderall|mesh-list
44864452|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44864453|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864454|NCT04509323|Huperzine A|huperzine a|mesh-list
44864455|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44864456|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864457|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864458|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
44864459|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864460|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864461|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44864462|NCT04509323|Protective Agents|protective agents|mesh-ancestor
44864463|NCT04508946|Ascorbic Acid|ascorbic acid|mesh-list
44864464|NCT04508946|Thiamine|thiamine|mesh-list
44864465|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
44864466|NCT04508946|Vitamins|vitamins|mesh-ancestor
44864467|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
44864468|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864469|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864470|NCT04508946|Antioxidants|antioxidants|mesh-ancestor
44864471|NCT04508946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864472|NCT04508946|Protective Agents|protective agents|mesh-ancestor
44864473|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
44864474|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
44864475|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44864476|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44864477|NCT04509219|Prednisolone|prednisolone|mesh-list
44864478|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
44864479|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44864480|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
44864481|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864482|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
44864483|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
44864484|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864485|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864486|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864487|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
44864488|NCT04509219|Hormones|hormones|mesh-ancestor
44864489|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864490|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44864491|NCT04509219|Protective Agents|protective agents|mesh-ancestor
44864492|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44864493|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864494|NCT04509232|Fluorides|fluorides|mesh-list
44864495|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
44864496|NCT04509232|Protective Agents|protective agents|mesh-ancestor
44864497|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864498|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
44864499|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
44864500|NCT04509258|Ondansetron|ondansetron|mesh-list
44864501|NCT04509258|Mineral Oil|mineral oil|mesh-list
44864502|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44864503|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
44864504|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
44864505|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864506|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864507|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864508|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
44864509|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
44864510|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44864511|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
44864512|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864513|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864514|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44864515|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44864516|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864517|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44864518|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44864519|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
44864520|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864521|NCT04509258|Expectorants|expectorants|mesh-ancestor
44864522|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
44351704|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44864523|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44864524|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
44864525|NCT04509258|Protective Agents|protective agents|mesh-ancestor
44864526|NCT04509258|Antidotes|antidotes|mesh-ancestor
44864527|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
44864528|NCT04509258|Vitamins|vitamins|mesh-ancestor
44864529|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
44864530|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
44864531|NCT04509258|Emollients|emollients|mesh-ancestor
44864532|NCT04508829|Antibodies|antibodies|mesh-list
44864533|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44864534|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
44864535|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864536|NCT04508816|Cetuximab|cetuximab|mesh-list
44864537|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
44864538|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864539|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864540|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
44864542|NCT04508894|Bupivacaine|bupivacaine|mesh-list
44864543|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864544|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
44864545|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864546|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864547|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
44864548|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864549|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44864550|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864551|NCT04508894|Analgesics|analgesics|mesh-ancestor
44864552|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44864553|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44864554|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44864555|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
44864556|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864557|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864558|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44864559|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44864560|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
44864561|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44864562|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44864563|NCT04508686|Capecitabine|capecitabine|mesh-list
44864564|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864565|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
44864566|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864567|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864568|NCT04508439|Heparin|heparin|mesh-list
44864569|NCT04508439|Enoxaparin|enoxaparin|mesh-list
44864570|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44864571|NCT04508439|Tinzaparin|tinzaparin|mesh-list
44864572|NCT04508439|Dalteparin|dalteparin|mesh-list
44864573|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
44864574|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44864575|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44864576|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864577|NCT04508400|Dexamethasone|dexamethasone|mesh-list
44864578|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
44864579|NCT04508400|Ondansetron|ondansetron|mesh-list
44864580|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
44864581|NCT04508400|Aprepitant|aprepitant|mesh-list
44864582|NCT04508400|BB 1101|bb 1101|mesh-list
44864583|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864584|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
44864585|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
44864586|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864587|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864588|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864589|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
44864590|NCT04508400|Hormones|hormones|mesh-ancestor
44864591|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864592|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44864593|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864594|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44864595|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864596|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864597|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
44864598|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
44864599|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44864600|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
44864601|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864602|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44864603|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44864604|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864605|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44864606|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44864607|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44864608|NCT04508452|Bevacizumab|bevacizumab|mesh-list
44864609|NCT04508452|Capecitabine|capecitabine|mesh-list
44864610|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
44864611|NCT04508452|Irinotecan|irinotecan|mesh-list
44864612|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864613|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864614|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44864615|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44864616|NCT04508452|Growth Substances|growth substances|mesh-ancestor
44864617|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864618|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
44864619|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864620|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
44864621|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864622|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44864623|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44864624|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864625|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
44864626|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44864627|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44864628|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864629|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
44864630|NCT04508036|Coagulants|coagulants|mesh-ancestor
44864631|NCT04508231|Hormones|hormones|mesh-list
44864632|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864633|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864634|NCT04507607|Tenofovir|tenofovir|mesh-list
44864635|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
44864636|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864637|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44864638|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44864639|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864640|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864641|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44864642|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44864643|NCT04507750|Apatinib|apatinib|mesh-list
44864644|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864645|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44864646|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864647|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864648|NCT04507217|Carboplatin|carboplatin|mesh-list
44864649|NCT04507217|Pemetrexed|pemetrexed|mesh-list
44864650|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864651|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864652|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864653|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44864654|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44864655|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
44864656|NCT04507165|Anesthetics|anesthetics|mesh-list
44864657|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864658|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864659|NCT04507165|Narcotics|narcotics|mesh-ancestor
44864660|NCT04507165|Analgesics|analgesics|mesh-ancestor
44864661|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
44864662|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864663|NCT04506957|Chrysarobin|chrysarobin|mesh-list
44864664|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44864665|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864666|NCT04506957|Analgesics|analgesics|mesh-ancestor
44864667|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
44864668|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864669|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864670|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864671|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864672|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
44864673|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44864674|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
44864675|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864676|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
44864677|NCT04506827|Protective Agents|protective agents|mesh-ancestor
44864678|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44864679|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44864680|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864681|NCT04506450|Anesthetics|anesthetics|mesh-list
44864682|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864683|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864684|NCT04506034|Lidocaine|lidocaine|mesh-list
44864685|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864686|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
44864687|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864688|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864689|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
44864690|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864691|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44864692|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44864693|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44864694|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44864695|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864696|NCT04506125|Chrysarobin|chrysarobin|mesh-list
44864697|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44864698|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864699|NCT04506125|Analgesics|analgesics|mesh-ancestor
44864700|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
44864701|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864702|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864703|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864704|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864706|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864707|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44864708|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864709|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864710|NCT04505904|Oxytocin|oxytocin|mesh-list
44864711|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
44864712|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44864713|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864714|NCT04505943|Isoniazid|isoniazid|mesh-list
44864715|NCT04505943|Misoprostol|misoprostol|mesh-list
44864716|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44864717|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
44864718|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44864719|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864720|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44864721|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864722|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
44864723|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
44864724|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44864725|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864726|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44864727|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44864728|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
44864729|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864730|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44864731|NCT04505995|Azacitidine|azacitidine|mesh-list
44864732|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
44864733|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864734|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
44864735|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864736|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864737|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864738|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44864739|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44864740|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44864741|NCT04505514|Hematinics|hematinics|mesh-ancestor
44864742|NCT04505644|Lidocaine|lidocaine|mesh-list
44864743|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864744|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
44351921|NCT01086631|Rituximab|rituximab|mesh-list
44864745|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864746|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864747|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
44864748|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864749|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44864750|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44864751|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44864752|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44864753|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864754|NCT04505475|Hemostatics|hemostatics|mesh-list
44864755|NCT04505475|Coagulants|coagulants|mesh-ancestor
44864756|NCT04505800|Tryptophan|tryptophan|mesh-list
44864757|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44864758|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
44864759|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44864760|NCT04505917|Misoprostol|misoprostol|mesh-list
44864761|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44650989|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
44864762|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
44864763|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44864764|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864765|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44864766|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864767|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
44864768|NCT04505683|Ertapenem|ertapenem|mesh-list
44864769|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44864770|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864771|NCT04505657|Celecoxib|celecoxib|mesh-list
44864772|NCT04505657|Lidocaine|lidocaine|mesh-list
44864773|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
44864774|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
44864775|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44864776|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864777|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
44864778|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864779|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44864780|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44864781|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44864782|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44864783|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864784|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44864785|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44864786|NCT04505657|Analgesics|analgesics|mesh-ancestor
44864787|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864788|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864789|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44864790|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44864791|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864792|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
44864793|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44864794|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44864795|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864796|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
44864797|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44864798|NCT04505228|Atropine|atropine|mesh-list
44864799|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44864800|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44864801|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44864802|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
44864803|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864804|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864805|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44864806|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864807|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
44864808|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
44864809|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44864810|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44864811|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
44864812|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864813|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864814|NCT04504877|Cannabidiol|cannabidiol|mesh-list
44864815|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
44864816|NCT04504851|Rifampin|rifampin|mesh-list
44864817|NCT04504851|Isoniazid|isoniazid|mesh-list
44864818|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
44864819|NCT04504851|Ethambutol|ethambutol|mesh-list
44864820|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44864821|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44864822|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44864823|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
44864824|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864825|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44864826|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44864827|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864828|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44864829|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
44864830|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44864831|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864832|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
44864833|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44864834|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44864835|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44864836|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44864837|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44864838|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44864839|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44864840|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44864841|NCT04504552|Avelumab|avelumab|mesh-list
44864842|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864843|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864844|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44864845|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44864846|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864847|NCT04503915|Estrogens|estrogens|mesh-list
44864848|NCT04503915|Hormones|hormones|mesh-ancestor
44864849|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864850|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864851|NCT04503967|Nivolumab|nivolumab|mesh-list
44864852|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44864853|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864854|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44864855|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864856|NCT04503850|Mirabegron|mirabegron|mesh-list
44864857|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44864858|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44864859|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44864860|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44864861|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
44864862|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864863|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864864|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864865|NCT04503850|Urological Agents|urological agents|mesh-ancestor
44864866|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44864867|NCT04503629|Rabeprazole|rabeprazole|mesh-list
44864868|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44864869|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864870|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44864871|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864872|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864873|NCT04503460|Fluticasone|fluticasone|mesh-list
44864874|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44864875|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44864876|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44864877|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44864878|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
44864879|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864880|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864881|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44864882|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44864883|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44864884|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44864885|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44864886|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44864887|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44864888|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
44864889|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864890|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864891|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
44864892|NCT04503460|Hormones|hormones|mesh-ancestor
44864893|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864894|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
44864895|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
44864896|NCT04502771|Clotrimazole|clotrimazole|mesh-list
44864897|NCT04502771|Miconazole|miconazole|mesh-list
44864898|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864899|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44864900|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44864901|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44864902|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864903|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864904|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44864905|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44864906|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864907|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864908|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44864909|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44864910|NCT04502849|Vitamin E|vitamin e|mesh-list
44864911|NCT04502849|Tocopherols|tocopherols|mesh-list
44864912|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
44864913|NCT04502849|Vitamins|vitamins|mesh-ancestor
44864914|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
44651208|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
44864915|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864917|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864918|NCT04502849|Protective Agents|protective agents|mesh-ancestor
44864919|NCT04502641|Cisplatin|cisplatin|mesh-list
44864920|NCT04502641|Docetaxel|docetaxel|mesh-list
44864921|NCT04502641|Fluorouracil|fluorouracil|mesh-list
44864922|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44864923|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44864924|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44864925|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44864926|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864927|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
44864928|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44864929|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44864930|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
44864931|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864932|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
44864933|NCT04502537|Hematinics|hematinics|mesh-ancestor
44864934|NCT04502368|Dimercaprol|dimercaprol|mesh-list
44864935|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
44864936|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
44864937|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697921|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697922|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697923|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
44697924|NCT05274113|Hormones|hormones|mesh-ancestor
44651278|NCT00203996|Pioglitazone|pioglitazone|mesh-list
44864938|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44864939|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44864940|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864942|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
44864943|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864944|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44864945|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44864946|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864947|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864948|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44864949|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
44864950|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44864951|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864952|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44864953|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44864954|NCT04502251|Naltrexone|naltrexone|mesh-list
44864955|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44864956|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44864957|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864958|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
44864959|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44864960|NCT04502017|Clopidogrel|clopidogrel|mesh-list
44864961|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44864962|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44864963|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44864964|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44864965|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
44864966|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864967|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864968|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864969|NCT04501965|Azithromycin|azithromycin|mesh-list
44864970|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
44864971|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44864972|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44864973|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
44864974|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44864975|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44864976|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44864977|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864978|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44864979|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44864980|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864981|NCT04501900|Clopidogrel|clopidogrel|mesh-list
44864982|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44864983|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44864984|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44864985|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44864986|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
44864987|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44864988|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44864989|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864990|NCT04501809|Misoprostol|misoprostol|mesh-list
44864991|NCT04501809|Oxytocin|oxytocin|mesh-list
44864992|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
44864993|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44864994|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44864995|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44864996|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
44864997|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44864998|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44864999|NCT04501783|Favipiravir|favipiravir|mesh-list
44865000|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
44865001|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865002|NCT04501523|Capecitabine|capecitabine|mesh-list
44865003|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865004|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
44865005|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865006|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865007|NCT04501224|Tenofovir|tenofovir|mesh-list
44865008|NCT04501224|Entecavir|entecavir|mesh-list
44865009|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
44651349|NCT00203307|Olanzapine|olanzapine|mesh-list
44865010|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865011|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44865012|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865013|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865014|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865015|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44865016|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44865017|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
44865018|NCT04501289|Analgesics|analgesics|mesh-ancestor
44865019|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
44865020|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865021|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865022|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
44865023|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865024|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865025|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
44865026|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44865027|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865028|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352223|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
44865029|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44865030|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
44865031|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865032|NCT04501367|Dexamethasone|dexamethasone|mesh-list
44865033|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
44865034|NCT04501367|Prednisone|prednisone|mesh-list
44865035|NCT04501367|BB 1101|bb 1101|mesh-list
44865036|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865037|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
44865038|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
44865039|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865040|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865041|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865042|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
44865043|NCT04501367|Hormones|hormones|mesh-ancestor
44865044|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865045|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865046|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865047|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
44865048|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865049|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865050|NCT04501107|Insulin|insulin|mesh-list
44865051|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44865052|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
44865053|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865054|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865055|NCT04501250|Insulin|insulin|mesh-list
44865056|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44865057|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865058|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865059|NCT04500808|Macitentan|macitentan|mesh-list
44865060|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44865061|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44865062|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865063|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44865064|NCT04500717|Carboplatin|carboplatin|mesh-list
44865065|NCT04500717|Pemetrexed|pemetrexed|mesh-list
44865066|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865067|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865068|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865069|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44865070|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865071|NCT04500496|Isoniazid|isoniazid|mesh-list
44865072|NCT04500496|Dinoprostone|dinoprostone|mesh-list
44865073|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
44865074|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865075|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865076|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
44865077|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865078|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865079|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44865080|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44865081|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
44865082|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865083|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44865084|NCT04500704|Carboplatin|carboplatin|mesh-list
44865085|NCT04500704|Pemetrexed|pemetrexed|mesh-list
44865086|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865087|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865088|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865089|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44865090|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865091|NCT04500743|Leuprolide|leuprolide|mesh-list
44865092|NCT04500743|Dienogest|dienogest|mesh-list
44865093|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44865094|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
44865095|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865096|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865097|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865098|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865099|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44865100|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
44865101|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44865102|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44865103|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44865104|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44865105|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
44865106|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865107|NCT04500522|Isoniazid|isoniazid|mesh-list
44865108|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
44865109|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865110|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865111|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44865112|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44865113|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
44865114|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865115|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44865116|NCT04500561|Gemcitabine|gemcitabine|mesh-list
44865117|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
44865118|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865119|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
44865120|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865121|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865122|NCT04500561|Antiviral Agents|antiviral agents|mesh-ancestor
44865123|NCT04500561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865124|NCT04500561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865125|NCT04500561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865126|NCT04500561|Immunologic Factors|immunologic factors|mesh-ancestor
44865127|NCT04500561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865128|NCT04499989|Isoniazid|isoniazid|mesh-list
44865129|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
44865130|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865131|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865132|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44865133|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44865134|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
44865135|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865136|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44865137|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
44865138|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
44865139|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865140|NCT04500678|Metformin|metformin|mesh-list
44865141|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865142|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865143|NCT04500002|Isoniazid|isoniazid|mesh-list
44865144|NCT04500002|Misoprostol|misoprostol|mesh-list
44865145|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44865146|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
44865147|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865148|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865149|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44865150|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865151|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
44865152|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
44865153|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865154|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865155|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44865156|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44865157|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
44865158|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865159|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44865160|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44865161|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44865162|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865163|NCT04499898|Carvedilol|carvedilol|mesh-list
44865164|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44865165|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44865166|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865167|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865168|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865169|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865170|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44865171|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
44865172|NCT04499898|Protective Agents|protective agents|mesh-ancestor
44865173|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44865174|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865175|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44865176|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865177|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44865178|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44865179|NCT04499885|Mineral Oil|mineral oil|mesh-list
44865180|NCT04499885|Emollients|emollients|mesh-ancestor
44865181|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44865182|NCT04499586|Irinotecan|irinotecan|mesh-list
44865183|NCT04499586|Raltitrexed|raltitrexed|mesh-list
44865184|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44865185|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865186|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352382|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865187|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865188|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865189|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865190|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
44865191|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44865192|NCT04499573|Cytarabine|cytarabine|mesh-list
44865193|NCT04499573|Dexamethasone|dexamethasone|mesh-list
44865194|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
44865195|NCT04499573|Fludarabine|fludarabine|mesh-list
44865196|NCT04499573|Etoposide|etoposide|mesh-list
44865197|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865198|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
44865199|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865200|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865201|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44865202|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
44865203|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865204|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865205|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44865206|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865207|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
44865208|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
44865209|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352426|NCT01088815|Gemcitabine|gemcitabine|mesh-list
44865210|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865211|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
44865212|NCT04499573|Hormones|hormones|mesh-ancestor
44865213|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865214|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865215|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865216|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865217|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
44865218|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865219|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44865220|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865221|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
44865222|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865223|NCT04499976|Misoprostol|misoprostol|mesh-list
44865224|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44865225|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
44865226|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865227|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865228|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44865229|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865230|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
44865231|NCT04499118|Paclitaxel|paclitaxel|mesh-list
44865232|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44865233|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865234|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865235|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44865236|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44865237|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44865238|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865239|NCT04499313|Dexamethasone|dexamethasone|mesh-list
44865240|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
44865241|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44865242|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44865243|NCT04499313|Prednisolone|prednisolone|mesh-list
44865244|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
44865245|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44865246|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
44865247|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865248|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
44865249|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
44865250|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865251|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865252|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352447|NCT01088906|Cisplatin|cisplatin|mesh-list
44865253|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
44865254|NCT04499313|Hormones|hormones|mesh-ancestor
44865255|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865256|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865257|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865258|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44865259|NCT04499313|Protective Agents|protective agents|mesh-ancestor
44865260|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
44865261|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865262|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44865263|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44865264|NCT04499209|Naproxen|naproxen|mesh-list
44865265|NCT04499209|Pregabalin|pregabalin|mesh-list
44865266|NCT04499209|Analgesics|analgesics|mesh-ancestor
44865267|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
44865268|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865269|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865270|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
44865271|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44865272|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865273|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865274|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44865275|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44865276|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44865277|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865278|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44865279|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44865280|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44865281|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865282|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865283|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
44865284|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44865285|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865286|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
44865287|NCT04498936|Ledipasvir|ledipasvir|mesh-list
44865288|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44865289|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
44865290|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
44865291|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352491|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
44865292|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44865293|NCT04498897|Acamprosate|acamprosate|mesh-list
44865294|NCT04498897|Vortioxetine|vortioxetine|mesh-list
44865295|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
44865296|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44865297|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44865298|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44865299|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865300|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865301|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44865302|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44865303|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865304|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865305|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865306|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
44865307|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44865308|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44865309|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44865310|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44865311|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44865312|NCT04498689|Gemcitabine|gemcitabine|mesh-list
44352527|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865313|NCT04498689|Paclitaxel|paclitaxel|mesh-list
44865314|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865315|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865316|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
44865317|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
44865318|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
44865319|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865320|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865321|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
44865322|NCT04498689|Antiviral Agents|antiviral agents|mesh-ancestor
44865323|NCT04498689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865324|NCT04498689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865325|NCT04498689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865326|NCT04498689|Immunologic Factors|immunologic factors|mesh-ancestor
44865327|NCT04498689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865328|NCT04498793|Paclitaxel|paclitaxel|mesh-list
44865329|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
44865330|NCT04498793|Doxorubicin|doxorubicin|mesh-list
44865331|NCT04498793|Epirubicin|epirubicin|mesh-list
44865332|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865333|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865334|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
44865335|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
44865336|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
44865337|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865338|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865339|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
44865340|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865341|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865342|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44865343|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
44865344|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44865345|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44865346|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44865347|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865348|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865349|NCT04498884|Insulin|insulin|mesh-list
44865350|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44865351|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865352|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865353|NCT04498325|Antibodies|antibodies|mesh-list
44865354|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
44865355|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865356|NCT04498520|Fulvestrant|fulvestrant|mesh-list
44865357|NCT04498520|Palbociclib|palbociclib|mesh-list
44865358|NCT04498520|Abexinostat|abexinostat|mesh-list
44865359|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865360|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865361|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44865362|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44865363|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44865364|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865365|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865366|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44865367|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865368|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865369|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44865370|NCT04498234|Bupivacaine|bupivacaine|mesh-list
44865371|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
44865372|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
44651724|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865373|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865374|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865376|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865377|NCT04498260|Triamcinolone|triamcinolone|mesh-list
44865378|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44865379|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44865380|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44865381|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865382|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
44865383|NCT04498260|Hormones|hormones|mesh-ancestor
44865384|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865385|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865386|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865387|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
44865388|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865389|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865390|NCT04497831|Morphine|morphine|mesh-list
44865391|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44865392|NCT04497831|Narcotics|narcotics|mesh-ancestor
44865393|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865394|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865395|NCT04497831|Analgesics|analgesics|mesh-ancestor
44865396|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
44865397|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865398|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
44865399|NCT04497766|Analgesics|analgesics|mesh-ancestor
44865400|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
44865401|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865402|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865403|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
44865404|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865405|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865406|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
44865407|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44865408|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865409|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865410|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44865411|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
44865412|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865413|NCT04497792|Metformin|metformin|mesh-list
44865414|NCT04497792|Empagliflozin|empagliflozin|mesh-list
44865415|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44865416|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865417|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44865418|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865419|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
44865420|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
44865421|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865422|NCT04496921|Vitamins|vitamins|mesh-list
44865423|NCT04496921|Vitamin K|vitamin k|mesh-list
44865424|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
44352637|NCT01090167|Clofarabine|clofarabine|mesh-list
44865425|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865426|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44865427|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44865428|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865429|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
44865430|NCT04496921|Coagulants|coagulants|mesh-ancestor
44865431|NCT04496882|Tenofovir|tenofovir|mesh-list
44865432|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
44865433|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865434|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44865435|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865436|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865437|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865438|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44865439|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44865440|NCT04496492|Tocotrienols|tocotrienols|mesh-list
44865441|NCT04496492|Vitamin E|vitamin e|mesh-list
44865442|NCT04496492|Tocopherols|tocopherols|mesh-list
44865443|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
44865444|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865445|NCT04496492|Protective Agents|protective agents|mesh-ancestor
44865446|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865447|NCT04496492|Vitamins|vitamins|mesh-ancestor
44865448|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
44865449|NCT04496141|Antibodies|antibodies|mesh-list
44865450|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
44865451|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865452|NCT04496037|Rituximab|rituximab|mesh-list
44865453|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44865454|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865455|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
44865456|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865457|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865458|NCT04496050|Alprostadil|alprostadil|mesh-list
44865459|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44865460|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865461|NCT04496050|Urological Agents|urological agents|mesh-ancestor
44865462|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44865463|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865464|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865465|NCT04495881|Incretins|incretins|mesh-ancestor
44865466|NCT04495881|Hormones|hormones|mesh-ancestor
44865467|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865468|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44865469|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
44865470|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865471|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865472|NCT04495933|Vaccines|vaccines|mesh-list
44865473|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44865474|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
44865475|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865476|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44865477|NCT04496024|Ofloxacin|ofloxacin|mesh-list
44865478|NCT04496024|Levofloxacin|levofloxacin|mesh-list
44865479|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44865480|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865481|NCT04496024|Renal Agents|renal agents|mesh-ancestor
44865482|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865483|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44865484|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865485|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865486|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865487|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865488|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44865489|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44865490|NCT04495569|Antibodies|antibodies|mesh-list
44865491|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44865492|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
44865493|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865494|NCT04495478|Ramucirumab|ramucirumab|mesh-list
44865495|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44865496|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865497|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
44865498|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865499|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
44865500|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44865501|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865502|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865503|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44865504|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44865505|NCT04495010|Nivolumab|nivolumab|mesh-list
44865506|NCT04495010|Ipilimumab|ipilimumab|mesh-list
44865507|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44865508|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865509|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44865510|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865511|NCT04494659|Rifampin|rifampin|mesh-list
44865512|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44865513|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
44865514|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865515|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865516|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
44865517|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865518|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865519|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865520|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44865521|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44865522|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44865523|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44865524|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44865525|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44865526|NCT04494763|Propranolol|propranolol|mesh-list
44865527|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44865528|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44865529|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865530|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865531|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865532|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865533|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865534|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44865535|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865536|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
44865537|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44865538|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865539|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865540|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44865541|NCT04494828|Analgesics|analgesics|mesh-ancestor
44865542|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
44865543|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865544|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44865545|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44865546|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44865547|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865548|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865549|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865550|NCT04494529|Betamethasone|betamethasone|mesh-list
44865551|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
44865552|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44865553|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
44865554|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44865555|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865556|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
44865557|NCT04494529|Hormones|hormones|mesh-ancestor
44865558|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865559|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865560|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44865561|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44865562|NCT04494321|Budesonide|budesonide|mesh-list
44865563|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
44865564|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865565|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44865566|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
44865567|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865568|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865569|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44865570|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
44865571|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
44865572|NCT04494321|Hormones|hormones|mesh-ancestor
44865573|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865574|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44865575|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44865576|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44865577|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865578|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865579|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865580|NCT04494100|Lidocaine|lidocaine|mesh-list
44865581|NCT04494100|Epinephrine|epinephrine|mesh-list
44865582|NCT04494100|Ropivacaine|ropivacaine|mesh-list
44865583|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
44865584|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
44865585|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865586|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865587|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
44865588|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865589|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865590|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44865591|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44865592|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865593|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865594|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44865595|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44865596|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865597|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865598|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44865599|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44865600|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
44865601|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44865602|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
44865603|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
44865604|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
44865605|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44865606|NCT04494243|Rabeprazole|rabeprazole|mesh-list
44865607|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44865608|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865609|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44865610|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865611|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865612|NCT04494399|Interferons|interferons|mesh-list
44865613|NCT04494399|Ribavirin|ribavirin|mesh-list
44865614|NCT04494399|Interferon-beta|interferon-beta|mesh-list
44865615|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
44865616|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865617|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
44865618|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865619|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
44865620|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865621|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
44865622|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865623|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44865624|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
44865625|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44865626|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44865627|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865628|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
44352846|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865629|NCT04494126|Coagulants|coagulants|mesh-ancestor
44865630|NCT04493554|Vasopressins|vasopressins|mesh-list
44865631|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
44865632|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
44865633|NCT04493554|Coagulants|coagulants|mesh-ancestor
44865634|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44865635|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44865636|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
44865637|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865638|NCT04493515|Oxytocin|oxytocin|mesh-list
44865639|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
44865640|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865641|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865642|NCT04493489|Propranolol|propranolol|mesh-list
44865643|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44865644|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44865645|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
44865646|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865647|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865648|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865649|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865650|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44865651|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865652|NCT04493528|Lidocaine|lidocaine|mesh-list
44865653|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
44865654|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
44865655|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352884|NCT01091753|Amlodipine|amlodipine|mesh-list
44865656|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865657|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
44865658|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865659|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865660|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44865661|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44865662|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865663|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865664|NCT04493229|Oxytocin|oxytocin|mesh-list
44865665|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
44865666|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44865667|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865668|NCT04493125|Mosapride|mosapride|mesh-list
44865669|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865670|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865671|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44865672|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
44865673|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865674|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865675|NCT04493398|Erythritol|erythritol|mesh-list
44865676|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865677|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
44865678|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44865679|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44865680|NCT04493463|Prednisolone|prednisolone|mesh-list
44865681|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
44865682|NCT04493463|Ropivacaine|ropivacaine|mesh-list
44865683|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44865684|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
44865685|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
44865686|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
44865687|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865688|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865689|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
44865690|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865691|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865692|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
44865693|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
44865694|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865695|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
44865696|NCT04493463|Hormones|hormones|mesh-ancestor
44865697|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352893|NCT01091792|Bevacizumab|bevacizumab|mesh-list
44865698|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44865699|NCT04493463|Protective Agents|protective agents|mesh-ancestor
44865700|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865701|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865702|NCT04493281|Edaravone|edaravone|mesh-list
44865703|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44865704|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
44865705|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865706|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44865707|NCT04493281|Protective Agents|protective agents|mesh-ancestor
44865708|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865710|NCT04493099|Venetoclax|venetoclax|mesh-list
44865711|NCT04493099|Alvocidib|alvocidib|mesh-list
44865712|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44865713|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
44865714|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865715|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865716|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865717|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
44865718|NCT04493099|Growth Substances|growth substances|mesh-ancestor
44865719|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865720|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44865721|NCT04493073|Mitomycins|mitomycins|mesh-list
44865722|NCT04493073|Mitomycin|mitomycin|mesh-list
44865723|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44865724|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865725|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
44865726|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865727|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44865728|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865729|NCT04492774|Dexamethasone|dexamethasone|mesh-list
44865730|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865731|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
44865732|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
44865733|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865734|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865735|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865736|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
44865737|NCT04492774|Hormones|hormones|mesh-ancestor
44865738|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865739|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865740|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865741|NCT04492813|Remifentanil|remifentanil|mesh-list
44865742|NCT04492813|Propofol|propofol|mesh-list
44352928|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
44865743|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44865744|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865745|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865746|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44865747|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
44865748|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
44865749|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44865750|NCT04492813|Narcotics|narcotics|mesh-ancestor
44865751|NCT04492813|Analgesics|analgesics|mesh-ancestor
44865752|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
44865753|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865754|NCT04492709|Midazolam|midazolam|mesh-list
44865755|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44865756|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44865757|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865758|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865759|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44865760|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44865761|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44865762|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44865763|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
44865764|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
44865765|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
44865766|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
44865767|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865768|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865769|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
44865770|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865771|NCT04492319|Neostigmine|neostigmine|mesh-list
44865772|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44865773|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865774|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865775|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
44865776|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865777|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865778|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44865779|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
44652176|NCT00174785|Dronedarone|dronedarone|mesh-list
44865780|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865781|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
44865782|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
44865783|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865784|NCT04492358|Prednisone|prednisone|mesh-list
44865785|NCT04492358|Colchicine|colchicine|mesh-list
44865786|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865787|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
44865788|NCT04492358|Hormones|hormones|mesh-ancestor
44865789|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865790|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865791|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44865792|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865793|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
44865794|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865795|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44865796|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44865797|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44697925|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697926|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44697927|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697928|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
44697929|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
44697930|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697931|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
44697932|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44697933|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
44697934|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697935|NCT05273944|Doxorubicin|doxorubicin|mesh-list
44697936|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44697937|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44697938|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697939|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44697940|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44697941|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44697942|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697943|NCT05273528|Vaccines|vaccines|mesh-list
44697944|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
44697945|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697947|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44697948|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
44697949|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
44697950|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
44697951|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353031|NCT01092806|Tacrolimus|tacrolimus|mesh-list
44697952|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697953|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44697954|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44697955|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44697956|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44697957|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44697958|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44697959|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44697960|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697961|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44697962|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
44697963|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
44697964|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
44697965|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
44697966|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697967|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697968|NCT05273346|Analgesics|analgesics|mesh-list
44697969|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
44697970|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697971|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697972|NCT05272930|Dienogest|dienogest|mesh-list
44697973|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44697974|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
44697975|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44697976|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697977|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44697978|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44697979|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44697980|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44697981|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
44697982|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697983|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44652255|NCT00168818|Enoxaparin|enoxaparin|mesh-list
44865798|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865799|NCT04492501|Remdesivir|remdesivir|mesh-list
44865800|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
44865801|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865802|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
44865803|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865804|NCT04491773|Tadalafil|tadalafil|mesh-list
44865805|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865806|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44865807|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44865808|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865809|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865810|NCT04491773|Urological Agents|urological agents|mesh-ancestor
44865811|NCT04491786|Gabapentin|gabapentin|mesh-list
44865812|NCT04491786|Nefopam|nefopam|mesh-list
44865813|NCT04491786|Analgesics|analgesics|mesh-ancestor
44865814|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
44865815|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865816|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865817|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
44865818|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44865819|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44865820|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865821|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44865822|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44865823|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44865824|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865825|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865826|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
44865827|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44865828|NCT04491474|Lidocaine|lidocaine|mesh-list
44865829|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
44865830|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
44865831|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865832|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865833|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
44865834|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865835|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44865836|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44865837|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44865838|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44865839|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652265|NCT00168805|Enoxaparin|enoxaparin|mesh-list
44865840|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
44865841|NCT04491357|Calcium|calcium|mesh-list
44865842|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44865843|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865844|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44865845|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
44865846|NCT04490967|Salicylates|salicylates|mesh-list
44865847|NCT04490967|Silybin|silybin|mesh-list
44865848|NCT04490967|Silymarin|silymarin|mesh-list
44865849|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
44865850|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865851|NCT04490967|Protective Agents|protective agents|mesh-ancestor
44865852|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865853|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865854|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
44865855|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
44865856|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
44865857|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44865858|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44865859|NCT04490967|Analgesics|analgesics|mesh-ancestor
44865860|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
44353103|NCT01093092|Vitamins|vitamins|mesh-ancestor
44865861|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865862|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865863|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865864|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44865865|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865866|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865867|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865868|NCT04490837|Antibodies|antibodies|mesh-list
44865869|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
44865870|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865871|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
44865872|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44865873|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865874|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865875|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865876|NCT04490980|Butorphanol|butorphanol|mesh-list
44865877|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44865878|NCT04490980|Narcotics|narcotics|mesh-ancestor
44865879|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865880|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865881|NCT04490980|Analgesics|analgesics|mesh-ancestor
44865882|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
44865883|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353152|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865884|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
44865885|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
44865886|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44865887|NCT04490694|Lenvatinib|lenvatinib|mesh-list
44865888|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865889|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44865890|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865891|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865892|NCT04490590|Etoposide|etoposide|mesh-list
44865893|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865894|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865895|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44865896|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865897|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865898|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865899|NCT04490434|Celecoxib|celecoxib|mesh-list
44865900|NCT04490434|Naproxen|naproxen|mesh-list
44865901|NCT04490434|Meloxicam|meloxicam|mesh-list
44865902|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44865903|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44865904|NCT04490434|Analgesics|analgesics|mesh-ancestor
44865905|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
44865906|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865907|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133116|NCT00152867|Hormones|hormones|mesh-ancestor
44865908|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44865909|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44865910|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44865911|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44865912|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865913|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865914|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
44865915|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44865916|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865917|NCT04490421|Cisplatin|cisplatin|mesh-list
44865918|NCT04490421|Etoposide|etoposide|mesh-list
44865919|NCT04490421|Apatinib|apatinib|mesh-list
44865920|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865921|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44865922|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44865923|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44865924|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865925|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865926|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44865927|NCT04490031|Ketamine|ketamine|mesh-list
44865928|NCT04490031|Analgesics|analgesics|mesh-ancestor
44865929|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
44865930|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44865931|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865932|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44865933|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44865934|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
44865935|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
44353204|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
44865936|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44865937|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44865938|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44865939|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44865940|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865941|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44865942|NCT04490213|Laxatives|laxatives|mesh-ancestor
44865943|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865944|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
44865945|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865946|NCT04489745|Androgens|androgens|mesh-list
44865947|NCT04489745|Hormones|hormones|mesh-ancestor
44865948|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44865949|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865950|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
44865951|NCT04489797|Rabeprazole|rabeprazole|mesh-list
44865952|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44865953|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44865954|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44865955|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865956|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865957|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44865958|NCT04489849|Apixaban|apixaban|mesh-list
44865959|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44865960|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
44865961|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44865962|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
44865963|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865964|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865965|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
44865966|NCT04489459|Meropenem|meropenem|mesh-list
44865967|NCT04489459|Colistin|colistin|mesh-list
44865968|NCT04489459|Tigecycline|tigecycline|mesh-list
44865969|NCT04489459|Polymyxins|polymyxins|mesh-list
44865970|NCT04489459|Polymyxin B|polymyxin b|mesh-list
44865971|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44865972|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865973|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44865974|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865975|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865976|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
44865977|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
44865978|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44865979|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44865980|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44865981|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44865982|NCT04489446|Urological Agents|urological agents|mesh-ancestor
44865983|NCT04489147|Metformin|metformin|mesh-list
44865984|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44865985|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44865986|NCT04489121|Omalizumab|omalizumab|mesh-list
44865987|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44865988|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44652420|NCT00163657|Cyclosporine|cyclosporine|mesh-list
44865989|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44865990|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
44865991|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44865992|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44865993|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44865994|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44865995|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44865996|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
44865997|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652491|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44865998|NCT04488705|Albuterol|albuterol|mesh-list
44865999|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44866000|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
44866001|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866002|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866003|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44866004|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
44866005|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
44866006|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44866007|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44866008|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44866009|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866010|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866011|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866012|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866013|NCT04488744|Nicotine|nicotine|mesh-list
44866014|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44866015|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
44866016|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866017|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866018|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44866019|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44866020|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
44866021|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353276|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866022|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866023|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
44866024|NCT04488614|Estrogens|estrogens|mesh-list
44866025|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44866026|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866027|NCT04488614|Hormones|hormones|mesh-ancestor
44866028|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866029|NCT04488926|Palmidrol|palmidrol|mesh-list
44866030|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866031|NCT04488926|Analgesics|analgesics|mesh-ancestor
44866032|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
44866033|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866034|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866035|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866036|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866037|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866038|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
44866039|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866040|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44866041|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44866042|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866043|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866044|NCT04488926|Hormones|hormones|mesh-ancestor
44866045|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866046|NCT04488107|Letrozole|letrozole|mesh-list
44866047|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866048|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44866049|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44866050|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866051|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866052|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44866053|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44866054|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866055|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866056|NCT04488172|Vitamins|vitamins|mesh-list
44866057|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
44866058|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866059|NCT04487951|Vitamin D|vitamin d|mesh-list
44866060|NCT04487951|Vitamins|vitamins|mesh-ancestor
44866061|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
44866062|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866063|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44866064|NCT04487743|Liraglutide|liraglutide|mesh-list
44866065|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866066|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866067|NCT04487743|Incretins|incretins|mesh-ancestor
44866068|NCT04487743|Hormones|hormones|mesh-ancestor
44866069|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866070|NCT04487834|Simethicone|simethicone|mesh-list
44866071|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
44866072|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866074|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866075|NCT04487587|Olaparib|olaparib|mesh-list
44866076|NCT04487587|Cediranib|cediranib|mesh-list
44866077|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44866078|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866079|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866080|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866081|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44866082|NCT04487392|Estrogens|estrogens|mesh-list
44866083|NCT04487392|Hormones|hormones|mesh-ancestor
44866084|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866085|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866086|NCT04487106|Azacitidine|azacitidine|mesh-list
44866087|NCT04487106|Venetoclax|venetoclax|mesh-list
44866088|NCT04487106|Trametinib|trametinib|mesh-list
44866089|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866090|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
44866091|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866092|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866093|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866094|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44866095|NCT04487093|Vaccines|vaccines|mesh-list
44866096|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
44866097|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866098|NCT04486690|Ketamine|ketamine|mesh-list
44866099|NCT04486690|Propofol|propofol|mesh-list
44866100|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44866101|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866102|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866103|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44866104|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
44866105|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
44866106|NCT04486690|Analgesics|analgesics|mesh-ancestor
44866107|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
44866108|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866109|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44866110|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44866111|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44866112|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866113|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866114|NCT04486651|Irinotecan|irinotecan|mesh-list
44866115|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44866116|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44866117|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866118|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866119|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866120|NCT04486508|Heparin|heparin|mesh-list
44866121|NCT04486508|Calcium heparin|calcium heparin|mesh-list
44866122|NCT04486508|Enoxaparin|enoxaparin|mesh-list
44866123|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
44866124|NCT04486508|Atorvastatin|atorvastatin|mesh-list
44866125|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44866126|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44866127|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44866128|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
44866129|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866130|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44866131|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866132|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
44866133|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44866134|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44353406|NCT01094990|Hormones|hormones|mesh-ancestor
44866135|NCT04486612|Anesthetics|anesthetics|mesh-list
44866136|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866137|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866138|NCT04486430|Salicylates|salicylates|mesh-list
44866139|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866140|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866141|NCT04486430|Analgesics|analgesics|mesh-ancestor
44866142|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
44866143|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866144|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866145|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866146|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866147|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44866148|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866149|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866150|NCT04486521|Siltuximab|siltuximab|mesh-list
44866151|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44697984|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866152|NCT04486092|Valproic Acid|valproic acid|mesh-list
44866153|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
44866154|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866155|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866156|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
44866157|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866158|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866159|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
44353429|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866160|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44866161|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866162|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44866163|NCT04485845|Metformin|metformin|mesh-list
44866164|NCT04485845|Vildagliptin|vildagliptin|mesh-list
44866165|NCT04485845|Captopril|captopril|mesh-list
44866166|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866167|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866168|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44866169|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44866170|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866171|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866172|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44866173|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44866174|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44866175|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44866176|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866177|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866178|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866179|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866180|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
44866181|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44866182|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44866183|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44866184|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44866185|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866186|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
44866187|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866188|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866189|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44866190|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866191|NCT04485702|Midazolam|midazolam|mesh-list
44866192|NCT04485702|Ketamine|ketamine|mesh-list
44866193|NCT04485702|Analgesics|analgesics|mesh-ancestor
44866194|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
44866195|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866196|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866197|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44866198|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44866199|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
44866200|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
44353457|NCT01095172|Hormones|hormones|mesh-ancestor
44866201|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866202|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44866203|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44866204|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866205|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866206|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44866207|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44866208|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44866209|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44866210|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44866211|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
44866212|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
44866213|NCT04485585|Tamsulosin|tamsulosin|mesh-list
44866214|NCT04485585|Mirabegron|mirabegron|mesh-list
44866215|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44866216|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44866217|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44866218|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866219|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866220|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866221|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866222|NCT04485585|Urological Agents|urological agents|mesh-ancestor
44866223|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44866224|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44652796|NCT00149825|Dexetimide|dexetimide|mesh-list
44866225|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866226|NCT04485689|Capsaicin|capsaicin|mesh-list
44866227|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
44866228|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866229|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
44866230|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866231|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866232|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
44866233|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44866234|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866235|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
44866236|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
44866237|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44866238|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44866239|NCT04485429|Prednisolone|prednisolone|mesh-list
44866240|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
44866241|NCT04485429|Heparin|heparin|mesh-list
44866242|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44866243|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
44866244|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866245|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
44866246|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
44866247|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866248|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866249|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866250|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
44866251|NCT04485429|Hormones|hormones|mesh-ancestor
44866252|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866253|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866254|NCT04485429|Protective Agents|protective agents|mesh-ancestor
44866255|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866256|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866257|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
44866258|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44866259|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44866260|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866261|NCT04485299|Listerine|listerine|mesh-list
44866262|NCT04485299|Fluorides|fluorides|mesh-list
44866263|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
44866264|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
44866265|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
44866266|NCT04485299|Protective Agents|protective agents|mesh-ancestor
44866267|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866268|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44866269|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866270|NCT04485403|Ibuprofen|ibuprofen|mesh-list
44866271|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866272|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866273|NCT04485403|Analgesics|analgesics|mesh-ancestor
44866274|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
44866275|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866276|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866277|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866278|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866279|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44866280|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866281|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866282|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
44866283|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44866284|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866285|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
44866286|NCT04485117|Anesthetics|anesthetics|mesh-list
44866287|NCT04485117|Propofol|propofol|mesh-list
44866288|NCT04485117|Sevoflurane|sevoflurane|mesh-list
44866289|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866290|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866291|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44866292|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44866293|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
44866294|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44866295|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44866296|NCT04485156|Rifampin|rifampin|mesh-list
44866297|NCT04485156|Isoniazid|isoniazid|mesh-list
44866298|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
44866299|NCT04485156|Ethambutol|ethambutol|mesh-list
44866300|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44866301|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
44866302|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44866303|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866304|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
44866305|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44866306|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866307|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866308|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44866309|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44866310|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44866311|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44866312|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44866313|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44866314|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44866315|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44866316|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
44866317|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44866318|NCT04485065|Azacitidine|azacitidine|mesh-list
44866319|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866320|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
44866321|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866322|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866323|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866324|NCT04485052|Azacitidine|azacitidine|mesh-list
44866325|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866326|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
44866327|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866328|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866329|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866330|NCT04484688|Bisoprolol|bisoprolol|mesh-list
44866331|NCT04484688|Perindopril|perindopril|mesh-list
44866332|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44866333|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
44866334|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
44866335|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866336|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866337|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44866338|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44866339|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44866340|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866341|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866342|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866343|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44866344|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44866345|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866346|NCT04484779|Insulin|insulin|mesh-list
44866347|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
44866348|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
44866349|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866350|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866351|NCT04484844|Listerine|listerine|mesh-list
44866352|NCT04484844|Fluorides|fluorides|mesh-list
44866353|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
44866354|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
44866355|NCT04484844|Protective Agents|protective agents|mesh-ancestor
44866356|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866357|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44866358|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866359|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
44866360|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866361|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866362|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44866363|NCT04484506|Prednisone|prednisone|mesh-list
44697985|NCT05272865|Dronabinol|dronabinol|mesh-list
44697986|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
44697987|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44697988|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44697989|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44697990|NCT05272865|Analgesics|analgesics|mesh-ancestor
44697991|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
44697992|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44697993|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44353637|NCT01096277|Incretins|incretins|mesh-ancestor
44353664|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44697994|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44697995|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44697996|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44697997|NCT05272865|Hormones|hormones|mesh-ancestor
44652939|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
44866364|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
44866365|NCT04484506|Etoposide|etoposide|mesh-list
44866366|NCT04484506|Vincristine|vincristine|mesh-list
44866367|NCT04484506|Pegaspargase|pegaspargase|mesh-list
44866368|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866369|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
44866370|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866371|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866372|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44866373|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
44866374|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866375|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866376|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44866377|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866378|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
44866379|NCT04484506|Hormones|hormones|mesh-ancestor
44866380|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866381|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866382|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44866383|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44866384|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44866385|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866386|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
44866387|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
44866388|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
44866389|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44866390|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44866391|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44866392|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866393|NCT04484467|Menthol|menthol|mesh-list
44866394|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
44866395|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866396|NCT04484259|Aspirin|aspirin|mesh-list
44866397|NCT04484259|Clopidogrel|clopidogrel|mesh-list
44866398|NCT04484259|Ticagrelor|ticagrelor|mesh-list
44866399|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866400|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866401|NCT04484259|Analgesics|analgesics|mesh-ancestor
44866402|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
44866403|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866404|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866405|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866406|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866407|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44866408|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44866409|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866410|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44866411|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44866412|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866413|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
44866414|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44866415|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44866416|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44866417|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
44866418|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866419|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44866420|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
44866421|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44866422|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
44866423|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866424|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44866425|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44866426|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44866427|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866428|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653001|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44866429|NCT04483765|Anesthetics|anesthetics|mesh-list
44866430|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866431|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866432|NCT04483596|Melatonin|melatonin|mesh-list
44866433|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
44866434|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866435|NCT04483596|Protective Agents|protective agents|mesh-ancestor
44866436|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866437|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866438|NCT04483427|Ketorolac|ketorolac|mesh-list
44866439|NCT04483427|Nalbuphine|nalbuphine|mesh-list
44866440|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866441|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866442|NCT04483427|Analgesics|analgesics|mesh-ancestor
44866443|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
44866444|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866445|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866446|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866447|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866448|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44866449|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866450|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866451|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44866452|NCT04483427|Narcotics|narcotics|mesh-ancestor
44866453|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866454|NCT04483635|Vitamin D|vitamin d|mesh-list
44866455|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
44866456|NCT04483635|Vitamins|vitamins|mesh-ancestor
44866457|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
44866458|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866459|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44866460|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44866461|NCT04483674|Tenofovir|tenofovir|mesh-list
44866462|NCT04483674|Emtricitabine|emtricitabine|mesh-list
44866463|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
44866464|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866465|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44866466|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44866467|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866468|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866469|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44866470|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44866471|NCT04483492|Caffeine|caffeine|mesh-list
44866472|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
44866473|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866474|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44866475|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866476|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44866477|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866478|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44866479|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44866480|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
44866481|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866482|NCT04483258|Sevoflurane|sevoflurane|mesh-list
44866483|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44866484|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44866485|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
44866486|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
44866487|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866488|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866489|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
44866490|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44866491|NCT04483284|Estrogens|estrogens|mesh-ancestor
44866492|NCT04483284|Hormones|hormones|mesh-ancestor
44866493|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866494|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866495|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866496|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866497|NCT04483219|Antibodies|antibodies|mesh-list
44866498|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
44866499|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866500|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
44866501|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44866502|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44866503|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866505|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866506|NCT04482907|Hormones|hormones|mesh-list
44353765|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
44866507|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866508|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866509|NCT04482842|Warfarin|warfarin|mesh-list
44866510|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
44866511|NCT04482881|Isosorbide|isosorbide|mesh-list
44866512|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44866513|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44866514|NCT04482881|Misoprostol|misoprostol|mesh-list
44866515|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44866516|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
44866517|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44866518|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866519|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44866520|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866521|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
44866522|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44866523|NCT04482881|Diuretics|diuretics|mesh-ancestor
44866524|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
44866525|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
44866526|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44866527|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866528|NCT04482985|Meclizine|meclizine|mesh-list
44866529|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
44866530|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
44866531|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866532|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866533|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866534|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44866535|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
44866536|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
44866537|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866538|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866539|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44866540|NCT04482504|Vitamin D|vitamin d|mesh-list
44866541|NCT04482504|Vitamins|vitamins|mesh-ancestor
44866542|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
44866543|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866544|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44866545|NCT04482712|Sirolimus|sirolimus|mesh-list
44866546|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44866547|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866548|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44866549|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866550|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
44866551|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866552|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
44866553|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866554|NCT04482764|Valproic Acid|valproic acid|mesh-list
44866555|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
44866556|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866557|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866558|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
44866559|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866560|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866561|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
44866562|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44866563|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866564|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44866565|NCT04482543|Methotrexate|methotrexate|mesh-list
44866566|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44866567|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
44866568|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44866569|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866570|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866571|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
44866572|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866573|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866574|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866575|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866576|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44866577|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866578|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
44866579|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866580|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44866581|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
44866582|NCT04482296|Astringents|astringents|mesh-ancestor
44866583|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866584|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866585|NCT04482257|Irinotecan|irinotecan|mesh-list
44866586|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44866587|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44866588|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353870|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866589|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866590|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866591|NCT04481802|Acemannan|acemannan|mesh-list
44866592|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44866593|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
44866594|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866595|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866596|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
44866597|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866598|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866599|NCT04481815|Rituximab|rituximab|mesh-list
44866600|NCT04481815|Methotrexate|methotrexate|mesh-list
44866601|NCT04481815|Lenalidomide|lenalidomide|mesh-list
44866602|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44866603|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866604|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
44866605|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866606|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866607|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44866608|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
44866609|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44866610|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866611|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
44866612|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866613|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866614|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866615|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44866616|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866617|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44866618|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44866619|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44866620|NCT04481815|Growth Substances|growth substances|mesh-ancestor
44866621|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44866622|NCT04481841|Vitamins|vitamins|mesh-list
44866623|NCT04481841|Vitamin E|vitamin e|mesh-list
44866624|NCT04481841|Riboflavin|riboflavin|mesh-list
44866625|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
44866626|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866627|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
44866628|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
44866629|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866630|NCT04481841|Protective Agents|protective agents|mesh-ancestor
44866631|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44866632|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
44866633|NCT04481971|Prednisolone|prednisolone|mesh-list
44866634|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866635|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
44866636|NCT04481971|Hormones|hormones|mesh-ancestor
44866637|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866638|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866639|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866640|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866641|NCT04481750|Edaravone|edaravone|mesh-list
44866642|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44866643|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
44866644|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866645|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866646|NCT04481750|Protective Agents|protective agents|mesh-ancestor
44866647|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866648|NCT04481789|Furosemide|furosemide|mesh-list
44866649|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
44866650|NCT04481789|Edaravone|edaravone|mesh-list
44866651|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44866652|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44866653|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44866654|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
44653233|NCT00141219|Pregabalin|pregabalin|mesh-list
44866655|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866656|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44866657|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44866659|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
44866660|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44866661|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44866662|NCT04481789|Urological Agents|urological agents|mesh-ancestor
44866663|NCT04481789|Diuretics|diuretics|mesh-ancestor
44866664|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
44866665|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866666|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44866667|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44866668|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44866669|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
44866670|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866671|NCT04481789|Protective Agents|protective agents|mesh-ancestor
44866672|NCT04481932|Trastuzumab|trastuzumab|mesh-list
44866673|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44866674|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866675|NCT04481282|Terbutaline|terbutaline|mesh-list
44866676|NCT04481282|Danazol|danazol|mesh-list
44866677|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44866678|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
44866679|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866680|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866681|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44866682|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
44866683|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
44866684|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
44866685|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44866686|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44866687|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44866688|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866689|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866690|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866691|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866692|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44866693|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44866694|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866695|NCT04481100|Itraconazole|itraconazole|mesh-list
44866696|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
44866697|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866698|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44866699|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44866700|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866701|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866702|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44866703|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
44866704|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866705|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866706|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44866708|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866709|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
44866710|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44866711|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44866712|NCT04480775|Prednisolone|prednisolone|mesh-list
44866713|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
44866714|NCT04480775|Triamcinolone|triamcinolone|mesh-list
44866715|NCT04480775|Bupivacaine|bupivacaine|mesh-list
44866716|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44866717|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
44866718|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
44866719|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
44866720|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866721|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866722|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
44866723|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866724|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866725|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
44866726|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
44866727|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866728|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
44866729|NCT04480775|Hormones|hormones|mesh-ancestor
44866730|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866731|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866732|NCT04480775|Protective Agents|protective agents|mesh-ancestor
44866733|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866734|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866735|NCT04480593|Propolis|propolis|mesh-list
44866736|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866737|NCT04480281|Lidocaine|lidocaine|mesh-list
44866738|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
44866739|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
44866740|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866741|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866742|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
44866743|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866744|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44866745|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44866746|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44866747|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44866748|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866749|NCT04480268|Gemcitabine|gemcitabine|mesh-list
44866750|NCT04480268|Paclitaxel|paclitaxel|mesh-list
44866751|NCT04480268|Cisplatin|cisplatin|mesh-list
44866752|NCT04480268|Capecitabine|capecitabine|mesh-list
44866753|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44866754|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866755|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44866756|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44866757|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44866758|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866759|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44866760|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
44866761|NCT04480268|Antiviral Agents|antiviral agents|mesh-ancestor
44866762|NCT04480268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866763|NCT04480268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866764|NCT04480268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866765|NCT04480268|Immunologic Factors|immunologic factors|mesh-ancestor
44866766|NCT04480268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866767|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
44866768|NCT04480333|Remdesivir|remdesivir|mesh-list
44866769|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
44866770|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866771|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
44866772|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866773|NCT04480333|Protective Agents|protective agents|mesh-ancestor
44354060|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44866774|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866775|NCT04480359|Meloxicam|meloxicam|mesh-list
44866776|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44866777|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44866778|NCT04480359|Analgesics|analgesics|mesh-ancestor
44866779|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
44866780|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866781|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653377|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
44866782|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866783|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866784|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44866785|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44866786|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866787|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866788|NCT04479748|Dexamethasone|dexamethasone|mesh-list
44866789|NCT04479748|Prednisolone|prednisolone|mesh-list
44866790|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44866791|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
44866792|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44866793|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
44866794|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44866795|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
44866796|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44866797|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
44866798|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
44866799|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866800|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866801|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44866802|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
44866803|NCT04479748|Hormones|hormones|mesh-ancestor
44866804|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354072|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866805|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44866806|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866807|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866808|NCT04479748|Protective Agents|protective agents|mesh-ancestor
44866809|NCT04479865|Donepezil|donepezil|mesh-list
44866810|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44866811|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866812|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866813|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
44866814|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866815|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866816|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
44866817|NCT04479891|Itraconazole|itraconazole|mesh-list
44866818|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
44866819|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866820|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44866821|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44866822|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866823|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866824|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44866825|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
44866826|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44866827|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866828|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44866829|NCT04479527|Apatinib|apatinib|mesh-list
44866830|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866831|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44866832|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866833|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866834|NCT04479202|Bentonite|bentonite|mesh-list
44866835|NCT04479202|Antidotes|antidotes|mesh-ancestor
44866836|NCT04479202|Protective Agents|protective agents|mesh-ancestor
44866837|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866838|NCT04479371|Bupivacaine|bupivacaine|mesh-list
44866839|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
44866840|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
44866841|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866842|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866843|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
44866844|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866845|NCT04479449|Otaplimastat|otaplimastat|mesh-list
44866846|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44866847|NCT04479449|Protective Agents|protective agents|mesh-ancestor
44866848|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866849|NCT04478617|Metronidazole|metronidazole|mesh-list
44866850|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866851|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44866852|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44866853|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44866854|NCT04478448|Favipiravir|favipiravir|mesh-list
44866855|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
44866856|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866857|NCT04478461|Antibodies|antibodies|mesh-list
44866858|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44866859|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
44866860|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866861|NCT04478526|Norepinephrine|norepinephrine|mesh-list
44866862|NCT04478526|Serotonin|serotonin|mesh-list
44866863|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44866864|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
44866865|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44866866|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866867|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866868|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866869|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866870|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866871|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
44866872|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
44354154|NCT01099748|Methadone|methadone|mesh-list
44866873|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866874|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44866875|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44866876|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
44866877|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44866878|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44866879|NCT04478357|Fesoterodine|fesoterodine|mesh-list
44866880|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44866881|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44866882|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
44866883|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866884|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866885|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866886|NCT04478357|Urological Agents|urological agents|mesh-ancestor
44866887|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
44866888|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44866889|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44866890|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866891|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866892|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44866893|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44866894|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44866895|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44866896|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866897|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866898|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
44866899|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44866900|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
44866901|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44866902|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44866903|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866904|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44866905|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44866906|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44866907|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866908|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866910|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44866911|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866912|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44866913|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44866914|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
44866915|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866916|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866917|NCT04477811|Vitamins|vitamins|mesh-list
44866918|NCT04477811|Vitamin K|vitamin k|mesh-list
44866919|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
44866920|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
44866921|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
44866922|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866923|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44866924|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44866925|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866926|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
44866927|NCT04477811|Coagulants|coagulants|mesh-ancestor
44866928|NCT04477590|Metformin|metformin|mesh-list
44866929|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44866930|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866931|NCT04477525|Bupivacaine|bupivacaine|mesh-list
44866932|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
44866933|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
44866934|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866935|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866936|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
44866937|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866938|NCT04477317|Epinephrine|epinephrine|mesh-list
44866939|NCT04477317|Racepinephrine|racepinephrine|mesh-list
44866940|NCT04477317|Nordefrin|nordefrin|mesh-list
44866941|NCT04477317|Mepivacaine|mepivacaine|mesh-list
44866942|NCT04477317|Carticaine|carticaine|mesh-list
44866943|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
44866944|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44866945|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866946|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866947|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44866948|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866949|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866950|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44866951|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44866952|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
44866953|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44866954|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44866955|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
44866956|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
44866957|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
44866958|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44866959|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
44866960|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
44866961|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44866962|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
44866963|NCT04477096|Emtricitabine|emtricitabine|mesh-list
44866964|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
44866965|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866966|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44866967|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44866968|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866969|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866970|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44866971|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44866972|NCT04476966|Mirabegron|mirabegron|mesh-list
44866973|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44866974|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44866975|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44866976|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
44866977|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354249|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354250|NCT01100294|Vaccines|vaccines|mesh-list
44866978|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866979|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866980|NCT04476966|Urological Agents|urological agents|mesh-ancestor
44866981|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
44866982|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
44866983|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44866984|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44866985|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44866986|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44866987|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866988|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44866989|NCT04477018|Ascorbic Acid|ascorbic acid|mesh-list
44866990|NCT04477018|Iron|iron|mesh-list
44866991|NCT04477018|Chelating Agents|chelating agents|mesh-list
44866992|NCT04477018|Vitamins|vitamins|mesh-ancestor
44866993|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
44866994|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44866995|NCT04477018|Trace Elements|trace elements|mesh-ancestor
44866996|NCT04477018|Antioxidants|antioxidants|mesh-ancestor
44866997|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44866998|NCT04477018|Protective Agents|protective agents|mesh-ancestor
44866999|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
44867000|NCT04476680|Vitamin D|vitamin d|mesh-list
44867001|NCT04476680|Vitamins|vitamins|mesh-ancestor
44867002|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
44867003|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867004|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44867005|NCT04476459|Apatinib|apatinib|mesh-list
44867006|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867007|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44867008|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867009|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867010|NCT04476121|Aspirin|aspirin|mesh-list
44867011|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867012|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867013|NCT04476121|Analgesics|analgesics|mesh-ancestor
44867014|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
44867015|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867016|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354277|NCT01100372|Antiviral Agents|antiviral agents|mesh-ancestor
44867017|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867018|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867019|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44867020|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44867021|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867022|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44867023|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44867024|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867025|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
44867026|NCT04476173|Morphine|morphine|mesh-list
44867027|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
44867028|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44867029|NCT04476173|Narcotics|narcotics|mesh-ancestor
44867030|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867031|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867032|NCT04476173|Analgesics|analgesics|mesh-ancestor
44867033|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
44867034|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867035|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44867036|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
44867037|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
44867038|NCT04476186|Acyclovir|acyclovir|mesh-list
44867039|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
44867040|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867041|NCT04476069|Ibuprofen|ibuprofen|mesh-list
44867042|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867043|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867044|NCT04476069|Analgesics|analgesics|mesh-ancestor
44867045|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
44867046|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867047|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867048|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867049|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867050|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44867051|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867052|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867053|NCT04475887|Iron|iron|mesh-list
44867054|NCT04475887|Trace Elements|trace elements|mesh-ancestor
44867055|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
44867056|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867057|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
44867058|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
44653689|NCT00133991|Hormones|hormones|mesh-ancestor
44867059|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867060|NCT04475276|Protective Agents|protective agents|mesh-ancestor
44867061|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867062|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
44867063|NCT04475276|Vitamins|vitamins|mesh-ancestor
44867064|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
44867065|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
44867066|NCT04475614|Vitamins|vitamins|mesh-ancestor
44867067|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
44867068|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867069|NCT04475107|Artesunate|artesunate|mesh-list
44867070|NCT04475107|Pyronaridine|pyronaridine|mesh-list
44867071|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
44867072|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44867073|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44867074|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867075|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867076|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
44867077|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
44867078|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44867079|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
44867080|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
44867081|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44867082|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867083|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44867084|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653754|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
44867085|NCT04475120|Lactoferrin|lactoferrin|mesh-list
44867086|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867087|NCT04475029|Morphine|morphine|mesh-list
44867088|NCT04475029|Methadone|methadone|mesh-list
44867089|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44867090|NCT04475029|Narcotics|narcotics|mesh-ancestor
44867091|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867092|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867093|NCT04475029|Analgesics|analgesics|mesh-ancestor
44867094|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
44867095|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867096|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
44867097|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
44867098|NCT04474457|Favipiravir|favipiravir|mesh-list
44867099|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
44867100|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867101|NCT04474327|Montelukast|montelukast|mesh-list
44867102|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44867103|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
44867104|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44867105|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44867106|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867107|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867108|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44867109|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44867110|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867111|NCT04474262|Midodrine|midodrine|mesh-list
44867112|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
44867113|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
44867114|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867115|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867116|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44867117|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44867118|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44867119|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44867120|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867121|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867122|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867123|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
44867124|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
44867125|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867126|NCT04474288|Antibodies|antibodies|mesh-list
44867127|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
44867128|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867129|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
44867130|NCT04474093|Methamphetamine|methamphetamine|mesh-list
44867131|NCT04474093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44867132|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867133|NCT04474093|Sympathomimetics|sympathomimetics|mesh-ancestor
44867134|NCT04474093|Autonomic Agents|autonomic agents|mesh-ancestor
44867135|NCT04474093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867136|NCT04474093|Dopamine Agents|dopamine agents|mesh-ancestor
44867137|NCT04474093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867138|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867139|NCT04474093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867140|NCT04474093|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44867141|NCT04474093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44867142|NCT04474093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867143|NCT04474093|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44867144|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
44867145|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44867146|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867147|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
44867148|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44867149|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867150|NCT04473989|Teriparatide|teriparatide|mesh-list
44867151|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44867152|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867153|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44867154|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
44867155|NCT04473911|Sirolimus|sirolimus|mesh-list
44867156|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
44867157|NCT04473911|Melphalan|melphalan|mesh-list
44867158|NCT04473911|Fludarabine|fludarabine|mesh-list
44867159|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653865|NCT00131352|Hylan|hylan|mesh-list
44867160|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
44867161|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867162|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867163|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44867164|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
44867165|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867166|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867167|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44867168|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44867169|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44867170|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
44867171|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867172|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867173|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867174|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
44867175|NCT04473820|Lidocaine|lidocaine|mesh-list
44867176|NCT04473820|Prilocaine|prilocaine|mesh-list
44867177|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44867178|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
44867179|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
44867180|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867181|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867182|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
44867183|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867184|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867185|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44867186|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44867187|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867188|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867189|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44867190|NCT04473846|Anesthetics|anesthetics|mesh-list
44867191|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867192|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867193|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
44867194|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44867195|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867196|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44867197|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867198|NCT04473274|Pioglitazone|pioglitazone|mesh-list
44867199|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44867200|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867201|NCT04473261|Iodine|iodine|mesh-list
44867202|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
44867203|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44867204|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867205|NCT04473261|Trace Elements|trace elements|mesh-ancestor
44867206|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
44867207|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867208|NCT04473053|Nafamostat|nafamostat|mesh-list
44867209|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867210|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44697998|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44697999|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44698000|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698001|NCT05272696|Paclitaxel|paclitaxel|mesh-list
44698002|NCT05272696|Cisplatin|cisplatin|mesh-list
44698003|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
44698004|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44698005|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698006|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44698007|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44698008|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44698009|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698010|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698011|NCT05272462|Minoxidil|minoxidil|mesh-list
44698012|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44698013|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
44698014|NCT05272371|Dinutuximab|dinutuximab|mesh-list
44698015|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698016|NCT05271539|Dexamethasone|dexamethasone|mesh-list
44698017|NCT05271539|Ranibizumab|ranibizumab|mesh-list
44698018|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698019|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
44698020|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
44698035|NCT05271448|Candesartan|candesartan|mesh-list
44867212|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
44867213|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867214|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867215|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867216|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867217|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
44867218|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
44867219|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867220|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867221|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44867222|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44867223|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44867224|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867225|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
44867226|NCT04473144|Urinastatin|urinastatin|mesh-list
44867227|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44867228|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44867229|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
44867230|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867231|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867232|NCT04472910|Folfirinox|folfirinox|mesh-list
44867233|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867234|NCT04472585|Ivermectin|ivermectin|mesh-list
44867235|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44867236|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867237|NCT04472806|Endostar protein|endostar protein|mesh-list
44867238|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44867239|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44867240|NCT04472806|Growth Substances|growth substances|mesh-ancestor
44867241|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867242|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44867243|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867244|NCT04472689|Lidocaine|lidocaine|mesh-list
44867245|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
44867246|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
44867247|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867248|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867249|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
44867250|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867251|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867252|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44867253|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44867254|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867255|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867256|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
44867257|NCT04472481|Vitamin D|vitamin d|mesh-list
44867258|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44867259|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867260|NCT04472481|Vitamins|vitamins|mesh-ancestor
44867261|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
44867262|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44867263|NCT04471922|Rabeprazole|rabeprazole|mesh-list
44867264|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44867265|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44867266|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44867267|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867268|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653956|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
44867269|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44354545|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
44867270|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867271|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867272|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
44867273|NCT04471441|Everolimus|everolimus|mesh-list
44867274|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867275|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867276|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
44867277|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867278|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44867279|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44867280|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
44867281|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867282|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867283|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867284|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867285|NCT04470908|Rifabutin|rifabutin|mesh-list
44867286|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
44867287|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867288|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44867289|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867290|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867291|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867292|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867293|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44867294|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
44867295|NCT04470479|Pilocarpine|pilocarpine|mesh-list
44867296|NCT04470479|Miotics|miotics|mesh-ancestor
44867297|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
44867298|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867299|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867300|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44867301|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44867302|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
44867303|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867304|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867305|NCT04470752|Capsaicin|capsaicin|mesh-list
44867306|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44867307|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
44867308|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867309|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
44867310|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867311|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867312|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44867313|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44867314|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867315|NCT04470531|Renal Agents|renal agents|mesh-ancestor
44867316|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867317|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
44867318|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44867319|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44867320|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
44867321|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44867322|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44867323|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867324|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
44867325|NCT04470557|Coagulants|coagulants|mesh-ancestor
44867326|NCT04470414|Antibodies|antibodies|mesh-list
44867327|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
44867328|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
44867329|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867330|NCT04470544|Camostat|camostat|mesh-list
44867331|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44867332|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867333|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867334|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44867335|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44867336|NCT04470791|Antivenins|antivenins|mesh-list
44867337|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
44867338|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867339|NCT04470609|Vaccines|vaccines|mesh-list
44867340|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
44867341|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867342|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44867343|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44867344|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44867345|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867346|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867347|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
44867348|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867349|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867350|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44867351|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867352|NCT04470076|Gemcitabine|gemcitabine|mesh-list
44867353|NCT04470076|Cisplatin|cisplatin|mesh-list
44867354|NCT04470076|Carboplatin|carboplatin|mesh-list
44867355|NCT04470076|Pemetrexed|pemetrexed|mesh-list
44867356|NCT04470076|Afatinib|afatinib|mesh-list
44867357|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867358|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44867359|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
44867360|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867361|NCT04470076|Antiviral Agents|antiviral agents|mesh-ancestor
44867362|NCT04470076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867363|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867364|NCT04470076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867365|NCT04470076|Immunologic Factors|immunologic factors|mesh-ancestor
44867366|NCT04470076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867367|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44867368|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44867369|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44867370|NCT04470310|Pioglitazone|pioglitazone|mesh-list
44867371|NCT04470310|Glimepiride|glimepiride|mesh-list
44867372|NCT04470310|Alogliptin|alogliptin|mesh-list
44867373|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44867374|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867375|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867376|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867377|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
44867378|NCT04470310|Incretins|incretins|mesh-ancestor
44867379|NCT04470310|Hormones|hormones|mesh-ancestor
44867380|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867381|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44867382|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354665|NCT01103115|Vitamin D|vitamin d|mesh-list
44867383|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867384|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867385|NCT04470115|Anesthetics|anesthetics|mesh-list
44867386|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867387|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867388|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
44867389|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44867390|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867391|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867392|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867393|NCT04470050|Analgesics|analgesics|mesh-ancestor
44867394|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
44867395|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867396|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44867397|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44354694|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
44867398|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44867399|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867400|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867401|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867402|NCT04469829|Methotrexate|methotrexate|mesh-list
44867403|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44867404|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
44867405|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44867406|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867407|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44867408|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
44867409|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867410|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867411|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867412|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867413|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44867414|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867415|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
44867416|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867417|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44867418|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
44867419|NCT04469777|Hematinics|hematinics|mesh-ancestor
44867420|NCT04469413|Acetaminophen|acetaminophen|mesh-list
44867421|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867422|NCT04469413|Analgesics|analgesics|mesh-ancestor
44867423|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
44867424|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867425|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867426|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
44867427|NCT04469283|Caffeine|caffeine|mesh-list
44867428|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44867429|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867430|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44867431|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354708|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
44867432|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867433|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44867434|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44867435|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
44867436|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867437|NCT04469010|Ascorbic Acid|ascorbic acid|mesh-list
44867438|NCT04469010|Iron|iron|mesh-list
44867439|NCT04469010|Chelating Agents|chelating agents|mesh-list
44867440|NCT04469010|Vitamins|vitamins|mesh-ancestor
44867441|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
44867442|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867443|NCT04469010|Trace Elements|trace elements|mesh-ancestor
44867444|NCT04469010|Antioxidants|antioxidants|mesh-ancestor
44867445|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867446|NCT04469010|Protective Agents|protective agents|mesh-ancestor
44867447|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
44867448|NCT04469114|Tofacitinib|tofacitinib|mesh-list
44867449|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44867450|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867451|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867452|NCT04469062|Mirikizumab|mirikizumab|mesh-list
44867453|NCT04469062|Vedolizumab|vedolizumab|mesh-list
44867454|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44867455|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867456|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867457|NCT04469062|Analgesics|analgesics|mesh-ancestor
44867458|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
44867459|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867460|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867461|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867462|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867463|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44867464|NCT04468711|Vitamin D|vitamin d|mesh-list
44867465|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
44867466|NCT04468711|Vitamins|vitamins|mesh-ancestor
44867467|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
44867468|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867469|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44867470|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867471|NCT04468685|Ondansetron|ondansetron|mesh-list
44867472|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
44867473|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
44867474|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867475|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867476|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44867477|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
44867478|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867479|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44867480|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
44867481|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867482|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867483|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44867484|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44867485|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867486|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44867487|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44867488|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
44867489|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867490|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
44867491|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
44867492|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867493|NCT04468139|Ascorbic Acid|ascorbic acid|mesh-list
44867494|NCT04468139|Quercetin|quercetin|mesh-list
44867495|NCT04468139|Vitamins|vitamins|mesh-ancestor
44867496|NCT04468139|Micronutrients|micronutrients|mesh-ancestor
44867497|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867498|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
44867499|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867500|NCT04468139|Protective Agents|protective agents|mesh-ancestor
44867501|NCT04468542|Triamcinolone|triamcinolone|mesh-list
44867502|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44867503|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44867504|NCT04468542|Bupivacaine|bupivacaine|mesh-list
44867505|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44867506|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44867507|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
44867508|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867509|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867510|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
44867511|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867512|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867513|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
44867514|NCT04468542|Hormones|hormones|mesh-ancestor
44867515|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867516|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867517|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
44867518|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867519|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867520|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44867521|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867522|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44867523|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
44867524|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867525|NCT04468438|Estrogens|estrogens|mesh-list
44867526|NCT04468438|Hormones|hormones|mesh-ancestor
44867527|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867528|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867529|NCT04468282|Vigabatrin|vigabatrin|mesh-list
44867530|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
44867531|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867532|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867533|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
44867534|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867535|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867536|NCT04467918|Cannabidiol|cannabidiol|mesh-list
44867537|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
44867538|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
44867539|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44867540|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44867541|NCT04467892|Prednisolone|prednisolone|mesh-list
44867542|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
44867543|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44867544|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
44867545|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867546|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
44867547|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
44867548|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867549|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867550|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44867551|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
44867552|NCT04467892|Hormones|hormones|mesh-ancestor
44867553|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867554|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44867555|NCT04467892|Protective Agents|protective agents|mesh-ancestor
44867556|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44867557|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867558|NCT04467931|Losartan|losartan|mesh-list
44867559|NCT04467931|Timolol|timolol|mesh-list
44867560|NCT04467931|Propranolol|propranolol|mesh-list
44867561|NCT04467931|Metoprolol|metoprolol|mesh-list
44867562|NCT04467931|Atenolol|atenolol|mesh-list
44867563|NCT04467931|Verapamil|verapamil|mesh-list
44867564|NCT04467931|Felodipine|felodipine|mesh-list
44867565|NCT04467931|Nadolol|nadolol|mesh-list
44867566|NCT04467931|Acebutolol|acebutolol|mesh-list
44867567|NCT04467931|Amlodipine|amlodipine|mesh-list
44867568|NCT04467931|Valsartan|valsartan|mesh-list
44867569|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44867570|NCT04467931|Telmisartan|telmisartan|mesh-list
44867571|NCT04467931|Clonidine|clonidine|mesh-list
44867572|NCT04467931|Carvedilol|carvedilol|mesh-list
44867573|NCT04467931|Candesartan|candesartan|mesh-list
44867574|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
44867575|NCT04467931|Ramipril|ramipril|mesh-list
44867576|NCT04467931|Olmesartan|olmesartan|mesh-list
44867577|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44867578|NCT04467931|Enalapril|enalapril|mesh-list
44867579|NCT04467931|Enalaprilat|enalaprilat|mesh-list
44867580|NCT04467931|Lisinopril|lisinopril|mesh-list
44867581|NCT04467931|Irbesartan|irbesartan|mesh-list
44867582|NCT04467931|Eplerenone|eplerenone|mesh-list
44867583|NCT04467931|Nebivolol|nebivolol|mesh-list
44867584|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
44867585|NCT04467931|Bisoprolol|bisoprolol|mesh-list
44867586|NCT04467931|Diltiazem|diltiazem|mesh-list
44867587|NCT04467931|Perindopril|perindopril|mesh-list
44867588|NCT04467931|Guanfacine|guanfacine|mesh-list
44867589|NCT04467931|Minoxidil|minoxidil|mesh-list
44867590|NCT04467931|Prazosin|prazosin|mesh-list
44867591|NCT04467931|Doxazosin|doxazosin|mesh-list
44867592|NCT04467931|Benazepril|benazepril|mesh-list
44867593|NCT04467931|Hydralazine|hydralazine|mesh-list
44867594|NCT04467931|Labetalol|labetalol|mesh-list
44867595|NCT04467931|Captopril|captopril|mesh-list
44867596|NCT04467931|Indapamide|indapamide|mesh-list
44867597|NCT04467931|Nicardipine|nicardipine|mesh-list
44867598|NCT04467931|Quinapril|quinapril|mesh-list
44867599|NCT04467931|Metolazone|metolazone|mesh-list
44867600|NCT04467931|Trandolapril|trandolapril|mesh-list
44654331|NCT00126659|Sorafenib|sorafenib|mesh-list
44867601|NCT04467931|Torsemide|torsemide|mesh-list
44867602|NCT04467931|Fosinopril|fosinopril|mesh-list
44867603|NCT04467931|Methyldopa|methyldopa|mesh-list
44867604|NCT04467931|Isradipine|isradipine|mesh-list
44867605|NCT04467931|Eprosartan|eprosartan|mesh-list
44867606|NCT04467931|Pindolol|pindolol|mesh-list
44867607|NCT04467931|Betaxolol|betaxolol|mesh-list
44867608|NCT04467931|Moexipril|moexipril|mesh-list
44867609|NCT04467931|Reserpine|reserpine|mesh-list
44867610|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
44867611|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
44867612|NCT04467931|Guanabenz|guanabenz|mesh-list
44867613|NCT04467931|Nisoldipine|nisoldipine|mesh-list
44867614|NCT04467931|Penbutolol|penbutolol|mesh-list
44867615|NCT04467931|Nifedipine|nifedipine|mesh-list
44867616|NCT04467931|Amiloride|amiloride|mesh-list
44867617|NCT04467931|Triamterene|triamterene|mesh-list
44867618|NCT04467931|Furosemide|furosemide|mesh-list
44867619|NCT04467931|Spironolactone|spironolactone|mesh-list
44867620|NCT04467931|Bumetanide|bumetanide|mesh-list
44867621|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
44867622|NCT04467931|Terazosin|terazosin|mesh-list
44867623|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44867624|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44867625|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44867626|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44867627|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867628|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867629|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44867630|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867631|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44867632|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44867633|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44867634|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867635|NCT04467931|Diuretics|diuretics|mesh-ancestor
44867636|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
44867637|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44354900|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44867638|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44867639|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44867640|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867641|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867642|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44867643|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
44867644|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
44867645|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867646|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44867647|NCT04467931|Analgesics|analgesics|mesh-ancestor
44867648|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
44867649|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44867650|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44867651|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44867652|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44867653|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
44867654|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867655|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44867656|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
44867657|NCT04467931|Protective Agents|protective agents|mesh-ancestor
44867658|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44867659|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44867660|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
44867661|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867662|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
44867663|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44867664|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44867665|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44867666|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44867667|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44867668|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44867669|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44867670|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
44867671|NCT04467931|Urological Agents|urological agents|mesh-ancestor
44867672|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44867673|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44867674|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
44867675|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44867676|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44354968|NCT01104883|Iodine|iodine|mesh-list
44867677|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867678|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44867679|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44867680|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44867681|NCT04467983|Denosumab|denosumab|mesh-list
44867682|NCT04467983|Abaloparatide|abaloparatide|mesh-list
44867683|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44867684|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867685|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
44867686|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
44867687|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
44867688|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867689|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867690|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
44867691|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867692|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44867693|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
44867694|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44867695|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44867696|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44867697|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867698|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867699|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
44867700|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867701|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867702|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44867703|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867704|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867705|NCT04467346|Temozolomide|temozolomide|mesh-list
44867706|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44867707|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
44867708|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867709|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867710|NCT04467125|Lidocaine|lidocaine|mesh-list
44867711|NCT04467125|Prilocaine|prilocaine|mesh-list
44867712|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44867713|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
44867714|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
44867715|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867716|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867717|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
44867718|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867719|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867720|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44867721|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44867722|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867723|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867724|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44867725|NCT04466904|Dulaglutide|dulaglutide|mesh-list
44867726|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44867727|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867728|NCT04466917|Paclitaxel|paclitaxel|mesh-list
44867729|NCT04466917|Bevacizumab|bevacizumab|mesh-list
44867730|NCT04466917|Carboplatin|carboplatin|mesh-list
44867731|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44867732|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867733|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
44867734|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
44867735|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
44867736|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867737|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44867738|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44867739|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44867740|NCT04466917|Growth Substances|growth substances|mesh-ancestor
44867741|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867742|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44867743|NCT04466943|Rocuronium|rocuronium|mesh-list
44867744|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44867745|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44867746|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44867747|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867748|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867749|NCT04466670|Aspirin|aspirin|mesh-list
44867750|NCT04466670|Heparin|heparin|mesh-list
44867751|NCT04466670|Calcium heparin|calcium heparin|mesh-list
44867752|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867753|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867754|NCT04466670|Analgesics|analgesics|mesh-ancestor
44867755|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
44867756|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867757|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867758|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867759|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867760|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44867761|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44654482|NCT00125190|Mecasermin|mecasermin|mesh-list
44355015|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867762|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867763|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44867764|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44867765|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867766|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
44867767|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
44867768|NCT04466436|Tryptophan|tryptophan|mesh-list
44867769|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44867770|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
44867771|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44867772|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
44867773|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867774|NCT04466254|Cetuximab|cetuximab|mesh-list
44867775|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44867776|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867777|NCT04466176|Fluticasone|fluticasone|mesh-list
44867778|NCT04466176|Xhance|xhance|mesh-list
44867779|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44867780|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44867781|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867782|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44867783|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
44867784|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867785|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867786|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44867787|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
44867788|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44867789|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44867790|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44867791|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44867792|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44867793|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
44867794|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44867795|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867796|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
44867797|NCT04466176|Hormones|hormones|mesh-ancestor
44867798|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867799|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
44867800|NCT04466241|Ritonavir|ritonavir|mesh-list
44867801|NCT04466241|Lopinavir|lopinavir|mesh-list
44867802|NCT04466241|Telmisartan|telmisartan|mesh-list
44867803|NCT04466241|Atorvastatin|atorvastatin|mesh-list
44867804|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44867805|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44867806|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
44867807|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867808|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44867809|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44867810|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867811|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44867812|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44867813|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
44867814|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44867815|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44867816|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
44867817|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867818|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44867819|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44867820|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44867821|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44867822|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44867823|NCT04465968|Cisplatin|cisplatin|mesh-list
44867824|NCT04465968|Durvalumab|durvalumab|mesh-list
44867825|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44867826|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867827|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44867828|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
44867829|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867830|NCT04466085|Vaccines|vaccines|mesh-list
44867831|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
44867832|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867833|NCT04465942|Paclitaxel|paclitaxel|mesh-list
44867834|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
44867835|NCT04465942|Nivolumab|nivolumab|mesh-list
44867836|NCT04465942|Pemetrexed|pemetrexed|mesh-list
44867837|NCT04465942|Atezolizumab|atezolizumab|mesh-list
44867838|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44867839|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867840|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44867841|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44867842|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44867843|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867844|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44867845|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44867846|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867847|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44867848|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44867849|NCT04465773|Remifentanil|remifentanil|mesh-list
44867850|NCT04465773|Propofol|propofol|mesh-list
44867851|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
44867852|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867853|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867854|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44867855|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44867856|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
44867857|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44867858|NCT04465773|Narcotics|narcotics|mesh-ancestor
44867859|NCT04465773|Analgesics|analgesics|mesh-ancestor
44867860|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
44867861|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867862|NCT04465500|Androgens|androgens|mesh-list
44867863|NCT04465500|Hormones|hormones|mesh-ancestor
44867864|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867865|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867866|NCT04465695|Interferons|interferons|mesh-list
44867867|NCT04465695|Interferon-beta|interferon-beta|mesh-list
44867868|NCT04465695|Clofazimine|clofazimine|mesh-list
44867869|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
44867870|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867871|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
44867872|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867873|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
44867874|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867875|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44867876|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867877|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
44867878|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867879|NCT04465851|Curcumin|curcumin|mesh-list
44867880|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44867881|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44867882|NCT04465851|Analgesics|analgesics|mesh-ancestor
44867883|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
44867884|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867885|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867886|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867887|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44867888|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867889|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867890|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867891|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
44867892|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44867893|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867894|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
44867895|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
44867896|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44867897|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
44867898|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867899|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44867900|NCT04465123|Spironolactone|spironolactone|mesh-list
44867901|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44867902|NCT04465123|Diuretics|diuretics|mesh-ancestor
44867903|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
44867904|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867905|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44867906|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867907|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867908|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44867909|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
44867910|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867911|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44867912|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
44867913|NCT04465175|Analgesics|analgesics|mesh-ancestor
44867914|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
44867915|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867916|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867917|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
44867918|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44867919|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44867920|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
44867921|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44867922|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867923|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867924|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44867926|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44867927|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44867928|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
44867929|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44867930|NCT04464967|Trastuzumab|trastuzumab|mesh-list
44867931|NCT04464967|Cetuximab|cetuximab|mesh-list
44867932|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355203|NCT01106547|Hormones|hormones|mesh-ancestor
44867933|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867934|NCT04464694|Ranibizumab|ranibizumab|mesh-list
44867935|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44867936|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44867937|NCT04464694|Growth Substances|growth substances|mesh-ancestor
44867938|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867939|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44867940|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867941|NCT04464811|Furosemide|furosemide|mesh-list
44867942|NCT04464811|Diuretics|diuretics|mesh-ancestor
44867943|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
44698036|NCT05271448|Ramipril|ramipril|mesh-list
44698037|NCT05271448|Enalapril|enalapril|mesh-list
44698038|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44698039|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44698040|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44698041|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44698042|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698043|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44698044|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698045|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698046|NCT05271370|Leronlimab|leronlimab|mesh-list
44698047|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
44698048|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44698049|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44355229|NCT01106872|Growth Substances|growth substances|mesh-ancestor
44698050|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698051|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44698052|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44698053|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
44698054|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698055|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
44698056|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698057|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
44698058|NCT05271253|Bupivacaine|bupivacaine|mesh-list
44698059|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
44698060|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
44698061|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698062|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698063|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
44698064|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698065|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44698066|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698067|NCT05271253|Analgesics|analgesics|mesh-ancestor
44698068|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44698069|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44698070|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698071|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698072|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698073|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698074|NCT05271188|Anesthetics|anesthetics|mesh-list
44698075|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
44698076|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698077|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698078|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
44698079|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698080|NCT05271162|Empagliflozin|empagliflozin|mesh-list
44698081|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44698082|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698083|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44698084|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698085|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
44355258|NCT01107067|Testosterone|testosterone|mesh-list
44698086|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44698087|NCT05271136|Protective Agents|protective agents|mesh-ancestor
44698088|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867944|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867945|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44867946|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44867947|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867948|NCT04465097|Exemestane|exemestane|mesh-list
44867949|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867950|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44867951|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44867952|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44867953|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867954|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44867955|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
44867956|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867957|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867958|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
44867959|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44867960|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867961|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
44867962|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44867963|NCT04465110|Protective Agents|protective agents|mesh-ancestor
44867964|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867965|NCT04464850|Iron|iron|mesh-list
44867966|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
44867967|NCT04464850|Folic Acid|folic acid|mesh-list
44867968|NCT04464850|Trace Elements|trace elements|mesh-ancestor
44867969|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
44867970|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867971|NCT04464850|Hematinics|hematinics|mesh-ancestor
44867972|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
44867973|NCT04464850|Vitamins|vitamins|mesh-ancestor
44867974|NCT04464863|Metronidazole|metronidazole|mesh-list
44867975|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44867976|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44867977|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44867978|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44867979|NCT04464629|Prednisolone|prednisolone|mesh-list
44867980|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44867981|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
44867982|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44867983|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
44867984|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44867985|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
44867986|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44867987|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
44867988|NCT04464629|Hormones|hormones|mesh-ancestor
44867989|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44867990|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44867991|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44867992|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44867993|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
44867994|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
44867995|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44867996|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44867997|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44867998|NCT04464629|Protective Agents|protective agents|mesh-ancestor
44867999|NCT04464642|Methotrexate|methotrexate|mesh-list
44868000|NCT04464642|Tofacitinib|tofacitinib|mesh-list
44868001|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44868002|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
44868003|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868004|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868005|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44868006|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
44868007|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868008|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868009|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868010|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868011|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44868012|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868013|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
44868014|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868015|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868016|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44868017|NCT04464616|Anesthetics|anesthetics|mesh-list
44868018|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868019|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868020|NCT04464135|Acetic Acid|acetic acid|mesh-list
44868021|NCT04464135|Retinol acetate|retinol acetate|mesh-list
44868022|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868023|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868024|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44868025|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
44868026|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868027|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44868028|NCT04464135|Protective Agents|protective agents|mesh-ancestor
44868029|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868030|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
44868031|NCT04464005|Analgesics|analgesics|mesh-ancestor
44868032|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
44868033|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868034|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868035|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
44868036|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868037|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44868038|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
44868039|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44868040|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44868041|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868042|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44868043|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
44868044|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868045|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
44868046|NCT04463875|Riboflavin|riboflavin|mesh-list
44868047|NCT04463875|Ubiquinone|ubiquinone|mesh-list
44868048|NCT04463875|Andrographolide|andrographolide|mesh-list
44868049|NCT04463875|Vitamins|vitamins|mesh-ancestor
44868050|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
44868051|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868052|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
44868053|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44868054|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868055|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868056|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44868057|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44868058|NCT04463875|Analgesics|analgesics|mesh-ancestor
44868059|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
44868060|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868061|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868062|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868063|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868064|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868065|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
44868066|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44868067|NCT04463784|Efavirenz|efavirenz|mesh-list
44868068|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44868069|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868070|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868071|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868072|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
44868073|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868074|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44868075|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44868076|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44868077|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44868078|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44868079|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44868080|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
44868081|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44868082|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868083|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868084|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
44868085|NCT04463966|Coagulants|coagulants|mesh-ancestor
44868086|NCT04463953|Dexamethasone|dexamethasone|mesh-list
44868087|NCT04463953|Ixazomib|ixazomib|mesh-list
44868088|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
44868089|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868090|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
44868091|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
44868092|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868093|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698089|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868094|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868095|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
44868096|NCT04463953|Hormones|hormones|mesh-ancestor
44868097|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868098|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868099|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868100|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868101|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868102|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868103|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44868104|NCT04463901|Mitomycins|mitomycins|mesh-list
44868105|NCT04463901|Mitomycin|mitomycin|mesh-list
44868106|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44868107|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868108|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
44355422|NCT01108133|Dexamethasone|dexamethasone|mesh-list
44868109|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868110|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868111|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868112|NCT04463459|Vitamins|vitamins|mesh-list
44868113|NCT04463459|Ascorbic Acid|ascorbic acid|mesh-list
44868114|NCT04463459|Vitamin E|vitamin e|mesh-list
44868115|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
44868116|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868117|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
44868118|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868119|NCT04463459|Protective Agents|protective agents|mesh-ancestor
44868120|NCT04463342|Methamphetamine|methamphetamine|mesh-list
44868121|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44868122|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868123|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
44868124|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
44868125|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868126|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
44868127|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868128|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868129|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
44868130|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44868131|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44868132|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44868133|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44868134|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
44868135|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868136|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868137|NCT04463056|Eculizumab|eculizumab|mesh-list
44868138|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44868139|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868140|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
44868141|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868142|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44868143|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44868144|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868145|NCT04462939|Micronutrients|micronutrients|mesh-list
44868146|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868147|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44868148|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868149|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
44868150|NCT04462796|Cathartics|cathartics|mesh-ancestor
44868151|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868152|NCT04462588|Metronidazole|metronidazole|mesh-list
44868153|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868154|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868155|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868156|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868157|NCT04462614|Heparin|heparin|mesh-list
44868158|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
44868159|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868160|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868161|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868162|NCT04462822|Fluticasone|fluticasone|mesh-list
44355494|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868163|NCT04462822|Xhance|xhance|mesh-list
44868164|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44868165|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44868166|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868167|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44868168|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
44868169|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868170|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868171|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44868172|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
44868173|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868174|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44868175|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44868176|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44868177|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44868178|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44868179|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868180|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868181|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
44868182|NCT04462822|Hormones|hormones|mesh-ancestor
44868183|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868184|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
44655033|NCT00117156|Rituximab|rituximab|mesh-list
44868185|NCT04462809|Talazoparib|talazoparib|mesh-list
44868186|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44868187|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868188|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868189|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868190|NCT04462666|Etoricoxib|etoricoxib|mesh-list
44868191|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44868192|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44868193|NCT04462666|Analgesics|analgesics|mesh-ancestor
44868194|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
44868195|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868196|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868197|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868198|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868199|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44868200|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44868201|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868202|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868203|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
44868204|NCT04462250|Narcotics|narcotics|mesh-ancestor
44868205|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868206|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868207|NCT04462250|Analgesics|analgesics|mesh-ancestor
44868208|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
44868209|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868210|NCT04462523|Prednisolone|prednisolone|mesh-list
44868211|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868212|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
44868213|NCT04462523|Hormones|hormones|mesh-ancestor
44868214|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868215|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868216|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868217|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868218|NCT04462094|Ketamine|ketamine|mesh-list
44868219|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
44868220|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868221|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868222|NCT04462094|Analgesics|analgesics|mesh-ancestor
44868223|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
44868224|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868225|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44868226|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44868227|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
44868228|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44868229|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44868230|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868231|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868232|NCT04462003|Enoxaparin|enoxaparin|mesh-list
44868233|NCT04462003|Apixaban|apixaban|mesh-list
44868234|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
44868235|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868236|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868237|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868238|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44868239|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
44868240|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44868241|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868242|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355563|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44868243|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44868244|NCT04461925|Azithromycin|azithromycin|mesh-list
44868245|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
44868246|NCT04461925|Dexamethasone|dexamethasone|mesh-list
44868247|NCT04461925|Enoxaparin|enoxaparin|mesh-list
44868248|NCT04461925|Anticoagulants|anticoagulants|mesh-list
44868249|NCT04461925|Hormones|hormones|mesh-list
44868250|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868251|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
44868252|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
44868253|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868254|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868255|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868256|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
44868257|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868258|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868259|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868260|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868261|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868262|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868263|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868264|NCT04461665|Vitamin D|vitamin d|mesh-list
44868265|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
44868266|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
44868267|NCT04461665|Vitamins|vitamins|mesh-list
44868268|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
44868269|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868270|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44868271|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44868272|NCT04461535|Hormones|hormones|mesh-list
44868273|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44868274|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44868275|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
44868276|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868277|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868278|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868279|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868280|NCT04461249|Travoprost|travoprost|mesh-list
44868281|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44868282|NCT04461249|Latanoprost|latanoprost|mesh-list
44868283|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44868284|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44868285|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
44868286|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
44868287|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868288|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868289|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868290|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868291|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868292|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868293|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
44868294|NCT04461418|Hormones|hormones|mesh-ancestor
44868295|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868296|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868297|NCT04461379|Vaccines|vaccines|mesh-list
44355635|NCT01109212|Bindarit|bindarit|mesh-list
44868298|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
44868299|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
44868300|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868301|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44868302|NCT04461340|Sirolimus|sirolimus|mesh-list
44868303|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868304|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868305|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44868306|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868307|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
44868308|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868309|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
44868310|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868311|NCT04461041|Empagliflozin|empagliflozin|mesh-list
44868312|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44868313|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868314|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44868315|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868316|NCT04460820|Doxorubicin|doxorubicin|mesh-list
44868317|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44868318|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44868319|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868320|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44868321|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44868322|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868323|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868324|NCT04460807|Exemestane|exemestane|mesh-list
44868325|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868326|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44868327|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44868328|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868329|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868330|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44868331|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
44868332|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868333|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868334|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44868335|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44868336|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44868337|NCT04460547|Interferons|interferons|mesh-list
44868338|NCT04460547|Interferon-beta|interferon-beta|mesh-list
44868339|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
44868340|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
44868341|NCT04460547|Ivermectin|ivermectin|mesh-list
44868342|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868343|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
44868344|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868345|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
44868346|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868347|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868348|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868349|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868350|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868351|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
44868352|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868353|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44868354|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
44868355|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
44868356|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868357|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
44868358|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44868359|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
44868360|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868361|NCT04460521|Expectorants|expectorants|mesh-ancestor
44868362|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44868363|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44868364|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
44868365|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868366|NCT04460521|Protective Agents|protective agents|mesh-ancestor
44868367|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868368|NCT04460521|Antidotes|antidotes|mesh-ancestor
44868369|NCT04460001|Triamcinolone|triamcinolone|mesh-list
44868370|NCT04460001|Ranibizumab|ranibizumab|mesh-list
44868371|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44698090|NCT05271058|Dexamethasone|dexamethasone|mesh-list
44868372|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44868373|NCT04460001|Growth Substances|growth substances|mesh-ancestor
44868374|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868375|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
44868376|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868377|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868379|NCT04460001|Hormones|hormones|mesh-ancestor
44868380|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868381|NCT04460092|Insulin|insulin|mesh-list
44868382|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44868383|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44868384|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868385|NCT04460079|Lenograstim|lenograstim|mesh-list
44868386|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44868387|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
44868388|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868389|NCT04459663|Axitinib|axitinib|mesh-list
44868390|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868391|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44868392|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868393|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868394|NCT04459702|Ritonavir|ritonavir|mesh-list
44868395|NCT04459702|Lopinavir|lopinavir|mesh-list
44868396|NCT04459702|Azithromycin|azithromycin|mesh-list
44868397|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
44868398|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44868399|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44868400|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868401|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868402|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868403|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44868404|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44868405|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
44868406|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868407|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44868408|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44868409|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868410|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
44868411|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868412|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868413|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868414|NCT04459676|Mitogens|mitogens|mesh-list
44868415|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44868416|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868417|NCT04459312|Antibodies|antibodies|mesh-list
44868418|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
44868419|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868420|NCT04458948|Azithromycin|azithromycin|mesh-list
44868421|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
44868422|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868423|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868424|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
44868425|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44868426|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44868427|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868428|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868429|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868430|NCT04459026|Ropivacaine|ropivacaine|mesh-list
44868431|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
44868432|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
44868433|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868434|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868435|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
44868436|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868437|NCT04458454|Methocarbamol|methocarbamol|mesh-list
44868438|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44868439|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868440|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44868441|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868442|NCT04458558|Mifepristone|mifepristone|mesh-list
44868443|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44868444|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
44868445|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868446|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868447|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44868448|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44868449|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44868450|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
44868451|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44868452|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44868453|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
44868454|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868455|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
44868456|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44868457|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44868458|NCT04458636|Prednisolone|prednisolone|mesh-list
44868459|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868460|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
44868461|NCT04458636|Hormones|hormones|mesh-ancestor
44868462|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868463|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868464|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868465|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868466|NCT04458285|Valsartan|valsartan|mesh-list
44868467|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44868468|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44868469|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44868470|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44868471|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868472|NCT04458116|Curcumin|curcumin|mesh-list
44868473|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44868474|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44868475|NCT04458116|Analgesics|analgesics|mesh-ancestor
44868476|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
44868477|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868478|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868479|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868480|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868481|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868482|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868483|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868484|NCT04457609|Azithromycin|azithromycin|mesh-list
44868485|NCT04457609|Oseltamivir|oseltamivir|mesh-list
44868486|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868487|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868488|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
44868489|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868490|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868491|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44868492|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44868493|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
44868494|NCT04457765|Povidone|povidone|mesh-list
44868495|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
44868496|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
44868497|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44868498|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868499|NCT04457050|Ribavirin|ribavirin|mesh-list
44868500|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
44868501|NCT04457050|Ledipasvir|ledipasvir|mesh-list
44868502|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
44868503|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868504|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
44868505|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868506|NCT04456985|Folic Acid|folic acid|mesh-list
44868507|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
44868508|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
44868509|NCT04456985|Vitamins|vitamins|mesh-ancestor
44868510|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
44868511|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868512|NCT04456985|Hematinics|hematinics|mesh-ancestor
44868513|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
44868514|NCT04456803|Sevelamer|sevelamer|mesh-list
44868515|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
44868516|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
44868517|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868518|NCT04456829|Resveratrol|resveratrol|mesh-list
44868519|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
44868520|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868521|NCT04456829|Protective Agents|protective agents|mesh-ancestor
44868522|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868523|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868524|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44868525|NCT04456777|Vortioxetine|vortioxetine|mesh-list
44868526|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
44868527|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44868528|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44868529|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44868530|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868531|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868532|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44868533|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44868534|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44868535|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868536|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868537|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
44868538|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44355859|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868539|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44868540|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44868541|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44868542|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
44868543|NCT04456712|Levofloxacin|levofloxacin|mesh-list
44868544|NCT04456712|Ofloxacin|ofloxacin|mesh-list
44868545|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868546|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868547|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44868548|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44868549|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868550|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868551|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868552|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44868553|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44868554|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44868555|NCT04456712|Renal Agents|renal agents|mesh-ancestor
44868556|NCT04456387|Factor VIII|factor viii|mesh-list
44868557|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44868558|NCT04456387|Coagulants|coagulants|mesh-ancestor
44868559|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
44868560|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868561|NCT04455932|Liver Extracts|liver extracts|mesh-list
44868562|NCT04455932|Hematinics|hematinics|mesh-ancestor
44868563|NCT04455802|Morphine|morphine|mesh-list
44868564|NCT04455802|Buprenorphine|buprenorphine|mesh-list
44868565|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44868566|NCT04455802|Narcotics|narcotics|mesh-ancestor
44868567|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868568|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868569|NCT04455802|Analgesics|analgesics|mesh-ancestor
44868570|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
44868571|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868572|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44868573|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
44868574|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44868575|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
44868576|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868577|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868578|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44868579|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
44868580|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44868581|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
44868582|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868583|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868584|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44868585|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
44868586|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
44868587|NCT04456088|Protective Agents|protective agents|mesh-ancestor
44868588|NCT04455711|Lidocaine|lidocaine|mesh-list
44355938|NCT01111253|Amoxicillin|amoxicillin|mesh-list
44868589|NCT04455711|Remifentanil|remifentanil|mesh-list
44868590|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
44868591|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
44868592|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868593|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868594|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
44868595|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868596|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44868597|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44868598|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44868599|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44868600|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868601|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44868602|NCT04455711|Narcotics|narcotics|mesh-ancestor
44868603|NCT04455711|Analgesics|analgesics|mesh-ancestor
44868604|NCT04455555|Rotigotine|rotigotine|mesh-list
44868605|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
44868606|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
44868607|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698091|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
44698092|NCT05271058|Triamcinolone|triamcinolone|mesh-list
44698093|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44698094|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44698095|NCT05271058|BB 1101|bb 1101|mesh-list
44868608|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698096|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44698097|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698098|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
44355947|NCT01111383|Tobramycin|tobramycin|mesh-list
44698099|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
44868609|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868610|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44868611|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
44868612|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698100|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868613|NCT04455594|Cisplatin|cisplatin|mesh-list
44868614|NCT04455594|Carboplatin|carboplatin|mesh-list
44868615|NCT04455594|Pemetrexed|pemetrexed|mesh-list
44868616|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44868617|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868618|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868619|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868620|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44868621|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868622|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44868623|NCT04455958|Ritonavir|ritonavir|mesh-list
44868624|NCT04455958|Lopinavir|lopinavir|mesh-list
44868625|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44868626|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44868627|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868628|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355966|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868629|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868630|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44868631|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44868632|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
44868633|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868634|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44868635|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44868636|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44868637|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44868638|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
44868639|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44868640|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
44868641|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868642|NCT04455243|Expectorants|expectorants|mesh-ancestor
44868643|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44868644|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44868645|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
44868646|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868647|NCT04455243|Protective Agents|protective agents|mesh-ancestor
44868648|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868649|NCT04455243|Antidotes|antidotes|mesh-ancestor
44868650|NCT04454775|Protein C|protein c|mesh-list
44868651|NCT04454775|Antithrombins|antithrombins|mesh-list
44868652|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
44868653|NCT04454775|Protein S|protein s|mesh-list
44868654|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44868655|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868656|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868657|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868658|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
44868659|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868660|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868661|NCT04454840|Riluzole|riluzole|mesh-list
44868662|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
44868663|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44868664|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44868665|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868666|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868667|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868668|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44868669|NCT04454840|Protective Agents|protective agents|mesh-ancestor
44868670|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44868671|NCT04454788|Tenecteplase|tenecteplase|mesh-list
44868672|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868673|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868674|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868675|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44868676|NCT04454580|Azacitidine|azacitidine|mesh-list
44868677|NCT04454580|Decitabine|decitabine|mesh-list
44868678|NCT04454580|Venetoclax|venetoclax|mesh-list
44868679|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44868680|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
44868681|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868682|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868683|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868684|NCT04454307|Tramadol|tramadol|mesh-list
44868685|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44868686|NCT04454307|Narcotics|narcotics|mesh-ancestor
44868687|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44868688|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868689|NCT04454307|Analgesics|analgesics|mesh-ancestor
44868690|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
44868691|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868692|NCT04454151|Azithromycin|azithromycin|mesh-list
44868693|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868694|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868695|NCT04454281|Naloxone|naloxone|mesh-list
44868696|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44868697|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868698|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
44868699|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868700|NCT04453930|Irinotecan|irinotecan|mesh-list
44868701|NCT04453930|Apatinib|apatinib|mesh-list
44868702|NCT04453930|Antibodies|antibodies|mesh-list
44868703|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
44868704|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868705|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44868706|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44868707|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868708|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868709|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868710|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44868711|NCT04453735|Atorvastatin|atorvastatin|mesh-list
44868712|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44868713|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44868714|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
44868715|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868716|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44868717|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44868718|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868719|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
44868720|NCT04453761|Vitamins|vitamins|mesh-ancestor
44868721|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
44868722|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868723|NCT04453280|Antibodies|antibodies|mesh-list
44868724|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
44868725|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868726|NCT04453423|Carboplatin|carboplatin|mesh-list
44868727|NCT04453423|Pemetrexed|pemetrexed|mesh-list
44868728|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868729|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868730|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868731|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44868732|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868733|NCT04453306|Topiramate|topiramate|mesh-list
44868734|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
44868735|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44868736|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868737|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44868738|NCT04453371|Plasminogen|plasminogen|mesh-list
44868739|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868740|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868741|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868742|NCT04453345|Thalidomide|thalidomide|mesh-list
44868743|NCT04453345|Prednisone|prednisone|mesh-list
44868744|NCT04453345|Methotrexate|methotrexate|mesh-list
44868745|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868746|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
44868747|NCT04453345|Hormones|hormones|mesh-ancestor
44868748|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356066|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44868749|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868750|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868751|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868752|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44868753|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
44868754|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868755|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44868756|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
44868757|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868758|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868759|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868760|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44868761|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868762|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
44868763|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868764|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868765|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
44868766|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868767|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868768|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44868769|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44868770|NCT04453345|Growth Substances|growth substances|mesh-ancestor
44868771|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44868773|NCT04453436|Lamivudine|lamivudine|mesh-list
44868774|NCT04453436|Dolutegravir|dolutegravir|mesh-list
44868775|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
44868776|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356105|NCT01112137|Clopidogrel|clopidogrel|mesh-list
44868777|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44868778|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44868779|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868780|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868781|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44868782|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44868783|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44868784|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44868785|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44868786|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44868787|NCT04453332|Hormones|hormones|mesh-list
44868788|NCT04453332|Estradiol|estradiol|mesh-list
44868789|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44868790|NCT04453332|Progesterone|progesterone|mesh-list
44868791|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868792|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868793|NCT04453332|Estrogens|estrogens|mesh-ancestor
44868794|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44868795|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
44868796|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868797|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44868798|NCT04453332|Progestins|progestins|mesh-ancestor
44868799|NCT04453189|Lansoprazole|lansoprazole|mesh-list
44868800|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
44868801|NCT04453189|Famotidine|famotidine|mesh-list
44868802|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44868803|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868804|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44868805|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868806|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868807|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44868808|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
44868809|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
44868810|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868811|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868812|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44868813|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868814|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
44868815|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44868816|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
44868817|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868818|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
44868819|NCT04453111|Protective Agents|protective agents|mesh-ancestor
44868820|NCT04452838|Fesoterodine|fesoterodine|mesh-list
44868821|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44868822|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44868823|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44356165|NCT01112540|Analgesics|analgesics|mesh-ancestor
44868824|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868825|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868826|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868827|NCT04452838|Urological Agents|urological agents|mesh-ancestor
44868828|NCT04452929|Calcitonin|calcitonin|mesh-list
44868829|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
44868830|NCT04452929|Cilostazol|cilostazol|mesh-list
44868831|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44868832|NCT04452929|Erenumab|erenumab|mesh-list
44868833|NCT04452929|Katacalcin|katacalcin|mesh-list
44868834|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44868835|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
44868836|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868837|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868838|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44868839|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
44868840|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868841|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868842|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868843|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44868844|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44868845|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44868846|NCT04452929|Protective Agents|protective agents|mesh-ancestor
44868847|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44868848|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44868849|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868850|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44868851|NCT04452929|Analgesics|analgesics|mesh-ancestor
44868852|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
44868853|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44868854|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44868855|NCT04452669|Epoprostenol|epoprostenol|mesh-list
44868856|NCT04452669|Tezosentan|tezosentan|mesh-list
44868857|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44868858|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44868859|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
44868860|NCT04452370|Etoposide|etoposide|mesh-list
44868861|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44868862|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868863|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44868864|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44868865|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868866|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868867|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
44868868|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
44868869|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44868870|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44868871|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868872|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44655916|NCT00102063|Aripiprazole|aripiprazole|mesh-list
44868873|NCT04451655|Insulin|insulin|mesh-list
44868874|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44868875|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868876|NCT04451395|Micronutrients|micronutrients|mesh-list
44868877|NCT04451395|Trace Elements|trace elements|mesh-list
44868878|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868879|NCT04451447|SMOFlipid|smoflipid|mesh-list
44868880|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44868881|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44868882|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44868883|NCT04451200|Busulfan|busulfan|mesh-list
44868884|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
44868885|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868886|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868887|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
44868888|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868889|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44868890|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868891|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44868892|NCT04451239|Cyclosporine|cyclosporine|mesh-list
44868893|NCT04451239|Cyclosporins|cyclosporins|mesh-list
44868894|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868895|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868896|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868897|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
44356217|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44868898|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868899|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
44868900|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868901|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44868902|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868903|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44868904|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44868905|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44868906|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44868907|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868908|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868909|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44868910|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44868911|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868912|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44868913|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868914|NCT04451174|Prednisone|prednisone|mesh-list
44868915|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868916|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
44868917|NCT04451174|Hormones|hormones|mesh-ancestor
44868918|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44868919|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868920|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44868921|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868922|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
44868923|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44868924|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868925|NCT04451083|Camostat|camostat|mesh-list
44868926|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
44868927|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44868928|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868929|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44868930|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44868931|NCT04450680|Lactams|lactams|mesh-list
44868932|NCT04450680|beta-Lactams|beta-lactams|mesh-list
44868933|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44868934|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868935|NCT04450576|Chrysarobin|chrysarobin|mesh-list
44868936|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44868937|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44868938|NCT04450576|Analgesics|analgesics|mesh-ancestor
44868939|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
44868940|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868941|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868942|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853844|NCT03725930|Clonidine|clonidine|mesh-list
44868943|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868944|NCT04450446|Heparin|heparin|mesh-list
44868945|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44868946|NCT04450446|Tinzaparin|tinzaparin|mesh-list
44868947|NCT04450446|Dalteparin|dalteparin|mesh-list
44868948|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
44655989|NCT00099359|Lamivudine|lamivudine|mesh-list
44868949|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44868950|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44868951|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868952|NCT04450160|Temozolomide|temozolomide|mesh-list
44868953|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44868954|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
44868955|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868956|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44868957|NCT04450134|Fexofenadine|fexofenadine|mesh-list
44868958|NCT04450134|Famotidine|famotidine|mesh-list
44868959|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44868960|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868961|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44868962|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
44868963|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
44868964|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44868965|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44868966|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868967|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44868968|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44356300|NCT01113164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44868969|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44868970|NCT04450095|Ambrisentan|ambrisentan|mesh-list
44868971|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44868972|NCT04449952|Listerine|listerine|mesh-list
44868973|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
44868974|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
44868975|NCT04449952|Protective Agents|protective agents|mesh-ancestor
44868976|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868977|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44868978|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44868979|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44868980|NCT04449718|Vitamin D|vitamin d|mesh-list
44868981|NCT04449718|Vitamins|vitamins|mesh-ancestor
44868982|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
44868983|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868984|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44868985|NCT04449224|Etanercept|etanercept|mesh-list
44868986|NCT04449224|Abatacept|abatacept|mesh-list
44868987|NCT04449224|Tofacitinib|tofacitinib|mesh-list
44868988|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44868989|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44868990|NCT04449224|Analgesics|analgesics|mesh-ancestor
44868991|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
44868992|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44868993|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44868994|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44868995|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44868996|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44868997|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44868998|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
44868999|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44869000|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869001|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869002|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869003|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869004|NCT04449289|Lidocaine|lidocaine|mesh-list
44869005|NCT04449289|Ropivacaine|ropivacaine|mesh-list
44869006|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869007|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
44869008|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869009|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869010|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
44869011|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869012|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44869013|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44869014|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44869015|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44869016|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869017|NCT04449471|Naproxen|naproxen|mesh-list
44869018|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44869019|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869020|NCT04449471|Analgesics|analgesics|mesh-ancestor
44869021|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
44869022|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869023|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656140|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869024|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869025|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869026|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
44869027|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44869028|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869029|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869031|NCT04449185|Clarithromycin|clarithromycin|mesh-list
44869032|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44869033|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869034|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44869035|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869036|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869037|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44869038|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44869039|NCT04449380|Interferons|interferons|mesh-list
44869040|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869041|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
44869042|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869043|NCT04448821|Metformin|metformin|mesh-list
44869044|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44869045|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869046|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
44869047|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
44869048|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869049|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44869050|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44869051|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869052|NCT04448587|Incretins|incretins|mesh-ancestor
44869053|NCT04448587|Hormones|hormones|mesh-ancestor
44356371|NCT01113671|Vitamin E|vitamin e|mesh-list
44869054|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869055|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44869056|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
44869057|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869058|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869059|NCT04448496|Dexamethasone|dexamethasone|mesh-list
44869060|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869061|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
44869062|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
44869063|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869064|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869065|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869066|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
44869067|NCT04448496|Hormones|hormones|mesh-ancestor
44869068|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869069|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44869070|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869071|NCT04448457|Sufentanil|sufentanil|mesh-list
44869072|NCT04448457|Oxycodone|oxycodone|mesh-list
44869073|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869074|NCT04448457|Narcotics|narcotics|mesh-ancestor
44869075|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869076|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869077|NCT04448457|Analgesics|analgesics|mesh-ancestor
44869078|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
44869079|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869080|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44869081|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869082|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
44869083|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
44869084|NCT04448379|Osimertinib|osimertinib|mesh-list
44869085|NCT04448379|Afatinib|afatinib|mesh-list
44869086|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869087|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43853991|NCT03718234|Hormones|hormones|mesh-ancestor
44869088|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869089|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869090|NCT04448223|Latanoprost|latanoprost|mesh-list
44869091|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44869092|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44869093|NCT04448119|Favipiravir|favipiravir|mesh-list
44869094|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
44869095|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869096|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
44869097|NCT04448015|Narcotics|narcotics|mesh-ancestor
44869098|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869099|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869100|NCT04448015|Analgesics|analgesics|mesh-ancestor
44869101|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
44869102|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869103|NCT04448028|Esomeprazole|esomeprazole|mesh-list
44869104|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44869105|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44869106|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869107|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869108|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869109|NCT04447612|Gemcitabine|gemcitabine|mesh-list
44869110|NCT04447612|Cisplatin|cisplatin|mesh-list
44869111|NCT04447612|Durvalumab|durvalumab|mesh-list
44869112|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869113|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869114|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
44869115|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869116|NCT04447612|Antiviral Agents|antiviral agents|mesh-ancestor
44869117|NCT04447612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869118|NCT04447612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869119|NCT04447612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869120|NCT04447612|Immunologic Factors|immunologic factors|mesh-ancestor
44869121|NCT04447612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356442|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356444|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
44869122|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44869124|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44869125|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44869126|NCT04447326|Growth Substances|growth substances|mesh-ancestor
44869127|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869128|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44869129|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869130|NCT04447274|Apatinib|apatinib|mesh-list
44869131|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869132|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869133|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869134|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869135|NCT04447209|Chrysarobin|chrysarobin|mesh-list
44869136|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44869137|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869138|NCT04447209|Analgesics|analgesics|mesh-ancestor
44869139|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
44869140|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869141|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869142|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869143|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869144|NCT04447443|Loperamide|loperamide|mesh-list
44869145|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
44869146|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869147|NCT04447560|Bupivacaine|bupivacaine|mesh-list
44869148|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869149|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
44869150|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869151|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869152|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
44869153|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869154|NCT04447092|Leucovorin|leucovorin|mesh-list
44869155|NCT04447092|Gemcitabine|gemcitabine|mesh-list
44869156|NCT04447092|Paclitaxel|paclitaxel|mesh-list
44869157|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
44869158|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
44869159|NCT04447092|Irinotecan|irinotecan|mesh-list
44869160|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44869161|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869162|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44869163|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44869164|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44869165|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869166|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869167|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
44869168|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
44869169|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869170|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869171|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869172|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
44869173|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869174|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44869175|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44869176|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44869177|NCT04447092|Antidotes|antidotes|mesh-ancestor
44869178|NCT04447092|Protective Agents|protective agents|mesh-ancestor
44869179|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
44869180|NCT04447092|Vitamins|vitamins|mesh-ancestor
44869181|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
44869182|NCT04447378|PENTA|penta|mesh-list
44869183|NCT04447378|Fondaparinux|fondaparinux|mesh-list
44869184|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44869185|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
44869186|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44869187|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44869188|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869189|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869190|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
44869191|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44869192|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44869193|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44356500|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
44869194|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44869195|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869196|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
44869197|NCT04447105|Anesthetics|anesthetics|mesh-list
44869198|NCT04447105|Propofol|propofol|mesh-list
44869199|NCT04447105|Desflurane|desflurane|mesh-list
44869200|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869201|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869202|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44869203|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869204|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
44869205|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44869206|NCT04446923|Propranolol|propranolol|mesh-list
44869207|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44869208|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44869209|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
44869210|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869211|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869212|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869213|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44869214|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44869215|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
44869216|NCT04446663|Paclitaxel|paclitaxel|mesh-list
44869217|NCT04446663|Cisplatin|cisplatin|mesh-list
44869218|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44869219|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44869220|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869221|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
44869222|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
44869223|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
44869224|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869225|NCT04446715|Sufentanil|sufentanil|mesh-list
44869226|NCT04446715|Meperidine|meperidine|mesh-list
44869227|NCT04446715|Bupivacaine|bupivacaine|mesh-list
44869228|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869229|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
44869230|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869231|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869232|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
44869233|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869234|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869235|NCT04446715|Narcotics|narcotics|mesh-ancestor
44869236|NCT04446715|Analgesics|analgesics|mesh-ancestor
44869237|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44869238|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869239|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
44356581|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
44869240|NCT04446598|Tadalafil|tadalafil|mesh-list
44869241|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44869242|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44869243|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44869244|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869245|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869246|NCT04446598|Urological Agents|urological agents|mesh-ancestor
44869247|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
44869248|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44869249|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44869250|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
44869251|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44869252|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869253|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
44869254|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
44869255|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44869256|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
44869257|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869258|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
44869259|NCT04446533|Protective Agents|protective agents|mesh-ancestor
44869260|NCT04446637|Albuterol|albuterol|mesh-list
44869261|NCT04446637|Ipratropium|ipratropium|mesh-list
44869262|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44869263|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
44869264|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869265|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869266|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44869267|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44869268|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
44869269|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44869270|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44869271|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44869272|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44869273|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44869274|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356612|NCT01115894|Naltrexone|naltrexone|mesh-list
44869275|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869276|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44869277|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44869278|NCT04446416|Bevacizumab|bevacizumab|mesh-list
44869279|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44869280|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869281|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44869282|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44869283|NCT04446416|Growth Substances|growth substances|mesh-ancestor
44869284|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869285|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
44869286|NCT04446403|Anesthetics|anesthetics|mesh-list
44869287|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869288|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869289|NCT04446338|Antibodies|antibodies|mesh-list
44869290|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
44869291|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356644|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869292|NCT04446364|Disinfectants|disinfectants|mesh-list
44869293|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869294|NCT04445922|Anastrozole|anastrozole|mesh-list
44869295|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44869296|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869297|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44869298|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44869299|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869300|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869301|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44869302|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
44869303|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869304|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869305|NCT04446234|Risperidone|risperidone|mesh-list
44869306|NCT04446234|Aripiprazole|aripiprazole|mesh-list
44869307|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44869308|NCT04446234|Ziprasidone|ziprasidone|mesh-list
44869309|NCT04446234|Amisulpride|amisulpride|mesh-list
44869310|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44869311|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
44869312|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869313|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869314|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869315|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44869316|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44869317|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869318|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44869319|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44869320|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
44869321|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
44869322|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
44869323|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44869324|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44869325|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44869326|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44869327|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44869328|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44869329|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
44869330|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869331|NCT04446065|Protective Agents|protective agents|mesh-ancestor
44869332|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869333|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44869334|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44869335|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869336|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44869337|NCT04445948|Amoxicillin|amoxicillin|mesh-list
44869338|NCT04445948|Metronidazole|metronidazole|mesh-list
44869339|NCT04445948|Clarithromycin|clarithromycin|mesh-list
44869340|NCT04445948|Lactoferrin|lactoferrin|mesh-list
44869341|NCT04445948|Esomeprazole|esomeprazole|mesh-list
44869342|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44869343|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869344|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869345|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869346|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44869347|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869348|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44869349|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869350|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869351|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44869352|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44869353|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44869354|NCT04446091|Irinotecan|irinotecan|mesh-list
44869355|NCT04446091|Apatinib|apatinib|mesh-list
44869356|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44869357|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44869358|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44869359|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869360|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869361|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869362|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869363|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44869364|NCT04446091|Growth Substances|growth substances|mesh-ancestor
44869365|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869366|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
44869367|NCT04446104|Ascorbic Acid|ascorbic acid|mesh-list
44869368|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
44869369|NCT04446104|Ivermectin|ivermectin|mesh-list
44869370|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
44869371|NCT04446104|Povidone|povidone|mesh-list
44869372|NCT04446104|Vitamins|vitamins|mesh-ancestor
44869373|NCT04446104|Micronutrients|micronutrients|mesh-ancestor
44869374|NCT04446104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869375|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
44869376|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869377|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869378|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869379|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869380|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869381|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869382|NCT04446104|Antioxidants|antioxidants|mesh-ancestor
44869383|NCT04446104|Protective Agents|protective agents|mesh-ancestor
44869384|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
44869385|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
44869386|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44869387|NCT04445935|Bivalirudin|bivalirudin|mesh-list
44869388|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
44869389|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44869390|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44869391|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869392|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869393|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
44869394|NCT04446130|Decitabine|decitabine|mesh-list
44869395|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869396|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
44869397|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869398|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869399|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869400|NCT04445857|Calcitonin|calcitonin|mesh-list
44869401|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
44869402|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44869403|NCT04445857|Katacalcin|katacalcin|mesh-list
44869404|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44869405|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869406|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44869407|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
44869408|NCT04445727|Ascorbic Acid|ascorbic acid|mesh-list
44869409|NCT04445727|Vitamins|vitamins|mesh-ancestor
44869410|NCT04445727|Micronutrients|micronutrients|mesh-ancestor
44869411|NCT04445727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869412|NCT04445727|Antioxidants|antioxidants|mesh-ancestor
44356737|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
44869413|NCT04445727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698101|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698102|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698103|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
44698104|NCT05271058|Hormones|hormones|mesh-ancestor
44356762|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698105|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698106|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44698107|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698108|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698109|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698110|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698111|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698112|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
44869414|NCT04445727|Protective Agents|protective agents|mesh-ancestor
44869415|NCT04445779|Ubiquinone|ubiquinone|mesh-list
44869416|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
44869417|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
44869418|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869419|NCT04445779|Vitamins|vitamins|mesh-ancestor
44869420|NCT04445467|Favipiravir|favipiravir|mesh-list
44869421|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
44869422|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869423|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44869424|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
44869425|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
44869426|NCT04445636|Morphine|morphine|mesh-list
44869427|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44356768|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44869428|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869429|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869430|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869431|NCT04445636|Analgesics|analgesics|mesh-ancestor
44869432|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
44869433|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869434|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44869435|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44869436|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44869437|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44869438|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869439|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869440|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869441|NCT04445636|Narcotics|narcotics|mesh-ancestor
44869442|NCT04445506|Dexamethasone|dexamethasone|mesh-list
44869443|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869444|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
44869445|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
44356794|NCT01116531|Narcotics|narcotics|mesh-ancestor
44869446|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869447|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869448|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869449|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
44869450|NCT04445506|Hormones|hormones|mesh-ancestor
44869451|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869452|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44869453|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869454|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44869455|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44869456|NCT04445311|Ivermectin|ivermectin|mesh-list
44869457|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869458|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869459|NCT04445194|Vaccines|vaccines|mesh-list
44869460|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
44869461|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869462|NCT04444986|Favipiravir|favipiravir|mesh-list
44869463|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
44869464|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869465|NCT04444635|Fentanyl|fentanyl|mesh-list
44869466|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869467|NCT04444635|Narcotics|narcotics|mesh-ancestor
44869468|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869469|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869470|NCT04444635|Analgesics|analgesics|mesh-ancestor
44869471|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
44869472|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869473|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44869474|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869475|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
44869476|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
44869477|NCT04444726|Betamethasone|betamethasone|mesh-list
44869478|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
44869479|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44869480|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
44869481|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44869482|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869483|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
44869484|NCT04444726|Hormones|hormones|mesh-ancestor
44356835|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
44869485|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869486|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869487|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44869488|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
44869489|NCT04444817|Tacrolimus|tacrolimus|mesh-list
44869490|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869491|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
44869492|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869493|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44869494|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869495|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869496|NCT04444349|Ubiquinone|ubiquinone|mesh-list
44356844|NCT01116635|Doxorubicin|doxorubicin|mesh-list
44869497|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
44869498|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
44869499|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869500|NCT04444349|Vitamins|vitamins|mesh-ancestor
44869501|NCT04444284|Vaccines|vaccines|mesh-list
44869502|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
44869503|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869504|NCT04444193|Durvalumab|durvalumab|mesh-list
44869505|NCT04444193|Lenvatinib|lenvatinib|mesh-list
44869506|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44869507|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44869508|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869509|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
44869510|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869511|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869512|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869513|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869514|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
44869515|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44869516|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44869517|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869518|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
44869519|NCT04443920|Coagulants|coagulants|mesh-ancestor
44869520|NCT04443946|Sufentanil|sufentanil|mesh-list
44869521|NCT04443946|Propofol|propofol|mesh-list
44869522|NCT04443946|Sevoflurane|sevoflurane|mesh-list
44869523|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44869524|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869525|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869526|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869527|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
44869528|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
44869529|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44869530|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44869531|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869532|NCT04443946|Narcotics|narcotics|mesh-ancestor
44869533|NCT04443946|Analgesics|analgesics|mesh-ancestor
44869534|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
44869535|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869536|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44869538|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
44869539|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
44869540|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869541|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869542|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869543|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869544|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869545|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869546|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
44869547|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
44869548|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44869549|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
44869550|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869551|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869552|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44869553|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
44869554|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44869555|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
44869556|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869557|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869558|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44869559|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44869560|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
44869561|NCT04443868|Protective Agents|protective agents|mesh-ancestor
44869562|NCT04443556|Tramadol|tramadol|mesh-list
44869563|NCT04443556|Anesthetics|anesthetics|mesh-list
44869564|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
44869565|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869566|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869567|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869568|NCT04443556|Narcotics|narcotics|mesh-ancestor
44869569|NCT04443556|Analgesics|analgesics|mesh-ancestor
44869570|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
44869571|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869572|NCT04443634|Bupivacaine|bupivacaine|mesh-list
44869573|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869574|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
44869575|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869576|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869577|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
44869578|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869579|NCT04443517|Propofol|propofol|mesh-list
44869580|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
44869581|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869582|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869583|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44869584|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869585|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
44869586|NCT04444011|Amoxicillin|amoxicillin|mesh-list
44869587|NCT04444011|Clarithromycin|clarithromycin|mesh-list
44869588|NCT04444011|Bismuth|bismuth|mesh-list
44869589|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44869590|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869591|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44869592|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869593|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869594|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44869595|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44869596|NCT04444011|Antacids|antacids|mesh-ancestor
44869597|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869598|NCT04443647|Oxytocin|oxytocin|mesh-list
44869599|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
44869600|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44869601|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869602|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44869603|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869604|NCT04443387|Vitamin D|vitamin d|mesh-list
44869605|NCT04443387|Vitamins|vitamins|mesh-ancestor
44869606|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
44869607|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869608|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44869609|NCT04443543|Fluorouracil|fluorouracil|mesh-list
44869610|NCT04443543|Capecitabine|capecitabine|mesh-list
44869611|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
44869612|NCT04443543|Irinotecan|irinotecan|mesh-list
44656807|NCT00092417|Vaccines|vaccines|mesh-list
44869613|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
44869614|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869615|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869617|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869618|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
44869619|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869620|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44869621|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44869622|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869623|NCT04443270|Chloroquine|chloroquine|mesh-list
44869624|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44869625|NCT04443270|Amebicides|amebicides|mesh-ancestor
44869626|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869627|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869628|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356962|NCT01117298|Tadalafil|tadalafil|mesh-list
44869629|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
44869630|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869631|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44869632|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869633|NCT04443270|Analgesics|analgesics|mesh-ancestor
44869634|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
44869635|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869636|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869637|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869638|NCT04443270|Filaricides|filaricides|mesh-ancestor
44869639|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
44869640|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
44869641|NCT04443322|Durvalumab|durvalumab|mesh-list
44869642|NCT04443322|Lenvatinib|lenvatinib|mesh-list
44869643|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44869644|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44869645|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869646|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
44869647|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869648|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869649|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869650|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869651|NCT04443036|Paclitaxel|paclitaxel|mesh-list
44869652|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44869653|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44869654|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869655|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
44869656|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
44869657|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
44869658|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869659|NCT04443049|Mebendazole|mebendazole|mesh-list
44869660|NCT04443049|Piperazine|piperazine|mesh-list
44869661|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
44869662|NCT04443049|Lenvatinib|lenvatinib|mesh-list
44869663|NCT04443049|DMP 777|dmp 777|mesh-list
44869664|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869665|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869666|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869667|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869668|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
44869669|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
44869670|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869671|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869672|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44869673|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44869674|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44869675|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
44869676|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44869677|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
44869678|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869679|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
44869680|NCT04443166|Protective Agents|protective agents|mesh-ancestor
44869681|NCT04442919|Morphine|morphine|mesh-list
44869682|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
44869683|NCT04442919|Ticagrelor|ticagrelor|mesh-list
44869684|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869685|NCT04442919|Narcotics|narcotics|mesh-ancestor
44869686|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869687|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869688|NCT04442919|Analgesics|analgesics|mesh-ancestor
44869689|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
44869690|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869691|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44869692|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44869693|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44869694|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44869695|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
44869696|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869697|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869698|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44869699|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
44869700|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
44869701|NCT04442750|Bupivacaine|bupivacaine|mesh-list
44869702|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869703|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
44869704|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869705|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869706|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
44869707|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869708|NCT04442984|Leucovorin|leucovorin|mesh-list
44869709|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
44869710|NCT04442984|Irinotecan|irinotecan|mesh-list
44869711|NCT04442984|Fluorouracil|fluorouracil|mesh-list
44869712|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869713|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44869714|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44869715|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869716|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869717|NCT04442984|Antidotes|antidotes|mesh-ancestor
44869718|NCT04442984|Protective Agents|protective agents|mesh-ancestor
44869719|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869720|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
44869721|NCT04442984|Vitamins|vitamins|mesh-ancestor
44869722|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
44869723|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
44869724|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869725|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869726|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
44869727|NCT04442906|Fentanyl|fentanyl|mesh-list
44869728|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
44869729|NCT04442906|Bupivacaine|bupivacaine|mesh-list
44869730|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869731|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
44869732|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869733|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869734|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
44869735|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869736|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44869737|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44357037|NCT01118286|Nifedipine|nifedipine|mesh-list
44869738|NCT04442906|Analgesics|analgesics|mesh-ancestor
44869739|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44869740|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44869741|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44869742|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44869743|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869744|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869745|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44869746|NCT04442906|Narcotics|narcotics|mesh-ancestor
44869747|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44869748|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44869749|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
44869750|NCT04442633|Miconazole|miconazole|mesh-list
44869751|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
44869752|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869753|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44869754|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44869755|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869756|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869757|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44869758|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
44869759|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869760|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869761|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44869762|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44869763|NCT04441918|Antibodies|antibodies|mesh-list
44869764|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44869765|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
44869766|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869767|NCT04441385|Maraviroc|maraviroc|mesh-list
44869768|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44869769|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44869770|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869771|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44869772|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44869773|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
44869774|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869775|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44869776|NCT04441424|Azithromycin|azithromycin|mesh-list
44869777|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
44869778|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357091|NCT01118598|Niacin|niacin|mesh-list
44869779|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869780|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
44869781|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869782|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869783|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869784|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869785|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869786|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
44869787|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869788|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869789|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
44869790|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44869791|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
44869792|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869793|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
44869794|NCT04441528|Protective Agents|protective agents|mesh-ancestor
44869795|NCT04441112|Triamcinolone|triamcinolone|mesh-list
44869796|NCT04441112|Ketorolac|ketorolac|mesh-list
44869797|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869798|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
44869799|NCT04441112|Hormones|hormones|mesh-ancestor
44869800|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869801|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869802|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869803|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869804|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44869805|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869806|NCT04441112|Analgesics|analgesics|mesh-ancestor
44869807|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
44869808|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869809|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869810|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44869811|NCT04440917|Apatinib|apatinib|mesh-list
44869812|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44869813|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869814|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869815|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869816|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869817|NCT04441021|Penicillins|penicillins|mesh-list
44869818|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357125|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
44869819|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869820|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
44869821|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44869822|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869823|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869824|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44869825|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44869826|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44869827|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
44869828|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
44869829|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869830|NCT04440267|Dexamethasone|dexamethasone|mesh-list
44869831|NCT04440267|Prednisone|prednisone|mesh-list
44869832|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
44869833|NCT04440267|Methotrexate|methotrexate|mesh-list
44869834|NCT04440267|Vincristine|vincristine|mesh-list
44869835|NCT04440267|Daunorubicin|daunorubicin|mesh-list
44869836|NCT04440267|Asparaginase|asparaginase|mesh-list
44869837|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
44869838|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869839|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
44869840|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869841|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869842|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44869843|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
44869844|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869845|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869846|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44869847|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869848|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
44869849|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
44869850|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869851|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869852|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
44869853|NCT04440267|Hormones|hormones|mesh-ancestor
44869854|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869855|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44869856|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44869857|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
44869858|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44869859|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44869860|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
44869861|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44869862|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869863|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44869864|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44869865|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44869866|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
44869867|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
44869868|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
44869869|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44869870|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44869871|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44869872|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
44869873|NCT04440436|Fludarabine|fludarabine|mesh-list
44869874|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44869875|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
44869876|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869877|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869878|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44869879|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
44869880|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869881|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869882|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44869883|NCT04440085|Midodrine|midodrine|mesh-list
44869884|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
44869885|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
44869886|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869887|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869888|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44869889|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44869890|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44869891|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44869892|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44869893|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869894|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869895|NCT04439929|Adalimumab|adalimumab|mesh-list
44869896|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869897|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869898|NCT04439890|Carboplatin|carboplatin|mesh-list
44869899|NCT04439890|Pemetrexed|pemetrexed|mesh-list
44869900|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869901|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869902|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869903|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44869904|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44869905|NCT04439786|Lidocaine|lidocaine|mesh-list
44869906|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869907|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
44869908|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869909|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869910|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
44869911|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869912|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44869913|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44869914|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44869915|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44869916|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869917|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
44869918|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44869919|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44869920|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869921|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
44869922|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44869923|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698113|NCT05271045|Vitamin D|vitamin d|mesh-list
44869924|NCT04439773|Lidocaine|lidocaine|mesh-list
44869925|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
44869926|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
44869927|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869928|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869929|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
44869930|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869931|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44869932|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44869933|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44869934|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44869935|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869936|NCT04439474|Vitamin D|vitamin d|mesh-list
44869937|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
44869938|NCT04439474|Vitamins|vitamins|mesh-ancestor
44869939|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
44869940|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869941|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44869942|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44869943|NCT04439305|Dasatinib|dasatinib|mesh-list
44869944|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869945|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869946|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869947|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869948|NCT04439487|Anesthetics|anesthetics|mesh-list
44869949|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44869950|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869951|NCT04439396|Ketorolac|ketorolac|mesh-list
44869952|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44869953|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44869954|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44869955|NCT04439396|Analgesics|analgesics|mesh-ancestor
44869956|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
44869957|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869958|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869959|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869960|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869961|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44869962|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869963|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869964|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
44869965|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44869966|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44869967|NCT04438980|Prednisolone|prednisolone|mesh-list
44869968|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
44869969|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44869970|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
44869971|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44869972|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
44869973|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
44869974|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44869975|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44869976|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44869977|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
44869978|NCT04438980|Hormones|hormones|mesh-ancestor
44869979|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44869980|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44869981|NCT04438980|Protective Agents|protective agents|mesh-ancestor
44869982|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44869983|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869984|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44869985|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869986|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
44869987|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
44357293|NCT01119742|Butenafine|butenafine|mesh-list
44869988|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44869989|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44869990|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44869991|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44869992|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869993|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44869994|NCT04438902|Osimertinib|osimertinib|mesh-list
44869995|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44869996|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44869997|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698114|NCT05271045|Vitamin A|vitamin a|mesh-list
44869998|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44869999|NCT04438733|Anastrozole|anastrozole|mesh-list
44870000|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44870001|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870002|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44870003|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44870004|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870005|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870006|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44870007|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
44870008|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870009|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870010|NCT04438811|Anesthetics|anesthetics|mesh-list
44870011|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870012|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870013|NCT04438850|Ivermectin|ivermectin|mesh-list
44870014|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44870015|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870016|NCT04438928|Micronutrients|micronutrients|mesh-list
44870017|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870018|NCT04438720|Nifedipine|nifedipine|mesh-list
44870019|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44870020|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870021|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870022|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44870023|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870024|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
44870025|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
44870026|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44870027|NCT04438772|Anesthetics|anesthetics|mesh-list
44357359|NCT01120314|Otamixaban|otamixaban|mesh-list
44870028|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870029|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870030|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
44870031|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44870032|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
44870033|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
44870034|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870035|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870036|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44870037|NCT05388942|Analgesics|analgesics|mesh-ancestor
44870038|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
44870039|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870040|NCT05388747|Cefuroxime|cefuroxime|mesh-list
44870041|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
44870042|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870043|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870044|NCT05388448|Amoxicillin|amoxicillin|mesh-list
44870045|NCT05388448|Rifampin|rifampin|mesh-list
44870046|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
44870047|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
44870048|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870049|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870050|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44870051|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
44870052|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
44870053|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44870054|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870055|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870056|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44870057|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44870058|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44870059|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44870060|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44870061|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44870062|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44870063|NCT05388188|Sufentanil|sufentanil|mesh-list
44870064|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44870065|NCT05388188|Narcotics|narcotics|mesh-ancestor
44870066|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870067|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870068|NCT05388188|Analgesics|analgesics|mesh-ancestor
44870069|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
44870070|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698115|NCT05271045|Vitamins|vitamins|mesh-ancestor
44870071|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44870072|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870073|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
44870074|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
44870075|NCT05388123|Rituximab|rituximab|mesh-list
44870076|NCT05388123|Vemurafenib|vemurafenib|mesh-list
44870077|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870078|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870079|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
44870080|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870081|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870082|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44870083|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870084|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870085|NCT05387967|Valsartan|valsartan|mesh-list
44870086|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44870087|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44870088|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44870089|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44870090|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870091|NCT05387954|Anticoagulants|anticoagulants|mesh-list
44870092|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
44870093|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
44870094|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44870095|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870096|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870097|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870098|NCT05387876|Vitamin D|vitamin d|mesh-list
44870099|NCT05387876|Vitamins|vitamins|mesh-ancestor
44870100|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
44870101|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870102|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44870103|NCT05387681|Endostatins|endostatins|mesh-list
44870104|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870105|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44870106|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44870107|NCT05387681|Growth Substances|growth substances|mesh-ancestor
44870108|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870109|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44870110|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
44870111|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870112|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870113|NCT05387603|Capecitabine|capecitabine|mesh-list
44870114|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
44870115|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870116|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
44870117|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870118|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870119|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44870120|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
44870121|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44870122|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870123|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870124|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870125|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44870126|NCT05387187|Protective Agents|protective agents|mesh-ancestor
44870127|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870128|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44870129|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44870130|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
44870131|NCT05387031|Ustekinumab|ustekinumab|mesh-list
44870132|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
44870133|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
44870134|NCT05386979|Anesthetics|anesthetics|mesh-list
44870135|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870136|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870137|NCT05386979|Narcotics|narcotics|mesh-ancestor
44870138|NCT05386979|Analgesics|analgesics|mesh-ancestor
44870139|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
44870140|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870141|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
44870142|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44870143|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44870144|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44870145|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870146|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870147|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
44870148|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870149|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870150|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44870151|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870152|NCT05379855|Atropine|atropine|mesh-list
44870153|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44870154|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44870155|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44870156|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44870157|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44870158|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
44870159|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870160|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870161|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44870162|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
44870163|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
44698116|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
44698117|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698118|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44698119|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44698120|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44698121|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698122|NCT05270434|Dipyrone|dipyrone|mesh-list
44698123|NCT05270434|Meperidine|meperidine|mesh-list
44698124|NCT05270434|Morphine|morphine|mesh-list
44698125|NCT05270434|Buprenorphine|buprenorphine|mesh-list
44698126|NCT05270434|Analgesics|analgesics|mesh-list
44698127|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44698128|NCT05270434|Narcotics|narcotics|mesh-ancestor
44698129|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698130|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698131|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
44698132|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698133|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44698134|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44698135|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44698136|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698137|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698138|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698139|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
44698140|NCT05270421|Furosemide|furosemide|mesh-list
44698141|NCT05270421|Diuretics|diuretics|mesh-ancestor
44698142|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
44698143|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698144|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44698145|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44698146|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698147|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
44698148|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44698149|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698150|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
44698151|NCT05270343|Vitamin D|vitamin d|mesh-list
44698152|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44698153|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698154|NCT05270343|Vitamins|vitamins|mesh-ancestor
44698155|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
44657482|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
44870164|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
44870165|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44870166|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44870167|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
44870168|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870169|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870170|NCT05376046|Thrombin|thrombin|mesh-list
44870171|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
44870172|NCT05376046|Coagulants|coagulants|mesh-ancestor
44870173|NCT05375084|Nivolumab|nivolumab|mesh-list
44870174|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870175|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870176|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44870177|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870178|NCT05374057|Ibuprofen|ibuprofen|mesh-list
44870179|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44870180|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44870181|NCT05374057|Analgesics|analgesics|mesh-ancestor
44870182|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
44870183|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870184|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870185|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870186|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870187|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44870188|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870189|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870190|NCT05373446|Ritonavir|ritonavir|mesh-list
44870191|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44870192|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44870193|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870194|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870195|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870196|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44870197|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44870198|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
44870199|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870200|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44357554|NCT01121497|Miotics|miotics|mesh-ancestor
44870201|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44870202|NCT05373433|Ritonavir|ritonavir|mesh-list
44870203|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44870204|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44870205|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870206|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870207|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870208|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44870209|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44870210|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
44870211|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870212|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44870213|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44870214|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44870215|NCT05363462|Vancomycin|vancomycin|mesh-list
44870216|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870217|NCT05301634|Bupivacaine|bupivacaine|mesh-list
44870218|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
44870219|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
44870220|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870221|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870222|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
44870223|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870224|NCT05231382|Leucovorin|leucovorin|mesh-list
44870225|NCT05231382|Fluorouracil|fluorouracil|mesh-list
44870226|NCT05231382|Raltitrexed|raltitrexed|mesh-list
44870227|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
44870228|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
44870229|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870230|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870231|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870232|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870233|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
44870234|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870235|NCT05231382|Antidotes|antidotes|mesh-ancestor
44870236|NCT05231382|Protective Agents|protective agents|mesh-ancestor
44870237|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
44870238|NCT05231382|Vitamins|vitamins|mesh-ancestor
44870239|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
44870240|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44870241|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870242|NCT05214599|Budesonide|budesonide|mesh-list
44870243|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870244|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44870245|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
44870246|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870247|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870248|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44870249|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
44870250|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
44870251|NCT05214599|Hormones|hormones|mesh-ancestor
44870252|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870253|NCT05199714|Pramlintide|pramlintide|mesh-list
44870254|NCT05199714|Pancrelipase|pancrelipase|mesh-list
44870255|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870256|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44870257|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870258|NCT05191875|Doxycycline|doxycycline|mesh-list
44870259|NCT05191875|Furazolidone|furazolidone|mesh-list
44870260|NCT05191875|Bismuth|bismuth|mesh-list
44870261|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870262|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870263|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
44870264|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44870265|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44870266|NCT05191875|Antacids|antacids|mesh-ancestor
44870267|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870268|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870269|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44870270|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44870271|NCT05191875|Renal Agents|renal agents|mesh-ancestor
44870272|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44870273|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44870274|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870275|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
44870276|NCT05170711|Anesthetics|anesthetics|mesh-list
44870277|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357637|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
44870278|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870279|NCT05069298|Silybin|silybin|mesh-list
44870280|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44870281|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870282|NCT05069298|Protective Agents|protective agents|mesh-ancestor
44870283|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870284|NCT05053659|Venetoclax|venetoclax|mesh-list
44870285|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44870286|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870287|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870288|NCT05016076|Dexamethasone|dexamethasone|mesh-list
44870289|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870290|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
44870291|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
44870292|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870293|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870294|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870295|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
44870296|NCT05016076|Hormones|hormones|mesh-ancestor
44870297|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870298|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44870299|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870300|NCT04973150|Anesthetics|anesthetics|mesh-list
44870301|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870302|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870303|NCT04950608|Psilocybin|psilocybin|mesh-list
44870304|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
44870305|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870306|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870307|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
44870308|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44870309|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44870310|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44870311|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870312|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870313|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
44870314|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870315|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870316|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44870317|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870319|NCT04939623|Probenecid|probenecid|mesh-list
44870320|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
44870321|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
44870322|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870323|NCT04939623|Renal Agents|renal agents|mesh-ancestor
44870324|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
44870325|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870327|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
44870328|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870329|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870330|NCT04879550|Antithrombins|antithrombins|mesh-list
44870331|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
44870332|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44870333|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870334|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870335|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870336|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
44870337|NCT04843462|Esketamine|esketamine|mesh-list
44870338|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
44870339|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870340|NCT04699591|Domperidone|domperidone|mesh-list
44870341|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
44870342|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
44870343|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870344|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870345|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870346|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44870347|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
44870348|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870349|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870350|NCT04650074|Lidocaine|lidocaine|mesh-list
44870351|NCT04650074|Ketamine|ketamine|mesh-list
44870352|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
44870353|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
44870354|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870355|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870356|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
44870357|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870358|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44870359|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44870360|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44870361|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870362|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870363|NCT04650074|Analgesics|analgesics|mesh-ancestor
44870364|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44870365|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870366|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
44870367|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44870368|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44870369|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870370|NCT04604366|Alprostadil|alprostadil|mesh-list
44870371|NCT04604366|Misoprostol|misoprostol|mesh-list
44870372|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44870373|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
44870374|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44870375|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870376|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44870377|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870378|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
44870379|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870380|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
44870381|NCT04604366|Urological Agents|urological agents|mesh-ancestor
44870382|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
44870383|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44870384|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44870385|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44870386|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44870387|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870388|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870389|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
44870390|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870391|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870392|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44870393|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870394|NCT04537715|Itraconazole|itraconazole|mesh-list
44870395|NCT04537715|Rifampin|rifampin|mesh-list
44870396|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
44870397|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870398|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44870399|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44870400|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870401|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870402|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44870403|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
44870404|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870405|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357757|NCT01122615|Sirolimus|sirolimus|mesh-list
44870406|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44870407|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44870408|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
44870409|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870410|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
44870411|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44870412|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44870413|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44870414|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44870415|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44870416|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44870417|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44870418|NCT04478734|Thiamine|thiamine|mesh-list
44870419|NCT04478734|Biotin|biotin|mesh-list
44870420|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
44870421|NCT04478734|Vitamins|vitamins|mesh-ancestor
44870422|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
44870423|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870424|NCT04460781|Vaccines|vaccines|mesh-list
44870425|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
44870426|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870427|NCT04427241|Amantadine|amantadine|mesh-list
44870428|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
44870429|NCT04427241|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44870430|NCT04427241|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44870431|NCT04427241|Antiviral Agents|antiviral agents|mesh-ancestor
44870432|NCT04427241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870433|NCT04427241|Dopamine Agents|dopamine agents|mesh-ancestor
44870434|NCT04427241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870435|NCT04427241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870436|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870437|NCT04427241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44870438|NCT04427241|Analgesics|analgesics|mesh-ancestor
44870439|NCT04427241|Sensory System Agents|sensory system agents|mesh-ancestor
44870440|NCT04427241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870441|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44870442|NCT04427241|Protective Agents|protective agents|mesh-ancestor
44870443|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
44870444|NCT04369469|Ravulizumab|ravulizumab|mesh-list
44870445|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44870446|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357808|NCT01122953|Phenytoin|phenytoin|mesh-list
44870447|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
44870448|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870449|NCT04132661|Bisacodyl|bisacodyl|mesh-list
44870450|NCT04132661|Cathartics|cathartics|mesh-ancestor
44870451|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870452|NCT04132661|Laxatives|laxatives|mesh-ancestor
44657828|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870453|NCT04119180|Midazolam|midazolam|mesh-list
44870454|NCT04119180|Ketamine|ketamine|mesh-list
44870455|NCT04119180|Analgesics|analgesics|mesh-ancestor
44870456|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
44870457|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870458|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870459|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44870460|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870461|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
44870462|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
44870463|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870464|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44870465|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44870466|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870467|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870468|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44870469|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44870470|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44870471|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44870472|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870473|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
44870474|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
44870475|NCT04019093|Ethanol|ethanol|mesh-list
44870476|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44870477|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870478|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870479|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870480|NCT04006210|Levodopa|levodopa|mesh-list
44870481|NCT04006210|Carbidopa|carbidopa|mesh-list
44870482|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44870483|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44870484|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
44870485|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870486|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357837|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870487|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870488|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44870489|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870490|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44870491|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870492|NCT03905265|Moxidectin|moxidectin|mesh-list
44870493|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
44870494|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44870495|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870496|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
44870497|NCT03900949|Cytarabine|cytarabine|mesh-list
44870498|NCT03900949|Daunorubicin|daunorubicin|mesh-list
44870499|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
44870500|NCT03900949|Midostaurin|midostaurin|mesh-list
44870501|NCT03900949|Calicheamicins|calicheamicins|mesh-list
44870502|NCT03900949|Staurosporine|staurosporine|mesh-list
44870503|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870504|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
44870505|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870506|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870507|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
44870508|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870509|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870510|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
44870511|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870512|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44870513|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44870514|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44870515|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870516|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870517|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44870518|NCT03878199|Cytarabine|cytarabine|mesh-list
44870519|NCT03878199|Daunorubicin|daunorubicin|mesh-list
44870520|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44870521|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870522|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
44870523|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870524|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870525|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
44870526|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870527|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657910|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870528|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
44870529|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870530|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44870531|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44870533|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870534|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44870535|NCT03851159|Mannitol|mannitol|mesh-list
44870536|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44870537|NCT03851159|Diuretics|diuretics|mesh-ancestor
44870538|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
44870539|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870540|NCT03797924|Ropivacaine|ropivacaine|mesh-list
44870541|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
44870542|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
44870543|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870544|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870545|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
44870546|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870547|NCT03787628|Cannabidiol|cannabidiol|mesh-list
44870548|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
44870549|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
44870550|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870551|NCT03772574|Nicotine|nicotine|mesh-list
44870552|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44870553|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
44870554|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870555|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870556|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44870557|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44870558|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
44870559|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870560|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870561|NCT03694808|Vaccines|vaccines|mesh-list
44870562|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
44870563|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870564|NCT03675893|Letrozole|letrozole|mesh-list
44870565|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870566|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44870567|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44870568|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870569|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870570|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44870571|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
44870572|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870573|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870574|NCT03643367|Propofol|propofol|mesh-list
44870575|NCT03643367|Sevoflurane|sevoflurane|mesh-list
44870576|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44870577|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870578|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870579|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870580|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
44870581|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
44870582|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870583|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44870584|NCT03632044|Ropivacaine|ropivacaine|mesh-list
44870585|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
44870586|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
44870587|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870588|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870589|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
44870590|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870591|NCT03533452|Ropivacaine|ropivacaine|mesh-list
44870592|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
44870593|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
44870594|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870595|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870596|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
44870597|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870598|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44870599|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870600|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870601|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870602|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44657993|NCT00073528|Letrozole|letrozole|mesh-list
44870603|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870604|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
44870605|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870606|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870607|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44870608|NCT03474276|Azithromycin|azithromycin|mesh-list
44870609|NCT03474276|Albendazole|albendazole|mesh-list
44870610|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
44870611|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870612|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
44870613|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
44870614|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44870615|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44870616|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44870617|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44870618|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44870619|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870620|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870621|NCT03467113|Cannabidiol|cannabidiol|mesh-list
44870622|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
44870623|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44870624|NCT03434041|Citalopram|citalopram|mesh-list
44870625|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44870626|NCT03434041|Sertraline|sertraline|mesh-list
44870627|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
44870628|NCT03434041|Esketamine|esketamine|mesh-list
44870629|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44870630|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44870631|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870632|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870633|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870634|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
44870635|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870636|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44870637|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870638|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870639|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44870640|NCT03434041|Analgesics|analgesics|mesh-ancestor
44870641|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
44870642|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
44870643|NCT03378466|Heparin|heparin|mesh-list
44870644|NCT03378466|Calcium heparin|calcium heparin|mesh-list
44870645|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
44870646|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44870647|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44870648|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870649|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44870650|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44870651|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44870652|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
44870653|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870654|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44870655|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44870656|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870657|NCT03123211|Veliparib|veliparib|mesh-list
44870658|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44870659|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870660|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870661|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870662|NCT03060434|Acetaminophen|acetaminophen|mesh-list
44870663|NCT03060434|Ibuprofen|ibuprofen|mesh-list
44870664|NCT03060434|Pregabalin|pregabalin|mesh-list
44870665|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
44870666|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44870667|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44870668|NCT03060434|Analgesics|analgesics|mesh-ancestor
44870669|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
44870670|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870671|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870672|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870673|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870674|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44870675|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870676|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870677|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
44658053|NCT00072280|Vincristine|vincristine|mesh-list
44870678|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44870679|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870680|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44870681|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44870682|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44870683|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870684|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870685|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
44870686|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44870687|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870688|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44870689|NCT03060434|Protective Agents|protective agents|mesh-ancestor
44870690|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44870691|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44870692|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
44870693|NCT03006705|Capecitabine|capecitabine|mesh-list
44870694|NCT03006705|Tegafur|tegafur|mesh-list
44870695|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
44870696|NCT03006705|Nivolumab|nivolumab|mesh-list
44870697|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870698|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
44870699|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870700|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870701|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870702|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44870703|NCT02918084|Letrozole|letrozole|mesh-list
44870704|NCT02918084|Anastrozole|anastrozole|mesh-list
44870705|NCT02918084|Exemestane|exemestane|mesh-list
44870706|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870707|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44870708|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44870709|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870710|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870711|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44870712|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44870713|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870714|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870715|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44870716|NCT02835222|Cytarabine|cytarabine|mesh-list
44870717|NCT02835222|Daunorubicin|daunorubicin|mesh-list
44870718|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870719|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
44870720|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870721|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870722|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
44870723|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870724|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870725|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
44870726|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870727|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44870728|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44870729|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44870730|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870731|NCT02819479|Bevacizumab|bevacizumab|mesh-list
44870732|NCT02819479|Mannitol|mannitol|mesh-list
44870733|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870734|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870735|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44870736|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44870737|NCT02819479|Growth Substances|growth substances|mesh-ancestor
44870738|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870739|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
44870740|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44870741|NCT02819479|Diuretics|diuretics|mesh-ancestor
44870742|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
44870743|NCT02816424|TEMPO|tempo|mesh-list
44870744|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
44870745|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870746|NCT02816424|Protective Agents|protective agents|mesh-ancestor
44870747|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870748|NCT02794896|Fentanyl|fentanyl|mesh-list
44870749|NCT02794896|Propofol|propofol|mesh-list
44870750|NCT02794896|Sevoflurane|sevoflurane|mesh-list
44870751|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44870752|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870753|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870754|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870755|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
44870756|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
44870757|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44870758|NCT02794896|Narcotics|narcotics|mesh-ancestor
44870759|NCT02794896|Analgesics|analgesics|mesh-ancestor
44870760|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
44870761|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870762|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44870763|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870764|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44870765|NCT02783404|Amoxicillin|amoxicillin|mesh-list
44870766|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
44870767|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
44870768|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870769|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870770|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44870771|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870772|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870773|NCT02728531|Cytarabine|cytarabine|mesh-list
44870774|NCT02728531|Rituximab|rituximab|mesh-list
44870775|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44870776|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870777|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870778|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
44870779|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870780|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870781|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870782|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
44870783|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870784|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
44870785|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870786|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870787|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44870788|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
44870789|NCT02693184|Vitamin D|vitamin d|mesh-list
44870790|NCT02693184|Calcium|calcium|mesh-list
44870791|NCT02693184|Vitamins|vitamins|mesh-ancestor
44870792|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
44870793|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870794|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44870795|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44870796|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
44870797|NCT02677181|Methotrexate|methotrexate|mesh-list
44870798|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
44870799|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44870800|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
44870801|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44870802|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870803|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870804|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
44870805|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870806|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870807|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44870808|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870809|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44870810|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870811|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
44870812|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870813|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44358164|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44870814|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44870815|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44870816|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
44870817|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870818|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870819|NCT02640664|Ranibizumab|ranibizumab|mesh-list
44870820|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44870821|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44870822|NCT02640664|Growth Substances|growth substances|mesh-ancestor
44870823|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870824|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
44870825|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870826|NCT02621944|Melatonin|melatonin|mesh-list
44870827|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
44870828|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870829|NCT02621944|Protective Agents|protective agents|mesh-ancestor
44870830|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870831|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870832|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44870833|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
44870834|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44870835|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44870836|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870837|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870838|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870839|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44870840|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870841|NCT02419560|Venetoclax|venetoclax|mesh-list
44870842|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870843|NCT02405520|Vaccines|vaccines|mesh-list
44870844|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
44870845|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870846|NCT02382445|Anesthetics|anesthetics|mesh-list
44870847|NCT02382445|Propofol|propofol|mesh-list
44870848|NCT02382445|Sevoflurane|sevoflurane|mesh-list
44870849|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44870850|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870851|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44870852|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44870853|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
44870854|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44870855|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44870856|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44870857|NCT02378805|Ramipril|ramipril|mesh-list
44870858|NCT02378805|Spironolactone|spironolactone|mesh-list
44358235|NCT01125150|Metformin|metformin|mesh-list
44358236|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44870859|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44870860|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44870861|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
44870862|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870863|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870864|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44870865|NCT02378805|Diuretics|diuretics|mesh-ancestor
44870866|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44870867|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870868|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358250|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358251|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358252|NCT01125410|Clindamycin|clindamycin|mesh-list
44870869|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870870|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44870871|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44870872|NCT02133872|Minocycline|minocycline|mesh-list
44870873|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44870874|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870875|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
44870876|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870877|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
44870878|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
44870879|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44870880|NCT01668719|Dexamethasone|dexamethasone|mesh-list
44698156|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44870881|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
44870882|NCT01668719|Lenalidomide|lenalidomide|mesh-list
44870883|NCT01668719|Bortezomib|bortezomib|mesh-list
44870884|NCT01668719|Elotuzumab|elotuzumab|mesh-list
44870885|NCT01668719|Ichthammol|ichthammol|mesh-list
44870886|NCT01668719|BB 1101|bb 1101|mesh-list
44870887|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870888|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
44870889|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
44870890|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870891|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870892|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870893|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
44870894|NCT01668719|Hormones|hormones|mesh-ancestor
44870895|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870896|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44870897|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870898|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
44870899|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44870900|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44870901|NCT01668719|Growth Substances|growth substances|mesh-ancestor
44870902|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
44870903|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44870904|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870905|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870906|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44870907|NCT01515748|Docetaxel|docetaxel|mesh-list
44870908|NCT01515748|Fluorouracil|fluorouracil|mesh-list
44870909|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
44870910|NCT01515748|Tegafur|tegafur|mesh-list
44870911|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870912|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44870913|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44870914|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44870915|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358292|NCT01125527|Vaccines|vaccines|mesh-list
44870916|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
44870917|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870918|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870919|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
44870920|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870921|NCT01261247|Panobinostat|panobinostat|mesh-list
44870922|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44870923|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870924|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870925|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870926|NCT01169259|Vitamin D|vitamin d|mesh-list
44870927|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
44870928|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
44870929|NCT01169259|Vitamins|vitamins|mesh-list
44870930|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
44870931|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870932|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44870933|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44870934|NCT01117441|Cytarabine|cytarabine|mesh-list
44870935|NCT01117441|Dexamethasone|dexamethasone|mesh-list
44658357|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658358|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658359|NCT00068393|Antiviral Agents|antiviral agents|mesh-ancestor
44658360|NCT00068393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658361|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658362|NCT00068393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658363|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
44658364|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658365|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658366|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658367|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658368|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658369|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
44658370|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658371|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658372|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658373|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658374|NCT00068250|Rituximab|rituximab|mesh-list
44658375|NCT00068250|Methotrexate|methotrexate|mesh-list
44658376|NCT00068250|Temozolomide|temozolomide|mesh-list
44658377|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44870936|NCT01117441|Prednisone|prednisone|mesh-list
44870937|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
44870938|NCT01117441|Ifosfamide|ifosfamide|mesh-list
44870939|NCT01117441|Doxorubicin|doxorubicin|mesh-list
44870940|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44870941|NCT01117441|Methotrexate|methotrexate|mesh-list
44870942|NCT01117441|Fludarabine|fludarabine|mesh-list
44870943|NCT01117441|Etoposide|etoposide|mesh-list
44870944|NCT01117441|Vincristine|vincristine|mesh-list
44870945|NCT01117441|Daunorubicin|daunorubicin|mesh-list
44870946|NCT01117441|Asparaginase|asparaginase|mesh-list
44870947|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
44870948|NCT01117441|Thioguanine|thioguanine|mesh-list
44870949|NCT01117441|Pegaspargase|pegaspargase|mesh-list
44870950|NCT01117441|Vindesine|vindesine|mesh-list
44870951|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44870952|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
44870953|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44870954|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44870955|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44870956|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
44870957|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870958|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870959|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44870960|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44870961|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
44870962|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
44870963|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44870964|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870965|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
44870966|NCT01117441|Hormones|hormones|mesh-ancestor
44870967|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44870968|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44870969|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44870970|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44870971|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44870972|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44870973|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44870974|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
44870975|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44870976|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44870977|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
44870978|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
44870979|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44870980|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44870981|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44870982|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
44870983|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44870984|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44870985|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44870986|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44870987|NCT01101451|Cisplatin|cisplatin|mesh-list
44870988|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44870989|NCT00790933|Vedolizumab|vedolizumab|mesh-list
44870990|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44870991|NCT00127673|Sertraline|sertraline|mesh-list
44870992|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
44870993|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44870994|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44870995|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44870996|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44870997|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44870998|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44870999|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
44871000|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871001|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
44871002|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44871003|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44871004|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
44871005|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44871006|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871007|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
44871008|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
44871009|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44871010|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
44658419|NCT00066807|Tamoxifen|tamoxifen|mesh-list
44871011|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871012|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
44871013|NCT04438421|Protective Agents|protective agents|mesh-ancestor
44871014|NCT04438577|Lidocaine|lidocaine|mesh-list
44871015|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
44871016|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
44871017|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871018|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871019|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
44871020|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871021|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44871022|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44871023|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44871024|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871025|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871027|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44871028|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44871029|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
44871030|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44871031|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871032|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
44871033|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
44871034|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44871035|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
44871036|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871037|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
44871038|NCT04438434|Protective Agents|protective agents|mesh-ancestor
44871039|NCT04437836|Rifampin|rifampin|mesh-list
44871040|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44871041|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
44871042|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871043|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871044|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
44871045|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44871046|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871047|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871048|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44871049|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44871050|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44871051|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44871052|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44871053|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44871054|NCT04437758|Ascorbic Acid|ascorbic acid|mesh-list
44871055|NCT04437758|Vitamins|vitamins|mesh-ancestor
44871056|NCT04437758|Micronutrients|micronutrients|mesh-ancestor
44871057|NCT04437758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871058|NCT04437758|Antioxidants|antioxidants|mesh-ancestor
44871059|NCT04437758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871060|NCT04437758|Protective Agents|protective agents|mesh-ancestor
44871061|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871062|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
44871063|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871064|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871065|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871066|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358458|NCT01126294|Melatonin|melatonin|mesh-list
44871067|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871068|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871069|NCT04437654|Apixaban|apixaban|mesh-list
44871070|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44871071|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
44871072|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44871073|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871074|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871075|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871076|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
44871077|NCT04437004|Fenfluramine|fenfluramine|mesh-list
44871078|NCT04437004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44358479|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358485|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
44871079|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44871080|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871081|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871082|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871083|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
44871084|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871085|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
44871086|NCT04437160|Epirubicin|epirubicin|mesh-list
44871087|NCT04437160|Pirarubicin|pirarubicin|mesh-list
44871088|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871089|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
44698157|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
44871090|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698158|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44698159|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
44698160|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698161|NCT05269654|Mannitol|mannitol|mesh-list
44698162|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44698163|NCT05269654|Diuretics|diuretics|mesh-ancestor
44698164|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
44698165|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698166|NCT05269459|Cannabidiol|cannabidiol|mesh-list
44698167|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
44698168|NCT05253846|Fluorouracil|fluorouracil|mesh-list
44698169|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
44698170|NCT05253846|Irinotecan|irinotecan|mesh-list
44698171|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
44698172|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698173|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44698174|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698175|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698176|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
44698177|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698178|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44698179|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44698180|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698181|NCT05250141|Levodopa|levodopa|mesh-list
44249760|NCT05214807|Chitosan|chitosan|mesh-list
44698182|NCT05250141|Carbidopa|carbidopa|mesh-list
44698183|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44698184|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44698221|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44698222|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
44698223|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
44698224|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
44698225|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44698227|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698228|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698230|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44358537|NCT01127009|Cytarabine|cytarabine|mesh-list
44698231|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698232|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698233|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698234|NCT05232006|Niraparib|niraparib|mesh-list
44698235|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44698236|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698237|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698238|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698239|NCT05209841|Heparin|heparin|mesh-list
44698240|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
44698241|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44698242|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44698243|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698244|NCT05207280|Terlipressin|terlipressin|mesh-list
44698245|NCT05207280|Norepinephrine|norepinephrine|mesh-list
44698246|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44698247|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44698248|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44698249|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698250|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698251|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358540|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
44698252|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698253|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698254|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
44698255|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
44698256|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698257|NCT05173142|Gemcitabine|gemcitabine|mesh-list
44698258|NCT05173142|Cisplatin|cisplatin|mesh-list
44698259|NCT05173142|Docetaxel|docetaxel|mesh-list
44698260|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698261|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44698262|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
44698263|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698264|NCT05173142|Antiviral Agents|antiviral agents|mesh-ancestor
44698265|NCT05173142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698266|NCT05173142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698267|NCT05173142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698268|NCT05173142|Immunologic Factors|immunologic factors|mesh-ancestor
44698269|NCT05173142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871091|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871092|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44871093|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
44871094|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871095|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871096|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44871097|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44871098|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44871099|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44871100|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871101|NCT04436601|Lactulose|lactulose|mesh-list
44871102|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871103|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
44871104|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
44871105|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871106|NCT04436419|Protective Agents|protective agents|mesh-ancestor
44871107|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871108|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
44871109|NCT04436419|Vitamins|vitamins|mesh-ancestor
44871110|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
44871111|NCT04436536|Methamphetamine|methamphetamine|mesh-list
44871112|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44871113|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871114|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
44871115|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
44871116|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871117|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
44871118|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871119|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871120|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44871121|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44871122|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44871123|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871124|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44871125|NCT04436172|Anesthetics|anesthetics|mesh-list
44871126|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871127|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871128|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
44871129|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44871130|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
44871131|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871132|NCT04435925|Fentanyl|fentanyl|mesh-list
44871133|NCT04435925|Remifentanil|remifentanil|mesh-list
44871134|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44871135|NCT04435925|Narcotics|narcotics|mesh-ancestor
44871136|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871137|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871138|NCT04435925|Analgesics|analgesics|mesh-ancestor
44871139|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
44871140|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871141|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44871142|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44871143|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
44871144|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
44871145|NCT04435743|Lenalidomide|lenalidomide|mesh-list
44871146|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
44871147|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871148|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44871149|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44871150|NCT04435743|Growth Substances|growth substances|mesh-ancestor
44871151|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
44871152|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871153|NCT04435704|Oxytocin|oxytocin|mesh-list
44871154|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
44871155|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871156|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871157|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44871158|NCT04435587|Ritonavir|ritonavir|mesh-list
44871159|NCT04435587|Darunavir|darunavir|mesh-list
44871160|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871161|NCT04435587|Ivermectin|ivermectin|mesh-list
44871162|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44871163|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44871164|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871165|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871166|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871167|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44871168|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44871169|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
44871170|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871171|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44358608|NCT01127217|Losartan|losartan|mesh-list
44871172|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44871173|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
44871174|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871175|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871176|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871177|NCT04435652|Paclitaxel|paclitaxel|mesh-list
44871178|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44871179|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44871180|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871181|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
44871182|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
44871183|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
44871184|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871185|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
44871186|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871187|NCT04435522|Maraviroc|maraviroc|mesh-list
44871188|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44871189|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44871190|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871191|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44871192|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44871193|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
44871194|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871195|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44871196|NCT04435574|Lactoferrin|lactoferrin|mesh-list
44871197|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871198|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
44871199|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871200|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871201|NCT04435418|Apixaban|apixaban|mesh-list
44871202|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44871203|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
44871204|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44871205|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871206|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871207|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871208|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
44871209|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
44871210|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871211|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871212|NCT04435028|Ketotifen|ketotifen|mesh-list
44871213|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
44871214|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
44871215|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44871216|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
44871217|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
44871218|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871219|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871220|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871221|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44871222|NCT04435210|Hydralazine|hydralazine|mesh-list
44871223|NCT04435210|Nifedipine|nifedipine|mesh-list
44871224|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44871225|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871226|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871227|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44871228|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871229|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
44871230|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
44871231|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871232|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44871233|NCT04434482|Temozolomide|temozolomide|mesh-list
44871234|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44871235|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
44871236|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871237|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871238|NCT04434378|Tamsulosin|tamsulosin|mesh-list
44871239|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44871240|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44871241|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44871242|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
44871243|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871244|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871245|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871246|NCT04434378|Urological Agents|urological agents|mesh-ancestor
44658714|NCT00064077|Gemcitabine|gemcitabine|mesh-list
44871247|NCT04434404|Silymarin|silymarin|mesh-list
44871248|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
44871249|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871250|NCT04434404|Protective Agents|protective agents|mesh-ancestor
44358739|NCT01127672|Lidocaine|lidocaine|mesh-list
44871251|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871252|NCT04434430|Gabapentin|gabapentin|mesh-list
44871253|NCT04434430|Analgesics|analgesics|mesh-ancestor
44871254|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
44871255|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871256|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871257|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
44871258|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44871259|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44871260|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871261|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44871262|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44871263|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44871264|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871265|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871266|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
44871267|NCT04434365|Aspirin|aspirin|mesh-list
44871268|NCT04434365|Clopidogrel|clopidogrel|mesh-list
44871269|NCT04434365|Atorvastatin|atorvastatin|mesh-list
44871270|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44871271|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871272|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871273|NCT04434365|Analgesics|analgesics|mesh-ancestor
44871274|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
44358740|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871275|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871276|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871277|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871278|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871279|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44871280|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44871281|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871282|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44871283|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871284|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871285|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
44871286|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44871287|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44871288|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
44871289|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44871290|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44871291|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44871292|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44871293|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44871294|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
44871295|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871296|NCT04434248|Ritonavir|ritonavir|mesh-list
44871297|NCT04434248|Lopinavir|lopinavir|mesh-list
44871298|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871299|NCT04434248|Chloroquine|chloroquine|mesh-list
44871300|NCT04434248|Favipiravir|favipiravir|mesh-list
44871301|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44871302|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44871303|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871304|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871305|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871306|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44871307|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44871308|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
44358773|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358780|NCT01127880|Clindamycin|clindamycin|mesh-list
44871309|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871310|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44871311|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44871312|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
44871313|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871314|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871315|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871316|NCT04434248|Amebicides|amebicides|mesh-ancestor
44871317|NCT04434105|Triamcinolone|triamcinolone|mesh-list
44871318|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44871319|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44871320|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44871321|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658786|NCT00063258|Paclitaxel|paclitaxel|mesh-list
44871322|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
44871323|NCT04434105|Hormones|hormones|mesh-ancestor
44871324|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871325|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871326|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871327|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
44871328|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358797|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
44871329|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871330|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
44871331|NCT04434144|Azithromycin|azithromycin|mesh-list
44871332|NCT04434144|Doxycycline|doxycycline|mesh-list
44871333|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871334|NCT04434144|Ivermectin|ivermectin|mesh-list
44871335|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871336|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871337|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
44871338|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871339|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871340|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871341|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871342|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871343|NCT04434170|Valsartan|valsartan|mesh-list
44871344|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44871345|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44871346|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44871347|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44871348|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871349|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44871350|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44871351|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44871352|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
44871353|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871354|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44871355|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44871356|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871357|NCT04433611|Lidocaine|lidocaine|mesh-list
44871358|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
44871359|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
44871360|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871361|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871362|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
44871363|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871364|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44871365|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44871366|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44871367|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871368|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871369|NCT04433481|Dabigatran|dabigatran|mesh-list
44871370|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
44871371|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44871372|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871373|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871374|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871375|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
44871376|NCT04433741|Oxytocin|oxytocin|mesh-list
44871377|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
44871378|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871379|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871380|NCT04433572|Sirolimus|sirolimus|mesh-list
44871381|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871382|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871383|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44871384|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871385|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
44871386|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871387|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
44871388|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871389|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
44871390|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44871391|NCT04433559|Tadalafil|tadalafil|mesh-list
44871392|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
44871393|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44871394|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44658864|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
44871395|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871396|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871397|NCT04433559|Urological Agents|urological agents|mesh-ancestor
44871398|NCT04433169|Tretinoin|tretinoin|mesh-list
44871399|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871400|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
44871401|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
44871402|NCT04433156|Prednisone|prednisone|mesh-list
44871403|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
44871404|NCT04433156|Rituximab|rituximab|mesh-list
44871405|NCT04433156|Bortezomib|bortezomib|mesh-list
44871406|NCT04433156|Epirubicin|epirubicin|mesh-list
44871407|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871408|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
44871409|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871410|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871411|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44871412|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
44871413|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871414|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871415|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44871416|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871417|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871418|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
44871419|NCT04433156|Hormones|hormones|mesh-ancestor
44871420|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871421|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44358883|NCT01129089|Trace Elements|trace elements|mesh-list
44871422|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44871423|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44871424|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44871425|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871426|NCT04433143|Minocycline|minocycline|mesh-list
44871427|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871428|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871429|NCT04433078|Doxycycline|doxycycline|mesh-list
44871430|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871431|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871432|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
44871433|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871434|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871435|NCT04432714|Prednisone|prednisone|mesh-list
44871436|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
44871437|NCT04432714|Rituximab|rituximab|mesh-list
44871438|NCT04432714|Doxorubicin|doxorubicin|mesh-list
44871439|NCT04432714|Etoposide|etoposide|mesh-list
44871440|NCT04432714|Vincristine|vincristine|mesh-list
44871441|NCT04432714|Lenalidomide|lenalidomide|mesh-list
44871442|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871443|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
44871444|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871445|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871446|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44871447|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
44871448|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871449|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871450|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44871451|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871452|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44871453|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44871454|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44871455|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871456|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871457|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
44871458|NCT04432714|Hormones|hormones|mesh-ancestor
44871459|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871460|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44871461|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44871462|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44871463|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44871464|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44871465|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44871466|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358918|NCT01129323|Fludarabine|fludarabine|mesh-list
44871467|NCT04432714|Growth Substances|growth substances|mesh-ancestor
44871468|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
44871469|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44871470|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44871471|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44871472|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871473|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871474|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44871475|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44871476|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44871477|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44871478|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44871479|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871480|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871481|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44871482|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44871484|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44871485|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44871486|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
44871487|NCT04432415|Fluorides|fluorides|mesh-list
44871488|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
44871489|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
44871490|NCT04432415|Protective Agents|protective agents|mesh-ancestor
44871491|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871492|NCT04432558|Acetaminophen|acetaminophen|mesh-list
44871493|NCT04432558|Diclofenac|diclofenac|mesh-list
44871494|NCT04432558|Tramadol|tramadol|mesh-list
44871495|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871496|NCT04432558|Analgesics|analgesics|mesh-ancestor
44871497|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
44871498|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871499|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871500|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
44871501|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871502|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871503|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871504|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871505|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871506|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871507|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44358957|NCT01129414|Omeprazole|omeprazole|mesh-list
44871508|NCT04432558|Narcotics|narcotics|mesh-ancestor
44871509|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871510|NCT04432402|Gemcitabine|gemcitabine|mesh-list
44871511|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
44871512|NCT04432402|Lenalidomide|lenalidomide|mesh-list
44871513|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871514|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
44871515|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871516|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44871517|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
44871518|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871519|NCT04432402|Antiviral Agents|antiviral agents|mesh-ancestor
44871520|NCT04432402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871521|NCT04432402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871522|NCT04432402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44871523|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44871524|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44871525|NCT04432402|Growth Substances|growth substances|mesh-ancestor
44871526|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
44871527|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
44871528|NCT04432324|Antibodies|antibodies|mesh-list
44871529|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
44871530|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44871531|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44871532|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
44871533|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871534|NCT04432220|Apixaban|apixaban|mesh-list
44871535|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44871536|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
44871537|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44871538|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
44871539|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871540|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871541|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
44871542|NCT04432259|Dexamethasone|dexamethasone|mesh-list
44871543|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871544|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
44871545|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
44871546|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871547|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871548|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871549|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
44871550|NCT04432259|Hormones|hormones|mesh-ancestor
44871551|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871552|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44871553|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871554|NCT04432233|Metronidazole|metronidazole|mesh-list
44871555|NCT04432233|Levofloxacin|levofloxacin|mesh-list
44871556|NCT04432233|Ofloxacin|ofloxacin|mesh-list
44871557|NCT04432233|Esomeprazole|esomeprazole|mesh-list
44871558|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871559|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44871560|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871561|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871562|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44871563|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871564|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44871565|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871566|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871567|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44871568|NCT04432233|Renal Agents|renal agents|mesh-ancestor
44871569|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44871570|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44871571|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871572|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44871573|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44871574|NCT04432155|Xenon|xenon|mesh-list
44871575|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44871576|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
44871577|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
44871578|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871579|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871580|NCT04431713|Exenatide|exenatide|mesh-list
44871581|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44871582|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871583|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44871584|NCT04431713|Incretins|incretins|mesh-ancestor
44871585|NCT04431713|Hormones|hormones|mesh-ancestor
44871586|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871587|NCT04431349|Clopidogrel|clopidogrel|mesh-list
44871588|NCT04431349|Ticagrelor|ticagrelor|mesh-list
44871589|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44871590|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44871591|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44871592|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44871593|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
44871594|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871595|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871596|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871597|NCT04431245|Entecavir|entecavir|mesh-list
44871598|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
44871599|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871600|NCT04431206|Oxytocin|oxytocin|mesh-list
44871601|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
44871602|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871603|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871604|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
44871605|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44871606|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44871607|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871608|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
44871609|NCT04430777|Coagulants|coagulants|mesh-ancestor
44871610|NCT04430933|Paclitaxel|paclitaxel|mesh-list
44871611|NCT04430933|Docetaxel|docetaxel|mesh-list
44871612|NCT04430933|Carboplatin|carboplatin|mesh-list
44871613|NCT04430933|Pemetrexed|pemetrexed|mesh-list
44871614|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44871615|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871616|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
44871617|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
44871618|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
44871619|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871620|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871621|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44871622|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44871623|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
44871624|NCT04430998|Polaprezinc|polaprezinc|mesh-list
44871625|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44871626|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871627|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
44871628|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44871629|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871630|NCT04430621|Hormones|hormones|mesh-list
44871631|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44871632|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871633|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871634|NCT04430556|Sertraline|sertraline|mesh-list
44871635|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
44871636|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44871637|NCT04430556|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44871638|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44871639|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871640|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871641|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871642|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
44871643|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871644|NCT04430361|Dexamethasone|dexamethasone|mesh-list
44871645|NCT04430361|Megestrol|megestrol|mesh-list
44871646|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
44871647|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871648|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
44871649|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
44871650|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871651|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871652|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871653|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
44871654|NCT04430361|Hormones|hormones|mesh-ancestor
44871655|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871656|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44871657|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871658|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44871659|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44871660|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44871661|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
44871662|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871663|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44871664|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44871666|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44871667|NCT04430166|Antibodies|antibodies|mesh-list
44871668|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44871669|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
44871670|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871671|NCT04430062|Anesthetics|anesthetics|mesh-list
44871672|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871673|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871674|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871675|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
44871676|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871677|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871678|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871679|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871680|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871681|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871682|NCT04429711|Ivermectin|ivermectin|mesh-list
44871683|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871684|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871685|NCT04429633|Candesartan|candesartan|mesh-list
44871686|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44871687|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44871688|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44359156|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359176|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44871689|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871690|NCT04429282|Ibuprofen|ibuprofen|mesh-list
44871691|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871692|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871693|NCT04429282|Analgesics|analgesics|mesh-ancestor
44871694|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
44871695|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871696|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871697|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871698|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871699|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871700|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871701|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871702|NCT04429295|Vaccines|vaccines|mesh-list
44871703|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
44871704|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871705|NCT04429191|Antibodies|antibodies|mesh-list
44871706|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44871707|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
44871708|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871709|NCT04429035|Vitamin K|vitamin k|mesh-list
44871710|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
44871711|NCT04429035|Vitamins|vitamins|mesh-ancestor
44871712|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
44871713|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871714|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44871715|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44871716|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871717|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
44871718|NCT04429035|Coagulants|coagulants|mesh-ancestor
44871719|NCT04428879|Topotecan|topotecan|mesh-list
44871720|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44871721|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44871722|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871723|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871724|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871725|NCT04428814|Ustekinumab|ustekinumab|mesh-list
44871726|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44871727|NCT04428437|Lenvatinib|lenvatinib|mesh-list
44871728|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871729|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44871730|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871731|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871732|NCT04428684|Goserelin|goserelin|mesh-list
44871733|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44871734|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871735|NCT04428268|Chloroquine|chloroquine|mesh-list
44871736|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44871737|NCT04428268|Losartan|losartan|mesh-list
44871738|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44871739|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44871740|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44871741|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44871742|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871743|NCT04428268|Amebicides|amebicides|mesh-ancestor
44871744|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871745|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871746|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871747|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
44871748|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871749|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871750|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871751|NCT04428268|Analgesics|analgesics|mesh-ancestor
44871752|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
44871753|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871754|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871755|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871756|NCT04428268|Filaricides|filaricides|mesh-ancestor
44871757|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
44359209|NCT01130805|Capecitabine|capecitabine|mesh-list
44871758|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
44871759|NCT04428632|Berotralstat|berotralstat|mesh-list
44871760|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871761|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871762|NCT04427826|Morphine|morphine|mesh-list
44871763|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44871764|NCT04427826|Narcotics|narcotics|mesh-ancestor
44871765|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44871766|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871767|NCT04427826|Analgesics|analgesics|mesh-ancestor
44871768|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
44871769|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871770|NCT04427865|Lactoferrin|lactoferrin|mesh-list
44871771|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871772|NCT04427787|Lanreotide|lanreotide|mesh-list
44359245|NCT01131000|Ibuprofen|ibuprofen|mesh-list
44871773|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871774|NCT04427540|Oxytocin|oxytocin|mesh-list
44871775|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
44871776|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871777|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871778|NCT04427020|Caseins|caseins|mesh-list
44871779|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
44871780|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
44871781|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871782|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44871783|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871784|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698270|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44871785|NCT04427098|Enoxaparin|enoxaparin|mesh-list
44871786|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
44871787|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
44871788|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44871789|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44871790|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871791|NCT04426734|Dexamethasone|dexamethasone|mesh-list
44871792|NCT04426734|Prednisolone|prednisolone|mesh-list
44871793|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44871794|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
44871795|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44871796|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
44871797|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44871798|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
44871799|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871800|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
44871801|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
44871802|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871803|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871804|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44871805|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
44871806|NCT04426734|Hormones|hormones|mesh-ancestor
44871807|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871808|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44871809|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871810|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44871811|NCT04426734|Protective Agents|protective agents|mesh-ancestor
44871812|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
44871813|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44871814|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
44871815|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871816|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
44871817|NCT04426721|Protective Agents|protective agents|mesh-ancestor
44871818|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
44871819|NCT04426552|Sevoflurane|sevoflurane|mesh-list
44871820|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44871821|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359273|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44871822|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871823|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871824|NCT04426552|Analgesics|analgesics|mesh-ancestor
44871825|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
44871826|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871827|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44871828|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44871829|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44871830|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
44871831|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871832|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871833|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44871834|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44871835|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
44871836|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
44871837|NCT04426578|Perhexiline|perhexiline|mesh-list
44871838|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44871839|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871840|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871841|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44871842|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871843|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44871844|NCT04426422|Metformin|metformin|mesh-list
44871845|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44871846|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871847|NCT04426487|Progesterone|progesterone|mesh-list
44871848|NCT04426487|Progestins|progestins|mesh-ancestor
44871849|NCT04426487|Hormones|hormones|mesh-ancestor
44871850|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44871851|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871852|NCT04426097|Iodine|iodine|mesh-list
44871853|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44871854|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871855|NCT04426097|Trace Elements|trace elements|mesh-ancestor
44871856|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
44871857|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871858|NCT04425993|Indomethacin|indomethacin|mesh-list
44871859|NCT04425993|Isosorbide|isosorbide|mesh-list
44871860|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44871861|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44871862|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871863|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871864|NCT04425993|Analgesics|analgesics|mesh-ancestor
44871865|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
44871866|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871867|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871868|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871869|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871870|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
44871871|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
44871872|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44871873|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871874|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871875|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871876|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44871877|NCT04425993|Diuretics|diuretics|mesh-ancestor
44871878|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
44871879|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44871880|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44871881|NCT04426955|Paclitaxel|paclitaxel|mesh-list
44871882|NCT04426955|Cisplatin|cisplatin|mesh-list
44871883|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44871884|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871885|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44871886|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44871887|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44871888|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871889|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
44871890|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44871891|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44871892|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44871893|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871894|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871895|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
44871896|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871897|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871898|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44871899|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871900|NCT04425564|Capecitabine|capecitabine|mesh-list
44871901|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
44871902|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44871903|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
44871904|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871905|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871906|NCT04425590|Aspirin|aspirin|mesh-list
44871907|NCT04425590|Atorvastatin|atorvastatin|mesh-list
44871908|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44871909|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44871910|NCT04425590|Analgesics|analgesics|mesh-ancestor
44871911|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
44871912|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871913|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871914|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44871915|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871916|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44871917|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44359384|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44871918|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871919|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44871920|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871921|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871922|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
44871923|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44871924|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44871925|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
44871926|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44871927|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44871928|NCT04425460|Favipiravir|favipiravir|mesh-list
44871929|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
44871930|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871931|NCT04425642|Methamphetamine|methamphetamine|mesh-list
44871932|NCT04425642|SMOFlipid|smoflipid|mesh-list
44871933|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44871934|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871935|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
44871936|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
44871937|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44871938|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
44871939|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44871940|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871941|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44871942|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44871943|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44871944|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44871945|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44871946|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44871947|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44871948|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44871949|NCT04425681|Bevacizumab|bevacizumab|mesh-list
44871950|NCT04425681|Osimertinib|osimertinib|mesh-list
44871951|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871952|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871953|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44871954|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44871955|NCT04425681|Growth Substances|growth substances|mesh-ancestor
44871956|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871957|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44871958|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44871959|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871960|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871961|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
44871962|NCT04425707|Ivermectin|ivermectin|mesh-list
44871963|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
44871964|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44871965|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44871966|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44871967|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871968|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871969|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871970|NCT04425824|Rituximab|rituximab|mesh-list
44871971|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871972|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871973|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
44871974|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871975|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44871976|NCT04425187|Bevacizumab|bevacizumab|mesh-list
44359439|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44871977|NCT04425187|Gefitinib|gefitinib|mesh-list
44871978|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44871979|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871980|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44871981|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44871982|NCT04425187|Growth Substances|growth substances|mesh-ancestor
44871983|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44871984|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
44871985|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44871986|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871987|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871988|NCT04425473|Esketamine|esketamine|mesh-list
44871989|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
44871990|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44871991|NCT04425135|Carboplatin|carboplatin|mesh-list
44871992|NCT04425135|Apatinib|apatinib|mesh-list
44871993|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44871994|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44871995|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44871996|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44871997|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
44871998|NCT04425226|Lenvatinib|lenvatinib|mesh-list
44871999|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44872000|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872001|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872002|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872003|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872004|NCT04424901|Dipyridamole|dipyridamole|mesh-list
44872005|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44872006|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872007|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872008|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44872009|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
44872010|NCT04424875|Melatonin|melatonin|mesh-list
44872011|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
44872012|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872013|NCT04424875|Protective Agents|protective agents|mesh-ancestor
44872014|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872015|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872016|NCT04424420|Acetaminophen|acetaminophen|mesh-list
44872017|NCT04424420|Ibuprofen|ibuprofen|mesh-list
44872018|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872019|NCT04424420|Analgesics|analgesics|mesh-ancestor
44872020|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
44872021|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872022|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872023|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
44872024|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872025|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872026|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872027|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872028|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872029|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872030|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
44872031|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44872032|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872033|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872034|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
44872035|NCT04424563|Coagulants|coagulants|mesh-ancestor
44872036|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
44872037|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872038|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872039|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
44872040|NCT04424459|Narcotics|narcotics|mesh-ancestor
44872041|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872042|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872043|NCT04424459|Analgesics|analgesics|mesh-ancestor
44872044|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
44872045|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872046|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
44872047|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44872048|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
44872049|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44872050|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44872051|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872052|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698271|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44698272|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44698273|NCT05168735|Ketamine|ketamine|mesh-list
44698274|NCT05168735|Analgesics|analgesics|mesh-ancestor
44698275|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
44698276|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698277|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698278|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44698279|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44698280|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
44698281|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
44698282|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698283|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44698284|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44698285|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698286|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698287|NCT05166746|Clindamycin|clindamycin|mesh-list
44698288|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
44698289|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
44698290|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44698291|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698292|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44698293|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872053|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
44872055|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
44872056|NCT04423926|Doxorubicin|doxorubicin|mesh-list
44872057|NCT04423926|Vincristine|vincristine|mesh-list
44872058|NCT04423926|Lenalidomide|lenalidomide|mesh-list
44872059|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872060|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
44872061|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872062|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872063|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44872064|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
44872065|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872066|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872067|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44872068|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872069|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44872070|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44872071|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872072|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44872073|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872074|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872075|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
44359547|NCT01131897|Levetiracetam|levetiracetam|mesh-list
44872076|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44872077|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44872078|NCT04423926|Growth Substances|growth substances|mesh-ancestor
44872079|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
44872080|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872081|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
44872082|NCT04423926|Hormones|hormones|mesh-ancestor
44872083|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872084|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44872085|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44872086|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872087|NCT04424017|Antibodies|antibodies|mesh-list
44872088|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
44872089|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872090|NCT04424134|Spironolactone|spironolactone|mesh-list
44872091|NCT04424134|Bromhexine|bromhexine|mesh-list
44872092|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44872093|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
44872094|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872095|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872096|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44872097|NCT04424134|Diuretics|diuretics|mesh-ancestor
44872098|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
44872099|NCT04424134|Expectorants|expectorants|mesh-ancestor
44872100|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872101|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44872102|NCT04423627|Clonidine|clonidine|mesh-list
44872103|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44872104|NCT04423627|Diuretics|diuretics|mesh-ancestor
44872105|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
44872106|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872107|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44872108|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359594|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44872109|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872110|NCT04423627|Analgesics|analgesics|mesh-ancestor
44872111|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
44872112|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872113|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
44872114|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
44872115|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44872116|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44872117|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44872118|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44872119|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872120|NCT04423510|Phenol|phenol|mesh-list
44872121|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44359613|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872122|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872123|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
44872124|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44872125|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44872126|NCT04423107|Acetaminophen|acetaminophen|mesh-list
44872127|NCT04423107|Ibuprofen|ibuprofen|mesh-list
44872128|NCT04423107|Oxycodone|oxycodone|mesh-list
44872129|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872130|NCT04423107|Analgesics|analgesics|mesh-ancestor
44872131|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
44872132|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872133|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872134|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
44872135|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872136|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872137|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872138|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872139|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872140|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872141|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44872142|NCT04423107|Narcotics|narcotics|mesh-ancestor
44872143|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872144|NCT04423276|Donepezil|donepezil|mesh-list
44872145|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44872146|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872147|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872148|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
44872149|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872150|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872151|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
44872152|NCT04423185|Atezolizumab|atezolizumab|mesh-list
44872153|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
44872154|NCT04423185|Palbociclib|palbociclib|mesh-list
44872155|NCT04423185|Niraparib|niraparib|mesh-list
44872156|NCT04423185|Vemurafenib|vemurafenib|mesh-list
44872157|NCT04423185|Crizotinib|crizotinib|mesh-list
44872158|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872159|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872160|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872161|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872162|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44872163|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
44359648|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
44359649|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359658|NCT01132222|Ibuprofen|ibuprofen|mesh-list
44872164|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872165|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872166|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872167|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872168|NCT04422275|Budesonide|budesonide|mesh-list
44872169|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872170|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44872171|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
44872172|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872173|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872174|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44872175|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872176|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
44659748|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
44872178|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872179|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44872180|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44872181|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44872182|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872183|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872184|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44872185|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44872186|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872187|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
44872188|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872189|NCT04422392|Paclitaxel|paclitaxel|mesh-list
44872190|NCT04422392|Carboplatin|carboplatin|mesh-list
44872191|NCT04422392|Pemetrexed|pemetrexed|mesh-list
44872192|NCT04422392|Antibodies|antibodies|mesh-list
44872193|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44872194|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359691|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359692|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359693|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
44359694|NCT01132248|Mefloquine|mefloquine|mesh-list
44359695|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
44359696|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44872195|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872196|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872197|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872198|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872199|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
44872200|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872201|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872202|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44872203|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44872204|NCT04422028|Desogestrel|desogestrel|mesh-list
44872205|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44872206|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44872207|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44872208|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
44872209|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44872210|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872211|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44872212|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44872213|NCT04422028|Progestins|progestins|mesh-ancestor
44872214|NCT04422028|Hormones|hormones|mesh-ancestor
44872215|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872216|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
44872217|NCT04422184|Diuretics|diuretics|mesh-ancestor
44872218|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
44872219|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872220|NCT04422184|Expectorants|expectorants|mesh-ancestor
44872221|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872222|NCT04421872|Anesthetics|anesthetics|mesh-list
44872223|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872224|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872225|NCT04421716|Ursolic acid|ursolic acid|mesh-list
44872226|NCT04421716|Curcumin|curcumin|mesh-list
44872227|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872228|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872229|NCT04421716|Analgesics|analgesics|mesh-ancestor
44872230|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
44872231|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872232|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872233|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872234|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872235|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872236|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872237|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872238|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872239|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44872240|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872241|NCT04421911|Diclofenac|diclofenac|mesh-list
44872242|NCT04421911|Ketoprofen|ketoprofen|mesh-list
44872243|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872244|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872245|NCT04421911|Analgesics|analgesics|mesh-ancestor
44872246|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
44872247|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872248|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872249|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659825|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872250|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872251|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872252|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872253|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872254|NCT04421742|Beclomethasone|beclomethasone|mesh-list
44872255|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
44872256|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44872257|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
44872258|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872259|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872260|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44872261|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872262|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44872263|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44872264|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44872265|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
44872266|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872267|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872268|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872269|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
44872270|NCT04421742|Hormones|hormones|mesh-ancestor
44872271|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872272|NCT04421547|Letrozole|letrozole|mesh-list
44872273|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872274|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44359733|NCT01132573|Clofarabine|clofarabine|mesh-list
44872275|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44872276|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872277|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872278|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44872279|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
44872280|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872281|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872282|NCT04421534|Lactoferrin|lactoferrin|mesh-list
44872283|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872284|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44872285|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
44872286|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44872287|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44872288|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
44872289|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872290|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
44872291|NCT04421300|Protective Agents|protective agents|mesh-ancestor
44872292|NCT04421209|Propranolol|propranolol|mesh-list
44872293|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44359786|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
44872294|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44872295|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44872296|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872297|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872298|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872299|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44872300|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44872301|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
44659899|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44872302|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44872303|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
44872304|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872305|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44872306|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44872307|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
44872308|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872309|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872310|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44872311|NCT04420871|Capecitabine|capecitabine|mesh-list
44872312|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872313|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
44872314|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872315|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872316|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44872317|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
44872318|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872319|NCT04419948|Ibuprofen|ibuprofen|mesh-list
44872320|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872321|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872322|NCT04419948|Analgesics|analgesics|mesh-ancestor
44872323|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
44872324|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872325|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872326|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872327|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872328|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872329|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872330|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872331|NCT04420351|Aspirin|aspirin|mesh-list
44872332|NCT04420351|Clopidogrel|clopidogrel|mesh-list
44872333|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872334|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872335|NCT04420351|Analgesics|analgesics|mesh-ancestor
44872336|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
44872337|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872338|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872339|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872340|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872341|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44359820|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44872342|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872343|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872344|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44872345|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872346|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872347|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
44872348|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44872349|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44872350|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44872351|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
44872352|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872353|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
44872354|NCT04420247|Chloroquine|chloroquine|mesh-list
44872355|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
44872356|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44872357|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44872358|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872359|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872360|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872361|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872362|NCT04420247|Amebicides|amebicides|mesh-ancestor
44872363|NCT04419662|Phenylephrine|phenylephrine|mesh-list
44872364|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
44872365|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44872366|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
44872367|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
44872368|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872369|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872370|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
44872371|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44872372|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
44872373|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872374|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44872375|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44872376|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44872377|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
44872378|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872379|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872380|NCT04419662|Protective Agents|protective agents|mesh-ancestor
44872381|NCT04419493|Heparin|heparin|mesh-list
44872382|NCT04419493|Calcium heparin|calcium heparin|mesh-list
44872383|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44872384|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
44872385|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44872386|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872387|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872388|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44872389|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872390|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872391|NCT04419259|Erenumab|erenumab|mesh-list
44872392|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44359887|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44359888|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44872393|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872394|NCT04419259|Analgesics|analgesics|mesh-ancestor
44872395|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
44872396|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872397|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872398|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
44872399|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44872400|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872401|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872402|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
44872403|NCT04419246|Coagulants|coagulants|mesh-ancestor
44872404|NCT04419038|Mitomycins|mitomycins|mesh-list
44872405|NCT04419038|Mitomycin|mitomycin|mesh-list
44872406|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872407|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872408|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
44872409|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872410|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44872411|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872412|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
44872413|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44872414|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
44872415|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872416|NCT04419025|Expectorants|expectorants|mesh-ancestor
44872417|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872418|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44872419|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
44872420|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872421|NCT04419025|Protective Agents|protective agents|mesh-ancestor
44872422|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872423|NCT04419025|Antidotes|antidotes|mesh-ancestor
44872424|NCT04418908|Cetrorelix|cetrorelix|mesh-list
44872425|NCT04418908|Estradiol|estradiol|mesh-list
44872426|NCT04418908|Estrogens|estrogens|mesh-ancestor
44872427|NCT04418908|Hormones|hormones|mesh-ancestor
44872428|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872429|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872430|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44872431|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44872432|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
44872433|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
44872434|NCT04418674|Fentanyl|fentanyl|mesh-list
44872435|NCT04418674|Ketamine|ketamine|mesh-list
44872436|NCT04418674|Analgesics|analgesics|mesh-ancestor
44872437|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
44872438|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872439|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872440|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44872441|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44872442|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
44872443|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
44872444|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872445|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44872446|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44872447|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872448|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872449|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44872450|NCT04418674|Narcotics|narcotics|mesh-ancestor
44660056|NCT00042289|Cycloserine|cycloserine|mesh-list
44872451|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44872452|NCT04418154|Paclitaxel|paclitaxel|mesh-list
44872453|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
44872454|NCT04418154|Epirubicin|epirubicin|mesh-list
44872455|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44872456|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44872457|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872458|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872459|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872460|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872461|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359957|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
44872462|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872463|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
44872464|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872465|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872466|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44872467|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
44872468|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44872469|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872470|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44872471|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44872472|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872473|NCT04418180|Fenofibrate|fenofibrate|mesh-list
44872474|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44872475|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
44872476|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872477|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44872478|NCT04418219|Interferons|interferons|mesh-list
44872479|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
44872480|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
44872481|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
44872482|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
44872483|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872484|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
44359982|NCT01133509|Vaccines|vaccines|mesh-list
44872485|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872486|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872487|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44872488|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
44872489|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872490|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872491|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44872492|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44872493|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
44872494|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872495|NCT04418128|Nafamostat|nafamostat|mesh-list
44872496|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872497|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872498|NCT04418128|Analgesics|analgesics|mesh-ancestor
44872499|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
44872500|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872501|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872502|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872503|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872504|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
44872505|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
44872506|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872507|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872508|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44872509|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44872510|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44872511|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872512|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
44872513|NCT04417920|Mitomycins|mitomycins|mesh-list
44872514|NCT04417920|Mitomycin|mitomycin|mesh-list
44872515|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872516|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872517|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
44872518|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872519|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44872520|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872521|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
44872522|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872523|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872524|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44872525|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44872526|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872527|NCT04418089|Simvastatin|simvastatin|mesh-list
44872528|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44872529|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44872530|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
44872531|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872532|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44872533|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44872534|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872535|NCT04417582|Liraglutide|liraglutide|mesh-list
44872536|NCT04417582|Orlistat|orlistat|mesh-list
44872537|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44872538|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872539|NCT04417582|Incretins|incretins|mesh-ancestor
44872540|NCT04417582|Hormones|hormones|mesh-ancestor
44872541|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872542|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872543|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872544|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44872545|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44872546|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
44872547|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872548|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872549|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872550|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
44872551|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44872552|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
44872553|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872554|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44872555|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44872556|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44872557|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
44872558|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872559|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44872560|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44872561|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872562|NCT04417348|Tretinoin|tretinoin|mesh-list
44872563|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872564|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
44872565|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44872566|NCT04417543|Memantine|memantine|mesh-list
44360071|NCT01133925|Sirolimus|sirolimus|mesh-list
44872567|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44872568|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44872569|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
44872570|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872571|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872572|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872573|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44872574|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44872575|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
44872576|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872577|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872578|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872579|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872580|NCT04416334|Acetaminophen|acetaminophen|mesh-list
44872581|NCT04416334|Colchicine|colchicine|mesh-list
44872582|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872583|NCT04416334|Analgesics|analgesics|mesh-ancestor
44872584|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
44872585|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872586|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872587|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
44360083|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872588|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
44872589|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872590|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872591|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872592|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872593|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872594|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872595|NCT04416399|Budesonide|budesonide|mesh-list
44872596|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872597|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44872598|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
44872599|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660286|NCT00039130|Dexamethasone|dexamethasone|mesh-list
44660287|NCT00039130|Prednisone|prednisone|mesh-list
44872600|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872601|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44872602|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
44872603|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
44872604|NCT04416399|Hormones|hormones|mesh-ancestor
44872605|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872606|NCT04416607|Menotropins|menotropins|mesh-list
44872607|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44360105|NCT01134289|Bupivacaine|bupivacaine|mesh-list
44872608|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
44872609|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44872610|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872611|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44872612|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44872613|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872614|NCT04416035|Paclitaxel|paclitaxel|mesh-list
44872615|NCT04416035|Bevacizumab|bevacizumab|mesh-list
44872616|NCT04416035|Carboplatin|carboplatin|mesh-list
44872617|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44872618|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872619|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872620|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872621|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872622|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872623|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44872624|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44872625|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44872626|NCT04416035|Growth Substances|growth substances|mesh-ancestor
44872627|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872628|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
44872629|NCT04415983|Metronidazole|metronidazole|mesh-list
44872630|NCT04415983|Clarithromycin|clarithromycin|mesh-list
44872631|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
44872632|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44872633|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872634|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44872635|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44872636|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44872637|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44872638|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872639|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872640|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44872641|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660363|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872643|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872644|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872645|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872646|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872647|NCT04415320|Ensartinib|ensartinib|mesh-list
44872648|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872649|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872650|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872651|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872652|NCT04415385|Apatinib|apatinib|mesh-list
44872653|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872654|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872655|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872656|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872657|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
44872658|NCT04415476|Sirolimus|sirolimus|mesh-list
44872659|NCT04415476|Prednisone|prednisone|mesh-list
44872660|NCT04415476|Tacrolimus|tacrolimus|mesh-list
44872661|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872662|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
44872663|NCT04415476|Hormones|hormones|mesh-ancestor
44872664|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872665|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872666|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44872667|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872668|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872669|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
44872670|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44872671|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360174|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872672|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872673|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872674|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44872675|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
44872676|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44872677|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872678|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
44872679|NCT04414995|Acetaminophen|acetaminophen|mesh-list
44872680|NCT04414995|Ibuprofen|ibuprofen|mesh-list
44872681|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44872682|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44360188|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44872683|NCT04414995|Analgesics|analgesics|mesh-ancestor
44872684|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
44872685|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872686|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872687|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872688|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872689|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44872690|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872691|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872692|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
44872693|NCT04414852|Apatinib|apatinib|mesh-list
44872694|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872695|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872696|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872697|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872698|NCT04415008|Cytarabine|cytarabine|mesh-list
44872699|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872700|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
44872701|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872702|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872703|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
44872704|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872705|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872706|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
44872707|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872708|NCT04414969|Asparaginase|asparaginase|mesh-list
44872709|NCT04414969|Pegaspargase|pegaspargase|mesh-list
44872710|NCT04414969|Antibodies|antibodies|mesh-list
44872711|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
44872712|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
44872713|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872714|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872715|NCT04415060|Sevoflurane|sevoflurane|mesh-list
44872716|NCT04415060|Isoflurane|isoflurane|mesh-list
44660439|NCT00035932|Ritonavir|ritonavir|mesh-list
44872717|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44872718|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44872719|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
44872720|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
44872721|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872722|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872723|NCT04414956|Vitamin K|vitamin k|mesh-list
44872724|NCT04414956|Agglutinins|agglutinins|mesh-list
44872725|NCT04414956|Vitamins|vitamins|mesh-ancestor
44872726|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
44872727|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872728|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44872729|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872730|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872731|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
44872732|NCT04414956|Coagulants|coagulants|mesh-ancestor
44872733|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
44872734|NCT04414800|Fentanyl|fentanyl|mesh-list
44872735|NCT04414800|Ketamine|ketamine|mesh-list
44872736|NCT04414800|Analgesics|analgesics|mesh-ancestor
44872737|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
44872738|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872739|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872740|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44872741|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44872742|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
44872743|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
44872744|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872745|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44872746|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44872747|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872748|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872749|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44872750|NCT04414800|Narcotics|narcotics|mesh-ancestor
44872751|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44872752|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44872753|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
44872754|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872755|NCT04414566|Gemcitabine|gemcitabine|mesh-list
44872756|NCT04414566|Cisplatin|cisplatin|mesh-list
44872757|NCT04414566|Docetaxel|docetaxel|mesh-list
44872758|NCT04414566|Fluorouracil|fluorouracil|mesh-list
44872759|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872760|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872761|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
44872762|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872763|NCT04414566|Antiviral Agents|antiviral agents|mesh-ancestor
44872764|NCT04414566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872765|NCT04414566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872766|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872767|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
44872768|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872769|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872770|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872771|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872772|NCT04414579|Insulin|insulin|mesh-list
44872773|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44872774|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
44872775|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
44872776|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44872777|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44872778|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872779|NCT04414254|Cefprozil|cefprozil|mesh-list
44872780|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44872781|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872782|NCT04414267|Vaccines|vaccines|mesh-list
44872783|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
44872784|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
44872785|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872786|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44872787|NCT04413734|Gemcitabine|gemcitabine|mesh-list
44872788|NCT04413734|Cisplatin|cisplatin|mesh-list
44872789|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872790|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872791|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
44872792|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872793|NCT04413734|Antiviral Agents|antiviral agents|mesh-ancestor
44872794|NCT04413734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872795|NCT04413734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872796|NCT04413734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872797|NCT04413734|Immunologic Factors|immunologic factors|mesh-ancestor
44872798|NCT04413734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872799|NCT04413838|Nivolumab|nivolumab|mesh-list
44872800|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44872801|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872802|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44872803|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872804|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
44872805|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44872806|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872807|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872808|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44872809|NCT04413864|Analgesics|analgesics|mesh-ancestor
44872810|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
44872811|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872812|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44872813|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44872814|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44872815|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
44872816|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872817|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872818|NCT04414020|Progesterone|progesterone|mesh-list
44872819|NCT04414020|Progestins|progestins|mesh-ancestor
44872820|NCT04414020|Hormones|hormones|mesh-ancestor
44872821|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872822|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872823|NCT04414137|Daptomycin|daptomycin|mesh-list
44872824|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44872825|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872826|NCT04413890|Dinoprostone|dinoprostone|mesh-list
44872827|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
44872828|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44872829|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872830|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44872831|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872832|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44360325|NCT01135550|BB 1101|bb 1101|mesh-list
44872833|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872834|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872835|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
44872836|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44872837|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
44872838|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872839|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872840|NCT04413227|Docetaxel|docetaxel|mesh-list
44872841|NCT04413227|Endostatins|endostatins|mesh-list
44872842|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872843|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44872844|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44872845|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44872846|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872847|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44872848|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44872849|NCT04413227|Growth Substances|growth substances|mesh-ancestor
44872850|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872851|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
44872852|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
44872853|NCT04412850|Analgesics|analgesics|mesh-ancestor
44872854|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
44872855|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872856|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872857|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
44872858|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872859|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44872860|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
44872861|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44872862|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44872863|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872864|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872865|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
44872866|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44872867|NCT04412538|Vaccines|vaccines|mesh-list
44872868|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
44872869|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872870|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
44872871|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44360355|NCT01135589|Micafungin|micafungin|mesh-list
44872872|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
44872873|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
44872874|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44872875|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872876|NCT04412421|Vitamins|vitamins|mesh-list
44872877|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
44872878|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872879|NCT04412304|Dalteparin|dalteparin|mesh-list
44872880|NCT04412304|Tinzaparin|tinzaparin|mesh-list
44872881|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44872882|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
44872883|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44872884|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44872885|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872886|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44872887|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44872888|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872889|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872890|NCT04412148|Triamcinolone|triamcinolone|mesh-list
44872891|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44872892|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44872893|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44872894|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872895|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
44872896|NCT04412148|Hormones|hormones|mesh-ancestor
44872897|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872898|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872899|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44872900|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
44872901|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872902|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872903|NCT04412252|Tofacitinib|tofacitinib|mesh-list
44872904|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872905|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872906|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872907|NCT04411875|Amlodipine|amlodipine|mesh-list
44872908|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44872909|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44872910|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44872911|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872912|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872913|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872914|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
44872915|NCT04411693|Dexamethasone|dexamethasone|mesh-list
44872916|NCT04411693|Aflibercept|aflibercept|mesh-list
44872917|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44872918|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
44872919|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
44872920|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44872921|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872922|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44872923|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
44872924|NCT04411693|Hormones|hormones|mesh-ancestor
44360418|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
44872925|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44872926|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44872927|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872928|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44872929|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44872930|NCT04411693|Growth Substances|growth substances|mesh-ancestor
44872931|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
44872932|NCT04411706|Capecitabine|capecitabine|mesh-list
44872934|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872935|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
44872936|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872937|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872938|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44872939|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872940|NCT04411524|Capecitabine|capecitabine|mesh-list
44872941|NCT04411524|Irinotecan|irinotecan|mesh-list
44872942|NCT04411524|Antibodies|antibodies|mesh-list
44872943|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
44872944|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872945|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872946|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
44872947|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872948|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872949|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44872950|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44872951|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872952|NCT04411862|Choline|choline|mesh-list
44872953|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
44872954|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44872955|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
44872956|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360461|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44872957|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44872958|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44872959|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
44872960|NCT04411537|Capecitabine|capecitabine|mesh-list
44872961|NCT04411537|Irinotecan|irinotecan|mesh-list
44872962|NCT04411537|Antibodies|antibodies|mesh-list
44872963|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
44872964|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872965|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44872966|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
44872967|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872968|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44872969|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44872970|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360473|NCT01136278|Clonidine|clonidine|mesh-list
44872971|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872972|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
44872973|NCT04411901|Vitamin D|vitamin d|mesh-list
44872974|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872975|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872976|NCT04411901|Vitamins|vitamins|mesh-ancestor
44872977|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
44872978|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44872979|NCT04411433|Azithromycin|azithromycin|mesh-list
44872980|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
44872981|NCT04411433|Favipiravir|favipiravir|mesh-list
44872982|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44872983|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44872984|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
44872985|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44872986|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44872987|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44872988|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44872989|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44872990|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
44872991|NCT04411446|Vitamin D|vitamin d|mesh-list
44872992|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
44872993|NCT04411446|Vitamins|vitamins|mesh-ancestor
44872994|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
44872995|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44872996|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44872997|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44872998|NCT04411329|Dexamethasone|dexamethasone|mesh-list
44872999|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
44873000|NCT04411329|Bupivacaine|bupivacaine|mesh-list
44873001|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873002|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
44873003|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
44873004|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873005|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873007|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
44873008|NCT04411329|Hormones|hormones|mesh-ancestor
44873009|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873010|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44873011|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873012|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873013|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
44873014|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873015|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
44873016|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873017|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873018|NCT04411329|Analgesics|analgesics|mesh-ancestor
44873019|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44873020|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44873021|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44873022|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873023|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873024|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873025|NCT04411225|Cannabidiol|cannabidiol|mesh-list
44873026|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
44873027|NCT04411160|Ascorbic Acid|ascorbic acid|mesh-list
44873028|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
44873029|NCT04411160|Vitamins|vitamins|mesh-ancestor
44873030|NCT04411160|Micronutrients|micronutrients|mesh-ancestor
44873031|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873032|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
44873033|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873034|NCT04411160|Protective Agents|protective agents|mesh-ancestor
44873035|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44873036|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
44873037|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873038|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44873039|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
44873040|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44873041|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873042|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44873043|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
44873044|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
44873045|NCT04411212|Lenograstim|lenograstim|mesh-list
44873046|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44873047|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
44873048|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873049|NCT04411069|Droperidol|droperidol|mesh-list
44873050|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873051|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
44873052|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
44873053|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873054|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873055|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44873056|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44873057|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873058|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873059|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873060|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44873061|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44873062|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
44873063|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873064|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873065|NCT04410874|Vaccines|vaccines|mesh-list
44873066|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
44873067|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873068|NCT04410887|Olaparib|olaparib|mesh-list
44873069|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44873070|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873071|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873072|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873073|NCT04411030|Itraconazole|itraconazole|mesh-list
44873074|NCT04411030|Midazolam|midazolam|mesh-list
44873075|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873076|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873077|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873078|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360557|NCT01136642|Nicotine|nicotine|mesh-list
44873079|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44873080|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873081|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873082|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873083|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
44873084|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
44873085|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
44873086|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
44873087|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873088|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873089|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
44873090|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360592|NCT01136850|Renal Agents|renal agents|mesh-ancestor
44873091|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44873092|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873093|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873094|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44873095|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
44873096|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873097|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44873098|NCT04410588|Fentanyl|fentanyl|mesh-list
44873099|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
44873100|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44698294|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698295|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
44698296|NCT05165875|Lidocaine|lidocaine|mesh-list
44698297|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
44698298|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
44698299|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698300|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698301|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
44698302|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698303|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44698304|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44698305|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44698306|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44698307|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698308|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698310|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698311|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698312|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44698313|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360602|NCT01136941|Zileuton|zileuton|mesh-list
44698314|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
44698315|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44698316|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698317|NCT05142267|Oxycodone|oxycodone|mesh-list
44698318|NCT05142267|Naloxone|naloxone|mesh-list
44698319|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44698320|NCT05142267|Narcotics|narcotics|mesh-ancestor
44698321|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698322|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698323|NCT05142267|Analgesics|analgesics|mesh-ancestor
44698324|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
44698325|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698326|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44698327|NCT05138029|Dexamethasone|dexamethasone|mesh-list
44698328|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
44698329|NCT05138029|Ranibizumab|ranibizumab|mesh-list
44698330|NCT05138029|BB 1101|bb 1101|mesh-list
44698331|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698332|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
44698333|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
44698334|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698335|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698336|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698337|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
44698338|NCT05138029|Hormones|hormones|mesh-ancestor
44698339|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698340|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44873101|NCT04410588|Narcotics|narcotics|mesh-ancestor
44873102|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873103|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873104|NCT04410588|Analgesics|analgesics|mesh-ancestor
44873105|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
44873106|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873107|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873108|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873109|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
44873110|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
44873111|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873112|NCT04410354|Remdesivir|remdesivir|mesh-list
44873113|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
44873114|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873115|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
44360636|NCT01137084|Hormones|hormones|mesh-ancestor
44873116|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873117|NCT04410263|Dimercaprol|dimercaprol|mesh-list
44873118|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
44873119|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
44873120|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873121|NCT04409912|Sirolimus|sirolimus|mesh-list
44873122|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873123|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873124|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44873125|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873126|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
44873127|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873128|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
44873129|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873130|NCT04410081|Lazertinib|lazertinib|mesh-list
43857393|NCT03330821|Cytarabine|cytarabine|mesh-list
44873131|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44873132|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873133|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873134|NCT04410094|Itraconazole|itraconazole|mesh-list
44873135|NCT04410094|Rifampin|rifampin|mesh-list
44873136|NCT04410094|Lazertinib|lazertinib|mesh-list
44873137|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
44873138|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873139|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44873140|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873141|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873142|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873143|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43857454|NCT03329001|Niraparib|niraparib|mesh-list
44873144|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44873145|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873146|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873147|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44873148|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44873149|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
44873150|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873151|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
44873152|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44873153|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44360708|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44873154|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44873155|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44873156|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44873157|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44873158|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44873159|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44873160|NCT04410211|Midazolam|midazolam|mesh-list
44873161|NCT04410211|Sevoflurane|sevoflurane|mesh-list
44873162|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873163|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873164|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873165|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873166|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44873167|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873168|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873169|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873170|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
44873171|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
44873172|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
44873173|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
44873174|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873175|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873176|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44873177|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44873178|NCT04409522|Melatonin|melatonin|mesh-list
44873179|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
44873180|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873181|NCT04409522|Protective Agents|protective agents|mesh-ancestor
44873182|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873183|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873184|NCT04409431|Epinephrine|epinephrine|mesh-list
44873185|NCT04409431|Racepinephrine|racepinephrine|mesh-list
44873186|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
44360733|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44873187|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44873188|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44873189|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873190|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873191|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873192|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873193|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44873194|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44873195|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
44873196|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873197|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44873198|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
44873199|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
44873200|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
44873201|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44873202|NCT04409691|Sirolimus|sirolimus|mesh-list
44873203|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873204|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873205|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44873206|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360748|NCT01137942|Clarithromycin|clarithromycin|mesh-list
44360749|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44360750|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873207|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
44873208|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873209|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
44873210|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873211|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44873212|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
44873213|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44873214|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873215|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873216|NCT04409223|Sunitinib|sunitinib|mesh-list
44873217|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873218|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44873219|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44873220|NCT04409223|Growth Substances|growth substances|mesh-ancestor
44873221|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873222|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
44873223|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44873224|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873225|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873226|NCT04409483|Ritonavir|ritonavir|mesh-list
44873227|NCT04409483|Lopinavir|lopinavir|mesh-list
44873228|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44873229|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44873230|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
44873231|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873232|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873233|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44873234|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44360769|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873235|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
44873236|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873237|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44873238|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873239|NCT04409327|Dactolisib|dactolisib|mesh-list
44873240|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873241|NCT04408989|Bevacizumab|bevacizumab|mesh-list
44873242|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44873243|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873244|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44873245|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44360798|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
44873246|NCT04408989|Growth Substances|growth substances|mesh-ancestor
44873247|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873248|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
44873249|NCT04408911|Midazolam|midazolam|mesh-list
44873250|NCT04408911|Lormetazepam|lormetazepam|mesh-list
44873251|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873252|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873253|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873254|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873255|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44873256|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873257|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873258|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873259|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
44873260|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
44873261|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
44873262|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
44360808|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873263|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873264|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873265|NCT04408313|Naltrexone|naltrexone|mesh-list
44873266|NCT04408313|Buprenorphine|buprenorphine|mesh-list
44873267|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44873268|NCT04408313|Narcotics|narcotics|mesh-ancestor
44873269|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873270|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873271|NCT04408313|Analgesics|analgesics|mesh-ancestor
44873272|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
44873273|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873274|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44873275|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44873276|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44873277|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
44873278|NCT04408326|Giapreza|giapreza|mesh-list
44873279|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
44873280|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873281|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44873282|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44873283|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
44873284|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873285|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873286|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
44873287|NCT04408144|Progestins|progestins|mesh-ancestor
44873288|NCT04408144|Hormones|hormones|mesh-ancestor
44873289|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873290|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873291|NCT04408443|Vitamin D|vitamin d|mesh-list
44873292|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
44873293|NCT04408443|Vitamins|vitamins|mesh-ancestor
44873294|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
44873295|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873296|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44873297|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44873298|NCT04408235|Enoxaparin|enoxaparin|mesh-list
44873299|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
44873300|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44873301|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44873302|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873303|NCT04407975|Betamethasone|betamethasone|mesh-list
44873304|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873305|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
44873306|NCT04407975|Hormones|hormones|mesh-ancestor
44873307|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360842|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44873308|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873309|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44873310|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44661076|NCT00006721|Vincristine|vincristine|mesh-list
44873312|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873313|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873314|NCT04407312|Aspirin|aspirin|mesh-list
44873315|NCT04407312|Cilostazol|cilostazol|mesh-list
44873316|NCT04407312|Clopidogrel|clopidogrel|mesh-list
44873317|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44873318|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873319|NCT04407312|Analgesics|analgesics|mesh-ancestor
44873320|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
44873321|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873322|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873323|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873324|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873325|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44873326|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44873327|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873328|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44873329|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44873330|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873331|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
44873332|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44873333|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44873334|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44873335|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
44873336|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873337|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44873338|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
44873339|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44873340|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44873341|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
44873342|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44873343|NCT04407312|Protective Agents|protective agents|mesh-ancestor
44873344|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44873345|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44873346|NCT04407234|Acetaminophen|acetaminophen|mesh-list
44873347|NCT04407234|Tirzepatide|tirzepatide|mesh-list
44873348|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873349|NCT04407234|Analgesics|analgesics|mesh-ancestor
44873350|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
44873351|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873352|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873353|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
44873354|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44873355|NCT04407234|Incretins|incretins|mesh-ancestor
44873356|NCT04407234|Hormones|hormones|mesh-ancestor
44873357|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873358|NCT04407130|Doxycycline|doxycycline|mesh-list
44873359|NCT04407130|Ivermectin|ivermectin|mesh-list
44873360|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873361|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873362|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
44873363|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44873364|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873365|NCT04407078|Neostigmine|neostigmine|mesh-list
44873366|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44873367|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873368|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873369|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
44873370|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873371|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873372|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44873373|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
44360925|NCT01139151|Cytarabine|cytarabine|mesh-list
44873374|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873375|NCT04406779|Hormones|hormones|mesh-list
44873376|NCT04406779|Autoantibodies|autoantibodies|mesh-list
44873377|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873378|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873379|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
44873380|NCT04406870|Sirolimus|sirolimus|mesh-list
44873381|NCT04406870|Propranolol|propranolol|mesh-list
44873382|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873383|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873384|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44873385|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873386|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
44873387|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873388|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
44873389|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873390|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44873391|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44873392|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873393|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873394|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873395|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44873396|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44873397|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44873398|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44360935|NCT01139203|Lamivudine|lamivudine|mesh-list
44873399|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44873400|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873401|NCT04407000|Favipiravir|favipiravir|mesh-list
44873402|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
44873403|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873404|NCT04406883|Simvastatin|simvastatin|mesh-list
44873405|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44873406|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44873407|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
44873408|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873409|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44873410|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44873411|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873412|NCT04406376|Prednisone|prednisone|mesh-list
44873413|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873414|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
44873415|NCT04406376|Hormones|hormones|mesh-ancestor
44873416|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873417|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873418|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44873419|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873420|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
44873421|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873422|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873423|NCT04406506|Erythromycin|erythromycin|mesh-list
44873424|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
44873425|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44873426|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
44873427|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873428|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873429|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44873430|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44873431|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873432|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873433|NCT04406025|Anesthetics|anesthetics|mesh-list
44873434|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873435|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873436|NCT04406051|Norepinephrine|norepinephrine|mesh-list
44873437|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44873438|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44873439|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873440|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873441|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873442|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873443|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
44873444|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
44873445|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873446|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44873447|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
44873448|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44873449|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44873450|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873451|NCT04405960|Vitamins|vitamins|mesh-ancestor
44873452|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
44873453|NCT04405843|Ivermectin|ivermectin|mesh-list
44873454|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873455|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873456|NCT04405921|Azithromycin|azithromycin|mesh-list
44361006|NCT01139749|Analgesics|analgesics|mesh-ancestor
44873457|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
44873458|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873459|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873460|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
44661230|NCT00006184|Vincristine|vincristine|mesh-list
44661231|NCT00006184|Bortezomib|bortezomib|mesh-list
44873461|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44873462|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873463|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873464|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873465|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873466|NCT04405622|Gemcitabine|gemcitabine|mesh-list
44873467|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44873468|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
44361023|NCT01139905|Ritonavir|ritonavir|mesh-list
44873469|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873470|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873471|NCT04405622|Antiviral Agents|antiviral agents|mesh-ancestor
44873472|NCT04405622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873473|NCT04405622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873474|NCT04405622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873475|NCT04405622|Immunologic Factors|immunologic factors|mesh-ancestor
44873476|NCT04405622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873477|NCT04405505|Paclitaxel|paclitaxel|mesh-list
44873478|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44873479|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873480|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
44873481|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
44873482|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
44873483|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873484|NCT04405375|Gemcitabine|gemcitabine|mesh-list
44873485|NCT04405375|Dexamethasone|dexamethasone|mesh-list
44873486|NCT04405375|Etoposide|etoposide|mesh-list
44873487|NCT04405375|Pegaspargase|pegaspargase|mesh-list
44873488|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873489|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
44873490|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
44873491|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873492|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873493|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44873494|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
44873495|NCT04405375|Hormones|hormones|mesh-ancestor
44361035|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873496|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873497|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44873498|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873499|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44873500|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44873501|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44873502|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873503|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873504|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44873505|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
44873506|NCT04405375|Antiviral Agents|antiviral agents|mesh-ancestor
44873507|NCT04405375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873508|NCT04405375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873509|NCT04405375|Immunologic Factors|immunologic factors|mesh-ancestor
44873510|NCT04405206|Capecitabine|capecitabine|mesh-list
44873511|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
44873512|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44873513|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
44873514|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873515|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873516|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
44873517|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44873518|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
44873519|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873520|NCT04405193|Expectorants|expectorants|mesh-ancestor
44873521|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44873522|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44873523|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
44873524|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873525|NCT04405193|Protective Agents|protective agents|mesh-ancestor
44873526|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873527|NCT04405193|Antidotes|antidotes|mesh-ancestor
44873528|NCT04405271|Tenofovir|tenofovir|mesh-list
44873529|NCT04405271|Emtricitabine|emtricitabine|mesh-list
44873530|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44873531|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
44873532|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873533|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44873534|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44873535|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873536|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873537|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44873538|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44873539|NCT04405154|Cisplatin|cisplatin|mesh-list
44873540|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873541|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44873542|NCT04405245|Latanoprost|latanoprost|mesh-list
44873543|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44873544|NCT04405011|Entecavir|entecavir|mesh-list
44873545|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
44873546|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873547|NCT04405323|Itraconazole|itraconazole|mesh-list
44873548|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
44873549|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873550|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44873551|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873552|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873553|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873554|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44873555|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
44873556|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44873557|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873558|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44873559|NCT04404946|Phenylephrine|phenylephrine|mesh-list
44873560|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
44873561|NCT04404946|Norepinephrine|norepinephrine|mesh-list
44873562|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44873563|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
44873564|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
44873565|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873566|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873567|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
44873568|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44873569|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
44873570|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44873571|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44873572|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44873573|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44873574|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873575|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873576|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873577|NCT04404946|Protective Agents|protective agents|mesh-ancestor
44873578|NCT04404881|Bevacizumab|bevacizumab|mesh-list
44873579|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44873580|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873581|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44873582|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44873583|NCT04404881|Growth Substances|growth substances|mesh-ancestor
44873584|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873585|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
44873586|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44873587|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873588|NCT04404751|Folic Acid|folic acid|mesh-list
44873589|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
44361161|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
44873590|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
44873592|NCT04404751|Vitamins|vitamins|mesh-ancestor
44873593|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
44873594|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873595|NCT04404751|Trace Elements|trace elements|mesh-ancestor
44873596|NCT04404751|Hematinics|hematinics|mesh-ancestor
44873597|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
44873598|NCT04404686|Indomethacin|indomethacin|mesh-list
44873599|NCT04404686|Nifedipine|nifedipine|mesh-list
44873600|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44873601|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44873602|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873603|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44873604|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873605|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44361175|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44873606|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
44873607|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44873608|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44873609|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873610|NCT04404686|Analgesics|analgesics|mesh-ancestor
44873611|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
44873612|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873613|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873614|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873615|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
44873616|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44661466|NCT00004259|Carmustine|carmustine|mesh-list
44873617|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873618|NCT04404517|Adalimumab|adalimumab|mesh-list
44873619|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873620|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873621|NCT04404491|Capecitabine|capecitabine|mesh-list
44873622|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44873623|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
44873624|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873625|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873626|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44873627|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44873628|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873629|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873630|NCT04404062|Antibodies|antibodies|mesh-list
44873631|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
44873632|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
44873633|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873634|NCT04404127|Basiliximab|basiliximab|mesh-list
44873635|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44873636|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
44873637|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873638|NCT04403776|Tofacitinib|tofacitinib|mesh-list
44873639|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44873640|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873641|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873642|NCT04403503|Thrombin|thrombin|mesh-list
44873643|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44873644|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
44873645|NCT04403503|Coagulants|coagulants|mesh-ancestor
44873646|NCT04403724|Fentanyl|fentanyl|mesh-list
44361197|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361198|NCT01140932|Prednisolone|prednisolone|mesh-list
44361199|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44361200|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
44361201|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44361202|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
44873647|NCT04403724|Morphine|morphine|mesh-list
44873648|NCT04403724|Bupivacaine|bupivacaine|mesh-list
44873649|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873650|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
44873651|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873652|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873653|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
44873654|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873655|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44873656|NCT04403724|Narcotics|narcotics|mesh-ancestor
44873657|NCT04403724|Analgesics|analgesics|mesh-ancestor
44873658|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873659|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873660|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
44873661|NCT04403568|Ursolic acid|ursolic acid|mesh-list
44873662|NCT04403568|Curcumin|curcumin|mesh-list
44873663|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44873664|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873665|NCT04403568|Analgesics|analgesics|mesh-ancestor
44873666|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
44873667|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873668|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873669|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873670|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873671|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873672|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873673|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873674|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873675|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44873676|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44873677|NCT04403555|Ivermectin|ivermectin|mesh-list
44873678|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873679|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873680|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
44873681|NCT04403334|Levofloxacin|levofloxacin|mesh-list
44873682|NCT04403334|Ofloxacin|ofloxacin|mesh-list
44873683|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873684|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873685|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44873686|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44873687|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873688|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873689|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873690|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44873691|NCT04403334|Renal Agents|renal agents|mesh-ancestor
44873692|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44873693|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873694|NCT04403100|Ritonavir|ritonavir|mesh-list
44873695|NCT04403100|Lopinavir|lopinavir|mesh-list
44873696|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
44873697|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44873698|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44873699|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
44873700|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873701|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873702|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44873703|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44873704|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
44361217|NCT01140932|Protective Agents|protective agents|mesh-ancestor
44873705|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873706|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44873707|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44873708|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
44873709|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44873710|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873711|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873712|NCT04403282|Eflornithine|eflornithine|mesh-list
44873713|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873714|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44873715|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44873716|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873717|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873718|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44873719|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873720|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873721|NCT04403191|Ondansetron|ondansetron|mesh-list
44873722|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
44873723|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
44873724|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873725|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873726|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44873727|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
44873728|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44873729|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44873730|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
44873731|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873732|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873733|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44873734|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873735|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873736|NCT04403191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873737|NCT04403191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44873739|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44873740|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873741|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873742|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873743|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
44873744|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873745|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873746|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873747|NCT04402762|Enoxaparin|enoxaparin|mesh-list
44873748|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
44873749|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
44873750|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44873751|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44873752|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873753|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
44873754|NCT04402580|Rituximab|rituximab|mesh-list
44873755|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361274|NCT01141153|Clopidogrel|clopidogrel|mesh-list
44873756|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873757|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
44873758|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873759|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873760|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44873761|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44873762|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
44873763|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873764|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873765|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873766|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873767|NCT04402671|Glutaral|glutaral|mesh-list
44873768|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
44361324|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44873769|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873770|NCT04402320|Midazolam|midazolam|mesh-list
44873771|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873772|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873773|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873774|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873775|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44873776|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44873777|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873778|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873779|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
44873780|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
44873781|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
44873782|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
44873783|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873784|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873785|NCT04402359|Meropenem|meropenem|mesh-list
44873786|NCT04402359|Ceftazidime|ceftazidime|mesh-list
44873787|NCT04402359|Avibactam|avibactam|mesh-list
44873788|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44873789|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873790|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44873791|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873792|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873793|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
44873794|NCT04402411|Narcotics|narcotics|mesh-ancestor
44873795|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873796|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873797|NCT04402411|Analgesics|analgesics|mesh-ancestor
44873798|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
44873799|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873800|NCT04402203|Favipiravir|favipiravir|mesh-list
44873801|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
44873802|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873803|NCT04402047|Diclofenac|diclofenac|mesh-list
44873804|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44873805|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873806|NCT04402047|Analgesics|analgesics|mesh-ancestor
44873807|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
44873808|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873809|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873810|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44873811|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873812|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44873813|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873814|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873815|NCT04402112|Pitavastatin|pitavastatin|mesh-list
44873816|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44873817|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44873818|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44873819|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
44873820|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873821|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873822|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44873823|NCT04401878|Lidocaine|lidocaine|mesh-list
44873824|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873825|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
44873826|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873827|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873828|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
44873829|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873830|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44873831|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44873832|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44361390|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
44361396|NCT01141855|Varenicline|varenicline|mesh-list
44873833|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44873834|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873835|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
44873836|NCT04401852|Analgesics|analgesics|mesh-ancestor
44873837|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
44873838|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873839|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873840|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
44873841|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873842|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44873843|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
44873844|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44873845|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44873846|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873847|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44873848|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
44873849|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44873850|NCT04401839|Oxytocin|oxytocin|mesh-list
44873851|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
44873852|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44873853|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873854|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44873855|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
44873856|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873857|NCT04401657|Adenosine|adenosine|mesh-list
44873858|NCT04401657|Analgesics|analgesics|mesh-ancestor
44873859|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
44873860|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873861|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873862|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44873863|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
44873864|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44873865|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
44873866|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
44873867|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361421|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
44873868|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873869|NCT04401137|Topiramate|topiramate|mesh-list
44873870|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
44873871|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44873872|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873873|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
44873874|NCT04401345|Bromides|bromides|mesh-list
44873875|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
44873876|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44873877|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44873878|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44873879|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
44873880|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873881|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873882|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873883|NCT04401085|Antibodies|antibodies|mesh-list
44873884|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
44873885|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873886|NCT04401007|Lidocaine|lidocaine|mesh-list
44873887|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873889|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873890|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873891|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
44873892|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873893|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44873894|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44873895|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44873896|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44873897|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873898|NCT04400747|Vitamin D|vitamin d|mesh-list
44873899|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
44873900|NCT04400747|Vitamins|vitamins|mesh-ancestor
44873901|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
44873902|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873903|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44873904|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44873905|NCT04400721|Ropivacaine|ropivacaine|mesh-list
44873906|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
44873907|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
44361440|NCT01141972|Vitamin D|vitamin d|mesh-list
44873908|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873909|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873910|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
44873911|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873912|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
44873913|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44873914|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44873915|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873916|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
44873917|NCT04400916|Coagulants|coagulants|mesh-ancestor
44873918|NCT04400890|Vitamin D|vitamin d|mesh-list
44873919|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
44873920|NCT04400890|Resveratrol|resveratrol|mesh-list
44873921|NCT04400890|Vitamins|vitamins|mesh-ancestor
44873922|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
44873923|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873924|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44873925|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44873926|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
44873927|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873928|NCT04400890|Protective Agents|protective agents|mesh-ancestor
44873929|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873930|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44873931|NCT04400188|Temozolomide|temozolomide|mesh-list
44873932|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44873933|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
44873934|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873935|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873936|NCT04400045|Treosulfan|treosulfan|mesh-list
44873937|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44873938|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
44873939|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873940|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44873941|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
44873942|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
44873943|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44873944|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44873945|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873946|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873947|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873948|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44873949|NCT04400136|Lansoprazole|lansoprazole|mesh-list
44873950|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
44873951|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44873952|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44873953|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44873954|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44873955|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873956|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44873957|NCT04399187|Eusol|eusol|mesh-list
44873958|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
44873959|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44873960|NCT04399213|Histamine|histamine|mesh-list
44873961|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
44873962|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
44873963|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
44873964|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873965|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873966|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873967|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
44873968|NCT04399226|Ketamine|ketamine|mesh-list
44873969|NCT04399226|Propofol|propofol|mesh-list
44873970|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44873971|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44873972|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873973|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44873974|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
44873975|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
44873976|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44873977|NCT04399226|Analgesics|analgesics|mesh-ancestor
44873978|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
44873979|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873980|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44873981|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44873982|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44873983|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44873984|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44873985|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44873986|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44873987|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44873988|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44873989|NCT04399395|Naltrexone|naltrexone|mesh-list
44873990|NCT04399395|Bupropion|bupropion|mesh-list
44873991|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44873992|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44873993|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44873994|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
44873995|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44873996|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44873997|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
44873998|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44873999|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44874000|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44874001|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44874002|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874003|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
44874004|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874005|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44874006|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44874007|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874008|NCT04399434|Insulin|insulin|mesh-list
44874009|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361555|NCT01142635|Bromides|bromides|mesh-list
44874010|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874011|NCT04399525|Cetirizine|cetirizine|mesh-list
44874012|NCT04399525|Loratadine|loratadine|mesh-list
44874013|NCT04399525|Levocetirizine|levocetirizine|mesh-list
44874014|NCT04399525|Desloratadine|desloratadine|mesh-list
44874015|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44874016|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44874017|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
44874018|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
44874019|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874020|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698341|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698342|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698343|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661919|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
44874021|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874022|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44874023|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44874024|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
44874026|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
44874027|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
44361583|NCT01142778|Bevacizumab|bevacizumab|mesh-list
44874028|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44874029|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874030|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874031|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44874032|NCT04399343|Analgesics|analgesics|mesh-ancestor
44874033|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
44874034|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874035|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44874036|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44874037|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44874038|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
44874039|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874040|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874041|NCT04399148|Ketotifen|ketotifen|mesh-list
44874042|NCT04399148|Aprepitant|aprepitant|mesh-list
44874043|NCT04399148|Desloratadine|desloratadine|mesh-list
44874044|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
44874045|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
44874046|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874047|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874048|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874049|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44874050|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874051|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874052|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44874053|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44874054|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44874055|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44874056|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
44874057|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
44874058|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
44874059|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
44874060|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44874061|NCT04398823|Polidocanol|polidocanol|mesh-list
44874062|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44874063|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44874064|NCT04399070|Ketamine|ketamine|mesh-list
44874065|NCT04399070|Esketamine|esketamine|mesh-list
44874066|NCT04399070|Analgesics|analgesics|mesh-ancestor
44874067|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
44361631|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874068|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874069|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874070|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44874071|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44874072|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
44874073|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
44874074|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874075|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44874076|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44874077|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874078|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874079|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
44874080|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44874081|NCT04398927|Folfirinox|folfirinox|mesh-list
44874082|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874083|NCT04399083|Caffeine|caffeine|mesh-list
44874084|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44874085|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361646|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874086|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44874087|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874088|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874089|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44874090|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44874091|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
44874092|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874093|NCT04398771|Valsartan|valsartan|mesh-list
44874094|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44661993|NCT00002597|Leuprolide|leuprolide|mesh-list
44874095|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44874096|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44874097|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
44874098|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874099|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44874100|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44874101|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874102|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44874103|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44874104|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44874105|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
44874106|NCT04398589|Ropivacaine|ropivacaine|mesh-list
44874107|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44874108|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874109|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874110|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44874111|NCT04398589|Analgesics|analgesics|mesh-ancestor
44874112|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
44874113|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874114|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44874115|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44874116|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44874117|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
44874118|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874119|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874120|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
44874121|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
44874122|NCT04398251|Febuxostat|febuxostat|mesh-list
44874123|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
44874124|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874125|NCT04398108|Margetuximab|margetuximab|mesh-list
44874126|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874127|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
44874128|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44874129|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
44874130|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874131|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874132|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44874133|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
44874134|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44874135|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
44874136|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874137|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874138|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44874139|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
44874140|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
44874141|NCT04398290|Protective Agents|protective agents|mesh-ancestor
44874142|NCT04398316|Lidocaine|lidocaine|mesh-list
44874143|NCT04398316|Hydromorphone|hydromorphone|mesh-list
44874144|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
44874145|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
44874146|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874147|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874148|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
44874149|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874150|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44874151|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44874152|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44874153|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44874154|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874155|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44874156|NCT04398316|Narcotics|narcotics|mesh-ancestor
44874157|NCT04398316|Analgesics|analgesics|mesh-ancestor
44874158|NCT04398004|Clarithromycin|clarithromycin|mesh-list
44874159|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874160|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874161|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44874162|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874163|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874164|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44874165|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44874166|NCT04397770|Temozolomide|temozolomide|mesh-list
44874167|NCT04397770|Apatinib|apatinib|mesh-list
44662070|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44874168|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44874170|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874171|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874172|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874173|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874174|NCT04397601|Bevacizumab|bevacizumab|mesh-list
44874175|NCT04397601|Aflibercept|aflibercept|mesh-list
44874176|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44874177|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874178|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44874179|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44874180|NCT04397601|Growth Substances|growth substances|mesh-ancestor
44874181|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874182|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
44874183|NCT04397653|Ezetimibe|ezetimibe|mesh-list
44874184|NCT04397653|Evolocumab|evolocumab|mesh-list
44874185|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44874186|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44874187|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
44874188|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874189|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44874190|NCT04397913|Acetaminophen|acetaminophen|mesh-list
44874191|NCT04397913|Ibuprofen|ibuprofen|mesh-list
44874192|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44874193|NCT04397913|Analgesics|analgesics|mesh-ancestor
44361763|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874194|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
44874195|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874196|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874197|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
44874198|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44874199|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874200|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874201|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44874202|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874203|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874204|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
44874205|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874206|NCT04397341|Cisplatin|cisplatin|mesh-list
44874207|NCT04397341|Docetaxel|docetaxel|mesh-list
44874208|NCT04397341|Fluorouracil|fluorouracil|mesh-list
44874209|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874210|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44874211|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44874212|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44874213|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874214|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
44874215|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44874216|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874217|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
44874218|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874219|NCT04397458|Dexamethasone|dexamethasone|mesh-list
44874220|NCT04397458|Bupivacaine|bupivacaine|mesh-list
44874221|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361788|NCT01144702|Mefloquine|mefloquine|mesh-list
44874222|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
44874223|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
44874224|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874225|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874226|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874227|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
44874228|NCT04397458|Hormones|hormones|mesh-ancestor
44874229|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874230|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44874231|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361804|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
44874232|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
44874233|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
44874234|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874235|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
44874236|NCT04397510|Heparin|heparin|mesh-list
44874237|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
44874238|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44874239|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44874240|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874241|NCT04397393|Midazolam|midazolam|mesh-list
44874242|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44874243|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44874244|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874245|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874246|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44874247|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44874248|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44874249|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44874250|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
44874251|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
44874252|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
44874253|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
44874254|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361814|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
44874255|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874256|NCT04397289|Heparin|heparin|mesh-list
44874257|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
44874258|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
44874259|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44874260|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44874261|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874262|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44874263|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
44874264|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44874265|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
44874266|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874267|NCT04397549|Morphine|morphine|mesh-list
44874268|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44874269|NCT04397549|Narcotics|narcotics|mesh-ancestor
44698344|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698345|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44698346|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44698347|NCT05138029|Growth Substances|growth substances|mesh-ancestor
44698348|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44698349|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44698350|NCT05137119|Vancomycin|vancomycin|mesh-list
44698351|NCT05137119|Clindamycin|clindamycin|mesh-list
44698352|NCT05137119|Cefazolin|cefazolin|mesh-list
44698353|NCT05137119|Daptomycin|daptomycin|mesh-list
44698354|NCT05137119|Penicillins|penicillins|mesh-list
44698355|NCT05137119|Penicillin G|penicillin g|mesh-list
44698356|NCT05137119|Lincomycin|lincomycin|mesh-list
44698357|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698358|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44698359|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698360|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698361|NCT05135039|Canagliflozin|canagliflozin|mesh-list
44698362|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44361837|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
44698363|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698364|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44698365|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698366|NCT05129332|Vitamin E|vitamin e|mesh-list
44698367|NCT05129332|Vitamins|vitamins|mesh-ancestor
44698368|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
44698369|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698370|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
44698371|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698372|NCT05129332|Protective Agents|protective agents|mesh-ancestor
44698373|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
44698374|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44249987|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698412|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698413|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698414|NCT05067439|Efavirenz|efavirenz|mesh-list
44698415|NCT05067439|Caffeine|caffeine|mesh-list
44698416|NCT05067439|Omeprazole|omeprazole|mesh-list
44698417|NCT05067439|Abrocitinib|abrocitinib|mesh-list
44698418|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44698419|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698420|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44698421|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698422|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698423|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44698424|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698425|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44698426|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44698427|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44698428|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
44698429|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698430|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44698431|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44698432|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
44698433|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698434|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44698435|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44698436|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44698437|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44698438|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44698439|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44874270|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874271|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874272|NCT04397549|Analgesics|analgesics|mesh-ancestor
44874273|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
44874274|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874275|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874276|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
44874277|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874278|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874279|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874280|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874281|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874282|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874283|NCT04396990|Prednisolone|prednisolone|mesh-list
44874284|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874285|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
44874286|NCT04396990|Hormones|hormones|mesh-ancestor
44874287|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874288|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874289|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44874290|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874291|NCT04396938|Lamotrigine|lamotrigine|mesh-list
44361899|NCT01145404|Lapatinib|lapatinib|mesh-list
44874292|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
44874293|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44874294|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44874295|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874296|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874297|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874298|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44874299|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44874300|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874301|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44874302|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44874303|NCT04396743|Clotrimazole|clotrimazole|mesh-list
44874304|NCT04396743|Miconazole|miconazole|mesh-list
44874305|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44874306|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874307|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
44874308|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44874309|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44874310|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874311|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874312|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44874313|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
44874314|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874315|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874316|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44874317|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44874318|NCT04396977|Histamine|histamine|mesh-list
44874319|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
44874320|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
44874321|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874322|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874323|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874324|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
44874325|NCT04396457|Pemetrexed|pemetrexed|mesh-list
44874326|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361959|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874327|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874328|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874329|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874330|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44874331|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44874332|NCT04396548|Midodrine|midodrine|mesh-list
44874333|NCT04396548|Anesthetics|anesthetics|mesh-list
44874334|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874335|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874336|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
44874337|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
44874338|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874339|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44874340|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44874341|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44874342|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44874343|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44874344|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874345|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874346|NCT04396223|Methotrexate|methotrexate|mesh-list
44874347|NCT04396223|Avelumab|avelumab|mesh-list
44874348|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44874349|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
44874350|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44874351|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874352|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44874353|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
44874354|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874355|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874356|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44874357|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874358|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44874359|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874360|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
44874361|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874362|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44874363|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44874364|NCT04396067|Tretinoin|tretinoin|mesh-list
44874365|NCT04396067|Isotretinoin|isotretinoin|mesh-list
44874366|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874367|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
44874368|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
44874369|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44874370|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44874371|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
44874372|NCT04395768|Vitamin D|vitamin d|mesh-list
44874373|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
44874374|NCT04395768|Vitamins|vitamins|mesh-list
44874375|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
44874376|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
44874377|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
44874378|NCT04395768|Azithromycin|azithromycin|mesh-list
44874379|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874380|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
44874381|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874382|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44874383|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874384|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874385|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874386|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874387|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
44874388|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44362008|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
44362009|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362010|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362011|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362012|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
44362013|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362014|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362015|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44362016|NCT01146002|Guanfacine|guanfacine|mesh-list
44362017|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44362018|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44362019|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44362020|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44362021|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
44362022|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362023|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874389|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874390|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874391|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874392|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
44874393|NCT04395768|Protective Agents|protective agents|mesh-ancestor
44874394|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
44874395|NCT04395768|Hematinics|hematinics|mesh-ancestor
44874396|NCT04395989|Paclitaxel|paclitaxel|mesh-list
44874397|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44874398|NCT04395989|Capecitabine|capecitabine|mesh-list
44874399|NCT04395989|Everolimus|everolimus|mesh-list
44874400|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44874401|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874402|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
44874403|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
44874404|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44874405|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874406|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44874407|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
44874408|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874409|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
44874410|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874411|NCT04395612|Niraparib|niraparib|mesh-list
44874412|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44874413|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874414|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874415|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874416|NCT04395638|Vitamin D|vitamin d|mesh-list
44874417|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
44874418|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
44874419|NCT04395638|Vitamins|vitamins|mesh-list
44874420|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
44874421|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698440|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874422|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44874423|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874424|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
44874425|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44874426|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
44874427|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874428|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
44874429|NCT04395417|Protective Agents|protective agents|mesh-ancestor
44874430|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44874431|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44874432|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874433|NCT04395365|Renal Agents|renal agents|mesh-ancestor
44874434|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874435|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
44874436|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874437|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874438|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44874439|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44874440|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
44874441|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44874442|NCT04395105|Dexamethasone|dexamethasone|mesh-list
44874443|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874444|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
44874445|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
44874446|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874447|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874448|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874449|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
44874450|NCT04395105|Hormones|hormones|mesh-ancestor
44874451|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874452|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44874453|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874454|NCT04394975|Sunitinib|sunitinib|mesh-list
44874455|NCT04394975|Axitinib|axitinib|mesh-list
44874456|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874457|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44874458|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44874459|NCT04394975|Growth Substances|growth substances|mesh-ancestor
44874460|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874461|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
44874462|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874463|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874464|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874465|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
44874466|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44874467|NCT04395170|Antibodies|antibodies|mesh-list
44874468|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
44874469|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874470|NCT04394897|Remifentanil|remifentanil|mesh-list
44874471|NCT04394897|Propofol|propofol|mesh-list
44874472|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44874473|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874474|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874475|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44874476|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
44874477|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
44874478|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44874479|NCT04394897|Narcotics|narcotics|mesh-ancestor
44874480|NCT04394897|Analgesics|analgesics|mesh-ancestor
44874481|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
44874482|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874483|NCT04394728|Trabectedin|trabectedin|mesh-list
44874484|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44874485|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
44698441|NCT05064137|Listerine|listerine|mesh-list
44698442|NCT05064137|Fluorides|fluorides|mesh-list
44698443|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
44698444|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
44698445|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
44698446|NCT05064137|Protective Agents|protective agents|mesh-ancestor
44698447|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698448|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44698449|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698450|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
44698451|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
44662467|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
44874486|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874487|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874488|NCT04394598|Capecitabine|capecitabine|mesh-list
44874489|NCT04394598|Irinotecan|irinotecan|mesh-list
44874490|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44874491|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
44874492|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874493|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874494|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44874495|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44874496|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874497|NCT04394533|Bupivacaine|bupivacaine|mesh-list
44874498|NCT04394533|Prilocaine|prilocaine|mesh-list
44874499|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
44874500|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
44874501|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874502|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874503|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
44874504|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662528|NCT04977986|Cannabidiol|cannabidiol|mesh-list
44874506|NCT04394234|Anticoagulants|anticoagulants|mesh-list
44874507|NCT04394208|Silymarin|silymarin|mesh-list
44874508|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
44874509|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874510|NCT04394208|Protective Agents|protective agents|mesh-ancestor
44874511|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874512|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874513|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
44874514|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874515|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874516|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874517|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874518|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874519|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874520|NCT04394390|Vitamin D|vitamin d|mesh-list
44874521|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
44874522|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
44874523|NCT04394390|Vitamins|vitamins|mesh-list
44874524|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
44874525|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874526|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44874527|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874528|NCT04394377|Heparin|heparin|mesh-list
44874529|NCT04394377|Enoxaparin|enoxaparin|mesh-list
44874530|NCT04394377|Calcium heparin|calcium heparin|mesh-list
44874531|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
44874532|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
44874533|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
44874534|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44874535|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44874536|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874537|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44874538|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
44874539|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44874540|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
44874541|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874542|NCT04394143|Mannitol|mannitol|mesh-list
44874543|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44874544|NCT04394143|Diuretics|diuretics|mesh-ancestor
44874545|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
44874546|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874547|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
44874548|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44874549|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874550|NCT04393805|Heparin|heparin|mesh-list
44874551|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44874552|NCT04393805|Tinzaparin|tinzaparin|mesh-list
44874553|NCT04393805|Dalteparin|dalteparin|mesh-list
44874554|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
44874555|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44874556|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44874557|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874558|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
44874559|NCT04393792|Povidone|povidone|mesh-list
44874560|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
44874561|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
44874562|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44874563|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874564|NCT04393610|Lidocaine|lidocaine|mesh-list
44874565|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
44874566|NCT04393610|Fentanyl|fentanyl|mesh-list
44874567|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
44874568|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
44874569|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874570|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874571|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
44874572|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874573|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44874574|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44874575|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44874576|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44874577|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874578|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44874579|NCT04393610|Narcotics|narcotics|mesh-ancestor
44874580|NCT04393610|Analgesics|analgesics|mesh-ancestor
44874581|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44874582|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44874583|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
44874584|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
44874585|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44874586|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874587|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
44874588|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44874589|NCT04393584|Leucovorin|leucovorin|mesh-list
44874590|NCT04393584|Docetaxel|docetaxel|mesh-list
44874591|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
44874592|NCT04393584|Irinotecan|irinotecan|mesh-list
44874593|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874594|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44874595|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44874596|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
44874597|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874598|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44874599|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44874600|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874601|NCT04393584|Antidotes|antidotes|mesh-ancestor
44874602|NCT04393584|Protective Agents|protective agents|mesh-ancestor
44874603|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874604|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
44874605|NCT04393584|Vitamins|vitamins|mesh-ancestor
44874606|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
44874607|NCT04393220|Bevacizumab|bevacizumab|mesh-list
44874608|NCT04393220|Nivolumab|nivolumab|mesh-list
44874609|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44874610|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874611|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44874612|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44874613|NCT04393220|Growth Substances|growth substances|mesh-ancestor
44874614|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874615|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
44874616|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44874617|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874618|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
44874619|NCT04393246|Ambrisentan|ambrisentan|mesh-list
44874620|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44874621|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874622|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44874623|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874624|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44874625|NCT04393025|Clopidogrel|clopidogrel|mesh-list
44874626|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874627|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874628|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44874629|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44874630|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44874631|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44874632|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
44874633|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874634|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874635|NCT04392973|Favipiravir|favipiravir|mesh-list
44874636|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
44874637|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874638|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874639|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874640|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874641|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874642|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874643|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
44874644|NCT04392427|Ribavirin|ribavirin|mesh-list
44874645|NCT04392427|Ivermectin|ivermectin|mesh-list
44874646|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
44874647|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
44874648|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874649|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
44874650|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874651|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874652|NCT04392700|Tenofovir|tenofovir|mesh-list
44874653|NCT04392700|Entecavir|entecavir|mesh-list
44874654|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
44874655|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874656|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44874657|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44874658|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662677|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44874659|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874660|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44874661|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44874662|NCT04392648|Dexamethasone|dexamethasone|mesh-list
44874663|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
44874664|NCT04392648|Bortezomib|bortezomib|mesh-list
44874665|NCT04392648|Pomalidomide|pomalidomide|mesh-list
44874666|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874667|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
44874668|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874669|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874670|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44874671|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
44362264|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874672|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874673|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874674|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44874675|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874676|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
44874677|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
44874678|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874679|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874680|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
44874681|NCT04392648|Hormones|hormones|mesh-ancestor
44874682|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874683|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44874684|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44874685|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44874686|NCT04392648|Growth Substances|growth substances|mesh-ancestor
44874687|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44874688|NCT04392479|Aflibercept|aflibercept|mesh-list
44874689|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44874690|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44874691|NCT04392479|Growth Substances|growth substances|mesh-ancestor
44874692|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874693|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
44874694|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874695|NCT04392557|Metformin|metformin|mesh-list
44874696|NCT04392557|Pioglitazone|pioglitazone|mesh-list
44698452|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698453|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
44698454|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698455|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698456|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
44698457|NCT05052528|Rituximab|rituximab|mesh-list
44698458|NCT05052528|Fludarabine|fludarabine|mesh-list
44698459|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
44698460|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44698461|NCT05052528|Antibodies|antibodies|mesh-list
44698462|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
44698463|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44698464|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698465|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
44698466|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698467|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698468|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44698469|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
44698470|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698471|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698472|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44698473|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44698474|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
44698475|NCT05051150|Epinephrine|epinephrine|mesh-list
44698476|NCT05051150|Racepinephrine|racepinephrine|mesh-list
44698477|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
44698478|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44698479|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698480|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698481|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698482|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698483|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698484|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44698485|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44698486|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
44698487|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698488|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44874697|NCT04392557|Alogliptin|alogliptin|mesh-list
44874698|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44874699|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874700|NCT04392557|Incretins|incretins|mesh-ancestor
44874702|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874703|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44362360|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
44874704|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
44874705|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874706|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874707|NCT04392713|Ivermectin|ivermectin|mesh-list
44874708|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874709|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874710|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
44874711|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
44874712|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874713|NCT04392063|Melatonin|melatonin|mesh-list
44874714|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
44874715|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874716|NCT04392063|Protective Agents|protective agents|mesh-ancestor
44874717|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874718|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874719|NCT04392128|Azithromycin|azithromycin|mesh-list
44874720|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874721|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874722|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874723|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
44874724|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874725|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874726|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874727|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874728|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662790|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
44874729|NCT04392297|Antibodies|antibodies|mesh-list
44874730|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
44874731|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
44874732|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874733|NCT04391998|Metronidazole|metronidazole|mesh-list
44874734|NCT04391998|Albendazole|albendazole|mesh-list
44874735|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874736|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874737|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874738|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874739|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
44874740|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
44874741|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44874742|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44874743|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44874744|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44874745|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874746|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874747|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
44874748|NCT04391868|Citric Acid|citric acid|mesh-list
44874749|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
44874750|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
44874751|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44874752|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
44874753|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
44874754|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874755|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44874756|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44874757|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44874758|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874759|NCT04391868|Urological Agents|urological agents|mesh-ancestor
44874760|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
44874761|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44874762|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44874763|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874764|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874765|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874766|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
44874767|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44874768|NCT04391621|Triamcinolone|triamcinolone|mesh-list
44874769|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44874770|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44874771|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44874772|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874773|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
44874774|NCT04391621|Hormones|hormones|mesh-ancestor
44874775|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874776|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874777|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874778|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
44874779|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874780|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874781|NCT04391660|Ethanol|ethanol|mesh-list
44874782|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44874783|NCT04391660|Eusol|eusol|mesh-list
44874784|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44874785|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44874786|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874787|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874788|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874789|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
44874790|NCT04391764|Naltrexone|naltrexone|mesh-list
44874791|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44874792|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44874793|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874794|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
44874795|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874796|NCT04391478|Milrinone|milrinone|mesh-list
44874797|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
44874798|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
44874799|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44874800|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44874801|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662867|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
44874802|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874803|NCT04391478|Urological Agents|urological agents|mesh-ancestor
44874804|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44874805|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44874806|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44874807|NCT04391478|Protective Agents|protective agents|mesh-ancestor
44874808|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874809|NCT04391361|Atropine|atropine|mesh-list
44874810|NCT04391361|Scopolamine|scopolamine|mesh-list
44874811|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
44874812|NCT04391361|Edaravone|edaravone|mesh-list
44874813|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44874814|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44874815|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44874816|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874817|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44874818|NCT04391361|Analgesics|analgesics|mesh-ancestor
44874819|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
44874820|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874821|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44874822|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44874823|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44874824|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
44874825|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874826|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874827|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44874828|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44874829|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44874830|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
44874831|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44874832|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
44874833|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
44874834|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
44874835|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44874836|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44874837|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
44874838|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
44874839|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874840|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44874841|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
44874842|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44874843|NCT04391361|Protective Agents|protective agents|mesh-ancestor
44874844|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
44874845|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44874846|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874847|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874848|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44874849|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44874850|NCT04391231|Protective Agents|protective agents|mesh-ancestor
44874851|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874852|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
44874853|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44874854|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
44874855|NCT04391283|Osimertinib|osimertinib|mesh-list
44874856|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362515|NCT01148446|Prednisone|prednisone|mesh-list
44874857|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874858|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874859|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874860|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874861|NCT04391127|Ivermectin|ivermectin|mesh-list
44874862|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
44874863|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874864|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874865|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874866|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874867|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874868|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874869|NCT04390789|Calcium|calcium|mesh-list
44874870|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44874871|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874872|NCT04390984|Apatinib|apatinib|mesh-list
44698489|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
44698490|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
44698491|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
44698492|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44698493|NCT05045313|Probenecid|probenecid|mesh-list
44698494|NCT05045313|Digoxin|digoxin|mesh-list
44698495|NCT05045313|Warfarin|warfarin|mesh-list
44698496|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
44698497|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44874873|NCT04390984|Gefitinib|gefitinib|mesh-list
44874874|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874875|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874876|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874877|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874878|NCT04390854|Clotrimazole|clotrimazole|mesh-list
44874879|NCT04390854|Miconazole|miconazole|mesh-list
44874880|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44874881|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874882|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
44874883|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44874884|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44874885|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874886|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874887|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44874888|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
44874889|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874890|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874891|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44874892|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44874893|NCT04390815|Insulin|insulin|mesh-list
44874894|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44874895|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44874896|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874897|NCT04390464|Ravulizumab|ravulizumab|mesh-list
44874898|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44874899|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874900|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
44874901|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874902|NCT04390685|Tacrolimus|tacrolimus|mesh-list
44874903|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874904|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
44874905|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874906|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44874907|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874908|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874909|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
44874910|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44874911|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44874912|NCT04391439|Prednisolone|prednisolone|mesh-list
44874913|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
44874914|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44874915|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
44874916|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874917|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
44874918|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
44874919|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874920|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874921|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874922|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
44874923|NCT04391439|Hormones|hormones|mesh-ancestor
44874924|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44874925|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44874926|NCT04391439|Protective Agents|protective agents|mesh-ancestor
44874927|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44874928|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874929|NCT04390334|Efavirenz|efavirenz|mesh-list
44874930|NCT04390334|Famotidine|famotidine|mesh-list
44874931|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44874932|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44874933|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874934|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874935|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
44874936|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44874937|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44874938|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44874939|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44874940|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44874941|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44874942|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44874943|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44874944|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44874945|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44874946|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
44874947|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
44874948|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44874949|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874950|NCT04390594|Nafamostat|nafamostat|mesh-list
44874951|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44874952|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44874953|NCT04390594|Analgesics|analgesics|mesh-ancestor
44874954|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
44874955|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44874956|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874957|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44874958|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874959|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
44874960|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
44874961|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874962|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362623|NCT01149005|Insulin|insulin|mesh-list
44874963|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44874964|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44874965|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44874966|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44874967|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
44874968|NCT04390295|Metformin|metformin|mesh-list
44874969|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44874970|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874971|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874972|NCT04390061|Tofacitinib|tofacitinib|mesh-list
44874973|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
44874974|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44874975|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44874976|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362648|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362649|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44874977|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874978|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874979|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44874980|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44874981|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
44874982|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44874983|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
44874984|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44874985|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
44874986|NCT04389866|Protective Agents|protective agents|mesh-ancestor
44874987|NCT04390152|Ritonavir|ritonavir|mesh-list
44874988|NCT04390152|Lopinavir|lopinavir|mesh-list
44874989|NCT04390152|Azithromycin|azithromycin|mesh-list
44874990|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
44874991|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44874992|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44874993|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44874994|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44874995|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44874996|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44874997|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44362661|NCT01149122|Immunologic Factors|immunologic factors|mesh-ancestor
44362662|NCT01149122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362663|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44362664|NCT01149174|Mitomycins|mitomycins|mesh-list
44362665|NCT01149174|Mitomycin|mitomycin|mesh-list
44362666|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44362667|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362668|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
44362669|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362670|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44362671|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362672|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
44362673|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44362676|NCT01149278|Benzocaine|benzocaine|mesh-list
44874998|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
44874999|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875000|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44875001|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44875002|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875003|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
44875004|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875005|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875006|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875007|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44875008|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
44875009|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44875010|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
44875011|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875012|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
44875013|NCT04390100|Protective Agents|protective agents|mesh-ancestor
44875014|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
44875015|NCT04390100|Coagulants|coagulants|mesh-ancestor
44875016|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
44875017|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44875018|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44875019|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875020|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
44875021|NCT04389554|Coagulants|coagulants|mesh-ancestor
44875022|NCT04389567|Famotidine|famotidine|mesh-list
44875023|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44875024|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44875025|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44875026|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
44875027|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
44875028|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875029|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875030|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875031|NCT04389801|Deferoxamine|deferoxamine|mesh-list
44875032|NCT04389801|Siderophores|siderophores|mesh-ancestor
44875033|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44875034|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
44875035|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
44875036|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875037|NCT04389580|Tamoxifen|tamoxifen|mesh-list
44875038|NCT04389580|Isotretinoin|isotretinoin|mesh-list
44875039|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44875040|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362697|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44362698|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
44362699|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44362700|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362701|NCT01149330|Adapalene|adapalene|mesh-list
44362702|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362703|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362704|NCT01149330|Analgesics|analgesics|mesh-ancestor
44362705|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
44362706|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362707|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362711|NCT01149356|Exemestane|exemestane|mesh-list
44875041|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875042|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875043|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44875044|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875045|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44875046|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44875047|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875048|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44875049|NCT04389424|Tamoxifen|tamoxifen|mesh-list
44875050|NCT04389424|Anastrozole|anastrozole|mesh-list
44875051|NCT04389424|Exemestane|exemestane|mesh-list
44875052|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44875053|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
44875054|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362724|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
44875055|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875056|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44875057|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875058|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44875059|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44875060|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875061|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44875062|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44875063|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875064|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875065|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875066|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
44875067|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875068|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875069|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875070|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875071|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875072|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875073|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875074|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
44875075|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875076|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875077|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875078|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875079|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875080|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875081|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
44362749|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44362750|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362751|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362752|NCT01149577|Olanzapine|olanzapine|mesh-list
44362753|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
44362754|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
44362755|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362756|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362757|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362758|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44362759|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362760|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362761|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362762|NCT01149577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362763|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362764|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675526|NCT02883478|Riboflavin|riboflavin|mesh-list
44875082|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44875083|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875084|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
44875085|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875086|NCT04389060|Protective Agents|protective agents|mesh-ancestor
44875087|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875088|NCT04389229|Aldesleukin|aldesleukin|mesh-list
44875089|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
44875090|NCT04389229|Fludarabine|fludarabine|mesh-list
44875091|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875092|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
44875093|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875094|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362765|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875095|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44875096|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
44875097|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875098|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875099|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44875100|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44875101|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44875102|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
44875103|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875104|NCT04388774|Ketamine|ketamine|mesh-list
44875105|NCT04388774|Analgesics|analgesics|mesh-ancestor
44875106|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
44875107|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875108|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875109|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44875110|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44875111|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
44875112|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
44875113|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875114|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44875115|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44875116|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698498|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44698499|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698500|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362784|NCT01149798|Cisplatin|cisplatin|mesh-list
44698501|NCT05045313|Protective Agents|protective agents|mesh-ancestor
44698502|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698503|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
44698504|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
44698505|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698506|NCT05045313|Renal Agents|renal agents|mesh-ancestor
44698507|NCT05007561|Naltrexone|naltrexone|mesh-list
44698508|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44698509|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44698510|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698511|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
44698512|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698513|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44698514|NCT05002738|Desogestrel|desogestrel|mesh-list
44698515|NCT05002738|Estradiol|estradiol|mesh-list
44698516|NCT05002738|Estrogens|estrogens|mesh-ancestor
44698517|NCT05002738|Hormones|hormones|mesh-ancestor
44698518|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698519|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698520|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44698521|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
44698522|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698523|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44698524|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44698525|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44698526|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44698527|NCT05002738|Progestins|progestins|mesh-ancestor
44698528|NCT05001724|Docetaxel|docetaxel|mesh-list
44698529|NCT05001724|Lenvatinib|lenvatinib|mesh-list
44698530|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698531|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44698532|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44698533|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44698534|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698535|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44698536|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698537|NCT04961801|Methotrexate|methotrexate|mesh-list
44698538|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
44698539|NCT04961801|Tacrolimus|tacrolimus|mesh-list
44698540|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44698541|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
44698542|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698543|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698544|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44698545|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
44698546|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698547|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698548|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44698549|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698550|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44698551|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875117|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875118|NCT04388709|Interferons|interferons|mesh-list
44875119|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875120|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
44875121|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875122|NCT04388176|Compound 21|compound 21|mesh-list
44875123|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875124|NCT04388904|Tenofovir|tenofovir|mesh-list
44875125|NCT04388904|Emtricitabine|emtricitabine|mesh-list
44875126|NCT04388904|Darunavir|darunavir|mesh-list
44875127|NCT04388904|Cobicistat|cobicistat|mesh-list
44875128|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44875129|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44875130|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
44875131|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875132|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44875133|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44875134|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875135|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875136|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44875137|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44875138|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44875139|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44875140|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875141|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44875142|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44875143|NCT04388202|Citalopram|citalopram|mesh-list
44875144|NCT04388202|Sertraline|sertraline|mesh-list
44875145|NCT04388202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44875146|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44875147|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44875148|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875149|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875150|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
44875151|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875152|NCT04388202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44875153|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
44875154|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44875155|NCT04388124|Bosentan|bosentan|mesh-list
44875156|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44875157|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44875158|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875159|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44875160|NCT04388189|Bupropion|bupropion|mesh-list
44875161|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44875162|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
44875163|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44875164|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44875165|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44875166|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44875167|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875168|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
44875169|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875170|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875171|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44875172|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44875173|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875174|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44875175|NCT04388189|Analgesics|analgesics|mesh-ancestor
44875176|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
44875177|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875178|NCT04388111|Morphine|morphine|mesh-list
44875179|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44875180|NCT04388111|Narcotics|narcotics|mesh-ancestor
44875181|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875182|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875183|NCT04388111|Analgesics|analgesics|mesh-ancestor
44875184|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
44875185|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875186|NCT04387786|Albuterol|albuterol|mesh-list
44875187|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44875188|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
44875189|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663252|NCT01208935|Nicotine|nicotine|mesh-list
44875190|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875191|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875192|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875193|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
44875194|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44875195|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44875196|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44875197|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875198|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875199|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875200|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875201|NCT04387929|Antibodies|antibodies|mesh-list
44875202|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
44875203|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875204|NCT04387695|Sorafenib|sorafenib|mesh-list
44875205|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875206|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44875207|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875208|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875209|NCT04388033|Temozolomide|temozolomide|mesh-list
44875210|NCT04388033|Interleukin-12|interleukin-12|mesh-list
44875211|NCT04388033|Vaccines|vaccines|mesh-list
44875212|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
44875213|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875214|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44875215|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
44875216|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875217|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875218|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44875219|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44875220|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44875221|NCT04388033|Growth Substances|growth substances|mesh-ancestor
44875222|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
44875223|NCT04387604|Ranibizumab|ranibizumab|mesh-list
44875224|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44875225|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44875226|NCT04387604|Growth Substances|growth substances|mesh-ancestor
44875227|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875228|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44362930|NCT01150344|Atovaquone|atovaquone|mesh-list
44875229|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875230|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
44875231|NCT04387539|Simeprevir|simeprevir|mesh-list
44875232|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
44875233|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875234|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875235|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875236|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875237|NCT04387565|Vanadium|vanadium|mesh-list
44875238|NCT04387565|Trace Elements|trace elements|mesh-ancestor
44875239|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
44875240|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875241|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
44875242|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
44875243|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875244|NCT04387500|Axitinib|axitinib|mesh-list
44875245|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875246|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44875247|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875248|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875249|NCT04387630|Metformin|metformin|mesh-list
44875250|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44875251|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698552|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
44875253|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875254|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875255|NCT04386876|Ritonavir|ritonavir|mesh-list
44875256|NCT04386876|Lopinavir|lopinavir|mesh-list
44875257|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44362986|NCT01150786|Trace Elements|trace elements|mesh-ancestor
44875258|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44875259|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875260|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875261|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875262|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44875263|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44875264|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
44875265|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875266|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44875267|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44875268|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44875269|NCT04386850|Calcifediol|calcifediol|mesh-list
44875270|NCT04386850|Vitamins|vitamins|mesh-ancestor
44875271|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
44875272|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875273|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875274|NCT04387097|Remifentanil|remifentanil|mesh-list
44875275|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44875276|NCT04387097|Narcotics|narcotics|mesh-ancestor
44875277|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875278|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875279|NCT04387097|Analgesics|analgesics|mesh-ancestor
44875280|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
44875281|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875282|NCT04386499|Folic Acid|folic acid|mesh-list
44875283|NCT04386499|Resveratrol|resveratrol|mesh-list
44875284|NCT04386499|Hematinics|hematinics|mesh-ancestor
44875285|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
44875286|NCT04386499|Vitamins|vitamins|mesh-ancestor
44875287|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
44875288|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875289|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
44875290|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875291|NCT04386499|Protective Agents|protective agents|mesh-ancestor
44875292|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875293|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44875294|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
44875295|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44875296|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44875297|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875298|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
44875299|NCT04386642|Coagulants|coagulants|mesh-ancestor
44875300|NCT04386577|Vitamin D|vitamin d|mesh-list
44875301|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
44875302|NCT04386577|Vitamins|vitamins|mesh-ancestor
44875303|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
44875304|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363024|NCT01151267|Anesthetics|anesthetics|mesh-list
44875305|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875306|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44875307|NCT04386122|Loxoprofen|loxoprofen|mesh-list
44875308|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44875309|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875310|NCT04386122|Analgesics|analgesics|mesh-ancestor
44875311|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
44875312|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875313|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875314|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875315|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875316|NCT04386447|Oxytocin|oxytocin|mesh-list
44875317|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
44875318|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44875319|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875320|NCT04385719|Remdesivir|remdesivir|mesh-list
44875321|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
44875322|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875323|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
44875324|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698553|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875325|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
44875326|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44875327|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875328|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875329|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875330|NCT04385602|Analgesics|analgesics|mesh-ancestor
44875331|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
44875332|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875333|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44875334|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875335|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875336|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875337|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875338|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875339|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44875340|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
44875341|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44875342|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44875343|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875344|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875345|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875346|NCT04385654|Axitinib|axitinib|mesh-list
44875347|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875348|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44875349|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875350|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875351|NCT04385563|Docetaxel|docetaxel|mesh-list
44875352|NCT04385563|Trastuzumab|trastuzumab|mesh-list
44875353|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875354|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44875355|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44875356|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44875357|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875358|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875359|NCT04385550|Paclitaxel|paclitaxel|mesh-list
44875360|NCT04385550|Docetaxel|docetaxel|mesh-list
44875361|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44875362|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875363|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
44875364|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
44875365|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
44875366|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875367|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875368|NCT04385264|Mannitol|mannitol|mesh-list
44875369|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
44875370|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875371|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875372|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875373|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875374|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875375|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875376|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44875377|NCT04385264|Diuretics|diuretics|mesh-ancestor
44875378|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
44875379|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875380|NCT04385407|Ribavirin|ribavirin|mesh-list
44875381|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
44875382|NCT04385407|Simeprevir|simeprevir|mesh-list
44875383|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
44363102|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363103|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
44875384|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875385|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
44875386|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875387|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875388|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875389|NCT04384744|Hormones|hormones|mesh-list
44875390|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875391|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875392|NCT04384783|Hormones|hormones|mesh-list
44875393|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875394|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663477|NCT01210287|Lamivudine|lamivudine|mesh-list
44875395|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44875396|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44875397|NCT04384666|Rotigotine|rotigotine|mesh-list
44875398|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
44875399|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
44875400|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875401|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875402|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875403|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875404|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
44875405|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875406|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875407|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875408|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698554|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44698555|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44698556|NCT04919564|Furosemide|furosemide|mesh-list
44698557|NCT04919564|Diuretics|diuretics|mesh-ancestor
44698558|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
44698559|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698560|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44698561|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44698562|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698563|NCT04918823|Cyclosporine|cyclosporine|mesh-list
44698564|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44250153|NCT03992443|Reteplase|reteplase|mesh-list
44698565|NCT04918823|Cyclosporins|cyclosporins|mesh-list
44698566|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698567|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698568|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698569|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
44698570|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698571|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
44698572|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698573|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
44698574|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698575|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44698576|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44698577|NCT04907825|Warfarin|warfarin|mesh-list
44698578|NCT04907825|Anticoagulants|anticoagulants|mesh-list
44698579|NCT04896645|Albuterol|albuterol|mesh-list
44698580|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44698581|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
44698582|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698583|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698584|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44698585|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
44698586|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
44698587|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698588|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44698589|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44698590|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698591|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698592|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698593|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698594|NCT04895579|Durvalumab|durvalumab|mesh-list
44698595|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698596|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698597|NCT04894435|Vaccines|vaccines|mesh-list
44698598|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
44698599|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698600|NCT04886284|Ertapenem|ertapenem|mesh-list
44698601|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44698602|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698603|NCT04879823|Acetaminophen|acetaminophen|mesh-list
44698604|NCT04879823|Dexamethasone|dexamethasone|mesh-list
44698605|NCT04879823|Ibuprofen|ibuprofen|mesh-list
44698606|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698607|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
44698608|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
44698609|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698610|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698611|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698612|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
44698613|NCT04879823|Hormones|hormones|mesh-ancestor
44698614|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875409|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875410|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875412|NCT04384653|Diuretics|diuretics|mesh-ancestor
44875413|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
44875414|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875415|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44875416|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44875417|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875418|NCT04384731|Poractant alfa|poractant alfa|mesh-list
44875419|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44875420|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875421|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875422|NCT04384458|Ivermectin|ivermectin|mesh-list
44875423|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
44875424|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875425|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875426|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875427|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875428|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875429|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875430|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
44875431|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44875432|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
44875433|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875434|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875435|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875436|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875437|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44875438|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
44875439|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875440|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875441|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44875442|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
44875443|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
44875444|NCT04384133|Protective Agents|protective agents|mesh-ancestor
44875445|NCT04383990|Insulin|insulin|mesh-list
44875446|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44875447|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875448|NCT04383977|Etoposide|etoposide|mesh-list
44875449|NCT04383977|Apatinib|apatinib|mesh-list
44875450|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44875451|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875452|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44875453|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44875454|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875455|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875456|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44875457|NCT04383717|Azithromycin|azithromycin|mesh-list
44875458|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
44363230|NCT01152931|Zinc|zinc|mesh-list
44875459|NCT04383717|Levamisole|levamisole|mesh-list
44875460|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
44875461|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875462|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875463|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
44875464|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875465|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875466|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875467|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875468|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875469|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44875470|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
44875471|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875472|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
44875473|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
44875474|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
44875475|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
44875476|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44875477|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875478|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875479|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875480|NCT04383418|Analgesics|analgesics|mesh-ancestor
44875481|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
44875482|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875483|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44875484|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875485|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875486|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875487|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875488|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875489|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
44875490|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44875491|NCT04383548|Antibodies|antibodies|mesh-list
44875492|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
44875493|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875494|NCT04383093|Tadalafil|tadalafil|mesh-list
44875495|NCT04383093|Tamsulosin|tamsulosin|mesh-list
44875496|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
44875497|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44875498|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44875499|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875500|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875501|NCT04383093|Urological Agents|urological agents|mesh-ancestor
44875502|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44875503|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44875504|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44875505|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875506|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875507|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875508|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44875509|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
44875510|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875511|NCT04382768|Ibuprofen|ibuprofen|mesh-list
44875512|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44875513|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875514|NCT04382768|Analgesics|analgesics|mesh-ancestor
44875515|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
44875516|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875517|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875518|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875519|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875520|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44875521|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875522|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875523|NCT04383275|Capecitabine|capecitabine|mesh-list
44875524|NCT04383275|Trastuzumab|trastuzumab|mesh-list
44875525|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44875526|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
44875527|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875528|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875529|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875530|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
44875531|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875532|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875533|NCT04383067|Aldesleukin|aldesleukin|mesh-list
44875534|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875535|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44875536|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44875537|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
44875538|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875539|NCT04382950|Tretinoin|tretinoin|mesh-list
44875540|NCT04382950|Isotretinoin|isotretinoin|mesh-list
44875541|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875542|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
44875543|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44875544|NCT04382859|Bupivacaine|bupivacaine|mesh-list
44875545|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
44875546|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
44875547|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875548|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875549|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
44875550|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875551|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875552|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
44875553|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875554|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875555|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875556|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875557|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875558|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663639|NCT01211210|Fluorouracil|fluorouracil|mesh-list
44875559|NCT04382443|Colchicine|colchicine|mesh-list
44875560|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
44875561|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875562|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44875563|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44875564|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44875565|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875566|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875567|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
44875568|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44875569|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875570|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875571|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875572|NCT04382170|Analgesics|analgesics|mesh-ancestor
44875573|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
44875574|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875575|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44875576|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875577|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875578|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875579|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875580|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875581|NCT04382079|Propolis|propolis|mesh-list
44875582|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875583|NCT04382209|Meperidine|meperidine|mesh-list
44875584|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44875585|NCT04382209|Narcotics|narcotics|mesh-ancestor
44875586|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875587|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875588|NCT04382209|Analgesics|analgesics|mesh-ancestor
44875589|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
44875590|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875591|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44875592|NCT04382300|Thalidomide|thalidomide|mesh-list
44875593|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875594|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
44875595|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875596|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
44875597|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875598|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875599|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44875600|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44875601|NCT04382300|Growth Substances|growth substances|mesh-ancestor
44875602|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
44875603|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875605|NCT04382027|Vitamin K|vitamin k|mesh-list
44875606|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
44875607|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
44875608|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875609|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44875610|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44875611|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875612|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
44875613|NCT04382027|Coagulants|coagulants|mesh-ancestor
44875614|NCT04381884|Ivermectin|ivermectin|mesh-list
44875615|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875616|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875617|NCT04381962|Azithromycin|azithromycin|mesh-list
44875618|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875619|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875620|NCT04381910|Irinotecan|irinotecan|mesh-list
44875621|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44875622|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44875623|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875624|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875625|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875626|NCT04381741|Antibodies|antibodies|mesh-list
44875627|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44875628|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
44875629|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875630|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
44875631|NCT04382144|Bupivacaine|bupivacaine|mesh-list
44875632|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
44875633|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
44875634|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875635|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875636|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
44875637|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875638|NCT04382014|Curcumin|curcumin|mesh-list
44875639|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44875640|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875641|NCT04382014|Analgesics|analgesics|mesh-ancestor
44875642|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
44875643|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875644|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875645|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875646|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875647|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875648|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875649|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875650|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
44875651|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44875652|NCT04381858|Antibodies|antibodies|mesh-list
44875653|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
44875654|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875655|NCT04381377|Bromides|bromides|mesh-list
44875656|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
44875657|NCT04381234|Citric Acid|citric acid|mesh-list
44875658|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
44875659|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
44875660|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
44875661|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44875662|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
44875663|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
44875664|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875665|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44875666|NCT04381104|Acetaminophen|acetaminophen|mesh-list
44875667|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875668|NCT04381104|Analgesics|analgesics|mesh-ancestor
44875669|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
44875670|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875671|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875672|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
44875673|NCT04380597|Betamethasone|betamethasone|mesh-list
44875674|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
44875675|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44875676|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
44875677|NCT04380597|Calcipotriene|calcipotriene|mesh-list
44875678|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44875679|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875680|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
44875681|NCT04380597|Hormones|hormones|mesh-ancestor
44875682|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875683|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875684|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875685|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875686|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
44875687|NCT04380818|Ritonavir|ritonavir|mesh-list
44875688|NCT04380818|Lopinavir|lopinavir|mesh-list
44875689|NCT04380818|Azithromycin|azithromycin|mesh-list
44875690|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875691|NCT04380818|Heparin|heparin|mesh-list
44875692|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44875693|NCT04380818|Tinzaparin|tinzaparin|mesh-list
44698615|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44698616|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698617|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698618|NCT04879823|Analgesics|analgesics|mesh-ancestor
44698619|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
44698620|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
44698621|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44698622|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698623|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44698624|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698625|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698626|NCT04870333|Ciclesonide|ciclesonide|mesh-list
44698627|NCT04870333|Niclosamide|niclosamide|mesh-list
44698628|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
44698629|NCT04870333|Hormones|hormones|mesh-ancestor
44698630|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698631|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698632|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44698633|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
44698634|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44698635|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
44698636|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44698637|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698638|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
44698639|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
44698640|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44698641|NCT04859829|Antibodies|antibodies|mesh-list
44250235|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
44698647|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698648|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698649|NCT04818957|Vitamin D|vitamin d|mesh-list
44698650|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
44698651|NCT04818957|Vitamins|vitamins|mesh-ancestor
44698652|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
44698653|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698654|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44698655|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44698656|NCT04801641|Nabilone|nabilone|mesh-list
44698657|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
44698658|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
44698659|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698660|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698661|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698662|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44698663|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44698664|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698665|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44698666|NCT04791761|Acetaminophen|acetaminophen|mesh-list
44698667|NCT04791761|Ibuprofen|ibuprofen|mesh-list
44698668|NCT04791761|Oxycodone|oxycodone|mesh-list
44698669|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
44698670|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698671|NCT04791761|Analgesics|analgesics|mesh-ancestor
44698672|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
44663863|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875694|NCT04380818|Dalteparin|dalteparin|mesh-list
44875695|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44875696|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44875697|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875698|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875699|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875700|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44875701|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44875702|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
44875703|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875704|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44875705|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44875706|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
44875707|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44875708|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44875709|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875710|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
44875711|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875712|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875713|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875714|NCT04380857|Dexamethasone|dexamethasone|mesh-list
44875715|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875716|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
44875717|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
44875718|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875719|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875720|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44875721|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
44875722|NCT04380857|Hormones|hormones|mesh-ancestor
44875723|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44875724|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44875725|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875726|NCT04380402|Atorvastatin|atorvastatin|mesh-list
44875727|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44875728|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44875729|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
44875730|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875731|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44875732|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44875733|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875734|NCT04380467|Vitamin D|vitamin d|mesh-list
44875735|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
44875736|NCT04380467|Vitamins|vitamins|mesh-ancestor
44875737|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
44875738|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875739|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875740|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44875741|NCT04380220|Protein C|protein c|mesh-list
44875742|NCT04380220|Antithrombins|antithrombins|mesh-list
44875743|NCT04380220|Protein S|protein s|mesh-list
44875744|NCT04380220|Factor VIII|factor viii|mesh-list
44875745|NCT04380220|Complement C3|complement c3|mesh-list
44875746|NCT04380220|Coagulants|coagulants|mesh-ancestor
44875747|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44875748|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875749|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875750|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875751|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
44363557|NCT01154881|Insulin|insulin|mesh-list
44875752|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44875753|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44875754|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
44875755|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875756|NCT04380376|Melphalan|melphalan|mesh-list
44875757|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44875758|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
44875759|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875760|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875761|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44875762|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875763|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
44875764|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875765|NCT04380181|Milrinone|milrinone|mesh-list
44875766|NCT04380181|Epinephrine|epinephrine|mesh-list
44875767|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875768|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875769|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875770|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875771|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875772|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875773|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44875774|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44875775|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
44875776|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875777|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875778|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875779|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
44875780|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
44875781|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44875782|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44875783|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44875784|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
44875785|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44875786|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44875787|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875788|NCT04380181|Protective Agents|protective agents|mesh-ancestor
44875789|NCT04380298|Ketorolac|ketorolac|mesh-list
44875790|NCT04380298|Epinephrine|epinephrine|mesh-list
44875791|NCT04380298|Ropivacaine|ropivacaine|mesh-list
44875792|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
44875793|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
44875794|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875795|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875796|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
44875797|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875798|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875799|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875800|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875801|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875802|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875803|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44875804|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44363618|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44363622|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
44875805|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
44875806|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875807|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875808|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
44875809|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
44875810|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44875811|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44875812|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875813|NCT04380298|Analgesics|analgesics|mesh-ancestor
44875814|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875815|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875816|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44875817|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875818|NCT04380103|Bevacizumab|bevacizumab|mesh-list
44875819|NCT04380103|Capecitabine|capecitabine|mesh-list
44875820|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
44875821|NCT04380103|Irinotecan|irinotecan|mesh-list
44875822|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875823|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875824|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44875825|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44875826|NCT04380103|Growth Substances|growth substances|mesh-ancestor
44875827|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875828|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
44875829|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44875830|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
44875831|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875832|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44363663|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44363664|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44363665|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44875833|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44875834|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875835|NCT04380012|Trastuzumab|trastuzumab|mesh-list
44875836|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875837|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875838|NCT04380025|Pycnogenols|pycnogenols|mesh-list
44875839|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44875840|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
44875841|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875842|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
44875843|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875844|NCT04380025|Protective Agents|protective agents|mesh-ancestor
44875845|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44875846|NCT04379739|Apatinib|apatinib|mesh-list
44875847|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875848|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44875849|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875850|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875851|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875852|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
44875853|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875854|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875855|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875856|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875857|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875858|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875859|NCT04379180|Bosentan|bosentan|mesh-list
44875860|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
44875861|NCT04379180|Tadalafil|tadalafil|mesh-list
44875862|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
44875863|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44875864|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44875865|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875866|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875867|NCT04379180|Urological Agents|urological agents|mesh-ancestor
44875868|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44875869|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44875870|NCT04379271|Calcium|calcium|mesh-list
44875871|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44875872|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875873|NCT04379219|Methotrexate|methotrexate|mesh-list
44875874|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44875875|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
44875876|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44875877|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875878|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44875879|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
44875880|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875881|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875882|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44875883|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875884|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44875885|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875886|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
44875887|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875888|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44875889|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
44875890|NCT04379310|Calcium|calcium|mesh-list
44875891|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44875892|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44875893|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875894|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44875895|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875896|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875897|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44875898|NCT04378972|Vitamin D|vitamin d|mesh-list
44875899|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
44875900|NCT04378972|Curcumin|curcumin|mesh-list
44875901|NCT04378972|Tramiprosate|tramiprosate|mesh-list
44875902|NCT04378972|Vitamins|vitamins|mesh-ancestor
44875903|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
44875904|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875905|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44875906|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44875907|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44875908|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44875909|NCT04378972|Analgesics|analgesics|mesh-ancestor
44875910|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
44875911|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875912|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44875913|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875914|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875915|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875916|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875917|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
44875918|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
44875919|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
44875920|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875921|NCT04379102|Anesthetics|anesthetics|mesh-list
44875922|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
44875923|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875924|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875925|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
44875926|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875927|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44875928|NCT04378868|Metronidazole|metronidazole|mesh-list
44875929|NCT04378868|Cefuroxime|cefuroxime|mesh-list
44875930|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
44875931|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44875932|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875933|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
44875934|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875935|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44875936|NCT04378608|Ribavirin|ribavirin|mesh-list
44875937|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
44875938|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875939|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
44875940|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875941|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44875942|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44875943|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44875944|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875945|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
44875946|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875947|NCT04378231|Amoxicillin|amoxicillin|mesh-list
44875948|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
44875949|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
44875950|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44698673|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698674|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698675|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
44698676|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44698677|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44698678|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698679|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44698680|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698681|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698682|NCT04791761|Narcotics|narcotics|mesh-ancestor
44698683|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698684|NCT04786093|Durvalumab|durvalumab|mesh-list
44698685|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44698686|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698687|NCT04783376|Insulin|insulin|mesh-list
44698688|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44698689|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363777|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698690|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698691|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
44698692|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44698693|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698694|NCT04767022|Paclitaxel|paclitaxel|mesh-list
44698695|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44698696|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44698697|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698698|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44698699|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44698700|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44698701|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698702|NCT04760912|Bromides|bromides|mesh-list
44698703|NCT04760912|Anesthetics|anesthetics|mesh-list
44698704|NCT04760912|Rocuronium|rocuronium|mesh-list
44698705|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698706|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698707|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
44698708|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44698709|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44875951|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44875952|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44875953|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44875954|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44875955|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875957|NCT04378283|Epinephrine|epinephrine|mesh-list
44875958|NCT04378283|Tetracaine|tetracaine|mesh-list
44875959|NCT04378283|Anesthetics|anesthetics|mesh-list
44875960|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
44875961|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44875962|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875963|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
44875964|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44875965|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44875966|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44875967|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44875968|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44875969|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875970|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44875971|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44875972|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
44875973|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44875974|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44875975|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44875976|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
44875977|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44875978|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44875979|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
44875980|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
44875981|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44875982|NCT04377867|Abatacept|abatacept|mesh-list
44875983|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44363857|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
44363858|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875984|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875985|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44875986|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44875987|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
44875988|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875989|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44875990|NCT04377789|Quercetin|quercetin|mesh-list
44875991|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
44875992|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44875993|NCT04377789|Protective Agents|protective agents|mesh-ancestor
44875994|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44875995|NCT04377646|Zinc|zinc|mesh-list
44875996|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
44875997|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
44875998|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44875999|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876000|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876001|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876002|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363859|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44018825|NCT03889444|Hormones|hormones|mesh-ancestor
44363860|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363861|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
44363862|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44363863|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
44363864|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
44363866|NCT01156584|Flucytosine|flucytosine|mesh-list
44876003|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876004|NCT04377646|Trace Elements|trace elements|mesh-ancestor
44876005|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
44876006|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876007|NCT04377386|Vitamin D|vitamin d|mesh-list
44876008|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
44876009|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
44876010|NCT04377386|Vitamins|vitamins|mesh-list
44876011|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
44876012|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876013|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44876014|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44876015|NCT04377399|Vitamin D|vitamin d|mesh-list
44876016|NCT04377399|Vitamins|vitamins|mesh-ancestor
44876017|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
44876018|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876019|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44876020|NCT04377321|Colchicine|colchicine|mesh-list
44876021|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
44876022|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876023|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
44876024|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
44876025|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
44876026|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876027|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876028|NCT04376970|Fluorometholone|fluorometholone|mesh-list
44876029|NCT04376970|Cyclosporine|cyclosporine|mesh-list
44876030|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44876031|NCT04376970|Cyclosporins|cyclosporins|mesh-list
44876032|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876033|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876034|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44876035|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
44876036|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876037|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
44876038|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876039|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876040|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876041|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44876042|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44876043|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876044|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
44876045|NCT04376970|Hormones|hormones|mesh-ancestor
44876046|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876047|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44876048|NCT04377048|Gemcitabine|gemcitabine|mesh-list
44876049|NCT04377048|Tegafur|tegafur|mesh-list
44876050|NCT04377048|Nivolumab|nivolumab|mesh-list
44876051|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44876052|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
44876053|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876054|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876055|NCT04377048|Antiviral Agents|antiviral agents|mesh-ancestor
44876056|NCT04377048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876057|NCT04377048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876058|NCT04377048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44876059|NCT04377048|Immunologic Factors|immunologic factors|mesh-ancestor
44876060|NCT04377048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876061|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44876062|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44876063|NCT04376788|Methylene Blue|methylene blue|mesh-list
44876064|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876065|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876066|NCT04376528|Cyclosporine|cyclosporine|mesh-list
44876067|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
44876068|NCT04376528|Cyclosporins|cyclosporins|mesh-list
44876069|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363920|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
44363921|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
44876070|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876071|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44876072|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
44876073|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876074|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
44876075|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876076|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876077|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876078|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44876079|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44876080|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876081|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44876082|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
44876083|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876084|NCT04376814|Ritonavir|ritonavir|mesh-list
44876085|NCT04376814|Lopinavir|lopinavir|mesh-list
44876086|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876087|NCT04376814|Favipiravir|favipiravir|mesh-list
44876088|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44698710|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44876089|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44876090|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876091|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876092|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876093|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44876094|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44876095|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
44876096|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876097|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44876098|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44876099|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
44876100|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876101|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876102|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876103|NCT04376554|Amoxicillin|amoxicillin|mesh-list
44876104|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
44876105|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
44876106|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44876107|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876108|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876109|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44876110|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876111|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876112|NCT04376541|Fentanyl|fentanyl|mesh-list
44876113|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44876114|NCT04376541|Narcotics|narcotics|mesh-ancestor
44876115|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876116|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876117|NCT04376541|Analgesics|analgesics|mesh-ancestor
44876118|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
44876119|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876120|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44876121|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44876122|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
44876123|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
44876124|NCT04376307|Anesthetics|anesthetics|mesh-list
44876125|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876126|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876127|NCT04376073|Niraparib|niraparib|mesh-list
44876128|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44876129|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876130|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876131|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876132|NCT04376086|Anesthetics|anesthetics|mesh-list
44876133|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876134|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876135|NCT04376216|Prednisone|prednisone|mesh-list
44876136|NCT04376216|Prednisolone|prednisolone|mesh-list
44876137|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876138|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
44876139|NCT04376216|Hormones|hormones|mesh-ancestor
44876140|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363976|NCT01156922|Rituximab|rituximab|mesh-list
44876141|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876142|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44876143|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876144|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
44876145|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44876146|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
44876147|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876148|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876149|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44876150|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
44876151|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44876152|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
44876153|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876154|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876155|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44364014|NCT01157026|Vitamin E|vitamin e|mesh-list
44876156|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
44876157|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
44876158|NCT04375995|Protective Agents|protective agents|mesh-ancestor
44876159|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44876160|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44876161|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876162|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876163|NCT04375852|Autoantibodies|autoantibodies|mesh-list
44876164|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
44876165|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876167|NCT04374981|Montelukast|montelukast|mesh-list
44876168|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44876169|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876170|NCT04374981|Analgesics|analgesics|mesh-ancestor
44876171|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
44876172|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876173|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876174|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876175|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876176|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44876177|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44876178|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876179|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876180|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44876181|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
44876182|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44876183|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
44876184|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876185|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44876186|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44876187|NCT04375267|Olaparib|olaparib|mesh-list
44876188|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44876189|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44876190|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876191|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876192|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876193|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44698711|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698712|NCT04760691|Tenofovir|tenofovir|mesh-list
44698713|NCT04760691|Emtricitabine|emtricitabine|mesh-list
44698714|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44698715|NCT04760691|Leuprolide|leuprolide|mesh-list
44698716|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44698717|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44698718|NCT04760691|Estradiol|estradiol|mesh-list
44698719|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44698720|NCT04760691|Estrogens|estrogens|mesh-list
44698721|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
44698722|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698723|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44364071|NCT01157455|Aspirin|aspirin|mesh-list
44698724|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44698725|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698726|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698727|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44698728|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44698729|NCT04760691|Hormones|hormones|mesh-ancestor
44698730|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698731|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698732|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44698733|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
44698734|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698735|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44698736|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44698737|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
44876194|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44876195|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
44876196|NCT04374929|Hormones|hormones|mesh-ancestor
44876197|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876198|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876199|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876200|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
44876201|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876202|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876203|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364090|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
44876204|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876205|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876206|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876207|NCT04374604|Mitogens|mitogens|mesh-list
44876208|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
44876209|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876210|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
44876211|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44876212|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876213|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876214|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876215|NCT04374318|Analgesics|analgesics|mesh-ancestor
44876216|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
44876217|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876218|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44876219|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44876220|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44876221|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
44876222|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876223|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876224|NCT04374799|Heparin|heparin|mesh-list
44876225|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
44876226|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876227|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876228|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876229|NCT04374279|Bicalutamide|bicalutamide|mesh-list
44876230|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
44876231|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
44876232|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876233|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876234|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876235|NCT04374552|Azithromycin|azithromycin|mesh-list
44876236|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876237|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876238|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876239|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
44876240|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876241|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876242|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876243|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876244|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876245|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
44876246|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44876247|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44876248|NCT04374071|Prednisolone|prednisolone|mesh-list
44876249|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
44876250|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44876251|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
44876252|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876253|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
44876254|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
44876255|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876256|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876257|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44876258|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
44876259|NCT04374071|Hormones|hormones|mesh-ancestor
44876260|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876261|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44876262|NCT04374071|Protective Agents|protective agents|mesh-ancestor
44876263|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44876264|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876265|NCT04373824|Ivermectin|ivermectin|mesh-list
44876266|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876267|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664428|NCT01216345|Cetuximab|cetuximab|mesh-list
44876268|NCT04374006|Propolis|propolis|mesh-list
44876269|NCT04374006|Dienogest|dienogest|mesh-list
44364157|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364158|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364159|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44876270|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876271|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44876272|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
44876273|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44876274|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876275|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44876276|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44876277|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44876278|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44876279|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
44876280|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876281|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44876282|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876283|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
44876284|NCT04374188|Levofloxacin|levofloxacin|mesh-list
44876285|NCT04374188|Ofloxacin|ofloxacin|mesh-list
44876286|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876287|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876288|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44876289|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44876290|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876291|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876292|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876293|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44876294|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44876295|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44876296|NCT04374188|Renal Agents|renal agents|mesh-ancestor
44876297|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
44876298|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876299|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876300|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876301|NCT04373967|Metformin|metformin|mesh-list
44876302|NCT04373967|Liraglutide|liraglutide|mesh-list
44876303|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44876304|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876305|NCT04373967|Incretins|incretins|mesh-ancestor
44876306|NCT04373967|Hormones|hormones|mesh-ancestor
44876307|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876308|NCT04373941|Lenograstim|lenograstim|mesh-list
44876309|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44876310|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
44876311|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876312|NCT04373356|Listerine|listerine|mesh-list
44876313|NCT04373356|Fluorides|fluorides|mesh-list
44876314|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
44876315|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
44876316|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
44876317|NCT04373356|Protective Agents|protective agents|mesh-ancestor
44876318|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876319|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44364186|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876320|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876321|NCT04373083|Cemiplimab|cemiplimab|mesh-list
44876322|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44876323|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876324|NCT04372849|Insulin|insulin|mesh-list
44876325|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44876326|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876327|NCT04372836|Vasopressins|vasopressins|mesh-list
44876328|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
44876329|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
44876330|NCT04372836|Coagulants|coagulants|mesh-ancestor
44876331|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44876332|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44876333|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
44876334|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876335|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876336|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
44876337|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876338|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876339|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876340|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876341|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876342|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876343|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
44876344|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44876345|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44876346|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44876347|NCT04373018|Eusol|eusol|mesh-list
44876348|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44876349|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876350|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
44876351|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876352|NCT04372732|Autoantibodies|autoantibodies|mesh-list
44876353|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
44876354|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876355|NCT04372589|Heparin|heparin|mesh-list
44876356|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
44876357|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876358|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876359|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876360|NCT04372342|Remifentanil|remifentanil|mesh-list
44876361|NCT04372342|Nalbuphine|nalbuphine|mesh-list
44876362|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44876363|NCT04372342|Narcotics|narcotics|mesh-ancestor
44876364|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876365|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876366|NCT04372342|Analgesics|analgesics|mesh-ancestor
44876367|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
44876368|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876369|NCT04372264|Acetaminophen|acetaminophen|mesh-list
44876370|NCT04372264|Ibuprofen|ibuprofen|mesh-list
44876371|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44876372|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44876373|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876374|NCT04372264|Analgesics|analgesics|mesh-ancestor
44876375|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
44876376|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876377|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876378|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876379|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876380|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44876381|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876382|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876383|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
44876384|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
44876385|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
44876386|NCT04372316|Vitamins|vitamins|mesh-ancestor
44876387|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
44876388|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876390|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
44876391|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876392|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44876393|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44876394|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876395|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876396|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44876397|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364259|NCT01158248|Panitumumab|panitumumab|mesh-list
44876398|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876399|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876400|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44876401|NCT04371874|Aspirin|aspirin|mesh-list
44876402|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44876403|NCT04371874|Captopril|captopril|mesh-list
44876404|NCT04371874|Nitrendipine|nitrendipine|mesh-list
44876405|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44876406|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876407|NCT04371874|Analgesics|analgesics|mesh-ancestor
44876408|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
44876409|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876410|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876411|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364301|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
44876412|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876413|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876414|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876415|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876416|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44876417|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44876418|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876419|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
44876420|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44876421|NCT04371874|Diuretics|diuretics|mesh-ancestor
44876422|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
44876423|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44876424|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44876425|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44876426|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876427|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44876428|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44876429|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
44364315|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44876430|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
44876431|NCT04371965|Povidone|povidone|mesh-list
44876432|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
44876433|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
44876434|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44876435|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876436|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876437|NCT04372082|Niclosamide|niclosamide|mesh-list
44876438|NCT04372082|Diltiazem|diltiazem|mesh-list
44876439|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
44876440|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876441|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876442|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876443|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876444|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876445|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876446|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44876447|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44876448|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44876449|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44876450|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876451|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
44876452|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
44876453|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44876454|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
44876455|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
44876456|NCT04371978|Linagliptin|linagliptin|mesh-list
44876457|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44876458|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876459|NCT04371978|Incretins|incretins|mesh-ancestor
44876460|NCT04371978|Hormones|hormones|mesh-ancestor
44876461|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664655|NCT01217294|Analgesics|analgesics|mesh-ancestor
44876462|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44876463|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876464|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876465|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876466|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876467|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
44876468|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876469|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876470|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876471|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876472|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876473|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876474|NCT04371757|Doxazosin|doxazosin|mesh-list
44876475|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
44876476|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44876477|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44876478|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44876479|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44876480|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364386|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876481|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876482|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876483|NCT04371601|Oseltamivir|oseltamivir|mesh-list
44876484|NCT04371601|Hormones|hormones|mesh-list
44876485|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44698738|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44698739|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698740|NCT04710641|Sorafenib|sorafenib|mesh-list
44698741|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698742|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44698743|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698744|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698745|NCT04707664|Sargramostim|sargramostim|mesh-list
44698746|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
44698747|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698748|NCT04706767|Lidocaine|lidocaine|mesh-list
44698749|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
44698750|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
44364387|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364388|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364409|NCT01159275|Lopinavir|lopinavir|mesh-list
44698751|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
44698752|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698753|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698754|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
44698755|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698756|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44698757|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44698758|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44698759|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44698760|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698761|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44698762|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698763|NCT04706767|Analgesics|analgesics|mesh-ancestor
44698764|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44698765|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44698766|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44698767|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
44698768|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698769|NCT04690686|Paclitaxel|paclitaxel|mesh-list
44698770|NCT04690686|Atezolizumab|atezolizumab|mesh-list
44698771|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44698772|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698773|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
44698774|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
44698775|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
44698776|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698777|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
44698778|NCT04682626|Vitamin D|vitamin d|mesh-list
44698779|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44698780|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698781|NCT04682626|Vitamins|vitamins|mesh-ancestor
44698782|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
44698783|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44698784|NCT04679818|Fentanyl|fentanyl|mesh-list
44698785|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
44698786|NCT04679818|Narcotics|narcotics|mesh-ancestor
44664732|NCT01217970|Ibudilast|ibudilast|mesh-list
44876486|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876487|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
44876488|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876489|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876490|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876491|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876492|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
44876493|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876494|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876495|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876496|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876497|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876498|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876499|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
44876500|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
44876501|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44876502|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876503|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876504|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876505|NCT04371224|Leucovorin|leucovorin|mesh-list
44876506|NCT04371224|Fluorouracil|fluorouracil|mesh-list
44876507|NCT04371224|Capecitabine|capecitabine|mesh-list
44876508|NCT04371224|Irinotecan|irinotecan|mesh-list
44876509|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
44876510|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876511|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44876512|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876513|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44876514|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
44876515|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876516|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44876517|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44876518|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876519|NCT04371224|Antidotes|antidotes|mesh-ancestor
44876520|NCT04371224|Protective Agents|protective agents|mesh-ancestor
44876521|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
44876522|NCT04371224|Vitamins|vitamins|mesh-ancestor
44876523|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
44876524|NCT04371575|Carbamazepine|carbamazepine|mesh-list
44876525|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
44876526|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
44876527|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
44876528|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44876529|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876530|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876531|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44876532|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876533|NCT04371575|Analgesics|analgesics|mesh-ancestor
44876534|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
44876535|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876536|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44876537|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364467|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
44876538|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876539|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44876540|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44876541|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44876542|NCT04371341|Bupivacaine|bupivacaine|mesh-list
44876543|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
44876544|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
44876545|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876546|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364489|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876547|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
44876548|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876549|NCT04371367|Avdoralimab|avdoralimab|mesh-list
44876550|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876551|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
44876552|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876553|NCT04371406|Azithromycin|azithromycin|mesh-list
44876554|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876555|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876556|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876557|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
44876558|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876559|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876560|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876561|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876562|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876563|NCT04371185|Ustekinumab|ustekinumab|mesh-list
44876565|NCT04371146|Methylphenidate|methylphenidate|mesh-list
44876566|NCT04371146|Reboxetine|reboxetine|mesh-list
44876567|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44876568|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876569|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44876570|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44876571|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44876572|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876573|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
44876574|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876575|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
44876576|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44876577|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44876578|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44876579|NCT04370977|Artesunate|artesunate|mesh-list
44876580|NCT04370977|Lumefantrine|lumefantrine|mesh-list
44876581|NCT04370977|Artemether|artemether|mesh-list
44876582|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44876583|NCT04370977|Amodiaquine|amodiaquine|mesh-list
44876584|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
44876585|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876586|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876587|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876588|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876589|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
44876590|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
44876591|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44876592|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
44876593|NCT04370782|Azithromycin|azithromycin|mesh-list
44876594|NCT04370782|Doxycycline|doxycycline|mesh-list
44364515|NCT01159847|Incretins|incretins|mesh-ancestor
44876595|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876596|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
44876597|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876598|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876599|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
44876600|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876601|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876602|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876603|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876604|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876605|NCT04370782|Astringents|astringents|mesh-ancestor
44876606|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876607|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876608|NCT04371107|Azithromycin|azithromycin|mesh-list
44876609|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876610|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876611|NCT04370431|Edaravone|edaravone|mesh-list
44876612|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44876613|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
44876614|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876615|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44876616|NCT04370431|Protective Agents|protective agents|mesh-ancestor
44876617|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876618|NCT04370262|Famotidine|famotidine|mesh-list
44876619|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44876620|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44876621|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44876622|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
44876623|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
44876624|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876625|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876626|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876627|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876628|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
44876629|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876630|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876631|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876632|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876633|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664828|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876634|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876635|NCT04370288|Ascorbic Acid|ascorbic acid|mesh-list
44876636|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
44876637|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44876638|NCT04370288|Methylene Blue|methylene blue|mesh-list
44876639|NCT04370288|Vitamins|vitamins|mesh-ancestor
44876640|NCT04370288|Micronutrients|micronutrients|mesh-ancestor
44876641|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876642|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
44876643|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876644|NCT04370288|Protective Agents|protective agents|mesh-ancestor
44876645|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
44876646|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876647|NCT04370288|Expectorants|expectorants|mesh-ancestor
44876648|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44876649|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44876650|NCT04370288|Antidotes|antidotes|mesh-ancestor
44876651|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876652|NCT04369534|Clopidogrel|clopidogrel|mesh-list
44876653|NCT04369534|Ticagrelor|ticagrelor|mesh-list
44876654|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44876655|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44876656|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44876657|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44876658|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
44876659|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876660|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876661|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876662|NCT04369586|Meplazumab|meplazumab|mesh-list
44876663|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
44876664|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876665|NCT04370080|Fluorides|fluorides|mesh-list
44876666|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
44876667|NCT04370080|Protective Agents|protective agents|mesh-ancestor
44876668|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876669|NCT04370392|Anesthetics|anesthetics|mesh-list
44876670|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
44876671|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876672|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876673|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
44876674|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876675|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
44876676|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876677|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876678|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44876679|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44876680|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876681|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876682|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876683|NCT04369222|Acetaminophen|acetaminophen|mesh-list
44876684|NCT04369222|Aspirin|aspirin|mesh-list
44876685|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
44876686|NCT04369222|Salicylates|salicylates|mesh-list
44364587|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876687|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44876688|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44876689|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876690|NCT04369222|Analgesics|analgesics|mesh-ancestor
44876691|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
44876692|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876693|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876694|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
44876695|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876696|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
44364638|NCT01160432|Narcotics|narcotics|mesh-ancestor
44364644|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44876697|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
44876698|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876699|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876700|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44876701|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876702|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876703|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876704|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876705|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44876706|NCT04368819|Allopurinol|allopurinol|mesh-list
44876707|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
44876708|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876709|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876710|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
44876711|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876712|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44876713|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
44876714|NCT04368819|Protective Agents|protective agents|mesh-ancestor
44876715|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876716|NCT04368585|Simethicone|simethicone|mesh-list
44876717|NCT04368585|Omeprazole|omeprazole|mesh-list
44876718|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44876719|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44876720|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
44876721|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
44876722|NCT04368585|TEMPO|tempo|mesh-list
44876723|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44876724|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44876725|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44876726|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876727|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876728|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
44876729|NCT04368585|Emollients|emollients|mesh-ancestor
44876730|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876731|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44876732|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
44876733|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876734|NCT04368585|Antacids|antacids|mesh-ancestor
44876735|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
44876736|NCT04368585|Protective Agents|protective agents|mesh-ancestor
44876737|NCT04368546|Sunitinib|sunitinib|mesh-list
44876738|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876739|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44876740|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44876741|NCT04368546|Growth Substances|growth substances|mesh-ancestor
44876742|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876743|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
44876744|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44876745|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876746|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876747|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
44876748|NCT04368598|Dexamethasone|dexamethasone|mesh-list
44876749|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
44876750|NCT04368598|BB 1101|bb 1101|mesh-list
44876751|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44876752|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876753|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
44876754|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
44876755|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876756|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876757|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44876758|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
44876759|NCT04368598|Hormones|hormones|mesh-ancestor
44876760|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364664|NCT01160627|Antidotes|antidotes|mesh-ancestor
44876761|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44876762|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876763|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876764|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876765|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876766|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
44876767|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876768|NCT04368598|Expectorants|expectorants|mesh-ancestor
44876769|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
44876770|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44876771|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
44876772|NCT04368598|Protective Agents|protective agents|mesh-ancestor
44876773|NCT04368598|Antidotes|antidotes|mesh-ancestor
44876774|NCT04368520|Vitamin D|vitamin d|mesh-list
44876775|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
44876776|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
44876777|NCT04368520|Vitamins|vitamins|mesh-list
44876778|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
44876779|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876780|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44876781|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44876782|NCT04368377|Aspirin|aspirin|mesh-list
44876783|NCT04368377|PENTA|penta|mesh-list
44876784|NCT04368377|Tirofiban|tirofiban|mesh-list
44876785|NCT04368377|Fondaparinux|fondaparinux|mesh-list
44876786|NCT04368377|Clopidogrel|clopidogrel|mesh-list
44876787|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44876788|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44876789|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44876790|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44876791|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
44876792|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876793|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876794|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876795|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44876796|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876797|NCT04368377|Analgesics|analgesics|mesh-ancestor
44876798|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
44876799|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876800|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876801|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876802|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876803|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876804|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44876805|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876806|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
44876807|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44876808|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
44876809|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44876810|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876811|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
44876812|NCT04368273|Antibodies|antibodies|mesh-list
44876813|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
44876814|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876815|NCT04368078|Lenvatinib|lenvatinib|mesh-list
44876816|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876817|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364729|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44876818|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876819|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876820|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44876821|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44876822|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876823|NCT04368351|Azithromycin|azithromycin|mesh-list
44876824|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876825|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876826|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876827|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
44876828|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876829|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876830|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876831|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876832|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876833|NCT04367831|Heparin|heparin|mesh-list
44876834|NCT04367831|Calcium heparin|calcium heparin|mesh-list
44876835|NCT04367831|Enoxaparin|enoxaparin|mesh-list
44876836|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
44876837|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
44876838|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876839|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876840|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876841|NCT04367818|Anesthetics|anesthetics|mesh-list
44876842|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
44876843|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876844|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876845|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
44876846|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876847|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
44876848|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44876849|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876850|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876851|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
44876852|NCT04367155|Coagulants|coagulants|mesh-ancestor
44876853|NCT04367051|Spironolactone|spironolactone|mesh-list
44876854|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44876855|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
44876856|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876857|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876858|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44876859|NCT04367051|Diuretics|diuretics|mesh-ancestor
44876860|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
44876861|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
44876862|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698787|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698788|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698789|NCT04679818|Analgesics|analgesics|mesh-ancestor
44698790|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
44698791|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698792|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44698793|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44698794|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
44698795|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
44698796|NCT04674514|Dexamethasone|dexamethasone|mesh-list
44698797|NCT04674514|Lenalidomide|lenalidomide|mesh-list
44698819|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698820|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698821|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44698822|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44698823|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
44698824|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
44698825|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44698826|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44698827|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
44698828|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698829|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698830|NCT04640636|Midazolam|midazolam|mesh-list
44698831|NCT04640636|Ketamine|ketamine|mesh-list
44698832|NCT04640636|Analgesics|analgesics|mesh-ancestor
44698833|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
44698834|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876863|NCT04366609|Methylphenidate|methylphenidate|mesh-list
44876864|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44876865|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876866|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44876867|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44876868|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44876869|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876870|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
44876871|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876872|NCT04366622|Riociguat|riociguat|mesh-list
44876873|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
44876874|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876875|NCT04366596|Paclitaxel|paclitaxel|mesh-list
44876876|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364786|NCT01161134|Meloxicam|meloxicam|mesh-list
44876877|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44876878|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
44876879|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44876880|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44876881|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876882|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
44876883|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
44876884|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
44876885|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876886|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876887|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44876888|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44876889|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44876890|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876891|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44876892|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44876893|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
44876894|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44876895|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876896|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
44364826|NCT01161186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364827|NCT01161186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44876897|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876898|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
44876899|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
44876900|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876901|NCT04366726|Abaloparatide|abaloparatide|mesh-list
44876902|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44876903|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876904|NCT04366960|Enoxaparin|enoxaparin|mesh-list
44876905|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
44876906|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44876907|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44876908|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876909|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44876910|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876911|NCT04366089|Azithromycin|azithromycin|mesh-list
44876912|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876913|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44876914|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876915|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
44876916|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876917|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876918|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876919|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876920|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876921|NCT04366050|Ramipril|ramipril|mesh-list
44876922|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44876923|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876924|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876925|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876926|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44876927|NCT04365686|Propofol|propofol|mesh-list
44876928|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44876929|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44876930|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876931|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44876932|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
44876933|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
44876934|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44876935|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44876936|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665179|NCT01219920|Leucovorin|leucovorin|mesh-list
44876937|NCT04365517|Incretins|incretins|mesh-ancestor
44876938|NCT04365517|Hormones|hormones|mesh-ancestor
44876939|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876940|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44876941|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876942|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876943|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876944|NCT04365582|Ritonavir|ritonavir|mesh-list
44876945|NCT04365582|Lopinavir|lopinavir|mesh-list
44876946|NCT04365582|Azithromycin|azithromycin|mesh-list
44876947|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
44876948|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44876949|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44876950|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
44876951|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44876952|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876953|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44876954|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44876955|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
44876956|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876957|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44876958|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44876959|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44364878|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
44876960|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
44876961|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44876962|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44876963|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44876964|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
44876965|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44876966|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
44876967|NCT04365270|Chitosan|chitosan|mesh-list
44876968|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44876969|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44876970|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
44876971|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
44876972|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44876973|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44876974|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
44876975|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44876976|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44876977|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
44876978|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
44876979|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
44876980|NCT04365270|Coagulants|coagulants|mesh-ancestor
44876981|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
44876982|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44876983|NCT04365270|Protective Agents|protective agents|mesh-ancestor
44876984|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876985|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44876986|NCT04365127|Progesterone|progesterone|mesh-list
44876987|NCT04365127|Progestins|progestins|mesh-ancestor
44876988|NCT04365127|Hormones|hormones|mesh-ancestor
44876989|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44876990|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876991|NCT04365309|Aspirin|aspirin|mesh-list
44876992|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44876993|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44876994|NCT04365309|Analgesics|analgesics|mesh-ancestor
44876995|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
44876996|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44876997|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44876998|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44876999|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877000|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44877001|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877002|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877003|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44877004|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44877005|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877006|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
44877007|NCT04365231|Azithromycin|azithromycin|mesh-list
44877008|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877009|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877010|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877011|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
44877012|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877013|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877014|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877015|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877016|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877017|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
44877018|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
44877019|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44877020|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364946|NCT01161966|Zonisamide|zonisamide|mesh-list
44364947|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
44877021|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44877022|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44877023|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44877024|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44877025|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877026|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877027|NCT04364906|Anesthetics|anesthetics|mesh-list
44877028|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877029|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877030|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877031|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
44877032|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877033|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877034|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877035|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877036|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877037|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877038|NCT04365049|Gemcitabine|gemcitabine|mesh-list
44877039|NCT04365049|Cisplatin|cisplatin|mesh-list
44877040|NCT04365049|Apatinib|apatinib|mesh-list
44877041|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877042|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877043|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
44877044|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877045|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
44877046|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877047|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877048|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877049|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
44877050|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877051|NCT04365049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44877052|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
44877053|NCT04364945|Remifentanil|remifentanil|mesh-list
44877054|NCT04364945|Sevoflurane|sevoflurane|mesh-list
44364980|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877055|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44877056|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877057|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877058|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44877059|NCT04364945|Analgesics|analgesics|mesh-ancestor
44877060|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
44877061|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877062|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44877063|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44877064|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44877065|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44877066|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877067|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877068|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44877069|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44877070|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
44877071|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
44877072|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44877073|NCT04364945|Narcotics|narcotics|mesh-ancestor
44877074|NCT04365036|Gemcitabine|gemcitabine|mesh-list
44877075|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
44877076|NCT04365036|Pegaspargase|pegaspargase|mesh-list
44877077|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877078|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
44877079|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877080|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877081|NCT04365036|Antiviral Agents|antiviral agents|mesh-ancestor
44877082|NCT04365036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877083|NCT04365036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365001|NCT01162824|Adenosine|adenosine|mesh-list
44877084|NCT04365036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877085|NCT04365036|Immunologic Factors|immunologic factors|mesh-ancestor
44877086|NCT04365036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877087|NCT04364516|Vitamin K|vitamin k|mesh-list
44877088|NCT04364516|Anticoagulants|anticoagulants|mesh-list
44665322|NCT01220570|Sirolimus|sirolimus|mesh-list
44877089|NCT04364516|Vitamins|vitamins|mesh-ancestor
44877090|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
44877091|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877092|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44877093|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877094|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877095|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
44877096|NCT04364516|Coagulants|coagulants|mesh-ancestor
44877097|NCT04364607|Neostigmine|neostigmine|mesh-list
44877098|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44877099|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877100|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877101|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
44877102|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877103|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877104|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44877105|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
44877106|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877107|NCT04364399|Vaccines|vaccines|mesh-list
44877108|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
44877109|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698835|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698836|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44698837|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44877110|NCT04364451|Asparaginase|asparaginase|mesh-list
44877111|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877112|NCT04364464|Riociguat|riociguat|mesh-list
44877113|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
44877114|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877115|NCT04364425|Triamcinolone|triamcinolone|mesh-list
44877116|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44877117|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44877118|NCT04364425|Lidocaine|lidocaine|mesh-list
44877119|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44877120|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
44877121|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
44877122|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877123|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877124|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
44877125|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877126|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44877127|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44877128|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44877129|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44877130|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877131|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877132|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
44877133|NCT04364425|Hormones|hormones|mesh-ancestor
44877134|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877135|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877136|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
44877137|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877138|NCT04364321|Diazepam|diazepam|mesh-list
44877139|NCT04364321|Clonazepam|clonazepam|mesh-list
44877140|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44877141|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
44877142|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
44877143|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
44877144|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877145|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877146|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877147|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44877148|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877149|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44877150|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44877151|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44877152|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44877153|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44877154|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44877155|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
44877156|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
44877157|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
44877158|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
44877159|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877160|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877161|NCT04364139|Metoprolol|metoprolol|mesh-list
44877162|NCT04364139|Amlodipine|amlodipine|mesh-list
44877163|NCT04364139|Ramipril|ramipril|mesh-list
44877164|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44877165|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44877166|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44877167|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877168|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44877169|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877170|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
44877171|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44877172|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
44877173|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
44877174|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877175|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44877176|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44877177|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44877178|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
44877179|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877180|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44877181|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877182|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877183|NCT04364581|Letrozole|letrozole|mesh-list
44877184|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877185|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44877186|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44877188|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877189|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44877190|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
44877191|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877192|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877193|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44877194|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877195|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877196|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
44877197|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877198|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877199|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877200|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877201|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877202|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877203|NCT04364113|Benzocaine|benzocaine|mesh-list
44877204|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
44877205|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
44877206|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877207|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877208|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
44877209|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877210|NCT04364022|Ritonavir|ritonavir|mesh-list
44877211|NCT04364022|Lopinavir|lopinavir|mesh-list
44877212|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44877213|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44877214|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877215|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877216|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877217|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44877218|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44877219|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
44877220|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877221|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44877222|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44877223|NCT04364035|Vesatolimod|vesatolimod|mesh-list
44877224|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
44877225|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877226|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877227|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
44877228|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877229|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877230|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877231|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877232|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877233|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877234|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
44877235|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877236|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
44877237|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
44877238|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
44877239|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877240|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
44877241|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877242|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877243|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877244|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877245|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877246|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877247|NCT04363203|Azithromycin|azithromycin|mesh-list
44877248|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877249|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877250|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877251|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
44877252|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877253|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877254|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877255|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877256|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877257|NCT04363255|Cisplatin|cisplatin|mesh-list
44877258|NCT04363255|Carboplatin|carboplatin|mesh-list
44877259|NCT04363255|Etoposide|etoposide|mesh-list
44365164|NCT01164046|Vitamin K|vitamin k|mesh-list
44877260|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
44877261|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877262|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44877263|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44877264|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44877265|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877266|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877267|NCT04363359|Vaccines|vaccines|mesh-list
44877268|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
44877269|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877270|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
44877271|NCT04363216|Vitamins|vitamins|mesh-ancestor
44877272|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
44877273|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877274|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
44877275|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877276|NCT04363216|Protective Agents|protective agents|mesh-ancestor
44877277|NCT04363060|Amoxicillin|amoxicillin|mesh-list
44877278|NCT04363060|Azithromycin|azithromycin|mesh-list
44877279|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
44877280|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
44877281|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44877282|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877283|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877284|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44877285|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877286|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877287|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44877288|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877289|NCT04362735|Vedolizumab|vedolizumab|mesh-list
44877290|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877291|NCT04362384|Vitamin E|vitamin e|mesh-list
44877292|NCT04362384|Prednisolone|prednisolone|mesh-list
44877293|NCT04362384|Vitamins|vitamins|mesh-ancestor
44877294|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
44877295|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877296|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877297|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
44877298|NCT04362384|Hormones|hormones|mesh-ancestor
44877299|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877300|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44877301|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877302|NCT04362384|Protective Agents|protective agents|mesh-ancestor
44877303|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
44877304|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877305|NCT04362241|Prednisolone|prednisolone|mesh-list
44877306|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44877307|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
44877308|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44877309|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
44877310|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44877311|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
44877312|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877313|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
44877314|NCT04362241|Hormones|hormones|mesh-ancestor
44877315|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365209|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44877316|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877317|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44877318|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877319|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
44877320|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
44877321|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877322|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877323|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44877324|NCT04362241|Protective Agents|protective agents|mesh-ancestor
44877325|NCT04362293|Sirolimus|sirolimus|mesh-list
44877326|NCT04362293|Plerixafor|plerixafor|mesh-list
44877327|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
44877328|NCT04362293|Thiotepa|thiotepa|mesh-list
44877329|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
44877330|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
44877331|NCT04362293|Azathioprine|azathioprine|mesh-list
44365269|NCT01164306|Nicotine|nicotine|mesh-list
44877332|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877333|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
44877334|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877335|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877336|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44877337|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
44877338|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877339|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877340|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44877341|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877342|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877343|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44877344|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
44877345|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877346|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
44877347|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877348|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44877349|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
44877350|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877351|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44877352|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44877353|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
44877354|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877355|NCT04362332|Chloroquine|chloroquine|mesh-list
44877356|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44877357|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
44877358|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877359|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877360|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877361|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877362|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877363|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877364|NCT04362332|Amebicides|amebicides|mesh-ancestor
44877365|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44877366|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44877367|NCT04362332|Analgesics|analgesics|mesh-ancestor
44877368|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
44877369|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877370|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877371|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877372|NCT04362332|Filaricides|filaricides|mesh-ancestor
44877373|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
44877374|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
44877375|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
44877376|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44877377|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
44877378|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877379|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44877380|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
44877381|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877382|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
44877383|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
44877384|NCT04361708|Leucovorin|leucovorin|mesh-list
44877385|NCT04361708|Docetaxel|docetaxel|mesh-list
44877386|NCT04361708|Fluorouracil|fluorouracil|mesh-list
44877387|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
44877388|NCT04361708|Irinotecan|irinotecan|mesh-list
44877389|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877390|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44877391|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44877392|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44877393|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877394|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
44877395|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877396|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877397|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
44877398|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877399|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44877400|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44877401|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877402|NCT04361708|Antidotes|antidotes|mesh-ancestor
44698838|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
44698839|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
44698840|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698841|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44698842|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44698843|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698844|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698845|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44698846|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44698847|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44698848|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44698849|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44698850|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
44698851|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
44250474|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
44698852|NCT04604691|Blinatumomab|blinatumomab|mesh-list
44698853|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698854|NCT04580381|Natalizumab|natalizumab|mesh-list
44698855|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
44698856|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698857|NCT04579848|Folic Acid|folic acid|mesh-list
44698858|NCT04579848|Methotrexate|methotrexate|mesh-list
44698859|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44698860|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
44698861|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698862|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698863|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365332|NCT01164761|Ramipril|ramipril|mesh-list
44698864|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
44698865|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698866|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698867|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
44698868|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698869|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44698870|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698871|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
44698872|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698873|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44698874|NCT04579848|Hematinics|hematinics|mesh-ancestor
44698875|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
44698876|NCT04579848|Vitamins|vitamins|mesh-ancestor
44698877|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
44698878|NCT04530006|Amantadine|amantadine|mesh-list
44698879|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44698880|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44698881|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
44698882|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698883|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
44698884|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877403|NCT04361708|Protective Agents|protective agents|mesh-ancestor
44877404|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
44877405|NCT04361708|Vitamins|vitamins|mesh-ancestor
44877406|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
44877407|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
44877408|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
44877409|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
44877410|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877411|NCT04361721|Erenumab|erenumab|mesh-list
44877412|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44877413|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877414|NCT04361721|Analgesics|analgesics|mesh-ancestor
44877415|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
44877416|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877417|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877418|NCT04361812|Omalizumab|omalizumab|mesh-list
44877419|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44877420|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44877421|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44877422|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44877423|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
44877424|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877425|NCT04361643|Lenalidomide|lenalidomide|mesh-list
44877426|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
44877427|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877428|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44877429|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44877430|NCT04361643|Growth Substances|growth substances|mesh-ancestor
44877431|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44877432|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877433|NCT04361513|Triamcinolone|triamcinolone|mesh-list
44877434|NCT04361513|Bupivacaine|bupivacaine|mesh-list
44877435|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
44877436|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
44877437|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877438|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877439|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
44877440|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877441|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877442|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
44365409|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44877443|NCT04361513|Hormones|hormones|mesh-ancestor
44877444|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877445|NCT04361175|Letrozole|letrozole|mesh-list
44877446|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877447|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877448|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44877449|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44877450|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877451|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44877452|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
44877453|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877454|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877455|NCT04361461|Azithromycin|azithromycin|mesh-list
44877456|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877457|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877458|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877459|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
44877460|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877461|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44365427|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
44877462|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877463|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877464|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877465|NCT04361279|Rituximab|rituximab|mesh-list
44877466|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877467|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877468|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
44877469|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877470|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877471|NCT04361188|Anesthetics|anesthetics|mesh-list
44877472|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877473|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877474|NCT04361422|Isotretinoin|isotretinoin|mesh-list
44877475|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
44877476|NCT04361331|Lenvatinib|lenvatinib|mesh-list
44877477|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877478|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44877479|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877480|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877481|NCT04361214|Leflunomide|leflunomide|mesh-list
44877482|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877483|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877484|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877485|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
44877486|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877487|NCT04361305|Tadalafil|tadalafil|mesh-list
44877488|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
44877489|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44877490|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44877491|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877492|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877493|NCT04361305|Urological Agents|urological agents|mesh-ancestor
44877494|NCT04361370|Bevacizumab|bevacizumab|mesh-list
44877495|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
44877496|NCT04361370|Olaparib|olaparib|mesh-list
44877497|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877498|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877499|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44877500|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44877501|NCT04361370|Growth Substances|growth substances|mesh-ancestor
44877502|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877503|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44877504|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44877505|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877506|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877507|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877508|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
44877509|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
44877510|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877511|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877512|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877513|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877514|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877515|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877516|NCT04361149|Capsaicin|capsaicin|mesh-list
44877517|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
44877518|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44877519|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
44877520|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877521|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365507|NCT01165866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44877522|NCT04361474|Budesonide|budesonide|mesh-list
44877523|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877524|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44877525|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
44877526|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877527|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877528|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44877529|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
44877530|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
44877531|NCT04361474|Hormones|hormones|mesh-ancestor
44877532|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877533|NCT04361058|Nivolumab|nivolumab|mesh-list
44877534|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877535|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877536|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44877537|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877538|NCT04361409|Gemcitabine|gemcitabine|mesh-list
44877539|NCT04361409|Rituximab|rituximab|mesh-list
44877540|NCT04361409|Cisplatin|cisplatin|mesh-list
44877541|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877542|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877543|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
44877544|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877545|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877546|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877547|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
44877548|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877549|NCT04361409|Antiviral Agents|antiviral agents|mesh-ancestor
44877550|NCT04361409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877551|NCT04361409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877552|NCT04361409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877553|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877554|NCT04360759|Chloroquine|chloroquine|mesh-list
44365541|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
44877555|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
44877556|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877557|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877558|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877559|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877560|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877561|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877562|NCT04360759|Amebicides|amebicides|mesh-ancestor
44877563|NCT04361032|Deferoxamine|deferoxamine|mesh-list
44877564|NCT04361032|Siderophores|siderophores|mesh-ancestor
44877565|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44877566|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
44877567|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
44877568|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877569|NCT04360824|Enoxaparin|enoxaparin|mesh-list
44877570|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
44877571|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44877572|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877573|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877574|NCT04360785|Methotrexate|methotrexate|mesh-list
44365542|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877575|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44877576|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
44877577|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44877578|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877579|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877580|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
44877581|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877582|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877583|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44877584|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877585|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44877586|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877587|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
44877588|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877589|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44877590|NCT04360655|Antibodies|antibodies|mesh-list
44877591|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44877592|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
44877593|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877594|NCT04360317|Docetaxel|docetaxel|mesh-list
44877595|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877596|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
44877597|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
44877598|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
44877599|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877600|NCT04359966|Amoxicillin|amoxicillin|mesh-list
44877601|NCT04359966|Metronidazole|metronidazole|mesh-list
44877602|NCT04359966|Clarithromycin|clarithromycin|mesh-list
44877603|NCT04359966|Levofloxacin|levofloxacin|mesh-list
44877604|NCT04359966|Ofloxacin|ofloxacin|mesh-list
44877605|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44877606|NCT04359966|Esomeprazole|esomeprazole|mesh-list
44877607|NCT04359966|Bismuth|bismuth|mesh-list
44877608|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877609|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877610|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877611|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877612|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44877613|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877614|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44877615|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365563|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
44877616|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877617|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44877618|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44877619|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44877620|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44877621|NCT04359966|Renal Agents|renal agents|mesh-ancestor
44877622|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44877623|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44877624|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877625|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44877626|NCT04359966|Antacids|antacids|mesh-ancestor
44877627|NCT04359862|Propofol|propofol|mesh-list
44877628|NCT04359862|Sevoflurane|sevoflurane|mesh-list
44877629|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44877630|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877631|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877632|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44877633|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
44877634|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
44877635|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44877636|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44877637|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
44877639|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877640|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
44877641|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877642|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44877643|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877644|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877645|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44877646|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877647|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44877648|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
44877649|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44365618|NCT01166542|Paclitaxel|paclitaxel|mesh-list
44877650|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877651|NCT04360122|Levamisole|levamisole|mesh-list
44877652|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
44877653|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44877654|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
44877655|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877656|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
44877657|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
44877658|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877659|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877660|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877661|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
44877662|NCT04360356|Ivermectin|ivermectin|mesh-list
44877663|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
44877664|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877665|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877666|NCT04360876|Dexamethasone|dexamethasone|mesh-list
44877667|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
44877668|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877669|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
44877670|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
44877671|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877672|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877673|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877674|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
44877675|NCT04360876|Hormones|hormones|mesh-ancestor
44877676|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365634|NCT01166685|Everolimus|everolimus|mesh-list
44877677|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44877678|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877679|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
44877680|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877681|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877682|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877683|NCT04359615|Favipiravir|favipiravir|mesh-list
44877684|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
44877685|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877686|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877687|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877688|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877689|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877690|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877691|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
44877692|NCT04359823|Lovastatin|lovastatin|mesh-list
44877693|NCT04359823|L 647318|l 647318|mesh-list
44877694|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
44877695|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44877696|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44877697|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
44877698|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877699|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44877700|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44877701|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666021|NCT01224951|Hormones|hormones|mesh-ancestor
44877703|NCT04359576|Coagulants|coagulants|mesh-ancestor
44877704|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877705|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
44877706|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877707|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877708|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877709|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877710|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877711|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877712|NCT04359485|Glycolic acid|glycolic acid|mesh-list
44877713|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
44877714|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44877715|NCT04359511|Prednisone|prednisone|mesh-list
44877716|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
44877717|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877718|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
44877719|NCT04359511|Hormones|hormones|mesh-ancestor
44877720|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877721|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877722|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44877723|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877724|NCT04359550|Antibodies|antibodies|mesh-list
44877725|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44877726|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
44877727|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877728|NCT04359524|Vitamin D|vitamin d|mesh-list
44877729|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
44877730|NCT04359524|Vitamins|vitamins|mesh-ancestor
44877731|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
44877732|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877733|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44877734|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44877735|NCT04359199|Cisplatin|cisplatin|mesh-list
44877736|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
44877737|NCT04359199|Nivolumab|nivolumab|mesh-list
44877738|NCT04359199|Cetuximab|cetuximab|mesh-list
44365685|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877739|NCT04359199|Durvalumab|durvalumab|mesh-list
44877740|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877741|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44877742|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44877743|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877744|NCT04359095|Tenofovir|tenofovir|mesh-list
44877745|NCT04359095|Emtricitabine|emtricitabine|mesh-list
44698885|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698886|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698887|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44698888|NCT04530006|Analgesics|analgesics|mesh-ancestor
44698889|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
44698890|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698891|NCT04525755|Nicotine|nicotine|mesh-list
44698892|NCT04525755|Varenicline|varenicline|mesh-list
44698893|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44698894|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
44698895|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44698896|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698897|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44698898|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44698899|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
44698900|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698901|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698902|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
44698903|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44698904|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
44698905|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698906|NCT04481412|Cetirizine|cetirizine|mesh-list
44698907|NCT04481412|Ethanol|ethanol|mesh-list
44698908|NCT04481412|Minoxidil|minoxidil|mesh-list
44698909|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44698910|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698911|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44698912|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698913|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44698914|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44698915|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44698916|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
44877746|NCT04359095|Colchicine|colchicine|mesh-list
44877747|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44877748|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
44877749|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877750|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44877751|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44877752|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877753|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877754|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44877755|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44877756|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44877757|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44877758|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
44877759|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44877760|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44877761|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
44877762|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877763|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44877764|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44877765|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44877766|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877767|NCT04359212|Heparin|heparin|mesh-list
44877768|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44877769|NCT04359212|Tinzaparin|tinzaparin|mesh-list
44877770|NCT04359212|Dalteparin|dalteparin|mesh-list
44877771|NCT04359212|PENTA|penta|mesh-list
44877772|NCT04359212|Fondaparinux|fondaparinux|mesh-list
44877773|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
44877774|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44877775|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877776|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877777|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44877778|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
44877779|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44877780|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877781|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877782|NCT04359316|Azithromycin|azithromycin|mesh-list
44877783|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
44877784|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44877785|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877786|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
44877787|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44877788|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44877789|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877790|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877791|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877792|NCT04358965|Misoprostol|misoprostol|mesh-list
44877793|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
44877794|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44877795|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44365772|NCT01167725|Growth Substances|growth substances|mesh-ancestor
44877796|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877797|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
44877798|NCT04358965|Coagulants|coagulants|mesh-ancestor
44877799|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44877800|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
44877801|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44877802|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877803|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44877804|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44877805|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
44877806|NCT04358614|Ritonavir|ritonavir|mesh-list
44877807|NCT04358614|Lopinavir|lopinavir|mesh-list
44877808|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44877809|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44877810|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877811|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877812|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877813|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44877814|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44877815|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
44877816|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877817|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44365806|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44877818|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44877819|NCT04358796|Perflubron|perflubron|mesh-list
44877820|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44877821|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
44877822|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44877823|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666137|NCT01225653|Latanoprost|latanoprost|mesh-list
44877824|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877825|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44877826|NCT04358627|Analgesics|analgesics|mesh-ancestor
44877827|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
44877828|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877829|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44877830|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44877831|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44877832|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44877833|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877834|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877835|NCT04358718|Anesthetics|anesthetics|mesh-list
44877836|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877837|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877838|NCT04358770|Clocortolone|clocortolone|mesh-list
44877839|NCT04358770|Fluocortolone|fluocortolone|mesh-list
44877840|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
44877841|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877842|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
44877843|NCT04358770|Hormones|hormones|mesh-ancestor
44877844|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877845|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877846|NCT04358562|Gefitinib|gefitinib|mesh-list
44877847|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877848|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44877849|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877850|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877851|NCT04358146|Locust bean gum|locust bean gum|mesh-list
44877852|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
44877853|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365864|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
44877854|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
44877855|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44877856|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44877857|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877858|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44877859|NCT04358367|Analgesics|analgesics|mesh-ancestor
44877860|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
44877861|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877862|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44877863|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44877864|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44877865|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
44877866|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44877867|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877868|NCT04358341|Doxorubicin|doxorubicin|mesh-list
44877869|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44877870|NCT04358341|Fluorouracil|fluorouracil|mesh-list
44877871|NCT04358341|Irinotecan|irinotecan|mesh-list
44877872|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44877873|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877874|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44877875|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44877876|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877877|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877878|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
44877879|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877880|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877881|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
44877882|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877883|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44877884|NCT04358432|Ezetimibe|ezetimibe|mesh-list
44877885|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44877886|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44877887|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
44877888|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877889|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44877890|NCT04358354|Fluorouracil|fluorouracil|mesh-list
44877891|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
44877892|NCT04358354|Irinotecan|irinotecan|mesh-list
44877893|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
44877894|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877895|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44877896|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877897|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44877898|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
44877899|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877900|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44877901|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44877902|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877904|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
44877905|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877906|NCT04358497|Ibuprofen|ibuprofen|mesh-list
44877907|NCT04358497|Polidocanol|polidocanol|mesh-list
44877908|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44365895|NCT01168336|Betahistine|betahistine|mesh-list
44877909|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44877910|NCT04358497|Analgesics|analgesics|mesh-ancestor
44877911|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
44877912|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44877913|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877914|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877915|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44877916|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44877917|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44877918|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877919|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44877920|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44365928|NCT01168505|Teferrol|teferrol|mesh-list
44877921|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
44877922|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44877923|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
44877924|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877925|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
44877926|NCT04358120|Protective Agents|protective agents|mesh-ancestor
44877927|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
44877928|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44877929|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
44877930|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877931|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
44877932|NCT04358055|Protective Agents|protective agents|mesh-ancestor
44877933|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44877934|NCT04358016|Terlipressin|terlipressin|mesh-list
44877935|NCT04358016|Somatostatin|somatostatin|mesh-list
44877936|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44877937|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44877938|NCT04358016|Hormones|hormones|mesh-ancestor
44877939|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877940|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877941|NCT04357522|Vaccines|vaccines|mesh-list
44877942|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44877943|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
44877944|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877945|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
44877946|NCT04357535|Giapreza|giapreza|mesh-list
44877947|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44877948|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
44877949|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44877950|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44877951|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877952|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44877953|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44877954|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
44877955|NCT04357483|Thrombin|thrombin|mesh-list
44877956|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
44877957|NCT04357483|Coagulants|coagulants|mesh-ancestor
44877958|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44877959|NCT04357392|Prednisone|prednisone|mesh-list
44877960|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877961|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44877962|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
44877963|NCT04357392|Hormones|hormones|mesh-ancestor
44877964|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44877965|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44877966|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877967|NCT04357093|Listerine|listerine|mesh-list
44877968|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
44877969|NCT04357093|Fluorides|fluorides|mesh-list
44877970|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
44877971|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
44877972|NCT04357093|Protective Agents|protective agents|mesh-ancestor
44877973|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877974|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44877975|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44877976|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44877977|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44877978|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
44877979|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877980|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
44877981|NCT04357002|Dinoprostone|dinoprostone|mesh-list
44877982|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44877983|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877984|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877985|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
44877986|NCT04357002|Coagulants|coagulants|mesh-ancestor
44877987|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
44877988|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44877989|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44877990|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44877991|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
44877992|NCT04357015|Carbetocin|carbetocin|mesh-list
44877993|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44877994|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44877995|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44877996|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
44877997|NCT04357015|Coagulants|coagulants|mesh-ancestor
44877998|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
44877999|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44698917|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
44698918|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44698919|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698920|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44698921|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
44698922|NCT04476745|Vitamin D|vitamin d|mesh-list
44698923|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
44698924|NCT04476745|Vitamins|vitamins|mesh-ancestor
44698925|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
44698926|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698927|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44698928|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44698945|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44698946|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698948|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
44698949|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44698950|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44698951|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698952|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44698953|NCT04391608|Tenofovir|tenofovir|mesh-list
44698954|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
44698955|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698956|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44698957|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44698958|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698959|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698960|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44698961|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44698962|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
44698963|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698964|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
44698965|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698966|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698967|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44878000|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878001|NCT04356872|Doxorubicin|doxorubicin|mesh-list
44878002|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44878003|NCT04356872|Ifosfamide|ifosfamide|mesh-list
44878004|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44878005|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878006|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44878007|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44878008|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366030|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44878009|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878010|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44878011|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
44878012|NCT04356508|Nivolumab|nivolumab|mesh-list
44878013|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44878014|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878015|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44878016|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878017|NCT04356677|Ribavirin|ribavirin|mesh-list
44878018|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
44878019|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878020|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
44878021|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878022|NCT04356833|Plasminogen|plasminogen|mesh-list
44878023|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44878024|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44878025|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44878026|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878027|NCT04356417|Antimalarials|antimalarials|mesh-list
44878028|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44878029|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44878030|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878031|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878032|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878033|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878034|NCT04356222|Methotrexate|methotrexate|mesh-list
44878035|NCT04356222|Durvalumab|durvalumab|mesh-list
44878036|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44878037|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
44878038|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44878039|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878040|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366069|NCT01169402|Fluconazole|fluconazole|mesh-list
44878041|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
44878042|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878043|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878044|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44878045|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878046|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44878047|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878048|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
44878049|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878050|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44878051|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44878052|NCT04356144|Thrombin|thrombin|mesh-list
44878053|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
44878054|NCT04356144|Coagulants|coagulants|mesh-ancestor
44878055|NCT04356118|Methotrexate|methotrexate|mesh-list
44878056|NCT04356118|Endostatins|endostatins|mesh-list
44878057|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44878058|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
44878059|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44878060|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878061|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878062|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
44878063|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878064|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878065|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44878066|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878067|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44878068|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878069|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
44878070|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878071|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44878072|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44878073|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44878074|NCT04356118|Growth Substances|growth substances|mesh-ancestor
44878075|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
44878076|NCT04356170|Cisplatin|cisplatin|mesh-list
44878077|NCT04356170|Docetaxel|docetaxel|mesh-list
44878078|NCT04356170|Fluorouracil|fluorouracil|mesh-list
44878079|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878080|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44878081|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44878082|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44878083|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878084|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
44878085|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878086|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878087|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
44878088|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878089|NCT04355845|Sumatriptan|sumatriptan|mesh-list
44878090|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44878091|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44878092|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44878093|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
44878094|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878095|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878096|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878097|NCT04355962|Sevoflurane|sevoflurane|mesh-list
44878098|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44878099|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44878100|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
44878101|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
44878102|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878103|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878104|NCT04355949|Vitamin D|vitamin d|mesh-list
44878105|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
44878106|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
44878107|NCT04355949|Vitamins|vitamins|mesh-list
44878108|NCT04355949|Folic Acid|folic acid|mesh-list
44878109|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
44878110|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
44878111|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
44878112|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
44878113|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878114|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44878115|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44878116|NCT04355949|Hematinics|hematinics|mesh-ancestor
44878117|NCT04355936|Telmisartan|telmisartan|mesh-list
44878118|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878119|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44366152|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
44366153|NCT01169740|Bilirubin|bilirubin|mesh-list
44366154|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
44366155|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366156|NCT01169740|Protective Agents|protective agents|mesh-ancestor
44366157|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366158|NCT01169792|Tamoxifen|tamoxifen|mesh-list
44366159|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44366160|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862976|NCT02588105|Leucovorin|leucovorin|mesh-list
44878120|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44878121|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878122|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44878123|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44878124|NCT04355806|Vaccines|vaccines|mesh-list
44878125|NCT04355806|Antibodies|antibodies|mesh-list
44878126|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
44878127|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44878128|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
44878129|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878130|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878131|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366161|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366162|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366163|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366164|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366165|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44366166|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44366167|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44878132|NCT04355598|Lidocaine|lidocaine|mesh-list
44878133|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
44878134|NCT04355598|Prilocaine|prilocaine|mesh-list
44878135|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44878136|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
44878137|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
44878138|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878139|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878140|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
44878141|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878142|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44878143|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44878144|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44878145|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44878146|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878147|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44878148|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44878149|NCT04355637|Budesonide|budesonide|mesh-list
44878150|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878151|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44878152|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
44878153|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878154|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878155|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44878156|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44878157|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
44878158|NCT04355637|Hormones|hormones|mesh-ancestor
44878159|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878160|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
44878161|NCT04355468|Anesthetics|anesthetics|mesh-list
44878162|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878163|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878164|NCT04355468|Narcotics|narcotics|mesh-ancestor
44878165|NCT04355468|Analgesics|analgesics|mesh-ancestor
44878166|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
44878167|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878168|NCT04355416|Curcumin|curcumin|mesh-list
44878169|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44878170|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44878171|NCT04355416|Analgesics|analgesics|mesh-ancestor
44878172|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
44878173|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878174|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878175|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878176|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878177|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878178|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878179|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878180|NCT04355494|Eculizumab|eculizumab|mesh-list
44878181|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44878182|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878183|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
44878184|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878185|NCT04355520|Fulvestrant|fulvestrant|mesh-list
44878186|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878187|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878188|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44878189|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44878190|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44878191|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878192|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878193|NCT04355273|Heparin|heparin|mesh-list
44878194|NCT04355273|Calcium heparin|calcium heparin|mesh-list
44878195|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
44878196|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44878197|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44878198|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878199|NCT04355429|Captopril|captopril|mesh-list
44878200|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44878201|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878202|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878203|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878204|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878205|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
44878206|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44878207|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44878208|NCT04355247|Prednisolone|prednisolone|mesh-list
44878209|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
44878210|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44878211|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
44878212|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878213|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
44878214|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
44878215|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878216|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878217|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878218|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
44878219|NCT04355247|Hormones|hormones|mesh-ancestor
44878220|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878221|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44878222|NCT04355247|Protective Agents|protective agents|mesh-ancestor
44666557|NCT01228227|Atorvastatin|atorvastatin|mesh-list
44878223|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878224|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878225|NCT04355455|Citalopram|citalopram|mesh-list
44878226|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44878227|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44878228|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44878229|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878230|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878231|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
44878232|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878233|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44878234|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44878235|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44878236|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878237|NCT04355026|Bromhexine|bromhexine|mesh-list
44878238|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
44878239|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878240|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878241|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878242|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878243|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878244|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878245|NCT04355026|Expectorants|expectorants|mesh-ancestor
44878246|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
44878247|NCT04355052|Azithromycin|azithromycin|mesh-list
44878248|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878249|NCT04355052|Camostat|camostat|mesh-list
44878250|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878251|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878252|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
44878253|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878254|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878255|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878256|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878257|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878258|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878259|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44878260|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44878261|NCT04354961|Paclitaxel|paclitaxel|mesh-list
44878262|NCT04354961|Carboplatin|carboplatin|mesh-list
44878263|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44878264|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878265|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44878266|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44878267|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44878268|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878269|NCT04355039|Dexamethasone|dexamethasone|mesh-list
44878270|NCT04355039|Pomalidomide|pomalidomide|mesh-list
44878271|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878272|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
44878273|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
44878274|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878275|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878276|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878277|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
44878278|NCT04355039|Hormones|hormones|mesh-ancestor
44878279|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878280|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878281|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878282|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
44878283|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44878284|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44878285|NCT04355039|Growth Substances|growth substances|mesh-ancestor
44878286|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44878287|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
44878288|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
44878289|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
44878290|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878291|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878292|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878293|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44878294|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44878295|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878296|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44878297|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44878298|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
44878299|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878300|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878301|NCT04355156|Axitinib|axitinib|mesh-list
44878302|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878303|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44878304|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878305|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878306|NCT04354662|Leucovorin|leucovorin|mesh-list
44878307|NCT04354662|Docetaxel|docetaxel|mesh-list
44878308|NCT04354662|Fluorouracil|fluorouracil|mesh-list
44878309|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
44878310|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878311|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
44878312|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
44878313|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
44878314|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878315|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
44878316|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878317|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878318|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
44878319|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878320|NCT04354662|Antidotes|antidotes|mesh-ancestor
44666711|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
44878321|NCT04354662|Protective Agents|protective agents|mesh-ancestor
44878322|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
44878323|NCT04354662|Vitamins|vitamins|mesh-ancestor
44878324|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
44878325|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878326|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
44878327|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878328|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878329|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878330|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698968|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
44698969|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698970|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698971|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44698972|NCT04368091|Sirolimus|sirolimus|mesh-list
44698973|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44698974|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44698975|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44698976|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44698977|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
44698978|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44698979|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
44698980|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44698981|NCT04367883|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44698982|NCT04367883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44698983|NCT04367883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44698984|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698985|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
44698986|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44698987|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44698988|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44698989|NCT04302168|Choline|choline|mesh-list
44698990|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
44698991|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44698992|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
44698993|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44698994|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44698995|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44698996|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
44698997|NCT04301271|Simvastatin|simvastatin|mesh-list
44698998|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44698999|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44699000|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
44366380|NCT01170767|Ranibizumab|ranibizumab|mesh-list
44699001|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699002|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44699003|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44699004|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699005|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
44699006|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699007|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699008|NCT04300127|Pioglitazone|pioglitazone|mesh-list
44699009|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699010|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699011|NCT04287049|Azithromycin|azithromycin|mesh-list
44699012|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699013|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699014|NCT04245644|Aspirin|aspirin|mesh-list
44699015|NCT04245644|Metformin|metformin|mesh-list
44699016|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44699017|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699018|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699019|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44699020|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699021|NCT04245644|Analgesics|analgesics|mesh-ancestor
44699022|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
44699023|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699024|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699025|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699026|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44699027|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44699028|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699029|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44699030|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44699031|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699032|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
44699033|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
44699034|NCT04238845|Vitamin A|vitamin a|mesh-list
44699035|NCT04238845|Vitamins|vitamins|mesh-ancestor
44699036|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
44878331|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878332|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878333|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44878334|NCT04354545|Lifitegrast|lifitegrast|mesh-list
44878335|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44878336|NCT04354350|Telmisartan|telmisartan|mesh-list
44878337|NCT04354350|Ramipril|ramipril|mesh-list
44878338|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878339|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44878340|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44878341|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878342|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44878343|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878344|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878345|NCT04354376|Telmisartan|telmisartan|mesh-list
44878346|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
44878347|NCT04354376|Diuretics|diuretics|mesh-list
44878348|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44878349|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44878350|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878351|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44878352|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44878353|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878354|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
44878355|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878356|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44878357|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44878358|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44878359|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
44878360|NCT04353986|Ledipasvir|ledipasvir|mesh-list
44878361|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44878362|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
44878363|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878364|NCT04353505|Dexamethasone|dexamethasone|mesh-list
44878365|NCT04353505|Ketorolac|ketorolac|mesh-list
44878366|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878367|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
44878368|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
44878369|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878370|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878371|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878372|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
44878373|NCT04353505|Hormones|hormones|mesh-ancestor
44878374|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878375|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878376|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878377|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44878378|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44878379|NCT04353505|Analgesics|analgesics|mesh-ancestor
44878380|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
44878381|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878382|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44878383|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878384|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878385|NCT04353479|Decitabine|decitabine|mesh-list
44878386|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44878387|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878388|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
44878389|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878390|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878391|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878392|NCT04353362|Amoxicillin|amoxicillin|mesh-list
44878393|NCT04353362|Metronidazole|metronidazole|mesh-list
44878394|NCT04353362|Ofloxacin|ofloxacin|mesh-list
44878395|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878396|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878397|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878398|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878399|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44878400|NCT04353362|Renal Agents|renal agents|mesh-ancestor
44878401|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44878402|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44878403|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666787|NCT01229332|Carbidopa|carbidopa|mesh-list
44878404|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878405|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878406|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44878407|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878408|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44878409|NCT04353713|Laxatives|laxatives|mesh-ancestor
44878410|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878411|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878412|NCT04353336|Chloroquine|chloroquine|mesh-list
44878413|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44878414|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
44878415|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878416|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878417|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878418|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878419|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878420|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878421|NCT04353336|Amebicides|amebicides|mesh-ancestor
44878422|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44878423|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44878424|NCT04353336|Analgesics|analgesics|mesh-ancestor
44366511|NCT01171781|Cisplatin|cisplatin|mesh-list
44366542|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
44878425|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
44878426|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878427|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878428|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878429|NCT04353336|Filaricides|filaricides|mesh-ancestor
44878430|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
44878431|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
44878433|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
44878434|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878435|NCT04353180|Tretinoin|tretinoin|mesh-list
44878436|NCT04353180|Isotretinoin|isotretinoin|mesh-list
44878437|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878438|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
44878439|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
44878440|NCT04353193|Octreotide|octreotide|mesh-list
44878441|NCT04353193|Terlipressin|terlipressin|mesh-list
44878442|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878443|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878444|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878445|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878446|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44878447|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878448|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
44878449|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878450|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878451|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878452|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878453|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878454|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878455|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878456|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
44878457|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878458|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44366543|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44366544|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366545|NCT01171885|Ropivacaine|ropivacaine|mesh-list
44366546|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
44878459|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878460|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878461|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878462|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878463|NCT04352855|Tazobactam|tazobactam|mesh-list
44878464|NCT04352855|Ceftolozane|ceftolozane|mesh-list
44878465|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44878466|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878467|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878468|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44878469|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878470|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878471|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44878472|NCT04352855|Renal Agents|renal agents|mesh-ancestor
44878473|NCT04352686|Buspirone|buspirone|mesh-list
44878474|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44878475|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44878476|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878477|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878478|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44878479|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44878480|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
44878481|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878482|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878483|NCT04352621|Ketamine|ketamine|mesh-list
44878484|NCT04352621|Analgesics|analgesics|mesh-ancestor
44878485|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
44878486|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878487|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878488|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44878489|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44878490|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
44878491|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
44878492|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878493|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44878494|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44878495|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878496|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878497|NCT04352400|Nafamostat|nafamostat|mesh-list
44878498|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44878499|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44878500|NCT04352400|Analgesics|analgesics|mesh-ancestor
44878501|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
44878502|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878503|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878504|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878505|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878506|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
44878507|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878508|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878509|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878510|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44699037|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699038|NCT04223037|Vaccines|vaccines|mesh-list
44699039|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
44699040|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699041|NCT04186663|Fluorides|fluorides|mesh-list
44699042|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
44699043|NCT04186663|Protective Agents|protective agents|mesh-ancestor
44366590|NCT01172171|Melatonin|melatonin|mesh-list
44699044|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699045|NCT04108026|Durvalumab|durvalumab|mesh-list
44699046|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699047|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699048|NCT04095104|Topiramate|topiramate|mesh-list
44699049|NCT04095104|Phentermine|phentermine|mesh-list
44699050|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
44699051|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699052|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699053|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44699054|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
44699055|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44699056|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
44699057|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
44699058|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699059|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699060|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699061|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699062|NCT04074512|Copper|copper|mesh-list
44699063|NCT04074512|Trace Elements|trace elements|mesh-ancestor
44366636|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44699064|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
44699065|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699066|NCT04044729|Cannabidiol|cannabidiol|mesh-list
44699096|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699097|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44699098|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699099|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699100|NCT03967925|Prednisone|prednisone|mesh-list
44699101|NCT03967925|Prednisolone|prednisolone|mesh-list
44699102|NCT03967925|Rituximab|rituximab|mesh-list
44699103|NCT03967925|Belimumab|belimumab|mesh-list
44699104|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699105|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699106|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
44699107|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699108|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699109|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699110|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
44699111|NCT03967925|Hormones|hormones|mesh-ancestor
44699112|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699113|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699114|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699115|NCT03954743|Vaccines|vaccines|mesh-list
44699116|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
44699117|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699118|NCT03947671|Acetaminophen|acetaminophen|mesh-list
44699119|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699120|NCT03947671|Analgesics|analgesics|mesh-ancestor
44699121|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
44699122|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699123|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699124|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
44699125|NCT03932318|Azacitidine|azacitidine|mesh-list
44699126|NCT03932318|Venetoclax|venetoclax|mesh-list
44699127|NCT03932318|Lintuzumab|lintuzumab|mesh-list
44699128|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44699129|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
44878511|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44878512|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44878513|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878514|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
44878515|NCT04352153|Febuxostat|febuxostat|mesh-list
44878516|NCT04352153|Citric Acid|citric acid|mesh-list
44878517|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
44878518|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44878519|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
44878520|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
44878521|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878522|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
44878523|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878524|NCT04352465|Methotrexate|methotrexate|mesh-list
44878525|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44878526|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
44878527|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44878528|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878529|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878530|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
44878531|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878532|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878533|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
44878534|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878535|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44878536|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878537|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
44878538|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878539|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44878540|NCT04351724|Ritonavir|ritonavir|mesh-list
44878541|NCT04351724|Lopinavir|lopinavir|mesh-list
44878542|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878543|NCT04351724|Chloroquine|chloroquine|mesh-list
44878544|NCT04351724|Remdesivir|remdesivir|mesh-list
44878545|NCT04351724|Candesartan|candesartan|mesh-list
44878546|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
44878547|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
44878548|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44878549|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44878550|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878551|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878552|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878553|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44878554|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44366713|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
44878555|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
44878556|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878557|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44878558|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878559|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
44878560|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878561|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878562|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878563|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44878564|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
44878565|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44878566|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
44878567|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44878568|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44878569|NCT04351724|Amebicides|amebicides|mesh-ancestor
44878570|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
44878571|NCT04351763|Amiodarone|amiodarone|mesh-list
44878572|NCT04351763|Verapamil|verapamil|mesh-list
44878573|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44878574|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
44878575|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44878576|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44878577|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878578|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44878579|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44878580|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878581|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878582|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44878583|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44878584|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44878585|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44878586|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44878587|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878588|NCT04352062|Amoxicillin|amoxicillin|mesh-list
44878589|NCT04352062|Levofloxacin|levofloxacin|mesh-list
44878590|NCT04352062|Ofloxacin|ofloxacin|mesh-list
44878591|NCT04352062|Melatonin|melatonin|mesh-list
44878592|NCT04352062|Pantoprazole|pantoprazole|mesh-list
44878593|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878594|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878595|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
44366765|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878596|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878597|NCT04352062|Protective Agents|protective agents|mesh-ancestor
44878598|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878599|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878600|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44878601|NCT04352062|Renal Agents|renal agents|mesh-ancestor
44878602|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44878603|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44878604|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878605|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878606|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44878607|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44366774|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863589|NCT02477644|Olaparib|olaparib|mesh-list
44878608|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44878609|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878610|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44878611|NCT04351919|Azithromycin|azithromycin|mesh-list
44878612|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878613|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878614|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878615|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
44878616|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878617|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878618|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878619|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878620|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878621|NCT04351867|Docetaxel|docetaxel|mesh-list
44878622|NCT04351867|Capecitabine|capecitabine|mesh-list
44878623|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
44878624|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878625|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44878626|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44878627|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44878628|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878629|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44878630|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
44878631|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878632|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
44878633|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878634|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44366797|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44878635|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878636|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878637|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878638|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878639|NCT04351412|Fluorides|fluorides|mesh-list
44878640|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
44878641|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
44878642|NCT04351412|Protective Agents|protective agents|mesh-ancestor
44878643|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878644|NCT04351594|Menthol|menthol|mesh-list
44878645|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
44878646|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
44878647|NCT04351347|Ivermectin|ivermectin|mesh-list
44878648|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878649|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878650|NCT04351308|Apatinib|apatinib|mesh-list
44878651|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878652|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44878653|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878654|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878655|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878656|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
44878657|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878658|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878659|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878660|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878661|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217527|NCT00473915|Xhance|xhance|mesh-list
44878662|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878663|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
44878664|NCT04351490|Vitamin D|vitamin d|mesh-list
44878665|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44878666|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878667|NCT04351490|Vitamins|vitamins|mesh-ancestor
44878668|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
44878669|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44878670|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878671|NCT04351191|Chloroquine|chloroquine|mesh-list
44878672|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
44878673|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878674|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878675|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878676|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366835|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44366837|NCT01173263|Propofol|propofol|mesh-list
44878677|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878678|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878679|NCT04351191|Amebicides|amebicides|mesh-ancestor
44878680|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
44878681|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44878682|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
44878683|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878684|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
44878685|NCT04351126|Bromocriptine|bromocriptine|mesh-list
44878686|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44878687|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44878688|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
44878689|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878690|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878691|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
44878692|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
44878693|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366851|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44878694|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878695|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878696|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
44878697|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878698|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
44878699|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44878700|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44878701|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878702|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
44878703|NCT04350645|Coagulants|coagulants|mesh-ancestor
44878704|NCT04350320|Colchicine|colchicine|mesh-list
44878705|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
44878706|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878707|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44878708|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44878709|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
44878710|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878711|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878712|NCT04350528|Pentobarbital|pentobarbital|mesh-list
44878713|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
44878714|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
44878715|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
44878716|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878717|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878718|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878719|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44878720|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44878721|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878722|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44878723|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44878724|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
44878725|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44878726|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878727|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44878728|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44878729|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
44878730|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
44878731|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
44878732|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44878733|NCT04350580|Antibodies|antibodies|mesh-list
44366892|NCT01173627|Analgesics|analgesics|mesh-ancestor
44878734|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
44878735|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878736|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44878737|NCT04350502|Amoxicillin|amoxicillin|mesh-list
44878738|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
44878739|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
44878740|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44878741|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878742|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878743|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878744|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44878745|NCT04350684|Interferons|interferons|mesh-list
44878746|NCT04350684|Ritonavir|ritonavir|mesh-list
44878747|NCT04350684|Lopinavir|lopinavir|mesh-list
44878748|NCT04350684|Interferon-beta|interferon-beta|mesh-list
44878749|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
44366908|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44878750|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878751|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878752|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
44878753|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878754|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44878755|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44878756|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878757|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878758|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878759|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44878760|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44878761|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44878762|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878763|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
44878764|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878765|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878766|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878767|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
44878768|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878769|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44878770|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878771|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
44878772|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44366924|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366925|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44878773|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878774|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878775|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878776|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878777|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878778|NCT04350671|Interferons|interferons|mesh-list
44878779|NCT04350671|Ritonavir|ritonavir|mesh-list
44878780|NCT04350671|Lopinavir|lopinavir|mesh-list
44878781|NCT04350671|Interferon-beta|interferon-beta|mesh-list
44878782|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
44878783|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878784|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878785|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
44878786|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878787|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44878788|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44878789|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
44878790|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878791|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878792|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44878793|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44366947|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44366948|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44366949|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366950|NCT01173978|Prednisolone|prednisolone|mesh-list
44878794|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44878795|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878796|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
44878797|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878798|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878799|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878800|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
44878801|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878802|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44878803|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
44878804|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44878805|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44878806|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878807|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44878808|NCT04350086|Analgesics|analgesics|mesh-ancestor
44878809|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
44878810|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878811|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44878812|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44878813|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44878814|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44878815|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699130|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699131|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699132|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699133|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699134|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44699135|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
44699136|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699137|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699138|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699139|NCT03897439|Bupropion|bupropion|mesh-list
44699140|NCT03897439|Nicotine|nicotine|mesh-list
44699141|NCT03897439|Varenicline|varenicline|mesh-list
44699142|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44699143|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
44699144|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699145|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699146|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44699147|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44699148|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44699149|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699150|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699151|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44699152|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
44699153|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44699154|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44699155|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44699156|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699157|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
44699158|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44699159|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44699160|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699161|NCT03883412|Liraglutide|liraglutide|mesh-list
44699162|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699163|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699164|NCT03883412|Incretins|incretins|mesh-ancestor
44699165|NCT03883412|Hormones|hormones|mesh-ancestor
44699166|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699167|NCT03867682|Venetoclax|venetoclax|mesh-list
44699168|NCT03867682|Lintuzumab|lintuzumab|mesh-list
44699169|NCT03867682|Spironolactone|spironolactone|mesh-list
44699170|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699172|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
44699173|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699174|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699175|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44699176|NCT03867682|Diuretics|diuretics|mesh-ancestor
44699177|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
44699178|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699179|NCT03858621|Fentanyl|fentanyl|mesh-list
44699180|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44699181|NCT03858621|Narcotics|narcotics|mesh-ancestor
44699182|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699183|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699184|NCT03858621|Analgesics|analgesics|mesh-ancestor
44699185|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
44699186|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699187|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44699188|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44699189|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
44699190|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
44699191|NCT03845270|Docetaxel|docetaxel|mesh-list
44699192|NCT03845270|Trastuzumab|trastuzumab|mesh-list
44878816|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878817|NCT04350281|Interferons|interferons|mesh-list
44878818|NCT04350281|Interferon-beta|interferon-beta|mesh-list
44878819|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878820|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
44878821|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878822|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
44878823|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878824|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
44878825|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878826|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878827|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878828|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878829|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878830|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
44878831|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878832|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44878833|NCT04349930|Cannabidiol|cannabidiol|mesh-list
44878834|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
44878835|NCT04349592|Azithromycin|azithromycin|mesh-list
44878836|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878837|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878838|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878839|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
44878840|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878841|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878842|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878843|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878844|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878845|NCT04349696|Mitiglinide|mitiglinide|mesh-list
44878846|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44878847|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878848|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878849|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
44878850|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878851|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878852|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878853|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878854|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878855|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878856|NCT04349410|Interferons|interferons|mesh-list
44878857|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
44878858|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
44878859|NCT04349410|Remdesivir|remdesivir|mesh-list
44878860|NCT04349410|Azithromycin|azithromycin|mesh-list
44878861|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878862|NCT04349410|Doxycycline|doxycycline|mesh-list
44878863|NCT04349410|Clindamycin|clindamycin|mesh-list
44878864|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
44878865|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
44878866|NCT04349410|Primaquine|primaquine|mesh-list
44878867|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
44878868|NCT04349410|Losartan|losartan|mesh-list
44878869|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878870|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
44878871|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878872|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878873|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
44878874|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
44878875|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878876|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878877|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878878|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
44878879|NCT04349410|Hormones|hormones|mesh-ancestor
44878880|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878881|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44878882|NCT04349410|Protective Agents|protective agents|mesh-ancestor
44878883|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
44878884|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878885|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
44878886|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878887|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878888|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878889|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878890|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878891|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44878892|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44878893|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44878894|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44878895|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44878896|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
44878897|NCT04349241|Favipiravir|favipiravir|mesh-list
44878898|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
44878899|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878900|NCT04348786|Amoxicillin|amoxicillin|mesh-list
44878901|NCT04348786|Doxycycline|doxycycline|mesh-list
44878902|NCT04348786|Levofloxacin|levofloxacin|mesh-list
44878903|NCT04348786|Ofloxacin|ofloxacin|mesh-list
44878904|NCT04348786|Esomeprazole|esomeprazole|mesh-list
44878905|NCT04348786|Bismuth|bismuth|mesh-list
44878906|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44878907|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44878908|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878909|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44878910|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878911|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44878912|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878913|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878914|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
44878915|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878916|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878917|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44878918|NCT04348786|Renal Agents|renal agents|mesh-ancestor
44878919|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44878920|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44878921|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878922|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44878923|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44878924|NCT04348786|Antacids|antacids|mesh-ancestor
44878925|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
44878926|NCT04348877|Antibodies|antibodies|mesh-list
44878927|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
44878928|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878929|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
44878930|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44878931|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878932|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
44878933|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878934|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878935|NCT04348006|Dexamethasone|dexamethasone|mesh-list
44878936|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
44878937|NCT04348006|Lenalidomide|lenalidomide|mesh-list
44878938|NCT04348006|Bortezomib|bortezomib|mesh-list
44878939|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878940|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
44878941|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878942|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367147|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
44878943|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44878944|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
44878945|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878946|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878947|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44878948|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878949|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
44878950|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
44878951|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44878952|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44878953|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
44878954|NCT04348006|Hormones|hormones|mesh-ancestor
44878955|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878956|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44878957|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44878958|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44878959|NCT04348006|Growth Substances|growth substances|mesh-ancestor
44367180|NCT01175161|Copper|copper|mesh-list
44878960|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44878961|NCT04347733|Triamcinolone|triamcinolone|mesh-list
44878962|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44878963|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44878964|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44878965|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44878966|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
44878967|NCT04347733|Hormones|hormones|mesh-ancestor
44878968|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44878969|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878970|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44878971|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
44878972|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878973|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878974|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44878975|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44878976|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44878977|NCT04348045|Durvalumab|durvalumab|mesh-list
44878978|NCT04348045|Olaparib|olaparib|mesh-list
44878979|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44878980|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44878981|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44878982|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878983|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878984|NCT04347889|Ascorbic Acid|ascorbic acid|mesh-list
44878985|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878986|NCT04347889|Vitamins|vitamins|mesh-ancestor
44878987|NCT04347889|Micronutrients|micronutrients|mesh-ancestor
44878988|NCT04347889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44878989|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
44878990|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44878991|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44878992|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44878993|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44878994|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44878995|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44878996|NCT04347889|Antioxidants|antioxidants|mesh-ancestor
44878997|NCT04347889|Protective Agents|protective agents|mesh-ancestor
44878998|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
44878999|NCT04347980|Dexamethasone|dexamethasone|mesh-list
44879000|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879001|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
44879002|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
44879003|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879004|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879005|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879006|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
44879007|NCT04347980|Hormones|hormones|mesh-ancestor
44879008|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879009|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879010|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879011|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
44879012|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879013|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879014|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879015|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879016|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879017|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879018|NCT04347720|Acetaminophen|acetaminophen|mesh-list
44879019|NCT04347720|Ibuprofen|ibuprofen|mesh-list
44879020|NCT04347720|Indomethacin|indomethacin|mesh-list
44879021|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879022|NCT04347720|Analgesics|analgesics|mesh-ancestor
44879023|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
44879024|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879025|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879026|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
44879027|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879028|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879029|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879030|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44879031|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879032|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879033|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
44879034|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
44879035|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44879036|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44879037|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44879038|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44879039|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879040|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879041|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879042|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879043|NCT04347577|Analgesics|analgesics|mesh-ancestor
44879044|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
44879045|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879046|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
44879047|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44879048|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
44699193|NCT03845270|Pertuzumab|pertuzumab|mesh-list
44699194|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699195|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699196|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699197|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699198|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699199|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699200|NCT03778944|Dopamine|dopamine|mesh-list
44699201|NCT03778944|Mannitol|mannitol|mesh-list
44699202|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44699203|NCT03778944|Diuretics|diuretics|mesh-ancestor
44699204|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
44699205|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699206|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44699207|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
44699208|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
44699209|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699210|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
44699211|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699212|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699213|NCT03778944|Protective Agents|protective agents|mesh-ancestor
44699214|NCT03777462|Gemcitabine|gemcitabine|mesh-list
44699215|NCT03777462|Paclitaxel|paclitaxel|mesh-list
44699216|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44699217|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44699218|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699219|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699220|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699221|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699222|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699223|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44699224|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
44699225|NCT03777462|Antiviral Agents|antiviral agents|mesh-ancestor
44699226|NCT03777462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879049|NCT04347512|Azithromycin|azithromycin|mesh-list
44879050|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879051|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44367301|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44879052|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879053|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
44879054|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879055|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879056|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879057|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879058|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879060|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879061|NCT04347252|Hormones|hormones|mesh-ancestor
44879062|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879063|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879064|NCT04346901|Methimazole|methimazole|mesh-list
44879065|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
44879066|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44879067|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879068|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879069|NCT04347031|Azithromycin|azithromycin|mesh-list
44879070|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879071|NCT04347031|Mefloquine|mefloquine|mesh-list
44879072|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879073|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879074|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
44879075|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879076|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879077|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879078|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879079|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879080|NCT04347005|Allopurinol|allopurinol|mesh-list
44879081|NCT04347005|Febuxostat|febuxostat|mesh-list
44879082|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
44879083|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879084|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879085|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
44879086|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879087|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44879088|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
44879089|NCT04347005|Protective Agents|protective agents|mesh-ancestor
44879090|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879091|NCT04347200|Anticoagulants|anticoagulants|mesh-list
44879092|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44879093|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
44879094|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
44879095|NCT04346862|Vitamins|vitamins|mesh-ancestor
44879096|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
44879097|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879098|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
44879099|NCT04346823|Sevoflurane|sevoflurane|mesh-list
44879100|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44879101|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44879102|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
44879103|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
44879104|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879105|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879106|NCT04347187|Anticoagulants|anticoagulants|mesh-list
44879107|NCT04346797|Eculizumab|eculizumab|mesh-list
44879108|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44879109|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44879110|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
44879111|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879112|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879113|NCT04346667|Chloroquine|chloroquine|mesh-list
44879114|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
44879115|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879116|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879117|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879118|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879119|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879120|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879121|NCT04346667|Amebicides|amebicides|mesh-ancestor
44879122|NCT04346407|Dronabinol|dronabinol|mesh-list
44879123|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
44879124|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879125|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44879126|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879127|NCT04346407|Analgesics|analgesics|mesh-ancestor
44879128|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
44879129|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879130|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44879131|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44879132|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879133|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879134|NCT04346407|Hormones|hormones|mesh-ancestor
44879135|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879136|NCT04346589|Antibodies|antibodies|mesh-list
44879137|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
44879138|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44879139|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
44879140|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879141|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44879142|NCT04346004|Hematinics|hematinics|mesh-ancestor
44879143|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879144|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
44879145|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879146|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879147|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879148|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879149|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879150|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879151|NCT04346277|Antibodies|antibodies|mesh-list
44879152|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44879153|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
44879154|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879155|NCT04345926|Propofol|propofol|mesh-list
44879156|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44879157|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879158|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879159|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44367392|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
44367419|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44879160|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
44879161|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
44879162|NCT04346030|Triamcinolone|triamcinolone|mesh-list
44879163|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44879164|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44879165|NCT04346030|Lidocaine|lidocaine|mesh-list
44879166|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44879167|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
44879168|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
44879169|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879170|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879171|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
44879172|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879173|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879174|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44879175|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44879176|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879177|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879178|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879179|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
44879180|NCT04346030|Hormones|hormones|mesh-ancestor
44879181|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879182|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44879183|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
44367442|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879184|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879185|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44879186|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879187|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879188|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
44879189|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
44879190|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879191|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
44879192|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879193|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44879194|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879195|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879196|NCT04345848|Heparin|heparin|mesh-list
44879197|NCT04345848|Enoxaparin|enoxaparin|mesh-list
44879198|NCT04345848|Calcium heparin|calcium heparin|mesh-list
44879199|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
44879200|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44879201|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44879202|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879203|NCT04345783|Apatinib|apatinib|mesh-list
44879204|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879205|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44879206|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879207|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879208|NCT04345432|Gabapentin|gabapentin|mesh-list
44879209|NCT04345432|Analgesics|analgesics|mesh-ancestor
44879210|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
44879211|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879212|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879213|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
44879214|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44879215|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44879216|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879217|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44879218|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44879219|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44879220|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879221|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879222|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
44879223|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879224|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
44879225|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879226|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879227|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879228|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879229|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879230|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879231|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
44879232|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44879233|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44879234|NCT04345445|Prednisolone|prednisolone|mesh-list
44879235|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
44879236|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44879237|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
44879238|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879239|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
44879240|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
44879241|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879242|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879243|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879244|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
44879245|NCT04345445|Hormones|hormones|mesh-ancestor
44367466|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
44879246|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879247|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44879248|NCT04345445|Protective Agents|protective agents|mesh-ancestor
44879249|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879250|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879251|NCT04345588|Dexamethasone|dexamethasone|mesh-list
44879252|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
44879253|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879254|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
44879255|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
44879256|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879257|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879258|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879259|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
44879260|NCT04345588|Hormones|hormones|mesh-ancestor
44879261|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879262|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879263|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879264|NCT04345458|Etanercept|etanercept|mesh-list
44879265|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879266|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879267|NCT04345458|Analgesics|analgesics|mesh-ancestor
44879268|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
44879269|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879270|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879271|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879272|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864913|NCT02166463|Antibodies|antibodies|mesh-list
44879273|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879274|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44879275|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
44879276|NCT04345419|Remdesivir|remdesivir|mesh-list
44879277|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
44879278|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879279|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
44879280|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879281|NCT04345406|Chloroquine|chloroquine|mesh-list
44699227|NCT03777462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699228|NCT03777462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699229|NCT03777462|Immunologic Factors|immunologic factors|mesh-ancestor
44699230|NCT03777462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699231|NCT03768440|Ropivacaine|ropivacaine|mesh-list
44699232|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699233|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
44699234|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699235|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699236|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
44367531|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367532|NCT01177579|Copper|copper|mesh-list
44699237|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699238|NCT03758170|Dexamethasone|dexamethasone|mesh-list
44699239|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699240|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
44699241|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
44699242|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699243|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699244|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699245|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
44699246|NCT03758170|Hormones|hormones|mesh-ancestor
44699247|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699248|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699249|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367551|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
44367552|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
44367553|NCT01177852|Ephedrine|ephedrine|mesh-list
44367554|NCT01177852|Dipropizine|dipropizine|mesh-list
44367555|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367556|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44367557|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44367558|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367559|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367560|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
44367561|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
44367562|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
44367563|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865031|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
43865032|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43865033|NCT02153580|Fludarabine|fludarabine|mesh-list
43865034|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
43865035|NCT02153580|Etoposide|etoposide|mesh-list
43865036|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
43865037|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
43865038|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865039|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
43865059|NCT02152982|Veliparib|veliparib|mesh-list
44699250|NCT03733119|TIC10 compound|tic10 compound|mesh-list
44699251|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699252|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44699253|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44699254|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699255|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
44699256|NCT03705962|Tobramycin|tobramycin|mesh-list
44699257|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699258|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699259|NCT03705338|Propofol|propofol|mesh-list
44699260|NCT03705338|Anesthetics|anesthetics|mesh-list
44699261|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
44699262|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699263|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367564|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
44699264|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699265|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44699266|NCT03704285|Propofol|propofol|mesh-list
44699267|NCT03704285|Anesthetics|anesthetics|mesh-list
44699268|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
44699269|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699270|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699271|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699272|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44699273|NCT03696537|Fludarabine|fludarabine|mesh-list
44699274|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699275|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
44699276|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699277|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699278|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699279|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699280|NCT03668951|Analgesics|analgesics|mesh-ancestor
44699281|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
44699282|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699283|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44699284|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699285|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44699286|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699287|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699288|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699289|NCT03665207|Insulin|insulin|mesh-list
44699290|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699291|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699292|NCT03661996|Lidocaine|lidocaine|mesh-list
44699293|NCT03661996|Epinephrine|epinephrine|mesh-list
44699294|NCT03661996|Capsaicin|capsaicin|mesh-list
44699295|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699296|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
44699297|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699298|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879282|NCT04345406|Enalapril|enalapril|mesh-list
44879283|NCT04345406|Captopril|captopril|mesh-list
44879284|NCT04345406|Amebicides|amebicides|mesh-ancestor
44879285|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879286|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879287|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879288|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
44879289|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879290|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44879291|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879292|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879293|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879294|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44879295|NCT04344951|Chloroquine|chloroquine|mesh-list
44879296|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44879297|NCT04344951|Amebicides|amebicides|mesh-ancestor
44879298|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879299|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879300|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879301|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
44879302|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879303|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44367627|NCT01178203|Naproxen|naproxen|mesh-list
44879304|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879305|NCT04344951|Analgesics|analgesics|mesh-ancestor
44879306|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
44879307|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879308|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879309|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879310|NCT04344951|Filaricides|filaricides|mesh-ancestor
44879311|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
44879312|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
44879313|NCT04345094|Hydroquinone|hydroquinone|mesh-list
44879314|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
44367644|NCT01178320|Niacin|niacin|mesh-list
44879315|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879316|NCT04345094|Protective Agents|protective agents|mesh-ancestor
44879317|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879318|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44879319|NCT04345276|Ritonavir|ritonavir|mesh-list
44879320|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44879321|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44879322|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879323|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879324|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879325|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44879326|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44879327|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
44879328|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879329|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44879330|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44879331|NCT04345198|Epinephrine|epinephrine|mesh-list
44879332|NCT04345198|Racepinephrine|racepinephrine|mesh-list
44879333|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
44879334|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44367648|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44367649|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44367650|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
44367651|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367652|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44367653|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44367654|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367655|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
44367656|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
44367657|NCT01178320|Vitamins|vitamins|mesh-ancestor
44879335|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44879336|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
44879337|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879338|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879339|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879340|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44879341|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44879342|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
44879343|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879344|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44879345|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
44879346|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
44879347|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
44879348|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44879349|NCT04344821|Calcium|calcium|mesh-list
44879350|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44879351|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879352|NCT04344483|Lidocaine|lidocaine|mesh-list
44879353|NCT04344483|Epinephrine|epinephrine|mesh-list
44879354|NCT04344483|Racepinephrine|racepinephrine|mesh-list
44879355|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
44879356|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
44879357|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
44879358|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879359|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879360|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
44879361|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879362|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879363|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44879364|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44879365|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879366|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879367|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44879368|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44879369|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44879370|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879371|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44879372|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44879373|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
44879374|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44879375|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
44879376|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
44879377|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
44879378|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44879379|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879380|NCT04344457|Azithromycin|azithromycin|mesh-list
44879381|NCT04344457|Indomethacin|indomethacin|mesh-list
44879382|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
44879383|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879384|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879385|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879386|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879387|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879388|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879389|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879390|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879391|NCT04344457|Analgesics|analgesics|mesh-ancestor
44879392|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
44879393|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879394|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879395|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879396|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
44879397|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
44879398|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44879399|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44879400|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879401|NCT04344756|Heparin|heparin|mesh-list
44879402|NCT04344756|Calcium heparin|calcium heparin|mesh-list
44879403|NCT04344756|Tinzaparin|tinzaparin|mesh-list
44879404|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44879405|NCT04344756|Dalteparin|dalteparin|mesh-list
44879406|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
44879407|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44879408|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44879409|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879410|NCT04344782|Bevacizumab|bevacizumab|mesh-list
44879411|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44879412|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879413|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44879414|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44879415|NCT04344782|Growth Substances|growth substances|mesh-ancestor
44879416|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879417|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
44879418|NCT04344730|Dexamethasone|dexamethasone|mesh-list
44879419|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
44879420|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879421|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
44879422|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
44879423|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879424|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879425|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879426|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
44879427|NCT04344730|Hormones|hormones|mesh-ancestor
44879428|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879429|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879430|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879431|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
44879432|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
44879433|NCT04344236|Povidone|povidone|mesh-list
44879434|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44879435|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879436|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
44879437|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
44879438|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
44879439|NCT04344288|Prednisone|prednisone|mesh-list
44879440|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879441|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
44879442|NCT04344288|Hormones|hormones|mesh-ancestor
44879443|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879444|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879445|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865490|NCT02053909|Aspirin|aspirin|mesh-list
44879446|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879447|NCT04344405|Vitamin D|vitamin d|mesh-list
44879448|NCT04344405|Vitamins|vitamins|mesh-ancestor
44879449|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
44879450|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879451|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44879452|NCT04344379|Azithromycin|azithromycin|mesh-list
44879453|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879454|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879455|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879456|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
44879457|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879458|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879459|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879460|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879461|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879462|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
44879463|NCT04344041|Vitamin D|vitamin d|mesh-list
44879464|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44879465|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879466|NCT04344041|Vitamins|vitamins|mesh-ancestor
44879467|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
44879468|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44879469|NCT04344158|Sorafenib|sorafenib|mesh-list
44879470|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879471|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44879472|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879473|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879474|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
44879475|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
44879476|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
44879477|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879478|NCT04343768|Interferons|interferons|mesh-list
44879479|NCT04343768|Ritonavir|ritonavir|mesh-list
44879480|NCT04343768|Lopinavir|lopinavir|mesh-list
44879481|NCT04343768|Interferon-beta|interferon-beta|mesh-list
44879482|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
44879483|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879484|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
44879485|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879486|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
44879487|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879488|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44879489|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44879490|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879491|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879492|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879493|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44879494|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44879495|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44879496|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44879497|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
44879498|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879499|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879500|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879501|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
44879502|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879503|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44879504|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
44879505|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44879506|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44879507|NCT04343729|Prednisolone|prednisolone|mesh-list
44879508|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
44367828|NCT01179438|Analgesics|analgesics|mesh-ancestor
44879509|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44879510|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
44879511|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879512|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
44879513|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
44879514|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879515|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865732|NCT01980823|Metformin|metformin|mesh-list
44699299|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
44699300|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699301|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44699302|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44699303|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44699304|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699305|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699306|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44879516|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879517|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
44879519|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879520|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44879521|NCT04343729|Protective Agents|protective agents|mesh-ancestor
44879522|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879523|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879524|NCT04343963|Bromides|bromides|mesh-list
44879525|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44879526|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
44879527|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44879528|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879529|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879530|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
44879531|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44879532|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879533|NCT04343326|Menthol|menthol|mesh-list
44879534|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
44879535|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44879536|NCT04343170|Folic Acid|folic acid|mesh-list
44879537|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
44879538|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
44879539|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
44879540|NCT04343170|Vitamins|vitamins|mesh-ancestor
44879541|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
44879542|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879543|NCT04343170|Hematinics|hematinics|mesh-ancestor
44879544|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
44879545|NCT04343001|Aspirin|aspirin|mesh-list
44879546|NCT04343001|Losartan|losartan|mesh-list
44879547|NCT04343001|Simvastatin|simvastatin|mesh-list
44879548|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879549|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879550|NCT04343001|Analgesics|analgesics|mesh-ancestor
44879551|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
44879552|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879553|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879554|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879555|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879556|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44879557|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44879558|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879559|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44879560|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44879561|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879562|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
44879563|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44879564|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44879565|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
44879566|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44879567|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44879568|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879569|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44879570|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44879571|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44879572|NCT04343144|Nivolumab|nivolumab|mesh-list
44879573|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44879574|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879575|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44879576|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879577|NCT04342910|Paclitaxel|paclitaxel|mesh-list
44879578|NCT04342910|Irinotecan|irinotecan|mesh-list
44879579|NCT04342910|Apatinib|apatinib|mesh-list
44879580|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44879581|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879582|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44879583|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44879584|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44879585|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879586|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44879587|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44879588|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879589|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44879590|NCT04342676|Panitumumab|panitumumab|mesh-list
44879591|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44879592|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879593|NCT04342598|Vitamin D|vitamin d|mesh-list
44879594|NCT04342598|Vitamins|vitamins|mesh-ancestor
44879595|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
44879596|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879597|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44879598|NCT04342858|Listerine|listerine|mesh-list
44879599|NCT04342858|Fluorides|fluorides|mesh-list
44879600|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
44879601|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
44879602|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879603|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
44879604|NCT04342858|Protective Agents|protective agents|mesh-ancestor
44879605|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44879606|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879607|NCT04342728|Vitamins|vitamins|mesh-list
44879608|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
44879609|NCT04342728|Zinc|zinc|mesh-list
44879610|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
44879611|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879612|NCT04342728|Trace Elements|trace elements|mesh-ancestor
44879613|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
44367934|NCT01180075|Ritonavir|ritonavir|mesh-list
44879614|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879615|NCT04342728|Protective Agents|protective agents|mesh-ancestor
44879616|NCT04342650|Chloroquine|chloroquine|mesh-list
44879617|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44879618|NCT04342650|Amebicides|amebicides|mesh-ancestor
44879619|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879620|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879621|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879622|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
44879623|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879624|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879625|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879626|NCT04342650|Analgesics|analgesics|mesh-ancestor
44879627|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
44879628|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879629|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879630|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879631|NCT04342650|Filaricides|filaricides|mesh-ancestor
44879632|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
44879633|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
44879634|NCT04342819|Empagliflozin|empagliflozin|mesh-list
44879635|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44879636|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879637|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44879638|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879639|NCT04342065|Celecoxib|celecoxib|mesh-list
44879640|NCT04342065|Pregabalin|pregabalin|mesh-list
44879641|NCT04342065|Analgesics|analgesics|mesh-ancestor
44879642|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
44879643|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879644|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879645|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
44879646|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44879647|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879648|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879649|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44879650|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44879651|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44879652|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879653|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44879654|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879655|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879656|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879657|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879658|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44879659|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44879660|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879661|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879662|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
44879663|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879664|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879665|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879666|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699307|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44879667|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879668|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879669|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879670|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
44879671|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879672|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879673|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879674|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879675|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879676|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879677|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
44879678|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44879679|NCT04342247|Testosterone|testosterone|mesh-list
44879680|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
44879681|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
44879682|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879683|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879684|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
44879685|NCT04342247|Hormones|hormones|mesh-ancestor
44879686|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879687|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879688|NCT04342247|Androgens|androgens|mesh-ancestor
44879689|NCT04342351|Valsartan|valsartan|mesh-list
44879690|NCT04342351|Perindopril|perindopril|mesh-list
44879691|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44879692|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44879693|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44879694|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44879695|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879696|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44879697|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879698|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879699|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
44879700|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879701|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879702|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44879703|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44879704|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879705|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879706|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879707|NCT04341870|Azithromycin|azithromycin|mesh-list
44879708|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879709|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879710|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879711|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
44879712|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879713|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879714|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879715|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879716|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879717|NCT04341935|Linagliptin|linagliptin|mesh-list
44879718|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44879719|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879720|NCT04341935|Incretins|incretins|mesh-ancestor
44879721|NCT04341935|Hormones|hormones|mesh-ancestor
44879722|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879723|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44879724|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879725|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879726|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879727|NCT04341831|Teicoplanin|teicoplanin|mesh-list
44879728|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879729|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879730|NCT04341844|Methylene Blue|methylene blue|mesh-list
44879731|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879732|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879733|NCT04341857|Antibodies|antibodies|mesh-list
44879734|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44879735|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
44879736|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879737|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
44879738|NCT04341402|Clotrimazole|clotrimazole|mesh-list
44879739|NCT04341402|Miconazole|miconazole|mesh-list
44879740|NCT04341402|Diclofenac|diclofenac|mesh-list
44879741|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879742|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879743|NCT04341402|Analgesics|analgesics|mesh-ancestor
44879744|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
44879745|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879746|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879747|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879748|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879749|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44879750|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879751|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879752|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879753|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44879754|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44879755|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44879756|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44879757|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
44879758|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879759|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44879760|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44879761|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44879762|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879763|NCT04341428|Lansoprazole|lansoprazole|mesh-list
44879764|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
44879765|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44879766|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879767|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44879768|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879769|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879770|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879771|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
44879772|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
44879773|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44368092|NCT01181063|Budesonide|budesonide|mesh-list
44879774|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879775|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879776|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879777|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879778|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879779|NCT04341675|Sirolimus|sirolimus|mesh-list
44879780|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879781|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879782|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44879783|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879784|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
44879785|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44879786|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
44879787|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879788|NCT04341818|Vitamin D|vitamin d|mesh-list
44879789|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
44368117|NCT01181154|Rituximab|rituximab|mesh-list
44879790|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
44879791|NCT04341818|Vitamins|vitamins|mesh-list
44879792|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
44879793|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879794|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44879795|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44879796|NCT04341727|Azithromycin|azithromycin|mesh-list
44879797|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879798|NCT04341727|Chloroquine|chloroquine|mesh-list
44879799|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44879800|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879801|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879802|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
44879803|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879804|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879805|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879806|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879807|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879808|NCT04341727|Amebicides|amebicides|mesh-ancestor
44879809|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44879810|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879811|NCT04341727|Analgesics|analgesics|mesh-ancestor
44879812|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
44879813|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879814|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879815|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879816|NCT04341727|Filaricides|filaricides|mesh-ancestor
44879817|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
44879818|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
44879820|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879821|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44879822|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44879823|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879824|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879825|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44879826|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
44879827|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879828|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879829|NCT04341207|Azithromycin|azithromycin|mesh-list
44879830|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879831|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879832|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879833|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
44879834|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879835|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879836|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879837|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879838|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879839|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
44879840|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44879841|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44879842|NCT04341038|Prednisolone|prednisolone|mesh-list
44879843|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
44879844|NCT04341038|Tacrolimus|tacrolimus|mesh-list
44879845|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44879846|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
44879847|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44879848|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
44879849|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879850|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44879851|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879852|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879853|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44879854|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
44879855|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
44879856|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879857|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699308|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699309|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699310|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44699311|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44699312|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
44699313|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44699314|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44699315|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
44699316|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
44699317|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44699318|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
44699319|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
44699320|NCT03659799|Insulin|insulin|mesh-list
44699321|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44250929|NCT03573648|Avelumab|avelumab|mesh-list
44699326|NCT03620903|Bortezomib|bortezomib|mesh-list
44699327|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699328|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699329|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
44699330|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699331|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699332|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
44699333|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699334|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699335|NCT03563690|Celecoxib|celecoxib|mesh-list
44699336|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44699337|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44879858|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
44879859|NCT04341038|Hormones|hormones|mesh-ancestor
44879860|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44879861|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44879862|NCT04341038|Protective Agents|protective agents|mesh-ancestor
44879863|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44879864|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879865|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879866|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
44879867|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879868|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879869|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879870|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879871|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879872|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879873|NCT04340869|Theobromine|theobromine|mesh-list
44879874|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44879875|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
44879876|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879877|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879878|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44879879|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
44879880|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
44879881|NCT04340778|Lidocaine|lidocaine|mesh-list
44879882|NCT04340778|Prilocaine|prilocaine|mesh-list
44879883|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44879884|NCT04340778|Dinoprostone|dinoprostone|mesh-list
44879885|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
44879886|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
44879887|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879888|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879889|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
44879890|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879891|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879892|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44879893|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44879894|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879895|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879896|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
44879897|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44879898|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44879899|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
44879900|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44879901|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879902|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44879903|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879904|NCT04340401|Capecitabine|capecitabine|mesh-list
44879905|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
44879906|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44879907|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
44879908|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879909|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44879910|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879911|NCT04340349|Bromhexine|bromhexine|mesh-list
44879912|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
44879913|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879914|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879915|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879916|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879917|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879918|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879919|NCT04340349|Expectorants|expectorants|mesh-ancestor
44879920|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
44879921|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44879922|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879923|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879924|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879926|NCT04340388|Lamivudine|lamivudine|mesh-list
44879927|NCT04340388|Zidovudine|zidovudine|mesh-list
44879928|NCT04340388|Dolutegravir|dolutegravir|mesh-list
44879929|NCT04340388|Darunavir|darunavir|mesh-list
44879930|NCT04340388|Abacavir|abacavir|mesh-list
44879931|NCT04340388|Cobicistat|cobicistat|mesh-list
44879932|NCT04340388|Rilpivirine|rilpivirine|mesh-list
44879933|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44023623|NCT00731770|Xhance|xhance|mesh-list
44879934|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
44879935|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879936|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44879937|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44879938|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879939|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879940|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44879941|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
44879942|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44879943|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44879944|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44879945|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44368287|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44879946|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44879947|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44879948|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44879949|NCT04339816|Azithromycin|azithromycin|mesh-list
44879950|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
44879951|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44879952|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44879953|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
44879954|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44879955|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44879956|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44879957|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879958|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879959|NCT04339868|Terlipressin|terlipressin|mesh-list
44879960|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44879961|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44368313|NCT01182168|Cisplatin|cisplatin|mesh-list
44879962|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44879963|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44879964|NCT04339361|Lidocaine|lidocaine|mesh-list
44879965|NCT04339361|Dinoprostone|dinoprostone|mesh-list
44879966|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
44879967|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
44879968|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879969|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879970|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
44879971|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879972|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879973|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44879974|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44879975|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879976|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368317|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
44879977|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
44879978|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44879979|NCT04339348|Lidocaine|lidocaine|mesh-list
44879980|NCT04339348|Prilocaine|prilocaine|mesh-list
44879981|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44879982|NCT04339348|Misoprostol|misoprostol|mesh-list
44879983|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
44879984|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
44879985|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44879986|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44879987|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
44879988|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44879989|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44879990|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44879991|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44879992|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44879993|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44879994|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44879995|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
44879996|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44879997|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44879998|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44879999|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
44880000|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44880001|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
44880002|NCT04338633|Calcium|calcium|mesh-list
44880003|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44880004|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880005|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44880006|NCT04338711|Tofacitinib|tofacitinib|mesh-list
44880007|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44880008|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880009|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880010|NCT04338763|Gemcitabine|gemcitabine|mesh-list
44880011|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44880012|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
44880013|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880014|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880015|NCT04338763|Antiviral Agents|antiviral agents|mesh-ancestor
44880016|NCT04338763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880017|NCT04338763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880018|NCT04338763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44880019|NCT04338763|Immunologic Factors|immunologic factors|mesh-ancestor
44880020|NCT04338763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880021|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880022|NCT04338906|Camostat|camostat|mesh-list
44880023|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
44880024|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880025|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880026|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880027|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880028|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880029|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880030|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
44880031|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44880032|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44880033|NCT04338802|Nintedanib|nintedanib|mesh-list
44880034|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023656|NCT00726180|Trastuzumab|trastuzumab|mesh-list
44880035|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44880036|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880037|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880038|NCT04338919|Aspirin|aspirin|mesh-list
44880039|NCT04338919|Ticagrelor|ticagrelor|mesh-list
44880040|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44368395|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
44880041|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880042|NCT04338919|Analgesics|analgesics|mesh-ancestor
44880043|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
44880044|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880045|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880046|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880047|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880048|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44880049|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44880050|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880051|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44880052|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880053|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880054|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
44880055|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44880056|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44880057|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44880058|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
44880059|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880060|NCT04338620|Paclitaxel|paclitaxel|mesh-list
44880061|NCT04338620|Cisplatin|cisplatin|mesh-list
44880062|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44880063|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44880064|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880065|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
44368400|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
44880066|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
44880067|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
44880068|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880069|NCT04338373|Atropine|atropine|mesh-list
44880070|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44880071|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880072|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44880073|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
44880074|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880075|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880076|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44880077|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880078|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
44880079|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
44880080|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44880081|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44880082|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44880083|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880084|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880085|NCT04338191|Leucovorin|leucovorin|mesh-list
44880086|NCT04338191|Fluorouracil|fluorouracil|mesh-list
44880087|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
44880088|NCT04338191|Irinotecan|irinotecan|mesh-list
44880089|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
44880090|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
44880091|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880092|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44880093|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880094|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44880095|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
44880096|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880097|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44880098|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44880099|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880100|NCT04338191|Antidotes|antidotes|mesh-ancestor
44880101|NCT04338191|Protective Agents|protective agents|mesh-ancestor
44880102|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
44880103|NCT04338191|Vitamins|vitamins|mesh-ancestor
44880104|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
44880105|NCT04338438|Apatinib|apatinib|mesh-list
44880106|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880107|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368432|NCT01183494|Irinotecan|irinotecan|mesh-list
44880108|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880109|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880110|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
44880111|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44880112|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44880113|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880114|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
44880115|NCT04338126|Coagulants|coagulants|mesh-ancestor
44880116|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
44880117|NCT04337879|Irinotecan|irinotecan|mesh-list
44880118|NCT04337879|Calcium|calcium|mesh-list
44880119|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44880120|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880121|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880122|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44880123|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44880124|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880125|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880126|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
44880127|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44880128|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44880129|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
44880130|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880131|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880132|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44880133|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880134|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44880135|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
44880136|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880137|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880138|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44880139|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
44880140|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
44880141|NCT04337918|Protective Agents|protective agents|mesh-ancestor
44880142|NCT04337814|Ibuprofen|ibuprofen|mesh-list
44880143|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44880144|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880145|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880146|NCT04337814|Analgesics|analgesics|mesh-ancestor
44880147|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
44880148|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880149|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880150|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880151|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880152|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880153|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880154|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880155|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
44880156|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
44880157|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880158|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44880159|NCT04337593|Pegaspargase|pegaspargase|mesh-list
44880160|NCT04337593|Basiliximab|basiliximab|mesh-list
44880161|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880162|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44880163|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
44880164|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880165|NCT04337632|Paclitaxel|paclitaxel|mesh-list
44880166|NCT04337632|Carboplatin|carboplatin|mesh-list
44880167|NCT04337632|Doxorubicin|doxorubicin|mesh-list
44880168|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44880169|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44880170|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880171|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
44880172|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
44880173|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
44880174|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880175|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44880176|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44880177|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44880178|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880179|NCT04337658|Capecitabine|capecitabine|mesh-list
44880180|NCT04337658|Trastuzumab|trastuzumab|mesh-list
44880181|NCT04337658|Fulvestrant|fulvestrant|mesh-list
44699338|NCT03563690|Analgesics|analgesics|mesh-ancestor
44699339|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
44699340|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699341|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699342|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699343|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699344|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44699345|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44699346|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699347|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699348|NCT03555877|Letrozole|letrozole|mesh-list
44699349|NCT03555877|Fulvestrant|fulvestrant|mesh-list
44699350|NCT03555877|Anastrozole|anastrozole|mesh-list
44699351|NCT03555877|Exemestane|exemestane|mesh-list
44699352|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699353|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44368537|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368538|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368539|NCT01184144|Pioglitazone|pioglitazone|mesh-list
44368540|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44368541|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368542|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
44368543|NCT01184196|Povidone|povidone|mesh-list
44368544|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
44699354|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44668801|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
44880182|NCT04337658|Pertuzumab|pertuzumab|mesh-list
44668815|NCT01250535|Warfarin|warfarin|mesh-list
44880183|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44880184|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
44880185|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880186|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880187|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44880188|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44368559|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44880189|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44880190|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44880191|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
44880192|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880193|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880195|NCT04337450|Dolutegravir|dolutegravir|mesh-list
44880196|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44880197|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44880198|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880199|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880200|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
44880201|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880202|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44880203|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44880204|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44880205|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44880206|NCT04337606|Decitabine|decitabine|mesh-list
44880207|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44880208|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
44880209|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880210|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880211|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880212|NCT04337268|Glucagon|glucagon|mesh-list
44880213|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44880214|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44880215|NCT04337268|Hormones|hormones|mesh-ancestor
44880216|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880217|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880218|NCT04337268|Incretins|incretins|mesh-ancestor
44880219|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
44368576|NCT01184404|Bosentan|bosentan|mesh-list
44880220|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44880221|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44880222|NCT04336891|Estradiol|estradiol|mesh-list
44880223|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44880224|NCT04336891|Testosterone|testosterone|mesh-list
44880225|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
44880226|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
44880227|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44880228|NCT04336891|Estrogens|estrogens|mesh-ancestor
44880229|NCT04336891|Hormones|hormones|mesh-ancestor
44880230|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880231|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880232|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44880233|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
44880234|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880235|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44880236|NCT04336891|Androgens|androgens|mesh-ancestor
44880237|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44880238|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880239|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
44880240|NCT04336904|Favipiravir|favipiravir|mesh-list
44880241|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
44880242|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880243|NCT04336917|Lidocaine|lidocaine|mesh-list
44880244|NCT04336917|Bupivacaine|bupivacaine|mesh-list
44880245|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
44880246|NCT04336917|Anesthetics|anesthetics|mesh-list
44880247|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880248|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880249|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
44880250|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880251|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880252|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44880253|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44880254|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880255|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880256|NCT04337099|Tempol|tempol|mesh-list
44880257|NCT04337099|TEMPO|tempo|mesh-list
44880258|NCT04337099|TEMPOL-H|tempol-h|mesh-list
44880259|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
44368627|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
44880260|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880261|NCT04337099|Protective Agents|protective agents|mesh-ancestor
44880262|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880263|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44880264|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880265|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44880266|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44880267|NCT04336566|Melatonin|melatonin|mesh-list
44880268|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
44880269|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880270|NCT04336566|Protective Agents|protective agents|mesh-ancestor
44880271|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880272|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880273|NCT04336332|Azithromycin|azithromycin|mesh-list
44880274|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880275|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44880276|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880277|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
44880278|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880279|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880280|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880281|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880282|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880283|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44880284|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
44880285|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880286|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
44880287|NCT04336488|Hormones|hormones|mesh-ancestor
44880288|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880289|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880290|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44880291|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
44880292|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880293|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880294|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44880295|NCT04336605|Analgesics|analgesics|mesh-list
44880296|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
44880297|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880298|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880299|NCT04336046|Bupivacaine|bupivacaine|mesh-list
44880300|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
44880301|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
44880302|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880303|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880304|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
44368690|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44880305|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880306|NCT04335786|Valsartan|valsartan|mesh-list
44880307|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44880308|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44880309|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44880310|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880311|NCT04335461|Anesthetics|anesthetics|mesh-list
44880312|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
44880313|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880314|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880315|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
44880316|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880317|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
44880318|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44880319|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44880320|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
44880321|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880322|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44880323|NCT04335383|Antibodies|antibodies|mesh-list
44880324|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
44880325|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880326|NCT04335123|Losartan|losartan|mesh-list
44880327|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880328|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44880329|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44880330|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44880331|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880332|NCT04335513|Insulin|insulin|mesh-list
44880333|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44880334|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880335|NCT04335006|Paclitaxel|paclitaxel|mesh-list
44880336|NCT04335006|Apatinib|apatinib|mesh-list
44880337|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44880338|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880339|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
44880340|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
44880341|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
44880342|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880343|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44880344|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880345|NCT04334993|Blinatumomab|blinatumomab|mesh-list
44880346|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880347|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44880348|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44880349|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44880350|NCT04334824|Diuretics|diuretics|mesh-ancestor
44880351|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
44880352|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880353|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44880354|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880355|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880356|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44880357|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880358|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
44880359|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880360|NCT04334967|Vitamins|vitamins|mesh-ancestor
44880361|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
44880362|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880363|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
44880364|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880365|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880366|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880367|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880368|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880369|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880370|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
44880371|NCT04334967|Protective Agents|protective agents|mesh-ancestor
44880372|NCT04334928|Tenofovir|tenofovir|mesh-list
44880373|NCT04334928|Emtricitabine|emtricitabine|mesh-list
44880374|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44880375|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880376|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
44880377|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880378|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44880379|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44880380|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880381|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880382|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44880383|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44880384|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
44880385|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880386|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880387|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880388|NCT04334629|Ibuprofen|ibuprofen|mesh-list
44880389|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880390|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880391|NCT04334629|Analgesics|analgesics|mesh-ancestor
44880392|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
44368761|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44880393|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880394|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880395|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880396|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880397|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880398|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880399|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880400|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44880401|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880403|NCT04334512|Vitamins|vitamins|mesh-list
44880404|NCT04334512|Ascorbic Acid|ascorbic acid|mesh-list
44880405|NCT04334512|Azithromycin|azithromycin|mesh-list
44880406|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880407|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
44368775|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44880408|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880409|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44880410|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44880411|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880412|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
44880413|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880414|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880415|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880416|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880417|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880418|NCT04334512|Antioxidants|antioxidants|mesh-ancestor
44880419|NCT04334512|Protective Agents|protective agents|mesh-ancestor
44880420|NCT04334382|Azithromycin|azithromycin|mesh-list
44880421|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880422|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44880423|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880424|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
44880425|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880426|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880427|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880428|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880429|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880430|NCT04334005|Vitamin D|vitamin d|mesh-list
44880431|NCT04334005|Vitamins|vitamins|mesh-ancestor
44880432|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
44880433|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880434|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44880435|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
44880436|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44880437|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880438|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44880439|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880440|NCT04333992|Remifentanil|remifentanil|mesh-list
44880441|NCT04333992|Propofol|propofol|mesh-list
44880442|NCT04333992|Sevoflurane|sevoflurane|mesh-list
44880443|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44880444|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880445|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880446|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44880447|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
44880448|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
44880449|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44880450|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44880451|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44880452|NCT04333992|Narcotics|narcotics|mesh-ancestor
44880453|NCT04333992|Analgesics|analgesics|mesh-ancestor
44880454|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
44880455|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880456|NCT04333628|Chloroquine|chloroquine|mesh-list
44880457|NCT04333628|Amebicides|amebicides|mesh-ancestor
44880458|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880459|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880460|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880461|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
44880462|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880463|NCT04333550|Deferoxamine|deferoxamine|mesh-list
44880464|NCT04333550|Siderophores|siderophores|mesh-ancestor
44880465|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44880466|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
44880467|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
44880468|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880469|NCT04333589|Favipiravir|favipiravir|mesh-list
44880470|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
44880471|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880472|NCT04332978|Fluticasone|fluticasone|mesh-list
44880473|NCT04332978|Xhance|xhance|mesh-list
44880474|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880475|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44880476|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
44880477|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880478|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880479|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44880480|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44368844|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
44880481|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44880482|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44880483|NCT04333095|Bupivacaine|bupivacaine|mesh-list
44880484|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
44880485|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
44880486|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880487|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880488|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
44880489|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880490|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
44880491|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44880492|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880493|NCT04332627|Neostigmine|neostigmine|mesh-list
44880494|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44880495|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368863|NCT01185847|Cisplatin|cisplatin|mesh-list
44880496|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880497|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
44880498|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880499|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880500|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44880501|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
44880502|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880503|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44880504|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44880505|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
44699355|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699356|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699357|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44699358|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
44699359|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368876|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44699360|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699361|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699362|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44699363|NCT03522584|Durvalumab|durvalumab|mesh-list
44699364|NCT03522584|Ipilimumab|ipilimumab|mesh-list
44699365|NCT03522584|Tremelimumab|tremelimumab|mesh-list
44699366|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
44699367|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44699368|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
44699369|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699370|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699371|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
44699372|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699373|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44699374|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699375|NCT03517722|Ustekinumab|ustekinumab|mesh-list
44699376|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
44699377|NCT03489018|Vaccines|vaccines|mesh-list
44699378|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44699379|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
44699380|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699381|NCT03439124|Cephalosporins|cephalosporins|mesh-list
44699382|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
44699383|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44699384|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699385|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699386|NCT03436368|Anesthetics|anesthetics|mesh-list
44699387|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699388|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699389|NCT03410355|Cortisone|cortisone|mesh-list
44699390|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699391|NCT03399617|Micronutrients|micronutrients|mesh-list
44699392|NCT03399617|Trace Elements|trace elements|mesh-list
44699393|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699394|NCT03386162|Fulvestrant|fulvestrant|mesh-list
44699395|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699396|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699397|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44699398|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44699399|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
44699400|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699401|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699402|NCT03360214|Bupivacaine|bupivacaine|mesh-list
44699403|NCT03360214|Ropivacaine|ropivacaine|mesh-list
44880506|NCT04332536|Codeine|codeine|mesh-list
44880507|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44880508|NCT04332536|Narcotics|narcotics|mesh-ancestor
44880509|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880510|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880511|NCT04332536|Analgesics|analgesics|mesh-ancestor
44880512|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
44880513|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880514|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
44880515|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880516|NCT04332809|Gentamicins|gentamicins|mesh-list
44880517|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44880518|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880519|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44880520|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368920|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44880521|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880522|NCT04332276|Dopamine|dopamine|mesh-list
44880523|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44880524|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
44880525|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
44880526|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880527|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880528|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
44880529|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880530|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880531|NCT04332276|Protective Agents|protective agents|mesh-ancestor
44880532|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
44880533|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880534|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44880535|NCT04332289|Protective Agents|protective agents|mesh-ancestor
44880536|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880537|NCT04332042|Tofacitinib|tofacitinib|mesh-list
44880538|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44880539|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880540|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880541|NCT04332094|Azithromycin|azithromycin|mesh-list
44880542|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880543|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44880544|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880545|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
44880546|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880547|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880548|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880549|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880550|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880551|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880552|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
44880553|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880554|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880555|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880556|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880557|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880558|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880559|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
44880560|NCT04331743|Analgesics|analgesics|mesh-ancestor
44880561|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
44880562|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880563|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880564|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880565|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44880566|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44880567|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368986|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880568|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880569|NCT04331626|Gemcitabine|gemcitabine|mesh-list
44880570|NCT04331626|Nivolumab|nivolumab|mesh-list
44880571|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44880572|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
44880573|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880574|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880575|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
44880576|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880577|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880578|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44880579|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
44880580|NCT04331626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880581|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44880582|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44880583|NCT04331600|Chloroquine|chloroquine|mesh-list
44880584|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44880585|NCT04331600|Amebicides|amebicides|mesh-ancestor
44880586|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880587|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880588|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880589|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
44880590|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880591|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880592|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880593|NCT04331600|Analgesics|analgesics|mesh-ancestor
44880594|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
44880595|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880596|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880597|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880598|NCT04331600|Filaricides|filaricides|mesh-ancestor
44880599|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
44880600|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
44880601|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
44880602|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44880603|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880604|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880605|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880606|NCT04331418|Analgesics|analgesics|mesh-ancestor
44880607|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
44880608|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880609|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44880610|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44880611|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44880612|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44880613|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880614|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880615|NCT04331470|Ritonavir|ritonavir|mesh-list
44699404|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699405|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
44699406|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699407|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699408|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
44699409|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699410|NCT03359239|Atezolizumab|atezolizumab|mesh-list
44699411|NCT03359239|Poly ICLC|poly iclc|mesh-list
44699412|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699413|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
44699414|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
44699415|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699416|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
44699417|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699418|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44699419|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699420|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699421|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
44699422|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44699423|NCT03328676|Protective Agents|protective agents|mesh-ancestor
44699424|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699425|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44699426|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44699427|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44699428|NCT03317405|Tamoxifen|tamoxifen|mesh-list
44699429|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44699430|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
44699431|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699432|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699433|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699434|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699435|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44699436|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44699437|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44699438|NCT03315039|Annamycin|annamycin|mesh-list
44699439|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44699440|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699441|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
44699442|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699443|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699444|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699445|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699446|NCT03289325|Analgesics|analgesics|mesh-ancestor
44699447|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
44699448|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699449|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44699450|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699451|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44699452|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699453|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699454|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699455|NCT03276533|Lidocaine|lidocaine|mesh-list
44699456|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
44699457|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699458|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
44699459|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880616|NCT04331470|Lopinavir|lopinavir|mesh-list
44880617|NCT04331470|Chloroquine|chloroquine|mesh-list
44880618|NCT04331470|Levamisole|levamisole|mesh-list
44880619|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880620|NCT04331470|Budesonide|budesonide|mesh-list
44880621|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
44880622|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44880623|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44880624|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44880625|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880626|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880627|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44880628|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44880629|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
44880630|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880631|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44880632|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44880633|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880634|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44880635|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
44880636|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880637|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880638|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44880639|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880640|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
44880641|NCT04331470|Hormones|hormones|mesh-ancestor
44880642|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880643|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44880644|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44880645|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44880646|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
44880647|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880648|NCT04331470|Amebicides|amebicides|mesh-ancestor
44880649|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880650|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880651|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
44880652|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880653|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
44880654|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
44880655|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44880656|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
44880657|NCT04331327|Mitogens|mitogens|mesh-list
44880658|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
44880659|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880660|NCT04331197|Letrozole|letrozole|mesh-list
44880661|NCT04331197|Clomiphene|clomiphene|mesh-list
44880662|NCT04331197|Enclomiphene|enclomiphene|mesh-list
44880663|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
44880664|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880665|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880666|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44880667|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44880668|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880669|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44880670|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
44880671|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880672|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880673|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44880674|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
44880675|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880676|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44880677|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44880678|NCT04331210|Diclofenac|diclofenac|mesh-list
44880679|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880680|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880681|NCT04331210|Analgesics|analgesics|mesh-ancestor
44880682|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
44880683|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880684|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880685|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880686|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880687|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880688|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880689|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880690|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44880691|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44880692|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880693|NCT04330872|Aspirin|aspirin|mesh-list
44880694|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880695|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880696|NCT04330872|Analgesics|analgesics|mesh-ancestor
44880697|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
44880698|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880699|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880700|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880701|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880702|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44880703|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44880704|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880705|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44880706|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880707|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880708|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
44880709|NCT04331093|Apatinib|apatinib|mesh-list
44880710|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880711|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44880712|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880713|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880714|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
44880715|NCT04330755|Simendan|simendan|mesh-list
44880716|NCT04330755|Analgesics|analgesics|mesh-ancestor
44880717|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
44880718|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880719|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880720|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
44880721|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880722|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880723|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
44880724|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44880725|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880726|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880727|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44880728|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
44880729|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880730|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44880731|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
44369179|NCT01187303|Ofatumumab|ofatumumab|mesh-list
44369223|NCT01187615|Cisplatin|cisplatin|mesh-list
44880732|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44880733|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44880734|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880735|NCT04330755|Protective Agents|protective agents|mesh-ancestor
44880736|NCT04330300|Losartan|losartan|mesh-list
44880737|NCT04330300|Verapamil|verapamil|mesh-list
44880738|NCT04330300|Felodipine|felodipine|mesh-list
44880739|NCT04330300|Amlodipine|amlodipine|mesh-list
44880740|NCT04330300|Valsartan|valsartan|mesh-list
44880741|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44880742|NCT04330300|Telmisartan|telmisartan|mesh-list
44880743|NCT04330300|Candesartan|candesartan|mesh-list
44880744|NCT04330300|Ramipril|ramipril|mesh-list
44880745|NCT04330300|Olmesartan|olmesartan|mesh-list
44880746|NCT04330300|Enalapril|enalapril|mesh-list
44880747|NCT04330300|Lisinopril|lisinopril|mesh-list
44369229|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44880748|NCT04330300|Irbesartan|irbesartan|mesh-list
44880749|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
44880750|NCT04330300|Diltiazem|diltiazem|mesh-list
44880751|NCT04330300|Perindopril|perindopril|mesh-list
44880752|NCT04330300|Benazepril|benazepril|mesh-list
44880753|NCT04330300|Captopril|captopril|mesh-list
44880754|NCT04330300|Indapamide|indapamide|mesh-list
44880755|NCT04330300|Nicardipine|nicardipine|mesh-list
44880756|NCT04330300|Nimodipine|nimodipine|mesh-list
44880757|NCT04330300|Quinapril|quinapril|mesh-list
44880758|NCT04330300|Metolazone|metolazone|mesh-list
44880759|NCT04330300|Trandolapril|trandolapril|mesh-list
44880760|NCT04330300|Fosinopril|fosinopril|mesh-list
44880761|NCT04330300|Eprosartan|eprosartan|mesh-list
44880762|NCT04330300|Nitrendipine|nitrendipine|mesh-list
44880763|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
44880764|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
44880765|NCT04330300|Nifedipine|nifedipine|mesh-list
44880766|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
44880767|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44880768|NCT04330300|Diuretics|diuretics|mesh-list
44369230|NCT01187719|Phenytoin|phenytoin|mesh-list
44880769|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44880770|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44880771|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880772|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44880773|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880774|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880775|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
44880776|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44880777|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880778|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
44880779|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44880780|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44880781|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880782|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
44880783|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880784|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44880785|NCT04330300|Protective Agents|protective agents|mesh-ancestor
44880786|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44880787|NCT04330547|Analgesics|analgesics|mesh-list
44880788|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
44880789|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880790|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880791|NCT04330586|Ciclesonide|ciclesonide|mesh-list
44880792|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
44880793|NCT04330586|Hormones|hormones|mesh-ancestor
44880794|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880795|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880796|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44880797|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44880798|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44880799|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880800|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
44880801|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880802|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880803|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880804|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369265|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44880805|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880806|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880807|NCT04330677|Oxytocin|oxytocin|mesh-list
44880808|NCT04330677|Estrogens|estrogens|mesh-list
44880809|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
44880810|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880811|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880812|NCT04330677|Hormones|hormones|mesh-ancestor
44880813|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880814|NCT04330027|Mitogens|mitogens|mesh-list
44880815|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44880816|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880817|NCT04330638|Siltuximab|siltuximab|mesh-list
44880818|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44880819|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880820|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880821|NCT04330326|Sorbitol|sorbitol|mesh-list
44880822|NCT04330326|Cathartics|cathartics|mesh-ancestor
44880823|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44880824|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880825|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
44880826|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880827|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880828|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880829|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880830|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880831|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880832|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
44880833|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44880834|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44880835|NCT04329650|Prednisolone|prednisolone|mesh-list
44880836|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
44880837|NCT04329650|Siltuximab|siltuximab|mesh-list
44880838|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44880839|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
44880840|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880841|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
44880842|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
44880843|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880844|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880845|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44880846|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
44880847|NCT04329650|Hormones|hormones|mesh-ancestor
44880848|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44880849|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44880850|NCT04329650|Protective Agents|protective agents|mesh-ancestor
44880851|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44880852|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880853|NCT04329858|Methamphetamine|methamphetamine|mesh-list
44880854|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44699460|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699461|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
44699462|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699463|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44699464|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44699465|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44699466|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699467|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699468|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699469|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699470|NCT03276533|Analgesics|analgesics|mesh-ancestor
44699471|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44699472|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699498|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699499|NCT03191240|Vasopressins|vasopressins|mesh-list
44699500|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
44699501|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
44699502|NCT03191240|Coagulants|coagulants|mesh-ancestor
44699503|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44699504|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44699505|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
44699506|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699508|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44699509|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
44699510|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44699511|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44699512|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44699513|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699514|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699515|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
44699516|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699517|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699518|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44699519|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44699520|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251183|NCT05335460|Capecitabine|capecitabine|mesh-list
44699521|NCT03141671|Prednisone|prednisone|mesh-list
44699522|NCT03141671|Bicalutamide|bicalutamide|mesh-list
44699523|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699524|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
44699525|NCT03141671|Hormones|hormones|mesh-ancestor
44699526|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699527|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699528|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699529|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699530|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
44699531|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
44699532|NCT03137173|Vancomycin|vancomycin|mesh-list
44699533|NCT03137173|Aztreonam|aztreonam|mesh-list
44699534|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
44699535|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44699536|NCT03137173|Cephalosporins|cephalosporins|mesh-list
44699537|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699538|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699539|NCT03110107|Nivolumab|nivolumab|mesh-list
44699540|NCT03110107|Ipilimumab|ipilimumab|mesh-list
44369374|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699541|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699542|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699543|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44699544|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699545|NCT03092011|Clonidine|clonidine|mesh-list
44699546|NCT03092011|Morphine|morphine|mesh-list
44699547|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44699548|NCT03092011|Narcotics|narcotics|mesh-ancestor
44699549|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699550|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699551|NCT03092011|Analgesics|analgesics|mesh-ancestor
44699552|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
44669583|NCT01256489|Infliximab|infliximab|mesh-list
44880855|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880856|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
44880857|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
44880858|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880859|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
44880860|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880861|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880862|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
44880863|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44880864|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44880865|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880866|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44880867|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
44880868|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
44880869|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880870|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44369404|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880871|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880872|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880873|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880874|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880875|NCT04329585|Flumazenil|flumazenil|mesh-list
44880876|NCT04329585|Antidotes|antidotes|mesh-ancestor
44880877|NCT04329585|Protective Agents|protective agents|mesh-ancestor
44880878|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880879|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
44880880|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
44880881|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880882|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880884|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880885|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880886|NCT04329403|Analgesics|analgesics|mesh-ancestor
44880887|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
44880888|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880889|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880890|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880891|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880892|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44880893|NCT04329390|Anticoagulants|anticoagulants|mesh-list
44880894|NCT04329130|Lenalidomide|lenalidomide|mesh-list
44880895|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
44880896|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880897|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44880898|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44880899|NCT04329130|Growth Substances|growth substances|mesh-ancestor
44880900|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44880901|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880902|NCT04329429|Trastuzumab|trastuzumab|mesh-list
44880903|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44880904|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44880905|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
44880906|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44880907|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880908|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880909|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880910|NCT04329091|Analgesics|analgesics|mesh-ancestor
44880911|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
44880912|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880913|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44880914|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44880915|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44880916|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44880917|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44880918|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880919|NCT04328870|Oxytocin|oxytocin|mesh-list
44880920|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880921|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
44880922|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880923|NCT04328805|Ibuprofen|ibuprofen|mesh-list
44880924|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880925|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880926|NCT04328805|Analgesics|analgesics|mesh-ancestor
44880927|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
44880928|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880929|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880930|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880931|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880932|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880933|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880934|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880935|NCT04329000|Esomeprazole|esomeprazole|mesh-list
44880936|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44880937|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44880938|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44880939|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880940|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880941|NCT04328883|Aspirin|aspirin|mesh-list
44880942|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880943|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880944|NCT04328883|Analgesics|analgesics|mesh-ancestor
44880945|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
44880946|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880947|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880948|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880949|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880950|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44880951|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44880952|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880953|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44880954|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44880955|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44880956|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
44880957|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
44880958|NCT04328636|Analgesics|analgesics|mesh-ancestor
44880959|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
44880960|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880961|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880962|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
44880963|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44880964|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44880965|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
44880966|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44880967|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44880968|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44880969|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44880970|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
44880971|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44880972|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
44880973|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44880974|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369508|NCT01189214|Memantine|memantine|mesh-list
44880975|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
44880976|NCT04328493|Chloroquine|chloroquine|mesh-list
44880977|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44880978|NCT04328493|Amebicides|amebicides|mesh-ancestor
44880979|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44880980|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44880981|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44880982|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
44880983|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880984|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44880985|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44880986|NCT04328493|Analgesics|analgesics|mesh-ancestor
44880987|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
44880988|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44880989|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44880990|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44880991|NCT04328493|Filaricides|filaricides|mesh-ancestor
44369517|NCT01189253|Doxorubicin|doxorubicin|mesh-list
44880992|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
44880993|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
44880994|NCT04328480|Colchicine|colchicine|mesh-list
44880995|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
44880996|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44880997|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
44880998|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
44880999|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881000|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881001|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881002|NCT04328272|Azithromycin|azithromycin|mesh-list
44881003|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881004|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881005|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881006|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
44881007|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881008|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881009|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881010|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881011|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881012|NCT04328194|Thrombin|thrombin|mesh-list
44881013|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
44881014|NCT04328194|Coagulants|coagulants|mesh-ancestor
44881015|NCT04327791|Baloxavir|baloxavir|mesh-list
44881016|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
44881017|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881018|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881019|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881020|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
44881021|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44881022|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
44881023|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881024|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
44881025|NCT04327947|Protective Agents|protective agents|mesh-ancestor
44881026|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44881027|NCT04328064|Calcium|calcium|mesh-list
44881028|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44881029|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881030|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44881031|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44669774|NCT01257373|Cobalt|cobalt|mesh-list
44881032|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
44881033|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881034|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44881035|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44881036|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881037|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
44881038|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881039|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881040|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881041|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881042|NCT04327726|Analgesics|analgesics|mesh-ancestor
44881043|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
44881044|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881045|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44881046|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44881047|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44881048|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44881049|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881050|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881051|NCT04327245|Tagatose|tagatose|mesh-list
44881052|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44881053|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
44881054|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
44881055|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881056|NCT04327401|Dexamethasone|dexamethasone|mesh-list
44881057|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881058|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
44881059|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
44881060|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881061|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881062|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881063|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
44881064|NCT04327401|Hormones|hormones|mesh-ancestor
44881065|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881066|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881067|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881068|NCT04327427|Aspirin|aspirin|mesh-list
44881069|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881070|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881071|NCT04327427|Analgesics|analgesics|mesh-ancestor
44881072|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
44881073|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881074|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881075|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881076|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881077|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44881078|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44881079|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881080|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44881081|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44881082|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881083|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
44881084|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44881085|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44881086|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881087|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
44881088|NCT04327232|Spironolactone|spironolactone|mesh-list
44881089|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44881090|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
44881091|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881092|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881093|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44369620|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
44881094|NCT04327232|Diuretics|diuretics|mesh-ancestor
44881095|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
44881096|NCT04327011|Flucytosine|flucytosine|mesh-list
44881097|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
44881098|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881099|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
44881100|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881101|NCT04326959|Triamcinolone|triamcinolone|mesh-list
44881102|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44881103|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44881104|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44881105|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881106|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
44881107|NCT04326959|Hormones|hormones|mesh-ancestor
44881108|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881110|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44881111|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
44881112|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881113|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881114|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
44881115|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44881116|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
44881117|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881118|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
44881119|NCT04326985|Protective Agents|protective agents|mesh-ancestor
44881120|NCT04326894|Methotrexate|methotrexate|mesh-list
44881121|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44881122|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
44881123|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44369654|NCT01190241|Sorafenib|sorafenib|mesh-list
44881124|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881125|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44881126|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
44881127|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881128|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881129|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44881130|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881131|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44881132|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44881133|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
44881134|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881135|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44881136|NCT04326868|Albendazole|albendazole|mesh-list
44881137|NCT04326868|Mebendazole|mebendazole|mesh-list
44881138|NCT04326868|Benzimidazole|benzimidazole|mesh-list
44881139|NCT04326868|Pyrantel|pyrantel|mesh-list
44881140|NCT04326868|Anthelmintics|anthelmintics|mesh-list
44881141|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881142|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369668|NCT01190293|Efavirenz|efavirenz|mesh-list
44699553|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699554|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44699555|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
44699556|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
44699557|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44699558|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699559|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44699560|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699561|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699562|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699563|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44134636|NCT00158834|Xhance|xhance|mesh-list
44699564|NCT03091660|Vaccines|vaccines|mesh-list
44699565|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
44699566|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
44699567|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699568|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44699569|NCT03078855|Vitamin D|vitamin d|mesh-list
44699570|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
44699571|NCT03078855|Rituximab|rituximab|mesh-list
44699572|NCT03078855|Vitamins|vitamins|mesh-ancestor
44699573|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
44699574|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369698|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
44699575|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699576|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699577|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
44699578|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699579|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44699580|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44699581|NCT03071601|Lidocaine|lidocaine|mesh-list
44699582|NCT03071601|Epinephrine|epinephrine|mesh-list
44699583|NCT03071601|Prilocaine|prilocaine|mesh-list
44699584|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44699585|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699586|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
44699587|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699588|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699589|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
44699590|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699591|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44699592|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44699593|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44699594|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699595|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699596|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44699597|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44699598|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699599|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699600|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44699601|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44699602|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
44699603|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44699604|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
44699605|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
44699606|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
44699607|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44699608|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44699609|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
44699610|NCT03070327|Lenalidomide|lenalidomide|mesh-list
44699611|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699612|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
44699613|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699614|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699615|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44699616|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
44699617|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881143|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
44699618|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699619|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44699620|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44881144|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44881145|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881146|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
44881147|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
44881148|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881149|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881150|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881151|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
44881152|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44881153|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44881154|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44881155|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881156|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881157|NCT04326764|Panobinostat|panobinostat|mesh-list
44881158|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881159|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44881160|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881161|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881162|NCT04326790|Colchicine|colchicine|mesh-list
44881163|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
44881164|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881165|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44881166|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44881167|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881168|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881169|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881170|NCT04326803|Vaccines|vaccines|mesh-list
44881171|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
44881172|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881173|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881174|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
44881175|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881176|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881177|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881178|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369751|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
44881179|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881180|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881181|NCT04326296|Lenalidomide|lenalidomide|mesh-list
44881182|NCT04326296|Antibodies|antibodies|mesh-list
44881183|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44881184|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
44881185|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881186|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44881187|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44881188|NCT04326296|Growth Substances|growth substances|mesh-ancestor
44881189|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44881190|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881191|NCT04326166|Metformin|metformin|mesh-list
44881192|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44881193|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881194|NCT04325984|Dexamethasone|dexamethasone|mesh-list
44881195|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881196|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
44881197|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
44881198|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881199|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881200|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881201|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
44881202|NCT04325984|Hormones|hormones|mesh-ancestor
44881203|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881204|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881205|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881206|NCT04325932|Kallikreins|kallikreins|mesh-list
44881207|NCT04325932|Coagulants|coagulants|mesh-ancestor
44881208|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44881209|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
44881210|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44881211|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881212|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881213|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
44881214|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881215|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881216|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881217|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881218|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881219|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669965|NCT01258296|Fentanyl|fentanyl|mesh-list
44881220|NCT04325633|Naproxen|naproxen|mesh-list
44881221|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881222|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881223|NCT04325633|Analgesics|analgesics|mesh-ancestor
44881224|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
44881225|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881226|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881227|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881228|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881229|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
44881230|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44881231|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881232|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881233|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
44881234|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
44881235|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881236|NCT04325698|Paclitaxel|paclitaxel|mesh-list
44881237|NCT04325698|Bevacizumab|bevacizumab|mesh-list
44881238|NCT04325698|Carboplatin|carboplatin|mesh-list
44881239|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44881240|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881241|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44881242|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44881243|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881244|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881245|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44881246|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44881247|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44881248|NCT04325698|Growth Substances|growth substances|mesh-ancestor
44881249|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881250|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
44881251|NCT04325581|Liraglutide|liraglutide|mesh-list
44881252|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44881253|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881254|NCT04325581|Incretins|incretins|mesh-ancestor
44881255|NCT04325581|Hormones|hormones|mesh-ancestor
44881256|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881257|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
44881258|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44881259|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881260|NCT04325425|Cisplatin|cisplatin|mesh-list
44881261|NCT04325425|Carboplatin|carboplatin|mesh-list
44881262|NCT04325425|Etoposide|etoposide|mesh-list
44881263|NCT04325425|Folfirinox|folfirinox|mesh-list
44881264|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881265|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44881266|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44881267|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44881268|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881269|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881270|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
44881271|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881272|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
44369857|NCT01191216|Tryptophan|tryptophan|mesh-list
44881273|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881274|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881275|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
44881276|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881277|NCT04325191|Melatonin|melatonin|mesh-list
44881278|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
44881279|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881280|NCT04325191|Protective Agents|protective agents|mesh-ancestor
44881281|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881282|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881283|NCT04325061|Dexamethasone|dexamethasone|mesh-list
44881284|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
44881285|NCT04325061|BB 1101|bb 1101|mesh-list
44369881|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44881286|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881287|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
44881288|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
44881289|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881290|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881291|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881292|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
44881293|NCT04325061|Hormones|hormones|mesh-ancestor
44881294|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881295|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881296|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881297|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881298|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881299|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881300|NCT04325009|Atorvastatin|atorvastatin|mesh-list
44881301|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44881302|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44881303|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
44881304|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881305|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44881306|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44881307|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881308|NCT04324411|Sirolimus|sirolimus|mesh-list
44881309|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881310|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881311|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44881312|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881313|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
44881314|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44881315|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
44881316|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881317|NCT04324346|Paclitaxel|paclitaxel|mesh-list
44881318|NCT04324346|Docetaxel|docetaxel|mesh-list
44881319|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44881320|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881321|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
44881322|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
44881323|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881324|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670117|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881325|NCT04324307|Gemcitabine|gemcitabine|mesh-list
44881326|NCT04324307|Paclitaxel|paclitaxel|mesh-list
44881327|NCT04324307|Fluorouracil|fluorouracil|mesh-list
44881328|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
44881329|NCT04324307|Irinotecan|irinotecan|mesh-list
44881330|NCT04324307|Folfirinox|folfirinox|mesh-list
44881331|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44881332|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881333|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
44881334|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
44881335|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881336|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881337|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44881338|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
44881339|NCT04324307|Antiviral Agents|antiviral agents|mesh-ancestor
44881340|NCT04324307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881341|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881342|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44881343|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
44881344|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881345|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44881346|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44881347|NCT04324476|Bevacizumab|bevacizumab|mesh-list
44881348|NCT04324476|Capecitabine|capecitabine|mesh-list
44881349|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
44881350|NCT04324476|Irinotecan|irinotecan|mesh-list
44881351|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44881352|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881353|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44881354|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369959|NCT01191957|Busulfan|busulfan|mesh-list
44881355|NCT04324476|Growth Substances|growth substances|mesh-ancestor
44881356|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881357|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
44881358|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44881359|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
44881360|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881361|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44881362|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44881363|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881364|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
44881365|NCT04324086|Calcium|calcium|mesh-list
44369963|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881366|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44881367|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881368|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44881369|NCT04324060|Danazol|danazol|mesh-list
44881370|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44881371|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
44881372|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369975|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
44881373|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881374|NCT04324294|Pancrelipase|pancrelipase|mesh-list
44881375|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881376|NCT04323761|Remdesivir|remdesivir|mesh-list
44881377|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
44881378|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881379|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
44881380|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881381|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
44881382|NCT04323657|Fludarabine|fludarabine|mesh-list
44881383|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369984|NCT01192165|Pemetrexed|pemetrexed|mesh-list
44881384|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
44881385|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881386|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881387|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44881388|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
44881389|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881390|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881391|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44881392|NCT04323527|Chloroquine|chloroquine|mesh-list
44881393|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44881394|NCT04323527|Amebicides|amebicides|mesh-ancestor
44881395|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881396|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881397|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881398|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
44670202|NCT01259531|Silodosin|silodosin|mesh-list
44881399|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881400|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881401|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881402|NCT04323527|Analgesics|analgesics|mesh-ancestor
44881403|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
44881404|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881405|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881406|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881407|NCT04323527|Filaricides|filaricides|mesh-ancestor
44881408|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
44881409|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
44881410|NCT04323514|Ascorbic Acid|ascorbic acid|mesh-list
44881411|NCT04323514|Vitamins|vitamins|mesh-ancestor
44881412|NCT04323514|Micronutrients|micronutrients|mesh-ancestor
44881413|NCT04323514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881414|NCT04323514|Antioxidants|antioxidants|mesh-ancestor
44369997|NCT01192230|Docetaxel|docetaxel|mesh-list
44881415|NCT04323514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881416|NCT04323514|Protective Agents|protective agents|mesh-ancestor
44881417|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881418|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
44881419|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881420|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881421|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881422|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881423|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881424|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881425|NCT04322955|Nivolumab|nivolumab|mesh-list
44881426|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44881427|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881428|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44881429|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881430|NCT04323280|Dexamethasone|dexamethasone|mesh-list
44881431|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881432|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
44881433|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
44881434|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881435|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881436|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881437|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
44881438|NCT04323280|Hormones|hormones|mesh-ancestor
44881439|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881440|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881441|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881442|NCT04323228|Antioxidants|antioxidants|mesh-list
44881443|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881444|NCT04323228|Protective Agents|protective agents|mesh-ancestor
44881445|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881446|NCT04322760|Lidocaine|lidocaine|mesh-list
44881447|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
44881448|NCT04322760|Bupivacaine|bupivacaine|mesh-list
44881449|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881450|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
44881451|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881452|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699621|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44699622|NCT03070327|Growth Substances|growth substances|mesh-ancestor
44699623|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44699624|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44699625|NCT03061903|Laxatives|laxatives|mesh-ancestor
44699626|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699627|NCT03061643|Docetaxel|docetaxel|mesh-list
44699628|NCT03061643|Androgens|androgens|mesh-list
44699629|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699630|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699631|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699632|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699633|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699634|NCT03061643|Hormones|hormones|mesh-ancestor
44699635|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699636|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699637|NCT03061630|Gemcitabine|gemcitabine|mesh-list
44699638|NCT03061630|Cisplatin|cisplatin|mesh-list
44699639|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699640|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44699641|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
44699642|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699643|NCT03061630|Antiviral Agents|antiviral agents|mesh-ancestor
44670306|NCT01260129|Silodosin|silodosin|mesh-list
44670315|NCT01260233|Nicotine|nicotine|mesh-list
44670316|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44881453|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
44881454|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881455|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44881456|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44881457|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44881458|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44881459|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881460|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881461|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881462|NCT04322760|Analgesics|analgesics|mesh-ancestor
44881463|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44881464|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44881465|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44881466|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44881467|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881468|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44881469|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881470|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881471|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881472|NCT04322422|Montelukast|montelukast|mesh-list
44881473|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44881474|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44881475|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44881476|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44881477|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881478|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881479|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44881480|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44881481|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881482|NCT04322175|Meloxicam|meloxicam|mesh-list
44370109|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
44881483|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881484|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881485|NCT04322175|Analgesics|analgesics|mesh-ancestor
44881486|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
44881487|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881488|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881489|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881490|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881491|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44881492|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44881493|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881494|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881495|NCT04322214|Cobicistat|cobicistat|mesh-list
44881496|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44881497|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44881498|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
44881499|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670317|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
44670318|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670319|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670320|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44670321|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44670322|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44670323|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670324|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670325|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44670326|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44670327|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670328|NCT01260246|Incretins|incretins|mesh-ancestor
44670329|NCT01260246|Hormones|hormones|mesh-ancestor
44670330|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370135|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670331|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44670332|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
44670333|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670334|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670335|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44670336|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670337|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44670338|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44881500|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44881501|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44881502|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881503|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881504|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
44881505|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
44881506|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881507|NCT04322240|Protective Agents|protective agents|mesh-ancestor
44881508|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881509|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
44881511|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
44881512|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
44881513|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
44881514|NCT04321785|Caffeine|caffeine|mesh-list
44881515|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44881516|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881517|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44881518|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881519|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881520|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44881521|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44881522|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
44881523|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881524|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
44881525|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881526|NCT04321655|Ibuprofen|ibuprofen|mesh-list
44881527|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881528|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881529|NCT04321655|Analgesics|analgesics|mesh-ancestor
44881530|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
44881531|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881532|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881533|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881534|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881535|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44881536|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881537|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881538|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
44881539|NCT04321642|Entonox|entonox|mesh-list
44881540|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44881541|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
44881542|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881543|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881544|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44881545|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
44881546|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881547|NCT04321642|Analgesics|analgesics|mesh-ancestor
44881548|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
44881549|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881551|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
44881552|NCT04321850|Trace Elements|trace elements|mesh-ancestor
44881553|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
44881554|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881555|NCT04321850|Astringents|astringents|mesh-ancestor
44881556|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44881557|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881558|NCT04321616|Remdesivir|remdesivir|mesh-list
44881559|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
44881560|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881561|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881562|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881563|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881564|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881565|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881566|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
44881567|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
44881568|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
44881569|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
44370194|NCT01193452|Leucovorin|leucovorin|mesh-list
44370239|NCT01193504|Hormones|hormones|mesh-ancestor
44881570|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881571|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44881572|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881573|NCT04321837|Vitamin D|vitamin d|mesh-list
44881574|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
44881575|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
44881576|NCT04321837|Vitamins|vitamins|mesh-ancestor
44881577|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
44881578|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881579|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44881580|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44881581|NCT04321278|Azithromycin|azithromycin|mesh-list
44881582|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881583|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881584|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881585|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
44881586|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881587|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881588|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670427|NCT01260727|Vaccines|vaccines|mesh-list
44881589|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881590|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881592|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
44881593|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
44881594|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881595|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881596|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44881597|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881598|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881599|NCT04321096|Camostat|camostat|mesh-list
44881600|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881601|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881602|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881603|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44881604|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44881605|NCT04320706|Oxytocin|oxytocin|mesh-list
44881606|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
44881607|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44881608|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881609|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
44881610|NCT04320589|Anesthetics|anesthetics|mesh-list
44881611|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
44881612|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881613|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881614|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881615|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881616|NCT04320589|Analgesics|analgesics|mesh-ancestor
44881617|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
44881618|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881619|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44881620|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44881621|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44881622|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
44881623|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881624|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881625|NCT04320238|Interferons|interferons|mesh-list
44134754|NCT00159133|Lorazepam|lorazepam|mesh-list
44881626|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
44881627|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44881628|NCT04320238|Thymalfasin|thymalfasin|mesh-list
44881629|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881630|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
44881631|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881632|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
44881633|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881634|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44881635|NCT04320277|Ritonavir|ritonavir|mesh-list
44881636|NCT04320277|Lopinavir|lopinavir|mesh-list
44881637|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44881638|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44881639|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881640|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881641|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881642|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44881643|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44881644|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
44881645|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881646|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44881647|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44881648|NCT04320225|Dexamethasone|dexamethasone|mesh-list
44881649|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881650|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
44881651|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
44881652|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881653|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881654|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881655|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
44881656|NCT04320225|Hormones|hormones|mesh-ancestor
44881657|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881658|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881659|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881660|NCT04319978|Dexamethasone|dexamethasone|mesh-list
44881661|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
44670491|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881662|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881663|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
44881664|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
44881665|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881666|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881667|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881668|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
44881670|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881671|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881672|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881673|NCT04320173|Lidocaine|lidocaine|mesh-list
44881674|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881675|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
44881676|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881677|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881678|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
44881679|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881680|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44881681|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44881682|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44881683|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44881684|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881685|NCT04319926|Lidocaine|lidocaine|mesh-list
44881686|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881687|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
44881688|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881689|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881690|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
44881691|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881692|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44881693|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44881694|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44881695|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44881696|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881697|NCT04319900|Chloroquine|chloroquine|mesh-list
44881698|NCT04319900|Favipiravir|favipiravir|mesh-list
44881699|NCT04319900|Amebicides|amebicides|mesh-ancestor
44881700|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881701|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881702|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881703|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
44881704|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881705|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
44881706|NCT04319471|Capecitabine|capecitabine|mesh-list
44881707|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44881708|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
44881709|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881710|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881711|NCT04319588|Anesthetics|anesthetics|mesh-list
44881712|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
44370329|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
44881713|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881714|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881715|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
44881716|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881717|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
44881718|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44881719|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
44881720|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881721|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
44881722|NCT04319770|Protective Agents|protective agents|mesh-ancestor
44881723|NCT04319484|Lenvatinib|lenvatinib|mesh-list
44881724|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881725|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44881726|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881727|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881728|NCT04319601|Rituximab|rituximab|mesh-list
44881729|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44881730|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881731|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
44881732|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881733|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881734|NCT04319692|Acetic Acid|acetic acid|mesh-list
44881735|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881736|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670588|NCT01261689|Dsuvia|dsuvia|mesh-list
44881737|NCT04319705|Azithromycin|azithromycin|mesh-list
44881738|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44881739|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881740|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44881741|NCT04319549|Eusol|eusol|mesh-list
44881742|NCT04319549|Ketorolac|ketorolac|mesh-list
44881743|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44881744|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44881745|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881746|NCT04319549|Analgesics|analgesics|mesh-ancestor
44370375|NCT01194791|Hormones|hormones|mesh-ancestor
44881747|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
44881748|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881749|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881750|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881751|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881752|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44881753|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881754|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881755|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
44881756|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881757|NCT04319289|Vitamin D|vitamin d|mesh-list
44881758|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
44699644|NCT03061630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699645|NCT03061630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699646|NCT03061630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699647|NCT03061630|Immunologic Factors|immunologic factors|mesh-ancestor
44699648|NCT03061630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699649|NCT03055390|Scopolamine|scopolamine|mesh-list
44699650|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44699651|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44699652|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
44699653|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
44699654|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699655|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699656|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699657|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
44699658|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44699659|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
44699660|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699661|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699662|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44699663|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
44699664|NCT03038802|Vaccines|vaccines|mesh-list
44699665|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
44699666|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699667|NCT03012672|Cytarabine|cytarabine|mesh-list
44025777|NCT00305643|Celecoxib|celecoxib|mesh-list
44699668|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44699669|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
44699670|NCT03012672|Cladribine|cladribine|mesh-list
44251279|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699671|NCT03012672|Lenograstim|lenograstim|mesh-list
44699672|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44699673|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
44699674|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699675|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699677|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699678|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699679|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
44699680|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699681|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44699682|NCT03012672|Analgesics|analgesics|mesh-ancestor
44699683|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
44699684|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699685|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44699686|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44699687|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699688|NCT03011775|Aspirin|aspirin|mesh-list
44699689|NCT03011775|Pioglitazone|pioglitazone|mesh-list
44699690|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44699691|NCT03011775|Ramipril|ramipril|mesh-list
44699692|NCT03011775|Bisoprolol|bisoprolol|mesh-list
44699693|NCT03011775|Isosorbide|isosorbide|mesh-list
44699694|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44699695|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44699696|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
44699697|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44699698|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44699699|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881759|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
44881761|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
44881762|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881763|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44881764|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44881765|NCT04319419|Micronutrients|micronutrients|mesh-list
44881766|NCT04319419|Trace Elements|trace elements|mesh-list
44881767|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881768|NCT04318847|Ondansetron|ondansetron|mesh-list
44881769|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
44881770|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
44881771|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881772|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881773|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881774|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
44881775|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44881776|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44881777|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
44881778|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881779|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881780|NCT04318847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44881781|NCT04318847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44881782|NCT04318847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881783|NCT04318847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44881784|NCT04318847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44881785|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
44881786|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
44881787|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881788|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881789|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881790|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881791|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881792|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881793|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
44881794|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44370501|NCT01196234|Paclitaxel|paclitaxel|mesh-list
44881795|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44881796|NCT04318652|Prednisolone|prednisolone|mesh-list
44881797|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
44881798|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44881799|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44881800|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
44881801|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881802|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
44881803|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
44881804|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881805|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881806|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881807|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
44881808|NCT04318652|Hormones|hormones|mesh-ancestor
44881809|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881810|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44881811|NCT04318652|Protective Agents|protective agents|mesh-ancestor
44881812|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881813|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881814|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44881815|NCT04318158|Fentanyl|fentanyl|mesh-list
44881816|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
44881817|NCT04318158|Bupivacaine|bupivacaine|mesh-list
44881818|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881819|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
44881820|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881821|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881822|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
44881823|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881824|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881825|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44881826|NCT04318158|Analgesics|analgesics|mesh-ancestor
44881827|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44881828|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44881829|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44881830|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44881831|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881832|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881833|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44881834|NCT04318158|Narcotics|narcotics|mesh-ancestor
44881835|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44881836|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44370513|NCT01196260|Capecitabine|capecitabine|mesh-list
44881837|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
44881838|NCT04318223|Palbociclib|palbociclib|mesh-list
44881839|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881840|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44881841|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881842|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881843|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44881844|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881845|NCT04318067|Melatonin|melatonin|mesh-list
44881846|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
44881847|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881848|NCT04318067|Protective Agents|protective agents|mesh-ancestor
44881849|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881850|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881851|NCT04317872|Dexamethasone|dexamethasone|mesh-list
44881852|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
44881853|NCT04317872|BB 1101|bb 1101|mesh-list
44881854|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881855|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
44881856|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
44881857|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881858|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881859|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881860|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
44881861|NCT04317872|Hormones|hormones|mesh-ancestor
44881862|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881863|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881864|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881865|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881866|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881867|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881868|NCT04317703|Metformin|metformin|mesh-list
44881869|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44881870|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881871|NCT04317508|Benzocaine|benzocaine|mesh-list
44881872|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881873|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
44881874|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881875|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881876|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
44881877|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881878|NCT04317235|Ropivacaine|ropivacaine|mesh-list
44881879|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
44881880|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
44881881|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881882|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881883|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
44881884|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881885|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
44881886|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44881887|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
44881888|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881889|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881890|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44881891|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
44881892|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881893|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881894|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44881895|NCT04316936|Dexamethasone|dexamethasone|mesh-list
44881896|NCT04316936|Prednisolone|prednisolone|mesh-list
44881897|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44881898|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
44881899|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44881900|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
44881901|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44881902|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
44881903|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44881904|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
44881905|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
44881906|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881907|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881908|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44881909|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
44881910|NCT04316936|Hormones|hormones|mesh-ancestor
44670735|NCT01262742|Carbetocin|carbetocin|mesh-list
44881911|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881912|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44881913|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881914|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44881915|NCT04316936|Protective Agents|protective agents|mesh-ancestor
44881916|NCT04317157|Caffeine|caffeine|mesh-list
44881917|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44881918|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881919|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44881920|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881921|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881922|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44881923|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44881924|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
44881925|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44881926|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44881927|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881928|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
44881929|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370627|NCT01197040|Prednisone|prednisone|mesh-list
44881930|NCT04317079|Protective Agents|protective agents|mesh-ancestor
44881931|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881932|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44881933|NCT04317183|Miconazole|miconazole|mesh-list
44881934|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
44881935|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881936|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44881937|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44881938|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881939|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881940|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44881941|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
44881942|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44881943|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881944|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44881945|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44881946|NCT04317001|Modafinil|modafinil|mesh-list
44881947|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44881948|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881949|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44881950|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44881951|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44881952|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881953|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44881954|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44881955|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881956|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
44370642|NCT01197144|Adalimumab|adalimumab|mesh-list
44881957|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
44881958|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44881959|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44881960|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44881961|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881962|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881963|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44881964|NCT04316351|Pemetrexed|pemetrexed|mesh-list
44881965|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881966|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881967|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881968|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44881969|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44881970|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
44881971|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44881972|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
44881973|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44881974|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
44881975|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44881976|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881977|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
44881978|NCT04316039|Temozolomide|temozolomide|mesh-list
44881979|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44881980|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
44881981|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44881982|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44881983|NCT04315935|Fentanyl|fentanyl|mesh-list
44881984|NCT04315935|Butorphanol|butorphanol|mesh-list
44881985|NCT04315935|Propofol|propofol|mesh-list
44881986|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44881987|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44881988|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44881989|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44881990|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
44881991|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
44370707|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
44881992|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44881993|NCT04315935|Narcotics|narcotics|mesh-ancestor
44881994|NCT04315935|Analgesics|analgesics|mesh-ancestor
44881995|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
44881996|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44881997|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44881998|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
44881999|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
44882000|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44882001|NCT04315909|Vitamin E|vitamin e|mesh-list
44882002|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44882003|NCT04315909|Vitamins|vitamins|mesh-ancestor
44699700|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44699701|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44699702|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
44699703|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699704|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44699705|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44699706|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699707|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44699708|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699709|NCT03011775|Analgesics|analgesics|mesh-ancestor
44699710|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
44699711|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699712|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699713|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699714|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44699715|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44699716|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44699717|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
44699718|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44699719|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44699720|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44699721|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
44699722|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
44670887|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44882004|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
44882005|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882006|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
44882007|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882008|NCT04315909|Protective Agents|protective agents|mesh-ancestor
44882009|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
44882010|NCT04315909|Coagulants|coagulants|mesh-ancestor
44882011|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
44882012|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44882013|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44882014|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44882015|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882016|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882017|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
44882018|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
44882019|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882020|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
44882021|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882022|NCT04315831|Buprenorphine|buprenorphine|mesh-list
44882023|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44882024|NCT04315831|Narcotics|narcotics|mesh-ancestor
44882025|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882026|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882027|NCT04315831|Analgesics|analgesics|mesh-ancestor
44882028|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
44882029|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882030|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44882032|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882033|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882034|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
44882035|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
44882036|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
44882037|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882038|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882039|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
44882040|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882041|NCT04315493|Maleic acid|maleic acid|mesh-list
44882042|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882043|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882044|NCT04315194|Clarithromycin|clarithromycin|mesh-list
44882045|NCT04315194|Oseltamivir|oseltamivir|mesh-list
44882046|NCT04315194|Naproxen|naproxen|mesh-list
44882047|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44882048|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882049|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44882050|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882051|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882052|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44882053|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882054|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882055|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882056|NCT04315194|Analgesics|analgesics|mesh-ancestor
44882057|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
44882058|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882059|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882060|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882061|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882062|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
44882063|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44882064|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
44882065|NCT04315155|Nivolumab|nivolumab|mesh-list
44882066|NCT04315155|Ipilimumab|ipilimumab|mesh-list
44882067|NCT04315155|Belinostat|belinostat|mesh-list
44882068|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882069|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882070|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44882071|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882072|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44882073|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882074|NCT04315116|Loperamide|loperamide|mesh-list
44882075|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
44882076|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44882077|NCT04314739|Resveratrol|resveratrol|mesh-list
44882078|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
44882079|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882080|NCT04314739|Protective Agents|protective agents|mesh-ancestor
44882081|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882082|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882083|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44882084|NCT04314310|Tenoxicam|tenoxicam|mesh-list
44882085|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882086|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882087|NCT04314310|Analgesics|analgesics|mesh-ancestor
44882088|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
44882089|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882090|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882091|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882092|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882093|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44882094|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882095|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882096|NCT04314297|Durvalumab|durvalumab|mesh-list
44882097|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882098|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671013|NCT01264354|Adefovir|adefovir|mesh-list
44882099|NCT04314674|Mannitol|mannitol|mesh-list
44882100|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44882101|NCT04314674|Diuretics|diuretics|mesh-ancestor
44882102|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
44882103|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882104|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
44882105|NCT04314505|Narcotics|narcotics|mesh-ancestor
44882106|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882107|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882108|NCT04314505|Analgesics|analgesics|mesh-ancestor
44882109|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
44882110|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882111|NCT04314193|Prednisolone|prednisolone|mesh-list
44882112|NCT04314193|Methotrexate|methotrexate|mesh-list
44882113|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44882114|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
44882115|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882116|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882117|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882118|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
44882119|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882120|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882121|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44882122|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882123|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44882124|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882125|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
44882126|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882127|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44882128|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882129|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
44882130|NCT04314193|Hormones|hormones|mesh-ancestor
44882131|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882132|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44882133|NCT04313907|Clonazepam|clonazepam|mesh-list
44882134|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
44882135|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
44882136|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
44882137|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882138|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882139|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882140|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44882141|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
44882142|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882143|NCT04313764|Bupivacaine|bupivacaine|mesh-list
44882144|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
44882145|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
44882146|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882147|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882148|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
44882149|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882150|NCT04313452|Insulin|insulin|mesh-list
44882151|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370883|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882152|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882153|NCT04313270|Evolocumab|evolocumab|mesh-list
44882154|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882155|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882156|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
44882157|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882158|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882159|NCT04313218|Misoprostol|misoprostol|mesh-list
44882160|NCT04313218|Carbetocin|carbetocin|mesh-list
44882161|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44882162|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
44882163|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882164|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882165|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44882166|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44882167|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
44882168|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44882169|NCT04313374|Morphine|morphine|mesh-list
44882170|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44882171|NCT04313374|Narcotics|narcotics|mesh-ancestor
44882172|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671086|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882173|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882174|NCT04313374|Analgesics|analgesics|mesh-ancestor
44882175|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
44882176|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882177|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882178|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882179|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882180|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882181|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44882182|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44882183|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44370900|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370901|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882184|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882185|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882186|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882187|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882188|NCT04313335|Analgesics|analgesics|mesh-ancestor
44882189|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
44882190|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882191|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
44882192|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44882193|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
44882194|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
44882195|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
44882196|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
44882197|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44882198|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
44882199|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44882200|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44882201|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882202|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
44882203|NCT04312880|Coagulants|coagulants|mesh-ancestor
44882204|NCT04313036|Defibrotide|defibrotide|mesh-list
44882205|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44882206|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44882207|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882208|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44882209|NCT04312750|Lidocaine|lidocaine|mesh-list
44882210|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
44882211|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
44882212|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882213|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882214|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
44882215|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882216|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44882217|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44882218|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44882219|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882220|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882221|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
44882222|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
44882223|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
44882224|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882225|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882226|NCT04312347|Tamoxifen|tamoxifen|mesh-list
44882227|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44882228|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882229|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882230|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882231|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44882232|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882233|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44882234|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44882235|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44882236|NCT04312438|Caseins|caseins|mesh-list
44882237|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
44882238|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
44882239|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882240|NCT04312360|Metronidazole|metronidazole|mesh-list
44882241|NCT04312360|Fosfomycin|fosfomycin|mesh-list
44882242|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882243|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44882244|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44882245|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882246|NCT04312204|Gemcitabine|gemcitabine|mesh-list
44882247|NCT04312204|Carboplatin|carboplatin|mesh-list
44882248|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370934|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882249|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882250|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
44882251|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882252|NCT04312204|Antiviral Agents|antiviral agents|mesh-ancestor
44882253|NCT04312204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882254|NCT04312204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882255|NCT04312204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882256|NCT04312204|Immunologic Factors|immunologic factors|mesh-ancestor
44882257|NCT04312204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882258|NCT04312282|Itraconazole|itraconazole|mesh-list
44882259|NCT04312282|Rifampin|rifampin|mesh-list
44882260|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
44882261|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882262|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44370982|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882263|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882264|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882265|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882266|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44882267|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882268|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882269|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882270|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44882271|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44882272|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
44882273|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44882274|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
44699723|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44699724|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44371005|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
44699725|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44699726|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44699727|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699728|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44699729|NCT03011775|Diuretics|diuretics|mesh-ancestor
44699730|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
44699731|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44699732|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
44699733|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699734|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699735|NCT02960997|Sirolimus|sirolimus|mesh-list
44699736|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699737|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699738|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44699739|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699740|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
44699741|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699742|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
44699743|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699744|NCT02924480|Lidocaine|lidocaine|mesh-list
44699745|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699746|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
44699747|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699748|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681447|NCT03504501|Lovastatin|lovastatin|mesh-list
44699749|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
44699750|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699751|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44699752|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44699753|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44699754|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44699755|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699756|NCT02924064|Metformin|metformin|mesh-list
44699757|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44699758|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699759|NCT02889900|Olaparib|olaparib|mesh-list
44699760|NCT02889900|Cediranib|cediranib|mesh-list
44699761|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44699762|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699763|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699764|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699765|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44699766|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44699767|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
44671243|NCT01265576|Analgesics|analgesics|mesh-ancestor
44882275|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44882276|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44882277|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44882278|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44882279|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44882280|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44882281|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44882282|NCT04312152|Vitamins|vitamins|mesh-list
44882283|NCT04312152|Vitamin E|vitamin e|mesh-list
44882284|NCT04312152|Tocopherols|tocopherols|mesh-list
44882285|NCT04312152|Folic Acid|folic acid|mesh-list
44882286|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
44882287|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
44882288|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882289|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
44882290|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882291|NCT04312152|Protective Agents|protective agents|mesh-ancestor
44882292|NCT04312152|Hematinics|hematinics|mesh-ancestor
44882293|NCT04312048|Isosorbide|isosorbide|mesh-list
44882294|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44882295|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44882296|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44882297|NCT04312048|Diuretics|diuretics|mesh-ancestor
44882298|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
44882299|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882300|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882301|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44882302|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882304|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44882305|NCT04312061|Narcotics|narcotics|mesh-ancestor
44882306|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882307|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882308|NCT04312061|Analgesics|analgesics|mesh-ancestor
44882309|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
44882310|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882311|NCT04311697|Phentolamine|phentolamine|mesh-list
44882312|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44882313|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44882314|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44882315|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
44882316|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882317|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882318|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882319|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44882320|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44882321|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882322|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44882323|NCT04311697|Protective Agents|protective agents|mesh-ancestor
44882324|NCT04311580|Mitomycins|mitomycins|mesh-list
44882325|NCT04311580|Mitomycin|mitomycin|mesh-list
44882326|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371061|NCT01199432|Fluorouracil|fluorouracil|mesh-list
44882327|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882328|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
44882329|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882330|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44882331|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882332|NCT04311424|Tirzepatide|tirzepatide|mesh-list
44882333|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882334|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882335|NCT04311424|Incretins|incretins|mesh-ancestor
44882336|NCT04311424|Hormones|hormones|mesh-ancestor
44882337|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882338|NCT04311658|Isosorbide|isosorbide|mesh-list
44882339|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44882340|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44882341|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44882342|NCT04311658|Diuretics|diuretics|mesh-ancestor
44882343|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
44882344|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882345|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882346|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44882347|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882348|NCT04311645|Charcoal|charcoal|mesh-list
44882349|NCT04311645|Antidotes|antidotes|mesh-ancestor
44882350|NCT04311645|Protective Agents|protective agents|mesh-ancestor
44882351|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882352|NCT04311255|Anesthetics|anesthetics|mesh-list
44882353|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882354|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882355|NCT04310943|Paclitaxel|paclitaxel|mesh-list
44882356|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44882357|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882358|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44882359|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44882360|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44882361|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882362|NCT04310683|Hormones|hormones|mesh-list
44882363|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882364|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882365|NCT04310579|Midazolam|midazolam|mesh-list
44882366|NCT04310579|Oxycodone|oxycodone|mesh-list
44882367|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44882368|NCT04310579|Paroxetine|paroxetine|mesh-list
44371116|NCT01199562|Foscarnet|foscarnet|mesh-list
44882369|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44882370|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44882371|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882372|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882373|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44882374|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44882375|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44882376|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44882377|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
44882378|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
44882379|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
44882380|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
44882381|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882382|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882383|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44882384|NCT04310579|Narcotics|narcotics|mesh-ancestor
44882385|NCT04310579|Analgesics|analgesics|mesh-ancestor
44882386|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
44882387|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882388|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
44882389|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44882390|NCT04310579|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44882391|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44882392|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882393|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
44882394|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44882395|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44882396|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882397|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882398|NCT04310774|Tegafur|tegafur|mesh-list
44882399|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882400|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
44882401|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882402|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882403|NCT04310254|Edetic Acid|edetic acid|mesh-list
44882404|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44882405|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
44882406|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
44371174|NCT01200108|Budesonide|budesonide|mesh-list
44882407|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44882408|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
44882409|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
44882410|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882411|NCT04310254|Antidotes|antidotes|mesh-ancestor
44882412|NCT04310254|Protective Agents|protective agents|mesh-ancestor
44882413|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882414|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44882415|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
44882416|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882417|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882418|NCT04310228|Favipiravir|favipiravir|mesh-list
44882419|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
44882420|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882421|NCT04310176|Bevacizumab|bevacizumab|mesh-list
44882422|NCT04310176|Fluorouracil|fluorouracil|mesh-list
44882423|NCT04310176|Capecitabine|capecitabine|mesh-list
44882424|NCT04310176|Valproic Acid|valproic acid|mesh-list
44882425|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882426|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882427|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44882428|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44882429|NCT04310176|Growth Substances|growth substances|mesh-ancestor
44882430|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882431|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44882432|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
44882433|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882434|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882435|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882436|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
44882437|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
44882438|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882439|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
44882440|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882441|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
44882442|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44882443|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882444|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44882445|NCT04309838|Treprostinil|treprostinil|mesh-list
44371211|NCT01200264|Analgesics|analgesics|mesh-ancestor
44882446|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44882447|NCT04310293|Hormones|hormones|mesh-list
44882448|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882449|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882450|NCT04309929|Analgesics|analgesics|mesh-list
44882451|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
44882452|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882453|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882454|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
44882455|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44882456|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
44882457|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
44882458|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44882459|NCT04309643|Estradiol|estradiol|mesh-list
44882460|NCT04309643|Estrogens|estrogens|mesh-ancestor
44882461|NCT04309643|Hormones|hormones|mesh-ancestor
44476059|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882462|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882463|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882464|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44882465|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882466|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44882467|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44882468|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44882469|NCT04309708|Nimodipine|nimodipine|mesh-list
44882470|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44882471|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44882472|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882473|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882474|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44882475|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882476|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882477|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44882478|NCT04309357|Plasminogen|plasminogen|mesh-list
44882479|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44882480|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44882481|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882482|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
44882483|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44882484|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
44882485|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44882486|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
44882487|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882488|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882489|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
44671491|NCT01266811|Dexamethasone|dexamethasone|mesh-list
44882490|NCT04308954|Flumazenil|flumazenil|mesh-list
44882491|NCT04308954|Antidotes|antidotes|mesh-ancestor
44882492|NCT04308954|Protective Agents|protective agents|mesh-ancestor
44882493|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882494|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
44882495|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
44882496|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882497|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882498|NCT04309058|Vitamin D|vitamin d|mesh-list
44882499|NCT04309058|Vitamins|vitamins|mesh-ancestor
44882500|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
44882501|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882502|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44882503|NCT04308551|Aspirin|aspirin|mesh-list
44882504|NCT04308551|Indobufen|indobufen|mesh-list
44882505|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882506|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882507|NCT04308551|Analgesics|analgesics|mesh-ancestor
44882508|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
44882509|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882510|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882511|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882512|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882513|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44882514|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44882515|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882516|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44882517|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44882518|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371288|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882519|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
44882520|NCT04308850|Vitamin D|vitamin d|mesh-list
44882521|NCT04308850|Vitamins|vitamins|mesh-ancestor
44882522|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
44882523|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882524|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44882525|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
44882526|NCT04308525|Narcotics|narcotics|mesh-ancestor
44882527|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882528|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882529|NCT04308525|Analgesics|analgesics|mesh-ancestor
44882530|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
44882531|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882532|NCT04308317|Tetrandrine|tetrandrine|mesh-list
44882533|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
44882534|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44882535|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882536|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882537|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44882538|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882539|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
44882540|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44882541|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882542|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882543|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44882544|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882545|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882546|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
44882547|NCT04308343|Methotrexate|methotrexate|mesh-list
44882548|NCT04308343|Letrozole|letrozole|mesh-list
44882549|NCT04308343|Cetrorelix|cetrorelix|mesh-list
44882550|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44882551|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
44882552|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371322|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
44882553|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882554|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882555|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
44882556|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882557|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882558|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
44882559|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882560|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44882561|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371333|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882562|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
44882563|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882564|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44671568|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882565|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44882566|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44699768|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44699769|NCT02879942|Growth Substances|growth substances|mesh-ancestor
44699770|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699771|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
44699772|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699773|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
44699774|NCT02873819|Sargramostim|sargramostim|mesh-list
44699775|NCT02873819|Poly ICLC|poly iclc|mesh-list
44699776|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699777|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
44699778|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699779|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699780|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44699781|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
44699782|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699783|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699784|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44699785|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
44699786|NCT02872467|Oxytocin|oxytocin|mesh-list
44699787|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
44699788|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44699789|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699790|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
44699791|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44699792|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
44699793|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44699794|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699795|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44699796|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44699797|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44699798|NCT02810457|Paclitaxel|paclitaxel|mesh-list
44699799|NCT02810457|Bevacizumab|bevacizumab|mesh-list
44699800|NCT02810457|Carboplatin|carboplatin|mesh-list
44699801|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44699802|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699803|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699804|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699805|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699806|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699807|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371343|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44699808|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44699809|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44699810|NCT02810457|Growth Substances|growth substances|mesh-ancestor
44699811|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699812|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
44699813|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
44699814|NCT02745535|Velpatasvir|velpatasvir|mesh-list
44699815|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44699816|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
44699817|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699818|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
44699819|NCT02729701|Estrogens|estrogens|mesh-list
44699820|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44699821|NCT02729701|Hormones|hormones|mesh-ancestor
44699822|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699823|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251404|NCT05217589|Hormones|hormones|mesh-ancestor
44699824|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44699825|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44699826|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
44371390|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
44699827|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44699828|NCT02723331|Gemcitabine|gemcitabine|mesh-list
44699829|NCT02723331|Paclitaxel|paclitaxel|mesh-list
44699830|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44699831|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44699832|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699833|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699834|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699835|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
44699836|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699837|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44699838|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
44699839|NCT02723331|Antiviral Agents|antiviral agents|mesh-ancestor
44882567|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44882568|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882569|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882570|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44882571|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
44882572|NCT04308174|Durvalumab|durvalumab|mesh-list
44371411|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44371412|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882573|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882574|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882575|NCT04308161|Vitamin D|vitamin d|mesh-list
44882576|NCT04308161|Miconazole|miconazole|mesh-list
44882577|NCT04308161|Vitamins|vitamins|mesh-ancestor
44882578|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
44882579|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882580|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44882581|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
44882582|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882583|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44882584|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882585|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882586|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882587|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44882588|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882589|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882590|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44882591|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44882592|NCT04308031|Digoxin|digoxin|mesh-list
44882593|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44882594|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44371433|NCT01201902|Vaccines|vaccines|mesh-list
44882595|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882596|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882597|NCT04308031|Protective Agents|protective agents|mesh-ancestor
44882598|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882599|NCT04308070|Hemostatics|hemostatics|mesh-list
44882600|NCT04308070|Coagulants|coagulants|mesh-ancestor
44882601|NCT04307693|Ritonavir|ritonavir|mesh-list
44882602|NCT04307693|Lopinavir|lopinavir|mesh-list
44882603|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
44882604|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44882605|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44882606|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
44882607|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882608|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882609|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44882610|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44371455|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44882611|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
44882612|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882613|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44882614|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882615|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
44882616|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44882617|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882618|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882619|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
44882620|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44882621|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882622|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882623|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882624|NCT04307290|Analgesics|analgesics|mesh-ancestor
44882625|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
44882626|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882627|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44882628|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44882629|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44882630|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
44882631|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882632|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882633|NCT04307147|Capecitabine|capecitabine|mesh-list
44371484|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44882634|NCT04307147|Vinorelbine|vinorelbine|mesh-list
44882635|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882636|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
44882637|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882638|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882639|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44882640|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
44882641|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
44882642|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
44882643|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
44882644|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
44882645|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882646|NCT04307069|Oxytocin|oxytocin|mesh-list
44882647|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
44882648|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882649|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882650|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
44882651|NCT04306913|Esmolol|esmolol|mesh-list
44882652|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44882653|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44882654|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44882655|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44882656|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882657|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882658|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882659|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44882660|NCT04306666|Anesthetics|anesthetics|mesh-list
44882661|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882662|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882663|NCT04306653|Betamethasone|betamethasone|mesh-list
44882664|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882665|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
44882666|NCT04306653|Hormones|hormones|mesh-ancestor
44882667|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882668|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882669|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44882670|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
44699840|NCT02723331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882671|NCT04306731|Trimethoprim|trimethoprim|mesh-list
44371494|NCT01202097|Hormones|hormones|mesh-ancestor
44882672|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44882673|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882674|NCT04306731|Renal Agents|renal agents|mesh-ancestor
44882675|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
44882676|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44882677|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882678|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44882679|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882680|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882681|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44882682|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44882683|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882684|NCT04306627|Amlodipine|amlodipine|mesh-list
44882685|NCT04306627|Perindopril|perindopril|mesh-list
44882686|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44882687|NCT04306627|Atorvastatin|atorvastatin|mesh-list
44882688|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882689|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882690|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
44882691|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882692|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44476060|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882693|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44882694|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882695|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44882696|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44882697|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882698|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44882699|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882700|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882701|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44882702|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
44882703|NCT04306354|Oxytocin|oxytocin|mesh-list
44882704|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
44882705|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882706|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882707|NCT04306276|Dienogest|dienogest|mesh-list
44882708|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44882709|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
44882710|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44882711|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882712|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44882713|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44882714|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44882715|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44882716|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882717|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882718|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44882719|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882720|NCT04306471|Evolocumab|evolocumab|mesh-list
44882721|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882722|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882723|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
44882724|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882725|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882726|NCT04306159|Anesthetics|anesthetics|mesh-list
44882727|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882728|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882729|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44882730|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44882731|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44882732|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882733|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882734|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44882735|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44882736|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882737|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
44882738|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882739|NCT04305964|Silicon|silicon|mesh-list
44882740|NCT04305964|Trace Elements|trace elements|mesh-ancestor
44882741|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
44882742|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371590|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
44671795|NCT01268839|Efavirenz|efavirenz|mesh-list
44671796|NCT01268839|Rilpivirine|rilpivirine|mesh-list
44882743|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
44882744|NCT04306042|Nivolumab|nivolumab|mesh-list
44882745|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882746|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882747|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44882748|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882749|NCT04306081|Evolocumab|evolocumab|mesh-list
44882750|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882751|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882752|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
44882753|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882754|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882755|NCT04305587|Clopidogrel|clopidogrel|mesh-list
44882756|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44882757|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44882758|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44882759|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44882760|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
44882761|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882762|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882763|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882764|NCT04305236|Fulvestrant|fulvestrant|mesh-list
44882765|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44882766|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882767|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44882768|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44882769|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
44882770|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882771|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882772|NCT04305028|Aspirin|aspirin|mesh-list
44882773|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
44882774|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44882775|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882776|NCT04305028|Analgesics|analgesics|mesh-ancestor
44882777|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
44882778|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882779|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882780|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882781|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882782|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44882783|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44882784|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882785|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44882786|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44882787|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882788|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
44882789|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44882790|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
44882791|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44882792|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
44882793|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
44882794|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44882795|NCT04304807|Melatonin|melatonin|mesh-list
44882796|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882797|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
44882798|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882799|NCT04304807|Protective Agents|protective agents|mesh-ancestor
44882800|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882801|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882802|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
44882803|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
44476061|NCT04020588|Analgesics|analgesics|mesh-ancestor
44882804|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882805|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882806|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
44882807|NCT04305015|Narcotics|narcotics|mesh-ancestor
44882808|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882809|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882810|NCT04305015|Analgesics|analgesics|mesh-ancestor
44882811|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
44882812|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882813|NCT04304716|Anesthetics|anesthetics|mesh-list
44882814|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882815|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882816|NCT04304573|Calcium|calcium|mesh-list
44882817|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371671|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882818|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882819|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
44882820|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44882821|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882822|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882823|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882824|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
44882825|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44882826|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44882827|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882828|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882829|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882830|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
44882831|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882832|NCT04304209|Capecitabine|capecitabine|mesh-list
44882833|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
44882834|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882835|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
44882836|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882837|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882838|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
44882839|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44882840|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44882841|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882842|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44882843|NCT04304157|Analgesics|analgesics|mesh-ancestor
44882844|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
44371686|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882845|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44882846|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44882847|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44882848|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44882849|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44882850|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44882851|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882852|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
44882853|NCT04304352|Capecitabine|capecitabine|mesh-list
44882854|NCT04304352|Vinorelbine|vinorelbine|mesh-list
44882855|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882856|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
44882857|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882858|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882859|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44882860|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
44882861|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882862|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882863|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44882864|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882865|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
44882866|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44882867|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
44882868|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
44882869|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44882870|NCT04304261|Metformin|metformin|mesh-list
44882871|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
44882872|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882873|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882874|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44882875|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882876|NCT04304248|Paclitaxel|paclitaxel|mesh-list
44882877|NCT04304248|Carboplatin|carboplatin|mesh-list
44882878|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44882879|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44882880|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699841|NCT02723331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699842|NCT02723331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699843|NCT02723331|Immunologic Factors|immunologic factors|mesh-ancestor
44699844|NCT02723331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699845|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
44699846|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
44699847|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699848|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
44882881|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
44882882|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
44882883|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
44882884|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882885|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
44882886|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882887|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
44882888|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44882889|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44882890|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882891|NCT04304313|Urological Agents|urological agents|mesh-ancestor
44882892|NCT04304196|TEMPO|tempo|mesh-list
44882893|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
44882894|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882895|NCT04304196|Protective Agents|protective agents|mesh-ancestor
44882896|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672009|NCT01269450|Progesterone|progesterone|mesh-list
44882897|NCT04303741|Apatinib|apatinib|mesh-list
44882898|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882899|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44882900|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882901|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882902|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44882903|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882904|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882905|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
44882906|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882907|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882908|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44882909|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882910|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
44882911|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882912|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882913|NCT04303988|Bevacizumab|bevacizumab|mesh-list
44882914|NCT04303988|Cisplatin|cisplatin|mesh-list
44882915|NCT04303988|Carboplatin|carboplatin|mesh-list
44882916|NCT04303988|Temozolomide|temozolomide|mesh-list
44882917|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44882918|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882919|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44882920|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44882921|NCT04303988|Growth Substances|growth substances|mesh-ancestor
44882922|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882923|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44882924|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44882925|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
44882926|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882927|NCT04303819|Exenatide|exenatide|mesh-list
44371797|NCT01203735|Valproic Acid|valproic acid|mesh-list
44882928|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44882929|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882930|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44882931|NCT04303819|Incretins|incretins|mesh-ancestor
44882932|NCT04303819|Hormones|hormones|mesh-ancestor
44882933|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44882934|NCT04303767|Calcium|calcium|mesh-list
44882935|NCT04303767|Caseins|caseins|mesh-list
44882936|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44882937|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882938|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
44882939|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
44882940|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882941|NCT04304014|Sulfalene|sulfalene|mesh-list
44882942|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882943|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44882944|NCT04304014|Renal Agents|renal agents|mesh-ancestor
44882945|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
44882946|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44882947|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44882948|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
44882949|NCT04303520|Fludarabine|fludarabine|mesh-list
44882950|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44882951|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
44882952|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882953|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44882954|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44882955|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
44882956|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882957|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882958|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44882959|NCT04303377|Evolocumab|evolocumab|mesh-list
44882960|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44882961|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44882962|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
44882963|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882964|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44882965|NCT04303312|Benzydamine|benzydamine|mesh-list
44882966|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882967|NCT04303429|Capecitabine|capecitabine|mesh-list
44882968|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44882969|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
44882970|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882971|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882973|NCT04303598|Lamivudine|lamivudine|mesh-list
44882974|NCT04303598|Efavirenz|efavirenz|mesh-list
44882975|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
44882976|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44882977|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44882978|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44882979|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44882980|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44882981|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44882982|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44882983|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44882984|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44882985|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44882986|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44882987|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44882988|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44882989|NCT04303130|Endostar protein|endostar protein|mesh-list
44882990|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44882991|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44882992|NCT04303130|Growth Substances|growth substances|mesh-ancestor
44882993|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44882994|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44882995|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44882996|NCT04303065|Dexamethasone|dexamethasone|mesh-list
44882997|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44882998|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
44882999|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
44883000|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883001|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883002|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883003|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
43596802|NCT03315000|Xhance|xhance|mesh-list
44883004|NCT04303065|Hormones|hormones|mesh-ancestor
44883005|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883006|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44883007|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883008|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
44883009|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44883010|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
44883011|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883012|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883013|NCT04302532|Ubiquinone|ubiquinone|mesh-list
44883014|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
44883015|NCT04302532|Clomiphene|clomiphene|mesh-list
44883016|NCT04302532|Enclomiphene|enclomiphene|mesh-list
44883017|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
44883018|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44883019|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883020|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883021|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883022|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44883023|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
44883024|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883025|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44883026|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44883027|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
44883028|NCT04302532|Vitamins|vitamins|mesh-ancestor
44883029|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
44883030|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44883031|NCT04302402|Rifaximin|rifaximin|mesh-list
44883032|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883033|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371898|NCT01204190|Progestins|progestins|mesh-ancestor
44883034|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883035|NCT04302441|Capecitabine|capecitabine|mesh-list
44883036|NCT04302441|Vinorelbine|vinorelbine|mesh-list
44883037|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883038|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
44883039|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883040|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883041|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44883042|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883043|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44883044|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883045|NCT04302584|Vasopressins|vasopressins|mesh-list
44883046|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
44883047|NCT04302584|Norepinephrine|norepinephrine|mesh-list
44883048|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44883049|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44883050|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44883051|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883052|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883053|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883054|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
44883055|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
44883056|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883057|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44883058|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
44883059|NCT04302584|Coagulants|coagulants|mesh-ancestor
44883060|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44883061|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
44883062|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
44883063|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44883064|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
44883065|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
44883066|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883067|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883068|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44883069|NCT04302350|Analgesics|analgesics|mesh-ancestor
44883070|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
44883071|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371924|NCT01204320|Paclitaxel|paclitaxel|mesh-list
44883072|NCT04302116|Prednisolone|prednisolone|mesh-list
44883073|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44883074|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
44883075|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44883076|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
44883077|NCT04302116|Vigabatrin|vigabatrin|mesh-list
44883078|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44883079|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
44883080|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883081|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
44883082|NCT04302116|Hormones|hormones|mesh-ancestor
44883083|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883084|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883085|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44883086|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883087|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
44883088|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
44883089|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883090|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883091|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44883092|NCT04302116|Protective Agents|protective agents|mesh-ancestor
44883093|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
44883094|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883095|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883096|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
44883097|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883098|NCT04301908|Interferons|interferons|mesh-list
44883099|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883100|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
44883101|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883102|NCT04301895|Remifentanil|remifentanil|mesh-list
44883103|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44883104|NCT04301895|Narcotics|narcotics|mesh-ancestor
44883105|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883106|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883107|NCT04301895|Analgesics|analgesics|mesh-ancestor
44883108|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
44883109|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883110|NCT04301882|Interferons|interferons|mesh-list
44883111|NCT04301882|Ribavirin|ribavirin|mesh-list
44883112|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
44883113|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883114|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883115|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
44883116|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883117|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44883118|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883119|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
44883120|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44883121|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44883122|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44883123|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883124|NCT04301739|Paclitaxel|paclitaxel|mesh-list
44883125|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
44883126|NCT04301739|Carboplatin|carboplatin|mesh-list
44883127|NCT04301739|Doxorubicin|doxorubicin|mesh-list
44883128|NCT04301739|Epirubicin|epirubicin|mesh-list
44883129|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44883130|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883131|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883132|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
44883133|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883134|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883135|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883136|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
44883137|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883138|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883139|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44883140|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
44883141|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44883142|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44883143|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44371971|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883144|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44883145|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883146|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
44883147|NCT04301583|Procyanidin|procyanidin|mesh-list
44883148|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
44883149|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883150|NCT04301583|Protective Agents|protective agents|mesh-ancestor
44883151|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883152|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44883153|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44883154|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883155|NCT04301557|Capecitabine|capecitabine|mesh-list
44883156|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
44883157|NCT04301557|Antibodies|antibodies|mesh-list
44883158|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
44883159|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883160|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883161|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
44883162|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883163|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699849|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
44699850|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699851|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699852|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699853|NCT02719314|Hormones|hormones|mesh-ancestor
44699854|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699855|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44699856|NCT02719314|Protective Agents|protective agents|mesh-ancestor
44699857|NCT02711826|Acetaminophen|acetaminophen|mesh-list
44699858|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
44699859|NCT02711826|Promethazine|promethazine|mesh-list
44699860|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
44699861|NCT02711826|Everolimus|everolimus|mesh-list
44699862|NCT02711826|Tacrolimus|tacrolimus|mesh-list
44699863|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699864|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
44699865|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699866|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44699867|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699868|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699869|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699870|NCT02711826|Analgesics|analgesics|mesh-ancestor
44699871|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
44699872|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699873|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
44699874|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699875|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44883165|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44883166|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44372022|NCT01204580|Metformin|metformin|mesh-list
44883167|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44883168|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883169|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44883170|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883171|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883172|NCT04301349|Misoprostol|misoprostol|mesh-list
44883173|NCT04301349|Dinoprostone|dinoprostone|mesh-list
44883174|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44883175|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
44883176|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883177|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883178|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44883179|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883180|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
44883181|NCT04301336|Zinc|zinc|mesh-list
44883182|NCT04301336|Folic Acid|folic acid|mesh-list
44883183|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
44883184|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
44883185|NCT04301336|Morphine|morphine|mesh-list
44883186|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
44883187|NCT04301336|Simvastatin|simvastatin|mesh-list
44883188|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44883189|NCT04301336|Narcotics|narcotics|mesh-ancestor
44883190|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883191|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883192|NCT04301336|Analgesics|analgesics|mesh-ancestor
44883193|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
44883194|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883195|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44883196|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44883197|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
44883198|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372086|NCT01205022|Fluorouracil|fluorouracil|mesh-list
44883199|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44883200|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44883201|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883202|NCT04301336|Trace Elements|trace elements|mesh-ancestor
44883203|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
44883204|NCT04301336|Hematinics|hematinics|mesh-ancestor
44883205|NCT04301336|Vitamins|vitamins|mesh-ancestor
44883206|NCT04301336|Astringents|astringents|mesh-ancestor
44883207|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44883208|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883209|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
44883210|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883211|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
44883212|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44883213|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
44883214|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
44883215|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883216|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883217|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44883218|NCT04301024|Analgesics|analgesics|mesh-ancestor
44883219|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
44883220|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883221|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44883222|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44883223|NCT04300959|Gemcitabine|gemcitabine|mesh-list
44883224|NCT04300959|Cisplatin|cisplatin|mesh-list
44883225|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372114|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
44883226|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883227|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
44883228|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883229|NCT04300959|Antiviral Agents|antiviral agents|mesh-ancestor
44883230|NCT04300959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883231|NCT04300959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883232|NCT04300959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883233|NCT04300959|Immunologic Factors|immunologic factors|mesh-ancestor
44883234|NCT04300959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883235|NCT04301375|Paclitaxel|paclitaxel|mesh-list
44883236|NCT04301375|Trastuzumab|trastuzumab|mesh-list
44883237|NCT04301375|Pertuzumab|pertuzumab|mesh-list
44672359|NCT01278082|Budesonide|budesonide|mesh-list
44883238|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372130|NCT01205087|Omeprazole|omeprazole|mesh-list
44883239|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883240|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883242|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883243|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883244|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883245|NCT04300686|Adalimumab|adalimumab|mesh-list
44883246|NCT04300686|Antibodies|antibodies|mesh-list
44883247|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
44883248|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
44883249|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883250|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883251|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883252|NCT04300881|Eplerenone|eplerenone|mesh-list
44883253|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44883254|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883255|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883256|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883257|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44883258|NCT04300881|Diuretics|diuretics|mesh-ancestor
44883259|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
44883260|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44883261|NCT04300452|Carbetocin|carbetocin|mesh-list
44883262|NCT04300452|Ergonovine|ergonovine|mesh-list
44883263|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
44883264|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883265|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883266|NCT04300374|Anesthetics|anesthetics|mesh-list
44883267|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883268|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883269|NCT04300322|Progesterone|progesterone|mesh-list
44883270|NCT04300322|Progestins|progestins|mesh-ancestor
44883271|NCT04300322|Hormones|hormones|mesh-ancestor
44883272|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883273|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883274|NCT04299971|Methotrexate|methotrexate|mesh-list
44883275|NCT04299971|Tofacitinib|tofacitinib|mesh-list
44883276|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44372147|NCT01205178|Chloroquine|chloroquine|mesh-list
44883277|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
44883278|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883279|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883280|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883281|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
44883282|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883283|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883284|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
44883285|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883286|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44883287|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883288|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
44883289|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883290|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883291|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44883292|NCT04299633|Calcium|calcium|mesh-list
44883293|NCT04299633|Sevelamer|sevelamer|mesh-list
44883294|NCT04299633|Calcium acetate|calcium acetate|mesh-list
44883295|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44883296|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883297|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
44883298|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
44883299|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883300|NCT04299854|Dinoprostone|dinoprostone|mesh-list
44883301|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
44883302|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883303|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883304|NCT04298775|Morphine|morphine|mesh-list
44883305|NCT04298775|Anesthetics|anesthetics|mesh-list
44883306|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883307|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883308|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44883309|NCT04298775|Narcotics|narcotics|mesh-ancestor
44883310|NCT04298775|Analgesics|analgesics|mesh-ancestor
44883311|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
44883312|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883313|NCT04298684|Metformin|metformin|mesh-list
44883314|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44883315|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44883316|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883317|NCT04298684|Incretins|incretins|mesh-ancestor
44883318|NCT04298684|Hormones|hormones|mesh-ancestor
44476062|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
44883319|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883320|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44883321|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
44883322|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883323|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883324|NCT04298372|Lenalidomide|lenalidomide|mesh-list
44883325|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
44883326|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883327|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44883328|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44883329|NCT04298372|Growth Substances|growth substances|mesh-ancestor
44883330|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44883331|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883332|NCT04298021|Durvalumab|durvalumab|mesh-list
44883333|NCT04298021|Olaparib|olaparib|mesh-list
44883334|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883335|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883336|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44883337|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883338|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883339|NCT04298008|Durvalumab|durvalumab|mesh-list
44883340|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883341|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883342|NCT04297839|Heparin|heparin|mesh-list
44883343|NCT04297839|Calcium heparin|calcium heparin|mesh-list
44883344|NCT04297839|Citric Acid|citric acid|mesh-list
44883345|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
44883346|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
44883347|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44883348|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
44883349|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
44883350|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883351|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44883352|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44883353|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
44883354|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44883355|NCT04297215|Chitosan|chitosan|mesh-list
44883356|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44883357|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44883358|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
44883359|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883360|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44883361|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
44883362|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
44372245|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883363|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
44883364|NCT04297215|Coagulants|coagulants|mesh-ancestor
44883365|NCT04297202|Apatinib|apatinib|mesh-list
44883366|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883367|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44883368|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883369|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883370|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44883371|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
44883372|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883373|NCT04297462|Oseltamivir|oseltamivir|mesh-list
44883374|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
44883375|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883376|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883377|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883378|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
44672520|NCT01281150|Paclitaxel|paclitaxel|mesh-list
44883379|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44883380|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
44883381|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44883382|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
44883383|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883384|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883385|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
44883387|NCT04297033|L 647318|l 647318|mesh-list
44883388|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
44883389|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44883390|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44883391|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
44883392|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883393|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44883394|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44883395|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699876|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44699877|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
44699878|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699879|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699880|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44699881|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44699882|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699883|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699884|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
44699885|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
44699886|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
44699887|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44699888|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44699889|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
44699890|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
44699891|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44699892|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44699893|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
44699894|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44699895|NCT02684253|Nivolumab|nivolumab|mesh-list
44699896|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44699897|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699898|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44699899|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699900|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44699902|NCT02666794|Morphine|morphine|mesh-list
44699903|NCT02666794|Dsuvia|dsuvia|mesh-list
44699904|NCT02666794|Bupivacaine|bupivacaine|mesh-list
44699905|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
44699906|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
44699907|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44699908|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699909|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
44699910|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699911|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44699912|NCT02666794|Narcotics|narcotics|mesh-ancestor
44699913|NCT02666794|Analgesics|analgesics|mesh-ancestor
44699914|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44699915|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44699916|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
44699917|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
44699918|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
44699919|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699920|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699921|NCT02642094|Sirolimus|sirolimus|mesh-list
44699922|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44699923|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44699924|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44699925|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699926|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
44699927|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699928|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
44699929|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699930|NCT02636569|Diclofenac|diclofenac|mesh-list
44699931|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44699932|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44699933|NCT02636569|Analgesics|analgesics|mesh-ancestor
44699934|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
44699935|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44699936|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699937|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883396|NCT04296851|Niclosamide|niclosamide|mesh-list
44883398|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44883399|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
44883400|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44883401|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883402|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
44883403|NCT04296422|Ibuprofen|ibuprofen|mesh-list
44883404|NCT04296422|Diclofenac|diclofenac|mesh-list
44883405|NCT04296422|Naproxen|naproxen|mesh-list
44883406|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44883407|NCT04296422|Piroxicam|piroxicam|mesh-list
44883408|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
44883409|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
44883410|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44883411|NCT04296422|Analgesics|analgesics|mesh-ancestor
44883412|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
44883413|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883414|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883415|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883416|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883417|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44883418|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883419|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883420|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
44883421|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883422|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44883423|NCT04296578|Selenious Acid|selenious acid|mesh-list
44883424|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
44883425|NCT04296578|Prednisone|prednisone|mesh-list
44883426|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
44883427|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883428|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
44883429|NCT04296578|Hormones|hormones|mesh-ancestor
44476063|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372367|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883430|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883431|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883432|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44883433|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883434|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44883435|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883436|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883437|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883438|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883439|NCT04296578|Trace Elements|trace elements|mesh-ancestor
44883440|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
44883441|NCT04296695|Tenofovir|tenofovir|mesh-list
44883442|NCT04296695|Efavirenz|efavirenz|mesh-list
44883443|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
44883444|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883445|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44883446|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883447|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883448|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883449|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44883450|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44883451|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44883452|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883453|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44883454|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44883455|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44883456|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44883457|NCT04296214|Azacitidine|azacitidine|mesh-list
44883458|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883459|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
44883460|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883461|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883462|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883463|NCT04296240|Capecitabine|capecitabine|mesh-list
44883464|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
44883465|NCT04296240|Antiemetics|antiemetics|mesh-list
44883466|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883467|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
44883468|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883469|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883470|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
44672600|NCT01281605|Insulin|insulin|mesh-list
44883471|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883472|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883473|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883474|NCT04296370|Apatinib|apatinib|mesh-list
44883475|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883476|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44883477|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883478|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883479|NCT04296383|Azithromycin|azithromycin|mesh-list
44883480|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883481|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883482|NCT04296175|Paclitaxel|paclitaxel|mesh-list
44883483|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44883484|NCT04296175|Carboplatin|carboplatin|mesh-list
44883485|NCT04296175|Epirubicin|epirubicin|mesh-list
44883486|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44883487|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883488|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883489|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
44883490|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883491|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883492|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44883493|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44883494|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44883495|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883496|NCT04296162|Capecitabine|capecitabine|mesh-list
44883497|NCT04296162|Trastuzumab|trastuzumab|mesh-list
44883498|NCT04296162|Vinorelbine|vinorelbine|mesh-list
44883499|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883500|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
44883501|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883502|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883503|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883504|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372459|NCT01206270|Hormones|hormones|mesh-ancestor
44883505|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
44883506|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
44883507|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883508|NCT04295993|Norepinephrine|norepinephrine|mesh-list
44883509|NCT04295993|Methylene Blue|methylene blue|mesh-list
44883510|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44883511|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44883512|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
44883513|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883514|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883515|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883516|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
44883517|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
44372468|NCT01206348|Clindamycin|clindamycin|mesh-list
44883518|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883519|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44883520|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883521|NCT04295967|Formaldehyde|formaldehyde|mesh-list
44883522|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
44883523|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883524|NCT04296149|Octreotide|octreotide|mesh-list
44883525|NCT04296149|Edotreotide|edotreotide|mesh-list
44883526|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883527|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44883528|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883529|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44883530|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883531|NCT04295408|Ropivacaine|ropivacaine|mesh-list
44883532|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883533|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
44883534|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372481|NCT01206530|Leucovorin|leucovorin|mesh-list
44883535|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883536|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
44883537|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883538|NCT04295317|Capecitabine|capecitabine|mesh-list
44883539|NCT04295317|Antibodies|antibodies|mesh-list
44883540|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
44883541|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
44883542|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883543|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883544|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
44883545|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883546|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883547|NCT04295551|Ritonavir|ritonavir|mesh-list
44883548|NCT04295551|Lopinavir|lopinavir|mesh-list
44883549|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44883550|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44883551|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
44883552|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883553|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699938|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883554|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44883555|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44883556|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
44883557|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883558|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44883559|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883560|NCT04295629|Anesthetics|anesthetics|mesh-list
44883561|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883562|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883563|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
44883564|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883565|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44883566|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372524|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44883567|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883568|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883569|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883570|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883571|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883572|NCT04294823|Esomeprazole|esomeprazole|mesh-list
44883573|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44883574|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883575|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44883576|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883577|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883578|NCT04294966|Dronabinol|dronabinol|mesh-list
44883579|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
44883580|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883581|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44372531|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
44883582|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44883583|NCT04294966|Analgesics|analgesics|mesh-ancestor
44883584|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
44883585|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883586|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44883587|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44883588|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883589|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883590|NCT04294966|Hormones|hormones|mesh-ancestor
44883591|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883592|NCT04294732|Bupivacaine|bupivacaine|mesh-list
44883593|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883594|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
44883595|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883596|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883597|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
44883598|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883599|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44883600|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44883601|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44883602|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44883603|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883604|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883605|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883606|NCT04294953|Analgesics|analgesics|mesh-ancestor
44883607|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
44883608|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883609|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
44883610|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44883611|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
44883612|NCT04294992|Ondansetron|ondansetron|mesh-list
44883613|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
44883614|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
44883615|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883616|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883617|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883618|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
44883619|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
44883620|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44883621|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
44883622|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883623|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883624|NCT04294992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44883625|NCT04294992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44883626|NCT04294992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883627|NCT04294992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44883628|NCT04294992|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44883629|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44883630|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883631|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883632|NCT04294537|Anesthetics|anesthetics|mesh-list
44883633|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883634|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883635|NCT04294329|Bupivacaine|bupivacaine|mesh-list
44883636|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883637|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
44883638|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883639|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883640|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
44883641|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883642|NCT04294056|Propofol|propofol|mesh-list
44883643|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44883644|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883645|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883646|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44883647|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
44883648|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
44883649|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
44883650|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44883651|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
44883652|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883653|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883654|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883655|NCT04293809|Bupivacaine|bupivacaine|mesh-list
44883656|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883657|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
44883658|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883659|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883660|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
44883661|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883662|NCT04293822|Cetirizine|cetirizine|mesh-list
44883663|NCT04293822|Minoxidil|minoxidil|mesh-list
44883664|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44883665|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44883666|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44883667|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
44883668|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
44883669|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883670|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883671|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883672|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44883673|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
44883674|NCT04293887|Interferons|interferons|mesh-list
44883675|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883676|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
44883677|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672900|NCT01283048|Bevacizumab|bevacizumab|mesh-list
44883678|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44883679|NCT04293549|Mitogens|mitogens|mesh-list
44883680|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44883681|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883682|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44883683|NCT04293419|Durvalumab|durvalumab|mesh-list
44883684|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883685|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883686|NCT04293081|Maleic acid|maleic acid|mesh-list
44883687|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883688|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883689|NCT04293172|Ticagrelor|ticagrelor|mesh-list
44699939|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44699940|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699941|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699942|NCT02636322|Prednisone|prednisone|mesh-list
44699943|NCT02636322|Cortisone|cortisone|mesh-list
44699944|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
44699945|NCT02636322|Rituximab|rituximab|mesh-list
44699946|NCT02636322|Doxorubicin|doxorubicin|mesh-list
44699947|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44699948|NCT02636322|Etoposide|etoposide|mesh-list
44699949|NCT02636322|Vincristine|vincristine|mesh-list
44699950|NCT02636322|Lenalidomide|lenalidomide|mesh-list
44699951|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
44699952|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
44699953|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44699954|NCT02636322|Antibodies|antibodies|mesh-list
44699955|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
44699956|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44699957|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44699958|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
44699959|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699960|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44699961|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44699962|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
44699963|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44699964|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699965|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44699966|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44699967|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44699968|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44699969|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44699970|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699971|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
44699972|NCT02636322|Hormones|hormones|mesh-ancestor
44699973|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699974|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699975|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251567|NCT04951388|Somatomedin B|somatomedin b|mesh-list
44699976|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44699977|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44699983|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
44699984|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44699985|NCT02619552|Prednisone|prednisone|mesh-list
44699986|NCT02619552|Budesonide|budesonide|mesh-list
44699987|NCT02619552|Adalimumab|adalimumab|mesh-list
44699988|NCT02619552|Infliximab|infliximab|mesh-list
44699989|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
44699990|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44699991|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
44699992|NCT02619552|Hormones|hormones|mesh-ancestor
44699993|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44699994|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44699995|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44699996|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44699997|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44699998|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
44699999|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700000|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44700001|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
44700002|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700003|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700004|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700005|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700006|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
44700007|NCT02578368|Leucovorin|leucovorin|mesh-list
44883690|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44883691|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44883692|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44883693|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44883694|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
44883695|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883696|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883697|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883699|NCT04292990|Morphine|morphine|mesh-list
44883700|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44883701|NCT04292990|Narcotics|narcotics|mesh-ancestor
44883702|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883703|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883704|NCT04292990|Analgesics|analgesics|mesh-ancestor
44883705|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
44883706|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883707|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44883708|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44883709|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
44883710|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
44883711|NCT04292886|Tamoxifen|tamoxifen|mesh-list
44883712|NCT04292886|Ascorbic Acid|ascorbic acid|mesh-list
44883713|NCT04292886|Vitamins|vitamins|mesh-ancestor
44883714|NCT04292886|Micronutrients|micronutrients|mesh-ancestor
44883715|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883716|NCT04292886|Antioxidants|antioxidants|mesh-ancestor
44883717|NCT04292886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883718|NCT04292886|Protective Agents|protective agents|mesh-ancestor
44883719|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44883720|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883721|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883722|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44883723|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883724|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44883725|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44883726|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44883727|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
44883728|NCT04292418|Tacrolimus|tacrolimus|mesh-list
44883729|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883730|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
44883731|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883732|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44883733|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883734|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883735|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44883736|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883737|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44883738|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
44883739|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883740|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883741|NCT04292444|Oxytocin|oxytocin|mesh-list
44883742|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
44883743|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883744|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883745|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
44883746|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44883747|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
44883748|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
44883749|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883750|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883751|NCT04292691|Ropivacaine|ropivacaine|mesh-list
44883752|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883753|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
44883754|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883755|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883756|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
44883757|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883758|NCT04292769|Decitabine|decitabine|mesh-list
44883759|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44883760|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
44883761|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883762|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883763|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883764|NCT04292704|Clotrimazole|clotrimazole|mesh-list
44883765|NCT04292704|Miconazole|miconazole|mesh-list
44883766|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44883767|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883768|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
44883769|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44883770|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883771|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883772|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883773|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44883774|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883775|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883776|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883777|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44883778|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44883779|NCT04292119|Crizotinib|crizotinib|mesh-list
44372807|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
44372808|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372809|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372810|NCT05553613|Clopidogrel|clopidogrel|mesh-list
44372811|NCT05553613|Ticagrelor|ticagrelor|mesh-list
44372812|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44883780|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883781|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44883782|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883783|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883784|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
44883785|NCT04292184|Antidotes|antidotes|mesh-ancestor
44883786|NCT04292184|Protective Agents|protective agents|mesh-ancestor
44883787|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883788|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
44883789|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883790|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
44883791|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883792|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883793|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
44883794|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
44883795|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44883796|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
44883797|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44883798|NCT04292236|Protective Agents|protective agents|mesh-ancestor
44883799|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883800|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883801|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
44883802|NCT04292314|Deferoxamine|deferoxamine|mesh-list
44883803|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883804|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
44883805|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883806|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883807|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883808|NCT04292314|Siderophores|siderophores|mesh-ancestor
44883809|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44883810|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
44883811|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
44883812|NCT04291794|Propofol|propofol|mesh-list
44883813|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44883814|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883815|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883816|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44883817|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
44883818|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
44883819|NCT04291729|Interferons|interferons|mesh-list
44883820|NCT04291729|Ritonavir|ritonavir|mesh-list
44883821|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883822|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
44883823|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883824|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44883825|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44883826|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44883827|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883828|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883829|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44883830|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44372815|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44883831|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44883832|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883833|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44883834|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44883835|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883836|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
44883837|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
44883838|NCT04291755|Nivolumab|nivolumab|mesh-list
44883839|NCT04291755|Ipilimumab|ipilimumab|mesh-list
44883840|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883841|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883842|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44883843|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883844|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44883845|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44883846|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883847|NCT04291313|Vitamin D|vitamin d|mesh-list
44883848|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
44883849|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
44883850|NCT04291313|Vitamins|vitamins|mesh-list
44883851|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
44883852|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883853|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44883854|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44883855|NCT04291456|Minocycline|minocycline|mesh-list
44883856|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883857|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883858|NCT04290819|Caffeine|caffeine|mesh-list
44883859|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44883860|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883861|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44883862|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883863|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883864|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44883865|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44883866|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
44883867|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883868|NCT04290936|Tenofovir|tenofovir|mesh-list
44883869|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
44883870|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883871|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44883872|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883873|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883874|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883875|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44883876|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44700008|NCT02578368|Docetaxel|docetaxel|mesh-list
44700009|NCT02578368|Fluorouracil|fluorouracil|mesh-list
44700010|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
44700011|NCT02578368|Trastuzumab|trastuzumab|mesh-list
44700012|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
44700013|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700014|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700015|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700016|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700017|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700018|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700019|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
44700020|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700021|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700022|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
44700023|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700024|NCT02578368|Antidotes|antidotes|mesh-ancestor
44700025|NCT02578368|Protective Agents|protective agents|mesh-ancestor
44700026|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
44700027|NCT02578368|Vitamins|vitamins|mesh-ancestor
44700028|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
44700029|NCT02575963|Cytarabine|cytarabine|mesh-list
44700030|NCT02575963|Lintuzumab|lintuzumab|mesh-list
44700031|NCT02575963|Furosemide|furosemide|mesh-list
44700032|NCT02575963|Spironolactone|spironolactone|mesh-list
44700033|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700034|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
44700035|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700036|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700037|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
44700038|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700039|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700040|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
44700041|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700042|NCT02575963|Diuretics|diuretics|mesh-ancestor
44700043|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
44700044|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44700045|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700046|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44700047|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
44700048|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700049|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44700050|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700052|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
44700053|NCT02539225|Ramucirumab|ramucirumab|mesh-list
44700054|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700055|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700056|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700057|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700058|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700059|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700060|NCT02535650|Tipifarnib|tipifarnib|mesh-list
44700061|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700062|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
44883877|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
44883878|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44883879|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
44883880|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883881|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883882|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44883883|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
44883884|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44883885|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
44883886|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883887|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883888|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44883889|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44883890|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
44883891|NCT04290871|Protective Agents|protective agents|mesh-ancestor
44883892|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
44883893|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44883894|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883895|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
44883896|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883897|NCT04291066|Expectorants|expectorants|mesh-ancestor
44883898|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
44883899|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44883900|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
44883901|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883902|NCT04291066|Protective Agents|protective agents|mesh-ancestor
44883903|NCT04291066|Antidotes|antidotes|mesh-ancestor
44883904|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
44883905|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44883906|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44883907|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883908|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
44883909|NCT04290884|Coagulants|coagulants|mesh-ancestor
44883910|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
44883911|NCT04290793|Trastuzumab|trastuzumab|mesh-list
44883912|NCT04290793|Epirubicin|epirubicin|mesh-list
44883913|NCT04290793|Taxane|taxane|mesh-list
44883914|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44883915|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
44883916|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883917|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44883918|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44883919|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
44883920|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883921|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44883922|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44883923|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44883924|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44883925|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44883926|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44883927|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883928|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
44883929|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44883930|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
44883931|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883932|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883933|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44883934|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
44883935|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44883936|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
44883937|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883938|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44883939|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44883940|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
44883941|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
44883942|NCT04290858|Protective Agents|protective agents|mesh-ancestor
44883943|NCT04291118|Budesonide|budesonide|mesh-list
44883944|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44883945|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44883946|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
44883947|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883948|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883949|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44883950|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44883951|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
44883952|NCT04291118|Hormones|hormones|mesh-ancestor
44883953|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883954|NCT04290442|Ropivacaine|ropivacaine|mesh-list
44883955|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
44883956|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
44883957|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44883958|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883959|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
44883960|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44883961|NCT04290455|Castor Oil|castor oil|mesh-list
44883962|NCT04290455|Cathartics|cathartics|mesh-ancestor
44883963|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883964|NCT04290429|Teduglutide|teduglutide|mesh-list
44883965|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44883966|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44883967|NCT04290429|Protective Agents|protective agents|mesh-ancestor
44883968|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883969|NCT04290572|Isotretinoin|isotretinoin|mesh-list
44883970|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44883971|NCT04290390|Itraconazole|itraconazole|mesh-list
44883972|NCT04290390|Rifampin|rifampin|mesh-list
44883973|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44883974|NCT04290390|Estradiol|estradiol|mesh-list
44883975|NCT04290390|Estrogens|estrogens|mesh-ancestor
44883976|NCT04290390|Hormones|hormones|mesh-ancestor
44883977|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44883978|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44883979|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44883980|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
44883981|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44883982|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44883983|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
44883984|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44883985|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44883986|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44883987|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44883988|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44883989|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44883990|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44883991|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44883992|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44883993|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
44883994|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44883995|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
44883996|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44883997|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44883998|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44883999|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44884000|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44884001|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44884002|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44884003|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44884004|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44884005|NCT04290195|Aflibercept|aflibercept|mesh-list
44884006|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44884007|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884008|NCT04290195|Growth Substances|growth substances|mesh-ancestor
44884009|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884010|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884011|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884012|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
44884013|NCT04290013|Norethindrone|norethindrone|mesh-list
44884014|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
44884015|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44884016|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44884017|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884018|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
44884019|NCT04290013|Coagulants|coagulants|mesh-ancestor
44884020|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44884021|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44884022|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44884023|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
44884024|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44884025|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884026|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44884027|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44884028|NCT04290208|Acetaminophen|acetaminophen|mesh-list
44884029|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884030|NCT04290208|Analgesics|analgesics|mesh-ancestor
44884031|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
44884032|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884033|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884034|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
44884035|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
44884036|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44884037|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44884038|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44884039|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884040|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884041|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44884042|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884043|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884044|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44884045|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884046|NCT04290104|Ampicillin|ampicillin|mesh-list
44884047|NCT04290104|Sulbactam|sulbactam|mesh-list
44884048|NCT04290104|Sultamicillin|sultamicillin|mesh-list
44884049|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44884050|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884051|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44884052|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884053|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884054|NCT04290026|Metoclopramide|metoclopramide|mesh-list
44884055|NCT04290026|Granisetron|granisetron|mesh-list
44884056|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
44884057|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
44884058|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884059|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884060|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884061|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44884062|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44884063|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
44884064|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884065|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884066|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44884067|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
44884068|NCT04289675|Interferons|interferons|mesh-list
44884069|NCT04289675|Interferon-beta|interferon-beta|mesh-list
44884070|NCT04289675|Teriflunomide|teriflunomide|mesh-list
44884071|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44884072|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884073|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
44884074|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884075|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
44884076|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884077|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44884078|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884079|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884080|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884081|NCT04289675|Analgesics|analgesics|mesh-ancestor
44884082|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
44884083|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884084|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884085|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884086|NCT04289974|Fulvestrant|fulvestrant|mesh-list
44884087|NCT04289974|Palbociclib|palbociclib|mesh-list
44884088|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884089|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884090|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44884091|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44884092|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
44884093|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884094|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884095|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44884096|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884097|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884098|NCT04289883|Calcium|calcium|mesh-list
44884099|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44884100|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884101|NCT04289792|Gemcitabine|gemcitabine|mesh-list
44884102|NCT04289792|Paclitaxel|paclitaxel|mesh-list
44884103|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44884104|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884105|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
44884106|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
44884107|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
44884108|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884109|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44884110|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
44884111|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
44884112|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884113|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884114|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700063|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44700064|NCT02527681|Cephalosporins|cephalosporins|mesh-list
44700065|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700066|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700067|NCT02526017|Nivolumab|nivolumab|mesh-list
44700068|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700069|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700070|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44700071|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700072|NCT02516657|Liraglutide|liraglutide|mesh-list
44700073|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700074|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700075|NCT02516657|Incretins|incretins|mesh-ancestor
44700076|NCT02516657|Hormones|hormones|mesh-ancestor
44700077|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700078|NCT02500849|Busulfan|busulfan|mesh-list
44700079|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
44700080|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700081|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700082|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
44700083|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700084|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44700085|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700086|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44700087|NCT02427581|Poly I-C|poly i-c|mesh-list
44700088|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44700089|NCT02427581|Poly ICLC|poly iclc|mesh-list
44700090|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
44700091|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
44700092|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700093|NCT02427581|Laxatives|laxatives|mesh-ancestor
44700094|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700095|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
44700096|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700097|NCT02423525|Afatinib|afatinib|mesh-list
44700098|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700099|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700100|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700101|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700102|NCT02369653|Apixaban|apixaban|mesh-list
44700103|NCT02369653|Anticoagulants|anticoagulants|mesh-list
44700104|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44700105|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
44700106|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44700107|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
44700108|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700109|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700110|NCT02326974|Pertuzumab|pertuzumab|mesh-list
44700111|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700112|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700113|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
44700114|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44700115|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44700116|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700117|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
44700118|NCT02314988|Coagulants|coagulants|mesh-ancestor
44700119|NCT02299999|Gemcitabine|gemcitabine|mesh-list
44700120|NCT02299999|Vincristine|vincristine|mesh-list
44700121|NCT02299999|Vinorelbine|vinorelbine|mesh-list
44700122|NCT02299999|Vinblastine|vinblastine|mesh-list
44700123|NCT02299999|Docetaxel|docetaxel|mesh-list
44700124|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
44700125|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
44700126|NCT02299999|Bevacizumab|bevacizumab|mesh-list
44700127|NCT02299999|Cisplatin|cisplatin|mesh-list
44700128|NCT02299999|Carboplatin|carboplatin|mesh-list
44884115|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
44884116|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884118|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884119|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
44884120|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884121|NCT04289467|Fenfluramine|fenfluramine|mesh-list
44884122|NCT04289467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44884123|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44884124|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884125|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884126|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884127|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
44884128|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884129|NCT04289090|Propofol|propofol|mesh-list
44884130|NCT04289090|Sevoflurane|sevoflurane|mesh-list
44884131|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884132|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884133|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884134|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884135|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
44884136|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
44373226|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
44884137|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44884138|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44884139|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44884140|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44884141|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884143|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44884144|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
44884145|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884146|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884147|NCT04288999|Capecitabine|capecitabine|mesh-list
44884148|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44884149|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
44884150|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884151|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884152|NCT04288765|Dexamethasone|dexamethasone|mesh-list
44884153|NCT04288765|Lenalidomide|lenalidomide|mesh-list
44884154|NCT04288765|Daratumumab|daratumumab|mesh-list
44884155|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884156|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
44884157|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
44884158|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884159|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884160|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884161|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
44884162|NCT04288765|Hormones|hormones|mesh-ancestor
44884163|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884164|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884165|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884166|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
44884167|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44884168|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884169|NCT04288765|Growth Substances|growth substances|mesh-ancestor
44884170|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884171|NCT04288700|Timolol|timolol|mesh-list
44884172|NCT04288700|Propranolol|propranolol|mesh-list
44884173|NCT04288700|Captopril|captopril|mesh-list
44884174|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44884175|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44884176|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44884177|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44373282|NCT04420975|Nivolumab|nivolumab|mesh-list
44884178|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884179|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884180|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884181|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884182|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44884183|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44884184|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884185|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
44884186|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44884187|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
44884188|NCT04288349|Epinephrine|epinephrine|mesh-list
44884189|NCT04288349|Racepinephrine|racepinephrine|mesh-list
44884190|NCT04288349|Ropivacaine|ropivacaine|mesh-list
44884191|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
44884192|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884193|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
44884194|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884195|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884196|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
44884197|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884198|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44884199|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44884200|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884201|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884202|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884203|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44884204|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44884205|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
44884206|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44884207|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
44884208|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
44884209|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
44884210|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44884211|NCT04288232|Aflibercept|aflibercept|mesh-list
44884212|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44884213|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884214|NCT04288232|Growth Substances|growth substances|mesh-ancestor
44884215|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884216|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884217|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884218|NCT04288219|Nifedipine|nifedipine|mesh-list
44884219|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44884220|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884221|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884222|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44884223|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884224|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44884225|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
44884226|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44884227|NCT04287894|Cisplatin|cisplatin|mesh-list
44884228|NCT04287894|Pemetrexed|pemetrexed|mesh-list
44884229|NCT04287894|Durvalumab|durvalumab|mesh-list
44884230|NCT04287894|Tremelimumab|tremelimumab|mesh-list
44884231|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884232|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884233|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884234|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44884235|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44884236|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44884237|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
44884238|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44884239|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
44884240|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
44884241|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884242|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884243|NCT04287777|Mupirocin|mupirocin|mesh-list
44884244|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44884245|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884246|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44884247|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884248|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884249|NCT04287842|Sevoflurane|sevoflurane|mesh-list
44884250|NCT04287842|Desflurane|desflurane|mesh-list
44884251|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44884252|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44884253|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
44884254|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
44884255|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884256|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884257|NCT04287426|Remifentanil|remifentanil|mesh-list
44884258|NCT04287426|Rocuronium|rocuronium|mesh-list
44884259|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44884260|NCT04287426|Narcotics|narcotics|mesh-ancestor
44884261|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884262|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884263|NCT04287426|Analgesics|analgesics|mesh-ancestor
44884264|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
44884265|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884266|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44884267|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44884268|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44884269|NCT04287543|Melatonin|melatonin|mesh-list
44884270|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
44884271|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884272|NCT04287543|Protective Agents|protective agents|mesh-ancestor
44884273|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884274|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884275|NCT04287361|Clonazepam|clonazepam|mesh-list
44884276|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
44884277|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
44884278|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
44884279|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884280|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884281|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884282|NCT04287387|Pioglitazone|pioglitazone|mesh-list
44884283|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44884284|NCT04287387|Metformin|metformin|mesh-list
44884285|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
44884286|NCT04287387|Glimepiride|glimepiride|mesh-list
44884287|NCT04287387|Acarbose|acarbose|mesh-list
44884288|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673635|NCT01287741|Hormones|hormones|mesh-ancestor
44884289|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884290|NCT04287387|Incretins|incretins|mesh-ancestor
44884291|NCT04287387|Hormones|hormones|mesh-ancestor
44884292|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884293|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44884294|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
44884295|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884296|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884297|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44884298|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44884299|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884300|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
44884301|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44884302|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
44884303|NCT04287205|Progestins|progestins|mesh-ancestor
44884304|NCT04287205|Hormones|hormones|mesh-ancestor
44884305|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884306|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373451|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884307|NCT04286711|Paclitaxel|paclitaxel|mesh-list
44884308|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44884309|NCT04286711|Apatinib|apatinib|mesh-list
44884310|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44884311|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884312|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44884313|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44884314|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44884315|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884316|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44884317|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884318|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44884319|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
44884320|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44884321|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44884322|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44884323|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44884324|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884325|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884326|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884327|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884328|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44884329|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44884330|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
44884331|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700129|NCT02299999|Doxorubicin|doxorubicin|mesh-list
44884332|NCT04286503|Ritonavir|ritonavir|mesh-list
44884333|NCT04286503|Lopinavir|lopinavir|mesh-list
44884334|NCT04286503|Chloroquine|chloroquine|mesh-list
44884335|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44884336|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44884337|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44884338|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
44884339|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884340|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884341|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44884342|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44884343|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
44884344|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884345|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44884346|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44884347|NCT04286503|Amebicides|amebicides|mesh-ancestor
44884348|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44884349|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44884350|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
44884351|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884352|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884353|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884354|NCT04286503|Analgesics|analgesics|mesh-ancestor
44884355|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
44884356|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884357|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884358|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884359|NCT04286503|Filaricides|filaricides|mesh-ancestor
44884360|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
44884361|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
44884362|NCT04286035|Bupivacaine|bupivacaine|mesh-list
44884363|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884364|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
44884365|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884366|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884367|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
44884368|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884369|NCT04286087|Anesthetics|anesthetics|mesh-list
44884370|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884371|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884372|NCT04285775|Chrysarobin|chrysarobin|mesh-list
44884373|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884374|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884375|NCT04285775|Analgesics|analgesics|mesh-ancestor
44884376|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
44884377|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884378|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884379|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884380|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884381|NCT04286152|Mirabegron|mirabegron|mesh-list
44884382|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44884383|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44884384|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44884385|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373487|NCT04102098|Bevacizumab|bevacizumab|mesh-list
44884386|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884387|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884388|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884389|NCT04286152|Urological Agents|urological agents|mesh-ancestor
44884390|NCT04285528|Lidocaine|lidocaine|mesh-list
44884391|NCT04285528|Fentanyl|fentanyl|mesh-list
44884392|NCT04285528|Ketamine|ketamine|mesh-list
44884393|NCT04285528|Propofol|propofol|mesh-list
44884394|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884395|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
44884396|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884397|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884398|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
44884399|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884400|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44884401|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44884402|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44884403|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884404|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884405|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884406|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884407|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
44884408|NCT04285528|Analgesics|analgesics|mesh-ancestor
44884409|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44884410|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44884411|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44884412|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884413|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44884414|NCT04285528|Narcotics|narcotics|mesh-ancestor
44884415|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44884416|NCT04285281|Gabapentin|gabapentin|mesh-list
44884417|NCT04285281|Analgesics|analgesics|mesh-ancestor
44884418|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
44884419|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884420|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884421|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
44884422|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44884423|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44884424|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884425|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44884426|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44884427|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44884428|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373533|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
44884429|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884430|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
44700130|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44700131|NCT02299999|Capecitabine|capecitabine|mesh-list
44700132|NCT02299999|Methotrexate|methotrexate|mesh-list
44700133|NCT02299999|Durvalumab|durvalumab|mesh-list
44700134|NCT02299999|Epirubicin|epirubicin|mesh-list
44700135|NCT02299999|Olaparib|olaparib|mesh-list
44700136|NCT02299999|Mitomycins|mitomycins|mesh-list
44700137|NCT02299999|Mitomycin|mitomycin|mesh-list
44700138|NCT02299999|Bicalutamide|bicalutamide|mesh-list
44700139|NCT02299999|Taxane|taxane|mesh-list
44700140|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700141|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700142|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700143|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700144|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700145|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700146|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700147|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
44700148|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700149|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700150|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44700151|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
44700152|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44700153|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700154|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44700155|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44700156|NCT02299999|Growth Substances|growth substances|mesh-ancestor
44700157|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
44700158|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700159|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
44700160|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
44700161|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700162|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700163|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44700164|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44700165|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44700166|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44700167|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
44700168|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44700169|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700170|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44700171|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44700172|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44700173|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
44700174|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
44700175|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700176|NCT02293109|Leucovorin|leucovorin|mesh-list
44700177|NCT02293109|Cytarabine|cytarabine|mesh-list
44700178|NCT02293109|Dexamethasone|dexamethasone|mesh-list
44700179|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
44700180|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44700181|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44700182|NCT02293109|Prednisolone|prednisolone|mesh-list
44700183|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
44884432|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44884433|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884434|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
44884435|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
44884436|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
44884437|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884438|NCT04285268|Rituximab|rituximab|mesh-list
44884439|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44884440|NCT04285268|Bortezomib|bortezomib|mesh-list
44884441|NCT04285268|Venetoclax|venetoclax|mesh-list
44884442|NCT04285268|Antibodies|antibodies|mesh-list
44884443|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
44884444|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44884445|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
44884446|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884447|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884448|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884449|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44884450|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44884451|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884452|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
44884453|NCT04284826|Mitomycins|mitomycins|mesh-list
44884454|NCT04284826|Mitomycin|mitomycin|mesh-list
44884455|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44884456|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884457|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
44884458|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884459|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44884460|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884461|NCT04284644|Propofol|propofol|mesh-list
44884462|NCT04284644|Sevoflurane|sevoflurane|mesh-list
44884463|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884464|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884465|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884466|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884467|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
44884468|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
44884469|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44884470|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44884471|NCT04284722|Metformin|metformin|mesh-list
44884472|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44884473|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884474|NCT04284761|Bicalutamide|bicalutamide|mesh-list
44884475|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
44884476|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44884477|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884478|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884479|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884480|NCT04284852|Niraparib|niraparib|mesh-list
44884481|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44884482|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884483|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884484|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884485|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44884486|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44884487|NCT04284215|Paclitaxel|paclitaxel|mesh-list
44884488|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44884489|NCT04284215|Cisplatin|cisplatin|mesh-list
44884490|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44884491|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884492|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
44884493|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
44884494|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
44884495|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884496|NCT04284202|Dasatinib|dasatinib|mesh-list
44884497|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884498|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44884499|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884500|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884501|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
44884502|NCT04284098|Bupivacaine|bupivacaine|mesh-list
44884503|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884504|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
44884505|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884506|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884507|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
44373663|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
44884508|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884509|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884510|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884511|NCT04284098|Analgesics|analgesics|mesh-ancestor
44884512|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44884513|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44884514|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44884515|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884516|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884517|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884518|NCT04284150|Midazolam|midazolam|mesh-list
44884519|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
44884520|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884521|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884522|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884523|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884524|NCT04284150|Analgesics|analgesics|mesh-ancestor
44884525|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
44884526|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884527|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44884528|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44884529|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44884530|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884531|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884532|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884533|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44884534|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44884535|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44884536|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44884537|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884538|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
44884539|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
44884540|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
44884541|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
44884542|NCT04284059|Vitamin D|vitamin d|mesh-list
44884543|NCT04284059|Vitamins|vitamins|mesh-list
44884544|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
44884545|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884546|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44884547|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
44884548|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44884549|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884550|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884551|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
44884552|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884553|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884554|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
44884555|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44884556|NCT04283747|Antibodies|antibodies|mesh-list
44884557|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
44884558|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884559|NCT04284007|Dexamethasone|dexamethasone|mesh-list
44884560|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
44884561|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
44884562|NCT04284007|BB 1101|bb 1101|mesh-list
44884563|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884564|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
44884565|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
44884566|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884567|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884568|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884569|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
44884570|NCT04284007|Hormones|hormones|mesh-ancestor
44884571|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884572|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884573|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884574|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44884575|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884576|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884577|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884578|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
44884579|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884580|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
44884581|NCT04283877|Methylphenidate|methylphenidate|mesh-list
44884582|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44884583|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884584|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44884585|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44884586|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884587|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884588|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
44884589|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884590|NCT04283630|Ascorbic Acid|ascorbic acid|mesh-list
44884591|NCT04283630|Vitamins|vitamins|mesh-ancestor
44884592|NCT04283630|Micronutrients|micronutrients|mesh-ancestor
44884593|NCT04283630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884594|NCT04283630|Antioxidants|antioxidants|mesh-ancestor
44884595|NCT04283630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884596|NCT04283630|Protective Agents|protective agents|mesh-ancestor
44884597|NCT04283487|Levan|levan|mesh-list
44884598|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884599|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
44884600|NCT04283331|Propoxycaine|propoxycaine|mesh-list
44884601|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
44884602|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
44884603|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884604|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884605|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
44884606|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884607|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
44884608|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44884609|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44884610|NCT04283435|Estradiol|estradiol|mesh-list
44884611|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44884612|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884613|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884614|NCT04283435|Estrogens|estrogens|mesh-ancestor
44884615|NCT04283435|Hormones|hormones|mesh-ancestor
44884616|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884617|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44884618|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
44884619|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44884620|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44884621|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44884622|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44884623|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44884624|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884625|NCT04283435|Urological Agents|urological agents|mesh-ancestor
44884626|NCT04283292|Capsaicin|capsaicin|mesh-list
44884627|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
44884628|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44884629|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
44884630|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884631|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884632|NCT04283526|Decitabine|decitabine|mesh-list
44884633|NCT04283526|Spartalizumab|spartalizumab|mesh-list
44884634|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44884635|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
44884636|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884637|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884638|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884639|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44884640|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
44884641|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
44884642|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44884643|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44884644|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884645|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884646|NCT04283240|Urological Agents|urological agents|mesh-ancestor
44884647|NCT04282902|Pirfenidone|pirfenidone|mesh-list
44884648|NCT04282902|Analgesics|analgesics|mesh-ancestor
44884649|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
44884650|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884651|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884652|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884653|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884654|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884655|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884656|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884657|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
44884658|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
44884659|NCT04283162|Calcium|calcium|mesh-list
44884660|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44884661|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884662|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44884663|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
44884664|NCT04283162|Coagulants|coagulants|mesh-ancestor
44884665|NCT04282824|Edetic Acid|edetic acid|mesh-list
44884666|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44884667|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
44884668|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
44884669|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884670|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
44884671|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44884672|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44884673|NCT04283058|Ketamine|ketamine|mesh-list
44884674|NCT04283058|Anesthetics|anesthetics|mesh-list
44884675|NCT04283058|Analgesics|analgesics|mesh-ancestor
44884676|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
44884677|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884678|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884679|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44884680|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884681|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
44884682|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884683|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44884684|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44884685|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884686|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884687|NCT04282941|Ibuprofen|ibuprofen|mesh-list
44884688|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884689|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884690|NCT04282941|Analgesics|analgesics|mesh-ancestor
44884691|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
44884692|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884693|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884694|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884695|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884696|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44884697|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884698|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884699|NCT04283110|Midazolam|midazolam|mesh-list
44884700|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44884701|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884702|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884703|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884704|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44884705|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44884706|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44884707|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884708|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
44884709|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
44884710|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
44884711|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
44884712|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884713|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884714|NCT04282746|Ketamine|ketamine|mesh-list
44884715|NCT04282746|Analgesics|analgesics|mesh-ancestor
44884716|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
44884717|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884718|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884719|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44884720|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884721|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
44884722|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
44884723|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884724|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44884725|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44884726|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884727|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884728|NCT04282291|Morphine|morphine|mesh-list
44884729|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44674126|NCT01290003|Tazobactam|tazobactam|mesh-list
44884730|NCT04282291|Narcotics|narcotics|mesh-ancestor
44884731|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884732|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884733|NCT04282291|Analgesics|analgesics|mesh-ancestor
44884734|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
44884735|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884736|NCT04282200|Ketorolac|ketorolac|mesh-list
44884737|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884738|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884739|NCT04282200|Analgesics|analgesics|mesh-ancestor
44884740|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
44884741|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884742|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884743|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884744|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44884745|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44884746|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884747|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884748|NCT04282096|Caseins|caseins|mesh-list
44884749|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
44884750|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
44884751|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884752|NCT04281862|Prednisolone|prednisolone|mesh-list
44884753|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884754|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
44884755|NCT04281862|Hormones|hormones|mesh-ancestor
44884756|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884757|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884758|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884759|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884760|NCT04282031|Letrozole|letrozole|mesh-list
44884761|NCT04282031|Fulvestrant|fulvestrant|mesh-list
44884762|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884763|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44884764|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44884765|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884766|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884767|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44884768|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44884769|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884770|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884771|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884772|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44884773|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
44884774|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44884775|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44884776|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44884777|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884778|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884779|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
44884780|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884781|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884782|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44884783|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884784|NCT04281576|Capecitabine|capecitabine|mesh-list
44884785|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
44884786|NCT04281576|Trastuzumab|trastuzumab|mesh-list
44884787|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44884788|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
44884789|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884790|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884791|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44884792|NCT04281706|Propofol|propofol|mesh-list
44884793|NCT04281706|Etomidate|etomidate|mesh-list
44884794|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884795|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884796|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884797|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884798|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
44884799|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
44884800|NCT04281628|Ketamine|ketamine|mesh-list
44884801|NCT04281628|Analgesics|analgesics|mesh-ancestor
44884802|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
44884803|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884804|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884805|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44884806|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44884807|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
44884808|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
44884809|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884810|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44884811|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44884812|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884813|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884814|NCT04281680|Octreotide|octreotide|mesh-list
44884815|NCT04281680|Pasireotide|pasireotide|mesh-list
44884816|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884817|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884818|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884819|NCT04281680|Hormones|hormones|mesh-ancestor
44884820|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884821|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884822|NCT04281290|Bleomycin|bleomycin|mesh-list
44884823|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44884824|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884825|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44884826|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44884827|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884828|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
44884829|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44884830|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44884831|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44884832|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44884833|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884834|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
44884835|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884836|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884837|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44700184|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
44700185|NCT02293109|Rituximab|rituximab|mesh-list
44700186|NCT02293109|Doxorubicin|doxorubicin|mesh-list
44700187|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44700188|NCT02293109|Methotrexate|methotrexate|mesh-list
44374034|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44700189|NCT02293109|Vincristine|vincristine|mesh-list
44700190|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44700191|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
44700192|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
44700193|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700194|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
44700195|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700196|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700197|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44700198|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
44700199|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700200|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700201|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44700202|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700203|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700204|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
44700205|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
44700206|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700207|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700208|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
44700209|NCT02293109|Hormones|hormones|mesh-ancestor
44700210|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700211|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44700212|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44700213|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44700214|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44700215|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700216|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44700217|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
44700218|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44700219|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374049|NCT05624229|Omeprazole|omeprazole|mesh-list
44700220|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
44700221|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700222|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44700223|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44700224|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
44700225|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700226|NCT02293109|Antidotes|antidotes|mesh-ancestor
44700227|NCT02293109|Protective Agents|protective agents|mesh-ancestor
44700228|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
44374081|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
44700229|NCT02293109|Vitamins|vitamins|mesh-ancestor
44700230|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
44700231|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700232|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700233|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700234|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700235|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44700236|NCT02195986|Estradiol|estradiol|mesh-list
44700237|NCT02195986|Estrogens|estrogens|mesh-ancestor
44700238|NCT02195986|Hormones|hormones|mesh-ancestor
44700239|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700240|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700241|NCT02183883|Afatinib|afatinib|mesh-list
44700242|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700243|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700244|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700245|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700246|NCT01982630|Liraglutide|liraglutide|mesh-list
44700247|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700248|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700249|NCT01982630|Incretins|incretins|mesh-ancestor
44884838|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884839|NCT04280874|Dinoprostone|dinoprostone|mesh-list
44884840|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
44884841|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44884842|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884843|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44884844|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44884845|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884846|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884847|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
44884848|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884849|NCT04280289|Cannabidiol|cannabidiol|mesh-list
44884850|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
44884851|NCT04280263|Caffeine|caffeine|mesh-list
44884852|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44884853|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884854|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44884855|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44884856|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884857|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44884858|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44884859|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
44884860|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884861|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
44884862|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44884863|NCT04279106|Listerine|listerine|mesh-list
44884864|NCT04279106|Fluorides|fluorides|mesh-list
44884865|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
44884866|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
44884867|NCT04279106|Protective Agents|protective agents|mesh-ancestor
44884868|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884869|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44884870|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884871|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
44884872|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44884873|NCT04278833|Dexamethasone|dexamethasone|mesh-list
44884874|NCT04278833|Triamcinolone|triamcinolone|mesh-list
44884875|NCT04278833|Betamethasone|betamethasone|mesh-list
44884876|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884877|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
44884878|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
44884879|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884880|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884881|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884882|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
44884883|NCT04278833|Hormones|hormones|mesh-ancestor
44884884|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44884885|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44884886|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884887|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44884888|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
44884889|NCT04278040|Melphalan|melphalan|mesh-list
44884890|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44884891|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
44884892|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884893|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884894|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44884895|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884896|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
44884897|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884898|NCT04277533|Calcium|calcium|mesh-list
44884899|NCT04277533|Bilirubin|bilirubin|mesh-list
44884900|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44374162|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
44884901|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884902|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
44884903|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884904|NCT04277533|Protective Agents|protective agents|mesh-ancestor
44884905|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
44884906|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44884907|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44884908|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884909|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884910|NCT04276883|Analgesics|analgesics|mesh-ancestor
44884911|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
44884912|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884913|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44884914|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44884915|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44884916|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
44884917|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44884918|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884919|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44884920|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44884921|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884922|NCT04274270|Endostar protein|endostar protein|mesh-list
44884923|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44884924|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884925|NCT04274270|Growth Substances|growth substances|mesh-ancestor
44884926|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884927|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884928|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884929|NCT04273997|Metronidazole|metronidazole|mesh-list
44884930|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884931|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44884932|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44884933|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44884934|NCT04273984|Misoprostol|misoprostol|mesh-list
44884935|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44884936|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
44884937|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44884938|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884939|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44884940|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44884941|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
44884942|NCT04273581|Thalidomide|thalidomide|mesh-list
44884943|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884944|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
44884945|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884946|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
44884947|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44884948|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44884949|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44374202|NCT05694975|Micronutrients|micronutrients|mesh-ancestor
44884950|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884951|NCT04273581|Growth Substances|growth substances|mesh-ancestor
44884952|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884953|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884954|NCT04273529|Thalidomide|thalidomide|mesh-list
44884955|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44884956|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
44884957|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884958|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
44884959|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44884960|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374225|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
44884961|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44884962|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44884963|NCT04273529|Growth Substances|growth substances|mesh-ancestor
44884964|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44884965|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44884966|NCT04273256|Inositol|inositol|mesh-list
44884967|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
44884968|NCT04273256|Vitamins|vitamins|mesh-ancestor
44884969|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
44884970|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884971|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44884972|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884973|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44884974|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
44884975|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44884976|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
44884977|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884978|NCT04269954|Heparin|heparin|mesh-list
44374235|NCT05694728|Vaccines|vaccines|mesh-list
44884979|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44884980|NCT04269954|Tinzaparin|tinzaparin|mesh-list
44884981|NCT04269954|Dalteparin|dalteparin|mesh-list
44884982|NCT04269954|Batroxobin|batroxobin|mesh-list
44884983|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
44884984|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44884985|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44884986|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44884987|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
44884988|NCT04269954|Coagulants|coagulants|mesh-ancestor
44884989|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
44884990|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
44884991|NCT04269863|Aspirin|aspirin|mesh-list
44884992|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44884993|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44884994|NCT04269863|Analgesics|analgesics|mesh-ancestor
44884995|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
44884996|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44884997|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44884998|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44884999|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885000|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44885001|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44885002|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885003|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44885004|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44885005|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885006|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
44885007|NCT04269928|Epinephrine|epinephrine|mesh-list
44885008|NCT04269928|Racepinephrine|racepinephrine|mesh-list
44885009|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
44885010|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44885011|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44885012|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885013|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885014|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885015|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885016|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44885017|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44885018|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
44885019|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885020|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44885021|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885022|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
44885023|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
44885024|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44885025|NCT04269369|Fluorouracil|fluorouracil|mesh-list
44885026|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
44885027|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885028|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885029|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885030|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885031|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
44885032|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885033|NCT04269460|Bupivacaine|bupivacaine|mesh-list
44885034|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
44885035|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
44885036|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885037|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885038|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
44885039|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885040|NCT04269187|Theophylline|theophylline|mesh-list
44885041|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44885042|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
44885043|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885044|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885045|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44885046|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885047|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44885048|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885049|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885050|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44885051|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44885052|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44885053|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
44885054|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885055|NCT04268966|Brincidofovir|brincidofovir|mesh-list
44885056|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
44885057|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885058|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
44885059|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44885060|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885061|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885062|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885063|NCT04269278|Analgesics|analgesics|mesh-ancestor
44885064|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
44885065|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885066|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44885067|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44885068|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44885069|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885070|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885071|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885072|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
44885073|NCT04269109|Narcotics|narcotics|mesh-ancestor
44885074|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885075|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885076|NCT04269109|Analgesics|analgesics|mesh-ancestor
44885077|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
44885078|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885079|NCT04268888|Nivolumab|nivolumab|mesh-list
44885080|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
44885081|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885082|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374357|NCT05693766|Capecitabine|capecitabine|mesh-list
44885083|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44885084|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885085|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44885086|NCT04268888|Estrogens|estrogens|mesh-ancestor
44885087|NCT04268888|Hormones|hormones|mesh-ancestor
44885088|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885089|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885090|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44885091|NCT04268927|Letrozole|letrozole|mesh-list
44476064|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885092|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
44885093|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44885094|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885095|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44885096|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44885097|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885098|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885099|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44885100|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
44885101|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885102|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885103|NCT04268927|Hormones|hormones|mesh-ancestor
44885104|NCT04268602|Anesthetics|anesthetics|mesh-list
44885105|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
44885106|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885107|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885108|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
44885109|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885110|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
44885111|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44885112|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885113|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885114|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885115|NCT04268303|Analgesics|analgesics|mesh-ancestor
44885116|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
44885117|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885118|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44885119|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44885120|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44885121|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885122|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885123|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885124|NCT04268524|Miltefosine|miltefosine|mesh-list
44885125|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
44885126|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885127|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885128|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44885129|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44885130|NCT04268563|Metformin|metformin|mesh-list
44885131|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44885132|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44885133|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700250|NCT01982630|Hormones|hormones|mesh-ancestor
44700251|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700252|NCT01982448|Paclitaxel|paclitaxel|mesh-list
44700253|NCT01982448|Cisplatin|cisplatin|mesh-list
44700254|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700255|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700256|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700257|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700258|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700259|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700260|NCT01951469|Pemetrexed|pemetrexed|mesh-list
44700261|NCT01951469|Gefitinib|gefitinib|mesh-list
44700262|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700263|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700264|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700265|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44700266|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44700267|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700268|NCT01940809|Nivolumab|nivolumab|mesh-list
44700269|NCT01940809|Ipilimumab|ipilimumab|mesh-list
44700270|NCT01940809|Trametinib|trametinib|mesh-list
44700271|NCT01940809|Dabrafenib|dabrafenib|mesh-list
44700272|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700273|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700274|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44700275|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700276|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700277|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700278|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44700279|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700280|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700281|NCT01879228|Incretins|incretins|mesh-ancestor
44700282|NCT01879228|Hormones|hormones|mesh-ancestor
44700283|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700284|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44700285|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44700286|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885134|NCT04268563|Incretins|incretins|mesh-ancestor
44885135|NCT04268563|Hormones|hormones|mesh-ancestor
44885136|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885137|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44885138|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885139|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885140|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885141|NCT04268472|Darunavir|darunavir|mesh-list
44885142|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44885143|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44885144|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885145|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885146|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885147|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44885148|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44885149|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
44885150|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885151|NCT04268537|Antibodies|antibodies|mesh-list
44885152|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
44374461|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
44885153|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
44885154|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885155|NCT04268394|Metformin|metformin|mesh-list
44885156|NCT04268394|Itraconazole|itraconazole|mesh-list
44885157|NCT04268394|Rifampin|rifampin|mesh-list
44885158|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
44885159|NCT04268394|Methotrexate|methotrexate|mesh-list
44885160|NCT04268394|Digoxin|digoxin|mesh-list
44885161|NCT04268394|Midazolam|midazolam|mesh-list
44885162|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44885163|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44885164|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885165|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44374473|NCT05687058|Empagliflozin|empagliflozin|mesh-list
44885166|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
44885167|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44885168|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885169|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
44885170|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885171|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885172|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
44885173|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885174|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44885175|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885176|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
44885177|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885178|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44885179|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44885180|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44885181|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885182|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44885183|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44885184|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885185|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44885186|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
44885187|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
44885188|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
44885189|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
44885190|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885191|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44885192|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44885193|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44885194|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44885195|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
44885196|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885197|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44885198|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44885199|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44885200|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
44885201|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885202|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44885203|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44885204|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
44885205|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44885206|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
44885207|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44885208|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44885209|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44885210|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44885211|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44885212|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44885213|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44885214|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44885215|NCT04268394|Protective Agents|protective agents|mesh-ancestor
44885216|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44885217|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885218|NCT04268394|Analgesics|analgesics|mesh-ancestor
44885219|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
44885220|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885221|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885222|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885223|NCT04267991|Tacrolimus|tacrolimus|mesh-list
44885224|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885225|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
44885226|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885227|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44885228|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885229|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885230|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44885231|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44885232|NCT04267653|Lactoferrin|lactoferrin|mesh-list
44885233|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885234|NCT04267679|Cannabidiol|cannabidiol|mesh-list
44885235|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
44885236|NCT04267913|Dexamethasone|dexamethasone|mesh-list
44885237|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
44885238|NCT04267913|Docetaxel|docetaxel|mesh-list
44885239|NCT04267913|Ramucirumab|ramucirumab|mesh-list
44885240|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44885241|NCT04267913|Antibodies|antibodies|mesh-list
44885242|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
44885243|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44885244|NCT04267913|Lexatumumab|lexatumumab|mesh-list
44885245|NCT04267913|BB 1101|bb 1101|mesh-list
44885246|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
44885247|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885248|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885249|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
44885250|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
44885251|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885252|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885253|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
44885254|NCT04267913|Hormones|hormones|mesh-ancestor
44885255|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885256|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44885257|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885258|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885259|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885260|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885261|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885262|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885263|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885264|NCT04267614|Etanercept|etanercept|mesh-list
44885265|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44885266|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885267|NCT04267614|Analgesics|analgesics|mesh-ancestor
44885268|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
44885269|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885270|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885271|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885272|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885273|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885274|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885275|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
44885276|NCT04267497|Amphotericin B|amphotericin b|mesh-list
44885277|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44885278|NCT04267497|Amebicides|amebicides|mesh-ancestor
44885279|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44885280|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44885281|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674751|NCT01293266|Propofol|propofol|mesh-list
44885282|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44885283|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
44885284|NCT04267549|Paclitaxel|paclitaxel|mesh-list
44885285|NCT04267549|Apatinib|apatinib|mesh-list
44885286|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44885287|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885288|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885289|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885290|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885291|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885292|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44885293|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885295|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885296|NCT04267224|Ticagrelor|ticagrelor|mesh-list
44885297|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44885298|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44885299|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44885300|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44885301|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
44885302|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885303|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885304|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885305|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
44885306|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44885307|NCT04267250|Estradiol|estradiol|mesh-list
44885308|NCT04267250|PF-06700841|pf-06700841|mesh-list
44885309|NCT04267250|Estrogens|estrogens|mesh-ancestor
44885310|NCT04267250|Hormones|hormones|mesh-ancestor
44885311|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885312|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885313|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44885314|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
44885315|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44885316|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44885317|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44885318|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44885319|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44885320|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44885321|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885322|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885323|NCT04267042|Budesonide|budesonide|mesh-list
44885324|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885325|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44885326|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
44885327|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374629|NCT05560399|Elotuzumab|elotuzumab|mesh-list
44885328|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885329|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44885330|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885331|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
44885332|NCT04267042|Hormones|hormones|mesh-ancestor
44885333|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885335|NCT04267146|Temozolomide|temozolomide|mesh-list
44885336|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885337|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885338|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44885339|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885340|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44885341|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
44885342|NCT04266756|Selexipag|selexipag|mesh-list
44885343|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44885344|NCT04266509|Rifampin|rifampin|mesh-list
44885345|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44885346|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
44885347|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44885348|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885349|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
44885350|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44885351|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885352|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885353|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44885354|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44885355|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44885356|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44885357|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44885358|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44885359|NCT04266288|Ketamine|ketamine|mesh-list
44885360|NCT04266288|Analgesics|analgesics|mesh-ancestor
44885361|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
44885362|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885363|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885364|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44885365|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44885366|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
44885367|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
44885368|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885369|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44885370|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44885371|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374695|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374696|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44374697|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374698|NCT05463744|Insulin|insulin|mesh-list
44374699|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374700|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683763|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43875721|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44885372|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885373|NCT04266132|Bupivacaine|bupivacaine|mesh-list
44885374|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
44885375|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
44885376|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885377|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885378|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
44700287|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700288|NCT01829958|Prednisone|prednisone|mesh-list
44700289|NCT01829958|Rituximab|rituximab|mesh-list
44700290|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700291|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700292|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
44700293|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43628946|NCT03063307|Fluorides|fluorides|mesh-list
43875762|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875763|NCT04720833|Vitamin D|vitamin d|mesh-list
43875764|NCT04720833|Calcium|calcium|mesh-list
43875765|NCT04720833|Vitamins|vitamins|mesh-ancestor
43875766|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
43875767|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875768|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43875770|NCT04720859|Canagliflozin|canagliflozin|mesh-list
44700294|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700295|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700296|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
44700297|NCT01829958|Hormones|hormones|mesh-ancestor
44700298|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700299|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44700300|NCT01805271|Everolimus|everolimus|mesh-list
44700301|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700302|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43683789|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
43875830|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43875831|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
43875832|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43875833|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
43875834|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875835|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875836|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
43875837|NCT04719819|Anesthetics|anesthetics|mesh-list
43875841|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44700303|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
44700304|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700305|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
44700306|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44700307|NCT01740297|Ipilimumab|ipilimumab|mesh-list
44700308|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44700309|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44700310|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700311|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44700312|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700313|NCT01729754|Etanercept|etanercept|mesh-list
43875842|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135729|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44135730|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
44135731|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
44135732|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135733|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44135734|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44135735|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44135736|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44700314|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44885379|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885380|NCT04265833|Calcium|calcium|mesh-list
44885381|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885382|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885383|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44885384|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
44135739|NCT00162409|Folic Acid|folic acid|mesh-list
44374745|NCT05443802|Insulin|insulin|mesh-list
44374746|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44374747|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374748|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374749|NCT05429762|Maytansine|maytansine|mesh-list
43683805|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875901|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885385|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885386|NCT04265872|Cisplatin|cisplatin|mesh-list
44885387|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
44885388|NCT04265872|Bortezomib|bortezomib|mesh-list
44885389|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885390|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885391|NCT04265456|Acetaminophen|acetaminophen|mesh-list
44885392|NCT04265456|Pregabalin|pregabalin|mesh-list
44885393|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885394|NCT04265456|Analgesics|analgesics|mesh-ancestor
44885395|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
44885396|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885397|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885398|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
43875902|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44885399|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
44885400|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44885401|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44885402|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885403|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885404|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44885405|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44885406|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885407|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885408|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44885409|NCT04265612|Laxatives|laxatives|mesh-ancestor
44885410|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885411|NCT04265508|Hemostatics|hemostatics|mesh-list
44885412|NCT04265508|Coagulants|coagulants|mesh-ancestor
44885414|NCT04265274|Cisplatin|cisplatin|mesh-list
44885415|NCT04265274|Disulfiram|disulfiram|mesh-list
44885416|NCT04265274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885417|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885418|NCT04265274|Trace Elements|trace elements|mesh-ancestor
44885419|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
44885420|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885421|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44885422|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44885423|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885424|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
44885425|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44885426|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
44885427|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885428|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
44885429|NCT04265001|Protective Agents|protective agents|mesh-ancestor
44885430|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
44885431|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44885432|NCT04264858|Antibodies|antibodies|mesh-list
44885433|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
44885434|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
44885435|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885436|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
44885437|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
44885438|NCT04264988|Protective Agents|protective agents|mesh-ancestor
44885439|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885440|NCT04265027|Opicapone|opicapone|mesh-list
44885441|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44885442|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885443|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885444|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44885445|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44885446|NCT04264676|Metronidazole|metronidazole|mesh-list
44885447|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885448|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44885449|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44885450|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44885451|NCT04264481|Lidocaine|lidocaine|mesh-list
44674945|NCT01294631|Canagliflozin|canagliflozin|mesh-list
44885452|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44885453|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
44885454|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374751|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885455|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885456|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
44885457|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885458|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44885459|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44885460|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44885461|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44885462|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885463|NCT04264624|Erythritol|erythritol|mesh-list
44885464|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
44885465|NCT04264078|Fludarabine|fludarabine|mesh-list
44885466|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
44885467|NCT04264078|Melphalan|melphalan|mesh-list
44885468|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885469|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885470|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885471|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
44885472|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885473|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885474|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44885475|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
44885476|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44885477|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44885478|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
44885479|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885480|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885481|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
44885482|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885483|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885484|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44885485|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44885486|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44885487|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885488|NCT04264039|Fludarabine|fludarabine|mesh-list
44885489|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
44885490|NCT04264039|Melphalan|melphalan|mesh-list
44885491|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885492|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885493|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885494|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
44885495|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885496|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885497|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44885498|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
44885499|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44885500|NCT04264260|Colchicine|colchicine|mesh-list
44885501|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
44885502|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885503|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
44374842|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44374846|NCT05285904|Ofatumumab|ofatumumab|mesh-list
44885504|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885505|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885506|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885507|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885508|NCT04264130|Artesunate|artesunate|mesh-list
44885509|NCT04264130|Lumefantrine|lumefantrine|mesh-list
44885510|NCT04264130|Artemether|artemether|mesh-list
44885511|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44885512|NCT04264130|Pyronaridine|pyronaridine|mesh-list
44885513|NCT04264130|Artefenomel|artefenomel|mesh-list
44885514|NCT04264130|Ferroquine|ferroquine|mesh-list
44885515|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
44885516|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44885517|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44885518|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885519|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885520|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
44885521|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
44885522|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44885523|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
44885524|NCT04264286|Esmolol|esmolol|mesh-list
44885525|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44885526|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44885527|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44885528|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885529|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876172|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876174|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
44885530|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885531|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885532|NCT04263870|Capecitabine|capecitabine|mesh-list
44885533|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
44885534|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885535|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
44885536|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885537|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675103|NCT01295294|Analgesics|analgesics|mesh-ancestor
44885538|NCT04263844|Midazolam|midazolam|mesh-list
44885539|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
44885540|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44885541|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885542|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885543|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885545|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
44885546|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885547|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44885548|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44885549|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44885550|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
44374893|NCT05222555|Lenalidomide|lenalidomide|mesh-list
44374904|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135802|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135803|NCT00162526|Vitamins|vitamins|mesh-ancestor
44135804|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
44135805|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
44135806|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135807|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135808|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135809|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44885551|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885552|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885553|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44885554|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44885555|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44885556|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885557|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44885558|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
44885559|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
44885560|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
44885561|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
44374922|NCT05207722|Aldesleukin|aldesleukin|mesh-list
44374923|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
44374924|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
44374925|NCT05207722|Trastuzumab|trastuzumab|mesh-list
44374926|NCT05207722|Fludarabine|fludarabine|mesh-list
44374927|NCT05207722|Interleukin-2|interleukin-2|mesh-list
44374928|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374929|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
44885562|NCT04263519|Tacrolimus|tacrolimus|mesh-list
44885563|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885564|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
44885565|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885566|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44885567|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885568|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885569|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
44885570|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44885571|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44885572|NCT04263402|Prednisolone|prednisolone|mesh-list
44885573|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
44885574|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44885575|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
44885576|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885577|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
44885578|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
44885579|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885580|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374930|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885581|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885582|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
44885583|NCT04263402|Hormones|hormones|mesh-ancestor
44885584|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44885585|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44885586|NCT04263402|Protective Agents|protective agents|mesh-ancestor
44885587|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44885588|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885589|NCT04262999|Levetiracetam|levetiracetam|mesh-list
44885590|NCT04262999|Valproic Acid|valproic acid|mesh-list
44885591|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
44885592|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
44885593|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885594|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885595|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
44885596|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885597|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885598|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
44885599|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44885600|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885601|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885602|NCT04262635|Capecitabine|capecitabine|mesh-list
44885603|NCT04262635|Cetuximab|cetuximab|mesh-list
44885604|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885605|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
44885606|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885607|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885608|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885609|NCT04262765|Amlodipine|amlodipine|mesh-list
44885610|NCT04262765|Ramipril|ramipril|mesh-list
44885611|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44885612|NCT04262765|Atorvastatin|atorvastatin|mesh-list
44885613|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44885614|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44885615|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
44885616|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885617|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44885618|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44885619|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885620|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44885621|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44700315|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44700316|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44700317|NCT01729754|Analgesics|analgesics|mesh-ancestor
44700318|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
44700319|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700320|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700321|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700322|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700323|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700324|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700325|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
44700326|NCT01622998|Nicotine|nicotine|mesh-list
44700327|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44700328|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
44700329|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374993|NCT05102721|Avelumab|avelumab|mesh-list
44374994|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374995|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700330|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700331|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44700332|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44700333|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
44700334|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700335|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700336|NCT01595620|Dronabinol|dronabinol|mesh-list
44700337|NCT01595620|Capsaicin|capsaicin|mesh-list
44700338|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
44700339|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700340|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700341|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44700342|NCT01595620|Analgesics|analgesics|mesh-ancestor
44700343|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
44700344|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374996|NCT05090033|Ofatumumab|ofatumumab|mesh-list
44700345|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44700346|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44700347|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700348|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700349|NCT01595620|Hormones|hormones|mesh-ancestor
44700350|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700351|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
44700352|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700353|NCT01591629|Dronabinol|dronabinol|mesh-list
44700354|NCT01591629|Naloxone|naloxone|mesh-list
44700355|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44700356|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700357|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
44375006|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44700358|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700359|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
44700360|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700361|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44700362|NCT01591629|Analgesics|analgesics|mesh-ancestor
44700363|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44700364|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44700365|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700366|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700367|NCT01591629|Hormones|hormones|mesh-ancestor
44700368|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700369|NCT01515306|Paclitaxel|paclitaxel|mesh-list
44700370|NCT01515306|Ramucirumab|ramucirumab|mesh-list
44700371|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700372|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700373|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700374|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700375|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700376|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700377|NCT01513187|Interferons|interferons|mesh-list
44700378|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
44700379|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
44700380|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700381|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
44885622|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44885623|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885624|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885625|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
44885626|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44885627|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885628|NCT04262804|Gemcitabine|gemcitabine|mesh-list
44885629|NCT04262804|Capecitabine|capecitabine|mesh-list
44885630|NCT04262804|Trastuzumab|trastuzumab|mesh-list
44885631|NCT04262804|Vinorelbine|vinorelbine|mesh-list
44885632|NCT04262804|Margetuximab|margetuximab|mesh-list
44885633|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885634|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
44885635|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885636|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885637|NCT04262804|Antiviral Agents|antiviral agents|mesh-ancestor
44885638|NCT04262804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885639|NCT04262804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885640|NCT04262804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885641|NCT04262804|Immunologic Factors|immunologic factors|mesh-ancestor
44885642|NCT04262804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885643|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885644|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44885645|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885646|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885647|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885648|NCT04262388|Durvalumab|durvalumab|mesh-list
44885649|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885650|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885651|NCT04262375|Durvalumab|durvalumab|mesh-list
44885652|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885653|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885654|NCT04262193|Suvorexant|suvorexant|mesh-list
44885655|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44885656|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44885657|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885658|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885659|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44885660|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885661|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885662|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
44885663|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885664|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885666|NCT04261907|Lopinavir|lopinavir|mesh-list
44885667|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44885668|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44885669|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885670|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885671|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885672|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44885673|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44885674|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
44885675|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885676|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44885677|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44885678|NCT04261634|Mitogens|mitogens|mesh-list
44885679|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885680|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885681|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
44885682|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44885683|NCT04261426|Antibodies|antibodies|mesh-list
44885684|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
44885685|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44885686|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
44885687|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885688|NCT04261465|Paclitaxel|paclitaxel|mesh-list
44885689|NCT04261465|Carboplatin|carboplatin|mesh-list
44885690|NCT04261465|Olaparib|olaparib|mesh-list
44885691|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44885692|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885693|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885694|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885695|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885696|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885697|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44885698|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885699|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
44885700|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
44885701|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44885702|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44885703|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885704|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885705|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885706|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885707|NCT04261270|Ritonavir|ritonavir|mesh-list
44885708|NCT04261270|Oseltamivir|oseltamivir|mesh-list
44885709|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44885710|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44885711|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
44885712|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885713|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885714|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44885715|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44885716|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
44885717|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885718|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44885719|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44885720|NCT04261023|Abatacept|abatacept|mesh-list
44375121|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375126|NCT04931342|Growth Substances|growth substances|mesh-ancestor
44375139|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375140|NCT04902443|Nivolumab|nivolumab|mesh-list
44375141|NCT04902443|Pomalidomide|pomalidomide|mesh-list
44375142|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375143|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375144|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44375145|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375146|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
44375150|NCT04902443|Growth Substances|growth substances|mesh-ancestor
44885721|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44885722|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885723|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885724|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885725|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
44885726|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885727|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885728|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
44885729|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
44885730|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885731|NCT04261036|Protective Agents|protective agents|mesh-ancestor
44885732|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885733|NCT04261036|Vitamins|vitamins|mesh-ancestor
44885734|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
44885735|NCT04260828|Aspirin|aspirin|mesh-list
44885736|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44885737|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885738|NCT04260828|Analgesics|analgesics|mesh-ancestor
44885739|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
44675334|NCT01296958|Niclosamide|niclosamide|mesh-list
44885740|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885741|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885742|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885743|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885744|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44885745|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44885746|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885747|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44885748|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44885749|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885751|NCT04260711|Interferons|interferons|mesh-list
44885752|NCT04260711|Teriflunomide|teriflunomide|mesh-list
44885753|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
44885754|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44885755|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
44031132|NCT00001017|Amebicides|amebicides|mesh-ancestor
44375177|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44885756|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885757|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
44885758|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885759|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44885760|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
44885761|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885762|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885763|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885764|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44885765|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885766|NCT04260711|Analgesics|analgesics|mesh-ancestor
44885767|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
44885768|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885769|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885770|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
44885771|NCT04260607|Ketamine|ketamine|mesh-list
44885772|NCT04260607|Analgesics|analgesics|mesh-ancestor
44885773|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
44885774|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885775|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885776|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44885777|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44885778|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
44885779|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
44885780|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885781|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44885782|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44885783|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375178|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44375202|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
44375203|NCT04854499|Cisplatin|cisplatin|mesh-list
44375204|NCT04854499|Carboplatin|carboplatin|mesh-list
44885784|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885785|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
44885786|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44885787|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
44885788|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885789|NCT04260516|Expectorants|expectorants|mesh-ancestor
44885790|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885791|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44885792|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
44885793|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885794|NCT04260516|Protective Agents|protective agents|mesh-ancestor
44885795|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885796|NCT04260516|Antidotes|antidotes|mesh-ancestor
44885797|NCT04260581|Amantadine|amantadine|mesh-list
44885798|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44885799|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44885800|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
44885801|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885802|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
44885803|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885804|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885805|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885806|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885807|NCT04260581|Analgesics|analgesics|mesh-ancestor
44885808|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
44885809|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885810|NCT04260685|Lidocaine|lidocaine|mesh-list
44885811|NCT04260685|Esmolol|esmolol|mesh-list
44885812|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
44885813|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
44885814|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885815|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375205|NCT04854499|Docetaxel|docetaxel|mesh-list
44375207|NCT04854499|Magrolimab|magrolimab|mesh-list
44885820|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44885821|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700382|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700383|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
44700384|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700385|NCT01464268|Riboflavin|riboflavin|mesh-list
44700386|NCT01464268|Dextrans|dextrans|mesh-list
44700387|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
44700388|NCT01464268|Vitamins|vitamins|mesh-ancestor
44700389|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
44700390|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700391|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44700392|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700393|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
44700394|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
44700395|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
44700396|NCT01433965|Lenalidomide|lenalidomide|mesh-list
44700397|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
44700398|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700399|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44700400|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44700401|NCT01433965|Growth Substances|growth substances|mesh-ancestor
44700402|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44700403|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700404|NCT01360593|Gemcitabine|gemcitabine|mesh-list
44700405|NCT01360593|Capecitabine|capecitabine|mesh-list
44700406|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700407|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
44700408|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700409|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700410|NCT01360593|Antiviral Agents|antiviral agents|mesh-ancestor
44700411|NCT01360593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700412|NCT01360593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700413|NCT01360593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700414|NCT01360593|Immunologic Factors|immunologic factors|mesh-ancestor
44700415|NCT01360593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700416|NCT01354977|Resveratrol|resveratrol|mesh-list
44700417|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
44700418|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700419|NCT01354977|Protective Agents|protective agents|mesh-ancestor
44700420|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700421|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700422|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44700423|NCT01334606|Insulin|insulin|mesh-list
44700424|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700425|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700426|NCT01226732|Capecitabine|capecitabine|mesh-list
44700427|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700428|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
44700429|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700430|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700435|NCT01152541|Riboflavin|riboflavin|mesh-list
44700436|NCT01152541|Dextrans|dextrans|mesh-list
44700438|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
44700439|NCT01152541|Vitamins|vitamins|mesh-ancestor
44700440|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
44700441|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700442|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44700443|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700444|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
44700445|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
44700446|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
44700447|NCT01112072|Riboflavin|riboflavin|mesh-list
44700448|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
44700449|NCT01112072|Vitamins|vitamins|mesh-ancestor
44700450|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
44700451|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700452|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44700453|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
44700454|NCT01107717|Metformin|metformin|mesh-list
44885822|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885823|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44885824|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44885825|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44885826|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44885827|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885829|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375298|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885830|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885831|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885832|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885833|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885834|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44885835|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885836|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
44885837|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44885838|NCT04260035|Protective Agents|protective agents|mesh-ancestor
44885839|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885840|NCT04260269|Trifluridine|trifluridine|mesh-list
44885841|NCT04260269|Fluorouracil|fluorouracil|mesh-list
44885842|NCT04260269|Capecitabine|capecitabine|mesh-list
44885843|NCT04260269|Tegafur|tegafur|mesh-list
44885844|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
44885845|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885846|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885847|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885848|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44885849|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
44885850|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885851|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
44885852|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885853|NCT04260113|Apatinib|apatinib|mesh-list
44885854|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885855|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44885856|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885857|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885858|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
44885859|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44885860|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
44885861|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885862|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885863|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44885864|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885865|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44885866|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
44375320|NCT04599634|Magrolimab|magrolimab|mesh-list
44375342|NCT04560868|Nicotine|nicotine|mesh-list
44885867|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885868|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885869|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44885870|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
44885871|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
44885872|NCT04259684|Protective Agents|protective agents|mesh-ancestor
44885873|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
44885874|NCT04259606|Antacids|antacids|mesh-ancestor
44885875|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885876|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44885877|NCT04259476|Ketamine|ketamine|mesh-list
44885878|NCT04259476|Analgesics|analgesics|mesh-ancestor
44885879|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
44885880|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885881|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885882|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44885883|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44375352|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
44885884|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
44885885|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
44885886|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885887|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44885888|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44885889|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885890|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885891|NCT04259333|Acetaminophen|acetaminophen|mesh-list
44885892|NCT04259333|Celecoxib|celecoxib|mesh-list
44885893|NCT04259333|Codeine|codeine|mesh-list
44885894|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44885895|NCT04259333|Analgesics|analgesics|mesh-ancestor
44885896|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
44885897|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885898|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885899|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
44885900|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44885901|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44885902|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44885903|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44885904|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44885905|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885906|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885907|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44885908|NCT04259333|Narcotics|narcotics|mesh-ancestor
44375365|NCT04524871|Bevacizumab|bevacizumab|mesh-list
44885909|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885910|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
44885911|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44885912|NCT04259073|Pregabalin|pregabalin|mesh-list
44885913|NCT04259073|Analgesics|analgesics|mesh-ancestor
44885914|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
44885915|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885916|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885917|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
44885918|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44885919|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44885920|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885921|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885922|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44885923|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44885924|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44885925|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44885926|NCT04258956|Avelumab|avelumab|mesh-list
44885927|NCT04258956|Axitinib|axitinib|mesh-list
44885928|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44885929|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885930|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44885931|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885932|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885933|NCT04259008|Manganese|manganese|mesh-list
44885934|NCT04259008|Trace Elements|trace elements|mesh-ancestor
44885935|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
44885936|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885937|NCT04258930|Calcium|calcium|mesh-list
44885938|NCT04258930|Calcium acetate|calcium acetate|mesh-list
44885939|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
44885940|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885941|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885942|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
44700455|NCT01107717|Pioglitazone|pioglitazone|mesh-list
44700456|NCT01107717|Exenatide|exenatide|mesh-list
44700457|NCT01107717|Glyburide|glyburide|mesh-list
44700458|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700459|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700460|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44700461|NCT01107717|Incretins|incretins|mesh-ancestor
44700462|NCT01107717|Hormones|hormones|mesh-ancestor
44700463|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700464|NCT01104350|Gemcitabine|gemcitabine|mesh-list
44700465|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700466|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
44700467|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700468|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700469|NCT01104350|Antiviral Agents|antiviral agents|mesh-ancestor
44700470|NCT01104350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700471|NCT01104350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700472|NCT01104350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700473|NCT01104350|Immunologic Factors|immunologic factors|mesh-ancestor
44700474|NCT01104350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700475|NCT00962988|Bupropion|bupropion|mesh-list
44700476|NCT00962988|Nicotine|nicotine|mesh-list
44700477|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44700478|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
44700479|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44885943|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
44885944|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885945|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44885946|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
44885948|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44885949|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885950|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885951|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885952|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885953|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885954|NCT04258553|Antioxidants|antioxidants|mesh-list
44885955|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885956|NCT04258553|Protective Agents|protective agents|mesh-ancestor
44885957|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885958|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
44885959|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
44885960|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44885961|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885962|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885963|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
44885964|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
44885965|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
44885966|NCT04258475|Calcium|calcium|mesh-list
44885967|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44885968|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44885969|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44885970|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44885971|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
44885972|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44885973|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44885974|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44885975|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885976|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885977|NCT04258644|Paclitaxel|paclitaxel|mesh-list
44885978|NCT04258644|Apatinib|apatinib|mesh-list
44885979|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44885980|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885981|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
44885982|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
44885983|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
44885984|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885985|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44885986|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44885987|NCT04258163|Gemcitabine|gemcitabine|mesh-list
44885988|NCT04258163|Capecitabine|capecitabine|mesh-list
44885989|NCT04258163|Doxorubicin|doxorubicin|mesh-list
44885990|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44885991|NCT04258163|Letrozole|letrozole|mesh-list
44885992|NCT04258163|Fulvestrant|fulvestrant|mesh-list
44885993|NCT04258163|Anastrozole|anastrozole|mesh-list
44885994|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44885995|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
44885996|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44885997|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44885998|NCT04258163|Antiviral Agents|antiviral agents|mesh-ancestor
44885999|NCT04258163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886000|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886001|NCT04258163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886002|NCT04258163|Immunologic Factors|immunologic factors|mesh-ancestor
44886003|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886004|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44886005|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44886006|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44886007|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44886008|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44886009|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44886010|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886011|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886012|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44886013|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44886014|NCT04258241|Bupivacaine|bupivacaine|mesh-list
44886015|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
44886016|NCT04258241|Anesthetics|anesthetics|mesh-list
44886017|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44886018|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886019|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886020|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
44886021|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886022|NCT04258423|Everolimus|everolimus|mesh-list
44886023|NCT04258423|Tacrolimus|tacrolimus|mesh-list
44886024|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886025|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
44886026|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886027|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44886028|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886029|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886030|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886031|NCT04258306|Resveratrol|resveratrol|mesh-list
44886032|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
44886033|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886034|NCT04258306|Protective Agents|protective agents|mesh-ancestor
44886035|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886036|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886037|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44886038|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
44886039|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44886040|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886041|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44886042|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886043|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44886044|NCT04258098|Metronidazole|metronidazole|mesh-list
44886045|NCT04258098|Streptomycin|streptomycin|mesh-list
44886046|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886047|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44886048|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44886049|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44886050|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886051|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886052|NCT04258007|Neostigmine|neostigmine|mesh-list
44886053|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44886054|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886055|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886056|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
44886057|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886058|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886059|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44886060|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
44886061|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886062|NCT04257838|Meropenem|meropenem|mesh-list
44886063|NCT04257838|Tazobactam|tazobactam|mesh-list
44886064|NCT04257838|Piperacillin|piperacillin|mesh-list
44886065|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44886066|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44886067|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886068|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44886069|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886070|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886071|NCT04257851|Sumatriptan|sumatriptan|mesh-list
44886072|NCT04257851|Theophylline|theophylline|mesh-list
44886073|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44886074|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44886075|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44886076|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
44886077|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886078|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886079|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886080|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44886081|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
44886082|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886083|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44375553|NCT04068597|Dexamethasone|dexamethasone|mesh-list
44886084|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
44886085|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44886086|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886087|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
44886088|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44886089|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44886090|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
44886091|NCT04257812|Tazobactam|tazobactam|mesh-list
44886092|NCT04257812|Ceftolozane|ceftolozane|mesh-list
44886093|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44886094|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44886095|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886096|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44886097|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476065|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375594|NCT04047472|Aflibercept|aflibercept|mesh-list
44886098|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886099|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44886100|NCT04257812|Renal Agents|renal agents|mesh-ancestor
44886101|NCT04257461|Capecitabine|capecitabine|mesh-list
44886102|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
44886103|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886104|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
44886105|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886106|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886107|NCT04257656|Remdesivir|remdesivir|mesh-list
44886108|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
44886109|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886110|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
44886111|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886112|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44886113|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886114|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
44886115|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44886116|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886117|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
44886118|NCT04257032|Dabigatran|dabigatran|mesh-list
44886119|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44886120|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44886121|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44886122|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
44476066|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886123|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886124|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44886125|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44886126|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886127|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
44886128|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44886129|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886130|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
44886131|NCT04256642|Morphine|morphine|mesh-list
44886132|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44886133|NCT04256642|Narcotics|narcotics|mesh-ancestor
44886134|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886135|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886136|NCT04256642|Analgesics|analgesics|mesh-ancestor
44886137|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
44886138|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886139|NCT04256733|Capsaicin|capsaicin|mesh-list
44886140|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
44886141|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44886142|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
44886143|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886144|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700480|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700481|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44700482|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44700483|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
44700484|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700485|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700486|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44700487|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
44886145|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44886147|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44886148|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44886149|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886150|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
44886151|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886152|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44886153|NCT04256343|Protective Agents|protective agents|mesh-ancestor
44886154|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886155|NCT04256252|Rituximab|rituximab|mesh-list
44886156|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886157|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886158|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
44886159|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886160|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886161|NCT04256525|Aspirin|aspirin|mesh-list
44886162|NCT04256525|Heparin|heparin|mesh-list
44886163|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
44886164|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44886165|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44886166|NCT04256525|Analgesics|analgesics|mesh-ancestor
44886167|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
44886168|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886169|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886170|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886171|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886172|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44886173|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44886174|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375654|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
44886175|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44886176|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44886177|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886178|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
44886179|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
44886180|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44886181|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
44886182|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44886183|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886184|NCT04256200|Dienogest|dienogest|mesh-list
44886185|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
44886186|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
44886187|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44886188|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44886189|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886190|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44886191|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44886192|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44886193|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44886194|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886195|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886196|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44886197|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886198|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
44886199|NCT04256057|Analgesics|analgesics|mesh-ancestor
44886200|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
44886201|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886202|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886203|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
44886204|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886205|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886206|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
44886207|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44886208|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886209|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886210|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886211|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
44886212|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44886213|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
44886214|NCT04255992|Vitamin D|vitamin d|mesh-list
44886215|NCT04255992|Calcium|calcium|mesh-list
44886216|NCT04255992|Vitamins|vitamins|mesh-ancestor
44886217|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
44886218|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675834|NCT04868565|Caffeine|caffeine|mesh-list
44886219|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886220|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44886221|NCT04255836|Durvalumab|durvalumab|mesh-list
44886222|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886223|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886224|NCT04255771|Gemcitabine|gemcitabine|mesh-list
44886225|NCT04255771|Cisplatin|cisplatin|mesh-list
44886226|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886227|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886228|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
44886229|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886230|NCT04255771|Antiviral Agents|antiviral agents|mesh-ancestor
44886231|NCT04255771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886232|NCT04255771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886233|NCT04255771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886234|NCT04255771|Immunologic Factors|immunologic factors|mesh-ancestor
44886235|NCT04255771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886236|NCT04255589|Ethanol|ethanol|mesh-list
44886237|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44886238|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886239|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886240|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886241|NCT04255576|Vitamin D|vitamin d|mesh-list
44886242|NCT04255576|Calcium|calcium|mesh-list
44886243|NCT04255576|Vitamins|vitamins|mesh-ancestor
44886244|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
44886245|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886246|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886247|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44886248|NCT04255498|Etanercept|etanercept|mesh-list
44886249|NCT04255498|Mifepristone|mifepristone|mesh-list
44886250|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44886251|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44886252|NCT04255498|Analgesics|analgesics|mesh-ancestor
44886253|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
44886254|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886255|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886256|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886257|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886258|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886259|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886260|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
44886261|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44886262|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
44886263|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44886264|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44886265|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44886266|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44886267|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
44886268|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44886269|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44886270|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886271|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886272|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
44886273|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44886274|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44886275|NCT04255368|Choline|choline|mesh-list
44886276|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
44886277|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44886278|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
44886279|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886280|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886281|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44886282|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
44886283|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
44886284|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44886285|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886286|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44886287|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886288|NCT04255251|Fluorides|fluorides|mesh-list
44886289|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
44886290|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
44886291|NCT04255251|Protective Agents|protective agents|mesh-ancestor
44886292|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675915|NCT04600999|Favipiravir|favipiravir|mesh-list
44886293|NCT04255134|Adalimumab|adalimumab|mesh-list
44886294|NCT04255134|Abatacept|abatacept|mesh-list
44886295|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886296|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886297|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44886298|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886299|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886300|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886301|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
44886302|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886303|NCT04255017|Ritonavir|ritonavir|mesh-list
44886304|NCT04255017|Lopinavir|lopinavir|mesh-list
44886305|NCT04255017|Oseltamivir|oseltamivir|mesh-list
44886306|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44886307|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44886308|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886309|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886310|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886311|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44886312|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44886313|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
44886314|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886315|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44886316|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44886317|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
44886318|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44886319|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886320|NCT04255121|Lidocaine|lidocaine|mesh-list
44886321|NCT04255121|Epinephrine|epinephrine|mesh-list
44886322|NCT04255121|Racepinephrine|racepinephrine|mesh-list
44886323|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
44886324|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886325|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
44886326|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886327|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700488|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700489|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44700490|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44700491|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700492|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
44700493|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44700494|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44700495|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700496|NCT00920621|Vitamin D|vitamin d|mesh-list
44700497|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
44700498|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
44700499|NCT00920621|Vitamins|vitamins|mesh-list
44700500|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
44700501|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700502|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44700503|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44700504|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
44700505|NCT00916747|Pravastatin|pravastatin|mesh-list
44700506|NCT00916747|Lonafarnib|lonafarnib|mesh-list
44700507|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44700508|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700509|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44700510|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44700511|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
44700512|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700513|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44700516|NCT00785525|Lenograstim|lenograstim|mesh-list
44700517|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44700518|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
44700519|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700520|NCT00768820|Risperidone|risperidone|mesh-list
44700521|NCT00768820|Methylphenidate|methylphenidate|mesh-list
44700522|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44700523|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
44700524|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700525|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700526|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700527|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44700528|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44700529|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44700530|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44886328|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
44886329|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886330|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886331|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886332|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886333|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886334|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886335|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44886337|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44886338|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886339|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44886340|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44886341|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
44886342|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44886343|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44886344|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
44886345|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
44886346|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44886347|NCT04254822|Carvedilol|carvedilol|mesh-list
44886348|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44886349|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44886350|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44886351|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886352|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886353|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886354|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44886355|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
44886356|NCT04254822|Protective Agents|protective agents|mesh-ancestor
44886357|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44886358|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886359|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886360|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
44886361|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44886362|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44886363|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
44886364|NCT04255056|Epirubicin|epirubicin|mesh-list
44886365|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886366|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
44886367|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886368|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886369|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44886370|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
44886371|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886372|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886373|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44886374|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44886375|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44886376|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44886377|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886378|NCT04254913|Edaravone|edaravone|mesh-list
44886379|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44886380|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
44886381|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886382|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44886383|NCT04254913|Protective Agents|protective agents|mesh-ancestor
44375935|NCT03473756|Atezolizumab|atezolizumab|mesh-list
44886384|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886385|NCT04254874|Interferons|interferons|mesh-list
44886386|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886387|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
44886388|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886389|NCT04254744|Sevoflurane|sevoflurane|mesh-list
44886390|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44886391|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44886392|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
44886393|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
44886394|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886395|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886396|NCT04254523|Morphine|morphine|mesh-list
44886397|NCT04254523|Bupivacaine|bupivacaine|mesh-list
44886398|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886399|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
44886400|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886401|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375951|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886403|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886404|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44886405|NCT04254523|Narcotics|narcotics|mesh-ancestor
44886406|NCT04254523|Analgesics|analgesics|mesh-ancestor
44886407|NCT04254601|Erythromycin|erythromycin|mesh-list
44886408|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
44886409|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44886410|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
44886411|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44886412|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886413|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886414|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44886415|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886416|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886417|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
44886418|NCT04254679|Analgesics|analgesics|mesh-list
44886419|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
44886420|NCT04254679|Narcotics|narcotics|mesh-ancestor
44886421|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886422|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886423|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
44886424|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886425|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
44886426|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44886427|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886428|NCT04254471|Carboplatin|carboplatin|mesh-list
44886429|NCT04254471|Etoposide|etoposide|mesh-list
44886430|NCT04254471|Rabeprazole|rabeprazole|mesh-list
44886431|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886432|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44886433|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44886434|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44886435|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375976|NCT03383458|Nivolumab|nivolumab|mesh-list
44886436|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886437|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44886438|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886439|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44886440|NCT04254640|Cytarabine|cytarabine|mesh-list
44886441|NCT04254640|Cladribine|cladribine|mesh-list
44886442|NCT04254640|Aclarubicin|aclarubicin|mesh-list
44886443|NCT04254640|Lenograstim|lenograstim|mesh-list
44886444|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886445|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
44886446|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886447|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886448|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
44886449|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886450|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886451|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
44886452|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886453|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44886454|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44886455|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44886456|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44886457|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886459|NCT04254042|Zofenopril|zofenopril|mesh-list
44886460|NCT04254042|Captopril|captopril|mesh-list
44886461|NCT04254042|Calcium|calcium|mesh-list
44886462|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886463|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886464|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44886465|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886466|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886467|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886468|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44886469|NCT04254081|Lidocaine|lidocaine|mesh-list
44886470|NCT04254081|Buprenorphine|buprenorphine|mesh-list
44886471|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886472|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
44886473|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886474|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886475|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
44886476|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886477|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886478|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886479|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886480|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886481|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886482|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44886483|NCT04254081|Narcotics|narcotics|mesh-ancestor
44886484|NCT04254081|Analgesics|analgesics|mesh-ancestor
44700531|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44700532|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
44700533|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44700534|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44700535|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44700536|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700537|NCT00678730|Dronabinol|dronabinol|mesh-list
44700538|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
44700539|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700540|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700541|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44700542|NCT00678730|Analgesics|analgesics|mesh-ancestor
44700543|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
44700544|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700545|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44700546|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44700547|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700548|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700549|NCT00678730|Hormones|hormones|mesh-ancestor
44700550|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700551|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44700552|NCT00600015|Sorafenib|sorafenib|mesh-list
44700553|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700554|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700555|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700556|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700557|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44700558|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44700559|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700560|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44700561|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44700562|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700563|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700564|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
44700565|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700566|NCT00447122|Gemcitabine|gemcitabine|mesh-list
44700567|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
44700568|NCT00447122|Lapatinib|lapatinib|mesh-list
44700569|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44700570|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
44700571|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700572|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700573|NCT00447122|Antiviral Agents|antiviral agents|mesh-ancestor
44700574|NCT00447122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700575|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700576|NCT00447122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886485|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44886486|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
44886487|NCT04253912|Povidone|povidone|mesh-list
44886488|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
44886489|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
44886490|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44886491|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886492|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44886493|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44886494|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886495|NCT04253678|Vortioxetine|vortioxetine|mesh-list
44886496|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
44886497|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44886498|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44886499|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44886500|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886501|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886502|NCT04253678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44886503|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44886504|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886505|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886506|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886507|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
44886508|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44886509|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44886510|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44886511|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44886512|NCT04253873|Temozolomide|temozolomide|mesh-list
44886513|NCT04253873|Apatinib|apatinib|mesh-list
44886514|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44886515|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
44886516|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886517|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886518|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44886519|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886520|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
44886521|NCT04253132|Analgesics|analgesics|mesh-ancestor
44886522|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
44886523|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886524|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886525|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44886526|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44886527|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886528|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886529|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44886530|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886531|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886532|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44886533|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44886534|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886535|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886536|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44886537|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
44886538|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886539|NCT04253145|Atezolizumab|atezolizumab|mesh-list
44886540|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886541|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44886542|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44886543|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44886544|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
44886545|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886546|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44886547|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44886548|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886549|NCT04253223|Volagidemab|volagidemab|mesh-list
44886550|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44886551|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886552|NCT04252963|Streptokinase|streptokinase|mesh-list
44886553|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44886554|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44886555|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886556|NCT04252664|Remdesivir|remdesivir|mesh-list
44886557|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
44886558|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886559|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
44886560|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886561|NCT04252885|Ritonavir|ritonavir|mesh-list
44886562|NCT04252885|Lopinavir|lopinavir|mesh-list
44886563|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44886564|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44886565|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886566|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886567|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886568|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44886569|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44886570|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
44886571|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886572|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44376163|NCT02593123|Molgramostim|molgramostim|mesh-list
44886573|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44886574|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
44886575|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886576|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886577|NCT04252456|Leucovorin|leucovorin|mesh-list
44886578|NCT04252456|Folic Acid|folic acid|mesh-list
44886579|NCT04252456|Fluorouracil|fluorouracil|mesh-list
44886580|NCT04252456|Aflibercept|aflibercept|mesh-list
44886581|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
44886582|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
44886583|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886584|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886585|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886586|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886587|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
44886588|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886589|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44886590|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44886591|NCT04252456|Growth Substances|growth substances|mesh-ancestor
44886592|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
44886593|NCT04252456|Antidotes|antidotes|mesh-ancestor
44886594|NCT04252456|Protective Agents|protective agents|mesh-ancestor
44886595|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
44886596|NCT04252456|Vitamins|vitamins|mesh-ancestor
44886597|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
44886598|NCT04252456|Hematinics|hematinics|mesh-ancestor
44886599|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
44886600|NCT04252443|Analgesics|analgesics|mesh-list
44886601|NCT04252443|Narcotics|narcotics|mesh-ancestor
44886602|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886603|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886604|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
44886605|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886606|NCT04252248|Decitabine|decitabine|mesh-list
44886607|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886608|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
44886609|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886610|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886611|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886612|NCT04252274|Darunavir|darunavir|mesh-list
44886613|NCT04252274|Cobicistat|cobicistat|mesh-list
44886614|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44886615|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44886616|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44886617|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886618|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886619|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886620|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44886621|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44886622|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
44886623|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886624|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44886625|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44886626|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44886627|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44886628|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44886629|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
44886630|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886631|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44886632|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44886633|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886634|NCT04252261|Sulforaphane|sulforaphane|mesh-list
44886635|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44886636|NCT04252261|Protective Agents|protective agents|mesh-ancestor
44886637|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886638|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886639|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44886641|NCT04252521|Metoclopramide|metoclopramide|mesh-list
44886642|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
44886643|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
44886644|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886645|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886646|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886647|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44886648|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44886649|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
44886650|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886651|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886652|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44886653|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44886654|NCT04252521|Analgesics|analgesics|mesh-ancestor
44886655|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
44886656|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886657|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886658|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44886659|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886660|NCT04251962|Fentanyl|fentanyl|mesh-list
44886661|NCT04251962|Bupivacaine|bupivacaine|mesh-list
44886662|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886663|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
44886664|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886665|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886666|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
44886667|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886668|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44886669|NCT04251962|Narcotics|narcotics|mesh-ancestor
44886670|NCT04251962|Analgesics|analgesics|mesh-ancestor
44886671|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44886672|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44886673|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
44886674|NCT04251871|Interferons|interferons|mesh-list
44886675|NCT04251871|Ritonavir|ritonavir|mesh-list
44886676|NCT04251871|Lopinavir|lopinavir|mesh-list
44886677|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
44886678|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44886679|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886680|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
44886681|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886682|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44886683|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44886684|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886685|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886686|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886687|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44886688|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44886689|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44886690|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44886691|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
44886692|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886693|NCT04251741|Adalimumab|adalimumab|mesh-list
44886694|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44886695|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886696|NCT04251845|Melatonin|melatonin|mesh-list
44886697|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
44886698|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886699|NCT04251845|Protective Agents|protective agents|mesh-ancestor
44886700|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886701|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886702|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
44886703|NCT04251832|Antidotes|antidotes|mesh-ancestor
44886704|NCT04251832|Protective Agents|protective agents|mesh-ancestor
44886705|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886706|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
44886707|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886708|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
44886709|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44886710|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886711|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
44886712|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
44886713|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
44886714|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44886715|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44886716|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886717|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
44886718|NCT04251247|Coagulants|coagulants|mesh-ancestor
44886719|NCT04251364|Acetazolamide|acetazolamide|mesh-list
44886720|NCT04251364|Atorvastatin|atorvastatin|mesh-list
44886721|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44886722|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44886723|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
44886724|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886725|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44886726|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44886727|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886728|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
44886729|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44886730|NCT04251364|Diuretics|diuretics|mesh-ancestor
44886731|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
44886732|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886733|NCT04250948|Capecitabine|capecitabine|mesh-list
44886734|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
44886735|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886736|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
44886737|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886738|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886739|NCT05253508|Lidocaine|lidocaine|mesh-list
44886740|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886741|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
44886742|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886743|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886744|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
44886745|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886746|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886747|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886748|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886749|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886750|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886751|NCT05253066|Docetaxel|docetaxel|mesh-list
44886752|NCT05253066|Epirubicin|epirubicin|mesh-list
44886753|NCT05253066|Exemestane|exemestane|mesh-list
44886754|NCT05253066|Goserelin|goserelin|mesh-list
44886755|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886756|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
44886757|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
44886758|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
44886759|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886760|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44886761|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44886762|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44886763|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886764|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44886765|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44886766|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44886767|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886768|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886769|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886770|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44886771|NCT05253014|Acetaminophen|acetaminophen|mesh-list
44886772|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44886773|NCT05253014|Analgesics|analgesics|mesh-ancestor
44886774|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
44886775|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886776|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886777|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
44886778|NCT05252715|Vaccines|vaccines|mesh-list
44886779|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
44886780|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886781|NCT05252325|Lidocaine|lidocaine|mesh-list
44886782|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
44886783|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886784|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
44376358|NCT01306019|Busulfan|busulfan|mesh-list
44886785|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886786|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886787|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
44886788|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886789|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886790|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886791|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886792|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886793|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886794|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44886795|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
44886796|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
44886797|NCT05252325|Protective Agents|protective agents|mesh-ancestor
44886798|NCT05252117|Mepivacaine|mepivacaine|mesh-list
44886799|NCT05252117|Carticaine|carticaine|mesh-list
44886800|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886801|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
44886802|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886803|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886804|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
44886805|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886806|NCT05251766|Paclitaxel|paclitaxel|mesh-list
44886807|NCT05251766|Docetaxel|docetaxel|mesh-list
44886808|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44886809|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886810|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
44886811|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
44886812|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
44886813|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886814|NCT05251662|Bevacizumab|bevacizumab|mesh-list
44886815|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886816|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886817|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44886818|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44886819|NCT05251662|Growth Substances|growth substances|mesh-ancestor
44886820|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886821|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44886822|NCT05251610|Propranolol|propranolol|mesh-list
44886823|NCT05251610|Oxytocin|oxytocin|mesh-list
44886824|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
44886825|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44886826|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886827|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44886828|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44886829|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
44886830|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886831|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886832|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886833|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44886834|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
44886835|NCT05213507|Amikacin|amikacin|mesh-list
44886836|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700577|NCT00447122|Immunologic Factors|immunologic factors|mesh-ancestor
44700578|NCT00447122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700579|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700580|NCT00430040|Carvedilol|carvedilol|mesh-list
44700581|NCT00430040|Lisinopril|lisinopril|mesh-list
44700582|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44700583|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44700584|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
44700585|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700586|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700587|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252128|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44700588|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700589|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
44700590|NCT00430040|Protective Agents|protective agents|mesh-ancestor
44700591|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44700592|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700593|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44700594|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
44700595|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44700596|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44700597|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44700598|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44700599|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700600|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44700601|NCT00309985|Docetaxel|docetaxel|mesh-list
44700602|NCT00309985|Androgens|androgens|mesh-list
44700603|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700604|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700605|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700606|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700607|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700608|NCT00309985|Hormones|hormones|mesh-ancestor
44700609|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700610|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700611|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
44700612|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44700613|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
44700614|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44700615|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700616|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44700617|NCT00066963|Fluorides|fluorides|mesh-list
44700618|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
44700619|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
44700620|NCT00066963|Protective Agents|protective agents|mesh-ancestor
44700621|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700622|NCT01397500|Testosterone|testosterone|mesh-list
44700623|NCT01397500|Androgens|androgens|mesh-ancestor
44700624|NCT01397500|Hormones|hormones|mesh-ancestor
44700625|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700626|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700627|NCT01397513|Aspirin|aspirin|mesh-list
44700628|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44376484|NCT05096312|Zinc|zinc|mesh-list
44700629|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44700630|NCT01397513|Analgesics|analgesics|mesh-ancestor
44700631|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
44700632|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700633|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700634|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700635|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44700636|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44700637|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44700638|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700639|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44700640|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44700641|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700642|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
44700643|NCT01397630|Oxytocin|oxytocin|mesh-list
44700644|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
44700645|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44700646|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700647|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
44676581|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
44886837|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886838|NCT04962503|Afamelanotide|afamelanotide|mesh-list
44886839|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
44886840|NCT04938882|Lidocaine|lidocaine|mesh-list
44886841|NCT04938882|Ropivacaine|ropivacaine|mesh-list
44886842|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886843|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
44886844|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886845|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886846|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
44886847|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886848|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886849|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886850|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886851|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886852|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886853|NCT04911517|Capecitabine|capecitabine|mesh-list
44886854|NCT04911517|Antibodies|antibodies|mesh-list
44886855|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44886856|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
44886857|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886858|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886859|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
44886860|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376509|NCT05089916|Osimertinib|osimertinib|mesh-list
44886861|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886862|NCT04865978|Warfarin|warfarin|mesh-list
44886863|NCT04865978|Apixaban|apixaban|mesh-list
44886864|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
44886865|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44886866|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
44886867|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44886868|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44886869|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886870|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886871|NCT04816513|Ustekinumab|ustekinumab|mesh-list
44886872|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
44886873|NCT04674670|Naltrexone|naltrexone|mesh-list
44886874|NCT04674670|Bromocriptine|bromocriptine|mesh-list
44886875|NCT04674670|Amisulpride|amisulpride|mesh-list
44886876|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44886877|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44886878|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886879|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
44886880|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886881|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44886882|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44886883|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886884|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44886885|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44886886|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
44886887|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886888|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886889|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44886890|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
44886891|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44886892|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44886893|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
44886894|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44886895|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
44886896|NCT04669132|Olanzapine|olanzapine|mesh-list
44376550|NCT05041647|Dronabinol|dronabinol|mesh-list
44376551|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
44376552|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376553|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44886897|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
44886898|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
44886899|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886900|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886901|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44886902|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44886903|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44886904|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886905|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44886906|NCT04669132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44886907|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44886908|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886909|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886910|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886911|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
44886912|NCT04648319|Nivolumab|nivolumab|mesh-list
44886913|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886914|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886915|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44886916|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886917|NCT04539873|Colchicine|colchicine|mesh-list
44886918|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
44886919|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886920|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
44886921|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
44886922|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44886923|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886924|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886925|NCT04173312|Bupivacaine|bupivacaine|mesh-list
44886926|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
44886927|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
44886928|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44886929|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886930|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
44886931|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44886932|NCT04160325|Azathioprine|azathioprine|mesh-list
44886933|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
44886934|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886935|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44886936|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886937|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886938|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
44886939|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886940|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44886941|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
44886942|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44886943|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886944|NCT03854019|Quinidine|quinidine|mesh-list
44886945|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
44886946|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
44886947|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44886948|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44886949|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44886950|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44886951|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886952|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886953|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44886954|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44886955|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44886956|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44886957|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
44886958|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44886959|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44886960|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44886961|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886962|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44886963|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44886964|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
44886965|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44886966|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44886967|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44886968|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44886969|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44886970|NCT03737370|Docetaxel|docetaxel|mesh-list
44886971|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886972|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
44886973|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
44886974|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
44886975|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886976|NCT03538899|Busulfan|busulfan|mesh-list
44886977|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
44886978|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886979|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44886980|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
44886981|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44886982|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44886983|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886984|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44886985|NCT03432897|Olaparib|olaparib|mesh-list
44886986|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44886987|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44886988|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44886989|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44886990|NCT03355157|Tamoxifen|tamoxifen|mesh-list
44886991|NCT03355157|Paclitaxel|paclitaxel|mesh-list
44886992|NCT03355157|Vinorelbine|vinorelbine|mesh-list
44886993|NCT03355157|Capecitabine|capecitabine|mesh-list
44886994|NCT03355157|Letrozole|letrozole|mesh-list
44886995|NCT03355157|Epirubicin|epirubicin|mesh-list
44886996|NCT03355157|Fulvestrant|fulvestrant|mesh-list
44886997|NCT03355157|Palbociclib|palbociclib|mesh-list
44886998|NCT03355157|Exemestane|exemestane|mesh-list
44886999|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887000|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887001|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887002|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887003|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887004|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887005|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887006|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
44887007|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44887008|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44887009|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887010|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44887011|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
44887012|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887013|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887014|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887015|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44887016|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44887017|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887018|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44887019|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44887020|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44887021|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44887022|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887023|NCT03324035|Tramadol|tramadol|mesh-list
44887024|NCT03324035|Amitriptyline|amitriptyline|mesh-list
44887025|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44887026|NCT03324035|Narcotics|narcotics|mesh-ancestor
44887027|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44887028|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887029|NCT03324035|Analgesics|analgesics|mesh-ancestor
44887030|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
44887031|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887032|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44887033|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
44887034|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44887035|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44887036|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44887037|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44887038|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44887039|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887040|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887041|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887042|NCT03196180|Fluorouracil|fluorouracil|mesh-list
44887043|NCT03196180|Imiquimod|imiquimod|mesh-list
44887044|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
44887045|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887046|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887047|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887048|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887049|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
44887050|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887051|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44887052|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
44887053|NCT02980731|Venetoclax|venetoclax|mesh-list
44887054|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887055|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
44887056|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44887057|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44887058|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887059|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44887060|NCT02819141|Analgesics|analgesics|mesh-ancestor
44887061|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
44887062|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887063|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44887064|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44887066|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887067|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887068|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887069|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
44887070|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44887071|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887072|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44887073|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700648|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700649|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
44887074|NCT02636946|Bimatoprost|bimatoprost|mesh-list
44887075|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44887076|NCT02631941|Budesonide|budesonide|mesh-list
44887077|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
44887078|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44887079|NCT02631941|Charcoal|charcoal|mesh-list
44887080|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887081|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44887082|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
44887083|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887084|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887085|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44887086|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
44887087|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
44887088|NCT02631941|Hormones|hormones|mesh-ancestor
44887089|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887090|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44887091|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44887092|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44887093|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887094|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887095|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887096|NCT02631941|Antidotes|antidotes|mesh-ancestor
44887097|NCT02631941|Protective Agents|protective agents|mesh-ancestor
44887098|NCT02562378|Doxorubicin|doxorubicin|mesh-list
44887099|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44887100|NCT02562378|Trastuzumab|trastuzumab|mesh-list
44887101|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887102|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887103|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44887104|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44887105|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887106|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887107|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887108|NCT02387099|Everolimus|everolimus|mesh-list
44887109|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887110|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887111|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
44887112|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887113|NCT02237508|Budesonide|budesonide|mesh-list
44887114|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
44887115|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44887116|NCT02237508|Charcoal|charcoal|mesh-list
44887117|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887118|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44887119|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
44887120|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887121|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887122|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44887123|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44887124|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
44887125|NCT02237508|Hormones|hormones|mesh-ancestor
44887126|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887127|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44887128|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44887129|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44887130|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887131|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887132|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887133|NCT02237508|Antidotes|antidotes|mesh-ancestor
44887134|NCT02237508|Protective Agents|protective agents|mesh-ancestor
44887135|NCT05580523|Aspirin|aspirin|mesh-list
44887136|NCT05580523|Metformin|metformin|mesh-list
44887137|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44887138|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887139|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44887140|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44887141|NCT05580523|Analgesics|analgesics|mesh-ancestor
44887142|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
44887143|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887144|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887145|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887146|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44887147|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44887148|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887149|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44887150|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44887152|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
44887153|NCT05580510|Empagliflozin|empagliflozin|mesh-list
44887154|NCT05580510|Valsartan|valsartan|mesh-list
44887155|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44887156|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44887157|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44887158|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44376826|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
44376827|NCT04716426|Tetracycline|tetracycline|mesh-list
44376828|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376829|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376830|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44376831|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877824|NCT04696523|Xenon|xenon|mesh-list
44887159|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887160|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44887161|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44887162|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887163|NCT05580029|Triamcinolone|triamcinolone|mesh-list
44887164|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887165|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
44887166|NCT05580029|Hormones|hormones|mesh-ancestor
44887167|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887168|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887169|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
44887170|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44887171|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44887172|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887173|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44887174|NCT05579964|Analgesics|analgesics|mesh-ancestor
44887175|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
44887176|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887177|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44887178|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44887179|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44887180|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887181|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887182|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887183|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
44887184|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44887185|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
44887186|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887187|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
44887188|NCT05579665|Protective Agents|protective agents|mesh-ancestor
44887189|NCT05579626|Ezetimibe|ezetimibe|mesh-list
44887190|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44887191|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44887192|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44887193|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
44887194|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887195|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44887196|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887197|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44887198|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44887199|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44887200|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44887201|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
44887202|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44887203|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887204|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44887205|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44887206|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44887207|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44887208|NCT05519241|Paclitaxel|paclitaxel|mesh-list
44887209|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887210|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887211|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887212|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887213|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887214|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887215|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
44887216|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887217|NCT05470244|Analgesics|analgesics|mesh-list
44887218|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
44887219|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887220|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887221|NCT05419180|Stiripentol|stiripentol|mesh-list
44887222|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
44887223|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44887224|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
44887225|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700650|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700651|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700652|NCT01397994|Nicorandil|nicorandil|mesh-list
44700653|NCT01397994|Atenolol|atenolol|mesh-list
44700654|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44700655|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700656|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
44677034|NCT01299558|Xhance|xhance|mesh-list
44887226|NCT05374564|Flutemetamol|flutemetamol|mesh-list
44376913|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376914|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
44376915|NCT04640168|Hormones|hormones|mesh-ancestor
44887227|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44887228|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887229|NCT05317689|Psilocybin|psilocybin|mesh-list
44887230|NCT05317689|Psilocin|psilocin|mesh-list
44887231|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
44887232|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887233|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44887234|NCT05293665|Vaccines|vaccines|mesh-list
44887235|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
44887236|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887237|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
44887238|NCT05286437|Letrozole|letrozole|mesh-list
44887239|NCT05286437|Lenvatinib|lenvatinib|mesh-list
44887240|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887241|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887242|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44887243|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44887244|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887245|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887246|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44887247|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
44887248|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887249|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887250|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887251|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
44887252|NCT05273554|Lenvatinib|lenvatinib|mesh-list
44887253|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887254|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887255|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887256|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887257|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887258|NCT05179005|Imidacloprid|imidacloprid|mesh-list
44887259|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
44887260|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887261|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887262|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887263|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
44887264|NCT05175625|Paraproteins|paraproteins|mesh-list
44887265|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
44887266|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887267|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
44887268|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44887269|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887270|NCT05116007|Carboplatin|carboplatin|mesh-list
44887271|NCT05116007|Etoposide|etoposide|mesh-list
44887272|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887273|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887274|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44887275|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44887276|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887277|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887278|NCT05080946|Aspirin|aspirin|mesh-list
44887279|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44887280|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44887281|NCT05080946|Analgesics|analgesics|mesh-ancestor
44887282|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
44887283|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887284|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887285|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887286|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887287|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44887288|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44887289|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887290|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44887291|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44887292|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887293|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
44887294|NCT05062785|Insulin|insulin|mesh-list
44887295|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44887296|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887297|NCT05058404|Prednisone|prednisone|mesh-list
44887298|NCT05058404|Rituximab|rituximab|mesh-list
44887299|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44887300|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
44887301|NCT05058404|Vincristine|vincristine|mesh-list
44887302|NCT05058404|Doxorubicin|doxorubicin|mesh-list
44887303|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887304|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887305|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
44887306|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887307|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887308|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44887309|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
44887310|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887311|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887312|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44887313|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887314|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
44887315|NCT05058404|Hormones|hormones|mesh-ancestor
44887316|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887317|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887318|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887319|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887320|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887321|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887322|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887323|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44887324|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44887325|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887326|NCT05043870|Infliximab|infliximab|mesh-list
44887327|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44887328|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44887329|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887330|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887331|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
44887332|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887333|NCT05038228|Vitamin K|vitamin k|mesh-list
44887334|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
44887335|NCT05038228|Apixaban|apixaban|mesh-list
44887336|NCT05038228|Dabigatran|dabigatran|mesh-list
44887337|NCT05038228|Vitamins|vitamins|mesh-ancestor
44887338|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
44887339|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887340|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44887341|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
44887342|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44887343|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44887344|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887345|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887346|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
44887347|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44887348|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44887349|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
44887350|NCT05038228|Coagulants|coagulants|mesh-ancestor
44887351|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
44887352|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44887353|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
44887354|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887355|NCT05034783|Exenatide|exenatide|mesh-list
44887356|NCT05034783|Edetic Acid|edetic acid|mesh-list
44887357|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
44887358|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
44887359|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887360|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
44887361|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44887362|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44887363|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887364|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44887365|NCT05034783|Incretins|incretins|mesh-ancestor
44887366|NCT05034783|Hormones|hormones|mesh-ancestor
44887367|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887368|NCT05014828|Lenvatinib|lenvatinib|mesh-list
44887369|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887370|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887371|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887372|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887373|NCT05012644|Palbociclib|palbociclib|mesh-list
44887374|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44887375|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887376|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887377|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677176|NCT01300780|Etoricoxib|etoricoxib|mesh-list
44887378|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887379|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44887380|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44887381|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
44887382|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887383|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887384|NCT04985955|Tofacitinib|tofacitinib|mesh-list
44887385|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887386|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887387|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887388|NCT04940286|Gemcitabine|gemcitabine|mesh-list
44887389|NCT04940286|Paclitaxel|paclitaxel|mesh-list
44887390|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44887391|NCT04940286|Durvalumab|durvalumab|mesh-list
44887392|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
44887393|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44887394|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
44887395|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887396|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887397|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887398|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887399|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887400|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887401|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887402|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
44887403|NCT04940286|Antiviral Agents|antiviral agents|mesh-ancestor
44887404|NCT04940286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887405|NCT04940286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887406|NCT04940286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887407|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
44887408|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887409|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887410|NCT04937413|Evolocumab|evolocumab|mesh-list
44887411|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44887412|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44887413|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
44887414|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887415|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44887416|NCT04899583|Sirolimus|sirolimus|mesh-list
44887417|NCT04899583|Paclitaxel|paclitaxel|mesh-list
44887418|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887419|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887420|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887421|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887422|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887423|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887424|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44887425|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887426|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887427|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
44887428|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887429|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
44887430|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887431|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44887432|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
44887433|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887434|NCT04834908|Immune Sera|immune sera|mesh-list
44887435|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
44887436|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887437|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44887438|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44887439|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44887440|NCT04789070|Sirolimus|sirolimus|mesh-list
44887441|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44887442|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887443|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887444|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887445|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
44887446|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887447|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
44887448|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887449|NCT04778904|Nivolumab|nivolumab|mesh-list
44887450|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887451|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887452|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44887453|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887454|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44887455|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
44887456|NCT04774393|Decitabine|decitabine|mesh-list
44887457|NCT04774393|Venetoclax|venetoclax|mesh-list
44887458|NCT04774393|Ivosidenib|ivosidenib|mesh-list
44887459|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887460|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
44700657|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
44700658|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700659|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700660|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44700661|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44700662|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44700663|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
44700664|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700665|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700666|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
44700667|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
44700668|NCT01397994|Vitamins|vitamins|mesh-ancestor
44700669|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
44700670|NCT01398033|Paclitaxel|paclitaxel|mesh-list
44700671|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700672|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700673|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700674|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700675|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700676|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700677|NCT01398046|Dasatinib|dasatinib|mesh-list
44700678|NCT01398046|Rabeprazole|rabeprazole|mesh-list
44700679|NCT01398046|Betaine|betaine|mesh-list
44700680|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700681|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700682|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700683|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700684|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44700685|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700686|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44700687|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
44700688|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44700689|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
44700690|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44700691|NCT01398072|Azithromycin|azithromycin|mesh-list
44700692|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
44700693|NCT01398072|Doxycycline|doxycycline|mesh-list
44700694|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700695|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700696|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44700697|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44700698|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700699|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700700|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700701|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
44700702|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44700703|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44700704|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
44700705|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
44700706|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44700707|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
44700708|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700709|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700710|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44700711|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
44700712|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44700713|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44700714|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44700715|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
44700716|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700717|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700718|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44700719|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44700720|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44700721|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
44700722|NCT01398189|Clozapine|clozapine|mesh-list
44700723|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44700724|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
44700725|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887461|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887462|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887463|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887464|NCT04753723|Gentamicins|gentamicins|mesh-list
44887465|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44887466|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887467|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44887468|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887469|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377193|NCT04493931|Rifampin|rifampin|mesh-list
44377250|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
44887470|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
44887471|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44887472|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44887473|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887474|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887475|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887476|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887477|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
44887478|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
44887479|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887480|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
44887481|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44887482|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
44887483|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44887484|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
44887485|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44887486|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
44887487|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44887488|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887489|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44887490|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887491|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887492|NCT04716712|Azithromycin|azithromycin|mesh-list
44887493|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44887494|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887495|NCT04706741|Prednisone|prednisone|mesh-list
44887496|NCT04706741|Prednisolone|prednisolone|mesh-list
44887497|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887498|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
44887499|NCT04706741|Hormones|hormones|mesh-ancestor
44887500|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677332|NCT01302002|Metformin|metformin|mesh-list
44677333|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677334|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677335|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
44677336|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44377260|NCT04470622|Aprepitant|aprepitant|mesh-list
44677337|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677338|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677339|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677340|NCT01302093|Racecadotril|racecadotril|mesh-list
44677341|NCT01302093|Thiorphan|thiorphan|mesh-list
44677342|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
44677343|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677344|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44677345|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677346|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677347|NCT01302106|Clofarabine|clofarabine|mesh-list
44677348|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677349|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
44677350|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677351|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677352|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
44677353|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44677354|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677355|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677356|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677357|NCT01302145|Metformin|metformin|mesh-list
44677358|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
44677359|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677360|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677361|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44677362|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677363|NCT01302158|Glimepiride|glimepiride|mesh-list
44677364|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
44887501|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887502|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887503|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677372|NCT01302171|Lenograstim|lenograstim|mesh-list
44887504|NCT04570631|Dexamethasone|dexamethasone|mesh-list
44887505|NCT04570631|Bortezomib|bortezomib|mesh-list
44887506|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887507|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
44887508|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
44887509|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887510|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887511|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887512|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
44887513|NCT04570631|Hormones|hormones|mesh-ancestor
44887514|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887515|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887516|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887517|NCT04565431|Natalizumab|natalizumab|mesh-list
44887518|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
44887519|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887520|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
44887521|NCT04527549|Trametinib|trametinib|mesh-list
44887522|NCT04527549|Dabrafenib|dabrafenib|mesh-list
44887523|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44887524|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
44887525|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44887526|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44887527|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887528|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887529|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887530|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887531|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887532|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887533|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44887534|NCT04527549|Protective Agents|protective agents|mesh-ancestor
44887535|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887536|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44887537|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
44887538|NCT04474847|Abatacept|abatacept|mesh-list
44887539|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44887540|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887541|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887542|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887543|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
44887544|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887545|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887546|NCT04435600|Ustekinumab|ustekinumab|mesh-list
44887547|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
44887548|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
44887549|NCT04420884|Fluorouracil|fluorouracil|mesh-list
44887550|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887551|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887552|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
44887553|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887554|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887555|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887556|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
44887557|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887558|NCT04322006|Antibodies|antibodies|mesh-list
44887559|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44887560|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
44887561|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887562|NCT04295772|Islatravir|islatravir|mesh-list
44887563|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
44887564|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887565|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887566|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887567|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44887568|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44887569|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44887570|NCT04216134|Edetic Acid|edetic acid|mesh-list
44887571|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44887572|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
44887573|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
44887574|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887575|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
44887576|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44887577|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44887578|NCT04136743|Dexamethasone|dexamethasone|mesh-list
44887579|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887580|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
44887581|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
44887582|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887583|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887584|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887585|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
44887586|NCT04136743|Hormones|hormones|mesh-ancestor
44887587|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887588|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887589|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887590|NCT04086485|Olaparib|olaparib|mesh-list
44887591|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44887592|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887593|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887594|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887595|NCT03910244|Pomalidomide|pomalidomide|mesh-list
44887596|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
44887597|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887598|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44887599|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44887600|NCT03910244|Growth Substances|growth substances|mesh-ancestor
44887601|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
44887602|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887603|NCT03852251|Capecitabine|capecitabine|mesh-list
44887604|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
44887605|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887606|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
44887607|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887608|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887609|NCT03763162|Dexamethasone|dexamethasone|mesh-list
44887610|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
44887611|NCT03763162|Bortezomib|bortezomib|mesh-list
44887612|NCT03763162|Daratumumab|daratumumab|mesh-list
44887613|NCT03763162|Ixazomib|ixazomib|mesh-list
44887614|NCT03763162|Ichthammol|ichthammol|mesh-list
44887615|NCT03763162|BB 1101|bb 1101|mesh-list
44887616|NCT03763162|Glycine|glycine|mesh-list
44887617|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887618|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
44887619|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
44887620|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887621|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887622|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887623|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
44887624|NCT03763162|Hormones|hormones|mesh-ancestor
44887625|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887626|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887627|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887628|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
44887629|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887630|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887631|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44887632|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
44887633|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887634|NCT03762096|Resveratrol|resveratrol|mesh-list
44377432|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887635|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
44887636|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887637|NCT03762096|Protective Agents|protective agents|mesh-ancestor
44887638|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887639|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887640|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44887641|NCT03721341|Hormones|hormones|mesh-list
44887642|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887643|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887644|NCT03711448|Prednisone|prednisone|mesh-list
44887645|NCT03711448|Ustekinumab|ustekinumab|mesh-list
44887646|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887647|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
44887648|NCT03711448|Hormones|hormones|mesh-ancestor
44887649|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887650|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887651|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887652|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887653|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
44887654|NCT03691493|Tamoxifen|tamoxifen|mesh-list
44887655|NCT03691493|Letrozole|letrozole|mesh-list
44887656|NCT03691493|Fulvestrant|fulvestrant|mesh-list
44677514|NCT01303237|Cetuximab|cetuximab|mesh-list
44887657|NCT03691493|Palbociclib|palbociclib|mesh-list
44887658|NCT03691493|Anastrozole|anastrozole|mesh-list
44887659|NCT03691493|Exemestane|exemestane|mesh-list
44887660|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887661|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44887662|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44887663|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887664|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887665|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44887666|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
44887667|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887668|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887669|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887670|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44887671|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44887672|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44887673|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44887674|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887675|NCT03679611|Neostigmine|neostigmine|mesh-list
44887676|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44887677|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887678|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887679|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44887680|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887681|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887682|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44887683|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
44887684|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887685|NCT03671811|Megestrol|megestrol|mesh-list
44887686|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
44887687|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44887688|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44887689|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44887690|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
44887691|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44887692|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887693|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44887694|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44887695|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887696|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887697|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
44887698|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44887699|NCT03620201|Atezolizumab|atezolizumab|mesh-list
44887700|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887701|NCT03612466|Plerixafor|plerixafor|mesh-list
44887702|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
44887703|NCT03612466|Calcium|calcium|mesh-list
44887704|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44887705|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887706|NCT03612466|Antacids|antacids|mesh-ancestor
44887707|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887708|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887709|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44887710|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44887711|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
44887712|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887713|NCT03575000|Bromocriptine|bromocriptine|mesh-list
44887714|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44887715|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44887716|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44700726|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700727|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700728|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44700729|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44700730|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44700731|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700732|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
44700733|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
44700734|NCT01398202|Vitamin D|vitamin d|mesh-list
44700735|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
44700736|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44252205|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
44700737|NCT01398202|Calcifediol|calcifediol|mesh-list
44700738|NCT01398202|Vitamins|vitamins|mesh-ancestor
44887717|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887718|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887719|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
44887720|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
44887721|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887722|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887723|NCT03532295|Bevacizumab|bevacizumab|mesh-list
44887724|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887725|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887726|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44887727|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44887728|NCT03532295|Growth Substances|growth substances|mesh-ancestor
44887729|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887730|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
44887731|NCT03524326|Cetuximab|cetuximab|mesh-list
44887732|NCT03524326|Lenvatinib|lenvatinib|mesh-list
44887733|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887734|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887735|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44887736|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887737|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887738|NCT03508232|Doxycycline|doxycycline|mesh-list
44887739|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44887740|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887741|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
44887742|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44887743|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44887744|NCT03464019|Etripamil|etripamil|mesh-list
44887745|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44887746|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44887747|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887748|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44887749|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887750|NCT03304821|Sargramostim|sargramostim|mesh-list
44887751|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
44887752|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887753|NCT03238430|Morphine|morphine|mesh-list
44887754|NCT03238430|Ropivacaine|ropivacaine|mesh-list
44887755|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44887756|NCT03238430|Narcotics|narcotics|mesh-ancestor
44887757|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44887758|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887759|NCT03238430|Analgesics|analgesics|mesh-ancestor
44887760|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
44887761|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887762|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
44887763|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
44887764|NCT03223220|Midazolam|midazolam|mesh-list
44887765|NCT03223220|Ketamine|ketamine|mesh-list
44887766|NCT03223220|Analgesics|analgesics|mesh-ancestor
44887767|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
44887768|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887769|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887770|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44887771|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44887772|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
44887773|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
44887774|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44887775|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44887776|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44887777|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887778|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887779|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44887780|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44887781|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44887782|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44887783|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44887784|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
44887785|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
44887787|NCT03205956|Carbidopa|carbidopa|mesh-list
44887788|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44887789|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44887790|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
44887791|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887792|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887793|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887794|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44887795|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887796|NCT03172377|Adalimumab|adalimumab|mesh-list
44887797|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887798|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887799|NCT02973789|Docetaxel|docetaxel|mesh-list
44887800|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44887801|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887802|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887803|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887804|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887805|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887806|NCT02937116|Gemcitabine|gemcitabine|mesh-list
44887807|NCT02937116|Cisplatin|cisplatin|mesh-list
44887808|NCT02937116|Capecitabine|capecitabine|mesh-list
44887809|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
44887810|NCT02937116|Irinotecan|irinotecan|mesh-list
44887811|NCT02937116|Etoposide|etoposide|mesh-list
44887812|NCT02937116|Pemetrexed|pemetrexed|mesh-list
44887813|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887814|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887815|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
44887816|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887817|NCT02937116|Antiviral Agents|antiviral agents|mesh-ancestor
44887818|NCT02937116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887819|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887820|NCT02937116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887821|NCT02937116|Immunologic Factors|immunologic factors|mesh-ancestor
44887822|NCT02937116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887823|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44887824|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44887825|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887826|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44887827|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44887828|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44887829|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
44887830|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44887831|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44887832|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
44887833|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887834|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
44887835|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887836|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887837|NCT02382406|Paclitaxel|paclitaxel|mesh-list
44887838|NCT02382406|Carboplatin|carboplatin|mesh-list
44887839|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
44887840|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887841|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887842|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44887843|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887844|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887845|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887846|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887847|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
44887848|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887849|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887850|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
44887851|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44887852|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
44887853|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44887854|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44887855|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887856|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44887857|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887858|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887859|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44887860|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
44887861|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
44887862|NCT02297516|Protective Agents|protective agents|mesh-ancestor
44887863|NCT02017704|Leucovorin|leucovorin|mesh-list
44887864|NCT02017704|Capecitabine|capecitabine|mesh-list
44887865|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
44887866|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887867|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
44887868|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377654|NCT04387136|Sufentanil|sufentanil|mesh-list
44887869|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887870|NCT02017704|Antidotes|antidotes|mesh-ancestor
44887871|NCT02017704|Protective Agents|protective agents|mesh-ancestor
44887872|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887873|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
44887874|NCT02017704|Vitamins|vitamins|mesh-ancestor
44887875|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
44887876|NCT01371630|Cytarabine|cytarabine|mesh-list
44887877|NCT01371630|Dexamethasone|dexamethasone|mesh-list
44887878|NCT01371630|Prednisone|prednisone|mesh-list
44887879|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
44887880|NCT01371630|Rituximab|rituximab|mesh-list
44887881|NCT01371630|Methotrexate|methotrexate|mesh-list
44887882|NCT01371630|Vincristine|vincristine|mesh-list
44887883|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
44887884|NCT01371630|Blinatumomab|blinatumomab|mesh-list
44887885|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44887886|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887887|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
44887888|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887889|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44887890|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44887891|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
44887892|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887893|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887894|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44887895|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44887896|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44887897|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
44887898|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
44887899|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887900|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887901|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
44887902|NCT01371630|Hormones|hormones|mesh-ancestor
44887903|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887904|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887905|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44887906|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
44887907|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44887908|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887909|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
44887910|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
44887911|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887912|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44887913|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44887914|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
44887915|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887916|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44887917|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44377722|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44887918|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44887919|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44887920|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44887921|NCT00834093|Vaccines|vaccines|mesh-list
44887922|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
44887923|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887924|NCT00774930|Lanreotide|lanreotide|mesh-list
44887925|NCT00774930|Somatostatin|somatostatin|mesh-list
44887926|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887927|NCT00774930|Hormones|hormones|mesh-ancestor
44887928|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887929|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887930|NCT00690898|Lanreotide|lanreotide|mesh-list
44887931|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887932|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44887933|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44887934|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44887935|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44887936|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887937|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
44887938|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887939|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887940|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44887941|NCT01822288|Tibolone|tibolone|mesh-list
44887942|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
44887943|NCT01822288|Estradiol|estradiol|mesh-list
44887944|NCT01822288|Estrogens|estrogens|mesh-ancestor
44887945|NCT01822288|Hormones|hormones|mesh-ancestor
44887946|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44887947|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887948|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44887949|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
44887950|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44887951|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44887952|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44887953|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44887954|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44887955|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44887956|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44887957|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887958|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
44887959|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
44887960|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44887961|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44887962|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
44887963|NCT01341600|Omeprazole|omeprazole|mesh-list
44887964|NCT01341600|Clopidogrel|clopidogrel|mesh-list
44887965|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44887966|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44887967|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44887968|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44887969|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
44887970|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44887971|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887972|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887973|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44887974|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44887975|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44887976|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887977|NCT01328626|Venetoclax|venetoclax|mesh-list
44887978|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887979|NCT00529113|Gemcitabine|gemcitabine|mesh-list
44887980|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44887981|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
44887982|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44887983|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44887984|NCT00529113|Antiviral Agents|antiviral agents|mesh-ancestor
44887985|NCT00529113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44887986|NCT00529113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44887987|NCT00529113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44887988|NCT00529113|Immunologic Factors|immunologic factors|mesh-ancestor
44887989|NCT00529113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887990|NCT04250792|Naltrexone|naltrexone|mesh-list
44887991|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44377775|NCT04353817|Ivacaftor|ivacaftor|mesh-list
44887992|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44887993|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44887994|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
44887995|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44887996|NCT04250831|Chromium|chromium|mesh-list
44887997|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44887998|NCT04250831|Trace Elements|trace elements|mesh-ancestor
44887999|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
44888000|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888001|NCT04250831|Cathartics|cathartics|mesh-ancestor
44888002|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888003|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
44888004|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888005|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888006|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44888007|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44888008|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888009|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888010|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888011|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44888012|NCT04250519|Eusol|eusol|mesh-list
44888013|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
44888014|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888015|NCT04250246|Nivolumab|nivolumab|mesh-list
44888016|NCT04250246|Ipilimumab|ipilimumab|mesh-list
44888017|NCT04250246|Guadecitabine|guadecitabine|mesh-list
44888018|NCT04250246|Azacitidine|azacitidine|mesh-list
44888019|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888020|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888021|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44888022|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888023|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888024|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
44888025|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888026|NCT04250116|Apixaban|apixaban|mesh-list
44888027|NCT04250116|Clopidogrel|clopidogrel|mesh-list
44888028|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888029|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44888030|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44888031|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44888032|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
44700739|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
44700740|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700741|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44377818|NCT04345367|Abrocitinib|abrocitinib|mesh-list
44700742|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44700744|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44700745|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
44700746|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700747|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700748|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700749|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44700750|NCT01398267|Protective Agents|protective agents|mesh-ancestor
44700751|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700752|NCT01398293|Ritonavir|ritonavir|mesh-list
44700753|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
44700754|NCT01398293|Lactams|lactams|mesh-list
44700755|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44700756|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44700757|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44700758|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
44700759|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700760|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700761|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44700762|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44700763|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
44700764|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700765|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44700766|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44700767|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700768|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44700769|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44700770|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700771|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44700772|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
44700773|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44700774|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377863|NCT04332874|Dactinomycin|dactinomycin|mesh-list
44700775|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44700776|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44700777|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44700778|NCT01398371|Digoxin|digoxin|mesh-list
44700779|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44700780|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44700781|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700782|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700783|NCT01398371|Protective Agents|protective agents|mesh-ancestor
44700784|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700785|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
44700786|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44700787|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
44700788|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44700789|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700790|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44700791|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44700792|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44700793|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
44700794|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888033|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888034|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888035|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888036|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44888037|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
44888038|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44888039|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
44888040|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888041|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
44888042|NCT04250051|Vidarabine|vidarabine|mesh-list
44888043|NCT04250051|Cytarabine|cytarabine|mesh-list
44888044|NCT04250051|Fludarabine|fludarabine|mesh-list
44888045|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
44888046|NCT04250051|Ivosidenib|ivosidenib|mesh-list
44888047|NCT04250051|Lenograstim|lenograstim|mesh-list
44888048|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888049|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888050|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
44888051|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888052|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888053|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
44888054|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888055|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
44888056|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888057|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44888058|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888059|NCT04249713|Brodalumab|brodalumab|mesh-list
44888060|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888061|NCT04249908|Maleic acid|maleic acid|mesh-list
44888062|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888063|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888064|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
44888065|NCT04249570|Povidone|povidone|mesh-list
44888066|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
44888067|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
44888068|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44888069|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888070|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
44888071|NCT04249804|Analgesics|analgesics|mesh-ancestor
44888072|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
44888073|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888074|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888075|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
44888076|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888077|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888078|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
44888079|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44888080|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888081|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888082|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44888083|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
44888084|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888085|NCT04249531|Amikacin|amikacin|mesh-list
44888086|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888087|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888088|NCT04249154|Leuprolide|leuprolide|mesh-list
44888089|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44888090|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
44888091|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888092|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888093|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888094|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888095|NCT04249284|BMS-986165|bms-986165|mesh-list
44888096|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888097|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44888098|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888099|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888100|NCT04249063|Lidocaine|lidocaine|mesh-list
44888101|NCT04249063|Anesthetics|anesthetics|mesh-list
44888102|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
44888103|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888104|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888105|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
44888106|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888107|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888108|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44888109|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44888110|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888111|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888112|NCT04249037|Tenofovir|tenofovir|mesh-list
44888113|NCT04249037|Emtricitabine|emtricitabine|mesh-list
44888114|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44888115|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44888116|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
44888117|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888118|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44888119|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44888120|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888121|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888122|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44888123|NCT04248621|Goserelin|goserelin|mesh-list
44888124|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44888125|NCT04248621|Leuprolide|leuprolide|mesh-list
44888126|NCT04248621|Flutamide|flutamide|mesh-list
44888127|NCT04248621|Bicalutamide|bicalutamide|mesh-list
44888128|NCT04248621|Androgens|androgens|mesh-list
44888129|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
44888130|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888131|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888132|NCT04248621|Hormones|hormones|mesh-ancestor
44888133|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888134|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888135|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
44888136|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
44888137|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44888138|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
44888139|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888140|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44888141|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44888142|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
44888143|NCT04248608|Morphine|morphine|mesh-list
44888144|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44888145|NCT04248608|Narcotics|narcotics|mesh-ancestor
44888146|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888147|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888148|NCT04248608|Analgesics|analgesics|mesh-ancestor
44888149|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
44888150|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888151|NCT04248348|Heparin|heparin|mesh-list
44888152|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44888153|NCT04248348|Tinzaparin|tinzaparin|mesh-list
44888154|NCT04248348|Dalteparin|dalteparin|mesh-list
44378009|NCT04285229|Ixekizumab|ixekizumab|mesh-list
44888155|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
44888156|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44888157|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44888158|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888159|NCT04248309|Progesterone|progesterone|mesh-list
44888160|NCT04248309|Progestins|progestins|mesh-ancestor
44888161|NCT04248309|Hormones|hormones|mesh-ancestor
44888162|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888163|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888164|NCT04248205|Ketamine|ketamine|mesh-list
44888165|NCT04248205|Analgesics|analgesics|mesh-ancestor
44888166|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
44888167|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888168|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888169|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44888170|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888171|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
44888172|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
44888173|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888174|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44378039|NCT04272775|Dexamethasone|dexamethasone|mesh-list
44888175|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44888176|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888177|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888178|NCT04247984|Bevacizumab|bevacizumab|mesh-list
44888179|NCT04247984|Fluorouracil|fluorouracil|mesh-list
44888180|NCT04247984|Capecitabine|capecitabine|mesh-list
44888181|NCT04247984|Irinotecan|irinotecan|mesh-list
44888182|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888183|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888184|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44888185|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44888186|NCT04247984|Growth Substances|growth substances|mesh-ancestor
44888187|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888188|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44888189|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
44888190|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888191|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888192|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888193|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
44888194|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44888195|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44888196|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888197|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
44888198|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44888199|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888200|NCT04248179|Sufentanil|sufentanil|mesh-list
44888201|NCT04248179|Ropivacaine|ropivacaine|mesh-list
44888202|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888203|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
44888204|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888205|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888206|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
44378088|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44378089|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
44378090|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378091|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44378092|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
44888207|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888208|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44888209|NCT04248179|Narcotics|narcotics|mesh-ancestor
44888210|NCT04248179|Analgesics|analgesics|mesh-ancestor
44888211|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44888212|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888213|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
44888214|NCT04247633|Palbociclib|palbociclib|mesh-list
44888215|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888216|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44888217|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136089|NCT00163319|Hormones|hormones|mesh-ancestor
44378102|NCT04238663|Bevacizumab|bevacizumab|mesh-list
44378103|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378104|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888218|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888219|NCT04247646|Melatonin|melatonin|mesh-list
44888220|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
44888221|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888222|NCT04247646|Protective Agents|protective agents|mesh-ancestor
44888223|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888224|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888225|NCT04247815|Methotrexate|methotrexate|mesh-list
44888226|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44888227|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
44888228|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888229|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888230|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888231|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
44888232|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888233|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888234|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888235|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888236|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44888237|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888238|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
44888239|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888240|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44888241|NCT04247373|Ropivacaine|ropivacaine|mesh-list
44888242|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888243|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
44888244|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888245|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888246|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
44888247|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888248|NCT04247230|Tetracaine|tetracaine|mesh-list
44888249|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888250|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
44888251|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888252|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888253|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
44888254|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888255|NCT04247087|Vitamin K|vitamin k|mesh-list
44888256|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
44888257|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44888258|NCT04247087|Vitamins|vitamins|mesh-ancestor
44888259|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
44888260|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888261|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44888262|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44888263|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888264|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
44888265|NCT04247087|Coagulants|coagulants|mesh-ancestor
44888266|NCT04246905|Sulforaphane|sulforaphane|mesh-list
44888267|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44888268|NCT04246905|Protective Agents|protective agents|mesh-ancestor
44888269|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888270|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888271|NCT04246567|Fentanyl|fentanyl|mesh-list
44888272|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44888273|NCT04246567|Narcotics|narcotics|mesh-ancestor
44888274|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888275|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888276|NCT04246567|Analgesics|analgesics|mesh-ancestor
44888277|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
44888278|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888279|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44888280|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888281|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
44888282|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
44888283|NCT04246697|Acetaminophen|acetaminophen|mesh-list
44888284|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44888285|NCT04246697|Morphine|morphine|mesh-list
44888286|NCT04246697|Oxycodone|oxycodone|mesh-list
44888287|NCT04246697|Gabapentin|gabapentin|mesh-list
44888288|NCT04246697|Bupivacaine|bupivacaine|mesh-list
44888289|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888290|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
44888291|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888292|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888293|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
44888294|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888295|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44888296|NCT04246697|Narcotics|narcotics|mesh-ancestor
44888297|NCT04246697|Analgesics|analgesics|mesh-ancestor
44888298|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
44888299|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44888300|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44888301|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44888302|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44888303|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44888304|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888305|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888306|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
44888307|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44888308|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
44888309|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44888310|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888311|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888312|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44888313|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888314|NCT04246502|Capecitabine|capecitabine|mesh-list
44888315|NCT04246502|Trastuzumab|trastuzumab|mesh-list
44888316|NCT04246502|Pertuzumab|pertuzumab|mesh-list
44700795|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700796|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44700797|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
44700798|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
44700799|NCT01398384|Protective Agents|protective agents|mesh-ancestor
44700800|NCT01398501|Sorafenib|sorafenib|mesh-list
44700801|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700802|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700803|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700804|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700805|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44700806|NCT01398592|Vildagliptin|vildagliptin|mesh-list
44700807|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700808|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700809|NCT01398592|Incretins|incretins|mesh-ancestor
44700810|NCT01398592|Hormones|hormones|mesh-ancestor
44700811|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252287|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
44700849|NCT01398995|Insulin|insulin|mesh-list
44700850|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700851|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700852|NCT01399086|Fulvestrant|fulvestrant|mesh-list
44700853|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44700854|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700855|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44888317|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888318|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
44888319|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888320|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888321|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888322|NCT04246255|Lidocaine|lidocaine|mesh-list
44888323|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888324|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
44888325|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888326|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888327|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
44888328|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888329|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888330|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44888331|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44888332|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888333|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888334|NCT04246229|Bilirubin|bilirubin|mesh-list
44888335|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
44888336|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888337|NCT04246229|Protective Agents|protective agents|mesh-ancestor
44888338|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888339|NCT04245787|Fluorides|fluorides|mesh-list
44888340|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
44888341|NCT04245787|Protective Agents|protective agents|mesh-ancestor
44888342|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888343|NCT04245774|Bupivacaine|bupivacaine|mesh-list
44888344|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
44888345|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888346|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
44888347|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888348|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888349|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
44888350|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888351|NCT04245371|Lidocaine|lidocaine|mesh-list
44888352|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888353|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
44888354|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888355|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888356|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
44888357|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888358|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888359|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44888360|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44888361|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888362|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888363|NCT04245618|Gemcitabine|gemcitabine|mesh-list
44888364|NCT04245618|Cisplatin|cisplatin|mesh-list
44888365|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888366|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888367|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
44888368|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888369|NCT04245618|Antiviral Agents|antiviral agents|mesh-ancestor
44888370|NCT04245618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888371|NCT04245618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888372|NCT04245618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888373|NCT04245618|Immunologic Factors|immunologic factors|mesh-ancestor
44888374|NCT04245618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888375|NCT04245046|Amlodipine|amlodipine|mesh-list
44888376|NCT04245046|Candesartan|candesartan|mesh-list
44888377|NCT04245046|Atorvastatin|atorvastatin|mesh-list
44888378|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44888379|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44888380|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
44888381|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888382|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44888383|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44888384|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888385|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44888386|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44888387|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888388|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44888389|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888390|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
44888391|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44888392|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44888393|NCT04245319|Acitretin|acitretin|mesh-list
44888394|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
44888395|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888396|NCT04244981|Thrombin|thrombin|mesh-list
44888397|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
44888398|NCT04244981|Coagulants|coagulants|mesh-ancestor
44888399|NCT04245033|Piperaquine|piperaquine|mesh-list
44888400|NCT04245033|Artenimol|artenimol|mesh-list
44888401|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
44888402|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44888403|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44888404|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888405|NCT04244695|Dexamethasone|dexamethasone|mesh-list
44888406|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888407|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
44888408|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
44888409|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888410|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888411|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888412|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
44888413|NCT04244695|Hormones|hormones|mesh-ancestor
44888414|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888415|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888416|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888417|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
44888418|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44888419|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44888420|NCT04244591|Prednisolone|prednisolone|mesh-list
44888421|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
44888422|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44888423|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
44888424|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888425|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
44888426|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
44888427|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888428|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888429|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888430|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
44888431|NCT04244591|Hormones|hormones|mesh-ancestor
44888432|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888433|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44888434|NCT04244591|Protective Agents|protective agents|mesh-ancestor
44888435|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888436|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888437|NCT04244708|Temozolomide|temozolomide|mesh-list
44888438|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44888439|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
44888440|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888441|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888442|NCT04244448|Emtricitabine|emtricitabine|mesh-list
44888443|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
44888444|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888445|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44888446|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44888447|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888448|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888449|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44888450|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44888452|NCT04243954|Hydromorphone|hydromorphone|mesh-list
44888453|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44888454|NCT04243954|Narcotics|narcotics|mesh-ancestor
44888455|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888456|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888457|NCT04243954|Analgesics|analgesics|mesh-ancestor
44888458|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
44888459|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888460|NCT04244097|Bupivacaine|bupivacaine|mesh-list
44888461|NCT04244097|Neostigmine|neostigmine|mesh-list
44888462|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888463|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
44888464|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888465|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888466|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
44888467|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888468|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44888469|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888470|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888471|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
44888472|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888473|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44888474|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
44888475|NCT04243993|Calcium|calcium|mesh-list
44888476|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44888477|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888478|NCT04243850|Empagliflozin|empagliflozin|mesh-list
44888479|NCT04243850|Caffeine|caffeine|mesh-list
44888480|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44888481|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888482|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44888483|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888484|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888485|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44888486|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44888487|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
44888488|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888489|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44888490|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44888491|NCT04243733|Pemetrexed|pemetrexed|mesh-list
44888492|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888493|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888494|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888495|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44888496|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44888497|NCT04243811|Anesthetics|anesthetics|mesh-list
44888498|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888499|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888500|NCT04243434|Prednisone|prednisone|mesh-list
44888501|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
44888502|NCT04243434|Doxorubicin|doxorubicin|mesh-list
44888503|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44888504|NCT04243434|Vincristine|vincristine|mesh-list
44888505|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888506|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
44888507|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888508|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888509|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44888510|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
44888511|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888512|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888513|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44888514|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44888515|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44888516|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44888517|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888518|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888519|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
44888520|NCT04243434|Hormones|hormones|mesh-ancestor
44888521|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888522|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888523|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44888524|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
44888525|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
44888526|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
44888527|NCT04243109|Dexamethasone|dexamethasone|mesh-list
44888528|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
44888529|NCT04243109|Pomalidomide|pomalidomide|mesh-list
44888530|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888531|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
44888532|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888533|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888534|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44888535|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
44888536|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888537|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888538|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44888539|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888540|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
44888541|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
44888542|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888543|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888544|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
44888545|NCT04243109|Hormones|hormones|mesh-ancestor
44888546|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888547|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888548|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44888549|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44888550|NCT04243109|Growth Substances|growth substances|mesh-ancestor
44888551|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
44888552|NCT04242914|Midazolam|midazolam|mesh-list
44888553|NCT04242914|Ketamine|ketamine|mesh-list
44888554|NCT04242914|Analgesics|analgesics|mesh-ancestor
44888555|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
44888556|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888557|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888558|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44888559|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888560|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
44888561|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
44888562|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888563|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44888564|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44888565|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888566|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888567|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44888568|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44888569|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44888570|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44888571|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44888572|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
44888573|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
44888574|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
44888575|NCT04242927|Niacin|niacin|mesh-list
44888576|NCT04242927|Niacinamide|niacinamide|mesh-list
44888577|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
44888578|NCT04242927|Vitamins|vitamins|mesh-ancestor
44888579|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
44888580|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888581|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44888582|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
44888583|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888584|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44888585|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
44888586|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
44888587|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888588|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
44888589|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44888590|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44888591|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888592|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44888593|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888594|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44888595|NCT04242758|Diuretics|diuretics|mesh-ancestor
44888596|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
44888597|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44888598|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888599|NCT04242212|Misoprostol|misoprostol|mesh-list
44888600|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44888601|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
44888602|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888603|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888604|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44888605|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888606|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
44888607|NCT04242368|Fluticasone|fluticasone|mesh-list
44888608|NCT04242368|Xhance|xhance|mesh-list
44888609|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888610|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44888611|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
44888612|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888613|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888614|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44888615|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
44888616|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888617|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44888618|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44888619|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
44888620|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44888621|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
44888622|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888623|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888624|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44888625|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44888626|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678643|NCT01309009|MEN 11420|men 11420|mesh-list
44888627|NCT04241705|Lumefantrine|lumefantrine|mesh-list
44888628|NCT04241705|Artemether|artemether|mesh-list
44888629|NCT04241705|Primaquine|primaquine|mesh-list
44888630|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44888631|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
44888632|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44888633|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44888634|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888635|NCT04241653|Sevoflurane|sevoflurane|mesh-list
44888636|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888637|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44888638|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
44700856|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44700857|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44700858|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700859|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700860|NCT01399151|Vitamin D|vitamin d|mesh-list
44700861|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
44700862|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
44700863|NCT01399151|Vitamins|vitamins|mesh-list
44700864|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
44700865|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700866|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44700867|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44700868|NCT01399216|Fucoidan|fucoidan|mesh-list
44700869|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44700870|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44700871|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
44700872|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700873|NCT01399242|Everolimus|everolimus|mesh-list
44700874|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44700875|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
44700876|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700877|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700878|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
44700879|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700880|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700881|NCT01399346|Insulin|insulin|mesh-list
44700882|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44700883|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
44700884|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
44700885|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44700886|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700887|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700888|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44700889|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44700890|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44700891|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44700892|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700893|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700894|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44700895|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44700896|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
44700897|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700898|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700899|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44700900|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44700901|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
44700902|NCT01399463|Paclitaxel|paclitaxel|mesh-list
44700903|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44700904|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700905|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
44700906|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
44700907|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
44700908|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700909|NCT01399515|Valproic Acid|valproic acid|mesh-list
44700910|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
44700911|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700912|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700913|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
44700914|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700915|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700916|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
44700917|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44700918|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888639|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
44888640|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888641|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888642|NCT04241731|Cetuximab|cetuximab|mesh-list
44888643|NCT04241731|Raltitrexed|raltitrexed|mesh-list
44888644|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888645|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888646|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888647|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
44888648|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888649|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44888650|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888651|NCT04241744|Vancomycin|vancomycin|mesh-list
44888652|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888653|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888654|NCT04241887|Anesthetics|anesthetics|mesh-list
44888655|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378631|NCT04123405|Antidotes|antidotes|mesh-ancestor
44888656|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888657|NCT04241601|Aldesleukin|aldesleukin|mesh-list
44888658|NCT04241601|Interleukin-2|interleukin-2|mesh-list
44888659|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888660|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44888661|NCT04241601|Analgesics|analgesics|mesh-ancestor
44888662|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
44888663|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888664|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888665|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44888666|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44888667|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
44888668|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888669|NCT04241523|Lenvatinib|lenvatinib|mesh-list
44888670|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888671|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44888672|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888673|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888674|NCT04241380|Heparin|heparin|mesh-list
44888675|NCT04241380|Anticoagulants|anticoagulants|mesh-list
44888676|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44888677|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44888678|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44888679|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888680|NCT04241211|Denosumab|denosumab|mesh-list
44888681|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44888682|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888683|NCT04241458|Midazolam|midazolam|mesh-list
44888684|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44888685|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44888686|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888687|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888688|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44888689|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44888690|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44888691|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888692|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
44888693|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
44888694|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
44888695|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
44888696|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888697|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888698|NCT04241276|Gemcitabine|gemcitabine|mesh-list
44888699|NCT04241276|Paclitaxel|paclitaxel|mesh-list
44888700|NCT04241276|Tretinoin|tretinoin|mesh-list
44888701|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44888702|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888703|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44888704|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44888705|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44888706|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888707|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888708|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
44888709|NCT04241276|Antiviral Agents|antiviral agents|mesh-ancestor
44888710|NCT04241276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888711|NCT04241276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888712|NCT04241276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888713|NCT04241276|Immunologic Factors|immunologic factors|mesh-ancestor
44888714|NCT04241276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888715|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
44888716|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888718|NCT04240834|Ticagrelor|ticagrelor|mesh-list
44888719|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44888720|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44888721|NCT04240834|Analgesics|analgesics|mesh-ancestor
44888722|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
44888723|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888724|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888725|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44888726|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888727|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44378650|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
44888728|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44888729|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888730|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888731|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44888732|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888733|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
44888734|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44888735|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44888736|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44888737|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
44888738|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888739|NCT04240496|Clozapine|clozapine|mesh-list
44888740|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44888741|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
44888742|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888743|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888744|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888745|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44888746|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44888747|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888748|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44888749|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
44888750|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
44888751|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44888752|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44888753|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44888754|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888755|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888756|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44888757|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888758|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888759|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
44888760|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888761|NCT04239794|Propofol|propofol|mesh-list
44888762|NCT04239794|Sevoflurane|sevoflurane|mesh-list
44888763|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44888764|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378730|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888765|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888766|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44888767|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
44888768|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
44888769|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888770|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44888771|NCT04239833|Gefitinib|gefitinib|mesh-list
44888772|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888773|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44888774|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888775|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888776|NCT04239560|Boron|boron|mesh-list
44888777|NCT04239560|Trace Elements|trace elements|mesh-ancestor
44888778|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
44888779|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888780|NCT04239625|Vitamin A|vitamin a|mesh-list
44888781|NCT04239625|Retinol acetate|retinol acetate|mesh-list
44888782|NCT04239625|Vitamins|vitamins|mesh-ancestor
44888783|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
44888784|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888785|NCT04239625|Protective Agents|protective agents|mesh-ancestor
44888786|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44888787|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888788|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44888789|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
44888790|NCT04239586|Glyburide|glyburide|mesh-list
44888791|NCT04239586|Glipizide|glipizide|mesh-list
44888792|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44888793|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888795|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888796|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888797|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
44888798|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44888799|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44888800|NCT04239443|Apatinib|apatinib|mesh-list
44888801|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44888802|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888803|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44888804|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888805|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888806|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44888807|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888808|NCT04238988|Paclitaxel|paclitaxel|mesh-list
44888809|NCT04238988|Carboplatin|carboplatin|mesh-list
44888810|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
44888811|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44888812|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888813|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
44888814|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
44888815|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
44888816|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888817|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888818|NCT04239118|Hemostatics|hemostatics|mesh-list
44888819|NCT04239118|Coagulants|coagulants|mesh-ancestor
44888820|NCT04239170|Gemcitabine|gemcitabine|mesh-list
44888821|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
44888822|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44888823|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
44888824|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888825|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888826|NCT04239170|Antiviral Agents|antiviral agents|mesh-ancestor
44888827|NCT04239170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888828|NCT04239170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888829|NCT04239170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888830|NCT04239170|Immunologic Factors|immunologic factors|mesh-ancestor
44888831|NCT04239170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888832|NCT04239014|Olaparib|olaparib|mesh-list
44888833|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44888834|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888835|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888836|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888837|NCT04238923|Vancomycin|vancomycin|mesh-list
44888838|NCT04238923|Gentamicins|gentamicins|mesh-list
44888839|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888840|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888841|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44888842|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888843|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888844|NCT04238975|Vaccines|vaccines|mesh-list
44888845|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
44888846|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888847|NCT04238806|Desflurane|desflurane|mesh-list
44888848|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44888849|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
44888850|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
44888851|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888852|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378801|NCT04067011|Doxycycline|doxycycline|mesh-list
44888853|NCT04238832|Nicotine|nicotine|mesh-list
44888854|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44888855|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
44888856|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888857|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888858|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44888859|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44888860|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
44888861|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888862|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888863|NCT04238884|Voriconazole|voriconazole|mesh-list
44888864|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
44888865|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888866|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44888867|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44888868|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888869|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888870|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44888871|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
44888872|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44888873|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888874|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44888875|NCT04238702|Empagliflozin|empagliflozin|mesh-list
44888876|NCT04238702|Losartan|losartan|mesh-list
44888877|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888878|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700919|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44888879|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44888880|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44888881|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888882|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44888883|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44888884|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888885|NCT04238208|Lidocaine|lidocaine|mesh-list
44888886|NCT04238208|Capsaicin|capsaicin|mesh-list
44888887|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
44888888|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
44888889|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888890|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888891|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
44888892|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888893|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44888894|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44888895|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44888896|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44888897|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888898|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
44888899|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888900|NCT04238221|Doxofylline|doxofylline|mesh-list
44888901|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
44888902|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
44888903|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44888904|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
44888905|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888906|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888907|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44888908|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44888909|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888910|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888911|NCT04238169|Bevacizumab|bevacizumab|mesh-list
44888912|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44888913|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888914|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44888915|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44888916|NCT04238169|Growth Substances|growth substances|mesh-ancestor
44888917|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888918|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
44700920|NCT01399645|Insulin|insulin|mesh-list
44700921|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44700922|NCT01399645|Metformin|metformin|mesh-list
44700923|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
44252394|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
44700924|NCT01399645|Liraglutide|liraglutide|mesh-list
44700925|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700926|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700927|NCT01399645|Incretins|incretins|mesh-ancestor
44700928|NCT01399645|Hormones|hormones|mesh-ancestor
44700929|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700930|NCT01399840|Talazoparib|talazoparib|mesh-list
44700931|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44700932|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700933|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700934|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700935|NCT01399853|Vaccines|vaccines|mesh-list
44700936|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
44700937|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700938|NCT01400009|Vitamin D|vitamin d|mesh-list
44700939|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
44378893|NCT04050865|Dexamethasone|dexamethasone|mesh-list
44700940|NCT01400009|Vitamins|vitamins|mesh-ancestor
44700941|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
44700942|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700943|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44700944|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44700945|NCT01400022|Cortisone|cortisone|mesh-list
44700946|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700947|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
44700948|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700949|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44700950|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44700951|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700952|NCT01400100|Octreotide|octreotide|mesh-list
44700953|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44700954|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44888920|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44888921|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888922|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44888923|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44888924|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888925|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888926|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888927|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
44888928|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44888929|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888930|NCT04237987|Cyclosporine|cyclosporine|mesh-list
44888931|NCT04237987|Aldesleukin|aldesleukin|mesh-list
44888932|NCT04237987|Interleukin-2|interleukin-2|mesh-list
44888933|NCT04237987|Cyclosporins|cyclosporins|mesh-list
44888934|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44888935|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888936|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888937|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
44888938|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888939|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
44888940|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44888941|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44888942|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44888943|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44888944|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44888945|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44888946|NCT04237987|Analgesics|analgesics|mesh-ancestor
44888947|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
44888948|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888949|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44888950|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44888951|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
44888952|NCT04237922|Clopidogrel|clopidogrel|mesh-list
44888953|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44888954|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888955|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44888956|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44888957|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44888958|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
44888959|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888960|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888961|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888962|NCT04237935|Clopidogrel|clopidogrel|mesh-list
44888963|NCT04237935|Ticagrelor|ticagrelor|mesh-list
44888964|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44888965|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44888966|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44888967|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44888968|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
44888969|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378946|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
44888970|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888971|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888972|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
44888973|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44888974|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888975|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44888976|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888977|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
44888978|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44888979|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888980|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888981|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378975|NCT04036110|Vitamins|vitamins|mesh-list
44378976|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
44888982|NCT04237532|Analgesics|analgesics|mesh-ancestor
44888983|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
44888984|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44888985|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44888986|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44888987|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44888988|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
44888989|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44888990|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44888991|NCT04237675|Anesthetics|anesthetics|mesh-list
44888992|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44888993|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888995|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44888996|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
44888997|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44888998|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44888999|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889000|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889001|NCT04237376|Tenofovir|tenofovir|mesh-list
44889002|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
44889003|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889004|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44889005|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44889006|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889007|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889008|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44889009|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44889010|NCT04237493|Insulin|insulin|mesh-list
44889011|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44889012|NCT04237493|Metformin|metformin|mesh-list
44889013|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
44889014|NCT04237493|Glimepiride|glimepiride|mesh-list
44889015|NCT04237493|Vildagliptin|vildagliptin|mesh-list
44889016|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889017|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889018|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44889019|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889020|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
44889021|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44889022|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889023|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889024|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889025|NCT04237480|Vitamin D|vitamin d|mesh-list
44889026|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
44889027|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
44889028|NCT04237480|Vitamins|vitamins|mesh-list
44889029|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
44889030|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889031|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44889032|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44889033|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
44889034|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889035|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889036|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
44889037|NCT04237090|Promethazine|promethazine|mesh-list
44889038|NCT04237090|Cetirizine|cetirizine|mesh-list
44889039|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44889040|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889041|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889042|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889043|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
44889044|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
44889045|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
44889046|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889047|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
44379078|NCT04009824|Antacids|antacids|mesh-ancestor
44889048|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
44889049|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44889050|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44889051|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
44889052|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
44889053|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889054|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889055|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44889056|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
44889057|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
44889058|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44889059|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
44889060|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889061|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889062|NCT04236778|Vancomycin|vancomycin|mesh-list
44889063|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44889064|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889065|NCT04236453|Tenofovir|tenofovir|mesh-list
44889066|NCT04236453|Emtricitabine|emtricitabine|mesh-list
44889067|NCT04236453|Darunavir|darunavir|mesh-list
44889068|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44889069|NCT04236453|Cobicistat|cobicistat|mesh-list
44889070|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44889071|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44889072|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
44889073|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889074|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44889075|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44889076|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889077|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889078|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44889079|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44889080|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44889081|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44889082|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889083|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44889084|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44889085|NCT04236323|Remifentanil|remifentanil|mesh-list
44889086|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44889087|NCT04236323|Narcotics|narcotics|mesh-ancestor
44889088|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889089|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889090|NCT04236323|Analgesics|analgesics|mesh-ancestor
44889091|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
44889092|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889093|NCT04236310|Trastuzumab|trastuzumab|mesh-list
44889094|NCT04236310|Anastrozole|anastrozole|mesh-list
44889095|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889096|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889097|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44889098|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44889099|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44889100|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889101|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889102|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44889103|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
44889104|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889105|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889106|NCT04236219|Rasburicase|rasburicase|mesh-list
44889107|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
44889108|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889109|NCT04236115|Felypressin|felypressin|mesh-list
44889110|NCT04236115|Carticaine|carticaine|mesh-list
44889111|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
44889112|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
44889113|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889114|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889115|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
44889116|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889117|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44889118|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
44889119|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44889120|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44889121|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889122|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
44889123|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
44889124|NCT04235816|Azithromycin|azithromycin|mesh-list
44889125|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44889126|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889127|NCT04235868|Mitogens|mitogens|mesh-list
44889128|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44476067|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44889129|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889130|NCT04235959|Tirzepatide|tirzepatide|mesh-list
44889131|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889132|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889133|NCT04235959|Incretins|incretins|mesh-ancestor
44889134|NCT04235959|Hormones|hormones|mesh-ancestor
44889135|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889136|NCT04235478|Triamcinolone|triamcinolone|mesh-list
44889137|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44889138|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889139|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
44889140|NCT04235478|Hormones|hormones|mesh-ancestor
44889141|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889142|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889143|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889144|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
44889145|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
44889146|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
44889147|NCT04235426|Diclofenac|diclofenac|mesh-list
44889148|NCT04235426|Vitamins|vitamins|mesh-ancestor
44889149|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
44889150|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889151|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44889152|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44889153|NCT04235426|Analgesics|analgesics|mesh-ancestor
44889154|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
44889155|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889156|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889157|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889158|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44889159|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889160|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889161|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
44889162|NCT04235426|Hematinics|hematinics|mesh-ancestor
44889163|NCT04235569|Enoxaparin|enoxaparin|mesh-list
44889164|NCT04235569|Warfarin|warfarin|mesh-list
44889165|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
44889166|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
44889167|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44889168|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44889169|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889170|NCT04235270|Tadalafil|tadalafil|mesh-list
44889171|NCT04235270|Macitentan|macitentan|mesh-list
44889172|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
44889173|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44889174|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44889175|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889176|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889177|NCT04235270|Urological Agents|urological agents|mesh-ancestor
44889178|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44889179|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44889180|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44889181|NCT04235296|Mitogens|mitogens|mesh-list
44889182|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889183|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889184|NCT04235894|Propofol|propofol|mesh-list
44889185|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889186|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889187|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889188|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889189|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
44889190|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
44889191|NCT04236050|Rocuronium|rocuronium|mesh-list
44379184|NCT03988842|Calcium heparin|calcium heparin|mesh-list
44889192|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44700955|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44700956|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44700957|NCT01400165|Pindolol|pindolol|mesh-list
44700958|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44700959|NCT01400165|Trazodone|trazodone|mesh-list
44700960|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
44700961|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44700962|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44700963|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44700964|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44700965|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700966|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44700967|NCT01400165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44700968|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44700969|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44700970|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700971|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44700972|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
44700973|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44700974|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44700975|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44700976|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
44679292|NCT01321034|Niacin|niacin|mesh-list
44889193|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44889194|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44889195|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379208|NCT03988088|Lasmiditan|lasmiditan|mesh-list
44889196|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889197|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
44889198|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889199|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889200|NCT04234776|Ketamine|ketamine|mesh-list
44889201|NCT04234776|Aripiprazole|aripiprazole|mesh-list
44889202|NCT04234776|Citalopram|citalopram|mesh-list
44889203|NCT04234776|Analgesics|analgesics|mesh-ancestor
44889204|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
44889205|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889206|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889207|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44889208|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889209|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
44889210|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
44889211|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889212|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44889213|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44889214|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889215|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889216|NCT04234776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44379228|NCT03981861|Metformin|metformin|mesh-list
44379229|NCT03981861|Spironolactone|spironolactone|mesh-list
44379230|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889217|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44889218|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44889219|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
44889220|NCT04234776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44889221|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
44889222|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44889223|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44889224|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44889225|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
44889226|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
44889227|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44889228|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44889229|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44889230|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44889231|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44889232|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44889233|NCT04234997|Suvorexant|suvorexant|mesh-list
44889234|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44889235|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889236|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889237|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889238|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44889239|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889240|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379249|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379250|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
44379251|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
44379252|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379253|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379254|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44379255|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44379256|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379257|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379258|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379259|NCT03978832|Risperidone|risperidone|mesh-list
44379260|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44889241|NCT04234932|Latanoprost|latanoprost|mesh-list
44889242|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44889243|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44889244|NCT04234321|Mitogens|mitogens|mesh-list
44889245|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889246|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889247|NCT04234594|Panitumumab|panitumumab|mesh-list
44889248|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889249|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889250|NCT04234607|Carboplatin|carboplatin|mesh-list
44889251|NCT04234607|Etoposide|etoposide|mesh-list
44889252|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889253|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44889254|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44889255|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44889256|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889257|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889258|NCT04234516|Morphine|morphine|mesh-list
44889259|NCT04234516|Buprenorphine|buprenorphine|mesh-list
44889260|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44889261|NCT04234516|Naloxone|naloxone|mesh-list
44889262|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44889263|NCT04234516|Narcotics|narcotics|mesh-ancestor
44889264|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889265|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889266|NCT04234516|Analgesics|analgesics|mesh-ancestor
44889267|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
44889268|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889269|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44889270|NCT04234191|Buprenorphine|buprenorphine|mesh-list
44889271|NCT04234191|Hydromorphone|hydromorphone|mesh-list
44889272|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44889273|NCT04234191|Naloxone|naloxone|mesh-list
44889274|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44889275|NCT04234191|Narcotics|narcotics|mesh-ancestor
44889276|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889277|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379311|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889278|NCT04234191|Analgesics|analgesics|mesh-ancestor
44889279|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
44889280|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889281|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44889282|NCT04233996|Meropenem|meropenem|mesh-list
44889283|NCT04233996|Tazobactam|tazobactam|mesh-list
44889284|NCT04233996|Piperacillin|piperacillin|mesh-list
44889285|NCT04233996|Cefepime|cefepime|mesh-list
44889286|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44889287|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44889288|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889289|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44889290|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889291|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889292|NCT04233697|Romidepsin|romidepsin|mesh-list
44889293|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44889294|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889295|NCT04233294|Decitabine|decitabine|mesh-list
44889296|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889297|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
44889298|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889299|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889300|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889301|NCT04233463|Budesonide|budesonide|mesh-list
44889302|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889303|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44889304|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
44889305|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889306|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889307|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44889308|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44889309|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
44889310|NCT04233463|Hormones|hormones|mesh-ancestor
44889311|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889312|NCT04233346|Ponatinib|ponatinib|mesh-list
44889313|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889314|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44889315|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889316|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889317|NCT04233203|Insulin|insulin|mesh-list
44889318|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44889319|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889320|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889321|NCT04233359|Anesthetics|anesthetics|mesh-list
44889322|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
44889323|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889324|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889325|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
44889326|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889327|NCT04233515|Anticoagulants|anticoagulants|mesh-list
44889328|NCT04233502|Melatonin|melatonin|mesh-list
44889329|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
44889330|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889331|NCT04233502|Protective Agents|protective agents|mesh-ancestor
44889332|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889333|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889334|NCT04232800|Riboflavin|riboflavin|mesh-list
44889335|NCT04232800|Vitamins|vitamins|mesh-ancestor
44889336|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
44889337|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889338|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
44889339|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44889340|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44889341|NCT04232813|Estradiol|estradiol|mesh-list
44889342|NCT04232813|Estrogens|estrogens|mesh-ancestor
44889343|NCT04232813|Hormones|hormones|mesh-ancestor
44889344|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889345|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889346|NCT04233021|Osimertinib|osimertinib|mesh-list
44889347|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889348|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44889349|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889350|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889351|NCT04232644|Amphetamine|amphetamine|mesh-list
44889352|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
44889353|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44889354|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889355|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
44889356|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
44889357|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889358|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
44889359|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889360|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889361|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
44889362|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44889363|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44889364|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44889365|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44889366|NCT04232722|Sorafenib|sorafenib|mesh-list
44889367|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889368|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44889369|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889370|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889371|NCT04232332|Mitogens|mitogens|mesh-list
44889372|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889373|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889374|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44889375|NCT04232150|Midazolam|midazolam|mesh-list
44889376|NCT04232150|Anesthetics|anesthetics|mesh-list
44889377|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889378|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889379|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44889380|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889381|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44889382|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44889383|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44889384|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889385|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
44889386|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
44889387|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
44889388|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889389|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889390|NCT04231864|Durvalumab|durvalumab|mesh-list
44889391|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
44889392|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44889393|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
44889394|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889395|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889396|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
44889397|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889398|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
44889399|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889400|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889401|NCT04231435|Metformin|metformin|mesh-list
44889402|NCT04231435|Digoxin|digoxin|mesh-list
44889403|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44889404|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889405|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889406|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44889407|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44889408|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
44889409|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889410|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44889411|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44889412|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889413|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44889414|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44889415|NCT04231435|Protective Agents|protective agents|mesh-ancestor
44889416|NCT04231617|Glyburide|glyburide|mesh-list
44889417|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889418|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889419|NCT04231682|Denosumab|denosumab|mesh-list
44889420|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44889421|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679571|NCT01322152|Irinotecan|irinotecan|mesh-list
44889422|NCT04231448|Prednisone|prednisone|mesh-list
44889423|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
44889424|NCT04231448|Rituximab|rituximab|mesh-list
44889425|NCT04231448|Doxorubicin|doxorubicin|mesh-list
44889426|NCT04231448|Vincristine|vincristine|mesh-list
44889427|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889428|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
44889429|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889430|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889431|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44889432|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
44889433|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889434|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889435|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44889436|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889437|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44889438|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44889439|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44889440|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889441|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889442|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
44889443|NCT04231448|Hormones|hormones|mesh-ancestor
44889444|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889445|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44889446|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44889447|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44889448|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44889449|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889450|NCT04231370|Lenalidomide|lenalidomide|mesh-list
44889451|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
44700977|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700978|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44700979|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
44700980|NCT01400191|Metformin|metformin|mesh-list
44700981|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44700982|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700983|NCT01400217|Beclomethasone|beclomethasone|mesh-list
44700984|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44700985|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
44700986|NCT01400217|Hormones|hormones|mesh-ancestor
44700987|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44700988|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44700989|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44700990|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
44700991|NCT01400256|Valsartan|valsartan|mesh-list
44700992|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44700993|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44700994|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44700995|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44700996|NCT01400308|Mupirocin|mupirocin|mesh-list
44700997|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44700998|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44700999|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44701010|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701012|NCT01400568|Xhance|xhance|mesh-list
44701013|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701014|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44701015|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
44701016|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701017|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701018|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44701019|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
44701020|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44701021|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44701022|NCT01400633|Decitabine|decitabine|mesh-list
44379507|NCT03943095|Fluorides|fluorides|mesh-list
44701023|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701024|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
44701025|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701026|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701027|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701028|NCT01400646|Vitamins|vitamins|mesh-list
44701029|NCT01400646|Vitamin K|vitamin k|mesh-list
44701030|NCT01400646|Warfarin|warfarin|mesh-list
44701031|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
44701032|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
44889452|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889453|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44889454|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44889455|NCT04231370|Growth Substances|growth substances|mesh-ancestor
44889456|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44889457|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889458|NCT04231123|Anesthetics|anesthetics|mesh-list
44889459|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
44889460|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889461|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889462|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
44889463|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889464|NCT04231279|Secretin|secretin|mesh-list
44889465|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44889466|NCT04231279|Hormones|hormones|mesh-ancestor
44889467|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889468|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889469|NCT04230564|Azacitidine|azacitidine|mesh-list
44889470|NCT04230564|Venetoclax|venetoclax|mesh-list
44889471|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889472|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
44889473|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889474|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889475|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889476|NCT04230460|Ethanol|ethanol|mesh-list
44889477|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44889478|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889479|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889480|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889481|NCT04230330|Gemcitabine|gemcitabine|mesh-list
44889482|NCT04230330|Dexamethasone|dexamethasone|mesh-list
44889483|NCT04230330|Cisplatin|cisplatin|mesh-list
44889484|NCT04230330|Nivolumab|nivolumab|mesh-list
44889485|NCT04230330|Asparaginase|asparaginase|mesh-list
44889486|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889487|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
44889488|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
44889489|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889490|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889491|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44889492|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
44889493|NCT04230330|Hormones|hormones|mesh-ancestor
44889494|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889495|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44889496|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889497|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889498|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
44889499|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889500|NCT04230330|Antiviral Agents|antiviral agents|mesh-ancestor
44889501|NCT04230330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889502|NCT04230330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889503|NCT04230330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889504|NCT04230330|Immunologic Factors|immunologic factors|mesh-ancestor
44889505|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889506|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44889507|NCT04230083|Dienogest|dienogest|mesh-list
44889508|NCT04230083|Nandrolone|nandrolone|mesh-list
44889509|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44889510|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
44889511|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44889512|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889513|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44889514|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44889515|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44379572|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379588|NCT03927144|Erenumab|erenumab|mesh-list
44379595|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44889516|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44889517|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
44889518|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889519|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44889520|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889521|NCT04230083|Androgens|androgens|mesh-ancestor
44889522|NCT04230083|Hormones|hormones|mesh-ancestor
44889523|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
44889524|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44889525|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44889526|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
44889527|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44889528|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44679678|NCT05460416|Aspirin|aspirin|mesh-list
44889529|NCT04230070|Estradiol|estradiol|mesh-list
44889530|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44889531|NCT04230070|Estrogens|estrogens|mesh-ancestor
44889532|NCT04230070|Hormones|hormones|mesh-ancestor
44889533|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889534|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889535|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44889536|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
44889537|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44889538|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44889539|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44889540|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44889541|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44889542|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44889543|NCT04229979|Cytarabine|cytarabine|mesh-list
44889544|NCT04229979|Azacitidine|azacitidine|mesh-list
44889545|NCT04229979|Decitabine|decitabine|mesh-list
44889546|NCT04229979|Venetoclax|venetoclax|mesh-list
44889547|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889548|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
44889549|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889550|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889551|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
44889552|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889553|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889554|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
44889555|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889556|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889557|NCT04229758|Anticoagulants|anticoagulants|mesh-list
44889558|NCT04229719|Melatonin|melatonin|mesh-list
44889559|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
44889560|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889561|NCT04229719|Protective Agents|protective agents|mesh-ancestor
44889562|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889563|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889564|NCT04229459|Cisplatin|cisplatin|mesh-list
44889565|NCT04229459|Nivolumab|nivolumab|mesh-list
44889566|NCT04229459|Cetuximab|cetuximab|mesh-list
44889567|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889568|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889569|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44889570|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889571|NCT04229212|Cimetidine|cimetidine|mesh-list
44889572|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44889573|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44889574|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44889575|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
44889576|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
44889577|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379617|NCT03922945|Topiramate|topiramate|mesh-list
44889578|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889579|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889580|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44889581|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44889582|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889583|NCT04229264|Apixaban|apixaban|mesh-list
44889584|NCT04229264|Clopidogrel|clopidogrel|mesh-list
44889585|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44889586|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44889587|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44889588|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44889589|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
44889590|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889591|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889592|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889593|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44889594|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
44889595|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44889596|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889597|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889598|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
44889599|NCT04229355|Sorafenib|sorafenib|mesh-list
44889600|NCT04229355|Lenvatinib|lenvatinib|mesh-list
44889601|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
44889602|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44889603|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889604|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44889605|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889606|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889607|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44889608|NCT04229355|Estrogens|estrogens|mesh-ancestor
44889609|NCT04229355|Hormones|hormones|mesh-ancestor
44889610|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889611|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889612|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701033|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701034|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
44701035|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44701036|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
44701037|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44701038|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
44701039|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701040|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701041|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44701042|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44701043|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
44701044|NCT01400646|Coagulants|coagulants|mesh-ancestor
44701045|NCT01400672|Imiquimod|imiquimod|mesh-list
44701046|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44701047|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
44701048|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701049|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701050|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
44701051|NCT01400685|Rituximab|rituximab|mesh-list
44701052|NCT01400685|Lenalidomide|lenalidomide|mesh-list
44701053|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44701054|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701055|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701056|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
44701057|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701058|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701059|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44701060|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44701061|NCT01400685|Growth Substances|growth substances|mesh-ancestor
44701062|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
44701063|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44701064|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
44701065|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701066|NCT01400737|Ibuprofen|ibuprofen|mesh-list
44701067|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44701068|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701069|NCT01400737|Analgesics|analgesics|mesh-ancestor
44701070|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
44701071|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701072|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701073|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701074|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701075|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44701076|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701077|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701078|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
44701079|NCT01400750|Tobramycin|tobramycin|mesh-list
44701080|NCT01400750|Colistin|colistin|mesh-list
44701081|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701082|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701083|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44701084|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44701085|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701086|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701087|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701088|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44701089|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44701090|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
44701091|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44701092|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701093|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701094|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
44701095|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701096|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701097|NCT01400828|Desloratadine|desloratadine|mesh-list
44701098|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44889613|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44889614|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44889615|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44889616|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379746|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
44889617|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889618|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889619|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889620|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44889621|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
44889623|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44889624|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889625|NCT04229407|Vitamins|vitamins|mesh-list
44889626|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
44889627|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
44889628|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889629|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44889630|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44889631|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
44889632|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44889633|NCT04228757|Estrogens|estrogens|mesh-ancestor
44889634|NCT04228757|Hormones|hormones|mesh-ancestor
44889635|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44889636|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889637|NCT04228315|Primaquine|primaquine|mesh-list
44889638|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
44889639|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44889640|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44889641|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889642|NCT04228263|Aspirin|aspirin|mesh-list
44889643|NCT04228263|Folic Acid|folic acid|mesh-list
44889644|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
44889645|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44889646|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44889647|NCT04228263|Analgesics|analgesics|mesh-ancestor
44889648|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
44889649|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889650|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889651|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889652|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889653|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44889654|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44889655|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889656|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44889657|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44889658|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889659|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
44889660|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
44889661|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44889662|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44889663|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889664|NCT04228263|Hematinics|hematinics|mesh-ancestor
44889665|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
44889666|NCT04228263|Vitamins|vitamins|mesh-ancestor
44889667|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
44889668|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
44889669|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
44889670|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889671|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889672|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889673|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889674|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
44889675|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889676|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44889677|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889678|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
44889679|NCT04227990|Docetaxel|docetaxel|mesh-list
44889680|NCT04227990|Doxorubicin|doxorubicin|mesh-list
44889681|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889682|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
44889683|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889684|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889685|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44889686|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
44889687|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889688|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889689|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44889690|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44379811|NCT03892707|Nimesulide|nimesulide|mesh-list
44889691|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44889692|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889693|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44889694|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44889695|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44889696|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889697|NCT04227886|Capecitabine|capecitabine|mesh-list
44889698|NCT04227886|Irinotecan|irinotecan|mesh-list
44889699|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889700|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
44889701|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889702|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889703|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44889704|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44889705|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889707|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889708|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44889709|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476068|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44889710|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889711|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44889712|NCT04227912|Anesthetics|anesthetics|mesh-list
44889713|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
44889714|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889715|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889716|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
44889717|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889718|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44889719|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44889720|NCT04227912|Analgesics|analgesics|mesh-ancestor
44889721|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889722|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889723|NCT04227652|Ibuprofen|ibuprofen|mesh-list
44889724|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44889725|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44889726|NCT04227652|Analgesics|analgesics|mesh-ancestor
44889727|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
44889728|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889729|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889730|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44889731|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44889732|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44889733|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889734|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889735|NCT04227210|Vaccines|vaccines|mesh-list
44889736|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
44889737|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889738|NCT04227522|Rucaparib|rucaparib|mesh-list
44889739|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44889740|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889741|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889742|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889743|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
44889744|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889745|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889746|NCT04227431|Insulin|insulin|mesh-list
44889747|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889748|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889749|NCT04227093|Acetazolamide|acetazolamide|mesh-list
44889750|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
44889751|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44889752|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889753|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889754|NCT04227093|Diuretics|diuretics|mesh-ancestor
44889755|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
44889756|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889757|NCT04227041|Capecitabine|capecitabine|mesh-list
44889758|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44889759|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
44889760|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889761|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889762|NCT04226963|Ketamine|ketamine|mesh-list
44889763|NCT04226963|Analgesics|analgesics|mesh-ancestor
44889764|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
44889765|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889766|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889767|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44889768|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889769|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
44889770|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
44889771|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889772|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44889773|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44889774|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889775|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889776|NCT04226885|Fentanyl|fentanyl|mesh-list
44889777|NCT04226885|Midazolam|midazolam|mesh-list
44889778|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
44889779|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889780|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889781|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889782|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44889783|NCT04226885|Analgesics|analgesics|mesh-ancestor
44889784|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
44889785|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889786|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44889787|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44889788|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44889789|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
44889790|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889791|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889792|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44889793|NCT04226885|Narcotics|narcotics|mesh-ancestor
44889794|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44889795|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889796|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
44889797|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
44889798|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44889799|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44889800|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44889801|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
44889802|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
44889803|NCT04226625|Propofol|propofol|mesh-list
44889804|NCT04226625|Desflurane|desflurane|mesh-list
44889805|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889806|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889807|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889808|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889809|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
44889810|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
44889811|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44889812|NCT04226443|Midazolam|midazolam|mesh-list
44889813|NCT04226443|Remifentanil|remifentanil|mesh-list
44889814|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44889815|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44889816|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889817|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889818|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44889819|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701099|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
44701100|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701101|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701102|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701103|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44701104|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44701105|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
44701106|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
44701107|NCT01400867|Vancomycin|vancomycin|mesh-list
44701108|NCT01400867|Clindamycin|clindamycin|mesh-list
44701109|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
44701110|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
44701111|NCT01400867|Cefazolin|cefazolin|mesh-list
44701112|NCT01400867|Linezolid|linezolid|mesh-list
44701113|NCT01400867|Cephalexin|cephalexin|mesh-list
44701114|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44701115|NCT01400867|Aztreonam|aztreonam|mesh-list
44701116|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701117|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701118|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44701119|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701120|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701121|NCT01400945|Pantoprazole|pantoprazole|mesh-list
44701122|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44701123|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701124|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44701125|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701126|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701127|NCT01401036|Umirolimus|umirolimus|mesh-list
44701128|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701129|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701130|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
44701131|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701132|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
44701133|NCT01401075|Doxifluridine|doxifluridine|mesh-list
44701134|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889820|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44889821|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44889822|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
44889823|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
44889824|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
44889825|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
44889826|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889827|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889828|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44889829|NCT04226443|Narcotics|narcotics|mesh-ancestor
44889830|NCT04226443|Analgesics|analgesics|mesh-ancestor
44889831|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
44889832|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889834|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44889835|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
44889836|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
44889837|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44889838|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44889839|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44889840|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889841|NCT04225780|Ganciclovir|ganciclovir|mesh-list
44379985|NCT03865732|Ganaxolone|ganaxolone|mesh-list
44889842|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44889843|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
44889844|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889845|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44889846|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889847|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889848|NCT04225728|Iron|iron|mesh-list
44889849|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44889850|NCT04225728|Teferrol|teferrol|mesh-list
44889851|NCT04225728|Trace Elements|trace elements|mesh-ancestor
44889852|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
44889853|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889854|NCT04225728|Hematinics|hematinics|mesh-ancestor
44889855|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
44889856|NCT04225468|Narcotics|narcotics|mesh-ancestor
44889857|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889858|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889859|NCT04225468|Analgesics|analgesics|mesh-ancestor
44889860|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
44889861|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889862|NCT04225364|Paclitaxel|paclitaxel|mesh-list
44889863|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44889864|NCT04225364|Cisplatin|cisplatin|mesh-list
44380019|NCT03861052|Dulaglutide|dulaglutide|mesh-list
44889865|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44889866|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889867|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
44889868|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
44889869|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889870|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889871|NCT04225325|Dolutegravir|dolutegravir|mesh-list
44889872|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44889873|NCT04225325|Emtricitabine|emtricitabine|mesh-list
44889874|NCT04225325|Darunavir|darunavir|mesh-list
44889875|NCT04225325|Cobicistat|cobicistat|mesh-list
44889876|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44889877|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44889878|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889879|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889880|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44889881|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44889882|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
44889883|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889884|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44889885|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44889886|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44889887|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44889888|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889889|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44889890|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44889891|NCT04225312|Natalizumab|natalizumab|mesh-list
44889892|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
44889893|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889894|NCT04224922|Paclitaxel|paclitaxel|mesh-list
44889895|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
44889896|NCT04224922|Epirubicin|epirubicin|mesh-list
44889897|NCT04224922|Carboplatin|carboplatin|mesh-list
44889898|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44889899|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889900|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44889901|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44889902|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889903|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889904|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44889905|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
44889906|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889907|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701135|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44889908|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44889909|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
44889910|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44889911|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44889912|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44889913|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44889914|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889915|NCT04225195|Amphotericin B|amphotericin b|mesh-list
44889916|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44889917|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
44889918|NCT04225195|Amebicides|amebicides|mesh-ancestor
44889919|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44889920|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44889921|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889922|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44889923|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
44889924|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44889925|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889926|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44889927|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889928|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44889929|NCT04225195|Protective Agents|protective agents|mesh-ancestor
44889930|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889931|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889932|NCT04225052|Varenicline|varenicline|mesh-list
44889933|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44889934|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44889935|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
44889936|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889937|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889938|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889939|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
44889940|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
44889941|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44889942|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44889943|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
44889944|NCT04224831|Mitogens|mitogens|mesh-list
44889945|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
44889946|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889947|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44889948|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44889949|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
44889950|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44889951|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
44889952|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44889953|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889954|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44889955|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44889956|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889957|NCT04224649|Lidocaine|lidocaine|mesh-list
44889958|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
44889959|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
44889960|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
44889961|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44889962|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889963|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
44889964|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889965|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44889966|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44889967|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44889968|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44889969|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889970|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44889971|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
44889972|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
44889973|NCT04224649|Protective Agents|protective agents|mesh-ancestor
44889974|NCT04224636|Bevacizumab|bevacizumab|mesh-list
44889975|NCT04224636|Atezolizumab|atezolizumab|mesh-list
44889976|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44889977|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44889978|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44889979|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44889980|NCT04224636|Growth Substances|growth substances|mesh-ancestor
44380135|NCT03850093|Bisoprolol|bisoprolol|mesh-list
44889981|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680242|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
44889982|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
44889983|NCT04224675|Atenolol|atenolol|mesh-list
44889984|NCT04224675|Captopril|captopril|mesh-list
44889985|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44889986|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44889987|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
44889988|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
44889989|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44889990|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44889991|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44889992|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44889993|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44889994|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
44889995|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44889996|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44889997|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44889998|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
44889999|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890000|NCT04224337|Doxorubicin|doxorubicin|mesh-list
44890001|NCT04224337|Durvalumab|durvalumab|mesh-list
44890002|NCT04224337|Ifosfamide|ifosfamide|mesh-list
44890003|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44890004|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890005|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44890006|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44890007|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890008|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890009|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890010|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44890011|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
44890012|NCT04224441|Temozolomide|temozolomide|mesh-list
44890013|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
44890014|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44890015|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
44890016|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890017|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890018|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
44890019|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
44890020|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890021|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890022|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890023|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44890024|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44890025|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890026|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890027|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44890028|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
44890029|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890030|NCT04224415|Irinotecan|irinotecan|mesh-list
44890031|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44890032|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44890033|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890034|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890035|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890036|NCT04224051|Metformin|metformin|mesh-list
44890037|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890038|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890039|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
44890040|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44890041|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
44890042|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890043|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890044|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44890045|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
44890046|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44890047|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
44890048|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890049|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890050|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44890051|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890052|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
44890053|NCT04224103|Protective Agents|protective agents|mesh-ancestor
44890054|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
44890055|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44890056|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44890057|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890058|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
44890059|NCT04224116|Coagulants|coagulants|mesh-ancestor
44890060|NCT04224350|Tacrolimus|tacrolimus|mesh-list
44890061|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890062|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
44890063|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890064|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44890065|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890066|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890067|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
44890068|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44890069|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44890070|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
44890071|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
44890072|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890073|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890074|NCT04223973|Insulin|insulin|mesh-list
44890075|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890076|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701136|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44701137|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
44701138|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701139|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701140|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
44701141|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701142|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701143|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
44701144|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701145|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
44701146|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44701147|NCT01401179|Clarithromycin|clarithromycin|mesh-list
44701149|NCT01401179|Erythromycin|erythromycin|mesh-list
44701150|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
44701151|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44701152|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
44701153|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701154|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701155|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44701156|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701157|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701158|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44701159|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44701160|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701161|NCT01401192|Gemcitabine|gemcitabine|mesh-list
44701162|NCT01401192|Cisplatin|cisplatin|mesh-list
44701163|NCT01401192|Pemetrexed|pemetrexed|mesh-list
44701164|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701165|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701166|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
44701167|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701168|NCT01401192|Antiviral Agents|antiviral agents|mesh-ancestor
44701169|NCT01401192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701170|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701171|NCT01401192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701172|NCT01401192|Immunologic Factors|immunologic factors|mesh-ancestor
44701173|NCT01401192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701174|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44701175|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44701176|NCT01401387|Pancreatin|pancreatin|mesh-list
44701177|NCT01401387|Pancrelipase|pancrelipase|mesh-list
44701178|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701179|NCT01401491|Clozapine|clozapine|mesh-list
44680391|NCT02536755|Eliglustat|eliglustat|mesh-list
44890077|NCT04223739|Amiodarone|amiodarone|mesh-list
44890078|NCT04223739|Landiolol|landiolol|mesh-list
44890079|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890080|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890081|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44890082|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890083|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890084|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44890085|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44890086|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44890087|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890088|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44890089|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44890090|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44890091|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44890092|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44890093|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
44890094|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890095|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890096|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
44890097|NCT04223219|Fentanyl|fentanyl|mesh-list
44890098|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
44890099|NCT04223219|Ketamine|ketamine|mesh-list
44890100|NCT04223219|Propofol|propofol|mesh-list
44890101|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44890102|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890103|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890104|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44890105|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
44890106|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
44890107|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44890108|NCT04223219|Analgesics|analgesics|mesh-ancestor
44890109|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
44890110|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890111|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44890112|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44890113|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44890114|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
44890115|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890116|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890117|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44890118|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44890119|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44890120|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44890121|NCT04223219|Narcotics|narcotics|mesh-ancestor
44890122|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44890123|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890124|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
44890125|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44890126|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890127|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44890128|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
44890129|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44890130|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
44890131|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44890132|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44890133|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890134|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
44890135|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
44890136|NCT04222842|Vorolanib|vorolanib|mesh-list
44890137|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44890138|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890139|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890140|NCT04222855|Diltiazem|diltiazem|mesh-list
44890141|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44890142|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44890143|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890144|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476069|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890145|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44890146|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890147|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890148|NCT04222920|Adalimumab|adalimumab|mesh-list
44890149|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701180|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
44890150|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890152|NCT04222517|Coagulants|coagulants|mesh-ancestor
44890153|NCT04222686|Losartan|losartan|mesh-list
44890154|NCT04222686|Perindopril|perindopril|mesh-list
44890155|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890156|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44890157|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44890158|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44890159|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890160|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44890161|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
44890162|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890163|NCT04222348|Metformin|metformin|mesh-list
44890164|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
44890165|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890166|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890167|NCT04222114|Catumaxomab|catumaxomab|mesh-list
44890168|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890169|NCT04222088|Chloroquine|chloroquine|mesh-list
44890170|NCT04222088|Lumefantrine|lumefantrine|mesh-list
44890171|NCT04222088|Amebicides|amebicides|mesh-ancestor
44890172|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44890173|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44890174|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890175|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
44890176|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890177|NCT04221906|Betamethasone|betamethasone|mesh-list
44890178|NCT04221906|Calcipotriene|calcipotriene|mesh-list
44890179|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44890180|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890181|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
44890182|NCT04221906|Hormones|hormones|mesh-ancestor
44890183|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890184|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890185|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44890186|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
44890187|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44890188|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44380369|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
44890189|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44890190|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44890191|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890192|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890193|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890194|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
44890195|NCT04221971|Fludarabine|fludarabine|mesh-list
44890196|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890197|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
44890198|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890199|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890200|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44890201|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
44890202|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890203|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890204|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44890205|NCT04222010|Anesthetics|anesthetics|mesh-list
44890206|NCT04222010|Ropivacaine|ropivacaine|mesh-list
44890207|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890208|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890209|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890210|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
44890211|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890212|NCT04221672|Terlipressin|terlipressin|mesh-list
44890213|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44890214|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44890215|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44890216|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
44890217|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44890218|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44890219|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890220|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890221|NCT04221256|Citalopram|citalopram|mesh-list
44890222|NCT04221256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44890223|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44890224|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890225|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890226|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890227|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
44890228|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236605|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890229|NCT04221256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44890230|NCT04221256|Antidepressive Agents|antidepressive agents|mesh-ancestor
44890231|NCT04221256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890232|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
44890233|NCT04221165|Narcotics|narcotics|mesh-ancestor
44890234|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890235|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890236|NCT04221165|Analgesics|analgesics|mesh-ancestor
44890237|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
44890238|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890239|NCT04221321|Atorvastatin|atorvastatin|mesh-list
44890240|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44890241|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44890242|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
44890243|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890244|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44890245|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44890246|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890247|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44890248|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44890249|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
44890250|NCT04221152|Empagliflozin|empagliflozin|mesh-list
44890251|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44890252|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890253|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890254|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890255|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
44890256|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44890257|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890258|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890259|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
44890260|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890261|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890263|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44890264|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890265|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44890266|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44890267|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890268|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890269|NCT04220996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44890270|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44890271|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890272|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890273|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890274|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
44890275|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44890276|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44890277|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44890278|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44890279|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
44890280|NCT04220892|Pemetrexed|pemetrexed|mesh-list
44890281|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890282|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890283|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890284|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890285|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44890286|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44890287|NCT04220528|Capecitabine|capecitabine|mesh-list
44890288|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890289|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
44890290|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890291|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890292|NCT04220398|Hormones|hormones|mesh-list
44890293|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890294|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890295|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
44890296|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890297|NCT04220632|Prednisone|prednisone|mesh-list
44890298|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
44890299|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44890300|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44890301|NCT04220632|Prednisolone|prednisolone|mesh-list
44890302|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
44890303|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44890304|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
44890305|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890306|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
44890307|NCT04220632|Hormones|hormones|mesh-ancestor
44890308|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890309|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890310|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44890311|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890312|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
44890313|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
44890314|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890315|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890316|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44890317|NCT04220632|Protective Agents|protective agents|mesh-ancestor
44890318|NCT04220476|Letrozole|letrozole|mesh-list
44890319|NCT04220476|Palbociclib|palbociclib|mesh-list
44890320|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890321|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44890322|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44890323|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890324|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890325|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44890326|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
44890327|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890328|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890329|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44890330|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
44890331|NCT04220281|Propofol|propofol|mesh-list
44890332|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44890333|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680646|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890334|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890335|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44890336|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
44890337|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
44890338|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890339|NCT04220073|Antibodies|antibodies|mesh-list
44890340|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44890341|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
44890342|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890343|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
44890344|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44890345|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44890346|NCT04219995|Prednisolone|prednisolone|mesh-list
44890347|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
44890348|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44890349|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
44890350|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890351|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
44890352|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
44890353|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890354|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890355|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890356|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
44890357|NCT04219995|Hormones|hormones|mesh-ancestor
44890358|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890359|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44890360|NCT04219995|Protective Agents|protective agents|mesh-ancestor
44890361|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44890362|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890363|NCT04219865|Edaravone|edaravone|mesh-list
44701181|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44701182|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
44701183|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701184|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701185|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701186|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44701187|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701188|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701189|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701190|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
44701191|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
44701192|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44701193|NCT01401491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44701194|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44701195|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44701196|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44701197|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
44701198|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44701199|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44701200|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701201|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44701202|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44701203|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44701204|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44701205|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701206|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
44701207|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701208|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701209|NCT01401933|Rifampin|rifampin|mesh-list
44701210|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44701211|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
44701212|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701213|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701214|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
44701215|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44701216|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701217|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701218|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44701219|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44701220|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44680723|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
44890364|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44890365|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
44890366|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890367|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44890368|NCT04219865|Protective Agents|protective agents|mesh-ancestor
44890369|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890370|NCT04219982|Scopolamine|scopolamine|mesh-list
44890371|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44890372|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44890373|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
44890374|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
44890375|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890376|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890377|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890378|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
44890379|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44890380|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
44890381|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890382|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890383|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44890384|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
44380633|NCT03783702|Ibuprofen|ibuprofen|mesh-list
44890385|NCT04219579|Antithrombins|antithrombins|mesh-list
44890386|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
44890387|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44890388|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
44890389|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890390|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890391|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
44890392|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
44890393|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44890394|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
44890395|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44890396|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890397|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890398|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890399|NCT04219046|Naloxegol|naloxegol|mesh-list
44890400|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44890401|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890402|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
44890403|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890404|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
44890405|NCT04218890|Thromboplastin|thromboplastin|mesh-list
44890406|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44890407|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44890408|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890409|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
44890410|NCT04218890|Coagulants|coagulants|mesh-ancestor
44890411|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
44890412|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44890413|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
44890414|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890415|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44890416|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
44890417|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
44890418|NCT04218981|Paroxetine|paroxetine|mesh-list
44890419|NCT04218981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44890420|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44890421|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890422|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890423|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890424|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
44890425|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890426|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44890427|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44890428|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890429|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44890430|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44890431|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890432|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44890433|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890434|NCT04218513|Edaravone|edaravone|mesh-list
44890435|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44890436|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
44890437|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890438|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44890439|NCT04218513|Protective Agents|protective agents|mesh-ancestor
44890440|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890442|NCT04218500|Niacin|niacin|mesh-list
44890443|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
44890444|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
44890445|NCT04218500|Vitamins|vitamins|mesh-ancestor
44890446|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
44890447|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890448|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44890449|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
44890450|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890451|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44890452|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890453|NCT04218435|Valsartan|valsartan|mesh-list
44890454|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44890455|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44890456|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44890457|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44890458|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890459|NCT04218760|Isosorbide|isosorbide|mesh-list
44890460|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44890461|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44890462|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44890463|NCT04218760|Diuretics|diuretics|mesh-ancestor
44890464|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
44890465|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890466|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890467|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44890468|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890469|NCT04218552|Amlodipine|amlodipine|mesh-list
44890470|NCT04218552|Telmisartan|telmisartan|mesh-list
44890471|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44890472|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44890473|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890474|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890475|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44890476|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890477|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890478|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44890479|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44890480|NCT04218734|Metformin|metformin|mesh-list
44890481|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890482|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890483|NCT04218149|Bupivacaine|bupivacaine|mesh-list
44890484|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890485|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
44890486|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890487|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890488|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
44890489|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890490|NCT04218162|Lasmiditan|lasmiditan|mesh-list
44890491|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44890492|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
44890493|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890494|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890495|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890496|NCT04217733|Ethosuximide|ethosuximide|mesh-list
44890497|NCT04217733|Mebeverine|mebeverine|mesh-list
44890498|NCT04217733|Alverine|alverine|mesh-list
44890499|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
44890500|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
44890501|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
44890502|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890503|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890504|NCT04217798|Etoposide|etoposide|mesh-list
44890505|NCT04217798|Niraparib|niraparib|mesh-list
44890506|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44890507|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890508|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44890509|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44890510|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890511|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890512|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44890513|NCT04217668|Isosorbide|isosorbide|mesh-list
44890514|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44890515|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44890516|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44890517|NCT04217668|Diuretics|diuretics|mesh-ancestor
44890518|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
44890519|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890520|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
44890521|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44890522|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890523|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44890524|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44890525|NCT04217265|Letrozole|letrozole|mesh-list
44890526|NCT04217265|Misoprostol|misoprostol|mesh-list
44890527|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890528|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44890529|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44890530|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890531|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890532|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44890533|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
44890534|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890535|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890536|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44890537|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
44890538|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44890539|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44890540|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890541|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
44890542|NCT04217447|Aspirin|aspirin|mesh-list
44890543|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44890544|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44890545|NCT04217447|Analgesics|analgesics|mesh-ancestor
44890546|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
44890547|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890548|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890549|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890550|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890551|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44890552|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44890553|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890554|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44890555|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44890556|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890557|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
44890558|NCT04217421|Allopurinol|allopurinol|mesh-list
44890559|NCT04217421|Mannitol|mannitol|mesh-list
44890560|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
44890561|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890562|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890563|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
44890564|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890565|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44890566|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
44890567|NCT04217421|Protective Agents|protective agents|mesh-ancestor
44890568|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890569|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44890570|NCT04217421|Diuretics|diuretics|mesh-ancestor
44890571|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
44890572|NCT04217512|Cisplatin|cisplatin|mesh-list
44890573|NCT04217512|Pantoprazole|pantoprazole|mesh-list
44890574|NCT04217512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890575|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44890576|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890577|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44890578|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890579|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890580|NCT04217148|Dexamethasone|dexamethasone|mesh-list
44890581|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
44890582|NCT04217148|Tretinoin|tretinoin|mesh-list
44701221|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44701222|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44701223|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44701225|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
44701226|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
44701227|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701228|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701229|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701230|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44701231|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701232|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701233|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
44701234|NCT01402076|Midazolam|midazolam|mesh-list
44701235|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44701236|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701237|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701238|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701239|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44701240|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701241|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701242|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701243|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
44701244|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
44701245|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
44701246|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
44701247|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701248|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701249|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701250|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44701251|NCT01402089|Sunitinib|sunitinib|mesh-list
44701252|NCT01402089|Midazolam|midazolam|mesh-list
44701253|NCT01402089|Caffeine|caffeine|mesh-list
44701254|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44380841|NCT03759600|Niraparib|niraparib|mesh-list
44701255|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701256|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701257|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701258|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44701259|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701260|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701261|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701262|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
44701263|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
44701264|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
44701265|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
44701266|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701267|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680981|NCT01326585|Dexamethasone|dexamethasone|mesh-list
44890583|NCT04217148|BB 1101|bb 1101|mesh-list
44890584|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890585|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
44890586|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
44890587|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890588|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890589|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890590|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
44890591|NCT04217148|Hormones|hormones|mesh-ancestor
44890592|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890593|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44890594|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890595|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
44890596|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890597|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890598|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
44890599|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
44890600|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
44890601|NCT04216836|Antacids|antacids|mesh-ancestor
44890602|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890603|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890604|NCT04217096|Paclitaxel|paclitaxel|mesh-list
44890605|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44890606|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890607|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
44890608|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
44890609|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
44890610|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890611|NCT04216758|Gemcitabine|gemcitabine|mesh-list
44890612|NCT04216758|Paclitaxel|paclitaxel|mesh-list
44890613|NCT04216758|Tegafur|tegafur|mesh-list
44890614|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44890615|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890616|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44890617|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44890618|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44890619|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890620|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890621|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
44890622|NCT04216758|Antiviral Agents|antiviral agents|mesh-ancestor
44890623|NCT04216758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890624|NCT04216758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890625|NCT04216758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890626|NCT04216758|Immunologic Factors|immunologic factors|mesh-ancestor
44890627|NCT04216758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890628|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
44890629|NCT04216706|Sympatholytics|sympatholytics|mesh-list
44890630|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44890631|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890632|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890633|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890634|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
44890635|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890636|NCT04216888|Ketamine|ketamine|mesh-list
44890637|NCT04216888|Analgesics|analgesics|mesh-ancestor
44890638|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
44890639|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890640|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890641|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44890642|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44890643|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
44890644|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
44890645|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890646|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44890647|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44890648|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890649|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890650|NCT04216628|Oxytocin|oxytocin|mesh-list
44890651|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
44890652|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44890653|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890654|NCT04216511|Autoantibodies|autoantibodies|mesh-list
44890655|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
44890656|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890657|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
44380967|NCT03751098|Phenylephrine|phenylephrine|mesh-list
44890658|NCT04216459|Thiamine|thiamine|mesh-list
44890659|NCT04216459|Vitamins|vitamins|mesh-ancestor
44890660|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
44890661|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890662|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44890663|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44890664|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
44890665|NCT04216355|Azacitidine|azacitidine|mesh-list
44890666|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890667|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
44890668|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890669|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890670|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890671|NCT04216771|Cytarabine|cytarabine|mesh-list
44890672|NCT04216771|Idarubicin|idarubicin|mesh-list
44890673|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890674|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
44890675|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890676|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890677|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
44890678|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890679|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890680|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
44890681|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890682|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44890683|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44890684|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44890685|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890686|NCT04216550|Apatinib|apatinib|mesh-list
44890687|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890688|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44890689|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890690|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890691|NCT00005112|Hormones|hormones|mesh-list
44890692|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44890693|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681085|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
44890694|NCT05629949|Docetaxel|docetaxel|mesh-list
44890695|NCT05629949|Trastuzumab|trastuzumab|mesh-list
44890696|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890697|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44890698|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44890699|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44890700|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890701|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890702|NCT05629806|Metformin|metformin|mesh-list
44890703|NCT05629806|Pioglitazone|pioglitazone|mesh-list
44890704|NCT05629806|Acarbose|acarbose|mesh-list
44890705|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890706|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890707|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44890708|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890709|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890710|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
44890711|NCT05629598|Hematinics|hematinics|mesh-ancestor
44890712|NCT05629546|Nivolumab|nivolumab|mesh-list
44890713|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890714|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890715|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44890716|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890717|NCT05629429|Olaparib|olaparib|mesh-list
44890718|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44890719|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890720|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890721|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890722|NCT05629325|Buspirone|buspirone|mesh-list
44890723|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44890724|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44890725|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890726|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890727|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890728|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44890729|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
44890730|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890731|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890732|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
44890733|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890734|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
44890735|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890736|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890737|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44890738|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
44890739|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890740|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890741|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44890742|NCT05629234|Osimertinib|osimertinib|mesh-list
44890743|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890744|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44890745|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890746|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890747|NCT05628662|Insulin|insulin|mesh-list
44890748|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890749|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890750|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
44890751|NCT05626348|Adalimumab|adalimumab|mesh-list
44890752|NCT05626348|Methotrexate|methotrexate|mesh-list
44890753|NCT05626348|Leflunomide|leflunomide|mesh-list
44890754|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44890755|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
44890756|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44890757|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890758|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890759|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
44890760|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890761|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890762|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44890763|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890764|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44890765|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890766|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
44890767|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890768|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44890769|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890770|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
44890771|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44890772|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44890773|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890774|NCT05625932|Tinzaparin|tinzaparin|mesh-list
44890775|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44890776|NCT05625932|Dalteparin|dalteparin|mesh-list
44890777|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
44890778|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44890779|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44890780|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890781|NCT05624957|Lidocaine|lidocaine|mesh-list
44890782|NCT05624957|Epinephrine|epinephrine|mesh-list
44890783|NCT05624957|Racepinephrine|racepinephrine|mesh-list
44890784|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
44890785|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890786|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
44890787|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890788|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890789|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
44890790|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890791|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890792|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44890793|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44890794|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890795|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890796|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44890797|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44890798|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
44890799|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890800|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44890801|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44890802|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
44890803|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44890804|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
44890805|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
44890806|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
44890807|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44890808|NCT05624190|Plasminogen|plasminogen|mesh-list
44890809|NCT05624190|Tenecteplase|tenecteplase|mesh-list
44890810|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44890811|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44890812|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44890813|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890814|NCT05620108|Rocuronium|rocuronium|mesh-list
44890815|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44890816|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44890817|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44890818|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890819|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890820|NCT05601492|Thalidomide|thalidomide|mesh-list
44890821|NCT05601492|Apremilast|apremilast|mesh-list
44890822|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44890823|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44890824|NCT05601492|Analgesics|analgesics|mesh-ancestor
44890825|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
44890826|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890827|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890828|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44890829|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890830|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44890831|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44890832|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890833|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890834|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890835|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
44890836|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
44890837|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44890838|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890839|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44890840|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44890841|NCT05601492|Growth Substances|growth substances|mesh-ancestor
44890842|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
44890843|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890844|NCT05595889|Irinotecan|irinotecan|mesh-list
44890845|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44890846|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44890847|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890848|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890849|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890850|NCT05591105|Lidocaine|lidocaine|mesh-list
44890851|NCT05591105|Ketamine|ketamine|mesh-list
44890852|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890853|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
44890854|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890855|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890856|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
44890857|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890858|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890859|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44890860|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44890861|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890862|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890863|NCT05591105|Analgesics|analgesics|mesh-ancestor
44890864|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44890865|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44890866|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
44890867|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44890868|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44890869|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890870|NCT05590286|Amoxicillin|amoxicillin|mesh-list
44890871|NCT05590286|Esomeprazole|esomeprazole|mesh-list
44890872|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44890873|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890874|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44890875|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44890876|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44890877|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890878|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890879|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44890880|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44890881|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
44890882|NCT05565105|Melphalan|melphalan|mesh-list
44890883|NCT05565105|Busulfan|busulfan|mesh-list
44890884|NCT05565105|Thiotepa|thiotepa|mesh-list
44890885|NCT05565105|Fludarabine|fludarabine|mesh-list
44890886|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890887|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
44890888|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890889|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44890890|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44890891|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
44890892|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890893|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890894|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44890895|NCT05554237|Ceftibuten|ceftibuten|mesh-list
44890896|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44890897|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701268|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701269|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44701270|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381204|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44701271|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44701272|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44701273|NCT01402089|Growth Substances|growth substances|mesh-ancestor
44681343|NCT01328457|Neomycin|neomycin|mesh-list
44890898|NCT05546658|Psilocybin|psilocybin|mesh-list
44890899|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
44890900|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890901|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44890902|NCT05544721|Ropivacaine|ropivacaine|mesh-list
44890903|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890904|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
44890905|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890906|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890907|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
44890908|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890909|NCT05510427|Bevacizumab|bevacizumab|mesh-list
44890910|NCT05510427|Atezolizumab|atezolizumab|mesh-list
44890911|NCT05510427|Infigratinib|infigratinib|mesh-list
44890912|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890913|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890914|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44890915|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44890916|NCT05510427|Growth Substances|growth substances|mesh-ancestor
44890917|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890918|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
44890919|NCT05501600|Lidocaine|lidocaine|mesh-list
44890920|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
44890921|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
44890922|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890923|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890924|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
44890925|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890926|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44890927|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44890928|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44890929|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44890930|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890931|NCT05501054|Nivolumab|nivolumab|mesh-list
44890932|NCT05501054|Ipilimumab|ipilimumab|mesh-list
44890933|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44890934|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890935|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44890936|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890937|NCT05493995|Gemcitabine|gemcitabine|mesh-list
44890938|NCT05493995|Paclitaxel|paclitaxel|mesh-list
44890939|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44890940|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890941|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
44890942|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
44890943|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
44890944|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890945|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890946|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
44890947|NCT05493995|Antiviral Agents|antiviral agents|mesh-ancestor
44890948|NCT05493995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44890949|NCT05493995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890950|NCT05493995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44890951|NCT05493995|Immunologic Factors|immunologic factors|mesh-ancestor
44890952|NCT05493995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890953|NCT05473585|Nicotine|nicotine|mesh-list
44890954|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44890955|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
44890956|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890957|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890958|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44890959|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44890960|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
44890961|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44890962|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890963|NCT05471830|Apixaban|apixaban|mesh-list
44890964|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44890965|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
44890966|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44890967|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
44890968|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890969|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890970|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
44890971|NCT05464680|Dimercaprol|dimercaprol|mesh-list
44890972|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
44890973|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
44890974|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890975|NCT05450718|Buprenorphine|buprenorphine|mesh-list
44890976|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44890978|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44890979|NCT05450718|Narcotics|narcotics|mesh-ancestor
44890980|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44890981|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890982|NCT05450718|Analgesics|analgesics|mesh-ancestor
44890983|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
44890984|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44890985|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44890986|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
44890987|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44890988|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890989|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44890990|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44890991|NCT05433532|Azacitidine|azacitidine|mesh-list
44890992|NCT05433532|Venetoclax|venetoclax|mesh-list
44890993|NCT05433532|HH-GV-678|hh-gv-678|mesh-list
44890994|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44890995|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
44890996|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44890997|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44890998|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44890999|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44891000|NCT05430243|Empagliflozin|empagliflozin|mesh-list
44891001|NCT05430243|Diuretics|diuretics|mesh-list
44891002|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44891003|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891004|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891005|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891006|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
44891007|NCT05416333|Azelaic acid|azelaic acid|mesh-list
44891008|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891009|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891010|NCT05377905|Doxorubicin|doxorubicin|mesh-list
44891011|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44891012|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44891013|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891014|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44891015|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891016|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891017|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891018|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44891019|NCT05335941|Pemetrexed|pemetrexed|mesh-list
44891020|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891021|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891022|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891023|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44891024|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891025|NCT05295784|Caffeine|caffeine|mesh-list
44891026|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
44891027|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891028|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44891029|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891030|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44891031|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891032|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44891033|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44891034|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
44891035|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891036|NCT05294523|Rocuronium|rocuronium|mesh-list
44891037|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44891038|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44891039|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44891040|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891041|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891042|NCT05291390|Pyronaridine|pyronaridine|mesh-list
44891043|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
44891044|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44891045|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44891046|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891047|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
44891048|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44891049|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
44891050|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891051|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
44891052|NCT05290727|Protective Agents|protective agents|mesh-ancestor
44891053|NCT05269537|Ephedrine|ephedrine|mesh-list
44891054|NCT05269537|Fentanyl|fentanyl|mesh-list
44891055|NCT05269537|Bupivacaine|bupivacaine|mesh-list
44891056|NCT05269537|Oxytocin|oxytocin|mesh-list
44891057|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
44891058|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
44891059|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891060|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891061|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
44891062|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891063|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44891064|NCT05269537|Narcotics|narcotics|mesh-ancestor
44891065|NCT05269537|Analgesics|analgesics|mesh-ancestor
44891066|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44891067|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44891068|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
44891069|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
44891070|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891071|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44891072|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
44891073|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
44891074|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44891075|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
44891076|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891077|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891078|NCT05260320|Anesthetics|anesthetics|mesh-list
44891079|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44037592|NCT00002489|Antidotes|antidotes|mesh-ancestor
44891080|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891081|NCT05224050|Nicotine|nicotine|mesh-list
44891082|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44891083|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
44891084|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891085|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891086|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44891087|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44891088|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
44891089|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891090|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891091|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
44891092|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891093|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701274|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891094|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
44891095|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891096|NCT05157581|Methoxsalen|methoxsalen|mesh-list
44891097|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44891098|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891099|NCT05154747|Rilpivirine|rilpivirine|mesh-list
44891100|NCT05154747|Cabotegravir|cabotegravir|mesh-list
44891101|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
44381402|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44891102|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44701275|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44701276|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44701277|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44701278|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44701279|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
44701280|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
44701281|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701282|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701283|NCT01402193|Anastrozole|anastrozole|mesh-list
44701284|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701285|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701286|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44701287|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44701288|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701289|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701290|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44701291|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44701292|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701293|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701294|NCT01402245|Vaccines|vaccines|mesh-list
44701295|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44701296|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
44701297|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701298|NCT01402271|Paclitaxel|paclitaxel|mesh-list
44701299|NCT01402271|Carboplatin|carboplatin|mesh-list
44701300|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44701301|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701302|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44701303|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701304|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44701305|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701306|NCT01402297|Acetovanillone|acetovanillone|mesh-list
44701307|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44701308|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701309|NCT01402297|Analgesics|analgesics|mesh-ancestor
44701310|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
44701311|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701312|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701313|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701314|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701315|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
44701316|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701317|NCT01402297|Protective Agents|protective agents|mesh-ancestor
44701318|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701319|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44701320|NCT01402336|Cetrorelix|cetrorelix|mesh-list
44701321|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44701322|NCT01402336|Hormones|hormones|mesh-ancestor
44701323|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701324|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381460|NCT03694821|Hylan|hylan|mesh-list
44701325|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
44701326|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44701327|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
44701328|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44701329|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44701330|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44701331|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701332|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44701333|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
44701334|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44701335|NCT01402479|Ramipril|ramipril|mesh-list
44701336|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44701337|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
44891103|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891104|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891105|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891106|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
44891107|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891108|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44891109|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44891110|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44891111|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44891112|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
44891113|NCT05109455|Procyanidin|procyanidin|mesh-list
44891114|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
44891115|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891116|NCT05109455|Protective Agents|protective agents|mesh-ancestor
44891117|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891118|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44891119|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44891120|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891121|NCT05087030|Denosumab|denosumab|mesh-list
44891122|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44891123|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891124|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
44891125|NCT05000216|Methotrexate|methotrexate|mesh-list
44891126|NCT05000216|Vaccines|vaccines|mesh-list
44891127|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44891128|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
44891129|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891130|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44891131|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
44891132|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891133|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891134|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
44891135|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891136|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891137|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891138|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891139|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44891140|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891141|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891142|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44891143|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44891144|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
44891145|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891146|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891147|NCT04964284|Hormones|hormones|mesh-list
44891148|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891149|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891150|NCT04916002|Cemiplimab|cemiplimab|mesh-list
44891151|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891152|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891153|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
44891154|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891155|NCT04858425|Niclosamide|niclosamide|mesh-list
44891156|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
44891157|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44891158|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
44891159|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44891160|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891161|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
44891162|NCT04787835|Anesthetics|anesthetics|mesh-list
44891163|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
44891164|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891165|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891166|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
44891167|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891168|NCT04783935|Cladribine|cladribine|mesh-list
44891169|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891170|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891171|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
44891172|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891173|NCT04777929|Progesterone|progesterone|mesh-list
44891174|NCT04777929|Estrogens|estrogens|mesh-list
44891175|NCT04777929|Progestins|progestins|mesh-ancestor
44891176|NCT04777929|Hormones|hormones|mesh-ancestor
44891177|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891178|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891179|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44891180|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44891181|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891183|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44891184|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44891185|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44891186|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44891187|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891188|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891189|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891190|NCT04641975|Urological Agents|urological agents|mesh-ancestor
44891191|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
44891192|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44891193|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
44891194|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891195|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44891196|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44891197|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891198|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891199|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
44891200|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891201|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
44891202|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891203|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891204|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891205|NCT04616547|Edetic Acid|edetic acid|mesh-list
44891206|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
44891207|NCT04616547|Antidotes|antidotes|mesh-ancestor
44891208|NCT04616547|Protective Agents|protective agents|mesh-ancestor
44891209|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891210|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
44891211|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
44891212|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891213|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44891214|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
44891215|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44891217|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
44891218|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891219|NCT04535141|Olanzapine|olanzapine|mesh-list
44891220|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
44891221|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
44891222|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891223|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891224|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44891225|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44891226|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44891227|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891228|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44891229|NCT04535141|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44891230|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44891231|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891232|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891233|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891234|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
44891235|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44891236|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
44891237|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44891238|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
44891239|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891240|NCT04492553|Testosterone|testosterone|mesh-list
44891241|NCT04492553|Androgens|androgens|mesh-ancestor
44891242|NCT04492553|Hormones|hormones|mesh-ancestor
44701338|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701339|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701340|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44701341|NCT01402583|Ribavirin|ribavirin|mesh-list
44701342|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
44701343|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701344|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
44701345|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701346|NCT01402596|Midazolam|midazolam|mesh-list
44701347|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
44701348|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44701349|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44701350|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701351|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701352|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44701353|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44701354|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44701355|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701356|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
44701357|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
44701358|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
44701359|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
44701360|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44701361|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701362|NCT01402622|Propofol|propofol|mesh-list
44701363|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
44701364|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701398|NCT01403025|Liraglutide|liraglutide|mesh-list
44701399|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701400|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701401|NCT01403025|Incretins|incretins|mesh-ancestor
44701402|NCT01403025|Hormones|hormones|mesh-ancestor
44701403|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701404|NCT01403103|Vitamin D|vitamin d|mesh-list
44701405|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
44701406|NCT01403103|Vitamins|vitamins|mesh-ancestor
44701407|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
44701408|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701409|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44701410|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44701411|NCT01403168|Analgesics|analgesics|mesh-list
44701412|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
44701413|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701414|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701415|NCT01403181|Ribavirin|ribavirin|mesh-list
44701416|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44701417|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
44701418|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891243|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891244|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891245|NCT04459871|Thrombin|thrombin|mesh-list
44891246|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
44891247|NCT04459871|Coagulants|coagulants|mesh-ancestor
44891248|NCT04458909|Gemcitabine|gemcitabine|mesh-list
44891249|NCT04458909|Cisplatin|cisplatin|mesh-list
44891250|NCT04458909|Carboplatin|carboplatin|mesh-list
44891251|NCT04458909|Nivolumab|nivolumab|mesh-list
44891252|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891253|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891254|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
44891255|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891256|NCT04458909|Antiviral Agents|antiviral agents|mesh-ancestor
44891257|NCT04458909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891258|NCT04458909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891259|NCT04458909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891260|NCT04458909|Immunologic Factors|immunologic factors|mesh-ancestor
44891261|NCT04458909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891262|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891263|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44891264|NCT04447183|Iodine|iodine|mesh-list
44891265|NCT04447183|Hormones|hormones|mesh-list
44891266|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891267|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891268|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44891269|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891270|NCT04447183|Trace Elements|trace elements|mesh-ancestor
44891271|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
44891272|NCT04421560|Rituximab|rituximab|mesh-list
44891273|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
44891274|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891275|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891276|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
44891277|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891278|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891279|NCT04418466|Risperidone|risperidone|mesh-list
44891280|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44891281|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
44891282|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891283|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381713|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
44891284|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891285|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44891286|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44891287|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891288|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44891289|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44891290|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
44891291|NCT04414748|Cetrorelix|cetrorelix|mesh-list
44891292|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
44891293|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44891294|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
44891295|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891296|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891297|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
44891298|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891299|NCT04414748|Progestins|progestins|mesh-ancestor
44891300|NCT04414748|Hormones|hormones|mesh-ancestor
44891301|NCT04300309|Lumefantrine|lumefantrine|mesh-list
44891302|NCT04300309|Artemether|artemether|mesh-list
44891303|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
44891304|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44891305|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44891306|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891307|NCT04231318|Triamcinolone|triamcinolone|mesh-list
44891308|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44891309|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44891310|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44891311|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891312|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
44891313|NCT04231318|Hormones|hormones|mesh-ancestor
44891314|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891315|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891316|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891317|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
44891318|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891319|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891320|NCT04223778|Islatravir|islatravir|mesh-list
44891321|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
44891322|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891323|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891324|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891325|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44891326|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891327|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44891328|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
44891329|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44891330|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891331|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381740|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
44891332|NCT04137185|Hormones|hormones|mesh-list
44891333|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891334|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891335|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44891336|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44891337|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891338|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891339|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
44891340|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891341|NCT04075136|Triamcinolone|triamcinolone|mesh-list
44891342|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44891343|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44891344|NCT04075136|Ranibizumab|ranibizumab|mesh-list
44891345|NCT04075136|Verteporfin|verteporfin|mesh-list
44891346|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44891347|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891348|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891349|NCT04075136|Growth Substances|growth substances|mesh-ancestor
44891350|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891351|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891352|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891353|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891354|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
44891355|NCT04075136|Hormones|hormones|mesh-ancestor
44381765|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381766|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381768|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44891356|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891357|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891358|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
44891359|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891360|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891361|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44891362|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891363|NCT04074564|Apatinib|apatinib|mesh-list
44891364|NCT04074564|Antibodies|antibodies|mesh-list
44891365|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
44891366|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891367|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381800|NCT03665441|Antidotes|antidotes|mesh-ancestor
44381805|NCT03665038|Brexanolone|brexanolone|mesh-list
44891368|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44891369|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891370|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891371|NCT04038502|Carboplatin|carboplatin|mesh-list
44891372|NCT04038502|Olaparib|olaparib|mesh-list
44891373|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891374|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44891375|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891376|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891377|NCT04008030|Leucovorin|leucovorin|mesh-list
44891378|NCT04008030|Bevacizumab|bevacizumab|mesh-list
44891379|NCT04008030|Nivolumab|nivolumab|mesh-list
44891380|NCT04008030|Cetuximab|cetuximab|mesh-list
44891381|NCT04008030|Ipilimumab|ipilimumab|mesh-list
44891382|NCT04008030|Fluorouracil|fluorouracil|mesh-list
44891383|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
44891384|NCT04008030|Irinotecan|irinotecan|mesh-list
44891385|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891386|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891387|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891388|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891389|NCT04008030|Growth Substances|growth substances|mesh-ancestor
44891390|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891391|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891392|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
44891393|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891394|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891395|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891396|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
44891397|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44891398|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44891399|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891400|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891402|NCT04008030|Protective Agents|protective agents|mesh-ancestor
44891403|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
44891404|NCT04008030|Vitamins|vitamins|mesh-ancestor
44891405|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
44891406|NCT03917914|Bisoprolol|bisoprolol|mesh-list
44891407|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44891408|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
44891409|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
44891410|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891411|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891412|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44891413|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44891414|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44891415|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
44891416|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891417|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891418|NCT03781544|Acetaminophen|acetaminophen|mesh-list
44891419|NCT03781544|Diclofenac|diclofenac|mesh-list
44891420|NCT03781544|Tramadol|tramadol|mesh-list
44891421|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44891422|NCT03781544|Analgesics|analgesics|mesh-ancestor
44891423|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
44891424|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891425|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891426|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
44891427|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44891428|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891429|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891430|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44891431|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891432|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701419|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
44701420|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701421|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
44701422|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701423|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
44701424|NCT01403285|Molgramostim|molgramostim|mesh-list
44701425|NCT01403285|Imiquimod|imiquimod|mesh-list
44701426|NCT01403285|Sargramostim|sargramostim|mesh-list
44701427|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701428|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
44701429|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701430|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701431|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44701432|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
44701433|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701434|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701435|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44701436|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44701437|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
44701438|NCT01403363|Fentanyl|fentanyl|mesh-list
44701439|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44701440|NCT01403363|Narcotics|narcotics|mesh-ancestor
44701441|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44701442|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701443|NCT01403363|Analgesics|analgesics|mesh-ancestor
44701444|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
44701445|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701446|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44701447|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44701448|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
44701449|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
44701450|NCT01403389|Eculizumab|eculizumab|mesh-list
44701451|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44701452|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701453|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
44701454|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701455|NCT01403415|Sirolimus|sirolimus|mesh-list
44701456|NCT01403415|Dexamethasone|dexamethasone|mesh-list
44701457|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
44701458|NCT01403415|Methotrexate|methotrexate|mesh-list
44701459|NCT01403415|Vincristine|vincristine|mesh-list
44701460|NCT01403415|Asparaginase|asparaginase|mesh-list
44891433|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44891434|NCT03781544|Narcotics|narcotics|mesh-ancestor
44891435|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891436|NCT03738228|Cisplatin|cisplatin|mesh-list
44891437|NCT03738228|Atezolizumab|atezolizumab|mesh-list
44891438|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44891439|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891440|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
44891441|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891442|NCT03697408|Everolimus|everolimus|mesh-list
44891443|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891444|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891445|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
44891446|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891447|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
44891448|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891449|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
44891450|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891451|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891452|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891453|NCT03580967|Vortioxetine|vortioxetine|mesh-list
44891454|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44891455|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44891456|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44891457|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381891|NCT03654326|Analgesics|analgesics|mesh-ancestor
44891458|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891459|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891460|NCT03580967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44891461|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44891462|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891463|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891464|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891465|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
44891466|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44891467|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44891468|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44891469|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44891470|NCT03521232|Niclosamide|niclosamide|mesh-list
44891471|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
44891472|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44891473|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
44891474|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44891475|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891476|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
44891477|NCT03478956|Etrolizumab|etrolizumab|mesh-list
44891478|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44891479|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
44891480|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891481|NCT03398824|Metformin|metformin|mesh-list
44891482|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891483|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891484|NCT03326193|Bevacizumab|bevacizumab|mesh-list
44891485|NCT03326193|Niraparib|niraparib|mesh-list
44891486|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701461|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
44701462|NCT01403415|Pegaspargase|pegaspargase|mesh-list
44701463|NCT01403415|BB 1101|bb 1101|mesh-list
44701464|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701465|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
44701466|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
44701467|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701468|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701469|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44701470|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
44701471|NCT01403415|Hormones|hormones|mesh-ancestor
44701472|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701473|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252950|NCT05342558|Xhance|xhance|mesh-list
44701474|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701475|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44701476|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
44701477|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44701478|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701479|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
44701480|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701481|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44701482|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701483|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44701484|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701485|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
44701486|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701487|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44701488|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44701489|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44701490|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44701491|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44701492|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701493|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701494|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44891487|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891488|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891489|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891490|NCT03326193|Growth Substances|growth substances|mesh-ancestor
44891491|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891492|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891493|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44891494|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891495|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891496|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44891497|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44891498|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44891499|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
44891500|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891501|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44891502|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44891503|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891504|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
44891505|NCT03179930|Entinostat|entinostat|mesh-list
44891506|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891507|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891508|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44891509|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891510|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891511|NCT03128905|Prednisone|prednisone|mesh-list
44891512|NCT03128905|Colchicine|colchicine|mesh-list
44382001|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44891513|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891514|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
44891515|NCT03128905|Hormones|hormones|mesh-ancestor
44891516|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891517|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891518|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44891519|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891520|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
44891521|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891522|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44891523|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44891524|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44891525|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891526|NCT03017872|Ritonavir|ritonavir|mesh-list
44891527|NCT03017872|Darunavir|darunavir|mesh-list
44891528|NCT03017872|Dolutegravir|dolutegravir|mesh-list
44891529|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44891530|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44891531|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
44891532|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891533|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891534|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44891535|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44891536|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
44891537|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891538|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44891539|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891540|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44891541|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44891542|NCT03009981|Prednisone|prednisone|mesh-list
44891543|NCT03009981|Leuprolide|leuprolide|mesh-list
44891544|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
44891545|NCT03009981|Bicalutamide|bicalutamide|mesh-list
44891546|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891547|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
44891548|NCT03009981|Hormones|hormones|mesh-ancestor
44891549|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891550|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891551|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44891552|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891553|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44891554|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
44891555|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891556|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44891557|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891558|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891559|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
44891560|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891561|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
44891562|NCT02979093|Oxytocin|oxytocin|mesh-list
44891563|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
44891564|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891565|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891566|NCT02960763|Aripiprazole|aripiprazole|mesh-list
44701495|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
44701496|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44701497|NCT01403415|Analgesics|analgesics|mesh-ancestor
44701498|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
44701499|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44701500|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44701501|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
44701502|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44701503|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
44701504|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701505|NCT01403506|Expectorants|expectorants|mesh-ancestor
44701506|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
44701507|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44701508|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
44701509|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701510|NCT01403506|Protective Agents|protective agents|mesh-ancestor
44701511|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701512|NCT01403506|Antidotes|antidotes|mesh-ancestor
44701513|NCT01403545|Curcumin|curcumin|mesh-list
44701514|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44701515|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44701516|NCT01403545|Analgesics|analgesics|mesh-ancestor
44701517|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
44701518|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44701519|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701520|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44701521|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701522|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701523|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701524|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701525|NCT01403662|Minocycline|minocycline|mesh-list
44701526|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701527|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701528|NCT01403740|Cyclosporine|cyclosporine|mesh-list
44701529|NCT01403740|Rituximab|rituximab|mesh-list
44701530|NCT01403740|Azathioprine|azathioprine|mesh-list
44701531|NCT01403740|Cyclosporins|cyclosporins|mesh-list
44701532|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44701533|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701534|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
44701535|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701536|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44701537|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44701538|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701539|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701540|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
44701541|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701542|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
44701543|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44701544|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
44701545|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44701546|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
44701547|NCT01403818|Mitiglinide|mitiglinide|mesh-list
44701548|NCT01403818|Calcium|calcium|mesh-list
44701549|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44701550|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701551|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44701552|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701553|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44701554|NCT01403844|Carotenoids|carotenoids|mesh-list
44701555|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
44701556|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701557|NCT01403844|Protective Agents|protective agents|mesh-ancestor
44701558|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701559|NCT01403896|Plerixafor|plerixafor|mesh-list
44701560|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44701561|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44701562|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
44701563|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701564|NCT01403948|BI 836826|bi 836826|mesh-list
44701565|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891567|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
44891568|NCT02960763|Bupropion|bupropion|mesh-list
44891569|NCT02960763|Nortriptyline|nortriptyline|mesh-list
44891570|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44891571|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
44891572|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44891573|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44891574|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44891575|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891576|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891577|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
44891578|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891579|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891580|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44891581|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891582|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382132|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
44891583|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44891584|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44891585|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891586|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
44891587|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44891588|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44891589|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
44891590|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44891591|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44891592|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44891593|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44891594|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
44891595|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44891596|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44891597|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
44891598|NCT02825160|Iloprost|iloprost|mesh-list
44891599|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44891600|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
44891601|NCT02770716|Terlipressin|terlipressin|mesh-list
44891602|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44891603|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44891604|NCT02764593|Cisplatin|cisplatin|mesh-list
44891605|NCT02764593|Nivolumab|nivolumab|mesh-list
44891606|NCT02764593|Cetuximab|cetuximab|mesh-list
44891607|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891608|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891609|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44891610|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891611|NCT02655016|Niraparib|niraparib|mesh-list
44891612|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44891613|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891614|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891615|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891616|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
44891617|NCT02517918|Sirolimus|sirolimus|mesh-list
44891618|NCT02517918|Methotrexate|methotrexate|mesh-list
44891619|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44891620|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
44891621|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891622|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891623|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891624|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
44426782|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891625|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891626|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891627|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891628|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891629|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44891630|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891631|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
44891632|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891633|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891634|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891635|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891636|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44891637|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
44891638|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44891639|NCT02430181|Interferons|interferons|mesh-list
44891640|NCT02430181|Ritonavir|ritonavir|mesh-list
44891641|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
44891642|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44891643|NCT02430181|Lonafarnib|lonafarnib|mesh-list
44891644|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891645|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
44891646|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891647|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44891648|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44891649|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
44891650|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382201|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44891651|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891652|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44891653|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44891654|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44891655|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44891656|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
44891657|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891658|NCT02118727|Memantine|memantine|mesh-list
44891659|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44891660|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44891661|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
44891662|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891663|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891664|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891665|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44891666|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44891667|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
44891668|NCT01976182|Methotrexate|methotrexate|mesh-list
44891669|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891670|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
44891671|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891672|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891673|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44891674|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
44426783|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891675|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891676|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891677|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44891678|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44891679|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
44891680|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891681|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891682|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
44891683|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
44891684|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891685|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44891686|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44891687|NCT01840007|Metformin|metformin|mesh-list
44891688|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891689|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891690|NCT01705977|Belimumab|belimumab|mesh-list
44891691|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891692|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
44891693|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891694|NCT01143246|Terlipressin|terlipressin|mesh-list
44891695|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44891696|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44891697|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
44891698|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891699|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
44891700|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891701|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891702|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44891703|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
44891704|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891705|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891706|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44891707|NCT01127659|Testosterone|testosterone|mesh-list
44891708|NCT01127659|Androgens|androgens|mesh-ancestor
44891709|NCT01127659|Hormones|hormones|mesh-ancestor
44891710|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891711|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891712|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
44891713|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44891714|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682256|NCT05602675|Warfarin|warfarin|mesh-list
44891715|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891716|NCT01033565|Melatonin|melatonin|mesh-list
44891717|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
44891718|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891719|NCT01033565|Protective Agents|protective agents|mesh-ancestor
44891720|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891721|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891722|NCT00823576|Ropivacaine|ropivacaine|mesh-list
44891723|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
44891724|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
44891725|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891726|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891727|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
44891728|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891729|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
44891730|NCT00436748|Hematinics|hematinics|mesh-ancestor
44891731|NCT00390325|Sorafenib|sorafenib|mesh-list
44891732|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891733|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44891734|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891735|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891736|NCT00114101|Lenalidomide|lenalidomide|mesh-list
44891737|NCT00114101|Melphalan|melphalan|mesh-list
44891738|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
44891739|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44891740|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
44891741|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891742|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891743|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891744|NCT00114101|Growth Substances|growth substances|mesh-ancestor
44891745|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891746|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891747|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44891748|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
44891749|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891750|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44891751|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891752|NCT04216186|Ubiquinone|ubiquinone|mesh-list
44891753|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
44891754|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44891755|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44701566|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701567|NCT01404000|Charcoal|charcoal|mesh-list
44701568|NCT01404000|Antidotes|antidotes|mesh-ancestor
44701569|NCT01404000|Protective Agents|protective agents|mesh-ancestor
44701570|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701571|NCT01404013|Montelukast|montelukast|mesh-list
44701572|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44701573|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44701574|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
44701575|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44701576|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
44701577|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44701578|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701579|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44701580|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44701581|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44701582|NCT01404104|Sirolimus|sirolimus|mesh-list
44701583|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44701584|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701585|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44701586|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701587|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
44701588|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44701589|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
44701590|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44701591|NCT01404117|Interferons|interferons|mesh-list
44701592|NCT01404117|Interferon-beta|interferon-beta|mesh-list
44701593|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
44701594|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
44701595|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44701596|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
44701597|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44701598|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
44701599|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682337|NCT05556512|Tirzepatide|tirzepatide|mesh-list
44891756|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44891757|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891758|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891759|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44891760|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44891761|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891762|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
44891763|NCT04216186|Vitamins|vitamins|mesh-ancestor
44891764|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
44382351|NCT03604341|Dronabinol|dronabinol|mesh-list
44891765|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44891767|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44891768|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44891769|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44891770|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891771|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891772|NCT04215731|Leucovorin|leucovorin|mesh-list
44891773|NCT04215731|Bevacizumab|bevacizumab|mesh-list
44891774|NCT04215731|Fluorouracil|fluorouracil|mesh-list
44891775|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
44891776|NCT04215731|Irinotecan|irinotecan|mesh-list
44891777|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
44891778|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891779|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891780|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44891781|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44891782|NCT04215731|Growth Substances|growth substances|mesh-ancestor
44891783|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891784|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
44891785|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
44891786|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891787|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891788|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891789|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
44891790|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44891791|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891792|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891793|NCT04215731|Antidotes|antidotes|mesh-ancestor
44891794|NCT04215731|Protective Agents|protective agents|mesh-ancestor
44891795|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
44891796|NCT04215731|Vitamins|vitamins|mesh-ancestor
44891797|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
44891798|NCT04215614|Lidocaine|lidocaine|mesh-list
44891799|NCT04215614|Bupivacaine|bupivacaine|mesh-list
44891800|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
44891801|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
44426784|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891802|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891803|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891804|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
44891805|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891806|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44891807|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44891808|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44891809|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891810|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891811|NCT04215835|Letrozole|letrozole|mesh-list
44891812|NCT04215835|Misoprostol|misoprostol|mesh-list
44891813|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891814|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44891815|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44891816|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891817|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891818|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44891819|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
44891820|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44891821|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382413|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891822|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44891823|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
44891824|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44891825|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44891826|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44891827|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
44891828|NCT04215770|Penicillins|penicillins|mesh-list
44891829|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44891830|NCT04215770|Penicillin G|penicillin g|mesh-list
44891831|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44891832|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
44891833|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44891834|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891835|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44891836|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891837|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891838|NCT04215536|Empagliflozin|empagliflozin|mesh-list
44891839|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44682450|NCT05507359|Benzocaine|benzocaine|mesh-list
44891840|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44891841|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891842|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891843|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891844|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
44891845|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891846|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44891847|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44891848|NCT04215159|Gemcitabine|gemcitabine|mesh-list
44891849|NCT04215159|Trastuzumab|trastuzumab|mesh-list
44891850|NCT04215159|Irinotecan|irinotecan|mesh-list
44891851|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44891852|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
44891853|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891854|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44891855|NCT04215159|Antiviral Agents|antiviral agents|mesh-ancestor
44891856|NCT04215159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891857|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891858|NCT04215159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44891859|NCT04215159|Immunologic Factors|immunologic factors|mesh-ancestor
44891860|NCT04215159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891861|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44891862|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44891863|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44891864|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
44891865|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44891866|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44891867|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891868|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891869|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891870|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
44891871|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891872|NCT04215445|Empagliflozin|empagliflozin|mesh-list
44891873|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44891874|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891875|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44891876|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891877|NCT04215432|Propolis|propolis|mesh-list
44891878|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44891879|NCT04215237|Atorvastatin|atorvastatin|mesh-list
44891880|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44891881|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44891882|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
44891883|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891884|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44891885|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44891886|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44891887|NCT04214938|Lidocaine|lidocaine|mesh-list
44891888|NCT04214938|Xylometazoline|xylometazoline|mesh-list
44891889|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
44891890|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
44891891|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44891892|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891893|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
44891894|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891895|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44891896|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44891897|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44891898|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44891899|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44891900|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
44891901|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44891902|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
44891903|NCT04214990|Aspirin|aspirin|mesh-list
44891904|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44891905|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44891906|NCT04214990|Analgesics|analgesics|mesh-ancestor
44891907|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
44891908|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44891909|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44891910|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44891911|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44891912|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44474945|NCT04193059|Epirubicin|epirubicin|mesh-list
44474946|NCT04193059|Pertuzumab|pertuzumab|mesh-list
44474947|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44474948|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474949|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44474950|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44474951|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44474952|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474953|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44474954|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
44474955|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474956|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44474957|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44474958|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
44474959|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44474960|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44474961|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44474962|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44474963|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44474969|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44474970|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
44474971|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44474972|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474973|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474974|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474975|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
44474977|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44474978|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
44474979|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474981|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474982|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474984|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44474985|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
44474986|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474987|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474988|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44474989|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
44474990|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474991|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474992|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44474993|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474994|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44474995|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44474996|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
44474997|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44474998|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44474999|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
44475000|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44475001|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44475002|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475003|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
44475004|NCT04192643|Coagulants|coagulants|mesh-ancestor
44475005|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44475006|NCT04192292|Gliclazide|gliclazide|mesh-list
44475007|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44475008|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426785|NCT02209181|Acetaminophen|acetaminophen|mesh-list
44475009|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475010|NCT04192292|Incretins|incretins|mesh-ancestor
44475011|NCT04192292|Hormones|hormones|mesh-ancestor
44475012|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475013|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475014|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475015|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475016|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
44475017|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44475018|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44475019|NCT04192656|Prednisolone|prednisolone|mesh-list
44475020|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
44475021|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44475022|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
44475023|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475024|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
44475025|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
44475026|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475027|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475028|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475029|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
44475030|NCT04192656|Hormones|hormones|mesh-ancestor
44475031|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475032|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44475033|NCT04192656|Protective Agents|protective agents|mesh-ancestor
44475034|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293905|NCT00795587|Mannitol|mannitol|mesh-list
44475035|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475037|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44475038|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
44475039|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44475040|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44475041|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44475042|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426702|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426703|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382586|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
44475044|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475046|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44475047|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475048|NCT04192032|Nicotine|nicotine|mesh-list
44475049|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44475050|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
44475051|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475052|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475053|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44475055|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
44475056|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475057|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475058|NCT04191694|Ondansetron|ondansetron|mesh-list
44475059|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
44475060|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
44475061|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160674|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
44475062|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475063|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475064|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
44475065|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
44475066|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44475067|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
44475068|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475069|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475070|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44475071|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44475072|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475073|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44475074|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44475075|NCT04190927|Estradiol|estradiol|mesh-list
44475076|NCT04190927|Progesterone|progesterone|mesh-list
44475077|NCT04190927|Estrogens|estrogens|mesh-ancestor
44475078|NCT04190927|Hormones|hormones|mesh-ancestor
44475079|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475080|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475081|NCT04190927|Progestins|progestins|mesh-ancestor
44475082|NCT04191278|Varenicline|varenicline|mesh-list
44475083|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44475084|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44475085|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
44475086|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475087|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475088|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735774|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735775|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735776|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44735777|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44735778|NCT05007106|Growth Substances|growth substances|mesh-ancestor
44735779|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735780|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
44735781|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735782|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
44735783|NCT05007106|Antiviral Agents|antiviral agents|mesh-ancestor
44735784|NCT05007106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735785|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735786|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735787|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
44735788|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735789|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
44735790|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735791|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735792|NCT04979052|Interferons|interferons|mesh-list
44293990|NCT00795847|Losartan|losartan|mesh-list
44735793|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
44475089|NCT04190745|Paclitaxel|paclitaxel|mesh-list
44475090|NCT04190745|Apatinib|apatinib|mesh-list
44475091|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475092|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475093|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475094|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475095|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475096|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475097|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44475098|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475099|NCT04190173|Prucalopride|prucalopride|mesh-list
44475100|NCT04190173|Laxatives|laxatives|mesh-ancestor
44475101|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475102|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44475103|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44475104|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
44475105|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475106|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475107|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475108|NCT04190160|Xultophy|xultophy|mesh-list
44475109|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475110|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475111|NCT04190160|Incretins|incretins|mesh-ancestor
44475112|NCT04190160|Hormones|hormones|mesh-ancestor
44475113|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475115|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
44475116|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
44475117|NCT04190004|Coagulants|coagulants|mesh-ancestor
44475118|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44475119|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44475120|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
44475121|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475122|NCT04198623|Montelukast|montelukast|mesh-list
43622031|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622032|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622034|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
43622035|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622036|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
43622037|NCT03111433|Vitamins|vitamins|mesh-ancestor
43622038|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43622039|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43622040|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622041|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622042|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43622043|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
43622044|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622045|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622046|NCT03111446|Anesthetics|anesthetics|mesh-list
43622047|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622048|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622049|NCT03111186|Acetaminophen|acetaminophen|mesh-list
43622050|NCT03111186|Ibuprofen|ibuprofen|mesh-list
43622064|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44382704|NCT03580382|Trametinib|trametinib|mesh-list
43622065|NCT03111186|Narcotics|narcotics|mesh-ancestor
43622066|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622067|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
43622068|NCT03111121|Neostigmine|neostigmine|mesh-list
43622069|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43622070|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622071|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622072|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622073|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622074|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622075|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43622076|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
43622077|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622078|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43622079|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43622080|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43622082|NCT03110952|Vaccines|vaccines|mesh-list
43622121|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622122|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
43622123|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
43622124|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622125|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622126|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622127|NCT03110848|Hormones|hormones|mesh-ancestor
43622128|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622129|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43622130|NCT03110848|Protective Agents|protective agents|mesh-ancestor
43622131|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43622132|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622133|NCT03110653|Remifentanil|remifentanil|mesh-list
43622134|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43622135|NCT03110653|Narcotics|narcotics|mesh-ancestor
43622136|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622137|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622138|NCT03110653|Analgesics|analgesics|mesh-ancestor
43622139|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
44475123|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44475124|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475125|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44475126|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382777|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475127|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475128|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475129|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44475130|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44475131|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475132|NCT04192370|Cannabidiol|cannabidiol|mesh-list
44475133|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
44475134|NCT04195204|Tropisetron|tropisetron|mesh-list
44475135|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
44475136|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
44475137|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475138|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475139|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475140|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44475141|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44475142|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
44475143|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475144|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475145|NCT04198363|Amoxicillin|amoxicillin|mesh-list
44475146|NCT04198363|Clarithromycin|clarithromycin|mesh-list
43870217|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44475148|NCT04198363|Esomeprazole|esomeprazole|mesh-list
44475149|NCT04198363|Bismuth|bismuth|mesh-list
44475150|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475151|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44475152|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475153|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44475154|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622365|NCT03108690|Piperacillin|piperacillin|mesh-list
43622366|NCT03108690|Ampicillin|ampicillin|mesh-list
43622367|NCT03108690|Cefuroxime|cefuroxime|mesh-list
43622368|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43622369|NCT03108690|Lactams|lactams|mesh-list
43622370|NCT03108690|beta-Lactams|beta-lactams|mesh-list
43622371|NCT03108690|Penicillin G|penicillin g|mesh-list
43622390|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622391|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43622392|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43622393|NCT03108313|Fluorides|fluorides|mesh-list
43622394|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
43622395|NCT03108313|Protective Agents|protective agents|mesh-ancestor
43622396|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622397|NCT03108625|Vortioxetine|vortioxetine|mesh-list
43622398|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
43622399|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622400|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43622401|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43622402|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622403|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622404|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43622405|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43622406|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622407|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622408|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622409|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
43622410|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43622411|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43622412|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43622413|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43622414|NCT03108300|Doxorubicin|doxorubicin|mesh-list
43622415|NCT03108300|Propranolol|propranolol|mesh-list
43622437|NCT03108365|Chitosan|chitosan|mesh-list
43622438|NCT03108365|Coagulants|coagulants|mesh-ancestor
43622439|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43622440|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43622441|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
43622442|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622443|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43622444|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
43622445|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
43622446|NCT03108248|Doxorubicin|doxorubicin|mesh-list
43622447|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
43622448|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43622449|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43622450|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622451|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43622452|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43622453|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622454|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622455|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
43622456|NCT03108248|Coagulants|coagulants|mesh-ancestor
43622457|NCT03108287|Amoxicillin|amoxicillin|mesh-list
43622458|NCT03108287|Clarithromycin|clarithromycin|mesh-list
43622459|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43622460|NCT03108287|Rabeprazole|rabeprazole|mesh-list
43622461|NCT03108287|Bismuth|bismuth|mesh-list
43622462|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622463|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622464|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43622465|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622466|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622469|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43622482|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622483|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622488|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622489|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622490|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43622491|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622492|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43622493|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
43622494|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622495|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382854|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43622496|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622497|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43622498|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43622499|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43622500|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
43622502|NCT03107858|Dopamine|dopamine|mesh-list
43622503|NCT03107858|Norepinephrine|norepinephrine|mesh-list
43622517|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
43622536|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622537|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622538|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622539|NCT03107923|Protective Agents|protective agents|mesh-ancestor
43622540|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43622541|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44475155|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44475156|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475157|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44475158|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44475159|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44475160|NCT04198363|Antacids|antacids|mesh-ancestor
44475161|NCT04198363|Diuretics|diuretics|mesh-ancestor
44475162|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
44475163|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475164|NCT04198363|Expectorants|expectorants|mesh-ancestor
44475165|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475167|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
44475168|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
44475169|NCT04195633|Treosulfan|treosulfan|mesh-list
44475170|NCT04195633|Busulfan|busulfan|mesh-list
44475171|NCT04195633|Fludarabine|fludarabine|mesh-list
44475172|NCT04195633|Cyclosporins|cyclosporins|mesh-list
44475173|NCT04195633|Lenograstim|lenograstim|mesh-list
44475174|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475175|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
44475176|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475177|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475178|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44475179|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
44475180|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475181|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475182|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44475183|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44475184|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475185|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
44475186|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475187|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
44134834|NCT00159445|Antiviral Agents|antiviral agents|mesh-ancestor
44382880|NCT03567616|Venetoclax|venetoclax|mesh-list
44475210|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475211|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
44475212|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
44475213|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44475214|NCT04195139|Nivolumab|nivolumab|mesh-list
44475215|NCT04195139|Temozolomide|temozolomide|mesh-list
44475216|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475217|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622886|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43622887|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
43622888|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622889|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43622890|NCT03105583|Vitamins|vitamins|mesh-list
43622891|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
43622892|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622893|NCT03105180|Mannitol|mannitol|mesh-list
43622894|NCT03105180|Sorbitol|sorbitol|mesh-list
43622895|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43622896|NCT03105180|Diuretics|diuretics|mesh-ancestor
44475218|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44475219|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475220|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44475221|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
44475223|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475224|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44475225|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475226|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475227|NCT04199169|Vaccines|vaccines|mesh-list
44475228|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
44475229|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475230|NCT04199026|Sirolimus|sirolimus|mesh-list
44475231|NCT04199026|Doxorubicin|doxorubicin|mesh-list
44475232|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44475233|NCT04199026|Daunorubicin|daunorubicin|mesh-list
44475234|NCT04199026|Irinotecan|irinotecan|mesh-list
44475235|NCT04199026|Vincristine|vincristine|mesh-list
44475236|NCT04199026|Everolimus|everolimus|mesh-list
44475237|NCT04199026|Temozolomide|temozolomide|mesh-list
44475238|NCT04199026|Ifosfamide|ifosfamide|mesh-list
44475239|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
44475240|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44475241|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44475242|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475243|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475244|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475245|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475246|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475247|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44475248|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475249|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475250|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475251|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475252|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475253|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
44475254|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475255|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43870225|NCT05286619|Gemcitabine|gemcitabine|mesh-list
43622904|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
43622905|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622906|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622907|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
43622908|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622909|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43622910|NCT03105115|Narcotics|narcotics|mesh-ancestor
43622911|NCT03105115|Analgesics|analgesics|mesh-ancestor
43622912|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43622913|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622914|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
43622926|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622927|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
43622928|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622929|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622930|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
43622931|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
43622932|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
44475270|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44475271|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475272|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475273|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44475274|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
44475275|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475276|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426704|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44426705|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44426706|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426707|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426708|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426709|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
44426710|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426711|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426712|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
44426713|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44426714|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
44426715|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426716|NCT02212678|Expectorants|expectorants|mesh-ancestor
44426717|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
44426718|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44426719|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
44426720|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426721|NCT02212678|Protective Agents|protective agents|mesh-ancestor
44426722|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426723|NCT02212678|Antidotes|antidotes|mesh-ancestor
44426724|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
44426725|NCT02212379|Etravirine|etravirine|mesh-list
44426726|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44426727|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44426728|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
44426729|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426730|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44426731|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44426732|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426733|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426734|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44426735|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44426736|NCT02212197|Leuprolide|leuprolide|mesh-list
44426737|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44426738|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
44426739|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44426740|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426741|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44426742|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426743|NCT02211638|Candesartan|candesartan|mesh-list
44426744|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
44426745|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44426757|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426758|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426759|NCT02210091|Factor VIII|factor viii|mesh-list
44426760|NCT02210091|BAX 855|bax 855|mesh-list
44426761|NCT02210091|Coagulants|coagulants|mesh-ancestor
44426762|NCT02209597|Bupropion|bupropion|mesh-list
44426763|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44426764|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
44426765|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426766|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44426767|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44426768|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426769|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426770|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
44426771|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426772|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426773|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44475294|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44475295|NCT04195100|Miotics|miotics|mesh-ancestor
44475296|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
44475297|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475298|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475299|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43870251|NCT05174312|Diuretics|diuretics|mesh-list
44475300|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44475301|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
44475302|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475303|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475304|NCT04193501|Melatonin|melatonin|mesh-list
44475305|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
44475306|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475307|NCT04193501|Protective Agents|protective agents|mesh-ancestor
44475308|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475309|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475310|NCT04196010|Cytarabine|cytarabine|mesh-list
44475311|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44475312|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
44475313|NCT04196010|Cladribine|cladribine|mesh-list
44475314|NCT04196010|Lenograstim|lenograstim|mesh-list
44475315|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44475316|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
44475317|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475318|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475319|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
44475320|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475321|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475322|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
44475323|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475324|NCT04196010|Analgesics|analgesics|mesh-ancestor
44475325|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
44475326|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475327|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475328|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475329|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475330|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44475331|NCT04193774|Anesthetics|anesthetics|mesh-list
44475332|NCT04193774|Benoxinate|benoxinate|mesh-list
44475333|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44475334|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
44475335|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475336|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475337|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43870278|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
44475349|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
44475350|NCT04024462|Docetaxel|docetaxel|mesh-list
44475351|NCT04024462|Doxorubicin|doxorubicin|mesh-list
44475352|NCT04024462|Trastuzumab|trastuzumab|mesh-list
44475353|NCT04024462|Pertuzumab|pertuzumab|mesh-list
44475354|NCT04024462|Hormones|hormones|mesh-list
44475355|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475356|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
44475357|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475358|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164684|NCT00257491|Telmisartan|telmisartan|mesh-list
44475359|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44475360|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
44475361|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475362|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475363|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44475364|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475365|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475366|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475367|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44475368|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475369|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475370|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475371|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475372|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475373|NCT04029480|Metformin|metformin|mesh-list
44475374|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
44475375|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475376|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475377|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44475378|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475379|NCT04022200|Paclitaxel|paclitaxel|mesh-list
44475380|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475381|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475382|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475383|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475384|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475385|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735794|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735795|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
44735796|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735797|NCT04948333|Niacinamide|niacinamide|mesh-list
44735798|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
44735799|NCT04948333|Vitamins|vitamins|mesh-ancestor
44735800|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
44735801|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475387|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
44383131|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
44475388|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475389|NCT04023227|Valsartan|valsartan|mesh-list
44475390|NCT04023227|Enalapril|enalapril|mesh-list
44475391|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44475392|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44475393|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44475394|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44475395|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475396|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44475397|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475398|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475399|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
44475400|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44475401|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
44475402|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475403|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
44475404|NCT04026191|Protective Agents|protective agents|mesh-ancestor
44475405|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44475406|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44475407|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475408|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475409|NCT04021108|Nivolumab|nivolumab|mesh-list
44475410|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475411|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475412|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44475413|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475414|NCT04022057|Ropivacaine|ropivacaine|mesh-list
44383156|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
44475415|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475441|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475442|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475443|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475445|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
44475446|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475458|NCT04029090|Protective Agents|protective agents|mesh-ancestor
44475459|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475460|NCT04029272|Metformin|metformin|mesh-list
44475461|NCT04029272|Exenatide|exenatide|mesh-list
44475462|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475463|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475464|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44475465|NCT04029272|Incretins|incretins|mesh-ancestor
44475466|NCT04029272|Hormones|hormones|mesh-ancestor
44475467|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475468|NCT04028778|Gefitinib|gefitinib|mesh-list
44475469|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475470|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44475471|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475472|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475473|NCT04028856|Interferons|interferons|mesh-list
44475474|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475475|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
44475476|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475477|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44475478|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44475479|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475480|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
44475481|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
44475482|NCT04028804|Fluorides|fluorides|mesh-list
44475483|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
44475484|NCT04028804|Protective Agents|protective agents|mesh-ancestor
44475485|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475486|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
44475487|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475488|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
44475489|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475490|NCT04028739|Curcumin|curcumin|mesh-list
44475491|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44475492|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475493|NCT04028739|Analgesics|analgesics|mesh-ancestor
44475494|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
44475495|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475496|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475497|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475498|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475499|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475500|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475501|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475502|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44475503|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475504|NCT04028505|Terlipressin|terlipressin|mesh-list
44475505|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44475506|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44475507|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44475509|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44475510|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44475511|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475512|NCT04028466|Omeprazole|omeprazole|mesh-list
44475513|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44475514|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475515|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44475516|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475517|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475518|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
44475519|NCT04027972|Neostigmine|neostigmine|mesh-list
44475520|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44475521|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475522|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475523|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383212|NCT03543137|Nicotine|nicotine|mesh-list
44475524|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475525|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475526|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44475527|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
44475528|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475529|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44475530|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44475531|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44475532|NCT04027764|Paclitaxel|paclitaxel|mesh-list
44475533|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475534|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475535|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475536|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475537|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475538|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475539|NCT04027751|Tropisetron|tropisetron|mesh-list
44475540|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
44475541|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
44475542|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475543|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475544|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475545|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44475546|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44475547|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
44475548|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475549|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475550|NCT04028024|Urinastatin|urinastatin|mesh-list
44475551|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44383262|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
44475552|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44475553|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475554|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475555|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475556|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
44475557|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
44475558|NCT04027959|Vitamins|vitamins|mesh-ancestor
44475559|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
44475560|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475561|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
44475562|NCT04027959|Hematinics|hematinics|mesh-ancestor
44735802|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44735803|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735804|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735805|NCT04935359|Gemcitabine|gemcitabine|mesh-list
44735806|NCT04935359|Paclitaxel|paclitaxel|mesh-list
44735807|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735808|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735809|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735810|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735811|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735812|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134903|NCT00159536|Metformin|metformin|mesh-list
44475571|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475573|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44475574|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44475575|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44475576|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44475577|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
44475578|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
44475579|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
44475580|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
44475581|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475582|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475583|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
44475584|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44475585|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44475586|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475587|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
44475588|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
44475589|NCT04027166|Methadone|methadone|mesh-list
44475590|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44475591|NCT04027166|Narcotics|narcotics|mesh-ancestor
44475592|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475593|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475594|NCT04027166|Analgesics|analgesics|mesh-ancestor
44475595|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
44475596|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475597|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
44475598|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475599|NCT04027283|Erythritol|erythritol|mesh-list
44475600|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
44475601|NCT04026841|Antibodies|antibodies|mesh-list
44475615|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44475617|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44475618|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44475619|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475620|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475621|NCT04026685|Protective Agents|protective agents|mesh-ancestor
44475622|NCT04026464|Acetaminophen|acetaminophen|mesh-list
44475623|NCT04026464|Ibuprofen|ibuprofen|mesh-list
44475624|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475625|NCT04026464|Analgesics|analgesics|mesh-ancestor
44475626|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
44475627|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475628|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475629|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
44475630|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44475631|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475632|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475633|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44475634|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475635|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475636|NCT04026074|Clonidine|clonidine|mesh-list
44475637|NCT04026074|Fentanyl|fentanyl|mesh-list
44475638|NCT04026074|Remifentanil|remifentanil|mesh-list
44475639|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44475640|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44475641|NCT04026074|Narcotics|narcotics|mesh-ancestor
44475642|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475643|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475644|NCT04026074|Analgesics|analgesics|mesh-ancestor
44475645|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
44475646|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475647|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44475648|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44475649|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
44475655|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44475656|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44475657|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44475658|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475659|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475660|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475661|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44475663|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44475664|NCT04026022|Narcotics|narcotics|mesh-ancestor
44475665|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475666|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475667|NCT04026022|Analgesics|analgesics|mesh-ancestor
44475668|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
44475669|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475670|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44475671|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44475672|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
44475673|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
44475674|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
44475675|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44475676|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44475677|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475678|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
44475679|NCT04025736|Coagulants|coagulants|mesh-ancestor
44475680|NCT04025918|Phenylephrine|phenylephrine|mesh-list
44475681|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
44475682|NCT04025918|Ephedrine|ephedrine|mesh-list
44475683|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44475684|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44475685|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
44475686|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
44475687|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475688|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475689|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
44475690|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
44475691|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
44475692|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44475693|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44475694|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44475695|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
44475696|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475697|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475698|NCT04025918|Protective Agents|protective agents|mesh-ancestor
44475699|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44475700|NCT04025567|Vancomycin|vancomycin|mesh-list
44475701|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623256|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
43623257|NCT04930458|Caseins|caseins|mesh-list
43623258|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43623259|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623260|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
43623261|NCT04930458|Protective Agents|protective agents|mesh-ancestor
43623262|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43623263|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475715|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
44475716|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475717|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475718|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44475719|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475720|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44475721|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475722|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475723|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383431|NCT03522506|Modafinil|modafinil|mesh-list
44475724|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475725|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
44475727|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475740|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44475741|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475742|NCT04025177|Analgesics|analgesics|mesh-ancestor
44475743|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
44475744|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475745|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475746|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475747|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475748|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
44475749|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
44475750|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44475751|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44475752|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475753|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475754|NCT04024683|Ropivacaine|ropivacaine|mesh-list
44475755|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
44475756|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
44475757|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475758|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475759|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
44475760|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475761|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
44475762|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475763|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475764|NCT04024865|Domperidone|domperidone|mesh-list
44475765|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
44475766|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
44475767|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475768|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475769|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475770|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44475771|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
44475772|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475773|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475774|NCT04024813|Seladelpar|seladelpar|mesh-list
44475775|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44475776|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
44383434|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44475777|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475778|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44475779|NCT04024527|Amoxicillin|amoxicillin|mesh-list
44475780|NCT04024527|Metronidazole|metronidazole|mesh-list
44475781|NCT04024527|Esomeprazole|esomeprazole|mesh-list
44475782|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44475783|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475784|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44475785|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44475786|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44475787|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475788|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44475789|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475790|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735849|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44475791|NCT04024384|Daratumumab|daratumumab|mesh-list
44475792|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475793|NCT04024241|Cytarabine|cytarabine|mesh-list
44475794|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
44475795|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44475796|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
44475797|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475798|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475799|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
44475800|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475801|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475802|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
44475803|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475804|NCT04024241|Analgesics|analgesics|mesh-ancestor
44475807|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475808|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475810|NCT04024163|Benzonidazole|benzonidazole|mesh-list
44475811|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475812|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
44383475|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44475813|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475814|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44475815|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44475816|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44475826|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475827|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475828|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475829|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
44475830|NCT04023565|Perindopril|perindopril|mesh-list
44475831|NCT04023565|Moxonidine|moxonidine|mesh-list
44475832|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44475833|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475834|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426774|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426775|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426776|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44426777|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44426778|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44426779|NCT02209454|Analgesics|analgesics|mesh-ancestor
44426780|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
44426781|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475835|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475836|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44475837|NCT04023617|Docetaxel|docetaxel|mesh-list
44475838|NCT04023617|Nivolumab|nivolumab|mesh-list
44475839|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475840|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475841|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475842|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
44426786|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475843|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475844|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475845|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44475846|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
44475847|NCT04023630|Clopidogrel|clopidogrel|mesh-list
44475848|NCT04023630|Ticagrelor|ticagrelor|mesh-list
44475849|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44475850|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44475851|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44475852|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44475853|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
44475854|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44475855|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475856|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475857|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44475858|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
44475859|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44475860|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
44475861|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475862|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
44475863|NCT04023149|Aldesleukin|aldesleukin|mesh-list
44475864|NCT04023149|Interleukin-2|interleukin-2|mesh-list
44294725|NCT00799136|Prednisone|prednisone|mesh-list
44475865|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475866|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475868|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
43623264|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
43623265|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
43623266|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623267|NCT04917588|Lidocaine|lidocaine|mesh-list
44383537|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
43623268|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623269|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
43623270|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623271|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623272|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
43623273|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623274|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623275|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623276|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623277|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623278|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623279|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
43623280|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43623281|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
43623282|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623283|NCT04832009|Protective Agents|protective agents|mesh-ancestor
43623284|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623289|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43623291|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43623292|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623293|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623294|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623295|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43623296|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43623297|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43623298|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43623299|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
43623300|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
43623301|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
43623302|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
43623303|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623304|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623306|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623307|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
43623308|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475870|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475871|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44475872|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44475873|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
44475874|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475875|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
44475876|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475877|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475878|NCT04023292|Tamoxifen|tamoxifen|mesh-list
44475879|NCT04023292|Letrozole|letrozole|mesh-list
44475880|NCT04023292|Exemestane|exemestane|mesh-list
44383564|NCT03518125|Vaccines|vaccines|mesh-list
44475881|NCT04023292|Anastrozole|anastrozole|mesh-list
44475882|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475883|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44475884|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44475885|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475886|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475887|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44475888|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
44475889|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475890|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475891|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44475892|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44475893|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44475894|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44475896|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44475897|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44475898|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
44475899|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
44475900|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44475901|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475902|NCT04022837|Pantoprazole|pantoprazole|mesh-list
44475903|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44475904|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475905|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44475906|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475907|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475908|NCT04022811|Tobramycin|tobramycin|mesh-list
44475909|NCT04022811|Dexamethasone|dexamethasone|mesh-list
44475910|NCT04022811|Bromfenac|bromfenac|mesh-list
44475911|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
44475912|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44475913|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
44475915|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44475916|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475917|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44475918|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
44475919|NCT04022811|Hormones|hormones|mesh-ancestor
44475920|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44475921|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44475922|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426787|NCT02209181|Analgesics|analgesics|mesh-ancestor
44475923|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44475924|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236603|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475925|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44475926|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
44475927|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
44475928|NCT04022811|Protective Agents|protective agents|mesh-ancestor
44475929|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44475930|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44475931|NCT04022811|Analgesics|analgesics|mesh-ancestor
44475932|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
44475933|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475934|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
44475935|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
44475936|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475937|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
44475938|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44475939|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475940|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475941|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
44475942|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475943|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475944|NCT04022525|Leflunomide|leflunomide|mesh-list
44475945|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475946|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475947|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475948|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
44475949|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475950|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
44475951|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
44475952|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44475953|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44475954|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475955|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475956|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475957|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475959|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44475960|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475961|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475962|NCT04022317|Insulin|insulin|mesh-list
44475963|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44475964|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475965|NCT04021992|Gemcitabine|gemcitabine|mesh-list
44475966|NCT04021992|Rituximab|rituximab|mesh-list
44475967|NCT04021992|Doxorubicin|doxorubicin|mesh-list
44475968|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44475969|NCT04021992|Vinorelbine|vinorelbine|mesh-list
44475970|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475971|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475972|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
44475973|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44475974|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475975|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44475976|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
44475977|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44475978|NCT04021992|Antiviral Agents|antiviral agents|mesh-ancestor
44475979|NCT04021992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44475980|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44475981|NCT04021992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44475982|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44475983|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44475984|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44475985|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44475986|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44475987|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44475988|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44475989|NCT04022005|Gemcitabine|gemcitabine|mesh-list
44475990|NCT04022005|Rituximab|rituximab|mesh-list
44475991|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
44475992|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44475993|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44475994|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
44475995|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134929|NCT00159666|Pregabalin|pregabalin|mesh-list
44475996|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44475997|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44475998|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
44475999|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476000|NCT04022005|Antiviral Agents|antiviral agents|mesh-ancestor
44476001|NCT04022005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476002|NCT04022005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476015|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44476016|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476017|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476019|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476020|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476021|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44476022|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735850|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735851|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44735860|NCT04911621|Temozolomide|temozolomide|mesh-list
44735861|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735862|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
44735863|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735864|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735865|NCT04895436|Venetoclax|venetoclax|mesh-list
44735866|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
44735867|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735868|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735872|NCT04892043|Nivolumab|nivolumab|mesh-list
44735873|NCT04892043|Ipilimumab|ipilimumab|mesh-list
44735874|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383763|NCT03509207|Vorinostat|vorinostat|mesh-list
44735875|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735876|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44735877|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735888|NCT04883242|Dexamethasone|dexamethasone|mesh-list
44735889|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
44735890|NCT04883242|Pomalidomide|pomalidomide|mesh-list
44735891|NCT04883242|Ichthammol|ichthammol|mesh-list
44735892|NCT04883242|BB 1101|bb 1101|mesh-list
44735893|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44735894|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44735895|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
44735896|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
44236604|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
44171807|NCT00286988|Topiramate|topiramate|mesh-list
44735897|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735898|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735899|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44735900|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
44735901|NCT04883242|Hormones|hormones|mesh-ancestor
44735902|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44735903|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44735911|NCT04883242|Growth Substances|growth substances|mesh-ancestor
44735912|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44735913|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44735914|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
44735915|NCT04881240|Fludarabine|fludarabine|mesh-list
44735916|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735917|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
44735918|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735919|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476023|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44476024|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44476025|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
44476026|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44476027|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44476028|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476029|NCT04020666|Kallikreins|kallikreins|mesh-list
44383781|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383797|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44476030|NCT04020666|Coagulants|coagulants|mesh-ancestor
43623648|NCT04150562|Avelumab|avelumab|mesh-list
43623649|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623650|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623651|NCT04115748|Adalimumab|adalimumab|mesh-list
43623652|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43623653|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623654|NCT04087408|Hormones|hormones|mesh-list
43623655|NCT04087408|Progesterone|progesterone|mesh-list
43623656|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43623657|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623658|NCT04087408|Progestins|progestins|mesh-ancestor
43623659|NCT04059172|Ibuprofen|ibuprofen|mesh-list
43623660|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43623661|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43623662|NCT04059172|Analgesics|analgesics|mesh-ancestor
43623663|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
43623664|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623665|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623666|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43623667|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623668|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43623669|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849424|NCT03929224|Bacitracin|bacitracin|mesh-list
43849425|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43849426|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849427|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623670|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623671|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
44383798|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774321|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774322|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44774323|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774324|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774325|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774326|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774327|NCT01848197|Paclitaxel|paclitaxel|mesh-list
44774328|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774329|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774330|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774331|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774332|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774333|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774335|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
44774336|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
44774337|NCT01848236|Vitamins|vitamins|mesh-list
44774338|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
44774339|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774340|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44774341|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774342|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44774343|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774344|NCT01848301|Acetylcholine|acetylcholine|mesh-list
44774345|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774346|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44774347|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
44774348|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774349|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774350|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774351|NCT01848340|Cabotegravir|cabotegravir|mesh-list
44774352|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44774353|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44774354|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774355|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774356|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44774357|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44774358|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
44774359|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774360|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44774361|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774362|NCT01848613|Vinorelbine|vinorelbine|mesh-list
44774363|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774364|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774365|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774366|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774367|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774368|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774369|NCT01848652|Doxorubicin|doxorubicin|mesh-list
44774370|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44774371|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774372|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44774373|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44774374|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774375|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774376|NCT01848665|Indomethacin|indomethacin|mesh-list
44774377|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44774378|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774379|NCT01848665|Analgesics|analgesics|mesh-ancestor
44774380|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
44774381|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774382|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774383|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774384|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774385|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
44774386|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
44774387|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44774388|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44774389|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774390|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774391|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
44774392|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
44774393|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774394|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
44774395|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774396|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774397|NCT01848743|Tenofovir|tenofovir|mesh-list
44774398|NCT01848743|Lamivudine|lamivudine|mesh-list
44774399|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
44774400|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774401|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44774402|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44774403|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774404|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774405|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44774406|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44774407|NCT01848769|Beclomethasone|beclomethasone|mesh-list
44774408|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
44774409|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44774410|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
44774411|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774412|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774413|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44691255|NCT01359930|Naltrexone|naltrexone|mesh-list
44691256|NCT01359930|Bupropion|bupropion|mesh-list
44691257|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44691258|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44691259|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691260|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
44691261|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691262|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44691263|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
44691264|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691265|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44691266|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691267|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691268|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691269|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
44691270|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691271|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44691272|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44691273|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691274|NCT01360034|Indomethacin|indomethacin|mesh-list
44691275|NCT01360034|Nifedipine|nifedipine|mesh-list
44691276|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44691277|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691278|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691279|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691280|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691281|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691282|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
44691283|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691284|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691285|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691286|NCT01360034|Analgesics|analgesics|mesh-ancestor
44691287|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
44691288|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691289|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691290|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691291|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
44691292|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691293|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691294|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
44691295|NCT01360060|Analgesics|analgesics|mesh-ancestor
44691296|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
44691297|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691298|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691299|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
44691300|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691301|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44691302|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
44691303|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44691304|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691305|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691306|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691307|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
44691308|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691309|NCT01360086|Leucovorin|leucovorin|mesh-list
44691310|NCT01360086|Cisplatin|cisplatin|mesh-list
44691311|NCT01360086|Fluorouracil|fluorouracil|mesh-list
44691312|NCT01360086|Cetuximab|cetuximab|mesh-list
44691313|NCT01360086|Calcium|calcium|mesh-list
44691314|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
44691315|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691316|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691317|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691318|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
44691319|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691320|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774414|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774415|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44774416|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44774417|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774418|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774419|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774420|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774421|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774422|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
44774423|NCT01848769|Hormones|hormones|mesh-ancestor
44774424|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774425|NCT01848808|Wobenzym|wobenzym|mesh-list
44774426|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44774427|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
44774428|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774429|NCT01848873|Amlodipine|amlodipine|mesh-list
44774430|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44774431|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44383998|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44774432|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774433|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774434|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774435|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774436|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774437|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
44774438|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774439|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
44774440|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774441|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774442|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44774443|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
44774444|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44774445|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
44774446|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774447|NCT01849016|Expectorants|expectorants|mesh-ancestor
44774448|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774449|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44774450|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
44774451|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774452|NCT01849016|Protective Agents|protective agents|mesh-ancestor
44774453|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774454|NCT01849016|Antidotes|antidotes|mesh-ancestor
44552348|NCT01293539|Melphalan|melphalan|mesh-list
44552349|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44552350|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
44552351|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552352|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774455|NCT01849042|Donepezil|donepezil|mesh-list
44774456|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44774457|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774458|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774459|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
44774460|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774461|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774462|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
44774463|NCT01849094|Milrinone|milrinone|mesh-list
44774464|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44774465|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44774466|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774467|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44774468|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44774469|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384033|NCT03486834|Vaccines|vaccines|mesh-list
44774470|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774471|NCT01849094|Protective Agents|protective agents|mesh-ancestor
44552353|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44552354|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552355|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
44552356|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552357|NCT01293123|Tenofovir|tenofovir|mesh-list
44552358|NCT01293123|Emtricitabine|emtricitabine|mesh-list
44552359|NCT01293123|Efavirenz|efavirenz|mesh-list
44552360|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
44774472|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774474|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44774475|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44774476|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44774477|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774478|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774479|NCT01849406|Budesonide|budesonide|mesh-list
44774480|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774481|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44774482|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
44774483|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774484|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774485|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44774486|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774487|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
44774488|NCT01849406|Hormones|hormones|mesh-ancestor
44774489|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774490|NCT01849640|Piperaquine|piperaquine|mesh-list
44774491|NCT01849640|Primaquine|primaquine|mesh-list
44774492|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
44774493|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44774494|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44774495|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774496|NCT01849666|Vemurafenib|vemurafenib|mesh-list
44774497|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
44774498|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774499|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44774500|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774501|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774502|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
44774503|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
44774504|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44774505|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44774506|NCT01849835|Menthol|menthol|mesh-list
44774507|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
44774508|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774509|NCT01849861|Methimazole|methimazole|mesh-list
44774510|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
44774511|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
43623672|NCT04021550|Telmisartan|telmisartan|mesh-list
44384073|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774512|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774513|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774514|NCT01849926|Amdinocillin|amdinocillin|mesh-list
44774515|NCT01849926|Ibuprofen|ibuprofen|mesh-list
44774516|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44774517|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774518|NCT01849926|Analgesics|analgesics|mesh-ancestor
44774519|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
44774520|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774521|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774522|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774523|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774524|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44774525|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774526|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774527|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44774528|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774529|NCT01849926|Renal Agents|renal agents|mesh-ancestor
44774530|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774531|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44774532|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
44774533|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774534|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
44774535|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44774536|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774537|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774538|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774539|NCT01850017|Analgesics|analgesics|mesh-ancestor
44774540|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
44774541|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774542|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44774543|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44774544|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774545|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774546|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552402|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
44774547|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774549|NCT01850095|Estradiol|estradiol|mesh-list
44774550|NCT01850095|Estrogens|estrogens|mesh-ancestor
44774551|NCT01850095|Hormones|hormones|mesh-ancestor
44774552|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774553|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774554|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774555|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774556|NCT01850121|Infliximab|infliximab|mesh-list
44774557|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774558|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44774559|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774560|NCT01850147|Sunitinib|sunitinib|mesh-list
44774561|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774562|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44774563|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44774564|NCT01850147|Growth Substances|growth substances|mesh-ancestor
44774565|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774566|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
44774567|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44774568|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774569|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774570|NCT01850160|Valsartan|valsartan|mesh-list
44774571|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
44774572|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
44774573|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
44774574|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44774575|NCT01850160|Diuretics|diuretics|mesh-list
44774576|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44774577|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44774578|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774579|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
44774580|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774581|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774582|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44774583|NCT01850251|Vitamin D|vitamin d|mesh-list
44774584|NCT01850251|Vitamins|vitamins|mesh-ancestor
44774585|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
44774586|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774587|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44774588|NCT01850277|Amiodarone|amiodarone|mesh-list
44774589|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774590|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44774591|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774592|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44774593|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774594|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44774595|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44774596|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44774597|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774598|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44774599|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44774600|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44774601|NCT01850303|Gemcitabine|gemcitabine|mesh-list
44774602|NCT01850303|Pemetrexed|pemetrexed|mesh-list
44774603|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774604|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
44774605|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774606|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774607|NCT01850303|Antiviral Agents|antiviral agents|mesh-ancestor
44774608|NCT01850303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774609|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774610|NCT01850303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774611|NCT01850303|Immunologic Factors|immunologic factors|mesh-ancestor
44774612|NCT01850303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774613|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44774614|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44774615|NCT01850511|Phenylephrine|phenylephrine|mesh-list
44774616|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
44774617|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44774618|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774619|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774620|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774621|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774622|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774623|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
44774624|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
44774625|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774626|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
44774627|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44774628|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774629|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44774631|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44774632|NCT01850511|Protective Agents|protective agents|mesh-ancestor
44774633|NCT01850628|Paclitaxel|paclitaxel|mesh-list
44774634|NCT01850628|Trastuzumab|trastuzumab|mesh-list
44774635|NCT01850628|Pertuzumab|pertuzumab|mesh-list
44774636|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774637|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774638|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774639|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774640|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774641|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774642|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774643|NCT01850680|Folic Acid|folic acid|mesh-list
44774644|NCT01850680|Methotrexate|methotrexate|mesh-list
44774645|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44774646|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44774647|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44774648|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774649|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774650|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
44774651|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774652|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774653|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774654|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774655|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44774656|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384219|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774657|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
44774658|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774659|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44774660|NCT01850680|Hematinics|hematinics|mesh-ancestor
44774661|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
44774662|NCT01850680|Vitamins|vitamins|mesh-ancestor
44774663|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
44774664|NCT01850940|Tolvaptan|tolvaptan|mesh-list
44774665|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44774666|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774667|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
44774668|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774669|NCT01850953|Varenicline|varenicline|mesh-list
44774670|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44774671|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44774672|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
44774673|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774674|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774675|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774676|NCT01850979|Tacrolimus|tacrolimus|mesh-list
44774677|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774678|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
43623680|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
44774679|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774680|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44774681|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774682|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774683|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
44774684|NCT01851005|Remifentanil|remifentanil|mesh-list
44774685|NCT01851005|Anesthetics|anesthetics|mesh-list
44774686|NCT01851005|Propofol|propofol|mesh-list
44774687|NCT01851005|Sevoflurane|sevoflurane|mesh-list
44774688|NCT01851005|Rocuronium|rocuronium|mesh-list
44774689|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774690|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774691|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44774692|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44774693|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
44774694|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774695|NCT01851005|Analgesics|analgesics|mesh-ancestor
44774696|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
44774697|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774698|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44774699|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44774700|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774701|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774702|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623681|NCT04021550|Vitamins|vitamins|mesh-ancestor
44774703|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774704|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44774705|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44774706|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44774707|NCT01851005|Narcotics|narcotics|mesh-ancestor
44774708|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44774709|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44774710|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44774711|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
44774712|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44774713|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
44774714|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774715|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774716|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774717|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44774718|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774719|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774720|NCT01851265|Olaparib|olaparib|mesh-list
44774721|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44774722|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774723|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774724|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774725|NCT01851278|Triamcinolone|triamcinolone|mesh-list
44774726|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44774727|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44774728|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44774729|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44774730|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
44774731|NCT01851278|Hormones|hormones|mesh-ancestor
44774732|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44774733|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774734|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774735|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
44774736|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774737|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774738|NCT01851408|Sirolimus|sirolimus|mesh-list
44774739|NCT01851408|Sorafenib|sorafenib|mesh-list
44552634|NCT01289119|Hormones|hormones|mesh-ancestor
44774740|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774741|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44774742|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774743|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774744|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774745|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774746|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44774747|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
44774748|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774749|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
44774750|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774751|NCT01851473|Quinine|quinine|mesh-list
44774752|NCT01851473|Acetazolamide|acetazolamide|mesh-list
44774753|NCT01851473|Cocaine|cocaine|mesh-list
44774754|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
44774755|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44774756|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774757|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774758|NCT01851473|Diuretics|diuretics|mesh-ancestor
44774759|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
44774760|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774761|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
44774762|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
44774763|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774764|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
44774765|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774766|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44774767|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44774768|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44774769|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384359|NCT03469258|Pancreatin|pancreatin|mesh-list
44774770|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
44774771|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774772|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
44774773|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44774774|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44774775|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774776|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44774777|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44774778|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774779|NCT01851473|Analgesics|analgesics|mesh-ancestor
44774780|NCT01851486|Clonidine|clonidine|mesh-list
44774781|NCT01851486|Naloxone|naloxone|mesh-list
44774782|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44774783|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774784|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
44774785|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774786|NCT01851486|Analgesics|analgesics|mesh-ancestor
44774787|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44774788|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
44774789|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
44774790|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44774791|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44774792|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774793|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774794|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623682|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
44774795|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774796|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44774797|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44774798|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774799|NCT01851551|Rituximab|rituximab|mesh-list
44552706|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552707|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552708|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44552709|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552710|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44552711|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552712|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552713|NCT01287520|Carboplatin|carboplatin|mesh-list
44552714|NCT01287520|Pemetrexed|pemetrexed|mesh-list
44552715|NCT01287520|Ranitidine|ranitidine|mesh-list
44552716|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44552717|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552718|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552719|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552720|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44552721|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552722|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44552726|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
44774800|NCT01851551|Vincristine|vincristine|mesh-list
44774801|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774802|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774803|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
44774804|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774805|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44774806|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44774807|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44774808|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44774809|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44774810|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384397|NCT03465436|Lasmiditan|lasmiditan|mesh-list
44774811|NCT01851681|Amoxicillin|amoxicillin|mesh-list
44774812|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774813|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774814|NCT01851733|Doxorubicin|doxorubicin|mesh-list
44774815|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44774816|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774817|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44774818|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44774819|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774820|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774821|NCT01851759|Cinepazide|cinepazide|mesh-list
44774822|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774823|NCT01851824|Vemurafenib|vemurafenib|mesh-list
44774824|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
44774825|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774826|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44774827|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774828|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774829|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
44774830|NCT01851850|Opicapone|opicapone|mesh-list
44774831|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44774832|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774833|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774834|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44774835|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44774836|NCT01851941|Leucovorin|leucovorin|mesh-list
44774837|NCT01851941|Folic Acid|folic acid|mesh-list
44774838|NCT01851941|Fluorouracil|fluorouracil|mesh-list
44774839|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
44774840|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
44774841|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
44774842|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774843|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44774844|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774845|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44774846|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
44774847|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774848|NCT01851941|Antidotes|antidotes|mesh-ancestor
44774849|NCT01851941|Protective Agents|protective agents|mesh-ancestor
44774850|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
44774851|NCT01851941|Vitamins|vitamins|mesh-ancestor
44774852|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
44774853|NCT01851941|Hematinics|hematinics|mesh-ancestor
44774854|NCT01851954|Clarithromycin|clarithromycin|mesh-list
44774855|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774856|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774857|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44774858|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774859|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384466|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44774860|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44774861|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44774862|NCT01851980|Furosemide|furosemide|mesh-list
44774863|NCT01851980|Diuretics|diuretics|mesh-ancestor
44774864|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
44774865|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774866|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44774867|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774868|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774869|NCT01851993|Ondansetron|ondansetron|mesh-list
44774870|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
44774871|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
44774872|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552760|NCT01287195|Omeprazole|omeprazole|mesh-list
44774873|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774874|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44774875|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
44774876|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774877|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44774878|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
44774879|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774880|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774881|NCT01851993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44774882|NCT01851993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44774883|NCT01851993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774884|NCT01851993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44774885|NCT01851993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44774886|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
44774887|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44774888|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44774889|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774890|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
44774891|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
44774892|NCT01852266|Vaccines|vaccines|mesh-list
44774893|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
43623683|NCT03994731|Acetaminophen|acetaminophen|mesh-list
44774894|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774895|NCT01852318|Fexofenadine|fexofenadine|mesh-list
44774896|NCT01852318|Pregabalin|pregabalin|mesh-list
44774897|NCT01852318|Analgesics|analgesics|mesh-ancestor
44774898|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
44774899|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774900|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774901|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
44774902|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44774903|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774904|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774905|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774906|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44774907|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44774908|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774909|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44774910|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44774911|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44774912|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44774913|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
44774914|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
44774915|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774916|NCT01852409|Bevacizumab|bevacizumab|mesh-list
44774917|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44774918|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774919|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44774920|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44774921|NCT01852409|Growth Substances|growth substances|mesh-ancestor
44774922|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774923|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
44774924|NCT01852461|Poractant alfa|poractant alfa|mesh-list
44774925|NCT01852461|Beractant|beractant|mesh-list
44774926|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44774927|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
44774928|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
44774929|NCT01852539|Propofol|propofol|mesh-list
44774930|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44774931|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44774932|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774933|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44774934|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
44774935|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
44774936|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44774937|NCT01852539|Analgesics|analgesics|mesh-ancestor
44774938|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
44774939|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44774940|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44774941|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44774942|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44774943|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
44774944|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44774945|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774946|NCT01852565|Diltiazem|diltiazem|mesh-list
44774947|NCT01852565|Darapladib|darapladib|mesh-list
44774948|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44774949|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44774950|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44774951|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774952|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774953|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774954|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
44774955|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44774956|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44774957|NCT01852604|Interferons|interferons|mesh-list
44774958|NCT01852604|Ritonavir|ritonavir|mesh-list
44774959|NCT01852604|Ribavirin|ribavirin|mesh-list
44691321|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691322|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
44691323|NCT01360086|Antidotes|antidotes|mesh-ancestor
44691324|NCT01360086|Protective Agents|protective agents|mesh-ancestor
44691325|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
44691326|NCT01360086|Vitamins|vitamins|mesh-ancestor
44691327|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
44691328|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691329|NCT01360151|Ranibizumab|ranibizumab|mesh-list
44691330|NCT01360151|Verteporfin|verteporfin|mesh-list
44691331|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44691332|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44691333|NCT01360151|Growth Substances|growth substances|mesh-ancestor
44691334|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691335|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
44691336|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691337|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44691338|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44691339|NCT01360190|Fluoxetine|fluoxetine|mesh-list
44691340|NCT01360190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44691341|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691342|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691343|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691344|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691345|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
44691346|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691347|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44691348|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
44691349|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384611|NCT03447821|Rifamycins|rifamycins|mesh-list
44691350|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44691351|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44691352|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691353|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
44691354|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44691355|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691356|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
44691357|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691358|NCT01360424|Teriparatide|teriparatide|mesh-list
44691359|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691360|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691361|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44691362|NCT01360437|Ticagrelor|ticagrelor|mesh-list
44691363|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44691364|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44691365|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44691366|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44691367|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44691368|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
44691369|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691370|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691371|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691372|NCT01360463|Methadone|methadone|mesh-list
44691373|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44691374|NCT01360463|Narcotics|narcotics|mesh-ancestor
44691375|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691376|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691377|NCT01360463|Analgesics|analgesics|mesh-ancestor
44691378|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
44691379|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691380|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
44691381|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691382|NCT01360476|Vitamin D|vitamin d|mesh-list
44691383|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
44691384|NCT01360476|Vitamins|vitamins|mesh-ancestor
44691385|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
44691386|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774960|NCT01852604|Simeprevir|simeprevir|mesh-list
44774961|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44774962|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
44774963|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774964|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44774965|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44774966|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
44774967|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623684|NCT03994731|Folic Acid|folic acid|mesh-list
44774968|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774969|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44774970|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44774971|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44774972|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44774973|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
44774974|NCT01852630|Imipenem|imipenem|mesh-list
44774975|NCT01852630|Cefepime|cefepime|mesh-list
44774976|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44774977|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44774978|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
44774979|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
44774980|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44774981|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44774982|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774983|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44774984|NCT01852903|Vitamins|vitamins|mesh-list
44774985|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
44774986|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
44774987|NCT01852903|Calcium|calcium|mesh-list
44774988|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
44774989|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44774990|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44774991|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
44774992|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44774993|NCT01852903|Protective Agents|protective agents|mesh-ancestor
44774994|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
44774995|NCT01852994|Testosterone|testosterone|mesh-list
44774996|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
44774997|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
44774998|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44774999|NCT01852994|Androgens|androgens|mesh-ancestor
44775000|NCT01852994|Hormones|hormones|mesh-ancestor
44775001|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775002|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775003|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44775004|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775005|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
44384646|NCT03447249|VX-659|vx-659|mesh-list
44775006|NCT01853111|Aldesleukin|aldesleukin|mesh-list
44775007|NCT01853111|Interleukin-2|interleukin-2|mesh-list
44775008|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775009|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775010|NCT01853111|Analgesics|analgesics|mesh-ancestor
44775011|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
44775012|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775013|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775014|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44775015|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44775016|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
44775017|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552981|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44552982|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44552983|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44552984|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
44552985|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775018|NCT01853306|Veliparib|veliparib|mesh-list
44775019|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44775020|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775021|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775022|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775023|NCT01853423|Sirolimus|sirolimus|mesh-list
44775024|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44775025|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775026|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44775027|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775028|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
44775029|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775030|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
44775031|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775032|NCT01853449|Fentanyl|fentanyl|mesh-list
44775033|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44775034|NCT01853449|Narcotics|narcotics|mesh-ancestor
44775035|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775036|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775037|NCT01853449|Analgesics|analgesics|mesh-ancestor
44775038|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
44552986|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552987|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552988|NCT01283152|Lactulose|lactulose|mesh-list
44552989|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44552990|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552991|NCT01283152|Laxatives|laxatives|mesh-ancestor
44775039|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775040|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44775041|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775042|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
44775043|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
44775044|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
44775045|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
44775046|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44775047|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44775048|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775049|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775050|NCT01853540|Urological Agents|urological agents|mesh-ancestor
44775051|NCT01853566|Hormones|hormones|mesh-list
44775052|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775053|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775054|NCT01853709|Bisacodyl|bisacodyl|mesh-list
44775055|NCT01853709|Cathartics|cathartics|mesh-ancestor
44775056|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775057|NCT01853709|Laxatives|laxatives|mesh-ancestor
44775058|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
44775059|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44775060|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775061|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
44775062|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775063|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775064|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775065|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775066|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44775067|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44775068|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44775069|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775070|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623685|NCT03994731|Fexofenadine|fexofenadine|mesh-list
44384716|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775071|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775072|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
44775073|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44775074|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
44775075|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44775076|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
44775077|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775078|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775079|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
44775080|NCT01853813|Bevacizumab|bevacizumab|mesh-list
44775081|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44775082|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775083|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44775084|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44775085|NCT01853813|Growth Substances|growth substances|mesh-ancestor
44775086|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775087|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44775088|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44775089|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
44775090|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775091|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775092|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775093|NCT01853956|Alprazolam|alprazolam|mesh-list
44775094|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775095|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775096|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775097|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44775098|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44775099|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44775100|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
44775101|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
44775102|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775103|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775104|NCT01854021|Anesthetics|anesthetics|mesh-list
44775105|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775106|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775107|NCT01854073|Scopolamine|scopolamine|mesh-list
44775108|NCT01854073|Bromides|bromides|mesh-list
44775109|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44775110|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
44775111|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44775112|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
44775113|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
44775114|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775115|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775116|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775117|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
44553034|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
44775118|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44775119|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
44775120|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775121|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775122|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44775123|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
44775124|NCT01854086|Diphosphonates|diphosphonates|mesh-list
44775125|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775126|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775127|NCT01854203|Gemcitabine|gemcitabine|mesh-list
44775128|NCT01854203|Cisplatin|cisplatin|mesh-list
44775129|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775130|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44775131|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
44775132|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775133|NCT01854203|Antiviral Agents|antiviral agents|mesh-ancestor
44775134|NCT01854203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775135|NCT01854203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775136|NCT01854203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775137|NCT01854203|Immunologic Factors|immunologic factors|mesh-ancestor
44775138|NCT01854203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775139|NCT01854216|Rotigotine|rotigotine|mesh-list
44775140|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
44775141|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
44775142|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775143|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775144|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775145|NCT01854411|Analgesics|analgesics|mesh-list
44775146|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
44775147|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775148|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775149|NCT01854424|Dimercaprol|dimercaprol|mesh-list
44775150|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
44775151|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
44775152|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775153|NCT01854463|Vitamin D|vitamin d|mesh-list
44775154|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
44775155|NCT01854463|Vitamins|vitamins|mesh-ancestor
44775156|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
44775157|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775158|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775159|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775160|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
44775161|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44775162|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44775163|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775164|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
44775165|NCT01854476|Coagulants|coagulants|mesh-ancestor
44775166|NCT01854489|Rifampin|rifampin|mesh-list
44775167|NCT01854489|Buprenorphine|buprenorphine|mesh-list
44775168|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44775169|NCT01854489|Narcotics|narcotics|mesh-ancestor
44775170|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775171|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775172|NCT01854489|Analgesics|analgesics|mesh-ancestor
44775173|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
44775174|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384853|NCT03430895|Durvalumab|durvalumab|mesh-list
44775175|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44775176|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44775177|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
44775178|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44775179|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775180|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
44775181|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44775182|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775183|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775184|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44775185|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44775186|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44775187|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44775188|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44775189|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44775190|NCT01854502|Fluorides|fluorides|mesh-list
44775191|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
44775192|NCT01854502|Protective Agents|protective agents|mesh-ancestor
44775193|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775194|NCT01854515|Dexamethasone|dexamethasone|mesh-list
44775195|NCT01854515|Budesonide|budesonide|mesh-list
44775196|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
44775197|NCT01854515|BB 1101|bb 1101|mesh-list
44775198|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775199|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
44775200|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
44775201|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775202|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775203|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775204|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
44775205|NCT01854515|Hormones|hormones|mesh-ancestor
44775206|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775207|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44775208|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775209|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775210|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775211|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775212|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44775213|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775214|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775215|NCT01854606|Everolimus|everolimus|mesh-list
44775216|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775217|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775218|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
44775219|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775220|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
44775221|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44775222|NCT01854723|Insulin|insulin|mesh-list
44775223|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44775224|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
44775225|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
44775226|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
44775227|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
44775228|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775229|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775230|NCT01854749|Cisplatin|cisplatin|mesh-list
44775231|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775232|NCT01854762|Ritonavir|ritonavir|mesh-list
44775233|NCT01854762|Lopinavir|lopinavir|mesh-list
44775234|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
44775235|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44775236|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44775237|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
44775238|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775239|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775240|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44775241|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44775242|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
44775243|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775244|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44384906|NCT03426995|Cantharidin|cantharidin|mesh-list
44775245|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44775246|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44775247|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44775248|NCT01854970|Esomeprazole|esomeprazole|mesh-list
44775249|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44775250|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775251|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44775252|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775253|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775254|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
44775255|NCT01855009|Vitamin D|vitamin d|mesh-list
44775256|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
44775257|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
44775258|NCT01855009|Calcium|calcium|mesh-list
44775259|NCT01855009|Vitamins|vitamins|mesh-ancestor
44775260|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
44775261|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775262|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775263|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775264|NCT01855009|Antacids|antacids|mesh-ancestor
44775265|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775266|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775267|NCT01855061|Midazolam|midazolam|mesh-list
44775268|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44775269|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775270|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775271|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775272|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44775273|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44775274|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44775275|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775276|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
44775277|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
44775278|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
44775279|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
44775280|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775281|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775282|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
44775283|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44775284|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
44775285|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44775286|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
44775287|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775288|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775289|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
44775290|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
44775291|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44775292|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
44775293|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44775294|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
44775295|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775296|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775297|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
44775298|NCT01855256|Oxybutynin|oxybutynin|mesh-list
44775299|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
44775300|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
44775301|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775302|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775303|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44775304|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44775305|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
44775306|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775307|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775308|NCT01855256|Urological Agents|urological agents|mesh-ancestor
44775309|NCT01855321|Vitamin D|vitamin d|mesh-list
44384968|NCT03421379|Hormones|hormones|mesh-ancestor
44775310|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
44775311|NCT01855321|Vitamins|vitamins|mesh-ancestor
44775312|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
44775313|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775314|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775315|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775316|NCT01855334|Spironolactone|spironolactone|mesh-list
44775317|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44775318|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
44775319|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775320|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553262|NCT01277510|Cinacalcet|cinacalcet|mesh-list
44775321|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44775322|NCT01855334|Diuretics|diuretics|mesh-ancestor
44775323|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
44775324|NCT01855386|Liver Extracts|liver extracts|mesh-list
44775325|NCT01855386|Hematinics|hematinics|mesh-ancestor
44775326|NCT01855490|Exenatide|exenatide|mesh-list
44775327|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775328|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775329|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44775330|NCT01855490|Incretins|incretins|mesh-ancestor
44775331|NCT01855490|Hormones|hormones|mesh-ancestor
44775332|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775333|NCT01855516|Heparin|heparin|mesh-list
44775334|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
44775335|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44775336|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44775337|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775338|NCT01855529|Ropivacaine|ropivacaine|mesh-list
44775339|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
44775340|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
44775341|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775342|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775343|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
44775344|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775345|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
44775346|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44775347|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44775348|NCT01855555|Propofol|propofol|mesh-list
44775349|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775350|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775351|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775352|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775353|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
44775354|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
44775355|NCT01855568|Methotrexate|methotrexate|mesh-list
44775356|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44775357|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
44775358|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44775359|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775360|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44775361|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
44775362|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775363|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775364|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44775365|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775366|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44775367|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775368|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
44775369|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44775370|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44775371|NCT01855581|Ketamine|ketamine|mesh-list
44775372|NCT01855581|Propofol|propofol|mesh-list
44775373|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775374|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775375|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775376|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775377|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
44775378|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
44775379|NCT01855581|Analgesics|analgesics|mesh-ancestor
44775380|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
44775381|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775382|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44775383|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44775384|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44775385|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775386|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775387|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
44775388|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
44775389|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44775390|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775391|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775392|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
44775393|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44775394|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775395|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775396|NCT01855711|Alosetron|alosetron|mesh-list
44775397|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775398|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44775399|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
44775401|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775402|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775403|NCT01855724|Gemcitabine|gemcitabine|mesh-list
44775404|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44775405|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
44775406|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775407|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775408|NCT01855724|Antiviral Agents|antiviral agents|mesh-ancestor
44775409|NCT01855724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775410|NCT01855724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775411|NCT01855724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775412|NCT01855724|Immunologic Factors|immunologic factors|mesh-ancestor
44775413|NCT01855724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775414|NCT01855737|Warfarin|warfarin|mesh-list
44775415|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
44775416|NCT01855763|Insulin|insulin|mesh-list
44775417|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44775418|NCT01855763|Metformin|metformin|mesh-list
44775419|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775420|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775421|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44775422|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
44775423|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775424|NCT01855971|Protective Agents|protective agents|mesh-ancestor
44775425|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775426|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44775427|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44775428|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775429|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44775430|NCT01855984|Tocotrienols|tocotrienols|mesh-list
44775431|NCT01855984|Vitamin E|vitamin e|mesh-list
44775432|NCT01855984|Tocopherols|tocopherols|mesh-list
44775433|NCT01855984|Tocovid|tocovid|mesh-list
44775434|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
44775435|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775436|NCT01855984|Protective Agents|protective agents|mesh-ancestor
44775437|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775438|NCT01855984|Vitamins|vitamins|mesh-ancestor
44775439|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
44775440|NCT01856023|Aldesleukin|aldesleukin|mesh-list
44775441|NCT01856023|Ipilimumab|ipilimumab|mesh-list
44775442|NCT01856023|Interleukin-2|interleukin-2|mesh-list
44775443|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44775444|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775445|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44775446|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775447|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775448|NCT01856023|Analgesics|analgesics|mesh-ancestor
44775449|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
44775450|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775451|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775452|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44775453|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44775454|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
44775455|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775456|NCT01856062|Dexamethasone|dexamethasone|mesh-list
44775457|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775458|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
44775459|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
44775460|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775461|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775462|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775463|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
44775464|NCT01856062|Hormones|hormones|mesh-ancestor
44775465|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553405|NCT01268046|Estradiol|estradiol|mesh-list
44553406|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44553407|NCT01268046|Estrogens|estrogens|mesh-list
44553408|NCT01268046|Hormones|hormones|mesh-ancestor
44553409|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553410|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553411|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44553412|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
44553413|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44553416|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44775466|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44775467|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775469|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775470|NCT01856127|Sertraline|sertraline|mesh-list
44775471|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44775472|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
44775473|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44775474|NCT01856127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44775475|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44775476|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623686|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
44775477|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775478|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775479|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
44775480|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775481|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44775482|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44775483|NCT01856166|Sufentanil|sufentanil|mesh-list
44775484|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
44775485|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44775486|NCT01856166|Narcotics|narcotics|mesh-ancestor
44775487|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775488|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775489|NCT01856166|Analgesics|analgesics|mesh-ancestor
44775490|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
44775491|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775492|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44775493|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775494|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
44775495|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
44775496|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
44775497|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
44775498|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44775499|NCT01856205|Antibodies|antibodies|mesh-list
44775500|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
44775501|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44775502|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
44775503|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775504|NCT01856348|Vitamin D|vitamin d|mesh-list
44775505|NCT01856348|Vitamins|vitamins|mesh-ancestor
44775506|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
44775507|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775508|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775509|NCT01856374|Sirolimus|sirolimus|mesh-list
44775510|NCT01856374|Everolimus|everolimus|mesh-list
44775511|NCT01856374|Atorvastatin|atorvastatin|mesh-list
44775512|NCT01856374|Pravastatin|pravastatin|mesh-list
44691387|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44691388|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691389|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
44691390|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44691391|NCT01360658|Antibodies|antibodies|mesh-list
44691392|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
44691393|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44691394|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
44691395|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691396|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
44691397|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691398|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44691399|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44691400|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691401|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691402|NCT01360671|Urological Agents|urological agents|mesh-ancestor
44691403|NCT01360710|Irbesartan|irbesartan|mesh-list
44691404|NCT01360710|Moxonidine|moxonidine|mesh-list
44691405|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691406|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44691407|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44691408|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691409|NCT01360749|Lidocaine|lidocaine|mesh-list
44691410|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
44691411|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
44691412|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691413|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775513|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44775514|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44775515|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
44775516|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775517|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44775518|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44775519|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775520|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775521|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775522|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
44775523|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775524|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44775525|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775526|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44775527|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
44775528|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
44775529|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
44775530|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775531|NCT01856517|Clonidine|clonidine|mesh-list
44775532|NCT01856517|Analgesics|analgesics|mesh-ancestor
44775533|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
44775534|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775535|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775536|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44775537|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
44775538|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
44775539|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44775540|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44775541|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44775542|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775543|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385229|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
44775544|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775545|NCT01856556|Glycine|glycine|mesh-list
44775546|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
44775547|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775548|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775549|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775550|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44775551|NCT01856621|Charcoal|charcoal|mesh-list
44775552|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775553|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
44775554|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775555|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775556|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775557|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775558|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
44775559|NCT01856621|Hormones|hormones|mesh-ancestor
44775560|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775561|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
44775562|NCT01856621|Antidotes|antidotes|mesh-ancestor
44775563|NCT01856621|Protective Agents|protective agents|mesh-ancestor
44775564|NCT01856738|Rivastigmine|rivastigmine|mesh-list
44775565|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44775566|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775567|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775568|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
44775569|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775570|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775571|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44775572|NCT01856738|Protective Agents|protective agents|mesh-ancestor
44553467|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
44553488|NCT01266590|Digoxin|digoxin|mesh-list
44775574|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44775575|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
44775576|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775577|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775578|NCT01856946|Vitamin D|vitamin d|mesh-list
44775579|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
44775580|NCT01856946|Vitamins|vitamins|mesh-ancestor
44775581|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
44775582|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775583|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775584|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775585|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
44775586|NCT01856959|Albuterol|albuterol|mesh-list
44775587|NCT01856959|Analgesics|analgesics|mesh-ancestor
44775588|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
44775589|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775590|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775591|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
44775592|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775593|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44775594|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
44775595|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44775596|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44775597|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775598|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775599|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
44775600|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44775601|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775602|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
44775603|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775604|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775605|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44775606|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44775607|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44775608|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775609|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775610|NCT01856985|Misoprostol|misoprostol|mesh-list
44775611|NCT01856985|Mifepristone|mifepristone|mesh-list
44775612|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44775613|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
44775614|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44775615|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775616|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44775617|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775618|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
44775619|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44775620|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44775621|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44775622|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44775623|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
44775624|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44775625|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44775626|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
44775627|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775628|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
44775629|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44775630|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44775631|NCT01856998|Propofol|propofol|mesh-list
44775632|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775633|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775634|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775635|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775636|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
44775637|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
44775638|NCT01857011|Iron|iron|mesh-list
44775639|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44775640|NCT01857011|Teferrol|teferrol|mesh-list
44775641|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
44775642|NCT01857011|Trace Elements|trace elements|mesh-ancestor
44775643|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
44775644|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775645|NCT01857011|Hematinics|hematinics|mesh-ancestor
44775646|NCT01857024|Sevelamer|sevelamer|mesh-list
44775647|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
44775648|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
44775649|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775650|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
44775651|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775652|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775653|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775654|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775655|NCT01857141|Analgesics|analgesics|mesh-ancestor
44775656|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
44775657|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775658|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44775659|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44775660|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44775661|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775662|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775663|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775664|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
44775665|NCT01857154|Vitamin D|vitamin d|mesh-list
44775666|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
44775667|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
44775668|NCT01857154|Calcium|calcium|mesh-list
44775669|NCT01857154|Vitamins|vitamins|mesh-ancestor
44775670|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
44775671|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775672|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775673|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775674|NCT01857154|Antacids|antacids|mesh-ancestor
44775675|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775676|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775677|NCT01857193|Everolimus|everolimus|mesh-list
44775678|NCT01857193|Exemestane|exemestane|mesh-list
44385386|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775679|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775680|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775681|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
44775682|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775683|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44775684|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44775685|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775686|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775687|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44775688|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44775689|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775690|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44775691|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44775692|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44775693|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775694|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
44775695|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775696|NCT01857349|Ethanol|ethanol|mesh-list
44775697|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
44775698|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44775699|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44775700|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775701|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775702|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775703|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
44775704|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44775705|NCT01857375|Insulin|insulin|mesh-list
44775706|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775707|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775708|NCT01857453|Etoposide|etoposide|mesh-list
44553620|NCT01265563|Antidotes|antidotes|mesh-ancestor
44553621|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44553622|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553623|NCT01265550|Baclofen|baclofen|mesh-list
44553624|NCT01265550|Desipramine|desipramine|mesh-list
44553625|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44553626|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553627|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44553628|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553629|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44553630|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
44553631|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
44553632|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553633|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553634|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44775709|NCT01857453|Carboplatin|carboplatin|mesh-list
44775710|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44775711|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775712|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44775713|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44775714|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775715|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775716|NCT01857479|Amphotericin B|amphotericin b|mesh-list
44775717|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44775718|NCT01857479|Budesonide|budesonide|mesh-list
44775719|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775720|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775721|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
44775722|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775723|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775724|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775725|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775726|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
44775727|NCT01857479|Hormones|hormones|mesh-ancestor
44775728|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775729|NCT01857479|Amebicides|amebicides|mesh-ancestor
44775730|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44775731|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44775732|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775733|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44775734|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
44775735|NCT01857544|Aflibercept|aflibercept|mesh-list
44775736|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44775737|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44775738|NCT01857544|Growth Substances|growth substances|mesh-ancestor
44775739|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775740|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
44775741|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775742|NCT01857596|Trazodone|trazodone|mesh-list
44775743|NCT01857596|Bupropion|bupropion|mesh-list
44775744|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44775745|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
44775746|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44775747|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44775748|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44775749|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385465|NCT03387046|Hormones|hormones|mesh-ancestor
44775750|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775751|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
44775752|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775753|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775754|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44775755|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44775756|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775757|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44775758|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44775759|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775760|NCT01857596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44775761|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
44775762|NCT01857609|Metformin|metformin|mesh-list
44775763|NCT01857609|Rabeprazole|rabeprazole|mesh-list
44775764|NCT01857609|Pantoprazole|pantoprazole|mesh-list
44775765|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775766|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775767|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44775768|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775769|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44775770|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775771|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775772|NCT01857726|Cisplatin|cisplatin|mesh-list
44775773|NCT01857726|Doxorubicin|doxorubicin|mesh-list
44775774|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775775|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44775776|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44775777|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44775778|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775779|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775780|NCT01857752|Temozolomide|temozolomide|mesh-list
44775781|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44775782|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
44775783|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775784|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775785|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44775786|NCT01857804|Amoxicillin|amoxicillin|mesh-list
44775787|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
44775788|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44775789|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44775790|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44775791|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
44775792|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
44775793|NCT01857817|Etodolac|etodolac|mesh-list
44775794|NCT01857817|Propranolol|propranolol|mesh-list
44775795|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44775796|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44775797|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775798|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775799|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775800|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775801|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44775802|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44775803|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44775804|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44775805|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775806|NCT01857817|Analgesics|analgesics|mesh-ancestor
44775807|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
44775808|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775809|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775810|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44775811|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44775812|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44775813|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775814|NCT01857843|Everolimus|everolimus|mesh-list
44775815|NCT01857843|Simvastatin|simvastatin|mesh-list
44775816|NCT01857843|Ezetimibe|ezetimibe|mesh-list
44775817|NCT01857843|Pravastatin|pravastatin|mesh-list
44775818|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775819|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775820|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
44775821|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775822|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44775823|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44775824|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
44775825|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775826|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44775827|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44775828|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775829|NCT01857856|Eplerenone|eplerenone|mesh-list
44385529|NCT03383692|Itraconazole|itraconazole|mesh-list
44775830|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44775831|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
44775832|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775833|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775834|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44775835|NCT01857856|Diuretics|diuretics|mesh-ancestor
44775836|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
44775837|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44775838|NCT01857895|Exenatide|exenatide|mesh-list
44775839|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44775840|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775841|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44775842|NCT01857895|Incretins|incretins|mesh-ancestor
44775843|NCT01857895|Hormones|hormones|mesh-ancestor
44775844|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775845|NCT01857921|Trimetazidine|trimetazidine|mesh-list
44775846|NCT01857921|Atorvastatin|atorvastatin|mesh-list
44775847|NCT01857921|Pravastatin|pravastatin|mesh-list
44775848|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44775849|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44775850|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
44775851|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775852|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44775853|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44775854|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775855|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
44775856|NCT01857999|Losartan|losartan|mesh-list
44775857|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44775858|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44775859|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44775860|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44775861|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775862|NCT01858025|Fluorouracil|fluorouracil|mesh-list
44775864|NCT01858025|Mitomycin|mitomycin|mesh-list
44775865|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
44775866|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775867|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44775868|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775869|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775870|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
44775871|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775872|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44775873|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
44775874|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44775875|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775876|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
44775877|NCT01858051|Vitamin D|vitamin d|mesh-list
44775878|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44775879|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775880|NCT01858051|Vitamins|vitamins|mesh-ancestor
44775881|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
44775882|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44775883|NCT01858077|Everolimus|everolimus|mesh-list
44775884|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775885|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44775886|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
44775887|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775888|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
44775889|NCT01858090|Promethazine|promethazine|mesh-list
44775890|NCT01858090|Diclofenac|diclofenac|mesh-list
44775891|NCT01858090|Atropine|atropine|mesh-list
44775892|NCT01858090|Ephedrine|ephedrine|mesh-list
44775893|NCT01858090|Fentanyl|fentanyl|mesh-list
44775894|NCT01858090|Sufentanil|sufentanil|mesh-list
44775895|NCT01858090|Meperidine|meperidine|mesh-list
44775896|NCT01858090|Metoclopramide|metoclopramide|mesh-list
44775897|NCT01858090|Propofol|propofol|mesh-list
44775898|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
44775899|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44775900|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775901|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775902|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44775903|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
44775904|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
44775905|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44775906|NCT01858090|Narcotics|narcotics|mesh-ancestor
44775907|NCT01858090|Analgesics|analgesics|mesh-ancestor
44775908|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
44775909|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775910|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44775911|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44775912|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775913|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775914|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44775915|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44775916|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775917|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775918|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44775919|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44775920|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
44775921|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44775922|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
44775923|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
44775924|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
44775925|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44775926|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44775927|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
44775928|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44775929|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44775930|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
44775931|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
44775932|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44775933|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44775934|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
44775935|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
44775936|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44553895|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44775937|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
44775938|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
44775939|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44775940|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44775941|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
44385651|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
44775942|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44775943|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
44775944|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44775945|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
44775946|NCT01858155|Melatonin|melatonin|mesh-list
44775947|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
44775948|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775949|NCT01858155|Protective Agents|protective agents|mesh-ancestor
44775950|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775951|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44775952|NCT01858168|Irinotecan|irinotecan|mesh-list
44775953|NCT01858168|Temozolomide|temozolomide|mesh-list
44775954|NCT01858168|Olaparib|olaparib|mesh-list
44775955|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44775956|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44775957|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775958|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775959|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775960|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44775961|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
44775962|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44775963|NCT01858207|Doxorubicin|doxorubicin|mesh-list
44775964|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44775965|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775966|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44775967|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44775968|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775969|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775970|NCT01858311|Tocotrienols|tocotrienols|mesh-list
44775971|NCT01858311|Vitamin E|vitamin e|mesh-list
44775972|NCT01858311|Tocopherols|tocopherols|mesh-list
44775973|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
44775974|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775975|NCT01858311|Protective Agents|protective agents|mesh-ancestor
44775976|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775977|NCT01858311|Vitamins|vitamins|mesh-ancestor
44775978|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
44775979|NCT01858402|Acetaminophen|acetaminophen|mesh-list
44775980|NCT01858402|Dipyrone|dipyrone|mesh-list
44775981|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44775982|NCT01858402|Analgesics|analgesics|mesh-ancestor
44775983|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
44775984|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44775985|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775986|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
44775987|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44775988|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44775989|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553896|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44553897|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44553898|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
44553899|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553900|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553901|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553902|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
44553903|NCT01263028|Vitamin D|vitamin d|mesh-list
44553904|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553905|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553906|NCT01263028|Vitamins|vitamins|mesh-ancestor
44553907|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
44553908|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44553909|NCT01263015|Lamivudine|lamivudine|mesh-list
44553910|NCT01263015|Abacavir|abacavir|mesh-list
44553911|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
43609814|NCT03185793|Benzbromarone|benzbromarone|mesh-list
43609815|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
43609816|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
43609817|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609818|NCT03185793|Renal Agents|renal agents|mesh-ancestor
43609819|NCT03185351|Midazolam|midazolam|mesh-list
43609820|NCT03185351|Bupivacaine|bupivacaine|mesh-list
44775990|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
44775991|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44775992|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44775993|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44775994|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44775995|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
44775996|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44775997|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44775998|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44776000|NCT01858571|Celecoxib|celecoxib|mesh-list
44776001|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
44776002|NCT01858571|Etoposide|etoposide|mesh-list
44776003|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776004|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
44385743|NCT03368664|Interferons|interferons|mesh-list
44776005|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776006|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776007|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44776008|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
44776009|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776010|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776011|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44776012|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44776013|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44776014|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776015|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776016|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776017|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776018|NCT01858571|Analgesics|analgesics|mesh-ancestor
44776019|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
44776020|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776021|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776022|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44776023|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44776024|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
44776025|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776026|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776027|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776028|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776029|NCT01858571|Growth Substances|growth substances|mesh-ancestor
44776030|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776031|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44776032|NCT01858610|Irbesartan|irbesartan|mesh-list
44776033|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776034|NCT01858610|Diuretics|diuretics|mesh-ancestor
44776035|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
44776036|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776037|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44776038|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385797|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44776039|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776040|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44776041|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44776042|NCT01858623|Losartan|losartan|mesh-list
44776043|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44776044|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44776045|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776046|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44776047|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44776048|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776049|NCT01858623|Diuretics|diuretics|mesh-ancestor
44776050|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
44776051|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776052|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44776053|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776054|NCT01858649|Bevacizumab|bevacizumab|mesh-list
44776055|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
44776056|NCT01858649|Irinotecan|irinotecan|mesh-list
44776057|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776058|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385798|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44385815|NCT03364686|Biotin|biotin|mesh-list
44776059|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776060|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776061|NCT01858649|Growth Substances|growth substances|mesh-ancestor
44776062|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776063|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776064|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44776065|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776066|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776067|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776068|NCT01858662|Leucovorin|leucovorin|mesh-list
44776069|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
44776070|NCT01858662|Irinotecan|irinotecan|mesh-list
44776071|NCT01858662|Cetuximab|cetuximab|mesh-list
44776072|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776073|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44776074|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776075|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776076|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776077|NCT01858662|Antidotes|antidotes|mesh-ancestor
44776078|NCT01858662|Protective Agents|protective agents|mesh-ancestor
44776079|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776080|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
44776081|NCT01858662|Vitamins|vitamins|mesh-ancestor
44776082|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
44776083|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776084|NCT01858792|Belimumab|belimumab|mesh-list
44776085|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776086|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
44776087|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776088|NCT01858831|Atovaquone|atovaquone|mesh-list
44776089|NCT01858831|Proguanil|proguanil|mesh-list
44776090|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44776091|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776092|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
44776093|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44776094|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44776095|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776096|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776097|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
44776098|NCT01858870|Lacosamide|lacosamide|mesh-list
44776099|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
44776100|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44776101|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44776102|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776103|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776104|NCT01858909|Melatonin|melatonin|mesh-list
44776105|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
44776106|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776107|NCT01858909|Protective Agents|protective agents|mesh-ancestor
44776108|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776109|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776110|NCT01858961|Interferons|interferons|mesh-list
44776111|NCT01858961|Ribavirin|ribavirin|mesh-list
44776112|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776113|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
44776114|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776115|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
43623687|NCT03994731|Methotrexate|methotrexate|mesh-list
44776116|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776117|NCT01859234|Bevacizumab|bevacizumab|mesh-list
44776118|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44776119|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776120|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776121|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776122|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776123|NCT01859234|Growth Substances|growth substances|mesh-ancestor
44691414|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
44243082|NCT00600054|Antibodies|antibodies|mesh-list
44691449|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691451|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44691452|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691453|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691454|NCT01361269|Clindamycin|clindamycin|mesh-list
44691455|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
44691456|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
44691457|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
44691458|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691459|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691460|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44691461|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691462|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691463|NCT01361373|Levodopa|levodopa|mesh-list
44691464|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44691465|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44691466|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
44691467|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691468|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691469|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691470|NCT01361399|Aspirin|aspirin|mesh-list
44776124|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691471|NCT01361399|Lidocaine|lidocaine|mesh-list
44776125|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776126|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44776127|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776128|NCT01859377|Ibuprofen|ibuprofen|mesh-list
44776129|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776130|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776131|NCT01859377|Analgesics|analgesics|mesh-ancestor
44776132|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
44776133|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776134|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776135|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776136|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776137|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44776138|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776139|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776140|NCT01859455|Atorvastatin|atorvastatin|mesh-list
44776141|NCT01859455|Simvastatin|simvastatin|mesh-list
44776142|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44776143|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44776144|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
44776145|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776146|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44776147|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44776148|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776149|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
44776150|NCT01859468|Calcium|calcium|mesh-list
44776151|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776152|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776153|NCT01859468|Antacids|antacids|mesh-ancestor
44776154|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776155|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776156|NCT01859481|Eletriptan|eletriptan|mesh-list
44776157|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44776158|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
44776159|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776160|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776161|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776162|NCT01859585|Ketorolac|ketorolac|mesh-list
44776163|NCT01859585|Parecoxib|parecoxib|mesh-list
44776164|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776165|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776166|NCT01859585|Analgesics|analgesics|mesh-ancestor
44776167|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
44776168|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776169|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385935|NCT03358472|Cisplatin|cisplatin|mesh-list
44776170|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776171|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776172|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44776173|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776174|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776175|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44776176|NCT01859624|Albuterol|albuterol|mesh-list
44776177|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44776178|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
44776179|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776180|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776181|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44776182|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776183|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
44776184|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44776185|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44776186|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44776187|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44776188|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385954|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776189|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776190|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776191|NCT01859728|Gemcitabine|gemcitabine|mesh-list
44776192|NCT01859728|Cisplatin|cisplatin|mesh-list
44776193|NCT01859728|Irinotecan|irinotecan|mesh-list
44776194|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776195|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44776196|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
44776197|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554107|NCT01259713|Amphotericin B|amphotericin b|mesh-list
44776198|NCT01859728|Antiviral Agents|antiviral agents|mesh-ancestor
44776199|NCT01859728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776200|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776201|NCT01859728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776202|NCT01859728|Immunologic Factors|immunologic factors|mesh-ancestor
44776203|NCT01859728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776204|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44776205|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776206|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
44776207|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44776208|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44776209|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
44776210|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776211|NCT01859858|Curcumin|curcumin|mesh-list
44776212|NCT01859858|Irinotecan|irinotecan|mesh-list
44776213|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44776214|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776215|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776216|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776217|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776218|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776219|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776220|NCT01859858|Analgesics|analgesics|mesh-ancestor
44776221|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
44776222|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776223|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776224|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776225|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776226|NCT01860014|Poractant alfa|poractant alfa|mesh-list
44776227|NCT01860014|Beractant|beractant|mesh-list
44776228|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44776229|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776230|NCT01860066|Fluticasone|fluticasone|mesh-list
44776231|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44776232|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44776233|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776234|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44776235|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
44776236|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776237|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776238|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44776239|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776240|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776241|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44776242|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44776243|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44776244|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44776245|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385977|NCT03355326|Glycerol|glycerol|mesh-list
44776246|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776247|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776248|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
44776249|NCT01860066|Hormones|hormones|mesh-ancestor
44776250|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776251|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
44776252|NCT01860105|Clopidogrel|clopidogrel|mesh-list
44776253|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44776254|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44554182|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44554183|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
44776255|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44776256|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44776257|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
44776258|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776259|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386029|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776260|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776261|NCT01860144|Bevacizumab|bevacizumab|mesh-list
44776262|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554184|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44554185|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554186|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44554187|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554188|NCT05536037|Metformin|metformin|mesh-list
44554189|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44554190|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776264|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776265|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776266|NCT01860144|Growth Substances|growth substances|mesh-ancestor
44776267|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776268|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776269|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
44776270|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44776271|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776272|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44776273|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
44776274|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776275|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776276|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776277|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776278|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44776279|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44776280|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776281|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776282|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44776283|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776284|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776285|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
44776286|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776287|NCT01860235|Anesthetics|anesthetics|mesh-list
44776288|NCT01860235|Benzocaine|benzocaine|mesh-list
44776289|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
44776290|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776291|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776292|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
44776293|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776294|NCT01860300|Amoxicillin|amoxicillin|mesh-list
44776295|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
44776296|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
44776297|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44776298|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776299|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776300|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44776301|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776302|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776303|NCT01860391|Fluorides|fluorides|mesh-list
44776304|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
44776305|NCT01860391|Protective Agents|protective agents|mesh-ancestor
44776306|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776307|NCT01860417|Mepivacaine|mepivacaine|mesh-list
44776308|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
44776309|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
44776310|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776311|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776312|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
44386089|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
44776313|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776314|NCT01860469|Vancomycin|vancomycin|mesh-list
44776315|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776316|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776317|NCT01860482|Rabeprazole|rabeprazole|mesh-list
44776318|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44776319|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776320|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44776321|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776322|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776323|NCT01860508|Carboplatin|carboplatin|mesh-list
44776324|NCT01860508|Pemetrexed|pemetrexed|mesh-list
44776325|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776326|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776327|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776328|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44776329|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44554249|NCT05340465|Iron|iron|mesh-list
44776330|NCT01860625|Donepezil|donepezil|mesh-list
44776331|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44776332|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776333|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776334|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
44776335|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776336|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776337|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
44776338|NCT01860638|Bevacizumab|bevacizumab|mesh-list
44776339|NCT01860638|Temozolomide|temozolomide|mesh-list
44776340|NCT01860638|Lomustine|lomustine|mesh-list
44776341|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776342|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776343|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776344|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776345|NCT01860638|Growth Substances|growth substances|mesh-ancestor
44776346|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776347|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776348|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44776349|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
44776350|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776351|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
44776352|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776353|NCT01860690|Methotrexate|methotrexate|mesh-list
44776354|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44776355|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
44691472|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
44691473|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
44386110|NCT03346057|Rocuronium|rocuronium|mesh-list
44691474|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691475|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691476|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
44691477|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691478|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44691479|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44691480|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44691481|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691482|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691483|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691484|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691485|NCT01361399|Analgesics|analgesics|mesh-ancestor
44691486|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691487|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386173|NCT03344172|Gemcitabine|gemcitabine|mesh-list
44691488|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44691489|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44691490|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44691491|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691492|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691493|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
44691494|NCT01361425|Methyldopa|methyldopa|mesh-list
44691495|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691496|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
44386176|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44691497|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
44691498|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691499|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691500|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44691501|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44691502|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44691503|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
44691504|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691505|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691506|NCT01361516|Anesthetics|anesthetics|mesh-list
44691507|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691508|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691509|NCT01361542|Etanercept|etanercept|mesh-list
44691510|NCT01361542|Infliximab|infliximab|mesh-list
44691511|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
44691512|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386177|NCT03344172|Avelumab|avelumab|mesh-list
44691513|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691514|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691515|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691516|NCT01361542|Analgesics|analgesics|mesh-ancestor
44691517|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
44691518|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691519|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776356|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44776357|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776358|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44776359|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
44776360|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776361|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776362|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776363|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776364|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44776365|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776366|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
44776367|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776368|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44776370|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
44776371|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776372|NCT01860716|Protective Agents|protective agents|mesh-ancestor
44776373|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776374|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776375|NCT01860729|Anacetrapib|anacetrapib|mesh-list
44776376|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44776377|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44776378|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
44776379|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776380|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44776381|NCT01860742|Interferons|interferons|mesh-list
44776382|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
44776383|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
44776384|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44776385|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386192|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
44776386|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
44776387|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776388|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
44776389|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776390|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44776391|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776392|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44776393|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44776394|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776395|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776396|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776397|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776398|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44776399|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44776400|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
44776401|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776402|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776403|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44776404|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44776405|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
44776406|NCT01860833|Ibuprofen|ibuprofen|mesh-list
44776407|NCT01860833|Celecoxib|celecoxib|mesh-list
44776408|NCT01860833|Diclofenac|diclofenac|mesh-list
44776409|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776410|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776411|NCT01860833|Analgesics|analgesics|mesh-ancestor
44776412|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
44776413|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776414|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776415|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776416|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776417|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44776418|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776419|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776420|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44776421|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44776422|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776423|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776424|NCT01861015|Vasopressins|vasopressins|mesh-list
44776425|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
44776426|NCT01861015|Epinephrine|epinephrine|mesh-list
44776427|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44776428|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44691520|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776429|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44776430|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776431|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776432|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776433|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44776434|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44776435|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
44776436|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776437|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44776438|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776439|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
44776440|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
44776441|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44776442|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
44776443|NCT01861015|Coagulants|coagulants|mesh-ancestor
44776444|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44776445|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
44776446|NCT01861041|Bupivacaine|bupivacaine|mesh-list
44776447|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
44776448|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
44386267|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
44776449|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776450|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776451|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
44776452|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776453|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
44776454|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776455|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776456|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44776457|NCT01861223|Afatinib|afatinib|mesh-list
44776458|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
44776459|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776460|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44776461|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776462|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776463|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776464|NCT01861340|Dexamethasone|dexamethasone|mesh-list
44776465|NCT01861340|Lenalidomide|lenalidomide|mesh-list
44776466|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776467|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
44776468|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
44776469|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776470|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776471|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776472|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
44776473|NCT01861340|Hormones|hormones|mesh-ancestor
44776474|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776475|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44776476|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776477|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
44776478|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776479|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776480|NCT01861340|Growth Substances|growth substances|mesh-ancestor
44776481|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776482|NCT01861535|Imiquimod|imiquimod|mesh-list
44776483|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44776484|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
44776485|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776486|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776487|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
44776488|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
44776489|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776490|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
44776491|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776492|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776493|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44776494|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
44776495|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776496|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776497|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44776498|NCT01861626|Isotretinoin|isotretinoin|mesh-list
44776499|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776500|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
44776501|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
44776502|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776503|NCT01861951|Doxorubicin|doxorubicin|mesh-list
44554431|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
44776504|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44776505|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386312|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44776506|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44776507|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776508|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776509|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776510|NCT01861990|Valproic Acid|valproic acid|mesh-list
44776511|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
44776512|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776513|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776514|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
44776515|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776516|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776517|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
44776518|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776519|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776520|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776521|NCT01862003|Leucovorin|leucovorin|mesh-list
44776522|NCT01862003|Folic Acid|folic acid|mesh-list
44776523|NCT01862003|Fluorouracil|fluorouracil|mesh-list
44776524|NCT01862003|Irinotecan|irinotecan|mesh-list
44776525|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
44776526|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
44776527|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776528|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44776529|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776530|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776531|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
44776532|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776533|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44776534|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776535|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776536|NCT01862003|Antidotes|antidotes|mesh-ancestor
44776537|NCT01862003|Protective Agents|protective agents|mesh-ancestor
44776538|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
44776539|NCT01862003|Vitamins|vitamins|mesh-ancestor
44776540|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
44776541|NCT01862003|Hematinics|hematinics|mesh-ancestor
44776542|NCT01862081|Paclitaxel|paclitaxel|mesh-list
44776543|NCT01862081|Docetaxel|docetaxel|mesh-list
44776544|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44776545|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776546|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44386361|NCT03338569|Vitamins|vitamins|mesh-ancestor
44776547|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44776548|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44776549|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776550|NCT01862120|Interleukin-2|interleukin-2|mesh-list
44776551|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776552|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776553|NCT01862120|Analgesics|analgesics|mesh-ancestor
44776554|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
44776555|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776556|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776557|NCT01862263|Vildagliptin|vildagliptin|mesh-list
44776558|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44776559|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776560|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44776561|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
44776562|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776563|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776564|NCT01862302|Haloperidol|haloperidol|mesh-list
44776565|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
44776566|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
44776567|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
44776568|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776569|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776570|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776571|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44776572|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776573|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776574|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776575|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44776576|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
44776577|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776578|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776579|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44776580|NCT01862354|Anesthetics|anesthetics|mesh-list
44776581|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776582|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554579|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44554580|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554582|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44554583|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44554584|NCT04673578|Analgesics|analgesics|mesh-ancestor
44554585|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
44554594|NCT04654052|Clopidogrel|clopidogrel|mesh-list
44776584|NCT01862497|Prazosin|prazosin|mesh-list
44776585|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44776586|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44776587|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
44776588|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776589|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776590|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776591|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776592|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
44776593|NCT01862497|Protective Agents|protective agents|mesh-ancestor
44776594|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44776595|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776596|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776597|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691521|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691522|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
44691523|NCT01361763|Dabigatran|dabigatran|mesh-list
44691524|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
44691525|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44691526|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
44691527|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691528|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691529|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
44691531|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
44691532|NCT01361789|Etoricoxib|etoricoxib|mesh-list
44691533|NCT01361789|Parecoxib|parecoxib|mesh-list
44691534|NCT01361789|Valdecoxib|valdecoxib|mesh-list
44691535|NCT01361789|BB 1101|bb 1101|mesh-list
44691536|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691537|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
44691538|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
44691539|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691540|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691541|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691542|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
44691543|NCT01361789|Hormones|hormones|mesh-ancestor
44691544|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691545|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44691546|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691547|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
44691548|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691549|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691550|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691551|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691552|NCT01361789|Analgesics|analgesics|mesh-ancestor
44691553|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
44691554|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691555|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44691556|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691557|NCT01361841|Bimatoprost|bimatoprost|mesh-list
44691558|NCT01361841|Travoprost|travoprost|mesh-list
44691559|NCT01361841|Latanoprost|latanoprost|mesh-list
44691560|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44691561|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44691562|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691563|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44691564|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
44691565|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44691566|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
44691567|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691568|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691569|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44691570|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691571|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44691572|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44691573|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44691574|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
44386470|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386476|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
44386507|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
44691575|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691576|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691577|NCT01361997|Ethanol|ethanol|mesh-list
44691578|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
44691579|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44691580|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691581|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554610|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776598|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44776599|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44776600|NCT01862523|Capsaicin|capsaicin|mesh-list
44776601|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
44776602|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776603|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
44776604|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776605|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776606|NCT01862835|Anastrozole|anastrozole|mesh-list
44776607|NCT01862835|Testosterone|testosterone|mesh-list
44776608|NCT01862835|Estrogens|estrogens|mesh-list
44776609|NCT01862835|Androgens|androgens|mesh-ancestor
44776610|NCT01862835|Hormones|hormones|mesh-ancestor
44776611|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776612|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776613|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44776614|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776615|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44776616|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44776617|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776618|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776619|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44776620|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
44776621|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
44776622|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776623|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776624|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44776625|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44776626|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776627|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776628|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776629|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
44776630|NCT01862926|Rituximab|rituximab|mesh-list
44776631|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776632|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
44776633|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776634|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776635|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44776636|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
44776637|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776638|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776639|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44776640|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44776641|NCT01862978|Heparin|heparin|mesh-list
44776642|NCT01862978|Nadroparin|nadroparin|mesh-list
44776643|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
44776644|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44776645|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44776646|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776647|NCT01863004|Bortezomib|bortezomib|mesh-list
44776648|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776649|NCT01863069|Interferons|interferons|mesh-list
44386526|NCT05682339|Analgesics|analgesics|mesh-ancestor
44776650|NCT01863069|Interferon-beta|interferon-beta|mesh-list
44776651|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
44776652|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776653|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
44776654|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776655|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
44776656|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776657|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44776658|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44776659|NCT01863147|Acarbose|acarbose|mesh-list
44776660|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44776661|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776662|NCT01863147|Incretins|incretins|mesh-ancestor
44776663|NCT01863147|Hormones|hormones|mesh-ancestor
44776664|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776665|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44776666|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44776667|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776668|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776669|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44776670|NCT01863173|Metoprolol|metoprolol|mesh-list
44776671|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44776672|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776673|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
44776674|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
44776675|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776676|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776677|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44776678|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44776679|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44776680|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44776681|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776682|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776683|NCT01863199|Ranibizumab|ranibizumab|mesh-list
44776684|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44776685|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44776686|NCT01863199|Growth Substances|growth substances|mesh-ancestor
44776687|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776688|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44776689|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776690|NCT01863225|Atorvastatin|atorvastatin|mesh-list
44776691|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44776692|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44776693|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44776694|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
44776695|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776696|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44776697|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44776698|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776699|NCT01863238|Ivacaftor|ivacaftor|mesh-list
44776700|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44776701|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776702|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776703|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44776704|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44776705|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44776706|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776707|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776708|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44776709|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776710|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776711|NCT01863277|Melatonin|melatonin|mesh-list
44776712|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
44776713|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776714|NCT01863277|Protective Agents|protective agents|mesh-ancestor
44776715|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776716|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776717|NCT01863355|Fentanyl|fentanyl|mesh-list
44776718|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44776719|NCT01863355|Narcotics|narcotics|mesh-ancestor
44776720|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776721|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776722|NCT01863355|Analgesics|analgesics|mesh-ancestor
44776723|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
44776724|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776725|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44776726|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44776727|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
44776728|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
44776729|NCT01863407|Metronidazole|metronidazole|mesh-list
44776730|NCT01863407|Dexamethasone|dexamethasone|mesh-list
44776731|NCT01863407|Allantoin|allantoin|mesh-list
44776732|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776733|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
44776734|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
44776735|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776736|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776737|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776738|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
44776739|NCT01863407|Hormones|hormones|mesh-ancestor
44776740|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776741|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44776742|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776743|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776744|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776745|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44776746|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44776747|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776748|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44776749|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44776750|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776751|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44776752|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44776753|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776754|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776755|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
44776756|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776757|NCT01863485|Vorolanib|vorolanib|mesh-list
44776758|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44776759|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776760|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776761|NCT01863511|Tolvaptan|tolvaptan|mesh-list
44776762|NCT01863511|Diuretics|diuretics|mesh-list
44776763|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44776764|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
44776765|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776766|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44776767|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776768|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776769|NCT01863589|Adefovir|adefovir|mesh-list
44776770|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
44776771|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776772|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44776773|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44386687|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44776774|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776775|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776776|NCT01863602|Lamotrigine|lamotrigine|mesh-list
44776777|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
44776778|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44776779|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776780|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776781|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776782|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776783|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44776784|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776785|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776786|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776787|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44776788|NCT01863615|Isotretinoin|isotretinoin|mesh-list
44776789|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
44776790|NCT01863641|Calcitriol|calcitriol|mesh-list
44776791|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776792|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776793|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44776794|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776795|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776796|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44776797|NCT01863641|Vitamins|vitamins|mesh-ancestor
44776798|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
44386708|NCT05681403|Cytarabine|cytarabine|mesh-list
44776799|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44776800|NCT01863654|Montelukast|montelukast|mesh-list
44776801|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44776802|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
44776803|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44776804|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44776805|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44776806|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776807|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44776808|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44776809|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776810|NCT01863706|Misoprostol|misoprostol|mesh-list
44776811|NCT01863706|Oxytocin|oxytocin|mesh-list
44776812|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
44776813|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44776814|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776815|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44776816|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
44776817|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44554778|NCT04291664|Hormones|hormones|mesh-ancestor
44776818|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776820|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776821|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776822|NCT01863810|Pregabalin|pregabalin|mesh-list
44776823|NCT01863810|Analgesics|analgesics|mesh-ancestor
44776824|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
44776825|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776826|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776827|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
44776828|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44776829|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776830|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776831|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776832|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44776833|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776834|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776835|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776836|NCT01863823|Amoxicillin|amoxicillin|mesh-list
44776837|NCT01863823|Tetracycline|tetracycline|mesh-list
44776838|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44776839|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44776840|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44776841|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776842|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776843|NCT01863888|Teriflunomide|teriflunomide|mesh-list
44776844|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
44776845|NCT01863888|Charcoal|charcoal|mesh-list
44776846|NCT01863888|Antidotes|antidotes|mesh-ancestor
44776847|NCT01863888|Protective Agents|protective agents|mesh-ancestor
44776848|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776849|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44776850|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776851|NCT01863888|Analgesics|analgesics|mesh-ancestor
44776852|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
44776853|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776854|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44776855|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776856|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776857|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
44776858|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44776859|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44776860|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
44776861|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776862|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44776863|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44776864|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44776865|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44776866|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
44776867|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776868|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44776869|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44554855|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
44554856|NCT04043494|Hormones|hormones|mesh-ancestor
44554857|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554858|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554859|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44554860|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44554861|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554862|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554863|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44554864|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
44554865|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44554866|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554867|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
44554868|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44554869|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44554870|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44554871|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
44554872|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554873|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554874|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44554875|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44776870|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776871|NCT01864057|Thiamine|thiamine|mesh-list
44776872|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
44776873|NCT01864057|Vitamins|vitamins|mesh-ancestor
44776874|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
44776875|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776876|NCT01864070|Everolimus|everolimus|mesh-list
44776877|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776878|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776879|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
44776880|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776881|NCT01864083|Fluorides|fluorides|mesh-list
44776882|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
44776883|NCT01864083|Protective Agents|protective agents|mesh-ancestor
44776884|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776885|NCT01864096|Metformin|metformin|mesh-list
44776886|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44776887|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776889|NCT01864161|Trace Elements|trace elements|mesh-ancestor
44776890|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
44776891|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776892|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
44776893|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44776894|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776895|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776896|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44776897|NCT01864187|Analgesics|analgesics|mesh-ancestor
44776898|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
44776899|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776900|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44776901|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44776902|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44776903|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44776904|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776905|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776906|NCT01864213|Tetracaine|tetracaine|mesh-list
44776907|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
44776908|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
44386845|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386846|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
44386847|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
44386848|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386849|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
44386850|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44386851|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44386852|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44386853|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44386868|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
44386869|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
44386870|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386871|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386872|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776909|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776910|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691582|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691583|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
44691584|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44691585|NCT01362010|Minocycline|minocycline|mesh-list
44691586|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691587|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44691588|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691589|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691590|NCT01362153|Golimumab|golimumab|mesh-list
44691591|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44691592|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44691593|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691594|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691595|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
44691596|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691597|NCT01362218|Aspirin|aspirin|mesh-list
44691598|NCT01362218|Ramipril|ramipril|mesh-list
44691599|NCT01362218|Simvastatin|simvastatin|mesh-list
44691600|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44691601|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44691602|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
44691603|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691604|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44691605|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44691618|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691620|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44691621|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
44691622|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44691623|NCT01362309|Cycloserine|cycloserine|mesh-list
44691624|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44691625|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691626|NCT01362309|Renal Agents|renal agents|mesh-ancestor
44691627|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44691628|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
44691629|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691630|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
44691631|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691632|NCT01362361|Nintedanib|nintedanib|mesh-list
44691633|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691634|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44691635|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691636|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691637|NCT01362400|Docetaxel|docetaxel|mesh-list
44691638|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691639|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
44691640|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
44691641|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
44691642|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691643|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44691644|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44691645|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44691646|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776911|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
44776912|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776913|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
44776914|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
44776915|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
44776916|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44776917|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
44776918|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776919|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44776920|NCT01864551|Lamotrigine|lamotrigine|mesh-list
44386877|NCT05638620|Bupivacaine|bupivacaine|mesh-list
44776921|NCT01864551|Olanzapine|olanzapine|mesh-list
44776922|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
44776923|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
44776924|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44776925|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776926|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776927|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44776928|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44776929|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44776930|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44776931|NCT01864551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44776932|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44776933|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776934|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776935|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776936|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
44776937|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
44776938|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44776939|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776940|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44776941|NCT01864616|Vitamin D|vitamin d|mesh-list
44776942|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
44776943|NCT01864616|Vitamins|vitamins|mesh-ancestor
44386929|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
44386930|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386931|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386932|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386933|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386934|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44776944|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
44776945|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776946|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44776947|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776948|NCT01864655|Saracatinib|saracatinib|mesh-list
44776949|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776950|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776951|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776952|NCT01864681|Metformin|metformin|mesh-list
44776953|NCT01864681|Gefitinib|gefitinib|mesh-list
44776954|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44776955|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776956|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44776957|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44776958|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44776959|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776960|NCT01864798|Denosumab|denosumab|mesh-list
44776961|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44776962|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776963|NCT01864824|Vitamins|vitamins|mesh-list
44776964|NCT01864824|Folic Acid|folic acid|mesh-list
44776965|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
44776966|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
44776967|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
44776968|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
44776969|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776970|NCT01864824|Hematinics|hematinics|mesh-ancestor
44776971|NCT01864863|Bosentan|bosentan|mesh-list
44776972|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776973|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44386940|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
44776974|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776975|NCT01864915|Prucalopride|prucalopride|mesh-list
44776976|NCT01864915|Laxatives|laxatives|mesh-ancestor
44776977|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44776978|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44776979|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44776980|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
44776981|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44776982|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776983|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776984|NCT01865175|Iron|iron|mesh-list
44776985|NCT01865175|Trace Elements|trace elements|mesh-ancestor
44554990|NCT03556696|Remifentanil|remifentanil|mesh-list
44776986|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
44776987|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776988|NCT01865188|Amlodipine|amlodipine|mesh-list
44776989|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44776990|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44776991|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44776992|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44776993|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44776994|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44776995|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44776996|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
44776997|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44776998|NCT01865201|Mannitol|mannitol|mesh-list
44776999|NCT01865201|Edaravone|edaravone|mesh-list
44777000|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44777001|NCT01865201|Diuretics|diuretics|mesh-ancestor
44777002|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
44777003|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777004|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44777005|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
44777006|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777007|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44777008|NCT01865201|Protective Agents|protective agents|mesh-ancestor
44777009|NCT01865279|Insulin|insulin|mesh-list
44777010|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777011|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777012|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
44777013|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
44777014|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
44777015|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777016|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777017|NCT01865292|Insulin|insulin|mesh-list
44777018|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777019|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
44777020|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777021|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777022|NCT01865305|Insulin|insulin|mesh-list
44777023|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777024|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
44777025|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777026|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44777027|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
44777028|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44777029|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
44777030|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777031|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777032|NCT01865318|Insulin|insulin|mesh-list
44777033|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777034|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777035|NCT01865331|Insulin|insulin|mesh-list
44777036|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777037|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
44777038|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777039|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777040|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777041|NCT01865500|Prednisolone|prednisolone|mesh-list
44777042|NCT01865500|Budesonide|budesonide|mesh-list
44777043|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777044|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
44777045|NCT01865500|Hormones|hormones|mesh-ancestor
44777046|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44777047|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777048|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44777049|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777050|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
44777051|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777052|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44777053|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44777054|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44777055|NCT01865630|Etanercept|etanercept|mesh-list
44777056|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44777057|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44777058|NCT01865630|Analgesics|analgesics|mesh-ancestor
44777059|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
44777060|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777061|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555067|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
44777062|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777063|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777064|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777065|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777066|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
44777067|NCT01865669|Oxytocin|oxytocin|mesh-list
44777068|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
44777069|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777070|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777071|NCT01865721|Entonox|entonox|mesh-list
44777072|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44777073|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
44777074|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777075|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777076|NCT01865760|Octreotide|octreotide|mesh-list
44777077|NCT01865760|Somatostatin|somatostatin|mesh-list
44777078|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777079|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44777080|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777081|NCT01865760|Hormones|hormones|mesh-ancestor
44777082|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44777083|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555142|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44555143|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555144|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555145|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44555146|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44555147|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555148|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555149|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44555150|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
44555151|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
44555152|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555153|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555154|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
44555155|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777084|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
44777085|NCT01865916|Bisacodyl|bisacodyl|mesh-list
44777086|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
44777087|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777088|NCT01865916|Protective Agents|protective agents|mesh-ancestor
44777089|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777090|NCT01865916|Vitamins|vitamins|mesh-ancestor
44777091|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
44777092|NCT01865916|Cathartics|cathartics|mesh-ancestor
44777093|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777094|NCT01865916|Laxatives|laxatives|mesh-ancestor
44777095|NCT01865968|Vaccines|vaccines|mesh-list
44777096|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
44777097|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777098|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44777099|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
44777100|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777101|NCT01866059|Methamphetamine|methamphetamine|mesh-list
44777102|NCT01866059|Calcium|calcium|mesh-list
44777103|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44777104|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777105|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44777106|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
44777107|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
44777108|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777109|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
44777110|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777111|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777112|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44777113|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44777114|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44777115|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777116|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44777117|NCT01866241|Misoprostol|misoprostol|mesh-list
44777118|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44777119|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
44777120|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777121|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777122|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44777123|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777124|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
44777125|NCT01866254|Morphine|morphine|mesh-list
44777126|NCT01866254|Hydromorphone|hydromorphone|mesh-list
44387097|NCT05432141|Vaccines|vaccines|mesh-list
44777127|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44777128|NCT01866254|Narcotics|narcotics|mesh-ancestor
44777129|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777130|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777131|NCT01866254|Analgesics|analgesics|mesh-ancestor
44777132|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
44777133|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777134|NCT01866267|Maraviroc|maraviroc|mesh-list
44777135|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44777136|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44777137|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777138|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44777139|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44777140|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
44777141|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777142|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44777143|NCT01866397|Cidofovir|cidofovir|mesh-list
44777144|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
44777145|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777146|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777147|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777148|NCT01866488|Misoprostol|misoprostol|mesh-list
44777149|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44777150|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
44777151|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777152|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777153|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44777154|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777155|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
44777156|NCT01866514|Lidocaine|lidocaine|mesh-list
44777157|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
44777158|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
44777159|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777160|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777161|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
44777162|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777163|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44777164|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44777165|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44777166|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777167|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777168|NCT01866553|Interferons|interferons|mesh-list
44777169|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
44777170|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
44777171|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44777172|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777173|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
44777174|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777175|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
44777176|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777177|NCT01866605|Midazolam|midazolam|mesh-list
44387147|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777178|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44777179|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44777180|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777181|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777182|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44777183|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777184|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777185|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44777186|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
44777187|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
44777188|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
44777189|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
44777190|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777191|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777192|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
44777193|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44777194|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
44777195|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777196|NCT01866644|Expectorants|expectorants|mesh-ancestor
44777197|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
44777198|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44777199|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
44777200|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777201|NCT01866644|Protective Agents|protective agents|mesh-ancestor
44777202|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777203|NCT01866644|Antidotes|antidotes|mesh-ancestor
44777204|NCT01867138|Vancomycin|vancomycin|mesh-list
44777205|NCT01867138|Cefazolin|cefazolin|mesh-list
44777206|NCT01867138|Amikacin|amikacin|mesh-list
44777207|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44777208|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777209|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44777210|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44777211|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44777212|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777213|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777214|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777215|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777216|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44777217|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
44777218|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777219|NCT01867268|Acetazolamide|acetazolamide|mesh-list
44777220|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
44777221|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44777222|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777223|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777224|NCT01867268|Diuretics|diuretics|mesh-ancestor
44777225|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
44777226|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777227|NCT01867281|Aspirin|aspirin|mesh-list
44777228|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44777229|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44777230|NCT01867281|Analgesics|analgesics|mesh-ancestor
44777231|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
44777232|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777233|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777234|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777235|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777236|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44777237|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44777238|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777239|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777240|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44777241|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777242|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
44777243|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44777244|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44777245|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
44777246|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777247|NCT01867463|Antacids|antacids|mesh-ancestor
44777248|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777249|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555348|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
44777250|NCT01867502|Metformin|metformin|mesh-list
44777251|NCT01867502|Vildagliptin|vildagliptin|mesh-list
44777252|NCT01867502|Glyburide|glyburide|mesh-list
44777253|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777254|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777255|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44777256|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44777257|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777258|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777259|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
44777260|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44777261|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777262|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
44777263|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44777264|NCT01867645|Antibodies|antibodies|mesh-list
44777265|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
44777266|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44777267|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
44777268|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777269|NCT01867697|Leucovorin|leucovorin|mesh-list
44777270|NCT01867697|Folic Acid|folic acid|mesh-list
44777271|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
44777272|NCT01867697|Irinotecan|irinotecan|mesh-list
44777273|NCT01867697|Cetuximab|cetuximab|mesh-list
44777274|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
44777275|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
44777276|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777277|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777278|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44777279|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44777280|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777281|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777282|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44777283|NCT01867697|Antidotes|antidotes|mesh-ancestor
44777284|NCT01867697|Protective Agents|protective agents|mesh-ancestor
44777285|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
44777286|NCT01867697|Vitamins|vitamins|mesh-ancestor
44777287|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
44777288|NCT01867697|Hematinics|hematinics|mesh-ancestor
44777289|NCT01867697|Antacids|antacids|mesh-ancestor
44777290|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777291|NCT01867775|Mirtazapine|mirtazapine|mesh-list
44777292|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
44777293|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777294|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44777295|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
44777296|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
44777297|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777298|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777299|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777300|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44777301|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777302|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777303|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44777304|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44777305|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44777306|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44777307|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44777308|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44777309|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
44387293|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
44777310|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44777311|NCT01867866|Trifluridine|trifluridine|mesh-list
44777312|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
44777313|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777314|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
44777315|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777316|NCT01867892|Leucovorin|leucovorin|mesh-list
44777317|NCT01867892|Gemcitabine|gemcitabine|mesh-list
44777318|NCT01867892|Fluorouracil|fluorouracil|mesh-list
44777319|NCT01867892|Irinotecan|irinotecan|mesh-list
44777320|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
44777321|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44777322|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
44777323|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777324|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777325|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
44777326|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777327|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777328|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777329|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
44777330|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777331|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44777332|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44777333|NCT01867892|Antidotes|antidotes|mesh-ancestor
44777334|NCT01867892|Protective Agents|protective agents|mesh-ancestor
44777335|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
44777336|NCT01867892|Vitamins|vitamins|mesh-ancestor
44777337|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
44777338|NCT01868048|Nabiximols|nabiximols|mesh-list
44777339|NCT01868048|Analgesics|analgesics|mesh-ancestor
44777340|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
44777341|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777342|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777343|NCT01868113|Fluticasone|fluticasone|mesh-list
44777344|NCT01868113|Xhance|xhance|mesh-list
44777345|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777346|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44777347|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
44387312|NCT05126511|Hormones|hormones|mesh-ancestor
44777348|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777349|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777350|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44777351|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
44777352|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777353|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44777354|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44777355|NCT01868126|Latanoprost|latanoprost|mesh-list
44777356|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44777357|NCT01868191|Thiamine|thiamine|mesh-list
44777358|NCT01868191|Benphothiamine|benphothiamine|mesh-list
44777359|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44777360|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
44777361|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777362|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
44777363|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
44777364|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777365|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
44777366|NCT01868191|Vitamins|vitamins|mesh-ancestor
44777367|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
44777368|NCT01868360|Aflibercept|aflibercept|mesh-list
44777369|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44777370|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44777371|NCT01868360|Growth Substances|growth substances|mesh-ancestor
44777372|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777373|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
44777374|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777375|NCT01868438|Artesunate|artesunate|mesh-list
44777376|NCT01868438|Pyronaridine|pyronaridine|mesh-list
44387344|NCT05059522|Axitinib|axitinib|mesh-list
44777377|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
44777378|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44777379|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44777380|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777381|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777382|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
44777383|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
44777384|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44777385|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
44777386|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
44777387|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44777388|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
44777389|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777390|NCT01868529|Insulin|insulin|mesh-list
44777391|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777392|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
44777393|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777394|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777395|NCT01868555|Insulin|insulin|mesh-list
44777396|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777397|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
44777398|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777399|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44777400|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777401|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777402|NCT01868568|Insulin|insulin|mesh-list
44777403|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777404|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
44777405|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777406|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44777407|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
44777408|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44777409|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777410|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777412|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44777413|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
44777414|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
44777415|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777416|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777417|NCT01868750|Calcitriol|calcitriol|mesh-list
44777418|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44387371|NCT05050084|Tryptophan|tryptophan|mesh-list
44387412|NCT05048264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387413|NCT05048264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44387414|NCT05048264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387415|NCT05048264|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44387416|NCT05048264|Protective Agents|protective agents|mesh-ancestor
44387417|NCT05048264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387418|NCT05048264|Immunologic Factors|immunologic factors|mesh-ancestor
44387419|NCT05048264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387420|NCT05048264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387421|NCT05048264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44387422|NCT05048264|Respiratory System Agents|respiratory system agents|mesh-ancestor
44777419|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777420|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44777421|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777422|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691647|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691648|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691649|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44691650|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44691651|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
44691652|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691653|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691654|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44691655|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44691656|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
44691657|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
44691658|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691659|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44691660|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691661|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691662|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
44691663|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691664|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691665|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44691666|NCT01363037|Maraviroc|maraviroc|mesh-list
44387445|NCT05022654|Irinotecan|irinotecan|mesh-list
44387446|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44387447|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44387448|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387449|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387450|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387451|NCT05020769|Osimertinib|osimertinib|mesh-list
44691667|NCT01363037|Dapivirine|dapivirine|mesh-list
44691668|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44691669|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44691670|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691671|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44691672|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44691673|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
44691674|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691675|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44691676|NCT01363063|Ketorolac|ketorolac|mesh-list
44691677|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44691678|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691679|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691680|NCT01363063|Analgesics|analgesics|mesh-ancestor
44691681|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
44691682|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691683|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691684|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691685|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44691686|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691687|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691688|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691689|NCT01363089|Ketorolac|ketorolac|mesh-list
44691690|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44691691|NCT01363089|Phenylephrine|phenylephrine|mesh-list
44691692|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
44691693|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44691694|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44691695|NCT01363089|Analgesics|analgesics|mesh-ancestor
44691696|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
44691697|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691698|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691699|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691700|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387452|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387456|NCT05020457|Paclitaxel|paclitaxel|mesh-list
44387474|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
44387475|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387476|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387477|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44387478|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
44387479|NCT05018091|Hormones|hormones|mesh-ancestor
44387480|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387481|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44387482|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387483|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387484|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387485|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387486|NCT05013229|Insulin|insulin|mesh-list
44387487|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44387488|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
44387489|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
44387490|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44691701|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44691702|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691703|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777423|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44777424|NCT01868750|Vitamins|vitamins|mesh-ancestor
44777425|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
44777426|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44777427|NCT01868802|Ketamine|ketamine|mesh-list
44777428|NCT01868802|Analgesics|analgesics|mesh-ancestor
44777429|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
44777430|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777431|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777432|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44777433|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44777434|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
44777435|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
44777436|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777437|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44777438|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44777439|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777440|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777441|NCT01868880|Bisoprolol|bisoprolol|mesh-list
44777442|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44777443|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44777444|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
44777445|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777446|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777447|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777448|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44777449|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
44777450|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
44777451|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777452|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44387515|NCT04992260|Vaccines|vaccines|mesh-list
44387516|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
44387517|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387518|NCT04977479|Vaccines|vaccines|mesh-list
44387519|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
44387520|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387521|NCT04971785|Firsocostat|firsocostat|mesh-list
44777453|NCT01868906|Temozolomide|temozolomide|mesh-list
44777454|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44777455|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
44777456|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777457|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777458|NCT01868945|Vitamin D|vitamin d|mesh-list
44777459|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
44777460|NCT01868945|Calcifediol|calcifediol|mesh-list
44777461|NCT01868945|Vitamins|vitamins|mesh-ancestor
44777462|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
44777463|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777464|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44777465|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44777466|NCT01868984|Paclitaxel|paclitaxel|mesh-list
44777467|NCT01868984|Heparin|heparin|mesh-list
44777468|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44777469|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777470|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
44777471|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
44777472|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
44777473|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777474|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
44777475|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44777476|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44777477|NCT01869010|Tenofovir|tenofovir|mesh-list
44777478|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
44777479|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777480|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44777481|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44777482|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777483|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777484|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44777485|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44777486|NCT01869023|Gemcitabine|gemcitabine|mesh-list
44777487|NCT01869023|Cisplatin|cisplatin|mesh-list
44777488|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777489|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44777490|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
44777491|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777492|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
44387522|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777493|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777494|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777495|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777496|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
44777497|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777498|NCT01869036|Morphine|morphine|mesh-list
44777499|NCT01869036|Anesthetics|anesthetics|mesh-list
44777500|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777501|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777502|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44777503|NCT01869036|Narcotics|narcotics|mesh-ancestor
44777504|NCT01869036|Analgesics|analgesics|mesh-ancestor
44777505|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
44777506|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777507|NCT01869205|Ivermectin|ivermectin|mesh-list
44777508|NCT01869205|Abamectin|abamectin|mesh-list
44777509|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44777510|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777511|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
44777512|NCT01869257|Triclosan|triclosan|mesh-list
44777513|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44777514|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777515|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44777516|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44777517|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
44777518|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387557|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
44777519|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44777520|NCT01869309|Ticagrelor|ticagrelor|mesh-list
44777521|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44777522|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777523|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44777524|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44777525|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44777526|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
44777527|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777528|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777529|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777530|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
44777531|NCT01869491|Antacids|antacids|mesh-ancestor
44777532|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777533|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777534|NCT01869556|Oxytocin|oxytocin|mesh-list
44777535|NCT01869556|Carboprost|carboprost|mesh-list
44777536|NCT01869556|Ergonovine|ergonovine|mesh-list
44777537|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
44777538|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777539|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777540|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44777541|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
44777542|NCT01869569|Pregabalin|pregabalin|mesh-list
44777543|NCT01869569|Analgesics|analgesics|mesh-ancestor
44777544|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
44777545|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777546|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777547|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
44777548|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44777549|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777550|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777551|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44777552|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44777553|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777554|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777555|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777556|NCT01869621|Metformin|metformin|mesh-list
44777557|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777558|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777559|NCT01869673|Anesthetics|anesthetics|mesh-list
44777560|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777561|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777562|NCT01869751|Prucalopride|prucalopride|mesh-list
44777563|NCT01869751|Laxatives|laxatives|mesh-ancestor
44777564|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777565|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44777566|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44777567|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
44777568|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777569|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777570|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777571|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
44777572|NCT01869803|Calicheamicins|calicheamicins|mesh-list
44777573|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44777574|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777575|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44777576|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
44777577|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44777578|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44777579|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777580|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777581|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44777582|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
44777583|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777584|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777585|NCT01869907|Minocycline|minocycline|mesh-list
44777586|NCT01869907|Amitriptyline|amitriptyline|mesh-list
44777587|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44777588|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777589|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44777590|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
44777591|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777592|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44777593|NCT01869907|Analgesics|analgesics|mesh-ancestor
44777594|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
44777595|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777596|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777597|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44777598|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44777599|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777600|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777601|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
44777602|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777603|NCT01869946|Ropivacaine|ropivacaine|mesh-list
44777604|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
44777605|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
44777606|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777607|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777608|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
44777609|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777610|NCT01870011|Anesthetics|anesthetics|mesh-list
44777611|NCT01870011|Propofol|propofol|mesh-list
44777612|NCT01870011|Desflurane|desflurane|mesh-list
44777613|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777614|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777615|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44777616|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44777617|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
44777618|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44777619|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
44777620|NCT01870024|Lorazepam|lorazepam|mesh-list
44777621|NCT01870024|Clonazepam|clonazepam|mesh-list
44777622|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
44777623|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
44777624|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
44777625|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777626|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777627|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777628|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44777629|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777630|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44555818|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777631|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777632|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777633|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
44777634|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
44777635|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777636|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777637|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44777638|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777639|NCT01870050|Dapsone|dapsone|mesh-list
44777640|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777641|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
44777642|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44777643|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44777644|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44777645|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777646|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777647|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
44777648|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44777649|NCT01870115|Vitamin D|vitamin d|mesh-list
44777650|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
44777651|NCT01870115|Melatonin|melatonin|mesh-list
44777652|NCT01870115|Vitamins|vitamins|mesh-ancestor
44777653|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
44777654|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777655|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44555819|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44555820|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555821|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44555822|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44555823|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44555824|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44555825|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555826|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555827|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555828|NCT01255163|Exenatide|exenatide|mesh-list
44555829|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777656|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777657|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44777658|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
44777659|NCT01870115|Protective Agents|protective agents|mesh-ancestor
44777660|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777661|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
44777662|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
44777663|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
44777664|NCT01870128|Methotrexate|methotrexate|mesh-list
44777665|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44777666|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
44777667|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777668|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777669|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44777670|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
44777671|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777672|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777673|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777674|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777675|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44777676|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777677|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
44777678|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777679|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44777680|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777681|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
44777682|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
44777683|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777684|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777685|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
44777686|NCT01870128|Hormones|hormones|mesh-ancestor
44777687|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44777688|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44777689|NCT01870128|Protective Agents|protective agents|mesh-ancestor
44777690|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
44777691|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44777692|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44777693|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777694|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44777695|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44777696|NCT01870128|Analgesics|analgesics|mesh-ancestor
44777697|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
44777698|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44777699|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44777700|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777701|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44777702|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777703|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777704|NCT01870219|Ketamine|ketamine|mesh-list
44777705|NCT01870219|Anesthetics|anesthetics|mesh-list
44777706|NCT01870219|Sevoflurane|sevoflurane|mesh-list
44777707|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44777708|NCT01870219|Analgesics|analgesics|mesh-ancestor
44777709|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
44777710|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777711|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777712|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44777713|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
44777714|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777715|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44777716|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44777717|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777718|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777719|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777720|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44777721|NCT01870284|Adalimumab|adalimumab|mesh-list
44777722|NCT01870284|Ixekizumab|ixekizumab|mesh-list
44777723|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777724|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777725|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777726|NCT01870427|Aflibercept|aflibercept|mesh-list
44777727|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44777728|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44777729|NCT01870427|Growth Substances|growth substances|mesh-ancestor
44777730|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777731|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
44777732|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777733|NCT01870440|Dexamethasone|dexamethasone|mesh-list
44777734|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
44777735|NCT01870440|BB 1101|bb 1101|mesh-list
44777736|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777737|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
44777738|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
44777739|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777740|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777741|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777742|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
44777743|NCT01870440|Hormones|hormones|mesh-ancestor
44777744|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44777745|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44777746|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777747|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
44777748|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777749|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777750|NCT01870466|Cilostazol|cilostazol|mesh-list
44777751|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44777752|NCT01870466|Simvastatin|simvastatin|mesh-list
44777753|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44777754|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44777755|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
44777756|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777757|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44777758|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44777759|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777760|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44777761|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
44777762|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777763|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777764|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44777765|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44777766|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44777767|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44777768|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777769|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
44777770|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44777771|NCT01870466|Protective Agents|protective agents|mesh-ancestor
44777772|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44777773|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44777774|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44777775|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44777776|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44777777|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777778|NCT01870635|Ondansetron|ondansetron|mesh-list
44777779|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
44777780|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
44777781|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777782|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777783|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777784|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
44777785|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777786|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44777787|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
44777788|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777789|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777790|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44387818|NCT04384692|Melphalan|melphalan|mesh-list
44777791|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777792|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777793|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777794|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44777795|NCT01870648|Ondansetron|ondansetron|mesh-list
44777796|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
44777797|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
44777798|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777799|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777800|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777801|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
44777802|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777803|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44777804|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
44777805|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777806|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777807|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44777808|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777809|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777810|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777811|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44777812|NCT01870674|Prucalopride|prucalopride|mesh-list
44777813|NCT01870674|YH12852|yh12852|mesh-list
44777814|NCT01870674|Laxatives|laxatives|mesh-ancestor
44777815|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777816|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44777817|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44777818|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
44777819|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777820|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777821|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777822|NCT01870804|Atorvastatin|atorvastatin|mesh-list
44777823|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44777824|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44777825|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44777826|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
44777827|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777828|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44777829|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44777830|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777831|NCT01870895|Ramosetron|ramosetron|mesh-list
44777832|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
44777833|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
44777834|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777835|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777836|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44777837|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44777838|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
44777839|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777840|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777841|NCT01870908|Tacrolimus|tacrolimus|mesh-list
44777842|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777843|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
44777844|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777845|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44777846|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777847|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777848|NCT01870986|Adalimumab|adalimumab|mesh-list
44777849|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777850|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777851|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
44777852|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44777853|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777854|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777855|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44777856|NCT01871129|Analgesics|analgesics|mesh-ancestor
44777857|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
44777858|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777859|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44777860|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44777861|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44777862|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
44777863|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777864|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777865|NCT01871311|Cetuximab|cetuximab|mesh-list
44777866|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44777867|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777868|NCT01871363|Capecitabine|capecitabine|mesh-list
44777869|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777870|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44777871|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
44777872|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777873|NCT01871376|Aflibercept|aflibercept|mesh-list
44777874|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44777875|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44777876|NCT01871376|Growth Substances|growth substances|mesh-ancestor
44777877|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777878|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
44777879|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777880|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
44777881|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44777882|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777883|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777884|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44777885|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44777886|NCT01871454|Protective Agents|protective agents|mesh-ancestor
44777887|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777888|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
44777889|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44777890|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
44777891|NCT01871467|Sargramostim|sargramostim|mesh-list
44777892|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
44777893|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777894|NCT01871480|Gefitinib|gefitinib|mesh-list
44777895|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777896|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44777897|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777898|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777899|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
44777900|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44777901|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777902|NCT01871649|Golimumab|golimumab|mesh-list
44777903|NCT01871649|Methotrexate|methotrexate|mesh-list
44777904|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44777905|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
44777906|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777907|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777908|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44777909|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
44777910|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777911|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777912|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
44777913|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777914|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44777915|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44777916|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
44777917|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777918|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44777919|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44387984|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777920|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44777921|NCT01871662|Interferons|interferons|mesh-list
44777922|NCT01871662|Ribavirin|ribavirin|mesh-list
44777923|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
44777924|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
44777925|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44777926|NCT01871662|Silybin|silybin|mesh-list
44777927|NCT01871662|Silymarin|silymarin|mesh-list
44777928|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777929|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
44777930|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777931|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
44777932|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777933|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
44556168|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777934|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777935|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
44777936|NCT01871662|Protective Agents|protective agents|mesh-ancestor
44777937|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44777938|NCT01871675|Rituximab|rituximab|mesh-list
44777939|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44777940|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44777941|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777942|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
44777943|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777944|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44777945|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44777946|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
44777947|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777948|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
44777949|NCT01871701|Dexetimide|dexetimide|mesh-list
44777950|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44777951|NCT01871701|Citalopram|citalopram|mesh-list
44777952|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44777953|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44777954|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44777955|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44777956|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44777957|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777958|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777959|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44777960|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44777961|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
44777962|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44777963|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777964|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44777965|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44777966|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44777967|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44777968|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44777969|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44777970|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44777971|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
44777972|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44777973|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
44777974|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44777975|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44777976|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44777977|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
44777978|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
44777979|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44777980|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44556169|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556170|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44556171|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44556172|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44556173|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44556174|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556175|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556176|NCT01250873|Sertraline|sertraline|mesh-list
44556177|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
44556178|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44556179|NCT01250873|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44556180|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44556181|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556182|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556183|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556184|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
44777981|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44777982|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
44777983|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44777984|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44777985|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44777986|NCT01871740|Folic Acid|folic acid|mesh-list
44777987|NCT01871740|Enalapril|enalapril|mesh-list
44777988|NCT01871740|Enalaprilat|enalaprilat|mesh-list
44777989|NCT01871740|Maleic acid|maleic acid|mesh-list
44777990|NCT01871740|Hematinics|hematinics|mesh-ancestor
44777991|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
44777992|NCT01871740|Vitamins|vitamins|mesh-ancestor
44777993|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
44777994|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44777995|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44777996|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44777997|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44777998|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
44777999|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44778000|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
44778001|NCT01871792|Pitavastatin|pitavastatin|mesh-list
44778002|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44691704|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44691705|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44691706|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
44691707|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691708|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
44691709|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
44691710|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
44691711|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44691712|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691713|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44691714|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
44691715|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44691716|NCT01363089|Protective Agents|protective agents|mesh-ancestor
44691717|NCT01363115|Vitamin D|vitamin d|mesh-list
44691718|NCT01363115|Calcium|calcium|mesh-list
44691719|NCT01363115|Vitamins|vitamins|mesh-ancestor
44691720|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
44691721|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691722|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691723|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44691724|NCT01363167|Vitamin D|vitamin d|mesh-list
44691725|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
44691726|NCT01363167|Vitamins|vitamins|mesh-ancestor
44691727|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
44691728|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691729|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44691730|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691731|NCT01363193|Heparin|heparin|mesh-list
44691732|NCT01363193|Calcium heparin|calcium heparin|mesh-list
44691733|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
44691734|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44691735|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44691736|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691737|NCT01363206|Ipilimumab|ipilimumab|mesh-list
44691738|NCT01363206|Molgramostim|molgramostim|mesh-list
44691739|NCT01363206|Sargramostim|sargramostim|mesh-list
44691740|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691741|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691742|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44691743|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691744|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
44691745|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691746|NCT01363271|Vancomycin|vancomycin|mesh-list
44691747|NCT01363271|Linezolid|linezolid|mesh-list
44691748|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691749|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691750|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44691751|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691752|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691753|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44691754|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44556193|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778003|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44778004|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44778005|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
44778006|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778007|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778008|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44778009|NCT01871844|Octreotide|octreotide|mesh-list
44778010|NCT01871844|Somatostatin|somatostatin|mesh-list
44778011|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778012|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44778013|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778014|NCT01871844|Hormones|hormones|mesh-ancestor
44778015|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778016|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778017|NCT01871857|Epinephrine|epinephrine|mesh-list
44778018|NCT01871857|Racepinephrine|racepinephrine|mesh-list
44778019|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
44778020|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44778021|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44778022|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44778023|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778024|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778025|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778026|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44778027|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44778028|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
44778029|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778030|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44778031|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
44778032|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
44778033|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
44778034|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44778035|NCT01871922|Atropine|atropine|mesh-list
44778036|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44778037|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44778038|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44778039|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
44778040|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778041|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778042|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44778043|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
44778044|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
44778045|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
44778046|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44778047|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44778048|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
44778049|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778050|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778051|NCT01871935|Sufentanil|sufentanil|mesh-list
44778052|NCT01871935|Remifentanil|remifentanil|mesh-list
44778053|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778054|NCT01871935|Narcotics|narcotics|mesh-ancestor
44778055|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778056|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778057|NCT01871935|Analgesics|analgesics|mesh-ancestor
44778058|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
44778059|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778060|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44778061|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44778062|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
44778063|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
44778064|NCT01871961|Methotrexate|methotrexate|mesh-list
44778065|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44778066|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
44778067|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44778068|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778069|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778070|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
43623688|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44388209|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44388210|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388211|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388221|NCT03527537|Insulin|insulin|mesh-list
44388222|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388223|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388224|NCT03525379|Resveratrol|resveratrol|mesh-list
44388225|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
44388226|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778071|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778072|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778073|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778074|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778075|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44778076|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778077|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
44778078|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778079|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44778080|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44778081|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
44778082|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778083|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44778084|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44778085|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778086|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778087|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44778088|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
44778089|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778090|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44778091|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44778092|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778093|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778094|NCT01872013|ASP7991|asp7991|mesh-list
44778095|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44388231|NCT03523000|Fentanyl|fentanyl|mesh-list
44778096|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
44778097|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778098|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778099|NCT01872026|ASP7991|asp7991|mesh-list
44778100|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44778101|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44778102|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778103|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778104|NCT01872039|Nicardipine|nicardipine|mesh-list
44778105|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44778106|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44778107|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44778108|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778109|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44778110|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778111|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
44778112|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
44778113|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
44778114|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
44778115|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778116|NCT01872351|Protective Agents|protective agents|mesh-ancestor
44778117|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778118|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
44778119|NCT01872351|Vitamins|vitamins|mesh-ancestor
44778120|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
44388240|NCT03523000|Narcotics|narcotics|mesh-ancestor
44388261|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388262|NCT03504410|Analgesics|analgesics|mesh-ancestor
44388263|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
44388264|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388276|NCT03384914|Vaccines|vaccines|mesh-list
44388277|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
44388278|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388279|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
44388280|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388281|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156347|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156348|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44156349|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44156350|NCT00230568|Donepezil|donepezil|mesh-list
44156351|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44156352|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156353|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156354|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156355|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778121|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
44778122|NCT01872403|Paclitaxel|paclitaxel|mesh-list
44778123|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44778124|NCT01872403|Carboplatin|carboplatin|mesh-list
44778125|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44778126|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778127|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
44778128|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
44778129|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44778130|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778131|NCT01872416|Doxorubicin|doxorubicin|mesh-list
44778132|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44778133|NCT01872416|Ifosfamide|ifosfamide|mesh-list
44778134|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778135|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778136|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778137|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778138|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778139|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778140|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44778141|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
44778142|NCT01872442|Interferons|interferons|mesh-list
44778143|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
44778144|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
44778145|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44778146|NCT01872442|Dasatinib|dasatinib|mesh-list
44778147|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778148|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
44778149|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778150|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
44778151|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778152|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778153|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156356|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156357|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
44156358|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44156359|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
44156360|NCT00230594|Coagulants|coagulants|mesh-ancestor
44156361|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44156362|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
44156363|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156364|NCT00230698|Topiramate|topiramate|mesh-list
44156365|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
44156366|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156367|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156368|NCT00230763|Timolol|timolol|mesh-list
44156369|NCT00230763|Latanoprost|latanoprost|mesh-list
44156370|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44156371|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44156372|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
44156373|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156374|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778154|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778155|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
44778156|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44778157|NCT01872494|Pentazocine|pentazocine|mesh-list
44778158|NCT01872494|Palonosetron|palonosetron|mesh-list
44778159|NCT01872494|Ropivacaine|ropivacaine|mesh-list
44778160|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
44778161|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
44778162|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778163|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778164|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
44778165|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778166|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
44778167|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
44778168|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778169|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44778170|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44778171|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
44778172|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778173|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156375|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156376|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44156377|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44388318|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
44388319|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388320|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778174|NCT01872494|Analgesics|analgesics|mesh-ancestor
44778175|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778176|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778177|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778178|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778179|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778180|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778181|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778182|NCT01872494|Narcotics|narcotics|mesh-ancestor
44778183|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44778184|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44778186|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778187|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778188|NCT01872702|Piperaquine|piperaquine|mesh-list
44778189|NCT01872702|Primaquine|primaquine|mesh-list
44778190|NCT01872702|Artenimol|artenimol|mesh-list
44778191|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
44778192|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44778193|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44778194|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778195|NCT01872728|Anesthetics|anesthetics|mesh-list
44778196|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778197|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556367|NCT01239732|Carboplatin|carboplatin|mesh-list
44556368|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44778199|NCT01872754|Propofol|propofol|mesh-list
44778200|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44778201|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778202|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778203|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44778204|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
44778205|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
44778206|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778207|NCT01872754|Narcotics|narcotics|mesh-ancestor
44778208|NCT01872754|Analgesics|analgesics|mesh-ancestor
44778209|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
44778210|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778211|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
44778212|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778213|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778214|NCT01872832|Verinurad|verinurad|mesh-list
44778215|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
44778216|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778217|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44778218|NCT01872845|Pravastatin|pravastatin|mesh-list
44778219|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44778220|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44778221|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
44778222|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778223|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44778224|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44778225|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778226|NCT01872858|Aspirin|aspirin|mesh-list
44778227|NCT01872858|Cilostazol|cilostazol|mesh-list
44778228|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778229|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778230|NCT01872858|Analgesics|analgesics|mesh-ancestor
44778231|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
44778232|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778233|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778234|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778235|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778236|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44778237|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44778238|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778239|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44778240|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778241|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778242|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
44778243|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44778244|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
44778245|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44778246|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
44778247|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
44778248|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44778249|NCT01872858|Protective Agents|protective agents|mesh-ancestor
44778250|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44778251|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44778252|NCT01872871|Acetaminophen|acetaminophen|mesh-list
44778253|NCT01872871|Anesthetics|anesthetics|mesh-list
44778254|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
44778255|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778256|NCT01872871|Analgesics|analgesics|mesh-ancestor
44778257|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
44778258|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778259|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778260|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
44778261|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778262|NCT01872884|Remifentanil|remifentanil|mesh-list
44778263|NCT01872884|Sevoflurane|sevoflurane|mesh-list
44778264|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778265|NCT01872884|Narcotics|narcotics|mesh-ancestor
44778266|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778267|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778268|NCT01872884|Analgesics|analgesics|mesh-ancestor
44778269|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
44778270|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778271|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44778272|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44778273|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
44778274|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
44778275|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
44778276|NCT01872897|Antacids|antacids|mesh-ancestor
44778277|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778278|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778279|NCT01872923|Bleomycin|bleomycin|mesh-list
44778280|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778281|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778282|NCT01872936|Ribavirin|ribavirin|mesh-list
44778283|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
44778284|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778285|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
44778286|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778287|NCT01872962|Gemcitabine|gemcitabine|mesh-list
44778288|NCT01872962|Cisplatin|cisplatin|mesh-list
44778289|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778290|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778291|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
44778292|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778293|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
44556514|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556515|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556516|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44778294|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778295|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778296|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778297|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
44778298|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778299|NCT01872988|Tenofovir|tenofovir|mesh-list
44778300|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
44778301|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778302|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44778303|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44778304|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778305|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778306|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44778307|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44778308|NCT01873001|Pioglitazone|pioglitazone|mesh-list
44778309|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
44778310|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778311|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778312|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778313|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44778314|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388433|NCT02710331|Ethanol|ethanol|mesh-list
44778315|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778316|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
44778317|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778318|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44778319|NCT01873027|Sirolimus|sirolimus|mesh-list
44778320|NCT01873027|Umirolimus|umirolimus|mesh-list
44778321|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778322|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778323|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
44778324|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778325|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778326|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778327|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778328|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778329|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
44778330|NCT01873079|Esomeprazole|esomeprazole|mesh-list
44778331|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44778332|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778333|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44778334|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556517|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44556518|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44556519|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
44556520|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44556521|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44556522|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44556523|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44556524|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
44556526|NCT01237223|Amlodipine|amlodipine|mesh-list
44778335|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778336|NCT01873144|Epinephrine|epinephrine|mesh-list
44778337|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44778338|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44778339|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44778340|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
44778341|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778342|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778343|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778344|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44778345|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44778346|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
44778347|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778348|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44778349|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44778350|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
44778351|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
44778352|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44778353|NCT01873157|Bortezomib|bortezomib|mesh-list
44778354|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778355|NCT01873222|Sirolimus|sirolimus|mesh-list
44778356|NCT01873222|Umirolimus|umirolimus|mesh-list
44778357|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778358|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778359|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
44778360|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778361|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778362|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778363|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778364|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778365|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
44778366|NCT01873313|Ropivacaine|ropivacaine|mesh-list
44778367|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
44778368|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
44778369|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778370|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778371|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
44778372|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778373|NCT01873339|Midazolam|midazolam|mesh-list
44778374|NCT01873339|Darapladib|darapladib|mesh-list
44778375|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44778376|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44778377|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778378|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778379|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44778380|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44778381|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778382|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44778383|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
44778384|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
44778385|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
44778386|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
44778387|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778388|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778389|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44778390|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778391|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44778392|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
44778393|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44778394|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
44778395|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44778396|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778397|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44778398|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44778399|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778400|NCT01873430|Melatonin|melatonin|mesh-list
44778401|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
44778402|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778403|NCT01873430|Protective Agents|protective agents|mesh-ancestor
44778404|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778405|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778406|NCT01873443|Folic Acid|folic acid|mesh-list
44778407|NCT01873443|Rituximab|rituximab|mesh-list
44778408|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44778409|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778410|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
44778411|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778412|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778413|NCT01873443|Hematinics|hematinics|mesh-ancestor
44778414|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
44778415|NCT01873443|Vitamins|vitamins|mesh-ancestor
44778416|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
44778417|NCT01873573|Triamcinolone|triamcinolone|mesh-list
44778418|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778419|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
44778420|NCT01873573|Hormones|hormones|mesh-ancestor
44778421|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778422|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778423|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
44778424|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778425|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778426|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778427|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778428|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778429|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778430|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778431|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44778432|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44778433|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
44778434|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
44778435|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44778436|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44778437|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778438|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
44778439|NCT01873768|Coagulants|coagulants|mesh-ancestor
44778440|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
44778441|NCT01873807|Etoposide|etoposide|mesh-list
44778442|NCT01873807|Idarubicin|idarubicin|mesh-list
44778443|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778444|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
44778445|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778446|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778447|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44778448|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
44778449|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778450|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778451|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44778452|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44778453|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778454|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778455|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778456|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778457|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
44778458|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
44778459|NCT01873820|Calcium|calcium|mesh-list
44778460|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44778461|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778462|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
44778463|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778464|NCT01873820|Protective Agents|protective agents|mesh-ancestor
44778465|NCT01873820|Vitamins|vitamins|mesh-ancestor
44778466|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
44778467|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
44778468|NCT01873833|Capecitabine|capecitabine|mesh-list
44778469|NCT01873833|Trastuzumab|trastuzumab|mesh-list
44778470|NCT01873833|Lapatinib|lapatinib|mesh-list
44778471|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778472|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
44778473|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778474|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778475|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44778476|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
44778477|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778478|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778479|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44778480|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778481|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
44778482|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44778483|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778484|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778485|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
44556619|NCT01235728|Vitamins|vitamins|mesh-ancestor
44778487|NCT01874002|Sirolimus|sirolimus|mesh-list
44778488|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778489|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778490|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44778491|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778492|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
44778493|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778494|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
44778495|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778496|NCT01874028|Trientine|trientine|mesh-list
44778497|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
44778498|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
44778499|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778500|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
44778501|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778502|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
44778503|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
44778504|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778505|NCT01874080|Metformin|metformin|mesh-list
44778506|NCT01874080|Saxagliptin|saxagliptin|mesh-list
44778507|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778508|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778509|NCT01874080|Incretins|incretins|mesh-ancestor
44778510|NCT01874080|Hormones|hormones|mesh-ancestor
44778511|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778512|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44778513|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
44778514|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778515|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778516|NCT01874171|Cisplatin|cisplatin|mesh-list
44778517|NCT01874171|Cetuximab|cetuximab|mesh-list
44778518|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778519|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44778520|NCT01874236|Bupivacaine|bupivacaine|mesh-list
44778521|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
44778522|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
44778523|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623689|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
44778524|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778525|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
44778526|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778527|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
44778528|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778529|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778530|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778531|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778532|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778533|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778534|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778535|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
44778536|NCT01874470|Diuretics|diuretics|mesh-list
44778537|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
44778538|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556693|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44778539|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
44778540|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778541|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778542|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778543|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778544|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778545|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778546|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778547|NCT01874574|Triamcinolone|triamcinolone|mesh-list
44778548|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44778549|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44778550|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44778551|NCT01874574|Hylan|hylan|mesh-list
44778552|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778553|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
44778554|NCT01874574|Hormones|hormones|mesh-ancestor
44778555|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778556|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778557|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778558|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
44778559|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778560|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778561|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
44778562|NCT01874574|Protective Agents|protective agents|mesh-ancestor
44556764|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44556765|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44778563|NCT01874639|Hemostatics|hemostatics|mesh-list
44778564|NCT01874639|Coagulants|coagulants|mesh-ancestor
44778565|NCT01874678|Cisplatin|cisplatin|mesh-list
44778566|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778567|NCT01874717|Midazolam|midazolam|mesh-list
44778568|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44778569|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44778570|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778571|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778572|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44778573|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44778574|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778575|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44778576|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
44778577|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
44778578|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
44778579|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
44778580|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778581|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778582|NCT01874730|Anesthetics|anesthetics|mesh-list
44778583|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778584|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778585|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44778586|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44778587|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44778588|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
44778589|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778590|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44778591|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44778592|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778593|NCT01874847|Melatonin|melatonin|mesh-list
44778594|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
44778595|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778596|NCT01874847|Protective Agents|protective agents|mesh-ancestor
44778597|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388712|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44778598|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778599|NCT01874964|Methadone|methadone|mesh-list
44778600|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778601|NCT01874964|Narcotics|narcotics|mesh-ancestor
44778602|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778603|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778604|NCT01874964|Analgesics|analgesics|mesh-ancestor
44556766|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556767|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
44556768|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556769|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556770|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44556771|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778605|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
44778606|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778607|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
44778608|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
44778609|NCT01875107|Insulin|insulin|mesh-list
44778610|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778611|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778612|NCT01875172|Bupropion|bupropion|mesh-list
44778613|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44778614|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388754|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
44778615|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778616|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44778617|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44778618|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44778619|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778620|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
44778621|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778622|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778623|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44778624|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44778625|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778626|NCT01875185|Aspirin|aspirin|mesh-list
44778627|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778628|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778629|NCT01875185|Analgesics|analgesics|mesh-ancestor
44778630|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
44778631|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778632|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778633|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778634|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778635|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44778636|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44778637|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778638|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44778639|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778640|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778641|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
44778642|NCT01875224|Abatacept|abatacept|mesh-list
44691755|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691756|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691757|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691758|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691759|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691760|NCT01363284|Analgesics|analgesics|mesh-ancestor
44691761|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
44691762|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691763|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
44691764|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691765|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
44691766|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44691767|NCT01363310|Citalopram|citalopram|mesh-list
44691768|NCT01363310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44691769|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691770|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691771|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691772|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691773|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
44691774|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691775|NCT01363310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44691776|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
44691777|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691778|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44691779|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44691780|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691781|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
44691782|NCT01363323|Naltrexone|naltrexone|mesh-list
44691783|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
44691784|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691785|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691786|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44691787|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44691788|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691789|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691790|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778643|NCT01875224|Tacrolimus|tacrolimus|mesh-list
44778644|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778645|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
44778646|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778647|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44778648|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778649|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778650|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44778651|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778652|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778653|NCT01875263|Levofloxacin|levofloxacin|mesh-list
44778654|NCT01875263|Ofloxacin|ofloxacin|mesh-list
44778655|NCT01875263|Cloxacillin|cloxacillin|mesh-list
44778656|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44778657|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778658|NCT01875263|Renal Agents|renal agents|mesh-ancestor
44778659|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778660|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778661|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778662|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778663|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778664|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778665|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44778666|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44778667|NCT01875653|Molgramostim|molgramostim|mesh-list
44778668|NCT01875653|Sargramostim|sargramostim|mesh-list
44778669|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
44778670|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778671|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778672|NCT01875666|Trastuzumab|trastuzumab|mesh-list
44778673|NCT01875666|Pertuzumab|pertuzumab|mesh-list
44778674|NCT01875666|Lapatinib|lapatinib|mesh-list
44778675|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44778676|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778677|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778678|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778679|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778680|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
44778681|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778682|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778683|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778684|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778685|NCT01875757|Vitamin D|vitamin d|mesh-list
44778686|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
44778687|NCT01875757|Vitamins|vitamins|mesh-ancestor
44778688|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
44778689|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778690|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44778691|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44778692|NCT01875822|Curcumin|curcumin|mesh-list
44778693|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778694|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778695|NCT01875822|Analgesics|analgesics|mesh-ancestor
44778696|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
44778697|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778698|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778699|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778700|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778701|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778702|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778703|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778704|NCT01875926|Gontivimab|gontivimab|mesh-list
44778705|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
44778706|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778707|NCT01875952|Isoniazid|isoniazid|mesh-list
44778708|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
44778709|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778710|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778711|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44778712|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44778713|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
44778714|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388888|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
44778715|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44556834|NCT01232556|Gemcitabine|gemcitabine|mesh-list
44778716|NCT01876004|Methotrexate|methotrexate|mesh-list
44778717|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44778718|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
44778719|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44778720|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778721|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778722|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
44778723|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778724|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778725|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778726|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778727|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44778728|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778729|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
44778730|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778731|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44778732|NCT01876108|Amoxicillin|amoxicillin|mesh-list
44778733|NCT01876108|Azithromycin|azithromycin|mesh-list
44778734|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44778735|NCT01876108|Omeprazole|omeprazole|mesh-list
44778736|NCT01876108|Bismuth|bismuth|mesh-list
44778737|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778738|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778739|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44778740|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778741|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44778742|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778743|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778744|NCT01876108|Antacids|antacids|mesh-ancestor
44778745|NCT01876121|Celecoxib|celecoxib|mesh-list
44778746|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778747|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778748|NCT01876121|Analgesics|analgesics|mesh-ancestor
44778749|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
44778750|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778751|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778752|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778753|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778754|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44778755|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778756|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778757|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778758|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
44778759|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44778760|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44778761|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
44778762|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778763|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388907|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
44778764|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778765|NCT01876186|Urological Agents|urological agents|mesh-ancestor
44778766|NCT01876290|Dexamethasone|dexamethasone|mesh-list
44778767|NCT01876290|Ondansetron|ondansetron|mesh-list
44778768|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778769|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
44778770|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
44778771|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778772|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778773|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44778774|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
44778776|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778777|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44778778|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778779|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
44778780|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778781|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44778782|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
44778783|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778784|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778785|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44778786|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44778787|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778788|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44778789|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44778790|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
44778791|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778792|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778793|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44778794|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44778795|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778796|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778797|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778798|NCT01876355|Clonidine|clonidine|mesh-list
44778799|NCT01876355|Analgesics|analgesics|mesh-ancestor
44778800|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
44778801|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778802|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778803|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44778804|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
44778805|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
44778806|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44778807|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44778808|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44778809|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44778810|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778811|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778812|NCT01876433|Mirabegron|mirabegron|mesh-list
44778813|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44778814|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44778815|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44778816|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
44778817|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778818|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778819|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778820|NCT01876433|Urological Agents|urological agents|mesh-ancestor
44778821|NCT01876550|Mupirocin|mupirocin|mesh-list
44778822|NCT01876550|Calcium|calcium|mesh-list
44778823|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44778824|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778825|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44778826|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778827|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44778828|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778829|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778830|NCT01876563|Vitamin D|vitamin d|mesh-list
44778831|NCT01876563|Vitamins|vitamins|mesh-ancestor
44778832|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
44778833|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778834|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44778835|NCT01876615|Diclofenac|diclofenac|mesh-list
44778836|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778837|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778838|NCT01876615|Analgesics|analgesics|mesh-ancestor
44778839|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
44556982|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778840|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778841|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778842|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778843|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778844|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778845|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778846|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778847|NCT01876641|Decitabine|decitabine|mesh-list
44778848|NCT01876641|Vemurafenib|vemurafenib|mesh-list
44778849|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778850|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
44778851|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778852|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778853|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778854|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778855|NCT01876797|Ticagrelor|ticagrelor|mesh-list
44778856|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44778857|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44778858|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44778859|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44778860|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44778861|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
44778862|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778863|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778864|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778865|NCT01876849|Exenatide|exenatide|mesh-list
44778866|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778867|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778868|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44778869|NCT01876849|Incretins|incretins|mesh-ancestor
44778870|NCT01876849|Hormones|hormones|mesh-ancestor
44778871|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778872|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44778873|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
44778874|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778875|NCT01876966|Ritonavir|ritonavir|mesh-list
44778876|NCT01876966|Darunavir|darunavir|mesh-list
44389040|NCT03310970|Lidocaine|lidocaine|mesh-list
44778877|NCT01876966|Lumefantrine|lumefantrine|mesh-list
44778878|NCT01876966|Artemether|artemether|mesh-list
44778879|NCT01876966|Etravirine|etravirine|mesh-list
44778880|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44778881|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44778882|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44778883|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44778884|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778885|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778886|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44778887|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44778888|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
44778889|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44778890|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44778891|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44778892|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
44778893|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44778894|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44778895|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44778896|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44778897|NCT01877122|Ibuprofen|ibuprofen|mesh-list
44778898|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44778899|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44778900|NCT01877122|Analgesics|analgesics|mesh-ancestor
44778901|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
44778902|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778903|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778904|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778905|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778906|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44778907|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778908|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778909|NCT01877226|Tapentadol|tapentadol|mesh-list
44778910|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44778911|NCT01877226|Narcotics|narcotics|mesh-ancestor
44778912|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778913|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778914|NCT01877226|Analgesics|analgesics|mesh-ancestor
44778915|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
44778916|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778917|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44778918|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44778919|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44778920|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778921|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44778922|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44778923|NCT01877356|Anesthetics|anesthetics|mesh-list
44778924|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44778925|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778926|NCT01877512|Hormones|hormones|mesh-list
44778927|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778928|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778929|NCT01877577|Vitamin D|vitamin d|mesh-list
44778930|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
44778931|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
44778932|NCT01877577|Vitamins|vitamins|mesh-list
44778933|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
44389100|NCT03308825|Vaccines|vaccines|mesh-list
44778934|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778935|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44778936|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44778937|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
44778938|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
44778939|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778940|NCT01877590|Protective Agents|protective agents|mesh-ancestor
44778941|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778942|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
44778943|NCT01877590|Vitamins|vitamins|mesh-ancestor
44778944|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
44778945|NCT01877746|Prednisone|prednisone|mesh-list
44778946|NCT01877746|Azathioprine|azathioprine|mesh-list
44778947|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778948|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
44778949|NCT01877746|Hormones|hormones|mesh-ancestor
44778950|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44778951|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778952|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44778953|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44778954|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
44778955|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778956|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44778957|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44778958|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
44778959|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44778960|NCT01877811|Agerafenib|agerafenib|mesh-list
44778961|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44778962|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44778963|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778964|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
44778965|NCT01877889|Canagliflozin|canagliflozin|mesh-list
44778966|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44778967|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778968|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44778969|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778970|NCT01877954|Fluticasone|fluticasone|mesh-list
44778971|NCT01877954|Xhance|xhance|mesh-list
44778972|NCT01877954|Beclomethasone|beclomethasone|mesh-list
44778973|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44778974|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44778975|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
44778976|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44778977|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778978|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44778979|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557131|NCT01229111|Calcium|calcium|mesh-list
44557132|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
44557133|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44557134|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557135|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
44557136|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557137|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557138|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557144|NCT01229111|Vitamins|vitamins|mesh-ancestor
44778980|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44778981|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44778982|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
44778983|NCT01877954|Hormones|hormones|mesh-ancestor
44778984|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557176|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44778985|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44778986|NCT01878136|Plasminogen|plasminogen|mesh-list
44778987|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44778988|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44778989|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778990|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
44778991|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44778992|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
44778993|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44778994|NCT01878201|Valsartan|valsartan|mesh-list
44778995|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44778996|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44778997|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44778998|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44778999|NCT01878227|Fenofibrate|fenofibrate|mesh-list
44779000|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44779001|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
44779002|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779003|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44779004|NCT01878318|Methotrexate|methotrexate|mesh-list
44779005|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44779006|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
44779007|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44779008|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779009|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779010|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
44779011|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779012|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779013|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779014|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779015|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44779016|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779017|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
44779018|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779019|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44779020|NCT01878357|Piperaquine|piperaquine|mesh-list
44779021|NCT01878357|Primaquine|primaquine|mesh-list
44779022|NCT01878357|Artenimol|artenimol|mesh-list
44779023|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
44779024|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44779025|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44779026|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779027|NCT01878422|Leucovorin|leucovorin|mesh-list
44779028|NCT01878422|Bevacizumab|bevacizumab|mesh-list
44779029|NCT01878422|Cetuximab|cetuximab|mesh-list
44779030|NCT01878422|Fluorouracil|fluorouracil|mesh-list
44779031|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
44779032|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44779033|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779034|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44779035|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44779036|NCT01878422|Growth Substances|growth substances|mesh-ancestor
44779037|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779038|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
44779039|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
44779040|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779041|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779042|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779043|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
44779044|NCT01878422|Antidotes|antidotes|mesh-ancestor
44779045|NCT01878422|Protective Agents|protective agents|mesh-ancestor
44779046|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
44779047|NCT01878422|Vitamins|vitamins|mesh-ancestor
44779048|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
44779049|NCT01878513|Risperidone|risperidone|mesh-list
44779050|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44779051|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
44779052|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779053|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779054|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779055|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44779056|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44779057|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779058|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44779059|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44779060|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
44779061|NCT01878539|Anticoagulants|anticoagulants|mesh-list
44779062|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44779063|NCT01878578|Phenytoin|phenytoin|mesh-list
44779064|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
44779065|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44779066|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779067|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389244|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44779068|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779069|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44779070|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44779071|NCT01878643|Vancomycin|vancomycin|mesh-list
44779072|NCT01878643|Gentamicins|gentamicins|mesh-list
44779073|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44779074|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779075|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44779076|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779077|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779078|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
44779079|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44779080|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
44779081|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779082|NCT01878695|Expectorants|expectorants|mesh-ancestor
44779083|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
44779084|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44779085|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
44779086|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779087|NCT01878695|Protective Agents|protective agents|mesh-ancestor
44779088|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779089|NCT01878695|Antidotes|antidotes|mesh-ancestor
44779090|NCT01878708|Dexamethasone|dexamethasone|mesh-list
44779091|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
44779092|NCT01878708|Asparaginase|asparaginase|mesh-list
44779093|NCT01878708|Pegaspargase|pegaspargase|mesh-list
44779094|NCT01878708|BB 1101|bb 1101|mesh-list
44779095|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779096|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
44779097|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
44779098|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779099|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779100|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779101|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
44779102|NCT01878708|Hormones|hormones|mesh-ancestor
44389278|NCT03302234|Ipilimumab|ipilimumab|mesh-list
44779103|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779104|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779105|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779106|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44779107|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779108|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779109|NCT01878734|Micronutrients|micronutrients|mesh-list
44779110|NCT01878734|Trace Elements|trace elements|mesh-list
44779111|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779112|NCT01878864|Lidocaine|lidocaine|mesh-list
44779113|NCT01878864|Bupivacaine|bupivacaine|mesh-list
44779114|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
44779115|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
44779116|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779117|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779118|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
44779119|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779120|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779121|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44779122|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779123|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779124|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779125|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44779126|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
44779127|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779128|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44779129|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44779130|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
44779131|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779132|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779133|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44779134|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
44779135|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44557328|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
44779136|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779137|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44779138|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44779139|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389311|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44779140|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779141|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779142|NCT01879033|Insulin|insulin|mesh-list
44779143|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779144|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779145|NCT01879202|Methylphenidate|methylphenidate|mesh-list
44779146|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44779147|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779148|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44779149|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44779150|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779151|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779152|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
44779153|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779154|NCT01879293|Metformin|metformin|mesh-list
44779155|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779156|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779157|NCT01879358|Sirolimus|sirolimus|mesh-list
44779158|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44779159|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779160|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44779161|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779162|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
44779163|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779164|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
44779165|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779166|NCT01879423|Lamotrigine|lamotrigine|mesh-list
44779167|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
44779168|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44779169|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779170|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779171|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44779172|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779173|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44779174|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44779175|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389388|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779176|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44779177|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779178|NCT01879488|Edetic Acid|edetic acid|mesh-list
44779179|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
44779180|NCT01879488|Antidotes|antidotes|mesh-ancestor
44779181|NCT01879488|Protective Agents|protective agents|mesh-ancestor
44779182|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779183|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
44779184|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
44779185|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779186|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44779187|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
44779188|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44779189|NCT01879514|Prednisone|prednisone|mesh-list
44779190|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779191|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
44779192|NCT01879514|Hormones|hormones|mesh-ancestor
44779193|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779194|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779195|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779196|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779197|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44779198|NCT01879527|Amiloride|amiloride|mesh-list
44779199|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
44779200|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779201|NCT01879527|Diuretics|diuretics|mesh-ancestor
44779202|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
44779203|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779204|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44779205|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779206|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779207|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44779208|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779209|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44779210|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44779211|NCT01879605|Bisacodyl|bisacodyl|mesh-list
44779212|NCT01879605|Sorbitol|sorbitol|mesh-list
44779213|NCT01879605|Cathartics|cathartics|mesh-ancestor
44779214|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779215|NCT01879605|Laxatives|laxatives|mesh-ancestor
44779216|NCT01879748|Rasagiline|rasagiline|mesh-list
44779217|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44779218|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779219|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779220|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44779221|NCT01879748|Protective Agents|protective agents|mesh-ancestor
44779222|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779223|NCT01879917|Liraglutide|liraglutide|mesh-list
44779224|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779225|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779226|NCT01879917|Incretins|incretins|mesh-ancestor
44779227|NCT01879917|Hormones|hormones|mesh-ancestor
44779228|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779229|NCT01879930|Doxycycline|doxycycline|mesh-list
44779230|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44779231|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779232|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
44779233|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44779234|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44691791|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691792|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44691793|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
44691794|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691795|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44691796|NCT01363336|Nifedipine|nifedipine|mesh-list
44691797|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44691798|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691799|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691800|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691801|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691802|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691803|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
44691804|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44691805|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
44691806|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44691807|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691808|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
44691809|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44779235|NCT01880112|Cefazolin|cefazolin|mesh-list
44779236|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44779237|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779238|NCT01880125|Acetaminophen|acetaminophen|mesh-list
44557533|NCT01222520|Amlodipine|amlodipine|mesh-list
44557534|NCT01222520|Telmisartan|telmisartan|mesh-list
44779239|NCT01880125|Tramadol|tramadol|mesh-list
44779240|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44779241|NCT01880125|Analgesics|analgesics|mesh-ancestor
44389423|NCT03291288|Tolbutamide|tolbutamide|mesh-list
44779242|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
44779243|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779244|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779245|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
44779246|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779247|NCT01880125|Narcotics|narcotics|mesh-ancestor
44779248|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779249|NCT01880138|Anesthetics|anesthetics|mesh-list
44779250|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779251|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779252|NCT01880216|Enoxaparin|enoxaparin|mesh-list
44779253|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
44779254|NCT01880216|Bemiparin|bemiparin|mesh-list
44779255|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
44779256|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44779257|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44779258|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779259|NCT01880307|Prednisolone|prednisolone|mesh-list
44779260|NCT01880307|Azathioprine|azathioprine|mesh-list
44779261|NCT01880307|Infliximab|infliximab|mesh-list
44779262|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779263|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
44779264|NCT01880307|Hormones|hormones|mesh-ancestor
44779265|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779266|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779267|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779268|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779269|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779270|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779271|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779272|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
44779273|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779274|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779275|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779276|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
44779277|NCT01880346|Vitamin D|vitamin d|mesh-list
44779278|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
44779279|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
44779280|NCT01880346|Vitamins|vitamins|mesh-list
44779281|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
44779282|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779283|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44779284|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44779285|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
44779286|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
44779287|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779288|NCT01880372|Protective Agents|protective agents|mesh-ancestor
44779289|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779290|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
44779291|NCT01880372|Vitamins|vitamins|mesh-ancestor
44779292|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
44779293|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
44779294|NCT01880385|Bevacizumab|bevacizumab|mesh-list
44779295|NCT01880385|Docetaxel|docetaxel|mesh-list
44557535|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44557536|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44557537|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44557538|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557539|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557540|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44557541|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557542|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557543|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44557544|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44557545|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44557547|NCT01222403|Vaccines|vaccines|mesh-list
44779296|NCT01880385|Fluorouracil|fluorouracil|mesh-list
44779297|NCT01880385|Trastuzumab|trastuzumab|mesh-list
44779298|NCT01880385|Epirubicin|epirubicin|mesh-list
44779299|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779300|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
44779301|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779302|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779303|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44779304|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
44779305|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779306|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779307|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44779308|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44779309|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44779310|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44779311|NCT01880385|Growth Substances|growth substances|mesh-ancestor
44779312|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
44779313|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44779314|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44779315|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44779316|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
44779317|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779318|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44779319|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44779320|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44779321|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779322|NCT01880463|Vitamin D|vitamin d|mesh-list
44779323|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
44779324|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
44779325|NCT01880463|Vitamins|vitamins|mesh-list
44779326|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
44779327|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779328|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44779329|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44779330|NCT01880619|Tamsulosin|tamsulosin|mesh-list
44779331|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
44779332|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44779333|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44779334|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44779335|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779336|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779337|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779338|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779339|NCT01880619|Urological Agents|urological agents|mesh-ancestor
44779340|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44779341|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44779342|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
44779343|NCT01880658|Capecitabine|capecitabine|mesh-list
44779344|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779345|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
44779346|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779347|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779348|NCT01880749|Everolimus|everolimus|mesh-list
44779349|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779350|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779351|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
44779352|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779353|NCT01880775|Bupivacaine|bupivacaine|mesh-list
44779354|NCT01880775|Prilocaine|prilocaine|mesh-list
44779355|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
44779356|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
44779357|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779358|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779359|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
44779360|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779361|NCT01879241|Rasagiline|rasagiline|mesh-list
44779362|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44779363|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779364|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779365|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44779366|NCT01879241|Protective Agents|protective agents|mesh-ancestor
44779367|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779368|NCT01880931|Remifentanil|remifentanil|mesh-list
44779369|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779370|NCT01880931|Narcotics|narcotics|mesh-ancestor
44779371|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779372|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557555|NCT01222247|Hormones|hormones|mesh-ancestor
44779373|NCT01880931|Analgesics|analgesics|mesh-ancestor
44779374|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
44779375|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779376|NCT01881074|Listerine|listerine|mesh-list
44779377|NCT01881074|Triclosan|triclosan|mesh-list
44779378|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
44779379|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
44779380|NCT01881074|Protective Agents|protective agents|mesh-ancestor
44779381|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779382|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44779383|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779384|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44779385|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44779386|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
44779387|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779388|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44779389|NCT01881100|Listerine|listerine|mesh-list
44779390|NCT01881100|Fluorides|fluorides|mesh-list
44779391|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
44779392|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
44779393|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44779394|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
44779395|NCT01881100|Protective Agents|protective agents|mesh-ancestor
44779396|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779397|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44779398|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779399|NCT01881347|Resveratrol|resveratrol|mesh-list
44779400|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
44779401|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779402|NCT01881347|Protective Agents|protective agents|mesh-ancestor
44779403|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779404|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779405|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44779406|NCT01881464|Adalimumab|adalimumab|mesh-list
44779407|NCT01881464|Infliximab|infliximab|mesh-list
44779408|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779409|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779410|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779411|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779412|NCT01881503|HBOC 201|hboc 201|mesh-list
44779413|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
44779414|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
44779415|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44779416|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44779417|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779418|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
44779419|NCT01881568|Coagulants|coagulants|mesh-ancestor
44557627|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
44557628|NCT01220297|Carmustine|carmustine|mesh-list
44779421|NCT01881763|Methohexital|methohexital|mesh-list
44779422|NCT01881763|Analgesics|analgesics|mesh-ancestor
44779423|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
44779424|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779425|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389643|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
44779426|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44779427|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44779428|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
44779429|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
44779430|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779431|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44779432|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44779433|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779434|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779435|NCT01881919|Quercetin|quercetin|mesh-list
44779436|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
44779437|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779438|NCT01881919|Protective Agents|protective agents|mesh-ancestor
44779439|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779440|NCT01881971|Calcium|calcium|mesh-list
44779441|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44779442|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779443|NCT01881997|Fentanyl|fentanyl|mesh-list
44779444|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779445|NCT01881997|Narcotics|narcotics|mesh-ancestor
44389665|NCT03274466|Laxatives|laxatives|mesh-ancestor
44779446|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779447|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779448|NCT01881997|Analgesics|analgesics|mesh-ancestor
44779449|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
44779450|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779451|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44779452|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44779453|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
44779454|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
44779455|NCT01882010|Sargramostim|sargramostim|mesh-list
44779456|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
44779457|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779458|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44779459|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
44779460|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
44779461|NCT01882127|Dexamethasone|dexamethasone|mesh-list
44779462|NCT01882127|Tretinoin|tretinoin|mesh-list
44779463|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779464|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
44779465|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
44779466|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779467|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779468|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779469|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
44779470|NCT01882127|Hormones|hormones|mesh-ancestor
44779471|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779472|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779473|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779474|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
44779475|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779476|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
44779477|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44779478|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
44779479|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
44779480|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779481|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779482|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44779483|NCT01882179|Diuretics|diuretics|mesh-ancestor
44779484|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
44779485|NCT01882179|Hormones|hormones|mesh-ancestor
44779486|NCT01882296|Pantoprazole|pantoprazole|mesh-list
44779487|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44779488|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779489|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44779490|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779491|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779492|NCT01882322|Tacrolimus|tacrolimus|mesh-list
44779493|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779494|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
44557721|NCT01219959|Icodextrin|icodextrin|mesh-list
44779495|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779496|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44779497|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779498|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779499|NCT01882361|Naltrexone|naltrexone|mesh-list
44779500|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44779501|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44779502|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779503|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
44779504|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779505|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44779506|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779507|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
44779508|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44779509|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779510|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
44779511|NCT01882400|Alendronate|alendronate|mesh-list
44779512|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
44779513|NCT01882400|Diphosphonates|diphosphonates|mesh-list
44779514|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44779515|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779516|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44779517|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779518|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779519|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44779520|NCT01882530|Acetaminophen|acetaminophen|mesh-list
44779521|NCT01882530|Ketoprofen|ketoprofen|mesh-list
44779522|NCT01882530|Morphine|morphine|mesh-list
44779523|NCT01882530|Nefopam|nefopam|mesh-list
44779524|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779525|NCT01882530|Narcotics|narcotics|mesh-ancestor
44779526|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779527|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779528|NCT01882530|Analgesics|analgesics|mesh-ancestor
44779529|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
44779530|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779531|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44779532|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
44779533|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44779534|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779535|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779536|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44779537|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779538|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779539|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
44779540|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44779541|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44779542|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44779543|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779544|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779545|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44779546|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779547|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779548|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44779549|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389754|NCT03269552|Rituximab|rituximab|mesh-list
44779550|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44779551|NCT01883011|Piracetam|piracetam|mesh-list
44779552|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44779553|NCT01883011|Protective Agents|protective agents|mesh-ancestor
44779554|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779555|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
44779556|NCT01883024|Insulin|insulin|mesh-list
44779557|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779558|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779559|NCT01883102|Capsaicin|capsaicin|mesh-list
44779560|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
44779561|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779562|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
44779563|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779564|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779565|NCT01883167|Febuxostat|febuxostat|mesh-list
44779566|NCT01883167|Verinurad|verinurad|mesh-list
44779567|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
44779568|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779569|NCT01883193|Micronutrients|micronutrients|mesh-list
44779570|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779572|NCT01883232|Epinephrine|epinephrine|mesh-list
44779573|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
44779574|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
44779575|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779576|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779577|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
44779578|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779579|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779580|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44779581|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779582|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779583|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779584|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44779585|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44779586|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779587|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779588|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44779589|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44779590|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
44779591|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44779592|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
44779593|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
44779594|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
44779595|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44779596|NCT01883323|Aldesleukin|aldesleukin|mesh-list
44779597|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
44779598|NCT01883323|Fludarabine|fludarabine|mesh-list
44779599|NCT01883323|Interleukin-2|interleukin-2|mesh-list
44779600|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779601|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
44779602|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779603|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779604|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44779605|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
44779606|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779607|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779608|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44779609|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44779610|NCT01883323|Analgesics|analgesics|mesh-ancestor
44779611|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
44779612|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779613|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44779614|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44779615|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
44779616|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557853|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
44557854|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
44557855|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557856|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557857|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557858|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
44557859|NCT01217957|Hormones|hormones|mesh-ancestor
44557860|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557861|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779617|NCT01883505|Levodopa|levodopa|mesh-list
44779618|NCT01883505|Carbidopa|carbidopa|mesh-list
44389845|NCT03261336|Vitamin D|vitamin d|mesh-list
44779619|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44779620|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44779621|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
44779622|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779623|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779624|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779625|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44779626|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779627|NCT01883518|Vaccines|vaccines|mesh-list
44779628|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
44779629|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779630|NCT01883531|Mannitol|mannitol|mesh-list
44779631|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44779632|NCT01883531|Diuretics|diuretics|mesh-ancestor
44779633|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
44779634|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779635|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
44779636|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44779637|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779638|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
44779639|NCT01883869|Ticagrelor|ticagrelor|mesh-list
44779640|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44779641|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44779642|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44779643|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44779644|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
44779645|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779646|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779647|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779648|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
44779649|NCT01883882|Narcotics|narcotics|mesh-ancestor
44779650|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779651|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779652|NCT01883882|Analgesics|analgesics|mesh-ancestor
44779653|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
44389879|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
44779654|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779655|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
44779656|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44779657|NCT01883921|Antibodies|antibodies|mesh-list
44779658|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
44779659|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779660|NCT01884038|Treprostinil|treprostinil|mesh-list
44779661|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779662|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44779663|NCT01884116|Capsaicin|capsaicin|mesh-list
44779664|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
44779665|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779666|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
44779667|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779668|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779669|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44779670|NCT01884116|Analgesics|analgesics|mesh-ancestor
44779671|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779672|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779673|NCT01884272|Naproxen|naproxen|mesh-list
44779674|NCT01884272|Indomethacin|indomethacin|mesh-list
44779675|NCT01884272|Lesinurad|lesinurad|mesh-list
44779676|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44779677|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44779678|NCT01884272|Analgesics|analgesics|mesh-ancestor
44779679|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
44779680|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779681|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779682|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779683|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779684|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
44779685|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44779686|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779687|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779688|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
44779689|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44779690|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
44779691|NCT01884272|Renal Agents|renal agents|mesh-ancestor
44779692|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
44557910|NCT01217814|Vitamins|vitamins|mesh-ancestor
44779693|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779694|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44779695|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779696|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779697|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
44389905|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
44779698|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779699|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779700|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44779702|NCT01884298|Remifentanil|remifentanil|mesh-list
44779703|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
44779704|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
44779705|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779706|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779707|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
44779708|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779709|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779710|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44779711|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44779712|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44779713|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779714|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779715|NCT01884298|Narcotics|narcotics|mesh-ancestor
44779716|NCT01884298|Analgesics|analgesics|mesh-ancestor
44779717|NCT01884402|Ribavirin|ribavirin|mesh-list
44779718|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44779719|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
44779720|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779721|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
44779722|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779723|NCT01884415|Vaccines|vaccines|mesh-list
44779724|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
44779725|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389944|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779726|NCT01884428|Gemcitabine|gemcitabine|mesh-list
44779727|NCT01884428|Prednisolone|prednisolone|mesh-list
44779728|NCT01884428|Vinorelbine|vinorelbine|mesh-list
44779729|NCT01884428|Ifosfamide|ifosfamide|mesh-list
44779730|NCT01884428|Panobinostat|panobinostat|mesh-list
44779731|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779732|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
44779733|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779734|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779735|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
44779736|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779737|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779738|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779739|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
44779740|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779741|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779742|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
44779743|NCT01884428|Hormones|hormones|mesh-ancestor
44779744|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779745|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779746|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44779747|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44779748|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44779749|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44779750|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44779751|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
44779752|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44389973|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779753|NCT01884441|Gemcitabine|gemcitabine|mesh-list
44779754|NCT01884441|Vinorelbine|vinorelbine|mesh-list
44779755|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44779756|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779757|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
44779758|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779759|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779760|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
44779761|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779762|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779763|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779764|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
44779765|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779766|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44779767|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44779768|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44779769|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44779770|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44779771|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
44779772|NCT01884467|Gentamicins|gentamicins|mesh-list
44779773|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44779774|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779775|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44779776|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779777|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779778|NCT01884506|Iron|iron|mesh-list
44779779|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
44779780|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44779781|NCT01884506|Trace Elements|trace elements|mesh-ancestor
44779782|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
44779783|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779784|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
44779785|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779786|NCT01884506|Protective Agents|protective agents|mesh-ancestor
44779787|NCT01884506|Vitamins|vitamins|mesh-ancestor
44779788|NCT01884558|Metformin|metformin|mesh-list
44779789|NCT01884558|Isavuconazole|isavuconazole|mesh-list
44779790|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779791|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779792|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
44779793|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779794|NCT01884623|Methotrexate|methotrexate|mesh-list
44779795|NCT01884623|Cetuximab|cetuximab|mesh-list
44779796|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44779797|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
44779798|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44779799|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390002|NCT03257267|Cemiplimab|cemiplimab|mesh-list
44779800|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779801|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
44779802|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779803|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779804|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779805|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779806|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44779807|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779808|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
44779809|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779810|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44779811|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44779812|NCT01884636|Isavuconazole|isavuconazole|mesh-list
44779813|NCT01884636|Methotrexate|methotrexate|mesh-list
44779814|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44779815|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
44779816|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44779817|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779818|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44779819|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
44779820|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779821|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779822|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779823|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779824|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44779825|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390049|NCT03255824|Narcotics|narcotics|mesh-ancestor
44779826|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
44779827|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779828|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44779829|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
44779830|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779831|NCT01884857|Metoprolol|metoprolol|mesh-list
44779832|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779833|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779834|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
44779835|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
44779836|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779837|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779838|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44779839|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44779840|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44779841|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779842|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779843|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779845|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779846|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779847|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
44779848|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
44779849|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779850|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390072|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779851|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44779852|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44779853|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44779854|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779855|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779856|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779857|NCT01884909|Metoprolol|metoprolol|mesh-list
44779858|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44779859|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779860|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
44779861|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
44779862|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779863|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779864|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44779865|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44779866|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44779867|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779868|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779869|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779870|NCT01884935|Natalizumab|natalizumab|mesh-list
44779871|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
44779872|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779873|NCT01885013|Metformin|metformin|mesh-list
44779874|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
44779875|NCT01885013|Doxorubicin|doxorubicin|mesh-list
44779876|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44779877|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
44779878|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779879|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44779880|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44779881|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
44390103|NCT03253094|Fluconazole|fluconazole|mesh-list
44779882|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779883|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779884|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44779885|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44779886|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44779887|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44779888|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44779889|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779890|NCT01885091|Kinetin|kinetin|mesh-list
44691810|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
44691811|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691812|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
44691813|NCT01363414|Protective Agents|protective agents|mesh-ancestor
44691814|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44691815|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691817|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44691818|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691819|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44691820|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44691821|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44691822|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691823|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
44691824|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44691825|NCT01363557|Gefitinib|gefitinib|mesh-list
44691826|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691827|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44691828|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691829|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691830|NCT01363570|Ranibizumab|ranibizumab|mesh-list
44691831|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44691832|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44691833|NCT01363570|Growth Substances|growth substances|mesh-ancestor
44691834|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691835|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
44779891|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44779892|NCT01885091|Growth Substances|growth substances|mesh-ancestor
44779893|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558179|NCT01214421|Tolvaptan|tolvaptan|mesh-list
44779894|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
44779895|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44779896|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
44779897|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779898|NCT01885338|Expectorants|expectorants|mesh-ancestor
44558253|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779899|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
44779900|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44779901|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
44779902|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779903|NCT01885338|Protective Agents|protective agents|mesh-ancestor
44779904|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779905|NCT01885338|Antidotes|antidotes|mesh-ancestor
44779906|NCT01885364|Remifentanil|remifentanil|mesh-list
44779907|NCT01885364|Propofol|propofol|mesh-list
44779908|NCT01885364|Esmolol|esmolol|mesh-list
44779909|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44779910|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44779911|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779912|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44779913|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
44779914|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
44779915|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44779916|NCT01885364|Narcotics|narcotics|mesh-ancestor
44779917|NCT01885364|Analgesics|analgesics|mesh-ancestor
44779918|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
44779919|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779920|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44779921|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44779922|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44779923|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779924|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779925|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779926|NCT01885481|Dexamethasone|dexamethasone|mesh-list
44779927|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
44779928|NCT01885481|Betamethasone|betamethasone|mesh-list
44779929|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
44779930|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44779931|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
44779932|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44779933|NCT01885481|BB 1101|bb 1101|mesh-list
44779934|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44779935|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
44779936|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
44779937|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779938|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779939|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44779940|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
44779941|NCT01885481|Hormones|hormones|mesh-ancestor
44779942|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44779943|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44779944|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44779945|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44779946|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779947|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779948|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44779949|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44779950|NCT01885585|Apixaban|apixaban|mesh-list
44779951|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44779952|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
44779953|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44779954|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44779955|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779956|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779957|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
44779958|NCT01885598|Apixaban|apixaban|mesh-list
44558254|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558255|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44558256|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44558257|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44558258|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558259|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558260|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558261|NCT01212770|Thalidomide|thalidomide|mesh-list
44558262|NCT01212770|Apremilast|apremilast|mesh-list
44779959|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44779960|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
44779961|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44779962|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
44779963|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779964|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779965|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
44779966|NCT01885715|Neostigmine|neostigmine|mesh-list
44390221|NCT03245398|Mebendazole|mebendazole|mesh-list
44390222|NCT03245398|Piperazine|piperazine|mesh-list
44779967|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44779968|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44779969|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779970|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
44779971|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779972|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779973|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44779974|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
44779975|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44779976|NCT01885988|Nebivolol|nebivolol|mesh-list
44779977|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44779978|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
44779979|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44779980|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44779981|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44779982|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44779983|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44779984|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44779985|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44779986|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
44779987|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44779988|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
44779989|NCT01886001|Povidone|povidone|mesh-list
44779990|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44779991|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44779992|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
44779993|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779994|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
44779995|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
44779996|NCT01886014|Oxytocin|oxytocin|mesh-list
44779997|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
44779998|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390250|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
44390251|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
44779999|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780000|NCT01886053|Ertapenem|ertapenem|mesh-list
44780001|NCT01886053|beta-Lactams|beta-lactams|mesh-list
44780002|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780003|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780004|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
44780005|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44780006|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780007|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780008|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780009|NCT01886079|Analgesics|analgesics|mesh-ancestor
44780010|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
44780011|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780012|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44780013|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44780014|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44780015|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780016|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780017|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780018|NCT01886196|Ibuprofen|ibuprofen|mesh-list
44780019|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44780020|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44780021|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780022|NCT01886196|Analgesics|analgesics|mesh-ancestor
44780023|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
44780024|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780025|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780026|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780027|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44780028|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780029|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780030|NCT01886209|Prednisone|prednisone|mesh-list
44780031|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
44780032|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44780033|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44780034|NCT01886209|Prednisolone|prednisolone|mesh-list
44780035|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
44780036|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44780037|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
44780038|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44780039|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
44780040|NCT01886209|Hormones|hormones|mesh-ancestor
44780041|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780042|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780043|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44780044|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780045|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
44780046|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
44780047|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780048|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780049|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44780050|NCT01886209|Protective Agents|protective agents|mesh-ancestor
44780051|NCT01886248|Antithrombins|antithrombins|mesh-list
44780052|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
44780053|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44780054|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780055|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780056|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780057|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
44780058|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
44780059|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
44780060|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
44780061|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780062|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780063|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
44780064|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780065|NCT01886365|Insulin|insulin|mesh-list
44780066|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44780067|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780068|NCT01886404|Efavirenz|efavirenz|mesh-list
44780069|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44780070|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44780071|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780072|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780073|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
44780074|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780075|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44780076|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780077|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44780078|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44780079|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44780080|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44780081|NCT01886443|Tocopherols|tocopherols|mesh-list
44780082|NCT01886443|Vitamin E|vitamin e|mesh-list
44780083|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
44780084|NCT01886443|Infliximab|infliximab|mesh-list
44780085|NCT01886443|Epoprostenol|epoprostenol|mesh-list
44780086|NCT01886443|Tezosentan|tezosentan|mesh-list
44780087|NCT01886443|Melatonin|melatonin|mesh-list
44780088|NCT01886443|Antithrombins|antithrombins|mesh-list
44780089|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
44780090|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
44780091|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44780092|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
44780093|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780094|NCT01886443|Protective Agents|protective agents|mesh-ancestor
44780095|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780096|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780097|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44780098|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780099|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780100|NCT01886443|Hematinics|hematinics|mesh-ancestor
44780101|NCT01886443|Vitamins|vitamins|mesh-ancestor
44780102|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
44390330|NCT03239483|Dapivirine|dapivirine|mesh-list
44780103|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44780104|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780105|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780106|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
44780107|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780108|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44558341|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
44780109|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
44780110|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44780111|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780112|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
44780113|NCT01886534|Diuretics|diuretics|mesh-list
44780114|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
44780115|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780116|NCT01886560|Doxycycline|doxycycline|mesh-list
44780117|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780118|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780119|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
44780120|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44780121|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44780122|NCT01886573|Azacitidine|azacitidine|mesh-list
44780123|NCT01886573|Entinostat|entinostat|mesh-list
44780124|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44780125|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44780126|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
44780127|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780128|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780129|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780130|NCT01886599|Asunaprevir|asunaprevir|mesh-list
44780131|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780132|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780133|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780134|NCT01886638|Abacavir|abacavir|mesh-list
44780135|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44780136|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44780137|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780138|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780139|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
44780140|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780141|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44780142|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44780143|NCT01886664|Sevoflurane|sevoflurane|mesh-list
44780144|NCT01886664|Desflurane|desflurane|mesh-list
44780145|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44780146|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44780147|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
44780148|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
44780149|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780150|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780151|NCT01886768|Anesthetics|anesthetics|mesh-list
44780152|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780153|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780154|NCT01886794|Estrogens|estrogens|mesh-list
44780155|NCT01886794|Hormones|hormones|mesh-ancestor
44780156|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780157|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780158|NCT01887119|Eplerenone|eplerenone|mesh-list
44780159|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44780160|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
44780161|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780162|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780163|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44780164|NCT01887119|Diuretics|diuretics|mesh-ancestor
44780165|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
44780166|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780167|NCT01887158|Bisacodyl|bisacodyl|mesh-list
44780168|NCT01887158|Cathartics|cathartics|mesh-ancestor
44780169|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780170|NCT01887158|Laxatives|laxatives|mesh-ancestor
44780171|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
44780172|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44390428|NCT03231228|Cefazolin|cefazolin|mesh-list
44780173|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780174|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780175|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780176|NCT01887184|Analgesics|analgesics|mesh-ancestor
44780177|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
44780178|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780179|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44780180|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44780181|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44780182|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780183|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780184|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780185|NCT01887197|Mannitol|mannitol|mesh-list
44780186|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44780187|NCT01887197|Diuretics|diuretics|mesh-ancestor
44780188|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
44780189|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780190|NCT01887223|Timolol|timolol|mesh-list
44780191|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44780192|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780193|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44780194|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44780195|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44780196|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780197|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780198|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780199|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780200|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44780201|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44780202|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44780203|NCT01887249|Metronidazole|metronidazole|mesh-list
44780204|NCT01887249|Clarithromycin|clarithromycin|mesh-list
44780205|NCT01887249|Esomeprazole|esomeprazole|mesh-list
44780206|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780207|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780208|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44780209|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44780210|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44780211|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780212|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44780213|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780214|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780215|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44780216|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44780217|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780218|NCT01887275|Interferons|interferons|mesh-list
44780219|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780220|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
44780221|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780222|NCT01887340|Cisplatin|cisplatin|mesh-list
44780223|NCT01887340|Carboplatin|carboplatin|mesh-list
44780224|NCT01887340|Etoposide|etoposide|mesh-list
44780225|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780226|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44780227|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44780228|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44780229|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780230|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780231|NCT01887379|Furosemide|furosemide|mesh-list
44780232|NCT01887379|Diuretics|diuretics|mesh-ancestor
44780233|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
44780234|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780235|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44780236|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780237|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780238|NCT01887405|Epinephrine|epinephrine|mesh-list
44780239|NCT01887405|Racepinephrine|racepinephrine|mesh-list
44780240|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
44780241|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44780242|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44780243|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780244|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780245|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780246|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780247|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44780248|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44780249|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
44780250|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390521|NCT03224182|Apaziquone|apaziquone|mesh-list
44780251|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44780252|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
44780253|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
44780254|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
44780255|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44780256|NCT01887457|Voriconazole|voriconazole|mesh-list
44780257|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
44780258|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780259|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44780260|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780261|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780262|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780263|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44780264|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
44780265|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780266|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780267|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44780268|NCT01887561|Dasatinib|dasatinib|mesh-list
44780269|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780270|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44780271|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780272|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780273|NCT01887613|Gabapentin|gabapentin|mesh-list
44780274|NCT01887613|Analgesics|analgesics|mesh-ancestor
44780275|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
44780276|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780277|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780278|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
44780279|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44780280|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780281|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780282|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780283|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44780284|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44780285|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780286|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780287|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
44780288|NCT01887626|Ticagrelor|ticagrelor|mesh-list
44780289|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44780290|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44390534|NCT03222349|Diazepam|diazepam|mesh-list
44780291|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44780292|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44780293|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
44780294|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780295|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780296|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780297|NCT01887691|Eszopiclone|eszopiclone|mesh-list
44780298|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44780299|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780300|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780301|NCT01887704|Aspirin|aspirin|mesh-list
44780302|NCT01887704|Sirolimus|sirolimus|mesh-list
44780303|NCT01887704|Paclitaxel|paclitaxel|mesh-list
44780304|NCT01887704|Everolimus|everolimus|mesh-list
44780305|NCT01887704|Clopidogrel|clopidogrel|mesh-list
44780306|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44780307|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780308|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44780309|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44780310|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
44780311|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780312|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44780313|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780314|NCT01887704|Analgesics|analgesics|mesh-ancestor
44780315|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
44780316|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780317|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780318|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44780319|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780320|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44780321|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44390575|NCT03219372|Pravastatin|pravastatin|mesh-list
44780322|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44780323|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44780324|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780325|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
44780326|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780327|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
44780328|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44780329|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44780330|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44780331|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
44780332|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780333|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780334|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780335|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44780336|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
44780337|NCT01887743|Pantoprazole|pantoprazole|mesh-list
44780338|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44780339|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780340|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44780341|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780342|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780343|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44780344|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780345|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44780346|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780347|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780348|NCT01887821|Chloroquine|chloroquine|mesh-list
44780349|NCT01887821|Piperaquine|piperaquine|mesh-list
44780350|NCT01887821|Artenimol|artenimol|mesh-list
44780351|NCT01887821|Amebicides|amebicides|mesh-ancestor
44780352|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44780353|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44780354|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780355|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
44780356|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780357|NCT01887847|Nicotine|nicotine|mesh-list
44780358|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44780359|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
44780360|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780361|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780362|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44780363|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44780364|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
44780365|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780366|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780367|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
44780368|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44780369|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
44780370|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780371|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
44780372|NCT01887873|Protective Agents|protective agents|mesh-ancestor
44780373|NCT01887951|Tramadol|tramadol|mesh-list
44780374|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44780375|NCT01887951|Narcotics|narcotics|mesh-ancestor
44780376|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558638|NCT01207440|Ponatinib|ponatinib|mesh-list
44780377|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780378|NCT01887951|Analgesics|analgesics|mesh-ancestor
44780379|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
44780380|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780381|NCT01888042|Everolimus|everolimus|mesh-list
44780382|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780383|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780384|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
44780385|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780386|NCT01888107|Risperidone|risperidone|mesh-list
44780387|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44780388|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
44780389|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780390|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780391|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780392|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780393|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780394|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780395|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44691836|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691837|NCT01363583|Epoprostenol|epoprostenol|mesh-list
44691838|NCT01363583|Tezosentan|tezosentan|mesh-list
44691839|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780396|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44780397|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
44780398|NCT01888120|Ziconotide|ziconotide|mesh-list
44780399|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780400|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780401|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780402|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780403|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780404|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44780405|NCT01888120|Protective Agents|protective agents|mesh-ancestor
44780406|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780407|NCT01888120|Analgesics|analgesics|mesh-ancestor
44780408|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
44780409|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780410|NCT01888224|Isotretinoin|isotretinoin|mesh-list
44780411|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44780412|NCT01888250|Lamotrigine|lamotrigine|mesh-list
44780413|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
44780414|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780415|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780416|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780417|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780418|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691840|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44691841|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
44691842|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
44691843|NCT01363609|Liraglutide|liraglutide|mesh-list
44691844|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44691845|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691846|NCT01363609|Incretins|incretins|mesh-ancestor
44558714|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44390685|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
44558715|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558716|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558717|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44558718|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44558719|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44558720|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
44558721|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558722|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558723|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558724|NCT01205581|Vaccines|vaccines|mesh-list
44558725|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
44558726|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558727|NCT01205529|Procainamide|procainamide|mesh-list
44558728|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44558729|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44558730|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44558731|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558732|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558733|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
44558734|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44780419|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780420|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44390724|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780421|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780422|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780423|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44780424|NCT01888263|Lamotrigine|lamotrigine|mesh-list
44780425|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
44780426|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780427|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780428|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780429|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780430|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780431|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780432|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780433|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780434|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780435|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44780436|NCT01888289|Isotretinoin|isotretinoin|mesh-list
44780437|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
44780438|NCT01888302|Gemcitabine|gemcitabine|mesh-list
44780439|NCT01888302|Sirolimus|sirolimus|mesh-list
44780440|NCT01888302|Cisplatin|cisplatin|mesh-list
44780441|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780442|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44780443|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
44780444|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780445|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
44780446|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780447|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780448|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780449|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
44780450|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780451|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780452|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44780453|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
44780454|NCT01888328|Isotretinoin|isotretinoin|mesh-list
44780455|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44780456|NCT01888341|Isotretinoin|isotretinoin|mesh-list
44780457|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
44780458|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44780459|NCT01888354|Hormones|hormones|mesh-ancestor
44780460|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780461|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780462|NCT01888393|Ivacaftor|ivacaftor|mesh-list
44780463|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44780464|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623690|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44780465|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780466|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
44780467|NCT01888445|Hematinics|hematinics|mesh-ancestor
44780468|NCT01888458|Micafungin|micafungin|mesh-list
44780469|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
44780470|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780471|NCT01888536|Pregabalin|pregabalin|mesh-list
44780472|NCT01888536|Alprostadil|alprostadil|mesh-list
44780473|NCT01888536|Analgesics|analgesics|mesh-ancestor
44780474|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
44780475|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780476|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780477|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
44780478|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780479|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780480|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780481|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780482|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44780483|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780484|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780485|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780486|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44390788|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44390808|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44780487|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
44780488|NCT01888536|Urological Agents|urological agents|mesh-ancestor
44558753|NCT01205035|Ranibizumab|ranibizumab|mesh-list
44780489|NCT01888562|Ponatinib|ponatinib|mesh-list
44780490|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780491|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44780492|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780493|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780494|NCT01888575|Aspirin|aspirin|mesh-list
44780495|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44780496|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780497|NCT01888575|Analgesics|analgesics|mesh-ancestor
44780498|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
44780499|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780500|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780501|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44780502|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44780503|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44780504|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44780505|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780506|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44780507|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44780508|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780509|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
44780510|NCT01888718|Fexofenadine|fexofenadine|mesh-list
44780511|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44780512|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44780513|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44780514|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
44780515|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
44780516|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780517|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780518|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780519|NCT01888731|Lamotrigine|lamotrigine|mesh-list
44780520|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
44780521|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780522|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780523|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780524|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780525|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780526|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780527|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780528|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780529|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780530|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44780531|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44780532|NCT01888744|Cetrorelix|cetrorelix|mesh-list
44780533|NCT01888744|Progesterone|progesterone|mesh-list
44780534|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44780535|NCT01888744|Ganirelix|ganirelix|mesh-list
44780536|NCT01888744|Progestins|progestins|mesh-ancestor
44780537|NCT01888744|Hormones|hormones|mesh-ancestor
44780538|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780539|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780540|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44780541|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44780542|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
44780543|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44780544|NCT01888757|Lamotrigine|lamotrigine|mesh-list
44780545|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
44780546|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44780547|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780548|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780549|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780550|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780551|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780552|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780553|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780554|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780555|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44780556|NCT01888796|Linagliptin|linagliptin|mesh-list
44780557|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44780558|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780559|NCT01888796|Incretins|incretins|mesh-ancestor
44780560|NCT01888796|Hormones|hormones|mesh-ancestor
44780561|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780562|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44780563|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780564|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780565|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780566|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
44780567|NCT01888822|Ampicillin|ampicillin|mesh-list
44780568|NCT01888822|Sulbactam|sulbactam|mesh-list
44780569|NCT01888822|Sultamicillin|sultamicillin|mesh-list
44780570|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780571|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780572|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44780573|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44780574|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780575|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780576|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780577|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44780578|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780579|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44780580|NCT01888835|Mirtazapine|mirtazapine|mesh-list
44780581|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
44780582|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780583|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44780584|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
44780585|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
44780586|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780587|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780588|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780589|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44780590|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44476045|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
44780591|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780592|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44780593|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44780594|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44780595|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780596|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44780597|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44780598|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
44780599|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44780600|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
44780601|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
44780602|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780603|NCT01888861|Protective Agents|protective agents|mesh-ancestor
44780604|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780605|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
44780606|NCT01888861|Vitamins|vitamins|mesh-ancestor
44780607|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
44780608|NCT01888978|Leucovorin|leucovorin|mesh-list
44780609|NCT01888978|Gemcitabine|gemcitabine|mesh-list
44780610|NCT01888978|Fluorouracil|fluorouracil|mesh-list
44780611|NCT01888978|Docetaxel|docetaxel|mesh-list
44780612|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
44780613|NCT01888978|Irinotecan|irinotecan|mesh-list
44780614|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
44780615|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44780616|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
44780617|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780618|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780619|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
44780620|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780621|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780622|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780623|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
44780624|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780625|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
44780626|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
44780627|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
44780628|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44780629|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44780630|NCT01888978|Antidotes|antidotes|mesh-ancestor
44390917|NCT03199911|Bacitracin|bacitracin|mesh-list
44780631|NCT01888978|Protective Agents|protective agents|mesh-ancestor
44780632|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
44780633|NCT01888978|Vitamins|vitamins|mesh-ancestor
44780634|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
44780635|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
44780636|NCT01889004|Propofol|propofol|mesh-list
44780637|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44780638|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780639|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780641|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
44780642|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
44780643|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44780644|NCT01889004|Analgesics|analgesics|mesh-ancestor
44780645|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
44780646|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780647|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44780648|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44780649|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44780650|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780651|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829893|NCT05401214|Hormones|hormones|mesh-ancestor
44780652|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780653|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
44780654|NCT01889056|Hematinics|hematinics|mesh-ancestor
44780655|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44780656|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44780657|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780658|NCT01889134|Alendronate|alendronate|mesh-list
44780659|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44780660|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780661|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
44780662|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44780663|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
44780664|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780665|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44780666|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780667|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44780668|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780669|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780670|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780671|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44780672|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780673|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44780674|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780675|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780676|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
44780677|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44780678|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780679|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
44780680|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780681|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
44780682|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44780683|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780684|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
44780685|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780686|NCT01889368|Protective Agents|protective agents|mesh-ancestor
44780687|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780688|NCT01889407|Idarubicin|idarubicin|mesh-list
44780689|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44780690|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780691|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44780692|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44780693|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780694|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780695|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44780696|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
44780697|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780698|NCT01889446|Calcium|calcium|mesh-list
44780699|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44476046|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
44780700|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780701|NCT01889498|Acetazolamide|acetazolamide|mesh-list
44780702|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
44780703|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44780704|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780705|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780706|NCT01889498|Diuretics|diuretics|mesh-ancestor
44780707|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
44780708|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780709|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
44780710|NCT01889576|Antacids|antacids|mesh-ancestor
44558986|NCT01202175|Nebivolol|nebivolol|mesh-list
44780711|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780712|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780714|NCT01889680|Fluorouracil|fluorouracil|mesh-list
44780715|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
44780716|NCT01889680|Aflibercept|aflibercept|mesh-list
44780717|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
44780718|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
44780719|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391027|NCT03192306|Ethanol|ethanol|mesh-list
44780720|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44780721|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780722|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780723|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
44780724|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780725|NCT01889680|Antidotes|antidotes|mesh-ancestor
44780726|NCT01889680|Protective Agents|protective agents|mesh-ancestor
44780727|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
44780728|NCT01889680|Vitamins|vitamins|mesh-ancestor
44780729|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
44780730|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44780731|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44780732|NCT01889680|Growth Substances|growth substances|mesh-ancestor
44780733|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
44780734|NCT01889758|Tacrolimus|tacrolimus|mesh-list
44780735|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780736|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
44780737|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780738|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44780739|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780740|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780741|NCT01889771|Nicotine|nicotine|mesh-list
44780742|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44780743|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
44780744|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780745|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780746|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44780747|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44780748|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
44780749|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780750|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780751|NCT01889810|Vitamin D|vitamin d|mesh-list
44780752|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
44780753|NCT01889810|Vitamins|vitamins|mesh-ancestor
44780754|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
44780755|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780756|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44780757|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44780758|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44780759|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44780760|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
44780761|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780762|NCT01889914|Insulin|insulin|mesh-list
44780763|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44780764|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44780765|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780766|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
44780767|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
44780768|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44780769|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44780770|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780771|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780772|NCT01889966|Urological Agents|urological agents|mesh-ancestor
44780773|NCT01889979|Tramadol|tramadol|mesh-list
44780774|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44780775|NCT01889979|Narcotics|narcotics|mesh-ancestor
44780776|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780777|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780778|NCT01889979|Analgesics|analgesics|mesh-ancestor
44780779|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
44780780|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780781|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
44780782|NCT01890538|Piracetam|piracetam|mesh-list
44780783|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
44780784|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
44780785|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780786|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780787|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780788|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44780789|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
44780790|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
44780791|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780792|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780793|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44780794|NCT01890538|Protective Agents|protective agents|mesh-ancestor
44780795|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
44780796|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
44780797|NCT01891292|Enalapril|enalapril|mesh-list
44780798|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44780799|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
44780800|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559126|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44780801|NCT01891292|Expectorants|expectorants|mesh-ancestor
44780802|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
44780803|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44780804|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
44780805|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780806|NCT01891292|Protective Agents|protective agents|mesh-ancestor
44780807|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780808|NCT01891292|Antidotes|antidotes|mesh-ancestor
44780809|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44780810|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780811|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780812|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780813|NCT01891487|Bimatoprost|bimatoprost|mesh-list
44780814|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44559127|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44559128|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44559129|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559130|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559131|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
44559132|NCT01200758|Hormones|hormones|mesh-ancestor
44559133|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780815|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
44780816|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780817|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
44780818|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44780819|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780821|NCT01893229|Valproic Acid|valproic acid|mesh-list
44780822|NCT01893229|Olanzapine|olanzapine|mesh-list
44780823|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44780824|NCT01893229|Ziprasidone|ziprasidone|mesh-list
44780825|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
44780826|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
44780827|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
44780828|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780829|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780830|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780831|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44780832|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780833|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780834|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780835|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44780836|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44780837|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780838|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780839|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780840|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
44780841|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
44780842|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780843|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
44780844|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
44780845|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
44780846|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44780847|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44780848|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
44780849|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44780850|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44780851|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44780852|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44780853|NCT01894269|Lamivudine|lamivudine|mesh-list
44780854|NCT01894269|Entecavir|entecavir|mesh-list
44780855|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44780856|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44780857|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780858|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780859|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
44780860|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780861|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44780862|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44780863|NCT01894789|Clopidogrel|clopidogrel|mesh-list
44780864|NCT01894789|Ticagrelor|ticagrelor|mesh-list
44780865|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44780866|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44780867|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44780868|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44780869|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
44780870|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780871|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780872|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780873|NCT01894815|Dexetimide|dexetimide|mesh-list
44780874|NCT01894815|Citalopram|citalopram|mesh-list
44780875|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44780876|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44780877|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780878|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780879|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780880|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
44780881|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780882|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44780883|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
44780884|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780885|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44780886|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44780887|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
44780888|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
44780889|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44780890|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44780891|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44780892|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
44780893|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
44780894|NCT01895049|Prednisone|prednisone|mesh-list
44780895|NCT01895049|Everolimus|everolimus|mesh-list
44780896|NCT01895049|Tacrolimus|tacrolimus|mesh-list
44780897|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
44780898|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44780899|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391203|NCT03178942|Permethrin|permethrin|mesh-list
44780900|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
44780901|NCT01895049|Hormones|hormones|mesh-ancestor
44780902|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780903|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780904|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44780905|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780906|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44780907|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
44780908|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44780909|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780910|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780911|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44780912|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44780913|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
44780914|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780915|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780916|NCT01896622|Ritonavir|ritonavir|mesh-list
44780917|NCT01896622|Cobicistat|cobicistat|mesh-list
44780918|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44780919|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44780920|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
44780921|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780922|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780923|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44780924|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44780925|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
44780926|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780927|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44780928|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780929|NCT01897051|Rifaximin|rifaximin|mesh-list
44780930|NCT01897051|Propranolol|propranolol|mesh-list
44780931|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44780932|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44780933|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44780934|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780935|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780936|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780937|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44780938|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44780939|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
44780940|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780941|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780942|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44780943|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
44780944|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
44780945|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44780946|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44780947|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780948|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780949|NCT01897740|Urological Agents|urological agents|mesh-ancestor
44780950|NCT01897753|Hormones|hormones|mesh-list
44780951|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44780952|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780953|NCT01898065|Misonidazole|misonidazole|mesh-list
44780954|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780955|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44780956|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44780957|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780958|NCT01898104|Capecitabine|capecitabine|mesh-list
44780959|NCT01898104|Valproic Acid|valproic acid|mesh-list
44780960|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44780961|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
44780962|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780963|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44780964|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
44780965|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780966|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
44780967|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44780968|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780969|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
44780970|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44780971|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780972|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44780973|NCT01898221|Ethanol|ethanol|mesh-list
44780974|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44780975|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780976|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44780977|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44780978|NCT01898338|Daptomycin|daptomycin|mesh-list
44780979|NCT01898338|Fosfomycin|fosfomycin|mesh-list
44780980|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44780981|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780982|NCT01899105|Ivacaftor|ivacaftor|mesh-list
44780983|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44780984|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44780985|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780986|NCT01900015|Efavirenz|efavirenz|mesh-list
44780987|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
44780988|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44780989|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44780990|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44780991|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780992|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
44780993|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44780994|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44780995|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44780996|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44780997|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44391332|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44780998|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44780999|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44781000|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44781001|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44781002|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44781003|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44781004|NCT01900028|Itraconazole|itraconazole|mesh-list
44781005|NCT01900028|Olaparib|olaparib|mesh-list
44781006|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44781007|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781008|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781009|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781010|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
44781011|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781012|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44781013|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44781014|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44781015|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
44781016|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781017|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781018|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44781019|NCT01900041|Minoxidil|minoxidil|mesh-list
44781020|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781021|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
44781022|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44781023|NCT01900093|Hormones|hormones|mesh-ancestor
44781024|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781025|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781026|NCT01900106|Ritonavir|ritonavir|mesh-list
44781027|NCT01900106|Darunavir|darunavir|mesh-list
44781028|NCT01900106|Lamivudine|lamivudine|mesh-list
44781029|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
44781030|NCT01900106|Abacavir|abacavir|mesh-list
44781031|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
44781032|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44781033|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44781034|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781035|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781036|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781037|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44781038|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44781039|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
44781040|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781041|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44781042|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44781043|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44781044|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44781045|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44781046|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44781047|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
44781048|NCT01900158|Gemcitabine|gemcitabine|mesh-list
44781049|NCT01900158|Cisplatin|cisplatin|mesh-list
44781050|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781051|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781052|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
44781053|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781054|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
44781055|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781056|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781057|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781058|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
44781059|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781060|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44781061|NCT01900197|Hematinics|hematinics|mesh-ancestor
44781062|NCT01900301|Scopolamine|scopolamine|mesh-list
44781063|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44781064|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44781065|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
44781066|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
44781067|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781068|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781069|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781070|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
44781071|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44781072|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781073|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781074|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781075|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44781076|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
44781077|NCT01900327|Gemcitabine|gemcitabine|mesh-list
44781078|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781079|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
44781080|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781081|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781082|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
44781083|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781084|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781085|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781086|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
44781087|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781088|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
44781089|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44781090|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781091|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781092|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44781093|NCT01900405|Analgesics|analgesics|mesh-ancestor
44781094|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
44781095|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781096|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44781097|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44781098|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44781099|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781100|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781101|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781102|NCT01900496|Rituximab|rituximab|mesh-list
44781103|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44781104|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44781105|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781106|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
44781107|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781108|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44781109|NCT01900509|Dexamethasone|dexamethasone|mesh-list
44781110|NCT01900509|Etoposide|etoposide|mesh-list
44781111|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
44781112|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44781113|NCT01900509|Clofarabine|clofarabine|mesh-list
44781114|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44781115|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
44781116|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
44781117|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781118|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781119|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781120|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
44781122|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781123|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44781124|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781125|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44781126|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44781127|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781128|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781129|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781130|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44781131|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
44781132|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781133|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
44781134|NCT01900587|Tapentadol|tapentadol|mesh-list
44781135|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44781136|NCT01900587|Narcotics|narcotics|mesh-ancestor
44781137|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781138|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781139|NCT01900587|Analgesics|analgesics|mesh-ancestor
44781140|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
44781141|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691847|NCT01363609|Hormones|hormones|mesh-ancestor
44691848|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691849|NCT01363648|Choline|choline|mesh-list
44691850|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
44781142|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44781143|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44781144|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781145|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781146|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781147|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781148|NCT01900639|Aspirin|aspirin|mesh-list
44781149|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44781150|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44781151|NCT01900639|Analgesics|analgesics|mesh-ancestor
44781152|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
44781153|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781154|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691851|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44691852|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
44691853|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691854|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691855|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44691856|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
44691857|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
44691858|NCT01363752|Sirolimus|sirolimus|mesh-list
44691859|NCT01363752|Tacrolimus|tacrolimus|mesh-list
44691860|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691861|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
44691862|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691863|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44691864|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691865|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559449|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
44559450|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559451|NCT01197560|Antiviral Agents|antiviral agents|mesh-ancestor
44559452|NCT01197560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559453|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559454|NCT01197560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559455|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559456|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44559457|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44559458|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44559459|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44559460|NCT01197560|Growth Substances|growth substances|mesh-ancestor
44559461|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
44559462|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
44781155|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44781156|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44781157|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44781158|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44781159|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781160|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44781161|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44781162|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781163|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
44781164|NCT01900717|Leucovorin|leucovorin|mesh-list
44781165|NCT01900717|Bevacizumab|bevacizumab|mesh-list
44781166|NCT01900717|Fluorouracil|fluorouracil|mesh-list
44781167|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
44781168|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44781169|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781170|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44781171|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44781172|NCT01900717|Growth Substances|growth substances|mesh-ancestor
44781173|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781174|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
44781175|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
44781176|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781177|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781178|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781179|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
44781180|NCT01900717|Antidotes|antidotes|mesh-ancestor
44781181|NCT01900717|Protective Agents|protective agents|mesh-ancestor
44781182|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
44781183|NCT01900717|Vitamins|vitamins|mesh-ancestor
44781184|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
44781185|NCT01900795|Ibuprofen|ibuprofen|mesh-list
44781186|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44781187|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44781188|NCT01900795|Analgesics|analgesics|mesh-ancestor
44781189|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
44781190|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781191|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781192|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44781193|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44781194|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44781195|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781196|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781198|NCT01900847|Morphine|morphine|mesh-list
44781199|NCT01900847|Analgesics|analgesics|mesh-ancestor
44781200|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
44781201|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781202|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391557|NCT03152552|Empagliflozin|empagliflozin|mesh-list
44781203|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44781204|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44781205|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
44781206|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
44781207|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781208|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44781209|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44781210|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781211|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781212|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44781213|NCT01900847|Narcotics|narcotics|mesh-ancestor
44781214|NCT01900860|Vitamin D|vitamin d|mesh-list
44781215|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
44781216|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
44781217|NCT01900860|Vitamins|vitamins|mesh-list
44781218|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
44781219|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781220|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44781221|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44781222|NCT01900886|Ribavirin|ribavirin|mesh-list
44781223|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44781224|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
44781225|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781226|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
44781227|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781228|NCT01900938|Midazolam|midazolam|mesh-list
44781229|NCT01900938|Propofol|propofol|mesh-list
44781230|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44781231|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781232|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781233|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44781234|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
44781235|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
44781236|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44391571|NCT03151551|Ixekizumab|ixekizumab|mesh-list
44781237|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44781238|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44781239|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44781240|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
44781241|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
44781242|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781243|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781244|NCT01900951|Temozolomide|temozolomide|mesh-list
44781245|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44781246|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
44781247|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781248|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781249|NCT01901003|Lorazepam|lorazepam|mesh-list
44781250|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
44781251|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
44781252|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
44781253|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781254|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781255|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781256|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44781257|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781258|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44781259|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44781260|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44781261|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
44781262|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
44781263|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781264|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781265|NCT01901120|Mirabegron|mirabegron|mesh-list
44781266|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44781267|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44781268|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44781269|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781270|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781271|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781272|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781273|NCT01901120|Urological Agents|urological agents|mesh-ancestor
44781274|NCT01901172|Posaconazole|posaconazole|mesh-list
44781275|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
44781276|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781277|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44781278|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44781279|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44781280|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44781281|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44781282|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781283|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781284|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44781285|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44781286|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781287|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781288|NCT01901198|Interferons|interferons|mesh-list
44781289|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
44781290|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
44781291|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781292|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
44781293|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781294|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
44781295|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781296|NCT01901276|Omeprazole|omeprazole|mesh-list
44781297|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44391635|NCT03147248|Infliximab|infliximab|mesh-list
44781298|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781299|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44781300|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781301|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781302|NCT01901380|Caseins|caseins|mesh-list
44781303|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
44781304|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
44781305|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781306|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44781307|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44781308|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781309|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781310|NCT01901471|Cyclosporine|cyclosporine|mesh-list
44781311|NCT01901471|Cyclosporins|cyclosporins|mesh-list
44781312|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781313|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781314|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781315|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
44781316|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781317|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
44781318|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781319|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
44781320|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44781321|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44781322|NCT01901484|Praziquantel|praziquantel|mesh-list
44781323|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
44781324|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44781325|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781326|NCT01901549|Metoprolol|metoprolol|mesh-list
44781327|NCT01901549|Lisinopril|lisinopril|mesh-list
44781328|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44781329|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781330|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
44781331|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
44781332|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781333|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781334|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44781335|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44781336|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44781337|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781338|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781339|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781340|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44781341|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781342|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781343|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44781344|NCT01901549|Protective Agents|protective agents|mesh-ancestor
44781345|NCT01901601|Anesthetics|anesthetics|mesh-list
44781346|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781347|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781348|NCT01901640|Udenafil|udenafil|mesh-list
44781349|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44781350|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44781351|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781352|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781353|NCT01901666|Hormones|hormones|mesh-list
44781354|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781355|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781356|NCT01901692|Sorafenib|sorafenib|mesh-list
44781357|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781358|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44781359|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781360|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781361|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44781362|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44781363|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781364|NCT01901861|Incretins|incretins|mesh-ancestor
44781365|NCT01901861|Hormones|hormones|mesh-ancestor
44781366|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781367|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44781368|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781369|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781370|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781371|NCT01902017|Ketotifen|ketotifen|mesh-list
44781372|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
44781373|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44781374|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44781375|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
44781376|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
44781377|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781378|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781379|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781380|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44781381|NCT01902108|Clonidine|clonidine|mesh-list
44781382|NCT01902108|Bupivacaine|bupivacaine|mesh-list
44781383|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
44781384|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
44781385|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781386|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781387|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
44781388|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781389|NCT01902108|Analgesics|analgesics|mesh-ancestor
44781390|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781391|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
44781392|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
44781393|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44781394|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44781395|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44781396|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781397|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781398|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391743|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
44781399|NCT01902121|Insulin|insulin|mesh-list
44781400|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44781401|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44781402|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781403|NCT01902160|Sirolimus|sirolimus|mesh-list
44781404|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44781405|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44781406|NCT01902160|Antibodies|antibodies|mesh-list
44781407|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
44781408|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44781409|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
44781410|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
44781411|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781412|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781413|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44781414|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781415|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44781416|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
44781417|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781418|NCT01902186|Ritonavir|ritonavir|mesh-list
44781419|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44781420|NCT01902186|Tenofovir|tenofovir|mesh-list
44781421|NCT01902186|Emtricitabine|emtricitabine|mesh-list
44781422|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
44559718|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44781423|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44781424|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44781425|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781426|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781427|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781428|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44781429|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44781430|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
44781431|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781432|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44781433|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44781434|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44781435|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44781436|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44781437|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44781439|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44781440|NCT01902225|Romidepsin|romidepsin|mesh-list
44781441|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44781442|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781443|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44781444|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781445|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781446|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781447|NCT01902238|Ethanol|ethanol|mesh-list
44781448|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
44781449|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44781450|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781451|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781452|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781453|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781454|NCT01902342|Oseltamivir|oseltamivir|mesh-list
44781455|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
44781456|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781457|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781458|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781459|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
44781460|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44781461|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44781462|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781463|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
44781464|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44781465|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
44781466|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44781467|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781468|NCT01902498|Aspirin|aspirin|mesh-list
44781469|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44781470|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44391809|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781471|NCT01902498|Analgesics|analgesics|mesh-ancestor
44781472|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
44781473|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781474|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781475|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44781476|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44781477|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44781478|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44781479|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781480|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44781481|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44781482|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781483|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
44781484|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
44781485|NCT01902511|Lenograstim|lenograstim|mesh-list
44781486|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44781487|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
44781488|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781489|NCT01902511|Hematinics|hematinics|mesh-ancestor
44781490|NCT01902524|Fentanyl|fentanyl|mesh-list
44781491|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44781492|NCT01902524|Narcotics|narcotics|mesh-ancestor
44781493|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781494|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781495|NCT01902524|Analgesics|analgesics|mesh-ancestor
44781496|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
44781497|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781498|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44781499|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44781500|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
44781501|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
44391842|NCT03136068|Digoxin|digoxin|mesh-list
44781502|NCT01902537|Prucalopride|prucalopride|mesh-list
44781503|NCT01902537|Laxatives|laxatives|mesh-ancestor
44781504|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781505|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44781506|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44781507|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
44781508|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781509|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781510|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781511|NCT01902550|Metoprolol|metoprolol|mesh-list
44781512|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44781513|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781514|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
44781515|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
44781516|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781517|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781518|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44781519|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44781520|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44781521|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781522|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781523|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691866|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44691867|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691868|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44691869|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
44691870|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691871|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691872|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
44691873|NCT01363817|Dexamethasone|dexamethasone|mesh-list
44691874|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691875|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
44691876|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
44691877|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691878|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691879|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44691880|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
44691881|NCT01363817|Hormones|hormones|mesh-ancestor
44691882|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691883|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44691884|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691885|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
44691886|NCT01363934|Hematinics|hematinics|mesh-ancestor
44691887|NCT01364012|Paclitaxel|paclitaxel|mesh-list
44691888|NCT01364012|Bevacizumab|bevacizumab|mesh-list
44691889|NCT01364012|Carboplatin|carboplatin|mesh-list
44243521|NCT00601692|Cisplatin|cisplatin|mesh-list
44691890|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44691891|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691892|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44691893|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44691894|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44691895|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691896|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691897|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44691898|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44691899|NCT01364012|Growth Substances|growth substances|mesh-ancestor
44691900|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691901|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
44781524|NCT01902641|Rocuronium|rocuronium|mesh-list
44781525|NCT01902641|Succinylcholine|succinylcholine|mesh-list
44781526|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44781527|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44781528|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44781529|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781530|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781531|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44781532|NCT01902771|Imiquimod|imiquimod|mesh-list
44781533|NCT01902771|Vaccines|vaccines|mesh-list
44781534|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
44781535|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781536|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44781537|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781538|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
44781539|NCT01902810|Propranolol|propranolol|mesh-list
44781540|NCT01902810|Metoprolol|metoprolol|mesh-list
44781541|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44781542|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44781543|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781544|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781545|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781546|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391933|NCT03131453|CNP520|cnp520|mesh-list
44781547|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44781548|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781549|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
44781550|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
44781551|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
44781552|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781553|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44781554|NCT01902862|Rituximab|rituximab|mesh-list
44781555|NCT01902862|Bortezomib|bortezomib|mesh-list
44781556|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44781557|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781558|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
44781559|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781560|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559945|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559946|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781562|NCT01902875|Cisplatin|cisplatin|mesh-list
44781563|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44781564|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781565|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44781566|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44781567|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44781568|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781569|NCT01903018|Cisplatin|cisplatin|mesh-list
44781570|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781571|NCT01903057|Azithromycin|azithromycin|mesh-list
44781572|NCT01903057|Ivermectin|ivermectin|mesh-list
44781573|NCT01903057|Albendazole|albendazole|mesh-list
44781574|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44781575|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781576|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44781577|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
44781578|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
44781579|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44781580|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44781581|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44781582|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44781583|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44781584|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781585|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781586|NCT01903070|Linagliptin|linagliptin|mesh-list
44781587|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44781588|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781589|NCT01903070|Incretins|incretins|mesh-ancestor
44781590|NCT01903070|Hormones|hormones|mesh-ancestor
44781591|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781592|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44781593|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781594|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781595|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781596|NCT01903083|Gemcitabine|gemcitabine|mesh-list
44781597|NCT01903083|Tadalafil|tadalafil|mesh-list
44781598|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781599|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
44781600|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781601|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781602|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
44781603|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781604|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781605|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781606|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
44781607|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781608|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
44781609|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44781610|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44781611|NCT01903083|Urological Agents|urological agents|mesh-ancestor
44781612|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
44781613|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44781614|NCT01903109|Cevimeline|cevimeline|mesh-list
44781615|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44781616|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
44781617|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781618|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781619|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44781620|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44781621|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781622|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781623|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781624|NCT01903122|Cevimeline|cevimeline|mesh-list
44781625|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44781626|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
44781627|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781628|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781629|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44781630|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44781631|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781632|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781633|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781634|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44781635|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
44781636|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44781637|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44781638|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44781639|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781640|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781641|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44781642|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
44781643|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781644|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44781645|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
44781646|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781647|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
44781648|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781649|NCT01903681|Melatonin|melatonin|mesh-list
44781650|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
44781651|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781652|NCT01903681|Protective Agents|protective agents|mesh-ancestor
44781653|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781654|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781655|NCT01903694|Sorafenib|sorafenib|mesh-list
44781656|NCT01903694|Pravastatin|pravastatin|mesh-list
44781657|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781658|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44781659|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781660|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781661|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44781662|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44781663|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
44781664|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44781665|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44781666|NCT01903785|Albuterol|albuterol|mesh-list
44781667|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44781668|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
44781669|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781670|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781671|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44781672|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
44781673|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
44781674|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44781675|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44781676|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44781677|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44781678|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781679|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781680|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781681|NCT01903824|Modafinil|modafinil|mesh-list
44781682|NCT01903824|Donepezil|donepezil|mesh-list
44781683|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44781684|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781685|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781686|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781687|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781688|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781689|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
44781690|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44781691|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44781692|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44781693|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44781694|NCT01904045|Tacrolimus|tacrolimus|mesh-list
44781695|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781696|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
44781697|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781698|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44781699|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781700|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781701|NCT01904097|Pregabalin|pregabalin|mesh-list
44781702|NCT01904097|Analgesics|analgesics|mesh-ancestor
44781703|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
44781704|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781705|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781706|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
44781707|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44781708|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781709|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781710|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44781711|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44781712|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44781713|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781714|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44781715|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
44781716|NCT01904110|Vitamin D|vitamin d|mesh-list
44781717|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
44781718|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
44781719|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44781720|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781721|NCT01904110|Vitamins|vitamins|mesh-ancestor
44781722|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
44781723|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44781724|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44781725|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781726|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781727|NCT01904162|Finafloxacin|finafloxacin|mesh-list
44781728|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44781729|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781730|NCT01904162|Renal Agents|renal agents|mesh-ancestor
44781731|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44781732|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44781733|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781734|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781735|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781736|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781737|NCT01904214|Siponimod|siponimod|mesh-list
44781738|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44781739|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781740|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44691902|NCT01364181|Udenafil|udenafil|mesh-list
44691903|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44691904|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44691905|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691906|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691907|NCT01364194|Bupivacaine|bupivacaine|mesh-list
44691908|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
44691909|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
44691910|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44691911|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691912|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
44691913|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691914|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44691915|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44691916|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44691917|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
44691918|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691919|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44691920|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44691921|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44691922|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
44691923|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44691924|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44691925|NCT01364376|Leucovorin|leucovorin|mesh-list
44691926|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
44691927|NCT01364376|Calcium|calcium|mesh-list
44691928|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
44691929|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44691930|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691931|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691932|NCT01364376|Antidotes|antidotes|mesh-ancestor
44691933|NCT01364376|Protective Agents|protective agents|mesh-ancestor
44691934|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
44691935|NCT01364376|Vitamins|vitamins|mesh-ancestor
44691936|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
44691937|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
44691938|NCT01364402|Hematinics|hematinics|mesh-ancestor
44691939|NCT01364415|Pasireotide|pasireotide|mesh-list
44691940|NCT01364415|Hormones|hormones|mesh-ancestor
44691941|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44691942|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691943|NCT01364493|Capecitabine|capecitabine|mesh-list
44691944|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
44691945|NCT01364493|Trastuzumab|trastuzumab|mesh-list
44691946|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44691947|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
44781741|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
44781742|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781743|NCT01904253|Topotecan|topotecan|mesh-list
44781744|NCT01904253|Amrubicin|amrubicin|mesh-list
44781745|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44781746|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781747|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781748|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781749|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781750|NCT01904357|Cefazolin|cefazolin|mesh-list
44781751|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44781752|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781753|NCT01904487|Tiagabine|tiagabine|mesh-list
44781754|NCT01904487|Flumazenil|flumazenil|mesh-list
44781755|NCT01904487|Antidotes|antidotes|mesh-ancestor
44781756|NCT01904487|Protective Agents|protective agents|mesh-ancestor
44781757|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781758|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
44781759|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
44781760|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781761|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781762|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
44781763|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44781764|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44781765|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781766|NCT01904500|Cefazolin|cefazolin|mesh-list
44781767|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44781768|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781769|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44781770|NCT01904539|Cathartics|cathartics|mesh-ancestor
44781771|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44781772|NCT01904591|Vitamin E|vitamin e|mesh-list
44781773|NCT01904591|Selenium|selenium|mesh-list
44781774|NCT01904591|Vitamins|vitamins|mesh-ancestor
44781775|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
44781776|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781777|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
44781778|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781779|NCT01904591|Protective Agents|protective agents|mesh-ancestor
44781780|NCT01904591|Trace Elements|trace elements|mesh-ancestor
44781781|NCT01904643|Cytarabine|cytarabine|mesh-list
44781782|NCT01904643|Etoposide|etoposide|mesh-list
44781783|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
44781784|NCT01904643|Lenalidomide|lenalidomide|mesh-list
44781785|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
44781786|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44781787|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781788|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44781789|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781790|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781791|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781792|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781793|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
44781794|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
44781795|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392232|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392233|NCT03112590|Interferons|interferons|mesh-list
44392234|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
44781796|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781797|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
44781798|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781799|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44781800|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44781801|NCT01904643|Growth Substances|growth substances|mesh-ancestor
44781802|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44781803|NCT01904643|Analgesics|analgesics|mesh-ancestor
44560206|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781804|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
44781805|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781806|NCT01904682|ON 01910|on 01910|mesh-list
44781807|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781808|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44781809|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781810|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781811|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
44781812|NCT01904695|Diuretics|diuretics|mesh-list
44781813|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44781814|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44781815|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
44781816|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560207|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44560208|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560209|NCT05657028|Analgesics|analgesics|mesh-ancestor
44560210|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44560211|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44560212|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44560213|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781817|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
44781818|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781819|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781820|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781821|NCT01904734|Clomiphene|clomiphene|mesh-list
44781822|NCT01904734|Enclomiphene|enclomiphene|mesh-list
44781823|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
44781824|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44781825|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
44781826|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44781827|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781828|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44781829|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
44781830|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44781831|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44392278|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781832|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44781833|NCT01904747|Palbociclib|palbociclib|mesh-list
44781834|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781835|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44781836|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781837|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781838|NCT01904786|Melatonin|melatonin|mesh-list
44781839|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
44781840|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781841|NCT01904786|Protective Agents|protective agents|mesh-ancestor
44781842|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781843|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781844|NCT01904981|Atenolol|atenolol|mesh-list
44781845|NCT01904981|Valsartan|valsartan|mesh-list
44781846|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44781847|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44781848|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44781849|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44781850|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781851|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44781852|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781853|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781854|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781855|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44781856|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
44781857|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
44781858|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781859|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44781860|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44781861|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
44781862|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781863|NCT01905059|Lamivudine|lamivudine|mesh-list
44781864|NCT01905059|Lopinavir|lopinavir|mesh-list
44781865|NCT01905059|Darunavir|darunavir|mesh-list
44781866|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44781867|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
44781868|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44781869|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44781870|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781871|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781872|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
44781873|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781874|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44781875|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44781876|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44781877|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44781878|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44781879|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
44781880|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44781881|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44781882|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44781883|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781884|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781885|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781886|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781887|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781888|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44781889|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781890|NCT01905150|Leucovorin|leucovorin|mesh-list
44781891|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
44781892|NCT01905150|Gemcitabine|gemcitabine|mesh-list
44781893|NCT01905150|Fluorouracil|fluorouracil|mesh-list
44781894|NCT01905150|Docetaxel|docetaxel|mesh-list
44781895|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
44781896|NCT01905150|Irinotecan|irinotecan|mesh-list
44781897|NCT01905150|Mitomycins|mitomycins|mesh-list
44781898|NCT01905150|Mitomycin|mitomycin|mesh-list
44781899|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
44781900|NCT01905150|Vitamins|vitamins|mesh-ancestor
44781901|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
44781902|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781903|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44781904|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
44781905|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781906|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44781907|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
44781908|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781909|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44781910|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44781911|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
44781912|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392370|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44781913|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
44781914|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
44781915|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44781916|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44781917|NCT01905150|Antidotes|antidotes|mesh-ancestor
44781918|NCT01905150|Protective Agents|protective agents|mesh-ancestor
44781919|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
44781920|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
44781921|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44781922|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
44781923|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44781924|NCT01905215|Vaccines|vaccines|mesh-list
44781925|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
44781926|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781927|NCT01905371|Amphetamine|amphetamine|mesh-list
44781928|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
44781929|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44781930|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781931|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
44781932|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
44781933|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781934|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
44781935|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781936|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781937|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44781938|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44781939|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44781940|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44781941|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44781942|NCT01905501|Anesthetics|anesthetics|mesh-list
44781943|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781944|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781945|NCT01905566|Clopidogrel|clopidogrel|mesh-list
44781946|NCT01905566|Ticagrelor|ticagrelor|mesh-list
44781947|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44781948|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44781949|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44781950|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44781951|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
44781952|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781953|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781954|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781955|NCT01905618|Nicotine|nicotine|mesh-list
44781956|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44781957|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
44781958|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781959|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781960|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44781961|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44781962|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
44781963|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44781964|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781965|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
44781966|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44781967|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
44781968|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44781969|NCT01905696|Expectorants|expectorants|mesh-ancestor
44560344|NCT01186939|Azacitidine|azacitidine|mesh-list
44781970|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
44781971|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44781973|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781974|NCT01905696|Protective Agents|protective agents|mesh-ancestor
44781975|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781976|NCT01905696|Antidotes|antidotes|mesh-ancestor
44781977|NCT01905774|Deferasirox|deferasirox|mesh-list
44781978|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44781979|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
44781980|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
44781981|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44781982|NCT01905904|Sevoflurane|sevoflurane|mesh-list
44781983|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44781984|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44781985|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
44781986|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
44781987|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781988|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781989|NCT01906073|Fentanyl|fentanyl|mesh-list
44781990|NCT01906073|Morphine|morphine|mesh-list
44781991|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44781992|NCT01906073|Narcotics|narcotics|mesh-ancestor
44781993|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44781994|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44781995|NCT01906073|Analgesics|analgesics|mesh-ancestor
44781996|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
44781997|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44781998|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44781999|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44782000|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
44782001|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
44782002|NCT01906125|Palbociclib|palbociclib|mesh-list
44782003|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782004|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782005|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782006|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782007|NCT01906216|Sorafenib|sorafenib|mesh-list
44782008|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782009|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782010|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782011|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782012|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
44782013|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44782014|NCT01906242|Eusol|eusol|mesh-list
44782015|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44782016|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782017|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
44782018|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44782019|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782020|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
44782021|NCT01906307|Giapreza|giapreza|mesh-list
44782022|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44782023|NCT01906411|Dopamine|dopamine|mesh-list
44782024|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44782025|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
44782026|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
44782027|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782028|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782029|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
44782030|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782031|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782032|NCT01906411|Protective Agents|protective agents|mesh-ancestor
44782033|NCT01906450|Azithromycin|azithromycin|mesh-list
44782034|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782035|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782036|NCT01906528|Mivacurium|mivacurium|mesh-list
44782037|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44782038|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44782039|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44782040|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782041|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782042|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44782043|NCT01906580|Entecavir|entecavir|mesh-list
44782044|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
44782045|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782046|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
44782047|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
44782048|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782049|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782050|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782051|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782052|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
44782053|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782054|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44782055|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782056|NCT01906749|Colchicine|colchicine|mesh-list
44782057|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
44782058|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782059|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782060|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782061|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782062|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782063|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782064|NCT01906762|Acetaminophen|acetaminophen|mesh-list
44782065|NCT01906762|Morphine|morphine|mesh-list
44782066|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44782067|NCT01906762|Narcotics|narcotics|mesh-ancestor
44782068|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782069|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782070|NCT01906762|Analgesics|analgesics|mesh-ancestor
44392498|NCT03097588|Palonosetron|palonosetron|mesh-list
44782071|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
44782072|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782073|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44782074|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
44782075|NCT01906788|Lumefantrine|lumefantrine|mesh-list
44782076|NCT01906788|Artemether|artemether|mesh-list
44782077|NCT01906788|Primaquine|primaquine|mesh-list
44782078|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44782079|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
44782080|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44782081|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44782082|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782083|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
44782084|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782085|NCT01906814|Carboplatin|carboplatin|mesh-list
44782086|NCT01906814|Etoposide|etoposide|mesh-list
44782087|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
44782088|NCT01906814|Vincristine|vincristine|mesh-list
44782089|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782090|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44782091|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782092|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782093|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782094|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782095|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782096|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782097|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782098|NCT01906879|Bismuth|bismuth|mesh-list
44782099|NCT01906879|Antacids|antacids|mesh-ancestor
44782100|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782101|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782102|NCT01906944|Triamcinolone|triamcinolone|mesh-list
44782103|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44782104|NCT01906944|Bupivacaine|bupivacaine|mesh-list
44782105|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
44782106|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
44782107|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782108|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782109|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
44782110|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782111|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782112|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
44782113|NCT01906944|Hormones|hormones|mesh-ancestor
44782114|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782115|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782116|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
44782117|NCT01907009|Melphalan|melphalan|mesh-list
44782118|NCT01907009|Lenograstim|lenograstim|mesh-list
44392564|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43885251|NCT04586465|Pemetrexed|pemetrexed|mesh-list
44782119|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44691948|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44691949|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44691950|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44691951|NCT01364519|Fluticasone|fluticasone|mesh-list
44691952|NCT01364519|Xhance|xhance|mesh-list
44691953|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44691954|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44691955|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
44691956|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44691957|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44691958|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44691959|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
44691960|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44691961|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44691962|NCT01364571|Vaccines|vaccines|mesh-list
44691963|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
44691964|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243594|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
44691965|NCT01364675|Metformin|metformin|mesh-list
44691966|NCT01364675|Enalapril|enalapril|mesh-list
44691997|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
44691998|NCT01364805|Gemcitabine|gemcitabine|mesh-list
44691999|NCT01364805|Vitamins|vitamins|mesh-ancestor
44692000|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
44692001|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692002|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44692003|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
44692004|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692005|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692006|NCT01364805|Antiviral Agents|antiviral agents|mesh-ancestor
44692007|NCT01364805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692008|NCT01364805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692009|NCT01364805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692010|NCT01364805|Immunologic Factors|immunologic factors|mesh-ancestor
44692011|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
44692012|NCT01364805|Protective Agents|protective agents|mesh-ancestor
44692013|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
44692014|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
44692015|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
44692016|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782120|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
44692017|NCT01364961|Resveratrol|resveratrol|mesh-list
44692018|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
44392601|NCT03092726|ASP8062|asp8062|mesh-list
44560563|NCT01184872|Cloxacillin|cloxacillin|mesh-list
44782121|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782122|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782123|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44782124|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782125|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
44782126|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782127|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44782128|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
44782129|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44782130|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
44782131|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44782132|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44782133|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782134|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782135|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
44782136|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
44782137|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44782138|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
44782139|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782140|NCT01907061|Expectorants|expectorants|mesh-ancestor
44782141|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44782142|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44782143|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
44782144|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782145|NCT01907061|Protective Agents|protective agents|mesh-ancestor
44782146|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782147|NCT01907061|Antidotes|antidotes|mesh-ancestor
44782148|NCT01907074|Cholic Acids|cholic acids|mesh-list
44782149|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782150|NCT01907165|Copper|copper|mesh-list
44782151|NCT01907165|Temozolomide|temozolomide|mesh-list
44782152|NCT01907165|Disulfiram|disulfiram|mesh-list
44782153|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44782154|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
44782155|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782156|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782157|NCT01907165|Trace Elements|trace elements|mesh-ancestor
44782158|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
44782159|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782160|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44782161|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44782162|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782163|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
44782164|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44782165|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44782166|NCT01907204|Prednisolone|prednisolone|mesh-list
44782167|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
44782168|NCT01907204|Budesonide|budesonide|mesh-list
44782169|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44782170|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
44782171|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782172|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
44782173|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
44782174|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782175|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782176|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782177|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
44782178|NCT01907204|Hormones|hormones|mesh-ancestor
44782179|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782180|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44392642|NCT03091348|Hormones|hormones|mesh-ancestor
44782181|NCT01907204|Protective Agents|protective agents|mesh-ancestor
44782182|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44782183|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782184|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44782185|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44782186|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44782187|NCT01907230|Entecavir|entecavir|mesh-list
44782188|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
44782189|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782190|NCT01907308|Docetaxel|docetaxel|mesh-list
44782191|NCT01907308|Trebananib|trebananib|mesh-list
44782192|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782193|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782194|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782195|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782196|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560598|NCT01183884|Tretinoin|tretinoin|mesh-list
44560599|NCT01183884|Isotretinoin|isotretinoin|mesh-list
44782197|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44782198|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44782199|NCT01907308|Growth Substances|growth substances|mesh-ancestor
44782200|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782201|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
44782202|NCT01907373|Probenecid|probenecid|mesh-list
44782203|NCT01907373|Olmesartan|olmesartan|mesh-list
44782204|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44782205|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44782206|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44782207|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44782208|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782209|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
44782210|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
44782211|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782212|NCT01907373|Renal Agents|renal agents|mesh-ancestor
44782213|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
44782214|NCT01907529|Docetaxel|docetaxel|mesh-list
44782215|NCT01907529|Epirubicin|epirubicin|mesh-list
44782216|NCT01907529|Endostar protein|endostar protein|mesh-list
44782217|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782218|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
44782219|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782220|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782221|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44782222|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
44782223|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782224|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782225|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44782226|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782227|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782228|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782229|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44782230|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782231|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782232|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782233|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44782234|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44782235|NCT01907529|Growth Substances|growth substances|mesh-ancestor
44782236|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44782237|NCT01907594|Cycloserine|cycloserine|mesh-list
44782238|NCT01907594|Nicotine|nicotine|mesh-list
44782239|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44782240|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
44782241|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392723|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782242|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782243|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44782244|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44782245|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
44782246|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782247|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782248|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44782249|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782250|NCT01907594|Renal Agents|renal agents|mesh-ancestor
44782251|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44782252|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
44782253|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782254|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
44782255|NCT01907633|Domperidone|domperidone|mesh-list
44782256|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
44782257|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
44782258|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782259|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782260|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782261|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44782262|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
44782263|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560675|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44560676|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44560677|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
44560678|NCT01190930|Leucovorin|leucovorin|mesh-list
44560679|NCT01190930|Folic Acid|folic acid|mesh-list
44560680|NCT01190930|Cytarabine|cytarabine|mesh-list
44560681|NCT01190930|Dexamethasone|dexamethasone|mesh-list
44560682|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
44560683|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
44560684|NCT01190930|Doxorubicin|doxorubicin|mesh-list
44560686|NCT01190930|Methotrexate|methotrexate|mesh-list
44782264|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782265|NCT01907685|Docetaxel|docetaxel|mesh-list
44782266|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782267|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782268|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782269|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782270|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782271|NCT01907724|Simeprevir|simeprevir|mesh-list
44782272|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
44782273|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782274|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
44782275|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782276|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782277|NCT01907776|Arbekacin|arbekacin|mesh-list
44782278|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44782279|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782280|NCT01907802|Dabrafenib|dabrafenib|mesh-list
44782281|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782282|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782283|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782284|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782285|NCT01907867|Finafloxacin|finafloxacin|mesh-list
44782286|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44782287|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782288|NCT01907867|Renal Agents|renal agents|mesh-ancestor
44782289|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782290|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782291|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782292|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782293|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782294|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782295|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
44782296|NCT01907880|Pamidronate|pamidronate|mesh-list
44782297|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44782298|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782299|NCT01907984|Diclofenac|diclofenac|mesh-list
44782300|NCT01907984|Midazolam|midazolam|mesh-list
44782301|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44782302|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44782303|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782304|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782305|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44782306|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44782307|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44782308|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44782309|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
44782310|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
44782311|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
44782312|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
44782313|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782314|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782315|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44782316|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44782317|NCT01907984|Analgesics|analgesics|mesh-ancestor
44782318|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
44782319|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782320|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782321|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782322|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44782323|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782324|NCT01907997|Lidocaine|lidocaine|mesh-list
44782325|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
44782326|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
44782327|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782328|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782329|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
44782330|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392816|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44392837|NCT03083639|Esomeprazole|esomeprazole|mesh-list
44782331|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44782332|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44560792|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560793|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782333|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44782334|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782335|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782336|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44782337|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44782338|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
44782339|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782340|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782341|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44560794|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560795|NCT01190228|Vaccines|vaccines|mesh-list
44560796|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
44560797|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560798|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
44560799|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44782342|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
44782343|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
44782344|NCT01908075|Hormones|hormones|mesh-ancestor
44782345|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392843|NCT03083470|Paclitaxel|paclitaxel|mesh-list
44782346|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
44782347|NCT01908114|Vaccines|vaccines|mesh-list
44782348|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
44782349|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782350|NCT01908257|Lesinurad|lesinurad|mesh-list
44782351|NCT01908257|Ranitidine|ranitidine|mesh-list
44782352|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44782353|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44782354|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782355|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44782356|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
44782357|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
44782358|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782359|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782360|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782361|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
44782362|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782363|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
44782364|NCT01908257|Renal Agents|renal agents|mesh-ancestor
44782365|NCT01908283|Vaccines|vaccines|mesh-list
44782366|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
44782367|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392859|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44782368|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44782369|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
44782370|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
44782371|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44782372|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44782373|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44782374|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782375|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782376|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44782377|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44782378|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44782379|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782380|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782381|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782382|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
44782383|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44782384|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44782385|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44782386|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782387|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44782388|NCT01908322|Sorafenib|sorafenib|mesh-list
44782389|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782390|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782391|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782392|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782393|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44782394|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
44782395|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
44782396|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782397|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
44782398|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782399|NCT01908348|Erythritol|erythritol|mesh-list
44782400|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
44782401|NCT01908387|Azacitidine|azacitidine|mesh-list
44782402|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782403|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
44782404|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782405|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782406|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782407|NCT01908452|Pyridoxine|pyridoxine|mesh-list
44782408|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
44782409|NCT01908452|Vitamins|vitamins|mesh-ancestor
44782410|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
44782411|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782412|NCT01908465|Ebastine|ebastine|mesh-list
44782413|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44782414|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
44560857|NCT01189604|Propofol|propofol|mesh-list
44782415|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
44782416|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782417|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782418|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782419|NCT01908478|Gemcitabine|gemcitabine|mesh-list
44782420|NCT01908478|Veliparib|veliparib|mesh-list
44782421|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782422|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
44782423|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782424|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782425|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
44782426|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782427|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782428|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782429|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
44782430|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782431|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44782432|NCT01908556|Letrozole|letrozole|mesh-list
44782433|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782434|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44782435|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44782436|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782437|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782438|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44782439|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
44782440|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782441|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782442|NCT01908621|Cytarabine|cytarabine|mesh-list
44782443|NCT01908621|Lenograstim|lenograstim|mesh-list
44782444|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44782445|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
44782446|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782447|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782448|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
44782449|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782450|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782451|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
44782452|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782453|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782454|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44782455|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
44782456|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782457|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
44782458|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782459|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782460|NCT01909037|Curcumin|curcumin|mesh-list
44782461|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44782462|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44782463|NCT01909037|Analgesics|analgesics|mesh-ancestor
44782464|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
44782465|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782466|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782467|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782468|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782469|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782470|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782471|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782472|NCT01909063|Vitamin D|vitamin d|mesh-list
44782473|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
44782474|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
44782475|NCT01909063|Vitamins|vitamins|mesh-list
44782476|NCT01909063|Vitamin E|vitamin e|mesh-list
44782477|NCT01909063|Vitamin A|vitamin a|mesh-list
44782478|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
44782479|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782480|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782481|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44782482|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
44782483|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782484|NCT01909063|Protective Agents|protective agents|mesh-ancestor
44782485|NCT01909115|Vitamin D|vitamin d|mesh-list
44782486|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
44782487|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
44782488|NCT01909115|Vitamins|vitamins|mesh-list
44782489|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
44782490|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782491|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44782492|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782493|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
44782495|NCT01909219|Cathartics|cathartics|mesh-ancestor
44782496|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782497|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
44782498|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
44782499|NCT01909557|Vitamins|vitamins|mesh-ancestor
44782500|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
44782501|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782502|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
44782503|NCT01909622|Vitamin D|vitamin d|mesh-list
44782504|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
44782505|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
44782506|NCT01909622|Vitamins|vitamins|mesh-list
44782507|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
44782508|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782509|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44782510|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782511|NCT01909661|Caseins|caseins|mesh-list
44782512|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
44782513|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
44782514|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782515|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
44782516|NCT01909752|Imiquimod|imiquimod|mesh-list
44782517|NCT01909752|Vaccines|vaccines|mesh-list
44782518|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
44782519|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782520|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782521|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782522|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44782523|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
44782524|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782525|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782526|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44782527|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44782528|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
44782529|NCT01909830|Gemcitabine|gemcitabine|mesh-list
44782530|NCT01909830|Pemetrexed|pemetrexed|mesh-list
44782531|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782532|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
44782533|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782534|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782535|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
44782536|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782537|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782538|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782539|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
44782540|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782541|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44782542|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44782543|NCT01909843|Gontivimab|gontivimab|mesh-list
44782544|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
44782545|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782546|NCT01909856|Dexamethasone|dexamethasone|mesh-list
44782547|NCT01909856|Cisplatin|cisplatin|mesh-list
44782548|NCT01909856|Palonosetron|palonosetron|mesh-list
44782549|NCT01909856|Granisetron|granisetron|mesh-list
44782550|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782551|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
44782552|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
44782553|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782554|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782555|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782556|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
44782557|NCT01909856|Hormones|hormones|mesh-ancestor
44782558|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782559|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44782560|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782561|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44782562|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44782563|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
44782564|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782565|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782566|NCT01910077|Tacrolimus|tacrolimus|mesh-list
44782567|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782568|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
44782569|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782570|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44782571|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782572|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782573|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
44782574|NCT01910090|Famotidine|famotidine|mesh-list
44782575|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44782576|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782577|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44782578|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
44782579|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
44782580|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782581|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782582|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782583|NCT01910090|Analgesics|analgesics|mesh-ancestor
44782584|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
44782585|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782586|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44782587|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44782588|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782589|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782590|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44782591|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782592|NCT01910142|Vitamin K|vitamin k|mesh-list
44782593|NCT01910142|Calcium|calcium|mesh-list
44782594|NCT01910142|Vitamins|vitamins|mesh-ancestor
44782595|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
44782596|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782597|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782598|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44782599|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44782600|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782601|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
44782602|NCT01910142|Coagulants|coagulants|mesh-ancestor
44782603|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
44782604|NCT01910155|Dexamethasone|dexamethasone|mesh-list
44782605|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782606|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
44782607|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
44782608|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782609|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782610|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782611|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
44782612|NCT01910155|Hormones|hormones|mesh-ancestor
44782613|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782614|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44782615|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782616|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782617|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782618|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782619|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782620|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782621|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782622|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44782623|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44782624|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
44782625|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782626|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782627|NCT01910246|Metformin|metformin|mesh-list
44782628|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782629|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782630|NCT01910259|Amiloride|amiloride|mesh-list
44782631|NCT01910259|Riluzole|riluzole|mesh-list
44782632|NCT01910259|Fluoxetine|fluoxetine|mesh-list
44782633|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44782634|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44782635|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782636|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782637|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782638|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
44782639|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782640|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44782641|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44782642|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44782643|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44782644|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44782645|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782646|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
44782647|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44782648|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44782649|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44782650|NCT01910259|Protective Agents|protective agents|mesh-ancestor
44561152|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561153|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44561154|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44561155|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
44561156|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44561157|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44561158|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
44561159|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
44561160|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561161|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44561162|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44561163|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44561164|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782651|NCT01910259|Diuretics|diuretics|mesh-ancestor
44782652|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
44782653|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44782654|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44782655|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44782656|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44782657|NCT01910285|Sufentanil|sufentanil|mesh-list
44782658|NCT01910285|Dsuvia|dsuvia|mesh-list
44782659|NCT01910285|Remifentanil|remifentanil|mesh-list
44782660|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44782661|NCT01910285|Narcotics|narcotics|mesh-ancestor
44782662|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782663|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782664|NCT01910285|Analgesics|analgesics|mesh-ancestor
44782665|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
44782666|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782667|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44782668|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44782669|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
44782670|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
44782671|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
44782672|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44782673|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44782674|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44782675|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782676|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782677|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
44782678|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782679|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782680|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44782681|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782682|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
44782683|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44782684|NCT01910415|Ivacaftor|ivacaftor|mesh-list
44782685|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782686|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782687|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782688|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782689|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782690|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782691|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782692|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44782693|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
44782694|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44782695|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782696|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44782697|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44782698|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44782699|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44782700|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782701|NCT01910428|Asparaginase|asparaginase|mesh-list
44782702|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782703|NCT01910480|Ketoconazole|ketoconazole|mesh-list
44782704|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
44782705|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782706|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44782707|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44782708|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782709|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782710|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44782711|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44782712|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782713|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782714|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44782715|NCT01910506|Verinurad|verinurad|mesh-list
44782716|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
44782717|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782718|NCT01910532|Clevidipine|clevidipine|mesh-list
44782719|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44782720|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782721|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782722|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782723|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782724|NCT01910545|OTS167|ots167|mesh-list
44782725|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782727|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782728|NCT01910610|Bevacizumab|bevacizumab|mesh-list
44782729|NCT01910610|Cetuximab|cetuximab|mesh-list
44782730|NCT01910610|Panitumumab|panitumumab|mesh-list
44782731|NCT01910610|Irinotecan|irinotecan|mesh-list
44782732|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44782733|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782734|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44782735|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44782736|NCT01910610|Growth Substances|growth substances|mesh-ancestor
44782737|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782738|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
44782739|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44782740|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782741|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782742|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782743|NCT01910766|Ubiquinone|ubiquinone|mesh-list
44782744|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
44782745|NCT01910766|Clomiphene|clomiphene|mesh-list
44782746|NCT01910766|Enclomiphene|enclomiphene|mesh-list
44782747|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
44782748|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44782749|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
44782750|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782751|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782752|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44782753|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
44782754|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44782755|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44782756|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44782757|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
44782758|NCT01910766|Vitamins|vitamins|mesh-ancestor
44782759|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
44782760|NCT01910844|Cisplatin|cisplatin|mesh-list
44782761|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782762|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
44782763|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782764|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782765|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44782766|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
44782767|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782768|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782769|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44782770|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
44782771|NCT01910870|Cisplatin|cisplatin|mesh-list
44782772|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782773|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
44782774|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782775|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44782776|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44782777|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
44782778|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782779|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782780|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44782781|NCT01910883|Finafloxacin|finafloxacin|mesh-list
44782782|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
44782783|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44782784|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44782785|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782786|NCT01910883|Renal Agents|renal agents|mesh-ancestor
44782787|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44782788|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44782789|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44782790|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782791|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782792|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782793|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44782794|NCT01910987|Dexamethasone|dexamethasone|mesh-list
44782795|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
44782796|NCT01910987|Bortezomib|bortezomib|mesh-list
44782797|NCT01910987|BB 1101|bb 1101|mesh-list
44782798|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44782799|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
44782800|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
44782801|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782802|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782803|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782804|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
44782805|NCT01910987|Hormones|hormones|mesh-ancestor
44782806|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44782807|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44782808|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782809|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
44782810|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782811|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782812|NCT01911195|Isoflurane|isoflurane|mesh-list
44782813|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44782814|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
44782815|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
44782816|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782817|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782818|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
44782819|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44782820|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
44782821|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782822|NCT01911247|Metformin|metformin|mesh-list
44782823|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782824|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782825|NCT01911299|Choline|choline|mesh-list
44782826|NCT01911299|Glycerol|glycerol|mesh-list
44782827|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
44782828|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44782829|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
44782830|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782831|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782832|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44782833|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
44782834|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44782835|NCT01911299|Protective Agents|protective agents|mesh-ancestor
44782836|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782837|NCT01911325|Docetaxel|docetaxel|mesh-list
44782838|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782839|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782840|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782841|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782842|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782843|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
44782844|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44782845|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
44782846|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782847|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782848|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44782849|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
44782850|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
44782851|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44782852|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
44782853|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782854|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782855|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
44782856|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44782857|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44782858|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44782859|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782860|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692019|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692020|NCT01364961|Protective Agents|protective agents|mesh-ancestor
44692021|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692022|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692023|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692024|NCT01364974|Peficitinib|peficitinib|mesh-list
44692025|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692026|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692027|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692028|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
44692029|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692030|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
44692031|NCT01364987|Peficitinib|peficitinib|mesh-list
44561317|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393347|NCT03061331|Ivacaftor|ivacaftor|mesh-list
44782861|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44782862|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782863|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782864|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44782865|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782866|NCT01911455|Acamprosate|acamprosate|mesh-list
44782867|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44782868|NCT01911468|Metformin|metformin|mesh-list
44782869|NCT01911468|Liraglutide|liraglutide|mesh-list
44782870|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44782871|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782872|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782873|NCT01911468|Incretins|incretins|mesh-ancestor
44782874|NCT01911468|Hormones|hormones|mesh-ancestor
44782875|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561376|NCT01178138|Prazosin|prazosin|mesh-list
44561377|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561378|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44561379|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44561380|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44561381|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561382|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561383|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561384|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782876|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
44782877|NCT01911494|Methyldopa|methyldopa|mesh-list
44782878|NCT01911494|Analgesics|analgesics|mesh-ancestor
44782879|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
44782880|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782881|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782882|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
44782883|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782884|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44782885|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
44782886|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44782887|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782888|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782889|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44782890|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
44782891|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44782892|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44782893|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
44782894|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
44782895|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44782896|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44782897|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44782898|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
44782899|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782900|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44782901|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782902|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44782903|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782904|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782905|NCT01911598|Paclitaxel|paclitaxel|mesh-list
44393414|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44393415|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
44393416|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
44393417|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782906|NCT01911598|Cisplatin|cisplatin|mesh-list
44782907|NCT01911598|Carboplatin|carboplatin|mesh-list
44782908|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44782909|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782910|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
44782911|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
44782912|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
44782913|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782914|NCT01911624|Enoxaparin|enoxaparin|mesh-list
44782915|NCT01911624|Dabigatran|dabigatran|mesh-list
44782916|NCT01911624|Argatroban|argatroban|mesh-list
44782917|NCT01911624|Thrombin|thrombin|mesh-list
44782918|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
44782919|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44782920|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44782921|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782922|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
44782923|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44782924|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44782925|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782926|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
44782927|NCT01911624|Coagulants|coagulants|mesh-ancestor
44782928|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44782929|NCT01911728|Pioglitazone|pioglitazone|mesh-list
44782930|NCT01911728|Midazolam|midazolam|mesh-list
44782931|NCT01911728|Omeprazole|omeprazole|mesh-list
44782932|NCT01911728|Warfarin|warfarin|mesh-list
44782933|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44782934|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44782935|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782936|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782937|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44782938|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44782939|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44782940|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44782941|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
44782942|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
44782943|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
44782944|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
44782945|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782946|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782947|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44782948|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
44782949|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44782950|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44782951|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44782952|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782953|NCT01911949|Epinephrine|epinephrine|mesh-list
44782954|NCT01911949|Bupivacaine|bupivacaine|mesh-list
44782955|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
44782956|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
44782957|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44782958|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782959|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
44782960|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44782961|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44782962|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44782963|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
44782964|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44782965|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782966|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44782967|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44782968|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
44782969|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44782970|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
44782971|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
44782972|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
44782973|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44782974|NCT01911975|Lacosamide|lacosamide|mesh-list
44782975|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
44782976|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44782977|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44782978|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44782979|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782980|NCT01912053|Gemcitabine|gemcitabine|mesh-list
44782981|NCT01912053|Cisplatin|cisplatin|mesh-list
44782982|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44782983|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44782984|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
44426788|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
44393502|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393503|NCT03053050|Selonsertib|selonsertib|mesh-list
44393504|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44393505|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393506|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393507|NCT03052816|Hydromorphone|hydromorphone|mesh-list
44393508|NCT03052816|Analgesics|analgesics|mesh-ancestor
44393509|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
44393510|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393511|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393512|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44393513|NCT03052816|Narcotics|narcotics|mesh-ancestor
44782985|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44782986|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
44782987|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44782988|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44782989|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44782990|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
44782991|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782992|NCT01912066|Aceclofenac|aceclofenac|mesh-list
44782993|NCT01912066|Misoprostol|misoprostol|mesh-list
44782994|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44782995|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
44782996|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44782997|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44782998|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44782999|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783000|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
44783001|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44783002|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783003|NCT01912066|Analgesics|analgesics|mesh-ancestor
44783004|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
44783005|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783006|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783007|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783008|NCT01912118|Remifentanil|remifentanil|mesh-list
44783009|NCT01912118|Propofol|propofol|mesh-list
44783010|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44783011|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783012|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783013|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44783014|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
44783015|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
44783016|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783017|NCT01912118|Narcotics|narcotics|mesh-ancestor
44783018|NCT01912118|Analgesics|analgesics|mesh-ancestor
44783019|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
44783020|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783021|NCT01912378|Oxytocin|oxytocin|mesh-list
44783022|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
44783023|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44783024|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783025|NCT01912391|Selegiline|selegiline|mesh-list
44783026|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
44783027|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783028|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44561502|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783029|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44783030|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44783031|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783032|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783033|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44783034|NCT01912391|Protective Agents|protective agents|mesh-ancestor
44783035|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783036|NCT01912443|Bevacizumab|bevacizumab|mesh-list
44783037|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783038|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783039|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783040|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783041|NCT01912443|Growth Substances|growth substances|mesh-ancestor
44783042|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783043|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783044|NCT01912534|Valsartan|valsartan|mesh-list
44783045|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44783046|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44783047|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44783048|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783049|NCT01912573|Naloxone|naloxone|mesh-list
44783050|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44783051|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783052|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
44783053|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783054|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
44783055|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783056|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44783057|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44783058|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783059|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783060|NCT01912586|Urological Agents|urological agents|mesh-ancestor
44783061|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
44783062|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44783063|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
44783064|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783065|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
44783066|NCT01912638|Protective Agents|protective agents|mesh-ancestor
44783067|NCT01912677|Labetalol|labetalol|mesh-list
44783068|NCT01912677|Methyldopa|methyldopa|mesh-list
44783069|NCT01912677|Nifedipine|nifedipine|mesh-list
44783070|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44783071|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783072|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783073|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44783074|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783075|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783076|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
44783077|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44783078|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44783079|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44783080|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783081|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783082|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44783083|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
44783084|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
44783085|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783086|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44783087|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44783088|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
44783089|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44783090|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44393593|NCT03050359|Lansoprazole|lansoprazole|mesh-list
44783091|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44783092|NCT01912755|Lidocaine|lidocaine|mesh-list
44783093|NCT01912755|Epinephrine|epinephrine|mesh-list
44783094|NCT01912755|Racepinephrine|racepinephrine|mesh-list
44783095|NCT01912755|Carticaine|carticaine|mesh-list
44783096|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
44783097|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
44783098|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
44783099|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783100|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783101|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
44783102|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783103|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44561579|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
44783104|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44783105|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44783106|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783107|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783108|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44783109|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44783110|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783111|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783112|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44783113|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44783114|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
44783115|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44783116|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
44783118|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
44783119|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44783120|NCT01912820|Quercetin|quercetin|mesh-list
44783121|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
44783122|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783123|NCT01912820|Protective Agents|protective agents|mesh-ancestor
44783124|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783125|NCT01912898|Vitamin D|vitamin d|mesh-list
44783126|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
44783127|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
44783128|NCT01912898|Vitamins|vitamins|mesh-list
44783129|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
44783130|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783131|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44783132|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44783133|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44783134|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44783135|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783136|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44783137|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
44783138|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44783139|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783140|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44783141|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44783142|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783143|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783144|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783145|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783146|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44783147|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783148|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
44783149|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783150|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44783151|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783152|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783153|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
44783154|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783155|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783156|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44783157|NCT01913054|Fentanyl|fentanyl|mesh-list
44783158|NCT01913054|Propofol|propofol|mesh-list
44783159|NCT01913054|Etomidate|etomidate|mesh-list
44783160|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44783161|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783162|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783163|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44783164|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
44783165|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
44561648|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
44561649|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783166|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783167|NCT01913054|Narcotics|narcotics|mesh-ancestor
44783168|NCT01913054|Analgesics|analgesics|mesh-ancestor
44783169|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
44561650|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561651|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561652|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561653|NCT01174186|Adalimumab|adalimumab|mesh-list
44561656|NCT01174173|Ranolazine|ranolazine|mesh-list
44783170|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783171|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44783172|NCT01913106|Valacyclovir|valacyclovir|mesh-list
44783173|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
44783174|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783175|NCT01913119|Romidepsin|romidepsin|mesh-list
44783176|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44783177|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561720|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783178|NCT01913379|Itraconazole|itraconazole|mesh-list
44783179|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
44783180|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
44783181|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783182|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44783183|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44783184|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783185|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783186|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44783187|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
44783188|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783189|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783190|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44783191|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44783192|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
44783193|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44783194|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44783195|NCT01913431|Entecavir|entecavir|mesh-list
44783196|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
44783197|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783198|NCT01913444|Antithrombins|antithrombins|mesh-list
44783199|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
44783200|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44783201|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
44783202|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783203|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783204|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
44783205|NCT01913691|Ipilimumab|ipilimumab|mesh-list
44783206|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783207|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783208|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44783209|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783210|NCT01913808|Iron|iron|mesh-list
44783211|NCT01913808|Glycine|glycine|mesh-list
44783212|NCT01913808|Trace Elements|trace elements|mesh-ancestor
44783213|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
44783214|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783215|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
44783216|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783217|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783218|NCT01913834|Teriparatide|teriparatide|mesh-list
44783219|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44783220|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783221|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44783222|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
44783223|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783224|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44783225|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44783226|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783227|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783228|NCT01913847|Urological Agents|urological agents|mesh-ancestor
44783229|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44783230|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783231|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
44783232|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
44783233|NCT01913964|Vitamins|vitamins|mesh-ancestor
44783234|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
44783235|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783236|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
44783237|NCT01913990|Dexamethasone|dexamethasone|mesh-list
44783238|NCT01913990|Ondansetron|ondansetron|mesh-list
44783239|NCT01913990|Aprepitant|aprepitant|mesh-list
44783240|NCT01913990|Antiemetics|antiemetics|mesh-list
44783241|NCT01913990|Emetics|emetics|mesh-list
44783242|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783243|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
44783244|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783245|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783246|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783247|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
44783248|NCT01913990|Hormones|hormones|mesh-ancestor
44783249|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783250|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44783251|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783252|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
44561793|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
44783253|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783254|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44783255|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
44783256|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783257|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783258|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44783259|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44783260|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783261|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783262|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44783263|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44783264|NCT01914042|Morphine|morphine|mesh-list
44783265|NCT01914042|Milnacipran|milnacipran|mesh-list
44783266|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
44783267|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783268|NCT01914042|Narcotics|narcotics|mesh-ancestor
44783269|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783270|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783271|NCT01914042|Analgesics|analgesics|mesh-ancestor
44783272|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
44783273|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783274|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44783275|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44783276|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783277|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783278|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783279|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783280|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
44783281|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783282|NCT01914081|Resveratrol|resveratrol|mesh-list
44783283|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
44783284|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783285|NCT01914081|Protective Agents|protective agents|mesh-ancestor
44783286|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783287|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783288|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44783289|NCT01914133|Acarbose|acarbose|mesh-list
44783290|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44783291|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783292|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783293|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783294|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783295|NCT01914146|Insulin|insulin|mesh-list
44783296|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44783297|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783298|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783299|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
44783300|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44783301|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44783302|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783303|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
44783304|NCT01914211|Coagulants|coagulants|mesh-ancestor
44783305|NCT01914237|Castor Oil|castor oil|mesh-list
44783306|NCT01914237|Cathartics|cathartics|mesh-ancestor
44783307|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783308|NCT01914250|Analgesics|analgesics|mesh-list
44783309|NCT01914250|Tetracaine|tetracaine|mesh-list
44783310|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
44783311|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783312|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783313|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
44783314|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
44783315|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783316|NCT01914380|Aflibercept|aflibercept|mesh-list
44783317|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783318|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783319|NCT01914380|Growth Substances|growth substances|mesh-ancestor
44783320|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783321|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783322|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783323|NCT01914419|Oxytocin|oxytocin|mesh-list
44783324|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
44783325|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44783326|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783327|NCT01914432|Telmisartan|telmisartan|mesh-list
44783328|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44783329|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44393858|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44692032|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44692033|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692034|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44692035|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
44692036|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44692037|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692038|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692039|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692040|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692041|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
44692042|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692044|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692045|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692046|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
44692047|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692048|NCT01365065|Vorinostat|vorinostat|mesh-list
44692049|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692050|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44692051|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692052|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692053|NCT01365104|Deferoxamine|deferoxamine|mesh-list
44692054|NCT01365104|Siderophores|siderophores|mesh-ancestor
44692055|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44692056|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
44692057|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
44692058|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692059|NCT01365117|Insulin|insulin|mesh-list
44692060|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44692061|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44692062|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692063|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44692064|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692065|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
44692066|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44692067|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
44393876|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
44783330|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44783331|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
44783332|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783333|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44783334|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44783335|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783336|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44783337|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44783338|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44783339|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44783340|NCT01914562|Cathartics|cathartics|mesh-ancestor
44783341|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783342|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
44783343|NCT01914627|Salicylates|salicylates|mesh-list
44783344|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783345|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
44783346|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
44783347|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783348|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44561939|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561940|NCT01169779|Metformin|metformin|mesh-list
44561941|NCT01169779|Lixisenatide|lixisenatide|mesh-list
44561942|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561943|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561944|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
44561945|NCT01169701|Everolimus|everolimus|mesh-list
44561946|NCT01169701|Tacrolimus|tacrolimus|mesh-list
44561947|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561948|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
44561949|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561950|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44561951|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561952|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561953|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561954|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44561955|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44561956|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
44561957|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44783349|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783350|NCT01914627|Analgesics|analgesics|mesh-ancestor
44783351|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
44783352|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783353|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783354|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783355|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783356|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44783357|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783358|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783359|NCT01914692|Somatostatin|somatostatin|mesh-list
44783361|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783362|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783363|NCT01914718|Rituximab|rituximab|mesh-list
44783364|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783365|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783366|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
44783367|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783368|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783369|NCT01914744|Lamivudine|lamivudine|mesh-list
44783370|NCT01914744|Entecavir|entecavir|mesh-list
44783371|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44783372|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44783373|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783374|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783375|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
44783376|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783377|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44783378|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44783379|NCT01914770|Belimumab|belimumab|mesh-list
44783380|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783381|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
44783382|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783383|NCT01914822|Methylphenidate|methylphenidate|mesh-list
44783384|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44783385|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783386|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44783387|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44783388|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783389|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783390|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
44783391|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783392|NCT01914900|Cisplatin|cisplatin|mesh-list
44783393|NCT01914900|Docetaxel|docetaxel|mesh-list
44783394|NCT01914900|Fluorouracil|fluorouracil|mesh-list
44783395|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783396|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44783397|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44783398|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783399|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783400|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
44783401|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44783402|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393968|NCT03031496|Amiloride|amiloride|mesh-list
44783403|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
44783404|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561959|NCT01169675|Pemetrexed|pemetrexed|mesh-list
44783406|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
44783407|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44783408|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783409|NCT01914965|Bupropion|bupropion|mesh-list
44783410|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44783411|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
44783412|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783413|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44783414|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44783415|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783416|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783417|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
44783418|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783419|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783420|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44783421|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44783422|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783423|NCT01915069|Cilostazol|cilostazol|mesh-list
44783424|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44783425|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
44783426|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783427|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783428|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44783429|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44783430|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44783431|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44783432|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783433|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44783434|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783435|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44783436|NCT01915069|Protective Agents|protective agents|mesh-ancestor
44783437|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44783438|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44783439|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783440|NCT01915082|Azithromycin|azithromycin|mesh-list
44783441|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44783442|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783443|NCT01915134|Gemcitabine|gemcitabine|mesh-list
44783444|NCT01915134|Cisplatin|cisplatin|mesh-list
44783445|NCT01915134|Endostatins|endostatins|mesh-list
44783446|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783447|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44783448|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
44783449|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783450|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
44783451|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783452|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783453|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783454|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
44783455|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783456|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783457|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783458|NCT01915134|Growth Substances|growth substances|mesh-ancestor
44783459|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783460|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44783461|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44783462|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
44783463|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783464|NCT01915264|Metformin|metformin|mesh-list
44783465|NCT01915264|Acarbose|acarbose|mesh-list
44783466|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783467|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783468|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44783469|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783470|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783471|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
44783472|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44783473|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783474|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783475|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783476|NCT01915277|Analgesics|analgesics|mesh-ancestor
44783477|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
44783478|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783479|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44783480|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44783481|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44783482|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783483|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783484|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783485|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
44783486|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44783487|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44783488|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44783489|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783490|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783491|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
44783492|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783493|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783494|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44783495|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783496|NCT01915472|Irinotecan|irinotecan|mesh-list
44783497|NCT01915472|Labetuzumab|labetuzumab|mesh-list
44783498|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
44783499|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
44783500|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783501|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44783502|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44783503|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783504|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783505|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783506|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783507|NCT01915537|Infliximab|infliximab|mesh-list
44783508|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783509|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783510|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783511|NCT01915550|Insulin|insulin|mesh-list
44783512|NCT01915550|Metformin|metformin|mesh-list
44783513|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44783514|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
44783515|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783516|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783517|NCT01915602|Sorafenib|sorafenib|mesh-list
44783518|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783519|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44783520|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783521|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783522|NCT01915758|Clindamycin|clindamycin|mesh-list
44783523|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
44783524|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
44783525|NCT01915758|Tretinoin|tretinoin|mesh-list
44783526|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44783527|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783528|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44783529|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783530|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783531|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783532|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
44783533|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783534|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44783535|NCT01915901|Bismuth|bismuth|mesh-list
44783536|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44783537|NCT01915901|Antacids|antacids|mesh-ancestor
44783538|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783539|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783540|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783541|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783542|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
44783543|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783544|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
44783545|NCT01915979|Betamethasone|betamethasone|mesh-list
44783546|NCT01915979|Mitogens|mitogens|mesh-list
44783547|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783548|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783549|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562107|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
44783550|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
44783551|NCT01915979|Hormones|hormones|mesh-ancestor
44783552|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783553|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783554|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44783555|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44783556|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44783557|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44783558|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783559|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44783560|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44783561|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783562|NCT01916174|Insulin|insulin|mesh-list
44783563|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44783564|NCT01916174|Liraglutide|liraglutide|mesh-list
44783565|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
44783566|NCT01916174|Xultophy|xultophy|mesh-list
44783567|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783568|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783569|NCT01916174|Incretins|incretins|mesh-ancestor
44783570|NCT01916174|Hormones|hormones|mesh-ancestor
44783571|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783572|NCT01916187|Imetelstat|imetelstat|mesh-list
44783573|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
44783574|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783575|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783576|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44783577|NCT01916200|Paroxetine|paroxetine|mesh-list
44783578|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44783579|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44783580|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783581|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783582|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783583|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
44783584|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783585|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44783586|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
44783587|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783588|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44783589|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44783590|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783591|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
44783592|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44783593|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
44783594|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783595|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
44783596|NCT01916213|Protective Agents|protective agents|mesh-ancestor
44783597|NCT01916252|Dexamethasone|dexamethasone|mesh-list
44783598|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
44783599|NCT01916252|Lenalidomide|lenalidomide|mesh-list
44783600|NCT01916252|Bortezomib|bortezomib|mesh-list
44783601|NCT01916252|Melphalan|melphalan|mesh-list
44783602|NCT01916252|Busulfan|busulfan|mesh-list
44783603|NCT01916252|BB 1101|bb 1101|mesh-list
44783604|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783605|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
44783606|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
44783607|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783608|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783609|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783610|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
44783611|NCT01916252|Hormones|hormones|mesh-ancestor
44783612|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783613|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44783614|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783615|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
44783616|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783617|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783618|NCT01916252|Growth Substances|growth substances|mesh-ancestor
44783619|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783620|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44783621|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
44783622|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783623|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44783624|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783625|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44783626|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783627|NCT01916265|Glucagon|glucagon|mesh-list
44783628|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783630|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783631|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783632|NCT01916382|Nitisinone|nitisinone|mesh-list
44783633|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783634|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783635|NCT01916395|Sumatriptan|sumatriptan|mesh-list
44783636|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44783637|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44783638|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44783639|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
44783640|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783641|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783642|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783643|NCT01916408|Wobenzym|wobenzym|mesh-list
44783644|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44783645|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
44783646|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783647|NCT01916447|Bevacizumab|bevacizumab|mesh-list
44783648|NCT01916447|Irinotecan|irinotecan|mesh-list
44783649|NCT01916447|Camptothecin|camptothecin|mesh-list
44783650|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394215|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
44783651|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783652|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783653|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783654|NCT01916447|Growth Substances|growth substances|mesh-ancestor
44783655|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783656|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783657|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44783658|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44783659|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783660|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783661|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44783662|NCT01916577|Plerixafor|plerixafor|mesh-list
44783663|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44783664|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44783665|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
44783666|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562256|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562257|NCT01165281|Analgesics|analgesics|mesh-ancestor
44562258|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
44562259|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562260|NCT01165216|Paclitaxel|paclitaxel|mesh-list
44562261|NCT01165216|Carboplatin|carboplatin|mesh-list
44562262|NCT01165216|Ipilimumab|ipilimumab|mesh-list
44562263|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44562265|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44783668|NCT01916642|Etomidate|etomidate|mesh-list
44783669|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
44783670|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
44783671|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783672|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783673|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
44783674|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783675|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44394242|NCT03020914|Methamphetamine|methamphetamine|mesh-list
44783676|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44783677|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44783678|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783679|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783680|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44783681|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44783682|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
44783683|NCT01916707|Enoxaparin|enoxaparin|mesh-list
44783684|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
44783685|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44783686|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44783687|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783688|NCT01916733|Insulin|insulin|mesh-list
44783689|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783690|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783691|NCT01916785|Dasatinib|dasatinib|mesh-list
44783692|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783693|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44783694|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783695|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783696|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44783697|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44783698|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44783699|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44783700|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44783701|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44783702|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783703|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783704|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783705|NCT01916863|Canagliflozin|canagliflozin|mesh-list
44783706|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44783707|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44783708|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783709|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44783710|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783711|NCT01916902|Ticagrelor|ticagrelor|mesh-list
44783712|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44783713|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44783714|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44783715|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44783716|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
44783717|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783718|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783719|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783720|NCT01916915|Tramadol|tramadol|mesh-list
44783721|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
44783722|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783723|NCT01916915|Narcotics|narcotics|mesh-ancestor
44783724|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783725|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783726|NCT01916915|Analgesics|analgesics|mesh-ancestor
44783727|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
44783728|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783729|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44783730|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
44783731|NCT01916954|Lumefantrine|lumefantrine|mesh-list
44783732|NCT01916954|Artemether|artemether|mesh-list
44783733|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44783734|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
44394321|NCT03018249|Entinostat|entinostat|mesh-list
44783735|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44562270|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44783736|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44783737|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783738|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
44783739|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44783740|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44783741|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783742|NCT01917032|Folic Acid|folic acid|mesh-list
44783743|NCT01917032|Vitamin A|vitamin a|mesh-list
44783744|NCT01917032|Micronutrients|micronutrients|mesh-list
44783745|NCT01917032|Trace Elements|trace elements|mesh-list
44783746|NCT01917032|Tretinoin|tretinoin|mesh-list
44783747|NCT01917032|Vitamins|vitamins|mesh-ancestor
44783748|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783749|NCT01917032|Hematinics|hematinics|mesh-ancestor
44783750|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
44783751|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783752|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
44783753|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
44783754|NCT01917045|Sufentanil|sufentanil|mesh-list
44783755|NCT01917045|Morphine|morphine|mesh-list
44783756|NCT01917045|Dsuvia|dsuvia|mesh-list
44783757|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783758|NCT01917045|Narcotics|narcotics|mesh-ancestor
44783759|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783760|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783761|NCT01917045|Analgesics|analgesics|mesh-ancestor
44783762|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
44783763|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783764|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44783765|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44783766|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
44783767|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
44783768|NCT01917058|Abatacept|abatacept|mesh-list
44783769|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44783770|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783771|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783772|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783773|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
44783774|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783775|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783776|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
44783777|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44783778|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783779|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783780|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783781|NCT01917097|Analgesics|analgesics|mesh-ancestor
44783782|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
44783783|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783784|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44783785|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44783786|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44783787|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783788|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783789|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783790|NCT01917149|Metoprolol|metoprolol|mesh-list
44783791|NCT01917149|Valsartan|valsartan|mesh-list
44783792|NCT01917149|Benazepril|benazepril|mesh-list
44783793|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44783794|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44783795|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44783796|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783797|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44783798|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
44783799|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
44783800|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783801|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783802|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44783803|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44783804|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44783805|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783806|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783807|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44783808|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
44783809|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783810|NCT01917279|Docetaxel|docetaxel|mesh-list
44783811|NCT01917279|Capecitabine|capecitabine|mesh-list
44783812|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783813|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394410|NCT03012061|Xhance|xhance|mesh-list
44783814|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
44783815|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783816|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783817|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44783818|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
44783819|NCT01917318|Iloperidone|iloperidone|mesh-list
44783820|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44783821|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44783822|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783823|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783824|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44783825|NCT01917331|Beclomethasone|beclomethasone|mesh-list
44783826|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
44783827|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
44783828|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44783829|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
44783830|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783831|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783832|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44783833|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
44783834|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44783835|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44783836|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44783837|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
44783838|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783839|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783840|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44783841|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44783842|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44783843|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
44783844|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783845|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
44783846|NCT01917331|Hormones|hormones|mesh-ancestor
44783847|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783848|NCT01917448|Morphine|morphine|mesh-list
44783849|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783850|NCT01917448|Narcotics|narcotics|mesh-ancestor
44783851|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783852|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783853|NCT01917448|Analgesics|analgesics|mesh-ancestor
44783854|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
44783855|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783856|NCT01917578|Paclitaxel|paclitaxel|mesh-list
44783857|NCT01917578|Docetaxel|docetaxel|mesh-list
44783858|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44783859|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
44783860|NCT01917578|Carboplatin|carboplatin|mesh-list
44783861|NCT01917578|Doxorubicin|doxorubicin|mesh-list
44783862|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44783863|NCT01917578|Fluorouracil|fluorouracil|mesh-list
44783864|NCT01917578|Trastuzumab|trastuzumab|mesh-list
44783865|NCT01917578|Epirubicin|epirubicin|mesh-list
44783866|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44783867|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783868|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44783869|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44783870|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783871|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783872|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783873|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
44783874|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783875|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783876|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44783877|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
44783878|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44394456|NCT03010423|Nicorandil|nicorandil|mesh-list
44783879|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44783880|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44783881|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44783882|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783883|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
44783884|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44783885|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783886|NCT01917617|Gemcitabine|gemcitabine|mesh-list
44783887|NCT01917617|Cisplatin|cisplatin|mesh-list
44783888|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44783889|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783890|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44783891|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
44783892|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783893|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
44783894|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783895|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783896|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783897|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
44783898|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783899|NCT01917708|Abatacept|abatacept|mesh-list
44783900|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44783901|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783902|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394497|NCT03008005|Hormones|hormones|mesh-ancestor
44783903|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783904|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
44783905|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783906|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783907|NCT01917721|Doxycycline|doxycycline|mesh-list
44783908|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44783909|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44783910|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
44783911|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44783912|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44783913|NCT01917799|Aspirin|aspirin|mesh-list
44783914|NCT01917799|Heparin|heparin|mesh-list
44783915|NCT01917799|Enoxaparin|enoxaparin|mesh-list
44783916|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44783917|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783918|NCT01917799|Analgesics|analgesics|mesh-ancestor
44783919|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
44783920|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783921|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783922|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783923|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783924|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44783925|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44426789|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783926|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783927|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44783928|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44783929|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783930|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
44783931|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
44783932|NCT01917877|Dexamethasone|dexamethasone|mesh-list
44783933|NCT01917877|Bevacizumab|bevacizumab|mesh-list
44783934|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44783935|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783936|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44783937|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44783938|NCT01917877|Growth Substances|growth substances|mesh-ancestor
44783939|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783940|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
44783941|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783942|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
44783943|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
44783944|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783945|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44783946|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
44783947|NCT01917877|Hormones|hormones|mesh-ancestor
44783948|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44783949|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44783950|NCT01917890|Curcumin|curcumin|mesh-list
44783951|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44783952|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44783953|NCT01917890|Analgesics|analgesics|mesh-ancestor
44783954|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
44783955|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783956|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783957|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44783958|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783959|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783960|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44783961|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783962|NCT01918098|Oxycodone|oxycodone|mesh-list
44783963|NCT01918098|Naloxone|naloxone|mesh-list
44783964|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44783965|NCT01918098|Narcotics|narcotics|mesh-ancestor
44783966|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44783967|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783969|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
44783970|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783971|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44783972|NCT01918111|Adenosine|adenosine|mesh-list
44783973|NCT01918111|Analgesics|analgesics|mesh-ancestor
44783974|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
44783975|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44783976|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783977|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44783978|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
44783979|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44783980|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
44783981|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
44783982|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44783983|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783984|NCT01918124|Paclitaxel|paclitaxel|mesh-list
44783985|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
44783986|NCT01918124|Cisplatin|cisplatin|mesh-list
44783987|NCT01918124|Carboplatin|carboplatin|mesh-list
44783988|NCT01918124|Doxorubicin|doxorubicin|mesh-list
44394560|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692068|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692069|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
44692070|NCT01365260|Protective Agents|protective agents|mesh-ancestor
44692071|NCT01365312|Ethanol|ethanol|mesh-list
44692072|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44692073|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692074|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692075|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692076|NCT01365351|Hormones|hormones|mesh-list
44692077|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692078|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692079|NCT01365403|Carbamazepine|carbamazepine|mesh-list
44692080|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
44692081|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
44692082|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44692083|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692084|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692085|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692086|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44692087|NCT01365403|Analgesics|analgesics|mesh-ancestor
44692088|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
44692089|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692090|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44692091|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692092|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692093|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44394594|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
44692094|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44692095|NCT01365598|Primaquine|primaquine|mesh-list
44692096|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
44692097|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44692098|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44692099|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692100|NCT01365676|Hypericin|hypericin|mesh-list
44692101|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692102|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692103|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692104|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
44692105|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692106|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692107|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692108|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692109|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
44692110|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692111|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44692112|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692113|NCT01365871|Anesthetics|anesthetics|mesh-list
44692114|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692115|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692116|NCT01365897|Modafinil|modafinil|mesh-list
44692117|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44692118|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562574|NCT01160744|Cisplatin|cisplatin|mesh-list
44783989|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44783990|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44783991|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
44783992|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
44783993|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
44783994|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44783995|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44783996|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
44783997|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44783998|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44783999|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44784000|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
44784001|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44784002|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44784003|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44784004|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44784005|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784006|NCT01918150|Cobalt|cobalt|mesh-list
44784007|NCT01918150|Chromium|chromium|mesh-list
44784008|NCT01918150|Trace Elements|trace elements|mesh-ancestor
44784009|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
44784010|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784011|NCT01918176|Palbociclib|palbociclib|mesh-list
44784012|NCT01918176|Rabeprazole|rabeprazole|mesh-list
44784013|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784014|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784015|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784016|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784017|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44784018|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784019|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44784020|NCT01918241|Lenograstim|lenograstim|mesh-list
44784021|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44784022|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
44784023|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784024|NCT01918254|Paclitaxel|paclitaxel|mesh-list
44784025|NCT01918254|Pertuzumab|pertuzumab|mesh-list
44784026|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44784027|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394659|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44784028|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
44784029|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
44784030|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
44784031|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784032|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44784033|NCT01918358|Valsartan|valsartan|mesh-list
44784034|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44784035|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44784036|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44784037|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
44784038|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784039|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44784040|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44784041|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784042|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44784043|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44784044|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44784045|NCT01918384|Arbekacin|arbekacin|mesh-list
44784046|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784047|NCT01918475|Carbetocin|carbetocin|mesh-list
44784048|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
44784049|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784050|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784051|NCT01918488|Amiloride|amiloride|mesh-list
44784052|NCT01918488|Triamterene|triamterene|mesh-list
44784053|NCT01918488|Diuretics|diuretics|mesh-ancestor
44784054|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
44784055|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784056|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44784057|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44784058|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44784059|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784060|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44784061|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44784062|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
44784063|NCT01918514|Analgesics|analgesics|mesh-ancestor
44784064|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
44784065|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784066|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784067|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
44784068|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784069|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44784070|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
44784071|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44784072|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44784073|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784074|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44784075|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
44784076|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784077|NCT01918631|Tenofovir|tenofovir|mesh-list
44784078|NCT01918631|Entecavir|entecavir|mesh-list
44784079|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
44784080|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784081|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44784082|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44784083|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784084|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784085|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44784086|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44784087|NCT01918709|Valsartan|valsartan|mesh-list
44784088|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44784089|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44784090|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44784091|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
44784092|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784093|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44784094|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44784095|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784096|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44784097|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44784098|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44784099|NCT01918813|Vancomycin|vancomycin|mesh-list
44784100|NCT01918813|Mupirocin|mupirocin|mesh-list
44784101|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784102|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784103|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44784104|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784105|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784106|NCT01918852|Bevacizumab|bevacizumab|mesh-list
44784107|NCT01918852|Capecitabine|capecitabine|mesh-list
44784108|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44784109|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784110|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44784111|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44784112|NCT01918852|Growth Substances|growth substances|mesh-ancestor
44784113|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784114|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
44784115|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44784116|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
44784117|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784118|NCT01918865|Metformin|metformin|mesh-list
44784119|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784120|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784121|NCT01918878|Aflibercept|aflibercept|mesh-list
44784122|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44784123|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44784124|NCT01918878|Growth Substances|growth substances|mesh-ancestor
44784125|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784126|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44784127|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784128|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
44784129|NCT01918904|Antidotes|antidotes|mesh-ancestor
44784130|NCT01918904|Protective Agents|protective agents|mesh-ancestor
44784131|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784132|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
44784133|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784134|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
44784135|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784136|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784137|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
44784138|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
44784139|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
44784140|NCT01918917|Morphine|morphine|mesh-list
44784141|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
44784142|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44784143|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784144|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784145|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784146|NCT01918917|Analgesics|analgesics|mesh-ancestor
44784147|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
44784148|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784149|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44784150|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44784151|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44784152|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784153|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784154|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784155|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784156|NCT01918917|Narcotics|narcotics|mesh-ancestor
44784157|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
44784158|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
44784159|NCT01918995|Regadenoson|regadenoson|mesh-list
44784160|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44784161|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44784162|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
44784163|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
44784164|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784165|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784166|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784167|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44784168|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
44394809|NCT02996097|Hormones|hormones|mesh-ancestor
44784169|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44784170|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44784171|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44784172|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784173|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784174|NCT01919047|Mirabegron|mirabegron|mesh-list
44784175|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44784176|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44784177|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44784178|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784179|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784180|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784181|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784182|NCT01919047|Urological Agents|urological agents|mesh-ancestor
44784183|NCT01919203|Remifentanil|remifentanil|mesh-list
44784184|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784185|NCT01919203|Narcotics|narcotics|mesh-ancestor
44784186|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784187|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784188|NCT01919203|Analgesics|analgesics|mesh-ancestor
44784189|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
44784190|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784191|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
44784192|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
44784193|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
44784194|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
44784195|NCT01919255|Citric Acid|citric acid|mesh-list
44784196|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
44784197|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44784198|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
44784199|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
44784200|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784201|NCT01919255|Cathartics|cathartics|mesh-ancestor
44784202|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784203|NCT01919255|Antacids|antacids|mesh-ancestor
44784204|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
44784205|NCT01919294|Testosterone|testosterone|mesh-list
44784206|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
44784207|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
44784208|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44784209|NCT01919294|Androgens|androgens|mesh-ancestor
44784210|NCT01919294|Hormones|hormones|mesh-ancestor
44784211|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784212|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784213|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44784214|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784215|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
44784216|NCT01919346|Eculizumab|eculizumab|mesh-list
44784217|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44784218|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784219|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
44784220|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784221|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
44784222|NCT01919424|Miotics|miotics|mesh-ancestor
44784223|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
44784224|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784225|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784226|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44784227|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44784228|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44784229|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44784230|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44784231|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
44784232|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784233|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784234|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
44784235|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44784236|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
44784237|NCT01919593|Povidone|povidone|mesh-list
44784238|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44784239|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784240|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
44784241|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
44784242|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
44784243|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
44784244|NCT01919788|Insulin|insulin|mesh-list
44784245|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784246|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784247|NCT01919879|Cetuximab|cetuximab|mesh-list
44784248|NCT01919879|Afatinib|afatinib|mesh-list
44784249|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44784250|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784251|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784252|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784253|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784254|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
44784255|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44562824|NCT01157182|Norethindrone|norethindrone|mesh-list
44784256|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44784257|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784258|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784259|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
44784260|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44784261|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784262|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784263|NCT01919905|Vitamin D|vitamin d|mesh-list
44784264|NCT01919905|Vitamins|vitamins|mesh-ancestor
44784265|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
44784266|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784267|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44784268|NCT01919918|Adenosine|adenosine|mesh-list
44784269|NCT01919918|Analgesics|analgesics|mesh-ancestor
44784270|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
44784271|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784272|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784273|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44394929|NCT02991859|Xhance|xhance|mesh-list
44784274|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
44784275|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44784276|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
44784277|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
44784278|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784279|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784280|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
44784281|NCT01920022|Mifepristone|mifepristone|mesh-list
44784282|NCT01920022|Etonogestrel|etonogestrel|mesh-list
44784283|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784284|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784285|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44784286|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
44784287|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44784288|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44784289|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44784290|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44784291|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44784292|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44784293|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784294|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
44784295|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44784296|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44784297|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
44784298|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
44562900|NCT01156051|Guanfacine|guanfacine|mesh-list
44784299|NCT01920516|Melphalan|melphalan|mesh-list
44784300|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44784301|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
44784302|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784303|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784304|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44784305|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784306|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
44784307|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784308|NCT01920984|Bevacizumab|bevacizumab|mesh-list
44784309|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44784310|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784311|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44784312|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44784313|NCT01920984|Growth Substances|growth substances|mesh-ancestor
44784314|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784315|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44784316|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
44784317|NCT01921374|Interferons|interferons|mesh-list
44784318|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
44784319|NCT01921374|Interleukin-2|interleukin-2|mesh-list
44784320|NCT01921374|Interleukin-4|interleukin-4|mesh-list
44394981|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
44784321|NCT01921374|Dinoprostone|dinoprostone|mesh-list
44784322|NCT01921374|Hormones|hormones|mesh-list
44784323|NCT01921374|Estradiol|estradiol|mesh-list
44784324|NCT01921374|Testosterone|testosterone|mesh-list
44784325|NCT01921374|Progesterone|progesterone|mesh-list
44784326|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44784327|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44784328|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44784329|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
44784330|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44784331|NCT01921374|Antibodies|antibodies|mesh-list
44784332|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
44784333|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
44784334|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
44784335|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
44784336|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
44784337|NCT01921374|Uric Acid|uric acid|mesh-list
44784338|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784339|NCT01921374|Vitamins|vitamins|mesh-ancestor
44784340|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
44784341|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784342|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
44784343|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784344|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784345|NCT01921374|Estrogens|estrogens|mesh-ancestor
44784346|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784347|NCT01921374|Androgens|androgens|mesh-ancestor
44784348|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
44784349|NCT01921374|Progestins|progestins|mesh-ancestor
44784350|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784351|NCT01921374|Analgesics|analgesics|mesh-ancestor
44784352|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
44784353|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784354|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
44784355|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426790|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784356|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784357|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
44784358|NCT01921374|Protective Agents|protective agents|mesh-ancestor
44784359|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
44784360|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44562968|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562969|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44562970|NCT01155479|Protective Agents|protective agents|mesh-ancestor
44562971|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562972|NCT01155466|Rasagiline|rasagiline|mesh-list
44562973|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44562974|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562975|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562976|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44562977|NCT01155466|Protective Agents|protective agents|mesh-ancestor
44784361|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44784362|NCT01921972|Memantine|memantine|mesh-list
44784363|NCT01921972|Galantamine|galantamine|mesh-list
44784364|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44784365|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44784366|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
44784367|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395018|NCT02989389|Itraconazole|itraconazole|mesh-list
44784368|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784369|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784370|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44784371|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44784372|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44784373|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784374|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44784375|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44784376|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
44784377|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784378|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
44784379|NCT01923454|Acetazolamide|acetazolamide|mesh-list
44784380|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
44784381|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44784382|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784383|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784384|NCT01923454|Diuretics|diuretics|mesh-ancestor
44784385|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
44784386|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784387|NCT01923935|Melphalan|melphalan|mesh-list
44784388|NCT01923935|Busulfan|busulfan|mesh-list
44784389|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44784390|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
44784391|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784392|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784393|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44784394|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784395|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
44784396|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784397|NCT01923974|Melatonin|melatonin|mesh-list
44784398|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
44784399|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784400|NCT01923974|Protective Agents|protective agents|mesh-ancestor
44784401|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784402|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784403|NCT01924013|Vitamin D|vitamin d|mesh-list
44784404|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
44784405|NCT01924013|Vitamins|vitamins|mesh-ancestor
44784406|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
44784407|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784408|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44784409|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44784410|NCT01924676|Oxycodone|oxycodone|mesh-list
44784411|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784412|NCT01924676|Narcotics|narcotics|mesh-ancestor
44784413|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784414|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784415|NCT01924676|Analgesics|analgesics|mesh-ancestor
44784416|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
44426791|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
44784417|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784418|NCT01925066|Vancomycin|vancomycin|mesh-list
44784419|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784420|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784421|NCT01927640|Cocaine|cocaine|mesh-list
44784422|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
44784423|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44784424|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784425|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784426|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784427|NCT01927640|Analgesics|analgesics|mesh-ancestor
44784428|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
44784429|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784430|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44784431|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44784432|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44784433|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784434|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784435|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784436|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
44784437|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
44784438|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44784439|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44784440|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44784441|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563002|NCT01155219|Latanoprost|latanoprost|mesh-list
44784442|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
44784443|NCT01927679|Vitamin E|vitamin e|mesh-list
44784444|NCT01927679|Antioxidants|antioxidants|mesh-list
44784445|NCT01927679|Vitamins|vitamins|mesh-ancestor
44784446|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
44784447|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395087|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
44784448|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784449|NCT01927679|Protective Agents|protective agents|mesh-ancestor
44784450|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
44784451|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44784452|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
44784453|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784454|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784455|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44784456|NCT01928407|Darunavir|darunavir|mesh-list
44784457|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44784458|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44784459|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
44784460|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784461|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784462|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44784463|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44784464|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
44784465|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784466|NCT01928875|Anesthetics|anesthetics|mesh-list
44784467|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784468|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784469|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
44784470|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784471|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44784472|NCT01929590|Laxatives|laxatives|mesh-ancestor
44784473|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784474|NCT01930019|Thiopental|thiopental|mesh-list
44784475|NCT01930019|Etomidate|etomidate|mesh-list
44784476|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
44784477|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784478|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784479|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44784480|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44784481|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
44784482|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
44784483|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
44784484|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
44784485|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784486|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784487|NCT01930201|Anesthetics|anesthetics|mesh-list
44784488|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784489|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784490|NCT01930292|Paclitaxel|paclitaxel|mesh-list
44784491|NCT01930292|Carboplatin|carboplatin|mesh-list
44784492|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44784493|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784494|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
44784495|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
44784496|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
44784497|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784498|NCT01930318|Parecoxib|parecoxib|mesh-list
44784499|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44784500|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44784501|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784502|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784503|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44784504|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784505|NCT01930318|Analgesics|analgesics|mesh-ancestor
44784506|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
44784507|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784508|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784509|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44784510|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44784511|NCT01930331|Piperaquine|piperaquine|mesh-list
44784512|NCT01930331|Artenimol|artenimol|mesh-list
44784513|NCT01930331|Artemisinins|artemisinins|mesh-list
44784514|NCT01930331|Artemisinin|artemisinin|mesh-list
44784515|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
44784516|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44784517|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44784518|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784519|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44784520|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
44784521|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
44784522|NCT01930396|Heparin|heparin|mesh-list
44784523|NCT01930396|Calcium heparin|calcium heparin|mesh-list
44784524|NCT01930396|Tinzaparin|tinzaparin|mesh-list
44784525|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44784526|NCT01930396|Dalteparin|dalteparin|mesh-list
44784527|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
44784528|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44784529|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44784530|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784531|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
44784532|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784533|NCT01930552|Leucovorin|leucovorin|mesh-list
44784534|NCT01930552|Fluorouracil|fluorouracil|mesh-list
44784535|NCT01930552|Irinotecan|irinotecan|mesh-list
44784536|NCT01930552|Aflibercept|aflibercept|mesh-list
44784537|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
44784538|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784539|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44784540|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784541|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784542|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
44784543|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692119|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44692120|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44692121|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44692122|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692123|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
44692124|NCT01365923|Remifentanil|remifentanil|mesh-list
44692125|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44692126|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692127|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692128|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44692129|NCT01365923|Analgesics|analgesics|mesh-ancestor
44692130|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
44692131|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395206|NCT02981342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692132|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44692133|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44692134|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44692135|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
44692136|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692137|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692138|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44692139|NCT01365923|Narcotics|narcotics|mesh-ancestor
44692140|NCT01365936|Menotropins|menotropins|mesh-list
44692141|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44692142|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
44692143|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44426792|NCT02208843|Afatinib|afatinib|mesh-list
44395223|NCT02980874|Hormones|hormones|mesh-ancestor
44692144|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692145|NCT01366001|Buprenorphine|buprenorphine|mesh-list
44692146|NCT01366001|ALKS-33|alks-33|mesh-list
44692147|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44692148|NCT01366001|Narcotics|narcotics|mesh-ancestor
44692149|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692150|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692151|NCT01366001|Analgesics|analgesics|mesh-ancestor
44692152|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
44692153|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692154|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692155|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
44692156|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692157|NCT01366183|Paclitaxel|paclitaxel|mesh-list
44692158|NCT01366183|Carboplatin|carboplatin|mesh-list
44692159|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44692160|NCT01366183|Lenograstim|lenograstim|mesh-list
44692161|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44692162|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692163|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44692164|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44692165|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44692166|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692167|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44692168|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
44692169|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692171|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44692172|NCT01366235|Amebicides|amebicides|mesh-ancestor
44692173|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44692174|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44692175|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692176|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
44692177|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44692178|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44692179|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44692180|NCT01366235|Analgesics|analgesics|mesh-ancestor
44692181|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
44692182|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692183|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784544|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44784545|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44784546|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784547|NCT01930552|Antidotes|antidotes|mesh-ancestor
44784548|NCT01930552|Protective Agents|protective agents|mesh-ancestor
44784549|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
44784550|NCT01930552|Vitamins|vitamins|mesh-ancestor
44784551|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
44784552|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44784553|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44784554|NCT01930552|Growth Substances|growth substances|mesh-ancestor
44784555|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44784556|NCT01930591|Clopidogrel|clopidogrel|mesh-list
44784557|NCT01930591|Ticagrelor|ticagrelor|mesh-list
44784558|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44784559|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44784560|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44784561|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44784562|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
44784563|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784564|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784565|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784566|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44784567|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44784568|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44784569|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44784570|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784571|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784572|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44784573|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44784574|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784575|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
44784576|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784577|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44784578|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44784579|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44784580|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44395285|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
44784581|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784582|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44784583|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
44784584|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784585|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
44784586|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784587|NCT01930734|Dobutamine|dobutamine|mesh-list
44784588|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44784589|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
44784590|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
44784591|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784592|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784593|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44784594|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44784595|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44784596|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784597|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395311|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44395313|NCT02978417|Naltrexone|naltrexone|mesh-list
44784598|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784599|NCT01930734|Protective Agents|protective agents|mesh-ancestor
44784600|NCT01930773|Clopidogrel|clopidogrel|mesh-list
44784601|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44784602|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44784603|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44784604|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44784605|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
44784606|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784607|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784608|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784609|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
44784610|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44784611|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44784612|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44784613|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44784614|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784615|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
44784616|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784617|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784618|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44784619|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784621|NCT01930812|Fluorides|fluorides|mesh-list
44784622|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
44784623|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44784624|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
44784625|NCT01930812|Protective Agents|protective agents|mesh-ancestor
44784626|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784627|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44784628|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784629|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44784630|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784631|NCT01930864|Metformin|metformin|mesh-list
44784632|NCT01930864|Irinotecan|irinotecan|mesh-list
44784633|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784634|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563301|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563302|NCT01151410|Enalapril|enalapril|mesh-list
44784635|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44784636|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44784637|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784638|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784639|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784640|NCT01930877|Lidocaine|lidocaine|mesh-list
44784641|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
44784642|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
44784643|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784644|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784645|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
44784646|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784647|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44784648|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44395370|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
44784649|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44784650|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44784651|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784652|NCT01930916|Anticoagulants|anticoagulants|mesh-list
44784653|NCT01930916|Antibodies|antibodies|mesh-list
44784654|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
44784655|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
44784656|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
44784657|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784658|NCT01930955|Amoxicillin|amoxicillin|mesh-list
44784659|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784660|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784661|NCT01931085|Triclabendazole|triclabendazole|mesh-list
44563303|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44563304|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
44563305|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395382|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395383|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
44563306|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563307|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44563308|NCT01151215|Anastrozole|anastrozole|mesh-list
44563309|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44563310|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563311|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44563312|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44563313|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563314|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563315|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44563316|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
44563317|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563318|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395401|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44563319|NCT01151137|Dronedarone|dronedarone|mesh-list
44563320|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44563321|NCT01151098|Buprenorphine|buprenorphine|mesh-list
44563322|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44563323|NCT01151098|Narcotics|narcotics|mesh-ancestor
44563324|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563325|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563326|NCT01151098|Analgesics|analgesics|mesh-ancestor
44563327|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
44784662|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44784663|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
44784664|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44784665|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784666|NCT01931098|Topotecan|topotecan|mesh-list
44784667|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44784668|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44784669|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784670|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784671|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784672|NCT01931137|Insulin|insulin|mesh-list
44784673|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784674|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784675|NCT01931189|Infliximab|infliximab|mesh-list
44784676|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395414|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
44784677|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784678|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44784679|NCT01931215|Clonidine|clonidine|mesh-list
44784680|NCT01931215|Morphine|morphine|mesh-list
44784681|NCT01931215|Ropivacaine|ropivacaine|mesh-list
44784682|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
44784683|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784684|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784685|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784686|NCT01931215|Narcotics|narcotics|mesh-ancestor
44784687|NCT01931215|Analgesics|analgesics|mesh-ancestor
44784688|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
44784689|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784690|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
44395436|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
44784691|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44784692|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
44784693|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
44784694|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44784695|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44784696|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44784697|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784698|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784699|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784700|NCT01931293|Folic Acid|folic acid|mesh-list
44784701|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
44784702|NCT01931293|Vitamins|vitamins|mesh-ancestor
44784703|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
44784704|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784705|NCT01931293|Hematinics|hematinics|mesh-ancestor
44784706|NCT01931306|Afatinib|afatinib|mesh-list
44784707|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784708|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784709|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784710|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784711|NCT01931319|Baclofen|baclofen|mesh-list
44784712|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44784713|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784714|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44784715|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784716|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44784717|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
44784718|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
44784719|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784720|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784721|NCT01931332|Heroin|heroin|mesh-list
44784722|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784723|NCT01931332|Narcotics|narcotics|mesh-ancestor
44784724|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784725|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784726|NCT01931332|Analgesics|analgesics|mesh-ancestor
44784727|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
44784728|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784729|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44784730|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784731|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784732|NCT01931410|Misoprostol|misoprostol|mesh-list
44784733|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44784734|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
44784735|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784736|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784737|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44784738|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784739|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
44784740|NCT01931501|Montelukast|montelukast|mesh-list
44784741|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44784742|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
44784743|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44784744|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
44784745|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784746|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784747|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44784748|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44395484|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784749|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784750|NCT01931514|Montelukast|montelukast|mesh-list
44784751|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44784752|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
44784753|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44784754|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
44784755|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784756|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784757|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44784758|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44784759|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784760|NCT01931592|Gentamicins|gentamicins|mesh-list
44784761|NCT01931592|Colistin|colistin|mesh-list
44784762|NCT01931592|Fosfomycin|fosfomycin|mesh-list
44784763|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784764|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784765|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44784766|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784767|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784768|NCT01931657|Mifepristone|mifepristone|mesh-list
44784769|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
44784770|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44784771|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
44784772|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44784773|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784774|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44784775|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44784776|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44784777|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
44784778|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44784779|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44784780|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
44784781|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784782|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
44784783|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44784784|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44784785|NCT01931683|Remifentanil|remifentanil|mesh-list
44784786|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784787|NCT01931683|Narcotics|narcotics|mesh-ancestor
44784788|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784789|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784790|NCT01931683|Analgesics|analgesics|mesh-ancestor
44784791|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
44784792|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784793|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
44784794|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
44784795|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784796|NCT01931787|Protective Agents|protective agents|mesh-ancestor
44784797|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784798|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
44784799|NCT01931787|Vitamins|vitamins|mesh-ancestor
44784800|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
44784801|NCT01931982|Liraglutide|liraglutide|mesh-list
44784802|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44784803|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784804|NCT01931982|Incretins|incretins|mesh-ancestor
44784805|NCT01931982|Hormones|hormones|mesh-ancestor
44784806|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784807|NCT01932151|Terlipressin|terlipressin|mesh-list
44784808|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44784809|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44784810|NCT01932177|Everolimus|everolimus|mesh-list
44784811|NCT01932177|Sorafenib|sorafenib|mesh-list
44784812|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563420|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563437|NCT01148810|Siponimod|siponimod|mesh-list
44784813|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784814|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
44784815|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784816|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784817|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784818|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784819|NCT01932203|Aspirin|aspirin|mesh-list
44784820|NCT01932203|Cilostazol|cilostazol|mesh-list
44784821|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44784822|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784823|NCT01932203|Analgesics|analgesics|mesh-ancestor
44784824|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
44784825|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784826|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784827|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44784828|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395568|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44784829|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44784830|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44784831|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784832|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44784833|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44784834|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784835|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
44784836|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44784837|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
44784838|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44784839|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
44784840|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44784841|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44784842|NCT01932203|Protective Agents|protective agents|mesh-ancestor
44784843|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44784844|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44784845|NCT01932229|Afatinib|afatinib|mesh-list
44784846|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784847|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784848|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784849|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784850|NCT01932268|Rifampin|rifampin|mesh-list
44784851|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44784852|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
44784853|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44784854|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784855|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
44784856|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44784857|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784858|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784859|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44784860|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44784861|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44784862|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44784863|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44784864|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44784865|NCT01932320|Ketoconazole|ketoconazole|mesh-list
44784866|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
44784867|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44784868|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44784869|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44784870|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784871|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784872|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44784873|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
44784874|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44784875|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784876|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44784877|NCT01932372|Etanercept|etanercept|mesh-list
44784878|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
44784879|NCT01932372|Tofacitinib|tofacitinib|mesh-list
44784880|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44784881|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784882|NCT01932372|Analgesics|analgesics|mesh-ancestor
44784883|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
44784884|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784885|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784886|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44784887|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44784888|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784889|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
44784890|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784891|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784892|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784893|NCT01932385|Sorafenib|sorafenib|mesh-list
44784894|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784895|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44784896|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784897|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784898|NCT01932424|Propofol|propofol|mesh-list
44784899|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44784900|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784901|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784902|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44784903|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
44784904|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
44784905|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
44784906|NCT01932502|Clobazam|clobazam|mesh-list
44784907|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
44784908|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44784909|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44784910|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784911|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784912|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44784913|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44563566|NCT01147393|Epratuzumab|epratuzumab|mesh-list
44563567|NCT01147393|Veltuzumab|veltuzumab|mesh-list
44563568|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44563569|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563570|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563571|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
44563572|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
44563573|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784915|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
44784916|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784917|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784918|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44784919|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44784920|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44784921|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784922|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784923|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44784924|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44784925|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44784926|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44784927|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
44784928|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44784929|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784930|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44784931|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44784932|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
44784933|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44784934|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44784935|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
44784936|NCT01932554|Ibuprofen|ibuprofen|mesh-list
44784937|NCT01932554|Fentanyl|fentanyl|mesh-list
44784938|NCT01932554|Morphine|morphine|mesh-list
44784939|NCT01932554|Hydromorphone|hydromorphone|mesh-list
44784940|NCT01932554|Narcotics|narcotics|mesh-list
44784941|NCT01932554|Abciximab|abciximab|mesh-list
44784942|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784943|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784944|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784945|NCT01932554|Analgesics|analgesics|mesh-ancestor
44784946|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
44784947|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784948|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44784949|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44784950|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
44784951|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
44784952|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44784953|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784954|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44784955|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44784956|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44784957|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44784958|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784959|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
44784960|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44784961|NCT01932580|Docetaxel|docetaxel|mesh-list
44784962|NCT01932580|Fluorouracil|fluorouracil|mesh-list
44784963|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
44784964|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44784965|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
44784966|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
44784967|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
44784968|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395729|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
44784969|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
44784970|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44784971|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44784972|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
44784973|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784974|NCT01932918|Ketorolac|ketorolac|mesh-list
44784975|NCT01932918|Morphine|morphine|mesh-list
44784976|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44784977|NCT01932918|Narcotics|narcotics|mesh-ancestor
44784978|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44784979|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784980|NCT01932918|Analgesics|analgesics|mesh-ancestor
44784981|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
44784982|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44784983|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44784984|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44784985|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44784986|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563631|NCT01146873|Stavudine|stavudine|mesh-list
44784987|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44784988|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563705|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44563706|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44784989|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44784990|NCT01932931|Vitamin D|vitamin d|mesh-list
44784991|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
44784992|NCT01932931|Vitamins|vitamins|mesh-ancestor
44784993|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
44784994|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44784995|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44784996|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44784997|NCT01933022|Leuprolide|leuprolide|mesh-list
44784998|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44784999|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
44785000|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44785001|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785002|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44785003|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785004|NCT01933061|Paclitaxel|paclitaxel|mesh-list
44785005|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44785006|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44785007|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785008|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785009|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785010|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785011|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785012|NCT01933152|Ranibizumab|ranibizumab|mesh-list
44785013|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44785014|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44785015|NCT01933152|Growth Substances|growth substances|mesh-ancestor
44785016|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785017|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44785018|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785019|NCT01933347|Gefitinib|gefitinib|mesh-list
44785020|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785021|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785022|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785023|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785024|NCT01933360|Misoprostol|misoprostol|mesh-list
44785025|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44785026|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
44785027|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44785028|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785029|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44785030|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785031|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
44785032|NCT01933412|Vaccines|vaccines|mesh-list
44785033|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
44785034|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785035|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
44785036|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785037|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785038|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44785039|NCT01933503|Cathartics|cathartics|mesh-ancestor
44785040|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785041|NCT01933516|Rituximab|rituximab|mesh-list
44785042|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44785043|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785044|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
44785045|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785046|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785047|NCT01933542|Morphine|morphine|mesh-list
44785048|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
44395773|NCT02961790|Oxybutynin|oxybutynin|mesh-list
44563707|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563708|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563709|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563710|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563711|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44563712|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44563713|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44563714|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395827|NCT02959892|Naxagolide|naxagolide|mesh-list
44563715|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44563716|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44563717|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44563718|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785049|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785050|NCT01933542|Narcotics|narcotics|mesh-ancestor
44785051|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785052|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785053|NCT01933542|Analgesics|analgesics|mesh-ancestor
44785054|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
44785055|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785056|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44785057|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44785058|NCT01933568|Cisplatin|cisplatin|mesh-list
44785059|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785060|NCT01933698|Amoxicillin|amoxicillin|mesh-list
44785061|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785062|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785063|NCT01933711|Rituximab|rituximab|mesh-list
44785064|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44785065|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395829|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395830|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
44785066|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
44785067|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785068|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785069|NCT01933906|Interferons|interferons|mesh-list
44785070|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
44785071|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
44785072|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44785073|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785074|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
44785075|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785076|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
44785077|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785078|NCT01933945|Sorafenib|sorafenib|mesh-list
44785079|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785080|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785081|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426793|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785082|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785083|NCT01933971|Lenograstim|lenograstim|mesh-list
44785084|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44785085|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
44785086|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785087|NCT01933997|Pyridoxine|pyridoxine|mesh-list
44785088|NCT01933997|Metadoxine|metadoxine|mesh-list
44785089|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44785090|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
44785091|NCT01933997|Vitamins|vitamins|mesh-ancestor
44785092|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
44785093|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785094|NCT01934023|Varenicline|varenicline|mesh-list
44785095|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44785096|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44785097|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
44785098|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785099|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785100|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785101|NCT01934049|Anesthetics|anesthetics|mesh-list
44785102|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785103|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785104|NCT01934088|Fentanyl|fentanyl|mesh-list
44785105|NCT01934088|Midazolam|midazolam|mesh-list
44785106|NCT01934088|Propofol|propofol|mesh-list
44785107|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785108|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785109|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785110|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785111|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
44785112|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
44785113|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785114|NCT01934088|Narcotics|narcotics|mesh-ancestor
44785115|NCT01934088|Analgesics|analgesics|mesh-ancestor
44785116|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
44785117|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785118|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785119|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44785120|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785121|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785122|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
44785123|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
44785124|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785125|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785126|NCT01934127|Vaccines|vaccines|mesh-list
44785127|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
44785128|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785129|NCT01934166|Nalmefene|nalmefene|mesh-list
44785130|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44785131|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785132|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
44785133|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692184|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44692185|NCT01366235|Filaricides|filaricides|mesh-ancestor
44692186|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
44692187|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
44692188|NCT01366300|Lidocaine|lidocaine|mesh-list
44692189|NCT01366300|Propofol|propofol|mesh-list
44692190|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
44692191|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
44692192|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692193|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692194|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
44692195|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692196|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44395898|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
44692197|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44692198|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44692199|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692200|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692201|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44692202|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44692203|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
44692204|NCT01366313|Acetaminophen|acetaminophen|mesh-list
44692205|NCT01366313|Morphine|morphine|mesh-list
44785134|NCT01934361|Carboplatin|carboplatin|mesh-list
44785135|NCT01934361|Lomustine|lomustine|mesh-list
44785136|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785137|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44785138|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
44785139|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785140|NCT01934569|Losartan|losartan|mesh-list
44785141|NCT01934569|Midazolam|midazolam|mesh-list
44785142|NCT01934569|Caffeine|caffeine|mesh-list
44785143|NCT01934569|Omeprazole|omeprazole|mesh-list
44785144|NCT01934569|Pravastatin|pravastatin|mesh-list
44785145|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785146|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785147|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785148|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785149|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44395937|NCT02955069|Spartalizumab|spartalizumab|mesh-list
44785150|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785151|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785152|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785153|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
44785154|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
44785155|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
44785156|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
44785157|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785158|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785159|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44785160|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44785161|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44785162|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44785163|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44785164|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395956|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395973|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785165|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44785166|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785167|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44785168|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44785169|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44785170|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44785171|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
44785172|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44785173|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44785174|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
44785175|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44785176|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44785177|NCT01934634|Gemcitabine|gemcitabine|mesh-list
44785178|NCT01934634|Paclitaxel|paclitaxel|mesh-list
44785179|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44785180|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785181|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785182|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785183|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785184|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785185|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44785186|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
44785187|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
44785188|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785189|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785190|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785191|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
44785192|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785193|NCT01934712|Insulin|insulin|mesh-list
44785194|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44785195|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
44785196|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
44785197|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44785198|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785199|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785200|NCT01934777|Vitamin E|vitamin e|mesh-list
44785201|NCT01934777|Choline|choline|mesh-list
44785202|NCT01934777|Vitamins|vitamins|mesh-ancestor
44785203|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
44785204|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785205|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
44785206|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785207|NCT01934777|Protective Agents|protective agents|mesh-ancestor
44785208|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
44785209|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44785210|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
44785211|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785212|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44785213|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
44785214|NCT01934816|Liraglutide|liraglutide|mesh-list
44785215|NCT01934816|Exenatide|exenatide|mesh-list
44785216|NCT01934816|Glucagon|glucagon|mesh-list
44785217|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44785218|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785219|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785220|NCT01934816|Incretins|incretins|mesh-ancestor
44785221|NCT01934816|Hormones|hormones|mesh-ancestor
44785222|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44785223|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44785224|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785225|NCT01934829|Sorafenib|sorafenib|mesh-list
44785226|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785227|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785228|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785229|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785230|NCT01934933|Celecoxib|celecoxib|mesh-list
44785231|NCT01934933|Etanercept|etanercept|mesh-list
44785232|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44785233|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785234|NCT01934933|Analgesics|analgesics|mesh-ancestor
44785235|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
44785236|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396031|NCT02953782|Magrolimab|magrolimab|mesh-list
44785237|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785238|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785239|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785240|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44785241|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44785242|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785243|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785244|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785245|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785246|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
44785247|NCT01935063|Lidocaine|lidocaine|mesh-list
44785248|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
44785249|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
44785250|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785251|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785252|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
44785253|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785254|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44785255|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44785256|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44785257|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785258|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785259|NCT01935089|Interferons|interferons|mesh-list
44785260|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
44785261|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
44785262|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44785263|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785264|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
44785265|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396049|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
44785266|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
44785267|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785268|NCT01935115|Ketamine|ketamine|mesh-list
44785269|NCT01935115|Propofol|propofol|mesh-list
44785270|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785271|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785272|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785273|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785274|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
44785275|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
44785276|NCT01935115|Analgesics|analgesics|mesh-ancestor
44785277|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
44785278|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785279|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44785280|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44785281|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44785282|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785283|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785284|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
44785285|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44563930|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
44785287|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785288|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44785289|NCT01935193|Analgesics|analgesics|mesh-ancestor
44785290|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
44785291|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785292|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785293|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44785294|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785295|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785296|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886959|NCT04560049|Phenol|phenol|mesh-list
44785297|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44785298|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44785299|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785300|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785301|NCT01935206|Naloxone|naloxone|mesh-list
44785302|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44785303|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785304|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
44785305|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785306|NCT01935310|Imiquimod|imiquimod|mesh-list
44785307|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44785308|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
44785309|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785310|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785311|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
44785312|NCT01935492|Paclitaxel|paclitaxel|mesh-list
44785313|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44785314|NCT01935492|Bevacizumab|bevacizumab|mesh-list
44785315|NCT01935492|Doxorubicin|doxorubicin|mesh-list
44785316|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44785317|NCT01935492|Capecitabine|capecitabine|mesh-list
44785318|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44785319|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785320|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785321|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785322|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785323|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785324|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44785325|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44785326|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44785327|NCT01935492|Growth Substances|growth substances|mesh-ancestor
44785328|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785329|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
43887006|NCT04559308|Metformin|metformin|mesh-list
44785330|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44785331|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44785332|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44785333|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785334|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44785335|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
44785336|NCT01935505|Bupropion|bupropion|mesh-list
44785337|NCT01935505|Nicotine|nicotine|mesh-list
44785338|NCT01935505|Varenicline|varenicline|mesh-list
44785339|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44785340|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
44785341|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785342|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785343|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44785344|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44785345|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
44785346|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396138|NCT02951429|Urological Agents|urological agents|mesh-ancestor
44785347|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785348|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44785349|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
44785350|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785351|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44785352|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44785353|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785354|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
44785355|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44785356|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44785357|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785358|NCT01935518|Fasudil|fasudil|mesh-list
44785359|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44785360|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785361|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785362|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44785363|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785364|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
44785365|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785366|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785368|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
44785369|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44785370|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785371|NCT01935531|Analgesics|analgesics|mesh-ancestor
44396155|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785372|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
44785373|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785374|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785375|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785376|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785377|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44785378|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785379|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785380|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44785381|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
44785382|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
44785383|NCT01935531|Protective Agents|protective agents|mesh-ancestor
44785384|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
44785385|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44785386|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785387|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785388|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
44785389|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785390|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785391|NCT01935557|Heparin|heparin|mesh-list
44785392|NCT01935557|Calcium heparin|calcium heparin|mesh-list
44785393|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
44785394|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44785395|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44785396|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785397|NCT01935596|Ropivacaine|ropivacaine|mesh-list
44785398|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
44785399|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
44785400|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
44396205|NCT02949271|Narcotics|narcotics|mesh-ancestor
44785401|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785402|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785403|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
44785404|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785405|NCT01935648|Ropivacaine|ropivacaine|mesh-list
44785406|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
44785407|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
44785408|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785409|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785410|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
44785411|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785412|NCT01935674|Ritonavir|ritonavir|mesh-list
44785413|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44785414|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44785415|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44785416|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
44785417|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785418|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785419|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44785420|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44785421|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
44785422|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785423|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44785424|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44785425|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44785426|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44785427|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
44785428|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44785429|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44785430|NCT01935713|Nicotine|nicotine|mesh-list
44785431|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44785432|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
44785433|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785434|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785435|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44785436|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44785437|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
44785438|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785439|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785440|NCT01935804|Metformin|metformin|mesh-list
44785441|NCT01935804|Pioglitazone|pioglitazone|mesh-list
44785442|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785443|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785444|NCT01935817|Vitamin E|vitamin e|mesh-list
44785445|NCT01935817|Silybin|silybin|mesh-list
44785446|NCT01935817|Vitamins|vitamins|mesh-ancestor
44785447|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
44785448|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785449|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
44785450|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785451|NCT01935817|Protective Agents|protective agents|mesh-ancestor
44785452|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44785453|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785454|NCT01935830|Ritonavir|ritonavir|mesh-list
44564149|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564150|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564151|NCT01138826|Amlodipine|amlodipine|mesh-list
44564152|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44564153|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44564154|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564155|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564156|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44564157|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564158|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564159|NCT01138657|Prednisone|prednisone|mesh-list
44564160|NCT01138657|Adalimumab|adalimumab|mesh-list
44564161|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564162|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
44564163|NCT01138657|Hormones|hormones|mesh-ancestor
44396243|NCT02948777|Evolocumab|evolocumab|mesh-list
44564164|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564165|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564166|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44564167|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564168|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564169|NCT01138501|Factor VIII|factor viii|mesh-list
44564170|NCT01138501|Coagulants|coagulants|mesh-ancestor
44564171|NCT01138150|Naproxen|naproxen|mesh-list
44564172|NCT01138150|Sumatriptan|sumatriptan|mesh-list
44785455|NCT01935830|Efavirenz|efavirenz|mesh-list
44785456|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44785457|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44785458|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396280|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785459|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785460|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785461|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44785462|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44785463|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
44785464|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785465|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44785466|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44785467|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44785468|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44785469|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44785470|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44785471|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44785472|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44785473|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44785474|NCT01935869|Petrolatum|petrolatum|mesh-list
44785475|NCT01935869|Emollients|emollients|mesh-ancestor
44785476|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
44785477|NCT01935882|Lumefantrine|lumefantrine|mesh-list
44785478|NCT01935882|Artemether|artemether|mesh-list
44785479|NCT01935882|Primaquine|primaquine|mesh-list
44785480|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44785481|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
44785482|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44785483|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44785484|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785485|NCT01935908|Levetiracetam|levetiracetam|mesh-list
44785486|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
44785487|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
44785488|NCT01935973|Trametinib|trametinib|mesh-list
44785489|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785490|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785491|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785492|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785493|NCT01936012|Lisinopril|lisinopril|mesh-list
44785494|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44785495|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
44785496|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785497|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785498|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44785499|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44785500|NCT01936012|Protective Agents|protective agents|mesh-ancestor
44785501|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785502|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44785503|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
44785504|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785505|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785506|NCT01936025|Incretins|incretins|mesh-ancestor
44785507|NCT01936025|Hormones|hormones|mesh-ancestor
44785508|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44785509|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44785510|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
44785511|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785512|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785513|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
44785514|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44785515|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44785516|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44785517|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785518|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
44785519|NCT01936064|Epirubicin|epirubicin|mesh-list
44785520|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785521|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
44785522|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785523|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785524|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44785525|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
44785526|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785527|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785528|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44785529|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44692206|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785530|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44785531|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44785532|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785533|NCT01936090|Bortezomib|bortezomib|mesh-list
44785534|NCT01936090|Melphalan|melphalan|mesh-list
44785535|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785536|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44785537|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
44785538|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785539|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44785540|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785541|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
44785542|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785543|NCT01936103|Atorvastatin|atorvastatin|mesh-list
44785544|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44785545|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44785546|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
44785547|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785548|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44785549|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44785550|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785551|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
44785552|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
44785553|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44785554|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
44785555|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785556|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785557|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785558|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
44785559|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785560|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785561|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785562|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785563|NCT01936233|Aspirin|aspirin|mesh-list
44785564|NCT01936233|Lamivudine|lamivudine|mesh-list
44785565|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44785566|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785567|NCT01936233|Analgesics|analgesics|mesh-ancestor
44785568|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
44785569|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785570|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785571|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785572|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785573|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44785574|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44785575|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785576|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44785577|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44785578|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785579|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
44785580|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44785581|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44785582|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
44785583|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785584|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44785585|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44785586|NCT01936285|Colchicine|colchicine|mesh-list
44785587|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
44785588|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785589|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785590|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785591|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785592|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785593|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785594|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
44785595|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
44785596|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44785597|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44785598|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785599|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785600|NCT01936350|Urological Agents|urological agents|mesh-ancestor
44785601|NCT01936532|Dexamethasone|dexamethasone|mesh-list
44785602|NCT01936532|Lenalidomide|lenalidomide|mesh-list
44785603|NCT01936532|Ixazomib|ixazomib|mesh-list
44785604|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785605|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
44785606|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
44785607|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785608|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785609|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785610|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
44785611|NCT01936532|Hormones|hormones|mesh-ancestor
44785612|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44785613|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44785614|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785615|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
44785616|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44396413|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44785617|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44785618|NCT01936532|Growth Substances|growth substances|mesh-ancestor
44785619|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
44785620|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44785621|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785622|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785623|NCT01936545|Propofol|propofol|mesh-list
44785624|NCT01936545|Desflurane|desflurane|mesh-list
44785625|NCT01936545|Liver Extracts|liver extracts|mesh-list
44785626|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785627|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785628|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785629|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785630|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
44785631|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
44785632|NCT01936545|Hematinics|hematinics|mesh-ancestor
44785633|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44785634|NCT01936636|Fentanyl|fentanyl|mesh-list
44785635|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785636|NCT01936636|Narcotics|narcotics|mesh-ancestor
44785637|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785638|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785639|NCT01936636|Analgesics|analgesics|mesh-ancestor
44785640|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
44785641|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785642|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785643|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785644|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
44785645|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
44785646|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44785647|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44785648|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44785649|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
44785650|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785651|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44785652|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44785653|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785654|NCT01936961|Antibodies|antibodies|mesh-list
44785655|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
44785656|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785657|NCT01937013|Oxytocin|oxytocin|mesh-list
44785658|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
44785659|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44785660|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785661|NCT01937078|Famotidine|famotidine|mesh-list
44785662|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44785663|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785664|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44785665|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
44785666|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
44785667|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785668|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785669|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785670|NCT01937104|Remifentanil|remifentanil|mesh-list
44785671|NCT01937104|Desflurane|desflurane|mesh-list
44785672|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785673|NCT01937104|Narcotics|narcotics|mesh-ancestor
44785674|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785675|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785676|NCT01937104|Analgesics|analgesics|mesh-ancestor
44785677|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
44785678|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785679|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44785680|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
44785681|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
44785682|NCT01937156|Granisetron|granisetron|mesh-list
44785683|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
44785684|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
44785685|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785686|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785687|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785688|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44785689|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
44785690|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785691|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785692|NCT01937169|Levodopa|levodopa|mesh-list
44785693|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44785694|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44785695|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
44785696|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785697|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396526|NCT02932579|Analgesics|analgesics|mesh-ancestor
44785698|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785699|NCT01937182|Citalopram|citalopram|mesh-list
44785700|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44785701|NCT01937182|Serotonin|serotonin|mesh-list
44785702|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44785703|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785704|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785705|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785706|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
44785707|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785708|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44785709|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
44785710|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785711|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44785712|NCT01937234|Metoclopramide|metoclopramide|mesh-list
44785713|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
44785714|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
44785715|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785716|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785717|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785718|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44785719|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44785720|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
44785721|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785722|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785723|NCT01937325|Ivacaftor|ivacaftor|mesh-list
44785724|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44785725|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785726|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785727|NCT01937338|AZD7624|azd7624|mesh-list
44785728|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785729|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785730|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785731|NCT01937442|Thalidomide|thalidomide|mesh-list
44785732|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785733|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
44785734|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785735|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
44785736|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785737|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785738|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44785739|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44785740|NCT01937442|Growth Substances|growth substances|mesh-ancestor
44396570|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
44785741|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
44785742|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785743|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
44785744|NCT01937494|Histamine|histamine|mesh-list
44785745|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
44785746|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
44785747|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785748|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785749|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785750|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
44785751|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
44785752|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785753|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
44785754|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785755|NCT01937611|Midazolam|midazolam|mesh-list
44785756|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
44785757|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785758|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785759|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785760|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785761|NCT01937611|Analgesics|analgesics|mesh-ancestor
44785762|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
44785763|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785764|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44785765|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44785766|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44785767|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
44785768|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785769|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785770|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785771|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44785772|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785773|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692207|NCT01366313|Narcotics|narcotics|mesh-ancestor
44692208|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692209|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692210|NCT01366313|Analgesics|analgesics|mesh-ancestor
44692211|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
44692212|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692213|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44692214|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
44692215|NCT01366326|Bromides|bromides|mesh-list
44692216|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
44692217|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
44692218|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692219|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692220|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
44564484|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564485|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396628|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396629|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44396630|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396631|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396632|NCT02929498|Azacitidine|azacitidine|mesh-list
44396633|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44396634|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
44396635|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396636|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396637|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564486|NCT01134055|Growth Substances|growth substances|mesh-ancestor
44564487|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564488|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564489|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564490|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44564491|NCT01134042|Fluticasone|fluticasone|mesh-list
44564492|NCT01134042|Xhance|xhance|mesh-list
44564493|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564494|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44564495|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
44564496|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564497|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564498|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564499|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564500|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564501|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44785774|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785775|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
44785776|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
44785777|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
44785778|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
44785779|NCT01937650|Metronidazole|metronidazole|mesh-list
44785780|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785781|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785782|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44785783|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44785784|NCT01937728|Interferons|interferons|mesh-list
44785785|NCT01937728|Ribavirin|ribavirin|mesh-list
44785786|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
44785787|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
44785788|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44785789|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785790|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
44785791|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785792|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
44785793|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785794|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
44785795|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785796|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
44785797|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44785798|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
44785799|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785800|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785801|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44785802|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44785803|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44785804|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
44785805|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785806|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785807|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44785808|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
44785809|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
44785810|NCT01937754|Protective Agents|protective agents|mesh-ancestor
44785811|NCT01937767|Fentanyl|fentanyl|mesh-list
44785812|NCT01937767|Remifentanil|remifentanil|mesh-list
44785813|NCT01937767|Propofol|propofol|mesh-list
44785814|NCT01937767|Sevoflurane|sevoflurane|mesh-list
44785815|NCT01937767|Rocuronium|rocuronium|mesh-list
44785816|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785817|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785818|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785819|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785820|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
44785821|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
44785822|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44785823|NCT01937767|Narcotics|narcotics|mesh-ancestor
44785824|NCT01937767|Analgesics|analgesics|mesh-ancestor
44785825|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
44785826|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785827|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785828|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44785829|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44785830|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44785831|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44785832|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44785833|NCT01937806|Tenofovir|tenofovir|mesh-list
44785834|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
44785835|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785836|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44785837|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44785838|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785839|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785840|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44785841|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44785842|NCT01937832|Ertapenem|ertapenem|mesh-list
44785843|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785844|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785845|NCT01938092|Diazepam|diazepam|mesh-list
44785846|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44785847|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
44564502|NCT01133977|Lenvatinib|lenvatinib|mesh-list
44785848|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
44785849|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
44785850|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785851|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785852|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785853|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44785854|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785855|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44785856|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44785857|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44785858|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785859|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785860|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44785861|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
44785862|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
44785863|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
44785864|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
44785865|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44785866|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785867|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
44785868|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44785869|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785870|NCT01938144|Acetaminophen|acetaminophen|mesh-list
44785871|NCT01938144|Ibuprofen|ibuprofen|mesh-list
44785872|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44785873|NCT01938144|Analgesics|analgesics|mesh-ancestor
44785874|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
44785875|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785876|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785877|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
44785878|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44785879|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785880|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785881|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44785882|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785883|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785884|NCT01938183|Metronidazole|metronidazole|mesh-list
44785885|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785886|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785887|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44785888|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44785889|NCT01938235|Exenatide|exenatide|mesh-list
44785890|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44785891|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785892|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44785893|NCT01938235|Incretins|incretins|mesh-ancestor
44785894|NCT01938235|Hormones|hormones|mesh-ancestor
44785895|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44785896|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
44785897|NCT01938300|Analgesics|analgesics|mesh-ancestor
44785898|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
44785899|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785900|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785901|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
44785902|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785903|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44785904|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
44785905|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44785906|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785907|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785908|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44785909|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
44785910|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44785911|NCT01938417|Tobramycin|tobramycin|mesh-list
44785912|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785913|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785914|NCT01938443|Trametinib|trametinib|mesh-list
44785915|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785916|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785917|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785918|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785919|NCT01938456|Docetaxel|docetaxel|mesh-list
44785920|NCT01938456|Trametinib|trametinib|mesh-list
44785921|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785922|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785923|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785924|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785925|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785926|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44785927|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785928|NCT01938508|Minocycline|minocycline|mesh-list
44785929|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44785930|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785931|NCT01938547|Clevidipine|clevidipine|mesh-list
44785932|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44785933|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44785934|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785935|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44785936|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785937|NCT01938612|Durvalumab|durvalumab|mesh-list
44785938|NCT01938612|Tremelimumab|tremelimumab|mesh-list
44785939|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44785940|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785941|NCT01938729|Gemcitabine|gemcitabine|mesh-list
44785942|NCT01938729|Dexamethasone|dexamethasone|mesh-list
44785943|NCT01938729|Floxuridine|floxuridine|mesh-list
44785944|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44785945|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
44785946|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
44785947|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785948|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785949|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44785950|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
44785951|NCT01938729|Hormones|hormones|mesh-ancestor
44396799|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44785952|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44785953|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44785954|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785955|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44785956|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
44785957|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785958|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
44785959|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785960|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44785961|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44785962|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
44785963|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
44785964|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
44785965|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
44785966|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785967|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785968|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
44785969|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44785970|NCT01938781|Entecavir|entecavir|mesh-list
44785971|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
44785972|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785973|NCT01938820|Entecavir|entecavir|mesh-list
44785974|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
44785975|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44785976|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44785977|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
44785978|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44785979|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44785980|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44785981|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44785982|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785983|NCT01938872|Paclitaxel|paclitaxel|mesh-list
44785984|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44785985|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785986|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785987|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44785988|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44785989|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44785990|NCT01938911|Oxytocin|oxytocin|mesh-list
44785991|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
44785992|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44785993|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44785994|NCT01939054|Docetaxel|docetaxel|mesh-list
44785995|NCT01939054|Capecitabine|capecitabine|mesh-list
44785996|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
44785997|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44785998|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44785999|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44786000|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44786001|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564654|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44786002|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786003|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
44786004|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786006|NCT01939093|Cinnarizine|cinnarizine|mesh-list
44786007|NCT01939093|Diazepam|diazepam|mesh-list
44786008|NCT01939093|Vitamins|vitamins|mesh-ancestor
44786009|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
44786010|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786011|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
44786012|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44786013|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
44786014|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
44786015|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
44786016|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786017|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44786018|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44786019|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786020|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44786021|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44786022|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44786023|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786024|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786025|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44786026|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
44786027|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
44786028|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
44786029|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
44786030|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786031|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786032|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44786033|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786034|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786035|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44786036|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
44786037|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
44786038|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
44786039|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
44786040|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786041|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786042|NCT01939327|Rituximab|rituximab|mesh-list
44786043|NCT01939327|Lenalidomide|lenalidomide|mesh-list
44786044|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786045|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786046|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
44786047|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786048|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786049|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786050|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44786051|NCT01939327|Growth Substances|growth substances|mesh-ancestor
44786052|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44786054|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44786055|NCT01939379|Morphine|morphine|mesh-list
44786056|NCT01939379|Oxycodone|oxycodone|mesh-list
44786057|NCT01939379|Analgesics|analgesics|mesh-list
44786058|NCT01939379|Ropivacaine|ropivacaine|mesh-list
44786059|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44786060|NCT01939379|Narcotics|narcotics|mesh-ancestor
44786061|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786062|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786063|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
44786064|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786065|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
44786066|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
44396904|NCT02919436|Tamsulosin|tamsulosin|mesh-list
44786067|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44786068|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44786069|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44786070|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786071|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
44786072|NCT01939418|Gemcitabine|gemcitabine|mesh-list
44786073|NCT01939418|Cisplatin|cisplatin|mesh-list
44786074|NCT01939418|Everolimus|everolimus|mesh-list
44786075|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786076|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786077|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
44786078|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786079|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
44786080|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786081|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786082|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786083|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
44786084|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786085|NCT01939444|Naloxone|naloxone|mesh-list
44786086|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44786087|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786088|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
44786089|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786090|NCT01939457|Misoprostol|misoprostol|mesh-list
44786091|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44786092|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
44786093|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786094|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786095|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44786096|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44786097|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
44786098|NCT01939483|Irinotecan|irinotecan|mesh-list
44786099|NCT01939483|Camptothecin|camptothecin|mesh-list
44786100|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44786101|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44786102|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564802|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44564803|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564804|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564805|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786103|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786104|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786105|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44786106|NCT01939509|Atenolol|atenolol|mesh-list
44786107|NCT01939509|Bisoprolol|bisoprolol|mesh-list
44786108|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44786109|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44786110|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
44786111|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
44786112|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786113|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564806|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
44564807|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564808|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44564809|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
44564810|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564811|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44786114|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44786115|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44786116|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44786117|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44786118|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786119|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786120|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44786121|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
44786122|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786123|NCT01939561|Lamotrigine|lamotrigine|mesh-list
44786124|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
44786125|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44786126|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786127|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786128|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786129|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786130|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44786131|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786132|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786133|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786134|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44786135|NCT01939574|Bevacizumab|bevacizumab|mesh-list
44786136|NCT01939574|Temozolomide|temozolomide|mesh-list
44786137|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786138|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786139|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786140|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44786141|NCT01939574|Growth Substances|growth substances|mesh-ancestor
44786142|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786143|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
44786144|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44786145|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
44786146|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786147|NCT01939639|Oxytocin|oxytocin|mesh-list
44786148|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
44786149|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786150|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786151|NCT01939691|Prednisolone|prednisolone|mesh-list
44786152|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44786153|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
44786154|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44786155|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
44786156|NCT01939691|Nepafenac|nepafenac|mesh-list
44786157|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44786158|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
44786159|NCT01939691|Difluprednate|difluprednate|mesh-list
44786160|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44786161|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
44786162|NCT01939691|Hormones|hormones|mesh-ancestor
44786163|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786164|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786165|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44786166|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786167|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
44786168|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
44786169|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786170|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44786171|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44786172|NCT01939691|Protective Agents|protective agents|mesh-ancestor
44786173|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44786174|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44786175|NCT01939691|Analgesics|analgesics|mesh-ancestor
44786176|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
44786177|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786178|NCT01939730|Rituximab|rituximab|mesh-list
44786179|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786180|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786181|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
44786182|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786183|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786184|NCT01939743|Diclofenac|diclofenac|mesh-list
44786185|NCT01939743|Lidocaine|lidocaine|mesh-list
44786186|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
44786187|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
44786188|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397041|NCT02915159|Abatacept|abatacept|mesh-list
44786189|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786190|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
44564932|NCT01128595|Xhance|xhance|mesh-list
44786191|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786192|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44786193|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44786194|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44786195|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786196|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786197|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44786198|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44786200|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44786201|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397056|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44158940|NCT00238004|Niacin|niacin|mesh-list
44786202|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44786203|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786204|NCT01939834|Insulin|insulin|mesh-list
44786205|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786206|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786207|NCT01939886|Artesunate|artesunate|mesh-list
44786208|NCT01939886|Lumefantrine|lumefantrine|mesh-list
44786209|NCT01939886|Artemether|artemether|mesh-list
44786210|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44786211|NCT01939886|Mefloquine|mefloquine|mesh-list
44786212|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
44786213|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44786214|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44786215|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786216|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786217|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
44786218|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
44786219|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44786220|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
44786221|NCT01939912|Adenosine|adenosine|mesh-list
44786222|NCT01939912|Analgesics|analgesics|mesh-ancestor
44786223|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
44786224|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786225|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786226|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44786227|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786228|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44786229|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
44786230|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
44786231|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786232|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786233|NCT01939990|Nebivolol|nebivolol|mesh-list
44786234|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44786235|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786236|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44786237|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44786238|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44786239|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
44786240|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786241|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786242|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786243|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44786244|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786245|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786246|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786247|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44786248|NCT01940172|Conatumumab|conatumumab|mesh-list
44786249|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786250|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786251|NCT01940224|Pregabalin|pregabalin|mesh-list
44786252|NCT01940224|Morphine|morphine|mesh-list
44786253|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44786254|NCT01940224|Narcotics|narcotics|mesh-ancestor
44786255|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786256|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786257|NCT01940224|Analgesics|analgesics|mesh-ancestor
44786258|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
44786259|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786260|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
44786261|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44786262|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786263|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397121|NCT02910583|Venetoclax|venetoclax|mesh-list
44786264|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786265|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44786266|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786267|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786268|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
44786269|NCT01940250|Analgesics|analgesics|mesh-ancestor
44786270|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
44786271|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786272|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786273|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
44786274|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786275|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44786276|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
44786277|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44786278|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786279|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786280|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786281|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
44786282|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786283|NCT01940393|Cetirizine|cetirizine|mesh-list
44786284|NCT01940393|Fexofenadine|fexofenadine|mesh-list
44786285|NCT01940393|Desloratadine|desloratadine|mesh-list
44786286|NCT01940393|Ebastine|ebastine|mesh-list
44786287|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44786288|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44786289|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44786290|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
44786291|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
44786292|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786293|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786294|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786295|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44786296|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
44786297|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
44786298|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44786299|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44786300|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786301|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
44786302|NCT01940419|Coagulants|coagulants|mesh-ancestor
44786303|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
44786304|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44786305|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44786306|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786307|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
44786308|NCT01940536|Coagulants|coagulants|mesh-ancestor
44786309|NCT01940601|Lenograstim|lenograstim|mesh-list
44786310|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44786311|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
44397170|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44786312|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786313|NCT01940627|Ubiquinone|ubiquinone|mesh-list
44786314|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
44786315|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
44786316|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786317|NCT01940627|Vitamins|vitamins|mesh-ancestor
44786318|NCT01940653|Estradiol|estradiol|mesh-list
44786319|NCT01940653|Progesterone|progesterone|mesh-list
44692221|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692222|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
44692223|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692224|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692225|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
44692226|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692227|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
44692228|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44397187|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
44692229|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692230|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
44692231|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692232|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
44692233|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692234|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692235|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
44692236|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692237|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
44692263|NCT01367028|Bevacizumab|bevacizumab|mesh-list
44692264|NCT01367028|Trastuzumab|trastuzumab|mesh-list
44786320|NCT01940653|Estrogens|estrogens|mesh-ancestor
44786321|NCT01940653|Hormones|hormones|mesh-ancestor
44786322|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786323|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786324|NCT01940653|Progestins|progestins|mesh-ancestor
44786325|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
44786326|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44786327|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44786328|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786329|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
44786330|NCT01940692|Coagulants|coagulants|mesh-ancestor
44786331|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
44786332|NCT01940718|Testosterone|testosterone|mesh-list
44786333|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
44786334|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
44786335|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44786336|NCT01940718|Androgens|androgens|mesh-ancestor
44786337|NCT01940718|Hormones|hormones|mesh-ancestor
44786338|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786339|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786340|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44786341|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786342|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
44786343|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44786344|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786345|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786346|NCT01940952|Donepezil|donepezil|mesh-list
44786347|NCT01940952|Udenafil|udenafil|mesh-list
44786348|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44786349|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786350|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786351|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
44786352|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786353|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786354|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
44786355|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44786356|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44786357|NCT01940965|Lixisenatide|lixisenatide|mesh-list
44786358|NCT01940965|Biguanides|biguanides|mesh-list
44786359|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786360|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786361|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
44786362|NCT01940978|Methylphenidate|methylphenidate|mesh-list
44786363|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44786364|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786365|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44786366|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44786367|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786368|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786369|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
44786370|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786371|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
44786372|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44786373|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44786374|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44786375|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
44786376|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
44786377|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44786378|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
44786379|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44786380|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44786381|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44786382|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786383|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786384|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
44786385|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786386|NCT01941056|Vaccines|vaccines|mesh-list
44786387|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
44786388|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786389|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
44786390|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44786391|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44786392|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
44786393|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
44786394|NCT01941134|Estradiol|estradiol|mesh-list
44786395|NCT01941134|Estrogens|estrogens|mesh-ancestor
44786396|NCT01941134|Hormones|hormones|mesh-ancestor
44786397|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786398|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786399|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44786400|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786401|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44786402|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44786403|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44786404|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44786405|NCT01941173|Leucovorin|leucovorin|mesh-list
44786406|NCT01941173|Fluorouracil|fluorouracil|mesh-list
44786407|NCT01941173|Irinotecan|irinotecan|mesh-list
44786408|NCT01941173|Aflibercept|aflibercept|mesh-list
44786409|NCT01941173|Calcium|calcium|mesh-list
44786410|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
44786411|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
44397286|NCT02903238|Analgesics|analgesics|mesh-ancestor
44786412|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786413|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786414|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
44786415|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786416|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786417|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786418|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786419|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
44786420|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44786421|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44786422|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786423|NCT01941173|Antidotes|antidotes|mesh-ancestor
44786424|NCT01941173|Protective Agents|protective agents|mesh-ancestor
44786425|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
44786426|NCT01941173|Vitamins|vitamins|mesh-ancestor
44786427|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
44786428|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786429|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44786430|NCT01941173|Growth Substances|growth substances|mesh-ancestor
44786431|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
44786432|NCT01941199|Metformin|metformin|mesh-list
44786433|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786434|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786435|NCT01941225|Iloprost|iloprost|mesh-list
44786436|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44786437|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786438|NCT01941264|Lumefantrine|lumefantrine|mesh-list
44786439|NCT01941264|Artemether|artemether|mesh-list
44786440|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44786441|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
44786442|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44786443|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44786444|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786445|NCT01941316|Irinotecan|irinotecan|mesh-list
44786446|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44786447|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44786448|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786449|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565143|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44565144|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44565145|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44565146|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565147|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565148|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565149|NCT01125514|Furosemide|furosemide|mesh-list
44565150|NCT01125514|Diuretics|diuretics|mesh-ancestor
44565151|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
44565152|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426794|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565153|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44565154|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565155|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565156|NCT01125293|Rituximab|rituximab|mesh-list
44565157|NCT01125293|Everolimus|everolimus|mesh-list
44786450|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786451|NCT01941329|Ranibizumab|ranibizumab|mesh-list
44786452|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786453|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44786454|NCT01941329|Growth Substances|growth substances|mesh-ancestor
44786455|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786456|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44786457|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786458|NCT01941407|Bevacizumab|bevacizumab|mesh-list
44786459|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786460|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786461|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44786462|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44786463|NCT01941407|Growth Substances|growth substances|mesh-ancestor
44786464|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786465|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
44786466|NCT01941524|Poractant alfa|poractant alfa|mesh-list
44786467|NCT01941524|Beractant|beractant|mesh-list
44786468|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44786469|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
44786470|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44786471|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
44786472|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786473|NCT01941602|Enoxaparin|enoxaparin|mesh-list
44786474|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
44786475|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44786476|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44786477|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786478|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
44786479|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786480|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44786481|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44786482|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786483|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786484|NCT01941732|Urological Agents|urological agents|mesh-ancestor
44786485|NCT01941758|Vaccines|vaccines|mesh-list
44786486|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
44786487|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786488|NCT01941771|Capecitabine|capecitabine|mesh-list
44786489|NCT01941771|Vinorelbine|vinorelbine|mesh-list
44786490|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786491|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
44786492|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786493|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786494|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44786495|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44786496|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44786497|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44786498|NCT01941810|Lactoferrin|lactoferrin|mesh-list
44786499|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786500|NCT01941888|Midazolam|midazolam|mesh-list
44786501|NCT01941888|Propofol|propofol|mesh-list
44786502|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44786503|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786504|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786505|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44786506|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
44786507|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
44786508|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44786509|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44786510|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786511|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786512|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
44786513|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
44786514|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786515|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786516|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
44786517|NCT01941901|Bleomycin|bleomycin|mesh-list
44786518|NCT01941901|Calcium|calcium|mesh-list
44786519|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786520|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786521|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44786522|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44786523|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786524|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
44786525|NCT01941914|Calcium|calcium|mesh-list
44786526|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786527|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786528|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44786529|NCT01941953|Metformin|metformin|mesh-list
44786530|NCT01941953|Fluorouracil|fluorouracil|mesh-list
44786531|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786532|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786533|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
44786534|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786535|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786536|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786537|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786538|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
44786539|NCT01941966|Capecitabine|capecitabine|mesh-list
44786540|NCT01941966|Mitomycins|mitomycins|mesh-list
44786541|NCT01941966|Mitomycin|mitomycin|mesh-list
44786542|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786543|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
44786544|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786545|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786546|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44786547|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
44786548|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44786549|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786550|NCT01941979|Leucovorin|leucovorin|mesh-list
44786551|NCT01941979|Capecitabine|capecitabine|mesh-list
44786552|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
44786553|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786554|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
44786555|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786556|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786557|NCT01941979|Antidotes|antidotes|mesh-ancestor
44786558|NCT01941979|Protective Agents|protective agents|mesh-ancestor
44786559|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786560|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
44786561|NCT01941979|Vitamins|vitamins|mesh-ancestor
44786562|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
44786563|NCT01942070|Everolimus|everolimus|mesh-list
44786564|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786565|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786566|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
44786567|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786568|NCT01942109|Torsemide|torsemide|mesh-list
44786569|NCT01942109|Furosemide|furosemide|mesh-list
44786570|NCT01942109|Diuretics|diuretics|mesh-ancestor
44786571|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
44786572|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786573|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44786574|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786575|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786576|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44786577|NCT01942174|Methotrexate|methotrexate|mesh-list
44786578|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44786579|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44786580|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
44786581|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786582|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786583|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44786584|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
44786585|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786586|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786587|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397466|NCT02892734|Nivolumab|nivolumab|mesh-list
44786588|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786589|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44786590|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786591|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
44786592|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786593|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44786594|NCT01942187|Aripiprazole|aripiprazole|mesh-list
44786595|NCT01942187|Bupropion|bupropion|mesh-list
44786596|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44786597|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
44786598|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786599|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44786600|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44786601|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786602|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786603|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
44786604|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786605|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786606|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44786607|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44786608|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786609|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44786610|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786611|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786612|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
44786613|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44786614|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44786615|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
44786616|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44786617|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44786618|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44786619|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44786620|NCT01942291|Niacin|niacin|mesh-list
44786621|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
44786622|NCT01942291|Vitamins|vitamins|mesh-ancestor
44786623|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
44786624|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786625|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
44786626|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44786627|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
44786628|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786629|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44786630|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786631|NCT01942304|Calcium|calcium|mesh-list
44786632|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786633|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786634|NCT01942343|Droperidol|droperidol|mesh-list
44786635|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44786636|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
44786637|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
44786638|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786639|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786640|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44786641|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44786642|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786643|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786644|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786645|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44786646|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44786647|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
44786648|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786649|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786650|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44786651|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
44786652|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44786653|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
44786654|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786655|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786656|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44786657|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44786658|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786659|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44786660|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44786661|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786662|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786663|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786664|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786665|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44786666|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44786667|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
44786668|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786669|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786670|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44786671|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44786672|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
44786673|NCT01942447|Vancomycin|vancomycin|mesh-list
44786674|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44786675|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786676|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44786677|NCT01942460|Hematinics|hematinics|mesh-ancestor
44786678|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44786679|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44786681|NCT01942551|Dutasteride|dutasteride|mesh-list
44397547|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
44786682|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786683|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44786684|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44786685|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786686|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786687|NCT01942551|Urological Agents|urological agents|mesh-ancestor
44786688|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44786689|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44786690|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
44786691|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786692|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786693|NCT01942577|Protective Agents|protective agents|mesh-list
44786694|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786695|NCT01942681|Propiverine|propiverine|mesh-list
44786696|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
44786697|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
44786698|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786699|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786700|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44786701|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44786702|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
44786703|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786704|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786705|NCT01942681|Urological Agents|urological agents|mesh-ancestor
44786706|NCT01942889|Antioxidants|antioxidants|mesh-list
44786707|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786708|NCT01942889|Protective Agents|protective agents|mesh-ancestor
44786709|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786710|NCT01943019|Linagliptin|linagliptin|mesh-list
44786711|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786712|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786713|NCT01943019|Incretins|incretins|mesh-ancestor
44786714|NCT01943019|Hormones|hormones|mesh-ancestor
44786715|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786716|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44786717|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44786718|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397596|NCT02886715|Tazarotene|tazarotene|mesh-list
44786719|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786720|NCT01943058|Megestrol|megestrol|mesh-list
44786721|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
44786722|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
44786723|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44786724|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
44786725|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786726|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786727|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44786728|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44786729|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44786730|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44786731|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44786732|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786733|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
44786734|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44786735|NCT01943136|Mupirocin|mupirocin|mesh-list
44786736|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44786737|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786738|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44786739|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786740|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786741|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
44786742|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44786743|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
44786744|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397631|NCT02884089|Metformin|metformin|mesh-list
44786745|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786746|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44786747|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
44786748|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786749|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786750|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44786751|NCT01943240|Ropivacaine|ropivacaine|mesh-list
44786752|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
44786753|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
44786754|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786755|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786756|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
44786757|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786758|NCT01943305|Vaccines|vaccines|mesh-list
44786759|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
44786760|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786761|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44786762|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44786763|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44565485|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565486|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565487|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565488|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565489|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565490|NCT01121549|Exemestane|exemestane|mesh-list
44565491|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565492|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44565493|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44565494|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565495|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565496|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44565497|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
44565498|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786764|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44786765|NCT01943422|Interferons|interferons|mesh-list
44786766|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
44786767|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
44786768|NCT01943422|Vemurafenib|vemurafenib|mesh-list
44786769|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786770|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
44786771|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786772|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
44786773|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786774|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44786775|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786776|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786778|NCT01943487|Tamsulosin|tamsulosin|mesh-list
44786779|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
44786780|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44786781|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44786782|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44786783|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
44786784|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786785|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786786|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786787|NCT01943487|Urological Agents|urological agents|mesh-ancestor
44786788|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44786789|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44786790|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
44786791|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44786792|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44786793|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44786794|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44786795|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44786796|NCT01943526|Natalizumab|natalizumab|mesh-list
44786797|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
44786798|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786799|NCT01943617|Entecavir|entecavir|mesh-list
44786800|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
44786801|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786802|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44786803|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44786804|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
44786805|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786806|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786807|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44786808|NCT01943630|Protective Agents|protective agents|mesh-ancestor
44786809|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44786810|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44786811|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786812|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786813|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
44786814|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786815|NCT01943760|Tramadol|tramadol|mesh-list
44786816|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44786817|NCT01943760|Narcotics|narcotics|mesh-ancestor
44786818|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786819|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786820|NCT01943760|Analgesics|analgesics|mesh-ancestor
44786821|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
44786822|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786823|NCT01943786|Cetuximab|cetuximab|mesh-list
44786824|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44786825|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786826|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44786827|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44786828|NCT01943812|Estradiol|estradiol|mesh-list
44786829|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44786830|NCT01943812|Progesterone|progesterone|mesh-list
44786831|NCT01943812|Estrogens|estrogens|mesh-ancestor
44786832|NCT01943812|Hormones|hormones|mesh-ancestor
44786833|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786834|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786835|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44786836|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
44786837|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44692265|NCT01367028|Docetaxel|docetaxel|mesh-list
44786838|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44786839|NCT01943812|Progestins|progestins|mesh-ancestor
44786840|NCT01943877|Propolis|propolis|mesh-list
44786841|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786842|NCT01943942|Montelukast|montelukast|mesh-list
44786843|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44786844|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44786845|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44786846|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44786847|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426795|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786848|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786849|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44786850|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44786851|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786852|NCT01944033|Terbutaline|terbutaline|mesh-list
44786853|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44786854|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
44786855|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786856|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786857|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44786858|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
44786859|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
44786860|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
44786861|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44786862|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44786863|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44397781|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786864|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44786865|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44786866|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786867|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786868|NCT01944085|Acetaminophen|acetaminophen|mesh-list
44786869|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
44786870|NCT01944085|Ibuprofen|ibuprofen|mesh-list
44786871|NCT01944085|Vitamins|vitamins|mesh-ancestor
44786872|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
44786873|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786874|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44786875|NCT01944085|Analgesics|analgesics|mesh-ancestor
44786876|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
44786877|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786878|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
44786879|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44786880|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44786881|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44786882|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44786883|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786884|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786885|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
44786886|NCT01944085|Protective Agents|protective agents|mesh-ancestor
44786887|NCT01944176|Simvastatin|simvastatin|mesh-list
44786888|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44786889|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44786890|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
44786891|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786892|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44786893|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44786894|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786895|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44786896|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
44786897|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44786898|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44786899|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44786900|NCT01944215|Caffeine|caffeine|mesh-list
44786901|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44786902|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786903|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44786904|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786905|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786906|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44786907|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44786908|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
44786909|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786910|NCT01944384|Spironolactone|spironolactone|mesh-list
44786911|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44786912|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
44786913|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44786914|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786915|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44786917|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
44397821|NCT02873338|Cytarabine|cytarabine|mesh-list
44786918|NCT01944410|Mitogens|mitogens|mesh-list
44786919|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
44786920|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786921|NCT01944436|Rivastigmine|rivastigmine|mesh-list
44786922|NCT01944436|Donepezil|donepezil|mesh-list
44786923|NCT01944436|Galantamine|galantamine|mesh-list
44786924|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44786925|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786926|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786927|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
44786928|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786929|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786930|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
44786931|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44786932|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
44786933|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786934|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44786935|NCT01944436|Protective Agents|protective agents|mesh-ancestor
44692266|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44692267|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692268|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44692269|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692270|NCT01367028|Growth Substances|growth substances|mesh-ancestor
44692271|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692272|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
44692273|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44565692|NCT01119859|Adalimumab|adalimumab|mesh-list
44786936|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
44786937|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44786938|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786939|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44786940|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786941|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
44786942|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786943|NCT01944683|Midazolam|midazolam|mesh-list
44786944|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44786945|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44786946|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786947|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786948|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44786949|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44786950|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44786951|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44786952|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
44786953|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
44786954|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
44786955|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
44786956|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786957|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786958|NCT01944735|Mannitol|mannitol|mesh-list
44786959|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44786960|NCT01944735|Diuretics|diuretics|mesh-ancestor
44786961|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
44786962|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786963|NCT01944800|Ticagrelor|ticagrelor|mesh-list
44786964|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44786965|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44786966|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44786967|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44786968|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44786969|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
44786970|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786971|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786972|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786973|NCT01944852|Icodextrin|icodextrin|mesh-list
44786974|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
44786975|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44786976|NCT01945021|Crizotinib|crizotinib|mesh-list
44786977|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44786978|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44786979|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786980|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786981|NCT01945047|Midazolam|midazolam|mesh-list
44786982|NCT01945047|Ketamine|ketamine|mesh-list
44786983|NCT01945047|Analgesics|analgesics|mesh-ancestor
44786984|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
44786985|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44786986|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44786987|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44397914|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44786988|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44786989|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
44786990|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
44786991|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44786992|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44786993|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44786994|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44786995|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44786996|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44786997|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44786998|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44786999|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787000|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787001|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
44787002|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
44787003|NCT01945099|Insulin|insulin|mesh-list
44787004|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44787005|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787006|NCT01945268|Vaccines|vaccines|mesh-list
44787007|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
44787008|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787009|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
44787010|NCT01945437|Analgesics|analgesics|mesh-ancestor
44787011|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
44787012|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787013|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787014|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
44397935|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44397940|NCT02866175|Vitamin K|vitamin k|mesh-list
44787015|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787016|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787017|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
44787018|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44787019|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787020|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787021|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787022|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
44787023|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787024|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44787025|NCT01945450|Clindamycin|clindamycin|mesh-list
44787026|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
44787027|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
44787028|NCT01945450|Gentamicins|gentamicins|mesh-list
44787029|NCT01945450|Ampicillin|ampicillin|mesh-list
44787030|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787031|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44787032|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787033|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787034|NCT01945476|Midazolam|midazolam|mesh-list
44787035|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44787036|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44787037|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787038|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787039|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44787040|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787041|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787042|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44787043|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
44787044|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
44787045|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
44787046|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
44787047|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787048|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787049|NCT01945528|Lidocaine|lidocaine|mesh-list
44787050|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
44787051|NCT01945528|Anesthetics|anesthetics|mesh-list
44787052|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787053|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787054|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
44787055|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787056|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787057|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44787058|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44787059|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787060|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787061|NCT01945554|Bupivacaine|bupivacaine|mesh-list
44787062|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
44787063|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
44787064|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787065|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787066|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
44787067|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787068|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
44787069|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44787070|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44787071|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44787072|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787073|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787074|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787075|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787076|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787077|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44787078|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787079|NCT01945736|Methadone|methadone|mesh-list
44787080|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44787081|NCT01945736|Narcotics|narcotics|mesh-ancestor
44787082|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787083|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787084|NCT01945736|Analgesics|analgesics|mesh-ancestor
44787085|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
44787086|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787087|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
44565900|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787088|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
44787089|NCT01945788|Teriparatide|teriparatide|mesh-list
44787090|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787091|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787092|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44787093|NCT01945801|Furosemide|furosemide|mesh-list
44787094|NCT01945801|Spironolactone|spironolactone|mesh-list
44787095|NCT01945801|Diuretics|diuretics|mesh-ancestor
44787096|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
44787097|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787098|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44787099|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787100|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787101|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44787102|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
44787103|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787104|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44787105|NCT05410782|Vitamins|vitamins|mesh-list
44398017|NCT02863419|Hormones|hormones|mesh-ancestor
44787106|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
44787107|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787108|NCT05410626|Methylphenidate|methylphenidate|mesh-list
44787109|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44787110|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787111|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44787112|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44787113|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787114|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787115|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
44787116|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787117|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44787118|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44787119|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787120|NCT05410483|Docetaxel|docetaxel|mesh-list
44787121|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787122|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
44787123|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44787124|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
44787125|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565901|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44565902|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44565903|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565904|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565905|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565906|NCT01117454|Flecainide|flecainide|mesh-list
44565907|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44565908|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44787126|NCT05410314|Inositol|inositol|mesh-list
44787127|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
44787128|NCT05410314|Vitamins|vitamins|mesh-ancestor
44787129|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
44787130|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787131|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
44787132|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44787133|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
44787134|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44787135|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
44787136|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787137|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398062|NCT02862535|Cisplatin|cisplatin|mesh-list
44787138|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
44787139|NCT05410158|Ketamine|ketamine|mesh-list
44787140|NCT05410158|Analgesics|analgesics|mesh-ancestor
44787141|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
44787142|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787143|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787144|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44787145|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44787146|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
44787147|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
44787148|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787149|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44787150|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44787151|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787152|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787153|NCT05410093|Vitamin E|vitamin e|mesh-list
44787154|NCT05410093|Tocopherols|tocopherols|mesh-list
44787155|NCT05410093|Resveratrol|resveratrol|mesh-list
44787156|NCT05410093|Vitamins|vitamins|mesh-ancestor
44787157|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
44787158|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787159|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
44787160|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787161|NCT05410093|Protective Agents|protective agents|mesh-ancestor
44787162|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787163|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44787164|NCT05409820|Anesthetics|anesthetics|mesh-list
44787165|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787166|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787167|NCT05409391|Insulin|insulin|mesh-list
44787168|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44787169|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787170|NCT05409339|Mannitol|mannitol|mesh-list
44787171|NCT05409339|Caffeine|caffeine|mesh-list
44787172|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44398109|NCT02859558|Cobicistat|cobicistat|mesh-list
44398111|NCT02859558|Elvitegravir|elvitegravir|mesh-list
44787173|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787174|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44787175|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787176|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787177|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44787178|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44787179|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
44787180|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787181|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44787182|NCT05409339|Diuretics|diuretics|mesh-ancestor
44787183|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
44787184|NCT05409157|Bisacodyl|bisacodyl|mesh-list
44787185|NCT05409157|Cathartics|cathartics|mesh-ancestor
44787186|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787187|NCT05409157|Laxatives|laxatives|mesh-ancestor
44787188|NCT05273567|Guanfacine|guanfacine|mesh-list
44787189|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44787190|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44787191|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44787192|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44787193|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44787194|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787195|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787196|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787197|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
44787198|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44787199|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44787200|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787201|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
44787202|NCT05248321|Coagulants|coagulants|mesh-ancestor
44787204|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44787205|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44787206|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44787207|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44398127|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787208|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
44787209|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787210|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787211|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787212|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787213|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44787214|NCT05155527|Ivermectin|ivermectin|mesh-list
44787215|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44787216|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787217|NCT05151146|Metformin|metformin|mesh-list
44787218|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44787219|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787220|NCT05068063|Bupivacaine|bupivacaine|mesh-list
44398161|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
44787221|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
44787222|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
44787223|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787224|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787225|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
44787226|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787227|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
44787228|NCT05049707|Analgesics|analgesics|mesh-ancestor
44787229|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
44787230|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787231|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787232|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
44787233|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787234|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787235|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
44787236|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44787237|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787238|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787239|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787240|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
44787241|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787242|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
44787243|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
44787244|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44787245|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787246|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787247|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44787248|NCT04946396|Analgesics|analgesics|mesh-ancestor
44787249|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
44787250|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787251|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44787252|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44787253|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44787254|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44787255|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787256|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787257|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
44787258|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
44787259|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44787260|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44787261|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787262|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787263|NCT04908657|Urological Agents|urological agents|mesh-ancestor
44787264|NCT04887389|Listerine|listerine|mesh-list
44787265|NCT04887389|Fluorides|fluorides|mesh-list
44787266|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
44787267|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
44787268|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
44787269|NCT04887389|Protective Agents|protective agents|mesh-ancestor
44787270|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787271|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44787272|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787273|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
44787274|NCT04812028|Analgesics|analgesics|mesh-ancestor
44787275|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
44787276|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787277|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787278|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
44787279|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787280|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787281|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
44787282|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44787283|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787284|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787285|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787286|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
44787287|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787288|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
44787289|NCT04773392|Prednisone|prednisone|mesh-list
44787290|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
44787291|NCT04773392|Azathioprine|azathioprine|mesh-list
44787292|NCT04773392|Tacrolimus|tacrolimus|mesh-list
44787293|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
44787294|NCT04773392|Basiliximab|basiliximab|mesh-list
44787295|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44787296|NCT04773392|Antimetabolites|antimetabolites|mesh-list
44787297|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787298|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
44787299|NCT04773392|Hormones|hormones|mesh-ancestor
44787300|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787301|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787302|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787303|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787304|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787305|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
44787306|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44787307|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787308|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787309|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44787310|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44787311|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
44787312|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44787313|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787314|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
44787315|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
44787316|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787317|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787318|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44787319|NCT04773392|Protective Agents|protective agents|mesh-ancestor
44787320|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44787321|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787322|NCT04724655|Mineral Oil|mineral oil|mesh-list
44787323|NCT04724655|Emollients|emollients|mesh-ancestor
44787324|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44787325|NCT04722835|Albuterol|albuterol|mesh-list
44787326|NCT04722835|Dimercaprol|dimercaprol|mesh-list
44787327|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44787328|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
44787329|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787330|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787331|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44787332|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
44787333|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
44787334|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787335|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44787336|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44787337|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44787338|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
44787339|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787340|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787341|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
44787342|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
44787343|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44787344|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
44787345|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787346|NCT04538053|Cefazolin|cefazolin|mesh-list
44787347|NCT04538053|Cephalexin|cephalexin|mesh-list
44787348|NCT04538053|Floxacillin|floxacillin|mesh-list
44787349|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44787350|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787351|NCT04487990|Heparin|heparin|mesh-list
44787352|NCT04487990|Calcium heparin|calcium heparin|mesh-list
44787353|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
44787354|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44787355|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44787356|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787357|NCT04476979|Dexamethasone|dexamethasone|mesh-list
44787358|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787359|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
44787360|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
44787361|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787362|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787363|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787364|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
44787365|NCT04476979|Hormones|hormones|mesh-ancestor
44787366|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787367|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787368|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787369|NCT04411953|Haloperidol|haloperidol|mesh-list
44787370|NCT04411953|Benztropine|benztropine|mesh-list
44787371|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
44787372|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
44787373|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
44787374|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787375|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787376|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787377|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44787378|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787379|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787380|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787381|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44398304|NCT02854527|Metformin|metformin|mesh-list
44398336|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
44787382|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
44787383|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787384|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787385|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44787386|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44787387|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
44787388|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44787389|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44787390|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787391|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44787392|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44787393|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398337|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787394|NCT04411940|Haloperidol|haloperidol|mesh-list
44787395|NCT04411940|Benztropine|benztropine|mesh-list
44787396|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
44787397|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
44787398|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
44787399|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787400|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787401|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787402|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44787403|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787404|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787405|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787406|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44787407|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
44787408|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787409|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787410|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44787411|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44787412|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
44787413|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44787414|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44787415|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787416|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44787417|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44787418|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787419|NCT04294160|Trametinib|trametinib|mesh-list
44787420|NCT04294160|Dabrafenib|dabrafenib|mesh-list
44787421|NCT04294160|Spartalizumab|spartalizumab|mesh-list
44787422|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787423|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787424|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787425|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398349|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787426|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44787427|NCT04150614|Dexamethasone|dexamethasone|mesh-list
44787428|NCT04150614|Ondansetron|ondansetron|mesh-list
44787429|NCT04150614|Granisetron|granisetron|mesh-list
44787430|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787431|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
44787432|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
44787433|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787434|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787435|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787436|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
44787437|NCT04150614|Hormones|hormones|mesh-ancestor
44787438|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787439|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787440|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787441|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
44787442|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44787443|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44787444|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
44787445|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787446|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787447|NCT04150614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44787448|NCT04150614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787449|NCT04150614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787450|NCT04150614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787451|NCT04150614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44787452|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44787453|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787454|NCT04030429|Crizotinib|crizotinib|mesh-list
44787455|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787456|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787457|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787458|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787459|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
44787460|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
44787461|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787462|NCT03970694|Capecitabine|capecitabine|mesh-list
44787463|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
44787464|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44787465|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
44787466|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787467|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787468|NCT03941132|Ustekinumab|ustekinumab|mesh-list
44787469|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
44787470|NCT03920007|Trimethoprim|trimethoprim|mesh-list
44787471|NCT03920007|Polymyxins|polymyxins|mesh-list
44787472|NCT03920007|Polymyxin B|polymyxin b|mesh-list
44787473|NCT03920007|Prednisone|prednisone|mesh-list
44787474|NCT03920007|Prednisolone|prednisolone|mesh-list
44398385|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
44787475|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787476|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
44787477|NCT03920007|Hormones|hormones|mesh-ancestor
44787478|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787479|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787480|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787481|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787482|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44787483|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787484|NCT03920007|Renal Agents|renal agents|mesh-ancestor
44787485|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
44787486|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44787487|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44787488|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44787489|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787490|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787491|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44787492|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44787493|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44787494|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566285|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
44566286|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566287|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566288|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44566289|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566290|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566291|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44566292|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44787495|NCT03873246|Varenicline|varenicline|mesh-list
44787496|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44787497|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44787498|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787499|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787500|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787501|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787502|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
44692274|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44692275|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44692276|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692277|NCT01367054|Metformin|metformin|mesh-list
44692278|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44692279|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692280|NCT01367210|Maraviroc|maraviroc|mesh-list
44692281|NCT01367210|Darunavir|darunavir|mesh-list
44692282|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44692283|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44692284|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44692285|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692286|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44692287|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
44692288|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692289|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44692290|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44692291|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44692292|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
44692293|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692294|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44692295|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44692296|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44692297|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
44692298|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44692299|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692300|NCT01367301|Paclitaxel|paclitaxel|mesh-list
44692301|NCT01367301|Carboplatin|carboplatin|mesh-list
44692302|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44692303|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692304|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
44692305|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44692306|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398479|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
44692307|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692308|NCT01367418|Sufentanil|sufentanil|mesh-list
44692309|NCT01367418|Morphine|morphine|mesh-list
44692310|NCT01367418|Bupivacaine|bupivacaine|mesh-list
44692311|NCT01367418|Ropivacaine|ropivacaine|mesh-list
44692312|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
44692313|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
44692314|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692315|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692316|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
44692317|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692318|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44692319|NCT01367418|Narcotics|narcotics|mesh-ancestor
44692320|NCT01367418|Analgesics|analgesics|mesh-ancestor
44692321|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44692322|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44692323|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
44692324|NCT01367431|Xanthohumol|xanthohumol|mesh-list
44692325|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692326|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44692327|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692328|NCT01367431|Growth Substances|growth substances|mesh-ancestor
44692329|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692330|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44692331|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
44692332|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692333|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692334|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
44692335|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692336|NCT01367496|Naltrexone|naltrexone|mesh-list
44692337|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
44692338|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692339|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692340|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
44692341|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787503|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44787504|NCT03866577|Antibodies|antibodies|mesh-list
44787505|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
44787506|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44787507|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
44787508|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787509|NCT03714880|Mifepristone|mifepristone|mesh-list
44787510|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44787511|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
44787512|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787513|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787514|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44787515|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44787516|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44787517|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
44787518|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44787519|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44787520|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
44787521|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787522|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
44787523|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44787524|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44787525|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
44787526|NCT03659734|Narcotics|narcotics|mesh-ancestor
44398538|NCT02847260|Treprostinil|treprostinil|mesh-list
44787527|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787528|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787529|NCT03659734|Analgesics|analgesics|mesh-ancestor
44787530|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
44787531|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787532|NCT03649048|Cisplatin|cisplatin|mesh-list
44787533|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787534|NCT03623633|Denosumab|denosumab|mesh-list
44787535|NCT03623633|Alendronate|alendronate|mesh-list
44787536|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44787537|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44787538|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787539|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44787540|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
44787541|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787542|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44787543|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44787544|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44787545|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44787546|NCT03619850|Hematinics|hematinics|mesh-ancestor
44787547|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44787548|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44787549|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
44787550|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787551|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
44787552|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787553|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787554|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
44787555|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787556|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
44787557|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787558|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787559|NCT03532516|Brivaracetam|brivaracetam|mesh-list
44787560|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
44787561|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
44787562|NCT03333005|Clotrimazole|clotrimazole|mesh-list
44787563|NCT03333005|Miconazole|miconazole|mesh-list
44787564|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787565|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44787566|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44787567|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44787568|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787569|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787570|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44787571|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
44787572|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692342|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44787573|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787574|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44787575|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44787576|NCT03148366|Levofloxacin|levofloxacin|mesh-list
44787578|NCT03148366|Bismuth|bismuth|mesh-list
44787579|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44787580|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787581|NCT03148366|Renal Agents|renal agents|mesh-ancestor
44787582|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44787583|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44787584|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44787585|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787586|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787587|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787588|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44787589|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44787590|NCT03148366|Antacids|antacids|mesh-ancestor
44787591|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787592|NCT03122496|Durvalumab|durvalumab|mesh-list
44787593|NCT03122496|Tremelimumab|tremelimumab|mesh-list
44787594|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787595|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787596|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
44787597|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44787598|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
44787599|NCT03118232|Povidone|povidone|mesh-list
44787600|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44787601|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787602|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
44787603|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
44787604|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
44787605|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
44787606|NCT03073694|Melphalan|melphalan|mesh-list
44787607|NCT03073694|Mitomycins|mitomycins|mesh-list
44787608|NCT03073694|Mitomycin|mitomycin|mesh-list
44787609|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44787610|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
44787611|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787612|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398618|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
44787613|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44787614|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787615|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
44787616|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787617|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44787618|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44787619|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787620|NCT03069703|Rituximab|rituximab|mesh-list
44787621|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787622|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787623|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
44787624|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787625|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787626|NCT03043313|Trastuzumab|trastuzumab|mesh-list
44787627|NCT03043313|Tucatinib|tucatinib|mesh-list
44787628|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787629|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787630|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787631|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787632|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787633|NCT02955082|Carboplatin|carboplatin|mesh-list
44398649|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
44787634|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787635|NCT02944617|Micronutrients|micronutrients|mesh-list
44787636|NCT02944617|Trace Elements|trace elements|mesh-list
44787637|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787638|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
44787639|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787640|NCT02818738|Levamisole|levamisole|mesh-list
44787641|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44787642|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
44787643|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787644|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
44787645|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
44787646|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44692343|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
44787647|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787648|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787649|NCT02553460|Leucovorin|leucovorin|mesh-list
44787650|NCT02553460|Cytarabine|cytarabine|mesh-list
44787651|NCT02553460|Dexamethasone|dexamethasone|mesh-list
44787652|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
44787653|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
44787654|NCT02553460|Methotrexate|methotrexate|mesh-list
44787655|NCT02553460|Etoposide|etoposide|mesh-list
44787656|NCT02553460|Vincristine|vincristine|mesh-list
44787657|NCT02553460|Bortezomib|bortezomib|mesh-list
44787658|NCT02553460|Asparaginase|asparaginase|mesh-list
44787659|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
44787660|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
44787661|NCT02553460|Vorinostat|vorinostat|mesh-list
44787662|NCT02553460|Pegaspargase|pegaspargase|mesh-list
44787663|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
44787664|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787665|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
44787666|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787667|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787668|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44787669|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
44787670|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787671|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787672|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44787673|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787674|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
44787675|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
44787676|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787677|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44787678|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
44787679|NCT02553460|Hormones|hormones|mesh-ancestor
44787680|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787681|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787682|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44787683|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
44787684|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787685|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44787686|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
44787687|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44787688|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787689|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44787690|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44787691|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44787692|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44787693|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44787694|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
44787695|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787696|NCT02553460|Antidotes|antidotes|mesh-ancestor
44787697|NCT02553460|Protective Agents|protective agents|mesh-ancestor
44787698|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
44787699|NCT02553460|Vitamins|vitamins|mesh-ancestor
44787700|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
44787701|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
44787702|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
44787703|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
44787704|NCT02553460|Analgesics|analgesics|mesh-ancestor
44787705|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
44787706|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44787707|NCT02335099|Ticagrelor|ticagrelor|mesh-list
44787708|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44787709|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44787710|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44787711|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44787712|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
44787713|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787714|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787715|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787716|NCT02330562|Bevacizumab|bevacizumab|mesh-list
44787717|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787718|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398730|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44787719|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44787720|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44787721|NCT02330562|Growth Substances|growth substances|mesh-ancestor
44787722|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787723|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
44787724|NCT02138617|Leucovorin|leucovorin|mesh-list
44787725|NCT02138617|Bevacizumab|bevacizumab|mesh-list
44787726|NCT02138617|Fluorouracil|fluorouracil|mesh-list
44787727|NCT02138617|Irinotecan|irinotecan|mesh-list
44787728|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
44787729|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787730|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787731|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44787732|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44787733|NCT02138617|Growth Substances|growth substances|mesh-ancestor
44787734|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787735|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
44787736|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
44787737|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787738|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398758|NCT02833948|Analgesics|analgesics|mesh-ancestor
44787739|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44787740|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
44787741|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44787742|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44787743|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787744|NCT02138617|Antidotes|antidotes|mesh-ancestor
44787745|NCT02138617|Protective Agents|protective agents|mesh-ancestor
44787746|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
44787747|NCT02138617|Vitamins|vitamins|mesh-ancestor
44787748|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
44787749|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
44787750|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44787751|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44787752|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787753|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
44787754|NCT02053363|Coagulants|coagulants|mesh-ancestor
44787755|NCT01100775|Galantamine|galantamine|mesh-list
44787756|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44787757|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787758|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787759|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787760|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787761|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787762|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44787763|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
44787764|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787765|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
44787766|NCT00504712|Testosterone|testosterone|mesh-list
44787767|NCT00504712|Androgens|androgens|mesh-ancestor
44787768|NCT00504712|Hormones|hormones|mesh-ancestor
44787769|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787770|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787771|NCT05413200|Isotretinoin|isotretinoin|mesh-list
44787772|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
44692344|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44566610|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787773|NCT05413096|Propolis|propolis|mesh-list
44787774|NCT05413096|Diclofenac|diclofenac|mesh-list
44787775|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44787776|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44787777|NCT05413096|Analgesics|analgesics|mesh-ancestor
44787778|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
44787779|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787780|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787781|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787782|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787783|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44787784|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787785|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787786|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787787|NCT05412914|Propofol|propofol|mesh-list
44787788|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44787789|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787790|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787791|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44787792|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
44787793|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
44787794|NCT05412706|Niraparib|niraparib|mesh-list
44787795|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44787796|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787797|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787798|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787799|NCT05412589|Apatinib|apatinib|mesh-list
44787800|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787801|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787802|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787803|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398809|NCT02831764|Lamivudine|lamivudine|mesh-list
44787804|NCT05412576|Lidocaine|lidocaine|mesh-list
44787805|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
44787806|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
44787807|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787808|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787809|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
44787810|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787811|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787812|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44787813|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44787814|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787815|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787816|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
44787817|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
44787818|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787819|NCT05412472|Protective Agents|protective agents|mesh-ancestor
44787820|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787821|NCT05412394|Prednisolone|prednisolone|mesh-list
44787822|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787823|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
44787824|NCT05412394|Hormones|hormones|mesh-ancestor
44787825|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787826|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787827|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787828|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787829|NCT05412147|Vitamins|vitamins|mesh-list
44787830|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
44787831|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787832|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44787833|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44787834|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787835|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566611|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566612|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
44566613|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566614|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566615|NCT01106898|Paclitaxel|paclitaxel|mesh-list
44566616|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
44566617|NCT01106898|Trastuzumab|trastuzumab|mesh-list
44566618|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44566619|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787836|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44787837|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787838|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787839|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787840|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787841|NCT05411887|Olmesartan|olmesartan|mesh-list
44787842|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44787843|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44787844|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44787845|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44787846|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
44787847|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787848|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44787849|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44787850|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787851|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44398878|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44787852|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44787853|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44787854|NCT05411757|Bevacizumab|bevacizumab|mesh-list
44787855|NCT05411757|Lenvatinib|lenvatinib|mesh-list
44787856|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787857|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787858|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44787859|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44787860|NCT05411757|Growth Substances|growth substances|mesh-ancestor
44787861|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787862|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44398896|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398898|NCT02824224|Tamoxifen|tamoxifen|mesh-list
44787863|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44787864|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787865|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787866|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
44787867|NCT05411744|Isoniazid|isoniazid|mesh-list
44787868|NCT05411744|Rifapentine|rifapentine|mesh-list
44787869|NCT05411744|Vitamins|vitamins|mesh-ancestor
44787870|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
44787871|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787872|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
44787873|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
44787874|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44787875|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787876|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44787877|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44787878|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
44787879|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787880|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44787881|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44787882|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
44787883|NCT05411718|Aspirin|aspirin|mesh-list
44787884|NCT05411718|Naproxen|naproxen|mesh-list
44787885|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44787886|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44787887|NCT05411718|Analgesics|analgesics|mesh-ancestor
44787888|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
44787889|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44787890|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787891|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44787892|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44787893|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44787894|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44787895|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787896|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44787897|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44787898|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787899|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
44787900|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
44787901|NCT05411679|Olaparib|olaparib|mesh-list
44787902|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44787903|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787904|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787905|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787906|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44787907|NCT05411276|Maleic acid|maleic acid|mesh-list
44787908|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787909|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787910|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44787911|NCT05405686|Hormones|hormones|mesh-ancestor
44787912|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787913|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787914|NCT05396781|Proflavine|proflavine|mesh-list
44787915|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44787916|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787917|NCT05384951|Vitamin D|vitamin d|mesh-list
44787918|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
44787919|NCT05384951|Vitamins|vitamins|mesh-ancestor
44787920|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
44787921|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787922|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44787923|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44787924|NCT05327595|Midazolam|midazolam|mesh-list
44787925|NCT05327595|Atorvastatin|atorvastatin|mesh-list
44787926|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44787927|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44398946|NCT02821715|Flecainide|flecainide|mesh-list
44787928|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44787929|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787930|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44787931|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44787932|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44787933|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44787934|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
44787935|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
44787936|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
44787937|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
44787938|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787939|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787940|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44787941|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44787942|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
44787943|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44787944|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44787945|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44787946|NCT05320406|Leuprolide|leuprolide|mesh-list
44787947|NCT05320406|Relugolix|relugolix|mesh-list
44787948|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44787949|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
44787950|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44787951|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787952|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44787953|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398997|NCT02819518|Immunologic Factors|immunologic factors|mesh-ancestor
44787954|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
44787955|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
44787956|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44787957|NCT05303038|Bevacizumab|bevacizumab|mesh-list
44787958|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44787959|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44787960|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44787961|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44787962|NCT05303038|Growth Substances|growth substances|mesh-ancestor
44787963|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787964|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
44787965|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44787966|NCT05275894|Metronidazole|metronidazole|mesh-list
44787967|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44787968|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44787969|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44692345|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787971|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44787972|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44787973|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44787974|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44787975|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787976|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787977|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787978|NCT05077800|Losartan|losartan|mesh-list
44787979|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44787980|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44787981|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44787982|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44787983|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787984|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
44787985|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44398998|NCT02819518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787986|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44787987|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787988|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
44787989|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44787990|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787991|NCT05042674|Ergothioneine|ergothioneine|mesh-list
44787992|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
44787993|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44787994|NCT05042674|Protective Agents|protective agents|mesh-ancestor
44787995|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787996|NCT04927585|Vaccines|vaccines|mesh-list
44787997|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
44787998|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44787999|NCT04917055|Dexamethasone|dexamethasone|mesh-list
44788000|NCT04917055|Epinephrine|epinephrine|mesh-list
44788001|NCT04917055|Ropivacaine|ropivacaine|mesh-list
44788002|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788003|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
44788004|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
44788005|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788006|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788007|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788008|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
44788009|NCT04917055|Hormones|hormones|mesh-ancestor
44788010|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788011|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788012|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788013|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
44788014|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
44788015|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788016|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
44788017|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44788018|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44788019|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788020|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788021|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788022|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44788023|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44788024|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44788025|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
44788026|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
44788027|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
44788028|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44788029|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
44788030|NCT04898478|Narcotics|narcotics|mesh-ancestor
44788031|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788032|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788033|NCT04898478|Analgesics|analgesics|mesh-ancestor
44399064|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399065|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
44788034|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
44788035|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788036|NCT04854512|Metformin|metformin|mesh-list
44788037|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44788038|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788039|NCT04792385|Drospirenone|drospirenone|mesh-list
44788040|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
44788041|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
44788042|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44788043|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44788044|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788045|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44788046|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44788047|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
44788048|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788049|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44788050|NCT04792385|Diuretics|diuretics|mesh-ancestor
44788051|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
44788052|NCT04777006|Amitriptyline|amitriptyline|mesh-list
44788053|NCT04777006|Fluoxetine|fluoxetine|mesh-list
44788054|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
44788055|NCT04777006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44788056|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44788057|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44788058|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788059|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788060|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
44788061|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788062|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44788063|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44788064|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44788065|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44788066|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788067|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44788068|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44788069|NCT04777006|Analgesics|analgesics|mesh-ancestor
44788070|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
44788071|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788072|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44788073|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788074|NCT04755244|Azacitidine|azacitidine|mesh-list
44788075|NCT04755244|Venetoclax|venetoclax|mesh-list
44788076|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44788077|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
44788078|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788079|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788080|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788081|NCT04733534|Dasatinib|dasatinib|mesh-list
44788082|NCT04733534|Quercetin|quercetin|mesh-list
44788083|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788084|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44788085|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788086|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788087|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
44788088|NCT04733534|Protective Agents|protective agents|mesh-ancestor
44399103|NCT02812186|Rocuronium|rocuronium|mesh-list
44788089|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788090|NCT04725864|Progesterone|progesterone|mesh-list
44788091|NCT04725864|Progestins|progestins|mesh-ancestor
44788092|NCT04725864|Hormones|hormones|mesh-ancestor
44788093|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788094|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788095|NCT04721821|Tofacitinib|tofacitinib|mesh-list
44788096|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44788097|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788098|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788099|NCT04721353|Prazosin|prazosin|mesh-list
44788100|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44788101|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44788102|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44788103|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44788104|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788105|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788106|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788107|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788108|NCT04655391|Decitabine|decitabine|mesh-list
44788109|NCT04655391|Venetoclax|venetoclax|mesh-list
44788110|NCT04655391|Ivosidenib|ivosidenib|mesh-list
44788111|NCT04655391|Maleic acid|maleic acid|mesh-list
44788112|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44788113|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
44788114|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788115|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788116|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788117|NCT04609098|Piperaquine|piperaquine|mesh-list
44788118|NCT04609098|Artenimol|artenimol|mesh-list
44788119|NCT04609098|Tafenoquine|tafenoquine|mesh-list
44788120|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
44788121|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44788122|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44788123|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788124|NCT04605614|Copper|copper|mesh-list
44788125|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
44788126|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788127|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788128|NCT04605614|Trace Elements|trace elements|mesh-ancestor
44788129|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
44788130|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788131|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
44788132|NCT04493333|Psyllium|psyllium|mesh-list
44788133|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44788134|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44788135|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
44788136|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788137|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
44788138|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788139|NCT04493333|Cathartics|cathartics|mesh-ancestor
44788140|NCT04475016|Paclitaxel|paclitaxel|mesh-list
44788141|NCT04475016|Cisplatin|cisplatin|mesh-list
44788142|NCT04475016|Ifosfamide|ifosfamide|mesh-list
44788143|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44788144|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
44788145|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44788146|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788147|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44788148|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44788149|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44788150|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788151|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788152|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
44788153|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566915|NCT01103713|Chloroquine|chloroquine|mesh-list
44788154|NCT04352777|Fulvestrant|fulvestrant|mesh-list
44788155|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44788156|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788157|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788158|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44788159|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44788160|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
44692346|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
44692347|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692348|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
44692349|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692350|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692351|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
44692352|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692353|NCT01367535|Naltrexone|naltrexone|mesh-list
44692354|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
44692355|NCT01367535|Paroxetine|paroxetine|mesh-list
44692356|NCT01367535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44692357|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692358|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692359|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692360|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692361|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
44692362|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692363|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692364|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692365|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692366|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44692367|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44692368|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692369|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692370|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
44692371|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692372|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44692373|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
44692374|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692375|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692376|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
44692377|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692378|NCT01367561|Naloxone|naloxone|mesh-list
44692379|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
44692380|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692381|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692382|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
44692383|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692384|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
44692385|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692386|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692387|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
44692388|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692389|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
44692390|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692391|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692392|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
44692393|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692394|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
44692395|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692396|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692397|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
44399236|NCT02805972|Naloxone|naloxone|mesh-list
44692398|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692399|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
44692400|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44692401|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692402|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
44692403|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692404|NCT01367626|Letrozole|letrozole|mesh-list
44692405|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692406|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44692407|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44692408|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692409|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692410|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44692411|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
44788161|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788162|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788163|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44788164|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788165|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788166|NCT04321551|Letrozole|letrozole|mesh-list
44788167|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
44788168|NCT04321551|Testosterone|testosterone|mesh-list
44788169|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
44788170|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
44788171|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44788172|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788173|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44788174|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44788175|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399268|NCT02803138|Ritonavir|ritonavir|mesh-list
44788176|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788177|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44788178|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
44788179|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788180|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788181|NCT04321551|Androgens|androgens|mesh-ancestor
44788182|NCT04321551|Hormones|hormones|mesh-ancestor
44788183|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788184|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
44788185|NCT04302324|Clarithromycin|clarithromycin|mesh-list
44788186|NCT04302324|Dexamethasone|dexamethasone|mesh-list
44788187|NCT04302324|Daratumumab|daratumumab|mesh-list
44788188|NCT04302324|Pomalidomide|pomalidomide|mesh-list
44788189|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788190|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
44788191|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
44788192|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788193|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788194|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788195|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
44788196|NCT04302324|Hormones|hormones|mesh-ancestor
44788197|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788198|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788199|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788200|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788201|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788202|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44788203|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788204|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788205|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44788206|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44788207|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
44788208|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44788209|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44788210|NCT04302324|Growth Substances|growth substances|mesh-ancestor
44788211|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44788212|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
44788213|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
44788214|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788215|NCT04225026|Protective Agents|protective agents|mesh-ancestor
44788216|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788217|NCT04074460|Propofol|propofol|mesh-list
44788218|NCT04074460|Sevoflurane|sevoflurane|mesh-list
44788219|NCT04074460|Desflurane|desflurane|mesh-list
44788220|NCT04074460|Isoflurane|isoflurane|mesh-list
44788221|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44788222|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788223|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788224|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44788225|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
44788226|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
44788227|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44788228|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44788229|NCT03993327|Iodine|iodine|mesh-list
44399309|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44788230|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44788231|NCT03993327|Antibodies|antibodies|mesh-list
44788232|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
44788233|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44788234|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
44788235|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788236|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788237|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44788238|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788239|NCT03993327|Trace Elements|trace elements|mesh-ancestor
44788240|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
44788241|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
44788242|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
44788243|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788244|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44788245|NCT03817125|Vancomycin|vancomycin|mesh-list
44788246|NCT03817125|Nivolumab|nivolumab|mesh-list
44788247|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788248|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788249|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44788250|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788251|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788252|NCT03747042|Letrozole|letrozole|mesh-list
44788253|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788254|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44788255|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44788256|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788257|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788258|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44788259|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
44788260|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788261|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788262|NCT03703102|KHK4083|khk4083|mesh-list
44788263|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44788264|NCT03690011|Cyclophosphamide|cyclophosphamide|mesh-list
44788265|NCT03690011|Fludarabine|fludarabine|mesh-list
44788266|NCT03690011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788267|NCT03690011|Immunologic Factors|immunologic factors|mesh-ancestor
44788268|NCT03690011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788269|NCT03690011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788270|NCT03690011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788271|NCT03690011|Alkylating Agents|alkylating agents|mesh-ancestor
44788272|NCT03690011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788273|NCT03690011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788274|NCT03690011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44788275|NCT03637764|Atezolizumab|atezolizumab|mesh-list
44788276|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788277|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44788278|NCT03581370|Cephalosporins|cephalosporins|mesh-list
44399385|NCT02798835|Fentanyl|fentanyl|mesh-list
44788279|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
44788280|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44788281|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788282|NCT03581370|Renal Agents|renal agents|mesh-ancestor
44788283|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788284|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44788285|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788286|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788287|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44788288|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44788289|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
44788290|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567071|NCT01101178|Analgesics|analgesics|mesh-ancestor
44567072|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
44567073|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567074|NCT01101165|Oxycodone|oxycodone|mesh-list
44567075|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567076|NCT01101165|Narcotics|narcotics|mesh-ancestor
44567077|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567078|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567079|NCT01101165|Analgesics|analgesics|mesh-ancestor
44567080|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
44567081|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567082|NCT01101035|Allopurinol|allopurinol|mesh-list
44567083|NCT01101035|Febuxostat|febuxostat|mesh-list
44567084|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
44567085|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567086|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567087|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
44567088|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567089|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44567090|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
44567091|NCT01101035|Protective Agents|protective agents|mesh-ancestor
44567092|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788291|NCT03539055|Dabigatran|dabigatran|mesh-list
44788292|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
44788293|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44788294|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
44788295|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788296|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788297|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
44788298|NCT03485534|Tenofovir|tenofovir|mesh-list
44788299|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
44788300|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788301|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44788302|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44788303|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788304|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788305|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44788306|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44788307|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
44788308|NCT03467386|Tacrolimus|tacrolimus|mesh-list
44788309|NCT03467386|Lenograstim|lenograstim|mesh-list
44788310|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788311|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
44788312|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788313|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788314|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788315|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
44788316|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788317|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788318|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44788319|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44788320|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788321|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44788322|NCT03427736|Ketorolac|ketorolac|mesh-list
44788323|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44788324|NCT03427736|Ketamine|ketamine|mesh-list
44788325|NCT03427736|Morphine|morphine|mesh-list
44788326|NCT03427736|Oxycodone|oxycodone|mesh-list
44788327|NCT03427736|Hydromorphone|hydromorphone|mesh-list
44788328|NCT03427736|Analgesics|analgesics|mesh-ancestor
44788329|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
44788330|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788331|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788332|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44788333|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44788334|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
44788335|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
44788336|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788337|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44788338|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44399443|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44788339|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788340|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788341|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44788342|NCT03427736|Narcotics|narcotics|mesh-ancestor
44788343|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44788344|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44788345|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788346|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788347|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44788348|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788349|NCT03395704|Hepcidins|hepcidins|mesh-list
44788350|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788351|NCT03299309|Vaccines|vaccines|mesh-list
44788352|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
44788353|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788354|NCT03246503|Bilirubin|bilirubin|mesh-list
44788355|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
44788356|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788357|NCT03246503|Protective Agents|protective agents|mesh-ancestor
44788358|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788359|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
44788360|NCT03123913|Testosterone|testosterone|mesh-list
44788361|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
44788362|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
44788363|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44788364|NCT03123913|Androgens|androgens|mesh-ancestor
44788365|NCT03123913|Hormones|hormones|mesh-ancestor
44788366|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788367|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788368|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788369|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788371|NCT03115567|Triamcinolone|triamcinolone|mesh-list
44788372|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788373|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
44788374|NCT03115567|Hormones|hormones|mesh-ancestor
44788375|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788376|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788377|NCT03091881|Granisetron|granisetron|mesh-list
44788378|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
44788379|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
44788380|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788381|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788382|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788383|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44788384|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
44788385|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399498|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
44788386|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788387|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
44788388|NCT03032406|Everolimus|everolimus|mesh-list
44788389|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788390|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788391|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
44788392|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788393|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
44788394|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44788395|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44788396|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788397|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788398|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788399|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788400|NCT02910414|Ethanol|ethanol|mesh-list
44788401|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44788402|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788403|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788404|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788405|NCT02897063|Midodrine|midodrine|mesh-list
44788406|NCT02897063|Droxidopa|droxidopa|mesh-list
44788407|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
44788408|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
44788409|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788410|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788411|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44788412|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44788413|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44788414|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44788415|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788416|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788417|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788418|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44788419|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44788420|NCT02864368|Temozolomide|temozolomide|mesh-list
44788421|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788422|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
44788423|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788424|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788425|NCT02856698|Midazolam|midazolam|mesh-list
44788426|NCT02856698|Morphine|morphine|mesh-list
44788427|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44788428|NCT02856698|Narcotics|narcotics|mesh-ancestor
44788429|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788430|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788431|NCT02856698|Analgesics|analgesics|mesh-ancestor
44788432|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
44788433|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788434|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44788435|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44788436|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44788437|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44788438|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44788439|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44399544|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
44788440|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
44788441|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
44788442|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
44788443|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
44788444|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788445|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788446|NCT02793375|Montelukast|montelukast|mesh-list
44788447|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44788448|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
44788449|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44788450|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
44788451|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788452|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788453|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44788454|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44788455|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567273|NCT01097577|Pregabalin|pregabalin|mesh-list
44788456|NCT02625610|Leucovorin|leucovorin|mesh-list
44788457|NCT02625610|Fluorouracil|fluorouracil|mesh-list
44788458|NCT02625610|Capecitabine|capecitabine|mesh-list
44788459|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
44788460|NCT02625610|Avelumab|avelumab|mesh-list
44788461|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
44788462|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
44788463|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788464|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44788465|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788466|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788467|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
44788468|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788469|NCT02625610|Antidotes|antidotes|mesh-ancestor
44788470|NCT02625610|Protective Agents|protective agents|mesh-ancestor
44788471|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
44788472|NCT02625610|Vitamins|vitamins|mesh-ancestor
44788473|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
44788474|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788475|NCT02515591|Dimercaprol|dimercaprol|mesh-list
44788476|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
44788477|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
44788478|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788479|NCT02514447|Topotecan|topotecan|mesh-list
44788480|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44788481|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44788482|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788483|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788484|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788485|NCT02352883|Hormones|hormones|mesh-list
44788486|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788487|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788488|NCT02257346|Lidocaine|lidocaine|mesh-list
44788489|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
44788490|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
44788491|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788492|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788493|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
44788494|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788495|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44788496|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44788497|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44788498|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44788499|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788500|NCT02192359|Irinotecan|irinotecan|mesh-list
44788501|NCT02192359|Camptothecin|camptothecin|mesh-list
44788502|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44788503|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44788504|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399601|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
44788505|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788506|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788507|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44788508|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
44788509|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
44788510|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
44788511|NCT01618357|Veliparib|veliparib|mesh-list
44788512|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44788513|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788514|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788515|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788516|NCT01530373|Clonidine|clonidine|mesh-list
44788517|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
44788518|NCT01530373|Analgesics|analgesics|mesh-ancestor
44788519|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
44788520|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788521|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788522|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44788523|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
44788524|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
44788525|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44788526|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44788527|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44788528|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788529|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788530|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788531|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44788532|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44788533|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44788534|NCT01530373|Urological Agents|urological agents|mesh-ancestor
44788536|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44788537|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
44788538|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44788539|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788540|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788541|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788542|NCT00712322|Darifenacin|darifenacin|mesh-list
44788543|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44788544|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44788545|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
44788546|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788547|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788548|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788549|NCT00712322|Urological Agents|urological agents|mesh-ancestor
44788550|NCT00572169|Thalidomide|thalidomide|mesh-list
44788551|NCT00572169|Dexamethasone|dexamethasone|mesh-list
44399655|NCT02789657|Paclitaxel|paclitaxel|mesh-list
44788552|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
44788553|NCT00572169|Cisplatin|cisplatin|mesh-list
44788554|NCT00572169|Doxorubicin|doxorubicin|mesh-list
44788555|NCT00572169|Etoposide|etoposide|mesh-list
44788556|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44788557|NCT00572169|Bortezomib|bortezomib|mesh-list
44788558|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788559|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
44788560|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788561|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788562|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788563|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
44788564|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788565|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788566|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44788567|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788568|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
44788569|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
44788570|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788571|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788572|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
44788573|NCT00572169|Hormones|hormones|mesh-ancestor
44788574|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788575|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788576|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44788577|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44788578|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44788579|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788580|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44788581|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
44788582|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788583|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788584|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44788585|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44788586|NCT00572169|Growth Substances|growth substances|mesh-ancestor
44788587|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
44788588|NCT00323856|Factor VIII|factor viii|mesh-list
44788589|NCT00323856|Coagulants|coagulants|mesh-ancestor
44788590|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44788591|NCT05415150|Eptifibatide|eptifibatide|mesh-list
44788592|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44788593|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44788594|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788595|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
44788596|NCT05414942|Narcotics|narcotics|mesh-ancestor
44788597|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788598|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788599|NCT05414942|Analgesics|analgesics|mesh-ancestor
44788600|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
44788601|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788602|NCT05414721|Anesthetics|anesthetics|mesh-list
44788603|NCT05414721|Desflurane|desflurane|mesh-list
44788604|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788605|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788606|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44788607|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
44788608|NCT05414669|Allopurinol|allopurinol|mesh-list
44788609|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
44788610|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788611|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788612|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
44788613|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788614|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44788615|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
44788616|NCT05414669|Protective Agents|protective agents|mesh-ancestor
44788617|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788618|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
44788619|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
44788620|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788621|NCT05414474|Protective Agents|protective agents|mesh-ancestor
44788622|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788623|NCT05414474|Vitamins|vitamins|mesh-ancestor
44788624|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
44788625|NCT05414292|Sirolimus|sirolimus|mesh-list
44788626|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788627|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788628|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44788629|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788630|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
44788631|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788632|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
44788633|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788634|NCT05414149|Ranibizumab|ranibizumab|mesh-list
44788635|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44788636|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44788637|NCT05414149|Growth Substances|growth substances|mesh-ancestor
44788638|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788639|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
44788640|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788641|NCT05414136|Trastuzumab|trastuzumab|mesh-list
44788642|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788643|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788644|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
44788645|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788646|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399753|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788647|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788648|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788649|NCT05413902|Acetaminophen|acetaminophen|mesh-list
44788650|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
44788651|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44788652|NCT05413902|Lidocaine|lidocaine|mesh-list
44788653|NCT05413902|Epinephrine|epinephrine|mesh-list
44788654|NCT05413902|Morphine|morphine|mesh-list
44788655|NCT05413902|Narcotics|narcotics|mesh-list
44788656|NCT05413902|Gabapentin|gabapentin|mesh-list
44788657|NCT05413902|Orphenadrine|orphenadrine|mesh-list
44788658|NCT05413902|Bupivacaine|bupivacaine|mesh-list
44788659|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
44788660|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
44788661|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567495|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567496|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567497|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
44567498|NCT01094808|Pregabalin|pregabalin|mesh-list
44567499|NCT01094808|Analgesics|analgesics|mesh-ancestor
44567500|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
44567501|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567502|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567503|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
44567504|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44567505|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567506|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567507|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44567508|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44567509|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44567510|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567511|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44567512|NCT01094288|Docetaxel|docetaxel|mesh-list
44567513|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567514|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
44788662|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788663|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
44788664|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788665|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44788666|NCT05413902|Analgesics|analgesics|mesh-ancestor
44788667|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44788668|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
44788669|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788670|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
44399787|NCT02782169|Analgesics|analgesics|mesh-ancestor
44788671|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
44788672|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788673|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
44788674|NCT05413902|Hormones|hormones|mesh-ancestor
44788675|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788676|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44788677|NCT05413902|Protective Agents|protective agents|mesh-ancestor
44788678|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44788679|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44788680|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44788681|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788682|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788683|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44788684|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44788685|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44788686|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
44788687|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
44788688|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
44788689|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44788690|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
44788691|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44788692|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44788693|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44788694|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44788695|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44788696|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
44788697|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44788698|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44788699|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44788700|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44788701|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44788702|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788703|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44788704|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788705|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44788706|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44788707|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44399835|NCT02780700|Capecitabine|capecitabine|mesh-list
44788708|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44788709|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
44788710|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44788711|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44788712|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
44788713|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
44788714|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44788715|NCT05413863|Insulin|insulin|mesh-list
44788716|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44788717|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44788718|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788719|NCT05413772|Temocillin|temocillin|mesh-list
44788720|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788721|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788722|NCT05413746|Antioxidants|antioxidants|mesh-list
44788723|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788724|NCT05413746|Protective Agents|protective agents|mesh-ancestor
44788725|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788726|NCT05413551|Isoniazid|isoniazid|mesh-list
44788727|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
44788728|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788729|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788730|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44788731|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44788732|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
44692412|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244020|NCT05641753|Ezetimibe|ezetimibe|mesh-list
44692413|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692414|NCT01367652|Letrozole|letrozole|mesh-list
44692415|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788733|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788734|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44788735|NCT05413343|Ceftazidime|ceftazidime|mesh-list
44788736|NCT05413343|Avibactam|avibactam|mesh-list
44788737|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44788738|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788739|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788740|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44788741|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788742|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788743|NCT05409365|Antibodies|antibodies|mesh-list
44788744|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
44788745|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44788746|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
44788747|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788748|NCT05397587|Vaccines|vaccines|mesh-list
44788749|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
44788750|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788751|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44788752|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788753|NCT05356936|Vitamin D|vitamin d|mesh-list
44788754|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
44788755|NCT05356936|Vitamins|vitamins|mesh-list
44788756|NCT05356936|Vitamin K|vitamin k|mesh-list
44788757|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
44788758|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
44788759|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788760|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44788761|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44788762|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44788763|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44788764|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788765|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
44399945|NCT02777242|Hormones|hormones|mesh-ancestor
44788766|NCT05356936|Coagulants|coagulants|mesh-ancestor
44788767|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
44788768|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
44788769|NCT05352178|Androgens|androgens|mesh-list
44788770|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44788771|NCT05352178|Hormones|hormones|mesh-ancestor
44788772|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788773|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788774|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
44788775|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788776|NCT05352178|Protective Agents|protective agents|mesh-ancestor
44788777|NCT05352178|Vitamins|vitamins|mesh-ancestor
44788778|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
44788779|NCT05352178|Estrogens|estrogens|mesh-ancestor
44788780|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788781|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788782|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
44788783|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
44788784|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
44788785|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788786|NCT05328141|Protective Agents|protective agents|mesh-ancestor
44788787|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788788|NCT05328141|Vitamins|vitamins|mesh-ancestor
44788789|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
44788790|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
44788791|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44788792|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44788793|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788794|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788795|NCT05259137|Enalaprilat|enalaprilat|mesh-list
44788796|NCT05259137|Enalapril|enalapril|mesh-list
44788797|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44788798|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
44788799|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788800|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788801|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44788803|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44788804|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44788805|NCT05251493|Trace Elements|trace elements|mesh-ancestor
44788806|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
44567693|NCT01091675|Etoricoxib|etoricoxib|mesh-list
44788807|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788808|NCT05251493|Hematinics|hematinics|mesh-ancestor
44788809|NCT05233709|Fesoterodine|fesoterodine|mesh-list
44788810|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44788811|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44788812|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
44788813|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788814|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788815|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788816|NCT05233709|Urological Agents|urological agents|mesh-ancestor
44788818|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
44788819|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44788820|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
44788821|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44788822|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788823|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44788824|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788825|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
44788826|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44788827|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
44788828|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44788829|NCT05173896|Tadalafil|tadalafil|mesh-list
44788830|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
44788831|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44788832|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44788833|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788834|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788835|NCT05173896|Urological Agents|urological agents|mesh-ancestor
44788836|NCT05150236|Nivolumab|nivolumab|mesh-list
44788837|NCT05150236|Ipilimumab|ipilimumab|mesh-list
44788838|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
44788839|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788840|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788841|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44788842|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788843|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44788844|NCT05111821|Deferiprone|deferiprone|mesh-list
44788845|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44788846|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
44788847|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
44788848|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788849|NCT05105282|Anesthetics|anesthetics|mesh-list
44788850|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
44788851|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788852|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788853|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
44788854|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788855|NCT05067387|Dronabinol|dronabinol|mesh-list
44788856|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
44788857|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788858|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44788859|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44788860|NCT05067387|Analgesics|analgesics|mesh-ancestor
44788861|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
44788862|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399993|NCT02773368|Insulin|insulin|mesh-list
44788863|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44788864|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44788865|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788866|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788867|NCT05067387|Hormones|hormones|mesh-ancestor
44788868|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788869|NCT05005455|Bevacizumab|bevacizumab|mesh-list
44788870|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44788871|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788872|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44788873|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44788874|NCT05005455|Growth Substances|growth substances|mesh-ancestor
44788875|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788876|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
44788877|NCT04910386|Gemcitabine|gemcitabine|mesh-list
44788878|NCT04910386|Cisplatin|cisplatin|mesh-list
44788879|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788880|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44788881|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
44788882|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788883|NCT04910386|Antiviral Agents|antiviral agents|mesh-ancestor
44788884|NCT04910386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567764|NCT01090102|Mesalamine|mesalamine|mesh-list
44788885|NCT04910386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788886|NCT04910386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788887|NCT04910386|Immunologic Factors|immunologic factors|mesh-ancestor
44788888|NCT04910386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788890|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
44788891|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788892|NCT04875715|Protective Agents|protective agents|mesh-ancestor
44788893|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788894|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44788895|NCT04809233|Tipifarnib|tipifarnib|mesh-list
44788896|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788897|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
44788898|NCT04776850|Dexamethasone|dexamethasone|mesh-list
44788899|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
44788900|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
44788901|NCT04776850|Busulfan|busulfan|mesh-list
44788902|NCT04776850|Rituximab|rituximab|mesh-list
44788903|NCT04776850|Fludarabine|fludarabine|mesh-list
44788904|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
44788905|NCT04776850|Bortezomib|bortezomib|mesh-list
44788906|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44788907|NCT04776850|Tacrolimus|tacrolimus|mesh-list
44788908|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
44788909|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44788910|NCT04776850|Antibodies|antibodies|mesh-list
44788911|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
44788912|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44788913|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
44400059|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
44788914|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44788915|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44788916|NCT04776850|BB 1101|bb 1101|mesh-list
44788917|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44788918|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
44788919|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788920|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44788921|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44788922|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
44788923|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788924|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788925|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44788926|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44788927|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
44788928|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
44788929|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788930|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44788931|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
44788932|NCT04776850|Hormones|hormones|mesh-ancestor
44788933|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788934|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44788935|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44788936|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788937|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44788938|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
44788939|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44788940|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44788941|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44788942|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
44788943|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44788944|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44788945|NCT04757662|Tadalafil|tadalafil|mesh-list
44788946|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
44788947|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44788948|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44788949|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788950|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788951|NCT04757662|Urological Agents|urological agents|mesh-ancestor
44788952|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
44788953|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44788954|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788955|NCT04641234|Aflibercept|aflibercept|mesh-list
44788956|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44788957|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44567912|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788958|NCT04641234|Growth Substances|growth substances|mesh-ancestor
44788959|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788960|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
44788961|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788962|NCT04636034|Anesthetics|anesthetics|mesh-list
44788963|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
44788964|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44788965|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788966|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
44788967|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44788968|NCT04547946|Trametinib|trametinib|mesh-list
44788969|NCT04547946|Dabrafenib|dabrafenib|mesh-list
44788970|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788971|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44788972|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788973|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788974|NCT04524663|Camostat|camostat|mesh-list
44788975|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
44788976|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788977|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788978|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44788979|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44788980|NCT04443309|Lenvatinib|lenvatinib|mesh-list
44788981|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44788982|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44788983|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44788984|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788985|NCT04435795|Ciclesonide|ciclesonide|mesh-list
44788986|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
44788987|NCT04435795|Hormones|hormones|mesh-ancestor
44788988|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44788989|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788990|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44788991|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44788992|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44788993|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44788994|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44788995|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44788996|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400123|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
44788997|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44788998|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44788999|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
44789000|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44789001|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789002|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44789003|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789004|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
44789005|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44789006|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
44789007|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44789008|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789009|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789010|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789011|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
44789012|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
44789013|NCT04233866|Leucovorin|leucovorin|mesh-list
44789014|NCT04233866|Folic Acid|folic acid|mesh-list
44789015|NCT04233866|Gemcitabine|gemcitabine|mesh-list
44789016|NCT04233866|Paclitaxel|paclitaxel|mesh-list
44789017|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44789018|NCT04233866|Fluorouracil|fluorouracil|mesh-list
44789019|NCT04233866|Irinotecan|irinotecan|mesh-list
44789020|NCT04233866|Calcium|calcium|mesh-list
44789021|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
44567913|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567914|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567915|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44567916|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
44567917|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
44567918|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44567919|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44789022|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44789023|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789024|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44789025|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44789026|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44789027|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789028|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44789029|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
44789030|NCT04233866|Antiviral Agents|antiviral agents|mesh-ancestor
44789031|NCT04233866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789032|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789033|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789034|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
44789035|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789036|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44789037|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44789038|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44789039|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44789040|NCT04233866|Antidotes|antidotes|mesh-ancestor
44789041|NCT04233866|Protective Agents|protective agents|mesh-ancestor
44789042|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
44789043|NCT04233866|Vitamins|vitamins|mesh-ancestor
44789044|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
44789045|NCT04233866|Hematinics|hematinics|mesh-ancestor
44789046|NCT04222283|Emtricitabine|emtricitabine|mesh-list
44789047|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
44789048|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789049|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44789050|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44789051|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789052|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789053|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44789054|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44789055|NCT04131504|Adalimumab|adalimumab|mesh-list
44789056|NCT04131504|Infliximab|infliximab|mesh-list
44789057|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789058|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789059|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44789060|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789061|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
44789062|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789063|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789064|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44789065|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789066|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789067|NCT03962998|Lactulose|lactulose|mesh-list
44789068|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789069|NCT03926143|Maytansine|maytansine|mesh-list
44789070|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
44789071|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44789072|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789073|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
44789074|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
44789075|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789076|NCT03891667|Disulfiram|disulfiram|mesh-list
44789077|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44789078|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44789079|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789080|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789081|NCT03859635|Bupivacaine|bupivacaine|mesh-list
44789082|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
44789083|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
44789084|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789085|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789086|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
44789087|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789088|NCT03783013|Lycopene|lycopene|mesh-list
44789089|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789090|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
44789091|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789092|NCT03783013|Protective Agents|protective agents|mesh-ancestor
44789093|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789094|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44789095|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44789096|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789097|NCT03762473|Tacrolimus|tacrolimus|mesh-list
44789098|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789099|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
44789100|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789101|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44789102|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789103|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789104|NCT03726229|Cholic Acids|cholic acids|mesh-list
44789105|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789107|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44789108|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
44789109|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789110|NCT03626922|Folic Acid|folic acid|mesh-list
44789111|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
44789112|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
44789113|NCT03626922|Dexamethasone|dexamethasone|mesh-list
44789114|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
44789115|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
44789116|NCT03626922|Pemetrexed|pemetrexed|mesh-list
44789117|NCT03626922|Vitamins|vitamins|mesh-ancestor
44789118|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
44789119|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789120|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789121|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
44789122|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
44789123|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789124|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789125|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
44789126|NCT03626922|Hormones|hormones|mesh-ancestor
44789127|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789128|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789129|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789130|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789131|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789132|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789133|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44789134|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44789135|NCT03626922|Hematinics|hematinics|mesh-ancestor
44789136|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
44789137|NCT03600818|Prednisone|prednisone|mesh-list
44789138|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789139|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
44789140|NCT03600818|Hormones|hormones|mesh-ancestor
44789141|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789142|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789143|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789144|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789145|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
44789146|NCT03578276|Prednisolone|prednisolone|mesh-list
44789147|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44789148|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
44789149|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44789150|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
44789151|NCT03578276|Bromfenac|bromfenac|mesh-list
44789152|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44789153|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
44789154|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789155|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
44789156|NCT03578276|Hormones|hormones|mesh-ancestor
44789157|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789158|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789159|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789160|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789161|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
44789162|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
44789163|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789164|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789165|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44789166|NCT03578276|Protective Agents|protective agents|mesh-ancestor
44789167|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44789168|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789169|NCT03578276|Analgesics|analgesics|mesh-ancestor
44789170|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
44789171|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789172|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789173|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789174|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44789175|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44789176|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44789177|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44789178|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789179|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789180|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
44789181|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789182|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789183|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44400331|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789184|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44789185|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44789186|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789187|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789188|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789189|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789190|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44789191|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
44789192|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44789193|NCT03491267|Tretinoin|tretinoin|mesh-list
44789194|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789195|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
44789196|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44789197|NCT03464292|Capsaicin|capsaicin|mesh-list
44789198|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
44789199|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44789200|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
44789201|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789202|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789203|NCT03390686|Paclitaxel|paclitaxel|mesh-list
44789204|NCT03390686|Bevacizumab|bevacizumab|mesh-list
44789205|NCT03390686|Carboplatin|carboplatin|mesh-list
44789206|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44789207|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789208|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
44789209|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
44789210|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
44789211|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789212|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789213|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44789214|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44789215|NCT03390686|Growth Substances|growth substances|mesh-ancestor
44789216|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789217|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
44789218|NCT03174184|Amoxicillin|amoxicillin|mesh-list
44789219|NCT03174184|Rifampin|rifampin|mesh-list
44789220|NCT03174184|Meropenem|meropenem|mesh-list
44789221|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
44789222|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
44789223|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44789224|NCT03174184|Rifamycins|rifamycins|mesh-list
44789225|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789226|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789227|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44789228|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
44789229|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
44789230|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44789231|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789232|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789233|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44789234|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44789235|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44789236|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44789237|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44789238|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44789239|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44789240|NCT03052933|Gemcitabine|gemcitabine|mesh-list
44789241|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44789242|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
44789243|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789244|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789245|NCT03052933|Antiviral Agents|antiviral agents|mesh-ancestor
44789246|NCT03052933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789247|NCT03052933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789248|NCT03052933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789249|NCT03052933|Immunologic Factors|immunologic factors|mesh-ancestor
44789250|NCT03052933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789251|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
44789252|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789253|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789254|NCT02959697|Lidocaine|lidocaine|mesh-list
44789255|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
44789256|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
44789257|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789258|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789259|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
44789260|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789261|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44789262|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44789263|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44789264|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789265|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789266|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
44789267|NCT02900560|Azacitidine|azacitidine|mesh-list
44789268|NCT02900560|Cc-486|cc-486|mesh-list
44789269|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789270|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789271|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44789272|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
44789273|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789274|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789275|NCT02877550|Venetoclax|venetoclax|mesh-list
44789276|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
44789277|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789278|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789279|NCT02807454|Dexamethasone|dexamethasone|mesh-list
44789280|NCT02807454|Durvalumab|durvalumab|mesh-list
44789281|NCT02807454|Daratumumab|daratumumab|mesh-list
44789282|NCT02807454|Pomalidomide|pomalidomide|mesh-list
44789283|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789284|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
44789285|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
44789286|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789287|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789288|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789289|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
44789290|NCT02807454|Hormones|hormones|mesh-ancestor
44789291|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692416|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44789292|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789293|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789294|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789295|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
44789296|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44789297|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44789298|NCT02807454|Growth Substances|growth substances|mesh-ancestor
44789299|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
44789300|NCT02775812|Cisplatin|cisplatin|mesh-list
44789301|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
44789302|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789303|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789304|NCT02734537|Cisplatin|cisplatin|mesh-list
44789305|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789306|NCT02679170|Crizotinib|crizotinib|mesh-list
44789307|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789308|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44789309|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789310|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789311|NCT02640534|Metformin|metformin|mesh-list
44789312|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44789313|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789314|NCT02518009|Estrogens|estrogens|mesh-list
44789315|NCT02518009|Androgens|androgens|mesh-list
44789316|NCT02518009|Hormones|hormones|mesh-ancestor
44789317|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789318|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789319|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44789320|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44789321|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44789322|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44789323|NCT02238496|Sirolimus|sirolimus|mesh-list
44789324|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789325|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789326|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44789327|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692417|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44692418|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692419|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692420|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44692421|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
44692422|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692423|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692424|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
44692425|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44692426|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692427|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
44692428|NCT01367743|Epinephrine|epinephrine|mesh-list
44692429|NCT01367743|Norepinephrine|norepinephrine|mesh-list
44692430|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44692431|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44692432|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44692433|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
44692434|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692435|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692436|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692437|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44692438|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44692439|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
44692440|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692441|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44692442|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44692443|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
44692444|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
44692445|NCT01367756|Citalopram|citalopram|mesh-list
44692446|NCT01367756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44692447|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692448|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692449|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692450|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692451|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
44692452|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692453|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692454|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
44789328|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
44789329|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789330|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
44789331|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789332|NCT02220426|Xenon|xenon|mesh-list
44789333|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44789334|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
44789335|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
44789336|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789337|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789338|NCT02034110|Trametinib|trametinib|mesh-list
44789339|NCT02034110|Dabrafenib|dabrafenib|mesh-list
44789340|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789341|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44789342|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789343|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789344|NCT01968213|Rucaparib|rucaparib|mesh-list
44789345|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44789346|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789347|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789348|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789349|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
44789350|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
44789351|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789352|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44789353|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789354|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789355|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
44789356|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789357|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44789358|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789359|NCT01498458|Capecitabine|capecitabine|mesh-list
44789360|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44789361|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
44789362|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789363|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789364|NCT01427712|Pancrelipase|pancrelipase|mesh-list
44789365|NCT01427712|Pancreatin|pancreatin|mesh-list
44789366|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789367|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
44789368|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789369|NCT01369147|Clevidipine|clevidipine|mesh-list
44789370|NCT01369147|Propofol|propofol|mesh-list
44789371|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44789372|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789373|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789374|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44789375|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
44789376|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
44789377|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44789378|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789379|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789380|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44789381|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
44789382|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789383|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
44789384|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789385|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789386|NCT01124695|Tamoxifen|tamoxifen|mesh-list
44789387|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44789388|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
44789389|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789390|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789391|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400579|NCT02750709|Nitisinone|nitisinone|mesh-list
44789392|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789393|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44568260|NCT01077076|Omeprazole|omeprazole|mesh-list
44789394|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44789395|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568261|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44568262|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44568263|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568267|NCT01076647|Insulin|insulin|mesh-list
44789396|NCT01079780|Irinotecan|irinotecan|mesh-list
44789397|NCT01079780|Cetuximab|cetuximab|mesh-list
44789398|NCT01079780|Ramucirumab|ramucirumab|mesh-list
44789399|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44789400|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44789401|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789402|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400609|NCT02749799|Betamethasone|betamethasone|mesh-list
44789403|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789404|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789405|NCT00075946|Rituximab|rituximab|mesh-list
44789406|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44789407|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789408|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
44789409|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789410|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789411|NCT00003641|Interferons|interferons|mesh-list
44789412|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
44789413|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
44789414|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789415|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
44789416|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789417|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
44789418|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789419|NCT01945840|Hormones|hormones|mesh-list
44789420|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789421|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789422|NCT01945879|Heparin|heparin|mesh-list
44789423|NCT01945879|Enoxaparin|enoxaparin|mesh-list
44789424|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44789425|NCT01945879|Tinzaparin|tinzaparin|mesh-list
44789426|NCT01945879|Dalteparin|dalteparin|mesh-list
44789427|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
44789428|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44789429|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44789430|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789431|NCT01945892|Dexamethasone|dexamethasone|mesh-list
44789432|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789433|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
44789434|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
44789435|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789436|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789437|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789438|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
44789439|NCT01945892|Hormones|hormones|mesh-ancestor
44789440|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789441|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789442|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789443|NCT01945957|Oxytocin|oxytocin|mesh-list
44789444|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
44789445|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44789446|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789447|NCT01945983|Norepinephrine|norepinephrine|mesh-list
44789448|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44789449|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400663|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
44789450|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
44789451|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789452|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789453|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789454|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
44789455|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
44789456|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789457|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44789458|NCT01946009|Cidofovir|cidofovir|mesh-list
44789459|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
44789460|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789461|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789462|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789463|NCT01946035|Doxazosin|doxazosin|mesh-list
44789464|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44789465|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44789466|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44789467|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44789468|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44789469|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789470|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789471|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789472|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
44789473|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789474|NCT01946256|Amoxicillin|amoxicillin|mesh-list
44789475|NCT01946256|Erythromycin|erythromycin|mesh-list
44789476|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
44789477|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44789478|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
44789479|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789480|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400664|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
44400671|NCT02748057|Ezetimibe|ezetimibe|mesh-list
44789481|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789482|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44789483|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789484|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789485|NCT01946295|Famotidine|famotidine|mesh-list
44789486|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44789487|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789488|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44789489|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
44789490|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
44789491|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789492|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789493|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789494|NCT01946386|Betamethasone|betamethasone|mesh-list
44789495|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
44789496|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44789497|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
44789498|NCT01946386|Clobetasol|clobetasol|mesh-list
44789499|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44789500|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789501|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
44789502|NCT01946386|Hormones|hormones|mesh-ancestor
44789503|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789504|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789505|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44789506|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
44789507|NCT01946399|Dexamethasone|dexamethasone|mesh-list
44789508|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789509|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
44789510|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
44789511|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789512|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789513|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789514|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
44789515|NCT01946399|Hormones|hormones|mesh-ancestor
44789516|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789517|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789518|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789519|NCT01946555|Fentanyl|fentanyl|mesh-list
44789520|NCT01946555|Morphine|morphine|mesh-list
44789521|NCT01946555|Oxycodone|oxycodone|mesh-list
44789522|NCT01946555|Buprenorphine|buprenorphine|mesh-list
44789523|NCT01946555|Methadone|methadone|mesh-list
44789524|NCT01946555|Hydromorphone|hydromorphone|mesh-list
44789525|NCT01946555|Tapentadol|tapentadol|mesh-list
44789526|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44789527|NCT01946555|Narcotics|narcotics|mesh-ancestor
44789528|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789529|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789530|NCT01946555|Analgesics|analgesics|mesh-ancestor
44789531|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
44789532|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789533|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44789534|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44789535|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
44789536|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
44789537|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44789538|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
44789539|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
44789540|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44400723|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44789541|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44789542|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789543|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789544|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
44789545|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789546|NCT01946568|Dalbavancin|dalbavancin|mesh-list
44789547|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789548|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789549|NCT01946594|Acetaminophen|acetaminophen|mesh-list
44789550|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789551|NCT01946594|Analgesics|analgesics|mesh-ancestor
44789552|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
44789553|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789554|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789555|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
44789556|NCT01946607|Citalopram|citalopram|mesh-list
44789557|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44789558|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44789559|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789560|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789561|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789562|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
44789563|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789564|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44789565|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
44789566|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44789567|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
44789568|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44789569|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
44789570|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789571|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789572|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44789573|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
44789574|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44789575|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44789576|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44789577|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
44789578|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789579|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789580|NCT01946815|Atorvastatin|atorvastatin|mesh-list
44789581|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44789582|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44789583|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
44789584|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789585|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44789586|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44789587|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789589|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789590|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789591|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789592|NCT01946971|Lansoprazole|lansoprazole|mesh-list
44789593|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
44789594|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44789595|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789596|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44789597|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789598|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789599|NCT01946984|Diclofenac|diclofenac|mesh-list
44789600|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44789601|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44789602|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789603|NCT01946984|Analgesics|analgesics|mesh-ancestor
44789604|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
44789605|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789606|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789607|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789608|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789609|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44789610|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789611|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789612|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44789613|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
44789614|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789615|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
44789616|NCT01947062|Cisplatin|cisplatin|mesh-list
44789617|NCT01947062|Etoposide|etoposide|mesh-list
44789618|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
44789619|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789620|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
44789621|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789622|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789623|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44789624|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
44789625|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789626|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789627|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44789628|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44789629|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44789630|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44789631|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789632|NCT01947114|Ketamine|ketamine|mesh-list
44789633|NCT01947114|Remifentanil|remifentanil|mesh-list
44789634|NCT01947114|Propofol|propofol|mesh-list
44789635|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44789636|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789637|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789638|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44789639|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
44789640|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
44789641|NCT01947114|Analgesics|analgesics|mesh-ancestor
44400830|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44789642|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
44789643|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789644|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44789645|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44789646|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44789647|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789648|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789649|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44789650|NCT01947114|Narcotics|narcotics|mesh-ancestor
44789651|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
44789652|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44789653|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789654|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
44789655|NCT01947205|Acetaminophen|acetaminophen|mesh-list
44789656|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44789657|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789658|NCT01947205|Analgesics|analgesics|mesh-ancestor
44789659|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
44789660|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789661|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789662|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
44789663|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44789664|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789665|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789666|NCT01947309|Lenalidomide|lenalidomide|mesh-list
44789667|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
44789668|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789669|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44789670|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44789671|NCT01947309|Growth Substances|growth substances|mesh-ancestor
44789672|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
44789673|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789674|NCT01947465|Vaccines|vaccines|mesh-list
44789675|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
44789676|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789677|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
44789678|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44789679|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789680|NCT01947608|Ceritinib|ceritinib|mesh-list
44789681|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789682|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44789683|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400855|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44789684|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789685|NCT01947660|Anesthetics|anesthetics|mesh-list
44789686|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789687|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789688|NCT01947699|Glyburide|glyburide|mesh-list
44789689|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44789690|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789691|NCT01947777|Rifampin|rifampin|mesh-list
44789692|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44789693|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
44789694|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789695|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789696|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
44789697|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44789698|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789699|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789700|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44789701|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44789702|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44789703|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44789704|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44789705|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44789706|NCT01947790|Metformin|metformin|mesh-list
44789707|NCT01947790|Pioglitazone|pioglitazone|mesh-list
44789708|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44789709|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789710|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44789711|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44789712|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44789713|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568633|NCT01073163|Rituximab|rituximab|mesh-list
44789714|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789715|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44789716|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44789717|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44789718|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
44789719|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789720|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400902|NCT02741076|Morphine|morphine|mesh-list
44789721|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44789722|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44789723|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
44789724|NCT01947920|Tramadol|tramadol|mesh-list
44789725|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44789726|NCT01947920|Narcotics|narcotics|mesh-ancestor
44789727|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789728|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789729|NCT01947920|Analgesics|analgesics|mesh-ancestor
44789730|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
44789731|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789732|NCT01947933|Mirikizumab|mirikizumab|mesh-list
44789733|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44789734|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789735|NCT01947933|Analgesics|analgesics|mesh-ancestor
44789736|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
44789737|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789738|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789739|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789740|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789741|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44789742|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789743|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
44789744|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44789745|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
44789746|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44789747|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789748|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789749|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789750|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
44789751|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
44789752|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44789753|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
44789754|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44789755|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789756|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789757|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789758|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
44789759|NCT01947998|Warfarin|warfarin|mesh-list
44789760|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
44789761|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44789762|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
44789763|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44789764|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
44789765|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44789766|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789767|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789768|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789769|NCT01948011|Racecadotril|racecadotril|mesh-list
44789770|NCT01948011|Thiorphan|thiorphan|mesh-list
44789771|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
44789772|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44789773|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789774|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789775|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789776|NCT01948024|Asenapine|asenapine|mesh-list
44789777|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44789778|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44789779|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789780|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789781|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44400997|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789782|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
44789783|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44789784|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
44789785|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
44789786|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789787|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789788|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789789|NCT01948115|Analgesics|analgesics|mesh-ancestor
44789790|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
44789791|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789792|NCT01948128|Vitamin D|vitamin d|mesh-list
44789793|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
44789794|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
44789795|NCT01948128|Vitamins|vitamins|mesh-list
44789796|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
44789797|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400998|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789798|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44789799|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44789800|NCT01948232|Perindopril|perindopril|mesh-list
44789801|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44789802|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
44789803|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789804|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789805|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44789806|NCT01948245|Taurolidine|taurolidine|mesh-list
44789807|NCT01948245|Heparin|heparin|mesh-list
44789808|NCT01948245|Calcium heparin|calcium heparin|mesh-list
44789809|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
44789810|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789811|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44789812|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44789813|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789814|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44789815|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692455|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692456|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44692457|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44692458|NCT01367912|Estradiol|estradiol|mesh-list
44692459|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44789816|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
44789817|NCT01948336|Ketamine|ketamine|mesh-list
44789818|NCT01948336|Propofol|propofol|mesh-list
44789819|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44789820|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789821|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789822|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44789823|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
44789824|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
44789825|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789826|NCT01948336|Analgesics|analgesics|mesh-ancestor
44789827|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
44789828|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789829|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44789830|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44789831|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44789832|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401038|NCT02736578|Cetuximab|cetuximab|mesh-list
44789833|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789834|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789835|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44789836|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44789837|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44789838|NCT01948362|Sulforaphane|sulforaphane|mesh-list
44789839|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44789840|NCT01948362|Protective Agents|protective agents|mesh-ancestor
44789841|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789842|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789843|NCT01948401|Prednisolone|prednisolone|mesh-list
44789844|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789845|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
44789846|NCT01948401|Hormones|hormones|mesh-ancestor
44789847|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789848|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789849|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44789850|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789851|NCT01948505|Acetaminophen|acetaminophen|mesh-list
44789852|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44789853|NCT01948505|Analgesics|analgesics|mesh-ancestor
44789854|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
44789855|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692460|NCT01367912|Estrogens|estrogens|mesh-ancestor
44692461|NCT01367912|Hormones|hormones|mesh-ancestor
44692462|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692463|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692464|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44692465|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
44692466|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44692467|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44692468|NCT01367964|Hormones|hormones|mesh-list
44692469|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44692470|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44568851|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568852|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568853|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568854|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568855|NCT01070329|Analgesics|analgesics|mesh-ancestor
44568856|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
44401051|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44568857|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568858|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
44568859|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44568860|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
44568861|NCT01070316|Everolimus|everolimus|mesh-list
44568862|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568863|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568864|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
44568865|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568866|NCT01070303|Adalimumab|adalimumab|mesh-list
44568867|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568868|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789856|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789858|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
44789859|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44789860|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
44789861|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789862|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
44789863|NCT01948583|Protective Agents|protective agents|mesh-ancestor
44789864|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44789865|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44789866|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44789867|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
44789868|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789869|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44789870|NCT01948765|Propofol|propofol|mesh-list
44789871|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44789872|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789873|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789874|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44789875|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
44789876|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
44789877|NCT01948804|Letrozole|letrozole|mesh-list
44789878|NCT01948804|Clomiphene|clomiphene|mesh-list
44789879|NCT01948804|Cetrorelix|cetrorelix|mesh-list
44789880|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44789881|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401099|NCT02732938|Gemcitabine|gemcitabine|mesh-list
44789882|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44789883|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44789884|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789885|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789886|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44789887|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
44789888|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789889|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789890|NCT01948804|Hormones|hormones|mesh-ancestor
44789891|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44789892|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
44789893|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44789894|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44789895|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44789896|NCT01948817|Deferasirox|deferasirox|mesh-list
44789897|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44789898|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
44789899|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
44789900|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789901|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44789902|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44789903|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44789904|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44789905|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789906|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789907|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789908|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
44789909|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44789910|NCT01948921|Meperidine|meperidine|mesh-list
44789911|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44789912|NCT01948921|Narcotics|narcotics|mesh-ancestor
44789913|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789914|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789915|NCT01948921|Analgesics|analgesics|mesh-ancestor
44789916|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
44789917|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44789918|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44789919|NCT01948960|Everolimus|everolimus|mesh-list
44789920|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789921|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789922|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
44789923|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789924|NCT01948999|Anesthetics|anesthetics|mesh-list
44789925|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789926|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789927|NCT01949038|Alprazolam|alprazolam|mesh-list
44789928|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44692471|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
44789929|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44789930|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789931|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44789932|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44789933|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44789934|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
44789935|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
44789936|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44789937|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789938|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
44789939|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789940|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
44789941|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
44789942|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
44789943|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
44789945|NCT01949129|Thiotepa|thiotepa|mesh-list
44789946|NCT01949129|Treosulfan|treosulfan|mesh-list
44789947|NCT01949129|Fludarabine|fludarabine|mesh-list
44789948|NCT01949129|Etoposide|etoposide|mesh-list
44789949|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
44789950|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44789951|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
44789952|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44789953|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
44789954|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789955|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44789956|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44789957|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
44789958|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789959|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789960|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44789961|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44789962|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44789963|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44789964|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44789965|NCT01949168|Ribavirin|ribavirin|mesh-list
44789966|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44789967|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
44789968|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789969|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
44789970|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789971|NCT01949233|Doxycycline|doxycycline|mesh-list
44789972|NCT01949233|Irbesartan|irbesartan|mesh-list
44789973|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789974|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789975|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
44789976|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44789977|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44789978|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44789979|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44789980|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44789981|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44789982|NCT01949363|Cefixime|cefixime|mesh-list
44789983|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44789984|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44789985|NCT01949454|Fluorometholone|fluorometholone|mesh-list
44789986|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44789987|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
44789988|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44789989|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44789990|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
44789991|NCT01949454|Hormones|hormones|mesh-ancestor
44789992|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44789993|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44789994|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44789995|NCT01949519|Lycopene|lycopene|mesh-list
44789996|NCT01949519|Docetaxel|docetaxel|mesh-list
44789997|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44789998|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
44789999|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790000|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
44568946|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790001|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790002|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790003|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
44790004|NCT01949519|Protective Agents|protective agents|mesh-ancestor
44790005|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790006|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44790007|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44790009|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44790010|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44790011|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44790012|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
44790013|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
44790014|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790015|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790016|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790017|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44790018|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44790019|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790020|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44790021|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44790022|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44790023|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
44790024|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44790025|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44790026|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
44790027|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44790028|NCT01949675|Vaccines|vaccines|mesh-list
44790029|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
44790030|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790031|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44790032|NCT01949766|Glycerol|glycerol|mesh-list
44790033|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44790034|NCT01949766|Protective Agents|protective agents|mesh-ancestor
44790035|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790036|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790037|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
44790038|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44790039|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
44790040|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790041|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
44790042|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790043|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790044|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790045|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
44790046|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790047|NCT01949818|Prednisone|prednisone|mesh-list
44790048|NCT01949818|Prednisolone|prednisolone|mesh-list
44790049|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
44790050|NCT01949818|Doxorubicin|doxorubicin|mesh-list
44790051|NCT01949818|Vincristine|vincristine|mesh-list
44790052|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790053|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
44790054|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790055|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790056|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44790057|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
44790058|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790059|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790060|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44790061|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44790062|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44790063|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44790064|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790065|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790066|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
44790067|NCT01949818|Hormones|hormones|mesh-ancestor
44790068|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790069|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44790070|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44790071|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
44790072|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790073|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
44790074|NCT01949857|Vaccines|vaccines|mesh-list
44790075|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
44401287|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44790076|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790077|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
44790078|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44790079|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
44790080|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790081|NCT01949935|Mupirocin|mupirocin|mesh-list
44790082|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790083|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790084|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44790085|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790086|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790087|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44790088|NCT01949948|Tenecteplase|tenecteplase|mesh-list
44790089|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44790090|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44790091|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790092|NCT01950000|Fentanyl|fentanyl|mesh-list
44790093|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44790094|NCT01950000|Narcotics|narcotics|mesh-ancestor
44790095|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790096|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790097|NCT01950000|Analgesics|analgesics|mesh-ancestor
44790098|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
44790099|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790100|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44790101|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44790102|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
44790103|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
44569092|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790104|NCT01950182|Tamoxifen|tamoxifen|mesh-list
44790105|NCT01950182|Gemcitabine|gemcitabine|mesh-list
44790106|NCT01950182|Capecitabine|capecitabine|mesh-list
44790107|NCT01950182|Trastuzumab|trastuzumab|mesh-list
44790108|NCT01950182|Vinorelbine|vinorelbine|mesh-list
44790109|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44790110|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44790111|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
44790112|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790113|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790114|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
44790115|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790116|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790117|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790118|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
44790119|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790120|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44790121|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401329|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
44790122|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44790123|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790124|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44790125|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44790126|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790127|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790128|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44790129|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44790130|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44790131|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44790132|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44790133|NCT01950195|Ipilimumab|ipilimumab|mesh-list
44790134|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44790135|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790136|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44790137|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790138|NCT01950416|Clopidogrel|clopidogrel|mesh-list
44790139|NCT01950416|Ticagrelor|ticagrelor|mesh-list
44790140|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790141|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44790142|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44790143|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44790144|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
44790145|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790146|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790147|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790148|NCT01950481|Ceritinib|ceritinib|mesh-list
44790149|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790150|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44790151|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790152|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790153|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
44790154|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44790155|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790156|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
44790157|NCT01950507|Fluconazole|fluconazole|mesh-list
44790158|NCT01950507|Voriconazole|voriconazole|mesh-list
44790159|NCT01950507|Micafungin|micafungin|mesh-list
44790160|NCT01950507|Budesonide|budesonide|mesh-list
44790161|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790162|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44790163|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
44790164|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790165|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790166|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44790167|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790168|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
44790169|NCT01950507|Hormones|hormones|mesh-ancestor
44790170|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790171|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
44790172|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790173|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44790174|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44790175|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790176|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569166|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
44790177|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44790178|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790179|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44790180|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44790181|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44790182|NCT01950546|Fluorides|fluorides|mesh-list
44790183|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
44790184|NCT01950546|Protective Agents|protective agents|mesh-ancestor
44790185|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790186|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
44790187|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790188|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
44790189|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790190|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790191|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790192|NCT01950611|Bortezomib|bortezomib|mesh-list
44790193|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790194|NCT01950689|Nimorazole|nimorazole|mesh-list
44790195|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44790196|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44790197|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44790198|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790199|NCT01950793|Triamcinolone|triamcinolone|mesh-list
44790200|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44790201|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44790202|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
44790203|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44790204|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790205|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
44790206|NCT01950793|Hormones|hormones|mesh-ancestor
44790207|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790208|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790209|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790210|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
44790211|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790212|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790213|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44790214|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
44790215|NCT01950793|Protective Agents|protective agents|mesh-ancestor
44790216|NCT01950884|Ezetimibe|ezetimibe|mesh-list
44790217|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44790218|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44790219|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
44790220|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401449|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401472|NCT02724020|Serabelisib|serabelisib|mesh-list
44790221|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44790222|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
44790223|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790224|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
44790225|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44790226|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44790227|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790228|NCT01950923|Urological Agents|urological agents|mesh-ancestor
44790229|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44790230|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
44790231|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
44790232|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44790233|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790234|NCT01951027|Lenograstim|lenograstim|mesh-list
44790235|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44790236|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
44790237|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790238|NCT01951053|Citalopram|citalopram|mesh-list
44790239|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44790240|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44790241|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401494|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790242|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790243|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790244|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
44790245|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790246|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44790247|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
44790248|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44790249|NCT01951079|Digoxin|digoxin|mesh-list
44790250|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44790251|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44790252|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790253|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790254|NCT01951079|Protective Agents|protective agents|mesh-ancestor
44790255|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790256|NCT01951144|Lorazepam|lorazepam|mesh-list
44790257|NCT01951144|PF-06372865|pf-06372865|mesh-list
44790258|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
44790259|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
44790260|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
44790261|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790262|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790263|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790264|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44790265|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790266|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44790267|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44790268|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44790269|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
44790270|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
44790271|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790272|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790273|NCT01951209|Rifaximin|rifaximin|mesh-list
44790274|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790275|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790276|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790277|NCT01951404|Allopurinol|allopurinol|mesh-list
44790278|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
44790279|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790280|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790281|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
44790282|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790283|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44790284|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
44790285|NCT01951404|Protective Agents|protective agents|mesh-ancestor
44790286|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790287|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44790288|NCT01951430|Cephalosporins|cephalosporins|mesh-list
44790289|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44790290|NCT01951430|Itraconazole|itraconazole|mesh-list
44790291|NCT01951430|Fluconazole|fluconazole|mesh-list
44790292|NCT01951430|Posaconazole|posaconazole|mesh-list
44790293|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
44790294|NCT01951430|Clotrimazole|clotrimazole|mesh-list
44790295|NCT01951430|Miconazole|miconazole|mesh-list
44790296|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790297|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44790298|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44790299|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790300|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790301|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44790302|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790303|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790304|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790305|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44790306|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44790307|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44569314|NCT01052272|Protective Agents|protective agents|mesh-ancestor
44569315|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569316|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44569317|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569318|NCT01050634|Exemestane|exemestane|mesh-list
44569319|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569320|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44569321|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44569322|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569323|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569324|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44569325|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
44569326|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569327|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569328|NCT01049503|Fluorides|fluorides|mesh-list
44569329|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
44569330|NCT01049503|Protective Agents|protective agents|mesh-ancestor
44569331|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790308|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44790309|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44790310|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44790311|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44790312|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44790313|NCT01951430|Renal Agents|renal agents|mesh-ancestor
44790314|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
44790315|NCT01951482|Bevacizumab|bevacizumab|mesh-list
44790316|NCT01951482|Cisplatin|cisplatin|mesh-list
44790317|NCT01951482|Pemetrexed|pemetrexed|mesh-list
44790318|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44790319|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790320|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44790321|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44790322|NCT01951482|Growth Substances|growth substances|mesh-ancestor
44790323|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790324|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
44790325|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790326|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790327|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44790328|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790329|NCT01951508|Methylphenidate|methylphenidate|mesh-list
44790330|NCT01951508|Modafinil|modafinil|mesh-list
44790331|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44790332|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790333|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44790334|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44790335|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44790336|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790337|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
44790338|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790339|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44790340|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44790341|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44790342|NCT01951560|Valproic Acid|valproic acid|mesh-list
44790343|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
44790344|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790345|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790346|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
44790347|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790348|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790349|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
44790350|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44790351|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790352|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44790353|NCT01951599|Osimertinib|osimertinib|mesh-list
44790354|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790355|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44790356|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790357|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790358|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44790359|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
44790360|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790361|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44790362|NCT01951677|Antacids|antacids|mesh-ancestor
44790363|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790364|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790365|NCT01951729|Atropine|atropine|mesh-list
44790366|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44790367|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44790368|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44790369|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
44790370|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790371|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790372|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44790373|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790374|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
44790375|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
44790376|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44790377|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44790378|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
44790379|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790380|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569381|NCT01045993|Analgesics|analgesics|mesh-list
44790382|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790383|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44790384|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790385|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790386|NCT01951872|Caffeine|caffeine|mesh-list
44790387|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44790388|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790389|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44790390|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790391|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790392|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44790393|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44790394|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
44790395|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790420|NCT01951898|Montelukast|montelukast|mesh-list
44790421|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44790422|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790423|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44790424|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790425|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790426|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790427|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44790428|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44790429|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790430|NCT01951911|Ketamine|ketamine|mesh-list
44790431|NCT01951911|Analgesics|analgesics|mesh-ancestor
44790432|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
44790433|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790434|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790435|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44790436|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44790437|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
44790438|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
44790439|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790440|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44790441|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44790442|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790443|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790444|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
44790445|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44790446|NCT01951924|Antibodies|antibodies|mesh-list
44790447|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
44790448|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
44401687|NCT02717195|Olanzapine|olanzapine|mesh-list
44790449|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790450|NCT01952314|Naftopidil|naftopidil|mesh-list
44790451|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44790452|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44790453|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
44790454|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790455|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790456|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790457|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44790458|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44790459|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44790460|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44790461|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790462|NCT01952561|Dapivirine|dapivirine|mesh-list
44790463|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44790464|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44790465|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
44790466|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790467|NCT01952626|Ondansetron|ondansetron|mesh-list
44790468|NCT01952626|Palonosetron|palonosetron|mesh-list
44790469|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
44790470|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
44790471|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790472|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790473|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790474|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
44790475|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
44790476|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44790477|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
44790478|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790479|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790480|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44790481|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44790482|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790483|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44790484|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44790485|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44790486|NCT01952652|Naproxen|naproxen|mesh-list
44790487|NCT01952652|Codeine|codeine|mesh-list
44790488|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44790489|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44790490|NCT01952652|Analgesics|analgesics|mesh-ancestor
44790491|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
44790492|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790493|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790494|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790495|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790496|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
44790497|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44790498|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790499|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790500|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44790501|NCT01952652|Narcotics|narcotics|mesh-ancestor
44790502|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790503|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
44790504|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790505|NCT01952756|Cilostazol|cilostazol|mesh-list
44790506|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44790507|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
44790508|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790509|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790510|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44790511|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790512|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44790513|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44790514|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790515|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790516|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
44790517|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44790518|NCT01952756|Protective Agents|protective agents|mesh-ancestor
44790519|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44790520|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44790521|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790522|NCT01952769|Pidilizumab|pidilizumab|mesh-list
44790523|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569536|NCT01038752|Suramin|suramin|mesh-list
44790524|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790525|NCT01952886|Ondansetron|ondansetron|mesh-list
44790526|NCT01952886|Granisetron|granisetron|mesh-list
44790527|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
44790528|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
44790529|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790530|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790531|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790532|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
44790533|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
44790534|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44790535|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
44790536|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790537|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790538|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44790539|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44790540|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790541|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401760|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
44790542|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44790543|NCT01952951|Fluorouracil|fluorouracil|mesh-list
44790544|NCT01952951|Capecitabine|capecitabine|mesh-list
44790545|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
44790546|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
44790547|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790548|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44692472|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692473|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692474|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692475|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692476|NCT01367990|Norepinephrine|norepinephrine|mesh-list
44692477|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44692478|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44692479|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
44692480|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692481|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692482|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692483|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
44692484|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
44692485|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692497|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
44692498|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692499|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692500|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44692501|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44692502|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
44692503|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692504|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692505|NCT01368068|Tibolone|tibolone|mesh-list
44692506|NCT01368068|Citalopram|citalopram|mesh-list
44692507|NCT01368068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44692508|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692509|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692510|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692511|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692512|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
44692513|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692514|NCT01368068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692515|NCT01368068|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692516|NCT01368068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692517|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
44692518|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
44692519|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692520|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44692521|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44692522|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692523|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44692524|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
44692525|NCT01368068|Hormones|hormones|mesh-ancestor
44401828|NCT02712788|Milrinone|milrinone|mesh-list
44692526|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44692527|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
44692528|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44692529|NCT01368328|Chromium|chromium|mesh-list
44790549|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790550|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790551|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
44790552|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790553|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
44790554|NCT01953107|Trace Elements|trace elements|mesh-ancestor
44790555|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
44790556|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790557|NCT01953172|Tocotrienols|tocotrienols|mesh-list
44790558|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
44790559|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
44790560|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790561|NCT01953172|Protective Agents|protective agents|mesh-ancestor
44790562|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790563|NCT01953172|Vitamins|vitamins|mesh-ancestor
44790564|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
44790565|NCT01953367|Tobramycin|tobramycin|mesh-list
44790566|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790567|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790568|NCT01953406|Fluorouracil|fluorouracil|mesh-list
44790569|NCT01953406|Mitomycins|mitomycins|mesh-list
44790570|NCT01953406|Mitomycin|mitomycin|mesh-list
44790571|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
44790572|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790573|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44790574|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790575|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790576|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
44790577|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790578|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44790579|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
44790580|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790581|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790582|NCT01953419|Pemetrexed|pemetrexed|mesh-list
44790583|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790584|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790585|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790586|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44790587|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790588|NCT01953445|Paclitaxel|paclitaxel|mesh-list
44790589|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44790590|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790591|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44790592|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790593|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44790594|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790595|NCT01953536|Folic Acid|folic acid|mesh-list
44790596|NCT01953536|Paclitaxel|paclitaxel|mesh-list
44790597|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44790598|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44790599|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790600|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
44790601|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790602|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
44790603|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790604|NCT01953536|Hematinics|hematinics|mesh-ancestor
44790605|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
44790606|NCT01953536|Vitamins|vitamins|mesh-ancestor
44790607|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
44790608|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790609|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
44790610|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44790611|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
44790612|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44790613|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790614|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44790615|NCT01953731|Rifampin|rifampin|mesh-list
44790616|NCT01953731|Palbociclib|palbociclib|mesh-list
44790617|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790618|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44790619|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790620|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401883|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
44790621|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44790622|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
44790623|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790624|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790625|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
44790626|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44692530|NCT01368328|Niacin|niacin|mesh-list
44790627|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44790628|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44790629|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44790630|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44790631|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44790632|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44790633|NCT01953744|Fluconazole|fluconazole|mesh-list
44790634|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44790635|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
44790636|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790637|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44790638|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44790639|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790640|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790641|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44790642|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790643|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790644|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790645|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44790646|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44790647|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44790648|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44790649|NCT01953757|Vitamins|vitamins|mesh-list
44790650|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
44790651|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
44790652|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
44790653|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
44790654|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790655|NCT01953757|Hematinics|hematinics|mesh-ancestor
44790656|NCT01953770|Cytarabine|cytarabine|mesh-list
44790657|NCT01953770|Prednisone|prednisone|mesh-list
44790658|NCT01953770|Methotrexate|methotrexate|mesh-list
44790659|NCT01953770|Daunorubicin|daunorubicin|mesh-list
44790660|NCT01953770|Asparaginase|asparaginase|mesh-list
44790661|NCT01953770|Pegaspargase|pegaspargase|mesh-list
44790662|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790663|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
44790664|NCT01953770|Hormones|hormones|mesh-ancestor
44790665|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790666|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401919|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790667|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44790668|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790669|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44790670|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
44790671|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44790672|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44790673|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
44790674|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790675|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44790676|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790677|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44790678|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790679|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
44790680|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790681|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790682|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
44790683|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790684|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44790685|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44790686|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44790687|NCT01953796|Clomiphene|clomiphene|mesh-list
44790688|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44790689|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
44790690|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790691|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790692|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44790693|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
44790694|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44790695|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44790696|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44790697|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44790698|NCT01953835|Simvastatin|simvastatin|mesh-list
44790699|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44790700|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44790701|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
44790702|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790703|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44790704|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44790705|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790706|NCT01953848|Tamsulosin|tamsulosin|mesh-list
44790707|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
44790708|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44790709|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44790710|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44790711|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
44790712|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790713|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790714|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790715|NCT01953848|Urological Agents|urological agents|mesh-ancestor
44790716|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44790717|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44790718|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
44790719|NCT01953887|Tamsulosin|tamsulosin|mesh-list
44790720|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
44790721|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44790722|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44790723|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44790724|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
44790725|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790726|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790727|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790728|NCT01953887|Urological Agents|urological agents|mesh-ancestor
44790729|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44790730|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44790731|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
44790732|NCT01953952|Cisplatin|cisplatin|mesh-list
44790733|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790734|NCT01953978|Acetaminophen|acetaminophen|mesh-list
44790735|NCT01953978|Dexamethasone|dexamethasone|mesh-list
44790736|NCT01953978|Ibuprofen|ibuprofen|mesh-list
44790737|NCT01953978|Morphine|morphine|mesh-list
44790738|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790739|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
44790740|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
44790741|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790742|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790743|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790744|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
44790745|NCT01953978|Hormones|hormones|mesh-ancestor
44790746|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790747|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44790748|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790749|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44790750|NCT01953978|Narcotics|narcotics|mesh-ancestor
44790751|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790752|NCT01953978|Analgesics|analgesics|mesh-ancestor
44790753|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
44790754|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44790755|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44790756|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790757|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44790758|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790759|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790760|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
44790761|NCT01954030|Bevacizumab|bevacizumab|mesh-list
44790762|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44790763|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44790764|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790765|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44790766|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44790767|NCT01954030|Growth Substances|growth substances|mesh-ancestor
44790768|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790769|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
44790770|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44569772|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569773|NCT01034137|Methotrexate|methotrexate|mesh-list
44569774|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44790771|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44790772|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790773|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44790775|NCT01954043|Dabrafenib|dabrafenib|mesh-list
44790776|NCT01954043|Rabeprazole|rabeprazole|mesh-list
44790777|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44790778|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790779|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44790780|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790781|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790782|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44790783|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
44790784|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790785|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790786|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
44790787|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44790788|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44790789|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44790790|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44790791|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44790792|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44790793|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44790794|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790795|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44790796|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
44790797|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44790798|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
44790799|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790800|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
44790801|NCT01954108|Protective Agents|protective agents|mesh-ancestor
44790802|NCT01954186|Oxytocin|oxytocin|mesh-list
44790803|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
44790804|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44790805|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790806|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
44790807|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44790808|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
44790809|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44790810|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
44790811|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790812|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790813|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
44790814|NCT01954290|Mannitol|mannitol|mesh-list
44790815|NCT01954290|Conivaptan|conivaptan|mesh-list
44790816|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44790817|NCT01954290|Diuretics|diuretics|mesh-ancestor
44790818|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
44790819|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790820|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44790821|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790822|NCT01954355|Paclitaxel|paclitaxel|mesh-list
44790823|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44790824|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790825|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
44790826|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
44790827|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
44790828|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790829|NCT01954368|Sufentanil|sufentanil|mesh-list
44790830|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44790831|NCT01954368|Narcotics|narcotics|mesh-ancestor
44790832|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790833|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790834|NCT01954368|Analgesics|analgesics|mesh-ancestor
44790835|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
44790836|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790837|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44790838|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44790839|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
44790840|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
44790841|NCT01954693|Everolimus|everolimus|mesh-list
44790842|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790843|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790844|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
44790845|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790846|NCT01954732|Metformin|metformin|mesh-list
44790847|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44790848|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790849|NCT01954784|Cyclosporine|cyclosporine|mesh-list
44790850|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
44790852|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
44790853|NCT01954784|Lenalidomide|lenalidomide|mesh-list
44790854|NCT01954784|Bortezomib|bortezomib|mesh-list
44790855|NCT01954784|Cyclosporins|cyclosporins|mesh-list
44790856|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790857|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44790858|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
44790859|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790860|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790861|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
44790862|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790863|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790864|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
44790865|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790866|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
44790867|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790868|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44790869|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44790870|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44790871|NCT01954784|Growth Substances|growth substances|mesh-ancestor
44790872|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
44790873|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44790874|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44790875|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
44790876|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44790877|NCT01954914|Plerixafor|plerixafor|mesh-list
44790878|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44790879|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44790880|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
44790881|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44790882|NCT01954992|Fluorouracil|fluorouracil|mesh-list
44790883|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
44790884|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790885|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44790886|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790887|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790888|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
44790889|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790890|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
44790891|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
44790892|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790893|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
44790894|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790895|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790896|NCT01955070|Ketamine|ketamine|mesh-list
44790897|NCT01955070|Analgesics|analgesics|mesh-ancestor
44790898|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
44790899|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790900|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790901|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44790902|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44790903|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
44790904|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
44790905|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790906|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44790907|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44790908|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790909|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790910|NCT01955135|Ketamine|ketamine|mesh-list
44790911|NCT01955135|Propofol|propofol|mesh-list
44790912|NCT01955135|Sevoflurane|sevoflurane|mesh-list
44790913|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44790914|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44790915|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790916|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44790917|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
44790918|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
44790919|NCT01955135|Analgesics|analgesics|mesh-ancestor
44790920|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
44790921|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790922|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44790923|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44790924|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44569932|NCT01031979|Yohimbine|yohimbine|mesh-list
44790925|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790926|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790927|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790928|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44790929|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
44790930|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44790931|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44790932|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790933|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44790934|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790935|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790936|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
44790937|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44790938|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44790939|NCT01955187|Prednisolone|prednisolone|mesh-list
44790940|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
44790941|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
44790942|NCT01955187|Rituximab|rituximab|mesh-list
44790943|NCT01955187|Tacrolimus|tacrolimus|mesh-list
44790944|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44790945|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
44790946|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44790947|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
44790948|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790949|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44790950|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44790951|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
44790952|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790953|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44790954|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44790955|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44790956|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44790957|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790958|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44790959|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
44790960|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
44790961|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790962|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44790963|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
44790964|NCT01955187|Hormones|hormones|mesh-ancestor
44790965|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44790966|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44790967|NCT01955187|Protective Agents|protective agents|mesh-ancestor
44790968|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44790969|NCT01955200|Cilostazol|cilostazol|mesh-list
44790970|NCT01955200|Clopidogrel|clopidogrel|mesh-list
44790971|NCT01955200|Ticagrelor|ticagrelor|mesh-list
44790972|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44790973|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44790974|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44790975|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44790976|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
44790977|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44790978|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44790979|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790980|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44790981|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
44790982|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44790983|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44790984|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44790985|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44790986|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44790987|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
44790988|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44790989|NCT01955200|Protective Agents|protective agents|mesh-ancestor
44790990|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44790991|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44790992|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44790993|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
44790994|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44790995|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44790996|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
44790997|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570014|NCT01030900|Hormones|hormones|mesh-ancestor
44790998|NCT01955252|Azithromycin|azithromycin|mesh-list
44790999|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44791000|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791001|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
44791002|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44791003|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791004|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
44791005|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44791006|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
44791007|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791008|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791009|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791010|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44791011|NCT01955421|Gefitinib|gefitinib|mesh-list
44791012|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791013|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44791014|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791015|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791016|NCT01955512|Clopidogrel|clopidogrel|mesh-list
44791017|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791018|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791019|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791020|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791021|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
44791022|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791023|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791024|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791025|NCT01955577|Vitamin D|vitamin d|mesh-list
44791026|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
44791027|NCT01955577|Vitamins|vitamins|mesh-ancestor
44791028|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
44791029|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791030|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44791031|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44791032|NCT01955642|Clopidogrel|clopidogrel|mesh-list
44791033|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791034|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791035|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791036|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791037|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
44791038|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791039|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791040|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791041|NCT01955655|Baclofen|baclofen|mesh-list
44791042|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44791043|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791044|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44791045|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791046|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44791047|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
44791048|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
44791049|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791050|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791051|NCT01955694|Eplerenone|eplerenone|mesh-list
44791052|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44791053|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
44791054|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791055|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791056|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44791057|NCT01955694|Diuretics|diuretics|mesh-ancestor
44791058|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
44791059|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791060|NCT01955759|Amiodarone|amiodarone|mesh-list
44791061|NCT01955759|Bisoprolol|bisoprolol|mesh-list
44791062|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44791063|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44791064|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44791065|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44791066|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
44791067|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791068|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44791069|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44791070|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791071|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44791072|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791073|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791074|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791075|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791076|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791077|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44791078|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791079|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791080|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44570152|NCT01028391|Hormones|hormones|mesh-ancestor
44570153|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791081|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44791082|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44791083|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44791084|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44791085|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791086|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
44791087|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
44791088|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791089|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44791090|NCT01955824|Lidocaine|lidocaine|mesh-list
44791091|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791092|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
44791093|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791094|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791095|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
44791096|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791097|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791098|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44791099|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791100|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791101|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570154|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44570155|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
44570156|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570157|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570158|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44570159|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44791103|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791104|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
44791105|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791106|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791107|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
44791108|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791109|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791110|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44791111|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791112|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791113|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791114|NCT01956006|Milrinone|milrinone|mesh-list
44791115|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44791116|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791117|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791118|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44402423|NCT02695719|Lubiprostone|lubiprostone|mesh-list
44791119|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44791120|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791121|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791122|NCT01956006|Protective Agents|protective agents|mesh-ancestor
44791123|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791124|NCT01956201|Atorvastatin|atorvastatin|mesh-list
44791125|NCT01956201|Fenofibrate|fenofibrate|mesh-list
44791126|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44791127|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44791128|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
44791129|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791130|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44791131|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44791132|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791133|NCT01956305|Metformin|metformin|mesh-list
44791134|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791135|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791136|NCT01956474|Riboflavin|riboflavin|mesh-list
44791137|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
44791138|NCT01956474|Vitamins|vitamins|mesh-ancestor
44791139|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
44791140|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791141|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44791142|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402457|NCT02694523|Adalimumab|adalimumab|mesh-list
44791143|NCT01956487|Propafenone|propafenone|mesh-list
44791144|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791145|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44791146|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791147|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791148|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791149|NCT01956591|Oxybutynin|oxybutynin|mesh-list
44791150|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
44791151|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
44791152|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791153|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791154|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44791155|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44791156|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
44791157|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791158|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791159|NCT01956591|Urological Agents|urological agents|mesh-ancestor
44791160|NCT01956604|Clonidine|clonidine|mesh-list
44791161|NCT01956604|Analgesics|analgesics|mesh-ancestor
44791162|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
44791163|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791164|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791165|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791166|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
44791167|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
44791168|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44791169|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44791170|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791171|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791172|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791173|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791174|NCT01956695|Rituximab|rituximab|mesh-list
44791175|NCT01956695|Lenalidomide|lenalidomide|mesh-list
44791176|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44791177|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791178|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
44791179|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791180|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44791181|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44791182|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44791183|NCT01956695|Growth Substances|growth substances|mesh-ancestor
44791184|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44791185|NCT01956734|Temozolomide|temozolomide|mesh-list
44692531|NCT01368328|Trace Elements|trace elements|mesh-ancestor
44692532|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
44692533|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692534|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44692535|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
44692536|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692537|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44692538|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
44692539|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
44692540|NCT01368328|Vitamins|vitamins|mesh-ancestor
44692541|NCT01368341|Amoxicillin|amoxicillin|mesh-list
44692542|NCT01368341|Doxycycline|doxycycline|mesh-list
44692543|NCT01368341|Penicillin V|penicillin v|mesh-list
44692544|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44692545|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692546|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
44692547|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44692548|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44692550|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44692551|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692552|NCT01368419|Growth Substances|growth substances|mesh-ancestor
44692553|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692554|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
44692555|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692556|NCT01368445|Azelastine|azelastine|mesh-list
44692557|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44692558|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
44692559|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692560|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692561|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44692562|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
44692563|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44692564|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692565|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692566|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44692567|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44692568|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44692569|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
44692570|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
44692571|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692572|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
44692573|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44692574|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692575|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692576|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692577|NCT01368627|Sirolimus|sirolimus|mesh-list
44692578|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44692579|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692580|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44692581|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692582|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
44692583|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692584|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
44692585|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692586|NCT01368757|Lenalidomide|lenalidomide|mesh-list
44692587|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
44692588|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692589|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44692590|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692591|NCT01368757|Growth Substances|growth substances|mesh-ancestor
44692592|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44692593|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692594|NCT01368783|Ritonavir|ritonavir|mesh-list
44692595|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44692596|NCT01368783|Tenofovir|tenofovir|mesh-list
44692597|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44570248|NCT01027754|Varenicline|varenicline|mesh-list
44791186|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44791187|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
44791188|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791189|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791190|NCT01956786|Amlodipine|amlodipine|mesh-list
44791191|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791192|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44791193|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791194|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791195|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44791196|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791197|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791198|NCT01956864|Vitamin D|vitamin d|mesh-list
44791199|NCT01956864|Vitamins|vitamins|mesh-ancestor
44791200|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
44791201|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791202|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44791203|NCT01956929|Metformin|metformin|mesh-list
44791204|NCT01956929|Lactulose|lactulose|mesh-list
44791205|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791206|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791207|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791208|NCT01956955|Heparin|heparin|mesh-list
44791209|NCT01956955|Enoxaparin|enoxaparin|mesh-list
44791210|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44791211|NCT01956955|Calcium heparin|calcium heparin|mesh-list
44791212|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
44791213|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44791214|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44791215|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791216|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
44791217|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
44791218|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44791219|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791220|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791221|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44791222|NCT01956981|Analgesics|analgesics|mesh-ancestor
44791223|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
44791224|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791225|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44791226|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44791227|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791228|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791229|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791230|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791231|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
44791232|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791233|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
44791234|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44791235|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791236|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44791237|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
44791238|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791239|NCT01957007|Docetaxel|docetaxel|mesh-list
44791240|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791241|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791242|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791243|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791244|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791245|NCT01957046|Laxatives|laxatives|mesh-list
44791246|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791247|NCT01957189|Tamsulosin|tamsulosin|mesh-list
44791248|NCT01957189|Dutasteride|dutasteride|mesh-list
44791249|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44791250|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44791251|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44791252|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791253|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791254|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791255|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791256|NCT01957189|Urological Agents|urological agents|mesh-ancestor
44791257|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44570255|NCT01027650|Dexamethasone|dexamethasone|mesh-list
44791258|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44791259|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791260|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
44791261|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791262|NCT01957293|Albuterol|albuterol|mesh-list
44791263|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44791264|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
44791265|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791266|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791267|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44791268|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
44791269|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
44791270|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791271|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44791272|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44791273|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791274|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791275|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791276|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791277|NCT01957319|Vitamin E|vitamin e|mesh-list
44791278|NCT01957319|Silybin|silybin|mesh-list
44791279|NCT01957319|Vitamins|vitamins|mesh-ancestor
44791280|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
44791281|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791282|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
44791283|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791284|NCT01957319|Protective Agents|protective agents|mesh-ancestor
44791285|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44791286|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791287|NCT01957436|Docetaxel|docetaxel|mesh-list
44791288|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
44791289|NCT01957436|Androgens|androgens|mesh-list
44791290|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791291|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791292|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791293|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791294|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791295|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44791296|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791297|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
44791298|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791299|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791300|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44791301|NCT01957436|Hormones|hormones|mesh-ancestor
44791302|NCT01957449|Propranolol|propranolol|mesh-list
44791303|NCT01957449|Metoprolol|metoprolol|mesh-list
44791304|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44791305|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44791306|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791307|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791308|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791309|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791310|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791311|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44402684|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44791312|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791313|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
44791314|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
44791315|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791316|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44791317|NCT01957540|Ticagrelor|ticagrelor|mesh-list
44791318|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44791319|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791320|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791321|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791322|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791323|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
44791324|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791325|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791326|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791327|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
44791328|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44791329|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44791330|NCT01957631|Prednisolone|prednisolone|mesh-list
44791331|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
44791332|NCT01957631|Bupivacaine|bupivacaine|mesh-list
44791333|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44791334|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
44791335|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791336|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
44791337|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402705|NCT02687815|Vitamin D|vitamin d|mesh-list
44791338|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791339|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
44791340|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791341|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791342|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
44791343|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
44791344|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791345|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
44791346|NCT01957631|Hormones|hormones|mesh-ancestor
44791347|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791348|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44791349|NCT01957631|Protective Agents|protective agents|mesh-ancestor
44791350|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44791351|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791352|NCT01957839|Cabergoline|cabergoline|mesh-list
44791353|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44791354|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44791355|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
44791356|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
44791357|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791358|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791359|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791360|NCT01957852|Thrombin|thrombin|mesh-list
44791361|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
44791362|NCT01957852|Coagulants|coagulants|mesh-ancestor
44791363|NCT01957943|SMOFlipid|smoflipid|mesh-list
44791364|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44791365|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44791366|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44791367|NCT01957995|Docetaxel|docetaxel|mesh-list
44791368|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791369|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791370|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791371|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791372|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791373|NCT01958138|Propofol|propofol|mesh-list
44791374|NCT01958138|Isoflurane|isoflurane|mesh-list
44791375|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44791376|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791377|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791378|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44791379|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
44791380|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
44791381|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44791382|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44791383|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44791384|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44791385|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44791386|NCT01958372|Cisplatin|cisplatin|mesh-list
44791387|NCT01958372|Etoposide|etoposide|mesh-list
44791388|NCT01958372|Pemetrexed|pemetrexed|mesh-list
44791389|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791390|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44791391|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44791392|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44791393|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791394|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791395|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44791396|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44791397|NCT01958580|Gemcitabine|gemcitabine|mesh-list
44791398|NCT01958580|Docetaxel|docetaxel|mesh-list
44791399|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44791400|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
44791401|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791402|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791403|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
44791404|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791405|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791406|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791407|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
44791408|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791409|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791410|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791411|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791413|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
44791414|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44791415|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
44791416|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791417|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791418|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44791419|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44791420|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44791421|NCT01958684|Trace Elements|trace elements|mesh-ancestor
44791422|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
44791423|NCT01958775|Glucagon|glucagon|mesh-list
44791424|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44791425|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791426|NCT01958775|Hormones|hormones|mesh-ancestor
44791427|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791428|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791429|NCT01958775|Incretins|incretins|mesh-ancestor
44791430|NCT01958814|Albuterol|albuterol|mesh-list
44791431|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44791432|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
44402794|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44791433|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791434|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791435|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44791436|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
44791437|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
44791438|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791439|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44791440|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44791441|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791442|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791443|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791444|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791445|NCT01958866|Acetaminophen|acetaminophen|mesh-list
44791446|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44791447|NCT01958866|Analgesics|analgesics|mesh-ancestor
44791448|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
44791449|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791450|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791451|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
44791452|NCT01958905|Lumefantrine|lumefantrine|mesh-list
44791453|NCT01958905|Artemether|artemether|mesh-list
44791454|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44791455|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
44791456|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44791457|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44402817|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
44791458|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791459|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
44791460|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44791461|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
44791462|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791463|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791464|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44791465|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
44791466|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44791467|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
44791468|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791469|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791470|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44791471|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791472|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
44791473|NCT01958944|Protective Agents|protective agents|mesh-ancestor
44791474|NCT01958996|Idarubicin|idarubicin|mesh-list
44791475|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44791476|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791477|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44791478|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44791479|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791480|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791481|NCT01959022|Doxazosin|doxazosin|mesh-list
44791482|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791483|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44791484|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44791485|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44791486|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791487|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791488|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791489|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791490|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
44791491|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
44791492|NCT01959061|Raltitrexed|raltitrexed|mesh-list
44791493|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791494|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44791495|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
44791496|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791497|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44791498|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791499|NCT01959074|Aceclofenac|aceclofenac|mesh-list
44791500|NCT01959074|Naftopidil|naftopidil|mesh-list
44791501|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44791502|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44791503|NCT01959074|Analgesics|analgesics|mesh-ancestor
44791504|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
44791505|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791506|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791507|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791508|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44791509|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44791510|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44791511|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791512|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791513|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791514|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791515|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44791516|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791517|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44791518|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791519|NCT01959100|Azithromycin|azithromycin|mesh-list
44791520|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44791521|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791522|NCT01959152|Imidacloprid|imidacloprid|mesh-list
44791523|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
44791524|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791525|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791526|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791527|NCT01959191|Aspirin|aspirin|mesh-list
44791528|NCT01959191|Clopidogrel|clopidogrel|mesh-list
44791529|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44791530|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44791531|NCT01959191|Analgesics|analgesics|mesh-ancestor
44791532|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
44791533|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791534|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570554|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570555|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44570556|NCT01023035|Ribavirin|ribavirin|mesh-list
44570557|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44570558|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
44570559|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
44570560|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570561|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
44570562|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570563|NCT01023035|Hematinics|hematinics|mesh-ancestor
44570564|NCT01022996|Everolimus|everolimus|mesh-list
44570565|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570566|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570567|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
44570568|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570569|NCT01022853|Nintedanib|nintedanib|mesh-list
44570570|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570571|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44570574|NCT01022762|Repaglinide|repaglinide|mesh-list
44791535|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791536|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44791537|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44791538|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44791539|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791540|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791541|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44791542|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791543|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
44791544|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791545|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791546|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791547|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
44791548|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791549|NCT01959386|Trastuzumab|trastuzumab|mesh-list
44791550|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44791551|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791552|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44791553|NCT01959399|Peficitinib|peficitinib|mesh-list
44791554|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44791555|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44791556|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
44791557|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791558|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44791559|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44791560|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791561|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791562|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
44791563|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791564|NCT01959438|Selenious Acid|selenious acid|mesh-list
44791565|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
44791566|NCT01959438|Trace Elements|trace elements|mesh-ancestor
44791567|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
44791568|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791569|NCT01959451|Clopidogrel|clopidogrel|mesh-list
44791570|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44402936|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
44791571|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791572|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791573|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791574|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791575|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
44791576|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791577|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791578|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791579|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
44791580|NCT01959477|Busulfan|busulfan|mesh-list
44791581|NCT01959477|Etoposide|etoposide|mesh-list
44791582|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
44791583|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791584|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
44791585|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791586|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44791587|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44791588|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
44791589|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791590|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791591|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44791592|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44791593|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44791594|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44791595|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791596|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
44791597|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44791598|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
44791599|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791600|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791601|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44791602|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
44791603|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44791604|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
44402979|NCT02676466|Losartan|losartan|mesh-list
44791605|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791606|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791607|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44791608|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791609|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
44791610|NCT01959828|Protective Agents|protective agents|mesh-ancestor
44791611|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44791612|NCT01959854|Laxatives|laxatives|mesh-ancestor
44791613|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791614|NCT01960023|Cetuximab|cetuximab|mesh-list
44791615|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44791616|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791617|NCT01960049|Ropivacaine|ropivacaine|mesh-list
44791618|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791619|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
44791620|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791621|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791622|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
44791623|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791624|NCT01960153|Tadalafil|tadalafil|mesh-list
44791625|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791626|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44791627|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44791628|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791629|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791630|NCT01960153|Urological Agents|urological agents|mesh-ancestor
44791631|NCT01960179|Lixisenatide|lixisenatide|mesh-list
44791632|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791633|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791634|NCT01960205|Metformin|metformin|mesh-list
44791635|NCT01960205|Saxagliptin|saxagliptin|mesh-list
44791636|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791637|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791638|NCT01960205|Incretins|incretins|mesh-ancestor
44791639|NCT01960205|Hormones|hormones|mesh-ancestor
44791640|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791641|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44791642|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
44791643|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791644|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791645|NCT01960283|Methotrexate|methotrexate|mesh-list
44791646|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44791647|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
44791648|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791649|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791650|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44791651|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
44791652|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791653|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791654|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44791655|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791656|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44791657|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791658|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
44791659|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44791660|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44791661|NCT01960426|Adalimumab|adalimumab|mesh-list
44791662|NCT01960426|Infliximab|infliximab|mesh-list
44791663|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791664|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403049|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
44791665|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
44791666|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791667|NCT01960543|Fentanyl|fentanyl|mesh-list
44791668|NCT01960543|Bupivacaine|bupivacaine|mesh-list
44791669|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
44791670|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791671|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
44791672|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791673|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791674|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
44791675|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791677|NCT01960543|Narcotics|narcotics|mesh-ancestor
44791678|NCT01960543|Analgesics|analgesics|mesh-ancestor
44791679|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44791680|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44791681|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
44791682|NCT01960569|Hirudins|hirudins|mesh-list
44791683|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
44791684|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44791685|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44791686|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791687|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791688|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
44791689|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44791690|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44791691|NCT01960595|Fentanyl|fentanyl|mesh-list
44791692|NCT01960595|Bupivacaine|bupivacaine|mesh-list
44791693|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791694|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
44791695|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791696|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791697|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
44791698|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791699|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44791700|NCT01960595|Narcotics|narcotics|mesh-ancestor
44791701|NCT01960595|Analgesics|analgesics|mesh-ancestor
44791702|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44791703|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44791704|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
44791705|NCT01960647|Paclitaxel|paclitaxel|mesh-list
44791706|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44791707|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791708|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791709|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791710|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791711|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791712|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44791713|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791714|NCT01960829|Everolimus|everolimus|mesh-list
44791715|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791716|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791717|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
44791718|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791719|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44791720|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44791721|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44791722|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
44791723|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44791724|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
44791725|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791726|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791727|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
44791728|NCT01961154|Hormones|hormones|mesh-ancestor
44791729|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791730|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
44791731|NCT01961180|Citalopram|citalopram|mesh-list
44791732|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44791733|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44791734|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791735|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791736|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791737|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
44791738|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403134|NCT02665689|Growth Substances|growth substances|mesh-ancestor
44791739|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44791740|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
44791741|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44791742|NCT01961193|Silicon|silicon|mesh-list
44791743|NCT01961193|Trace Elements|trace elements|mesh-ancestor
44791744|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
44791745|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791746|NCT01961219|Anesthetics|anesthetics|mesh-list
44791747|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791748|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791749|NCT01961336|Testosterone|testosterone|mesh-list
44791750|NCT01961336|Androgens|androgens|mesh-ancestor
44791751|NCT01961336|Hormones|hormones|mesh-ancestor
44791752|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791753|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791754|NCT01961388|Metformin|metformin|mesh-list
44791755|NCT01961388|Acarbose|acarbose|mesh-list
44791756|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791757|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791758|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44791759|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791760|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791761|NCT01961414|Aflibercept|aflibercept|mesh-list
44791762|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44791763|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44791764|NCT01961414|Growth Substances|growth substances|mesh-ancestor
44791765|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791766|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
44791767|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791768|NCT01961453|Isosorbide|isosorbide|mesh-list
44791769|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44791770|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44791771|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44791772|NCT01961453|Diuretics|diuretics|mesh-ancestor
44791773|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
44791774|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791775|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791776|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44791777|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791778|NCT01961635|Cimetidine|cimetidine|mesh-list
44791779|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44791780|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44791781|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44791782|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
44791783|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
44791784|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791785|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403145|NCT02665286|Analgesics|analgesics|mesh-ancestor
44692598|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44692599|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44692600|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692601|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692602|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44692603|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44692604|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
44692605|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692606|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44692607|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44692608|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44692609|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44692610|NCT01368848|Bevacizumab|bevacizumab|mesh-list
44692611|NCT01368848|Cisplatin|cisplatin|mesh-list
44692612|NCT01368848|Docetaxel|docetaxel|mesh-list
44692613|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44692614|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692615|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44692616|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692617|NCT01368848|Growth Substances|growth substances|mesh-ancestor
44692618|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692619|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
44692620|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44692621|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44692622|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44244236|NCT05550662|Xenon|xenon|mesh-list
44692623|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692624|NCT01368887|Niacinamide|niacinamide|mesh-list
44692626|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
44692627|NCT01368887|Calcipotriene|calcipotriene|mesh-list
44692628|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
44692629|NCT01368887|Vitamins|vitamins|mesh-ancestor
44692630|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
44692631|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692632|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44692633|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
44791786|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791787|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44791788|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44791789|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791790|NCT01961739|Lidocaine|lidocaine|mesh-list
44791791|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791792|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
44791793|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791794|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791795|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
44791796|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791797|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44791798|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44791799|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791800|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791801|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791802|NCT01961752|Triamcinolone|triamcinolone|mesh-list
44791803|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44791804|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44791805|NCT01961752|Bupivacaine|bupivacaine|mesh-list
44791806|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44791807|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791808|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
44791809|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791810|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791811|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
44791812|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791813|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791814|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
44791815|NCT01961752|Hormones|hormones|mesh-ancestor
44791816|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791817|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44791818|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
44791819|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791820|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791821|NCT01961830|Arbekacin|arbekacin|mesh-list
44791822|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791823|NCT01961843|Prednisone|prednisone|mesh-list
44791824|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
44791825|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44791826|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
44791827|NCT01961843|Hormones|hormones|mesh-ancestor
44791828|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791829|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791830|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44791831|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791832|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44791833|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791834|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791835|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
44791836|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44791837|NCT01961856|Clopidogrel|clopidogrel|mesh-list
44791838|NCT01961856|Ticagrelor|ticagrelor|mesh-list
44791839|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44791840|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44791841|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44791842|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44791843|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
44791844|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791845|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791846|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791847|NCT01961947|Vaccines|vaccines|mesh-list
44791848|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
44791849|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791850|NCT01962116|Heparin|heparin|mesh-list
44791851|NCT01962116|Calcium heparin|calcium heparin|mesh-list
44791852|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
44570916|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570917|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44570918|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
44570919|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570920|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570921|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44570922|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
44570923|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570924|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44570925|NCT01017874|Cisplatin|cisplatin|mesh-list
44791853|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791854|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44791855|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44791856|NCT01962181|Methylphenidate|methylphenidate|mesh-list
44791857|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44791858|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791859|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44791860|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44791861|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791862|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791863|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
44791864|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791865|NCT01962285|Propofol|propofol|mesh-list
44791866|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44791867|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791868|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791869|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44791870|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
44791871|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
44791872|NCT01962363|Tocotrienols|tocotrienols|mesh-list
44791873|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
44403324|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791874|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
44791875|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791876|NCT01962363|Protective Agents|protective agents|mesh-ancestor
44791877|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791878|NCT01962363|Vitamins|vitamins|mesh-ancestor
44791879|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
44791880|NCT01962376|Bevacizumab|bevacizumab|mesh-list
44791881|NCT01962376|Capecitabine|capecitabine|mesh-list
44791882|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
44791883|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44791884|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791885|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44791886|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44791887|NCT01962376|Growth Substances|growth substances|mesh-ancestor
44791888|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791889|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
44791890|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44791891|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
44791892|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791893|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
44791894|NCT01962454|Testosterone|testosterone|mesh-list
44403330|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
44791895|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
44791896|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
44791897|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44791898|NCT01962454|Androgens|androgens|mesh-ancestor
44791899|NCT01962454|Hormones|hormones|mesh-ancestor
44791900|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791901|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791902|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44791903|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791904|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
44791905|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
44791906|NCT01962571|Hematinics|hematinics|mesh-ancestor
44791907|NCT01962831|Dinoprostone|dinoprostone|mesh-list
44791908|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
44791909|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44791910|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791911|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44791912|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
44791913|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44791914|NCT01963039|Protective Agents|protective agents|mesh-ancestor
44791915|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791916|NCT01963182|Irinotecan|irinotecan|mesh-list
44791917|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44791918|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44791919|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791920|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791921|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791922|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44791923|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44791924|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791925|NCT01963299|Clonidine|clonidine|mesh-list
44791926|NCT01963299|Ropivacaine|ropivacaine|mesh-list
44791927|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791928|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
44791929|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791930|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791931|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
44791932|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791933|NCT01963299|Analgesics|analgesics|mesh-ancestor
44791934|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44791935|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
44791936|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
44791937|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44791938|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44791939|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791940|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791941|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791942|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791943|NCT01963325|Paclitaxel|paclitaxel|mesh-list
44791944|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44791945|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44791946|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44791947|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
44791948|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
44791949|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
44791950|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791951|NCT01963390|Testosterone|testosterone|mesh-list
44791952|NCT01963390|Androgens|androgens|mesh-ancestor
44791953|NCT01963390|Hormones|hormones|mesh-ancestor
44791954|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44791955|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791956|NCT01963416|Micronutrients|micronutrients|mesh-list
44791957|NCT01963416|Trace Elements|trace elements|mesh-list
44791958|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791959|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44791960|NCT01963442|Lactams|lactams|mesh-list
44791961|NCT01963442|beta-Lactams|beta-lactams|mesh-list
44791962|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44791963|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44791964|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44791965|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44791966|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791967|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
44791968|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791969|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791970|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44791971|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44791973|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
44791974|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791975|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44791976|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44791977|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44791978|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44791979|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44791980|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791981|NCT01963559|Lidocaine|lidocaine|mesh-list
44791982|NCT01963559|Prilocaine|prilocaine|mesh-list
44791983|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44791984|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
44791985|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
44791986|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44791987|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44791988|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
44791989|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44791990|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44403404|NCT02658149|Ropivacaine|ropivacaine|mesh-list
44791991|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44791992|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44791993|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44791994|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44791995|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44791996|NCT01963663|Metformin|metformin|mesh-list
44791997|NCT01963663|Pioglitazone|pioglitazone|mesh-list
44791998|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44791999|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792000|NCT01963702|Capecitabine|capecitabine|mesh-list
44792001|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
44792002|NCT01963702|Docetaxel|docetaxel|mesh-list
44792003|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44792004|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
44792005|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792006|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792007|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792008|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792009|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792010|NCT01963741|Histamine|histamine|mesh-list
44792011|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
44792012|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
44792013|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792014|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792015|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792016|NCT01963754|Epinephrine|epinephrine|mesh-list
44792017|NCT01963754|Racepinephrine|racepinephrine|mesh-list
44792018|NCT01963754|Anesthetics|anesthetics|mesh-list
44792019|NCT01963754|Carticaine|carticaine|mesh-list
44792020|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
44792021|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792022|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792023|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44792024|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44792025|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792026|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792027|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792028|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44792029|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44792030|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
44792031|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792032|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792033|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792034|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
44792035|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
44792036|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44792037|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792038|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
44792039|NCT01963832|Fluoxetine|fluoxetine|mesh-list
44792040|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44792041|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44792042|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792043|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792044|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792045|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
44792046|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792047|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44792048|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
44792049|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792050|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44792051|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44792052|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792053|NCT01963910|Mannitol|mannitol|mesh-list
44792054|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44792055|NCT01963910|Diuretics|diuretics|mesh-ancestor
44792056|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
44792057|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792058|NCT01963962|Copper|copper|mesh-list
44792059|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
44403500|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44792060|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44792061|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
44792062|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44792063|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792064|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44792065|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44792066|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44792067|NCT01963962|Trace Elements|trace elements|mesh-ancestor
44792068|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
44792069|NCT01964001|Vitamins|vitamins|mesh-list
44792070|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
44792071|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
44792072|NCT01964001|Pyridoxal|pyridoxal|mesh-list
44792073|NCT01964001|Pyridoxine|pyridoxine|mesh-list
44792074|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
44792075|NCT01964001|Ubiquinone|ubiquinone|mesh-list
44792076|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
44792077|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792078|NCT01964027|Irinotecan|irinotecan|mesh-list
44792079|NCT01964027|Epirubicin|epirubicin|mesh-list
44792080|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44792081|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44792082|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792083|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792084|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792085|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44792086|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44792087|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
44792088|NCT01964040|Bupivacaine|bupivacaine|mesh-list
44792089|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792090|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
44792091|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792092|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792093|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
44792094|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792095|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44792096|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792097|NCT01964040|Analgesics|analgesics|mesh-ancestor
44792098|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44792099|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44792100|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44792101|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792102|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792103|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792104|NCT01964079|Losartan|losartan|mesh-list
44792105|NCT01964079|Amlodipine|amlodipine|mesh-list
44792106|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44792107|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44792108|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792109|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792110|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44792111|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792112|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
44792113|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44792114|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44792115|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44792116|NCT01964157|Ceritinib|ceritinib|mesh-list
44792117|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792118|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44792119|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792120|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792122|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44792123|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792124|NCT01964183|Mirabegron|mirabegron|mesh-list
44792125|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44792126|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44792127|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44792128|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44792129|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792130|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792131|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792132|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792133|NCT01964183|Urological Agents|urological agents|mesh-ancestor
44792134|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44792135|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44792136|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
44792137|NCT01964248|Lidocaine|lidocaine|mesh-list
44792138|NCT01964248|Prilocaine|prilocaine|mesh-list
44792139|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44792140|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792141|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
44792142|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792143|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792144|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
44792145|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792146|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44792147|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44792148|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44792149|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792150|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792151|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44792152|NCT01964287|Leucovorin|leucovorin|mesh-list
44792153|NCT01964287|Gemcitabine|gemcitabine|mesh-list
44792154|NCT01964287|Paclitaxel|paclitaxel|mesh-list
44792155|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
44792156|NCT01964287|Irinotecan|irinotecan|mesh-list
44792157|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44792158|NCT01964287|Folfirinox|folfirinox|mesh-list
44792159|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44792160|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792161|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792162|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792163|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792164|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792165|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44792166|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
44792167|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
44792168|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792169|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792170|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792171|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
44792172|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792173|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44792174|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44792175|NCT01964287|Antidotes|antidotes|mesh-ancestor
44792176|NCT01964287|Protective Agents|protective agents|mesh-ancestor
44792177|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
44792178|NCT01964287|Vitamins|vitamins|mesh-ancestor
44792179|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
44792180|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
44792181|NCT01964365|Fenofibrate|fenofibrate|mesh-list
44792182|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44792183|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44792184|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
44792185|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792186|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44792187|NCT01964391|Paclitaxel|paclitaxel|mesh-list
44792188|NCT01964391|Docetaxel|docetaxel|mesh-list
44792189|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
44792190|NCT01964391|Carboplatin|carboplatin|mesh-list
44792191|NCT01964391|Doxorubicin|doxorubicin|mesh-list
44792192|NCT01964391|Trastuzumab|trastuzumab|mesh-list
44792193|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44792194|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792195|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792196|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792197|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792198|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792199|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792200|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
44792201|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792202|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792203|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44792204|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
44792205|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44792206|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44792207|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44792208|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44792209|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792210|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44792211|NCT01964404|Dronabinol|dronabinol|mesh-list
44792212|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
44792213|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792214|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792215|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792216|NCT01964404|Analgesics|analgesics|mesh-ancestor
44792217|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
44792218|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792219|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44792220|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44792221|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792222|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792223|NCT01964404|Hormones|hormones|mesh-ancestor
44792224|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792225|NCT01964534|Gemcitabine|gemcitabine|mesh-list
44403630|NCT02651688|Enclomiphene|enclomiphene|mesh-list
44792226|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44792227|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44792228|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
44792229|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792230|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792231|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
44792232|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792233|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792234|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792235|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
44792236|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792237|NCT01964573|Rotigotine|rotigotine|mesh-list
44792238|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
44792239|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
44792240|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792241|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792242|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792243|NCT01964586|Lidocaine|lidocaine|mesh-list
44792244|NCT01964586|Epinephrine|epinephrine|mesh-list
44792245|NCT01964586|Racepinephrine|racepinephrine|mesh-list
44792246|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
44571361|NCT01012713|Vitamins|vitamins|mesh-ancestor
44792247|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
44792248|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792249|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
44792250|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792251|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792252|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
44792253|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792254|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44792255|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44792256|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44792257|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44571362|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
44571363|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44571364|NCT01012622|Methylphenidate|methylphenidate|mesh-list
44571365|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44571366|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571367|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44571368|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44571369|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44571370|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792258|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792259|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44792260|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792262|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44792263|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44792264|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44792265|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792266|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792267|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44792268|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44792269|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
44792270|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792271|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792272|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
44792273|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
44792274|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44792275|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
44792276|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792277|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792278|NCT01964781|Epinephrine|epinephrine|mesh-list
44792279|NCT01964781|Racepinephrine|racepinephrine|mesh-list
44792280|NCT01964781|Bupivacaine|bupivacaine|mesh-list
44792281|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
44792282|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
44792283|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792284|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
44792285|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792286|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792287|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
44792288|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792289|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44792290|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44792291|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403714|NCT02648217|Insulin|insulin|mesh-list
44792292|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
44792293|NCT01964781|Coagulants|coagulants|mesh-ancestor
44792294|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44792295|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44792296|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792297|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792298|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44792299|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44792300|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
44792301|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792302|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792303|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
44792304|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
44792305|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44792306|NCT01964846|Curcumin|curcumin|mesh-list
44792307|NCT01964846|Resveratrol|resveratrol|mesh-list
44792308|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792309|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792310|NCT01964846|Analgesics|analgesics|mesh-ancestor
44792311|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
44792312|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792313|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792314|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792315|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792316|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792317|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792318|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792319|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
44792320|NCT01964846|Protective Agents|protective agents|mesh-ancestor
44792321|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44792322|NCT01964911|Ropivacaine|ropivacaine|mesh-list
44792323|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792324|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
44792325|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792326|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792327|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
44792328|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792329|NCT01965041|Aflibercept|aflibercept|mesh-list
44792330|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792331|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792332|NCT01965041|Growth Substances|growth substances|mesh-ancestor
44792333|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792334|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792335|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792336|NCT01965080|Exemestane|exemestane|mesh-list
44792337|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792338|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44403754|NCT02647320|Firuglipel|firuglipel|mesh-list
44792339|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44792340|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792341|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792342|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44792343|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44792344|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792345|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792346|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44792347|NCT01965275|Gefitinib|gefitinib|mesh-list
44792348|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792349|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44792350|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792351|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792352|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
44792353|NCT01965301|Promethazine|promethazine|mesh-list
44792354|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44792355|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44792356|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792357|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792358|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792359|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
44792360|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
44792361|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792362|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
44792363|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
44692634|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692635|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44692636|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
44692637|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
44692638|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44692639|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44692640|NCT01369043|Vitamins|vitamins|mesh-list
44692641|NCT01369043|Ascorbic Acid|ascorbic acid|mesh-list
44692642|NCT01369043|Vitamin E|vitamin e|mesh-list
44692643|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
44692644|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692645|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
44692646|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692647|NCT01369043|Protective Agents|protective agents|mesh-ancestor
44692648|NCT01369082|Cyclosporine|cyclosporine|mesh-list
44692649|NCT01369082|Sirolimus|sirolimus|mesh-list
44692650|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
44692651|NCT01369082|Tacrolimus|tacrolimus|mesh-list
44692652|NCT01369082|Cyclosporins|cyclosporins|mesh-list
44692653|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44692654|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
44692655|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692656|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44692657|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692658|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692659|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
44692660|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692661|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44692662|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44692663|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44692664|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692665|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44692666|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
44692667|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44692668|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44692669|NCT01369121|Hormones|hormones|mesh-ancestor
44692670|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692671|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692672|NCT01369186|Morphine|morphine|mesh-list
44692673|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44692674|NCT01369186|Narcotics|narcotics|mesh-ancestor
44692675|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692676|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692677|NCT01369186|Analgesics|analgesics|mesh-ancestor
44692678|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
44792364|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44792365|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44792366|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
44792367|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
44792368|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792369|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792370|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44792371|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
44792372|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44792373|NCT01965353|Dexamethasone|dexamethasone|mesh-list
44792374|NCT01965353|Lenalidomide|lenalidomide|mesh-list
44792375|NCT01965353|Bortezomib|bortezomib|mesh-list
44792376|NCT01965353|Panobinostat|panobinostat|mesh-list
44792377|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792378|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
44792379|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
44792380|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792381|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792382|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44792383|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
44792384|NCT01965353|Hormones|hormones|mesh-ancestor
44792385|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792386|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44792387|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792388|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
44792389|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792390|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792391|NCT01965353|Growth Substances|growth substances|mesh-ancestor
44792392|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792393|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44792394|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792395|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403878|NCT02642653|Lovastatin|lovastatin|mesh-list
44571527|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
44792397|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44792398|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
44792399|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792400|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44792401|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44792402|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792403|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792404|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
44792405|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792406|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792407|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44792408|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44792409|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792410|NCT01965522|Vitamin D|vitamin d|mesh-list
44792411|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
44792412|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
44792413|NCT01965522|Vitamins|vitamins|mesh-list
44792414|NCT01965522|Melatonin|melatonin|mesh-list
44792415|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
44792416|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792417|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44792418|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44792419|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
44403900|NCT02642159|Vitamins|vitamins|mesh-ancestor
44792420|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792421|NCT01965522|Protective Agents|protective agents|mesh-ancestor
44792422|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792423|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
44792424|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44792425|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
44792426|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44792427|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792428|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44792429|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44792430|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44792431|NCT01965626|Oseltamivir|oseltamivir|mesh-list
44792432|NCT01965626|Dexamethasone|dexamethasone|mesh-list
44792433|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792434|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
44792435|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
44792436|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792437|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792438|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44792439|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
44792440|NCT01965626|Hormones|hormones|mesh-ancestor
44792441|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792442|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44792443|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792444|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
44792445|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792446|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792447|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792448|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
44792449|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44792450|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44792451|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792452|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
44792453|NCT01965730|Coagulants|coagulants|mesh-ancestor
44792454|NCT01965925|Modafinil|modafinil|mesh-list
44792455|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44792456|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792457|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44792458|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44792459|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44792460|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792461|NCT01965977|Bortezomib|bortezomib|mesh-list
44792462|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792463|NCT01966055|Solithromycin|solithromycin|mesh-list
44792464|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44792465|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792466|NCT01966133|Doxorubicin|doxorubicin|mesh-list
44792467|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44792468|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
44792469|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44792470|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792471|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44792472|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44792473|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792474|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792475|NCT01966172|Acetaminophen|acetaminophen|mesh-list
44792476|NCT01966172|Ibuprofen|ibuprofen|mesh-list
44792477|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44792478|NCT01966172|Morphine|morphine|mesh-list
44792479|NCT01966172|Gabapentin|gabapentin|mesh-list
44792480|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44792481|NCT01966172|Narcotics|narcotics|mesh-ancestor
44792482|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792483|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792484|NCT01966172|Analgesics|analgesics|mesh-ancestor
44792485|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
44792486|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792487|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792488|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792489|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792490|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44792491|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792492|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792493|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
44792494|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
44792495|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44792496|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44792497|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792498|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44792499|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44792500|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792501|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
44792502|NCT01966276|Methylphenidate|methylphenidate|mesh-list
44792503|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44792504|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792505|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44792506|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44792507|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403967|NCT02638948|Methotrexate|methotrexate|mesh-list
44792508|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792509|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
44792510|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792511|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
44792512|NCT01966289|Guadecitabine|guadecitabine|mesh-list
44792513|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
44792514|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792515|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792516|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792517|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44792518|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
44792519|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792520|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792521|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44792522|NCT01966302|Beraprost|beraprost|mesh-list
44792523|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44792524|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44792525|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44792526|NCT01966341|Laxatives|laxatives|mesh-list
44792527|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
44792528|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792529|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44792530|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
44792531|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792532|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792533|NCT01966484|Succinylcholine|succinylcholine|mesh-list
44792534|NCT01966484|Mivacurium|mivacurium|mesh-list
44792535|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44792536|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44792537|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44792538|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404013|NCT02637895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44792539|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792540|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44792541|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44792542|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
44792543|NCT01966575|Progestins|progestins|mesh-list
44571680|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44792544|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44792545|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44792546|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44792547|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
44792548|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44792549|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792550|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44792551|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44792552|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44792553|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44792554|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792555|NCT01966575|Hormones|hormones|mesh-ancestor
44792556|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792557|NCT01966627|Liver Extracts|liver extracts|mesh-list
44792558|NCT01966627|Hematinics|hematinics|mesh-ancestor
44792559|NCT01966653|Fosfomycin|fosfomycin|mesh-list
44792560|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
44792561|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44792562|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792563|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44792564|NCT01966653|Renal Agents|renal agents|mesh-ancestor
44792565|NCT01966692|Fluticasone|fluticasone|mesh-list
44792566|NCT01966692|Xhance|xhance|mesh-list
44792567|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792568|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44792569|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
44792570|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792571|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792572|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792573|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792574|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44792575|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44792576|NCT01966783|Budesonide|budesonide|mesh-list
44792577|NCT01966783|Mesalamine|mesalamine|mesh-list
44792578|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792579|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44792580|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
44792581|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792582|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792583|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792584|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792585|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
44792586|NCT01966783|Hormones|hormones|mesh-ancestor
44792587|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792588|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792589|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792590|NCT01966783|Analgesics|analgesics|mesh-ancestor
44792591|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
44792592|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792593|NCT01966822|Ritonavir|ritonavir|mesh-list
44792594|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44792595|NCT01966822|Dolutegravir|dolutegravir|mesh-list
44792596|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
44792597|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44792598|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792599|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792600|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44792601|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44792602|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
44792603|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792604|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44792605|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44792606|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44792607|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44792608|NCT01966913|Bevacizumab|bevacizumab|mesh-list
44792609|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44792610|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792611|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792612|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792613|NCT01966913|Growth Substances|growth substances|mesh-ancestor
44792614|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792615|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792616|NCT01967017|Lidocaine|lidocaine|mesh-list
44792617|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792618|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
44792619|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792620|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792621|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
44792622|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792623|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44792624|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44792625|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44404084|NCT02635724|Peramivir|peramivir|mesh-list
44792626|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792627|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792628|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44792629|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792630|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44792631|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792632|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792633|NCT01967199|Paclitaxel|paclitaxel|mesh-list
44792634|NCT01967199|Everolimus|everolimus|mesh-list
44792635|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44792636|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792637|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792638|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792639|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792640|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792641|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792642|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
44792643|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792644|NCT01967251|Udenafil|udenafil|mesh-list
44792645|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44792646|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44792647|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792648|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792649|NCT01967264|Udenafil|udenafil|mesh-list
44792650|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44792651|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44792652|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792653|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571831|NCT01007435|Methotrexate|methotrexate|mesh-list
44792654|NCT01967368|Vaccines|vaccines|mesh-list
44792655|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
44792656|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792657|NCT01967381|Methamphetamine|methamphetamine|mesh-list
44792658|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44792659|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792660|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
44792661|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
44792662|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792663|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
44792664|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792665|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792666|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44792667|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44792668|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44404146|NCT02634606|Vitamin E|vitamin e|mesh-list
44404172|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792669|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792670|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44792671|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
44792672|NCT01967459|Vitamin D|vitamin d|mesh-list
44792673|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44792674|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792675|NCT01967459|Vitamins|vitamins|mesh-ancestor
44792676|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
44792677|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44792678|NCT01967472|Artesunate|artesunate|mesh-list
44792679|NCT01967472|Lumefantrine|lumefantrine|mesh-list
44792680|NCT01967472|Artemether|artemether|mesh-list
44792681|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44792682|NCT01967472|Amodiaquine|amodiaquine|mesh-list
44792683|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
44792684|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44792685|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44792686|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792687|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792688|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
44792689|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
44792690|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44792691|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
44792692|NCT01967498|Montelukast|montelukast|mesh-list
44792693|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44792694|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
44792695|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44792696|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
44792697|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792698|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792699|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44792700|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44404180|NCT02634333|Aflibercept|aflibercept|mesh-list
44792701|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792702|NCT01967524|Ropivacaine|ropivacaine|mesh-list
44792703|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44792704|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
44792705|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44792706|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792707|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
44792708|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792709|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792710|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
44792711|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792712|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44571905|NCT01006707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571906|NCT01006707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44571907|NCT01006707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44571908|NCT01006629|Palivizumab|palivizumab|mesh-list
44571909|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
44571910|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571911|NCT01006603|Glimepiride|glimepiride|mesh-list
44571912|NCT01006603|Saxagliptin|saxagliptin|mesh-list
44571913|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44571914|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571915|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571916|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571917|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
44571918|NCT01006603|Incretins|incretins|mesh-ancestor
44571919|NCT01006603|Hormones|hormones|mesh-ancestor
44571920|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792713|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792714|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792715|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
44792716|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792717|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44792718|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44792719|NCT01967758|Amoxicillin|amoxicillin|mesh-list
44792720|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44792721|NCT01967758|Trimethoprim|trimethoprim|mesh-list
44792722|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
44792723|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792724|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44792725|NCT01967758|Renal Agents|renal agents|mesh-ancestor
44792726|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
44792727|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44792728|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44792729|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44792730|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792731|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792732|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44792733|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44792734|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44792735|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44792736|NCT01967823|Aldesleukin|aldesleukin|mesh-list
44792737|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
44792738|NCT01967823|Fludarabine|fludarabine|mesh-list
44792739|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792740|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
44792741|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792742|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792743|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44792744|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
44792745|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792746|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792747|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44792748|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44792749|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44792750|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
44792751|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792752|NCT01967875|Cisplatin|cisplatin|mesh-list
44792753|NCT01967875|Docetaxel|docetaxel|mesh-list
44792754|NCT01967875|Capecitabine|capecitabine|mesh-list
44792755|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792756|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792757|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792758|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792759|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792760|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44792761|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
44792762|NCT01967927|Imidazole|imidazole|mesh-list
44792763|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792764|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792765|NCT01967979|Itraconazole|itraconazole|mesh-list
44792766|NCT01967979|Fluoxetine|fluoxetine|mesh-list
44792767|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
44792768|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792769|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44792770|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44792771|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792772|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792773|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44792774|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
44792775|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792776|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792777|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44792778|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44792779|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44792780|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792781|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792782|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
44792783|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44792784|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
44792785|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792786|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44792787|NCT01968005|Etodolac|etodolac|mesh-list
44792788|NCT01968005|Lidocaine|lidocaine|mesh-list
44792789|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792790|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
44792791|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792792|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792793|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
44792794|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792795|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44792796|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44792797|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44792798|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44792799|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792800|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792801|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792802|NCT01968005|Analgesics|analgesics|mesh-ancestor
44792803|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792804|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792805|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44792806|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44792807|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792808|NCT01968018|Acetaminophen|acetaminophen|mesh-list
44792809|NCT01968018|Tramadol|tramadol|mesh-list
44792810|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792811|NCT01968018|Analgesics|analgesics|mesh-ancestor
44792812|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
44792813|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792814|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792815|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
44792816|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44792817|NCT01968018|Narcotics|narcotics|mesh-ancestor
44792818|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792819|NCT01968044|Linagliptin|linagliptin|mesh-list
44792820|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44792821|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792822|NCT01968044|Incretins|incretins|mesh-ancestor
44792823|NCT01968044|Hormones|hormones|mesh-ancestor
44792824|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792825|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44792826|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
44792827|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792828|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792829|NCT01968083|Vaccines|vaccines|mesh-list
44792830|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
44792831|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792832|NCT01968161|Asenapine|asenapine|mesh-list
44792833|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44792834|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44792835|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792836|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792837|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44792838|NCT01968200|Enalapril|enalapril|mesh-list
44792839|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44792840|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
44792841|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792842|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792843|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44792844|NCT01968239|Ranibizumab|ranibizumab|mesh-list
44792845|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792846|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792847|NCT01968239|Growth Substances|growth substances|mesh-ancestor
44404326|NCT02630563|Cyclosporine|cyclosporine|mesh-list
44792848|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792849|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792850|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792851|NCT01968395|Caspofungin|caspofungin|mesh-list
44792852|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
44792853|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44792854|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792855|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792856|NCT01968460|Pramipexole|pramipexole|mesh-list
44792857|NCT01968460|Rasagiline|rasagiline|mesh-list
44792858|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
44792859|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792860|NCT01968460|Protective Agents|protective agents|mesh-ancestor
44792861|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792862|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44792863|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44792864|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
44792865|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
44792866|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44792867|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44792868|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792869|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44792870|NCT01968486|Ranibizumab|ranibizumab|mesh-list
44792871|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792872|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792873|NCT01968486|Growth Substances|growth substances|mesh-ancestor
44792874|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792875|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792876|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792877|NCT01968564|Curcumin|curcumin|mesh-list
44792878|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792879|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792880|NCT01968564|Analgesics|analgesics|mesh-ancestor
44792881|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
44792882|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792883|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792884|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792885|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792886|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792887|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792888|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792889|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44792890|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44404371|NCT02629861|Calcitonin|calcitonin|mesh-list
44792891|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44792892|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
44792893|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792894|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44792895|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44792896|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792897|NCT01968616|Ranibizumab|ranibizumab|mesh-list
44792898|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44792899|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44792900|NCT01968616|Growth Substances|growth substances|mesh-ancestor
44792901|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792902|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44792903|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792904|NCT01968655|Factor VIII|factor viii|mesh-list
44792905|NCT01968655|Coagulants|coagulants|mesh-ancestor
44792906|NCT01968759|Ramipril|ramipril|mesh-list
44792907|NCT01968759|Irbesartan|irbesartan|mesh-list
44792908|NCT01968759|Sevelamer|sevelamer|mesh-list
44792909|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44792910|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
44792911|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792912|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792913|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44792914|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44792915|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44792916|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
44792917|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
44792918|NCT01968798|Aspirin|aspirin|mesh-list
44792919|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44792920|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44792921|NCT01968798|Analgesics|analgesics|mesh-ancestor
44792922|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
44792923|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792924|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792925|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792926|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792927|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44792928|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44792929|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792930|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44792931|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44792932|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792933|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
44792934|NCT01968850|Vitamin D|vitamin d|mesh-list
44572096|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792935|NCT01968850|Alendronate|alendronate|mesh-list
44792936|NCT01968850|Vitamins|vitamins|mesh-ancestor
44792937|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
44792938|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792939|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44792940|NCT01968915|Paclitaxel|paclitaxel|mesh-list
44792941|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44792942|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792943|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792944|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792945|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792946|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792947|NCT01969006|Bupivacaine|bupivacaine|mesh-list
44792948|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
44792949|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
44792950|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44792951|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792952|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
44792953|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792954|NCT01969019|Prednisone|prednisone|mesh-list
44792955|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
44792956|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44792957|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44792958|NCT01969019|Prednisolone|prednisolone|mesh-list
44792959|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
44792960|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44792961|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
44792962|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44792963|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
44792964|NCT01969019|Hormones|hormones|mesh-ancestor
44792965|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44792966|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792967|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44792968|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792969|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
44792970|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
44792971|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44792972|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44792973|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44792974|NCT01969019|Protective Agents|protective agents|mesh-ancestor
44792975|NCT01969032|Paclitaxel|paclitaxel|mesh-list
44792976|NCT01969032|Doxorubicin|doxorubicin|mesh-list
44792977|NCT01969032|Capecitabine|capecitabine|mesh-list
44792978|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
44792979|NCT01969032|Carboplatin|carboplatin|mesh-list
44792980|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44792981|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44792982|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44792983|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44792984|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44792985|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44792986|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44792987|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44792988|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44792989|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44792990|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44792991|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
44792992|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44792993|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
44792994|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44792995|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44792996|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44792997|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
44792998|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44792999|NCT01969071|Simendan|simendan|mesh-list
44793000|NCT01969071|Dobutamine|dobutamine|mesh-list
44793001|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44793002|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
44793003|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44793004|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44793005|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793006|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793007|NCT01969071|Protective Agents|protective agents|mesh-ancestor
44793008|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793009|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
44572172|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44793010|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
44793011|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793012|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44793013|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44793014|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44793015|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
44793016|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793018|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44793019|NCT01969149|Exenatide|exenatide|mesh-list
44793020|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
44793021|NCT01969149|Incretins|incretins|mesh-list
44793022|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793023|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793024|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44793025|NCT01969149|Hormones|hormones|mesh-ancestor
44793026|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793027|NCT01969318|Metformin|metformin|mesh-list
44793028|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793029|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572248|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
44793030|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44793031|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793032|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793033|NCT01969357|Incretins|incretins|mesh-ancestor
44692679|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692680|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
44692681|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44692682|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44692683|NCT01369238|Analgesics|analgesics|mesh-ancestor
44692684|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
44692685|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692686|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692687|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44692688|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44692689|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
44692690|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
44476047|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692691|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44692692|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692693|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692694|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
44692695|NCT01369277|Vitamins|vitamins|mesh-ancestor
44692696|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
44244266|NCT05526755|Osimertinib|osimertinib|mesh-list
44692697|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692698|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44692699|NCT01369290|Citalopram|citalopram|mesh-list
44692700|NCT01369290|Bupropion|bupropion|mesh-list
44692701|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44692702|NCT01369290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44692703|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692704|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692705|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692706|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692707|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
44692708|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692709|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692710|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692711|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692712|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692713|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44692714|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
44692715|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44692716|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44692717|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692718|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44692719|NCT01369290|Analgesics|analgesics|mesh-ancestor
44692720|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
44692721|NCT01369303|Tenofovir|tenofovir|mesh-list
44692722|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
44692723|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692724|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44692725|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44692726|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692727|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692728|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44692729|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44692730|NCT01369368|Azacitidine|azacitidine|mesh-list
44692731|NCT01369368|Valproic Acid|valproic acid|mesh-list
44692732|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44692733|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
44692734|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692735|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692736|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692737|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
44692738|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
44692739|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692740|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692741|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
44692742|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44692743|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692744|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692745|NCT01369472|Carvedilol|carvedilol|mesh-list
44692746|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44692747|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44793035|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793036|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44793037|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
44793038|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793039|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793040|NCT01969617|Naltrexone|naltrexone|mesh-list
44793041|NCT01969617|Nalmefene|nalmefene|mesh-list
44793042|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44793043|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793044|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
44793045|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793046|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44793047|NCT01969656|Calcitriol|calcitriol|mesh-list
44793048|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44793049|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793050|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44793051|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793052|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793053|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44793054|NCT01969656|Vitamins|vitamins|mesh-ancestor
44793055|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
44793056|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793057|NCT01969669|Ketoconazole|ketoconazole|mesh-list
44793058|NCT01969669|Venetoclax|venetoclax|mesh-list
44793059|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793060|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
44793061|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793062|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44793063|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44793064|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793065|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793066|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44793067|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793068|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793069|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793070|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44793071|NCT01969682|Rifampin|rifampin|mesh-list
44793072|NCT01969682|Venetoclax|venetoclax|mesh-list
44793073|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793074|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44793075|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
44793076|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44793077|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793078|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
44793079|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44793080|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793081|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793082|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44793083|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44793084|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44793085|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44793086|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44793087|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44793088|NCT01969695|Venetoclax|venetoclax|mesh-list
44793089|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793090|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
44793091|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44793092|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44793093|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44793094|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793095|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793096|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
44793097|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793098|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793099|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44572326|NCT01001702|Aripiprazole|aripiprazole|mesh-list
44572327|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44572328|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44572329|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44404701|NCT02614859|Bicalutamide|bicalutamide|mesh-list
44398870|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572330|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44793100|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793101|NCT01969877|Cisplatin|cisplatin|mesh-list
44793102|NCT01969877|Cetuximab|cetuximab|mesh-list
44793103|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793104|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793105|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
44793106|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44793107|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793108|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793109|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44793110|NCT01969903|Analgesics|analgesics|mesh-ancestor
44793111|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
44793112|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793113|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44793114|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44793115|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44793116|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
44793117|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793118|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793119|NCT01969942|Melphalan|melphalan|mesh-list
44793120|NCT01969942|Busulfan|busulfan|mesh-list
44793121|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44793122|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
44793123|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793124|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793125|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44793126|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793127|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
44793128|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793129|NCT01969955|Paclitaxel|paclitaxel|mesh-list
44793130|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44793131|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793132|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404708|NCT02614794|Capecitabine|capecitabine|mesh-list
44793133|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793134|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793135|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793136|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793137|NCT01970046|Metformin|metformin|mesh-list
44793138|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793139|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793140|NCT01970059|Metoprolol|metoprolol|mesh-list
44793141|NCT01970059|Carvedilol|carvedilol|mesh-list
44793142|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44793143|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44793144|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
44793145|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
44793146|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793147|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793148|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44793149|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44793150|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44793151|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44793152|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793153|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793154|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
44793155|NCT01970059|Protective Agents|protective agents|mesh-ancestor
44793156|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44793157|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793158|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44793159|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
44793160|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44793161|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44793162|NCT01970072|Midazolam|midazolam|mesh-list
44793163|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44793164|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44793165|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793166|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793167|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44793168|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44793169|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44793170|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793171|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
44793172|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
44793173|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
44793174|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
44793175|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793176|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793178|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
44793179|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
44793180|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44793181|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44793182|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793183|NCT01970215|Atorvastatin|atorvastatin|mesh-list
44793184|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44793185|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44793186|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44793187|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
44793188|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793189|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44793190|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44793191|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793192|NCT01970280|Enoxaparin|enoxaparin|mesh-list
44793193|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
44793194|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44793195|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44793196|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793197|NCT01970358|Poly ICLC|poly iclc|mesh-list
44793198|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
44793199|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
44793200|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793201|NCT01970449|Vaccines|vaccines|mesh-list
44793202|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
44793203|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793204|NCT01970553|Gemcitabine|gemcitabine|mesh-list
44793205|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793206|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
44793207|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793208|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793209|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
44793210|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793211|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793212|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793213|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
44793214|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793215|NCT01970579|Paclitaxel|paclitaxel|mesh-list
44793216|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793217|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793218|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793219|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793220|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793221|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793222|NCT01970748|Propranolol|propranolol|mesh-list
44793223|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44793224|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44793225|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
44793226|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793227|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793228|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793229|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44793230|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44793231|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
44793232|NCT01970800|Hormones|hormones|mesh-list
44793233|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793234|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793235|NCT01970904|Ribavirin|ribavirin|mesh-list
44793236|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44793237|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
44793238|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793239|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
44793240|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793241|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44793242|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44793243|NCT01971034|Metformin|metformin|mesh-list
44793244|NCT01971034|Paclitaxel|paclitaxel|mesh-list
44793245|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793246|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793247|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793248|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44572407|NCT01001208|Etanercept|etanercept|mesh-list
44793249|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793250|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793251|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793252|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793254|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
44793255|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44793256|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793257|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793258|NCT01971190|Aflibercept|aflibercept|mesh-list
44793259|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44793260|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44793261|NCT01971190|Growth Substances|growth substances|mesh-ancestor
44793262|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793263|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793264|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793265|NCT01971242|Exenatide|exenatide|mesh-list
44793266|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793267|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793268|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44793269|NCT01971242|Incretins|incretins|mesh-ancestor
44793270|NCT01971242|Hormones|hormones|mesh-ancestor
44793271|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793272|NCT01971268|Cimetidine|cimetidine|mesh-list
44793273|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44793274|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793275|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44793276|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
44793277|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
44793278|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793279|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793280|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793281|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44793282|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44793283|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793284|NCT01971281|Gemcitabine|gemcitabine|mesh-list
44793285|NCT01971281|Paclitaxel|paclitaxel|mesh-list
44793286|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793287|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793288|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793289|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793290|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793291|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793292|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793293|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
44793294|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
44793295|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793296|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793297|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793298|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
44793299|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793300|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
44793301|NCT01971411|Vitamin D|vitamin d|mesh-list
44793302|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
44793303|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
44793304|NCT01971411|Vitamins|vitamins|mesh-list
44793305|NCT01971411|Calcium|calcium|mesh-list
44793306|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
44793307|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793308|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44793309|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793310|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
44793311|NCT01971424|Antacids|antacids|mesh-ancestor
44793312|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793313|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793314|NCT01971450|Iloprost|iloprost|mesh-list
44793315|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44793316|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
44793317|NCT01971489|Gemcitabine|gemcitabine|mesh-list
44793318|NCT01971489|Cisplatin|cisplatin|mesh-list
44793319|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793320|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793321|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
44793322|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793323|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
44793324|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793325|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793326|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793327|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
44793328|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793329|NCT01971515|Tamoxifen|tamoxifen|mesh-list
44793330|NCT01971515|Trastuzumab|trastuzumab|mesh-list
44793331|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793332|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793333|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44793334|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793335|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793336|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793337|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793338|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44793339|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44793340|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793341|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44793342|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44793343|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44793344|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
44793345|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793346|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44793347|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44793348|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793349|NCT01971632|Oxycodone|oxycodone|mesh-list
44793350|NCT01971632|Naloxone|naloxone|mesh-list
44793351|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793352|NCT01971632|Narcotics|narcotics|mesh-ancestor
44793353|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793354|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793355|NCT01971632|Analgesics|analgesics|mesh-ancestor
44793356|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
44793357|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793358|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44793359|NCT01971658|Thalidomide|thalidomide|mesh-list
44793360|NCT01971658|Dexamethasone|dexamethasone|mesh-list
44793361|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
44793362|NCT01971658|Bortezomib|bortezomib|mesh-list
44793363|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793364|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
44793365|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793366|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793367|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44793368|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
44793369|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793370|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793371|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44692748|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
44692749|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692750|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692751|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692752|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44692753|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
44692754|NCT01369472|Protective Agents|protective agents|mesh-ancestor
44692755|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44692756|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692757|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44692758|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
44692759|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44692760|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44692761|NCT01369576|Zopiclone|zopiclone|mesh-list
44692762|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44692763|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692764|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692765|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
44692766|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44692767|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692768|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692769|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
44692770|NCT01369602|Vitamins|vitamins|mesh-ancestor
44692771|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
44572626|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
44572627|NCT00998738|Calcium|calcium|mesh-list
44572628|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44572629|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572630|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44572631|NCT00998738|Analgesics|analgesics|mesh-ancestor
44572632|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
44572633|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572634|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
44572635|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572636|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44572637|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
44572638|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44572639|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572640|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572641|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
44572642|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44793372|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793373|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
44793374|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
44793375|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793376|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793377|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
44793378|NCT01971658|Hormones|hormones|mesh-ancestor
44793379|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793380|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793381|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
44793382|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44793383|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793384|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44793385|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44793386|NCT01971658|Growth Substances|growth substances|mesh-ancestor
44793387|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793388|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
44793389|NCT01971684|Sirolimus|sirolimus|mesh-list
44793390|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
44793391|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793392|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
44793393|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793394|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44793395|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44793396|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
44793397|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44793398|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793399|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793400|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793401|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
44793402|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793403|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
44793404|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793405|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44793406|NCT01971801|Vitamin D|vitamin d|mesh-list
44793407|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
44793408|NCT01971801|Vitamins|vitamins|mesh-ancestor
44793409|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
44793410|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476048|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
44793411|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793412|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44793413|NCT01971814|Infliximab|infliximab|mesh-list
44793414|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44793415|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793416|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793417|NCT01971918|Antibodies|antibodies|mesh-list
44793418|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
44793419|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793420|NCT01972113|Vitamins|vitamins|mesh-list
44793421|NCT01972113|Vitamin K|vitamin k|mesh-list
44793422|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
44793423|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
44793424|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
44793425|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793426|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44793427|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44793428|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793429|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
44793430|NCT01972113|Coagulants|coagulants|mesh-ancestor
44793431|NCT01972230|Remifentanil|remifentanil|mesh-list
44793432|NCT01972230|Sevoflurane|sevoflurane|mesh-list
44793433|NCT01972230|Propofol|propofol|mesh-list
44793434|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44793435|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44793436|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
44793437|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
44793438|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793439|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793440|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793441|NCT01972230|Narcotics|narcotics|mesh-ancestor
44793442|NCT01972230|Analgesics|analgesics|mesh-ancestor
44793443|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
44793444|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793445|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44793446|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793447|NCT01972269|Lidocaine|lidocaine|mesh-list
44793448|NCT01972269|Fentanyl|fentanyl|mesh-list
44793449|NCT01972269|Bupivacaine|bupivacaine|mesh-list
44793450|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
44793451|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
44793452|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793453|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793454|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
44793455|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793456|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44793457|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44793458|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44793459|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793460|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793461|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793462|NCT01972269|Narcotics|narcotics|mesh-ancestor
44793463|NCT01972269|Analgesics|analgesics|mesh-ancestor
44793464|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44793465|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793466|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
44793467|NCT01972373|Bevacizumab|bevacizumab|mesh-list
44793468|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793469|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793470|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44793471|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44405092|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793472|NCT01972373|Growth Substances|growth substances|mesh-ancestor
44793473|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793474|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793475|NCT01972490|Bevacizumab|bevacizumab|mesh-list
44793476|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793477|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793478|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44793479|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44793480|NCT01972490|Growth Substances|growth substances|mesh-ancestor
44793481|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793482|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793483|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
44793484|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793485|NCT01972620|Bupivacaine|bupivacaine|mesh-list
44793486|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44793487|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
44793488|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793489|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793490|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
44793491|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793492|NCT01972711|Amisulpride|amisulpride|mesh-list
44793493|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44793494|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44793495|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793496|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793497|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44793498|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44793499|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
44793500|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793501|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793502|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44793503|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
44793504|NCT01972763|Ranibizumab|ranibizumab|mesh-list
44793505|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44793506|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44793507|NCT01972763|Growth Substances|growth substances|mesh-ancestor
44793508|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793509|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793510|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793511|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44793512|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
44793513|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
44793514|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
44793515|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44793516|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793517|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793518|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793519|NCT01972906|Ibuprofen|ibuprofen|mesh-list
44793520|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44793521|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44793522|NCT01972906|Analgesics|analgesics|mesh-ancestor
44793523|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
44793524|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793525|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793526|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793527|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793528|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44793529|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793530|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793531|NCT01972984|Anastrozole|anastrozole|mesh-list
44793532|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793533|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793534|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44793535|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44793536|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793537|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793538|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44793539|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793540|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793541|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793542|NCT01973010|Ibuprofen|ibuprofen|mesh-list
44793543|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44793544|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44793545|NCT01973010|Analgesics|analgesics|mesh-ancestor
44793546|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
44793547|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793548|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793549|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793550|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793551|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44793552|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793553|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572855|NCT00996593|Iodine|iodine|mesh-list
44793554|NCT01973101|Gemcitabine|gemcitabine|mesh-list
44793555|NCT01973101|Cisplatin|cisplatin|mesh-list
44793556|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793557|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793558|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
44793559|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793560|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
44793561|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793562|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793563|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793564|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
44793565|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793566|NCT01973114|Latanoprost|latanoprost|mesh-list
44793567|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44793568|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44793569|NCT01973140|Tolvaptan|tolvaptan|mesh-list
44793570|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44793571|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793572|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
44793573|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793574|NCT01973309|Paclitaxel|paclitaxel|mesh-list
44793575|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793576|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793577|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793578|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793579|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793580|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793581|NCT01973322|Vaccines|vaccines|mesh-list
44793582|NCT01973322|Complement Factor H|complement factor h|mesh-list
44793583|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
44793584|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793585|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44793586|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793587|NCT01973400|Tocotrienols|tocotrienols|mesh-list
44793588|NCT01973400|Vitamin E|vitamin e|mesh-list
44793589|NCT01973400|Tocopherols|tocopherols|mesh-list
44793590|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
44793591|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793592|NCT01973400|Protective Agents|protective agents|mesh-ancestor
44793593|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793594|NCT01973400|Vitamins|vitamins|mesh-ancestor
44793595|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
44793596|NCT01973504|Chrysarobin|chrysarobin|mesh-list
44793597|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44793598|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44793599|NCT01973504|Analgesics|analgesics|mesh-ancestor
44793600|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
44793601|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793602|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793603|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793604|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793605|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44793606|NCT01973517|Hematinics|hematinics|mesh-ancestor
44793607|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44793608|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44793609|NCT01973660|Tamoxifen|tamoxifen|mesh-list
44793610|NCT01973660|Paclitaxel|paclitaxel|mesh-list
44793611|NCT01973660|Trastuzumab|trastuzumab|mesh-list
44793612|NCT01973660|Letrozole|letrozole|mesh-list
44793613|NCT01973660|Lapatinib|lapatinib|mesh-list
44793614|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793615|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793616|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793617|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793618|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793619|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793620|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793621|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44793622|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44793623|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793624|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44793625|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793626|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793627|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405267|NCT02600871|Povidone|povidone|mesh-list
44793628|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793629|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44793630|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44793631|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793632|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44793633|NCT01973751|Budesonide|budesonide|mesh-list
44793634|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793635|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44793636|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
44793637|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793638|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793639|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44793640|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
44793641|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
44793642|NCT01973751|Hormones|hormones|mesh-ancestor
44793643|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793644|NCT01973790|Z 338|z 338|mesh-list
44793645|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44793646|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793647|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793648|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
44793649|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793650|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793651|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44692772|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692773|NCT01369667|Vitamin D|vitamin d|mesh-list
44692774|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
44692775|NCT01369667|Vitamins|vitamins|mesh-ancestor
44692776|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
44692777|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692778|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44692779|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44692780|NCT01369693|Lobeline|lobeline|mesh-list
44692781|NCT01369693|Nicotine|nicotine|mesh-list
44692782|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44692783|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
44692784|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692785|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692786|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44692787|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44692788|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
44692789|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692790|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692791|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44692792|NCT01369719|Deferasirox|deferasirox|mesh-list
44692793|NCT01369719|Deferoxamine|deferoxamine|mesh-list
44692794|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44692795|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
44692796|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
44692797|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692798|NCT01369719|Siderophores|siderophores|mesh-ancestor
44692799|NCT01369979|Imidacloprid|imidacloprid|mesh-list
44692800|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
44692801|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692802|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692803|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692804|NCT01370031|Charcoal|charcoal|mesh-list
44692805|NCT01370031|Antidotes|antidotes|mesh-ancestor
44692806|NCT01370031|Protective Agents|protective agents|mesh-ancestor
44692807|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692808|NCT01370096|Epoprostenol|epoprostenol|mesh-list
44692809|NCT01370096|Vasopressins|vasopressins|mesh-list
44692810|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
44692811|NCT01370096|Tezosentan|tezosentan|mesh-list
44692812|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
44692813|NCT01370096|Coagulants|coagulants|mesh-ancestor
44692814|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44692815|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44692816|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
44692817|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692818|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44692819|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692820|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
44692821|NCT01370135|Ranibizumab|ranibizumab|mesh-list
44692822|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405321|NCT02597946|Paclitaxel|paclitaxel|mesh-list
44692823|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44692824|NCT01370135|Growth Substances|growth substances|mesh-ancestor
44692825|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692826|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
44793652|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
44793653|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44793654|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44793655|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44793656|NCT01973816|Estradiol|estradiol|mesh-list
44793657|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44793658|NCT01973816|Cyproterone|cyproterone|mesh-list
44793659|NCT01973816|Estrogens|estrogens|mesh-ancestor
44793660|NCT01973816|Hormones|hormones|mesh-ancestor
44793661|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793662|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793663|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44793664|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
44793665|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44793666|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44793667|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
44793668|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793669|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793670|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44793671|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
44793672|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793673|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44793674|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
44793675|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44793676|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
44793677|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44793678|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793679|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44793680|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793681|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793682|NCT01973855|Ribavirin|ribavirin|mesh-list
44793683|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
44793684|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793685|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
44793686|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793687|NCT01973868|Cetuximab|cetuximab|mesh-list
44793688|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793689|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793690|NCT01973920|Insulin|insulin|mesh-list
44793691|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793692|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793693|NCT01973933|Metformin|metformin|mesh-list
44405372|NCT02597062|Hormones|hormones|mesh-ancestor
44793694|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
44793695|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44793696|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793697|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
44793698|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44793699|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44793700|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793701|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44793702|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793703|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793704|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
44793705|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44793706|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44793707|NCT01974024|Prednisolone|prednisolone|mesh-list
44793708|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
44793709|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44793710|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
44793711|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793712|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
44793713|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
44793714|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793715|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793716|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793717|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
44793718|NCT01974024|Hormones|hormones|mesh-ancestor
44793719|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793720|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44793721|NCT01974024|Protective Agents|protective agents|mesh-ancestor
44793722|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793723|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793724|NCT01974037|Capsaicin|capsaicin|mesh-list
44793725|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
44793726|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
44692827|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793727|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
44793728|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793729|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793730|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
44793731|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44793732|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
44793733|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44793734|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793735|NCT01974167|Vitamins|vitamins|mesh-ancestor
44793736|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
44793737|NCT01974258|Vemurafenib|vemurafenib|mesh-list
44793738|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793739|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44793740|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793741|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793742|NCT01974297|Atorvastatin|atorvastatin|mesh-list
44793743|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
44793744|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44793745|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44793746|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
44793747|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793748|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44793749|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44793750|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793751|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44793752|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44793753|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793754|NCT01974375|Fluconazole|fluconazole|mesh-list
44793755|NCT01974375|Micafungin|micafungin|mesh-list
44793756|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
44793757|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793758|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44793759|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44793760|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793761|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793762|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44793763|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
44793764|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793765|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793766|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44793767|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44793768|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
44793769|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44793770|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793771|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
44793772|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
44793773|NCT01974518|Rituximab|rituximab|mesh-list
44793774|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44793775|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
44793776|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793777|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793778|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44793779|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
44793780|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793781|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793782|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44793783|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793784|NCT01974622|Verteporfin|verteporfin|mesh-list
44793785|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44793786|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44793787|NCT01974648|Remifentanil|remifentanil|mesh-list
44793788|NCT01974648|Propofol|propofol|mesh-list
44793789|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44793790|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573056|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44573057|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573058|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
44573059|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573060|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
44573061|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573062|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573063|NCT00993616|Carboplatin|carboplatin|mesh-list
44573064|NCT00993616|Belinostat|belinostat|mesh-list
44573065|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573067|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793791|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793792|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793793|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
44793794|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
44793795|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793796|NCT01974648|Narcotics|narcotics|mesh-ancestor
44793797|NCT01974648|Analgesics|analgesics|mesh-ancestor
44793798|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
44793799|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793800|NCT01974843|Bupivacaine|bupivacaine|mesh-list
44793801|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
44793802|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44793803|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
44405491|NCT02595398|Triamcinolone|triamcinolone|mesh-list
44793804|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793805|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793806|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
44793807|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793808|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44793809|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44793810|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44793811|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793812|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793813|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793814|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793815|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
44793816|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44793817|NCT01975012|Rilpivirine|rilpivirine|mesh-list
44793818|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44793819|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44793820|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793821|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793822|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
44793823|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793824|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44793825|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44793826|NCT01975051|Miltefosine|miltefosine|mesh-list
44793827|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
44793828|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793829|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793830|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44793831|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44793832|NCT01975129|Oxytocin|oxytocin|mesh-list
44793833|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
44793834|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44793835|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793836|NCT01975142|Trastuzumab|trastuzumab|mesh-list
44793837|NCT01975142|Maytansine|maytansine|mesh-list
44793838|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44793839|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793840|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44793841|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793842|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793843|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793844|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793845|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44793846|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44793847|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44793848|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
44793849|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793850|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44793851|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44793852|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793853|NCT01975259|Glucagon|glucagon|mesh-list
44793854|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44793855|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44793856|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793857|NCT01975259|Hormones|hormones|mesh-ancestor
44793858|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793859|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793860|NCT01975259|Incretins|incretins|mesh-ancestor
44793861|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
44793862|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44793863|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793864|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793865|NCT01975363|Curcumin|curcumin|mesh-list
44793866|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44793867|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44793868|NCT01975363|Analgesics|analgesics|mesh-ancestor
44793869|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
44793870|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793871|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793872|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793873|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44793874|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793875|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793876|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793877|NCT01975441|Ivermectin|ivermectin|mesh-list
44793878|NCT01975441|Albendazole|albendazole|mesh-list
44793879|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
44793880|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44573209|NCT00992511|Vaccines|vaccines|mesh-list
44793881|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793882|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
44793883|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
44793884|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44793885|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44793886|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44793887|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44793888|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44793889|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793890|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793891|NCT01975441|Filaricides|filaricides|mesh-ancestor
44793892|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
44793893|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44793894|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793895|NCT01975454|Capecitabine|capecitabine|mesh-list
44793896|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
44793897|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44793898|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
44793899|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793900|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793901|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44793902|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44793903|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44793904|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44793905|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793906|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793907|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793908|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
44793909|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44793910|NCT01975662|Vancomycin|vancomycin|mesh-list
44793911|NCT01975662|Daptomycin|daptomycin|mesh-list
44793912|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44793913|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793914|NCT01975688|Nabiximols|nabiximols|mesh-list
44793915|NCT01975688|Analgesics|analgesics|mesh-ancestor
44793916|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
44793917|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793918|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793919|NCT01975714|Bimatoprost|bimatoprost|mesh-list
44793920|NCT01975714|Latanoprost|latanoprost|mesh-list
44793921|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44793922|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44793923|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44793924|NCT01975727|Dexamethasone|dexamethasone|mesh-list
44793925|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
44793926|NCT01975727|BB 1101|bb 1101|mesh-list
44793927|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44793928|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
44793929|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
44793930|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793931|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793932|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793933|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
44793934|NCT01975727|Hormones|hormones|mesh-ancestor
44793935|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44793936|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44793937|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44793938|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44793939|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793940|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793941|NCT01975753|Fentanyl|fentanyl|mesh-list
44793942|NCT01975753|Morphine|morphine|mesh-list
44793943|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44793944|NCT01975753|Narcotics|narcotics|mesh-ancestor
44793945|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793946|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793947|NCT01975753|Analgesics|analgesics|mesh-ancestor
44793948|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
44793949|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44793950|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44793951|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793952|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
44793953|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
44793954|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
44793955|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44793956|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
44793957|NCT01975805|Povidone|povidone|mesh-list
44793958|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44793959|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44793960|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
44793961|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44793962|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
44793963|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
44793964|NCT01975961|Telmisartan|telmisartan|mesh-list
44793965|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44793966|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44793967|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44793968|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
44793969|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793970|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44063317|NCT02373813|Analgesics|analgesics|mesh-ancestor
44793971|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44793972|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793973|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44793974|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44793975|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44793976|NCT01976078|Midazolam|midazolam|mesh-list
44793977|NCT01976078|Esomeprazole|esomeprazole|mesh-list
44793978|NCT01976078|Ranitidine|ranitidine|mesh-list
44793979|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44793980|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44793981|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44793982|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44793983|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44793984|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44793985|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44793986|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44793987|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44793988|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
44793989|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
44793990|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
44793991|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
44793992|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44793993|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44793994|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44793995|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44793996|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44793997|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44793998|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44793999|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
44794000|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
44794001|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
44794002|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794003|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44794004|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44794005|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794006|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794007|NCT01976195|Thalidomide|thalidomide|mesh-list
44794008|NCT01976195|Dexamethasone|dexamethasone|mesh-list
44794009|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794010|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
44794011|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
44794012|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794013|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794014|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794015|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
44794016|NCT01976195|Hormones|hormones|mesh-ancestor
44794017|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794018|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794019|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794020|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44794021|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
44794022|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
44794023|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44794024|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794025|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44794026|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44794027|NCT01976195|Growth Substances|growth substances|mesh-ancestor
44794028|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44794029|NCT01976208|Omalizumab|omalizumab|mesh-list
44794030|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44794031|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794032|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
44692828|NCT01370148|Conivaptan|conivaptan|mesh-list
44794033|NCT01976520|Vaccines|vaccines|mesh-list
44794034|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
44794035|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794036|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
44794037|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44794038|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44794039|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44794040|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794041|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794042|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44794043|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794044|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794045|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44794046|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794047|NCT01976676|Folic Acid|folic acid|mesh-list
44794048|NCT01976676|Hematinics|hematinics|mesh-ancestor
44794049|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794050|NCT01976676|Vitamins|vitamins|mesh-ancestor
44794051|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
44794052|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794053|NCT01976780|Artesunate|artesunate|mesh-list
44794054|NCT01976780|Lumefantrine|lumefantrine|mesh-list
44794055|NCT01976780|Artemether|artemether|mesh-list
44794056|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44794057|NCT01976780|Mefloquine|mefloquine|mesh-list
44405736|NCT02585713|Dalteparin|dalteparin|mesh-list
44794058|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
44794059|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44794060|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44794061|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794062|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794063|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
44794064|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
44794065|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44794066|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
44794067|NCT01976923|Bevacizumab|bevacizumab|mesh-list
44794068|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44794069|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794070|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44794071|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44794072|NCT01976923|Growth Substances|growth substances|mesh-ancestor
44794073|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794074|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44794075|NCT01976936|Lovastatin|lovastatin|mesh-list
44794076|NCT01976936|L 647318|l 647318|mesh-list
44794077|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
44794078|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44794079|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44794080|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
44794081|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794082|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44794083|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44794084|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794085|NCT01977118|Streptokinase|streptokinase|mesh-list
44794086|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44794087|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44405781|NCT02584452|Dexamethasone|dexamethasone|mesh-list
44794088|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794089|NCT01977209|Gossypol|gossypol|mesh-list
44794090|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44573483|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44794091|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
44794092|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44794093|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794094|NCT01977235|Cisplatin|cisplatin|mesh-list
44794095|NCT01977235|Irinotecan|irinotecan|mesh-list
44794096|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794097|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44794098|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44794099|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794100|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794101|NCT01977300|Valproic Acid|valproic acid|mesh-list
44794102|NCT01977300|Olanzapine|olanzapine|mesh-list
44794103|NCT01977300|Risperidone|risperidone|mesh-list
44794104|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
44794105|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44794106|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
44794107|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794108|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794109|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794110|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44794111|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794112|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794113|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794114|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44794115|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
44794116|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
44794117|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
44794118|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794119|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794120|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44794121|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44794122|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794123|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
44794124|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794125|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
44794126|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
44794127|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
44794128|NCT01977339|Bupivacaine|bupivacaine|mesh-list
44794129|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
44794130|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
44794131|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794132|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794133|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
44794134|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794135|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44794136|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44794137|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44794138|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44573484|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573485|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
44573486|NCT00988637|Hormones|hormones|mesh-ancestor
44573487|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573488|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44573489|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
44573490|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44573491|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44573492|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794139|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794140|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794141|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794142|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476049|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44794143|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44794144|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44794145|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794146|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44794147|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44794148|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794149|NCT01977417|Analgesics|analgesics|mesh-ancestor
44794150|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
44794151|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794152|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794153|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794154|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794155|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44794156|NCT01977430|Furosemide|furosemide|mesh-list
44794157|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794158|NCT01977430|Diuretics|diuretics|mesh-ancestor
44794159|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
44794160|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794161|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44794162|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794163|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794164|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44794165|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44794166|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44794167|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44794168|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
44794169|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794170|NCT01977989|Vancomycin|vancomycin|mesh-list
44794171|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44794172|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794173|NCT01978015|Timolol|timolol|mesh-list
44794174|NCT01978015|Bimatoprost|bimatoprost|mesh-list
44794175|NCT01978015|Travoprost|travoprost|mesh-list
44794176|NCT01978015|Dextrans|dextrans|mesh-list
44794177|NCT01978015|Latanoprost|latanoprost|mesh-list
44794178|NCT01978015|Maleic acid|maleic acid|mesh-list
44794179|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44794180|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44794181|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794182|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794183|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794184|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794185|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44794186|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794187|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794188|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44794189|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44794190|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
44794191|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
44794192|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
44794193|NCT01978041|Fluorides|fluorides|mesh-list
44794194|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
44794195|NCT01978041|Protective Agents|protective agents|mesh-ancestor
44794196|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794197|NCT01978301|Triamcinolone|triamcinolone|mesh-list
44794198|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44794199|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44794200|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44794201|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794202|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
44794203|NCT01978301|Hormones|hormones|mesh-ancestor
44794204|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794205|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794206|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44794207|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
44794208|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794209|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794210|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
44794211|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
44794212|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794213|NCT01978405|Protective Agents|protective agents|mesh-ancestor
44794214|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794215|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794216|NCT01978405|Vitamins|vitamins|mesh-ancestor
44405928|NCT02582515|Cycloserine|cycloserine|mesh-list
44794217|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
44794218|NCT01978418|Albuterol|albuterol|mesh-list
44794219|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44794220|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
44794221|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794222|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794223|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794224|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794225|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
44794226|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44794227|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44794228|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44794229|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44794230|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794231|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794232|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794233|NCT01978431|Cocaine|cocaine|mesh-list
44794234|NCT01978431|Methylphenidate|methylphenidate|mesh-list
44794235|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44794236|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794237|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44794238|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44794239|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794240|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794241|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
44794242|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794243|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
44794244|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
44794245|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794246|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
44794247|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794248|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44794249|NCT01978457|Propranolol|propranolol|mesh-list
44794250|NCT01978457|Cocaine|cocaine|mesh-list
44794251|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44794252|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44794253|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794254|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794255|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794256|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794257|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44405956|NCT02581345|Adalimumab|adalimumab|mesh-list
44794258|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794259|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
44794260|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
44794261|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
44794262|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794263|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
44794264|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794265|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44794266|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44794267|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44794268|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794269|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
44794270|NCT01978483|Denosumab|denosumab|mesh-list
44794271|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44794272|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794273|NCT01978496|Eletriptan|eletriptan|mesh-list
44794274|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44794275|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
44794276|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794277|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794278|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794279|NCT01978665|Prednisone|prednisone|mesh-list
44794280|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794281|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
44794282|NCT01978665|Hormones|hormones|mesh-ancestor
44794283|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794284|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794285|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794286|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794287|NCT01978678|Budesonide|budesonide|mesh-list
44794288|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794289|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44794291|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794292|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794293|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794294|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794295|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
44794296|NCT01978678|Hormones|hormones|mesh-ancestor
44794297|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794298|NCT01978704|Insulin|insulin|mesh-list
44794299|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44794300|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44794301|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794302|NCT01978717|Anesthetics|anesthetics|mesh-list
44794303|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794304|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692829|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44692830|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692831|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
44692832|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692833|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44692834|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44692835|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44692836|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692837|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692838|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692839|NCT01370187|Montelukast|montelukast|mesh-list
44692840|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44692841|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44692842|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44692843|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
44692844|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692845|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692871|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
44692872|NCT01370343|Cyclosporine|cyclosporine|mesh-list
44692873|NCT01370343|Cyclosporins|cyclosporins|mesh-list
44692874|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44692875|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692876|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692877|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692878|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
44692879|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692880|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
44692881|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692882|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
44692883|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573664|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
44406037|NCT02579928|Midazolam|midazolam|mesh-list
44794305|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
44794306|NCT01978782|Citalopram|citalopram|mesh-list
44794307|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44794308|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44794309|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
44794310|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794311|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44794312|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44794313|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794314|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794315|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44794316|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44794317|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794318|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794319|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
44794320|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794321|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44794322|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
44794323|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794324|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
44794325|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
44794326|NCT01978873|Androgens|androgens|mesh-list
44794327|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44794328|NCT01978873|Hormones|hormones|mesh-ancestor
44794329|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794330|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794331|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
44794332|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794333|NCT01978873|Protective Agents|protective agents|mesh-ancestor
44794334|NCT01978873|Vitamins|vitamins|mesh-ancestor
44794335|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
44794336|NCT01978873|Estrogens|estrogens|mesh-ancestor
44794337|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794338|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794339|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
44794340|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44794341|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44406098|NCT02579616|Lenvatinib|lenvatinib|mesh-list
44794342|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794343|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
44794344|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44794345|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
44794346|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44794347|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44794348|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794349|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794350|NCT01979354|Morphine|morphine|mesh-list
44794351|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44794352|NCT01979354|Narcotics|narcotics|mesh-ancestor
44794353|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794354|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794355|NCT01979354|Analgesics|analgesics|mesh-ancestor
44794356|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
44794357|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794358|NCT01979406|Vaccines|vaccines|mesh-list
44794359|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
44794360|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794361|NCT01979510|Acetaminophen|acetaminophen|mesh-list
44794362|NCT01979510|Etoricoxib|etoricoxib|mesh-list
44794363|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794364|NCT01979510|Analgesics|analgesics|mesh-ancestor
44794365|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
44794366|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794367|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794368|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
44794369|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44794370|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794371|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794372|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44794373|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44794374|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794375|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794376|NCT01979653|Midazolam|midazolam|mesh-list
44794377|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
44794378|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44794379|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794380|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794381|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794382|NCT01979653|Analgesics|analgesics|mesh-ancestor
44794383|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
44794384|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794385|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44794386|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44794387|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44794388|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794389|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794390|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794391|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44794392|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44794393|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794394|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794395|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44794396|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
44794397|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
44794398|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
44794399|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
44794400|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44794401|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44794402|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794403|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406142|NCT02578706|Aspirin|aspirin|mesh-list
44794404|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794405|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794406|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44794407|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44794408|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44794409|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794410|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794411|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794412|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44794413|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44794414|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
44794415|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44794416|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44794417|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
44794418|NCT01979965|Ranolazine|ranolazine|mesh-list
44794419|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44794420|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794421|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794422|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
44794423|NCT01980004|Diuretics|diuretics|mesh-ancestor
44794424|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
44794425|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794426|NCT01980004|Expectorants|expectorants|mesh-ancestor
44794427|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794428|NCT01980069|Neostigmine|neostigmine|mesh-list
44794429|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44794430|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794431|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794432|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44794433|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794434|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794435|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44794436|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
44794437|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794438|NCT01980082|Cefazolin|cefazolin|mesh-list
44794439|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44794440|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794441|NCT01980277|Paclitaxel|paclitaxel|mesh-list
44794442|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44794443|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794444|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44794445|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44794446|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44794447|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794448|NCT01980303|Esketamine|esketamine|mesh-list
44794449|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
44794450|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794451|NCT01980316|Heparin|heparin|mesh-list
44794452|NCT01980316|Calcium heparin|calcium heparin|mesh-list
44794453|NCT01980316|Argatroban|argatroban|mesh-list
44794454|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
44794455|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44794456|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44794457|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794458|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
44794459|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44794460|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
44794461|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794462|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44794464|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44794465|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44794466|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794467|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44794468|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44794469|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
44794470|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794471|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44794472|NCT01980407|Leucovorin|leucovorin|mesh-list
44794473|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44794474|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
44794475|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794476|NCT01980407|Antidotes|antidotes|mesh-ancestor
44406214|NCT02577107|Ranibizumab|ranibizumab|mesh-list
44794477|NCT01980407|Protective Agents|protective agents|mesh-ancestor
44794478|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794479|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794480|NCT01980407|Vitamins|vitamins|mesh-ancestor
44794481|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
44573855|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573856|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573857|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44573858|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573859|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573860|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573861|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573862|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
44573863|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44573864|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573865|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573866|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573867|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573868|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
44573869|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44573870|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44573871|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573872|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573873|NCT00977431|Temozolomide|temozolomide|mesh-list
44573874|NCT00977431|Afatinib|afatinib|mesh-list
44794482|NCT01980472|Paclitaxel|paclitaxel|mesh-list
44794483|NCT01980472|Bevacizumab|bevacizumab|mesh-list
44794484|NCT01980472|Carboplatin|carboplatin|mesh-list
44794485|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44794486|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794487|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44794488|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44794489|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44794490|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794491|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44794492|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44794493|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44794494|NCT01980472|Growth Substances|growth substances|mesh-ancestor
44794495|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794496|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44794497|NCT01980498|Fentanyl|fentanyl|mesh-list
44794498|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44794499|NCT01980498|Narcotics|narcotics|mesh-ancestor
44794500|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794501|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794502|NCT01980498|Analgesics|analgesics|mesh-ancestor
44794503|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
44794504|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794505|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44794506|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44794507|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
44794508|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
44794509|NCT01980550|Nicotine|nicotine|mesh-list
44794510|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44794511|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
44794512|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794513|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794514|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44794515|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44794516|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
44794517|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794518|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794519|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44794520|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794521|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794522|NCT01980667|Cisplatin|cisplatin|mesh-list
44794523|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794524|NCT01980680|Estradiol|estradiol|mesh-list
44794525|NCT01980680|Progesterone|progesterone|mesh-list
44794526|NCT01980680|Estrogens|estrogens|mesh-ancestor
44794527|NCT01980680|Hormones|hormones|mesh-ancestor
44794528|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794529|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794530|NCT01980680|Progestins|progestins|mesh-ancestor
44794531|NCT01980745|Chloroquine|chloroquine|mesh-list
44794532|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44794533|NCT01980745|Amebicides|amebicides|mesh-ancestor
44794534|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44794535|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44794536|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794537|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
44794538|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794539|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44794540|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794541|NCT01980745|Analgesics|analgesics|mesh-ancestor
44794542|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
44794543|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794544|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794545|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794546|NCT01980745|Filaricides|filaricides|mesh-ancestor
44794547|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
44794548|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
44794549|NCT01980810|Paclitaxel|paclitaxel|mesh-list
44794550|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44794551|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44794552|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794553|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44794554|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44794555|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44692884|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44794556|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794557|NCT01980849|Nadroparin|nadroparin|mesh-list
44794558|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
44794559|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44794560|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44794561|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794562|NCT01980966|Oseltamivir|oseltamivir|mesh-list
44794563|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
44794564|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794565|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794566|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794567|NCT01980979|Treprostinil|treprostinil|mesh-list
44794568|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794569|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
44794570|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44794571|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794572|NCT01981278|Tapentadol|tapentadol|mesh-list
44794573|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44794574|NCT01981278|Narcotics|narcotics|mesh-ancestor
44794575|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794576|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794577|NCT01981278|Analgesics|analgesics|mesh-ancestor
44794578|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
44794579|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794580|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44794581|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44794582|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794583|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794584|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794585|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794586|NCT01981291|Anesthetics|anesthetics|mesh-list
44794587|NCT01981291|Mepivacaine|mepivacaine|mesh-list
44794588|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
44406338|NCT02575833|Erenumab|erenumab|mesh-list
44794589|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794590|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794591|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
44794592|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794593|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
44794594|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44794595|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
44794596|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794597|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
44794598|NCT01981330|Protective Agents|protective agents|mesh-ancestor
44794599|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
44794600|NCT01981369|Propofol|propofol|mesh-list
44794601|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44794602|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794603|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794604|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44794605|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
44794606|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
44794607|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794608|NCT01981369|Analgesics|analgesics|mesh-ancestor
44794609|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
44794610|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794611|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44794612|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44794613|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44794614|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794615|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794616|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794617|NCT01981447|Lacosamide|lacosamide|mesh-list
44794618|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
44794619|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44794620|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44794621|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794622|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794623|NCT01981460|Methylene Blue|methylene blue|mesh-list
44794624|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794625|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794626|NCT01981499|Cetirizine|cetirizine|mesh-list
44794627|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44794628|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44794629|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44794630|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
44794631|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
44794632|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794633|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794634|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794636|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44794637|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794638|NCT01981707|Choline|choline|mesh-list
44794639|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
44794640|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44794641|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
44794642|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794643|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794644|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44794645|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
44794646|NCT01981746|Ropivacaine|ropivacaine|mesh-list
44794647|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
44794648|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
44794649|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794650|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794651|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
44794652|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794653|NCT01981811|Aripiprazole|aripiprazole|mesh-list
44794654|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
44794655|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794656|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44794657|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794658|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794659|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794660|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
44794661|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
44794662|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794663|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794664|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44794665|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44794666|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
44794667|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44794668|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44794669|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44794670|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44794671|NCT01981889|Prednisone|prednisone|mesh-list
44794672|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794673|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
44794674|NCT01981889|Hormones|hormones|mesh-ancestor
44794675|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794676|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794677|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794678|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794679|NCT01981941|Gabapentin|gabapentin|mesh-list
44794680|NCT01981941|Analgesics|analgesics|mesh-ancestor
44794681|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
44794682|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794683|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794684|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
44794685|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44794686|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794687|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794688|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794689|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44794690|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44794691|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794692|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794693|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
44794694|NCT01982019|Hormones|hormones|mesh-list
44794695|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794696|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794697|NCT01982071|Micafungin|micafungin|mesh-list
44794698|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
44794699|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794700|NCT01982097|Sorafenib|sorafenib|mesh-list
44794701|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794702|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44794703|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794704|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794705|NCT01982201|Lesinurad|lesinurad|mesh-list
44574068|NCT00976027|Vaccines|vaccines|mesh-list
44794706|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
44794707|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794708|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
44794710|NCT01982396|Lamivudine|lamivudine|mesh-list
44794711|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44794712|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44794713|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794714|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794715|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
44794716|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794717|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44794718|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44794719|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44794720|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44794721|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44794722|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
44794723|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794724|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44794725|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44794726|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794727|NCT01982578|Genistein|genistein|mesh-list
44794728|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44794729|NCT01982578|Protective Agents|protective agents|mesh-ancestor
44794730|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794731|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794732|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406489|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44106943|NCT00077545|Cisplatin|cisplatin|mesh-list
44794733|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794734|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794735|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
44794736|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44794737|NCT01982578|Estrogens|estrogens|mesh-ancestor
44794738|NCT01982578|Hormones|hormones|mesh-ancestor
44794739|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794740|NCT01982734|Curcumin|curcumin|mesh-list
44794741|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44794742|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794743|NCT01982734|Analgesics|analgesics|mesh-ancestor
44794744|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
44794745|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794746|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794747|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794748|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794749|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794750|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794751|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794752|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44794753|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
44794754|NCT01982760|Coagulants|coagulants|mesh-ancestor
44794755|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44794756|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
44794757|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794758|NCT01982799|Acetaminophen|acetaminophen|mesh-list
44794759|NCT01982799|Ibuprofen|ibuprofen|mesh-list
44794760|NCT01982799|Naproxen|naproxen|mesh-list
44794761|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44794762|NCT01982799|Hydrocodone|hydrocodone|mesh-list
44794763|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44794764|NCT01982799|Analgesics|analgesics|mesh-ancestor
44794765|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
44406523|NCT02570711|Gemcitabine|gemcitabine|mesh-list
44794766|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794767|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794768|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
44794769|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44794770|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794771|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44794772|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44794773|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794774|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794775|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
44794776|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44794777|NCT01982799|Narcotics|narcotics|mesh-ancestor
44794778|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794779|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
44794780|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794781|NCT01982864|Gentamicins|gentamicins|mesh-list
44794782|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44794783|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44692885|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794784|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44794785|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794786|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794787|NCT01982929|Epinephrine|epinephrine|mesh-list
44794788|NCT01982929|Bupivacaine|bupivacaine|mesh-list
44794789|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
44794790|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
44794791|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794792|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794793|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
44794794|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794795|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44794796|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44406557|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
44794797|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794798|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794799|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794800|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44794801|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44794802|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
44794803|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794804|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
44794805|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
44794806|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
44794807|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44794808|NCT01983124|Vemurafenib|vemurafenib|mesh-list
44794809|NCT01983124|Fotemustine|fotemustine|mesh-list
44794810|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794811|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44794812|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794813|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794814|NCT01983137|Oxycodone|oxycodone|mesh-list
44794815|NCT01983137|Naloxone|naloxone|mesh-list
44794816|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44794817|NCT01983137|Narcotics|narcotics|mesh-ancestor
44794818|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794819|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794820|NCT01983137|Analgesics|analgesics|mesh-ancestor
44794821|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
44794822|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794823|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44794824|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44794825|NCT01983371|Hematinics|hematinics|mesh-ancestor
44794826|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44794827|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44794828|NCT01983384|Anesthetics|anesthetics|mesh-list
44794829|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794830|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794831|NCT01983449|Dexamethasone|dexamethasone|mesh-list
44794832|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
44794833|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44794834|NCT01983449|BB 1101|bb 1101|mesh-list
44794835|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794836|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
44794837|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
44794838|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794839|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794840|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794841|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
44794842|NCT01983449|Hormones|hormones|mesh-ancestor
44406588|NCT02569437|Fluticasone|fluticasone|mesh-list
44794843|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794844|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794845|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794846|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
44794847|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794848|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794849|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44794850|NCT01983462|Clonidine|clonidine|mesh-list
44794851|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794852|NCT01983462|Diuretics|diuretics|mesh-ancestor
44794853|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
44574276|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574277|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574278|NCT00972595|Ondansetron|ondansetron|mesh-list
44574279|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
44574280|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
44574281|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794854|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794855|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44794856|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44794857|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794858|NCT01983462|Analgesics|analgesics|mesh-ancestor
44794859|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
44794860|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794861|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
44794862|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
44794863|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44794864|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44794865|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44794866|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
44794867|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794868|NCT01983475|Denosumab|denosumab|mesh-list
44794869|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44794870|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794871|NCT01983501|Tucatinib|tucatinib|mesh-list
44794872|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794873|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794874|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44794875|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794876|NCT01983514|Oxytocin|oxytocin|mesh-list
44794877|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
44794878|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44794879|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794880|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
44794881|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44794882|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44794883|NCT01983527|Prednisolone|prednisolone|mesh-list
44794884|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
44794885|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44794886|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
44692886|NCT01370343|Vitamins|vitamins|mesh-ancestor
44692887|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
44692888|NCT01370434|Dexamethasone|dexamethasone|mesh-list
44692889|NCT01370434|Doxorubicin|doxorubicin|mesh-list
44692890|NCT01370434|Vincristine|vincristine|mesh-list
44692891|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44692892|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
44692893|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
44692894|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692895|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692896|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44692897|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
44692898|NCT01370434|Hormones|hormones|mesh-ancestor
44692899|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44692900|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44692901|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692902|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692903|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692904|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44692905|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44692906|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44692907|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44692908|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
44692909|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
44692910|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
44692911|NCT01370707|Metformin|metformin|mesh-list
44692912|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44692913|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692914|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
44692915|NCT01370772|Rituximab|rituximab|mesh-list
44692916|NCT01370772|Fludarabine|fludarabine|mesh-list
44692917|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692918|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
44692919|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692920|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476050|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44406687|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692921|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44692922|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
44692923|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692924|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692925|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44692926|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574348|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
44794887|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44794888|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
44794889|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
44794890|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44794891|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794892|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794893|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
44794894|NCT01983527|Hormones|hormones|mesh-ancestor
44794895|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44794896|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44794897|NCT01983527|Protective Agents|protective agents|mesh-ancestor
44794898|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44794899|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794900|NCT01983540|Vaccines|vaccines|mesh-list
44794901|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44794902|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
44794903|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794904|NCT01983657|Molgramostim|molgramostim|mesh-list
44794905|NCT01983657|Sargramostim|sargramostim|mesh-list
44794906|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
44794907|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794908|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794909|NCT01983722|Stiripentol|stiripentol|mesh-list
44794910|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
44794911|NCT01983735|Niacin|niacin|mesh-list
44794912|NCT01983735|Amlodipine|amlodipine|mesh-list
44794913|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44794914|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44794915|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44406720|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
44406723|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44794916|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794917|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44794918|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794919|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
44794920|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44794921|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
44794922|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44794923|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794924|NCT01983735|Vitamins|vitamins|mesh-ancestor
44794925|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
44794926|NCT01983761|Vidarabine|vidarabine|mesh-list
44794927|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
44794928|NCT01983761|Fludarabine|fludarabine|mesh-list
44794929|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
44794930|NCT01983761|Melphalan|melphalan|mesh-list
44794931|NCT01983761|Busulfan|busulfan|mesh-list
44794932|NCT01983761|Clofarabine|clofarabine|mesh-list
44794933|NCT01983761|Tacrolimus|tacrolimus|mesh-list
44794934|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44794935|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
44794936|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794937|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44794938|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
44794939|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794940|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44794941|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
44794942|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794943|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44794944|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44794945|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44794946|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44406762|NCT02565147|Heparin|heparin|mesh-list
44794947|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
44794948|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44794949|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44794950|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
44794951|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44794952|NCT01983800|Midazolam|midazolam|mesh-list
44794953|NCT01983800|Propofol|propofol|mesh-list
44794954|NCT01983800|Isoflurane|isoflurane|mesh-list
44794955|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44794956|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44794957|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794958|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44794959|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
44794960|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
44794961|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44794962|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44794963|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44794964|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44794965|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
44794966|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
44794967|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44794968|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794969|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44794970|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44794971|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44794972|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
44794973|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794974|NCT01983943|Protective Agents|protective agents|mesh-ancestor
44794975|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44794976|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44794977|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
44794978|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
44794979|NCT01984008|Citric Acid|citric acid|mesh-list
44794980|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
44794981|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
44794982|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44794983|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
44794984|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
44794985|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794986|NCT01984008|Cathartics|cathartics|mesh-ancestor
44794987|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44794988|NCT01984008|Antacids|antacids|mesh-ancestor
44794989|NCT01984073|Niacin|niacin|mesh-list
44794990|NCT01984073|Niacinamide|niacinamide|mesh-list
44794991|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
44794992|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44794993|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
44794994|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44794995|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44794996|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44794997|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
44794998|NCT01984073|Vitamins|vitamins|mesh-ancestor
44794999|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
44795000|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795001|NCT01984086|Albuterol|albuterol|mesh-list
44795002|NCT01984086|Charcoal|charcoal|mesh-list
44795003|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44795004|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
44795005|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795006|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795007|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44795008|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
44795009|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
44795010|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795011|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44795012|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44795013|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44795014|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44795015|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406825|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44795016|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795017|NCT01984086|Antidotes|antidotes|mesh-ancestor
44795018|NCT01984086|Protective Agents|protective agents|mesh-ancestor
44574454|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44574459|NCT00970502|Analgesics|analgesics|mesh-ancestor
44795019|NCT01984099|Folic Acid|folic acid|mesh-list
44795020|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
44795021|NCT01984099|Methotrexate|methotrexate|mesh-list
44795022|NCT01984099|Vitamins|vitamins|mesh-ancestor
44795023|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
44795024|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795025|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44795026|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
44795027|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795028|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44795029|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
44795030|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795031|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795032|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795033|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795034|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44795035|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795036|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
44795037|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795038|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44795039|NCT01984099|Hematinics|hematinics|mesh-ancestor
44795040|NCT01984177|Hormones|hormones|mesh-list
44795041|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44795042|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44795043|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795044|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795045|NCT01984255|Ipilimumab|ipilimumab|mesh-list
44795046|NCT01984255|Bavituximab|bavituximab|mesh-list
44795047|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795048|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795049|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44795050|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795051|NCT01984372|Insulin|insulin|mesh-list
44795052|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44795053|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795054|NCT01984463|Fentanyl|fentanyl|mesh-list
44795055|NCT01984463|Morphine|morphine|mesh-list
44795056|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44795057|NCT01984463|Narcotics|narcotics|mesh-ancestor
44795058|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795059|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795060|NCT01984463|Analgesics|analgesics|mesh-ancestor
44795061|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
44795062|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795063|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44795064|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44795065|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
44795066|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
44795067|NCT01984567|Vitamin E|vitamin e|mesh-list
44795068|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
44795069|NCT01984567|Vitamins|vitamins|mesh-ancestor
44795070|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
44795071|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795072|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
44795073|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795074|NCT01984567|Protective Agents|protective agents|mesh-ancestor
44795075|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
44795076|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44795077|NCT01984606|Empagliflozin|empagliflozin|mesh-list
44795078|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44795079|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795080|NCT01984606|Incretins|incretins|mesh-ancestor
44795081|NCT01984606|Hormones|hormones|mesh-ancestor
44795082|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795083|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44795084|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44795085|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795086|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795087|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44795088|NCT01984749|Febuxostat|febuxostat|mesh-list
44795089|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
44795090|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795091|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
44795092|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44795093|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795094|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795095|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795096|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795097|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795098|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795100|NCT01984931|Metoclopramide|metoclopramide|mesh-list
44795101|NCT01984931|Bromazepam|bromazepam|mesh-list
44795102|NCT01984931|Simethicone|simethicone|mesh-list
44795103|NCT01984931|Trimebutine|trimebutine|mesh-list
44795104|NCT01984931|Mosapride|mosapride|mesh-list
44795105|NCT01984931|Maleic acid|maleic acid|mesh-list
44795106|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795107|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795108|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
44795109|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
44795110|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795111|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795112|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795113|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44795114|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44795115|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
44795116|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795117|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
44795118|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44795119|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
44795120|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
44795121|NCT01984931|Emollients|emollients|mesh-ancestor
44795122|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795123|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44795124|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44795125|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795126|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795127|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
44795128|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
44795129|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
44795130|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795131|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44795132|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44795133|NCT01985061|Busulfan|busulfan|mesh-list
44795134|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
44795135|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795136|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795137|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
44795138|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795139|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795140|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795141|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44795142|NCT01985087|Temozolomide|temozolomide|mesh-list
44795143|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795144|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
44795145|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795146|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795147|NCT01985152|Choline|choline|mesh-list
44795148|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44795149|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44795150|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44795151|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795152|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
44795153|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44795154|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
44795155|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795156|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44795157|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
44795158|NCT01985256|Flucytosine|flucytosine|mesh-list
44795159|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
44795160|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795161|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
44795162|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795163|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
44795164|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44795165|NCT01985373|Antibodies|antibodies|mesh-list
44795166|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
44795167|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44795168|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
44795169|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795170|NCT01985451|Temozolomide|temozolomide|mesh-list
44795171|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44574617|NCT00967798|Hormones|hormones|mesh-ancestor
44795172|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
44795173|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795174|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795175|NCT01985477|Dexamethasone|dexamethasone|mesh-list
44795176|NCT01985477|Lenalidomide|lenalidomide|mesh-list
44795177|NCT01985477|Tretinoin|tretinoin|mesh-list
44795178|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795179|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
44795180|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
44795181|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795182|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406994|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
44406997|NCT02559505|Vaccines|vaccines|mesh-list
44795183|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795184|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
44795185|NCT01985477|Hormones|hormones|mesh-ancestor
44795186|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795187|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44795188|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795189|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
44795190|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44795191|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44795192|NCT01985477|Growth Substances|growth substances|mesh-ancestor
44795193|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
44795194|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
44795195|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795196|NCT01985594|Nifedipine|nifedipine|mesh-list
44795197|NCT01985594|Progesterone|progesterone|mesh-list
44795198|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44795199|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795200|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795201|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795202|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795203|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44795204|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
44795205|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795206|NCT01985594|Progestins|progestins|mesh-ancestor
44795207|NCT01985594|Hormones|hormones|mesh-ancestor
44795208|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795209|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
44795210|NCT01985724|Docetaxel|docetaxel|mesh-list
44795211|NCT01985724|Epirubicin|epirubicin|mesh-list
44795212|NCT01985724|Fluorouracil|fluorouracil|mesh-list
44795213|NCT01985724|Lenograstim|lenograstim|mesh-list
44795214|NCT01985724|Mitogens|mitogens|mesh-list
44795215|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795216|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
44795217|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795218|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795219|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795220|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
44795221|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795222|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795223|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44795224|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44795225|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44795226|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44795227|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44795228|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795229|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795230|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795231|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
44795232|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44795233|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44574688|NCT00967226|Prednisolone|prednisolone|mesh-list
44795234|NCT01985750|Cycloserine|cycloserine|mesh-list
44795235|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44795236|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795237|NCT01985750|Renal Agents|renal agents|mesh-ancestor
44795238|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44795239|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
44795240|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44795241|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
44795242|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795243|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
44795244|NCT01985789|Promethazine|promethazine|mesh-list
44795245|NCT01985789|Cetirizine|cetirizine|mesh-list
44795246|NCT01985789|Desloratadine|desloratadine|mesh-list
44795247|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44795248|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795249|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795250|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795251|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795252|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
44795253|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
44795254|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795255|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
44795256|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
44795257|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574754|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44795258|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44795259|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
44795260|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
44795261|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795262|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795263|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44795264|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
44795265|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795266|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44795267|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44795268|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44795269|NCT01985828|Androgens|androgens|mesh-list
44795270|NCT01985828|Hormones|hormones|mesh-ancestor
44795271|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407093|NCT02556918|Insulin|insulin|mesh-list
44795272|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795273|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
44795274|NCT01985841|Docetaxel|docetaxel|mesh-list
44795275|NCT01985841|Fluorouracil|fluorouracil|mesh-list
44795276|NCT01985841|Epirubicin|epirubicin|mesh-list
44795277|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795278|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
44795279|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795280|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795281|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795282|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
44574755|NCT00966654|Incretins|incretins|mesh-ancestor
44574756|NCT00966654|Hormones|hormones|mesh-ancestor
44574757|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574758|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574759|NCT00966355|Octreotide|octreotide|mesh-list
44574760|NCT00966355|Terlipressin|terlipressin|mesh-list
44574761|NCT00966355|Somatostatin|somatostatin|mesh-list
44574762|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574763|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44574764|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574765|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44574766|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44574767|NCT00966355|Hormones|hormones|mesh-ancestor
44574768|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574769|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574770|NCT00966277|Dalteparin|dalteparin|mesh-list
44574771|NCT00966277|Tinzaparin|tinzaparin|mesh-list
44574772|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44574773|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
44574774|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44574775|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44574776|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574777|NCT00965848|Doripenem|doripenem|mesh-list
44574778|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44795283|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795284|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795285|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44795286|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
44795287|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
44795288|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
44795289|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
44795290|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44795291|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44795292|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795293|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795294|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795295|NCT01985854|Propofol|propofol|mesh-list
44795296|NCT01985854|Desflurane|desflurane|mesh-list
44795297|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795298|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795299|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795300|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44795301|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
44795302|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
44795303|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44795304|NCT01985893|Trastuzumab|trastuzumab|mesh-list
44795305|NCT01985893|Lapatinib|lapatinib|mesh-list
44795306|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795307|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795308|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44795309|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795310|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795311|NCT01986036|Calcium|calcium|mesh-list
44795312|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795313|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795314|NCT01986049|Bupivacaine|bupivacaine|mesh-list
44795315|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795316|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
44795317|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795318|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795319|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
44795320|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795321|NCT01986088|Sumatriptan|sumatriptan|mesh-list
44795322|NCT01986088|Eletriptan|eletriptan|mesh-list
44795323|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44795324|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44795325|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44795326|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
44795327|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795328|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795329|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795330|NCT01986127|Adalimumab|adalimumab|mesh-list
44795331|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795332|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795333|NCT01986192|Warfarin|warfarin|mesh-list
44795334|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
44795335|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
44795336|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44795337|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
44795338|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44795339|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
44795340|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795341|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795342|NCT01986270|Sumatriptan|sumatriptan|mesh-list
44795343|NCT01986270|Eletriptan|eletriptan|mesh-list
44795344|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44795345|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44795346|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44795347|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
44795348|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795349|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795350|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795351|NCT01986283|Oxycodone|oxycodone|mesh-list
44795352|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44795353|NCT01986283|Narcotics|narcotics|mesh-ancestor
44795354|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795355|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795356|NCT01986283|Analgesics|analgesics|mesh-ancestor
44795357|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
44795358|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795359|NCT01986309|Lidocaine|lidocaine|mesh-list
44795360|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795361|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
44795362|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795363|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795364|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
44795365|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795366|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795367|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44795368|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44795369|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795370|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795372|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
44795373|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795374|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
44795375|NCT01986426|Ipilimumab|ipilimumab|mesh-list
44795376|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795377|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795378|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44795379|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795380|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44795381|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
44795382|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44795383|NCT01986465|Prednisolone|prednisolone|mesh-list
44795384|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
44795385|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44795386|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
44795387|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795388|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
44795389|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
44795390|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795391|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795392|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795393|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
44795394|NCT01986465|Hormones|hormones|mesh-ancestor
44795395|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795396|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44795397|NCT01986465|Protective Agents|protective agents|mesh-ancestor
44795398|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44795399|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795400|NCT01986556|Lesinurad|lesinurad|mesh-list
44795401|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
44795402|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795403|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
44795404|NCT01986556|Renal Agents|renal agents|mesh-ancestor
44795405|NCT01986582|Phenylephrine|phenylephrine|mesh-list
44795406|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
44795407|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44795408|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44795409|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
44795410|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795411|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795412|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795413|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
44795414|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
44795415|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795416|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
44795417|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44795418|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
44795419|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44795420|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
44795421|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44795422|NCT01986582|Protective Agents|protective agents|mesh-ancestor
44795423|NCT01986608|Lacosamide|lacosamide|mesh-list
44795424|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
44795425|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44407263|NCT02554318|Rifampin|rifampin|mesh-list
44795426|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44795427|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795428|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795429|NCT01986660|Ibuprofen|ibuprofen|mesh-list
44795430|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44795431|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44795432|NCT01986660|Analgesics|analgesics|mesh-ancestor
44795433|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
44795434|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795435|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795436|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795437|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795438|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44795439|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795440|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795441|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
44795442|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
44795443|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44795444|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44795445|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795446|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795447|NCT01986673|Urological Agents|urological agents|mesh-ancestor
44795448|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44795449|NCT01986764|Estradiol|estradiol|mesh-list
44795450|NCT01986764|Estrogens|estrogens|mesh-list
44795451|NCT01986764|Hormones|hormones|mesh-ancestor
44795452|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795453|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795454|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44795455|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44795456|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44795457|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795458|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795459|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
44795460|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795461|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44795462|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44795463|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795464|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44795465|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44795466|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795467|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795468|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
44795469|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795470|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
44795471|NCT01986894|Thalidomide|thalidomide|mesh-list
44795472|NCT01986894|Pomalidomide|pomalidomide|mesh-list
44795473|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44795474|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795475|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795476|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795477|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795478|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795479|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795480|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795481|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
44795482|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44795483|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44795484|NCT01986894|Growth Substances|growth substances|mesh-ancestor
44795485|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44795486|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795487|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
44795488|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
44795489|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44795490|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44795491|NCT01986998|Prednisolone|prednisolone|mesh-list
44795492|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
44795493|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44795494|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
44795495|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795496|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
44795497|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
44795498|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795499|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795500|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795501|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
44795502|NCT01986998|Hormones|hormones|mesh-ancestor
44795503|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795504|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44795505|NCT01986998|Protective Agents|protective agents|mesh-ancestor
44795506|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44795507|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795508|NCT01987076|Prednisone|prednisone|mesh-list
44795509|NCT01987076|Clobetasol|clobetasol|mesh-list
44795510|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795511|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
44795512|NCT01987076|Hormones|hormones|mesh-ancestor
44795513|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795514|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795515|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44795516|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795517|NCT01987128|Ropivacaine|ropivacaine|mesh-list
44795518|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795519|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
44795520|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795521|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795522|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
44795523|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795524|NCT01987154|Caseins|caseins|mesh-list
44795525|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
44795526|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
44795527|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795528|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44795529|NCT01987167|Hormones|hormones|mesh-ancestor
44795530|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795531|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795532|NCT01987297|Cytarabine|cytarabine|mesh-list
44795533|NCT01987297|Daunorubicin|daunorubicin|mesh-list
44795534|NCT01987297|Idarubicin|idarubicin|mesh-list
44795535|NCT01987297|Tretinoin|tretinoin|mesh-list
44795536|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
44795537|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44795538|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
44795539|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795540|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795541|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
44795542|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795543|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795544|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
44795545|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795546|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44795547|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795548|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795549|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795550|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
44795551|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795552|NCT01987310|Atorvastatin|atorvastatin|mesh-list
44795553|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44795554|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44795555|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
44795556|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795557|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44795558|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44795559|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795560|NCT01987323|Latanoprost|latanoprost|mesh-list
44795561|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44795562|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44795563|NCT01987375|Cetuximab|cetuximab|mesh-list
44795564|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795565|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795566|NCT01987570|Allopurinol|allopurinol|mesh-list
44795567|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
44795568|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795569|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795570|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
44795571|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795572|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44795573|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
44795574|NCT01987570|Protective Agents|protective agents|mesh-ancestor
44795575|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692927|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44692928|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
44575031|NCT00963599|Loratadine|loratadine|mesh-list
44795577|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44795578|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795579|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795580|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795581|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44795582|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
44795583|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
44795584|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795585|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795586|NCT01987804|Oxytocin|oxytocin|mesh-list
44795587|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
44795588|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795589|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795590|NCT01988077|Ipilimumab|ipilimumab|mesh-list
44795591|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795592|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795593|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44795594|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795595|NCT01988116|Calcitriol|calcitriol|mesh-list
44795596|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795597|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795598|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44795599|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795600|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795601|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44795602|NCT01988116|Vitamins|vitamins|mesh-ancestor
44795603|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
44795604|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44795605|NCT01988298|Acetaminophen|acetaminophen|mesh-list
44795606|NCT01988298|Ibuprofen|ibuprofen|mesh-list
44795607|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44795608|NCT01988298|Analgesics|analgesics|mesh-ancestor
44795609|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
44795610|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795611|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795612|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
44795613|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44795614|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795615|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795616|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44795617|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795618|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795619|NCT01988311|Psilocybin|psilocybin|mesh-list
44795620|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
44795621|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795622|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795623|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
44795624|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44795625|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795626|NCT01988506|Interleukin-2|interleukin-2|mesh-list
44795627|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795628|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44795629|NCT01988506|Analgesics|analgesics|mesh-ancestor
44795630|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
44795631|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795632|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795633|NCT01988545|Exenatide|exenatide|mesh-list
44795634|NCT01988545|Glucagon|glucagon|mesh-list
44795635|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44795636|NCT01988545|Incretins|incretins|mesh-ancestor
44795637|NCT01988545|Hormones|hormones|mesh-ancestor
44795638|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795639|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795640|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795641|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44795642|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44795643|NCT01988610|Mifepristone|mifepristone|mesh-list
44795644|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44795645|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
44795646|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795647|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795648|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44795649|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44795650|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44795651|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
44795652|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44795653|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44795654|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
44795655|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795656|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
44795657|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44795658|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44795659|NCT01988649|Oxytocin|oxytocin|mesh-list
44795660|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
44795661|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44795662|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795663|NCT01988831|Propranolol|propranolol|mesh-list
44795664|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44795665|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44795666|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
44795667|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795668|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795669|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795670|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795671|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44795672|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
44795673|NCT01988896|Atezolizumab|atezolizumab|mesh-list
44795674|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795675|NCT01988961|Golimumab|golimumab|mesh-list
44795676|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44795677|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795678|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795679|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
44795680|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795681|NCT01989000|Gemcitabine|gemcitabine|mesh-list
44795682|NCT01989000|Imidazole|imidazole|mesh-list
44795683|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44795684|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
44795685|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795686|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795687|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
44795688|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795689|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795690|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795691|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
44795692|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795693|NCT01989052|Lomustine|lomustine|mesh-list
44795694|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44795695|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795696|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
44795697|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795698|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795699|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44795700|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795701|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795702|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795703|NCT01989078|Losartan|losartan|mesh-list
44795704|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795705|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44795706|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44795707|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44795708|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795709|NCT01989091|Heparin|heparin|mesh-list
44795710|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
44795711|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44795712|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44795713|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795714|NCT01989312|Lidocaine|lidocaine|mesh-list
44795715|NCT01989312|Epinephrine|epinephrine|mesh-list
44795716|NCT01989312|Midazolam|midazolam|mesh-list
44795717|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
44795718|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795719|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
44795720|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795721|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795722|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
44575173|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
44795723|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795724|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795725|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44795726|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44795727|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795728|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795729|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44795730|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795731|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44795732|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44795733|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795734|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44795735|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
44795736|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
44795737|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
44795738|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795739|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44795740|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44795741|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407579|NCT02548078|Vaccines|vaccines|mesh-list
44795742|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44795743|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44795744|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
44795745|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44795746|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44795747|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
44795748|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
44795749|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44795750|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
44795751|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44795752|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44795753|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795754|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
44795755|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575246|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44575247|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44575248|NCT00960934|Antacids|antacids|mesh-ancestor
44575249|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575250|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575251|NCT00960869|Aspirin|aspirin|mesh-list
44575252|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44575253|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44575254|NCT00960869|Analgesics|analgesics|mesh-ancestor
44575255|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
44575256|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575257|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575258|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575259|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575260|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44575261|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44575262|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575263|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44575264|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44575265|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575266|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
44575267|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
44575268|NCT00960856|Fenofibrate|fenofibrate|mesh-list
44575269|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575270|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575271|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
44575273|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44795756|NCT01989507|Nicotine|nicotine|mesh-list
44795757|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44795758|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
44407626|NCT02547038|Bismuth|bismuth|mesh-list
44795759|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795760|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795761|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44795762|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44795763|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44795764|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795765|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795766|NCT01989559|Vaccines|vaccines|mesh-list
44795767|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
44795768|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795769|NCT01989611|Tenofovir|tenofovir|mesh-list
44795770|NCT01989611|Emtricitabine|emtricitabine|mesh-list
44795771|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
44795772|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795773|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44795774|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44795775|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795776|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795777|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44795778|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44795779|NCT01989663|Tenofovir|tenofovir|mesh-list
44795780|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
44795781|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795782|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44795783|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44795784|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795785|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795786|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44795787|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44795788|NCT01989676|Paclitaxel|paclitaxel|mesh-list
44795789|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44795790|NCT01989676|Trastuzumab|trastuzumab|mesh-list
44795791|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44795792|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795793|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44795794|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44795795|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44795796|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795797|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795798|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
44795799|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44795800|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
44795801|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44795802|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44795803|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795804|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795805|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
44795806|NCT01989884|IDN 5109|idn 5109|mesh-list
44795807|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795809|NCT01989897|Histamine|histamine|mesh-list
44795810|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
44795811|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
44795812|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795813|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795814|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795815|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44795816|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795817|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
44795818|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44795819|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44795820|NCT01989923|Nicotine|nicotine|mesh-list
44795821|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44795822|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
44795823|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795824|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795825|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44795826|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44795827|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
44795828|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795829|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795830|NCT01989936|Eletriptan|eletriptan|mesh-list
44795831|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44795832|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
44795833|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795834|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795835|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795836|NCT01990079|Bupropion|bupropion|mesh-list
44795837|NCT01990079|Nicotine|nicotine|mesh-list
44795838|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44795839|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
44795840|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795841|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795842|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44795843|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44795844|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
44795845|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795846|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795847|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44795848|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
44795849|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795850|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44795851|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44795852|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795853|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
44407716|NCT02545504|Vitamins|vitamins|mesh-ancestor
44795854|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44795855|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44795856|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795857|NCT01990118|Cyclosporine|cyclosporine|mesh-list
44795858|NCT01990118|Cyclosporins|cyclosporins|mesh-list
44795859|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795860|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795861|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44795862|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
44795863|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795864|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
44795865|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44795866|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44795867|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795868|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44795869|NCT01990144|Rituximab|rituximab|mesh-list
44795870|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44795871|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44795872|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795873|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
44795874|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795875|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44795876|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44795877|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
44795878|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795879|NCT01990378|Rabeprazole|rabeprazole|mesh-list
44795880|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44795881|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795882|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44407753|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
44795883|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795884|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795885|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
44795886|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44795887|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
44795888|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
44795889|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795890|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795891|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44795892|NCT01990404|Analgesics|analgesics|mesh-ancestor
44795893|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
44795894|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795895|NCT01990443|Reslizumab|reslizumab|mesh-list
44795896|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44795897|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44795898|NCT01990586|Rabeprazole|rabeprazole|mesh-list
44795899|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44795900|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795901|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44795902|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795903|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795904|NCT01990690|Antioxidants|antioxidants|mesh-list
44795905|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795906|NCT01990690|Protective Agents|protective agents|mesh-ancestor
44795907|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795908|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
44795910|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
44795911|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
44795912|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795913|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795914|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795915|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44795916|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44795917|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795918|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795919|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44795920|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44795921|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795922|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795923|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795924|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
44795925|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
44795926|NCT01990781|Dexamethasone|dexamethasone|mesh-list
44795927|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
44795928|NCT01990781|Lidocaine|lidocaine|mesh-list
44795929|NCT01990781|BB 1101|bb 1101|mesh-list
44795930|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44795931|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
44795932|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
44795933|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44795934|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795935|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44795936|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
44795937|NCT01990781|Hormones|hormones|mesh-ancestor
44795938|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44795939|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44795940|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795941|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
44795942|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795943|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795944|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
44795945|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
44795946|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795947|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
44795948|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795949|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44795950|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44795951|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795952|NCT01990807|Idarubicin|idarubicin|mesh-list
44795953|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44795954|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44795955|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44795956|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44795957|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44795958|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795959|NCT01990872|Vitamin D|vitamin d|mesh-list
44795960|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
44795961|NCT01990872|Vitamins|vitamins|mesh-ancestor
44795962|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
44795963|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795964|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44795965|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795966|NCT01990937|Midazolam|midazolam|mesh-list
44795967|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44795968|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44795969|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44795970|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795971|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44795972|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44795973|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44795974|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44795975|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
44795976|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
44795977|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
44795978|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
44795979|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44795980|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795981|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44795982|NCT01991054|Vitamin D|vitamin d|mesh-list
44795983|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
44795984|NCT01991054|Vitamins|vitamins|mesh-ancestor
44795985|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
44795986|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44795987|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44795988|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44795989|NCT01991119|Dronedarone|dronedarone|mesh-list
44795990|NCT01991119|Propafenone|propafenone|mesh-list
44795991|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44795992|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44795993|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44795994|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44795995|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44795996|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
44795997|NCT01991145|Hematinics|hematinics|mesh-ancestor
44795998|NCT01991158|Gemcitabine|gemcitabine|mesh-list
44795999|NCT01991158|Dexamethasone|dexamethasone|mesh-list
44796000|NCT01991158|Methotrexate|methotrexate|mesh-list
44796001|NCT01991158|Pegaspargase|pegaspargase|mesh-list
44796002|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796003|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
44796004|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
44796005|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796006|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796007|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796008|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
44796009|NCT01991158|Hormones|hormones|mesh-ancestor
44796010|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796011|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796012|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796013|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796014|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
44796015|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796016|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
44796017|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796018|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796019|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796020|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
44796021|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44796022|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
44796023|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44796024|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
44796025|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44796026|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796027|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44796028|NCT01991275|Morphine|morphine|mesh-list
44796029|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44796030|NCT01991275|Narcotics|narcotics|mesh-ancestor
44796031|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796032|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796033|NCT01991275|Analgesics|analgesics|mesh-ancestor
44796034|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
44796035|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796036|NCT01991288|Epinephrine|epinephrine|mesh-list
44796037|NCT01991288|Racepinephrine|racepinephrine|mesh-list
44796038|NCT01991288|Bupivacaine|bupivacaine|mesh-list
44796039|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
44796040|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
44796041|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
44796042|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
44796043|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796044|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796045|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
44796046|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796047|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44796048|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44796049|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44796050|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796051|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796052|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44796053|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44796054|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
44796055|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44796056|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44796057|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
44796058|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
44796059|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44796060|NCT01991327|Enclomiphene|enclomiphene|mesh-list
44796061|NCT01991327|Clomiphene|clomiphene|mesh-list
44796062|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
44796063|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44796064|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44796065|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796066|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796067|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44796068|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
44796069|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44796070|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44796071|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44575596|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
44796072|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44796073|NCT01991561|Vaccines|vaccines|mesh-list
44796074|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
44796075|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796076|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44796077|NCT01991561|Antacids|antacids|mesh-ancestor
44796078|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796079|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796080|NCT01991574|Calcium|calcium|mesh-list
44796081|NCT01991574|Calcium acetate|calcium acetate|mesh-list
44796082|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796083|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796084|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
44796085|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
44796086|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796087|NCT01991587|Vaccines|vaccines|mesh-list
44796088|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
44796089|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796091|NCT01991626|Trace Elements|trace elements|mesh-list
44796092|NCT01991626|Micronutrients|micronutrients|mesh-list
44796093|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796094|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
44796095|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796096|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44796097|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44796098|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796099|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796100|NCT01991834|Cefazolin|cefazolin|mesh-list
44796101|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44796102|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796103|NCT01991873|Leucovorin|leucovorin|mesh-list
44796104|NCT01991873|Folic Acid|folic acid|mesh-list
44796105|NCT01991873|Fluorouracil|fluorouracil|mesh-list
44796106|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
44796107|NCT01991873|Panitumumab|panitumumab|mesh-list
44796108|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
44796109|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
44796110|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407972|NCT02534935|Vaccines|vaccines|mesh-list
44796111|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796112|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796113|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796114|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
44796115|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796116|NCT01991873|Antidotes|antidotes|mesh-ancestor
44796117|NCT01991873|Protective Agents|protective agents|mesh-ancestor
44796118|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
44796119|NCT01991873|Vitamins|vitamins|mesh-ancestor
44796120|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
44796121|NCT01991873|Hematinics|hematinics|mesh-ancestor
44796122|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44796123|NCT01991951|Warfarin|warfarin|mesh-list
44796124|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
44796125|NCT01992133|Vitamin D|vitamin d|mesh-list
44796126|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
44796127|NCT01992133|Vitamins|vitamins|mesh-ancestor
44575671|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44575672|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575673|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44575674|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44575675|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
44575676|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44575677|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44575678|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
44575679|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575680|NCT00955721|Gemcitabine|gemcitabine|mesh-list
44575681|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
44575682|NCT00955721|Sorafenib|sorafenib|mesh-list
44575683|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44575684|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
44575685|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575686|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575687|NCT00955721|Antiviral Agents|antiviral agents|mesh-ancestor
44575688|NCT00955721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575689|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575690|NCT00955721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575691|NCT00955721|Immunologic Factors|immunologic factors|mesh-ancestor
44575692|NCT00955721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796129|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796130|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796131|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796132|NCT01992146|Naloxone|naloxone|mesh-list
44796133|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44796134|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796135|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
44796136|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796137|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
44796138|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44796139|NCT01992198|Metronidazole|metronidazole|mesh-list
44796140|NCT01992198|Meropenem|meropenem|mesh-list
44796141|NCT01992198|Cefoperazone|cefoperazone|mesh-list
44796142|NCT01992198|Sulperazone|sulperazone|mesh-list
44796143|NCT01992198|Somatostatin|somatostatin|mesh-list
44796144|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44796145|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796146|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
44796147|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
44796148|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44796149|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44796150|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44796151|NCT01992198|Hormones|hormones|mesh-ancestor
44796152|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796153|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796154|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44796155|NCT01992198|Renal Agents|renal agents|mesh-ancestor
44796156|NCT01992211|Metformin|metformin|mesh-list
44796157|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44796158|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44796159|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796160|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44796161|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44796162|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
44796163|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796164|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44796165|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44796166|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796167|NCT01992263|Vitamin D|vitamin d|mesh-list
44796168|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
44796169|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
44796170|NCT01992263|Vitamins|vitamins|mesh-list
44692929|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44692930|NCT01370889|Resveratrol|resveratrol|mesh-list
44692931|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
44692932|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692933|NCT01370889|Protective Agents|protective agents|mesh-ancestor
44692934|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692935|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692936|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692937|NCT01370915|Vitamins|vitamins|mesh-list
44692938|NCT01370915|Pregabalin|pregabalin|mesh-list
44692939|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
44692940|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692941|NCT01370915|Analgesics|analgesics|mesh-ancestor
44692942|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
44692943|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44692944|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
44692945|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44692946|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692947|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692948|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44692949|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44692950|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44692951|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44692952|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692953|NCT01371058|Clopidogrel|clopidogrel|mesh-list
44692954|NCT01371058|Policosanol|policosanol|mesh-list
44692955|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44692956|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44692957|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44692958|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44692959|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
44796171|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
44796172|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796173|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796174|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796175|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
44796176|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44796177|NCT01992328|Antibodies|antibodies|mesh-list
44796178|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
44796179|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
44796180|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44796181|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
44796182|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796183|NCT01992341|Paclitaxel|paclitaxel|mesh-list
44796184|NCT01992341|Trebananib|trebananib|mesh-list
44796185|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44796186|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796187|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44796188|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44796189|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44796190|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796191|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44796192|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44796193|NCT01992341|Growth Substances|growth substances|mesh-ancestor
44796194|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796195|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
44796196|NCT01992562|Ziconotide|ziconotide|mesh-list
44796197|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44796198|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796199|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796200|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796201|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796202|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796203|NCT01992562|Protective Agents|protective agents|mesh-ancestor
44796204|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796205|NCT01992562|Analgesics|analgesics|mesh-ancestor
44796206|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
44796207|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796208|NCT01992588|Insulin|insulin|mesh-list
44796209|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44796210|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
44796211|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
44796212|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44796213|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44796214|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796215|NCT01992601|Telmisartan|telmisartan|mesh-list
44796216|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44796217|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44796218|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44796219|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
44796220|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408129|NCT02528214|Prednisolone|prednisolone|mesh-list
44796221|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44796222|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44796223|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796224|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44796225|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44796226|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44796227|NCT01992653|Prednisone|prednisone|mesh-list
44796228|NCT01992653|Prednisolone|prednisolone|mesh-list
44796229|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
44796230|NCT01992653|Rituximab|rituximab|mesh-list
44796231|NCT01992653|Doxorubicin|doxorubicin|mesh-list
44796232|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
44796233|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796234|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
44796235|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796236|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796237|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44796238|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
44796239|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796240|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796241|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44796242|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44796243|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44796244|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44796245|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44796246|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796247|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796248|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
44796249|NCT01992653|Hormones|hormones|mesh-ancestor
44796250|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796251|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796252|NCT01992705|Fluorouracil|fluorouracil|mesh-list
44796253|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
44408164|NCT02527200|Liraglutide|liraglutide|mesh-list
44796254|NCT01992705|Irinotecan|irinotecan|mesh-list
44796255|NCT01992705|Folfirinox|folfirinox|mesh-list
44796256|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
44796257|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796258|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796259|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796260|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796261|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
44796262|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796263|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44796264|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44796265|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796266|NCT01992796|Telmisartan|telmisartan|mesh-list
44796267|NCT01992796|Candesartan|candesartan|mesh-list
44796268|NCT01992796|Olmesartan|olmesartan|mesh-list
44796269|NCT01992796|Irbesartan|irbesartan|mesh-list
44796270|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44796271|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44796272|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44796273|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796274|NCT01992900|Piperaquine|piperaquine|mesh-list
44796275|NCT01992900|Artenimol|artenimol|mesh-list
44796276|NCT01992900|Artemisinins|artemisinins|mesh-list
44796277|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
44796278|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44796279|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44796280|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796281|NCT01993134|Cefazolin|cefazolin|mesh-list
44796282|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44796283|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575821|NCT00954512|Antidotes|antidotes|mesh-ancestor
44796284|NCT01993173|Vaccines|vaccines|mesh-list
44796285|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
44796286|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796287|NCT01993212|Enclomiphene|enclomiphene|mesh-list
44796288|NCT01993212|Testosterone|testosterone|mesh-list
44796289|NCT01993212|Androgens|androgens|mesh-ancestor
44796290|NCT01993212|Hormones|hormones|mesh-ancestor
44796291|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796292|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796293|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44796294|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
44796295|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44796296|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
44796297|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44796298|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44796299|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44796300|NCT01993225|Enclomiphene|enclomiphene|mesh-list
44796301|NCT01993225|Testosterone|testosterone|mesh-list
44796302|NCT01993225|Androgens|androgens|mesh-ancestor
44796303|NCT01993225|Hormones|hormones|mesh-ancestor
44796304|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796305|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796306|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44796307|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44796308|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44796309|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
44796310|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44796311|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44796312|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44796313|NCT01993251|Melatonin|melatonin|mesh-list
44796314|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
44796315|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796316|NCT01993251|Protective Agents|protective agents|mesh-ancestor
44796317|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796318|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796319|NCT01993290|Ropivacaine|ropivacaine|mesh-list
44796320|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
44796321|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
44796322|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796323|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796324|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
44796325|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796326|NCT01993459|Midazolam|midazolam|mesh-list
44796327|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44796328|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44796329|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44796330|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796331|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796332|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44796333|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44796334|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796335|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44796336|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
44796337|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
44796338|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
44796339|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
44796340|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796341|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796342|NCT01993472|Andrographolide|andrographolide|mesh-list
44796343|NCT01993472|Capecitabine|capecitabine|mesh-list
44796344|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796345|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
44796346|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796347|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796348|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796349|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44796350|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796351|NCT01993472|Analgesics|analgesics|mesh-ancestor
44796352|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
44796353|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796354|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796355|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796356|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44796357|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44796358|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575891|NCT00953680|Diuretics|diuretics|mesh-ancestor
44796359|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
44796360|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44796361|NCT01993537|Vitamin D|vitamin d|mesh-list
44796362|NCT01993537|Vitamins|vitamins|mesh-ancestor
44796363|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
44796364|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796365|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796366|NCT01993589|Acetaminophen|acetaminophen|mesh-list
44796367|NCT01993589|Analgesics|analgesics|mesh-list
44796368|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796369|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
44796370|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796371|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796372|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
44796373|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
44796374|NCT01993680|Bromides|bromides|mesh-list
44796375|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44796376|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
44796377|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44796378|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796379|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796380|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
44796381|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796382|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796383|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796384|NCT01993771|Anesthetics|anesthetics|mesh-list
44796385|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796386|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796387|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
44796388|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44796389|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796390|NCT01993979|Gemcitabine|gemcitabine|mesh-list
44796391|NCT01993979|Cisplatin|cisplatin|mesh-list
44796392|NCT01993979|Carboplatin|carboplatin|mesh-list
44796393|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796394|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796395|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
44796396|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796397|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
44796398|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796399|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796400|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796401|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
44796402|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796403|NCT01994031|Paclitaxel|paclitaxel|mesh-list
44796404|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44796405|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44796406|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796407|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44796408|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44796409|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44796410|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796411|NCT01994070|Procainamide|procainamide|mesh-list
44796412|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44796413|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44796414|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44796415|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796416|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796417|NCT01994096|Caspofungin|caspofungin|mesh-list
44796418|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
44796419|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796420|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796421|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796422|NCT01994265|Warfarin|warfarin|mesh-list
44796423|NCT01994265|Dabigatran|dabigatran|mesh-list
44796424|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
44796425|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
44796426|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44796427|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
44796428|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796429|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796430|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44796431|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
44796432|NCT01994330|Coagulants|coagulants|mesh-ancestor
44796433|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44575964|NCT00953017|Bisacodyl|bisacodyl|mesh-list
44796434|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
44796435|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796436|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
44408380|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796437|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44796438|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796440|NCT01994460|Ethambutol|ethambutol|mesh-list
44796441|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44796442|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796443|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44796444|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796445|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796446|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
44796447|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
44796448|NCT01994642|Dexamethasone|dexamethasone|mesh-list
44796449|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
44796450|NCT01994642|BB 1101|bb 1101|mesh-list
44796451|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796452|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
44796453|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
44796454|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796455|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796456|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796457|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
44796458|NCT01994642|Hormones|hormones|mesh-ancestor
44796459|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796460|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796461|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796462|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
44796463|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796464|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796465|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44796466|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796467|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44796468|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44796469|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44796470|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44796471|NCT01994668|Lorazepam|lorazepam|mesh-list
44796472|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
44796473|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
44796474|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
44796475|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796476|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576037|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
44576038|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576039|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576040|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44576041|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576042|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44576043|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
44576044|NCT00952276|Vaccines|vaccines|mesh-list
44576045|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
44576046|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576047|NCT00952068|Tramadol|tramadol|mesh-list
44576048|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44576049|NCT00952068|Narcotics|narcotics|mesh-ancestor
44576050|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576051|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576052|NCT00952068|Analgesics|analgesics|mesh-ancestor
44576053|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
44576054|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576055|NCT00951912|Genistein|genistein|mesh-list
44576056|NCT00951912|Daidzein|daidzein|mesh-list
44576057|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44576058|NCT00951912|Protective Agents|protective agents|mesh-ancestor
44576059|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576060|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576061|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576062|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576063|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576064|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
44576065|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44576066|NCT00951912|Estrogens|estrogens|mesh-ancestor
44576067|NCT00951912|Hormones|hormones|mesh-ancestor
44576068|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796477|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796478|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44796479|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796480|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44796481|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44796482|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796483|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
44796484|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
44796485|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796486|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796487|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
44796488|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
44796489|NCT01994733|Calcium|calcium|mesh-list
44796490|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796491|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796492|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796493|NCT01994733|Antacids|antacids|mesh-ancestor
44796494|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796495|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796496|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
44796497|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44796498|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796499|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
44796500|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
44796501|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796502|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796503|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796504|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
44796505|NCT01994759|Hormones|hormones|mesh-ancestor
44796506|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796507|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796508|NCT01994759|Protective Agents|protective agents|mesh-ancestor
44796509|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
44796510|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44796511|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
44796512|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796513|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796514|NCT01994941|Clopidogrel|clopidogrel|mesh-list
44796515|NCT01994941|Ticagrelor|ticagrelor|mesh-list
44796516|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44796517|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44796518|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44796519|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44796520|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
44796521|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796522|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796523|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796524|NCT01994967|Bupivacaine|bupivacaine|mesh-list
44796525|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
44796526|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
44796527|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
44796528|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796529|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796530|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
44796531|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796532|NCT01995006|Dipyrone|dipyrone|mesh-list
44796533|NCT01995006|Naproxen|naproxen|mesh-list
44796534|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44796535|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796536|NCT01995006|Analgesics|analgesics|mesh-ancestor
44796537|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
44796538|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796539|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796540|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796541|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796542|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
44796543|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44796544|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796545|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796546|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
44796547|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
44796548|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44796549|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44796550|NCT01995019|Prednisolone|prednisolone|mesh-list
44796551|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
44796552|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44796553|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
44796554|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796555|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
44796556|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
44796557|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796558|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796559|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796560|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
44796561|NCT01995019|Hormones|hormones|mesh-ancestor
44796562|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408525|NCT02516592|Fluticasone|fluticasone|mesh-list
44796563|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796564|NCT01995019|Protective Agents|protective agents|mesh-ancestor
44796565|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796566|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796567|NCT01995032|Metformin|metformin|mesh-list
44796568|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44796569|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796570|NCT01995058|Prednisone|prednisone|mesh-list
44796571|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
44796572|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796573|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
44796574|NCT01995058|Hormones|hormones|mesh-ancestor
44796575|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796576|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796577|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796578|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796579|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44796580|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796581|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796582|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
44796583|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44796584|NCT01995084|Imidazole|imidazole|mesh-list
44796585|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796586|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796587|NCT01995188|Bevacizumab|bevacizumab|mesh-list
44796588|NCT01995188|Carboplatin|carboplatin|mesh-list
44796589|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44796590|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796591|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44796592|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44796593|NCT01995188|Growth Substances|growth substances|mesh-ancestor
44796594|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796595|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44796596|NCT01995214|Propofol|propofol|mesh-list
44796597|NCT01995214|Sevoflurane|sevoflurane|mesh-list
44796598|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44796599|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796600|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796601|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44796602|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
44796603|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
44796604|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44796605|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44796606|NCT01995292|Anesthetics|anesthetics|mesh-list
44796607|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
44796608|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796609|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796610|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
44796611|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796612|NCT01995331|Cyclosporine|cyclosporine|mesh-list
44796613|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
44796614|NCT01995331|Cyclosporins|cyclosporins|mesh-list
44796615|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796616|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
44796617|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796618|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796619|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44796620|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
44796621|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796622|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796623|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44796624|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796625|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
44796626|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796627|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
44796628|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44796630|NCT01995344|Fludarabine|fludarabine|mesh-list
44796631|NCT01995344|Interleukin-2|interleukin-2|mesh-list
44796632|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796633|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
44796634|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796635|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796636|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44796637|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
44476051|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796638|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796639|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796640|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44796641|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796642|NCT01995344|Analgesics|analgesics|mesh-ancestor
44796643|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
44796644|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796645|NCT01995370|Aspirin|aspirin|mesh-list
44796646|NCT01995370|Cilostazol|cilostazol|mesh-list
44796647|NCT01995370|Clopidogrel|clopidogrel|mesh-list
44796648|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44796649|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796650|NCT01995370|Analgesics|analgesics|mesh-ancestor
44796651|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
44796652|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796653|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796654|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796655|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796656|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44796657|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44796658|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796659|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44796660|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44796661|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796662|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
44796663|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44796664|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44796665|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44796666|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
44796667|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796668|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44796669|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
44796670|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44796671|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408611|NCT02515045|Nepafenac|nepafenac|mesh-list
44796672|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
44796673|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796674|NCT01995370|Protective Agents|protective agents|mesh-ancestor
44796675|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44796676|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44796677|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44796678|NCT01995695|Vaccines|vaccines|mesh-list
44796679|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
44796680|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796681|NCT01995734|Pasireotide|pasireotide|mesh-list
44796682|NCT01995734|Hormones|hormones|mesh-ancestor
44796683|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796684|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796685|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44796686|NCT01995799|Hematinics|hematinics|mesh-ancestor
44796687|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44796688|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44796689|NCT01995890|Nepafenac|nepafenac|mesh-list
44796690|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44796691|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796692|NCT01995890|Analgesics|analgesics|mesh-ancestor
44796693|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
44796694|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796695|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796696|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796697|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796698|NCT01996085|Amlodipine|amlodipine|mesh-list
44796699|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44796700|NCT01996085|Telmisartan|telmisartan|mesh-list
44796701|NCT01996085|Lisinopril|lisinopril|mesh-list
44796702|NCT01996085|Nebivolol|nebivolol|mesh-list
44796703|NCT01996085|Indapamide|indapamide|mesh-list
44796704|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44796705|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44796706|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796707|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796708|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796709|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796710|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
44796711|NCT01996085|Diuretics|diuretics|mesh-ancestor
44796712|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
44796713|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44796714|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44796715|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44796716|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44796717|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
44796718|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796719|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44796720|NCT01996085|Protective Agents|protective agents|mesh-ancestor
44796721|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44796722|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44796723|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44796724|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44796725|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796726|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44796728|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
44796729|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796730|NCT01996189|Insulin|insulin|mesh-list
44796731|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44796732|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796733|NCT01996306|Leucovorin|leucovorin|mesh-list
44796734|NCT01996306|Bevacizumab|bevacizumab|mesh-list
44796735|NCT01996306|Fluorouracil|fluorouracil|mesh-list
44796736|NCT01996306|Capecitabine|capecitabine|mesh-list
44796737|NCT01996306|Irinotecan|irinotecan|mesh-list
44796738|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44796739|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796740|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44796741|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44796742|NCT01996306|Growth Substances|growth substances|mesh-ancestor
44796743|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796744|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
44796745|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
44796746|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796747|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44796748|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796749|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
44796750|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44796751|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44796752|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796753|NCT01996306|Antidotes|antidotes|mesh-ancestor
44796754|NCT01996306|Protective Agents|protective agents|mesh-ancestor
44796755|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
44796756|NCT01996306|Vitamins|vitamins|mesh-ancestor
44796757|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
44796758|NCT01996358|Rocuronium|rocuronium|mesh-list
44796759|NCT01996358|Succinylcholine|succinylcholine|mesh-list
44796760|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44796761|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44796762|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44796763|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796764|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796765|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44796766|NCT01996384|Lidocaine|lidocaine|mesh-list
44796767|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
44796768|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
44796769|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796770|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796771|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
44796772|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796773|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44408715|NCT02513394|Palbociclib|palbociclib|mesh-list
44796774|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44796775|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44796776|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796777|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796778|NCT01996423|Vitamin D|vitamin d|mesh-list
44796779|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
44796780|NCT01996423|Vitamins|vitamins|mesh-ancestor
44796781|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
44796782|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796783|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796784|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44796785|NCT01996462|Dexetimide|dexetimide|mesh-list
44796786|NCT01996462|Citalopram|citalopram|mesh-list
44796787|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44796788|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44796789|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796790|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796791|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796792|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
44796793|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796794|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44796795|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
44796796|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796797|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44796798|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44796799|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
44796800|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
44796801|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796802|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44796803|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44796804|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
44796805|NCT01996475|Dexetimide|dexetimide|mesh-list
44796806|NCT01996475|Citalopram|citalopram|mesh-list
44796807|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44796808|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44796809|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796810|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796811|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796812|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
44796813|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796814|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44796815|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
44796816|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796817|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44796818|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44796819|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
44796820|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
44796821|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796822|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44796823|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44796824|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
44796825|NCT01996488|Olanzapine|olanzapine|mesh-list
44796826|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
44796827|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
44796828|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576372|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576373|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576374|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576375|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576376|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576377|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44576378|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44576379|NCT00948675|Growth Substances|growth substances|mesh-ancestor
44576380|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576381|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
44576382|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576383|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44576384|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44576385|NCT00948506|Cidofovir|cidofovir|mesh-list
44576386|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
44576387|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576388|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576389|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796829|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796830|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796831|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44796832|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44796833|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796834|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796835|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44408784|NCT02510794|Ranibizumab|ranibizumab|mesh-list
44408827|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44796836|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44796837|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796838|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796839|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796840|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
44796841|NCT01996501|Olanzapine|olanzapine|mesh-list
44796842|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
44796843|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
44796844|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796845|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796846|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796847|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44796848|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44796849|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796850|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796851|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44796852|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44796853|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796854|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796855|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796856|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
44796857|NCT01996579|Lactoferrin|lactoferrin|mesh-list
44796858|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796859|NCT01996618|Ranolazine|ranolazine|mesh-list
44796860|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44796861|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796862|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796863|NCT01996683|Deferiprone|deferiprone|mesh-list
44796864|NCT01996683|Deferoxamine|deferoxamine|mesh-list
44796865|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44796866|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
44796867|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
44796868|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796869|NCT01996683|Siderophores|siderophores|mesh-ancestor
44796870|NCT01996696|Metformin|metformin|mesh-list
44796871|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44796872|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796873|NCT01996735|Ticagrelor|ticagrelor|mesh-list
44796874|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44796875|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44796876|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44796877|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44796878|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
44796879|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796880|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796881|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796882|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
44796883|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796884|NCT01996761|Protective Agents|protective agents|mesh-ancestor
44796885|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796886|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
44796887|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44692960|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692961|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692962|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692963|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44692964|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44692965|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
44692966|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44692967|NCT01371331|Tacrolimus|tacrolimus|mesh-list
44796888|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
44796889|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44796890|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796891|NCT01997099|Diazepam|diazepam|mesh-list
44796892|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44796893|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
44796894|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
44796895|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
44796896|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796897|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796898|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796899|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44796900|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796901|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44796902|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44796903|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44796904|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44796905|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796906|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44796907|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
44796908|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
44796909|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
44796910|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
44796911|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796912|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796913|NCT01997112|Acetaminophen|acetaminophen|mesh-list
44796914|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44796915|NCT01997112|Analgesics|analgesics|mesh-ancestor
44796916|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
44796917|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796918|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796919|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
44796920|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44796921|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44796922|NCT01997164|Aflibercept|aflibercept|mesh-list
44796923|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44796924|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44796925|NCT01997164|Growth Substances|growth substances|mesh-ancestor
44796926|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796927|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
44796928|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796929|NCT01997190|Valacyclovir|valacyclovir|mesh-list
44796930|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
44796931|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796932|NCT01997203|Vitamin D|vitamin d|mesh-list
44796933|NCT01997203|Interferons|interferons|mesh-list
44796934|NCT01997203|Ribavirin|ribavirin|mesh-list
44796935|NCT01997203|Vitamins|vitamins|mesh-ancestor
44796936|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
44796937|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796938|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44796939|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796940|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
44796941|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44796942|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
44796943|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796944|NCT01997255|Everolimus|everolimus|mesh-list
44796945|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796946|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44796947|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
44796948|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796949|NCT01997294|Atorvastatin|atorvastatin|mesh-list
44796950|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44796951|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44796952|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
44796953|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796954|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44796955|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44796956|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44796957|NCT01997580|Citalopram|citalopram|mesh-list
44796958|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44796959|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44796960|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44796961|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44796962|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44796963|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
44796964|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796965|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44796966|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
44796967|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44796968|NCT01997593|Ropivacaine|ropivacaine|mesh-list
44796969|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
44796970|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
44796971|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44796972|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796973|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
44796974|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796975|NCT01997632|Vaccines|vaccines|mesh-list
44796976|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
44796977|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796978|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
44796979|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44796980|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44796981|NCT01997658|Prednisolone|prednisolone|mesh-list
44796982|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
44796983|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44796984|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
44796985|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44796986|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
44796987|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
44796988|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44796989|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44796990|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44796991|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
44796992|NCT01997658|Hormones|hormones|mesh-ancestor
44796993|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44796994|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44796995|NCT01997658|Protective Agents|protective agents|mesh-ancestor
44796996|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44796997|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44796998|NCT01997762|Resveratrol|resveratrol|mesh-list
44796999|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
44797000|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797001|NCT01997762|Protective Agents|protective agents|mesh-ancestor
44797002|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797003|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797004|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44797005|NCT01997775|Metformin|metformin|mesh-list
44797006|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797007|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797008|NCT01997788|Morphine|morphine|mesh-list
44797009|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797010|NCT01997788|Narcotics|narcotics|mesh-ancestor
44797011|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797012|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797013|NCT01997788|Analgesics|analgesics|mesh-ancestor
44797014|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
44797015|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797016|NCT01997801|Ketamine|ketamine|mesh-list
44797017|NCT01997801|Analgesics|analgesics|mesh-ancestor
44797018|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
44797019|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797020|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797021|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44797022|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44797023|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
44797024|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
44797025|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797026|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44797027|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44797028|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797029|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797030|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
44797031|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44797032|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797033|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44797034|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44797035|NCT01997944|Interferons|interferons|mesh-list
44797036|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
44797037|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
44797038|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44797039|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797040|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
44797041|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797042|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
44797043|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797044|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
44797045|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44797046|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797047|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797048|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797049|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797050|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797051|NCT01998113|Insulin|insulin|mesh-list
44797052|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44797053|NCT01998113|Metformin|metformin|mesh-list
44797054|NCT01998113|Glyburide|glyburide|mesh-list
44797055|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797056|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797057|NCT01998126|Nivolumab|nivolumab|mesh-list
44797058|NCT01998126|Ipilimumab|ipilimumab|mesh-list
44797059|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44797060|NCT01998126|Crizotinib|crizotinib|mesh-list
44797061|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44797062|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797063|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44797064|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797065|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44797066|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797067|NCT01998165|Remifentanil|remifentanil|mesh-list
44797068|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797069|NCT01998165|Narcotics|narcotics|mesh-ancestor
44797070|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797071|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797072|NCT01998165|Analgesics|analgesics|mesh-ancestor
44797073|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
44797074|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797075|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
44797076|NCT01998217|Remifentanil|remifentanil|mesh-list
44797077|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797078|NCT01998217|Narcotics|narcotics|mesh-ancestor
44797079|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797080|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797081|NCT01998217|Analgesics|analgesics|mesh-ancestor
44797082|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
44797083|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797084|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44797085|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44797086|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797087|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797088|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44797089|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797090|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797091|NCT01998295|Lumefantrine|lumefantrine|mesh-list
44797092|NCT01998295|Artemether|artemether|mesh-list
44797093|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44797094|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
44797095|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44797096|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44797097|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797098|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
44797099|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44797100|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
44797101|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797102|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
44797103|NCT01998308|Protective Agents|protective agents|mesh-ancestor
44797104|NCT01998347|Paclitaxel|paclitaxel|mesh-list
44797105|NCT01998347|Cisplatin|cisplatin|mesh-list
44797106|NCT01998347|Fluorouracil|fluorouracil|mesh-list
44797107|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44797108|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797109|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797110|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797111|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797112|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797113|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
44797114|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44797115|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797116|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
44797117|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797118|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44797119|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44797120|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797121|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44797122|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
44797123|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797124|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44797125|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797126|NCT01998503|Dexamethasone|dexamethasone|mesh-list
44797127|NCT01998503|Bortezomib|bortezomib|mesh-list
44797128|NCT01998503|Melphalan|melphalan|mesh-list
44797129|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797130|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
44797131|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
44797132|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797133|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797134|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797135|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
44797136|NCT01998503|Hormones|hormones|mesh-ancestor
44797137|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797138|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797139|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797140|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
44797141|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44797142|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
44797143|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797144|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44797145|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576682|NCT00943826|Growth Substances|growth substances|mesh-ancestor
44797147|NCT01998685|Midazolam|midazolam|mesh-list
44797148|NCT01998685|Remifentanil|remifentanil|mesh-list
44797149|NCT01998685|Propofol|propofol|mesh-list
44797150|NCT01998685|Sevoflurane|sevoflurane|mesh-list
44797151|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44797152|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797153|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797154|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44797155|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
44797156|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
44797157|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797158|NCT01998685|Narcotics|narcotics|mesh-ancestor
44797159|NCT01998685|Analgesics|analgesics|mesh-ancestor
44797160|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
44797161|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797162|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44797163|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44797164|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44797165|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44797166|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
44797167|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
44797168|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797169|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797170|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44797171|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44797172|NCT01998698|Lidocaine|lidocaine|mesh-list
44797173|NCT01998698|Dipivefrin|dipivefrin|mesh-list
44797174|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
44797175|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44797176|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44066804|NCT00008060|Antidotes|antidotes|mesh-ancestor
44797177|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797178|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797179|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797180|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44797181|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
44797182|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
44797183|NCT01998698|Protective Agents|protective agents|mesh-ancestor
44797184|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797185|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
44797186|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797187|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
44797188|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797189|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44797190|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44797191|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44797192|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797193|NCT01998763|Vitamin D|vitamin d|mesh-list
44797194|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
44797195|NCT01998763|Vitamins|vitamins|mesh-ancestor
44797196|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
44797197|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797198|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44797199|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44797200|NCT01998776|Misoprostol|misoprostol|mesh-list
44797201|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44797202|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
44797203|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44797204|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797205|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44797206|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797207|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
44797208|NCT01998789|Everolimus|everolimus|mesh-list
44797209|NCT01998789|Tacrolimus|tacrolimus|mesh-list
44797210|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797211|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
44797212|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797213|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44797214|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797215|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797216|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797217|NCT01999153|Ropivacaine|ropivacaine|mesh-list
44797218|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797219|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
44797220|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797221|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797222|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
44797223|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797225|NCT01999270|Irinotecan|irinotecan|mesh-list
44797226|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44797227|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797228|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44797229|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44797230|NCT01999270|Growth Substances|growth substances|mesh-ancestor
44797231|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797232|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
44797233|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44797234|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44797235|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797236|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797237|NCT01999309|Simvastatin|simvastatin|mesh-list
44797238|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44797239|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44797240|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
44797241|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797242|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44797243|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44797244|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797245|NCT01999413|Cytarabine|cytarabine|mesh-list
44797246|NCT01999413|Daunorubicin|daunorubicin|mesh-list
44797247|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44797248|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
44797249|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797250|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797251|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
44797252|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797253|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797254|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
44797255|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797256|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44797257|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44797258|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44797259|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797260|NCT01999647|Ropivacaine|ropivacaine|mesh-list
44797261|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
44797262|NCT01999647|Anesthetics|anesthetics|mesh-list
44797263|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797264|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797265|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
44797266|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797267|NCT01999673|Docetaxel|docetaxel|mesh-list
44797268|NCT01999673|Bavituximab|bavituximab|mesh-list
44797269|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44797270|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797271|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797272|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797273|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797274|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797275|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44797276|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
44409247|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797277|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797278|NCT01999686|Metformin|metformin|mesh-list
44797279|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797280|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797281|NCT01999738|Folic Acid|folic acid|mesh-list
44797282|NCT01999738|Hematinics|hematinics|mesh-ancestor
44797283|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44797284|NCT01999738|Vitamins|vitamins|mesh-ancestor
44797285|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
44797286|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797287|NCT01999829|Caffeine|caffeine|mesh-list
44576831|NCT00942266|Fluorouracil|fluorouracil|mesh-list
44576832|NCT00942266|Vorinostat|vorinostat|mesh-list
44576833|NCT00942266|Calcium|calcium|mesh-list
44576834|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
44576835|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44576836|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576837|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44576838|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
44576839|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576840|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44797288|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797289|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44797290|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797291|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44797292|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797293|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44797294|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44797295|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
44797296|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797297|NCT01999842|Vaccines|vaccines|mesh-list
44797298|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
44797299|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797300|NCT01999907|Vitamin D|vitamin d|mesh-list
44797301|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
44797302|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
44797303|NCT01999907|Vitamins|vitamins|mesh-list
44797304|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
44797305|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797306|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44797307|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44797308|NCT01999933|Cisplatin|cisplatin|mesh-list
44797309|NCT01999933|Docetaxel|docetaxel|mesh-list
44797310|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797311|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797312|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797313|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797314|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797315|NCT02000102|Aflibercept|aflibercept|mesh-list
44797316|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44797317|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44797318|NCT02000102|Growth Substances|growth substances|mesh-ancestor
44797319|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797320|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44797321|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797322|NCT02000193|Fulvestrant|fulvestrant|mesh-list
44797323|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797324|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797325|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44797326|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44797327|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44797328|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797329|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797330|NCT02000206|Ketamine|ketamine|mesh-list
44797331|NCT02000206|Alfentanil|alfentanil|mesh-list
44797332|NCT02000206|Propofol|propofol|mesh-list
44797333|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44797334|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797335|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797336|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44797337|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
44797338|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
44797339|NCT02000206|Analgesics|analgesics|mesh-ancestor
44797340|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
44797341|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797342|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44797343|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44797344|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44797345|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476052|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44797346|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797347|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797348|NCT02000206|Narcotics|narcotics|mesh-ancestor
44797349|NCT02000336|Prednisolone|prednisolone|mesh-list
44797350|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797351|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
44797352|NCT02000336|Hormones|hormones|mesh-ancestor
44797353|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797354|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797355|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797356|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797357|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44797358|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44797359|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
44797360|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797361|NCT02000388|Ketorolac|ketorolac|mesh-list
44576897|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
44797362|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44797363|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44797364|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44797365|NCT02000388|Analgesics|analgesics|mesh-ancestor
44797366|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
44797367|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797368|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797369|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797370|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797371|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44797372|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797373|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797374|NCT02000401|Ketorolac|ketorolac|mesh-list
44797375|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44797376|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44797377|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44797378|NCT02000401|Analgesics|analgesics|mesh-ancestor
44797379|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
44797380|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797381|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797382|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797383|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797384|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44797385|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797386|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797387|NCT02000414|Daptomycin|daptomycin|mesh-list
44797388|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44797389|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797390|NCT02000674|Rocuronium|rocuronium|mesh-list
44797391|NCT02000674|Succinylcholine|succinylcholine|mesh-list
44797392|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44797393|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44797394|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44797395|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797396|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797397|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44797398|NCT02000700|Canagliflozin|canagliflozin|mesh-list
44797399|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44797400|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797401|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797402|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797403|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
44797404|NCT02000726|Citalopram|citalopram|mesh-list
44797405|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44797406|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44797407|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44797408|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797409|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797410|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797411|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
44797412|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797413|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44797414|NCT02000804|Darapladib|darapladib|mesh-list
44797415|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44797416|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797417|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797418|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44797419|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797420|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797421|NCT02000947|Durvalumab|durvalumab|mesh-list
44797422|NCT02000947|Tremelimumab|tremelimumab|mesh-list
44797423|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44797424|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44797425|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797426|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
44797427|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797428|NCT02001012|Chloroquine|chloroquine|mesh-list
44797429|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44797430|NCT02001012|Lumefantrine|lumefantrine|mesh-list
44797431|NCT02001012|Artemether|artemether|mesh-list
44797432|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44797433|NCT02001012|Amebicides|amebicides|mesh-ancestor
44797434|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44797435|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44797436|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797437|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
44797438|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797439|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44692968|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692969|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
44692970|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692971|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44692972|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692973|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692974|NCT01371344|Tacrolimus|tacrolimus|mesh-list
44692975|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44692976|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
44692977|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692978|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44692979|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692980|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692981|NCT01371435|Paroxetine|paroxetine|mesh-list
44692982|NCT01371435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44692983|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692984|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692985|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692986|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44692987|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
44692988|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44692989|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44692990|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
44692991|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44692992|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44692993|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44692994|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44692995|NCT01371448|Paroxetine|paroxetine|mesh-list
44692996|NCT01371448|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44577049|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44409444|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
44797440|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44797441|NCT02001012|Analgesics|analgesics|mesh-ancestor
44797442|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
44797443|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797444|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797445|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797446|NCT02001012|Filaricides|filaricides|mesh-ancestor
44797447|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
44797448|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
44797449|NCT02001103|Memantine|memantine|mesh-list
44797450|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44797451|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44797452|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
44797453|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797454|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797455|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797456|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44797457|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44797458|NCT02001168|Docetaxel|docetaxel|mesh-list
44797459|NCT02001168|Pemetrexed|pemetrexed|mesh-list
44797460|NCT02001168|Cisplatin|cisplatin|mesh-list
44797461|NCT02001168|Endostatins|endostatins|mesh-list
44797462|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797463|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797464|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797465|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797466|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797467|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797468|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44797469|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44797470|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44797471|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44797472|NCT02001168|Growth Substances|growth substances|mesh-ancestor
44797473|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797474|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
44797475|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
44797476|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797477|NCT02001259|Lidocaine|lidocaine|mesh-list
44797478|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797479|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
44797480|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797481|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797482|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
44797483|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797484|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44797485|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44797486|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44797487|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797488|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797489|NCT02001272|Paclitaxel|paclitaxel|mesh-list
44797490|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44797491|NCT02001272|Carboplatin|carboplatin|mesh-list
44797492|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44409506|NCT02493868|Citalopram|citalopram|mesh-list
44797493|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797494|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797495|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797496|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797497|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797498|NCT02001285|Remifentanil|remifentanil|mesh-list
44797499|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797500|NCT02001285|Narcotics|narcotics|mesh-ancestor
44797501|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797502|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797503|NCT02001285|Analgesics|analgesics|mesh-ancestor
44797504|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
44797505|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797506|NCT02001298|Nitroprusside|nitroprusside|mesh-list
44797507|NCT02001298|Remifentanil|remifentanil|mesh-list
44797508|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797509|NCT02001298|Narcotics|narcotics|mesh-ancestor
44797510|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797511|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797512|NCT02001298|Analgesics|analgesics|mesh-ancestor
44797513|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
44797514|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409533|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44577092|NCT00939029|Nicotine|nicotine|mesh-list
44797515|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44797516|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44797517|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44797518|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797519|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
44797520|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44797521|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44797522|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797523|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
44797524|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44797525|NCT02001363|Liraglutide|liraglutide|mesh-list
44797526|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797527|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797528|NCT02001363|Incretins|incretins|mesh-ancestor
44797530|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797531|NCT02001428|Piperaquine|piperaquine|mesh-list
44797532|NCT02001428|Artenimol|artenimol|mesh-list
44797533|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
44797534|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44797535|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44797536|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797537|NCT02001506|Docetaxel|docetaxel|mesh-list
44797538|NCT02001506|Epirubicin|epirubicin|mesh-list
44797539|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797540|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797541|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
44797542|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797543|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797544|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44797545|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44797546|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44797547|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797548|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
44797549|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797550|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44797551|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797552|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797553|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
44476053|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44797554|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797555|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797556|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44797557|NCT02001584|Memantine|memantine|mesh-list
44797558|NCT02001584|Baclofen|baclofen|mesh-list
44797559|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44797560|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44797561|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
44797562|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797563|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797564|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797565|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44797566|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44797567|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44797568|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44797569|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797570|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44797571|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
44797572|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
44797573|NCT02001740|Lidocaine|lidocaine|mesh-list
44797574|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797575|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
44797576|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797577|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797578|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
44797579|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797580|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44797581|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44797582|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44797583|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409597|NCT02492763|Metformin|metformin|mesh-list
44797584|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797585|NCT02001818|Interferons|interferons|mesh-list
44797586|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
44797587|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
44797588|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44797589|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
44797590|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797591|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
44797592|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797593|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
44797594|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797595|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44797596|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797597|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797598|NCT02001857|Hemostatics|hemostatics|mesh-list
44797599|NCT02001857|Coagulants|coagulants|mesh-ancestor
44797600|NCT02001883|Policosanol|policosanol|mesh-list
44797601|NCT02001883|Atorvastatin|atorvastatin|mesh-list
44797602|NCT02001883|Simvastatin|simvastatin|mesh-list
44797603|NCT02001883|Red yeast rice|red yeast rice|mesh-list
44797604|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44797605|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44797606|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
44797607|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797608|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44797609|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44797610|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797611|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44797612|NCT02001896|Gemcitabine|gemcitabine|mesh-list
44797613|NCT02001896|Cisplatin|cisplatin|mesh-list
44797614|NCT02001896|Carboplatin|carboplatin|mesh-list
44797615|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44797616|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797617|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44797618|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
44797619|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409633|NCT02491411|Hormones|hormones|mesh-ancestor
44797620|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
44797621|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797622|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797623|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797624|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
44797625|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797626|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44797627|NCT02001909|Neomycin|neomycin|mesh-list
44797628|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44797629|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797630|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44797631|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797632|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797633|NCT02001935|Theophylline|theophylline|mesh-list
44797634|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44797635|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
44797636|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797637|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797638|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44797639|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
44797640|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44797641|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797642|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797643|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
44797644|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44797645|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44797646|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
44797647|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797648|NCT02001948|Morphine|morphine|mesh-list
44797649|NCT02001948|Bupivacaine|bupivacaine|mesh-list
44797650|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797651|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
44797652|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797653|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797654|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
44797655|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797656|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797657|NCT02001948|Narcotics|narcotics|mesh-ancestor
44797658|NCT02001948|Analgesics|analgesics|mesh-ancestor
44797659|NCT02001974|Paclitaxel|paclitaxel|mesh-list
44797660|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44797661|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409669|NCT02489968|Empagliflozin|empagliflozin|mesh-list
44797662|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797663|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577256|NCT00936702|Paclitaxel|paclitaxel|mesh-list
44797664|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797665|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797667|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
44797668|NCT02002000|Vitamins|vitamins|mesh-ancestor
44797669|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
44797670|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797671|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44797672|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44797673|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
44797674|NCT02002039|Hematinics|hematinics|mesh-ancestor
44797675|NCT02002065|Vaccines|vaccines|mesh-list
44797676|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
44797677|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797678|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44797679|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
44797680|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44797681|NCT02002078|Prednisolone|prednisolone|mesh-list
44797682|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
44797683|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44797684|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
44797685|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797686|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
44797687|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
44797688|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797689|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797690|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797691|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
44797692|NCT02002078|Hormones|hormones|mesh-ancestor
44797693|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797694|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44797695|NCT02002078|Protective Agents|protective agents|mesh-ancestor
44797696|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797697|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797698|NCT02002156|Vaccines|vaccines|mesh-list
44797699|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44797700|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
44797701|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
44797702|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797703|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44797704|NCT02002195|Leucovorin|leucovorin|mesh-list
44797705|NCT02002195|Fluorouracil|fluorouracil|mesh-list
44797706|NCT02002195|Capecitabine|capecitabine|mesh-list
44797707|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
44797708|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
44797709|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797710|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44797711|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797712|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797713|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
44409738|NCT02487446|Bromides|bromides|mesh-list
44797714|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797715|NCT02002195|Antidotes|antidotes|mesh-ancestor
44797716|NCT02002195|Protective Agents|protective agents|mesh-ancestor
44797717|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
44797718|NCT02002195|Vitamins|vitamins|mesh-ancestor
44797719|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
44797720|NCT02002247|Selenium|selenium|mesh-list
44797721|NCT02002247|Selenious Acid|selenious acid|mesh-list
44797722|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
44797723|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
44797724|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797725|NCT02002247|Protective Agents|protective agents|mesh-ancestor
44797726|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797727|NCT02002247|Trace Elements|trace elements|mesh-ancestor
44797728|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
44797729|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
44797730|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44797731|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
44797732|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
44577318|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44577319|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577320|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
44577321|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577322|NCT00935818|Bupropion|bupropion|mesh-list
44577323|NCT00935818|Varenicline|varenicline|mesh-list
44577324|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44577325|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
44797733|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44797734|NCT02002260|Estradiol|estradiol|mesh-list
44797735|NCT02002260|Estrogens|estrogens|mesh-ancestor
44797736|NCT02002260|Hormones|hormones|mesh-ancestor
44797737|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797738|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797739|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44797740|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44797741|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44797742|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44797743|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44797745|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44797746|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797747|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44797748|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
44797749|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44797750|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797751|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
44797752|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44797753|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
44797754|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797755|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797756|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44797757|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
44797758|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
44797759|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797760|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44797761|NCT02002325|Plasminogen|plasminogen|mesh-list
44797762|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44797763|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44797764|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797765|NCT02002377|Aflibercept|aflibercept|mesh-list
44797766|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44797767|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44797768|NCT02002377|Growth Substances|growth substances|mesh-ancestor
44797769|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797770|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
44797771|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797772|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44797773|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44797774|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797775|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797776|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
44797777|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797778|NCT02002403|Danazol|danazol|mesh-list
44797779|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44797780|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
44797781|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797782|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797783|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
44797784|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
44797785|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44797786|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797787|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
44797788|NCT02002598|Dexamethasone|dexamethasone|mesh-list
44797789|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
44797790|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44797791|NCT02002598|BB 1101|bb 1101|mesh-list
44797792|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797793|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
44797794|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
44797795|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797796|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797797|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797798|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
44797799|NCT02002598|Hormones|hormones|mesh-ancestor
44797800|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797801|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797802|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797803|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
44797804|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797805|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797806|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44797807|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
44797808|NCT02002611|Warfarin|warfarin|mesh-list
44797809|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
44797810|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
44797811|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44797812|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44797813|NCT02002663|Prednisolone|prednisolone|mesh-list
44797814|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
44797815|NCT02002663|Morphine|morphine|mesh-list
44797816|NCT02002663|Ropivacaine|ropivacaine|mesh-list
44797817|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44797818|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
44797819|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44797820|NCT02002663|Narcotics|narcotics|mesh-ancestor
44797821|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797822|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797823|NCT02002663|Analgesics|analgesics|mesh-ancestor
44797824|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
44797825|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797826|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
44797827|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
44797828|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797829|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
44797830|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
44797831|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44797832|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
44797833|NCT02002663|Hormones|hormones|mesh-ancestor
44797834|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797835|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44797836|NCT02002663|Protective Agents|protective agents|mesh-ancestor
44797837|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797838|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797839|NCT02002715|Budesonide|budesonide|mesh-list
44797840|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44797841|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44797842|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
44797843|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797844|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797845|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409842|NCT02486627|Levofloxacin|levofloxacin|mesh-list
44797846|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44797847|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
44797848|NCT02002715|Hormones|hormones|mesh-ancestor
44797849|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797850|NCT02002741|Acetaminophen|acetaminophen|mesh-list
44797851|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44797852|NCT02002741|Analgesics|analgesics|mesh-ancestor
44797853|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
44797854|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797855|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797856|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
44797857|NCT02002754|Bambuterol|bambuterol|mesh-list
44797858|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44797859|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
44797860|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797861|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797862|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44797863|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44797864|NCT02002806|Ethanol|ethanol|mesh-list
44797865|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44797866|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797867|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797868|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797869|NCT02002858|Nicotine|nicotine|mesh-list
44797870|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44797871|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
44797872|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797873|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797874|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44797875|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44797876|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797877|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797878|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797879|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
44797880|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44797881|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797882|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797883|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797884|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797885|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797886|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
44797887|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44797888|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44797889|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44797890|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797891|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797892|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797893|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797894|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797895|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44797896|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797897|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
44797898|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44797899|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44797900|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797901|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797902|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797903|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797904|NCT02003209|Carboplatin|carboplatin|mesh-list
44797905|NCT02003209|Docetaxel|docetaxel|mesh-list
44797906|NCT02003209|Trastuzumab|trastuzumab|mesh-list
44797907|NCT02003209|Pertuzumab|pertuzumab|mesh-list
44797908|NCT02003209|Goserelin|goserelin|mesh-list
44797909|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44797910|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44797911|NCT02003209|Antibodies|antibodies|mesh-list
44797912|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
44797913|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44797914|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44797915|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
44797916|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797917|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797918|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44797919|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409925|NCT02485158|Analgesics|analgesics|mesh-ancestor
44797920|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44797921|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797922|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44797923|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44797924|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797925|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44797926|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44797927|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44797928|NCT02003313|Vaccines|vaccines|mesh-list
44797929|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
44797930|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797931|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44797932|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44797933|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797934|NCT02003495|Vaccines|vaccines|mesh-list
44797935|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
44797936|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797937|NCT02003664|Baclofen|baclofen|mesh-list
44797938|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44797939|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797940|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44797941|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797942|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44797943|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
44797944|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
44797945|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797946|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797947|NCT02003677|Insulin|insulin|mesh-list
44797948|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44797949|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
44797950|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
44797951|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44797952|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44797953|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797954|NCT02003768|Propofol|propofol|mesh-list
44797955|NCT02003768|Desflurane|desflurane|mesh-list
44797956|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44797957|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797958|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797959|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44797960|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
44797961|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
44797962|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44797963|NCT02003885|Desflurane|desflurane|mesh-list
44797964|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44797965|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
44797966|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
44797967|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44797968|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797969|NCT02004067|Cyclosporine|cyclosporine|mesh-list
44797970|NCT02004067|Castor Oil|castor oil|mesh-list
44797971|NCT02004067|Cyclosporins|cyclosporins|mesh-list
44797972|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797973|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797974|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44797975|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
44797976|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797977|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
44797978|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44797979|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
44797980|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44797981|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44797982|NCT02004067|Cathartics|cathartics|mesh-ancestor
44797983|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577559|NCT00932165|Exemestane|exemestane|mesh-list
44797984|NCT02004171|Nicotine|nicotine|mesh-list
44797985|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44797986|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
44797987|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44797988|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44797989|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44797990|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44797991|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
44797992|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44797993|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797994|NCT02004184|Pemetrexed|pemetrexed|mesh-list
44797995|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44797996|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44797997|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44797998|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44797999|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44798000|NCT02004197|Amoxicillin|amoxicillin|mesh-list
44798001|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44798002|NCT02004197|Bismuth|bismuth|mesh-list
44798003|NCT02004197|Ranitidine|ranitidine|mesh-list
44798004|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44798005|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798006|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798007|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798008|NCT02004197|Antacids|antacids|mesh-ancestor
44798009|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798010|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44798011|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44798012|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
44798013|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
44798014|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798015|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798016|NCT02004301|Diclofenac|diclofenac|mesh-list
44798017|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798018|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798019|NCT02004301|Analgesics|analgesics|mesh-ancestor
44798020|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
44798021|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798022|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798023|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798024|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798025|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44798026|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798027|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798028|NCT02004314|Chloroquine|chloroquine|mesh-list
44798029|NCT02004314|Amebicides|amebicides|mesh-ancestor
44798030|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44798031|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44798032|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798033|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
44798034|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798035|NCT02004418|Choline|choline|mesh-list
44798036|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
44798037|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44798038|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
44798039|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798040|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798041|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44798042|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
44798043|NCT02004509|Anticoagulants|anticoagulants|mesh-list
44798044|NCT02004574|Betamethasone|betamethasone|mesh-list
44798045|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
44798046|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44798047|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
44798048|NCT02004574|Calcipotriene|calcipotriene|mesh-list
44798049|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44798050|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798051|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
44798052|NCT02004574|Hormones|hormones|mesh-ancestor
44798053|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798054|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798055|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44798056|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
44798057|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44798058|NCT02004652|Prucalopride|prucalopride|mesh-list
44798059|NCT02004652|Laxatives|laxatives|mesh-ancestor
44798060|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798061|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44798062|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44798063|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
44798064|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798065|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798066|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798067|NCT02004769|Docetaxel|docetaxel|mesh-list
44798068|NCT02004769|Capecitabine|capecitabine|mesh-list
44798069|NCT02004769|Trastuzumab|trastuzumab|mesh-list
44798070|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798071|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44798072|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44798073|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44798074|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44692997|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44692998|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44692999|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693000|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693001|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
44693002|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693003|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44693004|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
44693005|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693006|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44693007|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693008|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693009|NCT01371461|Paroxetine|paroxetine|mesh-list
44693010|NCT01371461|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44693011|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44693012|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693013|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693014|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693015|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
44693016|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244581|NCT05317000|Nivolumab|nivolumab|mesh-list
44693017|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44693019|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693020|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44693021|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693022|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693023|NCT01371474|Paroxetine|paroxetine|mesh-list
44693024|NCT01371474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44693025|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44693026|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693027|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693028|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693029|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
44693030|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693031|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44693032|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
44693033|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44693034|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44693035|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44693036|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693037|NCT01371487|Trametinib|trametinib|mesh-list
44693038|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693039|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44693040|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693041|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693042|NCT01371526|Cosyntropin|cosyntropin|mesh-list
44693043|NCT01371526|Hormones|hormones|mesh-ancestor
44693044|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693045|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693046|NCT01371604|Ribavirin|ribavirin|mesh-list
44693047|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44693048|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
44693049|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693050|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
44693051|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693052|NCT01371682|Ropinirole|ropinirole|mesh-list
44693053|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44798075|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798076|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
44798077|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577715|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
44577716|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44798078|NCT02004782|Prednisolone|prednisolone|mesh-list
44798079|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798080|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
44798082|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798083|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798084|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44798085|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798086|NCT02004860|Ciclopirox|ciclopirox|mesh-list
44798087|NCT02004860|Tacrolimus|tacrolimus|mesh-list
44798088|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798089|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
44798090|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798091|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44798092|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798093|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798094|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
44798095|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798096|NCT02004899|Fentanyl|fentanyl|mesh-list
44798097|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44798098|NCT02004899|Narcotics|narcotics|mesh-ancestor
44798099|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798100|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798101|NCT02004899|Analgesics|analgesics|mesh-ancestor
44798102|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
44798103|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798104|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44798105|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798106|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
44798107|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
44798108|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44798109|NCT02005068|Cephalosporins|cephalosporins|mesh-list
44798110|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798111|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798112|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44798113|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44577717|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
44577718|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577719|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577720|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577721|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577722|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44577723|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44577724|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44577725|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577726|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577727|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577728|NCT00931255|Sirolimus|sirolimus|mesh-list
44577729|NCT00931255|Tacrolimus|tacrolimus|mesh-list
44577730|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577731|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
44577732|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577733|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44577734|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577735|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577736|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44577737|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577738|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44577739|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577740|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
44577741|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
44577742|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44577743|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577744|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44577745|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44577746|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577747|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577748|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577749|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44798114|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44798115|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798116|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798117|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798118|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798119|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44798120|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
44798121|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44798122|NCT02005120|Bevacizumab|bevacizumab|mesh-list
44798123|NCT02005120|Endostatins|endostatins|mesh-list
44798124|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410210|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44798125|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798126|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44798127|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44798128|NCT02005120|Growth Substances|growth substances|mesh-ancestor
44798129|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798130|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
44798131|NCT02005289|Lenalidomide|lenalidomide|mesh-list
44798132|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
44798133|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798134|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44798135|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44798136|NCT02005289|Growth Substances|growth substances|mesh-ancestor
44798137|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44798138|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798139|NCT02005302|Vitamin D|vitamin d|mesh-list
44798140|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
44798141|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
44798142|NCT02005302|Vitamins|vitamins|mesh-list
44798143|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
44798144|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798145|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798146|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798147|NCT02005315|Gemcitabine|gemcitabine|mesh-list
44798148|NCT02005315|Paclitaxel|paclitaxel|mesh-list
44798149|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44798150|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798151|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44798152|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44798153|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44798154|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798155|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798156|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
44798157|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
44798158|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798159|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798160|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798161|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
44798162|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798163|NCT02005419|Metformin|metformin|mesh-list
44798164|NCT02005419|Gemcitabine|gemcitabine|mesh-list
44798165|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798166|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
44798167|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798168|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798169|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
44798170|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798171|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798172|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798173|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
44798174|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798175|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44798176|NCT02005523|RNS60|rns60|mesh-list
44798177|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798178|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798179|NCT02005523|Analgesics|analgesics|mesh-ancestor
44798180|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
44798181|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798182|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798183|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798184|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798185|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44798186|NCT02005575|Dexamethasone|dexamethasone|mesh-list
44577752|NCT00930930|Cisplatin|cisplatin|mesh-list
44798187|NCT02005575|Bupivacaine|bupivacaine|mesh-list
44798188|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798189|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
44798190|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
44798191|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798192|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798193|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798194|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
44798195|NCT02005575|Hormones|hormones|mesh-ancestor
44798196|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798197|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44798198|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798199|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798200|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
44798201|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798202|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
44798204|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
44798205|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
44798206|NCT02005588|Trace Elements|trace elements|mesh-ancestor
44798207|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
44798208|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798209|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
44798210|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
44798211|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798212|NCT02005653|Doxycycline|doxycycline|mesh-list
44798213|NCT02005653|Albendazole|albendazole|mesh-list
44798214|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
44798215|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798216|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798217|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
44798218|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44798219|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44798220|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
44798221|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
44798222|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44798223|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
44798224|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
44798225|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
44798226|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798227|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798228|NCT02005653|Filaricides|filaricides|mesh-ancestor
44798229|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
44798230|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44798231|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798232|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
44798233|NCT02005718|Vitamin D|vitamin d|mesh-list
44798234|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798235|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798236|NCT02005718|Vitamins|vitamins|mesh-ancestor
44798237|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
44410361|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798238|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798239|NCT02005757|Mizoribine|mizoribine|mesh-list
44798240|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798241|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798242|NCT02005757|Analgesics|analgesics|mesh-ancestor
44798243|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
44798244|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798245|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798246|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798247|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798248|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798249|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798250|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44798251|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410377|NCT02476006|Atorvastatin|atorvastatin|mesh-list
44798252|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
44798253|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44798254|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44798255|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798256|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798257|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798258|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
44798259|NCT02005770|Propofol|propofol|mesh-list
44798260|NCT02005770|Sevoflurane|sevoflurane|mesh-list
44798261|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798262|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798263|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798264|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798265|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
44798267|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44798268|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44798269|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
44798270|NCT02005783|Docetaxel|docetaxel|mesh-list
44798271|NCT02005783|Epirubicin|epirubicin|mesh-list
44798272|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798273|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
44798274|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798275|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798276|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44798277|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
44798278|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798279|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798280|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44798281|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
44798282|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
44798283|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
44798284|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44798285|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44798286|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44798287|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798288|NCT02005822|Valganciclovir|valganciclovir|mesh-list
44798289|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
44798290|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798291|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
44798292|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44798293|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
44798294|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798295|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798296|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44798297|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44798298|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44798299|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798300|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44798301|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798302|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798303|NCT02006173|Lidocaine|lidocaine|mesh-list
44798304|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798305|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
44798306|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798307|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798308|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
44798309|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798310|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798311|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44798312|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44798313|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798314|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798315|NCT02006225|Plerixafor|plerixafor|mesh-list
44798316|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44798317|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44798318|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
44798319|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798320|NCT02006277|Crizotinib|crizotinib|mesh-list
44798321|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44798322|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798323|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44798324|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798325|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798326|NCT02006355|Ropivacaine|ropivacaine|mesh-list
44798327|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798328|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
44410432|NCT02474199|Acetaminophen|acetaminophen|mesh-list
44798329|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798330|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798331|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
44798332|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798333|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44798334|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44798335|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44798336|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
44798337|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798338|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798339|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
44798340|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798341|NCT02006498|Silymarin|silymarin|mesh-list
44798342|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
44798343|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798344|NCT02006498|Protective Agents|protective agents|mesh-ancestor
44798345|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798346|NCT02006589|Candesartan|candesartan|mesh-list
44798347|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
44798348|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44798349|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44798350|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44798351|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798352|NCT02006602|Candesartan|candesartan|mesh-list
44798353|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
44798354|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44798355|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44798356|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44798357|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798358|NCT02006745|Ribavirin|ribavirin|mesh-list
44798359|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
44798360|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798361|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
44798362|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798363|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44798364|NCT02006849|Hormones|hormones|mesh-ancestor
44798365|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798366|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798367|NCT02006914|Chromium|chromium|mesh-list
44798368|NCT02006914|Picolinic acid|picolinic acid|mesh-list
44798369|NCT02006914|Trace Elements|trace elements|mesh-ancestor
44798370|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
44798371|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798372|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44798373|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
44798374|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
44798375|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798376|NCT02006966|Lidocaine|lidocaine|mesh-list
44798377|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798378|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
44798379|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798380|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798381|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
44798382|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798383|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798384|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44798385|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44798386|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798387|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798388|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
44798389|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798390|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44798391|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44798392|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
44798393|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798394|NCT02007148|Docetaxel|docetaxel|mesh-list
44798395|NCT02007148|Capecitabine|capecitabine|mesh-list
44798396|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798397|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
44798398|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
44798399|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44476054|NCT04020653|Trace Elements|trace elements|mesh-ancestor
44410509|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798400|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798401|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798402|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
44798403|NCT02007161|Diclofenac|diclofenac|mesh-list
44798404|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798405|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798406|NCT02007161|Analgesics|analgesics|mesh-ancestor
44798407|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
44798408|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798409|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798410|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798411|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798412|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44798413|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798414|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798415|NCT02007174|Bevacizumab|bevacizumab|mesh-list
44798416|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410543|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
44798417|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798418|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44798419|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44798420|NCT02007174|Growth Substances|growth substances|mesh-ancestor
44798421|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798422|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
44798423|NCT02007330|Lidocaine|lidocaine|mesh-list
44798424|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798425|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
44798426|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798427|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798428|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
44798429|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798430|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798431|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44798432|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44798433|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798434|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798435|NCT02007408|Lidocaine|lidocaine|mesh-list
44798436|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798437|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
44798438|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410558|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44798439|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798440|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
44798441|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798442|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798443|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44798444|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44798445|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798446|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798447|NCT02007447|Oxytocin|oxytocin|mesh-list
44798448|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
44798449|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44798450|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798451|NCT02007603|Amoxicillin|amoxicillin|mesh-list
44798452|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
44798453|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
44798454|NCT02007603|Ampicillin|ampicillin|mesh-list
44798455|NCT02007603|Sulbactam|sulbactam|mesh-list
44798456|NCT02007603|Sultamicillin|sultamicillin|mesh-list
44798457|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798458|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798459|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798460|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798461|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44798462|NCT02007629|Riociguat|riociguat|mesh-list
44798463|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
44798464|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798465|NCT02007746|Liver Extracts|liver extracts|mesh-list
44798466|NCT02007746|Hematinics|hematinics|mesh-ancestor
44798467|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
44798468|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798469|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798470|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798471|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798472|NCT02007798|Analgesics|analgesics|mesh-ancestor
44798473|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
44798474|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410600|NCT02469961|Propofol|propofol|mesh-list
44798475|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44798476|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44798477|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44798478|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
44798479|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798480|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578124|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44578125|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
44578126|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44578127|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44578128|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44578129|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578130|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578131|NCT00926367|Clindamycin|clindamycin|mesh-list
44578132|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
44578133|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
44578134|NCT00926367|Adapalene|adapalene|mesh-list
44578135|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44578136|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578137|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578138|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44798482|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798483|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798484|NCT02007837|Analgesics|analgesics|mesh-ancestor
44798485|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
44798486|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798487|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798488|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798489|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798490|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44798491|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44798492|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798493|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44798494|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44798495|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798496|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
44798497|NCT02007850|Ropivacaine|ropivacaine|mesh-list
44798498|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
44798499|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
44798500|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798501|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798502|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
44798503|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798504|NCT02007915|Pamidronate|pamidronate|mesh-list
44798505|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798506|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798507|NCT02007928|Olanzapine|olanzapine|mesh-list
44798508|NCT02007928|Risperidone|risperidone|mesh-list
44798509|NCT02007928|Aripiprazole|aripiprazole|mesh-list
44798510|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44798511|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
44798512|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798513|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798514|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798515|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44798516|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44798517|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798518|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44798519|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44798520|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
44798521|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
44798522|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
44798523|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798524|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798525|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44798526|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44798527|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798528|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
44798529|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
44798530|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44798531|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44798532|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44798533|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44798534|NCT02008006|Cytarabine|cytarabine|mesh-list
44798535|NCT02008006|Etoposide|etoposide|mesh-list
44798536|NCT02008006|Melphalan|melphalan|mesh-list
44798537|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44798538|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44798539|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798540|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44798541|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44798542|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798543|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798544|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798545|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
44798546|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
44798547|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798548|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798549|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
44410672|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410705|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
44798550|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798551|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44798552|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
44798553|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44798554|NCT02008019|Everolimus|everolimus|mesh-list
44578187|NCT00925990|Ribavirin|ribavirin|mesh-list
44798555|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798556|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44798557|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
44798558|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798559|NCT02008123|Primidone|primidone|mesh-list
44798560|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
44798561|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
44798562|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
44798563|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798564|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798565|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798566|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
44798567|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44798568|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798569|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798570|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
44798571|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798572|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798573|NCT02008162|Bromides|bromides|mesh-list
44798574|NCT02008162|Albuterol|albuterol|mesh-list
44798575|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
44798576|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
44798577|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
44798578|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798579|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798580|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44798581|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
44798582|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
44798583|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44798584|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
44798585|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798586|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798587|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
44798588|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
44798589|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44798590|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44798591|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44798592|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44798593|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
44798594|NCT02008201|Vitamin D|vitamin d|mesh-list
44798595|NCT02008201|Vitamins|vitamins|mesh-ancestor
44798596|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
44798597|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798598|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798599|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
44798600|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44798601|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798602|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798603|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44798604|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44798605|NCT02008214|Protective Agents|protective agents|mesh-ancestor
44798606|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798607|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
44798608|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44798609|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
44798610|NCT02008383|Panitumumab|panitumumab|mesh-list
44798611|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44798612|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798613|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
44798614|NCT02008422|Tegafur|tegafur|mesh-list
44798615|NCT02008422|Endostar protein|endostar protein|mesh-list
44798616|NCT02008422|Endostatins|endostatins|mesh-list
44798617|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798618|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798619|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
44798620|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798621|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44798622|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44798623|NCT02008422|Growth Substances|growth substances|mesh-ancestor
44798624|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798625|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
44798626|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
44798627|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44798628|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798629|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410745|NCT02463357|Metformin|metformin|mesh-list
44798631|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798632|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798633|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
44693054|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44693055|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
44693056|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
44693057|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693058|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693059|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693060|NCT01371968|Alfentanil|alfentanil|mesh-list
44693061|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44693062|NCT01371968|Narcotics|narcotics|mesh-ancestor
44693063|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44693064|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693065|NCT01371968|Analgesics|analgesics|mesh-ancestor
44693066|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
44693067|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693068|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44693069|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
44693070|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
44693071|NCT01372007|Lanreotide|lanreotide|mesh-list
44693072|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693073|NCT01372111|Cisplatin|cisplatin|mesh-list
44693074|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693075|NCT01372280|Galantamine|galantamine|mesh-list
44693076|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44693077|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693078|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693079|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44693080|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693081|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693082|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44693083|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
44693084|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693085|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
44693086|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
44693087|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
44693088|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44693089|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44244654|NCT05272878|Irbesartan|irbesartan|mesh-list
44693103|NCT01372371|Vancomycin|vancomycin|mesh-list
44693104|NCT01372371|Gentamicins|gentamicins|mesh-list
44693105|NCT01372371|Cefuroxime|cefuroxime|mesh-list
44693106|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
44693107|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44693108|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44693109|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44693110|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44693111|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693112|NCT01372423|Lubiprostone|lubiprostone|mesh-list
44693113|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44693114|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44693115|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693116|NCT01372449|Memantine|memantine|mesh-list
44693117|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44693118|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44693119|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
44693120|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693121|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693122|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693123|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44693124|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44693125|NCT01372540|Filanesib|filanesib|mesh-list
44693126|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
44693127|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
44693128|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693129|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693130|NCT01372579|Carboplatin|carboplatin|mesh-list
44693131|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693132|NCT01372644|Pasireotide|pasireotide|mesh-list
44693133|NCT01372644|Hormones|hormones|mesh-ancestor
44410843|NCT02461758|Vaccines|vaccines|mesh-list
44693134|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44693135|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693136|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
44578333|NCT00924664|Tanezumab|tanezumab|mesh-list
44798634|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44798635|NCT02008578|Antibodies|antibodies|mesh-list
44798636|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
44798637|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798638|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
44798639|NCT02008721|Protective Agents|protective agents|mesh-ancestor
44798640|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798641|NCT02008734|Palbociclib|palbociclib|mesh-list
44798642|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798643|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44798644|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798645|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798646|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
44798647|NCT02008747|Analgesics|analgesics|mesh-ancestor
44798648|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
44798649|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798650|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798651|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
44798652|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798653|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798654|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
44798655|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44798656|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798657|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798658|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798659|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
44798660|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44798661|NCT02008786|Ramipril|ramipril|mesh-list
44798662|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44798663|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44798664|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44798665|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
44798666|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798667|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44798668|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44798669|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798670|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44798671|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44798672|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44798673|NCT02008968|Allopurinol|allopurinol|mesh-list
44798674|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
44798675|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798676|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410893|NCT02460991|Sorafenib|sorafenib|mesh-list
44798677|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
44798678|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798679|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44798680|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
44798681|NCT02008968|Protective Agents|protective agents|mesh-ancestor
44798682|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798683|NCT02008981|Aspirin|aspirin|mesh-list
44798684|NCT02008981|Turmeric extract|turmeric extract|mesh-list
44798685|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44798686|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44798687|NCT02008981|Analgesics|analgesics|mesh-ancestor
44798688|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
44798689|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798690|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798691|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44798692|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44798693|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44798694|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44798695|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798696|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44798697|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44798698|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798699|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
44798700|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
44798701|NCT02008981|Protective Agents|protective agents|mesh-ancestor
44798702|NCT02009007|Phenylephrine|phenylephrine|mesh-list
44798703|NCT02009007|Dopamine|dopamine|mesh-list
44798704|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
44798705|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44798706|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
44798707|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
44798708|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578389|NCT00924287|Mesna|mesna|mesh-list
44798709|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798710|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
44798711|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44798712|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
44798713|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
44798714|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44798715|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44798716|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44798717|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
44798718|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798719|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798720|NCT02009007|Protective Agents|protective agents|mesh-ancestor
44798721|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
44798722|NCT02009098|Cefuroxime|cefuroxime|mesh-list
44798723|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
44798724|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798725|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798726|NCT02009189|Taurolidine|taurolidine|mesh-list
44798727|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798728|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44798729|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798730|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
44798731|NCT02009202|Cathartics|cathartics|mesh-ancestor
44798732|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798733|NCT02009215|Piperaquine|piperaquine|mesh-list
44798734|NCT02009215|Artenimol|artenimol|mesh-list
44798735|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
44798736|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44798737|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44798738|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798739|NCT02009280|Anesthetics|anesthetics|mesh-list
44798740|NCT02009280|Propofol|propofol|mesh-list
44798741|NCT02009280|Sevoflurane|sevoflurane|mesh-list
44798742|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798743|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798744|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798745|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798746|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
44798747|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44798748|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44798749|NCT02009306|Fentanyl|fentanyl|mesh-list
44798750|NCT02009306|Midazolam|midazolam|mesh-list
44798751|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44798752|NCT02009306|Narcotics|narcotics|mesh-ancestor
44798753|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798754|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798755|NCT02009306|Analgesics|analgesics|mesh-ancestor
44798756|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
44798757|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798758|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44798759|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798760|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
44798761|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
44798762|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798763|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44798764|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44798765|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44798766|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
44798767|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
44798768|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798769|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798770|NCT02009410|Pancrelipase|pancrelipase|mesh-list
44798771|NCT02009410|Pancreatin|pancreatin|mesh-list
44798772|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798773|NCT02009436|Azacitidine|azacitidine|mesh-list
44798774|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44798775|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
44798776|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798777|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798778|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798779|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44798780|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
44798781|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44798782|NCT02009462|Protective Agents|protective agents|mesh-ancestor
44798783|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798784|NCT02009488|Canagliflozin|canagliflozin|mesh-list
44798785|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44798786|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798787|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44798788|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798789|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
44798790|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
44798791|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44798792|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
44798793|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44798794|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44798795|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44798796|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798797|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798798|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
44798799|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798800|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798801|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44798802|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798803|NCT02009592|Rifaximin|rifaximin|mesh-list
44798804|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798805|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798806|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798807|NCT02009618|Rifaximin|rifaximin|mesh-list
44798808|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44798809|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798810|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798811|NCT02009631|Veliparib|veliparib|mesh-list
44798812|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44798813|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798814|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798815|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798816|NCT02009709|Riboflavin|riboflavin|mesh-list
44798817|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44798818|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44798819|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
44798820|NCT02009709|Vitamins|vitamins|mesh-ancestor
44798821|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
44798822|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798823|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44798824|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
44798825|NCT02009748|Vitamin D|vitamin d|mesh-list
44798826|NCT02009748|Vitamins|vitamins|mesh-ancestor
44798827|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
44798828|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798829|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798830|NCT02009787|Vitamin D|vitamin d|mesh-list
44798831|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
44798832|NCT02009787|Vitamins|vitamins|mesh-ancestor
44798833|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
44798834|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798835|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798836|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798837|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44798838|NCT02009943|Hematinics|hematinics|mesh-ancestor
44798839|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
44798840|NCT02010164|Ubiquinone|ubiquinone|mesh-list
44798841|NCT02010164|Vitamins|vitamins|mesh-ancestor
44798842|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
44798843|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798844|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44798845|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44798846|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44798847|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
44798848|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798849|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798850|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
44798851|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44798852|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44798853|NCT02010723|Polidocanol|polidocanol|mesh-list
44798854|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44798855|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44798856|NCT02010762|Vitamin D|vitamin d|mesh-list
44798857|NCT02010762|Vitamins|vitamins|mesh-ancestor
44798858|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
44798859|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798860|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44798861|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
44798862|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44798863|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44798864|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44798865|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798866|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798867|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
44798868|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798869|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798870|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44798871|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798872|NCT02010827|Glucagon|glucagon|mesh-list
44798873|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798874|NCT02010827|Hormones|hormones|mesh-ancestor
44798875|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798876|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798877|NCT02010905|Losartan|losartan|mesh-list
44798878|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44798879|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44798880|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44798881|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44411094|NCT02454478|Everolimus|everolimus|mesh-list
44411106|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44798882|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798883|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
44798885|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44798886|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44798887|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44798888|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798889|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798890|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798891|NCT02010944|Urological Agents|urological agents|mesh-ancestor
44798892|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44798893|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44798894|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44798895|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44798896|NCT02010957|Etomidate|etomidate|mesh-list
44798897|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798898|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798899|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798900|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798901|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
44798902|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
44798903|NCT02010970|Itraconazole|itraconazole|mesh-list
44798904|NCT02010970|Diltiazem|diltiazem|mesh-list
44798905|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
44798906|NCT02010970|Midazolam|midazolam|mesh-list
44798907|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798908|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798909|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44798910|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44798911|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798912|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44798913|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44798914|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44798915|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798916|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
44798917|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
44798918|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
44798919|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
44798920|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798921|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798922|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
44798923|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44798924|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44798925|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44798926|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578638|NCT00920907|Ipilimumab|ipilimumab|mesh-list
44578639|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578640|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578641|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44578642|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578643|NCT00920855|Bortezomib|bortezomib|mesh-list
44578644|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44578645|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578646|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578647|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
44578648|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578649|NCT00920829|Naltrexone|naltrexone|mesh-list
44578650|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44578651|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44578652|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578653|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
44578654|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578655|NCT00920816|Sorafenib|sorafenib|mesh-list
44578656|NCT00920816|Axitinib|axitinib|mesh-list
44578657|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578658|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578659|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578660|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578661|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
44578662|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578663|NCT00920699|Ubiquinone|ubiquinone|mesh-list
44578664|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
44578665|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
44798927|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44798928|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
44798929|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44798930|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44798931|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44798932|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798933|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
44798934|NCT02011126|Imetelstat|imetelstat|mesh-list
44798935|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
44798936|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798937|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798938|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44798939|NCT02011191|Biotin|biotin|mesh-list
44798940|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
44798941|NCT02011191|Vitamins|vitamins|mesh-ancestor
44798942|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
44798943|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798945|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44798946|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44798947|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798948|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44798949|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798950|NCT02011347|Ketamine|ketamine|mesh-list
44798951|NCT02011347|Analgesics|analgesics|mesh-ancestor
44798952|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
44798953|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798954|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798955|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44798956|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44798957|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
44798958|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
44798959|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44798960|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44798961|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44798962|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798963|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798964|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
44411179|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798965|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44798966|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44798967|NCT02011620|Isosorbide|isosorbide|mesh-list
44798968|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44798969|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44798970|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44798971|NCT02011620|Diuretics|diuretics|mesh-ancestor
44798972|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
44798973|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798974|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
44798975|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44798976|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798977|NCT02011633|Metformin|metformin|mesh-list
44798978|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44798979|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44798980|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798981|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44411219|NCT02451943|Olaratumab|olaratumab|mesh-list
44798982|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44798983|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
44798984|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798985|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44798986|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44798987|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44798988|NCT02011659|Ramosetron|ramosetron|mesh-list
44798989|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
44798990|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
44798991|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44798992|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44798993|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44798994|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44798995|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
44798996|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44798997|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44798998|NCT02011737|Naftopidil|naftopidil|mesh-list
44798999|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44799000|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44799001|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799002|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799003|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799004|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799005|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44799006|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44799007|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799008|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44799009|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44799010|NCT02011750|Valproic Acid|valproic acid|mesh-list
44799011|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
44799012|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799013|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799014|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
44799015|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693137|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
44799016|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799017|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
44799018|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799019|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799020|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799021|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
44799022|NCT02011828|Vitamin D|vitamin d|mesh-list
44799023|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44411238|NCT02451696|Everolimus|everolimus|mesh-list
44799024|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799025|NCT02011828|Vitamins|vitamins|mesh-ancestor
44799026|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
44799027|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44799028|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
44799029|NCT02011841|Rifaximin|rifaximin|mesh-list
44799030|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799031|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799032|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799033|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799034|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476056|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799035|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799036|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799037|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44799038|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44799039|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799040|NCT02011880|Corylifolin|corylifolin|mesh-list
44799041|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44799042|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799043|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799044|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799045|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799046|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799047|NCT02011906|Vitamins|vitamins|mesh-list
44799048|NCT02011906|Vitamin E|vitamin e|mesh-list
44799049|NCT02011906|Tocopherols|tocopherols|mesh-list
44799050|NCT02011906|Tocotrienols|tocotrienols|mesh-list
44799051|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
44799052|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
44799053|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799054|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
44799055|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799056|NCT02011906|Protective Agents|protective agents|mesh-ancestor
44799057|NCT02011958|Amphotericin B|amphotericin b|mesh-list
44799058|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44799059|NCT02011958|Miltefosine|miltefosine|mesh-list
44799060|NCT02011958|Amebicides|amebicides|mesh-ancestor
44799061|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44799062|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44799063|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799064|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799065|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
44799066|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799067|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44799068|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44799069|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
44799070|NCT02012049|Risperidone|risperidone|mesh-list
44799071|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44799072|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
44799073|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799074|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476057|NCT04020588|Minocycline|minocycline|mesh-list
44799075|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799076|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44799077|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799078|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799079|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799080|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44799081|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
44799082|NCT02012062|Cisplatin|cisplatin|mesh-list
44799083|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
44799084|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799085|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799086|NCT02012075|Metoprolol|metoprolol|mesh-list
44799087|NCT02012075|Carvedilol|carvedilol|mesh-list
44799088|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44799089|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44799090|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
44799091|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
44799092|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799093|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799094|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44799095|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44799096|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44799097|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799098|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799099|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799100|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
44799101|NCT02012075|Protective Agents|protective agents|mesh-ancestor
44799102|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44799103|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799104|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44799105|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
44799106|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44799107|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44799108|NCT02012088|Prednisone|prednisone|mesh-list
44799109|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
44799110|NCT02012088|Rituximab|rituximab|mesh-list
44799111|NCT02012088|Doxorubicin|doxorubicin|mesh-list
44799112|NCT02012088|Vincristine|vincristine|mesh-list
44799113|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799114|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
44799115|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799116|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44799117|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44799118|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
44799119|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799120|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799121|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44799122|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799123|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44411329|NCT02448810|Fluorouracil|fluorouracil|mesh-list
44799124|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799125|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799126|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799127|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44799128|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
44799129|NCT02012088|Hormones|hormones|mesh-ancestor
44799130|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799131|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44799132|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799133|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799134|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799135|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799136|NCT02012140|Ticagrelor|ticagrelor|mesh-list
44799137|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44799138|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44799139|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44799140|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44799141|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
44799142|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799143|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799144|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799145|NCT02012166|Insulin|insulin|mesh-list
44799146|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44799147|NCT02012166|Octreotide|octreotide|mesh-list
44799148|NCT02012166|Glucagon|glucagon|mesh-list
44799149|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44799150|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799151|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799152|NCT02012166|Hormones|hormones|mesh-ancestor
44799153|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799154|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44799155|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799156|NCT02012244|Fentanyl|fentanyl|mesh-list
44799157|NCT02012244|Anesthetics|anesthetics|mesh-list
44799158|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
44799159|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44799160|NCT02012244|Narcotics|narcotics|mesh-ancestor
44799161|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799162|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799163|NCT02012244|Analgesics|analgesics|mesh-ancestor
44799164|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
44693138|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44693139|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44693140|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
44799165|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799166|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44799167|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799168|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
44799169|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44799170|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
44799171|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799172|NCT02012322|Ubiquinone|ubiquinone|mesh-list
44799173|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
44799174|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
44799175|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799176|NCT02012322|Vitamins|vitamins|mesh-ancestor
44799177|NCT02012335|Ketamine|ketamine|mesh-list
44799178|NCT02012335|Analgesics|analgesics|mesh-ancestor
44799179|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
44799180|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799181|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799182|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44799183|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799184|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
44799185|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
44799186|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799187|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44799188|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44799189|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799190|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799191|NCT02012387|Omalizumab|omalizumab|mesh-list
44799192|NCT02012387|Vaccines|vaccines|mesh-list
44799193|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44799194|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
44799195|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411431|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799196|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44799197|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44799198|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
44799199|NCT02012465|Insulin|insulin|mesh-list
44799200|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
44799201|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44799202|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799203|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44799204|NCT02012517|Cefazolin|cefazolin|mesh-list
44799205|NCT02012517|Cephalexin|cephalexin|mesh-list
44799206|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44799207|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799208|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
44799209|NCT02012556|Tesamorelin|tesamorelin|mesh-list
44799210|NCT02012556|Growth Substances|growth substances|mesh-ancestor
44799211|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799212|NCT02012569|Hemostatics|hemostatics|mesh-list
44799213|NCT02012569|Coagulants|coagulants|mesh-ancestor
44799214|NCT02012595|Donepezil|donepezil|mesh-list
44799215|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44799216|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799217|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799218|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
44799219|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799220|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799221|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
44799222|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
44799223|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799224|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
44799225|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799226|NCT02012777|Propranolol|propranolol|mesh-list
44799227|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44799228|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44799229|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799230|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799231|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799232|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799233|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44799234|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44799235|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
44799236|NCT02012920|Seviteronel|seviteronel|mesh-list
44799237|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799238|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44799239|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476058|NCT04020588|Celecoxib|celecoxib|mesh-list
44799240|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799242|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44799243|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799244|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799245|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44799246|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799247|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693141|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
44799248|NCT02012946|Simendan|simendan|mesh-list
44799249|NCT02012946|Dobutamine|dobutamine|mesh-list
44799250|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44799251|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
44799252|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44799253|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44799254|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799255|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799256|NCT02012946|Protective Agents|protective agents|mesh-ancestor
44799257|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799258|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
44799259|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
44799260|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799261|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44799262|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44799263|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44799264|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799265|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799266|NCT02012998|Vaccines|vaccines|mesh-list
44799267|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
44799268|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799269|NCT02013089|Everolimus|everolimus|mesh-list
44799270|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44799271|NCT02013089|Sorafenib|sorafenib|mesh-list
44799272|NCT02013089|Sunitinib|sunitinib|mesh-list
44799273|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
44799274|NCT02013089|Gefitinib|gefitinib|mesh-list
44799275|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799276|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799277|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
44799278|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799279|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44799280|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799281|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799282|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44799283|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44799284|NCT02013089|Growth Substances|growth substances|mesh-ancestor
44799285|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44799286|NCT02013102|Decitabine|decitabine|mesh-list
44799287|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799288|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
44799289|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799290|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799291|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799292|NCT02013115|Budesonide|budesonide|mesh-list
44799293|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44799294|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44799295|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
44799296|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799297|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799298|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44799299|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
44799300|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
44799301|NCT02013115|Hormones|hormones|mesh-ancestor
44799302|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799303|NCT02013154|Paclitaxel|paclitaxel|mesh-list
44799304|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
44799305|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799306|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799307|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799308|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799309|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799310|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799311|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799312|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44799313|NCT02013219|Atezolizumab|atezolizumab|mesh-list
44799314|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799315|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44799316|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799317|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799318|NCT02013232|Aripiprazole|aripiprazole|mesh-list
44799319|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
44799320|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799321|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44799322|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799323|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799324|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799325|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
44799326|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
44799327|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799328|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799329|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44799330|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44799331|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
44799332|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44799333|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44799334|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44799335|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44799336|NCT02013258|Oxytocin|oxytocin|mesh-list
44799337|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
44799338|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44799339|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799340|NCT02013271|Paclitaxel|paclitaxel|mesh-list
44799341|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799342|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799343|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799344|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799345|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799346|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799347|NCT02013362|Folic Acid|folic acid|mesh-list
44799348|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
44799349|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
44799350|NCT02013362|Vitamins|vitamins|mesh-ancestor
44799351|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
44799352|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799353|NCT02013362|Hematinics|hematinics|mesh-ancestor
44799354|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
44799355|NCT02013427|Naproxen|naproxen|mesh-list
44799356|NCT02013427|Omeprazole|omeprazole|mesh-list
44799357|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44799358|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799359|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44799360|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799361|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799362|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44799363|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44799364|NCT02013427|Analgesics|analgesics|mesh-ancestor
44799365|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
44799366|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799367|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799368|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44799369|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44799370|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
44799371|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44799372|NCT02013453|Paclitaxel|paclitaxel|mesh-list
44799373|NCT02013453|Carboplatin|carboplatin|mesh-list
44799374|NCT02013453|Fluorouracil|fluorouracil|mesh-list
44799375|NCT02013453|Pemetrexed|pemetrexed|mesh-list
44799376|NCT02013453|Omeprazole|omeprazole|mesh-list
44799377|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799378|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799379|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799380|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799381|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799382|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799383|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
44799384|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799385|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799386|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
44799387|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799388|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799389|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44799390|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44799391|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44799392|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799393|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44799394|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
44799395|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44799396|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579203|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579204|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579205|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44799397|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799398|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44799400|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
44799401|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799402|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44799403|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44799404|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44799405|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799406|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799407|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799408|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
44799409|NCT02013856|Procyanidin|procyanidin|mesh-list
44799410|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
44799411|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799412|NCT02013856|Protective Agents|protective agents|mesh-ancestor
44799413|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799414|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44799415|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44799416|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799417|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
44799418|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44799419|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799420|NCT02013960|Misoprostol|misoprostol|mesh-list
44799421|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44799422|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
44799423|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44799424|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799425|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44799426|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799427|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
44799428|NCT02013986|Midazolam|midazolam|mesh-list
44799429|NCT02013986|Propofol|propofol|mesh-list
44799430|NCT02013986|Etomidate|etomidate|mesh-list
44799431|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44799432|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799433|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799434|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799435|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
44799436|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
44799437|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44799438|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44799439|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799440|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799441|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
44799442|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
44799443|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799444|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799445|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44799446|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44799447|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44799448|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799449|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799450|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799451|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799452|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799453|NCT02014103|Tacrolimus|tacrolimus|mesh-list
44799454|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799455|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
44799456|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799457|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44799458|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799459|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799460|NCT02014337|Mifepristone|mifepristone|mesh-list
44799461|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44799462|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
44799463|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44799464|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799465|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44799466|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44799467|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44799468|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
44799469|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44799470|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44799471|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
44799472|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799473|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
44799474|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44799475|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44799476|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
44799477|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44799478|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
44799479|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799480|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
44799481|NCT02014428|Protective Agents|protective agents|mesh-ancestor
44799483|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44799484|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44799485|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44799486|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44799487|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799488|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799489|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799490|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799491|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44799492|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44799493|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
44799494|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
44799495|NCT02014506|Fludarabine|fludarabine|mesh-list
44799496|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44799497|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799498|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
44411728|NCT02438371|Nifedipine|nifedipine|mesh-list
44799499|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799500|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44799501|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44799502|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
44799503|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799504|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799505|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44799506|NCT02014532|Montelukast|montelukast|mesh-list
44799507|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44799508|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44799509|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
44799510|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
44799511|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799512|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799513|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44799514|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44799515|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799516|NCT02014545|Lucanthone|lucanthone|mesh-list
44799517|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
44799518|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44799519|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
44799520|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44799521|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799522|NCT02014558|Voriconazole|voriconazole|mesh-list
44799523|NCT02014558|Cephalexin|cephalexin|mesh-list
44799524|NCT02014558|Midazolam|midazolam|mesh-list
44799525|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44799526|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44799527|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799528|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799529|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44799530|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799531|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799532|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44411762|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44799533|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
44799534|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
44799535|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
44799536|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
44799537|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799538|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799539|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
44799540|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799541|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44799542|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44799543|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799544|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44799545|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
44799546|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799547|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44799548|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799549|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
44799550|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
44799551|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799552|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799553|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799554|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
44799555|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799556|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799557|NCT02014714|Fentanyl|fentanyl|mesh-list
44799558|NCT02014714|Morphine|morphine|mesh-list
44799559|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44799560|NCT02014714|Narcotics|narcotics|mesh-ancestor
44799561|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799562|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799563|NCT02014714|Analgesics|analgesics|mesh-ancestor
44799564|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
44799565|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799566|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44799567|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799568|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
44799569|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
44799570|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44799571|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44799572|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
44799573|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799574|NCT02014727|Antacids|antacids|mesh-ancestor
44799575|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799576|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799577|NCT02014753|Cobalt|cobalt|mesh-list
44799578|NCT02014753|Chromium|chromium|mesh-list
44799579|NCT02014753|Everolimus|everolimus|mesh-list
44799580|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799581|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799582|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
44411830|NCT02436135|Idelalisib|idelalisib|mesh-list
44799583|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799584|NCT02014753|Trace Elements|trace elements|mesh-ancestor
44799585|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
44799586|NCT02014831|Cetuximab|cetuximab|mesh-list
44799587|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799588|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799589|NCT02014922|Vitamin E|vitamin e|mesh-list
44799590|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
44799591|NCT02014922|Tocopherols|tocopherols|mesh-list
44799592|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44799593|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44799594|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
44799595|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44799596|NCT02014922|Laxatives|laxatives|mesh-ancestor
44799597|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799598|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
44799599|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799600|NCT02014922|Protective Agents|protective agents|mesh-ancestor
44799601|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799602|NCT02014922|Vitamins|vitamins|mesh-ancestor
44799603|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
44799604|NCT02015156|Trastuzumab|trastuzumab|mesh-list
44799605|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799606|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799607|NCT02015169|Lapatinib|lapatinib|mesh-list
44799608|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799609|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44799610|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799611|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799612|NCT02015182|Bupivacaine|bupivacaine|mesh-list
44799613|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
44799614|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
44799615|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799616|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799617|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
44799618|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411872|NCT02435277|Metformin|metformin|mesh-list
44799619|NCT02015260|Citric Acid|citric acid|mesh-list
44799620|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
44799621|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44799622|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
44799623|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
44799624|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799625|NCT02015299|Linagliptin|linagliptin|mesh-list
44799626|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44799627|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44799628|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799629|NCT02015299|Incretins|incretins|mesh-ancestor
44799630|NCT02015299|Hormones|hormones|mesh-ancestor
44799631|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799632|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
44799633|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799634|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799635|NCT02015312|Silicon|silicon|mesh-list
44799636|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44799637|NCT02015312|Mannitol|mannitol|mesh-list
44799638|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44799639|NCT02015312|Diuretics|diuretics|mesh-ancestor
44799640|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
44799641|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799642|NCT02015312|Trace Elements|trace elements|mesh-ancestor
44799643|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
44799644|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
44799645|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799646|NCT02015312|Protective Agents|protective agents|mesh-ancestor
44799647|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44799648|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44799649|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799650|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44799651|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
44799652|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44799653|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
44799654|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799655|NCT02015403|Expectorants|expectorants|mesh-ancestor
44799656|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
44799657|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44799658|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
44799659|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799660|NCT02015403|Protective Agents|protective agents|mesh-ancestor
44799661|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799662|NCT02015403|Antidotes|antidotes|mesh-ancestor
44799663|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
44799664|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
44799665|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799666|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
44799667|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
44799668|NCT02015507|Ivacaftor|ivacaftor|mesh-list
44799669|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799670|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799671|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799672|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799673|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799674|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799675|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799676|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44799677|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44799678|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44799679|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799680|NCT02015559|Protective Agents|protective agents|mesh-list
44799681|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799682|NCT02015598|Carbocysteine|carbocysteine|mesh-list
44799683|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44799684|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799685|NCT02015598|Expectorants|expectorants|mesh-ancestor
44799686|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
44799687|NCT02015650|Fluorouracil|fluorouracil|mesh-list
44799688|NCT02015650|Cetuximab|cetuximab|mesh-list
44799689|NCT02015650|Mitomycins|mitomycins|mesh-list
44799690|NCT02015650|Mitomycin|mitomycin|mesh-list
44799691|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
44799692|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799693|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799694|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799695|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799696|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
44799697|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799698|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799699|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44799700|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
44799701|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44799702|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799703|NCT02015728|Etoposide|etoposide|mesh-list
44799704|NCT02015728|Everolimus|everolimus|mesh-list
44799705|NCT02015728|Temozolomide|temozolomide|mesh-list
44799706|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44799707|NCT02015728|Sorafenib|sorafenib|mesh-list
44799708|NCT02015728|Dasatinib|dasatinib|mesh-list
44799709|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799710|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799711|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799712|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799713|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799714|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799715|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799716|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
44799717|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799718|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44799719|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
44799720|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44799721|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44799722|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799723|NCT02015923|Panitumumab|panitumumab|mesh-list
44799724|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44799725|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799726|NCT02015949|Methylphenidate|methylphenidate|mesh-list
44799727|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44799728|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799729|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44799730|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44799731|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799732|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693142|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44693143|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44693144|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693145|NCT01372761|CKD732|ckd732|mesh-list
44693146|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44693147|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44693148|NCT01372761|Growth Substances|growth substances|mesh-ancestor
44693149|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693150|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
44693151|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44693152|NCT01372826|Naloxegol|naloxegol|mesh-list
44693153|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44693154|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44693155|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
44693156|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44693157|NCT01372839|Atorvastatin|atorvastatin|mesh-list
44693158|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44693159|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44693160|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
44693161|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799733|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
44799734|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799735|NCT02015988|Simvastatin|simvastatin|mesh-list
44799736|NCT02015988|Fenofibrate|fenofibrate|mesh-list
44799737|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44411961|NCT02432846|Sunitinib|sunitinib|mesh-list
44799738|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44799739|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
44799740|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799741|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44799742|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44799743|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799744|NCT02016001|Fluorides|fluorides|mesh-list
44799745|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
44799746|NCT02016001|Protective Agents|protective agents|mesh-ancestor
44799747|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799748|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
44799749|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799750|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799751|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44799752|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44799753|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799754|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799755|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799756|NCT02016196|Rifaximin|rifaximin|mesh-list
44799757|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799758|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799759|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799760|NCT02016209|Paclitaxel|paclitaxel|mesh-list
44799761|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44799762|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799763|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799764|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799765|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799766|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799767|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799768|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
44799769|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44799770|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799771|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799772|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799773|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799774|NCT02016261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44799775|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44799776|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799777|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799778|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799779|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
44799780|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44799781|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
44799782|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44799783|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44799784|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799785|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44799786|NCT02016274|Paclitaxel|paclitaxel|mesh-list
44799787|NCT02016274|Cisplatin|cisplatin|mesh-list
44412016|NCT02431533|Calcium|calcium|mesh-list
44799788|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799789|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799790|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799791|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799792|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799793|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799794|NCT02016287|Paclitaxel|paclitaxel|mesh-list
44799795|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44799796|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799797|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799798|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799799|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799800|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799801|NCT02016365|Doxycycline|doxycycline|mesh-list
44799802|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44799803|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44799804|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799805|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
44799806|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44799807|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44799808|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44799809|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799810|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
44799811|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44799812|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799813|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799814|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44799815|NCT02016391|Analgesics|analgesics|mesh-ancestor
44799816|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
44799817|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799818|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44799819|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44799820|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44799821|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799822|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799823|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799824|NCT02016417|Gemcitabine|gemcitabine|mesh-list
44799825|NCT02016417|Cisplatin|cisplatin|mesh-list
44799826|NCT02016417|Docetaxel|docetaxel|mesh-list
44799827|NCT02016417|Fluorouracil|fluorouracil|mesh-list
44799828|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799829|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799830|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
44799831|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799832|NCT02016417|Antiviral Agents|antiviral agents|mesh-ancestor
44799833|NCT02016417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44799834|NCT02016417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799835|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799836|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
44799837|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799838|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44799839|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44799840|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44799841|NCT02016443|Tizanidine|tizanidine|mesh-list
44799842|NCT02016443|Analgesics|analgesics|mesh-ancestor
44799843|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
44799844|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799845|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799846|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
44799847|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44799848|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44799849|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
44799850|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
44799851|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44799852|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44799853|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44412071|NCT02429427|Celecoxib|celecoxib|mesh-list
44799854|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44799855|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799856|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799857|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
44799858|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
44799859|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799860|NCT02016495|Protective Agents|protective agents|mesh-ancestor
44799861|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799862|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
44799863|NCT02016495|Vitamins|vitamins|mesh-ancestor
44799864|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
44799865|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44799866|NCT02016547|Abciximab|abciximab|mesh-list
44799867|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44799868|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44799869|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799870|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
44799871|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44799872|NCT02016664|Ketamine|ketamine|mesh-list
44799873|NCT02016664|Analgesics|analgesics|mesh-ancestor
44799874|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
44799875|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799876|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799877|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44799878|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799879|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
44799880|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
44799881|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579708|NCT00906282|Carboplatin|carboplatin|mesh-list
44799882|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44799883|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44799884|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799885|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799887|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
44799888|NCT02016729|Trametinib|trametinib|mesh-list
44799889|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799890|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44799891|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799892|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799893|NCT02016807|Sucralfate|sucralfate|mesh-list
44799894|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44799895|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799896|NCT02016820|Omeprazole|omeprazole|mesh-list
44799897|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44799898|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799899|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44799900|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799901|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579779|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
44579780|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44579781|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44579782|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579783|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44579784|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44579785|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579786|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579787|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
44579788|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579789|NCT00905307|Aripiprazole|aripiprazole|mesh-list
44579790|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
44579791|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44579792|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44579793|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44579794|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579795|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579796|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
44579797|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
44579798|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579799|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579800|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44579801|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44799902|NCT02016846|Liraglutide|liraglutide|mesh-list
44799903|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44799904|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799905|NCT02016846|Incretins|incretins|mesh-ancestor
44799906|NCT02016846|Hormones|hormones|mesh-ancestor
44799907|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44799908|NCT02016976|Midazolam|midazolam|mesh-list
44799909|NCT02016976|Meperidine|meperidine|mesh-list
44799910|NCT02016976|Analgesics|analgesics|mesh-list
44799911|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
44799912|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799913|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799914|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44799915|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44799916|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799917|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44799918|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44799919|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44799920|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44799921|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
44799922|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
44799923|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
44799924|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
44799925|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44799926|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799927|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44799928|NCT02016976|Narcotics|narcotics|mesh-ancestor
44799929|NCT02017119|Lactulose|lactulose|mesh-list
44799930|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44799931|NCT02017197|Warfarin|warfarin|mesh-list
44799932|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
44799933|NCT02017314|Morphine|morphine|mesh-list
44799934|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44799935|NCT02017314|Narcotics|narcotics|mesh-ancestor
44799936|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44799937|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799938|NCT02017314|Analgesics|analgesics|mesh-ancestor
44799939|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
44799940|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799941|NCT02017340|Nilvadipine|nilvadipine|mesh-list
44799942|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44799943|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44799944|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799945|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799946|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44799947|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799948|NCT02017392|Lidocaine|lidocaine|mesh-list
44799949|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44799950|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
44799951|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412239|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
44799952|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799953|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
44799954|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44799955|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44799956|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44799957|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44799958|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44799959|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799960|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
44799961|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44799962|NCT02017405|Antibodies|antibodies|mesh-list
44799963|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
44799964|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799965|NCT02017457|Azacitidine|azacitidine|mesh-list
44799966|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799967|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
44799968|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799969|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799970|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44799971|NCT02017561|Metformin|metformin|mesh-list
44799972|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44799973|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799974|NCT02017600|Cisplatin|cisplatin|mesh-list
44579834|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
44799975|NCT02017600|Fluorouracil|fluorouracil|mesh-list
44799976|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44799977|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
44799978|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44799979|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44799980|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44799981|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
44799982|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44799983|NCT02017613|Tenalisib|tenalisib|mesh-list
44412257|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507216|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507217|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507218|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507219|NCT03215940|Analgesics|analgesics|mesh-ancestor
44507220|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
44507221|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507222|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44507223|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44507224|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507225|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507226|NCT03215940|Hormones|hormones|mesh-ancestor
44507227|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507228|NCT03216343|Chiauranib|chiauranib|mesh-list
44507229|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507230|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507231|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507232|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507233|NCT03219528|Rifaximin|rifaximin|mesh-list
44507234|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507235|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507236|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507237|NCT03218722|Thrombin|thrombin|mesh-list
44507238|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
44507239|NCT03218722|Coagulants|coagulants|mesh-ancestor
44507240|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
44507241|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
44507242|NCT03219359|Vedolizumab|vedolizumab|mesh-list
44507243|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
44507244|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507245|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
44507246|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507247|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507248|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44507249|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
44507250|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507251|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507252|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44507253|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507254|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
44507255|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
44507256|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507257|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507258|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
44507259|NCT03219359|Hormones|hormones|mesh-ancestor
44507260|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507261|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44507262|NCT03219359|Protective Agents|protective agents|mesh-ancestor
44507263|NCT03211988|Entinostat|entinostat|mesh-list
44507264|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507265|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44507266|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507267|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507268|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44507269|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507270|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507271|NCT03216187|Pregabalin|pregabalin|mesh-list
44507272|NCT03216187|Analgesics|analgesics|mesh-ancestor
44507273|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
44507274|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507275|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507276|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
44507277|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44507278|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507279|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507280|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44507281|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44507282|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44507283|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507284|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507285|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
44507286|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507287|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507288|NCT03219788|Remifentanil|remifentanil|mesh-list
44507289|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44507290|NCT03219788|Narcotics|narcotics|mesh-ancestor
44507291|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507292|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507293|NCT03219788|Analgesics|analgesics|mesh-ancestor
44507294|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
44507295|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507297|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
44507298|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507299|NCT03219853|Protective Agents|protective agents|mesh-ancestor
44507300|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507301|NCT03219853|Trace Elements|trace elements|mesh-ancestor
44507302|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
44507303|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44507304|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507305|NCT03219970|Osimertinib|osimertinib|mesh-list
44507306|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507307|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507308|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507309|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507310|NCT03219983|Bupivacaine|bupivacaine|mesh-list
44507311|NCT03219983|Ropivacaine|ropivacaine|mesh-list
44507312|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
44507313|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
44507314|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507315|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507316|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
44507317|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507318|NCT03219710|Dexamethasone|dexamethasone|mesh-list
44507319|NCT03219710|Ondansetron|ondansetron|mesh-list
44507320|NCT03219710|Olanzapine|olanzapine|mesh-list
44507321|NCT03219710|Aprepitant|aprepitant|mesh-list
44507322|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507323|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
44507324|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
44507325|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412384|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507326|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507327|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507328|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
44507329|NCT03219710|Hormones|hormones|mesh-ancestor
44507330|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507331|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44507332|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507333|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
44507334|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507335|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44507336|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
44507337|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507338|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507339|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44507340|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44507341|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507342|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507343|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44507344|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44507345|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44507346|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507347|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44507348|NCT03219554|Palbociclib|palbociclib|mesh-list
44507349|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507350|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507351|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507352|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507353|NCT03219593|Apatinib|apatinib|mesh-list
44507354|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507355|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507356|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507357|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507358|NCT03219580|Fluorouracil|fluorouracil|mesh-list
44507359|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
44507360|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507361|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507362|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507363|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507364|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
44507365|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507367|NCT03219671|Ipilimumab|ipilimumab|mesh-list
44507368|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507369|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507370|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44412432|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44507371|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507372|NCT03219645|Aspirin|aspirin|mesh-list
44507373|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44507374|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507375|NCT03219645|Analgesics|analgesics|mesh-ancestor
44507376|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
44507377|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507378|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507379|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507380|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507381|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44507382|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44507383|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507384|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44507385|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44507386|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507387|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
44507388|NCT03218631|Oxandrolone|oxandrolone|mesh-list
44507389|NCT03218631|Androgens|androgens|mesh-ancestor
44507390|NCT03218631|Hormones|hormones|mesh-ancestor
44507391|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507392|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507393|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
44507394|NCT03218709|Vitamins|vitamins|mesh-list
44507395|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
44507396|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507397|NCT03218657|Cyclosporine|cyclosporine|mesh-list
44507398|NCT03218657|Levamisole|levamisole|mesh-list
44507399|NCT03218657|Cyclosporins|cyclosporins|mesh-list
44507400|NCT03218657|Androgens|androgens|mesh-list
44507401|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507402|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507403|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507404|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
44507405|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507406|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
44507407|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507408|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507409|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507410|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44507411|NCT03218657|Hormones|hormones|mesh-ancestor
44507412|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507413|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44507414|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
44507415|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
44507416|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44507417|NCT03218553|Dexamethasone|dexamethasone|mesh-list
44507418|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507419|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
44507420|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
44507421|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507422|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507423|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507424|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
44507425|NCT03218553|Hormones|hormones|mesh-ancestor
44507426|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507427|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412482|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507428|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507429|NCT03218852|Prednisone|prednisone|mesh-list
44507430|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
44507431|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507432|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
44507433|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507434|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507435|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44507436|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
44507437|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507438|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507439|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44507440|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507441|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
44507442|NCT03218852|Hormones|hormones|mesh-ancestor
44507443|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507444|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44507445|NCT03218514|Dalteparin|dalteparin|mesh-list
44507446|NCT03218514|Tinzaparin|tinzaparin|mesh-list
44507447|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44507448|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
44507449|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44507450|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44507451|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507452|NCT03218254|Methylphenidate|methylphenidate|mesh-list
44507453|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44507454|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507455|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44507456|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44507457|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507458|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507459|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
44507460|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507461|NCT03218280|Ascorbic Acid|ascorbic acid|mesh-list
44507462|NCT03218280|Vitamins|vitamins|mesh-ancestor
44327117|NCT00963729|Docetaxel|docetaxel|mesh-list
44507463|NCT03218280|Micronutrients|micronutrients|mesh-ancestor
44507464|NCT03218280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507465|NCT03218280|Antioxidants|antioxidants|mesh-ancestor
44412542|NCT02419612|Incretins|incretins|mesh-ancestor
44507466|NCT03218280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507467|NCT03218280|Protective Agents|protective agents|mesh-ancestor
44507468|NCT03218059|Methotrexate|methotrexate|mesh-list
44507469|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44507470|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
44507471|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44507472|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507473|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507474|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
44507475|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507476|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507477|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507478|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507479|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44507480|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507481|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
44507482|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507483|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44507484|NCT03218124|Remifentanil|remifentanil|mesh-list
44507485|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44507486|NCT03218124|Narcotics|narcotics|mesh-ancestor
44507487|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507488|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507489|NCT03218124|Analgesics|analgesics|mesh-ancestor
44507490|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
44507491|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507492|NCT03217838|Azacitidine|azacitidine|mesh-list
44507493|NCT03217838|Venetoclax|venetoclax|mesh-list
44507494|NCT03217838|Pyrazole|pyrazole|mesh-list
44507495|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507496|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
44507497|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507498|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507499|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507500|NCT03217825|Losartan|losartan|mesh-list
44507501|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44507502|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44507503|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44507504|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44507505|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507506|NCT03217942|Mitogens|mitogens|mesh-list
44507507|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44507508|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507509|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
44507510|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507511|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44507512|NCT03217409|Ezetimibe|ezetimibe|mesh-list
44507513|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44507514|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44507515|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
44507516|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507517|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44507518|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44507519|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507520|NCT03217292|Tramadol|tramadol|mesh-list
44507521|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44507522|NCT03217292|Narcotics|narcotics|mesh-ancestor
44507523|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507524|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507525|NCT03217292|Analgesics|analgesics|mesh-ancestor
44507526|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
44507527|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507528|NCT03217448|Warfarin|warfarin|mesh-list
44507529|NCT03217448|Dabigatran|dabigatran|mesh-list
44507530|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
44507531|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
44507532|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44507533|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44507534|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507535|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507536|NCT03217474|Ganciclovir|ganciclovir|mesh-list
44507537|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44327192|NCT00964041|Renal Agents|renal agents|mesh-ancestor
44507538|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
44507539|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507540|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44507541|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507542|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507543|NCT03217734|Adalimumab|adalimumab|mesh-list
44507544|NCT03217734|Methotrexate|methotrexate|mesh-list
44507545|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44507546|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
44507547|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44507548|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507549|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507550|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
44507551|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507552|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507553|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507554|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507555|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44507556|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507557|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
44507558|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507559|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44507560|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507561|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44507562|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507563|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507564|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507565|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44507566|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
44507567|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44507568|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507569|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507570|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507571|NCT03216759|Analgesics|analgesics|mesh-ancestor
44507572|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
44507573|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507574|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44507575|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44507576|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44507577|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507578|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507579|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507580|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44507581|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44507582|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507583|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507584|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
44507585|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507586|NCT03216980|Antioxidants|antioxidants|mesh-list
44507587|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507588|NCT03216980|Protective Agents|protective agents|mesh-ancestor
44507589|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507590|NCT03216876|Ursolic acid|ursolic acid|mesh-list
44507591|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507592|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44507593|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507594|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44507595|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507596|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507597|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44507598|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507599|NCT03216876|Analgesics|analgesics|mesh-ancestor
44507600|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
44507601|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507602|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507603|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507604|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507605|NCT03217084|Fluorides|fluorides|mesh-list
44507606|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
44507607|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
44507608|NCT03217084|Protective Agents|protective agents|mesh-ancestor
44327285|NCT00964171|Efavirenz|efavirenz|mesh-list
44507610|NCT03216941|Ketamine|ketamine|mesh-list
44507611|NCT03216941|Olanzapine|olanzapine|mesh-list
44507612|NCT03216941|Analgesics|analgesics|mesh-ancestor
44507613|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
44507614|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507615|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507616|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44507617|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44507618|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
44507619|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
44507620|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507621|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44507622|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44507623|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507624|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507625|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
44507626|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
44507627|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507628|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44507629|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44507630|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507631|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44507632|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44507633|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507634|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
44507635|NCT03216707|Capsaicin|capsaicin|mesh-list
44507636|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
44507637|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507638|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
44507639|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507640|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507641|NCT03216668|Silymarin|silymarin|mesh-list
44507642|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
44507643|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507644|NCT03216668|Protective Agents|protective agents|mesh-ancestor
44507645|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507646|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44507647|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507648|NCT03216525|Alvimopan|alvimopan|mesh-list
44507649|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44507650|NCT03216278|Metformin|metformin|mesh-list
44507651|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
44507652|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44507653|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507654|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44507655|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507656|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
44507657|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44507658|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44507659|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44507660|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507661|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507662|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44507663|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507664|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507665|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44507666|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507667|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
44507668|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44507669|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44507670|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44507671|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507672|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507673|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
44507674|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507675|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507676|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44507677|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507678|NCT03216564|Vitamin D|vitamin d|mesh-list
44507679|NCT03216564|Calcitriol|calcitriol|mesh-list
44507680|NCT03216564|Vitamins|vitamins|mesh-ancestor
44507681|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
44507682|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507683|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44507684|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44507685|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44507686|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507687|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507688|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44507690|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44507691|NCT03216304|Calcium|calcium|mesh-list
44507692|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44507693|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507694|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44507695|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44507696|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44507697|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
44507698|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507699|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44507700|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44507701|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507702|NCT03216395|Epinephrine|epinephrine|mesh-list
44412778|NCT02415556|Insulin|insulin|mesh-list
44507703|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44507704|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44507705|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507706|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507707|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507708|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507709|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44507710|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44507711|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
44507712|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507713|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44507714|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
44507715|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
44507716|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
44507717|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44507718|NCT03216447|Tacrolimus|tacrolimus|mesh-list
44507719|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507721|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507722|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44507723|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507724|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507725|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44507726|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44507727|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
44507728|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507729|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507730|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44507731|NCT03216538|Protective Agents|protective agents|mesh-ancestor
44507732|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44507733|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44507734|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507735|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507736|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
44507737|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507738|NCT03215875|Torsemide|torsemide|mesh-list
44507739|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44507740|NCT03215875|Diuretics|diuretics|mesh-ancestor
44507741|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
44507742|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507743|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44507744|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507745|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507746|NCT03215693|Ensartinib|ensartinib|mesh-list
44507747|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507748|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507749|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507750|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507751|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44507752|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44507753|NCT03215966|Tadalafil|tadalafil|mesh-list
44507754|NCT03215966|Macitentan|macitentan|mesh-list
44507755|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
44507756|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44507757|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44507758|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507759|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507760|NCT03215966|Urological Agents|urological agents|mesh-ancestor
44507761|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44507762|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44507763|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44507765|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44507766|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
44507767|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
44507768|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44507769|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44507770|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507771|NCT03215446|Anesthetics|anesthetics|mesh-list
44507772|NCT03215446|Propofol|propofol|mesh-list
44507773|NCT03215446|Sevoflurane|sevoflurane|mesh-list
44507774|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507775|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507776|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44507777|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44507778|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
44507779|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44507780|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44507781|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
44507782|NCT03215264|Entinostat|entinostat|mesh-list
44507783|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
44507784|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44507785|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44507786|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507787|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507788|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507789|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507790|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507791|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44507792|NCT03215407|Betamethasone|betamethasone|mesh-list
44507793|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44507794|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
44507795|NCT03215407|Hormones|hormones|mesh-ancestor
44507796|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507797|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507798|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44507799|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44507800|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
44507801|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44507802|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
44507803|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
44507804|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507805|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507806|NCT03214874|Torsemide|torsemide|mesh-list
44507807|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44507808|NCT03214874|Diuretics|diuretics|mesh-ancestor
44507809|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
44507810|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507811|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44507812|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507813|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507814|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
44507815|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44507816|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507817|NCT03214731|Artesunate|artesunate|mesh-list
44507818|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
44507819|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44507820|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44507821|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507822|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507823|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
44507824|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
44507825|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44507826|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
44507827|NCT03214536|Ropivacaine|ropivacaine|mesh-list
44507828|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
44507829|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235301|NCT00554164|Doxorubicin|doxorubicin|mesh-list
44507830|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507832|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
44507833|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507834|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
44507835|NCT03214770|Calcium|calcium|mesh-list
44507836|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44412893|NCT02412761|Lisinopril|lisinopril|mesh-list
44507837|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507838|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44507840|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44507841|NCT03214627|Hematinics|hematinics|mesh-list
44507842|NCT03214627|Trace Elements|trace elements|mesh-ancestor
44507843|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
44507844|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507845|NCT03214354|Sirolimus|sirolimus|mesh-list
44507846|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
44507847|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507848|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507849|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44507850|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507851|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
44507852|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507853|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
44507854|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507855|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507856|NCT03214393|Antibodies|antibodies|mesh-list
44507857|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
44507858|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507859|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
44507860|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44507861|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
44507862|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44507863|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
44507864|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507865|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507866|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
44507867|NCT03214003|Cisplatin|cisplatin|mesh-list
44507868|NCT03214003|Etoposide|etoposide|mesh-list
44507869|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
44507870|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507871|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44507872|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44507873|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44507874|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507875|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507876|NCT03214159|Ritonavir|ritonavir|mesh-list
44507877|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44507878|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44507879|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
44507880|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507881|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507882|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44507883|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44507884|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
44507885|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507886|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44507887|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44507888|NCT03214055|Mannitol|mannitol|mesh-list
44507889|NCT03214055|Diuretics|diuretics|mesh-list
44507890|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44507891|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
44507892|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507893|NCT03213964|Interleukin-2|interleukin-2|mesh-list
44507894|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507895|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507896|NCT03213964|Analgesics|analgesics|mesh-ancestor
44507897|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
44507898|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507899|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507900|NCT03213977|Prednisone|prednisone|mesh-list
44507901|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
44507902|NCT03213977|Doxorubicin|doxorubicin|mesh-list
44507903|NCT03213977|Etoposide|etoposide|mesh-list
44507904|NCT03213977|Vincristine|vincristine|mesh-list
44507905|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507906|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
44507907|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507908|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507909|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44507910|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
44507911|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507912|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507913|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44507914|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44507915|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44507916|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44507917|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507918|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44507919|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327634|NCT00965926|Mirabegron|mirabegron|mesh-list
44507920|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
44507922|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44507923|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44507924|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
44507925|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
44507926|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
44507927|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44507928|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44507929|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44507930|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507931|NCT03213886|Vitamin D|vitamin d|mesh-list
44507932|NCT03213886|Calcifediol|calcifediol|mesh-list
44507933|NCT03213886|Vitamins|vitamins|mesh-ancestor
44507934|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
44507935|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507936|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44507937|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
44507938|NCT03213444|Fluorouracil|fluorouracil|mesh-list
44507939|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507940|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
44507941|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507942|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507943|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507944|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
44507945|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507946|NCT03213587|Apatinib|apatinib|mesh-list
44507947|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507948|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44507949|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507950|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507951|NCT03213392|Anesthetics|anesthetics|mesh-list
44507952|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507953|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507954|NCT03213353|Acetaminophen|acetaminophen|mesh-list
44507955|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
44507956|NCT03213353|Phenylephrine|phenylephrine|mesh-list
44507957|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
44507958|NCT03213353|Guaifenesin|guaifenesin|mesh-list
44507959|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44507960|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507961|NCT03213353|Analgesics|analgesics|mesh-ancestor
44507962|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
44507963|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507964|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507965|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
44507966|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44507967|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
44507968|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
44507969|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
44507970|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44507971|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
44507972|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44507973|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44507974|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44507975|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44507976|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507977|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507978|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507979|NCT03213353|Protective Agents|protective agents|mesh-ancestor
44507980|NCT03213353|Expectorants|expectorants|mesh-ancestor
44507981|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
44507982|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44507984|NCT03213249|Cefazolin|cefazolin|mesh-list
44507985|NCT03213249|Bacitracin|bacitracin|mesh-list
44507986|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507987|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507988|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44507989|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507990|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507991|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44507992|NCT03213145|Rifampin|rifampin|mesh-list
44507993|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44507994|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
44507995|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507996|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507997|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
44507998|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44507999|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508000|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508001|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44508002|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44508003|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44508004|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44508005|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44508006|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44508007|NCT03213041|Carboplatin|carboplatin|mesh-list
44508008|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
44508009|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508010|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508011|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
44508012|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44508013|NCT03212716|Oseltamivir|oseltamivir|mesh-list
44508014|NCT03212716|Diltiazem|diltiazem|mesh-list
44508015|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
44508016|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413077|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
44508017|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508018|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508019|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508020|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44508021|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508022|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44508023|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508024|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44508025|NCT03212807|Lenalidomide|lenalidomide|mesh-list
44508026|NCT03212807|Durvalumab|durvalumab|mesh-list
44508027|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
44508028|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508029|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44508030|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44508031|NCT03212807|Growth Substances|growth substances|mesh-ancestor
44508032|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
44508033|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508034|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508035|NCT03213002|Capecitabine|capecitabine|mesh-list
44508036|NCT03213002|Temozolomide|temozolomide|mesh-list
44508037|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44508038|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
44508039|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508040|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508041|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508042|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
44508043|NCT03212820|Methamphetamine|methamphetamine|mesh-list
44508044|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44508045|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508046|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
44508047|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
44508048|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508049|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
44508050|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508051|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508052|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
44508053|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43917596|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
44508054|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44508055|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508056|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44508057|NCT03212833|Insulin|insulin|mesh-list
44508058|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508059|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508060|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
44508061|NCT03212781|Dextrans|dextrans|mesh-list
44508062|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
44508063|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
44508064|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
44508065|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
44508066|NCT03212781|Trace Elements|trace elements|mesh-ancestor
44508067|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
44508068|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508069|NCT03212781|Hematinics|hematinics|mesh-ancestor
44508070|NCT03212937|Carboplatin|carboplatin|mesh-list
44508071|NCT03212937|Etoposide|etoposide|mesh-list
44508072|NCT03212937|Ifosfamide|ifosfamide|mesh-list
44508073|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508074|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44508075|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44508076|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44508077|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508078|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508079|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508080|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
44508081|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
44508082|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44508083|NCT03212755|Antibodies|antibodies|mesh-list
44508084|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
44508085|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
44508086|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508087|NCT03212599|Disulfiram|disulfiram|mesh-list
44508088|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44508089|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44508090|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508091|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508092|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
44508093|NCT03212456|Ropivacaine|ropivacaine|mesh-list
44508094|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
44508095|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
44508096|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508097|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508098|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
44508099|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508100|NCT03212456|Narcotics|narcotics|mesh-ancestor
44508101|NCT03212456|Analgesics|analgesics|mesh-ancestor
44508102|NCT03212469|Durvalumab|durvalumab|mesh-list
44508103|NCT03212469|Tremelimumab|tremelimumab|mesh-list
44508104|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508105|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508106|NCT03212053|Hemostatics|hemostatics|mesh-list
44508107|NCT03212053|Coagulants|coagulants|mesh-ancestor
44508108|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
44508109|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44508110|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508111|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508112|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508113|NCT03211871|Analgesics|analgesics|mesh-ancestor
44508114|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
44508115|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508116|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44508117|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44508118|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44508119|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44508120|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508121|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508122|NCT03211897|Midazolam|midazolam|mesh-list
44508123|NCT03211897|Haloperidol|haloperidol|mesh-list
44508124|NCT03211897|Olanzapine|olanzapine|mesh-list
44508125|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
44508126|NCT03211897|Ziprasidone|ziprasidone|mesh-list
44508127|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44508128|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44508129|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508130|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508131|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44508132|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508133|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508134|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44508135|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
44508136|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
44508137|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
44508138|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
44508139|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508140|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508141|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
44508142|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
44508143|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508144|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44508145|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44508146|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44508147|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44508148|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508149|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
44508150|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44508151|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
44508152|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44508153|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44508154|NCT03211728|Pregabalin|pregabalin|mesh-list
44508155|NCT03211728|Analgesics|analgesics|mesh-ancestor
44508156|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
44508157|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508158|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508159|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
44508160|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44508161|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508162|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508163|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44508164|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44508165|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508166|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508167|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508168|NCT03211572|Tamoxifen|tamoxifen|mesh-list
44413248|NCT02406261|Midazolam|midazolam|mesh-list
44508169|NCT03211572|Anastrozole|anastrozole|mesh-list
44508170|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44508171|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
44508172|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508173|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508174|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508175|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508176|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44508177|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44508178|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44508179|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44508180|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44508182|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508183|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
44508184|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44508185|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
44508186|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508187|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
44508188|NCT03211650|Protective Agents|protective agents|mesh-ancestor
44508189|NCT03211455|Lidocaine|lidocaine|mesh-list
44508190|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
44508191|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
44508192|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508193|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508194|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
44508195|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508196|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44508197|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44508198|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44508199|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508200|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508201|NCT03211052|Leuprolide|leuprolide|mesh-list
44508202|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44508203|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
44508204|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508205|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508207|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508208|NCT03211104|Curcumin|curcumin|mesh-list
44508209|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508210|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508211|NCT03211104|Analgesics|analgesics|mesh-ancestor
44508212|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
44508213|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508214|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508215|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508216|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508217|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508218|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508219|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508220|NCT03211143|Esomeprazole|esomeprazole|mesh-list
44508221|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44508222|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44508223|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44508224|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508225|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508226|NCT03211013|Oxytocin|oxytocin|mesh-list
44508227|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
44508228|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508229|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508230|NCT03211351|Dextrans|dextrans|mesh-list
44508231|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
44508232|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
44508233|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
44413282|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508234|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44508235|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44508236|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508237|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508238|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508239|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
44508240|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508241|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508242|NCT03210610|Colchicine|colchicine|mesh-list
44508243|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
44508244|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508245|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44508246|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44508247|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44508248|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508249|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508250|NCT03210545|Betamethasone|betamethasone|mesh-list
44508251|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508252|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
44508253|NCT03210545|Hormones|hormones|mesh-ancestor
44508254|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508255|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508256|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44508257|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
44508258|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44508259|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
44508260|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508261|NCT03210532|Amlodipine|amlodipine|mesh-list
44508262|NCT03210532|Telmisartan|telmisartan|mesh-list
44508263|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44508264|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44508265|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508266|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44508267|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508268|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508269|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44508270|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508271|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44508272|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44508273|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44508274|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
44508275|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44508276|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44508277|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508278|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44508279|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44508280|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44508281|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44508282|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44508283|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
44508284|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508285|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508286|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44508287|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44413347|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44508288|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44508289|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44508290|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44508291|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44508292|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44508293|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44508294|NCT03210324|Mifepristone|mifepristone|mesh-list
44508295|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44508296|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
44508297|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508298|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508299|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44508300|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44508301|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44508302|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
44508303|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44508304|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44508305|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
44508306|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508307|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
44508308|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44508309|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44508310|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
44508311|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
44508312|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508313|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508314|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508315|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
44508316|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508317|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508318|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508319|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44508320|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
44508321|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508322|NCT03210064|Fluorouracil|fluorouracil|mesh-list
44508323|NCT03210064|Apatinib|apatinib|mesh-list
44508324|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
44508325|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508326|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44508327|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508328|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508329|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
44508330|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508331|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44508332|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508333|NCT03210025|Methyldopa|methyldopa|mesh-list
44508334|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508335|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
44508336|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
44508337|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508338|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508339|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44508340|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44508341|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44508342|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
44508343|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508344|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508345|NCT03210038|Lidocaine|lidocaine|mesh-list
44508346|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
44508347|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
44508348|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625278|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
44508349|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508350|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
44508351|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508352|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44508353|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44508354|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44508355|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508356|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508358|NCT03215524|Dexamethasone|dexamethasone|mesh-list
44508359|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
44508360|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
44508361|NCT03215524|Daratumumab|daratumumab|mesh-list
44508362|NCT03215524|Pomalidomide|pomalidomide|mesh-list
44508363|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44508364|NCT03215524|BB 1101|bb 1101|mesh-list
44508365|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508366|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
44508367|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508368|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508369|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508370|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
44508371|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508372|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508373|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44508374|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508375|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
44508376|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
44508377|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508378|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44508379|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
44508380|NCT03215524|Hormones|hormones|mesh-ancestor
44508381|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508382|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508383|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44508384|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508385|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44508386|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44508387|NCT03215524|Growth Substances|growth substances|mesh-ancestor
44508388|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44508389|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
44508390|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44508391|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508392|NCT03219437|Methotrexate|methotrexate|mesh-list
44508393|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44508394|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
44508395|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508396|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508397|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44508398|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
44508399|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508400|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508401|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44508402|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508403|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44508404|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508405|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
44508406|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508407|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44508408|NCT03219268|Margetuximab|margetuximab|mesh-list
44508409|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508410|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
44508411|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508412|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
44508413|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508414|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508415|NCT03212963|Clobetasol|clobetasol|mesh-list
44508416|NCT03212963|Halobetasol|halobetasol|mesh-list
44508417|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44508418|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508419|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
44508420|NCT03212963|Hormones|hormones|mesh-ancestor
44508421|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508422|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508423|NCT03213158|Ixazomib|ixazomib|mesh-list
44508424|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508425|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
44508426|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508427|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508428|NCT03219476|Tamoxifen|tamoxifen|mesh-list
44508429|NCT03219476|Letrozole|letrozole|mesh-list
44508430|NCT03219476|Anastrozole|anastrozole|mesh-list
44508431|NCT03219476|Exemestane|exemestane|mesh-list
44508432|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508433|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44508434|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44508435|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508436|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508437|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44508438|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
44508439|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508440|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508441|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508442|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44508443|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44508444|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44508445|NCT03217136|Metronidazole|metronidazole|mesh-list
44508446|NCT03217136|Meropenem|meropenem|mesh-list
44508447|NCT03217136|Tazobactam|tazobactam|mesh-list
44508448|NCT03217136|Ceftolozane|ceftolozane|mesh-list
44508449|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44508450|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508451|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44508452|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44508453|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44508454|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44508455|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508456|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508457|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44508458|NCT03217136|Renal Agents|renal agents|mesh-ancestor
44508459|NCT03219164|Aztreonam|aztreonam|mesh-list
44508460|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44508461|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508462|NCT03218969|Ecopipam|ecopipam|mesh-list
44508463|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44508464|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508465|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508466|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508467|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508468|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44508469|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
44508470|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508471|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508472|NCT03215797|Phenylephrine|phenylephrine|mesh-list
44508473|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
44508474|NCT03215797|Norepinephrine|norepinephrine|mesh-list
44508475|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
44508476|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44508477|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
44508478|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
44508479|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508480|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508481|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
44508482|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44508483|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
44508484|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
44508485|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44508486|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44508487|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44508488|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508489|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508490|NCT03215797|Protective Agents|protective agents|mesh-ancestor
44508491|NCT01830101|Temozolomide|temozolomide|mesh-list
44508492|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508493|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
44508494|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508495|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508496|NCT01830218|Anesthetics|anesthetics|mesh-list
44508497|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508498|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508499|NCT01830296|Morphine|morphine|mesh-list
44508500|NCT01830296|Remifentanil|remifentanil|mesh-list
44508501|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44508502|NCT01830296|Narcotics|narcotics|mesh-ancestor
44508503|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413561|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
44508504|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508505|NCT01830296|Analgesics|analgesics|mesh-ancestor
44508506|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
44508507|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508508|NCT01830322|Gemcitabine|gemcitabine|mesh-list
44508509|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44508510|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
44508511|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508512|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508513|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
44508514|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508515|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508516|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508517|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
44508518|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508519|NCT01830335|Indomethacin|indomethacin|mesh-list
44508520|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508521|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508522|NCT01830335|Analgesics|analgesics|mesh-ancestor
44508523|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
44508524|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508525|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508526|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508527|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508528|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
44508529|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
44508530|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44508531|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44508532|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508533|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508534|NCT01830361|Midostaurin|midostaurin|mesh-list
44508535|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508536|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44508537|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508538|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508539|NCT01830465|Rituximab|rituximab|mesh-list
44508540|NCT01830465|Bortezomib|bortezomib|mesh-list
44508541|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508542|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508543|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
44508544|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508545|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508546|NCT01830491|Aspirin|aspirin|mesh-list
44508547|NCT01830491|Clopidogrel|clopidogrel|mesh-list
44508548|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508549|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508550|NCT01830491|Analgesics|analgesics|mesh-ancestor
44508551|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
44508552|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508553|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508554|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508555|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508556|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44508557|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44508558|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508559|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44508560|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44508561|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508562|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
44508563|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44508564|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44508565|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44508566|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
44508567|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508568|NCT01830517|Losartan|losartan|mesh-list
44508569|NCT01830517|Amlodipine|amlodipine|mesh-list
44508570|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508571|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44508572|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508573|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508574|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44508575|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328374|NCT00969163|Hormones|hormones|mesh-ancestor
44508577|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44508578|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44508579|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44508580|NCT01830556|Cetuximab|cetuximab|mesh-list
44508581|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508582|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508583|NCT01830777|Cytarabine|cytarabine|mesh-list
44508584|NCT01830777|Etoposide|etoposide|mesh-list
44508585|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
44508586|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44508587|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44508588|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508589|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44508590|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44508591|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508592|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508593|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44508594|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
44508595|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
44508596|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508597|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44508598|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
44508599|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508600|NCT01830777|Analgesics|analgesics|mesh-ancestor
44508601|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
44508602|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508603|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508604|NCT01830829|Tamsulosin|tamsulosin|mesh-list
44508605|NCT01830829|Dutasteride|dutasteride|mesh-list
44508606|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44508607|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44508608|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44508609|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44508610|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508611|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508612|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508613|NCT01830829|Urological Agents|urological agents|mesh-ancestor
44508614|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44508615|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44508616|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508617|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44508618|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508619|NCT01830868|Zonisamide|zonisamide|mesh-list
44508620|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
44508621|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44508622|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508623|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508624|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44508625|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508626|NCT01830946|Caseins|caseins|mesh-list
44508627|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
44508628|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
44508629|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508630|NCT01831011|Aspirin|aspirin|mesh-list
44508631|NCT01831011|Cinepazide|cinepazide|mesh-list
44508632|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
44508633|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508634|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508635|NCT01831011|Analgesics|analgesics|mesh-ancestor
44508636|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
44508637|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508638|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508639|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508640|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508641|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44508642|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44508643|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508644|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44508645|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44508646|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508649|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44508650|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
44328469|NCT00969852|Sertraline|sertraline|mesh-list
44508651|NCT01831193|Curcumin|curcumin|mesh-list
44508652|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508653|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508654|NCT01831193|Analgesics|analgesics|mesh-ancestor
44508655|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
44508656|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508657|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508658|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508659|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508660|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508661|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508662|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508663|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44508664|NCT01831323|Rifaximin|rifaximin|mesh-list
44508665|NCT01831323|Mesalamine|mesalamine|mesh-list
44508666|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44508667|NCT01831323|Psyllium|psyllium|mesh-list
44508668|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508669|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44508670|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508671|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508672|NCT01831323|Analgesics|analgesics|mesh-ancestor
44508673|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
44508674|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508675|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508676|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508677|NCT01831323|Cathartics|cathartics|mesh-ancestor
44508678|NCT01831479|Olmesartan|olmesartan|mesh-list
44508679|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44508680|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44508681|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44508682|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44508683|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
44508684|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508685|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44508686|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44508687|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508688|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508689|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44508690|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44508691|NCT01831505|Prednisolone|prednisolone|mesh-list
44508692|NCT01831505|Rituximab|rituximab|mesh-list
44508693|NCT01831505|Doxorubicin|doxorubicin|mesh-list
44508694|NCT01831505|Vincristine|vincristine|mesh-list
44508695|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44508696|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508697|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508698|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
44508699|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508700|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508701|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44508702|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44508703|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44508704|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508705|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508706|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44508707|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
44508708|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
44508709|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
44508710|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508711|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
44508712|NCT01831505|Hormones|hormones|mesh-ancestor
44508713|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508714|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508715|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508716|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
44508717|NCT01831622|Methylphenidate|methylphenidate|mesh-list
44508718|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44508719|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508721|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44508722|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508723|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508724|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
44508725|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508726|NCT01831661|Metformin|metformin|mesh-list
44508727|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508728|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508729|NCT01831674|Metformin|metformin|mesh-list
44508730|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508731|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508732|NCT01831687|Etodolac|etodolac|mesh-list
44508733|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508734|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508735|NCT01831687|Analgesics|analgesics|mesh-ancestor
44508736|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
44508737|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508738|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508739|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44508740|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508741|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44508742|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44508743|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508744|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508745|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44508746|NCT01831700|Lisinopril|lisinopril|mesh-list
44508747|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
44508748|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508749|NCT01831700|Diuretics|diuretics|mesh-ancestor
44508750|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
44508751|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508752|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44508753|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508754|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508755|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44508756|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
44508757|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508758|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44508759|NCT01831700|Protective Agents|protective agents|mesh-ancestor
44508760|NCT01831947|Ranibizumab|ranibizumab|mesh-list
44508761|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44508762|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44508763|NCT01831947|Growth Substances|growth substances|mesh-ancestor
44508764|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508765|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
44508766|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508767|NCT01832051|Trastuzumab|trastuzumab|mesh-list
44508768|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508769|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508770|NCT01832129|Vitamins|vitamins|mesh-list
44508771|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
44508772|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
44508773|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
44508774|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
44508775|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508776|NCT01832129|Hematinics|hematinics|mesh-ancestor
44508777|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
44508778|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44508779|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508780|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508781|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508782|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508783|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44508784|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44508785|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44508786|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508787|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508788|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
44508789|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44508790|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
44508791|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43918307|NCT00525135|Valproic Acid|valproic acid|mesh-list
44508792|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44508793|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508794|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44508795|NCT01832363|Xenon|xenon|mesh-list
44508796|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44508797|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
44508798|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
44328611|NCT00970905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44508799|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508800|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508801|NCT01832415|Bevacizumab|bevacizumab|mesh-list
44508802|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508803|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508804|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44508805|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44508806|NCT01832415|Growth Substances|growth substances|mesh-ancestor
44508807|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508808|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44508809|NCT01832467|Cetuximab|cetuximab|mesh-list
44508810|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508811|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508812|NCT01832558|Eplerenone|eplerenone|mesh-list
44508813|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44508814|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
44508815|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508816|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508817|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44508818|NCT01832558|Diuretics|diuretics|mesh-ancestor
44508819|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
44508820|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44508821|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44508822|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44508823|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44508824|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508825|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508826|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
44508827|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508828|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44508829|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44508830|NCT01832623|Vitamin D|vitamin d|mesh-list
44508831|NCT01832623|Vitamins|vitamins|mesh-ancestor
44508832|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
44508833|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508834|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44508835|NCT01832662|Caffeine|caffeine|mesh-list
44508836|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44508837|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508838|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44508839|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508840|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508841|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44508842|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44508843|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
44508844|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508845|NCT01832675|Bupivacaine|bupivacaine|mesh-list
44508846|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
44508847|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
44508848|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508849|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508850|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
44508851|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508852|NCT01832870|Ipilimumab|ipilimumab|mesh-list
44508853|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508854|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508855|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44508856|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508857|NCT01832896|Ecallantide|ecallantide|mesh-list
44508858|NCT01832896|Analgesics|analgesics|mesh-ancestor
44508859|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
44508860|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508861|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508862|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44508863|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44508865|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508866|NCT01832922|Rituximab|rituximab|mesh-list
44508867|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44508868|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44508869|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508870|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
44508871|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508872|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44508873|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44508874|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
44508875|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508876|NCT01832935|Insulin|insulin|mesh-list
44508877|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44508878|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
44508879|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
44508880|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
44508881|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
44508882|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508883|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508884|NCT01832948|Leucovorin|leucovorin|mesh-list
44508885|NCT01832948|Folic Acid|folic acid|mesh-list
44508886|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
44508887|NCT01832948|Endostar protein|endostar protein|mesh-list
44508888|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
44508889|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508890|NCT01832948|Antidotes|antidotes|mesh-ancestor
44508891|NCT01832948|Protective Agents|protective agents|mesh-ancestor
44508892|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508893|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
44508894|NCT01832948|Vitamins|vitamins|mesh-ancestor
44508895|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
44508896|NCT01832948|Hematinics|hematinics|mesh-ancestor
44508897|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44508898|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44508899|NCT01832948|Growth Substances|growth substances|mesh-ancestor
44508900|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
44508901|NCT01832987|Trimethoprim|trimethoprim|mesh-list
44508902|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44508903|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
44508904|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44508905|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508906|NCT01832987|Renal Agents|renal agents|mesh-ancestor
44508907|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
44508908|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44508909|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44508910|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44508911|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508912|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508913|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44508914|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44508915|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44508916|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44508917|NCT01833299|Sorafenib|sorafenib|mesh-list
44508918|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
44508919|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508920|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44508921|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508922|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508923|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44508924|NCT01833299|Estrogens|estrogens|mesh-ancestor
44508925|NCT01833299|Hormones|hormones|mesh-ancestor
44508926|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508927|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508928|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44508929|NCT01833312|Meperidine|meperidine|mesh-list
44508930|NCT01833312|Buspirone|buspirone|mesh-list
44508931|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44508932|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44508933|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508934|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508935|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44508936|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44508937|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
44508938|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508939|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508941|NCT01833312|Narcotics|narcotics|mesh-ancestor
44508942|NCT01833312|Analgesics|analgesics|mesh-ancestor
44508943|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
44508944|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508945|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44508946|NCT01833351|Vitamins|vitamins|mesh-list
44508947|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
44508948|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
44508949|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508950|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
44508951|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508952|NCT01833351|Protective Agents|protective agents|mesh-ancestor
44508953|NCT01833559|Insulin|insulin|mesh-list
44508954|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44508955|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
44508956|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44508957|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508958|NCT01833572|Gefitinib|gefitinib|mesh-list
44508959|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44508960|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44508961|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44508962|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508963|NCT01833611|Entecavir|entecavir|mesh-list
44508964|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
44508965|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44508966|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
44508967|NCT01833663|Estrogens|estrogens|mesh-list
44508968|NCT01833663|Hormones|hormones|mesh-ancestor
44508969|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44508970|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508971|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44508972|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44508973|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
44508974|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44508975|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44508976|NCT01833663|Urological Agents|urological agents|mesh-ancestor
44508977|NCT01833676|Sevoflurane|sevoflurane|mesh-list
44508978|NCT01833676|Desflurane|desflurane|mesh-list
44508979|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44508980|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44508981|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
44508982|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
44508983|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508984|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508985|NCT01833715|Morphine|morphine|mesh-list
44508986|NCT01833715|Methadone|methadone|mesh-list
44508987|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44508988|NCT01833715|Narcotics|narcotics|mesh-ancestor
44508989|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44508990|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44508991|NCT01833715|Analgesics|analgesics|mesh-ancestor
44508992|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
44508993|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44508994|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
44508995|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44508996|NCT01833728|Acetaminophen|acetaminophen|mesh-list
44508997|NCT01833728|Propacetamol|propacetamol|mesh-list
44508998|NCT01833728|Nefopam|nefopam|mesh-list
44508999|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509000|NCT01833728|Analgesics|analgesics|mesh-ancestor
44509001|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
44509002|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509003|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509004|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44509005|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509006|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509007|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
44509008|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
44509009|NCT01833767|Interleukin-2|interleukin-2|mesh-list
44509010|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509011|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
44509012|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509013|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509014|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44509015|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
44235303|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509016|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509018|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44509019|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509020|NCT01833767|Analgesics|analgesics|mesh-ancestor
44509021|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
44509022|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509023|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
44509024|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44509025|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
44509026|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44509027|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509028|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44509029|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44509030|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44509031|NCT01833819|Lidocaine|lidocaine|mesh-list
44509032|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
44509033|NCT01833819|Remifentanil|remifentanil|mesh-list
44509034|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
44509035|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
44509036|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509037|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509038|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
44509039|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509040|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44509041|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44509042|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44509043|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509044|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509045|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44509046|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509047|NCT01833819|Analgesics|analgesics|mesh-ancestor
44509048|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44509049|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44509050|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44509051|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509052|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509053|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509054|NCT01833819|Narcotics|narcotics|mesh-ancestor
44509055|NCT01834014|Bevacizumab|bevacizumab|mesh-list
44509056|NCT01834014|Cetuximab|cetuximab|mesh-list
44509057|NCT01834014|Fluorouracil|fluorouracil|mesh-list
44509058|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
44509059|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509060|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509061|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509062|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509063|NCT01834014|Growth Substances|growth substances|mesh-ancestor
44509064|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509065|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509066|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
44509067|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509068|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509069|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509070|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
44509071|NCT01834170|Gemcitabine|gemcitabine|mesh-list
44509072|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509073|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
44509074|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509075|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509076|NCT01834170|Antiviral Agents|antiviral agents|mesh-ancestor
44509077|NCT01834170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509078|NCT01834170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509079|NCT01834170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509080|NCT01834170|Immunologic Factors|immunologic factors|mesh-ancestor
44509081|NCT01834170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509082|NCT01834183|Gemcitabine|gemcitabine|mesh-list
44509083|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509084|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
44509085|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509086|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509087|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
44509088|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509089|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509090|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509091|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
44509092|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509094|NCT01834209|Prednisolone|prednisolone|mesh-list
44509095|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
44509096|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509097|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
44509098|NCT01834209|Hormones|hormones|mesh-ancestor
44509099|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509100|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509101|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44509102|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509103|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44509104|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509105|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509106|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44509107|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44509109|NCT01834235|Paclitaxel|paclitaxel|mesh-list
44509110|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509111|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509112|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509113|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509114|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509115|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509116|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509117|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
44509118|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
44509119|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509120|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509121|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509122|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
44509123|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509124|NCT01834508|Entecavir|entecavir|mesh-list
44509125|NCT01834508|Adefovir|adefovir|mesh-list
44509126|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
44509127|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509128|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44509129|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44509130|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509131|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509132|NCT01834547|Methylphenidate|methylphenidate|mesh-list
44509133|NCT01834547|Caffeine|caffeine|mesh-list
44509134|NCT01834547|Modafinil|modafinil|mesh-list
44509135|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44509136|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509137|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44509138|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44509139|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509140|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509141|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
44509142|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509143|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44509144|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509145|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44509146|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44509147|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
44414246|NCT02379091|Antidotes|antidotes|mesh-ancestor
44509148|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44509149|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44509150|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44509151|NCT01834768|Eplerenone|eplerenone|mesh-list
44509152|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44509153|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
44509154|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509155|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509156|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44509157|NCT01834768|Diuretics|diuretics|mesh-ancestor
44509158|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
44509159|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44509160|NCT01834885|Fluticasone|fluticasone|mesh-list
44509161|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44509162|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44509163|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509165|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
44509166|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509167|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509168|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44509169|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509170|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509171|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44509172|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44509173|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44509174|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44509175|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509176|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509177|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509178|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
44509179|NCT01834885|Hormones|hormones|mesh-ancestor
44509180|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509181|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
44509182|NCT01834898|Oxycodone|oxycodone|mesh-list
44509183|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509184|NCT01834898|Narcotics|narcotics|mesh-ancestor
44509185|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509186|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509187|NCT01834898|Analgesics|analgesics|mesh-ancestor
44509188|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
44509189|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509190|NCT01834963|Interferons|interferons|mesh-list
44509191|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
44509192|NCT01834963|Cisplatin|cisplatin|mesh-list
44509193|NCT01834963|Fluorouracil|fluorouracil|mesh-list
44509194|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509195|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
44509196|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509197|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509198|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509199|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
44509200|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509201|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
44509202|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509203|NCT01834989|Mitogens|mitogens|mesh-list
44509204|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509205|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509206|NCT01835067|Ranibizumab|ranibizumab|mesh-list
44509207|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44509208|NCT01835067|Plasminogen|plasminogen|mesh-list
44509209|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509210|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509211|NCT01835067|Growth Substances|growth substances|mesh-ancestor
44509212|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509213|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509214|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509215|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44509216|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44509217|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509218|NCT01835184|Vemurafenib|vemurafenib|mesh-list
44509219|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509220|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509221|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509222|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509223|NCT01835236|Paclitaxel|paclitaxel|mesh-list
44509224|NCT01835236|Vinorelbine|vinorelbine|mesh-list
44509225|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44509226|NCT01835236|Trastuzumab|trastuzumab|mesh-list
44509227|NCT01835236|Pertuzumab|pertuzumab|mesh-list
44509228|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509229|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509230|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509231|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509232|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509233|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509234|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509235|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
44509236|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509237|NCT01835314|Stiripentol|stiripentol|mesh-list
44509238|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
44509239|NCT01835340|Anesthetics|anesthetics|mesh-list
44509241|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509242|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509243|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44509244|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44509245|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
44509246|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44509247|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44329061|NCT00972907|Nifedipine|nifedipine|mesh-list
44509248|NCT01835561|Thalidomide|thalidomide|mesh-list
44509249|NCT01835561|Pomalidomide|pomalidomide|mesh-list
44414329|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44509250|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
44509251|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509252|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509253|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509254|NCT01835561|Growth Substances|growth substances|mesh-ancestor
44509255|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509256|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509257|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509258|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
44509259|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44509260|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509261|NCT01835639|Vitamin D|vitamin d|mesh-list
44509262|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
44509263|NCT01835639|Vitamins|vitamins|mesh-ancestor
44509264|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
44509265|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509266|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44509267|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44509268|NCT01835665|Nimodipine|nimodipine|mesh-list
44509269|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44509270|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44509271|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509272|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509273|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44509274|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509275|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
44509276|NCT01835691|Vitamin D|vitamin d|mesh-list
44509277|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
44509278|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
44509279|NCT01835691|Vitamins|vitamins|mesh-list
44509280|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
44509281|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509282|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44509283|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44509284|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44509285|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509286|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509287|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509288|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509289|NCT01836016|Fluticasone|fluticasone|mesh-list
44509290|NCT01836016|Xhance|xhance|mesh-list
44509291|NCT01836016|Albuterol|albuterol|mesh-list
44509292|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
44509293|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44509294|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44509295|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509296|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44509297|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
44509298|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509299|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509300|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44509301|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509302|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509303|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44509304|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44509305|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44509306|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44509307|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509308|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509309|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509310|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
44509311|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44509312|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
44509313|NCT01836016|Hormones|hormones|mesh-ancestor
44509314|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509316|NCT01836094|Methylene Blue|methylene blue|mesh-list
44509317|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509318|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509319|NCT01836120|Docetaxel|docetaxel|mesh-list
44509320|NCT01836120|Raltitrexed|raltitrexed|mesh-list
44509321|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509322|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509323|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509324|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509325|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509326|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509327|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
44509328|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44509329|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509330|NCT01836224|Terlipressin|terlipressin|mesh-list
44509331|NCT01836224|Norepinephrine|norepinephrine|mesh-list
44509332|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44509333|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44509334|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44509335|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44509336|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509337|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414411|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44509338|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509339|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509340|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
44509341|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
44509342|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509343|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
44509344|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509345|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
44509346|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509347|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509348|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44509349|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
44509350|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509351|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509352|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44509353|NCT01836328|Methadone|methadone|mesh-list
44509354|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44509355|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509356|NCT01836328|Narcotics|narcotics|mesh-ancestor
44509357|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509358|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509359|NCT01836328|Analgesics|analgesics|mesh-ancestor
44509360|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
44509361|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509362|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
44509363|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509364|NCT01836341|Cisplatin|cisplatin|mesh-list
44509365|NCT01836341|Carboplatin|carboplatin|mesh-list
44509366|NCT01836341|Pemetrexed|pemetrexed|mesh-list
44509367|NCT01836341|Afatinib|afatinib|mesh-list
44509368|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509369|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509370|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509371|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44509372|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44509373|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509374|NCT01836406|Ketorolac|ketorolac|mesh-list
44509375|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44509376|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44509377|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509378|NCT01836406|Analgesics|analgesics|mesh-ancestor
44509379|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
44509380|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509381|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509382|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509383|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509384|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44509385|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509386|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509387|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44509388|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44509389|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509390|NCT01836536|Bevacizumab|bevacizumab|mesh-list
44509391|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509392|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509393|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509394|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509395|NCT01836536|Growth Substances|growth substances|mesh-ancestor
44509396|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509397|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509398|NCT01836575|Carboplatin|carboplatin|mesh-list
44509400|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509401|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509402|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509403|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44509404|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44509405|NCT01836653|Bevacizumab|bevacizumab|mesh-list
44509406|NCT01836653|Cetuximab|cetuximab|mesh-list
44509407|NCT01836653|Fluorouracil|fluorouracil|mesh-list
44509408|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
44509409|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509410|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509411|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509412|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509413|NCT01836653|Growth Substances|growth substances|mesh-ancestor
44509414|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509415|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509416|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
44509417|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509418|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509419|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509420|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
44509421|NCT01836679|Paclitaxel|paclitaxel|mesh-list
44509422|NCT01836679|Carboplatin|carboplatin|mesh-list
44509423|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509424|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509425|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509426|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509427|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509428|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509429|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
44509430|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509431|NCT01836822|Dimercaprol|dimercaprol|mesh-list
44509432|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
44509433|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
44509434|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509435|NCT01836900|Hemostatics|hemostatics|mesh-list
44509436|NCT01836900|Coagulants|coagulants|mesh-ancestor
44509437|NCT01837043|Cyclosporine|cyclosporine|mesh-list
44509438|NCT01837043|Abatacept|abatacept|mesh-list
44509439|NCT01837043|Tacrolimus|tacrolimus|mesh-list
44509440|NCT01837043|Cyclosporins|cyclosporins|mesh-list
44509441|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44509442|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509443|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
44509444|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509445|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509446|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509447|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
44509448|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509449|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509450|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509451|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44509452|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509453|NCT01837108|Eplerenone|eplerenone|mesh-list
44509454|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44509455|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
44509456|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509457|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509458|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44509459|NCT01837108|Diuretics|diuretics|mesh-ancestor
44509460|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
44509461|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44509462|NCT01837199|Amoxicillin|amoxicillin|mesh-list
44509463|NCT01837199|Metronidazole|metronidazole|mesh-list
44509464|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44509465|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509466|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44509467|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44509468|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44509469|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
44509470|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
44509471|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509472|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509473|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509474|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509475|NCT01837329|Growth Substances|growth substances|mesh-ancestor
44509476|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509477|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509478|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329360|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509479|NCT01837394|Acetaminophen|acetaminophen|mesh-list
44509480|NCT01837394|Morphine|morphine|mesh-list
44509481|NCT01837394|Ondansetron|ondansetron|mesh-list
44509482|NCT01837394|Metoclopramide|metoclopramide|mesh-list
44509483|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509484|NCT01837394|Narcotics|narcotics|mesh-ancestor
44509485|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509486|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509487|NCT01837394|Analgesics|analgesics|mesh-ancestor
44509488|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
44509489|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509490|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509491|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
44509492|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
44509493|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
44509494|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44509495|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
44509496|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509497|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44509498|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
44509499|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509500|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509501|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44509502|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44509503|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44509504|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44509505|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44509506|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44414578|NCT02370238|Paclitaxel|paclitaxel|mesh-list
44509507|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
44509508|NCT01837498|Neostigmine|neostigmine|mesh-list
44509509|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44509510|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509511|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509512|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
44509513|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509514|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509515|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44509516|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
44509517|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509518|NCT01837576|Calcipotriene|calcipotriene|mesh-list
44509519|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509520|NCT01837628|Lidocaine|lidocaine|mesh-list
44509521|NCT01837628|Mineral Oil|mineral oil|mesh-list
44509522|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
44509523|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
44509524|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509525|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509526|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
44509527|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509528|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44509529|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44509530|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44509531|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509532|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509533|NCT01837628|Emollients|emollients|mesh-ancestor
44509534|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509535|NCT01837667|Docetaxel|docetaxel|mesh-list
44509536|NCT01837667|LB100|lb100|mesh-list
44509537|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509538|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509539|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509540|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509541|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509542|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509544|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44509545|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509546|NCT01837810|Analgesics|analgesics|mesh-ancestor
44509547|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
44509548|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509549|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509550|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509551|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509552|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44509553|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509554|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509555|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
44509556|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
44509557|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44509558|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
44414629|NCT02367833|NuvaRing|nuvaring|mesh-list
44509559|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509560|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509561|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44509562|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509563|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
44509564|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44509565|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
44509566|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509567|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509568|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44509569|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44509570|NCT01837992|Primaquine|primaquine|mesh-list
44509571|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
44509572|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44509573|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44509574|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509575|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
44509576|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44509577|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509578|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
44509579|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44509580|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
44509581|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509582|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
44509583|NCT01838252|Protective Agents|protective agents|mesh-ancestor
44509584|NCT01838330|Psyllium|psyllium|mesh-list
44509585|NCT01838330|Cathartics|cathartics|mesh-ancestor
44509586|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44509587|NCT01838434|Lenalidomide|lenalidomide|mesh-list
44509588|NCT01838434|Idelalisib|idelalisib|mesh-list
44509589|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
44509590|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509591|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509592|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509593|NCT01838434|Growth Substances|growth substances|mesh-ancestor
44509594|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509595|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509596|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509597|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509598|NCT01838460|Lobeline|lobeline|mesh-list
44509599|NCT01838460|Nicotine|nicotine|mesh-list
44509600|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44509601|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
44509602|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509603|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509604|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44509605|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44509606|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
44509607|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509608|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509609|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509610|NCT01838473|Lobeline|lobeline|mesh-list
44509611|NCT01838473|Nicotine|nicotine|mesh-list
44509612|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44509613|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
44509614|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509615|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509616|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44509617|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44509618|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44509619|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509620|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509621|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44509622|NCT01838538|Paclitaxel|paclitaxel|mesh-list
44509623|NCT01838538|Bevacizumab|bevacizumab|mesh-list
44509624|NCT01838538|Carboplatin|carboplatin|mesh-list
44509625|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509626|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509627|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509628|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509629|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509630|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509631|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509632|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509633|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509634|NCT01838538|Growth Substances|growth substances|mesh-ancestor
44509635|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509636|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509637|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44509638|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44509639|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509640|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
44509641|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509642|NCT01838707|Fentanyl|fentanyl|mesh-list
44509643|NCT01838707|Morphine|morphine|mesh-list
44509644|NCT01838707|Bupivacaine|bupivacaine|mesh-list
44509645|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
44509646|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
44509647|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509648|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509649|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
44509650|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509651|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509652|NCT01838707|Narcotics|narcotics|mesh-ancestor
44509653|NCT01838707|Analgesics|analgesics|mesh-ancestor
44509654|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44509655|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44509656|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
44509657|NCT01838772|Interferons|interferons|mesh-list
44509658|NCT01838772|Ribavirin|ribavirin|mesh-list
44509659|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509660|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
44509661|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509662|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
44509663|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509664|NCT01838902|Primaquine|primaquine|mesh-list
44509665|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
44509666|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44509667|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44509668|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509669|NCT01838928|Bupivacaine|bupivacaine|mesh-list
44509670|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
44509671|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
44509672|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509673|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509674|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
44509675|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509676|NCT01838993|Lidocaine|lidocaine|mesh-list
44509677|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
44509678|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
44509679|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509680|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509681|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
44509682|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509683|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44509684|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44509685|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44509686|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509687|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509688|NCT01839032|Cisplatin|cisplatin|mesh-list
44509689|NCT01839032|Vinorelbine|vinorelbine|mesh-list
44509690|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509691|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509692|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509693|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509694|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509695|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509696|NCT01839084|Isoflurane|isoflurane|mesh-list
44509697|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44509698|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
44509699|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
44509700|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509701|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509702|NCT01839097|Prednisone|prednisone|mesh-list
44509703|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
44509704|NCT01839097|Doxorubicin|doxorubicin|mesh-list
44509705|NCT01839097|Vincristine|vincristine|mesh-list
44509706|NCT01839097|Belinostat|belinostat|mesh-list
44509707|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329527|NCT00974805|Hormones|hormones|mesh-ancestor
44509708|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
44509709|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509710|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509711|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44509712|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
44414768|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509713|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509714|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509715|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44509716|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44509717|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44509718|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44509719|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509720|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509721|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
44509722|NCT01839097|Hormones|hormones|mesh-ancestor
44509723|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509724|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44509725|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509726|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509727|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509728|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509729|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44509730|NCT01839149|Oxytocin|oxytocin|mesh-list
44509731|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
44509732|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44509733|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509734|NCT01839175|Vaccines|vaccines|mesh-list
44509735|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44509736|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
44509737|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509738|NCT01839240|Cytarabine|cytarabine|mesh-list
44509739|NCT01839240|Azacitidine|azacitidine|mesh-list
44509740|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
44509741|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509742|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
44509743|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509744|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509745|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
44509746|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509747|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509748|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
44509749|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509750|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509751|NCT01839240|Analgesics|analgesics|mesh-ancestor
44509752|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
44509753|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509754|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44509755|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44509756|NCT01839253|Atenolol|atenolol|mesh-list
44509757|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44509758|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44509759|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44509760|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
44509761|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
44509762|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509763|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509764|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44509765|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44509766|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44509767|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509768|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509769|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509771|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509772|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
44509773|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44509774|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
44509775|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44509776|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
44509777|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509778|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509779|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
44509780|NCT01839370|Pramlintide|pramlintide|mesh-list
44509781|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44509782|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509783|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
44509784|NCT01839383|Calcium|calcium|mesh-list
44509785|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44509786|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509787|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44509788|NCT01839500|Trastuzumab|trastuzumab|mesh-list
44509789|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509790|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509791|NCT01839552|Fentanyl|fentanyl|mesh-list
44509792|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44509793|NCT01839552|Narcotics|narcotics|mesh-ancestor
44509794|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44509795|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509796|NCT01839552|Analgesics|analgesics|mesh-ancestor
44509797|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
44509798|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509799|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44509800|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44509801|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
44509802|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
44509803|NCT01839630|Sorafenib|sorafenib|mesh-list
44509804|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509805|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509806|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509807|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509808|NCT01839643|Meloxicam|meloxicam|mesh-list
44509809|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44509810|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509811|NCT01839643|Analgesics|analgesics|mesh-ancestor
44509812|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
44509813|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509814|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509815|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509816|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509817|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44509818|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44509819|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509820|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509821|NCT01839734|Lubiprostone|lubiprostone|mesh-list
44509822|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44509823|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509824|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509825|NCT01839773|Paclitaxel|paclitaxel|mesh-list
44509826|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44509827|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509828|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509829|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509830|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509831|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509832|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509833|NCT01839812|Cosyntropin|cosyntropin|mesh-list
44509834|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44509835|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44509836|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
44509837|NCT01839812|Hormones|hormones|mesh-ancestor
44509838|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509839|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509840|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509841|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509842|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
44509843|NCT01839851|Hormones|hormones|mesh-ancestor
44509844|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44509845|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509846|NCT01839864|Chrysarobin|chrysarobin|mesh-list
44509847|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44509848|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44509849|NCT01839864|Analgesics|analgesics|mesh-ancestor
44509850|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
44509851|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44509852|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509853|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44509854|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509855|NCT01839890|Paclitaxel|paclitaxel|mesh-list
44509856|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509857|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509858|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509859|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509860|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509861|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509862|NCT01839929|Tacrolimus|tacrolimus|mesh-list
44509863|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509864|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
44509874|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509875|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
44509876|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44509877|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
44509878|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44509879|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509880|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
44509881|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44509882|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
44509883|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44509884|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44509885|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
44509886|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
44509887|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509888|NCT01839981|Protective Agents|protective agents|mesh-ancestor
44509889|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509890|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
44509892|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
44509893|NCT01834248|Poly I-C|poly i-c|mesh-list
44509894|NCT01834248|Decitabine|decitabine|mesh-list
44509895|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44509896|NCT01834248|Poly ICLC|poly iclc|mesh-list
44509897|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509898|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
44509899|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509900|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509901|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509902|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
44509903|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
44509904|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509905|NCT01834248|Laxatives|laxatives|mesh-ancestor
44509906|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44509907|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
44509908|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509909|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44509910|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
44509911|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44509912|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44509913|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509914|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509915|NCT01830478|Rituximab|rituximab|mesh-list
44509916|NCT01830478|Lenalidomide|lenalidomide|mesh-list
44509917|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509918|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509919|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
44509920|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509921|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44509922|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44509923|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44509924|NCT01830478|Growth Substances|growth substances|mesh-ancestor
44509925|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
44509926|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44509927|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44509928|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509930|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509931|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
44509932|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509933|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509934|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
44509935|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509936|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509937|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
44509938|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509939|NCT01838200|Isoniazid|isoniazid|mesh-list
44509940|NCT01838200|Ipilimumab|ipilimumab|mesh-list
44509941|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
44509942|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44509943|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509944|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44509945|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509946|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
44509947|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44509948|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509949|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44509950|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44509951|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
44509952|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44509953|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44509954|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
44509955|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509956|NCT01836432|Leucovorin|leucovorin|mesh-list
44509957|NCT01836432|Gemcitabine|gemcitabine|mesh-list
44509958|NCT01836432|Paclitaxel|paclitaxel|mesh-list
44509959|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44509960|NCT01836432|Fluorouracil|fluorouracil|mesh-list
44509961|NCT01836432|Capecitabine|capecitabine|mesh-list
44509962|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
44509963|NCT01836432|Irinotecan|irinotecan|mesh-list
44509964|NCT01836432|Folfirinox|folfirinox|mesh-list
44509965|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44509966|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509967|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
44509968|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
44509969|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
44509970|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509971|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44509972|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
44509973|NCT01836432|Antiviral Agents|antiviral agents|mesh-ancestor
44509974|NCT01836432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44509975|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509976|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44509977|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
44509978|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509979|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44509980|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44509981|NCT01836432|Antidotes|antidotes|mesh-ancestor
44509982|NCT01836432|Protective Agents|protective agents|mesh-ancestor
44509983|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
44509984|NCT01836432|Vitamins|vitamins|mesh-ancestor
44509985|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
44509986|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
44509987|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44509988|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44509989|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44509990|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509991|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
44509992|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44509993|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44509994|NCT01724606|Sorafenib|sorafenib|mesh-list
44509995|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44509996|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44509997|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44509998|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44509999|NCT01720030|Simendan|simendan|mesh-list
44510000|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44510001|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510002|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44510003|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44510005|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510006|NCT01720030|Protective Agents|protective agents|mesh-ancestor
44510007|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510008|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44510009|NCT01720056|Verapamil|verapamil|mesh-list
44510010|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510011|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
44510012|NCT01720056|Hormones|hormones|mesh-ancestor
44510013|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510014|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510015|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44510016|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
44510017|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510018|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44510019|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44510020|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510021|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510022|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510023|NCT01720095|Niacin|niacin|mesh-list
44510024|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
44510025|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44510026|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
44510027|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510028|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44510029|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510030|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
44510031|NCT01720095|Vitamins|vitamins|mesh-ancestor
44510032|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
44510033|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510034|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
44510035|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44510036|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
44510037|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44510038|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
44510039|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510040|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510041|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
44510042|NCT01720212|Mirabegron|mirabegron|mesh-list
44510043|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44510044|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44510045|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44510046|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510047|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510048|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510049|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510050|NCT01720212|Urological Agents|urological agents|mesh-ancestor
44510051|NCT01720238|Lamivudine|lamivudine|mesh-list
44510052|NCT01720238|Adefovir|adefovir|mesh-list
44510053|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44510054|NCT01720238|Entecavir|entecavir|mesh-list
44510055|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44510056|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44510057|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510058|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510059|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
44510060|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510061|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44510062|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44510063|NCT01720290|Metformin|metformin|mesh-list
44510064|NCT01720290|Repaglinide|repaglinide|mesh-list
44510065|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510066|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510067|NCT01720303|Insulin|insulin|mesh-list
44510068|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44510069|NCT01720303|Repaglinide|repaglinide|mesh-list
44510070|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
44510071|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
44510072|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
44510073|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510074|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510075|NCT01720394|Dinoprostone|dinoprostone|mesh-list
44510076|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
44510077|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510078|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510079|NCT01720498|Remifentanil|remifentanil|mesh-list
44510080|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510081|NCT01720498|Narcotics|narcotics|mesh-ancestor
44510082|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510083|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510084|NCT01720498|Analgesics|analgesics|mesh-ancestor
44510085|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
44510086|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510087|NCT01720615|Remifentanil|remifentanil|mesh-list
44510088|NCT01720615|Propofol|propofol|mesh-list
44510089|NCT01720615|Sevoflurane|sevoflurane|mesh-list
44510090|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44510091|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510092|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510093|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44510094|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
44510095|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
44510096|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44510097|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44510098|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510099|NCT01720615|Narcotics|narcotics|mesh-ancestor
44510100|NCT01720615|Analgesics|analgesics|mesh-ancestor
44510101|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
44510102|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510103|NCT01720628|Angiogenin|angiogenin|mesh-list
44510104|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44510105|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44510106|NCT01720628|Growth Substances|growth substances|mesh-ancestor
44510107|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510108|NCT01720875|Dexamethasone|dexamethasone|mesh-list
44510109|NCT01720875|Bortezomib|bortezomib|mesh-list
44510110|NCT01720875|Vorinostat|vorinostat|mesh-list
44510111|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510112|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
44510113|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
44510114|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415176|NCT02355028|Ranibizumab|ranibizumab|mesh-list
44510115|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510116|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510117|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
44510118|NCT01720875|Hormones|hormones|mesh-ancestor
44510119|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510120|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44510121|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510122|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44510123|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510124|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510126|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510127|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510128|NCT01721031|Tramadol|tramadol|mesh-list
44510129|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510130|NCT01721031|Narcotics|narcotics|mesh-ancestor
44510131|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510132|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510133|NCT01721031|Analgesics|analgesics|mesh-ancestor
44510134|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
44510135|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510136|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
44510137|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44510138|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510139|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510140|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44510141|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44510142|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510143|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510144|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510145|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44510146|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
44510147|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510148|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510149|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44510150|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44510151|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44510152|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44510153|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510154|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510155|NCT01721382|Incretins|incretins|mesh-ancestor
44510156|NCT01721382|Hormones|hormones|mesh-ancestor
44510157|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510158|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44510159|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
44510160|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510161|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510162|NCT01721434|Simendan|simendan|mesh-list
44510163|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44510164|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510165|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44510166|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44510167|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415222|NCT02354508|Hormones|hormones|mesh-ancestor
44510168|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510169|NCT01721434|Protective Agents|protective agents|mesh-ancestor
44510170|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510171|NCT01721525|Ribavirin|ribavirin|mesh-list
44510172|NCT01721525|Paclitaxel|paclitaxel|mesh-list
44510173|NCT01721525|Carboplatin|carboplatin|mesh-list
44510174|NCT01721525|Afatinib|afatinib|mesh-list
44510175|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44510176|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510177|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
44510178|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
44510179|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
44510180|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510181|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
44510182|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
44510183|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510184|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44510185|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510186|NCT01721616|Azithromycin|azithromycin|mesh-list
44510187|NCT01721616|Cefazolin|cefazolin|mesh-list
44510188|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510189|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510190|NCT01721655|Spironolactone|spironolactone|mesh-list
44510191|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44510192|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
44510193|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510194|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510195|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44510196|NCT01721655|Diuretics|diuretics|mesh-ancestor
44510197|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44510198|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44510217|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44510218|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44510220|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
44510221|NCT01721915|Vitamin D|vitamin d|mesh-list
44510222|NCT01721915|Vitamins|vitamins|mesh-ancestor
44510223|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
44510224|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510225|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510226|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
44510227|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510228|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510229|NCT01722110|Indomethacin|indomethacin|mesh-list
44510230|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44510231|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44510232|NCT01722110|Analgesics|analgesics|mesh-ancestor
44510233|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
44510234|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510235|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510236|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510237|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44510238|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
44510239|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
44510240|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510241|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44510242|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510243|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510244|NCT01722201|Risperidone|risperidone|mesh-list
44510245|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44510246|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
44510247|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510248|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510249|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510250|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44510251|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44510252|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510253|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44510254|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44510255|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
44510256|NCT01722227|Liraglutide|liraglutide|mesh-list
44510257|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510258|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510259|NCT01722227|Incretins|incretins|mesh-ancestor
44510261|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510262|NCT01722305|Dexamethasone|dexamethasone|mesh-list
44510263|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
44510264|NCT01722305|Pomalidomide|pomalidomide|mesh-list
44510265|NCT01722305|Ichthammol|ichthammol|mesh-list
44510266|NCT01722305|BB 1101|bb 1101|mesh-list
44510267|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510268|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
44510269|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
44510270|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510271|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510272|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510273|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
44510274|NCT01722305|Hormones|hormones|mesh-ancestor
44510275|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510276|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44510277|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510278|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
44510279|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510280|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510281|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
44510282|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44510283|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44510284|NCT01722305|Growth Substances|growth substances|mesh-ancestor
44510285|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44510286|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
44510287|NCT01722396|Vitamin D|vitamin d|mesh-list
44510288|NCT01722396|Vitamins|vitamins|mesh-ancestor
44510289|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
44510290|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510291|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510292|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
44510293|NCT01722409|Sevoflurane|sevoflurane|mesh-list
44510294|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44510295|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510296|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510297|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44510298|NCT01722409|Analgesics|analgesics|mesh-ancestor
44510299|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
44510300|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510301|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44510302|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44510303|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44510304|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510305|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510306|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510307|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44510308|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44510309|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
44510310|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
44510311|NCT01722448|Choline|choline|mesh-list
44510312|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
44510313|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44510314|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
44510315|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510316|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510317|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44510318|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
44510319|NCT01722513|Alprostadil|alprostadil|mesh-list
44510320|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44510321|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510322|NCT01722513|Urological Agents|urological agents|mesh-ancestor
44510323|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
44330192|NCT00978718|Selenium|selenium|mesh-list
44510324|NCT01722539|Piperaquine|piperaquine|mesh-list
44510325|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
44510326|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44510328|NCT01722539|Praziquantel|praziquantel|mesh-list
44510329|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
44510330|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44510331|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44510332|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510333|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44510334|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510335|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510336|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44510337|NCT01722539|Renal Agents|renal agents|mesh-ancestor
44510338|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
44510339|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
44510340|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44510341|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
44510342|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
44510343|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44510344|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510345|NCT01722630|Dopamine|dopamine|mesh-list
44510346|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44510347|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
44510348|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
44510349|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510350|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510351|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
44510352|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510353|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510354|NCT01722630|Protective Agents|protective agents|mesh-ancestor
44510355|NCT01722799|Paclitaxel|paclitaxel|mesh-list
44510356|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44510357|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510358|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
44510359|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
44510360|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
44510361|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510362|NCT01722942|Amiodarone|amiodarone|mesh-list
44510363|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44510364|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510365|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44510366|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510367|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510368|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44510369|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44510370|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44510371|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510372|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44510373|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44510374|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44510375|NCT01722968|Paclitaxel|paclitaxel|mesh-list
44510376|NCT01722968|Bevacizumab|bevacizumab|mesh-list
44510377|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44510378|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510379|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44510380|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44510381|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44510382|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510383|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44510384|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44510385|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44510386|NCT01722968|Growth Substances|growth substances|mesh-ancestor
44510387|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510388|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
44510389|NCT01723059|Amoxicillin|amoxicillin|mesh-list
44510390|NCT01723059|Metronidazole|metronidazole|mesh-list
44510391|NCT01723059|Clarithromycin|clarithromycin|mesh-list
44510392|NCT01723059|Omeprazole|omeprazole|mesh-list
44510393|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510394|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510395|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44510396|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44510397|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44510398|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510400|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510401|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510403|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44510404|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44510405|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
44510406|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
44510407|NCT01723150|Ertapenem|ertapenem|mesh-list
44510408|NCT01723150|Trimethoprim|trimethoprim|mesh-list
44510409|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
44510410|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44510411|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510412|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44510413|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44510414|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510415|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510416|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510417|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44510418|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44510419|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44510420|NCT01723150|Renal Agents|renal agents|mesh-ancestor
44510421|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
44510422|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44510423|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44510424|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44510425|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44510426|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44510428|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44510429|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44510430|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510431|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510432|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510433|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510434|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44510435|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
44510436|NCT01723371|Protective Agents|protective agents|mesh-ancestor
44510437|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44510438|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510439|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510440|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510441|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44510442|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44510443|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
44510444|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44510445|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510446|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
44510447|NCT01723527|Buprenorphine|buprenorphine|mesh-list
44510448|NCT01723527|Methadone|methadone|mesh-list
44510449|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510450|NCT01723527|Narcotics|narcotics|mesh-ancestor
44510451|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510452|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510453|NCT01723527|Analgesics|analgesics|mesh-ancestor
44510454|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
44510455|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510456|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44510457|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
44510458|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44510459|NCT01723553|Corticosterone|corticosterone|mesh-list
44510460|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510461|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
44510462|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44510463|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510464|NCT01723670|Flurbiprofen|flurbiprofen|mesh-list
44510465|NCT01723670|Analgesics|analgesics|mesh-ancestor
44510466|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
44510467|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510468|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510469|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44510470|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44510471|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510472|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44510473|NCT01723670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44510474|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510475|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510476|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44510477|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44510478|NCT01723735|Ezetimibe|ezetimibe|mesh-list
44510479|NCT01723735|Fenofibrate|fenofibrate|mesh-list
44510480|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44510481|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44510482|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
44510483|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510484|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44510485|NCT01723748|Hormones|hormones|mesh-list
44510486|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510487|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510488|NCT01723800|Carboplatin|carboplatin|mesh-list
44510489|NCT01723800|Pemetrexed|pemetrexed|mesh-list
44510490|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510491|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510492|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510493|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44510494|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44510495|NCT01724086|Interferons|interferons|mesh-list
44510496|NCT01724086|Ritonavir|ritonavir|mesh-list
44510497|NCT01724086|Ribavirin|ribavirin|mesh-list
44510498|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
44510499|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
44510500|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44510501|NCT01724086|Simeprevir|simeprevir|mesh-list
44510502|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510511|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44510512|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44510513|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44510514|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
44510515|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
44510516|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510517|NCT01724138|Deferasirox|deferasirox|mesh-list
44510518|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44510519|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
44510520|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
44510521|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510522|NCT01724190|Vitamin D|vitamin d|mesh-list
44510523|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
44510524|NCT01724190|Vitamins|vitamins|mesh-ancestor
44510525|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
44330490|NCT00980603|Cisplatin|cisplatin|mesh-list
44510526|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510527|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510528|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510529|NCT01724268|Prednisolone|prednisolone|mesh-list
44510530|NCT01724268|Methotrexate|methotrexate|mesh-list
44510531|NCT01724268|Methamphetamine|methamphetamine|mesh-list
44510532|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44510533|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
44510534|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510535|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510536|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44510537|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
44510538|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510539|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510540|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44510541|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510542|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44510543|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44510544|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
44510545|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44510546|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44510547|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510548|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
44510549|NCT01724268|Hormones|hormones|mesh-ancestor
44510550|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510551|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44510552|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
44510553|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510554|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44510555|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
44510556|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
44510557|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510558|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510559|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44510560|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44510561|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510562|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44510563|NCT01724372|Aripiprazole|aripiprazole|mesh-list
44510564|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
44510565|NCT01724372|Fluoxetine|fluoxetine|mesh-list
44510566|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
44510567|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44510568|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44510569|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510570|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510571|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
44510572|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
44510573|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510574|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510575|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44510576|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44510577|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
44510578|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44510579|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44510580|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44510581|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44510582|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44510583|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44510584|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510585|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44510586|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44510587|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44510588|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510589|NCT01724385|Bevacizumab|bevacizumab|mesh-list
44510590|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44510591|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510592|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44510593|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44510594|NCT01724385|Growth Substances|growth substances|mesh-ancestor
44510595|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510596|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
44510597|NCT01724424|Melatonin|melatonin|mesh-list
44330505|NCT00980707|Xhance|xhance|mesh-list
44510598|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
44510599|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510600|NCT01724424|Protective Agents|protective agents|mesh-ancestor
44510601|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510602|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510603|NCT01724554|Aflibercept|aflibercept|mesh-list
44510604|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44510605|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44510606|NCT01724554|Growth Substances|growth substances|mesh-ancestor
44510607|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510608|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
44510609|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510610|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
44510611|NCT01724619|Androgens|androgens|mesh-ancestor
44510612|NCT01724619|Hormones|hormones|mesh-ancestor
44510613|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510614|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510615|NCT01724788|Furosemide|furosemide|mesh-list
44510616|NCT01724788|Diuretics|diuretics|mesh-ancestor
44510617|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
44510618|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510619|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44510620|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510621|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510622|NCT01724814|Insulin|insulin|mesh-list
44510623|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510624|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510625|NCT01724918|Lacosamide|lacosamide|mesh-list
44510626|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
44510627|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44510628|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44510629|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510630|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510631|NCT01724931|Aminopterin|aminopterin|mesh-list
44510632|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44510633|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510634|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510636|NCT01724983|Ketamine|ketamine|mesh-list
44510637|NCT01724983|Analgesics|analgesics|mesh-ancestor
44510638|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
44510639|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510640|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510641|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44510642|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44510643|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
44510644|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
44510645|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510646|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44510647|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44510648|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510649|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510650|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510651|NCT01724983|Narcotics|narcotics|mesh-ancestor
44510652|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44510653|NCT01725009|Levetiracetam|levetiracetam|mesh-list
44510654|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
44510655|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
44510656|NCT01725048|Mirtazapine|mirtazapine|mesh-list
44510657|NCT01725048|Citalopram|citalopram|mesh-list
44510658|NCT01725048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44510659|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44510660|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510661|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510662|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510663|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
44510664|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510665|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44510666|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
44510667|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44510668|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44510669|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
44510670|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
44510671|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44510672|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44510673|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510674|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44510675|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44510676|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44510677|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510678|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44510679|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44510680|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44510681|NCT01725087|Tapentadol|tapentadol|mesh-list
44510682|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510683|NCT01725087|Narcotics|narcotics|mesh-ancestor
44510684|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510685|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510686|NCT01725087|Analgesics|analgesics|mesh-ancestor
44510687|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
44510688|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510689|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44510690|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44510691|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510692|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510693|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510694|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510695|NCT01725100|Trametinib|trametinib|mesh-list
44510696|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44510697|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510698|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44510699|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510700|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510701|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44510702|NCT01725100|Protective Agents|protective agents|mesh-ancestor
44510703|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510704|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44510706|NCT01725113|Calcitriol|calcitriol|mesh-list
44510707|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510708|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510709|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44510710|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510711|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510712|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44510713|NCT01725113|Vitamins|vitamins|mesh-ancestor
44510714|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
44510715|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510717|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415729|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
44510718|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44510719|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510720|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510721|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44510722|NCT01725230|Simvastatin|simvastatin|mesh-list
44510723|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44510724|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44510725|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
44510726|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510727|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44510728|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44510729|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510730|NCT01725243|Carbetocin|carbetocin|mesh-list
44510731|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
44510732|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510733|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510734|NCT01725360|Montelukast|montelukast|mesh-list
44510735|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44510736|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
44510737|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44510738|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44510739|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510740|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510741|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44510742|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44510743|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510744|NCT01725412|Thiamine|thiamine|mesh-list
44510745|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
44510746|NCT01725412|Vitamins|vitamins|mesh-ancestor
44510747|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
44510748|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510749|NCT01725477|Methylene Blue|methylene blue|mesh-list
44510750|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510751|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510752|NCT01725490|Metformin|metformin|mesh-list
44510753|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510754|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510755|NCT01725542|Ribavirin|ribavirin|mesh-list
44510756|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44510757|NCT01725542|Asunaprevir|asunaprevir|mesh-list
44510758|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
44510759|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510760|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
44510761|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510762|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
44510763|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510764|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
44510765|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44510766|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510767|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
44510768|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
44510769|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44510770|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44510771|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44510772|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510773|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
44510774|NCT01725607|Anesthetics|anesthetics|mesh-list
44510775|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510776|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510777|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44510778|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44510779|NCT01725607|Analgesics|analgesics|mesh-ancestor
44510780|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
44510781|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510782|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44510783|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44510784|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44510785|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510786|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510787|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510788|NCT01725620|Etanercept|etanercept|mesh-list
44510789|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44510802|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44510803|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510804|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44510805|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44510806|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
44510807|NCT01725776|Milrinone|milrinone|mesh-list
44510808|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44510809|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44510810|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44510811|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44510812|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44510813|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510814|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510815|NCT01725776|Protective Agents|protective agents|mesh-ancestor
44510816|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510817|NCT01725802|Levodopa|levodopa|mesh-list
44510818|NCT01725802|Carbidopa|carbidopa|mesh-list
44510819|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44510820|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44510821|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
44510822|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510823|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510824|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510825|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44510826|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510827|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44510828|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44510829|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510830|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
44510831|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44510832|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44510833|NCT01726075|Somatostatin|somatostatin|mesh-list
44510834|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44510835|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44510836|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44510837|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44510838|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44510839|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
44510840|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510841|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510842|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510843|NCT01726075|Hormones|hormones|mesh-ancestor
44510844|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510845|NCT01726088|Modafinil|modafinil|mesh-list
44510846|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44510847|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510848|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44510849|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44510850|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44510851|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510852|NCT01726192|Ropivacaine|ropivacaine|mesh-list
44510853|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
44510854|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
44510855|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510856|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510857|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
44510858|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510859|NCT01726205|Pregabalin|pregabalin|mesh-list
44510860|NCT01726205|Ropivacaine|ropivacaine|mesh-list
44510861|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
44510862|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
44510863|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510864|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510865|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
44510866|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510867|NCT01726205|Analgesics|analgesics|mesh-ancestor
44510868|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
44510869|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44510870|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44510871|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510872|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510873|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44510874|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44510875|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44510876|NCT01726283|Riboflavin|riboflavin|mesh-list
44510877|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
44510878|NCT01726283|Vitamins|vitamins|mesh-ancestor
44510879|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
44510880|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510881|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44510882|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44510883|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
44510884|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
44510885|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44510886|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44510887|NCT01726465|Prednisolone|prednisolone|mesh-list
44510888|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
44510889|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44510890|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
44510891|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44510892|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510893|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
44510894|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
44510895|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510896|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510897|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510898|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
44510899|NCT01726465|Hormones|hormones|mesh-ancestor
44510900|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44510901|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44510902|NCT01726465|Protective Agents|protective agents|mesh-ancestor
44510903|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44510904|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510905|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
44510906|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330847|NCT00982891|Morphine|morphine|mesh-list
44510908|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44510909|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44510910|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
44510911|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510912|NCT01726465|Antidotes|antidotes|mesh-ancestor
44510913|NCT01726478|Oxytocin|oxytocin|mesh-list
44510914|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
44510915|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44510916|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510917|NCT01726530|Fentanyl|fentanyl|mesh-list
44510918|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44510919|NCT01726530|Narcotics|narcotics|mesh-ancestor
44510920|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510921|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510922|NCT01726530|Analgesics|analgesics|mesh-ancestor
44510923|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
44510924|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510925|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44510926|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44510927|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
44510928|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
44510929|NCT01726686|Ropivacaine|ropivacaine|mesh-list
44510930|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
44510931|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
44510932|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44510933|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510934|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
44510935|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510936|NCT01726764|Metformin|metformin|mesh-list
44510937|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43625409|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
44510938|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510939|NCT01726777|Vitamin D|vitamin d|mesh-list
44510940|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
44510941|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
44510942|NCT01726777|Vitamins|vitamins|mesh-list
44510943|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
44510944|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510945|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44510946|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44510947|NCT01726816|Probucol|probucol|mesh-list
44510948|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44510949|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44510950|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
44510951|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510952|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44510953|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
44510954|NCT01726816|Protective Agents|protective agents|mesh-ancestor
44510955|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510956|NCT01726829|Pancrelipase|pancrelipase|mesh-list
44510957|NCT01726829|Pancreatin|pancreatin|mesh-list
44510958|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44510959|NCT01726920|Naproxen|naproxen|mesh-list
44510960|NCT01726920|Naratriptan|naratriptan|mesh-list
44510961|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44510962|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44510963|NCT01726920|Analgesics|analgesics|mesh-ancestor
44510964|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
44510965|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44510966|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510967|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44510968|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44510969|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
44510970|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44510971|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416000|NCT02336451|Ceritinib|ceritinib|mesh-list
44510972|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510973|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44510974|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44510975|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44510976|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
44510977|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44510978|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44510979|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
44510980|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44510981|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
44510982|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44510983|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44510984|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
44510985|NCT01727050|Coagulants|coagulants|mesh-ancestor
44510986|NCT01727271|Interferons|interferons|mesh-list
44510988|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
44510989|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
44510990|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44510991|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44510992|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
44510993|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44510994|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44510995|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44510996|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44510997|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44510998|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44510999|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44511000|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
44511001|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511002|NCT01727401|PENTA|penta|mesh-list
44511003|NCT01727401|Fondaparinux|fondaparinux|mesh-list
44511004|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44511005|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
44511006|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44511007|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44511008|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511009|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511010|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
44511011|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44511012|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44511013|NCT01727453|Warfarin|warfarin|mesh-list
44511014|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
44511015|NCT01727531|Chloroquine|chloroquine|mesh-list
44511016|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44511017|NCT01727531|Amebicides|amebicides|mesh-ancestor
44511018|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44511019|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44511020|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511021|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
44511022|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511023|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511024|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511025|NCT01727531|Analgesics|analgesics|mesh-ancestor
44511026|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
44511027|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511028|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511029|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511030|NCT01727531|Filaricides|filaricides|mesh-ancestor
44511031|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
44511032|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
44511033|NCT01727557|Anesthetics|anesthetics|mesh-list
44511034|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511035|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511036|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44511037|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44511038|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511039|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
44511040|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44511041|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44511042|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511043|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
44511044|NCT01727843|Coagulants|coagulants|mesh-ancestor
44511045|NCT01727869|Cetuximab|cetuximab|mesh-list
44511046|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44511047|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44511048|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511049|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511050|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511051|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511052|NCT01727973|Doxycycline|doxycycline|mesh-list
44511053|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44511054|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511055|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
44511056|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44331008|NCT00983554|Hormones|hormones|mesh-ancestor
44511057|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44511058|NCT01728051|Melphalan|melphalan|mesh-list
44511059|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44511060|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
44511061|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511062|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511063|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44511064|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511065|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
44511066|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511067|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
44511068|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44511069|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511070|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
44511071|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44511072|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511073|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511074|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511075|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511077|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511078|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511079|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
44511080|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
44511081|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511082|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511083|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44511084|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44511085|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44511086|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511087|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511088|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511089|NCT01728441|Paclitaxel|paclitaxel|mesh-list
44511090|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44511091|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44511092|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511093|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44511094|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44511095|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44511096|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511097|NCT01728480|Cisplatin|cisplatin|mesh-list
44511098|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511099|NCT01728571|Vitamin D|vitamin d|mesh-list
44511100|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
44511101|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
44511102|NCT01728571|Vitamins|vitamins|mesh-list
44511103|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
44511104|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511105|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44511106|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44511107|NCT01728740|Metformin|metformin|mesh-list
44511108|NCT01728740|Acarbose|acarbose|mesh-list
44511109|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44511110|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511111|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44511112|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511113|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511114|NCT01728818|Gemcitabine|gemcitabine|mesh-list
44511115|NCT01728818|Afatinib|afatinib|mesh-list
44511116|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44511117|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
44511118|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511119|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511120|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
44511121|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511122|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511123|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511124|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
44511125|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511126|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511127|NCT01728909|Oxytocin|oxytocin|mesh-list
44511128|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
44511129|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44511130|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511131|NCT01728922|Vitamin D|vitamin d|mesh-list
44511132|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
44511133|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
44511134|NCT01728922|Vitamins|vitamins|mesh-list
44331094|NCT00984347|Oxytocin|oxytocin|mesh-list
44511136|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511137|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44511138|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44511139|NCT01728935|Tenofovir|tenofovir|mesh-list
44511140|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
44511141|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511142|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44511143|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44511144|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511145|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511146|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44511147|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44511148|NCT01728948|Sorafenib|sorafenib|mesh-list
44511149|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511150|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511151|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511152|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511153|NCT01728961|Lumefantrine|lumefantrine|mesh-list
44511154|NCT01728961|Artemether|artemether|mesh-list
44511155|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44511156|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
44511157|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44511158|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44511159|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511160|NCT01728974|Anesthetics|anesthetics|mesh-list
44511161|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511162|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511163|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
44511164|NCT01728987|Vitamin D|vitamin d|mesh-list
44235308|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
44511165|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44511166|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511167|NCT01728987|Vitamins|vitamins|mesh-ancestor
44511168|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
44511169|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44511170|NCT01729104|Rituximab|rituximab|mesh-list
44511171|NCT01729104|Lenalidomide|lenalidomide|mesh-list
44511172|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44511173|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511174|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
44511175|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511176|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511177|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44511178|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44511179|NCT01729104|Growth Substances|growth substances|mesh-ancestor
44511180|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
44511181|NCT01729260|Mebendazole|mebendazole|mesh-list
44511182|NCT01729260|Piperazine|piperazine|mesh-list
44511183|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
44511184|NCT01729260|DMP 777|dmp 777|mesh-list
44511185|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
44511186|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
44511187|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44511188|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511189|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
44511190|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
44511191|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
44511192|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511193|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511194|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511195|NCT01729468|Aspirin|aspirin|mesh-list
44511196|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511197|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511198|NCT01729468|Analgesics|analgesics|mesh-ancestor
44511199|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
44511200|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511201|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511202|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511203|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511204|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44511205|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44511206|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511207|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44511208|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44511209|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511210|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
44511211|NCT01729481|Leucovorin|leucovorin|mesh-list
44511212|NCT01729481|Folic Acid|folic acid|mesh-list
44511213|NCT01729481|Gemcitabine|gemcitabine|mesh-list
44511214|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
44511215|NCT01729481|Irinotecan|irinotecan|mesh-list
44511216|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
44511217|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44511218|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
44511219|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511220|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511221|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
44511222|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511223|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511224|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511225|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
44511226|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511227|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44511228|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44511229|NCT01729481|Antidotes|antidotes|mesh-ancestor
44511230|NCT01729481|Protective Agents|protective agents|mesh-ancestor
44511231|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
44511232|NCT01729481|Vitamins|vitamins|mesh-ancestor
44511233|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
44511234|NCT01729481|Hematinics|hematinics|mesh-ancestor
44511235|NCT01729663|Interferons|interferons|mesh-list
44511236|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
44511237|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
44511238|NCT01729663|Molgramostim|molgramostim|mesh-list
44511239|NCT01729663|Sargramostim|sargramostim|mesh-list
44511240|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
44511241|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511242|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
44511243|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511244|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
44511245|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511246|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44511247|NCT01729767|Acyclovir|acyclovir|mesh-list
44511248|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
44511249|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511250|NCT01729806|Rituximab|rituximab|mesh-list
44511251|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44511252|NCT01729806|Ipilimumab|ipilimumab|mesh-list
44511253|NCT01729806|Antibodies|antibodies|mesh-list
44511254|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
44511255|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44511256|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
44511257|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511258|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511259|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511260|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44511261|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511263|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
44511264|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
44511265|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511266|NCT01720147|Quercetin|quercetin|mesh-list
44511267|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
44511268|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511269|NCT01720147|Protective Agents|protective agents|mesh-ancestor
44511270|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511271|NCT01720563|Leucovorin|leucovorin|mesh-list
44511272|NCT01720563|Cisplatin|cisplatin|mesh-list
44511273|NCT01720563|Tegafur|tegafur|mesh-list
44511274|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511275|NCT01720563|Antidotes|antidotes|mesh-ancestor
44511276|NCT01720563|Protective Agents|protective agents|mesh-ancestor
44511277|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511278|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
44511279|NCT01720563|Vitamins|vitamins|mesh-ancestor
44511280|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
44511281|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44511282|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
44511283|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511284|NCT01724346|Chlorambucil|chlorambucil|mesh-list
44511285|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44511286|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
44511287|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511288|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511289|NCT01724879|Dasatinib|dasatinib|mesh-list
44511290|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511291|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511292|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511293|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511294|NCT01723202|Trametinib|trametinib|mesh-list
44511295|NCT01723202|Dabrafenib|dabrafenib|mesh-list
44511296|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511297|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511298|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511299|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511300|NCT01729403|Metformin|metformin|mesh-list
44511301|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44511302|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511303|NCT01728753|Favipiravir|favipiravir|mesh-list
44511304|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
44511305|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511306|NCT01728064|Ubiquinone|ubiquinone|mesh-list
44511307|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
44511308|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511309|NCT01726946|Ribavirin|ribavirin|mesh-list
44511310|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
44511311|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511312|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
44511313|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511314|NCT01721733|Ubiquinone|ubiquinone|mesh-list
44511315|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
44511316|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511317|NCT01727336|Axitinib|axitinib|mesh-list
44511318|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511319|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44511320|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511321|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511322|NCT01720485|Prednisolone|prednisolone|mesh-list
44511323|NCT01720485|Betamethasone|betamethasone|mesh-list
44511324|NCT01720485|Desloratadine|desloratadine|mesh-list
44511325|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44511326|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511327|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
44511328|NCT01720485|Hormones|hormones|mesh-ancestor
44511329|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511330|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511331|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44511332|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511333|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511334|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511335|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44511336|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511337|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511338|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511339|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44511340|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44511341|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
44511342|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
44511343|NCT01721291|Albuterol|albuterol|mesh-list
44511344|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511345|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
44511346|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511347|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511348|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511349|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511350|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
44511351|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44511352|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44511353|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511354|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511355|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511356|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511357|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511358|NCT01722656|Aflibercept|aflibercept|mesh-list
44511359|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44511360|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44511361|NCT01722656|Growth Substances|growth substances|mesh-ancestor
44511362|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511363|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44511364|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511365|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
44511366|NCT01724658|Testosterone|testosterone|mesh-list
44511367|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
44511368|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
44511369|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44511370|NCT01724658|Androgens|androgens|mesh-ancestor
44511371|NCT01724658|Hormones|hormones|mesh-ancestor
44511372|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511373|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511374|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44511375|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511376|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
44511377|NCT01726725|Desflurane|desflurane|mesh-list
44511378|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44511379|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
44511380|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
44511381|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511382|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511383|NCT01729897|Fentanyl|fentanyl|mesh-list
44511384|NCT01729897|Propofol|propofol|mesh-list
44511385|NCT01729897|Etomidate|etomidate|mesh-list
44511386|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44511387|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511388|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511389|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44511390|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
44511391|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
44511392|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44511393|NCT01729897|Narcotics|narcotics|mesh-ancestor
44511394|NCT01729897|Analgesics|analgesics|mesh-ancestor
44511395|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
44511396|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511397|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44511398|NCT01725152|Ganaxolone|ganaxolone|mesh-list
44511399|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
44511400|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511401|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511402|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511403|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
44511404|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
44511405|NCT01048177|Lidocaine|lidocaine|mesh-list
44511406|NCT01048177|Heparin|heparin|mesh-list
44511407|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
44511408|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
44511409|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511410|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511411|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
44511412|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331376|NCT00986050|Abciximab|abciximab|mesh-list
44511413|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511414|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44511416|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44511417|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511418|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
44511419|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44511420|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44511421|NCT01041807|Losartan|losartan|mesh-list
44511422|NCT01041807|Amlodipine|amlodipine|mesh-list
44511423|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511424|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44511425|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44511426|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511427|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44511428|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511429|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
44511430|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511431|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44511432|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44511433|NCT01049984|Rasagiline|rasagiline|mesh-list
44511434|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44511435|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511436|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511437|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44511438|NCT01049984|Protective Agents|protective agents|mesh-ancestor
44511439|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511440|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
44511441|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511442|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
44511443|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511444|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511445|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511446|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511447|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44511448|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511449|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511450|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511451|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511452|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511453|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
44511454|NCT01049334|Analgesics|analgesics|mesh-ancestor
44511455|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
44511456|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511457|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511458|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511459|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511460|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511461|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511462|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44511463|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511464|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511465|NCT01049035|Vaccines|vaccines|mesh-list
44511466|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44511467|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
44511468|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511469|NCT01049009|Metoprolol|metoprolol|mesh-list
44511470|NCT01049009|Nebivolol|nebivolol|mesh-list
44511471|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511472|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511473|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
44511474|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
44511475|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511476|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511477|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44511478|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44511479|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44511480|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511481|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511482|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511483|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
44511484|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44511495|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511496|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511497|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511498|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44511499|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
44511500|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44511501|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44511502|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44511503|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44511504|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
44511505|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44511506|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44511507|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511508|NCT01048866|Acetaminophen|acetaminophen|mesh-list
44511509|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
44511510|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511511|NCT01048866|Analgesics|analgesics|mesh-ancestor
44511512|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
44511513|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511514|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511515|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
44511516|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511517|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511518|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511519|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44511520|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511521|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511523|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44511524|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511525|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
44511526|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511527|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
44511528|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44511529|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44511530|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
44511531|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511532|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44511533|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44511534|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511535|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511536|NCT01048502|Fenofibrate|fenofibrate|mesh-list
44511537|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44511538|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
44511539|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511540|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44511541|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
44511542|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44511543|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511544|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
44416553|NCT02318693|Glyburide|glyburide|mesh-list
44511545|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511546|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511547|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511548|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511549|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44511550|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511551|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511552|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511553|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511554|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511555|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44511556|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44511557|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44511558|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
44511559|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511560|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
44511561|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511562|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511563|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511564|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511565|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44511566|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511567|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511568|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511569|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511570|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511571|NCT01047436|Artemether|artemether|mesh-list
44511572|NCT01047436|Quinine|quinine|mesh-list
44511573|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
44511574|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44511575|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44511576|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511577|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44511578|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511579|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44511580|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511581|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511582|NCT01047436|Analgesics|analgesics|mesh-ancestor
44511583|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
44511584|NCT01047293|Leucovorin|leucovorin|mesh-list
44511585|NCT01047293|Bevacizumab|bevacizumab|mesh-list
44511586|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
44511587|NCT01047293|Everolimus|everolimus|mesh-list
44511588|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44511589|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511590|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44511591|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44511592|NCT01047293|Growth Substances|growth substances|mesh-ancestor
44511593|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511594|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
44511595|NCT01047293|Antidotes|antidotes|mesh-ancestor
44511596|NCT01047293|Protective Agents|protective agents|mesh-ancestor
44511597|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
44511598|NCT01047293|Vitamins|vitamins|mesh-ancestor
44511599|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
44511600|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511601|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
44511602|NCT01047007|Cisplatin|cisplatin|mesh-list
44511603|NCT01047007|Adavosertib|adavosertib|mesh-list
44511604|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511605|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511606|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511607|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44511608|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511609|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511610|NCT01046682|Analgesics|analgesics|mesh-ancestor
44511611|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
44511612|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511613|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511614|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511615|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511616|NCT01046643|Estradiol|estradiol|mesh-list
44511617|NCT01046643|Progesterone|progesterone|mesh-list
44511618|NCT01046643|Estrogens|estrogens|mesh-ancestor
44511619|NCT01046643|Hormones|hormones|mesh-ancestor
44511620|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511621|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511622|NCT01046643|Progestins|progestins|mesh-ancestor
44511623|NCT01046565|Adapalene|adapalene|mesh-list
44511624|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511625|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511626|NCT01046565|Analgesics|analgesics|mesh-ancestor
44511627|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
44511628|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511629|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625410|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511630|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511631|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511632|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44511633|NCT01046396|Adapalene|adapalene|mesh-list
44511634|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511635|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511636|NCT01046396|Analgesics|analgesics|mesh-ancestor
44511637|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
44511638|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511639|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511640|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511641|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511642|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
44511643|NCT01046253|Lansoprazole|lansoprazole|mesh-list
44511644|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
44511645|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44511646|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44511647|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44511648|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511649|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511650|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44511651|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44511652|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511653|NCT01046110|Incretins|incretins|mesh-ancestor
44511654|NCT01046110|Hormones|hormones|mesh-ancestor
44511655|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511656|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44511657|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
44511658|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511659|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511660|NCT01046084|Lansoprazole|lansoprazole|mesh-list
44511661|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
44511662|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44511663|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44511664|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44511665|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511666|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511667|NCT01045967|Lansoprazole|lansoprazole|mesh-list
44511668|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
44511669|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44511670|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44511671|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44511672|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416674|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
44511673|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511674|NCT01045798|Caspofungin|caspofungin|mesh-list
44511675|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
44511676|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511677|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511678|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511679|NCT01045694|Triamcinolone|triamcinolone|mesh-list
44511680|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44511681|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44511682|NCT01045694|Lidocaine|lidocaine|mesh-list
44511683|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
44511684|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44511685|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44511686|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44511687|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
44511688|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
44511689|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511690|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511691|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
44511692|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511693|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511694|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44511695|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44511696|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44511697|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511698|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44511699|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511700|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511701|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44511702|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511703|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
44511704|NCT01045694|Hormones|hormones|mesh-ancestor
44511705|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511706|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511707|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
44511708|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511709|NCT01045161|Bromides|bromides|mesh-list
44511710|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
44511711|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
44511712|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
44511713|NCT01044745|Busulfan|busulfan|mesh-list
44511714|NCT01044745|Rituximab|rituximab|mesh-list
44511715|NCT01044745|Fludarabine|fludarabine|mesh-list
44511716|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
44511717|NCT01044745|Tacrolimus|tacrolimus|mesh-list
44511718|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
44511719|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44511720|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44511721|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
44511722|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511723|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511724|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44511725|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
44511726|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511727|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511728|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44511729|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44511730|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44511731|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
44511732|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44511733|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511734|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44511735|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44511736|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
44511737|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416725|NCT02312934|Nicotine|nicotine|mesh-list
44511738|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511739|NCT01044498|Norinyl|norinyl|mesh-list
44511740|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44511741|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44511742|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44511743|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
44511744|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44511745|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511746|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44511747|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44511748|NCT01044459|Bromides|bromides|mesh-list
44511749|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
44511750|NCT01044433|Capecitabine|capecitabine|mesh-list
44511751|NCT01044433|Lapatinib|lapatinib|mesh-list
44511752|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44511753|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
44511754|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331787|NCT00988403|Levan|levan|mesh-list
44511763|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44511764|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511765|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511766|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511767|NCT01043185|Lesogaberan|lesogaberan|mesh-list
44511768|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44511769|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44511770|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
44511771|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
44511772|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511773|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511774|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511775|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
44511776|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44511777|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511778|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44511779|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511780|NCT01042938|Curcumin|curcumin|mesh-list
44511781|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511782|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511783|NCT01042938|Analgesics|analgesics|mesh-ancestor
44511784|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
44511785|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511786|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511787|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511788|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511789|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511790|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511791|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511792|NCT01042535|Tryptophan|tryptophan|mesh-list
44511793|NCT01042535|Vaccines|vaccines|mesh-list
44511794|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
44511795|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511796|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44511797|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
44511798|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44511799|NCT01042158|Ambrisentan|ambrisentan|mesh-list
44511800|NCT01042158|Tadalafil|tadalafil|mesh-list
44511801|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
44511802|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44511803|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44511804|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511805|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511806|NCT01042158|Urological Agents|urological agents|mesh-ancestor
44511807|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511808|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44511809|NCT01042093|Clonidine|clonidine|mesh-list
44511810|NCT01042093|Epinephrine|epinephrine|mesh-list
44511811|NCT01042093|Ropivacaine|ropivacaine|mesh-list
44511812|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
44511813|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
44511814|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511815|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511816|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
44511817|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511818|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44511819|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511820|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511821|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511822|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511823|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511824|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511825|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
44511826|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511827|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511828|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
44511829|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
44511830|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44511831|NCT01042093|Analgesics|analgesics|mesh-ancestor
44511832|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511833|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
44511834|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44511835|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44511836|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511837|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511838|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511839|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44511840|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511841|NCT01041859|Tapentadol|tapentadol|mesh-list
44511842|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44511843|NCT01041859|Narcotics|narcotics|mesh-ancestor
44511844|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511845|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511846|NCT01041859|Analgesics|analgesics|mesh-ancestor
44511847|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
44511848|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511849|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44511850|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44511851|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44511852|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511853|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511854|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511855|NCT01041638|Vitamin A|vitamin a|mesh-list
44511856|NCT01041638|Aldesleukin|aldesleukin|mesh-list
44511857|NCT01041638|Interleukin-2|interleukin-2|mesh-list
44511858|NCT01041638|Tretinoin|tretinoin|mesh-list
44511859|NCT01041638|Dinutuximab|dinutuximab|mesh-list
44511860|NCT01041638|Isotretinoin|isotretinoin|mesh-list
44511861|NCT01041638|Sargramostim|sargramostim|mesh-list
44511862|NCT01041638|Vitamins|vitamins|mesh-ancestor
44511863|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
44511864|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511865|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511866|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44511867|NCT01041638|Analgesics|analgesics|mesh-ancestor
44511868|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
44511869|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511870|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
44511871|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44511872|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44511873|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
44511874|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44511875|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
44511876|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
44511877|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44511878|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
44511879|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511880|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
44511881|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44511882|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
44511883|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44511884|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44511885|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511886|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44511887|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511888|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44511889|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44511890|NCT01041417|Molgramostim|molgramostim|mesh-list
44511891|NCT01041417|Sargramostim|sargramostim|mesh-list
44511892|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
44511893|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511894|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511895|NCT01041287|Metoprolol|metoprolol|mesh-list
44511896|NCT01041287|Nebivolol|nebivolol|mesh-list
44511897|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44511898|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44511899|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
44511900|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
44511901|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511902|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511903|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44511904|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44511905|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44511906|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
44511907|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511908|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511909|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
44511910|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44511911|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44511912|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44511913|NCT01040871|Prednisone|prednisone|mesh-list
44511914|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
44511915|NCT01040871|Rituximab|rituximab|mesh-list
44511916|NCT01040871|Doxorubicin|doxorubicin|mesh-list
44511917|NCT01040871|Vincristine|vincristine|mesh-list
44511918|NCT01040871|Bortezomib|bortezomib|mesh-list
44511919|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44511920|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
44511921|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511922|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511923|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44511924|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
44511925|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511926|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511927|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44511928|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44511929|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44511930|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44511931|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44511932|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44511933|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44511934|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
44511935|NCT01040871|Hormones|hormones|mesh-ancestor
44511936|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511937|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44511938|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44511939|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
44511940|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
44511941|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
44511942|NCT01040845|Colchicine|colchicine|mesh-list
44511943|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44511944|NCT01040845|Norethindrone|norethindrone|mesh-list
44511945|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
44511946|NCT01040845|Estradiol|estradiol|mesh-list
44511947|NCT01040845|Estrogens|estrogens|mesh-ancestor
44511948|NCT01040845|Hormones|hormones|mesh-ancestor
44511949|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44511950|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511951|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44511952|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
44511953|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44511954|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44511955|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
44511956|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44511957|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44511958|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44511959|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44511960|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511961|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44511962|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44511963|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44511964|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44511965|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
44511966|NCT01040728|Olodaterol|olodaterol|mesh-list
44511967|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511968|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
44511969|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511970|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511971|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511972|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511973|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
44511974|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44511975|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511976|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44511977|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511978|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
44511979|NCT01040689|Olodaterol|olodaterol|mesh-list
44511980|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44511981|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
44511982|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511983|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511984|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44511985|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
44511986|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
44511987|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44511988|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511989|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416967|NCT02305849|Methotrexate|methotrexate|mesh-list
44511990|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44511991|NCT01040260|Nicotine|nicotine|mesh-list
44511992|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44511993|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
44511994|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44511995|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44511996|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44511997|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44511998|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
44511999|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512000|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512001|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
44512002|NCT01040169|Calcium|calcium|mesh-list
44512003|NCT01040169|Fluorides|fluorides|mesh-list
44512004|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512005|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512006|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
44512007|NCT01040169|Protective Agents|protective agents|mesh-ancestor
44512008|NCT01040169|Antacids|antacids|mesh-ancestor
44512009|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512010|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512011|NCT01047540|Pritelivir|pritelivir|mesh-list
44512012|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
44512013|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512014|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512015|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512016|NCT01046422|Metformin|metformin|mesh-list
44512017|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44512018|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512019|NCT01044381|Luliconazole|luliconazole|mesh-list
44512020|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
44512021|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512022|NCT01043029|Pioglitazone|pioglitazone|mesh-list
44512023|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44512024|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512025|NCT01042925|Paclitaxel|paclitaxel|mesh-list
44512026|NCT01042925|Trastuzumab|trastuzumab|mesh-list
44512027|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44512028|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512029|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512030|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512031|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512032|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512033|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512034|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
44512035|NCT01045460|Melphalan|melphalan|mesh-list
44512036|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512037|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
44512038|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512039|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512040|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44512041|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
44512042|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512043|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512044|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44512045|NCT01042522|Paclitaxel|paclitaxel|mesh-list
44512046|NCT01042522|Etoposide|etoposide|mesh-list
44512047|NCT01042522|Cisplatin|cisplatin|mesh-list
44512048|NCT01042522|Carboplatin|carboplatin|mesh-list
44512049|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44512050|NCT01042522|Bleomycin|bleomycin|mesh-list
44512051|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
44512052|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44512053|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512054|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512055|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512056|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512057|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512058|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44512059|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44512060|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512061|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44512062|NCT03403621|Pentamidine|pentamidine|mesh-list
44512063|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
44512064|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512065|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44512066|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44512067|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44512068|NCT03404791|Gemcitabine|gemcitabine|mesh-list
44512069|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512070|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
44512071|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512072|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512073|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
44512074|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512075|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512076|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512077|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
44512078|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512079|NCT03400306|Paclitaxel|paclitaxel|mesh-list
44512080|NCT03400306|Carboplatin|carboplatin|mesh-list
44512081|NCT03400306|Veliparib|veliparib|mesh-list
44512082|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44512083|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512084|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512085|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512086|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512087|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512088|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44512089|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512090|NCT03406286|Tolvaptan|tolvaptan|mesh-list
44512091|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44512092|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512093|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
44512094|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512095|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
44512096|NCT03401710|Hematinics|hematinics|mesh-ancestor
44512097|NCT03401294|Leucovorin|leucovorin|mesh-list
44512098|NCT03401294|Bevacizumab|bevacizumab|mesh-list
44512099|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
44512100|NCT03401294|Irinotecan|irinotecan|mesh-list
44512101|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512102|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512103|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512104|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512105|NCT03401294|Growth Substances|growth substances|mesh-ancestor
44512106|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512107|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512108|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44417095|NCT02302807|Paclitaxel|paclitaxel|mesh-list
44512109|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44512110|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512111|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512112|NCT03401294|Antidotes|antidotes|mesh-ancestor
44512113|NCT03401294|Protective Agents|protective agents|mesh-ancestor
44512114|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
44512115|NCT03401294|Vitamins|vitamins|mesh-ancestor
44512116|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
44512117|NCT03408119|Vitamin D|vitamin d|mesh-list
44512118|NCT03408119|Calcium|calcium|mesh-list
44512119|NCT03408119|Vitamins|vitamins|mesh-ancestor
44512120|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
44512121|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512122|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512123|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44512124|NCT03405870|SMOFlipid|smoflipid|mesh-list
44512125|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44512126|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44512127|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44512128|NCT03409458|Avelumab|avelumab|mesh-list
44512134|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44512135|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512136|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512137|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44512138|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
44512139|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44512140|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512141|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
44512142|NCT03409198|Doxorubicin|doxorubicin|mesh-list
44512143|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44512144|NCT03409198|Nivolumab|nivolumab|mesh-list
44512145|NCT03409198|Ipilimumab|ipilimumab|mesh-list
44512146|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512147|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
44512148|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512149|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512150|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44512151|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
44512152|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512153|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512154|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44512155|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44512156|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44512157|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44512158|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512159|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512160|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512161|NCT03405155|Nivolumab|nivolumab|mesh-list
44417146|NCT02301936|Ledipasvir|ledipasvir|mesh-list
44512162|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512163|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512164|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512165|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512166|NCT03406247|Nivolumab|nivolumab|mesh-list
44512167|NCT03406247|Ipilimumab|ipilimumab|mesh-list
44512168|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512169|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512170|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512171|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512172|NCT03409874|Diclofenac|diclofenac|mesh-list
44512173|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44512174|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512175|NCT03409874|Analgesics|analgesics|mesh-ancestor
44512176|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
44512177|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512178|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512179|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512180|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512181|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44512182|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512183|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512184|NCT03409835|Ramosetron|ramosetron|mesh-list
44512185|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
44512186|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
44512187|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512188|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512189|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512190|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44512191|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
44512192|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512193|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512194|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44512195|NCT03409679|Murepavadin|murepavadin|mesh-list
44512196|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512197|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44512198|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44512199|NCT03409432|Lenalidomide|lenalidomide|mesh-list
44512200|NCT03409432|Antibodies|antibodies|mesh-list
44512201|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
44512202|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44512203|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
44512204|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
44512205|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512206|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512207|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512208|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512209|NCT03409432|Growth Substances|growth substances|mesh-ancestor
44512210|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512211|NCT03409367|Emollients|emollients|mesh-list
44512212|NCT03409367|Petrolatum|petrolatum|mesh-list
44512213|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
44512214|NCT03409250|Ranibizumab|ranibizumab|mesh-list
44512215|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512216|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512217|NCT03409250|Growth Substances|growth substances|mesh-ancestor
44512218|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512219|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512220|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512221|NCT03409068|Anesthetics|anesthetics|mesh-list
44512222|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512223|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512224|NCT03408587|Ipilimumab|ipilimumab|mesh-list
44512225|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512226|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512227|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512228|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512229|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44512230|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512231|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
44512232|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44512233|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
44512234|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512235|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
44512236|NCT03408145|Protective Agents|protective agents|mesh-ancestor
44512237|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
44512238|NCT03408054|Oxytocin|oxytocin|mesh-list
44512239|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
44512240|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44512241|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512242|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
44512243|NCT03408015|Lifitegrast|lifitegrast|mesh-list
44332297|NCT00990639|Candesartan|candesartan|mesh-list
44512244|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44512245|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44512246|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
44512247|NCT03407976|Apatinib|apatinib|mesh-list
44512248|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512249|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512250|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44512251|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512252|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512253|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44512254|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512255|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512256|NCT03407872|Esketamine|esketamine|mesh-list
44512257|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
44512258|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44332376|NCT00990886|Oxybutynin|oxybutynin|mesh-list
44512260|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44512261|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
44512262|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512263|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
44512264|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
44512265|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44512266|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44512267|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512268|NCT03407404|Midazolam|midazolam|mesh-list
44512269|NCT03407404|Ketamine|ketamine|mesh-list
44512270|NCT03407404|Morphine|morphine|mesh-list
44512271|NCT03407404|Analgesics|analgesics|mesh-ancestor
44512272|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
44512273|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512274|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512275|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44512276|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44512277|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
44512278|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
44512279|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512280|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44512281|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44512282|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512283|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512284|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512285|NCT03407404|Narcotics|narcotics|mesh-ancestor
44512286|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44512287|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512288|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44512289|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512290|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512291|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
44512292|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
44512293|NCT03407300|Docetaxel|docetaxel|mesh-list
44512294|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512295|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512296|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512297|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512298|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512299|NCT03407209|Anesthetics|anesthetics|mesh-list
44512300|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
44512301|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512302|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512303|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
44512304|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512305|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
44512306|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44512307|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512308|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44512309|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512310|NCT03407105|Ipilimumab|ipilimumab|mesh-list
44512311|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512312|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512313|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512314|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512315|NCT03406936|Midazolam|midazolam|mesh-list
44512316|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44512317|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512318|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512319|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512321|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512322|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512323|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44512324|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
44512325|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
44512326|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
44512327|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
44512328|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512329|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512330|NCT03406871|Nivolumab|nivolumab|mesh-list
44512331|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512332|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512333|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44512334|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512336|NCT03406793|Zinc|zinc|mesh-list
44512337|NCT03406793|Trace Elements|trace elements|mesh-ancestor
44512338|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
44512339|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512340|NCT03406689|Nepafenac|nepafenac|mesh-list
44512341|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
44512342|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44512343|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44512344|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44512345|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512346|NCT03406689|Analgesics|analgesics|mesh-ancestor
44512347|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
44512348|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512349|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512350|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512351|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512352|NCT03406676|Methylene Blue|methylene blue|mesh-list
44512353|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512354|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512355|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
44512356|NCT03406546|Remifentanil|remifentanil|mesh-list
44512357|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512358|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512359|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512360|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512361|NCT03406546|Analgesics|analgesics|mesh-ancestor
44512362|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
44512363|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512364|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44512365|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44512366|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44512367|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512368|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512369|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512370|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512371|NCT03406546|Narcotics|narcotics|mesh-ancestor
44512372|NCT03406533|Fentanyl|fentanyl|mesh-list
44512373|NCT03406533|Midazolam|midazolam|mesh-list
44512374|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
44512375|NCT03406533|Remifentanil|remifentanil|mesh-list
44512376|NCT03406533|Propofol|propofol|mesh-list
44512377|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512378|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512379|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512380|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44512381|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
44512382|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
44512383|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512384|NCT03406533|Analgesics|analgesics|mesh-ancestor
44512385|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
44512386|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512387|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44512388|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44512389|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44512390|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512391|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512392|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512393|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512394|NCT03406533|Narcotics|narcotics|mesh-ancestor
44512395|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44512396|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44512397|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512398|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512399|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
44512400|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
44512401|NCT03406403|Anesthetics|anesthetics|mesh-list
44512402|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512403|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512405|NCT03406299|Gemcitabine|gemcitabine|mesh-list
44512406|NCT03406299|Cisplatin|cisplatin|mesh-list
44512407|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
44332520|NCT00991796|Paclitaxel|paclitaxel|mesh-list
44512408|NCT03406299|Tegafur|tegafur|mesh-list
44512409|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512410|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512411|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
44512412|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512413|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
44512414|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512415|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512416|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512417|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
44512418|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512419|NCT03406299|Antidotes|antidotes|mesh-ancestor
44512420|NCT03406299|Protective Agents|protective agents|mesh-ancestor
44512421|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
44512422|NCT03406299|Vitamins|vitamins|mesh-ancestor
44512423|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
44512424|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
44512425|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
44512426|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
44512427|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44417412|NCT02296190|Etripamil|etripamil|mesh-list
44512428|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44512429|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512430|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512431|NCT03406169|Urological Agents|urological agents|mesh-ancestor
44512432|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44512433|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44512434|NCT03406169|Protective Agents|protective agents|mesh-ancestor
44512435|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512436|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44512437|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
44512438|NCT03406091|Plerixafor|plerixafor|mesh-list
44512439|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44512440|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44512441|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
44512442|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512443|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
44512444|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44512445|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44512446|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512447|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
44512448|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512449|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512450|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44512451|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
44512452|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512453|NCT03405584|Amoxicillin|amoxicillin|mesh-list
44512454|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
44512455|NCT03405584|Esomeprazole|esomeprazole|mesh-list
44512456|NCT03405584|Bismuth|bismuth|mesh-list
44512457|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512458|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512459|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512460|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44512461|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512462|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44512463|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512464|NCT03405584|Antacids|antacids|mesh-ancestor
44512465|NCT03405584|Diuretics|diuretics|mesh-ancestor
44512466|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
44512467|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512468|NCT03405584|Expectorants|expectorants|mesh-ancestor
44512469|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44512470|NCT03405376|Aflibercept|aflibercept|mesh-list
44512471|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512472|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512473|NCT03405376|Growth Substances|growth substances|mesh-ancestor
44512474|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512475|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512476|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512477|NCT03405337|Factor VIII|factor viii|mesh-list
44512478|NCT03405337|Coagulants|coagulants|mesh-ancestor
44512479|NCT03405272|Antibodies|antibodies|mesh-list
44512480|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44512481|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
44512482|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512483|NCT03405207|Vitamin D|vitamin d|mesh-list
44512484|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
44512485|NCT03405207|Vitamins|vitamins|mesh-ancestor
44512486|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
44512487|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512488|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44512489|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512490|NCT03405194|Efavirenz|efavirenz|mesh-list
44512491|NCT03405194|Cobicistat|cobicistat|mesh-list
44512492|NCT03405194|Elvitegravir|elvitegravir|mesh-list
44512493|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44512494|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44512495|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512496|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512497|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
44512498|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512499|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44512500|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44512501|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44512502|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44512503|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44512504|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44512505|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44512506|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44512507|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44512508|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44512509|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
44512510|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44512511|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512512|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512513|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44512514|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44512515|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512516|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512517|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512518|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44512519|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
44512520|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44512521|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512522|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44512523|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44512524|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44512525|NCT03405064|Linezolid|linezolid|mesh-list
44512526|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
44512527|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512528|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512529|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44512530|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512531|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512532|NCT03404908|Acetaminophen|acetaminophen|mesh-list
44512533|NCT03404908|Dipyrone|dipyrone|mesh-list
44512534|NCT03404908|Ketoprofen|ketoprofen|mesh-list
44512535|NCT03404908|Morphine|morphine|mesh-list
44512536|NCT03404908|Ropivacaine|ropivacaine|mesh-list
44512537|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512538|NCT03404908|Narcotics|narcotics|mesh-ancestor
44512539|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512540|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512541|NCT03404908|Analgesics|analgesics|mesh-ancestor
44512542|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
44512543|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512544|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
44512546|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512547|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
44512548|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44512549|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512550|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512551|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44512552|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512553|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512554|NCT03404752|Lenograstim|lenograstim|mesh-list
44512555|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44512556|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
44512557|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512572|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
44512573|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512574|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512575|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512576|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512577|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44512578|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44512579|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512580|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512581|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44512582|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44512583|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512584|NCT03404037|Endostatins|endostatins|mesh-list
44512585|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512586|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512587|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512588|NCT03404037|Growth Substances|growth substances|mesh-ancestor
44512589|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512590|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512591|NCT03404024|Mitogens|mitogens|mesh-list
44512592|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512593|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512594|NCT03403985|Calcium|calcium|mesh-list
44512595|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512596|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512597|NCT03403972|Vancomycin|vancomycin|mesh-list
44512598|NCT03403972|Simvastatin|simvastatin|mesh-list
44512599|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44512600|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44512601|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
44512602|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512603|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44512604|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44512605|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512606|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512607|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512608|NCT03403829|Gemcitabine|gemcitabine|mesh-list
44512609|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512610|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
44512611|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512612|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512613|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
44512614|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512615|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512616|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512617|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
44512618|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512619|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44512620|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
44512621|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512622|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44512623|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512624|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512625|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512626|NCT03403777|Avelumab|avelumab|mesh-list
44512627|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512628|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512629|NCT03403647|Vitamin D|vitamin d|mesh-list
44512630|NCT03403647|Vitamins|vitamins|mesh-ancestor
44512631|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
44157412|NCT00234416|Gefitinib|gefitinib|mesh-list
44512632|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512633|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44512634|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
44512635|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44512636|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512637|NCT03403452|Apatinib|apatinib|mesh-list
44512638|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512639|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44512640|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512641|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512642|NCT03403439|Itraconazole|itraconazole|mesh-list
44512643|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
44512644|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512645|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44512646|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44512647|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512648|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512649|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44512650|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
44512651|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44512652|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512653|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44512654|NCT03403140|Etanercept|etanercept|mesh-list
44512655|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44512656|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512657|NCT03403140|Analgesics|analgesics|mesh-ancestor
44512658|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
44512659|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512660|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512661|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512662|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512663|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512664|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512665|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
44512666|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
44512667|NCT03403101|Irinotecan|irinotecan|mesh-list
44512668|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512669|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44512670|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44512671|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512672|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512673|NCT03403049|Gemcitabine|gemcitabine|mesh-list
44512674|NCT03403049|Cisplatin|cisplatin|mesh-list
44512675|NCT03403049|Capecitabine|capecitabine|mesh-list
44512676|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44512677|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512678|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512679|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
44512680|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512681|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
44512682|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512683|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512684|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512685|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
44512686|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512687|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44512688|NCT03402984|Z 338|z 338|mesh-list
44512689|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44512690|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512691|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512692|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44512693|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512694|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512695|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512696|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
44512697|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
44512698|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
44512699|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512700|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512701|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
44512702|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512703|NCT03402815|Maraviroc|maraviroc|mesh-list
44512704|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44417666|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44512705|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44512706|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512707|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44512708|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44512709|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
44512710|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512711|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44512720|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512721|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512722|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44512724|NCT03402321|Coagulants|coagulants|mesh-ancestor
44512725|NCT03402295|Thalidomide|thalidomide|mesh-list
44512726|NCT03402295|Dexamethasone|dexamethasone|mesh-list
44512727|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
44512728|NCT03402295|Bortezomib|bortezomib|mesh-list
44512729|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512730|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
44512731|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512732|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512733|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44512734|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
44512735|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512736|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512737|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44512738|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512739|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
44512740|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
44512741|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512742|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512743|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
44512744|NCT03402295|Hormones|hormones|mesh-ancestor
44512745|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44512746|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44512747|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
44512748|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512749|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512750|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44512751|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44512752|NCT03402295|Growth Substances|growth substances|mesh-ancestor
44512753|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
44512754|NCT03402204|Ubenimex|ubenimex|mesh-list
44512755|NCT03402204|Simvastatin|simvastatin|mesh-list
44512756|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44512757|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44512758|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
44512759|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512760|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44512761|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44512762|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512763|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44512764|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
44512765|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512766|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512767|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512768|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44512769|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512770|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
44512771|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44512772|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44512773|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
44512774|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
44512775|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44512776|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44512777|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44512778|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512779|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512780|NCT03402191|Urological Agents|urological agents|mesh-ancestor
44512781|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
44512782|NCT03402165|Ledipasvir|ledipasvir|mesh-list
44512783|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44512784|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
44512785|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512786|NCT03402113|Midazolam|midazolam|mesh-list
44512787|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
44512788|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512789|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626255|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
44512790|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512792|NCT03402113|Analgesics|analgesics|mesh-ancestor
44512793|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
44512794|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512795|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44512796|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44512797|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44512798|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512799|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512800|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512801|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44512802|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44512803|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44512804|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44512805|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44512806|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
44512807|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
44512808|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
44512809|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
44512810|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44512811|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44512812|NCT03402087|Leucovorin|leucovorin|mesh-list
44512813|NCT03402087|Methotrexate|methotrexate|mesh-list
44512814|NCT03402087|BMS-986165|bms-986165|mesh-list
44512815|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44512816|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
44512817|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44512818|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512819|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512820|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
44512821|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512822|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512823|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44512824|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512825|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44512826|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512827|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
44512828|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512829|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44512830|NCT03402087|Antidotes|antidotes|mesh-ancestor
44512831|NCT03402087|Protective Agents|protective agents|mesh-ancestor
44512832|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
44512833|NCT03402087|Vitamins|vitamins|mesh-ancestor
44512834|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
44512835|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44512836|NCT03402048|Gemcitabine|gemcitabine|mesh-list
44512837|NCT03402048|Carboplatin|carboplatin|mesh-list
44512838|NCT03402048|Docetaxel|docetaxel|mesh-list
44512839|NCT03402048|Pemetrexed|pemetrexed|mesh-list
44512840|NCT03402048|Vinorelbine|vinorelbine|mesh-list
44512841|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512842|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512843|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
44512844|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512845|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
44512846|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512847|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512848|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512849|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
44512850|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512851|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512852|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512853|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512854|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44512855|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44512856|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44512857|NCT03401957|Cetuximab|cetuximab|mesh-list
44512858|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44512859|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512860|NCT03401827|Gemcitabine|gemcitabine|mesh-list
44512861|NCT03401827|Paclitaxel|paclitaxel|mesh-list
44512862|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44512863|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512864|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44512865|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44512866|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44512867|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512868|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44512869|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
44512870|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
44512871|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512872|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44512873|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512874|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
44512875|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512876|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
44512877|NCT03401606|Remifentanil|remifentanil|mesh-list
44512878|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44512879|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512880|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512881|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512882|NCT03401606|Analgesics|analgesics|mesh-ancestor
44512883|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
44512884|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512885|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44512886|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44512887|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44512888|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512889|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512890|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512891|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512892|NCT03401606|Narcotics|narcotics|mesh-ancestor
44512893|NCT03401593|Fentanyl|fentanyl|mesh-list
44512894|NCT03401593|Midazolam|midazolam|mesh-list
44512895|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512896|NCT03401593|Narcotics|narcotics|mesh-ancestor
44512897|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512898|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333063|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
44512899|NCT03401593|Analgesics|analgesics|mesh-ancestor
44512915|NCT03401541|Calcifediol|calcifediol|mesh-list
44512916|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
44512917|NCT03401541|Vitamins|vitamins|mesh-ancestor
44512918|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
44512919|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512920|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44512921|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44512922|NCT03401515|Propranolol|propranolol|mesh-list
44512923|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44512924|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44512925|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44512926|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512927|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512928|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512929|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44512930|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44512931|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
44512932|NCT03401502|Ranolazine|ranolazine|mesh-list
44512933|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44512934|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44512935|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512936|NCT03401476|Morphine|morphine|mesh-list
44512937|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44512938|NCT03401476|Narcotics|narcotics|mesh-ancestor
44512939|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44512940|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512941|NCT03401476|Analgesics|analgesics|mesh-ancestor
44512942|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
44512943|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512944|NCT03401372|Doxycycline|doxycycline|mesh-list
44512945|NCT03401372|Dexamethasone|dexamethasone|mesh-list
44512946|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
44512947|NCT03401372|Bortezomib|bortezomib|mesh-list
44512948|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44512949|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
44512950|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512951|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44512952|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44512953|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
44512954|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512955|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44512956|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44417877|NCT02287233|Cytarabine|cytarabine|mesh-list
44512957|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44512958|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
44512959|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
44512961|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44512962|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
44512964|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44512965|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44512966|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512967|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512968|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
44512969|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44512970|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44512971|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
44512972|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44512973|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
44512974|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
44512975|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44512976|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44512977|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512978|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44512979|NCT03401346|Analgesics|analgesics|mesh-ancestor
44512980|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
44512981|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44512982|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
44512983|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44512984|NCT03401268|Antibodies|antibodies|mesh-list
44512985|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
44512986|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512987|NCT03400995|Ziresovir|ziresovir|mesh-list
44512988|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
44512989|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512990|NCT03400969|Glycerol|glycerol|mesh-list
44512991|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44512992|NCT03400969|Protective Agents|protective agents|mesh-ancestor
44512993|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44512994|NCT03400735|Cefdinir|cefdinir|mesh-list
44512995|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44512996|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44512997|NCT03400722|Clomiphene|clomiphene|mesh-list
44512998|NCT03400722|Hormones|hormones|mesh-list
44512999|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44513000|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513001|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44513002|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
44513003|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44513004|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
44513005|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44513006|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44513007|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44513008|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
44513009|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44513010|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
44513011|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513012|NCT03400709|Expectorants|expectorants|mesh-ancestor
44513013|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513014|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44513015|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
44513016|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513017|NCT03400709|Protective Agents|protective agents|mesh-ancestor
44513018|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513019|NCT03400709|Antidotes|antidotes|mesh-ancestor
44513020|NCT03400683|Letrozole|letrozole|mesh-list
44513021|NCT03400683|Misoprostol|misoprostol|mesh-list
44513022|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513023|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44513024|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44513025|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513026|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513027|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44513028|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44513029|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44513030|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513031|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44513032|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
44513033|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44513034|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44513036|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
44333282|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
44513037|NCT03400592|Irinotecan|irinotecan|mesh-list
44513038|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
44513039|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44513040|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44513041|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513042|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513043|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513044|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44513045|NCT03400423|Caffeine|caffeine|mesh-list
44513046|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44513047|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513048|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44513049|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513050|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513051|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44513052|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44513053|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
44513054|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513055|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
44513056|NCT03400254|Gedatolisib|gedatolisib|mesh-list
44513057|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
44513058|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44513059|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44513060|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513061|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513062|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513063|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44513064|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44513065|NCT03400241|Bromides|bromides|mesh-list
44513066|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
44513067|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513068|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
44513069|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513070|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513071|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513072|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513073|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
44513074|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513075|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513076|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513077|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513078|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
44513079|NCT03400189|Sulthiame|sulthiame|mesh-list
44513080|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
44513081|NCT03400111|Acetaminophen|acetaminophen|mesh-list
44513082|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513083|NCT03400111|Analgesics|analgesics|mesh-ancestor
44513084|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
44513085|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513086|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513087|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
44513088|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
44513089|NCT03400020|Vitamins|vitamins|mesh-ancestor
44513090|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
44513091|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513092|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
44513093|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513094|NCT03400020|Protective Agents|protective agents|mesh-ancestor
44513095|NCT03406715|Nivolumab|nivolumab|mesh-list
44513096|NCT03406715|Ipilimumab|ipilimumab|mesh-list
44513097|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44513098|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513099|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44513100|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513101|NCT03401853|Rituximab|rituximab|mesh-list
44513102|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44513103|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
44513104|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
44513105|NCT03401853|Antibodies|antibodies|mesh-list
44513106|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
44513107|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44513108|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
44513109|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513110|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513112|NCT03403205|Choline|choline|mesh-list
44513113|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
44513131|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513132|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513133|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513134|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44513135|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44513136|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513137|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
44513138|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44513139|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513140|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
44513141|NCT03404011|Glycerol|glycerol|mesh-list
44513142|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44513143|NCT03404011|Protective Agents|protective agents|mesh-ancestor
44513144|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513145|NCT03405142|Panitumumab|panitumumab|mesh-list
44513146|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
44513147|NCT03405142|Dextrans|dextrans|mesh-list
44513148|NCT03405142|Edetic Acid|edetic acid|mesh-list
44513149|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
44513150|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44513151|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513152|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
44513153|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
44513154|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
44513155|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44513156|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513157|NCT03405142|Antidotes|antidotes|mesh-ancestor
44513158|NCT03405142|Protective Agents|protective agents|mesh-ancestor
44513159|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513160|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
44513161|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
44513162|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44513163|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44513164|NCT03400267|Acetaminophen|acetaminophen|mesh-list
44513165|NCT03400267|Fentanyl|fentanyl|mesh-list
44513166|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44513167|NCT03400267|Narcotics|narcotics|mesh-ancestor
44513168|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513169|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513170|NCT03400267|Analgesics|analgesics|mesh-ancestor
44513171|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
44513172|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513173|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44513174|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44513175|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
44513176|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
44513177|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513178|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
44513179|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44513180|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44513181|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513182|NCT00014911|Sirolimus|sirolimus|mesh-list
44513183|NCT00014911|Pentamidine|pentamidine|mesh-list
44513184|NCT00014911|Trimethoprim|trimethoprim|mesh-list
44513185|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
44513186|NCT00014911|Ganciclovir|ganciclovir|mesh-list
44513187|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44513188|NCT00014911|Tacrolimus|tacrolimus|mesh-list
44513189|NCT00014911|Daclizumab|daclizumab|mesh-list
44513190|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513191|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
44513192|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513193|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44513194|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513195|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513196|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513197|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513198|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44513199|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513200|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
44513201|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44513202|NCT00014911|Renal Agents|renal agents|mesh-ancestor
44513203|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
44513204|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44513205|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44513206|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44513207|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44513208|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44513209|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44513210|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
44513211|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44513212|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44513213|NCT00014495|Cytarabine|cytarabine|mesh-list
44513214|NCT00014495|Bismuth|bismuth|mesh-list
44513215|NCT00014495|Antibodies|antibodies|mesh-list
44513216|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44513217|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
44513218|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513219|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44513220|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
44513221|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513222|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513223|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
44513224|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513225|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513226|NCT00014495|Antacids|antacids|mesh-ancestor
44513227|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513228|NCT00013611|Aldesleukin|aldesleukin|mesh-list
44513229|NCT00013611|Interleukin-2|interleukin-2|mesh-list
44513230|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513231|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513232|NCT00013611|Analgesics|analgesics|mesh-ancestor
44513233|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
44513234|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513235|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513236|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44513237|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44513238|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
44513239|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513240|NCT00012012|Cisplatin|cisplatin|mesh-list
44513241|NCT00012012|Amifostine|amifostine|mesh-list
44513242|NCT00012012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513243|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44513244|NCT00012012|Protective Agents|protective agents|mesh-ancestor
44513245|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513246|NCT00010257|Paclitaxel|paclitaxel|mesh-list
44513247|NCT00010257|Carboplatin|carboplatin|mesh-list
44513248|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44513249|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513250|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
44513251|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
44513252|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
44513253|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513254|NCT00013897|Lamivudine|lamivudine|mesh-list
44513255|NCT00013897|Zidovudine|zidovudine|mesh-list
44513256|NCT00013897|Efavirenz|efavirenz|mesh-list
44513257|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44513258|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44513259|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44513260|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44513261|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513262|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513263|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
44513264|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513265|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44513266|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44513267|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
44513268|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44513269|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44513270|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44513271|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44513272|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44513273|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44513274|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44513275|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44513276|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
44513277|NCT02246270|Heparin|heparin|mesh-list
44513278|NCT02246270|Calcium heparin|calcium heparin|mesh-list
44513279|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
44418172|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
44513280|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44513281|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44513282|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513283|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44513284|NCT02240498|Methylene Blue|methylene blue|mesh-list
44513285|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44513286|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44513287|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44513288|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513289|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513290|NCT02240017|Gemcitabine|gemcitabine|mesh-list
44513291|NCT02240017|Cisplatin|cisplatin|mesh-list
44513292|NCT02240017|Carboplatin|carboplatin|mesh-list
44513293|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513294|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44513295|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
44513296|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513297|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
44513298|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513299|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513300|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513301|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
44513302|NCT02240017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513303|NCT02240043|Hormones|hormones|mesh-list
44513305|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513306|NCT02240160|Nabiximols|nabiximols|mesh-list
44513307|NCT02240160|Analgesics|analgesics|mesh-ancestor
44513308|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
44513309|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513310|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513311|NCT02240173|Haloperidol|haloperidol|mesh-list
44513312|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
44513313|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
44513314|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
44513315|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513316|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513317|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513318|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44513319|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44513320|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513321|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44513322|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44513323|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
44513324|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513325|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513326|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44513327|NCT02240199|Lidocaine|lidocaine|mesh-list
44513328|NCT02240199|Pregabalin|pregabalin|mesh-list
44513329|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
44513330|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
44513331|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513332|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513333|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
44513334|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513335|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513336|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44513337|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44513338|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513339|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513340|NCT02240199|Analgesics|analgesics|mesh-ancestor
44513341|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
44513342|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44513343|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44513344|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44513345|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44513346|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44513347|NCT02240212|Paclitaxel|paclitaxel|mesh-list
44513348|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44513349|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513350|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
44513351|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
44513352|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
44513353|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513354|NCT02240238|Gemcitabine|gemcitabine|mesh-list
44513355|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44513356|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
44513357|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513358|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513360|NCT02240238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513361|NCT02240238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513362|NCT02240238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513363|NCT02240238|Immunologic Factors|immunologic factors|mesh-ancestor
44513364|NCT02240238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513365|NCT02240433|Sorafenib|sorafenib|mesh-list
44513366|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513367|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44513368|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513369|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513370|NCT02240459|Fesoterodine|fesoterodine|mesh-list
44513371|NCT02240459|Oxybutynin|oxybutynin|mesh-list
44513372|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44513373|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513374|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513375|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513376|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513382|NCT02240537|Sargramostim|sargramostim|mesh-list
44513383|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44513384|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
44513385|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513386|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44513387|NCT02240602|Oxycodone|oxycodone|mesh-list
44513388|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44513389|NCT02240602|Narcotics|narcotics|mesh-ancestor
44513390|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513391|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513392|NCT02240602|Analgesics|analgesics|mesh-ancestor
44513393|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
44513394|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513395|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
44513396|NCT02240641|Lacidipine|lacidipine|mesh-list
44513397|NCT02240641|Diuretics|diuretics|mesh-list
44513398|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44513399|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44513400|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44513401|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44513402|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513403|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513404|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44513405|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513406|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513407|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513408|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
44513409|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44513410|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513411|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44513412|NCT02240719|Everolimus|everolimus|mesh-list
44513413|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44513414|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513415|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513416|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
44513417|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418298|NCT02276040|Bupivacaine|bupivacaine|mesh-list
44513418|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44513419|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
44513420|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513421|NCT02240927|Enoxaparin|enoxaparin|mesh-list
44513422|NCT02240927|Warfarin|warfarin|mesh-list
44513423|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
44513424|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
44513425|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44513426|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44513427|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513428|NCT02240953|Warfarin|warfarin|mesh-list
44513429|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
44513430|NCT02241031|Oprelvekin|oprelvekin|mesh-list
44513431|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513432|NCT02241083|Dopamine|dopamine|mesh-list
44513433|NCT02241083|Norepinephrine|norepinephrine|mesh-list
44513434|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44513435|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44513436|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922385|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
44513438|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513439|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513440|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
44513441|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
44513442|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513443|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44513444|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44513445|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
44513446|NCT02241083|Protective Agents|protective agents|mesh-ancestor
44513447|NCT02241096|Lidocaine|lidocaine|mesh-list
44513448|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
44513449|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
44513450|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513451|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513452|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
44513453|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513454|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513455|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44513456|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44333702|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
44513457|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513458|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513459|NCT02241148|Acetaminophen|acetaminophen|mesh-list
44513460|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513461|NCT02241148|Analgesics|analgesics|mesh-ancestor
44513462|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
44513463|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513464|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513465|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
44513466|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44513468|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
44513469|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513470|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
44513471|NCT02241200|Hematinics|hematinics|mesh-ancestor
44513472|NCT02241278|Ketamine|ketamine|mesh-list
44513473|NCT02241278|Analgesics|analgesics|mesh-ancestor
44513474|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
44418367|NCT02274792|Etanercept|etanercept|mesh-list
44513475|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513476|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513477|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44513478|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44513479|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
44513480|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
44513481|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513482|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44513483|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44513484|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513485|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513486|NCT02241356|Methamphetamine|methamphetamine|mesh-list
44513487|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44513488|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513489|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
44513490|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
44513491|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513492|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
44513493|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513494|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513495|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513496|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44513497|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44513498|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513499|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44513500|NCT02241421|Amoxicillin|amoxicillin|mesh-list
44513501|NCT02241421|Vancomycin|vancomycin|mesh-list
44513502|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513503|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513504|NCT02241460|Lidocaine|lidocaine|mesh-list
44513505|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
44513506|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
44513507|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513508|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513509|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
44513510|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513511|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513512|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44513513|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44513514|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513515|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513516|NCT02241499|Fluorouracil|fluorouracil|mesh-list
44513517|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
44513518|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
44513519|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513520|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44513521|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513522|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513523|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
44513524|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513525|NCT02241564|Sirolimus|sirolimus|mesh-list
44513526|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44513527|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513528|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418420|NCT02273752|Everolimus|everolimus|mesh-list
44513529|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513530|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513531|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44513532|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513533|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
44513534|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513535|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
44513536|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513537|NCT02241590|Entecavir|entecavir|mesh-list
44513538|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
44513539|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513540|NCT02241616|Entecavir|entecavir|mesh-list
44513541|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
44513542|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513543|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
44513544|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513545|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513546|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44513547|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44513548|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513549|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513550|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513551|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
44513552|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44513553|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
44513554|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513555|NCT02241876|Expectorants|expectorants|mesh-ancestor
44513556|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513557|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44513558|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
44513559|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513560|NCT02241876|Protective Agents|protective agents|mesh-ancestor
44513561|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513562|NCT02241876|Antidotes|antidotes|mesh-ancestor
44513563|NCT02241941|Daptomycin|daptomycin|mesh-list
44513564|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513565|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513566|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44513567|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44513568|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44513569|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44513570|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44513571|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513572|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
44513573|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44513574|NCT02242214|Misoprostol|misoprostol|mesh-list
44513575|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44513576|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
44513577|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44513578|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513579|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44513580|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513581|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
44513582|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44513583|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513584|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
43626362|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
44513586|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513587|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513588|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513589|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44513590|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44513591|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44513592|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513593|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513594|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513595|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
44513596|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
44513597|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513598|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
44513599|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513600|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513601|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513602|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513603|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44513604|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44513605|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44513606|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513620|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
44513621|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513622|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513623|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513624|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513625|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44513626|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44513627|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44513628|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513629|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
44513630|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513631|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
44513632|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513633|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513634|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513635|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513636|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
44513637|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513638|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513639|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513640|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513641|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
44513642|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44513643|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
44513644|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513645|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513646|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44513647|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513648|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
44513649|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513650|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513651|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513652|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513653|NCT02242292|Scopolamine|scopolamine|mesh-list
44513654|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44513655|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44513656|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
44513657|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
44513658|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513659|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513660|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513662|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44513663|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
44513664|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513665|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513666|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44513667|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
44513668|NCT02242318|Valsartan|valsartan|mesh-list
44513669|NCT02242318|Telmisartan|telmisartan|mesh-list
44513670|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513671|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513672|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513673|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513674|NCT02242331|Telmisartan|telmisartan|mesh-list
44513675|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513676|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513677|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513678|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513679|NCT02242344|Telmisartan|telmisartan|mesh-list
44513680|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513681|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513682|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513683|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513684|NCT02242357|Telmisartan|telmisartan|mesh-list
44513685|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513686|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513687|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513688|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513689|NCT02242370|Telmisartan|telmisartan|mesh-list
44513690|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513691|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513692|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513693|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513694|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44513695|NCT02242383|Telmisartan|telmisartan|mesh-list
44513696|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513697|NCT02242383|Diuretics|diuretics|mesh-ancestor
44513698|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513699|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513700|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44513701|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513702|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513703|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513704|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513705|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44513706|NCT02242396|Telmisartan|telmisartan|mesh-list
44513707|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44513708|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513709|NCT02242396|Diuretics|diuretics|mesh-ancestor
44513710|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513711|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513712|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44513713|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513714|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513715|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513716|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513717|NCT02242474|Adalimumab|adalimumab|mesh-list
44513718|NCT02242474|Etanercept|etanercept|mesh-list
44513719|NCT02242474|Golimumab|golimumab|mesh-list
44513720|NCT02242474|Infliximab|infliximab|mesh-list
44513721|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
44513722|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44513723|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44513724|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44513725|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
44513726|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513727|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44513728|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513729|NCT02242474|Analgesics|analgesics|mesh-ancestor
44513730|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
44513731|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513732|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513733|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513735|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44513736|NCT02242513|Lidocaine|lidocaine|mesh-list
44513737|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
44513738|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
44513739|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513740|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513741|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
44513742|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513743|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513744|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44513745|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44513746|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513747|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513748|NCT02242591|Ropivacaine|ropivacaine|mesh-list
44513749|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44334069|NCT03675139|Hormones|hormones|mesh-ancestor
44513759|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513760|NCT02242656|Analgesics|analgesics|mesh-ancestor
44513761|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
44513762|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513763|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
44513764|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513765|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
44513766|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
44513767|NCT02242695|Clotrimazole|clotrimazole|mesh-list
44513768|NCT02242695|Dequalinium|dequalinium|mesh-list
44513769|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44513770|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513771|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
44513772|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44513773|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44513774|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513775|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513776|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44513777|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
44513778|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44513779|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513780|NCT02242812|Metoprolol|metoprolol|mesh-list
44513781|NCT02242812|Telmisartan|telmisartan|mesh-list
44513782|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44418646|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
44513783|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513784|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513785|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513786|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513787|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
44513788|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
44513789|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513790|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513791|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44513792|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44513793|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44513794|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
44513795|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513796|NCT02242825|Telmisartan|telmisartan|mesh-list
44513797|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44513798|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513799|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513800|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513801|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513802|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44513803|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513804|NCT02242825|Diuretics|diuretics|mesh-ancestor
44513805|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513806|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513807|NCT02242838|Telmisartan|telmisartan|mesh-list
44513808|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513809|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513810|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513811|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513812|NCT02242851|Telmisartan|telmisartan|mesh-list
44513813|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513814|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513815|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513816|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513818|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44513819|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513820|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513821|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513822|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418712|NCT02265796|Ranolazine|ranolazine|mesh-list
44513823|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44513824|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513825|NCT02242864|Diuretics|diuretics|mesh-ancestor
44513826|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513827|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513828|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44513829|NCT02242877|Telmisartan|telmisartan|mesh-list
44513830|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44513831|NCT02242877|Diuretics|diuretics|mesh-ancestor
44513832|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
44513833|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513834|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44513835|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44513836|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513837|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44513838|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44513839|NCT02242929|Imiquimod|imiquimod|mesh-list
44513840|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44513841|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
44513842|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513843|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513844|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
44513845|NCT02242955|Diazepam|diazepam|mesh-list
44513846|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44513847|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
44513848|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
44513849|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
44513850|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513851|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513852|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513853|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44513854|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513855|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44513856|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44513857|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44513858|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44513859|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44513860|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44513861|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
44513862|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
44513863|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
44513864|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
44513865|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513866|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513867|NCT02243098|Digoxin|digoxin|mesh-list
44513868|NCT02243098|Atorvastatin|atorvastatin|mesh-list
44513869|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44513870|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44513871|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
44513872|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513873|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418757|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
44513874|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44513875|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513876|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513877|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44513878|NCT02243098|Protective Agents|protective agents|mesh-ancestor
44513879|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513880|NCT02243124|Dexamethasone|dexamethasone|mesh-list
44513881|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44513882|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
44513883|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
44513884|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513885|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513886|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513887|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
44513888|NCT02243124|Hormones|hormones|mesh-ancestor
44513889|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44513890|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44513891|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513892|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
44513893|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44513894|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44513895|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513896|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44513897|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44513898|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513899|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513900|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513901|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44513902|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
44513903|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44513904|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513905|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44513906|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44513907|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44513908|NCT02243254|Ibuprofen|ibuprofen|mesh-list
44513909|NCT02243254|Remifentanil|remifentanil|mesh-list
44513910|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44513911|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44513912|NCT02243254|Analgesics|analgesics|mesh-ancestor
44513913|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
44513914|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513915|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513916|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44513917|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44513918|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44513919|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418809|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44513920|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513921|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44513922|NCT02243254|Narcotics|narcotics|mesh-ancestor
44513923|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513924|NCT02243436|Cytarabine|cytarabine|mesh-list
44513925|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
44513926|NCT02243436|Cisplatin|cisplatin|mesh-list
44513927|NCT02243436|Etoposide|etoposide|mesh-list
44513928|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44513929|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44513930|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44513931|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44513932|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44513933|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513934|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513935|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44513936|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
44513937|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
44513938|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513939|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44513940|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
44513941|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513942|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44513943|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
44513944|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
44513945|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44513946|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513947|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
44513948|NCT02243436|Hormones|hormones|mesh-ancestor
44513949|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44513950|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44513951|NCT02243436|Protective Agents|protective agents|mesh-ancestor
44513952|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44513953|NCT02243553|Vitamin K|vitamin k|mesh-list
44513954|NCT02243553|Ritonavir|ritonavir|mesh-list
44513956|NCT02243553|Digoxin|digoxin|mesh-list
44513957|NCT02243553|Midazolam|midazolam|mesh-list
44513958|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
44513959|NCT02243553|Caffeine|caffeine|mesh-list
44513960|NCT02243553|Omeprazole|omeprazole|mesh-list
44513961|NCT02243553|Warfarin|warfarin|mesh-list
44513962|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44513964|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
44513965|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44513966|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44513967|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44513968|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44513969|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44513970|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44513971|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44513972|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44513973|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
44513974|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
44513975|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
44513976|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
44513977|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44513978|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44513979|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44513980|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44513981|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
44513982|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44513983|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44513984|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44513985|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
44513986|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44513987|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44513988|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44513989|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
44513990|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44513991|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44513992|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44513993|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44513994|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44513995|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44513996|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44513997|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
44513998|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44513999|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44514000|NCT02243553|Protective Agents|protective agents|mesh-ancestor
44514001|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44514002|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44514003|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
44514004|NCT02243553|Coagulants|coagulants|mesh-ancestor
44514005|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
44514006|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
44514007|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44514008|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44514009|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44514010|NCT02243566|Telmisartan|telmisartan|mesh-list
44514011|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44514012|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44514013|NCT02243566|Diuretics|diuretics|mesh-ancestor
44514014|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
44514015|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514016|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44514017|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514018|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514019|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44514020|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44514021|NCT02243618|Rebamipide|rebamipide|mesh-list
44514022|NCT02243618|Polaprezinc|polaprezinc|mesh-list
44514023|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44514024|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44514025|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
44514026|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514027|NCT02243618|Protective Agents|protective agents|mesh-ancestor
44514028|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514029|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514030|NCT02243644|Albendazole|albendazole|mesh-list
44514031|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
44514032|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44514033|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514034|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
44514035|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44514036|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44514037|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
44514038|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
44514039|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
44514040|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514041|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514042|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
44514044|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44514045|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514047|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
44514048|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44514049|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
44514050|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44514051|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
44514052|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
44514053|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514054|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514055|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44514056|NCT02243826|Analgesics|analgesics|mesh-ancestor
44514057|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
44514058|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514059|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44514060|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44514061|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514062|NCT02243852|Hormones|hormones|mesh-list
44514063|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514064|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514065|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44514066|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44514067|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514068|NCT02244073|Insulin|insulin|mesh-list
44514069|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44514070|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44514071|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514072|NCT02244086|Bupivacaine|bupivacaine|mesh-list
44418990|NCT02260492|Xhance|xhance|mesh-list
44514073|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
44514074|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
44514075|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514076|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514077|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
44514078|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514079|NCT02244112|Midazolam|midazolam|mesh-list
44514080|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44514081|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44514082|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514083|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514084|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44514085|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44514086|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44514087|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44514088|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
44514089|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
44514090|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
44514091|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
44514092|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514093|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514094|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44514095|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
44514096|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44514097|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
44514098|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44514099|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514100|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44514101|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44514102|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514103|NCT02244190|Ritonavir|ritonavir|mesh-list
44514104|NCT02244190|Tipranavir|tipranavir|mesh-list
44514105|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44514106|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44514107|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
44514108|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514109|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514110|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514111|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514112|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
44514113|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514114|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514115|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514116|NCT02244216|Fenoterol|fenoterol|mesh-list
44514117|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44514118|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
44514119|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514120|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514121|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44514122|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
44514123|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
44514124|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
44514125|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44514126|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44514127|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44514128|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44514129|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514130|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514131|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514132|NCT02244229|Tamsulosin|tamsulosin|mesh-list
44514133|NCT02244229|Finasteride|finasteride|mesh-list
44514134|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514135|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514136|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514137|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514138|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514139|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514140|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514141|NCT02244229|Urological Agents|urological agents|mesh-ancestor
44514142|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44514143|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44514144|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514145|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44514146|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514147|NCT02244242|Tamsulosin|tamsulosin|mesh-list
44514148|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514149|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514150|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514151|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514152|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514153|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514154|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514155|NCT02244242|Urological Agents|urological agents|mesh-ancestor
44514156|NCT02244255|Tamsulosin|tamsulosin|mesh-list
44514157|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514158|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514159|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514160|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514161|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514162|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514163|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514164|NCT02244255|Urological Agents|urological agents|mesh-ancestor
44514165|NCT02244268|Tamsulosin|tamsulosin|mesh-list
44514166|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514167|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514168|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514169|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514170|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419046|NCT02260154|Mebeverine|mebeverine|mesh-list
44514171|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514172|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514173|NCT02244268|Urological Agents|urological agents|mesh-ancestor
44514174|NCT02244281|Tamsulosin|tamsulosin|mesh-list
44514175|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514176|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514177|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514178|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514179|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514180|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514181|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514182|NCT02244281|Urological Agents|urological agents|mesh-ancestor
44514183|NCT02244294|Tamsulosin|tamsulosin|mesh-list
44334494|NCT00992576|Naloxone|naloxone|mesh-list
44514184|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514185|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514186|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514187|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514188|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514189|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514190|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514191|NCT02244294|Urological Agents|urological agents|mesh-ancestor
44514192|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
44514193|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44514194|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44514195|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514196|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514197|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514198|NCT02244320|Tamsulosin|tamsulosin|mesh-list
44514199|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514200|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514201|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514202|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514203|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514204|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514205|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514206|NCT02244320|Urological Agents|urological agents|mesh-ancestor
44514227|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419114|NCT02258659|Paclitaxel|paclitaxel|mesh-list
44514228|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44514229|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514230|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
44514231|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44514232|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514233|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514234|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44514235|NCT02244515|Analgesics|analgesics|mesh-ancestor
44514236|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
44514237|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514238|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44514239|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44514240|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44514241|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514242|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514243|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514244|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
44514245|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514246|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44514247|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44514249|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514250|NCT02244528|Urological Agents|urological agents|mesh-ancestor
44514251|NCT02244567|Metformin|metformin|mesh-list
44514252|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514253|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44514254|NCT02244632|Bevacizumab|bevacizumab|mesh-list
44514255|NCT02244632|Fluorouracil|fluorouracil|mesh-list
44514256|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
44514257|NCT02244632|Irinotecan|irinotecan|mesh-list
44514258|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44514259|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514260|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44514261|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44514262|NCT02244632|Growth Substances|growth substances|mesh-ancestor
44514263|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514264|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
44514265|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
44514266|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514267|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514268|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514269|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
44514270|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44514271|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44514272|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514273|NCT02244710|Clopidogrel|clopidogrel|mesh-list
44514274|NCT02244710|Ticagrelor|ticagrelor|mesh-list
44514275|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44514276|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44514277|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44514278|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44514279|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
44514280|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514281|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514282|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514283|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
44514284|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44514285|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514286|NCT02244879|Resveratrol|resveratrol|mesh-list
44514287|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
44419149|NCT02258074|Niacin|niacin|mesh-list
44514288|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514289|NCT02244879|Protective Agents|protective agents|mesh-ancestor
44514290|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514291|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514292|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44514293|NCT02245022|Tenofovir|tenofovir|mesh-list
44514294|NCT02245022|Lamivudine|lamivudine|mesh-list
44514295|NCT02245022|Efavirenz|efavirenz|mesh-list
44514296|NCT02245022|Dolutegravir|dolutegravir|mesh-list
44514297|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
44514298|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514299|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44514300|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44514301|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514302|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514303|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514304|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514305|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44514306|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514307|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44514308|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44514309|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44514310|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44514311|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44514312|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44514313|NCT02245126|Lidocaine|lidocaine|mesh-list
44514314|NCT02245126|Bupivacaine|bupivacaine|mesh-list
44514315|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
44514316|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
44514317|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514318|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514319|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
44514320|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514321|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44514322|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44514323|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44514324|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514325|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514326|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44514327|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514328|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514330|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
44514331|NCT02245191|Ephedrine|ephedrine|mesh-list
44514332|NCT02245191|Metaraminol|metaraminol|mesh-list
44514333|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44514334|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
44514335|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
44514336|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514337|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514338|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
44514339|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44514340|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
44514341|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
44514342|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44514343|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44514344|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44514345|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514346|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514347|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514348|NCT02245191|Protective Agents|protective agents|mesh-ancestor
44514349|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44514350|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
44514351|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44514352|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514353|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514354|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44514355|NCT02245256|Analgesics|analgesics|mesh-ancestor
44514356|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
44514357|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514358|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44514359|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44514360|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44514361|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514362|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514363|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514364|NCT02245269|Ritonavir|ritonavir|mesh-list
44514365|NCT02245269|Tipranavir|tipranavir|mesh-list
44514366|NCT02245269|Atorvastatin|atorvastatin|mesh-list
44514367|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44514368|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44514369|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
44514370|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514371|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44514372|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44514373|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514374|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44514375|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44514376|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44514377|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514378|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514379|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
44514380|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514381|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514382|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514383|NCT02245295|Anesthetics|anesthetics|mesh-list
44514384|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514385|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514386|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
44514387|NCT02245321|Hematinics|hematinics|mesh-ancestor
44514388|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
44514389|NCT02245334|Povidone|povidone|mesh-list
44514390|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
44514391|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
44514392|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44514393|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514394|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
44514395|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44514396|NCT02245438|Ritonavir|ritonavir|mesh-list
44514397|NCT02245438|Tipranavir|tipranavir|mesh-list
44514398|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44514399|NCT02245438|Norethindrone|norethindrone|mesh-list
44514400|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
44514401|NCT02245438|Norinyl|norinyl|mesh-list
44514402|NCT02245438|Estradiol|estradiol|mesh-list
44514403|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44514404|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44514405|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
44514406|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514407|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514408|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514409|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514410|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
44514411|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514412|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514413|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514414|NCT02245438|Estrogens|estrogens|mesh-ancestor
44514415|NCT02245438|Hormones|hormones|mesh-ancestor
44514416|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514417|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514418|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44514419|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
44514421|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44514422|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44514423|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44514424|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44514425|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44514426|NCT02245451|Ritonavir|ritonavir|mesh-list
44514427|NCT02245451|Tipranavir|tipranavir|mesh-list
44514428|NCT02245451|Methadone|methadone|mesh-list
44514429|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44514430|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44514431|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
44514432|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514433|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514434|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514435|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514436|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
44514437|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514438|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514439|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514440|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44514441|NCT02245451|Narcotics|narcotics|mesh-ancestor
44514442|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514443|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514444|NCT02245451|Analgesics|analgesics|mesh-ancestor
44514445|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
44419363|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
44419364|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419365|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44419372|NCT05650996|Calpastatin|calpastatin|mesh-list
44514446|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514447|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
44514448|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
44514449|NCT02245464|Telmisartan|telmisartan|mesh-list
44514450|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44514451|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44514452|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44514453|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514454|NCT02245477|Mitogens|mitogens|mesh-list
44514455|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
44514456|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44514457|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514458|NCT02245477|Growth Substances|growth substances|mesh-ancestor
44514459|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514460|NCT02245490|Tamsulosin|tamsulosin|mesh-list
44514461|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514462|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514463|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514464|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514465|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514466|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514467|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514468|NCT02245490|Urological Agents|urological agents|mesh-ancestor
44514469|NCT02245503|Tamsulosin|tamsulosin|mesh-list
44514470|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514471|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514472|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514473|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514474|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514475|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514476|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514477|NCT02245503|Urological Agents|urological agents|mesh-ancestor
44514478|NCT02245529|Tamsulosin|tamsulosin|mesh-list
44514479|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514480|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514481|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514482|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514483|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514484|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514485|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514486|NCT02245529|Urological Agents|urological agents|mesh-ancestor
44514487|NCT02245555|Tamsulosin|tamsulosin|mesh-list
44514488|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514489|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514490|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514491|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514492|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514493|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514494|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514495|NCT02245555|Urological Agents|urological agents|mesh-ancestor
44514496|NCT02245789|Remifentanil|remifentanil|mesh-list
44514497|NCT02245789|Propofol|propofol|mesh-list
44514498|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
44514499|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514500|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514501|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44514502|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44514503|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
44514504|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44514505|NCT02245789|Narcotics|narcotics|mesh-ancestor
44514506|NCT02245789|Analgesics|analgesics|mesh-ancestor
44514507|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
44514508|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514509|NCT02246023|Propofol|propofol|mesh-list
44514510|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44514511|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514512|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514513|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44514514|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
44514515|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
44514516|NCT02246049|Leucovorin|leucovorin|mesh-list
44514517|NCT02246049|Bevacizumab|bevacizumab|mesh-list
44514518|NCT02246049|Fluorouracil|fluorouracil|mesh-list
44514519|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
44514520|NCT02246049|Irinotecan|irinotecan|mesh-list
44514521|NCT02246049|Calcium|calcium|mesh-list
44514522|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
44514523|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44514524|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514525|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44514526|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44514527|NCT02246049|Growth Substances|growth substances|mesh-ancestor
44514528|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514529|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44514530|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44514531|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
44514532|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514533|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514534|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514535|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
44514536|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44514537|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44514538|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514539|NCT02246049|Antidotes|antidotes|mesh-ancestor
44514540|NCT02246049|Protective Agents|protective agents|mesh-ancestor
44514541|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44514542|NCT02246049|Vitamins|vitamins|mesh-ancestor
44334923|NCT00994786|Pregabalin|pregabalin|mesh-list
44514543|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
44514544|NCT02246127|Everolimus|everolimus|mesh-list
44514545|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514546|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514547|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
44514548|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514549|NCT02246244|Citalopram|citalopram|mesh-list
44514550|NCT02246244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44514551|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44514552|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514553|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514554|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514555|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
44514556|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514557|NCT02246244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44514558|NCT02246244|Antidepressive Agents|antidepressive agents|mesh-ancestor
44514559|NCT02246244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335051|NCT00995293|Cisplatin|cisplatin|mesh-list
44514569|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514570|NCT02246712|Analgesics|analgesics|mesh-ancestor
44514571|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
44514572|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514573|NCT02246816|Opium|opium|mesh-list
44514574|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44514575|NCT02246816|Narcotics|narcotics|mesh-ancestor
44514576|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419428|NCT05650216|Carboplatin|carboplatin|mesh-list
44514577|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514579|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
44514580|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514581|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
44514582|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44514583|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
44514584|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
44514585|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
44514586|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44514587|NCT02246842|Antibodies|antibodies|mesh-list
44514588|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44514589|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
44514590|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
44514591|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514592|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
44514593|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44514594|NCT02246855|Antibodies|antibodies|mesh-list
44514595|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
44514596|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514597|NCT02246868|Factor VIII|factor viii|mesh-list
44514598|NCT02246868|Coagulants|coagulants|mesh-ancestor
44514599|NCT02246881|Factor VIII|factor viii|mesh-list
44514600|NCT02246881|Coagulants|coagulants|mesh-ancestor
44514601|NCT02246894|Factor VIII|factor viii|mesh-list
44514602|NCT02246894|Coagulants|coagulants|mesh-ancestor
44514603|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
44514604|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44514605|NCT02247141|Antibodies|antibodies|mesh-list
44514606|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
44514607|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514608|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
44514609|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44335059|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
44514610|NCT02247154|Antibodies|antibodies|mesh-list
44514611|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
44514612|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514614|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
44514615|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514616|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514617|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514618|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514619|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
44514620|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514621|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44514622|NCT02247310|Interferons|interferons|mesh-list
44514623|NCT02247310|Interferon-beta|interferon-beta|mesh-list
44514624|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
44514625|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514626|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
44514627|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514628|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
44514629|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514630|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44514631|NCT02247362|Vaccines|vaccines|mesh-list
44514632|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
44514633|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
44514634|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514635|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
44514636|NCT02247414|Aspirin|aspirin|mesh-list
44514637|NCT02247414|Heparin|heparin|mesh-list
44514638|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44514639|NCT02247414|Tinzaparin|tinzaparin|mesh-list
44514640|NCT02247414|Dalteparin|dalteparin|mesh-list
44514641|NCT02247414|Dipyridamole|dipyridamole|mesh-list
44514642|NCT02247414|Warfarin|warfarin|mesh-list
44514643|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44514644|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44514645|NCT02247414|Analgesics|analgesics|mesh-ancestor
44514646|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
44514647|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514648|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514649|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514650|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44514651|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44514652|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44514653|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514654|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44514655|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44514656|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514657|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
44514658|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
44514659|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44514660|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514661|NCT02247505|Tadalafil|tadalafil|mesh-list
44514662|NCT02247505|Tamsulosin|tamsulosin|mesh-list
44514663|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514664|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44514665|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44514666|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514667|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514668|NCT02247505|Urological Agents|urological agents|mesh-ancestor
44514669|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514670|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514671|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514672|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514673|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514674|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514675|NCT02247518|Tadalafil|tadalafil|mesh-list
44514676|NCT02247518|Tamsulosin|tamsulosin|mesh-list
44514677|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514678|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44514679|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44514680|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514681|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514682|NCT02247518|Urological Agents|urological agents|mesh-ancestor
44514683|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44514684|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44514685|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514686|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514687|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514688|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514689|NCT02247544|Trabectedin|trabectedin|mesh-list
44514690|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44514691|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
44514692|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514693|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514694|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44514695|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44514696|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44514697|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514698|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514699|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44514700|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514701|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514702|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
44514703|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514704|NCT02247596|Resveratrol|resveratrol|mesh-list
44514705|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
44514706|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514707|NCT02247596|Protective Agents|protective agents|mesh-ancestor
44514708|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514709|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514710|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44514711|NCT02247648|Tramadol|tramadol|mesh-list
44514712|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44514713|NCT02247648|Narcotics|narcotics|mesh-ancestor
44514714|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514715|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514716|NCT02247648|Analgesics|analgesics|mesh-ancestor
44514717|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
44514718|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514719|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
44514720|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44514721|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
44514722|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44514723|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44514724|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
44514725|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514726|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44514727|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44514728|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514729|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514730|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44514732|NCT02248012|Temozolomide|temozolomide|mesh-list
44514733|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514734|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514735|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
44514736|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514737|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44514738|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
44514739|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514740|NCT02248051|CXA-10|cxa-10|mesh-list
44514741|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514742|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44514743|NCT02248129|Telmisartan|telmisartan|mesh-list
44514744|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44514745|NCT02248129|Diuretics|diuretics|mesh-ancestor
44514746|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
44514747|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514748|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44514749|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514750|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514751|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44514752|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44514753|NCT02248142|Pramipexole|pramipexole|mesh-list
44514754|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
44514755|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514756|NCT02248142|Protective Agents|protective agents|mesh-ancestor
44514757|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514758|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44514759|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514760|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514761|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
44514762|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514763|NCT02248155|Pramipexole|pramipexole|mesh-list
44514764|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
44514765|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514766|NCT02248155|Protective Agents|protective agents|mesh-ancestor
44514767|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514768|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44514769|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514770|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514771|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
44514772|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514773|NCT02248168|Pramipexole|pramipexole|mesh-list
44514774|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
44514775|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514776|NCT02248168|Protective Agents|protective agents|mesh-ancestor
44514777|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514778|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44514779|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514780|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514781|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
44514782|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514783|NCT02248181|Pramipexole|pramipexole|mesh-list
44514784|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
44514785|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514786|NCT02248181|Protective Agents|protective agents|mesh-ancestor
44514787|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514788|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44514789|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514790|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514791|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
44514792|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514793|NCT02248207|Pramipexole|pramipexole|mesh-list
44514794|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
44514795|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514796|NCT02248207|Protective Agents|protective agents|mesh-ancestor
44514797|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514798|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44514799|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514800|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514801|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
44514802|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514803|NCT02248220|Pramipexole|pramipexole|mesh-list
44514804|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
44514805|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514806|NCT02248220|Protective Agents|protective agents|mesh-ancestor
44514807|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514808|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44419663|NCT05647681|Acetaminophen|acetaminophen|mesh-list
44514809|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44514810|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
44514811|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
44514812|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514813|NCT02248233|Nimodipine|nimodipine|mesh-list
44514814|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44514815|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
44514816|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44514817|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44514818|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514819|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514820|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44514821|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514822|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514823|NCT02248259|Itraconazole|itraconazole|mesh-list
44514824|NCT02248259|BI 409306|bi 409306|mesh-list
44514825|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
44514826|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514827|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44514828|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514829|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514830|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514831|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44514832|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
44514833|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514834|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514835|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514836|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44514837|NCT02248415|Anesthetics|anesthetics|mesh-list
44514838|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44514839|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514841|NCT02248428|Thalidomide|thalidomide|mesh-list
44514842|NCT02248428|Dexamethasone|dexamethasone|mesh-list
44514843|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
44514844|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514845|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
44514846|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514847|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44514848|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44514849|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
44514850|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514851|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514852|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44514853|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514854|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
44514855|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
44514856|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514857|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44514858|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
44514859|NCT02248428|Hormones|hormones|mesh-ancestor
44419716|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44514860|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514861|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44514862|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44514863|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514864|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44514865|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514866|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514867|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514868|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
44514869|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44514870|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44514871|NCT02248428|Growth Substances|growth substances|mesh-ancestor
44514872|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
44514873|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
44514874|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44514875|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514876|NCT02248506|Clotrimazole|clotrimazole|mesh-list
44514877|NCT02248506|Miconazole|miconazole|mesh-list
44514878|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44514879|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514880|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
44514881|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44514882|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514883|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514884|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514885|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44514886|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
44514887|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514888|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514889|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44514890|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44514891|NCT02248571|Bevacizumab|bevacizumab|mesh-list
44514892|NCT02248571|Capecitabine|capecitabine|mesh-list
44514893|NCT02248571|Everolimus|everolimus|mesh-list
44514894|NCT02248571|Exemestane|exemestane|mesh-list
44514895|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44514896|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514897|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44514898|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44514899|NCT02248571|Growth Substances|growth substances|mesh-ancestor
44514900|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514901|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44514902|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514903|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
44514904|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514905|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514906|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
44514907|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44514908|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44514909|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514910|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44514911|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
44514912|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514913|NCT02248584|Ascorbic Acid|ascorbic acid|mesh-list
44514914|NCT02248584|Vitamins|vitamins|mesh-ancestor
44514915|NCT02248584|Micronutrients|micronutrients|mesh-ancestor
44514916|NCT02248584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514917|NCT02248584|Antioxidants|antioxidants|mesh-ancestor
44514918|NCT02248584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514919|NCT02248584|Protective Agents|protective agents|mesh-ancestor
44514920|NCT02248753|Metoprolol|metoprolol|mesh-list
44514921|NCT02248753|Digoxin|digoxin|mesh-list
44514922|NCT02248753|Amiodarone|amiodarone|mesh-list
44514923|NCT02248753|Verapamil|verapamil|mesh-list
44514924|NCT02248753|Flecainide|flecainide|mesh-list
44514925|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44514926|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44514927|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
44514928|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
44514929|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514930|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514931|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44514932|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44514933|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44514934|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44514935|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514936|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514937|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44514938|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514939|NCT02248753|Protective Agents|protective agents|mesh-ancestor
44514940|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
44514941|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44514942|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514943|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44514944|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44514945|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44514946|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44335417|NCT00997087|Flumazenil|flumazenil|mesh-list
44514956|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514957|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44514958|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
44514959|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514960|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514961|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44514962|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514963|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44514964|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44514965|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
44514966|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44514967|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44514968|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
44514969|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44514970|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44514971|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44514972|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44514973|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514974|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
44514975|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44514976|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514977|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44514978|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514980|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44514981|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
44514982|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
44514983|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44514984|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44514985|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44514986|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
44514987|NCT02248870|Hormones|hormones|mesh-ancestor
44514988|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44514989|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44514990|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514991|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
44514992|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44514993|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44514994|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44514995|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44514996|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44514997|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44514998|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44514999|NCT02248896|Telmisartan|telmisartan|mesh-list
44515000|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
44515001|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44515002|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44515003|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44515004|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44515005|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515006|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515007|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
44515008|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44515009|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515010|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515011|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44515012|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44515013|NCT02249026|Buprenorphine|buprenorphine|mesh-list
44515014|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
44515015|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44515016|NCT02249026|Narcotics|narcotics|mesh-ancestor
44515017|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515018|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515019|NCT02249026|Analgesics|analgesics|mesh-ancestor
44515020|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
44515021|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515022|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44515023|NCT02249039|Clonidine|clonidine|mesh-list
44515024|NCT02249039|Analgesics|analgesics|mesh-ancestor
44515025|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
44515026|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515027|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515028|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44515030|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
44515031|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44515032|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44515033|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44515034|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515035|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515036|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515037|NCT02249078|Quetmolimab|quetmolimab|mesh-list
44515038|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515039|NCT02249130|Ritonavir|ritonavir|mesh-list
44515040|NCT02249130|Lamivudine|lamivudine|mesh-list
44515041|NCT02249130|Zidovudine|zidovudine|mesh-list
44515042|NCT02249130|Stavudine|stavudine|mesh-list
44515043|NCT02249130|Tipranavir|tipranavir|mesh-list
44515044|NCT02249130|Delavirdine|delavirdine|mesh-list
44515045|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44515046|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44515047|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515048|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515049|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515050|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44515051|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44515052|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
44515053|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515054|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44515055|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515056|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44515057|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44515058|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
44515059|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44515060|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44515061|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515062|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515063|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44515064|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515065|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515066|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
44515067|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515068|NCT02249299|Nabiximols|nabiximols|mesh-list
44515069|NCT02249299|Analgesics|analgesics|mesh-ancestor
44515070|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
44515071|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515072|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515073|NCT02249364|Propofol|propofol|mesh-list
44515074|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44515075|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515076|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515077|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44515078|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
44515079|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
44515080|NCT02249416|Ritonavir|ritonavir|mesh-list
44515081|NCT02249416|Zidovudine|zidovudine|mesh-list
44515082|NCT02249416|Tipranavir|tipranavir|mesh-list
44515083|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44515084|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44515085|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515086|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515087|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515088|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44515089|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44515090|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
44515091|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515092|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44515093|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515094|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
44515095|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44515096|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44515097|NCT02249442|Ritonavir|ritonavir|mesh-list
44515098|NCT02249442|Tipranavir|tipranavir|mesh-list
44515099|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44515100|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44515101|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515102|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515103|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515104|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44515105|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44515106|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
44515107|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515108|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44515109|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515110|NCT02249481|Bupivacaine|bupivacaine|mesh-list
44515111|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44515112|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
44515113|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515114|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515115|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
44515116|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515117|NCT02249546|Amoxicillin|amoxicillin|mesh-list
44515118|NCT02249546|Clarithromycin|clarithromycin|mesh-list
44515119|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
44515120|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44515121|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44515122|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515123|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44515124|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515125|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515126|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44515127|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515128|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
44515129|NCT02249546|Expectorants|expectorants|mesh-ancestor
44515130|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515131|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44515132|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
44515133|NCT02249546|Protective Agents|protective agents|mesh-ancestor
44515134|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515135|NCT02249546|Antidotes|antidotes|mesh-ancestor
44515136|NCT02249702|Gemcitabine|gemcitabine|mesh-list
44515137|NCT02249702|Docetaxel|docetaxel|mesh-list
44515138|NCT02249702|Trabectedin|trabectedin|mesh-list
44515139|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515140|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
44515141|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515142|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515143|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
44515144|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515145|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515146|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515147|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
44515148|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515149|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515150|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515151|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515152|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515153|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
44515154|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
44515155|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44515156|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515157|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
44515158|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515159|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515160|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
44515161|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44515162|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515163|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
44515164|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44515165|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44515166|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
44515167|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515168|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44515169|NCT02249936|Omeprazole|omeprazole|mesh-list
44515170|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44515171|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515172|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44515173|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515174|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515175|NCT02245087|Atorvastatin|atorvastatin|mesh-list
44515176|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44515177|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44515178|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
44515179|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515180|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44515181|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44515182|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515183|NCT02243813|Psilocybin|psilocybin|mesh-list
44515184|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
44515185|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515186|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44515187|NCT02243709|Mifepristone|mifepristone|mesh-list
44515188|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44515189|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
44515190|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44515191|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515192|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44515193|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44515194|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44515195|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
44515196|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44515197|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44515198|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44515199|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515200|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
44515201|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44515202|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44515203|NCT02244762|Hydrocodone|hydrocodone|mesh-list
44515204|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44515205|NCT02244762|Narcotics|narcotics|mesh-ancestor
44515206|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515207|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515208|NCT02244762|Analgesics|analgesics|mesh-ancestor
44515209|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
44515210|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515211|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
44515212|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515213|NCT02242734|Hydrocodone|hydrocodone|mesh-list
44515214|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44515215|NCT02242734|Narcotics|narcotics|mesh-ancestor
44515216|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515217|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515218|NCT02242734|Analgesics|analgesics|mesh-ancestor
44515219|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
44515220|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515221|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
44515222|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515223|NCT02245672|Fluticasone|fluticasone|mesh-list
44515224|NCT02245672|Xhance|xhance|mesh-list
44515225|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44515226|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515227|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515228|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
44515229|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515230|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515231|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515232|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515233|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515234|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44515235|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44515236|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44515237|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44515238|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515239|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515240|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515241|NCT02244606|Fluconazole|fluconazole|mesh-list
44515242|NCT02244606|Micafungin|micafungin|mesh-list
44515243|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
44515244|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
44515245|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515246|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44515247|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515248|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515249|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515250|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44515251|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
44335752|NCT00998920|Equol|equol|mesh-list
44515266|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515267|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44515268|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
44515270|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44515271|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44515272|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515273|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
44515274|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44515275|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515276|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515277|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44515278|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
44515279|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515281|NCT02242409|Paclitaxel|paclitaxel|mesh-list
44515282|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44515283|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515284|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515285|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515286|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515287|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515288|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515289|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515290|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
44515291|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
44515292|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515293|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515294|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515295|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
44515296|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515297|NCT02243358|Gemcitabine|gemcitabine|mesh-list
44515298|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515299|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
44515300|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515301|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515302|NCT02243358|Antiviral Agents|antiviral agents|mesh-ancestor
44515303|NCT02243358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515304|NCT02243358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515305|NCT02243358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515306|NCT02243358|Immunologic Factors|immunologic factors|mesh-ancestor
44515307|NCT02243358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515308|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
44515309|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44515310|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515311|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515312|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
44515313|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515314|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515315|NCT02246920|Fluticasone|fluticasone|mesh-list
44515317|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515318|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515319|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
44515320|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515321|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515322|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515323|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515324|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515325|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44515326|NCT02249663|Fluticasone|fluticasone|mesh-list
44515327|NCT02249663|Xhance|xhance|mesh-list
44515328|NCT02249663|Azelastine|azelastine|mesh-list
44515329|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515330|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515331|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
44515332|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515333|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515334|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515335|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515336|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515337|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44515338|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44515339|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515340|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515341|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44515342|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44515343|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
44515344|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
44515345|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515346|NCT00559962|Atorvastatin|atorvastatin|mesh-list
44515347|NCT00559962|Ezetimibe|ezetimibe|mesh-list
44515348|NCT00559962|Fenofibrate|fenofibrate|mesh-list
44515349|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44515350|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44515351|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
44515352|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515353|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44515354|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44515355|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515356|NCT00559845|Paclitaxel|paclitaxel|mesh-list
44515357|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
44515358|NCT00559845|Bevacizumab|bevacizumab|mesh-list
44515359|NCT00559845|Fluorouracil|fluorouracil|mesh-list
44515360|NCT00559845|Epirubicin|epirubicin|mesh-list
44515361|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515362|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515363|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515364|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515365|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515366|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515367|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515368|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
44515369|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515370|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515371|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515372|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
44515373|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44515374|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44515375|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44420215|NCT05544734|Acetaminophen|acetaminophen|mesh-list
44515376|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44515377|NCT00559845|Growth Substances|growth substances|mesh-ancestor
44515378|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
44515379|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
44515380|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515381|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44515382|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44515383|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44515384|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515385|NCT00559754|Bevacizumab|bevacizumab|mesh-list
44515386|NCT00559754|Docetaxel|docetaxel|mesh-list
44515387|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44515388|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515389|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44515390|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44515391|NCT00559754|Growth Substances|growth substances|mesh-ancestor
44515392|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515393|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
44515394|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515395|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515396|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515397|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515398|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
44515399|NCT00559637|Hematinics|hematinics|mesh-ancestor
44515400|NCT00559585|Abatacept|abatacept|mesh-list
44515401|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44515402|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515403|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515404|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515405|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
44515406|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515407|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515408|NCT00559507|Saracatinib|saracatinib|mesh-list
44515409|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515410|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515411|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515412|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44515413|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44515414|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515415|NCT00559364|Omeprazole|omeprazole|mesh-list
44515416|NCT00559364|Pancrelipase|pancrelipase|mesh-list
44515417|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44515418|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44515419|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515420|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235338|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
44515421|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515422|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
44515423|NCT00559273|Hematinics|hematinics|mesh-ancestor
44515424|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
44515425|NCT00559104|Carmustine|carmustine|mesh-list
44515426|NCT00559104|Etoposide|etoposide|mesh-list
44515427|NCT00559104|Lenograstim|lenograstim|mesh-list
44515428|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515429|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
44515430|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515431|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515432|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515433|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
44515434|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515435|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515436|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44515437|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515438|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44515439|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44515440|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515441|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44515442|NCT00558896|Dexamethasone|dexamethasone|mesh-list
44515443|NCT00558896|Pomalidomide|pomalidomide|mesh-list
44515444|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515445|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
44515446|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
44515447|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515448|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515449|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515450|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
44515451|NCT00558896|Hormones|hormones|mesh-ancestor
44515452|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515453|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44515454|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515455|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
44515456|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44515457|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44515458|NCT00558896|Growth Substances|growth substances|mesh-ancestor
44515459|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44515460|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44515461|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515462|NCT00558753|Pregabalin|pregabalin|mesh-list
44515463|NCT00558753|Analgesics|analgesics|mesh-ancestor
44515464|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
44515465|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515466|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515467|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
44515468|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44515469|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515470|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515471|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515472|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44515473|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44515474|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515475|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44515476|NCT00558636|Paclitaxel|paclitaxel|mesh-list
44515477|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44515478|NCT00558636|Carboplatin|carboplatin|mesh-list
44515479|NCT00558636|Sorafenib|sorafenib|mesh-list
44515480|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515481|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515482|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515483|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515484|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515485|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515486|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515487|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515488|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
44515489|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515490|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
44515491|NCT00558558|Hormones|hormones|mesh-ancestor
44515492|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515493|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515494|NCT00558519|Cytarabine|cytarabine|mesh-list
44515495|NCT00558519|Dexamethasone|dexamethasone|mesh-list
44515496|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
44335968|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44515498|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44515500|NCT00558519|Vincristine|vincristine|mesh-list
44515501|NCT00558519|Daunorubicin|daunorubicin|mesh-list
44515502|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
44515503|NCT00558519|Pegaspargase|pegaspargase|mesh-list
44515504|NCT00558519|Thioguanine|thioguanine|mesh-list
44515505|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515506|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
44515507|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515508|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515509|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515510|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
44515511|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515512|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515513|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44515514|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515515|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
44515516|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
44515517|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515518|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515519|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
44515520|NCT00558519|Hormones|hormones|mesh-ancestor
44515521|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515522|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44515523|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44515524|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44515525|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44515526|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515527|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44515528|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
44515529|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44515530|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515531|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
44515532|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515533|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44515534|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44515535|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
44515536|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515537|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515538|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515539|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515540|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515541|NCT00558467|Pramipexole|pramipexole|mesh-list
44515542|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
44515543|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515544|NCT00558467|Protective Agents|protective agents|mesh-ancestor
44515545|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515546|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44515547|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44515548|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
44515549|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
44515550|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515551|NCT00558428|Amlodipine|amlodipine|mesh-list
44515552|NCT00558428|Telmisartan|telmisartan|mesh-list
44515553|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44515554|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44515555|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44515556|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515557|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515558|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515559|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515560|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
44515561|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44515562|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44515563|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
44515564|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44515565|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44515566|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44515567|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
44336044|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515568|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515569|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515570|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515580|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44515581|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515582|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515583|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515585|NCT00558103|Lapatinib|lapatinib|mesh-list
44515586|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515587|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515588|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515589|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515590|NCT00558064|Amlodipine|amlodipine|mesh-list
44515591|NCT00558064|Telmisartan|telmisartan|mesh-list
44515592|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44515593|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44515594|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44515595|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515596|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515597|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515598|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515599|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
44515600|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44515601|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44515602|NCT00558025|Pramipexole|pramipexole|mesh-list
44515603|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
44515604|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515605|NCT00558025|Protective Agents|protective agents|mesh-ancestor
44515606|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420491|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420492|NCT05252390|Olaparib|olaparib|mesh-list
44420493|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44420494|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420496|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515607|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44515608|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44515609|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
44515611|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515612|NCT00557830|Sorafenib|sorafenib|mesh-list
44515613|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515614|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515615|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515616|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515617|NCT00557622|Paroxetine|paroxetine|mesh-list
44515618|NCT00557622|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44515619|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44515620|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515621|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515622|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515623|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
44515624|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515625|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44515626|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
44515627|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44515628|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44515629|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44515630|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515631|NCT00557492|Gemcitabine|gemcitabine|mesh-list
44515632|NCT00557492|Bevacizumab|bevacizumab|mesh-list
44515633|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44515634|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515635|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44515636|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44515637|NCT00557492|Growth Substances|growth substances|mesh-ancestor
44515638|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515639|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
44515640|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515641|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
44515642|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515643|NCT00557492|Antiviral Agents|antiviral agents|mesh-ancestor
44515644|NCT00557492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515645|NCT00557492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515646|NCT00557492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515647|NCT00557492|Immunologic Factors|immunologic factors|mesh-ancestor
44515648|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
44515649|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515650|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
43924226|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
44515651|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515652|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515653|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515654|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515655|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44515656|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44515657|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44515658|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515659|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515660|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515661|NCT00557440|Fluticasone|fluticasone|mesh-list
44515662|NCT00557440|Xhance|xhance|mesh-list
44515663|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
44515664|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44515665|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44515666|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515667|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515668|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
44515669|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515670|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515671|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515672|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515673|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515674|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44515675|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44515676|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44515677|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44515678|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515679|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515680|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515681|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
44515682|NCT00557440|Hormones|hormones|mesh-ancestor
44515683|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515684|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
44515685|NCT00557310|Teriparatide|teriparatide|mesh-list
44515686|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515687|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515688|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44515689|NCT00557245|Tenofovir|tenofovir|mesh-list
44515690|NCT00557245|Emtricitabine|emtricitabine|mesh-list
44420528|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
44515691|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44515692|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
44515693|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515694|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44515695|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44515696|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515697|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515698|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44515699|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44515700|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44515701|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515702|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515703|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515704|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515705|NCT00556673|Fluticasone|fluticasone|mesh-list
44515706|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
44515707|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44515708|NCT00556673|Maleic acid|maleic acid|mesh-list
44515709|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515710|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44515711|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
44515712|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515713|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515714|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44515715|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44515716|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515717|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44515718|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44515719|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44515720|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44515721|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515722|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515723|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515724|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515725|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44515726|NCT00556322|Docetaxel|docetaxel|mesh-list
44515727|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515728|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44515729|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515730|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515731|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515732|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515733|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
44515734|NCT00555477|Anastrozole|anastrozole|mesh-list
44515735|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44515736|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515737|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44515738|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44515739|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515740|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515741|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44515742|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
44515743|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515744|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515745|NCT00555438|PENTA|penta|mesh-list
44515746|NCT00555438|Fondaparinux|fondaparinux|mesh-list
44515747|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44515748|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
44515749|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44515750|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515751|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515752|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515753|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
44515754|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44515755|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44515756|NCT00555425|Buprenorphine|buprenorphine|mesh-list
44515757|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44515758|NCT00555425|Naloxone|naloxone|mesh-list
44515759|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44515760|NCT00555425|Narcotics|narcotics|mesh-ancestor
44515761|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515762|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515763|NCT00555425|Analgesics|analgesics|mesh-ancestor
44515764|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
44515765|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515766|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44515767|NCT00555061|Retapamulin|retapamulin|mesh-list
44515768|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44515769|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515770|NCT00554840|Varenicline|varenicline|mesh-list
44515771|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44515772|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44515773|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
44515774|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515775|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515776|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515777|NCT00554619|Ambrisentan|ambrisentan|mesh-list
44515778|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44515779|NCT00554216|Topiramate|topiramate|mesh-list
44515780|NCT00554216|Phentermine|phentermine|mesh-list
44515781|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
44515782|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44515783|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515784|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44515785|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
44515786|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44515787|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
44515788|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
44515789|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515790|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515791|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515792|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515793|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44515794|NCT00554099|Mesalamine|mesalamine|mesh-list
44515795|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515796|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44515797|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44515798|NCT00554099|Analgesics|analgesics|mesh-ancestor
44515799|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
44515800|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515801|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515802|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515803|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515805|NCT00553644|Bortezomib|bortezomib|mesh-list
44515806|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
44515807|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515808|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44515809|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44515810|NCT00553644|Growth Substances|growth substances|mesh-ancestor
44515811|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44515812|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515813|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44515814|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44515815|NCT00553514|Hormones|hormones|mesh-ancestor
44515816|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515817|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515818|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44515819|NCT00553501|Rituximab|rituximab|mesh-list
44515820|NCT00553501|Epratuzumab|epratuzumab|mesh-list
44515821|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44515822|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515823|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
44515824|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515825|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515826|NCT00553462|Paclitaxel|paclitaxel|mesh-list
44515827|NCT00553462|Carboplatin|carboplatin|mesh-list
44515828|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44515829|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44515830|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44515831|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515832|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44515833|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44515848|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
44515849|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44515850|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44515851|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515852|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44515853|NCT00553267|Amlodipine|amlodipine|mesh-list
44515854|NCT00553267|Telmisartan|telmisartan|mesh-list
44515855|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44515856|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44515857|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44515858|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515859|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515860|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44515861|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515862|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
44515863|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44515864|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44515865|NCT00553202|Cyclosporine|cyclosporine|mesh-list
44515866|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
44515867|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44515868|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44515870|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
44515871|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
44515872|NCT00553202|Busulfan|busulfan|mesh-list
44515873|NCT00553202|Methotrexate|methotrexate|mesh-list
44515874|NCT00553202|Tacrolimus|tacrolimus|mesh-list
44515875|NCT00553202|Cyclosporins|cyclosporins|mesh-list
44515876|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
44515877|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44515878|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44515879|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
44515880|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515881|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
44515882|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515883|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515884|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515885|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
44515886|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515887|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515888|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44515889|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44420719|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
44515890|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
44515891|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44515892|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44515893|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
44515894|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44515895|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515896|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44515897|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44515898|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44515899|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
44515900|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515901|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515902|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
44515903|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
44515904|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515905|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515906|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
44515907|NCT00553202|Hormones|hormones|mesh-ancestor
44515908|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515909|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44515910|NCT00553202|Protective Agents|protective agents|mesh-ancestor
44515911|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44515912|NCT00553150|Everolimus|everolimus|mesh-list
44515913|NCT00553150|Temozolomide|temozolomide|mesh-list
44515914|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515915|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515916|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
44515917|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515918|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44515919|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
44515920|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515921|NCT00553059|Dexamethasone|dexamethasone|mesh-list
44515922|NCT00553059|Dronabinol|dronabinol|mesh-list
44515923|NCT00553059|Palonosetron|palonosetron|mesh-list
44515924|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44515925|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
44515926|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
44515927|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515928|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515929|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44515930|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
44515931|NCT00553059|Hormones|hormones|mesh-ancestor
44515932|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44515933|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44515934|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44515935|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44515936|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44515937|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
44515938|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515939|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515940|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
44515941|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44515942|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44515943|NCT00553059|Analgesics|analgesics|mesh-ancestor
44515944|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
44515945|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44515946|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44515948|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
44515949|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44515950|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44515951|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44515952|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515953|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515954|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44515955|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44515956|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44515957|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44515958|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515959|NCT00552578|Buprenorphine|buprenorphine|mesh-list
44515960|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44515961|NCT00552578|Naloxone|naloxone|mesh-list
44515962|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44515963|NCT00552578|Narcotics|narcotics|mesh-ancestor
43626363|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44515964|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44515965|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515966|NCT00552578|Analgesics|analgesics|mesh-ancestor
44515967|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
44515968|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44515969|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44515970|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
44515971|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44515972|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
44515973|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515974|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44515975|NCT00552305|Lacosamide|lacosamide|mesh-list
44515976|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
44515977|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44515978|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44515979|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44515980|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515981|NCT00552279|Vaccines|vaccines|mesh-list
44515982|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
44515983|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44515984|NCT00552240|Ritonavir|ritonavir|mesh-list
44515985|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44515986|NCT00552240|Tenofovir|tenofovir|mesh-list
44515987|NCT00552240|Emtricitabine|emtricitabine|mesh-list
44515988|NCT00552240|Nevirapine|nevirapine|mesh-list
44515989|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44515990|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44515991|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
44515992|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44515993|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44515994|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44515995|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44515996|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
44515997|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44515998|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44515999|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44516000|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44516001|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44516002|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44516003|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44516004|NCT00552188|Atreleuton|atreleuton|mesh-list
44516005|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44516006|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516007|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516008|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44516009|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44516010|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44516011|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516012|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516013|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516014|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516015|NCT00552175|Analgesics|analgesics|mesh-ancestor
44516016|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
44516031|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516032|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516033|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
44516034|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
44516035|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516036|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
44516037|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44516038|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516039|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44516040|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
44516041|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44516042|NCT00552110|Protective Agents|protective agents|mesh-ancestor
44516043|NCT00552071|Octreotide|octreotide|mesh-list
44516044|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44516045|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516046|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516047|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
44516048|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516049|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
44516050|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516051|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516053|NCT00551759|Fluorouracil|fluorouracil|mesh-list
44516054|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
44516055|NCT00551759|Cetuximab|cetuximab|mesh-list
44516056|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516057|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516058|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516059|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516060|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516061|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
44516062|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516063|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516064|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
44516065|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516066|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516067|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
44516068|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44516069|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
44516070|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516071|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516072|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516073|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516074|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44516075|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
44420894|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516076|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516077|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516078|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44516079|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516080|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
44516081|NCT00551642|Protective Agents|protective agents|mesh-ancestor
44516082|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44516083|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44516084|NCT00551525|Analgesics|analgesics|mesh-ancestor
44516085|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
44516086|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516087|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516088|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44516089|NCT00551421|Cetuximab|cetuximab|mesh-list
44516090|NCT00551421|Pertuzumab|pertuzumab|mesh-list
44516091|NCT00551421|Irinotecan|irinotecan|mesh-list
44516092|NCT00551421|Antibodies|antibodies|mesh-list
44516093|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
44516094|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44516095|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
44516096|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516097|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516098|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44516099|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516100|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516101|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516102|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
44516103|NCT00551291|Prednisone|prednisone|mesh-list
44516104|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
44516105|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516106|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
44516107|NCT00551291|Hormones|hormones|mesh-ancestor
44516108|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516109|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516110|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516111|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516112|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516113|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44516114|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
44516115|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44516116|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516117|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516118|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516119|NCT00551291|Hematinics|hematinics|mesh-ancestor
44516120|NCT00551213|Capecitabine|capecitabine|mesh-list
44516121|NCT00551213|Irinotecan|irinotecan|mesh-list
44516122|NCT00551213|Cetuximab|cetuximab|mesh-list
44516123|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516124|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
44516125|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516126|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516127|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44516128|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516129|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516130|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516132|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44516133|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44516134|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
44516135|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516136|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420931|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44516137|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516138|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44516139|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44516140|NCT00551031|Vaccines|vaccines|mesh-list
44516141|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
44516142|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516143|NCT00550953|Amlodipine|amlodipine|mesh-list
44516144|NCT00550953|Telmisartan|telmisartan|mesh-list
44516145|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44516146|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44516147|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44516148|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516149|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516150|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516151|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516152|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516153|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44516154|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44516155|NCT00550836|Gemcitabine|gemcitabine|mesh-list
44516156|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44516157|NCT00550836|Panitumumab|panitumumab|mesh-list
44516158|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516159|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
44516160|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516161|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516162|NCT00550836|Antiviral Agents|antiviral agents|mesh-ancestor
44516163|NCT00550836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516164|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516165|NCT00550836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516166|NCT00550836|Immunologic Factors|immunologic factors|mesh-ancestor
44516167|NCT00550836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516168|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516169|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516170|NCT00550771|Paclitaxel|paclitaxel|mesh-list
44516171|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44516172|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
44516173|NCT00550771|Doxorubicin|doxorubicin|mesh-list
44516174|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44516175|NCT00550771|Trastuzumab|trastuzumab|mesh-list
44516176|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44516177|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516178|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516179|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516180|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516181|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516182|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516183|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
44516184|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516185|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516186|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44516187|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
44516188|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44516189|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516190|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44516191|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516192|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516193|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516194|NCT00550732|Posaconazole|posaconazole|mesh-list
44516195|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
44516196|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516197|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44516198|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44516199|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43924686|NCT02592356|Lenvatinib|lenvatinib|mesh-list
44516200|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44516201|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44516202|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516203|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516204|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44516205|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
44516206|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516207|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516208|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
44516209|NCT00550680|Hematinics|hematinics|mesh-ancestor
44516210|NCT00550550|Fluticasone|fluticasone|mesh-list
44516211|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
44516212|NCT00550550|Loratadine|loratadine|mesh-list
44516213|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44516214|NCT00550550|Prednisone|prednisone|mesh-list
44516215|NCT00550550|Albuterol|albuterol|mesh-list
44516216|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516217|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
44516218|NCT00550550|Hormones|hormones|mesh-ancestor
44516219|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516220|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516221|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516222|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516223|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44516224|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
44516225|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516226|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516227|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516228|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516229|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44516230|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
44516231|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516232|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44516233|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44516234|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44516235|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516236|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516237|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516238|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
44516239|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44516240|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44516241|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
44516242|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
44516243|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44516244|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44516245|NCT00550550|Analgesics|analgesics|mesh-ancestor
44516246|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
44516247|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516248|NCT00550537|Paclitaxel|paclitaxel|mesh-list
44516249|NCT00550537|Bevacizumab|bevacizumab|mesh-list
44516250|NCT00550537|Carboplatin|carboplatin|mesh-list
44516251|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44516252|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44516253|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516254|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516255|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516256|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516257|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516258|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516259|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44516260|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44516261|NCT00550537|Growth Substances|growth substances|mesh-ancestor
44516262|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516263|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
44516264|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516265|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516266|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
44516267|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44516268|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336786|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516269|NCT00550173|Pemetrexed|pemetrexed|mesh-list
44516270|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44516271|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516272|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516273|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516274|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44516275|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44516276|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516277|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44516278|NCT00550147|Methylphenidate|methylphenidate|mesh-list
44516279|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44516280|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516281|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44516282|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44516283|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516284|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516285|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
44516286|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516287|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
44516288|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44516289|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44516290|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44516291|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44516292|NCT00559936|Bevacizumab|bevacizumab|mesh-list
44516293|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516294|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516295|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44516296|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44516297|NCT00559936|Growth Substances|growth substances|mesh-ancestor
44516298|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516299|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44516300|NCT00559247|Asunaprevir|asunaprevir|mesh-list
44516301|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
44516302|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516303|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516304|NCT00558207|Gemcitabine|gemcitabine|mesh-list
44516305|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516306|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
44516307|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516308|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516309|NCT00558207|Antiviral Agents|antiviral agents|mesh-ancestor
44516310|NCT00558207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516311|NCT00558207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516312|NCT00558207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516313|NCT00558207|Immunologic Factors|immunologic factors|mesh-ancestor
44516314|NCT00558207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516315|NCT00558038|Lactulose|lactulose|mesh-list
44516316|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44516317|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
44516318|NCT00557973|Baclofen|baclofen|mesh-list
44516319|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44516320|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516321|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44516322|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516323|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44516324|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
44516325|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
44516326|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516327|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516328|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
44516329|NCT00557401|Baclofen|baclofen|mesh-list
44516330|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44516331|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516332|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44516333|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516334|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44516335|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
44516336|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
44516337|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516338|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516339|NCT00557128|Lisinopril|lisinopril|mesh-list
44516340|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44516341|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
44516342|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516354|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516356|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
44516357|NCT00556920|Protective Agents|protective agents|mesh-ancestor
44516358|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44516359|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516360|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516361|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516362|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44516363|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44516365|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516366|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
44516367|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516368|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44516369|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516370|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516371|NCT00555035|Dolutegravir|dolutegravir|mesh-list
44516372|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44516373|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44516374|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516375|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516376|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44516377|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44516378|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
44516379|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516380|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44516381|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44516382|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44516383|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
44516384|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516385|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516386|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516387|NCT00553657|Urological Agents|urological agents|mesh-ancestor
44516388|NCT00553306|Aldesleukin|aldesleukin|mesh-list
44516389|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
44516390|NCT00553306|Interleukin-2|interleukin-2|mesh-list
44516391|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516392|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
44516393|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516394|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516395|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44516396|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
44516397|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516398|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516399|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44516400|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44516401|NCT00553306|Analgesics|analgesics|mesh-ancestor
44516402|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
44516403|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516404|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44516405|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44516406|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
44516407|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516408|NCT00552708|Lisinopril|lisinopril|mesh-list
44516409|NCT00552708|Carvedilol|carvedilol|mesh-list
44516410|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44516411|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44516412|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516413|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516414|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44516415|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44516416|NCT00552708|Protective Agents|protective agents|mesh-ancestor
44516417|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516418|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44516419|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44516420|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516421|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516422|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
44516423|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44516424|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516425|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516426|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516427|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44516428|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44516429|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
44516430|NCT00556374|Denosumab|denosumab|mesh-list
44516431|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44516432|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44516433|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516434|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44516435|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421223|NCT04615949|Cannabidiol|cannabidiol|mesh-list
44516436|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516437|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44516438|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
44516439|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516440|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
44516441|NCT00555321|Abatacept|abatacept|mesh-list
44516442|NCT00555321|Tacrolimus|tacrolimus|mesh-list
44516443|NCT00555321|Basiliximab|basiliximab|mesh-list
44516444|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516445|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
44516446|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516447|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44516448|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516449|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516450|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516451|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516452|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44516453|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
44516454|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44516455|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516456|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44516457|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516458|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
44516459|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516460|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516461|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44516463|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44516464|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516465|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
44516466|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516467|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
44516468|NCT00557193|Leucovorin|leucovorin|mesh-list
44516469|NCT00557193|Folic Acid|folic acid|mesh-list
44516470|NCT00557193|Cytarabine|cytarabine|mesh-list
44516471|NCT00557193|Dexamethasone|dexamethasone|mesh-list
44516472|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
44516473|NCT00557193|Prednisone|prednisone|mesh-list
44516474|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
44516475|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44516476|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44516477|NCT00557193|Prednisolone|prednisolone|mesh-list
44516478|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
44516479|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
44516480|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44516481|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44516482|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44516483|NCT00557193|Cortisone|cortisone|mesh-list
44516484|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
44516485|NCT00557193|Methotrexate|methotrexate|mesh-list
44516486|NCT00557193|Etoposide|etoposide|mesh-list
44516487|NCT00557193|Vincristine|vincristine|mesh-list
44516488|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
44516489|NCT00557193|Daunorubicin|daunorubicin|mesh-list
44516490|NCT00557193|Asparaginase|asparaginase|mesh-list
44516491|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
44516492|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
44516493|NCT00557193|Pegaspargase|pegaspargase|mesh-list
44516494|NCT00557193|Lenograstim|lenograstim|mesh-list
44516495|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44516496|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
44516497|NCT00557193|BB 1101|bb 1101|mesh-list
44516498|NCT00557193|Calcium|calcium|mesh-list
44516499|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
44516500|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516501|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
44516502|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516503|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516504|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44516505|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
44516506|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516507|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516508|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44516509|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516510|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
44516511|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
44516512|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516513|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44516515|NCT00557193|Hormones|hormones|mesh-ancestor
44516516|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516517|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516518|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
44516519|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516520|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516521|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44516522|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44516523|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
44516524|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516525|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516526|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
44516527|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516528|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44516529|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44516530|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44516531|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44516532|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516533|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
44516534|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516535|NCT00557193|Antidotes|antidotes|mesh-ancestor
44516536|NCT00557193|Protective Agents|protective agents|mesh-ancestor
44516537|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
44516538|NCT00557193|Vitamins|vitamins|mesh-ancestor
44516539|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
44516540|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44516541|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516542|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516543|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516544|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44516545|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516546|NCT00557193|Hematinics|hematinics|mesh-ancestor
44516547|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
44516548|NCT00555971|Omalizumab|omalizumab|mesh-list
44516549|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44516550|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516551|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516552|NCT03024437|Bevacizumab|bevacizumab|mesh-list
44516553|NCT03024437|Atezolizumab|atezolizumab|mesh-list
44516554|NCT03024437|Entinostat|entinostat|mesh-list
44516555|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516556|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516557|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44516558|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44516559|NCT03024437|Growth Substances|growth substances|mesh-ancestor
44516560|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516561|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
44516562|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44516563|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421344|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
44516564|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516565|NCT03022877|Simendan|simendan|mesh-list
44516566|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44516567|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516568|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44516569|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44516570|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516571|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516572|NCT03022877|Protective Agents|protective agents|mesh-ancestor
44516573|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516574|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
44516575|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44516576|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
44516577|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516578|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516579|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516580|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516581|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44516582|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
44516583|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516584|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516585|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44516586|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516587|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
44516589|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
44516590|NCT03026348|Vaccines|vaccines|mesh-list
44516591|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
44516592|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516593|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44516594|NCT03026348|Antacids|antacids|mesh-ancestor
44516595|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516596|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44516597|NCT03021993|Nivolumab|nivolumab|mesh-list
44516598|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516599|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516600|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44516601|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516621|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44516622|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516623|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44516624|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516625|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
44516626|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
44516627|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516628|NCT03022279|Ropivacaine|ropivacaine|mesh-list
44516629|NCT03022279|Anesthetics, Local|anesthetics, local|mesh-ancestor
44516630|NCT03022279|Anesthetics|anesthetics|mesh-ancestor
44516631|NCT03022279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44516632|NCT03022279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516633|NCT03022279|Sensory System Agents|sensory system agents|mesh-ancestor
44516634|NCT03022279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516635|NCT03023319|Pemetrexed|pemetrexed|mesh-list
44516636|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516637|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516638|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516639|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44516640|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44516641|NCT03029390|Metformin|metformin|mesh-list
44516642|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44516643|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516644|NCT03028766|Cisplatin|cisplatin|mesh-list
44516645|NCT03028766|Adavosertib|adavosertib|mesh-list
44516646|NCT03028766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516647|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516648|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516649|NCT03020030|Leucovorin|leucovorin|mesh-list
44516650|NCT03020030|Cytarabine|cytarabine|mesh-list
44516651|NCT03020030|Dexamethasone|dexamethasone|mesh-list
44516652|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
44516653|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
44516654|NCT03020030|Doxorubicin|doxorubicin|mesh-list
44516655|NCT03020030|Methotrexate|methotrexate|mesh-list
44516656|NCT03020030|Etoposide|etoposide|mesh-list
44516657|NCT03020030|Vincristine|vincristine|mesh-list
44516658|NCT03020030|Asparaginase|asparaginase|mesh-list
44516659|NCT03020030|Dasatinib|dasatinib|mesh-list
44516660|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
44516661|NCT03020030|Pegaspargase|pegaspargase|mesh-list
44516662|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
44516663|NCT03020030|Razoxane|razoxane|mesh-list
44516664|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
44516665|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516666|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
44516667|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516668|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516669|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44516670|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
44516671|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516672|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516673|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44516674|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516675|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
44516676|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
44516677|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516678|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44516679|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
44516680|NCT03020030|Hormones|hormones|mesh-ancestor
44516681|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516682|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516683|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516684|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44516685|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516686|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516687|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44516688|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
44516689|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516690|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516691|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
44516692|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516693|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44516694|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44516695|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44516696|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
44516697|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516698|NCT03020030|Antidotes|antidotes|mesh-ancestor
44516700|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
44516701|NCT03020030|Vitamins|vitamins|mesh-ancestor
44516702|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
44516703|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516704|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516705|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516706|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516707|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44516708|NCT03028350|Ifetroban|ifetroban|mesh-list
44516709|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44516710|NCT03029533|Leuprolide|leuprolide|mesh-list
44516711|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44516712|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
44516713|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516714|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516715|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44516716|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516717|NCT03029676|Fentanyl|fentanyl|mesh-list
44516718|NCT03029676|Midazolam|midazolam|mesh-list
44516719|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
44516720|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44516721|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516722|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44516723|NCT03029676|Narcotics|narcotics|mesh-ancestor
44516724|NCT03029676|Analgesics|analgesics|mesh-ancestor
44516725|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
44516726|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516727|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44516728|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44516729|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
44516730|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44516731|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44516732|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44516733|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44516734|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
44516735|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
44516736|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516737|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516738|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
44516739|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44516740|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44516741|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
44516742|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516743|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44516744|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44516745|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516746|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516747|NCT03029845|Propranolol|propranolol|mesh-list
44516748|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44516749|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44516750|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516751|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516752|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516753|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516754|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44516755|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44516756|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516757|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
44516758|NCT03029273|Fludarabine|fludarabine|mesh-list
44516759|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516760|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
44516761|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516762|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516763|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44516764|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
44516765|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516766|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516767|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44516768|NCT03029013|Apatinib|apatinib|mesh-list
44516769|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516770|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516771|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421533|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516772|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516773|NCT03028883|Buprenorphine|buprenorphine|mesh-list
44516774|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44516775|NCT03028883|Narcotics|narcotics|mesh-ancestor
44516776|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44516777|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516778|NCT03028883|Analgesics|analgesics|mesh-ancestor
44516779|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
44516780|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516781|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44516782|NCT03028701|Budesonide|budesonide|mesh-list
44516783|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
44516784|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516785|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44516786|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
44516787|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516788|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516789|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44516790|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44516791|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
44516792|NCT03028701|Hormones|hormones|mesh-ancestor
44516793|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44516794|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44516795|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44516796|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44516797|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516798|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516799|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516800|NCT03028909|Oseltamivir|oseltamivir|mesh-list
44516801|NCT03028909|MEDI8852|medi8852|mesh-list
44516802|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
44516803|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516804|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516805|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516806|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
44516807|NCT03028298|Citric Acid|citric acid|mesh-list
44516808|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
44516809|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
44516810|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44516811|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
44516812|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
44516813|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516814|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516815|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44516816|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44516817|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516818|NCT03028298|Urological Agents|urological agents|mesh-ancestor
44516819|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
44516820|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44516821|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
44516822|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516823|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
44516824|NCT03028428|Protective Agents|protective agents|mesh-ancestor
44516825|NCT03028571|Trimethaphan|trimethaphan|mesh-list
44516826|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
44516827|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44516828|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44516829|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44516830|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
44516831|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516832|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516833|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44516834|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44516835|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
44516836|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516837|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516838|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516839|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
44516840|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516841|NCT03027960|Empagliflozin|empagliflozin|mesh-list
44516842|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44516843|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516844|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44516845|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516846|NCT03027934|Ticagrelor|ticagrelor|mesh-list
44516847|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44516848|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44516849|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44516850|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44516851|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44516852|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
44516853|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516854|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516855|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516856|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
44516857|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
44516858|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44516859|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44516860|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516861|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
44516862|NCT03027973|Coagulants|coagulants|mesh-ancestor
44516863|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44516864|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
44516865|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516866|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516867|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44516868|NCT03027908|Fluorides|fluorides|mesh-list
44516869|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
44516870|NCT03027908|Protective Agents|protective agents|mesh-ancestor
44516871|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516872|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
44516873|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44516874|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516875|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44516876|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516877|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516878|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516879|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516880|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44516881|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44516882|NCT03027674|Nifedipine|nifedipine|mesh-list
44516883|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
44516884|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516885|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44516886|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44516887|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516888|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516889|NCT03027674|Urological Agents|urological agents|mesh-ancestor
44516890|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44516891|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44516892|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516893|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516894|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
44421655|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44516895|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44516896|NCT03027284|Gemcitabine|gemcitabine|mesh-list
44516897|NCT03027284|Cisplatin|cisplatin|mesh-list
44516898|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516899|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516900|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
44516901|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516902|NCT03027284|Antiviral Agents|antiviral agents|mesh-ancestor
44516903|NCT03027284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516904|NCT03027284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516905|NCT03027284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516906|NCT03027284|Immunologic Factors|immunologic factors|mesh-ancestor
44516907|NCT03027284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516908|NCT03027167|Aspirin|aspirin|mesh-list
44516909|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44516910|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44516911|NCT03027167|Analgesics|analgesics|mesh-ancestor
44516912|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
44516913|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516914|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516915|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44516916|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337432|NCT01010048|Hormones|hormones|mesh-ancestor
44516917|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44516918|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44516919|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516920|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44516921|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44516922|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516923|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
44516924|NCT03027219|Alprostadil|alprostadil|mesh-list
44516925|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44516926|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44516927|NCT03027219|Urological Agents|urological agents|mesh-ancestor
44516928|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44516929|NCT03026933|Calcium|calcium|mesh-list
44516930|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44516931|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516932|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44516933|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44516934|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
44516935|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516936|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44516937|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44516938|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516939|NCT03026842|Cytarabine|cytarabine|mesh-list
44516940|NCT03026842|Decitabine|decitabine|mesh-list
44516941|NCT03026842|Daunorubicin|daunorubicin|mesh-list
44516942|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
44516943|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
44516944|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44516945|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
44516946|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516947|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516948|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
44516949|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516950|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516951|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
44516952|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516953|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44516954|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44516955|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44516956|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516957|NCT03026842|Analgesics|analgesics|mesh-ancestor
44516958|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
44516959|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44516960|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44516961|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
44516962|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516963|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
44516964|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
44516965|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516969|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44516970|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
44516971|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44516972|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516973|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516974|NCT03027115|Urological Agents|urological agents|mesh-ancestor
44516975|NCT03026881|Paclitaxel|paclitaxel|mesh-list
44516976|NCT03026881|Apatinib|apatinib|mesh-list
44516977|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44516978|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516979|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44516980|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44516981|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44516982|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516983|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44516984|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516985|NCT03026946|Cyclosporine|cyclosporine|mesh-list
44516986|NCT03026946|Alitretinoin|alitretinoin|mesh-list
44516987|NCT03026946|Cyclosporins|cyclosporins|mesh-list
44516988|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44516989|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44516990|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44516991|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
44516992|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44516993|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
44516994|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44516995|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44516996|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44516997|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44516998|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44516999|NCT03026907|Azathioprine|azathioprine|mesh-list
44517000|NCT03026907|Alitretinoin|alitretinoin|mesh-list
44517001|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517002|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
44517003|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
44517004|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517005|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44517006|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517007|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
44517008|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517009|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517010|NCT03026725|Calcium|calcium|mesh-list
44517011|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44517012|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517013|NCT03026478|Betamethasone|betamethasone|mesh-list
44517014|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
44517015|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44517016|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
44517017|NCT03026478|Clobetasol|clobetasol|mesh-list
44517018|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44517019|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517020|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
44517021|NCT03026478|Hormones|hormones|mesh-ancestor
44517022|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517023|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517024|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44517025|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44517026|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
44517027|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44517028|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517029|NCT03026244|Vitamin D|vitamin d|mesh-list
44517030|NCT03026244|Caseins|caseins|mesh-list
44517031|NCT03026244|Vitamins|vitamins|mesh-ancestor
44517032|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
44517033|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517034|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44517035|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
44517036|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
44337579|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
44517037|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517038|NCT03026036|Raclopride|raclopride|mesh-list
44517039|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44517040|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517041|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517042|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517043|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517044|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44517045|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
44517046|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517047|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517048|NCT03026023|Ribavirin|ribavirin|mesh-list
44517049|NCT03026023|Grazoprevir|grazoprevir|mesh-list
44517050|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
44517051|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517052|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
44517053|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517054|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44517055|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517056|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517057|NCT03025867|Niraparib|niraparib|mesh-list
44517058|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44517059|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517060|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517061|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517062|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
44517063|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517064|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517065|NCT03025893|Sunitinib|sunitinib|mesh-list
44517066|NCT03025893|Lomustine|lomustine|mesh-list
44517067|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517068|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44517069|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44517070|NCT03025893|Growth Substances|growth substances|mesh-ancestor
44517071|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517072|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
44517073|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44517074|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517075|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517076|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44517077|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
44517078|NCT03025906|Valproic Acid|valproic acid|mesh-list
44517079|NCT03025906|Phenobarbital|phenobarbital|mesh-list
44517080|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
44517081|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517082|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517083|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
44517084|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517085|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517086|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
44517087|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517088|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517089|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517090|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517091|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44517092|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44517093|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
44517094|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44517095|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44517096|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44517097|NCT03025477|Paclitaxel|paclitaxel|mesh-list
44517098|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44517099|NCT03025477|Cisplatin|cisplatin|mesh-list
44517100|NCT03025477|Carboplatin|carboplatin|mesh-list
44517101|NCT03025477|Epirubicin|epirubicin|mesh-list
44517102|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517103|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517104|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517105|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517106|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517107|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517108|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44517109|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44517110|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44517111|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517112|NCT03025282|Betamethasone|betamethasone|mesh-list
44517113|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
44517114|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44517115|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517116|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
44517117|NCT03025282|Hormones|hormones|mesh-ancestor
44517118|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421882|NCT04093323|Celecoxib|celecoxib|mesh-list
44517119|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517120|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44517121|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
44517122|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
44517123|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517124|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517125|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517126|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517127|NCT03025295|Analgesics|analgesics|mesh-ancestor
44517128|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
44517129|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517130|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44517131|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44517132|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44517133|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
44517134|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517135|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517136|NCT03025009|Insulin|insulin|mesh-list
44517137|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44517138|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
44517139|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44517140|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517141|NCT03024879|Erythromycin|erythromycin|mesh-list
44517142|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
44517143|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44517144|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
44517145|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517146|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517147|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517148|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44517149|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517150|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517151|NCT03024905|Misoprostol|misoprostol|mesh-list
44517152|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44517153|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
44517154|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44517155|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517156|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44517157|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517158|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
44517159|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
44517160|NCT03024957|Morphine|morphine|mesh-list
44517161|NCT03024957|Bupivacaine|bupivacaine|mesh-list
44517162|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
44517163|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
44517164|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517165|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517166|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
44517167|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517168|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517169|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517170|NCT03024957|Analgesics|analgesics|mesh-ancestor
44517171|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44517172|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44517173|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44517174|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
44517175|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517176|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517177|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44517178|NCT03024957|Narcotics|narcotics|mesh-ancestor
44517179|NCT03025113|Ketoprofen|ketoprofen|mesh-list
44517180|NCT03025113|Amitriptyline|amitriptyline|mesh-list
44517181|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
44517182|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44517183|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517184|NCT03025113|Analgesics|analgesics|mesh-ancestor
44421942|NCT04016090|Folic Acid|folic acid|mesh-list
44517185|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
44517186|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517187|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517188|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517189|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517190|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44517191|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517192|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517193|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44517194|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
44517195|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517196|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44517197|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44517198|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517199|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517200|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44517201|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44517202|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44517203|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44517204|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517206|NCT03024840|Sevoflurane|sevoflurane|mesh-list
44517207|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517208|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517209|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517210|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44517211|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
44517212|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
44517213|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44517214|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44517215|NCT03024814|Acetaminophen|acetaminophen|mesh-list
44517216|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517217|NCT03024814|Analgesics|analgesics|mesh-ancestor
44517218|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
44517219|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517220|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517221|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
44517222|NCT03024502|Clotrimazole|clotrimazole|mesh-list
44517223|NCT03024502|Miconazole|miconazole|mesh-list
44517224|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44517225|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517226|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
44517227|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44517228|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44517229|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517230|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517231|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44517232|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
44517233|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517234|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517235|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44517236|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44517237|NCT03024580|Tamoxifen|tamoxifen|mesh-list
44517238|NCT03024580|Letrozole|letrozole|mesh-list
44517239|NCT03024580|Fulvestrant|fulvestrant|mesh-list
44517240|NCT03024580|Anastrozole|anastrozole|mesh-list
44517241|NCT03024580|Exemestane|exemestane|mesh-list
44517242|NCT03024580|Megestrol|megestrol|mesh-list
44517243|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
44517244|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517245|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44517246|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44517247|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517248|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517249|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44517250|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44517251|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517252|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517253|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517254|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44517255|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44517256|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44517257|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44517258|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44517259|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44517260|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44517261|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
44517262|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44517263|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44517264|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44517265|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
44517266|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44517267|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
44517268|NCT03024515|Narcotics|narcotics|mesh-ancestor
44517269|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517270|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517271|NCT03024515|Analgesics|analgesics|mesh-ancestor
44517272|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
44517273|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517274|NCT03024450|Trastuzumab|trastuzumab|mesh-list
44517275|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422062|NCT03905889|Growth Substances|growth substances|mesh-ancestor
44517276|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517277|NCT03024697|Anesthetics|anesthetics|mesh-list
44517278|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
44517279|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517280|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517281|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
44517282|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517283|NCT03024476|Olmesartan|olmesartan|mesh-list
44517284|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44517285|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44517286|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44517287|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517288|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44517289|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44517290|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
44517291|NCT03024216|Atezolizumab|atezolizumab|mesh-list
44517292|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517294|NCT03023982|Bupivacaine|bupivacaine|mesh-list
44517295|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
44517296|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
44517297|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517298|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517299|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
44517300|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517301|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44517302|NCT03023982|Narcotics|narcotics|mesh-ancestor
44517303|NCT03023982|Analgesics|analgesics|mesh-ancestor
44517304|NCT03023852|Oseltamivir|oseltamivir|mesh-list
44517305|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
44517306|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517307|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517308|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517309|NCT03023774|Lenograstim|lenograstim|mesh-list
44517310|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44517311|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
44517312|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517313|NCT03023904|Nivolumab|nivolumab|mesh-list
44517314|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517315|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517316|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44517317|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517318|NCT03023501|Gabapentin|gabapentin|mesh-list
44517319|NCT03023501|Analgesics|analgesics|mesh-ancestor
44517320|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
44517321|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517322|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517323|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
44517324|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44517325|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517326|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517327|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517328|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44517329|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44517330|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517331|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517332|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
44517333|NCT03023436|Cisplatin|cisplatin|mesh-list
44517334|NCT03023436|Fluorouracil|fluorouracil|mesh-list
44517335|NCT03023436|Capecitabine|capecitabine|mesh-list
44517336|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517337|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
44517338|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517339|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44517340|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517341|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
44517342|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517343|NCT03023358|Prednisone|prednisone|mesh-list
44517344|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
44517345|NCT03023358|Doxorubicin|doxorubicin|mesh-list
44517346|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44517347|NCT03023358|Vincristine|vincristine|mesh-list
44517348|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517349|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
44517350|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517351|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517352|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44517353|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
44517361|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517362|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
44517364|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517365|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517366|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517367|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517368|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517369|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517371|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44517372|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517373|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44517374|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517375|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517376|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44517377|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44517378|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
44517379|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517380|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
44517381|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44517382|NCT03022747|Allopurinol|allopurinol|mesh-list
44517383|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
44517384|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517385|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517386|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
44517387|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517388|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44517389|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
44517390|NCT03022747|Protective Agents|protective agents|mesh-ancestor
44517391|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517392|NCT03022565|Vorinostat|vorinostat|mesh-list
44517393|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517394|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44517395|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517396|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517397|NCT03022409|Olaparib|olaparib|mesh-list
44517398|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44517399|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517400|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517401|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517402|NCT03022240|Ondansetron|ondansetron|mesh-list
44517403|NCT03022240|Propofol|propofol|mesh-list
44517404|NCT03022240|Sevoflurane|sevoflurane|mesh-list
44517405|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517406|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517407|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517408|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44517409|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
44517410|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
44517411|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44517412|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44517413|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
44517414|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
44517415|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517416|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517417|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
44517418|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
44517419|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44517420|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
44517421|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517422|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517423|NCT03022240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44517424|NCT03022240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517425|NCT03022240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517426|NCT03022240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44517427|NCT03022201|Domperidone|domperidone|mesh-list
44517428|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
44517429|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
44517430|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517431|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517432|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517433|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44517434|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
44517435|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517436|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517437|NCT03022500|Durvalumab|durvalumab|mesh-list
44517438|NCT03022500|Tremelimumab|tremelimumab|mesh-list
44517439|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517440|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517441|NCT03021772|Dexamethasone|dexamethasone|mesh-list
44517442|NCT03021772|Neostigmine|neostigmine|mesh-list
44517443|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517444|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
44517445|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
44517446|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517447|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517448|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517449|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
44517450|NCT03021772|Hormones|hormones|mesh-ancestor
44517451|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517452|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517453|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517454|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44517455|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517456|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517457|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
44517458|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517459|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44517460|NCT03022123|Prednisone|prednisone|mesh-list
44517461|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
44517462|NCT03022123|Doxorubicin|doxorubicin|mesh-list
44517463|NCT03022123|Vincristine|vincristine|mesh-list
44517464|NCT03022123|Epirubicin|epirubicin|mesh-list
44517465|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517466|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
44517467|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517468|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517469|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44517470|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
44517471|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517472|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517473|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44517474|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44517475|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44517476|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44517477|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517478|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517479|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
44517480|NCT03022123|Hormones|hormones|mesh-ancestor
44517481|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517482|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517483|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517484|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517485|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517486|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517487|NCT03022006|Grazoprevir|grazoprevir|mesh-list
44517488|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
44517489|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517490|NCT03021629|Vitamin D|vitamin d|mesh-list
44517491|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44517492|NCT03021629|Vitamins|vitamins|mesh-ancestor
44517493|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
44517494|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517495|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44517496|NCT03021590|Amoxicillin|amoxicillin|mesh-list
44517497|NCT03021590|Clarithromycin|clarithromycin|mesh-list
44517498|NCT03021590|Levofloxacin|levofloxacin|mesh-list
44517499|NCT03021590|Ofloxacin|ofloxacin|mesh-list
44517500|NCT03021590|Tinidazole|tinidazole|mesh-list
44517501|NCT03021590|Esomeprazole|esomeprazole|mesh-list
44517502|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517503|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517504|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44517505|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517506|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44517507|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517508|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517509|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44517510|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44517511|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44517512|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44517513|NCT03021590|Renal Agents|renal agents|mesh-ancestor
44517514|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44517515|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44517516|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517517|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44517518|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
44517519|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44517520|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44517521|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44517522|NCT03021395|Decitabine|decitabine|mesh-list
44517523|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44517524|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
44517525|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517526|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517527|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517528|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44517529|NCT03021317|Hormones|hormones|mesh-ancestor
44517530|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517531|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517532|NCT03021330|Cytarabine|cytarabine|mesh-list
44517533|NCT03021330|Daunorubicin|daunorubicin|mesh-list
44517534|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44517535|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
44517536|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517537|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517538|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
44517539|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517540|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517541|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
44517542|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517543|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44517544|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44517545|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44517546|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517547|NCT03021421|Bupivacaine|bupivacaine|mesh-list
44517548|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
44517549|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
44517550|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517551|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517552|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
44517553|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517554|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
44517555|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517556|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517557|NCT03020979|Apatinib|apatinib|mesh-list
44517558|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517559|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44517560|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517561|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517562|NCT03020953|Estrogens|estrogens|mesh-list
44517563|NCT03020953|Hormones|hormones|mesh-ancestor
44517564|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517565|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517566|NCT03020940|Cefuroxime|cefuroxime|mesh-list
44517567|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
44517568|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517569|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517570|NCT03020901|Teicoplanin|teicoplanin|mesh-list
44517571|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517572|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517573|NCT03020563|Bupivacaine|bupivacaine|mesh-list
44517574|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
44517575|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
44517576|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517577|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517578|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
44517579|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517580|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
44517581|NCT03020706|Analgesics|analgesics|mesh-ancestor
44517582|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
44517583|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517584|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517585|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
44517586|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517587|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44517588|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
44517589|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44517590|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44517591|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517592|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44517593|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
44517594|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44517596|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44517597|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517598|NCT03020368|Analgesics|analgesics|mesh-ancestor
44517599|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
44517600|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517601|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517602|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517603|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517604|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44517605|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517606|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517607|NCT03020134|Ritonavir|ritonavir|mesh-list
44517608|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44517609|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44517610|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
44517611|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517612|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517613|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44517614|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44517615|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
44517616|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517617|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44517618|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44517619|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44517620|NCT03020056|Antioxidants|antioxidants|mesh-list
44517621|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44517622|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517623|NCT03020056|Protective Agents|protective agents|mesh-ancestor
44517624|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517625|NCT03026062|Durvalumab|durvalumab|mesh-list
44517626|NCT03026062|Ipilimumab|ipilimumab|mesh-list
44517627|NCT03026062|Tremelimumab|tremelimumab|mesh-list
44517628|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
44517629|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44517630|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
44517631|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517632|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517633|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
44517634|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517635|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44517636|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517637|NCT03020199|Betamethasone|betamethasone|mesh-list
44517638|NCT03020199|Calcipotriene|calcipotriene|mesh-list
44517639|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44517640|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517641|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
44517642|NCT03020199|Hormones|hormones|mesh-ancestor
44517643|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517644|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517645|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44517646|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
44517647|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
44517648|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
44517649|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
44517650|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44517651|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517652|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44517653|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44517654|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
44517655|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517656|NCT03029780|Nivolumab|nivolumab|mesh-list
44517657|NCT03029780|Ipilimumab|ipilimumab|mesh-list
44517658|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517659|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517660|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44517661|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517662|NCT03029234|Dexamethasone|dexamethasone|mesh-list
44517664|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
44517665|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
44517666|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926019|NCT00604019|Dopamine|dopamine|mesh-list
44517667|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517668|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517669|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
44517670|NCT03029234|Hormones|hormones|mesh-ancestor
44517671|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517672|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517673|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517674|NCT03020602|Ubiquinone|ubiquinone|mesh-list
44517675|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
44517676|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
44517677|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517678|NCT03020602|Vitamins|vitamins|mesh-ancestor
44517679|NCT03020589|Tacrolimus|tacrolimus|mesh-list
44517680|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44517681|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
44517682|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517683|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44517684|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517685|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517686|NCT03029611|Paclitaxel|paclitaxel|mesh-list
44517687|NCT03029611|Carboplatin|carboplatin|mesh-list
44517688|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44517689|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517690|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517691|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517692|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517693|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517694|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517695|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
44517696|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44517697|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
44517698|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44517699|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517700|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44517701|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44517702|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44338376|NCT01014416|Tolvaptan|tolvaptan|mesh-list
44517717|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
44517718|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
44517719|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
44517720|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44517721|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44517722|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44517723|NCT03025594|Analgesics|analgesics|mesh-ancestor
44517724|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
44517725|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338450|NCT01014637|Miconazole|miconazole|mesh-list
44517726|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517727|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44517728|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517729|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
44517730|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
44517731|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517732|NCT04270175|Dexamethasone|dexamethasone|mesh-list
44517733|NCT04270175|Daratumumab|daratumumab|mesh-list
44517734|NCT04270175|Pomalidomide|pomalidomide|mesh-list
44517735|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44517736|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
44517737|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
44517738|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517739|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517740|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517741|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
44517742|NCT04270175|Hormones|hormones|mesh-ancestor
44517743|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517744|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44517745|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517746|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
44517747|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44517748|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44517749|NCT04270175|Growth Substances|growth substances|mesh-ancestor
44517750|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
44517751|NCT04278573|Vitamin D|vitamin d|mesh-list
44517752|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
44517753|NCT04278573|Vitamins|vitamins|mesh-ancestor
44517754|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
44517755|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626364|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44517756|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44517757|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44517759|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
44517760|NCT04278053|Vitamins|vitamins|mesh-ancestor
44517761|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
44517762|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517763|NCT04279938|Rituximab|rituximab|mesh-list
44517764|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
44517765|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517766|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517767|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
44517768|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517769|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44517770|NCT04279379|Decitabine|decitabine|mesh-list
44517771|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44517772|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
44517773|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517774|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517775|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517776|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
44517777|NCT04278950|Povidone|povidone|mesh-list
44517778|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
44517779|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
44517780|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44517781|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517782|NCT04278859|Antibodies|antibodies|mesh-list
44517783|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44517784|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
44517785|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517786|NCT04278703|Oxycodone|oxycodone|mesh-list
44517787|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44517788|NCT04278703|Narcotics|narcotics|mesh-ancestor
44422526|NCT03462459|Vancomycin|vancomycin|mesh-list
44517789|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517790|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517791|NCT04278703|Analgesics|analgesics|mesh-ancestor
44517792|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
44517793|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517794|NCT04278807|Anesthetics|anesthetics|mesh-list
44517795|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517796|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517797|NCT04278677|Melatonin|melatonin|mesh-list
44517798|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
44517799|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517800|NCT04278677|Protective Agents|protective agents|mesh-ancestor
44517801|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517802|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517804|NCT04278599|Trace Elements|trace elements|mesh-ancestor
44517805|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
44517806|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517807|NCT04278937|Azithromycin|azithromycin|mesh-list
44517808|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517809|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517810|NCT04278378|Folic Acid|folic acid|mesh-list
44517811|NCT04278378|Riboflavin|riboflavin|mesh-list
44517812|NCT04278378|Hematinics|hematinics|mesh-ancestor
44517813|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
44517814|NCT04278378|Vitamins|vitamins|mesh-ancestor
44517815|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
44517816|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517817|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44517818|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
44517819|NCT04278287|Paclitaxel|paclitaxel|mesh-list
44517820|NCT04278287|Cisplatin|cisplatin|mesh-list
44517821|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44517822|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517823|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517824|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517825|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517826|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517827|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517828|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44517829|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
44517830|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517831|NCT04278495|Losartan|losartan|mesh-list
44517832|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44517833|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43926175|NCT00608062|Estradiol|estradiol|mesh-list
44517834|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44517835|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44517836|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517837|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
44517838|NCT04278547|Valganciclovir|valganciclovir|mesh-list
44517839|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
44517840|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517841|NCT04277702|Montelukast|montelukast|mesh-list
44517842|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44517843|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44517844|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44517845|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
44422586|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
44517846|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44517847|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517848|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44517849|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44517850|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517851|NCT04277923|SMOFlipid|smoflipid|mesh-list
44517852|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44517853|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44517854|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44517855|NCT04277143|Daptomycin|daptomycin|mesh-list
44517856|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517857|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517858|NCT04276688|Interferons|interferons|mesh-list
44517859|NCT04276688|Ritonavir|ritonavir|mesh-list
44517860|NCT04276688|Ribavirin|ribavirin|mesh-list
44517861|NCT04276688|Lopinavir|lopinavir|mesh-list
44517862|NCT04276688|Interferon-beta|interferon-beta|mesh-list
44517863|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
44517864|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517865|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
44517866|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517867|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44517868|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44517869|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44517870|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517871|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517872|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44517873|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44517874|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44517875|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44517876|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
44517877|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
44517878|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517879|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44517880|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
44517881|NCT04276649|Antacids|antacids|mesh-ancestor
44517882|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517883|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517884|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
44517885|NCT04276636|Antacids|antacids|mesh-ancestor
44517886|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517887|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44517888|NCT04276389|Paclitaxel|paclitaxel|mesh-list
44517889|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44517890|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44517891|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517892|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44517893|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44517894|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44517895|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517896|NCT04276480|Tazobactam|tazobactam|mesh-list
44422694|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422695|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422696|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
44422697|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422698|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422699|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422700|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
44422701|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422702|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44422703|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44422704|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44422705|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422706|NCT03052725|Reslizumab|reslizumab|mesh-list
44517897|NCT04276480|Piperacillin|piperacillin|mesh-list
44517898|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44517899|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44517900|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517901|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44517902|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517903|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517904|NCT04276428|Insulin|insulin|mesh-list
44517905|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44517906|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517907|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
44517908|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44517909|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517911|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44517912|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517913|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517914|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517915|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44517916|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517917|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517918|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44517919|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
44517920|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
44517921|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
44517922|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
44517923|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517924|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517925|NCT04275960|Selitrectinib|selitrectinib|mesh-list
44517926|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517927|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517928|NCT04275414|Bevacizumab|bevacizumab|mesh-list
44517929|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44517930|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517931|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44517932|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44517933|NCT04275414|Growth Substances|growth substances|mesh-ancestor
44517934|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517935|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
44517936|NCT04275388|Interferons|interferons|mesh-list
44517937|NCT04275388|Ritonavir|ritonavir|mesh-list
44517938|NCT04275388|Lopinavir|lopinavir|mesh-list
44517939|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
44517940|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44517941|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44517942|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
44517943|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44517944|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44517945|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44517946|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44517947|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44517948|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517949|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44517950|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44517951|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44517952|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44517953|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
44517954|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517955|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44517956|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
44517957|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517958|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
44517959|NCT04275258|Narcotics|narcotics|mesh-ancestor
44517960|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517961|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517962|NCT04275258|Analgesics|analgesics|mesh-ancestor
44517963|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
44517964|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44517965|NCT04275492|Pramipexole|pramipexole|mesh-list
44517966|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
44517967|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517968|NCT04275492|Protective Agents|protective agents|mesh-ancestor
44517969|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517970|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44517971|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44517972|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
44517973|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
44422735|NCT03003962|Paclitaxel|paclitaxel|mesh-list
44517974|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517975|NCT04275115|Midazolam|midazolam|mesh-list
44517976|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44517977|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44517978|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44517979|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44517980|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44517981|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44517982|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44517984|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
44517985|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
44517986|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
44517987|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
44517988|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44517989|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44517990|NCT04275180|Argatroban|argatroban|mesh-list
44517991|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
44518008|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44518009|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518010|NCT04275024|Calcipotriene|calcipotriene|mesh-list
44518011|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518012|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
44518014|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518015|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518016|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
44518017|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44518018|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44518019|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44518020|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518021|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518022|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518023|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518024|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518025|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44518026|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518027|NCT04274816|Tremelimumab|tremelimumab|mesh-list
44518028|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518029|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44518030|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44518031|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44518032|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44518033|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44518034|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
44518035|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518036|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
44518037|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518038|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518039|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518041|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518042|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518043|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
44518044|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518045|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518046|NCT04273763|Interferons|interferons|mesh-list
44518047|NCT04273763|Bromhexine|bromhexine|mesh-list
44518048|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518049|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
44518050|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518051|NCT04273763|Expectorants|expectorants|mesh-ancestor
44518052|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518053|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
44518054|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44518055|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44518056|NCT04273321|Prednisolone|prednisolone|mesh-list
44518057|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
44518058|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44518059|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
44518060|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518061|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
44518062|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
44518063|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518064|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518065|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518066|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
44518067|NCT04273321|Hormones|hormones|mesh-ancestor
44518068|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518069|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44518070|NCT04273321|Protective Agents|protective agents|mesh-ancestor
44518071|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44518072|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518073|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
44518074|NCT04273282|Dexamethasone|dexamethasone|mesh-list
44518075|NCT04273282|Prednisolone|prednisolone|mesh-list
44518077|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
44518078|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44518079|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
44518080|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44518081|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
44518082|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518083|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
44518084|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
44518085|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518086|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518087|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518088|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
44518089|NCT04273282|Hormones|hormones|mesh-ancestor
44518090|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518091|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44518092|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518093|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44518094|NCT04273282|Protective Agents|protective agents|mesh-ancestor
44518095|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44518096|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518097|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44518098|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44518099|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518100|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518101|NCT04273191|Brexanolone|brexanolone|mesh-list
44518102|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
44518103|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518104|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518105|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518107|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
44518108|NCT04273100|Lenvatinib|lenvatinib|mesh-list
44518109|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518110|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44518111|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518112|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518113|NCT04273035|Midazolam|midazolam|mesh-list
44518114|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44518115|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44518116|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518117|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518118|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44518119|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44518120|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44518121|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44518122|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
44518123|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
44518124|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
44518125|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
44518126|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518127|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518128|NCT04272788|Infliximab|infliximab|mesh-list
44518129|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518130|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518131|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518132|NCT04272645|Atezolizumab|atezolizumab|mesh-list
44518133|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518134|NCT04272567|Norepinephrine|norepinephrine|mesh-list
44518135|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44518136|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44518137|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518138|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518139|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518140|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518141|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
44518142|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
44518143|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518144|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44518145|NCT04272476|Fluoxetine|fluoxetine|mesh-list
44518146|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44518147|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44518148|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518149|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518150|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518151|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
44518152|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518153|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44518154|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
44518155|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44518156|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44518157|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44518158|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518159|NCT04272372|Ketoprofen|ketoprofen|mesh-list
44518160|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44518161|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518162|NCT04272372|Analgesics|analgesics|mesh-ancestor
44518163|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
44518164|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518165|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518166|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518167|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518168|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44518169|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518170|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518171|NCT04272255|Scopolamine|scopolamine|mesh-list
44518172|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44518173|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44518174|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
44518175|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
44518176|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518177|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518178|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518180|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44518181|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518182|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518183|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518184|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44518185|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
44518186|NCT04271839|Fluticasone|fluticasone|mesh-list
44518187|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
44518188|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518189|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44518190|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
44518191|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518192|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518193|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518194|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518195|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518196|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44518197|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44518198|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44518199|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44518200|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518201|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518202|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518203|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
44518204|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518205|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518206|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44518207|NCT04270994|Misoprostol|misoprostol|mesh-list
44518208|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44518209|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
44518210|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44518211|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518212|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44518213|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518214|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
44518215|NCT04271384|Nivolumab|nivolumab|mesh-list
44518216|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518217|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518218|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44518219|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518220|NCT04270864|Nivolumab|nivolumab|mesh-list
44518221|NCT04270864|Ipilimumab|ipilimumab|mesh-list
44518222|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518223|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518224|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44518225|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518226|NCT04270929|Folfirinox|folfirinox|mesh-list
44518227|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518228|NCT04270656|Insulin|insulin|mesh-list
44518229|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44518230|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518231|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
44518232|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44518233|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518234|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518235|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518236|NCT04270708|Analgesics|analgesics|mesh-ancestor
44518237|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
44518238|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518239|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44518240|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44518241|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44422969|NCT02775435|Paclitaxel|paclitaxel|mesh-list
44518242|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518243|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518244|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518245|NCT04270487|Octylonium|octylonium|mesh-list
44518246|NCT04270487|Bromides|bromides|mesh-list
44518247|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
44518248|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44518249|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518250|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518251|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44518252|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518253|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518254|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
44518255|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
44518256|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518257|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44518258|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44518259|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518260|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518261|NCT04270370|Atorvastatin|atorvastatin|mesh-list
44518262|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44518263|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44518264|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
44518265|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518266|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44518267|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44518268|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518269|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
44518270|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518271|NCT04270344|Valsartan|valsartan|mesh-list
44518272|NCT04270344|Pitavastatin|pitavastatin|mesh-list
44518273|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44518274|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44518275|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44518276|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518290|NCT04270019|Laxatives|laxatives|mesh-ancestor
44518291|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518292|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
44518293|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44518294|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44518295|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518296|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
44518297|NCT04272606|Coagulants|coagulants|mesh-ancestor
44518298|NCT04275999|Ivermectin|ivermectin|mesh-list
44518299|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44518300|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518301|NCT04271202|Erenumab|erenumab|mesh-list
44518302|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44518303|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518304|NCT04271202|Analgesics|analgesics|mesh-ancestor
44518305|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
44518306|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518307|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518308|NCT04270747|Aflibercept|aflibercept|mesh-list
44518309|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44518310|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44518311|NCT04270747|Growth Substances|growth substances|mesh-ancestor
44518312|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518313|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44518314|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518315|NCT04276493|Docetaxel|docetaxel|mesh-list
44518316|NCT04276493|Capecitabine|capecitabine|mesh-list
44518317|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
44518318|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518319|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44518320|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44518321|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44518322|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518323|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44518324|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
44518325|NCT04279197|Ascorbic Acid|ascorbic acid|mesh-list
44518326|NCT04279197|Vitamins|vitamins|mesh-ancestor
44518327|NCT04279197|Micronutrients|micronutrients|mesh-ancestor
44518328|NCT04279197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518329|NCT04279197|Antioxidants|antioxidants|mesh-ancestor
44518330|NCT04279197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518331|NCT04279197|Protective Agents|protective agents|mesh-ancestor
44518332|NCT04278781|Ivosidenib|ivosidenib|mesh-list
44518333|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518334|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518335|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518336|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
44518337|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44518338|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44518339|NCT04270669|Growth Substances|growth substances|mesh-ancestor
44518340|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518341|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44518342|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518343|NCT04274426|Gemcitabine|gemcitabine|mesh-list
44518344|NCT04274426|Paclitaxel|paclitaxel|mesh-list
44518345|NCT04274426|Maytansine|maytansine|mesh-list
44518346|NCT04274426|Carboplatin|carboplatin|mesh-list
44518347|NCT04274426|Doxorubicin|doxorubicin|mesh-list
44518348|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44518349|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44518350|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518351|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
44518352|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
44518353|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
44518354|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518355|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44518356|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
44518357|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
44518358|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518359|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518360|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44518361|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
44518362|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518363|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44518364|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44518365|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44518366|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
44518367|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44518368|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44518369|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44518370|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518371|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518372|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518373|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518374|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518375|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44518376|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518377|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
44518378|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44518379|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518380|NCT04272320|Bupivacaine|bupivacaine|mesh-list
44518381|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518382|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
44518383|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518384|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518385|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
44518386|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518388|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518389|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44518390|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518391|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518392|NCT04273737|Amantadine|amantadine|mesh-list
44518393|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44518394|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44518395|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
44518396|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518397|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
44518398|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518399|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518400|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518401|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518402|NCT04273737|Analgesics|analgesics|mesh-ancestor
44518403|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
44518404|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518405|NCT04278846|Bupivacaine|bupivacaine|mesh-list
44518406|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518407|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
44518408|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423118|NCT02412306|Blinatumomab|blinatumomab|mesh-list
44518409|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518410|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
44518411|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518412|NCT04278872|SJX-653|sjx-653|mesh-list
44518413|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
44518414|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518415|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518416|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
44518417|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518418|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518419|NCT03830164|Vitamins|vitamins|mesh-list
44518420|NCT03830164|Vitamin E|vitamin e|mesh-list
44518421|NCT03830164|Tocopherols|tocopherols|mesh-list
44518422|NCT03830164|Tocotrienols|tocotrienols|mesh-list
44518423|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
44518424|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
44518425|NCT03830164|Atorvastatin|atorvastatin|mesh-list
44518426|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
44518427|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518428|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44518429|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44518430|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
44518431|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518432|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44518433|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44518434|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518435|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
44518436|NCT03830164|Protective Agents|protective agents|mesh-ancestor
44518437|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44518438|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44518439|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44518440|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518441|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44518442|NCT03836651|Antioxidants|antioxidants|mesh-list
44518443|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518444|NCT03836651|Protective Agents|protective agents|mesh-ancestor
44518445|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518446|NCT03837626|Amiloride|amiloride|mesh-list
44518447|NCT03837626|Diuretics|diuretics|mesh-ancestor
44518448|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
44518449|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518450|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44518451|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44518452|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518453|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518454|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44518455|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44518456|NCT03837808|Cisplatin|cisplatin|mesh-list
44518457|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
44518458|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518459|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518460|NCT03838367|Leronlimab|leronlimab|mesh-list
44518461|NCT03838367|Carboplatin|carboplatin|mesh-list
44518463|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518464|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44518465|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44518466|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518467|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44518468|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44518469|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
44518470|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518471|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
44518472|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518473|NCT03831334|Minoxidil|minoxidil|mesh-list
44518474|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44518475|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518476|NCT03831113|Buprenorphine|buprenorphine|mesh-list
44518477|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44518478|NCT03831113|Narcotics|narcotics|mesh-ancestor
44518479|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518480|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518490|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
44518491|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
44518492|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518493|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518494|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518495|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
44518496|NCT03834506|Hormones|hormones|mesh-ancestor
44518497|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518498|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44518499|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518500|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
44518501|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
44518502|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
44518503|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518504|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518505|NCT03832010|Triamcinolone|triamcinolone|mesh-list
44518506|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
44518507|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518508|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
44518509|NCT03832010|Hormones|hormones|mesh-ancestor
44518510|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518511|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518512|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
44518513|NCT03831711|Bombesin|bombesin|mesh-list
44518514|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518515|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518516|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518517|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518518|NCT03837015|Estradiol|estradiol|mesh-list
44518519|NCT03837015|Estrogens|estrogens|mesh-ancestor
44518520|NCT03837015|Hormones|hormones|mesh-ancestor
44518521|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518522|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518523|NCT03832127|Fludarabine|fludarabine|mesh-list
44518524|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518525|NCT03835013|Exenatide|exenatide|mesh-list
44518526|NCT03835013|Glucagon|glucagon|mesh-list
44518527|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44518528|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44518529|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518530|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44518531|NCT03835013|Incretins|incretins|mesh-ancestor
44518532|NCT03835013|Hormones|hormones|mesh-ancestor
44518533|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518534|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518535|NCT03830866|Cisplatin|cisplatin|mesh-list
44518536|NCT03830866|Carboplatin|carboplatin|mesh-list
44518537|NCT03830866|Durvalumab|durvalumab|mesh-list
44518538|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423234|NCT02049866|Denosumab|denosumab|mesh-list
44518539|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518540|NCT03831503|Antibodies|antibodies|mesh-list
44518541|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
44518542|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518543|NCT03839888|Atropine|atropine|mesh-list
44518544|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44518545|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44518546|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44518547|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
44518548|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518549|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518550|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518551|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518552|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
44518553|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
44518554|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44518555|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44518556|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518557|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518558|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518559|NCT03839771|Ivosidenib|ivosidenib|mesh-list
44518560|NCT03839771|Glycine|glycine|mesh-list
44518561|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518562|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518563|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518564|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
44518565|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518566|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518567|NCT03839550|Apatinib|apatinib|mesh-list
44518568|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518569|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44518570|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518571|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518572|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
44518573|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
44518574|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44518575|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
44518576|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518577|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518578|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518579|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518580|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44518581|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
44518582|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518583|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518584|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44518585|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518586|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
44518587|NCT03839537|Protective Agents|protective agents|mesh-ancestor
44518588|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
44518589|NCT03839498|Axitinib|axitinib|mesh-list
44518590|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423297|NCT01582191|Everolimus|everolimus|mesh-list
44518591|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44518592|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518593|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518594|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44518595|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44518596|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518597|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
44518598|NCT03839251|Aripiprazole|aripiprazole|mesh-list
44518599|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
44518600|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44518601|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44518602|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44518603|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518604|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518605|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
44518606|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
44518607|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518608|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518609|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44518610|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44518611|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
44518612|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44518613|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44518614|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44518615|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44518616|NCT03839160|Morphine|morphine|mesh-list
44518617|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44518618|NCT03839160|Narcotics|narcotics|mesh-ancestor
44518619|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518620|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518621|NCT03839160|Analgesics|analgesics|mesh-ancestor
44518622|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
44518623|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518624|NCT03839134|Lidocaine|lidocaine|mesh-list
44518625|NCT03839134|Epinephrine|epinephrine|mesh-list
44518626|NCT03839134|Racepinephrine|racepinephrine|mesh-list
44518627|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
44518628|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518629|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
44518630|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518631|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518632|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
44518633|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518634|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44518635|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44518636|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44518637|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518638|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518639|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44518640|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44518641|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518642|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518643|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44518644|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44518645|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
44518646|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518647|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518648|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
44518649|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
44518650|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44518651|NCT03839433|Ciclesonide|ciclesonide|mesh-list
44518652|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
44518653|NCT03839433|Hormones|hormones|mesh-ancestor
44518654|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518655|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518656|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44518657|NCT03838926|Trichostatin A|trichostatin a|mesh-list
44518658|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
44518659|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518660|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44518661|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518662|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518663|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44518664|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44518665|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
44518666|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518667|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
44518668|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44518669|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44518670|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518671|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
44518672|NCT03838328|Coagulants|coagulants|mesh-ancestor
44518673|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
44518674|NCT03837886|Calcium|calcium|mesh-list
44518675|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44518676|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518677|NCT03837886|Antacids|antacids|mesh-ancestor
44518678|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518679|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518680|NCT03838133|Bupivacaine|bupivacaine|mesh-list
44518681|NCT03838133|Ropivacaine|ropivacaine|mesh-list
44518682|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518683|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
44518684|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518685|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518686|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
44518687|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518688|NCT03837938|Dipropizine|dipropizine|mesh-list
44518689|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
44518690|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518691|NCT03836807|Ketoprofen|ketoprofen|mesh-list
44518692|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
44518693|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44518694|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518695|NCT03836807|Analgesics|analgesics|mesh-ancestor
44518696|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
43626451|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518697|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518698|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518699|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518700|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518701|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44518702|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518703|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518705|NCT03836703|Trace Elements|trace elements|mesh-ancestor
44518706|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
44518707|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518708|NCT03836885|Apremilast|apremilast|mesh-list
44518709|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44518710|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518711|NCT03836885|Analgesics|analgesics|mesh-ancestor
44518712|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
44518713|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518714|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518715|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518716|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518717|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44518718|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44518719|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518720|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518721|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
44518722|NCT03836781|Ketorolac|ketorolac|mesh-list
44518723|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44518724|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518725|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
44518726|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44518727|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518728|NCT03836781|Analgesics|analgesics|mesh-ancestor
44518729|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
44518730|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518731|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518732|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518733|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518734|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44518735|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518736|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518737|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
44518738|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44518739|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518740|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518741|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518742|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518743|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518744|NCT03836599|Allopurinol|allopurinol|mesh-list
44518745|NCT03836599|Verinurad|verinurad|mesh-list
44518746|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
44518747|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518748|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518749|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
44518750|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518751|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44518752|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
44518753|NCT03836599|Protective Agents|protective agents|mesh-ancestor
44518754|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518755|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
44518756|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44518757|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518758|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518759|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44518760|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44518761|NCT03836222|Protective Agents|protective agents|mesh-ancestor
44518762|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518763|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518764|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44518765|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
44518766|NCT03836157|Bevacizumab|bevacizumab|mesh-list
44518767|NCT03836157|Maytansine|maytansine|mesh-list
44518768|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518769|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518770|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44518771|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44518772|NCT03836157|Growth Substances|growth substances|mesh-ancestor
44518773|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518774|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
44518775|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44518776|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
44518777|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44518778|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44518779|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518781|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44518782|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518783|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44518784|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518785|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44518786|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
44518787|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
44518788|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518789|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518798|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
44518799|NCT03835507|Hematinics|hematinics|mesh-ancestor
44518800|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
44518801|NCT03835286|Vitamins|vitamins|mesh-ancestor
44518802|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
44518803|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518804|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
44518805|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518806|NCT03835286|Protective Agents|protective agents|mesh-ancestor
44518807|NCT03834766|Amphetamine|amphetamine|mesh-list
44518808|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44518809|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518810|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
44518811|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
44518812|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518813|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
44518814|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518815|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518816|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518817|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44518818|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44518819|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518820|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44518821|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
44518822|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44518823|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518824|NCT03834935|Analgesics|analgesics|mesh-ancestor
44518825|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
44518826|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518827|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518828|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518829|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44518830|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518831|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44518832|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
44518833|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44518834|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518835|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518836|NCT03834610|Tadalafil|tadalafil|mesh-list
44518837|NCT03834610|Testosterone|testosterone|mesh-list
44518838|NCT03834610|Androgens|androgens|mesh-ancestor
44518839|NCT03834610|Hormones|hormones|mesh-ancestor
44518840|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518841|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518842|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
44518843|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44518844|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44518845|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518846|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518847|NCT03834610|Urological Agents|urological agents|mesh-ancestor
44518848|NCT03834233|Nivolumab|nivolumab|mesh-list
44518849|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44518850|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518851|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43927113|NCT00625404|Tenofovir|tenofovir|mesh-list
44518852|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518854|NCT03833999|Lactulose|lactulose|mesh-list
44339769|NCT01021735|Analgesics|analgesics|mesh-ancestor
44518856|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
44518857|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518858|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518859|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518860|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
44518861|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
44518862|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44518863|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
44423582|NCT05653024|Albuterol|albuterol|mesh-list
44518864|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518865|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518866|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44518867|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44518868|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518869|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44518870|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44518872|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518873|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
44518874|NCT03834012|Hormones|hormones|mesh-ancestor
44518875|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518876|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518877|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44518878|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518879|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
44518880|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44518881|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518882|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518883|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518884|NCT03834129|Analgesics|analgesics|mesh-ancestor
44518885|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
44518886|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518887|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44518888|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44518889|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44518890|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518891|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518892|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518893|NCT03833895|Phenylephrine|phenylephrine|mesh-list
44518894|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
44518895|NCT03833895|Norepinephrine|norepinephrine|mesh-list
44518896|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44518897|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
44518898|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
44518899|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518900|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518901|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
44518902|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44518903|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
44518904|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
44518905|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44518906|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44518907|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44518908|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
44518909|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518910|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518911|NCT03833895|Protective Agents|protective agents|mesh-ancestor
44518912|NCT03833947|Dexamethasone|dexamethasone|mesh-list
44518913|NCT03833947|Lidocaine|lidocaine|mesh-list
44518914|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44518915|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
44518916|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
44518917|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518918|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518919|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44518920|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
44518921|NCT03833947|Hormones|hormones|mesh-ancestor
44518922|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518923|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44518924|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518925|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44518926|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
43927179|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
44518927|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44518928|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
44518929|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44518930|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44518931|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44518932|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518933|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518934|NCT03833466|Metformin|metformin|mesh-list
44518935|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44518936|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518937|NCT03833362|Interferons|interferons|mesh-list
44518938|NCT03833362|Ritonavir|ritonavir|mesh-list
44518939|NCT03833362|Ribavirin|ribavirin|mesh-list
44518940|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
44518941|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
44518942|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44518943|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44518944|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44518945|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
44518946|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44518947|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44518948|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44518949|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
44518950|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44518951|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518952|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44518953|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44518954|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44518955|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44518956|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
44518957|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
44518958|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518959|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44518960|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44518961|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
44518962|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44518963|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44518964|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44518965|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44518966|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518967|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
44518968|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518969|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518970|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44518971|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518972|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44518973|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44518974|NCT03832894|Estradiol|estradiol|mesh-list
44518975|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44518976|NCT03832894|Progesterone|progesterone|mesh-list
44518977|NCT03832894|Estrogens|estrogens|mesh-ancestor
44518978|NCT03832894|Hormones|hormones|mesh-ancestor
44518979|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44518980|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518981|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44518982|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
44518983|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44518984|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44518985|NCT03832894|Progestins|progestins|mesh-ancestor
44518986|NCT03832816|Dronabinol|dronabinol|mesh-list
44518987|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
44518988|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44518989|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44518990|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44518991|NCT03832816|Analgesics|analgesics|mesh-ancestor
44518992|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
44518993|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44518994|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44518995|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44518996|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44518997|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44518998|NCT03832816|Hormones|hormones|mesh-ancestor
44518999|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519000|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
44519001|NCT03832699|Progesterone|progesterone|mesh-list
44519002|NCT03832699|Progestins|progestins|mesh-ancestor
44339954|NCT01022645|Copper|copper|mesh-list
44519003|NCT03832699|Hormones|hormones|mesh-ancestor
44519004|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519005|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519007|NCT03832465|Ofloxacin|ofloxacin|mesh-list
44519008|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44519009|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44519010|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519011|NCT03832465|Renal Agents|renal agents|mesh-ancestor
44519012|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44519013|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519014|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519015|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519016|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519017|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519018|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44519019|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44519020|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
44519021|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44519022|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44519023|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519024|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519025|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519026|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519027|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519028|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519029|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
44519030|NCT03831984|Bromfenac|bromfenac|mesh-list
44519031|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
44519032|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44519033|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
44519034|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519035|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
44519036|NCT03831984|Protective Agents|protective agents|mesh-ancestor
44519037|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44519038|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519039|NCT03831984|Analgesics|analgesics|mesh-ancestor
44519040|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
44519041|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519042|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519043|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519044|NCT03831815|Rocuronium|rocuronium|mesh-list
44519045|NCT03831815|Cisatracurium|cisatracurium|mesh-list
44519046|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44519047|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44519048|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44519049|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423747|NCT05648058|Analgesics|analgesics|mesh-ancestor
44519050|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519051|NCT03831321|Diclofenac|diclofenac|mesh-list
44519052|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44519053|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519054|NCT03831321|Analgesics|analgesics|mesh-ancestor
44519055|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
44519056|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519057|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519058|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519059|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519060|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44519061|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519062|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519063|NCT03831464|Metformin|metformin|mesh-list
44519064|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519065|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519066|NCT03831126|Betamethasone|betamethasone|mesh-list
44519067|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
44519068|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44519069|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
44519070|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44519071|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
44519072|NCT03831126|Hormones|hormones|mesh-ancestor
44519073|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519074|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519075|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519076|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44519077|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
44519079|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
44519080|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519081|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44519082|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44519083|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519084|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519085|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44519086|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44519087|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44519088|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519089|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519090|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
44519091|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44519092|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44519093|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44519111|NCT03830684|Protective Agents|protective agents|mesh-ancestor
44519112|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519113|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519114|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44519115|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
44519116|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519117|NCT03830606|Paclitaxel|paclitaxel|mesh-list
44519118|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519119|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519120|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519121|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519122|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519123|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519124|NCT03830398|Acetaminophen|acetaminophen|mesh-list
44519125|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519126|NCT03830398|Analgesics|analgesics|mesh-ancestor
44519127|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
44519128|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519129|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519130|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
44519131|NCT03830385|Cisplatin|cisplatin|mesh-list
44519132|NCT03830385|Carboplatin|carboplatin|mesh-list
44519133|NCT03830385|Bleomycin|bleomycin|mesh-list
44519134|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519135|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44519136|NCT03830086|Midazolam|midazolam|mesh-list
44519137|NCT03830086|Sufentanil|sufentanil|mesh-list
44519138|NCT03830086|Bupivacaine|bupivacaine|mesh-list
44519139|NCT03830086|Propofol|propofol|mesh-list
44519140|NCT03830086|Sevoflurane|sevoflurane|mesh-list
44519141|NCT03830086|Rocuronium|rocuronium|mesh-list
44519142|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
44519143|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
44519144|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519145|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519146|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
44519147|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519148|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44519149|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44519151|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44519152|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44519153|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44519154|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519155|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
44519156|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
44519157|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519158|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519159|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44519160|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44519161|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44519162|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44519163|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44519164|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44519165|NCT03830086|Narcotics|narcotics|mesh-ancestor
44519166|NCT03830086|Analgesics|analgesics|mesh-ancestor
44519167|NCT03830216|Insulin|insulin|mesh-list
44519168|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44519169|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44140072|NCT00177567|Lamotrigine|lamotrigine|mesh-list
44519170|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519172|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
44519173|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
44519174|NCT03830034|Trace Elements|trace elements|mesh-ancestor
44519175|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
44519176|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519177|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
44519178|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
44519179|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519180|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
44519181|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519182|NCT03837860|Oxycodone|oxycodone|mesh-list
44519183|NCT03837860|Risperidone|risperidone|mesh-list
44519184|NCT03837860|Ziprasidone|ziprasidone|mesh-list
44519185|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44519186|NCT03837860|Narcotics|narcotics|mesh-ancestor
44519187|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519188|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519189|NCT03837860|Analgesics|analgesics|mesh-ancestor
44519190|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
44519191|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519192|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44519193|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
44519194|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519195|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519196|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44519197|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44519198|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519199|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44519200|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
44519201|NCT03831165|Acyclovir|acyclovir|mesh-list
44519202|NCT03831165|Melatonin|melatonin|mesh-list
44519203|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
44519204|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519205|NCT03831165|Protective Agents|protective agents|mesh-ancestor
44519206|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519207|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519208|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
44519209|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519210|NCT03836014|Dexamethasone|dexamethasone|mesh-list
44519211|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
44519212|NCT03836014|Lenalidomide|lenalidomide|mesh-list
44519213|NCT03836014|Daratumumab|daratumumab|mesh-list
44519214|NCT03836014|BB 1101|bb 1101|mesh-list
44519215|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44519216|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519217|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
44519218|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
44519219|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519220|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519221|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519222|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
44519223|NCT03836014|Hormones|hormones|mesh-ancestor
44519224|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519225|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519226|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519227|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
44519228|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519229|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519230|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
44519231|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519232|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519233|NCT03836014|Growth Substances|growth substances|mesh-ancestor
44519234|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519235|NCT03837873|Cytarabine|cytarabine|mesh-list
44519236|NCT03837873|Dexamethasone|dexamethasone|mesh-list
44519237|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
44519238|NCT03837873|Rituximab|rituximab|mesh-list
44519239|NCT03837873|Cisplatin|cisplatin|mesh-list
44519240|NCT03837873|Doxorubicin|doxorubicin|mesh-list
44519241|NCT03837873|Etoposide|etoposide|mesh-list
44519242|NCT03837873|Vincristine|vincristine|mesh-list
44519243|NCT03837873|Lenalidomide|lenalidomide|mesh-list
44519244|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519245|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
44519246|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519247|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519248|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519249|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
44519250|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519251|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519252|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44519253|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519254|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423932|NCT05237960|Metformin|metformin|mesh-list
44519255|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
44519256|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
44519257|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519258|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519259|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
44519260|NCT03837873|Hormones|hormones|mesh-ancestor
44519261|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519262|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519263|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44519264|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519265|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519266|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519267|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519268|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44519269|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
44519270|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
44519271|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519272|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519273|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519274|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519275|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519276|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519277|NCT03837873|Growth Substances|growth substances|mesh-ancestor
44519278|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519279|NCT03836066|Bevacizumab|bevacizumab|mesh-list
44519280|NCT03836066|Atezolizumab|atezolizumab|mesh-list
44519281|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519282|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519283|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519284|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519285|NCT03836066|Growth Substances|growth substances|mesh-ancestor
44519286|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519287|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519288|NCT03838042|Nivolumab|nivolumab|mesh-list
44519289|NCT03838042|Entinostat|entinostat|mesh-list
44519290|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519291|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519292|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44519293|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519294|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44519295|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519296|NCT03834688|Rituximab|rituximab|mesh-list
44519297|NCT03834688|Venetoclax|venetoclax|mesh-list
44519298|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44519299|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340262|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
44519300|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519301|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
44519302|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519303|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519304|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519305|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
44519306|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519307|NCT03834571|Paclitaxel|paclitaxel|mesh-list
44519308|NCT03834571|Cisplatin|cisplatin|mesh-list
44519309|NCT03834571|Carboplatin|carboplatin|mesh-list
44519310|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44519311|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519312|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519313|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519314|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519315|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44423993|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519316|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340332|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44519317|NCT03836287|Bromides|bromides|mesh-list
44519318|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
44519319|NCT03834753|Bevacizumab|bevacizumab|mesh-list
44519320|NCT03834753|Ranibizumab|ranibizumab|mesh-list
44519321|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519322|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519324|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519325|NCT03834753|Growth Substances|growth substances|mesh-ancestor
44519326|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519327|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519328|NCT03838484|Nicotine|nicotine|mesh-list
44519329|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44519330|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
44519331|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519332|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519333|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44519334|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44519335|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
44519336|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519337|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519338|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
44519339|NCT03838575|Gentamicins|gentamicins|mesh-list
44519340|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
44519341|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44519342|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44519343|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
44519344|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44519345|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519346|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519347|NCT03832660|Valsartan|valsartan|mesh-list
44519348|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44519349|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44519350|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44519351|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44519352|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519353|NCT03838068|Anesthetics|anesthetics|mesh-list
44519354|NCT03838068|Procaine|procaine|mesh-list
44519355|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
44519356|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519357|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519358|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
44519359|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519360|NCT03836560|Nicotine|nicotine|mesh-list
44519361|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44519362|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
44519363|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519364|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519365|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44519366|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44519367|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
44519368|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519369|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519370|NCT03833596|Prednisone|prednisone|mesh-list
44519371|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519372|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
44519373|NCT03833596|Hormones|hormones|mesh-ancestor
44519374|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519375|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519376|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519377|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519378|NCT03831295|Antibodies|antibodies|mesh-list
44519379|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
44519380|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519381|NCT03838094|Calcium|calcium|mesh-list
44519382|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44519383|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519384|NCT03836833|Lamivudine|lamivudine|mesh-list
44519385|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44519386|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44519387|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519388|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519389|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
44519390|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340420|NCT01025466|Memantine|memantine|mesh-list
44519395|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519396|NCT05444569|Incretins|incretins|mesh-ancestor
44519397|NCT05444569|Hormones|hormones|mesh-ancestor
44519398|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519399|NCT05445128|Plerixafor|plerixafor|mesh-list
44519400|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44519401|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44519402|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
44519403|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519404|NCT05444699|Prednisolone|prednisolone|mesh-list
44519405|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44519406|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
44519407|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44519408|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
44519409|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44519410|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
44519411|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519412|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
44519413|NCT05444699|Hormones|hormones|mesh-ancestor
44519414|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519415|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519416|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519417|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519418|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
44519419|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
44519420|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519421|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519422|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44519423|NCT05444699|Protective Agents|protective agents|mesh-ancestor
44519424|NCT05440734|Melatonin|melatonin|mesh-list
44519425|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
44519426|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519427|NCT05440734|Protective Agents|protective agents|mesh-ancestor
44519428|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519429|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519430|NCT05440708|Bevacizumab|bevacizumab|mesh-list
44519431|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
44519432|NCT05440708|Atezolizumab|atezolizumab|mesh-list
44519433|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519434|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519435|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519436|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519437|NCT05440708|Growth Substances|growth substances|mesh-ancestor
44519438|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519439|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519440|NCT05447208|Hormones|hormones|mesh-list
44519441|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519442|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519443|NCT05442983|Probenecid|probenecid|mesh-list
44519444|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
44519445|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
44519446|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519447|NCT05442983|Renal Agents|renal agents|mesh-ancestor
44519448|NCT05444556|Repaglinide|repaglinide|mesh-list
44519449|NCT05444556|Quinidine|quinidine|mesh-list
44519450|NCT05444556|Digoxin|digoxin|mesh-list
44519451|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
44519452|NCT05444556|Omeprazole|omeprazole|mesh-list
44519453|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44519454|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44519455|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44519456|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
44519457|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519458|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44519459|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44519460|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519461|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44519462|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519463|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44519464|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44519465|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44519466|NCT05444556|Protective Agents|protective agents|mesh-ancestor
44519467|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519468|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
44340487|NCT01025882|Gemcitabine|gemcitabine|mesh-list
44519469|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
44519470|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44519471|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44519472|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519473|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519474|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44519475|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44519476|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519477|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
44519478|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44519479|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44519480|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519481|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44519482|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44519483|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44519484|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44519485|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44519486|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44519487|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44519488|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44519489|NCT05442749|Niraparib|niraparib|mesh-list
44519490|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44519491|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519492|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519493|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519494|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
44519495|NCT05442580|Fludarabine|fludarabine|mesh-list
44519496|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519497|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
44519498|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519499|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519500|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519501|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
44519502|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519503|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519504|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44519505|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
44519506|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44519507|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519508|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519509|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519510|NCT05447507|Analgesics|analgesics|mesh-ancestor
44519511|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
44519512|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519513|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44519514|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44519515|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44519516|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519517|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519518|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519519|NCT05445804|Cannabidiol|cannabidiol|mesh-list
44519520|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
44519521|NCT05444101|Nicotine|nicotine|mesh-list
44519522|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44519523|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
44519524|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519525|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519526|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44519527|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44519528|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44519529|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519530|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519531|NCT05448872|Valsartan|valsartan|mesh-list
44519532|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44519533|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44519534|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44519535|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44519536|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519537|NCT05446883|Paclitaxel|paclitaxel|mesh-list
44519538|NCT05446883|Cisplatin|cisplatin|mesh-list
44519539|NCT05446883|Carboplatin|carboplatin|mesh-list
44519540|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519541|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519542|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519543|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519544|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519545|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519546|NCT05440383|Leuprolide|leuprolide|mesh-list
44519547|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44519548|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
44519549|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44519550|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519551|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519552|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519553|NCT05441761|Gemcitabine|gemcitabine|mesh-list
44519554|NCT05441761|Dexamethasone|dexamethasone|mesh-list
44519556|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
44519557|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519558|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
44519559|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
44519560|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519561|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519562|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519563|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
44519565|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519566|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519567|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519568|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44519569|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
44519570|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519571|NCT05441761|Antiviral Agents|antiviral agents|mesh-ancestor
44519572|NCT05441761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519573|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519574|NCT05441761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519575|NCT05441761|Immunologic Factors|immunologic factors|mesh-ancestor
44519576|NCT05441761|Analgesics|analgesics|mesh-ancestor
44519577|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
44519578|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519579|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519580|NCT05441631|Insulin|insulin|mesh-list
44519581|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44519582|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519583|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519584|NCT05440591|Metformin|metformin|mesh-list
44519585|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
44519586|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519587|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519588|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44519589|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519590|NCT05440578|Bevacizumab|bevacizumab|mesh-list
44519591|NCT05440578|Olaparib|olaparib|mesh-list
44519592|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519593|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519594|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519595|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519596|NCT05440578|Growth Substances|growth substances|mesh-ancestor
44519597|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519598|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519599|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44519600|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519601|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519602|NCT05445856|Fentanyl|fentanyl|mesh-list
44519603|NCT05445856|Methadone|methadone|mesh-list
44519604|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44519605|NCT05445856|Narcotics|narcotics|mesh-ancestor
44519606|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519607|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519608|NCT05445856|Analgesics|analgesics|mesh-ancestor
44519609|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
44519610|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519611|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44519612|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44519613|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
44519614|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
44519615|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
44519616|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
44519617|NCT05445232|Midazolam|midazolam|mesh-list
44519618|NCT05445232|Caffeine|caffeine|mesh-list
44519619|NCT05445232|Warfarin|warfarin|mesh-list
44519620|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44519621|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44519622|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519623|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519624|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44519625|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44519626|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519627|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44519628|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
44340715|NCT01026714|Analgesics|analgesics|mesh-ancestor
44519630|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
44519631|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
44519632|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519633|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519634|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
44519635|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44519636|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44519637|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519638|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44519639|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44519640|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
44519641|NCT05444153|Empagliflozin|empagliflozin|mesh-list
44519642|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44519643|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519644|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519645|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519646|NCT05442268|Acetaminophen|acetaminophen|mesh-list
44519647|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44519648|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519649|NCT05442268|Analgesics|analgesics|mesh-ancestor
44519650|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
44519651|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519652|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519653|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
44519654|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44519655|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44519656|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44519657|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519658|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519659|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44519660|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519661|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
44519662|NCT05446142|Rabeprazole|rabeprazole|mesh-list
44519663|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44519664|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519665|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44519666|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519667|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519668|NCT05442463|Angiotensin II|angiotensin ii|mesh-list
44519669|NCT05442463|Giapreza|giapreza|mesh-list
44519670|NCT05442463|Angiotensinogen|angiotensinogen|mesh-list
44519671|NCT05442463|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44519672|NCT05442463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44519673|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44519674|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519675|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519676|NCT01054248|Artesunate|artesunate|mesh-list
44519677|NCT01054248|Piperaquine|piperaquine|mesh-list
44519678|NCT01054248|Artenimol|artenimol|mesh-list
44519679|NCT01054248|Mefloquine|mefloquine|mesh-list
44519680|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
44519681|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44519682|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44519683|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519684|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519685|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
44519686|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
44519687|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44519688|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
44519689|NCT01050855|Busulfan|busulfan|mesh-list
44519690|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
44519691|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
44519692|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519693|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519694|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
44519695|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519696|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519697|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519698|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927879|NCT00642694|Citalopram|citalopram|mesh-list
44519699|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519700|NCT01059188|Cisplatin|cisplatin|mesh-list
44519701|NCT01059188|Docetaxel|docetaxel|mesh-list
44519702|NCT01059188|Cetuximab|cetuximab|mesh-list
44519703|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519704|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519712|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519713|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519714|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44519715|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
44519716|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
44519717|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44519718|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44519719|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44519720|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44519721|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519722|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519723|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519724|NCT01059903|Rotigotine|rotigotine|mesh-list
44519725|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
44519726|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
44519727|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519728|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519729|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519730|NCT01059825|Metformin|metformin|mesh-list
44519731|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44519732|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
44519733|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44519734|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519735|NCT01059825|Incretins|incretins|mesh-ancestor
44519736|NCT01059825|Hormones|hormones|mesh-ancestor
44519737|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519738|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44519739|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
44519740|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519741|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519742|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44519743|NCT01059773|Methotrexate|methotrexate|mesh-list
44519744|NCT01059773|Ustekinumab|ustekinumab|mesh-list
44519745|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44519746|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
44519747|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44519748|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519749|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44519750|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
44519751|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519752|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519753|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
44519754|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519755|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44519756|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519757|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
44519758|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519759|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44519760|NCT01059617|Vaccines|vaccines|mesh-list
44519761|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
44519762|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519763|NCT01059526|Ecallantide|ecallantide|mesh-list
44519764|NCT01059526|Analgesics|analgesics|mesh-ancestor
44519765|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
44424455|NCT04219540|Analgesics|analgesics|mesh-ancestor
44519766|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519767|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519768|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44519769|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44519770|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519771|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519772|NCT01059318|Everolimus|everolimus|mesh-list
44519773|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519774|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519775|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
44519776|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519777|NCT01059071|Eflornithine|eflornithine|mesh-list
44519778|NCT01059071|Etoposide|etoposide|mesh-list
44519779|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519780|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519781|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44519782|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44519783|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519784|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519785|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44519787|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44519788|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519789|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44519790|NCT01058863|Albuterol|albuterol|mesh-list
44519791|NCT01058863|Procaterol|procaterol|mesh-list
44519792|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44519793|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
44519794|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519795|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519796|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44519797|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
44519798|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
44519799|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44519800|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44519801|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44519802|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44519803|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519804|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519805|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519806|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
44340951|NCT01028170|Furosemide|furosemide|mesh-list
44519807|NCT01058655|Everolimus|everolimus|mesh-list
44519808|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519809|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519810|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
44519811|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519812|NCT01058642|Pregabalin|pregabalin|mesh-list
44519813|NCT01058642|Analgesics|analgesics|mesh-ancestor
44519814|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
44519815|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519816|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519817|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
44519818|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44519819|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44519820|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519821|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44519822|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44519823|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44519824|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519825|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44519826|NCT01058395|Minocycline|minocycline|mesh-list
44519827|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44519828|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519829|NCT01058369|Deferasirox|deferasirox|mesh-list
44519830|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44519831|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
44519832|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
44519833|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519834|NCT01058005|Interferons|interferons|mesh-list
44519835|NCT01058005|Interferon-beta|interferon-beta|mesh-list
44519836|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
44519837|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
44519838|NCT01058005|Natalizumab|natalizumab|mesh-list
44519839|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
44519840|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519841|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
44519842|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519843|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
44519844|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519845|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44519846|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519847|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519848|NCT01057433|Ritonavir|ritonavir|mesh-list
44519849|NCT01057433|Lopinavir|lopinavir|mesh-list
44519850|NCT01057433|Pitavastatin|pitavastatin|mesh-list
44519851|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44519852|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44519853|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
44519854|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519855|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519856|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44519857|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44519858|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
44519859|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519860|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44519861|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44519862|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44519863|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44519864|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44519865|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
44519866|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44519867|NCT01057251|Nebivolol|nebivolol|mesh-list
44519868|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44519869|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
44519870|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44519871|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44519872|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44519873|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44519874|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519875|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519876|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519877|NCT01056523|Cytarabine|cytarabine|mesh-list
44341027|NCT01028482|Sertraline|sertraline|mesh-list
44519878|NCT01056523|Ribavirin|ribavirin|mesh-list
44519879|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44519880|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
44519881|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519882|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519883|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
44519884|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519885|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519886|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
44519887|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519888|NCT01056510|Rituximab|rituximab|mesh-list
44519889|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44519890|NCT01056510|Chlorambucil|chlorambucil|mesh-list
44519891|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519892|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519893|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
44519894|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519895|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519896|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519897|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
44519898|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519899|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
44519900|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44519901|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519902|NCT01056276|Dexamethasone|dexamethasone|mesh-list
44519903|NCT01056276|Bortezomib|bortezomib|mesh-list
44519904|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44519905|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44519906|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
44519907|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
44519908|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519909|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519910|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44519911|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
44519912|NCT01056276|Hormones|hormones|mesh-ancestor
44519913|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44519914|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44519915|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519916|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519917|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
44519918|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519919|NCT01055886|Nicotine|nicotine|mesh-list
44519920|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44519921|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
44519922|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519923|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519924|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44519925|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44519926|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44424597|NCT03836105|Cemiplimab|cemiplimab|mesh-list
44519927|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519928|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519929|NCT01055834|Eszopiclone|eszopiclone|mesh-list
44519930|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44519931|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44519932|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519933|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44519934|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44519935|NCT01055314|Dactinomycin|dactinomycin|mesh-list
44519936|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
44519937|NCT01055314|Temozolomide|temozolomide|mesh-list
44519938|NCT01055314|Ifosfamide|ifosfamide|mesh-list
44519939|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
44519940|NCT01055314|Doxorubicin|doxorubicin|mesh-list
44519941|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44519942|NCT01055314|Irinotecan|irinotecan|mesh-list
44519943|NCT01055314|Etoposide|etoposide|mesh-list
44519944|NCT01055314|Vincristine|vincristine|mesh-list
44519945|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
44519946|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
44519947|NCT01055314|Camptothecin|camptothecin|mesh-list
44519948|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44519949|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44519950|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
44519951|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519952|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44519953|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44519954|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
44519955|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519956|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519957|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44519958|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44341097|NCT01028729|Cisplatin|cisplatin|mesh-list
44519966|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519967|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
44519968|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
44519969|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44519970|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44519971|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44519972|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44519973|NCT01055028|Paclitaxel|paclitaxel|mesh-list
44519974|NCT01055028|Bevacizumab|bevacizumab|mesh-list
44519975|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44519976|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44519977|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44519978|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44519979|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44519980|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519981|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44519982|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44519983|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44519984|NCT01055028|Growth Substances|growth substances|mesh-ancestor
44341173|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
44519986|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
44519987|NCT01054976|Galantamine|galantamine|mesh-list
44519988|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44519989|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44519990|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44519991|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
44519992|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44519993|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44519994|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44519995|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
44519996|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44519997|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
44519998|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
44519999|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
44520000|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520001|NCT01054573|Interferons|interferons|mesh-list
44520002|NCT01054573|Ribavirin|ribavirin|mesh-list
44520003|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520004|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
44520005|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520006|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
44520007|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520008|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
44520009|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44520010|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520011|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44520012|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520013|NCT01053962|Plecanatide|plecanatide|mesh-list
44520014|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44520015|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
44520016|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520017|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520018|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
44520019|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44520020|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44520021|NCT01053247|Tacrolimus|tacrolimus|mesh-list
44520022|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520023|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
44520024|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520025|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44520026|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520027|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520028|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
44520029|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44520030|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520031|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44520032|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
44520033|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44520034|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520035|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520036|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520037|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44520038|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44520039|NCT01052779|Hematinics|hematinics|mesh-ancestor
44520040|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44520041|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44520042|NCT01052662|Memantine|memantine|mesh-list
44520043|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44520044|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44520045|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
44520046|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520047|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520048|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520049|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44520050|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44520051|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
44520052|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520053|NCT01052493|Hormones|hormones|mesh-ancestor
44520054|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520055|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520056|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
44520057|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520058|NCT01052038|Dexamethasone|dexamethasone|mesh-list
44520059|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
44520060|NCT01052038|BB 1101|bb 1101|mesh-list
44520061|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520062|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
44520063|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
44520064|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520065|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520066|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520067|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
44520068|NCT01052038|Hormones|hormones|mesh-ancestor
44520069|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520070|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44520071|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520072|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44520073|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520074|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520075|NCT01052012|Bupivacaine|bupivacaine|mesh-list
44520076|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44520077|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
44520078|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520079|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520080|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
44520081|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520082|NCT01051960|Ambrisentan|ambrisentan|mesh-list
44520083|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44520084|NCT01051921|Interferons|interferons|mesh-list
44520085|NCT01051921|Ribavirin|ribavirin|mesh-list
44520086|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520087|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
44520088|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520089|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
44520090|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520091|NCT01051791|Everolimus|everolimus|mesh-list
44520092|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520093|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520094|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
44520095|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520096|NCT01051661|Vaccines|vaccines|mesh-list
44520097|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
44520098|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520099|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44520100|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44520101|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44520102|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520103|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520104|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520105|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520106|NCT01051466|Analgesics|analgesics|mesh-ancestor
44520107|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
44520108|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520109|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
44520110|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520111|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
44520112|NCT01051349|Daclizumab|daclizumab|mesh-list
44520113|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520114|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
44520115|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520116|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
44520117|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44520118|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44520119|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
44520120|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520121|NCT01050790|Lenalidomide|lenalidomide|mesh-list
44520122|NCT01050790|Azacitidine|azacitidine|mesh-list
44520123|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
44520124|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520125|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520126|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520127|NCT01050790|Growth Substances|growth substances|mesh-ancestor
44520128|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520129|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520130|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44520131|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
44520132|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520133|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520134|NCT01050764|Vidarabine|vidarabine|mesh-list
44520135|NCT01050764|Fludarabine|fludarabine|mesh-list
44520136|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
44520137|NCT01050764|Melphalan|melphalan|mesh-list
44520138|NCT01050764|Thiotepa|thiotepa|mesh-list
44520139|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
44520140|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44520141|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520142|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44520143|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
44520144|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520145|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424828|NCT03518034|Hormones|hormones|mesh-ancestor
44520146|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
44520147|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520148|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
44520149|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520150|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44520151|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
44520152|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44520153|NCT01050569|Nicotine|nicotine|mesh-list
44520154|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44520155|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
44520156|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520157|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520158|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44520159|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44520160|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
44520161|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520162|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520163|NCT01050543|Neostigmine|neostigmine|mesh-list
44520164|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44520165|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520166|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520167|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
44520168|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520169|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520170|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44520171|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
44520172|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520173|NCT01050530|Tolvaptan|tolvaptan|mesh-list
44520174|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44520175|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520176|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
44520177|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520178|NCT01050257|Oseltamivir|oseltamivir|mesh-list
44520179|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
44520180|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520181|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520182|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520183|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44520184|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44520185|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44520186|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520187|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520188|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520189|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520190|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
44520191|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520192|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44520193|NCT01050062|Telmisartan|telmisartan|mesh-list
44520194|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44520195|NCT01050062|Diuretics|diuretics|mesh-ancestor
44520196|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
44520197|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520198|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44520199|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520200|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424879|NCT03224507|Hormones|hormones|mesh-ancestor
44520201|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44520202|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44520203|NCT01059448|Brodalumab|brodalumab|mesh-list
44520204|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
44520205|NCT01057147|Rebamipide|rebamipide|mesh-list
44520206|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44520207|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44520208|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44520209|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520210|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
44520211|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520212|NCT01057147|Protective Agents|protective agents|mesh-ancestor
44520213|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520214|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520216|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44520217|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44520218|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44520219|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
44520220|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520221|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
44520222|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520223|NCT01055444|Lidocaine|lidocaine|mesh-list
44520224|NCT01055444|Tetracaine|tetracaine|mesh-list
44520225|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
44520226|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
44520227|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520228|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520229|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
44520230|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520231|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44520232|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44520233|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44520234|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520235|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520237|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520238|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44520239|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44520240|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44520241|NCT01055015|Morphine|morphine|mesh-list
44520242|NCT01055015|Oxycodone|oxycodone|mesh-list
44520243|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44520244|NCT01055015|Narcotics|narcotics|mesh-ancestor
44424941|NCT02874430|Metformin|metformin|mesh-list
44520245|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520246|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520247|NCT01055015|Analgesics|analgesics|mesh-ancestor
44520248|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
44520249|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520250|NCT01051414|Asunaprevir|asunaprevir|mesh-list
44520251|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
44520252|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520253|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520254|NCT01054144|Dexamethasone|dexamethasone|mesh-list
44520255|NCT01054144|Prednisone|prednisone|mesh-list
44520256|NCT01054144|Lenalidomide|lenalidomide|mesh-list
44520257|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520258|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
44520259|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
44520260|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520261|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520262|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520263|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
44520264|NCT01054144|Hormones|hormones|mesh-ancestor
44520265|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520266|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44520267|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520268|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
44520269|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520270|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520271|NCT01054144|Growth Substances|growth substances|mesh-ancestor
44520272|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520273|NCT01051557|Sirolimus|sirolimus|mesh-list
44520274|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44520275|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520276|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44520277|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520278|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
44520279|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520280|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
44520281|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520282|NCT03277495|Nicotine|nicotine|mesh-list
44520283|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44520284|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
44520298|NCT03277482|Durvalumab|durvalumab|mesh-list
44520299|NCT03277482|Tremelimumab|tremelimumab|mesh-list
44520300|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520301|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520302|NCT03275857|Cisplatin|cisplatin|mesh-list
44520303|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520304|NCT03279289|Leucovorin|leucovorin|mesh-list
44520305|NCT03279289|Folic Acid|folic acid|mesh-list
44520306|NCT03279289|Fluorouracil|fluorouracil|mesh-list
44520307|NCT03279289|Irinotecan|irinotecan|mesh-list
44520308|NCT03279289|Aflibercept|aflibercept|mesh-list
44520309|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
44520310|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
44520311|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520312|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44520313|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520314|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520315|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
44520316|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520317|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44520318|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44520319|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520320|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520321|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520322|NCT03279289|Growth Substances|growth substances|mesh-ancestor
44520323|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520324|NCT03279289|Antidotes|antidotes|mesh-ancestor
44520325|NCT03279289|Protective Agents|protective agents|mesh-ancestor
44520326|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
44520327|NCT03279289|Vitamins|vitamins|mesh-ancestor
44520328|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
44520329|NCT03279289|Hematinics|hematinics|mesh-ancestor
44520330|NCT03274492|Prednisone|prednisone|mesh-list
44520331|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
44520332|NCT03274492|Rituximab|rituximab|mesh-list
44520333|NCT03274492|Doxorubicin|doxorubicin|mesh-list
44520334|NCT03274492|Vincristine|vincristine|mesh-list
44520335|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44520336|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
44520337|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520338|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
44520339|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520340|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44520341|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44520342|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
44520343|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520344|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520345|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44520346|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520347|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44520348|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44520349|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44520350|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520351|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520352|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
44520353|NCT03274492|Hormones|hormones|mesh-ancestor
44520354|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520355|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44520356|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44520357|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44520358|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44520359|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44520360|NCT03276052|Bromides|bromides|mesh-list
44520361|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
44520362|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
44520363|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44520364|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
44520365|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44520366|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44520367|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520368|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520369|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
44520370|NCT03270176|Avelumab|avelumab|mesh-list
44520371|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520372|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341516|NCT01031459|Interferons|interferons|mesh-list
44520373|NCT03277170|Montelukast|montelukast|mesh-list
44520374|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44520375|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
44520376|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44520377|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44520378|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520379|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520380|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44520381|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44520382|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520383|NCT03273413|Pravastatin|pravastatin|mesh-list
44520384|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44520385|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44520386|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
44520387|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520388|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44520389|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44520390|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520391|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
44520392|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520393|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520394|NCT03279978|Midazolam|midazolam|mesh-list
44520395|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44520396|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44520397|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520398|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520399|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44520400|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44520401|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520402|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44520403|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
44520404|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
44520405|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
44520406|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
44520407|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520408|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520409|NCT03279861|Valsartan|valsartan|mesh-list
44520410|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44520411|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44520412|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44520413|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44520414|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520415|NCT03279809|Aspirin|aspirin|mesh-list
44520416|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44520417|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44520418|NCT03279809|Analgesics|analgesics|mesh-ancestor
44520419|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
44520420|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520421|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520422|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520423|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44520424|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44520425|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44520426|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520427|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44520428|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44520429|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520430|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
44520431|NCT03279757|Lidocaine|lidocaine|mesh-list
44520432|NCT03279757|Epinephrine|epinephrine|mesh-list
44520433|NCT03279757|Racepinephrine|racepinephrine|mesh-list
44520434|NCT03279757|Tetracaine|tetracaine|mesh-list
44520435|NCT03279757|Carticaine|carticaine|mesh-list
44520436|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
44520437|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
44520438|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
44520439|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520440|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520441|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
44520442|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520443|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44520444|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44520445|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44520446|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520447|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520448|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44520449|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44520450|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44520451|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520452|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44520453|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44520454|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
44520455|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44520456|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44520457|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
44520458|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
44520459|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44520460|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
44520461|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520462|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520463|NCT03279601|Capecitabine|capecitabine|mesh-list
44520464|NCT03279601|Temozolomide|temozolomide|mesh-list
44520465|NCT03279601|Dacarbazine|dacarbazine|mesh-list
44520466|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44520467|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
44520468|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520469|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520470|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44520471|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
44520472|NCT03279562|Nalmefene|nalmefene|mesh-list
44520473|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44520474|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520475|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
44520476|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520478|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44520479|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520480|NCT03279536|Lactoferrin|lactoferrin|mesh-list
44520481|NCT03279536|Dextrans|dextrans|mesh-list
44520482|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
44520483|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520484|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
44520485|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
44520486|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
44520487|NCT03279536|Hematinics|hematinics|mesh-ancestor
44520488|NCT03279341|Prucalopride|prucalopride|mesh-list
44520489|NCT03279341|Bisacodyl|bisacodyl|mesh-list
44520490|NCT03279341|Laxatives|laxatives|mesh-ancestor
44520491|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520492|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44520493|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44520494|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
44520495|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520496|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520497|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520498|NCT03279341|Cathartics|cathartics|mesh-ancestor
44520499|NCT03279328|Petrolatum|petrolatum|mesh-list
44520500|NCT03279328|Emollients|emollients|mesh-ancestor
44520501|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44520502|NCT03279146|Tenofovir|tenofovir|mesh-list
44520503|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
44520504|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520505|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44520506|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44520507|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520508|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520509|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44520510|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44520511|NCT03279133|Ledipasvir|ledipasvir|mesh-list
44520512|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
44520513|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520514|NCT03279120|Tenofovir|tenofovir|mesh-list
44520515|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
44520516|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
44520517|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520518|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44520519|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44520520|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520521|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520522|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44520523|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44520524|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44520525|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
44520526|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44520537|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44520538|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520539|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520540|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
44520541|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520542|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520543|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44520544|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44520545|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520546|NCT03278938|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44520547|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
44520548|NCT03278860|Oxytocin|oxytocin|mesh-list
44520549|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
44520550|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44520551|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520552|NCT03278808|Azithromycin|azithromycin|mesh-list
44520553|NCT03278808|Chloroquine|chloroquine|mesh-list
44520554|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44520555|NCT03278808|Atovaquone|atovaquone|mesh-list
44520556|NCT03278808|Proguanil|proguanil|mesh-list
44520557|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44520558|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44520559|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520560|NCT03278808|Amebicides|amebicides|mesh-ancestor
44520561|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44520562|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44520563|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
44520564|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44520565|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44520566|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44520567|NCT03278808|Analgesics|analgesics|mesh-ancestor
44520568|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
44520569|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520570|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520571|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520572|NCT03278808|Filaricides|filaricides|mesh-ancestor
44520573|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
44520574|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
44520575|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520576|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520577|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
44520585|NCT03278652|Analgesics|analgesics|mesh-list
44520586|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
44520587|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520588|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520589|NCT03278522|Ramosetron|ramosetron|mesh-list
44520590|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
44520591|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
44520592|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520593|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520594|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520595|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44520596|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
44520597|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520598|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520599|NCT03278444|Trimetazidine|trimetazidine|mesh-list
44520600|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
44520601|NCT03278431|Albendazole|albendazole|mesh-list
44520602|NCT03278431|Mebendazole|mebendazole|mesh-list
44520603|NCT03278431|Piperazine|piperazine|mesh-list
44520604|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
44520605|NCT03278431|Pyrantel|pyrantel|mesh-list
44520606|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
44520607|NCT03278431|Oxantel|oxantel|mesh-list
44520608|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
44520609|NCT03278431|DMP 777|dmp 777|mesh-list
44520610|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
44520611|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44520612|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520613|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
44520614|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44520615|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44520616|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
44520617|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
44520618|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
44520619|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520620|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520621|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
44520622|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520623|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44520624|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44520625|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44520626|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520627|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520628|NCT03278405|Avelumab|avelumab|mesh-list
44520629|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520630|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520631|NCT03278379|Avelumab|avelumab|mesh-list
44520632|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520633|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520634|NCT03278314|Ivacaftor|ivacaftor|mesh-list
44520635|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44520636|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520637|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520638|NCT03278262|Aflibercept|aflibercept|mesh-list
44520639|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520640|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520641|NCT03278262|Growth Substances|growth substances|mesh-ancestor
44520642|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520643|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520644|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520646|NCT03278015|Paclitaxel|paclitaxel|mesh-list
44520647|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44520648|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44520649|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520650|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44520651|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44520652|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44520653|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520654|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44520655|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
44520656|NCT03278015|Antiviral Agents|antiviral agents|mesh-ancestor
44520657|NCT03278015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520658|NCT03278015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520659|NCT03278015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520660|NCT03278015|Immunologic Factors|immunologic factors|mesh-ancestor
44425299|NCT02252016|Grazoprevir|grazoprevir|mesh-list
44520661|NCT03278015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520662|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
44520663|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
44520664|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
44520665|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
44520666|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
44520667|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520668|NCT03277599|Tramadol|tramadol|mesh-list
44520669|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44520670|NCT03277599|Narcotics|narcotics|mesh-ancestor
44520671|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520672|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520673|NCT03277599|Analgesics|analgesics|mesh-ancestor
44520674|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
44520675|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520676|NCT03277430|Tacrolimus|tacrolimus|mesh-list
44520677|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520678|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
44520679|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520680|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44520681|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520682|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520683|NCT03277209|Plerixafor|plerixafor|mesh-list
44520684|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44520685|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44520686|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
44520687|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520688|NCT03277079|Ezetimibe|ezetimibe|mesh-list
44520689|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44520690|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44520691|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44520692|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
44520693|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520694|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44520695|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520696|NCT03276858|Midazolam|midazolam|mesh-list
44520697|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44520698|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44520699|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44520700|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520701|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520702|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44520703|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44520704|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520705|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44520706|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
44520707|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
44520708|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
44520709|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
44520710|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520711|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520712|NCT03276689|Pregabalin|pregabalin|mesh-list
44520713|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44520714|NCT03276689|Analgesics|analgesics|mesh-ancestor
44520715|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
44520716|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520717|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520718|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
44520719|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44520720|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520721|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520722|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44520723|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44520724|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44425358|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520725|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520726|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520727|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44520728|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44520729|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520730|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
44520731|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
44520732|NCT03276520|Ethanol|ethanol|mesh-list
44520733|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44520734|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520735|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520736|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520737|NCT03276325|Dexamethasone|dexamethasone|mesh-list
44520738|NCT03276325|Nalbuphine|nalbuphine|mesh-list
44520739|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520740|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
44520741|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
44341928|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
44520751|NCT03276325|Narcotics|narcotics|mesh-ancestor
44520752|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520753|NCT03276325|Analgesics|analgesics|mesh-ancestor
44520754|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
44520755|NCT03276156|Apatinib|apatinib|mesh-list
44520756|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520757|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44342014|NCT01035021|Rocuronium|rocuronium|mesh-list
44520758|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520759|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520761|NCT03276143|Apixaban|apixaban|mesh-list
44520762|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
44520763|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44520764|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44520765|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520766|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44520767|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
44520768|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44520769|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
44520770|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520771|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
44520772|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520773|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520774|NCT03275701|Triumeq|triumeq|mesh-list
44520775|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44520776|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44520777|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
44520778|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520779|NCT03275558|Sunitinib|sunitinib|mesh-list
44520780|NCT03275558|Axitinib|axitinib|mesh-list
44520781|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520782|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520783|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520784|NCT03275558|Growth Substances|growth substances|mesh-ancestor
44520785|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520786|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520787|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44520788|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520789|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520790|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44520791|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44520792|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520793|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
44520794|NCT03275506|Bevacizumab|bevacizumab|mesh-list
44520795|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
44520796|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520797|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520798|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44520799|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44520800|NCT03275506|Growth Substances|growth substances|mesh-ancestor
44520801|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520802|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44520803|NCT03275415|Budesonide|budesonide|mesh-list
44520804|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44520805|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44520806|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
44520807|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520808|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520809|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44520810|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
44520811|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
44520812|NCT03275415|Hormones|hormones|mesh-ancestor
44520813|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520814|NCT03275376|Atorvastatin|atorvastatin|mesh-list
44520815|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44520816|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44520817|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
44520818|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520819|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44520820|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44520821|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520822|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
44520823|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44520824|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520825|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520826|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44520827|NCT03275207|Analgesics|analgesics|mesh-ancestor
44520828|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
44520829|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520830|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44520831|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44520832|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44520833|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
44520834|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520835|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520836|NCT03275116|Bromides|bromides|mesh-list
44520837|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
44520838|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
44520839|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44520840|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
44520841|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520842|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520843|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44520844|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44520845|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44520846|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44520847|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44520848|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44520849|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520850|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520851|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
44520852|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44520853|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
44520854|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
44520855|NCT03275012|Morphine|morphine|mesh-list
44520856|NCT03275012|Gabapentin|gabapentin|mesh-list
44520857|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44520858|NCT03275012|Narcotics|narcotics|mesh-ancestor
44520859|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520860|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520861|NCT03275012|Analgesics|analgesics|mesh-ancestor
44520862|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
44520863|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520864|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
44520865|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44520866|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44520867|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520868|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44520869|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44520870|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520871|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520872|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
44520873|NCT03274895|Biguanides|biguanides|mesh-list
44520875|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
44520876|NCT03274895|Propamidine|propamidine|mesh-list
44520877|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44520878|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520879|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
44520880|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520881|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44520882|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44520883|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44520884|NCT03274817|Citalopram|citalopram|mesh-list
44520885|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44520886|NCT03274817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44520887|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44520888|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520889|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520890|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520891|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
44520892|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520893|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44520894|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
44520895|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520896|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44520897|NCT03274765|Estradiol|estradiol|mesh-list
44520898|NCT03274765|Estrogens|estrogens|mesh-ancestor
44520899|NCT03274765|Hormones|hormones|mesh-ancestor
44520900|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44520901|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520902|NCT03274700|Tamsulosin|tamsulosin|mesh-list
44520903|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44520904|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44520905|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44520906|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44520907|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520908|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520909|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520910|NCT03274700|Urological Agents|urological agents|mesh-ancestor
44520911|NCT03274427|Trimetazidine|trimetazidine|mesh-list
44520912|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
44520913|NCT03274323|Travoprost|travoprost|mesh-list
44520914|NCT03274323|Latanoprost|latanoprost|mesh-list
44520915|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44520916|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44520917|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44520918|NCT03274167|Gabapentin|gabapentin|mesh-list
44520919|NCT03274167|Analgesics|analgesics|mesh-ancestor
44520920|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
44520921|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520922|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520923|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
44520924|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44520925|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44520926|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520927|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44520928|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44520929|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44520930|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44520931|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520932|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
44520934|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
44520935|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520936|NCT03274024|Mitomycins|mitomycins|mesh-list
44520937|NCT03274024|Mitomycin|mitomycin|mesh-list
44520938|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44520939|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520940|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
44520941|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520942|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44425578|NCT02242045|Idelalisib|idelalisib|mesh-list
44520943|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520944|NCT03274011|Apatinib|apatinib|mesh-list
44520945|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520946|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44520947|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520948|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520952|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44520953|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44520954|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520955|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520956|NCT03273595|Paclitaxel|paclitaxel|mesh-list
44520957|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
44520958|NCT03273595|Trastuzumab|trastuzumab|mesh-list
44520959|NCT03273595|Epirubicin|epirubicin|mesh-list
44520960|NCT03273595|Lapatinib|lapatinib|mesh-list
44520961|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44520962|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44520963|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
44520964|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
44520965|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
44520966|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520967|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44520968|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
44520969|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520970|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44520971|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44520972|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
44520973|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44520974|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44520975|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44520976|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44520977|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44520978|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44520979|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44520980|NCT03273556|Lidocaine|lidocaine|mesh-list
44520981|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
44520982|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
44520983|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44520984|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44520985|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
44520986|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44520987|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44520988|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44520989|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44520990|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44520991|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44520992|NCT03273296|Amoxicillin|amoxicillin|mesh-list
44520993|NCT03273296|Azithromycin|azithromycin|mesh-list
44520994|NCT03273296|Vancomycin|vancomycin|mesh-list
44520995|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44520996|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44520997|NCT03273231|Ketamine|ketamine|mesh-list
44520998|NCT03273231|Analgesics|analgesics|mesh-ancestor
44520999|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
44521000|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521001|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521002|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44521003|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44521004|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
44521005|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
44521006|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521007|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44521008|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44521009|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521010|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521011|NCT03273075|Ticagrelor|ticagrelor|mesh-list
44521012|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44521013|NCT03273075|Cangrelor|cangrelor|mesh-list
44521014|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44521015|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44521016|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44521017|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44521018|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
44521019|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521020|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521021|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521022|NCT03273062|Tolcapone|tolcapone|mesh-list
44521023|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44521024|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44521025|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44521026|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521027|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521028|NCT03273036|Triamcinolone|triamcinolone|mesh-list
44521029|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521030|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
44521032|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521033|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521034|NCT03272867|Mannitol|mannitol|mesh-list
44521035|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44521036|NCT03272867|Diuretics|diuretics|mesh-ancestor
44521037|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
44521038|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521039|NCT03272802|Riluzole|riluzole|mesh-list
44521040|NCT03272802|Edaravone|edaravone|mesh-list
44521041|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
44521042|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44521043|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44521044|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521045|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521046|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521047|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44521048|NCT03272802|Protective Agents|protective agents|mesh-ancestor
44521049|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44521050|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
44521051|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44521052|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
44521053|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521054|NCT03272425|Allopurinol|allopurinol|mesh-list
44521055|NCT03272425|Lesinurad|lesinurad|mesh-list
44521056|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
44521057|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521058|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521059|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
44521060|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521061|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44521062|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
44521063|NCT03272425|Protective Agents|protective agents|mesh-ancestor
44521064|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521065|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
44521066|NCT03272425|Renal Agents|renal agents|mesh-ancestor
44521067|NCT03272503|Pimozide|pimozide|mesh-list
44521068|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44521069|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44521070|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521071|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521072|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44521073|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44521074|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
44521075|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521076|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521077|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44521078|NCT03272412|Progesterone|progesterone|mesh-list
44521079|NCT03272412|Progestins|progestins|mesh-ancestor
44521080|NCT03272412|Hormones|hormones|mesh-ancestor
44521081|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521082|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521083|NCT03272126|Vitamin D|vitamin d|mesh-list
44521084|NCT03272126|Vitamins|vitamins|mesh-ancestor
44521085|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
44521086|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521087|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44521088|NCT03272321|Oxytocin|oxytocin|mesh-list
44521089|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
44521090|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44521091|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521092|NCT03271918|Cabergoline|cabergoline|mesh-list
44521093|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44521094|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44521095|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
44521096|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
44521097|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521098|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521099|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521100|NCT03272009|Interferons|interferons|mesh-list
44342405|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
44521101|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
44521103|NCT03272009|Entecavir|entecavir|mesh-list
44521104|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44521105|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521106|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
44521107|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521108|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
44521109|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521110|NCT03271905|Bromides|bromides|mesh-list
44521111|NCT03271905|Albuterol|albuterol|mesh-list
44521112|NCT03271905|Ipratropium|ipratropium|mesh-list
44521113|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
44521114|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44521115|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
44521116|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521117|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521118|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521119|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521120|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
44521121|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44521122|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44521123|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44521124|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44521125|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521126|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521127|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521128|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44521129|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44521130|NCT03271450|Warfarin|warfarin|mesh-list
44521131|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
44521132|NCT03271450|Dabigatran|dabigatran|mesh-list
44521133|NCT03271450|Apixaban|apixaban|mesh-list
44521134|NCT03271450|Edoxaban|edoxaban|mesh-list
44521135|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
44521136|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44521137|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
44521138|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44521139|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44521140|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521141|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521142|NCT03271502|Anesthetics|anesthetics|mesh-list
44521143|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521144|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521145|NCT03271164|Vitamin E|vitamin e|mesh-list
44521146|NCT03271164|Vitamins|vitamins|mesh-ancestor
44521147|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
44521148|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521149|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
44521150|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521151|NCT03271164|Protective Agents|protective agents|mesh-ancestor
44521152|NCT03271255|Bevacizumab|bevacizumab|mesh-list
44521153|NCT03271255|Apatinib|apatinib|mesh-list
44521154|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44521155|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521156|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44521157|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44521158|NCT03271255|Growth Substances|growth substances|mesh-ancestor
44521159|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521160|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
44521161|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521162|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521163|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521164|NCT03271073|Apatinib|apatinib|mesh-list
44521165|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521166|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521167|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521168|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521169|NCT03270969|Tenofovir|tenofovir|mesh-list
44521170|NCT03270969|Emtricitabine|emtricitabine|mesh-list
44521171|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
44521172|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521173|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44521174|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44521175|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521176|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521177|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44521178|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44521180|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
44521181|NCT03270735|Coagulants|coagulants|mesh-ancestor
44521182|NCT03270709|Vitamin D|vitamin d|mesh-list
44521183|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
44521184|NCT03270709|Vitamins|vitamins|mesh-ancestor
44521185|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
44521186|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521187|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44521188|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44521189|NCT03270696|Propofol|propofol|mesh-list
44521190|NCT03270696|Rocuronium|rocuronium|mesh-list
44521191|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44521192|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521193|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521194|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44521195|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
44521196|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
44521197|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44521198|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44521199|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44521200|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521201|NCT03270553|Metformin|metformin|mesh-list
44521202|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521203|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521204|NCT03270007|Vinorelbine|vinorelbine|mesh-list
44521205|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44521206|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521207|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44521208|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44521209|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44521210|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521211|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
44521212|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521213|NCT03277261|Teriflunomide|teriflunomide|mesh-list
44425818|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521214|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44521215|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44521216|NCT03277261|Analgesics|analgesics|mesh-ancestor
44521217|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
44521218|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521219|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521220|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521224|NCT03277248|Teriflunomide|teriflunomide|mesh-list
44521225|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44521226|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44521227|NCT03277248|Analgesics|analgesics|mesh-ancestor
44521228|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
44521229|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521230|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521231|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521232|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521233|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521234|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
44521235|NCT03277066|Diclofenac|diclofenac|mesh-list
44521236|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44521237|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44521238|NCT03277066|Analgesics|analgesics|mesh-ancestor
44521239|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
44521240|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521241|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521242|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521243|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521244|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44521245|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521246|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521247|NCT03270462|Tacrolimus|tacrolimus|mesh-list
44521248|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521249|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
44521250|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521251|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44521252|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521253|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521254|NCT03271047|Nivolumab|nivolumab|mesh-list
44521255|NCT03271047|Ipilimumab|ipilimumab|mesh-list
44521256|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44521257|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521258|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44521259|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521261|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521262|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521263|NCT03271879|Empagliflozin|empagliflozin|mesh-list
44425881|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521264|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44521265|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521266|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521267|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521268|NCT03271983|Metronidazole|metronidazole|mesh-list
44521269|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521270|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521271|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44521272|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44342631|NCT01039441|Bupivacaine|bupivacaine|mesh-list
44521273|NCT01240096|Mirtazapine|mirtazapine|mesh-list
44521274|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
44521275|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44521276|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44521277|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
44521278|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
44521279|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521280|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521281|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521282|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44521283|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44521284|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521285|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44521286|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44521287|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44521288|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521289|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44521290|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44521291|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
44521292|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44521293|NCT01240109|Remifentanil|remifentanil|mesh-list
44521294|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44521295|NCT01240109|Narcotics|narcotics|mesh-ancestor
44521296|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521297|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521298|NCT01240109|Analgesics|analgesics|mesh-ancestor
44521299|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
44521300|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521302|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
44521303|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
44521304|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521305|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521306|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
44521307|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425929|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
44521308|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44521309|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44521310|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44521311|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521312|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521313|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44521314|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521315|NCT01240226|Ketoconazole|ketoconazole|mesh-list
44521316|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
44521317|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521318|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44521319|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44521320|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521321|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521322|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44521323|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521324|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521325|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521326|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44521327|NCT01240252|Insulin|insulin|mesh-list
43929351|NCT00675584|Hormones|hormones|mesh-ancestor
44521328|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44521329|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521330|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521331|NCT01240408|Lenvatinib|lenvatinib|mesh-list
44521332|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521333|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521334|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521335|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521336|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
44521337|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521338|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
44521339|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521340|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521341|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44521342|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
44521343|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342706|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
44521344|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521345|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44521347|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521348|NCT01240655|Paclitaxel|paclitaxel|mesh-list
44521349|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44521350|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521351|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
44521352|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
44521353|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
44521354|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521355|NCT01240824|Aminophylline|aminophylline|mesh-list
44521356|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44521357|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
44521358|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521359|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521360|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521361|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521362|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44521363|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44521364|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521365|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521366|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44521367|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44521368|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
44521369|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521370|NCT01240824|Protective Agents|protective agents|mesh-ancestor
44521371|NCT01240928|Exemestane|exemestane|mesh-list
44521372|NCT01240928|Goserelin|goserelin|mesh-list
44521373|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521374|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44521375|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44521376|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521377|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521378|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44521379|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521380|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521381|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521382|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44521383|NCT01240941|Exemestane|exemestane|mesh-list
44521384|NCT01240941|Goserelin|goserelin|mesh-list
44521385|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521386|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44521387|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44521388|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521389|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521390|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44521391|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521392|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521393|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521394|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44521395|NCT01241019|Topiramate|topiramate|mesh-list
44521396|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
44521397|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521398|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521399|NCT01241032|Udenafil|udenafil|mesh-list
44521400|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44521401|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44521402|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521403|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521404|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44521405|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521406|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521407|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521408|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521409|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521410|NCT01241097|Simvastatin|simvastatin|mesh-list
44521412|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44521413|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44521414|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
44521415|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521416|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44521427|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521428|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521429|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44521430|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44521431|NCT01241162|Decitabine|decitabine|mesh-list
44521432|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44521433|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
44521434|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521435|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521436|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521437|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
44521438|NCT01241175|Analgesics|analgesics|mesh-ancestor
44521439|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
44521440|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521441|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521442|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
44521443|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521444|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44521445|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
44521446|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44521447|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521448|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521449|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44521450|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
44521451|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44521452|NCT01241383|Bosentan|bosentan|mesh-list
44521453|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44521454|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44521455|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521457|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44521458|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44521459|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44521460|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521461|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521462|NCT01241422|Montelukast|montelukast|mesh-list
44521463|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521464|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521465|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44521466|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44521467|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521468|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521469|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44521470|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44521471|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521472|NCT01241487|Amlodipine|amlodipine|mesh-list
44521473|NCT01241487|Valsartan|valsartan|mesh-list
44521474|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44521475|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44521476|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521477|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521478|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44521479|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521480|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44521481|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44521482|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44521484|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521485|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521486|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521487|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521488|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
44521489|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521490|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
44521491|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521492|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521493|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44521494|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
44521495|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521496|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521497|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44521498|NCT01241773|Efavirenz|efavirenz|mesh-list
44521499|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
44521500|NCT01241773|Simeprevir|simeprevir|mesh-list
44521501|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44521502|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44521503|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521504|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521505|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
44521506|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521507|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44426126|NCT02227446|Vancomycin|vancomycin|mesh-list
44521508|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44521509|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44521510|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44521511|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44521512|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44521513|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44521514|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44521515|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44521516|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44521517|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
44521518|NCT01242046|Caffeine|caffeine|mesh-list
44521519|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44521520|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521521|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44521522|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521523|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521524|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44521525|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44521526|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
44521527|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521528|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
44521529|NCT01242072|Ifosfamide|ifosfamide|mesh-list
44521530|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44521531|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
44521532|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521533|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521534|NCT01242098|Fluticasone|fluticasone|mesh-list
44521535|NCT01242098|Beclomethasone|beclomethasone|mesh-list
44521536|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
44521537|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44521538|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521539|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44521540|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
44521541|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521542|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521543|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521544|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521545|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
44521546|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44521547|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44521548|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44521549|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44521550|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521551|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521552|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521553|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
44521554|NCT01242098|Hormones|hormones|mesh-ancestor
44521555|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521556|NCT01242202|Acarbose|acarbose|mesh-list
44521557|NCT01242202|Voglibose|voglibose|mesh-list
44521558|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44521559|NCT01242202|Miglitol|miglitol|mesh-list
44521560|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
44521561|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521562|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521563|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521564|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521565|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44521566|NCT01242215|Glimepiride|glimepiride|mesh-list
44521567|NCT01242215|Gliclazide|gliclazide|mesh-list
44521568|NCT01242215|Glyburide|glyburide|mesh-list
44521569|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
44521570|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44521571|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521572|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521573|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521574|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
44521575|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44521576|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521577|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44521578|NCT01242228|Vildagliptin|vildagliptin|mesh-list
44521579|NCT01242228|Saxagliptin|saxagliptin|mesh-list
44521580|NCT01242228|Alogliptin|alogliptin|mesh-list
44521581|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
44521582|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44521583|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521584|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521585|NCT01242228|Incretins|incretins|mesh-ancestor
44521586|NCT01242228|Hormones|hormones|mesh-ancestor
44521587|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44521588|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44521589|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521590|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521591|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44521592|NCT01242306|Acetylcholine|acetylcholine|mesh-list
44521593|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
44521594|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44521595|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
44521596|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521597|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521598|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521599|NCT01242332|Pregabalin|pregabalin|mesh-list
44521600|NCT01242332|Analgesics|analgesics|mesh-ancestor
44521601|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
44521602|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521603|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521604|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
44521605|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44521606|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521607|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521608|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44521609|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44521610|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44521611|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521612|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44521613|NCT01242384|Silicon|silicon|mesh-list
44521614|NCT01242384|Trace Elements|trace elements|mesh-ancestor
44521615|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
44521616|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521617|NCT01242449|Trastuzumab|trastuzumab|mesh-list
44521618|NCT01242449|Vinorelbine|vinorelbine|mesh-list
44521619|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44521620|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521621|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44521622|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44521623|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44521624|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44521625|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521626|NCT01242566|Temozolomide|temozolomide|mesh-list
44521627|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44521628|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
44521629|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521630|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521631|NCT01242579|Maraviroc|maraviroc|mesh-list
44521632|NCT01242579|Dapivirine|dapivirine|mesh-list
44521633|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44521634|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44521635|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521636|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44521637|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44521638|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
44521639|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521640|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44521641|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
44521642|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521643|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521644|NCT01242631|Everolimus|everolimus|mesh-list
44521645|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521646|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521647|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
44521648|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521649|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
44521650|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
44521651|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521652|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521653|NCT01242904|Icodextrin|icodextrin|mesh-list
44426278|NCT02224053|Omeprazole|omeprazole|mesh-list
44521654|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
44521655|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44521656|NCT01243060|Zolpidem|zolpidem|mesh-list
44521657|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44521658|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44521659|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521660|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521661|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44521662|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
44521663|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
44521664|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521665|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521666|NCT01243203|Varenicline|varenicline|mesh-list
44521667|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44521668|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44521669|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
44521670|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521671|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521672|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521673|NCT01243281|Entecavir|entecavir|mesh-list
44521674|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
44521675|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521676|NCT01243359|Bevacizumab|bevacizumab|mesh-list
44521677|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44521678|NCT01243359|Sunitinib|sunitinib|mesh-list
44521679|NCT01243359|Antibodies|antibodies|mesh-list
44521680|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
44521681|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44521682|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521683|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44521684|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44521685|NCT01243359|Growth Substances|growth substances|mesh-ancestor
44521686|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521687|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
44521688|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
44521689|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521690|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521691|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521692|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
44521693|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521694|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521695|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44521696|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44521697|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521698|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521699|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521700|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44521701|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44521702|NCT01243528|Vitamin D|vitamin d|mesh-list
44521703|NCT01243528|Vitamins|vitamins|mesh-ancestor
44521705|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521706|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44521707|NCT01243632|Gemcitabine|gemcitabine|mesh-list
44521713|NCT01243632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521714|NCT01243632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521715|NCT01243632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521716|NCT01243632|Immunologic Factors|immunologic factors|mesh-ancestor
44521717|NCT01243632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521718|NCT01243710|Taurolidine|taurolidine|mesh-list
44521719|NCT01243710|Heparin|heparin|mesh-list
44521720|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
44521721|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44521722|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44426316|NCT02222714|Protein C|protein c|mesh-list
44521723|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521724|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521725|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44521726|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521727|NCT01243736|Metoclopramide|metoclopramide|mesh-list
44521728|NCT01243736|Simethicone|simethicone|mesh-list
44521729|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
44521730|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
44521731|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521732|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521733|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44521734|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44521735|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44521736|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
44521737|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521738|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521739|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
44521740|NCT01243736|Emollients|emollients|mesh-ancestor
44521741|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44521742|NCT01243788|Fluticasone|fluticasone|mesh-list
44521743|NCT01243788|Xhance|xhance|mesh-list
44521744|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44521745|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521746|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44521747|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
44521748|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521749|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521750|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44521751|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521752|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44521753|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44521754|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44521755|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44521756|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44521757|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521758|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521759|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521760|NCT01243801|Ketamine|ketamine|mesh-list
44521761|NCT01243801|Analgesics|analgesics|mesh-ancestor
44521762|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
44521763|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521764|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521765|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44521766|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44521767|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
44521768|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
44521769|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521770|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44521771|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44521772|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521773|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521774|NCT01243827|Carvedilol|carvedilol|mesh-list
44521775|NCT01243827|Bisoprolol|bisoprolol|mesh-list
44521776|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44521777|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44521778|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521779|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521780|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521781|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521782|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44521783|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
44521784|NCT01243827|Protective Agents|protective agents|mesh-ancestor
44521785|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44521786|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521787|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44521788|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
44521789|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44521790|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44521791|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
44521792|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
44521793|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521794|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44521795|NCT01243970|Phenylephrine|phenylephrine|mesh-list
44521796|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
44521797|NCT01243970|Ephedrine|ephedrine|mesh-list
44521798|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44521799|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
44521800|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
44521801|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521802|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521803|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
44521804|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44521805|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
44521806|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
44521807|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44521808|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44521809|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44521810|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
44521811|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521812|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521813|NCT01243970|Protective Agents|protective agents|mesh-ancestor
44521814|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44521815|NCT01243996|Ibuprofen|ibuprofen|mesh-list
44521816|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44521817|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44521818|NCT01243996|Analgesics|analgesics|mesh-ancestor
44521819|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
44521820|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521821|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521822|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521823|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521824|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44521825|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521826|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521827|NCT01244009|Niraparib|niraparib|mesh-list
44521828|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44521829|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521830|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521831|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521832|NCT01244100|Aspirin|aspirin|mesh-list
44521833|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44521834|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44521835|NCT01244100|Analgesics|analgesics|mesh-ancestor
44521836|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
44521837|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521838|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521839|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44521840|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521841|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44521842|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44521843|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521844|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44521845|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44521846|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521847|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
44521848|NCT01244113|Propofol|propofol|mesh-list
44521849|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44521850|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521851|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521852|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44521853|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
44521854|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
44521855|NCT01244178|Insulin|insulin|mesh-list
44521856|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44521857|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521858|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521859|NCT01244204|Vitamin D|vitamin d|mesh-list
44521860|NCT01244204|Vitamins|vitamins|mesh-ancestor
44521861|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
44521862|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521863|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44521864|NCT01244217|Fexofenadine|fexofenadine|mesh-list
44521865|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44521866|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44521867|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44521868|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
44521869|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
44521870|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521871|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521872|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521873|NCT01244230|Fexofenadine|fexofenadine|mesh-list
44521874|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44521875|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44521876|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44521877|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
44521878|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
44521879|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521880|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521881|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521882|NCT01244269|Methylphenidate|methylphenidate|mesh-list
44521883|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44521884|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521885|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44521886|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44521887|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44521888|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521889|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
44521890|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343346|NCT01043744|Lumefantrine|lumefantrine|mesh-list
44521906|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521908|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521909|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
44521910|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521911|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44521912|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521913|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521914|NCT01244698|Clindamycin|clindamycin|mesh-list
44521915|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
44521916|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
44521917|NCT01244698|Cefazolin|cefazolin|mesh-list
44521918|NCT01244698|Cefadroxil|cefadroxil|mesh-list
44521919|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44521920|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44521921|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44521922|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521923|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521924|NCT01244932|Bupivacaine|bupivacaine|mesh-list
44521925|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
44521926|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
44343416|NCT01044329|Growth Substances|growth substances|mesh-ancestor
44521927|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521928|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521929|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
44521930|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521931|NCT01244971|Acarbose|acarbose|mesh-list
44521932|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44521933|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521934|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521935|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521936|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521937|NCT01245166|Metformin|metformin|mesh-list
44521938|NCT01245166|Acarbose|acarbose|mesh-list
44521939|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44521940|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521941|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44521942|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521943|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521944|NCT01245179|Panobinostat|panobinostat|mesh-list
44521945|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521946|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44521947|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521948|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521949|NCT01245205|Lapatinib|lapatinib|mesh-list
44521950|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521951|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44521952|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521953|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521954|NCT01245244|Morphine|morphine|mesh-list
44521955|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44521956|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44521957|NCT01245244|Narcotics|narcotics|mesh-ancestor
44521958|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44521959|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521960|NCT01245244|Analgesics|analgesics|mesh-ancestor
44521961|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
44521962|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44521963|NCT01245361|Infliximab|infliximab|mesh-list
44521964|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44521965|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44521966|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521967|NCT01245452|Methotrexate|methotrexate|mesh-list
44521968|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44521969|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
44521970|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44521971|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521972|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44521973|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
44521974|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521975|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521976|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
44521977|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521978|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44521979|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44521980|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
44521981|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44521982|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44521983|NCT01245530|Donepezil|donepezil|mesh-list
44521984|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44521985|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44521986|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521987|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
44521988|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44521989|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44521990|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
44521991|NCT01245543|Docetaxel|docetaxel|mesh-list
44521992|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44521993|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44521994|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44521995|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44521996|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44521997|NCT01245556|Ipilimumab|ipilimumab|mesh-list
44521998|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44521999|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522000|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44522001|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522002|NCT01245582|Capecitabine|capecitabine|mesh-list
44522003|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
44522004|NCT01245582|Sorafenib|sorafenib|mesh-list
44522005|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522006|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
44522007|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522008|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522009|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522010|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522011|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44522012|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44522013|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44522014|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
43929997|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
44522015|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522017|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44522018|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522019|NCT01245816|Eflornithine|eflornithine|mesh-list
44522020|NCT01245816|Sulindac|sulindac|mesh-list
44522021|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522022|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44522023|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44522024|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44522025|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522026|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44522027|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522028|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522029|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522030|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522031|NCT01245816|Analgesics|analgesics|mesh-ancestor
44522032|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
44522033|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522034|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522035|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522036|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522037|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44522038|NCT01245855|Alprostadil|alprostadil|mesh-list
44522039|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44522040|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
44522041|NCT01245855|Urological Agents|urological agents|mesh-ancestor
44522042|NCT01245868|Lidocaine|lidocaine|mesh-list
44522043|NCT01245868|Bupivacaine|bupivacaine|mesh-list
44522044|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
44522045|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
44522046|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522047|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522048|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
44522049|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522050|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44522051|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44522052|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44522053|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522054|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522055|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
44522056|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44522057|NCT01245881|Protective Agents|protective agents|mesh-ancestor
44522058|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522059|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522060|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44522061|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44522062|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44522063|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
44522064|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522065|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44522066|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44522067|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522068|NCT01245946|Doxycycline|doxycycline|mesh-list
44522069|NCT01245946|Adapalene|adapalene|mesh-list
44522070|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522071|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522072|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
44522073|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44522074|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44522075|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522076|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522077|NCT01245946|Analgesics|analgesics|mesh-ancestor
44522078|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
44522079|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522080|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522081|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522082|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522083|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522084|NCT01245998|Dalteparin|dalteparin|mesh-list
44522085|NCT01245998|Tinzaparin|tinzaparin|mesh-list
44522086|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44522087|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
44522088|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44522089|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44522090|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522091|NCT01246037|Bisoprolol|bisoprolol|mesh-list
44522092|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522093|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
44522094|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
44522095|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522096|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522097|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44522098|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44522099|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44522100|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
44522101|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522102|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426688|NCT02213055|Permethrin|permethrin|mesh-list
44522103|NCT01246089|Ranibizumab|ranibizumab|mesh-list
44522104|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522105|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522106|NCT01246089|Growth Substances|growth substances|mesh-ancestor
44522107|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522108|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522109|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522110|NCT01246180|Diclofenac|diclofenac|mesh-list
44522111|NCT01246180|Amiloride|amiloride|mesh-list
44522112|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522113|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522114|NCT01246180|Analgesics|analgesics|mesh-ancestor
44522115|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
44522116|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522117|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522118|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522119|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522120|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44522121|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522122|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522123|NCT01246180|Diuretics|diuretics|mesh-ancestor
44522124|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
44522125|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44522126|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44522127|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522128|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44522129|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44522130|NCT01246284|Triamcinolone|triamcinolone|mesh-list
44522131|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44522132|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44522133|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44522134|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522135|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
44522136|NCT01246284|Hormones|hormones|mesh-ancestor
44522137|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522138|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522139|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522140|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
44522141|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522142|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522143|NCT01246362|Etoricoxib|etoricoxib|mesh-list
44522144|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522145|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522146|NCT01246362|Analgesics|analgesics|mesh-ancestor
44522147|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
44522148|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522149|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522150|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522151|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522152|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44522153|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44522154|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522155|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522157|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522158|NCT01246557|Dexamethasone|dexamethasone|mesh-list
44522159|NCT01246557|Lenalidomide|lenalidomide|mesh-list
44522160|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522161|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
44522162|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
44522163|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522164|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522165|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522166|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
44522167|NCT01246557|Hormones|hormones|mesh-ancestor
44522168|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522169|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44522170|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522171|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
44522172|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522173|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522174|NCT01246557|Growth Substances|growth substances|mesh-ancestor
44522175|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522176|NCT01246622|Cytarabine|cytarabine|mesh-list
44522177|NCT01246622|Lenalidomide|lenalidomide|mesh-list
44522178|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522179|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
44522180|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522181|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522182|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
44522183|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522184|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522185|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
44522186|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522187|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522188|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522189|NCT01246622|Growth Substances|growth substances|mesh-ancestor
44522190|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522191|NCT01246752|Cytarabine|cytarabine|mesh-list
44522192|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522193|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
44522194|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522195|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522196|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
44522197|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522198|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522199|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
44522200|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522201|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
44522202|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44522203|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44522204|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
44522205|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522206|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44522207|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44522208|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522209|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522210|NCT01246817|Sirolimus|sirolimus|mesh-list
44522211|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522212|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522213|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44522214|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522215|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
44522216|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522217|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
44522218|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343677|NCT01045941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522228|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44522229|NCT01247077|Selenium|selenium|mesh-list
44522230|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
44522231|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522232|NCT01247077|Protective Agents|protective agents|mesh-ancestor
44426811|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
44522233|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522234|NCT01247077|Trace Elements|trace elements|mesh-ancestor
44522235|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
44522236|NCT01247311|Vitamin D|vitamin d|mesh-list
44522237|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
44522238|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
44522239|NCT01247311|Vitamins|vitamins|mesh-list
44522240|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
44522241|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522242|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44522243|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44522244|NCT01247337|Gemcitabine|gemcitabine|mesh-list
44522245|NCT01247337|Capecitabine|capecitabine|mesh-list
44522246|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
44522247|NCT01247337|Cetuximab|cetuximab|mesh-list
44522248|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522250|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522251|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522252|NCT01247337|Antiviral Agents|antiviral agents|mesh-ancestor
44522253|NCT01247337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522254|NCT01247337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522255|NCT01247337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522256|NCT01247337|Immunologic Factors|immunologic factors|mesh-ancestor
44522257|NCT01247337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522258|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44522259|NCT01247493|Cytarabine|cytarabine|mesh-list
44522260|NCT01247493|Fludarabine|fludarabine|mesh-list
44522261|NCT01247493|Idarubicin|idarubicin|mesh-list
44522262|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522263|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522264|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
44522265|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522266|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522267|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
44522268|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522269|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
44522270|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522271|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44522272|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44522273|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44522274|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522275|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
44522276|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44522277|NCT01247558|Vitamins|vitamins|mesh-ancestor
44522278|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
44522279|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522280|NCT01247688|Fludarabine|fludarabine|mesh-list
44522281|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
44522282|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522283|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522284|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522285|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
44522286|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522287|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522288|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44522289|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
44522290|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44522291|NCT01247714|Phentermine|phentermine|mesh-list
44522292|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44522293|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522294|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
44522295|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44522296|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
44522297|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
44522298|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522299|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44522300|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522301|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522302|NCT01247857|Ropivacaine|ropivacaine|mesh-list
44522303|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
44522304|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
44522305|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522306|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522307|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
44522308|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522309|NCT01247909|Gentamicins|gentamicins|mesh-list
44522310|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
44522311|NCT01247909|Penicillins|penicillins|mesh-list
44522312|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522313|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522314|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44522315|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522316|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522317|NCT01247961|Dexamethasone|dexamethasone|mesh-list
44522318|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
44522319|NCT01247961|BB 1101|bb 1101|mesh-list
44522320|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522321|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
44522322|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
44522323|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522324|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522325|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522327|NCT01247961|Hormones|hormones|mesh-ancestor
44522328|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522329|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44522330|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522331|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
44522332|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522333|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522334|NCT01248078|Cephalexin|cephalexin|mesh-list
44522335|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522336|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522337|NCT01248091|Nitroprusside|nitroprusside|mesh-list
44522338|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522339|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
44522340|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44522341|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522342|NCT01248117|Ranibizumab|ranibizumab|mesh-list
44522343|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522344|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522345|NCT01248117|Growth Substances|growth substances|mesh-ancestor
44522346|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522347|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522348|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522349|NCT01248234|Propofol|propofol|mesh-list
44522350|NCT01248234|Etomidate|etomidate|mesh-list
44522351|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44522352|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522353|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522354|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44522355|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
44522356|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
44522357|NCT01248260|Folic Acid|folic acid|mesh-list
44522358|NCT01248260|Hematinics|hematinics|mesh-ancestor
44522359|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
44522360|NCT01248260|Vitamins|vitamins|mesh-ancestor
44522361|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
44522362|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522363|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44522364|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
44522365|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522366|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44522367|NCT01248338|Metoprolol|metoprolol|mesh-list
44522368|NCT01248338|Nebivolol|nebivolol|mesh-list
44522369|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44522370|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522371|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
44522372|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
44522373|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522374|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522375|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44522376|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44522377|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44522378|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
44522379|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522380|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522381|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
44522382|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44522383|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44522384|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44522385|NCT01248403|Paclitaxel|paclitaxel|mesh-list
44522386|NCT01248403|Everolimus|everolimus|mesh-list
44522387|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44522388|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522389|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
44522390|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
44522391|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44522392|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522393|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522394|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
44522395|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522396|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
44522397|NCT01248442|Vitamin D|vitamin d|mesh-list
44343859|NCT01046708|Progesterone|progesterone|mesh-list
44522398|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44522399|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522401|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
44522402|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44522403|NCT01248481|Acarbose|acarbose|mesh-list
44522404|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44522405|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522406|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522407|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44522408|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522409|NCT01248494|Letrozole|letrozole|mesh-list
44522410|NCT01248494|Dactolisib|dactolisib|mesh-list
44522411|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522412|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44522413|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44522414|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522415|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522416|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44522417|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
44522418|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522419|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522420|NCT01248611|Fentanyl|fentanyl|mesh-list
44522421|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44522422|NCT01248611|Narcotics|narcotics|mesh-ancestor
44522423|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522424|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522425|NCT01248611|Analgesics|analgesics|mesh-ancestor
44522426|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
44522427|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522428|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44522429|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44522430|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
44522431|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
44522432|NCT01248819|Ropivacaine|ropivacaine|mesh-list
44522433|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
44522434|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
44522435|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522436|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522437|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
44522438|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522439|NCT01248858|Trametinib|trametinib|mesh-list
44522440|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522441|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522442|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522443|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522444|NCT01248923|Dexamethasone|dexamethasone|mesh-list
44522445|NCT01248923|Bortezomib|bortezomib|mesh-list
44522446|NCT01248923|Filanesib|filanesib|mesh-list
44522447|NCT01248923|Lenograstim|lenograstim|mesh-list
44522448|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44522449|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522450|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
44522451|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
44522452|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522453|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522454|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522455|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
44522456|NCT01248923|Hormones|hormones|mesh-ancestor
44522457|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522458|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44522459|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522460|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44522461|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
44522462|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
44522463|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522464|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522465|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
44522466|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
44522467|NCT01249001|Aprepitant|aprepitant|mesh-list
44522468|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
44522469|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
44522470|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
44522471|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522472|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522473|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522474|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44522475|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522476|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522477|NCT01249339|Lobeline|lobeline|mesh-list
44522478|NCT01249339|Nicotine|nicotine|mesh-list
44522479|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44522480|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
44522481|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522482|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522483|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44522484|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44522485|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
44522486|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522487|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522488|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
44522489|NCT01249430|Cytarabine|cytarabine|mesh-list
44522490|NCT01249430|Etoposide|etoposide|mesh-list
44522491|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
44522492|NCT01249430|Azacitidine|azacitidine|mesh-list
44522493|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
44522494|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44522495|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522496|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44522497|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44522498|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522499|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522500|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522501|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
44522502|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
44522503|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522504|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522505|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
44522506|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522507|NCT01249430|Analgesics|analgesics|mesh-ancestor
44522508|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
44522509|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522510|NCT01249443|Paclitaxel|paclitaxel|mesh-list
44522511|NCT01249443|Carboplatin|carboplatin|mesh-list
44522512|NCT01249443|Vorinostat|vorinostat|mesh-list
44522513|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44522514|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522515|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44522516|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44522517|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44522518|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522519|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44522520|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522521|NCT01249521|Bevacizumab|bevacizumab|mesh-list
44522522|NCT01249521|Trebananib|trebananib|mesh-list
44522523|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44522524|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522525|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522526|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522527|NCT01249521|Growth Substances|growth substances|mesh-ancestor
44522528|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522529|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522530|NCT01249547|Axitinib|axitinib|mesh-list
44522531|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522532|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522533|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522534|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522535|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
44522536|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44522537|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522538|NCT01249690|Thalidomide|thalidomide|mesh-list
44522539|NCT01249690|Dexamethasone|dexamethasone|mesh-list
44522540|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
44522541|NCT01249690|Bortezomib|bortezomib|mesh-list
44522542|NCT01249690|Pirarubicin|pirarubicin|mesh-list
44522543|NCT01249690|Doxorubicin|doxorubicin|mesh-list
44522544|NCT01249690|BB 1101|bb 1101|mesh-list
44522545|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522546|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
44522547|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
44522548|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522549|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522550|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522551|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
44522552|NCT01249690|Hormones|hormones|mesh-ancestor
44426834|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522553|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522554|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44522564|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522565|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522567|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522568|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44522569|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44522570|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44522571|NCT01249820|Anidulafungin|anidulafungin|mesh-list
44522572|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
44522573|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522574|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
44522575|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44522576|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44522578|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
44522579|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522580|NCT01244256|Gentamicins|gentamicins|mesh-list
44522581|NCT01244256|Clotrimazole|clotrimazole|mesh-list
44522582|NCT01244256|Miconazole|miconazole|mesh-list
44522583|NCT01244256|Beclomethasone|beclomethasone|mesh-list
44522584|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44522585|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522586|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44522587|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522588|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522589|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522590|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
44522591|NCT01244256|Hormones|hormones|mesh-ancestor
44522592|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522593|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522594|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44522595|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44522596|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44522597|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
44522598|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44522599|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44522600|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44522601|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
44522602|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44522603|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44522604|NCT01243658|Oxytocin|oxytocin|mesh-list
44522605|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
44522606|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44522607|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522608|NCT01249833|Oseltamivir|oseltamivir|mesh-list
44522609|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
44522610|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522611|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522612|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522613|NCT01249664|Aflibercept|aflibercept|mesh-list
44522614|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522615|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522616|NCT01249664|Growth Substances|growth substances|mesh-ancestor
44522617|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522618|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522619|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522620|NCT01249651|Esomeprazole|esomeprazole|mesh-list
44522621|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44522622|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44522623|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44522624|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522625|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522626|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
44522627|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44522628|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44522629|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44522630|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522631|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522632|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
44522633|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626452|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
44522635|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44522636|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522637|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
44522638|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44522639|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44522640|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44522641|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522642|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522643|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44522644|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522645|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522646|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44522647|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522648|NCT01249274|Progesterone|progesterone|mesh-list
44522649|NCT01249274|Progestins|progestins|mesh-ancestor
44522650|NCT01249274|Hormones|hormones|mesh-ancestor
44522651|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44522652|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522653|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
44522654|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
44522655|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44522656|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522657|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522658|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44522659|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522660|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44522661|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
44522662|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44522663|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522664|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522665|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44522666|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44522667|NCT01249092|Protective Agents|protective agents|mesh-ancestor
44522668|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522669|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
44522670|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44522671|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
44522672|NCT01248949|Paclitaxel|paclitaxel|mesh-list
44522673|NCT01248949|Bevacizumab|bevacizumab|mesh-list
44522674|NCT01248949|Carboplatin|carboplatin|mesh-list
44522675|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44522676|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522677|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44522678|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44522679|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44522680|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522681|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44522682|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522683|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522684|NCT01248949|Growth Substances|growth substances|mesh-ancestor
44522685|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522686|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522687|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44522688|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
44522689|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522690|NCT01248793|Golimumab|golimumab|mesh-list
44522691|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44522692|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44522693|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522694|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522695|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
44522696|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522697|NCT01248780|Golimumab|golimumab|mesh-list
44522698|NCT01248780|Methotrexate|methotrexate|mesh-list
44522699|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44522700|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
44522701|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44522702|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522703|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522704|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
44522705|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522706|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522707|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522708|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522709|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44522710|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522711|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
44522712|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522713|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44522714|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44522715|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522716|NCT01248715|Oseltamivir|oseltamivir|mesh-list
44522717|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
44522718|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522719|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522720|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522721|NCT01248468|Aspirin|aspirin|mesh-list
44522722|NCT01248468|Acetaminophen|acetaminophen|mesh-list
44522723|NCT01248468|Sumatriptan|sumatriptan|mesh-list
44522724|NCT01248468|Caffeine|caffeine|mesh-list
44522725|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522726|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522728|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
44522729|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522730|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522731|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522732|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522733|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44522734|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44522735|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522736|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44522737|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44522738|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522739|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
44522740|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44522741|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44522742|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44522743|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44522744|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
44522745|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522746|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44522747|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44522748|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44522749|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
44522750|NCT01248364|Empagliflozin|empagliflozin|mesh-list
44522751|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44522752|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522753|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44522754|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522755|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44522756|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522757|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522758|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522759|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522760|NCT01246999|Vaccines|vaccines|mesh-list
44522761|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
44522762|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522763|NCT01246973|Curcumin|curcumin|mesh-list
44522764|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44522765|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522766|NCT01246973|Analgesics|analgesics|mesh-ancestor
44522767|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
44522768|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522769|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522770|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522771|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44522772|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522773|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522774|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522775|NCT01246206|Tacrolimus|tacrolimus|mesh-list
44522776|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
44522777|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44522778|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
44522779|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522780|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44522781|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522782|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522783|NCT01246011|Warfarin|warfarin|mesh-list
44522784|NCT01246011|Argatroban|argatroban|mesh-list
44522785|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
44522786|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
44522787|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44522788|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44522789|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522790|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522791|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44522792|NCT01245673|Lenalidomide|lenalidomide|mesh-list
44522793|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44522794|NCT01245673|Poly ICLC|poly iclc|mesh-list
44344332|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522795|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
44522796|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522797|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522798|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522799|NCT01245673|Growth Substances|growth substances|mesh-ancestor
44522800|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522801|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522802|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
44522803|NCT01245140|Alitretinoin|alitretinoin|mesh-list
44522804|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522805|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522806|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
44522807|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44522808|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44522809|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
44522810|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522811|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44522812|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44522813|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522814|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522815|NCT01245062|Trametinib|trametinib|mesh-list
44522816|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522817|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522818|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522819|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522820|NCT01244984|Fluticasone|fluticasone|mesh-list
44522821|NCT01244984|Xhance|xhance|mesh-list
44522822|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44522823|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44522824|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
44522825|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522826|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522827|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44522828|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
44522829|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522830|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44522831|NCT01244815|Asenapine|asenapine|mesh-list
44522832|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44522833|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44522834|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522835|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522836|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44522837|NCT01244490|Guanfacine|guanfacine|mesh-list
44522838|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44522839|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44427419|NCT02194062|Xhance|xhance|mesh-list
44522840|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44522841|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522842|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522843|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44522844|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522845|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522846|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522847|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44522848|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44522849|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44522850|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44522851|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
44522852|NCT01244425|Coagulants|coagulants|mesh-ancestor
44522853|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44522854|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522855|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44522856|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522857|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522858|NCT01244126|Fentanyl|fentanyl|mesh-list
44522859|NCT01244126|Morphine|morphine|mesh-list
44522860|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44522861|NCT01244126|Narcotics|narcotics|mesh-ancestor
44522862|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522863|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522864|NCT01244126|Analgesics|analgesics|mesh-ancestor
44522865|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
44522866|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522867|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44522868|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44522869|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
44522870|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
44522871|NCT01243944|Lenalidomide|lenalidomide|mesh-list
44522872|NCT01243944|Pomalidomide|pomalidomide|mesh-list
44522873|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
44522874|NCT01243944|Pipobroman|pipobroman|mesh-list
44522875|NCT01243944|Anagrelide|anagrelide|mesh-list
44522876|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
44522877|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522878|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522879|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522880|NCT01243944|Growth Substances|growth substances|mesh-ancestor
44522881|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522882|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522883|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
44522884|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522885|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522886|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44522887|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44522888|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44522889|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44522890|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44522891|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
44522892|NCT01243775|Docetaxel|docetaxel|mesh-list
44522893|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
44522894|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522895|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
44522896|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
44522897|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
44522898|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522899|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44522900|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522901|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44522902|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44522903|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522904|NCT01243242|Metadoxine|metadoxine|mesh-list
44522905|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44522906|NCT01243177|Lacosamide|lacosamide|mesh-list
44522907|NCT01243177|Carbamazepine|carbamazepine|mesh-list
44522908|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
44522909|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44522910|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44522911|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44522912|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522913|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
44522914|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44522915|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522916|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522917|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44522918|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44522919|NCT01243177|Analgesics|analgesics|mesh-ancestor
44522920|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
44522921|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522922|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44522923|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44522924|NCT01242748|Goserelin|goserelin|mesh-list
44522925|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44522926|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522927|NCT01242176|Empagliflozin|empagliflozin|mesh-list
44522928|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44522929|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522930|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44522931|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522932|NCT01241786|Lenalidomide|lenalidomide|mesh-list
44522933|NCT01241786|Azacitidine|azacitidine|mesh-list
44522934|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
44522935|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522936|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44522937|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44522938|NCT01241786|Growth Substances|growth substances|mesh-ancestor
44522939|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44522940|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522941|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44522942|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
44522943|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522944|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44522945|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
44522946|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44522947|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44522948|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44522949|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
44522950|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44522951|NCT01241292|Elotuzumab|elotuzumab|mesh-list
44522952|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44522953|NCT01241240|Timolol|timolol|mesh-list
44522954|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44522955|NCT01241240|Bimatoprost|bimatoprost|mesh-list
44522956|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44522957|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44522958|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44522959|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44522960|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44522961|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44522962|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44522963|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522964|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44522965|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44522966|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44522967|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44522968|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44522969|NCT01240863|Hydrocodone|hydrocodone|mesh-list
44522970|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44522971|NCT01240863|Narcotics|narcotics|mesh-ancestor
44522972|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44522973|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522974|NCT01240863|Analgesics|analgesics|mesh-ancestor
44522975|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
44522976|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44522977|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
44522978|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
44522979|NCT01240811|Copper|copper|mesh-list
44522980|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
44522981|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44522982|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
44522983|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44522984|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44522985|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44522986|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44344642|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
44522998|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44522999|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
44523000|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523001|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
44523002|NCT01240382|Protective Agents|protective agents|mesh-ancestor
44523003|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
44523004|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44523005|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523006|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44523007|NCT01244828|Asenapine|asenapine|mesh-list
44523008|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44523009|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44523010|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523011|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523012|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44523013|NCT01243346|Crenolanib|crenolanib|mesh-list
44523014|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523015|NCT01243073|Imetelstat|imetelstat|mesh-list
44523016|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
44523017|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523018|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523019|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523020|NCT01242930|Niacinamide|niacinamide|mesh-list
44523021|NCT01242930|Lenalidomide|lenalidomide|mesh-list
44523022|NCT01242930|Imetelstat|imetelstat|mesh-list
44523023|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
44523024|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
44523025|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523026|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523027|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523028|NCT01242930|Growth Substances|growth substances|mesh-ancestor
44523029|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523030|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523031|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523032|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523033|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523034|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
44523035|NCT01242930|Vitamins|vitamins|mesh-ancestor
44523036|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
44523037|NCT01241214|Cetirizine|cetirizine|mesh-list
44523038|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44523039|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44523040|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44523041|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
44523042|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
44523043|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523044|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523045|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523046|NCT01240759|Metformin|metformin|mesh-list
44523047|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44523048|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523049|NCT01240512|Vitamin D|vitamin d|mesh-list
44523050|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
44523051|NCT01240512|Vitamins|vitamins|mesh-ancestor
44523052|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
44523053|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523054|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44523055|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44523056|NCT01240629|Doxorubicin|doxorubicin|mesh-list
44523057|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44523058|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44523059|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523060|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44523061|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44523062|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523063|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523064|NCT01240889|Fluticasone|fluticasone|mesh-list
44523065|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523066|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44523067|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
44523068|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523069|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523070|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44523071|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
44523072|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
44523073|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44523074|NCT01241006|Dexamethasone|dexamethasone|mesh-list
44523076|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
44523077|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523079|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
44085635|NCT00019812|Paclitaxel|paclitaxel|mesh-list
44523080|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523081|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523082|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523083|NCT01241006|Hormones|hormones|mesh-ancestor
44523084|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523085|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523086|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523087|NCT01241734|Lenalidomide|lenalidomide|mesh-list
44523088|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
44523089|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523090|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523091|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523092|NCT01241734|Growth Substances|growth substances|mesh-ancestor
44523093|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523094|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523095|NCT01244334|Prednisolone|prednisolone|mesh-list
44523096|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44523097|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
44523098|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44523099|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
44523100|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44523101|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
44523102|NCT01244334|Difluprednate|difluprednate|mesh-list
44523103|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523104|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
44523105|NCT01244334|Hormones|hormones|mesh-ancestor
44523106|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523107|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523108|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523109|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523110|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
44523111|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
44523112|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523113|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523114|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44523115|NCT01244334|Protective Agents|protective agents|mesh-ancestor
44523116|NCT01246232|Amisulpride|amisulpride|mesh-list
44523117|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44523118|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44523119|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523120|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523121|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44523122|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44523123|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
44523124|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523125|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523126|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44523127|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
44523128|NCT01248975|Montelukast|montelukast|mesh-list
44523129|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44523130|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44523131|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44523132|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
44523133|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523134|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427689|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
44523135|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44523136|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44523137|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523138|NCT01248962|Carboplatin|carboplatin|mesh-list
44523139|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523140|NCT01247090|Vasopressins|vasopressins|mesh-list
44523141|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
44523142|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
44523143|NCT01247090|Coagulants|coagulants|mesh-ancestor
44523144|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44523145|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44523146|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
44523147|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523148|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
44523149|NCT01247701|Busulfan|busulfan|mesh-list
44523150|NCT01247701|Fludarabine|fludarabine|mesh-list
44523151|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523152|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
44523153|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523154|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523155|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44523156|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
44523157|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523158|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523159|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44523160|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44523161|NCT01248247|Sorafenib|sorafenib|mesh-list
44523162|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523163|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523164|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523165|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523166|NCT04512066|Risperidone|risperidone|mesh-list
44523167|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44523168|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
44523169|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523170|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523171|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523172|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44523173|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44523174|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523175|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44523176|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44523177|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
44523178|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44523179|NCT04515628|Branebrutinib|branebrutinib|mesh-list
44523180|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44523181|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44523182|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
44427745|NCT02186652|Pantoprazole|pantoprazole|mesh-list
44523183|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523184|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44523185|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44523186|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523187|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523188|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
44523189|NCT04510051|Fludarabine|fludarabine|mesh-list
44523190|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523191|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
44523192|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523193|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523194|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44523195|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
44523196|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523197|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523198|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44523199|NCT04516317|Artesunate|artesunate|mesh-list
44523200|NCT04516317|Quinine|quinine|mesh-list
44523201|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
44523202|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44523203|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44523204|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523205|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523206|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
44523207|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
44523208|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44523209|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
44523210|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44523211|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523212|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44523213|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523214|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44523215|NCT04516317|Analgesics|analgesics|mesh-ancestor
44523216|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
44523217|NCT04515147|Vaccines|vaccines|mesh-list
44523218|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44523219|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
44523220|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523221|NCT04511416|Metformin|metformin|mesh-list
44523222|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44523223|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523224|NCT04515719|Belimumab|belimumab|mesh-list
44523225|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523226|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
44523227|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523228|NCT04518046|Nivolumab|nivolumab|mesh-list
44523229|NCT04518046|Ipilimumab|ipilimumab|mesh-list
44523230|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523231|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523232|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44523233|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523234|NCT04513717|Leuprolide|leuprolide|mesh-list
44523235|NCT04513717|Goserelin|goserelin|mesh-list
44523236|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44523237|NCT04513717|Flutamide|flutamide|mesh-list
44523238|NCT04513717|Bicalutamide|bicalutamide|mesh-list
44523239|NCT04513717|Tryptophan|tryptophan|mesh-list
44523240|NCT04513717|Buserelin|buserelin|mesh-list
44523241|NCT04513717|Hormones|hormones|mesh-list
44523242|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523243|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523244|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44523245|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
44523246|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44523247|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523248|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523249|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
44523250|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
44523251|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
44523252|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44523253|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
44523254|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44523255|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44523256|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
44523257|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44523258|NCT04512534|Antibodies|antibodies|mesh-list
44523259|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44523260|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
44523261|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523262|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523263|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523264|NCT04518124|Propranolol|propranolol|mesh-list
44523265|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44523266|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44523267|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
44523268|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523269|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523270|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523271|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523272|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44523273|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
44523274|NCT04511728|Propofol|propofol|mesh-list
44523275|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44523276|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523277|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523278|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44523279|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
44523280|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
44523281|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
44523282|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44523283|NCT04519983|Osimertinib|osimertinib|mesh-list
44523284|NCT04519983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523285|NCT04519983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523286|NCT04519983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523287|NCT04519983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523288|NCT04519463|Lidocaine|lidocaine|mesh-list
44523289|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
44523290|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
44523291|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523292|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523293|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
44523294|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523295|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523296|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44523297|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44523298|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523299|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523300|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44523301|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523302|NCT04519710|Rituximab|rituximab|mesh-list
44523303|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
44523304|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523305|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523306|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
44523307|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523308|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523309|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
44523310|NCT04519151|Lenvatinib|lenvatinib|mesh-list
44523311|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523312|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523313|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523314|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523315|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523316|NCT04519385|Dexamethasone|dexamethasone|mesh-list
44523317|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523318|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
44523319|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
44523320|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523321|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523322|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523323|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
44523324|NCT04519385|Hormones|hormones|mesh-ancestor
44523325|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523326|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523327|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523328|NCT04518852|Sorafenib|sorafenib|mesh-list
44523329|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523330|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523331|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523332|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523333|NCT04518735|Anticoagulants|anticoagulants|mesh-list
44523334|NCT04518618|Fentanyl|fentanyl|mesh-list
44523335|NCT04518618|Naloxone|naloxone|mesh-list
44523336|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44523337|NCT04518618|Narcotics|narcotics|mesh-ancestor
44523338|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523349|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
44523350|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523351|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523352|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523353|NCT04518982|Growth Substances|growth substances|mesh-ancestor
44523354|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523355|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523356|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
44523357|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523358|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
44523359|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
44523360|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523361|NCT04518540|Protective Agents|protective agents|mesh-ancestor
44523362|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523363|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
44523364|NCT04518540|Vitamins|vitamins|mesh-ancestor
44523365|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
44523366|NCT04518202|Lidocaine|lidocaine|mesh-list
44523367|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
44523368|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
44523369|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523370|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523371|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
44523372|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345038|NCT01051648|Triamcinolone|triamcinolone|mesh-list
44523373|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523374|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44523375|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44523376|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523377|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523378|NCT04518189|Lidocaine|lidocaine|mesh-list
44523379|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
44523380|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
44523381|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523382|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523383|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
44523384|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523385|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523386|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44523387|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44523388|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523389|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523390|NCT04517890|Lidocaine|lidocaine|mesh-list
44523391|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
44523392|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
44523393|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523394|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523395|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
44523396|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523397|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523398|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44523399|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43626648|NCT03090087|Regadenoson|regadenoson|mesh-list
44523400|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523401|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523402|NCT04518176|Oxytocin|oxytocin|mesh-list
44523403|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
44523404|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44523405|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523406|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
44523407|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44523408|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44523409|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523410|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
44523411|NCT04518163|Coagulants|coagulants|mesh-ancestor
44523412|NCT04517526|Bevacizumab|bevacizumab|mesh-list
44523413|NCT04517526|Durvalumab|durvalumab|mesh-list
44523414|NCT04517526|Cisplatin|cisplatin|mesh-list
44523415|NCT04517526|Carboplatin|carboplatin|mesh-list
44523416|NCT04517526|Pemetrexed|pemetrexed|mesh-list
44523417|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523418|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523419|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523420|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523421|NCT04517526|Growth Substances|growth substances|mesh-ancestor
44523422|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523423|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523424|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523425|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523426|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44523427|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44523428|NCT04517292|Gemcitabine|gemcitabine|mesh-list
44523429|NCT04517292|Cisplatin|cisplatin|mesh-list
44523430|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523431|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523432|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
44523433|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523434|NCT04517292|Antiviral Agents|antiviral agents|mesh-ancestor
44523435|NCT04517292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523436|NCT04517292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523437|NCT04517292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523438|NCT04517292|Immunologic Factors|immunologic factors|mesh-ancestor
44523439|NCT04517292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523440|NCT04517227|Durvalumab|durvalumab|mesh-list
44523441|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523442|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523443|NCT04517214|Gemcitabine|gemcitabine|mesh-list
44523444|NCT04517214|Cisplatin|cisplatin|mesh-list
44523445|NCT04517214|Capecitabine|capecitabine|mesh-list
44523446|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523447|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523448|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
44345062|NCT01051765|Cisplatin|cisplatin|mesh-list
44523450|NCT04517214|Antiviral Agents|antiviral agents|mesh-ancestor
44523451|NCT04517214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523452|NCT04517214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523453|NCT04517214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523454|NCT04517214|Immunologic Factors|immunologic factors|mesh-ancestor
44523455|NCT04517214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523456|NCT04517201|Insulin|insulin|mesh-list
44523457|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44523458|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44523459|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523460|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
44523461|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523462|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523463|NCT04517188|Iodine|iodine|mesh-list
44523464|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
44523465|NCT04517188|Povidone|povidone|mesh-list
44523466|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44523467|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523468|NCT04517188|Trace Elements|trace elements|mesh-ancestor
44523469|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
44523470|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523471|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
44523472|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
44523473|NCT04516616|Paclitaxel|paclitaxel|mesh-list
44523474|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44523475|NCT04516616|Cisplatin|cisplatin|mesh-list
44523476|NCT04516616|Antibodies|antibodies|mesh-list
44523477|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44523478|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44523479|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523480|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
44523481|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
44523482|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
44523483|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523484|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
44523485|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523486|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
44523487|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523488|NCT04516681|Vitamins|vitamins|mesh-ancestor
44523489|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
44523490|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
44523491|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523492|NCT04516681|Protective Agents|protective agents|mesh-ancestor
44523493|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
44523494|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44523495|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523496|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523497|NCT04516304|Equol|equol|mesh-list
44523498|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
44523499|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44523500|NCT04516304|Estrogens|estrogens|mesh-ancestor
44523501|NCT04516304|Hormones|hormones|mesh-ancestor
44523502|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523503|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523504|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
44523505|NCT04516174|Ropivacaine|ropivacaine|mesh-list
44523506|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44523507|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523508|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523509|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44523510|NCT04516174|Analgesics|analgesics|mesh-ancestor
44523511|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
44523512|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523513|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44523514|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44523515|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44523516|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
44523517|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523518|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523519|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
44523520|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
44523521|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
44523522|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44523523|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44523524|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523525|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
44523526|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44523527|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
44523528|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523529|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523530|NCT04515836|Olaparib|olaparib|mesh-list
44523531|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44523532|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523533|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523534|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523535|NCT04515732|Apremilast|apremilast|mesh-list
44523536|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44523537|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44523538|NCT04515732|Analgesics|analgesics|mesh-ancestor
44523539|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
44523540|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523541|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523542|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523543|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523544|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44523545|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44523546|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523547|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523548|NCT04515420|Norepinephrine|norepinephrine|mesh-list
44523549|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44523550|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44523551|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
44523552|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627324|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
44523553|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523554|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523555|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
44523556|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
44523557|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523558|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44523560|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
44523561|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523562|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523563|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523564|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44523565|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44523566|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44523567|NCT04514835|Cisplatin|cisplatin|mesh-list
44523568|NCT04514835|Capecitabine|capecitabine|mesh-list
44523569|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523570|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523571|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
44523572|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523573|NCT04514770|Misoprostol|misoprostol|mesh-list
44523574|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44523575|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
44523576|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44523577|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523578|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44523579|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523580|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
44523581|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
44523582|NCT04514731|Analgesics|analgesics|mesh-ancestor
44523583|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
44523584|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523585|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523586|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
44523587|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523588|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523589|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
44523590|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44523591|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523592|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523593|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44523594|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
44523595|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44523596|NCT04514796|Adalimumab|adalimumab|mesh-list
44523597|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523598|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523599|NCT04514419|Docetaxel|docetaxel|mesh-list
44523600|NCT04514419|Trastuzumab|trastuzumab|mesh-list
44523601|NCT04514419|Pertuzumab|pertuzumab|mesh-list
44523602|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523603|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
44523604|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
44523605|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
44523606|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523607|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523608|NCT04514588|Caffeine|caffeine|mesh-list
44523609|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44523610|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523611|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44523612|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523613|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523614|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44523615|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44523616|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
44523617|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523618|NCT04514094|Fluorides|fluorides|mesh-list
44523619|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
44523620|NCT04514094|Protective Agents|protective agents|mesh-ancestor
44523621|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523622|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44523623|NCT04514081|Decitabine|decitabine|mesh-list
44523624|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523625|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
44523626|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523627|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523628|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523629|NCT04513821|Ethanol|ethanol|mesh-list
44523630|NCT04513821|Minocycline|minocycline|mesh-list
44523631|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44523632|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523633|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523634|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523635|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44523636|NCT04513509|Propranolol|propranolol|mesh-list
44523637|NCT04513509|Metoprolol|metoprolol|mesh-list
44523638|NCT04513509|Digoxin|digoxin|mesh-list
44523639|NCT04513509|Atenolol|atenolol|mesh-list
44523640|NCT04513509|Verapamil|verapamil|mesh-list
44523641|NCT04513509|Nebivolol|nebivolol|mesh-list
44523642|NCT04513509|Bisoprolol|bisoprolol|mesh-list
44523643|NCT04513509|Diltiazem|diltiazem|mesh-list
44523644|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44523645|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44523646|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44523647|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523648|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523649|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523650|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523651|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44523652|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
44523653|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
44523654|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
44523655|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523656|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44523657|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44523658|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523659|NCT04513509|Protective Agents|protective agents|mesh-ancestor
44523660|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44523661|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44523662|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44523663|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44523664|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523665|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44523666|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
44523667|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44523668|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44523669|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
44523670|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523671|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44523672|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44523673|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523674|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523675|NCT04513457|Liver Extracts|liver extracts|mesh-list
44523676|NCT04513457|Hematinics|hematinics|mesh-ancestor
44523681|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
44523682|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44523683|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523684|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523685|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44523686|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523687|NCT04513379|Efavirenz|efavirenz|mesh-list
44523688|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44523689|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44523690|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523691|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523692|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
44523693|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523694|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44523695|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44523696|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44523697|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44523698|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44523699|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44523700|NCT04512872|Denosumab|denosumab|mesh-list
44523701|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44523702|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523703|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44523704|NCT04512638|Amoxicillin|amoxicillin|mesh-list
44523705|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
44523706|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44523707|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523708|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44523709|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
44523710|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
44523711|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44523712|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44523713|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44523714|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
44523715|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523716|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523717|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44523718|NCT04512313|Rocuronium|rocuronium|mesh-list
44523719|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44523720|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44523721|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44523722|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523723|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523724|NCT04512105|Venetoclax|venetoclax|mesh-list
44523725|NCT04512105|Pitavastatin|pitavastatin|mesh-list
44523726|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523727|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44523728|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44523729|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44523730|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
44523731|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523732|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523733|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44523734|NCT04511975|Azacitidine|azacitidine|mesh-list
44523735|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523736|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
44523737|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523738|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523739|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523740|NCT04511715|Bevacizumab|bevacizumab|mesh-list
44523741|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523742|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523743|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523744|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523745|NCT04511715|Growth Substances|growth substances|mesh-ancestor
44523746|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523747|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523748|NCT04511897|Expectorants|expectorants|mesh-list
44523749|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
44523750|NCT04511923|Heparin|heparin|mesh-list
44523751|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
44523752|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44523753|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44523754|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523755|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
44523756|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44523757|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
44523758|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44523759|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44523760|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523761|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428330|NCT02170025|Riociguat|riociguat|mesh-list
44523762|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
44523763|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
44523764|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44523765|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
44523766|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44523767|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
44523768|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523769|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523770|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
44523771|NCT04511299|SMOFlipid|smoflipid|mesh-list
44523772|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44523773|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44523774|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44523775|NCT04511000|Atorvastatin|atorvastatin|mesh-list
44523776|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44523777|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44523778|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
44523779|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523780|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44523781|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44523782|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523783|NCT04510935|Anesthetics|anesthetics|mesh-list
44523784|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523785|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523786|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
44523787|NCT04510870|Hematinics|hematinics|mesh-ancestor
44523788|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44523789|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
44523790|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523791|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523792|NCT04510649|Rifampin|rifampin|mesh-list
44523793|NCT04510649|Rabeprazole|rabeprazole|mesh-list
44523794|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44523795|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428355|NCT02169414|Levodopa|levodopa|mesh-list
44523796|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44523797|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523798|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523799|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44523800|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
44523801|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44523802|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523803|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
44523804|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44523805|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44523806|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44523807|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44523808|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44523809|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44523810|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44523811|NCT04510818|Capecitabine|capecitabine|mesh-list
44523812|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523813|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
44523814|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523815|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523816|NCT04510610|Decitabine|decitabine|mesh-list
44523817|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523818|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
44523819|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345512|NCT01053585|Baclofen|baclofen|mesh-list
44523820|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523821|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523822|NCT04510662|Telmisartan|telmisartan|mesh-list
44523823|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44523824|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44523825|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44523826|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523827|NCT04510220|Ofatumumab|ofatumumab|mesh-list
44523828|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523829|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
44523830|NCT04510337|Rocuronium|rocuronium|mesh-list
44523831|NCT04510337|Analgesics|analgesics|mesh-ancestor
44428387|NCT02169271|Aspirin|aspirin|mesh-list
44523832|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
44523833|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523834|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523835|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
44523836|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44523837|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44523838|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
44523839|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44523840|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523841|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523842|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44523843|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
44523844|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44523845|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44523846|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44523847|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44523848|NCT04510233|Ivermectin|ivermectin|mesh-list
44523849|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44523850|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523851|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
44523852|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44523853|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44523854|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
44523855|NCT04510428|Antibodies|antibodies|mesh-list
44523856|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
44523857|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44523858|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44523859|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
44523860|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523861|NCT04519645|Lacosamide|lacosamide|mesh-list
44523862|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
44523863|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44523864|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44523865|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44523866|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523867|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
44523868|NCT04512261|Trastuzumab|trastuzumab|mesh-list
44523869|NCT04512261|Tucatinib|tucatinib|mesh-list
44523870|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523871|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523872|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44523873|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523874|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523875|NCT04518345|Azacitidine|azacitidine|mesh-list
44428424|NCT02168842|Isradipine|isradipine|mesh-list
44523876|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44523877|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
44523878|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523879|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523880|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523881|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
44523882|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523883|NCT04513860|Cenobamate|cenobamate|mesh-list
44523884|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
44523885|NCT04517435|Prednisone|prednisone|mesh-list
44523886|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
44523887|NCT04517435|Rituximab|rituximab|mesh-list
44523888|NCT04517435|Doxorubicin|doxorubicin|mesh-list
44523889|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44523890|NCT04517435|Vincristine|vincristine|mesh-list
44523891|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44523892|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
44523893|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523894|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523895|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44523896|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
44523897|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523898|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523899|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44523900|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523901|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44523902|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44523903|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44523904|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523905|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523906|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
44523907|NCT04517435|Hormones|hormones|mesh-ancestor
44523908|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523909|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523910|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44523911|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44523912|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44523913|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44523914|NCT04510207|Vaccines|vaccines|mesh-list
44523915|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
44523916|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523917|NCT04510506|Pancrelipase|pancrelipase|mesh-list
44523918|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523919|NCT04512430|Bevacizumab|bevacizumab|mesh-list
44523920|NCT04512430|Carboplatin|carboplatin|mesh-list
44523921|NCT04512430|Pemetrexed|pemetrexed|mesh-list
44523922|NCT04512430|Atezolizumab|atezolizumab|mesh-list
44428473|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
44523923|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44523924|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523925|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44523926|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44523927|NCT04512430|Growth Substances|growth substances|mesh-ancestor
44523928|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523929|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
44523930|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523931|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523932|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44523933|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44523934|NCT04517851|Elotuzumab|elotuzumab|mesh-list
44523935|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523936|NCT04515238|Venetoclax|venetoclax|mesh-list
44345667|NCT01054118|Hormones|hormones|mesh-ancestor
44523957|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44523958|NCT04511832|Analgesics|analgesics|mesh-ancestor
44523959|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
44523960|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523961|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523962|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523963|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44523964|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44523965|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44523966|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523967|NCT04514029|Dexamethasone|dexamethasone|mesh-list
44523968|NCT04514029|Simvastatin|simvastatin|mesh-list
44523969|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44523970|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
44523971|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
44523972|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44523973|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44523974|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44523975|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
44523976|NCT04514029|Hormones|hormones|mesh-ancestor
44523977|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44523978|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44523979|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44523980|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44523981|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44523982|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
44523983|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44523984|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44523985|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44523986|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524008|NCT04511247|Sirolimus|sirolimus|mesh-list
44524009|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524010|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524011|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44524012|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524013|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
44524014|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524015|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
44524016|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524017|NCT04511234|Sirolimus|sirolimus|mesh-list
44524018|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524019|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524020|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44524021|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524022|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
44524023|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524024|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
44524025|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524026|NCT04516278|Bevacizumab|bevacizumab|mesh-list
44524027|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524028|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524029|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44524030|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44524031|NCT04516278|Growth Substances|growth substances|mesh-ancestor
44524032|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524033|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
44524034|NCT04518462|Bupivacaine|bupivacaine|mesh-list
44524035|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524036|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
44524037|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524038|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524039|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
44524040|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524041|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44524042|NCT02594072|Goserelin|goserelin|mesh-list
44524043|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44524044|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524046|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44524047|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
44524048|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524049|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524050|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44524051|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44524052|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
44524053|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524054|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524055|NCT02590094|Bevacizumab|bevacizumab|mesh-list
44524056|NCT02590094|Aflibercept|aflibercept|mesh-list
44524057|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524058|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524059|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44524060|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44524061|NCT02590094|Growth Substances|growth substances|mesh-ancestor
44524062|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524063|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
44524064|NCT02598999|Lactoferrin|lactoferrin|mesh-list
44524065|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
44524066|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524067|NCT02598960|Nivolumab|nivolumab|mesh-list
44524068|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524069|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524070|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44524071|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524072|NCT02597634|Ibuprofen|ibuprofen|mesh-list
44524073|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44524074|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524075|NCT02597634|Analgesics|analgesics|mesh-ancestor
44524076|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
44524077|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524078|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524079|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524080|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44524081|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44524082|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524083|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524095|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44524097|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524098|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524099|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
44524100|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44524101|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44524102|NCT02598583|Ravulizumab|ravulizumab|mesh-list
44524103|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44524104|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524105|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
44524106|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524107|NCT02596035|Nivolumab|nivolumab|mesh-list
44524108|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524109|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524110|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44524111|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524112|NCT02595489|Vitamin D|vitamin d|mesh-list
44524113|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
44524114|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
44524115|NCT02595489|Vitamins|vitamins|mesh-list
44524116|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
44524117|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524118|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44524119|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524120|NCT02595372|Omeprazole|omeprazole|mesh-list
44524121|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44524122|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524123|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44524124|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524125|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524126|NCT02596503|Cefixime|cefixime|mesh-list
44524127|NCT02596503|Irinotecan|irinotecan|mesh-list
44524128|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44524129|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44524130|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524131|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524132|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524133|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524134|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524135|NCT02598895|Carboplatin|carboplatin|mesh-list
44524137|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524138|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
44428640|NCT02164929|Hormones|hormones|mesh-ancestor
44524139|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
44524140|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
44524141|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524142|NCT02598557|Exemestane|exemestane|mesh-list
44524143|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524144|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44524145|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44524146|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524147|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524148|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44524149|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44524150|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524151|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524152|NCT05147272|Gemcitabine|gemcitabine|mesh-list
44524153|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524154|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
44524155|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524156|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524157|NCT05147272|Antiviral Agents|antiviral agents|mesh-ancestor
44524158|NCT05147272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524159|NCT05147272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524160|NCT05147272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524161|NCT05147272|Immunologic Factors|immunologic factors|mesh-ancestor
44524162|NCT05147272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524163|NCT05144945|Vaccines|vaccines|mesh-list
44524164|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
44524165|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524166|NCT05142072|Vitamin D|vitamin d|mesh-list
44524167|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
44524168|NCT05142072|Vitamins|vitamins|mesh-ancestor
44524169|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
44524170|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524171|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44524172|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524173|NCT05146778|Lidocaine|lidocaine|mesh-list
44524174|NCT05146778|Fentanyl|fentanyl|mesh-list
44524175|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
44524176|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
44524177|NCT05146778|Anesthetics|anesthetics|mesh-list
44524178|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524179|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524180|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524181|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
44524182|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524183|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524184|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44524185|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44524186|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524187|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524188|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44524189|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524190|NCT05146778|Analgesics|analgesics|mesh-ancestor
44524191|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44345926|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
44524192|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44524193|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44524194|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44524195|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524196|NCT05146778|Narcotics|narcotics|mesh-ancestor
44524197|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524198|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524199|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
44524200|NCT05145764|Suvorexant|suvorexant|mesh-list
44524201|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44524202|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44524203|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524204|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524205|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44524206|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524207|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524208|NCT05149560|Ticagrelor|ticagrelor|mesh-list
44524209|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44524210|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44524211|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44524212|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44524213|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
44524214|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524215|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524216|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524217|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44524218|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524219|NCT05143723|Hormones|hormones|mesh-list
44524220|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524221|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524222|NCT05143281|Dexamethasone|dexamethasone|mesh-list
44524223|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
44524224|NCT05143281|BB 1101|bb 1101|mesh-list
44524225|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524226|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
44524227|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
44524228|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524229|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524230|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524231|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
44524232|NCT05143281|Hormones|hormones|mesh-ancestor
44524233|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524234|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44524235|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524236|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44524237|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524238|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524239|NCT05143125|Decitabine|decitabine|mesh-list
44524240|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524241|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
44524242|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524243|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524244|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524245|NCT05142904|Iodine|iodine|mesh-list
44524246|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
44524247|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44524248|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524249|NCT05142904|Trace Elements|trace elements|mesh-ancestor
44524250|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
44524251|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524252|NCT05142865|Cisplatin|cisplatin|mesh-list
44524253|NCT05142865|Carboplatin|carboplatin|mesh-list
44524254|NCT05142865|Etoposide|etoposide|mesh-list
44524255|NCT05142865|Apatinib|apatinib|mesh-list
44524256|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524257|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44524258|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44524259|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44524260|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524261|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524262|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44524263|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44524264|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524265|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524266|NCT05146271|Anesthetics|anesthetics|mesh-list
44524267|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524268|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524269|NCT05146245|Risperidone|risperidone|mesh-list
44524270|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44524271|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
44524272|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524273|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524274|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524275|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44524276|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761034|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44428761|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
44524277|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524278|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524279|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44524280|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
44524281|NCT05146089|Bosentan|bosentan|mesh-list
44524282|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44524283|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44524284|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524286|NCT05145543|Dexamethasone|dexamethasone|mesh-list
44524287|NCT05145543|Fentanyl|fentanyl|mesh-list
44524288|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
44524289|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524290|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
44524291|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
44524292|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524293|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524294|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524295|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
44524296|NCT05145543|Hormones|hormones|mesh-ancestor
44524297|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524298|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44524299|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524300|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44524301|NCT05145543|Narcotics|narcotics|mesh-ancestor
44524302|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524303|NCT05145543|Analgesics|analgesics|mesh-ancestor
44524304|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
44524305|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524306|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524307|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
44524308|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
44524309|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524310|NCT05145270|Sulforaphane|sulforaphane|mesh-list
44524311|NCT05145270|Dexetimide|dexetimide|mesh-list
44524312|NCT05145270|Citalopram|citalopram|mesh-list
44524313|NCT05145270|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44524314|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44524315|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524316|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524317|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524318|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
44524319|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524320|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44524321|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
44524322|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524323|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44524324|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44524325|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
44524326|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
44428828|NCT02161731|Warfarin|warfarin|mesh-list
44524327|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524328|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44524329|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44524330|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
44524331|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44524332|NCT05145270|Protective Agents|protective agents|mesh-ancestor
44524333|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524334|NCT05147857|Misoprostol|misoprostol|mesh-list
44524335|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44524336|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
44524337|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44524338|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524339|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44524340|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524341|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
44524342|NCT05147753|Moxonidine|moxonidine|mesh-list
44524343|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44524344|NCT05147194|Trimetazidine|trimetazidine|mesh-list
44524345|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
44524346|NCT05146895|Imiquimod|imiquimod|mesh-list
44524347|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44524348|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
44524349|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524350|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524351|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
44524352|NCT05146713|Propolis|propolis|mesh-list
44524353|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44524354|NCT05146713|Eusol|eusol|mesh-list
44524355|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524357|NCT05145608|Lamotrigine|lamotrigine|mesh-list
44524358|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
44524359|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44524360|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346152|NCT01056874|Maraviroc|maraviroc|mesh-list
44524361|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524375|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524376|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
44524377|NCT05149339|Vitamin D|vitamin d|mesh-list
44524378|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524379|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524380|NCT05149339|Vitamins|vitamins|mesh-ancestor
44524381|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
44524382|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44524383|NCT05149170|Antibodies|antibodies|mesh-list
44524384|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44524385|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
44524386|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524387|NCT05149092|Caseins|caseins|mesh-list
44524388|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
44524389|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
44524390|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524391|NCT05148910|Copper|copper|mesh-list
44524392|NCT05148910|Trace Elements|trace elements|mesh-ancestor
44524393|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
44524394|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524395|NCT05148884|Befiradol|befiradol|mesh-list
44524396|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44524397|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44524398|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
44524399|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524400|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524401|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524402|NCT05148767|Irinotecan|irinotecan|mesh-list
44524403|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44524404|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44428881|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
44524405|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524406|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524407|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524408|NCT05148715|Tacrolimus|tacrolimus|mesh-list
44524409|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524410|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
44524411|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524412|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44524413|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524414|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524415|NCT05148689|Phenylephrine|phenylephrine|mesh-list
44524416|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
44524417|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44524418|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44524419|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44524420|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524421|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524422|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524423|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
44524424|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
44524425|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524426|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
44524427|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44524428|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
44524429|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44524430|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
44524431|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44524432|NCT05148689|Protective Agents|protective agents|mesh-ancestor
44524433|NCT05148442|Azacitidine|azacitidine|mesh-list
44524435|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524436|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
44524437|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524438|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524439|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524440|NCT05148403|Glyburide|glyburide|mesh-list
44524441|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44524442|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346275|NCT01057498|RNS60|rns60|mesh-list
44524444|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44524445|NCT05148169|Sulforaphane|sulforaphane|mesh-list
44524446|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44524447|NCT05148169|Protective Agents|protective agents|mesh-ancestor
44524448|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524449|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524450|NCT05148143|Raltitrexed|raltitrexed|mesh-list
44524451|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524452|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
44524453|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524454|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524455|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44524456|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524457|NCT05145218|Paclitaxel|paclitaxel|mesh-list
44524458|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44524459|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524460|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44524461|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44524462|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44524463|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524464|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
44524465|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44524466|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44524467|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
44524468|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524469|NCT05146687|Bevacizumab|bevacizumab|mesh-list
44524470|NCT05146687|Ranibizumab|ranibizumab|mesh-list
44524471|NCT05146687|Aflibercept|aflibercept|mesh-list
44524472|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524473|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524474|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44524475|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44524476|NCT05146687|Growth Substances|growth substances|mesh-ancestor
44524477|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524478|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
44524479|NCT05142098|Dexamethasone|dexamethasone|mesh-list
44524480|NCT05142098|Etoricoxib|etoricoxib|mesh-list
44524481|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
44524482|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
44524483|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524484|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
44524485|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
44524486|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524487|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524488|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524489|NCT05142098|Hormones|hormones|mesh-ancestor
44524490|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524491|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44524492|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524493|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44524494|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524495|NCT05142098|Analgesics|analgesics|mesh-ancestor
44524496|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
44524497|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44524498|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44524499|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524500|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524501|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44524502|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44524503|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524504|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524505|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
44524506|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524507|NCT05141240|Palbociclib|palbociclib|mesh-list
44524508|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524509|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44524510|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524511|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524512|NCT05141838|Vitamin D|vitamin d|mesh-list
44524513|NCT05141838|Vitamins|vitamins|mesh-ancestor
44524514|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
44524515|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428993|NCT02159352|Ritonavir|ritonavir|mesh-list
44524516|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44524517|NCT05141422|Efavirenz|efavirenz|mesh-list
44524518|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44524519|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44524520|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524521|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524522|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
44524523|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524524|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44524525|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44524526|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44524527|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44524528|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44524529|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44524530|NCT05146479|Fluorides|fluorides|mesh-list
44524531|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
44524532|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
44524533|NCT05146479|Protective Agents|protective agents|mesh-ancestor
44524534|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524535|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44524536|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44524537|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524538|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524539|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
44524540|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524541|NCT05148377|Heparin|heparin|mesh-list
44524542|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
44524543|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44524544|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44524545|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524546|NCT05144698|Sirolimus|sirolimus|mesh-list
44524547|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524548|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524549|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44524550|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524551|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
44524552|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524553|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
44524554|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524555|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
44524556|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44524557|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524558|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
44524559|NCT05146154|Imipenem|imipenem|mesh-list
44524560|NCT05146154|Relebactam|relebactam|mesh-list
44524561|NCT05146154|Cilastatin|cilastatin|mesh-list
44524562|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524563|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524564|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44524565|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524566|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524567|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44524568|NCT05148637|Lidocaine|lidocaine|mesh-list
44524569|NCT05148637|Fentanyl|fentanyl|mesh-list
44524570|NCT05148637|Anesthetics|anesthetics|mesh-list
44524571|NCT05148637|Sevoflurane|sevoflurane|mesh-list
44524572|NCT05148637|Desflurane|desflurane|mesh-list
44524573|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524574|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524575|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524576|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
44524577|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524578|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524579|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44524580|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44524581|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524582|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524583|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44524584|NCT05148637|Narcotics|narcotics|mesh-ancestor
44524585|NCT05148637|Analgesics|analgesics|mesh-ancestor
44524586|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524587|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524588|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
44524589|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44524590|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44524591|NCT05146674|Tadalafil|tadalafil|mesh-list
44346422|NCT01058291|Apomorphine|apomorphine|mesh-list
44524607|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524608|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524609|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44524610|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524611|NCT05143762|Acetaminophen|acetaminophen|mesh-list
44524612|NCT05143762|Dexamethasone|dexamethasone|mesh-list
44524613|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524614|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
44524615|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
44524616|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524617|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524618|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524619|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
44524620|NCT05143762|Hormones|hormones|mesh-ancestor
44524621|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524622|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44524623|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524624|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524625|NCT05143762|Analgesics|analgesics|mesh-ancestor
44524626|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
44524627|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
44524628|NCT05143073|Ethanol|ethanol|mesh-list
44524629|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44524630|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524631|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524632|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524633|NCT05144243|Azacitidine|azacitidine|mesh-list
44524634|NCT05144243|Venetoclax|venetoclax|mesh-list
44524635|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524636|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
44524637|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524638|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524639|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524640|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
44524641|NCT05149287|Lidocaine|lidocaine|mesh-list
44524642|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524643|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
44524644|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524645|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524646|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
44524647|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524648|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524649|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44524650|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44524651|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524652|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524653|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44524654|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524655|NCT05146232|Anesthetics|anesthetics|mesh-list
44524656|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524657|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524658|NCT05141305|Clopidogrel|clopidogrel|mesh-list
44524659|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524660|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524661|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44524662|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44524663|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44524664|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44524665|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
44524666|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524667|NCT05140148|Amantadine|amantadine|mesh-list
44524668|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44524669|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44524670|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
44524671|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524672|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
44524673|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524674|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524675|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524676|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524677|NCT05140148|Analgesics|analgesics|mesh-ancestor
44524678|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
44524679|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524680|NCT05143970|Trastuzumab|trastuzumab|mesh-list
44524681|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524682|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524683|NCT05147090|Empagliflozin|empagliflozin|mesh-list
44524684|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44524685|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524686|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44524687|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524688|NCT05144295|Lactulose|lactulose|mesh-list
44524689|NCT05144295|Bisacodyl|bisacodyl|mesh-list
44524690|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
44524691|NCT05144295|Lubiprostone|lubiprostone|mesh-list
44524692|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524693|NCT05144295|Cathartics|cathartics|mesh-ancestor
44524694|NCT05144295|Laxatives|laxatives|mesh-ancestor
44524695|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44524696|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524697|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524698|NCT05148195|Leucovorin|leucovorin|mesh-list
44524699|NCT05148195|Docetaxel|docetaxel|mesh-list
44524700|NCT05148195|Irinotecan|irinotecan|mesh-list
44524701|NCT05148195|Calcium|calcium|mesh-list
44524702|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
44524703|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524704|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
44524705|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
44524706|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
44524707|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524708|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524709|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524710|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44524711|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44524712|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524713|NCT05148195|Antidotes|antidotes|mesh-ancestor
44524714|NCT05148195|Protective Agents|protective agents|mesh-ancestor
44524715|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
44524716|NCT05148195|Vitamins|vitamins|mesh-ancestor
44524717|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
44524718|NCT05141344|Melatonin|melatonin|mesh-list
44524719|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
44524720|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524721|NCT05141344|Protective Agents|protective agents|mesh-ancestor
44524722|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524723|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524724|NCT05148312|Budesonide|budesonide|mesh-list
44524725|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44524726|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44524727|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
44524728|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524729|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524730|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44524731|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44524732|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
44524733|NCT05148312|Hormones|hormones|mesh-ancestor
44524734|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524735|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44524736|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
44524737|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524738|NCT05148975|Dimercaprol|dimercaprol|mesh-list
44524739|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
44524740|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
44524741|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524742|NCT05143489|Lidocaine|lidocaine|mesh-list
44524743|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524744|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
44524745|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524746|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524747|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
44524748|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524749|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524750|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44524751|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44524752|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524753|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524754|NCT03451825|Avelumab|avelumab|mesh-list
44524755|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44524756|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524757|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524758|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
44524759|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524761|NCT03459859|Pevonedistat|pevonedistat|mesh-list
44524762|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44524763|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
44524764|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524765|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524766|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
44524767|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524768|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44524769|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
44524770|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524771|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524772|NCT03455517|Rituximab|rituximab|mesh-list
44524773|NCT03455517|Venetoclax|venetoclax|mesh-list
44524774|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44524775|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524776|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
44524777|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524778|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44524779|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
44524780|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44524781|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
44524782|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524783|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44524784|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524785|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524786|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
44524787|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524788|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524789|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44524790|NCT03459911|Losartan|losartan|mesh-list
44524791|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524792|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44524793|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44524794|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44524795|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524796|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
44524797|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44524798|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
44524799|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524800|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
44524801|NCT03459833|Protective Agents|protective agents|mesh-ancestor
44524802|NCT03459417|Morphine|morphine|mesh-list
44524803|NCT03459417|Sulpiride|sulpiride|mesh-list
44524804|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44524805|NCT03459417|Narcotics|narcotics|mesh-ancestor
44524806|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524807|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524808|NCT03459417|Analgesics|analgesics|mesh-ancestor
44524809|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
44429275|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
44524810|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524811|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44524812|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44524813|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524814|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44524815|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
44524816|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524817|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524818|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44524819|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
44524820|NCT03459404|Sufentanil|sufentanil|mesh-list
44524821|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44524822|NCT03459404|Narcotics|narcotics|mesh-ancestor
44524823|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524824|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524825|NCT03459404|Analgesics|analgesics|mesh-ancestor
44524826|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
44524827|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524828|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524829|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524830|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
44524831|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
44524832|NCT03459248|Anesthetics|anesthetics|mesh-list
44524833|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524834|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524836|NCT03459144|Verteporfin|verteporfin|mesh-list
44524837|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44524838|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44524839|NCT03459144|Growth Substances|growth substances|mesh-ancestor
44524840|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524841|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44524842|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524843|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44524844|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
44524845|NCT03459105|Bupivacaine|bupivacaine|mesh-list
44524846|NCT03459105|Anesthetics|anesthetics|mesh-list
44524847|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
44524848|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524849|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524850|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
44524851|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524852|NCT03458923|Diclofenac|diclofenac|mesh-list
44524853|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44524854|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44524855|NCT03458923|Ranibizumab|ranibizumab|mesh-list
44524856|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
44524857|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44524858|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44524859|NCT03458923|Growth Substances|growth substances|mesh-ancestor
44524860|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524861|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44524862|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524863|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524864|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44524865|NCT03458923|Analgesics|analgesics|mesh-ancestor
44524866|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
44524867|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524868|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44524869|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44524870|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524871|NCT03458715|Empagliflozin|empagliflozin|mesh-list
44524872|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44524873|NCT03458715|Linagliptin|linagliptin|mesh-list
44524874|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44524875|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524876|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44524877|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524878|NCT03458715|Incretins|incretins|mesh-ancestor
44524879|NCT03458715|Hormones|hormones|mesh-ancestor
44524880|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44524881|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
44524882|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524883|NCT03458689|Analgesics|analgesics|mesh-list
44524884|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
44524885|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524886|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524887|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
44524888|NCT03458481|Yimitasvir|yimitasvir|mesh-list
44524889|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
44524890|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44524891|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
44524892|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44524893|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44524894|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524895|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
44524896|NCT03458468|Coagulants|coagulants|mesh-ancestor
44524897|NCT03458416|Cannabidiol|cannabidiol|mesh-list
44524898|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
44524899|NCT03458208|Metformin|metformin|mesh-list
44524900|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44524901|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524902|NCT03458143|Ketamine|ketamine|mesh-list
44524903|NCT03458143|Remifentanil|remifentanil|mesh-list
44524904|NCT03458143|Analgesics|analgesics|mesh-ancestor
44524905|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
44524906|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524907|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524908|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44524917|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44524918|NCT03458143|Narcotics|narcotics|mesh-ancestor
44524919|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
44524920|NCT03458078|Midazolam|midazolam|mesh-list
44524921|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524922|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44524923|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429390|NCT02151643|Iron|iron|mesh-list
44346932|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
44524924|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524925|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44524926|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44524927|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524928|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524929|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
44524930|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
44524931|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
44524932|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
44524933|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524934|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524935|NCT03458078|Analgesics|analgesics|mesh-ancestor
44524936|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
44524937|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524938|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524939|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
44524940|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44524941|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44524942|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44524943|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
44524944|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44524945|NCT03457753|Riluzole|riluzole|mesh-list
44524946|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
44524947|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44524948|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44524949|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524950|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524951|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524952|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44524953|NCT03457753|Protective Agents|protective agents|mesh-ancestor
44524954|NCT03457597|Pioglitazone|pioglitazone|mesh-list
44524955|NCT03457597|Tolbutamide|tolbutamide|mesh-list
44524956|NCT03457597|Metoprolol|metoprolol|mesh-list
44524957|NCT03457597|Midazolam|midazolam|mesh-list
44524958|NCT03457597|Omeprazole|omeprazole|mesh-list
44524959|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44524960|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44524961|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44524962|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524963|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44524964|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44524965|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44524966|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44524967|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
44524968|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
44524969|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
44524970|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
44524971|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524972|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429440|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
44429489|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44524973|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44524974|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44524975|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44524976|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44524977|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524978|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44524979|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44524980|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
44524981|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
44524982|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44524983|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44524984|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44524985|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44524986|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
44524987|NCT03457389|Cabergoline|cabergoline|mesh-list
44524988|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44524989|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44524990|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
44524991|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
44524992|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761446|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524993|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44524994|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44524995|NCT03457337|Gefitinib|gefitinib|mesh-list
44524996|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44524997|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44524998|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44524999|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525000|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44525001|NCT03457233|Cetrorelix|cetrorelix|mesh-list
44525003|NCT03457233|Progesterone|progesterone|mesh-list
44525004|NCT03457233|Progestins|progestins|mesh-ancestor
44525006|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525007|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525008|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525009|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44525010|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
44525011|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
44525012|NCT03457194|Vaccines|vaccines|mesh-list
44525013|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
44525014|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525015|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
44525016|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525017|NCT03456752|Dexamethasone|dexamethasone|mesh-list
44525018|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525019|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
44525020|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
44525021|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525022|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525023|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525024|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
44525025|NCT03456752|Hormones|hormones|mesh-ancestor
44525026|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525027|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525028|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525029|NCT03456713|Mirikizumab|mirikizumab|mesh-list
44525030|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525031|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525032|NCT03456713|Analgesics|analgesics|mesh-ancestor
44525033|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
44525034|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525035|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525036|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525037|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525038|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44525039|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525040|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
44525041|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
44525042|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44525043|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525044|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525045|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525046|NCT03456661|Analgesics|analgesics|mesh-ancestor
44525047|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
44525048|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525049|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44525050|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44525051|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44525052|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
44525053|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429517|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
44525054|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525055|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
44525056|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
44525057|NCT03456648|Apixaban|apixaban|mesh-list
44525058|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44525059|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
44525060|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44525061|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
44525062|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525063|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525064|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
44525065|NCT03456544|Vancomycin|vancomycin|mesh-list
44525066|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525067|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525068|NCT03456531|Aspirin|aspirin|mesh-list
44525069|NCT03456531|Analgesics|analgesics|mesh-list
44525070|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525071|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525072|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
44525073|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525074|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525075|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525076|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525077|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44525078|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44525079|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525080|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44525081|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44525082|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525083|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
44525084|NCT03456466|Rituximab|rituximab|mesh-list
44525085|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525086|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525087|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
44525088|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525089|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525090|NCT03456401|Sorafenib|sorafenib|mesh-list
44525091|NCT03456401|Sunitinib|sunitinib|mesh-list
44347098|NCT01062087|Lidocaine|lidocaine|mesh-list
44525103|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
44525104|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
44525105|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525106|NCT03455322|Octreotide|octreotide|mesh-list
44525107|NCT03455322|Norepinephrine|norepinephrine|mesh-list
44525108|NCT03455322|Midodrine|midodrine|mesh-list
44525109|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525110|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525111|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525112|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44525113|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44525114|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
44525115|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525116|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525117|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525118|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
44525119|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
44525120|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525121|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44525122|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44525123|NCT03455179|Methamphetamine|methamphetamine|mesh-list
44525124|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44525125|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525126|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
44525127|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
44525128|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525129|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
44525130|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525131|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525132|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
44525133|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44525134|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44525135|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44525136|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44525137|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
44525138|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44525139|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
44525140|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525141|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525142|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44525143|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44525144|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44525145|NCT03455049|Andrographolide|andrographolide|mesh-list
44525146|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525147|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525148|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525150|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
44525151|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525152|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525153|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525154|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44525155|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44525156|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525157|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
44525158|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44525159|NCT03454984|Guadecitabine|guadecitabine|mesh-list
44525160|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525161|NCT03454919|Palbociclib|palbociclib|mesh-list
44525162|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525163|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44525164|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525165|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525166|NCT03454841|Ticagrelor|ticagrelor|mesh-list
44525167|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44525168|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44525169|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44525170|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44525171|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44525172|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
44525173|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525174|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525175|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525176|NCT03454789|Lidocaine|lidocaine|mesh-list
44525177|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
44525178|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
44525179|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525180|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525181|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
44525182|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525183|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44525184|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44525185|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44525186|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44525187|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525188|NCT03454724|Sirolimus|sirolimus|mesh-list
44525189|NCT03454724|Everolimus|everolimus|mesh-list
44525190|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525191|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525192|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
44525193|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525194|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525195|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525196|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525197|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
44525198|NCT03454646|Rivastigmine|rivastigmine|mesh-list
44525199|NCT03454646|Donepezil|donepezil|mesh-list
44525200|NCT03454646|Galantamine|galantamine|mesh-list
44525201|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44525202|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525203|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525204|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
44525205|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525206|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525207|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
44525208|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44525209|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
44525210|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347218|NCT01062906|Lidocaine|lidocaine|mesh-list
44525211|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44525212|NCT03454646|Protective Agents|protective agents|mesh-ancestor
44525214|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44525215|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44525216|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525217|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525218|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347293|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525219|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
44525220|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525221|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44525222|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525223|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525225|NCT03454217|Tramadol|tramadol|mesh-list
44525226|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44525227|NCT03454217|Narcotics|narcotics|mesh-ancestor
44525228|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525229|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525230|NCT03454217|Analgesics|analgesics|mesh-ancestor
44525231|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
44525232|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525233|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44525234|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525235|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
44525236|NCT03453931|Hormones|hormones|mesh-ancestor
44525237|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525238|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525239|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44525240|NCT03453931|Protective Agents|protective agents|mesh-ancestor
44525241|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525242|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525243|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44525244|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44525245|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525246|NCT03453346|Ribavirin|ribavirin|mesh-list
44525247|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
44525248|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
44525249|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525250|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
44525251|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525252|NCT03453281|Aflibercept|aflibercept|mesh-list
44525253|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44525254|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44525255|NCT03453281|Growth Substances|growth substances|mesh-ancestor
44525256|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525257|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44525258|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525259|NCT03453177|Fosfomycin|fosfomycin|mesh-list
44525260|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525261|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525262|NCT03452891|Simvastatin|simvastatin|mesh-list
44525263|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44525264|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44525265|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
44525266|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525267|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44525268|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44525269|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525270|NCT03452722|Plasminogen|plasminogen|mesh-list
44525271|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44525272|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44525273|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44525274|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525275|NCT03452696|Calcium|calcium|mesh-list
44525276|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44525277|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525278|NCT03452657|Ranibizumab|ranibizumab|mesh-list
44525279|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44525280|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44525281|NCT03452657|Growth Substances|growth substances|mesh-ancestor
44525282|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525283|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44525284|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525285|NCT03452501|Infliximab|infliximab|mesh-list
44525286|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525287|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525288|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525289|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44525290|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44525291|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525292|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347375|NCT01063439|Cytarabine|cytarabine|mesh-list
44525293|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44525294|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44525295|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525296|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429759|NCT02141295|Antidotes|antidotes|mesh-ancestor
44525297|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347448|NCT01063816|Veliparib|veliparib|mesh-list
44525298|NCT03452332|Durvalumab|durvalumab|mesh-list
44525299|NCT03452332|Ipilimumab|ipilimumab|mesh-list
44525300|NCT03452332|Tremelimumab|tremelimumab|mesh-list
44525301|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
44525302|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44525303|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
44525304|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525305|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525306|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
44525307|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525308|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44525309|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525310|NCT03452306|Metformin|metformin|mesh-list
44525311|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44525312|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525313|NCT03452267|Metformin|metformin|mesh-list
44525314|NCT03452267|Pioglitazone|pioglitazone|mesh-list
44525315|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44525316|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525317|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
44525318|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44525319|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525320|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
44525321|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44525322|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44525323|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44525324|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525325|NCT03451695|Morphine|morphine|mesh-list
44525326|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44525327|NCT03451695|Narcotics|narcotics|mesh-ancestor
44525328|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525329|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525330|NCT03451695|Analgesics|analgesics|mesh-ancestor
44525331|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
44525332|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525333|NCT03451682|Procyanidin|procyanidin|mesh-list
44525334|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
44429805|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
44525335|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525336|NCT03451682|Protective Agents|protective agents|mesh-ancestor
44525337|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525338|NCT03451500|Levodopa|levodopa|mesh-list
44525339|NCT03451500|Carbidopa|carbidopa|mesh-list
44525340|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44525341|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44525342|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44525343|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
44525344|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525345|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525346|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525347|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44525348|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525349|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44525350|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
44525351|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
44525352|NCT03451487|Acetaminophen|acetaminophen|mesh-list
44525353|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525354|NCT03451487|Analgesics|analgesics|mesh-ancestor
44525355|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
44525356|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525357|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525358|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
44525359|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
44525360|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44525361|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
44525362|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525363|NCT03451435|Expectorants|expectorants|mesh-ancestor
44525364|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44525365|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44525366|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
44525367|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525368|NCT03451435|Protective Agents|protective agents|mesh-ancestor
44525369|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525370|NCT03451435|Antidotes|antidotes|mesh-ancestor
44525371|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
44525372|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525373|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525374|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44525375|NCT03451110|Fluconazole|fluconazole|mesh-list
44525387|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525388|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525389|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44525390|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44525392|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525393|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44525394|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
44525396|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525397|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44525398|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44525399|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44525400|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525401|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44525402|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44525403|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44525404|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
44525405|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525406|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44525407|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44525408|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44525409|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44525410|NCT03451019|Sevelamer|sevelamer|mesh-list
44525411|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
44525412|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
44525413|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525414|NCT03450967|Durvalumab|durvalumab|mesh-list
44525415|NCT03450967|Tremelimumab|tremelimumab|mesh-list
44525416|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525417|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525418|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
44525419|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44525420|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525421|NCT03450798|Anesthetics|anesthetics|mesh-list
44525422|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525423|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525424|NCT03450499|Ketamine|ketamine|mesh-list
44525425|NCT03450499|Analgesics|analgesics|mesh-ancestor
44525426|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
44525427|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429892|NCT02138916|Benralizumab|benralizumab|mesh-list
44525428|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525429|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44525430|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44525431|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
44525432|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
44525433|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525434|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44525435|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44525436|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525437|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525438|NCT03450317|Aspirin|aspirin|mesh-list
44525439|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525440|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525441|NCT03450317|Analgesics|analgesics|mesh-ancestor
44525442|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
44525443|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525444|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525445|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525446|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525447|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44525448|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44525449|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525450|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44525451|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44525452|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525453|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
44525454|NCT03450226|Bupivacaine|bupivacaine|mesh-list
44525455|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
44525456|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
44525457|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525458|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525459|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
44525460|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525461|NCT03450161|Fentanyl|fentanyl|mesh-list
44525462|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44525463|NCT03450161|Narcotics|narcotics|mesh-ancestor
43933016|NCT00767767|Thiopental|thiopental|mesh-list
44525464|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525465|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525466|NCT03450161|Analgesics|analgesics|mesh-ancestor
44429925|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525467|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
44525468|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525469|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44525470|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44525471|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
44525472|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
44525473|NCT03450109|Goserelin|goserelin|mesh-list
44525474|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525475|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525476|NCT03450057|Daratumumab|daratumumab|mesh-list
44525477|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525478|NCT03452579|Bevacizumab|bevacizumab|mesh-list
44525479|NCT03452579|Nivolumab|nivolumab|mesh-list
44525480|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525481|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525482|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44525483|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44525484|NCT03452579|Growth Substances|growth substances|mesh-ancestor
44525485|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525486|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
44525487|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44525488|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525489|NCT03456700|Sirolimus|sirolimus|mesh-list
44525490|NCT03456700|Auranofin|auranofin|mesh-list
44525491|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525492|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525493|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525494|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525495|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
44525496|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525497|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
44525498|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525499|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525500|NCT03453684|Vancomycin|vancomycin|mesh-list
44525501|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525502|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525503|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44525504|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44525505|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44525506|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44525507|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44525508|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44525509|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44525510|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44525511|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525512|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525513|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525514|NCT03456947|Pregabalin|pregabalin|mesh-list
44525515|NCT03456947|Analgesics|analgesics|mesh-ancestor
44525516|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
44525517|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525518|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525519|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
44525520|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44525521|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44525522|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525523|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44525524|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44525525|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44525526|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525527|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44525528|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
44525529|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525530|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525531|NCT03453164|Nivolumab|nivolumab|mesh-list
44525532|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525533|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525534|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44525535|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525536|NCT03450434|Histamine|histamine|mesh-list
44525537|NCT03450434|Glutarimide|glutarimide|mesh-list
44525538|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
44525539|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
44525540|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525541|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525542|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525543|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44525544|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525545|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44525546|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44525547|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
44525548|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525549|NCT00199797|Leucovorin|leucovorin|mesh-list
44525550|NCT00199797|Fluorouracil|fluorouracil|mesh-list
44525551|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
44525552|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
44525553|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525554|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525555|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525556|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525557|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
44525558|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525559|NCT00199797|Antidotes|antidotes|mesh-ancestor
44525560|NCT00199797|Protective Agents|protective agents|mesh-ancestor
44525561|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
44525562|NCT00199797|Vitamins|vitamins|mesh-ancestor
44525563|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
44525564|NCT00199381|Istradefylline|istradefylline|mesh-list
44525565|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44525566|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44525567|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44525568|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
44525569|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525570|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525571|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525572|NCT00198822|Vitamin A|vitamin a|mesh-list
44525573|NCT00198822|Beta Carotene|beta carotene|mesh-list
44525574|NCT00198822|Carotenoids|carotenoids|mesh-list
44525575|NCT00198822|Vitamins|vitamins|mesh-ancestor
44525576|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
44525577|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525578|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
44525579|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525580|NCT00198822|Protective Agents|protective agents|mesh-ancestor
44525581|NCT00198822|Provitamins|provitamins|mesh-ancestor
44525582|NCT00198133|Pemetrexed|pemetrexed|mesh-list
44525583|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525584|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525585|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525586|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44525587|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44525588|NCT00198029|Hylan|hylan|mesh-list
44525589|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
44525590|NCT00198029|Protective Agents|protective agents|mesh-ancestor
44525591|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525592|NCT00197145|Aplaviroc|aplaviroc|mesh-list
44525593|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44525594|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44525595|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525596|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44525597|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44525598|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
44525599|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525600|NCT00197106|Fluticasone|fluticasone|mesh-list
44525601|NCT00197106|Xhance|xhance|mesh-list
44525602|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44525603|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525604|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44525605|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
44525606|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525607|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525608|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44525609|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44525610|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525611|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44525612|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44525613|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44525614|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44525615|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44525616|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525617|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525618|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44525619|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
44525620|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525621|NCT00196976|Edetic Acid|edetic acid|mesh-list
44525622|NCT00196976|Vaccines|vaccines|mesh-list
44525623|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
44525624|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
44525625|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525626|NCT00196976|Antidotes|antidotes|mesh-ancestor
44525627|NCT00196976|Protective Agents|protective agents|mesh-ancestor
44525628|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
44525629|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
44525639|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525641|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44525642|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
44525643|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525644|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44525645|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44525646|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44525647|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44525648|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
44525649|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44525650|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
44525651|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525652|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525653|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44525654|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44525655|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44525656|NCT00195715|Adalimumab|adalimumab|mesh-list
44525657|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525658|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525659|NCT00195676|Adalimumab|adalimumab|mesh-list
44525660|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525661|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525662|NCT00195663|Adalimumab|adalimumab|mesh-list
44525663|NCT00195663|Methotrexate|methotrexate|mesh-list
44525664|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44525665|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
44525666|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525667|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525668|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525669|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
44525670|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525671|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525672|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525673|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525674|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44525675|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525676|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
44525677|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525678|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44525679|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525680|NCT00195650|Adalimumab|adalimumab|mesh-list
44525681|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525682|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525683|NCT00195507|Etanercept|etanercept|mesh-list
44525684|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525685|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525686|NCT00195507|Analgesics|analgesics|mesh-ancestor
44525687|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
44525688|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525689|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525690|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525691|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525692|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347914|NCT01066299|Oxytocin|oxytocin|mesh-list
44525693|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525694|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
44525695|NCT00195494|Etanercept|etanercept|mesh-list
44525696|NCT00195494|Methotrexate|methotrexate|mesh-list
44525697|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44525698|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
44525699|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525700|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525701|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525702|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
44525703|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525704|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525705|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525706|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525707|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44525708|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525709|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
44525710|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525711|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44525712|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44525713|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44525715|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
44525716|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525717|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525718|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44525719|NCT00195429|Sirolimus|sirolimus|mesh-list
44525720|NCT00195429|Prednisone|prednisone|mesh-list
44525721|NCT00195429|Tacrolimus|tacrolimus|mesh-list
44525722|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525723|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
44525724|NCT00195429|Hormones|hormones|mesh-ancestor
44525725|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525726|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525727|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525728|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525729|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525730|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
44525731|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44525732|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525733|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525734|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525735|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525736|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525737|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
44525738|NCT00195351|Metronidazole|metronidazole|mesh-list
44525739|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
44525740|NCT00195351|Tigecycline|tigecycline|mesh-list
44525741|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525742|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525743|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44525744|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44525745|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44525746|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525747|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525748|NCT00195273|Cyclosporine|cyclosporine|mesh-list
44525749|NCT00195273|Sirolimus|sirolimus|mesh-list
44525750|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
44525751|NCT00195273|Cyclosporins|cyclosporins|mesh-list
44525752|NCT00195273|Daclizumab|daclizumab|mesh-list
44525753|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525754|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525755|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525756|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
44525757|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525758|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
44525759|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525760|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525761|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525762|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44525763|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525764|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525765|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44525766|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
44525767|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44525768|NCT00194987|Prednisone|prednisone|mesh-list
44525769|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
44525770|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44525772|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
44525773|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44525774|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525775|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
44525776|NCT00194987|Hormones|hormones|mesh-ancestor
44525777|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525779|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525780|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525781|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
44525782|NCT00194792|Paclitaxel|paclitaxel|mesh-list
44525783|NCT00194792|Vinorelbine|vinorelbine|mesh-list
44525784|NCT00194792|Capecitabine|capecitabine|mesh-list
44525785|NCT00194792|Methotrexate|methotrexate|mesh-list
44525786|NCT00194792|Exemestane|exemestane|mesh-list
44525787|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44525788|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44525789|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525790|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
44525791|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525792|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
44525793|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525794|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525795|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
44525796|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44525797|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
44525798|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44525799|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525800|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44525801|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525802|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44525803|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525804|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
44525805|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525806|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44525807|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44525808|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44525809|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44525810|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
44525811|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525812|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
44525813|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44525814|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
44525815|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44525816|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525817|NCT00194675|Testosterone|testosterone|mesh-list
44525818|NCT00194675|Dutasteride|dutasteride|mesh-list
44525819|NCT00194675|Androgens|androgens|mesh-ancestor
44525820|NCT00194675|Hormones|hormones|mesh-ancestor
44430255|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525821|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525822|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525823|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44525824|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44525825|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525826|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525827|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
44525828|NCT00194077|Aripiprazole|aripiprazole|mesh-list
44525829|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
44525830|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44525831|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44525832|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44525833|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525834|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525835|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
44525836|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
44525837|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525838|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525839|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44525840|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44525841|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
44525842|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44525843|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44525844|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44525845|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44525846|NCT00194012|Aripiprazole|aripiprazole|mesh-list
44525847|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
44525848|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44525849|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44525850|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43933387|NCT00775658|Analgesics|analgesics|mesh-ancestor
44525851|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44525852|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525853|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
44525854|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
44525855|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44525856|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525857|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44525858|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44525859|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
44525860|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44525861|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44525862|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44525863|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44525864|NCT00193609|Capecitabine|capecitabine|mesh-list
44525865|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
44430307|NCT02128217|Ribavirin|ribavirin|mesh-list
44525866|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525867|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
44525868|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525869|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525870|NCT00193479|Prednisone|prednisone|mesh-list
44525871|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
44525872|NCT00193479|Rituximab|rituximab|mesh-list
44525873|NCT00193479|Vincristine|vincristine|mesh-list
44525874|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
44525875|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525876|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
44525877|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525878|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44525879|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44525880|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
44525881|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525882|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525883|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44525884|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525885|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44525886|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
44525887|NCT00193479|Hormones|hormones|mesh-ancestor
44525888|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44525889|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44525890|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44525891|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
44525892|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525893|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
44525894|NCT00193479|Analgesics|analgesics|mesh-ancestor
44525895|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
44525896|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44525897|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44525898|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44525899|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525900|NCT00193206|Gemcitabine|gemcitabine|mesh-list
44525901|NCT00193206|Paclitaxel|paclitaxel|mesh-list
44525902|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44525903|NCT00193206|Epirubicin|epirubicin|mesh-list
44525904|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44525905|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525906|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44525907|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525908|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44525909|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525910|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525911|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
44525912|NCT00193206|Antiviral Agents|antiviral agents|mesh-ancestor
44525913|NCT00193206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525914|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525915|NCT00193206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525916|NCT00193206|Immunologic Factors|immunologic factors|mesh-ancestor
44525917|NCT00193206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525918|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525919|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44525920|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44525922|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
44525923|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525924|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
44525925|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525926|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
44525927|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525928|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44525929|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525930|NCT00193063|Gemcitabine|gemcitabine|mesh-list
44525931|NCT00193063|Trastuzumab|trastuzumab|mesh-list
44525932|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525933|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
44525934|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525935|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525936|NCT00193063|Antiviral Agents|antiviral agents|mesh-ancestor
44525937|NCT00193063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525938|NCT00193063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525939|NCT00193063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525940|NCT00193063|Immunologic Factors|immunologic factors|mesh-ancestor
44525941|NCT00193063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525942|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44525943|NCT00193050|Gemcitabine|gemcitabine|mesh-list
44525944|NCT00193050|Docetaxel|docetaxel|mesh-list
44525945|NCT00193050|Epirubicin|epirubicin|mesh-list
44525946|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525947|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
44525948|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525949|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525950|NCT00193050|Antiviral Agents|antiviral agents|mesh-ancestor
44525951|NCT00193050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525952|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525953|NCT00193050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525954|NCT00193050|Immunologic Factors|immunologic factors|mesh-ancestor
44525955|NCT00193050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525956|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44525957|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44525958|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44525959|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44525960|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44525961|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44525962|NCT00192647|Ribavirin|ribavirin|mesh-list
44525963|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44525964|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
44525965|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
44525966|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525967|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
44525968|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525969|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525970|NCT00192075|Leucovorin|leucovorin|mesh-list
44525971|NCT00192075|Folic Acid|folic acid|mesh-list
44525972|NCT00192075|Gemcitabine|gemcitabine|mesh-list
44525973|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
44525974|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
44525975|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525976|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
44525977|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525978|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525979|NCT00192075|Antiviral Agents|antiviral agents|mesh-ancestor
44525980|NCT00192075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525981|NCT00192075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44525982|NCT00192075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44525983|NCT00192075|Immunologic Factors|immunologic factors|mesh-ancestor
44525984|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44525985|NCT00192075|Antidotes|antidotes|mesh-ancestor
44525986|NCT00192075|Protective Agents|protective agents|mesh-ancestor
44525987|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
44525988|NCT00192075|Vitamins|vitamins|mesh-ancestor
44525989|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
44525990|NCT00192075|Hematinics|hematinics|mesh-ancestor
44525991|NCT00192036|Gemcitabine|gemcitabine|mesh-list
44525992|NCT00192036|Cisplatin|cisplatin|mesh-list
44525993|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44525994|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44525995|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
44525996|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44525997|NCT00192036|Antiviral Agents|antiviral agents|mesh-ancestor
44525998|NCT00192036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44525999|NCT00192036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526000|NCT00192036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526001|NCT00192036|Immunologic Factors|immunologic factors|mesh-ancestor
44526002|NCT00192036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526003|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44526004|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526005|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526006|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526007|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526008|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526009|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526010|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526011|NCT00191984|Irinotecan|irinotecan|mesh-list
44526012|NCT00191984|Pemetrexed|pemetrexed|mesh-list
44526013|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44526014|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44526015|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526016|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526017|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526018|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526019|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526020|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44526021|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526022|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526023|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526024|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526025|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526026|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526027|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526028|NCT00191854|Gemcitabine|gemcitabine|mesh-list
44526029|NCT00191854|Paclitaxel|paclitaxel|mesh-list
44526030|NCT00191854|Cisplatin|cisplatin|mesh-list
44526031|NCT00191854|Carboplatin|carboplatin|mesh-list
44526032|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526033|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526034|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526035|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526036|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526037|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526038|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526039|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
44526040|NCT00191854|Antiviral Agents|antiviral agents|mesh-ancestor
44526041|NCT00191854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526042|NCT00191854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526043|NCT00191854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526044|NCT00191854|Immunologic Factors|immunologic factors|mesh-ancestor
44526045|NCT00191854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526046|NCT00191815|Gemcitabine|gemcitabine|mesh-list
44526047|NCT00191815|Cisplatin|cisplatin|mesh-list
44526048|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526049|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526050|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
44526051|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526052|NCT00191815|Antiviral Agents|antiviral agents|mesh-ancestor
44526053|NCT00191815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526054|NCT00191815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526055|NCT00191815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526056|NCT00191815|Immunologic Factors|immunologic factors|mesh-ancestor
44526057|NCT00191815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526058|NCT00191789|Gemcitabine|gemcitabine|mesh-list
44526059|NCT00191789|Cisplatin|cisplatin|mesh-list
44526060|NCT00191789|Doxorubicin|doxorubicin|mesh-list
44526061|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526062|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526063|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
44430505|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430547|NCT02121756|Dipyridamole|dipyridamole|mesh-list
44526064|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526065|NCT00191789|Antiviral Agents|antiviral agents|mesh-ancestor
44526066|NCT00191789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526067|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526068|NCT00191789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526069|NCT00191789|Immunologic Factors|immunologic factors|mesh-ancestor
44526070|NCT00191789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526071|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526079|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44526080|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526081|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526082|NCT00191646|Gemcitabine|gemcitabine|mesh-list
44526083|NCT00191646|Paclitaxel|paclitaxel|mesh-list
44526085|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526086|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526087|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526088|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526089|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526090|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526091|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526092|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
44526093|NCT00191646|Antiviral Agents|antiviral agents|mesh-ancestor
44526094|NCT00191646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526095|NCT00191646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526096|NCT00191646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526097|NCT00191646|Immunologic Factors|immunologic factors|mesh-ancestor
44526098|NCT00191646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526099|NCT00191451|Gemcitabine|gemcitabine|mesh-list
44526100|NCT00191451|Carboplatin|carboplatin|mesh-list
44526101|NCT00191451|Trastuzumab|trastuzumab|mesh-list
44526102|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526103|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526104|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
44526105|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526106|NCT00191451|Antiviral Agents|antiviral agents|mesh-ancestor
44430549|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526107|NCT00191451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526108|NCT00191451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526109|NCT00191451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526110|NCT00191451|Immunologic Factors|immunologic factors|mesh-ancestor
44526111|NCT00191451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526112|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44526113|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44526114|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526115|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526116|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526117|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526118|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526119|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526120|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526121|NCT00191334|Gemcitabine|gemcitabine|mesh-list
44526122|NCT00191334|Cisplatin|cisplatin|mesh-list
44526123|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526124|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526125|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
44526126|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526127|NCT00191334|Antiviral Agents|antiviral agents|mesh-ancestor
44526128|NCT00191334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526129|NCT00191334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526130|NCT00191334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526131|NCT00191334|Immunologic Factors|immunologic factors|mesh-ancestor
44526132|NCT00191334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526133|NCT00191308|Cisplatin|cisplatin|mesh-list
44526134|NCT00191308|Pemetrexed|pemetrexed|mesh-list
44526135|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526136|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526137|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526138|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526139|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526140|NCT00191282|Insulin|insulin|mesh-list
44526142|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
44526144|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
44526145|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
44526146|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
44526147|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44526148|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526149|NCT00191269|Gemcitabine|gemcitabine|mesh-list
44526150|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526151|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
44526152|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526153|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526154|NCT00191269|Antiviral Agents|antiviral agents|mesh-ancestor
44430585|NCT02121002|Diclofenac|diclofenac|mesh-list
44526155|NCT00191269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526156|NCT00191269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526157|NCT00191269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526158|NCT00191269|Immunologic Factors|immunologic factors|mesh-ancestor
44526159|NCT00191269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526160|NCT00191191|Pemetrexed|pemetrexed|mesh-list
44526161|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526162|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526163|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526164|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526165|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526166|NCT00191152|Gemcitabine|gemcitabine|mesh-list
44526167|NCT00191152|Capecitabine|capecitabine|mesh-list
44526168|NCT00191152|Docetaxel|docetaxel|mesh-list
44526169|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526170|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
44526171|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526172|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526173|NCT00191152|Antiviral Agents|antiviral agents|mesh-ancestor
44526174|NCT00191152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526175|NCT00191152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526176|NCT00191152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526177|NCT00191152|Immunologic Factors|immunologic factors|mesh-ancestor
44526178|NCT00191152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526179|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526180|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526181|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526182|NCT00191139|Gemcitabine|gemcitabine|mesh-list
44526183|NCT00191139|Cisplatin|cisplatin|mesh-list
44526184|NCT00191139|Docetaxel|docetaxel|mesh-list
44526185|NCT00191139|Etoposide|etoposide|mesh-list
44526186|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
44526187|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526188|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526189|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
44526190|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526191|NCT00191139|Antiviral Agents|antiviral agents|mesh-ancestor
44526192|NCT00191139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526193|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526194|NCT00191139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526195|NCT00191139|Immunologic Factors|immunologic factors|mesh-ancestor
44526196|NCT00191139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526197|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526198|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526199|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526200|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526201|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44526202|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44526203|NCT00190983|Pemetrexed|pemetrexed|mesh-list
44526204|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526205|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526206|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526207|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526208|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526209|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44526210|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526211|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526212|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526213|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526214|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526215|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526216|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526217|NCT00190749|Olanzapine|olanzapine|mesh-list
44526218|NCT00190749|Risperidone|risperidone|mesh-list
44526219|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44526220|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
44526221|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526222|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526223|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526224|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44526225|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44526226|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526227|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526228|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44526229|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
44526230|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
44526231|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
44526232|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526233|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526234|NCT00190749|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44526235|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526236|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526237|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44526238|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526239|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526240|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526241|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526242|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526243|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526244|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526245|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
44526247|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526248|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
44526249|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526250|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526251|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44526252|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
44526253|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526254|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526255|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44526256|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526257|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526258|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526259|NCT00193219|Leucovorin|leucovorin|mesh-list
44526260|NCT00193219|Bevacizumab|bevacizumab|mesh-list
44526261|NCT00193219|Cetuximab|cetuximab|mesh-list
44526262|NCT00193219|Fluorouracil|fluorouracil|mesh-list
44526263|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
44430698|NCT02119026|Irinotecan|irinotecan|mesh-list
44526264|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44526265|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526266|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526267|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526268|NCT00193219|Growth Substances|growth substances|mesh-ancestor
44526269|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526270|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526271|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
44526272|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526273|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526274|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526275|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
44526276|NCT00193219|Antidotes|antidotes|mesh-ancestor
44526277|NCT00193219|Protective Agents|protective agents|mesh-ancestor
44526278|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
44526279|NCT00193219|Vitamins|vitamins|mesh-ancestor
44526280|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
44526281|NCT00198276|Bleomycin|bleomycin|mesh-list
44526282|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526283|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526284|NCT00198263|Bleomycin|bleomycin|mesh-list
44526285|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526286|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526287|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
44526288|NCT00196339|Cyproterone|cyproterone|mesh-list
44526289|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
44526290|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
44526291|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526292|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526293|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526294|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44526295|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
44526296|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44526297|NCT00198107|Cycloserine|cycloserine|mesh-list
44526298|NCT00198107|Aripiprazole|aripiprazole|mesh-list
44526299|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
44526300|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526301|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44526302|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44526303|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526304|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526305|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
44526306|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
44526307|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430740|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526308|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526309|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43762172|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
44526310|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44526311|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
44526312|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44526313|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44526314|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44348571|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526315|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44526316|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44526317|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526318|NCT00198107|Renal Agents|renal agents|mesh-ancestor
44526319|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44526320|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
44526321|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44526322|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
44526323|NCT00179959|Mupirocin|mupirocin|mesh-list
44526324|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44526325|NCT00179959|Eusol|eusol|mesh-list
44526326|NCT00179959|Petrolatum|petrolatum|mesh-list
44526327|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44526328|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526329|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44526330|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526331|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526332|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
44526333|NCT00179959|Emollients|emollients|mesh-ancestor
44526334|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
44526335|NCT00179673|Lenalidomide|lenalidomide|mesh-list
44526336|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
44526337|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526338|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526339|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526340|NCT00179673|Growth Substances|growth substances|mesh-ancestor
44526341|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526342|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526343|NCT00179660|Lenalidomide|lenalidomide|mesh-list
44526344|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
44526345|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526346|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526347|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526348|NCT00179660|Growth Substances|growth substances|mesh-ancestor
44430788|NCT02117024|Gemcitabine|gemcitabine|mesh-list
44526349|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526350|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526351|NCT00179647|Dexamethasone|dexamethasone|mesh-list
44526352|NCT00179647|Lenalidomide|lenalidomide|mesh-list
44526353|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526354|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
44526355|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
44526356|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526357|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526358|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526359|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
44526360|NCT00179647|Hormones|hormones|mesh-ancestor
44526361|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526362|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526363|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526364|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
44526365|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526366|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526367|NCT00179647|Growth Substances|growth substances|mesh-ancestor
44526368|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526369|NCT00179517|Anastrozole|anastrozole|mesh-list
44526370|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526371|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526372|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44526373|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44526374|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526375|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526376|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44526377|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
44526378|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526379|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526380|NCT00179413|Interferons|interferons|mesh-list
44526381|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
44526382|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
44526383|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44526384|NCT00179413|Colchicine|colchicine|mesh-list
44526386|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
44526387|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526388|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
44348652|NCT01069770|Sunitinib|sunitinib|mesh-list
44526389|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526390|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
44526391|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526406|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526407|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526408|NCT00178464|Aspirin|aspirin|mesh-list
44526409|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44526410|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44526411|NCT00178464|Analgesics|analgesics|mesh-ancestor
44526412|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
44526413|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526414|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526415|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526416|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526417|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44526418|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44526419|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526420|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44526421|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44526422|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526423|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
44526424|NCT00178256|Paclitaxel|paclitaxel|mesh-list
44526425|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526426|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526427|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526428|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526429|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526430|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526431|NCT00177307|Bevacizumab|bevacizumab|mesh-list
44526432|NCT00177307|Capecitabine|capecitabine|mesh-list
44526433|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
44526434|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44526435|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348721|NCT01070108|Ketamine|ketamine|mesh-list
44526436|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526437|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526438|NCT00177307|Growth Substances|growth substances|mesh-ancestor
44526439|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526440|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526441|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526442|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
44526443|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526444|NCT00177294|Citalopram|citalopram|mesh-list
44526445|NCT00177294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44526446|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526447|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526448|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526449|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526450|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
44526451|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526452|NCT00177294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44526453|NCT00177294|Antidepressive Agents|antidepressive agents|mesh-ancestor
44526454|NCT00177294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526455|NCT00177216|Zolpidem|zolpidem|mesh-list
44526456|NCT00177216|Citalopram|citalopram|mesh-list
44526457|NCT00177216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44526458|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526459|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526460|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526461|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526462|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
44526463|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526464|NCT00177216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44526465|NCT00177216|Antidepressive Agents|antidepressive agents|mesh-ancestor
44526466|NCT00177216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526467|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44526468|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43933963|NCT00789776|Tacrolimus|tacrolimus|mesh-list
44526469|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526471|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
44526472|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
44526473|NCT00177164|Olanzapine|olanzapine|mesh-list
44526474|NCT00177164|Risperidone|risperidone|mesh-list
44526475|NCT00177164|Aripiprazole|aripiprazole|mesh-list
44526476|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44526477|NCT00177164|Ziprasidone|ziprasidone|mesh-list
44526478|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
44526479|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44526480|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
44526481|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526482|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526483|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526484|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44526485|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526486|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526487|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44526488|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
44526489|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
44526490|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
44526491|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526492|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526493|NCT00177164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44526494|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526495|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526496|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
44526497|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
44526498|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44526499|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44526500|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44526501|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44526502|NCT00176644|Estradiol|estradiol|mesh-list
44526503|NCT00176644|Estrogens|estrogens|mesh-ancestor
44526504|NCT00176644|Hormones|hormones|mesh-ancestor
44526505|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526506|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526507|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
44526508|NCT00176605|Etoposide|etoposide|mesh-list
44526509|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526510|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
44526511|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526512|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526513|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44526514|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
44526515|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526516|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526517|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44430959|NCT02116205|Vaccines|vaccines|mesh-list
44430986|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526518|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526519|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44526520|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44526521|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526522|NCT00176488|Vinorelbine|vinorelbine|mesh-list
44526523|NCT00176488|Epirubicin|epirubicin|mesh-list
44526524|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526525|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526526|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526527|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526528|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526529|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526530|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526531|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44526532|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44526533|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526534|NCT00176462|Leucovorin|leucovorin|mesh-list
44526535|NCT00176462|Cytarabine|cytarabine|mesh-list
44526536|NCT00176462|Dexamethasone|dexamethasone|mesh-list
44526537|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
44526538|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
44526539|NCT00176462|Methotrexate|methotrexate|mesh-list
44526540|NCT00176462|Vincristine|vincristine|mesh-list
44526541|NCT00176462|Asparaginase|asparaginase|mesh-list
44526542|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
44526543|NCT00176462|Thioguanine|thioguanine|mesh-list
44526544|NCT00176462|Daunorubicin|daunorubicin|mesh-list
44526545|NCT00176462|Aminopterin|aminopterin|mesh-list
44526546|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526547|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
44526548|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526549|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526550|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44526551|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
44526552|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526553|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526554|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44526555|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526556|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
44526557|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
44526558|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526559|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526560|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
44526561|NCT00176462|Hormones|hormones|mesh-ancestor
44526562|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526563|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526564|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44526565|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
44526566|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44526567|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526568|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
44526569|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
44526570|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526571|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44526572|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526573|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
44526574|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526575|NCT00176462|Antidotes|antidotes|mesh-ancestor
44526576|NCT00176462|Protective Agents|protective agents|mesh-ancestor
44526577|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
44526578|NCT00176462|Vitamins|vitamins|mesh-ancestor
44526579|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
44526580|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526581|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526582|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526583|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526584|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526585|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44526586|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44526589|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526590|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526591|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526592|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526593|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526594|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526595|NCT00175825|Brivaracetam|brivaracetam|mesh-list
44526596|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
44526597|NCT00175019|Allopurinol|allopurinol|mesh-list
44526598|NCT00175019|Febuxostat|febuxostat|mesh-list
44526599|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
44526600|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526601|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526602|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
44526603|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431069|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526604|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44526605|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
44526606|NCT00175019|Protective Agents|protective agents|mesh-ancestor
44526607|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526608|NCT00174967|Febuxostat|febuxostat|mesh-list
44526609|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
44526610|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526611|NCT00174941|Febuxostat|febuxostat|mesh-list
44526612|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
44526613|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526614|NCT00174915|Allopurinol|allopurinol|mesh-list
44526615|NCT00174915|Febuxostat|febuxostat|mesh-list
44526616|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
44526617|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526618|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526619|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
44526620|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526621|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44526622|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
44526623|NCT00174915|Protective Agents|protective agents|mesh-ancestor
44526624|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526625|NCT00174265|Olanzapine|olanzapine|mesh-list
44526626|NCT00174265|Asenapine|asenapine|mesh-list
44526627|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
44526628|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
44526629|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526630|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526631|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526632|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44526633|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44526634|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526635|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44526636|NCT00174265|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44526637|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526638|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526639|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526640|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526641|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
44526642|NCT00172185|Teduglutide|teduglutide|mesh-list
44526643|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526644|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44526645|NCT00172185|Protective Agents|protective agents|mesh-ancestor
44526646|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526647|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
44526648|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44526649|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526650|NCT00171951|Pasireotide|pasireotide|mesh-list
44526651|NCT00171951|Hormones|hormones|mesh-ancestor
44526652|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526653|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526654|NCT00171925|Vitamin D|vitamin d|mesh-list
44526655|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
44526656|NCT00171925|Calcium|calcium|mesh-list
44526657|NCT00171925|Vitamins|vitamins|mesh-ancestor
44526658|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
44526659|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526660|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44526661|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44526662|NCT00171873|Octreotide|octreotide|mesh-list
44526663|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526664|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526665|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526667|NCT00171834|Epothilone B|epothilone b|mesh-list
44526668|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526669|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526670|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526671|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526672|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526673|NCT00171704|Tamoxifen|tamoxifen|mesh-list
44526674|NCT00171704|Letrozole|letrozole|mesh-list
44526675|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526676|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44526677|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44526678|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526679|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526680|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44526681|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
44526682|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526683|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526684|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526685|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44526686|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44526687|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44526688|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
44526689|NCT00171340|Letrozole|letrozole|mesh-list
44526690|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526691|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44526692|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44526693|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526694|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526695|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44526696|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
44526697|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526698|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526699|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44526700|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
44526701|NCT00171314|Letrozole|letrozole|mesh-list
44526702|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526703|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44526704|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44526705|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526706|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526707|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44526708|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
44526709|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526710|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526711|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44526712|NCT00171301|Deferasirox|deferasirox|mesh-list
44526713|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44526714|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
44526715|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
44526716|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526717|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
44526718|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526719|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44526720|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526721|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526722|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
44526723|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526724|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44526725|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526726|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526727|NCT00171210|Deferasirox|deferasirox|mesh-list
44526728|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44526729|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
44526730|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
44526731|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526732|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
44526733|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526734|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44526735|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526736|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526737|NCT00171054|Amlodipine|amlodipine|mesh-list
44526738|NCT00171054|Valsartan|valsartan|mesh-list
44526739|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44526740|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44526741|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44526742|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526743|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526744|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44526745|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526746|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
44526747|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44526748|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44526749|NCT00171054|Diuretics|diuretics|mesh-ancestor
44526750|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
44526751|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44526752|NCT00170846|Everolimus|everolimus|mesh-list
44526753|NCT00170846|Azathioprine|azathioprine|mesh-list
44526754|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44526755|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526756|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526757|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
44526758|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526759|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526760|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526761|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
44526762|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526763|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526764|NCT00174837|Cisplatin|cisplatin|mesh-list
44526765|NCT00174837|Tirapazamine|tirapazamine|mesh-list
44526766|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526767|NCT00179400|Pioglitazone|pioglitazone|mesh-list
44526768|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44526769|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526770|NCT00476606|Ritonavir|ritonavir|mesh-list
44526771|NCT00476606|Nelfinavir|nelfinavir|mesh-list
44526772|NCT00476606|Indinavir|indinavir|mesh-list
44526773|NCT00476606|Saquinavir|saquinavir|mesh-list
44526774|NCT00476606|Lamivudine|lamivudine|mesh-list
44526775|NCT00476606|Zidovudine|zidovudine|mesh-list
44526777|NCT00476606|Didanosine|didanosine|mesh-list
44526778|NCT00476606|Stavudine|stavudine|mesh-list
44526779|NCT00476606|Efavirenz|efavirenz|mesh-list
44526780|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44526781|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44526782|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44526783|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526784|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526785|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44526786|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44526787|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
44526788|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431182|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
44526789|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44526790|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44526791|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44526792|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44526793|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
44526794|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44526795|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44526796|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44526797|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44526798|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44526799|NCT00476554|Sapacitabine|sapacitabine|mesh-list
44526800|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526801|NCT00479882|Simvastatin|simvastatin|mesh-list
44526802|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44526803|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44526804|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
44526805|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526806|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44526807|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44526808|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526809|NCT00479856|Paclitaxel|paclitaxel|mesh-list
44526810|NCT00479856|Docetaxel|docetaxel|mesh-list
44349104|NCT01071525|Niacin|niacin|mesh-list
44526811|NCT00479856|Capecitabine|capecitabine|mesh-list
44526812|NCT00479856|Lapatinib|lapatinib|mesh-list
44526825|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526826|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526827|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526828|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526829|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526830|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
44526831|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44526832|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
44526833|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526834|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
44526835|NCT00479687|Protective Agents|protective agents|mesh-ancestor
44526836|NCT00479674|Paclitaxel|paclitaxel|mesh-list
44526837|NCT00479674|Bevacizumab|bevacizumab|mesh-list
44526838|NCT00479674|Carboplatin|carboplatin|mesh-list
44526839|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44526840|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44526841|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526842|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44526843|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44526844|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44526845|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526846|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44526847|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526848|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526849|NCT00479674|Growth Substances|growth substances|mesh-ancestor
44526850|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526851|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526852|NCT00479466|Metformin|metformin|mesh-list
44526853|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44526854|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526855|NCT00479401|Pramipexole|pramipexole|mesh-list
44526856|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
44526857|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526858|NCT00479401|Protective Agents|protective agents|mesh-ancestor
44526859|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526860|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44526861|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44526862|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
44526863|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
44526864|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526865|NCT00479388|Niacin|niacin|mesh-list
44526866|NCT00479388|Atorvastatin|atorvastatin|mesh-list
44526867|NCT00479388|Simvastatin|simvastatin|mesh-list
44526868|NCT00479388|Calcium|calcium|mesh-list
44526869|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44526870|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526871|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44526872|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44526873|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
44431317|NCT02106390|Vaccines|vaccines|mesh-list
44526874|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526875|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44526876|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44526877|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526878|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
44526879|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
44526880|NCT00479388|Vitamins|vitamins|mesh-ancestor
44526881|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
44526882|NCT00479336|Tolvaptan|tolvaptan|mesh-list
44526883|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44526884|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526885|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
44526886|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526887|NCT00479232|Decitabine|decitabine|mesh-list
44526888|NCT00479232|Vorinostat|vorinostat|mesh-list
44526889|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526890|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
44526891|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526892|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526893|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526894|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44526895|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44526896|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
44526897|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44526898|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44526899|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526900|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526901|NCT00478881|Urological Agents|urological agents|mesh-ancestor
44526902|NCT00478777|Dexamethasone|dexamethasone|mesh-list
44526903|NCT00478777|Lenalidomide|lenalidomide|mesh-list
44526904|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526905|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
44526906|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
44526907|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526908|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526909|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526910|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
44526911|NCT00478777|Hormones|hormones|mesh-ancestor
44526912|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526913|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526914|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526915|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
44526916|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44526917|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44526918|NCT00478777|Growth Substances|growth substances|mesh-ancestor
44526919|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
44526920|NCT00478608|Sirolimus|sirolimus|mesh-list
44526921|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44526922|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44526923|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44526924|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526925|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
44526926|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526927|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
44526928|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526929|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
44431372|NCT02105974|Xhance|xhance|mesh-list
44526930|NCT00478244|Busulfan|busulfan|mesh-list
44526931|NCT00478244|Fludarabine|fludarabine|mesh-list
44526932|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
44526933|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526934|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
44526935|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526936|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44526937|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44526938|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
44526939|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526940|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526941|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44526942|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44526944|NCT00478205|Donepezil|donepezil|mesh-list
44526945|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44526946|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44526947|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526948|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
44526949|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526950|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526951|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
44526952|NCT00478140|Trastuzumab|trastuzumab|mesh-list
44526953|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44526954|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526955|NCT00478023|Morphine|morphine|mesh-list
44526956|NCT00478023|Tapentadol|tapentadol|mesh-list
44526957|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44526958|NCT00478023|Narcotics|narcotics|mesh-ancestor
44526959|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44526960|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526961|NCT00478023|Analgesics|analgesics|mesh-ancestor
44526962|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
44526963|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526964|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44526965|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44526966|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44526967|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526968|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44526969|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44526970|NCT00477971|Dexamethasone|dexamethasone|mesh-list
44526971|NCT00477971|Melphalan|melphalan|mesh-list
44526972|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526973|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
44526974|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
44526975|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44526976|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526977|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44526978|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
44526979|NCT00477971|Hormones|hormones|mesh-ancestor
44526980|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526981|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526982|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526983|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
44526984|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44526985|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
44526986|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44526987|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44526988|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44526989|NCT00477750|Prednisone|prednisone|mesh-list
44526990|NCT00477750|Lenalidomide|lenalidomide|mesh-list
44526991|NCT00477750|Melphalan|melphalan|mesh-list
44526992|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44526993|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
44526994|NCT00477750|Hormones|hormones|mesh-ancestor
44526995|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44526996|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44526997|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44526998|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44526999|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
44527000|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527001|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527002|NCT00477750|Growth Substances|growth substances|mesh-ancestor
44527003|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527004|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44527005|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
44527006|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527007|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44527008|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527009|NCT00477672|Pimavanserin|pimavanserin|mesh-list
44527010|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44527011|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44527012|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44527013|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44527014|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527015|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527016|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527017|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44527018|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44527019|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
44527020|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527021|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527022|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44527023|NCT00477633|Norethindrone|norethindrone|mesh-list
44527024|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
44527025|NCT00477633|Estradiol|estradiol|mesh-list
44527026|NCT00477633|Estrogens|estrogens|mesh-ancestor
44527027|NCT00477633|Hormones|hormones|mesh-ancestor
44527028|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527029|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527030|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44527031|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
44527032|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44527033|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44527034|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44527035|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44527036|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44527037|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
44527038|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
44527039|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527040|NCT00477607|Protective Agents|protective agents|mesh-ancestor
44527041|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527042|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
44527043|NCT00477607|Vitamins|vitamins|mesh-ancestor
44527044|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
44527045|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44527046|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
44527047|NCT00477490|Coagulants|coagulants|mesh-ancestor
44527048|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44527049|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
44527050|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527051|NCT00477464|Capecitabine|capecitabine|mesh-list
44527052|NCT00477464|Lapatinib|lapatinib|mesh-list
44527053|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527054|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
44527055|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527056|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527057|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527058|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527059|NCT00477386|Decitabine|decitabine|mesh-list
44527060|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527061|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
44527062|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527063|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527064|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527065|NCT00477334|Famciclovir|famciclovir|mesh-list
44527066|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
44431469|NCT02104804|Insulin|insulin|mesh-list
44527067|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527068|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44527069|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527070|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527071|NCT00477295|Carbamazepine|carbamazepine|mesh-list
44527072|NCT00477295|Zonisamide|zonisamide|mesh-list
44527073|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
44527074|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
44527075|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44527076|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527077|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527078|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527079|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527080|NCT00477295|Analgesics|analgesics|mesh-ancestor
44527081|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
44527082|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527083|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44527084|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527085|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527086|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44527087|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44527088|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44527089|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527090|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
44527091|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527092|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527093|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527094|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527095|NCT00477165|Citalopram|citalopram|mesh-list
44527096|NCT00477165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44527097|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527098|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527099|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527100|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527101|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
44527102|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527103|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44527104|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527105|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527106|NCT00476996|Methotrexate|methotrexate|mesh-list
44527107|NCT00476996|Leflunomide|leflunomide|mesh-list
44527108|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
44527109|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44527110|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
44527111|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44527112|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527113|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527114|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
44527115|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527116|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527117|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
44527118|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527119|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44527120|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527121|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
44527122|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527123|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44349431|NCT01073670|Acetaminophen|acetaminophen|mesh-list
44527142|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527143|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
44527144|NCT00476593|Hormones|hormones|mesh-ancestor
44527145|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527146|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527147|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527148|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44527149|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44527150|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527151|NCT00476593|Analgesics|analgesics|mesh-ancestor
44527152|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
44527153|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527154|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44527155|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527156|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527157|NCT00476593|Cathartics|cathartics|mesh-ancestor
44527158|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44527159|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527160|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527161|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527162|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527163|NCT00476229|Rituximab|rituximab|mesh-list
44527164|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
44527165|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44527166|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527167|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527168|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
44527169|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527170|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527171|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527172|NCT00476151|Ketamine|ketamine|mesh-list
44527173|NCT00476151|Amitriptyline|amitriptyline|mesh-list
44527174|NCT00476151|Analgesics|analgesics|mesh-ancestor
44527175|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
44527176|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527177|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349505|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44527178|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44527179|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44527180|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
44527181|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
44527182|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527183|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44527184|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44527185|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527186|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527187|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44527188|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527189|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527190|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527191|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44527192|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527193|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527194|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
44527195|NCT00476086|Gemcitabine|gemcitabine|mesh-list
44527196|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
44527197|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527198|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
44527199|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527200|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527201|NCT00476086|Antiviral Agents|antiviral agents|mesh-ancestor
44527202|NCT00476086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527203|NCT00476086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527204|NCT00476086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527205|NCT00476086|Immunologic Factors|immunologic factors|mesh-ancestor
44527206|NCT00476086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527207|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
44527208|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527210|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44431620|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44527211|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44527212|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
44527213|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527214|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527215|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527216|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44527217|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44527218|NCT00475865|Teriflunomide|teriflunomide|mesh-list
44527219|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
44527220|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
44527221|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44527222|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
44527223|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527224|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527225|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527226|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44527227|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527228|NCT00475865|Analgesics|analgesics|mesh-ancestor
44527229|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
44527230|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527231|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527232|NCT00475735|Methylphenidate|methylphenidate|mesh-list
44527233|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44527234|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527235|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44527236|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527237|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527238|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527239|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
44527240|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527241|NCT00475670|Paclitaxel|paclitaxel|mesh-list
44527242|NCT00475670|Docetaxel|docetaxel|mesh-list
44527243|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44527244|NCT00475670|Trastuzumab|trastuzumab|mesh-list
44527246|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44527247|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527248|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
44527249|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527250|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527252|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527253|NCT00475657|Cisplatin|cisplatin|mesh-list
44527254|NCT00475657|Pemetrexed|pemetrexed|mesh-list
44527255|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527256|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527257|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527258|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44527259|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44527260|NCT00475423|Rituximab|rituximab|mesh-list
44527261|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527262|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527263|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
44527264|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527265|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527266|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
44527267|NCT00475306|Promethazine|promethazine|mesh-list
44527268|NCT00475306|Metoclopramide|metoclopramide|mesh-list
44527269|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44527270|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44527271|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527272|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527273|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
44527274|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
44527275|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
44527276|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527277|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
44527278|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
44527279|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527280|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44527281|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
44527282|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
44527283|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527284|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527285|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44527286|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
44527287|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44527288|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44527289|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44527290|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
44527291|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
44527292|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44527293|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
44527294|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44527295|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527296|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44527297|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44527298|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44527299|NCT00475033|Vaccines|vaccines|mesh-list
44431691|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44527300|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44527301|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
44527302|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527303|NCT00474994|Sunitinib|sunitinib|mesh-list
44527304|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527305|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527306|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527307|NCT00474994|Growth Substances|growth substances|mesh-ancestor
44527308|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527309|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527310|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527311|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527312|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527313|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44527314|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
44527315|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527316|NCT00474929|Everolimus|everolimus|mesh-list
44527317|NCT00474929|Sorafenib|sorafenib|mesh-list
44527318|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527319|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527320|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
44527321|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527322|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527323|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527324|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527325|NCT00474903|Aspirin|aspirin|mesh-list
44527326|NCT00474903|Esomeprazole|esomeprazole|mesh-list
44527327|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44527328|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527329|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44527330|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349641|NCT01074333|Cetuximab|cetuximab|mesh-list
44527331|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527332|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44527333|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527334|NCT00474903|Analgesics|analgesics|mesh-ancestor
44527335|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
44527336|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527337|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527338|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527339|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527340|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44527341|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44527342|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44527343|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44527344|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
44527345|NCT00474812|Dasatinib|dasatinib|mesh-list
44527346|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527347|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527348|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527349|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527350|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44527351|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44527352|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527353|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527354|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527355|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527356|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527357|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44527358|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527359|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527360|NCT00474487|Vaccines|vaccines|mesh-list
44527361|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
44527362|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527363|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
44527364|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
44527365|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527366|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44527367|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527368|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527369|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
44527370|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527371|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527372|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44527373|NCT00474383|Hormones|hormones|mesh-ancestor
44527374|NCT00474253|Rocuronium|rocuronium|mesh-list
44527375|NCT00474253|Succinylcholine|succinylcholine|mesh-list
44527376|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44527377|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44527378|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44527379|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527380|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527381|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44527382|NCT00474240|Atorvastatin|atorvastatin|mesh-list
44527383|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44527384|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44527385|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
44527386|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527387|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44527388|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44527389|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527390|NCT00474058|Rotigotine|rotigotine|mesh-list
44527391|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
44527392|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
44527393|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527394|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527395|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527396|NCT00473889|Paclitaxel|paclitaxel|mesh-list
44527398|NCT00473889|Vorinostat|vorinostat|mesh-list
44527399|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44527400|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527401|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44349718|NCT01074697|Aprepitant|aprepitant|mesh-list
44527402|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527403|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527404|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527405|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44527406|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527407|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
44527408|NCT00473824|Antibodies|antibodies|mesh-list
44431822|NCT02096900|Midazolam|midazolam|mesh-list
44527409|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
44527410|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44527411|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44527412|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
44527413|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527414|NCT00473746|Dexamethasone|dexamethasone|mesh-list
44527415|NCT00473746|Prednisone|prednisone|mesh-list
44527416|NCT00473746|Prednisolone|prednisolone|mesh-list
44527417|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
44527418|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527419|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
44527420|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
44527421|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527422|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527423|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527424|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
44527425|NCT00473746|Hormones|hormones|mesh-ancestor
44527426|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527427|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527428|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527429|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44527430|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527431|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527432|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
44527433|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44527434|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
44527435|NCT00473694|Rocuronium|rocuronium|mesh-list
44527436|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
44527437|NCT00473694|Neostigmine|neostigmine|mesh-list
44527438|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44527439|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44527440|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44527441|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527442|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527443|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44527444|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527445|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527446|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
44527447|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527448|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44527449|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
44527450|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44527451|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44527452|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44527453|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44527454|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44527455|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44527456|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44527457|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
44431859|NCT02096744|Clonidine|clonidine|mesh-list
44527458|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527459|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44527460|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44527461|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527462|NCT00473590|Bevacizumab|bevacizumab|mesh-list
44527463|NCT00473590|Bortezomib|bortezomib|mesh-list
44527464|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527465|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527466|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527467|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527468|NCT00473590|Growth Substances|growth substances|mesh-ancestor
44527469|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527470|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527471|NCT00473512|Dexamethasone|dexamethasone|mesh-list
44527472|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
44527473|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527474|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
44527475|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
44527476|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349785|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
44527477|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527478|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527479|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
44527480|NCT00473512|Hormones|hormones|mesh-ancestor
44527481|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527482|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527483|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527484|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44527485|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527486|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527487|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
44527488|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44527489|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44527490|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44527491|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44527492|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527493|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527494|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527495|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44527496|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44527497|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
44527498|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527499|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527500|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44527501|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44527502|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
44527503|NCT00473382|Ranibizumab|ranibizumab|mesh-list
44527504|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527505|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527506|NCT00473382|Growth Substances|growth substances|mesh-ancestor
44527507|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527508|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527509|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527510|NCT00473265|Teriparatide|teriparatide|mesh-list
44527511|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527512|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527513|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44527514|NCT00473083|Minocycline|minocycline|mesh-list
44527515|NCT00473083|Clindamycin|clindamycin|mesh-list
44527516|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
44527517|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
44527518|NCT00473083|Triamcinolone|triamcinolone|mesh-list
44527519|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44527520|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44527521|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
44527522|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44527523|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527524|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527525|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527526|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
44527527|NCT00473083|Hormones|hormones|mesh-ancestor
44527528|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527529|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527530|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527531|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
44527532|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44527533|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527534|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44527535|NCT00472641|Ziprasidone|ziprasidone|mesh-list
44527536|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44527537|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
44527538|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527539|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527540|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527541|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44527542|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44527543|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527544|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527545|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44527546|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
44527548|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527549|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527550|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
44527551|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527552|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527553|NCT00472303|Morphine|morphine|mesh-list
44527554|NCT00472303|Tapentadol|tapentadol|mesh-list
44527555|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44527556|NCT00472303|Narcotics|narcotics|mesh-ancestor
44527557|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527558|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527559|NCT00472303|Analgesics|analgesics|mesh-ancestor
44527560|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
44527561|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527562|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44527563|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527564|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527565|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527566|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44527567|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527568|NCT00472199|Pramipexole|pramipexole|mesh-list
44527569|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
44527570|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527571|NCT00472199|Protective Agents|protective agents|mesh-ancestor
44527572|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527573|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44527574|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44527575|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
44527576|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
44527577|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527578|NCT00471887|Tremelimumab|tremelimumab|mesh-list
44527579|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527580|NCT00471445|Ketamine|ketamine|mesh-list
44527581|NCT00471445|Amitriptyline|amitriptyline|mesh-list
44527582|NCT00471445|Analgesics|analgesics|mesh-ancestor
44527583|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
44527584|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527585|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527586|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44527587|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44527588|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
44527589|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
44527590|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527591|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44527592|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44527593|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527594|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527595|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44527596|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527597|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527598|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44527599|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44527600|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527601|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527602|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
44527603|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44527604|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44527605|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527606|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527607|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527608|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
44527609|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527610|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527611|NCT00471328|Sunitinib|sunitinib|mesh-list
44527612|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
44527613|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527614|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527615|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527616|NCT00471328|Growth Substances|growth substances|mesh-ancestor
44527617|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527618|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527619|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527620|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527621|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527622|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44527623|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44527625|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527626|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527627|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527628|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527630|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
44527631|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527632|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527633|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527634|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
44527635|NCT00471237|Alendronate|alendronate|mesh-list
44527636|NCT00471237|Teriparatide|teriparatide|mesh-list
44527637|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44527638|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527639|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527640|NCT00470847|Trastuzumab|trastuzumab|mesh-list
44527641|NCT00470847|Lapatinib|lapatinib|mesh-list
44527642|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527643|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527644|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527645|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527646|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527647|NCT00470834|Bicalutamide|bicalutamide|mesh-list
44527648|NCT00470834|Dutasteride|dutasteride|mesh-list
44527649|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
44527650|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
44527651|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527652|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527653|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527654|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44527655|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44527656|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432063|NCT02093026|Methotrexate|methotrexate|mesh-list
44527657|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527658|NCT00470704|Trastuzumab|trastuzumab|mesh-list
44527659|NCT00470704|Lapatinib|lapatinib|mesh-list
44527660|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527661|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527662|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527663|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527664|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527665|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44527666|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527667|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527668|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527669|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527670|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
44527671|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527672|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527673|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527674|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527675|NCT00470366|Paclitaxel|paclitaxel|mesh-list
44527676|NCT00470366|Cisplatin|cisplatin|mesh-list
44527677|NCT00470366|Ifosfamide|ifosfamide|mesh-list
44527678|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44527679|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527680|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
44527681|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527682|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527683|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527684|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44527685|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
44527686|NCT00470275|Cytarabine|cytarabine|mesh-list
44527687|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527688|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
44527689|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935157|NCT00814177|Warfarin|warfarin|mesh-list
44527691|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
44527692|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527693|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527694|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
44527695|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527696|NCT00470184|Capecitabine|capecitabine|mesh-list
44527697|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
44350068|NCT01076439|Xhance|xhance|mesh-list
44527698|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527699|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
44527700|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527701|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527702|NCT00470158|Iron|iron|mesh-list
44527703|NCT00470158|Zinc|zinc|mesh-list
44527704|NCT00470158|Trace Elements|trace elements|mesh-ancestor
44527705|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
44527706|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527707|NCT00470093|Interferons|interferons|mesh-list
44527708|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527709|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
44527710|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527711|NCT00470067|Carboplatin|carboplatin|mesh-list
44527712|NCT00470067|Doxorubicin|doxorubicin|mesh-list
44527713|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44527714|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527715|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44527716|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44527717|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44527718|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527719|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527720|NCT00470054|Dasatinib|dasatinib|mesh-list
44527721|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527722|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527723|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527724|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527725|NCT00472186|Lansoprazole|lansoprazole|mesh-list
44527726|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
44527727|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44527728|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527729|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44527730|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527731|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527732|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44527733|NCT00479713|Simvastatin|simvastatin|mesh-list
44527734|NCT00479713|Ezetimibe|ezetimibe|mesh-list
44527735|NCT00479713|Calcium|calcium|mesh-list
44527736|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527737|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527738|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44527739|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44527740|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
44527741|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527742|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44432150|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527743|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44527744|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527745|NCT00479817|Paclitaxel|paclitaxel|mesh-list
44527746|NCT00479817|Trebananib|trebananib|mesh-list
44527747|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44527748|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527749|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
44527750|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527751|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527752|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527753|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527754|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527755|NCT00479817|Growth Substances|growth substances|mesh-ancestor
44527756|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527757|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527758|NCT00478972|Rimonabant|rimonabant|mesh-list
44527759|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44527760|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44527761|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44527762|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527763|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527764|NCT00478972|Hormones|hormones|mesh-ancestor
44527765|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527766|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527767|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44527768|NCT00478595|Rimonabant|rimonabant|mesh-list
44527769|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44527770|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44527771|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44527772|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527773|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527774|NCT00478595|Hormones|hormones|mesh-ancestor
44527775|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527776|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527777|NCT00478179|Bupivacaine|bupivacaine|mesh-list
44527778|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44527779|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
44527780|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527781|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527782|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
44527783|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527784|NCT00477529|Docetaxel|docetaxel|mesh-list
44527785|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527786|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
44527787|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527788|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527789|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527790|NCT00474188|Dexamethasone|dexamethasone|mesh-list
44527791|NCT00474188|Lenalidomide|lenalidomide|mesh-list
44527792|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527793|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
44527794|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
44527795|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527796|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527797|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527798|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
44527799|NCT00474188|Hormones|hormones|mesh-ancestor
44527800|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527801|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527802|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527803|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
44527804|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527805|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527806|NCT00474188|Growth Substances|growth substances|mesh-ancestor
44527807|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527808|NCT00472693|Bevacizumab|bevacizumab|mesh-list
44527809|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44527810|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527811|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527812|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527813|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527814|NCT00472693|Growth Substances|growth substances|mesh-ancestor
44527815|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527816|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527817|NCT00474526|Vaccines|vaccines|mesh-list
44527818|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44527819|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
44527820|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527821|NCT00478426|Sunitinib|sunitinib|mesh-list
44527822|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527823|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527824|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527825|NCT00478426|Growth Substances|growth substances|mesh-ancestor
44527826|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527827|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527828|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44527829|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432235|NCT02089737|Panitumumab|panitumumab|mesh-list
44527830|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527831|NCT00475020|Fludarabine|fludarabine|mesh-list
44527832|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
44527833|NCT00475020|Busulfan|busulfan|mesh-list
44527834|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
44527835|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44527836|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527837|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527838|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
44527839|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527840|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527841|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
44527842|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527843|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
44527844|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44527845|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44350163|NCT01076621|Norethindrone|norethindrone|mesh-list
44527847|NCT00477412|Dexamethasone|dexamethasone|mesh-list
44527848|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
44527849|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
44527851|NCT00477412|Doxorubicin|doxorubicin|mesh-list
44527852|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44527853|NCT00477412|Methotrexate|methotrexate|mesh-list
44527854|NCT00477412|Vincristine|vincristine|mesh-list
44527855|NCT00477412|Bortezomib|bortezomib|mesh-list
44527856|NCT00477412|Daunorubicin|daunorubicin|mesh-list
44527857|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44527858|NCT00477412|Antibodies|antibodies|mesh-list
44527859|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
44527860|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44527861|NCT00477412|BB 1101|bb 1101|mesh-list
44527862|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44527863|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
44527864|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527865|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44527866|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44527867|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
44527868|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527869|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527870|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44527871|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44527872|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
44527873|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
44527874|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527875|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527876|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
44527877|NCT00477412|Hormones|hormones|mesh-ancestor
44527878|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527879|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527880|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44527881|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44527882|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44527883|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527884|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44527885|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
44527886|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44527887|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44527888|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
44527889|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44527890|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44527891|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44527892|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
44527893|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527894|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44527895|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
44527896|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
44527897|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
44527898|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
44527899|NCT01083966|Bevacizumab|bevacizumab|mesh-list
44527900|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527901|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527902|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527903|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527904|NCT01083966|Growth Substances|growth substances|mesh-ancestor
44527905|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527906|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527907|NCT01086982|Octreotide|octreotide|mesh-list
44527908|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527909|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44527910|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527911|NCT01089647|Budesonide|budesonide|mesh-list
44527912|NCT01089647|Montelukast|montelukast|mesh-list
44527913|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935347|NCT00818961|Busulfan|busulfan|mesh-list
44527914|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44527915|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
44527916|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527917|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527918|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44527919|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
44527920|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
44350237|NCT01077206|Simvastatin|simvastatin|mesh-list
44527921|NCT01089647|Hormones|hormones|mesh-ancestor
44527922|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44527924|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
44527925|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44527926|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44527927|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527928|NCT01089608|Azithromycin|azithromycin|mesh-list
44527929|NCT01089608|Povidone|povidone|mesh-list
44527930|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44527931|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44527932|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
44527933|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
44527934|NCT01089556|Pregabalin|pregabalin|mesh-list
44527935|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44527936|NCT01089556|Analgesics|analgesics|mesh-ancestor
44527937|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
44527938|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527939|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527940|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
44527941|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44527942|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44527943|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527944|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44527945|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44527946|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44527947|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527948|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44527949|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44527950|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44527951|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527952|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
44527953|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
44527954|NCT01089543|Rabeprazole|rabeprazole|mesh-list
44527955|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44527956|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44527957|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44527958|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44527959|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527960|NCT01089504|Phenobarbital|phenobarbital|mesh-list
44527961|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
44527962|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44527963|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44527964|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527965|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44527966|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44527967|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527968|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527969|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
44527970|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
44527971|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44527972|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44432380|NCT02084082|Linagliptin|linagliptin|mesh-list
44527973|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44527974|NCT01089413|Bevacizumab|bevacizumab|mesh-list
44527975|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44527976|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44527977|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44527978|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44527979|NCT01089413|Growth Substances|growth substances|mesh-ancestor
44527980|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527981|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
44527982|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44527983|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44527984|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
44527985|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44527986|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44527987|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44527988|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
44527989|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44527990|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44527991|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44527992|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
44527993|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44527994|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44527995|NCT01088997|Milrinone|milrinone|mesh-list
44527996|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44527997|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44527998|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44527999|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44528000|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44528001|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528002|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528003|NCT01088997|Protective Agents|protective agents|mesh-ancestor
44528004|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528005|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44528006|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44528007|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
44528008|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528009|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528010|NCT01088529|Prednisone|prednisone|mesh-list
44528011|NCT01088529|Leuprolide|leuprolide|mesh-list
44528012|NCT01088529|Goserelin|goserelin|mesh-list
44528013|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
44528014|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528015|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
44528016|NCT01088529|Hormones|hormones|mesh-ancestor
44528017|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528018|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528019|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528020|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528021|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44528022|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
44528023|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44528024|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44528025|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528026|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528027|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
44528028|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44528029|NCT01088243|Mesalamine|mesalamine|mesh-list
44528030|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44528031|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528032|NCT01088243|Analgesics|analgesics|mesh-ancestor
44528033|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
44528034|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528035|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528036|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528037|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528038|NCT01088048|Rituximab|rituximab|mesh-list
44528039|NCT01088048|Fludarabine|fludarabine|mesh-list
44528040|NCT01088048|Lenalidomide|lenalidomide|mesh-list
44528041|NCT01088048|Everolimus|everolimus|mesh-list
44528042|NCT01088048|Bortezomib|bortezomib|mesh-list
44528043|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44528044|NCT01088048|Ofatumumab|ofatumumab|mesh-list
44528045|NCT01088048|Idelalisib|idelalisib|mesh-list
44528046|NCT01088048|Chlorambucil|chlorambucil|mesh-list
44528047|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528048|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528049|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
44528050|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528051|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528052|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528053|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528054|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44528055|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44528056|NCT01088048|Growth Substances|growth substances|mesh-ancestor
44528057|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528058|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44528059|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
44528060|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528061|NCT01087970|Cisplatin|cisplatin|mesh-list
44528062|NCT01087970|Carboplatin|carboplatin|mesh-list
44528063|NCT01087970|Pemetrexed|pemetrexed|mesh-list
44528064|NCT01087970|Cetuximab|cetuximab|mesh-list
44528065|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528066|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528067|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528068|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44528069|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44528070|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528071|NCT01087905|Nicotine|nicotine|mesh-list
44528072|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44528073|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
44528074|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528075|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528076|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44528077|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44528078|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528079|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528080|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528081|NCT01087814|Efavirenz|efavirenz|mesh-list
44350459|NCT01078961|Sorafenib|sorafenib|mesh-list
44528082|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44528083|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44528084|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528085|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528086|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
44528087|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528088|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44528089|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44528090|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44528091|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44528092|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44528093|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44528094|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
44528095|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528096|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
44528097|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528098|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528099|NCT01087723|Heparin|heparin|mesh-list
44528100|NCT01087723|Bivalirudin|bivalirudin|mesh-list
44528101|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
44528102|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44528103|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44528104|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528105|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
44528106|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44528107|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528108|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528109|NCT01087502|Glimepiride|glimepiride|mesh-list
44528110|NCT01087502|Linagliptin|linagliptin|mesh-list
44528111|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44528112|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44528113|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528114|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528115|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
44528116|NCT01087502|Incretins|incretins|mesh-ancestor
44528117|NCT01087502|Hormones|hormones|mesh-ancestor
44528118|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528119|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44528120|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528121|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528122|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528123|NCT01086410|Fluticasone|fluticasone|mesh-list
44528124|NCT01086410|Xhance|xhance|mesh-list
44528125|NCT01086410|Prednisolone|prednisolone|mesh-list
44528126|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528127|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44528128|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
44528129|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528130|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528131|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44528132|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44528133|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
44528134|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44528135|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
44528136|NCT01086410|Hormones|hormones|mesh-ancestor
43762173|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
44528137|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528138|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528139|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528140|NCT01086150|Lidocaine|lidocaine|mesh-list
44528141|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
44528142|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
44528143|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528144|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528145|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
44528146|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528147|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44528148|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44528149|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44528150|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44528151|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528152|NCT01085812|Milnacipran|milnacipran|mesh-list
44528153|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
44528154|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44350538|NCT01079338|Caffeine|caffeine|mesh-list
44528162|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528164|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
44528165|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528166|NCT01085734|Bevacizumab|bevacizumab|mesh-list
44528167|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528168|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528169|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44528170|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44528171|NCT01085734|Growth Substances|growth substances|mesh-ancestor
44528172|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528173|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528174|NCT01085591|Vancomycin|vancomycin|mesh-list
44528175|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44528176|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528177|NCT01085201|Regadenoson|regadenoson|mesh-list
44528178|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44528179|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44432582|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
44528180|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
44528181|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
44528182|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528183|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528184|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528185|NCT01085136|Afatinib|afatinib|mesh-list
44528186|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528187|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44528188|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528189|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528190|NCT01085045|Bromides|bromides|mesh-list
44528191|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
44528192|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
44528193|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44528194|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
44528195|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528196|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528197|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44528198|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
44528199|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44528200|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44528201|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44528202|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
44528203|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528204|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528205|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
44528206|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44528207|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528208|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
44528209|NCT01084707|Nicotine|nicotine|mesh-list
44528210|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44528211|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
44528212|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528213|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528214|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44528215|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44528216|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528217|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528218|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528219|NCT01084655|Prednisone|prednisone|mesh-list
44528220|NCT01084655|Docetaxel|docetaxel|mesh-list
44528221|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528222|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
44528223|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
44528224|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
44528225|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528226|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528227|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
44528228|NCT01084655|Hormones|hormones|mesh-ancestor
44528229|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528230|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528231|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528232|NCT01084603|Nicotine|nicotine|mesh-list
44528233|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44528234|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
44528235|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528236|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528237|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44528238|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44528239|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528240|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528241|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528242|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
44528243|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44528244|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528245|NCT01084538|Vitamins|vitamins|mesh-ancestor
44528246|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
44528247|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44528248|NCT01084135|Rivastigmine|rivastigmine|mesh-list
44528249|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44528250|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528251|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528252|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528253|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528254|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528255|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44528256|NCT01084135|Protective Agents|protective agents|mesh-ancestor
44528257|NCT01084083|Paclitaxel|paclitaxel|mesh-list
44528258|NCT01084083|Cisplatin|cisplatin|mesh-list
44528259|NCT01084083|Cetuximab|cetuximab|mesh-list
44528260|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44528261|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528262|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44528263|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44528264|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44528265|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528266|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528267|NCT01084005|Linagliptin|linagliptin|mesh-list
44528268|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44528269|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528270|NCT01084005|Incretins|incretins|mesh-ancestor
44528271|NCT01084005|Hormones|hormones|mesh-ancestor
44528272|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528273|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44528274|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528275|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528276|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528277|NCT01083810|Ritonavir|ritonavir|mesh-list
44528278|NCT01083810|Lopinavir|lopinavir|mesh-list
44528279|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44528280|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44528281|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528282|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528283|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528284|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44528285|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44528287|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528288|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44528289|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44528290|NCT01083641|Estradiol|estradiol|mesh-list
44528291|NCT01083641|Estrogens|estrogens|mesh-ancestor
44528292|NCT01083641|Hormones|hormones|mesh-ancestor
44528293|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528294|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528295|NCT01083602|Dexamethasone|dexamethasone|mesh-list
44528296|NCT01083602|Bortezomib|bortezomib|mesh-list
44528297|NCT01083602|Panobinostat|panobinostat|mesh-list
44528298|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528299|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
44528300|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
44528301|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528302|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528303|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528304|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
44528305|NCT01083602|Hormones|hormones|mesh-ancestor
44528306|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528307|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528308|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528309|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44528310|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528311|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528312|NCT01083576|Gentamicins|gentamicins|mesh-list
44528313|NCT01083576|Paromomycin|paromomycin|mesh-list
44528314|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44528315|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528316|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44528317|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528318|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528319|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44528320|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44528321|NCT01083485|Oxycodone|oxycodone|mesh-list
44528322|NCT01083485|Naloxone|naloxone|mesh-list
44528323|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44528324|NCT01083485|Narcotics|narcotics|mesh-ancestor
44528325|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528326|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528327|NCT01083485|Analgesics|analgesics|mesh-ancestor
44528328|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
44528329|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528330|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44528331|NCT01083316|Dexamethasone|dexamethasone|mesh-list
44528332|NCT01083316|Bortezomib|bortezomib|mesh-list
44528333|NCT01083316|Melphalan|melphalan|mesh-list
44528334|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528335|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
44528336|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
44528337|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528338|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528339|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528340|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
44528341|NCT01083316|Hormones|hormones|mesh-ancestor
44528342|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528343|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528344|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528345|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44528346|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
44528347|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528348|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44528349|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528350|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
44528351|NCT01082640|Febuxostat|febuxostat|mesh-list
44528352|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
44528353|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528354|NCT01082081|Acetaminophen|acetaminophen|mesh-list
44528355|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528356|NCT01082081|Analgesics|analgesics|mesh-ancestor
44528357|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
44528358|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528359|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528360|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
44528361|NCT01081873|Leuprolide|leuprolide|mesh-list
44528362|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44528364|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44528365|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528366|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528367|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528368|NCT01081795|Topiramate|topiramate|mesh-list
44528369|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
44528370|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44528371|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528372|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44528373|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
44528374|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44528375|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528376|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528377|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44528378|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44528379|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44528380|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
44528381|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528382|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528383|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44528384|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44528385|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
44528386|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44528388|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528389|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528390|NCT01081249|Oxytocin|oxytocin|mesh-list
44528391|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
44528392|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44528393|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528394|NCT01081145|Guanfacine|guanfacine|mesh-list
44528395|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44528396|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44528397|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44528398|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44528399|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44528400|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528401|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528402|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528403|NCT01081132|Guanfacine|guanfacine|mesh-list
44528404|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44528405|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44528406|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44528407|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44528408|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
44528409|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528410|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528411|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528412|NCT01080768|Amlodipine|amlodipine|mesh-list
44528413|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44528414|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44528415|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44528416|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528417|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44528418|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528419|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
44528420|NCT01080716|Vaccines|vaccines|mesh-list
44528421|NCT01080716|Complement Factor H|complement factor h|mesh-list
44528422|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
44528423|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528424|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44528425|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528426|NCT01080625|Phenylephrine|phenylephrine|mesh-list
44528427|NCT01080625|Epinephrine|epinephrine|mesh-list
44528428|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
44528429|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44528430|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44528431|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
44528432|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528433|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350819|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44528434|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528435|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44528436|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44528437|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
44528438|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528439|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44528440|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
44528441|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
44528443|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44528444|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44528445|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
44528446|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44528447|NCT01080625|Protective Agents|protective agents|mesh-ancestor
44528448|NCT01080300|Gabapentin|gabapentin|mesh-list
44528449|NCT01080300|Analgesics|analgesics|mesh-ancestor
44528450|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
44528451|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528452|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528453|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
44528454|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44528455|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44528456|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528457|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44528458|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44528459|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44528460|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528461|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528462|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
44528463|NCT01080131|Triamcinolone|triamcinolone|mesh-list
44528464|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44528465|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44528466|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44528467|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44528468|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528469|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
44528470|NCT01080131|Hormones|hormones|mesh-ancestor
44528471|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528472|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528473|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528474|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
44528475|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528476|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528477|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
44528478|NCT01085097|Prednisone|prednisone|mesh-list
44528479|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
44528480|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44528481|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44528482|NCT01085097|Prednisolone|prednisolone|mesh-list
44528483|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
44528484|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44528485|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
44528486|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528487|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
44528488|NCT01085097|Hormones|hormones|mesh-ancestor
44528489|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528490|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528491|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528492|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528493|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44528494|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44528495|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
44528496|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44528497|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528498|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528499|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528500|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
44528501|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
44528502|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528503|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528504|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44528505|NCT01085097|Protective Agents|protective agents|mesh-ancestor
44528506|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44528507|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44528508|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528516|NCT01087151|Rituximab|rituximab|mesh-list
44528517|NCT01087151|Navitoclax|navitoclax|mesh-list
44528518|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528519|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528520|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
44528521|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528522|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528523|NCT01086267|Cetuximab|cetuximab|mesh-list
44528524|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528525|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528526|NCT01084330|Docetaxel|docetaxel|mesh-list
44528527|NCT01084330|Irinotecan|irinotecan|mesh-list
44528528|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528529|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
44528530|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
44528531|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
44528532|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528533|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44528534|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44528535|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528536|NCT01084161|Morphine|morphine|mesh-list
44528537|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44528538|NCT01084161|Narcotics|narcotics|mesh-ancestor
44432911|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528539|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528540|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528541|NCT01084161|Analgesics|analgesics|mesh-ancestor
44528542|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
44528543|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528544|NCT01083615|Prednisone|prednisone|mesh-list
44528545|NCT01083615|Docetaxel|docetaxel|mesh-list
44528546|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528547|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44528548|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44528549|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44528550|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528551|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528552|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
44528553|NCT01083615|Hormones|hormones|mesh-ancestor
44528554|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528555|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528556|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528557|NCT01082549|Gemcitabine|gemcitabine|mesh-list
44528558|NCT01082549|Carboplatin|carboplatin|mesh-list
44528559|NCT01082549|Iniparib|iniparib|mesh-list
44528560|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528561|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44528562|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
44528563|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528564|NCT01082549|Antiviral Agents|antiviral agents|mesh-ancestor
44528565|NCT01082549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528566|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528567|NCT01082549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528568|NCT01082549|Immunologic Factors|immunologic factors|mesh-ancestor
44528569|NCT01082549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528570|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44528571|NCT01082068|Letrozole|letrozole|mesh-list
44528572|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528573|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44528574|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44528575|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528576|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528577|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44528578|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
44528579|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528580|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528581|NCT01081782|Ceralifimod|ceralifimod|mesh-list
44528582|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44528583|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528584|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528585|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
44528586|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528587|NCT01080222|Ribavirin|ribavirin|mesh-list
44528588|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44528589|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
44350977|NCT01081847|Mannitol|mannitol|mesh-list
44528590|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528591|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
44528592|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528593|NCT01085630|Pemetrexed|pemetrexed|mesh-list
44528594|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528595|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528596|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528597|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44528598|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44528599|NCT01088802|Cisplatin|cisplatin|mesh-list
44528600|NCT01088802|Carboplatin|carboplatin|mesh-list
44528601|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528603|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
44528604|NCT01086540|Promethazine|promethazine|mesh-list
44528605|NCT01086540|Prednisone|prednisone|mesh-list
44528606|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
44528607|NCT01086540|Rituximab|rituximab|mesh-list
44528608|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528609|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528610|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
44528611|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433015|NCT02066129|Fluticasone|fluticasone|mesh-list
44528612|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528613|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528614|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
44528615|NCT01086540|Hormones|hormones|mesh-ancestor
44528616|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528617|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528618|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528619|NCT01086540|Analgesics|analgesics|mesh-ancestor
44528620|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
44528621|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528622|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
44528623|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
44528624|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
44528625|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528626|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44528627|NCT01086540|Protective Agents|protective agents|mesh-ancestor
44528628|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44528629|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44528630|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528631|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
44528632|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
44528633|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44528634|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
44528635|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
44528636|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528637|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528638|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44528639|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
44528640|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
44528641|NCT01086748|Risperidone|risperidone|mesh-list
44528642|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44528643|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
44528644|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528645|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528646|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528647|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44528648|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44528649|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528650|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44528651|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44528652|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
44528653|NCT04992624|Dronabinol|dronabinol|mesh-list
44528654|NCT04992624|Cannabidiol|cannabidiol|mesh-list
44528655|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
44528656|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
44528657|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528658|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44528659|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528660|NCT04992624|Analgesics|analgesics|mesh-ancestor
44528661|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
44528662|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528663|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44528664|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44528665|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528666|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528667|NCT04992624|Hormones|hormones|mesh-ancestor
44528668|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528669|NCT04990037|Folfirinox|folfirinox|mesh-list
44528670|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528671|NCT04999228|Mesalamine|mesalamine|mesh-list
44528672|NCT04999228|Infliximab|infliximab|mesh-list
44528673|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44528674|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528675|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528676|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44528677|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44528678|NCT04999228|Analgesics|analgesics|mesh-ancestor
44528679|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
44528680|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528681|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528682|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528684|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44528685|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528686|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528687|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528688|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528689|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528690|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44528691|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
44528692|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528693|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
44528694|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528695|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528696|NCT04990778|Venetoclax|venetoclax|mesh-list
44528697|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528698|NCT04998279|Lenograstim|lenograstim|mesh-list
44528699|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44528700|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
44528701|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528702|NCT04998981|Fenofibrate|fenofibrate|mesh-list
44528703|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44528704|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
44528705|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528706|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44528707|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
44528708|NCT04990804|Analgesics|analgesics|mesh-list
44528709|NCT04990804|Narcotics|narcotics|mesh-ancestor
44528710|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528711|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528712|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
44528713|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528714|NCT04991974|Buprenorphine|buprenorphine|mesh-list
44528715|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44528716|NCT04991974|Naloxone|naloxone|mesh-list
44528717|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44528718|NCT04991974|Narcotics|narcotics|mesh-ancestor
44528719|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528720|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528721|NCT04991974|Analgesics|analgesics|mesh-ancestor
44528722|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
44528723|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528724|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44528725|NCT04991662|Phenylephrine|phenylephrine|mesh-list
44528726|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
44528727|NCT04991662|Norepinephrine|norepinephrine|mesh-list
44528728|NCT04991662|Metaraminol|metaraminol|mesh-list
44528729|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44528730|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
44528731|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
44528732|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528733|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528734|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
44528735|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44528736|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
44528737|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44528738|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44528739|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44528740|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44528741|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
44528742|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528743|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528744|NCT04991662|Protective Agents|protective agents|mesh-ancestor
44528745|NCT04997941|Tamoxifen|tamoxifen|mesh-list
44528746|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44528747|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44528748|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528749|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528750|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528751|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528752|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44528753|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44528754|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44528756|NCT04991103|Lenalidomide|lenalidomide|mesh-list
44528757|NCT04991103|Bortezomib|bortezomib|mesh-list
44528758|NCT04991103|Daratumumab|daratumumab|mesh-list
44528759|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528760|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
44528761|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
44528762|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528763|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528764|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528765|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
44528766|NCT04991103|Hormones|hormones|mesh-ancestor
44528767|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528768|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528769|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528770|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
44528771|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44528772|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44528773|NCT04991103|Growth Substances|growth substances|mesh-ancestor
44433156|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
44528774|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528775|NCT04995978|Pioglitazone|pioglitazone|mesh-list
44528776|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44528777|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528778|NCT04990323|Vidarabine|vidarabine|mesh-list
44528779|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
44528780|NCT04990323|Busulfan|busulfan|mesh-list
44528781|NCT04990323|Thiotepa|thiotepa|mesh-list
44528782|NCT04990323|Fludarabine|fludarabine|mesh-list
44528783|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
44528784|NCT04990323|Clofarabine|clofarabine|mesh-list
44528785|NCT04990323|Tacrolimus|tacrolimus|mesh-list
44528786|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528787|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
44528788|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528789|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528790|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44528791|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
44528792|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528793|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528794|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44528795|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44528796|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
44528797|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
44528798|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528799|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44528800|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528801|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
44528802|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44528803|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
44528804|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528805|NCT04992013|Niraparib|niraparib|mesh-list
44528806|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44528807|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528808|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528809|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528810|NCT04997850|Lenvatinib|lenvatinib|mesh-list
44528811|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528812|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44528813|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528814|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351276|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528838|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528839|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528840|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433206|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528841|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528842|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44528843|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44528844|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44528845|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44528846|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
44528847|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936147|NCT02187224|Progesterone|progesterone|mesh-list
44528848|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528849|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44528850|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
44528851|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
44528852|NCT02215122|Hormones|hormones|mesh-ancestor
44528853|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528854|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
44528855|NCT02215980|Dexamethasone|dexamethasone|mesh-list
44528856|NCT02215980|Lenalidomide|lenalidomide|mesh-list
44528857|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44528858|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
44528859|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
44528860|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528861|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528862|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44528863|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
44351356|NCT01083329|Niacin|niacin|mesh-list
44528864|NCT02215980|Hormones|hormones|mesh-ancestor
44528865|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528866|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44528867|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528868|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
44528869|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44528870|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44528871|NCT02215980|Growth Substances|growth substances|mesh-ancestor
44528872|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528873|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
44528874|NCT02210104|Ipilimumab|ipilimumab|mesh-list
44528875|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44528876|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
44528877|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433256|NCT02060370|Sunitinib|sunitinib|mesh-list
44528878|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44528879|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44528880|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
44528881|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528882|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528883|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44528884|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44528885|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44528886|NCT02210117|Bevacizumab|bevacizumab|mesh-list
44528887|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44528888|NCT02210117|Nivolumab|nivolumab|mesh-list
44528889|NCT02210117|Ipilimumab|ipilimumab|mesh-list
44528890|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
44528891|NCT02210117|Antibodies|antibodies|mesh-list
44528892|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
44528893|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44528894|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
44528895|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528896|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44528897|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44528898|NCT02210117|Growth Substances|growth substances|mesh-ancestor
44528899|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528900|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
44528901|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
44528902|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44528903|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528904|NCT02210182|Pentamidine|pentamidine|mesh-list
44528905|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
44528906|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528907|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44528908|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44528909|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44528910|NCT02210260|Heroin|heroin|mesh-list
44528911|NCT02210260|Bupivacaine|bupivacaine|mesh-list
44528912|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
44528913|NCT02210260|Anesthetics|anesthetics|mesh-list
44528914|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44528915|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528916|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
44528917|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528918|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44528919|NCT02210260|Narcotics|narcotics|mesh-ancestor
44528920|NCT02210260|Analgesics|analgesics|mesh-ancestor
44528921|NCT02210325|Azithromycin|azithromycin|mesh-list
44528922|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
44528923|NCT02210325|Solithromycin|solithromycin|mesh-list
44528924|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44528925|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528927|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44528928|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
44528929|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528930|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528931|NCT02210598|Oxytocin|oxytocin|mesh-list
44528932|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
44528933|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44528934|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528935|NCT02210663|Veliparib|veliparib|mesh-list
44528936|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44528937|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528938|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528939|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528940|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44528942|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44528943|NCT02210702|Norethindrone|norethindrone|mesh-list
44528944|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
44528945|NCT02210702|Estradiol|estradiol|mesh-list
44528946|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44528947|NCT02210702|Estrogens|estrogens|mesh-ancestor
44528948|NCT02210702|Hormones|hormones|mesh-ancestor
44528949|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44528950|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528951|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44528952|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
44528953|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44528954|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44528955|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44528956|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44528957|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44528958|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
44528959|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44528960|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44528961|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
44528962|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44528963|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44528964|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44528965|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528966|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528967|NCT02210754|Menthol|menthol|mesh-list
44528968|NCT02210754|Nicotine|nicotine|mesh-list
44528969|NCT02210754|Glycerol|glycerol|mesh-list
44528970|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44528971|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
44528972|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44528973|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528974|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44528975|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44528976|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
44528977|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44528978|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528979|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
44528980|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
44528981|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44528982|NCT02210754|Protective Agents|protective agents|mesh-ancestor
44528983|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
44528984|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44528985|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
44528986|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44528987|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
44528988|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44528989|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44528990|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
44528991|NCT02210858|Tipifarnib|tipifarnib|mesh-list
44528992|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44528993|NCT02210884|Vitamin D|vitamin d|mesh-list
44528994|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
44528995|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
44528996|NCT02210884|Vitamins|vitamins|mesh-list
44528997|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
44528998|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44528999|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44529000|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44433376|NCT02058940|Hormones|hormones|mesh-ancestor
44529001|NCT02211066|Clopidogrel|clopidogrel|mesh-list
44529002|NCT02211066|Ticagrelor|ticagrelor|mesh-list
44529003|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44529004|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44529005|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44529006|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44529007|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
44529008|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529009|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529010|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529011|NCT02211079|Tolbutamide|tolbutamide|mesh-list
44529012|NCT02211079|Midazolam|midazolam|mesh-list
44529013|NCT02211079|Caffeine|caffeine|mesh-list
44529014|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44529015|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44351479|NCT01084057|Vorinostat|vorinostat|mesh-list
44529016|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529017|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529018|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44529019|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44529020|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44529021|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529022|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
44529023|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
44529024|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
44529025|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
44529026|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529027|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529028|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44529029|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44529030|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529031|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44529032|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44529033|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
44529034|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529035|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
44529036|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529037|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529038|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529039|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44529040|NCT02211118|Analgesics|analgesics|mesh-ancestor
44529041|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
44529042|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529043|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44529044|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44529045|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44529046|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
44529047|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529048|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529049|NCT02211222|Lenvatinib|lenvatinib|mesh-list
44529050|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529051|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44529052|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529053|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529054|NCT02211391|Caseins|caseins|mesh-list
44529055|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
44529056|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
44529057|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529058|NCT02211443|Antibodies|antibodies|mesh-list
44529059|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44529060|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
44529061|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351559|NCT01084473|Narcotics|narcotics|mesh-ancestor
44529074|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
44529075|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44529076|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
44529077|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529078|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
44529079|NCT02211521|Protective Agents|protective agents|mesh-ancestor
44529080|NCT02211625|Oxycodone|oxycodone|mesh-list
44529081|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44529082|NCT02211625|Narcotics|narcotics|mesh-ancestor
44529083|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529084|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529085|NCT02211625|Analgesics|analgesics|mesh-ancestor
44529086|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
44529087|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529088|NCT02211690|Tenofovir|tenofovir|mesh-list
44529090|NCT02211690|Dolutegravir|dolutegravir|mesh-list
44529091|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
44529092|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529093|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44529094|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529095|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529096|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529097|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44529098|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44529099|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44529100|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44529101|NCT02211833|Pemetrexed|pemetrexed|mesh-list
44529102|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529103|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529104|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529105|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44529106|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529107|NCT02211846|Mirabegron|mirabegron|mesh-list
44529108|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44529109|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44529110|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44529111|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
44529112|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529113|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529114|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529115|NCT02211846|Urological Agents|urological agents|mesh-ancestor
44529116|NCT02211911|Bisacodyl|bisacodyl|mesh-list
44529117|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
44529118|NCT02211911|Cathartics|cathartics|mesh-ancestor
44529119|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529120|NCT02211911|Laxatives|laxatives|mesh-ancestor
44529121|NCT02211950|Acarbose|acarbose|mesh-list
44529122|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44529123|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529124|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529125|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529126|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529127|NCT02211976|Bisacodyl|bisacodyl|mesh-list
44529128|NCT02211976|Cathartics|cathartics|mesh-ancestor
44529129|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529130|NCT02211976|Laxatives|laxatives|mesh-ancestor
44529131|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
44529132|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44529133|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44529134|NCT02212210|Prednisolone|prednisolone|mesh-list
44529135|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
44529136|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44529137|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
44529138|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529139|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
44529140|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
44529141|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529142|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529143|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529144|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
44529145|NCT02212210|Hormones|hormones|mesh-ancestor
44529146|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529147|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44529148|NCT02212210|Protective Agents|protective agents|mesh-ancestor
44529149|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529150|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529151|NCT02212223|Vitamin D|vitamin d|mesh-list
44529152|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
44529153|NCT02212223|Vitamins|vitamins|mesh-ancestor
44529154|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
44529155|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529156|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44529157|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529158|NCT02212340|Remifentanil|remifentanil|mesh-list
44529159|NCT02212340|Desflurane|desflurane|mesh-list
44529160|NCT02212340|Propofol|propofol|mesh-list
44529161|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44529162|NCT02212340|Narcotics|narcotics|mesh-ancestor
44529163|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529164|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529165|NCT02212340|Analgesics|analgesics|mesh-ancestor
44529166|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
44529167|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529168|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44529169|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
44529170|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
44529171|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529172|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529173|NCT02212431|Cysteamine|cysteamine|mesh-list
44529174|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44529175|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529176|NCT02212561|Cytarabine|cytarabine|mesh-list
44529177|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
44529178|NCT02212561|Methotrexate|methotrexate|mesh-list
44529179|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
44529180|NCT02212561|Fludarabine|fludarabine|mesh-list
44529181|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44529182|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
44529183|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44529184|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529185|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44529186|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
44529187|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529188|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529189|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529190|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529191|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44529192|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529193|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
44529194|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529195|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529196|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
44529197|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529198|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529199|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
44529200|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
44529201|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529202|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529203|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529204|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
44529205|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
44529206|NCT02212639|Digoxin|digoxin|mesh-list
44529207|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44529208|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44529209|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529210|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529211|NCT02212639|Protective Agents|protective agents|mesh-ancestor
44529212|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529213|NCT02212652|Vitamin D|vitamin d|mesh-list
44529214|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
44529215|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
44529216|NCT02212652|Vitamins|vitamins|mesh-list
44529217|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
44529218|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529219|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44529220|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529221|NCT02212756|Metformin|metformin|mesh-list
44529222|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529223|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529224|NCT02212769|Losartan|losartan|mesh-list
44529225|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44529226|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529227|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529228|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529229|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529230|NCT02212782|Linagliptin|linagliptin|mesh-list
44529231|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529232|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529233|NCT02212782|Incretins|incretins|mesh-ancestor
44529234|NCT02212782|Hormones|hormones|mesh-ancestor
44529235|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529236|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44529237|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529238|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529239|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529240|NCT02212795|Levofloxacin|levofloxacin|mesh-list
44529241|NCT02212795|Ofloxacin|ofloxacin|mesh-list
44529243|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44529244|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529245|NCT02212795|Renal Agents|renal agents|mesh-ancestor
44529246|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529247|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44529248|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529249|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529250|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529251|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529252|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44529253|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44529254|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529255|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
44529256|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44529257|NCT02212821|Erythromycin|erythromycin|mesh-list
44529258|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
44529259|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44529260|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
44529261|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529262|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529263|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529264|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44529265|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529266|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529267|NCT02212990|Acetaminophen|acetaminophen|mesh-list
44529268|NCT02212990|Ibuprofen|ibuprofen|mesh-list
44529269|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44351762|NCT01085721|Expectorants|expectorants|mesh-ancestor
44529270|NCT02212990|Analgesics|analgesics|mesh-ancestor
44529271|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
44529272|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529273|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529274|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
44529275|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44529276|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529277|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529278|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44529279|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529280|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529281|NCT02213029|Oxytocin|oxytocin|mesh-list
44529282|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
44529283|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44529284|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529285|NCT02213146|Insulin|insulin|mesh-list
44529286|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
44529287|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44529288|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529289|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529290|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
44529291|NCT02213159|Morphine|morphine|mesh-list
44529292|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529293|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529294|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529295|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44529296|NCT02213159|Analgesics|analgesics|mesh-ancestor
44529297|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
44529298|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529299|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44529300|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44529301|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44529302|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
44529303|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529304|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529305|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44529306|NCT02213159|Narcotics|narcotics|mesh-ancestor
44529307|NCT02213211|Lumefantrine|lumefantrine|mesh-list
44529308|NCT02213211|Artemether|artemether|mesh-list
44529309|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44529310|NCT02213211|Artemisinins|artemisinins|mesh-list
44529311|NCT02213211|Artemisinin|artemisinin|mesh-list
44529312|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
44529313|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44529314|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44529315|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529316|NCT02213224|Amlodipine|amlodipine|mesh-list
44529317|NCT02213224|Telmisartan|telmisartan|mesh-list
44433652|NCT02055352|Hormones|hormones|mesh-ancestor
44529318|NCT02213224|Perindopril|perindopril|mesh-list
44529319|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529320|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44529321|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44529322|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529323|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529324|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529325|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
44529326|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529327|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529328|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44529329|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529330|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529331|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
44529332|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44529333|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529334|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
44529335|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529336|NCT02213419|Ethanol|ethanol|mesh-list
44529337|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44529338|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529339|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529340|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529341|NCT02213588|Antioxidants|antioxidants|mesh-list
44529342|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529343|NCT02213588|Protective Agents|protective agents|mesh-ancestor
44351843|NCT01086254|Cisplatin|cisplatin|mesh-list
44529344|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529345|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
44529346|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
44529347|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44529348|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529349|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529350|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
44529351|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44433711|NCT02053493|Isosorbide|isosorbide|mesh-list
44529352|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529353|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529354|NCT02213653|Iron|iron|mesh-list
44529355|NCT02213653|Trace Elements|trace elements|mesh-ancestor
44529356|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
44529357|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529358|NCT02213718|Sufentanil|sufentanil|mesh-list
44529359|NCT02213718|Propofol|propofol|mesh-list
44529360|NCT02213718|Desflurane|desflurane|mesh-list
44529361|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529362|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529363|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529364|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529365|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
44529366|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
44529367|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44529368|NCT02213718|Narcotics|narcotics|mesh-ancestor
44529369|NCT02213718|Analgesics|analgesics|mesh-ancestor
44529370|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
44529371|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529372|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44529373|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44529374|NCT02213783|Imipenem|imipenem|mesh-list
44529375|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529376|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529377|NCT02213796|Meropenem|meropenem|mesh-list
44529378|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529379|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529380|NCT02213848|Calcium|calcium|mesh-list
44529381|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529382|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529383|NCT02213887|Pantoprazole|pantoprazole|mesh-list
44529384|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44529385|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529386|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44529387|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529388|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529389|NCT02213913|Prednisone|prednisone|mesh-list
44529390|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
44529391|NCT02213913|Rituximab|rituximab|mesh-list
44529393|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44529394|NCT02213913|Etoposide|etoposide|mesh-list
44529395|NCT02213913|Vincristine|vincristine|mesh-list
44529396|NCT02213913|Lenalidomide|lenalidomide|mesh-list
44529397|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
44529398|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529399|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
44529400|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529401|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529402|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44529403|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
44529404|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529405|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529406|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44529407|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44529408|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529409|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44529410|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529411|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529412|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529413|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
44529414|NCT02213913|Hormones|hormones|mesh-ancestor
44529415|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529416|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529417|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44529418|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44529419|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44529420|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351911|NCT01086553|Hormones|hormones|mesh-ancestor
44529421|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44529431|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529432|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529433|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44529434|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44529435|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529436|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529437|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44529439|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529440|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529441|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529442|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529443|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
44529444|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
44529445|NCT02214381|Paclitaxel|paclitaxel|mesh-list
44529446|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
44529447|NCT02214381|Doxorubicin|doxorubicin|mesh-list
44529448|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44529449|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529450|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
44529451|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
44529452|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
44529453|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529454|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529455|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
44529456|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529457|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529458|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44529459|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
44529460|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44529461|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529462|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44529463|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529464|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529465|NCT02214433|Pantoprazole|pantoprazole|mesh-list
44529466|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44529467|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44529468|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529469|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44529470|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529471|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529472|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44529473|NCT02214498|Enalapril|enalapril|mesh-list
44529474|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529475|NCT02214498|Diuretics|diuretics|mesh-ancestor
44529476|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
44529477|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529478|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44529479|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44529480|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529481|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44351984|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44529482|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529483|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529484|NCT02214602|Doxorubicin|doxorubicin|mesh-list
44529486|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529487|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529488|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44529489|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529490|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529491|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529492|NCT02214680|Timolol|timolol|mesh-list
44529493|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44529494|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
44529495|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44529496|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44529497|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
44529498|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529499|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529500|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529501|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44529502|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529503|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44529504|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44529505|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44529506|NCT02214706|Sirolimus|sirolimus|mesh-list
44529507|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529508|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529509|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529510|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529511|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
44529512|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529513|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
44529514|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529515|NCT02214810|Bupivacaine|bupivacaine|mesh-list
44529516|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
44529517|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
44529518|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529519|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529520|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
44529521|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529522|NCT02214966|Telmisartan|telmisartan|mesh-list
44529523|NCT02214966|Ramipril|ramipril|mesh-list
44529524|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529525|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529526|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529527|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529528|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44529529|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529530|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529531|NCT02214979|Telmisartan|telmisartan|mesh-list
44529532|NCT02214979|Ramipril|ramipril|mesh-list
44529533|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529534|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529535|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529536|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529537|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44529538|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529539|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529540|NCT02214992|Telmisartan|telmisartan|mesh-list
44529541|NCT02214992|Ramipril|ramipril|mesh-list
44529542|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529543|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529544|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529545|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529546|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44529547|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529548|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529549|NCT02215005|Telmisartan|telmisartan|mesh-list
44529550|NCT02215005|Ramipril|ramipril|mesh-list
44529551|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529552|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529553|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44352046|NCT01087437|Calcium|calcium|mesh-list
44529554|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529555|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44529556|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
44529557|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529558|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44529559|NCT02215044|Gemcitabine|gemcitabine|mesh-list
44529560|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44529561|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
44529562|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529563|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529564|NCT02215044|Antiviral Agents|antiviral agents|mesh-ancestor
44529565|NCT02215044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529566|NCT02215044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529567|NCT02215044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529568|NCT02215044|Immunologic Factors|immunologic factors|mesh-ancestor
44529569|NCT02215044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529570|NCT02215057|Lidocaine|lidocaine|mesh-list
44529571|NCT02215057|Anesthetics|anesthetics|mesh-list
44529572|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
44529573|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529574|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529575|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
44529576|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529577|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44529578|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44529579|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44529580|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44529581|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529582|NCT02215148|Tolvaptan|tolvaptan|mesh-list
44529583|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44529584|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529585|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
44529586|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529587|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44529588|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44529589|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44529590|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
44529591|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529592|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44529593|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44529594|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529595|NCT02215330|Eplerenone|eplerenone|mesh-list
44529596|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44529597|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44529598|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529599|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529600|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44529601|NCT02215330|Diuretics|diuretics|mesh-ancestor
44529602|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
44529603|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529604|NCT02215382|Atropine|atropine|mesh-list
44529605|NCT02215382|Neostigmine|neostigmine|mesh-list
44529606|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44529607|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44529608|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44529609|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
44529610|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529611|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529612|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44529613|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44529614|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
44529615|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
44529616|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44529617|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44529619|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529620|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529621|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44529622|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529623|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44529624|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44529625|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
44529626|NCT02215395|Estradiol|estradiol|mesh-list
44529627|NCT02215395|Estrogens|estrogens|mesh-ancestor
44529628|NCT02215395|Hormones|hormones|mesh-ancestor
44529629|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529630|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529631|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44529632|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44529633|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44529634|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44529635|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44529636|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
44529637|NCT02215434|Testosterone|testosterone|mesh-list
44529638|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
44529639|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
44529640|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44529641|NCT02215434|Androgens|androgens|mesh-ancestor
44529642|NCT02215434|Hormones|hormones|mesh-ancestor
44529643|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529644|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529645|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529646|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529647|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
44529648|NCT02215447|Paclitaxel|paclitaxel|mesh-list
44529649|NCT02215447|Carboplatin|carboplatin|mesh-list
44529650|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44529651|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529652|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
44529653|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
44529654|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
44529655|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529656|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
44529657|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44529658|NCT02215460|Azithromycin|azithromycin|mesh-list
44529659|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44529660|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529661|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
44529662|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529663|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529664|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
44529665|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44529666|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44529667|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529668|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
44529669|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529670|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
44529671|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44529672|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529673|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
44529674|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
44529675|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529676|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529677|NCT02215538|Methylphenidate|methylphenidate|mesh-list
44529678|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44529679|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529680|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44529681|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44529682|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44529683|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529684|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
44529685|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529686|NCT02215720|Sirolimus|sirolimus|mesh-list
44529687|NCT02215720|Cetuximab|cetuximab|mesh-list
44529688|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44529689|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529690|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529691|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458752|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44529692|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529693|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
44529694|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529695|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
44529696|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529697|NCT02215733|Telmisartan|telmisartan|mesh-list
44529698|NCT02215733|Diuretics|diuretics|mesh-list
44529699|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44529700|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44529701|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44529702|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44529703|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529704|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
44529705|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529706|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44529707|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
44529708|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529709|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44529710|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44529711|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44529712|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44529713|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529714|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529715|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529716|NCT02215798|Analgesics|analgesics|mesh-ancestor
44529717|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
44529718|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529719|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
44529720|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44529721|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
44529722|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44529723|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
44529724|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529725|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
44529726|NCT02215876|Doxorubicin|doxorubicin|mesh-list
44529727|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529728|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
44529729|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529730|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44529731|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44529732|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
44529733|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529734|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529735|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44529736|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529737|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44529738|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529739|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529740|NCT02215993|Ticagrelor|ticagrelor|mesh-list
44529741|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44529742|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44529743|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44529744|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44529745|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44529746|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
44529747|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529748|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529749|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529750|NCT02216045|Ribavirin|ribavirin|mesh-list
44529751|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44529752|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
44529753|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
44529754|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529755|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
44529756|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529757|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
44352275|NCT01088282|Dipivefrin|dipivefrin|mesh-list
44529758|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529759|NCT02216058|Sirolimus|sirolimus|mesh-list
44529760|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529761|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529762|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44529763|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529764|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
44529765|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529766|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
44529767|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529768|NCT02216149|Capecitabine|capecitabine|mesh-list
44529769|NCT02216149|Tegafur|tegafur|mesh-list
44529770|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
44529771|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44529772|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
44529773|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529774|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529775|NCT02216227|Iodine|iodine|mesh-list
44529776|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
44529777|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44529778|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
44529779|NCT02216227|Vancomycin|vancomycin|mesh-list
44529780|NCT02216227|Cefazolin|cefazolin|mesh-list
44529781|NCT02216227|Mupirocin|mupirocin|mesh-list
44529782|NCT02216227|Povidone|povidone|mesh-list
44529783|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44529784|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529785|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
44529786|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529787|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529788|NCT02216227|Trace Elements|trace elements|mesh-ancestor
44529789|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
44529790|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529791|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
44529792|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
44529793|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44529794|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529795|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529796|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44529797|NCT02216266|Physostigmine|physostigmine|mesh-list
44529798|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44529799|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529800|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529801|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
44529802|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529803|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529804|NCT02216266|Miotics|miotics|mesh-ancestor
44529805|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
44529806|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529807|NCT02216331|Rifampin|rifampin|mesh-list
44529808|NCT02216331|Rifapentine|rifapentine|mesh-list
44529809|NCT02216331|Bedaquiline|bedaquiline|mesh-list
44529810|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44529811|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
44529812|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44529813|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44529814|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
44529815|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44529816|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529817|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529818|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44529819|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44434196|NCT02041429|Paclitaxel|paclitaxel|mesh-list
44529820|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44529821|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44529822|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44529823|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44529824|NCT02216383|Oxytocin|oxytocin|mesh-list
44529825|NCT02216383|Carbetocin|carbetocin|mesh-list
44529826|NCT02216383|Syntometrine|syntometrine|mesh-list
44529827|NCT02216383|Ergonovine|ergonovine|mesh-list
44529828|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
44529829|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44529830|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529831|NCT02216409|Magrolimab|magrolimab|mesh-list
44529832|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44529833|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529834|NCT02216487|Irinotecan|irinotecan|mesh-list
44529835|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44529836|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44529837|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529838|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529839|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529840|NCT02216513|Deferoxamine|deferoxamine|mesh-list
44529841|NCT02216513|Siderophores|siderophores|mesh-ancestor
44529842|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44529843|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
44529844|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
44529845|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529846|NCT02216552|Resveratrol|resveratrol|mesh-list
44529847|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
44529848|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529849|NCT02216552|Protective Agents|protective agents|mesh-ancestor
44529850|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529851|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529852|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44529853|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44529854|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44529855|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44529856|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529857|NCT02216617|Cisplatin|cisplatin|mesh-list
44529858|NCT02216617|Docetaxel|docetaxel|mesh-list
44529859|NCT02216617|Afatinib|afatinib|mesh-list
44529860|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529861|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
44529862|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
44529863|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
44529864|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529865|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44529866|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529867|NCT02216656|Cinacalcet|cinacalcet|mesh-list
44529868|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529869|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529870|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44529871|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
44529872|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529873|NCT02216669|Imidazole|imidazole|mesh-list
44529874|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44529875|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529876|NCT02216747|Prednisone|prednisone|mesh-list
44529877|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529878|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
44529879|NCT02216747|Hormones|hormones|mesh-ancestor
44529880|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529881|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529882|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529883|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529884|NCT02216786|Everolimus|everolimus|mesh-list
44529885|NCT02216786|Fulvestrant|fulvestrant|mesh-list
44529886|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529887|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44529888|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
44529889|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529890|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529891|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44529892|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44529893|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
44529894|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529895|NCT02216799|Insulin|insulin|mesh-list
44529896|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44529897|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
44529898|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529899|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529900|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44529901|NCT02216877|Antacids|antacids|mesh-ancestor
44529902|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529903|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529904|NCT02216994|Mineral Oil|mineral oil|mesh-list
44529905|NCT02216994|Lactulose|lactulose|mesh-list
44529906|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529907|NCT02216994|Emollients|emollients|mesh-ancestor
44529908|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529909|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
44529910|NCT02217007|Acamprosate|acamprosate|mesh-list
44352427|NCT01088815|Paclitaxel|paclitaxel|mesh-list
44529924|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529925|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529926|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44529927|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529928|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
44529929|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
44529930|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529931|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529932|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
44529933|NCT02217163|Hormones|hormones|mesh-ancestor
44529934|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529935|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44352503|NCT01089192|Metformin|metformin|mesh-list
44529936|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
44529937|NCT02217189|Astringents|astringents|mesh-ancestor
44529938|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529939|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44529940|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44529941|NCT02217202|Laxatives|laxatives|mesh-ancestor
44529942|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529943|NCT02217319|Sevoflurane|sevoflurane|mesh-list
44529944|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44529945|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44529946|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
44529947|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
44529948|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529949|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529950|NCT02217514|Midazolam|midazolam|mesh-list
44529951|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44529952|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44529953|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44529954|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529955|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44529956|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44529957|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44529958|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44529959|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
44529960|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
44529961|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
44529962|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
44529963|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44529964|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44529965|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
44529966|NCT02217553|Vitamin D|vitamin d|mesh-list
44529967|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44529968|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529969|NCT02217553|Vitamins|vitamins|mesh-ancestor
44529970|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
44529971|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44352546|NCT01089452|Amlodipine|amlodipine|mesh-list
44529972|NCT02217631|Prednisolone|prednisolone|mesh-list
44529973|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44529974|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
44529975|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44529976|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
44529977|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44529978|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
44529979|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44529980|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
44529981|NCT02217631|Hormones|hormones|mesh-ancestor
44529982|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44529983|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529984|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44529985|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44529986|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
44529987|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
44529988|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529989|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44529990|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44529991|NCT02217631|Protective Agents|protective agents|mesh-ancestor
44529992|NCT02217670|Metformin|metformin|mesh-list
44529993|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44529994|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44529995|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
44529996|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44529997|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
44529998|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44529999|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530000|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44530001|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530002|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44530003|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
44530004|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530005|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530006|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44530007|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44530008|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
44530009|NCT02217683|Protective Agents|protective agents|mesh-ancestor
44530010|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44530011|NCT02217722|Amoxicillin|amoxicillin|mesh-list
44530012|NCT02217722|Metronidazole|metronidazole|mesh-list
44530013|NCT02217722|Doxycycline|doxycycline|mesh-list
44530014|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530015|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44530016|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44530017|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
44530018|NCT02217826|Octreotide|octreotide|mesh-list
44530019|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530020|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530021|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530022|NCT02217839|Octreotide|octreotide|mesh-list
44530023|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530024|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530025|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530026|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44530027|NCT02217852|Captopril|captopril|mesh-list
44530028|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
44530029|NCT02217852|Nitrendipine|nitrendipine|mesh-list
44530030|NCT02217852|Diuretics|diuretics|mesh-ancestor
44530031|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44530032|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530033|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44530034|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44530035|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530036|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44530037|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
44530038|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530039|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44530040|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44530041|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
44530042|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
44530043|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530044|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530045|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44530046|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44530047|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352600|NCT01089959|Esomeprazole|esomeprazole|mesh-list
44530048|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530049|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530050|NCT02217956|Bevacizumab|bevacizumab|mesh-list
44530051|NCT02217956|Cisplatin|cisplatin|mesh-list
44530052|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530053|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530054|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530055|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530056|NCT02217956|Growth Substances|growth substances|mesh-ancestor
44530057|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530058|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530059|NCT02218021|Oxycodone|oxycodone|mesh-list
44530060|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44530061|NCT02218021|Narcotics|narcotics|mesh-ancestor
44530062|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530063|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530064|NCT02218021|Analgesics|analgesics|mesh-ancestor
44530065|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
44530066|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530067|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
44530068|NCT02218034|Tazarotene|tazarotene|mesh-list
44530069|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530070|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
44530071|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
44530072|NCT02218034|Vitamins|vitamins|mesh-ancestor
44530073|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
44530074|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530075|NCT02218047|Interferons|interferons|mesh-list
44530076|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
44530077|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
44530078|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530079|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
44530080|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530082|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530083|NCT02218177|Ranibizumab|ranibizumab|mesh-list
44530084|NCT02218177|Aflibercept|aflibercept|mesh-list
44530085|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530086|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530087|NCT02218177|Growth Substances|growth substances|mesh-ancestor
44530088|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530089|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530090|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530091|NCT02218359|Amikacin|amikacin|mesh-list
44530092|NCT02218359|Fosfomycin|fosfomycin|mesh-list
44530093|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44434426|NCT02036515|Metformin|metformin|mesh-list
44530094|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530095|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530096|NCT02218398|Albuterol|albuterol|mesh-list
44530097|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44530098|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
44530099|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530100|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530101|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44530102|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530103|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
44530104|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530105|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44530106|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44530107|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44530108|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
44530109|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530110|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530111|NCT02218645|Brotizolam|brotizolam|mesh-list
44530112|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44530113|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530114|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530115|NCT02218658|Brotizolam|brotizolam|mesh-list
44530116|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44530117|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530118|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530119|NCT02218671|Brotizolam|brotizolam|mesh-list
44530120|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44530121|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530122|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530123|NCT02218684|Telmisartan|telmisartan|mesh-list
44530124|NCT02218684|Lacidipine|lacidipine|mesh-list
44530125|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44530134|NCT02218762|Xhance|xhance|mesh-list
44530135|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44530136|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44530137|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530138|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44530139|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
44530140|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530141|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530142|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44530143|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530144|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530145|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44530146|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44530147|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44530148|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44530149|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
44530150|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530151|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530152|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
44530153|NCT02218762|Hormones|hormones|mesh-ancestor
44530154|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530155|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
44530156|NCT02218775|Aticaprant|aticaprant|mesh-list
44530157|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44530158|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530159|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
44530160|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530161|NCT02218814|Bupivacaine|bupivacaine|mesh-list
44530162|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
44530163|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
44530164|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530165|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530166|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
44530167|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530168|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44530169|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44530170|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44530171|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530172|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530173|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
44530174|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530175|NCT02219100|Mifepristone|mifepristone|mesh-list
44352747|NCT01090830|Paclitaxel|paclitaxel|mesh-list
44530176|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44530177|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
44530178|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530179|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530180|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44434524|NCT02034513|Insulin|insulin|mesh-list
44530181|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44530182|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44530183|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
44530184|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44530185|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44530186|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
44530187|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530188|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
44530189|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44530190|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44530191|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
44530192|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44530193|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44530194|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530195|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
44530196|NCT02219152|Coagulants|coagulants|mesh-ancestor
44530197|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
44530198|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44530199|NCT02219165|Antibodies|antibodies|mesh-list
44530200|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
44530201|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530202|NCT02219178|Dexamethasone|dexamethasone|mesh-list
44530203|NCT02219178|Lenalidomide|lenalidomide|mesh-list
44530204|NCT02219178|Bortezomib|bortezomib|mesh-list
44530205|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530206|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
44530207|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
44530208|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530209|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530210|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530211|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
44530212|NCT02219178|Hormones|hormones|mesh-ancestor
44530213|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530214|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530215|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530216|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
44530217|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530218|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530219|NCT02219178|Growth Substances|growth substances|mesh-ancestor
44530220|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530221|NCT02219191|Puerarin|puerarin|mesh-list
44530222|NCT02219191|Atorvastatin|atorvastatin|mesh-list
44530223|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44530224|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44530225|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
44530226|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530227|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44530228|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44530229|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530230|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44530231|NCT02219217|Dolutegravir|dolutegravir|mesh-list
44530232|NCT02219217|Cobicistat|cobicistat|mesh-list
44530233|NCT02219217|Elvitegravir|elvitegravir|mesh-list
44530234|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44530235|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44530236|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530237|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530238|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44530239|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44530240|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
44530241|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530242|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44530243|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44530244|NCT02219412|Aspirin|aspirin|mesh-list
44530245|NCT02219412|Ticagrelor|ticagrelor|mesh-list
44530246|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44530247|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44530248|NCT02219412|Analgesics|analgesics|mesh-ancestor
44530249|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
44530250|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530251|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530252|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530253|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530254|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44530255|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44530256|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530257|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44434589|NCT02032875|Ribavirin|ribavirin|mesh-list
44530258|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44530259|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530260|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
44530261|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44530262|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44530263|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44530264|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
44530265|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530266|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44530267|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
44530268|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44530269|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44530270|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530271|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530272|NCT02219646|Urological Agents|urological agents|mesh-ancestor
44530273|NCT02219672|Ritonavir|ritonavir|mesh-list
44530274|NCT02219672|Lopinavir|lopinavir|mesh-list
44530275|NCT02219672|Tenofovir|tenofovir|mesh-list
44530276|NCT02219672|Lamivudine|lamivudine|mesh-list
44530277|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
44530278|NCT02219672|Triptolide|triptolide|mesh-list
44530279|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44530280|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44530281|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
44530282|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530283|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530284|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44530285|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44530286|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
44530287|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530288|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44530289|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44530290|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44530291|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44530292|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44530293|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44530294|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44530295|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530296|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44530297|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
44530298|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530299|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530300|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
44530301|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44530302|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
44530303|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530304|NCT02219737|Rituximab|rituximab|mesh-list
44530305|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44530306|NCT02219737|Carboplatin|carboplatin|mesh-list
44530307|NCT02219737|Etoposide|etoposide|mesh-list
44530308|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
44530309|NCT02219737|Ifosfamide|ifosfamide|mesh-list
44530310|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
44530311|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
44530312|NCT02219737|Antibodies|antibodies|mesh-list
44530313|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
44530314|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44530315|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
44530316|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530317|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530318|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530319|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44530320|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44530321|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44530322|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530323|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530324|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44530325|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
44530326|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
44530327|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530328|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
44530329|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
44530330|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
44530331|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44530332|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44530333|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530334|NCT02219789|Fulvestrant|fulvestrant|mesh-list
44530335|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530336|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530337|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44530338|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44530339|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
44352946|NCT01092039|Lactoferrin|lactoferrin|mesh-list
44530348|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530349|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44530350|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44530351|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
44530352|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
44530353|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530354|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44530355|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44530356|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530357|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530358|NCT02219893|Immunotoxins|immunotoxins|mesh-list
44530359|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
44530360|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530361|NCT02219906|Resveratrol|resveratrol|mesh-list
44530362|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
44530363|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530364|NCT02219906|Protective Agents|protective agents|mesh-ancestor
44530365|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530366|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353022|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530367|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44530368|NCT02219984|Anticoagulants|anticoagulants|mesh-list
44530369|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
44530370|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44530371|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44530372|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44530373|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44530374|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530375|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44530376|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530377|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530378|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44530379|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530380|NCT02218606|Prednisone|prednisone|mesh-list
44530381|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
44530382|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530383|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
44530384|NCT02218606|Hormones|hormones|mesh-ancestor
44530385|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530386|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530387|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530388|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530389|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44530390|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434717|NCT02029638|Acetaminophen|acetaminophen|mesh-list
44530391|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530392|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
44530393|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44530394|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
44530395|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44530396|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530397|NCT02210806|Albuterol|albuterol|mesh-list
44530398|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44530399|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
44530400|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530401|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530402|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44530403|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530404|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
44530405|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530406|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44530407|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44530408|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44530409|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
44530410|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530411|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530412|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
44530413|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44530414|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
44530415|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530416|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530417|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44530418|NCT02213328|Tenofovir|tenofovir|mesh-list
44530419|NCT02213328|Emtricitabine|emtricitabine|mesh-list
44530420|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44530421|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
44530422|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530423|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44530424|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44530425|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530426|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530427|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44530428|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44530429|NCT02213627|Menotropins|menotropins|mesh-list
44530430|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44530431|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
44530432|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530433|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530434|NCT02214563|Vitamin D|vitamin d|mesh-list
44530435|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
44530436|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
44530437|NCT02214563|Vitamins|vitamins|mesh-list
44530438|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
44530439|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353085|NCT01093092|Calcitriol|calcitriol|mesh-list
44530440|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44530441|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44530442|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44530443|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
44530444|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530445|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44530446|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530447|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44530448|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
44530449|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530450|NCT02219490|Ribavirin|ribavirin|mesh-list
44530451|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
44530452|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530453|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
44530454|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530455|NCT02219659|Fentanyl|fentanyl|mesh-list
44530456|NCT02219659|Midazolam|midazolam|mesh-list
44530457|NCT02219659|Propofol|propofol|mesh-list
44530458|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44530459|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530460|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530461|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44530462|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
44530463|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
44530464|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44530465|NCT02219659|Narcotics|narcotics|mesh-ancestor
44530466|NCT02219659|Analgesics|analgesics|mesh-ancestor
44530467|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
44530468|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530469|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44530470|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44530471|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44530472|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44530473|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
44530474|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
44530475|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530476|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530477|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44530478|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44530479|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44530480|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44530481|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
44530482|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530483|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530484|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44530485|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44530486|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44530487|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44530488|NCT02212015|Paclitaxel|paclitaxel|mesh-list
44530489|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44530490|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530491|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44530492|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44530493|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44530494|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530495|NCT02211417|Mineral Oil|mineral oil|mesh-list
44530496|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530497|NCT02211417|Emollients|emollients|mesh-ancestor
44530498|NCT02215096|GSK2636771|gsk2636771|mesh-list
44530499|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530500|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44530501|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530502|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530503|NCT02218164|Interferons|interferons|mesh-list
44530504|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
44530505|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
44530506|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44530507|NCT02218164|Fluorouracil|fluorouracil|mesh-list
44530508|NCT02218164|Capecitabine|capecitabine|mesh-list
44530509|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
44530510|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530511|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530512|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530513|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530514|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
44530515|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530516|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
44530517|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530518|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44530519|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530520|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530521|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
44530522|NCT02213068|Abatacept|abatacept|mesh-list
44530523|NCT02213068|Tacrolimus|tacrolimus|mesh-list
44530524|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530525|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
44530526|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530527|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44530528|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530529|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530530|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44434850|NCT02027311|Etomidate|etomidate|mesh-list
44530531|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530532|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44530533|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
44530534|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530535|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530536|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44530537|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530538|NCT01640002|Bromides|bromides|mesh-list
44530539|NCT01640002|Propantheline|propantheline|mesh-list
44530540|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
44530541|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44530542|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530543|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44530544|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44530545|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
44530546|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530547|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530548|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530549|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
44530550|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530551|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44530552|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530553|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530554|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
44530555|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530556|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530557|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44530558|NCT01640210|Insulin|insulin|mesh-list
44530559|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44530560|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530561|NCT01640275|Propofol|propofol|mesh-list
44530562|NCT01640275|Isoflurane|isoflurane|mesh-list
44530563|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44530564|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530565|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530566|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44530567|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
44530568|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
44530569|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44530570|NCT01640405|Bevacizumab|bevacizumab|mesh-list
44530571|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530572|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530573|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530574|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530575|NCT01640405|Growth Substances|growth substances|mesh-ancestor
44530576|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530577|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530578|NCT01640444|Bevacizumab|bevacizumab|mesh-list
44530579|NCT01640444|Cetuximab|cetuximab|mesh-list
44530580|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530581|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530582|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530583|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530584|NCT01640444|Growth Substances|growth substances|mesh-ancestor
44530585|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530586|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530587|NCT01640496|Vitamin D|vitamin d|mesh-list
44530588|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
44530589|NCT01640496|Vitamins|vitamins|mesh-ancestor
44530590|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
44530593|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44530594|NCT01640535|Cetirizine|cetirizine|mesh-list
44530595|NCT01640535|Montelukast|montelukast|mesh-list
44530596|NCT01640535|Levocetirizine|levocetirizine|mesh-list
44530597|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44530598|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530599|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44530600|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
44530601|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530602|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530603|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44530604|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44530605|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530606|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44530607|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44530608|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
44530609|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
44530610|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530611|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44530612|NCT01640574|Chloroquine|chloroquine|mesh-list
44530613|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44530614|NCT01640574|Piperaquine|piperaquine|mesh-list
44530615|NCT01640574|Artenimol|artenimol|mesh-list
44530616|NCT01640574|Artemisinins|artemisinins|mesh-list
44530617|NCT01640574|Amebicides|amebicides|mesh-ancestor
44530618|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44530619|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44530620|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530621|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
44530622|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530623|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44530624|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44530625|NCT01640574|Analgesics|analgesics|mesh-ancestor
44530626|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
44530627|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530628|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530629|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530630|NCT01640574|Filaricides|filaricides|mesh-ancestor
44530631|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
44530632|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
44530633|NCT01640639|Thalidomide|thalidomide|mesh-list
44530634|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530635|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
44530636|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530637|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
44530638|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530639|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530640|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530641|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530642|NCT01640639|Growth Substances|growth substances|mesh-ancestor
44530643|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530644|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530645|NCT01640665|Capecitabine|capecitabine|mesh-list
44530646|NCT01640665|Sorafenib|sorafenib|mesh-list
44530647|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530648|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
44530649|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530650|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530651|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44530652|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530653|NCT01640691|Vaccines|vaccines|mesh-list
44530654|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
44530655|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353277|NCT01094444|Vitamin K|vitamin k|mesh-list
44530657|NCT01640782|Cisplatin|cisplatin|mesh-list
44530658|NCT01640782|Docetaxel|docetaxel|mesh-list
44530659|NCT01640782|Fluorouracil|fluorouracil|mesh-list
44530660|NCT01640782|Irinotecan|irinotecan|mesh-list
44530661|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
44530662|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530663|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44530664|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44530665|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44530666|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530667|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
44530668|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530669|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530670|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
44530671|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530672|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44530673|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44530674|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530675|NCT01640782|Antidotes|antidotes|mesh-ancestor
44530676|NCT01640782|Protective Agents|protective agents|mesh-ancestor
44530677|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
44530678|NCT01640782|Vitamins|vitamins|mesh-ancestor
44530679|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
44530680|NCT01640990|GW 328267|gw 328267|mesh-list
44530681|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44530682|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44530683|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
44530684|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
44530685|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530686|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530687|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530688|NCT01641224|Pinaverium|pinaverium|mesh-list
44530689|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44530690|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44530691|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530692|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44530693|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530694|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
44530695|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
44530696|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530697|NCT01641250|Cytarabine|cytarabine|mesh-list
44530698|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530699|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
44435024|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530700|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530701|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530702|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
44530703|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530704|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530705|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
44530706|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530707|NCT01641289|Acetaminophen|acetaminophen|mesh-list
44530708|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44530709|NCT01641289|Analgesics|analgesics|mesh-ancestor
44530710|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
44530711|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530712|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530713|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
44530714|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
44530715|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
44530716|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530717|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
44530718|NCT01641341|Pancrelipase|pancrelipase|mesh-list
44530719|NCT01641341|Pancreatin|pancreatin|mesh-list
44530720|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44530721|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530722|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530723|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
44530724|NCT01641406|Bevacizumab|bevacizumab|mesh-list
44530725|NCT01641406|Docetaxel|docetaxel|mesh-list
44530726|NCT01641406|Capecitabine|capecitabine|mesh-list
44530727|NCT01641406|Trastuzumab|trastuzumab|mesh-list
44530728|NCT01641406|Epirubicin|epirubicin|mesh-list
44530729|NCT01641406|Vinorelbine|vinorelbine|mesh-list
44353346|NCT01094821|ATI 7505|ati 7505|mesh-list
44530730|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530731|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
44530732|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530733|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530734|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44530735|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
44530736|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530737|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530738|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44530739|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530740|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44530741|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44530742|NCT01641406|Growth Substances|growth substances|mesh-ancestor
44435068|NCT02020616|Hormones|hormones|mesh-ancestor
44530743|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
44530744|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44530745|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44530746|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44530747|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530748|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
44530749|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44530750|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44530751|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44530752|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530753|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44530754|NCT01641419|Dexamethasone|dexamethasone|mesh-list
44530755|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
44530756|NCT01641419|BB 1101|bb 1101|mesh-list
44530757|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530758|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
44530759|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
44530760|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530761|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530762|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44530763|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
44530764|NCT01641419|Hormones|hormones|mesh-ancestor
44530765|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530766|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44530767|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530768|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
44530769|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530770|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530771|NCT01641458|Capecitabine|capecitabine|mesh-list
44530772|NCT01641458|Fluorouracil|fluorouracil|mesh-list
44530773|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530774|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
44530775|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530776|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530777|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530778|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
44530779|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530780|NCT01641510|Clopidogrel|clopidogrel|mesh-list
44530781|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44530782|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44530783|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44530784|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44530785|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44530786|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
44530787|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530788|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530789|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530790|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44530791|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
44530792|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44530793|NCT01641523|Protective Agents|protective agents|mesh-ancestor
44530794|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530795|NCT01641536|Entecavir|entecavir|mesh-list
44530796|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
44530797|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530798|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44530799|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44530800|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530801|NCT01641575|Gemcitabine|gemcitabine|mesh-list
44530802|NCT01641575|Cisplatin|cisplatin|mesh-list
44530803|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530804|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44530805|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
44530806|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530807|NCT01641575|Antiviral Agents|antiviral agents|mesh-ancestor
44530808|NCT01641575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530809|NCT01641575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530810|NCT01641575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44530811|NCT01641575|Immunologic Factors|immunologic factors|mesh-ancestor
44530812|NCT01641575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530814|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44530815|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
44530816|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
44530817|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530818|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
44530819|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530820|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
44530821|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530822|NCT01641783|Paclitaxel|paclitaxel|mesh-list
44530823|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44530824|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44530825|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530826|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
44530827|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
44530828|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
44530829|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530830|NCT01641796|Paromomycin|paromomycin|mesh-list
44530831|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44530832|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44530833|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44530834|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44530835|NCT01642030|Buprenorphine|buprenorphine|mesh-list
44530836|NCT01642030|Hydromorphone|hydromorphone|mesh-list
44530837|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44530838|NCT01642030|Narcotics|narcotics|mesh-ancestor
44530839|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44530840|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530841|NCT01642030|Analgesics|analgesics|mesh-ancestor
44530842|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
44530843|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530844|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44530845|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44530846|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43762367|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44530847|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530848|NCT01642108|Incretins|incretins|mesh-ancestor
44530849|NCT01642108|Hormones|hormones|mesh-ancestor
44530850|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44530851|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44530852|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
44530853|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530854|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530855|NCT01642134|Aspirin|aspirin|mesh-list
44530856|NCT01642134|Clopidogrel|clopidogrel|mesh-list
44530857|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44530858|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44530859|NCT01642134|Analgesics|analgesics|mesh-ancestor
44530860|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
44530861|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530862|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530863|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530864|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44530865|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44530866|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44530867|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530868|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44530869|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44530870|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530871|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
44530872|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44530873|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44530874|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44530875|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
44530876|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530877|NCT01642433|Prazosin|prazosin|mesh-list
44530878|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44530879|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44530880|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44530881|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44353500|NCT01095575|Morphine|morphine|mesh-list
44530882|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
44530883|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530884|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530885|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530887|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44530888|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
44530889|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44530890|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530891|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44530892|NCT01642524|Dextrans|dextrans|mesh-list
44530893|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
44530894|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
44530895|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
44530896|NCT01642667|Saruplase|saruplase|mesh-list
44530897|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44530898|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44435209|NCT02017171|Protective Agents|protective agents|mesh-ancestor
44530899|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530900|NCT01642745|Mannitol|mannitol|mesh-list
44530901|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
44530902|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44530903|NCT01642745|Diuretics|diuretics|mesh-ancestor
44530904|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
44530905|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530906|NCT01642745|Miotics|miotics|mesh-ancestor
44530907|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
44530908|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44530909|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44530910|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44530911|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
44530912|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44530913|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44530914|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
44530915|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530916|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530917|NCT01642862|Simvastatin|simvastatin|mesh-list
44530918|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44530919|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44530920|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
44530921|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530922|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44530923|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44530924|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530925|NCT01642940|Ticagrelor|ticagrelor|mesh-list
44530926|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44530927|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44530928|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44530929|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44530930|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44530931|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
44530932|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44530933|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530934|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530949|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
44530950|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
44530951|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44530952|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44530953|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530954|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
44530955|NCT01643135|Coagulants|coagulants|mesh-ancestor
44530956|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
44530957|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44530958|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44530959|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530960|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44530961|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44530962|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435276|NCT02016105|Adalimumab|adalimumab|mesh-list
44530963|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530964|NCT01643187|Vitamins|vitamins|mesh-list
44530965|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
44530966|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530967|NCT01643252|Riboflavin|riboflavin|mesh-list
44530968|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44530969|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44530970|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
44530971|NCT01643252|Vitamins|vitamins|mesh-ancestor
44530972|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
44530973|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44530974|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44530975|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
44530976|NCT01643265|Caseins|caseins|mesh-list
44530977|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
44530978|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
44530979|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530980|NCT01643278|Ipilimumab|ipilimumab|mesh-list
44530981|NCT01643278|Dasatinib|dasatinib|mesh-list
44530982|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44530983|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44530984|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44530985|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530986|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44530987|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530988|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44530989|NCT01643447|Urinastatin|urinastatin|mesh-list
44530990|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44530991|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44530992|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
44530993|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44530994|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44530995|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44530996|NCT01643499|Leucovorin|leucovorin|mesh-list
44530997|NCT01643499|Fluorouracil|fluorouracil|mesh-list
44530998|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
44530999|NCT01643499|Irinotecan|irinotecan|mesh-list
44531000|NCT01643499|Calcium|calcium|mesh-list
44531001|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
44531002|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531003|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531004|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
44531005|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531006|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531007|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531008|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531009|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
43763334|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
44531011|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44531012|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531013|NCT01643499|Antidotes|antidotes|mesh-ancestor
44531014|NCT01643499|Protective Agents|protective agents|mesh-ancestor
44531015|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
44531016|NCT01643499|Vitamins|vitamins|mesh-ancestor
44531017|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
44531018|NCT01643629|Minoxidil|minoxidil|mesh-list
44531019|NCT01643629|Finasteride|finasteride|mesh-list
44531020|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44531021|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531022|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44531023|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44531024|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531025|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531026|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
44531027|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531028|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531029|NCT01643629|Urological Agents|urological agents|mesh-ancestor
44531030|NCT01643759|Buprenorphine|buprenorphine|mesh-list
44531031|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44531032|NCT01643759|Narcotics|narcotics|mesh-ancestor
44531033|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531034|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531035|NCT01643759|Analgesics|analgesics|mesh-ancestor
44531036|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
44531037|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531038|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44531039|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
44531040|NCT01643889|Domperidone|domperidone|mesh-list
44531041|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531042|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531043|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44531044|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44531045|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531046|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531047|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531048|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531049|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
44531050|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
44531051|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531052|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531053|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44531054|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
44531055|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531056|NCT01644071|Dexetimide|dexetimide|mesh-list
44531057|NCT01644071|Citalopram|citalopram|mesh-list
44531058|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44531059|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44531060|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
44531061|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
44531062|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531063|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531064|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44531065|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44531066|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
44531067|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531068|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531069|NCT01644071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44531070|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44531071|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531072|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
44531073|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44531074|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
44531075|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44531076|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44531077|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
44531078|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
44531079|NCT01644110|Pomalidomide|pomalidomide|mesh-list
44531080|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
44531081|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531082|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44531083|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44531084|NCT01644110|Growth Substances|growth substances|mesh-ancestor
44531085|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
44531086|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531087|NCT01644253|Rituximab|rituximab|mesh-list
44531088|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
44531089|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44531090|NCT01644253|Idelalisib|idelalisib|mesh-list
44531091|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
44531092|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44531093|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531094|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
44531095|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531096|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531097|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44531098|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
44531099|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353739|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
44531100|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531101|NCT01644773|Dasatinib|dasatinib|mesh-list
44531102|NCT01644773|Crizotinib|crizotinib|mesh-list
44531103|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531104|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44531105|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531106|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531107|NCT01644799|Lenalidomide|lenalidomide|mesh-list
44531108|NCT01644799|Idelalisib|idelalisib|mesh-list
44531109|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
44531110|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531111|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44531112|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44531113|NCT01644799|Growth Substances|growth substances|mesh-ancestor
44531114|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
44531115|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531116|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531117|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531118|NCT01644825|Paclitaxel|paclitaxel|mesh-list
44531119|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531120|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531121|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531122|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531123|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531124|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531125|NCT01644838|Promethazine|promethazine|mesh-list
44531126|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
44531127|NCT01644838|Scopolamine|scopolamine|mesh-list
44531128|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44531129|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
44531130|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
44531131|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531132|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531133|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531134|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
44531135|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44531136|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44531137|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531138|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531139|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44531140|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
44531141|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44531142|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44531143|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
44531144|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
44531145|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44531146|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44531147|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44531148|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531149|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
44531150|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
44531151|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
44531152|NCT01644864|Ropivacaine|ropivacaine|mesh-list
44531153|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
44531154|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
44531155|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531156|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531157|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
44531158|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531159|NCT01644955|Carboplatin|carboplatin|mesh-list
44531160|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531161|NCT01644994|Cisplatin|cisplatin|mesh-list
44531162|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353809|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
44531163|NCT01645085|Mannitol|mannitol|mesh-list
44093730|NCT00038246|Paclitaxel|paclitaxel|mesh-list
44531164|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44531165|NCT01645085|Diuretics|diuretics|mesh-ancestor
44531166|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
44531167|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531168|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
44531169|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531170|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
44531171|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531172|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531173|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44531174|NCT01645241|Ganirelix|ganirelix|mesh-list
44531175|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
44531176|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531177|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531178|NCT01645254|Antimalarials|antimalarials|mesh-list
44531179|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44531180|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44531181|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531182|NCT01645384|Atorvastatin|atorvastatin|mesh-list
44531183|NCT01645384|Calcium|calcium|mesh-list
44531184|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531185|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531186|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531187|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531188|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
44531189|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531190|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531191|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531192|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531193|NCT01645410|Atorvastatin|atorvastatin|mesh-list
44531194|NCT01645410|Calcium|calcium|mesh-list
44531195|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531196|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531197|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531198|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531199|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
44531200|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531201|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531202|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531203|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531204|NCT01645423|Atorvastatin|atorvastatin|mesh-list
44531205|NCT01645423|Calcium|calcium|mesh-list
44531206|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531207|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531208|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531209|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531210|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
44531211|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531212|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531213|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531214|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531215|NCT01645449|Atorvastatin|atorvastatin|mesh-list
44531216|NCT01645449|Calcium|calcium|mesh-list
44531217|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531218|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531219|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531220|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531221|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
44531222|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531223|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531224|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531225|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531226|NCT01645748|Cisplatin|cisplatin|mesh-list
44531227|NCT01645748|Docetaxel|docetaxel|mesh-list
44531228|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531229|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531230|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531231|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531232|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531233|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
44531234|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44531235|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44531236|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
44531245|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
44531247|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531248|NCT01645826|Diltiazem|diltiazem|mesh-list
44531249|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44531250|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44531251|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531252|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531253|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531254|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531256|NCT01646229|Polymyxins|polymyxins|mesh-list
44531257|NCT01646229|Polymyxin B|polymyxin b|mesh-list
44531258|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531259|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531260|NCT01646281|Flecainide|flecainide|mesh-list
44531261|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44531262|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44531263|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44531264|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531265|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531266|NCT01646294|Mirabegron|mirabegron|mesh-list
44531267|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44531268|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44531269|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44531270|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44531271|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435566|NCT02010632|Clopidogrel|clopidogrel|mesh-list
44531272|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531273|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531274|NCT01646294|Urological Agents|urological agents|mesh-ancestor
44531275|NCT01646307|Atorvastatin|atorvastatin|mesh-list
44531276|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44531277|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531278|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531279|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
44531280|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531281|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531282|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531283|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531284|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
44531285|NCT01646554|Aflibercept|aflibercept|mesh-list
44531286|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531287|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44531288|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44531289|NCT01646554|Growth Substances|growth substances|mesh-ancestor
44531290|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531291|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
44531292|NCT01646567|Betamethasone|betamethasone|mesh-list
44531293|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
44531294|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44531295|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
44531296|NCT01646567|Calcipotriene|calcipotriene|mesh-list
44531297|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44531298|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531299|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
44531300|NCT01646567|Hormones|hormones|mesh-ancestor
44531301|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531302|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531303|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44531304|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
44531305|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
44531306|NCT01646684|Pasireotide|pasireotide|mesh-list
44531307|NCT01646684|Hormones|hormones|mesh-ancestor
44531308|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531309|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531310|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
44531311|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531312|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
44531313|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531314|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531315|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44531316|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
44531317|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531318|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531319|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44531320|NCT01646775|Fentanyl|fentanyl|mesh-list
44531321|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44531322|NCT01646775|Narcotics|narcotics|mesh-ancestor
44531323|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531324|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531326|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
44531327|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531328|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44531329|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44531330|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
44531331|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
44531332|NCT01646788|Paclitaxel|paclitaxel|mesh-list
44531333|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531334|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531335|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531336|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531337|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531338|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531339|NCT01646853|Cisplatin|cisplatin|mesh-list
44531340|NCT01646853|Fluorouracil|fluorouracil|mesh-list
44531341|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531342|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
44531343|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531344|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531345|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531346|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
44531347|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531348|NCT01647152|Ustekinumab|ustekinumab|mesh-list
44531349|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44531350|NCT01647165|Dexamethasone|dexamethasone|mesh-list
44531351|NCT01647165|Lenalidomide|lenalidomide|mesh-list
44531352|NCT01647165|Bortezomib|bortezomib|mesh-list
44531353|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531354|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
44531355|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
44531356|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531357|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531358|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531359|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
44531360|NCT01647165|Hormones|hormones|mesh-ancestor
44531361|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531362|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44531363|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531364|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
44531365|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44531366|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44531367|NCT01647165|Growth Substances|growth substances|mesh-ancestor
44531368|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
44531369|NCT01647256|Nikkomycin|nikkomycin|mesh-list
44531370|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
44531371|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531372|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531373|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531374|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
44531375|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44531376|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531377|NCT01647412|Curcumin|curcumin|mesh-list
44531378|NCT01647412|Hormones|hormones|mesh-list
44531379|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531380|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531381|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44531382|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44531383|NCT01647412|Analgesics|analgesics|mesh-ancestor
44531384|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
44531385|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531386|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531387|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531388|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531389|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531390|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531391|NCT01647529|Ganciclovir|ganciclovir|mesh-list
44531392|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44531393|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
44531394|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531395|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44531396|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531397|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531399|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44531400|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531409|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531410|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531411|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
44531413|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531414|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
44531415|NCT01647659|Trametinib|trametinib|mesh-list
44531416|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531417|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44531418|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531419|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531420|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44531421|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531422|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
44531423|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44531424|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44531425|NCT01647685|Prednisolone|prednisolone|mesh-list
44531426|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
44531427|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44531428|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
44531429|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531430|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
44531431|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
44435704|NCT02007434|Ibuprofen|ibuprofen|mesh-list
44531432|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531433|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531434|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531435|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
44531436|NCT01647685|Hormones|hormones|mesh-ancestor
44531437|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531438|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44531439|NCT01647685|Protective Agents|protective agents|mesh-ancestor
44531440|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44531441|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531442|NCT01647893|Bivalirudin|bivalirudin|mesh-list
44531443|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
44531444|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44531445|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
44531446|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531447|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531448|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
44531449|NCT01647984|Vitamins|vitamins|mesh-list
44531450|NCT01647984|Vitamin E|vitamin e|mesh-list
44531451|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
44531452|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
44531453|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531454|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
44531455|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531456|NCT01647984|Protective Agents|protective agents|mesh-ancestor
44531457|NCT01648010|Mitomycins|mitomycins|mesh-list
44531458|NCT01648010|Mitomycin|mitomycin|mesh-list
44531459|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44531460|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531461|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
44531462|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531463|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44531464|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531465|NCT01648036|Heparin|heparin|mesh-list
44531466|NCT01648036|Calcium heparin|calcium heparin|mesh-list
44531467|NCT01648036|Dalteparin|dalteparin|mesh-list
44531468|NCT01648036|Tinzaparin|tinzaparin|mesh-list
44531469|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44531470|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
44531471|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44531472|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44531473|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531474|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44531475|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531476|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531477|NCT01648231|Losartan|losartan|mesh-list
44531478|NCT01648231|Amlodipine|amlodipine|mesh-list
44531480|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44531481|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531482|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531483|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44531484|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531485|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531486|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44531487|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44531488|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44531489|NCT01648257|Cabotegravir|cabotegravir|mesh-list
44531490|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44531491|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44531492|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531493|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531494|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44531495|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44531496|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
44531497|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531498|NCT01648517|Gemcitabine|gemcitabine|mesh-list
44531499|NCT01648517|Carboplatin|carboplatin|mesh-list
44531500|NCT01648517|Docetaxel|docetaxel|mesh-list
44531501|NCT01648517|Vinorelbine|vinorelbine|mesh-list
44531502|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531503|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531504|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
44531505|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531506|NCT01648517|Antiviral Agents|antiviral agents|mesh-ancestor
44531507|NCT01648517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531508|NCT01648517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531509|NCT01648517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531510|NCT01648517|Immunologic Factors|immunologic factors|mesh-ancestor
44531511|NCT01648517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531512|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531513|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531514|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531515|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531516|NCT01648556|Prednisone|prednisone|mesh-list
44531517|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531518|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
44531519|NCT01648556|Hormones|hormones|mesh-ancestor
44531520|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531521|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531522|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44531523|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531524|NCT01648595|Fentanyl|fentanyl|mesh-list
44531525|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44531526|NCT01648595|Narcotics|narcotics|mesh-ancestor
44531527|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531528|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531529|NCT01648595|Analgesics|analgesics|mesh-ancestor
44531530|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
44531531|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531532|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44531533|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44531534|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
44531535|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
44531536|NCT01648608|Exemestane|exemestane|mesh-list
44531537|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531538|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44531539|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44531540|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531541|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531542|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44531543|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
44531544|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531545|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531546|NCT01648634|Nebivolol|nebivolol|mesh-list
44531547|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44531548|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531549|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44531550|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44531551|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44531552|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44531553|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531554|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531555|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531557|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
44531558|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44531559|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44531560|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531561|NCT01648829|Atorvastatin|atorvastatin|mesh-list
44531562|NCT01648829|Pitavastatin|pitavastatin|mesh-list
44531563|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44531564|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44531565|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
44531566|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531567|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44531568|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44531569|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531570|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44531571|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44531572|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531573|NCT01649037|Terlipressin|terlipressin|mesh-list
44531574|NCT01649037|Epinephrine|epinephrine|mesh-list
44531575|NCT01649037|Racepinephrine|racepinephrine|mesh-list
44531576|NCT01649037|Norepinephrine|norepinephrine|mesh-list
44531577|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
44531578|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44531579|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44531580|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
44531581|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531582|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531583|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531584|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44531585|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44531586|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
44531587|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531588|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44531589|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
44531590|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
44531591|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
44531592|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44531594|NCT01649245|Interferons|interferons|mesh-list
44531595|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531596|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
44531597|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531598|NCT01649258|Granisetron|granisetron|mesh-list
44531599|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
44531600|NCT01649258|Aprepitant|aprepitant|mesh-list
44531601|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
44531602|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
44531603|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531604|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531605|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531606|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44531607|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
44531608|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531609|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531610|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44531611|NCT01649284|Afatinib|afatinib|mesh-list
44531612|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531613|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44531614|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531615|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531616|NCT01649336|Paclitaxel|paclitaxel|mesh-list
44531617|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
44531618|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531619|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531620|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531621|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531622|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531623|NCT01649466|Insulin|insulin|mesh-list
44531624|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44531625|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44531626|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531627|NCT01649479|Antibodies|antibodies|mesh-list
44531628|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
43938703|NCT00886626|Exenatide|exenatide|mesh-list
44531630|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531631|NCT01649544|Amiodarone|amiodarone|mesh-list
44531632|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44531633|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531634|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44531635|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531636|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531637|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44531638|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44531639|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44531640|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531641|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44531642|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44531643|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44531644|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
44531645|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44531646|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531647|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44531648|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44531649|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
44531650|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531651|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531652|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
44531653|NCT01649635|Prednisone|prednisone|mesh-list
44531654|NCT01649635|Lenograstim|lenograstim|mesh-list
44531655|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531656|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
44531657|NCT01649635|Hormones|hormones|mesh-ancestor
44531658|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531659|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531660|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44531661|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531662|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531663|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531664|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44531665|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44531666|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531667|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531668|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44531669|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44531670|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44531671|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
44531672|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
44531673|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
44531674|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44531675|NCT01649674|Cathartics|cathartics|mesh-ancestor
44531676|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531677|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44531678|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531679|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44531680|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44531681|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531682|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531683|NCT01649739|Urological Agents|urological agents|mesh-ancestor
44531684|NCT01649830|Temozolomide|temozolomide|mesh-list
44531685|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44531686|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
44531687|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531688|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531701|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
44531702|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531703|NCT01648751|Estrogens|estrogens|mesh-list
44531705|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531706|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531707|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44531708|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
44531709|NCT01649505|Coagulants|coagulants|mesh-ancestor
44531710|NCT01649999|Peficitinib|peficitinib|mesh-list
44531711|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531712|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531713|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531714|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
44531715|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531716|NCT01643070|Capecitabine|capecitabine|mesh-list
44531717|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
44531718|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531719|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
44531720|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531721|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531722|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
44531723|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44531724|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531725|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531726|NCT01646515|Udenafil|udenafil|mesh-list
44531727|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44531728|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44531729|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531730|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531731|NCT01646580|Ciclopirox|ciclopirox|mesh-list
44531732|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
44531733|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531734|NCT01647828|Gemcitabine|gemcitabine|mesh-list
44531735|NCT01647828|Paclitaxel|paclitaxel|mesh-list
44531736|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531737|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531738|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531739|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531740|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094231|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44531741|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531742|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531743|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
44531744|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
44531745|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531746|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531747|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531748|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
44531749|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531750|NCT01643603|Dasatinib|dasatinib|mesh-list
44531751|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531752|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44531753|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531754|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531755|NCT02754011|Capecitabine|capecitabine|mesh-list
44531756|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531757|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
44531758|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531759|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531760|NCT02753998|Paclitaxel|paclitaxel|mesh-list
44531761|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531762|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531763|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531764|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531765|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531766|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531767|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
44531768|NCT02750319|Amiodarone|amiodarone|mesh-list
44531769|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44531770|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
44531771|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531772|NCT02750319|Expectorants|expectorants|mesh-ancestor
44531773|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
44531774|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44354538|NCT01102114|Vaccines|vaccines|mesh-list
44531775|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
44531776|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531777|NCT02750319|Protective Agents|protective agents|mesh-ancestor
44531778|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531779|NCT02750319|Antidotes|antidotes|mesh-ancestor
44531780|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44531781|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531782|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44531783|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531784|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44531785|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43763885|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
44531786|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44531788|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44531789|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44531790|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44531791|NCT02758847|Paclitaxel|paclitaxel|mesh-list
44531792|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44531793|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531794|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531795|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531796|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531797|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531798|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531799|NCT02755844|Metformin|metformin|mesh-list
44531800|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
44531801|NCT02755844|Olaparib|olaparib|mesh-list
44531802|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531803|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
44531804|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531805|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531806|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44531807|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
44531808|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531809|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531810|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44531811|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44531812|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44531813|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531814|NCT02756897|Venetoclax|venetoclax|mesh-list
44531815|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531816|NCT02755272|Gemcitabine|gemcitabine|mesh-list
44531817|NCT02755272|Carboplatin|carboplatin|mesh-list
44531818|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
44531819|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531820|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44531821|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
44531822|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531823|NCT02755272|Antiviral Agents|antiviral agents|mesh-ancestor
44531824|NCT02755272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531825|NCT02755272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531826|NCT02755272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531827|NCT02755272|Immunologic Factors|immunologic factors|mesh-ancestor
44531828|NCT02755272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531829|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44531830|NCT02750540|Tenofovir|tenofovir|mesh-list
44531831|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
44531832|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531833|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44531834|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44531835|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531836|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531837|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44531838|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44531839|NCT02754154|Warfarin|warfarin|mesh-list
44531840|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
44531841|NCT02754154|Dabigatran|dabigatran|mesh-list
44531842|NCT02754154|Apixaban|apixaban|mesh-list
44531843|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
44531844|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44531845|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
44531846|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44531847|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44531848|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44531849|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531851|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
44531852|NCT02757898|Vitamins|vitamins|mesh-ancestor
44531853|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
44531854|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531855|NCT02756208|Vaccines|vaccines|mesh-list
44531856|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
44531857|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531858|NCT02756013|Paclitaxel|paclitaxel|mesh-list
44531859|NCT02756013|Carboplatin|carboplatin|mesh-list
44531860|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44531861|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531862|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44531863|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44531864|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44531865|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531866|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44531867|NCT02758717|Nivolumab|nivolumab|mesh-list
44531868|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44531869|NCT02758717|Antibodies|antibodies|mesh-list
44531870|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
44531871|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44531872|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
44531873|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
44531874|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531875|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531876|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44531877|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531878|NCT01680042|Phenytoin|phenytoin|mesh-list
44531879|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
44531880|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44531881|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44531882|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44531883|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531884|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44531885|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44531886|NCT01680081|Adenosine|adenosine|mesh-list
44531887|NCT01680081|Analgesics|analgesics|mesh-ancestor
44531888|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
44531889|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531890|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531891|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44531892|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
44531893|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44531894|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
44531895|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
44531896|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531897|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531898|NCT01680107|Cycloserine|cycloserine|mesh-list
44531899|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44531900|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531901|NCT01680107|Renal Agents|renal agents|mesh-ancestor
44531902|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44531903|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
44531904|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531905|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
44531906|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531907|NCT01680146|Caseins|caseins|mesh-list
44531908|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
44531909|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
44531910|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531911|NCT01680185|Insulin|insulin|mesh-list
44531912|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44531913|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
44531914|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
44531915|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
44531916|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
44531917|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
44531918|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44531919|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531920|NCT01680250|Sirolimus|sirolimus|mesh-list
44531921|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44531922|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531923|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44531924|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531925|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
44531926|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44531927|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
44531928|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531929|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44531930|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44531931|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44531932|NCT01680263|Analgesics|analgesics|mesh-ancestor
44531933|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
44531934|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531935|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531936|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531937|NCT01680406|Chloroquine|chloroquine|mesh-list
44531938|NCT01680406|Lumefantrine|lumefantrine|mesh-list
44531939|NCT01680406|Artemether|artemether|mesh-list
44531940|NCT01680406|Primaquine|primaquine|mesh-list
44531941|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44531942|NCT01680406|Amebicides|amebicides|mesh-ancestor
44531943|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44531944|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44531945|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531946|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
44531947|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44531948|NCT01680471|Midazolam|midazolam|mesh-list
44531949|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44531950|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44531951|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44531952|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531953|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44531954|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44531955|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44531956|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44531957|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
44531958|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
44531959|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
44531960|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
44531961|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44531962|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531963|NCT01680536|Maraviroc|maraviroc|mesh-list
44531964|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44531965|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44531966|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44531967|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44531968|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44531969|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
44531970|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44531971|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44531972|NCT01680679|Vaccines|vaccines|mesh-list
44531973|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
44531974|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531975|NCT01680718|Vasopressins|vasopressins|mesh-list
44531976|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
44531977|NCT01680718|Oxytocin|oxytocin|mesh-list
44531978|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
44531979|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44531980|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531981|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
44531982|NCT01680718|Coagulants|coagulants|mesh-ancestor
44531983|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44531984|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44531985|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
44531986|NCT01680796|Dexamethasone|dexamethasone|mesh-list
44531987|NCT01680796|Bortezomib|bortezomib|mesh-list
44531988|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44531989|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
44531990|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
44531991|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44531992|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44531993|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44531994|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
44531995|NCT01680796|Hormones|hormones|mesh-ancestor
44531996|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44531997|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44531998|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44531999|NCT01680913|Anesthetics|anesthetics|mesh-list
44532000|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532001|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532002|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
44532003|NCT01680952|Sirolimus|sirolimus|mesh-list
44532004|NCT01680952|Tacrolimus|tacrolimus|mesh-list
44532005|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532006|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
44532007|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532008|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44532018|NCT01681134|Tacrolimus|tacrolimus|mesh-list
44532019|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532020|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
44532021|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532022|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44532023|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532024|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532025|NCT01681537|Cytarabine|cytarabine|mesh-list
44532026|NCT01681537|Etoposide|etoposide|mesh-list
44532027|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
44532028|NCT01681537|Lenalidomide|lenalidomide|mesh-list
44532029|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532030|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532031|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44532032|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44532033|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532034|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532035|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44532036|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
44532037|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
44532038|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532039|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532040|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
44532041|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532042|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44532043|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44532044|NCT01681537|Growth Substances|growth substances|mesh-ancestor
44532045|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
44532046|NCT01681537|Analgesics|analgesics|mesh-ancestor
44532047|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
44532048|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532049|NCT01681550|Incretins|incretins|mesh-list
44532050|NCT01681550|Hormones|hormones|mesh-ancestor
44532051|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532052|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532053|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
44532054|NCT01681563|Ofatumumab|ofatumumab|mesh-list
44532055|NCT01681563|Pentostatin|pentostatin|mesh-list
44532056|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532057|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
44532058|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532059|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532060|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44532061|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
44532062|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532063|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532064|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44532065|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44532066|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532067|NCT01681667|Ibuprofen|ibuprofen|mesh-list
44532068|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44532069|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532070|NCT01681667|Analgesics|analgesics|mesh-ancestor
44532071|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
44532072|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532073|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532074|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532075|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532076|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44532077|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532078|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532079|NCT01681680|Metformin|metformin|mesh-list
44532080|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532081|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532082|NCT01681693|Metformin|metformin|mesh-list
44532083|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532084|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532085|NCT01681966|Ropivacaine|ropivacaine|mesh-list
44532086|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44532087|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532088|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
44532089|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532090|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532091|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
44532092|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354881|NCT01104259|Cisplatin|cisplatin|mesh-list
44532093|NCT01681979|Fluticasone|fluticasone|mesh-list
44532094|NCT01681979|Xhance|xhance|mesh-list
44532095|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44532096|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532097|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44532098|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
44532099|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764089|NCT02422563|Cisplatin|cisplatin|mesh-list
44532100|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532101|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44532102|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44532103|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
44532104|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44532105|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44532106|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44532107|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44532108|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
44532109|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532110|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532111|NCT01682109|Valacyclovir|valacyclovir|mesh-list
44532112|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
44532113|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532114|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44532115|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44532116|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532117|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532118|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532119|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532120|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44532121|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44532122|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
44532123|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532124|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532125|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44532126|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44532127|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
44532128|NCT01682343|Calcium|calcium|mesh-list
44532129|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44532130|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532131|NCT01682408|Mannitol|mannitol|mesh-list
44532132|NCT01682408|Ranitidine|ranitidine|mesh-list
44532133|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44532134|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44532135|NCT01682408|Diuretics|diuretics|mesh-ancestor
44532136|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
44532137|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532138|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44532139|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532140|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44532141|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
44532142|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
44532143|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532144|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532145|NCT01682421|Dexamethasone|dexamethasone|mesh-list
44532146|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
44532147|NCT01682421|BB 1101|bb 1101|mesh-list
44532148|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532149|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532150|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532151|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
44532152|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
44532153|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532154|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532155|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
44532156|NCT01682421|Hormones|hormones|mesh-ancestor
44532157|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532158|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44532159|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532160|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
44532161|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532162|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
44532163|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
44532164|NCT01682499|Calcium|calcium|mesh-list
44532165|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44532166|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532167|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44532168|NCT01682499|Analgesics|analgesics|mesh-ancestor
44532169|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
44532170|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532171|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
44532172|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532173|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44532174|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
44532175|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44532176|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532177|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532178|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
44532179|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44532180|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
44532181|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44532182|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44532183|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44532184|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532185|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
44532186|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44532187|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532188|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532189|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
44532190|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532191|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532192|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44532194|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532195|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44532196|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44532197|NCT01682772|Olaparib|olaparib|mesh-list
44532198|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44532199|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532200|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532201|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532202|NCT01682902|Insulin|insulin|mesh-list
44532203|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44532204|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
44532205|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
44532206|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44532207|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532208|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532209|NCT01683006|Rocuronium|rocuronium|mesh-list
44532210|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44532211|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44532212|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44532213|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532214|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532215|NCT01683032|Methylphenidate|methylphenidate|mesh-list
44532216|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44532217|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532218|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44532219|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44532220|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532221|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532222|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
44532223|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532224|NCT01683149|Sorafenib|sorafenib|mesh-list
44532225|NCT01683149|Topotecan|topotecan|mesh-list
44532226|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
44532227|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436501|NCT01991795|Ticagrelor|ticagrelor|mesh-list
44532228|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44532229|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532230|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532231|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44532232|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44532233|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44532234|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44532235|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44532236|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44532237|NCT01683175|Cisplatin|cisplatin|mesh-list
44532238|NCT01683175|Vinorelbine|vinorelbine|mesh-list
44532239|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532240|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44532254|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532255|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532256|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532257|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44532258|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532259|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44532260|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
44532261|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
44532262|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532263|NCT01683253|Protective Agents|protective agents|mesh-ancestor
44532265|NCT01683292|Emetics|emetics|mesh-ancestor
44532266|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532267|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
44532268|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532269|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532270|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
44532271|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
44532272|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532273|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532275|NCT01683552|Prednisone|prednisone|mesh-list
44532276|NCT01683552|Aprepitant|aprepitant|mesh-list
44532277|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532278|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
44532279|NCT01683552|Hormones|hormones|mesh-ancestor
44532280|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532281|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532282|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44532283|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532284|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
44532285|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
44532286|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532287|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532288|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44532289|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532290|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532291|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44532292|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44532293|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44532294|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
44532295|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
44532296|NCT01683656|Niacin|niacin|mesh-list
44532297|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44532298|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
44532299|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532300|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44532301|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
44532302|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
44532303|NCT01683656|Vitamins|vitamins|mesh-ancestor
44532304|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
44532305|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532306|NCT01683682|Carboplatin|carboplatin|mesh-list
44532307|NCT01683682|Vinorelbine|vinorelbine|mesh-list
44532308|NCT01683682|Nintedanib|nintedanib|mesh-list
44532309|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532310|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532311|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532312|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44532313|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532314|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532315|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44532316|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532317|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
44532318|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44532319|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44532320|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532321|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
44532322|NCT01683747|Coagulants|coagulants|mesh-ancestor
44532323|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
44532324|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44532325|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44532326|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532327|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
44532328|NCT01683955|Coagulants|coagulants|mesh-ancestor
44532329|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
44532330|NCT01684059|Astringents|astringents|mesh-ancestor
44532331|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532332|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
44532333|NCT01684072|Vaccines|vaccines|mesh-list
44532334|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
44532335|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532336|NCT01684085|Lorazepam|lorazepam|mesh-list
44532338|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
44532339|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
44532340|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532341|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532342|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532343|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44532344|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532345|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44532346|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532347|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532348|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
44532349|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
44532350|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532351|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532352|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44532353|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44532354|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532355|NCT01684111|Vinorelbine|vinorelbine|mesh-list
44532356|NCT01684111|Nintedanib|nintedanib|mesh-list
44532357|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532358|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532359|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532360|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44532361|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532362|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532363|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44532364|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532365|NCT01684241|Vaccines|vaccines|mesh-list
44532366|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
44532367|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532368|NCT01684306|Modafinil|modafinil|mesh-list
44532369|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44532370|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532371|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44532372|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44532373|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44532374|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532375|NCT01684319|Caseins|caseins|mesh-list
44532376|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
44532377|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
44532378|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532379|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
44532380|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44532381|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44532382|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532383|NCT01684449|Gemcitabine|gemcitabine|mesh-list
44532384|NCT01684449|Sirolimus|sirolimus|mesh-list
44532385|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44532386|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
44532387|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532388|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532389|NCT01684449|Antiviral Agents|antiviral agents|mesh-ancestor
44532390|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532391|NCT01684449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532392|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532393|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
44532394|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532395|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44532396|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44532397|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
44532398|NCT01684657|Asenapine|asenapine|mesh-list
44532399|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44532400|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532401|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532402|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532403|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532404|NCT01684683|Theophylline|theophylline|mesh-list
44532405|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44532406|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
44532407|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532408|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532409|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44532410|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44532411|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44532412|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532413|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532414|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44532415|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44532416|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44532417|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
44532418|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532419|NCT01684774|Bupivacaine|bupivacaine|mesh-list
44532420|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532421|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
44532422|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532423|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532424|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
44532436|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
44532437|NCT01684800|Coagulants|coagulants|mesh-ancestor
44532438|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44532439|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
44532440|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532441|NCT01684865|Rituximab|rituximab|mesh-list
44532442|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44532443|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532444|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
44532445|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532446|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532447|NCT01684969|Haloperidol|haloperidol|mesh-list
44532448|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
44532449|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
44532450|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
44532451|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532452|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532453|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532454|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44532455|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532456|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532457|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532458|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44532459|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
44532460|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532461|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532462|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44532463|NCT01684995|Nicotine|nicotine|mesh-list
44532464|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44532465|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
44532466|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532467|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532468|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44532469|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44532470|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
44532471|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532472|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532473|NCT01685125|Prednisone|prednisone|mesh-list
44532474|NCT01685125|Dasatinib|dasatinib|mesh-list
44532475|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
44532476|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532477|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
44532478|NCT01685125|Hormones|hormones|mesh-ancestor
44532479|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532480|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532481|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44532482|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532483|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44532484|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532485|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532486|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44532487|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44532488|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44532489|NCT01685281|Metadoxine|metadoxine|mesh-list
44532490|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44532491|NCT01685398|Timolol|timolol|mesh-list
44532492|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44532493|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44532494|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44532495|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44532496|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
44532497|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532498|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532499|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532500|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44532501|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44532503|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44532504|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532505|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532506|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532507|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532508|NCT01685515|Decitabine|decitabine|mesh-list
44532509|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
44532510|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44532511|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
44532512|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532513|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532514|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532515|NCT01685658|Acetaminophen|acetaminophen|mesh-list
44532516|NCT01685658|Ketoprofen|ketoprofen|mesh-list
44532517|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532518|NCT01685658|Analgesics|analgesics|mesh-ancestor
44532519|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
44532520|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532521|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532522|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
44532523|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44532524|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532525|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532526|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44532527|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532528|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532529|NCT01685762|Metformin|metformin|mesh-list
44532530|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532531|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532532|NCT01685853|Bisacodyl|bisacodyl|mesh-list
44532533|NCT01685853|Cathartics|cathartics|mesh-ancestor
44532534|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532535|NCT01685853|Laxatives|laxatives|mesh-ancestor
44532536|NCT01685892|Venetoclax|venetoclax|mesh-list
44532537|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
44532538|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532539|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44532540|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44532541|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44532542|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532543|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532544|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532545|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532546|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44532547|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44532548|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
44532549|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532550|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532551|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44532552|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44532553|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
44532554|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
44532555|NCT01685970|Cathartics|cathartics|mesh-ancestor
44532556|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532557|NCT01686009|Ketamine|ketamine|mesh-list
44532558|NCT01686009|Analgesics|analgesics|mesh-ancestor
44532559|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
44532560|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532561|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532562|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44532563|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44532564|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
44532565|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
44532566|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532567|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44532568|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44532569|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532570|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532571|NCT01686217|Niacinamide|niacinamide|mesh-list
44532572|NCT01686217|Peficitinib|peficitinib|mesh-list
44532573|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532574|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532575|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532576|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
44532577|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532578|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
44532579|NCT01686217|Vitamins|vitamins|mesh-ancestor
44532580|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
44532581|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44532582|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44532583|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532584|NCT01686321|Rituximab|rituximab|mesh-list
44532585|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44532586|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44532587|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532588|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
44532589|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532590|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532591|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44532592|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
44532593|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532594|NCT01686347|Ropivacaine|ropivacaine|mesh-list
44532595|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532596|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
44532597|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532598|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532599|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
44532600|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532601|NCT01686464|Valacyclovir|valacyclovir|mesh-list
44532602|NCT01686464|Prednisone|prednisone|mesh-list
44532603|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532604|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
44532606|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532607|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436865|NCT01986010|Antacids|antacids|mesh-ancestor
44532608|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44532609|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532610|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
44532611|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532612|NCT01686529|Bevacizumab|bevacizumab|mesh-list
44532613|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44532614|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532615|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44532616|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44532617|NCT01686529|Growth Substances|growth substances|mesh-ancestor
44532618|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532619|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44532620|NCT01686555|Venetoclax|venetoclax|mesh-list
44532621|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532622|NCT01686607|Itraconazole|itraconazole|mesh-list
44532623|NCT01686607|Fluconazole|fluconazole|mesh-list
44532624|NCT01686607|Voriconazole|voriconazole|mesh-list
44532625|NCT01686607|Amphotericin B|amphotericin b|mesh-list
44532626|NCT01686607|Caspofungin|caspofungin|mesh-list
44532627|NCT01686607|Micafungin|micafungin|mesh-list
44532628|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
44532629|NCT01686607|Clotrimazole|clotrimazole|mesh-list
44532630|NCT01686607|Miconazole|miconazole|mesh-list
44532631|NCT01686607|Anidulafungin|anidulafungin|mesh-list
44532632|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532633|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44532634|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44532635|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532636|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532637|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44532638|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
44532639|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532640|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532641|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44532642|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44532643|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44532644|NCT01686607|Amebicides|amebicides|mesh-ancestor
44532645|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44532646|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44532647|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44532648|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44436878|NCT01985321|Ethanol|ethanol|mesh-list
44532650|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44532651|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532652|NCT01686659|Analgesics|analgesics|mesh-ancestor
44532653|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
44532654|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532655|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532656|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532657|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532658|NCT01686711|Pioglitazone|pioglitazone|mesh-list
44532659|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532660|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532661|NCT01686789|Interferons|interferons|mesh-list
44532662|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
44532663|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
44532664|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44532665|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532666|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
44532667|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532668|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
44532669|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532670|NCT01686802|Ibuprofen|ibuprofen|mesh-list
44532671|NCT01686802|Morphine|morphine|mesh-list
44532672|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44532673|NCT01686802|Narcotics|narcotics|mesh-ancestor
44532674|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532675|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532676|NCT01686802|Analgesics|analgesics|mesh-ancestor
44532677|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
44532678|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532679|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44532680|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532700|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
44532701|NCT01687127|Calcium|calcium|mesh-list
44532702|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44532703|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532704|NCT01687127|Hematinics|hematinics|mesh-ancestor
44532705|NCT01687127|Vitamins|vitamins|mesh-ancestor
44532706|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
44532707|NCT01687140|Cycloserine|cycloserine|mesh-list
44532708|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44532709|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532710|NCT01687140|Renal Agents|renal agents|mesh-ancestor
44532711|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44532712|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
44532713|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44532714|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
44532715|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532716|NCT01687205|Tenofovir|tenofovir|mesh-list
44532717|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
44532718|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532719|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44532720|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44532721|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532722|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532723|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44532724|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44532725|NCT01687348|Lidocaine|lidocaine|mesh-list
44532726|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532727|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
44532728|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532729|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532730|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
44532731|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532732|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44532733|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44532734|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44532735|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532736|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532737|NCT01687374|Hormones|hormones|mesh-list
44532738|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
44532739|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532740|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532741|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44458759|NCT01590797|Incretins|incretins|mesh-ancestor
44532742|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44532743|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44532744|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44532745|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44532746|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44532747|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
44436983|NCT01984164|Lisinopril|lisinopril|mesh-list
44532748|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532749|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532750|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532751|NCT01687439|Cisplatin|cisplatin|mesh-list
44532752|NCT01687439|Vinorelbine|vinorelbine|mesh-list
44532753|NCT01687439|Endostar protein|endostar protein|mesh-list
44532754|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532755|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532756|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532757|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
44532758|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532759|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532760|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44532761|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44532762|NCT01687439|Growth Substances|growth substances|mesh-ancestor
44532763|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532764|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
44532765|NCT01687491|Enoxaparin|enoxaparin|mesh-list
44532766|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
44532767|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44532768|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44532769|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532770|NCT01687582|Liraglutide|liraglutide|mesh-list
44532771|NCT01687582|Exenatide|exenatide|mesh-list
44532772|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44532773|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532774|NCT01687582|Incretins|incretins|mesh-ancestor
44532775|NCT01687582|Hormones|hormones|mesh-ancestor
44532776|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532777|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44532778|NCT01687699|Spironolactone|spironolactone|mesh-list
44532779|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44532780|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
44532781|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532782|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532783|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44532784|NCT01687699|Diuretics|diuretics|mesh-ancestor
44532785|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
44532786|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
44532787|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44532788|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436999|NCT01983969|Pyridoxine|pyridoxine|mesh-list
44532789|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532790|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532791|NCT01687868|Analgesics|analgesics|mesh-ancestor
44532792|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
44532793|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532794|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44532795|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44532796|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44532797|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44532798|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355694|NCT01109615|Pemetrexed|pemetrexed|mesh-list
44532799|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532800|NCT01687894|Vasopressins|vasopressins|mesh-list
44532801|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
44532802|NCT01687894|Propofol|propofol|mesh-list
44532803|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44532804|NCT01687894|Anesthetics|anesthetics|mesh-list
44532805|NCT01687894|Sevoflurane|sevoflurane|mesh-list
44532806|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
44532807|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44532808|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532809|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532810|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44532811|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44532812|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
44532813|NCT01687894|Coagulants|coagulants|mesh-ancestor
44532814|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44532815|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44532816|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
44532817|NCT01688024|Mitomycins|mitomycins|mesh-list
44532818|NCT01688024|Mitomycin|mitomycin|mesh-list
44532819|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44532820|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532821|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
44532822|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532823|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44532824|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532825|NCT01688089|Levodopa|levodopa|mesh-list
44532826|NCT01688089|Carbidopa|carbidopa|mesh-list
44532827|NCT01688089|Entacapone|entacapone|mesh-list
44532828|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44532829|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44532830|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
44532831|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532832|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532833|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532834|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44532835|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532836|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44532837|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
44532838|NCT01688154|Procyanidin|procyanidin|mesh-list
44532839|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
44532840|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532841|NCT01688154|Protective Agents|protective agents|mesh-ancestor
44532842|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532843|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44532844|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44532845|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532846|NCT01688206|Atezolizumab|atezolizumab|mesh-list
44532847|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532848|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
44532849|NCT01688349|Hormones|hormones|mesh-ancestor
44532850|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532851|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532852|NCT01688401|Melphalan|melphalan|mesh-list
44532853|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44532854|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
44532855|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532856|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532857|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44532858|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44532859|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
44532860|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532861|NCT01688518|Lidocaine|lidocaine|mesh-list
44532862|NCT01688518|Tetracaine|tetracaine|mesh-list
44532863|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532864|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
44532865|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532866|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532867|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
44532868|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532869|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44532870|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44532871|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44532872|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532873|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532874|NCT01688544|Benzimidazole|benzimidazole|mesh-list
44532875|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
44532876|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44532877|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44532878|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
44532879|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44532880|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44532881|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44532882|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532883|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532884|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532885|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532886|NCT01688570|Analgesics|analgesics|mesh-ancestor
44532887|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
44532888|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532889|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
44532890|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532903|NCT01688583|Narcotics|narcotics|mesh-ancestor
44532904|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437100|NCT01982331|Vaccines|vaccines|mesh-list
44532905|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532906|NCT01688583|Analgesics|analgesics|mesh-ancestor
44532907|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
44532908|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532909|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44532910|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44532911|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
44532912|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
44532913|NCT01688648|Lidocaine|lidocaine|mesh-list
44532914|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
44532915|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
44532916|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
44532917|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532918|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532919|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
44532920|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532921|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44532922|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44532923|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44532924|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532925|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532926|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44532927|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532928|NCT01688648|Analgesics|analgesics|mesh-ancestor
44532929|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44532930|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44532931|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44532932|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
44532933|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44532934|NCT01688700|Paclitaxel|paclitaxel|mesh-list
44532935|NCT01688700|Cisplatin|cisplatin|mesh-list
44532936|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
44355917|NCT01110941|Vitamins|vitamins|mesh-ancestor
44532937|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532938|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532939|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532940|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44532941|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532942|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532943|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44532944|NCT01688791|Paclitaxel|paclitaxel|mesh-list
44532945|NCT01688791|Carboplatin|carboplatin|mesh-list
44532946|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44532947|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532948|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
44532949|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44437150|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
44532950|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44532951|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532952|NCT01688934|Naproxen|naproxen|mesh-list
44532953|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44532954|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44532955|NCT01688934|Analgesics|analgesics|mesh-ancestor
44532956|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
44532957|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532958|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532959|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44532960|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44532961|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
44532962|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44532963|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44532964|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532965|NCT01688947|Pregabalin|pregabalin|mesh-list
44532966|NCT01688947|Analgesics|analgesics|mesh-ancestor
44532967|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
44532968|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44532969|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532970|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
44532971|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44532972|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44532973|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44532974|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44532976|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44532977|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44532978|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44532979|NCT01688960|Aflibercept|aflibercept|mesh-list
44532980|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44532981|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44532982|NCT01688960|Growth Substances|growth substances|mesh-ancestor
44532983|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532984|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
44532985|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44532986|NCT01689051|Glucagon|glucagon|mesh-list
44532987|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44532988|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44532989|NCT01689051|Hormones|hormones|mesh-ancestor
44532990|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44532991|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44532992|NCT01689051|Incretins|incretins|mesh-ancestor
44532993|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
44532994|NCT01689090|Citric Acid|citric acid|mesh-list
44532995|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
44532996|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44532997|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
44532998|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44532999|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
44533000|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
44533001|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533002|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44533003|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44533004|NCT01689090|Analgesics|analgesics|mesh-ancestor
44533005|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
44533006|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533007|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533008|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533009|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355962|NCT01111448|Sirolimus|sirolimus|mesh-list
44533010|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533011|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
44533012|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44533013|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533014|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533015|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44533016|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44533017|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533018|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533019|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533020|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44533021|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
44533022|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533023|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533024|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44533025|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44533026|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44533027|NCT01689129|Insulin|insulin|mesh-list
44533028|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44533029|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
44533030|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533031|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533032|NCT01689142|Insulin|insulin|mesh-list
44533033|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44533034|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
44533035|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533036|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533037|NCT01689194|Cisplatin|cisplatin|mesh-list
44533038|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533039|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
44533040|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44533041|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533042|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533043|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44533044|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533045|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44533046|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533047|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44533048|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533049|NCT01689285|Valacyclovir|valacyclovir|mesh-list
44533050|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
44533051|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533052|NCT01689298|Oxytocin|oxytocin|mesh-list
44533053|NCT01689298|Carbetocin|carbetocin|mesh-list
44533054|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
44437255|NCT01977729|Sertraline|sertraline|mesh-list
44533055|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533056|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533057|NCT01689311|Alprostadil|alprostadil|mesh-list
44533058|NCT01689311|Misoprostol|misoprostol|mesh-list
44533059|NCT01689311|Oxytocin|oxytocin|mesh-list
44533060|NCT01689311|Ergonovine|ergonovine|mesh-list
44533061|NCT01689311|Dinoprost|dinoprost|mesh-list
44533062|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
44533063|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
44533064|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533065|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533066|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44533067|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
44533068|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44533069|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533070|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44533071|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44533072|NCT01689311|Urological Agents|urological agents|mesh-ancestor
44533073|NCT01689558|Endostatins|endostatins|mesh-list
44533074|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533075|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44533076|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44533077|NCT01689558|Growth Substances|growth substances|mesh-ancestor
44533078|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533079|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44533080|NCT01689597|Morphine|morphine|mesh-list
44533081|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44533082|NCT01689597|Narcotics|narcotics|mesh-ancestor
44533083|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533084|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356038|NCT01111864|Trace Elements|trace elements|mesh-list
44533085|NCT01689597|Analgesics|analgesics|mesh-ancestor
44533086|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
44533087|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533088|NCT01689623|Simeprevir|simeprevir|mesh-list
44533089|NCT01689623|Atorvastatin|atorvastatin|mesh-list
44533090|NCT01689623|Simvastatin|simvastatin|mesh-list
44533091|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44533092|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44533093|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
44533094|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533095|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44533096|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44533097|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533098|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
44533099|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533100|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
44533101|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44533102|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44437296|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533103|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533104|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44533105|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44533106|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533107|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44533108|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44533109|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533110|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44533111|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44533112|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533113|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
44533114|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44533115|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533116|NCT01689870|Ipilimumab|ipilimumab|mesh-list
44533117|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44533118|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533119|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44533120|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533121|NCT01689896|Testosterone|testosterone|mesh-list
44533122|NCT01689896|Androgens|androgens|mesh-ancestor
44533123|NCT01689896|Hormones|hormones|mesh-ancestor
44533124|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533125|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533126|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44533127|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44533128|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44533129|NCT01689987|Sirolimus|sirolimus|mesh-list
44533130|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
44533131|NCT01689987|Dexamethasone|dexamethasone|mesh-list
44533132|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
44533133|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
44533134|NCT01689987|Ichthammol|ichthammol|mesh-list
44533135|NCT01689987|BB 1101|bb 1101|mesh-list
44533136|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533137|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
44533138|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533139|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533140|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44533141|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
44437343|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533142|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533143|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533144|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44533145|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533146|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
44533147|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
44533148|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533149|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533150|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
44533151|NCT01689987|Hormones|hormones|mesh-ancestor
44533152|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533153|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533154|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533155|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533156|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44533157|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
44533158|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
44533159|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44533160|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44533161|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533162|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
44533163|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44533164|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
44533165|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44533166|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44533167|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44533168|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533169|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533170|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
44533171|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533172|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533173|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44533174|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533197|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
44533198|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533199|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533200|NCT01685268|Prednisone|prednisone|mesh-list
44533201|NCT01685268|Prednisolone|prednisolone|mesh-list
44533202|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
44533203|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533204|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
44533205|NCT01685268|Hormones|hormones|mesh-ancestor
44533206|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533207|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533208|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533209|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533210|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44533211|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533212|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533213|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533214|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44356266|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533215|NCT01685255|Tamoxifen|tamoxifen|mesh-list
44533216|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44533217|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533218|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533219|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533220|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533221|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533222|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44533223|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44533224|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44533226|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533227|NCT01680939|Ibuprofen|ibuprofen|mesh-list
44533228|NCT01680939|Morphine|morphine|mesh-list
44437407|NCT01975272|Iron|iron|mesh-list
44533229|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44533230|NCT01680939|Narcotics|narcotics|mesh-ancestor
44533231|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533232|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533233|NCT01680939|Analgesics|analgesics|mesh-ancestor
44533234|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
44533235|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533236|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44533237|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44533238|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533239|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533240|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44533241|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533242|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533243|NCT01683188|Vemurafenib|vemurafenib|mesh-list
44533244|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533245|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44533246|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533247|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533248|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44533249|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
44533250|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533251|NCT01685827|Eflornithine|eflornithine|mesh-list
44533252|NCT01685827|Nifurtimox|nifurtimox|mesh-list
44533253|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533254|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44533255|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44533256|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44533257|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533258|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44533259|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533260|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533261|NCT01683084|Telmisartan|telmisartan|mesh-list
44533262|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44533263|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44533264|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44533265|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533266|NCT04823442|Bisoprolol|bisoprolol|mesh-list
44533267|NCT04823442|Mirabegron|mirabegron|mesh-list
44533268|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44533269|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44533270|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44533271|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533272|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533273|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533274|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533275|NCT04823442|Urological Agents|urological agents|mesh-ancestor
44533276|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44533277|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
44533278|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
44533279|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533280|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44533281|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44437454|NCT01974141|Dapsone|dapsone|mesh-list
44533282|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44533283|NCT04823065|Scopolamine|scopolamine|mesh-list
44533284|NCT04823065|Loperamide|loperamide|mesh-list
44533285|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
44533286|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44533287|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533288|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44533289|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
44533290|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
44533291|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533292|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533293|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
44533294|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44533295|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
44533296|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533297|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533298|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44533299|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
44533300|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44533301|NCT04828135|Xenon|xenon|mesh-list
44533302|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44533303|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
44533304|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
44533305|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533306|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533307|NCT04822337|Dexamethasone|dexamethasone|mesh-list
44533308|NCT04822337|Lenalidomide|lenalidomide|mesh-list
44533309|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533310|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
44533311|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
44533312|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533313|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533314|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533315|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
44533316|NCT04822337|Hormones|hormones|mesh-ancestor
44533317|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533318|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533319|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533320|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
44533321|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44533322|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44533323|NCT04822337|Growth Substances|growth substances|mesh-ancestor
44533324|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44533325|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
44533326|NCT04827836|Povidone|povidone|mesh-list
44533327|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44533328|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44533329|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
44533330|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
44533331|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44533332|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533333|NCT04821856|Cannabidiol|cannabidiol|mesh-list
44533334|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
44533335|NCT04828226|Clonidine|clonidine|mesh-list
44533336|NCT04828226|Analgesics|analgesics|mesh-ancestor
44533337|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
44533338|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533339|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533340|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44533341|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
44533342|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
44533343|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44533344|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44533345|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44533346|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533347|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533348|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533349|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
44533350|NCT04821141|Estrogens|estrogens|mesh-list
44533351|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44533352|NCT04821141|Hormones|hormones|mesh-ancestor
44533353|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533354|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533355|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44533356|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44533357|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533358|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44533359|NCT04823247|Interleukin-23|interleukin-23|mesh-list
44533360|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44533361|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44533362|NCT04823247|Growth Substances|growth substances|mesh-ancestor
44533363|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533364|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
44533365|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533366|NCT04829799|Ketorolac|ketorolac|mesh-list
44533380|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533381|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44533382|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44533383|NCT04829799|Analgesics|analgesics|mesh-ancestor
44533384|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533385|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533386|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44533387|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533388|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44533389|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
44533390|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
44533391|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
44533392|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44533393|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
44533394|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44533395|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44533396|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44533397|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44533398|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533399|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533400|NCT04829799|Protective Agents|protective agents|mesh-ancestor
44533401|NCT04824417|Itraconazole|itraconazole|mesh-list
44533402|NCT04824417|Voriconazole|voriconazole|mesh-list
44533403|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
44533404|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533405|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44533406|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44533407|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533408|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533409|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44533410|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533411|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533412|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533413|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44533414|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
44533415|NCT04821375|Estrogens|estrogens|mesh-list
44533416|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44533417|NCT04821375|Hormones|hormones|mesh-ancestor
44533418|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533419|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533420|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44533421|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44533422|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533423|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44533424|NCT04827979|Daratumumab|daratumumab|mesh-list
44533425|NCT04827979|Abatacept|abatacept|mesh-list
44533426|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
44533427|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
44533428|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
44533429|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533430|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533431|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44533432|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533433|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533434|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533435|NCT04822467|Ethanol|ethanol|mesh-list
44533436|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44533437|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533438|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533439|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533440|NCT04826484|Bupivacaine|bupivacaine|mesh-list
44533441|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
44533442|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
44533443|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533444|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533445|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
44533446|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533447|NCT04823468|Cisplatin|cisplatin|mesh-list
44533448|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533449|NCT04823962|Molgramostim|molgramostim|mesh-list
44533450|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533452|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44533453|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44533454|NCT04823845|Analgesics|analgesics|mesh-ancestor
44533455|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
44533456|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533457|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533458|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533459|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533460|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
44533461|NCT04828694|Naltrexone|naltrexone|mesh-list
44533462|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44533463|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44533464|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533465|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
44533466|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533467|NCT04820036|Insulin|insulin|mesh-list
44533468|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533469|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533470|NCT04825262|Tacrolimus|tacrolimus|mesh-list
44533471|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533472|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
44533473|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533474|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44533475|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437634|NCT01970501|Metoprolol|metoprolol|mesh-list
44533476|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533477|NCT04822597|Lidocaine|lidocaine|mesh-list
44533478|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
44533479|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
44533480|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533481|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533482|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
44533483|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533484|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44533485|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44533486|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44533487|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533488|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533489|NCT01600235|Phenylephrine|phenylephrine|mesh-list
44533490|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
44533491|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44533492|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
44533493|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
44533494|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533495|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533496|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
44533497|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44533498|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
44533499|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
44533500|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44533501|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44533502|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44533503|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533504|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533505|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533506|NCT01600235|Protective Agents|protective agents|mesh-ancestor
44533507|NCT01600274|Dienogest|dienogest|mesh-list
44533508|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44533509|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44533510|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44533511|NCT01600274|Estradiol|estradiol|mesh-list
44533512|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44533513|NCT01600274|Nandrolone|nandrolone|mesh-list
44356593|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44533514|NCT01600274|Estrogens|estrogens|mesh-ancestor
44533515|NCT01600274|Hormones|hormones|mesh-ancestor
44533516|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533517|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533518|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44533519|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
44533520|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533521|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44533522|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44533523|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44533524|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44533526|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533527|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533529|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
44533530|NCT01600365|Ganciclovir|ganciclovir|mesh-list
44533531|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44533532|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
44533533|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44533534|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44533535|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
44533536|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533537|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44533538|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533539|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533540|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44533541|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44533542|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44533543|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533544|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533545|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533546|NCT01600456|Sertraline|sertraline|mesh-list
44533547|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533548|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533549|NCT01600456|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44533550|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44533551|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533552|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533553|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533554|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
44533555|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533556|NCT01600573|Topotecan|topotecan|mesh-list
44533557|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44533558|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44533559|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533560|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533561|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533562|NCT01600612|Oxytocin|oxytocin|mesh-list
44533563|NCT01600612|Carbetocin|carbetocin|mesh-list
44533564|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
44533565|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533566|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533567|NCT01600625|Minocycline|minocycline|mesh-list
44533568|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533569|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533570|NCT01600742|Vorinostat|vorinostat|mesh-list
44533571|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533572|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44533573|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533574|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533575|NCT01600768|Lactams|lactams|mesh-list
44533576|NCT01600768|beta-Lactams|beta-lactams|mesh-list
44533577|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533578|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533579|NCT01600807|Gemcitabine|gemcitabine|mesh-list
44533580|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44533581|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44533582|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
44437749|NCT01968967|Bococizumab|bococizumab|mesh-list
44533583|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533584|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533585|NCT01600807|Antiviral Agents|antiviral agents|mesh-ancestor
44533586|NCT01600807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533587|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533588|NCT01600807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533589|NCT01600807|Immunologic Factors|immunologic factors|mesh-ancestor
44533590|NCT01600807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533591|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44533592|NCT01600963|Bedaquiline|bedaquiline|mesh-list
44533593|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
44533594|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
44533595|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533596|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533597|NCT01601002|Mirtazapine|mirtazapine|mesh-list
44533598|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533599|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533600|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44533601|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
44533602|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
44533603|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533604|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533605|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533606|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44533607|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44533608|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533609|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44533610|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44533611|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44533612|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533613|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44533614|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44533615|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
44533616|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44533617|NCT01601093|Sulbactam|sulbactam|mesh-list
44533618|NCT01601093|Cefoperazone|cefoperazone|mesh-list
44533619|NCT01601093|Sulperazone|sulperazone|mesh-list
44533620|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533621|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437806|NCT01968070|Celecoxib|celecoxib|mesh-list
44533622|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44533623|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533624|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533625|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44533626|NCT01601093|Renal Agents|renal agents|mesh-ancestor
44533627|NCT01601106|Prednisolone|prednisolone|mesh-list
44533628|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533629|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
44533630|NCT01601106|Hormones|hormones|mesh-ancestor
44533631|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533632|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533633|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533634|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533635|NCT01601184|Temozolomide|temozolomide|mesh-list
44533636|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44533637|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
44533638|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533639|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533640|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
44533641|NCT01601314|Analgesics|analgesics|mesh-ancestor
44533642|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
44533643|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533644|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533645|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
44533646|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533647|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44533648|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
44533649|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44533650|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533651|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533652|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44533653|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
44533654|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533655|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
44533656|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44533657|NCT01601327|Testosterone|testosterone|mesh-list
44533658|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
44533659|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
44533660|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44533661|NCT01601327|Androgens|androgens|mesh-ancestor
44533662|NCT01601327|Hormones|hormones|mesh-ancestor
44533663|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533664|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533665|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533666|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533667|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
44533668|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533676|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
44533677|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
44533678|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458766|NCT01590771|Metformin|metformin|mesh-list
44533679|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533680|NCT01601561|Insulin|insulin|mesh-list
44533681|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44533682|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533683|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533684|NCT01601730|Dexetimide|dexetimide|mesh-list
44533685|NCT01601730|Modafinil|modafinil|mesh-list
44533686|NCT01601730|Citalopram|citalopram|mesh-list
44533687|NCT01601730|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44533688|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44533689|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533690|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533691|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533692|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
44533693|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533694|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44533695|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533696|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533697|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44533698|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44533699|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
44533700|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
44533701|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533702|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44533703|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44533704|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
44533705|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44533706|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44533707|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44533708|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44533709|NCT01601795|Sevoflurane|sevoflurane|mesh-list
44533710|NCT01601795|Isoflurane|isoflurane|mesh-list
44533711|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44533712|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44533713|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
44533714|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
44533715|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533716|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533717|NCT01601899|Tenofovir|tenofovir|mesh-list
44533718|NCT01601899|Lamivudine|lamivudine|mesh-list
44533719|NCT01601899|Efavirenz|efavirenz|mesh-list
44533720|NCT01601899|Stavudine|stavudine|mesh-list
44533721|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
44533722|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533723|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44533724|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44533725|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533726|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533727|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44533728|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44533729|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44533730|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44533731|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44533732|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44533733|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44533734|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44533735|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
44533736|NCT01601912|Dexetimide|dexetimide|mesh-list
44533737|NCT01601912|Citalopram|citalopram|mesh-list
44533738|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44533739|NCT01601912|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44533740|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44533741|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533742|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533743|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533744|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
44533745|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533746|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44533747|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533748|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533749|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44533750|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44533751|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
44533752|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
43764090|NCT02422563|Carboplatin|carboplatin|mesh-list
44533753|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533754|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44533755|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44533756|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
44533757|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44533758|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533759|NCT01601938|Selenium|selenium|mesh-list
44533760|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
44533761|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533762|NCT01601938|Protective Agents|protective agents|mesh-ancestor
44533763|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533764|NCT01601938|Trace Elements|trace elements|mesh-ancestor
44533765|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
44533766|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44533767|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44533768|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533769|NCT01602003|Incretins|incretins|mesh-ancestor
44533770|NCT01602003|Hormones|hormones|mesh-ancestor
44533771|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533772|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44533773|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44533774|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533775|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533776|NCT01602055|Azithromycin|azithromycin|mesh-list
44533777|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533778|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533779|NCT01602185|Memantine|memantine|mesh-list
44533780|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
44533781|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
44533782|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44533783|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44533784|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
44533785|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533786|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533787|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533788|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44437953|NCT01964963|Incretins|incretins|mesh-ancestor
44533789|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44533790|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
44533791|NCT01602250|Ropivacaine|ropivacaine|mesh-list
44533792|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
44533793|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44533794|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
44533795|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
44533796|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533797|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533798|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
44533799|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533800|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44533801|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44533802|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44533803|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44533804|NCT01602289|Gefitinib|gefitinib|mesh-list
44533805|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533806|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44533807|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533808|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533809|NCT01602302|Adalimumab|adalimumab|mesh-list
44533810|NCT01602302|Etanercept|etanercept|mesh-list
44533811|NCT01602302|Golimumab|golimumab|mesh-list
44533812|NCT01602302|Abatacept|abatacept|mesh-list
44533813|NCT01602302|Infliximab|infliximab|mesh-list
44533814|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
44533815|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533816|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533817|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44533818|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533819|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44533820|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44533821|NCT01602302|Analgesics|analgesics|mesh-ancestor
44533822|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
44533823|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533824|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533825|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533826|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
44533827|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44533828|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533829|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533830|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44533831|NCT01602406|Trastuzumab|trastuzumab|mesh-list
44533832|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44533833|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533835|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
44533836|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533837|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44533838|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
44533839|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533840|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533841|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44533842|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
44533843|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
44533844|NCT01602523|Hormones|hormones|mesh-ancestor
44533845|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533846|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44533847|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44533848|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44533849|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44533850|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533851|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533852|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
44533853|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
44533854|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44533855|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44533856|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533857|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533858|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533859|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533860|NCT01602640|Fentanyl|fentanyl|mesh-list
44533861|NCT01602640|Midazolam|midazolam|mesh-list
44533862|NCT01602640|Morphine|morphine|mesh-list
44533863|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44533864|NCT01602640|Narcotics|narcotics|mesh-ancestor
44533865|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533866|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533867|NCT01602640|Analgesics|analgesics|mesh-ancestor
44533868|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
44533869|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533870|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44533871|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44533872|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
44533873|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
44533874|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44533875|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44533876|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44533877|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533878|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
44533879|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
44533880|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44533881|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533882|NCT01602757|Lidocaine|lidocaine|mesh-list
44533883|NCT01602757|Tetracaine|tetracaine|mesh-list
44533884|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
44533885|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
44533886|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533887|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533888|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
44533889|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533890|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44533891|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44533892|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44533893|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533894|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533895|NCT01602861|Spironolactone|spironolactone|mesh-list
44533896|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44533897|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44533898|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533899|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533913|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44533914|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44533915|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533918|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533919|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44533920|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533921|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533922|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44533923|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44533924|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533925|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44533926|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44533927|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
44533928|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44533929|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44533930|NCT01602939|Cladribine|cladribine|mesh-list
44533931|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533932|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44533933|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
44533934|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533935|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
44533936|NCT01603030|Prednisolone|prednisolone|mesh-list
44533937|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44533938|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
44357123|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44533939|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44533940|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
44533941|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44533942|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44533943|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
44533944|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44533945|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
44533946|NCT01603030|Hormones|hormones|mesh-ancestor
44533947|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44533948|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533949|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44533950|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44533951|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
44533952|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
44533953|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44533954|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533955|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44533956|NCT01603030|Protective Agents|protective agents|mesh-ancestor
44533957|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533958|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533959|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44533960|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44533961|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533962|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533963|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44533964|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
44533965|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44533966|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44533967|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44533968|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44533969|NCT01603108|Rifaximin|rifaximin|mesh-list
44533970|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44533971|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44533972|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44533973|NCT01603134|Allopurinol|allopurinol|mesh-list
44533974|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
44533975|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44533976|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44533977|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
44533978|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44533979|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44533980|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
44533981|NCT01603134|Protective Agents|protective agents|mesh-ancestor
44533982|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533983|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44533984|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533985|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533986|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44533987|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44458767|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44533988|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533989|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533990|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44533991|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
44533992|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44533993|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44533994|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44533995|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44533996|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44533997|NCT01603212|Interferons|interferons|mesh-list
44533998|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
44533999|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
44534000|NCT01603212|Aldesleukin|aldesleukin|mesh-list
44534001|NCT01603212|Interleukin-2|interleukin-2|mesh-list
44534002|NCT01603212|Vemurafenib|vemurafenib|mesh-list
44534003|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534004|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
44534005|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534006|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
44534007|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534008|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534009|NCT01603212|Analgesics|analgesics|mesh-ancestor
44534010|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
44534011|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534012|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44534013|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44534014|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534015|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534016|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534018|NCT01603251|Lumefantrine|lumefantrine|mesh-list
44534019|NCT01603251|Artemether|artemether|mesh-list
44534020|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44534021|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44534022|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534023|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
44534024|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44534025|NCT01603342|Clopidogrel|clopidogrel|mesh-list
44534026|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44534027|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44534028|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44534029|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44534030|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
44534031|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534032|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534033|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534034|NCT01603498|Dexamethasone|dexamethasone|mesh-list
44534035|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
44534036|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44534037|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44534038|NCT01603498|Prednisolone|prednisolone|mesh-list
44534039|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
44534040|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44534041|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
44534042|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534043|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
44534044|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
44534045|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534046|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534047|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534048|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
44534049|NCT01603498|Hormones|hormones|mesh-ancestor
44534050|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534051|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44534052|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534053|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44534054|NCT01603498|Protective Agents|protective agents|mesh-ancestor
44534055|NCT01603511|Charcoal|charcoal|mesh-list
44534056|NCT01603511|Antidotes|antidotes|mesh-ancestor
44534057|NCT01603511|Protective Agents|protective agents|mesh-ancestor
44534058|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534059|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
44534060|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
44534061|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
44534062|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534063|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
44534064|NCT01603654|Protective Agents|protective agents|mesh-ancestor
43764091|NCT02422563|Ifosfamide|ifosfamide|mesh-list
44534065|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534067|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
44534068|NCT01603654|Cathartics|cathartics|mesh-ancestor
44534069|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534070|NCT01603693|Calcium|calcium|mesh-list
44534071|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44534072|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534074|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44534075|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534076|NCT01603758|Ezetimibe|ezetimibe|mesh-list
44534077|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44534078|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44534079|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
44534080|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534081|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44534082|NCT01604031|Lenalidomide|lenalidomide|mesh-list
44534083|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
44534084|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534085|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44534086|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44534087|NCT01604031|Growth Substances|growth substances|mesh-ancestor
44534088|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44534089|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534090|NCT01604057|Teriparatide|teriparatide|mesh-list
44534091|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44534092|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534093|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44534094|NCT01604187|Fentanyl|fentanyl|mesh-list
44534095|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44534096|NCT01604187|Narcotics|narcotics|mesh-ancestor
44534097|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534098|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534099|NCT01604187|Analgesics|analgesics|mesh-ancestor
44534100|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
44534101|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534102|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44534103|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44534104|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
44534105|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
44534106|NCT01604330|Baclofen|baclofen|mesh-list
44534107|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44534108|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534109|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44534110|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534111|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44534112|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
44534113|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
44534114|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534115|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534116|NCT01604382|Remifentanil|remifentanil|mesh-list
44534117|NCT01604382|Bupivacaine|bupivacaine|mesh-list
44534118|NCT01604382|Anesthetics|anesthetics|mesh-list
44534119|NCT01604382|Propofol|propofol|mesh-list
44534120|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534121|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534122|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534123|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
44534124|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534125|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44534126|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44534127|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
44534128|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44534129|NCT01604382|Narcotics|narcotics|mesh-ancestor
44534130|NCT01604382|Analgesics|analgesics|mesh-ancestor
44534131|NCT01604629|Adalimumab|adalimumab|mesh-list
44534132|NCT01604629|Etanercept|etanercept|mesh-list
44534133|NCT01604629|Golimumab|golimumab|mesh-list
44534134|NCT01604629|Infliximab|infliximab|mesh-list
44534135|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44534136|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534137|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534138|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
44534139|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534140|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534141|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534142|NCT01604629|Analgesics|analgesics|mesh-ancestor
44458768|NCT01590771|Glimepiride|glimepiride|mesh-list
44534143|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
44534144|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534145|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534146|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534147|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
44534148|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44534149|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
44534150|NCT01604811|Tamsulosin|tamsulosin|mesh-list
44534151|NCT01604811|Urological Agents|urological agents|mesh-ancestor
44534152|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44534153|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44534154|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44534155|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
44534156|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534157|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534158|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534159|NCT01604863|Paclitaxel|paclitaxel|mesh-list
44534160|NCT01604863|Etoposide|etoposide|mesh-list
44534161|NCT01604863|Docetaxel|docetaxel|mesh-list
44534162|NCT01604863|Cisplatin|cisplatin|mesh-list
44534163|NCT01604863|Carboplatin|carboplatin|mesh-list
44534164|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44534165|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534166|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44534167|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44534168|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44534169|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534170|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44534171|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534172|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534173|NCT01604928|Mirabegron|mirabegron|mesh-list
44534174|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44534175|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44534176|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44534177|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44534178|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
44534179|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534180|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534181|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534182|NCT01604928|Urological Agents|urological agents|mesh-ancestor
44534183|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44534184|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44534185|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
44534186|NCT01605084|Ritonavir|ritonavir|mesh-list
44534187|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44534188|NCT01605084|Darunavir|darunavir|mesh-list
44534189|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44534190|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44534191|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44534192|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534193|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534194|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44534195|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44534196|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
44534197|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534198|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44534199|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44534200|NCT01605318|Irinotecan|irinotecan|mesh-list
44534201|NCT01605318|Labetuzumab|labetuzumab|mesh-list
44534202|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
44534203|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
44534204|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534205|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44534206|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534207|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534208|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534209|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534210|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44534211|NCT01605344|Leucovorin|leucovorin|mesh-list
44534212|NCT01605344|Fluorouracil|fluorouracil|mesh-list
44534213|NCT01605344|Irinotecan|irinotecan|mesh-list
44534214|NCT01605344|Atorvastatin|atorvastatin|mesh-list
44534215|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
44534216|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534217|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44534218|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534219|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534220|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
44534221|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534222|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44534223|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534224|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534235|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44534236|NCT01605357|Diuretics|diuretics|mesh-ancestor
44534237|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
44534238|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534239|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
44534240|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
44534241|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
44534242|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534243|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44534244|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
44534245|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
44534246|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534247|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534248|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534249|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44534250|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
44534251|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44534252|NCT01605513|Interferons|interferons|mesh-list
44534253|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534254|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
44534255|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534256|NCT01605526|Doxorubicin|doxorubicin|mesh-list
44534257|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44534258|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534259|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44534260|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534261|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438401|NCT01958918|Aflibercept|aflibercept|mesh-list
44534262|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534263|NCT01605721|Everolimus|everolimus|mesh-list
44534264|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534265|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534266|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
44534267|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534268|NCT01605734|Sorafenib|sorafenib|mesh-list
44534269|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
44534270|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534271|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534272|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534273|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534274|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44534275|NCT01605734|Estrogens|estrogens|mesh-ancestor
44534276|NCT01605734|Hormones|hormones|mesh-ancestor
44534277|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534278|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534279|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44534280|NCT01605773|Glyburide|glyburide|mesh-list
44534281|NCT01605773|Repaglinide|repaglinide|mesh-list
44534282|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44534283|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534284|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44534285|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44534286|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534287|NCT01605929|Mepivacaine|mepivacaine|mesh-list
44534288|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534289|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
44534290|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534291|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534292|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
44534293|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534294|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44534295|NCT01605968|Laxatives|laxatives|mesh-ancestor
44534296|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534297|NCT01605994|Antacids|antacids|mesh-list
44534298|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534299|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534300|NCT01606046|Anesthetics|anesthetics|mesh-list
44534301|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
44534302|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44534303|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
44534304|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534305|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534306|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
44534307|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534308|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44534309|NCT01606059|Acetaminophen|acetaminophen|mesh-list
44534310|NCT01606059|Tramadol|tramadol|mesh-list
44534311|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534312|NCT01606059|Analgesics|analgesics|mesh-ancestor
44534313|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
44534314|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534315|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534316|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
44534317|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44534318|NCT01606059|Narcotics|narcotics|mesh-ancestor
44534319|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534320|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
44534321|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44534322|NCT01606111|Protective Agents|protective agents|mesh-ancestor
44534323|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534324|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
44534325|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
44534326|NCT01606241|Vaccines|vaccines|mesh-list
44534327|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
44534328|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534329|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534330|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534331|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44534332|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
44534333|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534334|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534335|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44534336|NCT01606345|Valrubicin|valrubicin|mesh-list
44534337|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534338|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44534339|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534340|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534341|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534342|NCT01606358|Carboplatin|carboplatin|mesh-list
44534343|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534344|NCT01606384|Vasopressins|vasopressins|mesh-list
44534345|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
44534346|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
44534347|NCT01606384|Coagulants|coagulants|mesh-ancestor
44534348|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44534349|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44534350|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
44534351|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534352|NCT01606462|Oxytocin|oxytocin|mesh-list
44534353|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
44534354|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44534355|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534356|NCT01606527|Ibuprofen|ibuprofen|mesh-list
44534357|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534358|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534359|NCT01606527|Analgesics|analgesics|mesh-ancestor
44438497|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
44534360|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
44534361|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534362|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534363|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534364|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534365|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44534366|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534367|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534368|NCT01606540|Ibuprofen|ibuprofen|mesh-list
44534369|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534370|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534371|NCT01606540|Analgesics|analgesics|mesh-ancestor
44534372|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
44534373|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534374|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534375|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534376|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534377|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44534378|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534379|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534380|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
44534381|NCT01606878|Doxorubicin|doxorubicin|mesh-list
44534382|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44534383|NCT01606878|Vincristine|vincristine|mesh-list
44534384|NCT01606878|Topotecan|topotecan|mesh-list
44534385|NCT01606878|Crizotinib|crizotinib|mesh-list
44534386|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
44534387|NCT01606878|Razoxane|razoxane|mesh-list
44534388|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534389|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
44534390|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534391|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534392|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44534393|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
44534394|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534395|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534396|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44534397|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44534398|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44534399|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534400|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534401|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44534402|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
44534403|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
44534404|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
44534405|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44534406|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534407|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44534408|NCT01606878|Protective Agents|protective agents|mesh-ancestor
44534409|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44534410|NCT01607034|Pramipexole|pramipexole|mesh-list
44534411|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
44534412|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534413|NCT01607034|Protective Agents|protective agents|mesh-ancestor
44534414|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534416|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44534417|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
44534418|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
44534419|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534420|NCT01607086|Lamotrigine|lamotrigine|mesh-list
44534421|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
44534422|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44534423|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534424|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534425|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44534426|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534427|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44534428|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44534429|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534430|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44534431|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44534432|NCT01607125|Vortioxetine|vortioxetine|mesh-list
44534433|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
44534434|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44534435|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44534436|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44534437|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534438|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534439|NCT01607125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44534440|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44534441|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534442|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534443|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534444|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
44534445|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44534446|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44534447|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44534448|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44534449|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44534450|NCT01607333|Lamotrigine|lamotrigine|mesh-list
44534451|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
44534452|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44534453|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534454|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534455|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44534456|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534457|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44534458|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44534459|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534460|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44534461|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44534462|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
44534463|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44534464|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44534465|NCT01607580|Prednisolone|prednisolone|mesh-list
44534466|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
44534467|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44534468|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
44534469|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
44534470|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534471|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
44534472|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
44534473|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534474|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534475|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534476|NCT01607580|Hormones|hormones|mesh-ancestor
44534477|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534478|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44534479|NCT01607580|Protective Agents|protective agents|mesh-ancestor
44534480|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44534481|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534482|NCT01607671|Timolol|timolol|mesh-list
44534483|NCT01607671|Maleic acid|maleic acid|mesh-list
44534484|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44534485|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44534486|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
44534487|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534499|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
44534500|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534501|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534502|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534503|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44534504|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44534505|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534506|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44534507|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44534508|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
44534509|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
44534510|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
44534511|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534512|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534513|NCT01607762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44534514|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44534515|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534516|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
44534517|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
44534518|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44534519|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44534520|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44534521|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44534522|NCT01607879|Androgens|androgens|mesh-list
44534523|NCT01607879|Hormones|hormones|mesh-ancestor
44534524|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534525|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534526|NCT01607918|Amoxicillin|amoxicillin|mesh-list
44534527|NCT01607918|Metronidazole|metronidazole|mesh-list
44534528|NCT01607918|Clarithromycin|clarithromycin|mesh-list
44534529|NCT01607918|Lansoprazole|lansoprazole|mesh-list
44534530|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
44534531|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44534532|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534533|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44534534|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44534535|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44534536|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534537|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534538|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44534539|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44534540|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44458769|NCT01590771|Gliclazide|gliclazide|mesh-list
44534541|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534542|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44534543|NCT01607970|Oxytocin|oxytocin|mesh-list
44534544|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
44534545|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44534546|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534547|NCT01607996|Anesthetics|anesthetics|mesh-list
44534548|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534549|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534550|NCT01608009|Paclitaxel|paclitaxel|mesh-list
44534551|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44534552|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534553|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44534554|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44534555|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44534556|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534557|NCT01608139|Curcumin|curcumin|mesh-list
44534558|NCT01608139|Sorafenib|sorafenib|mesh-list
44534559|NCT01608139|Vorinostat|vorinostat|mesh-list
44534560|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534561|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534562|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534563|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534564|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44534565|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534566|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534567|NCT01608139|Analgesics|analgesics|mesh-ancestor
44534568|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
44534569|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534570|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534571|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534572|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534573|NCT01608269|Lamivudine|lamivudine|mesh-list
44534574|NCT01608269|Abacavir|abacavir|mesh-list
44534575|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44534576|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44534577|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534578|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534579|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
44534580|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534581|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44534582|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44534583|NCT01608334|Fentanyl|fentanyl|mesh-list
44534584|NCT01608334|Sufentanil|sufentanil|mesh-list
44534585|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44534586|NCT01608334|Narcotics|narcotics|mesh-ancestor
44534587|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534588|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534589|NCT01608334|Analgesics|analgesics|mesh-ancestor
44534590|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
44534591|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534592|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44534593|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44534594|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
44534595|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
44534596|NCT01608347|Folic Acid|folic acid|mesh-list
44534597|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
44534598|NCT01608347|Hematinics|hematinics|mesh-ancestor
44534599|NCT01608347|Vitamins|vitamins|mesh-ancestor
44534600|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
44534601|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534602|NCT01608360|Lidocaine|lidocaine|mesh-list
44534603|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534604|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
44534605|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534606|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534607|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
44534608|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534609|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44438738|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534610|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44534611|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44534612|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534613|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534614|NCT01608373|Lidocaine|lidocaine|mesh-list
44534615|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534616|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
44534617|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534618|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357873|NCT01123408|Haloperidol|haloperidol|mesh-list
44534619|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
44534620|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534621|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44534622|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44534623|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44534624|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44534625|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534627|NCT01608412|Tacrolimus|tacrolimus|mesh-list
44534628|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534629|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
44534630|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534631|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44534632|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534633|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534634|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534635|NCT01608464|Cisplatin|cisplatin|mesh-list
44534636|NCT01608464|Docetaxel|docetaxel|mesh-list
44534637|NCT01608464|Fluorouracil|fluorouracil|mesh-list
44534638|NCT01608464|Irinotecan|irinotecan|mesh-list
44534639|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534640|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
44534641|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
44534642|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
44534643|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534644|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
44534645|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44534646|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438799|NCT01949116|Folic Acid|folic acid|mesh-list
44534647|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
44534648|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534649|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44534650|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534651|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534652|NCT01608555|Tobramycin|tobramycin|mesh-list
44534653|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44534654|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534655|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
44534656|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534657|NCT01608698|Drospirenone|drospirenone|mesh-list
44534658|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44534659|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
44534660|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44534661|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44534662|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44534663|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
44534664|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44534665|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534666|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44534667|NCT01608698|Estrogens|estrogens|mesh-ancestor
44534668|NCT01608698|Hormones|hormones|mesh-ancestor
44534669|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534670|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44534671|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
44534672|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44534673|NCT01608698|Diuretics|diuretics|mesh-ancestor
44534674|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
44534675|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
44534676|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44534677|NCT01608711|Gemcitabine|gemcitabine|mesh-list
44534678|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44534679|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
44534680|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534681|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534682|NCT01608711|Antiviral Agents|antiviral agents|mesh-ancestor
44534683|NCT01608711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534684|NCT01608711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534685|NCT01608711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534686|NCT01608711|Immunologic Factors|immunologic factors|mesh-ancestor
44534687|NCT01608711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534688|NCT01608750|Folic Acid|folic acid|mesh-list
44534689|NCT01608750|Hematinics|hematinics|mesh-ancestor
44534690|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
44534691|NCT01608750|Vitamins|vitamins|mesh-ancestor
44534692|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
44534693|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534694|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44534695|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534696|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534697|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534698|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534700|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44534701|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44534702|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44534703|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534704|NCT01608984|Sufentanil|sufentanil|mesh-list
44534705|NCT01608984|Isoflurane|isoflurane|mesh-list
44534706|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44534707|NCT01608984|Narcotics|narcotics|mesh-ancestor
44534708|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534709|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534710|NCT01608984|Analgesics|analgesics|mesh-ancestor
44534711|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
44534712|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534713|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44534714|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44534715|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
44534716|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
44534717|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44534718|NCT01609049|Ribavirin|ribavirin|mesh-list
44534719|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44534720|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
44534721|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534722|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
44534723|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534724|NCT01609088|Erythritol|erythritol|mesh-list
44534725|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
44534726|NCT01609101|Cobalt|cobalt|mesh-list
44534727|NCT01609101|Trace Elements|trace elements|mesh-ancestor
44534728|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
44534729|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534730|NCT01609127|Capecitabine|capecitabine|mesh-list
44534731|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44534732|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
44534733|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534734|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534735|NCT01609166|Allopurinol|allopurinol|mesh-list
44534736|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
44534737|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534738|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534739|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
44534740|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534741|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44534742|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
44534743|NCT01609166|Protective Agents|protective agents|mesh-ancestor
44534744|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534745|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
44534746|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534747|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
44534748|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534749|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534750|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44534751|NCT01609205|Adalimumab|adalimumab|mesh-list
44534752|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534753|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534754|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44534755|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44534756|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534757|NCT01609387|Tocopherols|tocopherols|mesh-list
44534758|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
44534759|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534760|NCT01609387|Protective Agents|protective agents|mesh-ancestor
44534761|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534762|NCT01609387|Vitamins|vitamins|mesh-ancestor
44534763|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
44534764|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
44534765|NCT01609413|Antacids|antacids|mesh-ancestor
44534766|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534767|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534768|NCT01609439|Vitamin D|vitamin d|mesh-list
44534769|NCT01609439|Vitamins|vitamins|mesh-ancestor
44534770|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
44534771|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534785|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44534786|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44534787|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44534788|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
44534789|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534790|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534791|NCT01609491|Protective Agents|protective agents|mesh-ancestor
44534792|NCT01609517|Bupivacaine|bupivacaine|mesh-list
44534793|NCT01609517|Anesthetics|anesthetics|mesh-list
44534794|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534795|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534796|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534797|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
44534798|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534799|NCT01609647|Clopidogrel|clopidogrel|mesh-list
44534800|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44534801|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44534802|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44534803|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44534804|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44534805|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
44534806|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534807|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534808|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534809|NCT01609673|Everolimus|everolimus|mesh-list
44534810|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534811|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534812|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
44534813|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534814|NCT01609855|Scopolamine|scopolamine|mesh-list
44534815|NCT01609855|Bromides|bromides|mesh-list
44534816|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44534817|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
44534818|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44534819|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
44534820|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
44534821|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534822|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534823|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534824|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
44534825|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44534826|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
44534827|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534828|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534829|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44534830|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
44534831|NCT01609881|Ketorolac|ketorolac|mesh-list
44534832|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534833|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534834|NCT01609881|Analgesics|analgesics|mesh-ancestor
44534835|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
44534836|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534837|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534838|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534839|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534840|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44534841|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534842|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534843|NCT01609907|Valsartan|valsartan|mesh-list
44534844|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44438991|NCT01945866|Hormones|hormones|mesh-ancestor
44534845|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44534846|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44534847|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
44534848|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534849|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44534850|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44534851|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534852|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44534853|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44534854|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44534855|NCT01609959|Valsartan|valsartan|mesh-list
44534856|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44534857|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44534858|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44534859|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44534860|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534862|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
44534863|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534865|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44534866|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534867|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44534868|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44534869|NCT01606098|Growth Substances|growth substances|mesh-ancestor
44534870|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534871|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
44534872|NCT01601522|Ranitidine|ranitidine|mesh-list
44534873|NCT01601522|Desloratadine|desloratadine|mesh-list
44534874|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
44534875|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44534876|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44534877|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
44534878|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534879|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534880|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439015|NCT01945281|Caspofungin|caspofungin|mesh-list
44534881|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44534882|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
44534883|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44534884|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44534885|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44534886|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44534887|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44534888|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
44534889|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534890|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44534891|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534892|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44534893|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534894|NCT01606566|Bleomycin|bleomycin|mesh-list
44534895|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44534896|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534897|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
44534898|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44534899|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534900|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534901|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534902|NCT01604889|Ipilimumab|ipilimumab|mesh-list
44534903|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44534904|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534905|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44534906|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534907|NCT01609816|Dasatinib|dasatinib|mesh-list
44534908|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534909|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534910|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534911|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534912|NCT01602822|Ritonavir|ritonavir|mesh-list
44534913|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44534914|NCT01602822|Tenofovir|tenofovir|mesh-list
44534915|NCT01602822|Emtricitabine|emtricitabine|mesh-list
44534916|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44534917|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44439051|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
44534918|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44534919|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44534920|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534921|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534922|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44534923|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44534924|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
44534925|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534926|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44534927|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44534928|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44534929|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44534930|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
44534931|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44534932|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44534933|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44534934|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44534935|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534936|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534937|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534938|NCT01602393|Flurbiprofen|flurbiprofen|mesh-list
44534939|NCT01602393|Analgesics|analgesics|mesh-ancestor
44534940|NCT01602393|Sensory System Agents|sensory system agents|mesh-ancestor
44534941|NCT01602393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534942|NCT01602393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534943|NCT01602393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44534944|NCT01602393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44534945|NCT01602393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534946|NCT01602393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534947|NCT01602393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44534948|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534949|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534950|NCT02274155|Antibodies|antibodies|mesh-list
44534951|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
44534952|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534953|NCT02270034|Crizotinib|crizotinib|mesh-list
44534954|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534955|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44534956|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44534957|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534958|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
44534959|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44534960|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
44534961|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534962|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44534963|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44534964|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
44534965|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534966|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44534967|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44534968|NCT02270424|Fluticasone|fluticasone|mesh-list
44534969|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44534970|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44534971|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44534972|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44534973|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
44534974|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44534975|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534976|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44534977|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44534978|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44534979|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44534980|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44534981|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44534982|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44534983|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
44534984|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44534985|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44534986|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
44534987|NCT02270424|Hormones|hormones|mesh-ancestor
44534988|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44534989|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
44534990|NCT02270437|Epinephrine|epinephrine|mesh-list
44534991|NCT02270437|Racepinephrine|racepinephrine|mesh-list
44534992|NCT02270437|Fentanyl|fentanyl|mesh-list
44534993|NCT02270437|Ropivacaine|ropivacaine|mesh-list
44534994|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
44534995|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
44534996|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
44534997|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44534998|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44534999|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
44535000|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535001|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44535002|NCT02270437|Narcotics|narcotics|mesh-ancestor
44535003|NCT02270437|Analgesics|analgesics|mesh-ancestor
44535004|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44535005|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44535006|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
44535007|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44535008|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44535009|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44535010|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535011|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535012|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44535013|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44535014|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
44535015|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44535016|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44535017|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
44535018|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
44535019|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44535020|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
44535021|NCT02270606|Leucovorin|leucovorin|mesh-list
44535022|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44535023|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
44535024|NCT02270606|Fluorouracil|fluorouracil|mesh-list
44535025|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
44535026|NCT02270606|Calcium|calcium|mesh-list
44535027|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
44535028|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535029|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535030|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535031|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
44535032|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535033|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535034|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535035|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535036|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
44535037|NCT02270606|Antidotes|antidotes|mesh-ancestor
44535038|NCT02270606|Protective Agents|protective agents|mesh-ancestor
44535039|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
44535040|NCT02270606|Vitamins|vitamins|mesh-ancestor
44535041|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
44535042|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
44535043|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
44535044|NCT02270749|Vitamins|vitamins|mesh-ancestor
44535045|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
44535046|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535047|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
44535048|NCT02270749|Hematinics|hematinics|mesh-ancestor
44535049|NCT02270788|Leucovorin|leucovorin|mesh-list
44535050|NCT02270788|Cytarabine|cytarabine|mesh-list
44535051|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
44535052|NCT02270788|Methotrexate|methotrexate|mesh-list
44535053|NCT02270788|Sorafenib|sorafenib|mesh-list
44535054|NCT02270788|Crenolanib|crenolanib|mesh-list
44535055|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44535056|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
44535057|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535058|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535059|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535060|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
44535061|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535062|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535063|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535064|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535065|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44535066|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535067|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
44535068|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535069|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44535070|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
44535071|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535072|NCT02270788|Antidotes|antidotes|mesh-ancestor
44535073|NCT02270788|Protective Agents|protective agents|mesh-ancestor
44535074|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
44535075|NCT02270788|Vitamins|vitamins|mesh-ancestor
44535076|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
44535077|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44535078|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535079|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
44535080|NCT02270827|Aminophylline|aminophylline|mesh-list
44535081|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535082|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44535083|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
44535084|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535085|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535086|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44535094|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
44535095|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535096|NCT02270827|Protective Agents|protective agents|mesh-ancestor
44535098|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44535099|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
44535100|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44535101|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44535102|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535103|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535104|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
44535106|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535107|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
44535108|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535109|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
44535110|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44535111|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
44535112|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44535113|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
44535114|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535115|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
44535116|NCT02271035|Protective Agents|protective agents|mesh-ancestor
44535117|NCT02271113|Enoxaparin|enoxaparin|mesh-list
44535118|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
44535119|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
44535120|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535121|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535122|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535123|NCT02271126|Heparin|heparin|mesh-list
44535124|NCT02271126|Thromboplastin|thromboplastin|mesh-list
44535125|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
44535126|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535127|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535128|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535130|NCT02271126|Coagulants|coagulants|mesh-ancestor
44535131|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
44535132|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44535133|NCT02271165|Antibodies|antibodies|mesh-list
44535134|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
44535135|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535136|NCT02271191|Nicardipine|nicardipine|mesh-list
44535137|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44535138|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44535139|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535140|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535141|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535142|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535143|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44535144|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
44535145|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535146|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535147|NCT02271282|Toremifene|toremifene|mesh-list
44535148|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44535149|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535150|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44535151|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44535152|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535153|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535154|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535155|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535156|NCT02271295|Enoxaparin|enoxaparin|mesh-list
44535157|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
44535158|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535159|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535160|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358494|NCT01126606|Glycerol|glycerol|mesh-list
44535161|NCT02271347|Brincidofovir|brincidofovir|mesh-list
44535162|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
44535163|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535164|NCT02271360|Cabergoline|cabergoline|mesh-list
44535165|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
44535166|NCT02271360|Calcium|calcium|mesh-list
44535167|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535168|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535169|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44535170|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44535171|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
44535172|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
44535173|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535174|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535175|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
44535176|NCT02271360|Coagulants|coagulants|mesh-ancestor
44535177|NCT02271399|Aspirin|aspirin|mesh-list
44535178|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
44535179|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44535180|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44535181|NCT02271399|Analgesics|analgesics|mesh-ancestor
44535182|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
44535183|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535184|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535185|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535186|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535187|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535188|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535189|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535190|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535191|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44535192|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535193|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
44535194|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44535195|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
44535196|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44535197|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
44535198|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
44535199|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44535200|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44535201|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44535202|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535203|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535204|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535205|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535206|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
44535207|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535208|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
44535209|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44535210|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535211|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535212|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44535213|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44535214|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535215|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535216|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535217|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44535218|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
44535219|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535220|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535221|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44535222|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44535223|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44535224|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
44535225|NCT02271464|Bevacizumab|bevacizumab|mesh-list
44535226|NCT02271464|Capecitabine|capecitabine|mesh-list
44535227|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535228|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
44535229|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535230|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535231|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44535232|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
44535233|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535234|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535235|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44535236|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535237|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44535238|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44535239|NCT02271464|Growth Substances|growth substances|mesh-ancestor
44535240|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
44535241|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535242|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
44535243|NCT02271542|Propofol|propofol|mesh-list
44535244|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44535245|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535246|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535247|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44535248|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
44535249|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
44535250|NCT02271555|Remifentanil|remifentanil|mesh-list
44535251|NCT02271555|Sevoflurane|sevoflurane|mesh-list
44535252|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535253|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44535254|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
44535255|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
44535256|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535257|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535258|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44535259|NCT02271555|Narcotics|narcotics|mesh-ancestor
44535260|NCT02271555|Analgesics|analgesics|mesh-ancestor
44535261|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
44535262|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535263|NCT02271646|Bupivacaine|bupivacaine|mesh-list
44535264|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44535265|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
44535266|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535267|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535268|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
44535269|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535270|NCT02271802|Butyric Acid|butyric acid|mesh-list
44535271|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
44535272|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
44535273|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535274|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535275|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535276|NCT02271958|Mifepristone|mifepristone|mesh-list
44535277|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44535278|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
44535279|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535280|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535281|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44535282|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44535283|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44535284|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
44535285|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44535286|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44535287|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535288|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535289|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
44535290|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44535291|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44535292|NCT02271971|Vitamin D|vitamin d|mesh-list
44535293|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
44535294|NCT02271971|Vitamins|vitamins|mesh-ancestor
44535295|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
44535296|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535297|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535298|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535299|NCT02272049|Xenon|xenon|mesh-list
44535300|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44535301|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
44535302|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
44535303|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535304|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535305|NCT02272101|Vitamin D|vitamin d|mesh-list
44535306|NCT02272101|Vitamins|vitamins|mesh-ancestor
44535307|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
44535308|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358644|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
44535309|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535310|NCT02272270|Minocycline|minocycline|mesh-list
44535311|NCT02272270|Temozolomide|temozolomide|mesh-list
44535312|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44535313|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
44535314|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535315|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535316|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535317|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535318|NCT02272387|Vitamin D|vitamin d|mesh-list
44535319|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
44535320|NCT02272387|Vitamins|vitamins|mesh-ancestor
44535321|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
44535322|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535323|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535324|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535325|NCT02272478|Decitabine|decitabine|mesh-list
44535326|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
44535327|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535328|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
44535329|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535330|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535331|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535332|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535333|NCT02272517|Vortioxetine|vortioxetine|mesh-list
44535334|NCT02272517|Citalopram|citalopram|mesh-list
44535335|NCT02272517|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44535336|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44535337|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535338|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535339|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535340|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
44535341|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535342|NCT02272517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44535343|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
44535344|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535345|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44535346|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44535347|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535348|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44535349|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44535350|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44535351|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44535352|NCT02272582|Heparin|heparin|mesh-list
44535353|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
44535354|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535355|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535356|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535357|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44535358|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44535359|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44535360|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
44535361|NCT02272647|Estradiol|estradiol|mesh-list
44535362|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44535363|NCT02272647|Progesterone|progesterone|mesh-list
44535364|NCT02272647|Estrogens|estrogens|mesh-ancestor
44535365|NCT02272647|Hormones|hormones|mesh-ancestor
44535366|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535367|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535368|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44535369|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
44535370|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535371|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44535372|NCT02272647|Progestins|progestins|mesh-ancestor
44535373|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44535374|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44535375|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44535376|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44535377|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44535378|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535379|NCT02272660|Parecoxib|parecoxib|mesh-list
44535380|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44535381|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44535382|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535383|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535396|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535397|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535398|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535399|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44535400|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535401|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535402|NCT02272738|Gemcitabine|gemcitabine|mesh-list
44535403|NCT02272738|Paclitaxel|paclitaxel|mesh-list
44535404|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44439514|NCT01937299|Brinzolamide|brinzolamide|mesh-list
44535405|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44535406|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535407|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535408|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535409|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44535410|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535411|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535412|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
44535413|NCT02272738|Antiviral Agents|antiviral agents|mesh-ancestor
44535414|NCT02272738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535415|NCT02272738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535416|NCT02272738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535417|NCT02272738|Immunologic Factors|immunologic factors|mesh-ancestor
44535418|NCT02272738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535419|NCT02272764|Itraconazole|itraconazole|mesh-list
44535420|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44535421|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
44535422|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535423|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44535424|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44535425|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535426|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535427|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44535428|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535429|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535430|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535431|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44535433|NCT02272829|Narcotics|narcotics|mesh-ancestor
44535434|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535435|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535436|NCT02272829|Analgesics|analgesics|mesh-ancestor
44535437|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
44535438|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535439|NCT02272855|Ipilimumab|ipilimumab|mesh-list
44535440|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535441|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535442|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44535443|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535444|NCT02272868|Rifaximin|rifaximin|mesh-list
44535445|NCT02272868|Omeprazole|omeprazole|mesh-list
44535446|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44535447|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44535448|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44535449|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44535450|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535451|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535452|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535453|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535454|NCT02272868|Laxatives|laxatives|mesh-ancestor
44535455|NCT02272998|Ponatinib|ponatinib|mesh-list
44535456|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535457|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44535458|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535459|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535460|NCT02273102|Tretinoin|tretinoin|mesh-list
44535461|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
44535462|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535463|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
44535464|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535465|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
44535466|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535467|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44535468|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535469|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535470|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44535471|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44535472|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535473|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535474|NCT02273128|Calcitonin|calcitonin|mesh-list
44535475|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535476|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535477|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535478|NCT02273154|Buspirone|buspirone|mesh-list
44535479|NCT02273154|Paroxetine|paroxetine|mesh-list
44535480|NCT02273154|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44535481|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44535482|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535483|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535484|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535485|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
44535486|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535487|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44535488|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
44535489|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535490|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44535491|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44535492|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535493|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44535494|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44535495|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535496|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44535497|NCT02273258|Insulin|insulin|mesh-list
44535498|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44535499|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
44535500|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535501|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535502|NCT02273271|Alovudine|alovudine|mesh-list
44535503|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
44535504|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535505|NCT02273440|Theophylline|theophylline|mesh-list
44535506|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44535507|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
44535508|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535509|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535510|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44535511|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
44535512|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44535513|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535514|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535515|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
44535516|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44535517|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44535518|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
44535519|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535520|NCT02273453|Oxazepam|oxazepam|mesh-list
44535521|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44535522|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535523|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535524|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44535525|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44535526|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535527|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
44535528|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
44535529|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535530|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535531|NCT02273466|Desipramine|desipramine|mesh-list
44535532|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44535533|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
44535534|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44535535|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535536|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535537|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44535538|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44535539|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535540|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
44535541|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535542|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535543|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535544|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535545|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535546|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535547|NCT02273505|Aspirin|aspirin|mesh-list
44535548|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
44535549|NCT02273505|Salicylates|salicylates|mesh-list
44535551|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535552|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535553|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
44535554|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
44535555|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535556|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44535557|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44535558|NCT02273505|Analgesics|analgesics|mesh-ancestor
44535559|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
44535560|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535561|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535562|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535563|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535564|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44535565|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535566|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535567|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535568|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44535569|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44535570|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
44535571|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44535572|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
44535573|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535574|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535575|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535576|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535577|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535578|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535579|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44535580|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44535581|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
44535582|NCT02273583|Methotrexate|methotrexate|mesh-list
44535583|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535584|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
44535585|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535586|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535587|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44535588|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
44535589|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535590|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535591|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44535592|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44535593|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
44535594|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535595|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535596|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
44535597|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535598|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535599|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44535600|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44535601|NCT02273661|Amphotericin B|amphotericin b|mesh-list
44535602|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44535603|NCT02273661|Amebicides|amebicides|mesh-ancestor
44535604|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44535605|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44535606|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535607|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535608|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
44535609|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
44535610|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44535611|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
44535612|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44535613|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
44535614|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535615|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535616|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
44535618|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44535619|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535620|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535621|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535622|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942376|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
44535623|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535624|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44535625|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44535626|NCT02273791|Clomiphene|clomiphene|mesh-list
44535627|NCT02273791|Enclomiphene|enclomiphene|mesh-list
44535628|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
44535629|NCT02273791|Estradiol|estradiol|mesh-list
44535630|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44535631|NCT02273791|Estrogens|estrogens|mesh-ancestor
44535632|NCT02273791|Hormones|hormones|mesh-ancestor
44535633|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535634|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535635|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44535636|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
44535637|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535638|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44535639|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44535640|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535641|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44535642|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
44535643|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44535644|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44535645|NCT02273817|Ciclesonide|ciclesonide|mesh-list
44535646|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
44535647|NCT02273817|Hormones|hormones|mesh-ancestor
44535648|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535649|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535650|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44535651|NCT02273947|BMS-955176|bms-955176|mesh-list
44535652|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44535653|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44535654|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
44535655|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535656|NCT02273986|Digoxin|digoxin|mesh-list
44535657|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44535658|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44535659|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535660|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535661|NCT02273986|Protective Agents|protective agents|mesh-ancestor
44535662|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535663|NCT02274012|Paclitaxel|paclitaxel|mesh-list
44535664|NCT02274012|Afatinib|afatinib|mesh-list
44535665|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44535666|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535667|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535668|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535669|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44535670|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535671|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44535672|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535673|NCT02274051|Kinetin|kinetin|mesh-list
44535674|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44535675|NCT02274051|Growth Substances|growth substances|mesh-ancestor
44535676|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535677|NCT02274090|Metformin|metformin|mesh-list
44535678|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535679|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535680|NCT02274181|Enclomiphene|enclomiphene|mesh-list
44535681|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44535682|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535683|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535684|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535685|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44535686|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
44535687|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535688|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44535689|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44535690|NCT02274337|Abivertinib|abivertinib|mesh-list
44535691|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359083|NCT01130025|Tinzaparin|tinzaparin|mesh-list
44535692|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535693|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535694|NCT02274454|Oxytocin|oxytocin|mesh-list
44535695|NCT02274454|Calcium|calcium|mesh-list
44535696|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535697|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535699|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535700|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
44535701|NCT02274506|Fludarabine|fludarabine|mesh-list
44535702|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
44535703|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535704|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
44535705|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535706|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535707|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44535708|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
44535709|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535710|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535711|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44535712|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535713|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
44535714|NCT02274545|Vaccines|vaccines|mesh-list
44535715|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
44535716|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535717|NCT02274610|Docetaxel|docetaxel|mesh-list
44535718|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535719|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535720|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535721|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44535722|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535723|NCT02274623|Calcifediol|calcifediol|mesh-list
44535724|NCT02274623|Vitamins|vitamins|mesh-ancestor
44535725|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
44535726|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535727|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535728|NCT02274740|Metformin|metformin|mesh-list
44535729|NCT02274740|Lixisenatide|lixisenatide|mesh-list
44535730|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535731|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535732|NCT02274961|Pantoprazole|pantoprazole|mesh-list
44535733|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44535734|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44535735|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44535736|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535737|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535738|NCT02274974|Lidocaine|lidocaine|mesh-list
44535739|NCT02274974|Epinephrine|epinephrine|mesh-list
44535740|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
44535741|NCT02274974|Anesthetics|anesthetics|mesh-list
44535742|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535743|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535744|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
44535745|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535746|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44535747|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44535748|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44535749|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535750|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535751|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44535752|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44535753|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
44535754|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535755|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44535756|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44535757|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
44439864|NCT01929317|Ropinirole|ropinirole|mesh-list
44535758|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44535759|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44535760|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
44535761|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
44535762|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44535763|NCT02275013|Simendan|simendan|mesh-list
44535764|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44535765|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
44535766|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44535767|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44535768|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535769|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535770|NCT02275013|Protective Agents|protective agents|mesh-ancestor
44535771|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535772|NCT02275039|Gemcitabine|gemcitabine|mesh-list
44535773|NCT02275039|Vaccines|vaccines|mesh-list
44535774|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
44535775|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535776|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535778|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535779|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535780|NCT02275039|Antiviral Agents|antiviral agents|mesh-ancestor
44535781|NCT02275039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535782|NCT02275039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535783|NCT02275039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535784|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
44535785|NCT02275130|Calcium|calcium|mesh-list
44535786|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44535787|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535788|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44535789|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
44535790|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44535791|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535792|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535793|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44535794|NCT02275182|Analgesics|analgesics|mesh-ancestor
44535795|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
44535796|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535797|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44535798|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44535799|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44535800|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44535801|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535802|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535803|NCT02275247|Ropivacaine|ropivacaine|mesh-list
44535804|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
44535805|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
44535806|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44535807|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535808|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
44535809|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535810|NCT02275299|Methotrexate|methotrexate|mesh-list
44535811|NCT02275299|Leflunomide|leflunomide|mesh-list
44535812|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44535813|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
44535814|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535815|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535816|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535817|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
44535818|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535819|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535820|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535821|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535822|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44535823|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535824|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
44535825|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535826|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44535827|NCT02275416|Ipilimumab|ipilimumab|mesh-list
44535828|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535829|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535830|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44535831|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535832|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44535833|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44535834|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535835|NCT02275663|Cytarabine|cytarabine|mesh-list
44535836|NCT02275663|Fludarabine|fludarabine|mesh-list
44535837|NCT02275663|Azacitidine|azacitidine|mesh-list
44535838|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535839|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44535840|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
44535841|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535842|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535843|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
44535844|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535845|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
43942556|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
44535847|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535848|NCT02275702|Dexamethasone|dexamethasone|mesh-list
44535849|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44535850|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
44535851|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
44535852|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535853|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535854|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44535855|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
44535856|NCT02275702|Hormones|hormones|mesh-ancestor
44535857|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535858|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44535859|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359286|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
44535860|NCT02275806|Cisplatin|cisplatin|mesh-list
44535861|NCT02275806|Irinotecan|irinotecan|mesh-list
44535862|NCT02275806|Camptothecin|camptothecin|mesh-list
44535863|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535864|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44535865|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44535866|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535867|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535868|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44535869|NCT02275832|Minoxidil|minoxidil|mesh-list
44535870|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44535871|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
44535872|NCT02275845|Metformin|metformin|mesh-list
44535873|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535874|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535875|NCT02275897|Methamphetamine|methamphetamine|mesh-list
44535876|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44535877|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535878|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
44535879|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
44535880|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535881|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
44535882|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44535883|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535884|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
44535885|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44535886|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44535887|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535888|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44535889|NCT02275962|Rifampin|rifampin|mesh-list
44535890|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44535891|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
44535892|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535893|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535894|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
44535895|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44535896|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535897|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535898|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44535899|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44535900|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44535901|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44535902|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44535903|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44535904|NCT02275975|Fluconazole|fluconazole|mesh-list
44535905|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
44535906|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535907|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44535908|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44535909|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535910|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535911|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44535912|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
44535913|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44535914|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535915|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43942635|NCT00993798|Bupivacaine|bupivacaine|mesh-list
44535916|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44535917|NCT02275988|Clarithromycin|clarithromycin|mesh-list
44535918|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44535919|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535920|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44535921|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535922|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535923|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44535924|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44535925|NCT02276001|Cyclosporine|cyclosporine|mesh-list
44535926|NCT02276001|Cyclosporins|cyclosporins|mesh-list
44535927|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44535928|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535929|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535930|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
44535931|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535932|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
44535933|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535934|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44535935|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535936|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44535937|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
44535938|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44535939|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
44535940|NCT02276196|Lixisenatide|lixisenatide|mesh-list
44535941|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535942|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535943|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
44535944|NCT02276300|Imiquimod|imiquimod|mesh-list
44535945|NCT02276300|Sargramostim|sargramostim|mesh-list
44535946|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44535947|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
44535948|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535949|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44535950|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44535951|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
44535952|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535953|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535954|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44535955|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44535956|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
44535957|NCT02276365|Pioglitazone|pioglitazone|mesh-list
44535958|NCT02276365|Empagliflozin|empagliflozin|mesh-list
44535959|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44535960|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535961|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44535962|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535963|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44535964|NCT02276378|Telmisartan|telmisartan|mesh-list
44535965|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44535966|NCT02276378|Diuretics|diuretics|mesh-ancestor
44535967|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
44535968|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535969|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44535970|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44535971|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535972|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44535973|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44535974|NCT02276391|Telmisartan|telmisartan|mesh-list
44535975|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44535976|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44535977|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44535978|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535979|NCT02276677|Oxytocin|oxytocin|mesh-list
44535980|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
44535981|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44535982|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535983|NCT02276690|Hepcidins|hepcidins|mesh-list
44535984|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44535985|NCT02276768|Trimebutine|trimebutine|mesh-list
44535986|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44535987|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
44535988|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
44535989|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44535990|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44535992|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44535993|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44535994|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44535995|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44535996|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44535997|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44535998|NCT02276859|Insulin|insulin|mesh-list
44535999|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44536000|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
44536001|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
44536002|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
44536003|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536004|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536005|NCT02276911|Ibuprofen|ibuprofen|mesh-list
44536006|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44536007|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536008|NCT02276911|Analgesics|analgesics|mesh-ancestor
44536009|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
44536010|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536011|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536012|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536013|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44536014|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44536015|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536016|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536018|NCT02276989|Quinine|quinine|mesh-list
44536019|NCT02276989|Acetazolamide|acetazolamide|mesh-list
44536020|NCT02276989|Vitamins|vitamins|mesh-ancestor
44536021|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
44536022|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536023|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
44536024|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44536025|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44536026|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
44536027|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44536028|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536029|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536030|NCT02276989|Diuretics|diuretics|mesh-ancestor
44536031|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
44536032|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
44536033|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44440131|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
44536034|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44536035|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536036|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44536037|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44536038|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536039|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536040|NCT02276989|Analgesics|analgesics|mesh-ancestor
44536041|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
44536042|NCT02277041|Misoprostol|misoprostol|mesh-list
44536043|NCT02277041|Carbetocin|carbetocin|mesh-list
44536044|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44536045|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
44536046|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44536047|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536048|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44536049|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536050|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
44536051|NCT02277067|Misoprostol|misoprostol|mesh-list
44536052|NCT02277067|Carbetocin|carbetocin|mesh-list
44536053|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44536054|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
44536055|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44536056|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536057|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44536058|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536059|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
44536060|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
44536061|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536062|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44536063|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44536064|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536065|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942804|NCT00997620|Xhance|xhance|mesh-list
44536066|NCT02277132|Urological Agents|urological agents|mesh-ancestor
44536067|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
44536068|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44536069|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
44536070|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536071|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440179|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
44536072|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44536073|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44536074|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44536075|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
44536076|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536077|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536078|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44536079|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536080|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
44536081|NCT02277171|Protective Agents|protective agents|mesh-ancestor
44536082|NCT02277184|Cisplatin|cisplatin|mesh-list
44536083|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536084|NCT02277197|Cetuximab|cetuximab|mesh-list
44536085|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44536086|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536087|NCT02277223|Curcumin|curcumin|mesh-list
44536088|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44536089|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536090|NCT02277223|Analgesics|analgesics|mesh-ancestor
44536091|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
44536092|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536093|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536094|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536095|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44536096|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536097|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536098|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536099|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44536100|NCT02277457|Crizotinib|crizotinib|mesh-list
44536101|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536102|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44536103|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536104|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536105|NCT02277600|Darunavir|darunavir|mesh-list
44536106|NCT02277600|Cobicistat|cobicistat|mesh-list
44536107|NCT02277600|Fostemsavir|fostemsavir|mesh-list
44536108|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44536109|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44536110|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536111|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536112|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536113|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44536114|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44536115|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
44536116|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536117|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44536118|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44536119|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44536120|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44536121|NCT02277678|Morphine|morphine|mesh-list
44536122|NCT02277678|Oxycodone|oxycodone|mesh-list
44536123|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
44536124|NCT02277678|Narcotics|narcotics|mesh-ancestor
44536125|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536126|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536127|NCT02277678|Analgesics|analgesics|mesh-ancestor
44536128|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
44536129|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536130|NCT02277717|Trastuzumab|trastuzumab|mesh-list
44536131|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44536132|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536133|NCT02277730|Phenylephrine|phenylephrine|mesh-list
44536134|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
44536135|NCT02277730|Ephedrine|ephedrine|mesh-list
44536136|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44536137|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44536138|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
44536139|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
44536140|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764372|NCT02420509|Leucovorin|leucovorin|mesh-list
44536141|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536142|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
44536143|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
44536144|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
44536145|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44536146|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44536147|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44536148|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
44536149|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536150|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536151|NCT02277730|Protective Agents|protective agents|mesh-ancestor
44536152|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44536153|NCT02277886|Esomeprazole|esomeprazole|mesh-list
44536154|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44536155|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536156|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44536157|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536158|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536169|NCT02278172|Vitamins|vitamins|mesh-list
44536170|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
44536171|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536172|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44536173|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44536174|NCT02278250|Carboplatin|carboplatin|mesh-list
44536175|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536176|NCT02278302|Ethanol|ethanol|mesh-list
44536177|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44536178|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44536179|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536180|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536181|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359660|NCT01132222|Ephedrine|ephedrine|mesh-list
44536182|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44536184|NCT02278419|Simeprevir|simeprevir|mesh-list
44536185|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
44536186|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536187|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536188|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536189|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536190|NCT02278458|Gemcitabine|gemcitabine|mesh-list
44536191|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44536192|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
44536193|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536194|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536195|NCT02278458|Antiviral Agents|antiviral agents|mesh-ancestor
44536196|NCT02278458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536197|NCT02278458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536198|NCT02278458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536199|NCT02278458|Immunologic Factors|immunologic factors|mesh-ancestor
44536200|NCT02278458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536201|NCT02278510|Topotecan|topotecan|mesh-list
44536202|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44536203|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44536204|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536205|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536206|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536207|NCT02278575|Antithrombins|antithrombins|mesh-list
44536208|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
44536209|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44536210|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536211|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536212|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536213|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
44536214|NCT02278588|Rasagiline|rasagiline|mesh-list
44536215|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44536216|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536217|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536218|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44536219|NCT02278588|Protective Agents|protective agents|mesh-ancestor
44536220|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536221|NCT02278861|Tretinoin|tretinoin|mesh-list
44536222|NCT02278861|Isotretinoin|isotretinoin|mesh-list
44536223|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
44536224|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
44536225|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536226|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
44536227|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44536228|NCT02278861|Protective Agents|protective agents|mesh-ancestor
44536229|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536230|NCT02278913|Insulin|insulin|mesh-list
44536231|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
44536232|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44536233|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536234|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536235|NCT02278926|Insulin|insulin|mesh-list
44536236|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536237|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536238|NCT02278978|Nintedanib|nintedanib|mesh-list
44536239|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536240|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44536241|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536242|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536243|NCT02279121|Taurolidine|taurolidine|mesh-list
44536244|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44536245|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536246|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44536247|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536248|NCT02279134|Paclitaxel|paclitaxel|mesh-list
44536249|NCT02279134|Cisplatin|cisplatin|mesh-list
44536250|NCT02279134|Nedaplatin|nedaplatin|mesh-list
44536251|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44536252|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536253|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
44536254|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
44536255|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
44536256|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536257|NCT02279147|Neostigmine|neostigmine|mesh-list
44536258|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44536259|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536260|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536261|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
44536262|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536263|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536264|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44536265|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
44536266|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536267|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
44536268|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44536269|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44536270|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536271|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
44536272|NCT02279186|Coagulants|coagulants|mesh-ancestor
44536273|NCT02279316|Vitamin D|vitamin d|mesh-list
44536274|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
44536275|NCT02279316|Vitamins|vitamins|mesh-ancestor
44536276|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
44536277|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536278|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44536279|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44536280|NCT02279342|Febuxostat|febuxostat|mesh-list
44536281|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
44536282|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44536283|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
44536284|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44536285|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536286|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
44536287|NCT02279511|Adenosine|adenosine|mesh-list
44536288|NCT02279511|Analgesics|analgesics|mesh-ancestor
44536289|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
44536290|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536291|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536292|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44536293|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536294|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44536295|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
44536296|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
44536297|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536298|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536299|NCT02279563|Fluticasone|fluticasone|mesh-list
44536300|NCT02279563|Xhance|xhance|mesh-list
44536301|NCT02279563|Azelastine|azelastine|mesh-list
44536302|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536303|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44536304|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
44536305|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536306|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536307|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44536308|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
44536309|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
44536310|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44536311|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44536312|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536313|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536314|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44536315|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44536316|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
44536317|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
44536318|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536319|NCT02279576|Paclitaxel|paclitaxel|mesh-list
44536320|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44536321|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44536322|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536323|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44536324|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44536325|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44536326|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536327|NCT02279615|Tamsulosin|tamsulosin|mesh-list
44536328|NCT02279615|Mirabegron|mirabegron|mesh-list
44536329|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44536330|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44536331|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44536332|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
44536333|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536334|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536335|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536336|NCT02279615|Urological Agents|urological agents|mesh-ancestor
44536337|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44536338|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44536339|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44536340|NCT02279628|Morphine|morphine|mesh-list
44536341|NCT02279628|Ropivacaine|ropivacaine|mesh-list
44536342|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44536343|NCT02279628|Narcotics|narcotics|mesh-ancestor
44536344|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536345|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536346|NCT02279628|Analgesics|analgesics|mesh-ancestor
44536347|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
44536348|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536349|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
44536350|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
44536351|NCT02279758|Metformin|metformin|mesh-list
44536352|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536353|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536354|NCT02279875|Rifampin|rifampin|mesh-list
44536355|NCT02279875|Isoniazid|isoniazid|mesh-list
44536356|NCT02279875|Linezolid|linezolid|mesh-list
44536357|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
44536358|NCT02279875|Ethambutol|ethambutol|mesh-list
44536359|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44536360|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
44536361|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44536362|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536363|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
44536364|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44536365|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536366|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536367|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44536368|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44536369|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44536370|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44536371|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44536372|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44536373|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44536374|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44536375|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
44536376|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44536377|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44536378|NCT02279914|Misoprostol|misoprostol|mesh-list
44536379|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44536380|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
44536381|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44536382|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536383|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44536384|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536385|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
44536386|NCT02279966|Vortioxetine|vortioxetine|mesh-list
44536388|NCT02279966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44536389|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44536390|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44536391|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536392|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536393|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
44536394|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536395|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44536396|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
44536397|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536398|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44536399|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44536400|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536401|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44536402|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536403|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536404|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44536405|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44536406|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44536407|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44536408|NCT02279992|Carboplatin|carboplatin|mesh-list
44536409|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44536410|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536411|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536412|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44536413|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44536414|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536415|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536416|NCT02279992|Urological Agents|urological agents|mesh-ancestor
44536418|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536419|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536420|NCT02274571|Estrogens|estrogens|mesh-list
44536421|NCT02274571|Hormones|hormones|mesh-ancestor
44536422|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536423|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536424|NCT02278315|Dexamethasone|dexamethasone|mesh-list
44536425|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536426|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
44536427|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
44536428|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536429|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536430|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536431|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
44536432|NCT02278315|Hormones|hormones|mesh-ancestor
44536433|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536434|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44440521|NCT01919229|Letrozole|letrozole|mesh-list
44536435|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536436|NCT02271919|Nicotine|nicotine|mesh-list
44536437|NCT02271919|Varenicline|varenicline|mesh-list
44536438|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44536439|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
44536440|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536441|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536442|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44536443|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44536444|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
44536445|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536446|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536447|NCT02277106|Brexanolone|brexanolone|mesh-list
44536448|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
44536449|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536450|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536451|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536469|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44536471|NCT02271503|Levodopa|levodopa|mesh-list
44536472|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44536473|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
44536474|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536475|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44536476|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44536477|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
44536478|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
44536479|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536480|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536481|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44536482|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536483|NCT02271334|Albuterol|albuterol|mesh-list
44536484|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44536485|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
44536486|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536487|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536488|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44536489|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
44536490|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
44536491|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44536492|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44536493|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44536494|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44536495|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440572|NCT01917656|Metformin|metformin|mesh-list
44536496|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536497|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536516|NCT02276755|Vitamin D|vitamin d|mesh-list
44536517|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
44536518|NCT02276755|Vitamins|vitamins|mesh-ancestor
44536519|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
44536520|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536521|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44536522|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44536523|NCT02270957|Abatacept|abatacept|mesh-list
44536524|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44536525|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536526|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536527|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536528|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
44536529|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536530|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44536531|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
44536532|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
44536533|NCT02271997|Trace Elements|trace elements|mesh-ancestor
44536534|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
44536535|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536537|NCT02273765|Tenofovir|tenofovir|mesh-list
44536538|NCT02273765|Lamivudine|lamivudine|mesh-list
44536539|NCT02273765|Efavirenz|efavirenz|mesh-list
44536540|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
44536541|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
44536542|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536543|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44536544|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44536545|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536554|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44536555|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44536556|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44536558|NCT02279394|Lenalidomide|lenalidomide|mesh-list
44536559|NCT02279394|Elotuzumab|elotuzumab|mesh-list
44536560|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536561|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
44536562|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
44536563|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536564|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536565|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44536566|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
44536567|NCT02279394|Hormones|hormones|mesh-ancestor
44536568|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536569|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44536570|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536571|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
44536572|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44536573|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44536574|NCT02279394|Growth Substances|growth substances|mesh-ancestor
44536575|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
44536576|NCT02484924|Clopidogrel|clopidogrel|mesh-list
44536577|NCT02484924|Ticagrelor|ticagrelor|mesh-list
44536578|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44536579|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44536580|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44536581|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44536582|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
44536583|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536584|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536585|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536586|NCT02486718|Gemcitabine|gemcitabine|mesh-list
44536587|NCT02486718|Cisplatin|cisplatin|mesh-list
44536588|NCT02486718|Docetaxel|docetaxel|mesh-list
44536589|NCT02486718|Pemetrexed|pemetrexed|mesh-list
44536590|NCT02486718|Atezolizumab|atezolizumab|mesh-list
44536591|NCT02486718|Vinorelbine|vinorelbine|mesh-list
44536592|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536593|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44536594|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
44536595|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536596|NCT02486718|Antiviral Agents|antiviral agents|mesh-ancestor
44536597|NCT02486718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536598|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536599|NCT02486718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536600|NCT02486718|Immunologic Factors|immunologic factors|mesh-ancestor
44536601|NCT02486718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536602|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
44536603|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
44536604|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
44536605|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44536606|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44536607|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44536608|NCT02482753|Exemestane|exemestane|mesh-list
44536609|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536610|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44536611|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44536612|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536613|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536614|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44536615|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
44536616|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536617|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536619|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44536620|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536621|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536622|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44536623|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
44536624|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
44536625|NCT02488408|Cytarabine|cytarabine|mesh-list
44536626|NCT02488408|Decitabine|decitabine|mesh-list
44536627|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44536628|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
44536629|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536630|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536631|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
44536632|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536633|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536634|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
44536635|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536636|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536637|NCT02489006|Olaparib|olaparib|mesh-list
44536638|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44536639|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536640|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536641|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536642|NCT02483260|Ribavirin|ribavirin|mesh-list
44536643|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
44536644|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536645|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
44536646|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536647|NCT02483247|Paclitaxel|paclitaxel|mesh-list
44536648|NCT02483247|Doxorubicin|doxorubicin|mesh-list
44536649|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
44536650|NCT02483247|Capecitabine|capecitabine|mesh-list
44536651|NCT02483247|Nivolumab|nivolumab|mesh-list
44536652|NCT02483247|Sunitinib|sunitinib|mesh-list
44536653|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44536654|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536655|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
44536656|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
44536657|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
44536658|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536659|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44536660|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44536661|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44536662|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536663|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440700|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536664|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44536665|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
44536666|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44536667|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44536668|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44536669|NCT02483247|Growth Substances|growth substances|mesh-ancestor
44536670|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536671|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
44536672|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44536673|NCT02482233|Nicotine|nicotine|mesh-list
44536674|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44536675|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
44536676|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536677|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536678|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44536679|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44536680|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44536681|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536682|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536683|NCT02484664|Celecoxib|celecoxib|mesh-list
44536684|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44536685|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536686|NCT02484664|Analgesics|analgesics|mesh-ancestor
44536687|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
44536688|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536689|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536690|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44536691|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44536692|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44536693|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44536694|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536695|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536696|NCT02489942|Empagliflozin|empagliflozin|mesh-list
44536697|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44536698|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536699|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536700|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536701|NCT02486367|Clopidogrel|clopidogrel|mesh-list
44536702|NCT02486367|Ticagrelor|ticagrelor|mesh-list
44536703|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44536704|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44536705|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44536706|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44536707|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
44536708|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536709|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536710|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536711|NCT01580033|Vaccines|vaccines|mesh-list
44536712|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
44536713|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536714|NCT01580163|Methadone|methadone|mesh-list
44536715|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44536716|NCT01580163|Narcotics|narcotics|mesh-ancestor
44536717|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536718|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360166|NCT01134484|Hormones|hormones|mesh-ancestor
44536719|NCT01580163|Analgesics|analgesics|mesh-ancestor
44536720|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
44536721|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536722|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
44536723|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
44536724|NCT01580202|Lamivudine|lamivudine|mesh-list
44536725|NCT01580202|Entecavir|entecavir|mesh-list
44536726|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44536727|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44536728|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536729|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536730|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
44536731|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536732|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44536733|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44536734|NCT01580254|Latanoprost|latanoprost|mesh-list
44536735|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44536736|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44536737|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44536738|NCT01580371|CKD-581|ckd-581|mesh-list
44536739|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536740|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536741|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
44536742|NCT01580501|Tadalafil|tadalafil|mesh-list
44536743|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
44536744|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44536745|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44536746|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536747|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536748|NCT01580501|Urological Agents|urological agents|mesh-ancestor
44536749|NCT01580514|Exenatide|exenatide|mesh-list
44536750|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536751|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536752|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44536753|NCT01580514|Incretins|incretins|mesh-ancestor
44536754|NCT01580514|Hormones|hormones|mesh-ancestor
44536755|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536756|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
44536757|NCT01580683|Vitamins|vitamins|mesh-ancestor
44536758|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
44536759|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536760|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
44536761|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536762|NCT01580683|Protective Agents|protective agents|mesh-ancestor
44536763|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44536764|NCT01580839|Plasminogen|plasminogen|mesh-list
44536765|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44536766|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44536767|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536768|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
44536769|NCT01580865|Tacrolimus|tacrolimus|mesh-list
44536770|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536771|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
44536772|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536773|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44536774|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536775|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536776|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44536777|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536778|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44536779|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
44536780|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44536781|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536782|NCT01580878|Butenafine|butenafine|mesh-list
44536783|NCT01580878|Clotrimazole|clotrimazole|mesh-list
44536784|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
44536785|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536786|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44440818|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44536787|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44536788|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44536789|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536790|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536791|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44536792|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
44360252|NCT01134848|Hormones|hormones|mesh-ancestor
44536793|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536794|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536795|NCT01580891|Naftifine|naftifine|mesh-list
44536796|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
44536797|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536816|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536818|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536819|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44536820|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44536821|NCT01581151|Growth Substances|growth substances|mesh-ancestor
44536822|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
44536823|NCT01581164|Vaccines|vaccines|mesh-list
44536824|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
44536825|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536826|NCT01581242|Adefovir|adefovir|mesh-list
44536827|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44536828|NCT01581242|Clevudine|clevudine|mesh-list
44536829|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
44536830|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536831|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44536832|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44536833|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536834|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536835|NCT01581320|Vitamin D|vitamin d|mesh-list
44536836|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
44536837|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
44536838|NCT01581320|Vitamins|vitamins|mesh-ancestor
44536839|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
44536840|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536841|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44536842|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44536843|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44536844|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
44536845|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
44536846|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536847|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
44536848|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536850|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44536851|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44536852|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44536853|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536854|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
44536855|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44536856|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
44536857|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
44536858|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536859|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536860|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536861|NCT01581450|Analgesics|analgesics|mesh-ancestor
44536862|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
44536863|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536864|NCT01581515|Everolimus|everolimus|mesh-list
44536865|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536866|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44536867|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
44536868|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536869|NCT01581736|Insulin|insulin|mesh-list
44536870|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44536871|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536872|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536873|NCT01581775|Valproic Acid|valproic acid|mesh-list
44536874|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
44536875|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536876|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536877|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
44536878|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536879|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536880|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
44536881|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536882|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536883|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536884|NCT01581788|Valproic Acid|valproic acid|mesh-list
44536885|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
44536886|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536887|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536888|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
44536889|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536890|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536891|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
44536892|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536893|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536894|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536895|NCT01581814|Metformin|metformin|mesh-list
44536896|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44536897|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44536898|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536899|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536900|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44536901|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44536902|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44536903|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44536904|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
44536905|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44536906|NCT01581814|Estrogens|estrogens|mesh-ancestor
44536907|NCT01581814|Hormones|hormones|mesh-ancestor
44536908|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536909|NCT01581853|Ritonavir|ritonavir|mesh-list
44536910|NCT01581853|Lopinavir|lopinavir|mesh-list
44536911|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44536912|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44536913|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536914|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536915|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536916|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44536917|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44536918|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
44536919|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44536920|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44536921|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44536922|NCT01581866|Ziprasidone|ziprasidone|mesh-list
44536923|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44536924|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
44536925|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536926|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536927|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536928|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44536929|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536930|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536931|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536932|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44440970|NCT01910519|Vaccines|vaccines|mesh-list
44536933|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
44536934|NCT01581879|Ziprasidone|ziprasidone|mesh-list
44536935|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44536936|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
44536937|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44536938|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536939|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536940|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44536941|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536942|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536943|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536944|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44536945|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
44536946|NCT01581918|Carbamazepine|carbamazepine|mesh-list
44536947|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
44536948|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
44536949|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44536950|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536951|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536952|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44536953|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44536954|NCT01581918|Analgesics|analgesics|mesh-ancestor
44536955|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
44536956|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536957|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44536958|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44536959|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536960|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44536961|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44536962|NCT01581944|Goserelin|goserelin|mesh-list
44536963|NCT01581944|Hormones|hormones|mesh-list
44536964|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44536965|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536966|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44536967|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44536968|NCT01582022|Bupivacaine|bupivacaine|mesh-list
44536969|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
44536970|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
44536971|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44536972|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536973|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
44536974|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44536975|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44536976|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
44536977|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44536978|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44536979|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44536980|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
44536981|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536982|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44536983|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44536984|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536985|NCT01582230|Vildagliptin|vildagliptin|mesh-list
44536986|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44536987|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44536988|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44536989|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
44536990|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536991|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536992|NCT01582412|Isavuconazole|isavuconazole|mesh-list
44536993|NCT01582412|Digoxin|digoxin|mesh-list
44536994|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44536995|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44536996|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44536997|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44536998|NCT01582412|Protective Agents|protective agents|mesh-ancestor
44536999|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537000|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
44537001|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537002|NCT01582425|Isavuconazole|isavuconazole|mesh-list
44537004|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537005|NCT01582425|Narcotics|narcotics|mesh-ancestor
44537006|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537007|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537008|NCT01582425|Analgesics|analgesics|mesh-ancestor
44537009|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
44537010|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537011|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
44537012|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537013|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
44537014|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537015|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44537016|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
44537017|NCT01582542|Coagulants|coagulants|mesh-ancestor
44537018|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44537019|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
44537020|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537021|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
44537022|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44537023|NCT01582555|Antidotes|antidotes|mesh-ancestor
44537024|NCT01582555|Protective Agents|protective agents|mesh-ancestor
44537025|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537026|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
44537027|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537028|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
44537029|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537030|NCT01582555|Expectorants|expectorants|mesh-ancestor
44537031|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537032|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44537033|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
44537034|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537035|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
44537036|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537037|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537038|NCT01582607|Fentanyl|fentanyl|mesh-list
44537039|NCT01582607|Bupivacaine|bupivacaine|mesh-list
44537040|NCT01582607|Ropivacaine|ropivacaine|mesh-list
44537041|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
44537042|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
44537043|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
44537044|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537045|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537046|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
44537047|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537048|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537049|NCT01582607|Narcotics|narcotics|mesh-ancestor
44537050|NCT01582607|Analgesics|analgesics|mesh-ancestor
44537051|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44537052|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44537053|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
44537054|NCT01582646|Terbutaline|terbutaline|mesh-list
44537055|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44537056|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
44537057|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537058|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537059|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44537060|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537061|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
44537062|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
44537063|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44537064|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44537065|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44537066|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44537067|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537068|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537069|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537070|NCT01582672|Sunitinib|sunitinib|mesh-list
44537071|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537082|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
44537083|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44537084|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537085|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537086|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537087|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
44537088|NCT01582932|Calcipotriene|calcipotriene|mesh-list
44537089|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
44537090|NCT01582997|Dabrafenib|dabrafenib|mesh-list
44537091|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537092|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44537093|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537094|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537095|NCT01583023|Bupropion|bupropion|mesh-list
44537096|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44537097|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
44537098|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537099|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44537100|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44537101|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537102|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537103|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
44537104|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537105|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537106|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44537107|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44537108|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537109|NCT01583036|Digoxin|digoxin|mesh-list
44537110|NCT01583036|Ezogabine|ezogabine|mesh-list
44537111|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44537112|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44537113|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537114|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537115|NCT01583036|Protective Agents|protective agents|mesh-ancestor
44537116|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537117|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
44537118|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537119|NCT01583114|Perindopril|perindopril|mesh-list
44537120|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44537121|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537122|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537123|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537124|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360668|NCT01137591|Acetaminophen|acetaminophen|mesh-list
44537126|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44537127|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441123|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
44537128|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537129|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537130|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
44537131|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537132|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537133|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
44537134|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537135|NCT01583439|Ritonavir|ritonavir|mesh-list
44537136|NCT01583439|Lopinavir|lopinavir|mesh-list
44537137|NCT01583439|Tenofovir|tenofovir|mesh-list
44537138|NCT01583439|Lamivudine|lamivudine|mesh-list
44537139|NCT01583439|Zidovudine|zidovudine|mesh-list
44537140|NCT01583439|Emtricitabine|emtricitabine|mesh-list
44537141|NCT01583439|Efavirenz|efavirenz|mesh-list
44537142|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44537143|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44537144|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44537145|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537146|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537147|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537148|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44537149|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
44537150|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537151|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44537152|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44537153|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44537154|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44537155|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
44537156|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44537157|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44537158|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44537159|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44537160|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44537161|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44537162|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44537163|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537164|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537165|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44537166|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537167|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537168|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537169|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537170|NCT01583504|Anesthetics|anesthetics|mesh-list
44537171|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
44537172|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537173|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537174|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
44537175|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537176|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
44537177|NCT01583621|Vitamin D|vitamin d|mesh-list
44537178|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44537179|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537180|NCT01583621|Vitamins|vitamins|mesh-ancestor
44537181|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
44537182|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44537183|NCT01583660|Acetaminophen|acetaminophen|mesh-list
44537184|NCT01583660|Celecoxib|celecoxib|mesh-list
44537185|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44537186|NCT01583660|Oxycodone|oxycodone|mesh-list
44537187|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537188|NCT01583660|Analgesics|analgesics|mesh-ancestor
44537189|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
44537190|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537191|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537192|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
44537193|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537194|NCT01583660|Narcotics|narcotics|mesh-ancestor
44537195|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537196|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44537197|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537198|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537199|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44537200|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44537201|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537202|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537203|NCT01583777|Belinostat|belinostat|mesh-list
44537204|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537205|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44537206|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537207|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537208|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44537209|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537210|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537211|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537212|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44537213|NCT01583959|Folic Acid|folic acid|mesh-list
44537214|NCT01583959|Hematinics|hematinics|mesh-ancestor
44537215|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
44537216|NCT01583959|Vitamins|vitamins|mesh-ancestor
44537217|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
44537218|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537219|NCT01584050|Folic Acid|folic acid|mesh-list
44537220|NCT01584050|Hematinics|hematinics|mesh-ancestor
44537221|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
44537222|NCT01584050|Vitamins|vitamins|mesh-ancestor
44537223|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
44537224|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537225|NCT01584076|Donepezil|donepezil|mesh-list
44537226|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44537227|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537228|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537229|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537230|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537231|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537232|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
44537233|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
44537234|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44537235|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
44537236|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537237|NCT01584206|Ezetimibe|ezetimibe|mesh-list
44537238|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44537239|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44537240|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
44537241|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537242|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44537243|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44537244|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
44537245|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537246|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44537247|NCT01584297|Ketoconazole|ketoconazole|mesh-list
44537248|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
44537249|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537250|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44537251|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44537252|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537253|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537254|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44537255|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
44537256|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537257|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537258|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44537259|NCT01584492|Beclomethasone|beclomethasone|mesh-list
44537261|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
44537262|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44537263|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
44537264|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537265|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537266|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44537267|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537268|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44537269|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44537270|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44537271|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537272|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537273|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537274|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537275|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
44537276|NCT01584492|Hormones|hormones|mesh-ancestor
44537277|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537278|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
44537279|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44537280|NCT01584687|Omalizumab|omalizumab|mesh-list
44537281|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44537282|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44537283|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537284|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
44537285|NCT01584726|Analgesics|analgesics|mesh-ancestor
44537286|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
44537287|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537288|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537289|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
44537290|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537291|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44537292|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
44537293|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44537294|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537295|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537296|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44537297|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
44537298|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44537299|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
44537300|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
44537301|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537302|NCT01584791|Aspirin|aspirin|mesh-list
44537303|NCT01584791|Clopidogrel|clopidogrel|mesh-list
44537304|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44537305|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537306|NCT01584791|Analgesics|analgesics|mesh-ancestor
44537307|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
44537308|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537309|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537310|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537311|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537312|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44537313|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44537314|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537315|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44537316|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44537317|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537318|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
44537319|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44537320|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44537321|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44537322|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
44537323|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537324|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
44537325|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
44537326|NCT01584947|Bupivacaine|bupivacaine|mesh-list
44537327|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44537328|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
44537329|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537330|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537331|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
44537332|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537334|NCT01585051|Vitamins|vitamins|mesh-ancestor
44537335|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
44537336|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537337|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44537348|NCT01585415|Vemurafenib|vemurafenib|mesh-list
44537349|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537350|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
44537351|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537352|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537353|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44537354|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
44537355|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537356|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537357|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44537358|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44537359|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44537360|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
44537361|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537362|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44537363|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537364|NCT01585623|Metoprolol|metoprolol|mesh-list
44537365|NCT01585623|Midazolam|midazolam|mesh-list
44537366|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44537367|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44537368|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537369|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537370|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44537371|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44537372|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537373|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44537374|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
44537375|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
44537376|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
44537377|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
44537378|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537379|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537380|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44537381|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44537382|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
44537383|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
44537384|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537385|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44537386|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44537387|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44537388|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537389|NCT01585753|Maraviroc|maraviroc|mesh-list
44537390|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44537391|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44537392|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537393|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44537394|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44537395|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
44537396|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537397|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44537398|NCT01585792|Glimepiride|glimepiride|mesh-list
44537399|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44537400|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44537401|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537402|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537403|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
44537404|NCT01585870|Sorafenib|sorafenib|mesh-list
44537405|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537406|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44537407|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537408|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537409|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
44537410|NCT01586052|Hematinics|hematinics|mesh-ancestor
44537411|NCT01586117|Amifostine|amifostine|mesh-list
44537412|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44537413|NCT01586117|Protective Agents|protective agents|mesh-ancestor
44537414|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537415|NCT01586143|Acetaminophen|acetaminophen|mesh-list
44537416|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537417|NCT01586143|Analgesics|analgesics|mesh-ancestor
44537418|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
44537419|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537420|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537421|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
44537422|NCT01586169|Azithromycin|azithromycin|mesh-list
44537423|NCT01586169|Ivermectin|ivermectin|mesh-list
44537424|NCT01586169|Albendazole|albendazole|mesh-list
44537425|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44537426|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537427|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44537428|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
44537429|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
44537430|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44537431|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44537432|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
44537433|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
44537434|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
44537435|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537436|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537437|NCT01586208|Phenytoin|phenytoin|mesh-list
44537438|NCT01586208|Valproic Acid|valproic acid|mesh-list
44537439|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
44537440|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537441|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537442|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
44537443|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537444|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360973|NCT01139645|Esomeprazole|esomeprazole|mesh-list
44537445|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
44537446|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44537447|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537448|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537449|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44537450|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44537451|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537452|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44537453|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44537454|NCT01586286|Nifedipine|nifedipine|mesh-list
44537455|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44537456|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537457|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537458|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44537459|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537460|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
44537461|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
44537462|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44537463|NCT01586299|Acetaminophen|acetaminophen|mesh-list
44537464|NCT01586299|Ibuprofen|ibuprofen|mesh-list
44537465|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537466|NCT01586299|Analgesics|analgesics|mesh-ancestor
44537467|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
44537468|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537469|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537470|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
44537471|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44537472|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537474|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44537475|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537476|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537477|NCT01586494|Tramadol|tramadol|mesh-list
44537478|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537479|NCT01586494|Narcotics|narcotics|mesh-ancestor
44537480|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537481|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537482|NCT01586494|Analgesics|analgesics|mesh-ancestor
44537483|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
44537484|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537485|NCT01586507|Tramadol|tramadol|mesh-list
44537486|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537487|NCT01586507|Narcotics|narcotics|mesh-ancestor
44537488|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537489|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537490|NCT01586507|Analgesics|analgesics|mesh-ancestor
44537491|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
44537492|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537493|NCT01586533|Mesalamine|mesalamine|mesh-list
44537494|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44537495|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537496|NCT01586533|Analgesics|analgesics|mesh-ancestor
44537497|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
44537498|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537499|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537500|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537501|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537502|NCT01586572|Vaccines|vaccines|mesh-list
44537503|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
44537504|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537505|NCT01586611|Leucovorin|leucovorin|mesh-list
44537506|NCT01586611|Gemcitabine|gemcitabine|mesh-list
44537507|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
44537508|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44537509|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
44537510|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537511|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537512|NCT01586611|Antiviral Agents|antiviral agents|mesh-ancestor
44537513|NCT01586611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537514|NCT01586611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537515|NCT01586611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537516|NCT01586611|Immunologic Factors|immunologic factors|mesh-ancestor
44537517|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537518|NCT01586611|Antidotes|antidotes|mesh-ancestor
44537519|NCT01586611|Protective Agents|protective agents|mesh-ancestor
44537520|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
44537521|NCT01586611|Vitamins|vitamins|mesh-ancestor
44537523|NCT01587066|Valproic Acid|valproic acid|mesh-list
44537524|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44537525|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
44537526|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537527|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44537528|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44537529|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537530|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537531|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
44537532|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537533|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537534|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
44537535|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537536|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
44537537|NCT01587196|Naltrexone|naltrexone|mesh-list
44537538|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44537539|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44537540|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537541|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
44537542|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537543|NCT01587222|Octreotide|octreotide|mesh-list
44537544|NCT01587222|Midodrine|midodrine|mesh-list
44537545|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44537546|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44537547|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537548|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
44537549|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
44537550|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441529|NCT01900431|Folic Acid|folic acid|mesh-list
44537551|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537552|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44537553|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44537554|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44537555|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44537556|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537557|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537558|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537559|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
44537560|NCT01587261|Vitamins|vitamins|mesh-ancestor
44537561|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
44537562|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537563|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
44537564|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537565|NCT01587261|Protective Agents|protective agents|mesh-ancestor
44537566|NCT01587313|Hydralazine|hydralazine|mesh-list
44537567|NCT01587313|Isosorbide|isosorbide|mesh-list
44537568|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44537569|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44537570|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44537571|NCT01587313|Diuretics|diuretics|mesh-ancestor
44537572|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
44537573|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537574|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
44537575|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44537576|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537577|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44537578|NCT01587326|Citalopram|citalopram|mesh-list
44537579|NCT01587326|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44537580|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44537581|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537582|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537583|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537584|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
44537585|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537586|NCT01587326|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44537587|NCT01587326|Antidepressive Agents|antidepressive agents|mesh-ancestor
44537588|NCT01587326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537589|NCT01587430|Cytarabine|cytarabine|mesh-list
44537590|NCT01587430|Daunorubicin|daunorubicin|mesh-list
44537591|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
44537592|NCT01587430|Idarubicin|idarubicin|mesh-list
44537593|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44537594|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
44537595|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537596|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537597|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
44537598|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537599|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44537600|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
44537601|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537602|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44537603|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44537604|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44537605|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537606|NCT01587430|Analgesics|analgesics|mesh-ancestor
44537607|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
44537608|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537609|NCT01587495|Ertapenem|ertapenem|mesh-list
44537610|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44537611|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537612|NCT01587508|Meloxicam|meloxicam|mesh-list
44537613|NCT01587508|Amitriptyline|amitriptyline|mesh-list
44537614|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
44537615|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44537616|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44537617|NCT01587508|Analgesics|analgesics|mesh-ancestor
44537618|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
44537619|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537620|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537621|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537622|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44537623|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44537624|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44537625|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426835|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537626|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537627|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44537628|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
44537629|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537630|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44537631|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44537632|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44537633|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537634|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44537635|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44537636|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537637|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537638|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537639|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44537640|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
44537641|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537654|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
44537655|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537656|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537657|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
44537658|NCT01587638|Protective Agents|protective agents|mesh-ancestor
44537659|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44537660|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537661|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44537662|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
44537663|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44537664|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44537665|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
44537666|NCT01587729|Serotonin|serotonin|mesh-list
44537667|NCT01587729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44537668|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537669|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44537670|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
44537671|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537672|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537673|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537674|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44537675|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537676|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44537677|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537678|NCT01587807|Dimercaprol|dimercaprol|mesh-list
44537679|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
44537680|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
44537681|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537682|NCT01588002|Ritonavir|ritonavir|mesh-list
44537683|NCT01588002|Efavirenz|efavirenz|mesh-list
44537684|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44537685|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44537686|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537687|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441658|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537688|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537689|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44537690|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44537691|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
44537692|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537693|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44537694|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44537695|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44537696|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44537697|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44537698|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44537699|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44537700|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44537701|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44537702|NCT01588093|Mecasermin|mecasermin|mesh-list
44537703|NCT01588093|Growth Substances|growth substances|mesh-ancestor
44537704|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537705|NCT01588314|Gabapentin|gabapentin|mesh-list
44537706|NCT01588314|Analgesics|analgesics|mesh-ancestor
44537707|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
44537708|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537709|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537710|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
44537711|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44537712|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44537713|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537714|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44537715|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44537716|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44537717|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537718|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537719|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
44537720|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44537721|NCT01588587|Vildagliptin|vildagliptin|mesh-list
44537722|NCT01588587|Alogliptin|alogliptin|mesh-list
44537723|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44537724|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537725|NCT01588587|Incretins|incretins|mesh-ancestor
44537726|NCT01588587|Hormones|hormones|mesh-ancestor
44441697|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44537727|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537728|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44537729|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537730|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537731|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537732|NCT01588626|Ticagrelor|ticagrelor|mesh-list
44537733|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44537734|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44537735|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44537736|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44537737|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
44537738|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537739|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537740|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537741|NCT01588639|Insulin|insulin|mesh-list
44537742|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44537743|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44537744|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537745|NCT01588704|Bevacizumab|bevacizumab|mesh-list
44537746|NCT01588704|Pemetrexed|pemetrexed|mesh-list
44537747|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44537748|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537749|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44537750|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44537751|NCT01588704|Growth Substances|growth substances|mesh-ancestor
44537752|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537753|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
44537754|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537755|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537756|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44537757|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44537758|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
44537759|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44537760|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44537761|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44361329|NCT01141439|Xhance|xhance|mesh-list
44537762|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537763|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537764|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537765|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537766|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
44537767|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44537768|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537769|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
44537770|NCT01588756|Goralatide|goralatide|mesh-list
44537771|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
44537772|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537773|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44537774|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537775|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44537776|NCT01588756|Growth Substances|growth substances|mesh-ancestor
44537777|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537778|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44537779|NCT01588756|Protective Agents|protective agents|mesh-ancestor
44537780|NCT01588782|Ketoconazole|ketoconazole|mesh-list
44537781|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
44537782|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537783|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44537784|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44537785|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537786|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537787|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44537788|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
44537789|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537790|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537791|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44537792|NCT01588795|Vitamin D|vitamin d|mesh-list
44537793|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
44537794|NCT01588795|Diuretics|diuretics|mesh-list
44537795|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44537796|NCT01588795|Vitamins|vitamins|mesh-ancestor
44537797|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
44537798|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537799|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44537800|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44537801|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
44537802|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537803|NCT01588847|Sufentanil|sufentanil|mesh-list
44537804|NCT01588847|Bupivacaine|bupivacaine|mesh-list
44537805|NCT01588847|Anesthetics|anesthetics|mesh-list
44537806|NCT01588847|Propofol|propofol|mesh-list
44537807|NCT01588847|Sevoflurane|sevoflurane|mesh-list
44537808|NCT01588847|Rocuronium|rocuronium|mesh-list
44537809|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44537810|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44537811|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537812|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
44537813|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537814|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44441791|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
44537815|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44537816|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
44537817|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44537818|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44537819|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44537820|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44537821|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44537822|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44537823|NCT01588847|Narcotics|narcotics|mesh-ancestor
44537824|NCT01588847|Analgesics|analgesics|mesh-ancestor
44537825|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44537826|NCT01588912|Tenofovir|tenofovir|mesh-list
44537827|NCT01588912|Entecavir|entecavir|mesh-list
44537828|NCT01588912|Telbivudine|telbivudine|mesh-list
44537829|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
44537830|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537831|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44537832|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44537833|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537834|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537835|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44537836|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44537837|NCT01588925|Dexamethasone|dexamethasone|mesh-list
44537838|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
44537839|NCT01588925|BB 1101|bb 1101|mesh-list
44537840|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
44537841|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537842|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
44537843|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
44537844|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537845|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537846|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44537847|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
44537848|NCT01588925|Hormones|hormones|mesh-ancestor
44537849|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537850|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44537851|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537852|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
44537853|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537854|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537855|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44537856|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
44537857|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
44537858|NCT01588925|Protective Agents|protective agents|mesh-ancestor
44537860|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44537861|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
44537862|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537863|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537864|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44537865|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44537866|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537867|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537868|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537869|NCT01589068|Nicotine|nicotine|mesh-list
44537870|NCT01589068|Progesterone|progesterone|mesh-list
44537871|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44537872|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
44537873|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537874|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537875|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44537876|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44537877|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537878|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537879|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537880|NCT01589068|Progestins|progestins|mesh-ancestor
44537881|NCT01589068|Hormones|hormones|mesh-ancestor
44537882|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537883|NCT01589081|Nicotine|nicotine|mesh-list
44537884|NCT01589081|Progesterone|progesterone|mesh-list
44537885|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44537886|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
44537887|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537888|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537889|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44537890|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44537891|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537892|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537893|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537894|NCT01589081|Progestins|progestins|mesh-ancestor
44537895|NCT01589081|Hormones|hormones|mesh-ancestor
44537896|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537897|NCT01589146|Heparin|heparin|mesh-list
44537898|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44537899|NCT01589146|Tinzaparin|tinzaparin|mesh-list
44537900|NCT01589146|Dalteparin|dalteparin|mesh-list
44537901|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
44537902|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44537903|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44537904|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537905|NCT01589159|Capecitabine|capecitabine|mesh-list
44537906|NCT01589159|Etoposide|etoposide|mesh-list
44537907|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44537908|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
44537909|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537910|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537911|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44537912|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44537919|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537920|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
44537921|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537923|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
44537924|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44537925|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44537926|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537927|NCT01589419|Capecitabine|capecitabine|mesh-list
44537928|NCT01589419|Veliparib|veliparib|mesh-list
44537929|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44537930|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
44537931|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944346|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
44537932|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537933|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44537934|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44537935|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
44537936|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44537937|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44537938|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44537939|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44537940|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537941|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
44537942|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44537943|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537944|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44537945|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537946|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
44537947|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44537948|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
44537949|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
44537950|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44537951|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537952|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44537953|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
44537955|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44537956|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44537957|NCT01589549|Protective Agents|protective agents|mesh-ancestor
44537958|NCT01589562|Megestrol|megestrol|mesh-list
44537959|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
44537960|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44537961|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44537962|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44537963|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
44441921|NCT01894256|Olaparib|olaparib|mesh-list
44537964|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44537965|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44537966|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44537967|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44537968|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44537969|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537970|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
44537971|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44537972|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44537973|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
44537974|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44537975|NCT01589744|Hemostatics|hemostatics|mesh-list
44537976|NCT01589744|Coagulants|coagulants|mesh-ancestor
44537977|NCT01589809|Niacinamide|niacinamide|mesh-list
44537978|NCT01589809|Niacin|niacin|mesh-list
44537979|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
44537980|NCT01589809|Vitamins|vitamins|mesh-ancestor
44537981|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
44361563|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
44537983|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
44537984|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44537985|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
44537986|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44537987|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44537988|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
44537990|NCT01589952|Entecavir|entecavir|mesh-list
44537991|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44537992|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
44537993|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44537994|NCT01588431|Bevacizumab|bevacizumab|mesh-list
44537995|NCT01588431|Cetuximab|cetuximab|mesh-list
44537996|NCT01588431|Cisplatin|cisplatin|mesh-list
44537997|NCT01588431|Docetaxel|docetaxel|mesh-list
44537998|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44537999|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538000|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44538001|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44538002|NCT01588431|Growth Substances|growth substances|mesh-ancestor
44538003|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538004|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44538005|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
44538006|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
44538007|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538008|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538009|NCT01587352|Vorinostat|vorinostat|mesh-list
44538010|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441969|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44538011|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44538012|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538013|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538014|NCT01585805|Gemcitabine|gemcitabine|mesh-list
44538015|NCT01585805|Cisplatin|cisplatin|mesh-list
44538016|NCT01585805|Veliparib|veliparib|mesh-list
44538017|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538018|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538019|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
44538020|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538021|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
44538022|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538023|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538024|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538025|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
44538026|NCT01585805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538027|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44538028|NCT01583283|Dexamethasone|dexamethasone|mesh-list
44538029|NCT01583283|Lenalidomide|lenalidomide|mesh-list
44538030|NCT01583283|Ricolinostat|ricolinostat|mesh-list
44538031|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44538032|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538033|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
44538034|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
44538035|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538036|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538037|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538038|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
44538039|NCT01583283|Hormones|hormones|mesh-ancestor
44538040|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538041|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44538042|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538043|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
44538044|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44538045|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44538046|NCT01583283|Growth Substances|growth substances|mesh-ancestor
44538047|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
44538048|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538049|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538050|NCT01581840|Panitumumab|panitumumab|mesh-list
44538051|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44538052|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538053|NCT01586442|Eplerenone|eplerenone|mesh-list
44538054|NCT01586442|Spironolactone|spironolactone|mesh-list
44538055|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44538056|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
44538057|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538058|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442027|NCT01891864|Etanercept|etanercept|mesh-list
44538059|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44538060|NCT01586442|Diuretics|diuretics|mesh-ancestor
44538061|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
44538062|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44538063|NCT01580813|Acipimox|acipimox|mesh-list
44538064|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44538065|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
44538066|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538067|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44538068|NCT01588535|Benzocaine|benzocaine|mesh-list
44538069|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
44538070|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
44538071|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538072|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538073|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
44538074|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538075|NCT01587144|Lucanthone|lucanthone|mesh-list
44538076|NCT01587144|Temozolomide|temozolomide|mesh-list
44538077|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44538078|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
44538079|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538080|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538081|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
44538082|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44538083|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
44538084|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44538085|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538086|NCT01584531|ON 01910|on 01910|mesh-list
44538087|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538088|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44538089|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538090|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538091|NCT01582347|Buprenorphine|buprenorphine|mesh-list
44538092|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44538093|NCT01582347|Naloxone|naloxone|mesh-list
44538094|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538095|NCT01582347|Narcotics|narcotics|mesh-ancestor
44538096|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538097|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538098|NCT01582347|Analgesics|analgesics|mesh-ancestor
44538099|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
44538100|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538101|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44538102|NCT01581203|Interferons|interferons|mesh-list
44538103|NCT01581203|Ribavirin|ribavirin|mesh-list
44538104|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
44538105|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
44538106|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44538107|NCT01581203|Asunaprevir|asunaprevir|mesh-list
44538108|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538109|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
44538110|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538111|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
44538112|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538113|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
44538114|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538115|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
44538116|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538117|NCT01581177|Albuterol|albuterol|mesh-list
44538118|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44538119|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
44538120|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538121|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538122|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44538123|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538124|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
44538125|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44538126|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44538127|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44538128|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44538129|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538130|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538131|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538132|NCT01581138|Ribavirin|ribavirin|mesh-list
44538133|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
44538134|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538135|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
44538136|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538137|NCT01580696|Molgramostim|molgramostim|mesh-list
44538138|NCT01580696|Vaccines|vaccines|mesh-list
44538139|NCT01580696|Sargramostim|sargramostim|mesh-list
44538140|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
44538141|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538151|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538152|NCT01584557|Tolvaptan|tolvaptan|mesh-list
44538153|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44538154|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538155|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
44442109|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538156|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538157|NCT01588522|Calcitriol|calcitriol|mesh-list
44538158|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44538159|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538160|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44538161|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44538162|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538163|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44538164|NCT01588522|Vitamins|vitamins|mesh-ancestor
44538165|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
44538166|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44538167|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44538168|NCT01585935|SMOFlipid|smoflipid|mesh-list
44538169|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44538170|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44538171|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44538172|NCT01589523|Cholic Acids|cholic acids|mesh-list
44538173|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
44538174|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538175|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44538176|NCT01560013|Naltrexone|naltrexone|mesh-list
44538177|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44538178|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44538179|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538180|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
44538181|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538182|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
44538183|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44538184|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44538185|NCT01560052|Prednisolone|prednisolone|mesh-list
44538186|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
44538187|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44538188|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
44538189|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538190|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
44538191|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
44538192|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538193|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538194|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538195|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
44538196|NCT01560052|Hormones|hormones|mesh-ancestor
44538197|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538198|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44538199|NCT01560052|Protective Agents|protective agents|mesh-ancestor
44538200|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44538201|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538202|NCT01560065|Folic Acid|folic acid|mesh-list
44538203|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
44538204|NCT01560065|Inositol|inositol|mesh-list
44538205|NCT01560065|Hematinics|hematinics|mesh-ancestor
44538206|NCT01560065|Vitamins|vitamins|mesh-ancestor
44538207|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
44538208|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538209|NCT01560091|Tamsulosin|tamsulosin|mesh-list
44538210|NCT01560091|Silodosin|silodosin|mesh-list
44538211|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44538212|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44538213|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44538214|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538215|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538216|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538217|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538218|NCT01560091|Urological Agents|urological agents|mesh-ancestor
44538219|NCT01560221|Buprenorphine|buprenorphine|mesh-list
44538220|NCT01560221|Methadone|methadone|mesh-list
44538221|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538222|NCT01560221|Narcotics|narcotics|mesh-ancestor
44538223|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538224|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538225|NCT01560221|Analgesics|analgesics|mesh-ancestor
44538226|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
44538227|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538228|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44538229|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
44538230|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538231|NCT01560299|Methimazole|methimazole|mesh-list
44538232|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
44538233|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44538234|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538235|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538236|NCT01560390|Ketamine|ketamine|mesh-list
44538237|NCT01560390|Analgesics|analgesics|mesh-ancestor
44538238|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
44538239|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538240|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538241|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44538242|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44538243|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
44538244|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
44538245|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538246|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44538247|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44538248|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538249|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538250|NCT01560442|Buprenorphine|buprenorphine|mesh-list
44538251|NCT01560442|Methadone|methadone|mesh-list
44538252|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538253|NCT01560442|Narcotics|narcotics|mesh-ancestor
44538254|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538255|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538256|NCT01560442|Analgesics|analgesics|mesh-ancestor
44538257|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
44538258|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538259|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44538260|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
44538261|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538262|NCT01560481|Metformin|metformin|mesh-list
44538263|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538264|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538265|NCT01560546|Testosterone|testosterone|mesh-list
44538266|NCT01560546|Androgens|androgens|mesh-ancestor
44538267|NCT01560546|Hormones|hormones|mesh-ancestor
44538268|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538269|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538270|NCT01560663|Carboplatin|carboplatin|mesh-list
44538271|NCT01560663|Docetaxel|docetaxel|mesh-list
44538272|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538273|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
44538274|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
44538275|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538276|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538277|NCT01560689|Budesonide|budesonide|mesh-list
44538278|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
44538279|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538280|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44538281|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
44538282|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538283|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538284|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44538285|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538286|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
44538287|NCT01560689|Hormones|hormones|mesh-ancestor
44538288|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538289|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44538290|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44538291|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44538292|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538293|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538294|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538295|NCT01560702|Epinephrine|epinephrine|mesh-list
44538296|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44538297|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44538298|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538299|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538300|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538301|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538302|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44538303|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44538304|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
44538305|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538306|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44538307|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538308|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
44538309|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
44538310|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44538311|NCT01560962|Azithromycin|azithromycin|mesh-list
44538312|NCT01560962|Tobramycin|tobramycin|mesh-list
44538313|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
44538314|NCT01560962|Povidone|povidone|mesh-list
44538315|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538316|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538317|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
44538318|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
44538319|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44538320|NCT01561014|Fluorouracil|fluorouracil|mesh-list
44538321|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
43764373|NCT02420509|Capecitabine|capecitabine|mesh-list
44538322|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44538323|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44538324|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
44538325|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538326|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538327|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538328|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538329|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
44538330|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538331|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44538332|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538333|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44538334|NCT01561066|Octreotide|octreotide|mesh-list
44538335|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44538336|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538337|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44538338|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538339|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
44538340|NCT01561066|Coagulants|coagulants|mesh-ancestor
44538341|NCT01561092|Citalopram|citalopram|mesh-list
44538342|NCT01561092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44538343|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44538344|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44538345|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538346|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538347|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
44538348|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538349|NCT01561092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44538350|NCT01561092|Antidepressive Agents|antidepressive agents|mesh-ancestor
44538351|NCT01561092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538352|NCT01561131|Calcium|calcium|mesh-list
44538353|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44538354|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362075|NCT01146145|Ketamine|ketamine|mesh-list
44538355|NCT01561209|Amitriptyline|amitriptyline|mesh-list
44538356|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44538357|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
44538358|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538359|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538360|NCT01561209|Analgesics|analgesics|mesh-ancestor
44538361|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
44538362|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538363|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538364|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44538365|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44538366|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442319|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
44538367|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538368|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538369|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538370|NCT01561222|Calcitriol|calcitriol|mesh-list
44538371|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44538372|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538373|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44538374|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44538375|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538376|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44538377|NCT01561222|Vitamins|vitamins|mesh-ancestor
44538378|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
44538379|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44538380|NCT01561235|Hormones|hormones|mesh-list
44538381|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538382|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538383|NCT01561274|Bupivacaine|bupivacaine|mesh-list
44538384|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
44538385|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
44538386|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538387|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538388|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
44538389|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538390|NCT01561391|Factor VIII|factor viii|mesh-list
44538391|NCT01561391|Coagulants|coagulants|mesh-ancestor
44538392|NCT01561404|Everolimus|everolimus|mesh-list
44538393|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538394|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538395|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
44538396|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538398|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538399|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44538400|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44538401|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538402|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538403|NCT01561508|Butyric Acid|butyric acid|mesh-list
44538404|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
44538405|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
44538406|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538407|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538408|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538409|NCT01561742|Minocycline|minocycline|mesh-list
44538410|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538411|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538412|NCT01561781|Digoxin|digoxin|mesh-list
44538413|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44538414|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44538415|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538416|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538417|NCT01561781|Protective Agents|protective agents|mesh-ancestor
44538418|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538419|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
44538420|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538421|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538422|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44538423|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44538424|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538425|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538426|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538427|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44538428|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44538444|NCT01562197|Axitinib|axitinib|mesh-list
44538445|NCT01562197|Lomustine|lomustine|mesh-list
44538446|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538447|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44538448|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538449|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538450|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44538451|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
44538452|NCT01562210|Cisplatin|cisplatin|mesh-list
44538453|NCT01562210|Olaparib|olaparib|mesh-list
44538454|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538455|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44538456|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538457|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538458|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
44538459|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538460|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44538461|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44538462|NCT01562301|Carboplatin|carboplatin|mesh-list
44538463|NCT01562301|Docetaxel|docetaxel|mesh-list
44538464|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538465|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
44538466|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44538467|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538468|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538469|NCT01562405|Dexamethasone|dexamethasone|mesh-list
44538470|NCT01562405|Lenalidomide|lenalidomide|mesh-list
44538471|NCT01562405|Pomalidomide|pomalidomide|mesh-list
44538472|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538473|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
44538474|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
44538475|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538476|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538477|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538478|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
44362204|NCT01147133|Clopidogrel|clopidogrel|mesh-list
44538480|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538481|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44538482|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538483|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
44538484|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44538485|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44538486|NCT01562405|Growth Substances|growth substances|mesh-ancestor
44538487|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44538489|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
44538490|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538491|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538492|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538493|NCT01562483|Analgesics|analgesics|mesh-ancestor
44538494|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
44538495|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538496|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44538497|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44538498|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538499|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538500|NCT01562483|Hormones|hormones|mesh-ancestor
44538501|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538502|NCT01562561|Repaglinide|repaglinide|mesh-list
44538503|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
44538504|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
44538505|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
44538506|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538507|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538508|NCT01562626|Flucytosine|flucytosine|mesh-list
44538509|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
44538510|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538511|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
44538512|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538513|NCT01562691|Petrolatum|petrolatum|mesh-list
44538514|NCT01562691|Emollients|emollients|mesh-ancestor
44538515|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44538516|NCT01562717|Ibuprofen|ibuprofen|mesh-list
44538517|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44538518|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538519|NCT01562717|Analgesics|analgesics|mesh-ancestor
44538520|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
44538521|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538522|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538523|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538524|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538525|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44538526|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538527|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538528|NCT01562795|Fluorometholone|fluorometholone|mesh-list
44538529|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44538530|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
44538531|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44538532|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44538533|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
44538534|NCT01562795|Hormones|hormones|mesh-ancestor
44538535|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538536|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538537|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44538538|NCT01562808|Aripiprazole|aripiprazole|mesh-list
44538539|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
44538540|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538541|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44538542|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44538543|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538544|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538545|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
44538546|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
44538547|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538548|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538549|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44538550|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44538551|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
44362244|NCT01147224|Ciclesonide|ciclesonide|mesh-list
44538552|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44538553|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44538554|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44538555|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44538556|NCT01562951|Adalimumab|adalimumab|mesh-list
43944936|NCT01030783|Sorafenib|sorafenib|mesh-list
44538557|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538558|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538559|NCT01562977|Gemcitabine|gemcitabine|mesh-list
44538560|NCT01562977|Rituximab|rituximab|mesh-list
44538561|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
44538562|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44538563|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538564|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
44538565|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538566|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538567|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538568|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
44538569|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538570|NCT01562977|Antiviral Agents|antiviral agents|mesh-ancestor
44538571|NCT01562977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538572|NCT01562977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538573|NCT01562977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538574|NCT01562990|Gemcitabine|gemcitabine|mesh-list
44538575|NCT01562990|Rituximab|rituximab|mesh-list
44538576|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44538577|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
44538578|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44538579|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538580|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
44538581|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538582|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538583|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538584|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
44538585|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538586|NCT01562990|Antiviral Agents|antiviral agents|mesh-ancestor
44538587|NCT01562990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538588|NCT01562990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538589|NCT01562990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538590|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44538591|NCT01563068|Calcipotriene|calcipotriene|mesh-list
44538592|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44538593|NCT01563120|Metformin|metformin|mesh-list
44538594|NCT01563120|Glyburide|glyburide|mesh-list
44538595|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538596|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538597|NCT01563289|Ibuprofen|ibuprofen|mesh-list
44538598|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44538599|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538600|NCT01563289|Analgesics|analgesics|mesh-ancestor
44538601|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
44538602|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538603|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538604|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538605|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538606|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44538607|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538608|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538609|NCT01563328|Dolutegravir|dolutegravir|mesh-list
44538610|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44538611|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44538612|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538613|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538614|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44538615|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44538616|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
44538617|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538618|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44538619|NCT01563367|Hematinics|hematinics|mesh-ancestor
44538620|NCT01563601|Carboplatin|carboplatin|mesh-list
44538621|NCT01563601|Etoposide|etoposide|mesh-list
44538622|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
44538623|NCT01563601|Obatoclax|obatoclax|mesh-list
44538624|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538625|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44538626|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44538627|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44538628|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538629|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538630|NCT01563614|Cytarabine|cytarabine|mesh-list
44538631|NCT01563614|Lomustine|lomustine|mesh-list
44538632|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538633|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
43764736|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
44538634|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442560|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
44538635|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538636|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
44538637|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538638|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538639|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
44538640|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538641|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44538642|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
44538644|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538645|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538646|NCT01563718|Naltrexone|naltrexone|mesh-list
44538647|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44538648|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44538649|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538650|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
44538651|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538652|NCT01563835|Fentanyl|fentanyl|mesh-list
44538653|NCT01563835|Bupivacaine|bupivacaine|mesh-list
44538654|NCT01563835|Citric Acid|citric acid|mesh-list
44538655|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
44538656|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
44538657|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
44538658|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538659|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538660|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
44538661|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538662|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538663|NCT01563835|Narcotics|narcotics|mesh-ancestor
44538664|NCT01563835|Analgesics|analgesics|mesh-ancestor
44538665|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44538666|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44538667|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
44538668|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
44538669|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44538670|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
44538671|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
44538672|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538673|NCT01563939|Remifentanil|remifentanil|mesh-list
44442617|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
44538674|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538675|NCT01563939|Narcotics|narcotics|mesh-ancestor
44538676|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538677|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538678|NCT01563939|Analgesics|analgesics|mesh-ancestor
44538679|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
44538680|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538681|NCT01563952|Sirolimus|sirolimus|mesh-list
44538682|NCT01563952|Umirolimus|umirolimus|mesh-list
44538683|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538684|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538685|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44538686|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538687|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
44538688|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538689|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
44538690|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538691|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538692|NCT01564108|Ranibizumab|ranibizumab|mesh-list
44538693|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44538694|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44538695|NCT01564108|Growth Substances|growth substances|mesh-ancestor
44538696|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538697|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
44538698|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538699|NCT01564199|Fluticasone|fluticasone|mesh-list
44538700|NCT01564199|Xhance|xhance|mesh-list
44538701|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44538702|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538703|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44538704|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
44538705|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538706|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538707|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44538708|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538709|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
44538710|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44538711|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44538712|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44538713|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44538714|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538715|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538716|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538717|NCT01564251|Gemcitabine|gemcitabine|mesh-list
44538718|NCT01564251|GDC-0575|gdc-0575|mesh-list
44538719|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44538720|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
44538721|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538722|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538723|NCT01564251|Antiviral Agents|antiviral agents|mesh-ancestor
44538724|NCT01564251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538725|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538726|NCT01564251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538727|NCT01564251|Immunologic Factors|immunologic factors|mesh-ancestor
44538728|NCT01564251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538729|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44538730|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
44538731|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44538732|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44538733|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
44538734|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538735|NCT01564303|Expectorants|expectorants|mesh-ancestor
44538736|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538737|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44538738|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
44538739|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538740|NCT01564303|Protective Agents|protective agents|mesh-ancestor
44538741|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538742|NCT01564303|Antidotes|antidotes|mesh-ancestor
44538743|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44538744|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538745|NCT01564329|Endostar protein|endostar protein|mesh-list
44538746|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44538747|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44538748|NCT01564329|Growth Substances|growth substances|mesh-ancestor
44538749|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538750|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44538751|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538752|NCT01564355|Triamcinolone|triamcinolone|mesh-list
44538753|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538754|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
44538755|NCT01564355|Hormones|hormones|mesh-ancestor
44538756|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44538757|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362469|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44538758|NCT01564381|Resveratrol|resveratrol|mesh-list
44538759|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
44442691|NCT01876732|Vitamins|vitamins|mesh-ancestor
44538760|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538761|NCT01564381|Protective Agents|protective agents|mesh-ancestor
44538762|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538763|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538764|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44538765|NCT01564550|Insulin|insulin|mesh-list
44538766|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44538767|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538768|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538769|NCT01564680|Acetaminophen|acetaminophen|mesh-list
44538770|NCT01564680|Lornoxicam|lornoxicam|mesh-list
44538771|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538772|NCT01564680|Analgesics|analgesics|mesh-ancestor
44538773|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
44538774|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538775|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538776|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
44538777|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44538778|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538779|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538780|NCT01564810|Cetuximab|cetuximab|mesh-list
44538781|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44538782|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538783|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
44538784|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538785|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44538786|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538787|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538789|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
44538790|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
44538791|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538792|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538793|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538794|NCT01565096|Metformin|metformin|mesh-list
44538795|NCT01565096|Glimepiride|glimepiride|mesh-list
44538796|NCT01565096|Vildagliptin|vildagliptin|mesh-list
44538797|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538798|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538799|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44538800|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538801|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
44538802|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44538803|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
44538804|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538805|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538806|NCT01565109|Docetaxel|docetaxel|mesh-list
44538807|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538808|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
44538809|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
44538810|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538811|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538812|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44538813|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44538814|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44538815|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44362546|NCT01148472|Citalopram|citalopram|mesh-list
44538836|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44538838|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
44538839|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538840|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538841|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
44538842|NCT01565720|Isavuconazole|isavuconazole|mesh-list
44538843|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538844|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538845|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44538846|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44538847|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538848|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538849|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538850|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
44538851|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
44538852|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
44538853|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44538854|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538855|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538856|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44538857|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538858|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
44538859|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
44538860|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538861|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538862|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538863|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
44538864|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44538865|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538866|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538867|NCT01565772|Cisplatin|cisplatin|mesh-list
44538868|NCT01565772|Etoposide|etoposide|mesh-list
44538869|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538870|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44538871|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44538872|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44538873|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538874|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538875|NCT01565798|Copper|copper|mesh-list
44538876|NCT01565798|Trace Elements|trace elements|mesh-ancestor
44538877|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
44538878|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538880|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44538881|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538882|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44538883|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538884|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
44538885|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44538886|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44538887|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538888|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44538889|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
44538890|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538891|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538892|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538893|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538894|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44538895|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44538896|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538897|NCT01566253|Acetaminophen|acetaminophen|mesh-list
44538898|NCT01566253|Ketoprofen|ketoprofen|mesh-list
44538899|NCT01566253|Morphine|morphine|mesh-list
44538900|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44538901|NCT01566253|Narcotics|narcotics|mesh-ancestor
44538902|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538903|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538904|NCT01566253|Analgesics|analgesics|mesh-ancestor
44538905|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
44538906|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538907|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538908|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
44538909|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44538910|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538911|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538912|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44538913|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538914|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538915|NCT01566266|Amoxicillin|amoxicillin|mesh-list
44538916|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538917|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538918|NCT01566279|Everolimus|everolimus|mesh-list
44538919|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44538920|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538921|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
44538922|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538923|NCT01566474|Melatonin|melatonin|mesh-list
44538924|NCT01566474|Omeprazole|omeprazole|mesh-list
44538925|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
44538926|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538927|NCT01566474|Protective Agents|protective agents|mesh-ancestor
44538928|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538929|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538930|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44538931|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538932|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44538933|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538934|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44538935|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
44538936|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44538937|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44538938|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44538939|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44538940|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538941|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44538942|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
44538943|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538944|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44538945|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44538946|NCT01566565|Theophylline|theophylline|mesh-list
44538947|NCT01566565|Bambuterol|bambuterol|mesh-list
44538948|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44538949|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
44538950|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538951|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538952|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44538953|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
44538954|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44538955|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538956|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538957|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
44538958|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44538959|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44538960|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
44538961|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44538962|NCT01566578|Mitogens|mitogens|mesh-list
44538963|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44538964|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538965|NCT01566643|Metronidazole|metronidazole|mesh-list
44538966|NCT01566643|Rabeprazole|rabeprazole|mesh-list
44538967|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538968|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538969|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44538970|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44538971|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44538972|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44538973|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44442878|NCT01873859|Metformin|metformin|mesh-list
44538974|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538975|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538976|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44538977|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
44538978|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538979|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44538980|NCT01566669|Parecoxib|parecoxib|mesh-list
44538981|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44538982|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44538983|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44538984|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44538985|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44538986|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44538987|NCT01566669|Analgesics|analgesics|mesh-ancestor
44538988|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
44538989|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44538990|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538991|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44538992|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44538993|NCT01566734|Cefazolin|cefazolin|mesh-list
44538994|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44538995|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44538996|NCT01566799|Metformin|metformin|mesh-list
44538997|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44538998|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44538999|NCT01566825|Amitriptyline|amitriptyline|mesh-list
44539000|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44539001|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44539002|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539003|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44539004|NCT01566825|Analgesics|analgesics|mesh-ancestor
44539005|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
44539006|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539007|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539008|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44539009|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44539010|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539011|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539012|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
44539013|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539015|NCT01566942|Irinotecan|irinotecan|mesh-list
44539016|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539017|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44539018|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539019|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539020|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539021|NCT01567111|Metomidate|metomidate|mesh-list
44539022|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44539023|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539024|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539025|NCT01567124|Moxonidine|moxonidine|mesh-list
44539026|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44539028|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
44539029|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44539030|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539031|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539032|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539033|NCT01567358|Infliximab|infliximab|mesh-list
44539034|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44539035|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539036|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539037|NCT01567384|Pemetrexed|pemetrexed|mesh-list
44539038|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539039|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539040|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539041|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44539042|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44539043|NCT01567475|Rituximab|rituximab|mesh-list
44539044|NCT01567475|Everolimus|everolimus|mesh-list
44539045|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539046|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539047|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
44539048|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539049|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539050|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539051|NCT01567488|Everolimus|everolimus|mesh-list
44539052|NCT01567488|Octreotide|octreotide|mesh-list
44539053|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539054|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539055|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
44539056|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539057|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539058|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539059|NCT01567501|Cetirizine|cetirizine|mesh-list
44539060|NCT01567501|Levocetirizine|levocetirizine|mesh-list
44539061|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44539062|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44539063|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
44539064|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
44539065|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539066|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539067|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539068|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44539069|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44539070|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44539071|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539072|NCT01567540|Incretins|incretins|mesh-ancestor
44539073|NCT01567540|Hormones|hormones|mesh-ancestor
44539074|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539075|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44539076|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539077|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539078|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539080|NCT01567618|Fluorouracil|fluorouracil|mesh-list
44539081|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539082|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539083|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539084|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539085|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539086|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
44539087|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539088|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539089|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
44539090|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539091|NCT01567657|Midazolam|midazolam|mesh-list
44539092|NCT01567657|Meperidine|meperidine|mesh-list
44539093|NCT01567657|Propofol|propofol|mesh-list
44539094|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44539095|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539096|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539097|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44539098|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
44539099|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
44539100|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44539101|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44539102|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44539103|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539104|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
44539105|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
44539106|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539107|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539108|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44539109|NCT01567657|Narcotics|narcotics|mesh-ancestor
44539110|NCT01567657|Analgesics|analgesics|mesh-ancestor
44539111|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
44539112|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539113|NCT01567670|Naloxone|naloxone|mesh-list
44539114|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44539115|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539116|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
44539117|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539118|NCT01567683|Imiquimod|imiquimod|mesh-list
44539119|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44539120|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
44539121|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539122|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443040|NCT01870583|Iodine|iodine|mesh-list
44539123|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
44539124|NCT01567709|Vorinostat|vorinostat|mesh-list
44539125|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539126|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44539127|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539128|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539129|NCT01567735|Simeprevir|simeprevir|mesh-list
44539130|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
44539131|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539132|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539133|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539134|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539135|NCT01567774|Atorvastatin|atorvastatin|mesh-list
44539136|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44539137|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44539138|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44539139|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
44539140|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539141|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44539142|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44539143|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539144|NCT01567930|Sirolimus|sirolimus|mesh-list
44539145|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539146|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539147|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539148|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539149|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
44539150|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539151|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
44539152|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539153|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44539154|NCT01568125|Incretins|incretins|mesh-list
44362887|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539166|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
44539167|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539168|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539169|NCT01568281|Anastrozole|anastrozole|mesh-list
44539170|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539171|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539172|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44539173|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44539174|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539175|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539176|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44539177|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
44539178|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539179|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539180|NCT01568294|Pomalidomide|pomalidomide|mesh-list
44539181|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
44539182|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539183|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44539184|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44539185|NCT01568294|Growth Substances|growth substances|mesh-ancestor
44539186|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44539187|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539188|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
44443072|NCT01869699|Acetaminophen|acetaminophen|mesh-list
44539190|NCT01568307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44539191|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539192|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44539193|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
44539194|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539195|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539196|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539197|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44539198|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539199|NCT01568333|Decitabine|decitabine|mesh-list
44539200|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539201|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
44539202|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539203|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539204|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539205|NCT01568411|Itraconazole|itraconazole|mesh-list
44539206|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
44539207|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539208|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44539209|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44539210|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539211|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539212|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44539213|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
44539214|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539215|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539216|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44539217|NCT01568450|Oxycodone|oxycodone|mesh-list
44539218|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44539219|NCT01568450|Narcotics|narcotics|mesh-ancestor
44539220|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539221|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539222|NCT01568450|Analgesics|analgesics|mesh-ancestor
44539223|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
44539224|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539225|NCT01568749|Acetaminophen|acetaminophen|mesh-list
44539226|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44539227|NCT01568749|Analgesics|analgesics|mesh-ancestor
44539228|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
44539229|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539230|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539231|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
44539232|NCT01568788|Vaccines|vaccines|mesh-list
44539233|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
44539234|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539235|NCT01568853|Norepinephrine|norepinephrine|mesh-list
44539236|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44539237|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44539238|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
44539239|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539240|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539241|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539242|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
44539243|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
44539244|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539245|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44539246|NCT01568931|Coal Tar|coal tar|mesh-list
44539247|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
44539248|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44539249|NCT01568996|Sulforaphane|sulforaphane|mesh-list
44539250|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44539251|NCT01568996|Protective Agents|protective agents|mesh-ancestor
44539252|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539253|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539254|NCT01569035|Warfarin|warfarin|mesh-list
44362993|NCT01150955|Resveratrol|resveratrol|mesh-list
44539257|NCT01569048|Remifentanil|remifentanil|mesh-list
44539258|NCT01569048|Propofol|propofol|mesh-list
44539259|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44539260|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539261|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539262|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44539263|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
44539265|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44539266|NCT01569048|Analgesics|analgesics|mesh-ancestor
44539267|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
44539268|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539269|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44539270|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44539271|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44539272|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44539273|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539274|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539275|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44539276|NCT01569048|Narcotics|narcotics|mesh-ancestor
44539277|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
44539278|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44539279|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
44539280|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44539281|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44539282|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44539283|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
44539284|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44539285|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539286|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44539287|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44539288|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44539289|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44539290|NCT01569113|Estrogens|estrogens|mesh-ancestor
44539291|NCT01569113|Hormones|hormones|mesh-ancestor
44539292|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539293|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44539294|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44539295|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44539296|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44539297|NCT01569165|Fluorides|fluorides|mesh-list
44539298|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
44539299|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
44539300|NCT01569165|Protective Agents|protective agents|mesh-ancestor
44443196|NCT01867294|Diuretics|diuretics|mesh-ancestor
44539301|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539302|NCT01569204|Dexamethasone|dexamethasone|mesh-list
44539303|NCT01569204|Prednisone|prednisone|mesh-list
44539304|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
44539305|NCT01569204|Dacarbazine|dacarbazine|mesh-list
44539306|NCT01569204|Doxorubicin|doxorubicin|mesh-list
44539307|NCT01569204|Etoposide|etoposide|mesh-list
44539308|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44539309|NCT01569204|Procarbazine|procarbazine|mesh-list
44539310|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539311|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
44539312|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539313|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539314|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539315|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
44539316|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539317|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539318|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539319|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539320|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
44539321|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
44539322|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539323|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539324|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
44539325|NCT01569204|Hormones|hormones|mesh-ancestor
44539326|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539327|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539328|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539334|NCT01569256|Cabergoline|cabergoline|mesh-list
44539335|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44539336|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44539337|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
44539338|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
44539339|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539340|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539341|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539342|NCT01569919|Folic Acid|folic acid|mesh-list
44539343|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
44539345|NCT01569919|Dexamethasone|dexamethasone|mesh-list
44539346|NCT01569919|Pemetrexed|pemetrexed|mesh-list
44539347|NCT01569919|Vitamins|vitamins|mesh-ancestor
44539348|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
44539349|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539350|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539351|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
44539352|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
44539353|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539354|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539355|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
44539356|NCT01569919|Hormones|hormones|mesh-ancestor
44539357|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539358|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539359|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539360|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539361|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539362|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44539363|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44539364|NCT01569919|Hematinics|hematinics|mesh-ancestor
44539365|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
44539366|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44539367|NCT01569945|Clomiphene|clomiphene|mesh-list
44539368|NCT01569945|Menotropins|menotropins|mesh-list
44539369|NCT01569945|Estradiol|estradiol|mesh-list
44539370|NCT01569945|Estrogens|estrogens|mesh-ancestor
44539371|NCT01569945|Hormones|hormones|mesh-ancestor
44539372|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539373|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539374|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44539375|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
44539376|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44539377|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44539378|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44539379|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44539380|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44539381|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
44539382|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44539383|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
44539384|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44539385|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44539386|NCT01569984|Bevacizumab|bevacizumab|mesh-list
44539387|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539388|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539389|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44539390|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44539391|NCT01569984|Growth Substances|growth substances|mesh-ancestor
44539392|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539393|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44539394|NCT01565200|Trastuzumab|trastuzumab|mesh-list
44539395|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44539396|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539397|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539398|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539399|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539400|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539401|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539402|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
44539403|NCT01560572|Prednisolone|prednisolone|mesh-list
44539404|NCT01560572|Tacrolimus|tacrolimus|mesh-list
44539405|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539406|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
44539407|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539408|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44539409|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539410|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539411|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539412|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
44539413|NCT01560572|Hormones|hormones|mesh-ancestor
44539414|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539415|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539416|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539417|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539418|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44539419|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
44539420|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539421|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539422|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
44539423|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44539424|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539425|NCT01564537|Dexamethasone|dexamethasone|mesh-list
44539426|NCT01564537|Lenalidomide|lenalidomide|mesh-list
44539428|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539429|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
44539430|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
44539431|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539432|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539433|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539434|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
44539435|NCT01564537|Hormones|hormones|mesh-ancestor
44539436|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539437|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539438|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539439|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
44539440|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44539441|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44539442|NCT01564537|Growth Substances|growth substances|mesh-ancestor
44539443|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
44539444|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539445|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539446|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539447|NCT01567904|Semuloparin|semuloparin|mesh-list
44539448|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44539449|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44539450|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539451|NCT01567059|Cytarabine|cytarabine|mesh-list
44539452|NCT01567059|Decitabine|decitabine|mesh-list
44539453|NCT01567059|Azacitidine|azacitidine|mesh-list
44539454|NCT01567059|Tosedostat|tosedostat|mesh-list
44539455|NCT01567059|Glycine|glycine|mesh-list
44539456|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539457|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
44539458|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539459|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539460|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
44539461|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539462|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539463|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
44539464|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539465|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539466|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
44539467|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539468|NCT01565655|Peficitinib|peficitinib|mesh-list
44443361|NCT01863771|Golimumab|golimumab|mesh-list
44539469|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539470|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539471|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539472|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
44539473|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539474|NCT01561768|Vaccines|vaccines|mesh-list
44539475|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
44539476|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539477|NCT01560637|Treprostinil|treprostinil|mesh-list
44539478|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44539479|NCT01560754|Nicotine|nicotine|mesh-list
44539480|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44539481|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
44539482|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539483|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539484|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44539485|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44539486|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
44539487|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539488|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539489|NCT01561040|Vitamin D|vitamin d|mesh-list
44539490|NCT01561040|Vitamin A|vitamin a|mesh-list
44539491|NCT01561040|Vitamins|vitamins|mesh-ancestor
44539492|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
44539493|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539494|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44539495|NCT01563224|Baclofen|baclofen|mesh-list
44539496|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44539497|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539498|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44539499|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539500|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44539501|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
44539502|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
44539503|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539504|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539505|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
44539506|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44539507|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44539508|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44539509|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539510|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539511|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
44539512|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539513|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539514|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44539515|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539516|NCT01567605|Lidocaine|lidocaine|mesh-list
44539517|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
44539518|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
44539519|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539520|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539521|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
44539522|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539523|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44539524|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44539525|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44539526|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539527|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539528|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
44539529|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539530|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
44539531|NCT01567995|Hormones|hormones|mesh-ancestor
44539532|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539533|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539534|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44539535|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44539536|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44539537|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44539538|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539539|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539540|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44539541|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44539542|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44539543|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
44539544|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539545|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539546|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44539547|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44539548|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
44539549|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44539550|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44539551|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
44539552|NCT01560104|Paclitaxel|paclitaxel|mesh-list
44539553|NCT01560104|Carboplatin|carboplatin|mesh-list
44539554|NCT01560104|Veliparib|veliparib|mesh-list
44539555|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539556|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539557|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539558|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539559|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539560|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539561|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44539562|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539563|NCT00101972|Antibodies|antibodies|mesh-list
44539564|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44539565|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
44539566|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363365|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
44539577|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539579|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539581|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539582|NCT00109967|Sirolimus|sirolimus|mesh-list
44539583|NCT00109967|Rituximab|rituximab|mesh-list
44539584|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539585|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539586|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
44539587|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539588|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539589|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539590|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539591|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539592|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
44539593|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539594|NCT00109928|Gemcitabine|gemcitabine|mesh-list
44539595|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
44539596|NCT00109928|Etoposide|etoposide|mesh-list
44539597|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539598|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539599|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
44539600|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539601|NCT00109928|Antiviral Agents|antiviral agents|mesh-ancestor
44539602|NCT00109928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539603|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539604|NCT00109928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539605|NCT00109928|Immunologic Factors|immunologic factors|mesh-ancestor
44539606|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539607|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539608|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539609|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539610|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539611|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
44539612|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
44539613|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539614|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539615|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
44539616|NCT00109928|Hormones|hormones|mesh-ancestor
44539617|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539618|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44539619|NCT00109928|Protective Agents|protective agents|mesh-ancestor
44539620|NCT00109850|Cisplatin|cisplatin|mesh-list
44539621|NCT00109850|Irinotecan|irinotecan|mesh-list
44539622|NCT00109850|Cetuximab|cetuximab|mesh-list
44539623|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539624|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44539625|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539626|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539627|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539628|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539630|NCT00109837|Cytarabine|cytarabine|mesh-list
44539631|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44539632|NCT00109837|Dexamethasone|dexamethasone|mesh-list
44539633|NCT00109837|Prednisone|prednisone|mesh-list
44539634|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
44539635|NCT00109837|Doxorubicin|doxorubicin|mesh-list
44539636|NCT00109837|Methotrexate|methotrexate|mesh-list
44539637|NCT00109837|Vincristine|vincristine|mesh-list
44539638|NCT00109837|Daunorubicin|daunorubicin|mesh-list
44539639|NCT00109837|Asparaginase|asparaginase|mesh-list
44539640|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
44539641|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
44539642|NCT00109837|Thioguanine|thioguanine|mesh-list
44539643|NCT00109837|Allopurinol|allopurinol|mesh-list
44539644|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539645|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
44539646|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539647|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539648|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539649|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
44539650|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539651|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539652|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539653|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539654|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
44539655|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
44539656|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539657|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539659|NCT00109837|Hormones|hormones|mesh-ancestor
44539660|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539661|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539662|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539663|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539664|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539665|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539666|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44539667|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
44539668|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44539669|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539670|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
44539671|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44539672|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44539673|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44539674|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
44539675|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539676|NCT00109837|Antidotes|antidotes|mesh-ancestor
44539677|NCT00109837|Protective Agents|protective agents|mesh-ancestor
44539678|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
44539679|NCT00109837|Vitamins|vitamins|mesh-ancestor
44539680|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
44539681|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539682|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539683|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539684|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539685|NCT00109837|Analgesics|analgesics|mesh-ancestor
44539686|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
44539687|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
44539688|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44539689|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
44539690|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44539691|NCT00109837|Renal Agents|renal agents|mesh-ancestor
44539692|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539693|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
44539694|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44443585|NCT01857583|PENTA|penta|mesh-list
44539695|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44363497|NCT01154738|Lidocaine|lidocaine|mesh-list
44539696|NCT00109772|Lenalidomide|lenalidomide|mesh-list
44539697|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
44539698|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539699|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44539700|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44539701|NCT00109772|Growth Substances|growth substances|mesh-ancestor
44539702|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
44539703|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539704|NCT00109733|Hormones|hormones|mesh-list
44539705|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539706|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539707|NCT00109590|Ritonavir|ritonavir|mesh-list
44539708|NCT00109590|Lopinavir|lopinavir|mesh-list
44539709|NCT00109590|Zidovudine|zidovudine|mesh-list
44539710|NCT00109590|Nevirapine|nevirapine|mesh-list
44539711|NCT00109590|Didanosine|didanosine|mesh-list
44539712|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44539713|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44539714|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539715|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539716|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539717|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44539718|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44539719|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
44539720|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539721|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44539722|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44539723|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
44539724|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44539725|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44539726|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44539727|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44539728|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
44539729|NCT00109031|Etoposide|etoposide|mesh-list
44539730|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539731|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
43945943|NCT03822013|Miglustat|miglustat|mesh-list
44539733|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539734|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539735|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
44539736|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539737|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539738|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539739|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539740|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539741|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539742|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539743|NCT00108953|Doxorubicin|doxorubicin|mesh-list
44539744|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44539745|NCT00108953|Sorafenib|sorafenib|mesh-list
44539746|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539747|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539748|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539749|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539750|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539751|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539752|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44539753|NCT00108732|Metronidazole|metronidazole|mesh-list
44539754|NCT00108732|Goserelin|goserelin|mesh-list
44539755|NCT00108732|Bicalutamide|bicalutamide|mesh-list
44539756|NCT00108732|Vaccines|vaccines|mesh-list
44539757|NCT00108732|Sargramostim|sargramostim|mesh-list
44539758|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
44539759|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539760|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539761|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539762|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
44539763|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
44539764|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539765|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539766|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539767|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44539768|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44539769|NCT00108160|Mupirocin|mupirocin|mesh-list
44539770|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539771|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539772|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44363571|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
44539773|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539774|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539775|NCT00108082|Atenolol|atenolol|mesh-list
44539776|NCT00108082|Carvedilol|carvedilol|mesh-list
44539777|NCT00108082|Lisinopril|lisinopril|mesh-list
44539778|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44539779|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44539780|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
44539781|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539782|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539783|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539784|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44539785|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
44539786|NCT00108082|Protective Agents|protective agents|mesh-ancestor
44539787|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44539788|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539789|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44539790|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
44539791|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44539792|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44539793|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44539794|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539795|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539796|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44539797|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44539798|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
44539799|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
44539800|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539801|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44539802|NCT00107991|Etanercept|etanercept|mesh-list
44443689|NCT01856257|Abatacept|abatacept|mesh-list
44539803|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44539804|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44539805|NCT00107991|Analgesics|analgesics|mesh-ancestor
44539806|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
44539807|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539808|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539809|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539810|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539811|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44539812|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539813|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
44539815|NCT00107978|Telavancin|telavancin|mesh-list
44539816|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539817|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539818|NCT00107952|Vancomycin|vancomycin|mesh-list
44539819|NCT00107952|Telavancin|telavancin|mesh-list
44539820|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539821|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539822|NCT00107900|Edoxaban|edoxaban|mesh-list
44539823|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44539824|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
44539825|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44539826|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
44539827|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539828|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539829|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
44539830|NCT00107614|Rituximab|rituximab|mesh-list
44539831|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539832|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539833|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
44539834|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539835|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539836|NCT00107380|Prednisone|prednisone|mesh-list
44539837|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
44539838|NCT00107380|Rituximab|rituximab|mesh-list
44539839|NCT00107380|Doxorubicin|doxorubicin|mesh-list
44539840|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44539841|NCT00107380|Vincristine|vincristine|mesh-list
44539842|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
44539843|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539844|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
44539845|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443729|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
44539846|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539847|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539848|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
44363643|NCT01155206|Incretins|incretins|mesh-ancestor
44539849|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539850|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539851|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539852|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539853|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539854|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539855|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539856|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539857|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539858|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
44539859|NCT00107380|Hormones|hormones|mesh-ancestor
44539860|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539861|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539862|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539863|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539864|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539865|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539866|NCT00107315|Bevacizumab|bevacizumab|mesh-list
44539867|NCT00107315|Capecitabine|capecitabine|mesh-list
44539868|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44539869|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539870|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44539871|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44539872|NCT00107315|Growth Substances|growth substances|mesh-ancestor
44539873|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539874|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
44539875|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539876|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
44539877|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539878|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
44539879|NCT00107276|Capecitabine|capecitabine|mesh-list
44539880|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539881|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
44539882|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539883|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539884|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539885|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
44443771|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
44539886|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539887|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539888|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539889|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44539890|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
44539891|NCT00107198|Prednisone|prednisone|mesh-list
44539892|NCT00107198|Cortisone|cortisone|mesh-list
44539893|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
44539894|NCT00107198|Doxorubicin|doxorubicin|mesh-list
44539895|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44539896|NCT00107198|Vincristine|vincristine|mesh-list
44539897|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44539898|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
44539899|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539900|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44539901|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44539902|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
44539903|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539904|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539905|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44539906|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44539907|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44539908|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44539909|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539910|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44539911|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
44539912|NCT00107198|Hormones|hormones|mesh-ancestor
44539913|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44539914|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44539915|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44539916|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
44539917|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
44539918|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
44539919|NCT00107120|Citalopram|citalopram|mesh-list
44539920|NCT00107120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44539921|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44539922|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539923|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539924|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539925|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
44539926|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539927|NCT00107120|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44539928|NCT00107120|Antidepressive Agents|antidepressive agents|mesh-ancestor
44539929|NCT00107120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539948|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44539949|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44539950|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44539951|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44539952|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539953|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539954|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539955|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539956|NCT00105989|Analgesics|analgesics|mesh-ancestor
44539957|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
44539958|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539959|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
44539960|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539961|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
44539962|NCT00105586|Citalopram|citalopram|mesh-list
44539963|NCT00105586|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44539964|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44539965|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44539966|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539967|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44539968|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
44539969|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539970|NCT00105586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44539971|NCT00105586|Antidepressive Agents|antidepressive agents|mesh-ancestor
44539972|NCT00105586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44539973|NCT00105534|Azithromycin|azithromycin|mesh-list
44539974|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44539975|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44539976|NCT00105482|Naltrexone|naltrexone|mesh-list
44539977|NCT00105482|Nicotine|nicotine|mesh-list
44539978|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44539979|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
44539980|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44539981|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539982|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44539983|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44539984|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44539985|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443858|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44539986|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539987|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44539988|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44539989|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
44539990|NCT00105443|Sorafenib|sorafenib|mesh-list
44539991|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44539992|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44539993|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44539994|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44539995|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
44539996|NCT00105183|Antibodies|antibodies|mesh-list
44539997|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
44539998|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44539999|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44540000|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
44540001|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44540002|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
44540003|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540004|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540005|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
44540006|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540007|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540008|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
44540009|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540010|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44540011|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44540012|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540013|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540014|NCT00105079|Ritonavir|ritonavir|mesh-list
44540015|NCT00105079|Lopinavir|lopinavir|mesh-list
44540016|NCT00105079|Saquinavir|saquinavir|mesh-list
44540017|NCT00105079|Tenofovir|tenofovir|mesh-list
44540018|NCT00105079|Emtricitabine|emtricitabine|mesh-list
44540019|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44540020|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44540021|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44540022|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
44540023|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540024|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540025|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540026|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540027|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
44540028|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540029|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44540030|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44540031|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44540032|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540033|NCT00104884|Romidepsin|romidepsin|mesh-list
44540034|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44540035|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540036|NCT00104871|Bortezomib|bortezomib|mesh-list
44540037|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540038|NCT00104728|Gefitinib|gefitinib|mesh-list
44540039|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540040|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540041|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540042|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540043|NCT00104676|Paclitaxel|paclitaxel|mesh-list
44540044|NCT00104676|Etoposide|etoposide|mesh-list
44540045|NCT00104676|Cisplatin|cisplatin|mesh-list
44540046|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
44540047|NCT00104676|Ifosfamide|ifosfamide|mesh-list
44540048|NCT00104676|Bleomycin|bleomycin|mesh-list
44540049|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540050|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540051|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540052|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540053|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540054|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540055|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540056|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540057|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540058|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44540059|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
44540060|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44540061|NCT00104650|Diphosphonates|diphosphonates|mesh-list
44540062|NCT00104650|Denosumab|denosumab|mesh-list
44540063|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44540064|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540065|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
44540066|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540067|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
44540068|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44540069|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44540070|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540071|NCT00104637|Urological Agents|urological agents|mesh-ancestor
44540072|NCT00104416|Lamotrigine|lamotrigine|mesh-list
44540073|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
44540074|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44540075|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540076|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540077|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44540078|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540079|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44540080|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44540081|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540082|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44540083|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44540084|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
44540085|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44540086|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540087|NCT00104052|Ribavirin|ribavirin|mesh-list
44540088|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44540089|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
44540090|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
44540091|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540092|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
44540093|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540094|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
44540095|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540096|NCT00103740|Vitamin D|vitamin d|mesh-list
44540097|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
44540098|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
44540099|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
44540100|NCT00103740|Calcium|calcium|mesh-list
44540101|NCT00103740|Vitamins|vitamins|mesh-ancestor
44540102|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
44540103|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540104|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44540105|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44540106|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44540107|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540108|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540109|NCT00103662|Plerixafor|plerixafor|mesh-list
44540110|NCT00103662|Lenograstim|lenograstim|mesh-list
44540111|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44540112|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
44540113|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540114|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540115|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540116|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
44540117|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540118|NCT00103610|Plerixafor|plerixafor|mesh-list
44540119|NCT00103610|Lenograstim|lenograstim|mesh-list
44540120|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44540121|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
44540122|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540123|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540124|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540125|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
44540126|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540127|NCT00103506|Doxorubicin|doxorubicin|mesh-list
44540128|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44540129|NCT00103506|Bortezomib|bortezomib|mesh-list
44540130|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44540131|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540132|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540133|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540134|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540135|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540136|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
44540137|NCT00103285|Leucovorin|leucovorin|mesh-list
44540138|NCT00103285|Folic Acid|folic acid|mesh-list
44540139|NCT00103285|Cytarabine|cytarabine|mesh-list
44540140|NCT00103285|Dexamethasone|dexamethasone|mesh-list
44540141|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
44540142|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
44540143|NCT00103285|Doxorubicin|doxorubicin|mesh-list
44540144|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44540145|NCT00103285|Methotrexate|methotrexate|mesh-list
44540146|NCT00103285|Vincristine|vincristine|mesh-list
44540147|NCT00103285|Asparaginase|asparaginase|mesh-list
44540148|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
44540149|NCT00103285|Pegaspargase|pegaspargase|mesh-list
44540150|NCT00103285|Thioguanine|thioguanine|mesh-list
44540151|NCT00103285|BB 1101|bb 1101|mesh-list
44540152|NCT00103285|Calcium|calcium|mesh-list
44540153|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
44540154|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
44540155|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540156|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
44540157|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540158|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540159|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44540160|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
44540161|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540162|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540163|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44540164|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540165|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
44540166|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
44540167|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540168|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540169|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
44540170|NCT00103285|Hormones|hormones|mesh-ancestor
44540171|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540172|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540173|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
44540174|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540175|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44540176|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540177|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540178|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44540179|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44540180|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44540181|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
44540182|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44540183|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540184|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
44540185|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
44540186|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44540187|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540188|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
44540189|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540190|NCT00103285|Antidotes|antidotes|mesh-ancestor
44540191|NCT00103285|Protective Agents|protective agents|mesh-ancestor
44540192|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
44540193|NCT00103285|Vitamins|vitamins|mesh-ancestor
44540194|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
44540195|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540196|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540197|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540198|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540199|NCT00103285|Hematinics|hematinics|mesh-ancestor
44540200|NCT00103259|Irinotecan|irinotecan|mesh-list
44540201|NCT00103259|Bortezomib|bortezomib|mesh-list
44540202|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44540203|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540204|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540205|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540206|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540207|NCT00103207|Cetuximab|cetuximab|mesh-list
44540208|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540209|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540210|NCT00103142|Sargramostim|sargramostim|mesh-list
44540211|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
44540212|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540213|NCT00102960|Ritonavir|ritonavir|mesh-list
44540214|NCT00102960|Lopinavir|lopinavir|mesh-list
44540215|NCT00102960|Lamivudine|lamivudine|mesh-list
44540216|NCT00102960|Zidovudine|zidovudine|mesh-list
44540217|NCT00102960|Nevirapine|nevirapine|mesh-list
44540218|NCT00102960|Abacavir|abacavir|mesh-list
44540220|NCT00102960|Efavirenz|efavirenz|mesh-list
44540221|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44540222|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44540223|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
44540224|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540225|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540226|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540227|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540228|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
44540229|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540230|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44540231|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44540232|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44540233|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540234|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
44540235|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44540236|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44540237|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44540238|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44540239|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44540240|NCT00102804|Pemetrexed|pemetrexed|mesh-list
44540241|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540242|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540243|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540244|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44540245|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540246|NCT00102687|Azacitidine|azacitidine|mesh-list
44540247|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540248|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
44540249|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540250|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540251|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540252|NCT00102531|Cisplatin|cisplatin|mesh-list
44540253|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540254|NCT00102440|Allopurinol|allopurinol|mesh-list
44540255|NCT00102440|Febuxostat|febuxostat|mesh-list
44540256|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
44540257|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540258|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540259|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
44540260|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540261|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44540262|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
44540263|NCT00102440|Protective Agents|protective agents|mesh-ancestor
44540264|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540265|NCT00101907|Gemcitabine|gemcitabine|mesh-list
44540266|NCT00101907|Cisplatin|cisplatin|mesh-list
44540267|NCT00101907|Panitumumab|panitumumab|mesh-list
44540268|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
44540269|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540270|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540271|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
44540272|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540273|NCT00101907|Antiviral Agents|antiviral agents|mesh-ancestor
44540274|NCT00101907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540275|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540276|NCT00101907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540277|NCT00101907|Immunologic Factors|immunologic factors|mesh-ancestor
44540278|NCT00101907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540279|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540280|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540281|NCT00101686|Bevacizumab|bevacizumab|mesh-list
44540282|NCT00101686|Capecitabine|capecitabine|mesh-list
44540283|NCT00101686|Irinotecan|irinotecan|mesh-list
44540284|NCT00101686|Fluorouracil|fluorouracil|mesh-list
44540285|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540286|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540287|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44540288|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44540289|NCT00101686|Growth Substances|growth substances|mesh-ancestor
44540290|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444155|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
44540291|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
44540292|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540293|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
44540307|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540308|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
44540309|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540310|NCT00101452|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44540311|NCT00101452|Antidepressive Agents|antidepressive agents|mesh-ancestor
44540312|NCT00101452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44540313|NCT00101439|Ezetimibe|ezetimibe|mesh-list
44540314|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44540315|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44540316|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
44540317|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540318|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44540319|NCT00101283|Gemcitabine|gemcitabine|mesh-list
44540320|NCT00101283|Carboplatin|carboplatin|mesh-list
44540321|NCT00101283|Pemetrexed|pemetrexed|mesh-list
44540322|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540323|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540324|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
44540325|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540326|NCT00101283|Antiviral Agents|antiviral agents|mesh-ancestor
44540327|NCT00101283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540328|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540329|NCT00101283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540330|NCT00101283|Immunologic Factors|immunologic factors|mesh-ancestor
44540331|NCT00101283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540332|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44540333|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540334|NCT00101192|Cisplatin|cisplatin|mesh-list
44540335|NCT00101192|Cetuximab|cetuximab|mesh-list
44540336|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540337|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540338|NCT00101166|Vaccines|vaccines|mesh-list
44540339|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
44540340|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540341|NCT00101101|Aldesleukin|aldesleukin|mesh-list
44540342|NCT00101101|Dexamethasone|dexamethasone|mesh-list
44540343|NCT00101101|Prednisone|prednisone|mesh-list
44540344|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
44540345|NCT00101101|Doxorubicin|doxorubicin|mesh-list
44540346|NCT00101101|Vincristine|vincristine|mesh-list
44540347|NCT00101101|Interleukin-2|interleukin-2|mesh-list
44540348|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540349|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
44540350|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540351|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540352|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44540353|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
44540354|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540355|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540356|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44540357|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540358|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
44540359|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
44540360|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540361|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540362|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
44540363|NCT00101101|Hormones|hormones|mesh-ancestor
44540364|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540365|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540366|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44540367|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540368|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540369|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540370|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540371|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540372|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540373|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540374|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540375|NCT00101101|Analgesics|analgesics|mesh-ancestor
44540376|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
44540377|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540378|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540379|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
44540380|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540381|NCT00101010|Prednisone|prednisone|mesh-list
44540382|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
44540383|NCT00101010|Rituximab|rituximab|mesh-list
44540384|NCT00101010|Doxorubicin|doxorubicin|mesh-list
44364274|NCT01158365|Glycerol|glycerol|mesh-list
44540385|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44540386|NCT00101010|Vincristine|vincristine|mesh-list
44540387|NCT00101010|Lenograstim|lenograstim|mesh-list
44540388|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540389|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
44540390|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540391|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540392|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44540393|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
44540394|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540395|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540396|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44540397|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540398|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44444247|NCT01849289|Insulin|insulin|mesh-list
44540399|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540400|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540401|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540402|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540403|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
44540405|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540406|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540407|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44540408|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540409|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540410|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540411|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540412|NCT00100828|Irinotecan|irinotecan|mesh-list
44540413|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44540414|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540415|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540416|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540417|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540418|NCT00100815|Gemcitabine|gemcitabine|mesh-list
44540419|NCT00100815|Bevacizumab|bevacizumab|mesh-list
44540420|NCT00100815|Capecitabine|capecitabine|mesh-list
44540421|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540422|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540423|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44540424|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44540425|NCT00100815|Growth Substances|growth substances|mesh-ancestor
44540426|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540427|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44540428|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540429|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
44540430|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540431|NCT00100815|Antiviral Agents|antiviral agents|mesh-ancestor
44540432|NCT00100815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540433|NCT00100815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540434|NCT00100815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540435|NCT00100815|Immunologic Factors|immunologic factors|mesh-ancestor
44540436|NCT00100802|Temozolomide|temozolomide|mesh-list
44540437|NCT00100802|Lomustine|lomustine|mesh-list
44540438|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44540439|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
44540440|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540441|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540442|NCT00100789|Gemcitabine|gemcitabine|mesh-list
44540443|NCT00100789|Paclitaxel|paclitaxel|mesh-list
44540444|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540445|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540446|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540447|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540448|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540449|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540450|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540451|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
44540452|NCT00100789|Antiviral Agents|antiviral agents|mesh-ancestor
44540453|NCT00100789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540454|NCT00100789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540455|NCT00100789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540456|NCT00100789|Immunologic Factors|immunologic factors|mesh-ancestor
44540457|NCT00100789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540458|NCT00100048|Tenofovir|tenofovir|mesh-list
44540459|NCT00100048|Lamivudine|lamivudine|mesh-list
44540460|NCT00100048|Efavirenz|efavirenz|mesh-list
44540461|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
44540462|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
44540463|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540464|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44540465|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540466|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540467|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540468|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44540469|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44540470|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44540471|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44540472|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44540473|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44540474|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44540475|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44540476|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44540477|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44540478|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44540479|NCT00103038|Hematinics|hematinics|mesh-ancestor
44540480|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44540481|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44540482|NCT00109681|Iloprost|iloprost|mesh-list
44540483|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540484|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
44540485|NCT00109538|Lonafarnib|lonafarnib|mesh-list
44540486|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540487|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540488|NCT00108810|Ketoprofen|ketoprofen|mesh-list
44540489|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44540490|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540491|NCT00108810|Analgesics|analgesics|mesh-ancestor
44540492|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
44540493|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540494|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540495|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540496|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540497|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44540498|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540499|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540500|NCT00106808|Pioglitazone|pioglitazone|mesh-list
44540501|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44540502|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540503|NCT00106626|Cisplatin|cisplatin|mesh-list
44540504|NCT00106626|Pemetrexed|pemetrexed|mesh-list
44540505|NCT00106626|Vorinostat|vorinostat|mesh-list
44540506|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540507|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540508|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540509|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44540510|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44540511|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44540512|NCT00106340|Metformin|metformin|mesh-list
44540513|NCT00106340|Glimepiride|glimepiride|mesh-list
44540514|NCT00106340|Vildagliptin|vildagliptin|mesh-list
44540515|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44540516|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540517|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44540518|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540519|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
43946618|NCT01047189|Tretinoin|tretinoin|mesh-list
44540520|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44540521|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
44540522|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540523|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540524|NCT00103831|Taxane|taxane|mesh-list
44540525|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540526|NCT00102466|Metformin|metformin|mesh-list
44540527|NCT00102466|Vildagliptin|vildagliptin|mesh-list
44540528|NCT00102466|Gliclazide|gliclazide|mesh-list
44540529|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44540530|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540531|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44540532|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
44540533|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540534|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540535|NCT00101595|Dasatinib|dasatinib|mesh-list
44540536|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540537|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364428|NCT01159327|Sorafenib|sorafenib|mesh-list
44540547|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540548|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540549|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540550|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540551|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540552|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540553|NCT02030054|Atorvastatin|atorvastatin|mesh-list
44540554|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44540555|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44540556|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44540557|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
44540558|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540559|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44540560|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44540561|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540562|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
44540563|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44540564|NCT02030314|Diuretics|diuretics|mesh-ancestor
44540565|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
44540566|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540567|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44540568|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540569|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540570|NCT02030483|Dexamethasone|dexamethasone|mesh-list
44540571|NCT02030483|Lenalidomide|lenalidomide|mesh-list
44540572|NCT02030483|Palbociclib|palbociclib|mesh-list
44540573|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540574|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
44540575|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
44444420|NCT01845831|Incretins|incretins|mesh-ancestor
44540576|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540577|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540578|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540579|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
44540581|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540582|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540583|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540584|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
44540585|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44540586|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44540587|NCT02030483|Growth Substances|growth substances|mesh-ancestor
44540588|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
44540589|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540590|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540591|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540592|NCT02030639|ON 01910|on 01910|mesh-list
44540593|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540594|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540595|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540596|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540597|NCT02030678|Irinotecan|irinotecan|mesh-list
44540598|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44540599|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540600|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540601|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540602|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540603|NCT02030717|Clonidine|clonidine|mesh-list
44540604|NCT02030717|Anesthetics|anesthetics|mesh-list
44540605|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540606|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540607|NCT02030717|Analgesics|analgesics|mesh-ancestor
44540608|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
44540609|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540610|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44540611|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
44540612|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
44540613|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44540614|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44540615|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44540616|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
44540617|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540618|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540619|NCT02030912|Amoxicillin|amoxicillin|mesh-list
44540620|NCT02030912|Minocycline|minocycline|mesh-list
44540621|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44540622|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540623|NCT02030977|Resveratrol|resveratrol|mesh-list
44540624|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
44540625|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540626|NCT02030977|Protective Agents|protective agents|mesh-ancestor
44540627|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540628|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540629|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540630|NCT02031016|Fentanyl|fentanyl|mesh-list
44540631|NCT02031016|Remifentanil|remifentanil|mesh-list
44540632|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44540633|NCT02031016|Narcotics|narcotics|mesh-ancestor
44540634|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540635|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540636|NCT02031016|Analgesics|analgesics|mesh-ancestor
44540637|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
44540638|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540639|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44540640|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44540641|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
44540642|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
44540643|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44540644|NCT02031081|Prucalopride|prucalopride|mesh-list
44540645|NCT02031081|Laxatives|laxatives|mesh-ancestor
44540646|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540647|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44540648|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44540649|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
44540650|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540651|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540652|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540653|NCT02031211|Etanercept|etanercept|mesh-list
44540654|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44540655|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540656|NCT02031211|Analgesics|analgesics|mesh-ancestor
44540657|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
44540658|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540659|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540660|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540661|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540662|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540663|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44540664|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
44540665|NCT02031289|Folic Acid|folic acid|mesh-list
44540666|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
44540667|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
44540668|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
44540669|NCT02031289|Vitamins|vitamins|mesh-ancestor
44540670|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
44540671|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540672|NCT02031289|Hematinics|hematinics|mesh-ancestor
44540673|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
44540674|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
44540675|NCT02031510|Bupivacaine|bupivacaine|mesh-list
44540676|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
44540677|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
44540678|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540679|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540680|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
44540681|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540682|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44540683|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540684|NCT02031510|Analgesics|analgesics|mesh-ancestor
44540685|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44540686|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44540687|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44540688|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44540689|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540690|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540691|NCT02031523|Analgesics|analgesics|mesh-list
44540692|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
44540693|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540694|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540695|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44540696|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
44540697|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540698|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44540699|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540700|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540701|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540702|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540703|NCT02031861|Nifedipine|nifedipine|mesh-list
44540704|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44540705|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540706|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540707|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44540708|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540709|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
44540710|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
44540711|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44540712|NCT02031939|Capecitabine|capecitabine|mesh-list
44540713|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
44540714|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44540715|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
44540716|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540717|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540718|NCT02031965|Dexamethasone|dexamethasone|mesh-list
44540719|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540720|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
44540721|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
44540722|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540723|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540724|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540725|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
44540726|NCT02031965|Hormones|hormones|mesh-ancestor
44540727|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540728|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540729|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540730|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
44540731|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44540732|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
44540733|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44540734|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
44540735|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540736|NCT02032290|Clopidogrel|clopidogrel|mesh-list
44540737|NCT02032290|Ticagrelor|ticagrelor|mesh-list
44540738|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540739|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44540740|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44540741|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44540742|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
44540743|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540744|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540745|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540746|NCT02032303|Ticagrelor|ticagrelor|mesh-list
44540747|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44540748|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540749|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44540750|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44540751|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44540752|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
44540753|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540754|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540755|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540756|NCT02032355|Anesthetics|anesthetics|mesh-list
44540757|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540758|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540759|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
44540760|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44540761|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
44540762|NCT02032394|Povidone|povidone|mesh-list
44540763|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44540764|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540765|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
44540766|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
44540767|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
44540768|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
44540769|NCT02032784|Octreotide|octreotide|mesh-list
44540770|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540771|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44540772|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540773|NCT02032797|Progesterone|progesterone|mesh-list
44540774|NCT02032797|Progestins|progestins|mesh-ancestor
44540775|NCT02032797|Hormones|hormones|mesh-ancestor
44540776|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540777|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540778|NCT02032836|Iloprost|iloprost|mesh-list
44540779|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540780|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
44540781|NCT02032927|Acetaminophen|acetaminophen|mesh-list
44540782|NCT02032927|Oxycodone|oxycodone|mesh-list
44540783|NCT02032927|Codeine|codeine|mesh-list
44540784|NCT02032927|Naloxone|naloxone|mesh-list
44540785|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540786|NCT02032927|Analgesics|analgesics|mesh-ancestor
44540787|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
44540788|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540789|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540790|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
44540791|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44540792|NCT02032927|Narcotics|narcotics|mesh-ancestor
44540793|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540794|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44540795|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
44540796|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44540797|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44540798|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44540799|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44540800|NCT02033018|Aflibercept|aflibercept|mesh-list
44540801|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44540802|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44540803|NCT02033018|Growth Substances|growth substances|mesh-ancestor
44540804|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540805|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44540806|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540807|NCT02033031|Bevacizumab|bevacizumab|mesh-list
44540808|NCT02033031|Ranibizumab|ranibizumab|mesh-list
44540809|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44540810|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540811|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44540812|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44540813|NCT02033031|Growth Substances|growth substances|mesh-ancestor
44540814|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540815|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44540817|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540818|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540819|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
44540820|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44540821|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540822|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
44540823|NCT02033239|Insulin|insulin|mesh-list
44540824|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44540825|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
44540826|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
44540827|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44540828|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44540829|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540830|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44540832|NCT02033408|Metronidazole|metronidazole|mesh-list
44540833|NCT02033408|Vancomycin|vancomycin|mesh-list
44540834|NCT02033408|Doxycycline|doxycycline|mesh-list
44540835|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
44540836|NCT02033408|Gentamicins|gentamicins|mesh-list
44540837|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540838|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44540839|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44540840|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
44540841|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44540842|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44540843|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540844|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540845|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540846|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44540847|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44540848|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44540849|NCT02033434|Ketamine|ketamine|mesh-list
44540850|NCT02033434|Analgesics|analgesics|mesh-ancestor
44540851|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
44540852|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540853|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540854|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44540855|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44540856|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
44540857|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
44540858|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540859|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44540860|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44540861|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540862|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540863|NCT02033512|Hormones|hormones|mesh-list
44540864|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44540865|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540866|NCT02033538|Paclitaxel|paclitaxel|mesh-list
44540867|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44540868|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540869|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540870|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540871|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540872|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540873|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540874|NCT02033551|Paclitaxel|paclitaxel|mesh-list
44540875|NCT02033551|Carboplatin|carboplatin|mesh-list
44540876|NCT02033551|Veliparib|veliparib|mesh-list
44540877|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44540878|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540879|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44540880|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44540881|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44540882|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540883|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44540884|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540885|NCT02033603|Ropivacaine|ropivacaine|mesh-list
44540886|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
44540887|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
44540888|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44540889|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540890|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
44540907|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540908|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
44540909|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44540910|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44540911|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44540912|NCT02033798|Tamsulosin|tamsulosin|mesh-list
44444736|NCT01840943|Topotecan|topotecan|mesh-list
44540913|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44540914|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44364909|NCT01161667|Naratriptan|naratriptan|mesh-list
44540915|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44540916|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
44540917|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540918|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540919|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540921|NCT02033941|Phenol|phenol|mesh-list
44540922|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44540923|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44540924|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
44540925|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44540926|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44540927|NCT02033967|Milrinone|milrinone|mesh-list
44540928|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
44540929|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44540930|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540931|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44540932|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44540933|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540934|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540935|NCT02033967|Protective Agents|protective agents|mesh-ancestor
44540936|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540937|NCT02034071|Diazoxide|diazoxide|mesh-list
44540938|NCT02034071|Choline|choline|mesh-list
44540939|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
44540940|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44540941|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
44540942|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540943|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44540944|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44540945|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
44540946|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44540947|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
44540948|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44540949|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44540950|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44540951|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540952|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540953|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44540954|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44540955|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540956|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44540957|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44540958|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44540959|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540960|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
44540961|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540962|NCT02034292|Aspirin|aspirin|mesh-list
44540963|NCT02034292|Clopidogrel|clopidogrel|mesh-list
44540964|NCT02034292|APD791|apd791|mesh-list
44540965|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44540966|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44540967|NCT02034292|Analgesics|analgesics|mesh-ancestor
44444781|NCT01840228|Progesterone|progesterone|mesh-list
44540968|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
44540969|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44540970|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540971|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44540972|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44540973|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44540974|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44540975|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540976|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44540977|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44540978|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44540979|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
44540980|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44540981|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44540982|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44540983|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
44540984|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540985|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44540986|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44540987|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
44540988|NCT02034604|Tamsulosin|tamsulosin|mesh-list
44540989|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44540990|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44540991|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44540992|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44540993|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44540994|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44540995|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44540996|NCT02034604|Urological Agents|urological agents|mesh-ancestor
44540997|NCT02034630|Busulfan|busulfan|mesh-list
44540998|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
44540999|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541000|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541001|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
44541002|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541003|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44541004|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541005|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44541006|NCT02034838|Ritonavir|ritonavir|mesh-list
44541007|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44541008|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44541009|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44541010|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
44541011|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541012|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541013|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44541014|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44541015|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
44541016|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541017|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44541018|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44541019|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
44541020|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44541021|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
44541022|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541023|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
44541024|NCT02034890|Protective Agents|protective agents|mesh-ancestor
44541025|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
44541026|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541027|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541028|NCT02035072|Gemcitabine|gemcitabine|mesh-list
44541029|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
44541030|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541031|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
44541032|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541033|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541034|NCT02035072|Antiviral Agents|antiviral agents|mesh-ancestor
44541035|NCT02035072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541036|NCT02035072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541037|NCT02035072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541038|NCT02035072|Immunologic Factors|immunologic factors|mesh-ancestor
44541039|NCT02035072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541040|NCT02035215|Atorvastatin|atorvastatin|mesh-list
44541041|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44541042|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44541043|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
44541044|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541045|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44541046|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44541047|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365002|NCT01162824|Acetylcholine|acetylcholine|mesh-list
44541064|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541065|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541066|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541067|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541068|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541069|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44541070|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541072|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541073|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44541074|NCT02035904|Morphine|morphine|mesh-list
44541075|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
44541076|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541077|NCT02035904|Narcotics|narcotics|mesh-ancestor
44541078|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541079|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541080|NCT02035904|Analgesics|analgesics|mesh-ancestor
44541081|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
44541082|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541083|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541084|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
44541085|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
44541086|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44541087|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541088|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541089|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44541090|NCT02035930|Analgesics|analgesics|mesh-ancestor
44541091|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
44541092|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541093|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44541094|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44541095|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44541096|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
44541097|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541098|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541099|NCT02035943|Insulin|insulin|mesh-list
44541100|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44541101|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44541102|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541103|NCT02035982|Rivastigmine|rivastigmine|mesh-list
44541104|NCT02035982|Donepezil|donepezil|mesh-list
44541105|NCT02035982|Galantamine|galantamine|mesh-list
44541106|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44541107|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541108|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541109|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
44541110|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541111|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541112|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
44541113|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44541114|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
44541115|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541116|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44541117|NCT02035982|Protective Agents|protective agents|mesh-ancestor
44541118|NCT02036008|Liver Extracts|liver extracts|mesh-list
44541119|NCT02036008|Hematinics|hematinics|mesh-ancestor
44541120|NCT02036060|Prednisone|prednisone|mesh-list
44541121|NCT02036060|Docetaxel|docetaxel|mesh-list
44541122|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541123|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541124|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541125|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541126|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541127|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541128|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
44541129|NCT02036060|Hormones|hormones|mesh-ancestor
44541130|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541131|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541132|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541133|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
44541134|NCT02036073|Hematinics|hematinics|mesh-ancestor
44541135|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
44541136|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44541137|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44541138|NCT02036125|Prednisolone|prednisolone|mesh-list
44541139|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
44541140|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44541141|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
44541142|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541143|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
44541144|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
44541145|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541146|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541147|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541148|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
44541149|NCT02036125|Hormones|hormones|mesh-ancestor
44541150|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541151|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44541152|NCT02036125|Protective Agents|protective agents|mesh-ancestor
44541153|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541154|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541155|NCT02036164|Paclitaxel|paclitaxel|mesh-list
44541156|NCT02036164|Cisplatin|cisplatin|mesh-list
44541157|NCT02036164|Carboplatin|carboplatin|mesh-list
44541158|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541159|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541160|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541161|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541162|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541163|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541164|NCT02036229|Ivermectin|ivermectin|mesh-list
44541165|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44541166|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541167|NCT02036242|Sufentanil|sufentanil|mesh-list
44541168|NCT02036242|Ropivacaine|ropivacaine|mesh-list
44541169|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
44541170|NCT02036242|Anesthetics|anesthetics|mesh-list
44541171|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541172|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541173|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
44541174|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541175|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541176|NCT02036242|Narcotics|narcotics|mesh-ancestor
44541177|NCT02036242|Analgesics|analgesics|mesh-ancestor
44541178|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44541179|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541180|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
44541181|NCT02036281|Substance P|substance p|mesh-list
44541182|NCT02036281|Neurokinin A|neurokinin a|mesh-list
44541183|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541184|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541185|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541186|NCT02036359|Docetaxel|docetaxel|mesh-list
44541187|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44541188|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541189|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541190|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541191|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541192|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541193|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44541194|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541195|NCT02036372|Insulin|insulin|mesh-list
44541196|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44541197|NCT02036372|Liraglutide|liraglutide|mesh-list
44541198|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44541199|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541200|NCT02036372|Incretins|incretins|mesh-ancestor
44541201|NCT02036372|Hormones|hormones|mesh-ancestor
44541202|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541203|NCT02036437|Misoprostol|misoprostol|mesh-list
44541204|NCT02036437|Dinoprostone|dinoprostone|mesh-list
44541205|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44541206|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
44541207|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44541208|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541209|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44541210|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541211|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
44541212|NCT02036463|Prednisone|prednisone|mesh-list
44541213|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541214|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
44541215|NCT02036463|Hormones|hormones|mesh-ancestor
44541216|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541217|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541218|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541219|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541220|NCT02036489|Prednisone|prednisone|mesh-list
44541221|NCT02036489|Vincristine|vincristine|mesh-list
44541222|NCT02036489|Daunorubicin|daunorubicin|mesh-list
44541223|NCT02036489|Asparaginase|asparaginase|mesh-list
44541224|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
44541225|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541226|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
44541227|NCT02036489|Hormones|hormones|mesh-ancestor
44541228|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541229|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541230|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541231|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541232|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541233|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541234|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541236|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541237|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44541238|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44541239|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44541240|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541241|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
44541242|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541243|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541244|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
44541245|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541246|NCT02036528|Doxycycline|doxycycline|mesh-list
44541247|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
44541248|NCT02036528|Gentamicins|gentamicins|mesh-list
44541249|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44541250|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541251|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
44541252|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44541253|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44541254|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44541255|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44541256|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541257|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541258|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541259|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44541260|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44541261|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44541262|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
44541263|NCT02036554|Everolimus|everolimus|mesh-list
44541264|NCT02036554|Tacrolimus|tacrolimus|mesh-list
44541265|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541266|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
44541267|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541268|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44541269|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541270|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541271|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541272|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44541273|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44541274|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
44541275|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44541276|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541277|NCT02036697|Fentanyl|fentanyl|mesh-list
44541278|NCT02036697|Morphine|morphine|mesh-list
44541279|NCT02036697|Bupivacaine|bupivacaine|mesh-list
44541280|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541281|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
44541282|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541283|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541284|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
44541285|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541286|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541287|NCT02036697|Narcotics|narcotics|mesh-ancestor
44541288|NCT02036697|Analgesics|analgesics|mesh-ancestor
44541289|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44541290|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541291|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
44541292|NCT02036723|Bevacizumab|bevacizumab|mesh-list
44541293|NCT02036723|Ranibizumab|ranibizumab|mesh-list
44541294|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541295|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541296|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44541297|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44541298|NCT02036723|Growth Substances|growth substances|mesh-ancestor
44541299|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541300|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44541301|NCT02036736|Propofol|propofol|mesh-list
44541302|NCT02036736|Anesthetics|anesthetics|mesh-list
44541303|NCT02036736|Desflurane|desflurane|mesh-list
44541304|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44541305|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541306|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541307|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541308|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
44541309|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44541310|NCT02036827|Bromides|bromides|mesh-list
44541311|NCT02036827|Rocuronium|rocuronium|mesh-list
44541312|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
44541313|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44541314|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44541315|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44541316|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541317|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541318|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44541319|NCT02036879|Norethindrone|norethindrone|mesh-list
44541320|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
44541321|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44541322|NCT02036879|Estradiol|estradiol|mesh-list
44541323|NCT02036879|Estrogens|estrogens|mesh-ancestor
44541324|NCT02036879|Hormones|hormones|mesh-ancestor
44541325|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541326|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541327|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44541328|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
44541329|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44541330|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44541331|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44541332|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44541333|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44541334|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44541335|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44541336|NCT02036983|Anesthetics|anesthetics|mesh-list
44541337|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
44541338|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541339|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541340|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
44541341|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541342|NCT02037009|Anesthetics|anesthetics|mesh-list
44541343|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541344|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541345|NCT02037035|Ketamine|ketamine|mesh-list
44541346|NCT02037035|Analgesics|analgesics|mesh-ancestor
44541347|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
44541348|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541349|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541350|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44541351|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541352|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
44541353|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
44541354|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541355|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44541356|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44541357|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541358|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541373|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44541374|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541375|NCT02037399|Dexamethasone|dexamethasone|mesh-list
44541376|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541377|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
44541378|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
44541379|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541380|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541381|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541382|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
44541383|NCT02037399|Hormones|hormones|mesh-ancestor
44541384|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541385|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541386|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541387|NCT02037412|Clopidogrel|clopidogrel|mesh-list
44541388|NCT02037412|Ticagrelor|ticagrelor|mesh-list
44541389|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44541390|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44541391|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44541392|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44541394|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541395|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541396|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541397|NCT02037464|Capsaicin|capsaicin|mesh-list
44541398|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
44541399|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44541400|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
44541401|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541402|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541404|NCT02037503|Analgesics|analgesics|mesh-ancestor
44541405|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
44541406|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541407|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541408|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44541409|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541410|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
44541411|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
44541412|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541413|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44541414|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44541415|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541416|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541417|NCT02037516|Neostigmine|neostigmine|mesh-list
44541418|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44541419|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541420|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541421|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44541422|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541423|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541424|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44541425|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
44541426|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541427|NCT02037633|Fentanyl|fentanyl|mesh-list
44541428|NCT02037633|Ropivacaine|ropivacaine|mesh-list
44541429|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541430|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
44541431|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541432|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541433|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
44541434|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541435|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541436|NCT02037633|Narcotics|narcotics|mesh-ancestor
44541437|NCT02037633|Analgesics|analgesics|mesh-ancestor
44541438|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44541439|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541440|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
44541441|NCT02037672|Metformin|metformin|mesh-list
44541442|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44541443|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541444|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
44541445|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541446|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
44445236|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541447|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541448|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541449|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
44541450|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541451|NCT02037724|Iron|iron|mesh-list
44541452|NCT02037724|Trace Elements|trace elements|mesh-ancestor
44541453|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
44541454|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541455|NCT02037737|Abatacept|abatacept|mesh-list
44541456|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44541457|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541458|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541459|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541460|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
44541461|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541462|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44541463|NCT02037802|Fentanyl|fentanyl|mesh-list
44541464|NCT02037802|Meperidine|meperidine|mesh-list
44541465|NCT02037802|Bupivacaine|bupivacaine|mesh-list
44541466|NCT02037802|Propofol|propofol|mesh-list
44541467|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541468|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
44541469|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541470|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541471|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
44541472|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541473|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44541474|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44541476|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541477|NCT02037802|Narcotics|narcotics|mesh-ancestor
44541478|NCT02037802|Analgesics|analgesics|mesh-ancestor
44541479|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44541480|NCT02037815|Mannitol|mannitol|mesh-list
44541481|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44541482|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44541483|NCT02037815|Diuretics|diuretics|mesh-ancestor
44541484|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
44541485|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541486|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
44541487|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44541488|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541489|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
44541490|NCT02037997|Docetaxel|docetaxel|mesh-list
44541491|NCT02037997|Pemetrexed|pemetrexed|mesh-list
44541492|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44541493|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541494|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541495|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541496|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541497|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541498|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541499|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44541500|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541501|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44541502|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44541503|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44541504|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
44541505|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
44541506|NCT02038335|Etonogestrel|etonogestrel|mesh-list
44541507|NCT02038335|Norethindrone|norethindrone|mesh-list
44541508|NCT02038335|Estradiol|estradiol|mesh-list
44541509|NCT02038335|Estrogens|estrogens|mesh-ancestor
44541510|NCT02038335|Hormones|hormones|mesh-ancestor
44541511|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541512|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541513|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44541514|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
44541515|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44541516|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44541517|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44541518|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44541519|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44541520|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44541521|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541522|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541523|NCT02038491|Anesthetics|anesthetics|mesh-list
44541524|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541525|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541526|NCT02038621|Paclitaxel|paclitaxel|mesh-list
44541527|NCT02038621|Capecitabine|capecitabine|mesh-list
44541528|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
44541529|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541530|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541531|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541532|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541533|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541534|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541535|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541536|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
44541537|NCT02038699|TIC10 compound|tic10 compound|mesh-list
44541538|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541539|NCT02038816|Azacitidine|azacitidine|mesh-list
44541540|NCT02038816|Deferasirox|deferasirox|mesh-list
44541541|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541542|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
44541543|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541544|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541545|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541551|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541553|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44541554|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
44541555|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541556|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541557|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44541558|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
44541559|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
44541560|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44541561|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
44541562|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541563|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541564|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
44541565|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44541566|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
44541567|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541568|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541569|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44541570|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44541571|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
44541572|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44541573|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
44541574|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541575|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365619|NCT01166542|Carboplatin|carboplatin|mesh-list
44541589|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44541590|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44541591|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44541592|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44541593|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44541594|NCT02039336|Docetaxel|docetaxel|mesh-list
44541595|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541596|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541597|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541598|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541599|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541600|NCT02039362|Tenofovir|tenofovir|mesh-list
44541601|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
44541602|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541603|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44541604|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541605|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541606|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541607|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44541608|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44541609|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
44541610|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
44541611|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541612|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541613|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541614|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
44541615|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44541616|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541617|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541618|NCT02039518|Gemcitabine|gemcitabine|mesh-list
44541619|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541620|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
44541621|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541622|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541623|NCT02039518|Antiviral Agents|antiviral agents|mesh-ancestor
44541624|NCT02039518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541625|NCT02039518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541626|NCT02039518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541627|NCT02039518|Immunologic Factors|immunologic factors|mesh-ancestor
44541628|NCT02039518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541629|NCT02039531|Mitogens|mitogens|mesh-list
44541630|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
44365695|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44541631|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541632|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541633|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44541634|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
44541635|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541636|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
44541637|NCT02039531|Protective Agents|protective agents|mesh-ancestor
44541638|NCT02039661|Lidocaine|lidocaine|mesh-list
44541639|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
44541640|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
44541641|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541642|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541644|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541645|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44541646|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44541647|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44541648|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541649|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541650|NCT02039700|Lesinurad|lesinurad|mesh-list
44541651|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
44541652|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44541653|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
44541654|NCT02039700|Renal Agents|renal agents|mesh-ancestor
44541655|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44541656|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44541657|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44541658|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44541659|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44541660|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
44541661|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541662|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541663|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541664|NCT02039791|Paclitaxel|paclitaxel|mesh-list
44541665|NCT02039791|Carboplatin|carboplatin|mesh-list
44541666|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
44541667|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541668|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541669|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541670|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541671|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541672|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541673|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541674|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44541675|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
44541676|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44541677|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
44541678|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541679|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
44541680|NCT02039804|Protective Agents|protective agents|mesh-ancestor
44541681|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541682|NCT02039960|Bupropion|bupropion|mesh-list
44541683|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44541684|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
44541685|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541686|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44541687|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44541688|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541689|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541690|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
44541691|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541692|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541693|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44541694|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44541695|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541696|NCT02039999|Citric Acid|citric acid|mesh-list
44541697|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
44541698|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44541699|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
44541700|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44541701|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
44541702|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
44541703|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541704|NCT02038868|Tamsulosin|tamsulosin|mesh-list
44445473|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
44541705|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44541706|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44541707|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44541708|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44541709|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541710|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541711|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541712|NCT02038868|Urological Agents|urological agents|mesh-ancestor
44541713|NCT02034422|Antioxidants|antioxidants|mesh-list
44541714|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541716|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541717|NCT02030860|Gemcitabine|gemcitabine|mesh-list
44541718|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44541719|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541720|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
44541721|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541722|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541723|NCT02030860|Antiviral Agents|antiviral agents|mesh-ancestor
44541724|NCT02030860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541725|NCT02030860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541726|NCT02030860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541727|NCT02030860|Immunologic Factors|immunologic factors|mesh-ancestor
44541728|NCT02030860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541729|NCT02035137|Irinotecan|irinotecan|mesh-list
44541730|NCT02035137|Vincristine|vincristine|mesh-list
44541731|NCT02035137|Vorinostat|vorinostat|mesh-list
44541732|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44541733|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44541734|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44541735|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541736|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541737|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541738|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541739|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541740|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541741|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541742|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44541743|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44541744|NCT02032654|Floxacillin|floxacillin|mesh-list
44541745|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44541746|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541747|NCT02039674|Paclitaxel|paclitaxel|mesh-list
44541748|NCT02039674|Bevacizumab|bevacizumab|mesh-list
44541749|NCT02039674|Carboplatin|carboplatin|mesh-list
44541750|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
44541751|NCT02039674|Pemetrexed|pemetrexed|mesh-list
44541752|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44541753|NCT02039674|Ipilimumab|ipilimumab|mesh-list
44541754|NCT02039674|Gefitinib|gefitinib|mesh-list
44541755|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44541756|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541757|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445516|NCT01825876|Warfarin|warfarin|mesh-list
44541758|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541759|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541760|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541761|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541762|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44541763|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44541764|NCT02039674|Growth Substances|growth substances|mesh-ancestor
44541765|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541766|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
44541767|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541768|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44541769|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541770|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44541771|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44541772|NCT02038946|Nivolumab|nivolumab|mesh-list
44541773|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541774|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541775|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44541776|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541777|NCT02031601|Cisplatin|cisplatin|mesh-list
44541778|NCT02031601|Carboplatin|carboplatin|mesh-list
44541779|NCT02031601|Docetaxel|docetaxel|mesh-list
44541780|NCT02031601|Pemetrexed|pemetrexed|mesh-list
44541781|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44541782|NCT02031601|Gefitinib|gefitinib|mesh-list
44541783|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541784|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44541785|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44541786|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44541787|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541788|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541789|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44541790|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44541791|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44541792|NCT02034331|Acetylcholine|acetylcholine|mesh-list
44541793|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541794|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44541795|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44541796|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
44541797|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541798|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541799|NCT02034500|Vaccines|vaccines|mesh-list
44541800|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
44541801|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541802|NCT02037919|Etonogestrel|etonogestrel|mesh-list
44541803|NCT02037919|Desogestrel|desogestrel|mesh-list
44541804|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44541805|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
44541806|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44541807|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541808|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44541809|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44541810|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44541811|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44541812|NCT02037919|Progestins|progestins|mesh-ancestor
44541813|NCT02037919|Hormones|hormones|mesh-ancestor
44541814|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541815|NCT02038257|Petrolatum|petrolatum|mesh-list
44541816|NCT02038257|Emollients|emollients|mesh-ancestor
44541817|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44541818|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44541819|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
44541820|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44541821|NCT02038452|Prednisolone|prednisolone|mesh-list
44541822|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
44541823|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44541824|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
44541825|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44541826|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
44541827|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
44541828|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541829|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541830|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541831|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
44541832|NCT02038452|Hormones|hormones|mesh-ancestor
44541833|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541834|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44541835|NCT02038452|Protective Agents|protective agents|mesh-ancestor
44541836|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44541837|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541838|NCT00157937|Theophylline|theophylline|mesh-list
44541839|NCT00157937|Montelukast|montelukast|mesh-list
44541840|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541841|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541842|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541843|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
44541844|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541845|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44541846|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44541847|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44541848|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44541849|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44541850|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44541851|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44541852|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44541853|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44541854|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365898|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
44541855|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
44541856|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44541857|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44541858|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
44541859|NCT00157963|Losartan|losartan|mesh-list
44541860|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44541861|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44541862|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44541863|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44541864|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44541865|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541866|NCT00157963|Diuretics|diuretics|mesh-ancestor
44541867|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
44541868|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541869|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44541870|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541871|NCT00151424|Olanzapine|olanzapine|mesh-list
44541872|NCT00151424|Asenapine|asenapine|mesh-list
44541873|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
44541874|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
44541875|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541876|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541877|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541878|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44541879|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44541880|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541881|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541882|NCT00151424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44541883|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44541884|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445666|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
44541885|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541886|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541887|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
44541888|NCT00159796|Olanzapine|olanzapine|mesh-list
44541889|NCT00159796|Asenapine|asenapine|mesh-list
44541890|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
44541891|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
44541892|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541893|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541894|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541895|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44541896|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44541897|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541898|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541899|NCT00159796|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44541900|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44541901|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541902|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541903|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541904|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
44541905|NCT00159744|Olanzapine|olanzapine|mesh-list
44541906|NCT00159744|Asenapine|asenapine|mesh-list
44541907|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
44541908|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
44541909|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541910|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541911|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541912|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44541913|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44541914|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541915|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44541916|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44541917|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44541918|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44541919|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541920|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541921|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
44541922|NCT00159783|Olanzapine|olanzapine|mesh-list
44541923|NCT00159783|Asenapine|asenapine|mesh-list
44541924|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
44541925|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
44541926|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541927|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541928|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44541929|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44541938|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
44541940|NCT00159432|Capecitabine|capecitabine|mesh-list
44541941|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
44541942|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44541943|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541944|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44541945|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44541946|NCT00159432|Growth Substances|growth substances|mesh-ancestor
44541947|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541948|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
44541949|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44541950|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
44541951|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541952|NCT00158860|Valacyclovir|valacyclovir|mesh-list
44541953|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
44541954|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44541955|NCT00158756|Vaccines|vaccines|mesh-list
44541956|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
44541957|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541958|NCT00158184|Oxycodone|oxycodone|mesh-list
44541959|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44541960|NCT00158184|Narcotics|narcotics|mesh-ancestor
44541961|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541962|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541963|NCT00158184|Analgesics|analgesics|mesh-ancestor
44541964|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
44541965|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541966|NCT00157248|Dabigatran|dabigatran|mesh-list
44541967|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
44541968|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44541969|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
44541970|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44541971|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541972|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
44541973|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
44541974|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44541975|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
44541976|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541977|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44541978|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44541979|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
44445737|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44541980|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541981|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44541982|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44541983|NCT00156533|Zolpidem|zolpidem|mesh-list
44541984|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44541985|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44541986|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44541987|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44541988|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44541989|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
44541990|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
44541991|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44541992|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44541993|NCT00156065|Haloperidol|haloperidol|mesh-list
44541994|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
44541995|NCT00156065|Asenapine|asenapine|mesh-list
44541996|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
44541997|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
44541998|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44541999|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542000|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542001|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44542002|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542003|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542004|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542005|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44542006|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
44542007|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542008|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542009|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44542010|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
44542011|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
44542012|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542013|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542014|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542015|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542016|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
44542017|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44542018|NCT00154297|Everolimus|everolimus|mesh-list
44542019|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542020|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542021|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
44542022|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542023|NCT00154284|Cyclosporine|cyclosporine|mesh-list
44542024|NCT00154284|Prednisone|prednisone|mesh-list
44542025|NCT00154284|Everolimus|everolimus|mesh-list
44542026|NCT00154284|Cyclosporins|cyclosporins|mesh-list
44542027|NCT00154284|Basiliximab|basiliximab|mesh-list
44542028|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542029|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
44542030|NCT00154284|Hormones|hormones|mesh-ancestor
44542031|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542032|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542033|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542034|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542035|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542036|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542037|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542038|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
44542039|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
44542040|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542041|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542042|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542043|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44542044|NCT00154102|Leucovorin|leucovorin|mesh-list
44542045|NCT00154102|Folic Acid|folic acid|mesh-list
44542046|NCT00154102|Fluorouracil|fluorouracil|mesh-list
44542047|NCT00154102|Irinotecan|irinotecan|mesh-list
44542048|NCT00154102|Cetuximab|cetuximab|mesh-list
44542049|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
44542050|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
44542051|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542052|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44542053|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542054|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542055|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
44542056|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542057|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44542058|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44542059|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542060|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44542061|NCT00154102|Antidotes|antidotes|mesh-ancestor
44542062|NCT00154102|Protective Agents|protective agents|mesh-ancestor
44542063|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44542064|NCT00154102|Vitamins|vitamins|mesh-ancestor
44542065|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
44542066|NCT00154102|Hematinics|hematinics|mesh-ancestor
44542067|NCT00153920|Bortezomib|bortezomib|mesh-list
44542068|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542069|NCT00153179|Acipimox|acipimox|mesh-list
44542070|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44542071|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
44542072|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542073|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44542074|NCT00152971|Enoxaparin|enoxaparin|mesh-list
44542075|NCT00152971|Dabigatran|dabigatran|mesh-list
44542076|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
44542077|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44542078|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44542079|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542080|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
44542081|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44542082|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
44542083|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542084|NCT00152477|Paclitaxel|paclitaxel|mesh-list
44542085|NCT00152477|Carboplatin|carboplatin|mesh-list
44542086|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542087|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366128|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542088|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542089|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542090|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542091|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542092|NCT00152464|Levocetirizine|levocetirizine|mesh-list
44542093|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44542094|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44542095|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
44542096|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
44542097|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542098|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542099|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542100|NCT00152009|Guanfacine|guanfacine|mesh-list
44542101|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542102|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44542103|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44542104|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44542105|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542106|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542107|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542108|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542109|NCT00151996|Guanfacine|guanfacine|mesh-list
44542110|NCT00151996|Methylphenidate|methylphenidate|mesh-list
44542111|NCT00151996|Amphetamine|amphetamine|mesh-list
44542112|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44542113|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542114|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44542115|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44445878|NCT01818752|Hormones|hormones|mesh-ancestor
44542116|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44542117|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542118|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
44542119|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542120|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
44542121|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
44542122|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542123|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542124|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44542125|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542126|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44542127|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44542128|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44542129|NCT00151892|Mesalamine|mesalamine|mesh-list
44542130|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542131|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542132|NCT00151892|Analgesics|analgesics|mesh-ancestor
44542133|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
44542134|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542135|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542136|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542137|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542138|NCT00151775|Olmesartan|olmesartan|mesh-list
44542139|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44542140|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542141|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44542142|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44542143|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542144|NCT00151411|Metformin|metformin|mesh-list
44542145|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542146|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542147|NCT00151281|Thalidomide|thalidomide|mesh-list
44542148|NCT00151281|Prednisone|prednisone|mesh-list
44542149|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
44542150|NCT00151281|Rituximab|rituximab|mesh-list
44542151|NCT00151281|Etoposide|etoposide|mesh-list
44542152|NCT00151281|Procarbazine|procarbazine|mesh-list
44542153|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542154|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
44542155|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542156|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542157|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44542158|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
44542159|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542160|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542161|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44542162|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44542163|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542164|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
44542165|NCT00151281|Hormones|hormones|mesh-ancestor
44542166|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542167|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542168|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542169|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44542170|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44542171|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542172|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
44542173|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542174|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542175|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44542176|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44542177|NCT00151281|Growth Substances|growth substances|mesh-ancestor
44542178|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44542179|NCT00150813|Levetiracetam|levetiracetam|mesh-list
44542180|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
44542181|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
44366279|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
44542184|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44542185|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44542186|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44542187|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542188|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542189|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542190|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542191|NCT00150462|Dexamethasone|dexamethasone|mesh-list
44542192|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542193|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
44542194|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
44542195|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542196|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542197|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542198|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
44542200|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542201|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542202|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542203|NCT00150176|Asenapine|asenapine|mesh-list
44542204|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44542205|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542206|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542207|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542208|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542209|NCT00157339|Insulin|insulin|mesh-list
44542210|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44542211|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542212|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542213|NCT00157014|Cyclosporine|cyclosporine|mesh-list
44542214|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
44542215|NCT00157014|Prednisone|prednisone|mesh-list
44542216|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
44542217|NCT00157014|Tacrolimus|tacrolimus|mesh-list
44542218|NCT00157014|Cyclosporins|cyclosporins|mesh-list
44542219|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542220|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
44542221|NCT00157014|Hormones|hormones|mesh-ancestor
44542222|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542223|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542224|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542225|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542226|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542227|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
44542228|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44542229|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542230|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542231|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
44542232|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542233|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542234|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542235|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44542236|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44542237|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
44542238|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542239|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
44542240|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
44542241|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542242|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542243|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44542244|NCT00157014|Protective Agents|protective agents|mesh-ancestor
44542245|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44542246|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44542247|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
44542248|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44542249|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542252|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542253|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542254|NCT02449031|Tobramycin|tobramycin|mesh-list
44366355|NCT01170637|Ibuprofen|ibuprofen|mesh-list
44542255|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542256|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542257|NCT02441439|Iron|iron|mesh-list
44542258|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44542259|NCT02441439|Trace Elements|trace elements|mesh-ancestor
44542260|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
44542261|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542262|NCT02441439|Hematinics|hematinics|mesh-ancestor
44542263|NCT02440009|Itraconazole|itraconazole|mesh-list
44542264|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
44542265|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
44542266|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542267|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44542268|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44542269|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542270|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542271|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44542272|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
44542273|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542274|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542275|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44542276|NCT02440009|Hormones|hormones|mesh-ancestor
44542277|NCT02441686|Dexamethasone|dexamethasone|mesh-list
44542278|NCT02441686|Lenalidomide|lenalidomide|mesh-list
44542279|NCT02441686|Bortezomib|bortezomib|mesh-list
44542280|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542281|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
44542282|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
44542283|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542284|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542285|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542286|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
44542287|NCT02441686|Hormones|hormones|mesh-ancestor
44542288|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542289|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44542290|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542291|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
44542292|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44542293|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44542294|NCT02441686|Growth Substances|growth substances|mesh-ancestor
44542295|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
44542296|NCT02448329|Paclitaxel|paclitaxel|mesh-list
44542297|NCT02448329|Adavosertib|adavosertib|mesh-list
44542298|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542299|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542300|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542301|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542302|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542303|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542304|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542305|NCT02447419|Gefitinib|gefitinib|mesh-list
44542306|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542307|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542308|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542309|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542310|NCT02447406|Docetaxel|docetaxel|mesh-list
44542311|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542312|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542313|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542314|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542315|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542316|NCT02446834|Metformin|metformin|mesh-list
44542317|NCT02446834|Acarbose|acarbose|mesh-list
44542318|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542319|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542320|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44542321|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542322|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366425|NCT01171170|Paclitaxel|paclitaxel|mesh-list
44542338|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
44542339|NCT02443831|Fludarabine|fludarabine|mesh-list
44542340|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542341|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
44542342|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542343|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542344|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44542345|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
44542346|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542347|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542348|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44542349|NCT02447276|Fasinumab|fasinumab|mesh-list
44542350|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542351|NCT02447276|Analgesics|analgesics|mesh-ancestor
44542352|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
44542353|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542354|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542355|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
44542356|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542357|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542358|NCT02440425|Paclitaxel|paclitaxel|mesh-list
44542359|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
44542360|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542361|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542362|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542363|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542364|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542365|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542366|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44542367|NCT00701207|Nicotine|nicotine|mesh-list
44542368|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44542369|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
44542370|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542371|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542372|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44542373|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44542374|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
44542375|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542376|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542377|NCT00708448|Bevacizumab|bevacizumab|mesh-list
44542378|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44542379|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44542380|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542381|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44542382|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44542383|NCT00708448|Growth Substances|growth substances|mesh-ancestor
44542384|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542385|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44542386|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542387|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542388|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542389|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44542390|NCT00702988|Hormones|hormones|mesh-ancestor
44542391|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542392|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542393|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44542394|NCT00702195|Hormones|hormones|mesh-ancestor
44542395|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542396|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542397|NCT00701623|Heparin|heparin|mesh-list
44542398|NCT00701623|Calcium heparin|calcium heparin|mesh-list
44542399|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
44542400|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44542401|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44542402|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542403|NCT00709995|Sunitinib|sunitinib|mesh-list
44542404|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542405|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44542406|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44542407|NCT00709995|Growth Substances|growth substances|mesh-ancestor
44542408|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542409|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
44542410|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542411|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542412|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542413|NCT00709956|Iloprost|iloprost|mesh-list
44542414|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44542415|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
44542416|NCT00709761|Paclitaxel|paclitaxel|mesh-list
44542417|NCT00709761|Lapatinib|lapatinib|mesh-list
44542418|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542419|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542420|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542421|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542422|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542423|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542424|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542425|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542426|NCT00709735|Propranolol|propranolol|mesh-list
44542427|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44542428|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44542429|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542430|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542431|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542432|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542433|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44542434|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542435|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
44542436|NCT00709722|Gusperimus|gusperimus|mesh-list
44542437|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44542438|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542439|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542440|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542441|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542442|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
44542443|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44542444|NCT00709722|Protective Agents|protective agents|mesh-ancestor
44542445|NCT00709618|Vinorelbine|vinorelbine|mesh-list
44542446|NCT00709618|Lapatinib|lapatinib|mesh-list
44542447|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542448|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542449|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542450|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542451|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542452|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542453|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542454|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542455|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
44542456|NCT00709592|Tacrolimus|tacrolimus|mesh-list
44542457|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
44542458|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44542459|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542460|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
44542461|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542462|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44542463|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542464|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446187|NCT01814046|Analgesics|analgesics|mesh-ancestor
44542465|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44542466|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542467|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44542468|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
44542469|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542470|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542471|NCT00709228|Ribavirin|ribavirin|mesh-list
44542472|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542473|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
44542474|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542475|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
44542476|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542477|NCT00709202|Betahistine|betahistine|mesh-list
44542478|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
44542479|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
44542480|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
44542481|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542482|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542483|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542485|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44542486|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
44542487|NCT00709059|Ribavirin|ribavirin|mesh-list
44542488|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542489|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
44542490|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
44542491|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542492|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
44542493|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542494|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
44542495|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542496|NCT00708916|Apremilast|apremilast|mesh-list
44542497|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542498|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542499|NCT00708916|Analgesics|analgesics|mesh-ancestor
44542500|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
44542501|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542502|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542503|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542504|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542505|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44542506|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44542507|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542508|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542509|NCT00708552|Donepezil|donepezil|mesh-list
44542510|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44542511|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542512|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542513|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
44542514|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542515|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542516|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
44542517|NCT00708500|Interferons|interferons|mesh-list
44542518|NCT00708500|Ribavirin|ribavirin|mesh-list
44542519|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
44542520|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
44542521|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542522|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542523|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
44542524|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542525|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
44542526|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542527|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
44542528|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542529|NCT00708435|Protein C|protein c|mesh-list
44542530|NCT00708435|Protein S|protein s|mesh-list
44542531|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
44542532|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44542533|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44542534|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542535|NCT00708422|Travoprost|travoprost|mesh-list
44542536|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44542537|NCT00708422|Latanoprost|latanoprost|mesh-list
44542538|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44542539|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542540|NCT00708214|Letrozole|letrozole|mesh-list
44542541|NCT00708214|Afatinib|afatinib|mesh-list
44542542|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542543|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44542544|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44542545|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542546|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542547|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44542548|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
43766443|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
44542549|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542550|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542551|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542552|NCT00708201|Alvimopan|alvimopan|mesh-list
44542553|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542554|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
44542555|NCT00708162|Elvitegravir|elvitegravir|mesh-list
44542556|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44542573|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542574|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542575|NCT00707980|Vortioxetine|vortioxetine|mesh-list
44542576|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
44542577|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542578|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44542579|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542580|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542581|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542582|NCT00707980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44542583|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44542585|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542586|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542587|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
44542588|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44542589|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44542590|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44542591|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44542592|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44542593|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
44542594|NCT00707486|Coagulants|coagulants|mesh-ancestor
44542595|NCT00707174|Imiquimod|imiquimod|mesh-list
44542596|NCT00707174|Tazarotene|tazarotene|mesh-list
44542597|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44542598|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
44542599|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542600|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542601|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
44542602|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542603|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
44542604|NCT00707161|Cisplatin|cisplatin|mesh-list
44542605|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542606|NCT00707057|Ibuprofen|ibuprofen|mesh-list
44542607|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542608|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542609|NCT00707057|Analgesics|analgesics|mesh-ancestor
44542610|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
44542611|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542612|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542613|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542614|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542615|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44542616|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542617|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542618|NCT00706992|Aldesleukin|aldesleukin|mesh-list
44542619|NCT00706992|Vaccines|vaccines|mesh-list
44542620|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
44542621|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
44446341|NCT01810432|Evacetrapib|evacetrapib|mesh-list
44542622|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542623|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542624|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44542625|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44542626|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
44542627|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542628|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44542629|NCT00706966|Dutasteride|dutasteride|mesh-list
44542630|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44542631|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44542632|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542633|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542634|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
44542635|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542636|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542637|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
44542638|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44542639|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
44542640|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542641|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542642|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44542643|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
44542644|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44542645|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44542646|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44542647|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542648|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542649|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542650|NCT00706849|Mipomersen|mipomersen|mesh-list
44542651|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44542652|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44542653|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
44542654|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542655|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44542656|NCT00706797|Etanercept|etanercept|mesh-list
44542657|NCT00706797|Methotrexate|methotrexate|mesh-list
44542658|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44542659|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
44542660|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44542661|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542662|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44542663|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
44542664|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446385|NCT01809210|Carboplatin|carboplatin|mesh-list
44542665|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542666|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542667|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542668|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44542669|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542670|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
44542671|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542672|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44542673|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542674|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542675|NCT00706797|Analgesics|analgesics|mesh-ancestor
44542676|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
44542677|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542678|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542679|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542680|NCT00706654|Aripiprazole|aripiprazole|mesh-list
44542681|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
44542682|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542683|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44542684|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542685|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542686|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542687|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
44542688|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
44542689|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542690|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542691|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44542692|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44542693|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
44542694|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44542695|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44542696|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44542697|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44542698|NCT00706641|Dasatinib|dasatinib|mesh-list
44542699|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542700|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542701|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542702|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542703|NCT00706628|Nintedanib|nintedanib|mesh-list
44542704|NCT00706628|Afatinib|afatinib|mesh-list
44542705|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542706|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542707|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542708|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542709|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44542710|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44542711|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542712|NCT00706030|Vinorelbine|vinorelbine|mesh-list
44542713|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542714|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542715|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44542716|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44542717|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44542718|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542719|NCT00706004|Lubiprostone|lubiprostone|mesh-list
44542720|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44542721|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44542722|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542724|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542725|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
44542726|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542727|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
44542728|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542729|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44542730|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44542731|NCT00705575|Diuretics|diuretics|mesh-ancestor
44542732|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
44542733|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542734|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44542735|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44542736|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542737|NCT00705536|Insulin|insulin|mesh-list
44542738|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44542739|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
44542740|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542741|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542742|NCT00705523|Varenicline|varenicline|mesh-list
44542743|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44542744|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44542745|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
44542746|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542747|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542748|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542749|NCT00705484|Infliximab|infliximab|mesh-list
44542750|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542751|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542752|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542753|NCT00705432|Ribavirin|ribavirin|mesh-list
44542754|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542755|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
44542756|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542757|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
44542758|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542759|NCT00705406|Peramivir|peramivir|mesh-list
44542760|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
44542761|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542762|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542763|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542764|NCT00705367|Abatacept|abatacept|mesh-list
44542765|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44542766|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542767|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542768|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542769|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
44542770|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542771|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542772|NCT00705341|Fluticasone|fluticasone|mesh-list
44542773|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542774|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44542775|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
44542776|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542777|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542778|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44542779|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
44542780|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542781|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44542782|NCT00705289|Infliximab|infliximab|mesh-list
44542783|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
44542784|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44542785|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542786|NCT00705263|Ribavirin|ribavirin|mesh-list
44366910|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
44542787|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542788|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
44542789|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542790|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
44542791|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542792|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44542793|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44542794|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
44542795|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542796|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542797|NCT00705224|Interferons|interferons|mesh-list
44542799|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542800|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
44542801|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542802|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
44542803|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542804|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44542805|NCT00705159|Tobramycin|tobramycin|mesh-list
44542806|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542807|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542808|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44542809|NCT00704964|Ribavirin|ribavirin|mesh-list
44542810|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542811|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
44542812|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
44542813|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542814|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
44542815|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542816|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
44542817|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542818|NCT00704808|Temozolomide|temozolomide|mesh-list
44542819|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44542820|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
44542821|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542822|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542823|NCT00704535|Ezetimibe|ezetimibe|mesh-list
44542824|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44542825|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44542826|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
44542827|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542828|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44542829|NCT00704522|Ribavirin|ribavirin|mesh-list
44542830|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44542831|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
44542832|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542833|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
44542834|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542835|NCT00704418|Bromfenac|bromfenac|mesh-list
44542836|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542837|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542838|NCT00704418|Analgesics|analgesics|mesh-ancestor
44542839|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
44542840|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542841|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542842|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542843|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44542844|NCT00704405|Interferons|interferons|mesh-list
44542845|NCT00704405|Ribavirin|ribavirin|mesh-list
44542846|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542847|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
44542848|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542849|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
44542850|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542851|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44542852|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44542853|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542854|NCT00704132|Incretins|incretins|mesh-ancestor
44542855|NCT00704132|Hormones|hormones|mesh-ancestor
44542856|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542857|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44542858|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
44542859|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542860|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542861|NCT00703924|Paromomycin|paromomycin|mesh-list
44542862|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44542874|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44542875|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542876|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542877|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44542878|NCT00703781|Bromfenac|bromfenac|mesh-list
44542879|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44542880|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44542881|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44542882|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44542883|NCT00703781|Analgesics|analgesics|mesh-ancestor
44542884|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
44367052|NCT01174524|Estradiol|estradiol|mesh-list
44542885|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542886|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542887|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542889|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
44542890|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
44542891|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542892|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542893|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542894|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
44542895|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542896|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542897|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542898|NCT00703118|Ribavirin|ribavirin|mesh-list
44542899|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
44542900|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44542901|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
44542902|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542903|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
44542904|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542905|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542906|NCT00702962|Carboplatin|carboplatin|mesh-list
44542907|NCT00702962|Etoposide|etoposide|mesh-list
44542908|NCT00702962|Vorinostat|vorinostat|mesh-list
44542909|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542910|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44542911|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44542912|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44542913|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542914|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542915|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44542916|NCT00702949|Pregabalin|pregabalin|mesh-list
44542917|NCT00702949|Analgesics|analgesics|mesh-ancestor
44542918|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
44542919|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542920|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542921|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
44542922|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44542923|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44542924|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542925|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44542926|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44542927|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44542928|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44542929|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44542930|NCT00702923|Tremelimumab|tremelimumab|mesh-list
44542931|NCT00702923|Bicalutamide|bicalutamide|mesh-list
44542932|NCT00702923|Ipilimumab|ipilimumab|mesh-list
44542933|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44542934|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542935|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
44542936|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542937|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
44542938|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44542939|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542940|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44542941|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44542942|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542943|NCT00702650|Testosterone|testosterone|mesh-list
44542944|NCT00702650|Androgens|androgens|mesh-ancestor
44542945|NCT00702650|Hormones|hormones|mesh-ancestor
43948745|NCT01114555|Irinotecan|irinotecan|mesh-list
44542946|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542947|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542948|NCT00702507|Miconazole|miconazole|mesh-list
44542949|NCT00702507|Clotrimazole|clotrimazole|mesh-list
44542950|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
44542951|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44542952|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44542953|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44542954|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542955|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542956|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44542957|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
44542958|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542959|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542960|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44542961|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44542962|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44542963|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
44542964|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542965|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44542966|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44542967|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542968|NCT00702325|Budesonide|budesonide|mesh-list
44542969|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
44542970|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44542971|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44542972|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44542973|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
44542974|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44542975|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542976|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44542977|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
44542978|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
44542979|NCT00702325|Hormones|hormones|mesh-ancestor
44542980|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44542981|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44542982|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44542983|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44542984|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
44542985|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44542986|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44542987|NCT00702221|Vaccines|vaccines|mesh-list
44542988|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
44542989|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542990|NCT00702052|Everolimus|everolimus|mesh-list
44542991|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44542992|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44542993|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
44542994|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44542995|NCT00701779|Tamsulosin|tamsulosin|mesh-list
44542996|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44542997|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44542998|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44542999|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44543000|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543001|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543002|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543003|NCT00701779|Urological Agents|urological agents|mesh-ancestor
44543004|NCT00701727|Ezetimibe|ezetimibe|mesh-list
44543005|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44543006|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44543007|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
44543008|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543009|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44543010|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
44543011|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
44543012|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543013|NCT00701558|Gemcitabine|gemcitabine|mesh-list
44543014|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44543015|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543016|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
44543017|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543018|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543019|NCT00701558|Antiviral Agents|antiviral agents|mesh-ancestor
44543020|NCT00701558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543021|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543022|NCT00701558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543023|NCT00701558|Immunologic Factors|immunologic factors|mesh-ancestor
44543024|NCT00701558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543025|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543026|NCT00701363|Lanreotide|lanreotide|mesh-list
44543027|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543028|NCT00701311|Apremilast|apremilast|mesh-list
44543029|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44543030|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543031|NCT00701311|Analgesics|analgesics|mesh-ancestor
44543032|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
44543033|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543034|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543035|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543036|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543037|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44543038|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44543039|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543040|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543041|NCT00701129|Rituximab|rituximab|mesh-list
44543042|NCT00701129|Methotrexate|methotrexate|mesh-list
44543043|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543044|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543045|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
44543046|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543047|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543048|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44543049|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
44543050|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44543051|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543052|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
44543053|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543054|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44543055|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543056|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44543057|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543058|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44543059|NCT00701090|Metformin|metformin|mesh-list
44543060|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44543061|NCT00701090|Glimepiride|glimepiride|mesh-list
44543062|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543063|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543064|NCT00701090|Incretins|incretins|mesh-ancestor
44543065|NCT00701090|Hormones|hormones|mesh-ancestor
44543066|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543067|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44543068|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543069|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543070|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543071|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44543072|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543073|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
44543074|NCT00700999|Paroxetine|paroxetine|mesh-list
44543075|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44543076|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44543077|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543078|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543079|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543080|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
44543081|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543082|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44543083|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
44543084|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44543085|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44543086|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44543087|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543088|NCT00700817|Metformin|metformin|mesh-list
44543089|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44543090|NCT00700817|Liraglutide|liraglutide|mesh-list
44543091|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543092|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543093|NCT00700817|Incretins|incretins|mesh-ancestor
44543094|NCT00700817|Hormones|hormones|mesh-ancestor
44543095|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543096|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44543097|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543098|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543099|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543100|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44543101|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44543102|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543103|NCT00700622|Insulin|insulin|mesh-list
44543104|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44543105|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
44543130|NCT00700401|Ribavirin|ribavirin|mesh-list
44543131|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44543132|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
44543133|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543134|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
44543135|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543136|NCT00700271|Amlodipine|amlodipine|mesh-list
44543137|NCT00700271|Valsartan|valsartan|mesh-list
44543138|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44543139|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44543140|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543141|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543142|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44543143|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543144|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
44543145|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44543146|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44543147|NCT00700180|Bevacizumab|bevacizumab|mesh-list
44543148|NCT00700180|Carboplatin|carboplatin|mesh-list
44543149|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543150|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543151|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44543152|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44543153|NCT00700180|Growth Substances|growth substances|mesh-ancestor
44543154|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543155|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
44543156|NCT00703222|Interleukin-2|interleukin-2|mesh-list
44543157|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543158|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543159|NCT00703222|Analgesics|analgesics|mesh-ancestor
44543160|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
44543161|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543162|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543163|NCT00703326|Docetaxel|docetaxel|mesh-list
44543164|NCT00703326|Ramucirumab|ramucirumab|mesh-list
44543165|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543166|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44543167|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44543168|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44543169|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543170|NCT00708526|Anesthetics|anesthetics|mesh-list
44543171|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543172|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543173|NCT00703014|Progesterone|progesterone|mesh-list
44543174|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543175|NCT00703014|Ganirelix|ganirelix|mesh-list
44543176|NCT00703014|Progestins|progestins|mesh-ancestor
44543177|NCT00703014|Hormones|hormones|mesh-ancestor
44543178|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543179|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543180|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
44543181|NCT00702624|Hormones|hormones|mesh-list
44543182|NCT00702624|Progesterone|progesterone|mesh-list
44543183|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543184|NCT00702624|Ganirelix|ganirelix|mesh-list
44543185|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543186|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543187|NCT00702624|Progestins|progestins|mesh-ancestor
44543188|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
44543189|NCT00702546|Hormones|hormones|mesh-list
44543190|NCT00702546|Progesterone|progesterone|mesh-list
44543191|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543192|NCT00702546|Ganirelix|ganirelix|mesh-list
44543193|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543194|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543195|NCT00702546|Progestins|progestins|mesh-ancestor
44543196|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
44543197|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44543198|NCT00702520|Hormones|hormones|mesh-list
44543199|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543200|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543201|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543202|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
44543203|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44543204|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
44543205|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44543206|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44543207|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44543208|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543210|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543211|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543212|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543213|NCT00702273|Progesterone|progesterone|mesh-list
44543214|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44543215|NCT00702273|Ganirelix|ganirelix|mesh-list
44543216|NCT00702273|Progestins|progestins|mesh-ancestor
44543217|NCT00702273|Hormones|hormones|mesh-ancestor
44543218|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543219|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543220|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44543221|NCT00702234|Progesterone|progesterone|mesh-list
44543222|NCT00702234|Progestins|progestins|mesh-ancestor
44543223|NCT00702234|Hormones|hormones|mesh-ancestor
44543224|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543225|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543226|NCT00709904|Semuloparin|semuloparin|mesh-list
44543227|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44543228|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44446930|NCT01799590|Topiramate|topiramate|mesh-list
44543229|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44543230|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543231|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
44543232|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
44543233|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
44543234|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44543235|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44543236|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
44543237|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543238|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543239|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543240|NCT00709371|Zonisamide|zonisamide|mesh-list
44543241|NCT00709371|Bupropion|bupropion|mesh-list
44543242|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44543243|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
44543244|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44543245|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44543246|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44543247|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543248|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543249|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
44543250|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543251|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543252|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44543253|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44543254|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543255|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
44543256|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44543257|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44543258|NCT00707889|Leucovorin|leucovorin|mesh-list
44543259|NCT00707889|Folic Acid|folic acid|mesh-list
44543260|NCT00707889|Bevacizumab|bevacizumab|mesh-list
44543261|NCT00707889|Fluorouracil|fluorouracil|mesh-list
44543262|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
44543263|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
44543264|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543265|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543266|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44543267|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44543268|NCT00707889|Growth Substances|growth substances|mesh-ancestor
44543269|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543270|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44543271|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
44543272|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543273|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543274|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543275|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
44543276|NCT00707889|Antidotes|antidotes|mesh-ancestor
44543277|NCT00707889|Protective Agents|protective agents|mesh-ancestor
44543278|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
44543280|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
44367407|NCT01177176|Bupropion|bupropion|mesh-list
44543281|NCT00707889|Hematinics|hematinics|mesh-ancestor
44543282|NCT00707304|Lactoferrin|lactoferrin|mesh-list
44543283|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
44543284|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543285|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543286|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
44543287|NCT00704483|Sevelamer|sevelamer|mesh-list
44543288|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
44543289|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
44543290|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543291|NCT00704483|Hematinics|hematinics|mesh-ancestor
44543292|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
44543293|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543294|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543295|NCT00701883|Atorvastatin|atorvastatin|mesh-list
44543296|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44543297|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44543298|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
44543299|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543300|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44543301|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44543302|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543304|NCT00703820|Etoposide|etoposide|mesh-list
44543305|NCT00703820|Daunorubicin|daunorubicin|mesh-list
44543306|NCT00703820|Clofarabine|clofarabine|mesh-list
44543307|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44543308|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543309|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44543310|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44543311|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543312|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543313|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543314|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
44543315|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
44543316|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543317|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543318|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
44543319|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543320|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44543321|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
44543322|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543323|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543324|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543325|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543326|NCT00708305|Listerine|listerine|mesh-list
44543327|NCT00708305|Fluorides|fluorides|mesh-list
44543328|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
44543329|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
44543330|NCT00708305|Protective Agents|protective agents|mesh-ancestor
44543331|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543332|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44543333|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543334|NCT00708123|Listerine|listerine|mesh-list
44543335|NCT00708123|Fluorides|fluorides|mesh-list
44543336|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
44543337|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
44543338|NCT00708123|Protective Agents|protective agents|mesh-ancestor
44543339|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543340|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44543341|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543342|NCT00708097|Fluorides|fluorides|mesh-list
44543343|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
44543344|NCT00708097|Protective Agents|protective agents|mesh-ancestor
44543345|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543346|NCT00705783|Aripiprazole|aripiprazole|mesh-list
44543347|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
44543348|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44543349|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44543350|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44543351|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543352|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543353|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
44543354|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
44543355|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543356|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543357|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44543358|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44543359|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
44543360|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44543361|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44543362|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44543363|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44543364|NCT04055012|Metformin|metformin|mesh-list
44543365|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543366|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543367|NCT04058717|Nicotine|nicotine|mesh-list
44543368|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44543369|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
44543370|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543371|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543372|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44543373|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44543374|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
44543375|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543376|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543377|NCT04057131|Icatibant|icatibant|mesh-list
44543378|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44543389|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44543390|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543391|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
44543392|NCT04055389|Antithrombins|antithrombins|mesh-list
44543393|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
44543394|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44543395|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543396|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543397|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543398|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
44543399|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
44543400|NCT04050540|Doxycycline|doxycycline|mesh-list
44543401|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44543402|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543403|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
44543404|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44543405|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44543406|NCT04053478|Phenylephrine|phenylephrine|mesh-list
44543407|NCT04053478|Vasopressins|vasopressins|mesh-list
44543408|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
44543409|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
44543410|NCT04053478|Norepinephrine|norepinephrine|mesh-list
44543411|NCT04053478|Ephedrine|ephedrine|mesh-list
44543412|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44543413|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
44543414|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
44543415|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543416|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543417|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
44543418|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44543419|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
44543420|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44543421|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44543422|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44543423|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44543424|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
44543425|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543426|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543427|NCT04053478|Protective Agents|protective agents|mesh-ancestor
44543428|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
44543429|NCT04053478|Coagulants|coagulants|mesh-ancestor
44543430|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44543431|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
44543432|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44543433|NCT04055818|Niacinamide|niacinamide|mesh-list
44543434|NCT04055818|Niacin|niacin|mesh-list
44543435|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
44543436|NCT04055818|Decitabine|decitabine|mesh-list
44543437|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
44543438|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543439|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
44543440|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543441|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543442|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543443|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
44543444|NCT04055818|Vitamins|vitamins|mesh-ancestor
44543445|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
44543446|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543447|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44543448|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44543449|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
44543450|NCT04050085|Nivolumab|nivolumab|mesh-list
44543451|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543452|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543453|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44543454|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543455|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44543456|NCT04059770|Amphotericin B|amphotericin b|mesh-list
44543457|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
44543458|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543459|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44543460|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44543461|NCT04059770|Amebicides|amebicides|mesh-ancestor
44543462|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44543463|NCT04059887|Atezolizumab|atezolizumab|mesh-list
44543464|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543465|NCT04059978|Remifentanil|remifentanil|mesh-list
44543466|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44543467|NCT04059978|Narcotics|narcotics|mesh-ancestor
44543468|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543469|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543470|NCT04059978|Analgesics|analgesics|mesh-ancestor
44543471|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
44543472|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543473|NCT04059679|Aspirin|aspirin|mesh-list
44543474|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
44543475|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44543476|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543477|NCT04059679|Analgesics|analgesics|mesh-ancestor
44543478|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
44543479|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543480|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543481|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543482|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543483|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44543484|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44543485|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543486|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44543487|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44543488|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543489|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
44543490|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44543491|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
44543492|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44543493|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543494|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
44543496|NCT04059536|Heparin|heparin|mesh-list
44543497|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44543498|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543499|NCT04059536|Analgesics|analgesics|mesh-ancestor
44543500|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
44543501|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543502|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543503|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543504|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543505|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44543506|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44543507|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543508|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44543509|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44543510|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543511|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
44543512|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
44543513|NCT04059523|Tretinoin|tretinoin|mesh-list
44543514|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543515|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
44543516|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44543517|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
44543518|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543519|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543520|NCT04059198|Tenofovir|tenofovir|mesh-list
44543521|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
44543522|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543523|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44543524|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44543525|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543526|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543527|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44543528|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44543529|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
44543530|NCT04058899|Nalbuphine|nalbuphine|mesh-list
44543531|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44543532|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543533|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543534|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543535|NCT04058899|Analgesics|analgesics|mesh-ancestor
44543536|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
44543537|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543538|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44543539|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44543540|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44543541|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44543542|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543543|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543544|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44543545|NCT04058899|Narcotics|narcotics|mesh-ancestor
44543546|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
44543547|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543548|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543549|NCT04058145|Plerixafor|plerixafor|mesh-list
44543550|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
44543551|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543552|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543553|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44543554|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44543555|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
44543556|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543557|NCT04058210|Ivacaftor|ivacaftor|mesh-list
44543558|NCT04058210|Elexacaftor|elexacaftor|mesh-list
44543559|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44543560|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543561|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543562|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
44543563|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44543564|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44543565|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44543566|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543567|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543568|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
44543569|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543570|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543571|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44543572|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543573|NCT04057989|Ketamine|ketamine|mesh-list
44543575|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
44543576|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543577|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543578|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44543579|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44543580|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
44543581|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
44543582|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543583|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44543584|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44543585|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543586|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543587|NCT04057365|Nivolumab|nivolumab|mesh-list
44543588|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543589|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543590|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44543591|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543592|NCT04057261|Liraglutide|liraglutide|mesh-list
44543593|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543594|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543595|NCT04057261|Incretins|incretins|mesh-ancestor
44543596|NCT04057261|Hormones|hormones|mesh-ancestor
44543597|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543598|NCT04057326|Pancreatin|pancreatin|mesh-list
44543599|NCT04057326|Pancrelipase|pancrelipase|mesh-list
44543600|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44543601|NCT04057482|Dequalinium|dequalinium|mesh-list
44543602|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44543603|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543604|NCT04056923|Methylene Blue|methylene blue|mesh-list
44543605|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543606|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543607|NCT04056949|Paclitaxel|paclitaxel|mesh-list
44543608|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44543609|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44543610|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543611|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44543612|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44543613|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44543614|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543615|NCT04056897|Teriflunomide|teriflunomide|mesh-list
44543616|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44543617|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543618|NCT04056897|Analgesics|analgesics|mesh-ancestor
44543619|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
44543620|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543621|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543622|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543623|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44543624|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543625|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
44543626|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44543627|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44543628|NCT04056975|Antibodies|antibodies|mesh-list
44543629|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
44543630|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543631|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
44543632|NCT04056806|Terlipressin|terlipressin|mesh-list
44543633|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44543634|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543635|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44367846|NCT01179503|Vitamin D|vitamin d|mesh-list
44543636|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44543638|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44543639|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543640|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44543641|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543642|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543643|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44543644|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44543645|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
44543646|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543647|NCT04056754|Prednisone|prednisone|mesh-list
44543649|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543650|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
44543651|NCT04056754|Hormones|hormones|mesh-ancestor
44543652|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543653|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543654|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44543655|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543656|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44543657|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543658|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543659|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44543660|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44543661|NCT04056442|Cannabidiol|cannabidiol|mesh-list
44543662|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
44543663|NCT04056325|Ivermectin|ivermectin|mesh-list
44543664|NCT04056325|Moxidectin|moxidectin|mesh-list
44543665|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44543666|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543667|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
44543668|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
44543669|NCT04056702|Ivacaftor|ivacaftor|mesh-list
44543670|NCT04056702|Elexacaftor|elexacaftor|mesh-list
44543671|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44543672|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44543673|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543674|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44543675|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
44543676|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
44543677|NCT04056143|Apixaban|apixaban|mesh-list
44543678|NCT04056143|Edoxaban|edoxaban|mesh-list
44543679|NCT04056143|Dabigatran|dabigatran|mesh-list
44543680|NCT04056143|Thromboplastin|thromboplastin|mesh-list
44543681|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44543682|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
44543683|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44543684|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
44543685|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543686|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543687|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
44543688|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
44543689|NCT04056143|Coagulants|coagulants|mesh-ancestor
44543690|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44543691|NCT04056169|Ezetimibe|ezetimibe|mesh-list
44543692|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44543693|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44543694|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
44543695|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543696|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44543697|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44543698|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543699|NCT04056000|Caffeine|caffeine|mesh-list
44543700|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44543701|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543702|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44543703|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543704|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543705|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44543706|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44543707|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
44543708|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543709|NCT04055480|Insulin|insulin|mesh-list
44543710|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44543711|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
44543734|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543735|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44543736|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367992|NCT01180231|Moxonidine|moxonidine|mesh-list
44543738|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44543739|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44543740|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
44543741|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543742|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543743|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543744|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
44543745|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44543746|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44543747|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543748|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
44543749|NCT04055194|Coagulants|coagulants|mesh-ancestor
44543750|NCT04055142|Cidofovir|cidofovir|mesh-list
44543751|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
44543752|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543753|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543754|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543755|NCT04054531|Paclitaxel|paclitaxel|mesh-list
44543756|NCT04054531|Carboplatin|carboplatin|mesh-list
44543757|NCT04054531|Pemetrexed|pemetrexed|mesh-list
44543758|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44543759|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543760|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
44543761|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
44543762|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
44543763|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543764|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543765|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44543766|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44543767|NCT04054518|Durvalumab|durvalumab|mesh-list
44543768|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543769|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543770|NCT04054362|Gemcitabine|gemcitabine|mesh-list
44543771|NCT04054362|Paclitaxel|paclitaxel|mesh-list
44543772|NCT04054362|Cisplatin|cisplatin|mesh-list
44543773|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44543774|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44543775|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543776|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
44543777|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
44543778|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
44543779|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543780|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543781|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
44543782|NCT04054362|Antiviral Agents|antiviral agents|mesh-ancestor
44543783|NCT04054362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543784|NCT04054362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543785|NCT04054362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543786|NCT04054362|Immunologic Factors|immunologic factors|mesh-ancestor
44543787|NCT04054362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543788|NCT04054206|Ibudilast|ibudilast|mesh-list
44543789|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44543790|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
44447425|NCT01789281|Everolimus|everolimus|mesh-list
44543791|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543792|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543793|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44543794|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
44543795|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44543796|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543797|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543798|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44543799|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
44543800|NCT04054024|Erenumab|erenumab|mesh-list
44543801|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44543802|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543803|NCT04054024|Analgesics|analgesics|mesh-ancestor
44543804|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
44543805|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543806|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543807|NCT04054089|Tenofovir|tenofovir|mesh-list
44543808|NCT04054089|Lamivudine|lamivudine|mesh-list
44543809|NCT04054089|Emtricitabine|emtricitabine|mesh-list
44543810|NCT04054089|Dolutegravir|dolutegravir|mesh-list
44368067|NCT01180933|Folic Acid|folic acid|mesh-list
44543811|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
44543812|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543813|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44543814|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44543815|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543816|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543817|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44543818|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44543819|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44543820|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44543822|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44543823|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543824|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543825|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44543826|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
44543827|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
44543828|NCT04053959|Insulin|insulin|mesh-list
44543829|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44543830|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543831|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543832|NCT04053972|Lenvatinib|lenvatinib|mesh-list
44543833|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543834|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543835|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543836|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543837|NCT04053985|Lenvatinib|lenvatinib|mesh-list
44543838|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543839|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543840|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543841|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543842|NCT04053543|CXA-10|cxa-10|mesh-list
44543843|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44543844|NCT04053400|Ketamine|ketamine|mesh-list
44543845|NCT04053400|Analgesics|analgesics|mesh-ancestor
44543846|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
44543847|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543848|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543849|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44543850|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44543851|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
44543852|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
44543853|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543854|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44543855|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44543856|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543857|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543858|NCT04053491|Anesthetics|anesthetics|mesh-list
44543859|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543860|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543861|NCT04052711|Minocycline|minocycline|mesh-list
44543862|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44543863|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543864|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
44543865|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543866|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543867|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543868|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543869|NCT04052659|Azacitidine|azacitidine|mesh-list
44543870|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543871|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
44543872|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543873|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543874|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543875|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
44543876|NCT04052269|Tadalafil|tadalafil|mesh-list
44543877|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
44543878|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44543879|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44543880|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543881|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543882|NCT04052269|Urological Agents|urological agents|mesh-ancestor
44543883|NCT04052178|Capsaicin|capsaicin|mesh-list
44543884|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
44543885|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44543886|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
44543898|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44543899|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
44543900|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
44543901|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
44543902|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
44543903|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543904|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543905|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543906|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44543907|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543908|NCT04051827|Midazolam|midazolam|mesh-list
44543909|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44543910|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44543911|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543912|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543913|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44543914|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44543915|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44543916|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44543917|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
44543918|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
44543919|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
44543920|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
44543921|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44543922|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543923|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44543924|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
44543925|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543926|NCT04051632|Insulin|insulin|mesh-list
44543927|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543928|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543929|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
44543930|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44543931|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44543932|NCT04051255|Metronidazole|metronidazole|mesh-list
44543933|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543934|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44543935|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44543936|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44543937|NCT04051047|Gemcitabine|gemcitabine|mesh-list
44543938|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44543939|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
44543940|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543941|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543942|NCT04051047|Antiviral Agents|antiviral agents|mesh-ancestor
44543943|NCT04051047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543944|NCT04051047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44543945|NCT04051047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44543946|NCT04051047|Immunologic Factors|immunologic factors|mesh-ancestor
44543947|NCT04051047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543948|NCT04050592|Estradiol|estradiol|mesh-list
44543949|NCT04050592|Estrogens|estrogens|mesh-ancestor
44543950|NCT04050592|Hormones|hormones|mesh-ancestor
44543951|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543952|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543953|NCT04050670|Tirzepatide|tirzepatide|mesh-list
44543954|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543955|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543956|NCT04050670|Incretins|incretins|mesh-ancestor
44543957|NCT04050670|Hormones|hormones|mesh-ancestor
44543958|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44543959|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
44543960|NCT04050488|Astringents|astringents|mesh-ancestor
44543961|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543962|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
44543963|NCT04050761|Nivolumab|nivolumab|mesh-list
44543964|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44543965|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44543966|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44543967|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543968|NCT04050735|Ethanol|ethanol|mesh-list
44543969|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44543970|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44543971|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543972|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543973|NCT04050215|Edetic Acid|edetic acid|mesh-list
44543974|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44543975|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
44543976|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
44543977|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44543978|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
44543979|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44543980|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44543981|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
44543982|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44543983|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
44543984|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
44543985|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543986|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543987|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44543988|NCT04050267|Analgesics|analgesics|mesh-ancestor
44543989|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
44543990|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44543991|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44543992|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44543993|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543995|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44543996|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44543997|NCT04051268|Vaccines|vaccines|mesh-list
44543998|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
44543999|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544000|NCT04057469|Tulobuterol|tulobuterol|mesh-list
44368278|NCT01182077|Midazolam|midazolam|mesh-list
44544001|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44544002|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544003|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544004|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544005|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544006|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544007|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44544008|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
44544009|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544010|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544011|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544013|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
44544014|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544015|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544016|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
44544017|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544018|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44544019|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
44544020|NCT04052932|Protective Agents|protective agents|mesh-ancestor
44544021|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544022|NCT04059003|Taxane|taxane|mesh-list
44544023|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544024|NCT04050410|Moxonidine|moxonidine|mesh-list
44544025|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544026|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
44544027|NCT04052334|Fludarabine|fludarabine|mesh-list
44544028|NCT04052334|Interleukin-2|interleukin-2|mesh-list
44544029|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544030|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
44544031|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544032|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544033|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44544034|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
44544035|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544036|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544037|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44544038|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44544039|NCT04052334|Analgesics|analgesics|mesh-ancestor
44544040|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
44544041|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368374|NCT01182792|Vitamins|vitamins|mesh-ancestor
44544042|NCT04058743|Cobalt|cobalt|mesh-list
44544043|NCT04058743|Chromium|chromium|mesh-list
44544044|NCT04058743|Nickel|nickel|mesh-list
44544045|NCT04058743|Trace Elements|trace elements|mesh-ancestor
44544046|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
44544047|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544048|NCT04053322|Durvalumab|durvalumab|mesh-list
44544049|NCT04053322|Olaparib|olaparib|mesh-list
44544050|NCT04053322|Fulvestrant|fulvestrant|mesh-list
44544051|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44544052|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544053|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44544054|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544055|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544056|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44544057|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44544058|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44544059|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
44544060|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544061|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544063|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44544064|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
44544065|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544066|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544067|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544068|NCT04054713|Acetic Acid|acetic acid|mesh-list
44544069|NCT04054713|Retinol acetate|retinol acetate|mesh-list
44544070|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544071|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544072|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44544073|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
44544074|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544075|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44544076|NCT04054713|Protective Agents|protective agents|mesh-ancestor
44544077|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544078|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44544079|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44544080|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
44544081|NCT04056845|Acetaminophen|acetaminophen|mesh-list
44544082|NCT04056845|Diclofenac|diclofenac|mesh-list
44544083|NCT04056845|Analgesics|analgesics|mesh-list
44544084|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44544085|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44544086|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
44544087|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544088|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544089|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544090|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544091|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44544092|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544093|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544094|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
44544095|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
44544096|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44544097|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44544098|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544099|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
44544100|NCT04054687|Coagulants|coagulants|mesh-ancestor
44544101|NCT04056182|Lofexidine|lofexidine|mesh-list
44544102|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544103|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44544104|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544105|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
44544106|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544107|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44544108|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44544109|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544110|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44447712|NCT01783015|Analgesics|analgesics|mesh-ancestor
44544111|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544112|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544113|NCT04057937|Apremilast|apremilast|mesh-list
44544114|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44544115|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44544116|NCT04057937|Analgesics|analgesics|mesh-ancestor
44544117|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
44544130|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544131|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544133|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544134|NCT04053699|Factor VIII|factor viii|mesh-list
44544135|NCT04053699|Coagulants|coagulants|mesh-ancestor
44544136|NCT01064245|Mannitol|mannitol|mesh-list
44544137|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
44544138|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44544139|NCT01064245|Diuretics|diuretics|mesh-ancestor
44544140|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
44544141|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544142|NCT01064245|Miotics|miotics|mesh-ancestor
44544143|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
44544144|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544145|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44544146|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44544147|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
44368508|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44544148|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44544149|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44544150|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
44544151|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544152|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544154|NCT01061515|Capecitabine|capecitabine|mesh-list
44544155|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
44544156|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44544157|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544158|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544159|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544160|NCT01061515|Growth Substances|growth substances|mesh-ancestor
44544161|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544162|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544163|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44544164|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
44544165|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544166|NCT01063270|Rifampin|rifampin|mesh-list
44544167|NCT01063270|Clindamycin|clindamycin|mesh-list
44544168|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
44544169|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
44544170|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44544171|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
44544172|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544173|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544174|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
44544175|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44544176|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544177|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544178|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44544179|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44544180|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44544181|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44544182|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44544183|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44544184|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44544185|NCT01069939|Esomeprazole|esomeprazole|mesh-list
44544186|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44544187|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44544188|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44544189|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544190|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544191|NCT01069900|Amoxicillin|amoxicillin|mesh-list
44544192|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
44544193|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
44544194|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
44544195|NCT01069900|Ertapenem|ertapenem|mesh-list
44544196|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44544197|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44544198|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544199|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544200|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44544201|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44544202|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544203|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544204|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544205|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44544206|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
44544207|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44544208|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544209|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44544210|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44544211|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44544212|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44544213|NCT01069705|Tobramycin|tobramycin|mesh-list
44544214|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544215|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544216|NCT01069627|Bevacizumab|bevacizumab|mesh-list
44544217|NCT01069627|Fotemustine|fotemustine|mesh-list
44544218|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44544219|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544220|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544221|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544222|NCT01069627|Growth Substances|growth substances|mesh-ancestor
44544223|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544224|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544225|NCT01069523|Guanfacine|guanfacine|mesh-list
44544226|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544227|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44544228|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44544229|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544230|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544231|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544232|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544233|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544234|NCT01069341|Ranibizumab|ranibizumab|mesh-list
44544235|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544236|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544237|NCT01069341|Growth Substances|growth substances|mesh-ancestor
44544238|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544239|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544240|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544241|NCT01069289|Budesonide|budesonide|mesh-list
44544242|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
44544243|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44544244|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544245|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44544246|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
44544247|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544248|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544249|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544250|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544251|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
44544252|NCT01069289|Hormones|hormones|mesh-ancestor
44447857|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544253|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544254|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44544255|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44544256|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544257|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544258|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544259|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544260|NCT01069172|Dipivefrin|dipivefrin|mesh-list
44544261|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544262|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544263|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544264|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544265|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544266|NCT01068912|Favipiravir|favipiravir|mesh-list
44544267|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
44544268|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544269|NCT01068860|Insulin|insulin|mesh-list
44544270|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44544271|NCT01068860|Metformin|metformin|mesh-list
44544272|NCT01068860|Glimepiride|glimepiride|mesh-list
44544273|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
44544274|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
44544275|NCT01068860|Glyburide|glyburide|mesh-list
44544276|NCT01068860|Glipizide|glipizide|mesh-list
44544277|NCT01068860|Troglitazone|troglitazone|mesh-list
44544278|NCT01068860|Tolbutamide|tolbutamide|mesh-list
44544279|NCT01068860|Acetohexamide|acetohexamide|mesh-list
44544280|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
44544281|NCT01068860|Tolazamide|tolazamide|mesh-list
44544282|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
44544283|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44544284|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544285|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544286|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44544287|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544288|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
44544289|NCT01068743|Metformin|metformin|mesh-list
44544290|NCT01068743|Saxagliptin|saxagliptin|mesh-list
44544291|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544292|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544293|NCT01068743|Incretins|incretins|mesh-ancestor
44544294|NCT01068743|Hormones|hormones|mesh-ancestor
44426836|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544295|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544296|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44544298|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368614|NCT01184638|Propofol|propofol|mesh-list
44544299|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544300|NCT01068730|Metformin|metformin|mesh-list
44544301|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544302|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544303|NCT01068717|Metformin|metformin|mesh-list
44544304|NCT01068717|Saxagliptin|saxagliptin|mesh-list
44544305|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544306|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544307|NCT01068717|Incretins|incretins|mesh-ancestor
44544308|NCT01068717|Hormones|hormones|mesh-ancestor
44544309|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544310|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44544311|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44544312|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544313|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544314|NCT01068678|Insulin|insulin|mesh-list
44544315|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44544316|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
44544317|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544318|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544319|NCT01068652|Insulin|insulin|mesh-list
44544320|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44544321|NCT01068652|Metformin|metformin|mesh-list
44544322|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
44544323|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
44544324|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44544325|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
44544326|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
44544327|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44544328|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544329|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544330|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44544331|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44544332|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44447940|NCT01778010|Cocaine|cocaine|mesh-list
44544333|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
44544334|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544335|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44544336|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44544337|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544338|NCT01068418|Vitamin D|vitamin d|mesh-list
44544339|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
44544340|NCT01068418|Vitamins|vitamins|mesh-ancestor
44544341|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
44544342|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544343|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44544344|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44544345|NCT01068158|Ivermectin|ivermectin|mesh-list
44544346|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44544347|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544348|NCT01067846|Cycloserine|cycloserine|mesh-list
44544349|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44544350|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544351|NCT01067846|Renal Agents|renal agents|mesh-ancestor
44544352|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44544353|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
44544354|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544355|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
44544356|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544357|NCT01067469|Bevacizumab|bevacizumab|mesh-list
44544358|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44544359|NCT01067469|Lomustine|lomustine|mesh-list
44544360|NCT01067469|Antibodies|antibodies|mesh-list
44544361|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
44544362|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44544363|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544364|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544365|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544366|NCT01067469|Growth Substances|growth substances|mesh-ancestor
44544367|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544368|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544369|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
44544370|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44544371|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
44544372|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544373|NCT01067352|Hormones|hormones|mesh-list
44544374|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544375|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544376|NCT01067339|Darapladib|darapladib|mesh-list
44544377|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44544378|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544379|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544380|NCT01067105|Ciclesonide|ciclesonide|mesh-list
44544381|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
44544382|NCT01067105|Hormones|hormones|mesh-ancestor
44544383|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544384|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544385|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44544386|NCT01066923|Aspirin|aspirin|mesh-list
44544387|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44544388|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44544389|NCT01066923|Analgesics|analgesics|mesh-ancestor
44544390|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
44544391|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544392|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544393|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544394|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544395|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44544396|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44544397|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544398|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44544399|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44544400|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544401|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
44544402|NCT01066897|Pramipexole|pramipexole|mesh-list
44544403|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
44544404|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544405|NCT01066897|Protective Agents|protective agents|mesh-ancestor
44544406|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544407|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44544408|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44544409|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
44544410|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
44544411|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544412|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44544413|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44544414|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
44544415|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544416|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44544417|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44544418|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
44448015|NCT01777542|Insulin|insulin|mesh-list
44544419|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544420|NCT01066585|Ivermectin|ivermectin|mesh-list
44544421|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44544422|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544423|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44544424|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
44544425|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44544426|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44544427|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44544428|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44544429|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544430|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44544431|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
44544432|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44544433|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44544434|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44544435|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44544436|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544437|NCT01066104|Omalizumab|omalizumab|mesh-list
44544438|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44544439|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44544440|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544441|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544442|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
44544443|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544444|NCT01066039|Bisoprolol|bisoprolol|mesh-list
44544445|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544446|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
44544447|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
44544448|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368796|NCT01185470|Morphine|morphine|mesh-list
44544463|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544464|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44544465|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44544466|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
44544467|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544468|NCT01065818|Telbivudine|telbivudine|mesh-list
44544469|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
44544470|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544471|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44544472|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544473|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544474|NCT01065766|Metformin|metformin|mesh-list
44544475|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44544476|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544477|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544478|NCT01065766|Incretins|incretins|mesh-ancestor
44544479|NCT01065766|Hormones|hormones|mesh-ancestor
44544480|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544481|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44544482|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
44544483|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544484|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544485|NCT01065350|Ketamine|ketamine|mesh-list
44544486|NCT01065350|Propofol|propofol|mesh-list
44544487|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44544488|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44544489|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544490|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44544491|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
44544492|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
44544493|NCT01065350|Analgesics|analgesics|mesh-ancestor
44544494|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
44544495|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544496|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44544497|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44544498|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44544499|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544500|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544501|NCT01064947|Retapamulin|retapamulin|mesh-list
44544502|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544503|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544504|NCT01064687|Metformin|metformin|mesh-list
44544505|NCT01064687|Pioglitazone|pioglitazone|mesh-list
44544506|NCT01064687|Exenatide|exenatide|mesh-list
44544507|NCT01064687|Dulaglutide|dulaglutide|mesh-list
44544508|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544509|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544510|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44544511|NCT01064687|Incretins|incretins|mesh-ancestor
44544512|NCT01064687|Hormones|hormones|mesh-ancestor
44544513|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544514|NCT01064622|Gemcitabine|gemcitabine|mesh-list
44544515|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
44544516|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44544517|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
44544518|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544519|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544520|NCT01064622|Antiviral Agents|antiviral agents|mesh-ancestor
44544521|NCT01064622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544522|NCT01064622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544523|NCT01064622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544524|NCT01064622|Immunologic Factors|immunologic factors|mesh-ancestor
44544525|NCT01064622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544526|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544527|NCT01064414|Canagliflozin|canagliflozin|mesh-list
44544528|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44544529|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544530|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544531|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544532|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
44544533|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44544534|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44544535|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544536|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
44544537|NCT01064167|Coagulants|coagulants|mesh-ancestor
44544538|NCT01063868|Oxycodone|oxycodone|mesh-list
44544539|NCT01063868|Tapentadol|tapentadol|mesh-list
44544540|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44544541|NCT01063868|Narcotics|narcotics|mesh-ancestor
44544542|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44544543|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544544|NCT01063868|Analgesics|analgesics|mesh-ancestor
44544545|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
44544546|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544547|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44544548|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44544549|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44544550|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544551|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544552|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544553|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44544554|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44544555|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544556|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544557|NCT01063764|Levetiracetam|levetiracetam|mesh-list
44544558|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
44544559|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
44544560|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
44544561|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44544562|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
44544563|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544564|NCT01063348|Expectorants|expectorants|mesh-ancestor
44544565|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544566|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44544567|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
44544568|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544569|NCT01063348|Protective Agents|protective agents|mesh-ancestor
44544570|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544571|NCT01063348|Antidotes|antidotes|mesh-ancestor
44544572|NCT01063283|Bevacizumab|bevacizumab|mesh-list
44544573|NCT01063283|Carboplatin|carboplatin|mesh-list
44544574|NCT01063283|Pemetrexed|pemetrexed|mesh-list
44544575|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44544576|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544577|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544578|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544579|NCT01063283|Growth Substances|growth substances|mesh-ancestor
44544580|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544581|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544582|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544583|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544584|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44544585|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44544586|NCT01063153|Methylphenidate|methylphenidate|mesh-list
44544587|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44544588|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544589|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44544590|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44544591|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448168|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544592|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544593|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
44544594|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544595|NCT01063062|Methotrexate|methotrexate|mesh-list
44544596|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44544597|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
44544598|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44544599|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544600|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44544601|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
44544602|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544603|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544604|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
44544605|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544606|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44544607|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544608|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
44544609|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544610|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44544611|NCT01063036|Tenofovir|tenofovir|mesh-list
44544612|NCT01063036|Entecavir|entecavir|mesh-list
44544613|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
44544614|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544615|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44544616|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44544617|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544618|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544619|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44544620|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44544621|NCT01062971|Timolol|timolol|mesh-list
44544622|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44544623|NCT01062971|Dorzolamide|dorzolamide|mesh-list
44544624|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44544625|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44544626|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544627|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544628|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544629|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544630|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44448223|NCT01774786|Cisplatin|cisplatin|mesh-list
44544631|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544632|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44544633|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44544634|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544635|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44544636|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544637|NCT01062555|Cyclosporine|cyclosporine|mesh-list
44544638|NCT01062555|Sirolimus|sirolimus|mesh-list
44544639|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
44544640|NCT01062555|Tacrolimus|tacrolimus|mesh-list
44544641|NCT01062555|Cyclosporins|cyclosporins|mesh-list
44544642|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544643|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
44544644|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544645|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44544646|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544647|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544648|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
44544649|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544650|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
44544651|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544652|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44544653|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544654|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44544655|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
44544656|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544657|NCT01062425|Temozolomide|temozolomide|mesh-list
44544658|NCT01062425|Cediranib|cediranib|mesh-list
44544659|NCT01062425|Maleic acid|maleic acid|mesh-list
44544660|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44544661|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
44544662|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544663|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544664|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544665|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44544666|NCT01061866|Thalidomide|thalidomide|mesh-list
44544667|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544668|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
44544669|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544670|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
44448273|NCT01773473|Insulin|insulin|mesh-list
44544671|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544672|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544673|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544674|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544675|NCT01061866|Growth Substances|growth substances|mesh-ancestor
44544676|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544677|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544678|NCT01061775|Exenatide|exenatide|mesh-list
44544679|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544680|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544681|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44544682|NCT01061775|Incretins|incretins|mesh-ancestor
44544684|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544685|NCT01061671|Simvastatin|simvastatin|mesh-list
44544686|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44369004|NCT01186224|Plerixafor|plerixafor|mesh-list
44544687|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44544689|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544690|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44544691|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44544692|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544693|NCT01061606|Sirolimus|sirolimus|mesh-list
44544694|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544695|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544696|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44544697|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544698|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
44544699|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544700|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
44544701|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544702|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
44544703|NCT01061333|Nedocromil|nedocromil|mesh-list
44544704|NCT01061333|Montelukast|montelukast|mesh-list
44544705|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544706|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544707|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44544708|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
44544709|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544710|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544711|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44544712|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44544713|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544714|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544715|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
44544716|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44544717|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44544718|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
44544719|NCT01060384|Lenalidomide|lenalidomide|mesh-list
44544720|NCT01060384|Ofatumumab|ofatumumab|mesh-list
44544721|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
44544722|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544723|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544724|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544725|NCT01060384|Growth Substances|growth substances|mesh-ancestor
44544726|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544727|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544728|NCT01060150|Methylphenidate|methylphenidate|mesh-list
44544729|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44544730|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544731|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44544732|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44544733|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44544734|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544735|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
44544736|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544737|NCT01060124|Fentanyl|fentanyl|mesh-list
44544738|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44544739|NCT01060124|Narcotics|narcotics|mesh-ancestor
44544740|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44544741|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544742|NCT01060124|Analgesics|analgesics|mesh-ancestor
44544743|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
44544744|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544745|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44544746|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44544747|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
44544748|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
44544749|NCT01060111|Topiramate|topiramate|mesh-list
44544750|NCT01060111|Propranolol|propranolol|mesh-list
44544751|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44544752|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44544753|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448340|NCT01772368|Xhance|xhance|mesh-list
44544754|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544755|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544756|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544757|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44544758|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544759|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
44544760|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
44544761|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544762|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44544763|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44544764|NCT01060059|Exenatide|exenatide|mesh-list
44544765|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44544766|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544767|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44544768|NCT01060059|Incretins|incretins|mesh-ancestor
44544769|NCT01060059|Hormones|hormones|mesh-ancestor
44544770|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544771|NCT01060007|Leucovorin|leucovorin|mesh-list
44544772|NCT01060007|Fluorouracil|fluorouracil|mesh-list
44544773|NCT01060007|Capecitabine|capecitabine|mesh-list
44544774|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
44544775|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
44544776|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544777|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44544778|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544779|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544780|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
44544781|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544782|NCT01060007|Antidotes|antidotes|mesh-ancestor
44544783|NCT01060007|Protective Agents|protective agents|mesh-ancestor
44544784|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
44544785|NCT01060007|Vitamins|vitamins|mesh-ancestor
44544786|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
44544787|NCT01062399|Everolimus|everolimus|mesh-list
44544788|NCT01062399|Temozolomide|temozolomide|mesh-list
44544789|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544790|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544791|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
44544792|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544793|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44544794|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
44544795|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544796|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
44544797|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
44544798|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44544799|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
44544800|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544801|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544802|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544803|NCT01065779|Alendronate|alendronate|mesh-list
44544804|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44544805|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544806|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
44544807|NCT01069692|Hematinics|hematinics|mesh-ancestor
44544808|NCT01068704|Letrozole|letrozole|mesh-list
44544809|NCT01068704|Lapatinib|lapatinib|mesh-list
44544810|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544811|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44544812|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44544813|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544814|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544815|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44544816|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
44544817|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544818|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544819|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44544820|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
44544821|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44544822|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
44544823|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544824|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544825|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44544826|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544827|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
44544828|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44544829|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
44544830|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544831|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544832|NCT01065012|Udenafil|udenafil|mesh-list
44544833|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44544834|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44448423|NCT01770743|Vaccines|vaccines|mesh-list
44544835|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544836|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544837|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
44544838|NCT01064791|Tacrolimus|tacrolimus|mesh-list
44544840|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
44544841|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544842|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44544843|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544844|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544845|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44544846|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544847|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44544848|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
44544849|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544850|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544851|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
44544852|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44544853|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44544854|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44544855|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44544856|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544857|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
44544858|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544859|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544860|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44544861|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544862|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44544863|NCT01060579|Latanoprost|latanoprost|mesh-list
44544864|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44544865|NCT01064479|Cisplatin|cisplatin|mesh-list
44544866|NCT01064479|Carboplatin|carboplatin|mesh-list
44544867|NCT01064479|Docetaxel|docetaxel|mesh-list
44544868|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44544869|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544870|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
44544871|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
44544872|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
44544873|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544874|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44544875|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544876|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
44544877|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
44544878|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44544879|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44544880|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544881|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44544882|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544883|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544884|NCT01310101|Dexamethasone|dexamethasone|mesh-list
44544885|NCT01310101|Ofatumumab|ofatumumab|mesh-list
44544886|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44544887|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
44544888|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
44544889|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544890|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544891|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44544892|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
44544893|NCT01310101|Hormones|hormones|mesh-ancestor
44544894|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44544895|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44544896|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544897|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44544898|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44544899|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544900|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44544901|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
44544902|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544903|NCT01310244|Paclitaxel|paclitaxel|mesh-list
44544904|NCT01310244|Carboplatin|carboplatin|mesh-list
44544905|NCT01310244|Belinostat|belinostat|mesh-list
44544906|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44544907|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544908|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
44544909|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
44544910|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
44544911|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544912|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44544913|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544914|NCT01310283|Fluorides|fluorides|mesh-list
44544915|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
44544916|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
44544917|NCT01310283|Protective Agents|protective agents|mesh-ancestor
44544918|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544919|NCT01310296|Lofexidine|lofexidine|mesh-list
44544920|NCT01310296|Clonidine|clonidine|mesh-list
44544921|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44544922|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44544923|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544924|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
44544925|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544926|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44544927|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44544928|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44544929|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44544930|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544931|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544932|NCT01310296|Analgesics|analgesics|mesh-ancestor
44544933|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
44544934|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
44544935|NCT01310361|Amoxicillin|amoxicillin|mesh-list
44544936|NCT01310361|Penicillins|penicillins|mesh-list
44544937|NCT01310361|Penicillin G|penicillin g|mesh-list
44544938|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44544939|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
44544940|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544941|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544942|NCT01310478|Endostatins|endostatins|mesh-list
44544943|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44544944|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44544945|NCT01310478|Growth Substances|growth substances|mesh-ancestor
44544946|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544947|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
44544948|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44544949|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44544950|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44544951|NCT01310673|Allopurinol|allopurinol|mesh-list
44544952|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
44544953|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544954|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44544955|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
44544956|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44544957|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44544958|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
44544959|NCT01310673|Protective Agents|protective agents|mesh-ancestor
44544960|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544961|NCT01310712|Oxybutynin|oxybutynin|mesh-list
44544962|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
44544963|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
44544964|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544965|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544966|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44544967|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44544968|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
44544969|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544970|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544971|NCT01310712|Urological Agents|urological agents|mesh-ancestor
44544972|NCT01310738|Amphotericin B|amphotericin b|mesh-list
44544973|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44544974|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44544975|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44544976|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
44544977|NCT01310738|Amebicides|amebicides|mesh-ancestor
44544978|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44544979|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44544980|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44544981|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44544982|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
44544983|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44544984|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44544985|NCT01310751|Iloprost|iloprost|mesh-list
44544986|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44544987|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
44544988|NCT01310842|Nicotine|nicotine|mesh-list
44544989|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44544990|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
44369309|NCT01188005|Vitamins|vitamins|mesh-list
44544991|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44544992|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44544993|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44544994|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44544995|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
44544996|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44544997|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44544998|NCT01310985|Capecitabine|capecitabine|mesh-list
44544999|NCT01310985|Cetuximab|cetuximab|mesh-list
44545000|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545001|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
44545002|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545003|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545004|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545005|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44545006|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44545007|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545008|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545009|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44545010|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44545011|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545012|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545013|NCT01311050|Bevacizumab|bevacizumab|mesh-list
44545014|NCT01311050|Capecitabine|capecitabine|mesh-list
44545015|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
44545016|NCT01311050|Irinotecan|irinotecan|mesh-list
44545017|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545018|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545019|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44545020|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545021|NCT01311050|Growth Substances|growth substances|mesh-ancestor
44545022|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545023|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545024|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545025|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
44545026|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545027|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44545028|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44545029|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545030|NCT01311076|Insulin|insulin|mesh-list
44545031|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44545032|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
44545033|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545034|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545035|NCT01311141|Doripenem|doripenem|mesh-list
44545036|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545037|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545038|NCT01311167|Dexamethasone|dexamethasone|mesh-list
44545039|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545040|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
44545041|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
44545042|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545043|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545044|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44545045|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
44545046|NCT01311167|Hormones|hormones|mesh-ancestor
44545047|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545048|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44545049|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545050|NCT01311336|Loratadine|loratadine|mesh-list
44545051|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
44545052|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44545053|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44545054|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44545055|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44545056|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
44545057|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
44545058|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545059|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950540|NCT01145638|Iron|iron|mesh-list
44545061|NCT01311414|Urapidil|urapidil|mesh-list
44545062|NCT01311414|Theodrenaline|theodrenaline|mesh-list
44545063|NCT01311414|Cafedrine|cafedrine|mesh-list
44545064|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44545065|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545066|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44545067|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
44545068|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369470|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
44545069|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545070|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545071|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44545085|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
44545086|NCT01311700|Metoprolol|metoprolol|mesh-list
44545087|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44545088|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44545089|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
44545090|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
44545091|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545092|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545093|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44545094|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44545095|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44545096|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44545097|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545098|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545099|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
44545100|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
44545101|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
44545102|NCT01311739|Vitamins|vitamins|mesh-ancestor
44545103|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
44545104|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545105|NCT01311739|Hematinics|hematinics|mesh-ancestor
44545106|NCT01311778|Fentanyl|fentanyl|mesh-list
44545107|NCT01311778|Cannabidiol|cannabidiol|mesh-list
44545108|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545109|NCT01311778|Narcotics|narcotics|mesh-ancestor
44545110|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545111|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545112|NCT01311778|Analgesics|analgesics|mesh-ancestor
44545113|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
44545114|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545115|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44545116|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545117|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
44545118|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
44545119|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
44545120|NCT01311804|Parecoxib|parecoxib|mesh-list
44545121|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44545122|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44545123|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545124|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545125|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44545126|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545127|NCT01311804|Analgesics|analgesics|mesh-ancestor
44545128|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
44545129|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545130|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545131|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545132|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545133|NCT01311882|Zopiclone|zopiclone|mesh-list
44545134|NCT01311882|Suvorexant|suvorexant|mesh-list
44545135|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44545136|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545137|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545138|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44545139|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44545140|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545141|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545142|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44545143|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
44545144|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545145|NCT01311960|Bevacizumab|bevacizumab|mesh-list
44545146|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43950617|NCT01147627|Coagulants|coagulants|mesh-ancestor
44545147|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545148|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545149|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44448719|NCT01765582|Folic Acid|folic acid|mesh-list
44545150|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545151|NCT01311960|Growth Substances|growth substances|mesh-ancestor
44545152|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545153|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545154|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44545156|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545157|NCT01312064|Rituximab|rituximab|mesh-list
44545158|NCT01312064|Everolimus|everolimus|mesh-list
44545159|NCT01312064|Tacrolimus|tacrolimus|mesh-list
44545160|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
44545161|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545162|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545163|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
44545164|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545165|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545166|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545167|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44545168|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545169|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545170|NCT01312077|Morphine|morphine|mesh-list
44545171|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
44545172|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545173|NCT01312077|Narcotics|narcotics|mesh-ancestor
44545174|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545175|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545176|NCT01312077|Analgesics|analgesics|mesh-ancestor
44545177|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
44545178|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545179|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545180|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
44545181|NCT01312311|Cisplatin|cisplatin|mesh-list
44545182|NCT01312311|Docetaxel|docetaxel|mesh-list
44545183|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545184|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545185|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545186|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545187|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545188|NCT01312324|Cisplatin|cisplatin|mesh-list
44545189|NCT01312324|Docetaxel|docetaxel|mesh-list
44545190|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545191|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545192|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545193|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545194|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545195|NCT01312337|Gefitinib|gefitinib|mesh-list
44545196|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545197|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44545198|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545199|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545200|NCT01312350|Cisplatin|cisplatin|mesh-list
44545201|NCT01312350|Docetaxel|docetaxel|mesh-list
44545202|NCT01312350|Fluorouracil|fluorouracil|mesh-list
44545203|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545204|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545205|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545206|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545207|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545208|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
44545209|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545210|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545211|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
44545212|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545213|NCT01312363|Rivastigmine|rivastigmine|mesh-list
44545214|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44545215|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545216|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545217|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
44545218|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545219|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545220|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44545221|NCT01312363|Protective Agents|protective agents|mesh-ancestor
44545222|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
44545223|NCT01312376|Bevacizumab|bevacizumab|mesh-list
44545224|NCT01312376|Fludarabine|fludarabine|mesh-list
44545225|NCT01312376|Vaccines|vaccines|mesh-list
44545226|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
44545227|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545228|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545229|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545230|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44545231|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
44545232|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545233|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545234|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44545235|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545236|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44545237|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545238|NCT01312376|Growth Substances|growth substances|mesh-ancestor
44545239|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545240|NCT01312415|Morphine|morphine|mesh-list
44545241|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
44545242|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545243|NCT01312415|Narcotics|narcotics|mesh-ancestor
44545244|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545245|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545246|NCT01312415|Analgesics|analgesics|mesh-ancestor
44545247|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
44545248|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545249|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545250|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
44545251|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
44369630|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
44545252|NCT01312441|Vitamin D|vitamin d|mesh-list
44545253|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44545254|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545255|NCT01312441|Vitamins|vitamins|mesh-ancestor
44545256|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
44545257|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44545258|NCT01312493|Panitumumab|panitumumab|mesh-list
44545259|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545260|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545261|NCT01312714|Vitamin D|vitamin d|mesh-list
44545262|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
44545263|NCT01312714|Vitamins|vitamins|mesh-ancestor
44545264|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
44545265|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545266|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44545267|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44545268|NCT01312792|Ampicillin|ampicillin|mesh-list
44545269|NCT01312792|Cephradine|cephradine|mesh-list
44545270|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545271|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545272|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
44545273|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
44545274|NCT01312831|Vitamins|vitamins|mesh-ancestor
44545275|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
44545276|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545277|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
44545278|NCT01312831|Hematinics|hematinics|mesh-ancestor
44545279|NCT01313143|Esmolol|esmolol|mesh-list
44545280|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44545281|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44545282|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44545283|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
44545284|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448862|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
44545285|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545286|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545287|NCT01313247|Acetaminophen|acetaminophen|mesh-list
44545288|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545289|NCT01313247|Analgesics|analgesics|mesh-ancestor
44545290|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
44545291|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545292|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545293|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
44545294|NCT01313377|Gemcitabine|gemcitabine|mesh-list
44545295|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
44545296|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545297|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
44545298|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545299|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545300|NCT01313377|Antiviral Agents|antiviral agents|mesh-ancestor
44545302|NCT01313377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545303|NCT01313377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545304|NCT01313377|Immunologic Factors|immunologic factors|mesh-ancestor
44545305|NCT01313377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545306|NCT01313390|Docetaxel|docetaxel|mesh-list
44545307|NCT01313390|Everolimus|everolimus|mesh-list
44545308|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545309|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545310|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545311|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545312|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545313|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545314|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
44545315|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545316|NCT01313845|Amantadine|amantadine|mesh-list
44545317|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44545318|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44545319|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
44545320|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545321|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
44545322|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545323|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545324|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545325|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545326|NCT01313845|Analgesics|analgesics|mesh-ancestor
44545327|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
44545328|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545329|NCT01314027|Gemcitabine|gemcitabine|mesh-list
44545330|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
44545331|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545332|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
44545333|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545334|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545335|NCT01314027|Antiviral Agents|antiviral agents|mesh-ancestor
44545336|NCT01314027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545337|NCT01314027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545338|NCT01314027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545339|NCT01314027|Immunologic Factors|immunologic factors|mesh-ancestor
44545340|NCT01314027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545341|NCT01314144|Bupivacaine|bupivacaine|mesh-list
44545342|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545343|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
44545344|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545345|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545346|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
44545347|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545348|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
44545349|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44545350|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545351|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545352|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545353|NCT01314209|Analgesics|analgesics|mesh-ancestor
44545354|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
44545363|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545364|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545365|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44545366|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545367|NCT01314274|Growth Substances|growth substances|mesh-ancestor
44545368|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545369|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545371|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44545372|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
44545373|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545374|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448937|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
44545375|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545376|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44545377|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44545378|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
44545379|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
44545380|NCT01314352|Desloratadine|desloratadine|mesh-list
44545381|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44545382|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
44545383|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545384|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545385|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545386|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44545388|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
44545389|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
44545390|NCT01314482|Minocycline|minocycline|mesh-list
44545391|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545392|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545393|NCT01314495|Abatacept|abatacept|mesh-list
44545394|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44545395|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545396|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545397|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545398|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
44545399|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545400|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545401|NCT01314508|Mecasermin|mecasermin|mesh-list
44545402|NCT01314508|Growth Substances|growth substances|mesh-ancestor
44545403|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369856|NCT01191216|Docetaxel|docetaxel|mesh-list
44545404|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
44545405|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
44545406|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44545407|NCT01314586|Estrogens|estrogens|mesh-ancestor
44545409|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545410|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545411|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44545412|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44545413|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44545414|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545415|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
44545416|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44545417|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44545418|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
44545419|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545420|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545421|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545422|NCT01314781|Urological Agents|urological agents|mesh-ancestor
44545423|NCT01314833|Paclitaxel|paclitaxel|mesh-list
44545424|NCT01314833|Docetaxel|docetaxel|mesh-list
44545425|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
44545426|NCT01314833|Fluorouracil|fluorouracil|mesh-list
44545427|NCT01314833|Epirubicin|epirubicin|mesh-list
44545428|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44545429|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545430|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545431|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545432|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545433|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545434|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545435|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
44545436|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545437|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545438|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44545439|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
44545440|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44545441|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
44545442|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545443|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44545444|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44545445|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44545446|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545447|NCT01314937|Mebendazole|mebendazole|mesh-list
44545448|NCT01314937|Piperazine|piperazine|mesh-list
44545449|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
44545450|NCT01314937|DMP 777|dmp 777|mesh-list
44545451|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
44545452|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
44545453|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44545454|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545455|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545456|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545457|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545458|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545459|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545460|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545461|NCT01314976|Metronidazole|metronidazole|mesh-list
44545462|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545463|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545464|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44545465|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44545466|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
44545467|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
44545468|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44545469|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44545470|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44545471|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
44545472|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
44545473|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545474|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545475|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545476|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44545477|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
44545478|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44545479|NCT01315093|Heparin|heparin|mesh-list
44545480|NCT01315093|Calcium heparin|calcium heparin|mesh-list
44545481|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44545482|NCT01315093|Tinzaparin|tinzaparin|mesh-list
44545483|NCT01315093|Dalteparin|dalteparin|mesh-list
44545484|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
44545485|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44545486|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44545487|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545488|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
44545489|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545490|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44545491|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44545492|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545493|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545494|NCT01315262|Urological Agents|urological agents|mesh-ancestor
44545495|NCT01315275|Ranibizumab|ranibizumab|mesh-list
44545496|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44545497|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545498|NCT01315275|Growth Substances|growth substances|mesh-ancestor
44545499|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545500|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545501|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545502|NCT01315431|Capecitabine|capecitabine|mesh-list
44449055|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545503|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545504|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
44545505|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545506|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545507|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
44545508|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44545509|NCT01315496|Antibodies|antibodies|mesh-list
44545510|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
44545511|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
44545512|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545513|NCT01315691|Amikacin|amikacin|mesh-list
44545514|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545515|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545516|NCT01315704|Vitamin D|vitamin d|mesh-list
44545517|NCT01315704|Vitamins|vitamins|mesh-ancestor
44545518|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
44545519|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545520|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44545521|NCT01315795|Lanreotide|lanreotide|mesh-list
44545522|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545523|NCT01315886|Fentanyl|fentanyl|mesh-list
44545524|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545525|NCT01315886|Narcotics|narcotics|mesh-ancestor
44545526|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545527|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545528|NCT01315886|Analgesics|analgesics|mesh-ancestor
44545529|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
44545530|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545531|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44545532|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545533|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
44545534|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
44545535|NCT01315938|Abatacept|abatacept|mesh-list
44545536|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44545537|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545538|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545539|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545540|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
44545541|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545542|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545544|NCT01315951|Emollients|emollients|mesh-ancestor
44545545|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
44545546|NCT01315990|Cetuximab|cetuximab|mesh-list
44545547|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545548|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545549|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44545550|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
44545551|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44545552|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
44545553|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545554|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44545555|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44545556|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44545557|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545558|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545559|NCT01316081|Vitamins|vitamins|mesh-list
44545560|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
44545561|NCT01316081|Vitamin E|vitamin e|mesh-list
44545562|NCT01316081|Tocopherols|tocopherols|mesh-list
44545563|NCT01316081|Tocotrienols|tocotrienols|mesh-list
44545564|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
44545565|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
44545566|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545567|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
44545568|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545569|NCT01316081|Protective Agents|protective agents|mesh-ancestor
44545570|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
44545571|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44545572|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545573|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545574|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545575|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
44545576|NCT01316107|Nateglinide|nateglinide|mesh-list
44545577|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44545578|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545579|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545580|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545581|NCT01316133|Tacrolimus|tacrolimus|mesh-list
44545582|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545583|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
44545584|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545585|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44545587|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545588|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
44545589|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545590|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44545591|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545592|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545593|NCT01316549|Fludarabine|fludarabine|mesh-list
44545594|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545595|NCT01316718|Mesalamine|mesalamine|mesh-list
44545596|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44545597|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545598|NCT01316718|Analgesics|analgesics|mesh-ancestor
44545599|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
44545600|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545601|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545602|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545603|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545604|NCT01316744|Ketamine|ketamine|mesh-list
44545605|NCT01316744|Analgesics|analgesics|mesh-ancestor
44545606|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
44545607|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545608|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545609|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44545610|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545611|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
44545612|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
44545613|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545614|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44545615|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44545616|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545617|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545618|NCT01316757|Paclitaxel|paclitaxel|mesh-list
44545619|NCT01316757|Carboplatin|carboplatin|mesh-list
44545620|NCT01316757|Cetuximab|cetuximab|mesh-list
44545621|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44545622|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44545623|NCT01316757|Antibodies|antibodies|mesh-list
44545624|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
44545625|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44545626|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44545627|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545628|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44545629|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44545630|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44545631|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545632|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
44545633|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545634|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44545635|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545636|NCT01316952|Carvedilol|carvedilol|mesh-list
44545637|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44545638|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
44545639|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44545640|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545641|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545642|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545643|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44545644|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
44545645|NCT01316952|Protective Agents|protective agents|mesh-ancestor
44545646|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44545647|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44545648|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44545649|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545650|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44545651|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44545652|NCT01316978|Ibuprofen|ibuprofen|mesh-list
44545653|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44545654|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545655|NCT01316978|Analgesics|analgesics|mesh-ancestor
44545656|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
44545657|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370157|NCT01193192|Vitamins|vitamins|mesh-list
44545668|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
44545669|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545670|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44545671|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545672|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545673|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
44545674|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545675|NCT01317212|Carboplatin|carboplatin|mesh-list
44545676|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545677|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44545678|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44545679|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44545680|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44545681|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545682|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545683|NCT01317225|Progestins|progestins|mesh-ancestor
44545684|NCT01317225|Hormones|hormones|mesh-ancestor
44545685|NCT01317368|Ropivacaine|ropivacaine|mesh-list
44545686|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545687|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
44545688|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545689|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545690|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
44545691|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545692|NCT01317433|Doxycycline|doxycycline|mesh-list
44545693|NCT01317433|Cetuximab|cetuximab|mesh-list
44545694|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545695|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545696|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44545697|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545698|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
44545699|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44545700|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44545701|NCT01317446|Fluorides|fluorides|mesh-list
44545702|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
44545703|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
44545704|NCT01317446|Protective Agents|protective agents|mesh-ancestor
44545705|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545706|NCT01317511|Caseins|caseins|mesh-list
44545707|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
44545708|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
44545709|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545710|NCT01317563|Vitamin A|vitamin a|mesh-list
44545711|NCT01317563|Selenium|selenium|mesh-list
44545712|NCT01317563|Vitamins|vitamins|mesh-ancestor
44545713|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
44545714|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545715|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
44545716|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545717|NCT01317563|Protective Agents|protective agents|mesh-ancestor
44545718|NCT01317563|Trace Elements|trace elements|mesh-ancestor
44545719|NCT01317589|Fentanyl|fentanyl|mesh-list
44545720|NCT01317589|Methadone|methadone|mesh-list
44545721|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545722|NCT01317589|Narcotics|narcotics|mesh-ancestor
44545723|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545724|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545725|NCT01317589|Analgesics|analgesics|mesh-ancestor
44545726|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
44545727|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545728|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44545729|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545730|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
44545731|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
44545732|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
44545733|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
44545735|NCT01317849|Folic Acid|folic acid|mesh-list
44545736|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
44545737|NCT01317849|Hydroxocobalamin|hydroxocobalamin|mesh-list
44545738|NCT01317849|Pyridoxine|pyridoxine|mesh-list
44545739|NCT01317849|Pyridoxal|pyridoxal|mesh-list
44545740|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
44545741|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
44545742|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
44545743|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545744|NCT01317849|Hematinics|hematinics|mesh-ancestor
44545745|NCT01317927|Belinostat|belinostat|mesh-list
44545746|NCT01317927|Warfarin|warfarin|mesh-list
44545747|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
44545748|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545749|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44545750|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545751|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545752|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44545753|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
44545754|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545755|NCT01317953|Protective Agents|protective agents|mesh-ancestor
44545756|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545757|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44545758|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44545759|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545760|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44545761|NCT01317966|Rituximab|rituximab|mesh-list
44545762|NCT01317966|Oprelvekin|oprelvekin|mesh-list
44545763|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44545764|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545765|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
44545766|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545767|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44545768|NCT01317992|Ibudilast|ibudilast|mesh-list
44545769|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44545770|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
44545771|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545772|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545773|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44545774|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
44545775|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44545776|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545777|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449316|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
44545778|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44545779|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545780|NCT01318044|Thiopental|thiopental|mesh-list
44545781|NCT01318044|Propofol|propofol|mesh-list
44545782|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44545783|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545784|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545785|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545786|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
44545787|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
44545788|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
44545789|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
44545790|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
44545791|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545792|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545793|NCT01318096|Tenofovir|tenofovir|mesh-list
44545794|NCT01318096|Lamivudine|lamivudine|mesh-list
44545795|NCT01318096|Efavirenz|efavirenz|mesh-list
44545796|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
44545797|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
44545798|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545799|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44545800|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44545801|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545802|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545803|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44545804|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44545805|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44545806|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44545807|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44545808|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44545809|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44545810|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44545822|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545823|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545824|NCT01318161|Analgesics|analgesics|mesh-ancestor
44545825|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
44545826|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545827|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545828|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
44545829|NCT01318187|Acetaminophen|acetaminophen|mesh-list
44545830|NCT01318187|Morphine|morphine|mesh-list
44545831|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545832|NCT01318187|Narcotics|narcotics|mesh-ancestor
44545833|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545834|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545835|NCT01318187|Analgesics|analgesics|mesh-ancestor
44545836|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
44545837|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545838|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545839|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
44545840|NCT01318265|Ketoconazole|ketoconazole|mesh-list
44545841|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
44545842|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44545843|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44545844|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44545845|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545846|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545847|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44545848|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
44545849|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545850|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545851|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44545852|NCT01318369|Diazepam|diazepam|mesh-list
44545853|NCT01318369|Dronabinol|dronabinol|mesh-list
44545854|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
44545855|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545856|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44545857|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44545858|NCT01318369|Analgesics|analgesics|mesh-ancestor
44545859|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
44545860|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545861|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44545862|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44545863|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545864|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545866|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545867|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44545868|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
44545869|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
44545870|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
44545871|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44545872|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44545873|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545874|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44545875|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44545876|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44545877|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44545878|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44545879|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
44545880|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
44545881|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
44545882|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
44545883|NCT01318460|Simendan|simendan|mesh-list
44449404|NCT01751087|Mifepristone|mifepristone|mesh-list
44545884|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44545885|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545886|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44545887|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44545888|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545889|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545890|NCT01318460|Protective Agents|protective agents|mesh-ancestor
44545891|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545892|NCT01318564|Metformin|metformin|mesh-list
44545893|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545894|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545895|NCT01318590|Triamcinolone|triamcinolone|mesh-list
44545896|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44545897|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44545898|NCT01318590|Bupivacaine|bupivacaine|mesh-list
44545899|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44545900|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
44545901|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
44545902|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545903|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545904|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
44545905|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545906|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545907|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
44545908|NCT01318590|Hormones|hormones|mesh-ancestor
44545909|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545910|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44545911|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
44545912|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44545913|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545914|NCT01318655|Naloxegol|naloxegol|mesh-list
44545915|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44545916|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545917|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
44545918|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545919|NCT01318668|Vaccines|vaccines|mesh-list
44545920|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
44545921|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545922|NCT01318681|Fluticasone|fluticasone|mesh-list
44370461|NCT01195766|Ofatumumab|ofatumumab|mesh-list
44545923|NCT01318681|Xhance|xhance|mesh-list
44545924|NCT01318681|Cetirizine|cetirizine|mesh-list
44545925|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44545926|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44545927|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
44545928|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545929|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545930|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44545931|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
44545932|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
44545933|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44545934|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44545935|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44545936|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
44545937|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
44545938|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545939|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545940|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
44545941|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44545942|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44545943|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
44545944|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545945|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545946|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545947|NCT01318837|Urological Agents|urological agents|mesh-ancestor
44545948|NCT01319006|Glycine|glycine|mesh-list
44545949|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
44545950|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545951|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545952|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545953|NCT01319188|Ranibizumab|ranibizumab|mesh-list
44545954|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44545955|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44545956|NCT01319188|Growth Substances|growth substances|mesh-ancestor
44545957|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545958|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44545959|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44545960|NCT01319214|Propranolol|propranolol|mesh-list
44545961|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44545962|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44545963|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44545964|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44545965|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44545966|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545967|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44545968|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44545969|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
44545970|NCT01319240|Insulin|insulin|mesh-list
44545971|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44545972|NCT01319240|Liraglutide|liraglutide|mesh-list
44545973|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
44545974|NCT01319240|Xultophy|xultophy|mesh-list
44545975|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44545976|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545977|NCT01319240|Incretins|incretins|mesh-ancestor
44545978|NCT01319240|Hormones|hormones|mesh-ancestor
44545979|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44545980|NCT01319266|Hydrocodone|hydrocodone|mesh-list
44545981|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545982|NCT01319266|Narcotics|narcotics|mesh-ancestor
44545983|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545984|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545985|NCT01319266|Analgesics|analgesics|mesh-ancestor
44545986|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
44545987|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545988|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
44545989|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
44545990|NCT01319279|Hydrocodone|hydrocodone|mesh-list
44545991|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44545992|NCT01319279|Narcotics|narcotics|mesh-ancestor
44545993|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44545994|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44545995|NCT01319279|Analgesics|analgesics|mesh-ancestor
44545996|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
44545997|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44545998|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
44545999|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546000|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44546001|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
44546002|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44546003|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44546004|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546005|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546006|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546007|NCT01319344|Eplerenone|eplerenone|mesh-list
44449532|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
44546008|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44546009|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
44546010|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546012|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44546013|NCT01319344|Diuretics|diuretics|mesh-ancestor
44546014|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
44546015|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44546016|NCT01319357|Saxagliptin|saxagliptin|mesh-list
44546017|NCT01319357|Incretins|incretins|mesh-ancestor
44546018|NCT01319357|Hormones|hormones|mesh-ancestor
44546019|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546020|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546021|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546022|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546023|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546024|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546025|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546026|NCT01319370|Minoxidil|minoxidil|mesh-list
44546027|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44546028|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
44546029|NCT01319448|Artesunate|artesunate|mesh-list
44546030|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
44546031|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
44546032|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44546033|NCT01319448|Amodiaquine|amodiaquine|mesh-list
44546034|NCT01319448|Mefloquine|mefloquine|mesh-list
44546035|NCT01319448|Proguanil|proguanil|mesh-list
44546036|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
44546037|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44546038|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44546039|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546040|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546041|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
44546042|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
44546043|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44546044|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
44546045|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44546046|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546047|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546048|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44546049|NCT01319448|Renal Agents|renal agents|mesh-ancestor
44546050|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
44546051|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
44546052|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44546053|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
44546054|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546055|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
44546056|NCT01319461|Protective Agents|protective agents|mesh-ancestor
44546057|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44546058|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44546059|NCT01319682|Lidocaine|lidocaine|mesh-list
44546060|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
44546061|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
44546062|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546063|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546064|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
44546065|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546066|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44546067|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44546068|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44546069|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546070|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546071|NCT01319695|Hormones|hormones|mesh-list
44546072|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44546073|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546074|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546085|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
44546086|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44546087|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44546088|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546089|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546090|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546091|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546092|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546093|NCT01319825|Analgesics|analgesics|mesh-ancestor
43951450|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
44546094|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
44546095|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546096|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44546097|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44546098|NCT01319838|Isotretinoin|isotretinoin|mesh-list
44546099|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44546100|NCT01319864|Plerixafor|plerixafor|mesh-list
44546101|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44546102|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44546103|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
44546104|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546105|NCT01319903|Antibodies|antibodies|mesh-list
44546106|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44546107|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
44546108|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546109|NCT01319942|Sorafenib|sorafenib|mesh-list
44546110|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546111|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546112|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546113|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546114|NCT01316523|Rituximab|rituximab|mesh-list
44546115|NCT01316523|Lenalidomide|lenalidomide|mesh-list
44546116|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44546117|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546118|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
44546119|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546120|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546121|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44546122|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44546123|NCT01316523|Growth Substances|growth substances|mesh-ancestor
44546124|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
44546125|NCT01312857|Panitumumab|panitumumab|mesh-list
44546126|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44546127|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546128|NCT01318486|Heparin|heparin|mesh-list
44546129|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
44546130|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44546131|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44546132|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546133|NCT01319994|Metformin|metformin|mesh-list
44546134|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546135|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546136|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
44546137|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44546138|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44546139|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546140|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546141|NCT01319929|Hormones|hormones|mesh-ancestor
44546142|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546143|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546144|NCT01319721|Mitomycins|mitomycins|mesh-list
44546145|NCT01319721|Mitomycin|mitomycin|mesh-list
44546146|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44546147|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546148|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
44546149|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546150|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44546151|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546152|NCT01319422|Pomalidomide|pomalidomide|mesh-list
44546153|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
44546154|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546155|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44546156|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44546157|NCT01319422|Growth Substances|growth substances|mesh-ancestor
44546158|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
44546159|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546160|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
44546161|NCT01318915|Sirolimus|sirolimus|mesh-list
44546162|NCT01318915|Rituximab|rituximab|mesh-list
44546163|NCT01318915|Tacrolimus|tacrolimus|mesh-list
44546164|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
44546165|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44546166|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44546167|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546168|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
44546169|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546170|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546171|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546172|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44546173|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546174|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546175|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44546176|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44546177|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
44546178|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546179|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546180|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
44546182|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44546183|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546184|NCT01318499|Analgesics|analgesics|mesh-ancestor
44546185|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
44546186|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546187|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546188|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546189|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546190|NCT01318135|Metformin|metformin|mesh-list
44546191|NCT01318135|Glimepiride|glimepiride|mesh-list
44546192|NCT01318135|Alogliptin|alogliptin|mesh-list
44546193|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546194|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546195|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44546196|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546197|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
44546198|NCT01318135|Incretins|incretins|mesh-ancestor
44546199|NCT01318135|Hormones|hormones|mesh-ancestor
44546200|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546201|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546202|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546203|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546204|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546205|NCT01318122|Pioglitazone|pioglitazone|mesh-list
44546206|NCT01318122|Alogliptin|alogliptin|mesh-list
44546207|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546208|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546209|NCT01318122|Incretins|incretins|mesh-ancestor
44546210|NCT01318122|Hormones|hormones|mesh-ancestor
44546211|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546212|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546213|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546214|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546215|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546216|NCT01318109|Metformin|metformin|mesh-list
44546217|NCT01318109|Alogliptin|alogliptin|mesh-list
44546218|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546219|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546220|NCT01318109|Incretins|incretins|mesh-ancestor
44546221|NCT01318109|Hormones|hormones|mesh-ancestor
44546222|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546223|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546224|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546225|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546226|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546227|NCT01318083|Glimepiride|glimepiride|mesh-list
44546228|NCT01318083|Alogliptin|alogliptin|mesh-list
44546229|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44546230|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546231|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546232|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546233|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
44546234|NCT01318083|Incretins|incretins|mesh-ancestor
44546235|NCT01318083|Hormones|hormones|mesh-ancestor
44546236|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546237|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546238|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546239|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546240|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546241|NCT01318070|Pioglitazone|pioglitazone|mesh-list
44546242|NCT01318070|Alogliptin|alogliptin|mesh-list
44546243|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546244|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546246|NCT01318070|Hormones|hormones|mesh-ancestor
44546247|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546248|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546249|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546250|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546251|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546252|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
44546253|NCT01317940|Vitamin D|vitamin d|mesh-list
44546254|NCT01317940|Calcitriol|calcitriol|mesh-list
44546255|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44546256|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
44546257|NCT01317940|Calcium|calcium|mesh-list
44546258|NCT01317940|Vitamins|vitamins|mesh-ancestor
44546259|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
44546260|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546261|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44546262|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44546263|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546264|NCT01317940|Antacids|antacids|mesh-ancestor
44546265|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44546266|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44546267|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546268|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44546269|NCT01317550|Minocycline|minocycline|mesh-list
44546270|NCT01317550|Modafinil|modafinil|mesh-list
44546271|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546272|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546273|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44546274|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546275|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44546276|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44546277|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44546278|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546279|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
44546280|NCT01317472|Lansoprazole|lansoprazole|mesh-list
44546281|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44546282|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44546283|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44546284|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546285|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546286|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44546287|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
44546288|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44546289|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546290|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546291|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
44546292|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546293|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44546294|NCT01316913|Bromides|bromides|mesh-list
44546295|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
44546296|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44546297|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
44546298|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546299|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546300|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44546301|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546302|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
44546303|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44546304|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546305|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546306|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546307|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
44546308|NCT01316900|Bromides|bromides|mesh-list
44546309|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
44546310|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44546311|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
44546312|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546313|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546314|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44546315|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546316|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
44546317|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44546318|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546319|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546320|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546321|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
44546322|NCT01316419|Amlodipine|amlodipine|mesh-list
44546323|NCT01316419|Telmisartan|telmisartan|mesh-list
44546324|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44546325|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44546326|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546327|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546328|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44546329|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546330|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
44546331|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44546332|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44546333|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
44546334|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44546335|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
44546336|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546337|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546338|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44546339|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546340|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
44546341|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44546342|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546343|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546344|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546345|NCT01316276|Amikacin|amikacin|mesh-list
44546346|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546347|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546348|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
44546349|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44546350|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546351|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546352|NCT01315236|Amikacin|amikacin|mesh-list
44546353|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546354|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546355|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44546356|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44546357|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44546358|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546359|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546360|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546361|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546362|NCT01314872|Urological Agents|urological agents|mesh-ancestor
44546363|NCT01314443|Vitamin E|vitamin e|mesh-list
44546364|NCT01314443|Tocopherols|tocopherols|mesh-list
44546365|NCT01314443|Tocotrienols|tocotrienols|mesh-list
44546366|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
44546367|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
44546368|NCT01314443|Nicotine|nicotine|mesh-list
44546369|NCT01314443|Vitamins|vitamins|mesh-ancestor
44546370|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
44546371|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546372|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44546373|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
44546374|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546375|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44546376|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44546377|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546378|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546379|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546380|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
44546381|NCT01314443|Protective Agents|protective agents|mesh-ancestor
44546382|NCT01314105|Carboplatin|carboplatin|mesh-list
44546383|NCT01314105|Nintedanib|nintedanib|mesh-list
44546384|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546385|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546386|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546387|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546388|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
44546389|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44546390|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370936|NCT01198665|Hormones|hormones|mesh-ancestor
44546392|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546393|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546394|NCT05654818|Vitamin D|vitamin d|mesh-list
44546395|NCT05654818|Vitamins|vitamins|mesh-ancestor
44546396|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
44546397|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546398|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44546399|NCT05654662|Listerine|listerine|mesh-list
44546400|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
44546401|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44546402|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
44546403|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
44546404|NCT05654662|Protective Agents|protective agents|mesh-ancestor
44546405|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546406|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44546407|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546408|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
44546409|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44546410|NCT05654649|Dexamethasone|dexamethasone|mesh-list
44546411|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546412|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
44546413|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
44546414|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546415|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546416|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44546417|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
44546418|NCT05654649|Hormones|hormones|mesh-ancestor
44546419|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546420|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44546421|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546422|NCT05654506|Daratumumab|daratumumab|mesh-list
44546423|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546424|NCT05654467|Vaccines|vaccines|mesh-list
44546425|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
44546426|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546427|NCT05654454|Paclitaxel|paclitaxel|mesh-list
44546428|NCT05654454|Bevacizumab|bevacizumab|mesh-list
44546429|NCT05654454|Carboplatin|carboplatin|mesh-list
44546430|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44546431|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546432|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
44546433|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
44546434|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
44546435|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546436|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44546437|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44546438|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44546439|NCT05654454|Growth Substances|growth substances|mesh-ancestor
44546440|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546441|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
44546442|NCT05654415|Melatonin|melatonin|mesh-list
44546443|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
44546444|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546445|NCT05654415|Protective Agents|protective agents|mesh-ancestor
44546446|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546447|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546448|NCT05654363|Morphine|morphine|mesh-list
44546449|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44546450|NCT05654363|Narcotics|narcotics|mesh-ancestor
44546451|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546452|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546453|NCT05654363|Analgesics|analgesics|mesh-ancestor
44546454|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
44546455|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546470|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546472|NCT05654090|Renal Agents|renal agents|mesh-ancestor
44546473|NCT05654064|Fentanyl|fentanyl|mesh-list
44546474|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
44546475|NCT05654064|Remifentanil|remifentanil|mesh-list
44546476|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44546477|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546478|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546479|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546480|NCT05654064|Analgesics|analgesics|mesh-ancestor
44546481|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
44546482|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546483|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44546484|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44546485|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44546486|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44546491|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44546492|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44546493|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
44546494|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
44546495|NCT05653973|Acetylcholine|acetylcholine|mesh-list
44546496|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
44546497|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44546498|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546499|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546500|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546501|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546502|NCT05653895|Metformin|metformin|mesh-list
44546503|NCT05653895|Resveratrol|resveratrol|mesh-list
44546504|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546505|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546506|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
44546507|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546508|NCT05653895|Protective Agents|protective agents|mesh-ancestor
44546509|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546510|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44546511|NCT05653817|Paclitaxel|paclitaxel|mesh-list
44546512|NCT05653817|Apatinib|apatinib|mesh-list
44546513|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44546514|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44546515|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546516|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
44546517|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
44546518|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
44546519|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546520|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546521|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546526|NCT05653492|Sulforaphane|sulforaphane|mesh-list
44546527|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44546528|NCT05653492|Protective Agents|protective agents|mesh-ancestor
44546529|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546530|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546531|NCT05653453|Gemcitabine|gemcitabine|mesh-list
44546532|NCT05653453|Paclitaxel|paclitaxel|mesh-list
44546533|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44546534|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44546535|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546536|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
44546537|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
44546538|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
44546539|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546540|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44546541|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
44546542|NCT05653453|Antiviral Agents|antiviral agents|mesh-ancestor
44546543|NCT05653453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546544|NCT05653453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546545|NCT05653453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546546|NCT05653453|Immunologic Factors|immunologic factors|mesh-ancestor
44546547|NCT05653453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546548|NCT05653401|Diclofenac|diclofenac|mesh-list
44546549|NCT05653401|Lidocaine|lidocaine|mesh-list
44546550|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
44546551|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
44546552|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
44546553|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546554|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546555|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
44546556|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546557|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44546558|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44546559|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44546560|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546561|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546562|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44546563|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546564|NCT05653401|Analgesics|analgesics|mesh-ancestor
44546565|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546566|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546567|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44546568|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546569|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
44546570|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44546571|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44546572|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
44546573|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44546574|NCT05653258|Dasatinib|dasatinib|mesh-list
44546575|NCT05653258|Quercetin|quercetin|mesh-list
44546576|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546577|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546578|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546579|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546580|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
44546581|NCT05653258|Protective Agents|protective agents|mesh-ancestor
44546582|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546583|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
44546584|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546586|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
44546587|NCT05653193|Clotrimazole|clotrimazole|mesh-list
44546588|NCT05653193|Miconazole|miconazole|mesh-list
44546589|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
44546590|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546591|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
44546592|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546593|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44546594|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44546595|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44546596|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546597|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546598|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44546599|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44546600|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546601|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546602|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44546603|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44546604|NCT05653050|Insulin|insulin|mesh-list
44546605|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546606|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546607|NCT05650697|Cannabidiol|cannabidiol|mesh-list
44546608|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
44546609|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
44546610|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44546611|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44546612|NCT05649878|Prednisolone|prednisolone|mesh-list
44546613|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
44546614|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44546615|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
44546616|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546617|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
44546618|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
44546619|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546620|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546621|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44546622|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
44546623|NCT05649878|Hormones|hormones|mesh-ancestor
44546624|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546625|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44546626|NCT05649878|Protective Agents|protective agents|mesh-ancestor
44546627|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44546628|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546629|NCT05648487|Antibodies|antibodies|mesh-list
44546630|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
44546631|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546632|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
44546633|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546634|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
44546635|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
44546636|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546637|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546638|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44546640|NCT05647291|Hormones|hormones|mesh-ancestor
44546641|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546642|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44546643|NCT05647291|Protective Agents|protective agents|mesh-ancestor
44546644|NCT05645757|Ertapenem|ertapenem|mesh-list
44546645|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546646|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546647|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
44546648|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546649|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546650|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44546651|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546652|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546653|NCT05635708|Paclitaxel|paclitaxel|mesh-list
44546654|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44546655|NCT05635708|Cisplatin|cisplatin|mesh-list
44546656|NCT05635708|Carboplatin|carboplatin|mesh-list
44546657|NCT05635708|Pemetrexed|pemetrexed|mesh-list
44546658|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44546659|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546660|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44546661|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44546662|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44546663|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546664|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546665|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44546666|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44546676|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546677|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44546679|NCT05613426|Evolocumab|evolocumab|mesh-list
44546680|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44546681|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44546682|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
44546683|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546684|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44546685|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44546686|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546687|NCT05607550|Aflutinib|aflutinib|mesh-list
44546688|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546689|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546690|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546691|NCT05604131|Deferiprone|deferiprone|mesh-list
44546692|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44546693|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
44546694|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
44546695|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546696|NCT01380093|Naltrexone|naltrexone|mesh-list
44546697|NCT01380093|Morphine|morphine|mesh-list
44546698|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44371351|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
44546699|NCT01380093|Narcotics|narcotics|mesh-ancestor
44546700|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44546701|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546702|NCT01380093|Analgesics|analgesics|mesh-ancestor
44546703|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
44546704|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546705|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44546706|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44546707|NCT01380080|Efavirenz|efavirenz|mesh-list
44546708|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44546709|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44546710|NCT01380080|Rifampin|rifampin|mesh-list
44546711|NCT01380080|Isoniazid|isoniazid|mesh-list
44546712|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
44546713|NCT01380080|Ethambutol|ethambutol|mesh-list
44546714|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
44546715|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44546716|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44546717|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546718|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546719|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
44546720|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546721|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44546722|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44546723|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44546724|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44546725|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44546726|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44546727|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44546728|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44546729|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44546730|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
44546731|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44546732|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
44546733|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44546734|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44546735|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44546736|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44546737|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44546738|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
44546739|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44546740|NCT01379937|Vaccines|vaccines|mesh-list
44546741|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
44546742|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546743|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
44546744|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
44546745|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44546746|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44546747|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546748|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546749|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546750|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546751|NCT01379521|Everolimus|everolimus|mesh-list
44546752|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546753|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546754|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
44546755|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546756|NCT01379508|Tenofovir|tenofovir|mesh-list
44546757|NCT01379508|Telbivudine|telbivudine|mesh-list
44546758|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
44546759|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546760|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44546761|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44546762|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546763|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546764|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44546765|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44546766|NCT01379274|Lenalidomide|lenalidomide|mesh-list
44546767|NCT01379274|Azacitidine|azacitidine|mesh-list
44546768|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
44546769|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546770|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44546771|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44546772|NCT01379274|Growth Substances|growth substances|mesh-ancestor
44546773|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
44546774|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546775|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44546776|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
44546777|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546778|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546779|NCT01378975|Vemurafenib|vemurafenib|mesh-list
44546780|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546781|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546782|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546783|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546784|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44546785|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546786|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546787|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546788|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546789|NCT01378858|Varenicline|varenicline|mesh-list
44546790|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44546791|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44546792|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
44546793|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546794|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546795|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546796|NCT01378429|Ciclesonide|ciclesonide|mesh-list
44546797|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
44546798|NCT01378429|Hormones|hormones|mesh-ancestor
44546799|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546800|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546801|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44546802|NCT01378325|Phenylephrine|phenylephrine|mesh-list
44546803|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
44546804|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44546805|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
44546806|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
44546807|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546808|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546809|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
44546810|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44546811|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
44546812|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546813|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44546814|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44546815|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44546816|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
44546817|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546818|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546819|NCT01378325|Protective Agents|protective agents|mesh-ancestor
44546820|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
44546821|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44546822|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
44546823|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546824|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546825|NCT01378117|Incretins|incretins|mesh-ancestor
44546826|NCT01378117|Hormones|hormones|mesh-ancestor
44546827|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546828|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44546829|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
44546830|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546831|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546832|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44546833|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
44546834|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
44546835|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546836|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
44546837|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546838|NCT01377987|Acetazolamide|acetazolamide|mesh-list
44546839|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
44546840|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44546841|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546842|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546843|NCT01377987|Diuretics|diuretics|mesh-ancestor
44546844|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
44546845|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546846|NCT01377922|Amifampridine|amifampridine|mesh-list
44546847|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44546848|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546849|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546850|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44546851|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546852|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546853|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
44546854|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44546855|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546856|NCT01377480|Posaconazole|posaconazole|mesh-list
44546857|NCT01377480|Benzonidazole|benzonidazole|mesh-list
44546858|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
44546859|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546860|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44546861|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44546862|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44546863|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44546864|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44546865|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546866|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546867|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44546868|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426837|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546869|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44546870|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546871|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546872|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
44546874|NCT01377389|Leuprolide|leuprolide|mesh-list
44546875|NCT01377389|Goserelin|goserelin|mesh-list
44546876|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44546877|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546878|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44546879|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546880|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44546881|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
44546882|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44546883|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546884|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44546885|NCT01377194|Milnacipran|milnacipran|mesh-list
44546886|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
44546887|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44546888|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44546889|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546890|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546891|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44546892|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546893|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
44546894|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44546895|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546896|NCT01377194|Analgesics|analgesics|mesh-ancestor
44546897|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
44546898|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546899|NCT01376804|Valganciclovir|valganciclovir|mesh-list
44546900|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
44546901|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546902|NCT01376700|Factor VIII|factor viii|mesh-list
44546903|NCT01376700|Coagulants|coagulants|mesh-ancestor
44546904|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44546905|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44546906|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
44546907|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546908|NCT01376310|Gemcitabine|gemcitabine|mesh-list
44546909|NCT01376310|Paclitaxel|paclitaxel|mesh-list
44546910|NCT01376310|Docetaxel|docetaxel|mesh-list
44546911|NCT01376310|Carboplatin|carboplatin|mesh-list
44546912|NCT01376310|Pemetrexed|pemetrexed|mesh-list
44546913|NCT01376310|Everolimus|everolimus|mesh-list
44546914|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44546915|NCT01376310|Trametinib|trametinib|mesh-list
44546916|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44546917|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546918|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44546919|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44546920|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44546921|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546922|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44546923|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
44546924|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
44546925|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546926|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546927|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44546928|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
44450388|NCT01729156|Metformin|metformin|mesh-list
44546929|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546930|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44546931|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44546932|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44546933|NCT01376245|Fluticasone|fluticasone|mesh-list
44546935|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546936|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44546937|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
44546938|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546939|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546940|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44546941|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
44546942|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
44546943|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44546944|NCT01376167|Chloroquine|chloroquine|mesh-list
43952236|NCT01194453|Folic Acid|folic acid|mesh-list
44546945|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44546946|NCT01376167|Primaquine|primaquine|mesh-list
44546947|NCT01376167|Tafenoquine|tafenoquine|mesh-list
44546948|NCT01376167|Amebicides|amebicides|mesh-ancestor
44546949|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44546950|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44546951|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44546952|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
44546953|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44546954|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44546955|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44546956|NCT01376167|Analgesics|analgesics|mesh-ancestor
44546957|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
44546958|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44546959|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546960|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44546961|NCT01376167|Filaricides|filaricides|mesh-ancestor
44546962|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
44546963|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
44546964|NCT01375959|Resveratrol|resveratrol|mesh-list
44546965|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
44546966|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546967|NCT01375959|Protective Agents|protective agents|mesh-ancestor
44546968|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44546969|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546970|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44546971|NCT01375751|Evolocumab|evolocumab|mesh-list
44546972|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44546973|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44546974|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
44546975|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546976|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44546977|NCT01375608|Decitabine|decitabine|mesh-list
44546978|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44546979|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
44546980|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546981|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44546982|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44546983|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44546984|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
44546985|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44546986|NCT01375374|Lacosamide|lacosamide|mesh-list
44546987|NCT01375374|Levetiracetam|levetiracetam|mesh-list
44546988|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
44546989|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
44546990|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44546991|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44546992|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44546993|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44546994|NCT01375075|Atorvastatin|atorvastatin|mesh-list
44546995|NCT01375075|Evacetrapib|evacetrapib|mesh-list
44546996|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44546997|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44546998|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
44546999|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547008|NCT01375010|Vitamins|vitamins|mesh-list
44547009|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
44547010|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547011|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44547012|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547013|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
44547014|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547015|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
44547016|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547017|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547018|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44371682|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
44547019|NCT01374919|Hematinics|hematinics|mesh-ancestor
44547020|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44547021|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44547022|NCT01374906|Pasireotide|pasireotide|mesh-list
44547023|NCT01374906|Hormones|hormones|mesh-ancestor
44547024|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547025|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547026|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44547027|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426838|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
44547028|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547029|NCT01374568|Incretins|incretins|mesh-ancestor
44547030|NCT01374568|Hormones|hormones|mesh-ancestor
44547031|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547032|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44547033|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
44547034|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547035|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547036|NCT01374451|Everolimus|everolimus|mesh-list
44547037|NCT01374451|Pasireotide|pasireotide|mesh-list
44547038|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547039|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547040|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
44547041|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547042|NCT01374451|Hormones|hormones|mesh-ancestor
44547043|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547044|NCT01374425|Leucovorin|leucovorin|mesh-list
44547045|NCT01374425|Bevacizumab|bevacizumab|mesh-list
44547046|NCT01374425|Fluorouracil|fluorouracil|mesh-list
44547047|NCT01374425|Capecitabine|capecitabine|mesh-list
44547048|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
44547049|NCT01374425|Irinotecan|irinotecan|mesh-list
44547050|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44547051|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547052|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44547053|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547054|NCT01374425|Growth Substances|growth substances|mesh-ancestor
44547055|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547056|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
44547057|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
44547058|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547059|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44547060|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547061|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
44547062|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44547063|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44547064|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547065|NCT01374425|Antidotes|antidotes|mesh-ancestor
44547066|NCT01374425|Protective Agents|protective agents|mesh-ancestor
44547067|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
44547068|NCT01374425|Vitamins|vitamins|mesh-ancestor
44547069|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
44547070|NCT01374269|Acetaminophen|acetaminophen|mesh-list
44547071|NCT01374269|Celecoxib|celecoxib|mesh-list
44547072|NCT01374269|Naproxen|naproxen|mesh-list
44547073|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44547074|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44547075|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547076|NCT01374269|Analgesics|analgesics|mesh-ancestor
44547077|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
44547078|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547079|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547080|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
44547081|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547082|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44547083|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44547084|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547085|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547086|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
44547087|NCT01374217|Clarithromycin|clarithromycin|mesh-list
44547088|NCT01374217|Dexamethasone|dexamethasone|mesh-list
44547089|NCT01374217|Lenalidomide|lenalidomide|mesh-list
44547090|NCT01374217|Tadalafil|tadalafil|mesh-list
44547091|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547092|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
44547093|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
44547094|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547095|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547096|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547097|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
44547098|NCT01374217|Hormones|hormones|mesh-ancestor
44547099|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547100|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547101|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547102|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
44547103|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44547104|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547105|NCT01374217|Growth Substances|growth substances|mesh-ancestor
44547106|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
44547107|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547108|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547109|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44547110|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547111|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547112|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44547113|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44547114|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
44547115|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44547116|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44547117|NCT01374217|Urological Agents|urological agents|mesh-ancestor
44547118|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
44547119|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547120|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547121|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44547122|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
44547123|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44547124|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
44547125|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44547126|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547127|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44547128|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547129|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547130|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
44547131|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44547132|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547133|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547134|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44547135|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44547136|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547137|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547138|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547139|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44547140|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
44547141|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44547142|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547143|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44547144|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44547145|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44547146|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44547147|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44547148|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44547149|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44547150|NCT01373294|Lenalidomide|lenalidomide|mesh-list
44547151|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
44547152|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
44547153|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547154|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44547155|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547156|NCT01373294|Growth Substances|growth substances|mesh-ancestor
44547157|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44547158|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547159|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44547160|NCT01373229|Plerixafor|plerixafor|mesh-list
44547161|NCT01373229|Rituximab|rituximab|mesh-list
44547162|NCT01373229|Lenalidomide|lenalidomide|mesh-list
44547163|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44547164|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547165|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
44547166|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547167|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547168|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44547169|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547170|NCT01373229|Growth Substances|growth substances|mesh-ancestor
44547171|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44547172|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44547173|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44547174|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
44547175|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547176|NCT01373164|Gemcitabine|gemcitabine|mesh-list
44547177|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44547178|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
44547179|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547180|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547182|NCT01373164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547183|NCT01373164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547184|NCT01373164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547185|NCT01373164|Immunologic Factors|immunologic factors|mesh-ancestor
44547186|NCT01373164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547187|NCT01372995|Vitamin D|vitamin d|mesh-list
44547188|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
44547189|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
44547190|NCT01372995|Vitamins|vitamins|mesh-list
44547191|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
44547192|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547193|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44547194|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547195|NCT01372618|Pasireotide|pasireotide|mesh-list
44547196|NCT01372618|Hormones|hormones|mesh-ancestor
44547197|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547198|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547199|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
44547200|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44547201|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
44547202|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547203|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547204|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44547205|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44547206|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
44547207|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44547208|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
44547209|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547210|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547211|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44547212|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547213|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44547214|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547215|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547216|NCT01372150|Fluoxetine|fluoxetine|mesh-list
44547217|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44547218|NCT01372150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44547219|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44547220|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547221|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547222|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547223|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
44547224|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547225|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44450697|NCT01723072|Omalizumab|omalizumab|mesh-list
44547226|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
44547227|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547228|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44547229|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44547230|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547231|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44547232|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
44547233|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44547234|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44547235|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
44547236|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547237|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547238|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547239|NCT01371994|Urological Agents|urological agents|mesh-ancestor
44547240|NCT01371877|Vitamin D|vitamin d|mesh-list
44547241|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
44547242|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
44547243|NCT01371877|Vitamins|vitamins|mesh-list
44547244|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
44371849|NCT01204125|Paclitaxel|paclitaxel|mesh-list
44547245|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547246|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44547247|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547248|NCT01371851|Doxazosin|doxazosin|mesh-list
44547249|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43952538|NCT01202994|Flutemetamol|flutemetamol|mesh-list
44547250|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44547251|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44547252|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44547253|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
44547254|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547255|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547256|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547257|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
44547258|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44547259|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547260|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547261|NCT01371747|Losartan|losartan|mesh-list
44547262|NCT01371747|Spironolactone|spironolactone|mesh-list
44547263|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44547264|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44547265|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44547266|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44547267|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547268|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44547269|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
44547270|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547271|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547272|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44547273|NCT01371747|Diuretics|diuretics|mesh-ancestor
44547274|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
44547275|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44547276|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44547277|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44547278|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547279|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547280|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547281|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547282|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
44547283|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547284|NCT01371656|Levofloxacin|levofloxacin|mesh-list
44547285|NCT01371656|Ofloxacin|ofloxacin|mesh-list
44547286|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44547287|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547288|NCT01371656|Renal Agents|renal agents|mesh-ancestor
44547289|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547290|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44547291|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44547292|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547293|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547294|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547295|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44547296|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44547297|NCT01371643|Octreotide|octreotide|mesh-list
44547298|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547299|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547300|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547301|NCT01371565|Mifepristone|mifepristone|mesh-list
44547302|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44547303|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
44547304|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44547305|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547306|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44547307|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44547308|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44547309|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
44547310|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44547311|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44547312|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
44547313|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547314|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
44547315|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44547316|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44547322|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547323|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547325|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
44547326|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547327|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547328|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44547329|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44547330|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44547331|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44547332|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44547333|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547335|NCT01370694|Hormones|hormones|mesh-ancestor
44547336|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547337|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547338|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44547339|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44547340|NCT01370655|Diuretics|diuretics|mesh-ancestor
44547341|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44547342|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547343|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44547344|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547345|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547346|NCT01370642|Ribavirin|ribavirin|mesh-list
44547347|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
44547348|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547349|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
44547350|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547351|NCT01370616|Amoxicillin|amoxicillin|mesh-list
44547352|NCT01370616|Tazobactam|tazobactam|mesh-list
44547353|NCT01370616|Piperacillin|piperacillin|mesh-list
44547354|NCT01370616|Ertapenem|ertapenem|mesh-list
44547355|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44547356|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547357|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547358|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44547359|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547360|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547361|NCT01370603|Atorvastatin|atorvastatin|mesh-list
44547362|NCT01370603|Ezetimibe|ezetimibe|mesh-list
44547363|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44547364|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44547365|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
44547366|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547367|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44547368|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44547369|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547370|NCT01370590|Atorvastatin|atorvastatin|mesh-list
44547371|NCT01370590|Ezetimibe|ezetimibe|mesh-list
44547372|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44547373|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44547374|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
44372083|NCT01205022|Leucovorin|leucovorin|mesh-list
44547375|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547376|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44547377|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44547378|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547379|NCT01370538|Esomeprazole|esomeprazole|mesh-list
44547380|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44547381|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547382|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44547383|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547384|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547385|NCT01370525|Esomeprazole|esomeprazole|mesh-list
44547386|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44547387|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547388|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44547389|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547390|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547391|NCT01370499|Serotonin|serotonin|mesh-list
44547392|NCT01370499|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44547393|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44547394|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
44547395|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547396|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547397|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547398|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44547399|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547400|NCT01370408|Dexamethasone|dexamethasone|mesh-list
44547401|NCT01370408|Ondansetron|ondansetron|mesh-list
44547402|NCT01370408|Palonosetron|palonosetron|mesh-list
44547403|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547404|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
44547405|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
44547406|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547407|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547408|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547409|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
44547410|NCT01370408|Hormones|hormones|mesh-ancestor
44547411|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547412|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547413|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547414|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
44547415|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
44547416|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44547417|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
44547418|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547419|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547420|NCT01370408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44547421|NCT01370408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547422|NCT01370408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547423|NCT01370408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547424|NCT01370408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44547425|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44547426|NCT01370356|Varenicline|varenicline|mesh-list
44547427|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44547428|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44547429|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
44547430|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547431|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547432|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547433|NCT01370265|Adenosine|adenosine|mesh-list
44547434|NCT01370265|Regadenoson|regadenoson|mesh-list
44547435|NCT01370265|Analgesics|analgesics|mesh-ancestor
44547436|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
44547437|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547438|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547439|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44547440|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
44547441|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44547442|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
44547443|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
44547444|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547445|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547446|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44547447|NCT01370213|Interleukin-2|interleukin-2|mesh-list
44547448|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44547449|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547450|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547451|NCT01370213|Analgesics|analgesics|mesh-ancestor
44547452|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
44547453|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547454|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547455|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
44547456|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547457|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
44547458|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44547459|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450917|NCT01719783|Vaccines|vaccines|mesh-list
44547460|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547461|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44547462|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44547463|NCT01370005|Empagliflozin|empagliflozin|mesh-list
44547464|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44547465|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547466|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547467|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547468|NCT01369849|Rituximab|rituximab|mesh-list
44547469|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44547470|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44547472|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
44547473|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44547474|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
44547475|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547476|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547477|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547478|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44547479|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
44547480|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547481|NCT01369680|Ketamine|ketamine|mesh-list
44547482|NCT01369680|Analgesics|analgesics|mesh-ancestor
44547483|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
44547484|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547485|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547486|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44547487|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44547488|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
44547489|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
44547490|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547491|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44547492|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44547493|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547494|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547495|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
44547496|NCT01369641|Cisplatin|cisplatin|mesh-list
44547497|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547498|NCT01369641|Antidotes|antidotes|mesh-ancestor
44547499|NCT01369641|Protective Agents|protective agents|mesh-ancestor
44547500|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547501|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
44547502|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547503|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44547504|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547505|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547506|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
44547507|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
44547508|NCT01369615|Oxycodone|oxycodone|mesh-list
44547509|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44547510|NCT01369615|Narcotics|narcotics|mesh-ancestor
44547511|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450966|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547512|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547513|NCT01369615|Analgesics|analgesics|mesh-ancestor
44547514|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
44547515|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547516|NCT01369485|Caffeine|caffeine|mesh-list
44547517|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44547518|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547519|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44547520|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547521|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547522|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44547523|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44547524|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
44547525|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547526|NCT01369433|Sirolimus|sirolimus|mesh-list
44547527|NCT01369433|Paclitaxel|paclitaxel|mesh-list
44547528|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44547529|NCT01369433|Capecitabine|capecitabine|mesh-list
44547530|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44547531|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547532|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44547533|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44547534|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44547535|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547536|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44547537|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
44547538|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547539|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547540|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44547541|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
44547542|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547543|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
44547544|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547545|NCT01369355|Ustekinumab|ustekinumab|mesh-list
44547546|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
44547548|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
44547549|NCT01369329|Ustekinumab|ustekinumab|mesh-list
44547550|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
44547551|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44547552|NCT01369199|Entecavir|entecavir|mesh-list
44547553|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
44547554|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547555|NCT01369069|Insulin|insulin|mesh-list
44547556|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44547557|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547558|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547559|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
44547560|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44547561|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547562|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
44547563|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547564|NCT01368536|Amlodipine|amlodipine|mesh-list
44547565|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
44547566|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44547567|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44547568|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547569|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547570|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547571|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547572|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
44547573|NCT01368536|Diuretics|diuretics|mesh-ancestor
44547574|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
44547575|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44547576|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44547577|NCT01368497|Entecavir|entecavir|mesh-list
44547578|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
44547579|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547580|NCT01368432|Citalopram|citalopram|mesh-list
44547581|NCT01368432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44547582|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44547583|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547584|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547585|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547586|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
44547587|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547588|NCT01368432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44547589|NCT01368432|Antidepressive Agents|antidepressive agents|mesh-ancestor
44547590|NCT01368432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547591|NCT01368276|Molgramostim|molgramostim|mesh-list
44547592|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44547593|NCT01368276|Sargramostim|sargramostim|mesh-list
44547594|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
44547595|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547596|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547597|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44547598|NCT01368081|Metformin|metformin|mesh-list
44547599|NCT01368081|Empagliflozin|empagliflozin|mesh-list
44547600|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547601|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547602|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44547603|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547604|NCT01367886|Fesoterodine|fesoterodine|mesh-list
44547605|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44547606|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44547607|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44547608|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547609|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547610|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547611|NCT01367886|Urological Agents|urological agents|mesh-ancestor
44547612|NCT01367834|Hormones|hormones|mesh-list
44451062|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547613|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547614|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547615|NCT01367457|Sirolimus|sirolimus|mesh-list
44547616|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44547617|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547618|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44547619|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547620|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
44547621|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547622|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
44547623|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547624|NCT01367275|Irinotecan|irinotecan|mesh-list
44547625|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44547626|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44547627|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547628|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547629|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547630|NCT01367249|Bromfenac|bromfenac|mesh-list
44547631|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44547632|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44547633|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547634|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547635|NCT01367249|Analgesics|analgesics|mesh-ancestor
44547636|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
44547637|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547638|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547639|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547640|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547641|NCT01367158|Vaccines|vaccines|mesh-list
44547642|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
44547643|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547644|NCT01367119|Ketamine|ketamine|mesh-list
44547645|NCT01367119|Methohexital|methohexital|mesh-list
44547646|NCT01367119|Analgesics|analgesics|mesh-ancestor
44547647|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
44547648|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547649|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547650|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44547651|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44547652|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
44547653|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
44547654|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547655|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44547656|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44547657|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547658|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547659|NCT01366638|Ribavirin|ribavirin|mesh-list
44547660|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44547661|NCT01366638|Simeprevir|simeprevir|mesh-list
44547662|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
44547663|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547664|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
44547665|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547666|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
44547667|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547668|NCT01366534|Vaccines|vaccines|mesh-list
44547669|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
44547670|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547671|NCT01366209|Pirfenidone|pirfenidone|mesh-list
44547672|NCT01366209|Analgesics|analgesics|mesh-ancestor
44547673|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
44547674|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547675|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547676|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547677|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547678|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547679|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547680|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547681|NCT01366092|Interleukin-2|interleukin-2|mesh-list
44547682|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547683|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547684|NCT01366092|Analgesics|analgesics|mesh-ancestor
44547685|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
44547686|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547687|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547688|NCT01365507|Insulin|insulin|mesh-list
44547689|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
44547690|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547691|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547692|NCT01365481|Amlodipine|amlodipine|mesh-list
44547693|NCT01365481|Valsartan|valsartan|mesh-list
44547694|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44547695|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44547696|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44547697|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547698|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547699|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547700|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547701|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
44547702|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44547703|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44547705|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
44547706|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44547707|NCT01365468|Everolimus|everolimus|mesh-list
44547708|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547709|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547710|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
44547711|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547712|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44547713|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
44547714|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547715|NCT01365091|Metformin|metformin|mesh-list
44547716|NCT01365091|Saxagliptin|saxagliptin|mesh-list
44547717|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547718|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547719|NCT01365091|Incretins|incretins|mesh-ancestor
44547720|NCT01365091|Hormones|hormones|mesh-ancestor
44547721|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547722|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44547723|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44547724|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547725|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547726|NCT01365052|Naproxen|naproxen|mesh-list
44547727|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547728|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547729|NCT01365052|Analgesics|analgesics|mesh-ancestor
44547730|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
44547731|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547732|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547733|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547734|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547735|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
44547736|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44547737|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547738|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547739|NCT01364922|Acetaminophen|acetaminophen|mesh-list
44547740|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44547741|NCT01364922|Hydrocodone|hydrocodone|mesh-list
44547742|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547743|NCT01364922|Analgesics|analgesics|mesh-ancestor
44547744|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
44547745|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547746|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547747|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
44547748|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44547749|NCT01364922|Narcotics|narcotics|mesh-ancestor
44547769|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547770|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44547771|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547772|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547773|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44547774|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44547775|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44547776|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44547778|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
44547779|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
44547780|NCT01364467|Guaifenesin|guaifenesin|mesh-list
44547781|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44547782|NCT01364467|Expectorants|expectorants|mesh-ancestor
44547783|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
44547784|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44547785|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44547786|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44547787|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547788|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547789|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547790|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
44547792|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
44547793|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
44547794|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547795|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
44547796|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44547798|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44547799|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
44547800|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547801|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547802|NCT01364389|Prednisone|prednisone|mesh-list
44547803|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547804|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
44547805|NCT01364389|Hormones|hormones|mesh-ancestor
44547806|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547807|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547808|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44547809|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547810|NCT01364298|Pregabalin|pregabalin|mesh-list
44547811|NCT01364298|Gabapentin|gabapentin|mesh-list
44547812|NCT01364298|Analgesics|analgesics|mesh-ancestor
44547813|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
44547814|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547815|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547816|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
44547817|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44547818|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44547819|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547820|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44547821|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44547822|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547823|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547824|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547825|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44547826|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44547827|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547828|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
44547829|NCT01363986|Trastuzumab|trastuzumab|mesh-list
44547830|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44547831|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547832|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44547833|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44547834|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44547835|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44547836|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44547837|NCT01363700|Epinastine|epinastine|mesh-list
44547838|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547839|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547840|NCT01363700|Analgesics|analgesics|mesh-ancestor
44547841|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
44547842|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547843|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547844|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547845|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547846|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44547847|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44547848|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44547849|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
44547850|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
44547851|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547852|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547853|NCT01363661|Molsidomine|molsidomine|mesh-list
44547854|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
44547855|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44547856|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547857|NCT01363440|Aflibercept|aflibercept|mesh-list
44547858|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44547859|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44547860|NCT01363440|Growth Substances|growth substances|mesh-ancestor
44547861|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547862|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
44547863|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547864|NCT01363349|Risperidone|risperidone|mesh-list
44547865|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44547866|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
44547867|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547868|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547869|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547870|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44547871|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547872|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547873|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547874|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44547875|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
44547876|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44547877|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44547878|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547879|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44547880|NCT01363076|Ketorolac|ketorolac|mesh-list
44547881|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44547882|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547883|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547884|NCT01363076|Analgesics|analgesics|mesh-ancestor
44547885|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
44547886|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547887|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547888|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547889|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547890|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44547891|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547892|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547893|NCT01363011|Darunavir|darunavir|mesh-list
44547894|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44547895|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44547896|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44547897|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44547898|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547899|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547900|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44547901|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44547902|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
44547903|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44547904|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
44547905|NCT01362790|Pentostatin|pentostatin|mesh-list
44547906|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44547907|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547908|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
44547909|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547910|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547911|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44547912|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
44547913|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547914|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547915|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44547916|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44547917|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372653|NCT05623852|Fucoidan|fucoidan|mesh-list
44547925|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44547926|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547927|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44547928|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
44547929|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547930|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547932|NCT01362530|Aprepitant|aprepitant|mesh-list
44547933|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
44547934|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
44547935|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
44547936|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547937|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547938|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44547939|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
44547940|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
44547941|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44547942|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
44547943|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547944|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547945|NCT01362530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44547946|NCT01362530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547947|NCT01362530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547948|NCT01362530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547949|NCT01362530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44547950|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44547951|NCT01362491|Ibuprofen|ibuprofen|mesh-list
44547952|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44547953|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44547954|NCT01362491|Analgesics|analgesics|mesh-ancestor
44547955|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
44547956|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547957|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547958|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44547959|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44547960|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44547961|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547962|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547963|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44451387|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
44547964|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44547965|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44547966|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44547967|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547968|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44547969|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44547970|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44547971|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
44547972|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44547973|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547974|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44547975|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44547976|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
44547977|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44547978|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44547979|NCT01362296|Docetaxel|docetaxel|mesh-list
44547980|NCT01362296|Trametinib|trametinib|mesh-list
44547981|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44547982|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
44547983|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
44547984|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
44547985|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44547986|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44547987|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44547988|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
44547989|NCT01362140|Hematinics|hematinics|mesh-ancestor
44547990|NCT01361607|Nabiximols|nabiximols|mesh-list
44547991|NCT01361607|Analgesics|analgesics|mesh-ancestor
44547992|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
44547993|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44547994|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547995|NCT01361594|Insulin|insulin|mesh-list
44547996|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44547997|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44547998|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44547999|NCT01361464|Tipifarnib|tipifarnib|mesh-list
44548000|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548002|NCT01361308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44548003|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548004|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548005|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548006|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548007|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
44548008|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548009|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44548010|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548011|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548012|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44548013|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548014|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548015|NCT01361009|Pramipexole|pramipexole|mesh-list
44548016|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
44548017|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548018|NCT01361009|Protective Agents|protective agents|mesh-ancestor
44548019|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548020|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44548021|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44548022|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
44548023|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
44548024|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548025|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
44548026|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
44548027|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44548028|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548029|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44548030|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44548031|NCT01360866|Citalopram|citalopram|mesh-list
44548032|NCT01360866|Fluoxetine|fluoxetine|mesh-list
44548033|NCT01360866|Paroxetine|paroxetine|mesh-list
44548034|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44548035|NCT01360866|Sertraline|sertraline|mesh-list
44548036|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44548037|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548038|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548039|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548040|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548041|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
44548042|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548043|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44548044|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548045|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548046|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548047|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44548048|NCT01360866|Analgesics|analgesics|mesh-ancestor
44548049|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
44548050|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
44548051|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44548052|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548053|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548054|NCT01360762|Pentamidine|pentamidine|mesh-list
44548055|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
44548056|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548057|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44548058|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44548059|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44548060|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44548061|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548062|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548063|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548064|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548065|NCT01360021|Budesonide|budesonide|mesh-list
44548066|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44548067|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548068|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44548069|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
44548070|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548071|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548072|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44548084|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548085|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
44548086|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548087|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44548088|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
44548089|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548090|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
44372866|NCT05345002|Tretinoin|tretinoin|mesh-list
44548091|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44548092|NCT01359644|Ribavirin|ribavirin|mesh-list
44548093|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
44548094|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
44548095|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548096|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
44548097|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548098|NCT01359592|Prednisone|prednisone|mesh-list
44548099|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
44548100|NCT01359592|Rituximab|rituximab|mesh-list
44548101|NCT01359592|Doxorubicin|doxorubicin|mesh-list
44548102|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44548103|NCT01359592|Vincristine|vincristine|mesh-list
44548104|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44548105|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548106|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
44548107|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548108|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548109|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44548110|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
44548111|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548112|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548113|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44548114|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548115|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44548116|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44548117|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44548118|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548119|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548120|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
44548122|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548123|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44548124|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44548125|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
44548126|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
44548127|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
44548128|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44548129|NCT01359254|Fludarabine|fludarabine|mesh-list
44548130|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
44548131|NCT01359254|Melphalan|melphalan|mesh-list
44548132|NCT01359254|Busulfan|busulfan|mesh-list
44548133|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44548134|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548135|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548136|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
44548137|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548138|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548139|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
44548140|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548141|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44548142|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
44548143|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44548144|NCT01359150|Tofacitinib|tofacitinib|mesh-list
44548145|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548146|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548147|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548148|NCT01358968|Gemcitabine|gemcitabine|mesh-list
44548149|NCT01358968|Pemetrexed|pemetrexed|mesh-list
44548150|NCT01358968|Desipramine|desipramine|mesh-list
44548151|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548152|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
44548153|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548154|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548155|NCT01358968|Antiviral Agents|antiviral agents|mesh-ancestor
44548156|NCT01358968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548157|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548158|NCT01358968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548159|NCT01358968|Immunologic Factors|immunologic factors|mesh-ancestor
44548160|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548161|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548162|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548163|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44548164|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548165|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548166|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44548167|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548168|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548169|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548170|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548171|NCT01358864|Interferons|interferons|mesh-list
44548172|NCT01358864|Ribavirin|ribavirin|mesh-list
44548173|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
44548174|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548175|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
44548176|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548177|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
44548178|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548179|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
44548180|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548181|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44548182|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44548183|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
44548184|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548185|NCT01358734|Lenalidomide|lenalidomide|mesh-list
44548186|NCT01358734|Azacitidine|azacitidine|mesh-list
44548187|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
44548188|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548189|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44548190|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44548191|NCT01358734|Growth Substances|growth substances|mesh-ancestor
44548192|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44548193|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548194|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548195|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
44548196|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548197|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548198|NCT01358721|Nivolumab|nivolumab|mesh-list
44548199|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548200|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548201|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44548202|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548203|NCT01358578|Etanercept|etanercept|mesh-list
44548204|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44548205|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44548206|NCT01358578|Analgesics|analgesics|mesh-ancestor
44548207|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
44548208|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548209|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548210|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548211|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548212|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44548213|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548214|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
44548215|NCT01358526|Oxycodone|oxycodone|mesh-list
44548216|NCT01358526|Naloxone|naloxone|mesh-list
44548217|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44548218|NCT01358526|Narcotics|narcotics|mesh-ancestor
44548219|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548220|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548221|NCT01358526|Analgesics|analgesics|mesh-ancestor
44548222|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
44548223|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548224|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44548225|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44548226|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44548227|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548228|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548229|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548230|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548231|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44548232|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44548233|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44548234|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548235|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548236|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548237|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44548238|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44548239|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
44548240|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44548241|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44548242|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
44548243|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44548244|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
44548245|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548246|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
44548247|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44548248|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44548249|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44548250|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548251|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548252|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
44548253|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548254|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548255|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44548256|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548257|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
44548258|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44548259|NCT01357889|Incretins|incretins|mesh-ancestor
44548260|NCT01357889|Hormones|hormones|mesh-ancestor
44548261|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548262|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548263|NCT01357655|Dasatinib|dasatinib|mesh-list
44548264|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548265|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548266|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548267|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548268|NCT01357616|Timolol|timolol|mesh-list
44548269|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44548270|NCT01357616|Brinzolamide|brinzolamide|mesh-list
44548271|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44548272|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44548273|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44548274|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548275|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548276|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548277|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548278|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44548279|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44548280|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44548281|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548282|NCT01357161|Paclitaxel|paclitaxel|mesh-list
44548283|NCT01357161|Carboplatin|carboplatin|mesh-list
44548284|NCT01357161|Adavosertib|adavosertib|mesh-list
44548285|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44548286|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548287|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
44548288|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
44548289|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
44548290|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548291|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548292|NCT01356966|Folic Acid|folic acid|mesh-list
44548293|NCT01356966|Hematinics|hematinics|mesh-ancestor
44548294|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
44548295|NCT01356966|Vitamins|vitamins|mesh-ancestor
44548296|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
44548297|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548298|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
44548299|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44548300|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548301|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548302|NCT01356602|Triamcinolone|triamcinolone|mesh-list
44548303|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44548304|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44548305|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44548306|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44548307|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548308|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
44548309|NCT01356602|Hormones|hormones|mesh-ancestor
44548310|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548311|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548312|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548313|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
44548314|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548315|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548316|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
44548326|NCT01355523|Protective Agents|protective agents|mesh-ancestor
44548327|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548328|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548329|NCT01355302|Cisplatin|cisplatin|mesh-list
44548330|NCT01355302|Capecitabine|capecitabine|mesh-list
44548331|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548332|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548333|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
44548334|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548335|NCT01355289|Interferons|interferons|mesh-list
44548336|NCT01355289|Ribavirin|ribavirin|mesh-list
44548337|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548338|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
44548339|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548341|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548342|NCT01355159|Folic Acid|folic acid|mesh-list
44548343|NCT01355159|Hematinics|hematinics|mesh-ancestor
44548344|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
44548345|NCT01355159|Vitamins|vitamins|mesh-ancestor
44548346|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
44548347|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548348|NCT01355081|Vortioxetine|vortioxetine|mesh-list
44548349|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548350|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548351|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44548352|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548353|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548354|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548355|NCT01355081|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44548356|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548357|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548358|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548359|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548360|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
44548361|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44548362|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44548363|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44548364|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44548365|NCT01355068|Phenytoin|phenytoin|mesh-list
44548366|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
44548367|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44548368|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44548369|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548370|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548371|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44548372|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44548373|NCT01354964|Vitamin D|vitamin d|mesh-list
44548374|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
44548375|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
44548376|NCT01354964|Vitamins|vitamins|mesh-list
44548377|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
44548378|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548379|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44548380|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44548381|NCT01354938|Clarithromycin|clarithromycin|mesh-list
44373119|NCT04877093|Clonidine|clonidine|mesh-list
44548382|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548383|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548384|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44548385|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548386|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548387|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44548388|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548390|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548391|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548392|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44548393|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548394|NCT01354353|Aripiprazole|aripiprazole|mesh-list
44548395|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548396|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548397|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44548398|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548399|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548400|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548401|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
44548402|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
44548403|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548404|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548405|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44548406|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44548407|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
44548408|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44548409|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44548410|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44548411|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44548413|NCT01354314|Paroxetine|paroxetine|mesh-list
44548414|NCT01354314|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44451829|NCT01704079|Vitamins|vitamins|mesh-ancestor
44548415|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548416|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548417|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548418|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548419|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
44548420|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548421|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44548422|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548423|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548424|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44548425|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548426|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548427|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
44548428|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548429|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44548430|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44548431|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
44548432|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548433|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44548434|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44548435|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
44548436|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44548437|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
44548438|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548439|NCT01354132|Expectorants|expectorants|mesh-ancestor
44548440|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44548441|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44548442|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
44548443|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548444|NCT01354132|Protective Agents|protective agents|mesh-ancestor
44548445|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548446|NCT01354132|Antidotes|antidotes|mesh-ancestor
44548447|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44548448|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44548449|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548450|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548451|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548452|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548453|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548454|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548455|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548456|NCT01353911|Interferons|interferons|mesh-list
44548457|NCT01353911|Ribavirin|ribavirin|mesh-list
44548458|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
44548459|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
44548460|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44548461|NCT01353911|Grazoprevir|grazoprevir|mesh-list
44548462|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548463|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
44548464|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548465|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
44548466|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548467|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
44548468|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548469|NCT01353859|Methotrexate|methotrexate|mesh-list
44548470|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44548471|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
44548472|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44548473|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548474|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548475|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
44548476|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548477|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548478|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
44548479|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548480|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548481|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548482|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
44548483|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548484|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548485|NCT01353664|Romidepsin|romidepsin|mesh-list
44548486|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44548487|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548488|NCT01353508|Valsartan|valsartan|mesh-list
44548489|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44548490|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44548491|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44548492|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44548493|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548494|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
44548495|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373262|NCT04484818|Leuprolide|leuprolide|mesh-list
44548497|NCT01352741|Tapentadol|tapentadol|mesh-list
44548498|NCT01352741|Analgesics|analgesics|mesh-ancestor
44548499|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
44548500|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548501|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548502|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
44548503|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44548504|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548505|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548506|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44548507|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44548508|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548509|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548510|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548511|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44548512|NCT01352741|Narcotics|narcotics|mesh-ancestor
44548513|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44548514|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548515|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548516|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548517|NCT01352715|Ritonavir|ritonavir|mesh-list
44548518|NCT01352715|Lopinavir|lopinavir|mesh-list
44548519|NCT01352715|Tenofovir|tenofovir|mesh-list
44548520|NCT01352715|Lamivudine|lamivudine|mesh-list
44548521|NCT01352715|Zidovudine|zidovudine|mesh-list
44548522|NCT01352715|Emtricitabine|emtricitabine|mesh-list
44548523|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
44548524|NCT01352715|Abacavir|abacavir|mesh-list
44548525|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44548526|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
44548527|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44548528|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44548529|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
44548530|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548531|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548532|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44548533|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44548534|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
44548535|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548536|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44548537|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548538|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44548539|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548540|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
44548541|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44548542|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44548543|NCT01352585|Anagrelide|anagrelide|mesh-list
44548544|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44548545|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44548546|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548547|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44548548|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
44548549|NCT01352507|Tadalafil|tadalafil|mesh-list
44548550|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
44548551|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44548552|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44548553|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548554|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548555|NCT01352507|Urological Agents|urological agents|mesh-ancestor
44548556|NCT01352416|Ranolazine|ranolazine|mesh-list
44548557|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44451983|NCT01702298|Metformin|metformin|mesh-list
44548558|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548559|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548560|NCT01352221|Ferric maltol|ferric maltol|mesh-list
44548561|NCT01352221|Hematinics|hematinics|mesh-ancestor
44548562|NCT01352117|Tenofovir|tenofovir|mesh-list
44548563|NCT01352117|Emtricitabine|emtricitabine|mesh-list
44548564|NCT01352117|Efavirenz|efavirenz|mesh-list
44548565|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44548566|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44548567|NCT01352117|Etoposide|etoposide|mesh-list
44548568|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44548569|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548570|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44548571|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44548572|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548573|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548574|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
44548575|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548576|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44548577|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548578|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44548579|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44548580|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44548581|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548582|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44548583|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44548584|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44548585|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44548586|NCT01351415|Bevacizumab|bevacizumab|mesh-list
44548587|NCT01351415|Docetaxel|docetaxel|mesh-list
44548588|NCT01351415|Pemetrexed|pemetrexed|mesh-list
44548589|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44548590|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548591|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548592|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44548593|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44548594|NCT01351415|Growth Substances|growth substances|mesh-ancestor
44548595|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548596|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44548597|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44548598|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44452034|NCT01701973|Hormones|hormones|mesh-ancestor
44548599|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44548600|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548601|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548602|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548603|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548604|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548605|NCT01351350|Paclitaxel|paclitaxel|mesh-list
44548606|NCT01351350|Trastuzumab|trastuzumab|mesh-list
44548607|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44548608|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548609|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
44548610|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
44548611|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
44548612|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548613|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548614|NCT01351025|Atorvastatin|atorvastatin|mesh-list
44548615|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44548616|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44548617|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
44548618|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548619|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44548620|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44548621|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548622|NCT01350804|Abatacept|abatacept|mesh-list
44548623|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44548624|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548625|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548626|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548627|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
44548628|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548629|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548630|NCT01350271|Mebendazole|mebendazole|mesh-list
44548631|NCT01350271|Piperazine|piperazine|mesh-list
44548632|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
44548633|NCT01350271|DMP 777|dmp 777|mesh-list
44548634|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
44548635|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
44548636|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44548637|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548638|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44548639|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
44548640|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44548641|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548642|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548643|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548644|NCT01350141|Bococizumab|bococizumab|mesh-list
44548659|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44548660|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
44548661|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548662|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548663|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
44548664|NCT01350102|Bacitracin|bacitracin|mesh-list
44548665|NCT01350102|Vitamins|vitamins|mesh-ancestor
44548666|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
44548667|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548668|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
44548669|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548670|NCT01350102|Protective Agents|protective agents|mesh-ancestor
44548671|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44548672|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548673|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548674|NCT01349907|Asenapine|asenapine|mesh-list
44548675|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44548676|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548677|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548678|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548679|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548680|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
44548681|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44548682|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
44548683|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548684|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548685|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44548686|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
44548687|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44548688|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44548689|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44548690|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548691|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548692|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548693|NCT01349673|Budesonide|budesonide|mesh-list
44548694|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548695|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44548696|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
44548697|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548698|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548699|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44548700|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44548701|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
44548702|NCT01349673|Hormones|hormones|mesh-ancestor
44548703|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44548704|NCT01349660|Bevacizumab|bevacizumab|mesh-list
44548705|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44548706|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548707|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44548708|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44548709|NCT01349660|Growth Substances|growth substances|mesh-ancestor
44548710|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548711|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
44548712|NCT01349595|Bortezomib|bortezomib|mesh-list
44548713|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548714|NCT01349569|Lenalidomide|lenalidomide|mesh-list
44548715|NCT01349569|Vaccines|vaccines|mesh-list
44548716|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
44548717|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548718|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44548719|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44548720|NCT01349569|Growth Substances|growth substances|mesh-ancestor
44548721|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44548722|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548724|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44548725|NCT01349192|Minocycline|minocycline|mesh-list
44548726|NCT01349192|Rifampin|rifampin|mesh-list
44548727|NCT01349192|Trimethoprim|trimethoprim|mesh-list
44548728|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
44548729|NCT01349192|Mupirocin|mupirocin|mesh-list
44548730|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44548731|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548732|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
44548733|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
44548734|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548735|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44548736|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
44548737|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
44548738|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548739|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548740|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548741|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44548742|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44548743|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44548744|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44548745|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44548746|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44548747|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44548749|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
44548750|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44548751|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44548752|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548753|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44548754|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44548755|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548756|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44548757|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44548758|NCT01348763|Maraviroc|maraviroc|mesh-list
44548759|NCT01348763|Darunavir|darunavir|mesh-list
44548760|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44548761|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548762|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548763|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548764|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
44548765|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548766|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44548767|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44548768|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44548769|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44548770|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44548771|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44548772|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44548773|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
44548774|NCT01348542|Trazodone|trazodone|mesh-list
44548775|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44548776|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548777|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548778|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548779|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548780|NCT01348542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44548781|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44548782|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548783|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548784|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548785|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
44548786|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44548787|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
44548788|NCT01348139|AZD-3199|azd-3199|mesh-list
44548789|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44548790|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44548791|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44548792|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548793|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548794|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548795|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548797|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44548798|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548799|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548800|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548801|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548802|NCT01347866|Irinotecan|irinotecan|mesh-list
44548803|NCT01347866|Gedatolisib|gedatolisib|mesh-list
44548804|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44548805|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44548806|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548807|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548808|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548809|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548810|NCT01347762|Nabilone|nabilone|mesh-list
44548811|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
44548812|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
44548813|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548814|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548815|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44548816|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44548817|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44548818|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548819|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44548820|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44548821|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
44548822|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44548823|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548824|NCT01347580|Ticagrelor|ticagrelor|mesh-list
44548825|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44548826|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44548827|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44548828|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44548829|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
44548830|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548831|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548832|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548833|NCT01347554|Everolimus|everolimus|mesh-list
44548834|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548835|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548836|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
44548837|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548838|NCT01347112|Varenicline|varenicline|mesh-list
44548839|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44548840|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44548841|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
44548842|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548843|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548844|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548845|NCT01347073|Glycerol|glycerol|mesh-list
44548846|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44548847|NCT01347073|Protective Agents|protective agents|mesh-ancestor
44548848|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548849|NCT01346592|Vaccines|vaccines|mesh-list
44548850|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
44548851|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548852|NCT01346540|Nintedanib|nintedanib|mesh-list
44548853|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548854|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548855|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548856|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548857|NCT01346475|Valacyclovir|valacyclovir|mesh-list
44548858|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
44548859|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548860|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44548861|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
44548862|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44548863|NCT01346059|Vancomycin|vancomycin|mesh-list
44548864|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548865|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548866|NCT01345929|Levofloxacin|levofloxacin|mesh-list
44548867|NCT01345929|Ofloxacin|ofloxacin|mesh-list
44548868|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44548869|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548870|NCT01345929|Renal Agents|renal agents|mesh-ancestor
44548871|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44548872|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44548873|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44548874|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548875|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548876|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548877|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44548878|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548879|NCT01345682|Methotrexate|methotrexate|mesh-list
44548880|NCT01345682|Afatinib|afatinib|mesh-list
44548881|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44548882|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
44548883|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44548884|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548885|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44548886|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
44548887|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548888|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548889|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
44548890|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548891|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548892|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548893|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
44548894|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548895|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548896|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548897|NCT01345669|Afatinib|afatinib|mesh-list
44548898|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548899|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548900|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548901|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548902|NCT01345630|Ritonavir|ritonavir|mesh-list
44548903|NCT01345630|Darunavir|darunavir|mesh-list
44548904|NCT01345630|Tenofovir|tenofovir|mesh-list
44548905|NCT01345630|Emtricitabine|emtricitabine|mesh-list
44548906|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44548907|NCT01345630|Maraviroc|maraviroc|mesh-list
44548908|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44548909|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44548910|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
44548911|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548912|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548913|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44548914|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44548915|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
44548916|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548917|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44548918|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44548919|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44548920|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548921|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44548922|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44548923|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44548924|NCT01345292|Listerine|listerine|mesh-list
44548925|NCT01345292|Fluorides|fluorides|mesh-list
44548926|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
44548927|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
44548928|NCT01345292|Protective Agents|protective agents|mesh-ancestor
44548929|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548930|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44548931|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548932|NCT01345253|Belimumab|belimumab|mesh-list
44548933|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44548934|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
44548935|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548936|NCT01345188|Ranolazine|ranolazine|mesh-list
44548937|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44548938|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548939|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548940|NCT01345162|Ketorolac|ketorolac|mesh-list
44548941|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44548942|NCT01345162|Tramadol|tramadol|mesh-list
44548943|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44548944|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44548945|NCT01345162|Analgesics|analgesics|mesh-ancestor
44548946|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
44548947|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548948|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548949|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44548950|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44548951|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44548952|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452346|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548953|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548954|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44548955|NCT01345162|Narcotics|narcotics|mesh-ancestor
44548956|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548957|NCT01345058|Lacosamide|lacosamide|mesh-list
44548958|NCT01345058|Levetiracetam|levetiracetam|mesh-list
44548959|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
44548960|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
44548961|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44548962|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44548963|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44548964|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548965|NCT01344824|Bevacizumab|bevacizumab|mesh-list
44548966|NCT01344824|Carboplatin|carboplatin|mesh-list
44548967|NCT01344824|Pemetrexed|pemetrexed|mesh-list
44548968|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44548969|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373733|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44548970|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44548976|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44548977|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548978|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44548979|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44548980|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44548981|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
44548982|NCT01344759|Propofol|propofol|mesh-list
44548983|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44548984|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44548985|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44548986|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44548987|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
44548988|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
44548989|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44548990|NCT01344759|Analgesics|analgesics|mesh-ancestor
44548991|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
44548992|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44548993|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44548994|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44548995|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44548996|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44548997|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44548998|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44548999|NCT01344629|Telmisartan|telmisartan|mesh-list
44549000|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549001|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44549002|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44549003|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549004|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44549006|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44549007|NCT01344369|Norethindrone|norethindrone|mesh-list
44549008|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
44549009|NCT01344369|Estradiol|estradiol|mesh-list
44549010|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44549011|NCT01344369|Estrogens|estrogens|mesh-ancestor
44549012|NCT01344369|Hormones|hormones|mesh-ancestor
44452405|NCT01697800|Urological Agents|urological agents|mesh-ancestor
44549013|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549014|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549015|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44549016|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
44549017|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44549018|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44549019|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44549021|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44549022|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44549023|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549024|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44549025|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44549026|NCT01344161|Vitamin D|vitamin d|mesh-list
44549027|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
44549028|NCT01344161|Vitamins|vitamins|mesh-ancestor
44549029|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
44549030|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549031|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44549032|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549033|NCT01343901|Bevacizumab|bevacizumab|mesh-list
44549034|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44549035|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549036|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44549037|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44549038|NCT01343901|Growth Substances|growth substances|mesh-ancestor
44549039|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549040|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
44549041|NCT01343823|Ecallantide|ecallantide|mesh-list
44549042|NCT01343823|Analgesics|analgesics|mesh-ancestor
44549043|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
44549044|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549045|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549046|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44549047|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44549048|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549049|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549050|NCT01343368|Leuprolide|leuprolide|mesh-list
44549051|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44549052|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
44549053|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44549054|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549055|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44549056|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549057|NCT01343277|Dacarbazine|dacarbazine|mesh-list
44549058|NCT01343277|Trabectedin|trabectedin|mesh-list
44549059|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44549060|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
44549061|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549062|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549063|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549064|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44549065|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
44549066|NCT01343043|Fludarabine|fludarabine|mesh-list
44549067|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549068|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
44549069|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549070|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549071|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44549072|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
44549073|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549074|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549075|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44549076|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44549077|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373894|NCT00080756|Androgens|androgens|mesh-ancestor
44549078|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44549079|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549080|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549081|NCT01342913|Fluticasone|fluticasone|mesh-list
44549082|NCT01342913|Xhance|xhance|mesh-list
44549083|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44549084|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549085|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44549086|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
44549087|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549088|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549089|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44549090|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
44549091|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549092|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43954282|NCT01246713|Analgesics|analgesics|mesh-ancestor
44549093|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44549094|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44549095|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44549096|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549097|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549098|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549099|NCT01342887|Cyclosporine|cyclosporine|mesh-list
44549100|NCT01342887|Etoposide|etoposide|mesh-list
44549101|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
44549102|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
44549103|NCT01342887|Pravastatin|pravastatin|mesh-list
44549104|NCT01342887|Cyclosporins|cyclosporins|mesh-list
44549105|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44549106|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549107|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44549108|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44549109|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549110|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549111|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549112|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
44549113|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549114|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
44549115|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549116|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549117|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549118|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44549119|NCT01342887|Analgesics|analgesics|mesh-ancestor
44549120|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
44549121|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549122|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44549123|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44549124|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
44549125|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44549126|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44549127|NCT01342796|Vaccines|vaccines|mesh-list
44549128|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
44549129|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549130|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
44549131|NCT01342640|Hematinics|hematinics|mesh-ancestor
44549132|NCT01342510|Lidocaine|lidocaine|mesh-list
44549133|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
44549134|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
44549135|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
44549136|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549137|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549138|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
44549139|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549140|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549141|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44549142|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44549143|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549144|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549145|NCT01342510|Analgesics|analgesics|mesh-ancestor
44549146|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
44549147|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44549148|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549149|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
44549150|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44549151|NCT01342484|Linagliptin|linagliptin|mesh-list
44549152|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549153|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549164|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44549165|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44549166|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549167|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549168|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
44549169|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549171|NCT01342367|Finasteride|finasteride|mesh-list
44549172|NCT01342367|Dutasteride|dutasteride|mesh-list
44549173|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
44549174|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
44549175|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549176|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549177|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549178|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44549179|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44549180|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549181|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549182|NCT01342367|Urological Agents|urological agents|mesh-ancestor
44549183|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
44549184|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44549185|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549186|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44549187|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549188|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44549189|NCT01342211|Bococizumab|bococizumab|mesh-list
44549190|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44549191|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44549192|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
44549193|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549194|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549195|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44549196|NCT01342094|Timolol|timolol|mesh-list
44549197|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44549198|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549199|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44549200|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44549201|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549202|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549203|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549204|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549205|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549206|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549207|NCT01342081|Timolol|timolol|mesh-list
44549208|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44549209|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549210|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44549211|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44549212|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549213|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549214|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549215|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549216|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549217|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549218|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44549219|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
44549220|NCT01341782|Calcitriol|calcitriol|mesh-list
44549221|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
44549222|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549223|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549224|NCT01341782|Vitamins|vitamins|mesh-ancestor
44549225|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
44549226|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44549227|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549228|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549229|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44549230|NCT01341782|Protective Agents|protective agents|mesh-ancestor
44549231|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44549232|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549233|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549234|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44549235|NCT01341652|Molgramostim|molgramostim|mesh-list
44549236|NCT01341652|Sargramostim|sargramostim|mesh-list
44549237|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
44549238|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549239|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549240|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44549241|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
44549242|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549243|NCT01341457|Gemcitabine|gemcitabine|mesh-list
44549244|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44549245|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
44549246|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549247|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549248|NCT01341457|Antiviral Agents|antiviral agents|mesh-ancestor
44549249|NCT01341457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549274|NCT01340664|Metformin|metformin|mesh-list
44549275|NCT01340664|Canagliflozin|canagliflozin|mesh-list
44549276|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837958|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
44549277|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549278|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44549279|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549280|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44549281|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44549282|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44549283|NCT01340625|Norethindrone|norethindrone|mesh-list
44549284|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
44549285|NCT01340625|Estradiol|estradiol|mesh-list
44549286|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44549287|NCT01340625|Estrogens|estrogens|mesh-ancestor
44549288|NCT01340625|Hormones|hormones|mesh-ancestor
44549289|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549290|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549291|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44549292|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
44549293|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44549294|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44549295|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44549296|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44374142|NCT05419115|Furosemide|furosemide|mesh-list
44549297|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44549298|NCT01340300|Metformin|metformin|mesh-list
44549299|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452660|NCT01694433|Vitamin D|vitamin d|mesh-list
44549300|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549301|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
44549302|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44549303|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
44549304|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549305|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549306|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44549307|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
44549308|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
44549309|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44549310|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
44549311|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549312|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549313|NCT01340196|Tenofovir|tenofovir|mesh-list
44549314|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
44549315|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549316|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44549317|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44549318|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549319|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549320|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44549321|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44549322|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
44549323|NCT01340027|Mirabegron|mirabegron|mesh-list
44549324|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44549325|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44549326|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
44549327|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549328|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549329|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549330|NCT01340027|Urological Agents|urological agents|mesh-ancestor
44549331|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44549332|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44549333|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44549334|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549335|NCT01340014|Timolol|timolol|mesh-list
44549336|NCT01340014|Dorzolamide|dorzolamide|mesh-list
44549337|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549338|NCT01340014|Brinzolamide|brinzolamide|mesh-list
44549339|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44549340|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44549341|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44549342|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549343|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549344|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549345|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549346|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549347|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549348|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44549349|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549351|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
44549352|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549353|NCT01339559|Brivaracetam|brivaracetam|mesh-list
44549354|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
44549355|NCT01339273|Anesthetics|anesthetics|mesh-list
44549356|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
44549357|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549358|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549359|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
44549360|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549361|NCT01339000|Vaccines|vaccines|mesh-list
44452717|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
44549362|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44549363|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
44549364|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549365|NCT01338987|Alovudine|alovudine|mesh-list
44549366|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
44549367|NCT01338987|Busulfan|busulfan|mesh-list
44549368|NCT01338987|Methotrexate|methotrexate|mesh-list
44549369|NCT01338987|Fludarabine|fludarabine|mesh-list
44549370|NCT01338987|Leuprolide|leuprolide|mesh-list
44549371|NCT01338987|Tacrolimus|tacrolimus|mesh-list
44549372|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549373|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
44374188|NCT05695027|Niacinamide|niacinamide|mesh-list
44549374|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549375|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549376|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44549377|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
44549378|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549379|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549380|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44549381|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44549382|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
44549383|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44549384|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44549385|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
44549386|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549387|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549388|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44549389|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44549390|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44549391|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44549392|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
44549393|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44549394|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
44549395|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549396|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
44549397|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44549398|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44549399|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549400|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549401|NCT01338870|Incretins|incretins|mesh-ancestor
44549402|NCT01338870|Hormones|hormones|mesh-ancestor
44549403|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549404|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44549405|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549406|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549407|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549408|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
44549409|NCT01338870|Vitamins|vitamins|mesh-ancestor
44549410|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
44549411|NCT01338818|Methylphenidate|methylphenidate|mesh-list
44549412|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44549413|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549414|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44549415|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44549416|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549417|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549418|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
44549419|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549420|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
44549421|NCT01338792|Pemetrexed|pemetrexed|mesh-list
44549422|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549423|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549424|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549425|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44549426|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44549427|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44549428|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44549429|NCT01338415|Bosentan|bosentan|mesh-list
44549430|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549431|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44549432|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549433|NCT01338298|Aripiprazole|aripiprazole|mesh-list
44549434|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
44549435|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549436|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44549437|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549438|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549439|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549440|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
44549441|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
44549442|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549443|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549444|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44549445|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44549446|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
44374264|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549470|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549471|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549472|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549473|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
44452829|NCT01691482|Albuterol|albuterol|mesh-list
44549474|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549476|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
44549477|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549478|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44549479|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44549480|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44549481|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549482|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549483|NCT01337635|Vitamin D|vitamin d|mesh-list
44549484|NCT01337635|Vitamins|vitamins|mesh-ancestor
44549485|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
44549486|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549487|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44549488|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44549489|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
44549490|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549491|NCT01337115|Ropivacaine|ropivacaine|mesh-list
44549492|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
44549493|NCT01337115|Anesthetics|anesthetics|mesh-list
44549494|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549495|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549496|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
44549497|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549498|NCT01337089|Nabiximols|nabiximols|mesh-list
44549499|NCT01337089|Analgesics|analgesics|mesh-ancestor
44549500|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
44549501|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549502|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549503|NCT01336972|Tolvaptan|tolvaptan|mesh-list
44549504|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44549505|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549506|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
44549507|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549508|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
44549509|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44549510|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44549511|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549512|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549513|NCT01336738|Incretins|incretins|mesh-ancestor
44549514|NCT01336738|Hormones|hormones|mesh-ancestor
44549515|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549516|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44549517|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549518|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549519|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549520|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44549521|NCT01336738|Vitamins|vitamins|mesh-ancestor
44549522|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
44549523|NCT01336608|Fluticasone|fluticasone|mesh-list
44549524|NCT01336608|Xhance|xhance|mesh-list
44549525|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549526|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44549527|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
44549528|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549529|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549530|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44549531|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44549532|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549533|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44549534|NCT01336569|Timolol|timolol|mesh-list
44549535|NCT01336569|Travoprost|travoprost|mesh-list
44549536|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44549537|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44549538|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44549539|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549540|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549541|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549542|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44549543|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549544|NCT01336205|Naloxegol|naloxegol|mesh-list
44549545|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44549546|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549547|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
44549548|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549549|NCT01336023|Insulin|insulin|mesh-list
44549550|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44549551|NCT01336023|Liraglutide|liraglutide|mesh-list
44374368|NCT05693675|Methadone|methadone|mesh-list
44549552|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
44549554|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549555|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549556|NCT01336023|Incretins|incretins|mesh-ancestor
44549557|NCT01336023|Hormones|hormones|mesh-ancestor
44549558|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549559|NCT01335997|Niacin|niacin|mesh-list
44549560|NCT01335997|Niacinamide|niacinamide|mesh-list
44549561|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
44549562|NCT01335997|Simvastatin|simvastatin|mesh-list
44549563|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44549564|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44549565|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
44452912|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549566|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549567|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44549568|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44549569|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549570|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44549571|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
44549572|NCT01335997|Vitamins|vitamins|mesh-ancestor
44549573|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
44549574|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549575|NCT01335971|Sulforaphane|sulforaphane|mesh-list
44549576|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44549577|NCT01335971|Protective Agents|protective agents|mesh-ancestor
44549578|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549579|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549580|NCT01335698|Ritonavir|ritonavir|mesh-list
44549581|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44549582|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44549583|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44549584|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549585|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549586|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549587|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44549588|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44549589|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
44549590|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549591|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44549592|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44549593|NCT01335477|Nintedanib|nintedanib|mesh-list
44549594|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549595|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44549596|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549597|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549598|NCT01335464|Nintedanib|nintedanib|mesh-list
44549599|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549600|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44549601|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549602|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549603|NCT01335399|Dexamethasone|dexamethasone|mesh-list
44549604|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
44549605|NCT01335399|Lenalidomide|lenalidomide|mesh-list
44549606|NCT01335399|Elotuzumab|elotuzumab|mesh-list
44549607|NCT01335399|BB 1101|bb 1101|mesh-list
44549608|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549609|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
44549610|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
44549611|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452966|NCT01689207|Aztreonam|aztreonam|mesh-list
44549612|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549613|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44549614|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
44549615|NCT01335399|Hormones|hormones|mesh-ancestor
44549616|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549617|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44549618|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549619|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549620|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549621|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549622|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
44549623|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44549624|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44549625|NCT01335399|Growth Substances|growth substances|mesh-ancestor
44549626|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
44549627|NCT01335009|Antibodies|antibodies|mesh-list
44374507|NCT05664061|Xhance|xhance|mesh-list
44549628|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44549629|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
44549630|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549646|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
44549647|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44549648|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44549649|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44549650|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549651|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549652|NCT01334554|Urological Agents|urological agents|mesh-ancestor
44549653|NCT01334515|Isotretinoin|isotretinoin|mesh-list
44549654|NCT01334515|Sargramostim|sargramostim|mesh-list
44549655|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549656|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
44549657|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549658|NCT01334125|Metformin|metformin|mesh-list
44549659|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44549660|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549661|NCT01333956|Pregabalin|pregabalin|mesh-list
44453023|NCT01687712|Hormones|hormones|mesh-ancestor
44549662|NCT01333956|Analgesics|analgesics|mesh-ancestor
44549663|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
44549664|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549665|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549666|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
44549667|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44549668|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549669|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549670|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549671|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44549672|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549673|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549674|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549675|NCT01333865|Memantine|memantine|mesh-list
44549676|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44549677|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44549678|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
44549679|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549680|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549681|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549682|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44549683|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44549684|NCT01333722|Acetaminophen|acetaminophen|mesh-list
43767920|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44549685|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44549686|NCT01333722|Hydrocodone|hydrocodone|mesh-list
44549687|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44549688|NCT01333722|Analgesics|analgesics|mesh-ancestor
44549689|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
44549690|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549691|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549692|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
44549693|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44549694|NCT01333722|Narcotics|narcotics|mesh-ancestor
44549695|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549696|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
44549697|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44549698|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44549699|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549700|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549701|NCT01333501|Interferons|interferons|mesh-list
44549702|NCT01333501|Interferon-beta|interferon-beta|mesh-list
44549703|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44549704|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
44549705|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549706|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
44549707|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549708|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
44549709|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549710|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44549711|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549712|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549713|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44549714|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
44549715|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44549716|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44549717|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44549718|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549719|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549720|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
44549721|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549722|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549723|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44549724|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549725|NCT01333072|Risperidone|risperidone|mesh-list
44549726|NCT01333072|Aripiprazole|aripiprazole|mesh-list
44549727|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44549728|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
44549729|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549730|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549731|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549732|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44549733|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549734|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549735|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549736|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44549737|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
44549738|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
44549739|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
44549740|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44549741|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44549742|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44549743|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44549744|NCT01333059|Fentanyl|fentanyl|mesh-list
44549745|NCT01333059|Midazolam|midazolam|mesh-list
44549746|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44549747|NCT01333059|Narcotics|narcotics|mesh-ancestor
44549748|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549749|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549750|NCT01333059|Analgesics|analgesics|mesh-ancestor
44549751|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
44549752|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549753|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44549754|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44549755|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
44549756|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
44549757|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44549758|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44549759|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549760|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549761|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
44549762|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
44549763|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549764|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549765|NCT01333033|Leucovorin|leucovorin|mesh-list
44549766|NCT01333033|Paclitaxel|paclitaxel|mesh-list
44549767|NCT01333033|Carboplatin|carboplatin|mesh-list
44549768|NCT01333033|Fluorouracil|fluorouracil|mesh-list
44549769|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
44549770|NCT01333033|Calcium|calcium|mesh-list
44549771|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
44549772|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44549773|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549774|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44549775|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44549776|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44549777|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549778|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549779|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549780|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
44549781|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44549782|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549783|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
44549784|NCT01333033|Antidotes|antidotes|mesh-ancestor
44549785|NCT01333033|Protective Agents|protective agents|mesh-ancestor
44549786|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
44549787|NCT01333033|Vitamins|vitamins|mesh-ancestor
44549788|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
44549789|NCT01332994|Rituximab|rituximab|mesh-list
44549790|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44549791|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549792|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
44549793|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549794|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549795|NCT01332968|Prednisone|prednisone|mesh-list
44549796|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
44374689|NCT05473364|Diuretics|diuretics|mesh-ancestor
44549797|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44549799|NCT01332968|Doxorubicin|doxorubicin|mesh-list
44549800|NCT01332968|Vincristine|vincristine|mesh-list
44549801|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
44549802|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549803|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
44549804|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549805|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549806|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44549807|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
44549808|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549809|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549810|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44549811|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44549812|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44549813|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44549814|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44549815|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549816|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549817|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
44549818|NCT01332968|Hormones|hormones|mesh-ancestor
44549819|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549820|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44549821|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44549822|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44549823|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44549824|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44549825|NCT01332799|Allopurinol|allopurinol|mesh-list
44549826|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
44549827|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549828|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549829|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
44549830|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549831|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44549832|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
44549833|NCT01332799|Protective Agents|protective agents|mesh-ancestor
44549834|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549835|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
44549836|NCT01332630|Dexamethasone|dexamethasone|mesh-list
44549838|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44549839|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549840|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
44549841|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
44549842|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549843|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549844|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44549845|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
44549846|NCT01332630|Hormones|hormones|mesh-ancestor
44549847|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44549848|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44549849|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549850|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44549851|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44549852|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549853|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
44549854|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
44549855|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
44549856|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44549857|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
44549858|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
44549859|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549860|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549861|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44549862|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44549863|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44549864|NCT01332331|Ambrisentan|ambrisentan|mesh-list
44549865|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44549866|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
44549867|NCT01332318|Promethazine|promethazine|mesh-list
44549868|NCT01332318|Gabapentin|gabapentin|mesh-list
44549869|NCT01332318|Analgesics|analgesics|mesh-ancestor
44549870|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
44549871|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549872|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549883|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44549884|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44549885|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
44549887|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
44549888|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
44549889|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44549890|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44549891|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
44549892|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
44549893|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44549894|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
44549895|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549896|NCT01332292|Fluticasone|fluticasone|mesh-list
44549897|NCT01332292|Xhance|xhance|mesh-list
44549898|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549899|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44549900|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
44549901|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549902|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549903|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44549904|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
44549905|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44549906|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44549907|NCT01332227|Ritonavir|ritonavir|mesh-list
44549908|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44549909|NCT01332227|Tenofovir|tenofovir|mesh-list
44549910|NCT01332227|Emtricitabine|emtricitabine|mesh-list
44549911|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
44549912|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44549913|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44549914|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
44549915|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44549916|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549917|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44549918|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44549919|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
44549920|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549921|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44549922|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44549923|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44549924|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44549925|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44549926|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44549927|NCT01332149|Pregabalin|pregabalin|mesh-list
44549928|NCT01332149|Analgesics|analgesics|mesh-ancestor
44549929|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
44549930|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549931|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549932|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
44549933|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44549934|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549935|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549936|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44549937|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44549938|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44549939|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44549940|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549941|NCT01332019|Interferons|interferons|mesh-list
44549942|NCT01332019|Interferon-beta|interferon-beta|mesh-list
44549943|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
44549944|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549945|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
44549946|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44549947|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
44549948|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549949|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44549950|NCT01331837|Etanercept|etanercept|mesh-list
44549951|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44549952|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44549953|NCT01331837|Analgesics|analgesics|mesh-ancestor
44549954|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
44549955|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549956|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549957|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549958|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549959|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44549960|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44549961|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
44549962|NCT01331824|Amrubicin|amrubicin|mesh-list
44549963|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549964|NCT01331681|Aflibercept|aflibercept|mesh-list
44549965|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44549966|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44549967|NCT01331681|Growth Substances|growth substances|mesh-ancestor
44549968|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549969|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44549970|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44549971|NCT01331161|Vaccines|vaccines|mesh-list
44549972|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
44549973|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549974|NCT01331109|Milnacipran|milnacipran|mesh-list
44549975|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
44549976|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44549977|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44549978|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44549979|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44549980|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44549981|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549982|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44549983|NCT01331109|Analgesics|analgesics|mesh-ancestor
44549984|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
44549985|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549986|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
44549987|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44549988|NCT01331005|Nepafenac|nepafenac|mesh-list
44549989|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44549990|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44549991|NCT01331005|Analgesics|analgesics|mesh-ancestor
44549992|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
44549993|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44549994|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44549995|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44549996|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44549997|NCT01330459|Acetaminophen|acetaminophen|mesh-list
44549998|NCT01330459|Ibuprofen|ibuprofen|mesh-list
44549999|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44550000|NCT01330459|Lidocaine|lidocaine|mesh-list
44550001|NCT01330459|Hydrocodone|hydrocodone|mesh-list
44550002|NCT01330459|Lorazepam|lorazepam|mesh-list
44550003|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44550004|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
44550005|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550006|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550007|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
44550008|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550009|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44550010|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44550011|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44550012|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550013|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550014|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550015|NCT01330459|Analgesics|analgesics|mesh-ancestor
44550016|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
44550017|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44550018|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550019|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550020|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44550021|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550022|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44550023|NCT01330459|Narcotics|narcotics|mesh-ancestor
44550024|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
44550025|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550026|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
44550027|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
44550028|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
44550029|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550030|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44550031|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44550032|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44550033|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44550034|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
44550035|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
44550036|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550037|NCT01330381|Prucalopride|prucalopride|mesh-list
44550038|NCT01330381|Laxatives|laxatives|mesh-ancestor
44550039|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550040|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44550041|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44550042|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
44550043|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550044|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550045|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550046|NCT01330108|Ambrisentan|ambrisentan|mesh-list
44550047|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44550048|NCT01330030|Selegiline|selegiline|mesh-list
44550050|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44550051|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44550052|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44550053|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44550054|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550055|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550056|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44550057|NCT01330030|Protective Agents|protective agents|mesh-ancestor
44550058|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550059|NCT01330017|Loratadine|loratadine|mesh-list
44550060|NCT01330017|Phenylephrine|phenylephrine|mesh-list
44550061|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
44550062|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44550063|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
44550064|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
44550065|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550066|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550067|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
44550068|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44550069|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
44550070|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550071|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44550072|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44550073|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44550074|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550075|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550076|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550077|NCT01330017|Protective Agents|protective agents|mesh-ancestor
44550078|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
44550079|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550080|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44550081|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44550082|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44550083|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
44550084|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
44550085|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
44550086|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
44550087|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550088|NCT01329939|Montelukast|montelukast|mesh-list
44550089|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44550090|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550091|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44550092|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
44550093|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550094|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550095|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44550096|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44550097|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550098|NCT01329900|Etoposide|etoposide|mesh-list
44550099|NCT01329900|Ifosfamide|ifosfamide|mesh-list
44550100|NCT01329900|Ofatumumab|ofatumumab|mesh-list
44550101|NCT01329900|Lenograstim|lenograstim|mesh-list
44550102|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44550103|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550104|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44550105|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44550106|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550107|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550108|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44550109|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
44550110|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44550111|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
44550112|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550113|NCT01329562|Naproxen|naproxen|mesh-list
44550114|NCT01329562|Sumatriptan|sumatriptan|mesh-list
44550115|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44550116|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550117|NCT01329562|Analgesics|analgesics|mesh-ancestor
44550118|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
44550119|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550120|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550121|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550122|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550123|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
44550124|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44550125|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550126|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550127|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44550128|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44550129|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44550130|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
44550131|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550132|NCT01329549|Carboplatin|carboplatin|mesh-list
44550133|NCT01329549|Nintedanib|nintedanib|mesh-list
44550134|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550135|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44550136|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550137|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550138|NCT01329419|Adefovir|adefovir|mesh-list
44550139|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44550140|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
44550141|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550142|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44550143|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550144|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550145|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550146|NCT01329263|Menthol|menthol|mesh-list
44550147|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
44550148|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550149|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44550150|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550151|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44550152|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767921|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550153|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550154|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44550155|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44550156|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550157|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44550158|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44550159|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550160|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550161|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
44550162|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550163|NCT01328548|Vaccines|vaccines|mesh-list
44550164|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
44550165|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550166|NCT01328535|Temozolomide|temozolomide|mesh-list
44550167|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44550168|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
44550169|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550170|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550171|NCT01328093|Aripiprazole|aripiprazole|mesh-list
44550172|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
44550173|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44550174|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44550175|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44550176|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550177|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550178|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
44550179|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
44550180|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550181|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550182|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44550183|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44550184|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
44550185|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44550186|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44550187|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44550188|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44550189|NCT01328054|Lapatinib|lapatinib|mesh-list
44550190|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550191|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44550192|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550193|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550194|NCT01328041|Dolutegravir|dolutegravir|mesh-list
44550195|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44550205|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44550206|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44550207|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550208|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550209|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550210|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550211|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550213|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
44550214|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550215|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
44550216|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44550217|NCT01327885|Dacarbazine|dacarbazine|mesh-list
44550218|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44550219|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
44550220|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550221|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550222|NCT01327703|Pancreatin|pancreatin|mesh-list
44550223|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550224|NCT01327651|Tenofovir|tenofovir|mesh-list
44550225|NCT01327651|Emtricitabine|emtricitabine|mesh-list
44550226|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
44550227|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550228|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44550229|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550230|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550231|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550232|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44550233|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44550234|NCT01327612|Leucovorin|leucovorin|mesh-list
44550235|NCT01327612|Bevacizumab|bevacizumab|mesh-list
44550236|NCT01327612|Conatumumab|conatumumab|mesh-list
44550237|NCT01327612|Fluorouracil|fluorouracil|mesh-list
44550238|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
44550239|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44550240|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550241|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44550242|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44550243|NCT01327612|Growth Substances|growth substances|mesh-ancestor
44550244|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550245|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
44550246|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
44550247|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550248|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550249|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550250|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
44550251|NCT01327612|Antidotes|antidotes|mesh-ancestor
44550252|NCT01327612|Protective Agents|protective agents|mesh-ancestor
44550253|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
44550254|NCT01327612|Vitamins|vitamins|mesh-ancestor
44550255|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
44550256|NCT01327599|Timolol|timolol|mesh-list
44550257|NCT01327599|Travoprost|travoprost|mesh-list
44550258|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44550259|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44550260|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44550261|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44550262|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550263|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550264|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550265|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550266|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44550267|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44550268|NCT01327573|Eculizumab|eculizumab|mesh-list
44550269|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44550270|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550271|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
44550272|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550273|NCT01327547|Maraviroc|maraviroc|mesh-list
44550274|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44550275|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44550276|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550277|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44550278|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44550279|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
44550280|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550281|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44550282|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
44550283|NCT01327495|Testosterone|testosterone|mesh-list
44550284|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
44550285|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
44550286|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44550287|NCT01327495|Acyline|acyline|mesh-list
44550288|NCT01327495|Androgens|androgens|mesh-ancestor
44550289|NCT01327495|Hormones|hormones|mesh-ancestor
44550290|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550291|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550292|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44550293|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550294|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
44550295|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
44550296|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
44550297|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44550298|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44550299|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
44550300|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550301|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44550302|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44550303|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550304|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550305|NCT01327339|Ropinirole|ropinirole|mesh-list
44550306|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44550307|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44550308|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
44550309|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
44550310|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550311|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550312|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550313|NCT01327300|Mesalamine|mesalamine|mesh-list
44550314|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44550315|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550316|NCT01327300|Analgesics|analgesics|mesh-ancestor
44550317|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
44550318|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550319|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550320|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550321|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550322|NCT01326845|Deferasirox|deferasirox|mesh-list
44550323|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44550324|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
44550325|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
44550326|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550327|NCT01326702|Rituximab|rituximab|mesh-list
44550328|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44550329|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44550330|NCT01326702|Veliparib|veliparib|mesh-list
44550331|NCT01326702|Antibodies|antibodies|mesh-list
44550332|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
44550333|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44550334|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
44550335|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550336|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550337|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550338|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44550339|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
44550340|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550341|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44550342|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550343|NCT01326546|Entecavir|entecavir|mesh-list
44550344|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
44550345|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550346|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
44550347|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
44550348|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44550349|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44550350|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550351|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550352|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550353|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550354|NCT01326481|Capecitabine|capecitabine|mesh-list
44550355|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550356|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
44550357|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550358|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550360|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44453659|NCT01678131|Ribavirin|ribavirin|mesh-list
44550361|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
44550362|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44550363|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550365|NCT01325493|Analgesics|analgesics|mesh-ancestor
44550366|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
44550367|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550368|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550369|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44550370|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44550371|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
44550372|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
44550373|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550374|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44550375|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44550376|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550377|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550378|NCT01325428|Vinorelbine|vinorelbine|mesh-list
44550379|NCT01325428|Afatinib|afatinib|mesh-list
44550380|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44550381|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550382|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44550383|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44550384|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44550385|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550386|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44550387|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550388|NCT01325350|Bimatoprost|bimatoprost|mesh-list
44550389|NCT01325350|Minoxidil|minoxidil|mesh-list
44550390|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44550391|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44550392|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
44550393|NCT01325337|Bimatoprost|bimatoprost|mesh-list
44550394|NCT01325337|Minoxidil|minoxidil|mesh-list
44550395|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44550396|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44550397|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
44550398|NCT01325207|Trastuzumab|trastuzumab|mesh-list
44550399|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44550400|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550401|NCT01324999|Tadalafil|tadalafil|mesh-list
44550402|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
44550403|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44550404|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44550405|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550406|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550407|NCT01324999|Urological Agents|urological agents|mesh-ancestor
44550408|NCT01324947|Pomalidomide|pomalidomide|mesh-list
44550409|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
44550410|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550411|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44550412|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44550413|NCT01324947|Growth Substances|growth substances|mesh-ancestor
44550414|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
44550415|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550416|NCT01324570|Buprenorphine|buprenorphine|mesh-list
44550417|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44550418|NCT01324570|Narcotics|narcotics|mesh-ancestor
44550419|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550420|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550421|NCT01324570|Analgesics|analgesics|mesh-ancestor
44550422|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
44550423|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550424|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44550425|NCT01324388|Dulaglutide|dulaglutide|mesh-list
44550426|NCT01324388|Metoprolol|metoprolol|mesh-list
44550427|NCT01324388|Lisinopril|lisinopril|mesh-list
44550428|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44550429|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44550430|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
44550431|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
44550432|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550433|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550434|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44550435|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44550436|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44550437|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550438|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550439|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550444|NCT01324388|Protective Agents|protective agents|mesh-ancestor
44550445|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44550446|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44550447|NCT01324349|Hemostatics|hemostatics|mesh-list
44550448|NCT01324349|Coagulants|coagulants|mesh-ancestor
44550449|NCT01324323|Rifampin|rifampin|mesh-list
44550450|NCT01324323|Romidepsin|romidepsin|mesh-list
44550451|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44550452|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
44550453|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550454|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550455|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
44550456|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550457|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550458|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550459|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44550460|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44550461|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44550462|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44550463|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44550464|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44550465|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44550466|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550467|NCT01324310|Ketoconazole|ketoconazole|mesh-list
44550468|NCT01324310|Romidepsin|romidepsin|mesh-list
44550469|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
44550471|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44550472|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44550473|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550474|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550475|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44550476|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
44550477|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550478|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550479|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44550480|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44550481|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550482|NCT01324232|Quinidine|quinidine|mesh-list
44550483|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
44550484|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
44550485|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550486|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44550487|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44550488|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550489|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550490|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550491|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44550492|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44550493|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550494|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44550495|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
44550496|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44550497|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44550498|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550499|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550500|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44550501|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44550502|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550503|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44550504|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44550505|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550506|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44550507|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44550508|NCT01324141|Fluorouracil|fluorouracil|mesh-list
44550509|NCT01324141|Mitomycins|mitomycins|mesh-list
44550510|NCT01324141|Mitomycin|mitomycin|mesh-list
44550511|NCT01324141|Tempol|tempol|mesh-list
44550512|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
44550513|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550514|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550515|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550516|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550517|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
44550518|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550519|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44550520|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
44550521|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550522|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550523|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
44550524|NCT01324141|Protective Agents|protective agents|mesh-ancestor
44550525|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44550526|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44550527|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44550528|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44550529|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44550530|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550531|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44550532|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44550533|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550534|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550535|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
44550536|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550537|NCT01323920|Methotrexate|methotrexate|mesh-list
44550538|NCT01323920|Bortezomib|bortezomib|mesh-list
44550539|NCT01323920|Tacrolimus|tacrolimus|mesh-list
44550540|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44550541|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
44550542|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44550543|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550544|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550545|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
44550546|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550547|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550548|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550549|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550550|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44550551|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550552|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
44550553|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550554|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550555|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44550557|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44550558|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550559|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
44550560|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550561|NCT01323673|Clobetasol|clobetasol|mesh-list
44550562|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550563|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
44550564|NCT01323673|Hormones|hormones|mesh-ancestor
44550565|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550566|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550567|NCT01323634|Fluticasone|fluticasone|mesh-list
44550568|NCT01323634|Xhance|xhance|mesh-list
44550569|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44550570|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550571|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44550572|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
44550573|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550574|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550575|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44550576|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550577|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550578|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44550579|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44550580|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44550581|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44550582|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550583|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550584|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550585|NCT01323621|Fluticasone|fluticasone|mesh-list
44550586|NCT01323621|Xhance|xhance|mesh-list
44550587|NCT01323621|Albuterol|albuterol|mesh-list
44550588|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44550589|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550590|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44550591|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
44550592|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550593|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550594|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44550595|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550596|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550597|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44550598|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44550599|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44550600|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44550601|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550602|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550603|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550604|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
44550605|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44550606|NCT01323582|Azithromycin|azithromycin|mesh-list
44550607|NCT01323582|Erythromycin|erythromycin|mesh-list
44550608|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
44550609|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44550610|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
44550611|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550612|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550613|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550614|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44550615|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550616|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550618|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550619|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
44550620|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175785|NCT00301106|Interleukin-12|interleukin-12|mesh-list
44550621|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550622|NCT01323478|Vortioxetine|vortioxetine|mesh-list
44550623|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
44550624|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44550625|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44550626|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44550627|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550628|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550629|NCT01323478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44550630|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44550631|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550632|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550633|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550634|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
44550635|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44550636|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44550637|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44550638|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44550639|NCT01322490|Molgramostim|molgramostim|mesh-list
44550640|NCT01322490|Sargramostim|sargramostim|mesh-list
44550641|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
44550642|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550643|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550644|NCT01322386|Vancomycin|vancomycin|mesh-list
44550645|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550646|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550647|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
44550648|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44550649|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
44550650|NCT01322009|Probenecid|probenecid|mesh-list
44550651|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44550652|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
44550653|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550654|NCT01322009|Expectorants|expectorants|mesh-ancestor
44550655|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550656|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44550657|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
44550658|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550659|NCT01322009|Protective Agents|protective agents|mesh-ancestor
44550660|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550661|NCT01322009|Antidotes|antidotes|mesh-ancestor
44550662|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
44550663|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
44550664|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550665|NCT01322009|Renal Agents|renal agents|mesh-ancestor
44550666|NCT01321879|Telavancin|telavancin|mesh-list
44550667|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44375636|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
44550668|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175844|NCT00301301|Cisplatin|cisplatin|mesh-list
44550669|NCT01321723|Teriparatide|teriparatide|mesh-list
44550670|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44550671|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550672|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44550673|NCT01321710|Acetaminophen|acetaminophen|mesh-list
44550674|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550675|NCT01321710|Analgesics|analgesics|mesh-ancestor
44550676|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
44550677|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550678|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550679|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
44550680|NCT01321008|Prednisone|prednisone|mesh-list
44550681|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
44550682|NCT01321008|Doxorubicin|doxorubicin|mesh-list
44550683|NCT01321008|Vincristine|vincristine|mesh-list
44550684|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550685|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
44550686|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550687|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550688|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44550689|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
44550690|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550691|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550692|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44550693|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44550694|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44550695|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44550696|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550697|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550698|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
44550699|NCT01321008|Hormones|hormones|mesh-ancestor
44550700|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550701|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44550702|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44550703|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44550704|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44550705|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44550706|NCT01320722|Vitamin D|vitamin d|mesh-list
44550707|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
44550708|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
44550709|NCT01320722|Vitamins|vitamins|mesh-list
44550710|NCT01320722|Allopurinol|allopurinol|mesh-list
44550711|NCT01320722|Probenecid|probenecid|mesh-list
44550712|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
44550713|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550714|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44550715|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44550716|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
44550717|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550718|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550719|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
44550720|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550721|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44550722|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
44550723|NCT01320722|Protective Agents|protective agents|mesh-ancestor
44550724|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
44550725|NCT01320722|Renal Agents|renal agents|mesh-ancestor
44550726|NCT01320683|Leucovorin|leucovorin|mesh-list
44550727|NCT01320683|Bevacizumab|bevacizumab|mesh-list
44550728|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44550729|NCT01320683|Fluorouracil|fluorouracil|mesh-list
44550730|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
44550731|NCT01320683|Irinotecan|irinotecan|mesh-list
44550732|NCT01320683|Antibodies|antibodies|mesh-list
44550733|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
44550734|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44550735|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
44550736|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550737|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44550738|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44550739|NCT01320683|Growth Substances|growth substances|mesh-ancestor
44550740|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550741|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
44550742|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
44550743|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
44550744|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550745|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550746|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550747|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44550748|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44550749|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550750|NCT01320683|Antidotes|antidotes|mesh-ancestor
44550751|NCT01320683|Protective Agents|protective agents|mesh-ancestor
44550752|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
44550753|NCT01320683|Vitamins|vitamins|mesh-ancestor
44550754|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
44550755|NCT01320293|Adalimumab|adalimumab|mesh-list
44550756|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550757|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550758|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
44550759|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44550760|NCT01320033|Doxycycline|doxycycline|mesh-list
44550761|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550762|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550763|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
44550764|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44550765|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44550766|NCT01319383|Vorinostat|vorinostat|mesh-list
44550767|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550768|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44550769|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550770|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550771|NCT01318902|Dexamethasone|dexamethasone|mesh-list
44550772|NCT01318902|Ixazomib|ixazomib|mesh-list
44550773|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550774|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
44550775|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
44550776|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550777|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550778|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550779|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
44550780|NCT01318902|Hormones|hormones|mesh-ancestor
44550781|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550782|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44550783|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550784|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
44550785|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550786|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550787|NCT01318811|Heparin|heparin|mesh-list
44550788|NCT01318811|Calcium heparin|calcium heparin|mesh-list
44550789|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
44550790|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44550791|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44550792|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550793|NCT01317615|Paclitaxel|paclitaxel|mesh-list
44550794|NCT01317615|Carboplatin|carboplatin|mesh-list
44550795|NCT01317615|Everolimus|everolimus|mesh-list
44550796|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44550797|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550798|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44550799|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44550800|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44550801|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550802|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550803|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
44550804|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550805|NCT01315678|Tobramycin|tobramycin|mesh-list
44550806|NCT01315678|Amikacin|amikacin|mesh-list
44550807|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550808|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550809|NCT01315249|Fluticasone|fluticasone|mesh-list
44550811|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
44550812|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44550813|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44550814|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550815|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44550816|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
44550817|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550818|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550819|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44550820|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550821|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550822|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44550823|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44550826|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44550827|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550828|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550829|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44550830|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44550831|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44550832|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550833|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
44550835|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550836|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
44550837|NCT01314911|Oseltamivir|oseltamivir|mesh-list
44550838|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
44550839|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550840|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550841|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550842|NCT01314261|Interferons|interferons|mesh-list
44550843|NCT01314261|Ribavirin|ribavirin|mesh-list
44550844|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550845|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
44550846|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550847|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
44550848|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550850|NCT01313858|Methotrexate|methotrexate|mesh-list
44550851|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44550852|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
44550853|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44550854|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550855|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44550856|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
44550857|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550858|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550859|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550860|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550861|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44550862|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550863|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
44550864|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550865|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550866|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44550867|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550868|NCT01313780|Oxycodone|oxycodone|mesh-list
44550869|NCT01313780|Naloxone|naloxone|mesh-list
44550870|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44550871|NCT01313780|Narcotics|narcotics|mesh-ancestor
44550872|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44550873|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550874|NCT01313780|Analgesics|analgesics|mesh-ancestor
44550875|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
44550876|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550877|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44550878|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
44550879|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44550880|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44550881|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44550882|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550883|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550884|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550885|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550886|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550887|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44550888|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550889|NCT01313728|Dapsone|dapsone|mesh-list
44550890|NCT01313728|Tretinoin|tretinoin|mesh-list
44550891|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550892|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
44550893|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550894|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44550895|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
44550896|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44375882|NCT03565913|Calcium|calcium|mesh-list
44550898|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44550899|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550900|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550901|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
44550902|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44550903|NCT01313676|Fluticasone|fluticasone|mesh-list
44550904|NCT01313676|Xhance|xhance|mesh-list
44550905|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550906|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44550907|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
44550908|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550909|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550910|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44550911|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44550912|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
44550913|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44550914|NCT01313663|Pemetrexed|pemetrexed|mesh-list
44550915|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550916|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44550917|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550918|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44550919|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44550920|NCT01313637|Bromides|bromides|mesh-list
44550921|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
44550922|NCT01313559|Everolimus|everolimus|mesh-list
44550923|NCT01313559|Pasireotide|pasireotide|mesh-list
44550924|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955841|NCT01296646|Naltrexone|naltrexone|mesh-list
44550925|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550926|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
44550927|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550929|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550930|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
44550931|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44550932|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44550933|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44550934|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550935|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550936|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550937|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550938|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550939|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44550940|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550941|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
44550942|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44550943|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44550944|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44550945|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44550946|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550947|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
44550948|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44550949|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550950|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44550951|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550952|NCT01313286|Globalagliatin|globalagliatin|mesh-list
44550953|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
44550954|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550955|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
44550956|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
44550957|NCT01313273|Lanreotide|lanreotide|mesh-list
44550958|NCT01313273|Androgens|androgens|mesh-list
44550959|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44550960|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44550961|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
44550962|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
44550963|NCT01313273|Hormones|hormones|mesh-ancestor
44550964|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44550965|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550966|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
44550967|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44550968|NCT01313273|Protective Agents|protective agents|mesh-ancestor
44550969|NCT01313273|Vitamins|vitamins|mesh-ancestor
44550970|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
44550971|NCT01313273|Estrogens|estrogens|mesh-ancestor
44550972|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44550973|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44550974|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
44550975|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44550976|NCT01313221|Etanercept|etanercept|mesh-list
44550977|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44550978|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550979|NCT01313221|Analgesics|analgesics|mesh-ancestor
44550980|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
44550981|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550982|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550983|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550984|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550985|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550986|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550987|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
44550988|NCT01313208|Etanercept|etanercept|mesh-list
44550989|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44550990|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44550991|NCT01313208|Analgesics|analgesics|mesh-ancestor
44550992|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
44550993|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44550994|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44550995|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44550996|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44550997|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44550998|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44550999|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
44551000|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
44551001|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44551002|NCT01313182|Mupirocin|mupirocin|mesh-list
44551003|NCT01313182|Povidone|povidone|mesh-list
44551004|NCT01313182|Calcium|calcium|mesh-list
44551005|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44551006|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551007|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
44551008|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
44551009|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551010|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44551011|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44551012|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551013|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551014|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
44551015|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
44551016|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551017|NCT01313117|Protective Agents|protective agents|mesh-ancestor
44551018|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551019|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
44551020|NCT01313117|Vitamins|vitamins|mesh-ancestor
44551021|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
44551022|NCT01313078|Asparaginase|asparaginase|mesh-list
44551023|NCT01313078|Pegaspargase|pegaspargase|mesh-list
44551024|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551025|NCT01312961|Fluticasone|fluticasone|mesh-list
44551026|NCT01312961|Xhance|xhance|mesh-list
44551027|NCT01312961|Albuterol|albuterol|mesh-list
44551028|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44551029|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44551030|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44551031|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551032|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44551033|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
44551034|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551035|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551036|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44551037|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44551038|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44551039|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44551040|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44551041|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44551042|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44551043|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44551044|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551045|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551046|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
44551047|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44551048|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
44551049|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
44551050|NCT01312961|Hormones|hormones|mesh-ancestor
44551051|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551052|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
44551053|NCT01312909|Varenicline|varenicline|mesh-list
44551054|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44551055|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44551056|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551057|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551058|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551059|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551060|NCT01312467|Metformin|metformin|mesh-list
44551061|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551062|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551063|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
44551064|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551065|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44551066|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551067|NCT01312129|Analgesics|analgesics|mesh-ancestor
44551068|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
44551069|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551070|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551071|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551072|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551073|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551074|NCT01311661|Olodaterol|olodaterol|mesh-list
44551075|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44551076|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
44551077|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551078|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551079|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44551080|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
44551081|NCT01311648|Factor VIII|factor viii|mesh-list
44551082|NCT01311648|Coagulants|coagulants|mesh-ancestor
44551083|NCT01311505|Rifampin|rifampin|mesh-list
44551084|NCT01311505|Isoniazid|isoniazid|mesh-list
44551085|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44551086|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
44551087|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44551088|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551089|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
44551090|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44551091|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551092|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551093|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44551094|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44551095|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44551096|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44551097|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44551098|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44551099|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44551100|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44551101|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
44551102|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44551103|NCT01311024|Vaccines|vaccines|mesh-list
44551104|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
44551105|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551106|NCT01310868|Carmustine|carmustine|mesh-list
44551107|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44551108|NCT01310868|Levulinic acid|levulinic acid|mesh-list
44551109|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44551110|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
44551111|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551112|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551113|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551114|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44551115|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44551116|NCT01310803|Valrubicin|valrubicin|mesh-list
44551117|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551118|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44551119|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44551120|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551121|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551122|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44551123|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44551125|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44551126|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551127|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44551128|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44551129|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44551130|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44551131|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551132|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551133|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551134|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44551135|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551136|NCT01310127|Nepafenac|nepafenac|mesh-list
44551137|NCT01310127|Bromfenac|bromfenac|mesh-list
44551138|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44551139|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44551140|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44551141|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551142|NCT01310127|Analgesics|analgesics|mesh-ancestor
44551143|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
44551144|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551145|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551146|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551147|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551148|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44551149|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551150|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44551151|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551152|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551153|NCT01309997|Rituximab|rituximab|mesh-list
44551154|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
44551155|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551156|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551157|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
44551158|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551159|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551160|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44551161|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551162|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551163|NCT01309841|Naloxegol|naloxegol|mesh-list
44551164|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44551165|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551166|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
44551167|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551168|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44551169|NCT01309828|Olmesartan|olmesartan|mesh-list
44551170|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44551171|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
44551172|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44551173|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551174|NCT01309828|Diuretics|diuretics|mesh-ancestor
44551175|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
44551176|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551177|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44551178|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551179|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551180|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44551181|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44551182|NCT01309737|Tofacitinib|tofacitinib|mesh-list
44551183|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44551184|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551185|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551186|NCT01309659|Iron|iron|mesh-list
44551187|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44551188|NCT01309659|Trace Elements|trace elements|mesh-ancestor
44551189|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
44551190|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551191|NCT01309659|Hematinics|hematinics|mesh-ancestor
44551192|NCT01309386|Morphine|morphine|mesh-list
44551193|NCT01309386|Tapentadol|tapentadol|mesh-list
44551194|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551195|NCT01309386|Narcotics|narcotics|mesh-ancestor
44551196|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551197|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551198|NCT01309386|Analgesics|analgesics|mesh-ancestor
44551199|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
44551200|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551201|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44551202|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551203|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551204|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551205|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44551206|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551207|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44551208|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
44551209|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44551210|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44551211|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551212|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551213|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
44551214|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551215|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44551216|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44551217|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44551218|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44551219|NCT01309204|Brinzolamide|brinzolamide|mesh-list
44551220|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44551221|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551222|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44551223|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44551224|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44551225|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
44551226|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551227|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551228|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551229|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44551230|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551232|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
44551233|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44551234|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551235|NCT01308736|Varenicline|varenicline|mesh-list
44551236|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44551237|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44551238|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551239|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551240|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551241|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551242|NCT01308580|Prednisone|prednisone|mesh-list
44551243|NCT01308580|Prednisolone|prednisolone|mesh-list
44551244|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551245|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
44551246|NCT01308580|Hormones|hormones|mesh-ancestor
44551247|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551248|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551249|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44551250|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551251|NCT01308567|Prednisone|prednisone|mesh-list
44551252|NCT01308567|Docetaxel|docetaxel|mesh-list
44551253|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551254|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44551255|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44551256|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44551257|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551258|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551259|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
44551260|NCT01308567|Hormones|hormones|mesh-ancestor
44551261|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551262|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551263|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44551264|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44551265|NCT01307891|Paclitaxel|paclitaxel|mesh-list
44551266|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551267|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44376240|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551279|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551281|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
44551282|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551283|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551284|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44551285|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44551286|NCT01307449|Vaccines|vaccines|mesh-list
44376320|NCT01932125|Growth Substances|growth substances|mesh-ancestor
44551287|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44551288|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
44551289|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551290|NCT01307319|Beclomethasone|beclomethasone|mesh-list
44551291|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551292|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
44551293|NCT01307319|Hormones|hormones|mesh-ancestor
44551294|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551295|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551296|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44551297|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
44551298|NCT01307267|Rituximab|rituximab|mesh-list
44551299|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44551300|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
44551301|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551302|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551303|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
44551304|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551305|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551306|NCT01307111|Misoprostol|misoprostol|mesh-list
44551307|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44551308|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
44551309|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44551310|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176449|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44551311|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44551312|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551313|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
44551314|NCT01307020|Ibuprofen|ibuprofen|mesh-list
44551315|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44551316|NCT01307020|Ketoprofen|ketoprofen|mesh-list
44551317|NCT01307020|Tramadol|tramadol|mesh-list
44551318|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44551319|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551320|NCT01307020|Analgesics|analgesics|mesh-ancestor
44551321|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
44551322|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551323|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551324|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551325|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551326|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44551327|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551328|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551329|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551330|NCT01307020|Narcotics|narcotics|mesh-ancestor
44551331|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551332|NCT01306942|Paclitaxel|paclitaxel|mesh-list
44551333|NCT01306942|Trastuzumab|trastuzumab|mesh-list
44551334|NCT01306942|Dasatinib|dasatinib|mesh-list
44551335|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44551336|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551337|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44551338|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44551339|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44551340|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551341|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551342|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44551343|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551344|NCT01306656|Vitamin D|vitamin d|mesh-list
44551345|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
44551346|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
44551347|NCT01306656|Vitamins|vitamins|mesh-list
44551348|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
44551349|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551350|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44551351|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44551352|NCT01306643|Idelalisib|idelalisib|mesh-list
44551353|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551354|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551355|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551356|NCT01306617|Ritonavir|ritonavir|mesh-list
44551357|NCT01306617|Ribavirin|ribavirin|mesh-list
44551358|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44551359|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44551360|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
44551361|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176488|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44551362|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551364|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44551365|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
44551366|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551367|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44551368|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44551369|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
44551370|NCT01306331|Nonoxynol|nonoxynol|mesh-list
44551371|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44551372|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44551373|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551374|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44551375|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
44551376|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44551377|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44551378|NCT01306214|Empagliflozin|empagliflozin|mesh-list
44551379|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44551380|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551381|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551382|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551383|NCT01306162|Dronedarone|dronedarone|mesh-list
44551384|NCT01306162|Dabigatran|dabigatran|mesh-list
44551385|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
44551386|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44551387|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
44551388|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551389|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551390|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
44551391|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44551392|NCT01306058|Sorafenib|sorafenib|mesh-list
44551393|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551394|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44551395|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551396|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551397|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
44551398|NCT01306032|Veliparib|veliparib|mesh-list
44551399|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551400|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
44551401|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551402|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551403|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44551404|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
44176539|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551405|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551406|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551407|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44551408|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44551409|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551410|NCT01305941|Trastuzumab|trastuzumab|mesh-list
44551411|NCT01305941|Everolimus|everolimus|mesh-list
44551412|NCT01305941|Vinorelbine|vinorelbine|mesh-list
44551413|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551414|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551415|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551416|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
44551417|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551418|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44551419|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44551420|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44551421|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44551422|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551423|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
44551424|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44551425|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551426|NCT01305408|Modafinil|modafinil|mesh-list
44551427|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44551428|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551429|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44551430|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44551431|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44551432|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551433|NCT01305239|Exemestane|exemestane|mesh-list
44551434|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551435|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44376420|NCT05263206|Loratadine|loratadine|mesh-list
44551436|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44551437|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551438|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551439|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44551440|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
44551441|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551442|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551443|NCT01305200|Calcium|calcium|mesh-list
44176585|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44551444|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44551445|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551446|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44551447|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551448|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
44551449|NCT01304706|Hormones|hormones|mesh-ancestor
44551450|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551451|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551452|NCT01304693|Ranibizumab|ranibizumab|mesh-list
44551453|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44551454|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44551455|NCT01304693|Growth Substances|growth substances|mesh-ancestor
44551456|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551457|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
44551458|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551459|NCT01304498|Vaccines|vaccines|mesh-list
44551460|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
44551461|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551462|NCT01304329|Empagliflozin|empagliflozin|mesh-list
44551463|NCT01304329|Simvastatin|simvastatin|mesh-list
44551464|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44551465|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44551466|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
44551467|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551468|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44551469|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44551470|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551471|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44551472|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551473|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551474|NCT01304147|Ketamine|ketamine|mesh-list
44551475|NCT01304147|Analgesics|analgesics|mesh-ancestor
44551476|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
44551477|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176630|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
44551478|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551479|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44551480|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44551481|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
44551482|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
44551483|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551484|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44551485|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44551486|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551487|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551488|NCT01303965|Sirolimus|sirolimus|mesh-list
44551489|NCT01303965|Lenalidomide|lenalidomide|mesh-list
44551490|NCT01303965|Tacrolimus|tacrolimus|mesh-list
44551491|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551492|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
44551493|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551494|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44551495|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551496|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551497|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44551498|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44551499|NCT01303965|Growth Substances|growth substances|mesh-ancestor
44551500|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44551501|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551502|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44551503|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551504|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44551505|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
44551506|NCT01303861|Bupropion|bupropion|mesh-list
44551507|NCT01303861|Nicotine|nicotine|mesh-list
44551508|NCT01303861|Varenicline|varenicline|mesh-list
44551509|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44551510|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
44551511|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551512|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551513|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44551514|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44551515|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551516|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551517|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551518|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44551519|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551520|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551521|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44551522|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551523|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551524|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
43767979|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
44551525|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44551526|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44551527|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551529|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551530|NCT01303627|Narcotics|narcotics|mesh-ancestor
44551531|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551532|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551533|NCT01303627|Analgesics|analgesics|mesh-ancestor
44176670|NCT00303888|Docetaxel|docetaxel|mesh-list
44551534|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
44551535|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551536|NCT01303445|Omeprazole|omeprazole|mesh-list
44551537|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44551538|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44551539|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551540|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44551541|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551542|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551543|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44551544|NCT01303172|Gemcitabine|gemcitabine|mesh-list
44551545|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44551546|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
44551547|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551548|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551549|NCT01303172|Antiviral Agents|antiviral agents|mesh-ancestor
44551550|NCT01303172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551551|NCT01303172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551552|NCT01303172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551553|NCT01303172|Immunologic Factors|immunologic factors|mesh-ancestor
44551554|NCT01303172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551555|NCT01302964|Mirtazapine|mirtazapine|mesh-list
44551556|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551557|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551558|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44551559|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
44551560|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
44551561|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551562|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551563|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551564|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44551565|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44551566|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551567|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44551568|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44551569|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44551570|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44551571|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44551572|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44551573|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
44551574|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44551575|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44551576|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44551577|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44551578|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551579|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551580|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551581|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376564|NCT05024734|Gemcitabine|gemcitabine|mesh-list
44551591|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551593|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
44551594|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551595|NCT01302834|Cisplatin|cisplatin|mesh-list
44551596|NCT01302834|Cetuximab|cetuximab|mesh-list
44551597|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551598|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551599|NCT01302691|Losartan|losartan|mesh-list
44551600|NCT01302691|Amlodipine|amlodipine|mesh-list
44551601|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44551602|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551603|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44551604|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551605|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551606|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44551607|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551608|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
44551609|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44551610|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44551611|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44551613|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
44551614|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44551615|NCT01302119|Tavaborole|tavaborole|mesh-list
44551616|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44551617|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
44551618|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551619|NCT01302080|Sertraline|sertraline|mesh-list
44551620|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551621|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551622|NCT01302080|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44551623|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551624|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551625|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551626|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551627|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
44551628|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551629|NCT01302067|Fesoterodine|fesoterodine|mesh-list
44551630|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44551631|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44551632|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551633|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551634|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551635|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551636|NCT01302067|Urological Agents|urological agents|mesh-ancestor
44551637|NCT01302054|Fesoterodine|fesoterodine|mesh-list
44551638|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44551639|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44551640|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551641|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551642|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551643|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551644|NCT01302054|Urological Agents|urological agents|mesh-ancestor
44551645|NCT01301833|Biguanides|biguanides|mesh-list
44551646|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44551647|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551648|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551649|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551650|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551651|NCT01301729|Paclitaxel|paclitaxel|mesh-list
44551652|NCT01301729|Docetaxel|docetaxel|mesh-list
44551653|NCT01301729|Trastuzumab|trastuzumab|mesh-list
44551654|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44551655|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551656|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
44551657|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
44551658|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
44551659|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551660|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551661|NCT01301391|Maleic acid|maleic acid|mesh-list
44551662|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551663|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551664|NCT01301092|Dulaglutide|dulaglutide|mesh-list
44551665|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551666|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551667|NCT01301079|Ketamine|ketamine|mesh-list
44551668|NCT01301079|Analgesics|analgesics|mesh-ancestor
44551669|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
44551670|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551671|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551672|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44551673|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44551674|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
44551675|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
44551676|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551677|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44551678|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44551679|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551680|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551681|NCT01301066|Pravastatin|pravastatin|mesh-list
44551683|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44551684|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44551685|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
44551686|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551687|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44551688|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44551689|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551690|NCT01301027|Pioglitazone|pioglitazone|mesh-list
44551691|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551692|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551693|NCT01301001|Gabapentin|gabapentin|mesh-list
44551694|NCT01301001|Analgesics|analgesics|mesh-ancestor
44551695|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
44551696|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551697|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551698|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
44551699|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44551700|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44551701|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551702|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551703|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44551704|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44551705|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551706|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551707|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
44551708|NCT01300923|Acamprosate|acamprosate|mesh-list
44551709|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44551710|NCT01300819|Rotigotine|rotigotine|mesh-list
44551711|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
44551712|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
44551713|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551714|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551715|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551716|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
44551717|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
44551718|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551719|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
44551720|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
44551721|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551722|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44551723|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551724|NCT01300572|Cyclosporine|cyclosporine|mesh-list
44551725|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
44551726|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44551727|NCT01300572|Fludarabine|fludarabine|mesh-list
44551728|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
44551729|NCT01300572|Antibodies|antibodies|mesh-list
44551730|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
44551731|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44551732|NCT01300572|Cyclosporins|cyclosporins|mesh-list
44551733|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
44551734|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551735|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551736|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44551737|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
44551738|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551739|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551745|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44551746|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44551747|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44551748|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
44551749|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44551750|NCT01300546|Naproxen|naproxen|mesh-list
44551751|NCT01300546|Sumatriptan|sumatriptan|mesh-list
44551752|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44551753|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551754|NCT01300546|Analgesics|analgesics|mesh-ancestor
44551755|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
44551756|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551757|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453911|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551758|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551759|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551760|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
44551761|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44551762|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551763|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551764|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44551765|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44551766|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44551767|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
44551768|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551770|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44551771|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44551772|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551773|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551774|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44551775|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551776|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551777|NCT01300351|Fulvestrant|fulvestrant|mesh-list
44551778|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44551779|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551780|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44551781|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44551782|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
44551783|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551784|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551785|NCT01300260|Dulaglutide|dulaglutide|mesh-list
44551786|NCT01300260|Glucagon|glucagon|mesh-list
44551787|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44551788|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44551789|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551790|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551791|NCT01300260|Hormones|hormones|mesh-ancestor
44551792|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551793|NCT01300260|Incretins|incretins|mesh-ancestor
44551794|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
44551795|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44551796|NCT01300247|Fludarabine|fludarabine|mesh-list
44551797|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
44551798|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551799|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
44551800|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551801|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551802|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44551803|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
44551804|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551805|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551806|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44551807|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44551808|NCT01300234|Tenofovir|tenofovir|mesh-list
44551809|NCT01300234|Adefovir|adefovir|mesh-list
44551811|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
44551812|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44551813|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44551814|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44551815|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551816|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551817|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44551818|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44551819|NCT01299961|Abatacept|abatacept|mesh-list
44551820|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44551821|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551822|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551823|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551824|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
44551825|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551826|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551827|NCT01299896|Bupropion|bupropion|mesh-list
44551828|NCT01299896|Nicotine|nicotine|mesh-list
44551829|NCT01299896|Varenicline|varenicline|mesh-list
44551830|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44551831|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
44551832|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551833|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551834|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44176944|NCT00304720|Tacrolimus|tacrolimus|mesh-list
44551835|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43956641|NCT01321554|Lenvatinib|lenvatinib|mesh-list
44551836|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
44551837|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551838|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551839|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44551840|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551841|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551842|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44551843|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551844|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551845|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
44551846|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44551847|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44551848|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551849|NCT01299805|Vortioxetine|vortioxetine|mesh-list
44551850|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
44551851|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551852|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44551853|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44551854|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551855|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551856|NCT01299805|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44551857|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551858|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551859|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551860|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551861|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
44551862|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44551863|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44551864|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44551865|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44551866|NCT01299584|Remifentanil|remifentanil|mesh-list
44551867|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551868|NCT01299584|Narcotics|narcotics|mesh-ancestor
44551869|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44176986|NCT00304850|Ketamine|ketamine|mesh-list
44551870|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551871|NCT01299584|Analgesics|analgesics|mesh-ancestor
44551872|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
44551873|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551874|NCT01299571|Dutasteride|dutasteride|mesh-list
44551875|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44551876|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44551877|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551878|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551879|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
44551880|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376875|NCT04658784|Cyclopropane|cyclopropane|mesh-list
44551881|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551882|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44551883|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44551884|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44551885|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551886|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551887|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44551888|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44551889|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44551890|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
44551891|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551892|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551893|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44551894|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44551895|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
44551896|NCT01299272|Serotonin|serotonin|mesh-list
44551897|NCT01299272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44551898|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44551899|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
44551900|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551901|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551902|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551903|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44551904|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44551905|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
44551906|NCT01299116|Etonogestrel|etonogestrel|mesh-list
44551907|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
44551908|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44551909|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551910|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44551911|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44551912|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44551913|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44551914|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44551915|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
44551916|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551917|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44551918|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44551919|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551920|NCT01298778|Acetaminophen|acetaminophen|mesh-list
44551921|NCT01298778|Morphine|morphine|mesh-list
44551922|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551923|NCT01298778|Analgesics|analgesics|mesh-ancestor
44551924|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
44551925|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551926|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551927|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
44551928|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551929|NCT01298778|Narcotics|narcotics|mesh-ancestor
44551930|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551931|NCT01298765|Buprenorphine|buprenorphine|mesh-list
44551932|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44551933|NCT01298765|Narcotics|narcotics|mesh-ancestor
44551934|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44551935|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551936|NCT01298765|Analgesics|analgesics|mesh-ancestor
44551937|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
44551938|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551939|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44551940|NCT01298700|Bimatoprost|bimatoprost|mesh-list
44551941|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44551942|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44551943|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44551944|NCT01298570|Leucovorin|leucovorin|mesh-list
44551945|NCT01298570|Fluorouracil|fluorouracil|mesh-list
44551946|NCT01298570|Irinotecan|irinotecan|mesh-list
44551947|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
44551948|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
44551949|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551950|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44551951|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44551952|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551953|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
44551954|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376954|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
44551955|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44551956|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44551957|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551958|NCT01298570|Antidotes|antidotes|mesh-ancestor
44551959|NCT01298570|Protective Agents|protective agents|mesh-ancestor
44551960|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
44551961|NCT01298570|Vitamins|vitamins|mesh-ancestor
44551962|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
44551963|NCT01298531|Etanercept|etanercept|mesh-list
44551964|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44551965|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44551966|NCT01298531|Analgesics|analgesics|mesh-ancestor
44551967|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
44551968|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551969|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551970|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44551971|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44551972|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551973|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44551974|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
44551975|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44551976|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44551977|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44551978|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551979|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44551980|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
44551981|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44551982|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551983|NCT01298193|Phenothiazine|phenothiazine|mesh-list
44551985|NCT01298193|Haloperidol|haloperidol|mesh-list
44551986|NCT01298193|Aprepitant|aprepitant|mesh-list
44551987|NCT01298193|Metoclopramide|metoclopramide|mesh-list
44551988|NCT01298193|Domperidone|domperidone|mesh-list
44551989|NCT01298193|Alizapride|alizapride|mesh-list
44551990|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
44551991|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
44551992|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
44551993|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44551994|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44551995|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44551996|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44551997|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44551998|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44551999|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44552000|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44552001|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552002|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44552003|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44552004|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
44552005|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44552006|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44552007|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44552008|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44552009|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
44552010|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44552011|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44552012|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552013|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44552014|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44552015|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44552016|NCT01297920|Brinzolamide|brinzolamide|mesh-list
44552017|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44552018|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44552019|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44552020|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44552021|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44552022|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
44552023|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552024|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552025|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552026|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44552027|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552028|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44552029|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44377030|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
44552043|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44552045|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552046|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177156|NCT00305539|Adalimumab|adalimumab|mesh-list
44552047|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44552048|NCT01297062|Exenatide|exenatide|mesh-list
44552049|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
44552050|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552051|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552052|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44552053|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44552054|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552055|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552056|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552057|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552058|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552059|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44552060|NCT01297062|Incretins|incretins|mesh-ancestor
44552061|NCT01297062|Hormones|hormones|mesh-ancestor
44552062|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552063|NCT01296932|BI 836826|bi 836826|mesh-list
44552064|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552065|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552066|NCT01296698|Nicotine|nicotine|mesh-list
44552067|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44552068|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
44552069|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552070|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552071|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44552072|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44552073|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
44552074|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552075|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552076|NCT01296672|Finasteride|finasteride|mesh-list
44552077|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44552078|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44552079|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552080|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552081|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
44552082|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552083|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552084|NCT01296672|Urological Agents|urological agents|mesh-ancestor
44552085|NCT01296568|Gemcitabine|gemcitabine|mesh-list
44552086|NCT01296568|Pemetrexed|pemetrexed|mesh-list
44552087|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44552088|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
44177186|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552089|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552090|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552091|NCT01296568|Antiviral Agents|antiviral agents|mesh-ancestor
44552092|NCT01296568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552093|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552094|NCT01296568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552095|NCT01296568|Immunologic Factors|immunologic factors|mesh-ancestor
44552096|NCT01296568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552097|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44552098|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552099|NCT01296412|Metformin|metformin|mesh-list
44552100|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44552101|NCT01296412|Liraglutide|liraglutide|mesh-list
44552102|NCT01296412|Glimepiride|glimepiride|mesh-list
44552103|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552104|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552105|NCT01296412|Incretins|incretins|mesh-ancestor
44552106|NCT01296412|Hormones|hormones|mesh-ancestor
44552107|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552108|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44552109|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552110|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552111|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552112|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44552113|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552114|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
44552115|NCT01296347|Ketamine|ketamine|mesh-list
44552116|NCT01296347|Analgesics|analgesics|mesh-ancestor
44552117|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
44552118|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552119|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552120|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44552121|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44552122|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
44552123|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
44552124|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552125|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44552126|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44552127|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552128|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552129|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44552130|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
44552131|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44552132|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44552133|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44552134|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
44552135|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44552136|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552137|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44552138|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44552139|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44552140|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44552141|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552142|NCT01296035|Panitumumab|panitumumab|mesh-list
44552143|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552144|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552145|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
44552146|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552147|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552148|NCT01295814|Adalimumab|adalimumab|mesh-list
44552149|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552150|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552151|NCT01295034|Vitamin D|vitamin d|mesh-list
44552152|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
44552153|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
44552154|NCT01295034|Vitamins|vitamins|mesh-list
44552155|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
44552156|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552157|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44552158|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44552159|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
44552160|NCT01294787|Bromides|bromides|mesh-list
44552161|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
44552162|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44552163|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
44552164|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552165|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552166|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552167|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552168|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
44552169|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44552170|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
44552171|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552172|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552173|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
44552174|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44552175|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44552176|NCT01294683|Niacin|niacin|mesh-list
44552177|NCT01294683|Niacinamide|niacinamide|mesh-list
44552178|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
44552179|NCT01294683|Simvastatin|simvastatin|mesh-list
44552180|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44552181|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44552182|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
44552183|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552184|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44552185|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44552186|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552187|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44552188|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
44552189|NCT01294683|Vitamins|vitamins|mesh-ancestor
44552190|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
44377237|NCT04492475|Remdesivir|remdesivir|mesh-list
44552191|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552192|NCT01294670|Etoposide|etoposide|mesh-list
44552193|NCT01294670|Vorinostat|vorinostat|mesh-list
44552194|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44552195|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552196|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44552197|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44552198|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552199|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552200|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44552201|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
44552202|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44552203|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552204|NCT01294592|Tamsulosin|tamsulosin|mesh-list
44552205|NCT01294592|Dutasteride|dutasteride|mesh-list
44552206|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44552207|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44552208|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44552209|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44552210|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552211|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552212|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552213|NCT01294592|Urological Agents|urological agents|mesh-ancestor
44552214|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44552215|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44552216|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552217|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
44552218|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552219|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44552220|NCT01294579|Ofatumumab|ofatumumab|mesh-list
44552221|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44552222|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
44552223|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552224|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552225|NCT01294553|Metformin|metformin|mesh-list
44552226|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
44552227|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177312|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44177367|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
44552228|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552229|NCT01294462|Aspirin|aspirin|mesh-list
44552230|NCT01294462|Clopidogrel|clopidogrel|mesh-list
44552231|NCT01294462|Ticagrelor|ticagrelor|mesh-list
44552232|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44552233|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44552234|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44552235|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44552236|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
44552237|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552238|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552239|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552240|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44552241|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552242|NCT01294462|Analgesics|analgesics|mesh-ancestor
44552243|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
44552244|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552245|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552246|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552247|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44552248|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44552249|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44552250|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552251|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
44552252|NCT01294449|Cytarabine|cytarabine|mesh-list
44552253|NCT01294449|Dexamethasone|dexamethasone|mesh-list
44552254|NCT01294449|Methotrexate|methotrexate|mesh-list
44552255|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44552256|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
44552257|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552258|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552259|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
44552260|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552261|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552262|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
44552263|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552264|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552265|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
44552266|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
44552267|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552268|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552269|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
44552270|NCT01294449|Hormones|hormones|mesh-ancestor
44552271|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552272|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44552273|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44552274|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
44552275|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44552276|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552277|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552278|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44552279|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552280|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552281|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
44552282|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44552283|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552284|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552285|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552286|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
44552287|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44552288|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552289|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552290|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552292|NCT01294397|Etanercept|etanercept|mesh-list
44552293|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44552294|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552295|NCT01294397|Analgesics|analgesics|mesh-ancestor
44552296|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
44552297|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552298|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552299|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552300|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552301|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552302|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552303|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
44552304|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44552305|NCT01294358|Gemcitabine|gemcitabine|mesh-list
44552306|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44552307|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
44552308|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552309|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552310|NCT01294358|Antiviral Agents|antiviral agents|mesh-ancestor
44552311|NCT01294358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552312|NCT01294358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552313|NCT01294358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552314|NCT01294358|Immunologic Factors|immunologic factors|mesh-ancestor
44552315|NCT01294358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552316|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
44552317|NCT01293968|Promethazine|promethazine|mesh-list
44552318|NCT01293968|Ibuprofen|ibuprofen|mesh-list
44552319|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44177406|NCT00306475|Valproic Acid|valproic acid|mesh-list
44552320|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552321|NCT01293968|Analgesics|analgesics|mesh-ancestor
44552322|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
44552323|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552324|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552325|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552326|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552327|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44552328|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552329|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552330|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44552331|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44552332|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552333|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
44552334|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
44552335|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
44552336|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
44552337|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552338|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44552339|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
44552340|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
44552341|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552342|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44552343|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
44552344|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552345|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44552346|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552347|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552361|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
44552362|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552363|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44552364|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552365|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552366|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552367|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44552368|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44552369|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44552370|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44552371|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44552372|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44552373|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44552374|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43957163|NCT01334086|Aprepitant|aprepitant|mesh-list
44552375|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44552376|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44552377|NCT01293032|Tamoxifen|tamoxifen|mesh-list
44552378|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44552379|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552380|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44552381|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44552382|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552383|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552384|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44552385|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552386|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44552387|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44552388|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44552389|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44552390|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552391|NCT01293006|Suvorexant|suvorexant|mesh-list
44552392|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44552393|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44552394|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552395|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552396|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44552397|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552398|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552399|NCT01292837|Levetiracetam|levetiracetam|mesh-list
44552400|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
44552401|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
44552403|NCT01292603|Rituximab|rituximab|mesh-list
44552404|NCT01292603|Fludarabine|fludarabine|mesh-list
44552405|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552406|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
44552407|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552408|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552409|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44552410|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
44552411|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552412|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552413|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44552414|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552415|NCT01292473|Omalizumab|omalizumab|mesh-list
44552416|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44552417|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552418|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552419|NCT01292239|Ribavirin|ribavirin|mesh-list
44552420|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44552421|NCT01292239|Simeprevir|simeprevir|mesh-list
44552422|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
44552423|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552424|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
44552425|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552426|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552427|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552428|NCT01292226|Cyclosporine|cyclosporine|mesh-list
44552429|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
44552430|NCT01292226|Antibodies|antibodies|mesh-list
44552431|NCT01292226|Cyclosporins|cyclosporins|mesh-list
44552432|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
44552433|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552434|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552435|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552436|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552437|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
44552438|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552439|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552440|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552441|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44552442|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44552443|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552444|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44552445|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
44552446|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552447|NCT01292187|Calcitonin|calcitonin|mesh-list
44552448|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
44552449|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44552450|NCT01292187|Katacalcin|katacalcin|mesh-list
43767980|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
44552451|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44552452|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552453|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44552454|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44552455|NCT01292057|Aripiprazole|aripiprazole|mesh-list
44552456|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44552457|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44552458|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44552459|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44552460|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552461|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552462|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
44552463|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
44552464|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552465|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552466|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44552467|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44552468|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
44552469|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44552470|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44552471|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44552472|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44552473|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44552474|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44552475|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552476|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44552477|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44552478|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44552479|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552480|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
44552481|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552482|NCT01291017|Palbociclib|palbociclib|mesh-list
44552483|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552484|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44552485|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552486|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552487|NCT01290887|Reslizumab|reslizumab|mesh-list
44552488|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552489|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552490|NCT01290757|Dabigatran|dabigatran|mesh-list
44552491|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
44552492|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44552493|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552494|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552495|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552496|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
44552497|NCT01290731|Interferons|interferons|mesh-list
44552498|NCT01290731|Ribavirin|ribavirin|mesh-list
44552499|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44552500|NCT01290731|Simeprevir|simeprevir|mesh-list
44552501|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552502|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
44552503|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552504|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
44552505|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552506|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552507|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552508|NCT01290718|Capecitabine|capecitabine|mesh-list
44552509|NCT01290718|Trastuzumab|trastuzumab|mesh-list
44552510|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44552511|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
44552512|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552513|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552514|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552515|NCT01290679|Ribavirin|ribavirin|mesh-list
44552516|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44552517|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44552518|NCT01290679|Simeprevir|simeprevir|mesh-list
44552519|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
44552520|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552521|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
44552522|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552523|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552524|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552525|NCT01290601|Chloroquine|chloroquine|mesh-list
44552527|NCT01290601|Primaquine|primaquine|mesh-list
44552528|NCT01290601|Tafenoquine|tafenoquine|mesh-list
44552529|NCT01290601|Amebicides|amebicides|mesh-ancestor
44552530|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44552531|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44552532|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552533|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
44552534|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552535|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44552536|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552537|NCT01290601|Analgesics|analgesics|mesh-ancestor
44552538|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
44552539|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552540|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552541|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552542|NCT01290601|Filaricides|filaricides|mesh-ancestor
44552543|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
44552544|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
44552545|NCT01290341|Naftifine|naftifine|mesh-list
44552546|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
44552547|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552548|NCT01290315|Dextrans|dextrans|mesh-list
44552549|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44552550|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
44552551|NCT01290315|Hematinics|hematinics|mesh-ancestor
44552552|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
44552553|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
44552554|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
44552555|NCT01290263|Bevacizumab|bevacizumab|mesh-list
44552556|NCT01290263|Trebananib|trebananib|mesh-list
44552557|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552558|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552559|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44552560|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44552561|NCT01290263|Growth Substances|growth substances|mesh-ancestor
44552562|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552563|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
44552564|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
44552565|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44552566|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552567|NCT01290029|Cinacalcet|cinacalcet|mesh-list
44177627|NCT00307593|Rituximab|rituximab|mesh-list
44552568|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44552569|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552570|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44552571|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
44552572|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552573|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44552574|NCT01289990|Empagliflozin|empagliflozin|mesh-list
44552575|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552576|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552577|NCT01289990|Incretins|incretins|mesh-ancestor
44552578|NCT01289990|Hormones|hormones|mesh-ancestor
44552579|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552580|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44552581|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552582|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552583|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552584|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44552585|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
44552586|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44552587|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44552588|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
44552589|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552590|NCT01289821|Leucovorin|leucovorin|mesh-list
44552591|NCT01289821|Folic Acid|folic acid|mesh-list
44552592|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
44552593|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
44552594|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552595|NCT01289821|Antidotes|antidotes|mesh-ancestor
44552596|NCT01289821|Protective Agents|protective agents|mesh-ancestor
44552597|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552598|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
44552599|NCT01289821|Vitamins|vitamins|mesh-ancestor
44552600|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
44552601|NCT01289821|Hematinics|hematinics|mesh-ancestor
44552602|NCT01289782|Ribavirin|ribavirin|mesh-list
44552603|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44552605|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
44552606|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552607|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
44552608|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552609|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552610|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552611|NCT01289678|Interleukin-2|interleukin-2|mesh-list
44552612|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552613|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552614|NCT01289678|Analgesics|analgesics|mesh-ancestor
44552615|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
44552616|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552617|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552618|NCT01289639|Pioglitazone|pioglitazone|mesh-list
44552619|NCT01289639|Fenofibrate|fenofibrate|mesh-list
44552620|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552621|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552622|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44552623|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
44552624|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552625|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44552626|NCT01289353|Carboplatin|carboplatin|mesh-list
44552627|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552628|NCT01289119|Metformin|metformin|mesh-list
44552629|NCT01289119|Pioglitazone|pioglitazone|mesh-list
44552630|NCT01289119|Alogliptin|alogliptin|mesh-list
44552631|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552632|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552633|NCT01289119|Incretins|incretins|mesh-ancestor
44552635|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552636|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44552637|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552638|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552639|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552640|NCT01288937|Milnacipran|milnacipran|mesh-list
44552641|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
44552642|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44552643|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44552644|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44552645|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552646|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552647|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552648|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552649|NCT01288937|Analgesics|analgesics|mesh-ancestor
44552650|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
44552651|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552652|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
44552653|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44552654|NCT01288911|Bicalutamide|bicalutamide|mesh-list
44552655|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
44552656|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
44552657|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552658|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552659|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552660|NCT01288469|Atorvastatin|atorvastatin|mesh-list
44552661|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44552662|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44552663|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44552664|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
44552665|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552666|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44552667|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44552668|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552669|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
44552670|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552671|NCT01288443|Atorvastatin|atorvastatin|mesh-list
44552672|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44552673|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44552674|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44552675|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
44552676|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552677|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43957443|NCT01341730|Pioglitazone|pioglitazone|mesh-list
44552678|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44552680|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
44552681|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552682|NCT01288209|Ribavirin|ribavirin|mesh-list
44552683|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44552684|NCT01288209|Simeprevir|simeprevir|mesh-list
44552685|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
44552686|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552687|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
44552688|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552689|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552690|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177718|NCT00307671|Prednisolone|prednisolone|mesh-list
44552691|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44552692|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44552693|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44552694|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44552695|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552696|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552697|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552698|NCT01288079|Analgesics|analgesics|mesh-ancestor
44552699|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
44552700|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552701|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
44552702|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44552703|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
44552704|NCT01287832|Vancomycin|vancomycin|mesh-list
44552705|NCT01287832|Daptomycin|daptomycin|mesh-list
44552723|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552724|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44552725|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
44552727|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552728|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552729|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
44552730|NCT01287364|Ciclesonide|ciclesonide|mesh-list
44552731|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552732|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552733|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44552734|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
44552735|NCT01287364|Hormones|hormones|mesh-ancestor
44552736|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552737|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552738|NCT01287221|Riboflavin|riboflavin|mesh-list
44552739|NCT01287221|Rifampin|rifampin|mesh-list
44552740|NCT01287221|Vitamins|vitamins|mesh-ancestor
44552741|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
44552742|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552743|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
44552744|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44552745|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
44552746|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552747|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552748|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
44552749|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552750|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552751|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552752|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44552753|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44552754|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44552755|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44552756|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44552757|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44552758|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44552759|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552761|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
44552762|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44552763|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44552764|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44552765|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552766|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552767|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
44552768|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552769|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552770|NCT01287117|Omalizumab|omalizumab|mesh-list
44552772|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552773|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552774|NCT01287039|Reslizumab|reslizumab|mesh-list
44552775|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552776|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552777|NCT01286987|Talazoparib|talazoparib|mesh-list
44552778|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44552779|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552780|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552781|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552782|NCT01286753|Vemurafenib|vemurafenib|mesh-list
44552783|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552784|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44552785|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552786|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552787|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
44552788|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
44552789|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552790|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44552791|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552792|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552793|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552794|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44552795|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44552796|NCT01286558|Amlodipine|amlodipine|mesh-list
44552797|NCT01286558|Telmisartan|telmisartan|mesh-list
44552798|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44552799|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44552800|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44552801|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552802|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44552803|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552804|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
44552805|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44552806|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44552807|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
44552808|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44552809|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44552810|NCT01286168|Eusol|eusol|mesh-list
44552811|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44552812|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44552813|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552814|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
44552815|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552816|NCT01286077|Bortezomib|bortezomib|mesh-list
44552817|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552818|NCT01285908|Norepinephrine|norepinephrine|mesh-list
44552819|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44552820|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44377900|NCT04322682|Colchicine|colchicine|mesh-list
44552821|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
44552822|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552823|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552824|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552825|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
44552826|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
44552827|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552828|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44552829|NCT01285609|Paclitaxel|paclitaxel|mesh-list
44552830|NCT01285609|Carboplatin|carboplatin|mesh-list
44552831|NCT01285609|Ipilimumab|ipilimumab|mesh-list
44552832|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44552833|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552834|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
44552835|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
44552836|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
44552837|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552838|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552839|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44552840|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
44552841|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44552842|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
43957550|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
44552843|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552844|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552845|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552846|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552847|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
44552848|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44552849|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
44552850|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552851|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552852|NCT01285401|Interferons|interferons|mesh-list
44552853|NCT01285401|Interferon-beta|interferon-beta|mesh-list
44552854|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
44552855|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552856|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
44552857|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552858|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
44552859|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552860|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44552862|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44552863|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44552864|NCT01285310|Thalidomide|thalidomide|mesh-list
44552865|NCT01285310|Apremilast|apremilast|mesh-list
44552866|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44552867|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44552868|NCT01285310|Analgesics|analgesics|mesh-ancestor
44552869|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
44552870|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44552871|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552872|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552873|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552874|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44552875|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44552876|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552877|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552878|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552879|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
44552880|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
44552881|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552882|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552883|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44552884|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44552885|NCT01285310|Growth Substances|growth substances|mesh-ancestor
44552886|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
44552887|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552888|NCT01284959|Risperidone|risperidone|mesh-list
44552889|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44552890|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44552891|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
44552892|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44552893|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552894|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552895|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44552896|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44552897|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44552898|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44552899|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44552900|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
44552901|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44552902|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44552903|NCT01284634|Cannabidiol|cannabidiol|mesh-list
44552904|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
44552905|NCT01284621|Empagliflozin|empagliflozin|mesh-list
44552906|NCT01284621|Ramipril|ramipril|mesh-list
44552907|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44552908|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44552909|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552910|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552911|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44552912|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44552913|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44552914|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552915|NCT01283971|Adalimumab|adalimumab|mesh-list
44552916|NCT01283971|Methotrexate|methotrexate|mesh-list
44177926|NCT00308451|Chromium|chromium|mesh-list
44552917|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44552918|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
44552919|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44552920|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552921|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44552922|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
44552923|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552924|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552925|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552926|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552927|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44552928|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552929|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
44552930|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552931|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44552932|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44552933|NCT01283581|Vancomycin|vancomycin|mesh-list
44552934|NCT01283581|Linezolid|linezolid|mesh-list
44552935|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44552936|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44552937|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44552938|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552939|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552940|NCT01283542|Pasireotide|pasireotide|mesh-list
44552941|NCT01283542|Hormones|hormones|mesh-ancestor
44552942|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44552943|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552944|NCT01283516|Ceritinib|ceritinib|mesh-list
44552945|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552946|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44552947|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44552948|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552949|NCT01283464|Vitamin A|vitamin a|mesh-list
44552950|NCT01283464|Tretinoin|tretinoin|mesh-list
44552951|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552952|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
44552953|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44552954|NCT01283464|Vitamins|vitamins|mesh-ancestor
44552955|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
44552956|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552957|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
44552958|NCT01283386|Chlorambucil|chlorambucil|mesh-list
44552959|NCT01283386|Rituximab|rituximab|mesh-list
44552960|NCT01283386|Fludarabine|fludarabine|mesh-list
44552961|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552962|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
44552963|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552964|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44552965|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44552966|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
44552967|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44552968|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552969|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44552970|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552971|NCT01283334|Carboplatin|carboplatin|mesh-list
44552972|NCT01283334|Cetuximab|cetuximab|mesh-list
44552973|NCT01283334|Everolimus|everolimus|mesh-list
44552974|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44552975|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44552976|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44552977|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
44552978|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552979|NCT01283282|Clopidogrel|clopidogrel|mesh-list
44552980|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44552992|NCT01283139|Sifalimumab|sifalimumab|mesh-list
44552993|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44552994|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
44552995|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44552996|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
44552997|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44552998|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44552999|NCT01283009|Prednisolone|prednisolone|mesh-list
44553000|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
44553001|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44553002|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
44553003|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553004|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
44553005|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
44553006|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553007|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553008|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553009|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
44553010|NCT01283009|Hormones|hormones|mesh-ancestor
44553011|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553012|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44553013|NCT01283009|Protective Agents|protective agents|mesh-ancestor
44553014|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44553015|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553016|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44553017|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44553018|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44553019|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553020|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553021|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553022|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178002|NCT00308607|Bevacizumab|bevacizumab|mesh-list
44553023|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44553024|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
44553025|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553026|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44553027|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44553028|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44553029|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553030|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553031|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553032|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553033|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44553035|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553036|NCT01282476|Rituximab|rituximab|mesh-list
44553037|NCT01282476|Panobinostat|panobinostat|mesh-list
44553038|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553039|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553040|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
44553041|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553042|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553043|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44553044|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553045|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553046|NCT01282463|Docetaxel|docetaxel|mesh-list
44553047|NCT01282463|Ramucirumab|ramucirumab|mesh-list
44553048|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553049|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
44553050|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
44553051|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
44553052|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553053|NCT01282424|Idelalisib|idelalisib|mesh-list
44553054|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553055|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553056|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553057|NCT01282216|Vaccines|vaccines|mesh-list
44553058|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44553059|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
44553060|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553061|NCT01282164|Insulin|insulin|mesh-list
44553062|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44553063|NCT01282164|Glucagon|glucagon|mesh-list
44553064|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44553065|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553066|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553067|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553068|NCT01282164|Hormones|hormones|mesh-ancestor
44553069|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553070|NCT01282164|Incretins|incretins|mesh-ancestor
44553071|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
44553072|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44553073|NCT01281969|Antibodies|antibodies|mesh-list
44553074|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
44553075|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44553076|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
44553077|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553078|NCT01281956|Naluzotan|naluzotan|mesh-list
44553079|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44553080|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44553081|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
44553082|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553083|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553084|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553085|NCT01281917|Sirolimus|sirolimus|mesh-list
44553086|NCT01281917|Bortezomib|bortezomib|mesh-list
44553087|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553088|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44553089|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553090|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44553091|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
44553092|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553093|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
44553094|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553095|NCT01281865|Everolimus|everolimus|mesh-list
44553096|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
44553097|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553098|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553099|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
44553100|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553101|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553102|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553103|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553104|NCT01281839|Ribavirin|ribavirin|mesh-list
44553105|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44553106|NCT01281839|Simeprevir|simeprevir|mesh-list
44553107|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
44553108|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553109|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
44553110|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553111|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553112|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553113|NCT01281813|Ritonavir|ritonavir|mesh-list
44553114|NCT01281813|Darunavir|darunavir|mesh-list
44553115|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44553116|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44553117|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553118|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553119|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553120|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553121|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44553122|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
44553123|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553124|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44553125|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44553126|NCT01281306|Valsartan|valsartan|mesh-list
44553127|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44553128|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44553129|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44553130|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44553131|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553132|NCT01281202|Vigabatrin|vigabatrin|mesh-list
44553133|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
44553134|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553135|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553136|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
44553137|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553138|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553139|NCT01281189|Pramipexole|pramipexole|mesh-list
44553140|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
44553141|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553142|NCT01281189|Protective Agents|protective agents|mesh-ancestor
44553143|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553144|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44553145|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44553146|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
44553147|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
44553148|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553149|NCT01281124|Azacitidine|azacitidine|mesh-list
44553150|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44553151|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
44553152|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553153|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553154|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553155|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
44553156|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44553157|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44553158|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553160|NCT01280981|Coagulants|coagulants|mesh-ancestor
44553161|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44553162|NCT01280968|Vaccines|vaccines|mesh-list
44553163|NCT01280968|Nicotine|nicotine|mesh-list
44553164|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
44553165|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553166|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44553167|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
44553168|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553169|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44553170|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44553171|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
44553172|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553173|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553174|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44553175|NCT01280968|Antacids|antacids|mesh-ancestor
44553176|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553177|NCT01280955|Plerixafor|plerixafor|mesh-list
44553178|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553179|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44553180|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
44553181|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553182|NCT01280721|Tolvaptan|tolvaptan|mesh-list
44553183|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44553184|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553185|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
44553186|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553187|NCT01280656|Interferons|interferons|mesh-list
44553188|NCT01280656|Ribavirin|ribavirin|mesh-list
44553189|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44553190|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44553191|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553192|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
44553193|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553194|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
44553195|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553196|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
44553197|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44553198|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
44553199|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553200|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553201|NCT01280591|Naproxen|naproxen|mesh-list
44553202|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44553203|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553204|NCT01280591|Analgesics|analgesics|mesh-ancestor
44553205|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
44553206|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553207|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553208|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553209|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553210|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
44178218|NCT00309491|Tamoxifen|tamoxifen|mesh-list
44553211|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44553212|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553213|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553214|NCT01280266|Amlodipine|amlodipine|mesh-list
44553215|NCT01280266|Udenafil|udenafil|mesh-list
44553216|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44553217|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44553218|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553219|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553220|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553221|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553222|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
44553223|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44553224|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44553225|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553226|NCT01279850|Pregabalin|pregabalin|mesh-list
44553227|NCT01279850|Analgesics|analgesics|mesh-ancestor
44553228|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
44553229|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553230|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553231|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
44553232|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44553233|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553234|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553235|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553236|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44553237|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44553238|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553239|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553240|NCT01279447|Bupivacaine|bupivacaine|mesh-list
44553241|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
44553242|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
44553243|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553244|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553245|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
44553246|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553247|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44553248|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
44553249|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553250|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
44553251|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44553252|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
44553253|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553254|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553255|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44553256|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
44553257|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
44553258|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44553259|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
44553260|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553261|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553263|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553264|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553265|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44553266|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
44553267|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553268|NCT01276639|Tofacitinib|tofacitinib|mesh-list
44553269|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553270|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553271|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553272|NCT01275625|Maraviroc|maraviroc|mesh-list
44553273|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44553274|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44553275|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553276|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553277|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44553278|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
44553279|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553280|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44553281|NCT01274637|Dalteparin|dalteparin|mesh-list
44553282|NCT01274637|Tinzaparin|tinzaparin|mesh-list
44553283|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44553284|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
44553285|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44553286|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44553287|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553288|NCT01274338|Interferons|interferons|mesh-list
44553289|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
44553290|NCT01274338|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44553291|NCT01274338|Ipilimumab|ipilimumab|mesh-list
44553292|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553293|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
44553294|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553295|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553296|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44553297|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553298|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
44553299|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553300|NCT01273818|Gentamicins|gentamicins|mesh-list
44553301|NCT01273818|Cefazolin|cefazolin|mesh-list
44553302|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44553303|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553304|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44553305|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553306|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553307|NCT01273155|Belinostat|belinostat|mesh-list
44553308|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553309|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44553310|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553311|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553312|NCT01272193|Insulin|insulin|mesh-list
44553313|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44553314|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
44553315|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
44553316|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553317|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553318|NCT01271933|Pregabalin|pregabalin|mesh-list
44553319|NCT01271933|Analgesics|analgesics|mesh-ancestor
44553320|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
44553321|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553322|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553323|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
44553324|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44553325|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553326|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553327|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553328|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44553329|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44553330|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378491|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44553331|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553332|NCT01270828|Pregabalin|pregabalin|mesh-list
44553333|NCT01270828|Analgesics|analgesics|mesh-ancestor
44553334|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
44553335|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553336|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553337|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
44553338|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44553339|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553340|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553341|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553342|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44553343|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44553344|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553345|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553346|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
44553347|NCT01269918|Remifentanil|remifentanil|mesh-list
44553348|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44553349|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553350|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553351|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553352|NCT01269918|Analgesics|analgesics|mesh-ancestor
44553353|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
44553354|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553355|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44553356|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44553357|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44553358|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
44553359|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553360|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553361|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44553362|NCT01269918|Narcotics|narcotics|mesh-ancestor
44553363|NCT01269385|Rituximab|rituximab|mesh-list
44553364|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44553365|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
44553366|NCT01269385|Antibodies|antibodies|mesh-list
44553367|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
44553368|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44553369|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
44553370|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553371|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553372|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553373|NCT01269125|Leuprolide|leuprolide|mesh-list
44553374|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44553375|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
44553376|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44553377|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553378|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44553379|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553381|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44553382|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553383|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553384|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44553385|NCT01268891|Protective Agents|protective agents|mesh-ancestor
44553386|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553387|NCT01268683|Glyburide|glyburide|mesh-list
44553388|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553389|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553390|NCT01268293|Lenvatinib|lenvatinib|mesh-list
44553391|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553392|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553393|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553394|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553395|NCT01268059|Paclitaxel|paclitaxel|mesh-list
44553396|NCT01268059|Carboplatin|carboplatin|mesh-list
44553397|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44553398|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553399|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44553400|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44553401|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44553402|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553403|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44553404|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44378566|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44553414|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44553415|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44553417|NCT01267825|Bupivacaine|bupivacaine|mesh-list
44553418|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
44553419|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
44378641|NCT04117607|Rezafungin|rezafungin|mesh-list
44553420|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553421|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553422|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
44553423|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553424|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
44553425|NCT01267266|Saracatinib|saracatinib|mesh-list
44553426|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553427|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553428|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553429|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553430|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
44553431|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44553432|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44553433|NCT01267201|Prednisolone|prednisolone|mesh-list
44553434|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
44553435|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44553436|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
44553437|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553438|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
44553439|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
44553440|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553441|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553442|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553443|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
44553444|NCT01267201|Hormones|hormones|mesh-ancestor
44553445|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553446|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44553447|NCT01267201|Protective Agents|protective agents|mesh-ancestor
44553448|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44553449|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553450|NCT01267175|Insulin|insulin|mesh-list
44553451|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553452|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553453|NCT01266967|Dabrafenib|dabrafenib|mesh-list
44553454|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553455|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553456|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553457|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553458|NCT01266902|Rilpivirine|rilpivirine|mesh-list
44553459|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43958118|NCT01363843|Leucovorin|leucovorin|mesh-list
44553460|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44553461|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553462|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553463|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
44553464|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553465|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553466|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44378664|NCT04109222|Vaccines|vaccines|mesh-list
44553468|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44553469|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44553470|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
44553471|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
44553472|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553473|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553474|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
44553475|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553476|NCT01266603|Aldesleukin|aldesleukin|mesh-list
44553477|NCT01266603|Interleukin-2|interleukin-2|mesh-list
44553478|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553479|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553480|NCT01266603|Analgesics|analgesics|mesh-ancestor
44553481|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
44553482|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553483|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553484|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553485|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44553486|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
44553487|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553489|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44553490|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44553491|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553492|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553493|NCT01266590|Protective Agents|protective agents|mesh-ancestor
44553494|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553495|NCT01266460|Vaccines|vaccines|mesh-list
44553496|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
44553497|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553498|NCT01266317|Rituximab|rituximab|mesh-list
44553499|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553500|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553501|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
44553502|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553503|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553504|NCT01266291|Vigabatrin|vigabatrin|mesh-list
44553505|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
44553506|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553507|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553508|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
44553509|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553510|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553511|NCT01266265|Treprostinil|treprostinil|mesh-list
44553512|NCT01266265|Bosentan|bosentan|mesh-list
44553513|NCT01266265|Ambrisentan|ambrisentan|mesh-list
44553514|NCT01266265|Epoprostenol|epoprostenol|mesh-list
44553515|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
44553516|NCT01266265|Tadalafil|tadalafil|mesh-list
44553517|NCT01266265|Iloprost|iloprost|mesh-list
44553518|NCT01266265|Tezosentan|tezosentan|mesh-list
44553519|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44553520|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
44553521|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44553522|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553523|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553524|NCT01266265|Urological Agents|urological agents|mesh-ancestor
44553525|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44553526|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44553527|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44553528|NCT01266161|Ibuprofen|ibuprofen|mesh-list
44553529|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44553530|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553531|NCT01266161|Analgesics|analgesics|mesh-ancestor
44553532|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
44553533|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553534|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553535|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553536|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553537|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44553538|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553539|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553540|NCT01266148|Cyclosporine|cyclosporine|mesh-list
44553541|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
44553542|NCT01266148|Everolimus|everolimus|mesh-list
44553543|NCT01266148|Cyclosporins|cyclosporins|mesh-list
44553544|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44553545|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553546|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553547|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553548|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
44553549|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553550|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
44553551|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553552|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
44553553|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553554|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44553555|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553556|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44553557|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44553558|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
44553559|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44553560|NCT01265953|Sulforaphane|sulforaphane|mesh-list
44553561|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44553562|NCT01265953|Protective Agents|protective agents|mesh-ancestor
44553563|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553564|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553565|NCT01265875|Secretin|secretin|mesh-list
44553566|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553567|NCT01265875|Hormones|hormones|mesh-ancestor
44553568|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553569|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553570|NCT01265849|Indomethacin|indomethacin|mesh-list
44553571|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
44553572|NCT01265849|Cisplatin|cisplatin|mesh-list
44553573|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553574|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
44553575|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553576|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553577|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44553578|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
44553579|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553580|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553581|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44553582|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44553583|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553584|NCT01265849|Analgesics|analgesics|mesh-ancestor
44553585|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
44553586|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553587|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553588|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
44553589|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
44553590|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44553591|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44553592|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553593|NCT01265823|Adalimumab|adalimumab|mesh-list
44553594|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553595|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553596|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
44553597|NCT01265615|Vitamin D|vitamin d|mesh-list
44553598|NCT01265615|Calcitriol|calcitriol|mesh-list
44553599|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553600|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553601|NCT01265615|Vitamins|vitamins|mesh-ancestor
44553602|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
44235399|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553603|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44553604|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44553605|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553606|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553607|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44553609|NCT01265563|Silybin|silybin|mesh-list
44553610|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44553611|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
44553612|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553613|NCT01265563|Expectorants|expectorants|mesh-ancestor
44553614|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
44553615|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44553616|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
44553617|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553618|NCT01265563|Protective Agents|protective agents|mesh-ancestor
44553619|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553635|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
44553636|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553637|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553638|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44553639|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44553640|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553641|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44553642|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44553643|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
44553644|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553645|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44553646|NCT01265498|Cathartics|cathartics|mesh-ancestor
44553647|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553648|NCT01265394|Flutemetamol|flutemetamol|mesh-list
44553649|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44553650|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553651|NCT01265056|Gabapentin|gabapentin|mesh-list
44553652|NCT01265056|Analgesics|analgesics|mesh-ancestor
44553653|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
44553654|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553655|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553656|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
44553657|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44553658|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44553659|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553660|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553661|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44553662|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44553663|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553664|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553665|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
44553666|NCT01264965|Acetaminophen|acetaminophen|mesh-list
44378874|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
44553667|NCT01264965|Oxycodone|oxycodone|mesh-list
44553668|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44553669|NCT01264965|Analgesics|analgesics|mesh-ancestor
44553670|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
44553671|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553672|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553673|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
44553674|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44553675|NCT01264965|Narcotics|narcotics|mesh-ancestor
44553676|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553677|NCT01264939|Omalizumab|omalizumab|mesh-list
44553678|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
44553679|NCT01264939|Promethazine|promethazine|mesh-list
44553680|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44553681|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44553682|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
44553683|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44553684|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44553685|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
44553686|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44553687|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44553688|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553689|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553690|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
44553691|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
43958337|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
44553692|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
44553693|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553694|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
44553695|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
44553696|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44553697|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
44553698|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553699|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553700|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
44553701|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
44553702|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
44553703|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553704|NCT01264887|Tapentadol|tapentadol|mesh-list
44553705|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44553706|NCT01264887|Narcotics|narcotics|mesh-ancestor
44553707|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553708|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553709|NCT01264887|Analgesics|analgesics|mesh-ancestor
44553710|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
44553711|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553712|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44553713|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44553714|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553715|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553716|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
44553717|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553718|NCT01264770|Adalimumab|adalimumab|mesh-list
44553719|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44553720|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553721|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44553722|NCT01264679|Hematinics|hematinics|mesh-ancestor
44553723|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44553724|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44553725|NCT01264081|Lapatinib|lapatinib|mesh-list
44553726|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553727|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553728|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553729|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553730|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
44553731|NCT01263925|Alprostadil|alprostadil|mesh-list
44553732|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44553733|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553734|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553735|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44553736|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44553737|NCT01263925|Protective Agents|protective agents|mesh-ancestor
44553738|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553739|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
44553740|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44553741|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
44553742|NCT01263925|Urological Agents|urological agents|mesh-ancestor
44553743|NCT01263782|Bevacizumab|bevacizumab|mesh-list
44553744|NCT01263782|Carboplatin|carboplatin|mesh-list
44553745|NCT01263782|Pemetrexed|pemetrexed|mesh-list
44553746|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553747|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553748|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44553749|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44553750|NCT01263782|Growth Substances|growth substances|mesh-ancestor
44553751|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553752|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
44553753|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553754|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553755|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44553756|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44553757|NCT01263769|Axitinib|axitinib|mesh-list
44553758|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553759|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44553760|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553761|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553762|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
44553763|NCT01263704|Rituximab|rituximab|mesh-list
44553764|NCT01263704|Fludarabine|fludarabine|mesh-list
44553765|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44553766|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
44553767|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553768|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44553769|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44553770|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
44553771|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553772|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553773|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44553774|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553775|NCT01263691|Vaccines|vaccines|mesh-list
44553776|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
44553777|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553778|NCT01263509|Inositol|inositol|mesh-list
44553779|NCT01263509|Alogliptin|alogliptin|mesh-list
44553780|NCT01263509|Voglibose|voglibose|mesh-list
44553781|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553782|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553783|NCT01263509|Incretins|incretins|mesh-ancestor
44553784|NCT01263509|Hormones|hormones|mesh-ancestor
44553785|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553786|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44553787|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553788|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553789|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553790|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44553791|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
44553792|NCT01263509|Vitamins|vitamins|mesh-ancestor
44553793|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
44553794|NCT01263496|Alogliptin|alogliptin|mesh-list
44553795|NCT01263496|Voglibose|voglibose|mesh-list
44553796|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553797|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553798|NCT01263496|Incretins|incretins|mesh-ancestor
44553799|NCT01263496|Hormones|hormones|mesh-ancestor
44553800|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553801|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44553802|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553803|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553804|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553805|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44553806|NCT01263483|Inositol|inositol|mesh-list
44553807|NCT01263483|Alogliptin|alogliptin|mesh-list
44553808|NCT01263483|Voglibose|voglibose|mesh-list
44553809|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553810|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553811|NCT01263483|Incretins|incretins|mesh-ancestor
44553812|NCT01263483|Hormones|hormones|mesh-ancestor
44553813|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553814|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44553815|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553816|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553817|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553818|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44553819|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
44553820|NCT01263483|Vitamins|vitamins|mesh-ancestor
44553821|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
44553822|NCT01263470|Alogliptin|alogliptin|mesh-list
44553823|NCT01263470|Voglibose|voglibose|mesh-list
44553824|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553825|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553826|NCT01263470|Incretins|incretins|mesh-ancestor
44553827|NCT01263470|Hormones|hormones|mesh-ancestor
44553828|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553829|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44553830|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44553831|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553832|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553833|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44553834|NCT01263444|Timolol|timolol|mesh-list
44553835|NCT01263444|Bimatoprost|bimatoprost|mesh-list
44553836|NCT01263444|Travoprost|travoprost|mesh-list
44553837|NCT01263444|Latanoprost|latanoprost|mesh-list
44553838|NCT01263444|Brinzolamide|brinzolamide|mesh-list
44553839|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44553840|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44553841|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
44553842|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768074|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
44553843|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553844|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553845|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44553846|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44553847|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44553848|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44553849|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44553850|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553851|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
44553852|NCT01263197|Propranolol|propranolol|mesh-list
44553853|NCT01263197|Albuterol|albuterol|mesh-list
44553854|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44553855|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44553856|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
44553857|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553858|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553859|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553860|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44553861|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44553862|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
44553863|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44553864|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
44553865|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553866|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44553867|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
44553868|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
44553869|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44553870|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44553871|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44553872|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44553873|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44553874|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553875|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
44553876|NCT01263119|Warfarin|warfarin|mesh-list
44553877|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
44553878|NCT01263106|Theophylline|theophylline|mesh-list
44553879|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44553880|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
44553881|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553882|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553883|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44553884|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44553885|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44553886|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553887|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553888|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
44553889|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44553890|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44553891|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
44553892|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553893|NCT01263093|Clopidogrel|clopidogrel|mesh-list
44553894|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44553912|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44553914|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44553915|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44553916|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178860|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
44553917|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553918|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
44553919|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44553920|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44553921|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44553922|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44553923|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44553924|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
44553925|NCT01262872|Vaccines|vaccines|mesh-list
44553926|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44553927|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
44553928|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553929|NCT01262677|Pregabalin|pregabalin|mesh-list
44553930|NCT01262677|Analgesics|analgesics|mesh-ancestor
44553931|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
44553932|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553933|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553934|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
44553935|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44553936|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553937|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553938|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44553939|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44553940|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44553941|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553942|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44553943|NCT01262651|Nabiximols|nabiximols|mesh-list
44553944|NCT01262651|Analgesics|analgesics|mesh-ancestor
44553945|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
44553946|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553947|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553948|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44553949|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44553950|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
44553951|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553952|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44553953|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553954|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44553955|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553956|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44553957|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
44553958|NCT01262456|Coagulants|coagulants|mesh-ancestor
44553959|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44553960|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
44553961|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553962|NCT01262365|Epratuzumab|epratuzumab|mesh-list
44553963|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553964|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553965|NCT01262352|Ivacaftor|ivacaftor|mesh-list
44553966|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44553967|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553968|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553969|NCT01262287|Dutasteride|dutasteride|mesh-list
44553970|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44553971|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44553972|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44553973|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553974|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178907|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
44553975|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44553976|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553977|NCT01262092|Buprenorphine|buprenorphine|mesh-list
44553978|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44553979|NCT01262092|Narcotics|narcotics|mesh-ancestor
44553980|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44553981|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553982|NCT01262092|Analgesics|analgesics|mesh-ancestor
44553983|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
44553984|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44553985|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44553986|NCT01261793|Epratuzumab|epratuzumab|mesh-list
44553987|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44553988|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44553989|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
44553990|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44553991|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44553992|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44553993|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44553994|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44553995|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44553996|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44553997|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44553998|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44553999|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554000|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
44554001|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44554002|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44554003|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
44554004|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554005|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44554006|NCT01261325|Brivaracetam|brivaracetam|mesh-list
44554007|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
44554009|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44554010|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554011|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554012|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554013|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554014|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554015|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
44554016|NCT01260922|Donepezil|donepezil|mesh-list
44554017|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44554018|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554019|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554020|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554021|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554022|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554023|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
44554024|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44554025|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44554026|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44554027|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44554028|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554029|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554030|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554031|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44554032|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
44554033|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44554034|NCT01260584|Clopidogrel|clopidogrel|mesh-list
44554035|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44554036|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44554037|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44554038|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44554039|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44554040|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
44554041|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554042|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554043|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554044|NCT01260467|Memantine|memantine|mesh-list
44554045|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44554046|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44554047|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
44554048|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554049|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554050|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554051|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44554052|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44554053|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
44554054|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
44554055|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554056|NCT01260311|Fesoterodine|fesoterodine|mesh-list
44554057|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44554058|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44554059|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554060|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554061|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554062|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554063|NCT01260311|Urological Agents|urological agents|mesh-ancestor
44178993|NCT00311987|Hormones|hormones|mesh-ancestor
44554064|NCT01260194|Trastuzumab|trastuzumab|mesh-list
44554065|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554066|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554067|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44554068|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554069|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554070|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554071|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554072|NCT01260142|Propofol|propofol|mesh-list
44554073|NCT01260142|Fospropofol|fospropofol|mesh-list
44554074|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44554075|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554076|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554077|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44554078|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
44554079|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
44554080|NCT01259856|Aspirin|aspirin|mesh-list
44554081|NCT01259856|Interferons|interferons|mesh-list
44554082|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
44554083|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
44554084|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44554085|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
44554086|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554087|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
44554088|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554089|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44554090|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44554091|NCT01259856|Analgesics|analgesics|mesh-ancestor
44554092|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
44554093|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554094|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554095|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554096|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554097|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44554098|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44554099|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554100|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44554101|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44554102|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554103|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
44554104|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
44554105|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
44554106|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44379322|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
44554108|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44554109|NCT01259713|Amebicides|amebicides|mesh-ancestor
44554110|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44554111|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44554112|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554113|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44554114|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
44554115|NCT01259492|Methylphenidate|methylphenidate|mesh-list
44554116|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44554117|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554118|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44554119|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44554120|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44554121|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554122|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
44554123|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554124|NCT01259466|Nicotine|nicotine|mesh-list
44554125|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44554126|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
44554127|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554128|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554129|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44554130|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44554131|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554132|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554133|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554134|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
44554135|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
44554136|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44554137|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554138|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554139|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
44554140|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44554141|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554142|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554143|NCT01259375|Amrubicin|amrubicin|mesh-list
44554144|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554145|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
44554146|NCT05582590|Fludarabine|fludarabine|mesh-list
44554147|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554148|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
44554149|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554150|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554151|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44554152|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
44554153|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554154|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554155|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44554156|NCT05576415|Varenicline|varenicline|mesh-list
44554157|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44554158|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44554159|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554160|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554161|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554162|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554163|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44554164|NCT05558449|Midazolam|midazolam|mesh-list
44554165|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44554166|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44554167|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554168|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554169|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44554170|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44554171|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44554172|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44554173|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
44554174|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
44554175|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
44554176|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
44554177|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554178|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554179|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
44554180|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554181|NCT05552859|Insulin|insulin|mesh-list
44554191|NCT05525910|Ritonavir|ritonavir|mesh-list
44554192|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44554193|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44554194|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44554195|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554196|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554197|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44554198|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44554199|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
44554200|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554201|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44554202|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44554203|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44554204|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554205|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554206|NCT05512910|Minocycline|minocycline|mesh-list
44554207|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44554208|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554209|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44554210|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554211|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554212|NCT05458024|Vitamin D|vitamin d|mesh-list
44554213|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
44554214|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
44554215|NCT05458024|Vitamins|vitamins|mesh-list
44554216|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
44554217|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554218|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44554219|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44554220|NCT05399329|Palbociclib|palbociclib|mesh-list
44554221|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554222|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554223|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554224|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554225|NCT05383742|Rifampin|rifampin|mesh-list
44554226|NCT05383742|Isoniazid|isoniazid|mesh-list
44554227|NCT05383742|Linezolid|linezolid|mesh-list
44554228|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
44554229|NCT05383742|Ethambutol|ethambutol|mesh-list
44554230|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44554231|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
44554232|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44554233|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554234|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
44554235|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44554236|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554237|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554238|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44554239|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44554240|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44554241|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44554242|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44554243|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44554244|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44554245|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44554246|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
44554247|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44379468|NCT03952143|Insulin|insulin|mesh-list
44554248|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44554250|NCT05340465|Dextrans|dextrans|mesh-list
44554251|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
44554252|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44554253|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
44554254|NCT05340465|Trace Elements|trace elements|mesh-ancestor
44554255|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
44554256|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554257|NCT05340465|Hematinics|hematinics|mesh-ancestor
44554258|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44554259|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44554260|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
44554261|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
44554262|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
44554263|NCT05312866|Acetaminophen|acetaminophen|mesh-list
44554264|NCT05312866|Dexamethasone|dexamethasone|mesh-list
44554265|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
44554266|NCT05312866|Fentanyl|fentanyl|mesh-list
44554267|NCT05312866|Bupivacaine|bupivacaine|mesh-list
44554268|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554269|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
44554270|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
44554271|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554272|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554273|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44554274|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
44554275|NCT05312866|Hormones|hormones|mesh-ancestor
44554276|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554277|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554278|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554279|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
44554280|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
44554281|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554282|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
44554283|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44554284|NCT05312866|Narcotics|narcotics|mesh-ancestor
44554285|NCT05312866|Analgesics|analgesics|mesh-ancestor
44554286|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44554287|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44554288|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
44554289|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44554290|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
44554291|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44554292|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
44554293|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44554294|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44554295|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554296|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44554297|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
44554298|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44554299|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
44554300|NCT05286528|Dasatinib|dasatinib|mesh-list
44554301|NCT05286528|Ponatinib|ponatinib|mesh-list
44554302|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554303|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554304|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554305|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554306|NCT05262400|Letrozole|letrozole|mesh-list
44554307|NCT05262400|Fulvestrant|fulvestrant|mesh-list
44554308|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554309|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44554310|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44554311|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554312|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554313|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44554314|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
43958929|NCT01390818|Niacinamide|niacinamide|mesh-list
44554315|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554317|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554318|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44554319|NCT05241275|Xenon|xenon|mesh-list
44554320|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44554321|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
44554322|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
44554323|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554324|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554325|NCT05226871|Cetuximab|cetuximab|mesh-list
44554326|NCT05226871|Letrozole|letrozole|mesh-list
44554327|NCT05226871|Fulvestrant|fulvestrant|mesh-list
44554328|NCT05226871|Palbociclib|palbociclib|mesh-list
44554329|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554330|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554331|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44554332|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44554333|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554334|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554335|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44554336|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554337|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554338|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554339|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554340|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44554341|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554342|NCT05226663|Fluorides|fluorides|mesh-list
44554343|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
44554344|NCT05226663|Protective Agents|protective agents|mesh-ancestor
44554345|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554346|NCT05206266|Turmeric extract|turmeric extract|mesh-list
44554347|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
44554348|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554349|NCT05206266|Protective Agents|protective agents|mesh-ancestor
44554350|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554351|NCT05180773|Bromocriptine|bromocriptine|mesh-list
44554352|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
44554353|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44554354|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
44554355|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44554356|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
44554357|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554358|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554359|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
44554360|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44554361|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44554362|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554363|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554364|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554365|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
44554366|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
44554367|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554368|NCT05171075|Dalteparin|dalteparin|mesh-list
44554369|NCT05171075|Tinzaparin|tinzaparin|mesh-list
44554370|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44554371|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
44554372|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44554373|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44554374|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554375|NCT05171049|Apixaban|apixaban|mesh-list
44554376|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44554377|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
44554378|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44554379|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44554380|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554381|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554382|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
44554383|NCT05148962|Vaccines|vaccines|mesh-list
44554384|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
44554385|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554386|NCT05141877|Anesthetics|anesthetics|mesh-list
44554387|NCT05141877|Propofol|propofol|mesh-list
44554388|NCT05141877|Sevoflurane|sevoflurane|mesh-list
43768191|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
44554389|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554390|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554391|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44554392|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44554393|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
44554394|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44554395|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44554397|NCT05136898|Mitomycin|mitomycin|mesh-list
44554398|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44554399|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554400|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
44554401|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554402|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44554403|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554404|NCT05116774|Eculizumab|eculizumab|mesh-list
44554405|NCT05116774|Ravulizumab|ravulizumab|mesh-list
44554406|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44554407|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554408|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
44554409|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554410|NCT05101928|Prednisone|prednisone|mesh-list
44554411|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554412|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
44554413|NCT05101928|Hormones|hormones|mesh-ancestor
44554414|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554415|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554416|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554417|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554418|NCT05085002|Letrozole|letrozole|mesh-list
44554419|NCT05085002|Fulvestrant|fulvestrant|mesh-list
44554420|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554421|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44554422|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44554423|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554424|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554425|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44554426|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554427|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554428|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554429|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554430|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44554432|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44179337|NCT00313235|Vaccines|vaccines|mesh-list
44554433|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554434|NCT05014087|Digoxin|digoxin|mesh-list
44554435|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44554436|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44554437|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554438|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554439|NCT05014087|Protective Agents|protective agents|mesh-ancestor
44554440|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554441|NCT05003089|Prednisolone|prednisolone|mesh-list
44554442|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554443|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
44554444|NCT05003089|Hormones|hormones|mesh-ancestor
44554445|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554446|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554447|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554448|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554449|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
44554450|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44554451|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554452|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
44554453|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
44554454|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44554455|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554456|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554457|NCT04952402|Vaccines|vaccines|mesh-list
44554458|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
44554459|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554460|NCT04941105|Evolocumab|evolocumab|mesh-list
44554461|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44554462|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44554463|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
44554464|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554465|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44554467|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
44554468|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44554469|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
44554470|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44554471|NCT04935177|Eculizumab|eculizumab|mesh-list
44554472|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
44554473|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554474|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44554475|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554476|NCT04914741|Prednisolone|prednisolone|mesh-list
44554477|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
44554478|NCT04914741|Rituximab|rituximab|mesh-list
44554479|NCT04914741|Doxorubicin|doxorubicin|mesh-list
44554480|NCT04914741|Vincristine|vincristine|mesh-list
44554481|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554482|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
44554483|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554484|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554485|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44554486|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
44554487|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554488|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554489|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44554490|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554491|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44554492|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44554493|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554494|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554495|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554496|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
44554497|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
44554498|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
44554499|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554500|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
44554501|NCT04914741|Hormones|hormones|mesh-ancestor
44554502|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554503|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554504|NCT04904302|Nivolumab|nivolumab|mesh-list
44554505|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554506|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554507|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44554508|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554509|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
44554510|NCT04901169|Giapreza|giapreza|mesh-list
44554511|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
44554512|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44554513|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44554514|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
44554515|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554516|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554517|NCT04870112|Cisplatin|cisplatin|mesh-list
44554518|NCT04870112|Carboplatin|carboplatin|mesh-list
44554519|NCT04870112|Etoposide|etoposide|mesh-list
44554520|NCT04870112|Durvalumab|durvalumab|mesh-list
44554521|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554522|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554523|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44554524|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554525|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554526|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554527|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554528|NCT04842604|Azacitidine|azacitidine|mesh-list
44554529|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554530|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
44554531|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554532|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554533|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554534|NCT04820179|Atezolizumab|atezolizumab|mesh-list
44554535|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554536|NCT04775550|Dexamethasone|dexamethasone|mesh-list
44554537|NCT04775550|Lenalidomide|lenalidomide|mesh-list
44554538|NCT04775550|Bortezomib|bortezomib|mesh-list
44554539|NCT04775550|Daratumumab|daratumumab|mesh-list
44554540|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554541|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
44554542|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
44554543|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554544|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554545|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44554546|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
44554547|NCT04775550|Hormones|hormones|mesh-ancestor
44554548|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554549|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554550|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554551|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
44554552|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44554553|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44554554|NCT04775550|Growth Substances|growth substances|mesh-ancestor
44554555|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
44554556|NCT04752696|Leucovorin|leucovorin|mesh-list
44554557|NCT04752696|Fluorouracil|fluorouracil|mesh-list
44554558|NCT04752696|Irinotecan|irinotecan|mesh-list
44554559|NCT04752696|Onvansertib|onvansertib|mesh-list
44554560|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
44554561|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554562|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554563|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554564|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554565|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
44554566|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554567|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44554568|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554569|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554570|NCT04752696|Antidotes|antidotes|mesh-ancestor
44554571|NCT04752696|Protective Agents|protective agents|mesh-ancestor
44554572|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
44554573|NCT04752696|Vitamins|vitamins|mesh-ancestor
44554574|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
44554575|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554576|NCT04735978|Nivolumab|nivolumab|mesh-list
44554577|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554578|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554586|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554587|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554588|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554589|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554590|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44554591|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44554592|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554593|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554595|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44554596|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44554597|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44554598|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44554599|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
44554600|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554601|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554602|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554603|NCT04650893|Dexamethasone|dexamethasone|mesh-list
44554604|NCT04650893|Ketorolac|ketorolac|mesh-list
44554605|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554606|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
44554607|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
44554608|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554609|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554611|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
44554612|NCT04650893|Hormones|hormones|mesh-ancestor
44554613|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554614|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554615|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554616|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44554617|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44554618|NCT04650893|Analgesics|analgesics|mesh-ancestor
44554619|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
44554620|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554621|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44554622|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426839|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44554623|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554625|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
44554626|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554627|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554628|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554629|NCT04572815|Interleukin-12|interleukin-12|mesh-list
44554630|NCT04572815|Ustekinumab|ustekinumab|mesh-list
44554631|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
44554632|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
44554633|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
44554634|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554635|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44554636|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44554637|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44554638|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44554639|NCT04572815|Growth Substances|growth substances|mesh-ancestor
44554640|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44554641|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554642|NCT04554732|Mitogens|mitogens|mesh-list
44554643|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44554644|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554645|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44554646|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44554647|NCT04540835|Calcium|calcium|mesh-list
44554648|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44554649|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554650|NCT04515901|Lidocaine|lidocaine|mesh-list
44554651|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
44554652|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
44554653|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554654|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554655|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
44554656|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554657|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44554658|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44554659|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44554660|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44554661|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554662|NCT04514484|Nivolumab|nivolumab|mesh-list
44554663|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554664|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554665|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44554666|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554667|NCT04481256|Paclitaxel|paclitaxel|mesh-list
44554668|NCT04481256|Carboplatin|carboplatin|mesh-list
44554669|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554670|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554671|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44554672|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44554673|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44554674|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554675|NCT04479267|Prednisone|prednisone|mesh-list
44554676|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
44554677|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44554678|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44554679|NCT04479267|Prednisolone|prednisolone|mesh-list
44554680|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
44554681|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
44554682|NCT04479267|Cortisone|cortisone|mesh-list
44554683|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
44554684|NCT04479267|Rituximab|rituximab|mesh-list
44554685|NCT04479267|Doxorubicin|doxorubicin|mesh-list
44554686|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44554687|NCT04479267|Antibodies|antibodies|mesh-list
44554688|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
44554689|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44554690|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
44554691|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44554692|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
44554693|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554694|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
44554695|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554696|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554697|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44554698|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
44554699|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554700|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554701|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44554702|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554703|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44554704|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44554705|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554706|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554707|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554708|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
44554709|NCT04479267|Hormones|hormones|mesh-ancestor
44554710|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554711|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554712|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
44554713|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
44554714|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554715|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44554716|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44554717|NCT04479267|Protective Agents|protective agents|mesh-ancestor
44554718|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
44554719|NCT04439799|Testosterone|testosterone|mesh-list
44554720|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
44554721|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
44554722|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44554723|NCT04439799|Androgens|androgens|mesh-ancestor
44554724|NCT04439799|Hormones|hormones|mesh-ancestor
44554725|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554726|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554727|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554728|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554729|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
44554730|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
44554731|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44554732|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
44554733|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554734|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554735|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44554736|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
44554737|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44554738|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
44554739|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554740|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554741|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44554742|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44554743|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
44554744|NCT04397692|Protective Agents|protective agents|mesh-ancestor
44554745|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
44554746|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
44554747|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554748|NCT04357951|Cycloserine|cycloserine|mesh-list
44554749|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44554750|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554751|NCT04357951|Renal Agents|renal agents|mesh-ancestor
44554752|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44554753|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
44554754|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44554755|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
44554756|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554757|NCT04356430|Prednisone|prednisone|mesh-list
44554758|NCT04356430|Goserelin|goserelin|mesh-list
44554759|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
44554760|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554761|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
44554762|NCT04356430|Hormones|hormones|mesh-ancestor
44179649|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44554763|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554764|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554765|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554766|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554767|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44554768|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554769|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554770|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554771|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44554773|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554774|NCT04291664|Prednisone|prednisone|mesh-list
44554775|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
44554776|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554777|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
44554779|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554780|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554781|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554782|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554783|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44554784|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554785|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554786|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554787|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44554788|NCT04246684|Leucovorin|leucovorin|mesh-list
44554789|NCT04246684|Folic Acid|folic acid|mesh-list
44554790|NCT04246684|Capecitabine|capecitabine|mesh-list
44554791|NCT04246684|Fluorouracil|fluorouracil|mesh-list
44554792|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
44554793|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
44554794|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554795|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
44554796|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554797|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554798|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554799|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
44554800|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554801|NCT04246684|Antidotes|antidotes|mesh-ancestor
44554802|NCT04246684|Protective Agents|protective agents|mesh-ancestor
44554803|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
44554804|NCT04246684|Vitamins|vitamins|mesh-ancestor
44554805|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
44554806|NCT04246684|Hematinics|hematinics|mesh-ancestor
44554807|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
44554808|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44554809|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554810|NCT04187144|Renal Agents|renal agents|mesh-ancestor
44554811|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44554812|NCT04083118|Listerine|listerine|mesh-list
44554813|NCT04083118|Fluorides|fluorides|mesh-list
44554814|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
44554815|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
44554816|NCT04083118|Protective Agents|protective agents|mesh-ancestor
44554817|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554818|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44554819|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554820|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
44554821|NCT04070443|Ponatinib|ponatinib|mesh-list
44554822|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554823|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554824|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554825|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554826|NCT04043494|Cytarabine|cytarabine|mesh-list
44554827|NCT04043494|Dexamethasone|dexamethasone|mesh-list
44554828|NCT04043494|Prednisone|prednisone|mesh-list
44554829|NCT04043494|Prednisolone|prednisolone|mesh-list
44554830|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
44554831|NCT04043494|Ifosfamide|ifosfamide|mesh-list
44554832|NCT04043494|Doxorubicin|doxorubicin|mesh-list
44554833|NCT04043494|Methotrexate|methotrexate|mesh-list
44554834|NCT04043494|Vincristine|vincristine|mesh-list
44554835|NCT04043494|Daunorubicin|daunorubicin|mesh-list
44554836|NCT04043494|Asparaginase|asparaginase|mesh-list
44554837|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
44554838|NCT04043494|Thioguanine|thioguanine|mesh-list
44554839|NCT04043494|Pegaspargase|pegaspargase|mesh-list
44554840|NCT04043494|Vindesine|vindesine|mesh-list
44554841|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554842|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
44554843|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554844|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554845|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44554846|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
44554847|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554848|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380167|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44554849|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44554850|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44554851|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
44554852|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
44554853|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44554854|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44554876|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44554877|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44554878|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44554879|NCT04021017|Estradiol|estradiol|mesh-list
44554880|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44554881|NCT04021017|Estrogens|estrogens|mesh-ancestor
44554882|NCT04021017|Hormones|hormones|mesh-ancestor
44554883|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554884|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554885|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44554886|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
44554887|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44554888|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44554889|NCT04006457|Vaccines|vaccines|mesh-list
44554890|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
44554891|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554892|NCT04005287|Pirenzepine|pirenzepine|mesh-list
44554893|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44554894|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44554895|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44554896|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44554897|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
44554898|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44554899|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554900|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554901|NCT03971110|Goserelin|goserelin|mesh-list
44554902|NCT03971110|Bicalutamide|bicalutamide|mesh-list
44554903|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44554904|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554905|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
44554906|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44554907|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44554908|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554909|NCT03918278|Gemcitabine|gemcitabine|mesh-list
44554910|NCT03918278|Paclitaxel|paclitaxel|mesh-list
44554911|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44554912|NCT03918278|Carboplatin|carboplatin|mesh-list
44554913|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
44554914|NCT03918278|Pemetrexed|pemetrexed|mesh-list
44554915|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44554916|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554917|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44554918|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44554919|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44554920|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554921|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554922|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
44554923|NCT03918278|Antiviral Agents|antiviral agents|mesh-ancestor
44554924|NCT03918278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44554925|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554926|NCT03918278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554927|NCT03918278|Immunologic Factors|immunologic factors|mesh-ancestor
44554928|NCT03918278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554929|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554930|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44179794|NCT00314912|Tramiprosate|tramiprosate|mesh-list
44554931|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44554932|NCT03916185|Vaccines|vaccines|mesh-list
44554933|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
44554934|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554935|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
44554936|NCT03898180|Lenvatinib|lenvatinib|mesh-list
44554937|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554938|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554939|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554940|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554941|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554942|NCT03817502|Cariprazine|cariprazine|mesh-list
44554943|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44554944|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44554945|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554946|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554947|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44554948|NCT03764553|Leucovorin|leucovorin|mesh-list
44554950|NCT03764553|Fluorouracil|fluorouracil|mesh-list
44554951|NCT03764553|Capecitabine|capecitabine|mesh-list
44554952|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
44554953|NCT03764553|Irinotecan|irinotecan|mesh-list
44554954|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554955|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
44554956|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554957|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44554958|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554959|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
44554960|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554961|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44554962|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554963|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554964|NCT03764553|Antidotes|antidotes|mesh-ancestor
44554965|NCT03764553|Protective Agents|protective agents|mesh-ancestor
44554966|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
44554967|NCT03764553|Vitamins|vitamins|mesh-ancestor
44554968|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
44554969|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
44554970|NCT03709680|Temozolomide|temozolomide|mesh-list
44554971|NCT03709680|Irinotecan|irinotecan|mesh-list
44554972|NCT03709680|Topotecan|topotecan|mesh-list
44554973|NCT03709680|Palbociclib|palbociclib|mesh-list
44554974|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44554975|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
44554976|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554977|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44554978|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44554979|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
44554980|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44554981|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554982|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44554983|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44554984|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44554985|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44554986|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44554987|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
44554988|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44554989|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44554991|NCT03556696|Propofol|propofol|mesh-list
44554992|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44554993|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44554994|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44554995|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44554996|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
44554997|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
44554998|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44554999|NCT03556696|Narcotics|narcotics|mesh-ancestor
44555000|NCT03556696|Analgesics|analgesics|mesh-ancestor
44555001|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
44555002|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555003|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44555004|NCT03497676|Rilpivirine|rilpivirine|mesh-list
44555005|NCT03497676|Cabotegravir|cabotegravir|mesh-list
44555006|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
44555007|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555008|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44555009|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44555010|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555011|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555012|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44555013|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44555014|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44555015|NCT03482479|Naltrexone|naltrexone|mesh-list
44555016|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44555017|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44555018|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555019|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
44555020|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555021|NCT03455764|Trametinib|trametinib|mesh-list
44555022|NCT03455764|Dabrafenib|dabrafenib|mesh-list
44555023|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555024|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555025|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555026|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555027|NCT03434418|Osimertinib|osimertinib|mesh-list
44555028|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555029|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555030|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555031|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555032|NCT03433183|Sirolimus|sirolimus|mesh-list
44555033|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555034|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555035|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44555036|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555037|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
44555038|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555039|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
44555040|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555041|NCT03391882|Apomorphine|apomorphine|mesh-list
44555042|NCT03391882|Emetics|emetics|mesh-ancestor
44555043|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555044|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
44555045|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179874|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555046|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555047|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
44555048|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
44555049|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555050|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555051|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
44555052|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44555053|NCT03377478|Velpatasvir|velpatasvir|mesh-list
44555054|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
44555055|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555056|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44555057|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555058|NCT03221751|Prazosin|prazosin|mesh-list
44555059|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555060|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44555061|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44555062|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44555063|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44555064|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555065|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555066|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555068|NCT03219177|Narcotics|narcotics|mesh-ancestor
44555069|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555070|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555071|NCT03219177|Analgesics|analgesics|mesh-ancestor
44555072|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
44555073|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555074|NCT03192215|Aspirin|aspirin|mesh-list
44555075|NCT03192215|Apixaban|apixaban|mesh-list
44555076|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44555077|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555078|NCT03192215|Analgesics|analgesics|mesh-ancestor
44555079|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
44555080|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555081|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555082|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44555083|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555084|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44555085|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44555086|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555087|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44555088|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44555089|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555090|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
44555091|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44555092|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
44555093|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44555094|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44555095|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
44555096|NCT03181932|Vancomycin|vancomycin|mesh-list
44555097|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555098|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555099|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
44555100|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44555101|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555102|NCT03048825|Colchicine|colchicine|mesh-list
44555103|NCT03048825|Spironolactone|spironolactone|mesh-list
44555104|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
44555105|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555106|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555107|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555108|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555109|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555110|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555111|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44555112|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555113|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555114|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555115|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44555117|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555118|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555119|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
44555120|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555121|NCT02866071|Ketamine|ketamine|mesh-list
44555122|NCT02866071|Analgesics|analgesics|mesh-ancestor
44555123|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
44555124|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555125|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555126|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44555127|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44555128|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
44555129|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
44555130|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555131|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44555132|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44555133|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555134|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555135|NCT02797470|Cytarabine|cytarabine|mesh-list
44555136|NCT02797470|Etoposide|etoposide|mesh-list
44555137|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
44555138|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
44555139|NCT02797470|Melphalan|melphalan|mesh-list
44555140|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
44555141|NCT02797470|Carmustine|carmustine|mesh-list
44555156|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44555157|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
44555158|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44555159|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
44555160|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
44555161|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555162|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555163|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555164|NCT02702180|Molgramostim|molgramostim|mesh-list
44555165|NCT02702180|Sargramostim|sargramostim|mesh-list
44555166|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555167|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
44179989|NCT00315835|Analgesics|analgesics|mesh-ancestor
44555168|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555169|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
44555170|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44555171|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
44555172|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555173|NCT02583672|Expectorants|expectorants|mesh-ancestor
44555174|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
44555175|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44555176|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
44555177|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555178|NCT02583672|Protective Agents|protective agents|mesh-ancestor
44555179|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555180|NCT02583672|Antidotes|antidotes|mesh-ancestor
44555181|NCT02465164|Oxytocin|oxytocin|mesh-list
44555182|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
44555183|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555184|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555185|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44555186|NCT02438722|Cetuximab|cetuximab|mesh-list
44555187|NCT02438722|Afatinib|afatinib|mesh-list
44555188|NCT02438722|Antibodies|antibodies|mesh-list
44555189|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
44555190|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555191|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
44555192|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555193|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555194|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555195|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555196|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555197|NCT02029001|Everolimus|everolimus|mesh-list
44555198|NCT02029001|Sorafenib|sorafenib|mesh-list
44555199|NCT02029001|Durvalumab|durvalumab|mesh-list
44555200|NCT02029001|Olaparib|olaparib|mesh-list
44555201|NCT02029001|Lapatinib|lapatinib|mesh-list
44555202|NCT02029001|Tremelimumab|tremelimumab|mesh-list
44555203|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555204|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555205|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
44555206|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555207|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555208|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555209|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555210|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44555211|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44555212|NCT01993810|Paclitaxel|paclitaxel|mesh-list
44555213|NCT01993810|Etoposide|etoposide|mesh-list
44555214|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
44555215|NCT01993810|Cisplatin|cisplatin|mesh-list
44555216|NCT01993810|Carboplatin|carboplatin|mesh-list
44555217|NCT01993810|Pemetrexed|pemetrexed|mesh-list
44555218|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44555219|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
44555220|NCT01993810|Durvalumab|durvalumab|mesh-list
44555221|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
44555222|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555223|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
44555224|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555225|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555226|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555227|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555228|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555229|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555230|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44555231|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44555232|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555233|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44555234|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44555235|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44555236|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
44555237|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555238|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
44555239|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
44555240|NCT01696734|Domperidone|domperidone|mesh-list
44555241|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
44555242|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
44555243|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555244|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555245|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555246|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44555247|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
44555248|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555249|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555250|NCT01613495|Octreotide|octreotide|mesh-list
44555251|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555252|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555253|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555254|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44555255|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44555256|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44555257|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555258|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555259|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555260|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555261|NCT01598298|Analgesics|analgesics|mesh-ancestor
44555262|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
44555263|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555264|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555265|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555266|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
44555267|NCT01366612|Vidarabine|vidarabine|mesh-list
44555268|NCT01366612|Fludarabine|fludarabine|mesh-list
44555269|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
44555270|NCT01366612|Busulfan|busulfan|mesh-list
44555271|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555272|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44555273|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
44555274|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555275|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555276|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
44555277|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555278|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
44555279|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555280|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
44555281|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44555282|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44555284|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555285|NCT01313923|Sirolimus|sirolimus|mesh-list
44555286|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555287|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555288|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44555289|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555290|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
44555291|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555292|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
44555293|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555294|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
44555295|NCT01313884|Temozolomide|temozolomide|mesh-list
44555296|NCT01313884|Doxorubicin|doxorubicin|mesh-list
44555297|NCT01313884|Irinotecan|irinotecan|mesh-list
44555298|NCT01313884|Vincristine|vincristine|mesh-list
44555299|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555300|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
44555301|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555302|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555303|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44555304|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
44555305|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555306|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555307|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44555308|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44555309|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44555310|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44555311|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555312|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44555313|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555314|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555315|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555316|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555317|NCT01063517|Paclitaxel|paclitaxel|mesh-list
44555318|NCT01063517|Olaparib|olaparib|mesh-list
44555319|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555320|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555321|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555322|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555323|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555324|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555325|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44555326|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555327|NCT00946712|Paclitaxel|paclitaxel|mesh-list
44555328|NCT00946712|Bevacizumab|bevacizumab|mesh-list
44555329|NCT00946712|Carboplatin|carboplatin|mesh-list
44555330|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44555331|NCT00946712|Cetuximab|cetuximab|mesh-list
44555332|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44555333|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
44555334|NCT00946712|Antibodies|antibodies|mesh-list
44555335|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
44555336|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555337|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
44555338|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555339|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555340|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555341|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555342|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555343|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555344|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44555345|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44555346|NCT00946712|Growth Substances|growth substances|mesh-ancestor
44555347|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555349|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
44555351|NCT00694733|Leuprolide|leuprolide|mesh-list
44555352|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
44555353|NCT00694733|Estradiol|estradiol|mesh-list
44555354|NCT00694733|Estrogens|estrogens|mesh-list
44555355|NCT00694733|Testosterone|testosterone|mesh-list
44555356|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
44555357|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
44555358|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44555359|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44555360|NCT00694733|Hormones|hormones|mesh-ancestor
44555361|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555362|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555363|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555364|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555365|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555366|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44555367|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555368|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555369|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44555370|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555371|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44555372|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
44555373|NCT00694733|Androgens|androgens|mesh-ancestor
44555374|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
44555375|NCT00691158|Pramlintide|pramlintide|mesh-list
44555376|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44555377|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44555378|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555379|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
44555380|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44555381|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44555382|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555383|NCT01259297|Amlodipine|amlodipine|mesh-list
44555384|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44555385|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555386|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44555387|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555388|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555389|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44555390|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555391|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
44555392|NCT01259297|Diuretics|diuretics|mesh-ancestor
44555393|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555394|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44555395|NCT01259284|Atorvastatin|atorvastatin|mesh-list
44555396|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44555397|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44555398|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
44555399|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555400|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44555401|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44555402|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555403|NCT01259115|Ketoconazole|ketoconazole|mesh-list
44555404|NCT01259115|Buprenorphine|buprenorphine|mesh-list
44555405|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44555406|NCT01259115|Narcotics|narcotics|mesh-ancestor
44555407|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555408|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555409|NCT01259115|Analgesics|analgesics|mesh-ancestor
44555410|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
44555411|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555412|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44555413|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
44555414|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555415|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44555416|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44555417|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555418|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555419|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44555420|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555421|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555422|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44555423|NCT01259102|Buprenorphine|buprenorphine|mesh-list
44555424|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44555425|NCT01259102|Narcotics|narcotics|mesh-ancestor
44555426|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555427|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555428|NCT01259102|Analgesics|analgesics|mesh-ancestor
44555429|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
44555430|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555431|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44555432|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44555433|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555434|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555435|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555436|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555437|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
44555438|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44555439|NCT01259024|Estrogens|estrogens|mesh-ancestor
44555440|NCT01259024|Hormones|hormones|mesh-ancestor
44555441|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555442|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555443|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555444|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555445|NCT01258738|Etanercept|etanercept|mesh-list
44555446|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44555447|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555448|NCT01258738|Analgesics|analgesics|mesh-ancestor
44555449|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
44555450|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555451|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555452|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44555453|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555454|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555455|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555456|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
44555457|NCT01258660|Folic Acid|folic acid|mesh-list
44555458|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
44555459|NCT01258660|Drospirenone|drospirenone|mesh-list
44555460|NCT01258660|Hematinics|hematinics|mesh-ancestor
44555461|NCT01258660|Vitamins|vitamins|mesh-ancestor
44555462|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
44555463|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555464|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44555465|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555466|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555467|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44555468|NCT01258660|Diuretics|diuretics|mesh-ancestor
44555469|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555470|NCT01258608|Sorafenib|sorafenib|mesh-list
44555471|NCT01258608|Mapatumumab|mapatumumab|mesh-list
44555472|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555473|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555474|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555475|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555476|NCT01258595|Vaccines|vaccines|mesh-list
44555477|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
44555478|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555479|NCT01258348|Sunitinib|sunitinib|mesh-list
44555480|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555481|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44555482|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44555483|NCT01258348|Growth Substances|growth substances|mesh-ancestor
44555484|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555485|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44555486|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555487|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555488|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555489|NCT01258101|Ribavirin|ribavirin|mesh-list
44555490|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44555491|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
44555492|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
44555493|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555494|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
44555495|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555496|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
44555497|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555498|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44555499|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44555500|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44555501|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
44555502|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555503|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44555504|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44555505|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555506|NCT01257698|Timolol|timolol|mesh-list
44555507|NCT01257698|Dorzolamide|dorzolamide|mesh-list
44555508|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44555509|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44555510|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44555511|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44555512|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555513|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555514|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555515|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44555516|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555517|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44555518|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555519|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44555520|NCT01257581|Tamoxifen|tamoxifen|mesh-list
44555521|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44555522|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555523|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555524|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555525|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555526|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555527|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44555528|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44555529|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44555530|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
44555531|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
44555532|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
44555533|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44555534|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44555535|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555536|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555537|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555538|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44555539|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
44555540|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44555541|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
44180331|NCT00317200|Paclitaxel|paclitaxel|mesh-list
44555542|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555543|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555544|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44555545|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555546|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555547|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
44555548|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44555549|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
44555550|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555551|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555552|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44555553|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
44555554|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
44555555|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44555556|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44555557|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555558|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555559|NCT01257204|Interferons|interferons|mesh-list
44555560|NCT01257204|Ribavirin|ribavirin|mesh-list
44555561|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
44555562|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
44555563|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44555564|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555565|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
44555566|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555567|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
44555568|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555569|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
43960055|NCT01431014|Hormones|hormones|mesh-ancestor
44555570|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555571|NCT01256879|Cimetidine|cimetidine|mesh-list
44555572|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44555573|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555574|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44555575|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
44555576|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
44555577|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555578|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555579|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555580|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44555581|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44555582|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555583|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44555584|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44555585|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
44555586|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555587|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44555588|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44555589|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
44555590|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555591|NCT01256658|Lumefantrine|lumefantrine|mesh-list
44555592|NCT01256658|Artemether|artemether|mesh-list
44555593|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44555594|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
44555595|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44555596|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44555597|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555598|NCT01256593|Pregabalin|pregabalin|mesh-list
44555599|NCT01256593|Analgesics|analgesics|mesh-ancestor
44180389|NCT00317408|Busulfan|busulfan|mesh-list
44555600|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
44555601|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555602|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555603|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
44555604|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44555605|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555606|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555607|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44555608|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44555609|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44555610|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555611|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555612|NCT01256567|Docetaxel|docetaxel|mesh-list
44555613|NCT01256567|Ramucirumab|ramucirumab|mesh-list
44555614|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555615|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555616|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555617|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555618|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555619|NCT01256476|Pravastatin|pravastatin|mesh-list
44555620|NCT01256476|Pitavastatin|pitavastatin|mesh-list
44555621|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44555622|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44555623|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
44555624|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555625|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44555626|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44555627|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555628|NCT01256450|Buprenorphine|buprenorphine|mesh-list
44555629|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44555630|NCT01256450|Narcotics|narcotics|mesh-ancestor
44555631|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555632|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555633|NCT01256450|Analgesics|analgesics|mesh-ancestor
44555634|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
44555635|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555636|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44555637|NCT01256411|Amlodipine|amlodipine|mesh-list
44555638|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44555639|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44555640|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555641|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44555642|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555643|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555644|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44555645|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555646|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
44555647|NCT01256411|Diuretics|diuretics|mesh-ancestor
44555648|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555649|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44555650|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44555651|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
44555652|NCT01256398|Leucovorin|leucovorin|mesh-list
44555653|NCT01256398|Folic Acid|folic acid|mesh-list
44555654|NCT01256398|Cytarabine|cytarabine|mesh-list
44555655|NCT01256398|Dexamethasone|dexamethasone|mesh-list
44555656|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
44555657|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
44555658|NCT01256398|Melphalan|melphalan|mesh-list
44555659|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
44555660|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44555661|NCT01256398|Methotrexate|methotrexate|mesh-list
44555662|NCT01256398|Fludarabine|fludarabine|mesh-list
44555663|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
44555664|NCT01256398|Etoposide|etoposide|mesh-list
44555665|NCT01256398|Vincristine|vincristine|mesh-list
44555666|NCT01256398|Daunorubicin|daunorubicin|mesh-list
44555667|NCT01256398|Dasatinib|dasatinib|mesh-list
44555668|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
44555669|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
44555670|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
44555671|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44555672|NCT01256398|Tacrolimus|tacrolimus|mesh-list
44555673|NCT01256398|Antibodies|antibodies|mesh-list
44555674|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
44555675|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555676|NCT01256398|Lenograstim|lenograstim|mesh-list
44555677|NCT01256398|BB 1101|bb 1101|mesh-list
44555678|NCT01256398|Calcium|calcium|mesh-list
44555679|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
44555680|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555681|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
44555682|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555683|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555684|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44555685|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
44555686|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555687|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555688|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44555689|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44555690|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
44555691|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
44555692|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555693|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44555694|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
44555695|NCT01256398|Hormones|hormones|mesh-ancestor
44555696|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555697|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44555698|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
44555699|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555700|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44555701|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44555702|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44555703|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
44555704|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555705|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44555706|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
44555707|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44555708|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44555709|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44555710|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44555711|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44555712|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44555713|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
44555714|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555715|NCT01256398|Antidotes|antidotes|mesh-ancestor
44555716|NCT01256398|Protective Agents|protective agents|mesh-ancestor
44555717|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
44555718|NCT01256398|Vitamins|vitamins|mesh-ancestor
44555719|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
44555720|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44555721|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44555722|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
44555723|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
44555724|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
44555725|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44555726|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555728|NCT01256385|Sirolimus|sirolimus|mesh-list
44555729|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44555730|NCT01256385|Cetuximab|cetuximab|mesh-list
44555731|NCT01256385|Antibodies|antibodies|mesh-list
44555732|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
44555733|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555734|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
44555735|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555736|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555737|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555738|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555739|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44555740|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
44555741|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555742|NCT01256294|Tacrolimus|tacrolimus|mesh-list
44555743|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555744|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
44555745|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555746|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44555747|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555748|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555749|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44555750|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
44555751|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
44555752|NCT01256190|Coagulants|coagulants|mesh-ancestor
44555753|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44555754|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555755|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555756|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44555757|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44555758|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555759|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555760|NCT01256060|Oxytocin|oxytocin|mesh-list
44555761|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
44555762|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555763|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555764|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
44555765|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
44555766|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44555767|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555768|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555769|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555770|NCT01255904|Analgesics|analgesics|mesh-ancestor
44555771|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
44555772|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555773|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44555774|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44555775|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44555776|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44555777|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555778|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555779|NCT01255787|Vortioxetine|vortioxetine|mesh-list
44555780|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555781|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555782|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44555783|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44555784|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555785|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555786|NCT01255787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44555787|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44555788|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555789|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555790|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555791|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
44180572|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555792|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44555793|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44555794|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44555795|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44555796|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
44555797|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44555798|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
44555799|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555800|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555801|NCT01255670|Metronidazole|metronidazole|mesh-list
44555802|NCT01255670|Penicillins|penicillins|mesh-list
44555803|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555804|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555805|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44555806|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44555807|NCT01255423|Diclofenac|diclofenac|mesh-list
44555808|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44555809|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555810|NCT01255423|Analgesics|analgesics|mesh-ancestor
44555811|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
44555812|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555813|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555814|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44555815|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44555816|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44555817|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555830|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555831|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44555832|NCT01255163|Incretins|incretins|mesh-ancestor
44555833|NCT01255163|Hormones|hormones|mesh-ancestor
44555834|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555835|NCT01254890|Azacitidine|azacitidine|mesh-list
44555836|NCT01254890|Sorafenib|sorafenib|mesh-list
44555837|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44555838|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
44555839|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555840|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44555841|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555842|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44555843|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44555844|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555845|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555846|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44555847|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44555848|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555849|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555850|NCT01254669|Vaccines|vaccines|mesh-list
44555851|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
44555852|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555853|NCT01254656|Efavirenz|efavirenz|mesh-list
44555854|NCT01254656|Etravirine|etravirine|mesh-list
44555855|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44555856|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44555857|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555858|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555859|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
44555860|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555861|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44555862|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44555863|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44555864|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44555865|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44555866|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44381303|NCT03712280|Rifaximin|rifaximin|mesh-list
44555867|NCT01254630|Vaccines|vaccines|mesh-list
44555868|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
44555869|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555870|NCT01254604|Timolol|timolol|mesh-list
44555871|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44555872|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44555873|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44555874|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555875|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555876|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555877|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44555878|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44555879|NCT01254344|Metronidazole|metronidazole|mesh-list
44555880|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
44555881|NCT01254344|Ertapenem|ertapenem|mesh-list
44555882|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44555883|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44555884|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44555885|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44555886|NCT01254305|Milnacipran|milnacipran|mesh-list
44555887|NCT01254305|Sertraline|sertraline|mesh-list
44555888|NCT01254305|Fluoxetine|fluoxetine|mesh-list
44555889|NCT01254305|Paroxetine|paroxetine|mesh-list
44555890|NCT01254305|Citalopram|citalopram|mesh-list
44555891|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
44555892|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555893|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555894|NCT01254305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44555895|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44555896|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44555897|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555898|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555899|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
44555900|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555901|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44555902|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44555903|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44555904|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555905|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555906|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44555907|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555908|NCT01254305|Analgesics|analgesics|mesh-ancestor
44555909|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
44555910|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
44555911|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44555912|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
44555913|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555914|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555915|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44555916|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44555917|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44555918|NCT01254227|Deferasirox|deferasirox|mesh-list
44555919|NCT01254227|Deferoxamine|deferoxamine|mesh-list
44555920|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44555921|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
44555922|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
44555923|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555924|NCT01254227|Siderophores|siderophores|mesh-ancestor
44555925|NCT01254045|Oxytocin|oxytocin|mesh-list
44555926|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
44555927|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44555928|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555929|NCT01253421|Amisulpride|amisulpride|mesh-list
44555930|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44555931|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44555932|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44555933|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555934|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555935|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44555936|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
44555937|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555938|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555939|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44555940|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
44555941|NCT01253408|Dronabinol|dronabinol|mesh-list
44555942|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
44555943|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555944|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44555945|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44555946|NCT01253408|Analgesics|analgesics|mesh-ancestor
44555947|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
44555948|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44555949|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44555950|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44555951|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44555952|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555953|NCT01253408|Hormones|hormones|mesh-ancestor
44555954|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555955|NCT01253317|Mecasermin|mecasermin|mesh-list
44555956|NCT01253317|Growth Substances|growth substances|mesh-ancestor
44555957|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555958|NCT01253304|Dulaglutide|dulaglutide|mesh-list
44555959|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44555960|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555961|NCT01253265|Ixekizumab|ixekizumab|mesh-list
44555962|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
44555963|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44555964|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
44555965|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555966|NCT01253200|Acifluorfen|acifluorfen|mesh-list
44555967|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44555968|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44555969|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
44555970|NCT01253187|Drospirenone|drospirenone|mesh-list
44555971|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44555972|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555973|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555974|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555975|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44555976|NCT01253187|Diuretics|diuretics|mesh-ancestor
44555977|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555978|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
44555979|NCT01253187|Vitamins|vitamins|mesh-ancestor
44555980|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
44555981|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
44555982|NCT01253174|Drospirenone|drospirenone|mesh-list
44555983|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44555984|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44555985|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555986|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555987|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44555988|NCT01253174|Diuretics|diuretics|mesh-ancestor
44555989|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
44555990|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
44555991|NCT01253174|Vitamins|vitamins|mesh-ancestor
44555992|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
44555993|NCT01253161|Pasireotide|pasireotide|mesh-list
44555994|NCT01253161|Hormones|hormones|mesh-ancestor
44555995|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44555996|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44555997|NCT01253135|Petrolatum|petrolatum|mesh-list
44555998|NCT01253135|Emollients|emollients|mesh-ancestor
44555999|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556000|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
44556001|NCT01252953|Anacetrapib|anacetrapib|mesh-list
44556002|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44556003|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44556004|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
44556005|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556006|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44556007|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556008|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44556009|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556010|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
44556011|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
44556012|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556013|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44556014|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556015|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556016|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556017|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44556018|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44556019|NCT01252667|Cyclosporine|cyclosporine|mesh-list
44556020|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
44556021|NCT01252667|Clofarabine|clofarabine|mesh-list
44556022|NCT01252667|Cyclosporins|cyclosporins|mesh-list
44556023|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556024|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556025|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556026|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
44556027|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556028|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
44556029|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556030|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556031|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556032|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44556033|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44556034|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556035|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44556036|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
44556037|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44556038|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556039|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
44556040|NCT01252563|Amlodipine|amlodipine|mesh-list
44556041|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556042|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44556043|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556044|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556045|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556046|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556047|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
44556048|NCT01252355|Interferons|interferons|mesh-list
44556049|NCT01252355|Interferon-beta|interferon-beta|mesh-list
44556050|NCT01252355|Teriflunomide|teriflunomide|mesh-list
44454081|NCT01670721|Leucovorin|leucovorin|mesh-list
44556051|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556052|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
44556053|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556054|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
44556055|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556056|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44556057|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556058|NCT01252355|Analgesics|analgesics|mesh-ancestor
44556059|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
44556060|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556061|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556062|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556063|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556064|NCT01252251|Everolimus|everolimus|mesh-list
44556065|NCT01252251|Pasireotide|pasireotide|mesh-list
44556066|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556067|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556068|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
44556069|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556070|NCT01252251|Hormones|hormones|mesh-ancestor
44556071|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556072|NCT01252238|Amlodipine|amlodipine|mesh-list
44556073|NCT01252238|Valsartan|valsartan|mesh-list
44556074|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556075|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44556076|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556077|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556078|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556079|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556080|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
44556081|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44556082|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44556083|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
44556084|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
44556085|NCT01252186|Desogestrel|desogestrel|mesh-list
44556086|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
44556087|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44556088|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556089|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44556090|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44556091|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44556092|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44556093|NCT01252186|Progestins|progestins|mesh-ancestor
44556094|NCT01252186|Hormones|hormones|mesh-ancestor
44556095|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556096|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44556097|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
44556098|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556099|NCT01251861|Bicalutamide|bicalutamide|mesh-list
44556100|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
44556101|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556102|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556103|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556104|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556105|NCT01251653|Gemcitabine|gemcitabine|mesh-list
44556106|NCT01251653|Docetaxel|docetaxel|mesh-list
44556107|NCT01251653|Afatinib|afatinib|mesh-list
44556108|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556109|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
44556110|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556111|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556112|NCT01251653|Antiviral Agents|antiviral agents|mesh-ancestor
44556113|NCT01251653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556114|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556115|NCT01251653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556116|NCT01251653|Immunologic Factors|immunologic factors|mesh-ancestor
44556117|NCT01251653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556118|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
44556119|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
44556120|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
44556121|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556123|NCT01251614|Methotrexate|methotrexate|mesh-list
44556124|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44556125|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
44556126|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44556127|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556128|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556129|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
44556130|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556131|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556132|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556133|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556134|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44556135|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556136|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
44556137|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556138|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556139|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556140|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
44556141|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44556142|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44556143|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44556144|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556145|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556146|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44556147|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556148|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556149|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44556150|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556151|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
44556152|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44556153|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44556154|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44556155|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556156|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556157|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
44556158|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556159|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556160|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44556161|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556162|NCT01251146|Atenolol|atenolol|mesh-list
44556163|NCT01251146|Bisoprolol|bisoprolol|mesh-list
44556164|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44556165|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556166|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
44556167|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
44556185|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556186|NCT01250756|Vaccines|vaccines|mesh-list
44556187|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44556188|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
44556189|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556190|NCT01250418|Ketamine|ketamine|mesh-list
44556191|NCT01250418|Analgesics|analgesics|mesh-ancestor
44556192|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
44556194|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556195|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44556196|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44556197|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
44556198|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
44556199|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44556200|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44556201|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44556202|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556203|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556204|NCT01250379|Bevacizumab|bevacizumab|mesh-list
44556205|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556206|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556207|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44556208|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44556209|NCT01250379|Growth Substances|growth substances|mesh-ancestor
44556210|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556211|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44556212|NCT01250145|Teriparatide|teriparatide|mesh-list
44556213|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556214|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556215|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44556216|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44556217|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556218|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556219|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556220|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556221|NCT01250002|Lidocaine|lidocaine|mesh-list
44556222|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
44556223|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
44556224|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44556225|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556226|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
44556227|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556228|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44556229|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44556230|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44556231|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556232|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556233|NCT01248065|Vitamin D|vitamin d|mesh-list
44556234|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
44556235|NCT01248065|Ciclesonide|ciclesonide|mesh-list
44556236|NCT01248065|Vitamins|vitamins|mesh-ancestor
44556237|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
44556238|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556239|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44556240|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556241|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
44556242|NCT01248065|Hormones|hormones|mesh-ancestor
44556243|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556244|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44556245|NCT01246986|Sorafenib|sorafenib|mesh-list
44556246|NCT01246986|Ramucirumab|ramucirumab|mesh-list
44556247|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556248|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556249|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556250|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556251|NCT01246960|Leucovorin|leucovorin|mesh-list
44556252|NCT01246960|Fluorouracil|fluorouracil|mesh-list
44556253|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
44556254|NCT01246960|Ramucirumab|ramucirumab|mesh-list
44556255|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
44556256|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556257|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556258|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556259|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556260|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
44556261|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556262|NCT01246960|Antidotes|antidotes|mesh-ancestor
44556263|NCT01246960|Protective Agents|protective agents|mesh-ancestor
44556264|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
44556265|NCT01246960|Vitamins|vitamins|mesh-ancestor
44556266|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
44556267|NCT01246583|Tofacitinib|tofacitinib|mesh-list
44556268|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556269|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556270|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556271|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
44556272|NCT01244620|Tadalafil|tadalafil|mesh-list
44556273|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
44556274|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
44556275|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44556276|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44556278|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556279|NCT01244620|Urological Agents|urological agents|mesh-ancestor
44556280|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44556281|NCT01244061|Varenicline|varenicline|mesh-list
44556282|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44556283|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44556284|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
44556285|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556286|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556287|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556288|NCT01243671|Adalimumab|adalimumab|mesh-list
44556289|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556290|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381773|NCT03667053|Glucagon|glucagon|mesh-list
44556291|NCT01243424|Glimepiride|glimepiride|mesh-list
44556292|NCT01243424|Linagliptin|linagliptin|mesh-list
44556293|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44556294|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44556295|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556296|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556297|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
44556298|NCT01243424|Incretins|incretins|mesh-ancestor
44556299|NCT01243424|Hormones|hormones|mesh-ancestor
44556300|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556301|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44556302|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44556303|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556304|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556305|NCT01243151|Bococizumab|bococizumab|mesh-list
44556306|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44556307|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44556308|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
44556309|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556310|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44556311|NCT01241760|Interferons|interferons|mesh-list
44556312|NCT01241760|Ribavirin|ribavirin|mesh-list
44556313|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
44556314|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
44556315|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44556316|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556317|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
44556318|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556319|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
44556320|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556321|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
44556322|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556323|NCT01241591|Etanercept|etanercept|mesh-list
44556324|NCT01241591|Tofacitinib|tofacitinib|mesh-list
44556325|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44556326|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556327|NCT01241591|Analgesics|analgesics|mesh-ancestor
44556328|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
44556329|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556330|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556331|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556332|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556333|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44556334|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556335|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
44556336|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556337|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556338|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556339|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44556340|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
44556341|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556342|NCT01240785|Metformin|metformin|mesh-list
44556343|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44556344|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556346|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44556347|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
44556348|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556349|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44556350|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44556351|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
44556352|NCT01239992|Vitamins|vitamins|mesh-ancestor
44556353|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
44181112|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44556354|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556355|NCT01239745|Exemestane|exemestane|mesh-list
44556356|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556357|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44556358|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44556359|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556360|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556361|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44556362|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556363|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556364|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556365|NCT01239732|Paclitaxel|paclitaxel|mesh-list
44556366|NCT01239732|Bevacizumab|bevacizumab|mesh-list
44556369|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556370|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44556371|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44556372|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44556373|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556374|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556375|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44556376|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44556377|NCT01239732|Growth Substances|growth substances|mesh-ancestor
44556378|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556379|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
44556380|NCT01239472|Everolimus|everolimus|mesh-list
44556381|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556382|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556383|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
44556384|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556385|NCT01239394|Ofatumumab|ofatumumab|mesh-list
44556386|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556387|NCT01239342|Everolimus|everolimus|mesh-list
44556388|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556389|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556390|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
44556391|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556392|NCT01238861|Benralizumab|benralizumab|mesh-list
44556393|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44556394|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
44556395|NCT01238822|Methylphenidate|methylphenidate|mesh-list
44556396|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44556397|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556398|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44556399|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44556400|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556401|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556402|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
44556403|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556404|NCT01238588|Sevelamer|sevelamer|mesh-list
44556405|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
44556406|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
44556407|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556408|NCT01238575|Guanfacine|guanfacine|mesh-list
44556409|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556410|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44181148|NCT00319865|Growth Substances|growth substances|mesh-ancestor
44556411|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44556412|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44556413|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44556414|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556415|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556416|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556417|NCT01238211|Cytarabine|cytarabine|mesh-list
44556418|NCT01238211|Daunorubicin|daunorubicin|mesh-list
44556419|NCT01238211|Dasatinib|dasatinib|mesh-list
44556420|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556421|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
44556422|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556423|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556424|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
44556425|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556426|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556427|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
44556428|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556429|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44556430|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44556431|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44556432|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556433|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556434|NCT01238120|Ibuprofen|ibuprofen|mesh-list
44556435|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44556436|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44556437|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556438|NCT01238120|Analgesics|analgesics|mesh-ancestor
44556439|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
44556440|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556441|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556442|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556443|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44556444|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556445|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556446|NCT01237951|Gemcitabine|gemcitabine|mesh-list
44556447|NCT01237951|Dexamethasone|dexamethasone|mesh-list
44556448|NCT01237951|Melphalan|melphalan|mesh-list
44556449|NCT01237951|Busulfan|busulfan|mesh-list
44556450|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556451|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
44556452|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
44556453|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556454|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556455|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44556456|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
44556457|NCT01237951|Hormones|hormones|mesh-ancestor
44556458|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556459|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44556460|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556461|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556462|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
44556463|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556464|NCT01237951|Antiviral Agents|antiviral agents|mesh-ancestor
44556465|NCT01237951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556466|NCT01237951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556467|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556468|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
44556469|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556470|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
44556471|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44556472|NCT01237899|Eplerenone|eplerenone|mesh-list
44556473|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44556474|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556475|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556476|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556477|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44556478|NCT01237899|Diuretics|diuretics|mesh-ancestor
44556479|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
44556480|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556481|NCT01237678|Carboplatin|carboplatin|mesh-list
44556482|NCT01237678|Etoposide|etoposide|mesh-list
44556483|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44556484|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556485|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44556486|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44556487|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44556488|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556489|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556490|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556491|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44556492|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44556493|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44556494|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556495|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556496|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556497|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556498|NCT01237587|Analgesics|analgesics|mesh-ancestor
44556499|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
44556500|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556501|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
44556502|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44556503|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
44556504|NCT01237327|Exemestane|exemestane|mesh-list
44556505|NCT01237327|Megestrol|megestrol|mesh-list
44556506|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
44556507|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556508|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44556509|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44556510|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556511|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556512|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44556513|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556525|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44556527|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556528|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44556529|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556530|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556531|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556532|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556533|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
44556534|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44556535|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44556536|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556537|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
44556538|NCT01236573|Fludarabine|fludarabine|mesh-list
44556539|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556540|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
44556541|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556542|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556543|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556544|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
44556545|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556546|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556547|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44556548|NCT01236560|Bevacizumab|bevacizumab|mesh-list
44556549|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44556550|NCT01236560|Temozolomide|temozolomide|mesh-list
44556551|NCT01236560|Vorinostat|vorinostat|mesh-list
44556552|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
44556553|NCT01236560|Antibodies|antibodies|mesh-list
44556554|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
44556555|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44556556|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
44556557|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556558|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44556559|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44556560|NCT01236560|Growth Substances|growth substances|mesh-ancestor
44556561|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556562|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
44556563|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
44556564|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556565|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
44556566|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556567|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44556568|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556569|NCT01236534|Lubiprostone|lubiprostone|mesh-list
44556570|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44556571|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556572|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556573|NCT01236365|Atorvastatin|atorvastatin|mesh-list
44556574|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44556575|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44556576|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
44556577|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556578|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44556579|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44556580|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556581|NCT01236118|Ixekizumab|ixekizumab|mesh-list
44556582|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556583|NCT01236001|Lacosamide|lacosamide|mesh-list
44556584|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
44556585|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44556586|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44556587|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556588|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556589|NCT01235949|Acetaminophen|acetaminophen|mesh-list
44556590|NCT01235949|Ibuprofen|ibuprofen|mesh-list
44556591|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44556592|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556593|NCT01235949|Analgesics|analgesics|mesh-ancestor
44556594|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
44556595|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556596|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556597|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556598|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556599|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44556600|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556601|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556602|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
44556603|NCT01235793|Temozolomide|temozolomide|mesh-list
44556604|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556605|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
44556606|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556607|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556608|NCT01235741|Pramlintide|pramlintide|mesh-list
44556609|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44556610|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556611|NCT01235728|Calcitriol|calcitriol|mesh-list
44556612|NCT01235728|MK 0873|mk 0873|mesh-list
44556613|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44556614|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556615|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44556616|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556617|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556618|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44556620|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
44556621|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44556622|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44556623|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44556624|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556625|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44556626|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
44556627|NCT01235715|Coagulants|coagulants|mesh-ancestor
44556628|NCT01235689|Prednisone|prednisone|mesh-list
44556629|NCT01235689|Adalimumab|adalimumab|mesh-list
44556630|NCT01235689|Azathioprine|azathioprine|mesh-list
44556631|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556632|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
44556633|NCT01235689|Hormones|hormones|mesh-ancestor
44556634|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556635|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556636|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44556637|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556638|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556639|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
44556640|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556641|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556642|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556643|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
44556644|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
44556645|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556646|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
44556647|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556648|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556649|NCT01235546|Azithromycin|azithromycin|mesh-list
44556650|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44556651|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556652|NCT01235507|Methotrexate|methotrexate|mesh-list
44556653|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44556654|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
44556655|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44556656|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556657|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556658|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
44556659|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556660|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556661|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556662|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556663|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44556664|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556665|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
44556666|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556667|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556669|NCT01235442|Clobetasol|clobetasol|mesh-list
44556670|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44556671|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556672|NCT01235442|Analgesics|analgesics|mesh-ancestor
44556673|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
44556674|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556675|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556676|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556677|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556678|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44556679|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556680|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
44556681|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
44556682|NCT01235442|Hormones|hormones|mesh-ancestor
44556683|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556684|NCT01235403|Lacosamide|lacosamide|mesh-list
44556685|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
44556686|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44556687|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44556688|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556689|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556690|NCT01235351|Clopidogrel|clopidogrel|mesh-list
44556691|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44556692|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44556694|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44556695|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
44556696|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556697|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556698|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556699|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44556700|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44556701|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44556702|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44556703|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556704|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556705|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556706|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556707|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44556708|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
44556709|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44556710|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44556711|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44556712|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
44556713|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
44556714|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44556715|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44556716|NCT01234675|Milnacipran|milnacipran|mesh-list
44556717|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
44556718|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44556719|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44556720|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44556721|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556722|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556723|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556724|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556725|NCT01234675|Analgesics|analgesics|mesh-ancestor
44556726|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
44556727|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556728|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
44556729|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44556730|NCT01234649|Metformin|metformin|mesh-list
44556731|NCT01234649|Liraglutide|liraglutide|mesh-list
44556732|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44556733|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556734|NCT01234649|Incretins|incretins|mesh-ancestor
44556735|NCT01234649|Hormones|hormones|mesh-ancestor
44556736|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556737|NCT01234467|Rituximab|rituximab|mesh-list
44556738|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44556739|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556740|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556741|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
44181428|NCT00320983|Cisplatin|cisplatin|mesh-list
44556742|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556743|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556744|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556745|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
44556746|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556747|NCT01234402|Capecitabine|capecitabine|mesh-list
44556748|NCT01234402|Ramucirumab|ramucirumab|mesh-list
44556749|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556750|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
44556751|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556752|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556753|NCT01234337|Capecitabine|capecitabine|mesh-list
44556754|NCT01234337|Sorafenib|sorafenib|mesh-list
44556755|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556756|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
44556757|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556758|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556759|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556760|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556761|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
44556762|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44556763|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44556772|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44556773|NCT01233687|Rilotumumab|rilotumumab|mesh-list
44556774|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556775|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556776|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556777|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556778|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556779|NCT01233609|Valproic Acid|valproic acid|mesh-list
44556780|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
44556781|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556782|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556783|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
44556784|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556785|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556786|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
44556787|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44556788|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44556789|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44556790|NCT01233284|Bromides|bromides|mesh-list
44556791|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
44556792|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44556793|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
44556794|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556795|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556796|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44556797|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
44556798|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
44556799|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44556800|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
44556801|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556802|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556803|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
44556804|NCT01233258|Factor VIII|factor viii|mesh-list
44556805|NCT01233258|Coagulants|coagulants|mesh-ancestor
44556806|NCT01233050|Ethanol|ethanol|mesh-list
44556807|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
44556808|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44556809|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44556810|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556811|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44556812|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556813|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
44556814|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44556815|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
44556816|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44556817|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
44556818|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556819|NCT01232790|Expectorants|expectorants|mesh-ancestor
44556820|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44556821|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44556822|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
44556823|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556824|NCT01232790|Protective Agents|protective agents|mesh-ancestor
44556825|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556826|NCT01232790|Antidotes|antidotes|mesh-ancestor
44556827|NCT01232738|Rasagiline|rasagiline|mesh-list
44556828|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44556829|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556830|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556831|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44556832|NCT01232738|Protective Agents|protective agents|mesh-ancestor
44181501|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44556833|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382348|NCT03605212|Febuxostat|febuxostat|mesh-list
44556835|NCT01232556|Rituximab|rituximab|mesh-list
44556836|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44556837|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44556838|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44556839|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556840|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
44556841|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556842|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556843|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556844|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
44556845|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556846|NCT01232556|Antiviral Agents|antiviral agents|mesh-ancestor
44556847|NCT01232556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556848|NCT01232556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556849|NCT01232556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556850|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44556851|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
44556852|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44556853|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
44556854|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44556855|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556856|NCT01232452|Cisplatin|cisplatin|mesh-list
44556857|NCT01232452|Pemetrexed|pemetrexed|mesh-list
44556858|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556859|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556860|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556861|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44556862|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556863|NCT01232296|Sorafenib|sorafenib|mesh-list
44556864|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556865|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556866|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556867|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556868|NCT01232283|Apremilast|apremilast|mesh-list
44556869|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44556870|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44556871|NCT01232283|Analgesics|analgesics|mesh-ancestor
44556872|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
44556873|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556874|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181545|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
44556875|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556876|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556877|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44556878|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44556879|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556880|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556881|NCT01232127|Ritonavir|ritonavir|mesh-list
44556882|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44556883|NCT01232127|Tenofovir|tenofovir|mesh-list
44556884|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44556885|NCT01232127|Famotidine|famotidine|mesh-list
44556886|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44556887|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44556888|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
44556889|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556890|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556891|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44556892|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44556894|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556895|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44556896|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44556897|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556898|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44556899|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44556900|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44556901|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
44556902|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
44556903|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44556904|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556905|NCT01231659|Everolimus|everolimus|mesh-list
44556906|NCT01231659|Letrozole|letrozole|mesh-list
44556907|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382424|NCT03599089|Acetaminophen|acetaminophen|mesh-list
44556908|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556909|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
44556910|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556911|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44556912|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44556913|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556914|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556915|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44556916|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556917|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556918|NCT01231620|Oseltamivir|oseltamivir|mesh-list
44556919|NCT01231620|Zanamivir|zanamivir|mesh-list
44556920|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
44556921|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556922|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556923|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556924|NCT01231607|Finasteride|finasteride|mesh-list
44556925|NCT01231607|Dutasteride|dutasteride|mesh-list
44556926|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44556927|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44556928|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556929|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556930|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
44556931|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44556932|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556933|NCT01231607|Urological Agents|urological agents|mesh-ancestor
44556934|NCT01231581|Gemcitabine|gemcitabine|mesh-list
44556935|NCT01231581|Trametinib|trametinib|mesh-list
44556936|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44556937|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
44556938|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556939|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44556940|NCT01231581|Antiviral Agents|antiviral agents|mesh-ancestor
44556941|NCT01231581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556942|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556943|NCT01231581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44556944|NCT01231581|Immunologic Factors|immunologic factors|mesh-ancestor
44556945|NCT01231581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556946|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44556947|NCT01231555|Efavirenz|efavirenz|mesh-list
44556948|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44556949|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44556950|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556951|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556952|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
44556953|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556954|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44556955|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44556956|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44556957|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44556958|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44556959|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44556960|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
44556961|NCT01231516|Dolutegravir|dolutegravir|mesh-list
44556962|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44556963|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44556964|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
44556965|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44556966|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44556967|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44556968|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44556969|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44556970|NCT01231503|Vaccines|vaccines|mesh-list
44556971|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
44556972|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556973|NCT01231464|Fluticasone|fluticasone|mesh-list
44556974|NCT01231464|Xhance|xhance|mesh-list
44556975|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556976|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44556977|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
44556978|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556979|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556980|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44382500|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
44556981|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44556983|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44556984|NCT01231373|Polidocanol|polidocanol|mesh-list
44556985|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44556986|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44556987|NCT01231321|Adalimumab|adalimumab|mesh-list
44556988|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44556989|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44556990|NCT01230892|Atenolol|atenolol|mesh-list
44556991|NCT01230892|Nebivolol|nebivolol|mesh-list
44556992|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44556993|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44556994|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
44556995|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
44556996|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44556997|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44556998|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44556999|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44557000|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44557001|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44557002|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557003|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557004|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557005|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44557006|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44557007|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44557008|NCT01230827|Golimumab|golimumab|mesh-list
44557009|NCT01230827|Methotrexate|methotrexate|mesh-list
44557010|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44557011|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
44557012|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44557013|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557014|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557015|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
44557016|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557017|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181696|NCT00322595|Paroxetine|paroxetine|mesh-list
44557018|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557019|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557020|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44557021|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557022|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
44557023|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557024|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44557025|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44557026|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557027|NCT01230814|Metronidazole|metronidazole|mesh-list
44557028|NCT01230814|Miconazole|miconazole|mesh-list
44557029|NCT01230814|Clotrimazole|clotrimazole|mesh-list
44557030|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557031|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44557032|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44557033|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44557034|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
44557035|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44557036|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44557037|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557038|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557039|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44557041|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557042|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557043|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44557044|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44557045|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44557046|NCT01230788|Rituximab|rituximab|mesh-list
44557047|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557048|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557049|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
44557050|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557051|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557052|NCT01230749|Pioglitazone|pioglitazone|mesh-list
44557053|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557054|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557055|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44557056|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557057|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557058|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557059|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557060|NCT01230307|Vitamin D|vitamin d|mesh-list
44557061|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
44557062|NCT01230307|Vitamins|vitamins|mesh-ancestor
44557063|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
44557064|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557065|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44181728|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
44557066|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44557067|NCT01229735|Topiramate|topiramate|mesh-list
44557068|NCT01229735|Levetiracetam|levetiracetam|mesh-list
44557069|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
44557070|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557071|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557072|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
44557073|NCT01229449|Acetaminophen|acetaminophen|mesh-list
44557074|NCT01229449|Ibuprofen|ibuprofen|mesh-list
44557075|NCT01229449|Codeine|codeine|mesh-list
44557076|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44557077|NCT01229449|Analgesics|analgesics|mesh-ancestor
44557078|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
44557079|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557080|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557081|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
44557082|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44557083|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557084|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557085|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44557086|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557087|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557088|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44557089|NCT01229449|Narcotics|narcotics|mesh-ancestor
44557090|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557091|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
44557092|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557093|NCT01229371|Vaccines|vaccines|mesh-list
44557094|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
44557095|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557096|NCT01229267|Vaccines|vaccines|mesh-list
44557097|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
44557098|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557099|NCT01229254|Amiodarone|amiodarone|mesh-list
44557100|NCT01229254|Betrixaban|betrixaban|mesh-list
44557101|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44557102|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557103|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44557104|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557105|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557106|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44557107|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44557108|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44557109|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557110|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44557111|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44557112|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44557113|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44557114|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
44454199|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
44557115|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44557116|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
44557117|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
44557118|NCT01229176|Vaccines|vaccines|mesh-list
44557119|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44557120|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
44557121|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557122|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44557123|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557124|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557125|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557126|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557127|NCT01229111|Leucovorin|leucovorin|mesh-list
44382646|NCT03585504|Etonogestrel|etonogestrel|mesh-list
44557128|NCT01229111|Fluorouracil|fluorouracil|mesh-list
44557129|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
44557130|NCT01229111|Cediranib|cediranib|mesh-list
44557139|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557140|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
44557141|NCT01229111|Antidotes|antidotes|mesh-ancestor
44557142|NCT01229111|Protective Agents|protective agents|mesh-ancestor
44557143|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557145|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
44557146|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557147|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557148|NCT01228747|Levetiracetam|levetiracetam|mesh-list
44557149|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
44557150|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
44557151|NCT01228734|Leucovorin|leucovorin|mesh-list
44557152|NCT01228734|Folic Acid|folic acid|mesh-list
44557153|NCT01228734|Fluorouracil|fluorouracil|mesh-list
44557154|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
44557155|NCT01228734|Cetuximab|cetuximab|mesh-list
44557156|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
44557157|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
44557158|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557159|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557160|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557161|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557162|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
44557163|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557164|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557165|NCT01228734|Antidotes|antidotes|mesh-ancestor
44557166|NCT01228734|Protective Agents|protective agents|mesh-ancestor
44557167|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557168|NCT01228734|Vitamins|vitamins|mesh-ancestor
44557169|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
44557170|NCT01228734|Hematinics|hematinics|mesh-ancestor
44557171|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
44557172|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44557173|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557174|NCT01228175|Riboflavin|riboflavin|mesh-list
44557175|NCT01228175|Varenicline|varenicline|mesh-list
44557177|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44557178|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
44557179|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557180|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557181|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557182|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557183|NCT01228175|Vitamins|vitamins|mesh-ancestor
44557184|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
44557185|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44557186|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557187|NCT01228071|Testosterone|testosterone|mesh-list
44557188|NCT01228071|Androgens|androgens|mesh-ancestor
44557189|NCT01228071|Hormones|hormones|mesh-ancestor
44557190|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557191|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557192|NCT01228019|Niacin|niacin|mesh-list
44557193|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44557194|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
44557195|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557196|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44557197|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557198|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557199|NCT01228019|Vitamins|vitamins|mesh-ancestor
44557200|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
44557201|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557202|NCT01227967|Ribavirin|ribavirin|mesh-list
44557203|NCT01227967|Oseltamivir|oseltamivir|mesh-list
44557204|NCT01227967|Amantadine|amantadine|mesh-list
44557205|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
44557206|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557207|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
44557208|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557209|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557210|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44557211|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44557212|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
44557213|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557214|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557215|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44557216|NCT01227967|Analgesics|analgesics|mesh-ancestor
44557217|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
44181808|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557218|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557219|NCT01227902|Ezogabine|ezogabine|mesh-list
44557220|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
44557221|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557222|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557223|NCT01227889|Dacarbazine|dacarbazine|mesh-list
44557224|NCT01227889|Dabrafenib|dabrafenib|mesh-list
44557225|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557226|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
44557227|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557228|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557229|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557230|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557231|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
44557232|NCT01227824|Dolutegravir|dolutegravir|mesh-list
44557233|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44557234|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44557235|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
44557236|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557237|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44557238|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44557239|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557240|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557241|NCT01227707|Leucovorin|leucovorin|mesh-list
44557242|NCT01227707|Bevacizumab|bevacizumab|mesh-list
44557243|NCT01227707|Fluorouracil|fluorouracil|mesh-list
44557244|NCT01227707|Capecitabine|capecitabine|mesh-list
44557245|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557246|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557247|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557248|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557249|NCT01227707|Growth Substances|growth substances|mesh-ancestor
44557250|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557251|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557252|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
44557253|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557254|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557255|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557256|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
44557257|NCT01227707|Antidotes|antidotes|mesh-ancestor
44557258|NCT01227707|Protective Agents|protective agents|mesh-ancestor
44557259|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557260|NCT01227707|Vitamins|vitamins|mesh-ancestor
44557261|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
44557262|NCT01227668|Aripiprazole|aripiprazole|mesh-list
44557263|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
44557264|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557265|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44557266|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557267|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557268|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557269|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
44557270|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
44557271|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557272|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557273|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44557274|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44557275|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
44557276|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44557277|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44557278|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44557279|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44557281|NCT01227629|Dabigatran|dabigatran|mesh-list
44557282|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
44557283|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
44557284|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44557285|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
44557286|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557287|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557288|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
44557289|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44557290|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
44557291|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557292|NCT01227512|Tolvaptan|tolvaptan|mesh-list
44557293|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44557294|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557295|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
44557296|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557297|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
44557298|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44557299|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557300|NCT01227395|Azithromycin|azithromycin|mesh-list
44557301|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44557302|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557303|NCT01227278|Benralizumab|benralizumab|mesh-list
44557304|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44557305|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557306|NCT01227044|Naltrexone|naltrexone|mesh-list
44557307|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44557308|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44557309|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557310|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
44557311|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557312|NCT01226745|Ceralifimod|ceralifimod|mesh-list
44557313|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44557314|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557315|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557316|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
44557317|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557318|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44557319|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44557320|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44557321|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557322|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557323|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557324|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557325|NCT01226511|Analgesics|analgesics|mesh-ancestor
44557326|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
44557327|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557329|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557330|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
44557331|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
44557332|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557333|NCT01226459|Minoxidil|minoxidil|mesh-list
44557334|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44557335|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557336|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
44557337|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557338|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557339|NCT01225991|Milnacipran|milnacipran|mesh-list
44557340|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
44557341|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44557342|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44557343|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557344|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557345|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557346|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557347|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44557348|NCT01225991|Analgesics|analgesics|mesh-ancestor
44557349|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
44557350|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557351|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
44557352|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557353|NCT01225887|Nintedanib|nintedanib|mesh-list
44557354|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557355|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557356|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557357|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557358|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44557359|NCT01225835|Cetrorelix|cetrorelix|mesh-list
44557360|NCT01225835|Menotropins|menotropins|mesh-list
44557361|NCT01225835|Progesterone|progesterone|mesh-list
44557362|NCT01225835|Progestins|progestins|mesh-ancestor
44557363|NCT01225835|Hormones|hormones|mesh-ancestor
44557364|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557365|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557366|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44557367|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44557368|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
44557369|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
44557370|NCT01225822|Enoxaparin|enoxaparin|mesh-list
44557371|NCT01225822|Dabigatran|dabigatran|mesh-list
44557372|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
44557373|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44557374|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44557375|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557376|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
44557377|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44557378|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44557379|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557380|NCT01225562|Ticagrelor|ticagrelor|mesh-list
44557381|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44557382|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44557383|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44557384|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44557385|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
44557386|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557387|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557388|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557389|NCT01225549|Budesonide|budesonide|mesh-list
44557390|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557391|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44557392|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
44557393|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557394|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557395|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44557396|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557397|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
44557398|NCT01225549|Hormones|hormones|mesh-ancestor
44557399|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557400|NCT01225211|Ivacaftor|ivacaftor|mesh-list
44557401|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44557402|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557403|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557404|NCT01225172|Letrozole|letrozole|mesh-list
44557405|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557406|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44557407|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44557408|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557409|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557410|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44557411|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44557412|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557413|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557414|NCT01225146|Ranibizumab|ranibizumab|mesh-list
44557415|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557416|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557417|NCT01225146|Growth Substances|growth substances|mesh-ancestor
44557418|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557419|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557420|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557421|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
44557422|NCT01224821|Antibodies|antibodies|mesh-list
44557423|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
44557424|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557425|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557426|NCT01224639|Vaccines|vaccines|mesh-list
44557427|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
44557428|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557430|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
44557431|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
44557432|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557433|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557434|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
44557435|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557436|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44557437|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44557438|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44557439|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557440|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557441|NCT01224171|Vedolizumab|vedolizumab|mesh-list
44557442|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557443|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44557444|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
44557445|NCT01223937|Coagulants|coagulants|mesh-ancestor
44557446|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44557447|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
44557448|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557449|NCT01223404|Mecamylamine|mecamylamine|mesh-list
44557450|NCT01223404|Nicotine|nicotine|mesh-list
44557451|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44557452|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
44557453|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557454|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557455|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44557456|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44557457|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44557458|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557459|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557460|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44557461|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44557462|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44557463|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44557464|NCT01223365|Hydrocodone|hydrocodone|mesh-list
44557465|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44557466|NCT01223365|Narcotics|narcotics|mesh-ancestor
44557467|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557468|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557469|NCT01223365|Analgesics|analgesics|mesh-ancestor
44557470|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
44557471|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557472|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
44557473|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557474|NCT01223235|Bevacizumab|bevacizumab|mesh-list
44557475|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557476|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557477|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557478|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557479|NCT01223235|Growth Substances|growth substances|mesh-ancestor
44557480|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557481|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557482|NCT01223196|Pioglitazone|pioglitazone|mesh-list
44557483|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557484|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557485|NCT01223027|Sorafenib|sorafenib|mesh-list
44557486|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557487|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557488|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557489|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557490|NCT01222715|Sirolimus|sirolimus|mesh-list
44557491|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
44557492|NCT01222715|Bevacizumab|bevacizumab|mesh-list
44557493|NCT01222715|Vinorelbine|vinorelbine|mesh-list
44557494|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44557495|NCT01222715|Antibodies|antibodies|mesh-list
44557496|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
44557497|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44557498|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
44557499|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
44557500|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557501|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
44557502|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557503|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557504|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557505|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
44557506|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557507|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557508|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44557509|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557510|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557511|NCT01222715|Growth Substances|growth substances|mesh-ancestor
44557512|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557513|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44557514|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557515|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44557516|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
44557517|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44557518|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557519|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44557520|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44557521|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
44557522|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44557523|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
44557524|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557525|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557526|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44557527|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557528|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
44557529|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44557530|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
44557531|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557532|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557546|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557548|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44557549|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
44383141|NCT03551743|Edoxaban|edoxaban|mesh-list
44557550|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557551|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44557552|NCT01222247|Betamethasone|betamethasone|mesh-list
44557553|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557554|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
44557556|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557557|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557558|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44557559|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557560|NCT01221753|Cisplatin|cisplatin|mesh-list
44557561|NCT01221753|Carboplatin|carboplatin|mesh-list
44557562|NCT01221753|Docetaxel|docetaxel|mesh-list
44557563|NCT01221753|Fluorouracil|fluorouracil|mesh-list
44557564|NCT01221753|Cetuximab|cetuximab|mesh-list
44557565|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557566|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557567|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44557568|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44557569|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557570|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
44557571|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557572|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557573|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
44557574|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557575|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557576|NCT01221727|Denosumab|denosumab|mesh-list
44557577|NCT01221727|Midazolam|midazolam|mesh-list
44557578|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44557579|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44557580|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557581|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557582|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44557583|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557584|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557585|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44557586|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
44557587|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
44557588|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
44557589|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
44557590|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182160|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557591|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557592|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44557593|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
44557594|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
44557595|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557596|NCT01221350|Protective Agents|protective agents|mesh-ancestor
44557597|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557598|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557600|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
44557601|NCT01221272|Ranolazine|ranolazine|mesh-list
44557602|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44557603|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557604|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557605|NCT01221181|Eculizumab|eculizumab|mesh-list
44557606|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44557607|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557608|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
44557609|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557610|NCT01220609|Epothilones|epothilones|mesh-list
44557611|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557612|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
44557613|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
44557614|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557615|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557616|NCT01220557|Insulin|insulin|mesh-list
44557617|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557618|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557619|NCT01220414|Naltrexone|naltrexone|mesh-list
44557620|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44557621|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44557622|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557623|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
44557624|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557625|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
44557626|NCT01220297|Sirolimus|sirolimus|mesh-list
44557629|NCT01220297|Etoposide|etoposide|mesh-list
44557630|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
44557631|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557632|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
44557633|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557634|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557635|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557636|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
44557637|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557638|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557639|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44557640|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44557641|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44557642|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44557643|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557644|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44557645|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44557646|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
44557647|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44557648|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557649|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
44557650|NCT01220180|Pregabalin|pregabalin|mesh-list
44557651|NCT01220180|Analgesics|analgesics|mesh-ancestor
44557652|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
44557653|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557654|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557655|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
44557656|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44557657|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44557658|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557659|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44557660|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44557661|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557662|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557663|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557664|NCT01220167|Ondansetron|ondansetron|mesh-list
44557665|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
44557666|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
44557667|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557668|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557669|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557670|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
44557671|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557672|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44557673|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
44557674|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557675|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557676|NCT01220167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44557677|NCT01220167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557678|NCT01220167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557679|NCT01220167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557680|NCT01220167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44557681|NCT01220128|Paclitaxel|paclitaxel|mesh-list
44557682|NCT01220128|Docetaxel|docetaxel|mesh-list
44557683|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
44557684|NCT01220128|Carboplatin|carboplatin|mesh-list
44557685|NCT01220128|Doxorubicin|doxorubicin|mesh-list
44557686|NCT01220128|Fluorouracil|fluorouracil|mesh-list
44557687|NCT01220128|Trastuzumab|trastuzumab|mesh-list
44557688|NCT01220128|Epirubicin|epirubicin|mesh-list
44557689|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44557690|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44557691|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557692|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557693|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
44557694|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44557695|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557696|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557697|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
44557698|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557699|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557700|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557701|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
44557702|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44557703|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44557704|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44557705|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44557706|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557707|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
44557708|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557709|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44557710|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44557711|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44557712|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
44557713|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557714|NCT01220024|Bupivacaine|bupivacaine|mesh-list
44557715|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
44557716|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
44557717|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557718|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557719|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
44557720|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557722|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
44557723|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44557724|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
44557725|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44557726|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44557727|NCT01219933|Prednisolone|prednisolone|mesh-list
44557728|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
44557729|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44557730|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
44557731|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557732|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
44557733|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
44557734|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557735|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557736|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557737|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
44557738|NCT01219933|Hormones|hormones|mesh-ancestor
44557739|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44557740|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44557741|NCT01219933|Protective Agents|protective agents|mesh-ancestor
44557742|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44557743|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557744|NCT01218867|Aldesleukin|aldesleukin|mesh-list
44557745|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
44557746|NCT01218867|Fludarabine|fludarabine|mesh-list
44557747|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557748|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
44426840|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
44557749|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557750|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557751|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557752|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
44557753|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557754|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557755|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44557756|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44557757|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44557758|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
44557759|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44557760|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44557761|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44557762|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44557763|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
44557764|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557765|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44557766|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44557767|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557769|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
44557770|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557771|NCT01218594|Endostatins|endostatins|mesh-list
44557772|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557773|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557774|NCT01218594|Growth Substances|growth substances|mesh-ancestor
44557775|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383331|NCT03531905|Ezetimibe|ezetimibe|mesh-list
44557776|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557777|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557778|NCT01218516|Paclitaxel|paclitaxel|mesh-list
44557779|NCT01218516|Cisplatin|cisplatin|mesh-list
44557780|NCT01218516|Carboplatin|carboplatin|mesh-list
44557781|NCT01218516|Pemetrexed|pemetrexed|mesh-list
44557782|NCT01218516|Farletuzumab|farletuzumab|mesh-list
44557783|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44557784|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557785|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
44557786|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
44557787|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
44557788|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557789|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557790|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44557791|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44557792|NCT01218477|Dasatinib|dasatinib|mesh-list
44557793|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557794|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44557795|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557796|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557797|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44557798|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
44557799|NCT01218438|Antibodies|antibodies|mesh-list
44557800|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
44557801|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44557802|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44557803|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
44557804|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
44557805|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557806|NCT01218308|Vaccines|vaccines|mesh-list
44557807|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
44182339|NCT00324922|Vancomycin|vancomycin|mesh-list
44557808|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557809|NCT01218204|Atorvastatin|atorvastatin|mesh-list
44557810|NCT01218204|Ezetimibe|ezetimibe|mesh-list
44557811|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44557812|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44557813|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
44557814|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557815|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44557816|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44557817|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557818|NCT01218100|Lisinopril|lisinopril|mesh-list
44557819|NCT01218100|Nebivolol|nebivolol|mesh-list
44557820|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44557821|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
44557822|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557823|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557824|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44557825|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44557826|NCT01218100|Protective Agents|protective agents|mesh-ancestor
44557827|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557828|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
44557829|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44557830|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44557831|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44557832|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
44557833|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557835|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44557836|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
44557837|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557838|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557839|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44557840|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44557841|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
44557842|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44557843|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44557844|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44557845|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44557846|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44557847|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557848|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557849|NCT01217957|Dexamethasone|dexamethasone|mesh-list
44557850|NCT01217957|Lenalidomide|lenalidomide|mesh-list
44557851|NCT01217957|Ixazomib|ixazomib|mesh-list
44557852|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557862|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557863|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
44557864|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557865|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557866|NCT01217957|Growth Substances|growth substances|mesh-ancestor
44557867|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557868|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
44557869|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557870|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557871|NCT01217944|Ranibizumab|ranibizumab|mesh-list
44557872|NCT01217944|Verteporfin|verteporfin|mesh-list
44557873|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557874|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557875|NCT01217944|Growth Substances|growth substances|mesh-ancestor
44557876|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557877|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557878|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557879|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44557880|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557881|NCT01217892|Metformin|metformin|mesh-list
44557882|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
44557883|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557884|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557885|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44557886|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557887|NCT01217814|Leucovorin|leucovorin|mesh-list
44557888|NCT01217814|Folic Acid|folic acid|mesh-list
44557889|NCT01217814|Golimumab|golimumab|mesh-list
44557890|NCT01217814|Methotrexate|methotrexate|mesh-list
44557891|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
44557892|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44557893|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
44557894|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44557895|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557896|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44557897|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
44557898|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557899|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557900|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557901|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557902|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44557903|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44557904|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
44557905|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44557906|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44557907|NCT01217814|Antidotes|antidotes|mesh-ancestor
44557908|NCT01217814|Protective Agents|protective agents|mesh-ancestor
44557909|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
44557911|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
44557912|NCT01217814|Hematinics|hematinics|mesh-ancestor
44557913|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44557914|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44557915|NCT01217801|Ondansetron|ondansetron|mesh-list
44557916|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
44557917|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
44557918|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557919|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557920|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557921|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
44557922|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557923|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44557924|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
44557925|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557926|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557927|NCT01217801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44557928|NCT01217801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557929|NCT01217801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557930|NCT01217801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557931|NCT01217801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44557932|NCT01217606|Timolol|timolol|mesh-list
44557933|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44557934|NCT01217606|Bimatoprost|bimatoprost|mesh-list
44557935|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44557936|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44557937|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44557938|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44557939|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
44557940|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557941|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557942|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557943|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44557944|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44557945|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44557946|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44557947|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44557948|NCT01217437|Bevacizumab|bevacizumab|mesh-list
44557949|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44557950|NCT01217437|Irinotecan|irinotecan|mesh-list
44557951|NCT01217437|Temozolomide|temozolomide|mesh-list
44557952|NCT01217437|Camptothecin|camptothecin|mesh-list
44557953|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
44557954|NCT01217437|Antibodies|antibodies|mesh-list
44557955|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
44557956|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44557957|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
44557958|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44557959|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44557960|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44557961|NCT01217437|Growth Substances|growth substances|mesh-ancestor
44557962|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557963|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
44557964|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
44557965|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44557966|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44557967|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44557968|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557969|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44557970|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
44557971|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44557972|NCT01217307|Metformin|metformin|mesh-list
44557973|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557974|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557975|NCT01217190|Ondansetron|ondansetron|mesh-list
44557976|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
44557977|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
44557978|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44557979|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557980|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44557981|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
44557982|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44557983|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44557984|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
44557985|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44557986|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44557987|NCT01217190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44557988|NCT01217190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44557989|NCT01217190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44557990|NCT01217190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44557991|NCT01217190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44557992|NCT01217112|Cannabidiol|cannabidiol|mesh-list
44557993|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
44557995|NCT01217073|Pioglitazone|pioglitazone|mesh-list
44557996|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44557997|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44557998|NCT01217060|Dexamethasone|dexamethasone|mesh-list
44557999|NCT01217060|Docetaxel|docetaxel|mesh-list
44558000|NCT01217060|Fluorouracil|fluorouracil|mesh-list
44558001|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558002|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
44558003|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
44558004|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558005|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558006|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44558007|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
44558008|NCT01217060|Hormones|hormones|mesh-ancestor
44558009|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558010|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558011|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558012|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44558013|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44558014|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44558015|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558016|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
44558017|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44558018|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558019|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
44558020|NCT01216332|Vaccines|vaccines|mesh-list
44558021|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
44558022|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558023|NCT01216176|Anastrozole|anastrozole|mesh-list
44558024|NCT01216176|Saracatinib|saracatinib|mesh-list
44182557|NCT00325845|Hylan|hylan|mesh-list
44558025|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558026|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558027|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44558028|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44558029|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558030|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558031|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44558032|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
44558033|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558034|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558035|NCT01216163|Acetaminophen|acetaminophen|mesh-list
44558036|NCT01216163|Ibuprofen|ibuprofen|mesh-list
44558037|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558038|NCT01216163|Analgesics|analgesics|mesh-ancestor
44558039|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
44558040|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558041|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558042|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
44558043|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558044|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558045|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558046|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44558047|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558048|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558049|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44558050|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
44558051|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44558052|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558053|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558054|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
44558055|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383581|NCT03518112|Antibodies|antibodies|mesh-list
44558056|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44558057|NCT01215981|Vaccines|vaccines|mesh-list
44558058|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
44558059|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558060|NCT01215968|Dulaglutide|dulaglutide|mesh-list
44558061|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558062|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558063|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
44558064|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558065|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558066|NCT01215916|Pemetrexed|pemetrexed|mesh-list
44558067|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558068|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558069|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558070|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44558071|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44558072|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
44558073|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
44558074|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44558075|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558076|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44558077|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44558078|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558079|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558080|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558081|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
44558082|NCT01215734|Vaccines|vaccines|mesh-list
44558083|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
44558084|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558085|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
44558086|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44558087|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44558088|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
44558089|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558090|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558091|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558092|NCT01215721|Urological Agents|urological agents|mesh-ancestor
44558093|NCT01215435|Insulin|insulin|mesh-list
44558094|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44558095|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
44558096|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
44558097|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44558098|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
44558099|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44558100|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
44558101|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558102|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558103|NCT01215357|Ecopipam|ecopipam|mesh-list
44558104|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44558105|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558106|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558107|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558108|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558109|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44558110|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
44558111|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558112|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558113|NCT01215253|Ranolazine|ranolazine|mesh-list
44558114|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44558115|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558116|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558117|NCT01215227|Rasagiline|rasagiline|mesh-list
44558118|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44558119|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558120|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558121|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44558122|NCT01215227|Protective Agents|protective agents|mesh-ancestor
44558123|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558124|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44558125|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
44558126|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558127|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44558128|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
44558129|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558130|NCT01215097|Linagliptin|linagliptin|mesh-list
44558131|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558132|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558133|NCT01215097|Incretins|incretins|mesh-ancestor
44558134|NCT01215097|Hormones|hormones|mesh-ancestor
44558135|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558136|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44558137|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
44558138|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558139|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558140|NCT01215032|Metformin|metformin|mesh-list
44558141|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558142|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558143|NCT01214915|Anagrelide|anagrelide|mesh-list
44558144|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44558145|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44558146|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558147|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44558148|NCT01214850|Vaccines|vaccines|mesh-list
44558149|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
44558150|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558151|NCT01214720|Bevacizumab|bevacizumab|mesh-list
44558152|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558153|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558154|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558155|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558156|NCT01214720|Growth Substances|growth substances|mesh-ancestor
44558157|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558158|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558159|NCT01214668|Doxorubicin|doxorubicin|mesh-list
44558160|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44558161|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44558162|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558163|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44558164|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44558165|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558166|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558167|NCT01214616|Vinorelbine|vinorelbine|mesh-list
44558168|NCT01214616|Afatinib|afatinib|mesh-list
44558169|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44558170|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558171|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
44558172|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
44558173|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
44558174|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558175|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558176|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558177|NCT01214434|Emollients|emollients|mesh-list
44558178|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
44558180|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44558181|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558182|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
44558183|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558184|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
44558185|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44558186|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558187|NCT01214239|Linagliptin|linagliptin|mesh-list
44558188|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558189|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558190|NCT01214239|Incretins|incretins|mesh-ancestor
44558191|NCT01214239|Hormones|hormones|mesh-ancestor
44558192|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558193|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44558194|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
44558195|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558196|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558197|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
44558198|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
44558199|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558200|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
44558201|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558202|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558203|NCT01214044|Dexetimide|dexetimide|mesh-list
44558204|NCT01214044|Citalopram|citalopram|mesh-list
44558205|NCT01214044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44558206|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44558207|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558208|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558209|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558210|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
44558211|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558212|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44558213|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
44558214|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558215|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44558216|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44558217|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
44558218|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
44558219|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558220|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44558221|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44558222|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44558223|NCT01213966|Artefenomel|artefenomel|mesh-list
44558224|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
44558225|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44558226|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44558227|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558228|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44558229|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
44558230|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558231|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44558232|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558233|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558234|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558235|NCT01213524|Nicotine|nicotine|mesh-list
44558236|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44558237|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
44558238|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558239|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558240|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44558241|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44558242|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
44558243|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558244|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558245|NCT01213264|Anesthetics|anesthetics|mesh-list
44558246|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558247|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558248|NCT01213173|Metoprolol|metoprolol|mesh-list
44558249|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44558250|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44558251|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
44558252|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
44558263|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558264|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558265|NCT01212770|Analgesics|analgesics|mesh-ancestor
44558266|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
44383884|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558267|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558268|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558269|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558270|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558271|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44558272|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44558273|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558274|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558275|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558276|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
44558277|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
44558278|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44558279|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558280|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558281|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558282|NCT01212770|Growth Substances|growth substances|mesh-ancestor
44558283|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558284|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558285|NCT01212757|Thalidomide|thalidomide|mesh-list
44558286|NCT01212757|Apremilast|apremilast|mesh-list
44558287|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558288|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558289|NCT01212757|Analgesics|analgesics|mesh-ancestor
44558290|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
44558291|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558292|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558293|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558294|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558295|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44558296|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44558297|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558298|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558299|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558300|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
44558301|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
44558302|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44558303|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558304|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558305|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558306|NCT01212757|Growth Substances|growth substances|mesh-ancestor
44558307|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558308|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558309|NCT01212588|Mifepristone|mifepristone|mesh-list
44558310|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44558311|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
44558312|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44558313|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558314|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44558315|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44558316|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44558317|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
44558318|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44558319|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44558320|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
44558321|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558322|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
44558323|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44558324|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44558325|NCT01212185|Oxytocin|oxytocin|mesh-list
44558326|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
44558327|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44558328|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558329|NCT01212094|Rituximab|rituximab|mesh-list
44558330|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558331|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558332|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
44558333|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558334|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558335|NCT01211769|Naltrexone|naltrexone|mesh-list
44558336|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44558337|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44558338|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558339|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
44558340|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558342|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44558343|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44558344|NCT01211665|Prednisolone|prednisolone|mesh-list
44558345|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
44558346|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44558347|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
44558348|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558349|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
44558350|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
44558351|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558352|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558353|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44558354|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
44558355|NCT01211665|Hormones|hormones|mesh-ancestor
44558356|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558357|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44558358|NCT01211665|Protective Agents|protective agents|mesh-ancestor
44558359|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558360|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558361|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44558362|NCT01211522|Haloperidol|haloperidol|mesh-list
44558363|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
44558364|NCT01211522|Ziprasidone|ziprasidone|mesh-list
44558365|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
44558367|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558368|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558369|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44558370|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44558371|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558372|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558373|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558374|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44558375|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
44558376|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558377|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558378|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44558379|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44558380|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
44558381|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44558382|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558383|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558384|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558385|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558386|NCT01211197|Metformin|metformin|mesh-list
44558387|NCT01211197|Empagliflozin|empagliflozin|mesh-list
44558388|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558389|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558390|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44558391|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558392|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
44558393|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
44558394|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44558395|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44558396|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
44558397|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558398|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558399|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558400|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558401|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44558402|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558403|NCT01210495|Axitinib|axitinib|mesh-list
44558404|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558405|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558406|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558407|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558408|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
44558409|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44558410|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558411|NCT01210352|Oxymorphone|oxymorphone|mesh-list
44558412|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44558413|NCT01210352|Narcotics|narcotics|mesh-ancestor
44558414|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558415|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558416|NCT01210352|Analgesics|analgesics|mesh-ancestor
44558417|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
44558418|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558419|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44558420|NCT01210222|Trebananib|trebananib|mesh-list
44558421|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558422|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558423|NCT01210222|Growth Substances|growth substances|mesh-ancestor
44558424|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558425|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558426|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558427|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44558428|NCT01210144|Hormones|hormones|mesh-list
44558429|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44558430|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558431|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558432|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44558433|NCT01210001|Empagliflozin|empagliflozin|mesh-list
44558434|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44558435|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558436|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558437|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558438|NCT01209949|Adapalene|adapalene|mesh-list
44558439|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44558440|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
44558441|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558442|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558443|NCT01209949|Analgesics|analgesics|mesh-ancestor
44558444|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
44558445|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558446|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558447|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558448|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558449|NCT01209832|Midazolam|midazolam|mesh-list
44558450|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44558451|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44558452|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558453|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558454|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44558455|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558456|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558457|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44558458|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
44558459|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
44558460|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
44558461|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
44558462|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558463|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558464|NCT01209598|Palbociclib|palbociclib|mesh-list
44558465|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558466|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558467|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558468|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558469|NCT01209520|Paclitaxel|paclitaxel|mesh-list
44558470|NCT01209520|Vinorelbine|vinorelbine|mesh-list
44558471|NCT01209520|Docetaxel|docetaxel|mesh-list
44558472|NCT01209520|Cisplatin|cisplatin|mesh-list
44558473|NCT01209520|Carboplatin|carboplatin|mesh-list
44558474|NCT01209520|Pemetrexed|pemetrexed|mesh-list
44558475|NCT01209520|Azacitidine|azacitidine|mesh-list
44558476|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44558477|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558478|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44558479|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44558480|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182905|NCT00327379|Aprotinin|aprotinin|mesh-list
44558481|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558482|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558483|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44558484|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44558485|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44558486|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
44558487|NCT01209286|Blinatumomab|blinatumomab|mesh-list
44558488|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558489|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
44558490|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44558491|NCT01209143|Norethindrone|norethindrone|mesh-list
44558492|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
44558493|NCT01209143|Estradiol|estradiol|mesh-list
44558494|NCT01209143|Estrogens|estrogens|mesh-ancestor
44558495|NCT01209143|Hormones|hormones|mesh-ancestor
44558496|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558497|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558498|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44558499|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
44558500|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44558501|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44558502|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558503|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44558504|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44558505|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44558506|NCT01209078|Linezolid|linezolid|mesh-list
44558507|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44558508|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558509|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44558510|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558511|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558512|NCT01208402|Esmolol|esmolol|mesh-list
44558513|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44558514|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44558515|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44558516|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558517|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558518|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558519|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558520|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
44558521|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558522|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558523|NCT01208324|Estrogens|estrogens|mesh-list
44558524|NCT01208324|Hormones|hormones|mesh-ancestor
44558525|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558526|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558527|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
44558528|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44558529|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44558530|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558531|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558532|NCT01208207|Naproxen|naproxen|mesh-list
44558533|NCT01208207|Etoricoxib|etoricoxib|mesh-list
44558534|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558535|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558536|NCT01208207|Analgesics|analgesics|mesh-ancestor
44558537|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
44558538|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558539|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558540|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558541|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558542|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
44558543|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44558544|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558545|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558546|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44558547|NCT01208181|Etoricoxib|etoricoxib|mesh-list
44558548|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44558549|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558550|NCT01208181|Analgesics|analgesics|mesh-ancestor
44558551|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
44558552|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558553|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558554|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558555|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454351|NCT01666652|Antacids|antacids|mesh-ancestor
44558556|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44558557|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44558558|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558559|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558560|NCT01208103|Bevacizumab|bevacizumab|mesh-list
44558561|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44558562|NCT01208103|Capecitabine|capecitabine|mesh-list
44558563|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
44558564|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
44558565|NCT01208103|Antibodies|antibodies|mesh-list
44558566|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
44558567|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44558568|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
44558569|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558570|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558571|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558572|NCT01208103|Growth Substances|growth substances|mesh-ancestor
44558573|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558574|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558575|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
44558576|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44558577|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
44558578|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558579|NCT01208051|Lenalidomide|lenalidomide|mesh-list
44558580|NCT01208051|Cediranib|cediranib|mesh-list
44558581|NCT01208051|Maleic acid|maleic acid|mesh-list
44558582|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
44558583|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558584|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558585|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558586|NCT01208051|Growth Substances|growth substances|mesh-ancestor
44558587|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558588|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558589|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558590|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558591|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558592|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
44558593|NCT01208038|Testosterone|testosterone|mesh-list
44558594|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
44558595|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
44558596|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44558597|NCT01208038|Androgens|androgens|mesh-ancestor
44558599|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558600|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558601|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558602|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558603|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
44558604|NCT01207687|Bevacizumab|bevacizumab|mesh-list
44558605|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44558606|NCT01207687|Antibodies|antibodies|mesh-list
44558607|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
44558608|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44558609|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558610|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558611|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558612|NCT01207687|Growth Substances|growth substances|mesh-ancestor
44558613|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558614|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558615|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
44558616|NCT01207596|Hydromorphone|hydromorphone|mesh-list
44558617|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44558618|NCT01207596|Narcotics|narcotics|mesh-ancestor
44558619|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558620|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558621|NCT01207596|Analgesics|analgesics|mesh-ancestor
44558622|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
44558623|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558624|NCT01207453|Milnacipran|milnacipran|mesh-list
44558625|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
44558626|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44558627|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44558628|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558629|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558630|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558631|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558632|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44558633|NCT01207453|Analgesics|analgesics|mesh-ancestor
44558634|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
44558635|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384205|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
44558636|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
44558637|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558639|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558640|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558641|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558642|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558643|NCT01207414|Iloperidone|iloperidone|mesh-list
44558644|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44558645|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558646|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558647|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558648|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558649|NCT01207388|Blinatumomab|blinatumomab|mesh-list
44558650|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558651|NCT01207102|Paclitaxel|paclitaxel|mesh-list
44558652|NCT01207102|Carboplatin|carboplatin|mesh-list
44558653|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44558654|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44558655|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558656|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
44558657|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
44558658|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
44558659|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558660|NCT01206816|Afatinib|afatinib|mesh-list
44558661|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962756|NCT01519882|Rotigotine|rotigotine|mesh-list
44558662|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558663|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558664|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558665|NCT01206777|Rituximab|rituximab|mesh-list
44558666|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558667|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558668|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
44558669|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558670|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558671|NCT01206764|Everolimus|everolimus|mesh-list
44558672|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558673|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558674|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
44558675|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558676|NCT01206517|Asenapine|asenapine|mesh-list
44558677|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44558678|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558679|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558680|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558681|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558682|NCT01206439|Nebivolol|nebivolol|mesh-list
44558683|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44558684|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
44558685|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44558686|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44558687|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44558688|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558689|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558690|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558691|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558692|NCT01206322|Insulin|insulin|mesh-list
44558693|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558694|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558695|NCT01206140|Sirolimus|sirolimus|mesh-list
44558696|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44558697|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44558698|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44558699|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558700|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
44558701|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44558702|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
44558703|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558704|NCT01206101|Liraglutide|liraglutide|mesh-list
44558705|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558706|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558707|NCT01206101|Incretins|incretins|mesh-ancestor
44558708|NCT01206101|Hormones|hormones|mesh-ancestor
44558709|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558710|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44558711|NCT01205685|Letrozole|letrozole|mesh-list
44558712|NCT01205685|Goserelin|goserelin|mesh-list
44558713|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558735|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44558736|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44558737|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558738|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558739|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
44558740|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558741|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558742|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44558743|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558744|NCT01205126|Oxycodone|oxycodone|mesh-list
44558745|NCT01205126|Hydromorphone|hydromorphone|mesh-list
44558746|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44558747|NCT01205126|Narcotics|narcotics|mesh-ancestor
44558748|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558749|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558750|NCT01205126|Analgesics|analgesics|mesh-ancestor
44558751|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
44558752|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384357|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44558754|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44558755|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44558756|NCT01205035|Growth Substances|growth substances|mesh-ancestor
44558757|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558758|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
44558759|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558761|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
44558762|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44558763|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44558764|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558765|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558766|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558767|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44558768|NCT01204918|Protective Agents|protective agents|mesh-ancestor
44558769|NCT01204775|Metformin|metformin|mesh-list
44558770|NCT01204775|Saxagliptin|saxagliptin|mesh-list
44558771|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558772|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558773|NCT01204775|Incretins|incretins|mesh-ancestor
44558774|NCT01204775|Hormones|hormones|mesh-ancestor
44558775|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558776|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44558777|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44558778|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558779|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558780|NCT01204710|Prednisone|prednisone|mesh-list
44558781|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
44558782|NCT01204710|Olaratumab|olaratumab|mesh-list
44558783|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44558784|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
44558785|NCT01204710|Hormones|hormones|mesh-ancestor
44558786|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558787|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558788|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558789|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558790|NCT01204710|Analgesics|analgesics|mesh-ancestor
44558791|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
44558792|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558793|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44558794|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44558795|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558796|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558797|NCT01204697|Docetaxel|docetaxel|mesh-list
44558798|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44558799|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558800|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44558801|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44558802|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44558803|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558804|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558805|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558806|NCT01204671|Vaccines|vaccines|mesh-list
44558807|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
44558808|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558809|NCT01204658|Vaccines|vaccines|mesh-list
44558810|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44558811|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
44558812|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558813|NCT01204398|Amlodipine|amlodipine|mesh-list
44558814|NCT01204398|Telmisartan|telmisartan|mesh-list
44558815|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44558816|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44558817|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44558818|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558819|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558820|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44558821|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558822|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
44558823|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44558824|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44558825|NCT01204294|Metformin|metformin|mesh-list
44558826|NCT01204294|Linagliptin|linagliptin|mesh-list
44558827|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44558828|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558829|NCT01204294|Incretins|incretins|mesh-ancestor
44558830|NCT01204294|Hormones|hormones|mesh-ancestor
44558831|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962891|NCT01526356|Sirolimus|sirolimus|mesh-list
44558832|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44558834|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558835|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558836|NCT01203930|Rituximab|rituximab|mesh-list
44558837|NCT01203930|Idelalisib|idelalisib|mesh-list
44558838|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558839|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558840|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
44558841|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558842|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44558843|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558844|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558845|NCT01203917|Gefitinib|gefitinib|mesh-list
44558846|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558847|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558848|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558849|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558850|NCT01203878|Imiquimod|imiquimod|mesh-list
44558851|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44558852|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44558853|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
44558854|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558855|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558856|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
44558857|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44558858|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
44558859|NCT01203852|Metoprolol|metoprolol|mesh-list
44558860|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
44558861|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44558862|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44558863|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
44558864|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
44558865|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558866|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558867|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44558868|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44558869|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44558870|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558871|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558872|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558873|NCT01203852|Diuretics|diuretics|mesh-ancestor
44558874|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44558875|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44558876|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558877|NCT01203787|Sorafenib|sorafenib|mesh-list
44558878|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558879|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558880|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558881|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558882|NCT01203098|Enoxaparin|enoxaparin|mesh-list
44558883|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
44558884|NCT01203098|Edoxaban|edoxaban|mesh-list
44558885|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
44558886|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44558887|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44558888|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558889|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44558890|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
44558891|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44558892|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
44558893|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558894|NCT01203072|Edoxaban|edoxaban|mesh-list
44454424|NCT01664624|Hormones|hormones|mesh-ancestor
44558895|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44558896|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
44558897|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44558898|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
44558899|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558900|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558901|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
44558902|NCT01202955|Tolcapone|tolcapone|mesh-list
44558903|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44558904|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44558905|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44558906|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558907|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558908|NCT01202903|Omalizumab|omalizumab|mesh-list
44558909|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44558910|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44558911|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
44558912|NCT01202877|Azacitidine|azacitidine|mesh-list
44558913|NCT01202877|Midostaurin|midostaurin|mesh-list
44558914|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44558915|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
44558916|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558917|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558918|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558919|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44558920|NCT01202591|Fulvestrant|fulvestrant|mesh-list
44558921|NCT01202591|Exemestane|exemestane|mesh-list
44558922|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44558923|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558924|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44558925|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44558926|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
44558927|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44558928|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558929|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44558930|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44558931|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44558932|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558933|NCT01202409|Panitumumab|panitumumab|mesh-list
44558934|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558935|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558936|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
44558937|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
44558938|NCT01202279|Guaifenesin|guaifenesin|mesh-list
44558939|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44558940|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44558941|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
44558942|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558943|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558944|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44558945|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
44558946|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
44558947|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44558948|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
44558949|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558950|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558951|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558952|NCT01202279|Expectorants|expectorants|mesh-ancestor
44558953|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44558954|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44558955|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
44558956|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44558957|NCT01202227|Pregabalin|pregabalin|mesh-list
44558958|NCT01202227|Analgesics|analgesics|mesh-ancestor
44558959|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
44558960|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558961|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558962|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
44558963|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44558964|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44558965|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558966|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44558967|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44558968|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44558969|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44558970|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44558971|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
44558972|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
44558973|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44558974|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
44558975|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44558976|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558977|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44558978|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
44558979|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
44558980|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44558981|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
44558982|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558983|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558984|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44558985|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44558987|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44558988|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44558989|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44558990|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44558991|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44558992|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44558993|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44558994|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44558995|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44558996|NCT01201850|Bevacizumab|bevacizumab|mesh-list
44558997|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44558998|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44558999|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44559000|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44559001|NCT01201850|Growth Substances|growth substances|mesh-ancestor
44559002|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559003|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
44559004|NCT01201811|Azacitidine|azacitidine|mesh-list
44559005|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559006|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
44559007|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559008|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559009|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559010|NCT01201798|Prednisolone|prednisolone|mesh-list
44559011|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44559012|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
44559013|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44559014|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
44559015|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44559016|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
44559017|NCT01201798|Difluprednate|difluprednate|mesh-list
44559018|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559019|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
44559020|NCT01201798|Hormones|hormones|mesh-ancestor
44559021|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559022|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559023|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44559024|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559025|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
44559026|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
44559027|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559028|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44559029|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44559030|NCT01201798|Protective Agents|protective agents|mesh-ancestor
44559031|NCT01201785|Aspirin|aspirin|mesh-list
44559032|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559033|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559034|NCT01201785|Analgesics|analgesics|mesh-ancestor
44559035|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
44559036|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559037|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559038|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559039|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559040|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44559041|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44559042|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559043|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44559044|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44559045|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559046|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
44559047|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44559048|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
44559049|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559050|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559051|NCT01201759|Analgesics|analgesics|mesh-ancestor
44559052|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
44559053|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559054|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559055|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559057|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44559058|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559059|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559060|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44559061|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44559062|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559063|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559064|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
44559065|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559066|NCT01201343|Interferons|interferons|mesh-list
44559067|NCT01201343|Interferon-beta|interferon-beta|mesh-list
44559068|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
44559069|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559070|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
44559071|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559072|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
44559073|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559074|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44559075|NCT01201265|Gemcitabine|gemcitabine|mesh-list
44559076|NCT01201265|Bevacizumab|bevacizumab|mesh-list
44559077|NCT01201265|Carboplatin|carboplatin|mesh-list
44559078|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559079|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559080|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44559081|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44559082|NCT01201265|Growth Substances|growth substances|mesh-ancestor
44559083|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559084|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
44559085|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559086|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
44559087|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559088|NCT01201265|Antiviral Agents|antiviral agents|mesh-ancestor
44559089|NCT01201265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559090|NCT01201265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559091|NCT01201265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559092|NCT01201265|Immunologic Factors|immunologic factors|mesh-ancestor
44559093|NCT01200992|Mitomycins|mitomycins|mesh-list
44559094|NCT01200992|Mitomycin|mitomycin|mesh-list
44559095|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44559096|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559097|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
44559098|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559099|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44559100|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559101|NCT01200810|Bicalutamide|bicalutamide|mesh-list
44559102|NCT01200810|R04929097|r04929097|mesh-list
44559103|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
44559104|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
44559105|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559106|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559107|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559108|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559109|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559110|NCT01200758|Prednisone|prednisone|mesh-list
44559111|NCT01200758|Prednisolone|prednisolone|mesh-list
44559112|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
44559113|NCT01200758|Rituximab|rituximab|mesh-list
44559114|NCT01200758|Doxorubicin|doxorubicin|mesh-list
44559115|NCT01200758|Vincristine|vincristine|mesh-list
44559116|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559117|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
44559118|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559119|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559120|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44559121|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
44559122|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559123|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559124|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44559125|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559134|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44559135|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559136|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559137|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559138|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559140|NCT01200589|Ofatumumab|ofatumumab|mesh-list
44559141|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44559142|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559143|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559144|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
44559145|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559146|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559147|NCT01200485|Allopurinol|allopurinol|mesh-list
44559148|NCT01200485|Rasburicase|rasburicase|mesh-list
44559149|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
44559150|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559151|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559152|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
44559153|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559154|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44559155|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
44559156|NCT01200485|Protective Agents|protective agents|mesh-ancestor
44559157|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559158|NCT01200407|Amlodipine|amlodipine|mesh-list
44559159|NCT01200407|Olmesartan|olmesartan|mesh-list
44559160|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44559161|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44559162|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44559163|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44559164|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559165|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44559166|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559167|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
44559168|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44559169|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44559170|NCT01200368|Vaccines|vaccines|mesh-list
44559171|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44559172|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
44559173|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559174|NCT01200355|Posaconazole|posaconazole|mesh-list
44559175|NCT01200355|Micafungin|micafungin|mesh-list
44559176|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
44559177|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559178|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44559179|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44559180|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44559181|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44559182|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44559183|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559184|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559185|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44559186|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
44559187|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559188|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559189|NCT01200342|Paclitaxel|paclitaxel|mesh-list
44559190|NCT01200342|Carboplatin|carboplatin|mesh-list
44559191|NCT01200342|Oblimersen|oblimersen|mesh-list
44559192|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559193|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559194|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559195|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559196|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559197|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559198|NCT01200329|Gemcitabine|gemcitabine|mesh-list
44559199|NCT01200329|Melphalan|melphalan|mesh-list
44559200|NCT01200329|Busulfan|busulfan|mesh-list
44559201|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559202|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
44559203|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559204|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559205|NCT01200329|Antiviral Agents|antiviral agents|mesh-ancestor
44559206|NCT01200329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559207|NCT01200329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559208|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559209|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
44559210|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559211|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44559212|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
44559214|NCT01200069|Ibuprofen|ibuprofen|mesh-list
44559215|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559216|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559217|NCT01200069|Analgesics|analgesics|mesh-ancestor
44559218|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
44559219|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559220|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384797|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
44559221|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559222|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559223|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44559224|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559225|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559226|NCT01199939|Ritonavir|ritonavir|mesh-list
44559227|NCT01199939|Darunavir|darunavir|mesh-list
44559228|NCT01199939|Etravirine|etravirine|mesh-list
44559229|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44559230|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44559231|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
44559232|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559233|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559234|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44559235|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44559236|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
44559237|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559238|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44559239|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44559240|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44559241|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44559242|NCT01199861|Vaccines|vaccines|mesh-list
44559243|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44559244|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
44559245|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559246|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44559247|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559248|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559249|NCT01199822|Olaratumab|olaratumab|mesh-list
44559250|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559251|NCT01199731|Etravirine|etravirine|mesh-list
44559252|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44559253|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44559254|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559255|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559256|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
44559257|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559258|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
44559259|NCT01199705|Antibodies|antibodies|mesh-list
44559260|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
44559261|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44183596|NCT03474029|Rifampin|rifampin|mesh-list
44183597|NCT03474029|Rifapentine|rifapentine|mesh-list
44183598|NCT03474029|Isoniazid|isoniazid|mesh-list
44183599|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44183600|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
44559262|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44559263|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
44559264|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559265|NCT01199575|Rituximab|rituximab|mesh-list
44559266|NCT01199575|Lenalidomide|lenalidomide|mesh-list
44559267|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559268|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559269|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
44559270|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559271|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559272|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44559273|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44559274|NCT01199575|Growth Substances|growth substances|mesh-ancestor
44559275|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
44559276|NCT01199289|Brodalumab|brodalumab|mesh-list
44559277|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559278|NCT01199263|Paclitaxel|paclitaxel|mesh-list
44559279|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44559280|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559281|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559282|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559283|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559284|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559285|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559286|NCT01199198|Tolvaptan|tolvaptan|mesh-list
44559287|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44559288|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559289|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
44559290|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559291|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44559292|NCT01199068|Efatutazone|efatutazone|mesh-list
44559293|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559294|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44384875|NCT03428360|Diazepam|diazepam|mesh-list
44559295|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559296|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559297|NCT01199055|Paclitaxel|paclitaxel|mesh-list
44559298|NCT01199055|Carboplatin|carboplatin|mesh-list
44559299|NCT01199055|Efatutazone|efatutazone|mesh-list
44559300|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559301|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183601|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183617|NCT03412591|Suvorexant|suvorexant|mesh-list
44559302|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559303|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559304|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559305|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559306|NCT01198873|Dronedarone|dronedarone|mesh-list
44559307|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44559308|NCT01198795|Citalopram|citalopram|mesh-list
44559309|NCT01198795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44559310|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44559311|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44559312|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559313|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559314|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
44559315|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559316|NCT01198795|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44559317|NCT01198795|Antidepressive Agents|antidepressive agents|mesh-ancestor
44559318|NCT01198795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44559319|NCT01198756|Vaccines|vaccines|mesh-list
44559320|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
44559321|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559322|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
44559323|NCT01198587|Astringents|astringents|mesh-ancestor
44559324|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559325|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559326|NCT01198574|Vitamins|vitamins|mesh-list
44559327|NCT01198574|Folic Acid|folic acid|mesh-list
44559328|NCT01198574|Vitamin A|vitamin a|mesh-list
44559329|NCT01198574|Iron|iron|mesh-list
44559330|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
44559331|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
44559332|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559333|NCT01198574|Trace Elements|trace elements|mesh-ancestor
44559334|NCT01198574|Hematinics|hematinics|mesh-ancestor
44559335|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
44559336|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
44559337|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559338|NCT01198574|Protective Agents|protective agents|mesh-ancestor
44559339|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44559340|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559341|NCT01198548|Vitamin D|vitamin d|mesh-list
44559342|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
44559343|NCT01198548|Leucovorin|leucovorin|mesh-list
44559344|NCT01198548|Bevacizumab|bevacizumab|mesh-list
44559345|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44559346|NCT01198548|Fluorouracil|fluorouracil|mesh-list
44559347|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
44559348|NCT01198548|Antibodies|antibodies|mesh-list
44559349|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
44559350|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44559351|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
44559352|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559353|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44559354|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44559355|NCT01198548|Growth Substances|growth substances|mesh-ancestor
44559356|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559357|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
44559358|NCT01198548|Vitamins|vitamins|mesh-ancestor
44559359|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
44559360|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
44559361|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44559362|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44559363|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
44559364|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559365|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559366|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559367|NCT01198548|Antidotes|antidotes|mesh-ancestor
44559368|NCT01198548|Protective Agents|protective agents|mesh-ancestor
44559369|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
44559370|NCT01198509|Vancomycin|vancomycin|mesh-list
44559371|NCT01198509|Doxycycline|doxycycline|mesh-list
44559372|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44559373|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559374|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
44559375|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44559376|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44559377|NCT01198275|Amiodarone|amiodarone|mesh-list
44559378|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44559379|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
44559380|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44559381|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44559382|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559383|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44559384|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44559385|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44559386|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559387|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44559388|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44559389|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44559390|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
44559391|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559392|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559393|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559394|NCT01198145|Analgesics|analgesics|mesh-ancestor
44559395|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
44559396|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559397|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559398|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559399|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559400|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44559401|NCT01198132|Vitamin D|vitamin d|mesh-list
44559402|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
44559403|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
44559404|NCT01198132|Vitamins|vitamins|mesh-list
44559405|NCT01198132|Interferons|interferons|mesh-list
44559406|NCT01198132|Interferon-beta|interferon-beta|mesh-list
44559407|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
44559408|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
44559409|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559410|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44559411|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44559412|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559413|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
44559414|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559415|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
44559416|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44559417|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44559418|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559419|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44559420|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559421|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559422|NCT01198002|Methotrexate|methotrexate|mesh-list
44559423|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44559424|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
44559425|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44559426|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559427|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559428|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
44559429|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559430|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559431|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559432|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559433|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44559434|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559435|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
44559436|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559437|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44559438|NCT01197560|Gemcitabine|gemcitabine|mesh-list
44559439|NCT01197560|Rituximab|rituximab|mesh-list
44559440|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
44559441|NCT01197560|Etoposide|etoposide|mesh-list
44559442|NCT01197560|Lenalidomide|lenalidomide|mesh-list
44559443|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559444|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559445|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
44559446|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559447|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559448|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559463|NCT01197417|Analgesics|analgesics|mesh-ancestor
44559464|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
44559465|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559466|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559467|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
44559468|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559469|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44559470|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
44559471|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44559472|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44559473|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559474|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44559475|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
44559476|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44559477|NCT01197378|Cysteamine|cysteamine|mesh-list
44559478|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44559479|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559480|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
44559481|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44559482|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559483|NCT01196988|Vaccines|vaccines|mesh-list
44559484|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
44559485|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559486|NCT01196975|Vaccines|vaccines|mesh-list
44559487|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
44559488|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385100|NCT03412747|Adalimumab|adalimumab|mesh-list
44559489|NCT01196741|Paclitaxel|paclitaxel|mesh-list
44559490|NCT01196741|Saracatinib|saracatinib|mesh-list
44559491|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559492|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559493|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559494|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559495|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559496|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559497|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559498|NCT01196429|Sirolimus|sirolimus|mesh-list
44559499|NCT01196429|Paclitaxel|paclitaxel|mesh-list
44559500|NCT01196429|Docetaxel|docetaxel|mesh-list
44559501|NCT01196429|Carboplatin|carboplatin|mesh-list
44559502|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44559503|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559504|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559505|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559506|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559507|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559508|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559509|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44559510|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559511|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44559512|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
44559513|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559514|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
44559515|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559516|NCT01196416|Cisplatin|cisplatin|mesh-list
44559517|NCT01196416|Temozolomide|temozolomide|mesh-list
44559518|NCT01196416|Vinblastine|vinblastine|mesh-list
44559519|NCT01196416|R04929097|r04929097|mesh-list
44559520|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559521|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44559522|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
44559523|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559524|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559525|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559526|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559527|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559528|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559530|NCT01196390|Carboplatin|carboplatin|mesh-list
44559531|NCT01196390|Trastuzumab|trastuzumab|mesh-list
44559532|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44559533|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44559534|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44559535|NCT01196390|Antibodies|antibodies|mesh-list
44559536|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
44559537|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44559538|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559539|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559540|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559541|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559542|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183836|NCT00945724|Hormones|hormones|mesh-ancestor
44559543|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559544|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
44559545|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559546|NCT01196104|Insulin|insulin|mesh-list
44559547|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44559548|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
44559549|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
44559550|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559551|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559552|NCT01196091|Antimalarials|antimalarials|mesh-list
44559553|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44559554|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44559555|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44559556|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559557|NCT01196091|Analgesics|analgesics|mesh-ancestor
44559558|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
44559559|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559560|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559561|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559562|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
44559563|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44559564|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44559565|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559566|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44559567|NCT01196078|Vinorelbine|vinorelbine|mesh-list
44559568|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559569|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44559570|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559571|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559572|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559573|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559574|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559575|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559576|NCT01196052|Trastuzumab|trastuzumab|mesh-list
44559577|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44559578|NCT01196052|Maytansine|maytansine|mesh-list
44559579|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559580|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559581|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559582|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559583|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559584|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559585|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559586|NCT01195831|Calcipotriene|calcipotriene|mesh-list
44559587|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559588|NCT01195675|Empagliflozin|empagliflozin|mesh-list
44559589|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
44559590|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44559591|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559592|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44559593|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44559594|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559595|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559596|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559597|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559598|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44559599|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559600|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
44559601|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44236620|NCT00560170|Ezetimibe|ezetimibe|mesh-list
44559602|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559603|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559604|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559605|NCT01195415|Gemcitabine|gemcitabine|mesh-list
44559606|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559607|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
44559608|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559609|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559610|NCT01195415|Antiviral Agents|antiviral agents|mesh-ancestor
44559611|NCT01195415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559612|NCT01195415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559613|NCT01195415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559614|NCT01195415|Immunologic Factors|immunologic factors|mesh-ancestor
44559615|NCT01195415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559616|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44559617|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
44559618|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44559619|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44559620|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44559621|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559622|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559623|NCT01195103|Fentanyl|fentanyl|mesh-list
44559624|NCT01195103|Midazolam|midazolam|mesh-list
44559625|NCT01195103|Propofol|propofol|mesh-list
44559626|NCT01195103|Fospropofol|fospropofol|mesh-list
44559627|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44559628|NCT01195103|Narcotics|narcotics|mesh-ancestor
44559629|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559630|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559631|NCT01195103|Analgesics|analgesics|mesh-ancestor
44559632|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
44559633|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559634|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44559635|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44559636|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
44559637|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
44559638|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44559639|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44559640|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44559641|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44559642|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
44559643|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
44559644|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559645|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559646|NCT01195090|Pioglitazone|pioglitazone|mesh-list
44559647|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44559648|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559649|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559650|NCT01195090|Incretins|incretins|mesh-ancestor
44559651|NCT01195090|Hormones|hormones|mesh-ancestor
44559652|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559653|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44559654|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
44559655|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559656|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559657|NCT01194973|Eculizumab|eculizumab|mesh-list
44559658|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44559659|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559660|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
44559661|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559662|NCT01194869|Paclitaxel|paclitaxel|mesh-list
44559663|NCT01194869|Cisplatin|cisplatin|mesh-list
44559664|NCT01194869|Sorafenib|sorafenib|mesh-list
44559665|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44559666|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559667|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559668|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559669|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559670|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559671|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44559672|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559673|NCT01194830|Linagliptin|linagliptin|mesh-list
44559674|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559675|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559676|NCT01194830|Incretins|incretins|mesh-ancestor
44559677|NCT01194830|Hormones|hormones|mesh-ancestor
44559678|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559679|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44559680|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
44559681|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559682|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559683|NCT01194804|Eculizumab|eculizumab|mesh-list
44559684|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44559685|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559686|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
44559687|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559688|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
44559689|NCT01194440|Letrozole|letrozole|mesh-list
44559690|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559691|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44559692|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44559693|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559694|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559695|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44559696|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
44559697|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559698|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559699|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44559700|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
44559701|NCT01194271|Ipilimumab|ipilimumab|mesh-list
44559702|NCT01194271|Leuprolide|leuprolide|mesh-list
44559703|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559704|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559705|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44559706|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559707|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44559708|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
44559709|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44559710|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559711|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44559712|NCT01194258|Insulin|insulin|mesh-list
44559713|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44559714|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
44559715|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
44559716|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
44559717|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
44559719|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559720|NCT01194245|Insulin|insulin|mesh-list
44559721|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44559722|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
44559723|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
44559724|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
44559725|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
44559726|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559727|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559728|NCT01194219|Apremilast|apremilast|mesh-list
44559729|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559730|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559731|NCT01194219|Analgesics|analgesics|mesh-ancestor
44559732|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
44559733|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559734|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559735|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559736|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559737|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44559738|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44559739|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559740|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559741|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
44559742|NCT01194154|Hematinics|hematinics|mesh-ancestor
44559743|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44559744|NCT01193920|Vaccines|vaccines|mesh-list
44559745|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
44559746|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559747|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
44559748|NCT01193660|Hematinics|hematinics|mesh-ancestor
44559749|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44559750|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
44559751|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559752|NCT01193517|Capecitabine|capecitabine|mesh-list
44559753|NCT01193517|Azacitidine|azacitidine|mesh-list
44559755|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
44559756|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559757|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
44559758|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559759|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559760|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559761|NCT01193348|Eculizumab|eculizumab|mesh-list
44559762|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44559763|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559764|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
44559765|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559766|NCT01193335|Vaccines|vaccines|mesh-list
44559767|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44559768|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
44559769|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559770|NCT01193283|Cyclosporine|cyclosporine|mesh-list
44559771|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
44559772|NCT01193283|Cyclosporins|cyclosporins|mesh-list
44559773|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559774|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
44559775|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559776|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559777|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44559778|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
44559779|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559780|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559781|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44559782|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559783|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
44559784|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559785|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559786|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44559787|NCT01193257|Prednisone|prednisone|mesh-list
44559788|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559789|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
44559790|NCT01193257|Hormones|hormones|mesh-ancestor
44559791|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559792|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559793|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44559794|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559795|NCT01193244|Prednisone|prednisone|mesh-list
44559796|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559797|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
44559798|NCT01193244|Hormones|hormones|mesh-ancestor
44184027|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559799|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559800|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559801|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44559802|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559803|NCT01193218|Empagliflozin|empagliflozin|mesh-list
44559804|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44559805|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559806|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559807|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559808|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44559809|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44559810|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44559811|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559812|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559813|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44559814|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44559815|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44559816|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
44559817|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559818|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559819|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44559820|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44559821|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
44559822|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44559823|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44559824|NCT01193127|Mydriatics|mydriatics|mesh-list
44559825|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
44559826|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559827|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559828|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44559829|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44559830|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559831|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44559832|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559833|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44559834|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559835|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559836|NCT01192399|Eculizumab|eculizumab|mesh-list
44559837|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44559838|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559839|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
44559840|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559841|NCT01192295|Oxycodone|oxycodone|mesh-list
44559842|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44559843|NCT01192295|Narcotics|narcotics|mesh-ancestor
44559844|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559845|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559846|NCT01192295|Analgesics|analgesics|mesh-ancestor
44559847|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
44559848|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559849|NCT01192191|Fluticasone|fluticasone|mesh-list
44559850|NCT01192191|Xhance|xhance|mesh-list
44559851|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559852|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44559853|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
44559854|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559855|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559856|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44559857|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
44559858|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559859|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44559860|NCT01192178|Fluticasone|fluticasone|mesh-list
44559861|NCT01192178|Xhance|xhance|mesh-list
44559862|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44559863|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44559864|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559865|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44559866|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
44559867|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559868|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559869|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44559870|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
44559871|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44559872|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44559873|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44559874|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44559875|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44559876|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
44559877|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559878|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559879|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
44559880|NCT01192178|Hormones|hormones|mesh-ancestor
44559881|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559882|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
44559883|NCT01192152|Metformin|metformin|mesh-list
44559884|NCT01192152|Saxagliptin|saxagliptin|mesh-list
44559885|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559886|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559887|NCT01192152|Incretins|incretins|mesh-ancestor
44559888|NCT01192152|Hormones|hormones|mesh-ancestor
44559889|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44559890|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44559891|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44559892|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559893|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559894|NCT01191944|Pramipexole|pramipexole|mesh-list
44559895|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
44559896|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559897|NCT01191944|Protective Agents|protective agents|mesh-ancestor
44559898|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559899|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44559900|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44559901|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
44559903|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44559904|NCT01191840|Vancomycin|vancomycin|mesh-list
44559905|NCT01191840|Cefazolin|cefazolin|mesh-list
44559906|NCT01191840|Daptomycin|daptomycin|mesh-list
44559907|NCT01191840|Cloxacillin|cloxacillin|mesh-list
44559908|NCT01191840|Oxacillin|oxacillin|mesh-list
44559909|NCT01191840|Nafcillin|nafcillin|mesh-list
44559910|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44559911|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559912|NCT01191801|Cytarabine|cytarabine|mesh-list
44559913|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44559914|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
44559915|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559916|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559917|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
44559918|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44559919|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559920|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
44559921|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559922|NCT05656833|Cysteamine|cysteamine|mesh-list
44559923|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44559924|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559925|NCT05656742|Vitamin D|vitamin d|mesh-list
44559926|NCT05656742|Vitamins|vitamins|mesh-ancestor
44559927|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
44559928|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559929|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44559930|NCT05656703|Anesthetics|anesthetics|mesh-list
44559931|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559932|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559933|NCT05656664|Folic Acid|folic acid|mesh-list
44559934|NCT05656664|Hematinics|hematinics|mesh-ancestor
44559935|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
44559936|NCT05656664|Vitamins|vitamins|mesh-ancestor
44559937|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
44559938|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559939|NCT05656534|Suvorexant|suvorexant|mesh-list
44559940|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44559941|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44559942|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559943|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559944|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44559947|NCT05656352|Chrysarobin|chrysarobin|mesh-list
44559948|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44559949|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44559950|NCT05656352|Analgesics|analgesics|mesh-ancestor
44559951|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
44559952|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559953|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559954|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44559955|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559956|NCT05656170|Bupivacaine|bupivacaine|mesh-list
44559957|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
44559958|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
44559959|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559960|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559961|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
44559962|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44559963|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
44559964|NCT05656079|Docetaxel|docetaxel|mesh-list
44559965|NCT05656079|Doxorubicin|doxorubicin|mesh-list
44559966|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44559967|NCT05656079|Trastuzumab|trastuzumab|mesh-list
44559968|NCT05656079|Epirubicin|epirubicin|mesh-list
44559969|NCT05656079|Pertuzumab|pertuzumab|mesh-list
44559970|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44559971|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
44559972|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559973|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44559974|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44559975|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
44559976|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44559977|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44559978|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44559979|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
44559980|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
44559981|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
44559982|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44559983|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44559984|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44559985|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44559986|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559987|NCT05655754|Methohexital|methohexital|mesh-list
44559988|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44559989|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
44559990|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
44559991|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44559992|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559993|NCT05655728|Metformin|metformin|mesh-list
44559994|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44559995|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44559996|NCT05655715|Nivolumab|nivolumab|mesh-list
44559997|NCT05655715|Ipilimumab|ipilimumab|mesh-list
44559998|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44559999|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184224|NCT00329329|Capecitabine|capecitabine|mesh-list
44560000|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44560001|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560002|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
44560003|NCT05655689|Vancomycin|vancomycin|mesh-list
44560004|NCT05655689|Gentamicins|gentamicins|mesh-list
44560005|NCT05655689|Ceftazidime|ceftazidime|mesh-list
44560006|NCT05655689|Natamycin|natamycin|mesh-list
44560007|NCT05655689|Voriconazole|voriconazole|mesh-list
44560008|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44560009|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44560010|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44560011|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560012|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44560013|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44560014|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560015|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560016|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560017|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560018|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44560019|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
44560020|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44385635|NCT03378635|Glucagon|glucagon|mesh-list
44560021|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44560022|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44560023|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
44560024|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560025|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44560026|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44560027|NCT05655598|Palbociclib|palbociclib|mesh-list
44560028|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560029|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560030|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560031|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560032|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44560033|NCT05655338|Amoxicillin|amoxicillin|mesh-list
44560034|NCT05655338|Metronidazole|metronidazole|mesh-list
44560035|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
44560036|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44560037|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44560038|NCT05655273|Tacrolimus|tacrolimus|mesh-list
44560039|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560040|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
44560041|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560042|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44560043|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560044|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560045|NCT05655221|Mitogens|mitogens|mesh-list
44560046|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
44560047|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560048|NCT05655130|Dexamethasone|dexamethasone|mesh-list
44560049|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
44560050|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44560051|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44560052|NCT05655130|Prednisolone|prednisolone|mesh-list
44560053|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
44560054|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44560055|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
44560056|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560057|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
44560058|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
44560059|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560060|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560061|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44560062|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
44560063|NCT05655130|Hormones|hormones|mesh-ancestor
44560064|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560065|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560066|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560067|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44560068|NCT05655130|Protective Agents|protective agents|mesh-ancestor
44560069|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
44560070|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44560071|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
44560072|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560073|NCT05658549|Expectorants|expectorants|mesh-ancestor
44560074|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
44560075|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44560076|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
44560077|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560078|NCT05658549|Protective Agents|protective agents|mesh-ancestor
44560079|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560080|NCT05658549|Antidotes|antidotes|mesh-ancestor
44560081|NCT05658497|Interferons|interferons|mesh-list
44560082|NCT05658497|Interferon-beta|interferon-beta|mesh-list
44560083|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
44560084|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44560085|NCT05658497|Natalizumab|natalizumab|mesh-list
44560086|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560087|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
44560088|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560089|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
44560090|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560091|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44560092|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560093|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560094|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44560095|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560096|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560097|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
44560098|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560099|NCT05658159|Vitamin D|vitamin d|mesh-list
44560100|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
44560101|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
44560102|NCT05658159|Vitamins|vitamins|mesh-list
44560103|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
44560104|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560105|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44560106|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44560107|NCT05658146|Sulconazole|sulconazole|mesh-list
44560108|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
44560109|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560110|NCT05658120|Epinephrine|epinephrine|mesh-list
44560111|NCT05658120|Racepinephrine|racepinephrine|mesh-list
44560112|NCT05658120|Norepinephrine|norepinephrine|mesh-list
44560113|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
44560114|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44560115|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44560116|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44560117|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560118|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560119|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560120|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44560121|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44560122|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
44560123|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560124|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44560125|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44560126|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
44560127|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
44560128|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44560129|NCT05658055|Amoxicillin|amoxicillin|mesh-list
44560130|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44560131|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560132|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44560133|NCT05657704|Tramadol|tramadol|mesh-list
44560134|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44560135|NCT05657704|Narcotics|narcotics|mesh-ancestor
44560136|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560137|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560139|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
44560140|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560141|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44560142|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560143|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560144|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560145|NCT05657496|Triamcinolone|triamcinolone|mesh-list
44560146|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44560147|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44560148|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44560149|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560150|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
44560151|NCT05657496|Hormones|hormones|mesh-ancestor
44560152|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560153|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560154|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560155|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
44560156|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560157|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560158|NCT05657470|Tenecteplase|tenecteplase|mesh-list
44560159|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44560160|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44560161|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560162|NCT05657457|Tenecteplase|tenecteplase|mesh-list
44560163|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44560164|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44560165|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560166|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
44560167|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44560168|NCT05657171|Estradiol|estradiol|mesh-list
44560169|NCT05657171|Cyproterone|cyproterone|mesh-list
44560170|NCT05657171|Estrogens|estrogens|mesh-ancestor
44560171|NCT05657171|Hormones|hormones|mesh-ancestor
44560172|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560173|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560174|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44560175|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
44560176|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560177|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44560178|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44560179|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44560180|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
44560181|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
44560182|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560183|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44560184|NCT05657041|Clopidogrel|clopidogrel|mesh-list
44560185|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44560186|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44560187|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44560188|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44560189|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44560190|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
44560191|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560192|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560193|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560194|NCT05657028|Lidocaine|lidocaine|mesh-list
44560195|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
44560196|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
44560197|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
44560198|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560199|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560200|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
44560201|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560202|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44560203|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44560204|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44560205|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560214|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560215|NCT05657015|Simvastatin|simvastatin|mesh-list
44560216|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44560217|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44560218|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
44560219|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560220|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44560221|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44560222|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560223|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
44560224|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
44560225|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560226|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44560227|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
44560228|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44560229|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
44560230|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560231|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560232|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
44560233|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560234|NCT01188668|Aripiprazole|aripiprazole|mesh-list
44560235|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44560236|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
44560237|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560238|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44560239|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44560240|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560241|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560242|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
44560243|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
44560244|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560245|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560246|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44560247|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44560248|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
44560249|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44560250|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44560251|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44560252|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44560253|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44560254|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560255|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560256|NCT01188655|Etanercept|etanercept|mesh-list
44560257|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44560258|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560259|NCT01188655|Analgesics|analgesics|mesh-ancestor
44560260|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
44560261|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560262|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560263|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560264|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560265|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44560266|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560267|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
44560268|NCT01188551|Fentanyl|fentanyl|mesh-list
44560269|NCT01188551|Midazolam|midazolam|mesh-list
44560270|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
44560271|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44560272|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560273|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560274|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560275|NCT01188551|Analgesics|analgesics|mesh-ancestor
44560276|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
44560277|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560278|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44560279|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44560280|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44560281|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44560282|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560283|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560284|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44560285|NCT01188551|Narcotics|narcotics|mesh-ancestor
44560286|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44560287|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44560288|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
44560289|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
44560290|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44560291|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44560292|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560293|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
44560294|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
44560295|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44560296|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44560297|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560298|NCT01188538|Analgesics|analgesics|mesh-ancestor
44560299|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
44560300|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560301|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560302|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560303|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560304|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560305|NCT01187953|Tacrolimus|tacrolimus|mesh-list
44560306|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560307|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
44560308|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560309|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44560310|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560311|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560312|NCT01187901|Sulindac|sulindac|mesh-list
44560313|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44560314|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560315|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560316|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184497|NCT00330278|Cefazolin|cefazolin|mesh-list
44560317|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560318|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44560319|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44560320|NCT01187901|Analgesics|analgesics|mesh-ancestor
44560321|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
44560322|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560323|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560324|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560325|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560326|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44560327|NCT01187550|Hormones|hormones|mesh-list
44560328|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560329|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560330|NCT01187446|Vorinostat|vorinostat|mesh-list
44560331|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560332|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44560333|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560334|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560335|NCT01187407|Serotonin|serotonin|mesh-list
44560336|NCT01187407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44560337|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44560338|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
44560339|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560340|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560341|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560342|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560343|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560345|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560346|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
44560347|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560348|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560349|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560350|NCT01186796|Fulvestrant|fulvestrant|mesh-list
44560351|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560352|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560353|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44560354|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44560355|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
44560356|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560357|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560358|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
44560359|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44560360|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560361|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
44560362|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560363|NCT01186744|Tofacitinib|tofacitinib|mesh-list
44560364|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560365|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560366|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560367|NCT01186458|Rituximab|rituximab|mesh-list
44560368|NCT01186458|Fludarabine|fludarabine|mesh-list
44560369|NCT01186458|Bortezomib|bortezomib|mesh-list
44560370|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44560371|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560372|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
44560373|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560374|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560375|NCT01186328|Cytarabine|cytarabine|mesh-list
44560376|NCT01186328|Prednisone|prednisone|mesh-list
44560377|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
44560378|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44560379|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44560380|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44560381|NCT01186328|Cortisone|cortisone|mesh-list
44560382|NCT01186328|Doxorubicin|doxorubicin|mesh-list
44560383|NCT01186328|Methotrexate|methotrexate|mesh-list
44560384|NCT01186328|Vincristine|vincristine|mesh-list
44560385|NCT01186328|Asparaginase|asparaginase|mesh-list
44560386|NCT01186328|Pegaspargase|pegaspargase|mesh-list
44560387|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44560388|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560389|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44560390|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44560391|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560392|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560393|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560394|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
44560395|NCT01186328|Hormones|hormones|mesh-ancestor
44560396|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560397|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560398|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560399|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560400|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560401|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560402|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560403|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
44560404|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560405|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560406|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560407|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
44560408|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560409|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560410|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
44560411|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560412|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44560413|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44560414|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44560415|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44560416|NCT01185964|Doxorubicin|doxorubicin|mesh-list
44560417|NCT01185964|Olaratumab|olaratumab|mesh-list
44560418|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44560419|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560420|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44560421|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44560422|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560423|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560424|NCT01185821|Siponimod|siponimod|mesh-list
44560425|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44560426|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560427|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560428|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
44560429|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560430|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
44560431|NCT01185782|Hormones|hormones|mesh-list
44560432|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44560433|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560434|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560435|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44560436|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
44560437|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560438|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44560439|NCT01185704|Cetrorelix|cetrorelix|mesh-list
44560440|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44560441|NCT01185704|Hormones|hormones|mesh-list
44560442|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44560443|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560444|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560445|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44560446|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
44560447|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560448|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
44560449|NCT01185548|Tolbutamide|tolbutamide|mesh-list
44560450|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560451|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184647|NCT00330824|Hormones|hormones|mesh-ancestor
44560452|NCT01185509|Trastuzumab|trastuzumab|mesh-list
44560453|NCT01185509|Vinorelbine|vinorelbine|mesh-list
44560454|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44560455|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560456|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44560457|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
44560458|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
44560459|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
44560460|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560461|NCT01185366|Everolimus|everolimus|mesh-list
44560462|NCT01185366|Sunitinib|sunitinib|mesh-list
44560463|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560464|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560465|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
44560466|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560467|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44560468|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44560469|NCT01185366|Growth Substances|growth substances|mesh-ancestor
44560470|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
44560471|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560472|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560473|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560474|NCT01185353|Methotrexate|methotrexate|mesh-list
44560475|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560476|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560477|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560478|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560479|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560480|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
44560481|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560482|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560483|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560484|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560485|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560486|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560487|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
44560488|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560489|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560490|NCT01185340|Serotonin|serotonin|mesh-list
44560491|NCT01185340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44560492|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44560493|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
44560494|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560495|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560496|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560497|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560498|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560499|NCT01185301|Adalimumab|adalimumab|mesh-list
44560500|NCT01185301|Methotrexate|methotrexate|mesh-list
44560501|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560502|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560503|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560504|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560505|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560506|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
44560507|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560508|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560509|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560510|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560511|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560512|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560514|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560515|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560516|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560517|NCT01185288|Adalimumab|adalimumab|mesh-list
44560518|NCT01185288|Methotrexate|methotrexate|mesh-list
44560519|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560520|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560521|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560522|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560523|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560524|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
44560525|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560526|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560527|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560528|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560529|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560530|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560531|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
44560532|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560533|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560534|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560535|NCT01185171|Gefitinib|gefitinib|mesh-list
44560536|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560537|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560538|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560539|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560540|NCT01185080|Adenosine|adenosine|mesh-list
44560541|NCT01185080|Analgesics|analgesics|mesh-ancestor
44560542|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
44560543|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560544|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560545|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44560546|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
44560547|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44560548|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
44560549|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
44560550|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560551|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560552|NCT01184989|Dabigatran|dabigatran|mesh-list
44560553|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
44560554|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44560555|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560556|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560557|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560558|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
44560559|NCT01184872|Vancomycin|vancomycin|mesh-list
44560560|NCT01184872|Daptomycin|daptomycin|mesh-list
44560561|NCT01184872|Penicillins|penicillins|mesh-list
44560562|NCT01184872|Floxacillin|floxacillin|mesh-list
44560564|NCT01184872|Oxacillin|oxacillin|mesh-list
44560565|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44560566|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560567|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44560568|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
44560569|NCT01184859|Coagulants|coagulants|mesh-ancestor
44560570|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44560571|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
44560572|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560573|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
44560574|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44560575|NCT01184846|Antibodies|antibodies|mesh-list
44560576|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
44560577|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560578|NCT01184326|Everolimus|everolimus|mesh-list
44560579|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560580|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560581|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
44560582|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560583|NCT01184118|Fluticasone|fluticasone|mesh-list
44560584|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560585|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44560586|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
44560587|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560588|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560589|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44560591|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560592|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44560593|NCT01184079|Vaccines|vaccines|mesh-list
44560594|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
44560595|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560596|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
44560597|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386299|NCT03339726|Phenylephrine|phenylephrine|mesh-list
44560600|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560601|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
44560602|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560603|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44560604|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560605|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560606|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560607|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560608|NCT01183780|Leucovorin|leucovorin|mesh-list
44560609|NCT01183780|Folic Acid|folic acid|mesh-list
44560610|NCT01183780|Fluorouracil|fluorouracil|mesh-list
44560611|NCT01183780|Irinotecan|irinotecan|mesh-list
44560612|NCT01183780|Ramucirumab|ramucirumab|mesh-list
44560613|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
44560614|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
44560615|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560616|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560617|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560618|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560619|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
44560620|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560621|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44560622|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44560623|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560624|NCT01183780|Antidotes|antidotes|mesh-ancestor
44560625|NCT01183780|Protective Agents|protective agents|mesh-ancestor
44560626|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
44560627|NCT01183780|Vitamins|vitamins|mesh-ancestor
44560628|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
44560629|NCT01183780|Hematinics|hematinics|mesh-ancestor
44560630|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44560631|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
44560632|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44560633|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44560634|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560635|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560636|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560637|NCT01183390|Anastrozole|anastrozole|mesh-list
44560638|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560639|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560640|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44560641|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44560642|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560643|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560644|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44560645|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44560646|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560647|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560648|NCT01191762|Sevelamer|sevelamer|mesh-list
44560649|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
44560650|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
44560651|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560652|NCT01191268|Insulin|insulin|mesh-list
44560653|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44560654|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
44560655|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
44560656|NCT01191268|Dulaglutide|dulaglutide|mesh-list
44560657|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560658|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560659|NCT01191190|Ofatumumab|ofatumumab|mesh-list
44560660|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560661|NCT01191086|Topiramate|topiramate|mesh-list
44560662|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
44560663|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560664|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560665|NCT01191008|Timolol|timolol|mesh-list
44560666|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44560667|NCT01191008|Latanoprost|latanoprost|mesh-list
44560668|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44560670|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44560671|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
44560672|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560673|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560674|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560685|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44560687|NCT01190930|Vincristine|vincristine|mesh-list
44560688|NCT01190930|Asparaginase|asparaginase|mesh-list
44560689|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
44560690|NCT01190930|Pegaspargase|pegaspargase|mesh-list
44560691|NCT01190930|Thioguanine|thioguanine|mesh-list
44560692|NCT01190930|BB 1101|bb 1101|mesh-list
44560693|NCT01190930|Calcium|calcium|mesh-list
44560694|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
44560695|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
44560696|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560697|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
44560698|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560699|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560700|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44560701|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
44560702|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560703|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560704|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44560705|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44560706|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
44560707|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
44560708|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560709|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44560710|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
44560711|NCT01190930|Hormones|hormones|mesh-ancestor
44560712|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560713|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560714|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560715|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560716|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44560717|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44560718|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44560719|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44560720|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44560721|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560722|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560723|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560724|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560725|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
44560726|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560727|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560728|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560729|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
44560730|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560731|NCT01190930|Antidotes|antidotes|mesh-ancestor
44560732|NCT01190930|Protective Agents|protective agents|mesh-ancestor
44560733|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
44560734|NCT01190930|Vitamins|vitamins|mesh-ancestor
44560735|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
44560736|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44560737|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44560738|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44560739|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
44560740|NCT01190930|Hematinics|hematinics|mesh-ancestor
44560741|NCT01190839|Infliximab|infliximab|mesh-list
44560742|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560743|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44560744|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560745|NCT01190813|Levodopa|levodopa|mesh-list
44560746|NCT01190813|Carbidopa|carbidopa|mesh-list
44560747|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44560748|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44560749|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
44560750|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560751|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560752|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560753|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44560754|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560755|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44560756|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44560757|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560758|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560759|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560760|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560761|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560762|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
44560763|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560764|NCT01190449|Ofatumumab|ofatumumab|mesh-list
44560765|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560766|NCT01190436|Bisoprolol|bisoprolol|mesh-list
44560767|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44560768|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
44560769|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
44560770|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44560771|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560772|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44560773|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44560774|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44560775|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44560776|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560777|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560778|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
44560779|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560780|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
44560781|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560782|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560783|NCT01190267|Asenapine|asenapine|mesh-list
44560784|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184935|NCT00331786|Analgesics|analgesics|mesh-ancestor
44560785|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44560786|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560787|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560788|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560789|NCT01190254|Asenapine|asenapine|mesh-list
44560790|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44560791|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44560800|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44560801|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560802|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
44560803|NCT01190150|Coagulants|coagulants|mesh-ancestor
44560804|NCT01190098|Lacosamide|lacosamide|mesh-list
44560805|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
44560806|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44560807|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44560808|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560809|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560810|NCT01190020|Lubiprostone|lubiprostone|mesh-list
44560811|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44560812|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560813|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560814|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44560815|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44560816|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44560817|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
44560818|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560819|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44560820|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44560821|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44560822|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560823|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44560824|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560825|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44560826|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560827|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44560828|NCT01189890|Glimepiride|glimepiride|mesh-list
44560829|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560830|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560831|NCT01189890|Incretins|incretins|mesh-ancestor
44560832|NCT01189890|Hormones|hormones|mesh-ancestor
44184993|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560833|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560834|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44560835|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560837|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560838|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44560839|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560840|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
44560841|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
44560842|NCT01189812|Citalopram|citalopram|mesh-list
44560843|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
44560844|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560845|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560846|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560847|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
44560848|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44560849|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560850|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560851|NCT01189812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44560852|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560853|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560854|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560855|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
44560856|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44560858|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44560859|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44560860|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560861|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44560862|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
44560863|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
44560864|NCT01189500|Tamoxifen|tamoxifen|mesh-list
44560865|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44560866|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44560867|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185034|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44560868|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560869|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560870|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44560871|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560872|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44560873|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44560874|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44560875|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44560876|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560877|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560878|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560879|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560880|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
44560881|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44560882|NCT01189487|Ampicillin|ampicillin|mesh-list
44560883|NCT01189487|Sulbactam|sulbactam|mesh-list
44560884|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44560885|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44560886|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44560887|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560888|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560889|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44560890|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560891|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44560892|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560893|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560894|NCT01189266|Vorinostat|vorinostat|mesh-list
44560895|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560896|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44560897|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560898|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185077|NCT00332072|Timolol|timolol|mesh-list
44560899|NCT01189201|Linagliptin|linagliptin|mesh-list
44560900|NCT01189201|Empagliflozin|empagliflozin|mesh-list
44560901|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560902|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560903|NCT01189201|Incretins|incretins|mesh-ancestor
44560904|NCT01189201|Hormones|hormones|mesh-ancestor
44560905|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560906|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44560907|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560909|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560910|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44560911|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44560912|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44560913|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
44560914|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
44560915|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560916|NCT01188811|Protective Agents|protective agents|mesh-ancestor
44560917|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560918|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
44560919|NCT01188811|Vitamins|vitamins|mesh-ancestor
44560920|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
44560921|NCT01188798|Methotrexate|methotrexate|mesh-list
44560922|NCT01188798|Pentostatin|pentostatin|mesh-list
44560923|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44560924|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
44560925|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560926|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560927|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44560928|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
44560929|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560930|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560931|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44560932|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560933|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44560934|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560935|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
44560936|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44560937|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44560938|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44560939|NCT01183234|Methylphenidate|methylphenidate|mesh-list
44560940|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44560941|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560942|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44560943|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44560944|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44560945|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560946|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
44560947|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44560948|NCT01183221|Oxytocin|oxytocin|mesh-list
44560949|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
44560950|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44560951|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560952|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44560953|NCT01183143|Hormones|hormones|mesh-ancestor
44560954|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560955|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560956|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44560957|NCT01183104|Glimepiride|glimepiride|mesh-list
44560958|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560959|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560960|NCT01183104|Incretins|incretins|mesh-ancestor
44560961|NCT01183104|Hormones|hormones|mesh-ancestor
44560962|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560963|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44560964|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560965|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560966|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560967|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44560968|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44560969|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
44560970|NCT01183065|Folic Acid|folic acid|mesh-list
44560971|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
44560972|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
44560973|NCT01183065|Vitamins|vitamins|mesh-ancestor
44560974|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
44560975|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560976|NCT01183065|Hematinics|hematinics|mesh-ancestor
44560977|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
44560978|NCT01183013|Pioglitazone|pioglitazone|mesh-list
44560979|NCT01183013|Linagliptin|linagliptin|mesh-list
44560980|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44560981|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44560982|NCT01183013|Incretins|incretins|mesh-ancestor
44560983|NCT01183013|Hormones|hormones|mesh-ancestor
44560984|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44560985|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44560986|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
44560987|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44560988|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44560989|NCT01182441|Warfarin|warfarin|mesh-list
44560990|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
44560991|NCT01182350|Bevacizumab|bevacizumab|mesh-list
44560992|NCT01182350|Temozolomide|temozolomide|mesh-list
44560993|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44560994|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44560995|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44560996|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44560997|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44560998|NCT01182350|Growth Substances|growth substances|mesh-ancestor
44560999|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561000|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44561001|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44561002|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
44185144|NCT00332306|Lamivudine|lamivudine|mesh-list
44561003|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561004|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561005|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561006|NCT01182285|Valproic Acid|valproic acid|mesh-list
44561007|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
44561008|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561009|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561010|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
44561011|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561012|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561013|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
44561014|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44561015|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561016|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561017|NCT01182207|Drospirenone|drospirenone|mesh-list
44561018|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44561019|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44561020|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44561021|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44561022|NCT01182207|Estradiol|estradiol|mesh-list
44561023|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44561024|NCT01182207|Estrogens|estrogens|mesh-ancestor
44561025|NCT01182207|Hormones|hormones|mesh-ancestor
44561026|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561027|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561028|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44561029|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
44561030|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44561031|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44561032|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44561033|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44561034|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44561035|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561036|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44561037|NCT01182207|Diuretics|diuretics|mesh-ancestor
44561038|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
44561039|NCT01182194|Drospirenone|drospirenone|mesh-list
44185206|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561040|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44561041|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44561042|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44561043|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44561044|NCT01182194|Estradiol|estradiol|mesh-list
44561045|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44561046|NCT01182194|Estrogens|estrogens|mesh-ancestor
44561047|NCT01182194|Hormones|hormones|mesh-ancestor
44561048|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561049|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561050|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44561051|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
44561052|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44561053|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44561054|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44561055|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44561056|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44561057|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561058|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44561059|NCT01182194|Diuretics|diuretics|mesh-ancestor
44561060|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
44561061|NCT01182181|Anastrozole|anastrozole|mesh-list
44561062|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44561063|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561064|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44561065|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44561066|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561067|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561068|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44561069|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561070|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561071|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561072|NCT01181986|Exenatide|exenatide|mesh-list
44561073|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561074|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561075|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44561076|NCT01181986|Incretins|incretins|mesh-ancestor
44561077|NCT01181986|Hormones|hormones|mesh-ancestor
44561078|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561079|NCT01181921|Galantamine|galantamine|mesh-list
44561080|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44561081|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561082|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561083|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
44561084|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561085|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561086|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44561087|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
44561088|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561089|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
44561090|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44561091|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44561092|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
44561093|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561094|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561095|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44561096|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561097|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44561098|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44561099|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44561100|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561101|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561102|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561103|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44561104|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44561105|NCT01181726|Norethindrone|norethindrone|mesh-list
44561106|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
44561107|NCT01181726|Estradiol|estradiol|mesh-list
44561108|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44561109|NCT01181726|Estrogens|estrogens|mesh-ancestor
44561110|NCT01181726|Hormones|hormones|mesh-ancestor
44561111|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561112|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561113|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44561114|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
44561115|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44561116|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44561117|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44561118|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44561119|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44561120|NCT01181609|Bevacizumab|bevacizumab|mesh-list
44561121|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44561122|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561123|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44561124|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44561125|NCT01181609|Growth Substances|growth substances|mesh-ancestor
44561126|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561127|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44561128|NCT01181531|Vitamin D|vitamin d|mesh-list
44561129|NCT01181531|Cinacalcet|cinacalcet|mesh-list
44561130|NCT01181531|Vitamins|vitamins|mesh-ancestor
44561131|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
44561132|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561133|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44561134|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561135|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44561136|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561137|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561138|NCT01181271|Sirolimus|sirolimus|mesh-list
44561139|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
44561140|NCT01181271|Busulfan|busulfan|mesh-list
44561141|NCT01181271|Methotrexate|methotrexate|mesh-list
44561142|NCT01181271|Fludarabine|fludarabine|mesh-list
44561143|NCT01181271|Etoposide|etoposide|mesh-list
44561144|NCT01181271|Tacrolimus|tacrolimus|mesh-list
44561145|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561146|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
44561147|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561148|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561149|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44561150|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
44561151|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561165|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44561166|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44561167|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561168|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561169|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44561170|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
44561171|NCT01181167|Enoxaparin|enoxaparin|mesh-list
44561172|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
44561173|NCT01181167|Edoxaban|edoxaban|mesh-list
44561174|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
44561175|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44561176|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44561177|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561178|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44561179|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
44561180|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44561181|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561182|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561183|NCT01181141|Enoxaparin|enoxaparin|mesh-list
44561184|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
44561185|NCT01181141|Edoxaban|edoxaban|mesh-list
44561186|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
44561187|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44561188|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44561189|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561190|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44561191|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
44561192|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44561193|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561194|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561195|NCT01181128|Factor VIII|factor viii|mesh-list
44561196|NCT01181128|Coagulants|coagulants|mesh-ancestor
44561197|NCT01181102|Enoxaparin|enoxaparin|mesh-list
44561198|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
44561199|NCT01181102|Edoxaban|edoxaban|mesh-list
44561200|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
44185358|NCT00332904|Diuretics|diuretics|mesh-ancestor
44561201|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44561202|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44561203|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561204|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44561205|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
44561206|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44561207|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561208|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561209|NCT01181011|Amlodipine|amlodipine|mesh-list
44561210|NCT01181011|Telmisartan|telmisartan|mesh-list
44561211|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44561212|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561213|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44561214|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561215|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561216|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561217|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561218|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561219|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44561220|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44561223|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
44561224|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
44561225|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44561226|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561227|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
44561228|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561229|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
44561230|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561231|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
44561232|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561233|NCT01180660|Lidocaine|lidocaine|mesh-list
44561234|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
44561235|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
44561236|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561237|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561238|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
44561239|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561240|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44561241|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44561242|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44561243|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561244|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561245|NCT01180647|Naltrexone|naltrexone|mesh-list
44561246|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44561247|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44561248|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561249|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
44561250|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561251|NCT01180296|Progesterone|progesterone|mesh-list
44561252|NCT01180296|Progestins|progestins|mesh-ancestor
44561253|NCT01180296|Hormones|hormones|mesh-ancestor
44561254|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561255|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561256|NCT01180049|Sirolimus|sirolimus|mesh-list
44561257|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561258|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561259|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44561260|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561261|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
44561262|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561263|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
44561264|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185397|NCT00333021|PENTA|penta|mesh-list
44561265|NCT01179919|Oseltamivir|oseltamivir|mesh-list
44561266|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
44561267|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561268|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561269|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561270|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44561271|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44561272|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44561273|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561274|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561275|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561276|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561277|NCT01179672|Analgesics|analgesics|mesh-ancestor
44561278|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
44561279|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561280|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
44561281|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561282|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
44561283|NCT01179516|Vortioxetine|vortioxetine|mesh-list
44561284|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
44561285|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561286|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44561287|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44561288|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561289|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561290|NCT01179516|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44561291|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44561292|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965108|NCT01596699|Fludarabine|fludarabine|mesh-list
44561293|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561294|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561296|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44561297|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44561298|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44561299|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44561300|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
44561301|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44561302|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
44561303|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561304|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561305|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44561306|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561307|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
44185455|NCT00333125|Timolol|timolol|mesh-list
44561308|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44561309|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
44561310|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561311|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561312|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
44561313|NCT01179334|Riociguat|riociguat|mesh-list
44561314|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561315|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44561316|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44561318|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561319|NCT01179334|Urological Agents|urological agents|mesh-ancestor
44561320|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
44561321|NCT01179191|Naltrexone|naltrexone|mesh-list
44561322|NCT01179191|Morphine|morphine|mesh-list
44561323|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44561324|NCT01179191|Narcotics|narcotics|mesh-ancestor
44561325|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561326|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561327|NCT01179191|Analgesics|analgesics|mesh-ancestor
44561328|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
44561329|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561330|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44561331|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44561332|NCT01179048|Liraglutide|liraglutide|mesh-list
44561333|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561334|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561335|NCT01179048|Incretins|incretins|mesh-ancestor
44561336|NCT01179048|Hormones|hormones|mesh-ancestor
44561337|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561338|NCT01178853|Warfarin|warfarin|mesh-list
44561339|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44561340|NCT01178853|Pitavastatin|pitavastatin|mesh-list
44561341|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44561342|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44561343|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
44561344|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561345|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44561346|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44561347|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561348|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
44561349|NCT01178762|Azithromycin|azithromycin|mesh-list
44561350|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561351|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561352|NCT01178671|Mirtazapine|mirtazapine|mesh-list
44561353|NCT01178671|Sertraline|sertraline|mesh-list
44561354|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
44561355|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561356|NCT01178671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44561357|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44561358|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561359|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561360|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561361|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
44561362|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561363|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44561364|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
44561365|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
44561366|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44561367|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43703618|NCT02709720|Cisplatin|cisplatin|mesh-list
44561368|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561369|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44561370|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44561371|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44561372|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561373|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44561374|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44561375|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44561385|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44561386|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44561387|NCT01178086|Rituximab|rituximab|mesh-list
44561388|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44561389|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561390|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
44561391|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561392|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561393|NCT01178073|Ambrisentan|ambrisentan|mesh-list
44561394|NCT01178073|Tadalafil|tadalafil|mesh-list
44561395|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561396|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44561397|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44561398|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561399|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561400|NCT01178073|Urological Agents|urological agents|mesh-ancestor
44561401|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561402|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44561403|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44561404|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44561405|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561406|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561407|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561408|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561409|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561410|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44561411|NCT01177813|Empagliflozin|empagliflozin|mesh-list
44561412|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561413|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561414|NCT01177813|Incretins|incretins|mesh-ancestor
44561415|NCT01177813|Hormones|hormones|mesh-ancestor
44561416|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561417|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44561418|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561419|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561420|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561421|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44561422|NCT01177800|Infliximab|infliximab|mesh-list
44561423|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44561424|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44561425|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561426|NCT01177722|Vaccines|vaccines|mesh-list
44561427|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
44561428|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561429|NCT01177540|Decitabine|decitabine|mesh-list
44561430|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44561431|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
44561432|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561433|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561434|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561435|NCT01177410|Mesalamine|mesalamine|mesh-list
44561436|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44561437|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44561438|NCT01177410|Analgesics|analgesics|mesh-ancestor
44561439|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
44561440|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561441|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561442|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44561443|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561444|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44561445|NCT01177384|Glimepiride|glimepiride|mesh-list
44561446|NCT01177384|Acarbose|acarbose|mesh-list
44561447|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561448|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561449|NCT01177384|Incretins|incretins|mesh-ancestor
44561450|NCT01177384|Hormones|hormones|mesh-ancestor
44561451|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561452|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44561453|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561454|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561455|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561456|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44561457|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561458|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
44561459|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44561460|NCT01177293|Amlodipine|amlodipine|mesh-list
44561461|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561462|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44561463|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561464|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561465|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561466|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561467|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561468|NCT01177228|Vedolizumab|vedolizumab|mesh-list
44561469|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44561470|NCT01176968|Eplerenone|eplerenone|mesh-list
44561471|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44561472|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561473|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561474|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561475|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44561476|NCT01176968|Diuretics|diuretics|mesh-ancestor
44561477|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
44561478|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561479|NCT01176916|Exemestane|exemestane|mesh-list
44561480|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561481|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44561482|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44561483|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561484|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561485|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44561486|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185613|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44561487|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561488|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561489|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
44561490|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44561491|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
44561492|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561493|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
44561494|NCT01176773|Protective Agents|protective agents|mesh-ancestor
44561495|NCT01176565|Nicardipine|nicardipine|mesh-list
44561496|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561497|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44561498|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561499|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561500|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561501|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561503|NCT01176240|Mannitol|mannitol|mesh-list
44561504|NCT01176240|Droxidopa|droxidopa|mesh-list
44561505|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44561506|NCT01176240|Diuretics|diuretics|mesh-ancestor
44561507|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
44561508|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561509|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44561510|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44561511|NCT01176058|Fluconazole|fluconazole|mesh-list
44561512|NCT01176058|Anidulafungin|anidulafungin|mesh-list
44561513|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
44561514|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561515|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44561516|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44561517|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561518|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561519|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44561520|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
44561521|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561522|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561523|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44561524|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44561525|NCT01176032|Losartan|losartan|mesh-list
44561526|NCT01176032|Amlodipine|amlodipine|mesh-list
44561527|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44561528|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561529|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44561530|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561531|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561532|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561533|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561534|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561535|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44561536|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44561537|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44561538|NCT01176032|Diuretics|diuretics|mesh-ancestor
44561539|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
44561540|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44561541|NCT01175824|Insulin|insulin|mesh-list
44561542|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44561543|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
44561544|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
44561545|NCT01175824|Protamines|protamines|mesh-list
44561546|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561547|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561548|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
44561549|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561550|NCT01175824|Coagulants|coagulants|mesh-ancestor
44561551|NCT01175811|Insulin|insulin|mesh-list
44561552|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44561553|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
44561554|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
44561555|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
44561556|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
44561557|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44561558|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561559|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561560|NCT01175707|Vancomycin|vancomycin|mesh-list
44561561|NCT01175707|Daptomycin|daptomycin|mesh-list
44561562|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561563|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561564|NCT01175668|Clonidine|clonidine|mesh-list
44561565|NCT01175668|Phenobarbital|phenobarbital|mesh-list
44561566|NCT01175668|Analgesics|analgesics|mesh-ancestor
44561567|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
44561568|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561569|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561570|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561571|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
44561572|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
44561573|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44561574|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44561575|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44561576|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561577|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561578|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561580|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44561581|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561582|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44561583|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44561584|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
44561585|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
44561586|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44561587|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44561588|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44561589|NCT01175590|Besifloxacin|besifloxacin|mesh-list
44561590|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561591|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561592|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44561593|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44561594|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561595|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561596|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561597|NCT01175473|Metformin|metformin|mesh-list
44561598|NCT01175473|Liraglutide|liraglutide|mesh-list
44561599|NCT01175473|Lixisenatide|lixisenatide|mesh-list
44561600|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561601|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561602|NCT01175473|Incretins|incretins|mesh-ancestor
44561603|NCT01175473|Hormones|hormones|mesh-ancestor
44561604|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561605|NCT01175382|Tamsulosin|tamsulosin|mesh-list
44561606|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44561607|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44561608|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44561609|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44561610|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561611|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561612|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561613|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561614|NCT01175382|Urological Agents|urological agents|mesh-ancestor
44561615|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44561616|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44561617|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44561618|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44561619|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
44561620|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44561621|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
44561622|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561623|NCT01175135|Risperidone|risperidone|mesh-list
44561624|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44561625|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
44561626|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561627|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561628|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561629|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44561630|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44561631|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561632|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561633|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44561634|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
44561635|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44561636|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561637|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44561638|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561639|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561640|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561641|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561642|NCT01174238|Paclitaxel|paclitaxel|mesh-list
44561643|NCT01174238|Carboplatin|carboplatin|mesh-list
44561644|NCT01174238|Axitinib|axitinib|mesh-list
44561645|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44561646|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561647|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
44561654|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44561655|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561657|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44561658|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561659|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561660|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44561661|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561662|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561663|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561664|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561665|NCT01174004|Pimavanserin|pimavanserin|mesh-list
44561666|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44561667|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44561668|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44561669|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44561670|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44561671|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561672|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561673|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44561674|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44561675|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
44561676|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561677|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561678|NCT01173692|Minocycline|minocycline|mesh-list
44561679|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561680|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561681|NCT01173679|Rituximab|rituximab|mesh-list
44561683|NCT01173679|Dasatinib|dasatinib|mesh-list
44561684|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44561685|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561686|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
44561687|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561688|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561689|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561690|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561691|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561692|NCT01173601|Serotonin|serotonin|mesh-list
44561693|NCT01173601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44561694|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44561695|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
44561696|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561697|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561698|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561699|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44185829|NCT00334503|Miglitol|miglitol|mesh-list
44561700|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561701|NCT01173471|Niacinamide|niacinamide|mesh-list
44561702|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
44561703|NCT01173471|Vitamins|vitamins|mesh-ancestor
44561704|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
44561705|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561706|NCT01173120|Abatacept|abatacept|mesh-list
44561707|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44561708|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561709|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561710|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561711|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
44561712|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561713|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561714|NCT01173055|Milnacipran|milnacipran|mesh-list
44561715|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
44561716|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44561717|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44561718|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561719|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561721|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561722|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44561723|NCT01173055|Analgesics|analgesics|mesh-ancestor
44561724|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
44561725|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561726|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
44561727|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561728|NCT01172938|Thalidomide|thalidomide|mesh-list
44561729|NCT01172938|Apremilast|apremilast|mesh-list
44561730|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44561731|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44561732|NCT01172938|Analgesics|analgesics|mesh-ancestor
44561733|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
44561734|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561735|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561736|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44561737|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561738|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44561739|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44561740|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561741|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561742|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561743|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
44561744|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
44561745|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561746|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561747|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44561748|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44185866|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
44561749|NCT01172938|Growth Substances|growth substances|mesh-ancestor
44561750|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
44561751|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561752|NCT01172873|Cycloserine|cycloserine|mesh-list
44561753|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44561754|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561755|NCT01172873|Renal Agents|renal agents|mesh-ancestor
44561756|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44561757|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
44561758|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561759|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
44561760|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561761|NCT01172847|Oseltamivir|oseltamivir|mesh-list
44561762|NCT01172847|Rimantadine|rimantadine|mesh-list
44561763|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
44561764|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561765|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561766|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561767|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44561768|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
44561769|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44561770|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44561771|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
44561772|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561773|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561774|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44561775|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561776|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
44561777|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44561778|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
44561779|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561780|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561781|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44561782|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44561783|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44561784|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561785|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
44561786|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44561787|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44561788|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
44561789|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561790|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561791|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44561792|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561794|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44561795|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
44561796|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561797|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561798|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44561799|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44561800|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44561801|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561802|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
44561803|NCT01172639|Prednisone|prednisone|mesh-list
44561804|NCT01172639|Methotrexate|methotrexate|mesh-list
44561805|NCT01172639|Leflunomide|leflunomide|mesh-list
44561806|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44561807|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
44561808|NCT01172639|Hormones|hormones|mesh-ancestor
44561809|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44561810|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561811|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44561812|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561813|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44561814|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
44561815|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44561816|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44561817|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
44561818|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561819|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
44561820|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561821|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44561822|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44561823|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
44561824|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44561825|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44561826|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561827|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44561828|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44561829|NCT01172639|Analgesics|analgesics|mesh-ancestor
44561830|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
44561831|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44561832|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44561834|NCT01172535|Lopinavir|lopinavir|mesh-list
44561835|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44561836|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44561837|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
44561838|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561839|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561840|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44561841|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44561842|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
44561843|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561844|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44561845|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44561846|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
44561847|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44561848|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
44561849|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561850|NCT01172288|Expectorants|expectorants|mesh-ancestor
44561851|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561852|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44561853|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
44561854|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561855|NCT01172288|Protective Agents|protective agents|mesh-ancestor
44561856|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561857|NCT01172288|Antidotes|antidotes|mesh-ancestor
44561858|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
44561859|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44561860|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
44561861|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387593|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
44561862|NCT01172275|Expectorants|expectorants|mesh-ancestor
44561863|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
44561864|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44561865|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
44561866|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561867|NCT01172275|Protective Agents|protective agents|mesh-ancestor
44561868|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561869|NCT01172275|Antidotes|antidotes|mesh-ancestor
44561870|NCT01171976|Ranibizumab|ranibizumab|mesh-list
44561871|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44561872|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44561873|NCT01171976|Growth Substances|growth substances|mesh-ancestor
44561874|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561875|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44561876|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561877|NCT01171963|Vaccines|vaccines|mesh-list
44561878|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
44561879|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561880|NCT01171183|Carvedilol|carvedilol|mesh-list
44561881|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44561882|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44561883|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
44561884|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44561885|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561886|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561887|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44561888|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
44561889|NCT01171183|Protective Agents|protective agents|mesh-ancestor
44561890|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44561891|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561892|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44561893|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44561894|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44561895|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44561896|NCT01170962|Ribavirin|ribavirin|mesh-list
44561897|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44561898|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
44561899|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561900|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
44561901|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561902|NCT01170663|Paclitaxel|paclitaxel|mesh-list
44561903|NCT01170663|Ramucirumab|ramucirumab|mesh-list
44561904|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44561905|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561906|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
44561907|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
44561908|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
44561909|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561910|NCT01170364|Sibutramine|sibutramine|mesh-list
44561911|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
44561912|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44561913|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
44561914|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44561915|NCT01170273|Vitamin D|vitamin d|mesh-list
44561916|NCT01170273|Vitamins|vitamins|mesh-ancestor
44561917|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
44561918|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561919|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44561920|NCT01170221|Linezolid|linezolid|mesh-list
44561921|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
44561922|NCT01170221|Tedizolid|tedizolid|mesh-list
44561923|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44561924|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44561925|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44561926|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561927|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561928|NCT01170208|Insulin|insulin|mesh-list
44561929|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44561930|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561931|NCT01170065|Nintedanib|nintedanib|mesh-list
44561932|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561933|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561934|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561935|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561936|NCT01170039|Lubiprostone|lubiprostone|mesh-list
44561937|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44561938|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44561958|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387743|NCT04695977|Nivolumab|nivolumab|mesh-list
44561960|NCT01169675|Afatinib|afatinib|mesh-list
44561961|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561962|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561963|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561964|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44561965|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44561966|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44561967|NCT01169636|Carboplatin|carboplatin|mesh-list
44561968|NCT01169636|Etoposide|etoposide|mesh-list
44561969|NCT01169636|Ifosfamide|ifosfamide|mesh-list
44561970|NCT01169636|Panobinostat|panobinostat|mesh-list
44561971|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561972|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44561973|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44561974|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44561975|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561976|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561977|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44561978|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
44561979|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44561980|NCT01169558|Bevacizumab|bevacizumab|mesh-list
44561981|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44561982|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561983|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44561984|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44561985|NCT01169558|Growth Substances|growth substances|mesh-ancestor
44561986|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561987|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
44561988|NCT01169532|Vorinostat|vorinostat|mesh-list
44454556|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
44561989|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44561990|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44561991|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44561992|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561993|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44561994|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44561995|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44561996|NCT01169337|Lenalidomide|lenalidomide|mesh-list
44561997|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
44561998|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44561999|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43768443|NCT02394418|Sevoflurane|sevoflurane|mesh-list
44562000|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562001|NCT01169337|Growth Substances|growth substances|mesh-ancestor
44562002|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562003|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562005|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562006|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562007|NCT01169038|Azithromycin|azithromycin|mesh-list
44562008|NCT01169038|Rifampin|rifampin|mesh-list
44562009|NCT01169038|Ethambutol|ethambutol|mesh-list
44562010|NCT01169038|Levofloxacin|levofloxacin|mesh-list
44562011|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44562012|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562013|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44562014|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
44562015|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
44562016|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562017|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562018|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562019|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44562020|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44562021|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44562022|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44562023|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44186080|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44562024|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44562025|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44562026|NCT01169038|Renal Agents|renal agents|mesh-ancestor
44562027|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44562028|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44562029|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562030|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44387797|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
44562031|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44562032|NCT01168973|Docetaxel|docetaxel|mesh-list
44562033|NCT01168973|Ramucirumab|ramucirumab|mesh-list
44562034|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44562035|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562036|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
44562037|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
44562038|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
44562039|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562040|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
44562041|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562042|NCT01168596|Rasagiline|rasagiline|mesh-list
44562043|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44562044|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562045|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562046|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44562047|NCT01168596|Protective Agents|protective agents|mesh-ancestor
44562048|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562049|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
44562050|NCT01168349|Hematinics|hematinics|mesh-ancestor
44562051|NCT01168232|Epothilones|epothilones|mesh-list
44562052|NCT01168232|Epothilone B|epothilone b|mesh-list
44562053|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44562054|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44562055|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44562056|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562057|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562058|NCT01168219|Methotrexate|methotrexate|mesh-list
44562059|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
44562060|NCT01168219|Azacitidine|azacitidine|mesh-list
44562061|NCT01168219|Fludarabine|fludarabine|mesh-list
44562062|NCT01168219|Busulfan|busulfan|mesh-list
44562063|NCT01168219|Tacrolimus|tacrolimus|mesh-list
44562064|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44562065|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44562066|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
44562067|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562068|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562069|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562070|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
44562071|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562072|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562073|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562074|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562075|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562076|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562077|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
44562078|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562079|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562080|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44562081|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
44562082|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44562083|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44562084|NCT01167907|Ropivacaine|ropivacaine|mesh-list
44562085|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
44562086|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
44562087|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562088|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562089|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
44562090|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562091|NCT01167881|Glimepiride|glimepiride|mesh-list
44562092|NCT01167881|Empagliflozin|empagliflozin|mesh-list
44562093|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44562094|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562095|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562096|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562097|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
44562098|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44562099|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562100|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
44562101|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
44562102|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44562103|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
44562104|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562105|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387875|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
44562106|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562108|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44562109|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44562110|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44562111|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562112|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562113|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
44562114|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562115|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562116|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44562117|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562118|NCT01167192|Cisplatin|cisplatin|mesh-list
44562119|NCT01167192|Carboplatin|carboplatin|mesh-list
44562120|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562121|NCT01167153|Amlodipine|amlodipine|mesh-list
44562122|NCT01167153|Valsartan|valsartan|mesh-list
44562123|NCT01167153|Nifedipine|nifedipine|mesh-list
44562124|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44562125|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44562126|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562127|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562128|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44562129|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562130|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
44562131|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44562132|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44562133|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
44562134|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562135|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44562136|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44562137|NCT01166958|Teriparatide|teriparatide|mesh-list
44562138|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44562139|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44562140|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562141|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44562142|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44562143|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
44562144|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562145|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44562146|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44562147|NCT01166945|Amoxicillin|amoxicillin|mesh-list
44562148|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
44562149|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
44562150|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44562151|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44562152|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562153|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44562154|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562155|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562157|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
44562158|NCT01166763|Vitamins|vitamins|mesh-ancestor
44562159|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
44562160|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562161|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44562162|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44562163|NCT01166646|Clobetasol|clobetasol|mesh-list
44562164|NCT01166646|Halobetasol|halobetasol|mesh-list
44562165|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44562166|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562167|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
44562168|NCT01166646|Hormones|hormones|mesh-ancestor
44562169|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562170|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562171|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
44562172|NCT01166438|Trospium chloride|trospium chloride|mesh-list
44562173|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
44562174|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44562175|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44562176|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44562177|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562178|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387953|NCT04020848|Melatonin|melatonin|mesh-list
44562179|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
44562180|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562181|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562182|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44562183|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562184|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44562185|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44562186|NCT01166438|Urological Agents|urological agents|mesh-ancestor
44562187|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
44562188|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
44562189|NCT01166282|Adalimumab|adalimumab|mesh-list
44562190|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562191|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562192|NCT01166178|Vitamin D|vitamin d|mesh-list
44186258|NCT00335647|Fluphenazine|fluphenazine|mesh-list
44562193|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
44562194|NCT01166178|Calcium|calcium|mesh-list
44562195|NCT01166178|Vitamins|vitamins|mesh-ancestor
44562196|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
44562197|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562198|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44562199|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44562200|NCT01165996|Decitabine|decitabine|mesh-list
44562201|NCT01165996|Azacitidine|azacitidine|mesh-list
44562202|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562203|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
44562204|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562205|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562206|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562207|NCT01165684|Insulin|insulin|mesh-list
44562208|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44562209|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
44562210|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
44562211|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44562212|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
44562213|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562214|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562215|NCT01165554|Flutemetamol|flutemetamol|mesh-list
44562216|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44562217|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562218|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
44562219|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562220|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562221|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44562222|NCT01165320|Caspofungin|caspofungin|mesh-list
44562223|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
44562224|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562225|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562226|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562228|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
44562229|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
44562230|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
44562231|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44562232|NCT01165307|Estradiol|estradiol|mesh-list
44562233|NCT01165307|Estrogens|estrogens|mesh-ancestor
44562234|NCT01165307|Hormones|hormones|mesh-ancestor
44562235|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562236|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562237|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44562238|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562239|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44562240|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44562241|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44562242|NCT01165307|Analgesics|analgesics|mesh-ancestor
44562243|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
44562244|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562245|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562246|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562247|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
44562248|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44562249|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562250|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562251|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44562252|NCT01165281|Oxycodone|oxycodone|mesh-list
44562253|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44562254|NCT01165281|Narcotics|narcotics|mesh-ancestor
44562255|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562264|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562266|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44562267|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44388101|NCT03904550|Neostigmine|neostigmine|mesh-list
44562268|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562269|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44562271|NCT01165203|Vaccines|vaccines|mesh-list
44562272|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
44562273|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562274|NCT01165138|Fluticasone|fluticasone|mesh-list
44562275|NCT01165138|Xhance|xhance|mesh-list
44562276|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562277|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44562278|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
44562279|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562280|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562281|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44562282|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
44562283|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562284|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44562285|NCT01165021|Folic Acid|folic acid|mesh-list
44562286|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
44562287|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
44562288|NCT01165021|Dexamethasone|dexamethasone|mesh-list
44562289|NCT01165021|Pemetrexed|pemetrexed|mesh-list
44562290|NCT01165021|Vitamins|vitamins|mesh-ancestor
44562291|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
44562292|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562293|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562294|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
44562295|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
44562296|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562297|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44562298|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
44562299|NCT01165021|Hormones|hormones|mesh-ancestor
44562300|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562301|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44562302|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562303|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562304|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562305|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562306|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562307|NCT01165021|Hematinics|hematinics|mesh-ancestor
44562308|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
44562309|NCT01164956|Methylphenidate|methylphenidate|mesh-list
44562310|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44186331|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44562311|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562312|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44562313|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44562314|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562315|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562316|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
44562317|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562318|NCT01164579|Methotrexate|methotrexate|mesh-list
44562319|NCT01164579|Tofacitinib|tofacitinib|mesh-list
44562320|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44562321|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
44562322|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562323|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562324|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562325|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
44562326|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562327|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562328|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562329|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562330|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562331|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562332|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
44562333|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562334|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562335|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44562336|NCT01164501|Empagliflozin|empagliflozin|mesh-list
44562337|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44562338|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562339|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562340|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562342|NCT01164475|Lenograstim|lenograstim|mesh-list
44562343|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44562344|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
44562345|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562346|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44562347|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44562348|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
44562349|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562350|NCT01164007|Bevacizumab|bevacizumab|mesh-list
44562351|NCT01164007|Dacarbazine|dacarbazine|mesh-list
44562352|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44562353|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562354|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562355|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562356|NCT01164007|Growth Substances|growth substances|mesh-ancestor
44562357|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562358|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562359|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44562360|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
44562361|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562362|NCT01163851|Bococizumab|bococizumab|mesh-list
44562363|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44562364|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44562365|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
44562366|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562367|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44562368|NCT01163786|Bortezomib|bortezomib|mesh-list
44562369|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562370|NCT01163747|Methotrexate|methotrexate|mesh-list
44562371|NCT01163747|Vaccines|vaccines|mesh-list
44562372|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44562373|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
44562374|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562375|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44562376|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
44562377|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562378|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562379|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
44562380|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562381|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562383|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562384|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562385|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562386|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562387|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562388|NCT01163721|Ranolazine|ranolazine|mesh-list
44562389|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44562390|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562391|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562392|NCT01163617|Adalimumab|adalimumab|mesh-list
44562393|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562394|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562395|NCT01163266|Vortioxetine|vortioxetine|mesh-list
44562396|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
44562397|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562398|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44562399|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44562400|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562401|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562402|NCT01163266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44562403|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44562404|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562405|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562406|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562407|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
44562408|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44562409|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44562410|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44562411|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44562412|NCT01163253|Tofacitinib|tofacitinib|mesh-list
44562413|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44562414|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562415|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562416|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
44562417|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
44388191|NCT03653364|Baloxavir|baloxavir|mesh-list
44562418|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562419|NCT01162863|Lubiprostone|lubiprostone|mesh-list
44562420|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44562421|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562422|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562423|NCT01162486|Rifampin|rifampin|mesh-list
44562424|NCT01162486|Rifapentine|rifapentine|mesh-list
44562425|NCT01162486|Midazolam|midazolam|mesh-list
44562426|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44562427|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44562428|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562429|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562430|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44562431|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44562432|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562433|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44562434|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
44562435|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
44562436|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
44562437|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
44562438|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562439|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562440|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44562441|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
44562442|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44562443|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562444|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
44562445|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562446|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562447|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44562448|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44562449|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44186475|NCT00336739|Cinacalcet|cinacalcet|mesh-list
44562450|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44562451|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44562452|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44562453|NCT01162473|Caseins|caseins|mesh-list
44562454|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
44562455|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
44562456|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562457|NCT01162421|Adalimumab|adalimumab|mesh-list
44562458|NCT01162421|Methotrexate|methotrexate|mesh-list
44562459|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44562460|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
44562461|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562462|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562463|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562464|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
44562465|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562466|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562467|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562468|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562469|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562470|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562471|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
44562472|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562473|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562474|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562475|NCT01162304|Oxycodone|oxycodone|mesh-list
44562476|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44562477|NCT01162304|Narcotics|narcotics|mesh-ancestor
44562478|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562479|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562480|NCT01162304|Analgesics|analgesics|mesh-ancestor
44562481|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
44562482|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562483|NCT01162239|Varenicline|varenicline|mesh-list
44562484|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44562485|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44562486|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
44562487|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562488|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562489|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562490|NCT01162135|Digoxin|digoxin|mesh-list
44562491|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44562492|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44562493|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562494|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562495|NCT01162135|Protective Agents|protective agents|mesh-ancestor
44562496|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562497|NCT01162122|Vaccines|vaccines|mesh-list
44562498|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
44562499|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562500|NCT01161628|Rituximab|rituximab|mesh-list
44562501|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44562502|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562503|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
44562504|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562505|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562506|NCT01161537|Ivacaftor|ivacaftor|mesh-list
44562507|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44562508|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562509|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562510|NCT01161498|Cisplatin|cisplatin|mesh-list
44562511|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44562512|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562513|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44562514|NCT01161472|Alprazolam|alprazolam|mesh-list
44562515|NCT01161472|Fesoterodine|fesoterodine|mesh-list
44562516|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44562517|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562518|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562519|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44562520|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44562521|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562522|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
44562523|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
44562524|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562525|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562526|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44562527|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44562528|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
44562529|NCT01161472|Urological Agents|urological agents|mesh-ancestor
44562531|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
44562532|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
44562533|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562534|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
44562535|NCT01161407|Calcium|calcium|mesh-list
44186581|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
44562536|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44562537|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562538|NCT01161407|Antacids|antacids|mesh-ancestor
44562539|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562540|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44562541|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44562542|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562543|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44562544|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562545|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562546|NCT01160822|Naproxen|naproxen|mesh-list
44562547|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44562548|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44562549|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44562550|NCT01160822|Analgesics|analgesics|mesh-ancestor
44562551|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
44562552|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562553|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562554|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562555|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562556|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
44562557|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44562558|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562559|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562560|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
44562561|NCT01160770|Clobazam|clobazam|mesh-list
44562562|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
44562563|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44562564|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44562565|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562566|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388344|NCT03140176|Sunitinib|sunitinib|mesh-list
44562567|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562568|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44562569|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
44562570|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
44562571|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562572|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562573|NCT01160744|Gemcitabine|gemcitabine|mesh-list
44562575|NCT01160744|Carboplatin|carboplatin|mesh-list
44562576|NCT01160744|Pemetrexed|pemetrexed|mesh-list
44562577|NCT01160744|Ramucirumab|ramucirumab|mesh-list
44562578|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44562579|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562580|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562581|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
44562582|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562583|NCT01160744|Antiviral Agents|antiviral agents|mesh-ancestor
44562584|NCT01160744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562585|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562586|NCT01160744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562587|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
44562588|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562589|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44562590|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44562591|NCT01160640|Metronidazole|metronidazole|mesh-list
44562592|NCT01160640|Doxycycline|doxycycline|mesh-list
44562593|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
44562594|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562595|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44562596|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44562597|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44562598|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
44562599|NCT01160614|Oxycodone|oxycodone|mesh-list
44562600|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44562601|NCT01160614|Narcotics|narcotics|mesh-ancestor
44562602|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562603|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562604|NCT01160614|Analgesics|analgesics|mesh-ancestor
44562605|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
44562606|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562607|NCT01160484|Lenalidomide|lenalidomide|mesh-list
44562608|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
44562609|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562610|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562611|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562612|NCT01160484|Growth Substances|growth substances|mesh-ancestor
44562613|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562614|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562615|NCT01160354|Plerixafor|plerixafor|mesh-list
44562616|NCT01160354|Clofarabine|clofarabine|mesh-list
44562617|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562618|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
44562619|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562620|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562621|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44562622|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44562623|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
44562624|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562625|NCT01160289|Tadalafil|tadalafil|mesh-list
44562626|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
44562627|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44562628|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44562629|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562630|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562631|NCT01160289|Urological Agents|urological agents|mesh-ancestor
44562632|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
44562633|NCT01160198|Chelating Agents|chelating agents|mesh-list
44562634|NCT01160198|Glycine|glycine|mesh-list
44562635|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
44562636|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562637|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
44562638|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562639|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562640|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
44562641|NCT01160198|Protective Agents|protective agents|mesh-ancestor
44562642|NCT01160198|Vitamins|vitamins|mesh-ancestor
44562643|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
44562644|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
44562645|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562646|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562647|NCT01159912|Fluticasone|fluticasone|mesh-list
44562648|NCT01159912|Xhance|xhance|mesh-list
44562649|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562650|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44562651|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
44562652|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562653|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562654|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44562655|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
44562656|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562657|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44562658|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44562659|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44562660|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44562661|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44562662|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44562663|NCT01159769|Analgesics|analgesics|mesh-ancestor
44562664|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
44562665|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562666|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388493|NCT02324725|Naltrexone|naltrexone|mesh-list
44562667|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562668|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562669|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44562670|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44562671|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44562672|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
44562673|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
44562674|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562675|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562676|NCT01159665|Plasminogen|plasminogen|mesh-list
44562677|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
44562678|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44562679|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44562680|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562681|NCT01159600|Empagliflozin|empagliflozin|mesh-list
44562682|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44562683|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562684|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562685|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562686|NCT01159574|Clarithromycin|clarithromycin|mesh-list
44562687|NCT01159574|Dexamethasone|dexamethasone|mesh-list
44562688|NCT01159574|Pomalidomide|pomalidomide|mesh-list
44562689|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562690|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
44562691|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
44562692|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562693|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562694|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44562695|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
44562696|NCT01159574|Hormones|hormones|mesh-ancestor
44562697|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562698|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44562699|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562700|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44562701|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562702|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44562703|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562704|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562705|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44562706|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44562707|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
44562708|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562709|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562710|NCT01159574|Growth Substances|growth substances|mesh-ancestor
44562711|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562712|NCT01159171|Bevacizumab|bevacizumab|mesh-list
44562713|NCT01159171|Capecitabine|capecitabine|mesh-list
44562714|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
44562715|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44562716|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562717|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562718|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562719|NCT01159171|Growth Substances|growth substances|mesh-ancestor
44562720|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562721|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562722|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562723|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
44562724|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562725|NCT01158950|Tolcapone|tolcapone|mesh-list
44562726|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44562727|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44562728|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44562729|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562730|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562731|NCT01158534|Interferons|interferons|mesh-list
44562732|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
44562733|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
44562734|NCT01158534|Celecoxib|celecoxib|mesh-list
44562735|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562736|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
44562737|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562738|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
44562739|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562740|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44562741|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44562742|NCT01158534|Analgesics|analgesics|mesh-ancestor
44562743|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
44562744|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562745|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562746|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44562747|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44562748|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44562749|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562750|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562751|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44562752|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
44562753|NCT01158261|Coagulants|coagulants|mesh-ancestor
44562754|NCT01158222|Sunitinib|sunitinib|mesh-list
44562755|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562756|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562757|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562758|NCT01158222|Growth Substances|growth substances|mesh-ancestor
44562759|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562760|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562761|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44562762|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562763|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562765|NCT01158118|Sargramostim|sargramostim|mesh-list
44562766|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
44562767|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562768|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44562769|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44562770|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
44562771|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562772|NCT01157364|Bimatoprost|bimatoprost|mesh-list
44562773|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44562774|NCT01157351|Olanzapine|olanzapine|mesh-list
44562775|NCT01157351|Risperidone|risperidone|mesh-list
44562776|NCT01157351|Aripiprazole|aripiprazole|mesh-list
44562777|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44562778|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44562779|NCT01157351|Perphenazine|perphenazine|mesh-list
44562780|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44562781|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
44562782|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562783|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562784|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562785|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44562786|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44562787|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562788|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562789|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44562790|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
44562791|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
44562792|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
44562793|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562794|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44562795|NCT01157351|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44562796|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44562797|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562798|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
44562799|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
44562800|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44562801|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44562802|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44562803|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44562804|NCT01157234|Metoprolol|metoprolol|mesh-list
44562805|NCT01157234|Nebivolol|nebivolol|mesh-list
44562806|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44562807|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44562808|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
44562809|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
44562810|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562811|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562812|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44562813|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44562814|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44562815|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44562816|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562817|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562818|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
44562819|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44562820|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44562821|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44562822|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44562823|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44562825|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
44562826|NCT01157182|Estradiol|estradiol|mesh-list
44562827|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44562828|NCT01157182|Estrogens|estrogens|mesh-ancestor
44562829|NCT01157182|Hormones|hormones|mesh-ancestor
44562830|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562831|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562832|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44562833|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
44562834|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44562835|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44562836|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44562837|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44562838|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44562839|NCT01157169|Buprenorphine|buprenorphine|mesh-list
44186891|NCT00338312|Hormones|hormones|mesh-ancestor
44562840|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44562841|NCT01157169|Narcotics|narcotics|mesh-ancestor
44562842|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562843|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562844|NCT01157169|Analgesics|analgesics|mesh-ancestor
44562845|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
44562846|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562847|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44562848|NCT01157117|Omalizumab|omalizumab|mesh-list
44562849|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44562850|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44562851|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44562852|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44562853|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
44562854|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562855|NCT01157065|Ranibizumab|ranibizumab|mesh-list
44562856|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562857|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562858|NCT01157065|Growth Substances|growth substances|mesh-ancestor
44562859|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562860|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562861|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562862|NCT01156792|Montelukast|montelukast|mesh-list
44562863|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44562864|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44562865|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44562866|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
44562867|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562868|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562869|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44562870|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44562871|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562872|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
44562873|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562874|NCT01156376|Listerine|listerine|mesh-list
44562875|NCT01156376|Fluorides|fluorides|mesh-list
44562876|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
44562877|NCT01156376|Protective Agents|protective agents|mesh-ancestor
44562878|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562879|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44562880|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562881|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
44562882|NCT01156363|Hematinics|hematinics|mesh-ancestor
44562883|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44562884|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44562885|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44562886|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
44562887|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562888|NCT01156142|Doxepin|doxepin|mesh-list
44562889|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44562890|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44562891|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44562892|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562893|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44562894|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
44562895|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562896|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
44562897|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
44562898|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562899|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562901|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44562902|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44562903|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44562904|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44562905|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44562906|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562907|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768556|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562909|NCT01155869|Naltrexone|naltrexone|mesh-list
44562910|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44562911|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44562912|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562913|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
44562914|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562915|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
44562916|NCT01155661|Serotonin|serotonin|mesh-list
44562917|NCT01155661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44562918|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44562919|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
44562920|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562921|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562922|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562923|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44562924|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562925|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44562926|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44562927|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
44562928|NCT01155583|Dexamethasone|dexamethasone|mesh-list
44562929|NCT01155583|Lenalidomide|lenalidomide|mesh-list
44562930|NCT01155583|Azacitidine|azacitidine|mesh-list
44562931|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44562932|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
44562933|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
44562934|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562935|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562936|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44562937|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
44562938|NCT01155583|Hormones|hormones|mesh-ancestor
44562939|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562940|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44562941|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44562942|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
44562943|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44562944|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44562945|NCT01155583|Growth Substances|growth substances|mesh-ancestor
44562946|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
44562947|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44562948|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
44562949|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562950|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562951|NCT01155531|Sertraline|sertraline|mesh-list
44562952|NCT01155531|Telenzepine|telenzepine|mesh-list
44562953|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
44562954|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44562955|NCT01155531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44562956|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44562957|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44562958|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562959|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44562960|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
44562961|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562962|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
44562963|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
44562964|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44562965|NCT01155479|Rasagiline|rasagiline|mesh-list
44562966|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44562967|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562978|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562979|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
44562980|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44562981|NCT01155388|Hematinics|hematinics|mesh-ancestor
44562982|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44562983|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44562984|NCT01155388|Trace Elements|trace elements|mesh-ancestor
44562985|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
44562986|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562987|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44562988|NCT01155284|Lansoprazole|lansoprazole|mesh-list
44562989|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
44562990|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44562991|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44562992|NCT01155284|Incretins|incretins|mesh-ancestor
44562993|NCT01155284|Hormones|hormones|mesh-ancestor
44562994|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44562995|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44562996|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44562997|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44562998|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44562999|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44563000|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563001|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44563003|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44563004|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44563005|NCT01155167|Lidocaine|lidocaine|mesh-list
44563006|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
44563007|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
44563008|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
44563009|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563010|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563011|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
44563012|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563013|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44563014|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44563015|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44563016|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563017|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563018|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
44563019|NCT01155063|Exemestane|exemestane|mesh-list
44563020|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563021|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44563022|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44563023|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563024|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563025|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44563026|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44563027|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563028|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563029|NCT01154673|Ritonavir|ritonavir|mesh-list
44563030|NCT01154673|Lopinavir|lopinavir|mesh-list
44563031|NCT01154673|Tenofovir|tenofovir|mesh-list
44563032|NCT01154673|Emtricitabine|emtricitabine|mesh-list
44563033|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
44563034|NCT01154673|Maraviroc|maraviroc|mesh-list
44563035|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44563036|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44563037|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
44563038|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563039|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563040|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44563041|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44563042|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
44563043|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563044|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44563045|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563046|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44563047|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563048|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44563049|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44563050|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44563051|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44563052|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44563053|NCT01154452|R04929097|r04929097|mesh-list
44563054|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563055|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563056|NCT01154218|Crizotinib|crizotinib|mesh-list
44563057|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563058|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44563059|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187002|NCT00338793|Prednisolone|prednisolone|mesh-list
44563060|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563061|NCT01154166|Ropinirole|ropinirole|mesh-list
44563062|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44563063|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44563064|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
44563065|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
44563066|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563067|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563068|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563069|NCT01154153|Loratadine|loratadine|mesh-list
44563070|NCT01154153|Triamcinolone|triamcinolone|mesh-list
44563071|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44563072|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44388893|NCT03319719|Lidocaine|lidocaine|mesh-list
44563073|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44563074|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563075|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
44563076|NCT01154153|Hormones|hormones|mesh-ancestor
44563077|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563078|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563079|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563080|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
44563081|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563082|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563083|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
44563084|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563085|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44563086|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44563087|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44563088|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
44563089|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
44563090|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563091|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
44563092|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44563093|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44563094|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44563095|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
44563096|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563097|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563098|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563099|NCT01154036|Atorvastatin|atorvastatin|mesh-list
44563100|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44563101|NCT01154036|Ezetimibe|ezetimibe|mesh-list
44563102|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187057|NCT00339066|Sertraline|sertraline|mesh-list
44563103|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44563104|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
44563105|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563106|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44563107|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44563108|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563109|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44563110|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563111|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44563112|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563113|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563114|NCT01153971|Rituximab|rituximab|mesh-list
44563115|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563116|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563117|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
44563118|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563119|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563120|NCT01153958|Metronidazole|metronidazole|mesh-list
44563121|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
44563122|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563123|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563124|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44563125|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44563126|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44563127|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
44563128|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563129|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
44563130|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44563131|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44563132|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44563133|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563134|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563135|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
44563136|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563137|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563138|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44563139|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563140|NCT01153763|Dabrafenib|dabrafenib|mesh-list
44563141|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563142|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44563143|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563144|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563145|NCT01153724|Fluconazole|fluconazole|mesh-list
44388970|NCT03312907|Rituximab|rituximab|mesh-list
44563146|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
44563147|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563148|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44563149|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563150|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563151|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187099|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
44563152|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44563153|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44563154|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563155|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563156|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44563157|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44563158|NCT01153698|Dabigatran|dabigatran|mesh-list
44563159|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
44563160|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44563161|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
44563162|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563163|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563164|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
44563165|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
44563166|NCT01153425|Teriparatide|teriparatide|mesh-list
44563167|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44563168|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563169|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44563170|NCT01153269|Ritonavir|ritonavir|mesh-list
44563171|NCT01153269|Lopinavir|lopinavir|mesh-list
44563172|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44563173|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44563174|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44563175|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563176|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563177|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44563178|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44563179|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
44563180|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563181|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44563182|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563183|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44563184|NCT01153009|Vortioxetine|vortioxetine|mesh-list
44563185|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44563186|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44563187|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563188|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563189|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563190|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563191|NCT01153009|Analgesics|analgesics|mesh-ancestor
44563192|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
44563193|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563194|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
44563195|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563196|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
44563197|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44563198|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563199|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454666|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563200|NCT01153009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44563201|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
44563202|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44563203|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44563204|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44563205|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44563206|NCT01152996|Vortioxetine|vortioxetine|mesh-list
44563207|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44563208|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563209|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44563210|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563211|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563212|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563213|NCT01152996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44563214|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44563215|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563216|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563217|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563218|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
44563219|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44563220|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44563221|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44563222|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44563223|NCT01152788|Dacarbazine|dacarbazine|mesh-list
44563224|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44563225|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
44563226|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563227|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563228|NCT01152580|Melatonin|melatonin|mesh-list
44563229|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
44563230|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563231|NCT01152580|Protective Agents|protective agents|mesh-ancestor
44563232|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563233|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563234|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
44563235|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44563236|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
44563237|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563238|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563239|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44563240|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
44563241|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
44563242|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44563243|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
44563244|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563245|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563246|NCT01152437|Cetuximab|cetuximab|mesh-list
44563247|NCT01152437|Afatinib|afatinib|mesh-list
44563248|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563249|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563250|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44563251|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563252|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563253|NCT01152190|Tadalafil|tadalafil|mesh-list
44563254|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
44563255|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44563256|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44563257|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563258|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563259|NCT01152190|Urological Agents|urological agents|mesh-ancestor
44563260|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
44563261|NCT01152021|Propofol|propofol|mesh-list
44563262|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44563263|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563264|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563265|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44563266|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
44563267|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
44563268|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44563269|NCT01152021|Analgesics|analgesics|mesh-ancestor
44563270|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
44563271|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563272|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44563273|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44563274|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44563275|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563276|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563277|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563278|NCT01151579|Albuterol|albuterol|mesh-list
44563279|NCT01151579|Ipratropium|ipratropium|mesh-list
44563280|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44563281|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
44563282|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563283|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563284|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44563285|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
44563286|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
44563287|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563288|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44563289|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44563290|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44563291|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563292|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563293|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563294|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44563295|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
44563296|NCT01151540|Rufinamide|rufinamide|mesh-list
44563297|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
44563298|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44563299|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44563300|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389198|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
44563328|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563329|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44563330|NCT01151085|Voriconazole|voriconazole|mesh-list
44563331|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
44563332|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563333|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44563334|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563335|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563336|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563337|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44563338|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
44563339|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563340|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563341|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44563342|NCT01150123|Vaccines|vaccines|mesh-list
44563343|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
44563344|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563345|NCT01150097|Everolimus|everolimus|mesh-list
44563346|NCT01150097|Tacrolimus|tacrolimus|mesh-list
44563347|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563348|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
44563349|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563350|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44563351|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563352|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563353|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563354|NCT01149863|Plerixafor|plerixafor|mesh-list
44563355|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44563356|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44563357|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
44563358|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563359|NCT01149655|Aripiprazole|aripiprazole|mesh-list
44563360|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
44563361|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187223|NCT00343096|Lorazepam|lorazepam|mesh-list
44563362|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44563363|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563364|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563365|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563366|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
44563367|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
44563368|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563369|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563370|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44563371|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44563372|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
44563373|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44563374|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44563375|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44563376|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44563377|NCT01149538|Choline|choline|mesh-list
44563378|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
44563379|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44563380|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
44563381|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563382|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563383|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44563384|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
44563385|NCT01149486|Losartan|losartan|mesh-list
44563386|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44563387|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44563388|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44563389|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44563390|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44563391|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563392|NCT01149486|Diuretics|diuretics|mesh-ancestor
44563393|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
44563394|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563395|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44563396|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563397|NCT01149473|Losartan|losartan|mesh-list
44563398|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44563399|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44563400|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44563401|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44563402|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44563403|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563404|NCT01149473|Diuretics|diuretics|mesh-ancestor
44563405|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
44563406|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563407|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44563408|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563409|NCT01149460|Valacyclovir|valacyclovir|mesh-list
44563410|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
44563411|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563412|NCT01149421|Dulaglutide|dulaglutide|mesh-list
44563413|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44563414|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563415|NCT01149369|Aprepitant|aprepitant|mesh-list
44563416|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
44563417|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
44563418|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187260|NCT00343174|Ancrod|ancrod|mesh-list
44563419|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563421|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44563422|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563423|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563424|NCT01149096|Lenograstim|lenograstim|mesh-list
44563425|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44563426|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
44563427|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563428|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44563429|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44563430|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563431|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44563432|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44563433|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563434|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563435|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
44563436|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563438|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44563439|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563440|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563441|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
44563442|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563443|NCT01148771|Ertapenem|ertapenem|mesh-list
44563444|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563445|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563446|NCT01148693|Gentamicins|gentamicins|mesh-list
44563447|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563448|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563449|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44563450|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563451|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563452|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
44563453|NCT01148537|Buprenorphine|buprenorphine|mesh-list
44563454|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44563455|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563456|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563457|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44563458|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44563459|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187323|NCT00343369|Teniposide|teniposide|mesh-list
44187339|NCT00343369|Hormones|hormones|mesh-ancestor
44563460|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563461|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563462|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44563463|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
44563464|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563465|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563466|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44563467|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44563468|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44563469|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44563470|NCT01148537|Narcotics|narcotics|mesh-ancestor
44563471|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563472|NCT01148537|Analgesics|analgesics|mesh-ancestor
44563473|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
44563474|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563475|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44563476|NCT01148511|Ranibizumab|ranibizumab|mesh-list
44563477|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44563478|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44563479|NCT01148511|Growth Substances|growth substances|mesh-ancestor
44563480|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563481|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
44563482|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563483|NCT01148459|Vaccines|vaccines|mesh-list
44563484|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
44563485|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563486|NCT01148225|Adalimumab|adalimumab|mesh-list
44563487|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563488|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563489|NCT01147926|Prucalopride|prucalopride|mesh-list
44563490|NCT01147926|Laxatives|laxatives|mesh-ancestor
44563491|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563492|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44563493|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44563494|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
44563495|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563496|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563497|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563498|NCT01147848|Fluticasone|fluticasone|mesh-list
44563499|NCT01147848|Xhance|xhance|mesh-list
44563500|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44563501|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563502|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44563503|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
44563504|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563505|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563506|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44563507|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
44563508|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563509|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44563510|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44563511|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44563512|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44563513|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563514|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563515|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563516|NCT01147744|Fluticasone|fluticasone|mesh-list
44563517|NCT01147744|Xhance|xhance|mesh-list
44563518|NCT01147744|Montelukast|montelukast|mesh-list
44563519|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563520|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44563521|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
44563522|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563523|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563524|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44563525|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
44563526|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563527|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44563528|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44563529|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44563530|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563531|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44563532|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44563533|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563534|NCT01147640|Metronidazole|metronidazole|mesh-list
44563535|NCT01147640|Meropenem|meropenem|mesh-list
44563536|NCT01147640|Tazobactam|tazobactam|mesh-list
44563537|NCT01147640|Ceftolozane|ceftolozane|mesh-list
44563538|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563539|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563540|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44563541|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44563542|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44563543|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563544|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563545|NCT01147497|Misoprostol|misoprostol|mesh-list
44563546|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44563547|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
44563548|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563549|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563550|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44563551|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563552|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
44563553|NCT01147458|Naproxen|naproxen|mesh-list
44563554|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44563555|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44563556|NCT01147458|Analgesics|analgesics|mesh-ancestor
44563557|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
44563558|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187414|NCT00343525|Bavituximab|bavituximab|mesh-list
44563559|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563560|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563561|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563562|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
44563563|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44563564|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563565|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389486|NCT03288987|Vitamins|vitamins|mesh-ancestor
44563574|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
44563575|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563576|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
44563577|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563578|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563579|NCT01147250|Lixisenatide|lixisenatide|mesh-list
44563580|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44563581|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563582|NCT01147107|Efavirenz|efavirenz|mesh-list
44563583|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
44563584|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44563585|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563586|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563587|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563588|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
44563589|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563590|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44563591|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563592|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44563593|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44563594|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44563595|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44563596|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44563597|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44563598|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44563599|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44563600|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
44563601|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
44563602|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
44563603|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563604|NCT01147055|Rifampin|rifampin|mesh-list
44563605|NCT01147055|Crizotinib|crizotinib|mesh-list
44563606|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44563607|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
44563608|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563609|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563610|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
44563611|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563612|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563613|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563614|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44563615|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44563616|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44187467|NCT00343733|Analgesics|analgesics|mesh-ancestor
44563617|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44563618|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44563619|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44563620|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563621|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44563622|NCT01146951|Rufinamide|rufinamide|mesh-list
44563623|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
44563624|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44563625|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44563626|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563627|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563628|NCT01146873|Ritonavir|ritonavir|mesh-list
44563629|NCT01146873|Lopinavir|lopinavir|mesh-list
44563630|NCT01146873|Abacavir|abacavir|mesh-list
44563632|NCT01146873|Efavirenz|efavirenz|mesh-list
44563633|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44563634|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44563635|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
44563636|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563637|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563638|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44563639|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44563640|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
44563641|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563642|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44563643|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44563644|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44563645|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563646|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44563647|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44563648|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44563649|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44563650|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44563651|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
44563652|NCT01146795|Paclitaxel|paclitaxel|mesh-list
44563653|NCT01146795|Bevacizumab|bevacizumab|mesh-list
44563654|NCT01146795|Carboplatin|carboplatin|mesh-list
44563655|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44563656|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563657|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
44563658|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
44563659|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
44563660|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563661|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563662|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44563663|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44563664|NCT01146795|Growth Substances|growth substances|mesh-ancestor
44563665|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563666|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44563667|NCT01146613|Varenicline|varenicline|mesh-list
44563668|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44563669|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44563670|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
44563671|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563672|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563673|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563674|NCT01146561|Tanezumab|tanezumab|mesh-list
44563675|NCT01146561|Analgesics|analgesics|mesh-ancestor
44563676|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
44563677|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563678|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563679|NCT01146288|Furosemide|furosemide|mesh-list
44563680|NCT01146288|Acetazolamide|acetazolamide|mesh-list
44563681|NCT01146288|Diuretics|diuretics|mesh-ancestor
44563682|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
44563683|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563684|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44563685|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563686|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563687|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
44563688|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44563689|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563690|NCT01146054|Gemcitabine|gemcitabine|mesh-list
44563691|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44563692|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44563693|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
44563694|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563695|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563696|NCT01146054|Antiviral Agents|antiviral agents|mesh-ancestor
44563697|NCT01146054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563698|NCT01146054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563699|NCT01146054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563700|NCT01146054|Immunologic Factors|immunologic factors|mesh-ancestor
44563701|NCT01146054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563702|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44563703|NCT01145898|Timolol|timolol|mesh-list
44563704|NCT01145898|Dorzolamide|dorzolamide|mesh-list
44563719|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563720|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563721|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563722|NCT01145755|Analgesics|analgesics|mesh-ancestor
44187551|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
44563723|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
44563724|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563725|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
44563726|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563727|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
44563728|NCT01145625|Minoxidil|minoxidil|mesh-list
44563729|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44563730|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
44563731|NCT01145508|Metronidazole|metronidazole|mesh-list
44563732|NCT01145508|Prednisone|prednisone|mesh-list
44563733|NCT01145508|Cortisone|cortisone|mesh-list
44563734|NCT01145508|Docetaxel|docetaxel|mesh-list
44563735|NCT01145508|Vaccines|vaccines|mesh-list
44563736|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
44563737|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563738|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563739|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
44563740|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
44563741|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
44563742|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563743|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563744|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
44563745|NCT01145508|Hormones|hormones|mesh-ancestor
44563746|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44563747|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44563748|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563749|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44563750|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44563751|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44563752|NCT01145495|Rituximab|rituximab|mesh-list
44563753|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44563754|NCT01145495|Lenalidomide|lenalidomide|mesh-list
44563755|NCT01145495|Antibodies|antibodies|mesh-list
44563756|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
44563757|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44563758|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
44563759|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563760|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563761|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563762|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44563763|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44563764|NCT01145495|Growth Substances|growth substances|mesh-ancestor
44563765|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
44563766|NCT01145482|Insulin|insulin|mesh-list
44563767|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
44563768|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44563769|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563770|NCT01145417|Pregabalin|pregabalin|mesh-list
44563771|NCT01145417|Analgesics|analgesics|mesh-ancestor
44563772|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
44563773|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563774|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563775|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
44563776|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44563777|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44563778|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426841|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563779|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44563780|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44563781|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563782|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563783|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563784|NCT01145352|Etanercept|etanercept|mesh-list
44563785|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44563786|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44563787|NCT01145352|Analgesics|analgesics|mesh-ancestor
44563788|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
44563789|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563790|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563791|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44563792|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563793|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563794|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563795|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
44563796|NCT01145222|Midazolam|midazolam|mesh-list
44563797|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44563798|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44563799|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563800|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563801|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44563802|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563803|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563804|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44563805|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
44563806|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
44563807|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
44563808|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
44563809|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563810|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563811|NCT01145066|Borage oil|borage oil|mesh-list
44563812|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563813|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
44563814|NCT01144403|Rituximab|rituximab|mesh-list
44563815|NCT01144403|Fludarabine|fludarabine|mesh-list
44563816|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
44563817|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563818|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
44563819|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563820|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563821|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44563822|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
44563823|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563824|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563825|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44563826|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563827|NCT01144403|Analgesics|analgesics|mesh-ancestor
44563828|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
44563829|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563830|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44563831|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44563832|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563833|NCT01144364|Rituximab|rituximab|mesh-list
44563834|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44563835|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563836|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
44563837|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563838|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563839|NCT01144052|Interferons|interferons|mesh-list
44563840|NCT01144052|Interferon-beta|interferon-beta|mesh-list
44563841|NCT01144052|Natalizumab|natalizumab|mesh-list
44563842|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
44563843|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563844|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
44563845|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563846|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
44563847|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563848|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44563849|NCT01143714|Petrolatum|petrolatum|mesh-list
44563850|NCT01143714|Emollients|emollients|mesh-ancestor
44563851|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563852|NCT01143402|Temozolomide|temozolomide|mesh-list
44563853|NCT01143402|Dacarbazine|dacarbazine|mesh-list
44563854|NCT01143402|Imidazole|imidazole|mesh-list
44563855|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44563856|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
44563857|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563858|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563859|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563860|NCT01143389|Riboflavin|riboflavin|mesh-list
44563861|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
44563862|NCT01143389|Vitamins|vitamins|mesh-ancestor
44563863|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
44563864|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563865|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44563866|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563867|NCT01143337|Methotrexate|methotrexate|mesh-list
44563868|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44563869|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
44563870|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563871|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563872|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44563873|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
44563874|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563875|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563876|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563877|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563878|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44563879|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563880|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
44563881|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563882|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563883|NCT01143259|Alvimopan|alvimopan|mesh-list
44563884|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44563885|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44563886|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
44563887|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44563888|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44563889|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44563890|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
44563891|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563892|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563893|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44563894|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44563895|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44563896|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44563897|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563898|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44563899|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44563900|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563901|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563902|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563903|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563904|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44563905|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44563906|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44563907|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563908|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563909|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563910|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44563911|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44563912|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
44563913|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44563914|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44563915|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
44563916|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44563917|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44563918|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563919|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563920|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563921|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563922|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44563923|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44563924|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44563925|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563926|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563927|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563928|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44563929|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44563931|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44563932|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44563933|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
44563934|NCT01143051|Epinephrine|epinephrine|mesh-list
44563935|NCT01143051|Racepinephrine|racepinephrine|mesh-list
44563936|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
44563937|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44563938|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44563939|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44563940|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44563941|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563942|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563943|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44563944|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44563945|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
44563946|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44563947|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44563948|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
44563949|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
44563950|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
44563951|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44563952|NCT01142726|Methotrexate|methotrexate|mesh-list
44563953|NCT01142726|Abatacept|abatacept|mesh-list
44563954|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44563955|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
44563956|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44563957|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563958|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44563959|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
44563960|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563961|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563962|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44563963|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44563964|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44563965|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44563966|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
44563967|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44563968|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44563969|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44563970|NCT01142596|Asenapine|asenapine|mesh-list
44563971|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44563972|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44563973|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44563974|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563975|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44563976|NCT01142466|Interferons|interferons|mesh-list
44563977|NCT01142466|Interferon-beta|interferon-beta|mesh-list
44563978|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
44563979|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563980|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
44563981|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44563982|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
44563983|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563984|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44563985|NCT01142388|Paclitaxel|paclitaxel|mesh-list
44563986|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44563987|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44563988|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44563989|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44563990|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
44563991|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
44563992|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
44563993|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44563994|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
44563995|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44563996|NCT01142336|Simvastatin|simvastatin|mesh-list
44563997|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44563998|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44563999|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
44564000|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564001|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44564002|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44564003|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564004|NCT01142232|Lenalidomide|lenalidomide|mesh-list
44564005|NCT01142232|Melphalan|melphalan|mesh-list
44564006|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
44564007|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564008|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564009|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564010|NCT01142232|Growth Substances|growth substances|mesh-ancestor
44564011|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564012|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564013|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44564014|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
44564015|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564016|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44564017|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564018|NCT01142193|Topiramate|topiramate|mesh-list
44564019|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
44564020|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564021|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564022|NCT01142128|Esomeprazole|esomeprazole|mesh-list
44564023|NCT01142128|Pancrelipase|pancrelipase|mesh-list
44564024|NCT01142128|Pancreatin|pancreatin|mesh-list
44564025|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44564026|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564027|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44564028|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564029|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564030|NCT01142089|Rifamycins|rifamycins|mesh-list
44564031|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
44564032|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44564033|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564034|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564035|NCT01141478|Sorafenib|sorafenib|mesh-list
44564036|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564037|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564038|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564039|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564040|NCT01141283|Buprenorphine|buprenorphine|mesh-list
44564041|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44564042|NCT01141283|Narcotics|narcotics|mesh-ancestor
44564043|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564044|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564045|NCT01141283|Analgesics|analgesics|mesh-ancestor
44564046|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
44564047|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564048|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44564049|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44564050|NCT01140906|Vortioxetine|vortioxetine|mesh-list
44564051|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44564052|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44564053|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564054|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564055|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564056|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564057|NCT01140906|Analgesics|analgesics|mesh-ancestor
44564058|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
44564059|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564060|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
44564061|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564062|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
44564063|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44564064|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564065|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564066|NCT01140906|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44564067|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
44564068|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44564069|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44564070|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44564071|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44564072|NCT01140880|Tenofovir|tenofovir|mesh-list
44564073|NCT01140880|Emtricitabine|emtricitabine|mesh-list
44564074|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44389999|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564075|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
44564076|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564077|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44564078|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44564080|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564081|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44564082|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44564083|NCT01140503|Apremilast|apremilast|mesh-list
44564084|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44564085|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44564086|NCT01140503|Analgesics|analgesics|mesh-ancestor
44564087|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
44564088|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564089|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564090|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564091|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564092|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44564093|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564094|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564095|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564096|NCT01140347|Ramucirumab|ramucirumab|mesh-list
44564097|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564098|NCT01140061|MK 0873|mk 0873|mesh-list
44564099|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44564100|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564101|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564102|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564103|NCT01139775|Cisplatin|cisplatin|mesh-list
44564104|NCT01139775|Pemetrexed|pemetrexed|mesh-list
44564105|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564106|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564107|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564108|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44564109|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44564110|NCT01139762|Tadalafil|tadalafil|mesh-list
44564111|NCT01139762|Finasteride|finasteride|mesh-list
44564112|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564113|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44564114|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564115|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564116|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564117|NCT01139762|Urological Agents|urological agents|mesh-ancestor
44564118|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44564119|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44564120|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
44564121|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564122|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564123|NCT01139580|Calcipotriene|calcipotriene|mesh-list
44564124|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564125|NCT01139450|Tacrolimus|tacrolimus|mesh-list
44564126|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564127|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
44564128|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564129|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44564130|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564131|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564132|NCT01139125|Cysteamine|cysteamine|mesh-list
44564133|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44564134|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564135|NCT01139047|Metronidazole|metronidazole|mesh-list
44564136|NCT01139047|Azelaic acid|azelaic acid|mesh-list
44564137|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564138|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44564139|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44564140|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44564141|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564142|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564143|NCT01139008|Metronidazole|metronidazole|mesh-list
44564144|NCT01139008|Azelaic acid|azelaic acid|mesh-list
44564145|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564146|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44564147|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44564148|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44390073|NCT03254459|Morphine|morphine|mesh-list
44564173|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44564174|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44564175|NCT01138150|Analgesics|analgesics|mesh-ancestor
44564176|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
44564177|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564178|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564179|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564180|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564181|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
44564182|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44564183|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564184|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564185|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44564186|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44564187|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44564188|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
44564189|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564190|NCT01138046|Paclitaxel|paclitaxel|mesh-list
44564191|NCT01138046|Lapatinib|lapatinib|mesh-list
44564192|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44564193|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564194|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44564195|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44564196|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44454814|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44564197|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564198|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564199|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564200|NCT01137955|Rifaximin|rifaximin|mesh-list
44564201|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44564202|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564203|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564204|NCT01137812|Metformin|metformin|mesh-list
44564205|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44564206|NCT01137812|Canagliflozin|canagliflozin|mesh-list
44564207|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564208|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564209|NCT01137812|Incretins|incretins|mesh-ancestor
44564210|NCT01137812|Hormones|hormones|mesh-ancestor
44564211|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564212|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44564213|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
44564214|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564215|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564216|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44564217|NCT01137682|Octreotide|octreotide|mesh-list
44564218|NCT01137682|Lanreotide|lanreotide|mesh-list
44564219|NCT01137682|Pasireotide|pasireotide|mesh-list
44564220|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564221|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44564222|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564223|NCT01137682|Hormones|hormones|mesh-ancestor
44564224|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564225|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564226|NCT01137604|Bevacizumab|bevacizumab|mesh-list
44564227|NCT01137604|Lenvatinib|lenvatinib|mesh-list
44564228|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564229|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564230|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564231|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564232|NCT01137604|Growth Substances|growth substances|mesh-ancestor
44564233|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564234|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564235|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564236|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564237|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564238|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
44564239|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44564240|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564241|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564242|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564243|NCT01137292|Voriconazole|voriconazole|mesh-list
44564244|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
44564245|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564246|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44564247|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44564248|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564249|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564250|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44564251|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
44564252|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564253|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564254|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44564256|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44564257|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
44564258|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564259|NCT01136967|Lenvatinib|lenvatinib|mesh-list
44564260|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564261|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564262|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564263|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564264|NCT01136954|Zonisamide|zonisamide|mesh-list
44564265|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
44564266|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44564267|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564268|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564269|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44564270|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564271|NCT01136772|Haloperidol|haloperidol|mesh-list
44564272|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44564273|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
44564274|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44564275|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564276|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564277|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564278|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564279|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44564280|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44564281|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
44564282|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564283|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564284|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44564285|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44564286|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
44564287|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
44564288|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
44564289|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564290|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564291|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44564292|NCT01136746|Insulin|insulin|mesh-list
44564293|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44564294|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
44564295|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
44564296|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564297|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564298|NCT01136733|Everolimus|everolimus|mesh-list
44564299|NCT01136733|Lenvatinib|lenvatinib|mesh-list
44564300|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564301|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564302|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
44564303|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564304|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564305|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564306|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564307|NCT01136655|Budesonide|budesonide|mesh-list
44564308|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
44564309|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44564310|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564311|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44564312|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
44564313|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564314|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564315|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564316|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564317|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
44564318|NCT01136655|Hormones|hormones|mesh-ancestor
44564319|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564320|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44564321|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44564322|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44564323|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44564324|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564325|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564326|NCT01136408|Warfarin|warfarin|mesh-list
44564327|NCT01136408|Dabigatran|dabigatran|mesh-list
44564328|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
44564329|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
44564330|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44564331|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
44188076|NCT00346359|Methotrexate|methotrexate|mesh-list
44564332|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564333|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564334|NCT01136382|Budesonide|budesonide|mesh-list
44564335|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564336|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44564337|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
44564338|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564339|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564340|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564341|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564342|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
44564343|NCT01136382|Hormones|hormones|mesh-ancestor
44564344|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564345|NCT01136356|Morphine|morphine|mesh-list
44564346|NCT01136356|Buprenorphine|buprenorphine|mesh-list
44564347|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44564348|NCT01136356|Narcotics|narcotics|mesh-ancestor
44564349|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564350|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564351|NCT01136356|Analgesics|analgesics|mesh-ancestor
44564352|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
44564353|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564354|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44564355|NCT01136174|Nintedanib|nintedanib|mesh-list
44564356|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564357|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564358|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564359|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564360|NCT01135992|Insulin|insulin|mesh-list
44564361|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44564362|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
44564363|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564364|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564365|NCT01135914|Ranibizumab|ranibizumab|mesh-list
44564366|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564367|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564368|NCT01135914|Growth Substances|growth substances|mesh-ancestor
44564369|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564370|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564371|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564372|NCT01135524|Buprenorphine|buprenorphine|mesh-list
44564373|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44564374|NCT01135524|Narcotics|narcotics|mesh-ancestor
44564375|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564376|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564377|NCT01135524|Analgesics|analgesics|mesh-ancestor
44564378|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
44564379|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564380|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44564381|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44564382|NCT01135511|Tofacitinib|tofacitinib|mesh-list
44564383|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
44564384|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44564385|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564386|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564387|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564388|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44564389|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
44564390|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564391|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
44564392|NCT01135511|Protective Agents|protective agents|mesh-ancestor
44564393|NCT01135498|Bevacizumab|bevacizumab|mesh-list
44564394|NCT01135498|Capecitabine|capecitabine|mesh-list
44564395|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44564396|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
44564397|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564399|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564400|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564401|NCT01135498|Growth Substances|growth substances|mesh-ancestor
44564402|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564403|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564404|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564405|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
44564406|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564407|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564408|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564409|NCT01135394|Pioglitazone|pioglitazone|mesh-list
44564410|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564411|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564412|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
44564413|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564414|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564415|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44564416|NCT01135017|Dronedarone|dronedarone|mesh-list
44564417|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44564418|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44564419|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564420|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564421|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564422|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564423|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564424|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44564425|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44564426|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44564427|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
44564428|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564429|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44564430|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44564431|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
44564432|NCT01134705|Beclomethasone|beclomethasone|mesh-list
44564433|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564434|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
44564435|NCT01134705|Hormones|hormones|mesh-ancestor
44564436|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564437|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564438|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564439|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564440|NCT01134627|Minocycline|minocycline|mesh-list
44564441|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44564442|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564443|NCT01134614|Ipilimumab|ipilimumab|mesh-list
44564444|NCT01134614|Sargramostim|sargramostim|mesh-list
44188185|NCT00346645|Bortezomib|bortezomib|mesh-list
44564445|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564446|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564447|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44564448|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564449|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
44564450|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564451|NCT01134393|Amlodipine|amlodipine|mesh-list
44564452|NCT01134393|Telmisartan|telmisartan|mesh-list
44564453|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44564454|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44564455|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44564456|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564457|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564458|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44564459|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564460|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564461|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44564462|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44564463|NCT01134315|Calcitriol|calcitriol|mesh-list
44564464|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44564465|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564466|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44564467|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564468|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564469|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44564470|NCT01134315|Vitamins|vitamins|mesh-ancestor
44564471|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
44564472|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44564473|NCT01134263|Vaccines|vaccines|mesh-list
44564474|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
44564475|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564476|NCT01134107|Insulin|insulin|mesh-list
44564477|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44564478|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
44564479|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
44564480|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564481|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564482|NCT01134055|Ranibizumab|ranibizumab|mesh-list
44564483|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44564503|NCT01133977|Dacarbazine|dacarbazine|mesh-list
44564504|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564505|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564506|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564507|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564508|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44564509|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
44564510|NCT01133847|Guanfacine|guanfacine|mesh-list
44564511|NCT01133847|Methylphenidate|methylphenidate|mesh-list
44564512|NCT01133847|Amphetamine|amphetamine|mesh-list
44564513|NCT01133847|Adderall|adderall|mesh-list
44564514|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44564515|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44564516|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564517|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44564518|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44564519|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564520|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564521|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
44564522|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564523|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44564524|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44564525|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
44564526|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
44564527|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564528|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44564529|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44564530|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44564531|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44564532|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44564533|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
44564534|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564535|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44564536|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564537|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564538|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564539|NCT01133756|Gemcitabine|gemcitabine|mesh-list
44564540|NCT01133756|Carboplatin|carboplatin|mesh-list
44564541|NCT01133756|Lenvatinib|lenvatinib|mesh-list
44564542|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564543|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564544|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
44564545|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564546|NCT01133756|Antiviral Agents|antiviral agents|mesh-ancestor
44564547|NCT01133756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564548|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564549|NCT01133756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564550|NCT01133756|Immunologic Factors|immunologic factors|mesh-ancestor
44564551|NCT01133756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564552|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564553|NCT01133678|Paclitaxel|paclitaxel|mesh-list
44564554|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44564555|NCT01133678|Cisplatin|cisplatin|mesh-list
44564556|NCT01133678|Cetuximab|cetuximab|mesh-list
44564557|NCT01133678|Everolimus|everolimus|mesh-list
44564558|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44564559|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564560|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44564561|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44564562|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44564563|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564564|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564565|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564566|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
44564567|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564568|NCT01133665|Lenalidomide|lenalidomide|mesh-list
44564570|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
44564571|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564572|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564573|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564574|NCT01133665|Growth Substances|growth substances|mesh-ancestor
44564575|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564576|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390502|NCT03226249|Imidazole|imidazole|mesh-list
44564577|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564578|NCT01133626|Prednisone|prednisone|mesh-list
44564579|NCT01133626|Beclomethasone|beclomethasone|mesh-list
44564580|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564581|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
44564582|NCT01133626|Hormones|hormones|mesh-ancestor
44564583|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564584|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564585|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44564586|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564587|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564588|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564589|NCT01133522|Evolocumab|evolocumab|mesh-list
44564590|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44564591|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44564592|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
44564593|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564594|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44564595|NCT01133392|Insulin|insulin|mesh-list
44564596|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44564597|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
44564598|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564599|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564600|NCT01133379|Fluorides|fluorides|mesh-list
44564601|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
44564602|NCT01133379|Protective Agents|protective agents|mesh-ancestor
44564603|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564604|NCT01133275|Prednisone|prednisone|mesh-list
44564605|NCT01133275|Lenalidomide|lenalidomide|mesh-list
44564606|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564607|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
44564608|NCT01133275|Hormones|hormones|mesh-ancestor
44564609|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564610|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564611|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44564612|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564613|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
44564614|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564615|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564616|NCT01133275|Growth Substances|growth substances|mesh-ancestor
44564617|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564618|NCT01132820|Cediranib|cediranib|mesh-list
44564619|NCT01132820|Maleic acid|maleic acid|mesh-list
44564620|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564621|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564622|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564623|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564624|NCT01132807|Prednisone|prednisone|mesh-list
44564625|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
44564626|NCT01132807|Dacarbazine|dacarbazine|mesh-list
44564627|NCT01132807|Doxorubicin|doxorubicin|mesh-list
44564628|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44564629|NCT01132807|Etoposide|etoposide|mesh-list
44564630|NCT01132807|Bleomycin|bleomycin|mesh-list
44564631|NCT01132807|Vinblastine|vinblastine|mesh-list
44564632|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
44564633|NCT01132807|Procarbazine|procarbazine|mesh-list
44564634|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44564635|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564636|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
44564637|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564638|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564639|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44564640|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
44564641|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564642|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564643|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44564644|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44564645|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44564646|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44564647|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564648|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188384|NCT00347204|Analgesics|analgesics|mesh-ancestor
44564649|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
44564651|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564652|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44564653|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44564655|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44564656|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44564657|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44564658|NCT01132664|Capecitabine|capecitabine|mesh-list
44564659|NCT01132664|Trastuzumab|trastuzumab|mesh-list
44564660|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564661|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
44564662|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564663|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564664|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564665|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
44564666|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
44564667|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564668|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564669|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44564670|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
44564671|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
44564672|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564673|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564674|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564675|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44564676|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
44564677|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44564678|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
44564679|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564680|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44564681|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564682|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564683|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564684|NCT01132482|Urological Agents|urological agents|mesh-ancestor
44564685|NCT01132326|Droxidopa|droxidopa|mesh-list
44564686|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44564687|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44564688|NCT01132313|Ribavirin|ribavirin|mesh-list
44564689|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
44564690|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564691|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
44564692|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564693|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
44564694|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
44564695|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44564696|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44564697|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564698|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564699|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564700|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564701|NCT01131676|Empagliflozin|empagliflozin|mesh-list
44564702|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44564703|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564704|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564705|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564706|NCT01131585|Ranibizumab|ranibizumab|mesh-list
44564707|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44454841|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564708|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564709|NCT01131585|Growth Substances|growth substances|mesh-ancestor
44564710|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564711|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564712|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564713|NCT01131507|Pancrelipase|pancrelipase|mesh-list
44564714|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564715|NCT01131182|Metformin|metformin|mesh-list
44564716|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44564717|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564718|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564719|NCT01131182|Incretins|incretins|mesh-ancestor
44564720|NCT01131182|Hormones|hormones|mesh-ancestor
44564721|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564722|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44564723|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
44564724|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564725|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564726|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
44564727|NCT01131104|Tadalafil|tadalafil|mesh-list
44564728|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44564729|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44564730|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564731|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564732|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564733|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564734|NCT01131104|Urological Agents|urological agents|mesh-ancestor
44564735|NCT01131078|Bevacizumab|bevacizumab|mesh-list
44564736|NCT01131078|Capecitabine|capecitabine|mesh-list
44564737|NCT01131078|Irinotecan|irinotecan|mesh-list
44564738|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564739|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564740|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44564741|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44564742|NCT01131078|Growth Substances|growth substances|mesh-ancestor
44564743|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564744|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44564745|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564746|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
44564747|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564748|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44564749|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44564750|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564751|NCT01130597|Spironolactone|spironolactone|mesh-list
44564752|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44564753|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
44564754|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564755|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564756|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44564757|NCT01130597|Diuretics|diuretics|mesh-ancestor
44564758|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
44564759|NCT01130532|Tadalafil|tadalafil|mesh-list
44564760|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564761|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44564762|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44564763|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564764|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564765|NCT01130532|Urological Agents|urological agents|mesh-ancestor
44564766|NCT01130493|Levodopa|levodopa|mesh-list
44564767|NCT01130493|Carbidopa|carbidopa|mesh-list
44564768|NCT01130493|Entacapone|entacapone|mesh-list
44564769|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44564770|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44564771|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44564772|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
44564773|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564774|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564775|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564776|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44564777|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564778|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44564779|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44564780|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
44564781|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
44564782|NCT01130337|Capecitabine|capecitabine|mesh-list
44564783|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
44564784|NCT01130337|Trastuzumab|trastuzumab|mesh-list
44564785|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564786|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
44564787|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564788|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564789|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564790|NCT01130272|Eluxadoline|eluxadoline|mesh-list
44564791|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44564792|NCT01130168|Amlodipine|amlodipine|mesh-list
44564793|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44564794|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44564795|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564796|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564797|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44564798|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564799|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
44564800|NCT01130103|Paroxetine|paroxetine|mesh-list
44564801|NCT01130103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44390758|NCT03207243|Xhance|xhance|mesh-list
44564812|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44564813|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564814|NCT01130051|Colchicine|colchicine|mesh-list
44564815|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
44564816|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564817|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
44564818|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
44564819|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44564820|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564821|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564822|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44564823|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
44564824|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44564825|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44564826|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564827|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564828|NCT01129882|Aripiprazole|aripiprazole|mesh-list
44564829|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
44564830|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564831|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44564832|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564833|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564834|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564835|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
44564836|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
44564837|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564838|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564839|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44564840|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44564841|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
44564842|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44564843|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44564844|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44564845|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44564846|NCT01129622|Letrozole|letrozole|mesh-list
44564847|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564848|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44564849|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44564850|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564851|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564852|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44564853|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
44564854|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564855|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564856|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
44564857|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44564858|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44564859|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44564860|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564861|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564862|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
44564863|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44564864|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564865|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44564866|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564867|NCT01129557|Valsartan|valsartan|mesh-list
44564868|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44564869|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44564870|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44564871|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564872|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
44564873|NCT01129336|Diphosphonates|diphosphonates|mesh-list
44564874|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44564875|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564876|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44564877|NCT01129284|Hormones|hormones|mesh-ancestor
44564878|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564879|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564880|NCT01129011|Naproxen|naproxen|mesh-list
44564881|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44564882|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44564883|NCT01129011|Analgesics|analgesics|mesh-ancestor
44564884|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
44564885|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564886|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564887|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564888|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564889|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
44564890|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44564891|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564892|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564893|NCT01128959|Carbamazepine|carbamazepine|mesh-list
44564894|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
44564895|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
44564896|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44564897|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44564898|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564899|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44564900|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44564901|NCT01128959|Analgesics|analgesics|mesh-ancestor
44564902|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
44564903|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564904|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44564905|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44564906|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564907|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44564908|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44564909|NCT01128894|Liraglutide|liraglutide|mesh-list
44564910|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
44564911|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564912|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564913|NCT01128894|Incretins|incretins|mesh-ancestor
44564914|NCT01128894|Hormones|hormones|mesh-ancestor
44564915|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564916|NCT01128842|Capecitabine|capecitabine|mesh-list
44564917|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564918|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
44564919|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564920|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564921|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44564922|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564923|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564924|NCT01128621|Incretins|incretins|mesh-ancestor
44564925|NCT01128621|Hormones|hormones|mesh-ancestor
44188587|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
44564926|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564927|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44564928|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44564929|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564930|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564931|NCT01128595|Fluticasone|fluticasone|mesh-list
44564933|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564934|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44564935|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
44564936|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564937|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564938|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564939|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564940|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564941|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44564942|NCT01128569|Fluticasone|fluticasone|mesh-list
44564944|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44564945|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44564946|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
44564947|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44564948|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564949|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44564950|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
44564951|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44564952|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44564953|NCT01128543|Vinorelbine|vinorelbine|mesh-list
44564954|NCT01128543|Lapatinib|lapatinib|mesh-list
44564955|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44564956|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564957|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44564958|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44564959|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44564960|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564961|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44564962|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564963|NCT01128387|Panitumumab|panitumumab|mesh-list
44564964|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44564965|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564966|NCT01128296|Gemcitabine|gemcitabine|mesh-list
44564967|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
44564968|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44564969|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
44564970|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564971|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44564972|NCT01128296|Antiviral Agents|antiviral agents|mesh-ancestor
44564973|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44564974|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564975|NCT01128296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44564976|NCT01128296|Immunologic Factors|immunologic factors|mesh-ancestor
44564977|NCT01128296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564978|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
44564979|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44564980|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44564981|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44564982|NCT01128244|Pyridoxine|pyridoxine|mesh-list
44564983|NCT01128244|Pyridoxal|pyridoxal|mesh-list
44564984|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
44564985|NCT01128244|Vitamins|vitamins|mesh-ancestor
44564986|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
44564987|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564988|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
44564989|NCT01128153|Saxagliptin|saxagliptin|mesh-list
44564990|NCT01128153|Incretins|incretins|mesh-ancestor
44564991|NCT01128153|Hormones|hormones|mesh-ancestor
44564992|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44564993|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44564994|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44564995|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
44564996|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44564997|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44564998|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44564999|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44565000|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565001|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565002|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44565003|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565004|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565005|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188720|NCT00348400|Dorzolamide|dorzolamide|mesh-list
44565006|NCT01127893|Tanezumab|tanezumab|mesh-list
44565007|NCT01127893|Analgesics|analgesics|mesh-ancestor
44565008|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
44565009|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565010|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565011|NCT01127763|Carboplatin|carboplatin|mesh-list
44565012|NCT01127763|Everolimus|everolimus|mesh-list
44565013|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565014|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565015|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
44565016|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565017|NCT01127646|Methylphenidate|methylphenidate|mesh-list
44565018|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44565019|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44565020|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565021|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43968309|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
44565022|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565023|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565024|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565025|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
44565026|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565027|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44565028|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565029|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44565030|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44565031|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565032|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44565033|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565034|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565035|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565036|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
44565037|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565038|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
44565039|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565040|NCT01127165|Zonisamide|zonisamide|mesh-list
44565041|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
44565042|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44565043|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565044|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565045|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44565046|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565047|NCT01126879|Genistein|genistein|mesh-list
44565048|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44565049|NCT01126879|Protective Agents|protective agents|mesh-ancestor
44565050|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565051|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565052|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565053|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565054|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565055|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
44565056|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44565057|NCT01126879|Estrogens|estrogens|mesh-ancestor
44565058|NCT01126879|Hormones|hormones|mesh-ancestor
44565059|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565060|NCT01126736|Pemetrexed|pemetrexed|mesh-list
44565061|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565062|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565063|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565064|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44565065|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44565066|NCT01126580|Metformin|metformin|mesh-list
44565067|NCT01126580|Dulaglutide|dulaglutide|mesh-list
44565068|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44565069|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565070|NCT01126541|Rituximab|rituximab|mesh-list
44565071|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565072|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565073|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
44565074|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565075|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565076|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
44565077|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565078|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
44188753|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565079|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565080|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565081|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565082|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565083|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
44565084|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565085|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565086|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565087|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565088|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
44565089|NCT01126424|Oxybutynin|oxybutynin|mesh-list
44565090|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44565091|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565092|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565093|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565094|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565095|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565097|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
44565098|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
44565099|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565100|NCT01126359|Lidocaine|lidocaine|mesh-list
44565101|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44565102|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
44565103|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565104|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565105|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
44565106|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565107|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565108|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565109|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565110|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565111|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565112|NCT01126268|Retapamulin|retapamulin|mesh-list
44565113|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44565114|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565115|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44565116|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
44565117|NCT01126060|Coagulants|coagulants|mesh-ancestor
44565118|NCT01125930|Tretinoin|tretinoin|mesh-list
44565119|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565120|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
44565121|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
44565122|NCT01125917|Buprenorphine|buprenorphine|mesh-list
44565123|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44565124|NCT01125917|Narcotics|narcotics|mesh-ancestor
44565125|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188793|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
44565126|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565127|NCT01125917|Analgesics|analgesics|mesh-ancestor
44565128|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
44565129|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565130|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44565131|NCT01125813|Factor VIII|factor viii|mesh-list
44565132|NCT01125813|Coagulants|coagulants|mesh-ancestor
44565133|NCT01125748|Omalizumab|omalizumab|mesh-list
44565134|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44565135|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565136|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565137|NCT01125566|Trastuzumab|trastuzumab|mesh-list
44565138|NCT01125566|Vinorelbine|vinorelbine|mesh-list
44565139|NCT01125566|Afatinib|afatinib|mesh-list
44565140|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565141|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565142|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44565158|NCT01125293|Bortezomib|bortezomib|mesh-list
44565159|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565160|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565161|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
44565162|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565163|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565164|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565165|NCT01125189|Interferons|interferons|mesh-list
44565166|NCT01125189|Ribavirin|ribavirin|mesh-list
44565167|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
44565168|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
44565169|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44565170|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565171|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
44565172|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565173|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
44565174|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565175|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
44565176|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565177|NCT01125046|Bevacizumab|bevacizumab|mesh-list
44565178|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44565179|NCT01125046|Antibodies|antibodies|mesh-list
44565180|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
44565181|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44565182|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565183|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44565184|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44565185|NCT01125046|Growth Substances|growth substances|mesh-ancestor
44391167|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
44565186|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565187|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565188|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
44565189|NCT01124838|Prednisone|prednisone|mesh-list
44565190|NCT01124838|Adalimumab|adalimumab|mesh-list
44565191|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565192|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
44565193|NCT01124838|Hormones|hormones|mesh-ancestor
44565194|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565195|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565196|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44565197|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565198|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565199|NCT01124734|Temozolomide|temozolomide|mesh-list
44565200|NCT01124734|Interleukin-2|interleukin-2|mesh-list
44565201|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44565202|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
44565203|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565204|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565205|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44565206|NCT01124734|Analgesics|analgesics|mesh-ancestor
44565207|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
44565208|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565209|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565210|NCT01124617|Tapentadol|tapentadol|mesh-list
44565211|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44565212|NCT01124617|Narcotics|narcotics|mesh-ancestor
44565213|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565214|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565215|NCT01124617|Analgesics|analgesics|mesh-ancestor
44565216|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
44565217|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565218|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44565219|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565220|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565221|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565222|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565223|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565224|NCT01124604|Tapentadol|tapentadol|mesh-list
44565225|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44565226|NCT01124604|Narcotics|narcotics|mesh-ancestor
44565227|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565228|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565229|NCT01124604|Analgesics|analgesics|mesh-ancestor
44565230|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
44565231|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565232|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44565233|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565234|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565235|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565236|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565237|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565238|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
44565239|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565240|NCT01124448|Growth Substances|growth substances|mesh-ancestor
44565241|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565242|NCT01124422|Fluticasone|fluticasone|mesh-list
44565243|NCT01124422|Xhance|xhance|mesh-list
44565244|NCT01124422|Bromides|bromides|mesh-list
44565245|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
44565246|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44565247|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565248|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565249|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
44565250|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565251|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565252|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565253|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565254|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
44565255|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44565256|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
44565257|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565258|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565259|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768557|NCT02394002|Propofol|propofol|mesh-list
44565260|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565261|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44565262|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44565263|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44565264|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565266|NCT01124175|Losartan|losartan|mesh-list
44565267|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565268|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44565269|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44565270|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44565271|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565272|NCT01124162|Losartan|losartan|mesh-list
44565273|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565274|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44565275|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44565276|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44565277|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565278|NCT01124149|Mesalamine|mesalamine|mesh-list
44565279|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44565280|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44565281|NCT01124149|Analgesics|analgesics|mesh-ancestor
44565282|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
44565283|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565284|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565285|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565286|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565287|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44565288|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
44565289|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565290|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565291|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565292|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565293|NCT01124045|Prednisolone|prednisolone|mesh-list
44565294|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44565295|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
44565296|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44565297|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
44565298|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44565299|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
44565300|NCT01124045|Difluprednate|difluprednate|mesh-list
44565301|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565302|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
44565303|NCT01124045|Hormones|hormones|mesh-ancestor
44565304|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565305|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565306|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44565307|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565308|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
44565309|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
44565310|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565311|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565312|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44565313|NCT01124045|Protective Agents|protective agents|mesh-ancestor
44565314|NCT01123980|Insulin|insulin|mesh-list
44565315|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44565316|NCT01123980|Metformin|metformin|mesh-list
44565317|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
44565318|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
44565319|NCT01123980|Glimepiride|glimepiride|mesh-list
44565320|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
44565321|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44565322|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44565323|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565324|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565325|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565326|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
44565327|NCT01123889|Lidocaine|lidocaine|mesh-list
44565328|NCT01123889|Ropivacaine|ropivacaine|mesh-list
44565329|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44565330|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
44565331|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565332|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565333|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
44565334|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565335|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565336|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565337|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565338|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44188916|NCT00349024|Povidone|povidone|mesh-list
44565339|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565341|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
44565342|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565343|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
44565344|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
44565345|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
44565346|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565347|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565348|NCT01123356|Lenalidomide|lenalidomide|mesh-list
44565349|NCT01123356|Ofatumumab|ofatumumab|mesh-list
44565350|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
44565351|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565352|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44565353|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44565354|NCT01123356|Growth Substances|growth substances|mesh-ancestor
44565355|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565356|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565357|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
44565358|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
44565359|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565360|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565361|NCT01123070|Rituximab|rituximab|mesh-list
44565362|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565363|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565364|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
44565365|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565366|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565367|NCT01122927|Aripiprazole|aripiprazole|mesh-list
44565368|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565369|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565370|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44565371|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565372|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565373|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565374|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
44565375|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
44565376|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565377|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565378|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44565379|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44565380|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
44565381|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44565382|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44565383|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44565384|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44565385|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
44565386|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44565387|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565388|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
44565389|NCT01122680|Bromides|bromides|mesh-list
44565390|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
44565391|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565392|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
44565393|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565394|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565395|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565396|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565397|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
44565398|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565399|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565400|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565401|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565402|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
44565403|NCT01122381|Ethosuximide|ethosuximide|mesh-list
44565404|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
44565405|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
44565406|NCT01122264|Tadalafil|tadalafil|mesh-list
44565407|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565408|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
44565409|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44565410|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44565411|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391364|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
44565412|NCT01122264|Urological Agents|urological agents|mesh-ancestor
44565413|NCT01121991|Hormones|hormones|mesh-list
44565414|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565415|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565416|NCT01121926|Trazodone|trazodone|mesh-list
44565417|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44565418|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565419|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565420|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565421|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565422|NCT01121926|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44565423|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565424|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565425|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565426|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565427|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
44565428|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44565429|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565430|NCT01121913|Trazodone|trazodone|mesh-list
44565431|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44565432|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565433|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565434|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565435|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565436|NCT01121913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44565437|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565438|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565439|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565440|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565441|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
44565442|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44565443|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565444|NCT01121900|Trazodone|trazodone|mesh-list
44565445|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44565446|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44565447|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44565448|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565449|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565450|NCT01121900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44565451|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565452|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565453|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565454|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565455|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
44565456|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44565457|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565458|NCT01121757|Lenalidomide|lenalidomide|mesh-list
44565459|NCT01121757|Azacitidine|azacitidine|mesh-list
44565460|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
44565461|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565462|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44565463|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44565464|NCT01121757|Growth Substances|growth substances|mesh-ancestor
44565465|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565466|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565467|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565468|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
44565469|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565470|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565471|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44565472|NCT01121666|Hormones|hormones|mesh-ancestor
44565473|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565474|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565475|NCT01121575|Crizotinib|crizotinib|mesh-list
44565476|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565477|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565478|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830486|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565479|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565480|NCT01121562|Sunitinib|sunitinib|mesh-list
44565481|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565482|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44565483|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44565484|NCT01121562|Growth Substances|growth substances|mesh-ancestor
44565499|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565500|NCT01121536|Modafinil|modafinil|mesh-list
44565501|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44565502|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565503|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44565504|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44565505|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44565506|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565507|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44565508|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44565509|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565510|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565511|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565512|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565513|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565514|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565515|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565516|NCT01121406|Gemcitabine|gemcitabine|mesh-list
44565517|NCT01121406|Paclitaxel|paclitaxel|mesh-list
44565518|NCT01121406|Doxorubicin|doxorubicin|mesh-list
44565519|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44565520|NCT01121406|Topotecan|topotecan|mesh-list
44565521|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44565522|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565523|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44565524|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44565525|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44565526|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565527|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565528|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
44565529|NCT01121406|Antiviral Agents|antiviral agents|mesh-ancestor
44565530|NCT01121406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565531|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565532|NCT01121406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565533|NCT01121406|Immunologic Factors|immunologic factors|mesh-ancestor
44565534|NCT01121406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391512|NCT03157089|Afatinib|afatinib|mesh-list
44565535|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44565536|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44565537|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44565538|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44565539|NCT01121393|Gemcitabine|gemcitabine|mesh-list
44565540|NCT01121393|Cisplatin|cisplatin|mesh-list
44565541|NCT01121393|Afatinib|afatinib|mesh-list
44565542|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565543|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565544|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
44565545|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565546|NCT01121393|Antiviral Agents|antiviral agents|mesh-ancestor
44565547|NCT01121393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189140|NCT00349596|Decitabine|decitabine|mesh-list
44565548|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565549|NCT01121393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565550|NCT01121393|Immunologic Factors|immunologic factors|mesh-ancestor
44565551|NCT01121393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565552|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565553|NCT01120899|Minocycline|minocycline|mesh-list
44565554|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44565555|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565556|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
44565557|NCT01120691|Albuterol|albuterol|mesh-list
44565558|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
44565559|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565560|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
44565561|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565562|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565563|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565564|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565565|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
44565566|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565567|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565568|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565569|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565570|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
44565571|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44565572|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44565573|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44565574|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44565575|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565576|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44565577|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44565579|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44565580|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565581|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565582|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565583|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565584|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565585|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
44565586|NCT01120600|Vitamin D|vitamin d|mesh-list
44565587|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
44565588|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
44565589|NCT01120600|Calcium|calcium|mesh-list
44565590|NCT01120600|Vitamins|vitamins|mesh-ancestor
44565591|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
44565592|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565593|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44565594|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44565595|NCT01120600|Antacids|antacids|mesh-ancestor
44565596|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565597|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565598|NCT01120275|R04929097|r04929097|mesh-list
44565599|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565600|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565601|NCT01120184|Paclitaxel|paclitaxel|mesh-list
44565602|NCT01120184|Maytansine|maytansine|mesh-list
44565603|NCT01120184|Docetaxel|docetaxel|mesh-list
44565604|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44565605|NCT01120184|Trastuzumab|trastuzumab|mesh-list
44565606|NCT01120184|Pertuzumab|pertuzumab|mesh-list
44565607|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44565608|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565609|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44565610|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44565611|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44565612|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565613|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565614|NCT01120093|Bromides|bromides|mesh-list
44565615|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
44565616|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565617|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
44565618|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565619|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565620|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565621|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565622|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44565623|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44565624|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44565625|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565626|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565627|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565628|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
44565629|NCT01120028|Sirolimus|sirolimus|mesh-list
44565630|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
44565631|NCT01120028|Tacrolimus|tacrolimus|mesh-list
44565632|NCT01120028|Basiliximab|basiliximab|mesh-list
44565633|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565634|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
44565635|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565636|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44565637|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565638|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565639|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44565640|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565641|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44565642|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565643|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
44565644|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565645|NCT01119963|Castor Oil|castor oil|mesh-list
44565646|NCT01119963|Progesterone|progesterone|mesh-list
44565647|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44565648|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44565649|NCT01119963|Progestins|progestins|mesh-ancestor
44565650|NCT01119963|Hormones|hormones|mesh-ancestor
44189236|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565651|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565652|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565653|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44565654|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
44565655|NCT01119963|Cathartics|cathartics|mesh-ancestor
44565656|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565657|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
44565658|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44565659|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44565660|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565661|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565662|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565663|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565664|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565665|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
44565666|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
44565667|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44565668|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
44565669|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565670|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565671|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44565672|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565673|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
44565674|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44565675|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
44565676|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565677|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565678|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44565679|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44565680|NCT01119898|Diclofenac|diclofenac|mesh-list
44565681|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44565682|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44565683|NCT01119898|Analgesics|analgesics|mesh-ancestor
44565684|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
44565685|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565686|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565687|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565688|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565689|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44565690|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565691|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565693|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565694|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565695|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44565696|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44565697|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565698|NCT01119846|Incretins|incretins|mesh-ancestor
44565699|NCT01119846|Hormones|hormones|mesh-ancestor
44565700|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565701|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44565702|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44565703|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565704|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565705|NCT01119768|Esomeprazole|esomeprazole|mesh-list
44565706|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44565707|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565708|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44565709|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565710|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565711|NCT01119703|Vaccines|vaccines|mesh-list
44565712|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
44565713|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565714|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44565715|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
44565716|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565717|NCT01119508|Temozolomide|temozolomide|mesh-list
44565719|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44565720|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
44565721|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565722|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565723|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565724|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44565725|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44565726|NCT01119287|Dexamethasone|dexamethasone|mesh-list
44565727|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44565728|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565729|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
44565730|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
44565731|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565732|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565733|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565734|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
44565735|NCT01119287|Hormones|hormones|mesh-ancestor
44565736|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565737|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44565738|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565739|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44565740|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44565741|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44565742|NCT01119287|Analgesics|analgesics|mesh-ancestor
44565743|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
44565744|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565745|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44565746|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44565747|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44565748|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
44565749|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
44565750|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565751|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565752|NCT01119131|Vitamin D|vitamin d|mesh-list
44565753|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
44565754|NCT01119131|Calcium|calcium|mesh-list
44565755|NCT01119131|Vitamins|vitamins|mesh-ancestor
44565756|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
44565757|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565758|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44565759|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44565760|NCT01119105|Vancomycin|vancomycin|mesh-list
44565761|NCT01119105|Lefamulin|lefamulin|mesh-list
44565762|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44565763|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565764|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
44565765|NCT01119066|Melphalan|melphalan|mesh-list
44565766|NCT01119066|Busulfan|busulfan|mesh-list
44565767|NCT01119066|Thiotepa|thiotepa|mesh-list
44565768|NCT01119066|Fludarabine|fludarabine|mesh-list
44565769|NCT01119066|Clofarabine|clofarabine|mesh-list
44565770|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565771|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
44565772|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565773|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565774|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44565775|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
44565776|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565777|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565778|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44565779|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565780|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
44565781|NCT01118975|Lapatinib|lapatinib|mesh-list
44565782|NCT01118975|Vorinostat|vorinostat|mesh-list
44565783|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565784|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565785|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565786|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565787|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44565788|NCT01118962|Lacosamide|lacosamide|mesh-list
44565789|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
44565790|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565791|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565792|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969039|NCT01637090|Everolimus|everolimus|mesh-list
44565793|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565795|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
44565796|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565797|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565798|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565799|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565800|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44565801|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44565802|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565803|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565804|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565805|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565806|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565807|NCT01118780|Analgesics|analgesics|mesh-ancestor
44565808|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
44565809|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565810|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565811|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565812|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
44565813|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
44565814|NCT01118663|Edetic Acid|edetic acid|mesh-list
44565815|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44565816|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
44565817|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
44565818|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565819|NCT01118663|Expectorants|expectorants|mesh-ancestor
44565820|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
44565821|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44565822|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
44565823|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391789|NCT03137303|Albuterol|albuterol|mesh-list
44565824|NCT01118663|Protective Agents|protective agents|mesh-ancestor
44565825|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565826|NCT01118663|Antidotes|antidotes|mesh-ancestor
44565827|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
44565828|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44565829|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
44565830|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
44565831|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44565832|NCT01118520|Amlodipine|amlodipine|mesh-list
44565833|NCT01118520|Perindopril|perindopril|mesh-list
44565834|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44565835|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44565836|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565837|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565838|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44565839|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565840|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44565841|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44565842|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
44565843|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565844|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
44565845|NCT01118377|Capecitabine|capecitabine|mesh-list
44565846|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44565847|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
44565848|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565849|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565850|NCT01118351|Sunitinib|sunitinib|mesh-list
44565851|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565852|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44565853|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44565854|NCT01118351|Growth Substances|growth substances|mesh-ancestor
44565855|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189373|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
44565856|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44565857|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565858|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565859|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565860|NCT01118325|Clopidogrel|clopidogrel|mesh-list
44565861|NCT01118325|Ticagrelor|ticagrelor|mesh-list
44565862|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44565863|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44565864|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44565866|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
44565867|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565868|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565869|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565870|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
44565871|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44565872|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44565873|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44565874|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
44565875|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565876|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565877|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565878|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565879|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44565880|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44565881|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565882|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565883|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565884|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565885|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565886|NCT01117857|Analgesics|analgesics|mesh-ancestor
44565887|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
44565888|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565889|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
44565890|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44565891|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
44565892|NCT01117766|Pregabalin|pregabalin|mesh-list
44565893|NCT01117766|Analgesics|analgesics|mesh-ancestor
44565894|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
44565895|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44565896|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565897|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
44565898|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44565899|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391873|NCT03133793|Vitamins|vitamins|mesh-ancestor
44565909|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
44565910|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565911|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565912|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565913|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44565914|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44565915|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44565916|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565917|NCT01117350|Metformin|metformin|mesh-list
44565918|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
44565919|NCT01117350|Liraglutide|liraglutide|mesh-list
44565920|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44565921|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565922|NCT01117350|Incretins|incretins|mesh-ancestor
44565923|NCT01117350|Hormones|hormones|mesh-ancestor
44565924|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565925|NCT01117181|Methylphenidate|methylphenidate|mesh-list
44565926|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44565927|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565928|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44565929|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44565930|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565931|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565932|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
44565933|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565934|NCT01117051|Prucalopride|prucalopride|mesh-list
44565935|NCT01117051|Laxatives|laxatives|mesh-ancestor
44565936|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44565937|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44565938|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44565939|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
44565940|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44565941|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565942|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565943|NCT01117012|Ivacaftor|ivacaftor|mesh-list
44565944|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44565945|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44565946|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565947|NCT01116739|Fluorides|fluorides|mesh-list
44565948|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
44565949|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
44565950|NCT01116739|Protective Agents|protective agents|mesh-ancestor
44565951|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565952|NCT01116687|R04929097|r04929097|mesh-list
44565953|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565954|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565955|NCT01116648|Olaparib|olaparib|mesh-list
44565956|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44565957|NCT01116648|Cediranib|cediranib|mesh-list
44565958|NCT01116648|Maleic acid|maleic acid|mesh-list
44565959|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565960|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565961|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565962|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44565963|NCT01116427|Abatacept|abatacept|mesh-list
44565964|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44565965|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565966|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565967|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565968|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
44565969|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565970|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565971|NCT01116232|Sirolimus|sirolimus|mesh-list
44565972|NCT01116232|Rituximab|rituximab|mesh-list
44565973|NCT01116232|Tacrolimus|tacrolimus|mesh-list
44565974|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44565975|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44565976|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44565977|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
44565978|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565979|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44565980|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44565981|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44565982|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44565983|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44565984|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44565985|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44565986|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44565987|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
44565988|NCT01115855|Eplerenone|eplerenone|mesh-list
44565989|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44565990|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44565991|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44565992|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44565993|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44565994|NCT01115855|Diuretics|diuretics|mesh-ancestor
44565995|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
44565996|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44565997|NCT01115803|Everolimus|everolimus|mesh-list
44565998|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44565999|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566000|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566001|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
44566002|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566003|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44566004|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566005|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566006|NCT01115738|Clopidogrel|clopidogrel|mesh-list
44566007|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44566008|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566009|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44566010|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44566011|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566012|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
44566013|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566014|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566015|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566016|NCT01115569|Hydrocodone|hydrocodone|mesh-list
44566017|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44566018|NCT01115569|Narcotics|narcotics|mesh-ancestor
44566019|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566020|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566021|NCT01115569|Analgesics|analgesics|mesh-ancestor
44566022|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
44566023|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566024|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
44566025|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
44566026|NCT01115491|Bevacizumab|bevacizumab|mesh-list
44566027|NCT01115491|Temozolomide|temozolomide|mesh-list
44566028|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566029|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566030|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44566031|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44566032|NCT01115491|Growth Substances|growth substances|mesh-ancestor
44566033|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566034|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44566035|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44566036|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
44566037|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566038|NCT01114880|Adalimumab|adalimumab|mesh-list
44566039|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566040|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566041|NCT01114828|Tolvaptan|tolvaptan|mesh-list
44566042|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44566043|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566044|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
44566045|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566046|NCT01114737|Verapamil|verapamil|mesh-list
44566047|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44566048|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44566049|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566050|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566051|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44566052|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566053|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
44566054|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
44566055|NCT01114672|Vitamin D|vitamin d|mesh-list
44566056|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44392025|NCT03123588|Anagrelide|anagrelide|mesh-list
44566057|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566058|NCT01114672|Vitamins|vitamins|mesh-ancestor
44566059|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
44566060|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44566061|NCT01114529|Cyclosporine|cyclosporine|mesh-list
44566062|NCT01114529|Everolimus|everolimus|mesh-list
44566063|NCT01114529|Tacrolimus|tacrolimus|mesh-list
44566064|NCT01114529|Cyclosporins|cyclosporins|mesh-list
44566065|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566066|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
44566067|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566068|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44566069|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566070|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566071|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
44566072|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566073|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
44566074|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566075|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566076|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44189602|NCT00351871|Ribavirin|ribavirin|mesh-list
44566077|NCT01114516|Clindamycin|clindamycin|mesh-list
44566078|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
44566079|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
44566080|NCT01114516|Cefazolin|cefazolin|mesh-list
44566081|NCT01114516|Indomethacin|indomethacin|mesh-list
44566082|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566083|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44566084|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566085|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566086|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44566087|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566088|NCT01114516|Analgesics|analgesics|mesh-ancestor
44566089|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
44566090|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566091|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566092|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566093|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566094|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
44566095|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
44566096|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44566097|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44566099|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
44566100|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566101|NCT01114373|Protective Agents|protective agents|mesh-ancestor
44566102|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566103|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566104|NCT01114360|Melatonin|melatonin|mesh-list
44566105|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
44566106|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566107|NCT01114360|Protective Agents|protective agents|mesh-ancestor
44566108|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566109|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566110|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44566111|NCT01114217|Hematinics|hematinics|mesh-ancestor
44566112|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44566113|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44566114|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44566115|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44566116|NCT01114204|Hematinics|hematinics|mesh-ancestor
44566117|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44566118|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44566119|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44566120|NCT01114139|Hematinics|hematinics|mesh-ancestor
44566121|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44566122|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44566123|NCT01113931|Doxycycline|doxycycline|mesh-list
44566124|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566125|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566126|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
44566127|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44566128|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44566129|NCT01113710|Rotigotine|rotigotine|mesh-list
44566130|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
44566131|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
44566132|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566133|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566134|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566135|NCT01113541|Ziprasidone|ziprasidone|mesh-list
44566136|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566137|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
44566138|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566139|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566140|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566141|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566142|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566143|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566144|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566145|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44566146|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
44566147|NCT01112982|Colchicine|colchicine|mesh-list
44566148|NCT01112982|Febuxostat|febuxostat|mesh-list
44566149|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
44566150|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566151|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566152|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566153|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566154|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566155|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566156|NCT01112267|Acetaminophen|acetaminophen|mesh-list
44566157|NCT01112267|Tramadol|tramadol|mesh-list
44566158|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566159|NCT01112267|Analgesics|analgesics|mesh-ancestor
44566160|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
44566161|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566162|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566163|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
44566164|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44566165|NCT01112267|Narcotics|narcotics|mesh-ancestor
44566166|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566167|NCT01112059|Doxycycline|doxycycline|mesh-list
44566168|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566169|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566170|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
44566171|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44566172|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44566173|NCT01111851|Dexamethasone|dexamethasone|mesh-list
44566174|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
44566175|NCT01111851|Ondansetron|ondansetron|mesh-list
44566176|NCT01111851|Aprepitant|aprepitant|mesh-list
44566177|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
44566178|NCT01111851|BB 1101|bb 1101|mesh-list
44566179|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566180|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
44566181|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
44566182|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566183|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566184|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44566185|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
44566186|NCT01111851|Hormones|hormones|mesh-ancestor
44566187|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566188|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44566189|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566190|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566191|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189687|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
44566192|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566193|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
44566194|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44566195|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566196|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
44566197|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566198|NCT01111851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566199|NCT01111851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566200|NCT01111851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566201|NCT01111851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566202|NCT01111851|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44566203|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44566204|NCT01111825|Sirolimus|sirolimus|mesh-list
44566205|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566206|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566207|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44566208|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566209|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
44566210|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566211|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
44566212|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566213|NCT01111604|Ramucirumab|ramucirumab|mesh-list
44566214|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566215|NCT01111552|Aripiprazole|aripiprazole|mesh-list
44566216|NCT01111552|Citalopram|citalopram|mesh-list
44566217|NCT01111552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44566218|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566219|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566220|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566221|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566222|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
44566223|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566224|NCT01111552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44566225|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566226|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566227|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566228|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566229|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566230|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
44566231|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
44566232|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44566233|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44566234|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44566235|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566236|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44566237|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44566238|NCT01111539|Aripiprazole|aripiprazole|mesh-list
44566239|NCT01111539|Citalopram|citalopram|mesh-list
44566240|NCT01111539|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44566241|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44455018|NCT01654276|Febuxostat|febuxostat|mesh-list
44566242|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566243|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566244|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566246|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566247|NCT01111539|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44566248|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566249|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566250|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566251|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566252|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566253|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
44566254|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
44566255|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44566256|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44566257|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44566258|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566259|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44566260|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44566261|NCT01111526|Panobinostat|panobinostat|mesh-list
44566262|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566263|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44566264|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566265|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566266|NCT01111461|Lenvatinib|lenvatinib|mesh-list
44566267|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566268|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44566269|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566270|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566271|NCT01111292|Inositol|inositol|mesh-list
44566272|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
44566273|NCT01111292|Vitamins|vitamins|mesh-ancestor
44566274|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
44566275|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566276|NCT01111149|Bupropion|bupropion|mesh-list
44566277|NCT01111149|Varenicline|varenicline|mesh-list
44566278|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44566279|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566280|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566281|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44566282|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566283|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566284|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566293|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
44566294|NCT01111123|Halobetasol|halobetasol|mesh-list
44566295|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44566296|NCT01111019|Hormones|hormones|mesh-list
44566297|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566298|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566299|NCT01110707|Hormones|hormones|mesh-list
44566300|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44566301|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566302|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566303|NCT01110408|Amoxicillin|amoxicillin|mesh-list
44566304|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
44566305|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
44566306|NCT01110408|Cefepime|cefepime|mesh-list
44566307|NCT01110408|Doripenem|doripenem|mesh-list
44566308|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44566309|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566310|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566311|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44566312|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566313|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566314|NCT01110382|Amoxicillin|amoxicillin|mesh-list
44566315|NCT01110382|Meropenem|meropenem|mesh-list
44566316|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
44566317|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
44566318|NCT01110382|Doripenem|doripenem|mesh-list
44566319|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44566320|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566321|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566322|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44566323|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566324|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566325|NCT01110330|Ketoconazole|ketoconazole|mesh-list
44566326|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
44566327|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566328|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44566329|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566330|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566331|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566332|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44566333|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44566334|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566335|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566336|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44566337|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44566338|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44566339|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44566340|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
44566341|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566342|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566343|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44566344|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44566345|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44566346|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44566347|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44566348|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
44566349|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566350|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566351|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
44566352|NCT01110200|Hormones|hormones|mesh-ancestor
44566353|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566354|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
44566355|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44566356|NCT01109992|Regadenoson|regadenoson|mesh-list
44566357|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44566358|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44566359|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
44566360|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
44566361|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566362|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566363|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566364|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44566365|NCT01109979|Drospirenone|drospirenone|mesh-list
44566366|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44566367|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44566368|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
44566369|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44566370|NCT01109979|Estradiol|estradiol|mesh-list
44566371|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44566372|NCT01109979|Estrogens|estrogens|mesh-ancestor
44566373|NCT01109979|Hormones|hormones|mesh-ancestor
44566374|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566375|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566376|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44566377|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
44566378|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44566379|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44566380|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44566381|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44566382|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44566383|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44566384|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44566385|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566386|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44566387|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
44566388|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44566389|NCT01109979|Diuretics|diuretics|mesh-ancestor
44566390|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
44566391|NCT01109849|Methylphenidate|methylphenidate|mesh-list
44566392|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
44566393|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566394|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44392437|NCT03101150|Vitamin D|vitamin d|mesh-list
44566395|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566396|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566397|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566398|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
44566399|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566400|NCT01109524|Cisplatin|cisplatin|mesh-list
44566401|NCT01109524|Cetuximab|cetuximab|mesh-list
44566402|NCT01109524|Vinorelbine|vinorelbine|mesh-list
44566403|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566404|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566405|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44566406|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566407|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566408|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566409|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566410|NCT01109316|Insulin|insulin|mesh-list
44566411|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44566412|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
44566413|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
44566414|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566415|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566416|NCT01109173|Nepafenac|nepafenac|mesh-list
44566417|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44566418|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566419|NCT01109173|Analgesics|analgesics|mesh-ancestor
44566420|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
44566421|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566422|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566423|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566424|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566425|NCT01108809|Telmisartan|telmisartan|mesh-list
44566426|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566427|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44566428|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44566429|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566430|NCT01108731|Milnacipran|milnacipran|mesh-list
44566431|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
44566432|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44566433|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566434|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566435|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566436|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566437|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566438|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566439|NCT01108731|Analgesics|analgesics|mesh-ancestor
44566440|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
44566441|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566442|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566443|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566444|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44566445|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44566446|NCT01108510|Cobicistat|cobicistat|mesh-list
44566447|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44566448|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44566449|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566450|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566451|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
44566452|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566453|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44566454|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44566455|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44566456|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44566457|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566458|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44566459|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566460|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44566461|NCT01108458|Pertuzumab|pertuzumab|mesh-list
44566462|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566463|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44566464|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566465|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392509|NCT03097315|Triamcinolone|triamcinolone|mesh-list
44566466|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566467|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44566468|NCT01108341|Ofatumumab|ofatumumab|mesh-list
44566469|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44566470|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
44566471|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566472|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566473|NCT01108094|Itraconazole|itraconazole|mesh-list
44566474|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
44566475|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566476|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44566477|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566478|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566479|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566480|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44566481|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44566482|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566483|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566484|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44566485|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
44566486|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566487|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566488|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566489|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566490|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
44566491|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566492|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566493|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566494|NCT01108055|Paclitaxel|paclitaxel|mesh-list
44566495|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44566496|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566497|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566498|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566499|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566500|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566501|NCT01107925|Clopidogrel|clopidogrel|mesh-list
44566502|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44566503|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566504|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44566505|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44566506|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566507|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
44566508|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566509|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566510|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566511|NCT01107912|Clopidogrel|clopidogrel|mesh-list
44566512|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44566513|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566514|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44566515|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44566516|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566517|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
44566518|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566519|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566520|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566521|NCT01107899|Clopidogrel|clopidogrel|mesh-list
44566522|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44566523|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566524|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44566525|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44566526|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566527|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
44566528|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566529|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566530|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566531|NCT01107886|Saxagliptin|saxagliptin|mesh-list
44566532|NCT01107886|Incretins|incretins|mesh-ancestor
44566533|NCT01107886|Hormones|hormones|mesh-ancestor
43830487|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
44566534|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566535|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566536|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44566537|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566538|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566539|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566540|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566541|NCT01107743|Amlodipine|amlodipine|mesh-list
44566542|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44566543|NCT01107743|Atorvastatin|atorvastatin|mesh-list
44566544|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44566545|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44566546|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
44566547|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566548|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44566549|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44566550|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566551|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566552|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44566553|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566554|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44566555|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566556|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
44566557|NCT01107626|Paclitaxel|paclitaxel|mesh-list
44566558|NCT01107626|Bevacizumab|bevacizumab|mesh-list
44566559|NCT01107626|Carboplatin|carboplatin|mesh-list
44566560|NCT01107626|Pemetrexed|pemetrexed|mesh-list
44566561|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44566562|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566563|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566564|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566565|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566566|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566567|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566568|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44566569|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44566570|NCT01107626|Growth Substances|growth substances|mesh-ancestor
44566571|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566572|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
44566573|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566574|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44566575|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44566576|NCT01107535|Palivizumab|palivizumab|mesh-list
44566577|NCT01107535|Antibodies|antibodies|mesh-list
44566578|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44566579|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
44566580|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566581|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
44566582|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566583|NCT01107457|Ixekizumab|ixekizumab|mesh-list
44566584|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44566585|NCT01107444|Docetaxel|docetaxel|mesh-list
44566586|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566587|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566588|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566589|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566590|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566591|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44566592|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44566593|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
44566594|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44566595|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44566596|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44566597|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566598|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566599|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
44566600|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566601|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566602|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44566603|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566604|NCT01107353|Imipramine|imipramine|mesh-list
44566605|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44566606|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566607|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566608|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44566609|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566620|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566621|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566622|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566623|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566624|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566625|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
44566626|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566627|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566628|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44566629|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
44566630|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44566631|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44566632|NCT01106846|Ketamine|ketamine|mesh-list
44566633|NCT01106846|Analgesics|analgesics|mesh-ancestor
44566634|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
44566635|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566636|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566637|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44566638|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44566639|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
44566640|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
44566641|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566642|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44566643|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44566644|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566645|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566646|NCT01106690|Metformin|metformin|mesh-list
44566647|NCT01106690|Pioglitazone|pioglitazone|mesh-list
44566648|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44566649|NCT01106690|Canagliflozin|canagliflozin|mesh-list
44566650|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566651|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566652|NCT01106690|Incretins|incretins|mesh-ancestor
44566653|NCT01106690|Hormones|hormones|mesh-ancestor
44566654|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566655|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44566656|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566657|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566658|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566659|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44566660|NCT01106677|Metformin|metformin|mesh-list
44566661|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44566662|NCT01106677|Canagliflozin|canagliflozin|mesh-list
44566663|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566664|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566665|NCT01106677|Incretins|incretins|mesh-ancestor
44566666|NCT01106677|Hormones|hormones|mesh-ancestor
44566667|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566668|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44566669|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566670|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566671|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566672|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44566673|NCT01106651|Canagliflozin|canagliflozin|mesh-list
44566674|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44566675|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44566676|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566677|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566678|NCT01106625|Metformin|metformin|mesh-list
44566679|NCT01106625|Canagliflozin|canagliflozin|mesh-list
44566680|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566681|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566682|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44566683|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566684|NCT01106586|Ritonavir|ritonavir|mesh-list
44566685|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44566686|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44566687|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44566688|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566689|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566690|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566691|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44566692|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44566693|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
44566694|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566695|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44566696|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566697|NCT01106534|Aspirin|aspirin|mesh-list
44566698|NCT01106534|Everolimus|everolimus|mesh-list
44566699|NCT01106534|Clopidogrel|clopidogrel|mesh-list
44566700|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44566701|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44566702|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566703|NCT01106534|Analgesics|analgesics|mesh-ancestor
44566704|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
44566705|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566706|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566707|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566708|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566709|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44566710|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44566711|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566712|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566713|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44566714|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566715|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
44566716|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566717|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566718|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
44566719|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44566720|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44566721|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44566722|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
44566723|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566724|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44566725|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44566726|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44566727|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566728|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566729|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566730|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
44566731|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566732|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566733|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44566734|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44566735|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
44566736|NCT01106352|Docetaxel|docetaxel|mesh-list
44566737|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44566738|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566739|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
44566740|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
44566741|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44566742|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566743|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
44566744|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
44566745|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566746|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566747|NCT01106092|Vaccines|vaccines|mesh-list
44566748|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
44566749|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566750|NCT01106027|Eculizumab|eculizumab|mesh-list
44566751|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44566752|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44566753|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
44566754|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566755|NCT01106014|Selexipag|selexipag|mesh-list
44566756|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566757|NCT01105975|Atorvastatin|atorvastatin|mesh-list
44566758|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44566759|NCT01105975|Simvastatin|simvastatin|mesh-list
44566760|NCT01105975|Evacetrapib|evacetrapib|mesh-list
44566761|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44566762|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44566763|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
44566764|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566766|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44566767|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566768|NCT01105936|Acetaminophen|acetaminophen|mesh-list
44566769|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44566770|NCT01105936|Analgesics|analgesics|mesh-ancestor
44566771|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
44566772|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566773|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566774|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
44566775|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
44566776|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44566777|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44566778|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566779|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
44566780|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44566781|NCT01105377|Azacitidine|azacitidine|mesh-list
44566782|NCT01105377|Entinostat|entinostat|mesh-list
44566783|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44566784|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44566785|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
44566786|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566787|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566788|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566789|NCT01105091|Epoprostenol|epoprostenol|mesh-list
44566790|NCT01105091|Tezosentan|tezosentan|mesh-list
44566791|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566792|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44566793|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
44566794|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44566795|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566796|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44566797|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44566798|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44566799|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44566800|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566801|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566802|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566803|NCT01104870|Treprostinil|treprostinil|mesh-list
44566804|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566805|NCT01104792|Cariprazine|cariprazine|mesh-list
44566806|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566807|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566808|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566809|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566810|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566811|NCT01104779|Cariprazine|cariprazine|mesh-list
44566812|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566813|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566814|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566815|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566816|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566817|NCT01104766|Aripiprazole|aripiprazole|mesh-list
44566818|NCT01104766|Cariprazine|cariprazine|mesh-list
44566819|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566820|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566821|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44566822|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44566823|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44566824|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566825|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
44566826|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
44566827|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566828|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566829|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44566830|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44566831|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
44566832|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44566833|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566834|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44566835|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44566836|NCT01104701|Exenatide|exenatide|mesh-list
44566837|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44566838|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566839|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44566841|NCT01104701|Hormones|hormones|mesh-ancestor
44566842|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566843|NCT01104662|Vancomycin|vancomycin|mesh-list
44566844|NCT01104662|Daptomycin|daptomycin|mesh-list
44566845|NCT01104662|Penicillins|penicillins|mesh-list
44566846|NCT01104662|Cloxacillin|cloxacillin|mesh-list
44566847|NCT01104662|Oxacillin|oxacillin|mesh-list
44566848|NCT01104662|Nafcillin|nafcillin|mesh-list
44566849|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566850|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566851|NCT01104636|Varenicline|varenicline|mesh-list
44566852|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44566853|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44566854|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
44566855|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566856|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566857|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566858|NCT01104558|Bisoprolol|bisoprolol|mesh-list
44566859|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566860|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
44566861|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
44566862|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566863|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566864|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44566865|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44566866|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44566867|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
44566868|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566869|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566870|NCT01104376|Efavirenz|efavirenz|mesh-list
44566871|NCT01104376|Voriconazole|voriconazole|mesh-list
44566872|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44566873|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44566874|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566875|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566876|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
44566877|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566878|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44566879|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44566880|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44566881|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44566882|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44566883|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44566884|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
44566885|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44566886|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44566887|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
44566888|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566889|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566890|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44566891|NCT01104246|Testosterone|testosterone|mesh-list
44566892|NCT01104246|Androgens|androgens|mesh-ancestor
44566893|NCT01104246|Hormones|hormones|mesh-ancestor
44566894|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566895|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566896|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44190305|NCT00354458|Rolofylline|rolofylline|mesh-list
44566897|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566898|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44566899|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566900|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566901|NCT01103960|Amlodipine|amlodipine|mesh-list
44566902|NCT01103960|Telmisartan|telmisartan|mesh-list
44566903|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566904|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44566905|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566906|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566907|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44566908|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566909|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
44566910|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44566911|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44566912|NCT01103778|Bortezomib|bortezomib|mesh-list
44566913|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44566914|NCT01103713|Azithromycin|azithromycin|mesh-list
44566916|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566917|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566918|NCT01103713|Amebicides|amebicides|mesh-ancestor
44566919|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44566920|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44566921|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
44566922|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566923|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44566924|NCT01103245|Spironolactone|spironolactone|mesh-list
44566925|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44566926|NCT01103245|Diuretics|diuretics|mesh-ancestor
44566927|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
44566928|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566929|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44566930|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566931|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566932|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44566933|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
44566934|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44566935|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44566936|NCT01103180|Citalopram|citalopram|mesh-list
44566937|NCT01103180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44566938|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44566939|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44566940|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566941|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566942|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
44566943|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566944|NCT01103180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44566945|NCT01103180|Antidepressive Agents|antidepressive agents|mesh-ancestor
44566946|NCT01103180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44566947|NCT01103063|Azithromycin|azithromycin|mesh-list
44566948|NCT01103063|Chloroquine|chloroquine|mesh-list
44566949|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
44566950|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
44566951|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44566952|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566953|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566954|NCT01103063|Amebicides|amebicides|mesh-ancestor
44566955|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44566956|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44566957|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
44566958|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44566959|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44566960|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566961|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566962|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44566963|NCT01103063|Renal Agents|renal agents|mesh-ancestor
44566964|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44566965|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44566966|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44566967|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44566968|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44566969|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566970|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
44566971|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566972|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44566973|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44566974|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44566975|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44566976|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
44566977|NCT01102803|Cycloserine|cycloserine|mesh-list
44566978|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44566979|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44566980|NCT01102803|Renal Agents|renal agents|mesh-ancestor
44566981|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44566982|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
44566983|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44566984|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
44566985|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44566986|NCT01102491|Ramosetron|ramosetron|mesh-list
44566987|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
44566988|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
44566989|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44566990|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44566991|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44566992|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44566993|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
44566994|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44566995|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393128|NCT03072719|Fluorides|fluorides|mesh-list
44566996|NCT01102426|Dexamethasone|dexamethasone|mesh-list
44566997|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44566998|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
44566999|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
44567000|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567001|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567002|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567003|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
44567004|NCT01102426|Hormones|hormones|mesh-ancestor
44567005|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567006|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44567007|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567008|NCT01102374|Vitamin D|vitamin d|mesh-list
44567009|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
44567010|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
44567011|NCT01102374|Vitamins|vitamins|mesh-list
44567012|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
44567013|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567014|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44567015|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44567016|NCT01102231|Cetuximab|cetuximab|mesh-list
44567017|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567018|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567019|NCT01101841|Paroxetine|paroxetine|mesh-list
44567020|NCT01101841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44567021|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44567022|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567023|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567024|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567025|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
44567026|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567027|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44567028|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
44567029|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44190420|NCT00354952|Azithromycin|azithromycin|mesh-list
44567030|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44567031|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567032|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567033|NCT01101438|Metformin|metformin|mesh-list
44567034|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567035|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567036|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44567037|NCT01101334|Efatutazone|efatutazone|mesh-list
44567038|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567039|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567040|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567041|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567042|NCT01101321|Oxycodone|oxycodone|mesh-list
44567043|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567044|NCT01101321|Narcotics|narcotics|mesh-ancestor
44567045|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567046|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567047|NCT01101321|Analgesics|analgesics|mesh-ancestor
44567048|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
44567049|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567050|NCT01101308|Oxycodone|oxycodone|mesh-list
44567051|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567052|NCT01101308|Narcotics|narcotics|mesh-ancestor
44567053|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235417|NCT00554476|Analgesics|analgesics|mesh-ancestor
44567054|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567055|NCT01101308|Analgesics|analgesics|mesh-ancestor
44567056|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
44567057|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567058|NCT01101191|Oxycodone|oxycodone|mesh-list
44567059|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567060|NCT01101191|Narcotics|narcotics|mesh-ancestor
44567061|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567062|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567063|NCT01101191|Analgesics|analgesics|mesh-ancestor
44567064|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
44567065|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567066|NCT01101178|Oxycodone|oxycodone|mesh-list
44567067|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44393200|NCT03069352|Cytarabine|cytarabine|mesh-list
44567068|NCT01101178|Narcotics|narcotics|mesh-ancestor
44567069|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567070|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567093|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44567094|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44567095|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567096|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44567097|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44567098|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567099|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567100|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
44567101|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567102|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
44567103|NCT01100944|Cisplatin|cisplatin|mesh-list
44567104|NCT01100944|Doxorubicin|doxorubicin|mesh-list
44567105|NCT01100944|Belinostat|belinostat|mesh-list
44567106|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567107|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
44567108|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567109|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567110|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44567111|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
44567112|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567113|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567114|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44567115|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44567116|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44567117|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44567118|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567119|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44567120|NCT01100853|Naltrexone|naltrexone|mesh-list
44567121|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44567122|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44567123|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567124|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
44567125|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567126|NCT01100658|Methylphenidate|methylphenidate|mesh-list
44567127|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44567128|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567129|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44567130|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44567131|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567132|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567133|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
44567134|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567135|NCT01100528|Interferons|interferons|mesh-list
44567136|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
44567137|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
44567138|NCT01100528|Dacarbazine|dacarbazine|mesh-list
44567139|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567140|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
44567141|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567142|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
44567143|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567144|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44567145|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
44567146|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567147|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44567148|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567149|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567150|NCT01100437|Naltrexone|naltrexone|mesh-list
44567151|NCT01100437|Morphine|morphine|mesh-list
44567152|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567153|NCT01100437|Narcotics|narcotics|mesh-ancestor
44567154|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567155|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567156|NCT01100437|Analgesics|analgesics|mesh-ancestor
44567157|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
44567158|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567159|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44567160|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44567161|NCT01100320|Oxycodone|oxycodone|mesh-list
44567162|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567163|NCT01100320|Narcotics|narcotics|mesh-ancestor
44567164|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567165|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567166|NCT01100320|Analgesics|analgesics|mesh-ancestor
44567167|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
44567168|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567169|NCT01100086|Oxycodone|oxycodone|mesh-list
44567170|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567171|NCT01100086|Narcotics|narcotics|mesh-ancestor
44567172|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567173|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567174|NCT01100086|Analgesics|analgesics|mesh-ancestor
44567175|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
44567176|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567177|NCT01100034|Etanercept|etanercept|mesh-list
44567178|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44567179|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44567180|NCT01100034|Analgesics|analgesics|mesh-ancestor
44567181|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
44567182|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567183|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567184|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567185|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567186|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567187|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567188|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
44567189|NCT01099709|Oxycodone|oxycodone|mesh-list
44567190|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44567191|NCT01099709|Narcotics|narcotics|mesh-ancestor
44567192|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567193|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567194|NCT01099709|Analgesics|analgesics|mesh-ancestor
44567195|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
44567196|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567197|NCT01099579|Ritonavir|ritonavir|mesh-list
44567198|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44567199|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44567200|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44567201|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567202|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567203|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567204|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44567205|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44567206|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
44567207|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567208|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44567209|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567210|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44567211|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
44567212|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567213|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567214|NCT01098539|Incretins|incretins|mesh-ancestor
44567215|NCT01098539|Hormones|hormones|mesh-ancestor
44567216|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567217|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44567218|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567219|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567220|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567221|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44567222|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
44567223|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567224|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
44567225|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44567226|NCT01098461|Incretins|incretins|mesh-ancestor
44567227|NCT01098461|Hormones|hormones|mesh-ancestor
44567228|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567229|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567230|NCT01098305|Varenicline|varenicline|mesh-list
44567231|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44567232|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44567233|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
44567234|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567235|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567236|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567237|NCT01098110|Asenapine|asenapine|mesh-list
44567238|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44567239|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44567240|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567241|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567242|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44567243|NCT01098097|Ribavirin|ribavirin|mesh-list
44567244|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
44567245|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567246|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
44567247|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567248|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
44567249|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567250|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567251|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44567252|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
44567253|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567254|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567255|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567256|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567257|NCT01097629|Suvorexant|suvorexant|mesh-list
44567258|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44567259|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44567260|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567261|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567262|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44567263|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567264|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567265|NCT01097616|Suvorexant|suvorexant|mesh-list
44567266|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44567267|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44567268|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567269|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567270|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44567271|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567272|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393432|NCT03055988|Xhance|xhance|mesh-list
44567274|NCT01097577|Analgesics|analgesics|mesh-ancestor
44567275|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
44567276|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567277|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567278|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
44567279|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44567280|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567281|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567282|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44567283|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44567284|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44567285|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567286|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44567287|NCT01097421|Pramipexole|pramipexole|mesh-list
44567288|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
44567289|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567290|NCT01097421|Protective Agents|protective agents|mesh-ancestor
44567291|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567292|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44567293|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44567294|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
44567295|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
44567296|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567297|NCT01097330|Amiodarone|amiodarone|mesh-list
44567298|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44567299|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
44567300|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44567301|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567302|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567303|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44567304|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44567305|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567306|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567307|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44567308|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44567309|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44567310|NCT01097057|Plerixafor|plerixafor|mesh-list
44567311|NCT01097057|Rituximab|rituximab|mesh-list
44567312|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44567313|NCT01097057|Carboplatin|carboplatin|mesh-list
44567314|NCT01097057|Etoposide|etoposide|mesh-list
44567315|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
44567316|NCT01097057|Ifosfamide|ifosfamide|mesh-list
44567317|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
44567318|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
44567319|NCT01097057|Antibodies|antibodies|mesh-list
44567320|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
44567321|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44567322|NCT01097057|Lenograstim|lenograstim|mesh-list
44567323|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
44567324|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567325|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567326|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567327|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44567328|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44567329|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44567330|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567331|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567332|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44567333|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44567334|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
44567335|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44567336|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44567337|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
44567338|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567339|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
44567340|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567341|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44567342|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44567343|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44567344|NCT01097044|Afamelanotide|afamelanotide|mesh-list
44567345|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567346|NCT01096849|Levofloxacin|levofloxacin|mesh-list
44567347|NCT01096849|Ofloxacin|ofloxacin|mesh-list
44567348|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44567349|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567350|NCT01096849|Renal Agents|renal agents|mesh-ancestor
44567351|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44567352|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44567353|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44567354|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567355|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567356|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567357|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44567358|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567359|NCT01096784|Mecasermin|mecasermin|mesh-list
44567360|NCT01096784|Growth Substances|growth substances|mesh-ancestor
44567361|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567362|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
44567363|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44567364|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44567365|NCT01096667|Diuretics|diuretics|mesh-ancestor
44567366|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
44567367|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567368|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44567369|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567370|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567371|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44567372|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567373|NCT01096589|Monensin|monensin|mesh-list
44567374|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
44567375|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567376|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44567377|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44567378|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
44567379|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
44567380|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
44567381|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567382|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567383|NCT01096589|Ionophores|ionophores|mesh-ancestor
44567384|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567385|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
44567386|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44567387|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44567388|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44567389|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44567390|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
44567391|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567392|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567393|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567394|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44567395|NCT01096186|Carbidopa|carbidopa|mesh-list
44567396|NCT01096186|Levodopa|levodopa|mesh-list
44567397|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44567398|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
44567399|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567400|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44567401|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44567402|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
44567403|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
44567404|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567405|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567406|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44567407|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567408|NCT01096056|Vaccines|vaccines|mesh-list
44567409|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
44567410|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567411|NCT01096017|Albuterol|albuterol|mesh-list
44567412|NCT01096017|Terbutaline|terbutaline|mesh-list
44567413|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44567414|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
44567415|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567416|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567417|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44567418|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
44567419|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
44567420|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44567421|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44567422|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44567423|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44567424|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44567425|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567426|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567427|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
44567428|NCT01095978|Clarithromycin|clarithromycin|mesh-list
44567429|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44567430|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567431|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44567432|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567433|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567434|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44567435|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567436|NCT01095835|Interferons|interferons|mesh-list
44567437|NCT01095835|Lamivudine|lamivudine|mesh-list
44567438|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44567439|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
44567440|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567441|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
44567442|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567443|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44567444|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44567445|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567446|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190819|NCT00356486|Ribavirin|ribavirin|mesh-list
44567447|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44567448|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44567449|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
44567450|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567451|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44567452|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44567453|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44567454|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44567455|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567456|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567457|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
44567458|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567459|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44567460|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44567462|NCT01095666|Pioglitazone|pioglitazone|mesh-list
44567463|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
44567464|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567465|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567466|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44567467|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567468|NCT01095653|Metformin|metformin|mesh-list
44567469|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
44567470|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567471|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567472|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44567473|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567474|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44567475|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
44567476|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567477|NCT01095094|Ritonavir|ritonavir|mesh-list
44567478|NCT01095094|Lopinavir|lopinavir|mesh-list
44567479|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44567480|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44567481|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567482|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567483|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190870|NCT00356941|Docetaxel|docetaxel|mesh-list
44567484|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44567485|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44567486|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
44567487|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567488|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44567489|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567490|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
44567491|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44567492|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
44567493|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44567494|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567515|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
44567516|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
44567517|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567518|NCT01094184|Paclitaxel|paclitaxel|mesh-list
44567519|NCT01094184|Docetaxel|docetaxel|mesh-list
44567520|NCT01094184|Bevacizumab|bevacizumab|mesh-list
44567521|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44567522|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567523|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44567524|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44567525|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44567526|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567527|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567528|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44567529|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44567530|NCT01094184|Growth Substances|growth substances|mesh-ancestor
44567531|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567532|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
44567533|NCT01093885|Ambrisentan|ambrisentan|mesh-list
44567534|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44567535|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44567536|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
44567537|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567538|NCT01093755|Omeprazole|omeprazole|mesh-list
44567539|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
44567540|NCT01093755|Lansoprazole|lansoprazole|mesh-list
44567541|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44567542|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567543|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44567544|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567545|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567546|NCT01093586|Cyclosporine|cyclosporine|mesh-list
44393705|NCT03047980|Sirolimus|sirolimus|mesh-list
44567547|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
44567548|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
44567549|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44567550|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44567551|NCT01093586|Prednisolone|prednisolone|mesh-list
44567552|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
44567553|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
44567554|NCT01093586|Busulfan|busulfan|mesh-list
44567555|NCT01093586|Cyclosporins|cyclosporins|mesh-list
44567556|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
44567557|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44567558|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44567559|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
44567560|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567561|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
44567562|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567563|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190905|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
44567564|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44567565|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
44567566|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567567|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567568|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44567569|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567570|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
44567571|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567572|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567573|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44567574|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44567575|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44567576|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
44567577|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44567578|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567579|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
44567580|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
44567581|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567582|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567583|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
44567584|NCT01093586|Hormones|hormones|mesh-ancestor
44567585|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567586|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44567587|NCT01093586|Protective Agents|protective agents|mesh-ancestor
44567588|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44567589|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
44567590|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44567591|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44567592|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
44567593|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567594|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567595|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567596|NCT01093534|Urological Agents|urological agents|mesh-ancestor
44567597|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44567598|NCT01093222|Sorafenib|sorafenib|mesh-list
44567599|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567600|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567601|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567602|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567603|NCT01092832|Voriconazole|voriconazole|mesh-list
44567604|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
44567605|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567606|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44567607|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44567608|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567609|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567610|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44567611|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
44567612|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567613|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567614|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44393746|NCT03042910|Talazoparib|talazoparib|mesh-list
44567616|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44567617|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567618|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44567619|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44567620|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44567621|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567622|NCT01092728|Dasatinib|dasatinib|mesh-list
44567623|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567624|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567625|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567626|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567627|NCT01092702|Varenicline|varenicline|mesh-list
44567628|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44567629|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44567630|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
44567631|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567632|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567633|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567634|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44567635|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44567636|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567637|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567638|NCT01092663|Incretins|incretins|mesh-ancestor
44567639|NCT01092663|Hormones|hormones|mesh-ancestor
44567640|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567641|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44567642|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567643|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567644|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567645|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44567646|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44567647|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
44567648|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44567649|NCT01092546|Flutemetamol|flutemetamol|mesh-list
44567650|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44567651|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567652|NCT01092507|Vaccines|vaccines|mesh-list
44567653|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
44567654|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567655|NCT01092182|Prednisone|prednisone|mesh-list
44567656|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
44567657|NCT01092182|Rituximab|rituximab|mesh-list
44567658|NCT01092182|Doxorubicin|doxorubicin|mesh-list
44567659|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44567660|NCT01092182|Etoposide|etoposide|mesh-list
44567661|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
44567662|NCT01092182|Vincristine|vincristine|mesh-list
44567663|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567664|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
44567665|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191015|NCT00357305|Cytarabine|cytarabine|mesh-list
44567666|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567667|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44567668|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
44567669|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567670|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567671|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44567672|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567673|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44567674|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44567675|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44567676|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567677|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567678|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
44567679|NCT01092182|Hormones|hormones|mesh-ancestor
44567680|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567681|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44567682|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44567683|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44567684|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44567685|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44567686|NCT01091974|Modafinil|modafinil|mesh-list
44567687|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44567688|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567689|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44567690|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44567691|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44567692|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567694|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44567695|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44567696|NCT01091675|Analgesics|analgesics|mesh-ancestor
44567697|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
44567698|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567699|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567700|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567701|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567702|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44567703|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44567704|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567705|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567706|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44567707|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
44567708|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44567709|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44567710|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567711|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567712|NCT01091519|Fesoterodine|fesoterodine|mesh-list
44567713|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44567714|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44567715|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
44567716|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567717|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567718|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567719|NCT01091519|Urological Agents|urological agents|mesh-ancestor
44567720|NCT01091454|Cisplatin|cisplatin|mesh-list
44567721|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567722|NCT01091428|Paclitaxel|paclitaxel|mesh-list
44567723|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44567724|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567725|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44567726|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44567727|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44567728|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567729|NCT01091259|Bevacizumab|bevacizumab|mesh-list
44567730|NCT01091259|Irinotecan|irinotecan|mesh-list
44567731|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567732|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567733|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44567734|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44567735|NCT01091259|Growth Substances|growth substances|mesh-ancestor
44567736|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567737|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
44567738|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44567739|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44567740|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567741|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567742|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
44567743|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567744|NCT01090973|Panobinostat|panobinostat|mesh-list
44567745|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44567746|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567747|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567748|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567749|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44567750|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
44235426|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44567751|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567752|NCT01090427|Ustekinumab|ustekinumab|mesh-list
44567753|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567754|NCT01090414|Idelalisib|idelalisib|mesh-list
44567755|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567756|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191123|NCT00357617|Celecoxib|celecoxib|mesh-list
44567757|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567758|NCT01090323|Deferasirox|deferasirox|mesh-list
44567759|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44567760|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
44567761|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
44567762|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567763|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44567765|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44567766|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44567767|NCT01090102|Analgesics|analgesics|mesh-ancestor
44567768|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
44567769|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567770|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567771|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567772|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567773|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
44567774|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44567775|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567776|NCT01090063|Ustekinumab|ustekinumab|mesh-list
44567777|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567778|NCT01090050|Naproxen|naproxen|mesh-list
44567779|NCT01090050|Sumatriptan|sumatriptan|mesh-list
44567780|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44567781|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44567782|NCT01090050|Analgesics|analgesics|mesh-ancestor
44567783|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
44567784|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567785|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567786|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567787|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567788|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
44567789|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44567790|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567791|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567792|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44567793|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44567794|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44567795|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
44567796|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567797|NCT01090011|Cetuximab|cetuximab|mesh-list
44567798|NCT01090011|Afatinib|afatinib|mesh-list
44567799|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44567800|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567801|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44567802|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567803|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567804|NCT01089725|Tanezumab|tanezumab|mesh-list
44567805|NCT01089725|Analgesics|analgesics|mesh-ancestor
44567806|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
44567807|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567808|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567809|NCT01089361|Ketamine|ketamine|mesh-list
44567810|NCT01089361|Analgesics|analgesics|mesh-ancestor
44567811|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
44567812|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567813|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191172|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
44567814|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44567815|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44567816|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
44567817|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
44567818|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567819|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44567820|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44567821|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567822|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567823|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
44567824|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567825|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
44567826|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567827|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567828|NCT01087736|Topiramate|topiramate|mesh-list
44567829|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
44567830|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567831|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567832|NCT01087489|Lidocaine|lidocaine|mesh-list
44567833|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
44567834|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
44567835|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44567836|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567837|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
44567838|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567839|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44567840|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44567841|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44567842|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44567843|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567844|NCT01087203|Tanezumab|tanezumab|mesh-list
44567845|NCT01087203|Analgesics|analgesics|mesh-ancestor
44567846|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
44567847|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567848|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567849|NCT01086384|Fluticasone|fluticasone|mesh-list
44567850|NCT01086384|Xhance|xhance|mesh-list
44567851|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567852|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44567853|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
44567854|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567855|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567856|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44567857|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44567858|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567859|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44567860|NCT01086358|Naproxen|naproxen|mesh-list
44567861|NCT01086358|Sumatriptan|sumatriptan|mesh-list
44567862|NCT01086358|Naratriptan|naratriptan|mesh-list
44567863|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
44567864|NCT01086358|Rizatriptan|rizatriptan|mesh-list
44567865|NCT01086358|Eletriptan|eletriptan|mesh-list
44567866|NCT01086358|Almotriptan|almotriptan|mesh-list
44567867|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44567868|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44567869|NCT01086358|Analgesics|analgesics|mesh-ancestor
44567870|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
44567871|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567872|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567873|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567874|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567875|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
44567876|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44567877|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567878|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567879|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44567880|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44567881|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44567882|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
44567883|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567884|NCT01084252|Dexamethasone|dexamethasone|mesh-list
44567885|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
44567886|NCT01084252|BB 1101|bb 1101|mesh-list
44567887|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567888|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
44567889|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
44567890|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567891|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567892|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567893|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
44567894|NCT01084252|Hormones|hormones|mesh-ancestor
44567895|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567896|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44567897|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567898|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567899|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567900|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567901|NCT01082965|Donepezil|donepezil|mesh-list
44567903|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567904|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567905|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
44567906|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567907|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567908|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
44567909|NCT01082874|Clonidine|clonidine|mesh-list
44567910|NCT01082874|Analgesics|analgesics|mesh-ancestor
44567911|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
44567920|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44567921|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44567922|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567923|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44567924|NCT01081834|Canagliflozin|canagliflozin|mesh-list
44567925|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44567926|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567927|NCT01081834|Incretins|incretins|mesh-ancestor
44567928|NCT01081834|Hormones|hormones|mesh-ancestor
44567929|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567930|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44567931|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
44567932|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567933|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567934|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44567935|NCT01080807|Modafinil|modafinil|mesh-list
44567936|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44567937|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567938|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44567939|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44191287|NCT00358228|Hormones|hormones|mesh-ancestor
44567940|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44567941|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567942|NCT01080391|Dexamethasone|dexamethasone|mesh-list
44567943|NCT01080391|Lenalidomide|lenalidomide|mesh-list
44567944|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44567945|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
44567946|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
44567947|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567948|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567949|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44567950|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
44567951|NCT01080391|Hormones|hormones|mesh-ancestor
44567952|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44567953|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44567954|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567955|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
44567956|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44567957|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44567958|NCT01080391|Growth Substances|growth substances|mesh-ancestor
44567959|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
44567960|NCT01079988|Cyclosporine|cyclosporine|mesh-list
44567961|NCT01079988|Methotrexate|methotrexate|mesh-list
44567962|NCT01079988|Cyclosporins|cyclosporins|mesh-list
44567963|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44567964|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
44567965|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44567966|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567967|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44567968|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
44567969|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567970|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44567971|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44567972|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44567973|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44567974|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44567975|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
44567976|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44567977|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44567978|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
44567979|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44567980|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44567981|NCT01079962|Atenolol|atenolol|mesh-list
44567982|NCT01079962|Bisoprolol|bisoprolol|mesh-list
44567983|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44567984|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44567985|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
44567986|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
44567987|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44567988|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44567989|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44567990|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44567991|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44567992|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44567993|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44567994|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44567995|NCT01079949|Cetrorelix|cetrorelix|mesh-list
44191345|NCT00358358|Hormones|hormones|mesh-ancestor
44567996|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44567997|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44567998|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44567999|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
44568000|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44568001|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568002|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
44568003|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568004|NCT01079949|Hormones|hormones|mesh-ancestor
44568005|NCT01079936|Lenalidomide|lenalidomide|mesh-list
44568006|NCT01079936|Melphalan|melphalan|mesh-list
44568007|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
44568008|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568009|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568010|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568011|NCT01079936|Growth Substances|growth substances|mesh-ancestor
44568012|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568013|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568014|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44568015|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
44568016|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568017|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44568018|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568019|NCT01079806|Entecavir|entecavir|mesh-list
44568020|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
44568021|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568022|NCT01079741|Poly I-C|poly i-c|mesh-list
44568023|NCT01079741|Mineral Oil|mineral oil|mesh-list
44568024|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44568025|NCT01079741|Poly ICLC|poly iclc|mesh-list
44568026|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44568027|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
44568028|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
44568029|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
44568030|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568031|NCT01079741|Laxatives|laxatives|mesh-ancestor
44568032|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568033|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
44568034|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568035|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44568036|NCT01079741|Emollients|emollients|mesh-ancestor
44568037|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
44568038|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
44568039|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44568040|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191404|NCT00358618|Propofol|propofol|mesh-list
44568041|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
44568042|NCT01079234|Insulin|insulin|mesh-list
44568043|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44568044|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
44568045|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
44568046|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568047|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568048|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44568049|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568050|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
44568051|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568052|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568053|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568054|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568055|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44568056|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44568057|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44568058|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568059|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568060|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568061|NCT01078974|Dexamethasone|dexamethasone|mesh-list
44568062|NCT01078974|Rituximab|rituximab|mesh-list
44568063|NCT01078974|Pomalidomide|pomalidomide|mesh-list
44568064|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568065|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568066|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
44568067|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568068|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568069|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568070|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
44568071|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
44568072|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568073|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568074|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
44568075|NCT01078974|Hormones|hormones|mesh-ancestor
44568076|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568077|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44568078|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568079|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568080|NCT01078974|Growth Substances|growth substances|mesh-ancestor
44568081|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568082|NCT01078922|Ofatumumab|ofatumumab|mesh-list
44568083|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568084|NCT01078805|Teriparatide|teriparatide|mesh-list
44568085|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568086|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568087|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568088|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
44568089|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44568090|NCT01078675|Calcium|calcium|mesh-list
44568091|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568092|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568093|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568094|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44568095|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44568096|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
44568097|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568098|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44568099|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44568100|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568101|NCT01078662|Olaparib|olaparib|mesh-list
44568102|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44568103|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568104|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568105|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568106|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
44568107|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568108|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
44568109|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568110|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568111|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568112|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568113|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44568114|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44568115|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44568116|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568117|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568118|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568119|NCT01078571|Adalimumab|adalimumab|mesh-list
44568120|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568121|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568122|NCT01078545|Leuprolide|leuprolide|mesh-list
44568123|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44568124|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
44568125|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44568126|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568127|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44191474|NCT00359151|Analgesics|analgesics|mesh-ancestor
44568128|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568129|NCT01078441|Dexamethasone|dexamethasone|mesh-list
44568130|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
44568131|NCT01078441|Doxorubicin|doxorubicin|mesh-list
44568132|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44568133|NCT01078441|Bortezomib|bortezomib|mesh-list
44568134|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568135|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
44568136|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568137|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568138|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44568139|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
44568140|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568141|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568142|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44568143|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568144|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
44568145|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
44568146|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568147|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568148|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
44568149|NCT01078441|Hormones|hormones|mesh-ancestor
44568150|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568151|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44568152|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44568153|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44568154|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44568155|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568156|NCT01078389|Febuxostat|febuxostat|mesh-list
44568157|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
44568158|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568159|NCT01078298|Varenicline|varenicline|mesh-list
44568160|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44568161|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44568162|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44568163|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568164|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568165|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568166|NCT01078168|Acitretin|acitretin|mesh-list
44568167|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
44568168|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44568169|NCT01077960|Hormones|hormones|mesh-list
44568170|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568171|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568172|NCT01077739|Leucovorin|leucovorin|mesh-list
44568173|NCT01077739|Bevacizumab|bevacizumab|mesh-list
44568174|NCT01077739|Fluorouracil|fluorouracil|mesh-list
44568175|NCT01077739|Capecitabine|capecitabine|mesh-list
44568176|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
44568177|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568178|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568179|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568180|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568181|NCT01077739|Growth Substances|growth substances|mesh-ancestor
44568182|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568183|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568184|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
44568185|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568186|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44568187|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568188|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
44568189|NCT01077739|Antidotes|antidotes|mesh-ancestor
44568190|NCT01077739|Protective Agents|protective agents|mesh-ancestor
44568191|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
44568192|NCT01077739|Vitamins|vitamins|mesh-ancestor
44568193|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
44568194|NCT01077713|Gemcitabine|gemcitabine|mesh-list
44568195|NCT01077713|Bevacizumab|bevacizumab|mesh-list
44568196|NCT01077713|Cisplatin|cisplatin|mesh-list
44568197|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568198|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568199|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568200|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568201|NCT01077713|Growth Substances|growth substances|mesh-ancestor
44568202|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568203|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568204|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44568205|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
44568206|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568207|NCT01077713|Antiviral Agents|antiviral agents|mesh-ancestor
44568208|NCT01077713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568209|NCT01077713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568210|NCT01077713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568211|NCT01077713|Immunologic Factors|immunologic factors|mesh-ancestor
44568212|NCT01077622|Ofatumumab|ofatumumab|mesh-list
44568213|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568214|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44568215|NCT01077518|Ofatumumab|ofatumumab|mesh-list
44568216|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44191565|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
44568217|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44568218|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
44568219|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568220|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568221|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
44568222|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568223|NCT01077375|Milnacipran|milnacipran|mesh-list
44568224|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
44568225|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44568226|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44568227|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568228|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568229|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568230|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568231|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44568232|NCT01077375|Analgesics|analgesics|mesh-ancestor
44568233|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
44568234|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568235|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
44568236|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44568237|NCT01077362|Ustekinumab|ustekinumab|mesh-list
44568238|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
44568239|NCT01077323|Exenatide|exenatide|mesh-list
44568240|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44568241|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568242|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44568243|NCT01077323|Incretins|incretins|mesh-ancestor
44568244|NCT01077323|Hormones|hormones|mesh-ancestor
44568245|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568246|NCT01077284|Allopurinol|allopurinol|mesh-list
44568247|NCT01077284|Febuxostat|febuxostat|mesh-list
44568248|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
44568249|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568250|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568251|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
44568252|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568253|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44568254|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
44568255|NCT01077284|Protective Agents|protective agents|mesh-ancestor
44568256|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568257|NCT01077154|Denosumab|denosumab|mesh-list
44568258|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568259|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394437|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
44568264|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44568265|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568266|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568268|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44568269|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
44568270|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568271|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568272|NCT01076543|Sirolimus|sirolimus|mesh-list
44568273|NCT01076543|Lenalidomide|lenalidomide|mesh-list
44568274|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
44568275|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568276|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568277|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568278|NCT01076543|Growth Substances|growth substances|mesh-ancestor
44568279|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568280|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568281|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44568282|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568283|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44568284|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
44568285|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568287|NCT01076400|Topotecan|topotecan|mesh-list
44568288|NCT01076400|Adavosertib|adavosertib|mesh-list
44568289|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568290|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44568291|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44568292|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568293|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568294|NCT01076335|Docetaxel|docetaxel|mesh-list
44568295|NCT01076335|Leuprolide|leuprolide|mesh-list
44568296|NCT01076335|Goserelin|goserelin|mesh-list
44568297|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568298|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
44568299|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
44568300|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
44568301|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568302|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44568303|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
44568304|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44568305|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568306|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44568307|NCT01076166|Clarithromycin|clarithromycin|mesh-list
44568308|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44568309|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568310|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44568311|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568312|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568313|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568314|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568315|NCT01076153|Clarithromycin|clarithromycin|mesh-list
44568316|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44568317|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568318|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44568319|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568320|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568321|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568322|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568323|NCT01076088|Metformin|metformin|mesh-list
44568324|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44568325|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568326|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568327|NCT01076088|Incretins|incretins|mesh-ancestor
44568328|NCT01076088|Hormones|hormones|mesh-ancestor
44568329|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394515|NCT03007966|Clonidine|clonidine|mesh-list
44568330|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44568331|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
44568332|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568333|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568334|NCT01076075|Metformin|metformin|mesh-list
44568335|NCT01076075|Pioglitazone|pioglitazone|mesh-list
44568336|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44568337|NCT01076075|Glimepiride|glimepiride|mesh-list
44568338|NCT01076075|Gliclazide|gliclazide|mesh-list
44568339|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568340|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568341|NCT01076075|Incretins|incretins|mesh-ancestor
44568342|NCT01076075|Hormones|hormones|mesh-ancestor
44568343|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568344|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44568345|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
44568346|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568347|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568348|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44568349|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568350|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
44568351|NCT01076010|Sorafenib|sorafenib|mesh-list
44568352|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568353|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44568354|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568355|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568356|NCT01075984|Posaconazole|posaconazole|mesh-list
44568357|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
44568358|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568359|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44568360|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44568361|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44568362|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44568363|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568364|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568365|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568366|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44568367|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
44568368|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568369|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568370|NCT01075815|Hormones|hormones|mesh-list
44568371|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44568372|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568373|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568374|NCT01075763|Interferons|interferons|mesh-list
44568375|NCT01075763|Interferon-beta|interferon-beta|mesh-list
44568376|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
44568377|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568378|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
44568379|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568380|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
44568381|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568382|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44568383|NCT01075646|Ropivacaine|ropivacaine|mesh-list
44568384|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44568385|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44568386|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
44568387|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568388|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568389|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
44568390|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568391|NCT01075321|Lenalidomide|lenalidomide|mesh-list
44568392|NCT01075321|Everolimus|everolimus|mesh-list
44568393|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
44568394|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568395|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568396|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568397|NCT01075321|Growth Substances|growth substances|mesh-ancestor
44568398|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568399|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568400|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568401|NCT01075282|Metformin|metformin|mesh-list
44568402|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
44394582|NCT03004469|Finasteride|finasteride|mesh-list
44568403|NCT01075282|Glimepiride|glimepiride|mesh-list
44568404|NCT01075282|Dulaglutide|dulaglutide|mesh-list
44568405|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568406|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568407|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44568408|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568409|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
44568410|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
44568411|NCT01075256|Calcium|calcium|mesh-list
44568412|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568413|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568414|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568415|NCT01075243|Acetaminophen|acetaminophen|mesh-list
44568416|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44568417|NCT01075243|Analgesics|analgesics|mesh-ancestor
44568418|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
44568419|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568420|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568421|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
44568422|NCT01075152|Lamivudine|lamivudine|mesh-list
44568423|NCT01075152|Zidovudine|zidovudine|mesh-list
44568424|NCT01075152|Efavirenz|efavirenz|mesh-list
44568425|NCT01075152|Stavudine|stavudine|mesh-list
44568426|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44568427|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44568428|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568429|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568430|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
44568431|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568432|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43768880|NCT02391662|Antiviral Agents|antiviral agents|mesh-ancestor
44568433|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44568434|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
44568435|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44568436|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568437|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44568438|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44568439|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44568440|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44568441|NCT01075100|Carboplatin|carboplatin|mesh-list
44568442|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568443|NCT01075048|Irinotecan|irinotecan|mesh-list
44568444|NCT01075048|Cetuximab|cetuximab|mesh-list
44568445|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44568446|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44568447|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568448|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568449|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568450|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568451|NCT01074944|Eliglustat|eliglustat|mesh-list
44568452|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568453|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568454|NCT01074931|Ritonavir|ritonavir|mesh-list
44568455|NCT01074931|Lopinavir|lopinavir|mesh-list
44568456|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44568457|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44568458|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
44568459|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568460|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568461|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44568462|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44568463|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
44568464|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568465|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568466|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568467|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44568468|NCT01074554|Azithromycin|azithromycin|mesh-list
44568469|NCT01074554|Levofloxacin|levofloxacin|mesh-list
44568470|NCT01074554|Rifampin|rifampin|mesh-list
44568471|NCT01074554|Ethambutol|ethambutol|mesh-list
44568472|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568473|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44568474|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
44568475|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44568476|NCT01074554|Renal Agents|renal agents|mesh-ancestor
44568477|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44568478|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44568479|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568480|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568481|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568482|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44568483|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568484|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
44568485|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44568486|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44568487|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44568488|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44568489|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44568490|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44568491|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44568492|NCT01074502|Apremilast|apremilast|mesh-list
44568493|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44568494|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44568495|NCT01074502|Analgesics|analgesics|mesh-ancestor
44568496|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
44568497|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568498|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568499|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568500|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568501|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44568502|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44568503|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568504|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568505|NCT01074450|Pramipexole|pramipexole|mesh-list
44568506|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
44568507|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568508|NCT01074450|Protective Agents|protective agents|mesh-ancestor
44568509|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568510|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44568511|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44568512|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
44568513|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
44568514|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568515|NCT01074307|Bisoprolol|bisoprolol|mesh-list
44568516|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44568517|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
44568518|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
44568519|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568520|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568521|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44568522|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44568523|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44568524|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568525|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568526|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568527|NCT01074268|Insulin|insulin|mesh-list
44568528|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44568529|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
44568530|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
44568531|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568532|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568533|NCT01074255|Aprepitant|aprepitant|mesh-list
44568534|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
44568535|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
44568536|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568537|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568538|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568539|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44568540|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568541|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568542|NCT01074229|Ropivacaine|ropivacaine|mesh-list
44568543|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
44568544|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
44568545|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568546|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568547|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
44568548|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568549|NCT01074216|Vitamin D|vitamin d|mesh-list
44568550|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
44568551|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
44568552|NCT01074216|Vitamins|vitamins|mesh-list
44568553|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
44568554|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568555|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44568556|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568557|NCT01074190|Fentanyl|fentanyl|mesh-list
44568558|NCT01074190|Bupivacaine|bupivacaine|mesh-list
44568559|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
44568560|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
44568561|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568562|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568563|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
44568564|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568565|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44568566|NCT01074190|Narcotics|narcotics|mesh-ancestor
44568567|NCT01074190|Analgesics|analgesics|mesh-ancestor
44568568|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44568569|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44568570|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
44568571|NCT01074047|Azacitidine|azacitidine|mesh-list
44568572|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44568573|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
44568574|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568575|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568576|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568577|NCT01074008|Ritonavir|ritonavir|mesh-list
44568578|NCT01074008|Ribavirin|ribavirin|mesh-list
44568579|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44568580|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44568581|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44568582|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
44568583|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568584|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568585|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44568586|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44568587|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
44568588|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568589|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568590|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568591|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
44568592|NCT01073943|Bisacodyl|bisacodyl|mesh-list
44568593|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
44568594|NCT01073943|Cathartics|cathartics|mesh-ancestor
44568595|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568596|NCT01073943|Laxatives|laxatives|mesh-ancestor
44568597|NCT01073930|Bisacodyl|bisacodyl|mesh-list
44568598|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
44568599|NCT01073930|Cathartics|cathartics|mesh-ancestor
44568600|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568601|NCT01073930|Laxatives|laxatives|mesh-ancestor
44568602|NCT01073865|Goserelin|goserelin|mesh-list
44568603|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44568604|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568605|NCT01073631|Voriconazole|voriconazole|mesh-list
44568606|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
44191893|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
44568607|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568608|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44568609|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568610|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568611|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568612|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44568613|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
44568614|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568615|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568616|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568617|NCT01073618|Voriconazole|voriconazole|mesh-list
44568618|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
44568619|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568620|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44568621|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44568622|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568623|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568624|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44568625|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
44568626|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568627|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568628|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44568629|NCT01073566|Insulin|insulin|mesh-list
44568630|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44568631|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44568632|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568634|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44568635|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568636|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568637|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
44568638|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568639|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568640|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44568641|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
44568642|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568643|NCT01072929|Modafinil|modafinil|mesh-list
44568644|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44568645|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568646|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44568647|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44568648|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44568649|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568650|NCT01072877|Polidocanol|polidocanol|mesh-list
44568651|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44568652|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44568653|NCT01072630|Modafinil|modafinil|mesh-list
44568654|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44568655|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568656|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44568657|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44568658|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44568659|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568660|NCT01072539|Tigecycline|tigecycline|mesh-list
44568661|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44568662|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568663|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44568664|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568665|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568666|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
44568667|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568668|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
44568669|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568670|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568671|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568672|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568673|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
44568674|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44568675|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
44568676|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568677|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568678|NCT01072357|Bevacizumab|bevacizumab|mesh-list
44568679|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44568680|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568681|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568682|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568683|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568684|NCT01072357|Growth Substances|growth substances|mesh-ancestor
44568685|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568686|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568687|NCT01072357|Laxatives|laxatives|mesh-ancestor
44568688|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568689|NCT01072201|Triclosan|triclosan|mesh-list
44568690|NCT01072201|Fluorides|fluorides|mesh-list
44568691|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
44568692|NCT01072201|Protective Agents|protective agents|mesh-ancestor
44568693|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568694|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44568695|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568696|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44568697|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44568698|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
44568699|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568700|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44568701|NCT01072175|Trametinib|trametinib|mesh-list
44568702|NCT01072175|Dabrafenib|dabrafenib|mesh-list
44568703|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568704|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44568705|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568706|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568707|NCT01072149|Fluticasone|fluticasone|mesh-list
44568708|NCT01072149|Xhance|xhance|mesh-list
44568709|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568710|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568711|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
44568712|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568713|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568714|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568715|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568716|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44568717|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44568718|NCT01071798|Rituximab|rituximab|mesh-list
44568719|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44568720|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568721|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
44568722|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568723|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568724|NCT01071512|Natalizumab|natalizumab|mesh-list
44568725|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
44568726|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568727|NCT01071317|Naproxen|naproxen|mesh-list
44568728|NCT01071317|Sumatriptan|sumatriptan|mesh-list
44568729|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44568730|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44568731|NCT01071317|Analgesics|analgesics|mesh-ancestor
44568732|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
44568733|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568734|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568735|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568736|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568737|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
44568738|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44568739|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568740|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568741|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44568742|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44568743|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44568744|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
44568745|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568746|NCT01071200|Hormones|hormones|mesh-list
44568747|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44568748|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568749|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568750|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
44568751|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44568752|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44568753|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44568754|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568755|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568756|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
44568757|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568758|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568759|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44568760|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568761|NCT01071083|Interferons|interferons|mesh-list
44568762|NCT01071083|Interferon-beta|interferon-beta|mesh-list
44568763|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
44568764|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
44568765|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
44568766|NCT01071083|Natalizumab|natalizumab|mesh-list
44568767|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
44568768|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568769|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
44568770|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568771|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568772|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
44568773|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
44568774|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568775|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568776|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568777|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
44568778|NCT01071083|Hormones|hormones|mesh-ancestor
44568779|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568780|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44568781|NCT01071083|Protective Agents|protective agents|mesh-ancestor
44568782|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
44568783|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44568784|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568785|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568786|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44568787|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44568788|NCT01070979|Estradiol|estradiol|mesh-list
44568789|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44568790|NCT01070979|Estrogens|estrogens|mesh-list
44568791|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44568792|NCT01070979|Hormones|hormones|mesh-ancestor
44568793|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568794|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568795|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44568796|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
44568797|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44568798|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44568799|NCT01070888|Budesonide|budesonide|mesh-list
44568800|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
44568801|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568802|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568803|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
44568804|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568805|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568806|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568807|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568808|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
44568809|NCT01070888|Hormones|hormones|mesh-ancestor
44568810|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568811|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44568812|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44568813|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44568814|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568815|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568816|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568817|NCT01070784|Budesonide|budesonide|mesh-list
44568818|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
44568819|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44568820|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568821|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44568822|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
44568823|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568824|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568825|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44568826|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568827|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
44568828|NCT01070784|Hormones|hormones|mesh-ancestor
44568829|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568830|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44568831|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44568832|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44568833|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568834|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568835|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568836|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44568837|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
44568838|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568839|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44568840|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44568841|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568842|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44568843|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44568844|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568845|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568846|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
44568847|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568848|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44568849|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44568850|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44568869|NCT01070043|Amlodipine|amlodipine|mesh-list
44568870|NCT01070043|Valsartan|valsartan|mesh-list
44568871|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44568872|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44568873|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568874|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568875|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568876|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568877|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
44568878|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44568879|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44568880|NCT01068665|Insulin|insulin|mesh-list
44568881|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44568882|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
44568883|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192139|NCT00362310|Indinavir|indinavir|mesh-list
44568884|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568885|NCT01067144|Gabapentin|gabapentin|mesh-list
44568886|NCT01067144|Lorazepam|lorazepam|mesh-list
44568887|NCT01067144|Analgesics|analgesics|mesh-ancestor
44568888|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
44568889|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568890|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568891|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
44568892|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44568893|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44568894|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568895|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44568896|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44568897|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44568898|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568899|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568900|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
44568901|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
44568902|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
44568903|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44568904|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44568905|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
44568906|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
44568907|NCT01064856|Adalimumab|adalimumab|mesh-list
44568908|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568909|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568910|NCT01064648|Cisplatin|cisplatin|mesh-list
44568911|NCT01064648|Pemetrexed|pemetrexed|mesh-list
44568912|NCT01064648|Cediranib|cediranib|mesh-list
44568913|NCT01064648|Maleic acid|maleic acid|mesh-list
44568914|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568915|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568916|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568917|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44568918|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44568919|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44568920|NCT01064401|Interferons|interferons|mesh-list
44568921|NCT01064401|Interferon-beta|interferon-beta|mesh-list
44568922|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
44568923|NCT01064401|Daclizumab|daclizumab|mesh-list
44568924|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568925|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
44568926|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44568927|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
44568928|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568929|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44568930|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44568931|NCT01064310|Sunitinib|sunitinib|mesh-list
44568932|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44568933|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44568934|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44568935|NCT01064310|Growth Substances|growth substances|mesh-ancestor
44568936|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568937|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
44568938|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44568939|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568940|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568941|NCT01064297|Lamotrigine|lamotrigine|mesh-list
44568942|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
44568943|NCT01064297|Valproic Acid|valproic acid|mesh-list
44568944|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44568945|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44568947|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44568948|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568949|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44568950|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44568951|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44568952|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44568953|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44568954|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568955|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
44568956|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568957|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
44568958|NCT01062763|Spironolactone|spironolactone|mesh-list
44568959|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44568960|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
44568961|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44568962|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568963|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44568964|NCT01062763|Diuretics|diuretics|mesh-ancestor
44568965|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
44568966|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
44568967|NCT01062256|Guaifenesin|guaifenesin|mesh-list
44568968|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44568969|NCT01062256|Expectorants|expectorants|mesh-ancestor
44568970|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44568971|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44568972|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44568973|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
44568974|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44568975|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568976|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568977|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
44568978|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44568979|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
44568980|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
44568981|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568982|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
44568983|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44568984|NCT01062113|Celecoxib|celecoxib|mesh-list
44568985|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44568986|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44568987|NCT01062113|Analgesics|analgesics|mesh-ancestor
44568988|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
44568989|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44568990|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44568991|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44568992|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44568993|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44568994|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44568995|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44568996|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44568997|NCT01061736|Folic Acid|folic acid|mesh-list
44568998|NCT01061736|Methotrexate|methotrexate|mesh-list
44568999|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44569000|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
44569001|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44569002|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569003|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569004|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
44569005|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569006|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569007|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44569008|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569009|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44569010|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569011|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
44569012|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569013|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44569014|NCT01061736|Hematinics|hematinics|mesh-ancestor
44569015|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
44569016|NCT01061736|Vitamins|vitamins|mesh-ancestor
44569017|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
44569018|NCT01061710|Varenicline|varenicline|mesh-list
44569019|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44569020|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44569021|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
44569022|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569023|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569024|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569025|NCT01061359|Epirubicin|epirubicin|mesh-list
44569026|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44569027|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569028|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569029|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569030|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569031|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569032|NCT01061151|Ritonavir|ritonavir|mesh-list
44569033|NCT01061151|Lopinavir|lopinavir|mesh-list
44569034|NCT01061151|Tenofovir|tenofovir|mesh-list
44569035|NCT01061151|Lamivudine|lamivudine|mesh-list
44569036|NCT01061151|Zidovudine|zidovudine|mesh-list
44569037|NCT01061151|Emtricitabine|emtricitabine|mesh-list
44667710|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569038|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44569039|NCT01061151|Nevirapine|nevirapine|mesh-list
44569040|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44569041|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44569042|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44569043|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569044|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569045|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569046|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44569047|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44569048|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
44569049|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569050|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44569051|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44569052|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44569053|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44569054|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
44569055|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44569056|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44569057|NCT01059864|Atorvastatin|atorvastatin|mesh-list
44569058|NCT01059864|Tofacitinib|tofacitinib|mesh-list
44569059|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44569060|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44569061|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
44569062|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569063|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44569064|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44569065|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569066|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569067|NCT01059812|Insulin|insulin|mesh-list
44569068|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44569069|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
44569070|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
44569071|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44569072|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
44569073|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44569074|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569075|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569076|NCT01059799|Insulin|insulin|mesh-list
44569077|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44569078|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
44569079|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569080|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569081|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44569082|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
44569083|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44569084|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
44569085|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569086|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569087|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569088|NCT01059539|Cariprazine|cariprazine|mesh-list
44569089|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44569090|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569091|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395284|NCT02980042|Rituximab|rituximab|mesh-list
44569093|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569094|NCT01058668|Cariprazine|cariprazine|mesh-list
44569095|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44569096|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569097|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569098|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569099|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569100|NCT01058096|Cariprazine|cariprazine|mesh-list
44569101|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44569102|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569103|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569104|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569105|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569106|NCT01057862|Naltrexone|naltrexone|mesh-list
44569107|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44569108|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44569109|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569110|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
44569111|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569112|NCT01057810|Ipilimumab|ipilimumab|mesh-list
44569113|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569114|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569115|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44569116|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569117|NCT01057693|Pregabalin|pregabalin|mesh-list
44569118|NCT01057693|Analgesics|analgesics|mesh-ancestor
44569119|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
44569120|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569121|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569122|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
44569123|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44569124|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569125|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569126|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44569127|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44569128|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569129|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192385|NCT00363155|KRN 7000|krn 7000|mesh-list
44569130|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569131|NCT01057589|Folic Acid|folic acid|mesh-list
44569132|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
44569133|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
44569134|NCT01057589|Pemetrexed|pemetrexed|mesh-list
44569135|NCT01057589|Cetuximab|cetuximab|mesh-list
44569136|NCT01057589|Vitamins|vitamins|mesh-ancestor
44569137|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
44569138|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569139|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569140|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569141|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569142|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44569143|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44569144|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569145|NCT01057589|Hematinics|hematinics|mesh-ancestor
44569146|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
44569147|NCT01056718|Nebivolol|nebivolol|mesh-list
44569148|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569149|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
44569150|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44569151|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44569152|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44569153|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
44569154|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569155|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569156|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569157|NCT01056341|Propranolol|propranolol|mesh-list
44569158|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44569159|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44569160|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
44569161|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569162|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569163|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569164|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44569165|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569167|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44569168|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44569169|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44569170|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667711|NCT01235260|Becaplermin|becaplermin|mesh-list
44569171|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569172|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569173|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569174|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
44569175|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569176|NCT01056263|Axitinib|axitinib|mesh-list
44569177|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569178|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569179|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569180|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569181|NCT01056107|Glucagon|glucagon|mesh-list
44569182|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44569183|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569184|NCT01056107|Hormones|hormones|mesh-ancestor
44569185|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569186|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569187|NCT01056107|Incretins|incretins|mesh-ancestor
44569188|NCT01055496|Gemcitabine|gemcitabine|mesh-list
44569189|NCT01055496|Dexamethasone|dexamethasone|mesh-list
44569190|NCT01055496|Prednisone|prednisone|mesh-list
44569191|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
44569192|NCT01055496|Rituximab|rituximab|mesh-list
44569193|NCT01055496|Vincristine|vincristine|mesh-list
44569194|NCT01055496|Cisplatin|cisplatin|mesh-list
44569195|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44569196|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569197|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
44569198|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569199|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569200|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44569201|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
44569202|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569203|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569204|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44569205|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569206|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569207|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
44569208|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
44569209|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569210|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569211|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
44569212|NCT01055496|Hormones|hormones|mesh-ancestor
44569213|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569214|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44569215|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569216|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
44569217|NCT01055496|Antiviral Agents|antiviral agents|mesh-ancestor
44569218|NCT01055496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569219|NCT01055496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569220|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569221|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569222|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569223|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569224|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44569225|NCT01054820|Diclofenac|diclofenac|mesh-list
44569226|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44569227|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44569228|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44569229|NCT01054820|Analgesics|analgesics|mesh-ancestor
44569230|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
44569231|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569232|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569233|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569234|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569235|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44569236|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569237|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569238|NCT01054599|Memantine|memantine|mesh-list
44569239|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44569240|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44569241|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
44569242|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569243|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569244|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569245|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44569246|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44569247|NCT01054222|Fesoterodine|fesoterodine|mesh-list
44569248|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44569249|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44569250|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
44569251|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569252|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569253|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569254|NCT01054222|Urological Agents|urological agents|mesh-ancestor
44569255|NCT01053663|Oseltamivir|oseltamivir|mesh-list
44569256|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
44569257|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569258|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569259|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569260|NCT01053429|Ziprasidone|ziprasidone|mesh-list
44569261|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44569262|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
44569263|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569264|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569265|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569266|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44569267|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569268|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569269|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569270|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44569271|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
44569272|NCT01052844|Gabapentin|gabapentin|mesh-list
44569273|NCT01052844|Analgesics|analgesics|mesh-ancestor
44569274|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
44569275|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569276|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569277|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
44569278|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44569279|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569280|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569281|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569282|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44569283|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44569284|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569285|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569286|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
44569287|NCT01052428|Metoprolol|metoprolol|mesh-list
44569288|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44569289|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569290|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
44569291|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
44569292|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569293|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569294|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44569295|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44569296|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44569297|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44569298|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569299|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569300|NCT01052272|Allopurinol|allopurinol|mesh-list
44569301|NCT01052272|Candesartan|candesartan|mesh-list
44569302|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
44569303|NCT01052272|Ramipril|ramipril|mesh-list
44569304|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569305|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44569306|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44569307|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569308|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
44569309|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569310|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
44569311|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569312|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44569313|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
44569332|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
44569333|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569334|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569335|NCT01049217|Pregabalin|pregabalin|mesh-list
44569336|NCT01049217|Analgesics|analgesics|mesh-ancestor
44569337|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
44569338|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569339|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569340|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
44569341|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44569342|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569343|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569344|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44569345|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44569346|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44569347|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569348|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569349|NCT01048099|Trastuzumab|trastuzumab|mesh-list
44569350|NCT01048099|Pertuzumab|pertuzumab|mesh-list
44569351|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569352|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569353|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44569354|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44569355|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44569356|NCT01046903|Dalteparin|dalteparin|mesh-list
44569357|NCT01046903|Tinzaparin|tinzaparin|mesh-list
44569358|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44569359|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
44569360|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44569361|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44569362|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569363|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
44569364|NCT01046136|Guaifenesin|guaifenesin|mesh-list
44569365|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44569366|NCT01046136|Expectorants|expectorants|mesh-ancestor
44569367|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
44569368|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44569369|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44569370|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
44569371|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569372|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569373|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569374|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
44569375|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44569376|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
44569377|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
44569378|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569379|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
44569380|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44569382|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
44569383|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569384|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569385|NCT01045707|Insulin|insulin|mesh-list
44569386|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44569387|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
44569388|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
44569389|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569390|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569391|NCT01045447|Insulin|insulin|mesh-list
44569392|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44569393|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
44569394|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
44569395|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569396|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569397|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
44569398|NCT01045096|Lansoprazole|lansoprazole|mesh-list
44569399|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44569400|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569401|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44569402|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569403|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569404|NCT01042392|Ramipril|ramipril|mesh-list
44569405|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44569406|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569407|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569408|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569409|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569410|NCT01042379|Metformin|metformin|mesh-list
44569411|NCT01042379|Paclitaxel|paclitaxel|mesh-list
44569412|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44569413|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44569414|NCT01042379|Carboplatin|carboplatin|mesh-list
44569415|NCT01042379|Doxorubicin|doxorubicin|mesh-list
44569416|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
44569417|NCT01042379|Trastuzumab|trastuzumab|mesh-list
44569418|NCT01042379|Irinotecan|irinotecan|mesh-list
44569419|NCT01042379|Durvalumab|durvalumab|mesh-list
44569420|NCT01042379|Letrozole|letrozole|mesh-list
44569421|NCT01042379|Olaparib|olaparib|mesh-list
44569422|NCT01042379|Pertuzumab|pertuzumab|mesh-list
44569423|NCT01042379|Veliparib|veliparib|mesh-list
44569424|NCT01042379|Cemiplimab|cemiplimab|mesh-list
44569425|NCT01042379|Talazoparib|talazoparib|mesh-list
44569426|NCT01042379|Trebananib|trebananib|mesh-list
44569427|NCT01042379|Tucatinib|tucatinib|mesh-list
44569428|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44569429|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569430|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569431|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569432|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569433|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569434|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569435|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569436|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569437|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44569438|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569439|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569440|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569441|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395632|NCT02966340|Prazosin|prazosin|mesh-list
44569442|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44569443|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
44569444|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44569445|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44569446|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44569447|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
44569448|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569449|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44569450|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44569451|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44569452|NCT01042379|Growth Substances|growth substances|mesh-ancestor
44569453|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44569454|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569455|NCT01042236|Fesoterodine|fesoterodine|mesh-list
44569456|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44569457|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44569458|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
44569459|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569460|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569461|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569462|NCT01042236|Urological Agents|urological agents|mesh-ancestor
44569463|NCT01041404|Cisplatin|cisplatin|mesh-list
44569464|NCT01041404|Fluorouracil|fluorouracil|mesh-list
44569465|NCT01041404|Capecitabine|capecitabine|mesh-list
44569466|NCT01041404|Trastuzumab|trastuzumab|mesh-list
44569467|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569468|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
44569469|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569470|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569471|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569472|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
44569473|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569474|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569475|NCT01040832|Cetuximab|cetuximab|mesh-list
44569476|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569477|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569478|NCT01040793|Olodaterol|olodaterol|mesh-list
44569479|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44569480|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
44569481|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569482|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569483|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44569484|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
44569485|NCT01040780|Gefitinib|gefitinib|mesh-list
44569486|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569487|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569488|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569489|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569490|NCT01040403|Bromides|bromides|mesh-list
44569491|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
44569492|NCT01040403|Olodaterol|olodaterol|mesh-list
44569493|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44569494|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
44569495|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569496|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569497|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44569498|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
44569499|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
44569500|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44569501|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
44569502|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235447|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44569503|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569504|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
44569505|NCT01040130|Olodaterol|olodaterol|mesh-list
44569506|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44569507|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
44569508|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569509|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569510|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44569511|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
44569512|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
44569513|NCT01039688|Tofacitinib|tofacitinib|mesh-list
44569514|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569515|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569516|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569517|NCT01039584|Butoconazole|butoconazole|mesh-list
44569518|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
44569519|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569520|NCT01039376|Ofatumumab|ofatumumab|mesh-list
44569521|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569522|NCT01038921|Melatonin|melatonin|mesh-list
44569523|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
44569524|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569525|NCT01038921|Protective Agents|protective agents|mesh-ancestor
44569526|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569527|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569528|NCT01038869|Azelaic acid|azelaic acid|mesh-list
44569529|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569530|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
44569531|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44569532|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569533|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569534|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569535|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569537|NCT01038752|Carboplatin|carboplatin|mesh-list
44569538|NCT01038752|Docetaxel|docetaxel|mesh-list
44569539|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569540|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569541|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569542|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569543|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569544|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
44569545|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
44569546|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44569547|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569548|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44569549|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44569550|NCT01038635|Lenalidomide|lenalidomide|mesh-list
44569551|NCT01038635|Azacitidine|azacitidine|mesh-list
44569552|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
44569553|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569554|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44569555|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44569556|NCT01038635|Growth Substances|growth substances|mesh-ancestor
44569557|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
44569558|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569559|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569560|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
44569561|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569562|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569563|NCT01038609|Acetaminophen|acetaminophen|mesh-list
44569564|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44569565|NCT01038609|Morphine|morphine|mesh-list
44569566|NCT01038609|Hydrocodone|hydrocodone|mesh-list
44569567|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44569568|NCT01038609|Narcotics|narcotics|mesh-ancestor
44569569|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44569570|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569571|NCT01038609|Analgesics|analgesics|mesh-ancestor
44569572|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
44569573|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569574|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44569575|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
44569576|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
44569577|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
44569578|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44569579|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569580|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569582|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569583|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44569584|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44569585|NCT01038323|Milnacipran|milnacipran|mesh-list
44569586|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
44569587|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44569588|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44569589|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569590|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569591|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569592|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569593|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44569594|NCT01038323|Analgesics|analgesics|mesh-ancestor
44569595|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
44569596|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569597|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
44395786|NCT02961790|Renal Agents|renal agents|mesh-ancestor
44569598|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569599|NCT01038128|Memantine|memantine|mesh-list
44569600|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44569601|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44569602|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
44569603|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569604|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569605|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569606|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44569607|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44569608|NCT01037244|Udenafil|udenafil|mesh-list
44569609|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44569610|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44569611|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569612|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569613|NCT01037218|Udenafil|udenafil|mesh-list
44569614|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44569615|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44569616|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569617|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569618|NCT01037127|Trametinib|trametinib|mesh-list
44569619|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569620|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569621|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569622|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569623|NCT01036594|Ketoconazole|ketoconazole|mesh-list
44569624|NCT01036594|Dexamethasone|dexamethasone|mesh-list
44569625|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
44569626|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
44569627|NCT01036594|BB 1101|bb 1101|mesh-list
44569628|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569629|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
44569630|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
44569631|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569632|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569633|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569634|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
44569635|NCT01036594|Hormones|hormones|mesh-ancestor
44569636|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569637|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44569638|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569639|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569640|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569641|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569642|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
44569643|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569644|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44569645|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44569646|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44569647|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
44569648|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44569649|NCT01036087|Paclitaxel|paclitaxel|mesh-list
44569650|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44569651|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
44569652|NCT01036087|Carboplatin|carboplatin|mesh-list
44569653|NCT01036087|Fluorouracil|fluorouracil|mesh-list
44569654|NCT01036087|Epirubicin|epirubicin|mesh-list
44569655|NCT01036087|Panitumumab|panitumumab|mesh-list
44569656|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569657|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569658|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569659|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569660|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569661|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569662|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569663|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
44569664|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569665|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569666|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44569667|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
44569668|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44569669|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
44569670|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569671|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44569672|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569673|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569674|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667712|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
44569675|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569676|NCT01035463|Cytarabine|cytarabine|mesh-list
44569677|NCT01035463|Rituximab|rituximab|mesh-list
44569678|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44569679|NCT01035463|Etoposide|etoposide|mesh-list
44569680|NCT01035463|Lenalidomide|lenalidomide|mesh-list
44569681|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
44569682|NCT01035463|Melphalan|melphalan|mesh-list
44569683|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
44569684|NCT01035463|Carmustine|carmustine|mesh-list
44569685|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
44569686|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44569687|NCT01035463|Antibodies|antibodies|mesh-list
44569688|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
44569689|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44569690|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
44569691|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569692|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569693|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569694|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569695|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569696|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569697|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569698|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395933|NCT02955186|Saracatinib|saracatinib|mesh-list
44569699|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569700|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
44569701|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
44569702|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569703|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569704|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44569705|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44569706|NCT01035463|Growth Substances|growth substances|mesh-ancestor
44569707|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
44569708|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44569709|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
44569710|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44569711|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
44569712|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
44569713|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569714|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569715|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569716|NCT01035255|Enalapril|enalapril|mesh-list
44569717|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44569718|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44569719|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569720|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569721|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569722|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569723|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44569724|NCT01035229|Everolimus|everolimus|mesh-list
44569725|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569726|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569727|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
43769285|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
44569728|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569729|NCT01034657|Panobinostat|panobinostat|mesh-list
44569730|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
44569731|NCT01034657|Hematinics|hematinics|mesh-ancestor
44569732|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569733|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44569734|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569735|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569736|NCT01034631|Everolimus|everolimus|mesh-list
44569737|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569738|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569739|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
44569740|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569741|NCT01034462|Milnacipran|milnacipran|mesh-list
44569742|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
44569743|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44569744|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44569745|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569746|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569747|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569748|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569749|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
44569750|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569751|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44569752|NCT01034462|Analgesics|analgesics|mesh-ancestor
44455234|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
44569753|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
44569754|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569755|NCT01034176|Levofloxacin|levofloxacin|mesh-list
44569756|NCT01034176|Ofloxacin|ofloxacin|mesh-list
44569757|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44569758|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569759|NCT01034176|Renal Agents|renal agents|mesh-ancestor
44569760|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44569761|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569762|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569763|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569764|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569765|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569766|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44569767|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44569768|NCT01034163|Panobinostat|panobinostat|mesh-list
44569769|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569770|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44569771|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396010|NCT02954159|Vedolizumab|vedolizumab|mesh-list
44569775|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
44569776|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44569777|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569778|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44569779|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
44569780|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569781|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569782|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
44569783|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569784|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44569785|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569786|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
44569787|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44569788|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44569789|NCT01033942|Tenofovir|tenofovir|mesh-list
44569790|NCT01033942|Emtricitabine|emtricitabine|mesh-list
44569791|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
44569792|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569793|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44569794|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44569795|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569796|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569797|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44569798|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44569799|NCT01033825|Ciclesonide|ciclesonide|mesh-list
44569800|NCT01033825|Dexamethasone|dexamethasone|mesh-list
44569801|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
44569802|NCT01033825|BB 1101|bb 1101|mesh-list
44569803|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44569805|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
44569806|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569807|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569808|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569809|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
44569810|NCT01033825|Hormones|hormones|mesh-ancestor
44667713|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44569811|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44569812|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44569813|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569814|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
44569815|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569816|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569817|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44569818|NCT01033747|Deferasirox|deferasirox|mesh-list
44569819|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44569820|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
44569821|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
44569822|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569823|NCT01033734|Oseltamivir|oseltamivir|mesh-list
44569824|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
44569825|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569826|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569827|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569828|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44569829|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
44569830|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569831|NCT01033240|Sorafenib|sorafenib|mesh-list
44569832|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569833|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569834|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569835|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569836|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44569837|NCT01033071|Olmesartan|olmesartan|mesh-list
44569838|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44569839|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
44569840|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44569841|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44569842|NCT01033071|Diuretics|diuretics|mesh-ancestor
44569843|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
44569844|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569845|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44569846|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569847|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569848|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44569849|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44569850|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44569851|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
44569852|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569853|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
44569854|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44569855|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44569856|NCT01032837|Oseltamivir|oseltamivir|mesh-list
44569857|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
44569858|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569859|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569860|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569861|NCT01032629|Canagliflozin|canagliflozin|mesh-list
44569862|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44569863|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569864|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569865|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569866|NCT01032382|Gentamicins|gentamicins|mesh-list
44569867|NCT01032382|Paromomycin|paromomycin|mesh-list
44569868|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44569869|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569870|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44569871|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569872|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569873|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44569874|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44569875|NCT01032291|Lenalidomide|lenalidomide|mesh-list
44569876|NCT01032291|Cetuximab|cetuximab|mesh-list
44569877|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
44569879|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44569880|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44569881|NCT01032291|Growth Substances|growth substances|mesh-ancestor
44569882|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44569883|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569884|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569885|NCT01032239|Baclofen|baclofen|mesh-list
44569886|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44569887|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569888|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44569889|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569890|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44569891|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
44569892|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
44569893|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569894|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569895|NCT01032200|Modafinil|modafinil|mesh-list
44569896|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44569897|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569898|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44569899|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44569900|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44569901|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569902|NCT01032174|Azithromycin|azithromycin|mesh-list
44569903|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44569904|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44569905|NCT01032070|Etoposide|etoposide|mesh-list
44569906|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44569907|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569908|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569909|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44569910|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44569911|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569912|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569913|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569914|NCT01032018|Bupropion|bupropion|mesh-list
44569915|NCT01032018|Citalopram|citalopram|mesh-list
44569916|NCT01032018|Sertraline|sertraline|mesh-list
44569917|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44569918|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
44569919|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44569920|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44569921|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44569922|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44569923|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569924|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
44569925|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569926|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569927|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44569928|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44569929|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569930|NCT01032018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44569931|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
44569933|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
44569934|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
44569935|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44569936|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569937|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44569938|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44569939|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44569940|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
44569941|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44569942|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569943|NCT01031979|Urological Agents|urological agents|mesh-ancestor
44569944|NCT01031836|Sifalimumab|sifalimumab|mesh-list
44569945|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44569946|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
44569947|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569948|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
44569949|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44235449|NCT00554632|Norelgestromin|norelgestromin|mesh-list
44569950|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569952|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569953|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
44569954|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569955|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44569956|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569957|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569958|NCT01031446|Paclitaxel|paclitaxel|mesh-list
44569959|NCT01031446|Cisplatin|cisplatin|mesh-list
44569960|NCT01031446|Everolimus|everolimus|mesh-list
44569961|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44569962|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569963|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
44569964|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
44569965|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
44569966|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569967|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569968|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
44569969|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569970|NCT01031381|Bevacizumab|bevacizumab|mesh-list
44569971|NCT01031381|Everolimus|everolimus|mesh-list
44569972|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44569973|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44569974|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44569975|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44569976|NCT01031381|Growth Substances|growth substances|mesh-ancestor
44569977|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569978|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
44569979|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44569980|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
44569981|NCT01031069|Vaccines|vaccines|mesh-list
44569982|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
44569983|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569984|NCT01030952|Acarbose|acarbose|mesh-list
44569985|NCT01030952|Nateglinide|nateglinide|mesh-list
44569986|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44569987|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44569988|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44569989|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44569990|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44569991|NCT01030900|Prednisone|prednisone|mesh-list
44569992|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
44569993|NCT01030900|Rituximab|rituximab|mesh-list
44569994|NCT01030900|Doxorubicin|doxorubicin|mesh-list
44569995|NCT01030900|Etoposide|etoposide|mesh-list
44569996|NCT01030900|Vincristine|vincristine|mesh-list
44569997|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
44569998|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396234|NCT02949024|Growth Substances|growth substances|mesh-ancestor
44569999|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
44570000|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570001|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570002|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44570003|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
44570004|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570005|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570006|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44570007|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44570008|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570009|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44570010|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44570011|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570012|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570013|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
44570015|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570016|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570017|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44570018|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44570019|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44570020|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44570021|NCT01030822|Vaccines|vaccines|mesh-list
44570022|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44570023|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
44235450|NCT00554632|Ortho Evra|ortho evra|mesh-list
44570024|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570025|NCT01030718|Dasatinib|dasatinib|mesh-list
44570026|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570027|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44570028|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570029|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570030|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
44570031|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44570032|NCT01030666|Doxycycline|doxycycline|mesh-list
44570033|NCT01030666|Ibuprofen|ibuprofen|mesh-list
44570034|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44570035|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44570036|NCT01030666|Analgesics|analgesics|mesh-ancestor
44570037|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
44570038|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570039|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570040|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570041|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570042|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44570043|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570044|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570045|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44570046|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570047|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
44570048|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570049|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570050|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
44570051|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44570052|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44570053|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
44570054|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570055|NCT01030458|Amlodipine|amlodipine|mesh-list
44570056|NCT01030458|Valsartan|valsartan|mesh-list
44570057|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44570058|NCT01030458|Bisoprolol|bisoprolol|mesh-list
44570059|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570060|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44570061|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570062|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570063|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44570064|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570065|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
44570066|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44570067|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44570068|NCT01030458|Diuretics|diuretics|mesh-ancestor
44570069|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
44570070|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44570071|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
44570072|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
44570073|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570074|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44570075|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44570076|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44570077|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570078|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570079|NCT01030341|Insulin|insulin|mesh-list
44570080|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44570081|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570082|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570083|NCT01029886|Liraglutide|liraglutide|mesh-list
44570084|NCT01029886|Exenatide|exenatide|mesh-list
44570085|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570086|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570087|NCT01029886|Incretins|incretins|mesh-ancestor
44570088|NCT01029886|Hormones|hormones|mesh-ancestor
44570089|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570090|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44570091|NCT01029795|Glyburide|glyburide|mesh-list
44570092|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570093|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570094|NCT01029782|Cefazolin|cefazolin|mesh-list
44570095|NCT01029782|Cephalexin|cephalexin|mesh-list
44570096|NCT01029782|Probenecid|probenecid|mesh-list
44570097|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570098|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570099|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
44570100|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
44570101|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570102|NCT01029782|Renal Agents|renal agents|mesh-ancestor
44570103|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44570104|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570105|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570106|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570107|NCT01029652|Triamcinolone|triamcinolone|mesh-list
44570108|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44570109|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44570110|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44570111|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44570112|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570113|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
44570115|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570116|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570117|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570118|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
44570119|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570120|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570121|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
44570122|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44570123|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
44570124|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570125|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
44570126|NCT01029535|Protective Agents|protective agents|mesh-ancestor
44570127|NCT01029392|Vitamin D|vitamin d|mesh-list
44570128|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
44570129|NCT01029392|Vitamins|vitamins|mesh-ancestor
44570130|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
44570131|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570132|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44193246|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
44570133|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44570134|NCT01029340|Factor VIII|factor viii|mesh-list
44570135|NCT01029340|Coagulants|coagulants|mesh-ancestor
44570136|NCT01029262|Lenalidomide|lenalidomide|mesh-list
44570137|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
44570138|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570139|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570140|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570141|NCT01029262|Growth Substances|growth substances|mesh-ancestor
44570142|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570143|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570144|NCT01028651|Treprostinil|treprostinil|mesh-list
44570145|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570146|NCT01028391|Metformin|metformin|mesh-list
44570147|NCT01028391|Pioglitazone|pioglitazone|mesh-list
44570148|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44570149|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570150|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570160|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570161|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570162|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570163|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570164|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570165|NCT01028352|Analgesics|analgesics|mesh-ancestor
44570166|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
44570167|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570168|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
44570169|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570170|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
44570171|NCT01028222|Dacarbazine|dacarbazine|mesh-list
44570172|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44570173|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
44570174|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570175|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570176|NCT01028053|Flutemetamol|flutemetamol|mesh-list
44570177|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44570178|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570179|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44570180|NCT01028027|Tobramycin|tobramycin|mesh-list
44570181|NCT01028027|Dexamethasone|dexamethasone|mesh-list
44570182|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570183|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
43972900|NCT02115997|Prednisone|prednisone|mesh-list
44570184|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
44570185|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570186|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570187|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570188|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
44570189|NCT01028027|Hormones|hormones|mesh-ancestor
44570190|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570191|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570192|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570193|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570194|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570195|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44570196|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
44570197|NCT01028014|Ephedrine|ephedrine|mesh-list
44570198|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
44570199|NCT01028014|Imipramine|imipramine|mesh-list
44570200|NCT01028014|Tamsulosin|tamsulosin|mesh-list
44570201|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
44570202|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44570203|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44570204|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44570205|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570206|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570207|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570208|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570209|NCT01028014|Urological Agents|urological agents|mesh-ancestor
44570210|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44570211|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44570212|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570213|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44570214|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
44570215|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570216|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44570217|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
44570218|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
44570219|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44570220|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44570221|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
44570222|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44570223|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
44570224|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570225|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44570226|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44570227|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44570228|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44570229|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44570230|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570231|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570232|NCT01027949|Treprostinil|treprostinil|mesh-list
44570233|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570234|NCT01027897|Doripenem|doripenem|mesh-list
44570235|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570236|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570237|NCT01027884|Idebenone|idebenone|mesh-list
44570238|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
44570239|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570240|NCT01027884|Protective Agents|protective agents|mesh-ancestor
44570241|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570242|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
44570243|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396488|NCT02934503|Cisplatin|cisplatin|mesh-list
44570244|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570245|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44570246|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
44570247|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570249|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44570250|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44570251|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570252|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570253|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570254|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570256|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570257|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
44570258|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
44570259|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570260|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570261|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570262|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
44570263|NCT01027650|Hormones|hormones|mesh-ancestor
44570264|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570265|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570266|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570267|NCT01027416|Tamoxifen|tamoxifen|mesh-list
44570268|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44570269|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570270|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570271|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570272|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570273|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570274|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44570275|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44570276|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44570277|NCT01027351|Vaccines|vaccines|mesh-list
44570278|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
44570279|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570280|NCT01026948|Dinoprostone|dinoprostone|mesh-list
44570281|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
44570282|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44570283|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570284|NCT01026831|Timolol|timolol|mesh-list
44570285|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44570286|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44570287|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570288|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570289|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570290|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570291|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44570292|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570293|NCT01026818|Tadalafil|tadalafil|mesh-list
44570294|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
44570295|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44570296|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44570297|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570298|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570299|NCT01026818|Urological Agents|urological agents|mesh-ancestor
44570300|NCT01026792|Sirolimus|sirolimus|mesh-list
44570301|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570302|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570303|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570304|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570305|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
44570306|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570307|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
44570308|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570309|NCT01026493|Temozolomide|temozolomide|mesh-list
44570310|NCT01026493|Veliparib|veliparib|mesh-list
44570311|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44570312|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
44570313|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570314|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570315|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44570316|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570317|NCT01026454|Valacyclovir|valacyclovir|mesh-list
44570318|NCT01026454|Acyclovir|acyclovir|mesh-list
44570319|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
44570320|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570321|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44570322|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
44570323|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
44570324|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570325|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
44570326|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44570327|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570328|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570329|NCT01026220|Prednisone|prednisone|mesh-list
44570330|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
44570331|NCT01026220|Ifosfamide|ifosfamide|mesh-list
44570332|NCT01026220|Doxorubicin|doxorubicin|mesh-list
44570333|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44570335|NCT01026220|Vincristine|vincristine|mesh-list
44570336|NCT01026220|Vinorelbine|vinorelbine|mesh-list
44570337|NCT01026220|Bleomycin|bleomycin|mesh-list
44570338|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
44570339|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570340|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
44570341|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570342|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570343|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44570344|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
44570345|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570346|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570347|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44570348|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570349|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44570350|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44570351|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570352|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570353|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
44570354|NCT01026220|Hormones|hormones|mesh-ancestor
44570355|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570356|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570357|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44570358|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44570359|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44570360|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44570361|NCT01026194|Pioglitazone|pioglitazone|mesh-list
44570362|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570363|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570364|NCT01026142|Capecitabine|capecitabine|mesh-list
44570365|NCT01026142|Trastuzumab|trastuzumab|mesh-list
44570366|NCT01026142|Pertuzumab|pertuzumab|mesh-list
44570367|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44570368|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
44570369|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570370|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570371|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44570372|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44570373|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
44570374|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570375|NCT01025843|Candesartan|candesartan|mesh-list
44570376|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
44570377|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570378|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44570379|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44570380|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570381|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
44570382|NCT01025817|Everolimus|everolimus|mesh-list
44570383|NCT01025817|Tacrolimus|tacrolimus|mesh-list
44570384|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570385|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
44570386|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570387|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44570388|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570389|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570390|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570391|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570392|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44570393|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
44570394|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570395|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570396|NCT01025635|Azelaic acid|azelaic acid|mesh-list
44570397|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396714|NCT02927431|Oseltamivir|oseltamivir|mesh-list
44570398|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570399|NCT01025284|Lenograstim|lenograstim|mesh-list
44570400|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44570401|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
44570402|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570403|NCT01025232|Ranibizumab|ranibizumab|mesh-list
44570404|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570405|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570406|NCT01025232|Growth Substances|growth substances|mesh-ancestor
44570407|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570408|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570409|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570410|NCT01025193|Belimumab|belimumab|mesh-list
44570411|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570412|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
44570413|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570414|NCT01025154|Cytarabine|cytarabine|mesh-list
44570415|NCT01025154|Clofarabine|clofarabine|mesh-list
44570416|NCT01025154|Idarubicin|idarubicin|mesh-list
44570417|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44570418|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
44570419|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570420|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570421|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
44570422|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570423|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570424|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
44570425|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570426|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570427|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44570428|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44570429|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570430|NCT01024946|Everolimus|everolimus|mesh-list
44570431|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570432|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570433|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
44570434|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570435|NCT01024920|Sunitinib|sunitinib|mesh-list
44570436|NCT01024920|Nintedanib|nintedanib|mesh-list
44570437|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193508|NCT00368238|Aspirin|aspirin|mesh-list
44570438|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570439|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570440|NCT01024920|Growth Substances|growth substances|mesh-ancestor
44570441|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570442|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570443|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44570444|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570445|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570446|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44570447|NCT01024231|Nivolumab|nivolumab|mesh-list
44570448|NCT01024231|Ipilimumab|ipilimumab|mesh-list
44570449|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44570450|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570451|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44570452|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570453|NCT01024036|Siltuximab|siltuximab|mesh-list
44570454|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570455|NCT01023815|Cyclosporine|cyclosporine|mesh-list
44570456|NCT01023815|Everolimus|everolimus|mesh-list
44570457|NCT01023815|Cyclosporins|cyclosporins|mesh-list
44570458|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570459|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570460|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570461|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
44570462|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570463|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
44570464|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570465|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570466|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570467|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44570468|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570469|NCT01023672|Modafinil|modafinil|mesh-list
44570470|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44570471|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570472|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44570473|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44570474|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44570475|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570476|NCT01023659|Bupropion|bupropion|mesh-list
44570477|NCT01023659|Varenicline|varenicline|mesh-list
44570478|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44570479|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
44570480|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570481|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44570482|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570483|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570484|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570485|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
44570486|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570487|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570488|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44570489|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44570490|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570491|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44570492|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44570493|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570494|NCT01023581|Metformin|metformin|mesh-list
44570495|NCT01023581|Alogliptin|alogliptin|mesh-list
44570496|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570497|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570498|NCT01023581|Incretins|incretins|mesh-ancestor
44570499|NCT01023581|Hormones|hormones|mesh-ancestor
44570500|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570501|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44570502|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44570503|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570504|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570505|NCT01023308|Dexamethasone|dexamethasone|mesh-list
44570506|NCT01023308|Bortezomib|bortezomib|mesh-list
44570507|NCT01023308|Panobinostat|panobinostat|mesh-list
44570508|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570509|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
44570510|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
44570511|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570512|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570513|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570514|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
44570515|NCT01023308|Hormones|hormones|mesh-ancestor
44570516|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570517|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570518|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570519|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44570520|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570521|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570522|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44570523|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
44570524|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570525|NCT01023217|Lamivudine|lamivudine|mesh-list
44570526|NCT01023217|Adefovir|adefovir|mesh-list
44570527|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44570528|NCT01023217|Entecavir|entecavir|mesh-list
44570529|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44570530|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44570531|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570532|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570533|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
44570534|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570535|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44570536|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44570537|NCT01023061|Prednisone|prednisone|mesh-list
44570538|NCT01023061|Leuprolide|leuprolide|mesh-list
44570539|NCT01023061|Goserelin|goserelin|mesh-list
44570540|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
44570541|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570542|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
44570543|NCT01023061|Hormones|hormones|mesh-ancestor
44570544|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570545|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570546|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570547|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570548|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44570549|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
44570550|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44570551|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44570552|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570553|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570572|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570573|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570575|NCT01022762|Gliclazide|gliclazide|mesh-list
44570576|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570577|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570579|NCT01022580|Calfactant|calfactant|mesh-list
44570580|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44570581|NCT01022424|Tolvaptan|tolvaptan|mesh-list
44570582|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44570583|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570584|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
44570585|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570586|NCT01022398|Vitamin D|vitamin d|mesh-list
44570587|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
44570588|NCT01022398|Vitamins|vitamins|mesh-ancestor
44570589|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
44570590|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570591|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44570592|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44570593|NCT01021878|Icodextrin|icodextrin|mesh-list
44570594|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
44570595|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44570596|NCT01021813|Suvorexant|suvorexant|mesh-list
44570597|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44570598|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44570599|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44570600|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570601|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44570602|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570603|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570604|NCT01021683|Itraconazole|itraconazole|mesh-list
44570605|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
44570606|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570607|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44570608|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44570609|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570610|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570611|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44570612|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570613|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570614|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570615|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44570616|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
44570617|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570618|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570619|NCT01021423|Lenalidomide|lenalidomide|mesh-list
44570620|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
44570621|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570622|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570623|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570624|NCT01021423|Growth Substances|growth substances|mesh-ancestor
44570625|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570626|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570627|NCT01021332|Tamsulosin|tamsulosin|mesh-list
44570628|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
44570629|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44570630|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44570631|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44570632|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570633|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570634|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570635|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570636|NCT01021332|Urological Agents|urological agents|mesh-ancestor
44570637|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44570638|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44570639|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570640|NCT01021215|Celecoxib|celecoxib|mesh-list
44570641|NCT01021215|Zileuton|zileuton|mesh-list
44570642|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44570643|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44570644|NCT01021215|Analgesics|analgesics|mesh-ancestor
44570645|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
44570646|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570647|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570648|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570649|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570650|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44570651|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44570653|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570654|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44570655|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44570656|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570657|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570658|NCT01021020|Colchicine|colchicine|mesh-list
44570659|NCT01021020|Probenecid|probenecid|mesh-list
44570660|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
44570661|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570662|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
44570663|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
44570664|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
44570665|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570666|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570667|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
44570668|NCT01021020|Renal Agents|renal agents|mesh-ancestor
44570669|NCT01020877|Metronidazole|metronidazole|mesh-list
44570670|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570671|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570672|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44570673|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44570674|NCT01020799|Citalopram|citalopram|mesh-list
44570675|NCT01020799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44570676|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570677|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570678|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570679|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570680|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
44570681|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570682|NCT01020799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44570683|NCT01020799|Antidepressive Agents|antidepressive agents|mesh-ancestor
44570684|NCT01020799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570685|NCT01020786|Carboplatin|carboplatin|mesh-list
44570686|NCT01020786|Pemetrexed|pemetrexed|mesh-list
44570687|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570688|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570689|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570690|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44570691|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44570692|NCT01020747|Bevacizumab|bevacizumab|mesh-list
44570693|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44570694|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570695|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570696|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570697|NCT01020747|Growth Substances|growth substances|mesh-ancestor
44570698|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570699|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570700|NCT01020526|Pregabalin|pregabalin|mesh-list
44570701|NCT01020526|Analgesics|analgesics|mesh-ancestor
44570702|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
44570703|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570704|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570705|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
44570706|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44570707|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570708|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570709|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44570710|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44570711|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44570712|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44570713|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570714|NCT01020474|Pregabalin|pregabalin|mesh-list
44570715|NCT01020474|Analgesics|analgesics|mesh-ancestor
44570716|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
44570717|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570718|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570719|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
44570720|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44570721|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570722|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570723|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44570724|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44570725|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44570726|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397035|NCT02915835|Riociguat|riociguat|mesh-list
44570727|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570728|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44570729|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
44570730|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44570731|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
44193736|NCT00369538|Diuretics|diuretics|mesh-ancestor
44570732|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44570733|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570734|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44570735|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570736|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570737|NCT01020305|Sirolimus|sirolimus|mesh-list
44570738|NCT01020305|Bicalutamide|bicalutamide|mesh-list
44570739|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570740|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570741|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570742|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570743|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
44570744|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570745|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
44570746|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570747|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
44570748|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
44570749|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570750|NCT01020123|Glipizide|glipizide|mesh-list
44570751|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44570752|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570753|NCT01020019|Lofexidine|lofexidine|mesh-list
44570754|NCT01020019|Dronabinol|dronabinol|mesh-list
44570755|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
44570756|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570757|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570758|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44570759|NCT01020019|Analgesics|analgesics|mesh-ancestor
44570760|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
44570761|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570762|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44570763|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44570764|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570765|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570766|NCT01020019|Hormones|hormones|mesh-ancestor
44570767|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44570768|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44570769|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44570770|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44570771|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44570772|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44193798|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
44570773|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570774|NCT01019980|Acetaminophen|acetaminophen|mesh-list
44570775|NCT01019980|Diclofenac|diclofenac|mesh-list
44570776|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44570777|NCT01019980|Analgesics|analgesics|mesh-ancestor
44570778|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
44570779|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570780|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570781|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
44570782|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44570783|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44570784|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44570785|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44570786|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570787|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570788|NCT01019694|Albuterol|albuterol|mesh-list
44570789|NCT01019694|Ipratropium|ipratropium|mesh-list
44570790|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44570791|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
44570792|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570793|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570794|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44570795|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
44570797|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44570798|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44570799|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44570800|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44570801|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570802|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570803|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570804|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44570805|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570806|NCT01019486|Regadenoson|regadenoson|mesh-list
44570807|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44570808|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44570809|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44570810|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
44570811|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
44570812|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570813|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570814|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570815|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44570816|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44570817|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
44570818|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44570819|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44570820|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44570821|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
44570822|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44570823|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570824|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44193842|NCT00369993|Fluticasone|fluticasone|mesh-list
44570825|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44570826|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44570827|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44570828|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570829|NCT01019317|Cytarabine|cytarabine|mesh-list
44570830|NCT01019317|Fludarabine|fludarabine|mesh-list
44570831|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
44570832|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570833|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44570834|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
44570835|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570836|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570837|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
44570838|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570839|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
44570840|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570841|NCT01018862|Azelastine|azelastine|mesh-list
44570842|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44570843|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
44570844|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570845|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570846|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44570847|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44570848|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44570849|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570850|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570851|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44570852|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44570853|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44570854|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
44570855|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
44570856|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570857|NCT01018810|Interleukin-23|interleukin-23|mesh-list
44570858|NCT01018810|Antibodies|antibodies|mesh-list
44570859|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
44570860|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
44570861|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570862|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570863|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44570864|NCT01018810|Growth Substances|growth substances|mesh-ancestor
44570865|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
44570866|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570867|NCT01018732|Lactitol|lactitol|mesh-list
44570868|NCT01018732|Cathartics|cathartics|mesh-ancestor
44570869|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570870|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44570871|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44570872|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570873|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570874|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570875|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570876|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570877|NCT01018680|Analgesics|analgesics|mesh-ancestor
44570878|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
44570879|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570880|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
44570881|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44570882|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
44570883|NCT01018511|Tamsulosin|tamsulosin|mesh-list
44570884|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
44570885|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44570886|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44570887|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44570888|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44570889|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570890|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570891|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570892|NCT01018511|Urological Agents|urological agents|mesh-ancestor
44570893|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44570894|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44570895|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570896|NCT01018394|Nicotine|nicotine|mesh-list
44570897|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44570898|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
44570899|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570900|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570901|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44570902|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44570903|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570904|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570905|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570906|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
44570907|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44570908|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44570909|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
44570910|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570911|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570912|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570913|NCT01018264|Urological Agents|urological agents|mesh-ancestor
44570914|NCT01018186|Fluticasone|fluticasone|mesh-list
44570915|NCT01018186|Xhance|xhance|mesh-list
44570926|NCT01017874|Pemetrexed|pemetrexed|mesh-list
44570927|NCT01017874|Gefitinib|gefitinib|mesh-list
44570928|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570929|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570930|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570931|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44570932|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44570933|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44570934|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
44570935|NCT01017731|Promethazine|promethazine|mesh-list
44570936|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
44570937|NCT01017731|Ramucirumab|ramucirumab|mesh-list
44570938|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570939|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570940|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44570941|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44570942|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570943|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570944|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570945|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570946|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44570947|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44570948|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44570949|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
44570950|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
44570951|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
44570952|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44570953|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
44570954|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
44570955|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44570956|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44570957|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
44570958|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
44570959|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570960|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44570961|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
44570962|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570963|NCT01017575|Ribavirin|ribavirin|mesh-list
44570964|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44570965|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
44570966|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570967|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
44570968|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570969|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44570970|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
44570971|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44570972|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570973|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44570974|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44570975|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44570976|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570977|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
44570978|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44570979|NCT01017146|Tazarotene|tazarotene|mesh-list
44570980|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194040|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44570981|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
44570982|NCT01017120|Tazarotene|tazarotene|mesh-list
44570983|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
44570984|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
44570985|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
44570986|NCT01017029|Everolimus|everolimus|mesh-list
44570987|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44570988|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44570989|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
44570990|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44570991|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44570992|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44570993|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
44570994|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44570995|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44570996|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44570997|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44570998|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
44570999|NCT01016977|Clindamycin|clindamycin|mesh-list
44571000|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
44571001|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
44571002|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44571003|NCT01016977|Tazarotene|tazarotene|mesh-list
44571004|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571005|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571006|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44571007|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571008|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571009|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571010|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
44571011|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
44571012|NCT01016977|Vitamins|vitamins|mesh-ancestor
44571013|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
44571014|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571015|NCT01016912|Ribavirin|ribavirin|mesh-list
44571016|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44571017|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
44571018|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571019|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
44571020|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571021|NCT01016600|Lenalidomide|lenalidomide|mesh-list
44571022|NCT01016600|Azacitidine|azacitidine|mesh-list
44571023|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
44571024|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571025|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44571026|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571027|NCT01016600|Growth Substances|growth substances|mesh-ancestor
44571028|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
44571029|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769825|NCT02385071|Simeprevir|simeprevir|mesh-list
44571030|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571031|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
44571032|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571033|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571034|NCT01016262|Mesalamine|mesalamine|mesh-list
44571035|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44571036|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571037|NCT01016262|Analgesics|analgesics|mesh-ancestor
44571038|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
44571039|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571040|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571041|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571042|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571043|NCT01016015|Sirolimus|sirolimus|mesh-list
44571044|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44571045|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571046|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571047|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571048|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571049|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
44571050|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571051|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
44571052|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571053|NCT01015833|Doxorubicin|doxorubicin|mesh-list
44571054|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44571055|NCT01015833|Sorafenib|sorafenib|mesh-list
44571056|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571057|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571058|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44571059|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44571060|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571061|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571062|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571063|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44571064|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44571065|NCT01015677|Estradiol|estradiol|mesh-list
44571066|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44571067|NCT01015677|Estrogens|estrogens|mesh-ancestor
44571068|NCT01015677|Hormones|hormones|mesh-ancestor
44571069|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571070|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571071|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44571072|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
44571073|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44571074|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44571075|NCT01015638|Clindamycin|clindamycin|mesh-list
44571076|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
44571077|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
44571078|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44571079|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571080|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571081|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44571082|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571083|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571084|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571085|NCT01015560|Antibodies|antibodies|mesh-list
44571086|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44571087|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
44571088|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571089|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44571090|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44571091|NCT01015131|Alovudine|alovudine|mesh-list
44571092|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
44571093|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571094|NCT01015118|Paclitaxel|paclitaxel|mesh-list
44571095|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44571096|NCT01015118|Carboplatin|carboplatin|mesh-list
44571097|NCT01015118|Nintedanib|nintedanib|mesh-list
44571098|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571099|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571100|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571101|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571102|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571103|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571104|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571105|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571106|NCT01014988|Zanamivir|zanamivir|mesh-list
44571107|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
44571108|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571109|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571110|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571111|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
44571112|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44571113|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44571114|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571115|NCT01014767|Leucovorin|leucovorin|mesh-list
44571116|NCT01014767|Dactinomycin|dactinomycin|mesh-list
44571117|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
44571118|NCT01014767|Temozolomide|temozolomide|mesh-list
44571119|NCT01014767|Cisplatin|cisplatin|mesh-list
44571120|NCT01014767|Carboplatin|carboplatin|mesh-list
44571121|NCT01014767|Doxorubicin|doxorubicin|mesh-list
44571122|NCT01014767|Methotrexate|methotrexate|mesh-list
44571123|NCT01014767|Irinotecan|irinotecan|mesh-list
44571124|NCT01014767|Etoposide|etoposide|mesh-list
44571125|NCT01014767|Vincristine|vincristine|mesh-list
44571126|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571127|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
44194134|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571128|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571129|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571130|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571131|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
44571132|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571133|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571134|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44571135|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571136|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44571137|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44571138|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571139|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44571140|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
44571141|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44571142|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571143|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
44571144|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571145|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44571146|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44571147|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44571148|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571149|NCT01014767|Antidotes|antidotes|mesh-ancestor
44571150|NCT01014767|Protective Agents|protective agents|mesh-ancestor
44571151|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
44571152|NCT01014767|Vitamins|vitamins|mesh-ancestor
44571153|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
44571154|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571155|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571156|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571157|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571158|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571159|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44571160|NCT01014689|Lymecycline|lymecycline|mesh-list
44571161|NCT01014689|Adapalene|adapalene|mesh-list
44571162|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44571163|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571164|NCT01014689|Analgesics|analgesics|mesh-ancestor
44571165|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
44571166|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571167|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571168|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194182|NCT00370851|Bevacizumab|bevacizumab|mesh-list
44571169|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571170|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571171|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571172|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571173|NCT01014624|Clopidogrel|clopidogrel|mesh-list
44571174|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44571175|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44571176|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44571177|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44571178|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44571179|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
44571180|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571181|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571182|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571184|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
44571185|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44571186|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44571187|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44571188|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571189|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571190|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571191|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571192|NCT01014585|Analgesics|analgesics|mesh-ancestor
44571193|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
44571194|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571195|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
44571196|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44571197|NCT01014533|Gabapentin|gabapentin|mesh-list
44571198|NCT01014533|Analgesics|analgesics|mesh-ancestor
44571199|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
44571200|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571201|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571202|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
44571203|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44571204|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44571205|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571206|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44571207|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44571208|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44571209|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571210|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571211|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
44571212|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
44571213|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571214|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571215|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44571216|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
44571217|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571218|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571219|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571220|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571221|NCT01014208|Rituximab|rituximab|mesh-list
44571222|NCT01014208|Ofatumumab|ofatumumab|mesh-list
44571223|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571224|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571225|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
44571226|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571227|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571228|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
44571229|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44571230|NCT01014143|Triclosan|triclosan|mesh-list
44571231|NCT01014143|Fluorides|fluorides|mesh-list
44571232|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
44571233|NCT01014143|Protective Agents|protective agents|mesh-ancestor
44571234|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571235|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44571236|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571237|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
44571238|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571239|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44571240|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44571241|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
44571242|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571243|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44571244|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
44571245|NCT01014013|Ertapenem|ertapenem|mesh-list
44571246|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571247|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571248|NCT01013961|Rituximab|rituximab|mesh-list
44571249|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
44571250|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455385|NCT01646398|Vaccines|vaccines|mesh-list
44571251|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571252|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
44571253|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571254|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571255|NCT01013870|Atorvastatin|atorvastatin|mesh-list
44571256|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44235454|NCT00554632|Hormones|hormones|mesh-ancestor
44571258|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
44571259|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571260|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44571261|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44571262|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571263|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
44571264|NCT01013753|Olodaterol|olodaterol|mesh-list
44571265|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571266|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
44571267|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571268|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571269|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571270|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571271|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44571272|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44571273|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44571274|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44571275|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571276|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571277|NCT01013740|Capecitabine|capecitabine|mesh-list
44571278|NCT01013740|Vinorelbine|vinorelbine|mesh-list
44571279|NCT01013740|Lapatinib|lapatinib|mesh-list
44571280|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571281|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
44571282|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571283|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571284|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571285|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571286|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571287|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571288|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571289|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571290|NCT01013701|Fluticasone|fluticasone|mesh-list
44571291|NCT01013701|Xhance|xhance|mesh-list
44571292|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571293|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571294|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
44571295|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571296|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571297|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571298|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571299|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571300|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44571301|NCT01013597|Panobinostat|panobinostat|mesh-list
44571302|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571303|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44571304|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571305|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571306|NCT01013285|Bevacizumab|bevacizumab|mesh-list
44571307|NCT01013285|Temozolomide|temozolomide|mesh-list
44571308|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571309|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571310|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44571311|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571312|NCT01013285|Growth Substances|growth substances|mesh-ancestor
44571313|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571314|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
44571315|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571316|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
44571317|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571318|NCT01012999|Sufentanil|sufentanil|mesh-list
44571319|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44571320|NCT01012999|Narcotics|narcotics|mesh-ancestor
44571321|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571322|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571323|NCT01012999|Analgesics|analgesics|mesh-ancestor
44571324|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
44571325|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571326|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44571327|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44571328|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
44571329|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
44571330|NCT01012973|Aflibercept|aflibercept|mesh-list
44571332|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571333|NCT01012973|Growth Substances|growth substances|mesh-ancestor
44571334|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571335|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44571336|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571337|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
44571338|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571339|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
44571340|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571341|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571342|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571343|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571344|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
44571345|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44571346|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
44571347|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571348|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571349|NCT01012713|Calcitriol|calcitriol|mesh-list
44571350|NCT01012713|Clobetasol|clobetasol|mesh-list
44571351|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571352|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
44571353|NCT01012713|Hormones|hormones|mesh-ancestor
44571354|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571355|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571356|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44571357|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44571358|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44571359|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571360|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44571371|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
44571372|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571373|NCT01012609|Irinotecan|irinotecan|mesh-list
44571374|NCT01012609|Cetuximab|cetuximab|mesh-list
44571375|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44571376|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44571377|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571378|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571379|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571380|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571381|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
44571382|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
44571383|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571384|NCT01012258|Cetuximab|cetuximab|mesh-list
44571385|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571386|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571387|NCT01012219|Aspirin|aspirin|mesh-list
44571388|NCT01012219|Niacin|niacin|mesh-list
44194401|NCT00371904|Rituximab|rituximab|mesh-list
44571389|NCT01012219|Clopidogrel|clopidogrel|mesh-list
44571390|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44571391|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571392|NCT01012219|Analgesics|analgesics|mesh-ancestor
44571393|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
44571394|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571395|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571396|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571397|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571398|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44571399|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44571400|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571401|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44571402|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44571403|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571404|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
44571405|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44571406|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44571407|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44571408|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
44571409|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571410|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44571411|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
44571412|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44571413|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44571414|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
44571415|NCT01012219|Vitamins|vitamins|mesh-ancestor
44571416|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
44571417|NCT01012037|Linagliptin|linagliptin|mesh-list
44571418|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571419|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571420|NCT01012037|Incretins|incretins|mesh-ancestor
44571421|NCT01012037|Hormones|hormones|mesh-ancestor
44571422|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397797|NCT02873702|Lansoprazole|lansoprazole|mesh-list
44571423|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44571424|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
44571425|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571426|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571427|NCT01011907|Varenicline|varenicline|mesh-list
44571428|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44571429|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44571430|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
44571431|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571432|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571433|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571434|NCT01011868|Empagliflozin|empagliflozin|mesh-list
44571435|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44571436|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571437|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571438|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571439|NCT01011673|Ketorolac|ketorolac|mesh-list
44571440|NCT01011673|Metoclopramide|metoclopramide|mesh-list
44571441|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44571442|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571443|NCT01011673|Analgesics|analgesics|mesh-ancestor
44571444|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
44571445|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571446|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571447|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571448|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571449|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44571450|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571451|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571452|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
44571453|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
44571454|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44571455|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44571456|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44571457|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
44571458|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571459|NCT01011556|Teriparatide|teriparatide|mesh-list
44571460|NCT01011556|Hormones|hormones|mesh-list
44571461|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
44667714|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571462|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571463|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571464|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44571465|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44571466|NCT01011465|Oxytocin|oxytocin|mesh-list
44571467|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
44571468|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44571469|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571470|NCT01011439|Maleic acid|maleic acid|mesh-list
44571471|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571472|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571473|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44571474|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44571475|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44571476|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571477|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
44571478|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44571479|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
44571480|NCT01011283|Azacitidine|azacitidine|mesh-list
44571481|NCT01011283|Decitabine|decitabine|mesh-list
44571482|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571483|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
44571484|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571485|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571486|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571487|NCT01011049|Vaccines|vaccines|mesh-list
44571488|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
44571489|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571491|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
44571492|NCT01010971|Hormones|hormones|mesh-ancestor
44571493|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571494|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571495|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44571496|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44397851|NCT02872116|Leucovorin|leucovorin|mesh-list
44571497|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44571498|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44571499|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571500|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571501|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44667715|NCT01235260|Growth Substances|growth substances|mesh-ancestor
44571502|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44571503|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44571504|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
44571505|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571506|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571507|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44571508|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44571509|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
44571510|NCT01010750|Amphetamine|amphetamine|mesh-list
44571511|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44571512|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44571513|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571514|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
44571515|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
44571516|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571517|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
44571518|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571519|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571520|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
44571521|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44571522|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44571523|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44571524|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44571525|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44571526|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44571528|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
44571529|NCT01010217|Melphalan|melphalan|mesh-list
44571530|NCT01010217|Thiotepa|thiotepa|mesh-list
44571531|NCT01010217|Rituximab|rituximab|mesh-list
44571532|NCT01010217|Fludarabine|fludarabine|mesh-list
44571533|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
44571534|NCT01010217|Tacrolimus|tacrolimus|mesh-list
44571535|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571536|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
44571537|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571538|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571539|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571540|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
44571541|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571542|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571543|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44571544|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571545|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571546|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
44571547|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571548|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44571549|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571550|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571551|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44571552|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
44571553|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571554|NCT01010204|Varenicline|varenicline|mesh-list
44571555|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44571556|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44571557|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44571558|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571559|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571560|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571561|NCT01010126|Sirolimus|sirolimus|mesh-list
44571562|NCT01010126|Bevacizumab|bevacizumab|mesh-list
44571563|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44571564|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
44571565|NCT01010126|Antibodies|antibodies|mesh-list
44571566|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
44571567|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44571568|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
44571569|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571570|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44571571|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571572|NCT01010126|Growth Substances|growth substances|mesh-ancestor
44571573|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571574|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
44571575|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
44571576|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571577|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571578|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571579|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
44571580|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571581|NCT01010061|Rituximab|rituximab|mesh-list
44571582|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
44571583|NCT01010061|Chlorambucil|chlorambucil|mesh-list
44571584|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571585|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571586|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
44571587|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571588|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571589|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571590|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
44571591|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571592|NCT01009983|Paclitaxel|paclitaxel|mesh-list
44571593|NCT01009983|Carboplatin|carboplatin|mesh-list
44571594|NCT01009983|Panitumumab|panitumumab|mesh-list
44571595|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571596|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571597|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571598|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571599|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571600|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571601|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571602|NCT01009840|Bortezomib|bortezomib|mesh-list
44571603|NCT01009840|Busulfan|busulfan|mesh-list
44571604|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571605|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
44571606|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571607|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571608|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
44571609|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571610|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571611|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44571612|NCT01009814|Ritonavir|ritonavir|mesh-list
44571613|NCT01009814|Fostemsavir|fostemsavir|mesh-list
44571614|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44571615|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44571616|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44571617|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571618|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571619|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44571620|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44571621|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
44571622|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571623|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44571624|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44571625|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44571626|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44571627|NCT01009580|Insulin|insulin|mesh-list
44571628|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44571629|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
44571630|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
44571631|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44571632|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
44571633|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44571634|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571635|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571636|NCT01009554|Listerine|listerine|mesh-list
44571637|NCT01009554|Fluorides|fluorides|mesh-list
44571638|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
44571639|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
44571640|NCT01009554|Protective Agents|protective agents|mesh-ancestor
44571641|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571642|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44571643|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571644|NCT01009515|Paclitaxel|paclitaxel|mesh-list
44571645|NCT01009515|Carboplatin|carboplatin|mesh-list
44194600|NCT00372853|Ipilimumab|ipilimumab|mesh-list
44571646|NCT01009515|Temozolomide|temozolomide|mesh-list
44571647|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571648|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571649|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571650|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571651|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571652|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571653|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571654|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
44571655|NCT01009346|Cisplatin|cisplatin|mesh-list
44571656|NCT01009346|Carboplatin|carboplatin|mesh-list
44571657|NCT01009346|Cetuximab|cetuximab|mesh-list
44571658|NCT01009346|Everolimus|everolimus|mesh-list
44571659|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571660|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571661|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571662|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
44571663|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571664|NCT01009203|Sirolimus|sirolimus|mesh-list
44571665|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44571666|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571667|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571668|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571669|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571670|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44571671|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571672|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571673|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
44571674|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571675|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
44571676|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571677|NCT01009086|Ustekinumab|ustekinumab|mesh-list
44571678|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571679|NCT01009047|Aripiprazole|aripiprazole|mesh-list
44571681|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
44571682|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44571683|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44571684|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44571685|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571686|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571687|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
44571688|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
44571689|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571690|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571691|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44571692|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44571693|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
44571694|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44571695|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44571696|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44571697|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44571698|NCT01008995|Ustekinumab|ustekinumab|mesh-list
44571699|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571700|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
44571701|NCT01008904|Antacids|antacids|mesh-ancestor
44571702|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571703|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44571704|NCT01008748|Nicotine|nicotine|mesh-list
44571705|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44571706|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
44571707|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571708|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571709|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44571710|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44571711|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
44571712|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571713|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571714|NCT01008696|Rabeprazole|rabeprazole|mesh-list
44571715|NCT01008696|Lansoprazole|lansoprazole|mesh-list
44571716|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
44571717|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44571718|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44571719|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44571720|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571721|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571722|NCT01008618|Fentanyl|fentanyl|mesh-list
44571723|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44571724|NCT01008618|Narcotics|narcotics|mesh-ancestor
44571725|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571726|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571727|NCT01008618|Analgesics|analgesics|mesh-ancestor
44571728|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
44571729|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571730|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44571731|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44571732|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
44571733|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
44571734|NCT01008553|Fentanyl|fentanyl|mesh-list
44571735|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44571736|NCT01008553|Narcotics|narcotics|mesh-ancestor
44571737|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571738|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571739|NCT01008553|Analgesics|analgesics|mesh-ancestor
44571740|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
44571741|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571742|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44571743|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44571744|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
44571745|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
44571746|NCT01008475|Irinotecan|irinotecan|mesh-list
44571747|NCT01008475|Cetuximab|cetuximab|mesh-list
44571748|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44571749|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44571750|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571751|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571752|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571753|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571754|NCT01008423|Budesonide|budesonide|mesh-list
44398154|NCT02858895|Interleukin-4|interleukin-4|mesh-list
44571755|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571756|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571757|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
44571758|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571759|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571760|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571761|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571762|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
44571763|NCT01008423|Hormones|hormones|mesh-ancestor
44571764|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571765|NCT01008410|Budesonide|budesonide|mesh-list
44571766|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571767|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571768|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
44571769|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571770|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571771|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571772|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571773|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
44571774|NCT01008410|Hormones|hormones|mesh-ancestor
44571775|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571776|NCT01008150|Paclitaxel|paclitaxel|mesh-list
44571777|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
44571778|NCT01008150|Doxorubicin|doxorubicin|mesh-list
44571779|NCT01008150|Trastuzumab|trastuzumab|mesh-list
44571780|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571781|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571782|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571783|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571784|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571785|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571786|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571787|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
44571788|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571789|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571790|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571791|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
44571792|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44571793|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44571794|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44571795|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44571796|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571797|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571798|NCT01007942|Trastuzumab|trastuzumab|mesh-list
44571799|NCT01007942|Everolimus|everolimus|mesh-list
44571800|NCT01007942|Vinorelbine|vinorelbine|mesh-list
44571801|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571802|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571803|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571804|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
44571805|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571806|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44571807|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44571808|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44571809|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44571810|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571811|NCT01007552|Gemcitabine|gemcitabine|mesh-list
44571812|NCT01007552|Bevacizumab|bevacizumab|mesh-list
44571813|NCT01007552|Capecitabine|capecitabine|mesh-list
44571814|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44571815|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571816|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44571817|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44571818|NCT01007552|Growth Substances|growth substances|mesh-ancestor
44571819|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571820|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44571821|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571822|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
44571823|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571824|NCT01007552|Antiviral Agents|antiviral agents|mesh-ancestor
44571825|NCT01007552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571826|NCT01007552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571827|NCT01007552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571828|NCT01007552|Immunologic Factors|immunologic factors|mesh-ancestor
44571829|NCT01007448|Bexarotene|bexarotene|mesh-list
44571830|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571832|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44571833|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
44571834|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44571835|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571836|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571837|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
44571838|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571839|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571840|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571841|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571842|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44571843|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571844|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
44571845|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571846|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44571847|NCT01007253|Fluticasone|fluticasone|mesh-list
44571848|NCT01007253|Xhance|xhance|mesh-list
44571849|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44571850|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44571851|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44571852|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44571853|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44571854|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
44571855|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571856|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571857|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571858|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571859|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571860|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44571861|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44571862|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44571863|NCT01007253|Analgesics|analgesics|mesh-ancestor
44571864|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
44571865|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44571866|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44571867|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44571868|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
44571869|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
44571870|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571871|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571872|NCT01007149|Omalizumab|omalizumab|mesh-list
44571873|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44571874|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44571875|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44571876|NCT01006980|Dacarbazine|dacarbazine|mesh-list
44571877|NCT01006980|Vemurafenib|vemurafenib|mesh-list
44571878|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44571879|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
44571880|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571881|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571882|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571883|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571884|NCT01006889|Exenatide|exenatide|mesh-list
44571885|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571886|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571887|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44571888|NCT01006889|Incretins|incretins|mesh-ancestor
44571889|NCT01006889|Hormones|hormones|mesh-ancestor
44571890|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571891|NCT01006707|Ondansetron|ondansetron|mesh-list
44571892|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
44571893|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
44571894|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571895|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571896|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44571897|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
44571898|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44571899|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44571900|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
44571901|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571902|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571903|NCT01006707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44571904|NCT01006707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44571921|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44571922|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44571923|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571924|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571925|NCT01006590|Metformin|metformin|mesh-list
44571926|NCT01006590|Saxagliptin|saxagliptin|mesh-list
44571927|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571928|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571929|NCT01006590|Incretins|incretins|mesh-ancestor
44571930|NCT01006590|Hormones|hormones|mesh-ancestor
44571931|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44571932|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44571933|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44571934|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571935|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571936|NCT01006356|Hydromorphone|hydromorphone|mesh-list
44571937|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44571938|NCT01006356|Narcotics|narcotics|mesh-ancestor
44571939|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44571940|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571941|NCT01006356|Analgesics|analgesics|mesh-ancestor
44571942|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
44194888|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571943|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44571944|NCT01006291|Insulin|insulin|mesh-list
44571945|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44571946|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
44571947|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
44571948|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44571949|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571950|NCT01006265|Ponesimod|ponesimod|mesh-list
44571951|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44571952|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571953|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571954|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
44571955|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571956|NCT01005966|Listerine|listerine|mesh-list
44571957|NCT01005966|Fluorides|fluorides|mesh-list
44571958|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
44571959|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
44571960|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
44571961|NCT01005966|Protective Agents|protective agents|mesh-ancestor
44571962|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571963|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44571964|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571965|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
44571966|NCT01005901|Bromides|bromides|mesh-list
44571967|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
44571968|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44571969|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44571970|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44571971|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
44571972|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44571973|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571974|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44571975|NCT01005875|Sorafenib|sorafenib|mesh-list
44571976|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571977|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44571978|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571979|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571980|NCT01005719|Omeprazole|omeprazole|mesh-list
44571981|NCT01005719|Lansoprazole|lansoprazole|mesh-list
44571982|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44571983|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44571984|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44571985|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44571986|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571987|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571988|NCT01005680|Gemcitabine|gemcitabine|mesh-list
44571989|NCT01005680|Cisplatin|cisplatin|mesh-list
44571990|NCT01005680|Pemetrexed|pemetrexed|mesh-list
44571991|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44571992|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44571993|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
44571994|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44571995|NCT01005680|Antiviral Agents|antiviral agents|mesh-ancestor
44571996|NCT01005680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44571997|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44571998|NCT01005680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44571999|NCT01005680|Immunologic Factors|immunologic factors|mesh-ancestor
44572000|NCT01005680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572001|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572002|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572003|NCT01005602|Digoxin|digoxin|mesh-list
44572004|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44572005|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44572006|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572007|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572008|NCT01005602|Protective Agents|protective agents|mesh-ancestor
44572009|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572010|NCT01005329|Paclitaxel|paclitaxel|mesh-list
44572011|NCT01005329|Bevacizumab|bevacizumab|mesh-list
44572012|NCT01005329|Cisplatin|cisplatin|mesh-list
44572013|NCT01005329|Carboplatin|carboplatin|mesh-list
44572014|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44572015|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44572016|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
44572017|NCT01005329|Antibodies|antibodies|mesh-list
44572018|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
44572019|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44572020|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
44572021|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44572022|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572023|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
44572024|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
44572025|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
44572026|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572027|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44572028|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44572029|NCT01005329|Growth Substances|growth substances|mesh-ancestor
44572030|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572031|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44572032|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
44572033|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
44572034|NCT01005316|Prednisone|prednisone|mesh-list
44572035|NCT01005316|Tacrolimus|tacrolimus|mesh-list
44572036|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
44572037|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44572038|NCT01005316|Antibodies|antibodies|mesh-list
44572039|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
44572040|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44572041|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572042|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
44572043|NCT01005316|Hormones|hormones|mesh-ancestor
44572044|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572045|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572046|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44572047|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572048|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572049|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
44572050|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44572051|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572052|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572053|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44572054|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44572055|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
44572056|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44572057|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572058|NCT01005251|Lesogaberan|lesogaberan|mesh-list
44572059|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44572060|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44572061|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
44572062|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
44572063|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572064|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572065|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572066|NCT01004614|Amlodipine|amlodipine|mesh-list
44572067|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44572068|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44572069|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572070|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572071|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44572072|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572073|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
44572074|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
44572075|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44572076|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572077|NCT01004432|Golimumab|golimumab|mesh-list
44572078|NCT01004432|Methotrexate|methotrexate|mesh-list
44572079|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44572080|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44572081|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
44572082|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44572083|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572084|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572085|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
44667716|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572086|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572087|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572088|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572089|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572090|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572091|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572092|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
44572093|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572094|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572095|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44572097|NCT01004406|Atorvastatin|atorvastatin|mesh-list
44572098|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44572099|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44572100|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44572101|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
44572102|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572103|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44572104|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572105|NCT01004263|Rizatriptan|rizatriptan|mesh-list
44572106|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44572107|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
44572108|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572109|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572111|NCT01004250|Bevacizumab|bevacizumab|mesh-list
44572112|NCT01004250|Cisplatin|cisplatin|mesh-list
44572113|NCT01004250|Pemetrexed|pemetrexed|mesh-list
44572114|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572115|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572116|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44572117|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44572118|NCT01004250|Growth Substances|growth substances|mesh-ancestor
44572119|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572120|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
44572121|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572122|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572123|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572124|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572125|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44572126|NCT01004185|Mesalamine|mesalamine|mesh-list
44572127|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572128|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572129|NCT01004185|Analgesics|analgesics|mesh-ancestor
44572130|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
44572131|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572132|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572133|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572134|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572135|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
44572136|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44572137|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572138|NCT01004172|Bevacizumab|bevacizumab|mesh-list
44572139|NCT01004172|Trastuzumab|trastuzumab|mesh-list
44572140|NCT01004172|Carboplatin|carboplatin|mesh-list
44572141|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572142|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572143|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44572144|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44572145|NCT01004172|Growth Substances|growth substances|mesh-ancestor
44572146|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572147|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44572148|NCT01004159|Irinotecan|irinotecan|mesh-list
44572149|NCT01004159|Cetuximab|cetuximab|mesh-list
44572150|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44572151|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44572152|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572153|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572154|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572155|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572156|NCT01004003|Sorafenib|sorafenib|mesh-list
44572157|NCT01004003|Nintedanib|nintedanib|mesh-list
44572158|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572159|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44572160|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572161|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572162|NCT01003990|Ritonavir|ritonavir|mesh-list
44572163|NCT01003990|Lopinavir|lopinavir|mesh-list
44572164|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44572165|NCT01003990|Tenofovir|tenofovir|mesh-list
44572166|NCT01003990|Emtricitabine|emtricitabine|mesh-list
44572167|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44572168|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44572169|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
44572170|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572171|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572173|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44572174|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
44572175|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572176|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44572177|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44572178|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44572179|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572180|NCT01003899|Afatinib|afatinib|mesh-list
44572181|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572182|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44572183|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572184|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572185|NCT01003886|Doxazosin|doxazosin|mesh-list
44572186|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44572187|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44572188|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44572189|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44572191|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572192|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572193|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572194|NCT01003639|Aspirin|aspirin|mesh-list
44572195|NCT01003639|Acetaminophen|acetaminophen|mesh-list
44572196|NCT01003639|Ibuprofen|ibuprofen|mesh-list
44572197|NCT01003639|Naproxen|naproxen|mesh-list
44572198|NCT01003639|Acetazolamide|acetazolamide|mesh-list
44572199|NCT01003639|Codeine|codeine|mesh-list
44572200|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572201|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572202|NCT01003639|Analgesics|analgesics|mesh-ancestor
44572203|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
44572204|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572205|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572206|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572207|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572208|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44572209|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44572210|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572211|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44572212|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44572213|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572214|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
44572215|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
44572216|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
44572217|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44572218|NCT01003639|Diuretics|diuretics|mesh-ancestor
44572219|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
44572220|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44572221|NCT01003639|Narcotics|narcotics|mesh-ancestor
44572222|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572223|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
44572224|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
44572225|NCT01003249|Baclofen|baclofen|mesh-list
44572226|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44572227|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572228|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44572229|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572230|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44572231|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
44572232|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
44572233|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572234|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572235|NCT01003184|Exenatide|exenatide|mesh-list
44572236|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
44572237|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572238|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572239|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44572240|NCT01003184|Incretins|incretins|mesh-ancestor
44572241|NCT01003184|Hormones|hormones|mesh-ancestor
44572242|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572243|NCT01002820|Ganaxolone|ganaxolone|mesh-list
44572244|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
44572245|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572246|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572247|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572249|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
44572250|NCT01002573|Acetaminophen|acetaminophen|mesh-list
44572251|NCT01002573|Ibuprofen|ibuprofen|mesh-list
44572252|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572253|NCT01002573|Analgesics|analgesics|mesh-ancestor
44572254|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
44572255|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572256|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572257|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
44572258|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572259|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572260|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572261|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44572262|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572263|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572265|NCT01002547|Vitamin E|vitamin e|mesh-list
44572266|NCT01002547|Tocopherols|tocopherols|mesh-list
44572267|NCT01002547|Tocotrienols|tocotrienols|mesh-list
44572268|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
44572269|NCT01002547|Pioglitazone|pioglitazone|mesh-list
44572270|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
44572271|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572272|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572273|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
44572274|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572275|NCT01002547|Protective Agents|protective agents|mesh-ancestor
44572276|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
44572277|NCT01002339|Cyclosporine|cyclosporine|mesh-list
44572278|NCT01002339|Prednisone|prednisone|mesh-list
44572279|NCT01002339|Tacrolimus|tacrolimus|mesh-list
44572280|NCT01002339|Basiliximab|basiliximab|mesh-list
44572281|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572282|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
44572283|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572284|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44572285|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572286|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572287|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44572288|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572289|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44572290|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
44572291|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44572292|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572293|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572294|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
44572295|NCT01002339|Hormones|hormones|mesh-ancestor
44572296|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572297|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44572298|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
44572299|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572300|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572301|NCT01002105|Baclofen|baclofen|mesh-list
44572302|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44572303|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572304|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44572305|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572306|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44572307|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
44572308|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
44572309|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572310|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572311|NCT01001910|Carboplatin|carboplatin|mesh-list
44572312|NCT01001910|Pemetrexed|pemetrexed|mesh-list
44572313|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572314|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572315|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572316|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572317|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572318|NCT01001832|Abatacept|abatacept|mesh-list
44572319|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44572320|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572321|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572322|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572323|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
44572324|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572325|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572331|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572332|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572333|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
44572334|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
44572335|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572336|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572337|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44572338|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44572339|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
44572340|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44572341|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44572342|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44572343|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44572345|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44572346|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572347|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572348|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572349|NCT01001572|Amlodipine|amlodipine|mesh-list
44572350|NCT01001572|Valsartan|valsartan|mesh-list
44572351|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44572352|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44572353|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572354|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572355|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44572356|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572357|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
44572358|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44572359|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44572360|NCT01001520|Tolcapone|tolcapone|mesh-list
44572361|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44572362|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44572363|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44572364|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572365|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572366|NCT01001494|Bromides|bromides|mesh-list
44572367|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
44572368|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
44572369|NCT01001429|Propofol|propofol|mesh-list
44572370|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44572371|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572372|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572373|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44572374|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
44572375|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
44572376|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572377|NCT01001429|Analgesics|analgesics|mesh-ancestor
44572378|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
44572379|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572380|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44572381|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44572382|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44572383|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44572384|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572385|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572386|NCT01001377|Cetuximab|cetuximab|mesh-list
44572387|NCT01001377|Panitumumab|panitumumab|mesh-list
44572388|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195292|NCT00375869|Hematinics|hematinics|mesh-ancestor
44572389|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572390|NCT01001234|Rizatriptan|rizatriptan|mesh-list
44572391|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44572392|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
44572393|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572394|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572395|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572396|NCT01001221|Gemcitabine|gemcitabine|mesh-list
44572397|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572398|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
44572399|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572400|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572401|NCT01001221|Antiviral Agents|antiviral agents|mesh-ancestor
44572402|NCT01001221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572403|NCT01001221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572404|NCT01001221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572405|NCT01001221|Immunologic Factors|immunologic factors|mesh-ancestor
44572406|NCT01001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572408|NCT01001208|Methotrexate|methotrexate|mesh-list
44572409|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44572410|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
44572411|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44572412|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572413|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572414|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
44572415|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572416|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572417|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572418|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572419|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572420|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572421|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
44572422|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572423|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572424|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572425|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572427|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
44572428|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572429|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572430|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44572431|NCT01001104|Dulaglutide|dulaglutide|mesh-list
44572432|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572433|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572434|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44572435|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
44572436|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572437|NCT01000961|Cysteamine|cysteamine|mesh-list
44572438|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44572439|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572440|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44667717|NCT01235273|Hormones|hormones|mesh-list
44572441|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44572442|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44572443|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572444|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572445|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572446|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572447|NCT01000805|Analgesics|analgesics|mesh-ancestor
44572448|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
44572449|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572450|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
44572451|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44572452|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
44572453|NCT01000727|Darapladib|darapladib|mesh-list
44572454|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44572455|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572456|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572457|NCT01000649|Vasopressins|vasopressins|mesh-list
44572458|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
44572459|NCT01000649|Coagulants|coagulants|mesh-ancestor
44572460|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44572461|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44572462|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
44572463|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572464|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44572465|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44572466|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572467|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
44572468|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44572469|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44572470|NCT01000610|Prednisolone|prednisolone|mesh-list
44572471|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
44572472|NCT01000610|Rituximab|rituximab|mesh-list
44572473|NCT01000610|Methotrexate|methotrexate|mesh-list
44572474|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44572475|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
44572476|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572477|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572478|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
44572479|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572480|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572481|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44572482|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
44572483|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44572484|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572485|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
44572486|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572487|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572488|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974948|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
44195385|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
44572490|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572491|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572492|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572493|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
44572494|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
44572495|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572496|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44572497|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
44572498|NCT01000610|Hormones|hormones|mesh-ancestor
44572499|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572500|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44572501|NCT01000610|Protective Agents|protective agents|mesh-ancestor
44572502|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44572503|NCT01000480|Cisplatin|cisplatin|mesh-list
44572504|NCT01000480|Pemetrexed|pemetrexed|mesh-list
44572505|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572506|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572507|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572508|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572509|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44572510|NCT01000376|Ketoconazole|ketoconazole|mesh-list
44572511|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
44572512|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572513|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44572514|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44572515|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572516|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572517|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44572518|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572519|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572520|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572521|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44572522|NCT01000337|Propofol|propofol|mesh-list
44572523|NCT01000337|Sevoflurane|sevoflurane|mesh-list
44572524|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44572525|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572526|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572527|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44572528|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
44572529|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
44572530|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44572531|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44572532|NCT01000311|Vaccines|vaccines|mesh-list
44572533|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44572534|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
44572535|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572536|NCT01000155|Vorinostat|vorinostat|mesh-list
44572537|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572538|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44572539|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572540|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572541|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44572542|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44572543|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572544|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44572545|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44572546|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572547|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572548|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
44572549|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572550|NCT00999921|Tamoxifen|tamoxifen|mesh-list
44572551|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
44572552|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44572553|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572554|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572555|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572556|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44572557|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572558|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44236626|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44572559|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44572560|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44572561|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572562|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572564|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
44572565|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572566|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572567|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572568|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44572569|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
44572570|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572571|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44572572|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
44572573|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
44572574|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44572575|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
44572576|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572577|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572578|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44572579|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
44572580|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
44572581|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44572582|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
44572583|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572584|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572585|NCT00999713|Calfactant|calfactant|mesh-list
44572586|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44572587|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44572588|NCT00999544|Oxycodone|oxycodone|mesh-list
44572589|NCT00999544|Aprepitant|aprepitant|mesh-list
44572590|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
44572591|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44572592|NCT00999544|Narcotics|narcotics|mesh-ancestor
44572593|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572594|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572595|NCT00999544|Analgesics|analgesics|mesh-ancestor
44572596|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
44572597|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572598|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
44572599|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
44572600|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44572601|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44572602|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572603|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572604|NCT00999518|Tanezumab|tanezumab|mesh-list
44572605|NCT00999518|Analgesics|analgesics|mesh-ancestor
44572606|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
44572607|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572608|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572609|NCT00998985|Grazoprevir|grazoprevir|mesh-list
44572610|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
44572611|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572612|NCT00998946|Vitamins|vitamins|mesh-list
44572613|NCT00998946|Folic Acid|folic acid|mesh-list
44572614|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
44572615|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
44572616|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
44572617|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44572618|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
44572619|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572620|NCT00998946|Hematinics|hematinics|mesh-ancestor
44572621|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572622|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44572623|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572624|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572625|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
44572643|NCT00998335|Insulin|insulin|mesh-list
44572644|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44572645|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
44572646|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
44572647|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44572648|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
44572649|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572650|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572651|NCT00998309|Azithromycin|azithromycin|mesh-list
43975104|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
44572652|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44572653|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572654|NCT00998296|Nintedanib|nintedanib|mesh-list
44572655|NCT00998296|Afatinib|afatinib|mesh-list
44572656|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572657|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44572658|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572659|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572660|NCT00997984|Guanfacine|guanfacine|mesh-list
44572661|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44572662|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44572663|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44572664|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44572665|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
44572666|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572667|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572668|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572669|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44572670|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44572671|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44572672|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
44572673|NCT00997893|Estradiol|estradiol|mesh-list
44572674|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44572675|NCT00997893|Estrogens|estrogens|mesh-list
44572676|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
44572677|NCT00997893|Hormones|hormones|mesh-ancestor
44572678|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572679|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572680|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44572681|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
44572682|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44572683|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44572684|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44572685|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44572686|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44572687|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44572688|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44572689|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572690|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44572691|NCT00997503|Aspirin|aspirin|mesh-list
44572692|NCT00997503|Paclitaxel|paclitaxel|mesh-list
44572693|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44572694|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44572695|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572696|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
44572697|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
44572698|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
44572699|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572700|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44572701|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44572702|NCT00997503|Analgesics|analgesics|mesh-ancestor
44572703|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
44572704|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572705|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572706|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44572707|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44572708|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44572709|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44572710|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44572711|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44572712|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572713|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
44572714|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
44572715|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
44572716|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572717|NCT00997438|Protective Agents|protective agents|mesh-ancestor
44572718|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572719|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
44572720|NCT00997438|Vitamins|vitamins|mesh-ancestor
44572721|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
44572722|NCT00997386|Melphalan|melphalan|mesh-list
44572723|NCT00997386|Busulfan|busulfan|mesh-list
44572724|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
44572725|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44572726|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
44572727|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572728|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572729|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44572730|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572731|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
44572732|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572733|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572734|NCT00997373|Letrozole|letrozole|mesh-list
44572735|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572736|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44572737|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44572738|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572739|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572740|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44572741|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572742|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572743|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572744|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44572745|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572746|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44572747|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572748|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572749|NCT00997321|Ketamine|ketamine|mesh-list
44572750|NCT00997321|Propofol|propofol|mesh-list
44572751|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44572752|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572753|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572754|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44572755|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
44572756|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
44195558|NCT00376792|Docetaxel|docetaxel|mesh-list
44572757|NCT00997321|Analgesics|analgesics|mesh-ancestor
44572758|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
44572759|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572760|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44572761|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44572762|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44572763|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572764|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572765|NCT00997243|Azacitidine|azacitidine|mesh-list
44572766|NCT00997243|Lintuzumab|lintuzumab|mesh-list
44572767|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572768|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
44572769|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572770|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572771|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572772|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44572773|NCT00997126|Alfentanil|alfentanil|mesh-list
44572774|NCT00997126|Propofol|propofol|mesh-list
44572775|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44572776|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572777|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572778|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44572779|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
44572780|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
44572781|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44572782|NCT00997126|Narcotics|narcotics|mesh-ancestor
44572783|NCT00997126|Analgesics|analgesics|mesh-ancestor
44572784|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
44572785|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572786|NCT00997035|Voriconazole|voriconazole|mesh-list
44572787|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
44572788|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572789|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44572790|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44572791|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572792|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572793|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44572794|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572795|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572796|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572797|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44572798|NCT00996996|Iodine|iodine|mesh-list
44572799|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
44572800|NCT00996996|Antibodies|antibodies|mesh-list
44572801|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
44572802|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
44572803|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572804|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44572805|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572806|NCT00996996|Trace Elements|trace elements|mesh-ancestor
44572807|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
44572808|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572809|NCT00996944|Ropinirole|ropinirole|mesh-list
44572810|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44572811|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44572812|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
44572813|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
44572814|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572815|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572816|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572817|NCT00996801|Vitamin D|vitamin d|mesh-list
44572818|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
44572819|NCT00996801|Alendronate|alendronate|mesh-list
44572820|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
44572821|NCT00996801|Calcium|calcium|mesh-list
44572822|NCT00996801|Vitamins|vitamins|mesh-ancestor
44572823|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
44572824|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572825|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44572826|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44572827|NCT00996801|Antacids|antacids|mesh-ancestor
44572828|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572829|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44572830|NCT00996736|Voriconazole|voriconazole|mesh-list
44572831|NCT00996736|Natamycin|natamycin|mesh-list
44572832|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
44572833|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572834|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44572835|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44572836|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572837|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572838|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44572839|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
44572840|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572841|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572842|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44572843|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44572844|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44572845|NCT00996658|Linagliptin|linagliptin|mesh-list
44572846|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572847|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572848|NCT00996658|Incretins|incretins|mesh-ancestor
44572849|NCT00996658|Hormones|hormones|mesh-ancestor
44572850|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572851|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44572852|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
44572853|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572854|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572856|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
44572857|NCT00996593|Antibodies|antibodies|mesh-list
44572858|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
44572859|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
44572860|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572861|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44572862|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572863|NCT00996593|Trace Elements|trace elements|mesh-ancestor
44572864|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
44572865|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572866|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
44572867|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44572868|NCT00996580|Estradiol|estradiol|mesh-list
44572869|NCT00996580|Estrogens|estrogens|mesh-ancestor
44572870|NCT00996580|Hormones|hormones|mesh-ancestor
44572871|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44572872|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572873|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44572874|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
43975330|NCT01813149|Clonidine|clonidine|mesh-list
44572875|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44572876|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44572877|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44572878|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44572879|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44572880|NCT00996476|Simeprevir|simeprevir|mesh-list
44572881|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
44572882|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572883|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
44572884|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572885|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572886|NCT00996437|Ranibizumab|ranibizumab|mesh-list
44572887|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44572888|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44572889|NCT00996437|Growth Substances|growth substances|mesh-ancestor
44572890|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572891|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
44572892|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572893|NCT00996333|Gemcitabine|gemcitabine|mesh-list
44572894|NCT00996333|Capecitabine|capecitabine|mesh-list
44572895|NCT00996333|Docetaxel|docetaxel|mesh-list
44572896|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44572897|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
44572898|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572899|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572900|NCT00996333|Antiviral Agents|antiviral agents|mesh-ancestor
44572901|NCT00996333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572902|NCT00996333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572903|NCT00996333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44572904|NCT00996333|Immunologic Factors|immunologic factors|mesh-ancestor
44572905|NCT00996333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572906|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44572907|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44572908|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44572909|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44572910|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44572911|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
44572912|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572913|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44572914|NCT00996281|Olmesartan|olmesartan|mesh-list
44572915|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44572916|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
44572917|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44572918|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44572919|NCT00996281|Diuretics|diuretics|mesh-ancestor
44572920|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
44572921|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572922|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44572923|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44572924|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572925|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44572926|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44572927|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
44572928|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44572929|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
44572930|NCT00996034|Nicotine|nicotine|mesh-list
44572931|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572932|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44572933|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
44572934|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572935|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44572936|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44572937|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
44572938|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44572939|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572940|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44572941|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
44572942|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572943|NCT00995670|Ascorbic Acid|ascorbic acid|mesh-list
44572944|NCT00995670|Sevoflurane|sevoflurane|mesh-list
44572945|NCT00995670|Simvastatin|simvastatin|mesh-list
44572946|NCT00995670|Vitamins|vitamins|mesh-ancestor
44572947|NCT00995670|Micronutrients|micronutrients|mesh-ancestor
44572948|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572949|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44572950|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44572951|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
44572952|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572953|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44572954|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44572955|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44572956|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44572957|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44572958|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
44572959|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
44572960|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44572961|NCT00995670|Antioxidants|antioxidants|mesh-ancestor
44572962|NCT00995670|Protective Agents|protective agents|mesh-ancestor
44572963|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
44572964|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44572965|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572966|NCT00995488|Paclitaxel|paclitaxel|mesh-list
44572967|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44572968|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44572969|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572970|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
44572971|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
44572972|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
44572973|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44572974|NCT00995085|Pyridoxine|pyridoxine|mesh-list
44572975|NCT00995085|Metadoxine|metadoxine|mesh-list
44572976|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44572977|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
44572978|NCT00995085|Vitamins|vitamins|mesh-ancestor
44572979|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
44572980|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572981|NCT00995007|Carboplatin|carboplatin|mesh-list
44572982|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44572983|NCT00994890|Tanezumab|tanezumab|mesh-list
44572984|NCT00994890|Analgesics|analgesics|mesh-ancestor
44572985|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
44572986|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44572987|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572988|NCT00994682|Pioglitazone|pioglitazone|mesh-list
44572989|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44572990|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44572991|NCT00994643|Aldesleukin|aldesleukin|mesh-list
44572992|NCT00994643|Rituximab|rituximab|mesh-list
44572993|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44572994|NCT00994643|Interleukin-2|interleukin-2|mesh-list
44572995|NCT00994643|Antibodies|antibodies|mesh-list
44572996|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
44572997|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44572998|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
44572999|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573000|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573001|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573002|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44573003|NCT00994643|Analgesics|analgesics|mesh-ancestor
44573004|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
44573005|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573006|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44573007|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44573008|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
44573009|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573010|NCT00994461|Celecoxib|celecoxib|mesh-list
44573011|NCT00994461|Loxoprofen|loxoprofen|mesh-list
44573012|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44573013|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44573014|NCT00994461|Analgesics|analgesics|mesh-ancestor
44573015|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
44573016|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573017|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573018|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573019|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573020|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44573021|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44573022|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573023|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573024|NCT00994448|Bupropion|bupropion|mesh-list
44573025|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44573026|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
44573027|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573028|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44573029|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44573030|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573031|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573032|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
44573033|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573034|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573035|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44573036|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44573037|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573038|NCT00994422|Ivermectin|ivermectin|mesh-list
44573039|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44573040|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573041|NCT00994110|Pasireotide|pasireotide|mesh-list
44573042|NCT00994110|Hormones|hormones|mesh-ancestor
44573043|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573044|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573045|NCT00993967|Idebenone|idebenone|mesh-list
44573046|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
44573047|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573048|NCT00993967|Protective Agents|protective agents|mesh-ancestor
44573049|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573050|NCT00993915|Atorvastatin|atorvastatin|mesh-list
44573051|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44573052|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44573053|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
44573054|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573055|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44573066|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44573068|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573069|NCT00993499|Sirolimus|sirolimus|mesh-list
44573070|NCT00993499|Afatinib|afatinib|mesh-list
44573071|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44573072|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573073|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44573074|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573075|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
44573076|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573077|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
44573078|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573079|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573080|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573081|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573082|NCT00993473|Insulin|insulin|mesh-list
44573083|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44573084|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
44573085|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
44573086|NCT00993473|Protamines|protamines|mesh-list
44573087|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573088|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573089|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
44573090|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573091|NCT00993473|Coagulants|coagulants|mesh-ancestor
44573092|NCT00993421|Sibutramine|sibutramine|mesh-list
44573093|NCT00993421|Metoprolol|metoprolol|mesh-list
44573094|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44573095|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44573096|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
44573097|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
44573098|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573099|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573100|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44573101|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44573102|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44573103|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44573104|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573105|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573106|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
44573107|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573108|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
44573109|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44573110|NCT00993317|Methotrexate|methotrexate|mesh-list
44573111|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
44573112|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44573113|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
44573114|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44573115|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573116|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44573117|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
44573118|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573119|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573120|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
44573121|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573122|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44455519|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44573123|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573124|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
44573125|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573126|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44573127|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
44573128|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44573129|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
44573130|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573131|NCT00993265|Expectorants|expectorants|mesh-ancestor
44573132|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
44573133|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44573134|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
44573135|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573136|NCT00993265|Protective Agents|protective agents|mesh-ancestor
44573137|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573138|NCT00993265|Antidotes|antidotes|mesh-ancestor
44573139|NCT00993148|Ritonavir|ritonavir|mesh-list
44573140|NCT00993148|Darunavir|darunavir|mesh-list
44573141|NCT00993148|Maraviroc|maraviroc|mesh-list
44573142|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44573143|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44573144|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573145|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573146|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573147|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44573148|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44573149|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
44573150|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573151|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44573152|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44573153|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44573154|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44573155|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44573156|NCT00993044|Bevacizumab|bevacizumab|mesh-list
44573157|NCT00993044|Irinotecan|irinotecan|mesh-list
44573158|NCT00993044|Vincristine|vincristine|mesh-list
44573159|NCT00993044|Temozolomide|temozolomide|mesh-list
44573160|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44573161|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573162|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573163|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573164|NCT00993044|Growth Substances|growth substances|mesh-ancestor
44573165|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573166|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573167|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44573168|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44573169|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573170|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573171|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573172|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573173|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573174|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573175|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44573176|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
44573177|NCT00993031|Ritonavir|ritonavir|mesh-list
44573178|NCT00993031|Lopinavir|lopinavir|mesh-list
44573179|NCT00993031|Lamivudine|lamivudine|mesh-list
44573180|NCT00993031|Zidovudine|zidovudine|mesh-list
44573181|NCT00993031|Efavirenz|efavirenz|mesh-list
44573182|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44195937|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
44573183|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44573184|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573185|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573186|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573187|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44573188|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44573189|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
44573190|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573191|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44573192|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44573193|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44573194|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44573195|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
44573196|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44573197|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44573198|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44573199|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44573200|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44573201|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
44573202|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573203|NCT00992589|Rabeprazole|rabeprazole|mesh-list
44573204|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44573205|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44573206|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44573207|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573208|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573210|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
44573211|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573212|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44573213|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573214|NCT00992446|Cytarabine|cytarabine|mesh-list
44573215|NCT00992446|Rituximab|rituximab|mesh-list
44573216|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44573217|NCT00992446|Etoposide|etoposide|mesh-list
44573218|NCT00992446|Bortezomib|bortezomib|mesh-list
44573219|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
44573220|NCT00992446|Melphalan|melphalan|mesh-list
44573221|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
44573222|NCT00992446|Vorinostat|vorinostat|mesh-list
44573223|NCT00992446|Carmustine|carmustine|mesh-list
44573224|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
44573225|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44573226|NCT00992446|Antibodies|antibodies|mesh-list
44573227|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
44573228|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44573229|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
44573230|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573231|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573232|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573233|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573234|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44573235|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44573236|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573237|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573238|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44573239|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
44573240|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
44573241|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573242|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573243|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44573244|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
44573245|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44573246|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44573247|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
44573248|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44573249|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573250|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573251|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573252|NCT00992407|Risperidone|risperidone|mesh-list
44573253|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44573254|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
44573255|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573256|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399784|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
44573257|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573258|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44573259|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44573260|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573261|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573262|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44573263|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
44573264|NCT00992394|Etanercept|etanercept|mesh-list
44573265|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44573266|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44573267|NCT00992394|Analgesics|analgesics|mesh-ancestor
44573268|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
44573269|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573270|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573271|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573272|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573273|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44573274|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573275|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
44573276|NCT00992108|Lidocaine|lidocaine|mesh-list
44573277|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
44573278|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
44573279|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573280|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573281|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
44573282|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196071|NCT00378690|Leuprolide|leuprolide|mesh-list
44573283|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44573284|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44573285|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44573286|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573287|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573288|NCT00992056|Metoprolol|metoprolol|mesh-list
44573289|NCT00992056|Nebivolol|nebivolol|mesh-list
44573290|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44573291|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44573292|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
44573293|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
44573294|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573295|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573296|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44573297|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44573298|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44573299|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44573300|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573301|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573302|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
44573303|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44573304|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44573305|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44573306|NCT00991952|Irinotecan|irinotecan|mesh-list
44573307|NCT00991952|Alvocidib|alvocidib|mesh-list
44573308|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44573309|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44573310|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573311|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573312|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573313|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573314|NCT00991952|Growth Substances|growth substances|mesh-ancestor
44573315|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573316|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573317|NCT00991939|Dexamethasone|dexamethasone|mesh-list
44573318|NCT00991939|Prednisone|prednisone|mesh-list
44573319|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573320|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
44573321|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
44573322|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573323|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573324|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44573325|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
44573326|NCT00991939|Hormones|hormones|mesh-ancestor
44573327|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573328|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44573329|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573330|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
44573331|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44573332|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399864|NCT02778867|Xhance|xhance|mesh-list
44573333|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44573334|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
44573335|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44573336|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573337|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573338|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573339|NCT00991289|Interferons|interferons|mesh-list
44573340|NCT00991289|Ribavirin|ribavirin|mesh-list
44573341|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
44573342|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
44573343|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44573344|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
44573345|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573346|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
44573347|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573348|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
44573349|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573350|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
44573351|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573352|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44573353|NCT00991276|Pregabalin|pregabalin|mesh-list
44573354|NCT00991276|Pramipexole|pramipexole|mesh-list
44573355|NCT00991276|Analgesics|analgesics|mesh-ancestor
44573356|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
44573357|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573358|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573359|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
44573360|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44573361|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573362|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573363|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44573364|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44573365|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44573366|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573367|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573368|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
44573369|NCT00991276|Protective Agents|protective agents|mesh-ancestor
44573370|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44573371|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44573372|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
44573373|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
44573374|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573375|NCT00990821|Midazolam|midazolam|mesh-list
44573376|NCT00990821|Aprepitant|aprepitant|mesh-list
44573377|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
44573378|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44573379|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44573380|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573381|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573382|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44573383|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44573384|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573385|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44573386|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
44573387|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
44573388|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
44573389|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
44573390|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573391|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573392|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
44573393|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
44573394|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573395|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44573396|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44573397|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
44573398|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573399|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
44573400|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44573401|NCT00990704|Protective Agents|protective agents|mesh-ancestor
44573402|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573403|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44573404|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44573405|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
44573406|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44573407|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399940|NCT02777242|Testosterone|testosterone|mesh-list
44573408|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44573409|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44573410|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44573411|NCT00990652|Temozolomide|temozolomide|mesh-list
44573412|NCT00990652|Bortezomib|bortezomib|mesh-list
44573413|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44573414|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
43975803|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
44573415|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573416|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573417|NCT00990314|Epoprostenol|epoprostenol|mesh-list
44573418|NCT00990314|Beraprost|beraprost|mesh-list
44573419|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44573420|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
44573421|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44573422|NCT00990249|Busulfan|busulfan|mesh-list
44573423|NCT00990249|Clofarabine|clofarabine|mesh-list
44573424|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
44573425|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44573426|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
44573427|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573428|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573429|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
44573430|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573431|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44573432|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573433|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44573434|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44573435|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
44573436|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44573437|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44573438|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44573439|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
44196218|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44573440|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573441|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44573442|NCT00990106|Prazosin|prazosin|mesh-list
44573443|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44573444|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44573445|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44573446|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44573447|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44573448|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573449|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573450|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573451|NCT00989833|Budesonide|budesonide|mesh-list
44573452|NCT00989833|Terbutaline|terbutaline|mesh-list
44573453|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
44573454|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573455|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44573456|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
44573457|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573458|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573459|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44573460|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
44573461|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
44573462|NCT00989833|Hormones|hormones|mesh-ancestor
44573463|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573464|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44573465|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44573466|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44573467|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
44573468|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573469|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573470|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
44573471|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
44573472|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44573473|NCT00988637|Calcitriol|calcitriol|mesh-list
44573474|NCT00988637|Clobetasol|clobetasol|mesh-list
44573475|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44573476|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573477|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44196259|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573478|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573479|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573480|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44573481|NCT00988637|Vitamins|vitamins|mesh-ancestor
44573482|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
44573493|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573494|NCT00988208|Prednisone|prednisone|mesh-list
44573495|NCT00988208|Docetaxel|docetaxel|mesh-list
44573496|NCT00988208|Lenalidomide|lenalidomide|mesh-list
44573497|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573498|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573499|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573500|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573501|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573502|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573503|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
44573504|NCT00988208|Hormones|hormones|mesh-ancestor
44573505|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573506|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573507|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44573508|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
44573509|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573510|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573511|NCT00988208|Growth Substances|growth substances|mesh-ancestor
44573512|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573513|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
44573514|NCT00987389|Hormones|hormones|mesh-ancestor
44573515|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573516|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573517|NCT00986245|Ropinirole|ropinirole|mesh-list
44573518|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44573519|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44573520|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
44573521|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
44573522|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573523|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573524|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573525|NCT00986154|Heparin|heparin|mesh-list
44573526|NCT00986154|Calcium heparin|calcium heparin|mesh-list
44573527|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44573528|NCT00986154|Tinzaparin|tinzaparin|mesh-list
44573529|NCT00986154|Dalteparin|dalteparin|mesh-list
44573530|NCT00986154|Warfarin|warfarin|mesh-list
44573531|NCT00986154|Edoxaban|edoxaban|mesh-list
44573532|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
44573533|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44573534|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44573535|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573536|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44573537|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
44573538|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44573539|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573540|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573541|NCT00985985|Nicotine|nicotine|mesh-list
44573542|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44573543|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
44573544|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573545|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573546|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44573547|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44573548|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
44573549|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573550|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573551|NCT00985621|Oxycodone|oxycodone|mesh-list
44573552|NCT00985621|Tanezumab|tanezumab|mesh-list
44573553|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44573554|NCT00985621|Narcotics|narcotics|mesh-ancestor
44573555|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573556|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573557|NCT00985621|Analgesics|analgesics|mesh-ancestor
44573558|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
44573559|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573560|NCT00984620|Interferons|interferons|mesh-list
44573561|NCT00984620|Ribavirin|ribavirin|mesh-list
44573562|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
44573563|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573564|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
44573565|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573566|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
44573567|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573568|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
44573569|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573570|NCT00984282|Sorafenib|sorafenib|mesh-list
44573571|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573572|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573573|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196346|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
44573574|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573575|NCT00984126|Factor VIII|factor viii|mesh-list
44573576|NCT00984126|Coagulants|coagulants|mesh-ancestor
44573577|NCT00983385|Tapentadol|tapentadol|mesh-list
44573578|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44573579|NCT00983385|Narcotics|narcotics|mesh-ancestor
44573580|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573581|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573582|NCT00983385|Analgesics|analgesics|mesh-ancestor
44573583|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
44573584|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573585|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44573586|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44573587|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573588|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573589|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
44573590|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573591|NCT00982657|Sunitinib|sunitinib|mesh-list
44573592|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573593|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573594|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573595|NCT00982657|Growth Substances|growth substances|mesh-ancestor
44573596|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573597|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573598|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573599|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573600|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573601|NCT00982644|Insulin|insulin|mesh-list
44573602|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44573603|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
44573604|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573605|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573606|NCT00982228|Insulin|insulin|mesh-list
44573607|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44573608|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
44573609|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
44573610|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573611|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573612|NCT00981409|Heparin|heparin|mesh-list
44573613|NCT00981409|Calcium heparin|calcium heparin|mesh-list
44573614|NCT00981409|PENTA|penta|mesh-list
44573615|NCT00981409|Fondaparinux|fondaparinux|mesh-list
44573616|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
44573617|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44573618|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44573619|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573620|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44573621|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
44573622|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44573623|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573624|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573625|NCT00981058|Gemcitabine|gemcitabine|mesh-list
44573626|NCT00981058|Cisplatin|cisplatin|mesh-list
44573627|NCT00981058|Necitumumab|necitumumab|mesh-list
44573628|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573629|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44573630|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
44573631|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573632|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
44573633|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573634|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573635|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573636|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
44573637|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573638|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44573639|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
44573640|NCT00980980|Mupirocin|mupirocin|mesh-list
44573641|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44573642|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573643|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
44573644|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44573645|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44573646|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573647|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573648|NCT00979992|Sunitinib|sunitinib|mesh-list
44573649|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573650|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573651|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573652|NCT00979992|Growth Substances|growth substances|mesh-ancestor
44573653|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573654|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573655|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573656|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573657|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573658|NCT00979953|Oxycodone|oxycodone|mesh-list
44573659|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44573660|NCT00979953|Narcotics|narcotics|mesh-ancestor
44573661|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573662|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573663|NCT00979953|Analgesics|analgesics|mesh-ancestor
44573665|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573666|NCT00979901|Loratadine|loratadine|mesh-list
44573667|NCT00979901|Montelukast|montelukast|mesh-list
44455574|NCT01644188|Ezetimibe|ezetimibe|mesh-list
44573668|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44573669|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44573670|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44573671|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44573672|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573673|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573674|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44573675|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44573676|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573677|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
44573678|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44573679|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44573680|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44573681|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44573682|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
44573683|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
44573684|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573685|NCT00979654|Sifalimumab|sifalimumab|mesh-list
44573686|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
44573687|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573688|NCT00979628|Insulin|insulin|mesh-list
44573689|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44573690|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
44573691|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
44573692|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573693|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573694|NCT00979576|Pemetrexed|pemetrexed|mesh-list
44573695|NCT00979576|Nintedanib|nintedanib|mesh-list
44573696|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573697|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573698|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573699|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44573700|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44573701|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573702|NCT00979407|Vaccines|vaccines|mesh-list
44573703|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
44573704|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573705|NCT00978757|Ketamine|ketamine|mesh-list
44573706|NCT00978757|Analgesics|analgesics|mesh-ancestor
44573707|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
44573708|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573709|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573710|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44573711|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44573712|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
44573713|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
44573714|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573715|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44573716|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44573717|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573718|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573719|NCT00978731|Dasatinib|dasatinib|mesh-list
44573720|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573721|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573722|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573723|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573724|NCT00978627|Insulin|insulin|mesh-list
44573725|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44573726|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
44573727|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
44573728|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44573729|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
44573730|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573731|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573732|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44573733|NCT00978562|Hematinics|hematinics|mesh-ancestor
44573734|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44573735|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44573736|NCT00978432|Everolimus|everolimus|mesh-list
44573737|NCT00978432|Panobinostat|panobinostat|mesh-list
44573738|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573739|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573740|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
44573741|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573742|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44573743|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573744|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573745|NCT00978341|Pregabalin|pregabalin|mesh-list
44573746|NCT00978341|Analgesics|analgesics|mesh-ancestor
44573747|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
44573748|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573749|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573750|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
44573751|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44573752|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573753|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573754|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44573755|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44573756|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44573757|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573758|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573759|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
44573760|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
44573761|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573762|NCT00978120|Vaccines|vaccines|mesh-list
44573763|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
44573764|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573765|NCT00978068|Ritonavir|ritonavir|mesh-list
44573766|NCT00978068|Lopinavir|lopinavir|mesh-list
44573767|NCT00978068|Nevirapine|nevirapine|mesh-list
44573768|NCT00978068|Efavirenz|efavirenz|mesh-list
44573769|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44573770|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44573771|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44573772|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573773|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573774|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573775|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44573776|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44573777|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
44573778|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573779|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44573780|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44573781|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44573782|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44573783|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44573784|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44573785|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44573786|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44573787|NCT00977938|Aspirin|aspirin|mesh-list
44573788|NCT00977938|Clopidogrel|clopidogrel|mesh-list
44573789|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44573790|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44573791|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44573792|NCT00977938|Analgesics|analgesics|mesh-ancestor
44573793|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
44573794|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573795|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573796|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573797|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573798|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44573799|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44573800|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573801|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44573802|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44573804|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
44573805|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44573806|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44573807|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44573808|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
44573809|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44573810|NCT00977665|Rasagiline|rasagiline|mesh-list
44573811|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44573812|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573813|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573814|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44573815|NCT00977665|Protective Agents|protective agents|mesh-ancestor
44573816|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573817|NCT00977574|Sirolimus|sirolimus|mesh-list
44573818|NCT00977574|Paclitaxel|paclitaxel|mesh-list
44573819|NCT00977574|Epothilones|epothilones|mesh-list
44573820|NCT00977574|Epothilone B|epothilone b|mesh-list
44573821|NCT00977574|Bevacizumab|bevacizumab|mesh-list
44573822|NCT00977574|Carboplatin|carboplatin|mesh-list
44573823|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44573824|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44573825|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
44573826|NCT00977574|Antibodies|antibodies|mesh-list
44573827|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
44573828|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44573829|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
44573830|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573831|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573832|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573833|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573834|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573835|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573836|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573837|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573838|NCT00977574|Growth Substances|growth substances|mesh-ancestor
44573839|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573840|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573841|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
44573842|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44573843|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573844|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44573845|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
44573846|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44573847|NCT00977561|Cisplatin|cisplatin|mesh-list
44573848|NCT00977561|Carboplatin|carboplatin|mesh-list
44573849|NCT00977561|Etoposide|etoposide|mesh-list
44573850|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
44573851|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573852|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573853|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44573854|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44573875|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44573876|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
44196563|NCT00380939|Atorvastatin|atorvastatin|mesh-list
44573877|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573878|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573879|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573880|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573881|NCT00977379|Capecitabine|capecitabine|mesh-list
44573882|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44573883|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
44573884|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573885|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573886|NCT00977197|Pregabalin|pregabalin|mesh-list
44573887|NCT00977197|Analgesics|analgesics|mesh-ancestor
44573888|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
44573889|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573890|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573891|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
44573892|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44573893|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44573894|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573895|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44573896|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44573897|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44573898|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44573899|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44573900|NCT00977080|Cinacalcet|cinacalcet|mesh-list
44573901|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44573902|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573903|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44573904|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44573905|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573906|NCT00976989|Docetaxel|docetaxel|mesh-list
44573907|NCT00976989|Trastuzumab|trastuzumab|mesh-list
44573908|NCT00976989|Pertuzumab|pertuzumab|mesh-list
44573909|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573910|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573911|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573912|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573913|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573914|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44573915|NCT00976950|Ritonavir|ritonavir|mesh-list
44573916|NCT00976950|Tipranavir|tipranavir|mesh-list
44573917|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44573918|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44573919|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573920|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573921|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573922|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44573923|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44573924|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
44573925|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44573926|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44573927|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44573928|NCT00976937|Metformin|metformin|mesh-list
44573929|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44573930|NCT00976937|Lixisenatide|lixisenatide|mesh-list
44573931|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44573932|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573933|NCT00976937|Incretins|incretins|mesh-ancestor
44573934|NCT00976937|Hormones|hormones|mesh-ancestor
44573935|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44573936|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44573937|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
44573938|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573939|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573940|NCT00976911|Paclitaxel|paclitaxel|mesh-list
44573941|NCT00976911|Bevacizumab|bevacizumab|mesh-list
44573942|NCT00976911|Doxorubicin|doxorubicin|mesh-list
44573943|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44573944|NCT00976911|Topotecan|topotecan|mesh-list
44573945|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573946|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573947|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573948|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573949|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573950|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573951|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44573952|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573953|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573954|NCT00976911|Growth Substances|growth substances|mesh-ancestor
44573955|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573956|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573957|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44573958|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44573959|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44573960|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573961|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44573962|NCT00976716|Celecoxib|celecoxib|mesh-list
44573963|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44573964|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44573965|NCT00976716|Analgesics|analgesics|mesh-ancestor
44573966|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
44573967|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44573968|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573969|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44573970|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44573971|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44573972|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44573973|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400533|NCT02751931|Mirabegron|mirabegron|mesh-list
44573974|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573975|NCT00976677|Paclitaxel|paclitaxel|mesh-list
44573976|NCT00976677|Bevacizumab|bevacizumab|mesh-list
44573977|NCT00976677|Carboplatin|carboplatin|mesh-list
44573978|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44573979|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44573980|NCT00976677|Antibodies|antibodies|mesh-list
44573981|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
44573982|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44573983|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44573984|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44573985|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44573986|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44573987|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44573988|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44573989|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44573990|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44573991|NCT00976677|Growth Substances|growth substances|mesh-ancestor
44573992|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44573993|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44573994|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
44573995|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44573996|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44573997|NCT00976573|Paclitaxel|paclitaxel|mesh-list
44573998|NCT00976573|Bevacizumab|bevacizumab|mesh-list
44573999|NCT00976573|Carboplatin|carboplatin|mesh-list
44574000|NCT00976573|Everolimus|everolimus|mesh-list
44574001|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44574002|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574003|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44574004|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44574005|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44574006|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574007|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574008|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574009|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574010|NCT00976573|Growth Substances|growth substances|mesh-ancestor
44574011|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574012|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574013|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574014|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
44574015|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
44574016|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44574017|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44574018|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574019|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574020|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574021|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44574022|NCT00976495|Diuretics|diuretics|mesh-ancestor
44574023|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
44574024|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44574025|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196729|NCT00381589|Bromides|bromides|mesh-list
44574026|NCT00976456|Bevacizumab|bevacizumab|mesh-list
44574027|NCT00976456|Carboplatin|carboplatin|mesh-list
44574028|NCT00976456|Pemetrexed|pemetrexed|mesh-list
44574029|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574030|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574031|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574032|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574033|NCT00976456|Growth Substances|growth substances|mesh-ancestor
44574034|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574035|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574036|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574037|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574038|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44574039|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44574040|NCT00976391|Insulin|insulin|mesh-list
44574041|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44574042|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
44574043|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
44574044|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
44574045|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574046|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574047|NCT00976391|Incretins|incretins|mesh-ancestor
44574048|NCT00976391|Hormones|hormones|mesh-ancestor
44574049|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574050|NCT00976209|Phenylephrine|phenylephrine|mesh-list
44574051|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
44574052|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44574053|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
44574054|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
44574055|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574056|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574057|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
44574058|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44574059|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
44574060|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
44574061|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44574062|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44574063|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44196773|NCT00381914|Vitamin D|vitamin d|mesh-list
44574064|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574065|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574066|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574067|NCT00976209|Protective Agents|protective agents|mesh-ancestor
44574069|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
44574070|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574071|NCT00975975|Basiliximab|basiliximab|mesh-list
44574072|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574073|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
44574074|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574075|NCT00975806|Lenalidomide|lenalidomide|mesh-list
44574076|NCT00975806|Sunitinib|sunitinib|mesh-list
44574077|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
44574078|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574079|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574080|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574081|NCT00975806|Growth Substances|growth substances|mesh-ancestor
44574082|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574083|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574084|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44574085|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574086|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574087|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
44574088|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44574089|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
44574090|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574091|NCT00975689|Expectorants|expectorants|mesh-ancestor
44574092|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
44574093|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44574094|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
44574095|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574096|NCT00975689|Protective Agents|protective agents|mesh-ancestor
44574097|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574098|NCT00975689|Antidotes|antidotes|mesh-ancestor
44574099|NCT00975611|Amantadine|amantadine|mesh-list
44574100|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44574101|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44574102|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
44574103|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574104|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
44574105|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574106|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574107|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574108|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574109|NCT00975611|Analgesics|analgesics|mesh-ancestor
44574110|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
44574111|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574112|NCT00975481|Alprazolam|alprazolam|mesh-list
44574113|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44574114|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574115|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574116|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44574117|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44574118|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574119|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
44574120|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
44574121|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574122|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574123|NCT00975416|Oxytocin|oxytocin|mesh-list
44574124|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
44400694|NCT02747043|Rituximab|rituximab|mesh-list
44574125|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44574126|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574127|NCT00975286|Metformin|metformin|mesh-list
44574128|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
44574129|NCT00975286|Lixisenatide|lixisenatide|mesh-list
44574130|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44574131|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574132|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574133|NCT00975221|Cinacalcet|cinacalcet|mesh-list
44574134|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44574135|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574136|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44574137|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
44574138|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574139|NCT00975195|Fluticasone|fluticasone|mesh-list
44574140|NCT00975195|Xhance|xhance|mesh-list
44574141|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
44574142|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44574143|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574144|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44574145|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
44574146|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574147|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574148|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44574149|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
44574150|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574151|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44574152|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
44574153|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44574154|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
44574155|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574156|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574157|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44574158|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44574159|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44574160|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574161|NCT00975143|Isotretinoin|isotretinoin|mesh-list
44574162|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574163|NCT00975130|Golimumab|golimumab|mesh-list
44574164|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44574165|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44574166|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574167|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574168|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
44574169|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574170|NCT00975000|Cinacalcet|cinacalcet|mesh-list
44574171|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44574172|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574173|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44574174|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44574175|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574176|NCT00974974|Levodopa|levodopa|mesh-list
44574177|NCT00974974|Carbidopa|carbidopa|mesh-list
44574178|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44574179|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44574180|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44574181|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
44574182|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574183|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574184|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574185|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44574186|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574187|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44574188|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
44574189|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
44574190|NCT00974922|Vitamin D|vitamin d|mesh-list
44574191|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
44574192|NCT00974922|Vitamins|vitamins|mesh-ancestor
44574193|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
44574194|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574195|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44574196|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44574197|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44574198|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
44574199|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574201|NCT00974233|Lenalidomide|lenalidomide|mesh-list
44574202|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44574203|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574204|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574205|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
44574206|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574207|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44574208|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574209|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574210|NCT00974233|Growth Substances|growth substances|mesh-ancestor
44574211|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574212|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44574213|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
44574214|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574215|NCT00974220|Fentanyl|fentanyl|mesh-list
44574216|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44574217|NCT00974220|Narcotics|narcotics|mesh-ancestor
44574218|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574219|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574220|NCT00974220|Analgesics|analgesics|mesh-ancestor
44574221|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
44574222|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574223|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44574224|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44574225|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
44574226|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
44574227|NCT00974090|Glimepiride|glimepiride|mesh-list
44574228|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44574229|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574230|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574231|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574232|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
44574233|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44574234|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44196852|NCT00382330|Ciclopirox|ciclopirox|mesh-list
44574235|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574236|NCT00973765|Renal Agents|renal agents|mesh-ancestor
44574237|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44574238|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
44574239|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44574240|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44574241|NCT00973674|Estrogens|estrogens|mesh-list
44574242|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44574243|NCT00973674|Hormones|hormones|mesh-ancestor
44574244|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574245|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574246|NCT00973479|Golimumab|golimumab|mesh-list
44574247|NCT00973479|Methotrexate|methotrexate|mesh-list
44574248|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44574249|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
44574250|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44574251|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574252|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574253|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
44574254|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574255|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574256|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574257|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574258|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44574259|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574260|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
44574261|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44574262|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44574263|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44574264|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574265|NCT00973102|Estrogens|estrogens|mesh-list
44574266|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44574267|NCT00973102|Hormones|hormones|mesh-ancestor
44574268|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574269|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574270|NCT00972777|Besifloxacin|besifloxacin|mesh-list
44574271|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44236629|NCT00560209|Landiolol|landiolol|mesh-list
44574345|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
44574346|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574347|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574349|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44574350|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574351|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574352|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574353|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44574354|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44574355|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
44574356|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574357|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44574358|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574359|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574360|NCT00971945|Paclitaxel|paclitaxel|mesh-list
44574361|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44574362|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574363|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44574364|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44574365|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44574366|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574367|NCT00971932|Cisplatin|cisplatin|mesh-list
44574368|NCT00971932|Carboplatin|carboplatin|mesh-list
44574369|NCT00971932|Fluorouracil|fluorouracil|mesh-list
44574370|NCT00971932|Cetuximab|cetuximab|mesh-list
44574371|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196892|NCT00382421|Analgesics|analgesics|mesh-ancestor
44574372|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
44574373|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574374|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574375|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574376|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
44574377|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574378|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574379|NCT00971867|Paclitaxel|paclitaxel|mesh-list
44574380|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44574381|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574382|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44574383|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44574384|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44574385|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574386|NCT00971243|Metformin|metformin|mesh-list
44574387|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574388|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574389|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
44574390|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44574391|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574392|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574393|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574394|NCT00971178|Analgesics|analgesics|mesh-ancestor
44574395|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
44574396|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574397|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44574398|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44574399|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44574400|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574401|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574402|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574403|NCT00970944|Amantadine|amantadine|mesh-list
44574404|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44574405|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44574406|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
44574407|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574408|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
44574409|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574410|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574411|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574412|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574413|NCT00970944|Analgesics|analgesics|mesh-ancestor
44574414|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
44574415|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574416|NCT00970684|Gemcitabine|gemcitabine|mesh-list
44574417|NCT00970684|Bevacizumab|bevacizumab|mesh-list
44574418|NCT00970684|Docetaxel|docetaxel|mesh-list
44574419|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574420|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574421|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574422|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574423|NCT00970684|Growth Substances|growth substances|mesh-ancestor
44574424|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574425|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574426|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574427|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
44574428|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574429|NCT00970684|Antiviral Agents|antiviral agents|mesh-ancestor
44574430|NCT00970684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574431|NCT00970684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574432|NCT00970684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574433|NCT00970684|Immunologic Factors|immunologic factors|mesh-ancestor
44574434|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
44574435|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
44574436|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
44574437|NCT00970632|Tadalafil|tadalafil|mesh-list
44574438|NCT00970632|Tamsulosin|tamsulosin|mesh-list
44574439|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
44574440|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44574441|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44574442|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574443|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574444|NCT00970632|Urological Agents|urological agents|mesh-ancestor
44574445|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44574446|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44574447|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44574448|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574449|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574450|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574451|NCT00970502|Celecoxib|celecoxib|mesh-list
44574452|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44574453|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574455|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574456|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574457|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44574458|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574460|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
44574461|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574462|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574463|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574464|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44574465|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44574466|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44574467|NCT00970307|Vaccines|vaccines|mesh-list
44574468|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44574469|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
44574470|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574471|NCT00970281|Olanzapine|olanzapine|mesh-list
44574472|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
44574473|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
44574474|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574475|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574476|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574477|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44574478|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44574479|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574480|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574481|NCT00970281|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44574482|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574483|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574484|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574485|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574486|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
44574487|NCT00970268|Bromides|bromides|mesh-list
44574488|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
44574489|NCT00969709|Milnacipran|milnacipran|mesh-list
44574490|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
44574491|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44574492|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574493|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574494|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574495|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574496|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574497|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574498|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574499|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574500|NCT00969709|Analgesics|analgesics|mesh-ancestor
44197044|NCT00383357|Zolpidem|zolpidem|mesh-list
44574501|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
44574502|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574503|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44574504|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44574505|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574506|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574507|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574508|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574509|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574510|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574511|NCT00969150|Milnacipran|milnacipran|mesh-list
44574512|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
44574513|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44574514|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574515|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574516|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574517|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574518|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574519|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574520|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574521|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574522|NCT00969150|Analgesics|analgesics|mesh-ancestor
44574523|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
44574524|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574525|NCT00968968|Trastuzumab|trastuzumab|mesh-list
44574526|NCT00968968|Lapatinib|lapatinib|mesh-list
44574527|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574528|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574529|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44574530|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574531|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574532|NCT00968812|Metformin|metformin|mesh-list
44574533|NCT00968812|Glimepiride|glimepiride|mesh-list
44574534|NCT00968812|Canagliflozin|canagliflozin|mesh-list
44574535|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574536|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574537|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44574538|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574539|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
44574540|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44574541|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574542|NCT00968799|Cisplatin|cisplatin|mesh-list
44574543|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574544|NCT00968708|Alogliptin|alogliptin|mesh-list
44574545|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574546|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574547|NCT00968708|Incretins|incretins|mesh-ancestor
44574548|NCT00968708|Hormones|hormones|mesh-ancestor
44574549|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574550|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44574551|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44574552|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574553|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574554|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
44574555|NCT00968617|Hematinics|hematinics|mesh-ancestor
44574556|NCT00968539|Vaccines|vaccines|mesh-list
44574557|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
44574558|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574559|NCT00968253|Cytarabine|cytarabine|mesh-list
44574560|NCT00968253|Dexamethasone|dexamethasone|mesh-list
44574561|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
44574562|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44574563|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44574564|NCT00968253|Prednisolone|prednisolone|mesh-list
44574565|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
44574566|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
44574567|NCT00968253|Doxorubicin|doxorubicin|mesh-list
44574568|NCT00968253|Methotrexate|methotrexate|mesh-list
44574569|NCT00968253|Vincristine|vincristine|mesh-list
44574570|NCT00968253|Everolimus|everolimus|mesh-list
44574571|NCT00968253|Lenograstim|lenograstim|mesh-list
44574572|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44574573|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
44574574|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574575|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
44574576|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574577|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44574578|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44574579|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
43849534|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574580|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574581|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574582|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44574583|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574584|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
44574585|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
44574586|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574587|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574588|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
44574589|NCT00968253|Hormones|hormones|mesh-ancestor
44574590|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574591|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44574592|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44574593|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44574594|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44574595|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574596|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44574597|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
44574598|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44574599|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574600|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
44574601|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574602|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44574603|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44574604|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
44574605|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574606|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44574607|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44574608|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44574609|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44574610|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44574611|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44574612|NCT00968253|Protective Agents|protective agents|mesh-ancestor
44574613|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44574614|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44574615|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574616|NCT00967798|Incretins|incretins|mesh-ancestor
44574618|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574619|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44574620|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
44574621|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574622|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574623|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
44574624|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44574625|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
44574626|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
44574627|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574628|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574629|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574630|NCT00967694|Analgesics|analgesics|mesh-ancestor
44574631|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
44574632|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574633|NCT00967616|Leucovorin|leucovorin|mesh-list
44574634|NCT00967616|Fluorouracil|fluorouracil|mesh-list
44574635|NCT00967616|Irinotecan|irinotecan|mesh-list
44574636|NCT00967616|Efatutazone|efatutazone|mesh-list
44574637|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
44574638|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
44574639|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574640|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574641|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574642|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574643|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
44574644|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574645|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44574646|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44574647|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574648|NCT00967616|Antidotes|antidotes|mesh-ancestor
44574649|NCT00967616|Protective Agents|protective agents|mesh-ancestor
44574650|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
44574651|NCT00967616|Vitamins|vitamins|mesh-ancestor
44574652|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
44574653|NCT00967499|Ondansetron|ondansetron|mesh-list
44574654|NCT00967499|Palonosetron|palonosetron|mesh-list
44574655|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
44574656|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
44574657|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574658|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574659|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574660|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
44574661|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574662|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44574663|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
44574664|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574665|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574666|NCT00967499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44574667|NCT00967499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44574668|NCT00967499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574669|NCT00967499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574670|NCT00967499|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44574671|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44574672|NCT00967330|Bevacizumab|bevacizumab|mesh-list
44574673|NCT00967330|Irinotecan|irinotecan|mesh-list
44574674|NCT00967330|Temozolomide|temozolomide|mesh-list
44574675|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44574676|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574677|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574678|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574679|NCT00967330|Growth Substances|growth substances|mesh-ancestor
44574680|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574681|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574682|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44574683|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44574684|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574685|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574686|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44574687|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
44574689|NCT00967226|Propranolol|propranolol|mesh-list
44574690|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
44574691|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574692|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
44574693|NCT00967226|Hormones|hormones|mesh-ancestor
44574694|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574695|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574696|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44574697|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574698|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44574699|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44574700|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574701|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574702|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574703|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44574704|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44574705|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
44574706|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
44574707|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44574708|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
44574709|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574710|NCT00967005|Expectorants|expectorants|mesh-ancestor
44574711|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
44574712|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44574713|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
44574714|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574715|NCT00967005|Protective Agents|protective agents|mesh-ancestor
44574716|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574717|NCT00967005|Antidotes|antidotes|mesh-ancestor
44574718|NCT00966940|Travoprost|travoprost|mesh-list
44574719|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44574720|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44574721|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44574722|NCT00966875|Ixekizumab|ixekizumab|mesh-list
44574723|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574724|NCT00966693|Thalidomide|thalidomide|mesh-list
44574725|NCT00966693|Dexamethasone|dexamethasone|mesh-list
44574726|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
44574727|NCT00966693|Lenalidomide|lenalidomide|mesh-list
44574728|NCT00966693|Ichthammol|ichthammol|mesh-list
44574729|NCT00966693|BB 1101|bb 1101|mesh-list
44574730|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574731|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
44574732|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
44574733|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574734|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574735|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44574736|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
44574737|NCT00966693|Hormones|hormones|mesh-ancestor
44574738|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574739|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44574740|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574741|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
44574742|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574743|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574744|NCT00966693|Growth Substances|growth substances|mesh-ancestor
44574745|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574746|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574747|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
44574748|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44574749|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574750|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
44574751|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574752|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574753|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574779|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574780|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44574781|NCT00965731|Crizotinib|crizotinib|mesh-list
44574782|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574783|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44574784|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574785|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574786|NCT00965575|Melatonin|melatonin|mesh-list
44574787|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
44574788|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574789|NCT00965575|Protective Agents|protective agents|mesh-ancestor
44574790|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574791|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574792|NCT00965562|Fluoxetine|fluoxetine|mesh-list
44574793|NCT00965562|Calcium|calcium|mesh-list
44574794|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44574795|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574796|NCT00965562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44574797|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574798|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574799|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574800|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574801|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
44574802|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44574803|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574804|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574805|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44574806|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44574807|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574808|NCT00965497|Citalopram|citalopram|mesh-list
44574809|NCT00965497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44574810|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574811|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574812|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574813|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574814|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
44574815|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574816|NCT00965497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44574817|NCT00965497|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574818|NCT00965497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574819|NCT00965458|Alefacept|alefacept|mesh-list
44574820|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574821|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
44574822|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574823|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
44574824|NCT00965341|Testosterone|testosterone|mesh-list
44574825|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
44574826|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
44574827|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44574828|NCT00965341|Androgens|androgens|mesh-ancestor
44574829|NCT00965341|Hormones|hormones|mesh-ancestor
44574830|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44574831|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574832|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44574833|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574834|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
44574835|NCT00965263|Cocaine|cocaine|mesh-list
44574836|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
44574837|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
44574838|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44574839|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574840|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
44574841|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574842|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44574843|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44574844|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574845|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574846|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574847|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
44574848|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574849|NCT00965185|Atorvastatin|atorvastatin|mesh-list
44574850|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44574851|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44574852|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
44574853|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574854|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44574855|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44574856|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574857|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
44574858|NCT00965094|Everolimus|everolimus|mesh-list
44574859|NCT00965094|Tacrolimus|tacrolimus|mesh-list
44574860|NCT00965094|Basiliximab|basiliximab|mesh-list
44574861|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574862|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
44574863|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574864|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44574865|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574866|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574867|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574868|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44574869|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44574870|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
44574871|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44574872|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574873|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44574874|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44574875|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574876|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574877|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574878|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574879|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574880|NCT00965081|Analgesics|analgesics|mesh-ancestor
44574881|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
44574882|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574883|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574884|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574885|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
44574886|NCT00964886|Benztropine|benztropine|mesh-list
44574887|NCT00964886|Desipramine|desipramine|mesh-list
44574888|NCT00964886|Clomipramine|clomipramine|mesh-list
44574889|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44574890|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
44574891|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44574892|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574893|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574894|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44574895|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44574896|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574897|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574898|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574899|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574900|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44574901|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44574902|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
44574903|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
43977064|NCT05300841|Estradiol|estradiol|mesh-list
44574905|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44574906|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44574907|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44574908|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44574909|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
44574910|NCT00964886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44574911|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
44574912|NCT00964795|Aflibercept|aflibercept|mesh-list
44574913|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44574914|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44574915|NCT00964795|Growth Substances|growth substances|mesh-ancestor
44574916|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574917|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44574918|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574919|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
44574920|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
44574921|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44574922|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44574923|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574924|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574925|NCT00964782|Urological Agents|urological agents|mesh-ancestor
44574926|NCT00964743|Cytarabine|cytarabine|mesh-list
44574927|NCT00964743|Sorafenib|sorafenib|mesh-list
44574928|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44574929|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
44574930|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574931|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44574932|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
44574933|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574934|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44574935|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
44574936|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574937|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44574938|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574939|NCT00964678|Carvedilol|carvedilol|mesh-list
44574940|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44574941|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44574942|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
44574943|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574944|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574945|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574946|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44574947|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
44574948|NCT00964678|Protective Agents|protective agents|mesh-ancestor
44574949|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44574950|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44574951|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44574952|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
44574953|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44574954|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44574955|NCT00964366|Clindamycin|clindamycin|mesh-list
44574956|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
44574957|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
44574958|NCT00964366|Dapsone|dapsone|mesh-list
44574959|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44574960|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44574961|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574962|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44574963|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574964|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574965|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574966|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
44574967|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44574968|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44574969|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44574970|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
44574971|NCT00964223|Clindamycin|clindamycin|mesh-list
44574972|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
44574973|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
44574974|NCT00964223|Adapalene|adapalene|mesh-list
44574975|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44574976|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44574977|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44574978|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44574979|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44574980|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44574981|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574982|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44574983|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44574984|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44574985|NCT00964223|Analgesics|analgesics|mesh-ancestor
44574986|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
44574987|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44574988|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574989|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44574990|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44574991|NCT00963937|Sumatriptan|sumatriptan|mesh-list
44574992|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44574993|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44574994|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44574995|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
44574996|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44574997|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44574998|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44574999|NCT00963924|Cycloserine|cycloserine|mesh-list
44575000|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44575001|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575002|NCT00963924|Renal Agents|renal agents|mesh-ancestor
44575003|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44575004|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
44575005|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44575006|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
44575007|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575009|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575010|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575011|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
44575012|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575013|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
44575014|NCT00963807|Alovudine|alovudine|mesh-list
44575015|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
44575016|NCT00963807|Cisplatin|cisplatin|mesh-list
44575017|NCT00963807|Docetaxel|docetaxel|mesh-list
44575018|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44575019|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575020|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575021|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575022|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575023|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575024|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44575025|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
44575026|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
44575027|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575028|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44575029|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44575030|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575032|NCT00963599|Montelukast|montelukast|mesh-list
44575033|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44575034|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
44575035|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44575036|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
44575037|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575038|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575039|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44575040|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44575041|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575042|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
44575043|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575044|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44575045|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44575046|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44575047|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
44575048|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
44575049|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575050|NCT00963547|Trastuzumab|trastuzumab|mesh-list
44575051|NCT00963547|Lapatinib|lapatinib|mesh-list
44575052|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575053|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575054|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575055|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575056|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575057|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44575058|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
44575059|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575061|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44575062|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
44575063|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575064|NCT00962741|Etanercept|etanercept|mesh-list
44575065|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44575066|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44575067|NCT00962741|Analgesics|analgesics|mesh-ancestor
44575068|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
44575069|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575070|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575071|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575072|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575073|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575074|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575075|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
44575076|NCT00962585|Equol|equol|mesh-list
44575077|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
44575078|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44575079|NCT00962585|Estrogens|estrogens|mesh-ancestor
44575080|NCT00962585|Hormones|hormones|mesh-ancestor
44575081|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575082|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575083|NCT00962390|Equol|equol|mesh-list
44575084|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
44575085|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44575086|NCT00962390|Estrogens|estrogens|mesh-ancestor
44575087|NCT00962390|Hormones|hormones|mesh-ancestor
44575088|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575089|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575090|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44575091|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44575092|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575093|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575094|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575095|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
44575096|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575097|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575098|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
44575099|NCT00961961|Fluoxetine|fluoxetine|mesh-list
44575100|NCT00961961|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44575101|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575102|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575103|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575104|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575105|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
44575106|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575107|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44575108|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575109|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575110|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44575111|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44575112|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575113|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
44575114|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575115|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575116|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44575117|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44575118|NCT00961649|Brinzolamide|brinzolamide|mesh-list
44575119|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44575120|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44575121|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44575122|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44575123|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44575124|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44575125|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977231|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
44575126|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575127|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575128|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44575129|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575131|NCT00961636|Niacinamide|niacinamide|mesh-list
44575132|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
44575133|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575134|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
44575135|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575136|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575137|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
44575138|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
44575139|NCT00961636|Vitamins|vitamins|mesh-ancestor
44575140|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
44575141|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575142|NCT00961571|Capecitabine|capecitabine|mesh-list
44575143|NCT00961571|Sunitinib|sunitinib|mesh-list
44575144|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44575145|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
44575146|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575147|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575148|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44575149|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44575150|NCT00961571|Growth Substances|growth substances|mesh-ancestor
44575151|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575152|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44575153|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575154|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575155|NCT00961415|Bevacizumab|bevacizumab|mesh-list
44575156|NCT00961415|Cisplatin|cisplatin|mesh-list
44575157|NCT00961415|Pemetrexed|pemetrexed|mesh-list
44575158|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575159|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575160|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44575161|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44575162|NCT00961415|Growth Substances|growth substances|mesh-ancestor
44575163|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575164|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44575165|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197637|NCT00385463|Hormones|hormones|mesh-ancestor
44575166|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575167|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44575168|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44575169|NCT00961350|Aspirin|aspirin|mesh-list
44575170|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44575171|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44575172|NCT00961350|Analgesics|analgesics|mesh-ancestor
44575174|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575175|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575176|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575177|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575178|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44575179|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44575180|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575181|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44575182|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44575183|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575184|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
44575185|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44575186|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44575187|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575188|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575189|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575190|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575191|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575192|NCT00961298|Analgesics|analgesics|mesh-ancestor
44575193|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
44575194|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575195|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575196|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575197|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
44575198|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
44575199|NCT00961259|Fenofibrate|fenofibrate|mesh-list
44144202|NCT00191503|Pemetrexed|pemetrexed|mesh-list
44575200|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575202|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
44575203|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575204|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575205|NCT00961220|Carmustine|carmustine|mesh-list
44575206|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44575207|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44575208|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
44575209|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575210|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575211|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575212|NCT00961181|Paclitaxel|paclitaxel|mesh-list
44575213|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44575214|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575215|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575216|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575217|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575218|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575219|NCT00961116|Fenofibrate|fenofibrate|mesh-list
44575220|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
44575221|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575222|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
44575223|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575224|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575225|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575226|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44575227|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44575228|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575229|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575230|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575231|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575232|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575233|NCT00960986|Analgesics|analgesics|mesh-ancestor
44575234|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
44575235|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575236|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575237|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575238|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
44575239|NCT00960934|Vitamin D|vitamin d|mesh-list
44575240|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
44575241|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
44575242|NCT00960934|Calcium|calcium|mesh-list
44575243|NCT00960934|Vitamins|vitamins|mesh-ancestor
44575244|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
44575245|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575272|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575274|NCT00960804|Tanezumab|tanezumab|mesh-list
44575275|NCT00960804|Analgesics|analgesics|mesh-ancestor
44575276|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
44575277|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575278|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575279|NCT00960687|Fenofibrate|fenofibrate|mesh-list
44575280|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
44575281|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575282|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
44575283|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575284|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575285|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575286|NCT00960661|Insulin|insulin|mesh-list
44575287|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44575288|NCT00960661|Metformin|metformin|mesh-list
44575289|NCT00960661|Exenatide|exenatide|mesh-list
44575290|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
44575291|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44575292|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575293|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44575294|NCT00960661|Incretins|incretins|mesh-ancestor
44575295|NCT00960661|Hormones|hormones|mesh-ancestor
44575296|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575297|NCT00960570|Efavirenz|efavirenz|mesh-list
44575298|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
44575299|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44575300|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44575301|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977354|NCT03867500|Niacin|niacin|mesh-list
44575302|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575304|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575305|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44575306|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44575307|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44575308|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44575309|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44575310|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44575311|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575312|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575313|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
44575314|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575315|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
44575316|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44575317|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
44575318|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575319|NCT00960440|Tofacitinib|tofacitinib|mesh-list
44575320|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575321|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575322|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575323|NCT00960323|Colchicine|colchicine|mesh-list
44575324|NCT00960323|Atorvastatin|atorvastatin|mesh-list
44575325|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44575326|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575327|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
44575328|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575329|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575330|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44575331|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575332|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
44575333|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575334|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575335|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575336|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575337|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575338|NCT00960193|Colchicine|colchicine|mesh-list
44575339|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
44575340|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575341|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575342|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575343|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575344|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575345|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575346|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
44575347|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
44575348|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575349|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575350|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575351|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44575352|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
44575353|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575354|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575355|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44575356|NCT00960076|Metformin|metformin|mesh-list
44575357|NCT00960076|Saxagliptin|saxagliptin|mesh-list
44575358|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44575359|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575360|NCT00960076|Incretins|incretins|mesh-ancestor
44575361|NCT00960076|Hormones|hormones|mesh-ancestor
44575362|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575363|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44575364|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
44575365|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575366|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401973|NCT02709486|Tanezumab|tanezumab|mesh-list
44575367|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
44575368|NCT00960063|Temozolomide|temozolomide|mesh-list
44575369|NCT00960063|Ifosfamide|ifosfamide|mesh-list
44575370|NCT00960063|Doxorubicin|doxorubicin|mesh-list
44575371|NCT00960063|Irinotecan|irinotecan|mesh-list
44575372|NCT00960063|Etoposide|etoposide|mesh-list
44575373|NCT00960063|Vincristine|vincristine|mesh-list
44575374|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575375|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
44575376|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575377|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575378|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44575379|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
44575380|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575381|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575382|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44575383|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44575384|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44575385|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44575386|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575387|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44575388|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44575389|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575390|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575391|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575392|NCT00959946|Capecitabine|capecitabine|mesh-list
44575393|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44575394|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
44575395|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575396|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575397|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
44575398|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44575399|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44575400|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44575401|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44575402|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575403|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575404|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
44575405|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575406|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575407|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44575408|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575409|NCT00959894|Tenofovir|tenofovir|mesh-list
44575410|NCT00959894|Emtricitabine|emtricitabine|mesh-list
44575411|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44575412|NCT00959894|Etravirine|etravirine|mesh-list
44575413|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
44575414|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575415|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44575416|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44575417|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575418|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575419|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44575420|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44575421|NCT00959699|Interferons|interferons|mesh-list
44575422|NCT00959699|Ribavirin|ribavirin|mesh-list
44575423|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
44575424|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
44575425|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44575426|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575427|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
44575428|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575429|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
44575430|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575431|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
44575432|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575433|NCT00959647|Bevacizumab|bevacizumab|mesh-list
44575434|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575435|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575436|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44575437|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44575438|NCT00959647|Growth Substances|growth substances|mesh-ancestor
44575439|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575440|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
44575441|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
44575442|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44575443|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
44575444|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575445|NCT00959049|Vaccines|vaccines|mesh-list
44575446|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
44575447|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575448|NCT00958880|Yohimbine|yohimbine|mesh-list
44575449|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
44575450|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
44575452|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575453|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44575454|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44575455|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44575456|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
44575457|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575458|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575459|NCT00958880|Urological Agents|urological agents|mesh-ancestor
44575460|NCT00958841|Pasireotide|pasireotide|mesh-list
44575461|NCT00958841|Hormones|hormones|mesh-ancestor
44575462|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575463|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575464|NCT00958776|Peramivir|peramivir|mesh-list
44575465|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
44575466|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575467|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575468|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575469|NCT00958724|Vinorelbine|vinorelbine|mesh-list
44575470|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44575471|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575472|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575473|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575474|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575475|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575476|NCT00958568|Olanzapine|olanzapine|mesh-list
44575477|NCT00958568|Fluoxetine|fluoxetine|mesh-list
44575478|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
44575479|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
44575480|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575481|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575482|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575483|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44575484|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575485|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575486|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575487|NCT00958568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44575488|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575489|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575490|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575491|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575492|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
44575493|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44575494|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575495|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44575496|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44575497|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575498|NCT00958438|Rilonacept|rilonacept|mesh-list
44575499|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575500|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
44575501|NCT00958256|Rituximab|rituximab|mesh-list
44575502|NCT00958256|Bortezomib|bortezomib|mesh-list
44575503|NCT00958256|Lenograstim|lenograstim|mesh-list
44575504|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575505|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
44575506|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575507|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575508|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44575509|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
44575510|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575511|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575512|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44575513|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575514|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44575515|NCT00958243|Vaccines|vaccines|mesh-list
44575516|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
44402138|NCT02705716|Fluorides|fluorides|mesh-list
44575517|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575518|NCT00958074|Vorinostat|vorinostat|mesh-list
44575519|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575520|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44197963|NCT00386763|Artemether|artemether|mesh-list
44575521|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575522|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575523|NCT00957996|Peramivir|peramivir|mesh-list
44575524|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
44575525|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575526|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575527|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575528|NCT00957944|Rotigotine|rotigotine|mesh-list
44575529|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
44575530|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
44575531|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575532|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575533|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575534|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
44575535|NCT00957905|Leucovorin|leucovorin|mesh-list
44575536|NCT00957905|Folic Acid|folic acid|mesh-list
44575537|NCT00957905|Fluorouracil|fluorouracil|mesh-list
44575538|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
44575539|NCT00957905|Alvocidib|alvocidib|mesh-list
44575540|NCT00957905|Calcium|calcium|mesh-list
44575541|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
44575542|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44575543|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575544|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44575545|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
44575546|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575547|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44575548|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575549|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575550|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
44575551|NCT00957905|Antidotes|antidotes|mesh-ancestor
44575552|NCT00957905|Protective Agents|protective agents|mesh-ancestor
44575553|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
44575554|NCT00957905|Vitamins|vitamins|mesh-ancestor
44575555|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
44575556|NCT00957905|Hematinics|hematinics|mesh-ancestor
44575557|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
44575558|NCT00957905|Growth Substances|growth substances|mesh-ancestor
44575559|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575560|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575561|NCT00957853|Cetuximab|cetuximab|mesh-list
44575562|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575563|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575564|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
44575565|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44575566|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44575567|NCT00957801|Prednisolone|prednisolone|mesh-list
44575568|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
44575569|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
44575570|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44575571|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
44575572|NCT00957801|Testosterone|testosterone|mesh-list
44575573|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
44575574|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
44575575|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44575576|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575577|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
44575578|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
44575579|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575580|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575581|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575582|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
44575583|NCT00957801|Hormones|hormones|mesh-ancestor
44575584|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575585|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44575586|NCT00957801|Protective Agents|protective agents|mesh-ancestor
44575587|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44575588|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575589|NCT00957801|Androgens|androgens|mesh-ancestor
44575590|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
44575591|NCT00957580|Niacinamide|niacinamide|mesh-list
44575592|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
44575593|NCT00957580|Vitamins|vitamins|mesh-ancestor
44575594|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
44575595|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575597|NCT00957528|Testosterone|testosterone|mesh-list
44575598|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
44575599|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
44575600|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44575601|NCT00957528|Androgens|androgens|mesh-ancestor
44575602|NCT00957528|Hormones|hormones|mesh-ancestor
43849535|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575603|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575605|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44575606|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575607|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
44575608|NCT00957424|Nicotine|nicotine|mesh-list
44575609|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44575610|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
44575611|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575612|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575613|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44575614|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44575615|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
44575616|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575617|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575618|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44575619|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
44575620|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44575621|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44575622|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575623|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575624|NCT00957268|Alogliptin|alogliptin|mesh-list
44575625|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44575626|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575627|NCT00957268|Incretins|incretins|mesh-ancestor
44575628|NCT00957268|Hormones|hormones|mesh-ancestor
44575629|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575630|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44575631|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
44575632|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575633|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575634|NCT00957034|Testosterone|testosterone|mesh-list
44575635|NCT00957034|Androgens|androgens|mesh-ancestor
44575636|NCT00957034|Hormones|hormones|mesh-ancestor
44575637|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575638|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575639|NCT00956943|Nicotine|nicotine|mesh-list
44575640|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44575641|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
44575642|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575643|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575644|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44575645|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44575646|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44575647|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575648|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575649|NCT00956839|Vitamin D|vitamin d|mesh-list
44575650|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
44575651|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
44575652|NCT00956839|Vitamins|vitamins|mesh-list
44575653|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
44575654|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575655|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44575656|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44575657|NCT00956293|Cyclosporine|cyclosporine|mesh-list
44575658|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
44575659|NCT00956293|Everolimus|everolimus|mesh-list
44575660|NCT00956293|Cyclosporins|cyclosporins|mesh-list
44575661|NCT00956293|Basiliximab|basiliximab|mesh-list
44575662|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575663|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575664|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575665|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
44575666|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575667|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
44575668|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575669|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575670|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575693|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575694|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44575695|NCT00955474|Citalopram|citalopram|mesh-list
44575696|NCT00955474|Sertraline|sertraline|mesh-list
44575697|NCT00955474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44575698|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575699|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575700|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575701|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575703|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575704|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44575705|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575706|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575707|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44575708|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575709|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575710|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
44575711|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44575712|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
44575713|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575714|NCT00955357|Lacosamide|lacosamide|mesh-list
44575715|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
44575716|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44575717|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44575718|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575719|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575720|NCT00955305|Paclitaxel|paclitaxel|mesh-list
44575721|NCT00955305|Bevacizumab|bevacizumab|mesh-list
44575722|NCT00955305|Carboplatin|carboplatin|mesh-list
44575723|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44575724|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575725|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575726|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575727|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575728|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575729|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575730|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44575731|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44575732|NCT00955305|Growth Substances|growth substances|mesh-ancestor
44575733|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575734|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44402357|NCT02697617|Pioglitazone|pioglitazone|mesh-list
44575735|NCT00955279|Golimumab|golimumab|mesh-list
44575736|NCT00955279|Ustekinumab|ustekinumab|mesh-list
44575737|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575738|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44575739|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575740|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575741|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
44575742|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575743|NCT00955110|Oxymorphone|oxymorphone|mesh-list
44575744|NCT00955110|Oxycodone|oxycodone|mesh-list
44575745|NCT00955110|Hydromorphone|hydromorphone|mesh-list
44575746|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44575747|NCT00955110|Narcotics|narcotics|mesh-ancestor
44575748|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575749|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575750|NCT00955110|Analgesics|analgesics|mesh-ancestor
44575751|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
44575752|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575753|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44575754|NCT00954941|Ondansetron|ondansetron|mesh-list
44575755|NCT00954941|Aprepitant|aprepitant|mesh-list
44575756|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
44575757|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
44575758|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575759|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575760|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575761|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
44575762|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575763|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44575764|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
44575765|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575766|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575767|NCT00954941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44575768|NCT00954941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575769|NCT00954941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575770|NCT00954941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575771|NCT00954941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44575772|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44575773|NCT00954707|Aspirin|aspirin|mesh-list
44575774|NCT00954707|Clopidogrel|clopidogrel|mesh-list
44575775|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44575776|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44575777|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44575778|NCT00954707|Analgesics|analgesics|mesh-ancestor
44575779|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
44575780|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44575781|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575782|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575783|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44575784|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44575785|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44575786|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575787|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44575788|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44575789|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575790|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
44575791|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44575792|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44575793|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44575794|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
44575795|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575796|NCT00954512|Leucovorin|leucovorin|mesh-list
44575797|NCT00954512|Folic Acid|folic acid|mesh-list
44575798|NCT00954512|Gemcitabine|gemcitabine|mesh-list
44575799|NCT00954512|Carboplatin|carboplatin|mesh-list
44575800|NCT00954512|Trastuzumab|trastuzumab|mesh-list
44575801|NCT00954512|Irinotecan|irinotecan|mesh-list
44575802|NCT00954512|Cetuximab|cetuximab|mesh-list
44575803|NCT00954512|Everolimus|everolimus|mesh-list
44575804|NCT00954512|Epirubicin|epirubicin|mesh-list
44575805|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
44575806|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575807|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575808|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44575809|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
44575810|NCT00954512|Antiviral Agents|antiviral agents|mesh-ancestor
44575811|NCT00954512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575812|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575813|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575814|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
44575815|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575816|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44575817|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44575818|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44575819|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44575820|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44575822|NCT00954512|Protective Agents|protective agents|mesh-ancestor
44575823|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
44575824|NCT00954512|Vitamins|vitamins|mesh-ancestor
44575825|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
44575826|NCT00954512|Hematinics|hematinics|mesh-ancestor
44575827|NCT00954447|Linagliptin|linagliptin|mesh-list
44198229|NCT00388089|Bortezomib|bortezomib|mesh-list
44575828|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44575829|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575830|NCT00954447|Incretins|incretins|mesh-ancestor
44575831|NCT00954447|Hormones|hormones|mesh-ancestor
44575832|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575833|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44575834|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
44575835|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575836|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575837|NCT00954174|Paclitaxel|paclitaxel|mesh-list
44575838|NCT00954174|Carboplatin|carboplatin|mesh-list
44575839|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44575840|NCT00954174|Ifosfamide|ifosfamide|mesh-list
44575841|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
44575842|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44575843|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575844|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
44575845|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
44575846|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
44575847|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575848|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44575849|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
44575850|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44575851|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575852|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575853|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44575854|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575855|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575856|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575858|NCT00953745|Citalopram|citalopram|mesh-list
44575859|NCT00953745|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44575860|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44575861|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575862|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575863|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44575864|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
44575865|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575866|NCT00953745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44575867|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
44575868|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44575869|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44575870|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44575871|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44575872|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
44575873|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
44575874|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44575875|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44575876|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44575877|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44575878|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44575879|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44575880|NCT00953706|Ivacaftor|ivacaftor|mesh-list
44575881|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44575882|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575883|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575884|NCT00953680|Losartan|losartan|mesh-list
44575885|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44575886|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44575887|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44575888|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44575889|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44575890|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575892|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
44575893|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575894|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44575895|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575896|NCT00953667|Niacin|niacin|mesh-list
44575897|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44575898|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
44575899|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575900|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44575901|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
44575902|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
44575903|NCT00953667|Vitamins|vitamins|mesh-ancestor
44575904|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
44575905|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575906|NCT00953615|Thalidomide|thalidomide|mesh-list
44575907|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44575908|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
44575909|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575910|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
44575911|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44575912|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575913|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44575914|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44575915|NCT00953615|Growth Substances|growth substances|mesh-ancestor
44575916|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44575917|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575918|NCT00953576|Ketoconazole|ketoconazole|mesh-list
44575919|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
44575920|NCT00953576|Lapatinib|lapatinib|mesh-list
44575921|NCT00953576|Dutasteride|dutasteride|mesh-list
44575922|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575923|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575924|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44575925|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44575926|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575927|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
44575928|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44575929|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44575930|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44575931|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44575932|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
44575933|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575934|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575935|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44575936|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44575937|NCT00953524|Vaccines|vaccines|mesh-list
44575938|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
44575939|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575940|NCT00953329|Alefacept|alefacept|mesh-list
44575941|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575942|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
44575943|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575944|NCT00953225|Vitamin D|vitamin d|mesh-list
44575945|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
44575946|NCT00953225|Vitamins|vitamins|mesh-ancestor
44575947|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
44575948|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575949|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44575950|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44575951|NCT00953147|Ciclesonide|ciclesonide|mesh-list
44575952|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
44575953|NCT00953147|Hormones|hormones|mesh-ancestor
44575954|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575955|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575956|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44575957|NCT00953056|Vaccines|vaccines|mesh-list
44575958|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
44575959|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575960|NCT00953043|Lubiprostone|lubiprostone|mesh-list
44575961|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44402591|NCT02690727|Tenalisib|tenalisib|mesh-list
44575962|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575963|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575965|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44575966|NCT00953017|Lubiprostone|lubiprostone|mesh-list
44575967|NCT00953017|Cathartics|cathartics|mesh-ancestor
44575968|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44575969|NCT00953017|Laxatives|laxatives|mesh-ancestor
44575970|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44575971|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44575972|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44575973|NCT00952822|Factor VIII|factor viii|mesh-list
44575974|NCT00952822|Coagulants|coagulants|mesh-ancestor
44575975|NCT00952731|Tamoxifen|tamoxifen|mesh-list
44575976|NCT00952731|Afimoxifene|afimoxifene|mesh-list
44575977|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44575978|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
44575979|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575980|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575981|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44575982|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44575983|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44575984|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44575985|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44575986|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44575987|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44575988|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
44575989|NCT00952614|Hormones|hormones|mesh-ancestor
44575990|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44575991|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44575992|NCT00952523|Adapalene|adapalene|mesh-list
44575993|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44575994|NCT00952523|Tretinoin|tretinoin|mesh-list
44575995|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44575996|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44575997|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44575998|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44575999|NCT00952523|Analgesics|analgesics|mesh-ancestor
44576000|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
44576001|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576002|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576003|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44576004|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576005|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576006|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
44576007|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
44576008|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
44576009|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576010|NCT00952419|Vaccines|vaccines|mesh-list
44576011|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
44576012|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576013|NCT00952380|Dalteparin|dalteparin|mesh-list
44576014|NCT00952380|Tinzaparin|tinzaparin|mesh-list
44576015|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44576016|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
44576017|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44576018|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44576019|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576020|NCT00952341|Dexamethasone|dexamethasone|mesh-list
44576021|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
44576022|NCT00952341|Aprepitant|aprepitant|mesh-list
44576023|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
44576024|NCT00952341|Granisetron|granisetron|mesh-list
44576025|NCT00952341|BB 1101|bb 1101|mesh-list
44576026|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44576027|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
44576028|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
44576029|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576030|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576031|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44576032|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
44576033|NCT00952341|Hormones|hormones|mesh-ancestor
44576034|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576035|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44576036|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402663|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576069|NCT00951665|Paclitaxel|paclitaxel|mesh-list
44576070|NCT00951665|Maytansine|maytansine|mesh-list
44576071|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44576072|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44576073|NCT00951665|Trastuzumab|trastuzumab|mesh-list
44576074|NCT00951665|Pertuzumab|pertuzumab|mesh-list
44576075|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576076|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576077|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576078|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576079|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576080|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576081|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576082|NCT00951496|Paclitaxel|paclitaxel|mesh-list
44576083|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44576084|NCT00951496|Bevacizumab|bevacizumab|mesh-list
44576085|NCT00951496|Cisplatin|cisplatin|mesh-list
44576086|NCT00951496|Carboplatin|carboplatin|mesh-list
44576087|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44576088|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
44576089|NCT00951496|Antibodies|antibodies|mesh-list
44576090|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
44576091|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44576092|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
44576093|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576094|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576095|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576096|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576097|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576098|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576099|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44576100|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44576101|NCT00951496|Growth Substances|growth substances|mesh-ancestor
44576102|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576103|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
44576104|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
44576105|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44576106|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
44576107|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576108|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44576109|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44576110|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576111|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576112|NCT00951379|Pioglitazone|pioglitazone|mesh-list
44576113|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44576114|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576115|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
44576116|NCT00951041|Vaccines|vaccines|mesh-list
44576117|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
44576118|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576119|NCT00951015|Efavirenz|efavirenz|mesh-list
44576120|NCT00951015|Dolutegravir|dolutegravir|mesh-list
44576121|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44576122|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44576123|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576124|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576125|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
44576126|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576127|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44576128|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44576129|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44576130|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44576131|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44576132|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44576133|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44576134|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44576135|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44576136|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44576137|NCT00950911|Denosumab|denosumab|mesh-list
44576138|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44576139|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576140|NCT00950859|Dolutegravir|dolutegravir|mesh-list
44576141|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44576142|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44576143|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576144|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576145|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44576146|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44576147|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
44576148|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576149|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
44576150|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44576151|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
44576152|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576153|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576154|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44576155|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
44576156|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
44576157|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44576158|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44576159|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576160|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576161|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
44576162|NCT00950755|Antibodies|antibodies|mesh-list
44576163|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
44576164|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576165|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576166|NCT00950742|Trastuzumab|trastuzumab|mesh-list
44576167|NCT00950742|Afatinib|afatinib|mesh-list
44576168|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576169|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576170|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576171|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576172|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576173|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44576174|NCT00950690|Latanoprost|latanoprost|mesh-list
44576175|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44576176|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44576177|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44576178|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44576179|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576180|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576181|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44576182|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44576183|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576184|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
44576185|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576186|NCT00950651|Tramadol|tramadol|mesh-list
44576187|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44576188|NCT00950651|Narcotics|narcotics|mesh-ancestor
44576189|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576190|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576191|NCT00950651|Analgesics|analgesics|mesh-ancestor
44576192|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
44576193|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576194|NCT00950599|Saxagliptin|saxagliptin|mesh-list
44576195|NCT00950599|Incretins|incretins|mesh-ancestor
44576196|NCT00950599|Hormones|hormones|mesh-ancestor
44576197|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576198|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576199|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44576200|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
44576201|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576202|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576203|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44576204|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
44576205|NCT00950300|Docetaxel|docetaxel|mesh-list
44576206|NCT00950300|Fluorouracil|fluorouracil|mesh-list
44576207|NCT00950300|Trastuzumab|trastuzumab|mesh-list
44576208|NCT00950300|Epirubicin|epirubicin|mesh-list
44576209|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576210|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
44576211|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576212|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576213|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576214|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
44576215|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576216|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576217|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576218|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576219|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576220|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576221|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
44576222|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576223|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576224|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44576225|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44576226|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44576227|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576228|NCT00950248|Idebenone|idebenone|mesh-list
44576229|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
44576230|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576231|NCT00950248|Protective Agents|protective agents|mesh-ancestor
44576232|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576233|NCT00950170|Factor VIII|factor viii|mesh-list
44576234|NCT00950170|Coagulants|coagulants|mesh-ancestor
44576235|NCT00949988|Rituximab|rituximab|mesh-list
44576236|NCT00949988|Dasatinib|dasatinib|mesh-list
44576237|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576238|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576239|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
44576240|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576241|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576242|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576243|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576244|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576245|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44576246|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576247|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576248|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576249|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576250|NCT00949884|Losartan|losartan|mesh-list
44576251|NCT00949884|Olmesartan|olmesartan|mesh-list
44576252|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44576253|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44576254|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44576255|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44576256|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44576257|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576259|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576260|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576261|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576262|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576263|NCT00949650|Cisplatin|cisplatin|mesh-list
44576264|NCT00949650|Pemetrexed|pemetrexed|mesh-list
44576265|NCT00949650|Afatinib|afatinib|mesh-list
44576266|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576267|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576268|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576269|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44576270|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44576271|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576272|NCT00949533|Oseltamivir|oseltamivir|mesh-list
44576273|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
44576274|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576275|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576276|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576277|NCT00949325|Sirolimus|sirolimus|mesh-list
44576278|NCT00949325|Doxorubicin|doxorubicin|mesh-list
44576279|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44576280|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44576281|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576282|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44576283|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198613|NCT00389701|Hormones|hormones|mesh-ancestor
44576284|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576285|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576286|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44576287|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576288|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
44576289|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576290|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
44576291|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576292|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
44576293|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
44576294|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
44576295|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44576296|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44576297|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
44576298|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
44576299|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576300|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576301|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576302|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44576303|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
44576304|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44576305|NCT00948922|Fludarabine|fludarabine|mesh-list
44576306|NCT00948922|Bortezomib|bortezomib|mesh-list
44576307|NCT00948922|Melphalan|melphalan|mesh-list
44576308|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576309|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576310|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576311|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
44576312|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576313|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576314|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
44576315|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576316|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
44576317|NCT00948896|Piperaquine|piperaquine|mesh-list
44576318|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
44576319|NCT00948896|Trimethoprim|trimethoprim|mesh-list
44576320|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44576321|NCT00948896|Artenimol|artenimol|mesh-list
44576322|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44576323|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
44576324|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
44576325|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44576326|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44576327|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576328|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44576329|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576330|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576331|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44576332|NCT00948896|Renal Agents|renal agents|mesh-ancestor
44576333|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44576334|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44576335|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44576336|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44576337|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44576338|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44576339|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
44576340|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576341|NCT00948818|Linaclotide|linaclotide|mesh-list
44576342|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44576343|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
44576344|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576345|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44576346|NCT00948766|Rivastigmine|rivastigmine|mesh-list
44576347|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44576348|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576349|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576350|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
44576351|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576352|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576353|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44576354|NCT00948766|Protective Agents|protective agents|mesh-ancestor
44576356|NCT00948688|Fluorouracil|fluorouracil|mesh-list
44576357|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576358|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44576359|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576360|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576361|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
44576362|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576363|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576364|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
44576365|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576366|NCT00948675|Paclitaxel|paclitaxel|mesh-list
44576367|NCT00948675|Bevacizumab|bevacizumab|mesh-list
44576368|NCT00948675|Carboplatin|carboplatin|mesh-list
44576369|NCT00948675|Pemetrexed|pemetrexed|mesh-list
44576370|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576371|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576390|NCT00948441|Ethanol|ethanol|mesh-list
44576391|NCT00948441|Heparin|heparin|mesh-list
44576392|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
44576393|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44576394|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44576395|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576396|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44576397|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576398|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576399|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576400|NCT00948428|Imiquimod|imiquimod|mesh-list
44576401|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44576402|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
44576403|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576404|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576405|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
44576406|NCT00948389|Dasatinib|dasatinib|mesh-list
44576407|NCT00948389|Lomustine|lomustine|mesh-list
44576408|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576409|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576410|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576411|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576412|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576413|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
44576414|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
44576415|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44576416|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
44576417|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576418|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576419|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44576420|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
44576421|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44576422|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
44576423|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576424|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576425|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44576426|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576427|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
44576428|NCT00948194|Protective Agents|protective agents|mesh-ancestor
44576429|NCT00948155|Varenicline|varenicline|mesh-list
44576430|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44576431|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44576432|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44576433|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576434|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576435|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576436|NCT00948064|Azacitidine|azacitidine|mesh-list
44576437|NCT00948064|Vorinostat|vorinostat|mesh-list
44576438|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576439|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
44198761|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44576440|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576441|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576442|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576443|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44576444|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44576445|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576446|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576447|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44576448|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576449|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
44576450|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44576451|NCT00947531|Protective Agents|protective agents|mesh-ancestor
44576452|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576453|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
44576454|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44576455|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
44576456|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576457|NCT00947349|Interferons|interferons|mesh-list
44576458|NCT00947349|Ribavirin|ribavirin|mesh-list
44576459|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576460|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
44576461|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576462|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
44576463|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576464|NCT00947154|Aripiprazole|aripiprazole|mesh-list
44576465|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
44576466|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576467|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44576468|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44576469|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576470|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576471|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
44576472|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
44576473|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576474|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576475|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44576476|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44576477|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
44576478|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44576479|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44576480|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44576481|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44576482|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44576483|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44576484|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576485|NCT00947011|Incretins|incretins|mesh-ancestor
44576486|NCT00947011|Hormones|hormones|mesh-ancestor
44576487|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576488|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44576489|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44576490|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576491|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576492|NCT00946998|Sertraline|sertraline|mesh-list
44576493|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
44576494|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576495|NCT00946998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44576496|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44576497|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44576498|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576499|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576500|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
44576501|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576502|NCT00946985|Risperidone|risperidone|mesh-list
44576503|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44576504|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44576505|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
44576506|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576507|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576508|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576509|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44576510|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44576511|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576512|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576513|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44576514|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
44576515|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44576516|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44576517|NCT00946920|Goserelin|goserelin|mesh-list
44576518|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44576519|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576520|NCT00946647|Azacitidine|azacitidine|mesh-list
44576521|NCT00946647|Panobinostat|panobinostat|mesh-list
44576522|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576523|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
44576524|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576525|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576526|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576527|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44576528|NCT00946309|Sulforaphane|sulforaphane|mesh-list
44576529|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44576530|NCT00946309|Protective Agents|protective agents|mesh-ancestor
44576531|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576532|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576533|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44576534|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44576535|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44576536|NCT00946192|Desogestrel|desogestrel|mesh-list
44576537|NCT00946192|Estradiol|estradiol|mesh-list
44576538|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44576539|NCT00946192|Progesterone|progesterone|mesh-list
44576540|NCT00946192|Estrogens|estrogens|mesh-ancestor
44576541|NCT00946192|Hormones|hormones|mesh-ancestor
44576542|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576543|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576544|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44576545|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
44576546|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44576547|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44576548|NCT00946192|Progestins|progestins|mesh-ancestor
44576549|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44576550|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44576551|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44576552|NCT00946153|Lenvatinib|lenvatinib|mesh-list
44576553|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576554|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576555|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576556|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576557|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
44198875|NCT00390871|Analgesics|analgesics|mesh-ancestor
44576558|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576559|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44576560|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44576561|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576562|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576563|NCT00946114|Urological Agents|urological agents|mesh-ancestor
44576564|NCT00946088|Progesterone|progesterone|mesh-list
44576565|NCT00946088|Progestins|progestins|mesh-ancestor
44576566|NCT00946088|Hormones|hormones|mesh-ancestor
44576567|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576568|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576569|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44576570|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44576571|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44576572|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44576573|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576574|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576575|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576576|NCT00945945|Analgesics|analgesics|mesh-ancestor
44576577|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
44576578|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576579|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
44576580|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576581|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
44576582|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
44576583|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44576584|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44576585|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576586|NCT00945815|Cytarabine|cytarabine|mesh-list
44576587|NCT00945815|Clofarabine|clofarabine|mesh-list
44576588|NCT00945815|Epratuzumab|epratuzumab|mesh-list
44576589|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576590|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
44576591|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576592|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576593|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
44576594|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576595|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576596|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
44576597|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576598|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576599|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44576600|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576601|NCT00945321|Aprepitant|aprepitant|mesh-list
44576602|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
44576603|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
44576604|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
44576605|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576606|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576607|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44576608|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44576609|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576610|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576611|NCT00945191|Paclitaxel|paclitaxel|mesh-list
44576612|NCT00945191|Carboplatin|carboplatin|mesh-list
44576613|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576614|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576615|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576616|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576617|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576618|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576619|NCT00944697|Oxycodone|oxycodone|mesh-list
44576620|NCT00944697|Naloxone|naloxone|mesh-list
44576621|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44576622|NCT00944697|Narcotics|narcotics|mesh-ancestor
44576623|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576624|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576625|NCT00944697|Analgesics|analgesics|mesh-ancestor
44576626|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
44576627|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576628|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44576629|NCT00944658|Apremilast|apremilast|mesh-list
44576630|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44576631|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44576632|NCT00944658|Analgesics|analgesics|mesh-ancestor
44576633|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
44576634|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576635|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576636|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44576637|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576638|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44576639|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44576640|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576641|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576642|NCT00944645|Niacin|niacin|mesh-list
44576643|NCT00944645|Niacinamide|niacinamide|mesh-list
44576644|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
44576645|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44576646|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
43700440|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576647|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576648|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44576649|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576650|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
44576652|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
44576653|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576654|NCT00943917|Exenatide|exenatide|mesh-list
44576655|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44576656|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576657|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44576658|NCT00943917|Incretins|incretins|mesh-ancestor
44576659|NCT00943917|Hormones|hormones|mesh-ancestor
44576660|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576661|NCT00943852|Losartan|losartan|mesh-list
44576662|NCT00943852|Isosorbide|isosorbide|mesh-list
44576663|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44198976|NCT00391417|Estradiol|estradiol|mesh-list
44576664|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44576665|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44576666|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44576667|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44576668|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44576669|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576670|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44576671|NCT00943852|Diuretics|diuretics|mesh-ancestor
44576672|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44576673|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576674|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576675|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44576676|NCT00943826|Bevacizumab|bevacizumab|mesh-list
44576677|NCT00943826|Temozolomide|temozolomide|mesh-list
44576678|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576679|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576680|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44576681|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44576683|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576684|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44576685|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576686|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
44576687|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576688|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44576689|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576690|NCT00943761|Interferons|interferons|mesh-list
44576691|NCT00943761|Ribavirin|ribavirin|mesh-list
44576692|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576693|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
44576694|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576695|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
44576696|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576697|NCT00943735|Fesoterodine|fesoterodine|mesh-list
44576698|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44576699|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44576700|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
44576701|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576702|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576703|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576704|NCT00943735|Urological Agents|urological agents|mesh-ancestor
44576705|NCT00943670|Trastuzumab|trastuzumab|mesh-list
44576706|NCT00943670|Pertuzumab|pertuzumab|mesh-list
44576707|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44576708|NCT00943670|Maytansine|maytansine|mesh-list
44576709|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576710|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576711|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576712|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576713|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576714|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576715|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576716|NCT00943592|Melphalan|melphalan|mesh-list
44576717|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
44576718|NCT00943592|Clofarabine|clofarabine|mesh-list
44576719|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576720|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
44576721|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576722|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576723|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576724|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576725|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
44576726|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198996|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576727|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576728|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576730|NCT00943319|Fludarabine|fludarabine|mesh-list
44576731|NCT00943319|Busulfan|busulfan|mesh-list
44576732|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
44576733|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576734|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576735|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576736|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
44576737|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576738|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
44576739|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576740|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576741|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576742|NCT00943124|Niacin|niacin|mesh-list
44576743|NCT00943124|Niacinamide|niacinamide|mesh-list
44576744|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
44576745|NCT00943124|Simvastatin|simvastatin|mesh-list
44576746|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44576747|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44576748|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
44576749|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576750|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44576751|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44576752|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576753|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576754|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
44576755|NCT00943124|Vitamins|vitamins|mesh-ancestor
44576756|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
44576757|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576758|NCT00943111|Eliglustat|eliglustat|mesh-list
44576759|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576760|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576761|NCT00943072|Aflibercept|aflibercept|mesh-list
44576762|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44576763|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44576764|NCT00943072|Growth Substances|growth substances|mesh-ancestor
44576765|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576766|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
44576767|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576768|NCT00942994|Amlodipine|amlodipine|mesh-list
44576769|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44576770|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44576771|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44576772|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44576773|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576774|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44576775|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576776|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
44576777|NCT00942994|Diuretics|diuretics|mesh-ancestor
44576778|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
44576779|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44576780|NCT00942968|Dalteparin|dalteparin|mesh-list
44576781|NCT00942968|Tinzaparin|tinzaparin|mesh-list
44576782|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44576783|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
44576784|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44576785|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44576786|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576787|NCT00942734|Everolimus|everolimus|mesh-list
44199062|NCT00392106|Amiodarone|amiodarone|mesh-list
44199118|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44576788|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44576789|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576790|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576791|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
44576792|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576793|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576794|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576795|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576796|NCT00942708|Fluoxetine|fluoxetine|mesh-list
44576797|NCT00942708|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44576798|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44576799|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44576800|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576801|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576802|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
44576803|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576804|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44576805|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
44576806|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44576807|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44576808|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44576809|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576810|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44576811|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
44576812|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576813|NCT00942422|Protective Agents|protective agents|mesh-ancestor
44576814|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576815|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44576816|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44576817|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576818|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44576819|NCT00942357|Paclitaxel|paclitaxel|mesh-list
44576820|NCT00942357|Cisplatin|cisplatin|mesh-list
44576821|NCT00942357|Carboplatin|carboplatin|mesh-list
44576822|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44576823|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44576824|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576825|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576826|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576827|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576828|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576829|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
44576830|NCT00942266|Leucovorin|leucovorin|mesh-list
44576841|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576842|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576843|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
44576844|NCT00942266|Antidotes|antidotes|mesh-ancestor
44576845|NCT00942266|Protective Agents|protective agents|mesh-ancestor
44576846|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
44576847|NCT00942266|Vitamins|vitamins|mesh-ancestor
44576848|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
44576849|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44576850|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576851|NCT00942175|Esomeprazole|esomeprazole|mesh-list
44576852|NCT00942175|Omeprazole|omeprazole|mesh-list
44576853|NCT00942175|Lansoprazole|lansoprazole|mesh-list
44576854|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
44576855|NCT00942175|Clopidogrel|clopidogrel|mesh-list
44576856|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44576857|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44576858|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44576859|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44576860|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
44576861|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44576862|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576863|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576864|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44576865|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44576866|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44576867|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576868|NCT00942084|Acyclovir|acyclovir|mesh-list
44576869|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
44576870|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576871|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
44576872|NCT00941928|Fludarabine|fludarabine|mesh-list
44576873|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
44576874|NCT00941928|Interleukin-2|interleukin-2|mesh-list
44576875|NCT00941928|Epratuzumab|epratuzumab|mesh-list
44576876|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576877|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
44576878|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576879|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576880|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576881|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
43978702|NCT01924169|Lenalidomide|lenalidomide|mesh-list
44576882|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576883|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576884|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576885|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576886|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
44576887|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44576888|NCT00941928|Analgesics|analgesics|mesh-ancestor
44576889|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
44576890|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576891|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44576892|NCT00941863|Sorafenib|sorafenib|mesh-list
44576893|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576894|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576895|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576896|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576898|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44576899|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44576900|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44576901|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
44576902|NCT00941720|Busulfan|busulfan|mesh-list
44576903|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576904|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
44576905|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576906|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576907|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576908|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
44576909|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576910|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576911|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576912|NCT00941655|Leucovorin|leucovorin|mesh-list
44576913|NCT00941655|Fluorouracil|fluorouracil|mesh-list
44576914|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
44576915|NCT00941655|Irinotecan|irinotecan|mesh-list
44576916|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
44576917|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576918|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576919|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576920|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576921|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
44576922|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576923|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44576924|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44576925|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576926|NCT00941655|Antidotes|antidotes|mesh-ancestor
44576927|NCT00941655|Protective Agents|protective agents|mesh-ancestor
44576928|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
44576929|NCT00941655|Vitamins|vitamins|mesh-ancestor
44576930|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
44576931|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
44576932|NCT00941330|Docetaxel|docetaxel|mesh-list
44576933|NCT00941330|Exemestane|exemestane|mesh-list
44576934|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199205|NCT00392717|Atorvastatin|atorvastatin|mesh-list
44576935|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
44576936|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576937|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44576938|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44576939|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
44576940|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576941|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576942|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44576943|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
44576944|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
44576945|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
44576946|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44576947|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44576948|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576949|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44576950|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44576951|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44576952|NCT00941304|Oxycodone|oxycodone|mesh-list
44576953|NCT00941304|Buprenorphine|buprenorphine|mesh-list
44576954|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44576955|NCT00941304|Narcotics|narcotics|mesh-ancestor
44576956|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44576957|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576958|NCT00941304|Analgesics|analgesics|mesh-ancestor
44576959|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
44576960|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44576961|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44576962|NCT00941070|Cisplatin|cisplatin|mesh-list
44576963|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44576964|NCT00941070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576965|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44576966|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576967|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44576968|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
44576969|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576970|NCT00940875|Gemcitabine|gemcitabine|mesh-list
44576971|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44576972|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44576973|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
44576974|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576975|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44576976|NCT00940875|Antiviral Agents|antiviral agents|mesh-ancestor
44576977|NCT00940875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576978|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576979|NCT00940875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44576980|NCT00940875|Immunologic Factors|immunologic factors|mesh-ancestor
44576981|NCT00940875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44576982|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576983|NCT00940602|Deferasirox|deferasirox|mesh-list
44576984|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44576985|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
44576986|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
44576987|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576988|NCT00940498|Gedatolisib|gedatolisib|mesh-list
44576989|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44576990|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44576991|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44576992|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44576993|NCT00940485|Entecavir|entecavir|mesh-list
44576994|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
44576995|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44576996|NCT00940342|Rituximab|rituximab|mesh-list
44576997|NCT00940342|Molgramostim|molgramostim|mesh-list
44576998|NCT00940342|Sargramostim|sargramostim|mesh-list
44576999|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577000|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577001|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
44577002|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577003|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577004|NCT00940316|Irinotecan|irinotecan|mesh-list
44577005|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44577006|NCT00940316|Panitumumab|panitumumab|mesh-list
44577007|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44577008|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44577009|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577010|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577011|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577012|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577013|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577014|NCT00940017|Voriconazole|voriconazole|mesh-list
44577015|NCT00940017|Anidulafungin|anidulafungin|mesh-list
44577016|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
44577017|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577018|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44577019|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577020|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577021|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577022|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44577023|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
44577024|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577025|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577026|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44577027|NCT00939822|Simvastatin|simvastatin|mesh-list
44577028|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44577029|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44577030|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
44577031|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577032|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44577033|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44577034|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577035|NCT00939770|Crizotinib|crizotinib|mesh-list
44577036|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577037|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577038|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577039|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577040|NCT00939692|Topiramate|topiramate|mesh-list
44577041|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
44577042|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577043|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577044|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44577045|NCT00939627|Cetuximab|cetuximab|mesh-list
44577046|NCT00939627|Sorafenib|sorafenib|mesh-list
44577047|NCT00939627|Antibodies|antibodies|mesh-list
44577048|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
44577050|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
44577051|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577052|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577053|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577054|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577055|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577056|NCT00939523|Lapatinib|lapatinib|mesh-list
44577057|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199337|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577058|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577059|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577060|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577061|NCT00939510|Lenalidomide|lenalidomide|mesh-list
44577062|NCT00939510|Sargramostim|sargramostim|mesh-list
44577063|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
44577064|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577065|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44577066|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44577067|NCT00939510|Growth Substances|growth substances|mesh-ancestor
44577068|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
44577069|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577070|NCT00939341|Budesonide|budesonide|mesh-list
44577071|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
44577072|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44577073|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577074|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577075|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
44577076|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577077|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577078|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577079|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577080|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
44577081|NCT00939341|Hormones|hormones|mesh-ancestor
44577082|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577083|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44577084|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44577085|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44577086|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577087|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577088|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577089|NCT00939185|Azithromycin|azithromycin|mesh-list
44577090|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44577091|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577093|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44577094|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
44577095|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577096|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577097|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44577098|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44577099|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
44577100|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577101|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577102|NCT00939003|Adalimumab|adalimumab|mesh-list
44577103|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577104|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577105|NCT00938964|Lidocaine|lidocaine|mesh-list
44577106|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
44577107|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
44577108|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577109|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577110|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
44577111|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577112|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44577113|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44577114|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44577115|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44577116|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577118|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44577119|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44577120|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577121|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
44577122|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577123|NCT00938860|Cyclosporine|cyclosporine|mesh-list
44577124|NCT00938860|Tacrolimus|tacrolimus|mesh-list
44577125|NCT00938860|Cyclosporins|cyclosporins|mesh-list
44577126|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577127|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
44577128|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577129|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44577130|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577131|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577132|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
44577133|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577134|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
44577135|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577136|NCT00938717|Linaclotide|linaclotide|mesh-list
44577137|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44577138|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
44577139|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577140|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577141|NCT00938470|Docetaxel|docetaxel|mesh-list
44577142|NCT00938470|Fluorouracil|fluorouracil|mesh-list
44577143|NCT00938470|Capecitabine|capecitabine|mesh-list
44577144|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
44577145|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577146|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577147|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577148|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455798|NCT01641159|Buspirone|buspirone|mesh-list
44577149|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577150|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
44577151|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44577152|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577153|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
44577154|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577155|NCT00938431|Lacosamide|lacosamide|mesh-list
44577156|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
44577157|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44577158|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44577159|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44577160|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577161|NCT00938392|Vaccines|vaccines|mesh-list
44577162|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
44577163|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577164|NCT00938366|Cladribine|cladribine|mesh-list
44577165|NCT00938366|Pantoprazole|pantoprazole|mesh-list
44577166|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44403839|NCT02643355|Clonidine|clonidine|mesh-list
44577167|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577168|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44577169|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577170|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577171|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577172|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577173|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
44577174|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577175|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
44577176|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577177|NCT00937768|Leuprolide|leuprolide|mesh-list
44577178|NCT00937768|Goserelin|goserelin|mesh-list
44577179|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44577180|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
44577181|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44577182|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577184|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577185|NCT00937560|Paclitaxel|paclitaxel|mesh-list
44577186|NCT00937560|Bevacizumab|bevacizumab|mesh-list
44577187|NCT00937560|Carboplatin|carboplatin|mesh-list
44577188|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577189|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577190|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577191|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577192|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577193|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577194|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577195|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44577196|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44577197|NCT00937560|Growth Substances|growth substances|mesh-ancestor
44577198|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577199|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
44577200|NCT00937521|Antipyretics|antipyretics|mesh-list
44577201|NCT00937521|Vaccines|vaccines|mesh-list
44577202|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
44577203|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577204|NCT00937495|Bortezomib|bortezomib|mesh-list
44577205|NCT00937495|Vorinostat|vorinostat|mesh-list
44577206|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577207|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44577208|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577209|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577210|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
44577211|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
44577212|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44577213|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
44577214|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577215|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577216|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577217|NCT00936975|Listerine|listerine|mesh-list
44577218|NCT00936975|Fluorides|fluorides|mesh-list
44577219|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
44577220|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
44577221|NCT00936975|Protective Agents|protective agents|mesh-ancestor
44577222|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577223|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44577224|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577225|NCT00936910|Amphotericin B|amphotericin b|mesh-list
44577226|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44577227|NCT00936910|Amebicides|amebicides|mesh-ancestor
44577228|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44577229|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44577230|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577231|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44577232|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
44577233|NCT00936897|Denosumab|denosumab|mesh-list
44577234|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
44577235|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44577236|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577237|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
44577238|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44577239|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577240|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
44577241|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577242|NCT00936858|Everolimus|everolimus|mesh-list
44577243|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577244|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577245|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
44577246|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577247|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44577248|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44577249|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577250|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577251|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577252|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
44577253|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577254|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44577255|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44577257|NCT00936702|Carboplatin|carboplatin|mesh-list
44577258|NCT00936702|Everolimus|everolimus|mesh-list
44577259|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577260|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577261|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577262|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577263|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577264|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577265|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577266|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
44577267|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577268|NCT00936611|Panobinostat|panobinostat|mesh-list
44577269|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577270|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44577271|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577272|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577273|NCT00936598|Zolpidem|zolpidem|mesh-list
44577274|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44577275|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44577276|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577277|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577278|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44577279|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
44577280|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
44577281|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577282|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577283|NCT00936221|Dacarbazine|dacarbazine|mesh-list
44577284|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44577285|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
44577286|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577287|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577288|NCT00936117|Posaconazole|posaconazole|mesh-list
44577289|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
44577290|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577291|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44577292|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44577293|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44577294|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44577295|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577296|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577297|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577298|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44577299|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
44577300|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577301|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577302|NCT00936065|Etanercept|etanercept|mesh-list
44577303|NCT00936065|Acitretin|acitretin|mesh-list
44577304|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44577305|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44577306|NCT00936065|Analgesics|analgesics|mesh-ancestor
44577307|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
44577308|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577309|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577310|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577311|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577312|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577313|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577314|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
44577315|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
44577316|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
44577317|NCT00935883|Eculizumab|eculizumab|mesh-list
44577326|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44577327|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44577328|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44577329|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44577330|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577331|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
44199581|NCT00394966|Rolapitant|rolapitant|mesh-list
44577332|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577333|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577334|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44577335|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577336|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577337|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44577338|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44577339|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
44577340|NCT00935532|Insulin|insulin|mesh-list
44577341|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44577342|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
44577343|NCT00935532|Exenatide|exenatide|mesh-list
44577344|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577345|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577346|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44577347|NCT00935532|Incretins|incretins|mesh-ancestor
44577348|NCT00935532|Hormones|hormones|mesh-ancestor
44577349|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577350|NCT00935493|Guanfacine|guanfacine|mesh-list
44577351|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44577352|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44577353|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44577354|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44577355|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577356|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577357|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577358|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577359|NCT00935259|Simvastatin|simvastatin|mesh-list
44577360|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44577361|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44577362|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
44577363|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577364|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44577365|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44577366|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577367|NCT00935220|Linagliptin|linagliptin|mesh-list
44577368|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577369|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577370|NCT00935220|Incretins|incretins|mesh-ancestor
44577371|NCT00935220|Hormones|hormones|mesh-ancestor
44577372|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577373|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44577374|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577375|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577376|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577377|NCT00934947|Propranolol|propranolol|mesh-list
44577378|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44199617|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
44577379|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44577380|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577381|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577382|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577383|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577384|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44577385|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44577386|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
44577387|NCT00934856|Docetaxel|docetaxel|mesh-list
44577388|NCT00934856|Trastuzumab|trastuzumab|mesh-list
44577389|NCT00934856|Pertuzumab|pertuzumab|mesh-list
44577390|NCT00934856|Maytansine|maytansine|mesh-list
44577391|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44577392|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577393|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577394|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577395|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577396|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577397|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577398|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577399|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
44577400|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44577401|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44577402|NCT00934843|Prednisolone|prednisolone|mesh-list
44577403|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
44577404|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44577405|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
44577406|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
44577407|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577408|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
44577409|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
44577410|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577411|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577412|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577413|NCT00934843|Hormones|hormones|mesh-ancestor
44577414|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577415|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44577416|NCT00934843|Protective Agents|protective agents|mesh-ancestor
44577417|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577418|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577419|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
44577420|NCT00934791|Sirolimus|sirolimus|mesh-list
44577421|NCT00934791|Prednisone|prednisone|mesh-list
44577422|NCT00934791|Tacrolimus|tacrolimus|mesh-list
44577423|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577424|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
44577425|NCT00934791|Hormones|hormones|mesh-ancestor
44577426|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577427|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577428|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577429|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577430|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577431|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
44577432|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44577433|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577434|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577435|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44577436|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44577437|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
44577438|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44577439|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577440|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
44577441|NCT00934700|Xenon|xenon|mesh-list
44577442|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44577443|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
44577444|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
44577445|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577446|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577447|NCT00934661|Morphine|morphine|mesh-list
44577448|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44577449|NCT00934661|Narcotics|narcotics|mesh-ancestor
44577450|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577451|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577452|NCT00934661|Analgesics|analgesics|mesh-ancestor
44577453|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
44577454|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577455|NCT00934648|Rituximab|rituximab|mesh-list
44577456|NCT00934648|Methotrexate|methotrexate|mesh-list
44577457|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577458|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577459|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
44577460|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577461|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577462|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44577463|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
44577464|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44577465|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44577466|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
44577467|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577468|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
44577469|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577470|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44577471|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577472|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577473|NCT00934440|Bevacizumab|bevacizumab|mesh-list
44577474|NCT00934440|Azacitidine|azacitidine|mesh-list
44577475|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577476|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577477|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44577478|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44577479|NCT00934440|Growth Substances|growth substances|mesh-ancestor
44577480|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577481|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
44577482|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44577483|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
44577484|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577485|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577486|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44577487|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577488|NCT00934089|Latanoprost|latanoprost|mesh-list
44577489|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44577490|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44577491|NCT00934050|Inositol|inositol|mesh-list
44577492|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
44577493|NCT00934050|Vitamins|vitamins|mesh-ancestor
44577494|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
44577495|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577496|NCT00933608|Memantine|memantine|mesh-list
44577497|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44577498|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44577499|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
44577500|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577501|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577502|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577503|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44577504|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44577505|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
44577506|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577507|NCT00933244|Vitamin D|vitamin d|mesh-list
44577508|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
44577509|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
44577510|NCT00933244|Vitamins|vitamins|mesh-list
44577511|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
44577512|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577513|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44577514|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44577515|NCT00932893|Docetaxel|docetaxel|mesh-list
44577516|NCT00932893|Pemetrexed|pemetrexed|mesh-list
44577517|NCT00932893|Crizotinib|crizotinib|mesh-list
44577518|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577519|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577520|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577521|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577522|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577523|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577524|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44577525|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577526|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577527|NCT00932698|Ixazomib|ixazomib|mesh-list
44577528|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577529|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577530|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577531|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577532|NCT00932646|Olodaterol|olodaterol|mesh-list
44577533|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
44577534|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577535|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
44577536|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577537|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577538|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577539|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577540|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44577541|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44577542|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44577543|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577544|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577545|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577546|NCT00932451|Crizotinib|crizotinib|mesh-list
44577547|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577548|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44577549|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577550|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577551|NCT00932373|Trastuzumab|trastuzumab|mesh-list
44577552|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44577553|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577554|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577555|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577556|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577557|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577558|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577560|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577561|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44577562|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44577563|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577564|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577565|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44577566|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
44577567|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577568|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577569|NCT00932113|Folic Acid|folic acid|mesh-list
44577570|NCT00932113|Adalimumab|adalimumab|mesh-list
44577571|NCT00932113|Methotrexate|methotrexate|mesh-list
44577572|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44577573|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
44577574|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44577575|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577576|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44577577|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
44577578|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577579|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577580|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
44577581|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577582|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44577583|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577584|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
44577585|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577586|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577587|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577588|NCT00932113|Hematinics|hematinics|mesh-ancestor
44577589|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
44577590|NCT00932113|Vitamins|vitamins|mesh-ancestor
44577591|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
44577592|NCT00931944|Pramipexole|pramipexole|mesh-list
44577593|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
44577594|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577595|NCT00931944|Protective Agents|protective agents|mesh-ancestor
44577596|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577597|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44577598|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44577599|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
44577600|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
44577601|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577602|NCT00931918|Prednisone|prednisone|mesh-list
44577603|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
44577604|NCT00931918|Rituximab|rituximab|mesh-list
44577605|NCT00931918|Doxorubicin|doxorubicin|mesh-list
44577606|NCT00931918|Vincristine|vincristine|mesh-list
44577607|NCT00931918|Bortezomib|bortezomib|mesh-list
44577608|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577609|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
44577610|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577611|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577612|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44577613|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
44577614|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577615|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577616|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44577617|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577618|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44577619|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44577620|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44577621|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577622|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577623|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
44577624|NCT00931918|Hormones|hormones|mesh-ancestor
44577625|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577626|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577627|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577628|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577629|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577630|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577631|NCT00931801|Tenofovir|tenofovir|mesh-list
44577632|NCT00931801|Emtricitabine|emtricitabine|mesh-list
44577633|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
44577634|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44577635|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
44199851|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44577636|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577637|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44577638|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577639|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577640|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577641|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44577642|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44577643|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44577644|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44577645|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44577646|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44577647|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577648|NCT00931762|Panobinostat|panobinostat|mesh-list
44577649|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577650|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44577651|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577652|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577653|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44577654|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
44577655|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44577656|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44577657|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44577658|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577659|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577660|NCT00931710|Losartan|losartan|mesh-list
44577661|NCT00931710|Amlodipine|amlodipine|mesh-list
44577662|NCT00931710|Valsartan|valsartan|mesh-list
44577663|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44577664|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44577665|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44577666|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44577667|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577668|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44577669|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577670|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
44577671|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44577672|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44577673|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44577674|NCT00931710|Diuretics|diuretics|mesh-ancestor
44577675|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
44577676|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44577677|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
44577678|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577679|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
44577680|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577681|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577682|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577683|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577684|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44577685|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
44577686|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577687|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199906|NCT00396526|Amoxicillin|amoxicillin|mesh-list
44577688|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44577689|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
44577690|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
44577691|NCT00931632|Protective Agents|protective agents|mesh-ancestor
44577692|NCT00931528|Tadalafil|tadalafil|mesh-list
44577693|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
44577694|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44577695|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44577696|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577697|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577698|NCT00931528|Urological Agents|urological agents|mesh-ancestor
44577699|NCT00931463|Ritonavir|ritonavir|mesh-list
44577700|NCT00931463|Lopinavir|lopinavir|mesh-list
44577701|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
44577702|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44577703|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44577704|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577705|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577706|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577707|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44577708|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44577709|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
44577710|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577711|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44577712|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577713|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44577714|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44404438|NCT02626520|Antiviral Agents|antiviral agents|mesh-ancestor
44577750|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577751|NCT00930930|Paclitaxel|paclitaxel|mesh-list
44577753|NCT00930930|Everolimus|everolimus|mesh-list
44577754|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577755|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577756|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577757|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577758|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577759|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577760|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577761|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
44577762|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577764|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44577765|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577766|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577767|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577768|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44577769|NCT00930644|Teduglutide|teduglutide|mesh-list
44577770|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577771|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44577772|NCT00930644|Protective Agents|protective agents|mesh-ancestor
44577773|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577774|NCT00930579|Metformin|metformin|mesh-list
44577775|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577776|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577777|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
44577778|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577779|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577780|NCT00930046|Ropivacaine|ropivacaine|mesh-list
44577781|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
44577782|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
44577783|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44577784|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577785|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
44577786|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577787|NCT00929864|Adalimumab|adalimumab|mesh-list
44577788|NCT00929864|Abatacept|abatacept|mesh-list
44577789|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577790|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44577791|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44577792|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577793|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577794|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44577795|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
44577796|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577797|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44577798|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44577799|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44577800|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44577801|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
44577802|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577803|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44577804|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577805|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
44577806|NCT00929708|AZD-3199|azd-3199|mesh-list
44577807|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577808|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
44577809|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577810|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577811|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577812|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577813|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44577814|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44577815|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44577816|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44577817|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200003|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
44577818|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577819|NCT00929695|Prednisone|prednisone|mesh-list
44577820|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
44577821|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44577822|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44577823|NCT00929695|Prednisolone|prednisolone|mesh-list
44577824|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
44577825|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44404560|NCT02622074|Paclitaxel|paclitaxel|mesh-list
44577826|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
44577827|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236637|NCT00560222|Lactoferrin|lactoferrin|mesh-list
44577828|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
44577829|NCT00929695|Hormones|hormones|mesh-ancestor
44577830|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577831|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577832|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577833|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577834|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
44577835|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
44577836|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577837|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577838|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44577839|NCT00929695|Protective Agents|protective agents|mesh-ancestor
44577840|NCT00929669|Pasireotide|pasireotide|mesh-list
44577841|NCT00929669|Hormones|hormones|mesh-ancestor
44577842|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577843|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577844|NCT00929240|Bevacizumab|bevacizumab|mesh-list
44577845|NCT00929240|Capecitabine|capecitabine|mesh-list
44577846|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44577847|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577848|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44577849|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44577850|NCT00929240|Growth Substances|growth substances|mesh-ancestor
44577851|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577852|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
44577853|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44577854|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
44577855|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577856|NCT00929201|Metformin|metformin|mesh-list
44577857|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44577858|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577859|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577860|NCT00929201|Incretins|incretins|mesh-ancestor
44577861|NCT00929201|Hormones|hormones|mesh-ancestor
44200052|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577862|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577863|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44577864|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577865|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577866|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577867|NCT00929162|Paclitaxel|paclitaxel|mesh-list
44577868|NCT00929162|Carboplatin|carboplatin|mesh-list
44577869|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44577870|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577871|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
44577872|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
44577873|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
44577874|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577875|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
44577876|NCT00929110|Bromides|bromides|mesh-list
44577877|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
44577878|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577879|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
44577880|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577881|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577882|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577883|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577884|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
44577885|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44577886|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
44577887|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577888|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577889|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
44577890|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44577891|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44577892|NCT00928889|Acarbose|acarbose|mesh-list
44577893|NCT00928889|Nateglinide|nateglinide|mesh-list
44577894|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44577895|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577896|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577897|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44577898|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577899|NCT00928746|Bromides|bromides|mesh-list
44404632|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
44577900|NCT00928746|Ipratropium|ipratropium|mesh-list
44577901|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
44577902|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577904|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577905|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577906|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577907|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577908|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44577909|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
44577910|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577911|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577912|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
44577913|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44577914|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577915|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
44577916|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577917|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577918|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577919|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44577920|NCT00928668|Olodaterol|olodaterol|mesh-list
44577921|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44577922|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
44577923|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577924|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577925|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44577926|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
44577927|NCT00928486|Dexamethasone|dexamethasone|mesh-list
44577928|NCT00928486|Lenalidomide|lenalidomide|mesh-list
44577929|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44577930|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
44577931|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
44577932|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44577933|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577934|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44577935|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
44577936|NCT00928486|Hormones|hormones|mesh-ancestor
44577937|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577938|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577939|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577940|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
44577941|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44577942|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44577943|NCT00928486|Growth Substances|growth substances|mesh-ancestor
44577944|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
44577945|NCT00928434|Leuprolide|leuprolide|mesh-list
44577946|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44577947|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
44577948|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44577949|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577950|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44577951|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44577952|NCT00928408|Cinacalcet|cinacalcet|mesh-list
44577953|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44577954|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577955|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44577956|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
44577957|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44577958|NCT00928252|Fluorides|fluorides|mesh-list
44577959|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
44577960|NCT00928252|Protective Agents|protective agents|mesh-ancestor
44577961|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577962|NCT00928187|Ritonavir|ritonavir|mesh-list
44577963|NCT00928187|Lopinavir|lopinavir|mesh-list
44577964|NCT00928187|Darunavir|darunavir|mesh-list
44577965|NCT00928187|Tenofovir|tenofovir|mesh-list
44577966|NCT00928187|Emtricitabine|emtricitabine|mesh-list
44577967|NCT00928187|Abacavir|abacavir|mesh-list
44577968|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44577969|NCT00928187|Didanosine|didanosine|mesh-list
44577970|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44200157|NCT00397501|Antidotes|antidotes|mesh-ancestor
44577971|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44577972|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
44577973|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44577974|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577975|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44577976|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44577977|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
44577978|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44577979|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44577980|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44577981|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44577982|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44577983|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
44577984|NCT00928070|Fesoterodine|fesoterodine|mesh-list
44577985|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44577986|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44577987|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
44577988|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44577989|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44577990|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44577991|NCT00928070|Urological Agents|urological agents|mesh-ancestor
44577992|NCT00928018|Cyclosporine|cyclosporine|mesh-list
44577993|NCT00928018|Sirolimus|sirolimus|mesh-list
44577994|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
44577995|NCT00928018|Methotrexate|methotrexate|mesh-list
44577996|NCT00928018|Tacrolimus|tacrolimus|mesh-list
44577997|NCT00928018|Cyclosporins|cyclosporins|mesh-list
44577998|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44577999|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
44578000|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44578001|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578002|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578003|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
44578004|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578005|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578006|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
44578007|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578008|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44578009|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578010|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
44578011|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578012|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44578013|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44578014|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
44578015|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578016|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44578017|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44578018|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
44578019|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578020|NCT00927901|Maleic acid|maleic acid|mesh-list
44578021|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578022|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578023|NCT00927862|Warfarin|warfarin|mesh-list
44578024|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
44578025|NCT00927758|Fluticasone|fluticasone|mesh-list
44578026|NCT00927758|Xhance|xhance|mesh-list
44578027|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44578028|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44578029|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578030|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44578031|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
44578032|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578033|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578034|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44578035|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
44578036|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
44578037|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44578038|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44578039|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44578040|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44578041|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44578042|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578043|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578044|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
44578045|NCT00927758|Hormones|hormones|mesh-ancestor
44578046|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578047|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
44578048|NCT00927589|Carboplatin|carboplatin|mesh-list
44578049|NCT00927589|Docetaxel|docetaxel|mesh-list
44578050|NCT00927589|Trastuzumab|trastuzumab|mesh-list
44404784|NCT02613572|Vitamins|vitamins|mesh-ancestor
44578051|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578052|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44578053|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44578054|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44578055|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578056|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578057|NCT00927563|Tolcapone|tolcapone|mesh-list
44578058|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44578059|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44578060|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44578061|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578062|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578063|NCT00927485|Curcumin|curcumin|mesh-list
44578064|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44578065|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44578066|NCT00927485|Analgesics|analgesics|mesh-ancestor
44578067|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
44578068|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578069|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578070|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578071|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578072|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578073|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578074|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578075|NCT00927472|Permethrin|permethrin|mesh-list
44578076|NCT00927472|Malathion|malathion|mesh-list
44578077|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578078|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578079|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44578080|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
44578081|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578082|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578083|NCT00927394|Valsartan|valsartan|mesh-list
44578084|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578085|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44578086|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44578087|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578088|NCT00927355|Pioglitazone|pioglitazone|mesh-list
44578089|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578090|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578091|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
44578092|NCT00927186|Teriparatide|teriparatide|mesh-list
44578093|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578094|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578095|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578096|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44578097|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44578098|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578099|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44578100|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
44578101|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578102|NCT00927069|Adalimumab|adalimumab|mesh-list
44578103|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578104|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578105|NCT00926796|Azithromycin|azithromycin|mesh-list
44578106|NCT00926796|Gentamicins|gentamicins|mesh-list
44578107|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
44578108|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578109|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578110|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44578111|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578112|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578113|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44578114|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44578115|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578116|NCT00926575|Beclomethasone|beclomethasone|mesh-list
44578117|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578118|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
44578119|NCT00926575|Hormones|hormones|mesh-ancestor
44578120|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578121|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578122|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44578123|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44404895|NCT02610816|Xhance|xhance|mesh-list
44578139|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578140|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578141|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
44578142|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44578143|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44578144|NCT00926367|Analgesics|analgesics|mesh-ancestor
44578145|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
44578146|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578147|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578148|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578149|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578151|NCT00926328|Fluorides|fluorides|mesh-list
44578152|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
44578153|NCT00926328|Protective Agents|protective agents|mesh-ancestor
44578154|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578155|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44578156|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578157|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44578158|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44578159|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
44578160|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578161|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44578162|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44578163|NCT00926289|Telmisartan|telmisartan|mesh-list
44578164|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578165|NCT00926289|Diuretics|diuretics|mesh-ancestor
44578166|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
44578167|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578168|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44200341|NCT00398424|Cisplatin|cisplatin|mesh-list
44578169|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578170|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578171|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44578172|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44578173|NCT00926029|Listerine|listerine|mesh-list
44578174|NCT00926029|Triclosan|triclosan|mesh-list
44578175|NCT00926029|Fluorides|fluorides|mesh-list
44578176|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
44578177|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
44578178|NCT00926029|Protective Agents|protective agents|mesh-ancestor
44578179|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578180|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44578181|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578182|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44578183|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44578184|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
44578185|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578186|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44578188|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
44578189|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578190|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
44578191|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578192|NCT00925899|Melatonin|melatonin|mesh-list
44578193|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
44578194|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578195|NCT00925899|Protective Agents|protective agents|mesh-ancestor
44578196|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578197|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578198|NCT00925769|Bevacizumab|bevacizumab|mesh-list
44578199|NCT00925769|Capecitabine|capecitabine|mesh-list
44578200|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44578201|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578202|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578203|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44578204|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44578205|NCT00925769|Growth Substances|growth substances|mesh-ancestor
44578206|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578207|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
44578208|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578209|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
44578210|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578211|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578212|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578213|NCT00925704|Calcitriol|calcitriol|mesh-list
44578214|NCT00925704|Sevelamer|sevelamer|mesh-list
44200385|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578215|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578216|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578217|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44578218|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578219|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578220|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44578221|NCT00925704|Vitamins|vitamins|mesh-ancestor
44578222|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
44578223|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578224|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
44578225|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
44578226|NCT00925600|Denosumab|denosumab|mesh-list
44578227|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578228|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578229|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
44578230|NCT00925587|Hematinics|hematinics|mesh-ancestor
44578231|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
44578232|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578233|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
44578234|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578235|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578236|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578237|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
44578238|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578239|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578240|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578241|NCT00925353|Lidocaine|lidocaine|mesh-list
44578242|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
44578243|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
44578244|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578245|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578246|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
44578247|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578248|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44578249|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44578250|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44578251|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578252|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578253|NCT00925288|Vaccines|vaccines|mesh-list
44578254|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
44578255|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578256|NCT00925132|Temozolomide|temozolomide|mesh-list
44578257|NCT00925132|Decitabine|decitabine|mesh-list
44578258|NCT00925132|Panobinostat|panobinostat|mesh-list
44578259|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578260|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
44578261|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578262|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578263|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578264|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
44578265|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578266|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44578267|NCT00925015|Irinotecan|irinotecan|mesh-list
44578268|NCT00925015|Cetuximab|cetuximab|mesh-list
44578269|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44578270|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44578271|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44578272|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578273|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578274|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578275|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578276|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
44578277|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578278|NCT00924950|Calcitriol|calcitriol|mesh-list
44578279|NCT00924950|Betamethasone|betamethasone|mesh-list
44578280|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578281|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
44578282|NCT00924950|Hormones|hormones|mesh-ancestor
44578283|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578284|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578285|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44578286|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44578287|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578288|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44578289|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578290|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578291|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44578293|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
44578294|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578295|NCT00924898|Tenofovir|tenofovir|mesh-list
44578296|NCT00924898|Emtricitabine|emtricitabine|mesh-list
44578297|NCT00924898|Efavirenz|efavirenz|mesh-list
44578298|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
44578299|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578300|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44578301|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44578302|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578303|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578304|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44578305|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44578306|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44578307|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44578308|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44578309|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44578310|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44578311|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44578312|NCT00924820|Bevacizumab|bevacizumab|mesh-list
44578313|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578314|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578315|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44578316|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200479|NCT00398658|Gentamicins|gentamicins|mesh-list
44578317|NCT00924820|Growth Substances|growth substances|mesh-ancestor
44578318|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578319|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44578320|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
44578321|NCT00924781|Hematinics|hematinics|mesh-ancestor
44578322|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
44578323|NCT00924729|Besifloxacin|besifloxacin|mesh-list
44578324|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44578325|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44578326|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578327|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578328|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44578329|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44578330|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578331|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578332|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578334|NCT00924664|Analgesics|analgesics|mesh-ancestor
44578335|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
44578336|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578337|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578338|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44578339|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44578340|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
44578341|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44578342|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
44578343|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
44578344|NCT00924560|Estradiol|estradiol|mesh-list
44578345|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44578346|NCT00924560|Estrogens|estrogens|mesh-ancestor
44578347|NCT00924560|Hormones|hormones|mesh-ancestor
44578348|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578349|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578350|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44578351|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44578352|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44578353|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44578354|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44578355|NCT00924508|Triamcinolone|triamcinolone|mesh-list
44578356|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44578357|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44578358|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44578359|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578360|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
44578361|NCT00924508|Hormones|hormones|mesh-ancestor
44578362|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578363|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578364|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578365|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
44578366|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578367|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578368|NCT00924469|Prednisone|prednisone|mesh-list
44578369|NCT00924469|Leuprolide|leuprolide|mesh-list
44578370|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578371|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
44578372|NCT00924469|Hormones|hormones|mesh-ancestor
44578373|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578374|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200538|NCT00398853|Chromium|chromium|mesh-list
44578375|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44578376|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578377|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44578378|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
44578379|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44578380|NCT00924443|Clofarabine|clofarabine|mesh-list
44578381|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578382|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
44578383|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578384|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578385|NCT00924287|Aldesleukin|aldesleukin|mesh-list
44578386|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
44578387|NCT00924287|Fludarabine|fludarabine|mesh-list
44578388|NCT00924287|Interleukin-2|interleukin-2|mesh-list
44578390|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578391|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
44578392|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578393|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578394|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578395|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
44578396|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578397|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578398|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578399|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44578400|NCT00924287|Analgesics|analgesics|mesh-ancestor
44578401|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
44578402|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578403|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44578404|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44578405|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
44578406|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578407|NCT00924287|Protective Agents|protective agents|mesh-ancestor
44578408|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
44578409|NCT00924170|Fludarabine|fludarabine|mesh-list
44578410|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578411|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
44578412|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578413|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578414|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578415|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
44200591|NCT00399048|Oxycodone|oxycodone|mesh-list
44578416|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578417|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578418|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578419|NCT00923936|Bevacizumab|bevacizumab|mesh-list
44578420|NCT00923936|Doxorubicin|doxorubicin|mesh-list
44578421|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44578422|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578423|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578424|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44578425|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44578426|NCT00923936|Growth Substances|growth substances|mesh-ancestor
44578427|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578428|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44578429|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44578430|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44578431|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44578432|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578433|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578434|NCT00923845|Sirolimus|sirolimus|mesh-list
44578435|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
44578436|NCT00923845|Pentostatin|pentostatin|mesh-list
44578437|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578438|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
43700442|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
44578439|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578440|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578441|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578442|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
44578443|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578444|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578445|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578446|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578447|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578448|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44578449|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
44578450|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44578451|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578452|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
44578454|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
44578455|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44578456|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578457|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
44578458|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578459|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578460|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578461|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
44578462|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578463|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578464|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578465|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578466|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
44578467|NCT00923351|Vaccines|vaccines|mesh-list
44578468|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
44578469|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578470|NCT00923273|Folic Acid|folic acid|mesh-list
44578471|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
44578472|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
44578473|NCT00923273|Sirolimus|sirolimus|mesh-list
44578474|NCT00923273|Dexamethasone|dexamethasone|mesh-list
44578475|NCT00923273|Pemetrexed|pemetrexed|mesh-list
44578476|NCT00923273|Vitamins|vitamins|mesh-ancestor
44578477|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
44578478|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578479|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578480|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
44578481|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
44578482|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578483|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44578484|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
44578485|NCT00923273|Hormones|hormones|mesh-ancestor
44578486|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578487|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44578488|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578489|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578490|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578491|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44578492|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44578493|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578494|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578495|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44578496|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
44578497|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578498|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
44578499|NCT00923273|Hematinics|hematinics|mesh-ancestor
44578500|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
44578501|NCT00923195|Aldesleukin|aldesleukin|mesh-list
44578502|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
44578503|NCT00923195|Fludarabine|fludarabine|mesh-list
44578504|NCT00923195|Interleukin-2|interleukin-2|mesh-list
44578505|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44578506|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578507|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
44578508|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578509|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578510|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578511|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
44578512|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578513|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578514|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578515|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44578517|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
44578518|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578519|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44578520|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44578521|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
44578522|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578523|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44578524|NCT00923156|Ramipril|ramipril|mesh-list
44578525|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44578526|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
44578527|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578528|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578529|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578530|NCT00923130|Bevacizumab|bevacizumab|mesh-list
44578531|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44578532|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578533|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44578534|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44578535|NCT00923130|Growth Substances|growth substances|mesh-ancestor
44578536|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578537|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44578538|NCT00923091|Amlodipine|amlodipine|mesh-list
44578539|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44578540|NCT00923091|Olmesartan|olmesartan|mesh-list
44578541|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44578542|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
44578543|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578544|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44578545|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578546|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578547|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578548|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578549|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
44578550|NCT00923091|Diuretics|diuretics|mesh-ancestor
44578551|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
44578552|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44578553|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44578554|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44578555|NCT00922987|Pregabalin|pregabalin|mesh-list
44578556|NCT00922987|Analgesics|analgesics|mesh-ancestor
44578557|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
44578558|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578559|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578560|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
44578561|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44578562|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578563|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578564|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578565|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44578566|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44578567|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578568|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44578569|NCT00922779|Ribavirin|ribavirin|mesh-list
44578570|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44578571|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
44578572|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578573|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
44578574|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578575|NCT00922766|Dalteparin|dalteparin|mesh-list
44578576|NCT00922766|Tinzaparin|tinzaparin|mesh-list
44578577|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44578578|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
44578579|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44578580|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44578581|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578582|NCT00922636|Methylphenidate|methylphenidate|mesh-list
44578583|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44578584|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578585|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44578586|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44578587|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578588|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578589|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
44578590|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578591|NCT00922480|Losartan|losartan|mesh-list
44578592|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44200777|NCT00399659|Tegaserod|tegaserod|mesh-list
44578593|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578594|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44578595|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44578596|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578597|NCT00922441|Valsartan|valsartan|mesh-list
44578598|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578599|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44578600|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44578601|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578602|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44578603|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44578604|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578605|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44578606|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44578607|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578608|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578609|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
44578610|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578611|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44578612|NCT00922207|Entecavir|entecavir|mesh-list
44578613|NCT00922207|Adefovir|adefovir|mesh-list
44578614|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
44578615|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578616|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44578617|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44578618|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578619|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578620|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
44578621|NCT00922116|Hematinics|hematinics|mesh-ancestor
44578622|NCT00921557|Vitamin D|vitamin d|mesh-list
44578623|NCT00921557|Alendronate|alendronate|mesh-list
44578624|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
44578625|NCT00921557|Calcium|calcium|mesh-list
44578626|NCT00921557|Vitamins|vitamins|mesh-ancestor
44578627|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
44578628|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578629|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578630|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578631|NCT00921557|Antacids|antacids|mesh-ancestor
44578632|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578633|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44578634|NCT00921024|Ceftazidime|ceftazidime|mesh-list
44578635|NCT00921024|Ceftolozane|ceftolozane|mesh-list
44578636|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578637|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578666|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578667|NCT00920699|Vitamins|vitamins|mesh-ancestor
44578668|NCT00920686|Sumatriptan|sumatriptan|mesh-list
44578669|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44578670|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44578671|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44578672|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
44578673|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578674|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578675|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578676|NCT00920556|Bortezomib|bortezomib|mesh-list
44578677|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578678|NCT00920426|Cabotegravir|cabotegravir|mesh-list
44578679|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44578680|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44578681|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405525|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578682|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578683|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44578684|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44578685|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
44578686|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578687|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44578688|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
44578689|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578690|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44578691|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44578692|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
44578693|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578694|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578695|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44578696|NCT00920218|Vaccines|vaccines|mesh-list
44578697|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
44578698|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578699|NCT00920140|Trametinib|trametinib|mesh-list
44578700|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578701|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578702|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578703|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578704|NCT00919867|Guanfacine|guanfacine|mesh-list
44578705|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44578706|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44578707|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578708|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44578709|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44578710|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578711|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578712|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
44578713|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578714|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578715|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44578716|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44578717|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44578718|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
44578719|NCT00919854|Ritonavir|ritonavir|mesh-list
44578720|NCT00919854|Darunavir|darunavir|mesh-list
44578721|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44578722|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44578723|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
44578724|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578725|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578726|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44578727|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44578728|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
44578729|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578730|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44578731|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44578732|NCT00919711|Denosumab|denosumab|mesh-list
44578733|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
44578734|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44578735|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578736|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44578737|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578738|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578739|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578740|NCT00919633|Interferons|interferons|mesh-list
44578741|NCT00919633|Ribavirin|ribavirin|mesh-list
44578742|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
44578743|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
44578744|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44578745|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578746|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578747|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
44578748|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578749|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
44578750|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578751|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
44578752|NCT00919061|Gemcitabine|gemcitabine|mesh-list
44578753|NCT00919061|Cisplatin|cisplatin|mesh-list
44578754|NCT00919061|Sorafenib|sorafenib|mesh-list
44405570|NCT02592798|Abatacept|abatacept|mesh-list
44578755|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578756|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578757|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
44578758|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578759|NCT00919061|Antiviral Agents|antiviral agents|mesh-ancestor
44578760|NCT00919061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578761|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578762|NCT00919061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578763|NCT00919061|Immunologic Factors|immunologic factors|mesh-ancestor
44578764|NCT00919061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578765|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578766|NCT00918957|Tobramycin|tobramycin|mesh-list
44578767|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578768|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578769|NCT00918879|Saxagliptin|saxagliptin|mesh-list
44578770|NCT00918879|Incretins|incretins|mesh-ancestor
44578771|NCT00918879|Hormones|hormones|mesh-ancestor
44578772|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578773|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578774|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44578775|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
44578776|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578777|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578778|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578779|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
44578780|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44578781|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
44578782|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578783|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
44578784|NCT00918736|Protective Agents|protective agents|mesh-ancestor
44578785|NCT00918684|Citalopram|citalopram|mesh-list
44578786|NCT00918684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44578787|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44578788|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578789|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578790|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578791|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
44578792|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578793|NCT00918684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44578794|NCT00918684|Antidepressive Agents|antidepressive agents|mesh-ancestor
44578795|NCT00918684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44578796|NCT00918645|Calcium|calcium|mesh-list
44578797|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578798|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578799|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44578800|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44578801|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44578802|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578803|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578804|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44200907|NCT00400231|Metformin|metformin|mesh-list
44578805|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578806|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578807|NCT00918463|Dasatinib|dasatinib|mesh-list
44578808|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578809|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578810|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578811|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578812|NCT00918385|Dasatinib|dasatinib|mesh-list
44578813|NCT00918385|Nilutamide|nilutamide|mesh-list
44578814|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578815|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578816|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578817|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578818|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
44578819|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
44578820|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578821|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578822|NCT00918333|Everolimus|everolimus|mesh-list
44578823|NCT00918333|Panobinostat|panobinostat|mesh-list
44578824|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44578825|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578826|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578827|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
44578828|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578829|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578830|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578831|NCT00918255|Adalimumab|adalimumab|mesh-list
44578832|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578833|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44578834|NCT00918203|Paclitaxel|paclitaxel|mesh-list
44578835|NCT00918203|Carboplatin|carboplatin|mesh-list
44578836|NCT00918203|Olaratumab|olaratumab|mesh-list
44578837|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44578838|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578839|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44578840|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
44578841|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
44578842|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578843|NCT00918138|Metformin|metformin|mesh-list
44578844|NCT00918138|Saxagliptin|saxagliptin|mesh-list
44578845|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578846|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578847|NCT00918138|Incretins|incretins|mesh-ancestor
44578848|NCT00918138|Hormones|hormones|mesh-ancestor
44578849|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578850|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44578851|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
44578852|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578853|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578854|NCT00917644|Atorvastatin|atorvastatin|mesh-list
44578855|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44578856|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44578857|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
44578858|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578859|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44578860|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44578861|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578862|NCT00917579|Atorvastatin|atorvastatin|mesh-list
44578863|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44578864|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44578865|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
44578866|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578867|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44578868|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44578869|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578870|NCT00917553|Doxycycline|doxycycline|mesh-list
44578871|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44578872|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44578873|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
44578874|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44578875|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44578876|NCT00917462|Sorafenib|sorafenib|mesh-list
44578877|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578878|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44578879|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578880|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578881|NCT00917384|Ramucirumab|ramucirumab|mesh-list
44578882|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578883|NCT00917267|Exenatide|exenatide|mesh-list
44578884|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578885|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578886|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44578887|NCT00917267|Incretins|incretins|mesh-ancestor
44578888|NCT00917267|Hormones|hormones|mesh-ancestor
44578889|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578890|NCT00916721|Propranolol|propranolol|mesh-list
44578891|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44578892|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44578893|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44578894|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578895|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578896|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578897|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44578898|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44578899|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
44578900|NCT00916578|Capecitabine|capecitabine|mesh-list
44578901|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44578902|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
44578903|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578904|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578905|NCT00916383|Donepezil|donepezil|mesh-list
44578906|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44578907|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44578908|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578909|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
44578910|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578911|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578912|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
44578913|NCT00916357|Insulin|insulin|mesh-list
44578914|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44578915|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
44578916|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578917|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578918|NCT00916279|Paclitaxel|paclitaxel|mesh-list
44578919|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44578920|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578921|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
44578922|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
44578923|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
44578924|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578925|NCT00916149|Lamotrigine|lamotrigine|mesh-list
44578926|NCT00916149|Levetiracetam|levetiracetam|mesh-list
44578927|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
44578928|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
44578929|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44578930|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578931|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578932|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44578933|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578934|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44578935|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44578936|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578937|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44578938|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44578939|NCT00916058|Melphalan|melphalan|mesh-list
44578940|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44578941|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44578942|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
44578943|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578944|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578945|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44578946|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44578947|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
44578948|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578949|NCT00915772|Metformin|metformin|mesh-list
44578950|NCT00915772|Linagliptin|linagliptin|mesh-list
44578951|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44578952|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578953|NCT00915772|Incretins|incretins|mesh-ancestor
44578954|NCT00915772|Hormones|hormones|mesh-ancestor
44578955|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44578956|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44578957|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44578958|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201075|NCT00400777|Diuretics|diuretics|mesh-ancestor
44578959|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578960|NCT00915681|Silybin|silybin|mesh-list
44578961|NCT00915681|Protective Agents|protective agents|mesh-ancestor
44578962|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578963|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44578964|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44578965|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
44578966|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44578967|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44578968|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44578969|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578970|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578971|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
44578972|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44578973|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578974|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44578975|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578976|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
44578977|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44578978|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44578979|NCT00915473|Prednisolone|prednisolone|mesh-list
44578980|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
44578981|NCT00915473|Lidocaine|lidocaine|mesh-list
44578982|NCT00915473|Bupivacaine|bupivacaine|mesh-list
44578983|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44578984|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
44578985|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
44578986|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
44578987|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44578988|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44578989|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
44578990|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44578991|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44578992|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44578993|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44578994|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44578995|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44578996|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44578997|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
44578998|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
44578999|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579000|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
44579001|NCT00915473|Hormones|hormones|mesh-ancestor
44579002|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579003|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44579004|NCT00915473|Protective Agents|protective agents|mesh-ancestor
44579005|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201112|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
44579006|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579007|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
44579008|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44579009|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44579010|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44579011|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579012|NCT00915018|Paclitaxel|paclitaxel|mesh-list
44579013|NCT00915018|Trastuzumab|trastuzumab|mesh-list
44579014|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44579015|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44579016|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579017|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44579018|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44579019|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44579020|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579021|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579022|NCT00915005|Paclitaxel|paclitaxel|mesh-list
44579023|NCT00915005|Carboplatin|carboplatin|mesh-list
44579024|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44579025|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579026|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44579027|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44579028|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44579029|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579030|NCT00914966|Complement C1s|complement c1s|mesh-list
44579031|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44579032|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44579033|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
44579034|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579035|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44579036|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579037|NCT00914940|Fludarabine|fludarabine|mesh-list
44579038|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
44579039|NCT00914940|Thiotepa|thiotepa|mesh-list
44579040|NCT00914940|Tacrolimus|tacrolimus|mesh-list
44579041|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579042|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579043|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
44579044|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579045|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579046|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
44579047|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579048|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44579049|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579050|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44579051|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
44579052|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44579053|NCT00914849|Plerixafor|plerixafor|mesh-list
44579054|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44579055|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44579056|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
44579057|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579058|NCT00914810|Vitamin D|vitamin d|mesh-list
44579059|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
44579060|NCT00914810|Vitamins|vitamins|mesh-ancestor
44579061|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
44579062|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579063|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44579064|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44579065|NCT00914732|Vaccines|vaccines|mesh-list
44579066|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
44579067|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579068|NCT00914459|Factor VIII|factor viii|mesh-list
44579069|NCT00914459|Coagulants|coagulants|mesh-ancestor
44579070|NCT00914316|Ranolazine|ranolazine|mesh-list
44579071|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44579072|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579073|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579074|NCT00913835|Doxorubicin|doxorubicin|mesh-list
44579075|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44579076|NCT00913835|Olaratumab|olaratumab|mesh-list
44579077|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44579078|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579079|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44579080|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44579081|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579082|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579083|NCT00913770|Buprenorphine|buprenorphine|mesh-list
44579084|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44579085|NCT00913770|Narcotics|narcotics|mesh-ancestor
44579086|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579087|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579088|NCT00913770|Analgesics|analgesics|mesh-ancestor
44201201|NCT00401427|Vinorelbine|vinorelbine|mesh-list
44579089|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
44579090|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579091|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44579092|NCT00913692|Glycine|glycine|mesh-list
44579093|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
44579094|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579095|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579096|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579097|NCT00913458|Etanercept|etanercept|mesh-list
44579098|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44579099|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44579100|NCT00913458|Analgesics|analgesics|mesh-ancestor
44579101|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
44579102|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579103|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579104|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579105|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579106|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579107|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579108|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
44579109|NCT00912964|Mirabegron|mirabegron|mesh-list
44579110|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44579111|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44579112|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44579113|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44579114|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579115|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579116|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579117|NCT00912964|Urological Agents|urological agents|mesh-ancestor
44579118|NCT00912912|Sunitinib|sunitinib|mesh-list
44579119|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579120|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579121|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579122|NCT00912912|Growth Substances|growth substances|mesh-ancestor
44579123|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579124|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579125|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579126|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579127|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579128|NCT00912808|Donepezil|donepezil|mesh-list
44579129|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44579130|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579131|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579132|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
43700443|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
44579133|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579134|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579135|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
44579136|NCT00912782|Vitamin D|vitamin d|mesh-list
44579137|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
44579138|NCT00912782|Vitamins|vitamins|mesh-ancestor
44579139|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
44579140|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579141|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44579142|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44579143|NCT00912743|Olaparib|olaparib|mesh-list
44579144|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44579145|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579146|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579147|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579148|NCT00912509|Riboflavin|riboflavin|mesh-list
44579149|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
44579150|NCT00912509|Vitamins|vitamins|mesh-ancestor
44579151|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
44579152|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579153|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44579154|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44579155|NCT00912340|Trastuzumab|trastuzumab|mesh-list
44579156|NCT00912340|Everolimus|everolimus|mesh-list
44579157|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579158|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579159|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579160|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
44579161|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579162|NCT00912093|Icatibant|icatibant|mesh-list
44579163|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44579164|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44579165|NCT00912093|Analgesics|analgesics|mesh-ancestor
44579166|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
44579167|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579168|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579169|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579170|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579171|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44579172|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44579173|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579174|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44579175|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579176|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
44579177|NCT00912015|Tramadol|tramadol|mesh-list
44579178|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44579179|NCT00912015|Narcotics|narcotics|mesh-ancestor
44579180|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579181|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579182|NCT00912015|Analgesics|analgesics|mesh-ancestor
44579183|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
44579184|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579185|NCT00911937|Fesoterodine|fesoterodine|mesh-list
44579186|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44579187|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44579188|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
44579189|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579190|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579191|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579192|NCT00911937|Urological Agents|urological agents|mesh-ancestor
44579193|NCT00911859|Prednisone|prednisone|mesh-list
44579194|NCT00911859|Bortezomib|bortezomib|mesh-list
44579195|NCT00911859|Melphalan|melphalan|mesh-list
44579196|NCT00911859|Siltuximab|siltuximab|mesh-list
44579197|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44579198|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579199|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
44579200|NCT00911859|Hormones|hormones|mesh-ancestor
44579201|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579202|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579206|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
44579207|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579208|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44579209|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579210|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
44579211|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
44579212|NCT00911807|Donepezil|donepezil|mesh-list
44579213|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44579214|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579215|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579216|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44579217|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579218|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579219|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
44579220|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44579221|NCT00911807|Protective Agents|protective agents|mesh-ancestor
44579222|NCT00911625|Insulin|insulin|mesh-list
44579223|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44579224|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
44579225|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
44579226|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44579227|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579228|NCT00911534|Rabeprazole|rabeprazole|mesh-list
44579229|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44579230|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579231|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44579232|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579233|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579234|NCT00911300|Vitamin K|vitamin k|mesh-list
44579235|NCT00911300|Heparin|heparin|mesh-list
44579236|NCT00911300|Calcium heparin|calcium heparin|mesh-list
44579237|NCT00911300|PENTA|penta|mesh-list
44579238|NCT00911300|Fondaparinux|fondaparinux|mesh-list
44579239|NCT00911300|Vitamins|vitamins|mesh-ancestor
44579240|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
44579241|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579242|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
44579243|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44579244|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44579245|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579246|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44579247|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
44579248|NCT00911300|Coagulants|coagulants|mesh-ancestor
44579249|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44579250|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
44579251|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44579252|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44579253|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579254|NCT00911170|Bevacizumab|bevacizumab|mesh-list
44579255|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579256|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579257|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579258|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579259|NCT00911170|Growth Substances|growth substances|mesh-ancestor
44579260|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579261|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579262|NCT00911157|Heparin|heparin|mesh-list
44579263|NCT00911157|Calcium heparin|calcium heparin|mesh-list
44579264|NCT00911157|PENTA|penta|mesh-list
44579265|NCT00911157|Fondaparinux|fondaparinux|mesh-list
44579266|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
44579267|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44579268|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44579269|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579270|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44579271|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
44579272|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44579273|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
44579274|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579275|NCT00911144|Vaccines|vaccines|mesh-list
44579276|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44579277|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
44579278|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579279|NCT00910988|Olanzapine|olanzapine|mesh-list
44579280|NCT00910988|Ziprasidone|ziprasidone|mesh-list
44579281|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
44579282|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
44579283|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579284|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579285|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579286|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44579287|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44579288|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579289|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43700444|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
44579290|NCT00910988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44579291|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44579292|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579293|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201338|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
44579294|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579295|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
44579296|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44579297|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44579298|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
44579299|NCT00910910|Lenalidomide|lenalidomide|mesh-list
44579300|NCT00910910|Chlorambucil|chlorambucil|mesh-list
44579301|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
44579302|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579303|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579304|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579305|NCT00910910|Growth Substances|growth substances|mesh-ancestor
44579306|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579307|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579308|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44579309|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
44579310|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579311|NCT00910871|Bedaquiline|bedaquiline|mesh-list
44579312|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
44579313|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44579314|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579315|NCT00910858|Lenalidomide|lenalidomide|mesh-list
44579316|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
44579317|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
44579318|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579319|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579320|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579321|NCT00910858|Growth Substances|growth substances|mesh-ancestor
44579322|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579323|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579324|NCT00910858|Hematinics|hematinics|mesh-ancestor
44579325|NCT00910715|Doxycycline|doxycycline|mesh-list
44579326|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44579327|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579328|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
44579329|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44579330|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44579331|NCT00910689|Propranolol|propranolol|mesh-list
44579332|NCT00910689|Nadolol|nadolol|mesh-list
44579333|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44579334|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44579335|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44579336|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579337|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579338|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579339|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44579340|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44579341|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
44579342|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
44579343|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
44579344|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579345|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
44579346|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44579347|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579348|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44579349|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
44579350|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44579351|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579352|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579353|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579354|NCT00910624|Ribavirin|ribavirin|mesh-list
44579355|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44579356|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
44579357|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579358|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
44579359|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579360|NCT00910429|Riociguat|riociguat|mesh-list
44579361|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
44579362|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579363|NCT00910299|Clopidogrel|clopidogrel|mesh-list
44579364|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44579365|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44579366|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44579367|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44579368|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44579369|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
44579370|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579371|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579372|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579374|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44579375|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44579376|NCT00910273|Analgesics|analgesics|mesh-ancestor
44579377|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
44579378|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579379|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579380|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579381|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579382|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579383|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579384|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
44579385|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44579386|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
44579387|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44579388|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44579389|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579390|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579391|NCT00910091|Megestrol|megestrol|mesh-list
44579392|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
44579393|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44201433|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
44579394|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44579395|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44579396|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
44579397|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44579398|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579399|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44579400|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44579401|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579402|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579403|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
44579404|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44579405|NCT00910039|Sunitinib|sunitinib|mesh-list
44579406|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579407|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579408|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579409|NCT00910039|Growth Substances|growth substances|mesh-ancestor
44579410|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579411|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579412|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579413|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579414|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579415|NCT00910000|Gemcitabine|gemcitabine|mesh-list
44579416|NCT00910000|Carboplatin|carboplatin|mesh-list
44579417|NCT00910000|Vorinostat|vorinostat|mesh-list
44579418|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579419|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579420|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
44579421|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579422|NCT00910000|Antiviral Agents|antiviral agents|mesh-ancestor
44579423|NCT00910000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579424|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579425|NCT00910000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579426|NCT00910000|Immunologic Factors|immunologic factors|mesh-ancestor
44406315|NCT02576639|CNP520|cnp520|mesh-list
44579427|NCT00910000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579428|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44579429|NCT00909857|Dienogest|dienogest|mesh-list
44579430|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44579431|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44579432|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
44579433|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44579434|NCT00909857|Estradiol|estradiol|mesh-list
44579435|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44579436|NCT00909857|Estrogens|estrogens|mesh-ancestor
44579437|NCT00909857|Hormones|hormones|mesh-ancestor
44579438|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579439|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579440|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44579441|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
44579442|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44579443|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44579444|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44579445|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44579446|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44579447|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44579448|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44579449|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579450|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579451|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44579452|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
44579453|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44579454|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
44579455|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44579456|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579457|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44579458|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579459|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579460|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
44579461|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44579462|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
44579463|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579464|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579465|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44579466|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44579467|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44579468|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44579469|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44579470|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44579471|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579472|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579473|NCT00909727|Ivacaftor|ivacaftor|mesh-list
44579474|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44579475|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579476|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579477|NCT00909532|Ivacaftor|ivacaftor|mesh-list
44579478|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44579479|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579480|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579481|NCT00909480|Insulin|insulin|mesh-list
44579482|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44579483|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
44579484|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
44579485|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44579486|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579487|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
44579488|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44579489|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44579490|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
44579491|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201521|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44579492|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579493|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579494|NCT00909428|Urological Agents|urological agents|mesh-ancestor
44579495|NCT00909389|Simvastatin|simvastatin|mesh-list
44579496|NCT00909389|Ezetimibe|ezetimibe|mesh-list
44579497|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44579498|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44579499|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44579500|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
44579501|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579502|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44579503|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44579504|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579505|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
44579506|NCT00909181|Oxybutynin|oxybutynin|mesh-list
44579507|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
44579508|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
44579509|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579510|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579511|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44579512|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44579513|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
44579514|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579515|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579516|NCT00909181|Urological Agents|urological agents|mesh-ancestor
44579517|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44579518|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579519|NCT00909181|Renal Agents|renal agents|mesh-ancestor
44579520|NCT00908960|Enoxaparin|enoxaparin|mesh-list
44579521|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
44579522|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44579523|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44579524|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579525|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
44579526|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44579527|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44579528|NCT00908583|Prednisolone|prednisolone|mesh-list
44579529|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
44579530|NCT00908583|Rituximab|rituximab|mesh-list
44579531|NCT00908583|Bortezomib|bortezomib|mesh-list
44579532|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44579533|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
44579534|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579535|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579536|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
44579537|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579538|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579539|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579540|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
44579541|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
44579542|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579543|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579544|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
44579545|NCT00908583|Hormones|hormones|mesh-ancestor
44579546|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579547|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44579548|NCT00908583|Protective Agents|protective agents|mesh-ancestor
44579549|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579550|NCT00908375|Pregabalin|pregabalin|mesh-list
44579551|NCT00908375|Analgesics|analgesics|mesh-ancestor
44579552|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
44579553|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579554|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579555|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
44579556|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44579557|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579558|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579559|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44579560|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44579561|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44579562|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579563|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44579564|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
44579565|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
44579566|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44579567|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44579568|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579569|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579570|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44579571|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44579572|NCT00908232|Dexamethasone|dexamethasone|mesh-list
44579573|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
44579574|NCT00908232|Lenalidomide|lenalidomide|mesh-list
44579575|NCT00908232|Bortezomib|bortezomib|mesh-list
44579576|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579577|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
44579578|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579579|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201642|NCT00402766|Dexamethasone|dexamethasone|mesh-list
44579580|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44579581|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
44579582|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579583|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579584|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44579585|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579586|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
44579588|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579589|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579590|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
44579591|NCT00908232|Hormones|hormones|mesh-ancestor
44579592|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579593|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579594|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579595|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579596|NCT00908232|Growth Substances|growth substances|mesh-ancestor
44579597|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579598|NCT00908141|Sargramostim|sargramostim|mesh-list
44579599|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
44579600|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579601|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44579602|NCT00908011|Ezetimibe|ezetimibe|mesh-list
44579603|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44579604|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44579605|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
44579606|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579607|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44579608|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44579609|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579610|NCT00907777|Vaccines|vaccines|mesh-list
44579611|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44579612|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
44579613|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579614|NCT00907738|Vorinostat|vorinostat|mesh-list
44579615|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579616|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44579617|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579618|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579619|NCT00907517|Cytarabine|cytarabine|mesh-list
44579620|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579621|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
44579622|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579623|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579624|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
44579625|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579626|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579627|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
44579628|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406478|NCT02573012|Prednisone|prednisone|mesh-list
44579629|NCT00907374|Benazepril|benazepril|mesh-list
44579630|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44579631|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
44579632|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579633|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579634|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44579635|NCT00907335|Tretinoin|tretinoin|mesh-list
44579636|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44579637|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579638|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
44579639|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44579640|NCT00907257|Tretinoin|tretinoin|mesh-list
44579641|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44579642|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44579643|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579644|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
44579645|NCT00907153|Vitamin D|vitamin d|mesh-list
44579646|NCT00907153|Vitamins|vitamins|mesh-ancestor
44579647|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
44579648|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579649|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44579650|NCT00906945|Cytarabine|cytarabine|mesh-list
44579651|NCT00906945|Plerixafor|plerixafor|mesh-list
44579652|NCT00906945|Etoposide|etoposide|mesh-list
44579653|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
44579654|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44579655|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579656|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44579657|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44579658|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579659|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579660|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579661|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
44579662|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
44579663|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579664|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579665|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
44579666|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579667|NCT00906945|Analgesics|analgesics|mesh-ancestor
44579668|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
44579669|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579670|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44579671|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44579672|NCT00906698|Vinorelbine|vinorelbine|mesh-list
44579673|NCT00906698|Afatinib|afatinib|mesh-list
44579674|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44579675|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579676|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44579677|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44579678|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44579679|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579680|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579681|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579682|NCT00906399|Interferons|interferons|mesh-list
44579683|NCT00906399|Interferon-beta|interferon-beta|mesh-list
44579684|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
44579685|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579686|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
44579687|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579688|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
44579689|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579690|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44579691|NCT00906373|Sorafenib|sorafenib|mesh-list
44579692|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44579693|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579694|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579695|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579696|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579697|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
44579698|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579699|NCT00906347|Misoprostol|misoprostol|mesh-list
44579700|NCT00906347|Oxytocin|oxytocin|mesh-list
44579701|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
44579702|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44579703|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406541|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44579704|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44579705|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
44579706|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44579707|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579709|NCT00906282|Pemetrexed|pemetrexed|mesh-list
44579710|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579711|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579712|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579713|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44579714|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44579715|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
44579716|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44579717|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
44579718|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579719|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579720|NCT00906087|Timolol|timolol|mesh-list
44579721|NCT00906087|Dorzolamide|dorzolamide|mesh-list
44579722|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44579723|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44579724|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44579725|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44579726|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579727|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579728|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579729|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44579730|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44579731|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44579732|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579733|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44579734|NCT00906035|Aspirin|aspirin|mesh-list
44579735|NCT00906035|Dipyridamole|dipyridamole|mesh-list
44579736|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44579737|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44579738|NCT00906035|Analgesics|analgesics|mesh-ancestor
44579739|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
44579740|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579741|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579742|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579743|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579744|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44579745|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44579746|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579747|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44579748|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44579749|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579750|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
44579751|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44579752|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
44579753|NCT00905489|Nevirapine|nevirapine|mesh-list
44579754|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44579755|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44579756|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579757|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579758|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
44579759|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579760|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44579761|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44579762|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44579763|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44579764|NCT00905437|Pregabalin|pregabalin|mesh-list
44579765|NCT00905437|Analgesics|analgesics|mesh-ancestor
44579766|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
44579767|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579768|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579769|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
44579770|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44579771|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579772|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579773|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44579774|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44579775|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44579776|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44579777|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44579778|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44406620|NCT02569242|Paclitaxel|paclitaxel|mesh-list
44579802|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
44201833|NCT00403533|Atorvastatin|atorvastatin|mesh-list
44579803|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44579804|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44579805|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44579806|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44579807|NCT00905255|Lixisenatide|lixisenatide|mesh-list
44579808|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44579809|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579810|NCT00905034|Dexamethasone|dexamethasone|mesh-list
44579811|NCT00905034|Rituximab|rituximab|mesh-list
44579812|NCT00905034|Methotrexate|methotrexate|mesh-list
44579813|NCT00905034|Vincristine|vincristine|mesh-list
44579814|NCT00905034|Asparaginase|asparaginase|mesh-list
44579815|NCT00905034|Pegaspargase|pegaspargase|mesh-list
44579816|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579817|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579818|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
44579819|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579820|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579821|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579822|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
44579823|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
44579824|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579825|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579826|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
44579827|NCT00905034|Hormones|hormones|mesh-ancestor
44579828|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579829|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579830|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44579831|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
44579832|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44579833|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579835|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579836|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44579837|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579838|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44579839|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44579840|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44579841|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44579842|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44579843|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44579844|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44579846|NCT00905021|Exemestane|exemestane|mesh-list
44579847|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579848|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579849|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579850|NCT00905021|Growth Substances|growth substances|mesh-ancestor
44579851|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579852|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579853|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579854|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579855|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579856|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44579857|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44579858|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44579859|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
44579860|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579861|NCT00904839|Bevacizumab|bevacizumab|mesh-list
44579862|NCT00904839|Nintedanib|nintedanib|mesh-list
44579863|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579864|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579865|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579866|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579867|NCT00904839|Growth Substances|growth substances|mesh-ancestor
44201893|NCT00403780|Pregabalin|pregabalin|mesh-list
44579868|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579869|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579870|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44579871|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579872|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579873|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
44579874|NCT00904748|Citric Acid|citric acid|mesh-list
44579875|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
44579876|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
44579877|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44579878|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
44579879|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
44579880|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579881|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
44579882|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44579883|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44579884|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579885|NCT00904748|Urological Agents|urological agents|mesh-ancestor
44579886|NCT00904722|Rituximab|rituximab|mesh-list
44579887|NCT00904722|Pidilizumab|pidilizumab|mesh-list
44579888|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44579889|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579890|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
44579891|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579892|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44579893|NCT00904670|Methylphenidate|methylphenidate|mesh-list
44579894|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44579895|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579896|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44579897|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44579898|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579899|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579900|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
44579901|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44579902|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44579903|NCT00904215|Telmisartan|telmisartan|mesh-list
44579904|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44579905|NCT00904215|Diuretics|diuretics|mesh-ancestor
44579906|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
44579907|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579908|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44579909|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579911|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44579912|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44579913|NCT00904033|Calcitriol|calcitriol|mesh-list
44579914|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44579915|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579916|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44579917|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44579918|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579919|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44579920|NCT00904033|Vitamins|vitamins|mesh-ancestor
44579921|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
44579922|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44579923|NCT00903968|Plerixafor|plerixafor|mesh-list
44579924|NCT00903968|Dexamethasone|dexamethasone|mesh-list
44579925|NCT00903968|Bortezomib|bortezomib|mesh-list
44579926|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44579927|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
44579928|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
44579929|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44579930|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579931|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44579932|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
44579933|NCT00903968|Hormones|hormones|mesh-ancestor
44579934|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44579935|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44579936|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579937|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44579938|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44579939|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
44579940|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579941|NCT00903760|Decitabine|decitabine|mesh-list
44579942|NCT00903760|Clofarabine|clofarabine|mesh-list
44579943|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44579944|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
44579945|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579946|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579947|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579948|NCT00903682|Efavirenz|efavirenz|mesh-list
44579949|NCT00903682|Etravirine|etravirine|mesh-list
44579950|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44579951|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44579952|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579953|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579954|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
44579955|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44579956|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44579957|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44579958|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44579959|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44579960|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44579961|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44579962|NCT00903630|Doxorubicin|doxorubicin|mesh-list
44579963|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44579964|NCT00903630|Lenalidomide|lenalidomide|mesh-list
44579965|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44579966|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44579967|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44579968|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44579969|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579970|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579971|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
44579972|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579973|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44579974|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44579975|NCT00903630|Growth Substances|growth substances|mesh-ancestor
44579976|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44579977|NCT00903617|Niacin|niacin|mesh-list
44579978|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
44579979|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44579980|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
44579981|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579982|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44579983|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
44579984|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
44579985|NCT00903617|Vitamins|vitamins|mesh-ancestor
44579986|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
44579987|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44579988|NCT00903409|Simvastatin|simvastatin|mesh-list
44579989|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44579990|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44579991|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
44579992|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44579993|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44579994|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44579995|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44579996|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
44579997|NCT00903357|Montelukast|montelukast|mesh-list
44579998|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44579999|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44580000|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44580001|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
44580002|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580003|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580004|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44580005|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44580006|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580007|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
44580008|NCT00903357|Protective Agents|protective agents|mesh-ancestor
44580009|NCT00903357|Vitamins|vitamins|mesh-ancestor
44580010|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
44580011|NCT00903344|Vitamin D|vitamin d|mesh-list
44580012|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
44580013|NCT00903344|Vitamins|vitamins|mesh-ancestor
44580014|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
44580015|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580016|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44580017|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580018|NCT00903331|Macitentan|macitentan|mesh-list
44580019|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44580020|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44580021|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580022|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44580023|NCT00903175|Everolimus|everolimus|mesh-list
44580024|NCT00903175|Sunitinib|sunitinib|mesh-list
44580025|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580026|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580027|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
44580028|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580029|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580030|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580031|NCT00903175|Growth Substances|growth substances|mesh-ancestor
44580032|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580033|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580034|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580035|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580036|NCT00903006|Dasatinib|dasatinib|mesh-list
44580037|NCT00903006|Fulvestrant|fulvestrant|mesh-list
44580038|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580039|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580040|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580041|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580042|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44580043|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44580044|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44580045|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
44580046|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580047|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580048|NCT00902668|Lovastatin|lovastatin|mesh-list
44580049|NCT00902668|L 647318|l 647318|mesh-list
44580050|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
44580051|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44580052|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44580053|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
44580054|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580055|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44580056|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44580057|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580058|NCT00902577|Misonidazole|misonidazole|mesh-list
44580059|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580060|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44580061|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44580062|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580063|NCT00902564|Citalopram|citalopram|mesh-list
44580064|NCT00902564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44580065|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580066|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580067|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580068|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580069|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
44580070|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580071|NCT00902564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44580072|NCT00902564|Antidepressive Agents|antidepressive agents|mesh-ancestor
44580073|NCT00902564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580074|NCT00902538|Amlodipine|amlodipine|mesh-list
44580075|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44580076|NCT00902538|Olmesartan|olmesartan|mesh-list
44580077|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44580078|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44580079|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44580080|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580081|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580082|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580083|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580084|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
44580085|NCT00902538|Diuretics|diuretics|mesh-ancestor
44580086|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
44580087|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44580088|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44580089|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44580090|NCT00902304|Amlodipine|amlodipine|mesh-list
44580091|NCT00902304|Valsartan|valsartan|mesh-list
44580092|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44580093|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44580094|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44580095|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44580096|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580097|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580098|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580099|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580100|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
44580101|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44580102|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44580103|NCT00902304|Diuretics|diuretics|mesh-ancestor
44580104|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
44580105|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44580106|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44580107|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
44580108|NCT00902265|Coagulants|coagulants|mesh-ancestor
44580109|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44580110|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
44580111|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580112|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
44580113|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580114|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580115|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580116|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580117|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
44580118|NCT00902044|Fludarabine|fludarabine|mesh-list
44580119|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580120|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
44580121|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580122|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580123|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580124|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
44580125|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580126|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580127|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44580128|NCT00901927|Rituximab|rituximab|mesh-list
44580129|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44580130|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
44580131|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580132|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580133|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
44580134|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580135|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580136|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580137|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
44580138|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580139|NCT00901927|Analgesics|analgesics|mesh-ancestor
44580140|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
44580141|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580142|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44580143|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44580144|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580145|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44580146|NCT00901901|Sorafenib|sorafenib|mesh-list
44580147|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580148|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580149|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580150|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580151|NCT00901628|Cefuroxime|cefuroxime|mesh-list
44580152|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
44580153|NCT00901628|Ketorolac|ketorolac|mesh-list
44580154|NCT00901628|Epinephrine|epinephrine|mesh-list
44580155|NCT00901628|Morphine|morphine|mesh-list
44580156|NCT00901628|Ropivacaine|ropivacaine|mesh-list
44580157|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44580158|NCT00901628|Narcotics|narcotics|mesh-ancestor
44580159|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580160|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580161|NCT00901628|Analgesics|analgesics|mesh-ancestor
44580162|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
44580163|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580164|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
44580165|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
44580166|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44580167|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44580168|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
44580169|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580170|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580171|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44580172|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44580173|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
44580174|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44580175|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
44580176|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
44580177|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
44580178|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44580179|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580180|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580181|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580182|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580183|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44580184|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580185|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44580186|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580187|NCT00901576|Methylphenidate|methylphenidate|mesh-list
44580188|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44580189|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580190|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44580191|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580192|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580193|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580194|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
44580195|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580196|NCT00901394|Folic Acid|folic acid|mesh-list
44580197|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
44580198|NCT00901394|Hematinics|hematinics|mesh-ancestor
44580199|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
44580200|NCT00901394|Vitamins|vitamins|mesh-ancestor
44580201|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
44580202|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580203|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44580204|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
44580205|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
44580206|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580207|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580209|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
44580210|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580211|NCT00901186|Ranibizumab|ranibizumab|mesh-list
44580212|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580213|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580214|NCT00901186|Growth Substances|growth substances|mesh-ancestor
44580215|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580216|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580217|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580218|NCT00900757|Palonosetron|palonosetron|mesh-list
44580219|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
44580220|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
44580221|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580222|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580223|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580224|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44580225|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44580226|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
44580227|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580228|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580229|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
44580230|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44580231|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
44580232|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580233|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580234|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44580235|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
44580236|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
44580237|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44580238|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
44580239|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580240|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580241|NCT00900627|Paclitaxel|paclitaxel|mesh-list
44580242|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44580243|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580244|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44580245|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44580246|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44580247|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580248|NCT00900159|Eszopiclone|eszopiclone|mesh-list
44580249|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44580250|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580251|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580252|NCT00900146|Metformin|metformin|mesh-list
44580253|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44580254|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580255|NCT00899847|Acetaminophen|acetaminophen|mesh-list
44580256|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
44580257|NCT00899847|Promethazine|promethazine|mesh-list
44580258|NCT00899847|Cyclosporine|cyclosporine|mesh-list
44580259|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
44580260|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
44580261|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44580262|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
44580263|NCT00899847|Melphalan|melphalan|mesh-list
44580264|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
44580265|NCT00899847|Cyclosporins|cyclosporins|mesh-list
44580266|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
44580267|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44580268|NCT00899847|Lenograstim|lenograstim|mesh-list
44580269|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580270|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
44580271|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580272|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580273|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580274|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
44580275|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580276|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580277|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44580278|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44580279|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580280|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
44580281|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580282|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44580283|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44580284|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580285|NCT00899847|Analgesics|analgesics|mesh-ancestor
44580286|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
44580287|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580288|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
44580289|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44580290|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44580291|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
44580292|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44580293|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580294|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44580295|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44580296|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580297|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44580298|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
44580299|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
44580300|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
44580301|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580302|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44580303|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
44580304|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
44580305|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580306|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44580307|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
44580308|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
44580309|NCT00899847|Hormones|hormones|mesh-ancestor
44580310|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580311|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44580312|NCT00899847|Protective Agents|protective agents|mesh-ancestor
44580313|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44580314|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
44580315|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580316|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
44580317|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580318|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580319|NCT00899431|Rituximab|rituximab|mesh-list
44580320|NCT00899431|Fludarabine|fludarabine|mesh-list
44580321|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
44580322|NCT00899431|Lenalidomide|lenalidomide|mesh-list
44580323|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44580324|NCT00899431|Allopurinol|allopurinol|mesh-list
44580325|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
44580326|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44580327|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580328|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580329|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
44580330|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580331|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580332|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580333|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
44580334|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580335|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580336|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580337|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580338|NCT00899431|Growth Substances|growth substances|mesh-ancestor
44580339|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580340|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580341|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
44580342|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580343|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
44580344|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44580345|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
44580346|NCT00899431|Protective Agents|protective agents|mesh-ancestor
44580347|NCT00898807|Citalopram|citalopram|mesh-list
44580348|NCT00898807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44580349|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580350|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580351|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580352|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580353|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
44580354|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580355|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44580356|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
44580357|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580359|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580360|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580361|NCT00897715|Rilonacept|rilonacept|mesh-list
44580362|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580363|NCT00897390|Metformin|metformin|mesh-list
44580364|NCT00897390|Saxagliptin|saxagliptin|mesh-list
44580365|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44580366|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580367|NCT00897390|Incretins|incretins|mesh-ancestor
44580368|NCT00897390|Hormones|hormones|mesh-ancestor
44580369|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580370|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44580371|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580372|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580373|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580374|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
44580375|NCT00896532|Denosumab|denosumab|mesh-list
44580376|NCT00896532|Alendronate|alendronate|mesh-list
44580377|NCT00896532|Teriparatide|teriparatide|mesh-list
44580378|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44580379|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44580380|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580381|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580382|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
44580383|NCT00896454|Denosumab|denosumab|mesh-list
44580384|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44202396|NCT00405171|Nevirapine|nevirapine|mesh-list
44580385|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580386|NCT00896168|Methotrexate|methotrexate|mesh-list
44580387|NCT00896168|Infliximab|infliximab|mesh-list
44580388|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44580389|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
44580390|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44580391|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580392|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580393|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
44580394|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580395|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580396|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44580397|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580398|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44580399|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580400|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
44580401|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580402|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44580403|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580404|NCT00896051|Ritonavir|ritonavir|mesh-list
44580405|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44580406|NCT00896051|Tenofovir|tenofovir|mesh-list
44580407|NCT00896051|Etravirine|etravirine|mesh-list
44580408|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44580409|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44580410|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44580411|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580412|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580413|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580414|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44580415|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44580416|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
44580417|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580418|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44580419|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44580420|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44580421|NCT00895947|Interferons|interferons|mesh-list
44580422|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
44580423|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580424|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
44580425|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580426|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
44580427|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580428|NCT00895895|Donepezil|donepezil|mesh-list
44580429|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44580430|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580431|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580432|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
44580433|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580434|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580435|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
44580436|NCT00895843|Ibuprofen|ibuprofen|mesh-list
44580437|NCT00895843|Epinephrine|epinephrine|mesh-list
44580438|NCT00895843|Bupivacaine|bupivacaine|mesh-list
44580439|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44580440|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
44580441|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580442|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580443|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
44580444|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580445|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580446|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580447|NCT00895843|Analgesics|analgesics|mesh-ancestor
44580448|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580449|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580450|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44580451|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580452|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580453|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44580454|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44580455|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
44580456|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580457|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44580458|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44580459|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
44580460|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44580461|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44580462|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
44580463|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
44580464|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44580466|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580467|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580468|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
44580469|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580470|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580471|NCT00895583|Sirolimus|sirolimus|mesh-list
44580472|NCT00895583|Tacrolimus|tacrolimus|mesh-list
44580473|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580474|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
44580475|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580476|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44580477|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580478|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580479|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44580480|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580481|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44580482|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580483|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
44580484|NCT00895453|Iron|iron|mesh-list
44580485|NCT00895453|Itraconazole|itraconazole|mesh-list
44580486|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
44580487|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580488|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44580489|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44580490|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580491|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580492|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44580493|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
44580494|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580495|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580496|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44580497|NCT00895453|Trace Elements|trace elements|mesh-ancestor
44580498|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
44580499|NCT00895414|Doxorubicin|doxorubicin|mesh-list
44580500|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44580501|NCT00895414|Enalapril|enalapril|mesh-list
44580502|NCT00895414|Enalaprilat|enalaprilat|mesh-list
44580503|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44580504|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580505|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44580506|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44580507|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580508|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580509|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44580510|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580511|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44580513|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
44580514|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580515|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
44580516|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580517|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44580518|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44580519|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580520|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580521|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44580522|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
44580523|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580524|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580525|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44580526|NCT00895245|Dexamethasone|dexamethasone|mesh-list
44580527|NCT00895245|Cisplatin|cisplatin|mesh-list
44580528|NCT00895245|Palonosetron|palonosetron|mesh-list
44580529|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
44580530|NCT00895245|Aprepitant|aprepitant|mesh-list
44580531|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580532|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
44580533|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
44580534|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580535|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580536|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580538|NCT00895245|Hormones|hormones|mesh-ancestor
44580539|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580540|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44580541|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580542|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44580543|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44580544|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
44580545|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580546|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580547|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44580548|NCT00895037|Factor VIII|factor viii|mesh-list
44580549|NCT00895037|Coagulants|coagulants|mesh-ancestor
44580550|NCT00894803|Eptifibatide|eptifibatide|mesh-list
44580551|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44580552|NCT00894790|Celecoxib|celecoxib|mesh-list
44580553|NCT00894790|Diclofenac|diclofenac|mesh-list
44580554|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580555|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580556|NCT00894790|Analgesics|analgesics|mesh-ancestor
44580557|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
44580558|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580559|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580560|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580561|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580562|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44580563|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44580564|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580565|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580566|NCT00894647|Imiquimod|imiquimod|mesh-list
44580567|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44580568|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
44580569|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580570|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580571|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
44580572|NCT00894556|Sumatriptan|sumatriptan|mesh-list
44580573|NCT00894556|Rizatriptan|rizatriptan|mesh-list
44580574|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44580575|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44580576|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44580577|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
44580578|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580579|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580580|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580581|NCT00894543|Citalopram|citalopram|mesh-list
44580582|NCT00894543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44580583|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580584|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580585|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580586|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580587|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
44580588|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580589|NCT00894543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44580590|NCT00894543|Antidepressive Agents|antidepressive agents|mesh-ancestor
44580591|NCT00894543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580592|NCT00894413|Tadalafil|tadalafil|mesh-list
44580593|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
44580594|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44580595|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44580596|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580597|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580598|NCT00894413|Urological Agents|urological agents|mesh-ancestor
44580599|NCT00894322|Exenatide|exenatide|mesh-list
44580600|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44580601|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580602|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44580603|NCT00894322|Incretins|incretins|mesh-ancestor
44580604|NCT00894322|Hormones|hormones|mesh-ancestor
44580605|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580606|NCT00894166|Bupropion|bupropion|mesh-list
44580607|NCT00894166|Nicotine|nicotine|mesh-list
44580608|NCT00894166|Varenicline|varenicline|mesh-list
44580609|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44580610|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
44580611|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580612|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580613|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44580614|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44580615|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
44580616|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580617|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580618|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44580619|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
44580620|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580621|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44580622|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580623|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580624|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
44580625|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44580626|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44580627|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580629|NCT00893737|Sumatriptan|sumatriptan|mesh-list
44580630|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580631|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580632|NCT00893737|Analgesics|analgesics|mesh-ancestor
44580633|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
44580634|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580635|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580636|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580637|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580638|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
44580639|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44580640|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580641|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580642|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44580643|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44580644|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44580645|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
44580646|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580647|NCT00893464|Ixazomib|ixazomib|mesh-list
44580648|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580649|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580650|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580651|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580652|NCT00893113|Alfuzosin|alfuzosin|mesh-list
44580653|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44580654|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44580655|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44580656|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44580657|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580658|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580659|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580660|NCT00893113|Urological Agents|urological agents|mesh-ancestor
44580661|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44580663|NCT00892957|Aprotinin|aprotinin|mesh-list
44580664|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
44580665|NCT00892957|Coagulants|coagulants|mesh-ancestor
44580666|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44580667|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44202663|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
44580668|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580669|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580670|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580671|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44580672|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44580673|NCT00892437|Cobicistat|cobicistat|mesh-list
44580674|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44580675|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44580676|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580677|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580678|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
44580679|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580680|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44580681|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44580682|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44407548|NCT02548650|Aspirin|aspirin|mesh-list
44580683|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44580684|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580685|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44580686|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44580687|NCT00892281|Doxycycline|doxycycline|mesh-list
44580688|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44580689|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580690|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
44580691|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44580692|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44580693|NCT00892177|Bevacizumab|bevacizumab|mesh-list
44580695|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580696|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580697|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580698|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580699|NCT00892177|Growth Substances|growth substances|mesh-ancestor
44580700|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580701|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580702|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580703|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580704|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580705|NCT00892099|Vitamin D|vitamin d|mesh-list
44580706|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
44580707|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
44580708|NCT00892099|Vitamins|vitamins|mesh-list
44580709|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
44580710|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580711|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44202721|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580712|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580713|NCT00892047|Aripiprazole|aripiprazole|mesh-list
44580714|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44580715|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
44580716|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580717|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44580718|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44580719|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580720|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580721|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
44580722|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
44580723|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580724|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580725|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44580726|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44580727|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
44580728|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44580729|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44580730|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44580731|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44580732|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44580733|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44580734|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580735|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44580736|NCT00892008|Pregabalin|pregabalin|mesh-list
44580737|NCT00892008|Analgesics|analgesics|mesh-ancestor
44580738|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
44580739|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580740|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580741|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
44580742|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44580743|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580744|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580745|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580746|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44580747|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44580748|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44580749|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44580750|NCT00891930|Irinotecan|irinotecan|mesh-list
44580751|NCT00891930|Panitumumab|panitumumab|mesh-list
44580752|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44580753|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44580754|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580755|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580756|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580757|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580758|NCT00891904|Cetuximab|cetuximab|mesh-list
44580759|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580760|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580761|NCT00891839|Rituximab|rituximab|mesh-list
44580762|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44580763|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580764|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202766|NCT00406575|Methocarbamol|methocarbamol|mesh-list
44580765|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
44580766|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580767|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580768|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580769|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
44580770|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580771|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
44580772|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44580773|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580774|NCT00891813|Vitamins|vitamins|mesh-ancestor
44580775|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
44580776|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44580777|NCT00891735|Ranibizumab|ranibizumab|mesh-list
44580778|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580779|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580780|NCT00891735|Growth Substances|growth substances|mesh-ancestor
44580781|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580782|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580783|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580784|NCT00891527|Bevacizumab|bevacizumab|mesh-list
44580785|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
44580786|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580787|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580788|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580789|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580790|NCT00891527|Growth Substances|growth substances|mesh-ancestor
44580791|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580792|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580793|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44580794|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580795|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580796|NCT00891462|Bromides|bromides|mesh-list
44580797|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
44580798|NCT00891371|Lanreotide|lanreotide|mesh-list
44580799|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580800|NCT00891293|Fenofibrate|fenofibrate|mesh-list
44580801|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44580802|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
44580803|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580804|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44580805|NCT00891228|ST 1435|st 1435|mesh-list
44580806|NCT00891228|Testosterone|testosterone|mesh-list
44580807|NCT00891228|Androgens|androgens|mesh-ancestor
44580809|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580810|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580811|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44580812|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
44580813|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44580814|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44580815|NCT00891202|Eliglustat|eliglustat|mesh-list
44580816|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580817|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580818|NCT00890929|Lenalidomide|lenalidomide|mesh-list
44580819|NCT00890929|Azacitidine|azacitidine|mesh-list
44580820|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
44580821|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580822|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580823|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580824|NCT00890929|Growth Substances|growth substances|mesh-ancestor
44580825|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580826|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580827|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580828|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
44580829|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580830|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580832|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580833|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44580834|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44580835|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44580836|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580837|NCT00890552|Dexamethasone|dexamethasone|mesh-list
44580838|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
44580839|NCT00890552|Lenalidomide|lenalidomide|mesh-list
44580840|NCT00890552|Melphalan|melphalan|mesh-list
44580841|NCT00890552|BB 1101|bb 1101|mesh-list
44580842|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580843|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
44580844|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
44580845|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580846|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580847|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580848|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
44580849|NCT00890552|Hormones|hormones|mesh-ancestor
44580850|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580851|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44580852|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580853|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580854|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580855|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580856|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
44580857|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580858|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580859|NCT00890552|Growth Substances|growth substances|mesh-ancestor
44580860|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580861|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44580862|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
44580863|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44580864|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44580865|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44580866|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44580867|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44580868|NCT00890084|Telmisartan|telmisartan|mesh-list
44580869|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44580870|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44580871|NCT00890084|Diuretics|diuretics|mesh-ancestor
44580872|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
44580873|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580874|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44580875|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44580876|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580877|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44580878|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44580879|NCT00889720|Varenicline|varenicline|mesh-list
44580880|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44580881|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44580882|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
44580883|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580884|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580885|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580886|NCT00889603|Donepezil|donepezil|mesh-list
44580887|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44580888|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580889|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580890|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
44580891|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580892|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580893|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
44580894|NCT00889421|Apremilast|apremilast|mesh-list
44580895|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580896|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580897|NCT00889421|Analgesics|analgesics|mesh-ancestor
44580898|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
44580899|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580900|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580901|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580902|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580903|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44407764|NCT02543801|Ketorolac|ketorolac|mesh-list
44580913|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580914|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580915|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580916|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44580917|NCT00888940|Ecallantide|ecallantide|mesh-list
44580918|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
44580919|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44580920|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44580921|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580922|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
44580923|NCT00888940|Coagulants|coagulants|mesh-ancestor
44580924|NCT00888940|Analgesics|analgesics|mesh-ancestor
44580925|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
44580926|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580927|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580928|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44580929|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44580930|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44580931|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44580932|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
44580933|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580934|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44580935|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44580936|NCT00888654|Protective Agents|protective agents|mesh-ancestor
44580937|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580938|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580939|NCT00888615|Paclitaxel|paclitaxel|mesh-list
44580940|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44580941|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44580942|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580943|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44580944|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44580945|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44580946|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580947|NCT00888381|Vaccines|vaccines|mesh-list
44580948|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
44580949|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580950|NCT00888329|Aprepitant|aprepitant|mesh-list
44580951|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
44580952|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
44580953|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44580954|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580955|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44580956|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44580957|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44580958|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580959|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44580960|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44580961|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580962|NCT00888238|Incretins|incretins|mesh-ancestor
44580963|NCT00888238|Hormones|hormones|mesh-ancestor
44580964|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44580965|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44580966|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
44580967|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44580968|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580969|NCT00887978|Treprostinil|treprostinil|mesh-list
44580970|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44580971|NCT00887822|Bevacizumab|bevacizumab|mesh-list
44580972|NCT00887822|Cisplatin|cisplatin|mesh-list
44580973|NCT00887822|Capecitabine|capecitabine|mesh-list
44580974|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580975|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44580976|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580977|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580978|NCT00887822|Growth Substances|growth substances|mesh-ancestor
44580979|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580980|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580981|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580982|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
44580983|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580984|NCT00887809|Gemcitabine|gemcitabine|mesh-list
44580985|NCT00887809|Bevacizumab|bevacizumab|mesh-list
44580986|NCT00887809|Docetaxel|docetaxel|mesh-list
44580987|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44580989|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44580990|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44580991|NCT00887809|Growth Substances|growth substances|mesh-ancestor
44580992|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44580993|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
44580994|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44580995|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
44580996|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44580997|NCT00887809|Antiviral Agents|antiviral agents|mesh-ancestor
44580998|NCT00887809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44580999|NCT00887809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581000|NCT00887809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581001|NCT00887809|Immunologic Factors|immunologic factors|mesh-ancestor
44581002|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
44581003|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
44581004|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
44581005|NCT00887679|Citalopram|citalopram|mesh-list
44581006|NCT00887679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44581007|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44581008|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581009|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581010|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581011|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
44581012|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581013|NCT00887679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44581014|NCT00887679|Antidepressive Agents|antidepressive agents|mesh-ancestor
44581015|NCT00887679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581016|NCT00887588|Valsartan|valsartan|mesh-list
44581017|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44581018|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44581019|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44581020|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44581021|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581022|NCT00887549|Cisplatin|cisplatin|mesh-list
44581023|NCT00887549|Pemetrexed|pemetrexed|mesh-list
44581024|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581025|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581026|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581027|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44581028|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44581029|NCT00887484|Clindamycin|clindamycin|mesh-list
44581030|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
44581031|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
44581032|NCT00887484|Adapalene|adapalene|mesh-list
44581033|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44581034|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581035|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581036|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44581037|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581038|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581039|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581040|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44581041|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581042|NCT00887484|Analgesics|analgesics|mesh-ancestor
44581043|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
44581044|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581045|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581046|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581047|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581048|NCT00887432|Vitamin D|vitamin d|mesh-list
44581049|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
44581050|NCT00887432|Vitamins|vitamins|mesh-ancestor
44581051|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
44581052|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581053|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44581054|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581055|NCT00887354|Vitamin D|vitamin d|mesh-list
44581056|NCT00887354|Teriparatide|teriparatide|mesh-list
44581057|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
44581058|NCT00887354|Calcium|calcium|mesh-list
44581059|NCT00887354|Vitamins|vitamins|mesh-ancestor
44581060|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
44581061|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581062|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581063|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44581064|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44581065|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581066|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581067|NCT00887315|Cisplatin|cisplatin|mesh-list
44581068|NCT00887315|Docetaxel|docetaxel|mesh-list
44581069|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581070|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44581071|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44581072|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44581073|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581074|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44581075|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44581076|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44581077|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581078|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581079|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581080|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581081|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
44581082|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581083|NCT00887198|Prednisone|prednisone|mesh-list
44581084|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
44581085|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581086|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
44581087|NCT00887198|Hormones|hormones|mesh-ancestor
44581088|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581089|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581090|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44581091|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581092|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44581093|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581094|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581095|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
44581096|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44581097|NCT00887159|Cisplatin|cisplatin|mesh-list
44581098|NCT00887159|Etoposide|etoposide|mesh-list
44581099|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
44581100|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
44581101|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44581102|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581103|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44581104|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44581105|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44581106|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581107|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581108|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
44581109|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581110|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44581111|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
44581112|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
44581113|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
44581114|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581116|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581117|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
44581118|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581119|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581120|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581121|NCT00886834|Misoprostol|misoprostol|mesh-list
44581122|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44581123|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
44581124|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581125|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581126|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44581127|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581128|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
44581129|NCT00886795|Abatacept|abatacept|mesh-list
44581130|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44581131|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581132|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581133|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581134|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
44581135|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581136|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581137|NCT00886743|Oprelvekin|oprelvekin|mesh-list
44408070|NCT02531633|Prednisone|prednisone|mesh-list
44581138|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581139|NCT00886613|Vaccines|vaccines|mesh-list
44581140|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
44581171|NCT05660746|Infliximab|infliximab|mesh-list
44581172|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581173|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581174|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581175|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
44581176|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44581177|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581178|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581179|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44581180|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44581181|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581182|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581183|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581184|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44581185|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
44581186|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581187|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581188|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44581189|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44581190|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44581191|NCT05660694|Vitamin E|vitamin e|mesh-list
44581192|NCT05660694|Triamcinolone|triamcinolone|mesh-list
44581193|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
44581194|NCT05660694|Vitamins|vitamins|mesh-ancestor
44581195|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
44581196|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581197|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581198|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
44581199|NCT05660694|Hormones|hormones|mesh-ancestor
44581200|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581201|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203129|NCT00408135|Telithromycin|telithromycin|mesh-list
44581202|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581203|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
44581204|NCT05660694|Protective Agents|protective agents|mesh-ancestor
44581205|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44581206|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44581207|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44581208|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
44581209|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44581210|NCT05660681|Glycerol|glycerol|mesh-list
44581211|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44581212|NCT05660681|Protective Agents|protective agents|mesh-ancestor
44581213|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581214|NCT05660616|Gemcitabine|gemcitabine|mesh-list
44581215|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581217|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581218|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581219|NCT05660616|Antiviral Agents|antiviral agents|mesh-ancestor
44581220|NCT05660616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581221|NCT05660616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581222|NCT05660616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581223|NCT05660616|Immunologic Factors|immunologic factors|mesh-ancestor
44581224|NCT05660616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581225|NCT05660525|Nicotine|nicotine|mesh-list
44581226|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44581227|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
44581228|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581229|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581230|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44581231|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44581232|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
44581233|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581234|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581235|NCT05660473|Cytarabine|cytarabine|mesh-list
44581236|NCT05660473|Dexamethasone|dexamethasone|mesh-list
44581237|NCT05660473|Prednisone|prednisone|mesh-list
44581238|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
44581239|NCT05660473|Methotrexate|methotrexate|mesh-list
44581240|NCT05660473|Vincristine|vincristine|mesh-list
44581241|NCT05660473|Daunorubicin|daunorubicin|mesh-list
44581242|NCT05660473|Venetoclax|venetoclax|mesh-list
44581243|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
44581244|NCT05660473|Pegaspargase|pegaspargase|mesh-list
44581245|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581246|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
44581247|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581248|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581249|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44581250|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
44581251|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581252|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581253|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44581254|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581255|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
44581256|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
44581257|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581258|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581259|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
44581260|NCT05660473|Hormones|hormones|mesh-ancestor
44581261|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581262|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44581263|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44581264|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
44581265|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44203187|NCT00408252|Growth Substances|growth substances|mesh-ancestor
44581266|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581267|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
44581268|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581269|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581270|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44581271|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44581272|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
44581273|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581274|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44581275|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44581276|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44581277|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44581278|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44581279|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44581280|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44581281|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44581282|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
44581283|NCT05660447|Glycerol|glycerol|mesh-list
44581284|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44581285|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44581286|NCT05660447|Protective Agents|protective agents|mesh-ancestor
44581287|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581288|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44581289|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581290|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581292|NCT05660382|Clotrimazole|clotrimazole|mesh-list
44581293|NCT05660382|Mineral Oil|mineral oil|mesh-list
44581294|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
44581295|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581296|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44581297|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44581298|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581299|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581300|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44581301|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
44581302|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581303|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581304|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44581305|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44581306|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44581307|NCT05660382|Emollients|emollients|mesh-ancestor
44581308|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581309|NCT05660356|Hormones|hormones|mesh-list
44581310|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581311|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581312|NCT05660278|Caseins|caseins|mesh-list
44581313|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
44581314|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
44581315|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581316|NCT05660135|Amlodipine|amlodipine|mesh-list
44581317|NCT05660135|Olmesartan|olmesartan|mesh-list
44581318|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44581319|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44581320|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44581321|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44581322|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581323|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203252|NCT00408551|Vitamins|vitamins|mesh-ancestor
44581324|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581325|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581326|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
44581327|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44581328|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44581329|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
44581330|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44581331|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44581332|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581333|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44581334|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44581335|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44581336|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581337|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581338|NCT05659992|Cytarabine|cytarabine|mesh-list
44581339|NCT05659992|Azacitidine|azacitidine|mesh-list
44581340|NCT05659992|Venetoclax|venetoclax|mesh-list
44581341|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581342|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
44581343|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581344|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581345|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
44581346|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581347|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581348|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
44581349|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581350|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581351|NCT05659927|Antibodies|antibodies|mesh-list
44581352|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44581353|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
44581354|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581355|NCT05659823|Fentanyl|fentanyl|mesh-list
44581356|NCT05659823|Morphine|morphine|mesh-list
44581357|NCT05659823|Bupivacaine|bupivacaine|mesh-list
44581358|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581359|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
44581360|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581361|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581362|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
44581363|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581364|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44581366|NCT05659823|Analgesics|analgesics|mesh-ancestor
44581367|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44581368|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581369|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
44581370|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44581371|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44581372|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581373|NCT05659576|Sucralfate|sucralfate|mesh-list
44581374|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44581375|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581376|NCT05659537|Dulaglutide|dulaglutide|mesh-list
44581377|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44581378|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581379|NCT05659459|Pioglitazone|pioglitazone|mesh-list
44581380|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44581381|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581382|NCT05659407|Rituximab|rituximab|mesh-list
44581383|NCT05659407|Belimumab|belimumab|mesh-list
44581384|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581385|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581386|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
44581387|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581388|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581389|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581390|NCT05659381|Cisplatin|cisplatin|mesh-list
44581391|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581392|NCT05659368|Tirzepatide|tirzepatide|mesh-list
44581393|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44581394|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581395|NCT05659368|Incretins|incretins|mesh-ancestor
44581396|NCT05659368|Hormones|hormones|mesh-ancestor
44581397|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581398|NCT05659329|Gentamicins|gentamicins|mesh-list
44581399|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581400|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581401|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44581402|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581403|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581404|NCT05659251|Paclitaxel|paclitaxel|mesh-list
44581405|NCT05659251|Carboplatin|carboplatin|mesh-list
44581406|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44581407|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581408|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44581409|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44581410|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44581411|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581412|NCT05659212|Lidocaine|lidocaine|mesh-list
44581413|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
44581414|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
44581415|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581416|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
44581417|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581418|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581419|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
44581420|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581421|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44581422|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44581423|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44581424|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581425|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581426|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581427|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581428|NCT05659212|Analgesics|analgesics|mesh-ancestor
44581429|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44581430|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44581431|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581432|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581433|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581434|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
44581435|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44581436|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581437|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
44581438|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581439|NCT05659056|Trastuzumab|trastuzumab|mesh-list
44581440|NCT05659056|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44581441|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581442|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581443|NCT05658874|Methenamine|methenamine|mesh-list
44581444|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
44581445|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
44408396|NCT02519842|Hormones|hormones|mesh-ancestor
44581446|NCT05658874|Gabapentin|gabapentin|mesh-list
44581447|NCT05658874|Amitriptyline|amitriptyline|mesh-list
44581448|NCT05658874|Mirabegron|mirabegron|mesh-list
44581449|NCT05658874|Oxybutynin|oxybutynin|mesh-list
44581450|NCT05658874|Estrogens|estrogens|mesh-list
44581451|NCT05658874|Analgesics|analgesics|mesh-ancestor
44581452|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
44581453|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581454|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581455|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
44581456|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44581457|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44581458|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581459|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581460|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44581461|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44581462|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581463|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581464|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
44581465|NCT05658874|Hormones|hormones|mesh-ancestor
44581466|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581467|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44581468|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44581469|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581470|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581471|NCT05658874|Urological Agents|urological agents|mesh-ancestor
44581472|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44581473|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
44581474|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581475|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44581476|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44581477|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581478|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
44581479|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
44581480|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44581481|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44581482|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
44581483|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44581484|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581485|NCT05658874|Renal Agents|renal agents|mesh-ancestor
44581486|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581487|NCT05658861|Caseins|caseins|mesh-list
44581488|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
44581489|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
44581490|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581491|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
44581492|NCT05658692|Dexamethasone|dexamethasone|mesh-list
44581493|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
44581494|NCT05658692|Simendan|simendan|mesh-list
44581495|NCT05658692|Dopamine|dopamine|mesh-list
44581496|NCT05658692|Isoproterenol|isoproterenol|mesh-list
44581497|NCT05658692|Olprinone|olprinone|mesh-list
44581498|NCT05658692|Epinephrine|epinephrine|mesh-list
44581499|NCT05658692|Norepinephrine|norepinephrine|mesh-list
44581500|NCT05658692|Metaraminol|metaraminol|mesh-list
44581501|NCT05658692|Midazolam|midazolam|mesh-list
44581502|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
44581503|NCT05658692|Bromides|bromides|mesh-list
44581504|NCT05658692|Propofol|propofol|mesh-list
44581505|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44581506|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44581507|NCT05658692|Simvastatin|simvastatin|mesh-list
44581508|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
44581509|NCT05658692|Succinylcholine|succinylcholine|mesh-list
44581510|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
44581511|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581512|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
44581513|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
44581514|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581515|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581516|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581517|NCT05658692|Hormones|hormones|mesh-ancestor
44581518|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581519|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44581521|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581522|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581523|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581524|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581525|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
44581526|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
44581527|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581528|NCT05658692|Analgesics|analgesics|mesh-ancestor
44581529|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
44581530|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44581531|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44581532|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581533|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581534|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581535|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44581536|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44581537|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44581538|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581539|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
44581540|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
44581541|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44581542|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44581543|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
44581544|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44581545|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44581546|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44581547|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44581548|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44581549|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
44581550|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
44581551|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
44581552|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44581553|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
44581554|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44581555|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44581556|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44581557|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44581558|NCT05658692|Protective Agents|protective agents|mesh-ancestor
44581559|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
44581560|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44581561|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44581562|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44581563|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44581564|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44581565|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44581566|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
44581567|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44581568|NCT05658640|Cytarabine|cytarabine|mesh-list
44581569|NCT05658640|Dexamethasone|dexamethasone|mesh-list
44581570|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
44581571|NCT05658640|Trametinib|trametinib|mesh-list
44581572|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581573|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
44581574|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581575|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581576|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44581577|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
44581578|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581579|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581580|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44581581|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581582|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
44581583|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
44581584|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581585|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581586|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
44581587|NCT05658640|Hormones|hormones|mesh-ancestor
44581588|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581589|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44581590|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581591|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
44581592|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
44581593|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581594|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44581595|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581596|NCT05657678|Vitamin D|vitamin d|mesh-list
44581597|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
44581598|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
44581599|NCT05657678|Vitamins|vitamins|mesh-list
44581600|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
44581601|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408542|NCT02516410|Ivacaftor|ivacaftor|mesh-list
44581602|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44581603|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581604|NCT05656521|Dexamethasone|dexamethasone|mesh-list
44581605|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581606|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
44581607|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
44581608|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581609|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581610|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581611|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
44581612|NCT05656521|Hormones|hormones|mesh-ancestor
44581613|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581614|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44581615|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581616|NCT05656443|Ritonavir|ritonavir|mesh-list
44581617|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44581618|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44581619|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44581620|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581621|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581622|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44581623|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44581624|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
44581625|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581626|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44581627|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44581628|NCT05655468|Dronedarone|dronedarone|mesh-list
44581629|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44581630|NCT05655182|Vaccines|vaccines|mesh-list
44581631|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
44581632|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581633|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
44581634|NCT05654077|Fludarabine|fludarabine|mesh-list
44581635|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581636|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
44581637|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581638|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581639|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44581640|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
44581641|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581642|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581643|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44581644|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44581645|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
44581646|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581649|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581650|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
44581651|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581652|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581653|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
44581654|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581655|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
44581656|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44581658|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
44581659|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581660|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44581661|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44581662|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581663|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581664|NCT05642715|Varenicline|varenicline|mesh-list
44581665|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44581666|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44581667|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
44581668|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581669|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581670|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581671|NCT05637515|Adalimumab|adalimumab|mesh-list
44581672|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581673|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581674|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44581675|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44581676|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44581677|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
44581678|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581679|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44581680|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44581681|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581682|NCT05636904|Minoxidil|minoxidil|mesh-list
44581683|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44581684|NCT05636904|Dinoprost|dinoprost|mesh-list
44581685|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
44581686|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44581687|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
44581688|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44581689|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
44581690|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581691|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581692|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
44581693|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44581694|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581695|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581696|NCT05635201|Anesthetics|anesthetics|mesh-list
44581697|NCT05635201|Propofol|propofol|mesh-list
44581698|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581699|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203601|NCT00410306|Hormones|hormones|mesh-ancestor
44581700|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581701|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581702|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
44581703|NCT05634707|Temozolomide|temozolomide|mesh-list
44581704|NCT05634707|Fluoxetine|fluoxetine|mesh-list
44581705|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44581706|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
44581707|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581708|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581709|NCT05634707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44581710|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44581711|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581712|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581713|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
44581714|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581715|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44581716|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44581717|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581718|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44581719|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44581720|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581721|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
44581722|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581723|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581724|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581725|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581726|NCT05634148|Analgesics|analgesics|mesh-ancestor
44581727|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
44581728|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581729|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44581730|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44581731|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581732|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581733|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581734|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581735|NCT05633147|Clarithromycin|clarithromycin|mesh-list
44581736|NCT05633147|Midazolam|midazolam|mesh-list
44581737|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44581738|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581739|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581740|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581741|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44581742|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44581743|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581744|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581745|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
44581746|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
44581747|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
44581748|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
44581749|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581750|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581751|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581752|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581753|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44581754|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581755|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44581756|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44581757|NCT05630755|Islatravir|islatravir|mesh-list
44581758|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
44581759|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581760|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581761|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581762|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44581763|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44581764|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44581765|NCT05630677|Rabeprazole|rabeprazole|mesh-list
44581766|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44581767|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581768|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44581769|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581770|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581771|NCT05625802|Ropivacaine|ropivacaine|mesh-list
44581772|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581773|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
44581774|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581775|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581776|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
44581777|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581778|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
44581779|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
44581780|NCT05624151|Bupivacaine|bupivacaine|mesh-list
44581781|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581782|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
44581783|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581784|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581785|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
44581786|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203675|NCT00410553|Immunologic Factors|immunologic factors|mesh-ancestor
44581787|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581788|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44581789|NCT05624151|Analgesics|analgesics|mesh-ancestor
44581790|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44581791|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44581792|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581793|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581794|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581795|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581796|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44581797|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
44581798|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44581799|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581800|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44581801|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
44581802|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44408778|NCT02511184|Crizotinib|crizotinib|mesh-list
44581803|NCT05623592|Methotrexate|methotrexate|mesh-list
44581804|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44581805|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
44581806|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581807|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581808|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44581809|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
44581810|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581811|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581812|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581813|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581814|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44581815|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44581816|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
44581817|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581818|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44581819|NCT05622370|Brivaracetam|brivaracetam|mesh-list
44581821|NCT05605366|Minocycline|minocycline|mesh-list
44581822|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581823|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581824|NCT05598853|Nivolumab|nivolumab|mesh-list
44581825|NCT05598853|Ipilimumab|ipilimumab|mesh-list
44581826|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581827|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581828|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44581829|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581830|NCT05594589|Lemborexant|lemborexant|mesh-list
44581831|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44581832|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581833|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581834|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44581835|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581836|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581837|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581838|NCT05590598|Azelastine|azelastine|mesh-list
44581839|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44581840|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
44203725|NCT00410644|Narcotics|narcotics|mesh-ancestor
44581841|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581842|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581843|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44581844|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
44581845|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44581846|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581847|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581848|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44581849|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44581850|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44581851|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
44581852|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
44581853|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581854|NCT05589844|Vaccines|vaccines|mesh-list
44581855|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
44581856|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581857|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
44581858|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44581859|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44581860|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44581861|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44581862|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581863|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581864|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
44581865|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581866|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581867|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44581868|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581869|NCT05585112|Lidocaine|lidocaine|mesh-list
44581870|NCT05585112|Carticaine|carticaine|mesh-list
44581871|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
44581872|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
44581873|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581874|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581875|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
44581876|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581877|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44581878|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44581879|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44581880|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44581881|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581882|NCT05582174|Esomeprazole|esomeprazole|mesh-list
44581883|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44581884|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581885|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44581886|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581887|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581888|NCT05580003|Midazolam|midazolam|mesh-list
44581889|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44581890|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581891|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983194|NCT02100826|Cephalexin|cephalexin|mesh-list
44581892|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581893|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44581894|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44581895|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581896|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581897|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
44581898|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
44581899|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
44581900|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
44581901|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581902|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581903|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
44581904|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
44581905|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581906|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
44581907|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44581908|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581909|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581910|NCT05578092|Adagrasib|adagrasib|mesh-list
44581911|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581912|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
44581913|NCT05576740|Hormones|hormones|mesh-list
44581914|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581915|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581916|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44581917|NCT05574504|Avelumab|avelumab|mesh-list
44581918|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44581919|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581920|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581921|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581922|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
44581923|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44581924|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581925|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581926|NCT05570292|Folic Acid|folic acid|mesh-list
44581927|NCT05570292|Domperidone|domperidone|mesh-list
44581928|NCT05570292|Hematinics|hematinics|mesh-ancestor
44581929|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
44581930|NCT05570292|Vitamins|vitamins|mesh-ancestor
44581931|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
44581932|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581933|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
44581934|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
44581935|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581936|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44581937|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44581938|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
44581939|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581940|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581941|NCT05569421|Budesonide|budesonide|mesh-list
44581942|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
44581943|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44581944|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44581945|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
44581946|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44581947|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581948|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44581949|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
44581950|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
44581951|NCT05569421|Hormones|hormones|mesh-ancestor
44581952|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44581953|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44581954|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44581955|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44581956|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44581957|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581958|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581959|NCT05552508|Benralizumab|benralizumab|mesh-list
44581960|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44581961|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44581962|NCT05551936|Rituximab|rituximab|mesh-list
44581963|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44581964|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44581965|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44581966|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
44581967|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581968|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44581969|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44581970|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
44581971|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581972|NCT05550636|Midazolam|midazolam|mesh-list
44581973|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44581974|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44581975|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44581976|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44581977|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44581978|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44581979|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44581980|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44581981|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
44581982|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
44581983|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
44581984|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
44581985|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44581986|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581987|NCT05549115|Amoxicillin|amoxicillin|mesh-list
44581988|NCT05549115|Clarithromycin|clarithromycin|mesh-list
44581989|NCT05549115|Levofloxacin|levofloxacin|mesh-list
44581990|NCT05549115|Ofloxacin|ofloxacin|mesh-list
44581991|NCT05549115|Furazolidone|furazolidone|mesh-list
44581992|NCT05549115|Bismuth|bismuth|mesh-list
44581993|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44581994|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44581995|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44581996|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44581997|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44581998|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44581999|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44582000|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44582001|NCT05549115|Renal Agents|renal agents|mesh-ancestor
44582002|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44582003|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44582004|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582005|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44582006|NCT05549115|Antacids|antacids|mesh-ancestor
44582007|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44582008|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44582009|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44582010|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44582011|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44582012|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44582013|NCT05546554|Suvorexant|suvorexant|mesh-list
44582014|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44582015|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44582016|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582017|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582018|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44582019|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582020|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582021|NCT05540574|Zolpidem|zolpidem|mesh-list
44582022|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44582023|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44582024|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582025|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582026|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44582027|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
44582028|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
44582029|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582030|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582031|NCT05538052|Lidocaine|lidocaine|mesh-list
44582032|NCT05538052|Tramadol|tramadol|mesh-list
44582033|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
44582034|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
44582035|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582036|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582037|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
44409070|NCT02501629|Reslizumab|reslizumab|mesh-list
44582038|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582039|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44582040|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44582041|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44582042|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582043|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582044|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44582045|NCT05538052|Narcotics|narcotics|mesh-ancestor
44582046|NCT05538052|Analgesics|analgesics|mesh-ancestor
44582047|NCT05537935|Naltrexone|naltrexone|mesh-list
44582048|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44582049|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44582050|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582051|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
44203893|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44582052|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582053|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
44582054|NCT05521984|Carmustine|carmustine|mesh-list
44582055|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44582056|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582057|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582058|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582059|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582060|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
44582061|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582062|NCT05520619|Paclitaxel|paclitaxel|mesh-list
44582063|NCT05520619|Cisplatin|cisplatin|mesh-list
44582064|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44582065|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582066|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582067|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582068|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582069|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582070|NCT05514912|Gemcitabine|gemcitabine|mesh-list
44582071|NCT05514912|Paclitaxel|paclitaxel|mesh-list
44582072|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44582073|NCT05514912|Cisplatin|cisplatin|mesh-list
44582074|NCT05514912|Infigratinib|infigratinib|mesh-list
44582075|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44582076|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582077|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582078|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582079|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582080|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582081|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582082|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
44582083|NCT05514912|Antiviral Agents|antiviral agents|mesh-ancestor
44582084|NCT05514912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582085|NCT05514912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582086|NCT05514912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582087|NCT05514912|Immunologic Factors|immunologic factors|mesh-ancestor
44582088|NCT05514912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582090|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44582091|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582092|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582093|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
44582094|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582095|NCT05512819|Vaccines|vaccines|mesh-list
44582096|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44582097|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
44582098|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582099|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44582100|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44582101|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44582102|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582103|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582104|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44582105|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582106|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582107|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
44582108|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582109|NCT05511909|Lofexidine|lofexidine|mesh-list
44582110|NCT05511909|Buspirone|buspirone|mesh-list
44582111|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44582112|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582113|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582114|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582115|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582116|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44582117|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
44582118|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582119|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582120|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44582121|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44582122|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
44582123|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582124|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44582125|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44582126|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44582127|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
44582128|NCT05511428|Daratumumab|daratumumab|mesh-list
44582129|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44582130|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582131|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
44582132|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582133|NCT05504876|Midazolam|midazolam|mesh-list
44582134|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44582135|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44582136|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582137|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582138|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44582139|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582140|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582141|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44582142|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
44582143|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
44582144|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
44582145|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
44582146|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582147|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582148|NCT05502250|Gemcitabine|gemcitabine|mesh-list
44582149|NCT05502250|Cisplatin|cisplatin|mesh-list
44582150|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582151|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582152|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
44582153|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582154|NCT05502250|Antiviral Agents|antiviral agents|mesh-ancestor
44582155|NCT05502250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582157|NCT05502250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582158|NCT05502250|Immunologic Factors|immunologic factors|mesh-ancestor
44582159|NCT05502250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582160|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
44582161|NCT05501678|Promethazine|promethazine|mesh-list
44582162|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44582163|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44582164|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582165|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582166|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
44582167|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
44582168|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
44582169|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582170|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
44582171|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
44582172|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44582173|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44582174|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
44582175|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
44582176|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582177|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582178|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44582179|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
44582180|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
44409278|NCT02497391|Evacetrapib|evacetrapib|mesh-list
44582181|NCT05498103|Methazolamide|methazolamide|mesh-list
44582182|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44582183|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582184|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582185|NCT05498103|Diuretics|diuretics|mesh-ancestor
44582186|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
44582187|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582188|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
44582189|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582190|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582191|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
44582192|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44582196|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44582197|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582198|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
44582199|NCT05484167|Hormones|hormones|mesh-ancestor
44582200|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582201|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582202|NCT05484167|Androgens|androgens|mesh-ancestor
44582203|NCT05483933|Doxorubicin|doxorubicin|mesh-list
44582204|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44582205|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204032|NCT00411593|Bevacizumab|bevacizumab|mesh-list
44582206|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582207|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44582208|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44582209|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582210|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582211|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
44582212|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44582213|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44582214|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582215|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582216|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44582217|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582218|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582219|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
44582220|NCT05477589|Melphalan|melphalan|mesh-list
44582221|NCT05477589|Busulfan|busulfan|mesh-list
44582222|NCT05477589|Fludarabine|fludarabine|mesh-list
44582223|NCT05477589|Clofarabine|clofarabine|mesh-list
44582224|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582225|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
44582226|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582227|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582228|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582229|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
44582230|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582231|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582232|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44582233|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582234|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
44582235|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
44582236|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
44582237|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44582238|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44582239|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582240|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
44582241|NCT05474027|Coagulants|coagulants|mesh-ancestor
44582242|NCT05472753|Selenium|selenium|mesh-list
44582243|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44582244|NCT05472753|Curcumin|curcumin|mesh-list
44582245|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44582246|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44582247|NCT05472753|Analgesics|analgesics|mesh-ancestor
44582248|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
44582249|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582250|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582251|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44582252|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582253|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582254|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204092|NCT00411996|Ritonavir|ritonavir|mesh-list
44582255|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582256|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
44582257|NCT05472753|Protective Agents|protective agents|mesh-ancestor
44582258|NCT05472753|Trace Elements|trace elements|mesh-ancestor
44582259|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
44582260|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582261|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44582262|NCT05470699|Fluorides|fluorides|mesh-list
44582263|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
44582264|NCT05470699|Protective Agents|protective agents|mesh-ancestor
44582265|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582278|NCT05452772|Psilocybin|psilocybin|mesh-list
44582279|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44582280|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
44582281|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582282|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44582283|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
44582284|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
44582285|NCT05452772|Vitamins|vitamins|mesh-ancestor
44582286|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
44582287|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582288|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
44582289|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582290|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
44582291|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44582292|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
44582293|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44582294|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
44582295|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582296|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582297|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
44582298|NCT05445778|Bevacizumab|bevacizumab|mesh-list
44582299|NCT05445778|Maytansine|maytansine|mesh-list
44582300|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582301|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582302|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44582303|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44582304|NCT05445778|Growth Substances|growth substances|mesh-ancestor
44582305|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582306|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
44582307|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44582308|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582309|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582310|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582311|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582312|NCT05442190|Hypericin|hypericin|mesh-list
44582313|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
44582314|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582315|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582316|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
44582317|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582318|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582319|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582320|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582321|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
44582322|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582323|NCT05434559|Insulin|insulin|mesh-list
44582324|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582325|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582326|NCT05427786|Nicorandil|nicorandil|mesh-list
44582327|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44582328|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44582329|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
44582330|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
44582331|NCT05427786|Vitamins|vitamins|mesh-ancestor
44582332|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
44582333|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582334|NCT05423106|Tenofovir|tenofovir|mesh-list
44582335|NCT05423106|Entecavir|entecavir|mesh-list
44582336|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
44582337|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582338|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44582339|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44582340|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582341|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582342|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44582343|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44582344|NCT05421858|Fluconazole|fluconazole|mesh-list
44582345|NCT05421858|Caspofungin|caspofungin|mesh-list
44582346|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
44582347|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582348|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44582349|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44582350|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582351|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582352|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44204174|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
44582353|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582354|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582355|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582356|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44582357|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44582359|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582360|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
44582361|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582362|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582363|NCT05415644|Metformin|metformin|mesh-list
44582364|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582365|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582366|NCT05414422|Ketamine|ketamine|mesh-list
44582367|NCT05414422|Analgesics|analgesics|mesh-ancestor
44582368|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
44582369|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582370|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582371|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44582372|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44582373|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
44582374|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
44582375|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582376|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44582377|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44582378|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582379|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582380|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
44582381|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44582382|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
44582383|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582384|NCT05408247|Expectorants|expectorants|mesh-ancestor
44582385|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
44582386|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44582387|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
44582388|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582389|NCT05408247|Protective Agents|protective agents|mesh-ancestor
44582390|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582391|NCT05408247|Antidotes|antidotes|mesh-ancestor
44582392|NCT05401110|Osimertinib|osimertinib|mesh-list
44582393|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582394|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44582395|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582396|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582397|NCT05394337|Atezolizumab|atezolizumab|mesh-list
44582398|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582399|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44582400|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582401|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582402|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582403|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44582404|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44582405|NCT05387577|Estradiol|estradiol|mesh-list
44409489|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582406|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44582407|NCT05387577|Estrogens|estrogens|mesh-ancestor
44582408|NCT05387577|Hormones|hormones|mesh-ancestor
44204214|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582409|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582410|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582411|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44582412|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
44582413|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44582414|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44582415|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
44582416|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44582422|NCT05375903|Imiquimod|imiquimod|mesh-list
44582423|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44582424|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44582425|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
44582426|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582427|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582428|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
44582429|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
44582430|NCT05370326|Narcotics|narcotics|mesh-ancestor
44582431|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582432|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582433|NCT05370326|Analgesics|analgesics|mesh-ancestor
44582434|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
44582435|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582436|NCT05367089|Fluconazole|fluconazole|mesh-list
44582437|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
44582438|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582439|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44582440|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44582441|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582442|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582443|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44582444|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582445|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582446|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582447|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44582448|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44582449|NCT05364073|Aflutinib|aflutinib|mesh-list
44582450|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44582451|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582452|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582453|NCT05356091|Sevoflurane|sevoflurane|mesh-list
44582454|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44582455|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44582456|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
44582457|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
44582458|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582459|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582460|NCT05348577|Docetaxel|docetaxel|mesh-list
44582461|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582462|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582463|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582464|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582465|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582466|NCT05345457|Amoxicillin|amoxicillin|mesh-list
44582467|NCT05345457|Azithromycin|azithromycin|mesh-list
44582468|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44582469|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582475|NCT05327699|Ketamine|ketamine|mesh-list
44582476|NCT05327699|Analgesics|analgesics|mesh-ancestor
44582477|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
44582478|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582479|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582480|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44582481|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44582482|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
44582483|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
44582484|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582485|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44582486|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44582487|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582488|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582489|NCT05309655|Adenosine|adenosine|mesh-list
44582490|NCT05309655|Analgesics|analgesics|mesh-ancestor
44582491|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
44582492|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582500|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582502|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582503|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582504|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44582505|NCT05308420|Narcotics|narcotics|mesh-ancestor
44582506|NCT05308420|Analgesics|analgesics|mesh-ancestor
44582507|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
44582508|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582509|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44582510|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582511|NCT05304767|Xanomeline|xanomeline|mesh-list
44582512|NCT05304767|Trospium chloride|trospium chloride|mesh-list
44582513|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
44582514|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
44582515|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582516|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582517|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44582518|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44582519|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456118|NCT01634555|Antidotes|antidotes|mesh-ancestor
44582520|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582521|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582522|NCT05304767|Urological Agents|urological agents|mesh-ancestor
44582523|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44582524|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582525|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44582526|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44582527|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44582528|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44582529|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582530|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582531|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44582532|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582533|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582534|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582535|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44582536|NCT05293938|Cathartics|cathartics|mesh-ancestor
44582537|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44582538|NCT05288283|Cannabidiol|cannabidiol|mesh-list
44582539|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
44582540|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
44582541|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
44582542|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582543|NCT05282277|Raclopride|raclopride|mesh-list
44582544|NCT05282277|Estradiol|estradiol|mesh-list
44582545|NCT05282277|Progesterone|progesterone|mesh-list
44582546|NCT05282277|Estrogens|estrogens|mesh-ancestor
44582547|NCT05282277|Hormones|hormones|mesh-ancestor
44582548|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582549|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582550|NCT05282277|Progestins|progestins|mesh-ancestor
44582551|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44582552|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582553|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582554|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582555|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44582556|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
44582557|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582558|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582559|NCT05276908|Bupivacaine|bupivacaine|mesh-list
44582560|NCT05276908|Anesthetics|anesthetics|mesh-list
44582561|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
44582562|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582563|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582564|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
44582565|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582566|NCT05275686|Fluticasone|fluticasone|mesh-list
44582567|NCT05275686|Xhance|xhance|mesh-list
44582568|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44582569|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44582570|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
44582571|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582572|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236645|NCT00560300|Vitamin D|vitamin d|mesh-list
44582573|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44582574|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
44582575|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44582576|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44582577|NCT05274269|Ivacaftor|ivacaftor|mesh-list
44582578|NCT05274269|Elexacaftor|elexacaftor|mesh-list
44582579|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44582580|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582581|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582582|NCT05273710|Folic Acid|folic acid|mesh-list
44582583|NCT05273710|Hematinics|hematinics|mesh-ancestor
44582584|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
44582585|NCT05273710|Vitamins|vitamins|mesh-ancestor
44582586|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
44582587|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582588|NCT05267600|Prednisone|prednisone|mesh-list
44582589|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44582590|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
44582591|NCT05267600|Hormones|hormones|mesh-ancestor
44582592|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582593|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582594|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44582595|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582596|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44582597|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
44582598|NCT05264922|Coagulants|coagulants|mesh-ancestor
44582599|NCT05263583|Bromides|bromides|mesh-list
44582600|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
44582601|NCT05262751|Nintedanib|nintedanib|mesh-list
44582602|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582603|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44582604|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582605|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582606|NCT05251259|Montelukast|montelukast|mesh-list
44582607|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44582608|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
44582609|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44582610|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582611|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582612|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582613|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44582614|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44582615|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582616|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44582617|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582618|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582619|NCT05243550|Mitomycins|mitomycins|mesh-list
44582620|NCT05243550|Mitomycin|mitomycin|mesh-list
44582621|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44582622|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582623|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
44582624|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582625|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44582626|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582627|NCT05237726|Heparin|heparin|mesh-list
44582628|NCT05237726|Enoxaparin|enoxaparin|mesh-list
44582629|NCT05237726|Calcium heparin|calcium heparin|mesh-list
44582630|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
44582631|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
44582632|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44582633|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44582634|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582635|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
44582636|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44582637|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582638|NCT05231122|Bevacizumab|bevacizumab|mesh-list
44582639|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44582640|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
44582641|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
44582642|NCT05231122|Antibodies|antibodies|mesh-list
44582643|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
44582644|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44582645|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
44582646|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582647|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44582648|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44582649|NCT05231122|Growth Substances|growth substances|mesh-ancestor
44582650|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582651|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
44582652|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
44204413|NCT00413686|Antiviral Agents|antiviral agents|mesh-ancestor
44582653|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44582654|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582655|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582657|NCT05221151|Ondansetron|ondansetron|mesh-list
44582658|NCT05221151|Melatonin|melatonin|mesh-list
44582659|NCT05221151|Analgesics|analgesics|mesh-ancestor
44582660|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
44582661|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582662|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582663|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
44582664|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44582665|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582666|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582667|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44582668|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44582669|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582670|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582671|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582672|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
44582673|NCT05221151|Protective Agents|protective agents|mesh-ancestor
44582674|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
44582675|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
44582676|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44582677|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
44582678|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44582679|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44582680|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
44582682|NCT05221151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44582684|NCT05206448|Clomiphene|clomiphene|mesh-list
44582685|NCT05206448|Enclomiphene|enclomiphene|mesh-list
44582686|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
44582687|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582688|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582689|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44582690|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44582691|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582692|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44582693|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582694|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582695|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582696|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44582697|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
44582698|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44582699|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44582700|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44582701|NCT05204927|Prednisone|prednisone|mesh-list
44582702|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44582703|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
44582704|NCT05204927|Hormones|hormones|mesh-ancestor
44582705|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582706|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582707|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44582708|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582709|NCT05195645|Abatacept|abatacept|mesh-list
44582710|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44582711|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582712|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582713|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582714|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
44582715|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582716|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582717|NCT05190471|Decitabine|decitabine|mesh-list
44582718|NCT05190471|Oblimersen|oblimersen|mesh-list
44582719|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582720|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
44582721|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582722|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582723|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582724|NCT05188170|Niclosamide|niclosamide|mesh-list
44582725|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
44582726|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44582727|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
44582728|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44582729|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582730|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
44582731|NCT05187429|Nivolumab|nivolumab|mesh-list
44582732|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582733|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582734|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44582735|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582736|NCT05183035|Cytarabine|cytarabine|mesh-list
44582737|NCT05183035|Fludarabine|fludarabine|mesh-list
44582738|NCT05183035|Azacitidine|azacitidine|mesh-list
44582739|NCT05183035|Venetoclax|venetoclax|mesh-list
44582740|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
44582741|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582742|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582743|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
44582744|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582745|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582746|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
44582747|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582748|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
44582749|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582750|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582751|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582752|NCT05182931|Trametinib|trametinib|mesh-list
44582753|NCT05182931|Dabrafenib|dabrafenib|mesh-list
44582754|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582755|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44582756|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582757|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582758|NCT05180994|Infliximab|infliximab|mesh-list
44582759|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44582760|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44582761|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582762|NCT05176626|Phentermine|phentermine|mesh-list
44582763|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44582764|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582765|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
44582766|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44582767|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
44582768|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
44582769|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582770|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
44582771|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582772|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582773|NCT05176288|Palbociclib|palbociclib|mesh-list
44582774|NCT05176288|Avelumab|avelumab|mesh-list
44582775|NCT05176288|Axitinib|axitinib|mesh-list
44582776|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582777|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44582778|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582779|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582780|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582781|NCT05166577|Valganciclovir|valganciclovir|mesh-list
44582782|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
44582783|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582784|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582785|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
44582786|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582787|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
44582788|NCT05165225|Docetaxel|docetaxel|mesh-list
44582789|NCT05165225|Epirubicin|epirubicin|mesh-list
44582790|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582791|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
44582792|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582793|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582794|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582795|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
44582796|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582797|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582798|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44582799|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582800|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582801|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582802|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44582803|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44582804|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44582805|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582806|NCT05161195|Tamoxifen|tamoxifen|mesh-list
44582807|NCT05161195|Letrozole|letrozole|mesh-list
44582808|NCT05161195|Fulvestrant|fulvestrant|mesh-list
44582809|NCT05161195|Anastrozole|anastrozole|mesh-list
44582810|NCT05161195|Goserelin|goserelin|mesh-list
44204556|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582811|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582812|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44582813|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44582814|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582815|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582816|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44582817|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582818|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582819|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582820|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44582821|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44582822|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44582823|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44582824|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44582825|NCT05156892|Tamoxifen|tamoxifen|mesh-list
44582826|NCT05156892|Itraconazole|itraconazole|mesh-list
44582827|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44582828|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
44582829|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410008|NCT02483611|Analgesics|analgesics|mesh-ancestor
44582830|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582831|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44582832|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582833|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44582834|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44582835|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44582836|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
44582837|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582838|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44582839|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44582840|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582841|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582842|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44582843|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44582845|NCT05152147|Fluorouracil|fluorouracil|mesh-list
44582846|NCT05152147|Capecitabine|capecitabine|mesh-list
44582847|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
44582848|NCT05152147|Trastuzumab|trastuzumab|mesh-list
44582849|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582850|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
44582851|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582852|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582853|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582854|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
44582855|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582856|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582857|NCT05142189|Docetaxel|docetaxel|mesh-list
44582858|NCT05142189|Cemiplimab|cemiplimab|mesh-list
44582859|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582860|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582861|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582862|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582863|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582864|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582865|NCT05133518|Midazolam|midazolam|mesh-list
44582866|NCT05133518|Ketamine|ketamine|mesh-list
44582867|NCT05133518|Analgesics|analgesics|mesh-ancestor
44582868|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
44582869|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582870|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582871|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44582872|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44582873|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
44582874|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
44582875|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582876|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44582877|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44582878|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582879|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582880|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44582881|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44582883|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582884|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582885|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
44582886|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
44582887|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
44582888|NCT05132504|Folfirinox|folfirinox|mesh-list
44582889|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44582890|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582891|NCT05132075|Docetaxel|docetaxel|mesh-list
44582892|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582893|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582894|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582895|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582896|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582897|NCT05131178|Bupivacaine|bupivacaine|mesh-list
44582898|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
44582899|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
44582900|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582901|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582902|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
44582903|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582904|NCT05130463|Empagliflozin|empagliflozin|mesh-list
44582905|NCT05130463|Linagliptin|linagliptin|mesh-list
44582906|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44582907|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582908|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44582909|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582910|NCT05130463|Incretins|incretins|mesh-ancestor
44582911|NCT05130463|Hormones|hormones|mesh-ancestor
44582912|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44582913|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44582914|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44582915|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582916|NCT05130268|Dronedarone|dronedarone|mesh-list
44582917|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44410161|NCT02480153|Adalimumab|adalimumab|mesh-list
44582918|NCT05124691|Ivermectin|ivermectin|mesh-list
44582919|NCT05124691|Albendazole|albendazole|mesh-list
44582920|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44582921|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582922|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
44582923|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
44582924|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44582925|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44582926|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44582927|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44582928|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44582929|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582930|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582931|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
44582932|NCT05106296|Etoposide|etoposide|mesh-list
44582933|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582934|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
44582935|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582936|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582937|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582938|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
44582939|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582940|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582941|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44582942|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44582943|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44582944|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44582945|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44582946|NCT05103631|Cyclophosphamide|cyclophosphamide|mesh-list
44582947|NCT05103631|Fludarabine|fludarabine|mesh-list
44582948|NCT05103631|Fludarabine phosphate|fludarabine phosphate|mesh-list
44582949|NCT05103631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44582950|NCT05103631|Immunologic Factors|immunologic factors|mesh-ancestor
44236646|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
44582951|NCT05103631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582952|NCT05103631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44582953|NCT05103631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44582954|NCT05103631|Alkylating Agents|alkylating agents|mesh-ancestor
44582955|NCT05103631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582956|NCT05103631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44582957|NCT05103631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44582958|NCT05103631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44582959|NCT05103631|Antimetabolites|antimetabolites|mesh-ancestor
44582960|NCT05103410|Aripiprazole|aripiprazole|mesh-list
44582961|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
44582962|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44582963|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44582964|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44582965|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44582966|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582967|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
44582968|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
44582969|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582970|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582971|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44582972|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44582973|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
44582974|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44582975|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44582976|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44582977|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44582978|NCT05101187|Amphotericin B|amphotericin b|mesh-list
44582979|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44582980|NCT05101187|Olorofim|olorofim|mesh-list
44582981|NCT05101187|Amebicides|amebicides|mesh-ancestor
44582982|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44582983|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44582984|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44582985|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44582986|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
44582987|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44582988|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44582989|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44582990|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44582991|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44582992|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44582993|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
44582994|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44582995|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44582996|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44582997|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44582998|NCT05089708|Trifarotene|trifarotene|mesh-list
44582999|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583000|NCT05086224|Lidocaine|lidocaine|mesh-list
44583001|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
44583002|NCT05086224|Anesthetics|anesthetics|mesh-list
44583003|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583004|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583005|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
44583006|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583007|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44583008|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44583009|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44583010|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583011|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583012|NCT05073718|Aspirin|aspirin|mesh-list
44583013|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44583014|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44583015|NCT05073718|Analgesics|analgesics|mesh-ancestor
44583016|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
44583017|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583018|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583019|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583020|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583021|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44583022|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43984242|NCT02151487|Clonidine|clonidine|mesh-list
44583023|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583024|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44583025|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44583026|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583027|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
44583028|NCT05069545|Insulin|insulin|mesh-list
44583029|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44583030|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
44583031|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44583032|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583033|NCT05067634|Cenobamate|cenobamate|mesh-list
44583034|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
44583035|NCT05061550|Paclitaxel|paclitaxel|mesh-list
44583036|NCT05061550|Cisplatin|cisplatin|mesh-list
44583037|NCT05061550|Carboplatin|carboplatin|mesh-list
44583038|NCT05061550|Pemetrexed|pemetrexed|mesh-list
44583039|NCT05061550|Durvalumab|durvalumab|mesh-list
44583040|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583041|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583042|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583043|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583044|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204785|NCT00415922|Levodopa|levodopa|mesh-list
44583045|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583046|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583047|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44583048|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44583049|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583050|NCT05057494|Venetoclax|venetoclax|mesh-list
44583051|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
44583052|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
44583053|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583054|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583055|NCT05047250|Gemcitabine|gemcitabine|mesh-list
44583056|NCT05047250|Paclitaxel|paclitaxel|mesh-list
44583057|NCT05047250|Cisplatin|cisplatin|mesh-list
44583058|NCT05047250|Carboplatin|carboplatin|mesh-list
44583059|NCT05047250|Pemetrexed|pemetrexed|mesh-list
44583060|NCT05047250|Atezolizumab|atezolizumab|mesh-list
44583061|NCT05047250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583062|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583063|NCT05047250|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583064|NCT05047250|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583065|NCT05047250|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583066|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583067|NCT05047250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44410309|NCT02477332|Omalizumab|omalizumab|mesh-list
44583068|NCT05047250|Antimetabolites|antimetabolites|mesh-ancestor
44583069|NCT05047250|Antiviral Agents|antiviral agents|mesh-ancestor
44583070|NCT05047250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583071|NCT05047250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583072|NCT05047250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583073|NCT05047250|Immunologic Factors|immunologic factors|mesh-ancestor
44583074|NCT05047250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583075|NCT05047250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44583076|NCT05047250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44583077|NCT05038462|Lactoferrin|lactoferrin|mesh-list
44583078|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583079|NCT05037617|Oxytocin|oxytocin|mesh-list
44583080|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
44583081|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44583082|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583083|NCT05031936|Ropivacaine|ropivacaine|mesh-list
44583084|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
44583085|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
44583086|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583087|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583088|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
44583089|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583090|NCT05030766|Nicotine|nicotine|mesh-list
44583091|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44583092|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
44583093|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583094|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583095|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44583096|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44583097|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
44583098|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583099|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583100|NCT05028829|Atorvastatin|atorvastatin|mesh-list
44583101|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44583102|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44583103|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
44583104|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583105|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44583106|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44583107|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583108|NCT05020210|Sivelestat|sivelestat|mesh-list
44583109|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44583110|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
44583111|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583112|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583113|NCT05017246|Lidocaine|lidocaine|mesh-list
44583114|NCT05017246|Morphine|morphine|mesh-list
44583115|NCT05017246|Bupivacaine|bupivacaine|mesh-list
44583116|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
44583117|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
44583118|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583119|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583120|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
44583121|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583122|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44583123|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44583124|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44583125|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583126|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583127|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44583128|NCT05017246|Narcotics|narcotics|mesh-ancestor
44583129|NCT05017246|Analgesics|analgesics|mesh-ancestor
44583130|NCT05004350|Fluorouracil|fluorouracil|mesh-list
44583131|NCT05004350|Irinotecan|irinotecan|mesh-list
44583132|NCT05004350|Cetuximab|cetuximab|mesh-list
44583133|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
44583134|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583135|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583136|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583137|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583138|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
44583139|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583140|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44583141|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44583142|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583143|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583144|NCT04992065|Evolocumab|evolocumab|mesh-list
44583145|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44583157|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583159|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44583160|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
44583161|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583162|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583163|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44583164|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583165|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
44583166|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
44583167|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44583168|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44583169|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44583170|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44583171|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44583172|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583173|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410471|NCT02473445|Cysteamine|cysteamine|mesh-list
44583175|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583176|NCT04962152|Nalbuphine|nalbuphine|mesh-list
44583177|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44583178|NCT04962152|Narcotics|narcotics|mesh-ancestor
44583179|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583180|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583181|NCT04962152|Analgesics|analgesics|mesh-ancestor
44583182|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
44583183|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583184|NCT04949464|Nicotine|nicotine|mesh-list
44583185|NCT04949464|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44583186|NCT04949464|Autonomic Agents|autonomic agents|mesh-ancestor
44583187|NCT04949464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583188|NCT04949464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583189|NCT04949464|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44583190|NCT04949464|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44583191|NCT04949464|Cholinergic Agents|cholinergic agents|mesh-ancestor
44583192|NCT04949464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583193|NCT04949464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583194|NCT04942886|Entecavir|entecavir|mesh-list
44583195|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
44583196|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583197|NCT04940572|Valproic Acid|valproic acid|mesh-list
44583198|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
44583199|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583200|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583201|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
44583202|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583203|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583204|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
44583205|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44583206|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583207|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44583208|NCT04920292|Oxfendazole|oxfendazole|mesh-list
44583209|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
44583210|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44583211|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583212|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
44583213|NCT04910178|Empagliflozin|empagliflozin|mesh-list
44583214|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
44583215|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44583216|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44583217|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583218|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44583219|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583220|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44583221|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583222|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44583223|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44583224|NCT04910178|Protective Agents|protective agents|mesh-ancestor
44583225|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44583226|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44583227|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
44583228|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44583229|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583230|NCT04905407|Azacitidine|azacitidine|mesh-list
44583231|NCT04905407|Venetoclax|venetoclax|mesh-list
44583232|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583233|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
44583234|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583235|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583236|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583237|NCT04891289|Gemcitabine|gemcitabine|mesh-list
44583238|NCT04891289|Dexamethasone|dexamethasone|mesh-list
44583239|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
44583240|NCT04891289|Floxuridine|floxuridine|mesh-list
44583241|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583242|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
44204978|NCT00416533|Hormones|hormones|mesh-ancestor
44583243|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
44583244|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583245|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583246|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583247|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
44583248|NCT04891289|Hormones|hormones|mesh-ancestor
44583249|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583250|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583251|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583252|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583253|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
44583254|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583255|NCT04891289|Antiviral Agents|antiviral agents|mesh-ancestor
44583256|NCT04891289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583257|NCT04891289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583258|NCT04891289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583259|NCT04891289|Immunologic Factors|immunologic factors|mesh-ancestor
44583260|NCT04889066|Durvalumab|durvalumab|mesh-list
44583261|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583262|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583263|NCT04886154|Vaccines|vaccines|mesh-list
44583264|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
44583265|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583266|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
44583267|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
44583268|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583269|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583271|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44583272|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583273|NCT04872790|Prednisone|prednisone|mesh-list
44583274|NCT04872790|Cortisone|cortisone|mesh-list
44583275|NCT04872790|Rituximab|rituximab|mesh-list
44583276|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44583277|NCT04872790|Methotrexate|methotrexate|mesh-list
44583278|NCT04872790|Venetoclax|venetoclax|mesh-list
44583279|NCT04872790|Dasatinib|dasatinib|mesh-list
44583280|NCT04872790|Antibodies|antibodies|mesh-list
44583281|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
44583282|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44583283|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
44583284|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583285|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583286|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583287|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583288|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
44583289|NCT04872790|Hormones|hormones|mesh-ancestor
44583290|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583291|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583292|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44583293|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
44583294|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44583295|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583296|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
44583297|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583298|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583299|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583300|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44583301|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583302|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44583303|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44583304|NCT04865419|Voriconazole|voriconazole|mesh-list
44583305|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
44583306|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583307|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44583308|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44583309|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583310|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583311|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44583312|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583313|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583314|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583315|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44583316|NCT04856631|Cetuximab|cetuximab|mesh-list
44583317|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583318|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583319|NCT04851834|Cisplatin|cisplatin|mesh-list
44583320|NCT04851834|Carboplatin|carboplatin|mesh-list
44583321|NCT04851834|Temozolomide|temozolomide|mesh-list
44583322|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583323|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44583324|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
44583325|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583326|NCT04848753|Paclitaxel|paclitaxel|mesh-list
44583327|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44583328|NCT04848753|Cisplatin|cisplatin|mesh-list
44583329|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583330|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583331|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583332|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583333|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583334|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583335|NCT04843761|Remdesivir|remdesivir|mesh-list
44583336|NCT04843761|Phentolamine|phentolamine|mesh-list
44583337|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44583338|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
44583339|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583341|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583342|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44583343|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44583344|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
44583345|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583346|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583347|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44583348|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583349|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
44583350|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44583351|NCT04843761|Protective Agents|protective agents|mesh-ancestor
44583352|NCT04835805|Atezolizumab|atezolizumab|mesh-list
44583353|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583354|NCT04833855|Omalizumab|omalizumab|mesh-list
44583355|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44583356|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44583357|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44583358|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583359|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
44583360|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583361|NCT04832854|Gemcitabine|gemcitabine|mesh-list
44583362|NCT04832854|Paclitaxel|paclitaxel|mesh-list
44583363|NCT04832854|Cisplatin|cisplatin|mesh-list
44583364|NCT04832854|Carboplatin|carboplatin|mesh-list
44583365|NCT04832854|Pemetrexed|pemetrexed|mesh-list
44583366|NCT04832854|Atezolizumab|atezolizumab|mesh-list
44583367|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583368|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583369|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583370|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583371|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583372|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583373|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583374|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
44583375|NCT04832854|Antiviral Agents|antiviral agents|mesh-ancestor
44583376|NCT04832854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583377|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583378|NCT04832854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583379|NCT04832854|Immunologic Factors|immunologic factors|mesh-ancestor
44583380|NCT04832854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583381|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44583382|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44583383|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
44583384|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44583385|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583386|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583387|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44583388|NCT04824144|Analgesics|analgesics|mesh-ancestor
44583389|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
44583390|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583391|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44583392|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44583393|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44583394|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
44583395|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583396|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583397|NCT04821310|Pantoprazole|pantoprazole|mesh-list
44583398|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44583399|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583400|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44583401|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583402|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583403|NCT04821284|Leucovorin|leucovorin|mesh-list
44583404|NCT04821284|Gemcitabine|gemcitabine|mesh-list
44583405|NCT04821284|Paclitaxel|paclitaxel|mesh-list
44583406|NCT04821284|Fluorouracil|fluorouracil|mesh-list
44583407|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
44583408|NCT04821284|Irinotecan|irinotecan|mesh-list
44583409|NCT04821284|Calcium|calcium|mesh-list
44583410|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
44583411|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583412|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583413|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583414|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583415|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583416|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583417|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583418|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
44583419|NCT04821284|Antiviral Agents|antiviral agents|mesh-ancestor
44583420|NCT04821284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583421|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456184|NCT01634100|Empagliflozin|empagliflozin|mesh-list
44583422|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583423|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
44583424|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583425|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44583426|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44583427|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44583428|NCT04821284|Antidotes|antidotes|mesh-ancestor
44583429|NCT04821284|Protective Agents|protective agents|mesh-ancestor
44583430|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
44583431|NCT04821284|Vitamins|vitamins|mesh-ancestor
44583432|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
44583434|NCT04783194|Bupivacaine|bupivacaine|mesh-list
44583435|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583436|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
44583437|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
44583438|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583439|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583440|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583441|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
44583442|NCT04783194|Hormones|hormones|mesh-ancestor
44583443|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583444|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583445|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583446|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
44583447|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
44583448|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583449|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
44583450|NCT04778410|Cytarabine|cytarabine|mesh-list
44583451|NCT04778410|Etoposide|etoposide|mesh-list
44583452|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
44583453|NCT04778410|Azacitidine|azacitidine|mesh-list
44583454|NCT04778410|Venetoclax|venetoclax|mesh-list
44583455|NCT04778410|Cc-486|cc-486|mesh-list
44583456|NCT04778410|Magrolimab|magrolimab|mesh-list
44583457|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583458|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583459|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44583460|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44583461|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583462|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583463|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583464|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
44583465|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
44583466|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583467|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583468|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
44583469|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583470|NCT04778410|Analgesics|analgesics|mesh-ancestor
44583471|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
44583472|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583473|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583474|NCT04770896|Sorafenib|sorafenib|mesh-list
44583475|NCT04770896|Atezolizumab|atezolizumab|mesh-list
44583476|NCT04770896|Lenvatinib|lenvatinib|mesh-list
44583477|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583478|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44583479|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583480|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583481|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
44583482|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44583483|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44583484|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44583485|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44583486|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583487|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583488|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
44583489|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583490|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583491|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44583492|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583494|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44583495|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44583496|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
44583497|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583498|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583499|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44583500|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44583501|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
44583502|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583503|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583504|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
44583505|NCT04756063|Vitamins|vitamins|mesh-ancestor
44583506|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
44583507|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410846|NCT02461745|Ribavirin|ribavirin|mesh-list
44583508|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
44583525|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583526|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583527|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583528|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44583529|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44583530|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
44583531|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583532|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44583533|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583534|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
44583535|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
44583536|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44583537|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44583538|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
44583539|NCT04750070|Protective Agents|protective agents|mesh-ancestor
44583540|NCT04735367|Letrozole|letrozole|mesh-list
44583541|NCT04735367|Palbociclib|palbociclib|mesh-list
44583542|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583543|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44583544|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44583545|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583546|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583547|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44583548|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583549|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583550|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583551|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44583552|NCT04725695|Lidocaine|lidocaine|mesh-list
44583553|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
44583554|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
44583555|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583556|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583557|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
44583558|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583559|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44583560|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44583561|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44583562|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583563|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583564|NCT04713657|Propranolol|propranolol|mesh-list
44583565|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44583566|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44583567|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
44583568|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583569|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583570|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583571|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44583572|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44583573|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
44583574|NCT04701307|Niraparib|niraparib|mesh-list
44583575|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
44583576|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
44583577|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
44583578|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583579|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44583580|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583581|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583582|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583583|NCT04699461|Idelalisib|idelalisib|mesh-list
44583584|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44583585|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583586|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205231|NCT00417066|Ganirelix|ganirelix|mesh-list
44583587|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583588|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583589|NCT04699422|Pirinitramide|pirinitramide|mesh-list
44583590|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44583591|NCT04699422|Narcotics|narcotics|mesh-ancestor
44583592|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583593|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583594|NCT04699422|Analgesics|analgesics|mesh-ancestor
44583595|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
44583596|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583597|NCT04691726|Dipyrone|dipyrone|mesh-list
44583598|NCT04691726|Lidocaine|lidocaine|mesh-list
44583599|NCT04691726|Morphine|morphine|mesh-list
44583600|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
44583601|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
44583602|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583603|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583604|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
44583605|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583606|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44583607|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44583608|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44583609|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583610|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583611|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44583612|NCT04691726|Narcotics|narcotics|mesh-ancestor
44583613|NCT04691726|Analgesics|analgesics|mesh-ancestor
44583614|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44583615|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44583616|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583617|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583618|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
44583619|NCT04688931|Mitomycins|mitomycins|mesh-list
44583620|NCT04688931|Mitomycin|mitomycin|mesh-list
44583621|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44583622|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583623|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
44583624|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583625|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44583626|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583627|NCT04686929|Abatacept|abatacept|mesh-list
44583628|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44583629|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583630|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583631|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583632|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
44583633|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583634|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583635|NCT04679012|Prednisone|prednisone|mesh-list
44583636|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
44583637|NCT04679012|Rituximab|rituximab|mesh-list
44583638|NCT04679012|Doxorubicin|doxorubicin|mesh-list
44583639|NCT04679012|Etoposide|etoposide|mesh-list
44583640|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44583641|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583642|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
44583643|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583644|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583645|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44583646|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
44583647|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583648|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583649|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44583650|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583651|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44583652|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44583653|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44583654|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583655|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583656|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
44583657|NCT04679012|Hormones|hormones|mesh-ancestor
44583658|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583659|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583660|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583661|NCT04664959|Denosumab|denosumab|mesh-list
44583662|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44583663|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583664|NCT04663347|Gemcitabine|gemcitabine|mesh-list
44583665|NCT04663347|Cytarabine|cytarabine|mesh-list
44583666|NCT04663347|Dexamethasone|dexamethasone|mesh-list
44583667|NCT04663347|Prednisone|prednisone|mesh-list
44583668|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
44583669|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44583670|NCT04663347|Rituximab|rituximab|mesh-list
44583671|NCT04663347|Carboplatin|carboplatin|mesh-list
44583672|NCT04663347|Doxorubicin|doxorubicin|mesh-list
44583673|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44583674|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
44583675|NCT04663347|Vincristine|vincristine|mesh-list
44583676|NCT04663347|Lenalidomide|lenalidomide|mesh-list
44583677|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583678|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
44583679|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583680|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583681|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44583682|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
44583683|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583684|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583685|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44583686|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583687|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44583688|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
44583689|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
44583690|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583691|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583692|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
44583693|NCT04663347|Hormones|hormones|mesh-ancestor
44583694|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583695|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583696|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583697|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
44583698|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
44583699|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583700|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583701|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44583702|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44583703|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44583704|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583705|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583706|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583707|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583708|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44583709|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44583710|NCT04663347|Growth Substances|growth substances|mesh-ancestor
44583711|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
44583712|NCT04663308|Volixibat|volixibat|mesh-list
44583713|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44583714|NCT04663282|Insulin|insulin|mesh-list
44583715|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44583716|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583717|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
44583718|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583719|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583720|NCT04645667|Tacrolimus|tacrolimus|mesh-list
44583721|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583722|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
44583723|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583724|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44583725|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583726|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583727|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
44583728|NCT04634669|Bupropion|bupropion|mesh-list
44583729|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44583730|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
44583731|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44583732|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44583733|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44583734|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583735|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583736|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
44583737|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583738|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583739|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44583740|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44583741|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583742|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
44583743|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583744|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44583745|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44583746|NCT04629443|Azacitidine|azacitidine|mesh-list
44583747|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583748|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
44583749|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583750|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583751|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583753|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583755|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583756|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44583757|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583758|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583759|NCT04613492|Durvalumab|durvalumab|mesh-list
44583760|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583761|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583762|NCT04612530|Nivolumab|nivolumab|mesh-list
44583763|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583764|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583765|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44583766|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583767|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44583768|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44583769|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583770|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44583771|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44583772|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
44583773|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
44583774|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44583775|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583776|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44583777|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583778|NCT04586920|Itraconazole|itraconazole|mesh-list
44583779|NCT04586920|Midazolam|midazolam|mesh-list
44583780|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44583781|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44583782|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583783|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583784|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44583785|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44583786|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44583787|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44583788|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
44583789|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
44583790|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
44583791|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
44583792|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583793|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583794|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
44583795|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583796|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44583797|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44583798|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583799|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44583800|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583801|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583802|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44583803|NCT04585152|Rituximab|rituximab|mesh-list
44583804|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583805|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583806|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
44583807|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583808|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583810|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
44583811|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583812|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
44583813|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583814|NCT04582942|Lactulose|lactulose|mesh-list
44583815|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44583816|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
44583817|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583818|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
44583819|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583820|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583821|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44583822|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
44583823|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583824|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583825|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44583826|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
44583827|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583828|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583829|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
44205461|NCT00418132|Growth Substances|growth substances|mesh-ancestor
44583830|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44583831|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
44583832|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44583833|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583834|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583835|NCT04568616|Letrozole|letrozole|mesh-list
44583836|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583837|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44583838|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44583839|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583840|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583841|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44583842|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583843|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583844|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583845|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
44583846|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583847|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583848|NCT04554771|Paclitaxel|paclitaxel|mesh-list
44583849|NCT04554771|Carboplatin|carboplatin|mesh-list
44583850|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44583851|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583852|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44583853|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44583854|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44583855|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583856|NCT04547166|Bevacizumab|bevacizumab|mesh-list
44583857|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44583858|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583859|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44583860|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44583861|NCT04547166|Growth Substances|growth substances|mesh-ancestor
44583862|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583863|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
44583864|NCT04544475|Estrogens|estrogens|mesh-list
44583865|NCT04544475|Estradiol|estradiol|mesh-list
44583866|NCT04544475|Hormones|hormones|mesh-ancestor
44583867|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583868|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583869|NCT04544189|Fulvestrant|fulvestrant|mesh-list
44583870|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583871|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583872|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44583873|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44583874|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583875|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583876|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583877|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
44583878|NCT04541355|Cisplatin|cisplatin|mesh-list
44583879|NCT04541355|Antidotes|antidotes|mesh-list
44583880|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583881|NCT04541355|Protective Agents|protective agents|mesh-ancestor
44583882|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583883|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
44583884|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583885|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
44583886|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44583887|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583888|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
44583889|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
44583890|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
44583891|NCT04529005|Giapreza|giapreza|mesh-list
44583892|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
44583893|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44583894|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44583895|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
44583896|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583897|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583898|NCT04526795|Cytarabine|cytarabine|mesh-list
44583899|NCT04526795|Fludarabine|fludarabine|mesh-list
44583900|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583901|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44583902|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
44583903|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583904|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583905|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
44583906|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583907|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
44583908|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583909|NCT04522323|Lenvatinib|lenvatinib|mesh-list
44583910|NCT04522323|Axitinib|axitinib|mesh-list
44583911|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583912|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44583913|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583914|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583915|NCT04495855|Dienogest|dienogest|mesh-list
44583916|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44583917|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
44583918|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44583919|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583920|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44583921|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44583922|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44583923|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44583924|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44583925|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44583926|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44583927|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44583928|NCT04495452|Fentanyl|fentanyl|mesh-list
44583929|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44583930|NCT04495452|Narcotics|narcotics|mesh-ancestor
44583931|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44583932|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583933|NCT04495452|Analgesics|analgesics|mesh-ancestor
44583934|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
44583935|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44583936|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44583937|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44583938|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
44583939|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
44583940|NCT04486118|Lisinopril|lisinopril|mesh-list
44583941|NCT04486118|Benazepril|benazepril|mesh-list
44583942|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44583943|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44583944|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583945|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583946|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44583947|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44583948|NCT04486118|Protective Agents|protective agents|mesh-ancestor
44583949|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583950|NCT04476277|Biotin|biotin|mesh-list
44583951|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
44583952|NCT04476277|Vitamins|vitamins|mesh-ancestor
44583953|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
44583954|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583955|NCT04470804|Cyclosporine|cyclosporine|mesh-list
44583956|NCT04470804|Sirolimus|sirolimus|mesh-list
44583957|NCT04470804|Cyclosporins|cyclosporins|mesh-list
44583958|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44583959|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44583960|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44583961|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
44583962|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44583963|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
44583964|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44583965|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
44583966|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44583992|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44583994|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
44583995|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44583996|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44583997|NCT04433858|Psilocybin|psilocybin|mesh-list
44583998|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
44583999|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584000|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44584001|NCT04432610|Nebivolol|nebivolol|mesh-list
44584002|NCT04432610|Bisoprolol|bisoprolol|mesh-list
44584003|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44584004|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
44584005|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44584006|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44584007|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44584008|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
44584009|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584010|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584011|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584012|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
44584013|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
44584014|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584015|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44584016|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44584017|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44584019|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44584020|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584021|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584022|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584023|NCT04406272|Bevacizumab|bevacizumab|mesh-list
44584024|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584025|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584026|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44584027|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44584028|NCT04406272|Growth Substances|growth substances|mesh-ancestor
44584029|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584030|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
44584031|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
44584032|NCT04391855|Tramadol|tramadol|mesh-list
44584033|NCT04391855|Ropivacaine|ropivacaine|mesh-list
44584034|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44584035|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44584036|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584037|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584038|NCT04391855|Analgesics|analgesics|mesh-ancestor
44584039|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
44584040|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584041|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44584042|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44584043|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44584044|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
44584045|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584046|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584047|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
44584048|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
44584049|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44584050|NCT04391855|Narcotics|narcotics|mesh-ancestor
44584051|NCT04374773|Dronabinol|dronabinol|mesh-list
44584052|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
44584053|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584054|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44584055|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584056|NCT04374773|Analgesics|analgesics|mesh-ancestor
44584057|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
44584058|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584059|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44584060|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44584061|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584062|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584063|NCT04374773|Hormones|hormones|mesh-ancestor
44584064|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584065|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44584066|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
44584067|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584068|NCT04370054|Factor VIII|factor viii|mesh-list
44584069|NCT04370054|Coagulants|coagulants|mesh-ancestor
44411424|NCT02447718|Vaccines|vaccines|mesh-list
44584070|NCT04346654|Dexamethasone|dexamethasone|mesh-list
44584071|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584072|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
44584073|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
44584074|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584075|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584076|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584077|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
44584078|NCT04346654|Hormones|hormones|mesh-ancestor
44584079|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584080|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584081|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584082|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
44584083|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584084|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
44584085|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44584086|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584087|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44584088|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44584089|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
44584090|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584091|NCT04331288|Ethanol|ethanol|mesh-list
44584092|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44584093|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584094|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44584095|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584096|NCT04321330|Atezolizumab|atezolizumab|mesh-list
44584097|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584098|NCT04318730|Apatinib|apatinib|mesh-list
44584099|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584100|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44584101|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584102|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584103|NCT04313790|Heparin|heparin|mesh-list
44584104|NCT04313790|Calcium heparin|calcium heparin|mesh-list
44584105|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
44584106|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44584107|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44584108|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584109|NCT04307485|Ticagrelor|ticagrelor|mesh-list
44584110|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44584111|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44584112|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44584113|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44584114|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
44584115|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584116|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584117|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584118|NCT04306692|Inositol|inositol|mesh-list
44584119|NCT04306692|Clomiphene|clomiphene|mesh-list
44584120|NCT04306692|Enclomiphene|enclomiphene|mesh-list
44584121|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
44584122|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44584123|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
44584124|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584125|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584126|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44584127|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
44584128|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44584129|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44584130|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44584131|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
44584132|NCT04306692|Vitamins|vitamins|mesh-ancestor
44584133|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
44584134|NCT04306510|Antibodies|antibodies|mesh-list
44584135|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
44584136|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44584137|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
44584138|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584139|NCT04298567|Aspirin|aspirin|mesh-list
44584140|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
44584141|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44584142|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
44584143|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44584144|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
44584145|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584146|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584147|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
44584148|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584149|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584151|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
44584152|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584153|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584154|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584155|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584156|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44584157|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44584158|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44584159|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44584160|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
44584161|NCT04296396|Oxycodone|oxycodone|mesh-list
44584162|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44584163|NCT04296396|Narcotics|narcotics|mesh-ancestor
44584164|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44584165|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584166|NCT04296396|Analgesics|analgesics|mesh-ancestor
44584167|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
44584168|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584169|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
44584170|NCT04287816|Antithrombins|antithrombins|mesh-list
44584171|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44584172|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205769|NCT00419250|Lenalidomide|lenalidomide|mesh-list
44584173|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584174|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584175|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
44584176|NCT04284397|Aspirin|aspirin|mesh-list
44584177|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584178|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584179|NCT04284397|Analgesics|analgesics|mesh-ancestor
44584180|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
44584181|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584182|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584183|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584184|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584185|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44584186|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44584187|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584188|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44584189|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44584190|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584192|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
44584193|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44584194|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
44584195|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584196|NCT04278898|Expectorants|expectorants|mesh-ancestor
44584197|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44584198|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44584199|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
44584200|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584201|NCT04278898|Protective Agents|protective agents|mesh-ancestor
44584202|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584203|NCT04278898|Antidotes|antidotes|mesh-ancestor
44584204|NCT04270409|Dexamethasone|dexamethasone|mesh-list
44584205|NCT04270409|Lenalidomide|lenalidomide|mesh-list
44584206|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584207|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
44584208|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
44584209|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584210|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584211|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584212|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
44584213|NCT04270409|Hormones|hormones|mesh-ancestor
44584214|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584215|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584216|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584217|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
44584218|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44411573|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44584219|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44584220|NCT04270409|Growth Substances|growth substances|mesh-ancestor
44584221|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
44584222|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
44584223|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584224|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584225|NCT04255602|Ticagrelor|ticagrelor|mesh-list
44584226|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44584227|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44584228|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44584229|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44584230|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
44584231|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584232|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584233|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584234|NCT04253964|Paclitaxel|paclitaxel|mesh-list
44584235|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44584236|NCT04253964|Carboplatin|carboplatin|mesh-list
44584237|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
44584238|NCT04253964|Pemetrexed|pemetrexed|mesh-list
44584239|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44584240|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584241|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584242|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584243|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584244|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584245|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584246|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584247|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44584248|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584249|NCT04251533|Paclitaxel|paclitaxel|mesh-list
44584250|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44584251|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584252|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584253|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584254|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584255|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584256|NCT04248712|Loratadine|loratadine|mesh-list
44584257|NCT04248712|Famotidine|famotidine|mesh-list
44584258|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44584259|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584260|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44584261|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
44584262|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
44584263|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584264|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584265|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584266|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
44584267|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
44584268|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44584269|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44584270|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44584271|NCT04225988|Tacrolimus|tacrolimus|mesh-list
44584272|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584273|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
44584274|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584275|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44584276|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584277|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584278|NCT04223752|Tazobactam|tazobactam|mesh-list
44584279|NCT04223752|Ceftolozane|ceftolozane|mesh-list
44584280|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44584281|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44584282|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584283|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44584284|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584285|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584286|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44584287|NCT04223752|Renal Agents|renal agents|mesh-ancestor
44584288|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
44584289|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44584290|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
44584291|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584292|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584293|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411662|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
44584294|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44205877|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
44584295|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44584297|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584298|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584299|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44584300|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
44584301|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
44584302|NCT04216927|Protective Agents|protective agents|mesh-ancestor
44584303|NCT04208178|Trastuzumab|trastuzumab|mesh-list
44584304|NCT04208178|Pertuzumab|pertuzumab|mesh-list
44584305|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584306|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584307|NCT04206813|Vaccines|vaccines|mesh-list
44584308|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
44584309|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584310|NCT04205929|Curcumin|curcumin|mesh-list
44584311|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584312|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584313|NCT04205929|Analgesics|analgesics|mesh-ancestor
44584314|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
44584315|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584316|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584317|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584318|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584319|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584320|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584321|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584322|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44584323|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584324|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584325|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
44584326|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584327|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584328|NCT04186871|Abatacept|abatacept|mesh-list
44584329|NCT04186871|Branebrutinib|branebrutinib|mesh-list
44584330|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44584331|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584332|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205946|NCT00420030|Abciximab|abciximab|mesh-list
44584333|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584334|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
44584335|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584336|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584337|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44584338|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584339|NCT04181333|Trastuzumab|trastuzumab|mesh-list
44584340|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584341|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584342|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44584343|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44584344|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584345|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
44584346|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
44584347|NCT04179500|Bedaquiline|bedaquiline|mesh-list
44584348|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44584349|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584350|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44584351|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44584352|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584353|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584354|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584355|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
44584356|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
44584357|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44584358|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
44584359|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584360|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584361|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44584362|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44584363|NCT04167176|Lidocaine|lidocaine|mesh-list
44584364|NCT04167176|Bupivacaine|bupivacaine|mesh-list
44584365|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
44584366|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
44584367|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411727|NCT02438371|Indomethacin|indomethacin|mesh-list
44584391|NCT04138316|Candesartan|candesartan|mesh-list
44584392|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44584393|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44584394|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44584395|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584396|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
44584397|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
44584398|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584399|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
44584400|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584401|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584402|NCT04116047|Cisplatin|cisplatin|mesh-list
44584403|NCT04116047|Durvalumab|durvalumab|mesh-list
44584404|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584405|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584406|NCT04100135|Clopidogrel|clopidogrel|mesh-list
44584407|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44584408|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44584409|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44584410|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44584411|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44584412|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
44584413|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584414|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584415|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584416|NCT04100018|Prednisone|prednisone|mesh-list
44584417|NCT04100018|Docetaxel|docetaxel|mesh-list
44584418|NCT04100018|Nivolumab|nivolumab|mesh-list
44584419|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584420|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584421|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584422|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584423|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584424|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584425|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
44584426|NCT04100018|Hormones|hormones|mesh-ancestor
44584427|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584428|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584429|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584430|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584431|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44584432|NCT04091386|Factor VIII|factor viii|mesh-list
44584433|NCT04091386|Coagulants|coagulants|mesh-ancestor
44584434|NCT04070378|Daratumumab|daratumumab|mesh-list
44584435|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584436|NCT04068831|Avelumab|avelumab|mesh-list
44584437|NCT04068831|Talazoparib|talazoparib|mesh-list
44584438|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584439|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584440|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44584441|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584442|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584443|NCT04042740|Ribavirin|ribavirin|mesh-list
44584444|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
44584445|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584446|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
44584447|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584448|NCT04042116|Nivolumab|nivolumab|mesh-list
44584449|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584450|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584451|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44584452|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584453|NCT04037085|Ketamine|ketamine|mesh-list
44584454|NCT04037085|Analgesics|analgesics|mesh-ancestor
44584455|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
44584456|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584457|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584458|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44584459|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44584460|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
44584461|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
44584462|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44584463|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44584464|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44584465|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584466|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584467|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
44584468|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584469|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584470|NCT04029688|Cytarabine|cytarabine|mesh-list
44584471|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
44584472|NCT04029688|Fludarabine|fludarabine|mesh-list
44584473|NCT04029688|Topotecan|topotecan|mesh-list
44584474|NCT04029688|Venetoclax|venetoclax|mesh-list
44584475|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584476|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
44584477|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584478|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584479|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44584481|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584482|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584483|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44584484|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44584485|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
44584486|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
44584487|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584488|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44584489|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44584490|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584491|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
44584492|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584493|NCT04005872|Calcium|calcium|mesh-list
44584494|NCT04005872|Fluorides|fluorides|mesh-list
44584495|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44584496|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584497|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
44584498|NCT04005872|Protective Agents|protective agents|mesh-ancestor
44584499|NCT04002362|Triamcinolone|triamcinolone|mesh-list
44584500|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44584501|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44584502|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44584503|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584504|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
44584505|NCT04002362|Hormones|hormones|mesh-ancestor
44584506|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584507|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584508|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584509|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
44584510|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584511|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584512|NCT04000906|Paclitaxel|paclitaxel|mesh-list
44584513|NCT04000906|Cisplatin|cisplatin|mesh-list
44584514|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44584515|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584516|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584517|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584518|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584519|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584520|NCT03998176|Tenofovir|tenofovir|mesh-list
44584521|NCT03998176|Emtricitabine|emtricitabine|mesh-list
44584522|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44584523|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
44584524|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584525|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44584526|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584527|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584528|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584529|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44584530|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44411917|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
44584543|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
44584544|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44584545|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
44584546|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584547|NCT03982537|Expectorants|expectorants|mesh-ancestor
44584548|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
44584549|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44584550|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
44584551|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584552|NCT03982537|Protective Agents|protective agents|mesh-ancestor
44584553|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584554|NCT03982537|Antidotes|antidotes|mesh-ancestor
44584555|NCT03977467|Atezolizumab|atezolizumab|mesh-list
44584556|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584557|NCT03971669|Vaccines|vaccines|mesh-list
44206063|NCT00420654|Hormones|hormones|mesh-list
44584558|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
44584559|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584560|NCT03971071|Erenumab|erenumab|mesh-list
44584561|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44584562|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44584563|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584564|NCT03971071|Analgesics|analgesics|mesh-ancestor
44584565|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
44584566|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584567|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584568|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
44584569|NCT03965689|Paclitaxel|paclitaxel|mesh-list
44584570|NCT03965689|Carboplatin|carboplatin|mesh-list
44584571|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44584572|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44584573|NCT03965689|Pevonedistat|pevonedistat|mesh-list
44584574|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44584575|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584576|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584577|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584578|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584579|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584580|NCT03961165|Scopolamine|scopolamine|mesh-list
44584581|NCT03961165|Bromides|bromides|mesh-list
44584582|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44584583|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
44584584|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
44584585|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
44584586|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584587|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584588|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44584589|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44584590|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
44584591|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584592|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584593|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44584594|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
44584595|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584596|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
44584597|NCT03944577|Evolocumab|evolocumab|mesh-list
44584598|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44584599|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44584600|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
44206100|NCT00420901|Urological Agents|urological agents|mesh-ancestor
44584601|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584602|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44584603|NCT03944512|Pravastatin|pravastatin|mesh-list
44584604|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44584605|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44584606|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
44584607|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584608|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44584609|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44584610|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584611|NCT03940703|Osimertinib|osimertinib|mesh-list
44584612|NCT03940703|Tepotinib|tepotinib|mesh-list
44584613|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584614|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44584615|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584616|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584617|NCT03911973|Talazoparib|talazoparib|mesh-list
44584618|NCT03911973|Gedatolisib|gedatolisib|mesh-list
44584619|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44584620|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584621|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584622|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584623|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44584624|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44584625|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44584626|NCT03901131|Norethindrone|norethindrone|mesh-list
44584627|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
44584628|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
44584630|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44584631|NCT03901131|Estrogens|estrogens|mesh-ancestor
44584632|NCT03901131|Hormones|hormones|mesh-ancestor
44584633|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584634|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584635|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44584636|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
44584637|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44584638|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44584639|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44584640|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44584641|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44584642|NCT03893903|Avelumab|avelumab|mesh-list
44584643|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584644|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584645|NCT03892785|Prednisone|prednisone|mesh-list
44584646|NCT03892785|Methotrexate|methotrexate|mesh-list
44584647|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584648|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
44584649|NCT03892785|Hormones|hormones|mesh-ancestor
44584650|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584651|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584652|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584653|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584654|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44584655|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
44584656|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44584657|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44584658|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
44584659|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584660|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44584661|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584662|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44584663|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584664|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
44584665|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584666|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584667|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
44584668|NCT03890289|Idelalisib|idelalisib|mesh-list
44584669|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584670|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584671|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584672|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584673|NCT03873493|Venetoclax|venetoclax|mesh-list
44584674|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584675|NCT03872401|Evolocumab|evolocumab|mesh-list
44584676|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44584677|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44584678|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
44584679|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584680|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44584681|NCT03871829|Dexamethasone|dexamethasone|mesh-list
44584682|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
44584683|NCT03871829|BB 1101|bb 1101|mesh-list
44584684|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584685|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
44584686|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
44584687|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584688|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584689|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584690|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
44584691|NCT03871829|Hormones|hormones|mesh-ancestor
44584692|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584693|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584694|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584695|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
44584696|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584697|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412149|NCT02427802|Gentamicins|gentamicins|mesh-list
44584698|NCT03860597|Memantine|memantine|mesh-list
44584699|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44584700|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44584701|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
44584702|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584703|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584704|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584705|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44584706|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44584707|NCT03842696|Cyclosporine|cyclosporine|mesh-list
44584708|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
44584709|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
44584710|NCT03842696|Methotrexate|methotrexate|mesh-list
44584711|NCT03842696|Vorinostat|vorinostat|mesh-list
44584712|NCT03842696|Tacrolimus|tacrolimus|mesh-list
44584713|NCT03842696|Cyclosporins|cyclosporins|mesh-list
44584714|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584715|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
44584716|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584717|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584718|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44584719|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
44584720|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584721|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584722|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44584723|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44584724|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
44584725|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44584726|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44584727|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
44584728|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
44584729|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584730|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44584731|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584732|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44584733|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
44584734|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584735|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44584736|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44584737|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
44584738|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44584739|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44584740|NCT03833154|Durvalumab|durvalumab|mesh-list
44584741|NCT03833154|Osimertinib|osimertinib|mesh-list
44584742|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584743|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584744|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44584745|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584746|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584747|NCT03828773|Fluconazole|fluconazole|mesh-list
44584748|NCT03828773|Posaconazole|posaconazole|mesh-list
44584749|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
44584750|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584751|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44584752|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44584753|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584754|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584755|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44584756|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44584757|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584758|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584759|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44584760|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44584761|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44584762|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44584763|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44584764|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
44584765|NCT03823911|Grazoprevir|grazoprevir|mesh-list
44584766|NCT03823911|Ledipasvir|ledipasvir|mesh-list
44584767|NCT03823911|Velpatasvir|velpatasvir|mesh-list
44584768|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44584769|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44584770|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
44584771|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584772|NCT03822468|Letrozole|letrozole|mesh-list
44584774|NCT03822468|Goserelin|goserelin|mesh-list
44584775|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584776|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44584777|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44584778|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584779|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584780|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44584781|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
44584782|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584783|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584784|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584785|NCT03820531|Pancrelipase|pancrelipase|mesh-list
44584786|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44584787|NCT03808090|Calcium|calcium|mesh-list
44584788|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44584789|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584790|NCT03796273|Ketoconazole|ketoconazole|mesh-list
44584791|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
44584792|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584793|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44584794|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44206286|NCT00421538|Nadroparin|nadroparin|mesh-list
44584795|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584796|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584797|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44584798|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44584799|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584800|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584801|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44584802|NCT03785678|Tenecteplase|tenecteplase|mesh-list
44584803|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44584804|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44584805|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584806|NCT03783026|Apremilast|apremilast|mesh-list
44584807|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584808|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584809|NCT03783026|Analgesics|analgesics|mesh-ancestor
44584810|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
44584811|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584812|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584813|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584814|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584815|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44584816|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44584817|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584818|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584819|NCT03782207|Atezolizumab|atezolizumab|mesh-list
44584820|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584821|NCT03773276|Norepinephrine|norepinephrine|mesh-list
44584822|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44584823|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44584824|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
44584825|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584826|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584827|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584828|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
44584829|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
44584830|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584831|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44584832|NCT03770260|Ixazomib|ixazomib|mesh-list
44584833|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44584834|NCT03770260|Pevonedistat|pevonedistat|mesh-list
44584835|NCT03770260|Glycine|glycine|mesh-list
44584836|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584837|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584838|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
44584839|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
44584840|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44584841|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584842|NCT03769766|Curcumin|curcumin|mesh-list
44584843|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584844|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584845|NCT03769766|Analgesics|analgesics|mesh-ancestor
44584865|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584866|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584868|NCT03764540|Hormones|hormones|mesh-ancestor
44584869|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584870|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584871|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584872|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
44584873|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
44584874|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584875|NCT03753074|Tenofovir|tenofovir|mesh-list
44584876|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
44584877|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584878|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44584879|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44584880|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584881|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584882|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44584883|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44584884|NCT03748641|Prednisone|prednisone|mesh-list
44584885|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
44584886|NCT03748641|Niraparib|niraparib|mesh-list
44584887|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584888|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
44584889|NCT03748641|Hormones|hormones|mesh-ancestor
44584890|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44584891|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584892|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44584893|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584894|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44584895|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584896|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584897|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
44584898|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44584899|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44584900|NCT03747939|Thalidomide|thalidomide|mesh-list
44584901|NCT03747939|Apremilast|apremilast|mesh-list
44584902|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44584903|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44584904|NCT03747939|Analgesics|analgesics|mesh-ancestor
44584905|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
44584906|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584907|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584908|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44584909|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44584910|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44584911|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44584912|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584913|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584914|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44584915|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
44584916|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
44584917|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44584918|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584919|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44584920|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44584921|NCT03747939|Growth Substances|growth substances|mesh-ancestor
44584922|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44584923|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584924|NCT03747562|Gabapentin|gabapentin|mesh-list
44584925|NCT03747562|Analgesics|analgesics|mesh-ancestor
44584926|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
44584927|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44584928|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584929|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
44584930|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44584931|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44584932|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44584933|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44584934|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44584935|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44584936|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412380|NCT02421120|Tazobactam|tazobactam|mesh-list
44584937|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584938|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
44584939|NCT03747484|Interferons|interferons|mesh-list
44584940|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
44584941|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
44584942|NCT03747484|Avelumab|avelumab|mesh-list
44584944|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
44584945|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44584946|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584947|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584948|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
44584949|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44584950|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
44584951|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584952|NCT03737643|Paclitaxel|paclitaxel|mesh-list
44584953|NCT03737643|Bevacizumab|bevacizumab|mesh-list
44584954|NCT03737643|Carboplatin|carboplatin|mesh-list
44584955|NCT03737643|Durvalumab|durvalumab|mesh-list
44584956|NCT03737643|Olaparib|olaparib|mesh-list
44584957|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44584958|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44584959|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584960|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44584961|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44584962|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44584963|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584964|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44584965|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44584966|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44584967|NCT03737643|Growth Substances|growth substances|mesh-ancestor
44584968|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584969|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44584970|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
44584971|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44584972|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584973|NCT03728634|Vitamin A|vitamin a|mesh-list
44584974|NCT03728634|Vitamins|vitamins|mesh-ancestor
44584975|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
44584976|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584977|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44584978|NCT03712202|Nivolumab|nivolumab|mesh-list
44584979|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44584980|NCT03712202|Doxorubicin|doxorubicin|mesh-list
44584981|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44584982|NCT03712202|Daunorubicin|daunorubicin|mesh-list
44584983|NCT03712202|Bleomycin|bleomycin|mesh-list
44584984|NCT03712202|Dacarbazine|dacarbazine|mesh-list
44584985|NCT03712202|Vinblastine|vinblastine|mesh-list
44584986|NCT03712202|Antibodies|antibodies|mesh-list
44584987|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
44584988|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44584989|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
44584990|NCT03712202|Imidazole|imidazole|mesh-list
44584991|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
44584992|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44584993|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44584994|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44584995|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44584996|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44584997|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44584998|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44584999|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585000|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585001|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
44585002|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585003|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585004|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585005|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585006|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
44585007|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44585008|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
44585009|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585010|NCT03711838|Expectorants|expectorants|mesh-ancestor
44585011|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
44585012|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44585013|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
44585014|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585015|NCT03711838|Protective Agents|protective agents|mesh-ancestor
44585016|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585018|NCT03693300|Durvalumab|durvalumab|mesh-list
44585019|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585020|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585021|NCT03688178|Temozolomide|temozolomide|mesh-list
44585022|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585023|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
44585024|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585025|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585026|NCT03682289|Durvalumab|durvalumab|mesh-list
44585027|NCT03682289|Olaparib|olaparib|mesh-list
44585028|NCT03682289|Adenosine|adenosine|mesh-list
44585029|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44585030|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585031|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585032|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
44585033|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585034|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44585035|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585036|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585037|NCT03682289|Analgesics|analgesics|mesh-ancestor
44585038|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
44585039|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585040|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44585041|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
44585042|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44585043|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
44585044|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
44585045|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585046|NCT03679624|Daratumumab|daratumumab|mesh-list
44585047|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585048|NCT03651804|Acetaminophen|acetaminophen|mesh-list
44585049|NCT03651804|Diphosphonates|diphosphonates|mesh-list
44585050|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44585051|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44585052|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585053|NCT03651804|Analgesics|analgesics|mesh-ancestor
44585054|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
44585055|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585056|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585057|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
44585058|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44585059|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585060|NCT03651271|Nivolumab|nivolumab|mesh-list
44585061|NCT03651271|Ipilimumab|ipilimumab|mesh-list
44585062|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585063|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585064|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585065|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585066|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
44585067|NCT03645928|Nivolumab|nivolumab|mesh-list
44585068|NCT03645928|Ipilimumab|ipilimumab|mesh-list
44206504|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44585069|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585070|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585071|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585072|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585073|NCT03638128|Denosumab|denosumab|mesh-list
44585074|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44585075|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585076|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
44585077|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585078|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585079|NCT03632213|Losartan|losartan|mesh-list
44585080|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44585081|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44585082|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44585083|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44585084|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585085|NCT03611751|Apremilast|apremilast|mesh-list
44585086|NCT03611751|BMS-986165|bms-986165|mesh-list
44585087|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44585088|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585089|NCT03611751|Analgesics|analgesics|mesh-ancestor
44585090|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
44585092|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585093|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585094|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585095|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44585096|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44585097|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585109|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
44585110|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44585111|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
44585112|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585113|NCT03596125|Protective Agents|protective agents|mesh-ancestor
44585114|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585115|NCT03596125|Antidotes|antidotes|mesh-ancestor
44585116|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44585117|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
44585118|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585130|NCT03552692|Venetoclax|venetoclax|mesh-list
44585131|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585132|NCT03522064|Carboplatin|carboplatin|mesh-list
44585133|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
44585134|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44585135|NCT03522064|Testosterone|testosterone|mesh-list
44585136|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
44585137|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
44585138|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44585139|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585140|NCT03522064|Androgens|androgens|mesh-ancestor
44585141|NCT03522064|Hormones|hormones|mesh-ancestor
44585142|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585143|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585144|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585145|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
44585146|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
44585147|NCT03513211|Itraconazole|itraconazole|mesh-list
44585148|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
44585149|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44585150|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44585151|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585152|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585153|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585154|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585155|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
44585156|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44585157|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44585158|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44585159|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44585160|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585161|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585162|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44585163|NCT03509012|Paclitaxel|paclitaxel|mesh-list
44585164|NCT03509012|Etoposide|etoposide|mesh-list
44585165|NCT03509012|Cisplatin|cisplatin|mesh-list
44585166|NCT03509012|Carboplatin|carboplatin|mesh-list
44585167|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
44585168|NCT03509012|Pemetrexed|pemetrexed|mesh-list
44585169|NCT03509012|Durvalumab|durvalumab|mesh-list
44585170|NCT03509012|Tremelimumab|tremelimumab|mesh-list
44585171|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585172|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986146|NCT02223429|Vasopressins|vasopressins|mesh-list
44585173|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585174|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585175|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585176|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585177|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585178|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585179|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585180|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44585181|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44585182|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585183|NCT03488420|Edoxaban|edoxaban|mesh-list
44585184|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44585185|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
44585186|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44585187|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
44585188|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585189|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585190|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
44585191|NCT03484923|Spartalizumab|spartalizumab|mesh-list
44585192|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585193|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585194|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585195|NCT03481556|Dexamethasone|dexamethasone|mesh-list
44585196|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
44585197|NCT03481556|Bortezomib|bortezomib|mesh-list
44585198|NCT03481556|Melphalan|melphalan|mesh-list
44585199|NCT03481556|Daratumumab|daratumumab|mesh-list
44585200|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585201|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
44585202|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
44412698|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
44585203|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585204|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585205|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585206|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
44585207|NCT03481556|Hormones|hormones|mesh-ancestor
44585208|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585209|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585210|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585211|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585212|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
44585213|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585214|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585215|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585216|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
44585217|NCT03480776|Aspirin|aspirin|mesh-list
44585218|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44585219|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585220|NCT03480776|Analgesics|analgesics|mesh-ancestor
44585221|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
44585222|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585223|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585224|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585225|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585226|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44585227|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44585228|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585229|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44585230|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44585231|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585232|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
44585233|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
44585234|NCT03471767|Bupropion|bupropion|mesh-list
44585235|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44585236|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
44585237|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585238|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44585239|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44585240|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44585241|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585242|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
44585243|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585244|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585245|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44585246|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44585247|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585248|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
44585249|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
44585250|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44585251|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44585252|NCT03452137|Atezolizumab|atezolizumab|mesh-list
44585253|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585254|NCT03452111|ST 1435|st 1435|mesh-list
44585255|NCT03452111|Testosterone|testosterone|mesh-list
44585256|NCT03452111|Androgens|androgens|mesh-ancestor
44585257|NCT03452111|Hormones|hormones|mesh-ancestor
44585258|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585259|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585260|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44585261|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
44585262|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44585263|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44585264|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44585265|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585266|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585267|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585268|NCT03435107|Durvalumab|durvalumab|mesh-list
44585269|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585270|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585271|NCT03406507|Ravulizumab|ravulizumab|mesh-list
44585272|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44585273|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585274|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
44585275|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585276|NCT03395197|Talazoparib|talazoparib|mesh-list
44585277|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44585278|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585280|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585281|NCT03393611|Cytarabine|cytarabine|mesh-list
44585282|NCT03393611|Fludarabine|fludarabine|mesh-list
44585283|NCT03393611|Melphalan|melphalan|mesh-list
44585284|NCT03393611|Daunorubicin|daunorubicin|mesh-list
44585285|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
44585286|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585287|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585288|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
44585289|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585290|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585291|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
44585292|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585293|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
44585294|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585295|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585296|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
44585297|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585298|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44585299|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44206704|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
44585300|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585301|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585302|NCT03373188|Nivolumab|nivolumab|mesh-list
44585303|NCT03373188|Ipilimumab|ipilimumab|mesh-list
44585304|NCT03373188|Antibodies|antibodies|mesh-list
44585305|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44585306|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
44585307|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585308|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585309|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585310|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585311|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585312|NCT03367156|Dexamethasone|dexamethasone|mesh-list
44585313|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
44585314|NCT03367156|Ichthammol|ichthammol|mesh-list
44585315|NCT03367156|BB 1101|bb 1101|mesh-list
44585316|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585317|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
44585318|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
44585319|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986295|NCT02229461|Analgesics|analgesics|mesh-ancestor
44585322|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
44585323|NCT03367156|Hormones|hormones|mesh-ancestor
44585324|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585325|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585326|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585327|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
44585328|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585329|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585330|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
44585331|NCT03362099|Bupropion|bupropion|mesh-list
44585332|NCT03362099|Varenicline|varenicline|mesh-list
44585333|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44585334|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
44585335|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585336|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44585337|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44585338|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44585339|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585340|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
44585341|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585342|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585343|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44206761|NCT00423826|Cytarabine|cytarabine|mesh-list
44585344|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44585345|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585346|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44585347|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44585348|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
44585349|NCT03356834|Tenofovir|tenofovir|mesh-list
44585350|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
44585351|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585352|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44585353|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44585354|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585355|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585357|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44585358|NCT03354039|Tamoxifen|tamoxifen|mesh-list
44585359|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44585360|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
44585361|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585362|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585363|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585364|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585365|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44585366|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44585367|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44585368|NCT03351998|Atorvastatin|atorvastatin|mesh-list
44585369|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44585370|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44585371|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
44585372|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585373|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44585374|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44585375|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585376|NCT03342404|Luspatercept|luspatercept|mesh-list
44585377|NCT03342404|Hematinics|hematinics|mesh-ancestor
44585380|NCT03288545|Gemcitabine|gemcitabine|mesh-list
44585381|NCT03288545|Cisplatin|cisplatin|mesh-list
44585382|NCT03288545|Carboplatin|carboplatin|mesh-list
44585383|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
44585384|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585385|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585386|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
44585387|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585388|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
44585389|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585390|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585391|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585392|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
44585393|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585394|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585395|NCT03288324|Tofacitinib|tofacitinib|mesh-list
44585396|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585397|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585398|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585399|NCT03282916|Valacyclovir|valacyclovir|mesh-list
44585400|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
44585401|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585402|NCT03272217|Bevacizumab|bevacizumab|mesh-list
44585403|NCT03272217|Atezolizumab|atezolizumab|mesh-list
44585404|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585405|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585406|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44585407|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44585408|NCT03272217|Growth Substances|growth substances|mesh-ancestor
44585409|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585410|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
44585411|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44585412|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44585413|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585414|NCT03252587|BMS-986165|bms-986165|mesh-list
44585415|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44585416|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585417|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585418|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585419|NCT03250507|Bupivacaine|bupivacaine|mesh-list
44585420|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
44585421|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
44585422|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44585423|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585424|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
44585425|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585426|NCT03239340|Osimertinib|osimertinib|mesh-list
44412916|NCT02412670|Gemcitabine|gemcitabine|mesh-list
44585427|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585428|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585429|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585430|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585432|NCT03236805|Morphine|morphine|mesh-list
44585433|NCT03236805|Analgesics|analgesics|mesh-ancestor
44585434|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
44585435|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585436|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585437|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44585438|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44585439|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
44585440|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
44585441|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44585442|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44585443|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44585444|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585445|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585446|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44585447|NCT03236805|Narcotics|narcotics|mesh-ancestor
44585448|NCT03217812|Prednisone|prednisone|mesh-list
44585449|NCT03217812|Bortezomib|bortezomib|mesh-list
44585450|NCT03217812|Melphalan|melphalan|mesh-list
44585451|NCT03217812|Daratumumab|daratumumab|mesh-list
44585452|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585453|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
44585454|NCT03217812|Hormones|hormones|mesh-ancestor
44585455|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585456|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585457|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585458|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585459|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585460|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
44585461|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585462|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585463|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585464|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
44585465|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44585466|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44585467|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585468|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44585475|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44585476|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585477|NCT03178149|Tacrolimus|tacrolimus|mesh-list
44585478|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585479|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
44585480|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585481|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44585482|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585483|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585484|NCT03170882|Dexamethasone|dexamethasone|mesh-list
44585485|NCT03170882|Pomalidomide|pomalidomide|mesh-list
44585486|NCT03170882|Ixazomib|ixazomib|mesh-list
44585487|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585488|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
44585489|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
44585490|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585491|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585492|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585493|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
44585494|NCT03170882|Hormones|hormones|mesh-ancestor
44585495|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585496|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585497|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585498|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
44585499|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44585500|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44585512|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585514|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44585515|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
44585516|NCT03141177|Nivolumab|nivolumab|mesh-list
44585517|NCT03141177|Ipilimumab|ipilimumab|mesh-list
44585518|NCT03141177|Sunitinib|sunitinib|mesh-list
44585519|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585520|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585521|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585522|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585523|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44585524|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44585525|NCT03141177|Growth Substances|growth substances|mesh-ancestor
44585526|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585527|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44585528|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585529|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413062|NCT02484651|Rocuronium|rocuronium|mesh-list
44585530|NCT03140488|Oxytocin|oxytocin|mesh-list
44585531|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
44585532|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44585533|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585534|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
44585535|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585536|NCT03063944|Azacitidine|azacitidine|mesh-list
44585537|NCT03063944|Decitabine|decitabine|mesh-list
44585538|NCT03063944|Venetoclax|venetoclax|mesh-list
44585539|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585540|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
44585541|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585542|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585543|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585544|NCT03061474|Niacinamide|niacinamide|mesh-list
44585546|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
44585547|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
44585548|NCT03061474|Vitamins|vitamins|mesh-ancestor
44585549|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
44585550|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585551|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44585552|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
44585553|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585554|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44585555|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
44585556|NCT03045341|Naltrexone|naltrexone|mesh-list
44585557|NCT03045341|Bupropion|bupropion|mesh-list
44585558|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44585559|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44585560|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585561|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
44585562|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585563|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44585564|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
44585565|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585566|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44585567|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44585568|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44585569|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585570|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
44585571|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585572|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44585573|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44585574|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585575|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
44585576|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44585577|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
44585578|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585579|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
44585580|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44585581|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585582|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585583|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585584|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
44585585|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44585586|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44585587|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585588|NCT02996110|Nivolumab|nivolumab|mesh-list
44585589|NCT02996110|Ipilimumab|ipilimumab|mesh-list
44585590|NCT02996110|Linrodostat|linrodostat|mesh-list
44585591|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585592|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585593|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585594|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585595|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585596|NCT02987998|Cisplatin|cisplatin|mesh-list
44585597|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
44585598|NCT02987998|Etoposide|etoposide|mesh-list
44585599|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206991|NCT00424814|Ritonavir|ritonavir|mesh-list
44585600|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585601|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585602|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585603|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585604|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585605|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585607|NCT02939287|Aprepitant|aprepitant|mesh-list
44585608|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
44585609|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
44585610|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
44585611|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585612|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585613|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585614|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44585615|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44585616|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44585617|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585618|NCT02939287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44585619|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44585620|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44585621|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585622|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44585623|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
44585624|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44585625|NCT02917083|Cyclophosphamide|cyclophosphamide|mesh-list
44585626|NCT02917083|Fludarabine|fludarabine|mesh-list
44585627|NCT02917083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585628|NCT02917083|Immunologic Factors|immunologic factors|mesh-ancestor
44585629|NCT02917083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585630|NCT02917083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585631|NCT02917083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585632|NCT02917083|Alkylating Agents|alkylating agents|mesh-ancestor
44585633|NCT02917083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585634|NCT02917083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585635|NCT02917083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585636|NCT02909036|Melphalan|melphalan|mesh-list
44585637|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585638|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
44585639|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585640|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585641|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585642|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585643|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
44585644|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585645|NCT02891824|Bevacizumab|bevacizumab|mesh-list
44585646|NCT02891824|Atezolizumab|atezolizumab|mesh-list
44585647|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585648|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585649|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44585650|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44585651|NCT02891824|Growth Substances|growth substances|mesh-ancestor
44585652|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585653|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
44585654|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
44585655|NCT02875314|Thiotepa|thiotepa|mesh-list
44585656|NCT02875314|Cisplatin|cisplatin|mesh-list
44585657|NCT02875314|Carboplatin|carboplatin|mesh-list
44585658|NCT02875314|Methotrexate|methotrexate|mesh-list
44585659|NCT02875314|Etoposide|etoposide|mesh-list
44585660|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
44585661|NCT02875314|Vincristine|vincristine|mesh-list
44585662|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585663|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
44585664|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585665|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585666|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585667|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
44585668|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585669|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585670|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585671|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44585672|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
44585673|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44585674|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585675|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
44585676|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
44585677|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585678|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44585679|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44585680|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585681|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585682|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585683|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585684|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585685|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585687|NCT02873598|Paclitaxel|paclitaxel|mesh-list
44585688|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44585689|NCT02873598|Folfirinox|folfirinox|mesh-list
44585690|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585691|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585692|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585693|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585694|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585695|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585696|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585697|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
44585698|NCT02873598|Antiviral Agents|antiviral agents|mesh-ancestor
44585699|NCT02873598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585700|NCT02873598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585701|NCT02873598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585702|NCT02873598|Immunologic Factors|immunologic factors|mesh-ancestor
44585703|NCT02873598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585704|NCT02862275|Atezolizumab|atezolizumab|mesh-list
44585705|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44585706|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585707|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
44585708|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585709|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
44585710|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44585711|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44585712|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585713|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585714|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
44585715|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44585716|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44585717|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585719|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
44585720|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585721|NCT02854436|Niraparib|niraparib|mesh-list
44585722|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44585723|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585724|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585725|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585726|NCT02844907|Dexamethasone|dexamethasone|mesh-list
44585727|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585728|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
44585729|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
44585730|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585731|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585732|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585733|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
44585734|NCT02844907|Hormones|hormones|mesh-ancestor
44585735|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585736|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44585737|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585738|NCT02821832|Rifampin|rifampin|mesh-list
44585739|NCT02821832|Isoniazid|isoniazid|mesh-list
44585740|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
44585741|NCT02821832|Ethambutol|ethambutol|mesh-list
44585742|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44585743|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
44585744|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44585745|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585746|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
44585747|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44585748|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585749|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585750|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44585751|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44585752|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44585753|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44413272|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
44585754|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44585755|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44585756|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44585757|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44585758|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
44585759|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44585760|NCT02787369|Idelalisib|idelalisib|mesh-list
44585761|NCT02787369|Ricolinostat|ricolinostat|mesh-list
44585762|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585763|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585764|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585765|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44585766|NCT02782949|Curcumin|curcumin|mesh-list
44585767|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44585768|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585769|NCT02782949|Analgesics|analgesics|mesh-ancestor
44585770|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
44585771|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585772|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585773|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585774|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585775|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585776|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585777|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585778|NCT02739412|Aldesleukin|aldesleukin|mesh-list
44585779|NCT02739412|Interleukin-2|interleukin-2|mesh-list
44585780|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585781|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585783|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
44585784|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585785|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585786|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44585787|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44585788|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
44585789|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585790|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
44585791|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
44585792|NCT02703220|Acetazolamide|acetazolamide|mesh-list
44585793|NCT02703220|Finasteride|finasteride|mesh-list
44585794|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
44585795|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44585796|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585797|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585798|NCT02703220|Diuretics|diuretics|mesh-ancestor
44585799|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
44585800|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585801|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44585802|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44585803|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
44585804|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585805|NCT02703220|Urological Agents|urological agents|mesh-ancestor
44585806|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
44585807|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585808|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585809|NCT02677922|Azacitidine|azacitidine|mesh-list
44585810|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585811|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
44585812|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585813|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585814|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585815|NCT02607904|Cannabidiol|cannabidiol|mesh-list
44585816|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
44585817|NCT02607891|Cannabidiol|cannabidiol|mesh-list
44585818|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
44585819|NCT02607813|Spartalizumab|spartalizumab|mesh-list
44585820|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585821|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585822|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585823|NCT02595931|Irinotecan|irinotecan|mesh-list
44585824|NCT02595931|Camptothecin|camptothecin|mesh-list
44585825|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44585826|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585827|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585828|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585829|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413360|NCT02403271|Durvalumab|durvalumab|mesh-list
44585830|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585831|NCT02577406|Cytarabine|cytarabine|mesh-list
44585832|NCT02577406|Azacitidine|azacitidine|mesh-list
44585833|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585834|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
44585835|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585836|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585837|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
44585838|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585839|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585840|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
44585841|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585842|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585843|NCT02574728|Sirolimus|sirolimus|mesh-list
44585844|NCT02574728|Celecoxib|celecoxib|mesh-list
44585845|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
44585846|NCT02574728|Etoposide|etoposide|mesh-list
44585847|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585848|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
44585849|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585850|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44585851|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585852|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
44585853|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585854|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585855|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585856|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585857|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585858|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585859|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585860|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44585861|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585862|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44585863|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
44585864|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44585865|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44585867|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
44585868|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585869|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585870|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44585871|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44585872|NCT02570542|Cytarabine|cytarabine|mesh-list
44585873|NCT02570542|Plerixafor|plerixafor|mesh-list
44585874|NCT02570542|Etoposide|etoposide|mesh-list
44585875|NCT02570542|Melphalan|melphalan|mesh-list
44585876|NCT02570542|Carmustine|carmustine|mesh-list
44585877|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585878|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585879|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585880|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585881|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585882|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585883|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585884|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
44585885|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
44585886|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585887|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585888|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
44585889|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585890|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585891|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
44585892|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44585893|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44585894|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44585895|NCT02518594|Progesterone|progesterone|mesh-list
44585896|NCT02518594|Progestins|progestins|mesh-ancestor
44585897|NCT02518594|Hormones|hormones|mesh-ancestor
44585898|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585899|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585900|NCT02497300|Amiloride|amiloride|mesh-list
44585901|NCT02497300|Spironolactone|spironolactone|mesh-list
44585902|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44413425|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
44585903|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
44585904|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585905|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585906|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44585907|NCT02497300|Diuretics|diuretics|mesh-ancestor
44585908|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
44585909|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44585910|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44585911|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44585912|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585913|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44585915|NCT02489318|Hormones|hormones|mesh-ancestor
44585916|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585917|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585918|NCT02477826|Gemcitabine|gemcitabine|mesh-list
44585919|NCT02477826|Paclitaxel|paclitaxel|mesh-list
44585920|NCT02477826|Cisplatin|cisplatin|mesh-list
44585921|NCT02477826|Carboplatin|carboplatin|mesh-list
44585922|NCT02477826|Nivolumab|nivolumab|mesh-list
44585923|NCT02477826|Pemetrexed|pemetrexed|mesh-list
44585924|NCT02477826|Ipilimumab|ipilimumab|mesh-list
44585925|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585926|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585927|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585928|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585929|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585930|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585931|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585932|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
44585933|NCT02477826|Antiviral Agents|antiviral agents|mesh-ancestor
44585934|NCT02477826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44585935|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585936|NCT02477826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44585937|NCT02477826|Immunologic Factors|immunologic factors|mesh-ancestor
44585938|NCT02477826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585939|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44585940|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44585941|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44585942|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44585943|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
44585944|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585945|NCT02464969|Apixaban|apixaban|mesh-list
44585946|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44585947|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
44585948|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44585949|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
44585950|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585951|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585952|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
44585953|NCT02432274|Etoposide|etoposide|mesh-list
44585954|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
44585955|NCT02432274|Ifosfamide|ifosfamide|mesh-list
44585956|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
44585957|NCT02432274|Lenvatinib|lenvatinib|mesh-list
44585958|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585959|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585960|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44585961|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44585962|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585963|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585964|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44585965|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
44585966|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44585967|NCT02400242|Dexamethasone|dexamethasone|mesh-list
44585968|NCT02400242|Pomalidomide|pomalidomide|mesh-list
44585969|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44585970|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44585971|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
44585972|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
44585973|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44585974|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44585975|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44585976|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
44585977|NCT02400242|Hormones|hormones|mesh-ancestor
44585978|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44585979|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413498|NCT02399475|Hormones|hormones|mesh-list
44585980|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585981|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
44585982|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44585983|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44585984|NCT02400242|Growth Substances|growth substances|mesh-ancestor
44585985|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44585986|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44585987|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585988|NCT02376699|Gemcitabine|gemcitabine|mesh-list
44585989|NCT02376699|Paclitaxel|paclitaxel|mesh-list
44585990|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
44585991|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44585992|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44585993|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44585994|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44585995|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44585996|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44585997|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44585998|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
44585999|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
44586000|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586001|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586002|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586003|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
44586004|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586053|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586054|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586056|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586057|NCT02280525|Cytarabine|cytarabine|mesh-list
44586058|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
44586059|NCT02280525|Rituximab|rituximab|mesh-list
44586060|NCT02280525|Fludarabine|fludarabine|mesh-list
44586061|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
44586062|NCT02280525|Lenalidomide|lenalidomide|mesh-list
44586063|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586064|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
44586065|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586066|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586067|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586068|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
44586069|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586070|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586071|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586072|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586073|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586074|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
44586075|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
44586076|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586077|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44586078|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44586079|NCT02280525|Growth Substances|growth substances|mesh-ancestor
44586080|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
44586081|NCT02257736|Prednisone|prednisone|mesh-list
44586082|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
44586083|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586084|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
44586085|NCT02257736|Hormones|hormones|mesh-ancestor
44586086|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586087|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586088|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586089|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207422|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
44586090|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586091|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586092|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586093|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586094|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586095|NCT02213497|Paclitaxel|paclitaxel|mesh-list
44586096|NCT02213497|Carboplatin|carboplatin|mesh-list
44586097|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44586098|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44586099|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586100|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586101|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44586102|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586103|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586104|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44586105|NCT02206035|Methotrexate|methotrexate|mesh-list
44586106|NCT02206035|Tacrolimus|tacrolimus|mesh-list
44586107|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44586108|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
44586109|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44586110|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586111|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586112|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
44586113|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586114|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586115|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586116|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586117|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44586118|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586119|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
44586120|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586121|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44586122|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44586124|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44586125|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586126|NCT02141282|Venetoclax|venetoclax|mesh-list
44586127|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586128|NCT02091141|Trastuzumab|trastuzumab|mesh-list
44586129|NCT02091141|Pertuzumab|pertuzumab|mesh-list
44586130|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44586131|NCT02091141|Atezolizumab|atezolizumab|mesh-list
44586132|NCT02091141|Vemurafenib|vemurafenib|mesh-list
44586133|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586134|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586135|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586136|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586137|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586138|NCT02073474|Nabiximols|nabiximols|mesh-list
44586139|NCT02073474|Analgesics|analgesics|mesh-ancestor
44586140|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
44586141|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586142|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586143|NCT02052193|Vemurafenib|vemurafenib|mesh-list
44586144|NCT02052193|Dabrafenib|dabrafenib|mesh-list
44586145|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586146|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586147|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586148|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586149|NCT01972217|Prednisone|prednisone|mesh-list
44586150|NCT01972217|Prednisolone|prednisolone|mesh-list
44586151|NCT01972217|Olaparib|olaparib|mesh-list
44586152|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586153|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
44586154|NCT01972217|Hormones|hormones|mesh-ancestor
44207456|NCT00426478|Diuretics|diuretics|mesh-ancestor
44586155|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586156|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586157|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586158|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586159|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44586160|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586161|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586162|NCT01969643|Trastuzumab|trastuzumab|mesh-list
44586163|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586164|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586165|NCT01958021|Letrozole|letrozole|mesh-list
44586166|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586167|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44586168|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586169|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586170|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586171|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44586172|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586173|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586174|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586175|NCT01909453|Vemurafenib|vemurafenib|mesh-list
44586176|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586177|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586178|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586179|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586180|NCT01898520|Nabiximols|nabiximols|mesh-list
44586181|NCT01898520|Analgesics|analgesics|mesh-ancestor
44586182|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
44586183|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586184|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586185|NCT01887301|Nabiximols|nabiximols|mesh-list
44586186|NCT01887301|Analgesics|analgesics|mesh-ancestor
44586187|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
44586188|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586189|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586190|NCT01882660|Decitabine|decitabine|mesh-list
44586191|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586192|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
44586193|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586194|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586195|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586196|NCT01853631|Cyclophosphamide|cyclophosphamide|mesh-list
44586197|NCT01853631|Fludarabine|fludarabine|mesh-list
44586198|NCT01853631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586199|NCT01853631|Immunologic Factors|immunologic factors|mesh-ancestor
44586200|NCT01853631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586201|NCT01853631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586202|NCT01853631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586203|NCT01853631|Alkylating Agents|alkylating agents|mesh-ancestor
44586204|NCT01853631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586205|NCT01853631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586206|NCT01853631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586207|NCT01832402|Fentanyl|fentanyl|mesh-list
44586208|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44586209|NCT01832402|Narcotics|narcotics|mesh-ancestor
44586210|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586211|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586212|NCT01832402|Analgesics|analgesics|mesh-ancestor
44586213|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
44586214|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586215|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44586216|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44586217|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
44586218|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
44586219|NCT01828112|Docetaxel|docetaxel|mesh-list
44586220|NCT01828112|Pemetrexed|pemetrexed|mesh-list
44586221|NCT01828112|Ceritinib|ceritinib|mesh-list
44586222|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586223|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586224|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
44586225|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586226|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586227|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586228|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44586229|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44586230|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586231|NCT01812616|Nabiximols|nabiximols|mesh-list
44586232|NCT01812616|Analgesics|analgesics|mesh-ancestor
44586233|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
44586234|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586235|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586236|NCT01812603|Nabiximols|nabiximols|mesh-list
44586237|NCT01812603|Analgesics|analgesics|mesh-ancestor
44586238|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
44586239|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586240|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586241|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
44586242|NCT01716117|Antacids|antacids|mesh-ancestor
44586243|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586244|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586245|NCT01617096|Dapivirine|dapivirine|mesh-list
44586246|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44586247|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44586248|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
44586249|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586250|NCT01566695|Azacitidine|azacitidine|mesh-list
44586251|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586252|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
44207572|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44586253|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586254|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586255|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586256|NCT01445067|Calcitonin|calcitonin|mesh-list
44586257|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44586258|NCT01445067|Katacalcin|katacalcin|mesh-list
44586259|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44586260|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44586261|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586262|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44586263|NCT01430572|Everolimus|everolimus|mesh-list
44586264|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586265|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586266|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
44586267|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586268|NCT01430442|Sumatriptan|sumatriptan|mesh-list
44586269|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44586270|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44586271|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44586272|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
44586273|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586274|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586275|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586277|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44586278|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44586279|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44586280|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44586281|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586282|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586283|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
44586284|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586285|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586286|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44586287|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586288|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586289|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
44586290|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
44586291|NCT01349101|Busulfan|busulfan|mesh-list
44586292|NCT01349101|Fludarabine|fludarabine|mesh-list
44586293|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
44586294|NCT01349101|Tacrolimus|tacrolimus|mesh-list
44586295|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586296|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
44586297|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586298|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586299|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586300|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
44586301|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586302|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586303|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586304|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586305|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
44586306|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586307|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44586308|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586309|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44586310|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44586311|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
44586312|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44586313|NCT01314118|Prednisone|prednisone|mesh-list
44586314|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
44586315|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586316|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
44586317|NCT01314118|Hormones|hormones|mesh-ancestor
44586318|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586319|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586320|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586321|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586322|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586323|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586324|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586325|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586326|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586327|NCT01193842|Prednisone|prednisone|mesh-list
44586328|NCT01193842|Cortisone|cortisone|mesh-list
44586329|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
44586353|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44586354|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586355|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586356|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
44586357|NCT01193842|Hormones|hormones|mesh-ancestor
44586358|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586359|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586360|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44586361|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586362|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207659|NCT00427271|Aspirin|aspirin|mesh-list
44586363|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586364|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44586365|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
44586366|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586389|NCT01093612|Copper|copper|mesh-list
44586390|NCT01093612|Trastuzumab|trastuzumab|mesh-list
44586391|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586392|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586393|NCT01093612|Trace Elements|trace elements|mesh-ancestor
44586394|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
44586395|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413989|NCT02387216|Docetaxel|docetaxel|mesh-list
44586396|NCT00825630|Esomeprazole|esomeprazole|mesh-list
44586397|NCT00825630|Pantoprazole|pantoprazole|mesh-list
44586398|NCT00825630|Lansoprazole|lansoprazole|mesh-list
44586399|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
44586400|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44586401|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586402|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44586403|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586404|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586405|NCT00790010|Bevacizumab|bevacizumab|mesh-list
44586406|NCT00790010|Ipilimumab|ipilimumab|mesh-list
44586407|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586408|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586409|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44586410|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44586411|NCT00790010|Growth Substances|growth substances|mesh-ancestor
44586412|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586413|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
44586414|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44586415|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586416|NCT00782574|Cisplatin|cisplatin|mesh-list
44586417|NCT00782574|Olaparib|olaparib|mesh-list
44586418|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586419|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44586420|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586421|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586422|NCT00777582|Olaparib|olaparib|mesh-list
44586423|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44586424|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586425|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586426|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586427|NCT00753545|Olaparib|olaparib|mesh-list
44586428|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44586429|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207705|NCT00427388|Hormones|hormones|mesh-ancestor
44586430|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586431|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586432|NCT00516724|Paclitaxel|paclitaxel|mesh-list
44586433|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44586434|NCT00516724|Carboplatin|carboplatin|mesh-list
44586435|NCT00516724|Olaparib|olaparib|mesh-list
44586436|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44586437|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44586438|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586439|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586440|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44586441|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586442|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586443|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586444|NCT00516373|Olaparib|olaparib|mesh-list
44586445|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44586446|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586447|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586448|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586449|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
44586450|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44586451|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44586452|NCT00379431|Prednisolone|prednisolone|mesh-list
44586453|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
44586454|NCT00379431|Rituximab|rituximab|mesh-list
44586455|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44586456|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
44586457|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586458|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586459|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
44586460|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586461|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586462|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586463|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
44586464|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
44586465|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586466|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586467|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
44586468|NCT00379431|Hormones|hormones|mesh-ancestor
44586469|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586470|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44586482|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586484|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44586485|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
44586486|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44586487|NCT00175162|Protective Agents|protective agents|mesh-ancestor
44586488|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586489|NCT00099437|Fulvestrant|fulvestrant|mesh-list
44586490|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586491|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586492|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44586493|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44586494|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586495|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586496|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586497|NCT00049595|Prednisone|prednisone|mesh-list
44586498|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
44586499|NCT00049595|Dacarbazine|dacarbazine|mesh-list
44586500|NCT00049595|Doxorubicin|doxorubicin|mesh-list
44586501|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44586502|NCT00049595|Etoposide|etoposide|mesh-list
44586503|NCT00049595|Vincristine|vincristine|mesh-list
44586504|NCT00049595|Bleomycin|bleomycin|mesh-list
44586505|NCT00049595|Vinblastine|vinblastine|mesh-list
44586506|NCT00049595|Procarbazine|procarbazine|mesh-list
44586507|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586508|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
44586509|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586510|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586511|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586512|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
44586513|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586514|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586515|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586516|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44586517|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44586518|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44586519|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586520|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586521|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
44586522|NCT00049595|Hormones|hormones|mesh-ancestor
44586523|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586524|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44586525|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44586526|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586527|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
44586528|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586529|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
44586530|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586531|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586532|NCT05662410|Aflibercept|aflibercept|mesh-list
44586533|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44586534|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44586535|NCT05662410|Growth Substances|growth substances|mesh-ancestor
44586536|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586537|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44586538|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586539|NCT05662397|Cemiplimab|cemiplimab|mesh-list
44586540|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586541|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586542|NCT05662358|Denosumab|denosumab|mesh-list
44586543|NCT05662358|Alendronate|alendronate|mesh-list
44586544|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44586545|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586546|NCT05662319|Antithrombins|antithrombins|mesh-list
44586547|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
44586548|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44586549|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
44586550|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586551|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586552|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
44586553|NCT05662306|Aripiprazole|aripiprazole|mesh-list
44586554|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
44586555|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44586556|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586557|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44586558|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44586559|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586560|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586561|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
44586562|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
44586563|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586564|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586565|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44586566|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44586567|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
44586568|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44586569|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44586570|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44586571|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44586572|NCT05662228|Lorazepam|lorazepam|mesh-list
44586573|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
44586574|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44586575|NCT05662228|Antibodies|antibodies|mesh-list
44586576|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
44586577|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44586578|NCT05662228|Tofacitinib|tofacitinib|mesh-list
44586579|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
44586580|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586581|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586582|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586583|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586584|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
44586585|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
44586586|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
44586587|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586588|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586589|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44586590|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586591|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44586592|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44586593|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586594|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
44586595|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
44586596|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586597|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44586598|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44586599|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586600|NCT05662189|Exenatide|exenatide|mesh-list
44586601|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44586602|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586603|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44586604|NCT05662189|Incretins|incretins|mesh-ancestor
44586605|NCT05662189|Hormones|hormones|mesh-ancestor
44586606|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586607|NCT05662163|Anesthetics|anesthetics|mesh-list
44586608|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586609|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586610|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
44586611|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44586612|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586613|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
44586614|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586615|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
44586616|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586617|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586618|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44586619|NCT05661942|Calcium|calcium|mesh-list
44586620|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44586621|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586622|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
44586623|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586624|NCT05661708|Chitosan|chitosan|mesh-list
44586625|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44586626|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44586627|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
44586628|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586629|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44586630|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
44586631|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
44586632|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
44586633|NCT05661708|Coagulants|coagulants|mesh-ancestor
44586634|NCT05661682|Zinc|zinc|mesh-list
44586635|NCT05661682|Copper|copper|mesh-list
44586636|NCT05661682|Manganese|manganese|mesh-list
44586637|NCT05661682|Trace Elements|trace elements|mesh-list
44586638|NCT05661682|Selenious Acid|selenious acid|mesh-list
44586639|NCT05661682|Micronutrients|micronutrients|mesh-list
44586640|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
44586641|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
44586642|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586643|NCT05661682|Astringents|astringents|mesh-ancestor
44586644|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586645|NCT05661682|Antidotes|antidotes|mesh-ancestor
44586646|NCT05661682|Protective Agents|protective agents|mesh-ancestor
44586647|NCT05661682|Emetics|emetics|mesh-ancestor
44586648|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
44586649|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586650|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586652|NCT05661669|Analgesics|analgesics|mesh-ancestor
44586653|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
44586654|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586655|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586656|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44586657|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44586658|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
44586659|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
44586660|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586661|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44586662|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44586663|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586664|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586665|NCT05661643|Temozolomide|temozolomide|mesh-list
44586666|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586667|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
44586668|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586669|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586670|NCT05661591|Fluconazole|fluconazole|mesh-list
44586671|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
44586672|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586673|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44586674|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586675|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586676|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586677|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586678|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586679|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586680|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586681|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44586682|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44586683|NCT05661461|Sirolimus|sirolimus|mesh-list
44586684|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44586685|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586686|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44586687|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586688|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
44586689|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586690|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
44586691|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586692|NCT05661279|Acetaminophen|acetaminophen|mesh-list
44586693|NCT05661279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44586694|NCT05661279|Analgesics|analgesics|mesh-ancestor
44586695|NCT05661279|Sensory System Agents|sensory system agents|mesh-ancestor
44586696|NCT05661279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586697|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586698|NCT05661279|Antipyretics|antipyretics|mesh-ancestor
44586699|NCT05661253|Bupivacaine|bupivacaine|mesh-list
44586700|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
44586701|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
44586702|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586703|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586704|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
44586705|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586706|NCT05661240|Docetaxel|docetaxel|mesh-list
44586707|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586708|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
44586709|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
44586710|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
44586711|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586712|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
44586713|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44586714|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586715|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586716|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44586717|NCT05661227|Analgesics|analgesics|mesh-ancestor
44586718|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
44586719|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235518|NCT00554918|Docetaxel|docetaxel|mesh-list
44586720|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44586721|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44586722|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44586723|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
44586724|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586725|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586726|NCT05661188|Atezolizumab|atezolizumab|mesh-list
44586727|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586728|NCT05661045|Anesthetics|anesthetics|mesh-list
44586729|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586730|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586731|NCT05660213|Bevacizumab|bevacizumab|mesh-list
44586732|NCT05660213|Atezolizumab|atezolizumab|mesh-list
44586733|NCT05660213|Apatinib|apatinib|mesh-list
44586734|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586735|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586736|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44586737|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44586738|NCT05660213|Growth Substances|growth substances|mesh-ancestor
44586739|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586740|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44586741|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586742|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586743|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586744|NCT05657925|Ondansetron|ondansetron|mesh-list
44586745|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
44586746|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
44586747|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586748|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586749|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586750|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
44586751|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586752|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44586753|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
44586754|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586755|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586756|NCT05657925|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44586757|NCT05657925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44586758|NCT05657925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586759|NCT05657925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586760|NCT05657925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44586761|NCT05657860|Guanfacine|guanfacine|mesh-list
44586762|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44586763|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44586764|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44586765|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44586766|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
44586767|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44586768|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586769|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586770|NCT05650736|Abrocitinib|abrocitinib|mesh-list
44586771|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586772|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414374|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
44586773|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586774|NCT05645692|Atezolizumab|atezolizumab|mesh-list
44586775|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586776|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
44586777|NCT05633654|Capecitabine|capecitabine|mesh-list
44586778|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586779|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586780|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44586781|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
44586782|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586783|NCT05625308|Folic Acid|folic acid|mesh-list
44586784|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
44586785|NCT05625308|Hydroxocobalamin|hydroxocobalamin|mesh-list
44586786|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44586787|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
44586788|NCT05625308|Vitamins|vitamins|mesh-ancestor
44586789|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
44586790|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586791|NCT05625308|Hematinics|hematinics|mesh-ancestor
44586792|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
44586793|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44586794|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
44586796|NCT05625308|Protective Agents|protective agents|mesh-ancestor
44586797|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
44586798|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586799|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44586800|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44586801|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586802|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44586803|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
44586804|NCT05608291|Cemiplimab|cemiplimab|mesh-list
44586805|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586806|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586807|NCT05601648|Psilocybin|psilocybin|mesh-list
44586808|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
44586809|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586810|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586811|NCT05595642|Astegolimab|astegolimab|mesh-list
44586812|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44586813|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44586814|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
44586815|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586816|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44586817|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44586818|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44586819|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44586820|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586821|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586822|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
44586823|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586824|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44586825|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
44586826|NCT05588609|Afatinib|afatinib|mesh-list
44586827|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586828|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586829|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586830|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586831|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586832|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586833|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586834|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586835|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586836|NCT05543278|Amiodarone|amiodarone|mesh-list
44586837|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44586838|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
44586839|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44586840|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44586841|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586842|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44586843|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44586844|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586845|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586846|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44586847|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44586848|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44586849|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44586850|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586851|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586852|NCT05523596|Benzonidazole|benzonidazole|mesh-list
44586853|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586854|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
44586855|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586856|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44586857|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44586858|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44586859|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586860|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
44586861|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44586862|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44586863|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586864|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
44586865|NCT05517590|Coagulants|coagulants|mesh-ancestor
44586866|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
44586868|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586869|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586870|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586871|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
44586872|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586873|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586874|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
44586875|NCT05468359|Bevacizumab|bevacizumab|mesh-list
44586876|NCT05468359|Sorafenib|sorafenib|mesh-list
44586877|NCT05468359|Atezolizumab|atezolizumab|mesh-list
44586878|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44586879|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
44586880|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586881|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44586882|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44586883|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
44586884|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586885|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586886|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44586887|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586888|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44586889|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44586890|NCT05468359|Growth Substances|growth substances|mesh-ancestor
44586891|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
44586892|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586893|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586894|NCT05456932|Iron|iron|mesh-list
44586895|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
44586896|NCT05456932|Ferric maltol|ferric maltol|mesh-list
44586897|NCT05456932|Trace Elements|trace elements|mesh-ancestor
44414523|NCT02370888|Lenalidomide|lenalidomide|mesh-list
44586899|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586900|NCT05456932|Hematinics|hematinics|mesh-ancestor
44586901|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44586902|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44586903|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586904|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586905|NCT05440201|Enoxaparin|enoxaparin|mesh-list
44586906|NCT05440201|Anticoagulants|anticoagulants|mesh-list
44586907|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44586908|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44586909|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586910|NCT05431777|Avelumab|avelumab|mesh-list
44586911|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586912|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586913|NCT05406765|Bupivacaine|bupivacaine|mesh-list
44586914|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
44586915|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
44586916|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586917|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586918|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
44586919|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586920|NCT05404724|Itraconazole|itraconazole|mesh-list
44586921|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
44586922|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586923|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44586924|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44586925|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586926|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586927|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44586928|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44586929|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44586930|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208179|NCT00429754|Aprepitant|aprepitant|mesh-list
44586931|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44586932|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
44586933|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44586934|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44586935|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44586936|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
44586937|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586938|NCT05392127|Vitamin K|vitamin k|mesh-list
44586939|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
44586940|NCT05392127|Repaglinide|repaglinide|mesh-list
44586941|NCT05392127|Midazolam|midazolam|mesh-list
44586942|NCT05392127|Omeprazole|omeprazole|mesh-list
44586943|NCT05392127|Warfarin|warfarin|mesh-list
44586944|NCT05392127|Vitamins|vitamins|mesh-ancestor
44586945|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
44586946|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586947|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44586948|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44586949|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44586950|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44586951|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44586952|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44586953|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44586954|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
44586955|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
44586956|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
44586957|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
44586958|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414595|NCT02369510|Epinephrine|epinephrine|mesh-list
44586959|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586961|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44586962|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44586963|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44586964|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586965|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44586966|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44586967|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
44586968|NCT05392127|Coagulants|coagulants|mesh-ancestor
44586969|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44586970|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44586971|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44586972|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44586973|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44586974|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44586975|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586976|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
44586977|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44586978|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44586979|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44586980|NCT05366049|Acetaminophen|acetaminophen|mesh-list
44586981|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44586982|NCT05366049|Analgesics|analgesics|mesh-ancestor
44586983|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
44586984|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44586985|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586986|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
44586987|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44586988|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44586989|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44586990|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
44586991|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44586992|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44586993|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44586994|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44586995|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
44586996|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44586997|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
44586998|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
44586999|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44587000|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587001|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587002|NCT05357040|Analgesics|analgesics|mesh-ancestor
44587003|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
44587004|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587005|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44587006|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
44587007|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587008|NCT05346588|Propofol|propofol|mesh-list
44587009|NCT05346588|Anesthetics|anesthetics|mesh-list
44587010|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44587011|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44587012|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587013|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44587014|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
44587015|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44587016|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44587017|NCT05338398|Benzydamine|benzydamine|mesh-list
44587018|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587019|NCT05324501|Lomustine|lomustine|mesh-list
44587020|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587021|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
44587022|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587023|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587024|NCT05321420|Pirfenidone|pirfenidone|mesh-list
44587025|NCT05321420|Analgesics|analgesics|mesh-ancestor
44587026|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
44587027|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587028|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587029|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587030|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587031|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587032|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587033|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587034|NCT05305300|Vaccines|vaccines|mesh-list
44587035|NCT05305300|Somatomedin B|somatomedin b|mesh-list
44587036|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
44587037|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587038|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44587039|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44587040|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44587041|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587042|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587043|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
44587044|NCT05265325|Hematinics|hematinics|mesh-ancestor
44587045|NCT05238155|Antimetabolites|antimetabolites|mesh-list
44587046|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587047|NCT05232929|Risdiplam|risdiplam|mesh-list
44587048|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44587049|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587050|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587051|NCT05214976|Paclitaxel|paclitaxel|mesh-list
44587052|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587053|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587054|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587055|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587056|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587057|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587058|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44587059|NCT05206500|Amoxicillin|amoxicillin|mesh-list
44587060|NCT05206500|Metronidazole|metronidazole|mesh-list
44587061|NCT05206500|Clindamycin|clindamycin|mesh-list
44587062|NCT05206500|Linezolid|linezolid|mesh-list
44587063|NCT05206500|Tetracycline|tetracycline|mesh-list
44587064|NCT05206500|Penicillins|penicillins|mesh-list
44587065|NCT05206500|Ampicillin|ampicillin|mesh-list
44587066|NCT05206500|Fosfomycin|fosfomycin|mesh-list
44587067|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
44587068|NCT05206500|Cephalosporins|cephalosporins|mesh-list
44587069|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
44587070|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587071|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44587072|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44587073|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44587074|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587075|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587076|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44587077|NCT05206500|Renal Agents|renal agents|mesh-ancestor
44587078|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587079|NCT05204134|Insulin|insulin|mesh-list
44587080|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44587081|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587082|NCT05191706|Dexamethasone|dexamethasone|mesh-list
44587083|NCT05191706|Prednisolone|prednisolone|mesh-list
44587084|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44587085|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
44587086|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44587087|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
44587088|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44587089|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
44587090|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587091|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
44587092|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
44587093|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587094|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587095|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587096|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
44587097|NCT05191706|Hormones|hormones|mesh-ancestor
44587098|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587099|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44587100|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587101|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44587102|NCT05191706|Protective Agents|protective agents|mesh-ancestor
44587103|NCT05181436|Chrysarobin|chrysarobin|mesh-list
44587104|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587105|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587106|NCT05181436|Analgesics|analgesics|mesh-ancestor
44587107|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
44587108|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587109|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587110|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587111|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587112|NCT05180240|Cannabidiol|cannabidiol|mesh-list
44587113|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
44587114|NCT05169593|Adalimumab|adalimumab|mesh-list
44587115|NCT05169593|Infliximab|infliximab|mesh-list
44587116|NCT05169593|Ustekinumab|ustekinumab|mesh-list
44587117|NCT05169593|Vedolizumab|vedolizumab|mesh-list
44587118|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587119|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587120|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
44587121|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587122|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
44587124|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587125|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587126|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44587127|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
44587128|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587129|NCT05117736|Valsartan|valsartan|mesh-list
44587130|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44587131|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44587132|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44587133|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44587134|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587135|NCT05043090|Durvalumab|durvalumab|mesh-list
44587136|NCT05043090|Sunitinib|sunitinib|mesh-list
44587137|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587138|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587139|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44587140|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44587141|NCT05043090|Growth Substances|growth substances|mesh-ancestor
44587142|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587143|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
44587144|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44587145|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587146|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587147|NCT05027308|Teduglutide|teduglutide|mesh-list
44587148|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587149|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44587150|NCT05027308|Protective Agents|protective agents|mesh-ancestor
44587151|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587152|NCT05020184|Cimetidine|cimetidine|mesh-list
44587153|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44587154|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587155|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44587156|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
44587157|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
44587158|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587159|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587160|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587161|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44587162|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44587163|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587164|NCT05017571|Colchicine|colchicine|mesh-list
44587165|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
44587166|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587167|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587168|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587169|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587170|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587171|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587172|NCT05010876|Icatibant|icatibant|mesh-list
44587173|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44587174|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587175|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587176|NCT05010876|Analgesics|analgesics|mesh-ancestor
44587177|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
44587178|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587179|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587180|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587181|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587182|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44587183|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44587184|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587185|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44587186|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587187|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
44587188|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
44587189|NCT04989803|Fludarabine|fludarabine|mesh-list
44587190|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587191|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
44587192|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587193|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587194|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587195|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
44587196|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587197|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587198|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587199|NCT04933227|Capecitabine|capecitabine|mesh-list
44587200|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
44587201|NCT04933227|Atezolizumab|atezolizumab|mesh-list
44587202|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587203|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
44587204|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587205|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587206|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44587207|NCT04925531|Ampicillin|ampicillin|mesh-list
44587208|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587209|NCT04908475|Apremilast|apremilast|mesh-list
44587210|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587211|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587212|NCT04908475|Analgesics|analgesics|mesh-ancestor
44587213|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
44587214|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587215|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587216|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587217|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587218|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44587219|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44587220|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587221|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587222|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
44587223|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587224|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587225|NCT04891770|Tenofovir|tenofovir|mesh-list
44587226|NCT04891770|Nivolumab|nivolumab|mesh-list
44587227|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587228|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587229|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44587230|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587231|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
44587232|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587233|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44587234|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587235|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587236|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44587237|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44587238|NCT04885257|Methylphenidate|methylphenidate|mesh-list
44587239|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44587240|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587241|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44587242|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44587243|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44587244|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587245|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
44587246|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587248|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587249|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
44587250|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587251|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587252|NCT04865939|Antiviral Agents|antiviral agents|mesh-ancestor
44587253|NCT04865939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587254|NCT04865939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587255|NCT04865939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587256|NCT04865939|Immunologic Factors|immunologic factors|mesh-ancestor
44587257|NCT04865939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587259|NCT04865887|Lenvatinib|lenvatinib|mesh-list
44587260|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587261|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587262|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44587263|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587264|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587265|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44587266|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44587267|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587268|NCT04805073|Promethazine|promethazine|mesh-list
44587269|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
44587270|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
44587271|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44587272|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44587273|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
44587274|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
44587275|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587276|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587277|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587278|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44587279|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44587280|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44587281|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44587282|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
44587283|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
44587284|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
44587285|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587286|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
44587287|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
44587288|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587289|NCT04804007|Etoposide|etoposide|mesh-list
44587290|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587291|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587292|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44587293|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44587294|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587295|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587296|NCT04772196|Vitamin D|vitamin d|mesh-list
44587297|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
44587298|NCT04772196|Vitamins|vitamins|mesh-ancestor
44587299|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
44587300|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587301|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44587302|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44587303|NCT04738123|Xanomeline|xanomeline|mesh-list
44587304|NCT04738123|Trospium chloride|trospium chloride|mesh-list
44587305|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
44587306|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
44587307|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587308|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587309|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44587310|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44587311|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
44587312|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587313|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587314|NCT04738123|Urological Agents|urological agents|mesh-ancestor
44587315|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44587316|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44587317|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44587318|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44587319|NCT04730635|Donepezil|donepezil|mesh-list
44587320|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44208547|NCT00431080|Mitogens|mitogens|mesh-list
44587321|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587322|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587323|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
44587324|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587325|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587326|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
44587327|NCT04729205|Mitomycins|mitomycins|mesh-list
44587328|NCT04729205|Mitomycin|mitomycin|mesh-list
44587329|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44587330|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587331|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
44587332|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587333|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587334|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587335|NCT04710030|Valacyclovir|valacyclovir|mesh-list
44587336|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
44587337|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587338|NCT04679376|Atorvastatin|atorvastatin|mesh-list
44587339|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44587340|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44587341|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
44587342|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587343|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44587344|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44587345|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587346|NCT04677504|Gemcitabine|gemcitabine|mesh-list
44587347|NCT04677504|Bevacizumab|bevacizumab|mesh-list
44587348|NCT04677504|Cisplatin|cisplatin|mesh-list
44587349|NCT04677504|Atezolizumab|atezolizumab|mesh-list
44587350|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587351|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587352|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44587353|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44587354|NCT04677504|Growth Substances|growth substances|mesh-ancestor
44587355|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587356|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44587357|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587358|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
44587359|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587360|NCT04677504|Antiviral Agents|antiviral agents|mesh-ancestor
44587361|NCT04677504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587362|NCT04677504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587363|NCT04677504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587364|NCT04677504|Immunologic Factors|immunologic factors|mesh-ancestor
44587365|NCT04659174|Xanomeline|xanomeline|mesh-list
44587366|NCT04659174|Trospium chloride|trospium chloride|mesh-list
44587367|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
44587368|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
44587369|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587370|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587371|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44587372|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44587373|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44587374|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587375|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587376|NCT04659174|Urological Agents|urological agents|mesh-ancestor
44587377|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44587378|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44587379|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44587380|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44587381|NCT04574856|Temozolomide|temozolomide|mesh-list
44587382|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587383|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
44587384|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587385|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587386|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
44587387|NCT04521946|Fludarabine|fludarabine|mesh-list
44587388|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
44587389|NCT04521946|Etoposide|etoposide|mesh-list
44587390|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
44587391|NCT04521946|Melphalan|melphalan|mesh-list
44587392|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
44587393|NCT04521946|Thiotepa|thiotepa|mesh-list
44587394|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
44587395|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44587396|NCT04521946|Tacrolimus|tacrolimus|mesh-list
44587397|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
44587398|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44587399|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
44587411|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587412|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44587413|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44587414|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587415|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44587416|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44587417|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44587418|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
44587419|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44587420|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587421|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587422|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
44587423|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587424|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
44587425|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44587426|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587427|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587428|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587429|NCT04515394|Cetuximab|cetuximab|mesh-list
44587430|NCT04515394|Tepotinib|tepotinib|mesh-list
44587431|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587432|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587433|NCT04513925|Atezolizumab|atezolizumab|mesh-list
44587434|NCT04513925|Durvalumab|durvalumab|mesh-list
44587435|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208635|NCT00431197|Androgens|androgens|mesh-ancestor
44587436|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587437|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
44587438|NCT04477629|Abatacept|abatacept|mesh-list
44587439|NCT04477629|Tacrolimus|tacrolimus|mesh-list
44587440|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587441|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
44587442|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587443|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44587444|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587445|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587446|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44587447|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587448|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44587449|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
44587450|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44587451|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587452|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44587453|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587454|NCT04388163|Gentian Violet|gentian violet|mesh-list
44587455|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44587456|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587457|NCT04379011|Brivaracetam|brivaracetam|mesh-list
44587458|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
44587459|NCT04256421|Carboplatin|carboplatin|mesh-list
44587460|NCT04256421|Etoposide|etoposide|mesh-list
44587461|NCT04256421|Atezolizumab|atezolizumab|mesh-list
44587462|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587463|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587464|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44587465|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44587466|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587467|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587468|NCT04249076|Clobetasol|clobetasol|mesh-list
44587469|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587470|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
44587471|NCT04249076|Hormones|hormones|mesh-ancestor
44587472|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587473|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587474|NCT04246801|Clobetasol|clobetasol|mesh-list
44587475|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587476|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
44587477|NCT04246801|Hormones|hormones|mesh-ancestor
44587478|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587479|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587480|NCT04203160|Gemcitabine|gemcitabine|mesh-list
44587481|NCT04203160|Cisplatin|cisplatin|mesh-list
44587482|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587483|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587484|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
44587485|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587486|NCT04203160|Antiviral Agents|antiviral agents|mesh-ancestor
44587487|NCT04203160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587489|NCT04203160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587490|NCT04203160|Immunologic Factors|immunologic factors|mesh-ancestor
44587491|NCT04203160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587492|NCT04173494|Danazol|danazol|mesh-list
44587493|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44587494|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44587495|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
44587496|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587497|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587498|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44587499|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587500|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587501|NCT04170855|Furosemide|furosemide|mesh-list
44587502|NCT04170855|Diuretics|diuretics|mesh-ancestor
44587503|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
44587504|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587505|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44587506|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44587507|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587508|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44587509|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44587510|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44587511|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587512|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587513|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44587514|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44587515|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587516|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
44587517|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587519|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44587520|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
44587521|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587522|NCT04076579|Olaparib|olaparib|mesh-list
44587523|NCT04076579|Trabectedin|trabectedin|mesh-list
44587524|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44587525|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587526|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587527|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587528|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587529|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
44587530|NCT04041050|Celecoxib|celecoxib|mesh-list
44587531|NCT04041050|Navitoclax|navitoclax|mesh-list
44587532|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587533|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587534|NCT04041050|Analgesics|analgesics|mesh-ancestor
44587535|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
44587536|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587537|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587538|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587539|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587540|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44587541|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44587542|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587543|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587544|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587545|NCT03946111|Naltrexone|naltrexone|mesh-list
44587546|NCT03946111|Bupropion|bupropion|mesh-list
44587547|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44587548|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44587549|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587550|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
44587551|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587552|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44587553|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
44587554|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43769826|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
44587555|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44587556|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44587557|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44587558|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587560|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587561|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44587562|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44587563|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587564|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44587565|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
44587566|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587567|NCT03928847|Protective Agents|protective agents|mesh-ancestor
44587568|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587569|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44587570|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44587571|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587572|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44587573|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44587574|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44587575|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587576|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44587577|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44208795|NCT00431665|Hormones|hormones|mesh-ancestor
44587578|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44415353|NCT02351934|Diuretics|diuretics|mesh-ancestor
44587579|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587580|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
44587581|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587582|NCT03877315|Cimetidine|cimetidine|mesh-list
44587583|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44587584|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44587585|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44587586|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
44587587|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
44587588|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587589|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587590|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587591|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44587592|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44587593|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587594|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
44587595|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587596|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587597|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44587598|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44587599|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587600|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587601|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587602|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
44587603|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587604|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44587605|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44587606|NCT03829722|Paclitaxel|paclitaxel|mesh-list
44587607|NCT03829722|Carboplatin|carboplatin|mesh-list
44587608|NCT03829722|Nivolumab|nivolumab|mesh-list
44587609|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587610|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587611|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587612|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587613|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587614|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587615|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587616|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44587617|NCT03822312|Tobramycin|tobramycin|mesh-list
44587618|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44587619|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587620|NCT03800381|Rifampin|rifampin|mesh-list
44587621|NCT03800381|Isoniazid|isoniazid|mesh-list
44587622|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
44587623|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44587624|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
44587625|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44587626|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587627|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
44587628|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587629|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587630|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587631|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44587632|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44587633|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44587634|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44587635|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44587636|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44587637|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44587638|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44587639|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
44587640|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44587642|NCT03797014|Emtricitabine|emtricitabine|mesh-list
44587643|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44587644|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
44587645|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587646|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44587647|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587648|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587649|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587650|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44587651|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44587653|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
44587654|NCT03739931|Durvalumab|durvalumab|mesh-list
44587655|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587656|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587657|NCT03711318|Buprenorphine|buprenorphine|mesh-list
44587658|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44587659|NCT03711318|Naloxone|naloxone|mesh-list
44587660|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44587661|NCT03711318|Narcotics|narcotics|mesh-ancestor
44587662|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44587663|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587664|NCT03711318|Analgesics|analgesics|mesh-ancestor
44587665|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
44587666|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587667|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44587668|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
44587669|NCT03704298|Fludarabine|fludarabine|mesh-list
44587670|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587671|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
44587672|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587673|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587674|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587675|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
44587676|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587677|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587678|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587679|NCT03672695|Venetoclax|venetoclax|mesh-list
44587680|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587681|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
44587682|NCT03650764|Ramucirumab|ramucirumab|mesh-list
44587683|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587684|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587685|NCT03533283|Atezolizumab|atezolizumab|mesh-list
44587686|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
44587687|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587688|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587689|NCT03528551|Factor VIII|factor viii|mesh-list
44587690|NCT03528551|Coagulants|coagulants|mesh-ancestor
44587691|NCT03513770|Ketorolac|ketorolac|mesh-list
44587692|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44587693|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44587694|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44587695|NCT03513770|Analgesics|analgesics|mesh-ancestor
44587696|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
44587697|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587698|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587699|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587700|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587701|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44587702|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587703|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587704|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44587705|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44587706|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587707|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587708|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587709|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
44587710|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587711|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44587712|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44587713|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
44587714|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44587715|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
44587716|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587717|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
44587718|NCT03460158|Protective Agents|protective agents|mesh-ancestor
44587719|NCT03459846|Durvalumab|durvalumab|mesh-list
44587720|NCT03459846|Olaparib|olaparib|mesh-list
44587721|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587722|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587723|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44587724|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587725|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587726|NCT03451578|alpha-MSH|alpha-msh|mesh-list
44587727|NCT03451578|Hormones|hormones|mesh-ancestor
44208899|NCT00432120|Clopidogrel|clopidogrel|mesh-list
44587728|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587729|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587730|NCT03448042|Trastuzumab|trastuzumab|mesh-list
44587731|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587732|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587733|NCT03407144|Prednisone|prednisone|mesh-list
44587734|NCT03407144|Prednisolone|prednisolone|mesh-list
44587735|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
44587736|NCT03407144|Dacarbazine|dacarbazine|mesh-list
44587737|NCT03407144|Doxorubicin|doxorubicin|mesh-list
44587738|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
44587739|NCT03407144|Etoposide|etoposide|mesh-list
44587740|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
44587741|NCT03407144|Vincristine|vincristine|mesh-list
44587742|NCT03407144|Bleomycin|bleomycin|mesh-list
44587743|NCT03407144|Vinblastine|vinblastine|mesh-list
44587744|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587745|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
44587746|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587747|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587748|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587749|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
44587750|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587751|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587752|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587753|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44587754|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44587755|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44587756|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587757|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587758|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587759|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
44587760|NCT03407144|Hormones|hormones|mesh-ancestor
44587761|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587762|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44587763|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587764|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587765|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587766|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587767|NCT03384654|Cytarabine|cytarabine|mesh-list
44587768|NCT03384654|Prednisone|prednisone|mesh-list
44587769|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
44587770|NCT03384654|Doxorubicin|doxorubicin|mesh-list
44587771|NCT03384654|Methotrexate|methotrexate|mesh-list
44587772|NCT03384654|Vincristine|vincristine|mesh-list
44587773|NCT03384654|Asparaginase|asparaginase|mesh-list
44587774|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
44587775|NCT03384654|Daratumumab|daratumumab|mesh-list
44587776|NCT03384654|Pegaspargase|pegaspargase|mesh-list
44587777|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587778|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
44587779|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587780|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587781|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587782|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
44587783|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587784|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587785|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587786|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44587787|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44587788|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44587789|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587790|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587791|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
44587792|NCT03384654|Hormones|hormones|mesh-ancestor
44587793|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587794|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44587795|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44587796|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
44587797|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44587798|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587799|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
44587800|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
44587801|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44587802|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587803|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
44587804|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587805|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44587806|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587807|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587808|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587810|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587811|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587812|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44587813|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44587814|NCT03280563|Tamoxifen|tamoxifen|mesh-list
44587815|NCT03280563|Bevacizumab|bevacizumab|mesh-list
44587816|NCT03280563|Atezolizumab|atezolizumab|mesh-list
44587817|NCT03280563|Fulvestrant|fulvestrant|mesh-list
44587818|NCT03280563|Exemestane|exemestane|mesh-list
44587819|NCT03280563|Entinostat|entinostat|mesh-list
44587820|NCT03280563|Antibodies|antibodies|mesh-list
44587821|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587822|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587823|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44587824|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44587825|NCT03280563|Growth Substances|growth substances|mesh-ancestor
44587826|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587827|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44587828|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
44587829|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44587830|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
44587831|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587832|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44587833|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44587834|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44587835|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44587836|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44587837|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44587838|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44587839|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587840|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587841|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44587842|NCT03258723|Metformin|metformin|mesh-list
44587843|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44587844|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587845|NCT03242915|Carboplatin|carboplatin|mesh-list
44587846|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
44587847|NCT03242915|Pemetrexed|pemetrexed|mesh-list
44587848|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587849|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587850|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587851|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587852|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44587853|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587855|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587856|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
44587857|NCT03228693|Hormones|hormones|mesh-ancestor
44587858|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44587859|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587860|NCT03199040|Durvalumab|durvalumab|mesh-list
44587861|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587862|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587863|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
44587864|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44587865|NCT03178552|Gemcitabine|gemcitabine|mesh-list
44587866|NCT03178552|Bevacizumab|bevacizumab|mesh-list
44587867|NCT03178552|Cisplatin|cisplatin|mesh-list
44587868|NCT03178552|Carboplatin|carboplatin|mesh-list
44587869|NCT03178552|Docetaxel|docetaxel|mesh-list
44587870|NCT03178552|Pemetrexed|pemetrexed|mesh-list
44587871|NCT03178552|Atezolizumab|atezolizumab|mesh-list
44587872|NCT03178552|Vemurafenib|vemurafenib|mesh-list
44587873|NCT03178552|Entrectinib|entrectinib|mesh-list
44587874|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587875|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587876|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44587877|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44587878|NCT03178552|Growth Substances|growth substances|mesh-ancestor
44415649|NCT02343549|Bevacizumab|bevacizumab|mesh-list
44587879|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587880|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44587881|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587882|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
44587883|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587884|NCT03178552|Antiviral Agents|antiviral agents|mesh-ancestor
44587885|NCT03178552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587886|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587887|NCT03178552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587888|NCT03178552|Immunologic Factors|immunologic factors|mesh-ancestor
44587889|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44587890|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587891|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587892|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44587893|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44587894|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44587895|NCT03131765|Poly I-C|poly i-c|mesh-list
44587896|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
44587897|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587898|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
44587899|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
44587900|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587901|NCT03084471|Durvalumab|durvalumab|mesh-list
44587902|NCT03084471|Tremelimumab|tremelimumab|mesh-list
44587903|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44587904|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587905|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587906|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
44587907|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587923|NCT02963831|Durvalumab|durvalumab|mesh-list
44587924|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587925|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
44587926|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587927|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44587928|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44587929|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
44587930|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587931|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587932|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44587933|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587934|NCT02940769|Methamphetamine|methamphetamine|mesh-list
44587935|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44587936|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587937|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
44587938|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
44587939|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44587940|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
44587941|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988579|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
44587942|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587944|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44587945|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44587946|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44587947|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44587948|NCT02928406|Atezolizumab|atezolizumab|mesh-list
44587949|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587950|NCT02927301|Atezolizumab|atezolizumab|mesh-list
44587951|NCT02927301|Antibodies|antibodies|mesh-list
44587952|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44587953|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
44587954|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587955|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587956|NCT02846545|Golimumab|golimumab|mesh-list
44587957|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44587958|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44587959|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587960|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
44587961|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587962|NCT02826434|Durvalumab|durvalumab|mesh-list
44587963|NCT02826434|Poly ICLC|poly iclc|mesh-list
44587964|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44587965|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587966|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
44587967|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
44587968|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587969|NCT02777580|Tenecteplase|tenecteplase|mesh-list
44587970|NCT02777580|Clopidogrel|clopidogrel|mesh-list
44587971|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44587972|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44587973|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44587974|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44587975|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
44587976|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44587977|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587978|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587979|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44587980|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44587981|NCT02511132|Gemcitabine|gemcitabine|mesh-list
44587982|NCT02511132|Docetaxel|docetaxel|mesh-list
44587983|NCT02511132|Irinotecan|irinotecan|mesh-list
44587984|NCT02511132|Temozolomide|temozolomide|mesh-list
44587985|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44587986|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
44587987|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44587988|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44587989|NCT02511132|Antiviral Agents|antiviral agents|mesh-ancestor
44587990|NCT02511132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44587991|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44587992|NCT02511132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44587993|NCT02511132|Immunologic Factors|immunologic factors|mesh-ancestor
44587994|NCT02511132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44587995|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44415803|NCT02340949|Leucovorin|leucovorin|mesh-list
44587996|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44587997|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44587998|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44587999|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44588000|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588001|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
44588002|NCT02500407|Atezolizumab|atezolizumab|mesh-list
44588003|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588004|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
44588005|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44588006|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
44588007|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44588008|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
44588009|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588010|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588011|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
44588012|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
44588013|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
44588014|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44588015|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44588016|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
44588017|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588018|NCT02118584|Etrolizumab|etrolizumab|mesh-list
44588019|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588020|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
44588021|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588022|NCT02073838|Ribavirin|ribavirin|mesh-list
44588023|NCT02073838|Decitabine|decitabine|mesh-list
44588024|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
44588025|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588026|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
44588027|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588028|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588029|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588030|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588031|NCT02031250|Cisplatin|cisplatin|mesh-list
44588032|NCT02031250|Carboplatin|carboplatin|mesh-list
44588033|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588034|NCT01924533|Paclitaxel|paclitaxel|mesh-list
44588035|NCT01924533|Olaparib|olaparib|mesh-list
44588036|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44588037|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588038|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588039|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588040|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44588041|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588042|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44588043|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588044|NCT01632657|Sumatriptan|sumatriptan|mesh-list
44588045|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44588046|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44588047|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44588048|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
44588049|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588050|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588051|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588052|NCT01009788|Temozolomide|temozolomide|mesh-list
44588053|NCT01009788|Veliparib|veliparib|mesh-list
44588054|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588055|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
44588056|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588057|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588058|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44588059|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588060|NCT00782327|Losartan|losartan|mesh-list
44588061|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44588062|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44588063|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44588064|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44588065|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588066|NCT00642577|Leucovorin|leucovorin|mesh-list
44588067|NCT00642577|Bevacizumab|bevacizumab|mesh-list
44588068|NCT00642577|Fluorouracil|fluorouracil|mesh-list
44588069|NCT00642577|Irinotecan|irinotecan|mesh-list
44588070|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588071|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588072|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44588073|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44588074|NCT00642577|Growth Substances|growth substances|mesh-ancestor
44588075|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588076|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
44588077|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
44588078|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588079|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588080|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588081|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
44588082|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44588083|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44588084|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588085|NCT00642577|Antidotes|antidotes|mesh-ancestor
44588086|NCT00642577|Protective Agents|protective agents|mesh-ancestor
44588087|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
44588088|NCT00642577|Vitamins|vitamins|mesh-ancestor
44588089|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
44588090|NCT00559091|Ribavirin|ribavirin|mesh-list
44588091|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
44588092|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588093|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
44588094|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588095|NCT00365157|Halichondrin B|halichondrin b|mesh-list
44588096|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588097|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588098|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44588099|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588100|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588101|NCT05664568|Amoxicillin|amoxicillin|mesh-list
44588102|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
44209263|NCT00433459|Hormones|hormones|mesh-ancestor
44588103|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
44588104|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44588105|NCT05664568|Cephalexin|cephalexin|mesh-list
44588106|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44588107|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588108|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44588109|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588110|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588111|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
44588112|NCT05664542|Ropivacaine|ropivacaine|mesh-list
44588113|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44588114|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588115|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588116|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588117|NCT05664542|Analgesics|analgesics|mesh-ancestor
44588118|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
44588119|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588120|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44588121|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44588122|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44588123|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44588124|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588125|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588126|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44588127|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
44588128|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
44588129|NCT05664464|Temozolomide|temozolomide|mesh-list
44588130|NCT05664464|Gabapentin|gabapentin|mesh-list
44588131|NCT05664464|Memantine|memantine|mesh-list
44588132|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588133|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
44588134|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588135|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588136|NCT05664464|Analgesics|analgesics|mesh-ancestor
44588137|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
44588138|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588139|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588140|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
44588141|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44588142|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44588143|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588144|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44588145|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44588146|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44588147|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588148|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
44588149|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44588150|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44588151|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
44588152|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588153|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588154|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588155|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588156|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588157|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588158|NCT05664386|Propofol|propofol|mesh-list
44588159|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44588160|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588161|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588162|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44588163|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
44588164|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
44588165|NCT05664191|Simendan|simendan|mesh-list
44588166|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44588167|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
44588168|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44588169|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44588170|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588171|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588172|NCT05664191|Protective Agents|protective agents|mesh-ancestor
44588173|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588174|NCT05664074|Ketorolac|ketorolac|mesh-list
44588175|NCT05664074|Indomethacin|indomethacin|mesh-list
44588176|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588177|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588178|NCT05664074|Analgesics|analgesics|mesh-ancestor
44588179|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
44588180|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588181|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588182|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588183|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588184|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44588185|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588186|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588187|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
44588188|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
44588189|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44588190|NCT05663944|Sirolimus|sirolimus|mesh-list
44588191|NCT05663944|Liver Extracts|liver extracts|mesh-list
44588192|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456402|NCT01631825|Rotigotine|rotigotine|mesh-list
44588193|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588194|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44588195|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588196|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
44588197|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588198|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
44588199|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588200|NCT05663944|Hematinics|hematinics|mesh-ancestor
44588201|NCT05663905|Ambroxol|ambroxol|mesh-list
44588202|NCT05663905|Expectorants|expectorants|mesh-ancestor
44588203|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
44588204|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44588205|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44588206|NCT05663892|Estradiol|estradiol|mesh-list
44588207|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44588208|NCT05663892|Estrogens|estrogens|mesh-ancestor
44588209|NCT05663892|Hormones|hormones|mesh-ancestor
44588210|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588211|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588212|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44588213|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
44588214|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44588215|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44588216|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
44588217|NCT05663801|Ketamine|ketamine|mesh-list
44588218|NCT05663801|Bupivacaine|bupivacaine|mesh-list
44588219|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
44588220|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
44588221|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588222|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588223|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
44588224|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588225|NCT05663801|Analgesics|analgesics|mesh-ancestor
44588226|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44588227|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44588228|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
44588229|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44588230|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44588231|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588232|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588233|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44588234|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
44588235|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44588236|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44588237|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44588238|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
44209366|NCT00433927|Cetuximab|cetuximab|mesh-list
44588239|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44588240|NCT05663775|Mesalamine|mesalamine|mesh-list
44588241|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588242|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588243|NCT05663775|Analgesics|analgesics|mesh-ancestor
44588244|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
44588245|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588246|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588247|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588248|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588249|NCT05663749|Metformin|metformin|mesh-list
44588250|NCT05663749|Topiramate|topiramate|mesh-list
44588251|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44588252|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588253|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
44588254|NCT05663736|Glimepiride|glimepiride|mesh-list
44588255|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44588256|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44588257|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588258|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588259|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
44588260|NCT05663710|Nivolumab|nivolumab|mesh-list
44588261|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588262|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588263|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44588264|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588265|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
44588266|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44588267|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44588268|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
44588269|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
44588270|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588271|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588272|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
44588273|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588274|NCT05663580|Rilpivirine|rilpivirine|mesh-list
44588275|NCT05663580|Cabotegravir|cabotegravir|mesh-list
44588276|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44209417|NCT00434005|Antidotes|antidotes|mesh-ancestor
44588277|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44588278|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588279|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588280|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
44588281|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588282|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44588283|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44588284|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44588285|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44588286|NCT05663515|Insulin|insulin|mesh-list
44588287|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44588288|NCT05663515|Exenatide|exenatide|mesh-list
44588289|NCT05663515|Biguanides|biguanides|mesh-list
44588290|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44588291|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44588292|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588293|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44588294|NCT05663515|Incretins|incretins|mesh-ancestor
44588295|NCT05663515|Hormones|hormones|mesh-ancestor
44588296|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588297|NCT05663411|Cinacalcet|cinacalcet|mesh-list
44588298|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44588299|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588300|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44588301|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588302|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588303|NCT05663398|Ibuprofen|ibuprofen|mesh-list
44588304|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588305|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588306|NCT05663398|Analgesics|analgesics|mesh-ancestor
44588307|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
44588308|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588309|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588310|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588311|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588312|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44588313|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588314|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588315|NCT05663372|Eplerenone|eplerenone|mesh-list
44588316|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44588317|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588318|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588319|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588320|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44588321|NCT05663372|Diuretics|diuretics|mesh-ancestor
44588322|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
44588323|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416181|NCT02331368|Growth Substances|growth substances|mesh-ancestor
44588325|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588326|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588327|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588328|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44588329|NCT05663255|Azithromycin|azithromycin|mesh-list
44588330|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588331|NCT05663242|Anesthetics|anesthetics|mesh-list
44588332|NCT05663242|Propofol|propofol|mesh-list
44588333|NCT05663242|Sevoflurane|sevoflurane|mesh-list
44588334|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588335|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588336|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44588337|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44588338|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
44588339|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44588340|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44588341|NCT05663177|Vinorelbine|vinorelbine|mesh-list
44588342|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44588343|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588344|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588345|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588346|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44588347|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588348|NCT05663164|Thiamine|thiamine|mesh-list
44588349|NCT05663164|Vitamins|vitamins|mesh-ancestor
44588350|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
44588351|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588352|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
44588353|NCT05663125|Temozolomide|temozolomide|mesh-list
44588354|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588355|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
44588356|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588357|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588358|NCT05662956|Azacitidine|azacitidine|mesh-list
44588359|NCT05662956|Venetoclax|venetoclax|mesh-list
44588360|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588361|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
44588362|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588363|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588364|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588365|NCT05662943|Aflibercept|aflibercept|mesh-list
44588366|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44588367|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44588368|NCT05662943|Growth Substances|growth substances|mesh-ancestor
44588369|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588370|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
44588371|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588372|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
44588373|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588374|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588375|NCT05658887|Gabapentin|gabapentin|mesh-list
44588376|NCT05658887|Analgesics|analgesics|mesh-ancestor
44588377|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
44588378|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588379|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588380|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
44588381|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44588382|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44588383|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588384|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44588385|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44588386|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44588387|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588388|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588389|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
44588390|NCT05656508|Vaccines|vaccines|mesh-list
44588391|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
44588392|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588404|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588406|NCT05644041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588407|NCT05644041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588408|NCT05644041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588409|NCT05644041|Immunologic Factors|immunologic factors|mesh-ancestor
44588410|NCT05644041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588423|NCT05603065|Paclitaxel|paclitaxel|mesh-list
44588424|NCT05603065|Cisplatin|cisplatin|mesh-list
44588425|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44588426|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588427|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588428|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588429|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209545|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
44588430|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588431|NCT05597306|Venetoclax|venetoclax|mesh-list
44588432|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588433|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
44588434|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44588435|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44588436|NCT05586776|Mupirocin|mupirocin|mesh-list
44588437|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588438|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
44588439|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588440|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44588441|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44588442|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588443|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588444|NCT05584319|Empagliflozin|empagliflozin|mesh-list
44588445|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44588446|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588447|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44588448|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588449|NCT05582434|Clindamycin|clindamycin|mesh-list
44588450|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
44588451|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
44588452|NCT05582434|Adapalene|adapalene|mesh-list
44588453|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44588454|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44588455|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588456|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44588457|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588458|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588459|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588460|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588461|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588462|NCT05582434|Analgesics|analgesics|mesh-ancestor
44588463|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
44588464|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588465|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588466|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588467|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588468|NCT05561387|Dexamethasone|dexamethasone|mesh-list
44588469|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
44588470|NCT05561387|Lenalidomide|lenalidomide|mesh-list
44588471|NCT05561387|Bortezomib|bortezomib|mesh-list
44588472|NCT05561387|Daratumumab|daratumumab|mesh-list
44588473|NCT05561387|Ichthammol|ichthammol|mesh-list
44588474|NCT05561387|BB 1101|bb 1101|mesh-list
44588475|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44588476|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588477|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
44588478|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
44588479|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588480|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588481|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588482|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
44588483|NCT05561387|Hormones|hormones|mesh-ancestor
44588484|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588485|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44416343|NCT02324153|Riboflavin|riboflavin|mesh-list
44588486|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588487|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
44588488|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588489|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588490|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
44588491|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44588492|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44588493|NCT05561387|Growth Substances|growth substances|mesh-ancestor
44588494|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
44588495|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588496|NCT05551182|Nicergoline|nicergoline|mesh-list
44588497|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44588498|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44588499|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44588500|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588501|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588502|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588503|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
44588504|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
44588505|NCT05536349|Valacyclovir|valacyclovir|mesh-list
44588506|NCT05536349|Venetoclax|venetoclax|mesh-list
44588507|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
44588508|NCT05536349|Allopurinol|allopurinol|mesh-list
44588509|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588510|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588511|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
44588512|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588513|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588514|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
44588515|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588516|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44588517|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
44588518|NCT05536349|Protective Agents|protective agents|mesh-ancestor
44588519|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588520|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
44588521|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588522|NCT05511610|Sevoflurane|sevoflurane|mesh-list
44588523|NCT05511610|Desflurane|desflurane|mesh-list
44588524|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44588525|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44588526|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
44588527|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
44588528|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588529|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588530|NCT05501886|Fulvestrant|fulvestrant|mesh-list
44588531|NCT05501886|Palbociclib|palbociclib|mesh-list
44588532|NCT05501886|Gedatolisib|gedatolisib|mesh-list
44588533|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44588534|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588535|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44588536|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44588537|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588538|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588539|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588540|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44588541|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588542|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588543|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
44588545|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588546|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588547|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
44588548|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588549|NCT05498155|Durvalumab|durvalumab|mesh-list
44588550|NCT05498155|Olaparib|olaparib|mesh-list
44588551|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588552|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588553|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44588554|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588555|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588556|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
44588557|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588558|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588559|NCT05463133|Sirolimus|sirolimus|mesh-list
44588560|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
44588561|NCT05463133|Busulfan|busulfan|mesh-list
44588562|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
44588563|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588564|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
44588565|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588566|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588567|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588568|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
44209681|NCT00435500|Fluorides|fluorides|mesh-list
44588569|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588570|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588571|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44588572|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44588573|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588574|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44588575|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
44588576|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588577|NCT05449171|Vitamin D|vitamin d|mesh-list
44588578|NCT05449171|Vitamins|vitamins|mesh-list
44588579|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
44588580|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
44588581|NCT05449171|Pyridoxal|pyridoxal|mesh-list
44588582|NCT05449171|Pyridoxine|pyridoxine|mesh-list
44588583|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
44588584|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
44588585|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588586|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44588587|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
44588588|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44588589|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
44588590|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
44588591|NCT05449171|Protective Agents|protective agents|mesh-ancestor
44588592|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
44588593|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588594|NCT05448547|Hormones|hormones|mesh-list
44588595|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588596|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588597|NCT05375994|Adagrasib|adagrasib|mesh-list
44588598|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588599|NCT05372315|Dexamethasone|dexamethasone|mesh-list
44588600|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
44588601|NCT05372315|BB 1101|bb 1101|mesh-list
44588602|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588603|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
44588604|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
44588605|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588606|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588607|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588608|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
44588609|NCT05372315|Hormones|hormones|mesh-ancestor
44588610|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588611|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44588612|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588613|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
44588614|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588615|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588616|NCT05368558|Cariprazine|cariprazine|mesh-list
44588617|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44588618|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44236654|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
44588619|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588620|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588621|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44588622|NCT05364996|Dimercaprol|dimercaprol|mesh-list
44588623|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
44588624|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
44588625|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588626|NCT05364944|Octreotide|octreotide|mesh-list
44588627|NCT05364944|Lanreotide|lanreotide|mesh-list
44588628|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588629|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44588630|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588631|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
44588632|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44588633|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
44588634|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
44588635|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588636|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588637|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588638|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588639|NCT05351086|Analgesics|analgesics|mesh-ancestor
44588640|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
44588641|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588642|NCT05348213|Decitabine|decitabine|mesh-list
44588643|NCT05348213|Pomalidomide|pomalidomide|mesh-list
44588644|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
44588645|NCT05348213|Tofacitinib|tofacitinib|mesh-list
44588646|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588647|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
44588648|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588649|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588650|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588651|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
44588652|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588653|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44588654|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44588655|NCT05348213|Growth Substances|growth substances|mesh-ancestor
44588656|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44588657|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44588658|NCT05325593|Dexamethasone|dexamethasone|mesh-list
44588659|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
44588660|NCT05325593|BB 1101|bb 1101|mesh-list
44588661|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588662|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
44588663|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
44588664|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588665|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588666|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588667|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
44588668|NCT05325593|Hormones|hormones|mesh-ancestor
44588669|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588670|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44588671|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588672|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
44588673|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588674|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588675|NCT05300282|Gemcitabine|gemcitabine|mesh-list
44588676|NCT05300282|Atezolizumab|atezolizumab|mesh-list
44588677|NCT05300282|Vinorelbine|vinorelbine|mesh-list
44588678|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44588679|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588680|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
44588681|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588682|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588683|NCT05300282|Antiviral Agents|antiviral agents|mesh-ancestor
44588684|NCT05300282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588685|NCT05300282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588686|NCT05300282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588687|NCT05300282|Immunologic Factors|immunologic factors|mesh-ancestor
44588688|NCT05300282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588689|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44588690|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588691|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588692|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
44588693|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588694|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
44588695|NCT05299125|Carboplatin|carboplatin|mesh-list
44588696|NCT05299125|Pemetrexed|pemetrexed|mesh-list
44588697|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44588698|NCT05299125|Lazertinib|lazertinib|mesh-list
44588699|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588700|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588701|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588702|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44588703|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44588704|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44588705|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588706|NCT05284747|Evolocumab|evolocumab|mesh-list
44588707|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44588708|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44588709|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
44588710|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588711|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44588712|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44588713|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588714|NCT05279742|Valsartan|valsartan|mesh-list
44588715|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44588716|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44588717|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44588718|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44588719|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588720|NCT05273775|Vitamin K|vitamin k|mesh-list
44588721|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
44588722|NCT05273775|Digoxin|digoxin|mesh-list
44588723|NCT05273775|Midazolam|midazolam|mesh-list
44588724|NCT05273775|Omeprazole|omeprazole|mesh-list
44588725|NCT05273775|Warfarin|warfarin|mesh-list
44588726|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44588727|NCT05273775|Vitamins|vitamins|mesh-ancestor
44588728|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
44588729|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588730|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44588731|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44588732|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588733|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44588734|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44588735|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44588736|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44588737|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
44588738|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
44588739|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
44588740|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
44588741|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588742|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588743|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44588744|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44588745|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
44588746|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44588747|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44588748|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588749|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
44588750|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44588751|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44588752|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44209823|NCT00436657|Cisplatin|cisplatin|mesh-list
44588753|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44588754|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44588755|NCT05273775|Protective Agents|protective agents|mesh-ancestor
44588756|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44588757|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44588758|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
44588759|NCT05273775|Coagulants|coagulants|mesh-ancestor
44588770|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44588771|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
44588772|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588773|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588774|NCT05246670|Palmidrol|palmidrol|mesh-list
44588775|NCT05246670|Analgesics|analgesics|mesh-ancestor
44588776|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
44588777|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588778|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588779|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44588780|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588781|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44588782|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588783|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
44588784|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588785|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44588786|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44588787|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588788|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588789|NCT05246670|Hormones|hormones|mesh-ancestor
44588790|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588791|NCT05243823|Estradiol|estradiol|mesh-list
44588792|NCT05243823|Estrogens|estrogens|mesh-ancestor
44588793|NCT05243823|Hormones|hormones|mesh-ancestor
44588794|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588795|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588796|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
44588797|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588798|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
44588799|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588800|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588801|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588802|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
44588803|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588804|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588805|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44588806|NCT05227001|Camphor|camphor|mesh-list
44588807|NCT05227001|Menthol|menthol|mesh-list
44588808|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44588809|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588810|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
44588811|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588812|NCT05216211|Bupivacaine|bupivacaine|mesh-list
44588813|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
44588814|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
44588815|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588816|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588817|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
44588818|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588819|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
44588820|NCT05203445|Olaparib|olaparib|mesh-list
44588821|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588822|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588823|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44588824|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588825|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588826|NCT05179733|Rituximab|rituximab|mesh-list
44588827|NCT05179733|Lenalidomide|lenalidomide|mesh-list
44588828|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
44588829|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588830|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588831|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
44588832|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588833|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588834|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44588835|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44588836|NCT05179733|Growth Substances|growth substances|mesh-ancestor
44588837|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
44588838|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44588839|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588840|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588841|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
44588842|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588843|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588844|NCT05176951|Treprostinil|treprostinil|mesh-list
44588845|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44588846|NCT05147727|Fluconazole|fluconazole|mesh-list
44588847|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
44588848|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44588849|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44588850|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44588851|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588852|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588853|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44588857|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44588858|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44588859|NCT05116293|Acetaminophen|acetaminophen|mesh-list
44588861|NCT05116293|Midazolam|midazolam|mesh-list
44588862|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44588863|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44588864|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44588865|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588866|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44588867|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44588868|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44588869|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44588870|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
44588871|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
44588872|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
44588873|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
44588874|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44588875|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588876|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44588877|NCT05116293|Analgesics|analgesics|mesh-ancestor
44588878|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
44588879|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44588880|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
44588881|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44588882|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44588883|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588884|NCT05116293|Protective Agents|protective agents|mesh-ancestor
44588885|NCT05094336|Docetaxel|docetaxel|mesh-list
44588886|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588887|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44588888|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44588889|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44588890|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588891|NCT05079360|Everolimus|everolimus|mesh-list
44588892|NCT05079360|Exemestane|exemestane|mesh-list
44588893|NCT05079360|Estrogens|estrogens|mesh-list
44588894|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
44588895|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
44588896|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588897|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588898|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
44588899|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588900|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44588901|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44209965|NCT00437086|Bortezomib|bortezomib|mesh-list
44588902|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588903|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588904|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44588905|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588906|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588907|NCT05079360|Hormones|hormones|mesh-ancestor
44588908|NCT05076149|Ivacaftor|ivacaftor|mesh-list
44588909|NCT05076149|Elexacaftor|elexacaftor|mesh-list
44588910|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44588911|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44588912|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588913|NCT05074992|Ipilimumab|ipilimumab|mesh-list
44588914|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588915|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588916|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44588917|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588918|NCT05050136|Volixibat|volixibat|mesh-list
44588919|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44588920|NCT05033080|Ivacaftor|ivacaftor|mesh-list
44588921|NCT05033080|Elexacaftor|elexacaftor|mesh-list
44588922|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44588923|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44588924|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588944|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44588945|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588946|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44588947|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44588948|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588949|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588950|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44588951|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44588952|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588953|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
44588954|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44588955|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588956|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
44588957|NCT04895761|Letrozole|letrozole|mesh-list
44588958|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588959|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
44588960|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588961|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588962|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44588963|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
44588964|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588965|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588966|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44588967|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44588968|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44588969|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588970|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44588971|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44588972|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44588973|NCT04895202|Siponimod|siponimod|mesh-list
44588974|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44588975|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588976|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588977|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
44588978|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588979|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
44588980|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588981|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
44588982|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588983|NCT04837209|Niraparib|niraparib|mesh-list
44588984|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44588985|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44588986|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588987|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588988|NCT04786067|Abatacept|abatacept|mesh-list
44588989|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44588990|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44588991|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44588992|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44588993|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
44588994|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44588995|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44588996|NCT04773184|Capsaicin|capsaicin|mesh-list
44588997|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
44588998|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
44588999|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
44589000|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589001|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589002|NCT04740671|Ranibizumab|ranibizumab|mesh-list
44589003|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44589004|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44589005|NCT04740671|Growth Substances|growth substances|mesh-ancestor
44589006|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589007|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
44589008|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589009|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44589010|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44589011|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44589012|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589013|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
44589014|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210053|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
44589015|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589016|NCT04733183|Dacarbazine|dacarbazine|mesh-list
44589017|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589018|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
44589019|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589020|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589021|NCT04686786|PF-06372865|pf-06372865|mesh-list
44589022|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
44589023|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
44589024|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589025|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589026|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589027|NCT04685616|Doxorubicin|doxorubicin|mesh-list
44589028|NCT04685616|Bleomycin|bleomycin|mesh-list
44589029|NCT04685616|Dacarbazine|dacarbazine|mesh-list
44589030|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44589031|NCT04685616|Vinblastine|vinblastine|mesh-list
44589032|NCT04685616|Mitogens|mitogens|mesh-list
44589033|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44589034|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589035|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44589036|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589037|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589038|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589039|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589040|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589041|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
44589042|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589043|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589044|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589045|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589046|NCT04685590|Dasatinib|dasatinib|mesh-list
44589047|NCT04685590|Quercetin|quercetin|mesh-list
44589048|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589049|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589050|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589051|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589052|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
44589053|NCT04685590|Protective Agents|protective agents|mesh-ancestor
44589054|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589055|NCT04650984|Doxorubicin|doxorubicin|mesh-list
44589056|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44589057|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589058|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44589059|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589060|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589061|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589062|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
44589063|NCT04622007|Pemetrexed|pemetrexed|mesh-list
44589064|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589065|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589066|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589067|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589068|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44589069|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44589070|NCT04619797|Cisplatin|cisplatin|mesh-list
44589071|NCT04619797|Carboplatin|carboplatin|mesh-list
44589072|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
44589073|NCT04619797|Pemetrexed|pemetrexed|mesh-list
44589074|NCT04619797|Atezolizumab|atezolizumab|mesh-list
44589075|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589076|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589077|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589078|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589079|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44589080|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44589082|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589083|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
44589084|NCT04598477|Hormones|hormones|mesh-ancestor
44589085|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589086|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589087|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589088|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589089|NCT04598451|Prednisone|prednisone|mesh-list
44589090|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589091|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
44589092|NCT04598451|Hormones|hormones|mesh-ancestor
44589093|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589094|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589095|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589096|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589097|NCT04593927|Siponimod|siponimod|mesh-list
44589098|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44589099|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589100|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589101|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
44589102|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589103|NCT04570436|Diazepam|diazepam|mesh-list
44589104|NCT04570436|Gabapentin|gabapentin|mesh-list
44589105|NCT04570436|Analgesics|analgesics|mesh-ancestor
44589106|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
44589107|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589108|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589109|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
44589110|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44589111|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44589112|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589113|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44589114|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44589115|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44589116|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589117|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589118|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
44589119|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44589120|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
44589121|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
44589122|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44589123|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44589124|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44589125|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44589126|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44589127|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
44589128|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
44589129|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
44589130|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
44589131|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
44589132|NCT04558866|Testosterone|testosterone|mesh-list
44589133|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
44589134|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
44589135|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44589136|NCT04558866|Androgens|androgens|mesh-ancestor
44589138|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589139|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589140|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589141|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589142|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
44589143|NCT04550260|Cisplatin|cisplatin|mesh-list
44589144|NCT04550260|Fluorouracil|fluorouracil|mesh-list
44589145|NCT04550260|Capecitabine|capecitabine|mesh-list
44589146|NCT04550260|Durvalumab|durvalumab|mesh-list
44589147|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589148|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
44589149|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145143|NCT00193856|Leuprolide|leuprolide|mesh-list
44589150|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589151|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589152|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
44589153|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589154|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589155|NCT04477486|Venetoclax|venetoclax|mesh-list
44589156|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589157|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
44589158|NCT04459416|Narcotics|narcotics|mesh-ancestor
44589159|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589160|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589161|NCT04459416|Analgesics|analgesics|mesh-ancestor
44589162|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
44589163|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589164|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
44589165|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44589166|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44589167|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
44589168|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589169|NCT04401059|Gefitinib|gefitinib|mesh-list
44589170|NCT04401059|Osimertinib|osimertinib|mesh-list
44589171|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589172|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589173|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589174|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589175|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44589176|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
44589177|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
44589178|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589179|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
44589180|NCT04316169|Letrozole|letrozole|mesh-list
44589181|NCT04316169|Fulvestrant|fulvestrant|mesh-list
44589182|NCT04316169|Anastrozole|anastrozole|mesh-list
44589183|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589184|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44589185|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44589186|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589187|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589188|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44589189|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
44589190|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589191|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589192|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
44589193|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44589194|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44417109|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
44589195|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589196|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589197|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589198|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44589199|NCT04230408|Paclitaxel|paclitaxel|mesh-list
44589200|NCT04230408|Carboplatin|carboplatin|mesh-list
44589201|NCT04230408|Durvalumab|durvalumab|mesh-list
44589202|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589203|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589204|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589205|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589206|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589207|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589208|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589209|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
44589210|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589211|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
44589212|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589213|NCT04221542|Pembrolizumab|pembrolizumab|mesh-list
44589214|NCT04221542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589215|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589216|NCT04201756|Afatinib|afatinib|mesh-list
44589217|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589218|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589219|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589220|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589221|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
44589222|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210240|NCT00438087|Hormones|hormones|mesh-ancestor
44589223|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
44589224|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589225|NCT04183712|Gemcitabine|gemcitabine|mesh-list
44589226|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
44589227|NCT04183712|Afatinib|afatinib|mesh-list
44589228|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589229|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
44589230|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589231|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589232|NCT04183712|Antiviral Agents|antiviral agents|mesh-ancestor
44589233|NCT04183712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589234|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589235|NCT04183712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589236|NCT04183712|Immunologic Factors|immunologic factors|mesh-ancestor
44589237|NCT04183712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589238|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589239|NCT04098666|Metformin|metformin|mesh-list
44589240|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589241|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589242|NCT04059562|Irinotecan|irinotecan|mesh-list
44589243|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44589244|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589245|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589246|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589247|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589248|NCT04058990|Paclitaxel|paclitaxel|mesh-list
44589249|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44589250|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589251|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589252|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589253|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589254|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589255|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589256|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44589257|NCT04015219|Lifitegrast|lifitegrast|mesh-list
44589258|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44589259|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
44589260|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589261|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589262|NCT03978520|Upadacitinib|upadacitinib|mesh-list
44589263|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44589264|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589265|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589266|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589267|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589268|NCT03969901|Relebactam|relebactam|mesh-list
44210267|NCT00438113|Urological Agents|urological agents|mesh-ancestor
44589269|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44589270|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589271|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589276|NCT03945448|Fluconazole|fluconazole|mesh-list
44589277|NCT03945448|Amphotericin B|amphotericin b|mesh-list
44589278|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44589279|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
44589280|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589281|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44589282|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589283|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589284|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589285|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44589286|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
44589287|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589288|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589289|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44589290|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44589291|NCT03945448|Amebicides|amebicides|mesh-ancestor
44589292|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44589293|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44589294|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589295|NCT03912363|Insulin|insulin|mesh-list
44589296|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589297|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589298|NCT03861078|Nicotine|nicotine|mesh-list
44589299|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44589300|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
44589301|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589302|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589303|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44589304|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44589305|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
44589306|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589307|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589308|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
44589309|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589310|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589311|NCT03845166|Atezolizumab|atezolizumab|mesh-list
44589312|NCT03845166|Avelumab|avelumab|mesh-list
44589313|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589314|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589315|NCT03836001|Serlopitant|serlopitant|mesh-list
44589316|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44589317|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589318|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589319|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589320|NCT03818763|Factor VIII|factor viii|mesh-list
44589321|NCT03818763|Coagulants|coagulants|mesh-ancestor
44589322|NCT03779334|Risdiplam|risdiplam|mesh-list
44589323|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44589324|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589325|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589326|NCT03775525|Capecitabine|capecitabine|mesh-list
44589327|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589328|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
44589329|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589330|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589331|NCT03752216|Niraparib|niraparib|mesh-list
44589332|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44589333|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589334|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589335|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589336|NCT03751709|Blinatumomab|blinatumomab|mesh-list
44589337|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589338|NCT03679949|Oxycodone|oxycodone|mesh-list
44589339|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44589340|NCT03679949|Narcotics|narcotics|mesh-ancestor
44589341|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589342|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589343|NCT03679949|Analgesics|analgesics|mesh-ancestor
44589344|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
44589345|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589346|NCT03650894|Nivolumab|nivolumab|mesh-list
44589347|NCT03650894|Ipilimumab|ipilimumab|mesh-list
44589348|NCT03650894|Bicalutamide|bicalutamide|mesh-list
44589349|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589350|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589351|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44589352|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589353|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
44589354|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
44589355|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589356|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589357|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
44589358|NCT03630081|Meropenem|meropenem|mesh-list
44589359|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589360|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589361|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44589362|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589363|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589364|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589365|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589366|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44589367|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589368|NCT03609580|Tamsulosin|tamsulosin|mesh-list
44589369|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44589370|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44589371|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44589372|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
44589373|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589374|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589376|NCT03609580|Urological Agents|urological agents|mesh-ancestor
44589377|NCT03542266|Azacitidine|azacitidine|mesh-list
44589378|NCT03542266|Cc-486|cc-486|mesh-list
44589379|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589380|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
44589381|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589382|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589383|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589384|NCT03530696|Palbociclib|palbociclib|mesh-list
44589385|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589386|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589387|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589388|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589389|NCT03524235|Rituximab|rituximab|mesh-list
44589390|NCT03524235|Fludarabine|fludarabine|mesh-list
44589391|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44589392|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589393|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589394|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
44589395|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589396|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589397|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589398|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589399|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
44589400|NCT03475004|Bevacizumab|bevacizumab|mesh-list
44589401|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
44589402|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589403|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589404|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44589405|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44589406|NCT03475004|Growth Substances|growth substances|mesh-ancestor
44589407|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589408|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
44589409|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
44589410|NCT03448393|Fludarabine|fludarabine|mesh-list
44589411|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589412|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
44589413|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589414|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589415|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589416|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
44589417|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589418|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589419|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44589420|NCT03431350|Prednisone|prednisone|mesh-list
44589421|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
44589422|NCT03431350|Niraparib|niraparib|mesh-list
44589423|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589424|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
44589426|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589427|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589428|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589429|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589430|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44589431|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589432|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589433|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
44589434|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589435|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44589436|NCT03395587|Temozolomide|temozolomide|mesh-list
44589437|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589438|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
44589439|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589440|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589441|NCT03340064|Levetiracetam|levetiracetam|mesh-list
44589442|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
44589443|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
44589444|NCT03315910|Nicotine|nicotine|mesh-list
44589445|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44589446|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
44589447|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589448|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589450|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44589451|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
44589452|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589453|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589454|NCT03314935|Leucovorin|leucovorin|mesh-list
44589455|NCT03314935|Gemcitabine|gemcitabine|mesh-list
44589456|NCT03314935|Paclitaxel|paclitaxel|mesh-list
44589457|NCT03314935|Cisplatin|cisplatin|mesh-list
44589458|NCT03314935|Fluorouracil|fluorouracil|mesh-list
44589459|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
44589460|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589461|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589462|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589463|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589464|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589465|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589466|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589467|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
44589468|NCT03314935|Antiviral Agents|antiviral agents|mesh-ancestor
44589469|NCT03314935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589470|NCT03314935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589471|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589472|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
44589473|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589474|NCT03314935|Antidotes|antidotes|mesh-ancestor
44589475|NCT03314935|Protective Agents|protective agents|mesh-ancestor
44589476|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
44589477|NCT03314935|Vitamins|vitamins|mesh-ancestor
44589478|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
44589479|NCT03245489|Aspirin|aspirin|mesh-list
44589480|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
44589481|NCT03245489|Clopidogrel|clopidogrel|mesh-list
44589482|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589483|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589484|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44589485|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44589486|NCT03245489|Analgesics|analgesics|mesh-ancestor
44589487|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
44589488|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589489|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589490|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589491|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589492|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44589493|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44589494|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589495|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44589496|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44589497|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589498|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
44589499|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44589500|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44589502|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
44589503|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589504|NCT03215511|Selitrectinib|selitrectinib|mesh-list
44589505|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589506|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589507|NCT03214250|Gemcitabine|gemcitabine|mesh-list
44589508|NCT03214250|Paclitaxel|paclitaxel|mesh-list
44589509|NCT03214250|Nivolumab|nivolumab|mesh-list
44589510|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589511|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589512|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589513|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589514|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589515|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589516|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589517|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
44589518|NCT03214250|Antiviral Agents|antiviral agents|mesh-ancestor
44589519|NCT03214250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589520|NCT03214250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589521|NCT03214250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589522|NCT03214250|Immunologic Factors|immunologic factors|mesh-ancestor
44589523|NCT03214250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589524|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589525|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44589526|NCT03201250|Dexamethasone|dexamethasone|mesh-list
44589527|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589528|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
44589529|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
44589530|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589531|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589532|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44589533|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
44589534|NCT03201250|Hormones|hormones|mesh-ancestor
44589535|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589536|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589537|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589538|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44589539|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44589540|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589541|NCT03159897|Doxorubicin|doxorubicin|mesh-list
44589542|NCT03159897|Bleomycin|bleomycin|mesh-list
44589543|NCT03159897|Dacarbazine|dacarbazine|mesh-list
44589544|NCT03159897|Vinblastine|vinblastine|mesh-list
44589545|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44589546|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589547|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44589548|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589549|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589550|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589551|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589552|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
44589553|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589554|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589555|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589556|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589557|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
44210569|NCT00439283|Methotrexate|methotrexate|mesh-list
44589558|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589559|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589560|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44589561|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44589562|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589563|NCT03107793|Ustekinumab|ustekinumab|mesh-list
44589564|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
44589565|NCT03090776|Ketamine|ketamine|mesh-list
44589566|NCT03090776|Analgesics|analgesics|mesh-ancestor
44589567|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
44589568|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589569|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589570|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44589571|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44589572|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
44589573|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
44417497|NCT02294734|Nemiralisib|nemiralisib|mesh-list
44589574|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589575|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44589576|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44589577|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589578|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589579|NCT03017833|Metformin|metformin|mesh-list
44589580|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589581|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589582|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
44589583|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589584|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589585|NCT02955823|Dexamethasone|dexamethasone|mesh-list
44589586|NCT02955823|Rituximab|rituximab|mesh-list
44589587|NCT02955823|Lenalidomide|lenalidomide|mesh-list
44589588|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589589|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589590|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
44589591|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589592|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589593|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589594|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
44589595|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
44589596|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589597|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44589598|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
44589600|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589601|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589602|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44589603|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44589604|NCT02955823|Growth Substances|growth substances|mesh-ancestor
44589605|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
44589606|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44589607|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589608|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589610|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
44589611|NCT02734290|Capecitabine|capecitabine|mesh-list
44589612|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589613|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589614|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589615|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589616|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589617|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589618|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589619|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589620|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
44589621|NCT02731729|Nivolumab|nivolumab|mesh-list
44589622|NCT02731729|Ipilimumab|ipilimumab|mesh-list
44589623|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589624|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589625|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44589626|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589627|NCT02708836|Anesthetics|anesthetics|mesh-list
44589628|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589629|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589630|NCT02581943|Paclitaxel|paclitaxel|mesh-list
44589631|NCT02581943|Carboplatin|carboplatin|mesh-list
44589632|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
44589633|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44589634|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589635|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589636|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589637|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589638|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589639|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589640|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589641|NCT02544308|Dexamethasone|dexamethasone|mesh-list
44589642|NCT02544308|Lenalidomide|lenalidomide|mesh-list
44589643|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589644|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
44589645|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
44589646|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589647|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589648|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44589649|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
44589650|NCT02544308|Hormones|hormones|mesh-ancestor
44589651|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589652|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44589653|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589654|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
44589655|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44589656|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44589657|NCT02544308|Growth Substances|growth substances|mesh-ancestor
44589658|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
44589659|NCT02502786|Antibodies|antibodies|mesh-list
44589660|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
44589661|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589662|NCT02435212|Deferasirox|deferasirox|mesh-list
44589663|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44589664|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
44589665|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
44589666|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589667|NCT02242942|Venetoclax|venetoclax|mesh-list
44589668|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
44589669|NCT02242942|Chlorambucil|chlorambucil|mesh-list
44589670|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589671|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589672|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43990181|NCT02418676|Insulin|insulin|mesh-list
44589673|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
44589674|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589676|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44589677|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
44589678|NCT02176148|Hormones|hormones|mesh-ancestor
44589679|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417656|NCT02291913|Tamoxifen|tamoxifen|mesh-list
44589680|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589681|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44589682|NCT02118467|Phenylephrine|phenylephrine|mesh-list
44589683|NCT02118467|Vasopressins|vasopressins|mesh-list
44589684|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
44589685|NCT02118467|Epinephrine|epinephrine|mesh-list
44589686|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
44589687|NCT02118467|Norepinephrine|norepinephrine|mesh-list
44589688|NCT02118467|Synephrine|synephrine|mesh-list
44589689|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44589690|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44589691|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44589692|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589693|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589694|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589695|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44589696|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44589697|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
44589698|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589699|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44589700|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
44589701|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
44589702|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
44589703|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44589704|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44589705|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
44589706|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44589707|NCT02118467|Protective Agents|protective agents|mesh-ancestor
44589708|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
44589709|NCT02118467|Coagulants|coagulants|mesh-ancestor
44589710|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44589711|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
44589712|NCT01933932|Docetaxel|docetaxel|mesh-list
44589713|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589714|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589715|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589716|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589717|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589718|NCT01874353|Olaparib|olaparib|mesh-list
44589719|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44589720|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589721|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589722|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589723|NCT01842399|Resveratrol|resveratrol|mesh-list
44589724|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
44589725|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589726|NCT01842399|Protective Agents|protective agents|mesh-ancestor
44589727|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589728|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589729|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44589730|NCT01605253|Eszopiclone|eszopiclone|mesh-list
44589731|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44589732|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44589733|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589734|NCT01320345|Fenofibrate|fenofibrate|mesh-list
44589735|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44589736|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
44589737|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589738|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44589739|NCT01149083|Carboplatin|carboplatin|mesh-list
44589740|NCT01149083|Veliparib|veliparib|mesh-list
44589741|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589742|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44589743|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589744|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589745|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
44589746|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589747|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
44589748|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589749|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589750|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589751|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
44589752|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589753|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589754|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44589755|NCT00682318|Ethanol|ethanol|mesh-list
44589776|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589777|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589778|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44210731|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44589779|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44589780|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
44589781|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44589782|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589783|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
44589784|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44589785|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589786|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44589787|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44589788|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589789|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44589790|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44589791|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589792|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589793|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589794|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589795|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44589796|NCT00600496|Sirolimus|sirolimus|mesh-list
44589797|NCT00600496|Docetaxel|docetaxel|mesh-list
44589798|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44589799|NCT00600496|Dacarbazine|dacarbazine|mesh-list
44589800|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589801|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589802|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589803|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589804|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589805|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44589806|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589807|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589808|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589809|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44589810|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
44589811|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589812|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
44589813|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589814|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589815|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
44589817|NCT00577278|Rituximab|rituximab|mesh-list
44589818|NCT00577278|Fludarabine|fludarabine|mesh-list
44589819|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
44589820|NCT00577278|Melphalan|melphalan|mesh-list
44589821|NCT00577278|Tacrolimus|tacrolimus|mesh-list
44589822|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44589823|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589824|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589825|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
44589826|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589827|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44589828|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589829|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
44589830|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589831|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44589832|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44589833|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589834|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589835|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589836|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44589837|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
44589838|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589839|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
44589840|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44589841|NCT00885755|Capecitabine|capecitabine|mesh-list
44589842|NCT00885755|Trastuzumab|trastuzumab|mesh-list
44589843|NCT00885755|Taxane|taxane|mesh-list
43770508|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
44589844|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44589846|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589847|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589848|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44589849|NCT00885703|Fluconazole|fluconazole|mesh-list
44589850|NCT00885703|Amphotericin B|amphotericin b|mesh-list
44589851|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44589852|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44589853|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
44589854|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
44589855|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589856|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44589857|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589858|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589859|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589860|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44589861|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44589862|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589863|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589864|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44589865|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44589866|NCT00885703|Amebicides|amebicides|mesh-ancestor
44589867|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44589868|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44589869|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589870|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44589871|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44589872|NCT00885534|Cisplatin|cisplatin|mesh-list
44589873|NCT00885534|Temozolomide|temozolomide|mesh-list
44589874|NCT00885534|Vinblastine|vinblastine|mesh-list
44589875|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44589876|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44589877|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
44589878|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589879|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44589880|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
44589881|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
44589882|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
44589883|NCT00885495|Ritonavir|ritonavir|mesh-list
44589884|NCT00885495|Darunavir|darunavir|mesh-list
44589885|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44589886|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44589887|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44589888|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44589889|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589890|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589891|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44589892|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44589893|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
44589894|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589895|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44589896|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589897|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44589898|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44589899|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
44589900|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44589901|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44589903|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44589904|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44589905|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44589906|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
44589907|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589908|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589909|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44589910|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44589911|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
44589912|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589913|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44589914|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589915|NCT00885378|Metformin|metformin|mesh-list
44589916|NCT00885378|Saxagliptin|saxagliptin|mesh-list
44589917|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589918|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589920|NCT00885378|Hormones|hormones|mesh-ancestor
44589921|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589922|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44589923|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44589924|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589925|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589926|NCT00885365|Tobramycin|tobramycin|mesh-list
44589927|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44589928|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589929|NCT00885352|Metformin|metformin|mesh-list
44589930|NCT00885352|Pioglitazone|pioglitazone|mesh-list
44589931|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44589932|NCT00885352|Glipizide|glipizide|mesh-list
44589933|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589934|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589935|NCT00885352|Incretins|incretins|mesh-ancestor
44589936|NCT00885352|Hormones|hormones|mesh-ancestor
44589937|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44589938|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44589939|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
44589940|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589941|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589942|NCT00885170|Vitamin D|vitamin d|mesh-list
44589943|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
44589944|NCT00885170|Calcium|calcium|mesh-list
44589945|NCT00885170|Vitamins|vitamins|mesh-ancestor
44589946|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
44589947|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589948|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44589949|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44589950|NCT00885118|Empagliflozin|empagliflozin|mesh-list
44589951|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44589952|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589953|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44589954|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589955|NCT00885105|Vaccines|vaccines|mesh-list
44589956|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
44589957|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589958|NCT00884832|Clonidine|clonidine|mesh-list
44589959|NCT00884832|Analgesics|analgesics|mesh-ancestor
44589960|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
44589961|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44589962|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44589963|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44589964|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
44589965|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
44589966|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44589967|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44589968|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44589969|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
44589970|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44589971|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589972|NCT00884793|Ritonavir|ritonavir|mesh-list
44589973|NCT00884793|Lopinavir|lopinavir|mesh-list
44589974|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44589975|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
44589976|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
44589977|NCT00884793|Efavirenz|efavirenz|mesh-list
44589978|NCT00884793|Etravirine|etravirine|mesh-list
44589979|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44589980|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44589981|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
44589982|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44589983|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44589984|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44589985|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44589986|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
44589987|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44589988|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44589989|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44589990|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44589991|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44589992|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44589993|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44589994|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44589995|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44589996|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44589997|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44589998|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44589999|NCT00884741|Bevacizumab|bevacizumab|mesh-list
44590000|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44590001|NCT00884741|Temozolomide|temozolomide|mesh-list
44590002|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
44590003|NCT00884741|Antibodies|antibodies|mesh-list
44590004|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
44590005|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44590006|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
44590007|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590008|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590009|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590010|NCT00884741|Growth Substances|growth substances|mesh-ancestor
44590011|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590012|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590013|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
44590014|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44590015|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
44590016|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590017|NCT00884650|Analgesics|analgesics|mesh-list
44590018|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
44590019|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590020|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590021|NCT00884390|Factor VIII|factor viii|mesh-list
44590022|NCT00884390|Coagulants|coagulants|mesh-ancestor
44590023|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44590024|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44590025|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44590026|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590027|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
44590028|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44590029|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
44590030|NCT00884325|Levocetirizine|levocetirizine|mesh-list
44590031|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44590032|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44590033|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
44590034|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
44590035|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418006|NCT02284243|Analgesics|analgesics|mesh-ancestor
44590036|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590037|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590039|NCT00884273|Bicalutamide|bicalutamide|mesh-list
44590040|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590041|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590042|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
44590043|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44590044|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590045|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590046|NCT00884221|Menotropins|menotropins|mesh-list
44590047|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44590048|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
44590049|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44590050|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590051|NCT00884117|Oseltamivir|oseltamivir|mesh-list
44590052|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
44590053|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590054|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590055|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590056|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
44590057|NCT00884039|Anecortave|anecortave|mesh-list
44590058|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590059|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590060|NCT00884039|Growth Substances|growth substances|mesh-ancestor
44590061|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590062|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590063|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590064|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590065|NCT00883896|Fezakinumab|fezakinumab|mesh-list
44590066|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
44590067|NCT00883779|Gemcitabine|gemcitabine|mesh-list
44590068|NCT00883779|Cisplatin|cisplatin|mesh-list
44590069|NCT00883779|Carboplatin|carboplatin|mesh-list
44590070|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44590071|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590072|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590073|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
44590074|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590075|NCT00883779|Antiviral Agents|antiviral agents|mesh-ancestor
44590076|NCT00883779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590077|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590078|NCT00883779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590079|NCT00883779|Immunologic Factors|immunologic factors|mesh-ancestor
44590080|NCT00883779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590081|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590082|NCT00883740|Pregabalin|pregabalin|mesh-list
44590083|NCT00883740|Analgesics|analgesics|mesh-ancestor
44590084|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
44590085|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590086|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590087|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
44590088|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44590089|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44590090|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590091|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44590092|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44590093|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590094|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590095|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590096|NCT00883688|Bevacizumab|bevacizumab|mesh-list
44590097|NCT00883688|Lapatinib|lapatinib|mesh-list
44590098|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590099|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590100|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590101|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590102|NCT00883688|Growth Substances|growth substances|mesh-ancestor
44590103|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590104|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590105|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590106|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590107|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590108|NCT00883558|Insulin|insulin|mesh-list
44590109|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44590110|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
44590111|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
44418082|NCT02282345|Talazoparib|talazoparib|mesh-list
44590112|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44590113|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590114|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44590115|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
44590116|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
44590117|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590118|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44590119|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590120|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590121|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590122|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590123|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590124|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
44590125|NCT00883337|Interferons|interferons|mesh-list
44590126|NCT00883337|Interferon-beta|interferon-beta|mesh-list
44590127|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
44590128|NCT00883337|Teriflunomide|teriflunomide|mesh-list
44590129|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590130|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
44590131|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590132|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44590133|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44590134|NCT00883337|Analgesics|analgesics|mesh-ancestor
44590135|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
44590136|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590137|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590138|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590139|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590140|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590141|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
44590142|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44590143|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
44590144|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
44590145|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590146|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
44590147|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590148|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590149|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44590150|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
44590151|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590152|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590153|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44590154|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590155|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44590156|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
44590157|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44590158|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590159|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590161|NCT00883116|Doxorubicin|doxorubicin|mesh-list
44590162|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44590163|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590164|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590165|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590166|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590167|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590168|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590169|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590170|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590171|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590172|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590173|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
44590174|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44590175|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44590176|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590178|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44590179|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
44590180|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590181|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590182|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590183|NCT00882908|Ribavirin|ribavirin|mesh-list
44590184|NCT00882908|Simeprevir|simeprevir|mesh-list
44590185|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
44590186|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590187|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
44590188|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590189|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
44590190|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590191|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
44590192|NCT00882713|Hematinics|hematinics|mesh-ancestor
44590193|NCT00882583|Cisplatin|cisplatin|mesh-list
44590194|NCT00882583|Cetuximab|cetuximab|mesh-list
44590195|NCT00882583|Dasatinib|dasatinib|mesh-list
44590196|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590197|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590198|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590199|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590200|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590201|NCT00882557|Daptomycin|daptomycin|mesh-list
44590202|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44590203|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590204|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
44590205|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44590206|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
44590207|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590208|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44590209|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590210|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590211|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590212|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
44590213|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
44590214|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590215|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44590216|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44590217|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
44590218|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590219|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590220|NCT00882362|Aripiprazole|aripiprazole|mesh-list
44590221|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
44590222|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590223|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44590224|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590225|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590226|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590227|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
44590228|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
44590229|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590230|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590231|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44590232|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44590233|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
44590234|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44590235|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44590236|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44590237|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44590238|NCT00882310|Gemcitabine|gemcitabine|mesh-list
44590239|NCT00882310|Capecitabine|capecitabine|mesh-list
44590240|NCT00882310|Docetaxel|docetaxel|mesh-list
44590241|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590242|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
44590243|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590244|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590245|NCT00882310|Antiviral Agents|antiviral agents|mesh-ancestor
44590246|NCT00882310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590247|NCT00882310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590248|NCT00882310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590249|NCT00882310|Immunologic Factors|immunologic factors|mesh-ancestor
44590250|NCT00882310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590251|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590252|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590253|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590254|NCT00882115|Sulforaphane|sulforaphane|mesh-list
44590255|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44590256|NCT00882115|Protective Agents|protective agents|mesh-ancestor
44590257|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590258|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590259|NCT00881894|Rotigotine|rotigotine|mesh-list
44590260|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
44590261|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
44590262|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590263|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590264|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590265|NCT00881868|Clobetasol|clobetasol|mesh-list
44590266|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590267|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
44590268|NCT00881868|Hormones|hormones|mesh-ancestor
44590269|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590270|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590271|NCT00881751|Bevacizumab|bevacizumab|mesh-list
44590272|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44590273|NCT00881751|Sorafenib|sorafenib|mesh-list
44590274|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590275|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590276|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590277|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590278|NCT00881751|Growth Substances|growth substances|mesh-ancestor
44590279|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590280|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590281|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590282|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590283|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590284|NCT00881621|Capecitabine|capecitabine|mesh-list
44590285|NCT00881621|Lapatinib|lapatinib|mesh-list
44211181|NCT00441870|Folic Acid|folic acid|mesh-list
44590286|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590287|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
44590288|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590289|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590290|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590291|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590292|NCT00881569|Efatutazone|efatutazone|mesh-list
44590293|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590294|NCT00881530|Metformin|metformin|mesh-list
44590295|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44590296|NCT00881530|Empagliflozin|empagliflozin|mesh-list
44590297|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44590298|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590299|NCT00881530|Incretins|incretins|mesh-ancestor
44590300|NCT00881530|Hormones|hormones|mesh-ancestor
44590301|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590302|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44590303|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
44590304|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590305|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590306|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44590307|NCT00881504|Bevacizumab|bevacizumab|mesh-list
44590308|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590309|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590310|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590311|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590312|NCT00881504|Growth Substances|growth substances|mesh-ancestor
44590313|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590314|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590315|NCT00881205|Rivastigmine|rivastigmine|mesh-list
44590316|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44590317|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590318|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590319|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
44590320|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590321|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590322|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44590323|NCT00881205|Protective Agents|protective agents|mesh-ancestor
44590324|NCT00880906|Fluticasone|fluticasone|mesh-list
44590325|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44590326|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590327|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44590328|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
44590329|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211224|NCT00442026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590330|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590331|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44590332|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590333|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44590334|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44590335|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590336|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590337|NCT00880763|Interferons|interferons|mesh-list
44590338|NCT00880763|Ribavirin|ribavirin|mesh-list
44590339|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590340|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
44590341|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590342|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
44590343|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590344|NCT00880685|Memantine|memantine|mesh-list
44590345|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44590346|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44590347|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
44590348|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590349|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590350|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590351|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44590352|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44590353|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44590354|NCT00880620|Carbidopa|carbidopa|mesh-list
44590355|NCT00880620|Levodopa|levodopa|mesh-list
44590356|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44590357|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
44590358|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590359|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44590360|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44590361|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
44590362|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
44590363|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590364|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590365|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44590366|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590367|NCT00880607|Morphine|morphine|mesh-list
44590368|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44590369|NCT00880607|Narcotics|narcotics|mesh-ancestor
44590370|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590371|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590372|NCT00880607|Analgesics|analgesics|mesh-ancestor
44590373|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
44590374|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590375|NCT00880542|Sorafenib|sorafenib|mesh-list
44590376|NCT00880542|Ifosfamide|ifosfamide|mesh-list
44211271|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
44590377|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590378|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590379|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590380|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590381|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44590382|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
44590383|NCT00880334|Docetaxel|docetaxel|mesh-list
44590384|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590385|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590386|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590387|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590388|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590389|NCT00880269|Panobinostat|panobinostat|mesh-list
44590390|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590391|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44590392|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590393|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590394|NCT00880191|Dexamethasone|dexamethasone|mesh-list
44590395|NCT00880191|Gabapentin|gabapentin|mesh-list
44590396|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590397|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
44590398|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
44590399|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590400|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590401|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44590402|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
44590403|NCT00880191|Hormones|hormones|mesh-ancestor
44590404|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590405|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590406|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590407|NCT00880191|Analgesics|analgesics|mesh-ancestor
44590408|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
44590409|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
44590410|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44590411|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590412|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590413|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590414|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44590415|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44590416|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590417|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590418|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
44590419|NCT00880100|Pancrelipase|pancrelipase|mesh-list
44590420|NCT00880100|Pancreatin|pancreatin|mesh-list
44590421|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44590422|NCT00880009|Letrozole|letrozole|mesh-list
44590423|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590424|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44590425|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44590426|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211314|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590427|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590428|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44590429|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
44590430|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590431|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590432|NCT00879996|Buprenorphine|buprenorphine|mesh-list
44590433|NCT00879996|Methadone|methadone|mesh-list
44590434|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44590435|NCT00879996|Naloxone|naloxone|mesh-list
44590436|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44590437|NCT00879996|Narcotics|narcotics|mesh-ancestor
44590438|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590439|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590440|NCT00879996|Analgesics|analgesics|mesh-ancestor
44590441|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
44590442|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590443|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44590444|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
44590445|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590447|NCT00879970|Pioglitazone|pioglitazone|mesh-list
44590448|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
44590449|NCT00879970|Vitamins|vitamins|mesh-ancestor
44590450|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
44590451|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590452|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44590453|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44590454|NCT00879879|Losartan|losartan|mesh-list
44590455|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44590456|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590457|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44590458|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44590459|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590460|NCT00879814|Vaccines|vaccines|mesh-list
44590461|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
44590462|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590463|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
44590464|NCT00879775|Caffeine|caffeine|mesh-list
44590465|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44590466|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590467|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44590468|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590469|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590470|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44590471|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44590472|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
44590473|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590474|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
44590475|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590476|NCT00879710|Simvastatin|simvastatin|mesh-list
44590477|NCT00879710|Ezetimibe|ezetimibe|mesh-list
44590478|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44590479|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44590480|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
44590481|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590482|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44590483|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44590484|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590485|NCT00879658|Siponimod|siponimod|mesh-list
44590486|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44590487|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590488|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590489|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
44590490|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590491|NCT00879437|Bevacizumab|bevacizumab|mesh-list
44590492|NCT00879437|Valproic Acid|valproic acid|mesh-list
44590493|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590494|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590495|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590496|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590498|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590499|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590500|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
44590501|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590502|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590503|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
44590504|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590505|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
44590506|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590507|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590508|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590509|NCT00879411|Telmisartan|telmisartan|mesh-list
44590510|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590511|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44590512|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44590513|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590514|NCT00879398|Fesoterodine|fesoterodine|mesh-list
44590515|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44590516|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44590517|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
44590518|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590519|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590520|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590521|NCT00879398|Urological Agents|urological agents|mesh-ancestor
44590522|NCT00879333|Everolimus|everolimus|mesh-list
44590523|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590524|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590525|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
44590526|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590527|NCT00879229|Ambrisentan|ambrisentan|mesh-list
44590528|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590529|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
44590530|NCT00878995|Testosterone|testosterone|mesh-list
44590531|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
44590532|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
44590533|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44590534|NCT00878995|Androgens|androgens|mesh-ancestor
44590535|NCT00878995|Hormones|hormones|mesh-ancestor
44590536|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590537|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590538|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590539|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590540|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
44590541|NCT00878969|Valsartan|valsartan|mesh-list
44590542|NCT00878969|Ramipril|ramipril|mesh-list
44590543|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44590544|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590545|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44590546|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44590547|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590548|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
44590549|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590550|NCT00878800|Doxorubicin|doxorubicin|mesh-list
44590551|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44590552|NCT00878800|Belinostat|belinostat|mesh-list
44590553|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590554|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590555|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590556|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590557|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590558|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590559|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44590560|NCT00878722|Idarubicin|idarubicin|mesh-list
44590561|NCT00878722|Belinostat|belinostat|mesh-list
44590562|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590563|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590564|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590565|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590566|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590567|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590568|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44590569|NCT00878553|Zaleplon|zaleplon|mesh-list
44590570|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
44590571|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44590572|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590573|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590574|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
44590575|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
44590576|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590577|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590578|NCT00878215|Liver Extracts|liver extracts|mesh-list
44590579|NCT00878215|Hematinics|hematinics|mesh-ancestor
44590580|NCT00878072|Famciclovir|famciclovir|mesh-list
44590581|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
44590582|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590583|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44590584|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590585|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590587|NCT00877929|Telmisartan|telmisartan|mesh-list
44590588|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590589|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44590590|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44590591|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590592|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44590593|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590594|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44590595|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44590596|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44590598|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44590599|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590600|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44590601|NCT00877890|Incretins|incretins|mesh-ancestor
44590602|NCT00877890|Hormones|hormones|mesh-ancestor
44590603|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590604|NCT00877773|Sirolimus|sirolimus|mesh-list
44590605|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44590606|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590607|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590608|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590609|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
44590610|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590611|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
44590612|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590613|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44590614|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44590615|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590616|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44590617|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44590618|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44590619|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590620|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
44590621|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590622|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
44590623|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44590624|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
44590625|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590626|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590627|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44590628|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590629|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
44590630|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44590631|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
44590632|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590633|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590634|NCT00877071|Doxorubicin|doxorubicin|mesh-list
44590635|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590636|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590637|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590638|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590639|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590640|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590641|NCT00877006|Prednisone|prednisone|mesh-list
44590642|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
44590643|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44590644|NCT00877006|Rituximab|rituximab|mesh-list
44590645|NCT00877006|Doxorubicin|doxorubicin|mesh-list
44590646|NCT00877006|Vincristine|vincristine|mesh-list
44590647|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590648|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
44590649|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590650|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590651|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44590652|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
44590653|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590654|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590655|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44590656|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590657|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590658|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590659|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590660|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590661|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590662|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
44590663|NCT00877006|Hormones|hormones|mesh-ancestor
44590664|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590665|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590666|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590667|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590668|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590669|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590670|NCT00876928|Vitamin D|vitamin d|mesh-list
44590671|NCT00876928|Vitamins|vitamins|mesh-ancestor
44590672|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
44590673|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590674|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44590675|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44590676|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44590677|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
44590678|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590679|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590680|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44590681|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590682|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44590683|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44590684|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44590685|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
44590686|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590687|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590688|NCT00876460|Docetaxel|docetaxel|mesh-list
44590689|NCT00876460|Nintedanib|nintedanib|mesh-list
44590690|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590691|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590692|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590693|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590694|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590695|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590696|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590697|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
44590698|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44590699|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44590700|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44590701|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44590702|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590703|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
44590704|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590705|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590706|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44590707|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590708|NCT00876395|Paclitaxel|paclitaxel|mesh-list
44590709|NCT00876395|Trastuzumab|trastuzumab|mesh-list
44590710|NCT00876395|Everolimus|everolimus|mesh-list
44590711|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590712|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590713|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590714|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590715|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590716|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590730|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590731|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590732|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44590733|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44590734|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
44590735|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44590736|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44590737|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44590738|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44590739|NCT00876187|Naproxen|naproxen|mesh-list
44590740|NCT00876187|Tanezumab|tanezumab|mesh-list
44590741|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44590742|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44590743|NCT00876187|Analgesics|analgesics|mesh-ancestor
44590744|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
44590745|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590746|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590747|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590748|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590749|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
44590750|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44590751|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991122|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590752|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590754|NCT00875979|Pertuzumab|pertuzumab|mesh-list
44590755|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44590756|NCT00875979|Maytansine|maytansine|mesh-list
44590757|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590758|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590759|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590760|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590761|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590762|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590763|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590764|NCT00875667|Fludarabine|fludarabine|mesh-list
44590765|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
44590766|NCT00875667|Lenalidomide|lenalidomide|mesh-list
44590767|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590768|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590769|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
44590770|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590771|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590772|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
44590773|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590774|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44590775|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44590776|NCT00875667|Growth Substances|growth substances|mesh-ancestor
44590777|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
44590778|NCT00875615|Cisplatin|cisplatin|mesh-list
44590779|NCT00875615|Carboplatin|carboplatin|mesh-list
44590780|NCT00875615|Sorafenib|sorafenib|mesh-list
44590781|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590782|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590783|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590784|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590785|NCT00875524|Vaccines|vaccines|mesh-list
44590786|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
44590787|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590788|NCT00875433|Afatinib|afatinib|mesh-list
44590789|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590790|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44590791|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590792|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590793|NCT00875056|Vorinostat|vorinostat|mesh-list
44590794|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590795|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44590796|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590797|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590798|NCT00875017|Sevelamer|sevelamer|mesh-list
44590799|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
44590800|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
44590801|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590802|NCT00874939|Donepezil|donepezil|mesh-list
44590803|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44590804|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590805|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590806|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
44590807|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590808|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590809|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
44590810|NCT00874848|Paclitaxel|paclitaxel|mesh-list
44590811|NCT00874848|Carboplatin|carboplatin|mesh-list
44590812|NCT00874848|Cetuximab|cetuximab|mesh-list
44590813|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44590814|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590815|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590816|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590817|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590818|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590819|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590820|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44590821|NCT00874770|Ribavirin|ribavirin|mesh-list
44590822|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44590823|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
44590824|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590825|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
44590826|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590827|NCT00874731|Sirolimus|sirolimus|mesh-list
44590828|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44590829|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590830|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590831|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590832|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
44590833|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590834|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
44590835|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590836|NCT00874432|Lisinopril|lisinopril|mesh-list
44590837|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44590838|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44590839|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
44590840|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590841|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44590842|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44590843|NCT00874432|Protective Agents|protective agents|mesh-ancestor
44590844|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590845|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
44590846|NCT00874237|Loxapine|loxapine|mesh-list
44590847|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44590848|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590849|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590850|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590851|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590852|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590853|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590854|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590855|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44590856|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44590857|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44590858|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44590859|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44590860|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
44590861|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590862|NCT00874120|Phenylephrine|phenylephrine|mesh-list
44590863|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
44590864|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44590865|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
44590866|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
44590867|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44590868|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590869|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
44590870|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44590871|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
44590872|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590873|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44590874|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44590875|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44590876|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44590877|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590878|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590879|NCT00874120|Protective Agents|protective agents|mesh-ancestor
44590880|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44590881|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
44590882|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590884|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44590885|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44590886|NCT00873730|Analgesics|analgesics|mesh-ancestor
44590887|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
44590888|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211721|NCT00444418|Naloxone|naloxone|mesh-list
44590889|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590890|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590891|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590892|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44590893|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590894|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
44590895|NCT00873366|Tamoxifen|tamoxifen|mesh-list
44590896|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
44590897|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590898|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44590899|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
44590900|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590901|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590902|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590903|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590904|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44590905|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44590906|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44590907|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
44590908|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
44590909|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44590910|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44590911|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590912|NCT00873119|Paclitaxel|paclitaxel|mesh-list
44590913|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44590914|NCT00873119|Carboplatin|carboplatin|mesh-list
44590915|NCT00873119|Belinostat|belinostat|mesh-list
44590916|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590917|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590918|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590919|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590920|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590921|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590922|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44590923|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590924|NCT00873093|Leucovorin|leucovorin|mesh-list
44590925|NCT00873093|Cytarabine|cytarabine|mesh-list
44590926|NCT00873093|Prednisone|prednisone|mesh-list
44590927|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
44590928|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44590929|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44590930|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44590931|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
44590932|NCT00873093|Doxorubicin|doxorubicin|mesh-list
44590933|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44590934|NCT00873093|Methotrexate|methotrexate|mesh-list
44590935|NCT00873093|Etoposide|etoposide|mesh-list
44590936|NCT00873093|Vincristine|vincristine|mesh-list
44590937|NCT00873093|Bortezomib|bortezomib|mesh-list
44590938|NCT00873093|Asparaginase|asparaginase|mesh-list
44590939|NCT00873093|Pegaspargase|pegaspargase|mesh-list
44590940|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
44590941|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
44590942|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44590943|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
44590944|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590945|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44590946|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44590947|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
44590948|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590949|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590950|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44590951|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44590952|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44590953|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44590954|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44590955|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44590956|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
44590957|NCT00873093|Hormones|hormones|mesh-ancestor
44590958|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44590959|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44590960|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44590961|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
44590962|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44590963|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44590964|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
44590965|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
44590966|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44590967|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44590968|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44590969|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
44590970|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44590971|NCT00873093|Antidotes|antidotes|mesh-ancestor
44590972|NCT00873093|Protective Agents|protective agents|mesh-ancestor
44590973|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
44590974|NCT00873093|Vitamins|vitamins|mesh-ancestor
44590975|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
44590976|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590977|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590978|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590979|NCT00873041|Deferasirox|deferasirox|mesh-list
44590980|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44590981|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
44590982|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
44590983|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590984|NCT00872989|Docetaxel|docetaxel|mesh-list
44590985|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44590986|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
44590987|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
44590988|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44590989|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590990|NCT00872898|Memantine|memantine|mesh-list
44590991|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44590992|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44590993|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
44590994|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44590995|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44590996|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44590997|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44590998|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44590999|NCT00872599|Fenofibrate|fenofibrate|mesh-list
44591000|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44591001|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
44591002|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591003|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44591004|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
44591005|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
44591006|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44591007|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44591008|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591009|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591010|NCT00872170|Urological Agents|urological agents|mesh-ancestor
44591011|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44591012|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591013|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591014|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591015|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591016|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44591017|NCT00871871|Isosorbide|isosorbide|mesh-list
44591018|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44591019|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44591020|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44591021|NCT00871871|Diuretics|diuretics|mesh-ancestor
44591022|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
44591023|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591024|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44591025|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591026|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591027|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44591028|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44591029|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44419054|NCT02259582|Pemetrexed|pemetrexed|mesh-list
44591031|NCT00871858|Anastrozole|anastrozole|mesh-list
44591032|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44591033|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591034|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44591035|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44591036|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591037|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591038|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591039|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44591040|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44211865|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
44591041|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591042|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591043|NCT00871780|Natalizumab|natalizumab|mesh-list
44591044|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
44591045|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591046|NCT00871728|Itraconazole|itraconazole|mesh-list
44591047|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
44591048|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591049|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44591050|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591051|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770624|NCT02378441|Atorvastatin|atorvastatin|mesh-list
44591052|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591053|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44591054|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591055|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591056|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591057|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44591058|NCT00871494|Azithromycin|azithromycin|mesh-list
44591059|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44591060|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591061|NCT00871403|Cisplatin|cisplatin|mesh-list
44591062|NCT00871403|Pemetrexed|pemetrexed|mesh-list
44591063|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591064|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591065|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591066|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591067|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591068|NCT00871338|Vaccines|vaccines|mesh-list
44591069|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44591070|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
44591071|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591072|NCT00871234|Etravirine|etravirine|mesh-list
44591073|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44591074|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591075|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591076|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591077|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
44591078|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591079|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
44591080|NCT00871169|Irinotecan|irinotecan|mesh-list
44591081|NCT00871169|Cetuximab|cetuximab|mesh-list
44591082|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591083|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44591084|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44591085|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591086|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591087|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591088|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
44591089|NCT00871000|Antidotes|antidotes|mesh-ancestor
44591090|NCT00871000|Protective Agents|protective agents|mesh-ancestor
44591091|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591092|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
44591093|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
44591094|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591095|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44591096|NCT00870870|Gemcitabine|gemcitabine|mesh-list
44591097|NCT00870870|Cisplatin|cisplatin|mesh-list
44591098|NCT00870870|Carboplatin|carboplatin|mesh-list
44591099|NCT00870870|Cetuximab|cetuximab|mesh-list
44591100|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44591101|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591102|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591103|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
44591104|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591105|NCT00870870|Antiviral Agents|antiviral agents|mesh-ancestor
44591106|NCT00870870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591107|NCT00870870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591108|NCT00870870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591109|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
44591110|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591111|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591112|NCT00870740|Daclizumab|daclizumab|mesh-list
44591113|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591114|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
44591115|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591116|NCT00870727|Aripiprazole|aripiprazole|mesh-list
44591117|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
44591118|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591119|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44591120|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44591121|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591122|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591123|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
44591124|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
44591125|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591126|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591127|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44591128|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44591129|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
44591130|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44591131|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44591132|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44591133|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44591134|NCT00870584|Omalizumab|omalizumab|mesh-list
44591135|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44591136|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44591137|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44591138|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44591139|NCT00870194|Exenatide|exenatide|mesh-list
44591140|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44591141|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591142|NCT00870194|Incretins|incretins|mesh-ancestor
44591143|NCT00870194|Hormones|hormones|mesh-ancestor
44591144|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591145|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44591146|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
44591147|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591148|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591149|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44591150|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
44591151|NCT00870103|Dexamethasone|dexamethasone|mesh-list
44591152|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44591153|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591154|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
44591155|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
44591156|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591157|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591158|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44591159|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
44591160|NCT00870103|Hormones|hormones|mesh-ancestor
44591161|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591162|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44591163|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591164|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44591165|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591166|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44591167|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44591168|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591169|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591170|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44591171|NCT00869999|Rituximab|rituximab|mesh-list
44591172|NCT00869999|Everolimus|everolimus|mesh-list
44591173|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591174|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591175|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
44591176|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591177|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591178|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591179|NCT00869960|Ritonavir|ritonavir|mesh-list
44591180|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44591181|NCT00869960|Tenofovir|tenofovir|mesh-list
44591182|NCT00869960|Emtricitabine|emtricitabine|mesh-list
44591183|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44591184|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44591185|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
44591186|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591187|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591188|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44591189|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44591190|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
44591191|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591192|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44591193|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591194|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44591195|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591196|NCT00869778|Vaccines|vaccines|mesh-list
44591197|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
44591198|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991536|NCT02487563|Decitabine|decitabine|mesh-list
44591199|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44591200|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44591201|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44591202|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591203|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591204|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591205|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
44591206|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591207|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44591208|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44591209|NCT00869518|Trimethoprim|trimethoprim|mesh-list
44591210|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44591211|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
44591212|NCT00869518|Rifabutin|rifabutin|mesh-list
44591213|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44591214|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591215|NCT00869518|Renal Agents|renal agents|mesh-ancestor
44591216|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
44591217|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44591218|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44591219|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591220|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591221|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591222|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44591223|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44591224|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591225|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212031|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
44591226|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44591227|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
44591228|NCT00869440|Midazolam|midazolam|mesh-list
44591229|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44591230|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44591231|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591232|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591233|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44591234|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44591235|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591236|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44591237|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
44591238|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
44591239|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
44591240|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
44591241|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591242|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591243|NCT00869401|Temozolomide|temozolomide|mesh-list
44591244|NCT00869401|Dasatinib|dasatinib|mesh-list
44591245|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591246|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
44591247|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591248|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591249|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591250|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591251|NCT00869323|Rituximab|rituximab|mesh-list
44591252|NCT00869323|Bortezomib|bortezomib|mesh-list
44591253|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591254|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591255|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
44591256|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591257|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591258|NCT00869258|Gemcitabine|gemcitabine|mesh-list
44591259|NCT00869258|Capecitabine|capecitabine|mesh-list
44591260|NCT00869258|Docetaxel|docetaxel|mesh-list
44591261|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591262|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
44591263|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591264|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591265|NCT00869258|Antiviral Agents|antiviral agents|mesh-ancestor
44591266|NCT00869258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212093|NCT00446316|Antacids|antacids|mesh-list
44591267|NCT00869258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591268|NCT00869258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591269|NCT00869258|Immunologic Factors|immunologic factors|mesh-ancestor
44591270|NCT00869258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591271|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44591272|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44591273|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44591275|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44591276|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44591277|NCT00869089|Analgesics|analgesics|mesh-ancestor
44591278|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
44591279|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591280|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591281|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591282|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591283|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44591284|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44591285|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591286|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591287|NCT00869050|Capecitabine|capecitabine|mesh-list
44419351|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44591288|NCT00869050|Temozolomide|temozolomide|mesh-list
44591289|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591290|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
44591291|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591292|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591293|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591294|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
44591295|NCT00868998|Gemcitabine|gemcitabine|mesh-list
44591296|NCT00868998|Capecitabine|capecitabine|mesh-list
44591298|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591299|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
44591300|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591301|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591302|NCT00868998|Antiviral Agents|antiviral agents|mesh-ancestor
44591303|NCT00868998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591304|NCT00868998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591305|NCT00868998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591306|NCT00868998|Immunologic Factors|immunologic factors|mesh-ancestor
44591307|NCT00868998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591308|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44591309|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44591310|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44591311|NCT00868790|Metformin|metformin|mesh-list
44591312|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44591313|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212120|NCT00446420|Narcotics|narcotics|mesh-ancestor
44591314|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44591315|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591316|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591317|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44591318|NCT00868296|Pantoprazole|pantoprazole|mesh-list
44591319|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44591320|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44591321|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44591322|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591323|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591324|NCT00868231|Bromides|bromides|mesh-list
44591325|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
44591326|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44591327|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
44591328|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591329|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591330|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44591331|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
44591332|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
44591333|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44591334|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
44591335|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591336|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591337|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
44591338|NCT00868192|Bevacizumab|bevacizumab|mesh-list
44591339|NCT00868192|Pemetrexed|pemetrexed|mesh-list
44591340|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591341|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591342|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44591343|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591344|NCT00868192|Growth Substances|growth substances|mesh-ancestor
44591345|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591346|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591347|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591348|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591349|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591350|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591351|NCT00868166|Riluzole|riluzole|mesh-list
44591352|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
44591353|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44591354|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44591355|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591356|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591357|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591358|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44591359|NCT00868166|Protective Agents|protective agents|mesh-ancestor
44591360|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44591361|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591362|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
44591367|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44591368|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44591369|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44591370|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591371|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591372|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44591373|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591374|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
44591375|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44591376|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44591377|NCT00867490|Diuretics|diuretics|mesh-ancestor
44591378|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
44591379|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44591380|NCT00867360|Mifepristone|mifepristone|mesh-list
44591381|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44591382|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
44591383|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44591384|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591385|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44591386|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44591387|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44591388|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
44591389|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44591390|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44591391|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591392|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591393|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
44591394|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44591395|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44591396|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
44591397|NCT00867334|Panitumumab|panitumumab|mesh-list
44591398|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591399|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591400|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591401|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591402|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591403|NCT00867308|Lenalidomide|lenalidomide|mesh-list
44591404|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
44591405|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591406|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44591407|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591408|NCT00867308|Growth Substances|growth substances|mesh-ancestor
44591409|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591410|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591411|NCT00867165|Ezetimibe|ezetimibe|mesh-list
44591412|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44591413|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44591414|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
44591415|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591416|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44591417|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
44591418|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591419|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591420|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591421|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591422|NCT00867087|Rituximab|rituximab|mesh-list
44591423|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44591424|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591425|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591426|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
44591427|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591428|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591429|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44591430|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
44419465|NCT05649943|Androgens|androgens|mesh-list
44591432|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
44591433|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44591434|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591435|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
44591436|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44591437|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
44591438|NCT00867009|Cisplatin|cisplatin|mesh-list
44591439|NCT00867009|Pemetrexed|pemetrexed|mesh-list
44591440|NCT00867009|Cetuximab|cetuximab|mesh-list
44591441|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591442|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591443|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591444|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591445|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591446|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591447|NCT00866918|Vitamins|vitamins|mesh-list
44591448|NCT00866918|Vitamin A|vitamin a|mesh-list
44591449|NCT00866918|Cytarabine|cytarabine|mesh-list
44591450|NCT00866918|Methotrexate|methotrexate|mesh-list
44591451|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
44591452|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
44591453|NCT00866918|Idarubicin|idarubicin|mesh-list
44591454|NCT00866918|Tretinoin|tretinoin|mesh-list
44591455|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
44591456|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
44591457|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
44591458|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591459|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44591460|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
44591461|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44591462|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591463|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
44591464|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591465|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591466|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
44591467|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591468|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591469|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591470|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
44591471|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591472|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591473|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
44591474|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591475|NCT00866918|Analgesics|analgesics|mesh-ancestor
44591476|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
44591477|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591478|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44591479|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44591480|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44591481|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
44591482|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
44591483|NCT00866918|Protective Agents|protective agents|mesh-ancestor
44591484|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44591485|NCT00866788|Omalizumab|omalizumab|mesh-list
44591486|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
44456656|NCT01625611|Naltrexone|naltrexone|mesh-list
44591487|NCT00866788|Promethazine|promethazine|mesh-list
44591488|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44591489|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
44591490|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44591491|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44591492|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44591493|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44591494|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44591495|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591496|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591497|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
44591498|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
44591499|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
44591500|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591501|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
44591502|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
44591503|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44591504|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
44591505|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591506|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591507|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
44591508|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44591509|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44591510|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
44591511|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44591512|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44591513|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591514|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591515|NCT00866723|Bevacizumab|bevacizumab|mesh-list
44591516|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591517|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591518|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44591519|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591520|NCT00866723|Growth Substances|growth substances|mesh-ancestor
44591521|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591522|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591523|NCT00866658|Lixisenatide|lixisenatide|mesh-list
44591524|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44591525|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591526|NCT00866619|Vaccines|vaccines|mesh-list
44591527|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
44591528|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591529|NCT00866359|Apremilast|apremilast|mesh-list
44591530|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44591531|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44591532|NCT00866359|Analgesics|analgesics|mesh-ancestor
44591533|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
44591534|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591535|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591536|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591537|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591538|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44591539|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44591540|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591541|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591542|NCT00866333|Entinostat|entinostat|mesh-list
44591543|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591544|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44591545|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591546|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591547|NCT00866320|Sorafenib|sorafenib|mesh-list
44591548|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591549|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591550|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591551|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591552|NCT00866307|Cytarabine|cytarabine|mesh-list
44591553|NCT00866307|Dexamethasone|dexamethasone|mesh-list
44591554|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
44591555|NCT00866307|Prednisone|prednisone|mesh-list
44591556|NCT00866307|Cortisone|cortisone|mesh-list
44591557|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
44591558|NCT00866307|Doxorubicin|doxorubicin|mesh-list
44591559|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44591560|NCT00866307|Methotrexate|methotrexate|mesh-list
44591561|NCT00866307|Vincristine|vincristine|mesh-list
44591562|NCT00866307|Daunorubicin|daunorubicin|mesh-list
44591563|NCT00866307|Asparaginase|asparaginase|mesh-list
44591564|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
44591565|NCT00866307|Pegaspargase|pegaspargase|mesh-list
44591566|NCT00866307|Thioguanine|thioguanine|mesh-list
44591567|NCT00866307|BB 1101|bb 1101|mesh-list
44591568|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
44591569|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591570|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
44591571|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591572|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591573|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591574|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
44591575|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591576|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591577|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44591578|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591579|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
44591580|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
44591581|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591582|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44591583|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
44591585|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591586|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44591587|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
44591588|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591589|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44591590|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44591591|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44591592|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44591593|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
44591594|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44591595|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591596|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
44591597|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44591598|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591599|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591600|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
44591601|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591602|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44591603|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
44591604|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
44591605|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
44591607|NCT00866294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44591608|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44591609|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591610|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591611|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591612|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
44591613|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591614|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44591615|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
44591616|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591617|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44591618|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591619|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591620|NCT00866281|Midostaurin|midostaurin|mesh-list
44591621|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591622|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591623|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591624|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591625|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44591626|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591627|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591628|NCT00865709|Leucovorin|leucovorin|mesh-list
44591629|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
44591630|NCT00865709|Fluorouracil|fluorouracil|mesh-list
44591631|NCT00865709|Sorafenib|sorafenib|mesh-list
44591632|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
44591633|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591634|NCT00865709|Antidotes|antidotes|mesh-ancestor
44591635|NCT00865709|Protective Agents|protective agents|mesh-ancestor
44591636|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591637|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
44591638|NCT00865709|Vitamins|vitamins|mesh-ancestor
44591639|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
44591640|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
44591641|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591642|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591643|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591644|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
44591645|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591646|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591647|NCT00865566|Vaccines|vaccines|mesh-list
44591648|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
44591649|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591650|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
44591651|NCT00865280|Linezolid|linezolid|mesh-list
44591652|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44591653|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591654|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44591655|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44591656|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419686|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44591657|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591659|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44591661|NCT00865189|Folic Acid|folic acid|mesh-list
44591662|NCT00865189|Bevacizumab|bevacizumab|mesh-list
44591663|NCT00865189|Fluorouracil|fluorouracil|mesh-list
44591664|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
44591665|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
44591666|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44591667|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591668|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44591669|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44591670|NCT00865189|Growth Substances|growth substances|mesh-ancestor
44591671|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591672|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44591673|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
44591674|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591675|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591676|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591677|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
44591678|NCT00865189|Antidotes|antidotes|mesh-ancestor
44591679|NCT00865189|Protective Agents|protective agents|mesh-ancestor
44591680|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
44591681|NCT00865189|Vitamins|vitamins|mesh-ancestor
44591682|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
44591683|NCT00865189|Hematinics|hematinics|mesh-ancestor
44591684|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44591685|NCT00865124|Spironolactone|spironolactone|mesh-list
44591686|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44591687|NCT00865124|Diuretics|diuretics|mesh-ancestor
44591688|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
44591689|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591690|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44591691|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591692|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591693|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44591694|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591695|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591696|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44419757|NCT05647057|Polygeline|polygeline|mesh-list
44591729|NCT00864682|Lidocaine|lidocaine|mesh-list
44591730|NCT00864682|Propofol|propofol|mesh-list
44591731|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
44591732|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
44591733|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591734|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591735|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
44591736|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591737|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44591738|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44591739|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44591740|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591741|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212464|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591742|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44591743|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44591744|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
44591746|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591747|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591748|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591749|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44591750|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591751|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44591752|NCT00864253|Dacarbazine|dacarbazine|mesh-list
44591753|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591754|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591755|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
44591756|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591757|NCT00864097|Diclofenac|diclofenac|mesh-list
44591758|NCT00864097|Tanezumab|tanezumab|mesh-list
44591759|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44591760|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44591762|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
44591763|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591764|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591765|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591766|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591767|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44591768|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591769|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591770|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44591771|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44591772|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44591773|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591774|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591775|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591776|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591777|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
44591778|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591779|NCT00863772|Tanezumab|tanezumab|mesh-list
44591780|NCT00863772|Analgesics|analgesics|mesh-ancestor
44591781|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
44591782|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591783|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591784|NCT00863746|Sorafenib|sorafenib|mesh-list
44591785|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591786|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591787|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591788|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591789|NCT00863707|Regadenoson|regadenoson|mesh-list
44591790|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44591791|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44591792|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
44591793|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
44591794|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591795|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591796|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591797|NCT00863681|Riociguat|riociguat|mesh-list
44591798|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
44591799|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591800|NCT00863655|Everolimus|everolimus|mesh-list
44591801|NCT00863655|Exemestane|exemestane|mesh-list
44591802|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591803|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591804|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
44591805|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591806|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44591807|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44591808|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419882|NCT05642702|Niacin|niacin|mesh-list
44591809|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591810|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44591811|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591812|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591813|NCT00863512|Gemcitabine|gemcitabine|mesh-list
44591814|NCT00863512|Cisplatin|cisplatin|mesh-list
44591815|NCT00863512|Docetaxel|docetaxel|mesh-list
44591816|NCT00863512|Pemetrexed|pemetrexed|mesh-list
44591817|NCT00863512|Vinorelbine|vinorelbine|mesh-list
44591818|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591819|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44591820|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
44591821|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591822|NCT00863512|Antiviral Agents|antiviral agents|mesh-ancestor
44591823|NCT00863512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591824|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591825|NCT00863512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591826|NCT00863512|Immunologic Factors|immunologic factors|mesh-ancestor
44591827|NCT00863512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591828|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
44591829|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
44591830|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
44591831|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43992115|NCT02512575|Hormones|hormones|mesh-ancestor
44591832|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591833|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44591834|NCT00863317|Montelukast|montelukast|mesh-list
44591835|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44591836|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
44591837|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44591838|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591839|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591840|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591841|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44591842|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44591843|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591844|NCT00863304|Naproxen|naproxen|mesh-list
44591845|NCT00863304|Tanezumab|tanezumab|mesh-list
44591846|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44591847|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44591848|NCT00863304|Analgesics|analgesics|mesh-ancestor
44591849|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
44591850|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591851|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591852|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591853|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591854|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
44591855|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44591856|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591857|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591858|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44591859|NCT00863057|Methadone|methadone|mesh-list
44591860|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44591861|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44591862|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44591863|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591864|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591865|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591866|NCT00863057|Analgesics|analgesics|mesh-ancestor
44591867|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
44591868|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591869|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44591870|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591871|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
44591872|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44591873|NCT00863057|Narcotics|narcotics|mesh-ancestor
44591874|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591875|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
44591876|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
44591877|NCT00862992|Cariprazine|cariprazine|mesh-list
44591878|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44591879|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44591880|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44591881|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591882|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44591883|NCT00862979|Cyclosporine|cyclosporine|mesh-list
44591884|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
44591885|NCT00862979|Everolimus|everolimus|mesh-list
44591886|NCT00862979|Tacrolimus|tacrolimus|mesh-list
44591887|NCT00862979|Cyclosporins|cyclosporins|mesh-list
44591888|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44591889|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
44591890|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591891|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44591892|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591893|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591894|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
44591895|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591896|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
44591897|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591898|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591899|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44591900|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44591901|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
44591902|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44591903|NCT00862940|Memantine|memantine|mesh-list
44591904|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44591905|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44591907|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44591908|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591909|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591910|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44591911|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44591912|NCT00862849|Insulin|insulin|mesh-list
44591913|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44591914|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
44591915|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44591916|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591917|NCT00862823|Tenofovir|tenofovir|mesh-list
44591918|NCT00862823|Emtricitabine|emtricitabine|mesh-list
44591919|NCT00862823|Efavirenz|efavirenz|mesh-list
44591920|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
44591921|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591922|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44212657|NCT00449410|Ezetimibe|ezetimibe|mesh-list
44591923|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44591924|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591925|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591926|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44591927|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44591928|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44591929|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591930|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44591931|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44591932|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44591933|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44591934|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44591935|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44591936|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591937|NCT00862719|Incretins|incretins|mesh-ancestor
44591938|NCT00862719|Hormones|hormones|mesh-ancestor
44591939|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591940|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44591941|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44591942|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591943|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591944|NCT00862654|Ketoconazole|ketoconazole|mesh-list
44591945|NCT00862654|Clobetasol|clobetasol|mesh-list
44591946|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
44591947|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44591948|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44591949|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44591950|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591951|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591952|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44591953|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44591954|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44591955|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591979|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44591980|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44591982|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
44591983|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44591984|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44591985|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44591986|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44591987|NCT00862082|Sorafenib|sorafenib|mesh-list
44591988|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44591989|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44591990|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44591991|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44591992|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44591993|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44591994|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
44591995|NCT00861757|Tadalafil|tadalafil|mesh-list
44591996|NCT00861757|Tamsulosin|tamsulosin|mesh-list
44591997|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
44591998|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44591999|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44592000|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592001|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592002|NCT00861757|Urological Agents|urological agents|mesh-ancestor
44592003|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44592004|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44592005|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44592006|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44592007|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592008|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592009|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44592010|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
44592011|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592012|NCT00861692|Argatroban|argatroban|mesh-list
44592013|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
44592014|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44592015|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592016|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592017|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592018|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
44592019|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44592020|NCT00861614|Ipilimumab|ipilimumab|mesh-list
44592021|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592022|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592023|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44592024|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592025|NCT00861471|Docetaxel|docetaxel|mesh-list
44592026|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
44592027|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592028|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44592029|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44592030|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44592031|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592032|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592033|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592034|NCT00861380|Vaccines|vaccines|mesh-list
44592035|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44592036|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
44592037|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592038|NCT00861341|Aspirin|aspirin|mesh-list
44592039|NCT00861341|Pioglitazone|pioglitazone|mesh-list
44592040|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44592041|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44592042|NCT00861341|Analgesics|analgesics|mesh-ancestor
44592043|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
44592044|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592045|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592046|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592047|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592048|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44592049|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44592050|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592051|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44592052|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44592053|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592054|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
44592055|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592056|NCT00860743|Antioxidants|antioxidants|mesh-list
44592057|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592058|NCT00860743|Protective Agents|protective agents|mesh-ancestor
44592059|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592060|NCT00860574|Methotrexate|methotrexate|mesh-list
44592061|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
44592062|NCT00860574|Fludarabine|fludarabine|mesh-list
44592063|NCT00860574|Treosulfan|treosulfan|mesh-list
44592064|NCT00860574|Tacrolimus|tacrolimus|mesh-list
44592065|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44592066|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
44592067|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44592068|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592069|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44592070|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
44592071|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592072|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592074|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592075|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44592076|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592077|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
44592078|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592079|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44592080|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44592081|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592082|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
44592083|NCT00860470|Iron|iron|mesh-list
44592084|NCT00860470|Trace Elements|trace elements|mesh-list
44592085|NCT00860470|Folic Acid|folic acid|mesh-list
44592086|NCT00860470|Micronutrients|micronutrients|mesh-list
44592087|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592088|NCT00860470|Hematinics|hematinics|mesh-ancestor
44592089|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
44592090|NCT00860470|Vitamins|vitamins|mesh-ancestor
44212789|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592091|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44592092|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
44592093|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
44592094|NCT00860262|Amlodipine|amlodipine|mesh-list
44592095|NCT00860262|Telmisartan|telmisartan|mesh-list
44592096|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44592097|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44592098|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44592099|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44592100|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592101|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592102|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592103|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592104|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44592105|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44592106|NCT00860158|Dasatinib|dasatinib|mesh-list
44592107|NCT00860158|Leuprolide|leuprolide|mesh-list
44592108|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592109|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592110|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592111|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592112|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44592113|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
44592114|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44592115|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592116|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44592117|NCT00860028|Varenicline|varenicline|mesh-list
44592118|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44592119|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44592120|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
44592121|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592122|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592123|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592124|NCT00859937|Dasatinib|dasatinib|mesh-list
44592125|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592126|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592127|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592138|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44592139|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44592140|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44592141|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592142|NCT00859469|Gemcitabine|gemcitabine|mesh-list
44592143|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
44592144|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44592145|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
44592146|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592147|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592148|NCT00859469|Antiviral Agents|antiviral agents|mesh-ancestor
44592149|NCT00859469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592150|NCT00859469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592151|NCT00859469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592152|NCT00859469|Immunologic Factors|immunologic factors|mesh-ancestor
44592153|NCT00859469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592154|NCT00859456|Sunitinib|sunitinib|mesh-list
44592155|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592156|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43992363|NCT02523196|Cholic Acids|cholic acids|mesh-list
44592157|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592159|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592160|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592161|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592162|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592163|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592164|NCT00859313|Sufentanil|sufentanil|mesh-list
44592165|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44592166|NCT00859313|Narcotics|narcotics|mesh-ancestor
44592167|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592168|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592169|NCT00859313|Analgesics|analgesics|mesh-ancestor
44592170|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
44592171|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592172|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44592173|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44592174|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
44592175|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
44592176|NCT00859222|Bevacizumab|bevacizumab|mesh-list
44592177|NCT00859222|Panobinostat|panobinostat|mesh-list
44592178|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592179|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592180|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592181|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592182|NCT00859222|Growth Substances|growth substances|mesh-ancestor
44592183|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592184|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592185|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44592186|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592187|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592188|NCT00858988|Rifaximin|rifaximin|mesh-list
44592189|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44592190|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592191|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44592192|NCT00858845|Clonidine|clonidine|mesh-list
44592193|NCT00858845|Analgesics|analgesics|mesh-ancestor
44592194|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
44592195|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592196|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592197|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44592198|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
44592199|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
44592200|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44592201|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44592202|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44592203|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
44592204|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592205|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592206|NCT00858832|Methylergonovine|methylergonovine|mesh-list
44592207|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
44592208|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44592209|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592210|NCT00858780|Etanercept|etanercept|mesh-list
44592211|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44592212|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44592227|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592228|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44592229|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44592230|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592231|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44592232|NCT00858403|Dasatinib|dasatinib|mesh-list
44592233|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592234|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592235|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592236|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592237|NCT00858247|Vitamin D|vitamin d|mesh-list
44592238|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
44592239|NCT00858247|Vitamins|vitamins|mesh-ancestor
44592240|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
44592241|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592242|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44592243|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592244|NCT00858234|Bortezomib|bortezomib|mesh-list
44592246|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592247|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44592248|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592249|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592250|NCT00858117|Rituximab|rituximab|mesh-list
44592251|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
44592252|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592253|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592254|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
44592255|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592256|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592257|NCT00857948|Ivermectin|ivermectin|mesh-list
44592258|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44592259|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592260|NCT00857896|Fesoterodine|fesoterodine|mesh-list
44592261|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44592262|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44592263|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
44592264|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592265|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592266|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592267|NCT00857896|Urological Agents|urological agents|mesh-ancestor
44592268|NCT00857818|Risperidone|risperidone|mesh-list
44592269|NCT00857818|Aripiprazole|aripiprazole|mesh-list
44592270|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44592271|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44592272|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
44592273|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592274|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592275|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592276|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592277|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592278|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592279|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592280|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44592281|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
44592282|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
44592283|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
44592284|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44592285|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44592286|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44592287|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44592288|NCT00857792|Regadenoson|regadenoson|mesh-list
44592289|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44592290|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44592291|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
44592292|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
44592293|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592294|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592295|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592296|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44592297|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44592298|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
44592299|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592300|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592301|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44592302|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
44592303|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
44592304|NCT00857766|Hormones|hormones|mesh-ancestor
44592305|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592306|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
44592307|NCT00857649|Memantine|memantine|mesh-list
44592308|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44592309|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44592310|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
44592311|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592312|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592313|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592314|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44592315|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44592316|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44592317|NCT00857584|Sertraline|sertraline|mesh-list
43992508|NCT02530151|Morphine|morphine|mesh-list
44592319|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592320|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592321|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592322|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592323|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592324|NCT00857584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44592325|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44592326|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44592327|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592328|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592329|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
44592330|NCT00857454|Testosterone|testosterone|mesh-list
44592331|NCT00857454|Androgens|androgens|mesh-ancestor
44592332|NCT00857454|Hormones|hormones|mesh-ancestor
44592333|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592334|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592335|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
44592336|NCT00857389|Busulfan|busulfan|mesh-list
44592337|NCT00857389|Thiotepa|thiotepa|mesh-list
44592338|NCT00857389|Methotrexate|methotrexate|mesh-list
44592339|NCT00857389|Clofarabine|clofarabine|mesh-list
44592340|NCT00857389|Tacrolimus|tacrolimus|mesh-list
44592341|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
44592342|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44592343|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592344|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
44592345|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592346|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592347|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592348|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
44213029|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592349|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592350|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592351|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44592352|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44592353|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
44592354|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44592355|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44592356|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
44592357|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
44592358|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592359|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44592360|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44592361|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44592362|NCT00857311|Vaccines|vaccines|mesh-list
44592363|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
44592364|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592365|NCT00857259|Everolimus|everolimus|mesh-list
44592366|NCT00857259|Ranibizumab|ranibizumab|mesh-list
44592367|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592368|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592369|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
44592370|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592371|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592372|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592373|NCT00857259|Growth Substances|growth substances|mesh-ancestor
44592374|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592375|NCT00857246|Cisplatin|cisplatin|mesh-list
44592376|NCT00857246|Irinotecan|irinotecan|mesh-list
44592377|NCT00857246|Cetuximab|cetuximab|mesh-list
44592378|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592379|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44592380|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44592381|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592382|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592383|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592384|NCT00857233|Memantine|memantine|mesh-list
44592385|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44592386|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44592387|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
44213063|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
44592388|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592389|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592390|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592391|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44592392|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44592394|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44592395|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592396|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592397|NCT00856986|Metformin|metformin|mesh-list
44592398|NCT00856986|Liraglutide|liraglutide|mesh-list
44592399|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
44592400|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592401|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592402|NCT00856986|Incretins|incretins|mesh-ancestor
44592403|NCT00856986|Hormones|hormones|mesh-ancestor
44592404|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592405|NCT00856973|Eszopiclone|eszopiclone|mesh-list
44592406|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44592407|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592408|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592409|NCT00856856|Everolimus|everolimus|mesh-list
44592410|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592411|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592412|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
44592413|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592414|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44592415|NCT00856843|Laxatives|laxatives|mesh-ancestor
44592416|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44592417|NCT00856830|Carboplatin|carboplatin|mesh-list
44592418|NCT00856830|Irinotecan|irinotecan|mesh-list
44592419|NCT00856830|Etoposide|etoposide|mesh-list
44592420|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44592421|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592422|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44592423|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44592424|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592425|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592426|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44592427|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44592428|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592429|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
44592430|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44592431|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44592432|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44592433|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592434|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
44592435|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
44592436|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44592437|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
44592438|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592439|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592440|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592441|NCT00856609|Exenatide|exenatide|mesh-list
44592442|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592443|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592444|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44592445|NCT00856609|Incretins|incretins|mesh-ancestor
44592446|NCT00856609|Hormones|hormones|mesh-ancestor
44592447|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592448|NCT00856583|Risperidone|risperidone|mesh-list
44592449|NCT00856583|Sertindole|sertindole|mesh-list
44592450|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44592451|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
44592452|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592453|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592454|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592455|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592456|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592457|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592458|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592459|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44592460|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
44592461|NCT00856544|Tofacitinib|tofacitinib|mesh-list
44592462|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592463|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592464|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592465|NCT00856492|Paclitaxel|paclitaxel|mesh-list
44592466|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
44592467|NCT00856492|Bevacizumab|bevacizumab|mesh-list
44592468|NCT00856492|Doxorubicin|doxorubicin|mesh-list
44592469|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44592470|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44592471|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44592472|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592473|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44592474|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44592475|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44592476|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592477|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592478|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
44592479|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592480|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592481|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592482|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
44592483|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44592484|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592485|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592486|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592487|NCT00856492|Growth Substances|growth substances|mesh-ancestor
44592488|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592489|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44592490|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44592491|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44592492|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592493|NCT00856388|Fludarabine|fludarabine|mesh-list
44592494|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
44592495|NCT00856388|Melphalan|melphalan|mesh-list
44592496|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
44592497|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44592498|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
44592499|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592500|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44592501|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
44592502|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592503|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592504|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
44592505|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592506|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592507|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
44592508|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44592509|NCT00856375|Irinotecan|irinotecan|mesh-list
44592510|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
44592511|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44592512|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44592513|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592514|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592515|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592516|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44592517|NCT00856323|Tenofovir|tenofovir|mesh-list
44592518|NCT00856323|Emtricitabine|emtricitabine|mesh-list
44592519|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44592520|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
44592521|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592522|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44592523|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44592524|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592525|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592526|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44592527|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44592528|NCT00856297|Vaccines|vaccines|mesh-list
44592529|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
44592530|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592531|NCT00856284|Metformin|metformin|mesh-list
44592532|NCT00856284|Alogliptin|alogliptin|mesh-list
44592533|NCT00856284|Glipizide|glipizide|mesh-list
44592534|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592535|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592536|NCT00856284|Incretins|incretins|mesh-ancestor
44592537|NCT00856284|Hormones|hormones|mesh-ancestor
44592538|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592539|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44592540|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592541|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592542|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592543|NCT00856245|Rituximab|rituximab|mesh-list
44592544|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592545|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592546|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
44592547|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592548|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592549|NCT00856206|Rilonacept|rilonacept|mesh-list
44592550|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592551|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
44592552|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44592553|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44592554|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44592555|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
44592556|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592557|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592558|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592559|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
44592560|NCT00856180|Bevacizumab|bevacizumab|mesh-list
44592561|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592562|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
44592563|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592564|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592565|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44592566|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
44592593|NCT00855920|Analgesics|analgesics|mesh-ancestor
44592594|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
44592595|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592596|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592597|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592598|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592599|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
44592600|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
44592601|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44592602|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44592603|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592604|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592605|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44592606|NCT00855894|Pertuzumab|pertuzumab|mesh-list
44592607|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592608|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592609|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592610|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213249|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
44592611|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420695|NCT05078060|Vaccines|vaccines|mesh-list
44592612|NCT00855738|Topiramate|topiramate|mesh-list
44592613|NCT00855738|Pregabalin|pregabalin|mesh-list
44592614|NCT00855738|Lamotrigine|lamotrigine|mesh-list
44592615|NCT00855738|Zonisamide|zonisamide|mesh-list
44592616|NCT00855738|Gabapentin|gabapentin|mesh-list
44592617|NCT00855738|Levetiracetam|levetiracetam|mesh-list
44592618|NCT00855738|Tiagabine|tiagabine|mesh-list
44592619|NCT00855738|Analgesics|analgesics|mesh-ancestor
44592620|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
44592621|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592622|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592623|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
44592624|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44592625|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44592626|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592627|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592628|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44592629|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592630|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592631|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592632|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44592633|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44592634|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592635|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
44592636|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592637|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
44592638|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44592639|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44592640|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44592641|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44592643|NCT00855595|Metronidazole|metronidazole|mesh-list
44592644|NCT00855595|Doxycycline|doxycycline|mesh-list
44592645|NCT00855595|Azelaic acid|azelaic acid|mesh-list
44592646|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592647|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44592648|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44592649|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44592650|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
44592651|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592652|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44592653|NCT00855582|Tadalafil|tadalafil|mesh-list
44592654|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592655|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44592656|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44592657|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592658|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592659|NCT00855582|Urological Agents|urological agents|mesh-ancestor
44592660|NCT00855465|Riociguat|riociguat|mesh-list
44592661|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
44592662|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592663|NCT00855439|Exenatide|exenatide|mesh-list
44592664|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592665|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213299|NCT00452192|Telmisartan|telmisartan|mesh-list
44592666|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44592667|NCT00855439|Incretins|incretins|mesh-ancestor
44592668|NCT00855439|Hormones|hormones|mesh-ancestor
44592669|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592670|NCT00855335|Ritonavir|ritonavir|mesh-list
44592671|NCT00855335|Darunavir|darunavir|mesh-list
44592672|NCT00855335|Cobicistat|cobicistat|mesh-list
44592673|NCT00855335|Rilpivirine|rilpivirine|mesh-list
44592674|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44592675|NCT00855335|Etravirine|etravirine|mesh-list
44592676|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44592677|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44592678|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592679|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592680|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592681|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44592682|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44592683|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
44592684|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592685|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44592686|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44592687|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44592688|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44592689|NCT00855309|Acyclovir|acyclovir|mesh-list
44592690|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
44592691|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592692|NCT00855218|Sorafenib|sorafenib|mesh-list
44592693|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592694|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592695|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592696|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592697|NCT00855166|Metformin|metformin|mesh-list
44592698|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44592699|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
44592700|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592701|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592702|NCT00855166|Incretins|incretins|mesh-ancestor
44592703|NCT00855166|Hormones|hormones|mesh-ancestor
44592704|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592705|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44592706|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592707|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592708|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592709|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44592710|NCT00855062|Minocycline|minocycline|mesh-list
44592711|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44592712|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592713|NCT00854724|Puerarin|puerarin|mesh-list
44592714|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592715|NCT00854620|Sorafenib|sorafenib|mesh-list
44592716|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992853|NCT02541409|Interferons|interferons|mesh-list
44213361|NCT00452556|Hormones|hormones|mesh-ancestor
44592717|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592718|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592719|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592720|NCT00854581|Interferons|interferons|mesh-list
44592721|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
44592722|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
44592723|NCT00854581|Zidovudine|zidovudine|mesh-list
44592724|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44592725|NCT00854581|Valproic Acid|valproic acid|mesh-list
44592726|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592727|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
44592728|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592729|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
44592730|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592731|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
44592732|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592733|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44592734|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44592735|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592736|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44592737|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44592738|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
44592739|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
44592740|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44592741|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
44592742|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592743|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592744|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592745|NCT00854373|Hormones|hormones|mesh-list
44592746|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44592747|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592748|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592749|NCT00854360|Beclomethasone|beclomethasone|mesh-list
44592750|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592751|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
44592752|NCT00854360|Hormones|hormones|mesh-ancestor
44592753|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592754|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592755|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44592756|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
44592757|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44592758|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592759|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592760|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592761|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592762|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44592763|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592764|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44420821|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
44592787|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44592788|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592789|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592790|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592791|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592792|NCT00853905|Triamcinolone|triamcinolone|mesh-list
44592793|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44592794|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44592795|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44592796|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44592797|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592798|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
44592799|NCT00853905|Hormones|hormones|mesh-ancestor
44592800|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592801|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592802|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44592803|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
44592804|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592805|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592806|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44592807|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
44592808|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592809|NCT00853723|Teriparatide|teriparatide|mesh-list
44592810|NCT00853723|Hormones|hormones|mesh-list
44592811|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
44592812|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44592813|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592814|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592815|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592816|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44592817|NCT00853658|Enalapril|enalapril|mesh-list
44592818|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44592819|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592820|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592821|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592822|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44592823|NCT00853580|Lovastatin|lovastatin|mesh-list
44592824|NCT00853580|L 647318|l 647318|mesh-list
44592825|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
44592826|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44592827|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44592828|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
44592829|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592830|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44592831|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44592832|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592833|NCT00853385|Adalimumab|adalimumab|mesh-list
44592834|NCT00853385|Tofacitinib|tofacitinib|mesh-list
44592835|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592836|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592837|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592838|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592839|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592840|NCT00853372|Sunitinib|sunitinib|mesh-list
44592841|NCT00853372|Trebananib|trebananib|mesh-list
44592842|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44592843|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592844|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592845|NCT00853372|Growth Substances|growth substances|mesh-ancestor
44592846|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592847|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592848|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592849|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592850|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592851|NCT00853242|Sevelamer|sevelamer|mesh-list
44592852|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
44592853|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
44592854|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592855|NCT00853229|Pregabalin|pregabalin|mesh-list
44592856|NCT00853229|Analgesics|analgesics|mesh-ancestor
44592857|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
44592858|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592859|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592860|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
44592861|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44592862|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44592863|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592864|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44592865|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44592866|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44592867|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592868|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592869|NCT00853125|Sunitinib|sunitinib|mesh-list
44592870|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592871|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592872|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592873|NCT00853125|Growth Substances|growth substances|mesh-ancestor
44592874|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592875|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592876|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44592877|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592878|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592879|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
44592880|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592881|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44592882|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44592883|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592884|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592885|NCT00853112|Urological Agents|urological agents|mesh-ancestor
44592886|NCT00853099|Adalimumab|adalimumab|mesh-list
44592887|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44592888|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44592889|NCT00853073|Bevacizumab|bevacizumab|mesh-list
44592890|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592891|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592892|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592893|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592894|NCT00853073|Growth Substances|growth substances|mesh-ancestor
44592895|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592896|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592897|NCT00853047|Octreotide|octreotide|mesh-list
44592898|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44592899|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44592900|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592901|NCT00853021|Aldesleukin|aldesleukin|mesh-list
44592902|NCT00853021|Bevacizumab|bevacizumab|mesh-list
44592903|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592904|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592905|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44592906|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44592907|NCT00853021|Growth Substances|growth substances|mesh-ancestor
44592908|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592909|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44592910|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44592911|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44592912|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
44592913|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592914|NCT00852969|Niacin|niacin|mesh-list
44592915|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44592916|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
44592917|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592918|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44592919|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
44592920|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
44592921|NCT00852969|Vitamins|vitamins|mesh-ancestor
44592922|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
44592923|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592924|NCT00852917|Tramadol|tramadol|mesh-list
44592925|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44592926|NCT00852917|Narcotics|narcotics|mesh-ancestor
44592927|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44592928|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592929|NCT00852917|Analgesics|analgesics|mesh-ancestor
44592930|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
44592931|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44592932|NCT00852540|Linezolid|linezolid|mesh-list
44592933|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44592934|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592935|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44592957|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44592959|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
44592960|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44592961|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44592962|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44592963|NCT00851903|Incretins|incretins|mesh-ancestor
44592964|NCT00851903|Hormones|hormones|mesh-ancestor
44592965|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44592966|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44592967|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592968|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592969|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592970|NCT00851890|Interferons|interferons|mesh-list
44592971|NCT00851890|Ribavirin|ribavirin|mesh-list
44592972|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592973|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
44592974|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44592975|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
44592976|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592977|NCT00851877|Paclitaxel|paclitaxel|mesh-list
44592978|NCT00851877|Cisplatin|cisplatin|mesh-list
44592979|NCT00851877|Cetuximab|cetuximab|mesh-list
44592980|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44592981|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44592982|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44592983|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44592984|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44592985|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592986|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44592987|NCT00851799|Ritonavir|ritonavir|mesh-list
44592988|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44592989|NCT00851799|Darunavir|darunavir|mesh-list
44592990|NCT00851799|Tenofovir|tenofovir|mesh-list
44592991|NCT00851799|Emtricitabine|emtricitabine|mesh-list
44592992|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
44592993|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44592994|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44592995|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44592996|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
44592997|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44592998|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44592999|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44593000|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44593001|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
44593002|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593003|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44593004|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44593005|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44593006|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44593007|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44593008|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44593009|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
44593010|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44593011|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593012|NCT00851721|Factor VIII|factor viii|mesh-list
44593013|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44593014|NCT00851721|Coagulants|coagulants|mesh-ancestor
44593015|NCT00851630|Lamivudine|lamivudine|mesh-list
44593016|NCT00851630|Zidovudine|zidovudine|mesh-list
44593017|NCT00851630|Abacavir|abacavir|mesh-list
44593018|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44593019|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44593020|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593021|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593022|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
44593023|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593024|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44593025|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44593026|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
44593027|NCT00851591|Psyllium|psyllium|mesh-list
44593028|NCT00851591|Cathartics|cathartics|mesh-ancestor
44593029|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593030|NCT00851552|Rituximab|rituximab|mesh-list
44593031|NCT00851552|Doxorubicin|doxorubicin|mesh-list
44593032|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44593033|NCT00851552|Bortezomib|bortezomib|mesh-list
44593034|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593035|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593036|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
44593037|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593038|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593039|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44593040|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44593041|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44593042|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593043|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593044|NCT00851318|Methotrexate|methotrexate|mesh-list
44593045|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
44593046|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44593047|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
44593048|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44593049|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593050|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593051|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
44593052|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593053|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593054|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593055|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593056|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44593057|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593058|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
44593059|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593060|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44593061|NCT00851084|Leucovorin|leucovorin|mesh-list
44421119|NCT04666636|Mirabegron|mirabegron|mesh-list
44593062|NCT00851084|Folic Acid|folic acid|mesh-list
44593063|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
44593064|NCT00851084|Aflibercept|aflibercept|mesh-list
44593065|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
44593066|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593067|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44593068|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44593069|NCT00851084|Growth Substances|growth substances|mesh-ancestor
44593070|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593071|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593072|NCT00851084|Antidotes|antidotes|mesh-ancestor
44593073|NCT00851084|Protective Agents|protective agents|mesh-ancestor
44593074|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
44593075|NCT00851084|Vitamins|vitamins|mesh-ancestor
44593076|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
44593077|NCT00851084|Hematinics|hematinics|mesh-ancestor
44593078|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44593079|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593080|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593081|NCT00850564|Hormones|hormones|mesh-list
44593082|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44593083|NCT00850564|Tesamorelin|tesamorelin|mesh-list
44593084|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593085|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593086|NCT00850564|Growth Substances|growth substances|mesh-ancestor
44593087|NCT00850499|Rituximab|rituximab|mesh-list
44593088|NCT00850499|Fludarabine|fludarabine|mesh-list
44593089|NCT00850499|Bortezomib|bortezomib|mesh-list
44593090|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593091|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593092|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
44593093|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593094|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593096|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44593097|NCT00850460|Simvastatin|simvastatin|mesh-list
44593098|NCT00850460|Pravastatin|pravastatin|mesh-list
44593099|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44593100|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44593101|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
44593102|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593103|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44593104|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44593105|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593106|NCT00850395|Maraviroc|maraviroc|mesh-list
44593107|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44593108|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44593109|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593110|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44593111|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44593112|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
44593113|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593114|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44593115|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
44593116|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593117|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
44593118|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593119|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593120|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44593121|NCT00849901|Fluoxetine|fluoxetine|mesh-list
44593122|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44593123|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44593124|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593125|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593126|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593127|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593128|NCT00849901|Analgesics|analgesics|mesh-ancestor
44593129|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
44593130|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593131|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
44593132|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593133|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
44593134|NCT00849901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44593135|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
44593136|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44593137|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44593138|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44593139|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593140|NCT00849875|Dacarbazine|dacarbazine|mesh-list
44593142|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44593143|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
44593144|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593145|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593146|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593147|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44593148|NCT00849693|Fluoxetine|fluoxetine|mesh-list
44593149|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44593150|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44593151|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593152|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593153|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593154|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593155|NCT00849693|Analgesics|analgesics|mesh-ancestor
44593156|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
44593157|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593158|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
44593159|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593160|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
44593161|NCT00849693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44593162|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
44593163|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44593164|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44593165|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44421268|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44593166|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593167|NCT00849680|Vaccines|vaccines|mesh-list
44593168|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
44593169|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593170|NCT00849472|Paclitaxel|paclitaxel|mesh-list
44593171|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
44593172|NCT00849472|Doxorubicin|doxorubicin|mesh-list
44593173|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593174|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593175|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593176|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593177|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593178|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593179|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593180|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
44593181|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593182|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593183|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44593184|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
44593185|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44593186|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44593187|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44593188|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44593189|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593190|NCT00849186|Sunitinib|sunitinib|mesh-list
44593191|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593192|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44593193|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44593194|NCT00849186|Growth Substances|growth substances|mesh-ancestor
44593195|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593196|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593197|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593198|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593199|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593200|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
44593201|NCT00849056|Incretins|incretins|mesh-ancestor
44593202|NCT00849056|Hormones|hormones|mesh-ancestor
44593203|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593204|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593205|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
44593206|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44593207|NCT00849017|Incretins|incretins|mesh-ancestor
44593208|NCT00849017|Hormones|hormones|mesh-ancestor
44593209|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593210|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593211|NCT00848965|Fluticasone|fluticasone|mesh-list
44593213|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593214|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593215|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
44593216|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593217|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593218|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593219|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593220|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593221|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44593222|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44593223|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593224|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593225|NCT00848718|Paclitaxel|paclitaxel|mesh-list
44593226|NCT00848718|Docetaxel|docetaxel|mesh-list
44593227|NCT00848718|Carboplatin|carboplatin|mesh-list
44593228|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44593229|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593230|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593231|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593232|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593233|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593234|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593235|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593236|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593237|NCT00848549|Carbamazepine|carbamazepine|mesh-list
44593238|NCT00848549|Zonisamide|zonisamide|mesh-list
44593239|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
44593240|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
44421347|NCT04562285|Antibodies|antibodies|mesh-list
44593241|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44593265|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44593266|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593267|NCT00848497|Androgens|androgens|mesh-ancestor
44593268|NCT00848497|Hormones|hormones|mesh-ancestor
44593269|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593270|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593271|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44593272|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593273|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
44593274|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
44593275|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44593276|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44593277|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593278|NCT00848497|Urological Agents|urological agents|mesh-ancestor
44593279|NCT00848393|Fentanyl|fentanyl|mesh-list
44593280|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
44593281|NCT00848393|Citric Acid|citric acid|mesh-list
44593282|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
44593283|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44593284|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593285|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593286|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593287|NCT00848393|Analgesics|analgesics|mesh-ancestor
44593288|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
44593289|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593290|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44593291|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44593292|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44593293|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
44593294|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593295|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593296|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44593298|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44593299|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44593300|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
44593301|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
44593302|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
44593303|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44593304|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
44593305|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
44593306|NCT00848354|Etanercept|etanercept|mesh-list
44593307|NCT00848354|Methotrexate|methotrexate|mesh-list
44593308|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44593309|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
44593310|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44593311|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593312|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593313|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
44593314|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593315|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593316|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593317|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593318|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44593319|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593320|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
44593321|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593322|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44593323|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44213807|NCT00454831|Chitosan|chitosan|mesh-list
44593324|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593325|NCT00848354|Analgesics|analgesics|mesh-ancestor
44593326|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
44593327|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593328|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593329|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593330|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44593331|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44593332|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
44593333|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593334|NCT00848107|Treprostinil|treprostinil|mesh-list
44593335|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593336|NCT00848081|Tadalafil|tadalafil|mesh-list
44593337|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
44593338|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44593339|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44593340|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593341|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593342|NCT00848081|Urological Agents|urological agents|mesh-ancestor
44593343|NCT00847912|Fluorouracil|fluorouracil|mesh-list
44593344|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
44593345|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593346|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593347|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593348|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593349|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
44593350|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593351|NCT00847886|Methotrexate|methotrexate|mesh-list
44593352|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44593353|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
44593354|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44593355|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593356|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593357|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
44593358|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593359|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593360|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593361|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593362|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44593363|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593364|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
44593365|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593366|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44593367|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
44593368|NCT00847808|Lansoprazole|lansoprazole|mesh-list
44593369|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44593370|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593371|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44593372|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593373|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593374|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
44593375|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44593376|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44593377|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44593378|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593379|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593381|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
44593382|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593383|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44593384|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593385|NCT00847613|Tofacitinib|tofacitinib|mesh-list
44593386|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593387|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593388|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593389|NCT00847405|Sumatriptan|sumatriptan|mesh-list
44593390|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44593391|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44593392|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44593393|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
44593394|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593395|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593396|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593397|NCT00847145|Vaccines|vaccines|mesh-list
44593398|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
44213894|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593399|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593400|NCT00847015|Gemcitabine|gemcitabine|mesh-list
44593401|NCT00847015|Cisplatin|cisplatin|mesh-list
44593402|NCT00847015|Sunitinib|sunitinib|mesh-list
44593403|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593404|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593405|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
44593406|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593407|NCT00847015|Antiviral Agents|antiviral agents|mesh-ancestor
44593408|NCT00847015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593409|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593410|NCT00847015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593411|NCT00847015|Immunologic Factors|immunologic factors|mesh-ancestor
44593412|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593413|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44593414|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44593415|NCT00847015|Growth Substances|growth substances|mesh-ancestor
44593416|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593417|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593418|NCT00846768|Olodaterol|olodaterol|mesh-list
44593419|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593420|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
44593421|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593422|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593423|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593424|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593425|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
44593426|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593427|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
44593428|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593429|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593430|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593431|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593432|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
44593433|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44593434|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
44593435|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593436|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593437|NCT00846521|Acarbose|acarbose|mesh-list
44593438|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44593439|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593440|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593441|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44593442|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593443|NCT00846495|Topiramate|topiramate|mesh-list
44593444|NCT00846495|Frovatriptan|frovatriptan|mesh-list
44593445|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
44593446|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44593447|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593448|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44593449|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
44593450|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593451|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593453|NCT00846365|Olmesartan|olmesartan|mesh-list
44593454|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44593455|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
44593456|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44593457|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593458|NCT00846365|Diuretics|diuretics|mesh-ancestor
44593459|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
44593460|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593461|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44593462|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593463|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593464|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44593465|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44593466|NCT00846040|Fallypride|fallypride|mesh-list
44593467|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44593468|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44593469|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
44593470|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593471|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593472|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593473|NCT00846027|Gemcitabine|gemcitabine|mesh-list
44593474|NCT00846027|Paclitaxel|paclitaxel|mesh-list
44593475|NCT00846027|Bevacizumab|bevacizumab|mesh-list
44593476|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593477|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593478|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593479|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593480|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593481|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593482|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593483|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44593484|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44593485|NCT00846027|Growth Substances|growth substances|mesh-ancestor
44593486|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593487|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593488|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593489|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
44593490|NCT00846027|Antiviral Agents|antiviral agents|mesh-ancestor
44593491|NCT00846027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593492|NCT00846027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593493|NCT00846027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593494|NCT00846027|Immunologic Factors|immunologic factors|mesh-ancestor
44593495|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
44593496|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44593497|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593498|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593499|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
44593500|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593501|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593502|NCT00845871|Deferasirox|deferasirox|mesh-list
44593503|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44593504|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
44593505|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
44593506|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593507|NCT00845858|Metoclopramide|metoclopramide|mesh-list
44593508|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
44593509|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
44593510|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593511|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593512|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421622|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
44593513|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44593514|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44593515|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
44593516|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593517|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593519|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593520|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593521|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
44593522|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593523|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593524|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
44593525|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593526|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
44593527|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593528|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593529|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593530|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593531|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
44593532|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44593533|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
44593534|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593535|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593537|NCT00845676|Ribavirin|ribavirin|mesh-list
44593538|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
44593539|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
44593540|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44593541|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593542|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
44593543|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593544|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
44214017|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593545|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593546|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
44593547|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593548|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
44593549|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
44593550|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44593551|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44593552|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
44593553|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593554|NCT00845429|Vaccines|vaccines|mesh-list
44593555|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
44593556|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593557|NCT00845182|Pioglitazone|pioglitazone|mesh-list
44593558|NCT00845182|Exenatide|exenatide|mesh-list
44593559|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44593560|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593561|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44593562|NCT00845182|Incretins|incretins|mesh-ancestor
44593563|NCT00845182|Hormones|hormones|mesh-ancestor
44593564|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593565|NCT00845065|Ribavirin|ribavirin|mesh-list
44593566|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44593567|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
44593568|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593569|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
44593570|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593571|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
44593572|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593573|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593574|NCT00844883|Sorafenib|sorafenib|mesh-list
44593575|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593576|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593577|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593578|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593579|NCT00844857|Olanzapine|olanzapine|mesh-list
44593580|NCT00844857|Fluoxetine|fluoxetine|mesh-list
44593581|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
44593582|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
44593583|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593584|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593585|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593586|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44593587|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44593588|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593604|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
44593605|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593607|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43869055|NCT00194090|Celecoxib|celecoxib|mesh-list
44593608|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593609|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593610|NCT00844805|Naproxen|naproxen|mesh-list
44593611|NCT00844805|Infliximab|infliximab|mesh-list
44593612|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593613|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44593614|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593615|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44593616|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593617|NCT00844805|Analgesics|analgesics|mesh-ancestor
44593618|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
44593619|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593620|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593621|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593622|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
44593623|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44593624|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593625|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593626|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44593627|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44593628|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44593629|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593630|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593631|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44593632|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593633|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593634|NCT00844649|Gemcitabine|gemcitabine|mesh-list
44593635|NCT00844649|Paclitaxel|paclitaxel|mesh-list
44593636|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44593637|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593638|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593639|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593640|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593641|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593642|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214125|NCT00456027|Antacids|antacids|mesh-ancestor
44593643|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593644|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
44593645|NCT00844649|Antiviral Agents|antiviral agents|mesh-ancestor
44593646|NCT00844649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593647|NCT00844649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593648|NCT00844649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593649|NCT00844649|Immunologic Factors|immunologic factors|mesh-ancestor
44593650|NCT00844649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593651|NCT00844545|Eculizumab|eculizumab|mesh-list
44593652|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44593653|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593654|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
44593655|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593656|NCT00844519|Maraviroc|maraviroc|mesh-list
44593657|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44593658|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44593659|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593660|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44593661|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44593662|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
44593663|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593664|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44593665|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
44593666|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44593667|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593668|NCT00844428|Eculizumab|eculizumab|mesh-list
44593669|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44593670|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593671|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
44593672|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593673|NCT00844415|Dabigatran|dabigatran|mesh-list
44593674|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
44593675|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44593676|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44593677|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593678|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593679|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
44593680|NCT00844376|Atorvastatin|atorvastatin|mesh-list
44593681|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44593682|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44593683|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
44593684|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593685|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44593686|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44593687|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593688|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44593689|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44593690|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44593691|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593692|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593694|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593695|NCT00844194|Analgesics|analgesics|mesh-ancestor
44593696|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
44593697|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593698|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
44593699|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593700|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
44593701|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
44593702|NCT00843856|Tacrolimus|tacrolimus|mesh-list
44593703|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593704|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
44593705|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593706|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44593707|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593708|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593709|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44593710|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593711|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44593712|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
44593713|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44593714|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593715|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
44593716|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593717|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
44593718|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593719|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593720|NCT00843635|Tadalafil|tadalafil|mesh-list
44593721|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
44593722|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44593723|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44593724|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593725|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593726|NCT00843635|Urological Agents|urological agents|mesh-ancestor
44593727|NCT00843492|PENTA|penta|mesh-list
44593728|NCT00843492|Nadroparin|nadroparin|mesh-list
44593729|NCT00843492|Fondaparinux|fondaparinux|mesh-list
44593730|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44593731|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
44593732|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44593733|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
44593734|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593735|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593736|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
44593737|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44593738|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44593739|NCT00843284|Pregabalin|pregabalin|mesh-list
44593740|NCT00843284|Analgesics|analgesics|mesh-ancestor
44593741|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
44593742|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593743|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593744|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
44593745|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44456811|NCT01622673|TEMPO|tempo|mesh-list
44593746|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593747|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593748|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44593749|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44593750|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44593751|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593752|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593753|NCT00843193|Fluticasone|fluticasone|mesh-list
44593754|NCT00843193|Xhance|xhance|mesh-list
44593755|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593756|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593757|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
44593758|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593759|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593760|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593761|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593762|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593763|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44593764|NCT00843115|Donepezil|donepezil|mesh-list
44593765|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44593766|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593767|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593768|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
44593769|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593770|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593771|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
44593772|NCT00843024|Naproxen|naproxen|mesh-list
44593773|NCT00843024|Sumatriptan|sumatriptan|mesh-list
44593774|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44593775|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593776|NCT00843024|Analgesics|analgesics|mesh-ancestor
44593777|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
44593778|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593779|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593780|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593781|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593782|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
44593783|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44593784|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593785|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593786|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44593787|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44593788|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44593789|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
44593790|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593791|NCT00842985|Dronabinol|dronabinol|mesh-list
44593792|NCT00842985|Modafinil|modafinil|mesh-list
44593793|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44593794|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593795|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44593796|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44593797|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44593798|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593799|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
44593800|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593801|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44593802|NCT00842985|Analgesics|analgesics|mesh-ancestor
44593806|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44593807|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593809|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593810|NCT00842829|Fentanyl|fentanyl|mesh-list
44593811|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44593812|NCT00842829|Narcotics|narcotics|mesh-ancestor
44593813|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593814|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593815|NCT00842829|Analgesics|analgesics|mesh-ancestor
44593816|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
44593817|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593818|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44593819|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44593820|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
44593821|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
44593822|NCT00842712|Gemcitabine|gemcitabine|mesh-list
44593823|NCT00842712|Cisplatin|cisplatin|mesh-list
44593824|NCT00842712|Cetuximab|cetuximab|mesh-list
44593825|NCT00842712|Vinorelbine|vinorelbine|mesh-list
44593826|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593827|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593828|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
44593829|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593830|NCT00842712|Antiviral Agents|antiviral agents|mesh-ancestor
44593831|NCT00842712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593832|NCT00842712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593833|NCT00842712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593834|NCT00842712|Immunologic Factors|immunologic factors|mesh-ancestor
44593835|NCT00842712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593836|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593837|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593838|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593839|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593840|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593841|NCT00842530|Vaccines|vaccines|mesh-list
44593842|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
44593843|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593844|NCT00842361|Insulin|insulin|mesh-list
44593845|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44593846|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
44593847|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
44593848|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44593849|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
44593850|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44593851|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44593852|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593853|NCT00842309|Cycloserine|cycloserine|mesh-list
44593854|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44593855|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593856|NCT00842309|Renal Agents|renal agents|mesh-ancestor
44593857|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44593858|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
44593859|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44593860|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
44593861|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593862|NCT00842257|Panitumumab|panitumumab|mesh-list
44593863|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44593864|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593865|NCT00842244|Cisplatin|cisplatin|mesh-list
44593866|NCT00842244|Capecitabine|capecitabine|mesh-list
44593867|NCT00842244|Axitinib|axitinib|mesh-list
44593868|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593869|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44593870|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
44593871|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593872|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593873|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593874|NCT00842153|Clobetasol|clobetasol|mesh-list
44593875|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44593877|NCT00842153|Hormones|hormones|mesh-ancestor
44593878|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593879|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593880|NCT00841763|Vaccines|vaccines|mesh-list
44593881|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
44593882|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593883|NCT00841672|Amlodipine|amlodipine|mesh-list
44593884|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593885|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44593886|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593887|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593888|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44593889|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593890|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
44593891|NCT00841568|Tolvaptan|tolvaptan|mesh-list
44593892|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44593893|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593894|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
44593895|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593896|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44593897|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593898|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593899|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593900|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593901|NCT00840996|Lidocaine|lidocaine|mesh-list
44593902|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
44593903|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
44593904|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593905|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593906|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
44593907|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593908|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44593909|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44593910|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44593911|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44593912|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593913|NCT00840827|Cyclosporine|cyclosporine|mesh-list
44593915|NCT00840827|Cyclosporins|cyclosporins|mesh-list
44593916|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593917|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593918|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593919|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
44593920|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593921|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
44593922|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593923|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44593924|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44593925|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44593926|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44593927|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44593928|NCT00840827|Growth Substances|growth substances|mesh-ancestor
44593929|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
44593930|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593931|NCT00840463|Ambrisentan|ambrisentan|mesh-list
44593932|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44593933|NCT00840450|Paclitaxel|paclitaxel|mesh-list
44593934|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44593935|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
44593936|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44593937|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593938|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
44593939|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
44593940|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
44593941|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593942|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44593943|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593944|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
44593945|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44593946|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44593947|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44593948|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44593949|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593950|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593951|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593952|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44593953|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44593954|NCT00839956|Bortezomib|bortezomib|mesh-list
44593955|NCT00839956|Vorinostat|vorinostat|mesh-list
44593956|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44593957|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44593958|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44593959|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593960|NCT00839852|Cariprazine|cariprazine|mesh-list
44593961|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44593962|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44593963|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44593964|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593965|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44593966|NCT00839800|Terbutaline|terbutaline|mesh-list
44593967|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44593968|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44593969|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
44593970|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44593971|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
44593972|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44593973|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593974|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
44593975|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
44593976|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44593977|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44593978|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44593979|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44593980|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44593981|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44593982|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44593983|NCT00839527|Metformin|metformin|mesh-list
44593984|NCT00839527|Pioglitazone|pioglitazone|mesh-list
44593985|NCT00839527|Glimepiride|glimepiride|mesh-list
44593986|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
44593987|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44593988|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44593989|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44593990|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44593991|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44593992|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
44593993|NCT00839527|Incretins|incretins|mesh-ancestor
44593994|NCT00839527|Hormones|hormones|mesh-ancestor
44593995|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44593996|NCT00839423|Vortioxetine|vortioxetine|mesh-list
44593997|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44593998|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44593999|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594000|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594001|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594002|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594003|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594004|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44594005|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594006|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594007|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44594008|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44594009|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594010|NCT00839423|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44594011|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
44594012|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44594013|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44594014|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44594015|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44594016|NCT00839332|Gemcitabine|gemcitabine|mesh-list
44594017|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44594018|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
44594019|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594021|NCT00839332|Antiviral Agents|antiviral agents|mesh-ancestor
44594022|NCT00839332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594023|NCT00839332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594024|NCT00839332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594025|NCT00839332|Immunologic Factors|immunologic factors|mesh-ancestor
44594026|NCT00839332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594027|NCT00839306|Rabeprazole|rabeprazole|mesh-list
44594028|NCT00839306|Ranitidine|ranitidine|mesh-list
44594029|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44594030|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594031|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594032|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44594033|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594034|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214452|NCT00457678|Hormones|hormones|mesh-ancestor
44594035|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44594036|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
44594037|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
44594038|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594039|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594040|NCT00839254|Vaccines|vaccines|mesh-list
44594041|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44594042|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
44594043|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594044|NCT00839072|Trazodone|trazodone|mesh-list
44594045|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44594046|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44594047|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594048|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594049|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594050|NCT00839072|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44594051|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594052|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594053|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594054|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594055|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
44594056|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44594057|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594058|NCT00838929|Vorinostat|vorinostat|mesh-list
44594059|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594060|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44594061|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770625|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594062|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594063|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
44594064|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
44594065|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594066|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594067|NCT00838916|Incretins|incretins|mesh-ancestor
44594068|NCT00838916|Hormones|hormones|mesh-ancestor
44594069|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594070|NCT00838903|Metformin|metformin|mesh-list
44594071|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44594072|NCT00838903|Glimepiride|glimepiride|mesh-list
44594073|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
44594074|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44594075|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594076|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594077|NCT00838903|Incretins|incretins|mesh-ancestor
44594078|NCT00838903|Hormones|hormones|mesh-ancestor
44594079|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594080|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44594081|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594082|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594083|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214507|NCT00457964|Everolimus|everolimus|mesh-list
44594084|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44594085|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594086|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
44594087|NCT00838682|Omeprazole|omeprazole|mesh-list
44594088|NCT00838682|Rabeprazole|rabeprazole|mesh-list
44594089|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594090|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594091|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44594092|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594093|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594095|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44594096|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44594097|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594098|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594099|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594100|NCT00838539|Sirolimus|sirolimus|mesh-list
44594101|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44594102|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594103|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44594104|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594105|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
44594106|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594107|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
44594108|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594109|NCT00838526|Rabeprazole|rabeprazole|mesh-list
44594110|NCT00838526|Ranitidine|ranitidine|mesh-list
44594111|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44594112|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594113|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594114|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44594115|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594116|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594117|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44594118|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
44594119|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
44456838|NCT01622569|Xhance|xhance|mesh-list
44594120|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594121|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594122|NCT00838513|Eculizumab|eculizumab|mesh-list
44594123|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44594124|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594125|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
44594126|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594127|NCT00838435|Verapamil|verapamil|mesh-list
44594128|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44594129|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44594130|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594131|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594132|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44594133|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594134|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44594135|NCT00838201|Denosumab|denosumab|mesh-list
44594136|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44594137|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594139|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44594140|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44594141|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
44594142|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44594143|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
44594144|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594145|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594146|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
44594147|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
44594148|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44594149|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44594150|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44594151|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44594152|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
44594153|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594154|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594155|NCT00837876|Sorafenib|sorafenib|mesh-list
44594156|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594157|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594158|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594159|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594160|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44594161|NCT00837759|Lansoprazole|lansoprazole|mesh-list
44594162|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
44594163|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594164|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594165|NCT00837759|Incretins|incretins|mesh-ancestor
44594166|NCT00837759|Hormones|hormones|mesh-ancestor
44594167|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594168|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44594170|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594171|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594172|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594173|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594174|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44594175|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44594176|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44594177|NCT00837616|Estradiol|estradiol|mesh-list
44594178|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44594179|NCT00837616|Estrogens|estrogens|mesh-ancestor
44594180|NCT00837616|Hormones|hormones|mesh-ancestor
44594181|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594182|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594183|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44594184|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
44594185|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44594186|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44594187|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44594188|NCT00837577|Voglibose|voglibose|mesh-list
44594189|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594190|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594191|NCT00837577|Incretins|incretins|mesh-ancestor
44594192|NCT00837577|Hormones|hormones|mesh-ancestor
44594193|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594194|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44594195|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594196|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594197|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594198|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44594199|NCT00837434|Adalimumab|adalimumab|mesh-list
44594200|NCT00837434|Etanercept|etanercept|mesh-list
44594201|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594202|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594203|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44594204|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44594205|NCT00837434|Analgesics|analgesics|mesh-ancestor
44594206|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
44214624|NCT00458419|Naloxone|naloxone|mesh-list
44594207|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594208|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594209|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594210|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594211|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
44594212|NCT00837330|Ranibizumab|ranibizumab|mesh-list
44594213|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44594214|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44594215|NCT00837330|Growth Substances|growth substances|mesh-ancestor
44594216|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594217|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44594218|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594219|NCT00837213|Doxycycline|doxycycline|mesh-list
44594220|NCT00837213|Clindamycin|clindamycin|mesh-list
44594221|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
44594222|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
44594223|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44594224|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44594225|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594226|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
44594227|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44594228|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44594229|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44594230|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594231|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594232|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
44594233|NCT00837148|Sorafenib|sorafenib|mesh-list
44594234|NCT00837148|Dacarbazine|dacarbazine|mesh-list
44594235|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594236|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594237|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594238|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594239|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44594240|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
44594241|NCT00836927|Sirolimus|sirolimus|mesh-list
44594242|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44594243|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594244|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44594245|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594246|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
44594247|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594248|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
44594249|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594250|NCT00836875|Voriconazole|voriconazole|mesh-list
44594251|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
44594252|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594253|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44594254|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44594255|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594256|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594257|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44594258|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
44594259|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594260|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594261|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44594263|NCT00836810|Prednisolone|prednisolone|mesh-list
44594264|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594265|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
44594266|NCT00836810|Hormones|hormones|mesh-ancestor
44594267|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594268|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594269|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44594270|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594271|NCT00836693|Tadalafil|tadalafil|mesh-list
44594272|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
44594273|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44594274|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44594275|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594276|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594277|NCT00836693|Urological Agents|urological agents|mesh-ancestor
44594278|NCT00836277|Irinotecan|irinotecan|mesh-list
44594279|NCT00836277|Panitumumab|panitumumab|mesh-list
44594280|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44594281|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44594282|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422457|NCT03505320|Leucovorin|leucovorin|mesh-list
44594283|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594284|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838344|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44594285|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44594286|NCT00835978|Axitinib|axitinib|mesh-list
44594287|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594288|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594289|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594290|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594291|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44594292|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44594293|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594294|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
44594295|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594296|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
44594297|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
44594298|NCT00835731|Misoprostol|misoprostol|mesh-list
44594299|NCT00835731|Vitamins|vitamins|mesh-ancestor
44594300|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
44594301|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594302|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44594303|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
44594304|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44594305|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594306|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594307|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
44594308|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
44594309|NCT00835731|Hematinics|hematinics|mesh-ancestor
44594310|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44594311|NCT00835679|Cetuximab|cetuximab|mesh-list
44594312|NCT00835679|Dasatinib|dasatinib|mesh-list
44594313|NCT00835679|Antibodies|antibodies|mesh-list
44594314|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
44594315|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44594316|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
44594317|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594318|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594319|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594320|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594321|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594322|NCT00835120|Pioglitazone|pioglitazone|mesh-list
44594323|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594324|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594325|NCT00834912|Tramadol|tramadol|mesh-list
44594326|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594327|NCT00834912|Narcotics|narcotics|mesh-ancestor
44594328|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594329|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594330|NCT00834912|Analgesics|analgesics|mesh-ancestor
44594331|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
44594332|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594333|NCT00834899|Eptifibatide|eptifibatide|mesh-list
44594334|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44594335|NCT00834834|Fluoxetine|fluoxetine|mesh-list
44594336|NCT00834834|Citalopram|citalopram|mesh-list
44594337|NCT00834834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44594338|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594339|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594340|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594341|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594342|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
44594343|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594344|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44594345|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594346|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594347|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44594348|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44594349|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594351|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594352|NCT00834366|Narcotics|narcotics|mesh-ancestor
44594353|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594354|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594355|NCT00834366|Analgesics|analgesics|mesh-ancestor
44594356|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
44594357|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594358|NCT00834080|Naltrexone|naltrexone|mesh-list
44594359|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44594360|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44594361|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838345|NCT04846231|Red yeast rice|red yeast rice|mesh-list
44594362|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
44594363|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594364|NCT00833911|Tramadol|tramadol|mesh-list
44594365|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594366|NCT00833911|Narcotics|narcotics|mesh-ancestor
44594367|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594368|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594369|NCT00833911|Analgesics|analgesics|mesh-ancestor
44594370|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
44594371|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594372|NCT00833833|Aspirin|aspirin|mesh-list
44594373|NCT00833833|Dexamethasone|dexamethasone|mesh-list
44594374|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
44594375|NCT00833833|Pomalidomide|pomalidomide|mesh-list
44594376|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44594377|NCT00833833|BB 1101|bb 1101|mesh-list
44594378|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594379|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
44594380|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
44594381|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594382|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594383|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594384|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
44594385|NCT00833833|Hormones|hormones|mesh-ancestor
44594386|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594387|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44594388|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594389|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594390|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594391|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594392|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44594393|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44594394|NCT00833833|Analgesics|analgesics|mesh-ancestor
44594395|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
44594396|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594397|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44594398|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44594399|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44594400|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44594401|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
44594402|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
44594403|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44594404|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44594405|NCT00833833|Growth Substances|growth substances|mesh-ancestor
44594406|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
44594407|NCT00833794|Tramadol|tramadol|mesh-list
44594408|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594409|NCT00833794|Narcotics|narcotics|mesh-ancestor
44594410|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594411|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594412|NCT00833794|Analgesics|analgesics|mesh-ancestor
44594413|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
44594414|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594415|NCT00833755|Ketamine|ketamine|mesh-list
44594416|NCT00833755|Analgesics|analgesics|mesh-ancestor
44594417|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
44594418|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594419|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594420|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44594421|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44594422|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
44594423|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
44594424|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594425|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44594426|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44594427|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594428|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594429|NCT00833703|Clopidogrel|clopidogrel|mesh-list
44594430|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44594431|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44594432|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44594433|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44594434|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
44594435|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994335|NCT00544414|Vitamins|vitamins|mesh-ancestor
44594436|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594437|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594438|NCT00833638|Tadalafil|tadalafil|mesh-list
44594439|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
44594440|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44594441|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44594442|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594443|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594444|NCT00833638|Urological Agents|urological agents|mesh-ancestor
44594445|NCT00833560|Dexamethasone|dexamethasone|mesh-list
44594446|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
44594447|NCT00833560|Bortezomib|bortezomib|mesh-list
44594448|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594449|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
44594450|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594451|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594452|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44594453|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
44594454|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594455|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594456|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44594457|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594458|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
44594459|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
44594460|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594461|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594462|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
44594463|NCT00833560|Hormones|hormones|mesh-ancestor
44594464|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594465|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44594466|NCT00833547|Eszopiclone|eszopiclone|mesh-list
44594467|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44594468|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594469|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594470|NCT00833482|Ritonavir|ritonavir|mesh-list
44594471|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44594472|NCT00833482|Voriconazole|voriconazole|mesh-list
44594473|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44594474|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44594475|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594476|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594477|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594478|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44594479|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44594480|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
44594481|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594482|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44594483|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44594484|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
44594485|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44594486|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44594487|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
44594488|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594489|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594490|NCT00833469|Citalopram|citalopram|mesh-list
44594491|NCT00833469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44594492|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594493|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594494|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594495|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594496|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
44594497|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594498|NCT00833469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44594499|NCT00833469|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594500|NCT00833469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594502|NCT00833261|Cisplatin|cisplatin|mesh-list
44594503|NCT00833261|Cetuximab|cetuximab|mesh-list
44594504|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44594505|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594506|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
44594507|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
44594508|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994416|NCT02592629|Triamcinolone|triamcinolone|mesh-list
44594509|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594510|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44594512|NCT00833248|Bicalutamide|bicalutamide|mesh-list
44594513|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44594514|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594515|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
44594516|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
44594517|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594518|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594519|NCT00833053|Methotrexate|methotrexate|mesh-list
44594520|NCT00833053|Infliximab|infliximab|mesh-list
44594521|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44594522|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
44594523|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44214898|NCT00460252|Insulin|insulin|mesh-list
44594524|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594525|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44594526|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
44594527|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594528|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594529|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44594530|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594531|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44594532|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594533|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
44594534|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594535|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44594536|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594537|NCT00833040|Sufentanil|sufentanil|mesh-list
44594538|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44594539|NCT00833040|Narcotics|narcotics|mesh-ancestor
44594540|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594541|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594542|NCT00833040|Analgesics|analgesics|mesh-ancestor
44594543|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
44594544|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594545|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44594546|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44594547|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
44594548|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
44594549|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44594550|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594551|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594552|NCT00833027|Incretins|incretins|mesh-ancestor
44594553|NCT00833027|Hormones|hormones|mesh-ancestor
44594554|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594555|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44594556|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594557|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594558|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594559|NCT00832819|Paclitaxel|paclitaxel|mesh-list
44594560|NCT00832819|Carboplatin|carboplatin|mesh-list
44594561|NCT00832819|Lenvatinib|lenvatinib|mesh-list
44594562|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44594563|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594564|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
44594565|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
44594566|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
44594567|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594568|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594569|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594570|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
44594571|NCT00832650|Fesoterodine|fesoterodine|mesh-list
44594572|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44594601|NCT00832377|Timolol|timolol|mesh-list
44594602|NCT00832377|Dorzolamide|dorzolamide|mesh-list
44594603|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44594604|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44594605|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
44594606|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594607|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594608|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594609|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44594610|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44594611|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44594612|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594613|NCT00832117|Cisplatin|cisplatin|mesh-list
44594614|NCT00832117|Epothilones|epothilones|mesh-list
44594615|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594616|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
44594617|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422806|NCT02975999|Coagulants|coagulants|mesh-ancestor
44594618|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
44594619|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594620|NCT00832000|Mexiletine|mexiletine|mesh-list
44594621|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44594622|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44594623|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44594624|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594625|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594626|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44594627|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
44594628|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594629|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
44594630|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44594631|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594632|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594633|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594634|NCT00831701|Tamsulosin|tamsulosin|mesh-list
44594635|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44594636|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44594637|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44594638|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44594639|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594640|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594641|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594642|NCT00831701|Urological Agents|urological agents|mesh-ancestor
44594643|NCT00831493|Vorinostat|vorinostat|mesh-list
44594644|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594645|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44594646|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594647|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594648|NCT00831441|Apixaban|apixaban|mesh-list
44594649|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44594650|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
44594651|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44594652|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594653|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594654|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594655|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
44594656|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44594657|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44594658|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594659|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594660|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594661|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594662|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594663|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594664|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594665|NCT00831311|Vaccines|vaccines|mesh-list
44594666|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
44594667|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594668|NCT00831233|Goserelin|goserelin|mesh-list
44594669|NCT00831233|Bicalutamide|bicalutamide|mesh-list
44594670|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44594671|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594672|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
44594673|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
44594674|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594675|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594676|NCT00831181|Leucovorin|leucovorin|mesh-list
44594677|NCT00831181|Fluorouracil|fluorouracil|mesh-list
44594678|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
44594679|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
44594680|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594681|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44594682|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594683|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594684|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
44594685|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594686|NCT00831181|Antidotes|antidotes|mesh-ancestor
44594687|NCT00831181|Protective Agents|protective agents|mesh-ancestor
44594688|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
44594689|NCT00831181|Vitamins|vitamins|mesh-ancestor
44422852|NCT02944578|Curcumin|curcumin|mesh-list
44594690|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
44594691|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
44594692|NCT00831129|Simvastatin|simvastatin|mesh-list
44594693|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44594694|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44594695|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
44594696|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594697|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44594698|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44594699|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594700|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44594701|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594702|NCT00830960|Clopidogrel|clopidogrel|mesh-list
44594703|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44594704|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44594705|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44594706|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44594707|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44594708|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
44594709|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594710|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594711|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594712|NCT00830869|Ixazomib|ixazomib|mesh-list
44594713|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594714|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594715|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594716|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594717|NCT00830804|Ritonavir|ritonavir|mesh-list
44594718|NCT00830804|Darunavir|darunavir|mesh-list
44594719|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
44594720|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44594721|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44594722|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594723|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594724|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594725|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44594726|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44594727|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
44594728|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594729|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44594730|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44594731|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44594732|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44594733|NCT00830765|Progesterone|progesterone|mesh-list
44594734|NCT00830765|Progestins|progestins|mesh-ancestor
44594735|NCT00830765|Hormones|hormones|mesh-ancestor
44594736|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594737|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594738|NCT00830375|Memantine|memantine|mesh-list
44594739|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44594740|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44594741|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
44594742|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594743|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594744|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594745|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44594746|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44594747|NCT00830167|Pregabalin|pregabalin|mesh-list
44594748|NCT00830167|Analgesics|analgesics|mesh-ancestor
44594749|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
44594750|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594751|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594752|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
44594753|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44594754|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594755|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594756|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44594757|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44594758|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44594759|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594760|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594761|NCT00830128|Pregabalin|pregabalin|mesh-list
44594762|NCT00830128|Analgesics|analgesics|mesh-ancestor
44594763|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
44594764|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594765|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594766|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
44594767|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44594768|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594769|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594770|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44594771|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44594772|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44594773|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594774|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594775|NCT00830115|Pantoprazole|pantoprazole|mesh-list
44594776|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44594777|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594778|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44594779|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594780|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594781|NCT00830063|Naproxen|naproxen|mesh-list
44594782|NCT00830063|Tanezumab|tanezumab|mesh-list
44594783|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44594784|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44594785|NCT00830063|Analgesics|analgesics|mesh-ancestor
44594786|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
44594787|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594788|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594789|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594790|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594791|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
44594792|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44594793|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594794|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594795|NCT00829933|Warfarin|warfarin|mesh-list
44594796|NCT00829933|Edoxaban|edoxaban|mesh-list
44594797|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
44594798|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44594799|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
44594800|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44594801|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
44594802|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594803|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594804|NCT00829829|Rilonacept|rilonacept|mesh-list
44594805|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594806|NCT00829439|Levodopa|levodopa|mesh-list
44594807|NCT00829439|Carbidopa|carbidopa|mesh-list
44594808|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44594809|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44594810|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
44594811|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594812|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594813|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594814|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44594815|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594816|NCT00829296|Metoprolol|metoprolol|mesh-list
44594817|NCT00829296|Nebivolol|nebivolol|mesh-list
44594818|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44594819|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44594820|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
44594821|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
44594822|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594823|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594824|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44594825|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44594826|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44594827|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44594828|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594829|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594830|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
44594831|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44594832|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44594833|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44594835|NCT00829283|Sibutramine|sibutramine|mesh-list
44594836|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594837|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594838|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44594839|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44594840|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
44594841|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594842|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
44594843|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44594844|NCT00829244|Hormones|hormones|mesh-ancestor
44594845|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594846|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594847|NCT00829179|Omalizumab|omalizumab|mesh-list
44594848|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44594849|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44594850|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
44594851|NCT00829166|Capecitabine|capecitabine|mesh-list
44594852|NCT00829166|Trastuzumab|trastuzumab|mesh-list
44594853|NCT00829166|Lapatinib|lapatinib|mesh-list
44594854|NCT00829166|Maytansine|maytansine|mesh-list
44594855|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44594856|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44594857|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
44594858|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594859|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594860|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44594861|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44594862|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594863|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44594864|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44594865|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44594866|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44594867|NCT00829010|Vaccines|vaccines|mesh-list
44594868|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44594869|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
44594870|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594871|NCT00828984|Laxatives|laxatives|mesh-list
44594872|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44594873|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594874|NCT00828672|Bevacizumab|bevacizumab|mesh-list
44594875|NCT00828672|Capecitabine|capecitabine|mesh-list
44594876|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
44594877|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44594878|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594879|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44594880|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44594881|NCT00828672|Growth Substances|growth substances|mesh-ancestor
44594882|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594883|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
44594884|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44594885|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
44594886|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594887|NCT00828568|Imiquimod|imiquimod|mesh-list
44594888|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44594889|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
44594890|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594891|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594892|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
44594893|NCT00828464|Clobetasol|clobetasol|mesh-list
44594894|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44594895|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
44594896|NCT00828464|Hormones|hormones|mesh-ancestor
44594897|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44594898|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594899|NCT00828204|Interferons|interferons|mesh-list
44594900|NCT00828204|Interferon-beta|interferon-beta|mesh-list
44594901|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
44594902|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594903|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
44594904|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44594905|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
44594906|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594907|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44594908|NCT00828139|Aflibercept|aflibercept|mesh-list
44594909|NCT00828139|Topotecan|topotecan|mesh-list
44594910|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
44594911|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44594912|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44594913|NCT00828139|Growth Substances|growth substances|mesh-ancestor
44594914|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594915|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
44594916|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594917|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44594918|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44594919|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44594920|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594921|NCT00828113|Varenicline|varenicline|mesh-list
44594922|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44594923|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44594924|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
44594925|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594926|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594927|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594928|NCT00828009|Paclitaxel|paclitaxel|mesh-list
44594929|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
44594930|NCT00828009|Bevacizumab|bevacizumab|mesh-list
44594931|NCT00828009|Carboplatin|carboplatin|mesh-list
44594932|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44594933|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44594934|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44594935|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44594936|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44594937|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594938|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44594939|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
44594940|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594941|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44594942|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44594943|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
44594944|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44594945|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44594946|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44594947|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44594948|NCT00828009|Growth Substances|growth substances|mesh-ancestor
44594949|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
44594950|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
44594951|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44594952|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44594953|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594954|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
44594955|NCT00827931|Coagulants|coagulants|mesh-ancestor
44594956|NCT00827918|Olanzapine|olanzapine|mesh-list
44594957|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
44594958|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
44594959|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44594960|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594961|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44594962|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44594963|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44594964|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44594965|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44594966|NCT00827918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44594967|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44594968|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594969|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594970|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594971|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
44594972|NCT00827775|Carvedilol|carvedilol|mesh-list
44594973|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44594974|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44594975|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44594976|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44594977|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44594978|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44594979|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44594980|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
44594981|NCT00827775|Protective Agents|protective agents|mesh-ancestor
44594982|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44594983|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44594984|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44594986|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44594987|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44594988|NCT00827606|Atorvastatin|atorvastatin|mesh-list
44423175|NCT02158507|Lapatinib|lapatinib|mesh-list
44595001|NCT00827541|Tigecycline|tigecycline|mesh-list
44595002|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595003|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595004|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44595005|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595006|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595007|NCT00827359|Everolimus|everolimus|mesh-list
44595008|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595009|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595010|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
44595011|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595012|NCT00827242|Tadalafil|tadalafil|mesh-list
44595013|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
44595014|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44595015|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44595016|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595017|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595018|NCT00827242|Urological Agents|urological agents|mesh-ancestor
44595019|NCT00827112|Ritonavir|ritonavir|mesh-list
44595020|NCT00827112|Lopinavir|lopinavir|mesh-list
44595021|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44595022|NCT00827112|Darunavir|darunavir|mesh-list
44595023|NCT00827112|Tenofovir|tenofovir|mesh-list
44595024|NCT00827112|Emtricitabine|emtricitabine|mesh-list
44595025|NCT00827112|Maraviroc|maraviroc|mesh-list
44595026|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44595027|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44595028|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44595029|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595030|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595031|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44595032|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44595033|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
44595034|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595035|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44595036|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44595037|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44595038|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44595039|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44595040|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44595041|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44595042|NCT00826943|Cetirizine|cetirizine|mesh-list
44595043|NCT00826943|Levocetirizine|levocetirizine|mesh-list
44595044|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44595045|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44595046|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44595047|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
44595048|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
44595049|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595050|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595051|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595052|NCT00826748|Beclomethasone|beclomethasone|mesh-list
44595053|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595054|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
44595055|NCT00826748|Hormones|hormones|mesh-ancestor
44595056|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595057|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595058|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595059|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595060|NCT00826618|Ranibizumab|ranibizumab|mesh-list
44595061|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44595062|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44595063|NCT00826618|Growth Substances|growth substances|mesh-ancestor
44595064|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595065|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
44595066|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595067|NCT00826540|Bevacizumab|bevacizumab|mesh-list
44595068|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44595069|NCT00826540|Sorafenib|sorafenib|mesh-list
44595070|NCT00826540|Antibodies|antibodies|mesh-list
44595071|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
44595072|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44595073|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595074|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44595075|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44595076|NCT00826540|Growth Substances|growth substances|mesh-ancestor
44595077|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595078|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
44595079|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
44595080|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595081|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595082|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595083|NCT00826514|Tanezumab|tanezumab|mesh-list
44595084|NCT00826514|Analgesics|analgesics|mesh-ancestor
44595085|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
44595086|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595087|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595088|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44595090|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595091|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595092|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595093|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595094|NCT00826280|Caffeine|caffeine|mesh-list
44595095|NCT00826280|Regadenoson|regadenoson|mesh-list
44595096|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44595097|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595098|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44595099|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595100|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595101|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44595102|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44595103|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
44595104|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595105|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44595106|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44595107|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
44595108|NCT00826267|Trastuzumab|trastuzumab|mesh-list
44595109|NCT00826267|Lapatinib|lapatinib|mesh-list
44595110|NCT00826267|Afatinib|afatinib|mesh-list
44595111|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595112|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595113|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595114|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595115|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595116|NCT00826241|Temozolomide|temozolomide|mesh-list
44595117|NCT00826241|Lapatinib|lapatinib|mesh-list
44595118|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44595119|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
44595120|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595121|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595122|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595123|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595124|NCT00826228|Teriparatide|teriparatide|mesh-list
44595125|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44595126|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595127|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44595128|NCT00826111|Eszopiclone|eszopiclone|mesh-list
44595129|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44595130|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595131|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595132|NCT00825825|Citalopram|citalopram|mesh-list
44595133|NCT00825825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44595134|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44595135|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595136|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595137|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595138|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
44595139|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595140|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44595141|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44595142|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44595143|NCT00825812|Atropine|atropine|mesh-list
44595144|NCT00825812|Neostigmine|neostigmine|mesh-list
44595145|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44595146|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44595147|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595148|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
44595149|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595150|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595151|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595152|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595153|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
44595154|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
44595155|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44595156|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44595157|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595158|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215445|NCT00462852|Gemcitabine|gemcitabine|mesh-list
44595159|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595160|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44595161|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595162|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44595163|NCT00825305|Vaccines|vaccines|mesh-list
44595164|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
44595165|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595166|NCT00825162|Vaccines|vaccines|mesh-list
44595167|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
44595168|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595169|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
44595170|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595171|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44595172|NCT00824850|Vaccines|vaccines|mesh-list
44595173|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44595174|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
44595175|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595176|NCT00824616|Insulin|insulin|mesh-list
44595177|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595178|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595179|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
44595180|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44595181|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595182|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595183|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
44595184|NCT00824564|Coagulants|coagulants|mesh-ancestor
44595185|NCT00824473|Azelastine|azelastine|mesh-list
44595186|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595187|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
44595188|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595189|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595190|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595191|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595192|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44595193|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595194|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595195|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44595196|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44595197|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44595198|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
44595199|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
44595200|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595201|NCT00824408|Pemetrexed|pemetrexed|mesh-list
44595202|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595203|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215498|NCT00463073|Bevacizumab|bevacizumab|mesh-list
44595204|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595205|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44595206|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44595207|NCT00824382|Olodaterol|olodaterol|mesh-list
44595208|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595209|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
44595210|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595211|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595212|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595213|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595214|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44595215|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44595216|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44595217|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595218|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595219|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595220|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595221|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
44595222|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44595224|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44595225|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44595226|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595227|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595228|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
44595229|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595230|NCT00823901|Clindamycin|clindamycin|mesh-list
44595231|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
44595232|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
44595233|NCT00823901|Tretinoin|tretinoin|mesh-list
44595253|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595254|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595255|NCT00823719|Ofatumumab|ofatumumab|mesh-list
44595256|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44595257|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595258|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
44595259|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595260|NCT00823472|Ganirelix|ganirelix|mesh-list
44595261|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
44595262|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595263|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595264|NCT00823264|Charcoal|charcoal|mesh-list
44595265|NCT00823264|Antidotes|antidotes|mesh-ancestor
44595266|NCT00823264|Protective Agents|protective agents|mesh-ancestor
44595267|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595268|NCT00823212|Aspirin|aspirin|mesh-list
44595269|NCT00823212|Ticlopidine|ticlopidine|mesh-list
44595270|NCT00823212|Clopidogrel|clopidogrel|mesh-list
44595271|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44595272|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44595273|NCT00823212|Analgesics|analgesics|mesh-ancestor
44595274|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
44215547|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44595275|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595276|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595277|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595278|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595279|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44595280|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595281|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595282|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44595283|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44595284|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595285|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
44595286|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44595287|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44595288|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44595289|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
44595290|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595291|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44595292|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44595293|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
44595294|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44595295|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44595296|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44595297|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595298|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595299|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595300|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595301|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595302|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44595303|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595304|NCT00822900|Progesterone|progesterone|mesh-list
44595305|NCT00822900|Progestins|progestins|mesh-ancestor
44595306|NCT00822900|Hormones|hormones|mesh-ancestor
44235534|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
44595307|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595308|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595309|NCT00822770|Plerixafor|plerixafor|mesh-list
44595310|NCT00822770|Fludarabine|fludarabine|mesh-list
44595311|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
44595312|NCT00822770|Busulfan|busulfan|mesh-list
44595313|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
44595314|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44595315|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595316|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44595317|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
44595318|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595319|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595320|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
44595321|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595322|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
44595323|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595324|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
44595325|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44595326|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44595327|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44595328|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44595329|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44595330|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44595331|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595332|NCT00822692|Renal Agents|renal agents|mesh-ancestor
44595333|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595334|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
44595335|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44595336|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44595337|NCT00822237|Vaccines|vaccines|mesh-list
44595338|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
44595339|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595340|NCT00822172|Cilostazol|cilostazol|mesh-list
44595341|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595342|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
44595343|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595344|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595345|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595346|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595347|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44595348|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595349|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595350|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44595351|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
44595352|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44595353|NCT00822172|Protective Agents|protective agents|mesh-ancestor
44595354|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44595355|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44595356|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595357|NCT00822120|Prednisone|prednisone|mesh-list
44595358|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
44595359|NCT00822120|Dacarbazine|dacarbazine|mesh-list
44595360|NCT00822120|Doxorubicin|doxorubicin|mesh-list
44595361|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44595362|NCT00822120|Etoposide|etoposide|mesh-list
44595363|NCT00822120|Vincristine|vincristine|mesh-list
44595364|NCT00822120|Bleomycin|bleomycin|mesh-list
44595365|NCT00822120|Vinblastine|vinblastine|mesh-list
44595366|NCT00822120|Procarbazine|procarbazine|mesh-list
44595367|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595368|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
44595369|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595370|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595371|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44595372|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
44595373|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595374|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595375|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44595376|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44595377|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44595378|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44595379|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595380|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595381|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
44595382|NCT00822120|Hormones|hormones|mesh-ancestor
43849544|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44595383|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595384|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44595385|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44595386|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44595387|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44595388|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44595389|NCT00821509|Disinfectants|disinfectants|mesh-list
44595390|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595391|NCT00821327|Gemcitabine|gemcitabine|mesh-list
44595392|NCT00821327|Cisplatin|cisplatin|mesh-list
44595393|NCT00821327|Sunitinib|sunitinib|mesh-list
44595394|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595395|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44595396|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
44595397|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595398|NCT00821327|Antiviral Agents|antiviral agents|mesh-ancestor
44595399|NCT00821327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595400|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595401|NCT00821327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595402|NCT00821327|Immunologic Factors|immunologic factors|mesh-ancestor
44595403|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595404|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44595405|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44595406|NCT00821327|Growth Substances|growth substances|mesh-ancestor
44595407|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44595408|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595409|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44595410|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595411|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
44595412|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595413|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595414|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595415|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595416|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44595417|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44595418|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44595419|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44595420|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595421|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595422|NCT00820950|Betamethasone|betamethasone|mesh-list
44595423|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
44595424|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44595425|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
44595426|NCT00820950|Calcipotriene|calcipotriene|mesh-list
44595427|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44595428|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595429|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
44595430|NCT00820950|Hormones|hormones|mesh-ancestor
44595431|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595432|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595433|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595434|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595435|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595436|NCT00820898|Gemcitabine|gemcitabine|mesh-list
44595437|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44595438|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
44423674|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
44595443|NCT00820898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595444|NCT00820898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595445|NCT00820898|Immunologic Factors|immunologic factors|mesh-ancestor
44595446|NCT00820898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595447|NCT00820755|Cetuximab|cetuximab|mesh-list
44595448|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595449|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595450|NCT00820248|Cisplatin|cisplatin|mesh-list
44595451|NCT00820248|Panitumumab|panitumumab|mesh-list
44595452|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595453|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595454|NCT00820222|Capecitabine|capecitabine|mesh-list
44595455|NCT00820222|Trastuzumab|trastuzumab|mesh-list
44595456|NCT00820222|Lapatinib|lapatinib|mesh-list
44595457|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44595458|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
44595459|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595460|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595461|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595462|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595463|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595465|NCT00820170|Dasatinib|dasatinib|mesh-list
44595466|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44595467|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595468|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44595469|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44595470|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44595471|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595472|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595473|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595474|NCT00820027|Ibuprofen|ibuprofen|mesh-list
44595475|NCT00820027|Etoricoxib|etoricoxib|mesh-list
44595476|NCT00820027|Morphine|morphine|mesh-list
44595477|NCT00820027|Oxycodone|oxycodone|mesh-list
44595478|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44595479|NCT00820027|Narcotics|narcotics|mesh-ancestor
44595480|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595481|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595482|NCT00820027|Analgesics|analgesics|mesh-ancestor
44595483|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
44595484|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595485|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44595486|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44595487|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595488|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595489|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44595490|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595491|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595492|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44595493|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
44595494|NCT00819910|Fenofibrate|fenofibrate|mesh-list
44595495|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595496|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595497|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44595498|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
44595499|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595500|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44595501|NCT00819767|Valsartan|valsartan|mesh-list
44595502|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44595503|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44595504|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44595505|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595506|NCT00819741|Metformin|metformin|mesh-list
44595507|NCT00819741|Repaglinide|repaglinide|mesh-list
44595508|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595509|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595510|NCT00819585|Colchicine|colchicine|mesh-list
44595511|NCT00819585|Allopurinol|allopurinol|mesh-list
44595512|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44595513|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
44595514|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595515|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44595516|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44595517|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44595518|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595519|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595520|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
44595521|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595522|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44595523|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
44595524|NCT00819585|Protective Agents|protective agents|mesh-ancestor
44595525|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595526|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
44595527|NCT00819390|Chloroquine|chloroquine|mesh-list
44595528|NCT00819390|Amebicides|amebicides|mesh-ancestor
44595529|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44595530|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44595531|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595532|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
44595533|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595534|NCT00819234|Pramlintide|pramlintide|mesh-list
44595535|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595536|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595537|NCT00819091|Linagliptin|linagliptin|mesh-list
44595538|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595539|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595540|NCT00819091|Incretins|incretins|mesh-ancestor
44595541|NCT00819091|Hormones|hormones|mesh-ancestor
44595542|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595543|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44595544|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44595545|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595546|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595547|NCT00819052|Nevirapine|nevirapine|mesh-list
44595548|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44595549|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44595550|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595551|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595552|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
44595553|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595554|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44595555|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44595556|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44595557|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44595558|NCT00819039|Ondansetron|ondansetron|mesh-list
44595559|NCT00819039|Aprepitant|aprepitant|mesh-list
44595560|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
44595561|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
44595562|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595563|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595564|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44595565|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
44595566|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595567|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44595568|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
44595569|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595570|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595571|NCT00819039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44595572|NCT00819039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44595573|NCT00819039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595574|NCT00819039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44595575|NCT00819039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44595576|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44595577|NCT00819013|Vaccines|vaccines|mesh-list
44595578|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
44595579|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595580|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44595581|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
44595582|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44595583|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44595584|NCT00818883|Diuretics|diuretics|mesh-ancestor
44595585|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
44595586|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595587|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44215788|NCT00464763|Analgesics|analgesics|mesh-ancestor
44595588|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595589|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595590|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44595591|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44595592|NCT00818779|Amlodipine|amlodipine|mesh-list
44595593|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44595594|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44595595|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595596|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595597|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44595598|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595599|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
44595600|NCT00818766|Vancomycin|vancomycin|mesh-list
44595601|NCT00818766|Cefazolin|cefazolin|mesh-list
44595602|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595603|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595604|NCT00818753|Heparin|heparin|mesh-list
44595605|NCT00818753|Calcium heparin|calcium heparin|mesh-list
44595606|NCT00818753|Dabigatran|dabigatran|mesh-list
44595607|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
44595608|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44595609|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595610|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595611|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
44595612|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44595613|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
44595614|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595615|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44595616|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
44595617|NCT00818662|Antibodies|antibodies|mesh-list
44595618|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
44595619|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44595620|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44595621|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
44595622|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
44595623|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595624|NCT00818649|Bortezomib|bortezomib|mesh-list
44595625|NCT00818649|Vorinostat|vorinostat|mesh-list
44595626|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595627|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44595628|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595629|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595630|NCT00818519|Drospirenone|drospirenone|mesh-list
44595631|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44595632|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
44595633|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595634|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595635|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44595636|NCT00818519|Diuretics|diuretics|mesh-ancestor
44595637|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
44595638|NCT00818454|Albuterol|albuterol|mesh-list
44595639|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44595640|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
44595641|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595642|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595643|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595644|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595645|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
44595646|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44595647|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44595648|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44595649|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44595650|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
44595651|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595652|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595653|NCT00818389|Riluzole|riluzole|mesh-list
44595654|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
44595655|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44595656|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44595657|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595658|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595659|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
44595660|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44595661|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595662|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595674|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
44595675|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
44595676|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595677|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595678|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44595679|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
44595680|NCT00818259|Hormones|hormones|mesh-ancestor
44595681|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595682|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44595683|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595684|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
44595685|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595686|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44595687|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
44595688|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595689|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595690|NCT00818259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44595691|NCT00818259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44595692|NCT00818259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595693|NCT00818259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44595694|NCT00818259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44595695|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44595697|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595698|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44595699|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595700|NCT00817635|Eplerenone|eplerenone|mesh-list
44595701|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44595702|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
44595703|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595704|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595705|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44595706|NCT00817635|Diuretics|diuretics|mesh-ancestor
44595707|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
44595708|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44595709|NCT00817531|Dasatinib|dasatinib|mesh-list
44595710|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595711|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595712|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595713|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595714|NCT00817479|Dexamethasone|dexamethasone|mesh-list
44595715|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595716|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
44595717|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
44595718|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595719|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595720|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44595721|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
44595722|NCT00817479|Hormones|hormones|mesh-ancestor
44595723|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595724|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44595725|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595726|NCT00817206|Tacrolimus|tacrolimus|mesh-list
44595727|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595728|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
44595729|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595730|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44595731|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595732|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595733|NCT00817089|Naltrexone|naltrexone|mesh-list
44595734|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44595735|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44595736|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215932|NCT00465439|Lidocaine|lidocaine|mesh-list
44595737|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
44595738|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595739|NCT00817063|Alitretinoin|alitretinoin|mesh-list
44595740|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595741|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595742|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
44595743|NCT00816595|Bevacizumab|bevacizumab|mesh-list
44595744|NCT00816595|Rituximab|rituximab|mesh-list
44595745|NCT00816595|Pentostatin|pentostatin|mesh-list
44595746|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44595747|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
44595748|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595749|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595750|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44595751|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
44595752|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595753|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595754|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44595755|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44595756|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44595757|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44595758|NCT00816595|Growth Substances|growth substances|mesh-ancestor
44595759|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44595760|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44595761|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595762|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44595763|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44595764|NCT00816556|Estradiol|estradiol|mesh-list
44595765|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44595766|NCT00816556|Estrogens|estrogens|mesh-ancestor
44595767|NCT00816556|Hormones|hormones|mesh-ancestor
44595768|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595769|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595770|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44595771|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
44595772|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44595773|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44595775|NCT00816166|Clopidogrel|clopidogrel|mesh-list
44595776|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44595777|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44595778|NCT00816166|Analgesics|analgesics|mesh-ancestor
44595779|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
44595780|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595781|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595782|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595783|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595784|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44595785|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44595786|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595787|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44595788|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44595789|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595790|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
44595791|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44595792|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44595793|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44595794|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
44595795|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595796|NCT00816023|Ecallantide|ecallantide|mesh-list
44595797|NCT00816023|Analgesics|analgesics|mesh-ancestor
44595798|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
44595799|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595800|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595801|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44595802|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44595803|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595804|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595805|NCT00815919|Prednisone|prednisone|mesh-list
44595806|NCT00815919|Bortezomib|bortezomib|mesh-list
44595807|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595808|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
44595809|NCT00815919|Hormones|hormones|mesh-ancestor
44595810|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595811|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595812|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44595813|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595814|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44595815|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44595816|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44595817|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
44595818|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595819|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44595820|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44595821|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595822|NCT00815633|Alefacept|alefacept|mesh-list
44595823|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
44595824|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
44595825|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595826|NCT00815516|Amphotericin B|amphotericin b|mesh-list
44595827|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44595828|NCT00815516|Micafungin|micafungin|mesh-list
44595829|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44595830|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
44595831|NCT00815516|Amebicides|amebicides|mesh-ancestor
44595832|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44595833|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44595834|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44595835|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44595836|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
44595837|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44595838|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44595839|NCT00815308|Paclitaxel|paclitaxel|mesh-list
44595840|NCT00815308|Cisplatin|cisplatin|mesh-list
44595841|NCT00815308|Cetuximab|cetuximab|mesh-list
44595842|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44595843|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595844|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
44595845|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
44595846|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
44595865|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595866|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44595867|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44595868|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
44595869|NCT00814801|Galantamine|galantamine|mesh-list
44595870|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44595871|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595872|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595873|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595874|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595875|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595876|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44595877|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
44595878|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595879|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
44595880|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44595881|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
44595882|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595883|NCT00814658|Nimodipine|nimodipine|mesh-list
44595884|NCT00814658|Galantamine|galantamine|mesh-list
44595885|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44595886|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595887|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595888|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595889|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595890|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595891|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44595892|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
44595893|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595894|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
44595895|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44595896|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44595897|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595898|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44595899|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
44595900|NCT00814632|Apremilast|apremilast|mesh-list
44595901|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44595902|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44595903|NCT00814632|Analgesics|analgesics|mesh-ancestor
44595904|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
44595905|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595906|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595907|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44595908|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44595909|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44595910|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44595911|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595912|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595913|NCT00814580|Oxycodone|oxycodone|mesh-list
44595914|NCT00814580|Tapentadol|tapentadol|mesh-list
44595915|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44595916|NCT00814580|Narcotics|narcotics|mesh-ancestor
44595917|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595918|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595919|NCT00814580|Analgesics|analgesics|mesh-ancestor
44595920|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
44595921|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44595922|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44595923|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44595924|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44595925|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595926|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
44595927|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595928|NCT00814502|Zolpidem|zolpidem|mesh-list
44595929|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44595930|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44595931|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44595932|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595933|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44595934|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
44595935|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
44595936|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595937|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595939|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
44595940|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
44595941|NCT00814333|Coagulants|coagulants|mesh-ancestor
44595942|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
44595943|NCT00814320|Antibodies|antibodies|mesh-list
44595944|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
44595945|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44595946|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44595947|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
44595948|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
44595949|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595950|NCT00814307|Tofacitinib|tofacitinib|mesh-list
44595951|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44595952|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595953|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595954|NCT00814164|Daunorubicin|daunorubicin|mesh-list
44595955|NCT00814164|Clofarabine|clofarabine|mesh-list
44595956|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44595957|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595958|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44595959|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44595960|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595961|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595962|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44595963|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
44595964|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44595965|NCT00813995|Metformin|metformin|mesh-list
44595966|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44595967|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595968|NCT00813995|Incretins|incretins|mesh-ancestor
44595969|NCT00813995|Hormones|hormones|mesh-ancestor
44595970|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44595971|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44595972|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
44595973|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44595974|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595975|NCT00813943|Temozolomide|temozolomide|mesh-list
44595976|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44595977|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
44595978|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595979|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44595980|NCT00813917|Varenicline|varenicline|mesh-list
44595981|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44595982|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44595983|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595984|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595985|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595986|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595987|NCT00813800|Varenicline|varenicline|mesh-list
44595988|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44595989|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44595990|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
44595991|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44595992|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44595993|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44595994|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44595995|NCT00813748|Omalizumab|omalizumab|mesh-list
44595996|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44595997|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44595998|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44595999|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
44596000|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44596001|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
44596002|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596003|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596004|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
44596005|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596006|NCT00813592|Pasireotide|pasireotide|mesh-list
44596007|NCT00813592|Hormones|hormones|mesh-ancestor
44596008|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596009|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596010|NCT00813488|Fentanyl|fentanyl|mesh-list
44596011|NCT00813488|Oxycodone|oxycodone|mesh-list
44596012|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44596013|NCT00813488|Narcotics|narcotics|mesh-ancestor
44596014|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596015|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596016|NCT00813488|Analgesics|analgesics|mesh-ancestor
44596017|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
44596018|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596019|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44596020|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44596021|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
44596022|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
44596023|NCT00813293|Sorafenib|sorafenib|mesh-list
44596024|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596025|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44596026|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596027|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596028|NCT00813150|Dexamethasone|dexamethasone|mesh-list
44596029|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
44596030|NCT00813150|Bortezomib|bortezomib|mesh-list
44596031|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596032|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
44596033|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596034|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596035|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596036|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
44596037|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596038|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596039|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44596040|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596041|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
44596042|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
44596043|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596044|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596045|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
44596046|NCT00813150|Hormones|hormones|mesh-ancestor
44596047|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596048|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596049|NCT00813124|Fludarabine|fludarabine|mesh-list
44596050|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
44596051|NCT00813124|Azacitidine|azacitidine|mesh-list
44596052|NCT00813124|Busulfan|busulfan|mesh-list
44596053|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
44596054|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44596055|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596056|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596057|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
44596058|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596059|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596060|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
44596061|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596062|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596063|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
44596064|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596065|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44596066|NCT00812968|Lenalidomide|lenalidomide|mesh-list
44596067|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
44596068|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596069|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44596070|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44596071|NCT00812968|Growth Substances|growth substances|mesh-ancestor
44596072|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
44596073|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596074|NCT00812955|Simvastatin|simvastatin|mesh-list
44596075|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44596076|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44596077|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
44596078|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596079|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44596080|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44596081|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596082|NCT00812812|Paroxetine|paroxetine|mesh-list
44596083|NCT00812812|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44596084|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44596085|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596086|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596087|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596088|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
44596089|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596090|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44596091|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
44596092|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596093|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44596094|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44596095|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596096|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
44596097|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44596098|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44596099|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
44596100|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596101|NCT00812487|Insulin|insulin|mesh-list
44596102|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44596103|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44596104|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596105|NCT00812461|Nalmefene|nalmefene|mesh-list
44596106|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44596107|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596108|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
44596109|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596110|NCT00812331|Simeprevir|simeprevir|mesh-list
44596111|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
44596112|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596113|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596114|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596115|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596116|NCT00812253|Insulin|insulin|mesh-list
44596117|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44596118|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44596119|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596120|NCT00811954|Ritonavir|ritonavir|mesh-list
44596121|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44596122|NCT00811954|Darunavir|darunavir|mesh-list
44596123|NCT00811954|Tenofovir|tenofovir|mesh-list
44596124|NCT00811954|Emtricitabine|emtricitabine|mesh-list
44596125|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
44596126|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44596127|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44596128|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44596129|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596130|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596131|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596132|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44596133|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44596134|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
44596135|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596136|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44596137|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44596138|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44596139|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596140|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44596141|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44596142|NCT00811941|Nalmefene|nalmefene|mesh-list
44596143|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44596144|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596145|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
44596146|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596147|NCT00811928|Fluconazole|fluconazole|mesh-list
44596148|NCT00811928|Posaconazole|posaconazole|mesh-list
44596149|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
44596150|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596151|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44216281|NCT00467181|Fenoldopam|fenoldopam|mesh-list
44596152|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44596153|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596154|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596155|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44596156|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
44596157|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596158|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596159|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44596160|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44596161|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44424459|NCT04216784|Furosemide|furosemide|mesh-list
44596182|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
44596183|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596184|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596185|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44596186|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
44596187|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596188|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44596189|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44596190|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596191|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596192|NCT00811395|Interferons|interferons|mesh-list
44596193|NCT00811395|Interferon-beta|interferon-beta|mesh-list
44596194|NCT00811395|Teriflunomide|teriflunomide|mesh-list
44596195|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
44596196|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
44596197|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
44596198|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596199|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
44596200|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596201|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44596202|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
44596203|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596204|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596205|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596206|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44596207|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596208|NCT00811395|Analgesics|analgesics|mesh-ancestor
44596209|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
44596210|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596211|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596212|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44596213|NCT00811252|Vortioxetine|vortioxetine|mesh-list
44596214|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44596215|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44596216|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596217|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596218|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596219|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596221|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
44596222|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596223|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
44596224|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596225|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
44596226|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44596227|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44596228|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596229|NCT00811252|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44596230|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
44596231|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44596232|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44596233|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44596234|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44596235|NCT00811187|Lidocaine|lidocaine|mesh-list
44596236|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
44596237|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
44596238|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596239|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596240|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
44596241|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596242|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44596243|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44596244|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44596245|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596246|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596247|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
44596248|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44596249|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44596250|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
44596251|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596252|NCT00811135|Bevacizumab|bevacizumab|mesh-list
44596253|NCT00811135|Trastuzumab|trastuzumab|mesh-list
44596254|NCT00811135|Capecitabine|capecitabine|mesh-list
44596255|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44596256|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596257|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44596258|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216389|NCT00467883|Amphotericin B|amphotericin b|mesh-list
44596259|NCT00811135|Growth Substances|growth substances|mesh-ancestor
44596260|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596261|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
44596262|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596263|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
44596264|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596266|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
44596267|NCT00811057|Nifedipine|nifedipine|mesh-list
44596268|NCT00811057|Analgesics|analgesics|mesh-ancestor
44596269|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
44596270|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596271|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596272|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
44596273|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596274|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44596275|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
44596276|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44596277|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596278|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596279|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44596280|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
44596281|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596282|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
44596283|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44596284|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596285|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596286|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596287|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
44596288|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44424587|NCT03856515|Nicotine|nicotine|mesh-list
44596289|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596290|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
44596291|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44596292|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596293|NCT00810693|Riociguat|riociguat|mesh-list
44596294|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
44596295|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596296|NCT00810602|Vorinostat|vorinostat|mesh-list
44596297|NCT00810602|Tacrolimus|tacrolimus|mesh-list
44596298|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596299|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
44596300|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596301|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44596302|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596303|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596304|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596305|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44596306|NCT00810407|Rifabutin|rifabutin|mesh-list
44596307|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44596308|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596309|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44596310|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
44596311|NCT00810394|Sorafenib|sorafenib|mesh-list
44596312|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596313|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44596314|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596315|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596316|NCT00810199|Methotrexate|methotrexate|mesh-list
44596317|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44596318|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
44596319|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596320|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596321|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596322|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
44596323|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596324|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596325|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596326|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596327|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596328|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596329|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
44596330|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995957|NCT02635828|Dexamethasone|dexamethasone|mesh-list
44596331|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424662|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596332|NCT00810108|Ritonavir|ritonavir|mesh-list
44596333|NCT00810108|Lopinavir|lopinavir|mesh-list
44596334|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44596335|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44596336|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596337|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596338|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596339|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44596340|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44596341|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
44596342|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596343|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44596344|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44596345|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44596346|NCT00810069|Citalopram|citalopram|mesh-list
44596347|NCT00810069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44596348|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44596349|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596350|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596351|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596352|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
44596353|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596354|NCT00810069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44596355|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
44596356|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596357|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596358|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44596359|NCT00810069|Analgesics|analgesics|mesh-ancestor
44596360|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
44596361|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
44596362|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
44596363|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44596364|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
44596365|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44596366|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596367|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596368|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596369|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
44596370|NCT00809926|Valsartan|valsartan|mesh-list
44596371|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44596372|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44596373|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44596374|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596375|NCT00809835|Galantamine|galantamine|mesh-list
44596376|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44596377|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596378|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596379|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596380|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596381|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596382|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44596383|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
44596384|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596385|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
44596386|NCT00809783|Tanezumab|tanezumab|mesh-list
44596387|NCT00809783|Analgesics|analgesics|mesh-ancestor
44596388|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
44596389|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596390|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596391|NCT00809757|Albuterol|albuterol|mesh-list
44596392|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44596393|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
44596394|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596395|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596396|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44596397|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44596398|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
44596399|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596400|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44596401|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44596402|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44596403|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44596404|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596405|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596406|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44596407|NCT00809354|Tanezumab|tanezumab|mesh-list
44596408|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596409|NCT00809354|Analgesics|analgesics|mesh-ancestor
44596410|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
44596411|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596412|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596413|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596414|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596415|NCT00809341|Prednisone|prednisone|mesh-list
44596416|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
44596417|NCT00809341|Ifosfamide|ifosfamide|mesh-list
44596418|NCT00809341|Rituximab|rituximab|mesh-list
44596419|NCT00809341|Carboplatin|carboplatin|mesh-list
44596420|NCT00809341|Doxorubicin|doxorubicin|mesh-list
44596421|NCT00809341|Etoposide|etoposide|mesh-list
44596422|NCT00809341|Vincristine|vincristine|mesh-list
44596423|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596424|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
44596425|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596426|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596427|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596428|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
44596429|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596430|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596431|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44596432|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44596433|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44596434|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44596435|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44596436|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596437|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596438|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
44596439|NCT00809341|Hormones|hormones|mesh-ancestor
44596440|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596441|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596442|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596443|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596444|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596445|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596446|NCT00809328|Azithromycin|azithromycin|mesh-list
44596447|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44596448|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596449|NCT00809133|Paclitaxel|paclitaxel|mesh-list
44596450|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44596451|NCT00809133|Bevacizumab|bevacizumab|mesh-list
44596452|NCT00809133|Carboplatin|carboplatin|mesh-list
44596453|NCT00809133|Afatinib|afatinib|mesh-list
44596454|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596455|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596456|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596457|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596458|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596459|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596460|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44596461|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44596462|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44596463|NCT00809133|Growth Substances|growth substances|mesh-ancestor
44596464|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596465|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
44596466|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44596467|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596468|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
44596469|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44596470|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
44596471|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596472|NCT00809094|Expectorants|expectorants|mesh-ancestor
44596473|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
44596474|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44596475|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
44596476|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596477|NCT00809094|Protective Agents|protective agents|mesh-ancestor
44596478|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596479|NCT00809094|Antidotes|antidotes|mesh-ancestor
44596480|NCT00808899|Sirolimus|sirolimus|mesh-list
44596481|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
44596482|NCT00808899|Cisplatin|cisplatin|mesh-list
44596483|NCT00808899|Doxorubicin|doxorubicin|mesh-list
44596484|NCT00808899|Irinotecan|irinotecan|mesh-list
44596485|NCT00808899|Etoposide|etoposide|mesh-list
44596486|NCT00808899|Topotecan|topotecan|mesh-list
44596487|NCT00808899|Tretinoin|tretinoin|mesh-list
44596488|NCT00808899|Isotretinoin|isotretinoin|mesh-list
44596489|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596490|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
44596491|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596492|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596493|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596494|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
44596495|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596496|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596497|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44596498|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44596499|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44596500|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44596501|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596502|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44596503|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596504|NCT00808899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44596505|NCT00808899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596506|NCT00808899|Antifungal Agents|antifungal agents|mesh-ancestor
44596507|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
44596508|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596509|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
44596510|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44596511|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596512|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596513|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596514|NCT00808665|Analgesics|analgesics|mesh-ancestor
44596515|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
44596516|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596517|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44596518|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44596519|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44596520|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
44596521|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596522|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596523|NCT00808639|Cisplatin|cisplatin|mesh-list
44596524|NCT00808639|Doxorubicin|doxorubicin|mesh-list
44596525|NCT00808639|Methotrexate|methotrexate|mesh-list
44596526|NCT00808639|Vinblastine|vinblastine|mesh-list
44596527|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596528|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44596529|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44596530|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44596531|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596532|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216587|NCT00469300|Acyclovir|acyclovir|mesh-list
44596533|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44596534|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
44596535|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596536|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596537|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596538|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
44596539|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596540|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596541|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596542|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
44596543|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596544|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596545|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596546|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596547|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596548|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596549|NCT00808509|Adalimumab|adalimumab|mesh-list
44596550|NCT00808509|Methotrexate|methotrexate|mesh-list
44596551|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44596552|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
44596553|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596554|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596555|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596556|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
44596557|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596558|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596559|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596560|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596561|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596562|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596563|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
44596564|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596565|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596566|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596567|NCT00808444|Vaccines|vaccines|mesh-list
44596568|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44596569|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
44596570|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596571|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
44596572|NCT00808210|Methotrexate|methotrexate|mesh-list
44596573|NCT00808210|Infliximab|infliximab|mesh-list
44596574|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
44596575|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44596576|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
44596577|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596578|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596579|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44596580|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
44596581|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596582|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596583|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596584|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596585|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596586|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596587|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
44596588|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596589|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596590|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596591|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
44596592|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
44596593|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596594|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596595|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
44596596|NCT00808210|Hormones|hormones|mesh-ancestor
44596597|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596598|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44596599|NCT00808210|Protective Agents|protective agents|mesh-ancestor
44596600|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
44596601|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44596602|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
44596603|NCT00808132|Estrogens|estrogens|mesh-list
44596604|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44596605|NCT00808132|Hormones|hormones|mesh-ancestor
44596606|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596607|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596608|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44596609|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44596610|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44596611|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
44596612|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596613|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44596614|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44596615|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44596616|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596617|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596618|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44596619|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44596620|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
44596621|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44596622|NCT00808067|Dabigatran|dabigatran|mesh-list
44596623|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
44596624|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44596625|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596626|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596627|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596628|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
44596630|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
44596631|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596632|NCT00808015|Varenicline|varenicline|mesh-list
44596633|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44596634|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44596635|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596636|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596637|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596638|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596639|NCT00807937|Lorazepam|lorazepam|mesh-list
44596640|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
44596641|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
44596642|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
44596643|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596644|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596645|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596646|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44596647|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596648|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44596649|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44596650|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596651|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
44596652|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
44596653|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596654|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596655|NCT00807846|Celecoxib|celecoxib|mesh-list
44596656|NCT00807846|Naproxen|naproxen|mesh-list
44596657|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44596658|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596659|NCT00807846|Analgesics|analgesics|mesh-ancestor
44596660|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
44596661|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596662|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596663|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596664|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596665|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44596666|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44596667|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596668|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596669|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
44596670|NCT00807742|Nicotine|nicotine|mesh-list
44596671|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44596672|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
44596673|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596674|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596675|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44596676|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44596677|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596678|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596679|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596680|NCT00807599|Dexamethasone|dexamethasone|mesh-list
44596681|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
44596682|NCT00807599|Lenalidomide|lenalidomide|mesh-list
44596683|NCT00807599|Melphalan|melphalan|mesh-list
44596684|NCT00807599|BB 1101|bb 1101|mesh-list
44596685|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596686|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
44596687|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
44596688|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596689|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596690|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596691|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
44596692|NCT00807599|Hormones|hormones|mesh-ancestor
44596693|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596694|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596695|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596696|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596697|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596698|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596699|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
44596700|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44596701|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44596702|NCT00807599|Growth Substances|growth substances|mesh-ancestor
44596703|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
44596704|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596705|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
44596706|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44596707|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596708|NCT00807573|Paclitaxel|paclitaxel|mesh-list
44596710|NCT00807573|Pemetrexed|pemetrexed|mesh-list
44216764|NCT00469846|Protective Agents|protective agents|mesh-ancestor
44596711|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596712|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596713|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596714|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596715|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596716|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596717|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44596718|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44596719|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44596720|NCT00807573|Growth Substances|growth substances|mesh-ancestor
44596721|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596722|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
44596723|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596724|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596725|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596726|NCT00807365|Hormones|hormones|mesh-list
44596727|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44596728|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596729|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596730|NCT00807248|Gaboxadol|gaboxadol|mesh-list
44596731|NCT00807248|Dexetimide|dexetimide|mesh-list
44596732|NCT00807248|Citalopram|citalopram|mesh-list
44596733|NCT00807248|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44596734|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44596735|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596736|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596737|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596738|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
44596739|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596740|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44596741|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
44596742|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596743|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44596744|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44596745|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
44596746|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
44596747|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596748|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44596749|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44596750|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596751|NCT00807248|Analgesics|analgesics|mesh-ancestor
44596752|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
44596753|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
44596754|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
44596755|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
44596756|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44596757|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
44596758|NCT00807144|Tacrolimus|tacrolimus|mesh-list
44596759|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44596760|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
44596761|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596762|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44596763|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596764|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596765|NCT00807092|Insulin|insulin|mesh-list
44596766|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44596767|NCT00807092|Metformin|metformin|mesh-list
44596768|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
44596769|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
44596770|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44596771|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44596772|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596773|NCT00807014|Adapalene|adapalene|mesh-list
44596774|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44596775|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44596776|NCT00807014|Analgesics|analgesics|mesh-ancestor
44596777|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
44596778|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596779|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596780|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596781|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596782|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596783|NCT00806819|Folic Acid|folic acid|mesh-list
44596784|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
44596785|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
44596787|NCT00806819|Dexamethasone|dexamethasone|mesh-list
44596788|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
44596789|NCT00806819|Pemetrexed|pemetrexed|mesh-list
44596790|NCT00806819|Nintedanib|nintedanib|mesh-list
44596791|NCT00806819|BB 1101|bb 1101|mesh-list
44596792|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596793|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
44596794|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
44596795|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596796|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596797|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596798|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
44596799|NCT00806819|Hormones|hormones|mesh-ancestor
44596800|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596801|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596802|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596803|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596804|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596805|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596806|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44596807|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596808|NCT00806819|Hematinics|hematinics|mesh-ancestor
44596809|NCT00806819|Vitamins|vitamins|mesh-ancestor
44596810|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
44596811|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44596812|NCT00806624|Warfarin|warfarin|mesh-list
44596813|NCT00806624|Edoxaban|edoxaban|mesh-list
44596814|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
44596815|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44596816|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
44596817|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44596818|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44596819|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596820|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596821|NCT00806494|Fesoterodine|fesoterodine|mesh-list
44596822|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44596823|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44596824|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596825|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596826|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596827|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596828|NCT00806494|Urological Agents|urological agents|mesh-ancestor
44596829|NCT00806442|Borage oil|borage oil|mesh-list
44596830|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596831|NCT00806416|Vitamin D|vitamin d|mesh-list
44596832|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
44596833|NCT00806416|Alendronate|alendronate|mesh-list
44596834|NCT00806416|Vitamins|vitamins|mesh-ancestor
44596835|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
44596836|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596837|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44596838|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44596839|NCT00806351|Caspofungin|caspofungin|mesh-list
44596840|NCT00806351|Anidulafungin|anidulafungin|mesh-list
44596841|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
44596842|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596843|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596844|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596845|NCT00806286|Paclitaxel|paclitaxel|mesh-list
44596846|NCT00806286|Carboplatin|carboplatin|mesh-list
44596847|NCT00806286|Efatutazone|efatutazone|mesh-list
44596848|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44596849|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596850|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596851|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596852|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596853|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596854|NCT00806260|Ethanol|ethanol|mesh-list
44596855|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44596856|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596857|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596858|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596859|NCT00806195|Vaccines|vaccines|mesh-list
44596860|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44596861|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
44596862|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596863|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
44596864|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596865|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44596866|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44596867|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596868|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596869|NCT00806026|Pregabalin|pregabalin|mesh-list
44596870|NCT00806026|Pramipexole|pramipexole|mesh-list
44596871|NCT00806026|Analgesics|analgesics|mesh-ancestor
44596872|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
44596873|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596874|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596875|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
44596876|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44596877|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596878|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596879|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44596880|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44596881|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44596882|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596883|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44596884|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
44596885|NCT00806026|Protective Agents|protective agents|mesh-ancestor
44596886|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44596887|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44596888|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
44596889|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
44596890|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596891|NCT00805935|Leuprolide|leuprolide|mesh-list
44596892|NCT00805935|Menotropins|menotropins|mesh-list
44596893|NCT00805935|Progesterone|progesterone|mesh-list
44596894|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44596895|NCT00805935|Progestins|progestins|mesh-ancestor
44596896|NCT00805935|Hormones|hormones|mesh-ancestor
44596897|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596898|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596899|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44596900|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
44596901|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44596902|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44596903|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596904|NCT00805792|Donepezil|donepezil|mesh-list
44596905|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44596906|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596907|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596908|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
44596909|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596910|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596911|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
44596912|NCT00805766|Infliximab|infliximab|mesh-list
44596913|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
44596914|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44596915|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44596916|NCT00805740|Caspofungin|caspofungin|mesh-list
44596917|NCT00805740|Anidulafungin|anidulafungin|mesh-list
44596918|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
44596919|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596920|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596921|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596922|NCT00805675|Tenofovir|tenofovir|mesh-list
44596923|NCT00805675|Telbivudine|telbivudine|mesh-list
44596924|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
44596925|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596926|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44596927|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44596928|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596929|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596930|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44596931|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44596932|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44596933|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44596934|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44596935|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
44596936|NCT00805285|Budesonide|budesonide|mesh-list
44596937|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
44596938|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44596939|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44596941|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596942|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596943|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44596944|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
44596945|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
44596946|NCT00805285|Hormones|hormones|mesh-ancestor
44596947|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596948|NCT00805207|Estradiol|estradiol|mesh-list
44596949|NCT00805207|Estrogens|estrogens|mesh-list
44596950|NCT00805207|Testosterone|testosterone|mesh-list
44596951|NCT00805207|Progesterone|progesterone|mesh-list
44596952|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
44596953|NCT00805207|Hormones|hormones|mesh-ancestor
44596954|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44596955|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596956|NCT00805207|Androgens|androgens|mesh-ancestor
44596957|NCT00805207|Progestins|progestins|mesh-ancestor
44596958|NCT00805194|Docetaxel|docetaxel|mesh-list
44596959|NCT00805194|Nintedanib|nintedanib|mesh-list
44596960|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596961|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44596962|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44596963|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44596964|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596965|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44596966|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596967|NCT00805142|Tapentadol|tapentadol|mesh-list
44596968|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44596969|NCT00805142|Narcotics|narcotics|mesh-ancestor
44596970|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44596971|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44596972|NCT00805142|Analgesics|analgesics|mesh-ancestor
44596973|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
44596974|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44596975|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44596976|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44596977|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44596978|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596979|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
44596980|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44596981|NCT00804908|Temozolomide|temozolomide|mesh-list
44596982|NCT00804908|Veliparib|veliparib|mesh-list
44596983|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44596984|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
44596985|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596986|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44596987|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44596988|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596989|NCT00804843|Niacin|niacin|mesh-list
44596990|NCT00804843|Atorvastatin|atorvastatin|mesh-list
44596991|NCT00804843|Simvastatin|simvastatin|mesh-list
44596992|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44596993|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44596994|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
44596995|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44596996|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44596997|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44596998|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44596999|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
44597000|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
44597001|NCT00804843|Vitamins|vitamins|mesh-ancestor
44597002|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
44597003|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597004|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
44597005|NCT00804687|Ephedrine|ephedrine|mesh-list
44597006|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44597007|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
44597008|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597009|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597010|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44597011|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44597012|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
44597013|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44597047|NCT00803634|Nicardipine|nicardipine|mesh-list
44597048|NCT00803634|Clevidipine|clevidipine|mesh-list
44597049|NCT00803634|Isosorbide|isosorbide|mesh-list
44597050|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44597051|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
44597052|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
44217068|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44597053|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44597054|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597055|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597056|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44597057|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597058|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44597059|NCT00803634|Diuretics|diuretics|mesh-ancestor
44597060|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
44597061|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44597062|NCT00803595|Oseltamivir|oseltamivir|mesh-list
44597063|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
44597064|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597065|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597066|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597067|NCT00803452|Azithromycin|azithromycin|mesh-list
44597068|NCT00803452|Doxycycline|doxycycline|mesh-list
44597069|NCT00803452|Minocycline|minocycline|mesh-list
44597070|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597071|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597072|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
44597073|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44597074|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44597075|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44597076|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44597077|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597078|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597079|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597080|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597081|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597082|NCT00803361|Analgesics|analgesics|mesh-ancestor
44597083|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
44597084|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597085|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
44597086|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597087|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
44597088|NCT00803179|Hormones|hormones|mesh-list
44597089|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597090|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597091|NCT00803101|Protein C|protein c|mesh-list
44597092|NCT00803101|Protein S|protein s|mesh-list
44597093|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
44597094|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44597095|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44597096|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597097|NCT00803049|Teriflunomide|teriflunomide|mesh-list
44597098|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44597099|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44597100|NCT00803049|Analgesics|analgesics|mesh-ancestor
44597101|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
44597102|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597103|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597104|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597105|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597106|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597107|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
44597108|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
44597109|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44597110|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44597111|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
44597112|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
44597113|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44597114|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597115|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
44597116|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597117|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44597118|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44597119|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597120|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597121|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
44597122|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597123|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597124|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597125|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597126|NCT00802737|Ofatumumab|ofatumumab|mesh-list
44597127|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597128|NCT00802672|Ciclopirox|ciclopirox|mesh-list
44597129|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
44597130|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597131|NCT00802529|Gentamicins|gentamicins|mesh-list
44597132|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
44597133|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44597134|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44597135|NCT00802529|Prednisolone|prednisolone|mesh-list
44597136|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
44597137|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44597138|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
44597139|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597140|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
44597141|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
44597142|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597143|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597144|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597145|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
44597146|NCT00802529|Hormones|hormones|mesh-ancestor
44597147|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597148|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44597149|NCT00802529|Protective Agents|protective agents|mesh-ancestor
44597150|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44597151|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597152|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597153|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597154|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44597155|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597156|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597157|NCT00802360|Menotropins|menotropins|mesh-list
44597158|NCT00802360|Progesterone|progesterone|mesh-list
44597159|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44597160|NCT00802360|Ganirelix|ganirelix|mesh-list
44597161|NCT00802360|Progestins|progestins|mesh-ancestor
44597162|NCT00802360|Hormones|hormones|mesh-ancestor
44597163|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597164|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597165|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44597166|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44597167|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
44597168|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44597169|NCT00802074|Ritonavir|ritonavir|mesh-list
44597170|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
44597171|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
44597172|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44597173|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44597174|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
44597175|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597176|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597177|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44597178|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44597179|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
44597180|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597181|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44597182|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44597183|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44597184|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44597185|NCT00801632|Prednisone|prednisone|mesh-list
44597186|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
44597187|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
44597188|NCT00801632|Rituximab|rituximab|mesh-list
44597189|NCT00801632|Tacrolimus|tacrolimus|mesh-list
44597190|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597191|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
44597192|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597193|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597194|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597195|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
44217210|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597196|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597197|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597198|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44597199|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597200|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597201|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
44597202|NCT00801632|Hormones|hormones|mesh-ancestor
44597203|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597204|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44597205|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44597206|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597207|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
44597208|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
44597209|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597210|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597211|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44597212|NCT00801632|Protective Agents|protective agents|mesh-ancestor
44597213|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44597214|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44597215|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597216|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44597217|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597218|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597219|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597220|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
44597221|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597222|NCT00801099|Amoxicillin|amoxicillin|mesh-list
44597223|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44597224|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
44597225|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
44597226|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597227|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597228|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44597229|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597230|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597231|NCT00800982|Etanercept|etanercept|mesh-list
44597232|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44597233|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44597234|NCT00800982|Analgesics|analgesics|mesh-ancestor
44597235|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
44597236|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597237|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597238|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597239|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597240|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597241|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597242|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
44597243|NCT00800735|Interferons|interferons|mesh-list
44597244|NCT00800735|Ribavirin|ribavirin|mesh-list
44597245|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
44597246|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
44597247|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44597248|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597249|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
44597250|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597251|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
44597252|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597253|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
44597254|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597255|NCT00800683|Linagliptin|linagliptin|mesh-list
44597256|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44597257|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597258|NCT00800683|Incretins|incretins|mesh-ancestor
44597259|NCT00800683|Hormones|hormones|mesh-ancestor
44597260|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597261|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44597262|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44597263|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597264|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597265|NCT00800540|Timolol|timolol|mesh-list
44597266|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44597267|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44597268|NCT00800540|Brinzolamide|brinzolamide|mesh-list
44597269|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44597270|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44597271|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425620|NCT02241187|Cetuximab|cetuximab|mesh-list
44597272|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597273|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597274|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597275|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597276|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44597277|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44597278|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44597279|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44597280|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44597281|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44597282|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597283|NCT00800436|Trastuzumab|trastuzumab|mesh-list
44597284|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597285|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597286|NCT00800202|Paclitaxel|paclitaxel|mesh-list
44597287|NCT00800202|Bevacizumab|bevacizumab|mesh-list
44597288|NCT00800202|Carboplatin|carboplatin|mesh-list
44597289|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44597290|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44597291|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597292|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
44597293|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
44597294|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
44597295|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597296|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597297|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597298|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597299|NCT00800202|Growth Substances|growth substances|mesh-ancestor
44597300|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597301|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597302|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597303|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597304|NCT00799903|Darapladib|darapladib|mesh-list
44597305|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44597306|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597307|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597308|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44597309|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44597310|NCT00799708|Estradiol|estradiol|mesh-list
44597311|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44597312|NCT00799708|Estrogens|estrogens|mesh-ancestor
44597313|NCT00799708|Hormones|hormones|mesh-ancestor
44597314|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597315|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597316|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44597317|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
44597318|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44597319|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44597320|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
44597321|NCT00799617|Testosterone|testosterone|mesh-list
44597322|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
44597323|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
44597324|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44597325|NCT00799617|Androgens|androgens|mesh-ancestor
44597326|NCT00799617|Hormones|hormones|mesh-ancestor
44597327|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597328|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597329|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44597330|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597331|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
44597332|NCT00799487|Methylphenidate|methylphenidate|mesh-list
44597333|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44597334|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597335|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44597336|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597337|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597338|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597339|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
44597340|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597341|NCT00799409|Methylphenidate|methylphenidate|mesh-list
43700445|NCT02731430|Morphine|morphine|mesh-list
44597342|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44597343|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597344|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44597345|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597346|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597347|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597348|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
44597349|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597350|NCT00799383|Vitamin D|vitamin d|mesh-list
44597351|NCT00799383|Calcium|calcium|mesh-list
44597352|NCT00799383|Vitamins|vitamins|mesh-ancestor
44597353|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
44597354|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597355|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44597356|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44597357|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
44597358|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44597359|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597360|NCT00799058|Dapivirine|dapivirine|mesh-list
44597361|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44597362|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44597363|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
44597364|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597365|NCT00798967|Teduglutide|teduglutide|mesh-list
44597366|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597367|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44597368|NCT00798967|Protective Agents|protective agents|mesh-ancestor
44597369|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597370|NCT00798889|Sunitinib|sunitinib|mesh-list
44597371|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597372|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597373|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597374|NCT00798889|Growth Substances|growth substances|mesh-ancestor
44597375|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597376|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597377|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597378|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597379|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597380|NCT00798759|Travoprost|travoprost|mesh-list
44597381|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44597382|NCT00798759|Latanoprost|latanoprost|mesh-list
44597383|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44597384|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44597385|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44597386|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44597387|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597388|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597389|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597390|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597391|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597392|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44597393|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597394|NCT00798694|Travoprost|travoprost|mesh-list
44597395|NCT00798694|Latanoprost|latanoprost|mesh-list
44597396|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44597397|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44597398|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44597399|NCT00798655|Cisplatin|cisplatin|mesh-list
44597400|NCT00798655|Panitumumab|panitumumab|mesh-list
44597401|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597402|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597403|NCT00798603|Bevacizumab|bevacizumab|mesh-list
44597404|NCT00798603|Carboplatin|carboplatin|mesh-list
44597405|NCT00798603|Pemetrexed|pemetrexed|mesh-list
44597406|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597407|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597408|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597409|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597410|NCT00798603|Growth Substances|growth substances|mesh-ancestor
44597411|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597412|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597413|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597414|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597415|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44597416|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44597417|NCT00798590|Glucagon|glucagon|mesh-list
44597418|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44597419|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597420|NCT00798590|Hormones|hormones|mesh-ancestor
44597421|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597423|NCT00798590|Incretins|incretins|mesh-ancestor
44597424|NCT00798434|Fesoterodine|fesoterodine|mesh-list
44597425|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44597426|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44597427|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
44597428|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597429|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597430|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597431|NCT00798434|Urological Agents|urological agents|mesh-ancestor
44597432|NCT00798369|Triamcinolone|triamcinolone|mesh-list
44597433|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44597434|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44597435|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44597436|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44597437|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597438|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
44597439|NCT00798369|Hormones|hormones|mesh-ancestor
44597440|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597441|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597442|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597443|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
44597444|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597445|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597446|NCT00798317|Plasminogen|plasminogen|mesh-list
44597447|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44597448|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44597449|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597450|NCT00798304|Vaccines|vaccines|mesh-list
44597451|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
44597452|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597453|NCT00798161|Metformin|metformin|mesh-list
44597454|NCT00798161|Linagliptin|linagliptin|mesh-list
44597455|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44597456|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597457|NCT00798161|Incretins|incretins|mesh-ancestor
44597458|NCT00798161|Hormones|hormones|mesh-ancestor
44597459|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597460|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44597461|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
44597462|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597463|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597464|NCT00798135|Itraconazole|itraconazole|mesh-list
44597465|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
44597466|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597467|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44597468|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44597469|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597470|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597471|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44597472|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
44597473|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597474|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597475|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44597476|NCT00797966|Citalopram|citalopram|mesh-list
44597477|NCT00797966|Fluoxetine|fluoxetine|mesh-list
44597478|NCT00797966|Paroxetine|paroxetine|mesh-list
44597479|NCT00797966|Sertraline|sertraline|mesh-list
44597480|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44597481|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
44597482|NCT00797966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44597483|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597484|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597485|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597486|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597487|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
44597488|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597489|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44597490|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
44597491|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597492|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44597501|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44597502|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597503|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597504|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44597505|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597506|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
44597507|NCT00797862|Diuretics|diuretics|mesh-ancestor
44597508|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
44597509|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44597510|NCT00797823|Insulin|insulin|mesh-list
44597511|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44597512|NCT00797823|Glucagon|glucagon|mesh-list
44597513|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44597514|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597515|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597516|NCT00797823|Hormones|hormones|mesh-ancestor
44597517|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597518|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44597519|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44597520|NCT00797316|Diuretics|diuretics|mesh-ancestor
44597521|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
44597522|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597523|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44597524|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597525|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597526|NCT00797225|Leuprolide|leuprolide|mesh-list
44597527|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44597528|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
44597529|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44597530|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597531|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44597532|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597533|NCT00797108|Amoxicillin|amoxicillin|mesh-list
44597534|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
44597535|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
44597536|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
44597537|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44597538|NCT00797108|Lactams|lactams|mesh-list
44597539|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597540|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597541|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44597542|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597543|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597544|NCT00796991|Paclitaxel|paclitaxel|mesh-list
44597545|NCT00796991|Carboplatin|carboplatin|mesh-list
44597546|NCT00796991|Ipilimumab|ipilimumab|mesh-list
44597547|NCT00796991|Dacarbazine|dacarbazine|mesh-list
44597548|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44597549|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597550|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44597551|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44597552|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44597553|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597554|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597555|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44597556|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597557|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
44597558|NCT00796978|Trastuzumab|trastuzumab|mesh-list
44597559|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597560|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597561|NCT00796861|Sunitinib|sunitinib|mesh-list
44597562|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597563|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597564|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597565|NCT00796861|Growth Substances|growth substances|mesh-ancestor
44597566|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597567|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597568|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597569|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597570|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597571|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
44597572|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44597573|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597574|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597575|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44597576|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44597577|NCT00796822|Protective Agents|protective agents|mesh-ancestor
44597578|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597579|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
44597580|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44597581|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
44597582|NCT00796757|Interferons|interferons|mesh-list
44597583|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
44597584|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
44597585|NCT00796757|Bevacizumab|bevacizumab|mesh-list
44597586|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597587|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597588|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597589|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597590|NCT00796757|Growth Substances|growth substances|mesh-ancestor
44597591|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597592|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597593|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
44597594|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597595|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
44597596|NCT00796718|Capecitabine|capecitabine|mesh-list
44597597|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44597598|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
44597599|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597600|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597601|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
44597602|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
44597603|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
44597604|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44597605|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44597606|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597607|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597608|NCT00796666|Urological Agents|urological agents|mesh-ancestor
44597609|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44597610|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
44597611|NCT00796653|Olodaterol|olodaterol|mesh-list
44597612|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44597613|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
44597614|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597615|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597616|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44597617|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
44597618|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44597619|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44597620|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44597621|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597622|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597623|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597624|NCT00796614|Tamsulosin|tamsulosin|mesh-list
44597625|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44597626|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44597627|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44597628|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597629|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217579|NCT00474110|Ketamine|ketamine|mesh-list
44597630|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597631|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597632|NCT00796614|Urological Agents|urological agents|mesh-ancestor
44597633|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
44597634|NCT00796562|Busulfan|busulfan|mesh-list
44597635|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597636|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
44597637|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597638|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597639|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597640|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
44597641|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597642|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597643|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44597644|NCT00796549|Afatinib|afatinib|mesh-list
44597645|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597646|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597647|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597648|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597649|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
44597650|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
44597651|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
44597652|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44597653|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44597654|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597655|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597656|NCT00796510|Urological Agents|urological agents|mesh-ancestor
44597657|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44597658|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44597659|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
44597660|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
44597661|NCT00796328|Phenylephrine|phenylephrine|mesh-list
44597662|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
44597663|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44597664|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
44597665|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
44597666|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597667|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597668|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
44597669|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44597670|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
44597671|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44597672|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44597673|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44597674|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44597675|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44217611|NCT00474279|Hormones|hormones|mesh-list
44217656|NCT00474721|Acetaminophen|acetaminophen|mesh-list
44597676|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597677|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597678|NCT00796328|Protective Agents|protective agents|mesh-ancestor
44597679|NCT00796315|Doxylamine|doxylamine|mesh-list
44597680|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
44597681|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
44597682|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
44597683|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597684|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597685|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597686|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44597687|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
44597688|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
44597689|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597690|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597691|NCT00796224|Azithromycin|azithromycin|mesh-list
44597692|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597693|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597694|NCT00796120|Doxorubicin|doxorubicin|mesh-list
44597695|NCT00796120|Ifosfamide|ifosfamide|mesh-list
44597696|NCT00796120|Trabectedin|trabectedin|mesh-list
44597697|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44597698|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597699|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44597700|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44597701|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597702|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597703|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597704|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
44597705|NCT00796107|Letrozole|letrozole|mesh-list
44597706|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597707|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44597708|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44597709|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597710|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597711|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44597712|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44597713|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597714|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597715|NCT00796003|Decitabine|decitabine|mesh-list
44597716|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44597717|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
44597718|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597719|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597720|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597721|NCT00795886|Sirolimus|sirolimus|mesh-list
44597722|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597723|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597724|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44597725|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597726|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
44597727|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597728|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
44597729|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597730|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
44597731|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44597732|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597734|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44597735|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
44597736|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
44597737|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
44597738|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
44597739|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44597740|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597741|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44597742|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44597743|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44597744|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
44597745|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597746|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597747|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597748|NCT00795509|Urological Agents|urological agents|mesh-ancestor
44597749|NCT00795132|Cyclosporine|cyclosporine|mesh-list
44597750|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
44597751|NCT00795132|Fludarabine|fludarabine|mesh-list
44597752|NCT00795132|Busulfan|busulfan|mesh-list
44597753|NCT00795132|Cyclosporins|cyclosporins|mesh-list
44597754|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
44597755|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44597756|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597757|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597758|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597759|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
44597760|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597761|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597762|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
44597763|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597764|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
44597765|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597766|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44597767|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44597768|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44597769|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
44597770|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44597771|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
44597772|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597773|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44597774|NCT00794963|Metformin|metformin|mesh-list
44597775|NCT00794963|Orlistat|orlistat|mesh-list
44597776|NCT00794963|Irbesartan|irbesartan|mesh-list
44597777|NCT00794963|Fenofibrate|fenofibrate|mesh-list
44597778|NCT00794963|Pravastatin|pravastatin|mesh-list
44597779|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44597780|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597781|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44597782|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
44597783|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597784|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44597785|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44597786|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44597787|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597788|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44597789|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44597790|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44597791|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44597792|NCT00794950|Sunitinib|sunitinib|mesh-list
44597793|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597794|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597795|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597796|NCT00794950|Growth Substances|growth substances|mesh-ancestor
44597797|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597798|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597799|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597800|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597801|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597802|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
44597803|NCT00794820|Rituximab|rituximab|mesh-list
44597804|NCT00794820|Fludarabine|fludarabine|mesh-list
44597805|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
44597806|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597807|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
44597808|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597809|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597810|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597811|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
44597812|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597813|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597814|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44597815|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44597816|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44597817|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
44597818|NCT00794664|Mipomersen|mipomersen|mesh-list
44597819|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44597820|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44597821|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
44597822|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597823|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44597824|NCT00794573|Varenicline|varenicline|mesh-list
44597825|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44597826|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44597827|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
44597828|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597829|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597830|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597831|NCT00794417|Cisplatin|cisplatin|mesh-list
44597832|NCT00794417|Pemetrexed|pemetrexed|mesh-list
44597833|NCT00794417|Aflibercept|aflibercept|mesh-list
44597834|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597835|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597836|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597837|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44597838|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44597839|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597840|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597841|NCT00794417|Growth Substances|growth substances|mesh-ancestor
44597842|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597843|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597845|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44597846|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44597847|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
44597848|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597849|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597850|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597851|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44597852|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44597853|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597854|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
44597855|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597856|NCT00794040|Methylphenidate|methylphenidate|mesh-list
44597857|NCT00794040|Citalopram|citalopram|mesh-list
44597858|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44597859|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597860|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44597861|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44597862|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44597863|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597864|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
44597865|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597866|NCT00794040|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44597867|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
44597868|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44597869|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
44597870|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597871|NCT00793910|Gabapentin|gabapentin|mesh-list
44597872|NCT00793910|Analgesics|analgesics|mesh-ancestor
44597873|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
44597874|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597875|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597876|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
44597877|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44597878|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44597879|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44597880|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44597881|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44597882|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44597883|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597884|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597885|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
44597886|NCT00793871|Sunitinib|sunitinib|mesh-list
44597887|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597888|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44597889|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44597890|NCT00793871|Growth Substances|growth substances|mesh-ancestor
44597891|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597892|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
44597893|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44597894|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597895|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597896|NCT00793819|Silodosin|silodosin|mesh-list
44597897|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44597898|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44597899|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44597900|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597901|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597902|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597903|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597904|NCT00793819|Urological Agents|urological agents|mesh-ancestor
44597905|NCT00793780|Naltrexone|naltrexone|mesh-list
44597906|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44597907|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44597908|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597909|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
44597910|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597911|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
44597912|NCT00793624|Olodaterol|olodaterol|mesh-list
44597913|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44597914|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
44597915|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597916|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597917|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44597918|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44597919|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44597920|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44597921|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44597922|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44597923|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44597924|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597925|NCT00793598|Brincidofovir|brincidofovir|mesh-list
44597926|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
44597927|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44597928|NCT00793585|Allopurinol|allopurinol|mesh-list
44597929|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
44597930|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597931|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597932|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
44597933|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597934|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44597935|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
44597936|NCT00793585|Protective Agents|protective agents|mesh-ancestor
44597937|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597938|NCT00793546|Exemestane|exemestane|mesh-list
44597939|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597940|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44597941|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44597942|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44597943|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597944|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44597945|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
44597946|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597947|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597948|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
44597949|NCT00792948|Leucovorin|leucovorin|mesh-list
44597950|NCT00792948|Folic Acid|folic acid|mesh-list
44597951|NCT00792948|Cytarabine|cytarabine|mesh-list
44597952|NCT00792948|Sirolimus|sirolimus|mesh-list
44597953|NCT00792948|Dexamethasone|dexamethasone|mesh-list
44597954|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
44597955|NCT00792948|Prednisone|prednisone|mesh-list
44597956|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
44597957|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44597958|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44597959|NCT00792948|Prednisolone|prednisolone|mesh-list
44597960|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
44597961|NCT00792948|Cortisone|cortisone|mesh-list
44597962|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
44597963|NCT00792948|Doxorubicin|doxorubicin|mesh-list
44597964|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44597965|NCT00792948|Methotrexate|methotrexate|mesh-list
44597966|NCT00792948|Etoposide|etoposide|mesh-list
44597967|NCT00792948|Vincristine|vincristine|mesh-list
44597968|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
44597969|NCT00792948|Dasatinib|dasatinib|mesh-list
44597970|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
44597971|NCT00792948|Tacrolimus|tacrolimus|mesh-list
44597972|NCT00792948|Lenograstim|lenograstim|mesh-list
44597973|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44597974|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
44597975|NCT00792948|BB 1101|bb 1101|mesh-list
44597976|NCT00792948|Calcium|calcium|mesh-list
44597977|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
44597978|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44597979|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
44597980|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44597981|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44597982|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44597983|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
44597984|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44597985|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44597986|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44597987|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44597988|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
44597989|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
44597990|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44597991|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44597992|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
44597993|NCT00792948|Hormones|hormones|mesh-ancestor
44597994|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44597995|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44597996|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598012|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
44598013|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598014|NCT00792948|Antidotes|antidotes|mesh-ancestor
44598015|NCT00792948|Protective Agents|protective agents|mesh-ancestor
44598016|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
44598017|NCT00792948|Vitamins|vitamins|mesh-ancestor
44598018|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
44598019|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44598020|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44598021|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
44598022|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
44598023|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44598024|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44598025|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
44598026|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44598027|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598028|NCT00792948|Hematinics|hematinics|mesh-ancestor
44598029|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
44598030|NCT00792935|Metformin|metformin|mesh-list
44598031|NCT00792935|Glimepiride|glimepiride|mesh-list
44598032|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598033|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598034|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44598035|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598036|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
44598037|NCT00792909|Vaccines|vaccines|mesh-list
44598038|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44598039|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
44598040|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598041|NCT00792701|Gemcitabine|gemcitabine|mesh-list
44598042|NCT00792701|Cisplatin|cisplatin|mesh-list
44598043|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700446|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44598044|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44598046|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598047|NCT00792701|Antiviral Agents|antiviral agents|mesh-ancestor
44598048|NCT00792701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598049|NCT00792701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598050|NCT00792701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598051|NCT00792701|Immunologic Factors|immunologic factors|mesh-ancestor
44598052|NCT00792701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598053|NCT00792636|Naproxen|naproxen|mesh-list
44598054|NCT00792636|Sumatriptan|sumatriptan|mesh-list
44598055|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44598056|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598057|NCT00792636|Analgesics|analgesics|mesh-ancestor
44598058|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
44598059|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598060|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598061|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598062|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598063|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
44598064|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44598065|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598066|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598067|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44598068|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44598069|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44598070|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
44598071|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598072|NCT00792571|Epoprostenol|epoprostenol|mesh-list
44598073|NCT00792571|Beraprost|beraprost|mesh-list
44598074|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44598075|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
44598076|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44598077|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44598078|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44598079|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598080|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598081|NCT00792298|Suvorexant|suvorexant|mesh-list
44598082|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44598083|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44598084|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598085|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598086|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44598087|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598088|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598089|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
44598090|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598091|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
44598092|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598093|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598094|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
44598095|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598096|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
44598097|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598098|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598099|NCT00791778|Sorafenib|sorafenib|mesh-list
44598100|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598101|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598102|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598103|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598104|NCT00791765|Etanercept|etanercept|mesh-list
44598105|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44598106|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598107|NCT00791765|Analgesics|analgesics|mesh-ancestor
44598108|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
44598109|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598110|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598111|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598112|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598113|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598114|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598115|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
44598116|NCT00791700|Maraviroc|maraviroc|mesh-list
44598117|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44598118|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44598119|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598120|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44598121|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44598122|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
44598123|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598124|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44598125|NCT00791648|Atorvastatin|atorvastatin|mesh-list
44598126|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44598127|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44598128|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
44598129|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598130|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44598131|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44598132|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598133|NCT00791557|Infliximab|infliximab|mesh-list
44598134|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44598135|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598136|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598137|NCT00791479|Dulaglutide|dulaglutide|mesh-list
44598138|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598139|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598140|NCT00791258|Amlodipine|amlodipine|mesh-list
44598141|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44598142|NCT00791258|Olmesartan|olmesartan|mesh-list
44598143|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44598144|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44598145|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44598146|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598147|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598148|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598149|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598150|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
44598151|NCT00791258|Diuretics|diuretics|mesh-ancestor
44598152|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
44598153|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44598154|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44598155|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44598156|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
44598157|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598158|NCT00791076|Hormones|hormones|mesh-ancestor
44598159|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598160|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598161|NCT00790907|Heparin|heparin|mesh-list
44598162|NCT00790907|PENTA|penta|mesh-list
44598163|NCT00790907|Fondaparinux|fondaparinux|mesh-list
44598164|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
44598165|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44598166|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44598167|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598168|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44598169|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
44598170|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44598171|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598172|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598173|NCT00790868|Cycloserine|cycloserine|mesh-list
44598174|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44598175|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598176|NCT00790868|Renal Agents|renal agents|mesh-ancestor
44598177|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44598178|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
44598179|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44598180|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
44598181|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598182|NCT00790842|Dexamethasone|dexamethasone|mesh-list
44598183|NCT00790842|Lenalidomide|lenalidomide|mesh-list
44598184|NCT00790842|Heparin|heparin|mesh-list
44598185|NCT00790842|Calcium heparin|calcium heparin|mesh-list
44598186|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44598187|NCT00790842|Tinzaparin|tinzaparin|mesh-list
44598188|NCT00790842|Dalteparin|dalteparin|mesh-list
44598189|NCT00790842|Anticoagulants|anticoagulants|mesh-list
44598190|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598191|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
44598192|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
44598193|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598194|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598195|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598196|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
44598197|NCT00790842|Hormones|hormones|mesh-ancestor
44598198|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598199|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44598200|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598201|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44598202|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44598203|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598204|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
44598205|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44598206|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44598207|NCT00790842|Growth Substances|growth substances|mesh-ancestor
44598208|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
44598209|NCT00790647|Bortezomib|bortezomib|mesh-list
44598210|NCT00790647|Melphalan|melphalan|mesh-list
44598211|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
44598212|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598213|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598214|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598215|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
44598216|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598217|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44598218|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598219|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
44598220|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
44598221|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598222|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598223|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598224|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
44598225|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598226|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598227|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598228|NCT00790569|Nicotine|nicotine|mesh-list
44598229|NCT00790569|Varenicline|varenicline|mesh-list
44598230|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44598231|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
44598232|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598233|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598234|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44598235|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44426599|NCT02216123|Tafenoquine|tafenoquine|mesh-list
44598236|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
44598237|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598238|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598239|NCT00790452|Aspirin|aspirin|mesh-list
44598240|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44598241|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598242|NCT00790452|Analgesics|analgesics|mesh-ancestor
44598243|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
44598244|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598245|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598246|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598247|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598248|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44598249|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44598250|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598251|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44598252|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44598253|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598254|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
44598255|NCT00790400|Everolimus|everolimus|mesh-list
44598256|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598257|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598258|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
44598259|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598260|NCT00790296|Hormones|hormones|mesh-list
44598261|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
44598262|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598263|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598264|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44598265|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598266|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598267|NCT00790205|Incretins|incretins|mesh-ancestor
44598268|NCT00790205|Hormones|hormones|mesh-ancestor
44598269|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598270|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44598271|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598272|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598273|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598274|NCT00790036|Everolimus|everolimus|mesh-list
44598275|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598276|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598277|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
44598278|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598279|NCT00790023|Ciclesonide|ciclesonide|mesh-list
44598280|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
44598281|NCT00790023|Hormones|hormones|mesh-ancestor
44598282|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598283|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598284|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44598285|NCT00789958|Gemcitabine|gemcitabine|mesh-list
44598286|NCT00789958|Capecitabine|capecitabine|mesh-list
44598287|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44598288|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
44598289|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598290|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598291|NCT00789958|Antiviral Agents|antiviral agents|mesh-ancestor
44598292|NCT00789958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598293|NCT00789958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598294|NCT00789958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598295|NCT00789958|Immunologic Factors|immunologic factors|mesh-ancestor
44598296|NCT00789958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598297|NCT00789880|Vitamin D|vitamin d|mesh-list
44598298|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
44598299|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
44598300|NCT00789880|Vitamins|vitamins|mesh-list
44598301|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
44598302|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598303|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44598304|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598305|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44598306|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
44598307|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44598308|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
44598309|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598310|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44598311|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598312|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598313|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598314|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598315|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598316|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
44598317|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44598318|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44598319|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598320|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218199|NCT00477126|Ritonavir|ritonavir|mesh-list
44598321|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44598322|NCT00789828|Everolimus|everolimus|mesh-list
44598323|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598324|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598325|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
44598326|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598327|NCT00789815|Midazolam|midazolam|mesh-list
44598328|NCT00789815|Propofol|propofol|mesh-list
44598329|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44598330|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598331|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598332|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44598333|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
44598334|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
44598335|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44598336|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44598337|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598338|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598339|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
44598340|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
44598341|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700447|NCT02731430|Narcotics|narcotics|mesh-ancestor
44598342|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598343|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44598344|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44598345|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44598346|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
44598347|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598348|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44598349|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44598350|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44598351|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
44598352|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598353|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44598354|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598355|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598356|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598357|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44598358|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44598359|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44598360|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44598361|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598362|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598363|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44598364|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44598365|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
44598366|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44598367|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44598368|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
44598369|NCT00789581|Paclitaxel|paclitaxel|mesh-list
44598370|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
44598371|NCT00789581|Doxorubicin|doxorubicin|mesh-list
44598372|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44598373|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44598374|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598375|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
44598376|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
44598377|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
44598378|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598379|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598380|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
44598381|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598382|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598383|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598384|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
44598385|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44598386|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44598387|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44598388|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44598389|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598390|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44598391|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44598392|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598393|NCT00789555|Analgesics|analgesics|mesh-ancestor
44598394|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
44598395|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598396|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598397|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598398|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598399|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44598400|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44598401|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44598402|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
44598403|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
44598404|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598405|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598406|NCT00789477|Aflibercept|aflibercept|mesh-list
44598407|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44598408|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44598409|NCT00789477|Growth Substances|growth substances|mesh-ancestor
44598410|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598411|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
44598412|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598413|NCT00789373|Cisplatin|cisplatin|mesh-list
44598414|NCT00789373|Pemetrexed|pemetrexed|mesh-list
44598415|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598416|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598417|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598418|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44598419|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44598420|NCT00789360|Loxapine|loxapine|mesh-list
44598421|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44598422|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598423|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598424|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598425|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598426|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44598427|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
44598428|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598429|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598430|NCT00789321|Amlodipine|amlodipine|mesh-list
44598431|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44598432|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44598433|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598434|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598435|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598436|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598437|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
44598438|NCT00789191|Metformin|metformin|mesh-list
44598439|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44598440|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
44598441|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598442|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598443|NCT00789191|Incretins|incretins|mesh-ancestor
44598444|NCT00789191|Hormones|hormones|mesh-ancestor
44598445|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598446|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44598447|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598448|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598449|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598450|NCT00789035|Metformin|metformin|mesh-list
44598451|NCT00789035|Empagliflozin|empagliflozin|mesh-list
44598452|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598453|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598454|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44598455|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598456|NCT00788957|Panitumumab|panitumumab|mesh-list
44598457|NCT00788957|Rilotumumab|rilotumumab|mesh-list
44598458|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44598459|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426843|NCT02207816|Vaccines|vaccines|mesh-list
44598462|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598463|NCT00788710|Analgesics|analgesics|mesh-ancestor
44598464|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
44598465|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598466|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598467|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598468|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598469|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44598470|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44598471|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598472|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598473|NCT00788593|Pancreatin|pancreatin|mesh-list
44598474|NCT00788593|Pancrelipase|pancrelipase|mesh-list
44598475|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598476|NCT00788372|Fentanyl|fentanyl|mesh-list
44598477|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44598478|NCT00788372|Narcotics|narcotics|mesh-ancestor
44598479|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598480|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598481|NCT00788372|Analgesics|analgesics|mesh-ancestor
44598482|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
44598483|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598484|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44598485|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44598486|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
44598487|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
44598488|NCT00788151|Vaccines|vaccines|mesh-list
44235541|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
44598489|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44598490|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
44598491|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598492|NCT00788125|Carboplatin|carboplatin|mesh-list
44598493|NCT00788125|Etoposide|etoposide|mesh-list
44598494|NCT00788125|Dasatinib|dasatinib|mesh-list
44598495|NCT00788125|Ifosfamide|ifosfamide|mesh-list
44598496|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
44598497|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598498|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44598499|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44598500|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44598501|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598502|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598503|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598504|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598505|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
44598506|NCT00787930|Valproic Acid|valproic acid|mesh-list
44598507|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
44598508|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598509|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598510|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
44598511|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598512|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598513|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
44598514|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598515|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598516|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598517|NCT00787917|Omalizumab|omalizumab|mesh-list
44598518|NCT00787917|Itraconazole|itraconazole|mesh-list
44598519|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
44598520|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598521|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44598522|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44598523|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598524|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598525|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44598526|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
44598527|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598528|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598529|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44598530|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44598531|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44598532|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
44598534|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44598535|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598536|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44598537|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598538|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598539|NCT00787787|Capecitabine|capecitabine|mesh-list
44598540|NCT00787787|Sunitinib|sunitinib|mesh-list
44598541|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44598542|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
44598543|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598544|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598545|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44598546|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44598547|NCT00787787|Growth Substances|growth substances|mesh-ancestor
44598548|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598549|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
44598550|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598551|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598552|NCT00787644|Pioglitazone|pioglitazone|mesh-list
44598553|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598554|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598555|NCT00787605|Amlodipine|amlodipine|mesh-list
44598556|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44598557|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44598558|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44598559|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598560|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598561|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598562|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598563|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
44598564|NCT00787605|Diuretics|diuretics|mesh-ancestor
44598565|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
44598566|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44598567|NCT00787566|Granisetron|granisetron|mesh-list
44598568|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
44598569|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
44598570|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598571|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598572|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598573|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44598574|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
44598575|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598576|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598577|NCT00787527|Prednisone|prednisone|mesh-list
44598578|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
44598579|NCT00787527|Doxorubicin|doxorubicin|mesh-list
44598580|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44598581|NCT00787527|Vincristine|vincristine|mesh-list
44598582|NCT00787527|Vorinostat|vorinostat|mesh-list
44598583|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598584|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
44598585|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598586|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598587|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598588|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
44598589|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598590|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598591|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44598592|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44598593|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44598594|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44598595|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598596|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598597|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
44598598|NCT00787527|Hormones|hormones|mesh-ancestor
44598599|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598600|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44598601|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44598602|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44598603|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44598604|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44598605|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44598606|NCT00787267|Dasatinib|dasatinib|mesh-list
44598607|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598608|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598609|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598610|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598611|NCT00787254|Lansoprazole|lansoprazole|mesh-list
44598612|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
44598613|NCT00787254|Gefarnate|gefarnate|mesh-list
44598614|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44598615|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598616|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44598617|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598618|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598619|NCT00787150|Warfarin|warfarin|mesh-list
44598620|NCT00787150|Apixaban|apixaban|mesh-list
44598621|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
44598622|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44598623|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
44598624|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44598625|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598626|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598627|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598628|NCT00786838|Trabectedin|trabectedin|mesh-list
44598629|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598630|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
44598631|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598632|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598633|NCT00786474|Dalteparin|dalteparin|mesh-list
44598634|NCT00786474|Tinzaparin|tinzaparin|mesh-list
44598635|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44598636|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
44598638|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44598639|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598640|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
44598641|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44598642|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
44598643|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44598644|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
44598645|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598646|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598647|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
44598648|NCT00786188|Paroxetine|paroxetine|mesh-list
44598649|NCT00786188|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44598650|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44598651|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598652|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598653|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598654|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
44598655|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598656|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44598657|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
44598658|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598659|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44598660|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44598661|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598662|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
44598663|NCT00785980|Quinine|quinine|mesh-list
44598664|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44598665|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598666|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44598667|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44598668|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598669|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598670|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598671|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44598672|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44598673|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
44598674|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44598675|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44598676|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44598677|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598678|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44598679|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427058|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
44598680|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598681|NCT00785980|Analgesics|analgesics|mesh-ancestor
44598682|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
44598683|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
44598684|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598685|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598686|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598687|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598688|NCT00785629|Calcium|calcium|mesh-list
44598689|NCT00785629|Sevelamer|sevelamer|mesh-list
44598690|NCT00785629|Calcium acetate|calcium acetate|mesh-list
44598691|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598692|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598693|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
44598694|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
44598695|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598696|NCT00785577|Pregabalin|pregabalin|mesh-list
44598697|NCT00785577|Analgesics|analgesics|mesh-ancestor
44598698|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
44598699|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598700|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598701|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
44598702|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44598703|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598704|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598705|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44598706|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44598707|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146086|NCT00197340|Ropivacaine|ropivacaine|mesh-list
44598708|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598709|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598710|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44598711|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
44598712|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598713|NCT00785512|Nebivolol|nebivolol|mesh-list
44598714|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44598715|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
44598716|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44598717|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44598718|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44598719|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
44598720|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598721|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598722|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598723|NCT00785486|Quinine|quinine|mesh-list
44598724|NCT00785486|Midazolam|midazolam|mesh-list
44598725|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44598726|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44598727|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598728|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598729|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44598730|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598731|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598732|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44598733|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
44598734|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
44598735|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
44598736|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
44598737|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598738|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598739|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
44598740|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44598741|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44598742|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598743|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44598744|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44598745|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598746|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598747|NCT00785486|Analgesics|analgesics|mesh-ancestor
44598748|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
44598749|NCT00785291|Paclitaxel|paclitaxel|mesh-list
44598750|NCT00785291|Epothilones|epothilones|mesh-list
44598751|NCT00785291|Epothilone B|epothilone b|mesh-list
44598752|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44598753|NCT00785291|Bevacizumab|bevacizumab|mesh-list
44598754|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44598755|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
44598756|NCT00785291|Antibodies|antibodies|mesh-list
44598757|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
44598758|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44598759|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
44598760|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44598761|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598762|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44598763|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44598764|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44598765|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598766|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44598767|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44598768|NCT00785291|Growth Substances|growth substances|mesh-ancestor
44598769|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598770|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44598771|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
44598772|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
44598773|NCT00785213|Quinine|quinine|mesh-list
44598774|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44598775|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598776|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
44598777|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44598778|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44598779|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598780|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44598781|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44598782|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598783|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598784|NCT00785213|Analgesics|analgesics|mesh-ancestor
43770771|NCT02376972|Metronidazole|metronidazole|mesh-list
44598785|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
44598787|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
44598788|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598789|NCT00784927|Dexamethasone|dexamethasone|mesh-list
44598790|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
44598791|NCT00784927|Rituximab|rituximab|mesh-list
44598792|NCT00784927|Lenalidomide|lenalidomide|mesh-list
44598793|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598794|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
44598795|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598796|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598797|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44598798|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
44598799|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598800|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598801|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44598802|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44598803|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598804|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
44598805|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
44598806|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598807|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598808|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
44598809|NCT00784927|Hormones|hormones|mesh-ancestor
44598810|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44598811|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44598812|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44598813|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44598814|NCT00784927|Growth Substances|growth substances|mesh-ancestor
44598815|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
44598816|NCT00784875|Zolpidem|zolpidem|mesh-list
44218670|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44598817|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44598818|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44598819|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598820|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598821|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44598822|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
44598823|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
44598824|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598825|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598826|NCT00784836|Interferons|interferons|mesh-list
44598827|NCT00784836|Interferon-beta|interferon-beta|mesh-list
44598828|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
44598829|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598830|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
44598831|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598832|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
44598833|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598834|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44598835|NCT00784810|Acetaminophen|acetaminophen|mesh-list
44598836|NCT00784810|Oxycodone|oxycodone|mesh-list
44598837|NCT00784810|Codeine|codeine|mesh-list
44598838|NCT00784810|Naloxone|naloxone|mesh-list
44598839|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44598840|NCT00784810|Analgesics|analgesics|mesh-ancestor
44598841|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
44598842|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598843|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598844|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
44598845|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44598846|NCT00784810|Narcotics|narcotics|mesh-ancestor
44598847|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598848|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44598849|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
44598850|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
44598851|NCT00784784|Zanamivir|zanamivir|mesh-list
44598852|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
44598853|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598854|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598855|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598856|NCT00784719|Cyclosporine|cyclosporine|mesh-list
44598857|NCT00784719|Cyclosporins|cyclosporins|mesh-list
44598858|NCT00784719|Tofacitinib|tofacitinib|mesh-list
44598859|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44598860|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598861|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598862|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
44598863|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598864|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
44598865|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598866|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44598867|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598868|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44598869|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44598870|NCT00784693|Tanezumab|tanezumab|mesh-list
44598871|NCT00784693|Analgesics|analgesics|mesh-ancestor
44598872|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
44457254|NCT01613599|Rituximab|rituximab|mesh-list
44598873|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598874|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598875|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44598876|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44598877|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598878|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44598879|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44598880|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598881|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598882|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
44598883|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598884|NCT00784550|Fluticasone|fluticasone|mesh-list
44598885|NCT00784550|Xhance|xhance|mesh-list
44598886|NCT00784550|Bromides|bromides|mesh-list
44598887|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
44598888|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44598889|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44598890|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44598891|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
44598892|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598893|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598894|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44598895|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44598896|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44598897|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44598898|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
44598899|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44598900|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
44598901|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598902|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598903|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44598904|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44598905|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44598906|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44598907|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
44598908|NCT00784459|Abatacept|abatacept|mesh-list
44598909|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44598910|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598911|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598912|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598913|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
44598914|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598915|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44598916|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44598917|NCT00784277|Oxycodone|oxycodone|mesh-list
44598918|NCT00784277|Tapentadol|tapentadol|mesh-list
44598919|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44598920|NCT00784277|Narcotics|narcotics|mesh-ancestor
44598921|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44598922|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598923|NCT00784277|Analgesics|analgesics|mesh-ancestor
44598924|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
44598925|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44598926|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44598927|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44598928|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598929|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598930|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
44598931|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598932|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44598933|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44598934|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44598935|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838406|NCT04842682|Diazepam|diazepam|mesh-list
44598936|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598937|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44598938|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44598939|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44598940|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
44598941|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598942|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598943|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44598944|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44598945|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
44598946|NCT00784147|Ibalizumab|ibalizumab|mesh-list
44598947|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44598948|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44598949|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44598950|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
44598951|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44598952|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
44598953|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598954|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44598955|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44598956|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44598957|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598958|NCT00783835|Methylphenidate|methylphenidate|mesh-list
44598959|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44598960|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598961|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44598962|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44598963|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44598964|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44598965|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
44598966|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44598967|NCT00783796|Everolimus|everolimus|mesh-list
44598968|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44598969|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44598970|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
44598971|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598972|NCT00783718|Vedolizumab|vedolizumab|mesh-list
44598973|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598974|NCT00783705|Inositol|inositol|mesh-list
44598975|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
44598976|NCT00783705|Vitamins|vitamins|mesh-ancestor
44598977|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
44598978|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44598979|NCT00783692|Vedolizumab|vedolizumab|mesh-list
44598980|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44598981|NCT00783432|Azelastine|azelastine|mesh-list
44598982|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44598983|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
44427351|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44599000|NCT00783224|Fluticasone|fluticasone|mesh-list
44599001|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
44599002|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599003|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599004|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
44599005|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599006|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599007|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599008|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599009|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599010|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44599011|NCT00783094|Tadalafil|tadalafil|mesh-list
44599012|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599013|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44599014|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44599015|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599016|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599017|NCT00783094|Urological Agents|urological agents|mesh-ancestor
44599018|NCT00782795|Pioglitazone|pioglitazone|mesh-list
44218826|NCT00480376|Gentamicins|gentamicins|mesh-list
44599019|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599020|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599021|NCT00782717|Prednisolone|prednisolone|mesh-list
44599022|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44599023|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
44599024|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44599025|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
44599026|NCT00782717|Nepafenac|nepafenac|mesh-list
44599027|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44599028|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
44599029|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599031|NCT00782717|Hormones|hormones|mesh-ancestor
44599032|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599033|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599034|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599035|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599036|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
44599037|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
44599038|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599039|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599040|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44599041|NCT00782717|Protective Agents|protective agents|mesh-ancestor
44599042|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44599043|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599044|NCT00782717|Analgesics|analgesics|mesh-ancestor
44599045|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
44599046|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599047|NCT00782626|Everolimus|everolimus|mesh-list
44599048|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599049|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599050|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
44599051|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599052|NCT00782509|Olodaterol|olodaterol|mesh-list
44599053|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599054|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
44599055|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599056|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599057|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599058|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599059|NCT00782418|Exenatide|exenatide|mesh-list
44599060|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599061|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599062|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44599063|NCT00782418|Incretins|incretins|mesh-ancestor
44599064|NCT00782418|Hormones|hormones|mesh-ancestor
44599065|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599066|NCT00782340|Droxidopa|droxidopa|mesh-list
44599067|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44599068|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44599069|NCT00782275|Sirolimus|sirolimus|mesh-list
44599070|NCT00782275|Bevacizumab|bevacizumab|mesh-list
44599071|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44599072|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599073|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44599074|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44599075|NCT00782275|Growth Substances|growth substances|mesh-ancestor
44599076|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599077|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44599078|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599079|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599080|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44599081|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
44599082|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599083|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
44599084|NCT00782210|Olodaterol|olodaterol|mesh-list
44599085|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599086|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
44599087|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599088|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599089|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599090|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599091|NCT00782067|Midostaurin|midostaurin|mesh-list
44599092|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599093|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44599094|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599095|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599096|NCT00781937|Liraglutide|liraglutide|mesh-list
44599097|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599098|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599099|NCT00781937|Incretins|incretins|mesh-ancestor
44599100|NCT00781937|Hormones|hormones|mesh-ancestor
44599101|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599102|NCT00781911|Octreotide|octreotide|mesh-list
44599103|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599104|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599105|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599106|NCT00781885|Beraprost|beraprost|mesh-list
44599107|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44599108|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599109|NCT00781859|Plasminogen|plasminogen|mesh-list
44599110|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44599111|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44599112|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599113|NCT00781768|Ondansetron|ondansetron|mesh-list
44599114|NCT00781768|Aprepitant|aprepitant|mesh-list
44599115|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
44599116|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
44599117|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599118|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599119|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599120|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
44599121|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599122|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44599123|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
44599124|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599125|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599126|NCT00781768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44599127|NCT00781768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44599128|NCT00781768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599129|NCT00781768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44599130|NCT00781768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44599131|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44599132|NCT00781599|Varenicline|varenicline|mesh-list
44599133|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44599134|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44599135|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599136|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599137|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599138|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599139|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
44599140|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
44599141|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
44599142|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44599143|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599144|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44599145|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44599146|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44599147|NCT00781391|Warfarin|warfarin|mesh-list
44599148|NCT00781391|Edoxaban|edoxaban|mesh-list
44599149|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
44599150|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44599151|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
44599152|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44599153|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
44599154|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599155|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599156|NCT00781326|Nimodipine|nimodipine|mesh-list
44599157|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599158|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44599159|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599160|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599161|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44599162|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599163|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599164|NCT00781274|Ribavirin|ribavirin|mesh-list
44599165|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44599166|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
44599167|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599168|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
44599169|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599170|NCT00780910|Ribavirin|ribavirin|mesh-list
44599171|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44599172|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
44599173|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599174|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
44599175|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599176|NCT00780416|Ribavirin|ribavirin|mesh-list
44599177|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44599178|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
44599179|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
44599180|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599181|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
44599182|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599183|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
44599184|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599185|NCT00780273|Cimetidine|cimetidine|mesh-list
44599186|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44599187|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599188|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44599189|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
44599190|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
44599191|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218996|NCT00480935|Sunitinib|sunitinib|mesh-list
44599192|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427565|NCT02188784|Iron|iron|mesh-list
44599193|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599194|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44599195|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44599196|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599198|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599199|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
44599200|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599201|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599202|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
44599203|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599204|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599205|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
44599206|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599207|NCT00779909|Vitamin D|vitamin d|mesh-list
44599208|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
44599209|NCT00779909|Vitamins|vitamins|mesh-ancestor
44599210|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
44599211|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599212|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44599213|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44599214|NCT00779675|Infliximab|infliximab|mesh-list
44599215|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599216|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599217|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599218|NCT00779584|Gemcitabine|gemcitabine|mesh-list
44599219|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599220|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
44599221|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599222|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599223|NCT00779584|Antiviral Agents|antiviral agents|mesh-ancestor
44599224|NCT00779584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599225|NCT00779584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599226|NCT00779584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599227|NCT00779584|Immunologic Factors|immunologic factors|mesh-ancestor
44599228|NCT00779584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599229|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44599230|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
44599231|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44599232|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44599233|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44599234|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599235|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599236|NCT00779467|Fentanyl|fentanyl|mesh-list
44599237|NCT00779467|Bupivacaine|bupivacaine|mesh-list
44599238|NCT00779467|Neostigmine|neostigmine|mesh-list
44599239|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
44599240|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
44599241|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599242|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599243|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
44599244|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599245|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44599246|NCT00779467|Narcotics|narcotics|mesh-ancestor
44599247|NCT00779467|Analgesics|analgesics|mesh-ancestor
44599248|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44599249|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44599250|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
44599251|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44599252|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599253|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599254|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599255|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599256|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44599257|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
44599258|NCT00779324|Amantadine|amantadine|mesh-list
44599259|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44599260|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44599261|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
44599262|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599263|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
44599264|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599265|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599266|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599267|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599268|NCT00779324|Analgesics|analgesics|mesh-ancestor
44599269|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
44599270|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599272|NCT00779259|Theophylline|theophylline|mesh-list
44599273|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599274|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
44599275|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599276|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599277|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599278|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599279|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44599280|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599281|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599282|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599283|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44599284|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44599285|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
44599286|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599287|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
44599288|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44599289|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44599290|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599291|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44599292|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44599293|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599294|NCT00779259|Analgesics|analgesics|mesh-ancestor
44599295|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
44427714|NCT02187055|Adalimumab|adalimumab|mesh-list
44599296|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
44599297|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44599298|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44599299|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599300|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
44599301|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599302|NCT00779142|Methotrexate|methotrexate|mesh-list
44599303|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44599304|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
44599305|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44599306|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599307|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599308|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
44599309|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599310|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599311|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599312|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599313|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44599314|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599315|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
44599316|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599317|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44599318|NCT00779038|Fentanyl|fentanyl|mesh-list
44599319|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44599320|NCT00779038|Narcotics|narcotics|mesh-ancestor
44599321|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599322|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599323|NCT00779038|Analgesics|analgesics|mesh-ancestor
44599324|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
44599325|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599326|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44599327|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44599328|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
44599329|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
44599330|NCT00778921|Amlodipine|amlodipine|mesh-list
44599331|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599332|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44599333|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599334|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599335|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44599336|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599337|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599339|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44599340|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599341|NCT00778817|Mitotane|mitotane|mesh-list
44599342|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599343|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599344|NCT00778622|Metformin|metformin|mesh-list
44599345|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599346|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599347|NCT00778375|Cytarabine|cytarabine|mesh-list
44599348|NCT00778375|Decitabine|decitabine|mesh-list
44599349|NCT00778375|Clofarabine|clofarabine|mesh-list
44599350|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599351|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
44599352|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599353|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599354|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
44599355|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599356|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599357|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
44599358|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599359|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599360|NCT00778102|Leucovorin|leucovorin|mesh-list
44599361|NCT00778102|Bevacizumab|bevacizumab|mesh-list
44599362|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
44599363|NCT00778102|Irinotecan|irinotecan|mesh-list
44599364|NCT00778102|Fluorouracil|fluorouracil|mesh-list
44599365|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
44599366|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44599367|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599368|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44599369|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44599370|NCT00778102|Growth Substances|growth substances|mesh-ancestor
44599371|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599372|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44599373|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44599374|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44599375|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599376|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599377|NCT00778102|Antidotes|antidotes|mesh-ancestor
44599378|NCT00778102|Protective Agents|protective agents|mesh-ancestor
44599379|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44599380|NCT00778102|Vitamins|vitamins|mesh-ancestor
44599381|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
44599382|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
44599383|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599384|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599385|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
44599386|NCT00777946|Amlodipine|amlodipine|mesh-list
44599387|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44219189|NCT00481741|Hemostatics|hemostatics|mesh-list
44599388|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44599389|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599390|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599391|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44599392|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599393|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599394|NCT00777920|Ambrisentan|ambrisentan|mesh-list
44599395|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599396|NCT00777829|Zolpidem|zolpidem|mesh-list
44599397|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44599398|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44599399|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599400|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599401|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44599402|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
44599403|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
44599404|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599405|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599406|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
44599407|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44599408|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44599409|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44599410|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44599411|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599412|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599413|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599414|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599415|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599416|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44599417|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599418|NCT00777608|Donepezil|donepezil|mesh-list
44599419|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44599420|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599421|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599422|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599423|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599424|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599425|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
44599426|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
44599427|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44599428|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
44599429|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44599430|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599431|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44599432|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44599433|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44599434|NCT00777296|Amikacin|amikacin|mesh-list
44599435|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599436|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599437|NCT00777153|Cediranib|cediranib|mesh-list
44599438|NCT00777153|Lomustine|lomustine|mesh-list
44599439|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599440|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44599441|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599442|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599443|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44599444|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
44599445|NCT00777101|Capecitabine|capecitabine|mesh-list
44599446|NCT00777101|Lapatinib|lapatinib|mesh-list
44599447|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599461|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599462|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599464|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44599465|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44599466|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599467|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44599468|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44599469|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44599470|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599471|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599472|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
44599473|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
44599474|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599475|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
44599476|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599477|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599478|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599479|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599480|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
44599481|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44599482|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599483|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599484|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599485|NCT00776919|Clindamycin|clindamycin|mesh-list
44599486|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
44599487|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
44599488|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44599489|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599490|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599491|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44599492|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599493|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599494|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599495|NCT00776659|Exemestane|exemestane|mesh-list
44599496|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599497|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44599498|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44599499|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599500|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599501|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44599502|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
44599503|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599504|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599505|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44427933|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599506|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
44599507|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44599508|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599509|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44599510|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44599511|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599512|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599513|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
44599514|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599515|NCT00776230|Vaccines|vaccines|mesh-list
44599516|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
44599517|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599518|NCT00776009|Methylphenidate|methylphenidate|mesh-list
44599519|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44599520|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44599521|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599522|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44599523|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44599524|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599525|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599526|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
44599527|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599528|NCT00775606|Ritonavir|ritonavir|mesh-list
44599529|NCT00775606|Lopinavir|lopinavir|mesh-list
44599530|NCT00775606|Efavirenz|efavirenz|mesh-list
44599531|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44599532|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44599533|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44599534|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599535|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599536|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44599537|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44599538|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
44599539|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599540|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44599541|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44599542|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44599543|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44599544|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44599545|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44599546|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44599547|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44599548|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44599549|NCT00775593|Sirolimus|sirolimus|mesh-list
44599550|NCT00775593|Clofarabine|clofarabine|mesh-list
44599551|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599552|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599553|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44599554|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599555|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
44599556|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599557|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
44599558|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599559|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599560|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
44599561|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599562|NCT00775528|Pancrelipase|pancrelipase|mesh-list
44599563|NCT00775528|Pancreatin|pancreatin|mesh-list
44599564|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599565|NCT00775463|Treprostinil|treprostinil|mesh-list
44599566|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599568|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
44599569|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599570|NCT00775437|Adalimumab|adalimumab|mesh-list
44599571|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599572|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599573|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44599574|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44599575|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599576|NCT00775203|Trazodone|trazodone|mesh-list
44599577|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44599578|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44599579|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599580|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599581|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44599582|NCT00775203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44599583|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44599584|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599585|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599586|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599587|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
44599588|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44599589|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44599591|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44599592|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44599593|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
44599594|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44599595|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599596|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44599597|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44599598|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44599599|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599600|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599601|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44599602|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44599603|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599604|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599605|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599606|NCT00775138|Amikacin|amikacin|mesh-list
44599607|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599608|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599609|NCT00774852|Prednisone|prednisone|mesh-list
44599610|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
44599611|NCT00774852|Abatacept|abatacept|mesh-list
44599612|NCT00774852|Azathioprine|azathioprine|mesh-list
44599613|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599614|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
44599615|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599616|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599617|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44599618|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
44599619|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599620|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599621|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44599622|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599623|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
44599624|NCT00774852|Hormones|hormones|mesh-ancestor
44599625|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599626|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599627|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44599628|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
44599629|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599630|NCT00774800|Insulin|insulin|mesh-list
44599631|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44599632|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
44599633|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599634|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599635|NCT00774787|Imiquimod|imiquimod|mesh-list
44599636|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44599637|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
44599638|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599639|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599640|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
44599641|NCT00774345|Lenalidomide|lenalidomide|mesh-list
44599642|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
44599643|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599644|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44599645|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44599646|NCT00774345|Growth Substances|growth substances|mesh-ancestor
44599647|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44599648|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599649|NCT00774306|Phenytoin|phenytoin|mesh-list
44599650|NCT00774306|Levetiracetam|levetiracetam|mesh-list
44599651|NCT00774306|Valproic Acid|valproic acid|mesh-list
44599652|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
44599653|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
44599654|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599655|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599656|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
44599657|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599658|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599659|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
44599660|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44599661|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599662|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44599663|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44599664|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44599665|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599666|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44599667|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44599668|NCT00774046|Cytarabine|cytarabine|mesh-list
44599669|NCT00774046|Etoposide|etoposide|mesh-list
44599670|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
44599671|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44599672|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599673|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44599674|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44599675|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599676|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599677|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44599678|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
44599679|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
44599680|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599681|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599682|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
44599683|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599684|NCT00774046|Analgesics|analgesics|mesh-ancestor
44599685|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
44599686|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599687|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
44599688|NCT00773968|Hematinics|hematinics|mesh-ancestor
44599689|NCT00773838|Dexamethasone|dexamethasone|mesh-list
44599690|NCT00773838|Bortezomib|bortezomib|mesh-list
44599691|NCT00773838|Vorinostat|vorinostat|mesh-list
44599692|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599693|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
44599694|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
44599695|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599696|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599697|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599698|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
44599699|NCT00773838|Hormones|hormones|mesh-ancestor
44599700|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219442|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599701|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599702|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599703|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44599704|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599705|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599706|NCT00773747|Bortezomib|bortezomib|mesh-list
44599707|NCT00773747|Vorinostat|vorinostat|mesh-list
44599708|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599709|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44599710|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599711|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599712|NCT00773734|Thalidomide|thalidomide|mesh-list
44599713|NCT00773734|Apremilast|apremilast|mesh-list
44599714|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44599715|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599716|NCT00773734|Analgesics|analgesics|mesh-ancestor
44599717|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
44599718|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599719|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599720|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599721|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599722|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44599723|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44599724|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599725|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599726|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599727|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
44599728|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
44428159|NCT02175966|Ribavirin|ribavirin|mesh-list
44599729|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599730|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599731|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44599732|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44599733|NCT00773734|Growth Substances|growth substances|mesh-ancestor
44599734|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44599735|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599736|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
44599737|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
44599738|NCT00773513|Hematinics|hematinics|mesh-ancestor
44219488|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599739|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44599740|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599741|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44599742|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599743|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599744|NCT00773292|Cyclosporine|cyclosporine|mesh-list
44599745|NCT00773292|Cyclosporins|cyclosporins|mesh-list
44599746|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599747|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599748|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599749|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
44599750|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599751|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
44599752|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599753|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599754|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599755|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44599756|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
44599757|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44599758|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44599759|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44599760|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599761|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599762|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599763|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599764|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599765|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44599766|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599767|NCT00773136|Bimatoprost|bimatoprost|mesh-list
44599768|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599769|NCT00773097|Poly ICLC|poly iclc|mesh-list
44599770|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
44599771|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
44599772|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599773|NCT00772967|Naproxen|naproxen|mesh-list
44599774|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44599775|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599776|NCT00772967|Analgesics|analgesics|mesh-ancestor
44599777|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
44599778|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599779|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599780|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599781|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599782|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
44599783|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44599784|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599785|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599786|NCT00772954|Vaccines|vaccines|mesh-list
44599787|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
44599788|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599789|NCT00772941|Varenicline|varenicline|mesh-list
44599790|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44599791|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44599792|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599793|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599794|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599795|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599796|NCT00772928|Vaccines|vaccines|mesh-list
44599797|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44599798|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
44599799|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599800|NCT00772668|Prednisone|prednisone|mesh-list
44599801|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
44599802|NCT00772668|Rituximab|rituximab|mesh-list
44599803|NCT00772668|Bortezomib|bortezomib|mesh-list
44599804|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599805|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
44599806|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599807|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599808|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44599809|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
44599810|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599811|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599812|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44599813|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44599814|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599815|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
44599817|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599818|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44599819|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
44599820|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
44599821|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44599822|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44599823|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599824|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599825|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44599826|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44599827|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44599828|NCT00772577|Ramipril|ramipril|mesh-list
44599829|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599830|NCT00772577|Diuretics|diuretics|mesh-ancestor
44599831|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
44599832|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599833|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44599834|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599835|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599836|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44599837|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
44599838|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599839|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
44599840|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44599841|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
44599842|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599843|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599844|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44599845|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
44599846|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
44599847|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44599848|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
44599849|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599850|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599851|NCT00772447|Vancomycin|vancomycin|mesh-list
44599852|NCT00772447|Daptomycin|daptomycin|mesh-list
44599853|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599854|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599855|NCT00772148|Tacrolimus|tacrolimus|mesh-list
44599856|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599857|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
44599858|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599859|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44599860|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599861|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599863|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
44599864|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599865|NCT00772070|Vaccines|vaccines|mesh-list
44599866|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
44599867|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599868|NCT00772031|Topiramate|topiramate|mesh-list
44599869|NCT00772031|Propranolol|propranolol|mesh-list
44599870|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44599871|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44599872|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
44599873|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599874|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599875|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599876|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44428291|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599877|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599878|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599879|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
44599880|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599881|NCT00772005|Modafinil|modafinil|mesh-list
44599882|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44599883|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599884|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44599885|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44599886|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44599887|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599888|NCT00771953|Docetaxel|docetaxel|mesh-list
44599889|NCT00771953|Pemetrexed|pemetrexed|mesh-list
44599890|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599891|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44599892|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44599893|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44599894|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599895|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599896|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44599897|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44599898|NCT00771927|Lacosamide|lacosamide|mesh-list
44599899|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
44219648|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
44599900|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44599901|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44599902|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599903|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599904|NCT00771914|Aspirin|aspirin|mesh-list
44599905|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44599906|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44599907|NCT00771914|Analgesics|analgesics|mesh-ancestor
44599908|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
44599909|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599910|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599911|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599912|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44599913|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44599914|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44599915|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599916|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44599917|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44599918|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599919|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
44599920|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44599921|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44599922|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599923|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
44599924|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599925|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44599926|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599927|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44599928|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44599929|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
44599930|NCT00771758|Oxycodone|oxycodone|mesh-list
44599931|NCT00771758|Tapentadol|tapentadol|mesh-list
44599932|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44599933|NCT00771758|Narcotics|narcotics|mesh-ancestor
44599934|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599935|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599936|NCT00771758|Analgesics|analgesics|mesh-ancestor
44599937|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
44599938|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44599939|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44599940|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44599941|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44599942|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599943|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44599944|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44599945|NCT00771667|Ustekinumab|ustekinumab|mesh-list
44599946|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599947|NCT00771472|Vorinostat|vorinostat|mesh-list
44599948|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599949|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44599950|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599951|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599952|NCT00771316|Meropenem|meropenem|mesh-list
44599953|NCT00771316|Ertapenem|ertapenem|mesh-list
44599954|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44599955|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44599956|NCT00771030|Brodalumab|brodalumab|mesh-list
44599957|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
44599958|NCT00770913|Rabeprazole|rabeprazole|mesh-list
44599959|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44599960|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44599961|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44599962|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599963|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599964|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44599965|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44599966|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
44599967|NCT00770770|Hormones|hormones|mesh-ancestor
44599968|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44599969|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599970|NCT00770692|Eszopiclone|eszopiclone|mesh-list
44599971|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44599972|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44599973|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599974|NCT00770679|Atorvastatin|atorvastatin|mesh-list
44599975|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44599976|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44599977|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
44599978|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599979|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44599980|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44599981|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599982|NCT00770653|Metformin|metformin|mesh-list
44599983|NCT00770653|Pioglitazone|pioglitazone|mesh-list
44599984|NCT00770653|Glimepiride|glimepiride|mesh-list
44599985|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44599986|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44599987|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44599988|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44599989|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
44599990|NCT00770588|Gefitinib|gefitinib|mesh-list
44599991|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599992|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44599993|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44599994|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44599995|NCT00770562|Dexamethasone|dexamethasone|mesh-list
44599996|NCT00770562|Rituximab|rituximab|mesh-list
44599997|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44599998|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44599999|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
44600000|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600001|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600002|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600003|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
44600004|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
43771211|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44600005|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600006|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600008|NCT00770562|Hormones|hormones|mesh-ancestor
44600009|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600010|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44600011|NCT00770510|Zolpidem|zolpidem|mesh-list
44600012|NCT00770510|Eszopiclone|eszopiclone|mesh-list
44600013|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44600014|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44600015|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600016|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600017|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44600018|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
44600019|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
44600020|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600021|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600022|NCT00770484|Propranolol|propranolol|mesh-list
44600023|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44600024|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44600025|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
44600026|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600027|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600028|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600029|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44600030|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44600031|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600032|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44600033|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44600034|NCT00770432|Laxatives|laxatives|mesh-ancestor
44600035|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600036|NCT00770367|Pioglitazone|pioglitazone|mesh-list
44600037|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600038|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600039|NCT00770341|Vancomycin|vancomycin|mesh-list
44600040|NCT00770341|Daptomycin|daptomycin|mesh-list
44600041|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44600042|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600043|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
44219781|NCT00484133|Dopamine|dopamine|mesh-list
44600044|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44600045|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600046|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600047|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44600048|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44600049|NCT00770328|Protective Agents|protective agents|mesh-ancestor
44600050|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600051|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600052|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44600053|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
44600054|NCT00770224|Prednisone|prednisone|mesh-list
44600055|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
44600056|NCT00770224|Rituximab|rituximab|mesh-list
44600057|NCT00770224|Doxorubicin|doxorubicin|mesh-list
44600058|NCT00770224|Vincristine|vincristine|mesh-list
44600059|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
44600060|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600061|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
44600062|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600063|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600064|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44600065|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
44600066|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600067|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600068|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44600069|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44600070|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44600071|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44600072|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44600073|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600074|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600075|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
44600076|NCT00770224|Hormones|hormones|mesh-ancestor
44600077|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600078|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44236664|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
44600079|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44600080|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
44600081|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
44600082|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
44600083|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
44600084|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44600085|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44600086|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44600087|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44600088|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600089|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600090|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
44600091|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600092|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600093|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44600094|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600095|NCT00770146|Mipomersen|mipomersen|mesh-list
44600096|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44600097|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600098|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
44600099|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600100|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600101|NCT00770120|Everolimus|everolimus|mesh-list
44600102|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600103|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600104|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
44600105|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600106|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
44600107|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44600108|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44600109|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44600110|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44600111|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600112|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600113|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
44600114|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600115|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600116|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44600117|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600118|NCT00769704|Molgramostim|molgramostim|mesh-list
44600119|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44600120|NCT00769704|Sargramostim|sargramostim|mesh-list
44600121|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
44600122|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600123|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600124|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44600125|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
44600126|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600127|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
44600128|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
44600129|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
44600130|NCT00769483|Gemcitabine|gemcitabine|mesh-list
44600131|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44600132|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600133|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
44428593|NCT02166333|Vitamin D|vitamin d|mesh-list
44600134|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600135|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600137|NCT00769483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600138|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600139|NCT00769483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600140|NCT00769483|Immunologic Factors|immunologic factors|mesh-ancestor
44600141|NCT00769483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600142|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600143|NCT00769184|Clobetasol|clobetasol|mesh-list
44600144|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600145|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
44600146|NCT00769184|Hormones|hormones|mesh-ancestor
44600147|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600148|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600150|NCT00769132|Niacinamide|niacinamide|mesh-list
44600151|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
44600152|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600153|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
44600154|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600155|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600156|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600157|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
44600158|NCT00769132|Vitamins|vitamins|mesh-ancestor
44600159|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
44600160|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600161|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44600162|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600163|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600164|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600165|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600166|NCT00768989|Ritonavir|ritonavir|mesh-list
44600167|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44600168|NCT00768989|Tenofovir|tenofovir|mesh-list
44600169|NCT00768989|Emtricitabine|emtricitabine|mesh-list
44600170|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
44600171|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44600172|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44600173|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
44600174|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600175|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600176|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44600177|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44600178|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
44600179|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600180|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44600181|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44600182|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44600183|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44600184|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44600185|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44600186|NCT00768755|Pemetrexed|pemetrexed|mesh-list
44600187|NCT00768755|Axitinib|axitinib|mesh-list
44600188|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600189|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600190|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600191|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44600192|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44600193|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600194|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44600195|NCT00768651|Pantoprazole|pantoprazole|mesh-list
44600196|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600197|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600198|NCT00768651|Incretins|incretins|mesh-ancestor
44600199|NCT00768651|Hormones|hormones|mesh-ancestor
44600200|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600201|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44600202|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
44600203|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600204|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600205|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44600206|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600207|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44600208|NCT00768560|Nifedipine|nifedipine|mesh-list
44600209|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44600210|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600211|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600212|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44600213|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600214|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600215|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
44600216|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44600218|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44600219|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600220|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
44600221|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
44600222|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
44600223|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600224|NCT00768430|Midazolam|midazolam|mesh-list
44600225|NCT00768430|Ketamine|ketamine|mesh-list
44600226|NCT00768430|Analgesics|analgesics|mesh-ancestor
44600227|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
44600228|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600229|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600230|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44600231|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44600232|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
44600233|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
44600234|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600235|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44600236|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44600237|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600238|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600239|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44600240|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44600241|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44600242|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600243|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600244|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
44600245|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
44600246|NCT00768300|Ambrisentan|ambrisentan|mesh-list
44600247|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44600248|NCT00768248|Ropivacaine|ropivacaine|mesh-list
44600249|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
44600250|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
44600251|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600252|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600253|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
44600254|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600255|NCT00768222|Triclosan|triclosan|mesh-list
44600256|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44600257|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600258|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44600259|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600260|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
44600261|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600262|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600263|NCT00768144|Sunitinib|sunitinib|mesh-list
44600264|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600265|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44600266|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44600267|NCT00768144|Growth Substances|growth substances|mesh-ancestor
44600268|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600269|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44600270|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600271|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600272|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600273|NCT00768079|Benralizumab|benralizumab|mesh-list
44600274|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44600275|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44600276|NCT00768053|Etanercept|etanercept|mesh-list
44600277|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44600278|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600279|NCT00768053|Analgesics|analgesics|mesh-ancestor
44600280|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
44600281|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600282|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600283|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600284|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600285|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600286|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600287|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
44600289|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600290|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600291|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
44600292|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600293|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44220017|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44600294|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44600295|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44600296|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600297|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600298|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600299|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600300|NCT00767806|Analgesics|analgesics|mesh-ancestor
44600301|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
44600302|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600303|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
44600304|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600305|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
44600306|NCT00767520|Dasatinib|dasatinib|mesh-list
44600307|NCT00767520|Exemestane|exemestane|mesh-list
44600308|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600309|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600310|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600311|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600312|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44600313|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44600314|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44600315|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44600316|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600317|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600318|NCT00767325|Methotrexate|methotrexate|mesh-list
44600319|NCT00767325|Abatacept|abatacept|mesh-list
44600320|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44600321|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
44600322|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44600323|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600324|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600325|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
44600326|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600327|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600328|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
44600329|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600330|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44600331|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600332|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
44600333|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600334|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44600335|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44600336|NCT00767039|Poractant alfa|poractant alfa|mesh-list
44600337|NCT00767039|Beractant|beractant|mesh-list
44600338|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44600339|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44600340|NCT00767000|Metformin|metformin|mesh-list
44600341|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
44600342|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600343|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600344|NCT00766831|Hydromorphone|hydromorphone|mesh-list
44600345|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600346|NCT00766831|Narcotics|narcotics|mesh-ancestor
44600347|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600348|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600349|NCT00766831|Analgesics|analgesics|mesh-ancestor
44600350|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
44600351|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600352|NCT00766675|Acetaminophen|acetaminophen|mesh-list
44600353|NCT00766675|Tramadol|tramadol|mesh-list
44600354|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600355|NCT00766675|Analgesics|analgesics|mesh-ancestor
44600356|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
44600357|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600358|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600359|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
44600360|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600361|NCT00766675|Narcotics|narcotics|mesh-ancestor
44600362|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600363|NCT00766636|Gemcitabine|gemcitabine|mesh-list
44600364|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44600365|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600366|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
44600367|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600368|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600369|NCT00766636|Antiviral Agents|antiviral agents|mesh-ancestor
44600370|NCT00766636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600371|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600372|NCT00766636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600373|NCT00766636|Immunologic Factors|immunologic factors|mesh-ancestor
44600374|NCT00766636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600375|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600376|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44600378|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600379|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600380|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44600381|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
44600382|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600383|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600384|NCT00766506|Fentanyl|fentanyl|mesh-list
44600385|NCT00766506|Morphine|morphine|mesh-list
44600386|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600387|NCT00766506|Narcotics|narcotics|mesh-ancestor
44600388|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600389|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600390|NCT00766506|Analgesics|analgesics|mesh-ancestor
44600391|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
44220095|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
44600392|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600393|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44600394|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44600395|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
44600396|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
44600397|NCT00766467|Modafinil|modafinil|mesh-list
44600398|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44600399|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600400|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44600401|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44600402|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44600403|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600404|NCT00766363|Rivastigmine|rivastigmine|mesh-list
44600405|NCT00766363|Donepezil|donepezil|mesh-list
44600406|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44600407|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600408|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600409|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
44600410|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600411|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600412|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
44600413|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44600414|NCT00766363|Protective Agents|protective agents|mesh-ancestor
44600415|NCT00766142|Leucovorin|leucovorin|mesh-list
44600416|NCT00766142|Fluorouracil|fluorouracil|mesh-list
44600417|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
44600418|NCT00766142|Cetuximab|cetuximab|mesh-list
44600419|NCT00766142|Calcium|calcium|mesh-list
44600420|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
44600421|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44600422|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600423|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
44600424|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600425|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600426|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600427|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600428|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
44600429|NCT00766142|Antidotes|antidotes|mesh-ancestor
44600430|NCT00766142|Protective Agents|protective agents|mesh-ancestor
44600431|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
44600432|NCT00766142|Vitamins|vitamins|mesh-ancestor
44600433|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
44600434|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44600435|NCT00766038|Hormones|hormones|mesh-list
44600436|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600437|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600438|NCT00765999|Linaclotide|linaclotide|mesh-list
44600439|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44600440|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
44600441|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600442|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600443|NCT00765882|Linaclotide|linaclotide|mesh-list
44600444|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44600445|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
44600446|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600447|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600448|NCT00765817|Exenatide|exenatide|mesh-list
44600449|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600450|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600451|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44600452|NCT00765817|Incretins|incretins|mesh-ancestor
44600454|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600455|NCT00765726|Factor VIII|factor viii|mesh-list
44600456|NCT00765726|Coagulants|coagulants|mesh-ancestor
44600457|NCT00765674|Amlodipine|amlodipine|mesh-list
44600458|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44600459|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44600460|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44600461|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600462|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600463|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44600464|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600465|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600466|NCT00765674|Diuretics|diuretics|mesh-ancestor
44600467|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
44600468|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44600469|NCT00765336|Minocycline|minocycline|mesh-list
44600470|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44600471|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600472|NCT00765245|Rituximab|rituximab|mesh-list
44600473|NCT00765245|Lenalidomide|lenalidomide|mesh-list
44600474|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44600475|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600476|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
44600477|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600478|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600479|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44600480|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44600481|NCT00765245|Growth Substances|growth substances|mesh-ancestor
44600482|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
44600483|NCT00765102|Bortezomib|bortezomib|mesh-list
44600484|NCT00765102|Romidepsin|romidepsin|mesh-list
44600485|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600486|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44600487|NCT00765063|Dalteparin|dalteparin|mesh-list
44600488|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
44600489|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44600490|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44600491|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600492|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
44600493|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44600494|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44600495|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
44600496|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600497|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44600498|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44600499|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600500|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600501|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44600502|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44600503|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44600504|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
44600505|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44600506|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600507|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44600508|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44600509|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44600510|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44600511|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44600512|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44600513|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44600514|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44600515|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44600516|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44600517|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600518|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44600519|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44600520|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600521|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600522|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
44146275|NCT00198094|Alprazolam|alprazolam|mesh-list
44600523|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600524|NCT00764751|Calcipotriene|calcipotriene|mesh-list
44600525|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
44600526|NCT00764699|Mecasermin|mecasermin|mesh-list
44600527|NCT00764699|Growth Substances|growth substances|mesh-ancestor
44600528|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600529|NCT00764517|Rituximab|rituximab|mesh-list
44600530|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44600531|NCT00764517|Vorinostat|vorinostat|mesh-list
44600532|NCT00764517|Cladribine|cladribine|mesh-list
44600533|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44600534|NCT00764517|Antibodies|antibodies|mesh-list
44600535|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
44600536|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44600537|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
44600538|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600539|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600540|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600541|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44600542|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600543|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600544|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600545|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600546|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
44429020|NCT02158975|Ixazomib|ixazomib|mesh-list
44600547|NCT00764478|Asenapine|asenapine|mesh-list
44600548|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44600549|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600550|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600551|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600552|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600553|NCT00764465|Ritonavir|ritonavir|mesh-list
44600554|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
44600555|NCT00764465|Maraviroc|maraviroc|mesh-list
44600556|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44600557|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44600558|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
44600559|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600560|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600561|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44600562|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44600563|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
44600564|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600565|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44600566|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44600567|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44600568|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44600569|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44600570|NCT00764361|Doxycycline|doxycycline|mesh-list
44600571|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44600572|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600573|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
44600574|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44600575|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44600576|NCT00764322|Tamoxifen|tamoxifen|mesh-list
44600577|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44600578|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
44600579|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600580|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600581|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44600582|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600583|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44600584|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44600585|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44600586|NCT00763971|Methylphenidate|methylphenidate|mesh-list
44600587|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44600588|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44600589|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600590|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44600591|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44600592|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600593|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600594|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
44600595|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600596|NCT00763958|Buprenorphine|buprenorphine|mesh-list
44600597|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600599|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600600|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600601|NCT00763958|Analgesics|analgesics|mesh-ancestor
44600602|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
44600603|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600604|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44600605|NCT00763815|Metformin|metformin|mesh-list
44600606|NCT00763815|Pioglitazone|pioglitazone|mesh-list
44600607|NCT00763815|Lixisenatide|lixisenatide|mesh-list
44600608|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600609|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600610|NCT00763555|Calcitriol|calcitriol|mesh-list
44600611|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44600612|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600613|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44600614|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600615|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600616|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44600617|NCT00763555|Vitamins|vitamins|mesh-ancestor
44600618|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
44600619|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44600620|NCT00763451|Metformin|metformin|mesh-list
44600621|NCT00763451|Lixisenatide|lixisenatide|mesh-list
44600622|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600623|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600624|NCT00763321|Acetaminophen|acetaminophen|mesh-list
44600625|NCT00763321|Hydrocodone|hydrocodone|mesh-list
44600626|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600627|NCT00763321|Analgesics|analgesics|mesh-ancestor
44600628|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
44600629|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600630|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600631|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
44600632|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600633|NCT00763321|Narcotics|narcotics|mesh-ancestor
44600634|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600635|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
44600636|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
44600637|NCT00763269|Silicon|silicon|mesh-list
44600638|NCT00763269|Triclosan|triclosan|mesh-list
44600639|NCT00763269|Fluorides|fluorides|mesh-list
44600640|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
44600641|NCT00763269|Protective Agents|protective agents|mesh-ancestor
44600642|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600643|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44600644|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600645|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44600646|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600647|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
44600648|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600649|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600650|NCT00763269|Trace Elements|trace elements|mesh-ancestor
44600651|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
44600652|NCT00763256|Triclosan|triclosan|mesh-list
44600653|NCT00763256|Fluorides|fluorides|mesh-list
44600654|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
44600655|NCT00763256|Protective Agents|protective agents|mesh-ancestor
44600656|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600657|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44600658|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600659|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44600660|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600661|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
44600662|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600663|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600664|NCT00763139|Pioglitazone|pioglitazone|mesh-list
44600665|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44600666|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600667|NCT00763035|Dobutamine|dobutamine|mesh-list
44600668|NCT00763035|Regadenoson|regadenoson|mesh-list
44600669|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44600670|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
44600671|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
44600672|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600673|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600674|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44600675|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44600677|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44600678|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600679|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600680|NCT00763035|Protective Agents|protective agents|mesh-ancestor
44600681|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44600682|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44600683|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
44600684|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
44600685|NCT00763009|Dipyridamole|dipyridamole|mesh-list
44600686|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44600687|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600688|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600689|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44600690|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
44600691|NCT00762892|Tenofovir|tenofovir|mesh-list
44600692|NCT00762892|Emtricitabine|emtricitabine|mesh-list
44600693|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
44600694|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44600695|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44600696|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
44600697|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600698|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44600727|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600728|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600730|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600731|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44600732|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44600733|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600734|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600735|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
44600736|NCT00762372|Sevoflurane|sevoflurane|mesh-list
44600737|NCT00762372|Desflurane|desflurane|mesh-list
44600738|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44600739|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44600740|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
44600741|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
44600742|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600743|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429232|NCT02154061|Metronidazole|metronidazole|mesh-list
44600744|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600745|NCT00762372|Analgesics|analgesics|mesh-ancestor
44600746|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
44600747|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600748|NCT00762359|Lansoprazole|lansoprazole|mesh-list
44600749|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
44600750|NCT00762359|Gefarnate|gefarnate|mesh-list
44600751|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44600752|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600753|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44600754|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600755|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600756|NCT00762229|Ezetimibe|ezetimibe|mesh-list
44600757|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44600758|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600759|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
44600760|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600761|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600762|NCT00762164|Simvastatin|simvastatin|mesh-list
44600763|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44600764|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44600765|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44600766|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
44600767|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600768|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600769|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44600770|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600771|NCT00762073|Budesonide|budesonide|mesh-list
44600772|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600773|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44600774|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
44600775|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600776|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600777|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44600778|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
44600779|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
44600780|NCT00762073|Hormones|hormones|mesh-ancestor
44600781|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600782|NCT00762034|Paclitaxel|paclitaxel|mesh-list
44600783|NCT00762034|Bevacizumab|bevacizumab|mesh-list
44600784|NCT00762034|Carboplatin|carboplatin|mesh-list
44600785|NCT00762034|Pemetrexed|pemetrexed|mesh-list
44600786|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44600787|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600788|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44600789|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44600790|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44600791|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600792|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44600793|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44600794|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44600795|NCT00762034|Growth Substances|growth substances|mesh-ancestor
44600796|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600797|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
44600798|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600799|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44600800|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44600801|NCT00761891|Aspirin|aspirin|mesh-list
44600802|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44600803|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600804|NCT00761891|Analgesics|analgesics|mesh-ancestor
44600805|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
44600806|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600807|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600808|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600809|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600810|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44600811|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44600812|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600813|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44600814|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44600815|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600816|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
44600817|NCT00761774|Brivaracetam|brivaracetam|mesh-list
44600818|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
44600820|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44600821|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
44600822|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600823|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
44600824|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600825|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44600826|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
44600827|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600828|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44600829|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44600830|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600831|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600832|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600833|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600834|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44600835|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44600836|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
44600837|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600838|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600839|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44600840|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44600841|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
44600842|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44600843|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44600844|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600845|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600846|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600847|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43771212|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600848|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44600849|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44600850|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
44600851|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600852|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600853|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44600854|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44600855|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
44600856|NCT00761527|Desloratadine|desloratadine|mesh-list
44600857|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44600858|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
44600859|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600860|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600861|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600862|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44600863|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44600864|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
44600865|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
44600866|NCT00761514|Adalimumab|adalimumab|mesh-list
44600867|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44600868|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600869|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44600870|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
44600871|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600872|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44600873|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44600874|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600875|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600876|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600877|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44600878|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44600879|NCT00761319|Travoprost|travoprost|mesh-list
44600880|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44600881|NCT00761319|Latanoprost|latanoprost|mesh-list
44600882|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44600883|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44600884|NCT00761306|Vortioxetine|vortioxetine|mesh-list
44600885|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44600886|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600887|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44600888|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220553|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
44600889|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600890|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600891|NCT00761306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44600892|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44600893|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600894|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600895|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600896|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
44600897|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44600898|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44600899|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44600900|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44600901|NCT00761280|Temozolomide|temozolomide|mesh-list
44600902|NCT00761280|Carmustine|carmustine|mesh-list
44600903|NCT00761280|Lomustine|lomustine|mesh-list
44600904|NCT00761280|Trabedersen|trabedersen|mesh-list
44600905|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44600906|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
44600907|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600908|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600909|NCT00761267|Fluconazole|fluconazole|mesh-list
44600910|NCT00761267|Anidulafungin|anidulafungin|mesh-list
44600911|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
44600912|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457391|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
44600913|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44600914|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44600915|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600916|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600917|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44600918|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
44235555|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600919|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44600920|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600921|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44600922|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44600923|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
44600924|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44600925|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600926|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44600927|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44600928|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44600929|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600930|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600931|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44600932|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44600933|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44600934|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
44600935|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600936|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600937|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44600938|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44600939|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
44600940|NCT00761150|Acetaminophen|acetaminophen|mesh-list
44600941|NCT00761150|Hydrocodone|hydrocodone|mesh-list
44600942|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44600943|NCT00761150|Analgesics|analgesics|mesh-ancestor
44600944|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
44600945|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600946|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600947|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
44600948|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44600949|NCT00761150|Narcotics|narcotics|mesh-ancestor
44600950|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44600951|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
44600952|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
44600953|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44600954|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44600955|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600956|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600957|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600958|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600959|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
44600960|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600961|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
44600962|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600963|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44600964|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600966|NCT00760838|Azithromycin|azithromycin|mesh-list
44600967|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44600968|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44600969|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44600970|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44600971|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44600972|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44600973|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600974|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
44600975|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44600976|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600977|NCT00760669|Methotrexate|methotrexate|mesh-list
44600978|NCT00760669|Infliximab|infliximab|mesh-list
44600979|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44600980|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
44600981|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44600982|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44600983|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44600984|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
44220600|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44600985|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44600986|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44600987|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
44600988|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44600989|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44600990|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44600991|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
44600992|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44600993|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44600994|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44600995|NCT00760474|Pregabalin|pregabalin|mesh-list
44600996|NCT00760474|Analgesics|analgesics|mesh-ancestor
44600997|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
44600998|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44600999|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601000|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
44601001|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44601002|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601003|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601004|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44601005|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601006|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601007|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601008|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601009|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44601010|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44601011|NCT00760266|Diuretics|diuretics|mesh-ancestor
44601012|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
44601013|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601014|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44601015|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601016|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601017|NCT00760214|Ramipril|ramipril|mesh-list
44601018|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44601019|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44601020|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601021|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601022|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601023|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44601024|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44601025|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44601026|NCT00760084|Decitabine|decitabine|mesh-list
44601027|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601028|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
44601029|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601030|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601031|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601032|NCT00759954|Morphine|morphine|mesh-list
44601033|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44601034|NCT00759954|Narcotics|narcotics|mesh-ancestor
44601035|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601036|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601037|NCT00759954|Analgesics|analgesics|mesh-ancestor
44601038|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
44601039|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601040|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44601041|NCT00759941|Latanoprost|latanoprost|mesh-list
44601042|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44601043|NCT00759941|Brinzolamide|brinzolamide|mesh-list
44601044|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44601045|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601046|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601047|NCT00759915|Morphine|morphine|mesh-list
44601048|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44601049|NCT00759915|Narcotics|narcotics|mesh-ancestor
44601050|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601051|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601052|NCT00759915|Analgesics|analgesics|mesh-ancestor
44601053|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
44601054|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601055|NCT00759902|Morphine|morphine|mesh-list
44601056|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44601057|NCT00759902|Narcotics|narcotics|mesh-ancestor
44601058|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601059|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601060|NCT00759902|Analgesics|analgesics|mesh-ancestor
44601061|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
44601062|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601063|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44601064|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
44601065|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601066|NCT00759759|Morphine|morphine|mesh-list
44601067|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44601068|NCT00759759|Narcotics|narcotics|mesh-ancestor
44601069|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601070|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601071|NCT00759759|Analgesics|analgesics|mesh-ancestor
44601072|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
44601073|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601074|NCT00759681|Thrombin|thrombin|mesh-list
44601075|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44601076|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
44601077|NCT00759681|Coagulants|coagulants|mesh-ancestor
44601078|NCT00759564|Lactams|lactams|mesh-list
44601079|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601080|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601081|NCT00759356|Morphine|morphine|mesh-list
44601082|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44601083|NCT00759356|Narcotics|narcotics|mesh-ancestor
44601084|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601085|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601086|NCT00759356|Analgesics|analgesics|mesh-ancestor
44601087|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
44601088|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601089|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
44601090|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44601091|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44601092|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44601093|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601094|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601095|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44601096|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44601097|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601098|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601099|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601100|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44601101|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
44601102|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601103|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601104|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44601105|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44601106|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44601107|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44601108|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
44601109|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601110|NCT00759031|Listerine|listerine|mesh-list
44601111|NCT00759031|Triclosan|triclosan|mesh-list
44601112|NCT00759031|Fluorides|fluorides|mesh-list
44429582|NCT02145078|Gemcitabine|gemcitabine|mesh-list
44601113|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
44601114|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
44601115|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
44601116|NCT00759031|Protective Agents|protective agents|mesh-ancestor
44601117|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601118|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44601119|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601120|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44601121|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44601122|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
44601123|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601124|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44601125|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
44601126|NCT00758602|Tacrolimus|tacrolimus|mesh-list
44601127|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601128|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
44601129|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601130|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44601131|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601132|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601133|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44601134|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601135|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44601136|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
44601137|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601138|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601139|NCT00758524|Eplerenone|eplerenone|mesh-list
44601140|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44601141|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
44601142|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601143|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601144|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44601145|NCT00758524|Diuretics|diuretics|mesh-ancestor
44601146|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
44601147|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44601148|NCT00758498|Modafinil|modafinil|mesh-list
44601149|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44601150|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601151|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44601152|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44601153|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44601154|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601166|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44601167|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
44601168|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601169|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44601171|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44601172|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
44601173|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601174|NCT00758160|Methylphenidate|methylphenidate|mesh-list
44601175|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44601176|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601177|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44601178|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601179|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601180|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601181|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
44601182|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601183|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44601184|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601185|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601186|NCT00758069|Incretins|incretins|mesh-ancestor
44601187|NCT00758069|Hormones|hormones|mesh-ancestor
44601188|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601189|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44601190|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601191|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601192|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601193|NCT00758043|Ribavirin|ribavirin|mesh-list
44601194|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44601195|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
44601196|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601197|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
44601198|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601199|NCT00757783|Ritonavir|ritonavir|mesh-list
44601200|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44601201|NCT00757783|Darunavir|darunavir|mesh-list
44601202|NCT00757783|Tenofovir|tenofovir|mesh-list
44601203|NCT00757783|Emtricitabine|emtricitabine|mesh-list
44601204|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44601205|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44601206|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601207|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601208|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601209|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44601210|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44601211|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
44601212|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601213|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44601214|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44601215|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44601216|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44601217|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44601218|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44601219|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601220|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601221|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601222|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601223|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44601224|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44601225|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
44601226|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601227|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601228|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44601229|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44601230|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
44601231|NCT00757627|Etoricoxib|etoricoxib|mesh-list
44601232|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44601233|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44601234|NCT00757627|Analgesics|analgesics|mesh-ancestor
44601235|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
44601236|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601237|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601238|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44601239|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601240|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44601241|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44601242|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601243|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601244|NCT00757588|Insulin|insulin|mesh-list
44601245|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44601246|NCT00757588|Saxagliptin|saxagliptin|mesh-list
44601247|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601248|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601249|NCT00757588|Incretins|incretins|mesh-ancestor
44601250|NCT00757588|Hormones|hormones|mesh-ancestor
44601251|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601252|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44601253|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601254|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601255|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601256|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44601257|NCT00757237|Tobramycin|tobramycin|mesh-list
44601258|NCT00757237|Aztreonam|aztreonam|mesh-list
44601259|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44601260|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44601261|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601262|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
44601263|NCT00757172|Cisplatin|cisplatin|mesh-list
44601264|NCT00757172|Docetaxel|docetaxel|mesh-list
44601265|NCT00757172|Panitumumab|panitumumab|mesh-list
44601266|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601267|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44601268|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44601269|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44601270|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601271|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44601272|NCT00756938|Losartan|losartan|mesh-list
44601273|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44601274|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44601275|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44601276|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44601277|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601278|NCT00756886|Atorvastatin|atorvastatin|mesh-list
44601279|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44601280|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44601281|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
44601282|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601283|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44601284|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44601285|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601286|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44601287|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44601288|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44601289|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601290|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601291|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601292|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44601293|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44601294|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
44601295|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601296|NCT00756470|Paclitaxel|paclitaxel|mesh-list
44601297|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
44601298|NCT00756470|Fluorouracil|fluorouracil|mesh-list
44601299|NCT00756470|Epirubicin|epirubicin|mesh-list
44601300|NCT00756470|Lapatinib|lapatinib|mesh-list
44601301|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44601302|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601303|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44601304|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44601305|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44601306|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601307|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601308|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
44601309|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601310|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601311|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44601312|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
44601313|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44601314|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
44601315|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601316|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44601317|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44601318|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44601319|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601320|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44601322|NCT00756444|Panitumumab|panitumumab|mesh-list
44601323|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601324|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44601325|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
44601326|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601327|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601328|NCT00756275|Nicotine|nicotine|mesh-list
44601329|NCT00756275|Varenicline|varenicline|mesh-list
44601330|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44601331|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
44601332|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601333|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601334|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601335|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601336|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601337|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601338|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601339|NCT00755846|Alogliptin|alogliptin|mesh-list
44601340|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601341|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601342|NCT00755846|Incretins|incretins|mesh-ancestor
44601343|NCT00755846|Hormones|hormones|mesh-ancestor
44601344|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601345|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44601346|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601347|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601348|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601349|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44601350|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44601351|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601352|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601353|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601354|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601355|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601356|NCT00755807|Analgesics|analgesics|mesh-ancestor
44601357|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
44601358|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601359|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
44601360|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601361|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
44601362|NCT00755716|Topiramate|topiramate|mesh-list
44601363|NCT00755716|Nicotine|nicotine|mesh-list
44601364|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44601365|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
44601366|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601367|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601368|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601369|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601370|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601371|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771213|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601372|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601373|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
44601374|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601375|NCT00755417|Gabapentin|gabapentin|mesh-list
44601376|NCT00755417|Analgesics|analgesics|mesh-ancestor
44601377|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
44601378|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601379|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601380|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
44601381|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601382|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220996|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
44601383|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601384|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601385|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44601386|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44601387|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429898|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44601388|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601389|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
44601390|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
44601391|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44601392|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44601393|NCT00755183|Testosterone|testosterone|mesh-list
44601394|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
44601395|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
44601396|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44601397|NCT00755183|Androgens|androgens|mesh-ancestor
44601398|NCT00755183|Hormones|hormones|mesh-ancestor
44601399|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601400|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601401|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44601402|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601403|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
44601404|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
44601405|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
44601406|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601407|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601408|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601409|NCT00754936|Citalopram|citalopram|mesh-list
44601410|NCT00754936|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44601411|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601412|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601413|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601414|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601415|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
44601416|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601417|NCT00754936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44601418|NCT00754936|Antidepressive Agents|antidepressive agents|mesh-ancestor
44601419|NCT00754936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601420|NCT00754793|Dexetimide|dexetimide|mesh-list
44601421|NCT00754793|Citalopram|citalopram|mesh-list
44601422|NCT00754793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44601423|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601424|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601425|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601426|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601427|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
44601428|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601429|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44601430|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
44601431|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601432|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44601433|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44601434|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
44601435|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
44601436|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221040|NCT00489528|Hormones|hormones|mesh-list
44601437|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44601438|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44601439|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601440|NCT00754650|Bevacizumab|bevacizumab|mesh-list
44601441|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44601442|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601443|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44601444|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44601445|NCT00754650|Growth Substances|growth substances|mesh-ancestor
44601446|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601447|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
44601448|NCT00754624|Insulin|insulin|mesh-list
44601449|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601450|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601451|NCT00754572|Methotrexate|methotrexate|mesh-list
44601452|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44601453|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
44601454|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601455|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601456|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601457|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
44601458|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601459|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601460|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44601461|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601462|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44601463|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601464|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
44601465|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601466|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44601467|NCT00754442|Teriparatide|teriparatide|mesh-list
44601468|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44601469|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601470|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44601471|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
44601472|NCT00754390|Calcium|calcium|mesh-list
44601473|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44601474|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601475|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44601476|NCT00754338|Dipivefrin|dipivefrin|mesh-list
44601477|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44601478|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
44601479|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601480|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601481|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601482|NCT00754325|Dasatinib|dasatinib|mesh-list
44601483|NCT00754325|Fulvestrant|fulvestrant|mesh-list
44601484|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601485|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44601486|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601487|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601488|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44601489|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44601490|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44601491|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
44601492|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601493|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601494|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
44601495|NCT00754065|Dienogest|dienogest|mesh-list
44601496|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44601497|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44601498|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44601499|NCT00754065|Estradiol|estradiol|mesh-list
44601500|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44601501|NCT00754065|Estrogens|estrogens|mesh-ancestor
44601502|NCT00754065|Hormones|hormones|mesh-ancestor
44601503|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601504|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601505|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44601506|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
44601507|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601508|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44601509|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44601510|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44601511|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44601512|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
44601513|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44601514|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601515|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44601517|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601518|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44601519|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44601520|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221115|NCT00489840|Anecortave|anecortave|mesh-list
44601521|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601522|NCT00754052|Donepezil|donepezil|mesh-list
44601523|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44601524|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601525|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601526|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601527|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601528|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601529|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
44601530|NCT00754013|Donepezil|donepezil|mesh-list
44601531|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44601532|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601533|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601534|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601535|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601536|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601537|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
44601538|NCT00753896|Exenatide|exenatide|mesh-list
44601539|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601540|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601541|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44601542|NCT00753896|Incretins|incretins|mesh-ancestor
44601543|NCT00753896|Hormones|hormones|mesh-ancestor
44601544|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601545|NCT00753714|Gemcitabine|gemcitabine|mesh-list
44601546|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601547|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
44601548|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601549|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601550|NCT00753714|Antiviral Agents|antiviral agents|mesh-ancestor
44601551|NCT00753714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601552|NCT00753714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601553|NCT00753714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601554|NCT00753714|Immunologic Factors|immunologic factors|mesh-ancestor
44601555|NCT00753714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601556|NCT00753675|Gemcitabine|gemcitabine|mesh-list
44601557|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601558|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
44601559|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601560|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601561|NCT00753675|Antiviral Agents|antiviral agents|mesh-ancestor
44601562|NCT00753675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601563|NCT00753675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601564|NCT00753675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601565|NCT00753675|Immunologic Factors|immunologic factors|mesh-ancestor
44601566|NCT00753675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601567|NCT00753506|Artemisinins|artemisinins|mesh-list
44601568|NCT00753506|Artemisinin|artemisinin|mesh-list
44601569|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
44601570|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44601571|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44601572|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601573|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
44601574|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601575|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
44601576|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601577|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601578|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44601579|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44601580|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601581|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44601582|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601583|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601584|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601585|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
44601586|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601587|NCT00752986|Fulvestrant|fulvestrant|mesh-list
44146372|NCT00198367|Cisplatin|cisplatin|mesh-list
44601588|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44601589|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601590|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44601591|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44601592|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
44601593|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601594|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601595|NCT00752856|Ritonavir|ritonavir|mesh-list
44601596|NCT00752856|Lopinavir|lopinavir|mesh-list
44601597|NCT00752856|Tenofovir|tenofovir|mesh-list
44601598|NCT00752856|Emtricitabine|emtricitabine|mesh-list
44601599|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
44601600|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44601601|NCT00752856|Efavirenz|efavirenz|mesh-list
44601602|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44601603|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44601604|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601605|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601606|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601607|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44601608|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44601609|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
44601610|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601611|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44601612|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44601613|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44601614|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44601615|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44601616|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44601617|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44601618|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44601619|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44601620|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44601621|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44601622|NCT00752726|Orlistat|orlistat|mesh-list
44601623|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601624|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601625|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44601626|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44601627|NCT00752622|Infliximab|infliximab|mesh-list
44601628|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44601629|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44601630|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601631|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
44601632|NCT00752557|Vitamin D|vitamin d|mesh-list
44601633|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
44601634|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
44601635|NCT00752557|Diphosphonates|diphosphonates|mesh-list
44601636|NCT00752557|Vitamins|vitamins|mesh-list
44601637|NCT00752557|Calcium|calcium|mesh-list
44601638|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
44601639|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601640|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44601641|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44601642|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
44601643|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44601644|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
44601645|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601646|NCT00752219|Metronidazole|metronidazole|mesh-list
44601647|NCT00752219|Meropenem|meropenem|mesh-list
44601648|NCT00752219|Ceftazidime|ceftazidime|mesh-list
44601649|NCT00752219|Avibactam|avibactam|mesh-list
44601650|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601651|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601652|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44601653|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44601654|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44601655|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601656|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601657|NCT00752206|Saracatinib|saracatinib|mesh-list
44601658|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601659|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601660|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601661|NCT00751933|Vaccines|vaccines|mesh-list
44601662|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
44601663|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601665|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44601666|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44601667|NCT00751881|Analgesics|analgesics|mesh-ancestor
44601668|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
44601669|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601670|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601671|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44601672|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601673|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44601674|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
44601675|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44601676|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
44601677|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44601678|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
44601679|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601680|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601681|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44601682|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430197|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
44601683|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601695|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601696|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601697|NCT00751296|Lenalidomide|lenalidomide|mesh-list
44601698|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
44601699|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601700|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44601701|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44601702|NCT00751296|Growth Substances|growth substances|mesh-ancestor
44601703|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44601704|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601705|NCT00751114|Metformin|metformin|mesh-list
44601706|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
44601707|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44601708|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601709|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601710|NCT00751114|Incretins|incretins|mesh-ancestor
44601711|NCT00751114|Hormones|hormones|mesh-ancestor
44601712|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601713|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44601714|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601715|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601716|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601717|NCT00751101|Nicotine|nicotine|mesh-list
44601718|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44601719|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
44601720|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601721|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601722|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601723|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601724|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601725|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601726|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221312|NCT00490711|Gemcitabine|gemcitabine|mesh-list
44601727|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
44601728|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601729|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44601730|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601731|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601732|NCT00751023|Modafinil|modafinil|mesh-list
44601733|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44601734|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601735|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44601736|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44601737|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44601738|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601739|NCT00750919|Mirtazapine|mirtazapine|mesh-list
44601740|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44601741|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601742|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44601743|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
44601744|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
44601745|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601746|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601747|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601748|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601749|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601750|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601751|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44601752|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44601753|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44601754|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44601755|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44601756|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44601757|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
44601758|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44601759|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
44601760|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44601761|NCT00750867|Antibodies|antibodies|mesh-list
44601762|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
44601763|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44601764|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
44601765|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601766|NCT00750737|Amphotericin B|amphotericin b|mesh-list
44601767|NCT00750737|Posaconazole|posaconazole|mesh-list
44601768|NCT00750737|Amebicides|amebicides|mesh-ancestor
44601769|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44601770|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44601771|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601772|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44601773|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
44601774|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44601775|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44601776|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44601777|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601778|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601779|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44601780|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
44601781|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601782|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601783|NCT00750308|Ramipril|ramipril|mesh-list
44601784|NCT00750308|Tadalafil|tadalafil|mesh-list
44601785|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
44601786|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44601787|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44601788|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601789|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601790|NCT00750308|Urological Agents|urological agents|mesh-ancestor
44601791|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44601792|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601793|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44601794|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
44601795|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
44601796|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601797|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601798|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601799|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
44601800|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601801|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601802|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601803|NCT00749944|Varenicline|varenicline|mesh-list
44601804|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601805|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601806|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601807|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601808|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601809|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601810|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44601811|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601812|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44601813|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601814|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601815|NCT00749684|Interferons|interferons|mesh-list
44601816|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601817|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
44601818|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601819|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
44601820|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44457459|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
44601821|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44601822|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
44601823|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601824|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44601825|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44601826|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601827|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601828|NCT00749463|Nicotine|nicotine|mesh-list
44601829|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44601830|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
44601831|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601832|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601833|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601834|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601835|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601836|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601837|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601838|NCT00749398|Infliximab|infliximab|mesh-list
44601839|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44601840|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44601841|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44601842|NCT00749203|Midazolam|midazolam|mesh-list
44601843|NCT00749203|Ketamine|ketamine|mesh-list
44601844|NCT00749203|Analgesics|analgesics|mesh-ancestor
44601845|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
44601846|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601847|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601848|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44601849|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44601850|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
44601851|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
44601852|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601853|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44601854|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44601855|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601856|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601857|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44601858|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44601859|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601860|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601861|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601862|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
44601863|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
44601864|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44601865|NCT00749190|Empagliflozin|empagliflozin|mesh-list
44601866|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601867|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601868|NCT00749190|Incretins|incretins|mesh-ancestor
44430433|NCT02123966|Sirolimus|sirolimus|mesh-list
44601869|NCT00749190|Hormones|hormones|mesh-ancestor
44601870|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44601871|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44601872|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
44601873|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601874|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601875|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44601876|NCT00748709|Afatinib|afatinib|mesh-list
44601877|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601878|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44601879|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601880|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601881|NCT00748566|Ziprasidone|ziprasidone|mesh-list
44601882|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44601883|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
44601884|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601885|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601886|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601887|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44601888|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601889|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601890|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601892|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
44601893|NCT00748553|Paclitaxel|paclitaxel|mesh-list
44601894|NCT00748553|Azacitidine|azacitidine|mesh-list
44601895|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44221468|NCT00491166|Analgesics|analgesics|mesh-ancestor
44601896|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44601897|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601898|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
44601899|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
44601900|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
44601901|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601902|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44601903|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
44601904|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601905|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
44601906|NCT00748215|Loperamide|loperamide|mesh-list
44601907|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
44601908|NCT00748215|Calcium|calcium|mesh-list
44601909|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44601910|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601911|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44601912|NCT00748189|Ofatumumab|ofatumumab|mesh-list
44601913|NCT00748189|Chlorambucil|chlorambucil|mesh-list
44601914|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601915|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44601916|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
44601917|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601918|NCT00748098|Gabapentin|gabapentin|mesh-list
44601919|NCT00748098|Analgesics|analgesics|mesh-ancestor
44601920|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
44601921|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601922|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601923|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
44601924|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44601925|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601926|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601927|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44601928|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44601929|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44601930|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601931|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601932|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
44601933|NCT00747643|Varenicline|varenicline|mesh-list
44601934|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44601935|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44601936|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
44601937|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601938|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601939|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601940|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44601941|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44601942|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601943|NCT00747344|Ustekinumab|ustekinumab|mesh-list
44601944|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
44601945|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44601946|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44601947|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44601948|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
44601949|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601950|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44601951|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44601952|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44601953|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
44601954|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44601955|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601956|NCT00746941|Mefloquine|mefloquine|mesh-list
44601957|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
44601958|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44601959|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44601960|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44601961|NCT00746798|Vaccines|vaccines|mesh-list
44601962|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
44601963|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601964|NCT00746785|Olanzapine|olanzapine|mesh-list
44601965|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
44601966|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
44601967|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601968|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601969|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44601970|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44601971|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44601972|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44601973|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221536|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
44601974|NCT00746785|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44601975|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601976|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601977|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601978|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601979|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
44601980|NCT00746733|Amphetamine|amphetamine|mesh-list
44601981|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44601982|NCT00746733|Adderall|adderall|mesh-list
44601983|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44601984|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44601985|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
44601986|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
44601987|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44601988|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
44601989|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44601990|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44601991|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
44601992|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44601993|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44601994|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44601995|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44601996|NCT00746590|Tretazicar|tretazicar|mesh-list
44601997|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44601998|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44601999|NCT00746551|Hematinics|hematinics|mesh-ancestor
44602000|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
44602001|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
44602002|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44602003|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
44602004|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602005|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602006|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602007|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602008|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44602009|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44602010|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44602011|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602012|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602013|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602014|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602015|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
44602016|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44430584|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602017|NCT00746252|Risperidone|risperidone|mesh-list
44602018|NCT00746252|Aripiprazole|aripiprazole|mesh-list
44602019|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44602020|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
44602021|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602022|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602023|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602024|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44602025|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44602026|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602027|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44602028|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44602029|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
44602030|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
44602031|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
44602032|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44602033|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44602034|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44602035|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44602036|NCT00745901|Drospirenone|drospirenone|mesh-list
44602037|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44602038|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44602039|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44602040|NCT00745901|Norgestimate|norgestimate|mesh-list
44602041|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44602043|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44602044|NCT00745901|Estrogens|estrogens|mesh-ancestor
44602045|NCT00745901|Hormones|hormones|mesh-ancestor
44602046|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602047|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602048|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44602049|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
44602050|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44602051|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44602052|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44602053|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44602054|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44602055|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44602056|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44602057|NCT00745901|Diuretics|diuretics|mesh-ancestor
44602058|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
44602059|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44602060|NCT00745875|Pemetrexed|pemetrexed|mesh-list
44602061|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602062|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602063|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602064|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44602065|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602066|NCT00745849|Esomeprazole|esomeprazole|mesh-list
44602067|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44602068|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44602069|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44602070|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602071|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602072|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
44602073|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44602074|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44602075|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44602076|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
44602077|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602078|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44602079|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44602080|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602081|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602082|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44602083|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602084|NCT00745498|Bevacizumab|bevacizumab|mesh-list
44602085|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602086|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602087|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602088|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44602089|NCT00745498|Growth Substances|growth substances|mesh-ancestor
44602126|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602127|NCT00744627|Vortioxetine|vortioxetine|mesh-list
44602128|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
44602129|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44602130|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44602131|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44602132|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602133|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602134|NCT00744627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44602135|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44602136|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602137|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602138|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602139|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
44602140|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44602141|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44602142|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44602143|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44602144|NCT00744497|Prednisone|prednisone|mesh-list
44602145|NCT00744497|Docetaxel|docetaxel|mesh-list
44602146|NCT00744497|Dasatinib|dasatinib|mesh-list
44602147|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602148|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44602149|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44602150|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44602151|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602152|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602153|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
44602154|NCT00744497|Hormones|hormones|mesh-ancestor
44602155|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602156|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602157|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44602158|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44602159|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602160|NCT00744471|Tanezumab|tanezumab|mesh-list
44602161|NCT00744471|Analgesics|analgesics|mesh-ancestor
44602162|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
44602163|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602164|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602165|NCT00744328|Sertraline|sertraline|mesh-list
44602166|NCT00744328|Estradiol|estradiol|mesh-list
44602167|NCT00744328|Estrogens|estrogens|mesh-ancestor
44602168|NCT00744328|Hormones|hormones|mesh-ancestor
44602169|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221705|NCT00492388|Ketamine|ketamine|mesh-list
44602170|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602171|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
44602172|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44602173|NCT00744328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44602174|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44602175|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602176|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602177|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602178|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
44602179|NCT00744263|Vaccines|vaccines|mesh-list
44602180|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44602181|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
44602182|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602183|NCT00744237|Metoprolol|metoprolol|mesh-list
44602184|NCT00744237|Nebivolol|nebivolol|mesh-list
44602185|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44602186|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602187|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
44602188|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
44602189|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602190|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602191|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44602192|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44602193|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44602194|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602195|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602196|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602197|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602198|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44602199|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44602200|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44602201|NCT00744055|Prazosin|prazosin|mesh-list
44602202|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602203|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44602204|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44602205|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44602206|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602207|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602208|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602209|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602210|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
44602211|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
44602212|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602213|NCT00743652|Vaccines|vaccines|mesh-list
44602214|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44602215|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
44602216|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602217|NCT00743509|Sirolimus|sirolimus|mesh-list
44602218|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
44602219|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602220|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
44602221|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602222|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602223|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602224|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
44602225|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602226|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602227|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44602228|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44602229|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602230|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602231|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
44602232|NCT00743444|Lesogaberan|lesogaberan|mesh-list
44602233|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44602234|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44602235|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
44602236|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
44602237|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602238|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602239|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602240|NCT00743431|Doxorubicin|doxorubicin|mesh-list
44602241|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602242|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602243|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602244|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602245|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221779|NCT00492518|Expectorants|expectorants|mesh-ancestor
44602246|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602247|NCT00743366|Riboflavin|riboflavin|mesh-list
44602248|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44602249|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
44602250|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44602251|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44602252|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44602253|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602254|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602255|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
44602256|NCT00743366|Vitamins|vitamins|mesh-ancestor
44602257|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
44602258|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44602259|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44602260|NCT00743340|Emtricitabine|emtricitabine|mesh-list
44602261|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
44602262|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602263|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44602264|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602265|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602266|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602267|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44602268|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44602269|NCT00743288|Melphalan|melphalan|mesh-list
44602270|NCT00743288|Panobinostat|panobinostat|mesh-list
44602271|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602272|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
44602273|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430848|NCT02116660|Nevirapine|nevirapine|mesh-list
44602274|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602275|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44602276|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602277|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
44602278|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602279|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44602280|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602281|NCT00743197|Aspirin|aspirin|mesh-list
44602282|NCT00743197|Lisinopril|lisinopril|mesh-list
44602283|NCT00743197|Simvastatin|simvastatin|mesh-list
44602284|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44602285|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602286|NCT00743197|Analgesics|analgesics|mesh-ancestor
44602287|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
44602288|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602289|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602290|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602291|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602292|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44602293|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44602294|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602295|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44602296|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44602297|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602299|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44602300|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44602301|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
44602302|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44602303|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44602304|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44602305|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
44602306|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602307|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44602308|NCT00743197|Protective Agents|protective agents|mesh-ancestor
44602309|NCT00743145|Naltrexone|naltrexone|mesh-list
44602310|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44602311|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44602312|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602313|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
44602314|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602315|NCT00743119|Dronabinol|dronabinol|mesh-list
44602316|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
44602317|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602318|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44602319|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602320|NCT00743119|Analgesics|analgesics|mesh-ancestor
44602321|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
44602322|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602323|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44602324|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44602325|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602326|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602327|NCT00743119|Hormones|hormones|mesh-ancestor
44602328|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602329|NCT00743106|Fenoldopam|fenoldopam|mesh-list
44602330|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602331|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602332|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
44602333|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
44602334|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602335|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602336|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602337|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
44602338|NCT00742924|Leucovorin|leucovorin|mesh-list
44602339|NCT00742924|Cisplatin|cisplatin|mesh-list
44602340|NCT00742924|Doxorubicin|doxorubicin|mesh-list
44602341|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44602342|NCT00742924|Methotrexate|methotrexate|mesh-list
44602343|NCT00742924|Etoposide|etoposide|mesh-list
44602344|NCT00742924|Ifosfamide|ifosfamide|mesh-list
44602345|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
44602346|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
44602347|NCT00742924|Razoxane|razoxane|mesh-list
44602348|NCT00742924|Imidazole|imidazole|mesh-list
44602349|NCT00742924|Lenograstim|lenograstim|mesh-list
44602350|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
44602351|NCT00742924|Mesna|mesna|mesh-list
44602352|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602353|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602354|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602355|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602356|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602357|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602358|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602359|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44602360|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
44602361|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44602362|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602363|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
44602364|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44602365|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44602366|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602367|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
44602368|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602369|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602370|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44602371|NCT00742924|Antidotes|antidotes|mesh-ancestor
44602372|NCT00742924|Protective Agents|protective agents|mesh-ancestor
44602373|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
44602375|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
44602376|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44602377|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602378|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
44602379|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44602380|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44602381|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44602382|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44602383|NCT00742859|Warfarin|warfarin|mesh-list
44602384|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
44602385|NCT00742859|Betrixaban|betrixaban|mesh-list
44602386|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
44602387|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44602388|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
44602389|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44602390|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44602391|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602392|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602393|NCT00742781|Vitamin D|vitamin d|mesh-list
44602394|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
44602395|NCT00742781|Vitamins|vitamins|mesh-ancestor
44602396|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
44602397|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602398|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44602399|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44602400|NCT00742625|Cytarabine|cytarabine|mesh-list
44602401|NCT00742625|Bortezomib|bortezomib|mesh-list
44602402|NCT00742625|Daunorubicin|daunorubicin|mesh-list
44602403|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602404|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
44602405|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602406|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602407|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
44602408|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602409|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602410|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
44602411|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602412|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602413|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602414|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602415|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602416|NCT00742560|Dexamethasone|dexamethasone|mesh-list
44602417|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
44602418|NCT00742560|Lenalidomide|lenalidomide|mesh-list
44602419|NCT00742560|Elotuzumab|elotuzumab|mesh-list
44602420|NCT00742560|BB 1101|bb 1101|mesh-list
44602421|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602422|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
44602423|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
44602424|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602425|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602426|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44602427|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
44431005|NCT02115113|Everolimus|everolimus|mesh-list
44602428|NCT00742560|Hormones|hormones|mesh-ancestor
44602429|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602430|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44602431|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602432|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
44602433|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602434|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602435|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
44602436|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602437|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44602438|NCT00742560|Growth Substances|growth substances|mesh-ancestor
44602439|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
44602440|NCT00742508|Carvedilol|carvedilol|mesh-list
44602441|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44602442|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44602443|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602444|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602445|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602446|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602447|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602448|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
44602449|NCT00742508|Protective Agents|protective agents|mesh-ancestor
44001228|NCT05433961|Xenon|xenon|mesh-list
44602450|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44602451|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602452|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44602453|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602454|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44602455|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44602457|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44602458|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602459|NCT00742235|Vitamin D|vitamin d|mesh-list
44602460|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
44602461|NCT00742235|Vitamins|vitamins|mesh-ancestor
44602462|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
44602463|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602464|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44602465|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44602466|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44602467|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44602468|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602469|NCT00742079|Cycloserine|cycloserine|mesh-list
44602470|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44602471|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602472|NCT00742079|Renal Agents|renal agents|mesh-ancestor
44602473|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44602474|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
44602475|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44602476|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
44602477|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602478|NCT00742027|Panobinostat|panobinostat|mesh-list
44602479|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602480|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44602481|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602482|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602483|NCT00741819|Treprostinil|treprostinil|mesh-list
44602484|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602485|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44602486|NCT00741598|Galantamine|galantamine|mesh-list
44602487|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44602488|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602489|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602490|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
44602491|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602492|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602493|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44602494|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
44602495|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602496|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
44602497|NCT00741338|Cyclosporine|cyclosporine|mesh-list
44602498|NCT00741338|Azathioprine|azathioprine|mesh-list
44602499|NCT00741338|Cyclosporins|cyclosporins|mesh-list
44602500|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602501|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602502|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602503|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
44602504|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602505|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
44602506|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602507|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
44602508|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602509|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44602510|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
44602511|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602512|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602513|NCT00741286|Aspirin|aspirin|mesh-list
44602514|NCT00741286|Cilostazol|cilostazol|mesh-list
44602515|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44602516|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602517|NCT00741286|Analgesics|analgesics|mesh-ancestor
44602518|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
44602519|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602520|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602521|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602522|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602523|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44602524|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44602525|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602526|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44602527|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44602528|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602529|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
44602530|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44602531|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
44602532|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602533|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602534|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602535|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44602536|NCT00741286|Protective Agents|protective agents|mesh-ancestor
44602537|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44602538|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44602539|NCT00741260|Capecitabine|capecitabine|mesh-list
44602540|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602541|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
44602542|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602543|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602545|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44602546|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
44602547|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602548|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44602550|NCT00741013|Lovastatin|lovastatin|mesh-list
44602551|NCT00741013|L 647318|l 647318|mesh-list
44602552|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
44602553|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44602554|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44602555|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
44602556|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602557|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44602558|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44602559|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602560|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
44602561|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44602562|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44602563|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602564|NCT00740857|Ibuprofen|ibuprofen|mesh-list
44602565|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44602566|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602567|NCT00740857|Analgesics|analgesics|mesh-ancestor
44602568|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
44602569|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602570|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602571|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602572|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602573|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44602574|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602575|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602576|NCT00740792|Fluticasone|fluticasone|mesh-list
44602577|NCT00740792|Xhance|xhance|mesh-list
44602578|NCT00740792|Azelastine|azelastine|mesh-list
44602579|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602580|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44602581|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
44602582|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602583|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602584|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602585|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602586|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44602587|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44602588|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44602589|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602590|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602591|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44602592|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44602593|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
44602594|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
44602595|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602596|NCT00740779|Silodosin|silodosin|mesh-list
44602597|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44602598|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44602599|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44602600|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602601|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222087|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
44602602|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602603|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602604|NCT00740779|Urological Agents|urological agents|mesh-ancestor
44602606|NCT00740714|Vitamin E|vitamin e|mesh-list
44602607|NCT00740714|Tocopherols|tocopherols|mesh-list
44602608|NCT00740714|Tocotrienols|tocotrienols|mesh-list
44602609|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
44602610|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
44602611|NCT00740714|Ubiquinone|ubiquinone|mesh-list
44602612|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
44602613|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602614|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
44602615|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602616|NCT00740714|Protective Agents|protective agents|mesh-ancestor
44602617|NCT00740636|Temozolomide|temozolomide|mesh-list
44602640|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602641|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602642|NCT00739973|Amlodipine|amlodipine|mesh-list
44602643|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602644|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44602645|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602646|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602647|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44602648|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602649|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602650|NCT00739934|Voriconazole|voriconazole|mesh-list
44602651|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
44602652|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602653|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44602654|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44602655|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602656|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602657|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44602658|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
44602659|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222129|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602660|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602661|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44602662|NCT00739882|Antibodies|antibodies|mesh-list
44602663|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44602664|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
44602665|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602666|NCT00739648|Levofloxacin|levofloxacin|mesh-list
44602667|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44602668|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602669|NCT00739648|Renal Agents|renal agents|mesh-ancestor
44602670|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44602671|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602672|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602673|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602674|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602675|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602676|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44602677|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44602678|NCT00739596|Amlodipine|amlodipine|mesh-list
44602679|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44602680|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44602681|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44602682|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602683|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602684|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44602685|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602686|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602687|NCT00739596|Diuretics|diuretics|mesh-ancestor
44602688|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
44602689|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44602690|NCT00739297|Montelukast|montelukast|mesh-list
44602691|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602692|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602693|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44602694|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
44602695|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602696|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602697|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44602698|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44602699|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602700|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44602701|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602702|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44602703|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222165|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44602704|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602705|NCT00738894|Dipyridamole|dipyridamole|mesh-list
44602706|NCT00738894|Clopidogrel|clopidogrel|mesh-list
44602707|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602708|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602709|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44602710|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602711|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44602712|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44602713|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44602714|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
44602715|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602716|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44602717|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602718|NCT00738881|Pemetrexed|pemetrexed|mesh-list
44602719|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44602720|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602721|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602722|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602723|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44602724|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602725|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44602726|NCT00738699|Paclitaxel|paclitaxel|mesh-list
44602727|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44602728|NCT00738699|Farletuzumab|farletuzumab|mesh-list
44602729|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44602730|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602731|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44602732|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44602733|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44602734|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602735|NCT00738582|Cisplatin|cisplatin|mesh-list
44602736|NCT00738582|Pemetrexed|pemetrexed|mesh-list
44602737|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602738|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602739|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602740|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44602741|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602742|NCT00738530|Interferons|interferons|mesh-list
44602743|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
44602744|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
44602745|NCT00738530|Bevacizumab|bevacizumab|mesh-list
44602746|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602747|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602748|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602749|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44602750|NCT00738530|Growth Substances|growth substances|mesh-ancestor
44602751|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602752|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
44602753|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
44602754|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602755|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
44602756|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44602757|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
44602758|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44602759|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44602760|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235571|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602761|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602762|NCT00738400|Urological Agents|urological agents|mesh-ancestor
44602764|NCT00738374|Chlorambucil|chlorambucil|mesh-list
44602765|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602766|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602767|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
44602768|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602769|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602770|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602771|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
44602772|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602773|NCT00738062|Droxidopa|droxidopa|mesh-list
44602774|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44602775|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44602776|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
44602777|NCT00737711|Hematinics|hematinics|mesh-ancestor
44602778|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44602779|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44602780|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602781|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602782|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602783|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
44602784|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602785|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44602786|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44602787|NCT00737529|Lenalidomide|lenalidomide|mesh-list
44602788|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
44602789|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602790|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602791|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44602792|NCT00737529|Growth Substances|growth substances|mesh-ancestor
44602793|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44602794|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602795|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
44602796|NCT00737477|Hematinics|hematinics|mesh-ancestor
44602797|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
44602798|NCT00737464|Hematinics|hematinics|mesh-ancestor
44602799|NCT00737438|Bevacizumab|bevacizumab|mesh-list
44602800|NCT00737438|Cisplatin|cisplatin|mesh-list
44602801|NCT00737438|Docetaxel|docetaxel|mesh-list
44602802|NCT00737438|Capecitabine|capecitabine|mesh-list
44602803|NCT00737438|Irinotecan|irinotecan|mesh-list
44602804|NCT00737438|Epirubicin|epirubicin|mesh-list
44602805|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602806|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602807|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44602808|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44602809|NCT00737438|Growth Substances|growth substances|mesh-ancestor
44602810|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602811|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
44602812|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
44602813|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
44602814|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
44602815|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602816|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602817|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
44602818|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44602819|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602820|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602821|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602822|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602823|NCT00737100|Bromides|bromides|mesh-list
44602824|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
44602825|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44602826|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
44602827|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602828|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602829|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602830|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602831|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
44602832|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44602833|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
44602834|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602835|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157745|NCT00235157|Sirolimus|sirolimus|mesh-list
44602836|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
44602837|NCT00737048|Acetaminophen|acetaminophen|mesh-list
44602838|NCT00737048|Tramadol|tramadol|mesh-list
44602839|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602840|NCT00737048|Analgesics|analgesics|mesh-ancestor
44602841|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
44602842|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602843|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602844|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
44602845|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44602846|NCT00737048|Narcotics|narcotics|mesh-ancestor
44602847|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602848|NCT00736996|Pioglitazone|pioglitazone|mesh-list
44602849|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44602850|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602851|NCT00736957|Acetaminophen|acetaminophen|mesh-list
44602852|NCT00736957|Tramadol|tramadol|mesh-list
44602853|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602854|NCT00736957|Analgesics|analgesics|mesh-ancestor
44602855|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
44602856|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602857|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602858|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
44602859|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44602860|NCT00736957|Narcotics|narcotics|mesh-ancestor
44602861|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602862|NCT00736944|Cisplatin|cisplatin|mesh-list
44602863|NCT00736944|Cetuximab|cetuximab|mesh-list
44602864|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44602865|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222282|NCT00494897|Cytarabine|cytarabine|mesh-list
44602866|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602868|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44602869|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602870|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44602871|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602872|NCT00736853|Acetaminophen|acetaminophen|mesh-list
44602873|NCT00736853|Tramadol|tramadol|mesh-list
44602874|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44602875|NCT00736853|Analgesics|analgesics|mesh-ancestor
44602876|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
44602877|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602878|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602879|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
44602880|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44602881|NCT00736853|Narcotics|narcotics|mesh-ancestor
44602882|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44602883|NCT00736645|Selenium|selenium|mesh-list
44602884|NCT00736645|Finasteride|finasteride|mesh-list
44602885|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44602886|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44602887|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602888|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602889|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
44602890|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602891|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602892|NCT00736645|Urological Agents|urological agents|mesh-ancestor
44602893|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
44602894|NCT00736645|Protective Agents|protective agents|mesh-ancestor
44602895|NCT00736645|Trace Elements|trace elements|mesh-ancestor
44602896|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
44602897|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
44602898|NCT00736489|AZD-3199|azd-3199|mesh-list
44602899|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44602900|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
44602901|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222323|NCT00494988|Insulin|insulin|mesh-list
44602902|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602903|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44602904|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44602905|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44602906|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44602907|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44602908|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
44602909|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602910|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602911|NCT00736476|Vaccines|vaccines|mesh-list
44602912|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
44602913|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602914|NCT00736450|Prednisone|prednisone|mesh-list
44602915|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
44602916|NCT00736450|Rituximab|rituximab|mesh-list
44602917|NCT00736450|Doxorubicin|doxorubicin|mesh-list
44602918|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44602919|NCT00736450|Vincristine|vincristine|mesh-list
44602920|NCT00736450|Oblimersen|oblimersen|mesh-list
44602921|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602922|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
44602923|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602924|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44602925|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44602926|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
44602927|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602928|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602929|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44602930|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44602931|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602932|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602933|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602934|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602935|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44602936|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
44602937|NCT00736450|Hormones|hormones|mesh-ancestor
44602938|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44602939|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44602940|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44602942|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
44602943|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
44602944|NCT00736385|Metformin|metformin|mesh-list
44602945|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44602946|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602947|NCT00736333|Doxorubicin|doxorubicin|mesh-list
44602948|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44602949|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44602950|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602951|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44602952|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44602953|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602954|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602955|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44602956|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
44602957|NCT00736255|Nicotine|nicotine|mesh-list
44602958|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44602959|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
44602960|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44602961|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602962|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44602963|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44602964|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
44602965|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44602966|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602967|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44602968|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44602969|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44602970|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44602971|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
44602972|NCT00736190|Tenofovir|tenofovir|mesh-list
44602973|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
44602974|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602975|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44602976|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44602977|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602978|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602979|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44602980|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44602981|NCT00736099|Pioglitazone|pioglitazone|mesh-list
44602982|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222397|NCT00495313|Doxycycline|doxycycline|mesh-list
44602983|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602984|NCT00735904|Gemcitabine|gemcitabine|mesh-list
44602985|NCT00735904|Cisplatin|cisplatin|mesh-list
44602986|NCT00735904|Axitinib|axitinib|mesh-list
44602987|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44602988|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44602989|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
44602990|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44602991|NCT00735904|Antiviral Agents|antiviral agents|mesh-ancestor
44602992|NCT00735904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44602993|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44602994|NCT00735904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44602995|NCT00735904|Immunologic Factors|immunologic factors|mesh-ancestor
44602996|NCT00735904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44602997|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44602998|NCT00735878|Carboplatin|carboplatin|mesh-list
44602999|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603000|NCT00735709|Vortioxetine|vortioxetine|mesh-list
44603001|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
44603002|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603003|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603004|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603005|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603006|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603007|NCT00735709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44603008|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44603009|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603010|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603011|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603012|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
44603013|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44603014|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44603015|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44603016|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603017|NCT00735696|Paclitaxel|paclitaxel|mesh-list
44603018|NCT00735696|Carboplatin|carboplatin|mesh-list
44603019|NCT00735696|Ramucirumab|ramucirumab|mesh-list
44603020|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603021|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603022|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603023|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44603024|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44603025|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603026|NCT00735644|Vaccines|vaccines|mesh-list
44603027|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
44603028|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603029|NCT00735475|Vaccines|vaccines|mesh-list
44603030|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
44603031|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603032|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44603033|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44603034|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603035|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44603036|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44603037|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603038|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603039|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
44603040|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603041|NCT00735072|Maraviroc|maraviroc|mesh-list
44603042|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44603043|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44603044|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603045|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44603046|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44603047|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
44603048|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603049|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44222487|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603050|NCT00734994|Mitomycins|mitomycins|mesh-list
44603051|NCT00734994|Mitomycin|mitomycin|mesh-list
44603052|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44603053|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603054|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
44603055|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603056|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44603057|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603058|NCT00734929|Dexamethasone|dexamethasone|mesh-list
44603059|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
44603061|NCT00734929|Aprepitant|aprepitant|mesh-list
44603062|NCT00734929|BB 1101|bb 1101|mesh-list
44603063|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603064|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
44603065|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
44603066|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603067|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603068|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603069|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
44603070|NCT00734929|Hormones|hormones|mesh-ancestor
44603071|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603072|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603073|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603074|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603075|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603076|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603077|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
44603078|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603079|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603080|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
44603081|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603082|NCT00734929|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44603083|NCT00734929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603084|NCT00734929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603085|NCT00734929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603086|NCT00734929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603087|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44603090|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603091|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603092|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
44603093|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
44603094|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603095|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603096|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44222506|NCT00495846|Octreotide|octreotide|mesh-list
44603097|NCT00734851|Growth Substances|growth substances|mesh-ancestor
44603098|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603099|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603100|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603101|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603102|NCT00734656|Ethanol|ethanol|mesh-list
44603103|NCT00734656|Dutasteride|dutasteride|mesh-list
44603104|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44603105|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603106|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603107|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603108|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44603109|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44603110|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603111|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603112|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603113|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603114|NCT00734630|Losartan|losartan|mesh-list
44603115|NCT00734630|Lisinopril|lisinopril|mesh-list
44603116|NCT00734630|Nebivolol|nebivolol|mesh-list
44603117|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44603118|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44603119|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44603120|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44603121|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603122|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44603123|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603124|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603125|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44603126|NCT00734630|Protective Agents|protective agents|mesh-ancestor
44222552|NCT00496028|Paclitaxel|paclitaxel|mesh-list
44603127|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603128|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
44603129|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44603130|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44603131|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44603132|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
44603133|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603134|NCT00734617|Nicotine|nicotine|mesh-list
44603136|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
44603137|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603138|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603139|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44603140|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44603141|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44603142|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603143|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603144|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
44603145|NCT00734604|Tadalafil|tadalafil|mesh-list
44603146|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603147|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
44603148|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44603149|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44603150|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603151|NCT00734604|Urological Agents|urological agents|mesh-ancestor
44431780|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603152|NCT00734578|Guanfacine|guanfacine|mesh-list
44603153|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44603154|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44603155|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44603156|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44603157|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
44603158|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603159|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603160|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603161|NCT00734539|Fluconazole|fluconazole|mesh-list
44603162|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
44603163|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603164|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44603165|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44603166|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603167|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603168|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44603169|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603170|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603171|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603172|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44603173|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44603174|NCT00734474|Metformin|metformin|mesh-list
44603175|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44603176|NCT00734474|Dulaglutide|dulaglutide|mesh-list
44603177|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44603178|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603179|NCT00734474|Incretins|incretins|mesh-ancestor
44603180|NCT00734474|Hormones|hormones|mesh-ancestor
44603181|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603182|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44603183|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603184|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603185|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603186|NCT00734162|Tenofovir|tenofovir|mesh-list
44603187|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
44603188|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603189|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44603190|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44603191|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603192|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603193|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44603194|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44603195|NCT00734149|Prednisone|prednisone|mesh-list
44603196|NCT00734149|Bortezomib|bortezomib|mesh-list
44603197|NCT00734149|Melphalan|melphalan|mesh-list
44603198|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603199|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
44603200|NCT00734149|Hormones|hormones|mesh-ancestor
44603201|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603202|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603203|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603204|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603205|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44603207|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222623|NCT00496301|Immunologic Factors|immunologic factors|mesh-ancestor
44603208|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44603209|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603210|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
44603211|NCT00734097|Esomeprazole|esomeprazole|mesh-list
44603212|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44603213|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603214|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44603215|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603216|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603217|NCT00734071|Vortioxetine|vortioxetine|mesh-list
44603218|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
44603219|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603220|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603221|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603222|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603223|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431856|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
44603224|NCT00734071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44603225|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44603226|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603227|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603228|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603229|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
44603230|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44603231|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44603232|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44603233|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603234|NCT00734032|Darapladib|darapladib|mesh-list
44603235|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44603236|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603237|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603238|NCT00733954|Clobetasol|clobetasol|mesh-list
44603239|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603240|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
44603241|NCT00733954|Hormones|hormones|mesh-ancestor
44603242|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603243|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603244|NCT00733902|Tanezumab|tanezumab|mesh-list
44603245|NCT00733902|Analgesics|analgesics|mesh-ancestor
44603246|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
44603247|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603248|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603249|NCT00733824|Plerixafor|plerixafor|mesh-list
44603250|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44603251|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44603252|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
44603253|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603254|NCT00733746|Gemcitabine|gemcitabine|mesh-list
44603255|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44603256|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44603257|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
44603258|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603259|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603260|NCT00733746|Antiviral Agents|antiviral agents|mesh-ancestor
44603261|NCT00733746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603262|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603263|NCT00733746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603264|NCT00733746|Immunologic Factors|immunologic factors|mesh-ancestor
44603265|NCT00733746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603266|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603267|NCT00733421|Etoricoxib|etoricoxib|mesh-list
44603268|NCT00733421|Tramadol|tramadol|mesh-list
44603269|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44603270|NCT00733421|Narcotics|narcotics|mesh-ancestor
44603271|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603272|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603273|NCT00733421|Analgesics|analgesics|mesh-ancestor
44603274|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
44603275|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603276|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44603277|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44603278|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603280|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44603281|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44603282|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603283|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603284|NCT00733408|Paclitaxel|paclitaxel|mesh-list
44603285|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44603286|NCT00733408|Bevacizumab|bevacizumab|mesh-list
44603287|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44603288|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44603289|NCT00733408|Antibodies|antibodies|mesh-list
44603290|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
44603291|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44603292|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603293|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603294|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603295|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44603296|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44603297|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603298|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603299|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44603300|NCT00733408|Growth Substances|growth substances|mesh-ancestor
44603301|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603302|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603303|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
44603304|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603305|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603306|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44603308|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44603309|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
44603310|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603311|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
44603312|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603313|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603314|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44603315|NCT00732992|Pemetrexed|pemetrexed|mesh-list
44603316|NCT00732992|Sunitinib|sunitinib|mesh-list
44603317|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603318|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603319|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603320|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44603321|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44603322|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603323|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44603324|NCT00732992|Growth Substances|growth substances|mesh-ancestor
44603325|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603326|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603327|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603328|NCT00732940|Belimumab|belimumab|mesh-list
44603329|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603330|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
44603331|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603332|NCT00732875|Methotrexate|methotrexate|mesh-list
44603333|NCT00732875|Infliximab|infliximab|mesh-list
44603334|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44603335|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
44603336|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44603337|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603338|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44603339|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
44603340|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603341|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603342|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603343|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603344|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44603345|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603346|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
44603347|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603348|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44603349|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603350|NCT00732758|Vitamin D|vitamin d|mesh-list
44603351|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
44603352|NCT00732758|Vitamins|vitamins|mesh-ancestor
44603353|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
44603354|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603355|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44603356|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44603358|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
44603359|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44603360|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44603361|NCT00732498|Prednisolone|prednisolone|mesh-list
44603362|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
44603363|NCT00732498|Rituximab|rituximab|mesh-list
44603364|NCT00732498|Etoposide|etoposide|mesh-list
44603365|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44603366|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44603367|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
44603368|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44603369|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603370|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
44603371|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603372|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603373|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603374|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44603375|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44603376|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603377|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603378|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44603379|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
44603380|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
44603381|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603382|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603383|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603385|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
44603386|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603387|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603388|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
44603389|NCT00732498|Hormones|hormones|mesh-ancestor
44603390|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603391|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44603392|NCT00732498|Protective Agents|protective agents|mesh-ancestor
44603393|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603394|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
44603395|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603396|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603397|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44603398|NCT00732303|Pemetrexed|pemetrexed|mesh-list
44603399|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603400|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603401|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603402|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44222816|NCT00497328|Expectorants|expectorants|mesh-ancestor
44603403|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44603404|NCT00732251|Allopurinol|allopurinol|mesh-list
44603405|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
44603406|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603407|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603408|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
44603409|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603410|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44603411|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
44603412|NCT00732251|Protective Agents|protective agents|mesh-ancestor
44603413|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603414|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44603415|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603416|NCT00732069|Valsartan|valsartan|mesh-list
44603417|NCT00732069|Ramipril|ramipril|mesh-list
44603418|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44603419|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44603420|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44603421|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603422|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44603423|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603424|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603425|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
44603426|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44603427|NCT00731783|Mupirocin|mupirocin|mesh-list
44603428|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44603429|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603430|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
44603432|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603433|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44603434|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603435|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603436|NCT00731731|Temozolomide|temozolomide|mesh-list
44603437|NCT00731731|Vorinostat|vorinostat|mesh-list
44603438|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44603439|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
44603440|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603441|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603442|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44603443|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603444|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44603445|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44603446|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603447|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432086|NCT02093026|Hormones|hormones|mesh-ancestor
44603448|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
44603449|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603450|NCT00731679|Rifaximin|rifaximin|mesh-list
44603451|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603452|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603453|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603454|NCT00731549|Aripiprazole|aripiprazole|mesh-list
44603455|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
44603456|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603457|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44603458|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603459|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603460|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603461|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
44603462|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
44603463|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603464|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603465|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44603466|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44603467|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
44603468|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44603469|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603470|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44603471|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44603472|NCT00731133|Disulfiram|disulfiram|mesh-list
44603473|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44603474|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44603475|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603476|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603477|NCT00731120|Vortioxetine|vortioxetine|mesh-list
44603478|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
44603479|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603480|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603481|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603482|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603483|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603484|NCT00731120|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44603485|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44603486|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603487|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603488|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603489|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
44603490|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44603491|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44603492|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44603493|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603494|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44603495|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44603496|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603497|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603498|NCT00730925|Paclitaxel|paclitaxel|mesh-list
44603499|NCT00730925|Afatinib|afatinib|mesh-list
44603500|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603501|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603502|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603503|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
44603504|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
44603505|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603506|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603507|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603508|NCT00730912|Loratadine|loratadine|mesh-list
44603509|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
44603510|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603511|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44603512|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44603513|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44603514|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
44603515|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
44603516|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603517|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603518|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603519|NCT00730847|Vaccines|vaccines|mesh-list
44603520|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
44432153|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
44603521|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603522|NCT00730756|Fluticasone|fluticasone|mesh-list
44603523|NCT00730756|Xhance|xhance|mesh-list
44603524|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603525|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44603526|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
44603527|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603528|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603529|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44603530|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
44603531|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603532|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44603533|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44603534|NCT00730691|Vortioxetine|vortioxetine|mesh-list
44603535|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44603536|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44603537|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603538|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603539|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603540|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603541|NCT00730691|Analgesics|analgesics|mesh-ancestor
44603542|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
44603543|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603544|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44603545|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603546|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
44603547|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603548|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603549|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603550|NCT00730691|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44603551|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
44603552|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44603553|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44603554|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44603555|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44603556|NCT00730405|Albaconazole|albaconazole|mesh-list
44603557|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
44603558|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603559|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44603560|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44603561|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603562|NCT00730275|Incretins|incretins|mesh-ancestor
44603563|NCT00730275|Hormones|hormones|mesh-ancestor
44603564|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603565|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44603566|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603567|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603568|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603569|NCT00730171|Linaclotide|linaclotide|mesh-list
44603570|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44603571|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
44603572|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603573|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603574|NCT00730158|Irinotecan|irinotecan|mesh-list
44603575|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44603576|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44603577|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603578|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603579|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603580|NCT00730132|Ezetimibe|ezetimibe|mesh-list
44603581|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44603582|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44603583|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
44603584|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603585|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44603586|NCT00730028|Clindamycin|clindamycin|mesh-list
44603587|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
44603588|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
44603589|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44603590|NCT00730028|Trimethoprim|trimethoprim|mesh-list
44603591|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
44603592|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603593|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603594|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44603595|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603596|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603597|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44603598|NCT00730028|Renal Agents|renal agents|mesh-ancestor
44603599|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
44603600|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44603601|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44603602|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44603603|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44603604|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44603605|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44603606|NCT00730015|Linaclotide|linaclotide|mesh-list
44603607|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44603608|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
44603609|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603610|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603611|NCT00729937|Clindamycin|clindamycin|mesh-list
44603612|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
44603613|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
44603614|NCT00729937|Cephalexin|cephalexin|mesh-list
44603615|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44603616|NCT00729937|Trimethoprim|trimethoprim|mesh-list
44603617|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
44603618|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603619|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603620|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44603621|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603622|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603623|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44603624|NCT00729937|Renal Agents|renal agents|mesh-ancestor
44603625|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
44603626|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44603627|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44603628|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44603629|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44603630|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44603631|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44603632|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
44603633|NCT00729859|Anastrozole|anastrozole|mesh-list
44603634|NCT00729859|Testosterone|testosterone|mesh-list
44603635|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
44603636|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
44603637|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44603638|NCT00729859|Acyline|acyline|mesh-list
44603639|NCT00729859|Androgens|androgens|mesh-ancestor
44603640|NCT00729859|Hormones|hormones|mesh-ancestor
44603641|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603642|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603643|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603644|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603645|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
44603646|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44603647|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44603648|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603649|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603650|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44603651|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603653|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603654|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603655|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44603656|NCT00729833|Growth Substances|growth substances|mesh-ancestor
44603657|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603658|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603659|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603660|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603661|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603662|NCT00729690|Pregabalin|pregabalin|mesh-list
44603663|NCT00729690|Analgesics|analgesics|mesh-ancestor
44603664|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
44603665|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603666|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603667|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
44603668|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44603669|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44603670|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603671|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44603672|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603673|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603674|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603675|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603676|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
44603677|NCT00729651|Vitamin D|vitamin d|mesh-list
44603678|NCT00729651|Alendronate|alendronate|mesh-list
44603679|NCT00729651|Calcium|calcium|mesh-list
44223069|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
44603680|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44603681|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603682|NCT00729651|Vitamins|vitamins|mesh-ancestor
44603683|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
44603684|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44603685|NCT00729612|Paclitaxel|paclitaxel|mesh-list
44603686|NCT00729612|Carboplatin|carboplatin|mesh-list
44603687|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44603688|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603689|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603690|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44603691|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44603692|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44603693|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603694|NCT00729586|Tamoxifen|tamoxifen|mesh-list
44603695|NCT00729586|Sirolimus|sirolimus|mesh-list
44603696|NCT00729586|Megestrol|megestrol|mesh-list
44603697|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
44603698|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603699|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603700|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44603701|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603702|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
44603703|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603704|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
44603705|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603706|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44603707|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603708|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603709|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603710|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44603711|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44603712|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44603713|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44603714|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44603715|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44603716|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
44603717|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44603718|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44603719|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44603720|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
44603721|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44603722|NCT00729560|Flutamide|flutamide|mesh-list
44603723|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
44603724|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223106|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603725|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603726|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603727|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603728|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603729|NCT00729365|Ramipril|ramipril|mesh-list
44603730|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44603731|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
44603732|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603733|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603734|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44603735|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44603736|NCT00729326|Exenatide|exenatide|mesh-list
44603737|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44603738|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603739|NCT00729326|Incretins|incretins|mesh-ancestor
44603740|NCT00729326|Hormones|hormones|mesh-ancestor
44603741|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603742|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44432379|NCT02084082|Metformin|metformin|mesh-list
44603780|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44603781|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44603782|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603783|NCT00728949|Tamoxifen|tamoxifen|mesh-list
44603784|NCT00728949|Letrozole|letrozole|mesh-list
44603785|NCT00728949|Fulvestrant|fulvestrant|mesh-list
44603786|NCT00728949|Anastrozole|anastrozole|mesh-list
44603787|NCT00728949|Exemestane|exemestane|mesh-list
44603788|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44603789|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603790|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44603791|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44603792|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603793|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603794|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44603795|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603796|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603797|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603798|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44603799|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44603800|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44603801|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44603802|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44603803|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
44603804|NCT00728494|Ribavirin|ribavirin|mesh-list
44603805|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44603806|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
44603807|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
44603808|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603809|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
44603810|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603811|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
44603812|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603813|NCT00728481|Budesonide|budesonide|mesh-list
44603814|NCT00728481|Esomeprazole|esomeprazole|mesh-list
44603815|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603816|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44603817|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
44603818|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603819|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603820|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44603821|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44603822|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
44603823|NCT00728481|Hormones|hormones|mesh-ancestor
44603824|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603825|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44603826|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603827|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44603828|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603829|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603830|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
44603831|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44603832|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44603833|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44603834|NCT00727961|Doxorubicin|doxorubicin|mesh-list
44603835|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44603836|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44603837|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603838|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44603839|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44603840|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603841|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603842|NCT00727844|Linezolid|linezolid|mesh-list
44603843|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44603844|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603845|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44603846|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603847|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603848|NCT00727649|Loperamide|loperamide|mesh-list
44603849|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
44603850|NCT00727649|Psyllium|psyllium|mesh-list
44603851|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603852|NCT00727649|Cathartics|cathartics|mesh-ancestor
44603853|NCT00727532|Sorafenib|sorafenib|mesh-list
44603854|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603855|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603856|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603857|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603858|NCT00727506|Afatinib|afatinib|mesh-list
44603859|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603860|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603861|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603862|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603863|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
44603864|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603865|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
44603866|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603867|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603868|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44603869|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
44603870|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603871|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603872|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44603873|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
44603874|NCT00727415|Fludarabine|fludarabine|mesh-list
44603875|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
44603876|NCT00727415|Lenalidomide|lenalidomide|mesh-list
44603877|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603878|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
44603879|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603880|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44603881|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44603882|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
44603883|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603884|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603885|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44603886|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44603887|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
44603888|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44603889|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44603890|NCT00727415|Growth Substances|growth substances|mesh-ancestor
44603891|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44603892|NCT00727311|Ribavirin|ribavirin|mesh-list
44603893|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44603894|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
44603895|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
44603896|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603897|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
44603898|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603899|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
44603900|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603901|NCT00727272|Quinine|quinine|mesh-list
44603902|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
44603903|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44603904|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44603905|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603906|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44603907|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603908|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44603909|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603910|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44603912|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
44603913|NCT00727259|Ribavirin|ribavirin|mesh-list
44603914|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44603915|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
44603916|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603917|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
44603918|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603919|NCT00727246|Choline|choline|mesh-list
44603920|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44603921|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
44603922|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44603923|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
44603924|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603925|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44603926|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44603927|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
44603928|NCT00727194|Eculizumab|eculizumab|mesh-list
44603929|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44603930|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44603931|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
44603932|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603933|NCT00726999|Morphine|morphine|mesh-list
44603934|NCT00726999|Gabapentin|gabapentin|mesh-list
44603935|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44603936|NCT00726999|Narcotics|narcotics|mesh-ancestor
44603937|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44603938|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603939|NCT00726999|Analgesics|analgesics|mesh-ancestor
44603940|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
44603941|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603942|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
44603943|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44603944|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44603945|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44603946|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44603947|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44603948|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44603949|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603950|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
44603951|NCT00726986|Cisplatin|cisplatin|mesh-list
44603952|NCT00726986|Etoposide|etoposide|mesh-list
44603953|NCT00726986|Sorafenib|sorafenib|mesh-list
44603954|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603955|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44603956|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44603957|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44603958|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603959|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603960|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603961|NCT00726895|Quinine|quinine|mesh-list
44603962|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
44603963|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44603964|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44603965|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603966|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44603967|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603968|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44603969|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44603970|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44603971|NCT00726895|Analgesics|analgesics|mesh-ancestor
44603972|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
44603973|NCT00726752|Axitinib|axitinib|mesh-list
44603974|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603975|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44603976|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603977|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603978|NCT00726609|Posaconazole|posaconazole|mesh-list
44603979|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
44603980|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44603981|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44603982|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44603983|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44603984|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44603985|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44603986|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44603987|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44603988|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44603989|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
44603990|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44603991|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44603992|NCT00726557|Interferons|interferons|mesh-list
44603993|NCT00726557|Ribavirin|ribavirin|mesh-list
44603994|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
44603995|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
44603996|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44603997|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44603998|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
44603999|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604000|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
44604001|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604002|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
44604003|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604004|NCT00726388|Diclofenac|diclofenac|mesh-list
44604005|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44604006|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44604007|NCT00726388|Analgesics|analgesics|mesh-ancestor
44604008|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
44604009|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604010|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604011|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604012|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604013|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44604014|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604015|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604016|NCT00725985|Cladribine|cladribine|mesh-list
44604017|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604018|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604019|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
44604020|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604021|NCT00725920|Topiramate|topiramate|mesh-list
44604022|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
44604023|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44604024|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604025|NCT00725842|Ribavirin|ribavirin|mesh-list
44604026|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
44604027|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604028|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
44604029|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604030|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
44604031|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604032|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604033|NCT00725621|Infliximab|infliximab|mesh-list
44604034|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604035|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604036|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604037|NCT00725608|Buprenorphine|buprenorphine|mesh-list
44604038|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44604039|NCT00725608|Naloxone|naloxone|mesh-list
44604040|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44604041|NCT00725608|Narcotics|narcotics|mesh-ancestor
44604042|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604043|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604044|NCT00725608|Analgesics|analgesics|mesh-ancestor
44604045|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
44604046|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604047|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44604048|NCT00725543|Infliximab|infliximab|mesh-list
44604049|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604050|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604051|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604052|NCT00725452|Infliximab|infliximab|mesh-list
44604053|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604054|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604055|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604056|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
44604057|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44604058|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44604059|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43838448|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604060|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44604061|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604062|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
44604063|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604064|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604065|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44604066|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604067|NCT00725296|Infliximab|infliximab|mesh-list
44604068|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604069|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604070|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604071|NCT00725205|Ribavirin|ribavirin|mesh-list
44604072|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604073|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
44604074|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
44604075|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604076|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
44604077|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604078|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
44604079|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604080|NCT00725010|Temozolomide|temozolomide|mesh-list
44604081|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604082|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
44604083|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604084|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604085|NCT00724971|Rituximab|rituximab|mesh-list
44604086|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44604087|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604088|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604089|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
44604090|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604091|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604092|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604093|NCT00724958|Infliximab|infliximab|mesh-list
44604094|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604095|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604096|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604097|NCT00724932|Atropine|atropine|mesh-list
44604098|NCT00724932|Bromides|bromides|mesh-list
44604099|NCT00724932|Rocuronium|rocuronium|mesh-list
44604100|NCT00724932|Neostigmine|neostigmine|mesh-list
44604101|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
44604102|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44604103|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44604104|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44604105|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604106|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604107|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44604108|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44604109|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44604110|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
44604111|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44604112|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
44604113|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
44604114|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
44604115|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44604116|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44604117|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
44604118|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604119|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604120|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44604121|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604122|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44604123|NCT00724893|Interferons|interferons|mesh-list
44604124|NCT00724893|Ribavirin|ribavirin|mesh-list
44604125|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
44604126|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
44604127|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604128|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604129|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
44604130|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604131|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
44604132|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604133|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
44604134|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604135|NCT00724867|Belimumab|belimumab|mesh-list
44604136|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604137|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
44604138|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457635|NCT01606306|Xhance|xhance|mesh-list
44604140|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604141|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
44604142|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
44604143|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604144|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
44604145|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604146|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
44604147|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604148|NCT00724815|Sumatriptan|sumatriptan|mesh-list
44604149|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44604150|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44604151|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44604152|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
44604153|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604154|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604155|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604156|NCT00724711|Tenofovir|tenofovir|mesh-list
44604157|NCT00724711|Lamivudine|lamivudine|mesh-list
44604158|NCT00724711|Emtricitabine|emtricitabine|mesh-list
44604159|NCT00724711|Abacavir|abacavir|mesh-list
44604183|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604184|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604186|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604187|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604188|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604189|NCT00724126|Rifaximin|rifaximin|mesh-list
44604190|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604191|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604192|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604193|NCT00724061|Interferons|interferons|mesh-list
44604194|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
44604195|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
44604196|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44604197|NCT00724061|Furocoumarins|furocoumarins|mesh-list
44604198|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604199|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
44604200|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604201|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
44604202|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604203|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604204|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44604205|NCT00723957|Paclitaxel|paclitaxel|mesh-list
44604206|NCT00723957|Carboplatin|carboplatin|mesh-list
44604207|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44604208|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604209|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
44604210|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
44604211|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604212|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604215|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
44604216|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
44604217|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604218|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
44604219|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604220|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
44604221|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604222|NCT00723801|Losartan|losartan|mesh-list
44604223|NCT00723801|Atenolol|atenolol|mesh-list
44604224|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44604225|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44604226|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44604227|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44604228|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604229|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
44604230|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
44604231|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604232|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604233|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44604234|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44604235|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44604236|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
44604238|NCT00723710|Interferons|interferons|mesh-list
44604239|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
44604240|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
44604241|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604242|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
44604243|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604244|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
44604245|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604246|NCT00723697|Buprenorphine|buprenorphine|mesh-list
44604247|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44604248|NCT00723697|Narcotics|narcotics|mesh-ancestor
44604249|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604250|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604251|NCT00723697|Analgesics|analgesics|mesh-ancestor
44604252|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
44604253|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604254|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44604255|NCT00723606|Haloperidol|haloperidol|mesh-list
44604256|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
44604257|NCT00723606|Ziprasidone|ziprasidone|mesh-list
44604258|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
44604259|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
44604260|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604261|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604262|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604263|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44604264|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44604265|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604266|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44604267|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44604268|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
44604269|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604270|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604271|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44604272|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44604273|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
44604274|NCT00723554|Iloprost|iloprost|mesh-list
44604275|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44604276|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44604277|NCT00723528|Ustekinumab|ustekinumab|mesh-list
44604278|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604279|NCT00723450|Lamotrigine|lamotrigine|mesh-list
44604280|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
44604281|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44604282|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44604283|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604284|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44604285|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604286|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44604287|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44604288|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604290|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44604291|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44604292|NCT00723398|Pitavastatin|pitavastatin|mesh-list
44604293|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44604294|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44604295|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44604296|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
44604297|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604298|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604299|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44604300|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44604301|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604302|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604303|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604304|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44604305|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44604306|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44604307|NCT00723255|Sirolimus|sirolimus|mesh-list
44604308|NCT00723255|Bevacizumab|bevacizumab|mesh-list
44604309|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44604310|NCT00723255|Antibodies|antibodies|mesh-list
44604311|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
44604312|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44604313|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604314|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44604315|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44604316|NCT00723255|Growth Substances|growth substances|mesh-ancestor
44604317|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604318|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
44604319|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
44604320|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604321|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604322|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604323|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
44604324|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604325|NCT00723229|Acyclovir|acyclovir|mesh-list
44604326|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
44604327|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604328|NCT00723203|Panobinostat|panobinostat|mesh-list
44604329|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604330|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44604331|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604332|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604333|NCT00723190|Clonidine|clonidine|mesh-list
44604334|NCT00723190|Analgesics|analgesics|mesh-ancestor
44604335|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
44604336|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604337|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604338|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44604339|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
44604340|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
44604341|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44604342|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44604343|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44604344|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44604345|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604346|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604347|NCT00723125|Paclitaxel|paclitaxel|mesh-list
44604348|NCT00723125|Bevacizumab|bevacizumab|mesh-list
44604349|NCT00723125|Carboplatin|carboplatin|mesh-list
44604350|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44604351|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44604352|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604353|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44604354|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44604355|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604356|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604357|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604358|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44604359|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44604360|NCT00723125|Growth Substances|growth substances|mesh-ancestor
44604361|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604362|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44604364|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44604365|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44604366|NCT00723021|Analgesics|analgesics|mesh-ancestor
44604367|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
44604368|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604369|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604370|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604371|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604372|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44223616|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
44604373|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604374|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604375|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44604376|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604377|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604378|NCT00722800|Drospirenone|drospirenone|mesh-list
44604379|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44604380|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44604381|NCT00722800|Estradiol|estradiol|mesh-list
44604382|NCT00722800|Estrogens|estrogens|mesh-ancestor
44604383|NCT00722800|Hormones|hormones|mesh-ancestor
44604384|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604385|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604386|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44604387|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
44604388|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44604389|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44604390|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44604391|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44604392|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44604393|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604394|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44604395|NCT00722800|Diuretics|diuretics|mesh-ancestor
44604396|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
44604397|NCT00722761|Drospirenone|drospirenone|mesh-list
44604398|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44604399|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44604400|NCT00722761|Estradiol|estradiol|mesh-list
44604401|NCT00722761|Estrogens|estrogens|mesh-ancestor
44604402|NCT00722761|Hormones|hormones|mesh-ancestor
44604403|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604404|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604405|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44604406|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
44604407|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44604408|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44604409|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44604410|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44604411|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44604412|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604413|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44604414|NCT00722761|Diuretics|diuretics|mesh-ancestor
44604415|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
44604416|NCT00722371|Metformin|metformin|mesh-list
44604417|NCT00722371|Pioglitazone|pioglitazone|mesh-list
44604418|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44604419|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44604420|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604421|NCT00722371|Incretins|incretins|mesh-ancestor
44604422|NCT00722371|Hormones|hormones|mesh-ancestor
44604423|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604424|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44604425|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
44604426|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604427|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604428|NCT00722137|Prednisone|prednisone|mesh-list
44604429|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
44604430|NCT00722137|Rituximab|rituximab|mesh-list
44604431|NCT00722137|Doxorubicin|doxorubicin|mesh-list
44604432|NCT00722137|Vincristine|vincristine|mesh-list
44604433|NCT00722137|Bortezomib|bortezomib|mesh-list
44604434|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433072|NCT02065245|Penicillins|penicillins|mesh-list
44604435|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
44604436|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604437|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604438|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604439|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
44604440|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604441|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604442|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44604443|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604444|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604445|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44604446|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44604447|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604448|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604449|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
44604451|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604452|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44604453|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44604454|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44604455|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44604456|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604457|NCT00721955|Loxapine|loxapine|mesh-list
44604458|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44604459|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44604460|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604461|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604462|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44604463|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44604464|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
44604465|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604466|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604467|NCT00721630|Capecitabine|capecitabine|mesh-list
44604468|NCT00721630|Lapatinib|lapatinib|mesh-list
44604469|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44604470|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
44604471|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604472|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604473|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604474|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604475|NCT00721578|Voriconazole|voriconazole|mesh-list
44604476|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
44604477|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604478|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44604479|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44604480|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604481|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604482|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44604483|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604484|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604485|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604486|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44604487|NCT00721409|Letrozole|letrozole|mesh-list
44604488|NCT00721409|Palbociclib|palbociclib|mesh-list
44604489|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604490|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44604491|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44604492|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604493|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604494|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44223746|NCT00502060|Cediranib|cediranib|mesh-list
44604495|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
44604496|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604497|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604498|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604499|NCT00721396|Vaccines|vaccines|mesh-list
44604500|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44604501|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
44604502|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604503|NCT00721279|Pramipexole|pramipexole|mesh-list
44604504|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
44604505|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433203|NCT02061280|Xhance|xhance|mesh-list
44604506|NCT00721279|Protective Agents|protective agents|mesh-ancestor
44604507|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604508|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44604509|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44604510|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
44604511|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
44604512|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604513|NCT00721214|Azacitidine|azacitidine|mesh-list
44604514|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44604515|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
44604516|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604517|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604518|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604519|NCT00721110|Lidocaine|lidocaine|mesh-list
44604520|NCT00721110|Ketamine|ketamine|mesh-list
44604521|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
44604522|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
44604523|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44604524|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604525|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
44604526|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604527|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44604528|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44604529|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44604530|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44604531|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604533|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44604534|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44604535|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
44604536|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44604537|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44604538|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604539|NCT00720941|Sunitinib|sunitinib|mesh-list
44604540|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604541|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44604542|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44604543|NCT00720941|Growth Substances|growth substances|mesh-ancestor
44604544|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604545|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
44604546|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604547|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604548|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604549|NCT00720902|Hormones|hormones|mesh-list
44604550|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44604551|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604552|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604553|NCT00720876|Rituximab|rituximab|mesh-list
44604554|NCT00720876|Vorinostat|vorinostat|mesh-list
44604555|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604556|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604557|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
44604558|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604559|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604560|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44604561|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604562|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604563|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44604564|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44604565|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
44604566|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44604567|NCT00720798|Analgesics|analgesics|mesh-ancestor
44604568|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
44604569|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604570|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604571|NCT00720759|Cycloserine|cycloserine|mesh-list
44604572|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44604573|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604574|NCT00720759|Renal Agents|renal agents|mesh-ancestor
44604575|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44604576|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
44223819|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
44604577|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604578|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
44604579|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604580|NCT00720499|Bromides|bromides|mesh-list
44604581|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
44604582|NCT00720499|Olodaterol|olodaterol|mesh-list
44604583|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44604584|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
44604585|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604586|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604587|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44604588|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44604589|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
44604590|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44604591|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44604592|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604593|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604594|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
44604595|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
44604596|NCT00720382|Azelastine|azelastine|mesh-list
44604597|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604598|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604599|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44604600|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44604601|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
44604602|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604603|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604604|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44604605|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44604606|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44604607|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604608|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604609|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44604610|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44604611|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
44604612|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
44604613|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604614|NCT00720356|Bevacizumab|bevacizumab|mesh-list
44604615|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44604616|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604617|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604618|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44604619|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44604620|NCT00720356|Growth Substances|growth substances|mesh-ancestor
44604621|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604622|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
44604623|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604624|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604625|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604626|NCT00720343|Choline|choline|mesh-list
44604627|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
44604628|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44604629|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
44604630|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604631|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604632|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44604633|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
44604634|NCT00720278|Azelastine|azelastine|mesh-list
44604635|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44604636|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
44604637|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604638|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604639|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44604640|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44604641|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44604642|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604643|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604644|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44604645|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44604646|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44604647|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
44604648|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
44604649|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604650|NCT00720226|Losartan|losartan|mesh-list
44604651|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44604652|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44604653|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44604654|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44604655|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604656|NCT00720122|Insulin|insulin|mesh-list
44604657|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44604658|NCT00720122|Mitogens|mitogens|mesh-list
44604659|NCT00720122|Mecasermin|mecasermin|mesh-list
44604660|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44604661|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604662|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604663|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604664|NCT00720122|Growth Substances|growth substances|mesh-ancestor
44604665|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
44604666|NCT00720109|Leucovorin|leucovorin|mesh-list
44604667|NCT00720109|Folic Acid|folic acid|mesh-list
44604668|NCT00720109|Cytarabine|cytarabine|mesh-list
44604669|NCT00720109|Dexamethasone|dexamethasone|mesh-list
44604670|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
44604671|NCT00720109|Prednisone|prednisone|mesh-list
44604672|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
44604673|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44604674|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44604675|NCT00720109|Prednisolone|prednisolone|mesh-list
44604676|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
44604677|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
44604678|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44604679|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44604680|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44604681|NCT00720109|Cortisone|cortisone|mesh-list
44604683|NCT00720109|Ifosfamide|ifosfamide|mesh-list
44604684|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
44604685|NCT00720109|Methotrexate|methotrexate|mesh-list
44604686|NCT00720109|Etoposide|etoposide|mesh-list
44604687|NCT00720109|Vincristine|vincristine|mesh-list
44604688|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
44604689|NCT00720109|Daunorubicin|daunorubicin|mesh-list
44604690|NCT00720109|Asparaginase|asparaginase|mesh-list
44604691|NCT00720109|Dasatinib|dasatinib|mesh-list
44604692|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
44604693|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
44604694|NCT00720109|Pegaspargase|pegaspargase|mesh-list
44604695|NCT00720109|Lenograstim|lenograstim|mesh-list
44604696|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44604697|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
44433371|NCT02058940|Exenatide|exenatide|mesh-list
44604698|NCT00720109|BB 1101|bb 1101|mesh-list
44604699|NCT00720109|Calcium|calcium|mesh-list
44604700|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
44604701|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604702|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
44604724|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
44604725|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44604726|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44604727|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
44604728|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604729|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44604730|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44604731|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44604732|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44604733|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44604734|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
44604735|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604736|NCT00720109|Antidotes|antidotes|mesh-ancestor
44604737|NCT00720109|Protective Agents|protective agents|mesh-ancestor
44604738|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
44604739|NCT00720109|Vitamins|vitamins|mesh-ancestor
44604740|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
44604741|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44604742|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
44604743|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
44604744|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604745|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44604746|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604747|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604748|NCT00720109|Hematinics|hematinics|mesh-ancestor
44604749|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
44604750|NCT00720096|Doxorubicin|doxorubicin|mesh-list
44604751|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44604752|NCT00720096|Topotecan|topotecan|mesh-list
44604753|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604754|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604755|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44604756|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44604757|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604758|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604759|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44604760|NCT00720083|Cisplatin|cisplatin|mesh-list
44604761|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604762|NCT00720057|Naproxen|naproxen|mesh-list
44604763|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44604764|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44604765|NCT00720057|Analgesics|analgesics|mesh-ancestor
44604766|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
44604767|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604768|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604769|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604770|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604771|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
44604772|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44604773|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604774|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604775|NCT00719901|Bortezomib|bortezomib|mesh-list
44604776|NCT00719901|Obatoclax|obatoclax|mesh-list
44604777|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604778|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604779|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604780|NCT00719862|Azelastine|azelastine|mesh-list
44604781|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44604782|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
44604783|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604784|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604785|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44604786|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44604787|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44604788|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604789|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604790|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44604791|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44604792|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44604793|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
44604794|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
44604795|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604796|NCT00719849|Cyclosporine|cyclosporine|mesh-list
44604797|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
44604798|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
44604799|NCT00719849|Fludarabine|fludarabine|mesh-list
44604800|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
44604801|NCT00719849|Cyclosporins|cyclosporins|mesh-list
44604802|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44604803|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604804|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
44604805|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604806|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604807|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604808|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
44604809|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604810|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604811|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44604812|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44604813|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
44604814|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604815|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
44604816|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604817|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604818|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44604819|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604820|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44604821|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
44604822|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604823|NCT00719810|Tigecycline|tigecycline|mesh-list
44604824|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
44604825|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604826|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604827|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44604828|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604829|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604830|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44604831|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
44604832|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
44604833|NCT00719706|Vitamins|vitamins|mesh-ancestor
44604834|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
44604835|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604836|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
44604837|NCT00719537|Aspirin|aspirin|mesh-list
44604838|NCT00719537|Progesterone|progesterone|mesh-list
44604839|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44604840|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44604841|NCT00719537|Analgesics|analgesics|mesh-ancestor
44604842|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
44604843|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604844|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604845|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604846|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604847|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44224068|NCT00503516|Megestrol|megestrol|mesh-list
44604848|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44604849|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604850|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44604851|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44604852|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604853|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
44604854|NCT00719537|Progestins|progestins|mesh-ancestor
44604855|NCT00719537|Hormones|hormones|mesh-ancestor
44604856|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604858|NCT00719472|Prednisone|prednisone|mesh-list
44604859|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
44604860|NCT00719472|Rituximab|rituximab|mesh-list
44604861|NCT00719472|Doxorubicin|doxorubicin|mesh-list
44604862|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44604863|NCT00719472|Vincristine|vincristine|mesh-list
44604864|NCT00719472|Analgesics|analgesics|mesh-list
44604865|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
44604866|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44604867|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604868|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
44604869|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604870|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604871|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604872|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
44604873|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604874|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604875|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44604876|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604877|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44604878|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44604879|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44604880|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604881|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44604882|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
44604883|NCT00719472|Hormones|hormones|mesh-ancestor
44604884|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604885|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44604886|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44604887|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44604888|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44604889|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44604890|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
44604891|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604892|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
44604893|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44604894|NCT00719264|Interferons|interferons|mesh-list
44604895|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
44604896|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
44604897|NCT00719264|Bevacizumab|bevacizumab|mesh-list
44604898|NCT00719264|Everolimus|everolimus|mesh-list
44604899|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604900|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604901|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44604902|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44604903|NCT00719264|Growth Substances|growth substances|mesh-ancestor
44604904|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604905|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
44604906|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
44604907|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604908|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604909|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
44604910|NCT00719043|Vaccines|vaccines|mesh-list
44604911|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
44604912|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604913|NCT00718887|Entecavir|entecavir|mesh-list
44604914|NCT00718887|Adefovir|adefovir|mesh-list
44604915|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
44604916|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604917|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44604918|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44604919|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604920|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604921|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
44604922|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44604923|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604924|NCT00718809|Saracatinib|saracatinib|mesh-list
44604925|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604926|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604927|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604928|NCT00718770|Bexarotene|bexarotene|mesh-list
44604929|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604930|NCT00718718|Methotrexate|methotrexate|mesh-list
44604932|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44604933|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
44604934|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44604935|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604936|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44604937|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
44604938|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604939|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604940|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44604941|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604942|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44604943|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604944|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
44604945|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604946|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44604947|NCT00718640|Dexamethasone|dexamethasone|mesh-list
44604948|NCT00718640|Bortezomib|bortezomib|mesh-list
44604949|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433614|NCT02055820|Venetoclax|venetoclax|mesh-list
44604950|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
44604951|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
44604952|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44604953|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604954|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604955|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
44604957|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44604958|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44604959|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604960|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
44604961|NCT00718549|Rituximab|rituximab|mesh-list
44604962|NCT00718549|Cladribine|cladribine|mesh-list
44604963|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44604964|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
44604965|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604966|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44604967|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44604968|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
44604969|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604970|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604971|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44604972|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44604973|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44604974|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
44604975|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44604976|NCT00718328|Simvastatin|simvastatin|mesh-list
44604977|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44604978|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44604979|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
44604980|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604981|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44604982|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44604983|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604984|NCT00718315|Erythromycin|erythromycin|mesh-list
44604985|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
44604986|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44604987|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
44604988|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
44604989|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44604990|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44604991|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44604992|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44604993|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44604994|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44604995|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44604996|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44604997|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44604998|NCT00718081|Sufentanil|sufentanil|mesh-list
44604999|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44605000|NCT00718081|Narcotics|narcotics|mesh-ancestor
44605001|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605002|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605003|NCT00718081|Analgesics|analgesics|mesh-ancestor
44605004|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
44605005|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605006|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44605007|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44605008|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
44605009|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
44605010|NCT00717860|Caspofungin|caspofungin|mesh-list
44605011|NCT00717860|Micafungin|micafungin|mesh-list
44605012|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
44605013|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605014|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605015|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605016|NCT00717756|Lenalidomide|lenalidomide|mesh-list
44605017|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
44457705|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44605018|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605019|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605020|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605021|NCT00717756|Growth Substances|growth substances|mesh-ancestor
44605022|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605023|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605024|NCT00717522|Pomalidomide|pomalidomide|mesh-list
44605025|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
44605026|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605027|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605028|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605029|NCT00717522|Growth Substances|growth substances|mesh-ancestor
44605030|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605031|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605032|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
44605033|NCT00717366|Hematinics|hematinics|mesh-ancestor
44605034|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
44605035|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44605036|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605037|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44605038|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
44605039|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605040|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605041|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605042|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605043|NCT00717275|Temozolomide|temozolomide|mesh-list
44605044|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605045|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
44605046|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605047|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605048|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
44605049|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605050|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
44605051|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605052|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605053|NCT00717197|Capecitabine|capecitabine|mesh-list
44605054|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605055|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
44605056|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605057|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605058|NCT00717093|Varenicline|varenicline|mesh-list
44605059|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44605060|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44605061|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
44605062|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605063|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605064|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605066|NCT00717067|Saquinavir|saquinavir|mesh-list
44605067|NCT00717067|Maraviroc|maraviroc|mesh-list
44605068|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44605069|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44605070|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605071|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605072|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605073|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44605074|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44605075|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
44605076|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605077|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44605078|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605079|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44605080|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44605081|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44605083|NCT00716976|Antidotes|antidotes|mesh-ancestor
44605084|NCT00716976|Protective Agents|protective agents|mesh-ancestor
44605085|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605086|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
44605087|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605088|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
44605089|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605090|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605091|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
44605092|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
44605093|NCT00716859|Timolol|timolol|mesh-list
44605094|NCT00716859|Latanoprost|latanoprost|mesh-list
44605095|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44605096|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44605097|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
44605098|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605099|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605100|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433774|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
44605102|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44605103|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44605104|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44605105|NCT00716625|Sunitinib|sunitinib|mesh-list
44605106|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605107|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605108|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605109|NCT00716625|Growth Substances|growth substances|mesh-ancestor
44605110|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605111|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605112|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605113|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605114|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605115|NCT00716456|Cetuximab|cetuximab|mesh-list
44605116|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44605117|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605118|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605119|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605120|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605121|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605122|NCT00716417|Afatinib|afatinib|mesh-list
44605123|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605124|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605125|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605126|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605127|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44605128|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44605129|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44605130|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605131|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605132|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
44605133|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605134|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605135|NCT00716144|R 115866|r 115866|mesh-list
44605136|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605137|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605138|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605139|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44605140|NCT00716092|Linagliptin|linagliptin|mesh-list
44605141|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605142|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605143|NCT00716092|Incretins|incretins|mesh-ancestor
44605144|NCT00716092|Hormones|hormones|mesh-ancestor
44605145|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605146|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44605147|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605148|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605149|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605150|NCT00715910|Vaccines|vaccines|mesh-list
44605152|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605153|NCT00715793|Temozolomide|temozolomide|mesh-list
44605154|NCT00715793|Decitabine|decitabine|mesh-list
44605155|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605156|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
44605157|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605158|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605159|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605160|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
44605161|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605162|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44605163|NCT00715676|Vitamins|vitamins|mesh-ancestor
44605164|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
44605165|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605166|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44605167|NCT00715624|Metformin|metformin|mesh-list
44605168|NCT00715624|Lixisenatide|lixisenatide|mesh-list
44605169|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605170|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605171|NCT00715559|Cysteamine|cysteamine|mesh-list
44605172|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44433839|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605173|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605175|NCT00715520|Carbidopa|carbidopa|mesh-list
44605176|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44605177|NCT00715520|Methylphenidate|methylphenidate|mesh-list
44605178|NCT00715520|Amphetamine|amphetamine|mesh-list
44605179|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44605180|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605181|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44605182|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44605183|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605184|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605185|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
44605186|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605187|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44605188|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44605189|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44605190|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605191|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
44605192|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
44605193|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605194|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44605195|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44605196|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44605197|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
44605198|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
44605199|NCT00715429|Vitamin D|vitamin d|mesh-list
44605200|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
44605201|NCT00715429|Vitamins|vitamins|mesh-ancestor
44605202|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
44605203|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605204|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44605205|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44605206|NCT00715403|Nintedanib|nintedanib|mesh-list
44605207|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605208|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605209|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605210|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605211|NCT00715208|Prednisone|prednisone|mesh-list
44605212|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
44605213|NCT00715208|Rituximab|rituximab|mesh-list
44605214|NCT00715208|Doxorubicin|doxorubicin|mesh-list
44605215|NCT00715208|Bortezomib|bortezomib|mesh-list
44605216|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605217|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
44605218|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605219|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605220|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605221|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
44605222|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605223|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605224|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44605225|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605227|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44605228|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44605229|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605230|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605231|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
44605232|NCT00715208|Hormones|hormones|mesh-ancestor
44605233|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605234|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605235|NCT00715117|Naltrexone|naltrexone|mesh-list
44605236|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44605237|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44605238|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605239|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
44605240|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605241|NCT00714948|Gemcitabine|gemcitabine|mesh-list
44605242|NCT00714948|Cisplatin|cisplatin|mesh-list
44605243|NCT00714948|Sorafenib|sorafenib|mesh-list
44605244|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605245|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433916|NCT02047045|Prucalopride|prucalopride|mesh-list
44605246|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
44605247|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605248|NCT00714948|Antiviral Agents|antiviral agents|mesh-ancestor
44605249|NCT00714948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605250|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605251|NCT00714948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605252|NCT00714948|Immunologic Factors|immunologic factors|mesh-ancestor
44605253|NCT00714948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605254|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605256|NCT00714714|Tretinoin|tretinoin|mesh-list
44605257|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44605258|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44605259|NCT00714714|Analgesics|analgesics|mesh-ancestor
44605260|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
44605261|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605262|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605263|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605264|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605265|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605266|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605267|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
44605268|NCT00714688|Methylphenidate|methylphenidate|mesh-list
44605269|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44605270|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605271|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44605272|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44605273|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605274|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605275|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
44605276|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605277|NCT00714493|Infliximab|infliximab|mesh-list
44605278|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605279|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605280|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605281|NCT00714285|Vaccines|vaccines|mesh-list
44605282|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
44605283|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605284|NCT00714259|Fludarabine|fludarabine|mesh-list
44605285|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605286|NCT00713830|Metformin|metformin|mesh-list
44605287|NCT00713830|Lixisenatide|lixisenatide|mesh-list
44605288|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605289|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605290|NCT00713609|Clindamycin|clindamycin|mesh-list
44605291|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
44605292|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
44605293|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44605294|NCT00713609|Tazarotene|tazarotene|mesh-list
44605295|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605296|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605297|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44605298|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605299|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605300|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605301|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
44433991|NCT02046070|Dexamethasone|dexamethasone|mesh-list
44605313|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605314|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605315|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605316|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605317|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44605318|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605319|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
44605320|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605321|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44605322|NCT05684705|Rifabutin|rifabutin|mesh-list
44605323|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605324|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605325|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44605326|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
44605327|NCT05684692|Siltuximab|siltuximab|mesh-list
44605328|NCT05684692|Erenumab|erenumab|mesh-list
44605329|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44605330|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44605331|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605332|NCT05684692|Analgesics|analgesics|mesh-ancestor
44605333|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
44605334|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605335|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605336|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
44605337|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605338|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
44605339|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
44605340|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44605341|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44605342|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605343|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605344|NCT05684289|Urological Agents|urological agents|mesh-ancestor
44605345|NCT05684211|Cetuximab|cetuximab|mesh-list
44605346|NCT05684211|Antibodies|antibodies|mesh-list
44605347|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44605348|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
44605349|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224487|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605350|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605351|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605352|NCT05683977|Durvalumab|durvalumab|mesh-list
44605353|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605354|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605355|NCT05683912|Aflibercept|aflibercept|mesh-list
44605356|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605357|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605358|NCT05683912|Growth Substances|growth substances|mesh-ancestor
44605359|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605360|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605361|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605362|NCT05683821|Nicotine|nicotine|mesh-list
44605363|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44605364|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
44605365|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605366|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605367|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44605368|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44605369|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
44605370|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605371|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605372|NCT05683808|Apixaban|apixaban|mesh-list
44605373|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44605374|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
44605375|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44605376|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605377|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605378|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605379|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
44605380|NCT05683782|Chitosan|chitosan|mesh-list
44605381|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
44605382|NCT05683782|Hematinics|hematinics|mesh-ancestor
44605383|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44605384|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44605385|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
44605386|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605387|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44605389|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
44605390|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
44605391|NCT05683782|Coagulants|coagulants|mesh-ancestor
44605392|NCT05683626|Adalimumab|adalimumab|mesh-list
44605393|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605394|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605395|NCT05683574|Etoricoxib|etoricoxib|mesh-list
44605396|NCT05683574|Amitriptyline|amitriptyline|mesh-list
44605397|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
44605398|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44605399|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44605400|NCT05683574|Analgesics|analgesics|mesh-ancestor
44605401|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
44605402|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605403|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605404|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605405|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605406|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44605407|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44605408|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605409|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605410|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44605411|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
44605412|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44605413|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44605414|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44605415|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44605416|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605417|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44605418|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44605419|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605420|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
44605421|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434147|NCT02042443|Capecitabine|capecitabine|mesh-list
44605422|NCT05683548|Interferons|interferons|mesh-list
44605423|NCT05683548|Tenofovir|tenofovir|mesh-list
44605424|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
44605425|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
44605426|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44605427|NCT05683548|REP 2139|rep 2139|mesh-list
44605428|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605429|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
44605430|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605431|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44605432|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44605433|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605434|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605435|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44605436|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44605437|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
44605438|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605439|NCT05683535|Atropine|atropine|mesh-list
44605440|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44605441|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44605442|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44605443|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
44605444|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605445|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605446|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44605447|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44605448|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
44605449|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
44605450|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44605451|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44605452|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
44224597|NCT00505817|Leuprolide|leuprolide|mesh-list
44605453|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605454|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605455|NCT05683444|Octreotide|octreotide|mesh-list
44605456|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605457|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605458|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605459|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44605460|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44605461|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
44003873|NCT04965714|Nivolumab|nivolumab|mesh-list
44605465|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605466|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605468|NCT05683301|Perindopril|perindopril|mesh-list
44605469|NCT05683301|Indapamide|indapamide|mesh-list
44605470|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
44605471|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44605472|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44605473|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605474|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605475|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44605476|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605477|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44605478|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44605479|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605480|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605481|NCT05683301|Diuretics|diuretics|mesh-ancestor
44605482|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
44605483|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44605484|NCT05683171|Rituximab|rituximab|mesh-list
44605485|NCT05683171|Lenalidomide|lenalidomide|mesh-list
44605486|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605487|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605488|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
44605489|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605490|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605491|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605492|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605493|NCT05683171|Growth Substances|growth substances|mesh-ancestor
44605494|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605495|NCT05681650|Paclitaxel|paclitaxel|mesh-list
44605496|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
44605497|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44605498|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44605499|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605501|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
44605502|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
44605503|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605504|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605505|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
44605506|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605507|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605508|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605509|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
44605510|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44605515|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
44605516|NCT05678205|Fludarabine|fludarabine|mesh-list
44605517|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605518|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
44605519|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605520|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605521|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605522|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
44605523|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605524|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605525|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44605526|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
44605527|NCT05676684|Spironolactone|spironolactone|mesh-list
44605528|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44605529|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605530|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605531|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605532|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44605533|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605534|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605535|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44605536|NCT05676684|Diuretics|diuretics|mesh-ancestor
44605537|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
44605538|NCT05674994|Prednisone|prednisone|mesh-list
44605539|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605540|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
44605541|NCT05674994|Hormones|hormones|mesh-ancestor
44605542|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605543|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605544|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605545|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605546|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
44605547|NCT05665062|Fludarabine|fludarabine|mesh-list
44605548|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605549|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
44605550|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605551|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44605552|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605553|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
44605554|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605555|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605556|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44605557|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44605558|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605559|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605560|NCT05653661|Paclitaxel|paclitaxel|mesh-list
44605561|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44605562|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44605563|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605564|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
44605565|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
44605566|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
44605567|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605568|NCT05636514|Decitabine|decitabine|mesh-list
44605569|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605570|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
44605571|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605572|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605573|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605574|NCT05617859|Lenvatinib|lenvatinib|mesh-list
44605575|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605576|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605577|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605578|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605579|NCT05593042|Vaccines|vaccines|mesh-list
44605580|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
44605581|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605582|NCT05590923|Dexamethasone|dexamethasone|mesh-list
44605583|NCT05590923|Olanzapine|olanzapine|mesh-list
44605584|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605585|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
44605586|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
44224697|NCT00506532|Calfactant|calfactant|mesh-list
44605587|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605588|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605589|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605590|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
44605591|NCT05590923|Hormones|hormones|mesh-ancestor
44605592|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605593|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605594|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605595|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44605596|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44605597|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605598|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44605599|NCT05590923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44605600|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44605601|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605602|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605603|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605604|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
44605605|NCT05576350|Ethanol|ethanol|mesh-list
44605606|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44605607|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004022|NCT04459611|Paclitaxel|paclitaxel|mesh-list
44605609|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605610|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44605611|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
44605612|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605615|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44605616|NCT05561673|Vaccines|vaccines|mesh-list
44605617|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
44605618|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605619|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44605620|NCT05561673|Antacids|antacids|mesh-ancestor
44605621|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605622|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605623|NCT05559476|Vaccines|vaccines|mesh-list
44605624|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
44224734|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
44605625|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605626|NCT05557721|Lidocaine|lidocaine|mesh-list
44605627|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
44605628|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
44605629|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605630|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605631|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
44605632|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605633|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44605634|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44605635|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44605636|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605637|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605638|NCT05556616|Lenalidomide|lenalidomide|mesh-list
44605639|NCT05556616|Pomalidomide|pomalidomide|mesh-list
44605640|NCT05556616|Bortezomib|bortezomib|mesh-list
44605641|NCT05556616|Daratumumab|daratumumab|mesh-list
44605642|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
44605643|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605644|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605645|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605646|NCT05556616|Growth Substances|growth substances|mesh-ancestor
44605647|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605648|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605649|NCT05538663|Gemcitabine|gemcitabine|mesh-list
44605650|NCT05538663|Docetaxel|docetaxel|mesh-list
44605651|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
44605652|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605653|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
44605654|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605655|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605656|NCT05538663|Antiviral Agents|antiviral agents|mesh-ancestor
44605657|NCT05538663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605658|NCT05538663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605659|NCT05538663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605660|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
44605661|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605662|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
44605663|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
44605664|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
44605665|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44605666|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44605667|NCT05526157|Glucagon|glucagon|mesh-list
44605668|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44605669|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605670|NCT05526157|Hormones|hormones|mesh-ancestor
44605671|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605672|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605673|NCT05526157|Incretins|incretins|mesh-ancestor
44605674|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605675|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605676|NCT05520177|Ranibizumab|ranibizumab|mesh-list
44605677|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44605678|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44605679|NCT05520177|Growth Substances|growth substances|mesh-ancestor
44605680|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605681|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605682|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605683|NCT05519189|Ropivacaine|ropivacaine|mesh-list
44605684|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
44605685|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
44605686|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605687|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605712|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44605713|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605714|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
44605715|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605716|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605717|NCT05508867|Antiviral Agents|antiviral agents|mesh-ancestor
44605718|NCT05508867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605719|NCT05508867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605720|NCT05508867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605721|NCT05508867|Immunologic Factors|immunologic factors|mesh-ancestor
44605722|NCT05508867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605723|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605724|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605725|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
44605727|NCT05487599|Prednisone|prednisone|mesh-list
44605728|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
44605729|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44605730|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44605731|NCT05487599|Prednisolone|prednisolone|mesh-list
44605732|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
44605733|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44605734|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
44605735|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605736|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
44605737|NCT05487599|Hormones|hormones|mesh-ancestor
44605738|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605739|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605740|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605741|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605742|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605743|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605744|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44605745|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
44605746|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605747|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
44605748|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
44605749|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
44605750|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605751|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605752|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44605753|NCT05487599|Protective Agents|protective agents|mesh-ancestor
44605754|NCT05468073|Aldesleukin|aldesleukin|mesh-list
44605755|NCT05468073|Interleukin-2|interleukin-2|mesh-list
44605756|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224843|NCT00507195|Desflurane|desflurane|mesh-list
44605757|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44605758|NCT05468073|Analgesics|analgesics|mesh-ancestor
44605759|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
44605760|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605761|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605762|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44605763|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44605764|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
44605765|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605766|NCT05467891|Letrozole|letrozole|mesh-list
44605767|NCT05467891|Fulvestrant|fulvestrant|mesh-list
44605768|NCT05467891|Anastrozole|anastrozole|mesh-list
44605769|NCT05467891|Exemestane|exemestane|mesh-list
44605770|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605771|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44605772|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44605773|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605774|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605775|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44605776|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605777|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605778|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605779|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44605780|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44605781|NCT05467761|Psilocybin|psilocybin|mesh-list
44605782|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
44605783|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605784|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44605785|NCT05466474|Dacarbazine|dacarbazine|mesh-list
44605786|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44605788|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605789|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605790|NCT05462756|Insulin|insulin|mesh-list
44605791|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44605792|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
44605793|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
44605794|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44605795|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605796|NCT05461755|Tretinoin|tretinoin|mesh-list
44605797|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605798|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
44605799|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44605800|NCT05459298|Vitamin D|vitamin d|mesh-list
44605801|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
44605802|NCT05459298|Vitamins|vitamins|mesh-ancestor
44605803|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
44605804|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605805|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44605806|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44605807|NCT05458102|Voriconazole|voriconazole|mesh-list
44605808|NCT05458102|Cobicistat|cobicistat|mesh-list
44605809|NCT05458102|Rifabutin|rifabutin|mesh-list
44605810|NCT05458102|Vesatolimod|vesatolimod|mesh-list
44605811|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
44605812|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605813|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44605814|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605815|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605816|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605817|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44605818|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605819|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605820|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605821|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44605822|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44605823|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44605824|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
44605825|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44605826|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44605827|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
44605828|NCT05450692|Docetaxel|docetaxel|mesh-list
44605829|NCT05450692|Durvalumab|durvalumab|mesh-list
44605830|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605831|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
44605832|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
44605833|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
44605834|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605835|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605836|NCT05439616|Cariprazine|cariprazine|mesh-list
44605837|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44605838|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44605839|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605840|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605841|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44605842|NCT05435911|Propofol|propofol|mesh-list
44605843|NCT05435911|Flumazenil|flumazenil|mesh-list
44605844|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44605845|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605846|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605847|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44605848|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
44605849|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
44605850|NCT05435911|Antidotes|antidotes|mesh-ancestor
44605851|NCT05435911|Protective Agents|protective agents|mesh-ancestor
44605852|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
44605853|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
44605854|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605855|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605856|NCT05435846|Trametinib|trametinib|mesh-list
44605857|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605858|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44605859|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605860|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605861|NCT05429268|Lenalidomide|lenalidomide|mesh-list
44605867|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
44605868|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605869|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
44605870|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605871|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605876|NCT05400148|Bupivacaine|bupivacaine|mesh-list
44605877|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
44605878|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
44605879|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44605880|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605881|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
44605882|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605883|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
44605884|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605885|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44605886|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605887|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605888|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605889|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605890|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605891|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605893|NCT05382286|Paclitaxel|paclitaxel|mesh-list
44605894|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44605895|NCT05382286|Carboplatin|carboplatin|mesh-list
44605896|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
44605897|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44605898|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605899|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
44605900|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
44605901|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
44605902|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605903|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605904|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
44605905|NCT05382286|Antiviral Agents|antiviral agents|mesh-ancestor
44605906|NCT05382286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605907|NCT05382286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605908|NCT05382286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605909|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
44605910|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605911|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44605912|NCT05371223|Gemcitabine|gemcitabine|mesh-list
44605913|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44605914|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44605915|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
44605916|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605917|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605918|NCT05371223|Antiviral Agents|antiviral agents|mesh-ancestor
44605919|NCT05371223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605920|NCT05371223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605921|NCT05371223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605922|NCT05371223|Immunologic Factors|immunologic factors|mesh-ancestor
44605923|NCT05371223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605924|NCT05353257|Cisplatin|cisplatin|mesh-list
44605925|NCT05353257|Carboplatin|carboplatin|mesh-list
44605926|NCT05353257|Etoposide|etoposide|mesh-list
44605927|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44605928|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44605929|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44605930|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44605931|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605932|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605933|NCT05338632|Naloxone|naloxone|mesh-list
44605934|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44605935|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605936|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
44605937|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44605940|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44605941|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44605942|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44605943|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44605944|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605945|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605946|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44605947|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
44605948|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
44605949|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44605950|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605951|NCT05334004|Ritonavir|ritonavir|mesh-list
44605952|NCT05334004|Lopinavir|lopinavir|mesh-list
44605953|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44605954|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44605955|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
44605956|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605957|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605958|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44605959|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44605960|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
44605961|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605962|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44605963|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605964|NCT05332730|Golimumab|golimumab|mesh-list
44605965|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44605966|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44605967|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44605968|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44605969|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
44605970|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605971|NCT05304533|Itraconazole|itraconazole|mesh-list
44605972|NCT05304533|Verapamil|verapamil|mesh-list
44605973|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
44605974|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44605975|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44605976|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44605977|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44605978|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605979|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44605980|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
44605981|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44605982|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605983|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44605984|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44605985|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44605986|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44605987|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44605988|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
44605989|NCT05290129|Oxytocin|oxytocin|mesh-list
44605990|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
44605991|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44605992|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605993|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
44605994|NCT05277285|Antidotes|antidotes|mesh-ancestor
44605995|NCT05277285|Protective Agents|protective agents|mesh-ancestor
44605996|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44605997|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
44605998|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44605999|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
44606000|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44606001|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606002|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
44606003|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
44606004|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
44606005|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44606006|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606007|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606008|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606009|NCT05271552|Analgesics|analgesics|mesh-ancestor
44606010|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
44606011|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606012|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44606013|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44606014|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44606015|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
44606016|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606017|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606019|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
44606020|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606021|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
44606022|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606023|NCT05257824|Aspirin|aspirin|mesh-list
44606024|NCT05257824|Clopidogrel|clopidogrel|mesh-list
44606025|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44606026|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606027|NCT05257824|Analgesics|analgesics|mesh-ancestor
44606028|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
44606029|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606030|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606031|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606032|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606033|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44606034|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44606035|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606036|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44606037|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44606038|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606039|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
44606040|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44606041|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44606042|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44606043|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
44606044|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606045|NCT05228249|Cytarabine|cytarabine|mesh-list
44606046|NCT05228249|Etoposide|etoposide|mesh-list
44606047|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
44606048|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
44606049|NCT05228249|Melphalan|melphalan|mesh-list
44606050|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
44606051|NCT05228249|Carmustine|carmustine|mesh-list
44606052|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44606053|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44606054|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606055|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606056|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44606057|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606058|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606059|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606060|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606061|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
44606062|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
44606063|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606064|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606065|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
44606066|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606067|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606068|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
44606069|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606070|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
44606071|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
44606072|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606073|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606074|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606075|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606076|NCT05227612|Psilocybin|psilocybin|mesh-list
44606077|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
44606078|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606079|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44606080|NCT05223829|Brexanolone|brexanolone|mesh-list
44606081|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
44606082|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606083|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606084|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606085|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
44606086|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
44606087|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
44606091|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44606092|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606093|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44606094|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606095|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606096|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606097|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
44606098|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606099|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606100|NCT05209308|Rituximab|rituximab|mesh-list
44606101|NCT05209308|Venetoclax|venetoclax|mesh-list
44606102|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606103|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606104|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
44606105|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606106|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606107|NCT05190120|Ropivacaine|ropivacaine|mesh-list
44606108|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
44606109|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
44606110|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606111|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606112|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
44606113|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606114|NCT05189509|Plasminogen|plasminogen|mesh-list
44606115|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44606116|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44606117|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44606118|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606119|NCT05172401|Triamcinolone|triamcinolone|mesh-list
44606120|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44606121|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44606122|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44606123|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606124|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
44606125|NCT05172401|Hormones|hormones|mesh-ancestor
44606126|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606127|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606128|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606129|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
44606130|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606131|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606132|NCT05153408|Carboplatin|carboplatin|mesh-list
44606133|NCT05153408|Pemetrexed|pemetrexed|mesh-list
44606134|NCT05153408|Osimertinib|osimertinib|mesh-list
44606135|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606136|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606137|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606138|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44606139|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44606140|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606141|NCT05112965|Atezolizumab|atezolizumab|mesh-list
44606142|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606143|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
44606144|NCT05073237|Estrogens|estrogens|mesh-list
44606145|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44606146|NCT05073237|Hormones|hormones|mesh-ancestor
44606147|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606148|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606149|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44606150|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44606151|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
44606152|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44606153|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44606154|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44606155|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
44606156|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
44606157|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44606158|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44606159|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44606160|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434953|NCT02023866|Cysteamine|cysteamine|mesh-list
44606200|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
44606201|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606202|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44606203|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44606205|NCT04988295|Carboplatin|carboplatin|mesh-list
44606206|NCT04988295|Pemetrexed|pemetrexed|mesh-list
44606207|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44606208|NCT04988295|Lazertinib|lazertinib|mesh-list
44606209|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606210|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606211|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606212|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44606213|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44606214|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606215|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606216|NCT04980222|Prednisone|prednisone|mesh-list
44606217|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
44606218|NCT04980222|Rituximab|rituximab|mesh-list
44606219|NCT04980222|Doxorubicin|doxorubicin|mesh-list
44606220|NCT04980222|Vincristine|vincristine|mesh-list
44606221|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606222|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
44606223|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606224|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606225|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606226|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
44606227|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606228|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606229|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606230|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606231|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44606232|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44606233|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606234|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606235|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606236|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
44606237|NCT04980222|Hormones|hormones|mesh-ancestor
44606238|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606239|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44606240|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606241|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606242|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606243|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606244|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
44606245|NCT04972968|Hormones|hormones|mesh-ancestor
44606246|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606247|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606248|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
44606249|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
44606250|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606251|NCT04952389|Budesonide|budesonide|mesh-list
44606252|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606253|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44606254|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
44606255|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004579|NCT02740660|Albuterol|albuterol|mesh-list
44606256|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606257|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44606258|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
44606259|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
44606260|NCT04952389|Hormones|hormones|mesh-ancestor
44606261|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606262|NCT04941144|Vaccines|vaccines|mesh-list
44606263|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
44606264|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606265|NCT04930783|Nivolumab|nivolumab|mesh-list
44606266|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606267|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606268|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44606269|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606270|NCT04908956|Osimertinib|osimertinib|mesh-list
44606271|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606272|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606273|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606274|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606275|NCT04895280|Triamcinolone|triamcinolone|mesh-list
44606276|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44606277|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44606278|NCT04895280|Ketorolac|ketorolac|mesh-list
44606279|NCT04895280|Bupivacaine|bupivacaine|mesh-list
44606280|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44606281|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44606282|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
44606283|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606284|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606285|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
44606286|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606287|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606288|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
44606289|NCT04895280|Hormones|hormones|mesh-ancestor
44606290|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606291|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606292|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
44606293|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606294|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606295|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44606296|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606297|NCT04895280|Analgesics|analgesics|mesh-ancestor
44606298|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606299|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44606300|NCT04847557|Tirzepatide|tirzepatide|mesh-list
44606301|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44606302|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606303|NCT04847557|Incretins|incretins|mesh-ancestor
44606304|NCT04847557|Hormones|hormones|mesh-ancestor
44606305|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606306|NCT04840511|Lidocaine|lidocaine|mesh-list
44606307|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
44606308|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
44606309|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606310|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606311|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
44606312|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606313|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44606314|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44606315|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44606316|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44606317|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606318|NCT04833426|Testosterone|testosterone|mesh-list
44606319|NCT04833426|Androgens|androgens|mesh-ancestor
44606320|NCT04833426|Hormones|hormones|mesh-ancestor
44606321|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606322|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606323|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
44606324|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44606325|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606326|NCT04775953|Vancomycin|vancomycin|mesh-list
44606327|NCT04775953|Cefazolin|cefazolin|mesh-list
44606328|NCT04775953|Daptomycin|daptomycin|mesh-list
44606330|NCT04775953|Oxacillin|oxacillin|mesh-list
44606331|NCT04775953|Nafcillin|nafcillin|mesh-list
44606332|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44606333|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606334|NCT04763408|Sorafenib|sorafenib|mesh-list
44606335|NCT04763408|Lenvatinib|lenvatinib|mesh-list
44606336|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606337|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606338|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606339|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606340|NCT04756401|Dexamethasone|dexamethasone|mesh-list
44606341|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
44606342|NCT04756401|Daratumumab|daratumumab|mesh-list
44606343|NCT04756401|Ichthammol|ichthammol|mesh-list
44606344|NCT04756401|BB 1101|bb 1101|mesh-list
44606345|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606346|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
44606347|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
44606348|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606349|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606350|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606351|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
44606352|NCT04756401|Hormones|hormones|mesh-ancestor
44606353|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606354|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44606355|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606356|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44606357|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606358|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606359|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
44606360|NCT04756037|Relugolix|relugolix|mesh-list
44606361|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
44606362|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44606363|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606364|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606365|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44606366|NCT04750954|Peposertib|peposertib|mesh-list
44606367|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606368|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44606369|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606370|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606371|NCT04745832|Prednisone|prednisone|mesh-list
44606372|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
44606373|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44606374|NCT04745832|Rituximab|rituximab|mesh-list
44606375|NCT04745832|Vincristine|vincristine|mesh-list
44606376|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606377|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
44606378|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225379|NCT00510016|Clonidine|clonidine|mesh-list
44606379|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606380|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606381|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
44606382|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606383|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606384|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606385|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606386|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606387|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
44606388|NCT04745832|Hormones|hormones|mesh-ancestor
44606389|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606390|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44606391|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606392|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606393|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606394|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606395|NCT04731272|Dulaglutide|dulaglutide|mesh-list
44606396|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44606397|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606398|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
44606399|NCT04724044|Clarithromycin|clarithromycin|mesh-list
44606400|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
44606401|NCT04724044|Lactams|lactams|mesh-list
44606402|NCT04724044|beta-Lactams|beta-lactams|mesh-list
44606403|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44606404|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44606405|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606406|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44606407|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606408|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606409|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606410|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606411|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44606412|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
44606413|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44606414|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606415|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44606416|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44606417|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44606418|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44606419|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44606420|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44606421|NCT04718727|Olanzapine|olanzapine|mesh-list
44606422|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
44606423|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
44606424|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606425|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225408|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
44606426|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606427|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44606428|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44606429|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606430|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44606431|NCT04718727|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44606432|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44606433|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44606434|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606435|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606436|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
44606437|NCT04712643|Atezolizumab|atezolizumab|mesh-list
44606438|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606439|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606440|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
44606441|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606442|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
44606443|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606444|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606445|NCT04679389|Acetazolamide|acetazolamide|mesh-list
44606446|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
44606447|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44606448|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606449|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606450|NCT04679389|Diuretics|diuretics|mesh-ancestor
44606451|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
44606452|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606453|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
44606454|NCT04673617|Rituximab|rituximab|mesh-list
44606455|NCT04673617|Fludarabine|fludarabine|mesh-list
44606456|NCT04673617|Interleukin-2|interleukin-2|mesh-list
44606457|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606458|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
44606459|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606460|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606461|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606462|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
44606463|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606464|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606465|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606466|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606467|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606468|NCT04673617|Analgesics|analgesics|mesh-ancestor
44606469|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
44606470|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606471|NCT04664023|Vaccines|vaccines|mesh-list
44606472|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
44606473|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606474|NCT04660344|Atezolizumab|atezolizumab|mesh-list
44606475|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606476|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44606477|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
44606478|NCT04637763|Fludarabine|fludarabine|mesh-list
44606479|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225469|NCT00510367|Doxorubicin|doxorubicin|mesh-list
44606480|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
44606481|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606482|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606483|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606484|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
44606485|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606486|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606487|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44606488|NCT04626635|Cemiplimab|cemiplimab|mesh-list
44606489|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606490|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606491|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44606492|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606493|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
44606494|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606495|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606496|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606497|NCT04558112|Levodopa|levodopa|mesh-list
44606498|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44606499|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44606500|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
44606501|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606502|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606503|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606504|NCT04523922|Oxytocin|oxytocin|mesh-list
44606505|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
44606506|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44606507|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606508|NCT04502550|Propofol|propofol|mesh-list
44606509|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44606510|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606511|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606512|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44606513|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
44606514|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
44606515|NCT04497961|Lenalidomide|lenalidomide|mesh-list
44606516|NCT04497961|Daratumumab|daratumumab|mesh-list
44606517|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
44606518|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606519|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44606520|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44606521|NCT04497961|Growth Substances|growth substances|mesh-ancestor
44606522|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
44606523|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606524|NCT04494425|Paclitaxel|paclitaxel|mesh-list
44606525|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44606526|NCT04494425|Capecitabine|capecitabine|mesh-list
44606527|NCT04494425|Trastuzumab|trastuzumab|mesh-list
44606528|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606529|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606530|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606531|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606532|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606533|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606534|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606535|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
44606536|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606537|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44606538|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606539|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606540|NCT04454658|Navitoclax|navitoclax|mesh-list
44606541|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606542|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44606543|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606544|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44606545|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606546|NCT04350190|Apatinib|apatinib|mesh-list
44606547|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606548|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606549|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606550|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606551|NCT04330820|Venetoclax|venetoclax|mesh-list
44606552|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606553|NCT04330690|Artesunate|artesunate|mesh-list
44606554|NCT04330690|Dexamethasone|dexamethasone|mesh-list
44606555|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
44606556|NCT04330690|Infliximab|infliximab|mesh-list
44606557|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606558|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
44606559|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
44606560|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606561|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606562|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606563|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
44606564|NCT04330690|Hormones|hormones|mesh-ancestor
44606565|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606566|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44606567|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606568|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44606569|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606570|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606571|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44606572|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606573|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
44606574|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44606575|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44606576|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606577|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
44606578|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
44606579|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44606580|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
44606581|NCT04245085|Paclitaxel|paclitaxel|mesh-list
44606582|NCT04245085|Bevacizumab|bevacizumab|mesh-list
44606583|NCT04245085|Carboplatin|carboplatin|mesh-list
44606584|NCT04245085|Pemetrexed|pemetrexed|mesh-list
44606585|NCT04245085|Atezolizumab|atezolizumab|mesh-list
44606586|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606587|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606588|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606589|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606590|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606591|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606592|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606593|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44606594|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44606595|NCT04245085|Growth Substances|growth substances|mesh-ancestor
44606596|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606597|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
44606598|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606599|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44606600|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44606601|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44606602|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606603|NCT04232553|Mirikizumab|mirikizumab|mesh-list
44606604|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44606605|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606606|NCT04232553|Analgesics|analgesics|mesh-ancestor
44606607|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
44606608|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606609|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606610|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606611|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606612|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44606613|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606614|NCT04228042|Infigratinib|infigratinib|mesh-list
44606615|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606616|NCT04165772|Capecitabine|capecitabine|mesh-list
44606617|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606618|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
44606619|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606620|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606621|NCT04154956|Docetaxel|docetaxel|mesh-list
44606622|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606623|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606624|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606625|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606626|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606627|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
44606628|NCT04123366|Olaparib|olaparib|mesh-list
44606630|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606631|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44606632|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606633|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606634|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44606635|NCT04117945|Cetuximab|cetuximab|mesh-list
44606636|NCT04117945|Panitumumab|panitumumab|mesh-list
44606637|NCT04117945|Irinotecan|irinotecan|mesh-list
44606638|NCT04117945|Antibodies|antibodies|mesh-list
44606639|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
44606640|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606641|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
44606642|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606643|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606644|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44606645|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606646|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606647|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606648|NCT04099251|Nivolumab|nivolumab|mesh-list
44606649|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606650|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606651|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44606652|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606653|NCT04089553|Durvalumab|durvalumab|mesh-list
44606654|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606655|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606656|NCT04078152|Durvalumab|durvalumab|mesh-list
44606657|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606658|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606659|NCT04072601|Atorvastatin|atorvastatin|mesh-list
44606660|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44606661|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44606662|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
44606663|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606664|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44606665|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44606666|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606667|NCT04045665|Anticoagulants|anticoagulants|mesh-list
44606668|NCT04043806|Ivacaftor|ivacaftor|mesh-list
44606669|NCT04043806|Elexacaftor|elexacaftor|mesh-list
44606670|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44606671|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44606672|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606673|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
44606674|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
44606675|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44606676|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44606677|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606678|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606679|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606680|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606703|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44606704|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
44606705|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
44606706|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
44606707|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44606708|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44606709|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
44606710|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606711|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606712|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44606713|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606714|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44606715|NCT03897127|Cytarabine|cytarabine|mesh-list
44606716|NCT03897127|Daunorubicin|daunorubicin|mesh-list
44606717|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606718|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
44606719|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606720|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606721|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
44606722|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606723|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606724|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
44606725|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606726|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44606727|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44606728|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606729|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606730|NCT03895203|Adalimumab|adalimumab|mesh-list
44606731|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606732|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606733|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44606734|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
44606735|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606736|NCT03864406|Darunavir|darunavir|mesh-list
44606737|NCT03864406|Cobicistat|cobicistat|mesh-list
44606738|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44606739|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
44606740|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44606741|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
44606742|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44606743|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
44606744|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606745|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606746|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
44606747|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44606748|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44606749|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44606750|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44606751|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
44606752|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606753|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44606754|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44606755|NCT03834740|Everolimus|everolimus|mesh-list
44606756|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606757|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606758|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
44606759|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606760|NCT03823300|Aflibercept|aflibercept|mesh-list
44606761|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44606762|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44606763|NCT03823300|Growth Substances|growth substances|mesh-ancestor
44606764|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606765|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
44606766|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606767|NCT03816488|Metformin|metformin|mesh-list
44606768|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44606769|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44606770|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606771|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44606772|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44606773|NCT03816488|Analgesics|analgesics|mesh-ancestor
44606774|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
44606775|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606776|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606777|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606778|NCT03785158|Melatonin|melatonin|mesh-list
44606779|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
44606780|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606781|NCT03785158|Protective Agents|protective agents|mesh-ancestor
44606782|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606783|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606785|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606786|NCT03759288|Adalimumab|adalimumab|mesh-list
44606787|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606788|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44606789|NCT03742895|Olaparib|olaparib|mesh-list
44606790|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44606791|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606792|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606793|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606794|NCT03715933|Cisplatin|cisplatin|mesh-list
44606795|NCT03715933|Carboplatin|carboplatin|mesh-list
44606796|NCT03715933|Fluorouracil|fluorouracil|mesh-list
44606797|NCT03715933|Irinotecan|irinotecan|mesh-list
44606798|NCT03715933|Pemetrexed|pemetrexed|mesh-list
44606799|NCT03715933|Temozolomide|temozolomide|mesh-list
44606800|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606801|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
44606802|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606803|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606804|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606805|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
44606806|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606807|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44606808|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44606809|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606810|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44606811|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44606812|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606813|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
44606814|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
44606815|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606816|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606817|NCT03647969|Nivolumab|nivolumab|mesh-list
44606818|NCT03647969|Ipilimumab|ipilimumab|mesh-list
44606819|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606820|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606821|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44606822|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606823|NCT03600701|Atezolizumab|atezolizumab|mesh-list
44606824|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606825|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606826|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
44606827|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606828|NCT03579316|Olaparib|olaparib|mesh-list
44606829|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44606830|NCT03579316|Adavosertib|adavosertib|mesh-list
44606831|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606832|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606833|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606834|NCT03565783|Cemiplimab|cemiplimab|mesh-list
44606835|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606836|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606837|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
44606838|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44606839|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44606840|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
44606841|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606842|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44606843|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606844|NCT03476369|Fentanyl|fentanyl|mesh-list
44606845|NCT03476369|Ticagrelor|ticagrelor|mesh-list
44606846|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44606847|NCT03476369|Narcotics|narcotics|mesh-ancestor
44606848|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606849|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606850|NCT03476369|Analgesics|analgesics|mesh-ancestor
44606851|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
44606852|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606853|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44606854|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44435703|NCT02007434|Loratadine|loratadine|mesh-list
44606855|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
44606856|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
44606857|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44606858|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44606859|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44606860|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44606861|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
44606862|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606863|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606864|NCT03475277|Ketamine|ketamine|mesh-list
44606865|NCT03475277|Analgesics|analgesics|mesh-ancestor
44606866|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
44606867|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606868|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606869|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44606870|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44606871|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
44606872|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
44606873|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606874|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44606875|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44606876|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44606877|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606878|NCT03472040|Berotralstat|berotralstat|mesh-list
44606879|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606880|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606881|NCT03451799|Temozolomide|temozolomide|mesh-list
44606882|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44606883|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
44606884|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606885|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606886|NCT03440372|Ozanimod|ozanimod|mesh-list
44606887|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44606888|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606889|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606890|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
44225843|NCT00512486|Benralizumab|benralizumab|mesh-list
44606891|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606892|NCT03415828|Ethanol|ethanol|mesh-list
44606893|NCT03415828|Prednisolone|prednisolone|mesh-list
44606894|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44606895|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
44606896|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44606897|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
44606898|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44606899|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
44606900|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44606901|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
44606902|NCT03415828|Hormones|hormones|mesh-ancestor
44606903|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44606904|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606905|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44606906|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606907|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
44606908|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
44606909|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44606910|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606911|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44606912|NCT03415828|Protective Agents|protective agents|mesh-ancestor
44606913|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44606914|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606915|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44606916|NCT03371017|Gemcitabine|gemcitabine|mesh-list
44606917|NCT03371017|Carboplatin|carboplatin|mesh-list
44606918|NCT03371017|Capecitabine|capecitabine|mesh-list
44606919|NCT03371017|Atezolizumab|atezolizumab|mesh-list
44606920|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606921|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606922|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
44606923|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606924|NCT03371017|Antiviral Agents|antiviral agents|mesh-ancestor
44606925|NCT03371017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606926|NCT03371017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606927|NCT03371017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435779|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
44606929|NCT03371017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606930|NCT03355794|Everolimus|everolimus|mesh-list
44606931|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606932|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606933|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
44606934|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606935|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
44606936|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
44606937|NCT03350516|Calcium|calcium|mesh-list
44606938|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44606939|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606940|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44606941|NCT03350516|Antacids|antacids|mesh-ancestor
44606942|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606943|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44606944|NCT03337724|Paclitaxel|paclitaxel|mesh-list
44606945|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44606946|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606947|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606948|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606949|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606950|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606952|NCT03326921|Fludarabine|fludarabine|mesh-list
44606953|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
44606954|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606955|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606956|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
44606957|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606958|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606959|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
44606960|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606961|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
44606962|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606963|NCT03317158|Gemcitabine|gemcitabine|mesh-list
44606964|NCT03317158|Docetaxel|docetaxel|mesh-list
44606965|NCT03317158|Durvalumab|durvalumab|mesh-list
44606966|NCT03317158|Tremelimumab|tremelimumab|mesh-list
44606967|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44606968|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
44606969|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44606970|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
44606971|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606972|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606973|NCT03317158|Antiviral Agents|antiviral agents|mesh-ancestor
44606974|NCT03317158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44606975|NCT03317158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606976|NCT03317158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606977|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
44606978|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606979|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606980|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606981|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606982|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44606983|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44606984|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44606985|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606986|NCT03289650|Tacrolimus|tacrolimus|mesh-list
44606987|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44606988|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
44606989|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44606990|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44606991|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44606992|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606993|NCT03246347|Docetaxel|docetaxel|mesh-list
44606994|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44606995|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44606996|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44606997|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44606998|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44606999|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
44607000|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44607001|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
44607002|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607003|NCT03205761|Olaparib|olaparib|mesh-list
44607004|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44607006|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607007|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607008|NCT03194867|Cemiplimab|cemiplimab|mesh-list
44607009|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607010|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435930|NCT02004886|Metformin|metformin|mesh-list
44607011|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44607012|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44607013|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
44607014|NCT03065335|Ketamine|ketamine|mesh-list
44607015|NCT03065335|Analgesics|analgesics|mesh-ancestor
44607016|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
44607017|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607018|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607019|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44607020|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44607021|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
44607022|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
44607023|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607024|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44607025|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44607026|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607027|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607028|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
44607029|NCT03012100|Vaccines|vaccines|mesh-list
44607030|NCT03012100|Sargramostim|sargramostim|mesh-list
44607031|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
44607032|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607033|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607034|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607035|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607036|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
44607037|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607038|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607039|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44607040|NCT03011814|Lenalidomide|lenalidomide|mesh-list
44607041|NCT03011814|Durvalumab|durvalumab|mesh-list
44607042|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
44607043|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44607044|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
44607045|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
44607046|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607047|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607048|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607049|NCT03011814|Growth Substances|growth substances|mesh-ancestor
44226020|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
44607050|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607051|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607052|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607053|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
44607054|NCT02973997|Lenvatinib|lenvatinib|mesh-list
44607055|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607056|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607057|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607058|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607059|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607060|NCT02950766|Ipilimumab|ipilimumab|mesh-list
44607061|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607062|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607063|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44607064|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607065|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
44607066|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607067|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44607068|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44607069|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
44607070|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607071|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44607072|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
44607073|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44607074|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607075|NCT02947126|Antidotes|antidotes|mesh-ancestor
44607076|NCT02947126|Protective Agents|protective agents|mesh-ancestor
44607077|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607078|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
44607079|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
44607080|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44607081|NCT02915198|Metformin|metformin|mesh-list
44607082|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44607083|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607084|NCT02914938|Rituximab|rituximab|mesh-list
44607085|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
44607086|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607087|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607088|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
44607089|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607090|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607091|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607092|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607093|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607095|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607096|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44607098|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607099|NCT02632448|Gemcitabine|gemcitabine|mesh-list
44607100|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607101|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
44607102|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607103|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607104|NCT02632448|Antiviral Agents|antiviral agents|mesh-ancestor
44607105|NCT02632448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607106|NCT02632448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607107|NCT02632448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607108|NCT02632448|Immunologic Factors|immunologic factors|mesh-ancestor
44607109|NCT02632448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607111|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44607112|NCT02628405|Carboplatin|carboplatin|mesh-list
44607113|NCT02628405|Etoposide|etoposide|mesh-list
44607114|NCT02628405|Lenalidomide|lenalidomide|mesh-list
44607115|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
44607116|NCT02628405|Ifosfamide|ifosfamide|mesh-list
44607117|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
44607118|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
44607119|NCT02628405|Antibodies|antibodies|mesh-list
44607120|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
44607121|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44607122|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
44607123|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607124|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607125|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607126|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607127|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44607128|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44607129|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607130|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607131|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607132|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607133|NCT02628405|Growth Substances|growth substances|mesh-ancestor
44607134|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607135|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607136|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
44607137|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
44607138|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44607139|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607140|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607141|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607142|NCT02620579|Propranolol|propranolol|mesh-list
44607143|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44607144|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44607145|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
44607146|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607147|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607148|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607149|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44607150|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44607151|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
44607152|NCT02611960|Gemcitabine|gemcitabine|mesh-list
44607153|NCT02611960|Capecitabine|capecitabine|mesh-list
44607154|NCT02611960|Docetaxel|docetaxel|mesh-list
44607155|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
44607156|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607157|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
44607158|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607159|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607160|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
44607161|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607162|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607163|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607164|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
44607165|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607166|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607167|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607168|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607169|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607226|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607227|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44607229|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607230|NCT02422615|Fulvestrant|fulvestrant|mesh-list
44607231|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44607232|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607233|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44607234|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44607235|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
44607236|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607237|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607253|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607254|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
44607255|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
44607256|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607257|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607258|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607259|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
44607260|NCT02253316|Hormones|hormones|mesh-ancestor
44607261|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607262|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44607263|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607264|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
44607265|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607266|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607267|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
44607268|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607269|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607270|NCT02253316|Growth Substances|growth substances|mesh-ancestor
44607271|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607273|NCT02135419|Imiquimod|imiquimod|mesh-list
44607274|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
44607275|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607276|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607277|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607278|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607279|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
44607280|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607281|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44607282|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
44607283|NCT02099058|Nivolumab|nivolumab|mesh-list
44607284|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44607285|NCT02099058|Osimertinib|osimertinib|mesh-list
44607286|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44607287|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607288|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607289|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44607290|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607291|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607292|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607293|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
44607294|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607295|NCT02022982|Palbociclib|palbociclib|mesh-list
44607296|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607297|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607298|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607299|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607300|NCT01815359|Leucovorin|leucovorin|mesh-list
44607301|NCT01815359|Mitomycins|mitomycins|mesh-list
44607302|NCT01815359|Mitomycin|mitomycin|mesh-list
44607303|NCT01815359|Antidotes|antidotes|mesh-ancestor
44607304|NCT01815359|Protective Agents|protective agents|mesh-ancestor
44607305|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607306|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
44607307|NCT01815359|Vitamins|vitamins|mesh-ancestor
44607308|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
44607309|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44607310|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607311|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
44607312|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607313|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44607314|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607315|NCT01528046|Metformin|metformin|mesh-list
44607316|NCT01528046|Irinotecan|irinotecan|mesh-list
44607317|NCT01528046|Camptothecin|camptothecin|mesh-list
44607318|NCT01528046|Vincristine|vincristine|mesh-list
44607319|NCT01528046|Temozolomide|temozolomide|mesh-list
44607320|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44607321|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607322|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44607323|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44436243|NCT01998906|Paclitaxel|paclitaxel|mesh-list
44607324|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607325|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607326|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607327|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607328|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607329|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607330|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607331|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607332|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
44607334|NCT01366144|Carboplatin|carboplatin|mesh-list
44226200|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
44607391|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44607392|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607393|NCT01081262|Paclitaxel|paclitaxel|mesh-list
44607394|NCT01081262|Bevacizumab|bevacizumab|mesh-list
44607395|NCT01081262|Carboplatin|carboplatin|mesh-list
44607396|NCT01081262|Capecitabine|capecitabine|mesh-list
44607397|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
44607398|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44607399|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44607400|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
44607401|NCT01081262|Antibodies|antibodies|mesh-list
44607402|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
44607403|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44607404|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
44607405|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607406|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607407|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607408|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607409|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607410|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607411|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607412|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607413|NCT01081262|Growth Substances|growth substances|mesh-ancestor
44607414|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607415|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607416|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
44607417|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607418|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
44607419|NCT00501826|Cytarabine|cytarabine|mesh-list
44607420|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
44607421|NCT00501826|Dexamethasone|dexamethasone|mesh-list
44607422|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
44607423|NCT00501826|Prednisone|prednisone|mesh-list
44607424|NCT00501826|Cortisone|cortisone|mesh-list
44607425|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
44607426|NCT00501826|Doxorubicin|doxorubicin|mesh-list
44607427|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44607428|NCT00501826|Methotrexate|methotrexate|mesh-list
44607429|NCT00501826|Vincristine|vincristine|mesh-list
44607430|NCT00501826|Venetoclax|venetoclax|mesh-list
44607431|NCT00501826|Asparaginase|asparaginase|mesh-list
44607432|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
44607433|NCT00501826|Pegaspargase|pegaspargase|mesh-list
44607434|NCT00501826|BB 1101|bb 1101|mesh-list
44607435|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607436|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
44607437|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607438|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607439|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607440|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
44607441|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607442|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607443|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44607444|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607445|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
44607446|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
44607447|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607448|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607449|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
44607450|NCT00501826|Hormones|hormones|mesh-ancestor
44607451|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607452|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44607453|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44607454|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607455|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44607456|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44607457|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44607458|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44607459|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
44607460|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44607461|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607462|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
44607463|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44607464|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44607465|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44607466|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
44607467|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607468|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607469|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607470|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607471|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607472|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
44607473|NCT00186888|Carboplatin|carboplatin|mesh-list
44607474|NCT00186888|Doxorubicin|doxorubicin|mesh-list
44607475|NCT00186888|Etoposide|etoposide|mesh-list
44607476|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
44436395|NCT01994382|Rituximab|rituximab|mesh-list
44607477|NCT00186888|Vincristine|vincristine|mesh-list
44607478|NCT00186888|Topotecan|topotecan|mesh-list
44607479|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607480|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
44607481|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607482|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607483|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44607484|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
44607485|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607486|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607487|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44607489|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44607490|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44607491|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607492|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607493|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607494|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607495|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607496|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44607497|NCT00095784|Decitabine|decitabine|mesh-list
44607498|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607499|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
44607500|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607501|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607502|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607503|NCT00045201|Irinotecan|irinotecan|mesh-list
44607504|NCT00045201|Camptothecin|camptothecin|mesh-list
44607505|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44607506|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44607507|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44607508|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226324|NCT00514293|Cisplatin|cisplatin|mesh-list
44607509|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607510|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607511|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607512|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44607513|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44607514|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
44607515|NCT00713596|Coagulants|coagulants|mesh-ancestor
44607516|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44607517|NCT00713544|Etanercept|etanercept|mesh-list
44607518|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44607519|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44607520|NCT00713544|Analgesics|analgesics|mesh-ancestor
44607521|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
44607522|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607523|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607524|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607525|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607526|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607527|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607528|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
44607529|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44607530|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607531|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44607532|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44607533|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
44607534|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607535|NCT00713323|Nabiximols|nabiximols|mesh-list
44607536|NCT00713323|Analgesics|analgesics|mesh-ancestor
44607537|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
44607538|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607539|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607540|NCT00713310|Mesalamine|mesalamine|mesh-list
44607541|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44607542|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44607543|NCT00713310|Analgesics|analgesics|mesh-ancestor
44607544|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
44607545|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607546|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607547|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607548|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607549|NCT00713258|Alendronate|alendronate|mesh-list
44607550|NCT00713258|Hormones|hormones|mesh-list
44607551|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
44607552|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436467|NCT01993329|Mitomycin|mitomycin|mesh-list
44607553|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607554|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44607555|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44607562|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607564|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
44607565|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44607566|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607567|NCT00712933|Belimumab|belimumab|mesh-list
44607568|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607569|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
44607570|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607571|NCT00712920|Azelastine|azelastine|mesh-list
44607572|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44607573|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
44607574|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607575|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607576|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44607577|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
44607578|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44607579|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607580|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607581|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44607582|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44607583|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44607584|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
44607585|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
44607586|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607587|NCT00712712|Acetaminophen|acetaminophen|mesh-list
44607588|NCT00712712|Morphine|morphine|mesh-list
44607589|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44607590|NCT00712712|Narcotics|narcotics|mesh-ancestor
44607591|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226409|NCT00514982|Adalimumab|adalimumab|mesh-list
44607592|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607593|NCT00712712|Analgesics|analgesics|mesh-ancestor
44607594|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
44607595|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607596|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44607597|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
44607598|NCT00712673|Metformin|metformin|mesh-list
44607599|NCT00712673|Lixisenatide|lixisenatide|mesh-list
44607600|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44607601|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607602|NCT00712543|Lactulose|lactulose|mesh-list
44607603|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607604|NCT00712335|Fluticasone|fluticasone|mesh-list
44607606|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44607607|NCT00712335|Montelukast|montelukast|mesh-list
44607608|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44607609|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607610|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44607611|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
44607612|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607613|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607614|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44607615|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
44607616|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44607617|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44607618|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44607619|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44607620|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44607621|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44607622|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607623|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607624|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44607625|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607627|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44607628|NCT00712270|Risperidone|risperidone|mesh-list
44607629|NCT00712270|Aripiprazole|aripiprazole|mesh-list
44607630|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44607631|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
44607632|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607633|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607634|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607635|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44607636|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44607637|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607638|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44607639|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44607640|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
44607641|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
44607642|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
44607643|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44607644|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44607645|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44607646|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44607648|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
44607649|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
44607650|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607651|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44607652|NCT00711880|Nabiximols|nabiximols|mesh-list
44607653|NCT00711880|Analgesics|analgesics|mesh-ancestor
44607654|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
44607655|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607656|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607657|NCT00711802|Daptomycin|daptomycin|mesh-list
44607658|NCT00711802|Cloxacillin|cloxacillin|mesh-list
44607659|NCT00711802|Oxacillin|oxacillin|mesh-list
44607660|NCT00711802|Nafcillin|nafcillin|mesh-list
44607661|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44607662|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607663|NCT00711646|Nabiximols|nabiximols|mesh-list
44607664|NCT00711646|Analgesics|analgesics|mesh-ancestor
44607665|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
44607666|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607667|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607668|NCT00711594|Afatinib|afatinib|mesh-list
44607669|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607670|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607671|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607672|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607673|NCT00711529|Gabapentin|gabapentin|mesh-list
44607674|NCT00711529|Analgesics|analgesics|mesh-ancestor
44607675|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
44607676|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607677|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607678|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
44607679|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44607680|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44607681|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607682|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44607683|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44607684|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44607685|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607686|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607687|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
44607688|NCT00711516|Modafinil|modafinil|mesh-list
44607689|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44607690|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607691|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44607692|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44607693|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44607694|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607695|NCT00711477|Naltrexone|naltrexone|mesh-list
44607696|NCT00711477|Bupropion|bupropion|mesh-list
44607697|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44607698|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44607699|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607700|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
44607701|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607702|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44607703|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
44607704|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44607705|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44607706|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44607707|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44607708|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607709|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
44607710|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607711|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44607712|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44607713|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607714|NCT00711412|Capecitabine|capecitabine|mesh-list
44607715|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
44607716|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607717|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
44607718|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607719|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607720|NCT00711243|Docetaxel|docetaxel|mesh-list
44607721|NCT00711243|Fluorouracil|fluorouracil|mesh-list
44607722|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
44607723|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607724|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44607725|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44607726|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44607727|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607728|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
44607729|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607730|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607731|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
44607732|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607733|NCT00711191|Antibodies|antibodies|mesh-list
44607734|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44607735|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
44607736|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607737|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
44607738|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44607739|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44607740|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44607741|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44607742|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607743|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
44607744|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607745|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607746|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44607747|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607748|NCT00711009|Ritonavir|ritonavir|mesh-list
44607749|NCT00711009|Lopinavir|lopinavir|mesh-list
44607750|NCT00711009|Tenofovir|tenofovir|mesh-list
44607751|NCT00711009|Emtricitabine|emtricitabine|mesh-list
44607752|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
44607753|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44607754|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44607755|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44607756|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
44607757|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607758|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607759|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44607760|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44607761|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
44607762|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607763|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44607764|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44607765|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44607766|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44607767|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44607768|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44607769|NCT00710762|Nintedanib|nintedanib|mesh-list
44607770|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607771|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607772|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607773|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607774|NCT00710684|Donepezil|donepezil|mesh-list
44607775|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44607776|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607777|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607778|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
44607779|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607780|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607781|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
44607782|NCT00710606|NuvaRing|nuvaring|mesh-list
44607783|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44607784|NCT00710606|Desogestrel|desogestrel|mesh-list
44607785|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44607786|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
44607787|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44607788|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607789|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44607790|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44607791|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44607792|NCT00710606|Estrogens|estrogens|mesh-ancestor
44607793|NCT00710606|Hormones|hormones|mesh-ancestor
44607794|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607795|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44607796|NCT00710606|Progestins|progestins|mesh-ancestor
44607797|NCT00710554|Nabiximols|nabiximols|mesh-list
44607798|NCT00710554|Analgesics|analgesics|mesh-ancestor
44607799|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
44607800|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607801|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607802|NCT00710424|Nabiximols|nabiximols|mesh-list
44607803|NCT00710424|Analgesics|analgesics|mesh-ancestor
44607804|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
44607805|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607806|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607807|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44607808|NCT00710385|Buprenorphine|buprenorphine|mesh-list
44607809|NCT00710385|Heroin|heroin|mesh-list
44607810|NCT00710385|Naloxone|naloxone|mesh-list
44607811|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44607812|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607813|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
44607814|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607815|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44607816|NCT00710385|Narcotics|narcotics|mesh-ancestor
44607817|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44607818|NCT00710385|Analgesics|analgesics|mesh-ancestor
44607819|NCT00710034|Nicotine|nicotine|mesh-list
44607820|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44607821|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
44607822|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607823|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607824|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44607825|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44607826|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
44607827|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607828|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607829|NCT00710021|Vitamin D|vitamin d|mesh-list
44607830|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
44607831|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
44607832|NCT00710021|Vitamins|vitamins|mesh-list
44607833|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
44607834|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607835|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44607836|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44607837|NCT00709111|Maraviroc|maraviroc|mesh-list
44607838|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44607839|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44607840|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607841|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44607842|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44607843|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
44607844|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607845|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44607846|NCT00708708|Etanercept|etanercept|mesh-list
44607847|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44436847|NCT01986062|Amphetamine|amphetamine|mesh-list
44607848|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44607850|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
44607851|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607852|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607853|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607854|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607855|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607856|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607857|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
44607858|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44607859|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
44607860|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607861|NCT00708175|Pioglitazone|pioglitazone|mesh-list
44607862|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44607863|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607864|NCT00707746|Mipomersen|mipomersen|mesh-list
44607865|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44607866|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44607867|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
44607868|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607869|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44607870|NCT00707239|Imipenem|imipenem|mesh-list
44607871|NCT00707239|Tigecycline|tigecycline|mesh-list
44607872|NCT00707239|Cilastatin|cilastatin|mesh-list
44607873|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44607874|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607875|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44607876|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607877|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607878|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
44607879|NCT00707031|Metformin|metformin|mesh-list
44607880|NCT00707031|Exenatide|exenatide|mesh-list
44607881|NCT00707031|Lixisenatide|lixisenatide|mesh-list
44607882|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44607883|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607884|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44607885|NCT00707031|Incretins|incretins|mesh-ancestor
44607886|NCT00707031|Hormones|hormones|mesh-ancestor
44607887|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44607888|NCT00706706|Sunitinib|sunitinib|mesh-list
44607889|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607890|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607891|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607892|NCT00706706|Growth Substances|growth substances|mesh-ancestor
44607893|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607894|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607895|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44607896|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607897|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607898|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44607899|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44607900|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607901|NCT00705757|Bimatoprost|bimatoprost|mesh-list
44607902|NCT00705757|Travoprost|travoprost|mesh-list
44607903|NCT00705757|Latanoprost|latanoprost|mesh-list
44607904|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44607905|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44607906|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44607907|NCT00705679|Tenofovir|tenofovir|mesh-list
44607908|NCT00705679|Emtricitabine|emtricitabine|mesh-list
44607909|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44607910|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
44607911|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607912|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44607913|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44607914|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607915|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607916|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44226656|NCT00516152|Busulfan|busulfan|mesh-list
44607917|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44607918|NCT00705614|Infliximab|infliximab|mesh-list
44607919|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44607920|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44607921|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607922|NCT00705016|Cisplatin|cisplatin|mesh-list
44607923|NCT00705016|Fluorouracil|fluorouracil|mesh-list
44607924|NCT00705016|Cetuximab|cetuximab|mesh-list
44607925|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607926|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
44607927|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607928|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607929|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44607930|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
44607931|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607932|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607933|NCT00704184|Interferons|interferons|mesh-list
44607935|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607936|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
44607937|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607938|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
44607939|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607940|NCT00703534|Lesogaberan|lesogaberan|mesh-list
44607941|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235611|NCT00555334|Lamivudine|lamivudine|mesh-list
44607942|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44607943|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
44607944|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
44607945|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44607946|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607947|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607949|NCT00700115|Lopinavir|lopinavir|mesh-list
44607950|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
44607951|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44607952|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44607953|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44607954|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
44607955|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607956|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607957|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44607958|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
44607959|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44607960|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44607961|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44607962|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44607963|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44607964|NCT00700102|Bevacizumab|bevacizumab|mesh-list
44607965|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44607966|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607967|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44607968|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44607969|NCT00700102|Growth Substances|growth substances|mesh-ancestor
44607970|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607971|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44607972|NCT00700011|Clofarabine|clofarabine|mesh-list
44607973|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44607974|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
44607975|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607976|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44607977|NCT00699998|Aspirin|aspirin|mesh-list
44607978|NCT00699998|Clopidogrel|clopidogrel|mesh-list
44607979|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44607980|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44607981|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44607982|NCT00699998|Analgesics|analgesics|mesh-ancestor
44607983|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
44607984|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44607985|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44607986|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44607987|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44607988|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44607989|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44607990|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44607991|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44607992|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44607993|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44607994|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
44607995|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44607996|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44607997|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44607998|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
44608000|NCT00699907|Flutamide|flutamide|mesh-list
44608001|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
44608002|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
44608003|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608004|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608005|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44608006|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608007|NCT00699842|Lenalidomide|lenalidomide|mesh-list
44608008|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
44608009|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608010|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608011|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608012|NCT00699842|Growth Substances|growth substances|mesh-ancestor
44608013|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608014|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608015|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44006063|NCT00966914|Paclitaxel|paclitaxel|mesh-list
44608016|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608017|NCT00699608|Zopiclone|zopiclone|mesh-list
44608018|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44608019|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608020|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608021|NCT00699374|Sorafenib|sorafenib|mesh-list
44608022|NCT00699374|Sunitinib|sunitinib|mesh-list
44608023|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608024|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608025|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608026|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608027|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608028|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608029|NCT00699374|Growth Substances|growth substances|mesh-ancestor
44608030|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608031|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608032|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
44608033|NCT00699348|Hematinics|hematinics|mesh-ancestor
44608034|NCT00699335|Fentanyl|fentanyl|mesh-list
44608035|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44608036|NCT00699335|Narcotics|narcotics|mesh-ancestor
44608037|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608038|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608039|NCT00699335|Analgesics|analgesics|mesh-ancestor
44608040|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
44608041|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608042|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44608043|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44608044|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
44608045|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
44608046|NCT00699283|Brivaracetam|brivaracetam|mesh-list
44608047|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
44608048|NCT00699192|Amlodipine|amlodipine|mesh-list
44608049|NCT00699192|Valsartan|valsartan|mesh-list
44608050|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608051|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44608052|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608053|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608054|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608055|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608056|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608057|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608058|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608059|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44608060|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44608061|NCT00698932|Saxagliptin|saxagliptin|mesh-list
44608062|NCT00698932|Incretins|incretins|mesh-ancestor
44608063|NCT00698932|Hormones|hormones|mesh-ancestor
44608064|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608065|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608066|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44608067|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44608068|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608069|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608070|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44608071|NCT00698841|Cetuximab|cetuximab|mesh-list
44608072|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44608073|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608074|NCT00698815|Pemetrexed|pemetrexed|mesh-list
44608075|NCT00698815|Sunitinib|sunitinib|mesh-list
44608076|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608077|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608078|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608079|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44608080|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44608081|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608082|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608083|NCT00698815|Growth Substances|growth substances|mesh-ancestor
44608084|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608085|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608086|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608087|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
44608088|NCT00698685|Pentostatin|pentostatin|mesh-list
44608089|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44608090|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771646|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
44608091|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44608092|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608093|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608094|NCT00698646|Valsartan|valsartan|mesh-list
44608095|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44608096|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608097|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608098|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608099|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608100|NCT00698646|Diuretics|diuretics|mesh-ancestor
44608101|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
44608102|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608103|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44608104|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608105|NCT00698581|Brivaracetam|brivaracetam|mesh-list
44608106|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
44608107|NCT00698516|Bevacizumab|bevacizumab|mesh-list
44608108|NCT00698516|Topotecan|topotecan|mesh-list
44608109|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44608110|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608111|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608112|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608113|NCT00698516|Growth Substances|growth substances|mesh-ancestor
44608114|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608115|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608116|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44608117|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44608118|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608119|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608120|NCT00698451|Bevacizumab|bevacizumab|mesh-list
44608121|NCT00698451|Carboplatin|carboplatin|mesh-list
44608122|NCT00698451|Doxorubicin|doxorubicin|mesh-list
44608123|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44608124|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44608125|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608126|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608127|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608128|NCT00698451|Growth Substances|growth substances|mesh-ancestor
44608129|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608130|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608131|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44608132|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44608133|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44608134|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608135|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608136|NCT00698204|Celecoxib|celecoxib|mesh-list
44608137|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44608138|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608139|NCT00698204|Analgesics|analgesics|mesh-ancestor
44608140|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
44608141|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608142|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608143|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608144|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608145|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44608146|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44608155|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608156|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608157|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608158|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
44608159|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608160|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608161|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44608162|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608163|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
44608164|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608165|NCT00698009|Analgesics|analgesics|mesh-ancestor
44608166|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
44608167|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608168|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
44608169|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44608170|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608171|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608172|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608173|NCT00697788|Analgesics|analgesics|mesh-ancestor
44608174|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
44608175|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608176|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44608177|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44608178|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44608179|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
44608180|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608181|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608182|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
44608183|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44226916|NCT00517218|Oblimersen|oblimersen|mesh-list
44608184|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608186|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44608187|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
44608188|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608189|NCT00697463|Teriparatide|teriparatide|mesh-list
44608190|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608191|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608192|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44608193|NCT00697112|Sirolimus|sirolimus|mesh-list
44608194|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44608195|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608196|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44608197|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608198|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
44608199|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608200|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
44608201|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608202|NCT00697073|Idebenone|idebenone|mesh-list
44608203|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
44608204|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608205|NCT00697073|Protective Agents|protective agents|mesh-ancestor
44608206|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608207|NCT00696787|Pregabalin|pregabalin|mesh-list
44608208|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44608209|NCT00696787|Analgesics|analgesics|mesh-ancestor
44608210|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
44608211|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608212|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608213|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
44608214|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44608215|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608216|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608217|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608218|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44608219|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44608220|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608221|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608222|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44608223|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44608224|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608225|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44608226|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44608227|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44608228|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44608229|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608230|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608231|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608232|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608233|NCT00696774|Analgesics|analgesics|mesh-ancestor
44608234|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
44608235|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608236|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
44608237|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608238|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
44608239|NCT00696696|Gemcitabine|gemcitabine|mesh-list
44608240|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44608241|NCT00696696|Sorafenib|sorafenib|mesh-list
44608242|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608243|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
44608244|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608245|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608246|NCT00696696|Antiviral Agents|antiviral agents|mesh-ancestor
44608247|NCT00696696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608248|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608249|NCT00696696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608250|NCT00696696|Immunologic Factors|immunologic factors|mesh-ancestor
44608251|NCT00696696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608252|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608253|NCT00696657|Liraglutide|liraglutide|mesh-list
44608254|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44608255|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608256|NCT00696657|Incretins|incretins|mesh-ancestor
44608257|NCT00696657|Hormones|hormones|mesh-ancestor
44608258|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608259|NCT00696436|Valsartan|valsartan|mesh-list
44608260|NCT00696436|Olmesartan|olmesartan|mesh-list
44608261|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44608262|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608263|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608264|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608265|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608266|NCT00696410|Zinc|zinc|mesh-list
44608267|NCT00696410|Trace Elements|trace elements|mesh-ancestor
44608268|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
44608269|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608270|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
44608271|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
44608272|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44608273|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608274|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608275|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608276|NCT00696384|Diuretics|diuretics|mesh-ancestor
44608277|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
44608278|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608279|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44608280|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608281|NCT00696241|Olmesartan|olmesartan|mesh-list
44608282|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44608283|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44608284|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608285|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608286|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608287|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608288|NCT00696137|Fentanyl|fentanyl|mesh-list
44608289|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44608290|NCT00696137|Narcotics|narcotics|mesh-ancestor
44608291|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608292|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608293|NCT00696137|Analgesics|analgesics|mesh-ancestor
44608294|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
44608295|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608296|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44608297|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44608298|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
44608299|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
44608300|NCT00696072|Letrozole|letrozole|mesh-list
44608301|NCT00696072|Dasatinib|dasatinib|mesh-list
44608302|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608303|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44608304|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44608305|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608306|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608307|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44608308|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
44608309|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608310|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608311|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608312|NCT00696020|Bromides|bromides|mesh-list
44608313|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
44608314|NCT00696020|Olodaterol|olodaterol|mesh-list
44608315|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44608316|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
44608317|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608318|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608319|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44608320|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
44608321|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
44608322|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44608323|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608324|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608325|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608326|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
44608327|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44608328|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
44608329|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44608330|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608331|NCT00695955|Diuretics|diuretics|mesh-ancestor
44608332|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
44608333|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608334|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44608335|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608336|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227026|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
44608337|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44608338|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44608340|NCT00695903|Daptomycin|daptomycin|mesh-list
44608341|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44608342|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608343|NCT00695864|Ondansetron|ondansetron|mesh-list
44608344|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
44608345|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
44608346|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608347|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608348|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608349|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
44608350|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608351|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44608352|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
44608353|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608354|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608355|NCT00695864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44608356|NCT00695864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44608357|NCT00695864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608358|NCT00695864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608359|NCT00695864|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44608360|NCT00695786|Rituximab|rituximab|mesh-list
44608361|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44608362|NCT00695786|Lenalidomide|lenalidomide|mesh-list
44608363|NCT00695786|Antibodies|antibodies|mesh-list
44608364|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
44608365|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44608366|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
44608367|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608368|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608369|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608370|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608371|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608372|NCT00695786|Growth Substances|growth substances|mesh-ancestor
44608373|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608374|NCT00695565|Clonidine|clonidine|mesh-list
44608375|NCT00695565|Analgesics|analgesics|mesh-ancestor
44608376|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
44608377|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608378|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608379|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608380|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
44608381|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
44608382|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44608383|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44608384|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44608385|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
44608386|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608387|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608388|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
44608389|NCT00695396|Hematinics|hematinics|mesh-ancestor
44608390|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44608391|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608392|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
44608393|NCT00695318|Hormones|hormones|mesh-ancestor
44608394|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608395|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608397|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44608398|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608399|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608400|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608401|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608402|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437430|NCT01975220|Metformin|metformin|mesh-list
44608403|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
44608404|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
44608405|NCT00695110|Testosterone|testosterone|mesh-list
44608406|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
44608407|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
44608408|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44608409|NCT00695110|Androgens|androgens|mesh-ancestor
44608410|NCT00695110|Hormones|hormones|mesh-ancestor
44608411|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608412|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608413|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44608414|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608415|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
44608416|NCT00695019|Interferons|interferons|mesh-list
44608417|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
44608418|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
44608419|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44608420|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608421|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
44608422|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608423|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
44608424|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608425|NCT00694707|Risperidone|risperidone|mesh-list
44608426|NCT00694707|Cariprazine|cariprazine|mesh-list
44608427|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44608428|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
44608429|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608430|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608431|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608432|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44608433|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44608434|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608435|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608436|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44608437|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
44608438|NCT00694551|Poly I-C|poly i-c|mesh-list
44608439|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44608440|NCT00694551|Vaccines|vaccines|mesh-list
44608441|NCT00694551|Poly ICLC|poly iclc|mesh-list
44608442|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
44227123|NCT00518271|Sirolimus|sirolimus|mesh-list
44608443|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608444|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
44608445|NCT00694551|Laxatives|laxatives|mesh-ancestor
44608446|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608447|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
44608448|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608449|NCT00694369|Acetaminophen|acetaminophen|mesh-list
44608450|NCT00694369|Ibuprofen|ibuprofen|mesh-list
44608451|NCT00694369|Etoricoxib|etoricoxib|mesh-list
44608452|NCT00694369|Codeine|codeine|mesh-list
44608453|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608454|NCT00694369|Analgesics|analgesics|mesh-ancestor
44608455|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
44608456|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608457|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608458|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
44608459|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44608460|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608461|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608462|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44608463|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608464|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608465|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44608466|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44608467|NCT00694369|Narcotics|narcotics|mesh-ancestor
44608468|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608469|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
44608470|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
44608471|NCT00694304|Vortioxetine|vortioxetine|mesh-list
44608472|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
44608473|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608474|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44608475|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44608476|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608477|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608478|NCT00694304|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44608479|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44608480|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608481|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608482|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608483|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
44608484|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44608485|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44608486|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44608487|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44608488|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
44608489|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44608490|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608492|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44608493|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44608494|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
44608495|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608496|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44608497|NCT00694096|Sunitinib|sunitinib|mesh-list
44608498|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608499|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608500|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608501|NCT00694096|Growth Substances|growth substances|mesh-ancestor
44608502|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608503|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608504|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608505|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608506|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608507|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
44608508|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44608509|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44608510|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44608511|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44608512|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608513|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608514|NCT00693472|Propranolol|propranolol|mesh-list
44608515|NCT00693472|Haloperidol|haloperidol|mesh-list
44608516|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
44608517|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44608518|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
44608519|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
44608520|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608521|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608522|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608523|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44608524|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44608525|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44608526|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608527|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44608528|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
44608529|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608530|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608531|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44608532|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608533|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44608534|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44608535|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
44608536|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44608537|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608538|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608539|NCT00693420|Bimatoprost|bimatoprost|mesh-list
44608540|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44608541|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608542|NCT00693225|Omeprazole|omeprazole|mesh-list
44608543|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44608544|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44608545|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608546|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44608547|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608548|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608550|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
44608551|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44608552|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608553|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608554|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608555|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608556|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
44608558|NCT00692913|Alendronate|alendronate|mesh-list
44608559|NCT00692913|Calcium|calcium|mesh-list
44608560|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608561|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608562|NCT00692913|Vitamins|vitamins|mesh-ancestor
44608563|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
44608564|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44608565|NCT00692770|Sorafenib|sorafenib|mesh-list
44608566|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608567|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44608568|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608569|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608570|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
44608571|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608572|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44608573|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44608574|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608575|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608576|NCT00692237|Urological Agents|urological agents|mesh-ancestor
44608577|NCT00692003|Zonisamide|zonisamide|mesh-list
44608578|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
44608579|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44608580|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608581|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608582|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608583|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608584|NCT00691938|Decitabine|decitabine|mesh-list
44608585|NCT00691938|Panobinostat|panobinostat|mesh-list
44608586|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608587|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
44608588|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608589|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608590|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608591|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44608592|NCT00691704|Prednisone|prednisone|mesh-list
44608593|NCT00691704|Lenalidomide|lenalidomide|mesh-list
44608594|NCT00691704|Bortezomib|bortezomib|mesh-list
44608595|NCT00691704|Melphalan|melphalan|mesh-list
44608596|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608597|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
44608598|NCT00691704|Hormones|hormones|mesh-ancestor
44608599|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608600|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457926|NCT01601847|Vitamin D|vitamin d|mesh-list
44608601|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44608602|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608603|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608604|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
44608605|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608606|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608607|NCT00691704|Growth Substances|growth substances|mesh-ancestor
44608608|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608609|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608610|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
44608611|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44608612|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608613|NCT00691483|Varenicline|varenicline|mesh-list
44608614|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44608615|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44608616|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608617|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608618|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608619|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608620|NCT00691301|Cisplatin|cisplatin|mesh-list
44608621|NCT00691301|Pemetrexed|pemetrexed|mesh-list
44608622|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608623|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608624|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608625|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44608626|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44608627|NCT00691210|Niacinamide|niacinamide|mesh-list
44608628|NCT00691210|Niacin|niacin|mesh-list
44608629|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
44608630|NCT00691210|Etoposide|etoposide|mesh-list
44608631|NCT00691210|Vorinostat|vorinostat|mesh-list
44608632|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44608633|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608634|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44608635|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44608636|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608637|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608638|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44608639|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
44608641|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
44608642|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608643|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44608644|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
44608645|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44608646|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608647|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
44608648|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608649|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608650|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44608651|NCT00691132|Protective Agents|protective agents|mesh-ancestor
44608652|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608653|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608654|NCT00691093|Fesoterodine|fesoterodine|mesh-list
44608655|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44608656|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44608657|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608658|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608659|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608660|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608661|NCT00691093|Urological Agents|urological agents|mesh-ancestor
44608662|NCT00691054|Paclitaxel|paclitaxel|mesh-list
44608663|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44608664|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44608665|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608666|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44608667|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44608668|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44608669|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608670|NCT00691028|Infliximab|infliximab|mesh-list
44608671|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608672|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608673|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608674|NCT00691015|Cytarabine|cytarabine|mesh-list
44608675|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
44608676|NCT00691015|Melphalan|melphalan|mesh-list
44608677|NCT00691015|Busulfan|busulfan|mesh-list
44608678|NCT00691015|Carmustine|carmustine|mesh-list
44608679|NCT00691015|Rituximab|rituximab|mesh-list
44608680|NCT00691015|Fludarabine|fludarabine|mesh-list
44608681|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
44608682|NCT00691015|Etoposide|etoposide|mesh-list
44608683|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
44608684|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44608685|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608686|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
44608687|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608688|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608689|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608690|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
44608691|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608692|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608693|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44608694|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44608695|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608696|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
44608697|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44608698|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43771647|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
44608699|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44608700|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608701|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
44608702|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608703|NCT00690820|Pancrelipase|pancrelipase|mesh-list
44608704|NCT00690820|Pancreatin|pancreatin|mesh-list
44608705|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608706|NCT00690794|Travoprost|travoprost|mesh-list
44608707|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44608708|NCT00690794|Latanoprost|latanoprost|mesh-list
44608741|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608742|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44608743|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608744|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608745|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44608746|NCT00689936|Thalidomide|thalidomide|mesh-list
44608747|NCT00689936|Dexamethasone|dexamethasone|mesh-list
44608748|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
44437801|NCT01968434|Carbocysteine|carbocysteine|mesh-list
44608749|NCT00689936|Prednisone|prednisone|mesh-list
44608750|NCT00689936|Lenalidomide|lenalidomide|mesh-list
44608751|NCT00689936|Melphalan|melphalan|mesh-list
44608753|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608754|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
44608755|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
44608756|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608757|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608758|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608759|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
44608760|NCT00689936|Hormones|hormones|mesh-ancestor
44608761|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608762|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44608763|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608764|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
44608765|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608766|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608767|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
44227386|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608768|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44608769|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44608770|NCT00689936|Growth Substances|growth substances|mesh-ancestor
44608771|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44608772|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608773|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
44608774|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44608775|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608776|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
44608777|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44608778|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608779|NCT00689793|Iron|iron|mesh-list
44608780|NCT00689793|Trace Elements|trace elements|mesh-ancestor
44608781|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
44608782|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608783|NCT00689611|Bupropion|bupropion|mesh-list
44608784|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44608785|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
44608786|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44608787|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44608788|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44608789|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608790|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608791|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
44608792|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608793|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608794|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44608795|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44608796|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608797|NCT00689390|Ribavirin|ribavirin|mesh-list
44608798|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44608799|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
44608800|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608801|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
44608802|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608803|NCT00689351|Vaccines|vaccines|mesh-list
44608804|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44608805|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
44608806|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608807|NCT00689338|Fluconazole|fluconazole|mesh-list
44608808|NCT00689338|Voriconazole|voriconazole|mesh-list
44608809|NCT00689338|Anidulafungin|anidulafungin|mesh-list
44608810|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
44608811|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608812|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44608813|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44608814|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608815|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608816|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44608817|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
44608818|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608819|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608820|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44608821|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44608822|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44608823|NCT00689221|Temozolomide|temozolomide|mesh-list
44437871|NCT01967173|Xhance|xhance|mesh-list
44608824|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608825|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
44608826|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608827|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608829|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
44608830|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
44608831|NCT00689117|Tretinoin|tretinoin|mesh-list
44608832|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44608833|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608834|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44608835|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608836|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608837|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608838|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
44608839|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608840|NCT00689104|Mirabegron|mirabegron|mesh-list
44608841|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44608842|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44608843|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44608844|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44608845|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
44608846|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608847|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608848|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608849|NCT00689104|Urological Agents|urological agents|mesh-ancestor
44608850|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44608851|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44608852|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608853|NCT00689052|Pramipexole|pramipexole|mesh-list
44608854|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
44608855|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608856|NCT00689052|Protective Agents|protective agents|mesh-ancestor
44608857|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608858|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44608859|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44608860|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
44608861|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
44608862|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608863|NCT00689026|Lubiprostone|lubiprostone|mesh-list
44608864|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44608865|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608866|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608867|NCT00688909|Letrozole|letrozole|mesh-list
44608868|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608869|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44608870|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44608871|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608872|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608873|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44608874|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
44608875|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44608876|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608877|NCT00688753|Everolimus|everolimus|mesh-list
44608878|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608879|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608880|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
44608881|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608882|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
44608883|NCT00688740|Docetaxel|docetaxel|mesh-list
44608884|NCT00688740|Doxorubicin|doxorubicin|mesh-list
44608885|NCT00688740|Fluorouracil|fluorouracil|mesh-list
44608886|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608887|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
44608888|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608889|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608890|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44608891|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
44608892|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608893|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608894|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44608895|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44608896|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44437913|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44608897|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44608898|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44608899|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44608900|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44608901|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608902|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
44608903|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608904|NCT00688701|Lixisenatide|lixisenatide|mesh-list
44608905|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44608906|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608907|NCT00688688|Mirabegron|mirabegron|mesh-list
44608908|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44608909|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44608910|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44608911|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44608912|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44608913|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44608914|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608915|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608916|NCT00688688|Urological Agents|urological agents|mesh-ancestor
44608917|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44608918|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44608919|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
44608920|NCT00688636|Infliximab|infliximab|mesh-list
44608921|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608922|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608923|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608924|NCT00688623|Everolimus|everolimus|mesh-list
44608925|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608926|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227556|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
44608927|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
44608928|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608929|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44608930|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
44608931|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608932|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608933|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608934|NCT00688545|Celecoxib|celecoxib|mesh-list
44608935|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44608936|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608937|NCT00688545|Analgesics|analgesics|mesh-ancestor
44608938|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
44608939|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608940|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608941|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608942|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608943|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44608944|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44608945|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608946|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608947|NCT00688324|Acamprosate|acamprosate|mesh-list
44608948|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44437998|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
44608949|NCT00688103|Etanercept|etanercept|mesh-list
44608950|NCT00688103|Methotrexate|methotrexate|mesh-list
44608951|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44608952|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
44608953|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44608954|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608955|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44608956|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
44608957|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608958|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44608959|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608960|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44608961|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44608962|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44608963|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
44608964|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608965|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44608966|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44608967|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608968|NCT00688103|Analgesics|analgesics|mesh-ancestor
44608969|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
44608970|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608971|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608972|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44608973|NCT00688064|Doxycycline|doxycycline|mesh-list
44608974|NCT00688064|Adapalene|adapalene|mesh-list
44608975|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44608976|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44608977|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
44608978|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44608979|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44608980|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44608981|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44608982|NCT00688064|Analgesics|analgesics|mesh-ancestor
44608983|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
44608984|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44608985|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608986|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44608987|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44608988|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
44608989|NCT00687973|Atenolol|atenolol|mesh-list
44608990|NCT00687973|Amlodipine|amlodipine|mesh-list
44608991|NCT00687973|Valsartan|valsartan|mesh-list
44608992|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44608993|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44608994|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44608995|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44608996|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44608997|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44608998|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
44608999|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44609000|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44609001|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44609002|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
44609003|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
44609004|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609005|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44609006|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44609007|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44609008|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
44609009|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609010|NCT00687804|Ranibizumab|ranibizumab|mesh-list
44609011|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609012|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609013|NCT00687804|Growth Substances|growth substances|mesh-ancestor
44609014|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609015|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609016|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609017|NCT00687739|Leuprolide|leuprolide|mesh-list
44609018|NCT00687739|Estradiol|estradiol|mesh-list
44609019|NCT00687739|Estrogens|estrogens|mesh-ancestor
44609020|NCT00687739|Hormones|hormones|mesh-ancestor
44609021|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609022|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609023|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44609024|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44609025|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
44609026|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609027|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609028|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44609029|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44609030|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44609031|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609032|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609033|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44609034|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609035|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609037|NCT00687440|Doxorubicin|doxorubicin|mesh-list
44609038|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44609039|NCT00687440|Trastuzumab|trastuzumab|mesh-list
44609040|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609041|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609042|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609043|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609044|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609045|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44609046|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44609047|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44609048|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609049|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609050|NCT00687401|Infliximab|infliximab|mesh-list
44609051|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609052|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609053|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609054|NCT00687362|Infliximab|infliximab|mesh-list
44609055|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609056|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609057|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609058|NCT00687323|Temozolomide|temozolomide|mesh-list
44609059|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609060|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
44609061|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227680|NCT00520949|Antacids|antacids|mesh-ancestor
44609062|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609063|NCT00687297|Carboplatin|carboplatin|mesh-list
44609064|NCT00687297|Docetaxel|docetaxel|mesh-list
44609065|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609066|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609067|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609068|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609069|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609070|NCT00687271|Atorvastatin|atorvastatin|mesh-list
44609071|NCT00687271|Calcium|calcium|mesh-list
44609072|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44609073|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609074|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44609075|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44609076|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
44609077|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609078|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44609079|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44609080|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609081|NCT00687219|Ribavirin|ribavirin|mesh-list
44609082|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44609083|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
44609084|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609085|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
44609086|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609087|NCT00687193|Tofacitinib|tofacitinib|mesh-list
44609088|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44609089|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609090|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609091|NCT00686998|Olanzapine|olanzapine|mesh-list
44609092|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
44609093|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
44609094|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609095|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438140|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44609096|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609097|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44609098|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457984|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
44609099|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609100|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609101|NCT00686998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44609102|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44609103|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609104|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609105|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609106|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
44609108|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44609109|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609110|NCT00686972|Hormones|hormones|mesh-ancestor
44609111|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609112|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609113|NCT00686972|Incretins|incretins|mesh-ancestor
44609114|NCT00686959|Paclitaxel|paclitaxel|mesh-list
44609115|NCT00686959|Etoposide|etoposide|mesh-list
44609116|NCT00686959|Vinorelbine|vinorelbine|mesh-list
44609117|NCT00686959|Cisplatin|cisplatin|mesh-list
44609118|NCT00686959|Carboplatin|carboplatin|mesh-list
44609119|NCT00686959|Pemetrexed|pemetrexed|mesh-list
44609120|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44609121|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609122|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609123|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609124|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609125|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609126|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44609127|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44609128|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609129|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44609130|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44609131|NCT00686920|Rifaximin|rifaximin|mesh-list
44609132|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44609133|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609134|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609135|NCT00686894|Infliximab|infliximab|mesh-list
44609136|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609137|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609138|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609139|NCT00686881|Interferons|interferons|mesh-list
44609140|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
44609141|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
44609142|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44609143|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609144|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
44609145|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609146|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
44609147|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609148|NCT00686855|Dexamethasone|dexamethasone|mesh-list
44609149|NCT00686855|Tacrolimus|tacrolimus|mesh-list
44609150|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609151|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
44609152|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
44609153|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609154|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609155|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609156|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
44609157|NCT00686855|Hormones|hormones|mesh-ancestor
44609158|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609159|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609160|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609161|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609162|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
44609163|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44609164|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609165|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609166|NCT00686829|Maleic acid|maleic acid|mesh-list
44609167|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609168|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609169|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44609170|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
44609171|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
44609172|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609173|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
44438218|NCT01960296|Clopidogrel|clopidogrel|mesh-list
44609201|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609202|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609203|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609204|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44609205|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609206|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609207|NCT00686634|Incretins|incretins|mesh-ancestor
44609208|NCT00686634|Hormones|hormones|mesh-ancestor
44609209|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609210|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44609211|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
44609212|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609213|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609214|NCT00686595|Infliximab|infliximab|mesh-list
44609215|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609216|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609217|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609218|NCT00686543|Posaconazole|posaconazole|mesh-list
44609219|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
44609220|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609221|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44609222|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44438293|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
44609223|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44609224|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44609225|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44609226|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609227|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609228|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44609229|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
44609230|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609231|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609232|NCT00686517|Interferons|interferons|mesh-list
44609233|NCT00686517|Ribavirin|ribavirin|mesh-list
44609234|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
44609235|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
44609236|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44609237|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609238|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
44609239|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609240|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
44609241|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609242|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
44609243|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609244|NCT00686374|Adalimumab|adalimumab|mesh-list
44609245|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609246|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609247|NCT00686335|Prednisone|prednisone|mesh-list
44609248|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609249|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
44609250|NCT00686335|Hormones|hormones|mesh-ancestor
44609251|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609252|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609253|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609254|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227811|NCT00521521|Cisplatin|cisplatin|mesh-list
44609255|NCT00686166|Capecitabine|capecitabine|mesh-list
44609256|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
44609257|NCT00686166|Cetuximab|cetuximab|mesh-list
44609258|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44609259|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
44609260|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609261|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609262|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609263|NCT00686127|Lidocaine|lidocaine|mesh-list
44609264|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
44609265|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
44609266|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609267|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609268|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
44609269|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609270|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44609271|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44609272|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44609273|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609274|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609275|NCT00685945|Isosorbide|isosorbide|mesh-list
44609276|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44609277|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44609278|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
44609279|NCT00685945|Bradykinin|bradykinin|mesh-list
44609280|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44609281|NCT00685945|Kininogens|kininogens|mesh-list
44609282|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
44609283|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44609284|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44609285|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609286|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609287|NCT00685945|Urological Agents|urological agents|mesh-ancestor
44609288|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44609289|NCT00685945|Diuretics|diuretics|mesh-ancestor
44609290|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
44609291|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609292|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44609293|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44609294|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
44609295|NCT00685802|Cilostazol|cilostazol|mesh-list
44609296|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44609297|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
44438362|NCT01959139|Leucovorin|leucovorin|mesh-list
44609298|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609299|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609300|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44609301|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
44609302|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44609303|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44609304|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609305|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44609306|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
44609307|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44609308|NCT00685802|Protective Agents|protective agents|mesh-ancestor
44609309|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44609310|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44609311|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609312|NCT00685763|Gemcitabine|gemcitabine|mesh-list
44609313|NCT00685763|Capecitabine|capecitabine|mesh-list
44609314|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44609315|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
44609316|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609317|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609318|NCT00685763|Antiviral Agents|antiviral agents|mesh-ancestor
44609319|NCT00685763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609320|NCT00685763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609321|NCT00685763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609322|NCT00685763|Immunologic Factors|immunologic factors|mesh-ancestor
44609323|NCT00685763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609324|NCT00685685|Lovastatin|lovastatin|mesh-list
44609325|NCT00685685|L 647318|l 647318|mesh-list
44609326|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
44609327|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44609328|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44609329|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
44609330|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609331|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44227884|NCT00521963|Infliximab|infliximab|mesh-list
44609332|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44609333|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609334|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44609335|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
44609336|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609337|NCT00685334|Olanzapine|olanzapine|mesh-list
44609338|NCT00685334|Aripiprazole|aripiprazole|mesh-list
44609339|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
44609340|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
44609341|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609342|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609343|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609344|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44609345|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44609346|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609347|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609348|NCT00685334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44609349|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44609350|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609351|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609352|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609353|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
44609354|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
44609355|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
44609356|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
44609357|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44609358|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44609359|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44609360|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44609361|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44609362|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44609363|NCT00685178|Topiramate|topiramate|mesh-list
44609364|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
44609365|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609366|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609367|NCT00685165|Primidone|primidone|mesh-list
44609368|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
44609369|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
44609370|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
44609371|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227928|NCT00522210|Insulin|insulin|mesh-list
44609372|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609373|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609374|NCT00684996|Bevacizumab|bevacizumab|mesh-list
44609375|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44609377|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
44609378|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44609379|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609380|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609381|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609382|NCT00684996|Growth Substances|growth substances|mesh-ancestor
44609383|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609384|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609385|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
44609386|NCT00684814|Zolpidem|zolpidem|mesh-list
44609387|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44609388|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44609389|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609390|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609391|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44609392|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
44609393|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
44609394|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609395|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609396|NCT00684762|Cilostazol|cilostazol|mesh-list
44609397|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44609398|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
44609399|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609400|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609401|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44609402|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
44609403|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44609404|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44609405|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609406|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44609407|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
44609408|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44609409|NCT00684762|Protective Agents|protective agents|mesh-ancestor
44609410|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44609411|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44609412|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609413|NCT00684645|Sunitinib|sunitinib|mesh-list
44609414|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609415|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609416|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609417|NCT00684645|Growth Substances|growth substances|mesh-ancestor
44609418|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609419|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609420|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44609421|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609422|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609423|NCT00684567|Temozolomide|temozolomide|mesh-list
44609424|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609425|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
44609426|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609427|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609428|NCT00684515|Aspirin|aspirin|mesh-list
44609429|NCT00684515|Vorapaxar|vorapaxar|mesh-list
44609430|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44609431|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44609432|NCT00684515|Analgesics|analgesics|mesh-ancestor
44609433|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
44609434|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609435|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609436|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609437|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609438|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44609439|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44609440|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609441|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44609442|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44609443|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609444|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
44609445|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
44438491|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609446|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609447|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44609448|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609449|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609450|NCT00684307|Vitamin K|vitamin k|mesh-list
44609451|NCT00684307|Warfarin|warfarin|mesh-list
44609452|NCT00684307|Vitamins|vitamins|mesh-ancestor
44609453|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
44609454|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609455|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
44609456|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44609457|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44609458|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609459|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
44609460|NCT00684307|Coagulants|coagulants|mesh-ancestor
44609461|NCT00684203|Aspirin|aspirin|mesh-list
44609462|NCT00684203|Clopidogrel|clopidogrel|mesh-list
44609463|NCT00684203|Vorapaxar|vorapaxar|mesh-list
44609464|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44609465|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44609466|NCT00684203|Analgesics|analgesics|mesh-ancestor
44609467|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
44609468|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609469|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609470|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609471|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609472|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44609473|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44609474|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609475|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44609476|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44609477|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609478|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
44609479|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44609480|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44609481|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44609482|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
44609483|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609484|NCT00684177|Retapamulin|retapamulin|mesh-list
44609485|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44609486|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609487|NCT00684073|Buprenorphine|buprenorphine|mesh-list
44609488|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44609489|NCT00684073|Naloxone|naloxone|mesh-list
44609490|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44609491|NCT00684073|Narcotics|narcotics|mesh-ancestor
44609492|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609493|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609494|NCT00684073|Analgesics|analgesics|mesh-ancestor
44609495|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
44609496|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609497|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44609498|NCT00683917|Leuprolide|leuprolide|mesh-list
44458056|NCT01599806|Avibactam|avibactam|mesh-list
44609499|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44609500|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
44609501|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44609502|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609503|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609504|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609505|NCT00683904|Carboplatin|carboplatin|mesh-list
44609506|NCT00683904|Epothilones|epothilones|mesh-list
44609507|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609508|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609509|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609510|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609511|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609512|NCT00683878|Pioglitazone|pioglitazone|mesh-list
44609513|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
44609514|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44609515|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609516|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609517|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44609518|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609519|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44609520|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44438567|NCT01953783|Ixazomib|ixazomib|mesh-list
44609521|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44609522|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609523|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609524|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609525|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609526|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
44609527|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609529|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609530|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609531|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609532|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609533|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609534|NCT00683774|Diazoxide|diazoxide|mesh-list
44609535|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44609536|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
44609537|NCT00683657|Saxagliptin|saxagliptin|mesh-list
44609538|NCT00683657|Incretins|incretins|mesh-ancestor
44609539|NCT00683657|Hormones|hormones|mesh-ancestor
44609540|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609541|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609542|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44609543|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
44609544|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609545|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609546|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609547|NCT00683644|Zinc|zinc|mesh-list
44609548|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
44609549|NCT00683644|Trace Elements|trace elements|mesh-ancestor
44609550|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
44609551|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609552|NCT00683644|Astringents|astringents|mesh-ancestor
44609553|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609554|NCT00683618|Atorvastatin|atorvastatin|mesh-list
44609555|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44609556|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44609557|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44609558|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
44609559|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609560|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44609561|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44609562|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609563|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44609564|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
44609565|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609566|NCT00683592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44609567|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44609568|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44609569|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609570|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609571|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
44609572|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609573|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44609574|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44609575|NCT00683475|Prednisone|prednisone|mesh-list
44609576|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
44609577|NCT00683475|Ramucirumab|ramucirumab|mesh-list
44609578|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44609579|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609580|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
44609581|NCT00683475|Hormones|hormones|mesh-ancestor
44609582|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609583|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609584|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609585|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609586|NCT00683475|Analgesics|analgesics|mesh-ancestor
44609587|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
44609588|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609589|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44609590|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44609591|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609592|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609593|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
44609594|NCT00683384|Etanercept|etanercept|mesh-list
44609595|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44609596|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44609597|NCT00683384|Analgesics|analgesics|mesh-ancestor
44609598|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
44609599|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609600|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609601|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609602|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609603|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609604|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609605|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
44609606|NCT00682929|Dronabinol|dronabinol|mesh-list
44609607|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
44609608|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609609|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609610|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44609611|NCT00682929|Analgesics|analgesics|mesh-ancestor
44609612|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
44609613|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609614|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44609615|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44609616|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609617|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609618|NCT00682929|Hormones|hormones|mesh-ancestor
44609619|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609620|NCT00682890|Metformin|metformin|mesh-list
44609621|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609622|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609623|NCT00682786|Fluorouracil|fluorouracil|mesh-list
44609624|NCT00682786|Irinotecan|irinotecan|mesh-list
44609625|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
44609626|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609627|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44609628|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609629|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609630|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
44609631|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609632|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44609633|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44609634|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609635|NCT00682643|Fluticasone|fluticasone|mesh-list
44609637|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609638|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44609639|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
44609640|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609641|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609642|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44609643|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
44609644|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609645|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44609647|NCT00682539|Bevacizumab|bevacizumab|mesh-list
44609648|NCT00682539|Ranibizumab|ranibizumab|mesh-list
44609649|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609650|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609651|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609652|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609653|NCT00682539|Growth Substances|growth substances|mesh-ancestor
44609654|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609655|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609656|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609657|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
44609658|NCT00682539|Hormones|hormones|mesh-ancestor
44609659|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609660|NCT00682461|Nicotine|nicotine|mesh-list
44609661|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44609662|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
44609663|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609664|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609665|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44609666|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44609667|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
44609668|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609669|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609691|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44609692|NCT00681824|Thrombin|thrombin|mesh-list
44609693|NCT00681824|Aprotinin|aprotinin|mesh-list
44609694|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
44609695|NCT00681824|Coagulants|coagulants|mesh-ancestor
44609696|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44609697|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44609698|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44609699|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609700|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609701|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44609702|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
44609703|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609704|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44609705|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44609706|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609707|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609708|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44609709|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
44609710|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44609711|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44609712|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44609713|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44609714|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609715|NCT00681590|Vitamin D|vitamin d|mesh-list
44609716|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
44609717|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
44609718|NCT00681590|Vitamins|vitamins|mesh-list
44609719|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
44609720|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609721|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44609722|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44609723|NCT00681187|Lanreotide|lanreotide|mesh-list
44609724|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609725|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44609726|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
44609727|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609728|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44609729|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44609730|NCT00680992|Denosumab|denosumab|mesh-list
44609731|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
44609732|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
44609733|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
44609734|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609735|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44609736|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44609737|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
44609738|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609739|NCT00680901|Capecitabine|capecitabine|mesh-list
44609740|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
44609741|NCT00680901|Lapatinib|lapatinib|mesh-list
44007509|NCT02802111|Albuterol|albuterol|mesh-list
44609742|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44609743|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
44609744|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609745|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609746|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44609747|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609748|NCT00680836|Rifaximin|rifaximin|mesh-list
44609749|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44609750|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609751|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609752|NCT00680745|Metformin|metformin|mesh-list
44609753|NCT00680745|Pioglitazone|pioglitazone|mesh-list
44609754|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
44609755|NCT00680745|Glimepiride|glimepiride|mesh-list
44609756|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
44609757|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609758|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609759|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44609760|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609761|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44609762|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609763|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
44609764|NCT00680407|Silymarin|silymarin|mesh-list
44609765|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
44609766|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609767|NCT00680407|Protective Agents|protective agents|mesh-ancestor
44609768|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609769|NCT00680186|Warfarin|warfarin|mesh-list
44609770|NCT00680186|Dabigatran|dabigatran|mesh-list
44609771|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
44609772|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
44609773|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44609774|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44609775|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609776|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609777|NCT00680121|Benphothiamine|benphothiamine|mesh-list
44609778|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44609779|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
44609780|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609781|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
44609782|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
44609783|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609784|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
44609785|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
44609786|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44609787|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
44609788|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609789|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609790|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438868|NCT01946880|Prednisone|prednisone|mesh-list
44609791|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44609792|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44609793|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44609794|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44609795|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44609796|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609797|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609798|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
44609799|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44609800|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
44609801|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
44609802|NCT00680043|Hematinics|hematinics|mesh-ancestor
44609803|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44609804|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
44609805|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44609806|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44609807|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
44609808|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609809|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44609810|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44609811|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609812|NCT00679939|Metformin|metformin|mesh-list
44609813|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
44609814|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609815|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609816|NCT00679783|Olaparib|olaparib|mesh-list
44609817|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44609819|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609820|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609821|NCT00679627|Galantamine|galantamine|mesh-list
44609822|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44609823|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609824|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609825|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
44609826|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44609827|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609828|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44609829|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
44609830|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609831|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
44609832|NCT00679432|Budesonide|budesonide|mesh-list
44609833|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609834|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44609835|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
44609836|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609837|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609838|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44609839|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44609840|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
44609841|NCT00679432|Hormones|hormones|mesh-ancestor
44609842|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609843|NCT00679367|Dexamethasone|dexamethasone|mesh-list
44609844|NCT00679367|Lenalidomide|lenalidomide|mesh-list
44609845|NCT00679367|Melphalan|melphalan|mesh-list
44609846|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609847|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
44609848|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
44609849|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609850|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609851|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609852|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
44609853|NCT00679367|Hormones|hormones|mesh-ancestor
44609854|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609855|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44609856|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228312|NCT00524186|Leucovorin|leucovorin|mesh-list
44609857|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
44609858|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609859|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609860|NCT00679367|Growth Substances|growth substances|mesh-ancestor
44609861|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609862|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609863|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
44609864|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609865|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44609866|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609867|NCT00679341|Docetaxel|docetaxel|mesh-list
44609868|NCT00679341|Trastuzumab|trastuzumab|mesh-list
44609869|NCT00679341|Maytansine|maytansine|mesh-list
44609870|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44609871|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609872|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609873|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609874|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609875|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609876|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609877|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44609878|NCT00679302|Trimethoprim|trimethoprim|mesh-list
44609879|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44609880|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
44609881|NCT00679302|Simethicone|simethicone|mesh-list
44609882|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44609883|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609884|NCT00679302|Renal Agents|renal agents|mesh-ancestor
44609885|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
44609886|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44609887|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44609888|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44609889|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609890|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609892|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44609893|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44609894|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
44609895|NCT00679302|Emollients|emollients|mesh-ancestor
44609896|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44609897|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44609898|NCT00679289|Interferons|interferons|mesh-list
44609899|NCT00679289|Ecromeximab|ecromeximab|mesh-list
44609900|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609901|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
44609902|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609903|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609904|NCT00679211|Trastuzumab|trastuzumab|mesh-list
44609905|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44609906|NCT00679211|Maytansine|maytansine|mesh-list
44228362|NCT00524433|Tezosentan|tezosentan|mesh-list
44609907|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44609908|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609909|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44609910|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44609911|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44609912|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44609913|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609914|NCT00679042|Exenatide|exenatide|mesh-list
44609915|NCT00679042|Sirolimus|sirolimus|mesh-list
44609916|NCT00679042|Etanercept|etanercept|mesh-list
44609917|NCT00679042|Tacrolimus|tacrolimus|mesh-list
44609918|NCT00679042|Basiliximab|basiliximab|mesh-list
44609919|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609920|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
44609921|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609922|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44609923|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609924|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609925|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44609926|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609927|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44609928|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609929|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
44609930|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44609931|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44609932|NCT00679042|Analgesics|analgesics|mesh-ancestor
44609933|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
44609934|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609935|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44609936|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609937|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44609938|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44609939|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44439028|NCT01945242|Alogliptin|alogliptin|mesh-list
44609940|NCT00679042|Incretins|incretins|mesh-ancestor
44609941|NCT00679042|Hormones|hormones|mesh-ancestor
44609942|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44609943|NCT00679029|Gemcitabine|gemcitabine|mesh-list
44609944|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
44609945|NCT00679029|Bevacizumab|bevacizumab|mesh-list
44609946|NCT00679029|Doxorubicin|doxorubicin|mesh-list
44609947|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44609948|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44609949|NCT00679029|Antibodies|antibodies|mesh-list
44609950|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
44609951|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44609952|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609953|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609954|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609955|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
44609956|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609957|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44609958|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44609959|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
44609960|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44609961|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44609962|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44609963|NCT00679029|Growth Substances|growth substances|mesh-ancestor
44609964|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44609965|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44609967|NCT00679029|Antiviral Agents|antiviral agents|mesh-ancestor
44609968|NCT00679029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44609969|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609970|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44609971|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44609972|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44609973|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
44609974|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
44609975|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609976|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44609977|NCT00678795|Nabiximols|nabiximols|mesh-list
44609978|NCT00678795|Analgesics|analgesics|mesh-ancestor
44609979|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
44609980|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44609981|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609982|NCT00678691|Modafinil|modafinil|mesh-list
44609983|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44228421|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44609984|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609985|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44609986|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44609987|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44609988|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609989|NCT00678652|Vaccines|vaccines|mesh-list
44609990|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
44609991|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44609992|NCT00678561|Tofacitinib|tofacitinib|mesh-list
44609993|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44609994|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44609995|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44609996|NCT00678392|Sorafenib|sorafenib|mesh-list
44609997|NCT00678392|Axitinib|axitinib|mesh-list
44609998|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44609999|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610000|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610001|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610002|NCT00678379|Lidocaine|lidocaine|mesh-list
44610003|NCT00678379|Clonidine|clonidine|mesh-list
44610004|NCT00678379|Bupivacaine|bupivacaine|mesh-list
44610005|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
44610006|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
44610007|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610008|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610009|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
44610010|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610011|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44610012|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44610013|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44610014|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610015|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610016|NCT00678379|Analgesics|analgesics|mesh-ancestor
44610017|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44610018|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
44610019|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
44610020|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44610021|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44610022|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44610023|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610024|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610025|NCT00678301|Vaccines|vaccines|mesh-list
44610026|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
44610027|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610028|NCT00678288|Interferons|interferons|mesh-list
44610029|NCT00678288|Sorafenib|sorafenib|mesh-list
44610030|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610031|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
44610032|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610033|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610034|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610035|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610036|NCT00678210|Tofacitinib|tofacitinib|mesh-list
44610037|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610038|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610039|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610040|NCT00678080|Metformin|metformin|mesh-list
44610042|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610043|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
44610044|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44610045|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610046|NCT00678041|Renal Agents|renal agents|mesh-ancestor
44610047|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610048|NCT00677833|Azithromycin|azithromycin|mesh-list
44610049|NCT00677833|Chloroquine|chloroquine|mesh-list
44610050|NCT00677833|Lumefantrine|lumefantrine|mesh-list
44610051|NCT00677833|Artemether|artemether|mesh-list
44610052|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44610053|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610054|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610055|NCT00677833|Amebicides|amebicides|mesh-ancestor
44610056|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44610057|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44610058|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
44610059|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610060|NCT00677534|Vitamin D|vitamin d|mesh-list
44610061|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
44610062|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
44610063|NCT00677534|Vitamins|vitamins|mesh-ancestor
44610064|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
44610065|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610066|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44610067|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44610068|NCT00677365|Levofloxacin|levofloxacin|mesh-list
44610069|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44610070|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610071|NCT00677365|Renal Agents|renal agents|mesh-ancestor
44610072|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610073|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610074|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610075|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610076|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610077|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228513|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44610078|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44610079|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44610080|NCT00677352|Sertraline|sertraline|mesh-list
44610081|NCT00677352|Paroxetine|paroxetine|mesh-list
44610082|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610083|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610084|NCT00677352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44610085|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44610086|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610087|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610088|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610089|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
44610090|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610091|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44439155|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
44610092|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44610093|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44610094|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610095|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
44610096|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610097|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610098|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610099|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610100|NCT00676663|Exemestane|exemestane|mesh-list
44610101|NCT00676663|Entinostat|entinostat|mesh-list
44610102|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610103|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44610104|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44610105|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610106|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610107|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44610108|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44610109|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610110|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610111|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44610112|NCT00676650|Prednisone|prednisone|mesh-list
44610113|NCT00676650|Sunitinib|sunitinib|mesh-list
44610114|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610115|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
44610116|NCT00676650|Hormones|hormones|mesh-ancestor
44228551|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610117|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610118|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610119|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44610120|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610121|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610122|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610123|NCT00676650|Growth Substances|growth substances|mesh-ancestor
44610124|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
44610125|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610126|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610127|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610128|NCT00676520|Everolimus|everolimus|mesh-list
44610129|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610130|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610131|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
44610132|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610133|NCT00676403|Pregabalin|pregabalin|mesh-list
44610134|NCT00676403|Analgesics|analgesics|mesh-ancestor
44610135|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
44610136|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610137|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610138|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
44610139|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44610140|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610141|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610142|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44610143|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44610144|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44610145|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610146|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610147|NCT00676338|Metformin|metformin|mesh-list
44610148|NCT00676338|Pioglitazone|pioglitazone|mesh-list
44610149|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44610150|NCT00676338|Exenatide|exenatide|mesh-list
44610151|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610152|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610153|NCT00676338|Incretins|incretins|mesh-ancestor
44610154|NCT00676338|Hormones|hormones|mesh-ancestor
44610155|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610156|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44610157|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
44228596|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
44610158|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610159|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610160|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44610161|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
44610162|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44610163|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
44610164|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610165|NCT00676195|Expectorants|expectorants|mesh-ancestor
44610166|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
44610167|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44439285|NCT01940497|Paclitaxel|paclitaxel|mesh-list
44610168|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
44610169|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610170|NCT00676195|Protective Agents|protective agents|mesh-ancestor
44610171|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610172|NCT00676195|Antidotes|antidotes|mesh-ancestor
44610173|NCT00676130|Trimethoprim|trimethoprim|mesh-list
44610174|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44610175|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
44610176|NCT00676130|Cephalexin|cephalexin|mesh-list
44610177|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44610178|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610179|NCT00676130|Renal Agents|renal agents|mesh-ancestor
44610180|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
44610181|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44610182|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44610183|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44610184|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610185|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610186|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44610187|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44610188|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44610190|NCT00676091|Vaccines|vaccines|mesh-list
44610191|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44610192|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
44610193|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610194|NCT00675948|Nabiximols|nabiximols|mesh-list
44610195|NCT00675948|Analgesics|analgesics|mesh-ancestor
44610196|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
44610197|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228635|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610198|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610199|NCT00675597|Bevacizumab|bevacizumab|mesh-list
44610200|NCT00675597|Docetaxel|docetaxel|mesh-list
44610201|NCT00675597|Vinorelbine|vinorelbine|mesh-list
44610202|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610203|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610204|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610205|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610206|NCT00675597|Growth Substances|growth substances|mesh-ancestor
44610207|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610208|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
44610209|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44610210|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610211|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610212|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610213|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44610214|NCT00675506|Hormones|hormones|mesh-list
44610215|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44610216|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610217|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610218|NCT00675441|Lenalidomide|lenalidomide|mesh-list
44610219|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
44610220|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610221|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610222|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610223|NCT00675441|Growth Substances|growth substances|mesh-ancestor
44610224|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
44610225|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610226|NCT00675428|Natalizumab|natalizumab|mesh-list
44610227|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
44610228|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610229|NCT00675025|Donepezil|donepezil|mesh-list
44610230|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44610231|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610232|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610233|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
44610234|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610235|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610236|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
44610237|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44610238|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610239|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610240|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610241|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610242|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
44610243|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610244|NCT00674661|Riboflavin|riboflavin|mesh-list
44610245|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44610246|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44610247|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
44610248|NCT00674661|Vitamins|vitamins|mesh-ancestor
44610249|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
44610250|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610251|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44610252|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610253|NCT00674570|Cycloserine|cycloserine|mesh-list
44610254|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
44610255|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610256|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44610257|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610258|NCT00674570|Renal Agents|renal agents|mesh-ancestor
44610259|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44610260|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
44610261|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610262|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
44610263|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610265|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610266|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
44610267|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610268|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610269|NCT00674323|Ranibizumab|ranibizumab|mesh-list
44610270|NCT00674323|Verteporfin|verteporfin|mesh-list
44610271|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610272|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610273|NCT00674323|Growth Substances|growth substances|mesh-ancestor
44610274|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610275|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
44610276|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610277|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44610278|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610279|NCT00674154|Vitamin D|vitamin d|mesh-list
44610280|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
44610281|NCT00674154|Vitamins|vitamins|mesh-ancestor
44610282|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
44610283|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610284|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44610285|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44610286|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44610287|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44610288|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44610289|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610290|NCT00673920|Methotrexate|methotrexate|mesh-list
44610291|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
44610292|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610293|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
44610294|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610295|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610296|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610297|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
44610298|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610299|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610300|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610301|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610302|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44610303|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610304|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
44610305|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610306|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44610307|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44610308|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610309|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610310|NCT00673894|Incretins|incretins|mesh-ancestor
44610311|NCT00673894|Hormones|hormones|mesh-ancestor
44610312|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610313|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44610314|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
44610315|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610316|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610317|NCT00673881|Choline|choline|mesh-list
44610318|NCT00673881|Fenofibrate|fenofibrate|mesh-list
44610335|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610336|NCT00673790|Losartan|losartan|mesh-list
44610337|NCT00673790|Lisinopril|lisinopril|mesh-list
44610338|NCT00673790|Nebivolol|nebivolol|mesh-list
44610339|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44610340|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44610341|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44610342|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44610343|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610344|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44610345|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44610346|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610347|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44610348|NCT00673790|Protective Agents|protective agents|mesh-ancestor
44610349|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610350|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44228767|NCT00526006|Esomeprazole|esomeprazole|mesh-list
44610351|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44610352|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44610353|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44610354|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610355|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610356|NCT00673673|Bevacizumab|bevacizumab|mesh-list
44610357|NCT00673673|Fluorouracil|fluorouracil|mesh-list
44610358|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610359|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610360|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44610361|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44610362|NCT00673673|Growth Substances|growth substances|mesh-ancestor
44610363|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610364|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44610365|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
44610366|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610367|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610368|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610369|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
44610370|NCT00673465|Metformin|metformin|mesh-list
44610371|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610372|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610373|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44610374|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44610375|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44610376|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610377|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610378|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610379|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610380|NCT00673452|Analgesics|analgesics|mesh-ancestor
44610381|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
44610382|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610383|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610384|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610385|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
44610386|NCT00673387|Pramlintide|pramlintide|mesh-list
44610387|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44610388|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610389|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610390|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
44610391|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44610392|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44610393|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610395|NCT00673361|Sorafenib|sorafenib|mesh-list
44610396|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610397|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
44610398|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610399|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610400|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610401|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610402|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
44610403|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44610404|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610405|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610406|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610407|NCT00673179|Leucovorin|leucovorin|mesh-list
44610408|NCT00673179|Gemcitabine|gemcitabine|mesh-list
44610409|NCT00673179|Doxorubicin|doxorubicin|mesh-list
44610410|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44610411|NCT00673179|Methotrexate|methotrexate|mesh-list
44610412|NCT00673179|Ifosfamide|ifosfamide|mesh-list
44610413|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
44610414|NCT00673179|Razoxane|razoxane|mesh-list
44610415|NCT00673179|Sargramostim|sargramostim|mesh-list
44610416|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610417|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610418|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
44610419|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610420|NCT00673179|Antiviral Agents|antiviral agents|mesh-ancestor
44610421|NCT00673179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610422|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610423|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610424|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
44610425|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610426|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44610427|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610428|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610429|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610430|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
44610431|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610432|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610433|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44610434|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610435|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44610436|NCT00673179|Antidotes|antidotes|mesh-ancestor
44610437|NCT00673179|Protective Agents|protective agents|mesh-ancestor
44610438|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
44610439|NCT00673179|Vitamins|vitamins|mesh-ancestor
44610440|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
44610441|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610442|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
44610443|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44610444|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610445|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610446|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44610447|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610448|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610449|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610450|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610451|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
44610452|NCT00672984|Guanfacine|guanfacine|mesh-list
44610453|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610454|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610455|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610456|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610457|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610458|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610459|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610460|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610461|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44610462|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44610463|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44610464|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44610465|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610466|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610467|NCT00672958|Vortioxetine|vortioxetine|mesh-list
44610468|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610469|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610470|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44610471|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44610472|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610473|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610474|NCT00672958|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44610475|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44610476|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610477|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610478|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610479|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
44610480|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44610481|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44610482|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44610483|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44610484|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
44610485|NCT00672841|Clotrimazole|clotrimazole|mesh-list
44610486|NCT00672841|Miconazole|miconazole|mesh-list
44610487|NCT00672841|Anidulafungin|anidulafungin|mesh-list
44610488|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610489|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44610490|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44610491|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44610492|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610493|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610494|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44610495|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
44610496|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610497|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610498|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44610499|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44610501|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44610502|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44610503|NCT00672646|Analgesics|analgesics|mesh-ancestor
44610504|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
44610505|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610506|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610507|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610508|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610509|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
44610510|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44610511|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610512|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610513|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44610514|NCT00672620|Vortioxetine|vortioxetine|mesh-list
44610515|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44610516|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44610517|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610518|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610519|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610520|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610521|NCT00672620|Analgesics|analgesics|mesh-ancestor
44610522|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
44610523|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610524|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610525|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610526|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
44610527|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44610528|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44610529|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610530|NCT00672620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44610531|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
44610532|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44610533|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44610534|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44610535|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44610536|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44610537|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610538|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610539|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44610540|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44458093|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
44610541|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610542|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610543|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
44610544|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44610545|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610546|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
44610547|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610548|NCT00672139|Bromides|bromides|mesh-list
44610549|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
44610550|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
44610551|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44610552|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610553|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
44610554|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610555|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
44610556|NCT00671931|Propofol|propofol|mesh-list
44610557|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44610558|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610559|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610560|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44610561|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
44610562|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
44610563|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44610564|NCT00671931|Analgesics|analgesics|mesh-ancestor
44610565|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
44610566|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610567|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44610568|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44610569|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44610570|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610571|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610572|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610573|NCT00671879|Carisoprodol|carisoprodol|mesh-list
44610574|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44610575|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610576|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44610577|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610578|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44610579|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610580|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610581|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44610582|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44610583|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610584|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610585|NCT00671788|Dasatinib|dasatinib|mesh-list
44610586|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610587|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44610588|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610589|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610590|NCT00671749|Clindamycin|clindamycin|mesh-list
44610591|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
44610592|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
44610593|NCT00671749|Adapalene|adapalene|mesh-list
44610594|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44610595|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610596|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610597|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44610598|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610599|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610600|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610601|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44610602|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44610603|NCT00671749|Analgesics|analgesics|mesh-ancestor
44610604|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
44610605|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610606|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610607|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610608|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610609|NCT00671658|Cytarabine|cytarabine|mesh-list
44610610|NCT00671658|Dexamethasone|dexamethasone|mesh-list
44610611|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
44610612|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44610613|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44610614|NCT00671658|Prednisolone|prednisolone|mesh-list
44610615|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
44610616|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
44610617|NCT00671658|Rituximab|rituximab|mesh-list
44610618|NCT00671658|Doxorubicin|doxorubicin|mesh-list
44610619|NCT00671658|Methotrexate|methotrexate|mesh-list
44610620|NCT00671658|Vincristine|vincristine|mesh-list
44610621|NCT00671658|Asparaginase|asparaginase|mesh-list
44610622|NCT00671658|Pegaspargase|pegaspargase|mesh-list
44610623|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44610624|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
44610625|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610626|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
44610627|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610628|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610629|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610630|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
44610631|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610632|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610633|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44610634|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610635|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610636|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
44610637|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
44610638|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610639|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610640|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
44610641|NCT00671658|Hormones|hormones|mesh-ancestor
44610642|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610643|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44610644|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44610645|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610646|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610647|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610648|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610649|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
44610650|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610651|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610652|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
44610653|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610654|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44610655|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44610656|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
44610657|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610658|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44610659|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
44610660|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610661|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610662|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44610663|NCT00671658|Protective Agents|protective agents|mesh-ancestor
44610664|NCT00671437|Cetuximab|cetuximab|mesh-list
44610665|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610666|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610667|NCT00671060|Misoprostol|misoprostol|mesh-list
44610668|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610669|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
44610670|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610671|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610672|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44610673|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610674|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
44610675|NCT00671034|Cytarabine|cytarabine|mesh-list
44610676|NCT00671034|Dexamethasone|dexamethasone|mesh-list
44610677|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
44610678|NCT00671034|Prednisone|prednisone|mesh-list
44610679|NCT00671034|Cortisone|cortisone|mesh-list
44610680|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
44610681|NCT00671034|Doxorubicin|doxorubicin|mesh-list
44610682|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44610683|NCT00671034|Methotrexate|methotrexate|mesh-list
44610684|NCT00671034|Vincristine|vincristine|mesh-list
44610685|NCT00671034|Daunorubicin|daunorubicin|mesh-list
44610686|NCT00671034|Asparaginase|asparaginase|mesh-list
44610687|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
44610688|NCT00671034|Pegaspargase|pegaspargase|mesh-list
44610689|NCT00671034|Thioguanine|thioguanine|mesh-list
44439765|NCT01931475|Analgesics|analgesics|mesh-ancestor
44610690|NCT00671034|BB 1101|bb 1101|mesh-list
44610691|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
44610692|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610693|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
44610694|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610695|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610696|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610697|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
44610698|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610699|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610700|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44610701|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610702|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
44610703|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
44610704|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610705|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610706|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
44610707|NCT00671034|Hormones|hormones|mesh-ancestor
44610708|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610709|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44610710|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
44610711|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610712|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44610713|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610714|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610715|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610716|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
44610717|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610718|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610719|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
44610720|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610721|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44610722|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44610723|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
44610724|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610725|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44610726|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44610727|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610728|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610730|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44610731|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44610732|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44610733|NCT00670800|Metformin|metformin|mesh-list
44610734|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610735|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610736|NCT00670748|Aldesleukin|aldesleukin|mesh-list
44610737|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
44610738|NCT00670748|Fludarabine|fludarabine|mesh-list
44610739|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
44610740|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610741|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
44610742|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610743|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610744|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610745|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
44610746|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610747|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610748|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44610749|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610750|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
44229152|NCT00527683|Vigabatrin|vigabatrin|mesh-list
44610751|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44610752|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44610753|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
44610754|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610755|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44610756|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44610757|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610758|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610759|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
44610760|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610761|NCT00670306|Cetrorelix|cetrorelix|mesh-list
44610762|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44610763|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
44610764|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610765|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610766|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
44610767|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610768|NCT00670228|Insulin|insulin|mesh-list
44439849|NCT01929863|Metformin|metformin|mesh-list
44610769|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44610770|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
44610771|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
44610772|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610773|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610774|NCT00670046|Valproic Acid|valproic acid|mesh-list
44610775|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
44610776|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610777|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610778|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
44610779|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610780|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610781|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
44610782|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44610783|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44610784|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610785|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
44610786|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44610787|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610788|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610789|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44610790|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44610791|NCT00669955|Amoxicillin|amoxicillin|mesh-list
44610792|NCT00669955|Metronidazole|metronidazole|mesh-list
44610793|NCT00669955|Clarithromycin|clarithromycin|mesh-list
44610794|NCT00669955|Tetracycline|tetracycline|mesh-list
44610795|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44610796|NCT00669955|Omeprazole|omeprazole|mesh-list
44610797|NCT00669955|Bismuth|bismuth|mesh-list
44610798|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44610799|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008483|NCT02902770|Lidocaine|lidocaine|mesh-list
44610800|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44610801|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44610802|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44610803|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610804|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44610805|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610806|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610807|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44610808|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44610809|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44610810|NCT00669955|Antacids|antacids|mesh-ancestor
44610811|NCT00669877|Cytarabine|cytarabine|mesh-list
44610812|NCT00669877|Dexamethasone|dexamethasone|mesh-list
44610813|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
44610814|NCT00669877|Rituximab|rituximab|mesh-list
44610815|NCT00669877|Doxorubicin|doxorubicin|mesh-list
44610816|NCT00669877|Methotrexate|methotrexate|mesh-list
44610817|NCT00669877|Vincristine|vincristine|mesh-list
44610818|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610819|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
44610820|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610821|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44610822|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610823|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
44610824|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610825|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610826|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44610827|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610828|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610829|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
44610830|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
44610831|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610832|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44610833|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
44610834|NCT00669877|Hormones|hormones|mesh-ancestor
44610835|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610836|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44610837|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44610838|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44610839|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44610840|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610841|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44610842|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
44439911|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610843|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610844|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610845|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
44610848|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44610849|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
44610850|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610851|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44610852|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44610853|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610854|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610855|NCT00669864|Metformin|metformin|mesh-list
44610856|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
44610857|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
44610858|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44610859|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44610860|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610861|NCT00669669|Plerixafor|plerixafor|mesh-list
44610862|NCT00669669|Temozolomide|temozolomide|mesh-list
44610863|NCT00669669|Carmustine|carmustine|mesh-list
44610864|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44610865|NCT00669669|Lenograstim|lenograstim|mesh-list
44610866|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44610867|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
44610868|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610869|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44610870|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
44610871|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610872|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610873|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44610874|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44610875|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
44610876|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610877|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610878|NCT00669617|Fluticasone|fluticasone|mesh-list
44610879|NCT00669617|Xhance|xhance|mesh-list
44610880|NCT00669617|Albuterol|albuterol|mesh-list
44610881|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44610882|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610883|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44610884|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
44610885|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610886|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610887|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44610888|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
44610889|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610890|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44610891|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44610892|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44610893|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44610894|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
44610895|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610896|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610897|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
44610898|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610899|NCT00669409|Tanezumab|tanezumab|mesh-list
44610900|NCT00669409|Analgesics|analgesics|mesh-ancestor
44610901|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
44610902|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44610903|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610904|NCT00669396|Copper|copper|mesh-list
44610905|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
44610906|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44610907|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
44610908|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610909|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610910|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44610911|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44610912|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44610913|NCT00669396|Trace Elements|trace elements|mesh-ancestor
44610914|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
44610915|NCT00669331|Mannitol|mannitol|mesh-list
44610916|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44610917|NCT00669331|Diuretics|diuretics|mesh-ancestor
44610918|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
44610919|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610920|NCT00669318|Rituximab|rituximab|mesh-list
44610921|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
44610922|NCT00669318|Pentostatin|pentostatin|mesh-list
44610923|NCT00669318|Sargramostim|sargramostim|mesh-list
44610924|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44610925|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610926|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
44610927|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610928|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458119|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44610929|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44610930|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44610931|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610932|NCT00669240|Varenicline|varenicline|mesh-list
44610933|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44610934|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44610935|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
44610936|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610937|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610938|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610939|NCT00669162|Docetaxel|docetaxel|mesh-list
44610940|NCT00669162|Leuprolide|leuprolide|mesh-list
44610941|NCT00669162|Goserelin|goserelin|mesh-list
44610942|NCT00669162|Bicalutamide|bicalutamide|mesh-list
44610943|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610944|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
44610945|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
44610946|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
44610947|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610948|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44610949|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
44610950|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44610951|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610952|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44610953|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
44610954|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
44610955|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610956|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44610957|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44610958|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44610959|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44610960|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610961|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44610962|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610963|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
44610964|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44610965|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44610967|NCT00669071|Hydroquinone|hydroquinone|mesh-list
44610968|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610969|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
44610970|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44610971|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44610972|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
44610973|NCT00669071|Hormones|hormones|mesh-ancestor
44229332|NCT00528619|Cisplatin|cisplatin|mesh-list
44610974|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44610975|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610976|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
44610977|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610978|NCT00669071|Protective Agents|protective agents|mesh-ancestor
44610979|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44610980|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
44610981|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44610982|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
44610983|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610984|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
44610985|NCT00669032|Protective Agents|protective agents|mesh-ancestor
44610986|NCT00668863|Leucovorin|leucovorin|mesh-list
44610987|NCT00668863|Fluorouracil|fluorouracil|mesh-list
44610988|NCT00668863|Irinotecan|irinotecan|mesh-list
44610989|NCT00668863|Sunitinib|sunitinib|mesh-list
44610990|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
44610991|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
44610992|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44610993|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44610994|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44610995|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44610996|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
44610997|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44610998|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44610999|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44611000|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611001|NCT00668863|Antidotes|antidotes|mesh-ancestor
44611002|NCT00668863|Protective Agents|protective agents|mesh-ancestor
44611003|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
44611004|NCT00668863|Vitamins|vitamins|mesh-ancestor
44611005|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
44611006|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611007|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611008|NCT00668863|Growth Substances|growth substances|mesh-ancestor
44611009|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611010|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611011|NCT00668746|Minocycline|minocycline|mesh-list
44611012|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44611013|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611014|NCT00668707|Melatonin|melatonin|mesh-list
44611015|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
44611016|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611017|NCT00668707|Protective Agents|protective agents|mesh-ancestor
44611018|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611019|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611020|NCT00668395|Efavirenz|efavirenz|mesh-list
44611021|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44611022|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44611023|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611024|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611025|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
44611026|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008701|NCT02911818|Incretins|incretins|mesh-ancestor
44611027|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44611028|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44611029|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44611030|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44611031|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44611032|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44611033|NCT00668317|Omeprazole|omeprazole|mesh-list
44611034|NCT00668317|Ranitidine|ranitidine|mesh-list
44611035|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44611036|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44611037|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611038|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44611039|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611040|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611041|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44611042|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
44611043|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
44611044|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611045|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611046|NCT00668200|Vitamin D|vitamin d|mesh-list
44611047|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
44611048|NCT00668200|Calcium|calcium|mesh-list
44611049|NCT00668200|Vitamins|vitamins|mesh-ancestor
44611050|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
44611051|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611052|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44611053|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44611054|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44611055|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
44611056|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611057|NCT00667992|Budesonide|budesonide|mesh-list
44611058|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611059|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44611060|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
44611061|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611062|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611063|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44611064|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
44611065|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
44611066|NCT00667992|Hormones|hormones|mesh-ancestor
44611067|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611068|NCT00667875|Naltrexone|naltrexone|mesh-list
44611069|NCT00667875|Aripiprazole|aripiprazole|mesh-list
44440132|NCT01925703|Hematinics|hematinics|mesh-ancestor
44611070|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44611071|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44611072|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611073|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
44611074|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611075|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
44611076|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611077|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44611078|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44611079|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611080|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
44611081|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
44611082|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611083|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611084|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44611085|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44611086|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
44611087|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44611088|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44611089|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44611090|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44611091|NCT00667862|Panobinostat|panobinostat|mesh-list
44611092|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611093|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44611094|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611095|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611096|NCT00667823|Macitentan|macitentan|mesh-list
44611097|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44611098|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44611099|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611100|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44611101|NCT00667732|Exenatide|exenatide|mesh-list
44611102|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611103|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611104|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44611105|NCT00667732|Incretins|incretins|mesh-ancestor
44611106|NCT00667732|Hormones|hormones|mesh-ancestor
44611107|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611108|NCT00667719|Amlodipine|amlodipine|mesh-list
44611109|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44611110|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44611111|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44611112|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611113|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611114|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44611115|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611116|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
44611117|NCT00667719|Diuretics|diuretics|mesh-ancestor
44611118|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
44611119|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44611121|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611122|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
44611123|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44611124|NCT00667576|Protective Agents|protective agents|mesh-ancestor
44611125|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611127|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44611128|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
44611129|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44611130|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611131|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44611132|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611133|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
44611134|NCT00667420|Epirubicin|epirubicin|mesh-list
44611135|NCT00667420|Panitumumab|panitumumab|mesh-list
44611136|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611137|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611138|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44611139|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44611140|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44611141|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229506|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
44611142|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611143|NCT00667394|Bevacizumab|bevacizumab|mesh-list
44611144|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611145|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611146|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611147|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611148|NCT00667394|Growth Substances|growth substances|mesh-ancestor
44611149|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611150|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611151|NCT00667368|Metronidazole|metronidazole|mesh-list
44611152|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611153|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44611154|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44611155|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44611156|NCT00667355|Adalimumab|adalimumab|mesh-list
44611157|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611158|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611159|NCT00667342|Bevacizumab|bevacizumab|mesh-list
44611160|NCT00667342|Cisplatin|cisplatin|mesh-list
44611161|NCT00667342|Doxorubicin|doxorubicin|mesh-list
44611162|NCT00667342|Methotrexate|methotrexate|mesh-list
44611163|NCT00667342|Etoposide|etoposide|mesh-list
44611164|NCT00667342|Ifosfamide|ifosfamide|mesh-list
44611165|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611166|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611167|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611168|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611169|NCT00667342|Growth Substances|growth substances|mesh-ancestor
44611170|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611171|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611172|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44611173|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44611174|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44611175|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611176|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611177|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44611178|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
44611179|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44611180|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611182|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
44611183|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44611184|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611185|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
44611186|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611187|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44611188|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611189|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44611190|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
44611191|NCT00667277|Bevacizumab|bevacizumab|mesh-list
44611192|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611193|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611194|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611195|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611196|NCT00667277|Growth Substances|growth substances|mesh-ancestor
44611197|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611198|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611199|NCT00667251|Paclitaxel|paclitaxel|mesh-list
44611200|NCT00667251|Docetaxel|docetaxel|mesh-list
44611201|NCT00667251|Trastuzumab|trastuzumab|mesh-list
44611202|NCT00667251|Lapatinib|lapatinib|mesh-list
44611203|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611204|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611205|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611206|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611207|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611208|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611209|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611210|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611211|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611212|NCT00667225|Cantharidin|cantharidin|mesh-list
44611213|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611214|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611215|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44611216|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44611217|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44611218|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611219|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611220|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44611221|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611222|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229588|NCT00530478|Donepezil|donepezil|mesh-list
44611223|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
44611224|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611225|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44611226|NCT00667095|Protective Agents|protective agents|mesh-ancestor
44611227|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44611228|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
44611229|NCT00667017|Immunotoxins|immunotoxins|mesh-list
44611230|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
44611231|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611232|NCT00666965|Rotigotine|rotigotine|mesh-list
44611233|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
44611234|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
44611235|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611236|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611237|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611238|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
44611239|NCT00666835|Hematinics|hematinics|mesh-ancestor
44611240|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44611241|NCT00666757|Sertraline|sertraline|mesh-list
44611242|NCT00666757|Fluoxetine|fluoxetine|mesh-list
44611243|NCT00666757|Paroxetine|paroxetine|mesh-list
44611244|NCT00666757|Citalopram|citalopram|mesh-list
44611245|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44611246|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44611247|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611248|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008925|NCT02921061|Lenograstim|lenograstim|mesh-list
44611249|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611250|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611252|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
44611253|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611254|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
44611255|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611256|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
44611257|NCT00666757|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44611258|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
44611259|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44611260|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44611261|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44611262|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611263|NCT00666718|Insulin|insulin|mesh-list
44611264|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44611265|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
44611266|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
44611267|NCT00666718|Protamines|protamines|mesh-list
44611268|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611269|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611270|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
44611271|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611272|NCT00666718|Coagulants|coagulants|mesh-ancestor
44611273|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
44611274|NCT00666705|Maraviroc|maraviroc|mesh-list
44611275|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44611276|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44611277|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
44611278|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611279|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44611280|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44611281|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611282|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611283|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44611284|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44611285|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44611286|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
44611287|NCT00666679|Montelukast|montelukast|mesh-list
44611288|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44611289|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
44611290|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44611291|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
44611292|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611293|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611294|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44611295|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44611296|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611297|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611298|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
44611299|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44611300|NCT00666588|Cytarabine|cytarabine|mesh-list
44611301|NCT00666588|Etoposide|etoposide|mesh-list
44611302|NCT00666588|Idarubicin|idarubicin|mesh-list
44611303|NCT00666588|Bortezomib|bortezomib|mesh-list
44611304|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
44611305|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611306|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611307|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44611308|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44611309|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611310|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611311|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611312|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
44611313|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
44611314|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611315|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611316|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
44611317|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611318|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44611319|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44611320|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
44611321|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611322|NCT00666562|Protective Agents|protective agents|mesh-ancestor
44611323|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611324|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44611325|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44611326|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611327|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44611329|NCT00666536|Valsartan|valsartan|mesh-list
44611330|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44611331|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44611332|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44611333|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611334|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611335|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44611336|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611337|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
44611338|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44611339|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44611340|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44611341|NCT00666458|Saxagliptin|saxagliptin|mesh-list
44611342|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611343|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611344|NCT00666458|Incretins|incretins|mesh-ancestor
44611345|NCT00666458|Hormones|hormones|mesh-ancestor
44611346|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611347|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44611348|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
44611349|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611350|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611351|NCT00666328|Clevidipine|clevidipine|mesh-list
44611352|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44611353|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611354|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611355|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44611356|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611357|NCT00666276|Linezolid|linezolid|mesh-list
44611358|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44611359|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611360|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44611361|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611362|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611363|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44611364|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
44611365|NCT00666263|Antibodies|antibodies|mesh-list
44611366|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
44611367|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44611368|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44611369|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
44611370|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611371|NCT00666237|Mitomycins|mitomycins|mesh-list
44611372|NCT00666237|Mitomycin|mitomycin|mesh-list
44611373|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44611374|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611375|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
44611376|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611377|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44611378|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611398|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
44611399|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611400|NCT00665652|Lenalidomide|lenalidomide|mesh-list
44611401|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
44611402|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611403|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611404|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611405|NCT00665652|Growth Substances|growth substances|mesh-ancestor
44611406|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611407|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611408|NCT00665561|Maraviroc|maraviroc|mesh-list
44611409|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44611410|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44611411|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44611412|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611413|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44611414|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
44229694|NCT00531167|Lamivudine|lamivudine|mesh-list
44611415|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611416|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44611417|NCT00665444|Aripiprazole|aripiprazole|mesh-list
44611418|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
44611419|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611420|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44611421|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44611422|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611423|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611424|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
44611425|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
44611426|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611427|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611428|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44611429|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44611430|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
44611431|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44611432|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44611433|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44611434|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44611435|NCT00665431|Celecoxib|celecoxib|mesh-list
44611436|NCT00665431|Antacids|antacids|mesh-list
44611437|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44611438|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44611439|NCT00665431|Analgesics|analgesics|mesh-ancestor
44611440|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
44611441|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611442|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611443|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611444|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611445|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44611446|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44611447|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611448|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611449|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611450|NCT00665392|Cisplatin|cisplatin|mesh-list
44611451|NCT00665392|Docetaxel|docetaxel|mesh-list
44611452|NCT00665392|Fluorouracil|fluorouracil|mesh-list
44611453|NCT00665392|Cetuximab|cetuximab|mesh-list
44611454|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611455|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611456|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611457|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611458|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611459|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
44611460|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611461|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611462|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
44229727|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
44611463|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611464|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611465|NCT00665366|Valproic Acid|valproic acid|mesh-list
44611466|NCT00665366|Aripiprazole|aripiprazole|mesh-list
44611467|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
44611468|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611469|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44611470|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440590|NCT01916980|Desloratadine|desloratadine|mesh-list
44611471|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611472|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611473|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
44611474|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
44611475|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611476|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611477|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44611478|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44611479|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
44611480|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44611481|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44611482|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44611483|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44611484|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611485|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
44611486|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
44611487|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
44611488|NCT00665353|Pioglitazone|pioglitazone|mesh-list
44611490|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
44611491|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611492|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
44611493|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611494|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611495|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611496|NCT00665002|Sargramostim|sargramostim|mesh-list
44611497|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44611498|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
44611499|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611500|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44611501|NCT00664859|Atorvastatin|atorvastatin|mesh-list
44611502|NCT00664859|Fenofibrate|fenofibrate|mesh-list
44611503|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44611504|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44611505|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
44611506|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611507|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44611508|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44611509|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611510|NCT00664560|Celecoxib|celecoxib|mesh-list
44611511|NCT00664560|Antacids|antacids|mesh-list
44611512|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44611513|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44611514|NCT00664560|Analgesics|analgesics|mesh-ancestor
44229777|NCT00531440|Everolimus|everolimus|mesh-list
44611515|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
44611516|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611517|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611518|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611519|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611520|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44611521|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44611522|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611523|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611524|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611525|NCT00664534|Insulin|insulin|mesh-list
44611526|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44611527|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
44611528|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
44611529|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611530|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611531|NCT00664521|Rituximab|rituximab|mesh-list
44611532|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611533|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611534|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
44611535|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611536|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611537|NCT00664209|Amoxicillin|amoxicillin|mesh-list
44611538|NCT00664209|Omeprazole|omeprazole|mesh-list
44611539|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44611540|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611541|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44611542|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611543|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44611544|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611545|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611546|NCT00664105|Carboplatin|carboplatin|mesh-list
44611547|NCT00664105|Docetaxel|docetaxel|mesh-list
44440674|NCT01915940|Timolol|timolol|mesh-list
44611548|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611549|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611550|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611551|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44229828|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611552|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611554|NCT00664066|Hematinics|hematinics|mesh-ancestor
44611555|NCT00663962|Pregabalin|pregabalin|mesh-list
44611556|NCT00663962|Analgesics|analgesics|mesh-ancestor
44611557|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
44611558|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611559|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611560|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
44611561|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44235637|NCT00555386|Selenium|selenium|mesh-list
44611562|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611563|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611564|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44611565|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44611566|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44611567|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611568|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611570|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44611571|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
44611572|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44611573|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611574|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
44611575|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611576|NCT00663702|Abatacept|abatacept|mesh-list
44611577|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44611578|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611579|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611580|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611581|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
44611582|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611583|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611584|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
44611585|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44611586|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611587|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611588|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229881|NCT00531908|Furosemide|furosemide|mesh-list
44611589|NCT00663234|Atorvastatin|atorvastatin|mesh-list
44611590|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44611591|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44611592|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
44611593|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611594|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44611595|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44611596|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611597|NCT00663117|Naltrexone|naltrexone|mesh-list
44611598|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44611599|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44611600|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611601|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
44611602|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611603|NCT00663052|Etanercept|etanercept|mesh-list
44611604|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44611605|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44611606|NCT00663052|Analgesics|analgesics|mesh-ancestor
44611607|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
44611608|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611609|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611610|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611611|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611612|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611613|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611614|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
44611615|NCT00662909|Mirabegron|mirabegron|mesh-list
44611616|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44611617|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44611618|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44611619|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
44611620|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611621|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611622|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611624|NCT00662857|Insulin|insulin|mesh-list
44611625|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44611626|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611627|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611628|NCT00662831|Dalteparin|dalteparin|mesh-list
44611629|NCT00662831|Tinzaparin|tinzaparin|mesh-list
44611630|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44611631|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
44611632|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44611633|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44611634|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611635|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
44611636|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44611637|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44611638|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
44611639|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611640|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611641|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44611642|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44611643|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
44611644|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44611645|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
44611646|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611647|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611648|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44611649|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44611650|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44611651|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
44611652|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44611653|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44611654|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611655|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611656|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
44611657|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611659|NCT00662558|Tramadol|tramadol|mesh-list
44611660|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44611661|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44611662|NCT00662558|Analgesics|analgesics|mesh-ancestor
44611663|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
44611664|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611665|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611666|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611667|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611668|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44611669|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44611670|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611671|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611672|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44611673|NCT00662558|Narcotics|narcotics|mesh-ancestor
44611674|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611675|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44611676|NCT00662532|Minocycline|minocycline|mesh-list
44611677|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611678|NCT00662363|Lubiprostone|lubiprostone|mesh-list
44611679|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44611680|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229954|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44611681|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611682|NCT00662311|Paclitaxel|paclitaxel|mesh-list
44611683|NCT00662311|Vorinostat|vorinostat|mesh-list
44611684|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611685|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611686|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611687|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611688|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611689|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611690|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44611691|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611692|NCT00662259|Alprazolam|alprazolam|mesh-list
44611693|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44611694|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440806|NCT01913405|BAX 855|bax 855|mesh-list
44611695|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611696|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44611697|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44611698|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611699|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
44611701|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611702|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611703|NCT00662129|Gemcitabine|gemcitabine|mesh-list
44611704|NCT00662129|Paclitaxel|paclitaxel|mesh-list
44611705|NCT00662129|Bevacizumab|bevacizumab|mesh-list
44611706|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44611707|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611708|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611709|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611711|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611712|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611713|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611714|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611715|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611716|NCT00662129|Growth Substances|growth substances|mesh-ancestor
44611717|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611718|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611719|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611720|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
44611721|NCT00662129|Antiviral Agents|antiviral agents|mesh-ancestor
44611722|NCT00662129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611723|NCT00662129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611724|NCT00662129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611725|NCT00662129|Immunologic Factors|immunologic factors|mesh-ancestor
44611726|NCT00662038|Pirfenidone|pirfenidone|mesh-list
44611727|NCT00662038|Analgesics|analgesics|mesh-ancestor
44611728|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
44611729|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611730|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611731|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44611732|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44611733|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44611734|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44611735|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611736|NCT00662025|Capecitabine|capecitabine|mesh-list
44611737|NCT00662025|Sunitinib|sunitinib|mesh-list
44611738|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611739|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
44611740|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611741|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611742|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611743|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611744|NCT00662025|Growth Substances|growth substances|mesh-ancestor
44611745|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611746|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611747|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611748|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611749|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44611750|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44611751|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44611752|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611753|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
44611754|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44611755|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
44611756|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
44611757|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
44611758|NCT00661999|Hematinics|hematinics|mesh-ancestor
44611759|NCT00661830|Gemcitabine|gemcitabine|mesh-list
44611760|NCT00661830|Sorafenib|sorafenib|mesh-list
44611761|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611762|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
44611763|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611764|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611765|NCT00661830|Antiviral Agents|antiviral agents|mesh-ancestor
44611766|NCT00661830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611767|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611768|NCT00661830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611769|NCT00661830|Immunologic Factors|immunologic factors|mesh-ancestor
44611770|NCT00661830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611771|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611772|NCT00661778|Bevacizumab|bevacizumab|mesh-list
44611773|NCT00661778|Cisplatin|cisplatin|mesh-list
44611774|NCT00661778|Docetaxel|docetaxel|mesh-list
44611775|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611776|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611777|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44611778|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44611779|NCT00661778|Growth Substances|growth substances|mesh-ancestor
44611780|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611781|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
44611782|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611783|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611784|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44235638|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
44611785|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611786|NCT00661726|Decitabine|decitabine|mesh-list
44611787|NCT00661726|Azacitidine|azacitidine|mesh-list
44611788|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611789|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
44611790|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611791|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611792|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611793|NCT00661713|Vaccines|vaccines|mesh-list
44611794|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
44611795|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611796|NCT00661661|Tofacitinib|tofacitinib|mesh-list
44611797|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611798|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611799|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611800|NCT00661622|Molgramostim|molgramostim|mesh-list
44611801|NCT00661622|Sargramostim|sargramostim|mesh-list
44611802|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
44611803|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611804|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611805|NCT00661531|Anastrozole|anastrozole|mesh-list
44611806|NCT00661531|Estradiol|estradiol|mesh-list
44611807|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44611808|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611809|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44611810|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44611811|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611812|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611813|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44611814|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230028|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44611815|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611816|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611817|NCT00661531|Estrogens|estrogens|mesh-ancestor
44611818|NCT00661531|Hormones|hormones|mesh-ancestor
44611819|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
44611820|NCT00661505|Hematinics|hematinics|mesh-ancestor
44611821|NCT00661492|Cetuximab|cetuximab|mesh-list
44611822|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
44611823|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611824|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611825|NCT00661492|Analgesics|analgesics|mesh-ancestor
44611826|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
44611827|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611828|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611829|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44611830|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44611831|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611832|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611833|NCT00661427|Cetuximab|cetuximab|mesh-list
44611834|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44611835|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611836|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
44611837|NCT00661388|Hematinics|hematinics|mesh-ancestor
44611838|NCT00661362|Metformin|metformin|mesh-list
44611839|NCT00661362|Saxagliptin|saxagliptin|mesh-list
44611840|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611841|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611842|NCT00661362|Incretins|incretins|mesh-ancestor
44611843|NCT00661362|Hormones|hormones|mesh-ancestor
44611844|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44611845|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44611846|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
44611847|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611848|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611849|NCT00661193|Paclitaxel|paclitaxel|mesh-list
44611850|NCT00661193|Carboplatin|carboplatin|mesh-list
44611851|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44611852|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44611853|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611854|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611855|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611856|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611857|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611858|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611859|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611860|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
44611861|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44611863|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44611864|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44611865|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611866|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
44611867|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611868|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611869|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44611870|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611871|NCT00660907|Metformin|metformin|mesh-list
44611872|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
44611873|NCT00660907|Glipizide|glipizide|mesh-list
44611874|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44611875|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611876|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44611877|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611878|NCT00660829|Azelastine|azelastine|mesh-list
44611879|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44611880|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
44611881|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611882|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611883|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44611884|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44611885|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44611886|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611887|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611888|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44611889|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44611890|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44611891|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
44611892|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
44611893|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611894|NCT00660816|Docetaxel|docetaxel|mesh-list
44611895|NCT00660816|Pemetrexed|pemetrexed|mesh-list
44611896|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44611897|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611898|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611899|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611900|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611901|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611902|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611903|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44611904|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44611905|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44611906|NCT00660699|Gemcitabine|gemcitabine|mesh-list
44611907|NCT00660699|Docetaxel|docetaxel|mesh-list
44611908|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611909|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
44611910|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611911|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611912|NCT00660699|Antiviral Agents|antiviral agents|mesh-ancestor
44611913|NCT00660699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44611914|NCT00660699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611915|NCT00660699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44611916|NCT00660699|Immunologic Factors|immunologic factors|mesh-ancestor
44611917|NCT00660699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611918|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44611919|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44611920|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44611921|NCT00660660|Esomeprazole|esomeprazole|mesh-list
44611922|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44611923|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44611924|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44611925|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611926|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611927|NCT00660595|Risperidone|risperidone|mesh-list
44611928|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44611929|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44611930|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
44611931|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611932|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611933|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611934|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44611935|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44611936|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611937|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44611938|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44611939|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
44611940|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
44611941|NCT00660400|Azacitidine|azacitidine|mesh-list
44611942|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44611943|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
44611944|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611945|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611946|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611947|NCT00660387|Levodopa|levodopa|mesh-list
44611948|NCT00660387|Carbidopa|carbidopa|mesh-list
44611949|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44611950|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44611951|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44611952|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
44611953|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44611954|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611955|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611956|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44611957|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611958|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44611959|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
44611960|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
44611961|NCT00660348|Morphine|morphine|mesh-list
44611962|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44611963|NCT00660348|Narcotics|narcotics|mesh-ancestor
44611964|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44611965|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611966|NCT00660348|Analgesics|analgesics|mesh-ancestor
44611967|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
44611968|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44611969|NCT00660309|Irbesartan|irbesartan|mesh-list
44611970|NCT00660309|Captopril|captopril|mesh-list
44611971|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44611972|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44611973|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44611974|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611975|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44611976|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
44611977|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611978|NCT00660179|Macitentan|macitentan|mesh-list
44230196|NCT05061654|Tazobactam|tazobactam|mesh-list
44611979|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44611980|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44611981|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611982|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44611983|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
44611984|NCT00660023|Hematinics|hematinics|mesh-ancestor
44611985|NCT00660010|Leuprolide|leuprolide|mesh-list
44611986|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44611987|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
44611988|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44611989|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44611990|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44611991|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611992|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44611993|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44611994|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44611995|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44611996|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44611997|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44611998|NCT00659581|Telmisartan|telmisartan|mesh-list
44611999|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44612000|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44612001|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44612002|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612003|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
44612004|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
44612005|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44612006|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44612007|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612012|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612013|NCT00659490|Analgesics|analgesics|mesh-ancestor
44612014|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
44612015|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612016|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612017|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612018|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612019|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
44612020|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44612021|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612022|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612023|NCT00659438|Bicalutamide|bicalutamide|mesh-list
44612024|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
44612025|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
44612026|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458299|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
44612027|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612028|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612029|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
44612030|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612032|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44612033|NCT00659373|Exemestane|exemestane|mesh-list
44612034|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44612035|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
44612036|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612037|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612038|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44612039|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612040|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44612041|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44612042|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44612043|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44612044|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44612045|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612046|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612047|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
44612048|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44612049|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
44612050|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44612051|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44612052|NCT00659269|Vitamins|vitamins|mesh-list
44612053|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
44612054|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
44612055|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
44612056|NCT00659269|Pyridoxal|pyridoxal|mesh-list
44612057|NCT00659269|Pyridoxine|pyridoxine|mesh-list
44612058|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
44612059|NCT00659269|Vincristine|vincristine|mesh-list
44612060|NCT00659269|Vinorelbine|vinorelbine|mesh-list
44612061|NCT00659269|Docetaxel|docetaxel|mesh-list
44612062|NCT00659269|Cisplatin|cisplatin|mesh-list
44612063|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
44612064|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612065|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612066|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612067|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612068|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
44230250|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612069|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612070|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
44612071|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612094|NCT00658788|Clobetasol|clobetasol|mesh-list
44612095|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44612096|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612097|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44612098|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612099|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612100|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44612102|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
44612103|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44612104|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612105|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
44612106|NCT00658788|Hormones|hormones|mesh-ancestor
44612107|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612108|NCT00658775|Esomeprazole|esomeprazole|mesh-list
44612109|NCT00658775|Rabeprazole|rabeprazole|mesh-list
44612110|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44612111|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44612112|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44612113|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612114|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612115|NCT00658684|Fesoterodine|fesoterodine|mesh-list
44612116|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44612117|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44612118|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
44612119|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612120|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612121|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612122|NCT00658684|Urological Agents|urological agents|mesh-ancestor
44612123|NCT00658658|Panitumumab|panitumumab|mesh-list
44612124|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612125|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612126|NCT00658632|Esomeprazole|esomeprazole|mesh-list
44612127|NCT00658632|Rabeprazole|rabeprazole|mesh-list
44612128|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44612129|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230292|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44612130|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44612131|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612132|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612133|NCT00658606|Alefacept|alefacept|mesh-list
44612134|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612135|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
44612136|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612137|NCT00658567|Pimavanserin|pimavanserin|mesh-list
44612138|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44612139|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44612140|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44612141|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44612142|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612143|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612144|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44612145|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44612146|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44612147|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
44612148|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612149|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612150|NCT00658541|Zolpidem|zolpidem|mesh-list
44612151|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44612152|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44612153|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612154|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612155|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44612156|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
44612157|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
44612158|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612159|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612160|NCT00658528|Esomeprazole|esomeprazole|mesh-list
44612161|NCT00658528|Rabeprazole|rabeprazole|mesh-list
44612162|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44612163|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44612164|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44612165|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612166|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612167|NCT00658359|Cyclosporine|cyclosporine|mesh-list
44612168|NCT00658359|Cyclosporins|cyclosporins|mesh-list
44612169|NCT00658359|Tofacitinib|tofacitinib|mesh-list
44612170|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612171|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612172|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612174|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612175|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
44612176|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612177|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612178|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612179|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44612180|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612181|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
44612182|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612183|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612184|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44612185|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
44612186|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44612187|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612188|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612189|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612190|NCT00658320|Cyclosporine|cyclosporine|mesh-list
44612191|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
44612192|NCT00658320|Everolimus|everolimus|mesh-list
44612193|NCT00658320|Cyclosporins|cyclosporins|mesh-list
44612194|NCT00658320|Basiliximab|basiliximab|mesh-list
44612195|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612196|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612197|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612198|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
44612199|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612200|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
44612201|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612202|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612203|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612204|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44612205|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612206|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612207|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44612208|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
44612209|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44612210|NCT00658021|Exenatide|exenatide|mesh-list
44612211|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44612212|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612213|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44612214|NCT00658021|Incretins|incretins|mesh-ancestor
44612215|NCT00658021|Hormones|hormones|mesh-ancestor
44612216|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612217|NCT00657709|Vaccines|vaccines|mesh-list
44612218|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44612219|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
44612220|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612221|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44612222|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44612223|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44612224|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612225|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
44612226|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44612227|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
44612228|NCT00657553|Bortezomib|bortezomib|mesh-list
44612229|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612230|NCT00657358|Lidocaine|lidocaine|mesh-list
44612231|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
44612232|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
44612233|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612234|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612235|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
44612236|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612237|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44612238|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44612239|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44612240|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612241|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612242|NCT00657267|Temozolomide|temozolomide|mesh-list
44612243|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612244|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
44612245|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612246|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612247|NCT00657150|Enoxaparin|enoxaparin|mesh-list
44612248|NCT00657150|Dabigatran|dabigatran|mesh-list
44612249|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
44612250|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44612251|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44612252|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612253|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
44612254|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44612255|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44612256|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612257|NCT00657046|Droxidopa|droxidopa|mesh-list
44612258|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44612259|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44612260|NCT00657020|Nicotine|nicotine|mesh-list
44612261|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44612262|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
44458337|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
44612263|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612264|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612265|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44612266|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44612267|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
44612268|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612269|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612271|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44612272|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612273|NCT00656799|Bromides|bromides|mesh-list
44612274|NCT00656799|Rocuronium|rocuronium|mesh-list
44612275|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
44612276|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44612277|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44612278|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44612279|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612280|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612281|NCT00656669|Paclitaxel|paclitaxel|mesh-list
44612282|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
44612283|NCT00656669|Doxorubicin|doxorubicin|mesh-list
44612284|NCT00656669|Sunitinib|sunitinib|mesh-list
44612285|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612286|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612287|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612288|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612289|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612290|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612291|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612292|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
44612293|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612294|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612295|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612296|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
44612297|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612298|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612299|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612300|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612301|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612302|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44612303|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44612304|NCT00656669|Growth Substances|growth substances|mesh-ancestor
44612305|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44612306|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612307|NCT00656617|Cytarabine|cytarabine|mesh-list
44612308|NCT00656617|Vorinostat|vorinostat|mesh-list
44612309|NCT00656617|Idarubicin|idarubicin|mesh-list
44612310|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612311|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
44612312|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612313|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612314|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
44612315|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612316|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612317|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
44612318|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612319|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44612320|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612321|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612322|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44009847|NCT02988986|Tamoxifen|tamoxifen|mesh-list
44612323|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612324|NCT00656513|Pilocarpine|pilocarpine|mesh-list
44612325|NCT00656513|Miotics|miotics|mesh-ancestor
44612326|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
44612327|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612328|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612329|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44612330|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44612331|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
44612332|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612333|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612334|NCT00656292|Simvastatin|simvastatin|mesh-list
44612335|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44612336|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44612337|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
44612338|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612339|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44612340|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44612341|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612342|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
44612343|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44612344|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44612345|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
44612346|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612347|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44612348|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44612349|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612350|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612351|NCT00656136|Afatinib|afatinib|mesh-list
44612352|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612353|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612354|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612355|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612356|NCT00656084|Gemcitabine|gemcitabine|mesh-list
44612357|NCT00656084|Rituximab|rituximab|mesh-list
44612358|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
44612359|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612360|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612361|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
44612362|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612363|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612364|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612365|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
44612366|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612367|NCT00656084|Antiviral Agents|antiviral agents|mesh-ancestor
44612368|NCT00656084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612369|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612370|NCT00656084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612371|NCT00656084|Analgesics|analgesics|mesh-ancestor
44612372|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
44612373|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612374|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612375|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612376|NCT00656058|Montelukast|montelukast|mesh-list
44612377|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44612378|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
44612379|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44612380|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
44612381|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612382|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612383|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44612384|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44612385|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612386|NCT00656019|Vitamin D|vitamin d|mesh-list
44612387|NCT00656019|Calcipotriene|calcipotriene|mesh-list
44612388|NCT00656019|Vitamins|vitamins|mesh-ancestor
44612389|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
44612390|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612391|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44612392|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612393|NCT00655980|Folic Acid|folic acid|mesh-list
44612394|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
44612395|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
44612396|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
44612397|NCT00655980|Vitamins|vitamins|mesh-ancestor
44612398|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
44612399|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612400|NCT00655980|Hematinics|hematinics|mesh-ancestor
44612401|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
44612402|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44612403|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
44612404|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
44612405|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612406|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612407|NCT00655980|Analgesics|analgesics|mesh-ancestor
44612408|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
44612409|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612410|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
44230524|NCT03539614|Prazosin|prazosin|mesh-list
44612411|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44612412|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
44612413|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612414|NCT00655928|Expectorants|expectorants|mesh-ancestor
44612415|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
44612416|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44612417|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
44612418|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612419|NCT00655928|Protective Agents|protective agents|mesh-ancestor
44612420|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612421|NCT00655928|Antidotes|antidotes|mesh-ancestor
44612422|NCT00655863|Pioglitazone|pioglitazone|mesh-list
44612423|NCT00655863|Alogliptin|alogliptin|mesh-list
44612424|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44612425|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612426|NCT00655863|Incretins|incretins|mesh-ancestor
44612427|NCT00655863|Hormones|hormones|mesh-ancestor
44612428|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612429|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44612430|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
44612431|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612432|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612433|NCT00655850|Gemcitabine|gemcitabine|mesh-list
44612434|NCT00655850|Paclitaxel|paclitaxel|mesh-list
44612435|NCT00655850|Bevacizumab|bevacizumab|mesh-list
44612436|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612437|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612438|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612439|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612440|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612441|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612442|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612443|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
44612444|NCT00655850|Antiviral Agents|antiviral agents|mesh-ancestor
44612445|NCT00655850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612446|NCT00655850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612447|NCT00655850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612448|NCT00655850|Immunologic Factors|immunologic factors|mesh-ancestor
44612449|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612450|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612451|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44612452|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44612453|NCT00655850|Growth Substances|growth substances|mesh-ancestor
44612454|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
44612455|NCT00655824|Ofatumumab|ofatumumab|mesh-list
44612456|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612457|NCT00655746|Dasatinib|dasatinib|mesh-list
44612458|NCT00655746|Omeprazole|omeprazole|mesh-list
44612459|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44612460|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44458348|NCT01595438|Renal Agents|renal agents|mesh-ancestor
44612461|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44612462|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612463|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612464|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612465|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612466|NCT00655668|Lenalidomide|lenalidomide|mesh-list
44612467|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
44612468|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612469|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44612470|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44612471|NCT00655668|Growth Substances|growth substances|mesh-ancestor
44612472|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
44612473|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612474|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44612475|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44612476|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44612477|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44612478|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612479|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612480|NCT00655629|Urological Agents|urological agents|mesh-ancestor
44612481|NCT00655564|Alefacept|alefacept|mesh-list
44612482|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612483|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
44612484|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612485|NCT00655551|Lacosamide|lacosamide|mesh-list
44612486|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
44612487|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44612488|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44612489|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612490|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612491|NCT00655499|Irinotecan|irinotecan|mesh-list
44612492|NCT00655499|Panitumumab|panitumumab|mesh-list
44612493|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44612494|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612495|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612496|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612497|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612498|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612499|NCT00655486|Lacosamide|lacosamide|mesh-list
44612500|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
44612501|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44612502|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44612503|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612504|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612505|NCT00654940|Pregabalin|pregabalin|mesh-list
44612506|NCT00654940|Analgesics|analgesics|mesh-ancestor
44612507|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
44612508|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612509|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612510|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
44612511|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44612512|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612513|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612514|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44612515|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44612516|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44612517|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612518|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44612519|NCT00654901|Vaccines|vaccines|mesh-list
44612520|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
44612521|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612522|NCT00654745|Amlodipine|amlodipine|mesh-list
44612523|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44612524|NCT00654745|Olmesartan|olmesartan|mesh-list
44612525|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44612526|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44612527|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44612528|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612529|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612530|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44612531|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612532|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
44612533|NCT00654745|Diuretics|diuretics|mesh-ancestor
44612534|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
44612535|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44612536|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44612537|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44612538|NCT00654732|Rituximab|rituximab|mesh-list
44612539|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44612540|NCT00654732|Doxorubicin|doxorubicin|mesh-list
44612541|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44612542|NCT00654732|Dacarbazine|dacarbazine|mesh-list
44612543|NCT00654732|Bleomycin|bleomycin|mesh-list
44612544|NCT00654732|Vinblastine|vinblastine|mesh-list
44612546|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
44612547|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44612548|NCT00654732|Imidazole|imidazole|mesh-list
44612549|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
44612550|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612551|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612552|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612553|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612554|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612555|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612556|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612557|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612558|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612559|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
44612560|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612561|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612562|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612563|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612564|NCT00654498|Pramipexole|pramipexole|mesh-list
44612565|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
44612566|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612567|NCT00654498|Protective Agents|protective agents|mesh-ancestor
44612568|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441709|NCT01896856|Irinotecan|irinotecan|mesh-list
44612569|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44612570|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44612571|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
44612572|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
44612573|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612574|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44612575|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612576|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612577|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612578|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612579|NCT00654381|Inositol|inositol|mesh-list
44612580|NCT00654381|Linagliptin|linagliptin|mesh-list
44612581|NCT00654381|Voglibose|voglibose|mesh-list
44612582|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44612583|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612584|NCT00654381|Incretins|incretins|mesh-ancestor
44612585|NCT00654381|Hormones|hormones|mesh-ancestor
44612586|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612587|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44612588|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44612589|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612590|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612591|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44612592|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
44612593|NCT00654381|Vitamins|vitamins|mesh-ancestor
44612594|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
44612595|NCT00654368|Etanercept|etanercept|mesh-list
44612596|NCT00654368|Methotrexate|methotrexate|mesh-list
44612597|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44612598|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
44612599|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44612600|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612601|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612602|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
44612603|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612604|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612605|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612606|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612607|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44612608|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612609|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
44612610|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612611|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44612612|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44612613|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612614|NCT00654368|Analgesics|analgesics|mesh-ancestor
44612615|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
44612616|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612617|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612618|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44612619|NCT00654355|Tacrolimus|tacrolimus|mesh-list
44612620|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612621|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
44612622|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612623|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44612624|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612625|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612626|NCT00654238|Sorafenib|sorafenib|mesh-list
44612627|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612628|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612629|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612630|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612631|NCT00654186|Lenalidomide|lenalidomide|mesh-list
44612632|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
44612633|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612634|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44612635|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44612636|NCT00654186|Growth Substances|growth substances|mesh-ancestor
44612637|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44612638|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612639|NCT00654095|Atorvastatin|atorvastatin|mesh-list
44612640|NCT00654095|Ezetimibe|ezetimibe|mesh-list
44612641|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44441784|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
44612642|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44612643|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
44612670|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612671|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44612672|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44612673|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612674|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
44612675|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44612676|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
44612677|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612678|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
44612679|NCT00653432|Protective Agents|protective agents|mesh-ancestor
44612680|NCT00653328|Doxorubicin|doxorubicin|mesh-list
44612681|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44612682|NCT00653328|Atrasentan|atrasentan|mesh-list
44612683|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612684|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612685|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612686|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612687|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612688|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612689|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44612690|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44612691|NCT00653224|Levocetirizine|levocetirizine|mesh-list
44612692|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44612693|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44612694|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
44612695|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
44612696|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612697|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612698|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612699|NCT00653159|Copper|copper|mesh-list
44612700|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
44612701|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44612702|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
44612703|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44612704|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612705|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44612706|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44612707|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44612708|NCT00653159|Trace Elements|trace elements|mesh-ancestor
44612709|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
44612710|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
44612711|NCT00653068|Leucovorin|leucovorin|mesh-list
44612712|NCT00653068|Folic Acid|folic acid|mesh-list
44612713|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
44612714|NCT00653068|Thiotepa|thiotepa|mesh-list
44612715|NCT00653068|Cisplatin|cisplatin|mesh-list
44612716|NCT00653068|Carboplatin|carboplatin|mesh-list
44612717|NCT00653068|Methotrexate|methotrexate|mesh-list
44612718|NCT00653068|Etoposide|etoposide|mesh-list
44612719|NCT00653068|Vincristine|vincristine|mesh-list
44612720|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
44612721|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
44230761|NCT01220583|Cisplatin|cisplatin|mesh-list
44612722|NCT00653068|Lenograstim|lenograstim|mesh-list
44612723|NCT00653068|Calcium|calcium|mesh-list
44612724|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
44612725|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612726|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
44612727|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612728|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612729|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612730|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
44612731|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612732|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612733|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612734|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44612735|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44612736|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44612737|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
44612738|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44612739|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612740|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
44612741|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612742|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612743|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44612744|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44612745|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612746|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612747|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612748|NCT00653068|Antidotes|antidotes|mesh-ancestor
44612749|NCT00653068|Protective Agents|protective agents|mesh-ancestor
44612750|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
44612751|NCT00653068|Vitamins|vitamins|mesh-ancestor
44612752|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
44612753|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44612754|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612755|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612756|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612757|NCT00653068|Hematinics|hematinics|mesh-ancestor
44612758|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
44612759|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44612760|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
44612761|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612762|NCT00652899|Aldesleukin|aldesleukin|mesh-list
44612763|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
44612764|NCT00652899|Fludarabine|fludarabine|mesh-list
44612765|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
44612766|NCT00652899|Interleukin-2|interleukin-2|mesh-list
44612767|NCT00652899|Allopurinol|allopurinol|mesh-list
44612768|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612769|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
44612770|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612771|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612772|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612773|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
44612774|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612775|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612776|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612777|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612778|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
44612779|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
44612780|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612781|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612782|NCT00652899|Analgesics|analgesics|mesh-ancestor
44612783|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
44612784|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612785|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44612786|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44612787|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612788|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
44612789|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44612790|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
44612791|NCT00652899|Protective Agents|protective agents|mesh-ancestor
44612792|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
44612793|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44010239|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
44612794|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612795|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44612796|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
44612797|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44612798|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612800|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612801|NCT00652626|Azacitidine|azacitidine|mesh-list
44612802|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612803|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
44612804|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612805|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612806|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612807|NCT00652366|Gemcitabine|gemcitabine|mesh-list
44612808|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44612809|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612810|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
44612811|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612812|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612813|NCT00652366|Antiviral Agents|antiviral agents|mesh-ancestor
44612814|NCT00652366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612815|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612816|NCT00652366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612817|NCT00652366|Immunologic Factors|immunologic factors|mesh-ancestor
44612818|NCT00652366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612819|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44441963|NCT01893281|Hormones|hormones|mesh-ancestor
44612820|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44612821|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612822|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612823|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612824|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612825|NCT00652327|Atorvastatin|atorvastatin|mesh-list
44612826|NCT00652327|Simvastatin|simvastatin|mesh-list
44612827|NCT00652327|Ezetimibe|ezetimibe|mesh-list
44612828|NCT00652327|Pravastatin|pravastatin|mesh-list
44612829|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44612830|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44612831|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44612832|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
44612833|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612834|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44612835|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612836|NCT00652093|Acetaminophen|acetaminophen|mesh-list
44612837|NCT00652093|Oxymorphone|oxymorphone|mesh-list
44612838|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
44612839|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
44612840|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
44612841|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612842|NCT00652093|Analgesics|analgesics|mesh-ancestor
44612843|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
44612844|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612845|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612846|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
44612847|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44612848|NCT00652093|Narcotics|narcotics|mesh-ancestor
44612849|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612850|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44612851|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
44612852|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
44612853|NCT00652028|Fentanyl|fentanyl|mesh-list
44612854|NCT00652028|Midazolam|midazolam|mesh-list
44612855|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
44612856|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44612857|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612858|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612859|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44612860|NCT00652028|Analgesics|analgesics|mesh-ancestor
44612861|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
44612862|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612863|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44612864|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44612865|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44612866|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010314|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
44612867|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612868|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612869|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44612870|NCT00652028|Narcotics|narcotics|mesh-ancestor
44612871|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44612872|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44612873|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
44612874|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
44612875|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44612876|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44612877|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44612878|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
44612879|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
44612880|NCT00651937|Melphalan|melphalan|mesh-list
44612881|NCT00651937|Lenograstim|lenograstim|mesh-list
44612882|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612883|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
44612884|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612885|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612886|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612887|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612888|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
44612889|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612890|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44612891|NCT00651755|Prednisone|prednisone|mesh-list
44612892|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
44612893|NCT00651755|Rituximab|rituximab|mesh-list
44612894|NCT00651755|Doxorubicin|doxorubicin|mesh-list
44612895|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44442031|NCT01891864|Analgesics|analgesics|mesh-ancestor
44612896|NCT00651755|Vincristine|vincristine|mesh-list
44612897|NCT00651755|Ondansetron|ondansetron|mesh-list
44612898|NCT00651755|Aprepitant|aprepitant|mesh-list
44612899|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612900|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
44612901|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612902|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44612903|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44612904|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
44612905|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612906|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612907|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44612908|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44612909|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612910|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612911|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612912|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612913|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612914|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
44612915|NCT00651755|Hormones|hormones|mesh-ancestor
44612916|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612917|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44612918|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44612919|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
44612920|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
44612921|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
44612922|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
44612923|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
44612924|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612925|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44612926|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
44612927|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44612928|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44612929|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
44612930|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612931|NCT00651755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44612932|NCT00651755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44612933|NCT00651755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612934|NCT00651755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44612935|NCT00651755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44612936|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44612937|NCT00651313|Lidocaine|lidocaine|mesh-list
44612938|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
44612939|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
44612940|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44612941|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612942|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
44612943|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612944|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44612945|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44612946|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44612947|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44612948|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612949|NCT00651261|Cytarabine|cytarabine|mesh-list
44612950|NCT00651261|Dexamethasone|dexamethasone|mesh-list
44612951|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
44612952|NCT00651261|Daunorubicin|daunorubicin|mesh-list
44612953|NCT00651261|Midostaurin|midostaurin|mesh-list
44612954|NCT00651261|BB 1101|bb 1101|mesh-list
44612955|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612956|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
44612957|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
44612958|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612959|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612960|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44612961|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
44612962|NCT00651261|Hormones|hormones|mesh-ancestor
44612963|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44612964|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44612965|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44612966|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44612967|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
44612968|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612969|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
44612970|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44612971|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44612972|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
44612973|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44612974|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44612975|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44612976|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44612977|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44612978|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
44612979|NCT00651183|Pramipexole|pramipexole|mesh-list
44612980|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
44612981|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44612982|NCT00651183|Protective Agents|protective agents|mesh-ancestor
44612983|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612984|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44612985|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44612986|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
44612987|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
44230950|NCT00532623|Gemcitabine|gemcitabine|mesh-list
44612988|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44612989|NCT00651118|Fluticasone|fluticasone|mesh-list
44612991|NCT00651118|Azelastine|azelastine|mesh-list
44612992|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44612993|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44612994|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
44612995|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44612996|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44612997|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44612998|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44612999|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44613000|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44613001|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44613002|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613003|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613004|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44613005|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44613006|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
44613007|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
44613008|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613009|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44613010|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
44613011|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
44235650|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613012|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613014|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44613015|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613016|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613017|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613018|NCT00650104|Ropinirole|ropinirole|mesh-list
44613019|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44613020|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613021|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
44613022|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
44613023|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613024|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613025|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613026|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
44230992|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
44613027|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44613028|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
44613029|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613030|NCT00650091|Expectorants|expectorants|mesh-ancestor
44613031|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
44613032|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44613033|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
44613034|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613035|NCT00650091|Protective Agents|protective agents|mesh-ancestor
44613036|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613037|NCT00650091|Antidotes|antidotes|mesh-ancestor
44613039|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44613040|NCT00649389|Olmesartan|olmesartan|mesh-list
44613041|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44613042|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44613043|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44613044|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613045|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613046|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44613047|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613048|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
44613049|NCT00649389|Diuretics|diuretics|mesh-ancestor
44613050|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
44613051|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44613052|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44613053|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44613054|NCT00649220|Memantine|memantine|mesh-list
44613055|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44613056|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613057|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
44613058|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613059|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613060|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613061|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44613062|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44613063|NCT00648895|Metoprolol|metoprolol|mesh-list
44613064|NCT00648895|Nebivolol|nebivolol|mesh-list
44613065|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44613066|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44613067|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
44613068|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
44613069|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613070|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613071|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44613072|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44613073|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44613074|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
44613075|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613076|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613077|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
44613078|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44613079|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44613080|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44613081|NCT00648037|Rituximab|rituximab|mesh-list
44613082|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613083|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613084|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
44010543|NCT03036163|Macozinone|macozinone|mesh-list
44613085|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613086|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613087|NCT00647699|Riboflavin|riboflavin|mesh-list
44613088|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44613089|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44613090|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
44613091|NCT00647699|Vitamins|vitamins|mesh-ancestor
44613092|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
44613093|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613094|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44613095|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44613096|NCT00647556|Adapalene|adapalene|mesh-list
44613097|NCT00647556|Tretinoin|tretinoin|mesh-list
44613098|NCT00647556|Emollients|emollients|mesh-list
44613099|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44613100|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613101|NCT00647556|Analgesics|analgesics|mesh-ancestor
44613102|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
44231073|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
44613103|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613104|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613105|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613106|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613107|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44613108|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613109|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
44613110|NCT00647426|Carboplatin|carboplatin|mesh-list
44613111|NCT00647426|Docetaxel|docetaxel|mesh-list
44613112|NCT00647426|Sorafenib|sorafenib|mesh-list
44613113|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613114|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
44613115|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
44613116|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
44613117|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613118|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44613119|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613121|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44613122|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44613123|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
44613124|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613125|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44613126|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44613127|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613128|NCT00647296|Pramipexole|pramipexole|mesh-list
44613129|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
44613130|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613131|NCT00647296|Protective Agents|protective agents|mesh-ancestor
44613132|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613133|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44613134|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613135|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
44613136|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
44613137|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613138|NCT00647270|Adalimumab|adalimumab|mesh-list
44613139|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613140|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613141|NCT00646958|Linezolid|linezolid|mesh-list
44613142|NCT00646958|Radezolid|radezolid|mesh-list
44613143|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
44613144|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613145|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613146|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44613147|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613148|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613149|NCT00646906|Aspirin|aspirin|mesh-list
44613150|NCT00646906|Acetaminophen|acetaminophen|mesh-list
44613151|NCT00646906|Ibuprofen|ibuprofen|mesh-list
44613152|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44613153|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613154|NCT00646906|Analgesics|analgesics|mesh-ancestor
44613155|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
44613156|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613157|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613158|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613159|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613160|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44613161|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44613162|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613163|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44613164|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44613165|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613166|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
44613168|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44613169|NCT00646776|Rifabutin|rifabutin|mesh-list
44613170|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44613171|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44613172|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613173|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613174|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613175|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44613176|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44613177|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
44613178|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613179|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44613180|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44613181|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613182|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44613183|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
44613184|NCT00646451|Pregabalin|pregabalin|mesh-list
44613185|NCT00646451|Analgesics|analgesics|mesh-ancestor
44613186|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
44613187|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613188|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442334|NCT01885182|Narcotics|narcotics|mesh-ancestor
44613190|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44613191|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613192|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613193|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44613194|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44613195|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613196|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613197|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613198|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44613199|NCT00646282|Vitamins|vitamins|mesh-ancestor
44613200|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
44613201|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613202|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44613203|NCT00645944|Eszopiclone|eszopiclone|mesh-list
44613204|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44613205|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613206|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613207|NCT00645853|Warfarin|warfarin|mesh-list
44613208|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
44613209|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44613210|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613211|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
44613212|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613213|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613214|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44613215|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44613216|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613217|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613218|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613219|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44613220|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44613221|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44613222|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44613223|NCT00645593|Gemcitabine|gemcitabine|mesh-list
44613224|NCT00645593|Cisplatin|cisplatin|mesh-list
44613225|NCT00645593|Cetuximab|cetuximab|mesh-list
44613226|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613227|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44613228|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
44231189|NCT00533455|Gabapentin|gabapentin|mesh-list
44613229|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613230|NCT00645593|Antiviral Agents|antiviral agents|mesh-ancestor
44613231|NCT00645593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613232|NCT00645593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613233|NCT00645593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44613234|NCT00645593|Immunologic Factors|immunologic factors|mesh-ancestor
44613235|NCT00645593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613236|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613237|NCT00645528|Insulin|insulin|mesh-list
44613249|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613250|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44613251|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613252|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613253|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613254|NCT00645099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613255|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613256|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613257|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613258|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613259|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
44613260|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44613261|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44613262|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44613263|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44613264|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
44613265|NCT00644969|Varenicline|varenicline|mesh-list
44613266|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44613267|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44613268|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
44613269|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613270|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613271|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613272|NCT00644787|Fentanyl|fentanyl|mesh-list
44613273|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44613274|NCT00644787|Narcotics|narcotics|mesh-ancestor
44613275|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613276|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613277|NCT00644787|Analgesics|analgesics|mesh-ancestor
44613278|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
44613279|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613280|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44613281|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44613282|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
44613283|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
44613284|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44613285|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613286|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613287|NCT00644358|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613288|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613289|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613290|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613291|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613292|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
44613293|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231242|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
44613294|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44613295|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44613296|NCT00644332|Ranolazine|ranolazine|mesh-list
44613297|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44613298|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613299|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613326|NCT00644059|Vaccines|vaccines|mesh-list
44613327|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
44613328|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613329|NCT00643851|Metformin|metformin|mesh-list
44613330|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
44613331|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613332|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613333|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44613334|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613335|NCT00643760|Pregabalin|pregabalin|mesh-list
44613336|NCT00643760|Gabapentin|gabapentin|mesh-list
44613337|NCT00643760|Analgesics|analgesics|mesh-ancestor
44613338|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
44613339|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613340|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613341|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
44613342|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44613343|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613344|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613345|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44613346|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44613347|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613348|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613349|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613350|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44613351|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44613352|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613353|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
44613354|NCT00643604|Treprostinil|treprostinil|mesh-list
44613355|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44613356|NCT00643565|Bevacizumab|bevacizumab|mesh-list
44613357|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613358|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613359|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613360|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613361|NCT00643565|Growth Substances|growth substances|mesh-ancestor
44613362|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613363|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
44613364|NCT00643201|Enoxaparin|enoxaparin|mesh-list
44613365|NCT00643201|Warfarin|warfarin|mesh-list
44613366|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
44613367|NCT00643201|Apixaban|apixaban|mesh-list
44613368|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
44613369|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44613370|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44613371|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613372|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44613373|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
44613374|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44613375|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613376|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613377|NCT00643162|Citalopram|citalopram|mesh-list
44613378|NCT00643162|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613379|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613380|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613381|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613382|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613383|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
44613384|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771946|NCT02369822|Antioxidants|antioxidants|mesh-ancestor
44613386|NCT00643162|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613387|NCT00643162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613388|NCT00643123|Allopurinol|allopurinol|mesh-list
44613389|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
44613390|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613391|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613392|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
44613393|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613394|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44613395|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
44613396|NCT00643123|Protective Agents|protective agents|mesh-ancestor
44613397|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613398|NCT00642954|Dexamethasone|dexamethasone|mesh-list
44613399|NCT00642954|Lenalidomide|lenalidomide|mesh-list
44613400|NCT00642954|Vorinostat|vorinostat|mesh-list
44613401|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613402|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
44613403|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
44613404|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613405|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613406|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613407|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
44613408|NCT00642954|Hormones|hormones|mesh-ancestor
44613409|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442562|NCT01880528|Lisinopril|lisinopril|mesh-list
44613410|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613411|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613412|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
44231376|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
44613413|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613414|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613415|NCT00642954|Growth Substances|growth substances|mesh-ancestor
44613416|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
44613417|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44613418|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613419|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613420|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
44613421|NCT00642850|Hematinics|hematinics|mesh-ancestor
44613422|NCT00642811|Aspirin|aspirin|mesh-list
44613423|NCT00642811|Clopidogrel|clopidogrel|mesh-list
44613424|NCT00642811|Ticagrelor|ticagrelor|mesh-list
44613425|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44613426|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613427|NCT00642811|Analgesics|analgesics|mesh-ancestor
44613428|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
44613429|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613430|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613431|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613432|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613433|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44613434|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44613435|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613436|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44613437|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44613438|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613439|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
44613440|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44613441|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44613442|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44613443|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
44613444|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613445|NCT00642759|Paclitaxel|paclitaxel|mesh-list
44613446|NCT00642759|Bevacizumab|bevacizumab|mesh-list
44613447|NCT00642759|Carboplatin|carboplatin|mesh-list
44613448|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44613449|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613450|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
44613451|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
44613452|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
44613453|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613454|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613455|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613456|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613457|NCT00642759|Growth Substances|growth substances|mesh-ancestor
44613458|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613459|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
44613460|NCT00642746|Leucovorin|leucovorin|mesh-list
44613461|NCT00642746|Fluorouracil|fluorouracil|mesh-list
44613462|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
44613463|NCT00642746|Irinotecan|irinotecan|mesh-list
44613464|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44613465|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
44613466|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613467|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44613468|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613469|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44613470|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
44613471|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613472|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44613473|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44613474|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613475|NCT00642746|Antidotes|antidotes|mesh-ancestor
44613476|NCT00642746|Protective Agents|protective agents|mesh-ancestor
44613477|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
44613478|NCT00642746|Vitamins|vitamins|mesh-ancestor
44613479|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
44613480|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44613481|NCT00642707|Leronlimab|leronlimab|mesh-list
44613482|NCT00642707|Antibodies|antibodies|mesh-list
44613483|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44613484|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
44613485|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613486|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44613487|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44613488|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613489|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44613490|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44613491|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
44613492|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613493|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
44613494|NCT00642668|Hematinics|hematinics|mesh-ancestor
44613495|NCT00642616|Insulin|insulin|mesh-list
44613496|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613497|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613498|NCT00642473|Metronidazole|metronidazole|mesh-list
44613499|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44613500|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613501|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44613502|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613503|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613504|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613505|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613506|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44613507|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44613508|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44613509|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44613510|NCT00642460|Methotrexate|methotrexate|mesh-list
44613511|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44613512|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
44613513|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44613514|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613515|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44613516|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
44613517|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613518|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613519|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44613520|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613521|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44613522|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44613523|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
44613524|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613525|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44613526|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613527|NCT00642460|Analgesics|analgesics|mesh-ancestor
44613528|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
44613529|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613530|NCT00642369|Haloperidol|haloperidol|mesh-list
44613531|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44613532|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
44613533|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613534|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613535|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44613536|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613537|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613538|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613539|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
44613540|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
44613541|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613542|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613543|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44613544|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
44613545|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613546|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613547|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613548|NCT00642356|Levodopa|levodopa|mesh-list
44613549|NCT00642356|Carbidopa|carbidopa|mesh-list
44613550|NCT00642356|Entacapone|entacapone|mesh-list
44613551|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44613552|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44613553|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613554|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
44613555|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613556|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613557|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613558|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44613559|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613560|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44613561|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44613562|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
44613563|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
44613564|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
44613565|NCT00642304|Hematinics|hematinics|mesh-ancestor
44613566|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44613567|NCT00642278|Canagliflozin|canagliflozin|mesh-list
44613568|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613569|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613570|NCT00642278|Incretins|incretins|mesh-ancestor
44613571|NCT00642278|Hormones|hormones|mesh-ancestor
44613572|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613573|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44613574|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613575|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613576|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613577|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44613578|NCT00642174|Clopidogrel|clopidogrel|mesh-list
44613579|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44613580|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44613581|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44613582|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44613583|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44613584|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
44613585|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613586|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613587|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613588|NCT00642018|Prednisone|prednisone|mesh-list
44613589|NCT00642018|Docetaxel|docetaxel|mesh-list
44231448|NCT00534573|Amisulpride|amisulpride|mesh-list
44613590|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613591|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44613592|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44613593|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44613594|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613595|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613596|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
44613597|NCT00642018|Hormones|hormones|mesh-ancestor
44613598|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613599|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613600|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613601|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44613602|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44613603|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613604|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613605|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613606|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613607|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613608|NCT00641719|Analgesics|analgesics|mesh-ancestor
44613609|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
44613610|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613611|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613612|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613613|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
44613614|NCT00641706|Bortezomib|bortezomib|mesh-list
44613615|NCT00641706|Vorinostat|vorinostat|mesh-list
44613616|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613617|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44613618|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613619|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613620|NCT00641667|Fentanyl|fentanyl|mesh-list
44613621|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44613622|NCT00641667|Narcotics|narcotics|mesh-ancestor
44613623|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613624|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613625|NCT00641667|Analgesics|analgesics|mesh-ancestor
44613626|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
44613627|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613628|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44231507|NCT00534651|Acetaminophen|acetaminophen|mesh-list
44613629|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44613630|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
44613631|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
44613632|NCT00641537|Cladribine|cladribine|mesh-list
44613633|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613634|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44613635|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
44613636|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613637|NCT00641147|Curcumin|curcumin|mesh-list
44613638|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44613639|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44613640|NCT00641147|Analgesics|analgesics|mesh-ancestor
44613641|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
44613642|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613643|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613644|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613645|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613646|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613647|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613648|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613649|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
44613650|NCT00641056|Exenatide|exenatide|mesh-list
44613651|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613652|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613653|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44613654|NCT00641056|Incretins|incretins|mesh-ancestor
44613655|NCT00641056|Hormones|hormones|mesh-ancestor
44613656|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613657|NCT00641043|Pioglitazone|pioglitazone|mesh-list
44613658|NCT00641043|Linagliptin|linagliptin|mesh-list
44613659|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613660|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613661|NCT00641043|Incretins|incretins|mesh-ancestor
44613662|NCT00641043|Hormones|hormones|mesh-ancestor
44613663|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613664|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44613665|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613666|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613667|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613668|NCT00640926|Radezolid|radezolid|mesh-list
44613669|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
44613670|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613671|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613672|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44613673|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231548|NCT00534898|Bexarotene|bexarotene|mesh-list
44613674|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613675|NCT00640835|Buprenorphine|buprenorphine|mesh-list
44613676|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44613677|NCT00640835|Naloxone|naloxone|mesh-list
44613678|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44613679|NCT00640835|Narcotics|narcotics|mesh-ancestor
44613680|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613681|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613682|NCT00640835|Analgesics|analgesics|mesh-ancestor
44613683|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
44613684|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613685|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44613686|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44613687|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613688|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613689|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44613690|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613691|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613692|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613693|NCT00640562|Risperidone|risperidone|mesh-list
44613694|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44613695|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44613696|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
44613697|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613698|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613699|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613700|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44613701|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613702|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613703|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613704|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44613705|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
44613706|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613707|NCT00640510|Olanzapine|olanzapine|mesh-list
44613708|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
44613709|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
44613710|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613711|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613712|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613713|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44613714|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613738|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
44613739|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613740|NCT00640315|Riociguat|riociguat|mesh-list
44613741|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
44613742|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613743|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
44613744|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44613745|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44613746|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613747|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
44613748|NCT00640224|Drospirenone|drospirenone|mesh-list
44613749|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44613750|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44613751|NCT00640224|Estradiol|estradiol|mesh-list
44613752|NCT00640224|Estrogens|estrogens|mesh-ancestor
44613753|NCT00640224|Hormones|hormones|mesh-ancestor
44613754|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613755|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613756|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44613757|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
44613758|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44613759|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44613760|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613761|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44613762|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44613763|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44613764|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
44613765|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44613766|NCT00640224|Diuretics|diuretics|mesh-ancestor
44613767|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
44613768|NCT00640146|Bromides|bromides|mesh-list
44613769|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
44613770|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
44613771|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44613772|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613773|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
44613774|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613775|NCT00640042|Morphine|morphine|mesh-list
44613776|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44613777|NCT00640042|Narcotics|narcotics|mesh-ancestor
44613778|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235661|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
44613779|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613780|NCT00640042|Analgesics|analgesics|mesh-ancestor
44613781|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
44613782|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613783|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44613784|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
44613785|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613786|NCT00638690|Prednisone|prednisone|mesh-list
44613787|NCT00638690|Prednisolone|prednisolone|mesh-list
44613788|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
44613789|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613790|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
44613791|NCT00638690|Hormones|hormones|mesh-ancestor
44613792|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613793|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613794|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613795|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613796|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44613797|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613798|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613799|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44613800|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44613801|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
44613802|NCT00638443|Promethazine|promethazine|mesh-list
44613803|NCT00638443|Pregabalin|pregabalin|mesh-list
44613804|NCT00638443|Analgesics|analgesics|mesh-ancestor
44613805|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
44613806|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613807|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613808|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
44613809|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44613810|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613811|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613812|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44613813|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44613814|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613815|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613816|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613817|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44613818|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44613819|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
44613821|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
44613822|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
44613823|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613824|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44613825|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
44613826|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
44613827|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613828|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44613829|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
44613830|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44613831|NCT00636168|Ipilimumab|ipilimumab|mesh-list
44613832|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613833|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613834|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44613835|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613836|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
44613837|NCT00635570|NuvaRing|nuvaring|mesh-list
44613838|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44613839|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44613840|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
44613841|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44613842|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613843|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44613844|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44613845|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44613846|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44613847|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44613848|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44613849|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44613850|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613851|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613852|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613853|NCT00635492|Insulin|insulin|mesh-list
44613854|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44613855|NCT00635492|Exenatide|exenatide|mesh-list
44613856|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44613857|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613858|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44613859|NCT00635492|Incretins|incretins|mesh-ancestor
44613860|NCT00635492|Hormones|hormones|mesh-ancestor
44613861|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613862|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44613863|NCT00635219|Vortioxetine|vortioxetine|mesh-list
44613864|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44613865|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44613866|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613867|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613868|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44613869|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613870|NCT00635219|Analgesics|analgesics|mesh-ancestor
44613871|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
44613872|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613873|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
44613874|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613875|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
44613876|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44613877|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613878|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613879|NCT00635219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44613880|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
44613881|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44613882|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44613883|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44613884|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44613885|NCT00635154|Dexamethasone|dexamethasone|mesh-list
44613886|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
44613887|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44613888|NCT00635154|BB 1101|bb 1101|mesh-list
44613889|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613890|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
44613891|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
44613892|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613893|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613894|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613895|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
44613896|NCT00635154|Hormones|hormones|mesh-ancestor
44613897|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613898|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613899|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613900|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613901|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613902|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613903|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613904|NCT00634933|Prednisone|prednisone|mesh-list
44613905|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
44613906|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44613907|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44613908|NCT00634933|Prednisolone|prednisolone|mesh-list
44613909|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
44613910|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44613911|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
44613912|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613913|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
44613914|NCT00634933|Hormones|hormones|mesh-ancestor
44613915|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613916|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613917|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44231750|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
44613918|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613919|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
44613920|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
44613921|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613922|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44613923|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44613924|NCT00634933|Protective Agents|protective agents|mesh-ancestor
44613925|NCT00634647|Prednisone|prednisone|mesh-list
44613926|NCT00634647|Satraplatin|satraplatin|mesh-list
44613927|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44613928|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
44613929|NCT00634647|Hormones|hormones|mesh-ancestor
44613930|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44613931|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613932|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44613933|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613934|NCT00633893|Apixaban|apixaban|mesh-list
44613935|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44613936|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
44613937|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44613938|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613939|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613940|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613941|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
44613942|NCT00633880|Droxidopa|droxidopa|mesh-list
44613943|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44613944|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44613945|NCT00633594|Rituximab|rituximab|mesh-list
44613946|NCT00633594|Lenalidomide|lenalidomide|mesh-list
44613947|NCT00633594|Bortezomib|bortezomib|mesh-list
44613948|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613949|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613950|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
44613951|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613952|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44613953|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613954|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613955|NCT00633594|Growth Substances|growth substances|mesh-ancestor
44613956|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44613957|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
44613958|NCT00632125|Hematinics|hematinics|mesh-ancestor
44613959|NCT00631917|Ramipril|ramipril|mesh-list
44613960|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44613961|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
44613962|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613963|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613964|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44613965|NCT00631696|Pregabalin|pregabalin|mesh-list
44613966|NCT00631696|Analgesics|analgesics|mesh-ancestor
44613967|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
44613968|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44613969|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613970|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
44613971|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44613972|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44613973|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613974|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44613975|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44613976|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44613977|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44613978|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44613979|NCT00631410|Sunitinib|sunitinib|mesh-list
44613980|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613981|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613982|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613983|NCT00631410|Growth Substances|growth substances|mesh-ancestor
44613984|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613985|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44613986|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44613987|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44613988|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44613990|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
44613991|NCT00631371|Sirolimus|sirolimus|mesh-list
44613992|NCT00631371|Bevacizumab|bevacizumab|mesh-list
44613993|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44613994|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44613995|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44613996|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44613997|NCT00631371|Growth Substances|growth substances|mesh-ancestor
44613998|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44613999|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614000|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
44614001|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614002|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
44614004|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44614005|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
44614006|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614007|NCT00630812|Mannitol|mannitol|mesh-list
44614008|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44614009|NCT00630812|Diuretics|diuretics|mesh-ancestor
44614010|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
44614011|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614012|NCT00629798|Fludarabine|fludarabine|mesh-list
44614013|NCT00629798|Melphalan|melphalan|mesh-list
44614014|NCT00629798|Busulfan|busulfan|mesh-list
44614015|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44614016|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614017|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614018|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614019|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
44614020|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614021|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44614022|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
44614023|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44614024|NCT00629772|Infliximab|infliximab|mesh-list
44614025|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44614026|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614027|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614028|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
44614029|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614030|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
44614031|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614032|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614033|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614034|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614035|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44614036|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44614037|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44614038|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
44614039|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614040|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614041|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44614042|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
44614043|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44614044|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614045|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614046|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614047|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
44614048|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614049|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614050|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44614051|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44614052|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44614053|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44614054|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443258|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
44614055|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614056|NCT00628355|Lidocaine|lidocaine|mesh-list
44614057|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
44614058|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
44614059|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614060|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614061|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
44614062|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614063|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44614064|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44614065|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44231879|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614066|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614067|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614068|NCT00628251|Doxorubicin|doxorubicin|mesh-list
44614069|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44614070|NCT00628251|Olaparib|olaparib|mesh-list
44614071|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44614072|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614073|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44614074|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235664|NCT00555542|Rituximab|rituximab|mesh-list
44614075|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614076|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614077|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44614078|NCT00628108|Levocetirizine|levocetirizine|mesh-list
44614079|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44614080|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44614081|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
44614082|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
44614083|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614084|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614085|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614086|NCT00627926|Interferons|interferons|mesh-list
44614087|NCT00627926|Ribavirin|ribavirin|mesh-list
44614088|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
44614089|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
44614090|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44614091|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614092|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
44614093|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614094|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
44614095|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614096|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
44614097|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614098|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
44614099|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44614100|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
44614101|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614102|NCT00627705|Expectorants|expectorants|mesh-ancestor
44614103|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614104|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44614105|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
44614106|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614107|NCT00627705|Protective Agents|protective agents|mesh-ancestor
44614108|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614109|NCT00627705|Antidotes|antidotes|mesh-ancestor
44614110|NCT00627458|Vaccines|vaccines|mesh-list
44614111|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
44614112|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614113|NCT00627445|Insulin|insulin|mesh-list
44614114|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44614115|NCT00627445|Metformin|metformin|mesh-list
44614116|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
44614117|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
44614118|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44614119|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
44614120|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44614121|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614122|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614123|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
44614124|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44614125|NCT00627393|Dexamethasone|dexamethasone|mesh-list
44614126|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614127|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
44443333|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44614128|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
44614146|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44614147|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614148|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614149|NCT00626925|Topiramate|topiramate|mesh-list
44614150|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
44614151|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614152|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614153|NCT00626795|Mupirocin|mupirocin|mesh-list
44614154|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614155|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614156|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44614157|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614158|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614159|NCT00626639|Cisplatin|cisplatin|mesh-list
44614160|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614161|NCT00626561|Paclitaxel|paclitaxel|mesh-list
44614162|NCT00626561|Bevacizumab|bevacizumab|mesh-list
44614163|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44614164|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614165|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
44614166|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44614167|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44614168|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614169|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614170|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614171|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614172|NCT00626561|Growth Substances|growth substances|mesh-ancestor
44614173|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614174|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614176|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
44614177|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614178|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
44614179|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614180|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614181|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614182|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614183|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44614184|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44614185|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44614186|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
44614188|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614189|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
44614191|NCT00626405|Bevacizumab|bevacizumab|mesh-list
44614192|NCT00626405|Carboplatin|carboplatin|mesh-list
44614193|NCT00626405|Temozolomide|temozolomide|mesh-list
44614194|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44614195|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44614196|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614197|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44614198|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44614199|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44614200|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614201|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614202|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614203|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614204|NCT00626405|Growth Substances|growth substances|mesh-ancestor
44614205|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614206|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614207|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44614208|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
44614209|NCT00626392|Aspirin|aspirin|mesh-list
44614210|NCT00626392|Niacin|niacin|mesh-list
44614211|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44614212|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614213|NCT00626392|Analgesics|analgesics|mesh-ancestor
44614214|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
44614215|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614216|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614217|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614218|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614219|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44614220|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44614221|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614222|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44614223|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44614224|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614225|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
44614226|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44614227|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
44614228|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44614229|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44614230|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
44614231|NCT00626392|Vitamins|vitamins|mesh-ancestor
44614232|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
44614233|NCT00626275|Naproxen|naproxen|mesh-list
44614234|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44614235|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614236|NCT00626275|Analgesics|analgesics|mesh-ancestor
44614237|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
44614238|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614239|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614240|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614241|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614242|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
44614243|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44614244|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614245|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614246|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
44614247|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
44614248|NCT00626197|Azathioprine|azathioprine|mesh-list
44614249|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
44614250|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614251|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
44614252|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614253|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614254|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44614255|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
44614256|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614257|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614258|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44614259|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44614260|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44614261|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
44614262|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614263|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614264|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614265|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
44614266|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614267|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
44614268|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614269|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
44614270|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614271|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614272|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614273|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614274|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44614275|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
44614276|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614277|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614278|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44614279|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
44614280|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
44614281|NCT00626028|Protective Agents|protective agents|mesh-ancestor
44614282|NCT00625820|Ascorbic Acid|ascorbic acid|mesh-list
44614283|NCT00625820|Vitamins|vitamins|mesh-ancestor
44614284|NCT00625820|Micronutrients|micronutrients|mesh-ancestor
44614285|NCT00625820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614286|NCT00625820|Antioxidants|antioxidants|mesh-ancestor
44614287|NCT00625820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614288|NCT00625820|Protective Agents|protective agents|mesh-ancestor
44614289|NCT00625742|Ibuprofen|ibuprofen|mesh-list
44614290|NCT00625742|Atenolol|atenolol|mesh-list
44614291|NCT00625742|Melatonin|melatonin|mesh-list
44614292|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44614293|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614294|NCT00625742|Analgesics|analgesics|mesh-ancestor
44614295|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
44614296|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614297|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614298|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614299|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614300|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44614301|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614302|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614303|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
44614304|NCT00625742|Protective Agents|protective agents|mesh-ancestor
44614305|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614306|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44614307|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44614308|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
44614309|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
44232114|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44614310|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44614311|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44614312|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44614313|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011580|NCT03115801|Atezolizumab|atezolizumab|mesh-list
44614314|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614315|NCT00625586|Gemcitabine|gemcitabine|mesh-list
44614316|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614317|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
44614318|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614319|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614320|NCT00625586|Antiviral Agents|antiviral agents|mesh-ancestor
44614321|NCT00625586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614322|NCT00625586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614323|NCT00625586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614324|NCT00625586|Immunologic Factors|immunologic factors|mesh-ancestor
44614325|NCT00625586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614326|NCT00625378|Sorafenib|sorafenib|mesh-list
44614327|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614328|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44614329|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614330|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614331|NCT00625183|Selenium|selenium|mesh-list
44614332|NCT00625183|Capecitabine|capecitabine|mesh-list
44614333|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
44614334|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614335|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
44614336|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614337|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614339|NCT00625183|Protective Agents|protective agents|mesh-ancestor
44614340|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614341|NCT00625183|Trace Elements|trace elements|mesh-ancestor
44614342|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
44614343|NCT00625131|Bupropion|bupropion|mesh-list
44614344|NCT00625131|Nicotine|nicotine|mesh-list
44614345|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44614346|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
44614347|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614348|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614349|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44614350|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44614351|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
44614352|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614353|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614354|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44614355|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
44614356|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614357|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44614358|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44614359|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614360|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
44614361|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44614362|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44614363|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614364|NCT00624832|Omalizumab|omalizumab|mesh-list
44614365|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44614366|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614367|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614368|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44614369|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
44614370|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614371|NCT00624780|Pregabalin|pregabalin|mesh-list
44614372|NCT00624780|Lorazepam|lorazepam|mesh-list
44614373|NCT00624780|Analgesics|analgesics|mesh-ancestor
44614374|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
44614375|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614376|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614377|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
44614378|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44614379|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614380|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614381|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614382|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44614383|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44614384|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614385|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614386|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
44614387|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
44614388|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614389|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44614390|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
44614391|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
44614392|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614393|NCT00624585|Dasatinib|dasatinib|mesh-list
44614394|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614395|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44614396|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614397|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614398|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
44614399|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614400|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
44614401|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614402|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614403|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614404|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614405|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
44614406|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44614407|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44614408|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614409|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614410|NCT00624065|Carvedilol|carvedilol|mesh-list
44614411|NCT00624065|Lisinopril|lisinopril|mesh-list
44614412|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44614413|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44614414|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44614415|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614416|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614417|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614418|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44614419|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
44614420|NCT00624065|Protective Agents|protective agents|mesh-ancestor
44614421|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44614422|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614423|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614424|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44614425|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44614426|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44614427|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44614428|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614429|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614430|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44614431|NCT00624052|Amlodipine|amlodipine|mesh-list
44614432|NCT00624052|Telmisartan|telmisartan|mesh-list
44614433|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44614434|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44614435|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614436|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614437|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614438|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614439|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
44614440|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44614441|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44614442|NCT00623935|Fludarabine|fludarabine|mesh-list
44614443|NCT00623935|Busulfan|busulfan|mesh-list
44614444|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614445|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614446|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614447|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
44614448|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614449|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
44614450|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44614451|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44614452|NCT00623805|Bevacizumab|bevacizumab|mesh-list
44614453|NCT00623805|Capecitabine|capecitabine|mesh-list
44614454|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
44614455|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614456|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614457|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614458|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614459|NCT00623805|Growth Substances|growth substances|mesh-ancestor
44614460|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614461|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614462|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614463|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
44614464|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614465|NCT00623779|Aspirin|aspirin|mesh-list
44614466|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44614467|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614468|NCT00623779|Analgesics|analgesics|mesh-ancestor
44614469|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
44614470|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614471|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614472|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614473|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614474|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44614475|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44614476|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614477|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44614478|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44614479|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614480|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
44614481|NCT00623766|Dexamethasone|dexamethasone|mesh-list
44614482|NCT00623766|Prednisone|prednisone|mesh-list
44614483|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
44614484|NCT00623766|Prednisolone|prednisolone|mesh-list
44443691|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
44614485|NCT00623766|Triamcinolone|triamcinolone|mesh-list
44614486|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
44614487|NCT00623766|Betamethasone|betamethasone|mesh-list
44614488|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
44614490|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614491|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
44614492|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
44614493|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614494|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614495|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614496|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
44614497|NCT00623766|Hormones|hormones|mesh-ancestor
44614498|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614499|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44614500|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614501|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614502|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44614503|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614504|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44614505|NCT00623766|Protective Agents|protective agents|mesh-ancestor
44614506|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614507|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614508|NCT00623727|Factor VIII|factor viii|mesh-list
44614509|NCT00623727|Coagulants|coagulants|mesh-ancestor
44614510|NCT00623623|Enoxaparin|enoxaparin|mesh-list
44614511|NCT00623623|Tenecteplase|tenecteplase|mesh-list
44614512|NCT00623623|Clopidogrel|clopidogrel|mesh-list
44614513|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44614514|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44614515|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44614516|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44614517|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
44614518|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614519|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614520|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614521|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
44614522|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44614523|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44614524|NCT00623597|Ritonavir|ritonavir|mesh-list
44614525|NCT00623597|Saquinavir|saquinavir|mesh-list
44614526|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44614527|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44614528|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614529|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614530|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614531|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44614532|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44614533|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
44614534|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614535|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44614536|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44614537|NCT00623545|Exenatide|exenatide|mesh-list
44614538|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614539|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614540|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44614541|NCT00623545|Incretins|incretins|mesh-ancestor
44614542|NCT00623545|Hormones|hormones|mesh-ancestor
44614543|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614544|NCT00623480|Factor VIII|factor viii|mesh-list
44614545|NCT00623480|Coagulants|coagulants|mesh-ancestor
44614546|NCT00623428|Ribavirin|ribavirin|mesh-list
44614547|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44614548|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
44614549|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614550|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
44614551|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614552|NCT00623363|Piclozotan|piclozotan|mesh-list
44614553|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44614554|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44614555|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
44614556|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614557|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443766|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44614558|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614559|NCT00623233|Gemcitabine|gemcitabine|mesh-list
44614560|NCT00623233|Bevacizumab|bevacizumab|mesh-list
44614561|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614562|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614563|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614564|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614565|NCT00623233|Growth Substances|growth substances|mesh-ancestor
44614566|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614567|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614568|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614569|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
44614570|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614571|NCT00623233|Antiviral Agents|antiviral agents|mesh-ancestor
44614572|NCT00623233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614573|NCT00623233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614574|NCT00623233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614575|NCT00623233|Immunologic Factors|immunologic factors|mesh-ancestor
44614576|NCT00623194|Insulin|insulin|mesh-list
44614577|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44614578|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
44614579|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
44614580|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614581|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614582|NCT00623103|Rivastigmine|rivastigmine|mesh-list
44614583|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44614584|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232396|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614585|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614586|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
44614587|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614588|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614589|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44614590|NCT00623103|Protective Agents|protective agents|mesh-ancestor
44443841|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44614591|NCT00622908|Besifloxacin|besifloxacin|mesh-list
44614592|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614593|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614594|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44614595|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44614596|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614597|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614598|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614599|NCT00622869|Everolimus|everolimus|mesh-list
44614600|NCT00622869|Tacrolimus|tacrolimus|mesh-list
44614601|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614602|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
44614603|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614604|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44614605|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614606|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614607|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614608|NCT00622739|Ziprasidone|ziprasidone|mesh-list
44614609|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44614610|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
44614611|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614612|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614613|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614615|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44614616|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614617|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614618|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44614619|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
44614620|NCT00622726|Bevacizumab|bevacizumab|mesh-list
44614621|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44614622|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614623|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614624|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614625|NCT00622726|Growth Substances|growth substances|mesh-ancestor
44614626|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614627|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614628|NCT00622713|Rivastigmine|rivastigmine|mesh-list
44614629|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44614630|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614631|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614632|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
44614633|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614634|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614635|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44614636|NCT00622713|Protective Agents|protective agents|mesh-ancestor
44614637|NCT00622700|Teriflunomide|teriflunomide|mesh-list
44614638|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44614639|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614640|NCT00622700|Analgesics|analgesics|mesh-ancestor
44614641|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
44614642|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614643|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614644|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614645|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44614646|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614647|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
44614648|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44614649|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44614650|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
44614651|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614652|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614653|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44614654|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
44614655|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44614656|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44614657|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44614658|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
44614659|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614660|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614661|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
44614662|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44614663|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443917|NCT01854047|Albuterol|albuterol|mesh-list
44614664|NCT00622466|Paclitaxel|paclitaxel|mesh-list
44614665|NCT00622466|Sorafenib|sorafenib|mesh-list
44614666|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44614667|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614668|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
44614669|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
44614670|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
44614671|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614672|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44614673|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614674|NCT00622401|Interleukin-12|interleukin-12|mesh-list
44614675|NCT00622401|Vaccines|vaccines|mesh-list
44614676|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
44614677|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614678|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44614679|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614680|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614681|NCT00622401|Growth Substances|growth substances|mesh-ancestor
44614682|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614683|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614685|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614686|NCT00622336|Lenalidomide|lenalidomide|mesh-list
44614687|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
44614688|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614689|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44614690|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44614691|NCT00622336|Growth Substances|growth substances|mesh-ancestor
44614692|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44614693|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614694|NCT00622284|Glimepiride|glimepiride|mesh-list
44614695|NCT00622284|Linagliptin|linagliptin|mesh-list
44614696|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44614697|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614698|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614699|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614700|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
44614701|NCT00622284|Incretins|incretins|mesh-ancestor
44614702|NCT00622284|Hormones|hormones|mesh-ancestor
44614703|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614704|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44614705|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614706|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614707|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614708|NCT00621985|Dexamethasone|dexamethasone|mesh-list
44614709|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
44614710|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44614711|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
44614712|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
44614713|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614714|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614715|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614716|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
44614717|NCT00621985|Hormones|hormones|mesh-ancestor
44614718|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614719|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44614720|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614721|NCT00621959|Levocetirizine|levocetirizine|mesh-list
44614722|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44614723|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44614724|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
44614725|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
44614726|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614727|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614728|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614729|NCT00621855|Dabigatran|dabigatran|mesh-list
44614730|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
44614731|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44614732|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614733|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614734|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614735|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
44614736|NCT00621842|Lamotrigine|lamotrigine|mesh-list
44614737|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
44614738|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44614739|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614754|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614755|NCT00621764|Vaccines|vaccines|mesh-list
44614756|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
44614757|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614758|NCT00621751|Carbamazepine|carbamazepine|mesh-list
44614759|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
44614760|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
44614761|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44614762|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614763|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614764|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614765|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44614766|NCT00621751|Analgesics|analgesics|mesh-ancestor
44614767|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
44614768|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614769|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44614770|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614771|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614772|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44614773|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44614774|NCT00621543|Copper|copper|mesh-list
44614775|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
44614776|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44614777|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
44614778|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44614779|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614780|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44614781|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44614782|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44614783|NCT00621543|Trace Elements|trace elements|mesh-ancestor
44614784|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
44614785|NCT00621517|Bupropion|bupropion|mesh-list
44614786|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44614787|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
44614788|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614789|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44614790|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44614791|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614792|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614793|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
44614794|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614795|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614796|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44614797|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44614798|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614799|NCT00621504|Clarithromycin|clarithromycin|mesh-list
44614800|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
44614801|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44614802|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614803|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614804|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44614805|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614806|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614807|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44614808|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44614809|NCT00621322|Vaccines|vaccines|mesh-list
44614810|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
44614811|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614812|NCT00621309|Rifampin|rifampin|mesh-list
44614813|NCT00621309|Rifamycins|rifamycins|mesh-list
44614814|NCT00621309|Sulforaphane|sulforaphane|mesh-list
44232619|NCT00541021|Sorafenib|sorafenib|mesh-list
44614815|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44614816|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
44614817|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614818|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614819|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
44614820|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44614821|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614822|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614823|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44614824|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44614825|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44444100|NCT01851863|Omeprazole|omeprazole|mesh-list
44614826|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44614827|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44614828|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44614829|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44614830|NCT00621309|Protective Agents|protective agents|mesh-ancestor
44614831|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614832|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614833|NCT00621257|Vitamin D|vitamin d|mesh-list
44614834|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
44614835|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
44614836|NCT00621257|Vitamins|vitamins|mesh-list
44614837|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
44614838|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614839|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44614840|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614841|NCT00621244|Panobinostat|panobinostat|mesh-list
44614842|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614843|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44614844|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614845|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614846|NCT00621192|Meropenem|meropenem|mesh-list
44614847|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44614848|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614849|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44614850|NCT00621153|Candesartan|candesartan|mesh-list
44614851|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
44614852|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44614853|NCT00621153|Diuretics|diuretics|mesh-ancestor
44614854|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
44614855|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614856|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44614857|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232656|NCT00541073|Hematinics|hematinics|mesh-ancestor
44614858|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614859|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44614860|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44614861|NCT00621140|Linagliptin|linagliptin|mesh-list
44614862|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614863|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614864|NCT00621140|Incretins|incretins|mesh-ancestor
44614865|NCT00621140|Hormones|hormones|mesh-ancestor
44614866|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614867|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44614868|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
44614869|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614870|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614871|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
44614872|NCT00621023|Decitabine|decitabine|mesh-list
44614873|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
44614874|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614875|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
44614876|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614877|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614878|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614879|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
44614880|NCT00621023|Protective Agents|protective agents|mesh-ancestor
44614881|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614882|NCT00621023|Vitamins|vitamins|mesh-ancestor
44614883|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
44614884|NCT00620854|Calcitonin|calcitonin|mesh-list
44614885|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
44614886|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44614887|NCT00620854|Katacalcin|katacalcin|mesh-list
44614888|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614889|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614890|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44614891|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
44614892|NCT00620815|Vaccines|vaccines|mesh-list
44614893|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44614894|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
44614895|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614896|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44614897|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44614898|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44614899|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44614900|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44614901|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614902|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614903|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614904|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44614905|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
44614906|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614908|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44614909|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44614910|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614911|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
44614912|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614913|NCT00620659|Modafinil|modafinil|mesh-list
44614914|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44614915|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614916|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44614917|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44147651|NCT00201812|Hormones|hormones|mesh-ancestor
44614918|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44614919|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614921|NCT00620555|Analgesics|analgesics|mesh-ancestor
44614922|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
44614923|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44614924|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614925|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
44614926|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44614927|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44614928|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44614929|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44614930|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44614931|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44614932|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44614933|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614934|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
44614935|NCT00620542|Atorvastatin|atorvastatin|mesh-list
44614936|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44614937|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44614938|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44614939|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
44614940|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614941|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44614942|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44614943|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614944|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44614945|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44614946|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614947|NCT00620321|Cytarabine|cytarabine|mesh-list
44614948|NCT00620321|Idarubicin|idarubicin|mesh-list
44232753|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
44614949|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44614950|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
44614951|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614952|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614953|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
44614954|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614955|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614956|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
44614957|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614958|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44614959|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44614960|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44614961|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44614962|NCT00620282|Liraglutide|liraglutide|mesh-list
44614963|NCT00620282|Glimepiride|glimepiride|mesh-list
44614964|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44614965|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614966|NCT00620282|Incretins|incretins|mesh-ancestor
44614967|NCT00620282|Hormones|hormones|mesh-ancestor
44614968|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614969|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44614970|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44614971|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
44614972|NCT00620113|Vitamin D|vitamin d|mesh-list
44614973|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
44614974|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
44614976|NCT00620113|Vitamins|vitamins|mesh-ancestor
44614977|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
44614978|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614979|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44614980|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44614981|NCT00620113|Antacids|antacids|mesh-ancestor
44614982|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614983|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44614984|NCT00620074|Voriconazole|voriconazole|mesh-list
44614985|NCT00620074|Anidulafungin|anidulafungin|mesh-list
44614986|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
44614987|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44614988|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44232793|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
44614989|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44614990|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235672|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44614991|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44614993|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
44614994|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44614995|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44614996|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44614997|NCT00619983|Gabapentin|gabapentin|mesh-list
44614998|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44614999|NCT00619983|Donepezil|donepezil|mesh-list
44615000|NCT00619983|Analgesics|analgesics|mesh-ancestor
44615001|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
44615002|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615003|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615004|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
44615005|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44615006|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615007|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615008|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615009|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44615010|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44615011|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615012|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615013|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
44615014|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44615015|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615016|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615017|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615018|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
44615019|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44615020|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615021|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
44615022|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
44615023|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
44615024|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44615025|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615026|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615027|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44615028|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615029|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44615030|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44615031|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615032|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615033|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44615034|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615035|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615036|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615037|NCT00619801|Levocetirizine|levocetirizine|mesh-list
44615038|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44615039|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44615040|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
44615041|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
44615042|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615043|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615044|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615045|NCT00619645|Cyclosporine|cyclosporine|mesh-list
44615046|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
44615047|NCT00619645|Fludarabine|fludarabine|mesh-list
44615048|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
44615049|NCT00619645|Busulfan|busulfan|mesh-list
44615050|NCT00619645|Cyclosporins|cyclosporins|mesh-list
44615051|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615052|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615053|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
44615054|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615055|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615056|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
44615057|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615058|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615059|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
44615060|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615061|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615062|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615064|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44615065|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44615066|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
44615067|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44615068|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
44615069|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44615070|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44615071|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44615072|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44615073|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615074|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615075|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615076|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615077|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615078|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615079|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615080|NCT00619489|Vedolizumab|vedolizumab|mesh-list
44615081|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615082|NCT00619476|Gabapentin|gabapentin|mesh-list
44615083|NCT00619476|Analgesics|analgesics|mesh-ancestor
44615084|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
44615085|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615086|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615087|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
44615088|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44615089|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615090|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615091|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615092|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44615093|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44615094|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615095|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615096|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
44615097|NCT00619359|Dexamethasone|dexamethasone|mesh-list
44615098|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
44615099|NCT00619359|Ondansetron|ondansetron|mesh-list
44615100|NCT00619359|Aprepitant|aprepitant|mesh-list
44615101|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
44615102|NCT00619359|BB 1101|bb 1101|mesh-list
44615103|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615104|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
44615105|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
44615106|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615107|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615108|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615109|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
44615110|NCT00619359|Hormones|hormones|mesh-ancestor
44615111|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615112|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44615113|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615114|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
44615115|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615116|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615117|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
44615118|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615119|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44444384|NCT01846221|Clonidine|clonidine|mesh-list
44615121|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615122|NCT00619359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44615123|NCT00619359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615124|NCT00619359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615125|NCT00619359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615126|NCT00619359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44615127|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44615128|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
44615129|NCT00619307|Ibuprofen|ibuprofen|mesh-list
44615130|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44615131|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44615132|NCT00619307|Analgesics|analgesics|mesh-ancestor
44615133|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
44615134|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615135|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615136|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615138|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44615139|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615140|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615141|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44615142|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
44615143|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615144|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
44615145|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615146|NCT00619229|Alprostadil|alprostadil|mesh-list
44615147|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44615148|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
44615149|NCT00619229|Urological Agents|urological agents|mesh-ancestor
44615150|NCT00619112|Temozolomide|temozolomide|mesh-list
44615151|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44615152|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
44615153|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615154|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615155|NCT00619099|Decitabine|decitabine|mesh-list
44615156|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615157|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
44615158|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615159|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615160|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615161|NCT00618995|Niacin|niacin|mesh-list
44615162|NCT00618995|Niacinamide|niacinamide|mesh-list
44615163|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
44615164|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44615165|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
44615166|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615167|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44615168|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
44615169|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
44615170|NCT00618995|Vitamins|vitamins|mesh-ancestor
44615171|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
44615172|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615173|NCT00618982|Sorafenib|sorafenib|mesh-list
44615174|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615175|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44615176|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615177|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615178|NCT00618956|Milnacipran|milnacipran|mesh-list
44615179|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
44615180|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44615181|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615182|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615183|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615184|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615185|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615186|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44615187|NCT00618956|Analgesics|analgesics|mesh-ancestor
44615188|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
44615189|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615190|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615191|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615192|NCT00618826|Gemcitabine|gemcitabine|mesh-list
44615193|NCT00618826|Paclitaxel|paclitaxel|mesh-list
44615194|NCT00618826|Bevacizumab|bevacizumab|mesh-list
44615195|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44615196|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615197|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44615198|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44615199|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44615200|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615201|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615202|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
44615203|NCT00618826|Antiviral Agents|antiviral agents|mesh-ancestor
44615204|NCT00618826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615205|NCT00618826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615206|NCT00618826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615207|NCT00618826|Immunologic Factors|immunologic factors|mesh-ancestor
44615208|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615209|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615210|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44615211|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44615212|NCT00618826|Growth Substances|growth substances|mesh-ancestor
44615213|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44615214|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
44615216|NCT00618813|Doxorubicin|doxorubicin|mesh-list
44615217|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44615218|NCT00618813|Etoposide|etoposide|mesh-list
44615219|NCT00618813|Vincristine|vincristine|mesh-list
44615220|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
44615221|NCT00618813|Topotecan|topotecan|mesh-list
44615222|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615223|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
44615224|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615225|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615226|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44615227|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
44615228|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615229|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615230|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44615231|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44615232|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44615233|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44615234|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615235|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44615236|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
44615237|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
44615238|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
44615239|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44615240|NCT00618774|Amlodipine|amlodipine|mesh-list
44615241|NCT00618774|Telmisartan|telmisartan|mesh-list
44615242|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44615243|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44615244|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615245|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615246|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44615247|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615248|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
44615249|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44615250|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44615251|NCT00618748|Olanzapine|olanzapine|mesh-list
44615252|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
44615253|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
44615254|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615255|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615256|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615257|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44615258|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615259|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615260|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615261|NCT00618748|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44615262|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615263|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615264|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615265|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615266|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
44615267|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
44615268|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44615269|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615270|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
44615271|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44615272|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615273|NCT00618449|Azithromycin|azithromycin|mesh-list
44615274|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44615275|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615276|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
44615277|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44615278|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44615279|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
44615280|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615281|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44615282|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44615283|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615284|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615285|NCT00618072|Metformin|metformin|mesh-list
44615286|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
44615287|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615288|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615289|NCT00617929|Rituximab|rituximab|mesh-list
44615290|NCT00617929|Clofarabine|clofarabine|mesh-list
44615291|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
44615292|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44615293|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615294|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615295|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
44615296|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615297|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615298|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615299|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615300|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
44615301|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615302|NCT00617903|Azelaic acid|azelaic acid|mesh-list
44615303|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615304|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615305|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44615306|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
44615307|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615308|NCT00617851|Vaccines|vaccines|mesh-list
44615309|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
44615310|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615311|NCT00617734|Cetuximab|cetuximab|mesh-list
44615312|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44615313|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615314|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615315|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
44615316|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615317|NCT00617708|Gemcitabine|gemcitabine|mesh-list
44615318|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44615319|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44615320|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615321|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
44615322|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615323|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615324|NCT00617708|Antiviral Agents|antiviral agents|mesh-ancestor
44615325|NCT00617708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615326|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615327|NCT00617708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615328|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
44615329|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615330|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44615331|NCT00617669|Docetaxel|docetaxel|mesh-list
44615332|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615333|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44615334|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44615335|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44615336|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615337|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
44615338|NCT00617604|Alefacept|alefacept|mesh-list
44615339|NCT00617604|Tacrolimus|tacrolimus|mesh-list
44615340|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615341|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
44615342|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615343|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44615344|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615345|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615371|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615372|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615373|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
44615374|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44615375|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44615376|NCT00617591|Growth Substances|growth substances|mesh-ancestor
44615377|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
44615378|NCT00617461|Gabapentin|gabapentin|mesh-list
44615379|NCT00617461|Analgesics|analgesics|mesh-ancestor
44615380|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
44615381|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615382|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615383|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
44615384|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44615385|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615386|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615387|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615388|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44615389|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44615390|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615391|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615392|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
44615393|NCT00617409|Paclitaxel|paclitaxel|mesh-list
44615394|NCT00617409|Tretinoin|tretinoin|mesh-list
44615395|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44615396|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615397|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
44615398|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
44615399|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
44615400|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615401|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
44615402|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615404|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
44615405|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615406|NCT00617305|Ambrisentan|ambrisentan|mesh-list
44615407|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
44615408|NCT00617305|Tadalafil|tadalafil|mesh-list
44615409|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
44615410|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44615411|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44615412|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615413|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615414|NCT00617305|Urological Agents|urological agents|mesh-ancestor
44615415|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44615416|NCT00617240|Metformin|metformin|mesh-list
44615417|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615418|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615419|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44615420|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44615421|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615422|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615423|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615424|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44615425|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615426|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615427|NCT00617123|Vorapaxar|vorapaxar|mesh-list
44615428|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44615429|NCT00617084|Everolimus|everolimus|mesh-list
44615430|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615431|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615432|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
44615433|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615434|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
44615435|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44615436|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615437|NCT00616902|Vitamins|vitamins|mesh-ancestor
44615438|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
44615439|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44615440|NCT00616759|Propofol|propofol|mesh-list
44615441|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44615442|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615443|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615444|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44615445|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
44615446|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
44615447|NCT00616655|Eszopiclone|eszopiclone|mesh-list
44615448|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44615449|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615450|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615451|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
44615452|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615453|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615454|NCT00616603|Dexamethasone|dexamethasone|mesh-list
44615455|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
44615456|NCT00616603|Ropivacaine|ropivacaine|mesh-list
44615457|NCT00616603|BB 1101|bb 1101|mesh-list
44615458|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615459|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
44615460|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
44615461|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615463|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615464|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
44615465|NCT00616603|Hormones|hormones|mesh-ancestor
44615466|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615467|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44615468|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615469|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44615470|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615471|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615472|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
44615473|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
44615474|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615475|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
44615476|NCT00616434|Interferons|interferons|mesh-list
44615477|NCT00616434|Interferon-beta|interferon-beta|mesh-list
44615478|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
44615479|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615481|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615482|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
44615483|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615484|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44615485|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
44615486|NCT00616239|Salicylates|salicylates|mesh-list
44615487|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615488|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
44615489|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
44615490|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615491|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44615492|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44615493|NCT00616239|Analgesics|analgesics|mesh-ancestor
44615494|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
44615495|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615496|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615497|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615498|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615499|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44615500|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615501|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615502|NCT00616018|Acetaminophen|acetaminophen|mesh-list
44615503|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44615504|NCT00616018|Analgesics|analgesics|mesh-ancestor
44615505|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
44615506|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615507|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615508|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
44615509|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
44615510|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44615511|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
44615512|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615513|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615514|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44615515|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
44615516|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
44615517|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44615518|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
44615519|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615520|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615521|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
44615522|NCT00615901|Fluorouracil|fluorouracil|mesh-list
44615523|NCT00615901|Methotrexate|methotrexate|mesh-list
44615524|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615525|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
44615526|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615527|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615528|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44615529|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
44615530|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615531|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615532|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44615533|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
44615534|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615535|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44615536|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
44615537|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44615538|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44615539|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615540|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44615541|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44615542|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44615543|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
44615544|NCT00615836|Coagulants|coagulants|mesh-ancestor
44615545|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44615546|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
44615547|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615548|NCT00615550|Progesterone|progesterone|mesh-list
44615549|NCT00615550|Progestins|progestins|mesh-ancestor
44615550|NCT00615550|Hormones|hormones|mesh-ancestor
44615551|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615552|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615553|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
44615554|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44615555|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
44615556|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615557|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615558|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44615559|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
44615560|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
44615561|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44615562|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
44615563|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615564|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615565|NCT00615290|Tipranavir|tipranavir|mesh-list
44615566|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44615567|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44615568|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
44615569|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615570|NCT00615199|Tofacitinib|tofacitinib|mesh-list
44615571|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44615572|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615573|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615574|NCT00615056|Leucovorin|leucovorin|mesh-list
44615575|NCT00615056|Bevacizumab|bevacizumab|mesh-list
44615576|NCT00615056|Fluorouracil|fluorouracil|mesh-list
44615577|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
44615578|NCT00615056|Irinotecan|irinotecan|mesh-list
44615579|NCT00615056|Axitinib|axitinib|mesh-list
44615580|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
44615581|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615582|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615583|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44615584|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44615585|NCT00615056|Growth Substances|growth substances|mesh-ancestor
44615586|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615587|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
44615588|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
44615589|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615590|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615591|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615592|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
44615593|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44615594|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44615595|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615596|NCT00615056|Antidotes|antidotes|mesh-ancestor
44615597|NCT00615056|Protective Agents|protective agents|mesh-ancestor
44615598|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
44615599|NCT00615056|Vitamins|vitamins|mesh-ancestor
44615600|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
44615601|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44615602|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44615603|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44615604|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
44615605|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615606|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615607|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44615608|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
44615609|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44615610|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44615611|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44615612|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
44615613|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615614|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615616|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
44615617|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
44615618|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44615619|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44615620|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44615621|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615622|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615623|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44615624|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44615625|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
44615626|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615627|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44615628|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44615629|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44615630|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44615631|NCT00614939|Saxagliptin|saxagliptin|mesh-list
44615632|NCT00614939|Incretins|incretins|mesh-ancestor
44615633|NCT00614939|Hormones|hormones|mesh-ancestor
44615634|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615635|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615636|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44615637|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
44615638|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615639|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615640|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615641|NCT00614926|Modafinil|modafinil|mesh-list
44615642|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44615643|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615644|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44615645|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44615646|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44615647|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615648|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
44615649|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615650|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615651|NCT00614822|Bevacizumab|bevacizumab|mesh-list
44615652|NCT00614822|Carboplatin|carboplatin|mesh-list
44615653|NCT00614822|Pemetrexed|pemetrexed|mesh-list
44615654|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615655|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615656|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44615657|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44615658|NCT00614822|Growth Substances|growth substances|mesh-ancestor
44615659|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615660|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
44615661|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615662|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615663|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44615664|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44615665|NCT00614614|Vaccines|vaccines|mesh-list
44615666|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
44615667|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615668|NCT00614393|Irinotecan|irinotecan|mesh-list
44615669|NCT00614393|Cetuximab|cetuximab|mesh-list
44615670|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44615671|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44615672|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44615673|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615674|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615675|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615676|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615677|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
44615678|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615679|NCT00614380|Amlodipine|amlodipine|mesh-list
44615680|NCT00614380|Telmisartan|telmisartan|mesh-list
44615681|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44615682|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44615683|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44615684|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615685|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012703|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
44615686|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44615687|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615689|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44615690|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44615691|NCT00614120|Metformin|metformin|mesh-list
44615692|NCT00614120|Liraglutide|liraglutide|mesh-list
44615693|NCT00614120|Glimepiride|glimepiride|mesh-list
44615694|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615695|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615696|NCT00614120|Incretins|incretins|mesh-ancestor
44615697|NCT00614120|Hormones|hormones|mesh-ancestor
44615698|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44615699|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44615700|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615701|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
44615702|NCT00614055|Insulin|insulin|mesh-list
44615703|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44615704|NCT00614055|Metformin|metformin|mesh-list
44615705|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
44615706|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
44615707|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
44615708|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44615709|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615710|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615711|NCT00613951|Insulin|insulin|mesh-list
44615712|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44615713|NCT00613951|Metformin|metformin|mesh-list
44615714|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
44615715|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
44615716|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44615717|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
44615718|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615719|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615720|NCT00613938|Oxycodone|oxycodone|mesh-list
44615721|NCT00613938|Tapentadol|tapentadol|mesh-list
44615722|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44615723|NCT00613938|Narcotics|narcotics|mesh-ancestor
44615724|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233425|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
44615725|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615726|NCT00613938|Analgesics|analgesics|mesh-ancestor
44615727|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
44615728|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615729|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44615730|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615731|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615732|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615733|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
44615734|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615735|NCT00613834|Lidocaine|lidocaine|mesh-list
44615736|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
44615737|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
44615738|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615739|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615740|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
44615741|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615742|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44615743|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44615744|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44615745|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615746|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615747|NCT00613821|Lidocaine|lidocaine|mesh-list
44615748|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
44615749|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
44615750|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615751|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615752|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
44615753|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615754|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44615755|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44615756|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44615757|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615758|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615759|NCT00613730|Gemcitabine|gemcitabine|mesh-list
44615760|NCT00613730|Panitumumab|panitumumab|mesh-list
44615761|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615762|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
44615763|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615764|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615765|NCT00613730|Antiviral Agents|antiviral agents|mesh-ancestor
44615766|NCT00613730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615767|NCT00613730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615768|NCT00613730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615769|NCT00613730|Immunologic Factors|immunologic factors|mesh-ancestor
44615770|NCT00613730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615771|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615772|NCT00613626|Cisplatin|cisplatin|mesh-list
44615773|NCT00613626|Etoposide|etoposide|mesh-list
44615774|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615775|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44615776|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44615777|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44445113|NCT01833533|Ribavirin|ribavirin|mesh-list
44615778|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615779|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615780|NCT00613574|Bromides|bromides|mesh-list
44615781|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
44615782|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44615783|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
44615784|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615785|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615786|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44615787|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
44615788|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
44615789|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44615790|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
44615791|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615792|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615793|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
44615794|NCT00613509|Interferons|interferons|mesh-list
44615795|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
44615796|NCT00613509|Vaccines|vaccines|mesh-list
44615797|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615798|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
44615799|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615800|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
44615801|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615802|NCT00613366|Misoprostol|misoprostol|mesh-list
44615803|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
44615804|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44615805|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
44615806|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44615807|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615808|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44615809|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44615810|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
44615811|NCT00613366|Antacids|antacids|mesh-ancestor
44615812|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615813|NCT00613327|Oxybutynin|oxybutynin|mesh-list
44615814|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
44615815|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
44615816|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44615817|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615818|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44615819|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44615820|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
44615821|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615822|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615823|NCT00613327|Urological Agents|urological agents|mesh-ancestor
44615824|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
44615825|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615826|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44615827|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615828|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615829|NCT00613106|Ibuprofen|ibuprofen|mesh-list
44615830|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44615831|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44615832|NCT00613106|Analgesics|analgesics|mesh-ancestor
44615833|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
44615835|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615836|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44615837|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44615838|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44615839|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615840|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615841|NCT00613080|Leucovorin|leucovorin|mesh-list
44615842|NCT00613080|Fluorouracil|fluorouracil|mesh-list
44615843|NCT00613080|Capecitabine|capecitabine|mesh-list
44615844|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
44615845|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
44615846|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615847|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615848|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615849|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615850|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
44615851|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615852|NCT00613080|Antidotes|antidotes|mesh-ancestor
44615853|NCT00613080|Protective Agents|protective agents|mesh-ancestor
44615854|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
44615855|NCT00613080|Vitamins|vitamins|mesh-ancestor
44615856|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
44615857|NCT00613015|Guanfacine|guanfacine|mesh-list
44615858|NCT00613015|Modafinil|modafinil|mesh-list
44615859|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44615860|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615861|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44615862|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44615863|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44615864|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615865|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44615866|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44615867|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44615868|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44615869|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44615870|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615871|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
44615872|NCT00612807|Bupropion|bupropion|mesh-list
44615873|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44615874|NCT00612807|Sertraline|sertraline|mesh-list
44615875|NCT00612807|Nortriptyline|nortriptyline|mesh-list
44615876|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44615877|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615878|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615879|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44615880|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615881|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615882|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615883|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
44615884|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615885|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615886|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44615887|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44615888|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615889|NCT00612807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44615890|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
44615891|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44615892|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615893|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44615894|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44615895|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44615896|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
44615897|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44615898|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44615899|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
44615900|NCT00612677|Pemetrexed|pemetrexed|mesh-list
44615901|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615902|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615903|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615904|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44615905|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44615906|NCT00612586|Leucovorin|leucovorin|mesh-list
44615907|NCT00612586|Bevacizumab|bevacizumab|mesh-list
44615908|NCT00612586|Fluorouracil|fluorouracil|mesh-list
44615909|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44615910|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44615911|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44615912|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44615913|NCT00612586|Growth Substances|growth substances|mesh-ancestor
44615914|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615915|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
44615916|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
44615917|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615918|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44615919|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44615920|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
44615921|NCT00612586|Antidotes|antidotes|mesh-ancestor
44615922|NCT00612586|Protective Agents|protective agents|mesh-ancestor
44615923|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
44615924|NCT00612586|Vitamins|vitamins|mesh-ancestor
44615925|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
44615926|NCT00612534|Sufentanil|sufentanil|mesh-list
44615928|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44615952|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
44615953|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44615954|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44615955|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44615956|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44615957|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44615958|NCT00612508|Progestins|progestins|mesh-ancestor
44615959|NCT00612352|Ethanol|ethanol|mesh-list
44615960|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44615961|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44615962|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44615963|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615964|NCT00612313|Fluoxetine|fluoxetine|mesh-list
44615965|NCT00612313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44615966|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615967|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615968|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615969|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44615970|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
44615971|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615972|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44615973|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615974|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615975|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44615976|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44615977|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44615978|NCT00612105|Ezogabine|ezogabine|mesh-list
44615979|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
44615980|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44615981|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44615982|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
44615983|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615984|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615985|NCT00612040|Insulin|insulin|mesh-list
44615986|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44615987|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
44615988|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
44615989|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
44615990|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44615991|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44615992|NCT00611975|Bupropion|bupropion|mesh-list
44615993|NCT00611975|Fluoxetine|fluoxetine|mesh-list
44615994|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44615995|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
44615996|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44615997|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44615998|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44615999|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616000|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616001|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
44616002|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616003|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616004|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43772253|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
44616005|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44616006|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616007|NCT00611975|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44616008|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
44616009|NCT00611923|Flutamide|flutamide|mesh-list
44616010|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
44616011|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44616012|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616013|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616014|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616015|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616016|NCT00611884|Insulin|insulin|mesh-list
44616017|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44616018|NCT00611884|Metformin|metformin|mesh-list
44616019|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
44616020|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
44616021|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616022|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616023|NCT00611858|Fluorouracil|fluorouracil|mesh-list
44616024|NCT00611858|Cetuximab|cetuximab|mesh-list
44616025|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
44445356|NCT01828099|Cisplatin|cisplatin|mesh-list
44616026|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616027|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616028|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616029|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616030|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
44616031|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616032|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44616033|NCT00611806|Folic Acid|folic acid|mesh-list
44616034|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
44616035|NCT00611806|Hematinics|hematinics|mesh-ancestor
44616036|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
44616037|NCT00611806|Vitamins|vitamins|mesh-ancestor
44616038|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
44616039|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616040|NCT00611767|Thiopental|thiopental|mesh-list
44616041|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
44616042|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44616043|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616044|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616045|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44616046|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
44616047|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
44616048|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
44616049|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
44616050|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616051|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616052|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44616053|NCT00611715|Letrozole|letrozole|mesh-list
44616054|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616055|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616056|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616057|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616058|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44616059|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44616060|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44616061|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
44616062|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616063|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616064|NCT00611559|PENTA|penta|mesh-list
44616065|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
44616066|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44616067|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44616068|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616069|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44616070|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44616071|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616072|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616073|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616074|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44616075|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616076|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616077|NCT00611455|Ofatumumab|ofatumumab|mesh-list
44616078|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616079|NCT00611247|Temozolomide|temozolomide|mesh-list
44616080|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44616081|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
44616082|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616083|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616084|NCT00611130|Vigabatrin|vigabatrin|mesh-list
44616085|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
44616086|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616087|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616088|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
44616089|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616090|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616091|NCT00611026|Fesoterodine|fesoterodine|mesh-list
44616092|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44616093|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44616094|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44616095|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
44616096|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233774|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
44616097|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616098|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616099|NCT00611026|Urological Agents|urological agents|mesh-ancestor
44616101|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
44616102|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616103|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616104|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616105|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44616106|NCT00610857|Antibodies|antibodies|mesh-list
44616107|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
44616108|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44616109|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
44616110|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616111|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616112|NCT00610714|Paclitaxel|paclitaxel|mesh-list
44616113|NCT00610714|Carboplatin|carboplatin|mesh-list
44616114|NCT00610714|Saracatinib|saracatinib|mesh-list
44616115|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44616116|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616117|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44616118|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44616119|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44616120|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616121|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616122|NCT00610675|Mirtazapine|mirtazapine|mesh-list
44616123|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616124|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616125|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44616126|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
44616127|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
44616128|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616129|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616130|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616131|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44616132|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616133|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616134|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44616135|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44616136|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44616137|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
44616138|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616139|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616140|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
44616141|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44616142|NCT00610363|Rilonacept|rilonacept|mesh-list
44616143|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616144|NCT00610168|Vaccines|vaccines|mesh-list
44616145|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
44616146|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616147|NCT00610155|Pregabalin|pregabalin|mesh-list
44616148|NCT00610155|Tramadol|tramadol|mesh-list
44616149|NCT00610155|Analgesics|analgesics|mesh-ancestor
44616150|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
44616151|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616152|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616153|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
44616154|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44616155|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616156|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616157|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44616158|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44616159|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616160|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616161|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616162|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44616163|NCT00610155|Narcotics|narcotics|mesh-ancestor
44616164|NCT00609986|Insulin|insulin|mesh-list
44616165|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44616166|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
44616167|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
44616168|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
44616169|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
44616170|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616171|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616172|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
44616173|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44616174|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616175|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44616176|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44616177|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616178|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616179|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616180|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44616181|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44616183|NCT00609869|Lenalidomide|lenalidomide|mesh-list
44616184|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44616185|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616186|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
44616187|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616188|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44616189|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44616190|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44616191|NCT00609869|Growth Substances|growth substances|mesh-ancestor
44616192|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
44616193|NCT00609791|Paclitaxel|paclitaxel|mesh-list
44616194|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44616195|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44616196|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616197|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870095|NCT05605080|Coagulants|coagulants|mesh-ancestor
43870096|NCT05598957|Vitamin D|vitamin d|mesh-list
43870097|NCT05598957|Vitamins|vitamins|mesh-ancestor
43870098|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
43870099|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870100|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43870101|NCT05596721|Azithromycin|azithromycin|mesh-list
43870102|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870103|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870104|NCT05580042|Tofacitinib|tofacitinib|mesh-list
43870105|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43870106|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616198|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44616199|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44616200|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616201|NCT00609765|Dexamethasone|dexamethasone|mesh-list
44616202|NCT00609765|Bevacizumab|bevacizumab|mesh-list
44616203|NCT00609765|Doxorubicin|doxorubicin|mesh-list
44616204|NCT00609765|Fluorouracil|fluorouracil|mesh-list
44616205|NCT00609765|Streptozocin|streptozocin|mesh-list
44616206|NCT00609765|Ondansetron|ondansetron|mesh-list
44616207|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44616208|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616209|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44616210|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44616211|NCT00609765|Growth Substances|growth substances|mesh-ancestor
44616212|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616213|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
44616214|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616215|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
44616216|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
44616217|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616218|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616219|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
44616220|NCT00609765|Hormones|hormones|mesh-ancestor
44616221|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616222|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616223|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44616224|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44616225|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44616226|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616227|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616229|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616230|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616231|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
44616232|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
44616233|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44616234|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616235|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
44616236|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616237|NCT00609765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616238|NCT00609765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616239|NCT00609765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616240|NCT00609765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616241|NCT00609765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44616242|NCT00609674|Fluticasone|fluticasone|mesh-list
44616243|NCT00609674|Xhance|xhance|mesh-list
44616244|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616245|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44616246|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
43870107|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616247|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616248|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616249|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44616250|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
44616251|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
44616252|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44616253|NCT00609622|Bevacizumab|bevacizumab|mesh-list
44616254|NCT00609622|Sunitinib|sunitinib|mesh-list
44616255|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44445675|NCT01822756|Paclitaxel|paclitaxel|mesh-list
44616256|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616257|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44616258|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44616259|NCT00609622|Growth Substances|growth substances|mesh-ancestor
44616260|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616261|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
44616262|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616263|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616264|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616265|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
44616266|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44616267|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44616268|NCT00609609|Prednisolone|prednisolone|mesh-list
44616269|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
44616270|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44616271|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
44616272|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616273|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
44616274|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
44616275|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616276|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616277|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616278|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
44616279|NCT00609609|Hormones|hormones|mesh-ancestor
44616280|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616281|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44616282|NCT00609609|Protective Agents|protective agents|mesh-ancestor
43870143|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616283|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616284|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616285|NCT00609518|Folic Acid|folic acid|mesh-list
44616286|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
44616287|NCT00609518|Hydroxocobalamin|hydroxocobalamin|mesh-list
44616288|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
44616289|NCT00609518|Dexamethasone|dexamethasone|mesh-list
44616290|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
44616291|NCT00609518|Pemetrexed|pemetrexed|mesh-list
44616292|NCT00609518|BB 1101|bb 1101|mesh-list
44616293|NCT00609518|Vitamins|vitamins|mesh-ancestor
44616294|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
44616295|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616296|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616297|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
44616298|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
44616299|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147851|NCT00202514|Valproic Acid|valproic acid|mesh-list
44616300|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616301|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
44616302|NCT00609518|Hormones|hormones|mesh-ancestor
44616303|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616304|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616305|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616306|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
44616307|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616308|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616309|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44616310|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44616311|NCT00609518|Hematinics|hematinics|mesh-ancestor
44616312|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44616313|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
44616314|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616315|NCT00609466|Morphine|morphine|mesh-list
44616316|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44616317|NCT00609466|Narcotics|narcotics|mesh-ancestor
44616318|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616319|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616320|NCT00609466|Analgesics|analgesics|mesh-ancestor
44616321|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
44616322|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616323|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
44616324|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616325|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616326|NCT00609336|Gemcitabine|gemcitabine|mesh-list
44616327|NCT00609336|Capecitabine|capecitabine|mesh-list
44616328|NCT00609336|Docetaxel|docetaxel|mesh-list
44616329|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
44616330|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616331|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
44616332|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616333|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616334|NCT00609336|Antiviral Agents|antiviral agents|mesh-ancestor
44616335|NCT00609336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616336|NCT00609336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616337|NCT00609336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616338|NCT00609336|Immunologic Factors|immunologic factors|mesh-ancestor
44616339|NCT00609336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616340|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44616341|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44616342|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44616343|NCT00609245|Valproic Acid|valproic acid|mesh-list
44616344|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
44616345|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616346|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616347|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
44616348|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616349|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616350|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
44616351|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616352|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616353|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616354|NCT00609167|Dexamethasone|dexamethasone|mesh-list
44616355|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
44616356|NCT00609167|Bortezomib|bortezomib|mesh-list
44616357|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616358|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
44616359|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616360|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44616361|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44616362|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
43870220|NCT05287893|Pyronaridine|pyronaridine|mesh-list
44616363|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616364|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616365|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44616366|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616367|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
44616368|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
44616369|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616370|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616371|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
44616372|NCT00609167|Hormones|hormones|mesh-ancestor
44616373|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616374|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616375|NCT00608985|Zolpidem|zolpidem|mesh-list
44616376|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44616377|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44616378|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616379|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616380|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44616381|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
44616382|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
44616383|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616384|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616385|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
44616386|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44616387|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616388|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
44616389|NCT00608907|Rifampin|rifampin|mesh-list
44616390|NCT00608907|Dexamethasone|dexamethasone|mesh-list
44616391|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
44616392|NCT00608907|Bortezomib|bortezomib|mesh-list
44616393|NCT00608907|BB 1101|bb 1101|mesh-list
44616394|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616395|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
44616396|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
44616397|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616398|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616399|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616400|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
44616401|NCT00608907|Hormones|hormones|mesh-ancestor
44616402|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616403|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616404|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616405|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44616406|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616407|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616408|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44616409|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
44445812|NCT01821677|Danazol|danazol|mesh-list
44616424|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
44616426|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616427|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616428|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616429|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616430|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616431|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
44616432|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44616433|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616434|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616435|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
44616436|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616437|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44616438|NCT00608881|Ubiquinone|ubiquinone|mesh-list
44616439|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
44616440|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
44616441|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616442|NCT00608881|Vitamins|vitamins|mesh-ancestor
44616443|NCT00608868|Gefitinib|gefitinib|mesh-list
44616444|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616445|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616446|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616447|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616448|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
44616449|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44616450|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616451|NCT00608569|Ritonavir|ritonavir|mesh-list
44616452|NCT00608569|Lopinavir|lopinavir|mesh-list
44616453|NCT00608569|Tenofovir|tenofovir|mesh-list
44616454|NCT00608569|Zidovudine|zidovudine|mesh-list
44616455|NCT00608569|Emtricitabine|emtricitabine|mesh-list
44616456|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44616457|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44616458|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44616459|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44616460|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616461|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616462|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44616464|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
44616465|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870240|NCT05257629|Nicotine|nicotine|mesh-list
44616466|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44616467|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44616468|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44616469|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44616470|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
44616471|NCT00608543|Aripiprazole|aripiprazole|mesh-list
44616472|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616473|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616474|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616475|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616476|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616477|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616478|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
44616479|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
44616480|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616481|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616482|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44616483|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44616484|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
44616485|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616486|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616487|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616488|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616489|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
44616490|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
44616491|NCT00608517|Fludarabine|fludarabine|mesh-list
44616492|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
44616493|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44616494|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616495|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
44616496|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616497|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445894|NCT01818700|Buprenorphine|buprenorphine|mesh-list
44616498|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44616499|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
44616500|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616501|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616502|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44616503|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616504|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
44616505|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616506|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
44616507|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
44616508|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870300|NCT05061992|Lactulose|lactulose|mesh-list
44616509|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44616510|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
44616511|NCT00608517|Hormones|hormones|mesh-ancestor
44616512|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616513|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44616514|NCT00608517|Protective Agents|protective agents|mesh-ancestor
44616515|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
44616516|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44616517|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
44616518|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616519|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616520|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44616521|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
44616522|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44616523|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
44616524|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616525|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616526|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44616527|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
44616528|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
44616529|NCT00608322|Protective Agents|protective agents|mesh-ancestor
44616530|NCT00608244|Tacrolimus|tacrolimus|mesh-list
44616531|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616532|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
44616533|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616534|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44616535|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616536|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616537|NCT00608205|Cisplatin|cisplatin|mesh-list
44616538|NCT00608205|Fluorouracil|fluorouracil|mesh-list
44616539|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616540|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
44616541|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616542|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616543|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616544|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
44616545|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616546|NCT00608023|Tesamorelin|tesamorelin|mesh-list
44616547|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44616548|NCT00608023|Growth Substances|growth substances|mesh-ancestor
44616549|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616550|NCT00608023|Hormones|hormones|mesh-ancestor
43870316|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616551|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616552|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44616553|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44616554|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616555|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616556|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616557|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44616558|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616559|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616560|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44616561|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44616562|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616563|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616564|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616565|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616566|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616567|NCT00607789|Analgesics|analgesics|mesh-ancestor
44616568|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
44445977|NCT01817582|Cyclosporine|cyclosporine|mesh-list
44616570|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616571|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616572|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
44616573|NCT00607373|Mipomersen|mipomersen|mesh-list
44616574|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44616575|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44616576|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
44616577|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616578|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44616579|NCT00607087|Insulin|insulin|mesh-list
44616580|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44616581|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
44616582|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
44616583|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
44616584|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616585|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616586|NCT00607048|Paclitaxel|paclitaxel|mesh-list
44616587|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44616588|NCT00607048|Carboplatin|carboplatin|mesh-list
44616589|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44616590|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44616591|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616592|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
44616593|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
44616594|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
44616595|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616596|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
44616597|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616598|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
44616599|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
44616600|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44616601|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44616602|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
44616603|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616604|NCT00606892|Nicotine|nicotine|mesh-list
44616605|NCT00606892|Varenicline|varenicline|mesh-list
44616606|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44616607|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
44616608|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772302|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
44616609|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616610|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44616611|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44616612|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
44616613|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616614|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616615|NCT00606801|Galantamine|galantamine|mesh-list
44616616|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44616617|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616618|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616619|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
44616620|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616621|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616622|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44616623|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
44616624|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616625|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
44616626|NCT00606580|Paromomycin|paromomycin|mesh-list
44616627|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44616628|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616629|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44616630|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44616632|NCT00606502|Folic Acid|folic acid|mesh-list
44616633|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
44616634|NCT00606502|Hydroxocobalamin|hydroxocobalamin|mesh-list
44616635|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
44616636|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44616637|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44616638|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
44616639|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616640|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616641|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616642|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616643|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616644|NCT00606502|Hematinics|hematinics|mesh-ancestor
44616645|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44616647|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616648|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616649|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616650|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616651|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616652|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616653|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
44616654|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
44616655|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616656|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616657|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44616658|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44616659|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
44616660|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616661|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616662|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616663|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616664|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44616665|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44616666|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616667|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616668|NCT00606294|Misonidazole|misonidazole|mesh-list
44616669|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616670|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44616671|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44616672|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616673|NCT00606281|Aripiprazole|aripiprazole|mesh-list
44616674|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616675|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616676|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616677|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616678|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616679|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616680|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
44616681|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
44616682|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235691|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
44616683|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616684|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44616685|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44616686|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
44616687|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616688|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616689|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616690|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616691|NCT00606229|Aripiprazole|aripiprazole|mesh-list
44616692|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616693|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616694|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616695|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616696|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870478|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
44616697|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616698|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
44616699|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
44616700|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616701|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616702|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44616703|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44616704|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
44616705|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616706|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616707|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616708|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616709|NCT00606177|Aripiprazole|aripiprazole|mesh-list
44616710|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616711|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616712|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616713|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616714|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616715|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616716|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
44616717|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
44616718|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616719|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616720|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44616721|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44616722|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
44616723|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616724|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616725|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616726|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616727|NCT00606086|Interferons|interferons|mesh-list
44616728|NCT00606086|Ribavirin|ribavirin|mesh-list
44616729|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44616730|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
44616731|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616732|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
44616733|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616734|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
44616735|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616736|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
44616737|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616738|NCT00606034|Insulin|insulin|mesh-list
44616739|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616740|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616741|NCT00606021|Pemetrexed|pemetrexed|mesh-list
44616742|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616743|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616744|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616745|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44616746|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44616747|NCT00606008|Sunitinib|sunitinib|mesh-list
44616748|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616749|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44616750|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44616751|NCT00606008|Growth Substances|growth substances|mesh-ancestor
44616752|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616753|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
44616754|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616755|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616756|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616757|NCT00605917|Sertraline|sertraline|mesh-list
44616758|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616759|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616760|NCT00605917|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44616761|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616762|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616763|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616764|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616765|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
44616766|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616767|NCT00605865|Sertraline|sertraline|mesh-list
44616768|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616769|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616770|NCT00605865|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44616771|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616772|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616773|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616774|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616775|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
43870541|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
44616776|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616777|NCT00605813|Sertraline|sertraline|mesh-list
44616778|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44616779|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616780|NCT00605813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44616781|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44616782|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44616783|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616784|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616785|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
44616786|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616787|NCT00605722|Bevacizumab|bevacizumab|mesh-list
44616788|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44616789|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44616790|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616791|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44616792|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44616793|NCT00605722|Growth Substances|growth substances|mesh-ancestor
44616794|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616795|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44616796|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616797|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616798|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616800|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
44616801|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616802|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616803|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
44616804|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616805|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616806|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
44616807|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616808|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616809|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616810|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
44616811|NCT00605566|Sorafenib|sorafenib|mesh-list
44616812|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616813|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
44616814|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616815|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44616816|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44616817|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
44616818|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616819|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616820|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44616821|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616822|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616823|NCT00605475|Metformin|metformin|mesh-list
43870543|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
44616824|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44616825|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616826|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
44616827|NCT00605345|Hematinics|hematinics|mesh-ancestor
44616828|NCT00605319|Fesoterodine|fesoterodine|mesh-list
44616829|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44616830|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44616831|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
44616832|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616833|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616834|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616835|NCT00605319|Urological Agents|urological agents|mesh-ancestor
44616836|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
44616837|NCT00605306|Maleic acid|maleic acid|mesh-list
44616838|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616839|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616840|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616841|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44616842|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44616843|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
44616844|NCT00605293|Hematinics|hematinics|mesh-ancestor
44616845|NCT00605267|Tamoxifen|tamoxifen|mesh-list
44616846|NCT00605267|Goserelin|goserelin|mesh-list
44616847|NCT00605267|Anastrozole|anastrozole|mesh-list
44616848|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44616849|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
44616850|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616851|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616852|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44616853|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616854|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44616855|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44616856|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44616857|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44616858|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44616859|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616860|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616861|NCT00605215|Interferons|interferons|mesh-list
44616862|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
44616863|NCT00605215|Interferon-beta|interferon-beta|mesh-list
44616864|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616865|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
44616866|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616867|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44616868|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
44616869|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616870|NCT00605176|Imiquimod|imiquimod|mesh-list
44616871|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44616872|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
44616873|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870636|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44616874|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616875|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
44616876|NCT00605033|Buprenorphine|buprenorphine|mesh-list
44616877|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44616878|NCT00605033|Naloxone|naloxone|mesh-list
44616879|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44616880|NCT00605033|Narcotics|narcotics|mesh-ancestor
44616881|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616882|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616883|NCT00605033|Analgesics|analgesics|mesh-ancestor
44616884|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
44616885|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616886|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44616887|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44616888|NCT00604825|Estrogens|estrogens|mesh-ancestor
44616889|NCT00604825|Hormones|hormones|mesh-ancestor
44616890|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44616891|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616892|NCT00604786|Omalizumab|omalizumab|mesh-list
44616893|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44616894|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44616895|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
44616896|NCT00604708|Vaccines|vaccines|mesh-list
44616897|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
44616898|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616899|NCT00604695|Tenecteplase|tenecteplase|mesh-list
44616900|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44616901|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44616902|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616903|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
44616904|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
44616905|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44616907|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616908|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616909|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44616910|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44616911|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44616912|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44616913|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44616914|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
44616915|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616916|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616917|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616918|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
44616919|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44616920|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
44616921|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616922|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616923|NCT00604279|Risperidone|risperidone|mesh-list
44616924|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44616925|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44616926|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
44616927|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616928|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616929|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616930|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44616931|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616932|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616933|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616934|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44616935|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
44616936|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44616937|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44616938|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44616939|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616940|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44616941|NCT00604188|Buprenorphine|buprenorphine|mesh-list
44616942|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44616943|NCT00604188|Narcotics|narcotics|mesh-ancestor
44616944|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616945|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616946|NCT00604188|Analgesics|analgesics|mesh-ancestor
44616947|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
44616948|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616949|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44616951|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44616952|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44616953|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616954|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44616955|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44616956|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44616957|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
44616958|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
44616959|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44616960|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616961|NCT00603941|Paclitaxel|paclitaxel|mesh-list
44616962|NCT00603941|Efatutazone|efatutazone|mesh-list
44616963|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44616964|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616965|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44616966|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44616967|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44616968|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616969|NCT00603915|Gemcitabine|gemcitabine|mesh-list
44616970|NCT00603915|Cisplatin|cisplatin|mesh-list
44616971|NCT00603915|Carboplatin|carboplatin|mesh-list
44616972|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44616973|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44616974|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44616975|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
44616976|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44616977|NCT00603915|Antiviral Agents|antiviral agents|mesh-ancestor
44616978|NCT00603915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44616979|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44616980|NCT00603915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44616982|NCT00603915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616983|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44616995|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44616996|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44616997|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44616998|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44616999|NCT00603538|Paclitaxel|paclitaxel|mesh-list
44617000|NCT00603538|Carboplatin|carboplatin|mesh-list
44617001|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617002|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617003|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617004|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617005|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617006|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617007|NCT00603525|Ofatumumab|ofatumumab|mesh-list
44617008|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617009|NCT00603512|Tofacitinib|tofacitinib|mesh-list
44617010|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44617011|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617012|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617013|NCT00603473|Gabapentin|gabapentin|mesh-list
44617014|NCT00603473|Analgesics|analgesics|mesh-ancestor
44617015|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
44617016|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617017|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617018|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
44617019|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617020|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617021|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617022|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617023|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44617024|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44134939|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617025|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617026|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617027|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
44617028|NCT00603447|Dexamethasone|dexamethasone|mesh-list
44617029|NCT00603447|Lenalidomide|lenalidomide|mesh-list
44617030|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617031|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
44617032|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
44617033|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617034|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617035|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617036|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
44617037|NCT00603447|Hormones|hormones|mesh-ancestor
44617038|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617039|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617040|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617041|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
44617042|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617043|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617044|NCT00603447|Growth Substances|growth substances|mesh-ancestor
44617045|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617046|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
44617047|NCT00603304|Urological Agents|urological agents|mesh-ancestor
44617048|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44617049|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44617050|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617051|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617052|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617053|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617054|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617055|NCT00603265|Analgesics|analgesics|mesh-ancestor
44617056|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
44617057|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617058|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617059|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617060|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
44617061|NCT00603239|Exenatide|exenatide|mesh-list
44617062|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617063|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617064|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44617065|NCT00603239|Incretins|incretins|mesh-ancestor
44617066|NCT00603239|Hormones|hormones|mesh-ancestor
44617067|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617068|NCT00602927|Varenicline|varenicline|mesh-list
44446506|NCT01808144|Febuxostat|febuxostat|mesh-list
44617069|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44617070|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44617071|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
44617072|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617073|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617074|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617076|NCT00602797|Vinorelbine|vinorelbine|mesh-list
44617077|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44617078|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617079|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617080|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617081|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617082|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617083|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617084|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
44617085|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44617086|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617087|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617088|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617089|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617090|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
44617091|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617092|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617093|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617094|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44617095|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617096|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617097|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617098|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44617099|NCT00602472|Linagliptin|linagliptin|mesh-list
44617100|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617101|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617102|NCT00602472|Incretins|incretins|mesh-ancestor
44617103|NCT00602472|Hormones|hormones|mesh-ancestor
44617104|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617105|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44617106|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
44617107|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870768|NCT03808610|Cytarabine|cytarabine|mesh-list
43870809|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617108|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617109|NCT00602420|Naproxen|naproxen|mesh-list
44617110|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617111|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617112|NCT00602420|Analgesics|analgesics|mesh-ancestor
44617113|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
44617114|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617115|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617116|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617117|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617118|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
44617119|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44617120|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617121|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617122|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44617123|NCT00602030|Entinostat|entinostat|mesh-list
44617124|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617125|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44617126|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617127|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617128|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44617129|NCT00601835|Vaccines|vaccines|mesh-list
44617130|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
44617131|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617132|NCT00601705|Cisplatin|cisplatin|mesh-list
44617133|NCT00601705|Fluorouracil|fluorouracil|mesh-list
44617134|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
44617135|NCT00601705|Epirubicin|epirubicin|mesh-list
44617136|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617137|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
43772589|NCT02365493|Cloxacillin|cloxacillin|mesh-list
44617138|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617139|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617140|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617141|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
44617142|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617143|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44617144|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44617145|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44617146|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617147|NCT00601640|Eflornithine|eflornithine|mesh-list
44617148|NCT00601640|Diclofenac|diclofenac|mesh-list
44617149|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617150|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617151|NCT00601640|Analgesics|analgesics|mesh-ancestor
44617152|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
44617153|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617154|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617155|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617156|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617157|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44617158|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617159|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617160|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617161|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44617162|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44617163|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44617164|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617165|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44617166|NCT00601523|Pramipexole|pramipexole|mesh-list
44617167|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
44617168|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617169|NCT00601523|Protective Agents|protective agents|mesh-ancestor
44617170|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617171|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44617172|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44617173|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617174|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
44617175|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617176|NCT00601484|Tanezumab|tanezumab|mesh-list
44617177|NCT00601484|Analgesics|analgesics|mesh-ancestor
44617178|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
44617179|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617180|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617181|NCT00601458|Naproxen|naproxen|mesh-list
44617182|NCT00601458|Pregabalin|pregabalin|mesh-list
44617183|NCT00601458|Analgesics|analgesics|mesh-ancestor
44617184|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
44617185|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617186|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617187|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
44617188|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44617189|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617190|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617191|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44617192|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617193|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617194|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617195|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617196|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617197|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617198|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617199|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617201|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44617202|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617203|NCT00601354|Orlistat|orlistat|mesh-list
44617204|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617205|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617206|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44617207|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44617208|NCT00601250|Linagliptin|linagliptin|mesh-list
44617209|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617210|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617211|NCT00601250|Incretins|incretins|mesh-ancestor
44617212|NCT00601250|Hormones|hormones|mesh-ancestor
44617213|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617214|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44617215|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
44617216|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617217|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617219|NCT00601172|Ondansetron|ondansetron|mesh-list
44617220|NCT00601172|Casopitant|casopitant|mesh-list
44617221|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617222|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
44617223|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
44617224|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617225|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617226|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617227|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
44617228|NCT00601172|Hormones|hormones|mesh-ancestor
44617229|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617230|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617231|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617232|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
44617233|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44617234|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617235|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
44617236|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617237|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617238|NCT00601172|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44617239|NCT00601172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617240|NCT00601172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617241|NCT00601172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617242|NCT00601172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617243|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44617244|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44617245|NCT00601107|Vitamins|vitamins|mesh-ancestor
44617246|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
44617247|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617248|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44617249|NCT00600938|Deferasirox|deferasirox|mesh-list
44617250|NCT00600938|Deferoxamine|deferoxamine|mesh-list
44617251|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44617252|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
44617253|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
44617254|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617255|NCT00600938|Siderophores|siderophores|mesh-ancestor
44617256|NCT00600886|Octreotide|octreotide|mesh-list
44617257|NCT00600886|Pasireotide|pasireotide|mesh-list
44617258|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617259|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617260|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617261|NCT00600886|Hormones|hormones|mesh-ancestor
44617262|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617263|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617264|NCT00600821|Paclitaxel|paclitaxel|mesh-list
44617265|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44617266|NCT00600821|Bevacizumab|bevacizumab|mesh-list
44617267|NCT00600821|Carboplatin|carboplatin|mesh-list
44617268|NCT00600821|Axitinib|axitinib|mesh-list
44617269|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617270|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617271|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617272|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617273|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617274|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617275|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617276|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617277|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617278|NCT00600821|Growth Substances|growth substances|mesh-ancestor
44617279|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617280|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617281|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44617282|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617284|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44617285|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617286|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
44617287|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617288|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617289|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617290|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44617291|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617292|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617293|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617294|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44617295|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
44617296|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617297|NCT00600483|Gentamicins|gentamicins|mesh-list
44617298|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44617299|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617300|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44617301|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617302|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617303|NCT00600353|Dexamethasone|dexamethasone|mesh-list
44617304|NCT00600353|Aprepitant|aprepitant|mesh-list
44617305|NCT00600353|Palonosetron|palonosetron|mesh-list
44617306|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617307|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
44617308|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
44617309|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617310|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617311|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617312|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
44617313|NCT00600353|Hormones|hormones|mesh-ancestor
44617314|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617315|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617316|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617317|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44617318|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617319|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617320|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44617321|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617322|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
44617323|NCT00600119|Naloxegol|naloxegol|mesh-list
44617324|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44617325|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617326|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
44617327|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617328|NCT00600067|Topiramate|topiramate|mesh-list
44617329|NCT00600067|Phentermine|phentermine|mesh-list
44617330|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
44617331|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617332|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617333|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44617334|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
44617335|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44617336|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
44617337|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
44617338|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617339|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
44617340|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617341|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617342|NCT00600028|Thalidomide|thalidomide|mesh-list
44617343|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617344|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
44617345|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617346|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
44617347|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44617348|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617349|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44014159|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
44617350|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617351|NCT00600028|Growth Substances|growth substances|mesh-ancestor
44617352|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617353|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617354|NCT00599924|Leucovorin|leucovorin|mesh-list
44617355|NCT00599924|Sunitinib|sunitinib|mesh-list
44617356|NCT00599924|Fluorouracil|fluorouracil|mesh-list
44617357|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
44617358|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617359|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617360|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617361|NCT00599924|Growth Substances|growth substances|mesh-ancestor
44617362|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617363|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617364|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44617365|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446805|NCT01802385|Sertraline|sertraline|mesh-list
44617366|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617367|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
44617368|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617369|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617370|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
44617371|NCT00599924|Antidotes|antidotes|mesh-ancestor
44617372|NCT00599924|Protective Agents|protective agents|mesh-ancestor
44617373|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
44617374|NCT00599924|Vitamins|vitamins|mesh-ancestor
44617375|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
44617376|NCT00599755|Gemcitabine|gemcitabine|mesh-list
44617377|NCT00599755|Cisplatin|cisplatin|mesh-list
44617378|NCT00599755|Carboplatin|carboplatin|mesh-list
44617379|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617380|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617381|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
44617382|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617383|NCT00599755|Antiviral Agents|antiviral agents|mesh-ancestor
44617384|NCT00599755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617385|NCT00599755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617386|NCT00599755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617387|NCT00599755|Immunologic Factors|immunologic factors|mesh-ancestor
44617388|NCT00599755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617389|NCT00599638|Pregabalin|pregabalin|mesh-list
44617390|NCT00599638|Analgesics|analgesics|mesh-ancestor
44617391|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
44617392|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617393|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617394|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
44617395|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44617396|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617397|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617398|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44617399|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617400|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617401|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617402|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617403|NCT00599521|Adapalene|adapalene|mesh-list
44617404|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617405|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617406|NCT00599521|Analgesics|analgesics|mesh-ancestor
44617407|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
44617408|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617409|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617410|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617411|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617412|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
44617413|NCT00599326|Deferasirox|deferasirox|mesh-list
44617414|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44617415|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
44617416|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
44617417|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617418|NCT00599313|Sunitinib|sunitinib|mesh-list
44617419|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617420|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617421|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617422|NCT00599313|Growth Substances|growth substances|mesh-ancestor
44617423|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617424|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617425|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44617426|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617427|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617428|NCT00599196|Rotigotine|rotigotine|mesh-list
44617429|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617430|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
44617431|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617432|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617433|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617434|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
44617435|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617436|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
44617437|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44617438|NCT00598975|Irinotecan|irinotecan|mesh-list
44617439|NCT00598975|Cetuximab|cetuximab|mesh-list
44617440|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
44617441|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44617442|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44617443|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617479|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617480|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617481|NCT00598585|Urological Agents|urological agents|mesh-ancestor
44617482|NCT00598559|Acetaminophen|acetaminophen|mesh-list
44617483|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617484|NCT00598559|Analgesics|analgesics|mesh-ancestor
44617485|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
44617486|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617487|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617488|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
44617489|NCT00598481|Busulfan|busulfan|mesh-list
44617490|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
44617491|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617492|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617493|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
44617494|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617495|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44617496|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617497|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44617498|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
44617499|NCT00598442|Hematinics|hematinics|mesh-ancestor
44617500|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
44617501|NCT00598273|Hematinics|hematinics|mesh-ancestor
44617502|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
44617503|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44617504|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44617505|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
44617506|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
44617507|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617508|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617509|NCT00597766|Triamcinolone|triamcinolone|mesh-list
44617510|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44617511|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44617512|NCT00597766|Lidocaine|lidocaine|mesh-list
44617513|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44617514|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
44617515|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
44617516|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617517|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617518|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
44617519|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617520|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44617521|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44617522|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44617523|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617524|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617525|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617526|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
44617527|NCT00597766|Hormones|hormones|mesh-ancestor
44617528|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617529|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617530|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
44617531|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617532|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
44617533|NCT00597753|Hematinics|hematinics|mesh-ancestor
44617534|NCT00597701|Lorazepam|lorazepam|mesh-list
44617535|NCT00597701|Baclofen|baclofen|mesh-list
44617536|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44617537|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617538|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44617539|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617540|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44617541|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
44617542|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
44617543|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617544|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617545|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
43887475|NCT04552067|Enoxaparin|enoxaparin|mesh-list
44617546|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
44617547|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
44617548|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617549|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44617550|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617551|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44446986|NCT01797432|Triamcinolone|triamcinolone|mesh-list
44617552|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617553|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617554|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
44617556|NCT00597584|Hematinics|hematinics|mesh-ancestor
44617557|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
44617558|NCT00597519|Fludarabine|fludarabine|mesh-list
44617559|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617560|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
44617561|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617562|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617563|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44617564|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
44617565|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617566|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617567|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44617568|NCT00597506|Bevacizumab|bevacizumab|mesh-list
44617570|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617571|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617572|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617573|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617574|NCT00597506|Growth Substances|growth substances|mesh-ancestor
44617575|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617576|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617577|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617578|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
44617579|NCT00597116|Vinorelbine|vinorelbine|mesh-list
44617580|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617581|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617582|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617583|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617584|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617585|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617586|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
44617587|NCT00596947|Prednisone|prednisone|mesh-list
44136403|NCT00164710|Artesunate|artesunate|mesh-list
44617588|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
44617589|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44617590|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44617591|NCT00596947|Prednisolone|prednisolone|mesh-list
44617592|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
44617593|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44617594|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
44617595|NCT00596947|Tacrolimus|tacrolimus|mesh-list
44617596|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
44617597|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44617598|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617599|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
44617600|NCT00596947|Hormones|hormones|mesh-ancestor
44617601|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617602|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617603|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617604|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617605|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617606|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
44617607|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44617608|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617609|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617610|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44617611|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44617612|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
44617613|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44617614|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617615|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
44617616|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
44617617|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617618|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617619|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44617620|NCT00596947|Protective Agents|protective agents|mesh-ancestor
44617621|NCT00596830|Paclitaxel|paclitaxel|mesh-list
44617622|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44617623|NCT00596830|Carboplatin|carboplatin|mesh-list
44617624|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617625|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617626|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617627|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617628|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617629|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617630|NCT00596817|Vortioxetine|vortioxetine|mesh-list
44617631|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617632|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617633|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617634|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617635|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617636|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617637|NCT00596817|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44617638|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617639|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617640|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617641|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617642|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
44617643|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44617644|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44617645|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44617646|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617647|NCT00596752|Alprostadil|alprostadil|mesh-list
44617648|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44617649|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
44617650|NCT00596752|Urological Agents|urological agents|mesh-ancestor
44617651|NCT00596687|Insulin|insulin|mesh-list
44617652|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44617653|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
44617654|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
44617655|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617656|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617657|NCT00596466|Pregabalin|pregabalin|mesh-list
44617658|NCT00596466|Analgesics|analgesics|mesh-ancestor
44617659|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
44617660|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617661|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617662|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
44617663|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44617664|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617665|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617666|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44617667|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44617668|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617669|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617670|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617671|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44617672|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43887585|NCT04550234|Verinurad|verinurad|mesh-list
44617673|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44617674|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
44617675|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617676|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44617677|NCT00596362|Bevacizumab|bevacizumab|mesh-list
44617678|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617679|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617680|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44617681|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44617682|NCT00596362|Growth Substances|growth substances|mesh-ancestor
44617683|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617684|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
44617685|NCT00595920|Vaccines|vaccines|mesh-list
44617686|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
43773172|NCT02361177|Oxytocin|oxytocin|mesh-list
44617687|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617688|NCT00595868|Varenicline|varenicline|mesh-list
44617689|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44617690|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44617691|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
44617692|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617693|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617694|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617695|NCT00595582|Curcumin|curcumin|mesh-list
44617696|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617697|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617698|NCT00595582|Analgesics|analgesics|mesh-ancestor
44617699|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
44617700|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617701|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617702|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617703|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617704|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617705|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617706|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617708|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44617709|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617710|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44617711|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617712|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617713|NCT00595413|Adalimumab|adalimumab|mesh-list
44617714|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617715|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617716|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
44617717|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44617718|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44617719|NCT00595335|Prednisolone|prednisolone|mesh-list
44617720|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
44617721|NCT00595335|Rituximab|rituximab|mesh-list
44617722|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44617723|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
44617724|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617725|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617726|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
44617727|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617728|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617729|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617730|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
44617731|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
44617732|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617733|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617734|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
44617735|NCT00595335|Hormones|hormones|mesh-ancestor
44617736|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617737|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44617738|NCT00595335|Protective Agents|protective agents|mesh-ancestor
44617739|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44617740|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
44617741|NCT00595127|Fludarabine|fludarabine|mesh-list
44617742|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617743|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
44617744|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617745|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617746|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44617747|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
44617748|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887642|NCT04549012|Coagulants|coagulants|mesh-ancestor
44617749|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617750|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44617751|NCT00594958|Vaccines|vaccines|mesh-list
44617752|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
44617753|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617754|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
44617755|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44617756|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617757|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44617758|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
44617759|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44617760|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617761|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617762|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617763|NCT00594906|Teriparatide|teriparatide|mesh-list
44617764|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44617765|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617766|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44617767|NCT00594880|Interferons|interferons|mesh-list
44617768|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
44617769|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
44617770|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44617771|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617772|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
44617773|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617774|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
44617775|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617776|NCT00594854|Diclofenac|diclofenac|mesh-list
44617777|NCT00594854|Arthrotec|arthrotec|mesh-list
44617778|NCT00594854|Misoprostol|misoprostol|mesh-list
44617779|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44617780|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
44617781|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44617782|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617783|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43887689|NCT04548284|Hormones|hormones|mesh-ancestor
44617784|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44617785|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
44617786|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44617787|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44617788|NCT00594854|Analgesics|analgesics|mesh-ancestor
44617789|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
44617790|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617791|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44617792|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617793|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44617794|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617795|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617796|NCT00594815|Leucovorin|leucovorin|mesh-list
44617797|NCT00594815|Cytarabine|cytarabine|mesh-list
44617798|NCT00594815|Rituximab|rituximab|mesh-list
44617799|NCT00594815|Methotrexate|methotrexate|mesh-list
44617800|NCT00594815|Vincristine|vincristine|mesh-list
44617801|NCT00594815|Procarbazine|procarbazine|mesh-list
44617802|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44617803|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617804|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
44617805|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617806|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44617807|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44617808|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
44617809|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44617810|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617811|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
44617812|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617813|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44617814|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617815|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44617816|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617817|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44617818|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
44617819|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617820|NCT00594815|Antidotes|antidotes|mesh-ancestor
44617821|NCT00594815|Protective Agents|protective agents|mesh-ancestor
44617822|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
44617823|NCT00594815|Vitamins|vitamins|mesh-ancestor
44617824|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
44617825|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44617826|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617827|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617828|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617829|NCT00594646|Tenofovir|tenofovir|mesh-list
44617830|NCT00594646|Emtricitabine|emtricitabine|mesh-list
44617831|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
44617832|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44617833|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
44617834|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44617835|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44617836|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43887714|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
44617838|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617839|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44617840|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44617841|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44617842|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44617843|NCT00594516|Tapentadol|tapentadol|mesh-list
44617844|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44617845|NCT00594516|Narcotics|narcotics|mesh-ancestor
44617846|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617847|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617848|NCT00594516|Analgesics|analgesics|mesh-ancestor
44617849|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
44617850|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44617851|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44617852|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617853|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617854|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617855|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
44617856|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617857|NCT00594464|Rotigotine|rotigotine|mesh-list
44617858|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617859|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
44617860|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617861|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617862|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617863|NCT00594386|Rotigotine|rotigotine|mesh-list
44617864|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617865|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
44617866|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617867|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617868|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617869|NCT00594204|Varenicline|varenicline|mesh-list
44617870|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44617871|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44617872|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44617873|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617874|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617875|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617876|NCT00594165|Rotigotine|rotigotine|mesh-list
44617877|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617878|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
44617879|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887766|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44617880|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617881|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617882|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
44617883|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
44617884|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
44617885|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44617886|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44617887|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617888|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617889|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617891|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44617892|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44617893|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44617894|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617895|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617896|NCT00593606|Rotigotine|rotigotine|mesh-list
44617897|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617898|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
44617899|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617900|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617901|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617902|NCT00593554|Fludarabine|fludarabine|mesh-list
44617903|NCT00593554|Thiotepa|thiotepa|mesh-list
44617904|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
44617905|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44617906|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617907|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617908|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617909|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
44014679|NCT03287674|Nivolumab|nivolumab|mesh-list
44617910|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617911|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44617912|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
44617913|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44617914|NCT00593489|Insulin|insulin|mesh-list
44617915|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44617916|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617917|NCT00593112|Methylphenidate|methylphenidate|mesh-list
44617918|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44617919|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617920|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44617921|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617922|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617923|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617924|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
44617925|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617926|NCT00592852|Fluoxetine|fluoxetine|mesh-list
44617927|NCT00592852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44617928|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617929|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617930|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617931|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617932|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
44617933|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617934|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44617935|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617936|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617937|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44617938|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44617939|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44617940|NCT00592839|Estrogens|estrogens|mesh-list
44617941|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44617942|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
44617943|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
44617944|NCT00592839|Hormones|hormones|mesh-ancestor
44617945|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44617946|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617947|NCT00592683|Aripiprazole|aripiprazole|mesh-list
44617948|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617949|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617950|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44617951|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617952|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617953|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617954|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
44617955|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
44617956|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617957|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617958|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44617959|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44617960|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
44447433|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
44617961|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44617962|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617963|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44617964|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44617965|NCT00592501|Cisplatin|cisplatin|mesh-list
44617966|NCT00592501|Fluorouracil|fluorouracil|mesh-list
44617967|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44617968|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
44617969|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617970|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44617971|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44617972|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
44617973|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617974|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44617975|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44617976|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44617977|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44617978|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887787|NCT04547179|Erenumab|erenumab|mesh-list
44617979|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617980|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617981|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44617982|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
44617983|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617984|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44617985|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44617986|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44617987|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44617988|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44617989|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44617990|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44617991|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44617992|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
44617993|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44617994|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44617995|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44617996|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44617997|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
44617999|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44618000|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618001|NCT00592319|Analgesics|analgesics|mesh-ancestor
44618002|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
44618003|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618004|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618005|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618006|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618007|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43887840|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618008|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44618009|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618010|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618011|NCT00592072|Decanoic acid|decanoic acid|mesh-list
44618012|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
44618013|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618014|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44618015|NCT00592007|Fulvestrant|fulvestrant|mesh-list
44618016|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618017|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618018|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618019|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618020|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44618021|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44618022|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44618023|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
44618024|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44618025|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618026|NCT00591851|Paclitaxel|paclitaxel|mesh-list
44618027|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
44618028|NCT00591851|Doxorubicin|doxorubicin|mesh-list
44618029|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44618030|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618031|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618032|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618041|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
44618042|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44618043|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44618044|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44618045|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44618046|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618047|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
44618048|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44618049|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44618050|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44618051|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618052|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618053|NCT00591773|Diuretics|diuretics|mesh-ancestor
44618054|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
44618055|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618056|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44618057|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618058|NCT00591734|Bevacizumab|bevacizumab|mesh-list
44618059|NCT00591734|Everolimus|everolimus|mesh-list
44618060|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618061|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618062|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618063|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618064|NCT00591734|Growth Substances|growth substances|mesh-ancestor
44618065|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618066|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618067|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618068|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
44618069|NCT00591630|Cytarabine|cytarabine|mesh-list
44618070|NCT00591630|Rituximab|rituximab|mesh-list
44618071|NCT00591630|Etoposide|etoposide|mesh-list
44618072|NCT00591630|Melphalan|melphalan|mesh-list
44618073|NCT00591630|Carmustine|carmustine|mesh-list
44618074|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618075|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618076|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
44618077|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618078|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618079|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618080|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44618081|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44618082|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618083|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618084|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618085|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
44618086|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
44618087|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618088|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618089|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618090|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
44618091|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44618092|NCT00591578|Valsartan|valsartan|mesh-list
44618093|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44618094|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618095|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44618096|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43887909|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44618097|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618098|NCT00591565|Acamprosate|acamprosate|mesh-list
44618099|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44618100|NCT00591370|Temozolomide|temozolomide|mesh-list
44618101|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618102|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
44618103|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618104|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618105|NCT00591266|Amlodipine|amlodipine|mesh-list
44618106|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44618107|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618108|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44618109|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618110|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618111|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44618112|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618113|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
44618114|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44618115|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44618116|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44618117|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44618118|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44618119|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618120|NCT00591149|Docetaxel|docetaxel|mesh-list
44618121|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
44618122|NCT00591149|Cetuximab|cetuximab|mesh-list
44618123|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618124|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618125|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618126|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618127|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618128|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618129|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
44618130|NCT00591006|Phenytoin|phenytoin|mesh-list
44618131|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618133|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43887953|NCT04545450|Hormones|hormones|mesh-ancestor
43888000|NCT04544228|Ketamine|ketamine|mesh-list
44618134|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618135|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618136|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618137|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44618138|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44618139|NCT00590967|Cisplatin|cisplatin|mesh-list
44618140|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618141|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44618142|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618143|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618144|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618145|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618146|NCT00590824|Interleukin-2|interleukin-2|mesh-list
44618147|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618148|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618149|NCT00590824|Analgesics|analgesics|mesh-ancestor
44618150|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
44618151|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618152|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618153|NCT00590681|Bevacizumab|bevacizumab|mesh-list
44618154|NCT00590681|Temozolomide|temozolomide|mesh-list
44618155|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618156|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618157|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618158|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618159|NCT00590681|Growth Substances|growth substances|mesh-ancestor
44618160|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618161|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618162|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618163|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
44618164|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618165|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
44618166|NCT00590590|Promethazine|promethazine|mesh-list
44618167|NCT00590590|Lidocaine|lidocaine|mesh-list
44618168|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
44618169|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
44618170|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618171|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618172|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
44618173|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618174|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44618175|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44618176|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618177|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618178|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618179|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44618180|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44618181|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
44618182|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
44618183|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618184|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44618185|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
44618186|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
44618187|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618188|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44618189|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
44618190|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
44618191|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44618192|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44618193|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44618194|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618195|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618196|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44618197|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44618198|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44618199|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
44618200|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618201|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618202|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44618203|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44618204|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
44618205|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44618206|NCT00590538|Genistein|genistein|mesh-list
44618207|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618208|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44618209|NCT00590538|Protective Agents|protective agents|mesh-ancestor
44618210|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618211|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618212|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618213|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618214|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
44618215|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44618216|NCT00590538|Estrogens|estrogens|mesh-ancestor
44618217|NCT00590538|Hormones|hormones|mesh-ancestor
44618218|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44618219|NCT00590317|Ondansetron|ondansetron|mesh-list
44618220|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
44618221|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
44618222|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
44618223|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618224|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618225|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618226|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
44618227|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
44618228|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44618229|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
44618230|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618231|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618232|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44618233|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44618234|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618235|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44618236|NCT00590317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44618237|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44618238|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
44618239|NCT00590135|Atorvastatin|atorvastatin|mesh-list
44618240|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44618241|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44618242|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
44618243|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618244|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44618245|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44618246|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618247|NCT00590044|Insulin|insulin|mesh-list
44618248|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44618249|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
44618250|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
44618251|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44618252|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618253|NCT00590031|Cisplatin|cisplatin|mesh-list
44618254|NCT00590031|Irinotecan|irinotecan|mesh-list
44618255|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618256|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44618257|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44618258|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618259|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618260|NCT00589979|Lidocaine|lidocaine|mesh-list
44618261|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
44618262|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
44136549|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618263|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618264|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618265|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
44618266|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618267|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44618268|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44618269|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618270|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618271|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618272|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44618274|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44618275|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44618276|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618277|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618278|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44618279|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44618280|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44618282|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618283|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618284|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44618285|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44618286|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
44618287|NCT00589784|Sunitinib|sunitinib|mesh-list
44618288|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
44618289|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618290|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618291|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618292|NCT00589784|Growth Substances|growth substances|mesh-ancestor
44618293|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618294|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618295|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618296|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618297|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618298|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44618299|NCT00589693|Imipenem|imipenem|mesh-list
44618300|NCT00589693|Doripenem|doripenem|mesh-list
44618301|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44618302|NCT00589693|Cilastatin|cilastatin|mesh-list
44618303|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44618304|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618305|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
44618306|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618307|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618308|NCT00589667|Gemcitabine|gemcitabine|mesh-list
44618309|NCT00589667|Pemetrexed|pemetrexed|mesh-list
44618310|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618311|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
44618312|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618313|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618314|NCT00589667|Antiviral Agents|antiviral agents|mesh-ancestor
44618315|NCT00589667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618316|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618317|NCT00589667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618318|NCT00589667|Immunologic Factors|immunologic factors|mesh-ancestor
44618319|NCT00589667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618320|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44618321|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44618322|NCT00589628|Infliximab|infliximab|mesh-list
44618323|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44618324|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618325|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618326|NCT00589472|Vorinostat|vorinostat|mesh-list
44618327|NCT00589472|Leuprolide|leuprolide|mesh-list
44618328|NCT00589472|Goserelin|goserelin|mesh-list
44618329|NCT00589472|Bicalutamide|bicalutamide|mesh-list
44618330|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618331|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44618332|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618333|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618334|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44618335|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
44618336|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618337|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618338|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44618340|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
44618341|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44618342|NCT00589420|Docetaxel|docetaxel|mesh-list
44618343|NCT00589420|Sorafenib|sorafenib|mesh-list
44618344|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618345|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618346|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618347|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618348|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618349|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618350|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618351|NCT00589303|Metoprolol|metoprolol|mesh-list
44618352|NCT00589303|Amiodarone|amiodarone|mesh-list
44618353|NCT00589303|Verapamil|verapamil|mesh-list
44618354|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44618355|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618356|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
44618357|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
44618358|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618359|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618360|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44618361|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44618362|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44618363|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618364|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618365|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618366|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
44618367|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44618368|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618369|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618370|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44618371|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44618372|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618373|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44618374|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44618375|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44618376|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44618377|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44618378|NCT00589290|Belinostat|belinostat|mesh-list
44618379|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618380|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44618381|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618382|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618383|NCT00588952|Ketamine|ketamine|mesh-list
44618384|NCT00588952|Analgesics|analgesics|mesh-ancestor
44618385|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
44618386|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618387|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618388|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44618389|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44618390|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
44618391|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
44618392|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618393|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44618394|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44618395|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618396|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618397|NCT00588822|Rituximab|rituximab|mesh-list
44618398|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618399|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618400|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
44618401|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618402|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618403|NCT00588731|Cannabidiol|cannabidiol|mesh-list
44618404|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
44447884|NCT01780545|Docetaxel|docetaxel|mesh-list
44618405|NCT00588666|Gemcitabine|gemcitabine|mesh-list
44618406|NCT00588666|Bevacizumab|bevacizumab|mesh-list
44618407|NCT00588666|Carboplatin|carboplatin|mesh-list
44618408|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618409|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618410|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618411|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618412|NCT00588666|Growth Substances|growth substances|mesh-ancestor
44618413|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618414|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618415|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618416|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
44618417|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618418|NCT00588666|Antiviral Agents|antiviral agents|mesh-ancestor
44618419|NCT00588666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618420|NCT00588666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618421|NCT00588666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618422|NCT00588666|Immunologic Factors|immunologic factors|mesh-ancestor
44618423|NCT00588640|Methadone|methadone|mesh-list
44618424|NCT00588640|D-methadone|d-methadone|mesh-list
44618425|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44618426|NCT00588640|Narcotics|narcotics|mesh-ancestor
44618427|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618428|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618429|NCT00588640|Analgesics|analgesics|mesh-ancestor
44618430|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
44618431|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618432|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
44618433|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618434|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618435|NCT00588445|Gefitinib|gefitinib|mesh-list
44618436|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618437|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618438|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618439|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618440|NCT00588354|Triamcinolone|triamcinolone|mesh-list
44618441|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44618442|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44618443|NCT00588354|Lidocaine|lidocaine|mesh-list
44618444|NCT00588354|Clonidine|clonidine|mesh-list
44618445|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44618446|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
44618447|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
44618448|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618449|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618450|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
44618451|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618452|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44618453|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44618454|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618455|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618456|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618457|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618458|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
44618459|NCT00588354|Hormones|hormones|mesh-ancestor
44618460|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888218|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
44618461|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618462|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
44618463|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618464|NCT00588354|Analgesics|analgesics|mesh-ancestor
44618465|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618466|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
44618467|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
44618468|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44618469|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44618470|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44618471|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618472|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618473|NCT00588341|Temozolomide|temozolomide|mesh-list
44618474|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618475|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
44618476|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447957|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
44618477|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618478|NCT00588237|Paclitaxel|paclitaxel|mesh-list
44618479|NCT00588237|Bevacizumab|bevacizumab|mesh-list
44618480|NCT00588237|Cisplatin|cisplatin|mesh-list
44618481|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618482|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618483|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618484|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618485|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618486|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618487|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618488|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618489|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618490|NCT00588237|Growth Substances|growth substances|mesh-ancestor
44618491|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618492|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618493|NCT00588146|Interferons|interferons|mesh-list
44618494|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
44618495|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
44618496|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44618497|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618498|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
44618499|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618500|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
44618501|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618502|NCT00588094|Rituximab|rituximab|mesh-list
44618503|NCT00588094|Carboplatin|carboplatin|mesh-list
44618504|NCT00588094|Etoposide|etoposide|mesh-list
44618505|NCT00588094|Ifosfamide|ifosfamide|mesh-list
44618506|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618507|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618508|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
44618509|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618510|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618511|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618512|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44618513|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44618514|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618515|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618516|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618517|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
44618518|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
44618519|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618520|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618521|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
44618522|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618523|NCT00587431|Docetaxel|docetaxel|mesh-list
44618524|NCT00587431|Leuprolide|leuprolide|mesh-list
44618525|NCT00587431|Testosterone|testosterone|mesh-list
44618526|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618527|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618528|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618529|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
43888283|NCT04540666|Propofol|propofol|mesh-list
44618530|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618531|NCT00587431|Androgens|androgens|mesh-ancestor
44618532|NCT00587431|Hormones|hormones|mesh-ancestor
44618533|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44618534|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618535|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44618536|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44618537|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
44618538|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618539|NCT00587288|Reslizumab|reslizumab|mesh-list
44618540|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44618541|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618542|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
44618543|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618544|NCT00586898|Ketoconazole|ketoconazole|mesh-list
44618545|NCT00586898|Bicalutamide|bicalutamide|mesh-list
44618546|NCT00586898|Testosterone|testosterone|mesh-list
44618547|NCT00586898|Estrogens|estrogens|mesh-list
44618548|NCT00586898|Androgens|androgens|mesh-ancestor
44618549|NCT00586898|Hormones|hormones|mesh-ancestor
44618550|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44618551|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618552|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618553|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
44618554|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618555|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44618556|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44618577|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
44618578|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
44618579|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44618580|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618581|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
44618582|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618583|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44618584|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44618585|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44618586|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44618587|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618588|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44618589|NCT00586690|Antibodies|antibodies|mesh-list
44618590|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
44618591|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44618592|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
43888321|NCT04539314|Analgesics|analgesics|mesh-ancestor
43888363|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618593|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618594|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618595|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
44618596|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44618597|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44618598|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44618599|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
44618600|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44618601|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44618602|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
44618603|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618604|NCT00586521|Factor VIII|factor viii|mesh-list
44618605|NCT00586521|Coagulants|coagulants|mesh-ancestor
44618606|NCT00586508|Bevacizumab|bevacizumab|mesh-list
44618607|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
44618608|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44618609|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618610|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44618611|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44618612|NCT00586508|Growth Substances|growth substances|mesh-ancestor
44618613|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618614|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
44618615|NCT00586495|Sorafenib|sorafenib|mesh-list
44618616|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618617|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618618|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618619|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618620|NCT00586157|Methylphenidate|methylphenidate|mesh-list
44618621|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44618622|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618623|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44618624|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44618625|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618626|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618627|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
44618628|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618629|NCT00586105|Sorafenib|sorafenib|mesh-list
44618630|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618631|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618632|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618633|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618634|NCT00586066|Memantine|memantine|mesh-list
44618635|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44618636|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44618637|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
44618638|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618639|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618640|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618641|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44618642|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44618643|NCT00585975|Bromfenac|bromfenac|mesh-list
44618644|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44618645|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44618646|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44618647|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618648|NCT00585975|Analgesics|analgesics|mesh-ancestor
44618649|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
44618650|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618651|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618652|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618653|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618654|NCT00585689|Gemcitabine|gemcitabine|mesh-list
44618655|NCT00585689|Carboplatin|carboplatin|mesh-list
44618656|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44618657|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618658|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618659|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
44618660|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618661|NCT00585689|Antiviral Agents|antiviral agents|mesh-ancestor
44618662|NCT00585689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618663|NCT00585689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618664|NCT00585689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618665|NCT00585689|Immunologic Factors|immunologic factors|mesh-ancestor
44618666|NCT00585689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618667|NCT00585585|Betahistine|betahistine|mesh-list
44618668|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
44618669|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
44618670|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
43773173|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
44618671|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618672|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618673|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618674|NCT00585546|Clenbuterol|clenbuterol|mesh-list
44618675|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44618676|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44618677|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618678|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618679|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618680|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618681|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44618682|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
44618683|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618684|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44618685|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618686|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
44618687|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44618688|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618689|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618690|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618691|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618692|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
44618693|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44618694|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618695|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44618696|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
44618697|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44618698|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618699|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618700|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618702|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44618703|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44618704|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618705|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44618706|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
44618707|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
44618708|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618709|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618710|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618711|NCT00585325|Lidocaine|lidocaine|mesh-list
44618712|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44618713|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
44618714|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618715|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618716|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
44618717|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618718|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44618719|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44618720|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44618721|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618722|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618723|NCT00585312|Celecoxib|celecoxib|mesh-list
44448196|NCT01774968|Insulin|insulin|mesh-list
44618724|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44618725|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618726|NCT00585312|Analgesics|analgesics|mesh-ancestor
44618727|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
44618728|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618729|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618730|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618731|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618732|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44618733|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44618734|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618735|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618736|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44618737|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
44618738|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618739|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618740|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618741|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618742|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
44618743|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618745|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44618746|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44618747|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
44618748|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618749|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618750|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618751|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44618752|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44618753|NCT00585078|Capecitabine|capecitabine|mesh-list
44618754|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
44618755|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618756|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
44618757|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618758|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618759|NCT00585052|Paclitaxel|paclitaxel|mesh-list
44618760|NCT00585052|Lovastatin|lovastatin|mesh-list
44618761|NCT00585052|L 647318|l 647318|mesh-list
44618762|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
44618763|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618764|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618765|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618766|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618767|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618768|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618769|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44618770|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44618771|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
44618772|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44618773|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44618774|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618775|NCT00585039|Albuterol|albuterol|mesh-list
44618776|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44618777|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
44618778|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618779|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618780|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44618781|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618782|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
44618783|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618784|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44618785|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44618786|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44618787|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618788|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618789|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618790|NCT00584987|Fluticasone|fluticasone|mesh-list
44618791|NCT00584987|Xhance|xhance|mesh-list
44618792|NCT00584987|Phenylephrine|phenylephrine|mesh-list
44618793|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
43871132|NCT02661035|Tacrolimus|tacrolimus|mesh-list
44618794|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618795|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44618796|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
44618797|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618798|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618799|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44618800|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618801|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44618802|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44618803|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44618804|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44618805|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618806|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618807|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618808|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
44618809|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
44618810|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44618811|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44618812|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
44618813|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44618814|NCT00584987|Protective Agents|protective agents|mesh-ancestor
44618815|NCT00584909|Paclitaxel|paclitaxel|mesh-list
44618816|NCT00584909|Carboplatin|carboplatin|mesh-list
44618817|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44618818|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618819|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618820|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
44618821|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618822|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618823|NCT00584870|Naproxen|naproxen|mesh-list
44618824|NCT00584870|Tanezumab|tanezumab|mesh-list
44618825|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44618826|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618827|NCT00584870|Analgesics|analgesics|mesh-ancestor
44618828|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
44618829|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618830|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618831|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618832|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618833|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
44618834|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44618835|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618836|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618837|NCT00584012|Docetaxel|docetaxel|mesh-list
44618838|NCT00584012|Lovastatin|lovastatin|mesh-list
44618839|NCT00584012|L 647318|l 647318|mesh-list
44618840|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
44618841|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618842|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44618843|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
43888513|NCT04536831|Vitamin D|vitamin d|mesh-list
44618844|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44618845|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618846|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44618847|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44618848|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
44618849|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44618850|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44618851|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618852|NCT00583947|Albuterol|albuterol|mesh-list
44618853|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
44618854|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44618855|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
44618856|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618857|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618858|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44618859|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
44618860|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
44618861|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618862|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44618863|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44618864|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44618865|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44618866|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618867|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618868|NCT00583557|Belimumab|belimumab|mesh-list
44618869|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618870|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
44618871|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618872|NCT00583453|Celecoxib|celecoxib|mesh-list
44618873|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44618874|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618875|NCT00583453|Analgesics|analgesics|mesh-ancestor
44618876|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
44618877|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618878|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618879|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618880|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44618881|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44618882|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44136575|NCT00165139|Melphalan|melphalan|mesh-list
44618883|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618884|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618885|NCT00583362|Belimumab|belimumab|mesh-list
44618886|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618887|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
44618888|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618889|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44618890|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44618891|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44618892|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44618893|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44618894|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618895|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
44618896|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44618897|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618898|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44618899|NCT00583219|Protective Agents|protective agents|mesh-ancestor
44618900|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44618901|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
44618902|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44618903|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618904|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
44618905|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618906|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618907|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618908|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618909|NCT00583102|Cytarabine|cytarabine|mesh-list
44618910|NCT00583102|Lovastatin|lovastatin|mesh-list
44618911|NCT00583102|L 647318|l 647318|mesh-list
44618912|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
44618913|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618914|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
44618915|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618916|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618917|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
44618918|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618919|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618920|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
44618921|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618922|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44618923|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44618924|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44618925|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44618926|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618927|NCT00582972|Omeprazole|omeprazole|mesh-list
44618928|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44618929|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618930|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44618931|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618932|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618933|NCT00582933|Vidarabine|vidarabine|mesh-list
44618934|NCT00582933|Fludarabine|fludarabine|mesh-list
44618935|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
44618936|NCT00582933|Melphalan|melphalan|mesh-list
44618937|NCT00582933|Busulfan|busulfan|mesh-list
44618938|NCT00582933|Lenograstim|lenograstim|mesh-list
44618939|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618940|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44618941|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
44618942|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618943|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618944|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
44618945|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618946|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
44618947|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44618948|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44618949|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
44618950|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44618951|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44618952|NCT00582907|Rilonacept|rilonacept|mesh-list
44618953|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44618954|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
44618955|NCT00582790|Interleukin-2|interleukin-2|mesh-list
44618956|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618957|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44618958|NCT00582790|Analgesics|analgesics|mesh-ancestor
44618959|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
44618960|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44618961|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618962|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44618963|NCT00582738|Everolimus|everolimus|mesh-list
44618964|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618965|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44618966|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
44618967|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888570|NCT04535973|Hormones|hormones|mesh-list
43888613|NCT04535960|Hormones|hormones|mesh-ancestor
44618968|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
44618969|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
44618970|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44618971|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618972|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618973|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
44618974|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44618975|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44618976|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618977|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
44618978|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44618979|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44618980|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618981|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
44618983|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44618984|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618985|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44618986|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
44618987|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44618988|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44618989|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44618990|NCT00582491|Modafinil|modafinil|mesh-list
44618991|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44618992|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44618993|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44618994|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44618995|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44618996|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44618997|NCT00582426|Octreotide|octreotide|mesh-list
44618998|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44618999|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619000|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619001|NCT00582309|Insulin|insulin|mesh-list
44619002|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44619003|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619004|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888617|NCT04536181|Prednisone|prednisone|mesh-list
44619005|NCT00582166|Rituximab|rituximab|mesh-list
44619006|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44619007|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619008|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619009|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
44619010|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619011|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619012|NCT00582114|Atenolol|atenolol|mesh-list
44619013|NCT00582114|Lisinopril|lisinopril|mesh-list
44619014|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44619015|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
44619016|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619017|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619018|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44619019|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44619020|NCT00582114|Protective Agents|protective agents|mesh-ancestor
44619021|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619022|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44619023|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
44619024|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
44619025|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619026|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44619027|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44619028|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44619029|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44619030|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619031|NCT00582036|Insulin|insulin|mesh-list
44619032|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44619033|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619034|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619035|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
44619036|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44619037|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
44619038|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619039|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619040|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44015700|NCT03415581|Oxycodone|oxycodone|mesh-list
44619041|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619042|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44619043|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
44619044|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619045|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619046|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44619047|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44619048|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
44619049|NCT00582010|Protective Agents|protective agents|mesh-ancestor
44619050|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
44619051|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619052|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
44619053|NCT00581919|Vitamins|vitamins|mesh-ancestor
44619054|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
44619055|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
44619056|NCT00581893|Phenytoin|phenytoin|mesh-list
44619057|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
44619058|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44619059|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44619060|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619061|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619062|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44619063|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44619064|NCT00581828|Vitamin D|vitamin d|mesh-list
44619065|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
44619066|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
44619067|NCT00581828|Vitamins|vitamins|mesh-list
44619068|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
44619069|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619070|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44619071|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619072|NCT00581776|Dexamethasone|dexamethasone|mesh-list
44619073|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
44619074|NCT00581776|Rituximab|rituximab|mesh-list
44619075|NCT00581776|Doxorubicin|doxorubicin|mesh-list
44619076|NCT00581776|Vincristine|vincristine|mesh-list
44619077|NCT00581776|Bortezomib|bortezomib|mesh-list
44619078|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619079|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
44619080|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619081|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619082|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619083|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
44619084|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619085|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619086|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619087|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619088|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619089|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
44619090|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
44619091|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619092|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619093|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
44619094|NCT00581776|Hormones|hormones|mesh-ancestor
44619095|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619096|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619097|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619098|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619099|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619100|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888704|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619101|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619102|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
44619103|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
44619104|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619105|NCT00581555|Etanercept|etanercept|mesh-list
44619106|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44619107|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44619108|NCT00581555|Analgesics|analgesics|mesh-ancestor
44619109|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
44619110|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619111|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619112|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619113|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619114|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619115|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619116|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
44619149|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619150|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619151|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44619152|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44619153|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619154|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619155|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
44619156|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619157|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619158|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
44619159|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619161|NCT00580970|L 647318|l 647318|mesh-list
44619162|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
44619163|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44619164|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44619165|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
44619166|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619167|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44619168|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44619169|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619170|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
44619171|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619172|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
44619173|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888752|NCT04533984|Teriparatide|teriparatide|mesh-list
44619174|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619175|NCT00580801|Interferons|interferons|mesh-list
44619176|NCT00580801|Ribavirin|ribavirin|mesh-list
44619177|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
44619178|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
44619179|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44619180|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619181|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
44619182|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619183|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
44619184|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619185|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
44619186|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619187|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
44619188|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44619189|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619190|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619191|NCT00580606|Glycerol|glycerol|mesh-list
44619192|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44619193|NCT00580606|Protective Agents|protective agents|mesh-ancestor
44619194|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619195|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
44619196|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619197|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619198|NCT00579982|Lamotrigine|lamotrigine|mesh-list
44619199|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
44619200|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44619201|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619202|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619203|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619204|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619205|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44619206|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44619207|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44619208|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44619209|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44619210|NCT00579670|Ziprasidone|ziprasidone|mesh-list
44619211|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44619212|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
44619213|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619214|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619215|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619216|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44619217|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44619218|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44619219|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448757|NCT01765543|Rifampin|rifampin|mesh-list
44619220|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44619221|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
44619222|NCT00579553|Progesterone|progesterone|mesh-list
44619223|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44619224|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44619226|NCT00579553|Hormones|hormones|mesh-ancestor
44619227|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619228|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619229|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44619230|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44619231|NCT00579501|Dexamethasone|dexamethasone|mesh-list
44619232|NCT00579501|Trabectedin|trabectedin|mesh-list
44619233|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619234|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
44619235|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
44619236|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619237|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619238|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619239|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
44619240|NCT00579501|Hormones|hormones|mesh-ancestor
44619241|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619242|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619243|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619244|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619245|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
44619246|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619247|NCT00579345|Vaccines|vaccines|mesh-list
44619248|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
44619249|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619250|NCT00579254|Amlodipine|amlodipine|mesh-list
44619251|NCT00579254|Atorvastatin|atorvastatin|mesh-list
44619252|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44619253|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44619254|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
44619255|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619256|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44619257|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44619258|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619259|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44619260|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44619261|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619262|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619263|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619264|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44619265|NCT00579098|Atorvastatin|atorvastatin|mesh-list
44619266|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44619267|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44619268|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
44619269|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619270|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44619271|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44619272|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619273|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
44619274|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619275|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619276|NCT00578877|Nonoxynol|nonoxynol|mesh-list
44619277|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44619278|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44619279|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136713|NCT00165308|Tamoxifen|tamoxifen|mesh-list
44619280|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44619281|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
44619282|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44619283|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44619284|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
44619285|NCT00578864|Cisplatin|cisplatin|mesh-list
44619286|NCT00578864|Doxorubicin|doxorubicin|mesh-list
44619287|NCT00578864|Etoposide|etoposide|mesh-list
44619288|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
44619289|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619290|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
44619291|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619292|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619293|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619294|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
44619295|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619296|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619298|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619299|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619300|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619301|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619302|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619304|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44619305|NCT00578643|Cyclosporine|cyclosporine|mesh-list
44619306|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
44619307|NCT00578643|Busulfan|busulfan|mesh-list
44619308|NCT00578643|Fludarabine|fludarabine|mesh-list
44619309|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
44619310|NCT00578643|Cyclosporins|cyclosporins|mesh-list
44619311|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619312|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
44619313|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619314|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619315|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619316|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
44619317|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619318|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619319|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619320|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619321|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
44619322|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619323|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
44619324|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44619325|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619326|NCT00578565|Rituximab|rituximab|mesh-list
44619327|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619328|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619329|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
44619330|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619331|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619332|NCT00578448|Abatacept|abatacept|mesh-list
44619333|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44619334|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619335|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619336|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619337|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
44619338|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619339|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619340|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
44619341|NCT00578344|Busulfan|busulfan|mesh-list
44619342|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
44619343|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619344|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
44619345|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619346|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619347|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619348|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
44619349|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619350|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619351|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619352|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619353|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
44619354|NCT00578292|Busulfan|busulfan|mesh-list
44619355|NCT00578292|Fludarabine|fludarabine|mesh-list
44619356|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
44619357|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619358|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
44619359|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619360|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619361|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619362|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
44619363|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619364|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619365|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619366|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619367|NCT00578227|Vaccines|vaccines|mesh-list
44619368|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
44619369|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235715|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44619370|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44619371|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
44619372|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619373|NCT00578136|Bupivacaine|bupivacaine|mesh-list
44619374|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
44619375|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
44619376|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888875|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
44619377|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619378|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
44619379|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619380|NCT00577993|Interferons|interferons|mesh-list
44619381|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
44619382|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
44619383|NCT00577993|Dexamethasone|dexamethasone|mesh-list
44619384|NCT00577993|Prednisone|prednisone|mesh-list
44619385|NCT00577993|Prednisolone|prednisolone|mesh-list
44619386|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44619387|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
44619388|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44619389|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
44619390|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
44619391|NCT00577993|Rituximab|rituximab|mesh-list
44619392|NCT00577993|Doxorubicin|doxorubicin|mesh-list
44619393|NCT00577993|Fludarabine|fludarabine|mesh-list
44619394|NCT00577993|Etoposide|etoposide|mesh-list
44619395|NCT00577993|Vincristine|vincristine|mesh-list
44619396|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
44619397|NCT00577993|Bleomycin|bleomycin|mesh-list
44619398|NCT00577993|Procarbazine|procarbazine|mesh-list
44619399|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44619400|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
44619401|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619402|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
44619403|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619404|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619405|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619406|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
44619407|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619408|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619409|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619410|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619411|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619412|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
44619413|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
44619414|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619415|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619416|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
44619417|NCT00577993|Hormones|hormones|mesh-ancestor
44619418|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619419|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619420|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619421|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619422|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619423|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619424|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619425|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
44619426|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619427|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44619428|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44619429|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619430|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44619431|NCT00577993|Protective Agents|protective agents|mesh-ancestor
44619432|NCT00577993|Analgesics|analgesics|mesh-ancestor
44619433|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
44619434|NCT00577889|Gemcitabine|gemcitabine|mesh-list
44619435|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619436|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
44619437|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619438|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619439|NCT00577889|Antiviral Agents|antiviral agents|mesh-ancestor
44619440|NCT00577889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619441|NCT00577889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619442|NCT00577889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619443|NCT00577889|Immunologic Factors|immunologic factors|mesh-ancestor
44448982|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619444|NCT00577889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619445|NCT00577863|Teriparatide|teriparatide|mesh-list
44619446|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619447|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619448|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44619449|NCT00577824|Exenatide|exenatide|mesh-list
44619450|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619451|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619452|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44619453|NCT00577824|Incretins|incretins|mesh-ancestor
44619454|NCT00577824|Hormones|hormones|mesh-ancestor
44619455|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619456|NCT00577772|Rifaximin|rifaximin|mesh-list
44619457|NCT00577772|Lactulose|lactulose|mesh-list
44619458|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43888997|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619459|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619460|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619461|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
44619462|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
44619463|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44619464|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619465|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619466|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619467|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619468|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44619469|NCT00577707|Cisplatin|cisplatin|mesh-list
44619470|NCT00577707|Pemetrexed|pemetrexed|mesh-list
44619471|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44619472|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619473|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619474|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619475|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44619476|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44619477|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619478|NCT00577655|Albuterol|albuterol|mesh-list
44619479|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44619480|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
44619481|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619482|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619483|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44619484|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619485|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
44619486|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44619487|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44619488|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44619489|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44619490|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44619491|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619492|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619493|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
44619494|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44619495|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619496|NCT00577629|Cytarabine|cytarabine|mesh-list
44619497|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
43888999|NCT04531800|Mitogens|mitogens|mesh-list
44619498|NCT00577629|Rituximab|rituximab|mesh-list
44619499|NCT00577629|Doxorubicin|doxorubicin|mesh-list
44619500|NCT00577629|Etoposide|etoposide|mesh-list
44619501|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619502|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
44619503|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619504|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619505|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619506|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
44619507|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619508|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619509|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619510|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619511|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619512|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619513|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619514|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619515|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619516|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619517|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
44619518|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
44619519|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619521|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44619522|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44619523|NCT00577473|Analgesics|analgesics|mesh-ancestor
44619524|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
44619525|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619526|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619527|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619528|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619529|NCT00577460|Pramipexole|pramipexole|mesh-list
44619530|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
44619531|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619532|NCT00577460|Protective Agents|protective agents|mesh-ancestor
44619533|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619534|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44619535|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44619536|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
44619537|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
44619538|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619540|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44619541|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44619542|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619543|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
44619544|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619545|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
44619546|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44619547|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619548|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619549|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44619550|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619551|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44619552|NCT00577382|Sunitinib|sunitinib|mesh-list
44619553|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619554|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619555|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619556|NCT00577382|Growth Substances|growth substances|mesh-ancestor
44619557|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619558|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619559|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619560|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619561|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619562|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
44619563|NCT00577122|Methotrexate|methotrexate|mesh-list
44619564|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44619565|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
44619566|NCT00577122|Progesterone|progesterone|mesh-list
44619567|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619568|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
44619569|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619570|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619571|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619572|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
44619573|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619574|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619575|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619576|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44619577|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
44619578|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44619579|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619580|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
44619581|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
44619582|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619583|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44619584|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44619585|NCT00577122|Progestins|progestins|mesh-ancestor
44619586|NCT00577122|Hormones|hormones|mesh-ancestor
44619587|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619588|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44619589|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44619590|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44619591|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
44619592|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44619593|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44619594|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44619595|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619596|NCT00577096|Thalidomide|thalidomide|mesh-list
44619597|NCT00577096|Dexamethasone|dexamethasone|mesh-list
44619598|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
44619599|NCT00577096|Melphalan|melphalan|mesh-list
44619600|NCT00577096|Cisplatin|cisplatin|mesh-list
44619601|NCT00577096|Doxorubicin|doxorubicin|mesh-list
44619602|NCT00577096|Etoposide|etoposide|mesh-list
44619603|NCT00577096|Vincristine|vincristine|mesh-list
44619604|NCT00577096|Heparin|heparin|mesh-list
44619605|NCT00577096|Calcium heparin|calcium heparin|mesh-list
44619606|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44619607|NCT00577096|Tinzaparin|tinzaparin|mesh-list
44619608|NCT00577096|Dalteparin|dalteparin|mesh-list
44619609|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
44619610|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619611|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
44619612|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619613|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619614|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619615|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
44619616|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619617|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619618|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619619|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619620|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
44619621|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
44619622|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619623|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619624|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
44619625|NCT00577096|Hormones|hormones|mesh-ancestor
44619626|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619627|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619628|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619629|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619630|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619631|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619632|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619633|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
44619634|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
44619635|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619636|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
44619637|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44619638|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44619639|NCT00577096|Hematinics|hematinics|mesh-ancestor
44619640|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
44619641|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44619642|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619643|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619644|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619645|NCT00577096|Growth Substances|growth substances|mesh-ancestor
44619646|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619647|NCT00577031|Bevacizumab|bevacizumab|mesh-list
44619648|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
44619649|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619650|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619651|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619652|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619653|NCT00577031|Growth Substances|growth substances|mesh-ancestor
44619654|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619655|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619656|NCT00577005|Levetiracetam|levetiracetam|mesh-list
44619657|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
44619658|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
44619659|NCT00576901|Bevacizumab|bevacizumab|mesh-list
44619660|NCT00576901|Docetaxel|docetaxel|mesh-list
44619661|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619662|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619663|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619664|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619665|NCT00576901|Growth Substances|growth substances|mesh-ancestor
44619666|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619667|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619668|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44619669|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44449212|NCT01754259|Ranolazine|ranolazine|mesh-list
44619670|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619671|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619673|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44619674|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44619694|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44619695|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44619696|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44619697|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44619698|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44619699|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
44619700|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
44619701|NCT00576628|Hematinics|hematinics|mesh-ancestor
44619702|NCT00576576|Atorvastatin|atorvastatin|mesh-list
44619703|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44619704|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44619705|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
44619706|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619707|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44619708|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44619709|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619710|NCT00576472|Methylphenidate|methylphenidate|mesh-list
44619711|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44619712|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619713|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44619714|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44619715|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619716|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619717|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
44619718|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619719|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
44619720|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44619721|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44619722|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619723|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44619724|NCT00576381|Analgesics|analgesics|mesh-ancestor
44619725|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
44619726|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619727|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44619728|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44619729|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44619730|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44619731|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619732|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619733|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44619734|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44619735|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619736|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
44619737|NCT00576303|Hematinics|hematinics|mesh-ancestor
44619738|NCT00576199|Bevacizumab|bevacizumab|mesh-list
44619739|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44619740|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619741|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619742|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619743|NCT00576199|Growth Substances|growth substances|mesh-ancestor
44619744|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619745|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619746|NCT00576056|Sorafenib|sorafenib|mesh-list
44619747|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619748|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619749|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619750|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619751|NCT00575666|Insulin|insulin|mesh-list
44619752|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619753|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619754|NCT00575588|Metformin|metformin|mesh-list
44619755|NCT00575588|Saxagliptin|saxagliptin|mesh-list
44619756|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619757|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619758|NCT00575588|Incretins|incretins|mesh-ancestor
44619759|NCT00575588|Hormones|hormones|mesh-ancestor
44619760|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619761|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44619762|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
44619763|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619764|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619765|NCT00575380|Azithromycin|azithromycin|mesh-list
44619766|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
44619767|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44619768|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44619769|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44619770|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44619771|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619772|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619773|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619774|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619775|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619776|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619777|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44619778|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
44619779|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44619780|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619781|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44619782|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44619783|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44619784|NCT00575094|Tigecycline|tigecycline|mesh-list
44619785|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44619786|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619787|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44619788|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619789|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619790|NCT00575042|Fenofibrate|fenofibrate|mesh-list
44619791|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44619792|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
44619793|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619794|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44619795|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
44619796|NCT00574951|Imetelstat|imetelstat|mesh-list
44619797|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619798|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619799|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619800|NCT00574912|Insulin|insulin|mesh-list
44619801|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44619802|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
44619803|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619804|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619805|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
44619806|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619807|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619808|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619809|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619810|NCT00574847|Citalopram|citalopram|mesh-list
44619811|NCT00574847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44619812|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44619813|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619814|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619815|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619816|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
44619817|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619818|NCT00574847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44619819|NCT00574847|Antidepressive Agents|antidepressive agents|mesh-ancestor
44619820|NCT00574847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44619821|NCT00574405|Insulin|insulin|mesh-list
44619822|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44619823|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
44619824|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
44619825|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
44619826|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
44619827|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
44619828|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44619829|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619830|NCT00574288|Dexamethasone|dexamethasone|mesh-list
44619831|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
44619832|NCT00574288|Daratumumab|daratumumab|mesh-list
44619833|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44619834|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619835|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
44619836|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
44619837|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619838|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619839|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619840|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
44619842|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619843|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619844|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619845|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44619846|NCT00574288|Protective Agents|protective agents|mesh-ancestor
44619847|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
44619849|NCT00574275|Aflibercept|aflibercept|mesh-list
44619850|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619851|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
44619852|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619853|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619854|NCT00574275|Antiviral Agents|antiviral agents|mesh-ancestor
44619855|NCT00574275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619856|NCT00574275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619857|NCT00574275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619858|NCT00574275|Immunologic Factors|immunologic factors|mesh-ancestor
44619859|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619860|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619861|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619862|NCT00574275|Growth Substances|growth substances|mesh-ancestor
44619863|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619864|NCT00574249|Adalimumab|adalimumab|mesh-list
44619865|NCT00574249|Betamethasone|betamethasone|mesh-list
44619866|NCT00574249|Calcipotriene|calcipotriene|mesh-list
44619867|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619868|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619869|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
44619870|NCT00574249|Hormones|hormones|mesh-ancestor
44619871|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619872|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619873|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44619874|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619875|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
44619876|NCT00574119|Spironolactone|spironolactone|mesh-list
44619877|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44619878|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
44619879|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619880|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619881|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44619882|NCT00574119|Diuretics|diuretics|mesh-ancestor
44619883|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
44619884|NCT00574080|Cytarabine|cytarabine|mesh-list
44619885|NCT00574080|Thalidomide|thalidomide|mesh-list
44619886|NCT00574080|Dexamethasone|dexamethasone|mesh-list
44619887|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
44619888|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
44619889|NCT00574080|Melphalan|melphalan|mesh-list
44619890|NCT00574080|Carmustine|carmustine|mesh-list
44619891|NCT00574080|Cisplatin|cisplatin|mesh-list
44619892|NCT00574080|Etoposide|etoposide|mesh-list
44619893|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
44619894|NCT00574080|Doxorubicin|doxorubicin|mesh-list
44619895|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44619896|NCT00574080|Bortezomib|bortezomib|mesh-list
44619897|NCT00574080|BB 1101|bb 1101|mesh-list
44619898|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44619899|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
44619900|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619901|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619902|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44619903|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
44619904|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619905|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619906|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44619907|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619908|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
44619909|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
44619910|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619911|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44619912|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
44619913|NCT00574080|Hormones|hormones|mesh-ancestor
44619914|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619915|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619916|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
44619917|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136755|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44619918|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44619919|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44619920|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44619921|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44619922|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
44619923|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
44619924|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619925|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44619926|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
44619927|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44619928|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44619929|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44619930|NCT00574080|Growth Substances|growth substances|mesh-ancestor
44619931|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
44619932|NCT00573937|Morphine|morphine|mesh-list
44619933|NCT00573937|Methadone|methadone|mesh-list
44619934|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44619935|NCT00573937|Narcotics|narcotics|mesh-ancestor
44619936|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44619937|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619938|NCT00573937|Analgesics|analgesics|mesh-ancestor
44619939|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
44619940|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619941|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
44619942|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44619943|NCT00573859|Methylphenidate|methylphenidate|mesh-list
44619944|NCT00573859|Amphetamine|amphetamine|mesh-list
44619945|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44619946|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
44619947|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44619948|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44619949|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619950|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44619951|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44619952|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619953|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619954|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
44619955|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44619956|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44619957|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
44619958|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
44619959|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
44619960|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619961|NCT00573794|Adalimumab|adalimumab|mesh-list
44619962|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619963|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619964|NCT00573768|Diclofenac|diclofenac|mesh-list
44619965|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44619966|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44619967|NCT00573768|Analgesics|analgesics|mesh-ancestor
44619968|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
44619969|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44619970|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619971|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44619972|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44619973|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44619974|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619975|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619976|NCT00573755|Sorafenib|sorafenib|mesh-list
44619977|NCT00573755|Letrozole|letrozole|mesh-list
44619978|NCT00573755|Anastrozole|anastrozole|mesh-list
44619979|NCT00573755|Exemestane|exemestane|mesh-list
44619980|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44619981|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44619982|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44619983|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619984|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44619985|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44619986|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44619987|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44619988|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44619989|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619990|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44619991|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44619992|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44619993|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44619994|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43889478|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44619995|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44619996|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44619997|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44619998|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
44619999|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620000|NCT00573443|Quinidine|quinidine|mesh-list
44620001|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
44620002|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
44620003|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
44620004|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620005|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44620006|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44620007|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620008|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620009|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620010|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44620011|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44620012|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620013|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44620014|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
44620015|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44620016|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44620017|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620018|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620019|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44620020|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44620021|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620022|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44620023|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44620024|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620025|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44620026|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44620027|NCT00573430|Candesartan|candesartan|mesh-list
44620028|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
44620029|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44620030|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44620031|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44620032|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620034|NCT00573391|Dexamethasone|dexamethasone|mesh-list
44620035|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
44620036|NCT00573391|Melphalan|melphalan|mesh-list
44620037|NCT00573391|Bortezomib|bortezomib|mesh-list
44620038|NCT00573391|BB 1101|bb 1101|mesh-list
44620039|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620040|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
44620041|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
44620042|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620043|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620044|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620045|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
44620046|NCT00573391|Hormones|hormones|mesh-ancestor
44620047|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620048|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620049|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620050|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
44620051|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620052|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620053|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620054|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
44620055|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620056|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620057|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
44620058|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
44620059|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620060|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620061|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44620062|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44620063|NCT00573391|Growth Substances|growth substances|mesh-ancestor
44620064|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
44620065|NCT00573248|Nicotine|nicotine|mesh-list
44620066|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44620067|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
44620068|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620069|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620070|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44620071|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44620072|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620073|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620074|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620075|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
44620076|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44620077|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620078|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44620079|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
44620080|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620081|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620082|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620083|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620084|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44620085|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
44620086|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620087|NCT00573131|Paclitaxel|paclitaxel|mesh-list
44620088|NCT00573131|Cisplatin|cisplatin|mesh-list
44620089|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620090|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620091|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620092|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620093|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620094|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620095|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
44620096|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44620097|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620098|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620099|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44620100|NCT00573066|Analgesics|analgesics|mesh-ancestor
44620101|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
44620102|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620103|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44620104|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44620105|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44620106|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620107|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620137|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44620138|NCT00571701|Celecoxib|celecoxib|mesh-list
44620139|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44620140|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44620141|NCT00571701|Analgesics|analgesics|mesh-ancestor
44620142|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
44620143|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620144|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620145|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620146|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620147|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44620148|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44620149|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620150|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620151|NCT00571688|Risperidone|risperidone|mesh-list
44620152|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44620153|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
44620154|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620155|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620156|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620157|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44620158|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620159|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620160|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620161|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44620162|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
44620163|NCT00571662|Cyclosporine|cyclosporine|mesh-list
44620164|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
44620165|NCT00571662|Pentostatin|pentostatin|mesh-list
44620166|NCT00571662|Cyclosporins|cyclosporins|mesh-list
44620167|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620168|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620169|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620170|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
44620171|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620172|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
44620173|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620174|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44620175|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620176|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44620177|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44620178|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620179|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44620180|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
44620181|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620182|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44620183|NCT00571649|Enoxaparin|enoxaparin|mesh-list
44620184|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
44620185|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
44620186|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44620187|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
44620188|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44620189|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
44620190|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620191|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620192|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
44620193|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44620194|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44620195|NCT00571519|Metformin|metformin|mesh-list
44620196|NCT00571519|Pioglitazone|pioglitazone|mesh-list
44620197|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620198|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620199|NCT00571103|Acamprosate|acamprosate|mesh-list
44620200|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44620201|NCT00571064|Donepezil|donepezil|mesh-list
44620202|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44620203|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620204|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620205|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620206|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620207|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620208|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
44620209|NCT00570921|Everolimus|everolimus|mesh-list
44620210|NCT00570921|Fulvestrant|fulvestrant|mesh-list
44620211|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620212|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620213|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
44620214|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620215|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620216|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44620217|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44620218|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
44620219|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620220|NCT00570908|Capecitabine|capecitabine|mesh-list
44620221|NCT00570908|Sunitinib|sunitinib|mesh-list
44620222|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44620223|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
44620224|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620225|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620226|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44620227|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43889604|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
44620228|NCT00570908|Growth Substances|growth substances|mesh-ancestor
44620229|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620230|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
44620231|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620232|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620233|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
44620234|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44620235|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44620236|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44620237|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620238|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620239|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620240|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620241|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44620242|NCT00570765|Cathartics|cathartics|mesh-ancestor
44620243|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620244|NCT00570739|Metformin|metformin|mesh-list
44620245|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44620246|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620247|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620248|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44620249|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44620250|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
44620251|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620252|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44620253|NCT00570713|Gemcitabine|gemcitabine|mesh-list
44620254|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44620255|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
44620256|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620257|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620258|NCT00570713|Antiviral Agents|antiviral agents|mesh-ancestor
44620259|NCT00570713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620260|NCT00570713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620261|NCT00570713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620262|NCT00570713|Immunologic Factors|immunologic factors|mesh-ancestor
44620263|NCT00570713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620264|NCT00570687|Insulin|insulin|mesh-list
44620265|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620266|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620267|NCT00570674|Paclitaxel|paclitaxel|mesh-list
44620268|NCT00570674|Carboplatin|carboplatin|mesh-list
44620269|NCT00570674|Cetuximab|cetuximab|mesh-list
44620270|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44620271|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620272|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620273|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620274|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620275|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620276|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620277|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620278|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44620279|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44620280|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620281|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620282|NCT00570492|Fluticasone|fluticasone|mesh-list
44620283|NCT00570492|Xhance|xhance|mesh-list
44620284|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620285|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44136783|NCT00165451|Analgesics|analgesics|mesh-ancestor
44449836|NCT01739790|Protective Agents|protective agents|mesh-ancestor
44620286|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
44620287|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620288|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620289|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44620290|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620291|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
44620292|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44620293|NCT00570401|Dasatinib|dasatinib|mesh-list
44620294|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620295|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620296|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620297|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620298|NCT00570323|Fulvestrant|fulvestrant|mesh-list
44620299|NCT00570323|Anastrozole|anastrozole|mesh-list
44620300|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620301|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620302|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44620303|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44620304|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
44620305|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620306|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620307|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44620308|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44620309|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620310|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620311|NCT00570310|Pregabalin|pregabalin|mesh-list
44620312|NCT00570310|Analgesics|analgesics|mesh-ancestor
44620313|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
44620314|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620315|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620316|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
44620317|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44620318|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620319|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620320|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44620321|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44620322|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620323|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620324|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620325|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44620326|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620327|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620328|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620329|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620331|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44620332|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620333|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620334|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620335|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620336|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620337|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
44620338|NCT00569946|Axitinib|axitinib|mesh-list
44620339|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620340|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620341|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620342|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620343|NCT00569803|Abatacept|abatacept|mesh-list
44620344|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44620345|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620346|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620347|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620348|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
44620349|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620350|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620351|NCT00569777|Ketotifen|ketotifen|mesh-list
44620352|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
44620353|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44620354|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44620355|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
44620356|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
44620357|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620358|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620359|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620360|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44620361|NCT00569582|Mifepristone|mifepristone|mesh-list
44620362|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44620363|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
44620364|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44620365|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620366|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44620367|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44620368|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44620369|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
44620370|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44620371|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44620372|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
44620373|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620374|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
44620375|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44620376|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44620377|NCT00569374|Modafinil|modafinil|mesh-list
44620378|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44620379|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620380|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44620381|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44620382|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44620383|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620384|NCT00569127|Interferons|interferons|mesh-list
44620385|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
44620386|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
44620387|NCT00569127|Bevacizumab|bevacizumab|mesh-list
44620388|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44620390|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
44620391|NCT00569127|Antibodies|antibodies|mesh-list
44620392|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
44620393|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44620394|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
44620395|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620396|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44620397|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44620398|NCT00569127|Growth Substances|growth substances|mesh-ancestor
44620399|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620400|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
44620401|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
44620402|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
44620403|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620404|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620405|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620406|NCT00568958|Naltrexone|naltrexone|mesh-list
44620407|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44620408|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44620409|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620410|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
44620411|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620412|NCT00568776|Inositol|inositol|mesh-list
44620413|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
44620414|NCT00568776|Vitamins|vitamins|mesh-ancestor
44620415|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
44620416|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620417|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44620418|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44620419|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44620420|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620421|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620422|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620423|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620424|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620425|NCT00568555|Naltrexone|naltrexone|mesh-list
44620426|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44620427|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44620428|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620429|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
44620430|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620431|NCT00568451|Paclitaxel|paclitaxel|mesh-list
44620432|NCT00568451|Carboplatin|carboplatin|mesh-list
44620433|NCT00568451|Temozolomide|temozolomide|mesh-list
44620434|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620435|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620436|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620437|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620438|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620439|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620440|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620441|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
44620442|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
44620443|NCT00568399|Antidotes|antidotes|mesh-ancestor
44620444|NCT00568399|Protective Agents|protective agents|mesh-ancestor
44620445|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620446|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
44620447|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620448|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
44620449|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620450|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620451|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
44620452|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
44620453|NCT00568321|Tanezumab|tanezumab|mesh-list
44620454|NCT00568321|Analgesics|analgesics|mesh-ancestor
44620455|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
44620456|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620457|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620458|NCT00568178|Losartan|losartan|mesh-list
44620459|NCT00568178|Amlodipine|amlodipine|mesh-list
44620460|NCT00568178|Enalapril|enalapril|mesh-list
44620461|NCT00568178|Enalaprilat|enalaprilat|mesh-list
44620462|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44620463|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44620464|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620465|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620466|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44620467|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620468|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44620469|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44620470|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44620471|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44620472|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620473|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44620474|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
44620475|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
44620476|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44620477|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
44620478|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620479|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620480|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44620481|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620482|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44620483|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
44620484|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620485|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620486|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44620487|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
44620488|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
44620489|NCT00568061|Protective Agents|protective agents|mesh-ancestor
44620490|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44620491|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44620492|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
44620493|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620494|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620495|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44620496|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620497|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44620498|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44620499|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44620500|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620501|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620502|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620503|NCT00567879|Trastuzumab|trastuzumab|mesh-list
44620504|NCT00567879|Panobinostat|panobinostat|mesh-list
44620505|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620506|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620507|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44620508|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620509|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620511|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620512|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620513|NCT00567580|Leuprolide|leuprolide|mesh-list
44620514|NCT00567580|Goserelin|goserelin|mesh-list
44620515|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44620516|NCT00567580|Flutamide|flutamide|mesh-list
44620517|NCT00567580|Bicalutamide|bicalutamide|mesh-list
44620518|NCT00567580|Buserelin|buserelin|mesh-list
44620519|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44620520|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
44620521|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44620522|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620523|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620524|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620525|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
44620526|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44620527|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620528|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
44620529|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44620530|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
44620531|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44620532|NCT00567567|Vitamin A|vitamin a|mesh-list
44620533|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
44620534|NCT00567567|Melphalan|melphalan|mesh-list
44620535|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
44620536|NCT00567567|Thiotepa|thiotepa|mesh-list
44620537|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44620538|NCT00567567|Cisplatin|cisplatin|mesh-list
44620539|NCT00567567|Carboplatin|carboplatin|mesh-list
44620540|NCT00567567|Doxorubicin|doxorubicin|mesh-list
44620541|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44620542|NCT00567567|Etoposide|etoposide|mesh-list
44620543|NCT00567567|Vincristine|vincristine|mesh-list
44620544|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
44620545|NCT00567567|Topotecan|topotecan|mesh-list
44620546|NCT00567567|Tretinoin|tretinoin|mesh-list
44620547|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
44620548|NCT00567567|Isotretinoin|isotretinoin|mesh-list
44620549|NCT00567567|Lenograstim|lenograstim|mesh-list
44620550|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620551|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
44620552|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620553|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620554|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620555|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
44620556|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620557|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620558|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620559|NCT00567567|Vitamins|vitamins|mesh-ancestor
44620560|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
44620561|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44620562|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44620563|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44620564|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620565|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620566|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44620567|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620568|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620569|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620570|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44620571|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
44620572|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
44620573|NCT00567489|Icodextrin|icodextrin|mesh-list
44620574|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
44620575|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44620576|NCT00567476|Omalizumab|omalizumab|mesh-list
44620577|NCT00567476|Terbutaline|terbutaline|mesh-list
44620578|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
44620579|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
44620580|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44620581|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
44620582|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620583|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620584|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44620585|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620586|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
44620587|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44620588|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44620589|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44620590|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620591|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620592|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44620593|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
44620594|NCT00567398|Icodextrin|icodextrin|mesh-list
44620595|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
44620596|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44620597|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44620598|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620599|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620600|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620601|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620602|NCT00567268|Gabapentin|gabapentin|mesh-list
44620603|NCT00567268|Analgesics|analgesics|mesh-ancestor
44620604|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
44620605|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620606|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620607|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
44620608|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44620609|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620610|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620611|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620612|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44620613|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44620614|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620615|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620616|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
44620618|NCT00567255|Bupropion|bupropion|mesh-list
44620619|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44620620|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44620621|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620622|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
44620623|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620624|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44620625|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
44620626|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620627|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44620628|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44620629|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620630|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620631|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
44620632|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889927|NCT04179266|Ketamine|ketamine|mesh-list
44620633|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44620634|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44620635|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620636|NCT00567190|Docetaxel|docetaxel|mesh-list
44620637|NCT00567190|Trastuzumab|trastuzumab|mesh-list
44620638|NCT00567190|Pertuzumab|pertuzumab|mesh-list
44620639|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620640|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620641|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620642|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620643|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620644|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620645|NCT00567164|Drospirenone|drospirenone|mesh-list
44620646|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44620647|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
44620648|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620649|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620650|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44620651|NCT00567164|Diuretics|diuretics|mesh-ancestor
44620652|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
44620653|NCT00566852|Memantine|memantine|mesh-list
44620654|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44620655|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44620656|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
44620657|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620658|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620659|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620660|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44620661|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44620662|NCT00566735|Galantamine|galantamine|mesh-list
44620663|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44620664|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620665|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620666|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620667|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620668|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620669|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44620670|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
44620671|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620672|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
44620673|NCT00566722|Adalimumab|adalimumab|mesh-list
44620674|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620675|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620676|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
44620677|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
44620678|NCT00566696|Melphalan|melphalan|mesh-list
44620679|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
44620680|NCT00566696|Thiotepa|thiotepa|mesh-list
44620681|NCT00566696|Rituximab|rituximab|mesh-list
44620682|NCT00566696|Fludarabine|fludarabine|mesh-list
44620683|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
44620684|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
44620685|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44620686|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
44620687|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620688|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
44620689|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620690|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620691|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620692|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
44620693|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620694|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620695|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620696|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620697|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44620698|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44620699|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
44620700|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620701|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620702|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620703|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44620704|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44620705|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620706|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620707|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620708|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620709|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44620710|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44620711|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
44620712|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620713|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620714|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44620715|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44620716|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
44620718|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44620719|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620720|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620721|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620722|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620723|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620724|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
44620725|NCT00566254|Zonisamide|zonisamide|mesh-list
44620726|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
44620727|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44620728|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620729|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620730|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44620731|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620732|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
44620733|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620734|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620735|NCT00566098|Melphalan|melphalan|mesh-list
44620736|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620737|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
44620738|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620739|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620740|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620741|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620742|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
44620743|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620744|NCT00566020|Lamotrigine|lamotrigine|mesh-list
44620745|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
44620746|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44620747|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44620748|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620749|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44620750|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620751|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44620752|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620753|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620754|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620755|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44620756|NCT00565773|Sirolimus|sirolimus|mesh-list
44620757|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
44620758|NCT00565773|Abatacept|abatacept|mesh-list
44620759|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44620760|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620761|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44620762|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620763|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
44620764|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620765|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
44620766|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620767|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620768|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44620769|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620770|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620772|NCT00565448|Docetaxel|docetaxel|mesh-list
44620773|NCT00565448|Fluorouracil|fluorouracil|mesh-list
44620774|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620775|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620776|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620777|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620778|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620779|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
44620780|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44620781|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620782|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
44620783|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620784|NCT00565409|Etanercept|etanercept|mesh-list
44620785|NCT00565409|Methotrexate|methotrexate|mesh-list
44620786|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44620787|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
44620788|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44620789|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620790|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44620791|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
44620792|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620793|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620794|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44620795|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620796|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44620797|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620798|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
44620799|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620800|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44620801|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44620802|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44620803|NCT00565409|Analgesics|analgesics|mesh-ancestor
44620804|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
44620805|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620806|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620807|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620808|NCT00564889|Dexamethasone|dexamethasone|mesh-list
44620809|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
44620810|NCT00564889|Lenalidomide|lenalidomide|mesh-list
44620811|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620812|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
44620813|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620814|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620815|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620816|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
44620817|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620818|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620819|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620820|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620821|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
44620822|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
44620823|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620824|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620825|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
44620826|NCT00564889|Hormones|hormones|mesh-ancestor
44620827|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620828|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620829|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44620830|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44620831|NCT00564889|Growth Substances|growth substances|mesh-ancestor
44620832|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44620833|NCT00564733|Gemcitabine|gemcitabine|mesh-list
44620834|NCT00564733|Paclitaxel|paclitaxel|mesh-list
44620835|NCT00564733|Docetaxel|docetaxel|mesh-list
44620836|NCT00564733|Carboplatin|carboplatin|mesh-list
44620837|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44620838|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620839|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620840|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620841|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620842|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620843|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620844|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44620845|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
44620846|NCT00564733|Antiviral Agents|antiviral agents|mesh-ancestor
44620847|NCT00564733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44620848|NCT00564733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620849|NCT00564733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620850|NCT00564733|Immunologic Factors|immunologic factors|mesh-ancestor
44620851|NCT00564733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620852|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44620853|NCT00564629|Acetaminophen|acetaminophen|mesh-list
44620854|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44620855|NCT00564629|Analgesics|analgesics|mesh-ancestor
44620856|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
44620857|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620858|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620859|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
44620860|NCT00564486|Acetaminophen|acetaminophen|mesh-list
44620861|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44620862|NCT00564486|Analgesics|analgesics|mesh-ancestor
44620863|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
44620864|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620865|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620866|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
44620867|NCT00564395|Insulin|insulin|mesh-list
44620868|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44620869|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
44620870|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620871|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620872|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
44620873|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620874|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
44620875|NCT00564018|Protamines|protamines|mesh-list
44620876|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620877|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620878|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
44620879|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620880|NCT00564018|Coagulants|coagulants|mesh-ancestor
44620881|NCT00563797|Mecamylamine|mecamylamine|mesh-list
44620882|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44620883|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44620884|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
44620885|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620886|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620887|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44620888|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44620889|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620890|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620891|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620892|NCT00563784|Paclitaxel|paclitaxel|mesh-list
44620893|NCT00563784|Carboplatin|carboplatin|mesh-list
44620894|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44620895|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620896|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620897|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44620898|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
44620899|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44620900|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620901|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44620902|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620903|NCT00563706|Risperidone|risperidone|mesh-list
44620904|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44620905|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
44620906|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620907|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620908|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620909|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44620910|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44620911|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44620912|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44620913|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44620914|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
44620915|NCT00563381|Bromides|bromides|mesh-list
44620916|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
44620917|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44620918|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44620919|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
44620920|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620921|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620922|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44620923|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
44620924|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
44620925|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44620926|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44620927|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620928|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620929|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44620930|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43890117|NCT03947632|Chrysarobin|chrysarobin|mesh-list
44620931|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44620932|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620933|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
44620934|NCT00563368|Topiramate|topiramate|mesh-list
44620935|NCT00563368|Phentermine|phentermine|mesh-list
44620936|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
44620937|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44620938|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620939|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44620940|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
44620941|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44620942|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
44620943|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
44620944|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620945|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
44620946|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44620947|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620948|NCT00563316|Irinotecan|irinotecan|mesh-list
44620949|NCT00563316|Panitumumab|panitumumab|mesh-list
44620950|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44620951|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44620952|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620953|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620954|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620955|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620956|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
44620957|NCT00562978|Etoposide|etoposide|mesh-list
44620958|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620959|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
44620960|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620961|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620962|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620963|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
44620964|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620965|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620966|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620967|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44620968|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44620969|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44620970|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44620971|NCT00562965|Dexamethasone|dexamethasone|mesh-list
44620972|NCT00562965|Prednisone|prednisone|mesh-list
44620973|NCT00562965|Prednisolone|prednisolone|mesh-list
44620974|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
44620975|NCT00562965|Rituximab|rituximab|mesh-list
44620976|NCT00562965|Fludarabine|fludarabine|mesh-list
44620977|NCT00562965|Vincristine|vincristine|mesh-list
44620978|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
44620979|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44620980|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44620981|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
44620982|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44620983|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44620984|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44620985|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
44620986|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44620987|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44620988|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44620989|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44620990|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44620991|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
44620992|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
44620993|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44620994|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44620995|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
44620997|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44620998|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44620999|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621000|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621001|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621002|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621003|NCT00562965|Analgesics|analgesics|mesh-ancestor
44621004|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
44621005|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44621006|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44621007|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621008|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44621009|NCT00562861|Lamotrigine|lamotrigine|mesh-list
44621010|NCT00562861|Carbamazepine|carbamazepine|mesh-list
44621011|NCT00562861|Valproic Acid|valproic acid|mesh-list
44621012|NCT00562861|Citalopram|citalopram|mesh-list
44621013|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
44621014|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44621015|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621016|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621017|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44621018|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621019|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44621020|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621021|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621022|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621023|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44621024|NCT00562861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44621025|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44621026|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621027|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
44621028|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44621029|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
44621030|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621031|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621032|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
44621033|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
44621034|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621035|NCT00562861|Analgesics|analgesics|mesh-ancestor
44621036|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
44621037|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44621038|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44621039|NCT00562718|Capecitabine|capecitabine|mesh-list
44621040|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621041|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
44621042|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621043|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621044|NCT00562627|Ketorolac|ketorolac|mesh-list
44621045|NCT00562627|Epinephrine|epinephrine|mesh-list
44621046|NCT00562627|Racepinephrine|racepinephrine|mesh-list
44621047|NCT00562627|Fentanyl|fentanyl|mesh-list
44621048|NCT00562627|Morphine|morphine|mesh-list
44621049|NCT00562627|Bupivacaine|bupivacaine|mesh-list
44621050|NCT00562627|Ropivacaine|ropivacaine|mesh-list
44621051|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
44621052|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
44621053|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
44621054|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621055|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621056|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
44621057|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621058|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44621059|NCT00562627|Narcotics|narcotics|mesh-ancestor
44621060|NCT00562627|Analgesics|analgesics|mesh-ancestor
44621061|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44621062|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44621063|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
44621064|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44621065|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44621066|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621067|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621068|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621069|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44621070|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44621072|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44621073|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44621074|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
44621075|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
44621076|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44621077|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44621078|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621079|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621080|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621081|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44621082|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621083|NCT00562588|Dipyridamole|dipyridamole|mesh-list
44621084|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44621085|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44621086|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621087|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621088|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44621089|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
44621090|NCT00562159|Fluticasone|fluticasone|mesh-list
44621091|NCT00562159|Xhance|xhance|mesh-list
44621092|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
44621093|NCT00562159|Loratadine|loratadine|mesh-list
44621094|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44621095|NCT00562159|Prednisone|prednisone|mesh-list
44621096|NCT00562159|Albuterol|albuterol|mesh-list
44621097|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621098|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
44621099|NCT00562159|Hormones|hormones|mesh-ancestor
44621100|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621101|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621102|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44621103|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621104|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44621105|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
44621106|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621107|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44621108|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
44621109|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44621110|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44621111|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
44621112|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44621113|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44621114|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44621115|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44621116|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621117|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621118|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621119|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
44621120|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44621121|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44621122|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
44621123|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
44621124|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44621126|NCT00562159|Analgesics|analgesics|mesh-ancestor
44621127|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
44621128|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621129|NCT00562120|Fexofenadine|fexofenadine|mesh-list
44621130|NCT00562120|Terfenadine|terfenadine|mesh-list
44621131|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44621132|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44621133|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44621134|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
44621135|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
44621136|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621137|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621138|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621139|NCT00562094|Pantoprazole|pantoprazole|mesh-list
44621140|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44621141|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621142|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44621143|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621144|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621145|NCT00561951|Fesoterodine|fesoterodine|mesh-list
44621146|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44621147|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44621148|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
44621149|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621150|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621151|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621152|NCT00561951|Urological Agents|urological agents|mesh-ancestor
44621153|NCT00561925|Nevirapine|nevirapine|mesh-list
44621154|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44621155|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44621156|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621157|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621158|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
44621159|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621160|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44621161|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44621162|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44621163|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44621164|NCT00561912|Interferons|interferons|mesh-list
44621165|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
44621166|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
44621167|NCT00561912|Decitabine|decitabine|mesh-list
44621168|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621169|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
44621170|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621171|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
44621172|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621173|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621174|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
44621175|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621176|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621177|NCT00561821|Mirtazapine|mirtazapine|mesh-list
44621178|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
44621179|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621180|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44621181|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
44621182|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
44621183|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621184|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621185|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621186|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621187|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621188|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621189|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44621190|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44621191|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44621192|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621193|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621194|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621195|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
44621196|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44621197|NCT00561795|Paclitaxel|paclitaxel|mesh-list
44621198|NCT00561795|Carboplatin|carboplatin|mesh-list
44621199|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621200|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621201|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621202|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621203|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621204|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621206|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44621207|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621208|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44621209|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621210|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621211|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
44621212|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44621213|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621214|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621215|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621216|NCT00561678|Analgesics|analgesics|mesh-ancestor
44621217|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
43773418|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44621218|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621219|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44621220|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44621221|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44621222|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621223|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621224|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621225|NCT00561574|Mirtazapine|mirtazapine|mesh-list
44621226|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
44621227|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621228|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44621229|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
44621230|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
44621231|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621232|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621233|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621234|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621235|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621236|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621237|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44621238|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44621239|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44621240|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621241|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621242|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621243|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
44621244|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44621245|NCT00561470|Leucovorin|leucovorin|mesh-list
44621246|NCT00561470|Fluorouracil|fluorouracil|mesh-list
44621247|NCT00561470|Irinotecan|irinotecan|mesh-list
44621248|NCT00561470|Aflibercept|aflibercept|mesh-list
44621249|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
44621250|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
44621251|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621252|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621253|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621254|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621255|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
44621256|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621257|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44621258|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44621259|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621260|NCT00561470|Antidotes|antidotes|mesh-ancestor
44621261|NCT00561470|Protective Agents|protective agents|mesh-ancestor
44621262|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
44621263|NCT00561470|Vitamins|vitamins|mesh-ancestor
44621264|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
44621265|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621266|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621267|NCT00561470|Growth Substances|growth substances|mesh-ancestor
44621268|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621269|NCT00561392|Rivastigmine|rivastigmine|mesh-list
44621270|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44621271|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621272|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621299|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621300|NCT00560833|Mirtazapine|mirtazapine|mesh-list
44621301|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621302|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
44621303|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621304|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43890335|NCT05168618|Atezolizumab|atezolizumab|mesh-list
44621305|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
44621306|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
44621307|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621308|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621309|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621310|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621311|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621312|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44621313|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44621314|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44621315|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
43773419|NCT02359331|Antacids|antacids|mesh-ancestor
44621316|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621317|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621318|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
44621319|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44621320|NCT00560794|Blinatumomab|blinatumomab|mesh-list
44621321|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44621322|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621323|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
44621324|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621325|NCT00560703|Doxycycline|doxycycline|mesh-list
44621326|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44621327|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621328|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
44621329|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44621330|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44621331|NCT00560573|Gemcitabine|gemcitabine|mesh-list
44621332|NCT00560573|Cisplatin|cisplatin|mesh-list
44621333|NCT00560573|Pemetrexed|pemetrexed|mesh-list
44621334|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621335|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621336|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
44621337|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621338|NCT00560573|Antiviral Agents|antiviral agents|mesh-ancestor
44621339|NCT00560573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621340|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621341|NCT00560573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621342|NCT00560573|Immunologic Factors|immunologic factors|mesh-ancestor
44621343|NCT00560573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621344|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44621345|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44621346|NCT00560508|Pramipexole|pramipexole|mesh-list
44621347|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
44621348|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621349|NCT00560508|Protective Agents|protective agents|mesh-ancestor
44621350|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621351|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44621352|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44621353|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
44621354|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
44621355|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621356|NCT00560417|Insulin|insulin|mesh-list
44621357|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44621358|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
44621359|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
44621360|NCT00560417|Protamines|protamines|mesh-list
44621361|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44621362|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621363|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
44621364|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621365|NCT00560417|Coagulants|coagulants|mesh-ancestor
44621366|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
44621367|NCT00560404|Hematinics|hematinics|mesh-ancestor
44621368|NCT00560391|Dexamethasone|dexamethasone|mesh-list
44621369|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
44621370|NCT00560391|Lenalidomide|lenalidomide|mesh-list
44621371|NCT00560391|Dasatinib|dasatinib|mesh-list
44621372|NCT00560391|BB 1101|bb 1101|mesh-list
44621373|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621374|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
44621375|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
44621376|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621377|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621378|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621379|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
44621380|NCT00560391|Hormones|hormones|mesh-ancestor
44621381|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621382|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44621383|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621384|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
44621385|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621386|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621387|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
44621388|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621389|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621390|NCT00560391|Growth Substances|growth substances|mesh-ancestor
44621391|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621392|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621393|NCT00560352|Dexamethasone|dexamethasone|mesh-list
44621395|NCT00560352|Dasatinib|dasatinib|mesh-list
44621396|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621397|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
44450943|NCT01719003|Metformin|metformin|mesh-list
44621398|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
44621399|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621400|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621401|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621402|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
44621404|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621405|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44621406|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621407|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621408|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621409|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621410|NCT00560066|Vaccines|vaccines|mesh-list
44621411|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
44621412|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621413|NCT00558363|Dutasteride|dutasteride|mesh-list
44621414|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44621415|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44621416|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621417|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621418|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
44621419|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621420|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890413|NCT05324917|Rituximab|rituximab|mesh-list
44621421|NCT00556998|Voriconazole|voriconazole|mesh-list
44621422|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
44621423|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621424|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44621425|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44621426|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621427|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621428|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44621429|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
44621430|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621431|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621432|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44621433|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
44621434|NCT00556933|Sirolimus|sirolimus|mesh-list
44621435|NCT00556933|Tacrolimus|tacrolimus|mesh-list
44621436|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
44621437|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44621438|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621439|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
44621440|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621441|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44621442|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621443|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621444|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44621445|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621446|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44621447|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
44621448|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44621449|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621450|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
44621451|NCT00556439|Abatacept|abatacept|mesh-list
44621452|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44621453|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621454|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621455|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621456|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
44621457|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621458|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621459|NCT00555906|Dexamethasone|dexamethasone|mesh-list
44621460|NCT00555906|Bortezomib|bortezomib|mesh-list
44621461|NCT00555906|Palbociclib|palbociclib|mesh-list
44621462|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621463|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
44621464|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
44621465|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621466|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621467|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621468|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
44621469|NCT00555906|Hormones|hormones|mesh-ancestor
44621470|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621471|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44621472|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451017|NCT01716754|Omalizumab|omalizumab|mesh-list
44621473|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621474|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621475|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621476|NCT00555672|Cisplatin|cisplatin|mesh-list
44621477|NCT00555672|Fluorouracil|fluorouracil|mesh-list
44621478|NCT00555672|Sunitinib|sunitinib|mesh-list
44621479|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621480|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
44621481|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621482|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621483|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621484|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
44621485|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621486|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621487|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621488|NCT00555672|Growth Substances|growth substances|mesh-ancestor
44621489|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621490|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621491|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621492|NCT00555620|Cisplatin|cisplatin|mesh-list
44621493|NCT00555620|Capecitabine|capecitabine|mesh-list
44621494|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
44621495|NCT00555620|Sunitinib|sunitinib|mesh-list
44621496|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621497|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621498|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
44621499|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621500|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621501|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621502|NCT00555620|Growth Substances|growth substances|mesh-ancestor
44621503|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621504|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621505|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621506|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621507|NCT00555217|Losartan|losartan|mesh-list
44621508|NCT00555217|Lisinopril|lisinopril|mesh-list
44621509|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44621510|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44621511|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44621512|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44621513|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621514|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44621515|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
44621516|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621517|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44621518|NCT00555217|Protective Agents|protective agents|mesh-ancestor
44621519|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621520|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
44621521|NCT00554788|Thiotepa|thiotepa|mesh-list
44621522|NCT00554788|Cisplatin|cisplatin|mesh-list
44621523|NCT00554788|Carboplatin|carboplatin|mesh-list
44621524|NCT00554788|Etoposide|etoposide|mesh-list
44621525|NCT00554788|Vincristine|vincristine|mesh-list
44621526|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
44621527|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
44621528|NCT00554788|Lenograstim|lenograstim|mesh-list
44621529|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621530|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
44621531|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621532|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621533|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44621534|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
44621535|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621536|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621537|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44621538|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621539|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44621540|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44621541|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621542|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44621543|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621544|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621545|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621546|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
44621547|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44621548|NCT00554515|Aldesleukin|aldesleukin|mesh-list
44621549|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621550|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44621551|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44621552|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
44621553|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621554|NCT00553696|Cisplatin|cisplatin|mesh-list
44621555|NCT00553696|Sunitinib|sunitinib|mesh-list
44621556|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621557|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621558|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621559|NCT00553696|Growth Substances|growth substances|mesh-ancestor
44621560|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621561|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621562|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621563|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621564|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621565|NCT00553605|Ketoprofen|ketoprofen|mesh-list
44621566|NCT00553605|Parecoxib|parecoxib|mesh-list
44621567|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44621568|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44621569|NCT00553605|Analgesics|analgesics|mesh-ancestor
44621570|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
44621571|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621572|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621573|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621574|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621575|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44621576|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621577|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621578|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44621579|NCT00553475|Pregabalin|pregabalin|mesh-list
44621580|NCT00553475|Analgesics|analgesics|mesh-ancestor
44621581|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
44621582|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621583|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621584|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
44621585|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44621586|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621587|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621588|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44621589|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621590|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621591|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621592|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621593|NCT00553358|Paclitaxel|paclitaxel|mesh-list
44621594|NCT00553358|Trastuzumab|trastuzumab|mesh-list
44621595|NCT00553358|Lapatinib|lapatinib|mesh-list
44621596|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621597|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621598|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621599|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621600|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621601|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621602|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44621603|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621604|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621605|NCT00553280|Pregabalin|pregabalin|mesh-list
44621606|NCT00553280|Analgesics|analgesics|mesh-ancestor
44621607|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
44621608|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621609|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621610|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
44621611|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44621612|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621613|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621614|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44621615|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621616|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621617|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621618|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621619|NCT00552669|Sirolimus|sirolimus|mesh-list
44621620|NCT00552669|Paclitaxel|paclitaxel|mesh-list
44621621|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621622|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621623|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621624|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621625|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621626|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621627|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44621628|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621629|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44621630|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
44621631|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621632|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
44621633|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621634|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
44621635|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44621636|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
44621637|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44621638|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621639|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44621640|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44621641|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44621642|NCT00551135|Pregabalin|pregabalin|mesh-list
44621643|NCT00551135|Analgesics|analgesics|mesh-ancestor
44621644|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
44621645|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621646|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621647|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
44621648|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44621649|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621650|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621651|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44621652|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44621653|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621654|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621655|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621657|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621658|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621659|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621660|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621661|NCT00550446|Adalimumab|adalimumab|mesh-list
44621662|NCT00550446|Tofacitinib|tofacitinib|mesh-list
44621663|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621664|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621665|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621666|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621667|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621668|NCT00550407|Lamotrigine|lamotrigine|mesh-list
44621669|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
44621670|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44621671|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621672|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621673|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44621674|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621675|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44621676|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621677|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621678|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621679|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44621680|NCT00550238|Pimavanserin|pimavanserin|mesh-list
44621681|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44621682|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44621683|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44621684|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621685|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621686|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621687|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621688|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621689|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621690|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
44621691|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621692|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621693|NCT00549939|Alfuzosin|alfuzosin|mesh-list
44621694|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44621695|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44621696|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44621697|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621698|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621699|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621700|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621701|NCT00549939|Urological Agents|urological agents|mesh-ancestor
44621702|NCT00549900|Vaccines|vaccines|mesh-list
44621703|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
44621704|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621705|NCT00549848|Cytarabine|cytarabine|mesh-list
44621706|NCT00549848|Dexamethasone|dexamethasone|mesh-list
44621707|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
44621708|NCT00549848|Prednisone|prednisone|mesh-list
44621709|NCT00549848|Prednisolone|prednisolone|mesh-list
44621710|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
44621711|NCT00549848|Doxorubicin|doxorubicin|mesh-list
44621712|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44621713|NCT00549848|Methotrexate|methotrexate|mesh-list
44621714|NCT00549848|Etoposide|etoposide|mesh-list
44621715|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
44621716|NCT00549848|Vincristine|vincristine|mesh-list
44621717|NCT00549848|Daunorubicin|daunorubicin|mesh-list
44621718|NCT00549848|Asparaginase|asparaginase|mesh-list
44621719|NCT00549848|Dasatinib|dasatinib|mesh-list
44621720|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
44621721|NCT00549848|Clofarabine|clofarabine|mesh-list
44621722|NCT00549848|Pegaspargase|pegaspargase|mesh-list
44621723|NCT00549848|Thioguanine|thioguanine|mesh-list
44621724|NCT00549848|BB 1101|bb 1101|mesh-list
44621725|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621726|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
44621727|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621728|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621729|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44621730|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
44621731|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621732|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621733|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44621734|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44621735|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
44621736|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
44621737|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44621738|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44621739|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
44621740|NCT00549848|Hormones|hormones|mesh-ancestor
44621741|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621742|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44621743|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
44621744|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621745|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44621746|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44621747|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44621748|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44621749|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
44621750|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44621751|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621752|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
44621753|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
44621754|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44621755|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44621756|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44621757|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
44621758|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621759|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44621760|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44621761|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44621762|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621763|NCT00549770|Valsartan|valsartan|mesh-list
44621764|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43773698|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
44621765|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44621766|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44621767|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44621768|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621769|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44621770|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44621771|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44621772|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44621773|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621774|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44621775|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44621776|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44621777|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44621778|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621779|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621780|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621781|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44621782|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44621783|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
44621784|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44621785|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44621786|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
44621787|NCT00549640|Methylphenidate|methylphenidate|mesh-list
44621788|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44621789|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621790|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44621791|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44621792|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621793|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621794|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
44621795|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621796|NCT00549601|Rivastigmine|rivastigmine|mesh-list
44621797|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44621798|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621799|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621800|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
44621801|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621802|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621803|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44621804|NCT00549601|Protective Agents|protective agents|mesh-ancestor
44621828|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621829|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44621830|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44621831|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621832|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621833|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
44621834|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
44621835|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44621836|NCT00549445|Azithromycin|azithromycin|mesh-list
44621837|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44621838|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621839|NCT00549302|Tadalafil|tadalafil|mesh-list
44621840|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44621841|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44621842|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44621843|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621844|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621845|NCT00549302|Urological Agents|urological agents|mesh-ancestor
44621846|NCT00549198|Tenofovir|tenofovir|mesh-list
44621847|NCT00549198|Lamivudine|lamivudine|mesh-list
44621848|NCT00549198|Emtricitabine|emtricitabine|mesh-list
44621849|NCT00549198|Efavirenz|efavirenz|mesh-list
44621850|NCT00549198|Abacavir|abacavir|mesh-list
44621851|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
44621852|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621853|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44621854|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44621855|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621856|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621857|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44621858|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44621859|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44621860|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44621861|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44621862|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44621863|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44621864|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44621865|NCT00548847|Interferons|interferons|mesh-list
44621866|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
44621867|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
44621868|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44621869|NCT00548847|Molgramostim|molgramostim|mesh-list
44621870|NCT00548847|Sargramostim|sargramostim|mesh-list
44621871|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621872|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
44621873|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621874|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
44621875|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621876|NCT00548808|Insulin|insulin|mesh-list
44621877|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44621878|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
44621879|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
44621880|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44621881|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621882|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
44621883|NCT00548717|Sirolimus|sirolimus|mesh-list
44621884|NCT00548717|Bortezomib|bortezomib|mesh-list
44621885|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44621886|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621887|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44621888|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
44621889|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43890820|NCT02842359|Irbesartan|irbesartan|mesh-list
44621890|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621891|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621892|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621893|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
44621894|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621895|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
44621896|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621897|NCT00548548|Bevacizumab|bevacizumab|mesh-list
44621898|NCT00548548|Cisplatin|cisplatin|mesh-list
44621899|NCT00548548|Fluorouracil|fluorouracil|mesh-list
44621900|NCT00548548|Capecitabine|capecitabine|mesh-list
44621901|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44621902|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621903|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44621904|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44621905|NCT00548548|Growth Substances|growth substances|mesh-ancestor
44621906|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621907|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
44621908|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
44621909|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621910|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44621911|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44621912|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
44621913|NCT00548405|Interferons|interferons|mesh-list
44621914|NCT00548405|Interferon-beta|interferon-beta|mesh-list
44621915|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
44621916|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
44621917|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621918|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
44621919|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44621920|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44621921|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
44621922|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621923|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44621924|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44621925|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44621926|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44621927|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621928|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621929|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621930|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621931|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621932|NCT00548262|Voriconazole|voriconazole|mesh-list
44621933|NCT00548262|Anidulafungin|anidulafungin|mesh-list
44621934|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
44621936|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44621937|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44621938|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621939|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621940|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44621941|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
44621942|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44621943|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621944|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44621945|NCT00548249|Iron|iron|mesh-list
44621946|NCT00548249|Trace Elements|trace elements|mesh-ancestor
44621947|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
44621948|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621949|NCT00548184|Trastuzumab|trastuzumab|mesh-list
44621950|NCT00548184|Lapatinib|lapatinib|mesh-list
44621951|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44621952|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621953|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44621954|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621955|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621956|NCT00548145|Ezetimibe|ezetimibe|mesh-list
44621957|NCT00548145|Pitavastatin|pitavastatin|mesh-list
44621958|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44621959|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44621960|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
44621961|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621962|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44621963|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44621964|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621965|NCT00547911|Carbidopa|carbidopa|mesh-list
44621966|NCT00547911|Entacapone|entacapone|mesh-list
44621967|NCT00547911|Droxidopa|droxidopa|mesh-list
44621968|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44621969|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44621970|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
44621971|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621972|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621973|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621974|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44621975|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44621976|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44621977|NCT00547703|Nortriptyline|nortriptyline|mesh-list
44621978|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44621979|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
44621981|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44621982|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44621983|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44621984|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621985|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
44621986|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44621987|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621988|NCT00547534|Rituximab|rituximab|mesh-list
44621989|NCT00547534|Bortezomib|bortezomib|mesh-list
44621990|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44621991|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44621992|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44621993|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
44621994|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44621995|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44621996|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44621997|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
44621998|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44621999|NCT00547521|Methotrexate|methotrexate|mesh-list
44622000|NCT00547521|Abatacept|abatacept|mesh-list
44622001|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44622002|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
44622003|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44622004|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622005|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44622006|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
44235721|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44622007|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622008|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622009|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622010|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622011|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44622012|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622013|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
44622014|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622015|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44622016|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44622017|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
44622018|NCT00547365|Antibodies|antibodies|mesh-list
44622019|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
44622020|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44622021|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44622022|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
44622023|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622024|NCT00547300|Metoprolol|metoprolol|mesh-list
44622025|NCT00547300|Nebivolol|nebivolol|mesh-list
44622026|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44622027|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44622028|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
44622029|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
44622030|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622031|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622032|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44622033|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44622034|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44622035|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622036|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622037|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622038|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
44622039|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44622040|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44622041|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44622042|NCT00547248|Vaccines|vaccines|mesh-list
44622043|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44622044|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
44622045|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622046|NCT00547157|Cisplatin|cisplatin|mesh-list
44622047|NCT00547157|Panitumumab|panitumumab|mesh-list
44622048|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622049|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622050|NCT00547118|Rimonabant|rimonabant|mesh-list
44622051|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44622052|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44622053|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44622054|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622055|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622056|NCT00547118|Hormones|hormones|mesh-ancestor
44622057|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622058|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622059|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44622060|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44622061|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44622062|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622063|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622064|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622065|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622066|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622067|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
44622068|NCT00546871|Antibodies|antibodies|mesh-list
44622069|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
44622070|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44622071|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44622072|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
44622073|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622074|NCT00546637|Fesoterodine|fesoterodine|mesh-list
44622075|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44622076|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44622077|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44622078|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622079|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622080|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622081|NCT00546637|Urological Agents|urological agents|mesh-ancestor
44622082|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44622083|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
44622084|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622085|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
44622086|NCT00546481|Hematinics|hematinics|mesh-ancestor
44622087|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
44622088|NCT00546377|Rituximab|rituximab|mesh-list
44622089|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
44622090|NCT00546377|Pentostatin|pentostatin|mesh-list
44622091|NCT00546377|Sargramostim|sargramostim|mesh-list
44622092|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622093|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
44622094|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622095|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622096|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622097|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
44622098|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622099|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622100|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622101|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622102|NCT00546377|Analgesics|analgesics|mesh-ancestor
44622103|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
44622104|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622105|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44622106|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44622107|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622108|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44622109|NCT00546364|Docetaxel|docetaxel|mesh-list
44622110|NCT00546364|Capecitabine|capecitabine|mesh-list
44622111|NCT00546364|Epothilones|epothilones|mesh-list
44622112|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622113|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622114|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622115|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622116|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622117|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44622118|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
44622119|NCT00546351|Lacosamide|lacosamide|mesh-list
44622120|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
44622121|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44622122|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44622123|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622124|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622125|NCT00546117|Lansoprazole|lansoprazole|mesh-list
44622126|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
44622127|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44622128|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622129|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44622130|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622131|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622132|NCT00546078|Vaccines|vaccines|mesh-list
44622133|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
44622134|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622135|NCT00546052|Losartan|losartan|mesh-list
44622136|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44622137|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44622138|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44622139|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44622140|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44622141|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622142|NCT00546052|Diuretics|diuretics|mesh-ancestor
44622143|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
44622144|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622145|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44622146|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622147|NCT00546000|Fluticasone|fluticasone|mesh-list
44622148|NCT00546000|Xhance|xhance|mesh-list
44622149|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622150|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44622151|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
44622152|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622153|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622154|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773699|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
44622155|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622157|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44622158|NCT00545948|Cisplatin|cisplatin|mesh-list
44622159|NCT00545948|Pemetrexed|pemetrexed|mesh-list
44622160|NCT00545948|Vinorelbine|vinorelbine|mesh-list
44622161|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622162|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622163|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622164|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44622165|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44622166|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622167|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622168|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622169|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622170|NCT00545844|Montelukast|montelukast|mesh-list
44622171|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622172|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622173|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44622174|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
44622175|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622176|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622177|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44622178|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44622179|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622180|NCT00545792|Bevacizumab|bevacizumab|mesh-list
44622181|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622182|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622183|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622184|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622185|NCT00545792|Growth Substances|growth substances|mesh-ancestor
44622186|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622187|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622188|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
44622189|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44622190|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622191|NCT00545753|Permethrin|permethrin|mesh-list
44622192|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622193|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622194|NCT00545740|Mesalamine|mesalamine|mesh-list
44622195|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44622196|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44622197|NCT00545740|Analgesics|analgesics|mesh-ancestor
44622198|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
44622199|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622200|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622201|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622203|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
44622204|NCT00545714|Rituximab|rituximab|mesh-list
44622205|NCT00545714|Fludarabine|fludarabine|mesh-list
44622206|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622207|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
44622208|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622209|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622210|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622211|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
44622212|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622213|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622214|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622215|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622216|NCT00545688|Docetaxel|docetaxel|mesh-list
44622217|NCT00545688|Trastuzumab|trastuzumab|mesh-list
44622218|NCT00545688|Pertuzumab|pertuzumab|mesh-list
44622219|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622220|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622221|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622222|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622223|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622224|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622225|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44622226|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44622227|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622228|NCT00545584|Incretins|incretins|mesh-ancestor
44622229|NCT00545584|Hormones|hormones|mesh-ancestor
44622230|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622231|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44622232|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
44622233|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622234|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622236|NCT00545571|Hematinics|hematinics|mesh-ancestor
44622237|NCT00545532|Oseltamivir|oseltamivir|mesh-list
44622238|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
44622239|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622240|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622241|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622242|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
44622243|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44622244|NCT00545402|Tacrolimus|tacrolimus|mesh-list
44622245|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622246|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
44622247|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622248|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44622249|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622250|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622251|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44622252|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622253|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44622254|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
44622255|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622256|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622257|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622258|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
44622259|NCT00545402|Hormones|hormones|mesh-ancestor
44622260|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622261|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622262|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44622263|NCT00545402|Protective Agents|protective agents|mesh-ancestor
44622264|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
44622265|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44622266|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622267|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
44622268|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44622269|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
44622270|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622271|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622272|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622273|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622274|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44622275|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
44622276|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622277|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622278|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44622279|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44622280|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
44622281|NCT00545298|Protective Agents|protective agents|mesh-ancestor
44622282|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
44622283|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44622284|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
44622285|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622286|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622287|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622288|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622289|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44622290|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44622291|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44622292|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622293|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622294|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622295|NCT00545233|Pioglitazone|pioglitazone|mesh-list
44622296|NCT00545233|Ribavirin|ribavirin|mesh-list
44622297|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44622298|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
44622299|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622300|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
44622301|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622302|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44622303|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622305|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622306|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622307|NCT00545129|Tanezumab|tanezumab|mesh-list
44622308|NCT00545129|Analgesics|analgesics|mesh-ancestor
44622309|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
44622310|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622311|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622312|NCT00545103|Mesalamine|mesalamine|mesh-list
44622313|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44622314|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44622315|NCT00545103|Analgesics|analgesics|mesh-ancestor
44622316|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
44622317|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622318|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622319|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622320|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622321|NCT00545077|Bevacizumab|bevacizumab|mesh-list
44622322|NCT00545077|Letrozole|letrozole|mesh-list
44622323|NCT00545077|Fulvestrant|fulvestrant|mesh-list
44622324|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622325|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622326|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622327|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622328|NCT00545077|Growth Substances|growth substances|mesh-ancestor
44622329|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622330|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622331|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44622332|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44622333|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622334|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622335|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44622336|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44622337|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622338|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622339|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44622340|NCT00545064|Timolol|timolol|mesh-list
44622341|NCT00545064|Dorzolamide|dorzolamide|mesh-list
44622342|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44622343|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44622344|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891295|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
44622345|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622346|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622347|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622348|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44622349|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44622350|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622351|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44622352|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
44622353|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44622354|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622355|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44622356|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44622357|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44622358|NCT00544882|Desogestrel|desogestrel|mesh-list
44622359|NCT00544882|Oviol|oviol|mesh-list
44622360|NCT00544882|Estradiol|estradiol|mesh-list
44622361|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44622362|NCT00544882|Estrogens|estrogens|mesh-ancestor
44622363|NCT00544882|Hormones|hormones|mesh-ancestor
44622364|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622365|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622366|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44622367|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
44622368|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44622369|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44622370|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44622371|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44622372|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44622373|NCT00544882|Progestins|progestins|mesh-ancestor
44622374|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44622375|NCT00544869|Tolvaptan|tolvaptan|mesh-list
44622376|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44622377|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622378|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
44622379|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622380|NCT00544817|Temozolomide|temozolomide|mesh-list
44622382|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622383|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
44622384|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622385|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622386|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44622387|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622388|NCT00544648|Paclitaxel|paclitaxel|mesh-list
44622389|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44622390|NCT00544648|Carboplatin|carboplatin|mesh-list
44622391|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622392|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622393|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622394|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622395|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622396|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622397|NCT00544557|Etanercept|etanercept|mesh-list
44622398|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44622399|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44622400|NCT00544557|Analgesics|analgesics|mesh-ancestor
44622401|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
44622402|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622403|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622404|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622405|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622406|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622407|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622408|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
44622409|NCT00544544|Riluzole|riluzole|mesh-list
44622410|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
44622411|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44622412|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44622413|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622414|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622415|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622416|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44622417|NCT00544544|Protective Agents|protective agents|mesh-ancestor
44622418|NCT00544440|Prednisone|prednisone|mesh-list
44622419|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
44622420|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622421|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
44452015|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622422|NCT00544440|Hormones|hormones|mesh-ancestor
44622423|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622424|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622425|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622426|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622427|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44622428|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622429|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622430|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
43891336|NCT03576313|Artenimol|artenimol|mesh-list
44622431|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44622432|NCT00544167|Paclitaxel|paclitaxel|mesh-list
44622433|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
44622434|NCT00544167|Doxorubicin|doxorubicin|mesh-list
44622435|NCT00544167|Sorafenib|sorafenib|mesh-list
44622436|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622437|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622438|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622439|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622440|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622441|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622442|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622443|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
44622444|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622445|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622446|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622447|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
44622448|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43749824|NCT02508623|Rifaximin|rifaximin|mesh-list
44622450|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44622451|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44622452|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622453|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44622454|NCT00543855|Donepezil|donepezil|mesh-list
44622455|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44622456|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622457|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622458|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
44622459|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622460|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622461|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
44622462|NCT00543725|Efavirenz|efavirenz|mesh-list
44622463|NCT00543725|Rilpivirine|rilpivirine|mesh-list
44622464|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44622465|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44622466|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622467|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622468|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
44622469|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622470|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44622471|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44622472|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44622473|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44622474|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44622475|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44622476|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44622477|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44622478|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
44622479|NCT00543569|Alefacept|alefacept|mesh-list
44622480|NCT00543569|Tacrolimus|tacrolimus|mesh-list
44622481|NCT00543569|Basiliximab|basiliximab|mesh-list
44622482|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622483|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
44622484|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622485|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44622486|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622487|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622488|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44622489|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622490|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44622491|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
44622492|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622493|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622494|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622495|NCT00543439|Factor VIII|factor viii|mesh-list
44622496|NCT00543439|Coagulants|coagulants|mesh-ancestor
44622497|NCT00543387|Docetaxel|docetaxel|mesh-list
44622498|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622499|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622500|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622501|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622502|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622503|NCT00543309|Milrinone|milrinone|mesh-list
44622504|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44622505|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
44622506|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622507|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44622508|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44622509|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
44622510|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44622511|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44622512|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622513|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622514|NCT00543309|Protective Agents|protective agents|mesh-ancestor
44622515|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44622516|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622517|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
44622518|NCT00543296|Hormones|hormones|mesh-ancestor
44622519|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622520|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452168|NCT01700829|Midazolam|midazolam|mesh-list
44622530|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622531|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622533|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
44622534|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622535|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622536|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44622537|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44622538|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44622539|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44622540|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44622541|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
44622542|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622543|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
44622544|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44622545|NCT00542997|Antibodies|antibodies|mesh-list
44622546|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
44622547|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622548|NCT00542880|Fluticasone|fluticasone|mesh-list
44622549|NCT00542880|Budesonide|budesonide|mesh-list
44622550|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
44622551|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44622552|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44622553|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44622554|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622555|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44622556|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
44622557|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622558|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622559|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622560|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622561|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622562|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44622563|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
44622564|NCT00542880|Hormones|hormones|mesh-ancestor
44622565|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622566|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44622567|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44622568|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44622569|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622570|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622571|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622572|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
44622573|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
44622574|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
44622575|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44622576|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
44622577|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622578|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622579|NCT00542815|Sevelamer|sevelamer|mesh-list
44622580|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
43891505|NCT02444728|Hormones|hormones|mesh-ancestor
44622581|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
44622582|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622583|NCT00542789|Esomeprazole|esomeprazole|mesh-list
44622584|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44622585|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622586|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44622587|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622588|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622589|NCT00542425|Teriparatide|teriparatide|mesh-list
44622590|NCT00542425|Abaloparatide|abaloparatide|mesh-list
44622591|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44622592|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44622593|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622594|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44622595|NCT00542269|Amlodipine|amlodipine|mesh-list
44622596|NCT00542269|Ramipril|ramipril|mesh-list
44622597|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44622598|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44622599|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622600|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622601|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44622602|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622603|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
44622604|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44622606|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622607|NCT00542191|Paclitaxel|paclitaxel|mesh-list
44622608|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
44622609|NCT00542191|Carboplatin|carboplatin|mesh-list
44622610|NCT00542191|Doxorubicin|doxorubicin|mesh-list
44622611|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622612|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622613|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622614|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622615|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622616|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891574|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
44622617|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622618|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
44622619|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622620|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622621|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622622|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
44622623|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622624|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44622625|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44622626|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44622627|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622628|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44622629|NCT00542178|Simvastatin|simvastatin|mesh-list
44622630|NCT00542178|Fenofibrate|fenofibrate|mesh-list
44622631|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44622632|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44622633|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
44622634|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622635|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44622636|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44622637|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622638|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622639|NCT00541970|Vaccines|vaccines|mesh-list
44622640|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
44622641|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622642|NCT00541866|Cytarabine|cytarabine|mesh-list
44622643|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44622644|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
44622645|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622646|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622647|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
44622648|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622649|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622650|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
44622651|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622652|NCT00541775|Metformin|metformin|mesh-list
44622653|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44622654|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
44622655|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44622656|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622657|NCT00541775|Incretins|incretins|mesh-ancestor
44622658|NCT00541775|Hormones|hormones|mesh-ancestor
44622659|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622660|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44622661|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44622662|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622663|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622664|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
44622665|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
44622666|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44622667|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622668|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622669|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44622670|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622671|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44622672|NCT00541450|Metformin|metformin|mesh-list
44622673|NCT00541450|Pioglitazone|pioglitazone|mesh-list
44622674|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44622675|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44622676|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452331|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
44622677|NCT00541450|Incretins|incretins|mesh-ancestor
44622679|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622680|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44622681|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44622682|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622683|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622684|NCT00541385|Artesunate|artesunate|mesh-list
44622685|NCT00541385|Lumefantrine|lumefantrine|mesh-list
44622686|NCT00541385|Pyronaridine|pyronaridine|mesh-list
44622687|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
44622688|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44622689|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44622690|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622691|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622692|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
44622693|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
44622694|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44622695|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
44622696|NCT00541346|Methylphenidate|methylphenidate|mesh-list
44622697|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44622698|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622699|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44622700|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44622701|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43891608|NCT05281965|Tretinoin|tretinoin|mesh-list
44622702|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622703|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
44622704|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622705|NCT00541307|Heparin|heparin|mesh-list
44622706|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
44622707|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44622708|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44622709|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622710|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44622711|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44622712|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622713|NCT00541229|Incretins|incretins|mesh-ancestor
44622714|NCT00541229|Hormones|hormones|mesh-ancestor
44622715|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622716|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44622717|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
44622718|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622719|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622720|NCT00541099|Bevacizumab|bevacizumab|mesh-list
44622721|NCT00541099|Docetaxel|docetaxel|mesh-list
44622722|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622723|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622724|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622725|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622726|NCT00541099|Growth Substances|growth substances|mesh-ancestor
44622727|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622728|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622729|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622730|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622731|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622732|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622733|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
44622734|NCT00541034|Rituximab|rituximab|mesh-list
44622735|NCT00541034|Pentostatin|pentostatin|mesh-list
44622736|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622737|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
44622738|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622739|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622740|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622741|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
44622742|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622743|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622744|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622745|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44622746|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44622747|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622748|NCT00540644|Prednisone|prednisone|mesh-list
44622749|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
44622750|NCT00540644|Lenalidomide|lenalidomide|mesh-list
44622751|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622752|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
44622754|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622755|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622756|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
44622757|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622758|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622759|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622760|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622761|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
44622762|NCT00540644|Hormones|hormones|mesh-ancestor
44622763|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622764|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622765|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622766|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622767|NCT00540644|Growth Substances|growth substances|mesh-ancestor
44622768|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622769|NCT00540514|Paclitaxel|paclitaxel|mesh-list
44622770|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44622771|NCT00540514|Carboplatin|carboplatin|mesh-list
44622772|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622773|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622774|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44622775|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44622776|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44622777|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622778|NCT00540449|Efavirenz|efavirenz|mesh-list
44622779|NCT00540449|Rilpivirine|rilpivirine|mesh-list
44622780|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44622781|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44622782|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622783|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622784|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
44622785|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622786|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44622787|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44622788|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44622789|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44622790|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44622791|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44622792|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44622793|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44622794|NCT00540436|Ambrisentan|ambrisentan|mesh-list
44622795|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44622796|NCT00540293|Atorvastatin|atorvastatin|mesh-list
44622797|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44622798|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44622799|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
44622800|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622801|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44622802|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44622803|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622804|NCT00540124|Tadalafil|tadalafil|mesh-list
44622805|NCT00540124|Tamsulosin|tamsulosin|mesh-list
44622806|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
44622807|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44622808|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44622809|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622810|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622811|NCT00540124|Urological Agents|urological agents|mesh-ancestor
44622812|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44622813|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44622814|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44622815|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622816|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622817|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622818|NCT00540046|Copper|copper|mesh-list
44622819|NCT00540046|Trace Elements|trace elements|mesh-ancestor
44622820|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
44622821|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622822|NCT00539994|Retapamulin|retapamulin|mesh-list
44622823|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622824|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622825|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
44622826|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
44622827|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622828|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
44622829|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
44622830|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
44622831|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
44622832|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622833|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
44622834|NCT00539838|Prednisone|prednisone|mesh-list
44622835|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
44622836|NCT00539838|Methotrexate|methotrexate|mesh-list
44622837|NCT00539838|Azathioprine|azathioprine|mesh-list
44622838|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44622839|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
44622840|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891818|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
43891819|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891820|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43891821|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622841|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
44622842|NCT00539838|Hormones|hormones|mesh-ancestor
44622843|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622844|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622845|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622846|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622847|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44622848|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
44622849|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44622850|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44622851|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
44622852|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622853|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622854|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622855|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44622856|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
44622857|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622858|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44622859|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44622860|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44622861|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
44622862|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622863|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622864|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
44622865|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
44622866|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622867|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622868|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44622869|NCT00539838|Protective Agents|protective agents|mesh-ancestor
44622870|NCT00539734|Ranibizumab|ranibizumab|mesh-list
44622871|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622872|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622873|NCT00539734|Growth Substances|growth substances|mesh-ancestor
44622874|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622875|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622876|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622877|NCT00539591|Interferons|interferons|mesh-list
44622878|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
44622879|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
44622880|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44622881|NCT00539591|Temozolomide|temozolomide|mesh-list
44622882|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622883|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
44622884|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622885|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622886|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
44622887|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622888|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
44622889|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622890|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
44622891|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44622892|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
44622893|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622894|NCT00539513|Expectorants|expectorants|mesh-ancestor
44622895|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622896|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44622897|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
44622898|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622899|NCT00539513|Protective Agents|protective agents|mesh-ancestor
44622900|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622901|NCT00539513|Antidotes|antidotes|mesh-ancestor
44622902|NCT00539500|Carboplatin|carboplatin|mesh-list
44622903|NCT00539500|Etoposide|etoposide|mesh-list
44622904|NCT00539500|Melphalan|melphalan|mesh-list
44622905|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622906|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44622907|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44622908|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44622909|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44622910|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622911|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44622912|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
44622913|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44622914|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44622915|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
44622916|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622917|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
44622918|NCT00539305|Testosterone|testosterone|mesh-list
44622919|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
44622920|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
44622921|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44622922|NCT00539305|Androgens|androgens|mesh-ancestor
44622923|NCT00539305|Hormones|hormones|mesh-ancestor
44622924|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622925|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622926|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622927|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622928|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
44622929|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
44622930|NCT00539240|Nortriptyline|nortriptyline|mesh-list
44622931|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
44622932|NCT00539240|Rabeprazole|rabeprazole|mesh-list
44622933|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44622934|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622935|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44622936|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891843|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44622937|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622938|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44622939|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44622940|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44622941|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44622942|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44622943|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44622944|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622945|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
44622946|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44622947|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
44622948|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622949|NCT00539188|Expectorants|expectorants|mesh-ancestor
44622950|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622951|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44622952|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
44622953|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44622954|NCT00539188|Protective Agents|protective agents|mesh-ancestor
44622955|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622956|NCT00539188|Antidotes|antidotes|mesh-ancestor
44622957|NCT00539032|Vaccines|vaccines|mesh-list
44622958|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
44622959|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622960|NCT00539006|Fluticasone|fluticasone|mesh-list
44622961|NCT00539006|Xhance|xhance|mesh-list
44622962|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622963|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44622964|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
44622965|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44622966|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622967|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44622968|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
44622969|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
44622970|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44622971|NCT00538902|Adalimumab|adalimumab|mesh-list
44622972|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622973|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44622974|NCT00538785|Palivizumab|palivizumab|mesh-list
44622975|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
44622976|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622977|NCT00538733|Clarithromycin|clarithromycin|mesh-list
44622978|NCT00538733|Thalidomide|thalidomide|mesh-list
44622979|NCT00538733|Dexamethasone|dexamethasone|mesh-list
44622980|NCT00538733|Lenalidomide|lenalidomide|mesh-list
44622981|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44622982|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
44622983|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
44622984|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891894|NCT05262257|Metformin|metformin|mesh-list
44622985|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44622986|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44622987|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
44622988|NCT00538733|Hormones|hormones|mesh-ancestor
44622989|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44622990|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44622991|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44622992|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
44622993|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44622994|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44622995|NCT00538733|Growth Substances|growth substances|mesh-ancestor
44622996|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
44622997|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44622998|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44622999|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44623000|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623001|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623002|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623003|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623004|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623005|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
44623006|NCT00538681|Cisplatin|cisplatin|mesh-list
44623007|NCT00538681|Pemetrexed|pemetrexed|mesh-list
44623008|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623009|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623010|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623011|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44623012|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623013|NCT00538590|Mitomycins|mitomycins|mesh-list
44623014|NCT00538590|Mitomycin|mitomycin|mesh-list
44623015|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44623016|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623017|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
44623018|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623019|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623020|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623021|NCT00538291|Capecitabine|capecitabine|mesh-list
44623022|NCT00538291|Cetuximab|cetuximab|mesh-list
44623023|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623024|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
44623025|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623026|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623027|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623028|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
44623029|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623030|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623031|NCT00537979|Vitamins|vitamins|mesh-ancestor
44623032|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
44623033|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44623034|NCT00537940|Pregabalin|pregabalin|mesh-list
44623035|NCT00537940|Gabapentin|gabapentin|mesh-list
44623036|NCT00537940|Analgesics|analgesics|mesh-ancestor
44623037|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
44623038|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623039|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623040|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
44623041|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44623042|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623043|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623044|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623045|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44623046|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623047|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623048|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623049|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44623050|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44623051|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623052|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
44623053|NCT00537823|Leucovorin|leucovorin|mesh-list
44623054|NCT00537823|Bevacizumab|bevacizumab|mesh-list
44623057|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
44623058|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623059|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623060|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623061|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623062|NCT00537823|Growth Substances|growth substances|mesh-ancestor
44623063|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623064|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623065|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
44623066|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623067|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623068|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623069|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
44623070|NCT00537823|Antidotes|antidotes|mesh-ancestor
44623071|NCT00537823|Protective Agents|protective agents|mesh-ancestor
44623072|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
44623074|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
44623075|NCT00537810|Sibutramine|sibutramine|mesh-list
44623076|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623077|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623078|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
44623079|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44623080|NCT00537771|Tamoxifen|tamoxifen|mesh-list
44623081|NCT00537771|Anastrozole|anastrozole|mesh-list
44623082|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44623083|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44623084|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623085|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623086|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44623087|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623088|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44623089|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44623090|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44623091|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44623092|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44623093|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623094|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623095|NCT00537745|Naltrexone|naltrexone|mesh-list
44623096|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44623097|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44623098|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623099|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
44623100|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623101|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
44623102|NCT00537394|Maraviroc|maraviroc|mesh-list
44623103|NCT00537394|Darunavir|darunavir|mesh-list
44623104|NCT00537394|Tipranavir|tipranavir|mesh-list
44623105|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
44623106|NCT00537394|Etravirine|etravirine|mesh-list
44623107|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44623108|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44623109|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
44623110|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623111|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44623112|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44623113|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623114|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623115|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44623116|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44623117|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44623118|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44623119|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44623120|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623121|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44623122|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623123|NCT00537381|Prednisone|prednisone|mesh-list
44623124|NCT00537381|Docetaxel|docetaxel|mesh-list
44623125|NCT00537381|Intetumumab|intetumumab|mesh-list
44623126|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623127|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623128|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623129|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
44452779|NCT01691885|Xhance|xhance|mesh-list
44623130|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623148|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623149|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623150|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623151|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
44623152|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623153|NCT00537303|Insulin|insulin|mesh-list
44623154|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44623155|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
44623156|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
44623157|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44623158|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
44623159|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44623160|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623161|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
44623162|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
44623163|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44623164|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44623165|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623166|NCT00537238|Pregabalin|pregabalin|mesh-list
44623167|NCT00537238|Levetiracetam|levetiracetam|mesh-list
44623168|NCT00537238|Analgesics|analgesics|mesh-ancestor
44623169|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
44623170|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623171|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623172|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
44623173|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43892072|NCT05137574|Ketamine|ketamine|mesh-list
44623174|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623175|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623176|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623177|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44623178|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623179|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623180|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623181|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
44623182|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44623183|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44623184|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623185|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623186|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
44623187|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623188|NCT00537056|Sunitinib|sunitinib|mesh-list
44623189|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44623190|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623191|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623192|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623193|NCT00537056|Growth Substances|growth substances|mesh-ancestor
44623194|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623195|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623196|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623197|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623198|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623199|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44623200|NCT00537030|Asparaginase|asparaginase|mesh-list
44623201|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623202|NCT00537017|Levodopa|levodopa|mesh-list
44623203|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44623204|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44623205|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
44623206|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623207|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623208|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623209|NCT00536991|Calcitriol|calcitriol|mesh-list
44623210|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44623211|NCT00536991|Ketoconazole|ketoconazole|mesh-list
44623212|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
44623213|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44623214|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44623215|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44623216|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623217|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
44623218|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623219|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44623220|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623221|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623223|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44623224|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
44623225|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623226|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623227|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623228|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623229|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44623230|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623231|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44623232|NCT00536991|Vitamins|vitamins|mesh-ancestor
44623233|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
44623234|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44623235|NCT00536978|Cytarabine|cytarabine|mesh-list
44623236|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
44623237|NCT00536978|Melphalan|melphalan|mesh-list
44623238|NCT00536978|Carmustine|carmustine|mesh-list
44623239|NCT00536978|Rituximab|rituximab|mesh-list
44623240|NCT00536978|Methotrexate|methotrexate|mesh-list
44623241|NCT00536978|Fludarabine|fludarabine|mesh-list
44623242|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
44623243|NCT00536978|Etoposide|etoposide|mesh-list
44623244|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
44623245|NCT00536978|Tacrolimus|tacrolimus|mesh-list
44623246|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623247|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
44623248|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623249|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623250|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44623251|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
44623252|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623253|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623254|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44623255|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623256|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44623257|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
44623258|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44623259|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623260|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
44623261|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44623262|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623263|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44623264|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623265|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
44623266|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623267|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44623268|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44623269|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44623270|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44623271|NCT00536939|Paclitaxel|paclitaxel|mesh-list
44623272|NCT00536939|Bevacizumab|bevacizumab|mesh-list
44623273|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44623274|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623275|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623276|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623277|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623278|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623279|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623280|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623281|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623282|NCT00536939|Growth Substances|growth substances|mesh-ancestor
44623283|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623284|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623285|NCT00536874|Gemcitabine|gemcitabine|mesh-list
44623286|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
44623287|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623288|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
44623289|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623290|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623291|NCT00536874|Antiviral Agents|antiviral agents|mesh-ancestor
44623292|NCT00536874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623293|NCT00536874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623294|NCT00536874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623295|NCT00536874|Immunologic Factors|immunologic factors|mesh-ancestor
44623296|NCT00536874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623297|NCT00536809|Capecitabine|capecitabine|mesh-list
44623298|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
44623299|NCT00536809|Lapatinib|lapatinib|mesh-list
44623300|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623301|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
44623302|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623303|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623304|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623305|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623306|NCT00536731|Budesonide|budesonide|mesh-list
44623307|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44623308|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44623309|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
44623310|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623311|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44623312|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
44623313|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623314|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623315|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
44623316|NCT00536731|Hormones|hormones|mesh-ancestor
44623317|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623318|NCT00536575|Bortezomib|bortezomib|mesh-list
44623319|NCT00536575|Sorafenib|sorafenib|mesh-list
44623320|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623321|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623322|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623323|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623324|NCT00536510|Niacin|niacin|mesh-list
44623325|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44623326|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
44623327|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623328|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44623329|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
44623330|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
44623331|NCT00536510|Vitamins|vitamins|mesh-ancestor
44623332|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
44623333|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623334|NCT00536484|Fesoterodine|fesoterodine|mesh-list
44623335|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44623336|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44623337|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
44623338|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623339|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623340|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623341|NCT00536484|Urological Agents|urological agents|mesh-ancestor
44623342|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44623343|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44623344|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623345|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623346|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623347|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623348|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623349|NCT00536471|Analgesics|analgesics|mesh-ancestor
44623350|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
43892250|NCT04951947|Lenvatinib|lenvatinib|mesh-list
44623351|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623352|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623353|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623354|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
44623355|NCT00536263|Interferons|interferons|mesh-list
44623356|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
44623357|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
44623358|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44623359|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623360|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
44623361|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623362|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
44623363|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623364|NCT00536198|Sertraline|sertraline|mesh-list
44623365|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623366|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623367|NCT00536198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44623368|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623369|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700448|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623370|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623372|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
44623373|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623374|NCT00536120|Natalizumab|natalizumab|mesh-list
44623375|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44623376|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
44623377|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623378|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44623379|NCT00536107|Docetaxel|docetaxel|mesh-list
44623380|NCT00536107|Gefitinib|gefitinib|mesh-list
44623381|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623382|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623383|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623384|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623385|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623386|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623387|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623388|NCT00535847|Interferons|interferons|mesh-list
44623389|NCT00535847|Ribavirin|ribavirin|mesh-list
44623390|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
44623391|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
44623392|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44623393|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892302|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623394|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
44623395|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623396|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
44623397|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623398|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
44623399|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623400|NCT00535730|Vaccines|vaccines|mesh-list
44623401|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44623402|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
44623403|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623404|NCT00535288|Mirtazapine|mirtazapine|mesh-list
44623405|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623406|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623407|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623408|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44623409|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
44623410|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
44623411|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623412|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623413|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44623414|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623415|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623416|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44623417|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44623418|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44623419|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623420|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44623421|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44623422|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
44623423|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44623424|NCT00535262|Selegiline|selegiline|mesh-list
44623425|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623426|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623427|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44623428|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44623429|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44623430|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623431|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623432|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44623433|NCT00535262|Protective Agents|protective agents|mesh-ancestor
44623434|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623436|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44623437|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623438|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623439|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623440|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623441|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44623442|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44623443|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
44623444|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623445|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623446|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44623447|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44623448|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
44623449|NCT00535132|Risperidone|risperidone|mesh-list
44623450|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44623451|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44623452|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
44623453|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623454|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623455|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623456|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44623457|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623458|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623459|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623460|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44623461|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
44623462|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44623463|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44623464|NCT00534976|Montelukast|montelukast|mesh-list
44623465|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44623466|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
44623467|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44623468|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
44623469|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623470|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623471|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44623472|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44623473|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623474|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44623475|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623476|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623477|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44623478|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44623479|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892344|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623480|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623481|NCT00534495|Rilonacept|rilonacept|mesh-list
44623482|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623483|NCT00534404|Nicotine|nicotine|mesh-list
44623484|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44623485|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
44623486|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623487|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623488|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44623489|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44623490|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44623491|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623492|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623493|NCT00534352|Ritonavir|ritonavir|mesh-list
44623494|NCT00534352|Darunavir|darunavir|mesh-list
44623495|NCT00534352|Etravirine|etravirine|mesh-list
44623496|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44623497|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44623498|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623499|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623500|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623501|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44623502|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44623503|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
44623504|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623505|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623506|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623507|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44623508|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623510|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44623511|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623512|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623513|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623514|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
44623515|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623516|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623517|NCT00533949|Paclitaxel|paclitaxel|mesh-list
44623518|NCT00533949|Carboplatin|carboplatin|mesh-list
44623519|NCT00533949|Cetuximab|cetuximab|mesh-list
44623520|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44623521|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623522|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623523|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623524|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623525|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623526|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623527|NCT00533897|Abatacept|abatacept|mesh-list
44623528|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44623529|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623530|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623531|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623532|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
44623533|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892396|NCT04788108|Hormones|hormones|mesh-ancestor
44623534|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623535|NCT00533845|Bupivacaine|bupivacaine|mesh-list
44623536|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
44623537|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
44623538|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623539|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623540|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
44623541|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623542|NCT00533702|Dacarbazine|dacarbazine|mesh-list
44623543|NCT00533702|Ramucirumab|ramucirumab|mesh-list
44623544|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44623545|NCT00533702|Imidazole|imidazole|mesh-list
44623546|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44623547|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
44623548|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623549|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623550|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
44623551|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623552|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623553|NCT00533507|Vaccines|vaccines|mesh-list
44623554|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44623555|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
44623556|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623557|NCT00533429|Bevacizumab|bevacizumab|mesh-list
44623558|NCT00533429|Carboplatin|carboplatin|mesh-list
44623559|NCT00533429|Pemetrexed|pemetrexed|mesh-list
44623560|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623561|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623562|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623563|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623564|NCT00533429|Growth Substances|growth substances|mesh-ancestor
44623565|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623566|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623567|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623568|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623569|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44623570|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623571|NCT00532948|Capecitabine|capecitabine|mesh-list
44623572|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44623573|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
44623574|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623575|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623576|NCT00532935|Metformin|metformin|mesh-list
44623577|NCT00532935|Pioglitazone|pioglitazone|mesh-list
44623578|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44623579|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44623580|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623581|NCT00532935|Incretins|incretins|mesh-ancestor
44623582|NCT00532935|Hormones|hormones|mesh-ancestor
44623583|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623584|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44623585|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623586|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623587|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623588|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
44623589|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623590|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
44623591|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700449|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623592|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623593|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623594|NCT00532844|Vitamins|vitamins|mesh-list
44623595|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
44623596|NCT00532844|Verapamil|verapamil|mesh-list
44623597|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
44623598|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623599|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
44623600|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623601|NCT00532844|Protective Agents|protective agents|mesh-ancestor
44623602|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44623603|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44623604|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623605|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623606|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
44623607|NCT00532779|Naltrexone|naltrexone|mesh-list
44623608|NCT00532779|Bupropion|bupropion|mesh-list
44623609|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44623610|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44623611|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623612|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
44623613|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623614|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44623615|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623616|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623617|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44623618|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623619|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623620|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623621|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
44623622|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623623|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44623624|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623625|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623626|NCT00532493|Prazosin|prazosin|mesh-list
44623627|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44623628|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44623629|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44623630|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44623631|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623632|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623633|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623634|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623635|NCT00532441|Docetaxel|docetaxel|mesh-list
44623636|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44623637|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623638|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623639|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623640|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623641|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623642|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623643|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623644|NCT00532298|Vaccines|vaccines|mesh-list
44623645|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
44623646|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623647|NCT00532259|Pidilizumab|pidilizumab|mesh-list
44623648|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623649|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623650|NCT00532155|Dexamethasone|dexamethasone|mesh-list
44623651|NCT00532155|Docetaxel|docetaxel|mesh-list
44623652|NCT00532155|Aflibercept|aflibercept|mesh-list
44623653|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623654|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
44623655|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
44623656|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623663|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623664|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623665|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623666|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623667|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623668|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623669|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623670|NCT00532155|Growth Substances|growth substances|mesh-ancestor
44623671|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623673|NCT00532129|Chlorambucil|chlorambucil|mesh-list
44623674|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623675|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623676|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
44623677|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623678|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44623679|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44623680|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
44623681|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623682|NCT00531960|Bevacizumab|bevacizumab|mesh-list
44623683|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44623684|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623685|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623686|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623687|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623688|NCT00531960|Growth Substances|growth substances|mesh-ancestor
44623689|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623690|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623691|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892550|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44623692|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623693|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623694|NCT00531947|Selegiline|selegiline|mesh-list
44623695|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623696|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623697|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44623698|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44623699|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44623700|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623701|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623702|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44623703|NCT00531947|Protective Agents|protective agents|mesh-ancestor
44623704|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623705|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44623706|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623707|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623708|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623709|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623710|NCT00531479|Voriconazole|voriconazole|mesh-list
44623711|NCT00531479|Anidulafungin|anidulafungin|mesh-list
44623712|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
44623713|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623714|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44623715|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623716|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623717|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623718|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44623719|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
44623720|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623721|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623722|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623723|NCT00531427|Buprenorphine|buprenorphine|mesh-list
44623724|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44623725|NCT00531427|Narcotics|narcotics|mesh-ancestor
44623726|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44623727|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623728|NCT00531427|Analgesics|analgesics|mesh-ancestor
44623729|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
43892551|NCT04597320|Narcotics|narcotics|mesh-ancestor
44623730|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623731|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44623732|NCT00531284|Dexamethasone|dexamethasone|mesh-list
44623733|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623734|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
44623735|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
44623736|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623737|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623738|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44623739|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
44623740|NCT00531284|Hormones|hormones|mesh-ancestor
44623741|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623742|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44623743|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623744|NCT00531206|Ritonavir|ritonavir|mesh-list
44623745|NCT00531206|Tipranavir|tipranavir|mesh-list
44623746|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44623747|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44623748|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623749|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623750|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623751|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44623752|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44623753|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
44623754|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623755|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623756|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623757|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44623758|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44623759|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
44623760|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623761|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623762|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44623763|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44623764|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44623765|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44623766|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44623767|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623768|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892591|NCT04524702|Gemcitabine|gemcitabine|mesh-list
44623769|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623770|NCT00531011|Paclitaxel|paclitaxel|mesh-list
44623771|NCT00531011|Everolimus|everolimus|mesh-list
44623772|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44623773|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623774|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44623775|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44623776|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44623777|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623778|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623779|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
44623780|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623781|NCT00530946|Amlodipine|amlodipine|mesh-list
44623782|NCT00530946|Atorvastatin|atorvastatin|mesh-list
44623783|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44623784|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44623785|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
44623786|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623787|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44623788|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44623789|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623790|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44623791|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44623792|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623793|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44623794|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623795|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
44623796|NCT00530920|Ritonavir|ritonavir|mesh-list
44623797|NCT00530920|Tipranavir|tipranavir|mesh-list
44623798|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44623799|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44623800|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623801|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623802|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623803|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44623804|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44623805|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
44623806|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892634|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
44623807|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44623808|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44623809|NCT00530855|Lacosamide|lacosamide|mesh-list
44623810|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
44623811|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44623812|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44623813|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623814|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623815|NCT00530842|Fluticasone|fluticasone|mesh-list
44623816|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
44623817|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44019833|NCT02994251|Antiviral Agents|antiviral agents|mesh-ancestor
44623818|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44623819|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623820|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44623821|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
44623822|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623823|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623824|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44623825|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
44623826|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44623827|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44623828|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
44623829|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44623830|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
44623831|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623832|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623833|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44623834|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44623835|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44623836|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623837|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
44623838|NCT00530842|Hormones|hormones|mesh-ancestor
44623839|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623840|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
44623841|NCT00530790|Ropinirole|ropinirole|mesh-list
44623842|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44623843|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44623844|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
44623845|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
44623846|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623847|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623848|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623849|NCT00530777|Valacyclovir|valacyclovir|mesh-list
44623850|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
44623851|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623852|NCT00530621|Pemetrexed|pemetrexed|mesh-list
44623853|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623854|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623855|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623856|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44623857|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623858|NCT00530348|Interferons|interferons|mesh-list
44623859|NCT00530348|Interferon-beta|interferon-beta|mesh-list
44623860|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
44623861|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
44623862|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623863|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
44623864|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623865|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44623866|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
44453529|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
44623867|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623868|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44623869|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44623870|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44623871|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623872|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623873|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623874|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623875|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623876|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623877|NCT00530270|Dexamethasone|dexamethasone|mesh-list
44623878|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44623879|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
44623880|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
44623881|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623882|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623883|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44623884|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
44623885|NCT00530270|Hormones|hormones|mesh-ancestor
44623886|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44623887|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44623888|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623889|NCT00530257|Methylphenidate|methylphenidate|mesh-list
44623890|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44623891|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623892|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44623893|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623894|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623895|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623896|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
44623897|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623898|NCT00530218|Ganciclovir|ganciclovir|mesh-list
44623899|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44623900|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
44623901|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623902|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44623903|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623904|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623905|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44623906|NCT00530088|Trioxsalen|trioxsalen|mesh-list
44623907|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623908|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
44623909|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44623910|NCT00530075|Gusperimus|gusperimus|mesh-list
44623911|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44623912|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623913|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44623914|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623915|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623916|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
44623917|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44623918|NCT00530075|Protective Agents|protective agents|mesh-ancestor
44623919|NCT00530023|Insulin|insulin|mesh-list
44623920|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44623921|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623922|NCT00529802|Everolimus|everolimus|mesh-list
44623923|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623924|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623925|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
44623926|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623927|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44623928|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44623929|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44623930|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44623931|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623932|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623933|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623934|NCT00529789|Analgesics|analgesics|mesh-ancestor
44623935|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
44623936|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623937|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
44623938|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44623939|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
44623940|NCT00529763|Dasatinib|dasatinib|mesh-list
44623941|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623942|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44623943|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623944|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623945|NCT00529633|Thalidomide|thalidomide|mesh-list
44623946|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44623947|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
44623948|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623949|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
44623950|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44623951|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44623952|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44623953|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44623954|NCT00529633|Growth Substances|growth substances|mesh-ancestor
44623955|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
44623956|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44623957|NCT00529542|Atorvastatin|atorvastatin|mesh-list
44623958|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44623959|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44623960|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
44623961|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623962|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43700450|NCT02731430|Analgesics|analgesics|mesh-ancestor
44623963|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44623965|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44623966|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44623967|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
44623968|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44623969|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623970|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44623971|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44623972|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44623973|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44623974|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44623975|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44623976|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44623977|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623979|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44623980|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
44623981|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44623982|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623983|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44623984|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44623985|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
44623986|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44623987|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
44623988|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44623989|NCT00529399|Antacids|antacids|mesh-ancestor
44623990|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44623991|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44623992|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
44623993|NCT00529373|Vitamin D|vitamin d|mesh-list
44623994|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
44623995|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
44623996|NCT00529373|Calcium|calcium|mesh-list
44623997|NCT00529373|Vitamins|vitamins|mesh-ancestor
44623998|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
44623999|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624000|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624001|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44624002|NCT00529373|Antacids|antacids|mesh-ancestor
44624003|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624004|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624005|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
44624006|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44624007|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44624008|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
44624009|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624010|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44624011|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44624012|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624013|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624014|NCT00529100|Cisplatin|cisplatin|mesh-list
44624015|NCT00529100|Pemetrexed|pemetrexed|mesh-list
44624016|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624017|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624018|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624019|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44624020|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624021|NCT00529087|Bromides|bromides|mesh-list
44624022|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
44624023|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
44624024|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44624025|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624026|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
44624027|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624028|NCT00529035|Interleukin-2|interleukin-2|mesh-list
44624029|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624030|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624031|NCT00529035|Analgesics|analgesics|mesh-ancestor
44624032|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
44624033|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624034|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624035|NCT00528996|Bromides|bromides|mesh-list
44624036|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
44624037|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44624038|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
44624039|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624040|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624042|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
44624043|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
44624044|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44624045|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
44624046|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624047|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624048|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
44624049|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
44624050|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44624051|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624052|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
44624053|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624054|NCT00528957|Tenofovir|tenofovir|mesh-list
44624055|NCT00528957|Zidovudine|zidovudine|mesh-list
44624056|NCT00528957|Stavudine|stavudine|mesh-list
44624057|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
44624058|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624059|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44624060|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624061|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624062|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624063|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44624064|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44624065|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
44624066|NCT00528879|Metformin|metformin|mesh-list
44624067|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
44624068|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44624069|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624070|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44624071|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624072|NCT00528866|Docetaxel|docetaxel|mesh-list
44624073|NCT00528866|Bicalutamide|bicalutamide|mesh-list
44624074|NCT00528866|Flutamide|flutamide|mesh-list
44624075|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624076|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624077|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624078|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624079|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624080|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
44624081|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
44624082|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624083|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624084|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44624085|NCT00528645|Saracatinib|saracatinib|mesh-list
44624086|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624087|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624088|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624089|NCT00528567|Bevacizumab|bevacizumab|mesh-list
44624090|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624091|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624092|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624093|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624094|NCT00528567|Growth Substances|growth substances|mesh-ancestor
44624095|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624096|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624097|NCT00528528|Ribavirin|ribavirin|mesh-list
44624098|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
44624099|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
44624100|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44624101|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44624102|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44624103|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
44624104|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624105|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
44624106|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624107|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
44624108|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624109|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624110|NCT00528411|Aspirin|aspirin|mesh-list
44624111|NCT00528411|Clopidogrel|clopidogrel|mesh-list
44624112|NCT00528411|Ticagrelor|ticagrelor|mesh-list
44624113|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624115|NCT00528411|Analgesics|analgesics|mesh-ancestor
44624116|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
44624117|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624118|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624119|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624120|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624121|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44624122|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44624123|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624124|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44624125|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44624126|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624127|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
44624128|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44624129|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44624130|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44624131|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
44624132|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624133|NCT00528372|Metformin|metformin|mesh-list
44624134|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
44624135|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44624136|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624137|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44624138|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624139|NCT00527982|Celecoxib|celecoxib|mesh-list
44624140|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624141|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624142|NCT00527982|Analgesics|analgesics|mesh-ancestor
44624143|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
44624144|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624145|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624146|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624147|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624148|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44624149|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44624150|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624151|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624152|NCT00527904|Naproxen|naproxen|mesh-list
44624153|NCT00527904|Esomeprazole|esomeprazole|mesh-list
44624154|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44624155|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624156|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44624157|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624158|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624159|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624160|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624161|NCT00527904|Analgesics|analgesics|mesh-ancestor
44624162|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
44624163|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624164|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624165|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624166|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624167|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
44624168|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44624169|NCT00527826|Fluticasone|fluticasone|mesh-list
44624171|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44624172|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624173|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44624174|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
44624175|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624176|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624177|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44624178|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
44624179|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44624180|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44624181|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44624182|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44624183|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44624184|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44624185|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624186|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624187|NCT00527787|Naproxen|naproxen|mesh-list
44624188|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624189|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624190|NCT00527787|Analgesics|analgesics|mesh-ancestor
44624191|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
44624192|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624193|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624194|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624195|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624196|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
44624197|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44624198|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624199|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624200|NCT00527735|Paclitaxel|paclitaxel|mesh-list
44624201|NCT00527735|Carboplatin|carboplatin|mesh-list
44624202|NCT00527735|Ipilimumab|ipilimumab|mesh-list
44624203|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624204|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624205|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624206|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624207|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624208|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624209|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624210|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44624211|NCT00527618|Valacyclovir|valacyclovir|mesh-list
44624212|NCT00527618|Acyclovir|acyclovir|mesh-list
44624213|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
44624214|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624215|NCT00527605|Dutasteride|dutasteride|mesh-list
44624216|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44624217|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44624218|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624219|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624220|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
44624221|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624222|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624223|NCT00527514|Amlodipine|amlodipine|mesh-list
44624224|NCT00527514|Olmesartan|olmesartan|mesh-list
44624225|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44624226|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44624227|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44624228|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624229|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624230|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624231|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624232|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
44624233|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44624234|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44624235|NCT00527423|Aflibercept|aflibercept|mesh-list
44624236|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624237|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624238|NCT00527423|Growth Substances|growth substances|mesh-ancestor
44624239|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624240|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624241|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175843|NCT00301301|Rituximab|rituximab|mesh-list
44624242|NCT00527397|Insulin|insulin|mesh-list
44624243|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44624244|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624245|NCT00527332|Fentanyl|fentanyl|mesh-list
44624246|NCT00527332|Morphine|morphine|mesh-list
44624247|NCT00527332|Bupivacaine|bupivacaine|mesh-list
44624248|NCT00527332|Propofol|propofol|mesh-list
44624249|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
44624250|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
44624251|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44624252|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624253|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
44624254|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624255|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44624256|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44624257|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
44624258|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44624259|NCT00527332|Narcotics|narcotics|mesh-ancestor
44624260|NCT00527332|Analgesics|analgesics|mesh-ancestor
44624261|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44624262|NCT00527111|Fluorouracil|fluorouracil|mesh-list
44624263|NCT00527111|Cetuximab|cetuximab|mesh-list
44624264|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
44624265|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624266|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624267|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624268|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624269|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
44624270|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624271|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624272|NCT00527072|Infliximab|infliximab|mesh-list
44624273|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
44624274|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624275|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624276|NCT00526890|Selenium|selenium|mesh-list
44624277|NCT00526890|Paclitaxel|paclitaxel|mesh-list
44624278|NCT00526890|Carboplatin|carboplatin|mesh-list
44624279|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624280|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624281|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624282|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624283|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624284|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624285|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
44624286|NCT00526890|Protective Agents|protective agents|mesh-ancestor
44624287|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624288|NCT00526890|Trace Elements|trace elements|mesh-ancestor
44624289|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
44624290|NCT00526799|Sorafenib|sorafenib|mesh-list
44624291|NCT00526799|Topotecan|topotecan|mesh-list
44624292|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624293|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624294|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624295|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624296|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44624297|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624298|NCT00526669|Capecitabine|capecitabine|mesh-list
44624299|NCT00526669|Lapatinib|lapatinib|mesh-list
44624300|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624301|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
44624302|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624303|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624304|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624305|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624306|NCT00526656|Sunitinib|sunitinib|mesh-list
44624307|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624308|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624309|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624310|NCT00526656|Growth Substances|growth substances|mesh-ancestor
44624311|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624312|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624313|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624314|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624315|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624316|NCT00526630|Methylphenidate|methylphenidate|mesh-list
44624317|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44624318|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624319|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44624320|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44624321|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624322|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624324|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624325|NCT00526110|Docetaxel|docetaxel|mesh-list
44624326|NCT00526110|Fluorouracil|fluorouracil|mesh-list
44624327|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
44624328|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624329|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624330|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624331|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624332|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624333|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
44624334|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624335|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624336|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
44624337|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624338|NCT00526097|Bisacodyl|bisacodyl|mesh-list
44624339|NCT00526097|Cathartics|cathartics|mesh-ancestor
44624340|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624342|NCT00525915|Fluorouracil|fluorouracil|mesh-list
44624343|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
44624344|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
44624345|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624346|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624347|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624348|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624349|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
44624350|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624351|NCT00525902|Adalimumab|adalimumab|mesh-list
44624352|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624353|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624354|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44624355|NCT00525824|Simvastatin|simvastatin|mesh-list
44624356|NCT00525824|Ezetimibe|ezetimibe|mesh-list
44624357|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44624358|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44624359|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
44624360|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624361|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44624362|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44624363|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624364|NCT00525785|Leucovorin|leucovorin|mesh-list
44624365|NCT00525785|Folic Acid|folic acid|mesh-list
44624366|NCT00525785|Fluorouracil|fluorouracil|mesh-list
44624367|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
44624368|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
44624369|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
44624370|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624371|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624372|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624373|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624374|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
44624375|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624376|NCT00525785|Antidotes|antidotes|mesh-ancestor
44624377|NCT00525785|Protective Agents|protective agents|mesh-ancestor
44624378|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
44624379|NCT00525785|Vitamins|vitamins|mesh-ancestor
44624380|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
44624381|NCT00525785|Hematinics|hematinics|mesh-ancestor
44624382|NCT00525590|Carmustine|carmustine|mesh-list
44624383|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44624384|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
44624385|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624386|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624387|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
44624388|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44624389|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
44624390|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624391|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624392|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44624393|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
44624394|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
44624395|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44624396|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
44624397|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624398|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624399|NCT00525499|Androgens|androgens|mesh-list
44624400|NCT00525499|Hormones|hormones|mesh-ancestor
44624401|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624402|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624403|NCT00525265|Tolvaptan|tolvaptan|mesh-list
44624404|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44624405|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624406|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
44624407|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624408|NCT00525161|Sorafenib|sorafenib|mesh-list
44624409|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624410|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624411|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624412|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624413|NCT00525148|Afatinib|afatinib|mesh-list
44624414|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235732|NCT00555984|Analgesics|analgesics|mesh-ancestor
44624416|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624417|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624418|NCT00525044|Ambroxol|ambroxol|mesh-list
44624419|NCT00525044|Expectorants|expectorants|mesh-ancestor
44624420|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
44624421|NCT00525031|Interferons|interferons|mesh-list
44624422|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
44624423|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
44624424|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44624425|NCT00525031|Temozolomide|temozolomide|mesh-list
44624426|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624427|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
44624428|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624429|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44624430|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
44624431|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624432|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
44624433|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624434|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
44624435|NCT00524680|Vitamin D|vitamin d|mesh-list
44624436|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624437|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624438|NCT00524680|Vitamins|vitamins|mesh-ancestor
44624439|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
44624440|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44624441|NCT00524589|Calcitriol|calcitriol|mesh-list
44624442|NCT00524589|Dexamethasone|dexamethasone|mesh-list
44624443|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624444|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
44624445|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
44624446|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624447|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624448|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624449|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
44624450|NCT00524589|Hormones|hormones|mesh-ancestor
44624451|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624452|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44624453|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624454|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624455|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44624456|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624457|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624458|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44624459|NCT00524589|Vitamins|vitamins|mesh-ancestor
44624460|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
44624461|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44624462|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44624463|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44624464|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44624465|NCT00524459|Docetaxel|docetaxel|mesh-list
44624466|NCT00524459|Doxorubicin|doxorubicin|mesh-list
44624467|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44624468|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624469|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624470|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44176083|NCT00301899|Trastuzumab|trastuzumab|mesh-list
44624471|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624472|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624473|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44624474|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44624475|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624476|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624477|NCT00524368|Ritonavir|ritonavir|mesh-list
44624478|NCT00524368|Darunavir|darunavir|mesh-list
44624479|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44624480|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44624481|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
44624482|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624483|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624484|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44624485|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44624486|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
44624487|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624488|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44020489|NCT02429583|Vaccines|vaccines|mesh-list
43893261|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
44624489|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44624490|NCT00524316|Doxorubicin|doxorubicin|mesh-list
44624491|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44624492|NCT00524316|Sunitinib|sunitinib|mesh-list
44624493|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44624494|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624495|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44624496|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624497|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624498|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624499|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624500|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624501|NCT00524316|Growth Substances|growth substances|mesh-ancestor
44624502|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624503|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624504|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624505|NCT00524303|Paclitaxel|paclitaxel|mesh-list
44624506|NCT00524303|Trastuzumab|trastuzumab|mesh-list
44624507|NCT00524303|Lapatinib|lapatinib|mesh-list
44624508|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624509|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624510|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624511|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624512|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624513|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624514|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624515|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624516|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624517|NCT00524173|Tenofovir|tenofovir|mesh-list
44624518|NCT00524173|Emtricitabine|emtricitabine|mesh-list
44624519|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
44624520|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624521|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44624522|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624523|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624524|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624525|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44624526|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44624527|NCT00524134|Carvedilol|carvedilol|mesh-list
44624528|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43893349|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624529|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44624530|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44624531|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624532|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624533|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624534|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44624535|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
44624536|NCT00524134|Protective Agents|protective agents|mesh-ancestor
44624537|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44624538|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624539|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624540|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
44624541|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44624542|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44624543|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44624544|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624545|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624546|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624547|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624548|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44624549|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44624550|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44624551|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44624552|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624553|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44624554|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44624555|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44624556|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
44624557|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624558|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624559|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44624560|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44624561|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
44624562|NCT00524030|Pregabalin|pregabalin|mesh-list
44624563|NCT00524030|Analgesics|analgesics|mesh-ancestor
44624564|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
44624565|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893358|NCT03367312|Xenon|xenon|mesh-list
44624566|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624567|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
44624568|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44624569|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624570|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624571|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624572|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44624573|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44624574|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44624575|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44624576|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
44624577|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44624578|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
44624579|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624580|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624581|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44624582|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
44624583|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
44624584|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44624585|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
44624586|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624587|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624588|NCT00523978|Sotalol|sotalol|mesh-list
44624589|NCT00523978|Flecainide|flecainide|mesh-list
44624590|NCT00523978|Propafenone|propafenone|mesh-list
44624591|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44624592|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44624593|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
44624594|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624595|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624596|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624597|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44624598|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
44624599|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
44624600|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624601|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44624602|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44624603|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624604|NCT00523848|Thalidomide|thalidomide|mesh-list
44624605|NCT00523848|Doxorubicin|doxorubicin|mesh-list
44624606|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44624607|NCT00523848|Bortezomib|bortezomib|mesh-list
44624608|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44624609|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624610|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44624611|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624612|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624613|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624614|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624615|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
44176218|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44624616|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624617|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
44624618|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44624619|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624620|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624621|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624622|NCT00523848|Growth Substances|growth substances|mesh-ancestor
44624623|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624625|NCT00523744|Valsartan|valsartan|mesh-list
44624626|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44624627|NCT00523744|Olmesartan|olmesartan|mesh-list
44624628|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44624629|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44624630|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44624631|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624632|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624633|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624634|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624635|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
44624636|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44624637|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44624638|NCT00523744|Diuretics|diuretics|mesh-ancestor
44624639|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
44624640|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44624641|NCT00523718|Riluzole|riluzole|mesh-list
44624642|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
44624643|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44624644|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44624645|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624646|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624647|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624648|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44624649|NCT00523718|Protective Agents|protective agents|mesh-ancestor
44624650|NCT00523705|Citalopram|citalopram|mesh-list
44624651|NCT00523705|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44624652|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44624653|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624654|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624655|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624656|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
44624657|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624658|NCT00523705|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44624659|NCT00523705|Antidepressive Agents|antidepressive agents|mesh-ancestor
44624660|NCT00523705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44624661|NCT00523640|Gemcitabine|gemcitabine|mesh-list
44624662|NCT00523640|Bevacizumab|bevacizumab|mesh-list
44624663|NCT00523640|Capecitabine|capecitabine|mesh-list
44624664|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624665|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624666|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624667|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624668|NCT00523640|Growth Substances|growth substances|mesh-ancestor
44624669|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624670|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624671|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624672|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
44624673|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624674|NCT00523640|Antiviral Agents|antiviral agents|mesh-ancestor
44624675|NCT00523640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624676|NCT00523640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624677|NCT00523640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624678|NCT00523640|Immunologic Factors|immunologic factors|mesh-ancestor
44624679|NCT00523549|Amlodipine|amlodipine|mesh-list
44624680|NCT00523549|Valsartan|valsartan|mesh-list
44624681|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44624682|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44624683|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624684|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624685|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44624686|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624687|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
44624688|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44624689|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44624690|NCT00523419|Pemetrexed|pemetrexed|mesh-list
44624691|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624692|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624693|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624694|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44624695|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624696|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
44624697|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44624698|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624699|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44624700|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
44624701|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44624702|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624703|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624704|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624705|NCT00522431|Testosterone|testosterone|mesh-list
44624706|NCT00522431|Androgens|androgens|mesh-ancestor
44624707|NCT00522431|Hormones|hormones|mesh-ancestor
44624708|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624709|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624710|NCT00522392|Dexamethasone|dexamethasone|mesh-list
44624711|NCT00522392|Lenalidomide|lenalidomide|mesh-list
44624712|NCT00522392|Bortezomib|bortezomib|mesh-list
44624713|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624714|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
44624715|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
44624716|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624717|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624718|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624719|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
44624720|NCT00522392|Hormones|hormones|mesh-ancestor
44624721|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624722|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44624723|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624724|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
44624725|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624726|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624727|NCT00522392|Growth Substances|growth substances|mesh-ancestor
44624728|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624729|NCT00522379|Rotigotine|rotigotine|mesh-list
44624730|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
44624731|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
44624732|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44624733|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624734|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624735|NCT00522301|Sorafenib|sorafenib|mesh-list
44624736|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624737|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624738|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624739|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624740|NCT00522275|Lacosamide|lacosamide|mesh-list
44624741|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
44624742|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44624743|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44624744|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624745|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624746|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
44624747|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
44624748|NCT00521586|Vaccines|vaccines|mesh-list
44624749|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44624750|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
44624751|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624752|NCT00521404|Gemcitabine|gemcitabine|mesh-list
44624753|NCT00521404|Antibodies|antibodies|mesh-list
44624754|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
44624755|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893534|NCT02542657|Clarithromycin|clarithromycin|mesh-list
44624756|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624757|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
44624758|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624759|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624760|NCT00521404|Antiviral Agents|antiviral agents|mesh-ancestor
44624761|NCT00521404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624762|NCT00521404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624763|NCT00521404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624764|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44624765|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
44624766|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44624767|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44624768|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44624769|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44624770|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624771|NCT00521339|Apremilast|apremilast|mesh-list
44624772|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624773|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624774|NCT00521339|Analgesics|analgesics|mesh-ancestor
44624775|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
44624776|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624777|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624778|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624779|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624780|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44624781|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44624782|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624783|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624784|NCT00521144|Topotecan|topotecan|mesh-list
44624785|NCT00521144|Obatoclax|obatoclax|mesh-list
44624786|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44624787|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624788|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624789|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624790|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624791|NCT00521014|Cytarabine|cytarabine|mesh-list
44624792|NCT00521014|Rituximab|rituximab|mesh-list
44624793|NCT00521014|Etoposide|etoposide|mesh-list
44624794|NCT00521014|Melphalan|melphalan|mesh-list
44624795|NCT00521014|Carmustine|carmustine|mesh-list
44624796|NCT00521014|Sargramostim|sargramostim|mesh-list
44624797|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624798|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624799|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
44624800|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624801|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624802|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624803|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44624804|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44624805|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624806|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624807|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624808|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
44624809|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
44624810|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624811|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624812|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44624813|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
44624814|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44624815|NCT00521001|Everolimus|everolimus|mesh-list
44624816|NCT00521001|Temozolomide|temozolomide|mesh-list
44624817|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624818|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624819|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
44624820|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624821|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44624822|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
44624823|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624824|NCT00520975|Paclitaxel|paclitaxel|mesh-list
44624825|NCT00520975|Bevacizumab|bevacizumab|mesh-list
44624826|NCT00520975|Carboplatin|carboplatin|mesh-list
44624827|NCT00520975|Trastuzumab|trastuzumab|mesh-list
44624828|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44624829|NCT00520975|Antibodies|antibodies|mesh-list
44624830|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
44624831|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44624832|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624833|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624834|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624835|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624836|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624837|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624838|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624839|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624840|NCT00520975|Growth Substances|growth substances|mesh-ancestor
44624841|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624842|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624843|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
44624844|NCT00520936|Pemetrexed|pemetrexed|mesh-list
44624845|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624846|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624847|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624848|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44624849|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624850|NCT00520845|Celecoxib|celecoxib|mesh-list
44624851|NCT00520845|Docetaxel|docetaxel|mesh-list
44624852|NCT00520845|Pemetrexed|pemetrexed|mesh-list
44624853|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624854|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624855|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624856|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624857|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624858|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624859|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44624860|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624861|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624862|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624863|NCT00520845|Analgesics|analgesics|mesh-ancestor
44624864|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
44624865|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624866|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624867|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624868|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624869|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44624870|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44624871|NCT00520767|Dexamethasone|dexamethasone|mesh-list
44624872|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
44624873|NCT00520767|Bortezomib|bortezomib|mesh-list
44624874|NCT00520767|Melphalan|melphalan|mesh-list
44624875|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44624876|NCT00520767|BB 1101|bb 1101|mesh-list
44624877|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624878|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
44624879|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
44624880|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624881|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624882|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624883|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
44624884|NCT00520767|Hormones|hormones|mesh-ancestor
44624885|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44624886|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44624887|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624888|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
44624889|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624890|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624891|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44624892|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
44624893|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44624894|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624895|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
44624896|NCT00520741|Lacosamide|lacosamide|mesh-list
44624897|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
44624898|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44624899|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44624900|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44624901|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624902|NCT00520676|Carboplatin|carboplatin|mesh-list
44624903|NCT00520676|Docetaxel|docetaxel|mesh-list
44624904|NCT00520676|Pemetrexed|pemetrexed|mesh-list
44624905|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624906|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624907|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624908|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624909|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624910|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624911|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44624912|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44624913|NCT00520572|Etanercept|etanercept|mesh-list
44624914|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44624915|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44624916|NCT00520572|Analgesics|analgesics|mesh-ancestor
44624917|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
44624918|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44624919|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624920|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44624921|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624922|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44624923|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624924|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
44624925|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44624926|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
44624927|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624928|NCT00520403|Interferons|interferons|mesh-list
44624929|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
44624930|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
44624931|NCT00520403|Bevacizumab|bevacizumab|mesh-list
44624932|NCT00520403|Vinblastine|vinblastine|mesh-list
44624933|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893678|NCT02098954|Gemcitabine|gemcitabine|mesh-list
44624934|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624935|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624936|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624937|NCT00520403|Growth Substances|growth substances|mesh-ancestor
44624938|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624939|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624940|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
44624941|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624942|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
44624943|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624944|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624945|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624946|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624947|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624948|NCT00520130|Cytarabine|cytarabine|mesh-list
44624949|NCT00520130|Cyclosporine|cyclosporine|mesh-list
44624950|NCT00520130|Rituximab|rituximab|mesh-list
44624951|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
44624952|NCT00520130|Fludarabine|fludarabine|mesh-list
44624953|NCT00520130|Cyclosporins|cyclosporins|mesh-list
44624954|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624955|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624956|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
44624957|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624958|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44624959|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44624960|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
44624961|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624962|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44624963|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
44624964|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44624965|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624966|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
44624967|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44624968|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44624969|NCT00520013|Paclitaxel|paclitaxel|mesh-list
44624970|NCT00520013|Bevacizumab|bevacizumab|mesh-list
44624971|NCT00520013|Carboplatin|carboplatin|mesh-list
44624972|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43893707|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44624973|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44624974|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624975|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44624976|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44624977|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44624978|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624979|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624980|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624981|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624982|NCT00520013|Growth Substances|growth substances|mesh-ancestor
44624983|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624984|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
44624985|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624986|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624987|NCT00519896|Sunitinib|sunitinib|mesh-list
44624988|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44624989|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44624990|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44624991|NCT00519896|Growth Substances|growth substances|mesh-ancestor
44624992|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44624993|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44176592|NCT00303771|Antidotes|antidotes|mesh-ancestor
44624994|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44624995|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44624996|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44624997|NCT00519831|Cetuximab|cetuximab|mesh-list
44624998|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44624999|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625000|NCT00519636|Fluticasone|fluticasone|mesh-list
44625002|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625003|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44625004|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
44625005|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625006|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625007|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44625008|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
44625009|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44625010|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44625011|NCT00519623|Insulin|insulin|mesh-list
44625012|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625013|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625014|NCT00519532|Rotigotine|rotigotine|mesh-list
44625015|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
44625016|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
44625017|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625018|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893746|NCT00107250|Capecitabine|capecitabine|mesh-list
44625019|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625020|NCT00519428|Dexetimide|dexetimide|mesh-list
44625021|NCT00519428|Citalopram|citalopram|mesh-list
44625022|NCT00519428|Bupropion|bupropion|mesh-list
44625023|NCT00519428|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44625024|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44625025|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625026|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625027|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625028|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
44625029|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625030|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44625031|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
44625032|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625033|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44625034|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44625035|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
44625036|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
44625037|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625038|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44625039|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44625040|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
44625041|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44625042|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
44625043|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44625044|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44625045|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625046|NCT00519285|Prednisone|prednisone|mesh-list
44625047|NCT00519285|Prednisolone|prednisolone|mesh-list
44625048|NCT00519285|Docetaxel|docetaxel|mesh-list
44625049|NCT00519285|Aflibercept|aflibercept|mesh-list
44625050|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625051|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625052|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625053|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625054|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625055|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625056|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
44625057|NCT00519285|Hormones|hormones|mesh-ancestor
44625058|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625059|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625060|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44625061|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44625062|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44625063|NCT00519285|Growth Substances|growth substances|mesh-ancestor
44625064|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
44625065|NCT00519077|Gefitinib|gefitinib|mesh-list
44625066|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625067|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625068|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625069|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625070|NCT00518986|Modafinil|modafinil|mesh-list
44176751|NCT00304213|Hormones|hormones|mesh-ancestor
44625071|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44625072|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625073|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44625074|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44625075|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44625076|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625077|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44625078|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
44625079|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625080|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625081|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625082|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021064|NCT01938833|Paclitaxel|paclitaxel|mesh-list
44625083|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625085|NCT00518882|Exenatide|exenatide|mesh-list
44625086|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625087|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625088|NCT00518882|Incretins|incretins|mesh-ancestor
44625089|NCT00518882|Hormones|hormones|mesh-ancestor
44625090|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625091|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44625092|NCT00518687|Vaccines|vaccines|mesh-list
44625093|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
44625094|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625095|NCT00518531|Denosumab|denosumab|mesh-list
44625096|NCT00518531|Alendronate|alendronate|mesh-list
44625097|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44625098|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625099|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44625100|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625101|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625102|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625103|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625104|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137411|NCT00167960|Lactams|lactams|mesh-list
44625105|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44625106|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44625107|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
44625108|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625109|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625110|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44625111|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44625112|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
44625113|NCT00518284|Paclitaxel|paclitaxel|mesh-list
44625114|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44625115|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625116|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625117|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625118|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625119|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625120|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625121|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
44625122|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625123|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
44625124|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625125|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625126|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625127|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
44625128|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625129|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625130|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44625131|NCT00518180|Lactitol|lactitol|mesh-list
44625132|NCT00518180|Vaccines|vaccines|mesh-list
44625133|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
44625134|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625135|NCT00518180|Cathartics|cathartics|mesh-ancestor
44625136|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625137|NCT00518115|Exenatide|exenatide|mesh-list
44625138|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
44625139|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625140|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625141|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44625142|NCT00518115|Incretins|incretins|mesh-ancestor
44625143|NCT00518115|Hormones|hormones|mesh-ancestor
44625144|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625145|NCT00518011|Gemcitabine|gemcitabine|mesh-list
44625146|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44625147|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625148|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
44625149|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625150|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625151|NCT00518011|Antiviral Agents|antiviral agents|mesh-ancestor
44625152|NCT00518011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625153|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625154|NCT00518011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625155|NCT00518011|Immunologic Factors|immunologic factors|mesh-ancestor
44625156|NCT00518011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625157|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625158|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
44625159|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625160|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
44625161|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44625162|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44625163|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625164|NCT00517933|Urological Agents|urological agents|mesh-ancestor
44625165|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
44625166|NCT00517881|Hematinics|hematinics|mesh-ancestor
44625167|NCT00517829|Docetaxel|docetaxel|mesh-list
44625168|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
44625169|NCT00517829|Cetuximab|cetuximab|mesh-list
44625170|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625171|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625172|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625173|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625174|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625175|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625176|NCT00517699|Cytarabine|cytarabine|mesh-list
44625177|NCT00517699|Rituximab|rituximab|mesh-list
44625178|NCT00517699|Methotrexate|methotrexate|mesh-list
44625179|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625180|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625181|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
44625182|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625183|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625184|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44625185|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
44625186|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44625187|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625188|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
44625189|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625190|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44625191|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625192|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44625193|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625194|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44625195|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
44625196|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625197|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
44625198|NCT00517413|Hematinics|hematinics|mesh-ancestor
44625199|NCT00517361|Bevacizumab|bevacizumab|mesh-list
44625200|NCT00517361|Carboplatin|carboplatin|mesh-list
44625201|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625202|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625203|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44625204|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44625205|NCT00517361|Growth Substances|growth substances|mesh-ancestor
44625206|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625207|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
44625208|NCT00517296|Adalimumab|adalimumab|mesh-list
44625209|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625210|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625211|NCT00517192|Ritonavir|ritonavir|mesh-list
44625212|NCT00517192|Darunavir|darunavir|mesh-list
44625213|NCT00517192|Tipranavir|tipranavir|mesh-list
44625214|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44625215|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44625216|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
44625217|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625218|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625219|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44625220|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44625221|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
44625222|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625223|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44625224|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44625225|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
44625226|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44625227|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44625228|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625229|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
44625230|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44625231|NCT00516893|Natalizumab|natalizumab|mesh-list
44625232|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
44625233|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625234|NCT00516737|Rizatriptan|rizatriptan|mesh-list
44625235|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44625236|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
44625237|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893955|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44625238|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625239|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625240|NCT00516386|Mecasermin|mecasermin|mesh-list
44625241|NCT00516386|Growth Substances|growth substances|mesh-ancestor
44625242|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625243|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
44625244|NCT00516295|Bevacizumab|bevacizumab|mesh-list
44625245|NCT00516295|Vincristine|vincristine|mesh-list
44625246|NCT00516295|Topotecan|topotecan|mesh-list
44625247|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44625248|NCT00516295|Antibodies|antibodies|mesh-list
44625249|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
44625250|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44625251|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625252|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
44625253|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625254|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625255|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625256|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
44625257|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625258|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625259|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44625260|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44625261|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44625262|NCT00516295|Growth Substances|growth substances|mesh-ancestor
44625263|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
44625264|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625265|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625266|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625267|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625268|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44625269|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625270|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625271|NCT00516269|Methylphenidate|methylphenidate|mesh-list
44625272|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44625273|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625274|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44625275|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44625276|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625277|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625278|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
44625279|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625280|NCT00516139|Lamotrigine|lamotrigine|mesh-list
44625281|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
44625282|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44625283|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625284|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625285|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44625286|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625287|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625288|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625289|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625290|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625291|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44625292|NCT00516074|Exenatide|exenatide|mesh-list
44625293|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625294|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625295|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44625296|NCT00516074|Incretins|incretins|mesh-ancestor
44625297|NCT00516074|Hormones|hormones|mesh-ancestor
44625298|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625299|NCT00516048|Exenatide|exenatide|mesh-list
44625300|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625301|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625302|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44625303|NCT00516048|Incretins|incretins|mesh-ancestor
44625304|NCT00516048|Hormones|hormones|mesh-ancestor
44625305|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625306|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
44625307|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44625308|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44625309|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
44625310|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625311|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44625312|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44625313|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625314|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625316|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
44625317|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44625318|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44625319|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625320|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625321|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
44625322|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44625323|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
44625324|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625325|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625326|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44625327|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
44625328|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
44625329|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44625330|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
44625331|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625332|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625333|NCT00515463|Denosumab|denosumab|mesh-list
44625334|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44625335|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625336|NCT00515294|Caffeine|caffeine|mesh-list
44625337|NCT00515294|Methamphetamine|methamphetamine|mesh-list
44625338|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44625339|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625340|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44625341|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625342|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625343|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44625344|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44625345|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
44625346|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625347|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
44625348|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
44625349|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625350|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
44625351|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44625352|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44625353|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44625354|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625355|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44625356|NCT00515216|Leucovorin|leucovorin|mesh-list
44625357|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
44625358|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44625359|NCT00515216|Fluorouracil|fluorouracil|mesh-list
44625360|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
44625361|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
44625362|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
44625363|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625364|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625365|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625366|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625367|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
44625368|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625369|NCT00515216|Antidotes|antidotes|mesh-ancestor
44625370|NCT00515216|Protective Agents|protective agents|mesh-ancestor
44625371|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44625372|NCT00515216|Vitamins|vitamins|mesh-ancestor
44625373|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
44625374|NCT00515112|Testosterone|testosterone|mesh-list
44625375|NCT00515112|Androgens|androgens|mesh-ancestor
44625376|NCT00515112|Hormones|hormones|mesh-ancestor
44625377|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625378|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625379|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
44625380|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44625381|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
44625382|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625383|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625384|NCT00515086|Everolimus|everolimus|mesh-list
44625385|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625386|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625387|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
44625388|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625390|NCT00515073|Promethazine|promethazine|mesh-list
44625391|NCT00515073|Dexamethasone|dexamethasone|mesh-list
44625392|NCT00515073|Paclitaxel|paclitaxel|mesh-list
44625393|NCT00515073|Cimetidine|cimetidine|mesh-list
44625394|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625395|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625396|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625397|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625398|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625399|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625400|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625401|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
44625402|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
44625403|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625404|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625405|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625406|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
44625407|NCT00515073|Hormones|hormones|mesh-ancestor
44625408|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625409|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44625410|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44625411|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44625412|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625413|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
44625414|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
44625415|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
44625416|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44625417|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
44625418|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
44625419|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625420|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44625421|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
44625422|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44625423|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44625424|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44625425|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44625426|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44625427|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625428|NCT00515034|Imipenem|imipenem|mesh-list
44625429|NCT00515034|Doripenem|doripenem|mesh-list
44625430|NCT00515034|Cilastatin|cilastatin|mesh-list
44625431|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625432|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625433|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
44625434|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625435|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625436|NCT00514943|Cetuximab|cetuximab|mesh-list
44625437|NCT00514943|Afatinib|afatinib|mesh-list
44625438|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625439|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625440|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625441|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625442|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625443|NCT00514917|Docetaxel|docetaxel|mesh-list
44625444|NCT00514917|Leuprolide|leuprolide|mesh-list
44625445|NCT00514917|Bicalutamide|bicalutamide|mesh-list
44625446|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625447|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625448|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625449|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625450|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625451|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44625452|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
44625453|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44625454|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625455|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44625456|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
44625457|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
44625458|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625459|NCT00514904|Vaccines|vaccines|mesh-list
44625460|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
44625461|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625462|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44625464|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625465|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625466|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625467|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625468|NCT00514540|Cisplatin|cisplatin|mesh-list
44625469|NCT00514540|Carboplatin|carboplatin|mesh-list
44625470|NCT00514540|Docetaxel|docetaxel|mesh-list
44625471|NCT00514540|Etoposide|etoposide|mesh-list
44625472|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625473|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625474|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625475|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625476|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625477|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625478|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44625479|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625480|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625481|NCT00514514|Cyclosporine|cyclosporine|mesh-list
44625482|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
44625483|NCT00514514|Everolimus|everolimus|mesh-list
44625484|NCT00514514|Cyclosporins|cyclosporins|mesh-list
44625485|NCT00514514|Basiliximab|basiliximab|mesh-list
44625486|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625487|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625488|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625489|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
44625490|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625491|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
44625492|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625493|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
44625494|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625495|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44625496|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625497|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44625498|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44625499|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
44625500|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625501|NCT00514449|Valacyclovir|valacyclovir|mesh-list
44625502|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
44625503|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625504|NCT00514020|Leucovorin|leucovorin|mesh-list
44625505|NCT00514020|Fluorouracil|fluorouracil|mesh-list
44625506|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
44625507|NCT00514020|Calcium|calcium|mesh-list
44625508|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
44625509|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44625510|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625511|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
44625512|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625513|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625514|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625515|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625516|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
44625517|NCT00514020|Antidotes|antidotes|mesh-ancestor
44625518|NCT00514020|Protective Agents|protective agents|mesh-ancestor
44625519|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
44625520|NCT00514020|Vitamins|vitamins|mesh-ancestor
44625521|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
44625522|NCT00513695|Paclitaxel|paclitaxel|mesh-list
44625523|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
44625524|NCT00513695|Doxorubicin|doxorubicin|mesh-list
44625525|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44625526|NCT00513695|Sunitinib|sunitinib|mesh-list
44625527|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625528|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625529|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625530|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625532|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625533|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625534|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
44625535|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625536|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625537|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625538|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
44625539|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44625540|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44625541|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44625542|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625543|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625544|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44625545|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44625546|NCT00513695|Growth Substances|growth substances|mesh-ancestor
44625547|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44625548|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625549|NCT00513682|Pancrelipase|pancrelipase|mesh-list
44625550|NCT00513682|Pancreatin|pancreatin|mesh-list
44625551|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625552|NCT00513604|Aldesleukin|aldesleukin|mesh-list
44625553|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
44625554|NCT00513604|Fludarabine|fludarabine|mesh-list
44625555|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
44625556|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625557|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
44625558|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625559|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625560|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625561|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
44625562|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625563|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625564|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44625565|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625566|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
44625567|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44625568|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44625569|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
44625570|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625571|NCT00513500|Amoxicillin|amoxicillin|mesh-list
44625572|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44625573|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625574|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625575|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
44625576|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44625577|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44625578|NCT00513474|Cyclosporine|cyclosporine|mesh-list
44625579|NCT00513474|Sirolimus|sirolimus|mesh-list
44625580|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
44625581|NCT00513474|Busulfan|busulfan|mesh-list
44625582|NCT00513474|Methotrexate|methotrexate|mesh-list
44625583|NCT00513474|Fludarabine|fludarabine|mesh-list
44625584|NCT00513474|Etoposide|etoposide|mesh-list
44625585|NCT00513474|Allopurinol|allopurinol|mesh-list
44625586|NCT00513474|Rasburicase|rasburicase|mesh-list
44625587|NCT00513474|Tacrolimus|tacrolimus|mesh-list
44625588|NCT00513474|Cyclosporins|cyclosporins|mesh-list
44625589|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625590|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
44625591|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625592|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625593|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625594|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
44625595|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625596|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625597|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44625598|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44625599|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
44625600|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44625601|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625602|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
44625603|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
44177237|NCT00305812|Dexamethasone|dexamethasone|mesh-list
44625604|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625605|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44625606|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44625607|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625608|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43894271|NCT03140423|Mupirocin|mupirocin|mesh-list
44625609|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625610|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44625611|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
44625612|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625613|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625614|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44625615|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
44625616|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44625618|NCT00513474|Protective Agents|protective agents|mesh-ancestor
44625619|NCT00513357|Melatonin|melatonin|mesh-list
44625620|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
44625621|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625622|NCT00513357|Protective Agents|protective agents|mesh-ancestor
44625623|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625624|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625625|NCT00513305|Cytarabine|cytarabine|mesh-list
44625626|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
44625627|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625628|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
44625629|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625630|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625631|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
44625632|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625633|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625634|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
44625635|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625636|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
44625637|NCT00513240|Hematinics|hematinics|mesh-ancestor
44625638|NCT00513071|Saracatinib|saracatinib|mesh-list
44625639|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625640|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625641|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625642|NCT00513019|Lamotrigine|lamotrigine|mesh-list
44625643|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
44625644|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44625645|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625646|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625647|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44625648|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625649|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625650|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625651|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625652|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625653|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44625654|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
44625655|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625656|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625657|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625658|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625659|NCT00512798|Temozolomide|temozolomide|mesh-list
44625660|NCT00512798|Bortezomib|bortezomib|mesh-list
44625661|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625662|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
44625663|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625664|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625665|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
44625666|NCT00512707|Testosterone|testosterone|mesh-list
44625667|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625668|NCT00512707|Androgens|androgens|mesh-ancestor
44625669|NCT00512707|Hormones|hormones|mesh-ancestor
44625670|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625671|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625672|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
44625673|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44625674|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44625675|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625676|NCT00512707|Urological Agents|urological agents|mesh-ancestor
44625677|NCT00512252|Cytarabine|cytarabine|mesh-list
44625678|NCT00512252|Plerixafor|plerixafor|mesh-list
44625679|NCT00512252|Etoposide|etoposide|mesh-list
44625680|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
44177307|NCT00306020|Analgesics|analgesics|mesh-ancestor
44625681|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625682|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625683|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44625684|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625685|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625686|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625687|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625688|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
44625689|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
44625690|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625691|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625692|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
44625693|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625694|NCT00512252|Analgesics|analgesics|mesh-ancestor
44625695|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
44625696|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625697|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44625698|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44625699|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
44625700|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44625701|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44625702|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44625703|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44625704|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625705|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625706|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
44625707|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625708|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625709|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44625710|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625711|NCT00512096|Paclitaxel|paclitaxel|mesh-list
44625712|NCT00512096|Cisplatin|cisplatin|mesh-list
44625713|NCT00512096|Ifosfamide|ifosfamide|mesh-list
44625714|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625715|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625716|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625717|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625718|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625719|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625720|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44625721|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
44625722|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
44625723|NCT00511901|Hematinics|hematinics|mesh-ancestor
44625724|NCT00511875|Doxycycline|doxycycline|mesh-list
44625725|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625726|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625727|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
44625728|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44625729|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44625730|NCT00511836|Naltrexone|naltrexone|mesh-list
44625731|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44625732|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44625733|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625734|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
44625735|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625736|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
44625737|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625738|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625739|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
44625740|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44625741|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44625742|NCT00511355|Estradiol|estradiol|mesh-list
44625743|NCT00511355|Estrogens|estrogens|mesh-ancestor
44625744|NCT00511355|Hormones|hormones|mesh-ancestor
44625745|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625746|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625747|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44625748|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
44625749|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44625750|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44625751|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44625752|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44625753|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44625754|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44625755|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
44625756|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44625757|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
44625758|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44625759|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
44625760|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625761|NCT00511108|Pioglitazone|pioglitazone|mesh-list
44625762|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44625763|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625764|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625765|NCT00511108|Incretins|incretins|mesh-ancestor
44625766|NCT00511108|Hormones|hormones|mesh-ancestor
44625767|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625768|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44625769|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
44625770|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625771|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625773|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
44625774|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
44625775|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44625776|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625777|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
44625778|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44625779|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44625780|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625781|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625782|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625783|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625784|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625785|NCT00511004|Filaricides|filaricides|mesh-ancestor
44625786|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
44625787|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44625788|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625789|NCT00510952|Insulin|insulin|mesh-list
44625790|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44625791|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
44625792|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
44625793|NCT00510952|Protamines|protamines|mesh-list
44625794|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625795|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625796|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
44625797|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894409|NCT00303849|Etoposide|etoposide|mesh-list
44625798|NCT00510952|Coagulants|coagulants|mesh-ancestor
44625799|NCT00510887|Dexamethasone|dexamethasone|mesh-list
44625800|NCT00510887|Rituximab|rituximab|mesh-list
44625801|NCT00510887|Fludarabine|fludarabine|mesh-list
44625802|NCT00510887|Bortezomib|bortezomib|mesh-list
44625803|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
44625804|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625805|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625806|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
44625807|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625808|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625809|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625810|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
44625811|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
44625812|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625813|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625814|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
44625815|NCT00510887|Hormones|hormones|mesh-ancestor
44625816|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625817|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44625818|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625819|NCT00510887|Analgesics|analgesics|mesh-ancestor
44625820|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
44625821|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44625822|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44625823|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625824|NCT00510783|Phenytoin|phenytoin|mesh-list
44625825|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
44625826|NCT00510783|Levetiracetam|levetiracetam|mesh-list
44625827|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
44625828|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
44177424|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44625829|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44625830|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44625831|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625832|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625833|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44625834|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44625835|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
44625836|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137495|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
44625837|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625838|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625839|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625840|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
44625841|NCT00510510|Bromides|bromides|mesh-list
44625842|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
44625843|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44625844|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44625845|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44625846|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
44625847|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625848|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625849|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625850|NCT00510484|Pancrelipase|pancrelipase|mesh-list
44625852|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625853|NCT00510289|Sorafenib|sorafenib|mesh-list
44625854|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625855|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625856|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625857|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625858|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44625859|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44625860|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44625861|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625862|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625863|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
44625864|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625865|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625866|NCT00510146|Olanzapine|olanzapine|mesh-list
44625867|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
44625868|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
44625869|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625870|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625871|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625872|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625873|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625874|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625875|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625876|NCT00510146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44625877|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44625878|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44625879|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894473|NCT03811366|Prednisone|prednisone|mesh-list
44625880|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44625881|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
44625882|NCT00510068|Everolimus|everolimus|mesh-list
44625883|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625884|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625885|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
44625886|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625887|NCT00509925|Insulin|insulin|mesh-list
44625888|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44625889|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
44625890|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
44625891|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
44625892|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
44625893|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
44625894|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625895|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625896|NCT00509795|Ranibizumab|ranibizumab|mesh-list
44625897|NCT00509795|Aflibercept|aflibercept|mesh-list
44625898|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44625899|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44625900|NCT00509795|Growth Substances|growth substances|mesh-ancestor
44625901|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625902|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44625903|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625904|NCT00509769|Trastuzumab|trastuzumab|mesh-list
44625905|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44177492|NCT00306826|Pioglitazone|pioglitazone|mesh-list
44625906|NCT00509769|Maytansine|maytansine|mesh-list
44625907|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44625908|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625909|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44625910|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625911|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625912|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625913|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625914|NCT00509600|Etanercept|etanercept|mesh-list
44625915|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44625916|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44625917|NCT00509600|Analgesics|analgesics|mesh-ancestor
44625918|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
44625919|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625920|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625921|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44625922|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44625923|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894522|NCT03767712|Antibodies|antibodies|mesh-list
44625924|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625925|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
44625926|NCT00509366|Gemcitabine|gemcitabine|mesh-list
44625927|NCT00509366|Cisplatin|cisplatin|mesh-list
44625928|NCT00509366|Docetaxel|docetaxel|mesh-list
44625929|NCT00509366|Pemetrexed|pemetrexed|mesh-list
44625930|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625931|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44625932|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
44625933|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625934|NCT00509366|Antiviral Agents|antiviral agents|mesh-ancestor
44625935|NCT00509366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625936|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625937|NCT00509366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44625938|NCT00509366|Immunologic Factors|immunologic factors|mesh-ancestor
44625939|NCT00509366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625940|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
44625941|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
44625942|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
44625943|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44625944|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44625945|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44625946|NCT00509262|Glipizide|glipizide|mesh-list
44625947|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625948|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625949|NCT00509262|Incretins|incretins|mesh-ancestor
44625950|NCT00509262|Hormones|hormones|mesh-ancestor
44625951|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625952|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44625953|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
44625954|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625955|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625956|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44625957|NCT00509236|Glipizide|glipizide|mesh-list
44625958|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44625959|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625960|NCT00509236|Incretins|incretins|mesh-ancestor
44625961|NCT00509236|Hormones|hormones|mesh-ancestor
44625962|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44625963|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44625964|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
44625965|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625966|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625967|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
44625968|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44625969|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44625970|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44625971|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
44625972|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44625973|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44625974|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44625975|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625976|NCT00509067|Olanzapine|olanzapine|mesh-list
44625977|NCT00509067|Risperidone|risperidone|mesh-list
44625978|NCT00509067|Aripiprazole|aripiprazole|mesh-list
44625979|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44625980|NCT00509067|Ziprasidone|ziprasidone|mesh-list
44625981|NCT00509067|Choline|choline|mesh-list
44177574|NCT00307307|Vitamins|vitamins|mesh-ancestor
44625982|NCT00509067|Galantamine|galantamine|mesh-list
44625983|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44625984|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44625985|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
44625986|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894562|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625987|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44625988|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44625989|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44625990|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44625991|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44625992|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44625993|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44625994|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
44625995|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
44625996|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
44625997|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44625998|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44625999|NCT00509067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44626000|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626001|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626002|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
44626003|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
44626004|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44626005|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44626006|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44626007|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44626008|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
44626009|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44626010|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
44626011|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44626012|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
44626013|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44626014|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626015|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
44626016|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44626017|NCT00509028|Budesonide|budesonide|mesh-list
44626018|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626019|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44626020|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
44626021|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626022|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626023|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44626024|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
44626025|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
44626026|NCT00509028|Hormones|hormones|mesh-ancestor
44626027|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626028|NCT00508924|Heparin|heparin|mesh-list
44626029|NCT00508924|Argatroban|argatroban|mesh-list
44626030|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
44626031|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44626032|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44626033|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626034|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
44626035|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44626036|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
44626037|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626038|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44626039|NCT00508872|Leucovorin|leucovorin|mesh-list
44626040|NCT00508872|Bevacizumab|bevacizumab|mesh-list
44626041|NCT00508872|Fluorouracil|fluorouracil|mesh-list
44626042|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
44626043|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626044|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626045|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626046|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626047|NCT00508872|Growth Substances|growth substances|mesh-ancestor
44626048|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626049|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626050|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
44626051|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626052|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626053|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626054|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
44626055|NCT00508872|Antidotes|antidotes|mesh-ancestor
44626056|NCT00508872|Protective Agents|protective agents|mesh-ancestor
44626057|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
44626058|NCT00508872|Vitamins|vitamins|mesh-ancestor
44626059|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
44626060|NCT00508742|Vaccines|vaccines|mesh-list
44626061|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44626062|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
44626063|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626064|NCT00508482|Lactulose|lactulose|mesh-list
44626065|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44626066|NCT00508404|Panitumumab|panitumumab|mesh-list
44626067|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626068|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626069|NCT00508274|Capecitabine|capecitabine|mesh-list
44626071|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626072|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
44626073|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626074|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626075|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626076|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626078|NCT00508157|Risperidone|risperidone|mesh-list
44626079|NCT00508157|Aripiprazole|aripiprazole|mesh-list
44626080|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44626081|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
44626082|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44626083|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
44626084|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626085|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626086|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626087|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44626088|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626089|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44626090|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44626091|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
44626092|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
44626093|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
44626094|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626095|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44626096|NCT00508157|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44626097|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626098|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626099|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
44626100|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
44626101|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44626102|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44626103|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44626104|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44626105|NCT00508144|Pemetrexed|pemetrexed|mesh-list
44626106|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626107|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626108|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626109|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626110|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626111|NCT00508027|Simvastatin|simvastatin|mesh-list
44626112|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44626113|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44626114|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
44626115|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626116|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44626117|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44626118|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626119|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
44626120|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
44626121|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44626122|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44626123|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626124|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626125|NCT00507819|Urological Agents|urological agents|mesh-ancestor
44626126|NCT00507728|Bupropion|bupropion|mesh-list
44626127|NCT00507728|Varenicline|varenicline|mesh-list
44626128|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44626129|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
44626130|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44626131|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626132|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626133|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626134|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626135|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
44626136|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626137|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626138|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44626139|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44626140|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626141|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44626142|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44626143|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
44626144|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
44626145|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44626146|NCT00507689|Antibodies|antibodies|mesh-list
44626147|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
44626148|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626149|NCT00507507|Tenofovir|tenofovir|mesh-list
44626150|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
44626151|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626152|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44626153|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626154|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626155|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626156|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44626157|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44626158|NCT00507455|Tamsulosin|tamsulosin|mesh-list
44626159|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
44626160|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44626161|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44626162|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44626163|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
44626164|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626165|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626166|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626167|NCT00507455|Urological Agents|urological agents|mesh-ancestor
44626168|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44626169|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44626170|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
44626171|NCT00507442|Dexamethasone|dexamethasone|mesh-list
44626172|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
44626173|NCT00507442|Lenalidomide|lenalidomide|mesh-list
44626174|NCT00507442|Bortezomib|bortezomib|mesh-list
44626175|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626176|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
44626177|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626178|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626179|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44626180|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
44626181|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626182|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626183|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626184|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626185|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
44626186|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
44626187|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626188|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44626189|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
44626190|NCT00507442|Hormones|hormones|mesh-ancestor
44626191|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626192|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44626193|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626194|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626195|NCT00507442|Growth Substances|growth substances|mesh-ancestor
44626196|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626197|NCT00507429|Paclitaxel|paclitaxel|mesh-list
44626198|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
44626199|NCT00507429|Combretastatin|combretastatin|mesh-list
44626200|NCT00507429|Carboplatin|carboplatin|mesh-list
44626201|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626202|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626203|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626204|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626205|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626206|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177795|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
44626207|NCT00507416|Thalidomide|thalidomide|mesh-list
44626208|NCT00507416|Dexamethasone|dexamethasone|mesh-list
44626209|NCT00507416|Prednisone|prednisone|mesh-list
44626210|NCT00507416|Bortezomib|bortezomib|mesh-list
44626211|NCT00507416|Melphalan|melphalan|mesh-list
44626212|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626213|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
44626214|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
44626215|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626216|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626217|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44626218|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
44626220|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626221|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44626222|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626223|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44626224|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
44626225|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626226|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626227|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626228|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
44626229|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
44626230|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44626231|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626232|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626233|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626234|NCT00507416|Growth Substances|growth substances|mesh-ancestor
44626235|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626236|NCT00507026|Diclofenac|diclofenac|mesh-list
44626237|NCT00507026|Ketorolac|ketorolac|mesh-list
44626238|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44626239|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44626240|NCT00507026|Analgesics|analgesics|mesh-ancestor
44626241|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
44626242|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626243|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626244|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626245|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626246|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44626247|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626248|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626249|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
44626250|NCT00506948|Sirolimus|sirolimus|mesh-list
44626251|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
44626252|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44626253|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44626254|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626255|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44626256|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
44626257|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44626258|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626259|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626260|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626261|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
44626262|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626263|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
44626264|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626265|NCT00506922|Methotrexate|methotrexate|mesh-list
44626266|NCT00506922|Pentostatin|pentostatin|mesh-list
44626267|NCT00506922|Tacrolimus|tacrolimus|mesh-list
44626268|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44626269|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
44626270|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626271|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626272|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626273|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
44626274|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626275|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626276|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626277|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626278|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626279|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626280|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
44626281|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626282|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626283|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44626284|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44626285|NCT00506883|Colchicine|colchicine|mesh-list
44626286|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
44626287|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626288|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626289|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626290|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44148617|NCT00204737|Hormones|hormones|mesh-ancestor
44626291|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626292|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626294|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626295|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626296|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626297|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626298|NCT00506779|Paclitaxel|paclitaxel|mesh-list
44626299|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
44626300|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626301|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626302|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626303|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626304|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626305|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894872|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
44626306|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626307|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626308|NCT00506662|Insulin|insulin|mesh-list
44626309|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44626310|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
44626311|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
44626312|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
44626313|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
44626314|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44626315|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626316|NCT00506519|Antithrombins|antithrombins|mesh-list
44626317|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
44626318|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44626319|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44626320|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626321|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626322|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
44626323|NCT00506415|Rivastigmine|rivastigmine|mesh-list
44626324|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44626325|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626326|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626327|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
44626328|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626329|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626330|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44626331|NCT00506415|Protective Agents|protective agents|mesh-ancestor
44626332|NCT00506389|Mirtazapine|mirtazapine|mesh-list
44626333|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44626334|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44626335|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44626336|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
44626337|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
44626338|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626339|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626340|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626341|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44626342|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44626343|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626344|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44626345|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44626346|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44626347|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44626348|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44626349|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44626350|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
44626351|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44626352|NCT00506350|Vaccines|vaccines|mesh-list
44626353|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
44626354|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626355|NCT00506285|Methylphenidate|methylphenidate|mesh-list
44626356|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626357|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626358|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626359|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626360|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626361|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626362|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
44626363|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626364|NCT00506142|Vincristine|vincristine|mesh-list
44626365|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626366|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626367|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626368|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626369|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626370|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626371|NCT00506129|Fludarabine|fludarabine|mesh-list
44626372|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
44626373|NCT00506129|Melphalan|melphalan|mesh-list
44626374|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
44626375|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44626376|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626377|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626378|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
44626379|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626380|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626381|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
44626382|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626383|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44626384|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
44626385|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626386|NCT00505934|Levetiracetam|levetiracetam|mesh-list
44626387|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
44626388|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
44626389|NCT00505921|Cytarabine|cytarabine|mesh-list
44626390|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
44626391|NCT00505921|Melphalan|melphalan|mesh-list
44626392|NCT00505921|Carmustine|carmustine|mesh-list
44626393|NCT00505921|Fludarabine|fludarabine|mesh-list
44626394|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
44626395|NCT00505921|Etoposide|etoposide|mesh-list
44626396|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
44626397|NCT00505921|Molgramostim|molgramostim|mesh-list
44626398|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
44626399|NCT00505921|Sargramostim|sargramostim|mesh-list
44626400|NCT00505921|Lenograstim|lenograstim|mesh-list
44626401|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626402|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
44626403|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626404|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626405|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894966|NCT01131169|Vidarabine|vidarabine|mesh-list
44626406|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
44626407|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626408|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626409|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626410|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626411|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
44626412|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
44626413|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626414|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626415|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44626416|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44626417|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626418|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44626419|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626420|NCT00505778|Mesalamine|mesalamine|mesh-list
44626421|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44626422|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44626423|NCT00505778|Analgesics|analgesics|mesh-ancestor
44626424|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
44626425|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626426|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626427|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626428|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626429|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44626430|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44626431|NCT00505752|Hormones|hormones|mesh-ancestor
44626432|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626433|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626434|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626435|NCT00505687|Rotigotine|rotigotine|mesh-list
44626436|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
44626437|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
44626438|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626439|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626440|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626442|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626443|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44626444|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44626445|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626446|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626447|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44626448|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
44626449|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626450|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626451|NCT00505414|Morphine|morphine|mesh-list
44626452|NCT00505414|Tapentadol|tapentadol|mesh-list
44626453|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44626454|NCT00505414|Narcotics|narcotics|mesh-ancestor
44626455|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626456|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626457|NCT00505414|Analgesics|analgesics|mesh-ancestor
44626458|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
44626459|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626460|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44626461|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626462|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626463|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626464|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
44626465|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626466|NCT00505375|Abatacept|abatacept|mesh-list
44626467|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44626468|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626469|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626470|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626471|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
44626472|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626473|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626474|NCT00504894|Thiopental|thiopental|mesh-list
44626475|NCT00504894|Propofol|propofol|mesh-list
44626476|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44626477|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626478|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626479|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44626480|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
44626481|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
44626482|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
44626483|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
44626484|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
44626485|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626486|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626487|NCT00504881|Brivaracetam|brivaracetam|mesh-list
44626488|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
44626489|NCT00504829|Atorvastatin|atorvastatin|mesh-list
44626490|NCT00504829|Fenofibrate|fenofibrate|mesh-list
44626491|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44626492|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44626493|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
44626494|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626495|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44626496|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43895075|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626497|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626498|NCT00504777|Rituximab|rituximab|mesh-list
44626499|NCT00504777|Methotrexate|methotrexate|mesh-list
44626500|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626501|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626502|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
44626503|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626504|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626505|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44626506|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
44626507|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626508|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626509|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
44626510|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626511|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626512|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626513|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626514|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626515|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626516|NCT00504725|Ketamine|ketamine|mesh-list
44626517|NCT00504725|Analgesics|analgesics|mesh-ancestor
44626518|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
44626519|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626520|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626521|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44626522|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44626523|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
44626524|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
44626525|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626526|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44626527|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44626528|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626529|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626530|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44626531|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
44626532|NCT00504582|Coagulants|coagulants|mesh-ancestor
44626533|NCT00504556|Warfarin|warfarin|mesh-list
44626534|NCT00504556|Edoxaban|edoxaban|mesh-list
44626535|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
44626536|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44626537|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
44626538|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44626539|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
44626540|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626541|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626542|NCT00504348|Tacrolimus|tacrolimus|mesh-list
44626543|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626544|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
44626545|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626546|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44626547|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626548|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178188|NCT00309478|Tamoxifen|tamoxifen|mesh-list
44626549|NCT00504257|Bevacizumab|bevacizumab|mesh-list
44626550|NCT00504257|Docetaxel|docetaxel|mesh-list
44626551|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626552|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626553|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626554|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626555|NCT00504257|Growth Substances|growth substances|mesh-ancestor
44626556|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626557|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626558|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626559|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626560|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626561|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626562|NCT00504166|Alendronate|alendronate|mesh-list
44626563|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44626564|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626565|NCT00504153|Dasatinib|dasatinib|mesh-list
44626566|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626567|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626568|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626569|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626570|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
44626571|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44626572|NCT00504075|Antibodies|antibodies|mesh-list
44626573|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
44626574|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44626575|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
44626576|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626577|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
44626578|NCT00503997|Pemetrexed|pemetrexed|mesh-list
44626579|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626580|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626581|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626582|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626583|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626584|NCT00503984|Prednisone|prednisone|mesh-list
44626585|NCT00503984|Docetaxel|docetaxel|mesh-list
44626586|NCT00503984|Azacitidine|azacitidine|mesh-list
44626587|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626588|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626589|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626590|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626591|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626592|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626593|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
44626594|NCT00503984|Hormones|hormones|mesh-ancestor
44626595|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626596|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626597|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44626598|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626599|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
44626600|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626601|NCT00503906|Gemcitabine|gemcitabine|mesh-list
44626602|NCT00503906|Paclitaxel|paclitaxel|mesh-list
44626603|NCT00503906|Bevacizumab|bevacizumab|mesh-list
44626604|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44626605|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626606|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626607|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626608|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626609|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626610|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626611|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626612|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626613|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626614|NCT00503906|Growth Substances|growth substances|mesh-ancestor
44626615|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626616|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626617|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626618|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
44626619|NCT00503906|Antiviral Agents|antiviral agents|mesh-ancestor
44626620|NCT00503906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626621|NCT00503906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626622|NCT00503906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626623|NCT00503906|Immunologic Factors|immunologic factors|mesh-ancestor
44626624|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44626625|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626626|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626627|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626628|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626630|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44626631|NCT00503776|Protective Agents|protective agents|mesh-ancestor
44626632|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626633|NCT00503685|Cetuximab|cetuximab|mesh-list
44626634|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626635|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626636|NCT00503581|Megestrol|megestrol|mesh-list
44626637|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
44626638|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44626639|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44626640|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44626641|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
44626642|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626643|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626644|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44626645|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44626646|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44626647|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626648|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
44626649|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626650|NCT00503425|Rituximab|rituximab|mesh-list
44626651|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626652|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626653|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
44626654|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626655|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626656|NCT00503399|Teriparatide|teriparatide|mesh-list
44626657|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
44626658|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44626659|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626660|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44626661|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44626662|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626663|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626664|NCT00503139|Etanercept|etanercept|mesh-list
44626665|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44626666|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44626667|NCT00503139|Analgesics|analgesics|mesh-ancestor
44626668|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
44626669|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626670|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626671|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626672|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626673|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44626674|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626675|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
44626676|NCT00503009|Fluticasone|fluticasone|mesh-list
44626677|NCT00503009|Xhance|xhance|mesh-list
44626678|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44626679|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626680|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44626681|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
44626682|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626683|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626684|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44626685|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44626686|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626687|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44626688|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44626689|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44626690|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44626691|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44626692|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626693|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626694|NCT00502996|Rituximab|rituximab|mesh-list
44626695|NCT00502996|Methotrexate|methotrexate|mesh-list
44626696|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626697|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178309|NCT00309621|Alitretinoin|alitretinoin|mesh-list
44626698|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
44626699|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626700|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626701|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44626702|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
44626703|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626704|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626705|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
44626706|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626707|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626708|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626709|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626710|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626711|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626712|NCT00502840|Rituximab|rituximab|mesh-list
44626713|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626714|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626715|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
44626716|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626717|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626718|NCT00502801|Doripenem|doripenem|mesh-list
44626719|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44626720|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626721|NCT00502775|Fluticasone|fluticasone|mesh-list
44626722|NCT00502775|Xhance|xhance|mesh-list
44626723|NCT00502775|Fexofenadine|fexofenadine|mesh-list
44626724|NCT00502775|Terfenadine|terfenadine|mesh-list
44626725|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626726|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44626727|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
44626728|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626729|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626730|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44626731|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
44626732|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626733|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44626734|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44626735|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44626736|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
44626737|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
44626738|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626739|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626741|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626742|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
44626743|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626744|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626745|NCT00502242|Ramipril|ramipril|mesh-list
44626746|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44626747|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
44626748|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626749|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626750|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44626751|NCT00502203|Paclitaxel|paclitaxel|mesh-list
44626752|NCT00502203|Carboplatin|carboplatin|mesh-list
44626753|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626754|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626755|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626756|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626757|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626758|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626759|NCT00501969|Rotigotine|rotigotine|mesh-list
44626760|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
44626761|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
44626762|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626763|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626764|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626765|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
44626766|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
44626767|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44626768|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
44626769|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626770|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626771|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44626772|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
44626773|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
44626774|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44626775|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
44626776|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626777|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626778|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44626779|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44626781|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
44626782|NCT00501644|Carboplatin|carboplatin|mesh-list
44626783|NCT00501644|Molgramostim|molgramostim|mesh-list
44626784|NCT00501644|Sargramostim|sargramostim|mesh-list
44626785|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626786|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
44626787|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626788|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
44626789|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626790|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
44626791|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
44626792|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44626793|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626794|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626795|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
44626796|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44626797|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626798|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626799|NCT00501293|Methylphenidate|methylphenidate|mesh-list
44626800|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626801|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626802|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626803|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626804|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895332|NCT05096169|Citric Acid|citric acid|mesh-list
44626805|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626806|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
44626807|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626808|NCT00501228|Lenograstim|lenograstim|mesh-list
44626809|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44626810|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
44626811|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626812|NCT00501059|Aspirin|aspirin|mesh-list
44626813|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44022746|NCT01071993|Atorvastatin|atorvastatin|mesh-list
44626814|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44626815|NCT00501059|Analgesics|analgesics|mesh-ancestor
44626816|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
44626817|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626818|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626819|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44626820|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626821|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44626822|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44626823|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626824|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44626825|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44626826|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626827|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
44626828|NCT00500760|Cisplatin|cisplatin|mesh-list
44626829|NCT00500760|Panitumumab|panitumumab|mesh-list
44626830|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626831|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626832|NCT00500539|Omalizumab|omalizumab|mesh-list
44626833|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44626834|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44626835|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
44626836|NCT00500370|Exenatide|exenatide|mesh-list
44626837|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44626838|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626839|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44626840|NCT00500370|Incretins|incretins|mesh-ancestor
44626841|NCT00500370|Hormones|hormones|mesh-ancestor
44626842|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626843|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43895378|NCT04940338|Analgesics|analgesics|mesh-ancestor
44626844|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
44626845|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626846|NCT00500331|Pioglitazone|pioglitazone|mesh-list
44626847|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44626848|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626849|NCT00500318|Bromides|bromides|mesh-list
44626850|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
44626851|NCT00500292|Leucovorin|leucovorin|mesh-list
44626852|NCT00500292|Folic Acid|folic acid|mesh-list
44626853|NCT00500292|Fluorouracil|fluorouracil|mesh-list
44626854|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
44626855|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
44626856|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
44626857|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626858|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626859|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626860|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626861|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
44626862|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626863|NCT00500292|Antidotes|antidotes|mesh-ancestor
44626864|NCT00500292|Protective Agents|protective agents|mesh-ancestor
44626865|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
44626866|NCT00500292|Vitamins|vitamins|mesh-ancestor
44626867|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
44626868|NCT00500292|Hematinics|hematinics|mesh-ancestor
44626869|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44626870|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
44626871|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626872|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44626873|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626874|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626875|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626876|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626877|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626878|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626879|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
44626880|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626881|NCT00500110|Docetaxel|docetaxel|mesh-list
44626882|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
44626883|NCT00500110|Leuprolide|leuprolide|mesh-list
44626884|NCT00500110|Goserelin|goserelin|mesh-list
44626885|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626886|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44626887|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44626888|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44626889|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626890|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626891|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626892|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44626894|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626895|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626896|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44626897|NCT00499889|Vidarabine|vidarabine|mesh-list
44626898|NCT00499889|Methotrexate|methotrexate|mesh-list
44626899|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
44626900|NCT00499889|Fludarabine|fludarabine|mesh-list
44626901|NCT00499889|Busulfan|busulfan|mesh-list
44626902|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
44626903|NCT00499889|Tacrolimus|tacrolimus|mesh-list
44626904|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
44626905|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44626906|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44626907|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
44626908|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44626909|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626910|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44626911|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
44626912|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626913|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626914|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
44626915|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626916|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44626917|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626918|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
44626919|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626920|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44626921|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
44626922|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44626923|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44626924|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
44178518|NCT00310024|Bortezomib|bortezomib|mesh-list
44626925|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44626926|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626927|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626928|NCT00499863|Methylphenidate|methylphenidate|mesh-list
44626929|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626930|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626931|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626932|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626933|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626934|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626935|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
44626936|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626938|NCT00499746|Hydromorphone|hydromorphone|mesh-list
44626939|NCT00499746|Methylphenidate|methylphenidate|mesh-list
44626940|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44626941|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626942|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44626943|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44626944|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44626945|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626946|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
44626947|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44626948|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44626949|NCT00499746|Narcotics|narcotics|mesh-ancestor
44626950|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44626951|NCT00499746|Analgesics|analgesics|mesh-ancestor
44626952|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
44626953|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44626954|NCT00499694|Bevacizumab|bevacizumab|mesh-list
44626955|NCT00499694|Satraplatin|satraplatin|mesh-list
44626956|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44626957|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626958|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44626959|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44626960|NCT00499694|Growth Substances|growth substances|mesh-ancestor
44626961|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626962|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44626963|NCT00499681|Letrozole|letrozole|mesh-list
44626964|NCT00499681|Lapatinib|lapatinib|mesh-list
44626965|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626966|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44626967|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44626968|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626969|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626970|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44626971|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
44626972|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44626973|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626974|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44626975|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
44626976|NCT00499616|Carboplatin|carboplatin|mesh-list
44626977|NCT00499616|Doxorubicin|doxorubicin|mesh-list
44626978|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44626979|NCT00499616|Etoposide|etoposide|mesh-list
44626980|NCT00499616|Topotecan|topotecan|mesh-list
44626981|NCT00499616|Isotretinoin|isotretinoin|mesh-list
44626982|NCT00499616|Lenograstim|lenograstim|mesh-list
44626983|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44626984|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
44626985|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44626986|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44626987|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44626988|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
44626989|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44626990|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44626991|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44626992|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44626993|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44626994|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44626995|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44626996|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44626997|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44178597|NCT00310206|Vaccines|vaccines|mesh-list
44626998|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44626999|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
44627001|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
44627002|NCT00499603|Fluorouracil|fluorouracil|mesh-list
44627003|NCT00499603|Epirubicin|epirubicin|mesh-list
44627004|NCT00499603|Everolimus|everolimus|mesh-list
44627005|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627006|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627007|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627008|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627009|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627010|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627011|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627012|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
44627013|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627014|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627015|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627016|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
44627017|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627018|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
43895524|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44627019|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627020|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627021|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627022|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627023|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627024|NCT00499590|Ranibizumab|ranibizumab|mesh-list
44627025|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627026|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44627027|NCT00499590|Growth Substances|growth substances|mesh-ancestor
44627028|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627029|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627030|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627031|NCT00499486|Sirolimus|sirolimus|mesh-list
44627032|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627033|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627034|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627035|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627036|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
44627037|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627038|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
44627039|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627040|NCT00499460|Oxycodone|oxycodone|mesh-list
44627041|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44627042|NCT00499460|Narcotics|narcotics|mesh-ancestor
44627043|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627044|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627045|NCT00499460|Analgesics|analgesics|mesh-ancestor
44627046|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
44627047|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627048|NCT00499369|Leucovorin|leucovorin|mesh-list
44627049|NCT00499369|Bevacizumab|bevacizumab|mesh-list
44627050|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44627051|NCT00499369|Cetuximab|cetuximab|mesh-list
44627052|NCT00499369|Fluorouracil|fluorouracil|mesh-list
44627053|NCT00499369|Irinotecan|irinotecan|mesh-list
44627054|NCT00499369|Antibodies|antibodies|mesh-list
44627055|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
44627056|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44627057|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
44627058|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627059|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627060|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43895574|NCT03942887|Hormones|hormones|mesh-ancestor
44627061|NCT00499369|Growth Substances|growth substances|mesh-ancestor
44627062|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627063|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627064|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
44627065|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
44627066|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627067|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627068|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627069|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44627070|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627071|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627072|NCT00499369|Antidotes|antidotes|mesh-ancestor
44627073|NCT00499369|Protective Agents|protective agents|mesh-ancestor
44627074|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
44627075|NCT00499369|Vitamins|vitamins|mesh-ancestor
44627076|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
44627077|NCT00499252|Paclitaxel|paclitaxel|mesh-list
44627078|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44627079|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627080|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627081|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627082|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627083|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627084|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627085|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
44627086|NCT00499122|Docetaxel|docetaxel|mesh-list
44627087|NCT00499122|Doxorubicin|doxorubicin|mesh-list
44627088|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627089|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
44627090|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627091|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627092|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627093|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
44627094|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627095|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627096|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627097|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627098|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627099|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627100|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627101|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627102|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627103|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627104|NCT00499083|Tamoxifen|tamoxifen|mesh-list
44627105|NCT00499083|Paclitaxel|paclitaxel|mesh-list
44627106|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
44627107|NCT00499083|Doxorubicin|doxorubicin|mesh-list
44627108|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44627109|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44627110|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627111|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627112|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627113|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627114|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627115|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627116|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627117|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
44627118|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627119|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627120|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627121|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
44627122|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627123|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627124|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627125|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627126|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627127|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44627128|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
44627129|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627130|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44627131|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44627132|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44627133|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627134|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44627135|NCT00499031|Cetuximab|cetuximab|mesh-list
44627136|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627137|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627138|NCT00498797|Prednisolone|prednisolone|mesh-list
44627139|NCT00498797|Docetaxel|docetaxel|mesh-list
44627140|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627141|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627142|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627143|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627144|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627145|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627146|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
44627147|NCT00498797|Hormones|hormones|mesh-ancestor
44627148|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627149|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178751|NCT00310895|Imetelstat|imetelstat|mesh-list
44627150|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44627151|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
44627152|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44627153|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
44627154|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627155|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
44627156|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44627157|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44627158|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
44627159|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
44627160|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627161|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627162|NCT00498433|Amlodipine|amlodipine|mesh-list
44627163|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44627164|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44627165|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627166|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627167|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44627168|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627169|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44627170|NCT00498368|Rituximab|rituximab|mesh-list
44627171|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
44627172|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627173|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627174|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
44627175|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627176|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627177|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44627178|NCT00498355|Ranibizumab|ranibizumab|mesh-list
44627179|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627180|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44627181|NCT00498355|Growth Substances|growth substances|mesh-ancestor
44627182|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627183|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627184|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627185|NCT00498186|Rotigotine|rotigotine|mesh-list
44627186|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
44627187|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
44627188|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627189|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627190|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627191|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44627192|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44627193|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44627194|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627195|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627196|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44627197|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627198|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627199|NCT00497796|Ganciclovir|ganciclovir|mesh-list
44627200|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44627201|NCT00497796|Maribavir|maribavir|mesh-list
44627202|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
44627203|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627204|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44627205|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627206|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627207|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
44627208|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44627209|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
44627210|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44627211|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44627212|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44627213|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627214|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627215|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
44627216|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627217|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627218|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44627219|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627220|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
44627221|NCT00496873|Rituximab|rituximab|mesh-list
44627222|NCT00496873|Pentostatin|pentostatin|mesh-list
44627223|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627247|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44627248|NCT00496769|Analgesics|analgesics|mesh-ancestor
44627249|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
44627250|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627251|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627252|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627253|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627254|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44627255|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44627256|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627257|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44627258|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44627259|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627260|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
44627261|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44627262|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
44627263|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44627264|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
44627265|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
44627266|NCT00496587|Gemcitabine|gemcitabine|mesh-list
44627267|NCT00496587|Bevacizumab|bevacizumab|mesh-list
44627268|NCT00496587|Capecitabine|capecitabine|mesh-list
44627269|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627270|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627271|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627272|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44627273|NCT00496587|Growth Substances|growth substances|mesh-ancestor
44454001|NCT01672736|Bortezomib|bortezomib|mesh-list
44627274|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627275|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627276|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627277|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
44627278|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627279|NCT00496587|Antiviral Agents|antiviral agents|mesh-ancestor
44627280|NCT00496587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627281|NCT00496587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627282|NCT00496587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627283|NCT00496587|Immunologic Factors|immunologic factors|mesh-ancestor
44627284|NCT00496483|Tacrolimus|tacrolimus|mesh-list
44627285|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627286|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
44627287|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627288|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44627289|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627290|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627291|NCT00496470|Budesonide|budesonide|mesh-list
44627292|NCT00496470|Bromides|bromides|mesh-list
44627293|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
44627294|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
44627295|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44627296|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627297|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44627298|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
44627299|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627300|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627301|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43895782|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
44627302|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
44627303|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
44627304|NCT00496470|Hormones|hormones|mesh-ancestor
44627305|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627306|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44627307|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44627308|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44627309|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
44627310|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627311|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627312|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
44627313|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44627314|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
44627315|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
44627316|NCT00496366|Capecitabine|capecitabine|mesh-list
44627317|NCT00496366|Lapatinib|lapatinib|mesh-list
44627318|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627319|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
44627320|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627321|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627322|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627323|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627324|NCT00496197|Fluconazole|fluconazole|mesh-list
44627325|NCT00496197|Voriconazole|voriconazole|mesh-list
44627326|NCT00496197|Anidulafungin|anidulafungin|mesh-list
44627327|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
44627328|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627329|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44627330|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44627331|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627332|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627333|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44627334|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
44627335|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627336|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627337|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44627338|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44627339|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44627340|NCT00496054|Vaccines|vaccines|mesh-list
44627341|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
44627342|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627343|NCT00496015|Acetaminophen|acetaminophen|mesh-list
44627344|NCT00496015|Vaccines|vaccines|mesh-list
44627345|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44627346|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
44627347|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627348|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44627349|NCT00496015|Analgesics|analgesics|mesh-ancestor
44627350|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
44627351|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627352|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
44627353|NCT00495820|Methylphenidate|methylphenidate|mesh-list
44627354|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44627355|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627356|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44627357|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44627358|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627359|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627360|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
44627361|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627363|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627364|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627365|NCT00495677|PF 232798|pf 232798|mesh-list
44627366|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44627367|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627368|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44627369|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44627370|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
44627371|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627372|NCT00495625|Sunitinib|sunitinib|mesh-list
44627373|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627374|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627375|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44627376|NCT00495625|Growth Substances|growth substances|mesh-ancestor
44627377|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627378|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627379|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627380|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627381|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627382|NCT00495612|Omalizumab|omalizumab|mesh-list
44627383|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44627384|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44627385|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
44627386|NCT00495586|Amoxicillin|amoxicillin|mesh-list
44627387|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
44627388|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
44627389|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627390|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627391|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627392|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627393|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44627394|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44627395|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
44627396|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627397|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627398|NCT00495391|Ribavirin|ribavirin|mesh-list
44627399|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44627400|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
44627401|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
44627402|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627403|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
44627404|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627405|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44627406|NCT00495170|Paclitaxel|paclitaxel|mesh-list
44627407|NCT00495170|Carboplatin|carboplatin|mesh-list
44627408|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627409|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627410|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627411|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627412|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627413|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627414|NCT00494871|Warfarin|warfarin|mesh-list
44627415|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
44627416|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
44627417|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44627418|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
44627419|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44627420|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
44627421|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627422|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627423|NCT00494780|Prednisone|prednisone|mesh-list
44627424|NCT00494780|Prednisolone|prednisolone|mesh-list
44627425|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
44627426|NCT00494780|Doxorubicin|doxorubicin|mesh-list
44627427|NCT00494780|Vincristine|vincristine|mesh-list
44627428|NCT00494780|Ofatumumab|ofatumumab|mesh-list
44627429|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627430|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
44627431|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627432|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627433|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627434|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
44627435|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627436|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627437|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627438|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627439|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627440|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627441|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627442|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627443|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
44627444|NCT00494780|Hormones|hormones|mesh-ancestor
44627445|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627446|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44627447|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627448|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627449|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627450|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627451|NCT00494676|Methamphetamine|methamphetamine|mesh-list
44627452|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44627453|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627454|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
44627455|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
44627456|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627457|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
44179064|NCT00312260|Analgesics|analgesics|mesh-ancestor
44627458|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627459|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627460|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
44627461|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44627462|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44627463|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627464|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44627465|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
44627466|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44627467|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627468|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627469|NCT00494481|Docetaxel|docetaxel|mesh-list
44627470|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627471|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627472|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627473|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627474|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627475|NCT00494442|Olaparib|olaparib|mesh-list
44627476|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44627477|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627478|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627479|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627480|NCT00494299|Sorafenib|sorafenib|mesh-list
44627481|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627482|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627483|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627484|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627485|NCT00494221|Leucovorin|leucovorin|mesh-list
44627486|NCT00494221|Fluorouracil|fluorouracil|mesh-list
44627487|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
44627488|NCT00494221|Cediranib|cediranib|mesh-list
44627489|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
44627490|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
44627491|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627492|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627493|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627494|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627495|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
44627496|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627497|NCT00494221|Antidotes|antidotes|mesh-ancestor
44627498|NCT00494221|Protective Agents|protective agents|mesh-ancestor
44627499|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
44627500|NCT00494221|Vitamins|vitamins|mesh-ancestor
44627501|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
44627502|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627503|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627504|NCT00494091|Sirolimus|sirolimus|mesh-list
44627505|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627506|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895955|NCT05234619|Analgesics|analgesics|mesh-ancestor
44627507|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44627508|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627509|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
44627510|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627511|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
44627512|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627514|NCT00494026|Pemetrexed|pemetrexed|mesh-list
44627515|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627516|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627517|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627518|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44627519|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44627520|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
44627521|NCT00494013|Protamines|protamines|mesh-list
44627522|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44627523|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627524|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
44627525|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627526|NCT00494013|Coagulants|coagulants|mesh-ancestor
44627527|NCT00493974|Zileuton|zileuton|mesh-list
44627528|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44627529|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44627530|NCT00493974|Analgesics|analgesics|mesh-ancestor
44627531|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
44627532|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627533|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627534|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627535|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627536|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44627537|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627538|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627539|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44627540|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
44627541|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627542|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
44627543|NCT00493649|Docetaxel|docetaxel|mesh-list
44627544|NCT00493649|Trastuzumab|trastuzumab|mesh-list
44627545|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627546|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
44627547|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627548|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627549|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627550|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
44627551|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627552|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627553|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627554|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627555|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627556|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627557|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627558|NCT00493636|Gemcitabine|gemcitabine|mesh-list
44627559|NCT00493636|Capecitabine|capecitabine|mesh-list
44627560|NCT00493636|Sorafenib|sorafenib|mesh-list
44627561|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627562|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
44627563|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627564|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627565|NCT00493636|Antiviral Agents|antiviral agents|mesh-ancestor
44627566|NCT00493636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627567|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627568|NCT00493636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627569|NCT00493636|Immunologic Factors|immunologic factors|mesh-ancestor
44627570|NCT00493636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627571|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627572|NCT00493467|Rituximab|rituximab|mesh-list
44627573|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627574|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627575|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
44627576|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627577|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627578|NCT00493454|Rituximab|rituximab|mesh-list
44627579|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44627580|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627581|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627582|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
44627583|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627584|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627585|NCT00493311|Acetaminophen|acetaminophen|mesh-list
44627586|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44627588|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
44627589|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627590|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627591|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
44627592|NCT00493246|Acetaminophen|acetaminophen|mesh-list
44627593|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44627594|NCT00493246|Analgesics|analgesics|mesh-ancestor
44627595|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
44137654|NCT00168870|Gemcitabine|gemcitabine|mesh-list
44627596|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627597|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627598|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
44627599|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
44627600|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627601|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627602|NCT00493038|Amoxicillin|amoxicillin|mesh-list
44627603|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
44627604|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
44627605|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
44627606|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44627607|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44627608|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627609|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627610|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627611|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627612|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627613|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627614|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627615|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44627616|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
44627617|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44627618|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627619|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44627620|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44627621|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44627622|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44627623|NCT00493025|Paclitaxel|paclitaxel|mesh-list
44627624|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44627625|NCT00493025|Cisplatin|cisplatin|mesh-list
44627626|NCT00493025|Gefitinib|gefitinib|mesh-list
44627627|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44627628|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627629|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627630|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627631|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627632|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627633|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627634|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627635|NCT00493012|Vitamin D|vitamin d|mesh-list
44627636|NCT00493012|Vitamins|vitamins|mesh-ancestor
44627637|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
44627638|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627639|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627640|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
44627641|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627642|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
44627643|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627644|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627645|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627646|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
44627647|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627648|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627649|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627650|NCT00492752|Sorafenib|sorafenib|mesh-list
44627651|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896045|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
44627652|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627653|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627654|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627655|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
44627656|NCT00492726|Ertapenem|ertapenem|mesh-list
44627657|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44627658|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627659|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023501|NCT00780455|Interferons|interferons|mesh-list
44627661|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627662|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627663|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627664|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627665|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44627666|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
44627667|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44627668|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627669|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44627670|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44627671|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44627672|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44627673|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
44627674|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627675|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
44627676|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44627677|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
44627678|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44627679|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627680|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627681|NCT00492531|Urological Agents|urological agents|mesh-ancestor
44627683|NCT00492297|Dacarbazine|dacarbazine|mesh-list
44627684|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627685|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627686|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896105|NCT05208034|Methotrexate|methotrexate|mesh-list
44627687|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627688|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627689|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
44627690|NCT00492284|Dexamethasone|dexamethasone|mesh-list
44627691|NCT00492284|Ranibizumab|ranibizumab|mesh-list
44627692|NCT00492284|Verteporfin|verteporfin|mesh-list
44627693|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627694|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
44627695|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
44627696|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627697|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627698|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44627699|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
44627700|NCT00492284|Hormones|hormones|mesh-ancestor
44627701|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627702|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44627703|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627704|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44627705|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44627706|NCT00492284|Growth Substances|growth substances|mesh-ancestor
44627707|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44627708|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44627709|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44627710|NCT00492232|Zolpidem|zolpidem|mesh-list
44627711|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44627712|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44627713|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627714|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627715|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44627716|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
44627717|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
44627718|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627719|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627720|NCT00492063|Vaccines|vaccines|mesh-list
44627721|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
44627722|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627723|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
44627724|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44627725|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44627726|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627727|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44627728|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44627729|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627730|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627731|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627732|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44627733|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
44627734|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44627735|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627736|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44627737|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44627738|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44627739|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
44627740|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44627741|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44627742|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44627743|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
44627744|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627745|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627746|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627747|NCT00491764|Posaconazole|posaconazole|mesh-list
44627748|NCT00491764|Terbinafine|terbinafine|mesh-list
44627749|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
44627750|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627751|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44627752|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44627753|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44627754|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44627755|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44627756|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627757|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627758|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44627759|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
44627760|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627761|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627762|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44627763|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
44627764|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627765|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
44627766|NCT00491530|Atorvastatin|atorvastatin|mesh-list
44627767|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44627768|NCT00491530|Simvastatin|simvastatin|mesh-list
44627769|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
44627770|NCT00491530|Calcium|calcium|mesh-list
44627771|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44627772|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627773|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627774|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44627775|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44627776|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
44627777|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627778|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44627779|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44627780|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627781|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
44627782|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627783|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44627784|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44627785|NCT00491400|Atorvastatin|atorvastatin|mesh-list
44627786|NCT00491400|Fenofibrate|fenofibrate|mesh-list
44627787|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44627788|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44627789|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
44627790|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896154|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
44627791|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44627792|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44627793|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627794|NCT00491387|Metoprolol|metoprolol|mesh-list
44627795|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44627796|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44627797|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
44627798|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
44627799|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627800|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627801|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44627802|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44627803|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44627804|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
44627805|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627806|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627807|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
44627808|NCT00491322|Vitamin D|vitamin d|mesh-list
44627809|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44627810|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627811|NCT00491322|Vitamins|vitamins|mesh-ancestor
44627812|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
44627813|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627814|NCT00491179|Interferons|interferons|mesh-list
44627815|NCT00491179|Ribavirin|ribavirin|mesh-list
44627816|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
44627817|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
44627818|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44627819|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627820|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
44627821|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627822|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
44627823|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627824|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
44627825|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627826|NCT00491075|Gemcitabine|gemcitabine|mesh-list
44627827|NCT00491075|Pemetrexed|pemetrexed|mesh-list
44627828|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44627829|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
44627830|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627831|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627832|NCT00491075|Antiviral Agents|antiviral agents|mesh-ancestor
44627833|NCT00491075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627834|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627835|NCT00491075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627836|NCT00491075|Immunologic Factors|immunologic factors|mesh-ancestor
44627837|NCT00491075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627838|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44627839|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44627840|NCT00490971|Olanzapine|olanzapine|mesh-list
44627841|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44627842|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
44627843|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
44627844|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627845|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627846|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44627847|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44627848|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44627849|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627850|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44627851|NCT00490971|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44627852|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44627853|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44627854|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627855|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44627856|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
44627857|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44627858|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44627859|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44627860|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44627861|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
44627862|NCT00490919|Buprenorphine|buprenorphine|mesh-list
44627863|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44627864|NCT00490919|Narcotics|narcotics|mesh-ancestor
44627865|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627866|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627867|NCT00490919|Analgesics|analgesics|mesh-ancestor
44627868|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
44627869|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44627870|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44627871|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44627872|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627873|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
44627874|NCT00490815|Hormones|hormones|mesh-ancestor
44627875|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627876|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627877|NCT00490776|Panobinostat|panobinostat|mesh-list
44627878|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627879|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44627881|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627882|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44627883|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
44627884|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627885|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
44627886|NCT00490698|Atorvastatin|atorvastatin|mesh-list
44627887|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44627888|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44627889|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
44627890|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627891|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44627892|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44627893|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627894|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627895|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627896|NCT00490646|Docetaxel|docetaxel|mesh-list
44627897|NCT00490646|Trastuzumab|trastuzumab|mesh-list
44627898|NCT00490646|Epothilones|epothilones|mesh-list
44627899|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627900|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
44627901|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
44627902|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
44627903|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627904|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627905|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
44627906|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44627907|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627908|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
44627909|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44627910|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
44627911|NCT00490555|Testosterone|testosterone|mesh-list
44627912|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
44627913|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
44627914|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44627915|NCT00490555|Dutasteride|dutasteride|mesh-list
44627916|NCT00490555|Androgens|androgens|mesh-ancestor
44627917|NCT00490555|Hormones|hormones|mesh-ancestor
44627918|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627919|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627920|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44627921|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627922|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
44627923|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44627924|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44627925|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627926|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627927|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
44627928|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44627929|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44627930|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44627931|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
44627932|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44627933|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44627934|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44627935|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44627936|NCT00490542|Ziprasidone|ziprasidone|mesh-list
44627937|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44627938|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
44627939|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896281|NCT05369468|Bupivacaine|bupivacaine|mesh-list
44627940|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627941|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627942|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44627943|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44627944|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44627945|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44627946|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44627947|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
44627948|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
44627949|NCT00490529|Rituximab|rituximab|mesh-list
44627950|NCT00490529|Vaccines|vaccines|mesh-list
44627951|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
44627952|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627953|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44627954|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44627955|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44627956|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
44627957|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627958|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627959|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44627960|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627962|NCT00490490|Lugol's solution|lugol's solution|mesh-list
44627963|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44627964|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44627965|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44627966|NCT00490490|Trace Elements|trace elements|mesh-ancestor
44627967|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
44627968|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627969|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
44627970|NCT00490490|Coagulants|coagulants|mesh-ancestor
44627971|NCT00490139|Trastuzumab|trastuzumab|mesh-list
44627972|NCT00490139|Lapatinib|lapatinib|mesh-list
44627973|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44627974|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627975|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627976|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627977|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627978|NCT00490061|Lapatinib|lapatinib|mesh-list
44627979|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44627980|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44627981|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44627982|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44627983|NCT00490035|Brivaracetam|brivaracetam|mesh-list
44627984|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
44627985|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
44627986|NCT00490022|Androgens|androgens|mesh-ancestor
44627987|NCT00490022|Hormones|hormones|mesh-ancestor
44627988|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44627989|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627990|NCT00489918|Teriparatide|teriparatide|mesh-list
44627991|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44137754|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
43896356|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896357|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
43896358|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43896359|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896360|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896361|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896362|NCT05342376|Analgesics|analgesics|mesh-ancestor
43896363|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
44627992|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44627993|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44627994|NCT00489853|Budesonide|budesonide|mesh-list
44627995|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
44627996|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44627997|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44627998|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
44627999|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628000|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628001|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44628002|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
44628003|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
44628004|NCT00489853|Hormones|hormones|mesh-ancestor
44628005|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628006|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44628007|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44628008|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44628009|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
44628010|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628011|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628012|NCT00489736|Amiodarone|amiodarone|mesh-list
44628013|NCT00489736|Dronedarone|dronedarone|mesh-list
44628014|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44628015|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44628016|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44628017|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628018|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628019|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44628020|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44628021|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44628022|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628023|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44628024|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44628025|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44628026|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44628027|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
44628028|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628029|NCT00489541|Paclitaxel|paclitaxel|mesh-list
44628030|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628031|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628032|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628033|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628034|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628035|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628036|NCT00489489|Interferons|interferons|mesh-list
44628037|NCT00489489|Interferon-beta|interferon-beta|mesh-list
44628038|NCT00489489|Teriflunomide|teriflunomide|mesh-list
44628039|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
44628040|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628041|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
44628042|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628043|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628044|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
44628045|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628046|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44628047|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628048|NCT00489489|Analgesics|analgesics|mesh-ancestor
44628049|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
44628050|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628051|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628052|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628053|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628054|NCT00489476|Loxapine|loxapine|mesh-list
44628055|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44628056|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44628057|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628058|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628060|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44628061|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
44628062|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628063|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628064|NCT00489424|Acetaminophen|acetaminophen|mesh-list
44628065|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628066|NCT00489424|Analgesics|analgesics|mesh-ancestor
44628067|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
44628068|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628069|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628070|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
44628071|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44628072|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44628073|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44628074|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628075|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628076|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628077|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628078|NCT00489411|Analgesics|analgesics|mesh-ancestor
44628079|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
44628080|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628081|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
44628082|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628083|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
44628084|NCT00489359|Carboplatin|carboplatin|mesh-list
44628085|NCT00489359|Pemetrexed|pemetrexed|mesh-list
44628086|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628087|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628088|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628089|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44628090|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44628091|NCT00488982|Docetaxel|docetaxel|mesh-list
44628092|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628093|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628094|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628095|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628096|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628097|NCT00488826|Vaccines|vaccines|mesh-list
44628098|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44628099|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
44628100|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628101|NCT00488774|Golimumab|golimumab|mesh-list
44628103|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44628104|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628105|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628106|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
44628107|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628108|NCT00488683|Vaccines|vaccines|mesh-list
44628109|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
44628110|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628111|NCT00488631|Golimumab|golimumab|mesh-list
44628112|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44628113|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44628114|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628115|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628116|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
44628117|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628118|NCT00488618|Cariprazine|cariprazine|mesh-list
44628119|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44628120|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44628121|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628122|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628123|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628124|NCT00488592|Molgramostim|molgramostim|mesh-list
44628125|NCT00488592|Sargramostim|sargramostim|mesh-list
44628126|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44628127|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
44628128|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628129|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628130|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628131|NCT00488514|Naproxen|naproxen|mesh-list
44628132|NCT00488514|Sumatriptan|sumatriptan|mesh-list
44628133|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44628134|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628135|NCT00488514|Analgesics|analgesics|mesh-ancestor
44628136|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
44628137|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628138|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628139|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628140|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628141|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
44628142|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44628143|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628144|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628145|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44628146|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44628147|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44628148|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
44628149|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628151|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44628152|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628153|NCT00488475|Analgesics|analgesics|mesh-ancestor
44628154|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
44628155|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628156|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628157|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628158|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628159|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44628160|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628161|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
44628162|NCT00488345|Tigecycline|tigecycline|mesh-list
44628163|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628164|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628165|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44628166|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628167|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628168|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44628169|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44628170|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44628171|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628172|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628173|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628174|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44628175|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44628176|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
44628177|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628178|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628179|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44628180|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44628181|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
44628182|NCT00487942|Modafinil|modafinil|mesh-list
44628183|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44628184|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628185|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44628186|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44628187|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44628188|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628189|NCT00487825|Methotrexate|methotrexate|mesh-list
44628190|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44628191|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
44628192|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44628193|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628194|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628195|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
44628196|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628197|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628198|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628199|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628200|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44628201|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628202|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
44628203|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628204|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44628205|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44628206|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
44628207|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628208|NCT00487578|Naratriptan|naratriptan|mesh-list
44628209|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44628210|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44628211|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44628212|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
44628213|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628214|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628215|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628216|NCT00487539|Golimumab|golimumab|mesh-list
44628217|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44628218|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44628219|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628220|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628221|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
44628222|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628223|NCT00487435|Tapentadol|tapentadol|mesh-list
44628224|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44628225|NCT00487435|Narcotics|narcotics|mesh-ancestor
44628226|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628227|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628228|NCT00487435|Analgesics|analgesics|mesh-ancestor
44628229|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
44628230|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628231|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44628232|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44628233|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628234|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628235|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
44628236|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628237|NCT00487240|Insulin|insulin|mesh-list
44628238|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44628239|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
44628240|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
44628241|NCT00487240|Protamines|protamines|mesh-list
44628242|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628243|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628244|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
44628245|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628246|NCT00487240|Coagulants|coagulants|mesh-ancestor
44628247|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44628248|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
44628249|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
44628250|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628251|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44628252|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44628253|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628254|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44628255|NCT00487162|Insulin|insulin|mesh-list
44628256|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628257|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628259|NCT00487084|Morphine|morphine|mesh-list
44628260|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
44628261|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
44628262|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628263|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628264|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
44628265|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628266|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44628267|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44628268|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44628269|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628270|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628271|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44628272|NCT00487084|Narcotics|narcotics|mesh-ancestor
44628273|NCT00487084|Analgesics|analgesics|mesh-ancestor
44628274|NCT00486954|Paclitaxel|paclitaxel|mesh-list
44628275|NCT00486954|Lapatinib|lapatinib|mesh-list
44628276|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628277|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628278|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628279|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628280|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628281|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628282|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628283|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628284|NCT00486902|Ketamine|ketamine|mesh-list
44628285|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
44628286|NCT00486902|Analgesics|analgesics|mesh-ancestor
44628287|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
44628288|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628289|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628290|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44628291|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44628292|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
44628293|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
44628294|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628295|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44628296|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44628297|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628298|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628299|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44628300|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
44628301|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44628302|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628303|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628304|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44628305|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44628306|NCT00486811|Oxycodone|oxycodone|mesh-list
44628307|NCT00486811|Tapentadol|tapentadol|mesh-list
44628308|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44628309|NCT00486811|Narcotics|narcotics|mesh-ancestor
44628310|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628311|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628312|NCT00486811|Analgesics|analgesics|mesh-ancestor
44628313|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
44628314|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628315|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44628316|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44628317|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628318|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628319|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
44628320|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628321|NCT00486759|Bevacizumab|bevacizumab|mesh-list
44628322|NCT00486759|Rituximab|rituximab|mesh-list
44628323|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628324|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628326|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44628327|NCT00486759|Growth Substances|growth substances|mesh-ancestor
44628328|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628329|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
44628330|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
44628331|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628332|NCT00486720|Vorinostat|vorinostat|mesh-list
44628333|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628334|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44628335|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628336|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628337|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
44628338|NCT00486603|Temozolomide|temozolomide|mesh-list
44628339|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44628340|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
44628341|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628342|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628343|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
44628344|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44628345|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44628346|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628347|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628348|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628349|NCT00486434|Calcitonin|calcitonin|mesh-list
44628350|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
44628351|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44628352|NCT00486434|Katacalcin|katacalcin|mesh-list
43896661|NCT03775629|Tramadol|tramadol|mesh-list
44628353|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44628354|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628355|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44628356|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44628357|NCT00486330|Ritonavir|ritonavir|mesh-list
44628358|NCT00486330|Tipranavir|tipranavir|mesh-list
44628359|NCT00486330|Buprenorphine|buprenorphine|mesh-list
44628360|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44628361|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44628362|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
44628363|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628364|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628365|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44628366|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44628367|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
44628368|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628369|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44628370|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44628371|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44628372|NCT00486330|Narcotics|narcotics|mesh-ancestor
44628373|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628374|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628375|NCT00486330|Analgesics|analgesics|mesh-ancestor
44628376|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
44628377|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628378|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44628379|NCT00486044|Simvastatin|simvastatin|mesh-list
44628380|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44628381|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44628382|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
44628383|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628384|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44628385|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44628386|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628387|NCT00485758|Niacin|niacin|mesh-list
44628388|NCT00485758|Niacinamide|niacinamide|mesh-list
44628389|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
44628390|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44628391|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
44628392|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628393|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44628394|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
44628395|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
44628396|NCT00485758|Vitamins|vitamins|mesh-ancestor
44628397|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
44628398|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628399|NCT00485732|Vaccines|vaccines|mesh-list
44628400|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
44628401|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628402|NCT00485589|Methotrexate|methotrexate|mesh-list
44628403|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
44628404|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43896706|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
44628405|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
44628406|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44628407|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628408|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628409|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
44628410|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628411|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628412|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628413|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628414|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44628415|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628416|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
44628417|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628418|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44628420|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
44628421|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44628422|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44628423|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628424|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628425|NCT00485303|Prednisone|prednisone|mesh-list
44628426|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
44628427|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628428|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
44628429|NCT00485303|Hormones|hormones|mesh-ancestor
44628430|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628431|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628432|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44628433|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628434|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44628435|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628436|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628437|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
44628438|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44628439|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
44628440|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44628441|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44628442|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
44628443|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628444|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44628445|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44628446|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628447|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628448|NCT00485134|Vaccines|vaccines|mesh-list
44628449|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
44628450|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628451|NCT00485069|Levodopa|levodopa|mesh-list
43896754|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
44628452|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44628453|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44628454|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
44628455|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628456|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628457|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628458|NCT00484939|Bevacizumab|bevacizumab|mesh-list
44628459|NCT00484939|Capecitabine|capecitabine|mesh-list
44628460|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628461|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628462|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44628463|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44628464|NCT00484939|Growth Substances|growth substances|mesh-ancestor
44628465|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628466|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44628467|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628468|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
44628469|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628470|NCT00484679|Triamcinolone|triamcinolone|mesh-list
44628471|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44628472|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44628473|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44628474|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628476|NCT00484679|Hormones|hormones|mesh-ancestor
44628477|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628478|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628479|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628480|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
44628481|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628482|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628483|NCT00484315|Paclitaxel|paclitaxel|mesh-list
44628484|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44628485|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628486|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628487|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628488|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628489|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628490|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628491|NCT00484289|Abatacept|abatacept|mesh-list
44628492|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44628493|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628494|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628495|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628496|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
44628497|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628498|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628499|NCT00484198|Pioglitazone|pioglitazone|mesh-list
44628500|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628501|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628502|NCT00484159|Lidocaine|lidocaine|mesh-list
44628503|NCT00484159|Bupivacaine|bupivacaine|mesh-list
44628504|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
44628505|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
44628506|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628507|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628508|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
44628509|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628510|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44628511|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44628512|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44628513|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628514|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628515|NCT00484094|Sirolimus|sirolimus|mesh-list
44628516|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628517|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628518|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44628519|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628520|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
44628521|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628522|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
44628523|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628524|NCT00483938|Interferons|interferons|mesh-list
44628525|NCT00483938|Ribavirin|ribavirin|mesh-list
44628526|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
44628527|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
44628528|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44628529|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628530|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
44628531|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628532|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
44628533|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628534|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
44628535|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628536|NCT00483756|Cyclosporine|cyclosporine|mesh-list
44628537|NCT00483756|Cyclosporins|cyclosporins|mesh-list
44628538|NCT00483756|Tofacitinib|tofacitinib|mesh-list
44628539|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628540|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628541|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628542|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
44628543|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628544|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
44628545|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628546|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628547|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628548|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44628549|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628551|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44628552|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44628553|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628554|NCT00483717|Analgesics|analgesics|mesh-ancestor
44628555|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
44628556|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628557|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628558|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628559|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628560|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44628561|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628562|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628563|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
44628564|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44628565|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44628566|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628567|NCT00483574|Vaccines|vaccines|mesh-list
44628568|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
44628569|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628570|NCT00483548|Ziprasidone|ziprasidone|mesh-list
44628571|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44628572|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
44628573|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628574|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628575|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628576|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44628577|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44628578|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628579|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628580|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44628581|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
44628582|NCT00483405|Capecitabine|capecitabine|mesh-list
44628583|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
44628584|NCT00483405|Cetuximab|cetuximab|mesh-list
44628585|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628586|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
44628587|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628588|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628589|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628590|NCT00483327|Megestrol|megestrol|mesh-list
44628591|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
44628592|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44628593|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44628594|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44628595|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
44628596|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44628597|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628598|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44628599|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44628600|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44628601|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628602|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
44628603|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44628604|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
44628605|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
44628606|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44628607|NCT00483119|Antibodies|antibodies|mesh-list
44628608|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
44628609|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44628610|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628611|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
44628612|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628613|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628614|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44628615|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
44628616|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628617|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628618|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44628619|NCT00483002|Varenicline|varenicline|mesh-list
44628620|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44628621|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44628622|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
44628623|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628624|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628625|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628626|NCT00482729|Metformin|metformin|mesh-list
44628627|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44628628|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628629|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628630|NCT00482729|Incretins|incretins|mesh-ancestor
44628631|NCT00482729|Hormones|hormones|mesh-ancestor
44628632|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628633|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44628634|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44628635|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628636|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628637|NCT00482703|Dasatinib|dasatinib|mesh-list
44628638|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628639|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628640|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628641|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628642|NCT00482612|Mirtazapine|mirtazapine|mesh-list
44628643|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
44628644|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628645|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44628646|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
44628647|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
44628648|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628649|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628650|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628651|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44628652|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44628653|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628654|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44628655|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44628656|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44628657|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44628658|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44628659|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44628660|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
44628661|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44628662|NCT00482391|Paclitaxel|paclitaxel|mesh-list
44628663|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
44628664|NCT00482391|Doxorubicin|doxorubicin|mesh-list
44628665|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44628666|NCT00482391|Trastuzumab|trastuzumab|mesh-list
44628667|NCT00482391|Lapatinib|lapatinib|mesh-list
44628668|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628669|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628670|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628671|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628672|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628673|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628674|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628675|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
44628676|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628677|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628678|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44628679|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
44628680|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44628681|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44628682|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44628683|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44628684|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628685|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628686|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628687|NCT00482274|Docetaxel|docetaxel|mesh-list
44628688|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628689|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628690|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628691|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628692|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628693|NCT00482170|Etanercept|etanercept|mesh-list
44628694|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44628695|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628696|NCT00482170|Analgesics|analgesics|mesh-ancestor
44628697|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
44628698|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628699|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628700|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628701|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628702|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44628703|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628704|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
44628705|NCT00482053|Acetaminophen|acetaminophen|mesh-list
44628706|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
44628707|NCT00482053|Promethazine|promethazine|mesh-list
44628708|NCT00482053|Cyclosporine|cyclosporine|mesh-list
44628709|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
44628710|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
44628711|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44628712|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
44628713|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
44628715|NCT00482053|Rituximab|rituximab|mesh-list
44628716|NCT00482053|Etoposide|etoposide|mesh-list
44628717|NCT00482053|Cyclosporins|cyclosporins|mesh-list
44628718|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44628719|NCT00482053|Lenograstim|lenograstim|mesh-list
44628720|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628721|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
44628722|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628723|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628724|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44628725|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
44628726|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628727|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628728|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44628729|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628730|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628731|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44628732|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44628733|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628734|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628735|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
44628736|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628737|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628738|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44628739|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628740|NCT00482053|Analgesics|analgesics|mesh-ancestor
44628741|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
44628742|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628743|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
44628744|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44628745|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44628746|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
44628747|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628748|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628749|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
44628750|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
43647973|NCT05035680|Vaccines|vaccines|mesh-list
43897055|NCT04413786|Oxytocin|oxytocin|mesh-list
44628751|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44628752|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
44628753|NCT00482053|Hormones|hormones|mesh-ancestor
44628754|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628755|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44628756|NCT00482053|Protective Agents|protective agents|mesh-ancestor
44628757|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44628758|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44628759|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44628760|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44628761|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
44628762|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
44628763|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44628764|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
44628765|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
44628766|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628767|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44628768|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
44628769|NCT00482014|Cisplatin|cisplatin|mesh-list
44628770|NCT00482014|Carboplatin|carboplatin|mesh-list
44628771|NCT00482014|Pemetrexed|pemetrexed|mesh-list
44628772|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628773|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628774|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628775|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44628776|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44628777|NCT00482001|Donepezil|donepezil|mesh-list
44628778|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44628779|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628780|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628781|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44628782|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628783|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628784|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
44628785|NCT00481871|Vitamins|vitamins|mesh-list
44628786|NCT00481871|Folic Acid|folic acid|mesh-list
44628787|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
44628788|NCT00481871|Hydroxocobalamin|hydroxocobalamin|mesh-list
44628789|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
44628790|NCT00481871|Gemcitabine|gemcitabine|mesh-list
44628791|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44628792|NCT00481871|Aminopterin|aminopterin|mesh-list
44628793|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
44628794|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628795|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44628796|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
44628797|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628798|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628799|NCT00481871|Antiviral Agents|antiviral agents|mesh-ancestor
44628800|NCT00481871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628801|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628802|NCT00481871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628803|NCT00481871|Immunologic Factors|immunologic factors|mesh-ancestor
44628804|NCT00481871|Hematinics|hematinics|mesh-ancestor
44628805|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44628806|NCT00481832|Cyclosporine|cyclosporine|mesh-list
44628807|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
44628808|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
44628809|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44628810|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44628811|NCT00481832|Prednisolone|prednisolone|mesh-list
44628812|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
44628813|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
44628814|NCT00481832|Carmustine|carmustine|mesh-list
44628815|NCT00481832|Rituximab|rituximab|mesh-list
44628816|NCT00481832|Etoposide|etoposide|mesh-list
44628817|NCT00481832|Cyclosporins|cyclosporins|mesh-list
44628818|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44628819|NCT00481832|Lenograstim|lenograstim|mesh-list
44628820|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44628821|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
44628822|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628823|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
44628824|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628825|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44628826|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44628827|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
44628828|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628829|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628830|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44628831|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44628832|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628833|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44628834|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44628835|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628836|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628837|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
44628838|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628839|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628840|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44628841|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44628842|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44628843|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
44628844|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628845|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44628846|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
44628847|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
44628848|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628849|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44628850|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
44628851|NCT00481832|Hormones|hormones|mesh-ancestor
44628852|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628853|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44628854|NCT00481832|Protective Agents|protective agents|mesh-ancestor
44628855|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44628856|NCT00481767|Vaccines|vaccines|mesh-list
44628857|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
44628858|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628859|NCT00481676|Omalizumab|omalizumab|mesh-list
44628860|NCT00481676|Loratadine|loratadine|mesh-list
44628861|NCT00481676|Clemastine|clemastine|mesh-list
44628862|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44628863|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44628864|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44628865|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44628866|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
44628867|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628868|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
44628869|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
44628870|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44628871|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44628872|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
44628873|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
44628874|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628875|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628876|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
44628877|NCT00481247|Dasatinib|dasatinib|mesh-list
44628878|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628879|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628880|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628881|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628882|NCT00481195|Modafinil|modafinil|mesh-list
44628883|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44628884|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628885|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44628886|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44628887|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44628888|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628889|NCT00481078|Paclitaxel|paclitaxel|mesh-list
44628890|NCT00481078|Carboplatin|carboplatin|mesh-list
44628891|NCT00481078|Vorinostat|vorinostat|mesh-list
44628892|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44628893|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628894|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628895|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628896|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628897|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628898|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44628899|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628900|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44628901|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628902|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
44628903|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628904|NCT00480857|Docetaxel|docetaxel|mesh-list
44628905|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628906|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44628907|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
44628908|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44628909|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628910|NCT00480636|Dalteparin|dalteparin|mesh-list
44628911|NCT00480636|Tinzaparin|tinzaparin|mesh-list
44628912|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44628913|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
44628914|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44628915|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44628916|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628917|NCT00480532|Doxycycline|doxycycline|mesh-list
44628918|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
44628919|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44628920|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44628921|NCT00480532|Estradiol|estradiol|mesh-list
44628922|NCT00480532|Estrogens|estrogens|mesh-ancestor
44628923|NCT00480532|Hormones|hormones|mesh-ancestor
43897144|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44628924|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628925|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628926|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44628928|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44628929|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44628930|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628931|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628932|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
44628933|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44628934|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44628935|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44628936|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44628937|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44628938|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44628939|NCT00480441|Dronabinol|dronabinol|mesh-list
44628940|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
44628941|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628942|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44628943|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44628944|NCT00480441|Analgesics|analgesics|mesh-ancestor
44628945|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
44628946|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44628947|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44628948|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44628949|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44628950|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628951|NCT00480441|Hormones|hormones|mesh-ancestor
44628952|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44628953|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
44628954|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44628955|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
44628956|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628957|NCT00479167|Bortezomib|bortezomib|mesh-list
44628958|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
44628959|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628960|NCT00478231|Maraviroc|maraviroc|mesh-list
44628961|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44628962|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44628963|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628964|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44628965|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44628966|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
44628967|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628968|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44628969|NCT00477594|Mipomersen|mipomersen|mesh-list
44628970|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44628971|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44628972|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
44628973|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628974|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44628975|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44628976|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44628977|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628978|NCT00475176|Ribavirin|ribavirin|mesh-list
44628979|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44628980|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
44628981|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628982|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
44628983|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628984|NCT00474786|Sirolimus|sirolimus|mesh-list
44628985|NCT00474786|Sorafenib|sorafenib|mesh-list
44628986|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44628987|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44628988|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44628989|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44628990|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44628991|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44628992|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44628993|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
44628994|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44628995|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
44628996|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44628997|NCT00474630|Naltrexone|naltrexone|mesh-list
44628998|NCT00474630|Bupropion|bupropion|mesh-list
44628999|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44629001|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629002|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
44629003|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629004|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44629005|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
44629006|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44629007|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44629008|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44629009|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44629010|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629011|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
44629012|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629013|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44629014|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44629015|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629016|NCT00474539|Vaccines|vaccines|mesh-list
44629017|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44629018|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
44629019|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629020|NCT00474175|Benzocaine|benzocaine|mesh-list
44629021|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
44629022|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
44629023|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629024|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629025|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
44629026|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629027|NCT00474045|Insulin|insulin|mesh-list
44629028|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44629029|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
44629030|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
44629031|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
44629032|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
44629033|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
44629034|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44629035|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629036|NCT00473876|Metformin|metformin|mesh-list
44629037|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44629038|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629039|NCT00473330|Ranibizumab|ranibizumab|mesh-list
44629040|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629041|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629042|NCT00473330|Growth Substances|growth substances|mesh-ancestor
44629043|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629044|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629045|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629046|NCT00472030|Omalizumab|omalizumab|mesh-list
44629047|NCT00472030|Prednisone|prednisone|mesh-list
44629048|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629049|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
44629050|NCT00472030|Hormones|hormones|mesh-ancestor
44629051|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629052|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629053|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44629054|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629055|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44629056|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44629057|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629058|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
44629059|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629060|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629061|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629062|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629063|NCT00471276|Sunitinib|sunitinib|mesh-list
44629064|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629065|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629066|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629067|NCT00471276|Growth Substances|growth substances|mesh-ancestor
44629068|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629069|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629070|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629071|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629072|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629073|NCT00471146|Gemcitabine|gemcitabine|mesh-list
44629074|NCT00471146|Axitinib|axitinib|mesh-list
44629075|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629076|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
44629077|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629078|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629079|NCT00471146|Antiviral Agents|antiviral agents|mesh-ancestor
44629080|NCT00471146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629081|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629082|NCT00471146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629083|NCT00471146|Immunologic Factors|immunologic factors|mesh-ancestor
44629084|NCT00471146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629085|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629086|NCT00470262|Pioglitazone|pioglitazone|mesh-list
44629087|NCT00470262|Fenofibrate|fenofibrate|mesh-list
44629088|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44629089|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629090|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44629091|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
44629092|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629093|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44629094|NCT00469898|Carboplatin|carboplatin|mesh-list
44629095|NCT00469898|Irinotecan|irinotecan|mesh-list
44629096|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629097|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44629098|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44629099|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629100|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629101|NCT00469859|Cytarabine|cytarabine|mesh-list
44629102|NCT00469859|Idarubicin|idarubicin|mesh-list
44629103|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629104|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
44629105|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897267|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
44629106|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629107|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
44629108|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629109|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629110|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
44629111|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629112|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44629113|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44629114|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44629115|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629116|NCT00469833|Insulin|insulin|mesh-list
44629117|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44629118|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
44629119|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
44629120|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44629121|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629122|NCT00469456|Memantine|memantine|mesh-list
44629123|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44629124|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44629125|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
44629126|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629127|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629128|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629129|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44629130|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44629131|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
44629132|NCT00469209|Bortezomib|bortezomib|mesh-list
44629133|NCT00469209|Melphalan|melphalan|mesh-list
44629134|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
44629135|NCT00469209|Vitamins|vitamins|mesh-ancestor
44629136|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
44629137|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629138|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629139|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44629140|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
44629141|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629142|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44629143|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629144|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
44629145|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
44629146|NCT00469209|Protective Agents|protective agents|mesh-ancestor
44629147|NCT00469144|Fludarabine|fludarabine|mesh-list
44629148|NCT00469144|Busulfan|busulfan|mesh-list
44629149|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629150|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629151|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629152|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
44629153|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629154|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
44629155|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44629156|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44629157|NCT00469092|Insulin|insulin|mesh-list
44629158|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44629159|NCT00469092|Metformin|metformin|mesh-list
44629160|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
44629161|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
44629162|NCT00469092|Glimepiride|glimepiride|mesh-list
44629163|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
44629164|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43897313|NCT03476317|Vancomycin|vancomycin|mesh-list
44629165|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629166|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44629167|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629168|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
44629169|NCT00469079|Nicotine|nicotine|mesh-list
44629170|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44629171|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
44629172|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629173|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629174|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44629175|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44629176|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
44629177|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629178|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629179|NCT00469014|Fludarabine|fludarabine|mesh-list
44629180|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
44629181|NCT00469014|Busulfan|busulfan|mesh-list
44629182|NCT00469014|Clofarabine|clofarabine|mesh-list
44629183|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
44629184|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44629185|NCT00469014|Lenograstim|lenograstim|mesh-list
44629186|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629187|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629188|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
44629189|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629190|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629191|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
44629192|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629193|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44629194|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
44629195|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44629196|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44629197|NCT00468910|Aspirin|aspirin|mesh-list
44629198|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44629199|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629200|NCT00468910|Analgesics|analgesics|mesh-ancestor
44629201|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
44629202|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629203|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629204|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629205|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629206|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44629207|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44629208|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629209|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44629210|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44629211|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629212|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
44629213|NCT00468845|Pregabalin|pregabalin|mesh-list
44629214|NCT00468845|Analgesics|analgesics|mesh-ancestor
44629215|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
44629216|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629217|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629218|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
44629219|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44629220|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44629221|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629222|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44629223|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44629224|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44629225|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629226|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44629227|NCT00468728|Vancomycin|vancomycin|mesh-list
44629228|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629229|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629230|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
44629231|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629232|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
44629233|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44629234|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44629235|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629236|NCT00468650|Urological Agents|urological agents|mesh-ancestor
44629237|NCT00468585|Bevacizumab|bevacizumab|mesh-list
44629238|NCT00468585|Capecitabine|capecitabine|mesh-list
44629239|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629240|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629241|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629242|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629243|NCT00468585|Growth Substances|growth substances|mesh-ancestor
44629244|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629245|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629246|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629247|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
44629248|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629249|NCT00468559|Esomeprazole|esomeprazole|mesh-list
44629250|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44629251|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629252|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44629253|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629254|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629255|NCT00468546|Methotrexate|methotrexate|mesh-list
44629256|NCT00468546|Rituximab|rituximab|mesh-list
44629257|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44629258|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
44629259|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44629260|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629261|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629262|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
44629263|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629264|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629265|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
44629266|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629267|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44629268|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629269|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
44629270|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629271|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44629272|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629273|NCT00468481|Drospirenone|drospirenone|mesh-list
44629274|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44629275|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44629276|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44629277|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44629278|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44629279|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
44629280|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44629281|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629282|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44629283|NCT00468481|Estrogens|estrogens|mesh-ancestor
44629284|NCT00468481|Hormones|hormones|mesh-ancestor
44629285|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629286|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44629287|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
44629288|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44629289|NCT00468481|Diuretics|diuretics|mesh-ancestor
44629290|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
44629291|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
44629292|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629293|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44629294|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44629295|NCT00468299|Misoprostol|misoprostol|mesh-list
44629296|NCT00468299|Mifepristone|mifepristone|mesh-list
44629297|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44629298|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
44629299|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44629300|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629302|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629303|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
44629304|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44629305|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44629306|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44629307|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44629308|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
44629309|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44629310|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44629311|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44629312|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629313|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
44629314|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44629315|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44629316|NCT00468169|Cisplatin|cisplatin|mesh-list
44629317|NCT00468169|Cetuximab|cetuximab|mesh-list
44629318|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
44629319|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629320|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629321|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
44629322|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629323|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629324|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44629325|NCT00468143|Adderall|adderall|mesh-list
44629326|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44629327|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629328|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44629329|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44629330|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44629331|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629332|NCT00468052|Fentanyl|fentanyl|mesh-list
44629333|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
44629334|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44629335|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629336|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629337|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629338|NCT00468052|Analgesics|analgesics|mesh-ancestor
44629339|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
44629340|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629341|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44629342|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44629343|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44629344|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
44629345|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629346|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629347|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44629348|NCT00468052|Narcotics|narcotics|mesh-ancestor
44629349|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44629350|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44629351|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
44629352|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
44629353|NCT00467896|Iloprost|iloprost|mesh-list
44629354|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44629355|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
44629356|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
44629357|NCT00467870|Testosterone|testosterone|mesh-list
44629358|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
44629359|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
44629360|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44629361|NCT00467870|Androgens|androgens|mesh-ancestor
44629362|NCT00467870|Hormones|hormones|mesh-ancestor
44629363|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629364|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629365|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44629366|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629367|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
44629368|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
44629369|NCT00467831|Erythromycin|erythromycin|mesh-list
44629370|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
44629371|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44629372|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
44629373|NCT00467831|Zileuton|zileuton|mesh-list
44629374|NCT00467831|Losartan|losartan|mesh-list
44629375|NCT00467831|Pravastatin|pravastatin|mesh-list
44629376|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44629377|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44629378|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44629379|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44629380|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44629381|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629382|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
44629383|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629384|NCT00467831|Expectorants|expectorants|mesh-ancestor
44629385|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629386|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44629387|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
44629388|NCT00467831|Protective Agents|protective agents|mesh-ancestor
44629389|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629390|NCT00467831|Antidotes|antidotes|mesh-ancestor
44629391|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44629392|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44629393|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
44629394|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44629395|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44629396|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629397|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629398|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629399|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44629400|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44629401|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629402|NCT00467831|Analgesics|analgesics|mesh-ancestor
44629403|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
44629404|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629405|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629406|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629407|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44629408|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44629409|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
44629410|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629411|NCT00467779|Midazolam|midazolam|mesh-list
44629412|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
44629413|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44629414|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44629415|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629416|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629417|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44629418|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44629419|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44629420|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44629421|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
44629422|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
44629423|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
44629424|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
44629425|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629426|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629427|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
44629428|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629429|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44629430|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44629431|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
44629432|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
44629433|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44629434|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44629435|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44629436|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629437|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44629438|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44629439|NCT00467740|Olodaterol|olodaterol|mesh-list
44629440|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44629441|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
44629442|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629443|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629444|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44629445|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629446|NCT00467649|Insulin|insulin|mesh-list
44629447|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44629450|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
44629451|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
44629452|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
44629453|NCT00467649|Pramlintide|pramlintide|mesh-list
44629454|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
44629455|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44629456|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629457|NCT00467597|Levodopa|levodopa|mesh-list
44629458|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44629459|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44629460|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
44629461|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629462|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629463|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629464|NCT00467584|Aspirin|aspirin|mesh-list
44629465|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44629466|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629467|NCT00467584|Analgesics|analgesics|mesh-ancestor
44629468|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
44629469|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629470|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629471|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629472|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629473|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44629474|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44629475|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629476|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44629477|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44629478|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629479|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
44629480|NCT00467558|Naltrexone|naltrexone|mesh-list
44629481|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44629482|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44629483|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629484|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
44629485|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629486|NCT00467363|Aspirin|aspirin|mesh-list
44629487|NCT00467363|Folic Acid|folic acid|mesh-list
44629488|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44629489|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629490|NCT00467363|Analgesics|analgesics|mesh-ancestor
44629491|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
44629492|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629493|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629494|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629495|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629496|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44629497|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44629498|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629499|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44629500|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44629501|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629502|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
44629503|NCT00467363|Hematinics|hematinics|mesh-ancestor
44629504|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
44629505|NCT00467363|Vitamins|vitamins|mesh-ancestor
44629506|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
44629507|NCT00467272|Daptomycin|daptomycin|mesh-list
44629508|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629509|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629510|NCT00467259|Testosterone|testosterone|mesh-list
44629511|NCT00467259|Androgens|androgens|mesh-ancestor
44629512|NCT00467259|Hormones|hormones|mesh-ancestor
44629513|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629514|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629515|NCT00467142|Leucovorin|leucovorin|mesh-list
44629516|NCT00467142|Bevacizumab|bevacizumab|mesh-list
44629517|NCT00467142|Fluorouracil|fluorouracil|mesh-list
44629518|NCT00467142|Irinotecan|irinotecan|mesh-list
44629519|NCT00467142|Calcium|calcium|mesh-list
44629520|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
44629521|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629522|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629523|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629524|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629525|NCT00467142|Growth Substances|growth substances|mesh-ancestor
44629526|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629527|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629528|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44629529|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
44629530|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629531|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629532|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629533|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
44629534|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44629535|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44629536|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629538|NCT00467142|Protective Agents|protective agents|mesh-ancestor
44629539|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
44629540|NCT00467142|Vitamins|vitamins|mesh-ancestor
44629541|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
44629542|NCT00467051|Paclitaxel|paclitaxel|mesh-list
44629543|NCT00467051|Carboplatin|carboplatin|mesh-list
44629544|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44629545|NCT00467051|Ifosfamide|ifosfamide|mesh-list
44629546|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
44629547|NCT00467051|Lenograstim|lenograstim|mesh-list
44629548|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44629549|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629550|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
44629551|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
44629552|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44629553|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629554|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44629555|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
44629556|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629557|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44629558|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
44629559|NCT00466947|Vaccines|vaccines|mesh-list
44629560|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44629561|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
44629562|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629563|NCT00466921|Lenalidomide|lenalidomide|mesh-list
44629564|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
44629565|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629566|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629567|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629568|NCT00466921|Growth Substances|growth substances|mesh-ancestor
44629569|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629570|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629571|NCT00466726|Sargramostim|sargramostim|mesh-list
44629572|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
44629573|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629574|NCT00466687|Bevacizumab|bevacizumab|mesh-list
44629575|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44629576|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629577|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629578|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629579|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629580|NCT00466687|Growth Substances|growth substances|mesh-ancestor
44629581|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629582|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629583|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629584|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629585|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629586|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
44629587|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629588|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
44629589|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629590|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629591|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44629592|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
44629593|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629594|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629595|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44629596|NCT00466505|Celecoxib|celecoxib|mesh-list
44629597|NCT00466505|Cetuximab|cetuximab|mesh-list
44629598|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629599|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148875|NCT00206154|Budesonide|budesonide|mesh-list
44629600|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44629601|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629602|NCT00466505|Analgesics|analgesics|mesh-ancestor
44629603|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
44629604|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629605|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629606|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629607|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629608|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44629609|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44629610|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629611|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629612|NCT00466440|Prednisone|prednisone|mesh-list
44629613|NCT00466440|Docetaxel|docetaxel|mesh-list
44629614|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629615|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
44629616|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
44629617|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
44629618|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629619|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629620|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
44629621|NCT00466440|Hormones|hormones|mesh-ancestor
44629622|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629623|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629624|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44629625|NCT00466193|Zolpidem|zolpidem|mesh-list
44629626|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44629627|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44629628|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629629|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629630|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44629631|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
44629632|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
44629633|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629634|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629635|NCT00466167|Pramipexole|pramipexole|mesh-list
44629636|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
44629637|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629638|NCT00466167|Protective Agents|protective agents|mesh-ancestor
44629639|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629640|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44629641|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44629642|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
44629643|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
44629644|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629645|NCT00465972|Doxepin|doxepin|mesh-list
44629646|NCT00465972|Temazepam|temazepam|mesh-list
44629647|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44629648|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44629649|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629650|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629651|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44629652|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
44629653|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44629654|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
44629655|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
44629656|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629657|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629658|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44629659|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44629660|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
44629661|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
44629662|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44629663|NCT00465894|Estradiol|estradiol|mesh-list
44629664|NCT00465894|Estrogens|estrogens|mesh-ancestor
44629665|NCT00465894|Hormones|hormones|mesh-ancestor
44629666|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629667|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629668|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44629669|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44629670|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
44629671|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629672|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629673|NCT00465894|Urological Agents|urological agents|mesh-ancestor
44629674|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
44629675|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44629676|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44629677|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44629678|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44629679|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44629680|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629681|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
44629682|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629683|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629684|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44629685|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629686|NCT00465647|Hydromorphone|hydromorphone|mesh-list
44629687|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44629688|NCT00465647|Narcotics|narcotics|mesh-ancestor
44629689|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629690|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629691|NCT00465647|Analgesics|analgesics|mesh-ancestor
44629692|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
44629693|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629694|NCT00465179|Sunitinib|sunitinib|mesh-list
44629695|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629696|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629697|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629698|NCT00465179|Growth Substances|growth substances|mesh-ancestor
44629699|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629700|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629701|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629702|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629703|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629704|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44629705|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
44629706|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629707|NCT00464737|Rotigotine|rotigotine|mesh-list
44629708|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
44629709|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
44629710|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629711|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629712|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629713|NCT00464672|Vaccines|vaccines|mesh-list
44629714|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
44629715|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629716|NCT00464620|Dasatinib|dasatinib|mesh-list
44629717|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629718|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629719|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629720|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629721|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44629722|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44629723|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44629724|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629725|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629726|NCT00464542|Metronidazole|metronidazole|mesh-list
44629727|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629728|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629729|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44629730|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44629731|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
44629732|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44629733|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629734|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629735|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44629736|NCT00464490|Analgesics|analgesics|mesh-ancestor
44629737|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
44629738|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629739|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44629740|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44629741|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44629742|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44629743|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629744|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629745|NCT00464308|Esomeprazole|esomeprazole|mesh-list
44629747|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44629748|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629749|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44629750|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629751|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629752|NCT00464269|Brivaracetam|brivaracetam|mesh-list
44629753|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
44629754|NCT00464178|Bortezomib|bortezomib|mesh-list
44629755|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629756|NCT00464087|Heparin|heparin|mesh-list
44629757|NCT00464087|Calcium heparin|calcium heparin|mesh-list
44629758|NCT00464087|PENTA|penta|mesh-list
44629759|NCT00464087|Bivalirudin|bivalirudin|mesh-list
44629760|NCT00464087|Fondaparinux|fondaparinux|mesh-list
44629761|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
44629762|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44629763|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44629764|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629765|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
44629766|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44629767|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
44629768|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629769|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44629770|NCT00463866|Budesonide|budesonide|mesh-list
44629771|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
44629772|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629773|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44629774|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
44629775|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629776|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629777|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44629778|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629779|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
44629780|NCT00463866|Hormones|hormones|mesh-ancestor
44629781|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629782|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44629783|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44629784|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44629785|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44629786|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629787|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629788|NCT00463840|Fluorouracil|fluorouracil|mesh-list
44629789|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
44629790|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
44629791|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629792|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629793|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629794|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629795|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
44629796|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629797|NCT00463801|Daptomycin|daptomycin|mesh-list
44629798|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629799|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629800|NCT00463788|Cisplatin|cisplatin|mesh-list
44629801|NCT00463788|Cetuximab|cetuximab|mesh-list
44629802|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629803|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629804|NCT00463684|Vaccines|vaccines|mesh-list
44629805|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
44629806|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629807|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
44629808|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44629809|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
44629810|NCT00463606|Calcium|calcium|mesh-list
44629811|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44629812|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629813|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44629814|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44629815|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44629816|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
44629817|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629818|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44629819|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44629820|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629821|NCT00463580|Infliximab|infliximab|mesh-list
44629822|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44629823|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629824|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629825|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
44629826|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
44629827|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44629828|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
44629829|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629830|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629831|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44629832|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
44629833|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44629834|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44629835|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44629836|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44629837|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44629838|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629839|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
44629840|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44629841|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
44629842|NCT00463385|Thalidomide|thalidomide|mesh-list
44629843|NCT00463385|Prednisone|prednisone|mesh-list
44629844|NCT00463385|Pomalidomide|pomalidomide|mesh-list
44629845|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629846|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
44629847|NCT00463385|Hormones|hormones|mesh-ancestor
44629848|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44629849|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629850|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44629851|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629852|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
44629853|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629854|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629855|NCT00463385|Growth Substances|growth substances|mesh-ancestor
44629856|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629857|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629858|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
44629859|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44629860|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629861|NCT00463346|Acamprosate|acamprosate|mesh-list
44629862|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44629863|NCT00463151|Rebamipide|rebamipide|mesh-list
44629864|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44629865|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44629866|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
44629867|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629868|NCT00463151|Protective Agents|protective agents|mesh-ancestor
44629869|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629870|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629871|NCT00463060|Sunitinib|sunitinib|mesh-list
44629872|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629873|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43897954|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
44629874|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629875|NCT00463060|Growth Substances|growth substances|mesh-ancestor
44629876|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629877|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629878|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181423|NCT00320970|Candesartan|candesartan|mesh-list
44629879|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629880|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629881|NCT00463047|Fentanyl|fentanyl|mesh-list
44629882|NCT00463047|Oxycodone|oxycodone|mesh-list
44629883|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44629884|NCT00463047|Narcotics|narcotics|mesh-ancestor
44629885|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629886|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629887|NCT00463047|Analgesics|analgesics|mesh-ancestor
44629888|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
44629889|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44629890|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44629891|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44629892|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
44629893|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
44629894|NCT00462982|Sunitinib|sunitinib|mesh-list
44629895|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629896|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629897|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629898|NCT00462982|Growth Substances|growth substances|mesh-ancestor
44629899|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629900|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629901|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44629902|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629903|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629904|NCT00462865|Gemcitabine|gemcitabine|mesh-list
44629905|NCT00462865|Bevacizumab|bevacizumab|mesh-list
44629906|NCT00462865|Capecitabine|capecitabine|mesh-list
44629907|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629908|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629909|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629910|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629911|NCT00462865|Growth Substances|growth substances|mesh-ancestor
44629912|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629913|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629914|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629915|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
44629916|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629917|NCT00462865|Antiviral Agents|antiviral agents|mesh-ancestor
44629918|NCT00462865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629919|NCT00462865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629920|NCT00462865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629921|NCT00462865|Immunologic Factors|immunologic factors|mesh-ancestor
44629922|NCT00462826|Aflibercept|aflibercept|mesh-list
44629923|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
44629924|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629925|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629926|NCT00462826|Growth Substances|growth substances|mesh-ancestor
44629927|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629928|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629929|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629930|NCT00462709|Complement C1s|complement c1s|mesh-list
44629931|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44629932|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44629933|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
44629934|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629935|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44629936|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629937|NCT00462670|Tolvaptan|tolvaptan|mesh-list
44629938|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44629939|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629940|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
44629941|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629942|NCT00462501|Leucovorin|leucovorin|mesh-list
44629943|NCT00462501|Bevacizumab|bevacizumab|mesh-list
44629944|NCT00462501|Fluorouracil|fluorouracil|mesh-list
44629945|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
44629946|NCT00462501|Calcium|calcium|mesh-list
44629947|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
44629948|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629949|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629950|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44629951|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44629952|NCT00462501|Growth Substances|growth substances|mesh-ancestor
44629953|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629954|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
44629955|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44629956|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
44629957|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629958|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629959|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629960|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
44629961|NCT00462501|Antidotes|antidotes|mesh-ancestor
44629962|NCT00462501|Protective Agents|protective agents|mesh-ancestor
44629963|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44629964|NCT00462501|Vitamins|vitamins|mesh-ancestor
44629965|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
44629966|NCT00462462|Ethanol|ethanol|mesh-list
44629967|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44629968|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44629969|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44629970|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629971|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
44629972|NCT00462384|Hematinics|hematinics|mesh-ancestor
44629973|NCT00462345|Rituximab|rituximab|mesh-list
44629974|NCT00462345|Methotrexate|methotrexate|mesh-list
44629975|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44629976|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44629977|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
44629978|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629979|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44629980|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44629981|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
44629982|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44629983|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44629984|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
44629985|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44629986|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
44629987|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44629988|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44629989|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44629990|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44629991|NCT00461981|Vaccines|vaccines|mesh-list
44629992|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
44629993|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44629994|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
44629995|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44629996|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44629997|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44629998|NCT00461786|Pemetrexed|pemetrexed|mesh-list
44629999|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630000|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630001|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630002|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44630003|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630004|NCT00461708|Gemcitabine|gemcitabine|mesh-list
44630005|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44630006|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630007|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
44630008|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630009|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630010|NCT00461708|Antiviral Agents|antiviral agents|mesh-ancestor
44630011|NCT00461708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630012|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630013|NCT00461708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630014|NCT00461708|Immunologic Factors|immunologic factors|mesh-ancestor
44630015|NCT00461708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630016|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630017|NCT00461630|Niacin|niacin|mesh-list
44630018|NCT00461630|Simvastatin|simvastatin|mesh-list
44630019|NCT00461630|Ezetimibe|ezetimibe|mesh-list
44630020|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44630021|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44630022|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44630023|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
44630024|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630025|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44630026|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44630027|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630028|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
44630029|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
44630030|NCT00461630|Vitamins|vitamins|mesh-ancestor
44630031|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
44630032|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630033|NCT00461500|Fluticasone|fluticasone|mesh-list
44630034|NCT00461500|Xhance|xhance|mesh-list
44630035|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44630036|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630037|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630038|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
44630039|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630040|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630041|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630042|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630043|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630044|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630045|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44630046|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44630047|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44630048|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630049|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630050|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630051|NCT00461305|Drospirenone|drospirenone|mesh-list
44630052|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44630053|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
44630054|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630055|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630056|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44630057|NCT00461305|Diuretics|diuretics|mesh-ancestor
44630058|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
44630059|NCT00461253|Copper|copper|mesh-list
44630060|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
44630061|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44630062|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
44630063|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44630064|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630065|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44630066|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44630067|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44630068|NCT00461253|Trace Elements|trace elements|mesh-ancestor
44630069|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
44630070|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44630071|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
44630072|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44630073|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44630074|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630075|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630076|NCT00461123|Urological Agents|urological agents|mesh-ancestor
44630077|NCT00460811|Linaclotide|linaclotide|mesh-list
44630078|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44630079|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
44630080|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630081|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630082|NCT00460798|Sunitinib|sunitinib|mesh-list
44630083|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630084|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630085|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630086|NCT00460798|Growth Substances|growth substances|mesh-ancestor
44630087|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630088|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630089|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630090|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630091|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630092|NCT00460746|Ritonavir|ritonavir|mesh-list
44630093|NCT00460746|Darunavir|darunavir|mesh-list
44630094|NCT00460746|Etravirine|etravirine|mesh-list
44630095|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44630096|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44630097|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630098|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630099|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630100|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44630101|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44630102|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
44630103|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630104|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44630105|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44630106|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44630107|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630109|NCT00460603|Axitinib|axitinib|mesh-list
44630110|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44630111|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630112|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630113|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630114|NCT00460603|Growth Substances|growth substances|mesh-ancestor
44630115|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630116|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630117|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630118|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630119|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630120|NCT00460577|Bromides|bromides|mesh-list
44630121|NCT00460577|Fenoterol|fenoterol|mesh-list
44630122|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
44630123|NCT00460577|Ipratropium|ipratropium|mesh-list
44630124|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630125|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
44630126|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630127|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630128|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630129|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630130|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44630131|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44630132|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44630133|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630134|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630135|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630136|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
44630137|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44630138|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44630139|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
44630140|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
44630141|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44630142|NCT00460239|Morphine|morphine|mesh-list
44630143|NCT00460239|Buprenorphine|buprenorphine|mesh-list
44630144|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44630145|NCT00460239|Narcotics|narcotics|mesh-ancestor
44630146|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44630147|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630148|NCT00460239|Analgesics|analgesics|mesh-ancestor
44630149|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
44630150|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630151|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44630152|NCT00460109|Rituximab|rituximab|mesh-list
44630153|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
44630154|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44630155|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630156|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
44630157|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630158|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630159|NCT00460031|Ketoconazole|ketoconazole|mesh-list
44630160|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
44630161|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44630162|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44630163|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44630164|NCT00460031|Lenalidomide|lenalidomide|mesh-list
44630165|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
44630166|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630167|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630168|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630169|NCT00460031|Growth Substances|growth substances|mesh-ancestor
44630170|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630171|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630172|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630173|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
44630174|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630175|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44630176|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44630177|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630178|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630179|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44630180|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44630181|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630183|NCT00459979|Sunitinib|sunitinib|mesh-list
44630184|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630185|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630186|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630187|NCT00459979|Growth Substances|growth substances|mesh-ancestor
44630188|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630189|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630190|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630191|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630192|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630193|NCT00459953|Nicotine|nicotine|mesh-list
44630194|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44630195|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
44630196|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630197|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630198|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44630200|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
44630201|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630202|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630203|NCT00459875|Sunitinib|sunitinib|mesh-list
44630204|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630205|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630206|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630207|NCT00459875|Growth Substances|growth substances|mesh-ancestor
44630208|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630209|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630210|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630211|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630212|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630213|NCT00459706|Etanercept|etanercept|mesh-list
44630214|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44630215|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630216|NCT00459706|Analgesics|analgesics|mesh-ancestor
44630217|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
44630218|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630219|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630220|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630221|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630222|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630223|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630224|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
44630225|NCT00459667|Interferons|interferons|mesh-list
44630226|NCT00459667|Interferon-beta|interferon-beta|mesh-list
44630227|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
44630228|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630229|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
44630230|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630231|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
44630232|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630233|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44630234|NCT00459537|Terbinafine|terbinafine|mesh-list
44630235|NCT00459537|Amorolfine|amorolfine|mesh-list
44630236|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
44630237|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630238|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630239|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630240|NCT00459342|Dasatinib|dasatinib|mesh-list
44630241|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630242|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630243|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630244|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630245|NCT00459290|Mifepristone|mifepristone|mesh-list
44630246|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44630247|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
44630248|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44630249|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630250|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44630251|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44630252|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44630253|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
44630254|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44630255|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44630256|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
44630257|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630258|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
44630259|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44630260|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44630261|NCT00459186|Prednisone|prednisone|mesh-list
44630262|NCT00459186|Docetaxel|docetaxel|mesh-list
44630263|NCT00459186|Everolimus|everolimus|mesh-list
44630264|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630265|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630266|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630267|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630268|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630269|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630270|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
44630271|NCT00459186|Hormones|hormones|mesh-ancestor
44630272|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630273|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630274|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44630275|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630276|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
44630277|NCT00459108|Dasatinib|dasatinib|mesh-list
44630278|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630279|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630280|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630281|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630282|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44630283|NCT00459056|Carvedilol|carvedilol|mesh-list
44630284|NCT00459056|Lisinopril|lisinopril|mesh-list
44630285|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44630286|NCT00459056|Diuretics|diuretics|mesh-ancestor
44630287|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
44630288|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630289|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44630290|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630291|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630292|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44630293|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44630294|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630295|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630296|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
44630297|NCT00459056|Protective Agents|protective agents|mesh-ancestor
44630298|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44630299|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44630300|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
44630301|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44630302|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44630303|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44630304|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630305|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630306|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44630307|NCT00459043|Docetaxel|docetaxel|mesh-list
44630308|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630309|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630310|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630311|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630312|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630313|NCT00458705|Thalidomide|thalidomide|mesh-list
44630314|NCT00458705|Dexamethasone|dexamethasone|mesh-list
44630315|NCT00458705|Doxorubicin|doxorubicin|mesh-list
44630316|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44630317|NCT00458705|Bortezomib|bortezomib|mesh-list
44630318|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630319|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
44630320|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
44630321|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630322|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630323|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630324|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
44630325|NCT00458705|Hormones|hormones|mesh-ancestor
44630326|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630327|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44630328|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630329|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44630330|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44630331|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44630332|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630333|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630334|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630335|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
44630336|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
44630337|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44630338|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630339|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630340|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630341|NCT00458705|Growth Substances|growth substances|mesh-ancestor
44630342|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630343|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44630344|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44630345|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630346|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630347|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630349|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630350|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44630351|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44630352|NCT00458302|Darunavir|darunavir|mesh-list
44630353|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44630354|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44630355|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630356|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630357|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630358|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44630359|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44630360|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
44630361|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630362|NCT00458211|Ziprasidone|ziprasidone|mesh-list
44630363|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44630364|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
44630365|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630366|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630367|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630368|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44630369|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44630370|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44630371|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44630372|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44630373|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
44630374|NCT00457821|Ivacaftor|ivacaftor|mesh-list
44630375|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44630376|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630377|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630378|NCT00457743|Sunitinib|sunitinib|mesh-list
44630379|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630380|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630381|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630382|NCT00457743|Growth Substances|growth substances|mesh-ancestor
44630383|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630384|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630385|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630386|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630387|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630388|NCT00457691|Leucovorin|leucovorin|mesh-list
44630389|NCT00457691|Fluorouracil|fluorouracil|mesh-list
44630390|NCT00457691|Irinotecan|irinotecan|mesh-list
44630391|NCT00457691|Sunitinib|sunitinib|mesh-list
44630392|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
44630393|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
44630394|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630395|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630396|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630397|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630398|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
44630399|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630400|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44630401|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181884|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
44630402|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630403|NCT00457691|Antidotes|antidotes|mesh-ancestor
44630404|NCT00457691|Protective Agents|protective agents|mesh-ancestor
44630405|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
44630407|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
44630408|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630409|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898449|NCT03798639|Ipilimumab|ipilimumab|mesh-list
44630410|NCT00457691|Growth Substances|growth substances|mesh-ancestor
44630411|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630412|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630413|NCT00457665|Efavirenz|efavirenz|mesh-list
44630414|NCT00457665|Nelfinavir|nelfinavir|mesh-list
44630415|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44630416|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630417|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630418|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630419|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
44630420|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630421|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44630422|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44630423|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44630424|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44630425|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44630426|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44630427|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44630428|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44630429|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630431|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44630432|NCT00457639|Cholic Acids|cholic acids|mesh-list
44630433|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630434|NCT00457626|Valsartan|valsartan|mesh-list
44630435|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44630436|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44630437|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44630438|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630439|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44630440|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
44630441|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630442|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44630443|NCT00457392|Sunitinib|sunitinib|mesh-list
44630444|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630445|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630446|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630447|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630448|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630449|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630450|NCT00457392|Growth Substances|growth substances|mesh-ancestor
44630451|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630452|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630453|NCT00457015|Ecallantide|ecallantide|mesh-list
44630454|NCT00457015|Analgesics|analgesics|mesh-ancestor
44630455|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
44630456|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630457|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630458|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44630459|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630460|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630461|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630462|NCT00457002|Enoxaparin|enoxaparin|mesh-list
44630463|NCT00457002|Apixaban|apixaban|mesh-list
44630464|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
44630465|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44630466|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44630467|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630468|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44630469|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
44630470|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44630471|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630472|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630473|NCT00456846|Paclitaxel|paclitaxel|mesh-list
44630474|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44630475|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44630476|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630477|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44138046|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
44630478|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630479|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630480|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630481|NCT00456599|Gemcitabine|gemcitabine|mesh-list
44630482|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
44630483|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630484|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
44630485|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630486|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630487|NCT00456599|Antiviral Agents|antiviral agents|mesh-ancestor
44630488|NCT00456599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630489|NCT00456599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630490|NCT00456599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630491|NCT00456599|Immunologic Factors|immunologic factors|mesh-ancestor
44630492|NCT00456599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630493|NCT00456521|Naltrexone|naltrexone|mesh-list
44630494|NCT00456521|Bupropion|bupropion|mesh-list
44630495|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44026104|NCT00089128|Gemcitabine|gemcitabine|mesh-list
44630496|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44630497|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630498|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
44630499|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630500|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44630501|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
44630502|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44630503|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44630504|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44630505|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630506|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630507|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
44630508|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630509|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44630510|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44630511|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630512|NCT00456495|Ranibizumab|ranibizumab|mesh-list
44630513|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630514|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630515|NCT00456495|Growth Substances|growth substances|mesh-ancestor
44630516|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630517|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630518|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630519|NCT00456365|Pravastatin|pravastatin|mesh-list
44630520|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44630521|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44630522|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
44630523|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630524|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44630525|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44630526|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630527|NCT00456300|Exenatide|exenatide|mesh-list
44630528|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44630529|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630530|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44630531|NCT00456300|Incretins|incretins|mesh-ancestor
44630532|NCT00456300|Hormones|hormones|mesh-ancestor
44630533|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630534|NCT00456092|Apremilast|apremilast|mesh-list
44630535|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44630536|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630537|NCT00456092|Analgesics|analgesics|mesh-ancestor
44630538|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
44630539|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898544|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44630540|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630541|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630542|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630543|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44630544|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44630545|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630546|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630547|NCT00455923|Fluticasone|fluticasone|mesh-list
44630548|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44630549|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630550|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
44630551|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630552|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630553|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630554|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630555|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
44630556|NCT00455923|Hormones|hormones|mesh-ancestor
44630557|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630558|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
44630559|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630560|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630561|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630562|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
44630563|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44630564|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630565|NCT00455741|Estradiol|estradiol|mesh-list
44630566|NCT00455741|Progesterone|progesterone|mesh-list
44630567|NCT00455741|Estrogens|estrogens|mesh-ancestor
44630568|NCT00455741|Hormones|hormones|mesh-ancestor
44630569|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630570|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630571|NCT00455741|Progestins|progestins|mesh-ancestor
44630572|NCT00455533|Paclitaxel|paclitaxel|mesh-list
44630573|NCT00455533|Epothilones|epothilones|mesh-list
44630574|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
44630575|NCT00455533|Doxorubicin|doxorubicin|mesh-list
44630576|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44630577|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630578|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630579|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630580|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630581|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630582|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630583|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
44630584|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630585|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630586|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44630587|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
44630588|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44630589|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44630590|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44630591|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44630592|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630593|NCT00455520|Tapentadol|tapentadol|mesh-list
44630594|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44630595|NCT00455520|Narcotics|narcotics|mesh-ancestor
44630596|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44630597|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630598|NCT00455520|Analgesics|analgesics|mesh-ancestor
44630599|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
44630600|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630601|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44630602|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44630603|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630604|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630605|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630606|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630607|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44630608|NCT00455325|Chloroquine|chloroquine|mesh-list
44630609|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44630610|NCT00455325|Amebicides|amebicides|mesh-ancestor
44630611|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44630612|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44630613|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630614|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
44630615|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630616|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44630617|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630618|NCT00455325|Analgesics|analgesics|mesh-ancestor
44630619|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
44630620|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630621|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630622|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630623|NCT00455325|Filaricides|filaricides|mesh-ancestor
44630624|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
44630625|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
44630626|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
44630627|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
44630628|NCT00455312|Fludarabine|fludarabine|mesh-list
44630629|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
44630630|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
44630631|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44630632|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630633|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
44630634|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630635|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630636|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44630637|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
44630638|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630639|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630640|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44630641|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630642|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
44630643|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
44630644|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630645|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630646|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
44630648|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630649|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44630650|NCT00455312|Protective Agents|protective agents|mesh-ancestor
43898652|NCT05586516|Paclitaxel|paclitaxel|mesh-list
44630651|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44630652|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
44630653|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44630654|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44630655|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630656|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630657|NCT00455143|Analgesics|analgesics|mesh-ancestor
44630658|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
44630659|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630660|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44630661|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44630662|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44630663|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630664|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630665|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630666|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
44630667|NCT00455013|Sirolimus|sirolimus|mesh-list
44630668|NCT00455013|Abatacept|abatacept|mesh-list
44630669|NCT00455013|Tacrolimus|tacrolimus|mesh-list
44630670|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
44630671|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630672|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
44630673|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630674|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44630675|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630676|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630677|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44630678|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630679|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44630680|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
44630681|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44630682|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630683|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
44630684|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44630685|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630686|NCT00454805|Fulvestrant|fulvestrant|mesh-list
44630687|NCT00454805|Cediranib|cediranib|mesh-list
44630688|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44630689|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630690|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44630691|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44630692|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
44630693|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44630694|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630695|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630696|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630697|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630698|NCT00454779|Cisplatin|cisplatin|mesh-list
44630699|NCT00454779|Docetaxel|docetaxel|mesh-list
44630700|NCT00454779|Panitumumab|panitumumab|mesh-list
44630701|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630702|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630703|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630704|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630705|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630706|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44630707|NCT00454649|Gemcitabine|gemcitabine|mesh-list
44630708|NCT00454649|Paclitaxel|paclitaxel|mesh-list
44630709|NCT00454649|Docetaxel|docetaxel|mesh-list
44630710|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44630711|NCT00454649|Cisplatin|cisplatin|mesh-list
44630712|NCT00454649|Carboplatin|carboplatin|mesh-list
44630713|NCT00454649|Capecitabine|capecitabine|mesh-list
44630714|NCT00454649|Pemetrexed|pemetrexed|mesh-list
44630715|NCT00454649|Axitinib|axitinib|mesh-list
44630716|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44630717|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630718|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630719|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630720|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630721|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630722|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630723|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
44630724|NCT00454649|Antiviral Agents|antiviral agents|mesh-ancestor
44630725|NCT00454649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630726|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630727|NCT00454649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630728|NCT00454649|Immunologic Factors|immunologic factors|mesh-ancestor
44630729|NCT00454649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630730|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44630731|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630732|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630733|NCT00454636|Cisplatin|cisplatin|mesh-list
44630734|NCT00454636|Docetaxel|docetaxel|mesh-list
44630735|NCT00454636|Capecitabine|capecitabine|mesh-list
44630736|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
44630737|NCT00454636|Epirubicin|epirubicin|mesh-list
44630738|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630739|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630740|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630741|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630742|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630743|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630744|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
44630745|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44630746|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44630747|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44630748|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630749|NCT00454584|Etanercept|etanercept|mesh-list
44630750|NCT00454584|Ustekinumab|ustekinumab|mesh-list
44630751|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44630752|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44630753|NCT00454584|Analgesics|analgesics|mesh-ancestor
44630754|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
44630755|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630756|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630757|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630758|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630759|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44630760|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630761|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
44630762|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630763|NCT00454571|Leuprolide|leuprolide|mesh-list
44630764|NCT00454571|Goserelin|goserelin|mesh-list
44630765|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44630766|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
44630767|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44630768|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630769|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44630770|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630771|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
44630772|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
44630773|NCT00454246|Hematinics|hematinics|mesh-ancestor
44182215|NCT00324571|Calcium|calcium|mesh-list
44630774|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
44630775|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630776|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
44630777|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44630778|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44630779|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630780|NCT00454207|Urological Agents|urological agents|mesh-ancestor
44630782|NCT00454194|Sorafenib|sorafenib|mesh-list
44630783|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630784|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630785|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630786|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44630787|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44630788|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630789|NCT00454181|Interferons|interferons|mesh-list
44630790|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
44630791|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630792|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
44630793|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630794|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
44630795|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630796|NCT00454051|Omalizumab|omalizumab|mesh-list
44630797|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630798|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630799|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630800|NCT00453999|Oseltamivir|oseltamivir|mesh-list
44630801|NCT00453999|Peramivir|peramivir|mesh-list
44630802|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
44630803|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630804|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630805|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630806|NCT00453921|Methylphenidate|methylphenidate|mesh-list
44630807|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44630808|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630809|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44630810|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44630811|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630812|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630813|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
44630814|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630815|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44630816|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630817|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630818|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630819|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630820|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
44630821|NCT00453349|Metronidazole|metronidazole|mesh-list
44630822|NCT00453349|Levofloxacin|levofloxacin|mesh-list
44630823|NCT00453349|Ofloxacin|ofloxacin|mesh-list
44630824|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44630825|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44630826|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630827|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44630828|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44630829|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630830|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630831|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630832|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44630833|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
44630834|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44630835|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630836|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44630837|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44630838|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44630839|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44630840|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44630841|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44630842|NCT00453349|Renal Agents|renal agents|mesh-ancestor
44630843|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44630844|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44630845|NCT00453310|Sunitinib|sunitinib|mesh-list
44630846|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630847|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630848|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630849|NCT00453310|Growth Substances|growth substances|mesh-ancestor
44630850|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630851|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630852|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630853|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630854|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630856|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44630857|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
44630858|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630859|NCT00453180|Expectorants|expectorants|mesh-ancestor
44630860|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630861|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44630862|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
44630863|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630864|NCT00453180|Protective Agents|protective agents|mesh-ancestor
44630865|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630866|NCT00453180|Antidotes|antidotes|mesh-ancestor
44630867|NCT00453154|Cisplatin|cisplatin|mesh-list
44630868|NCT00453154|Carboplatin|carboplatin|mesh-list
44630869|NCT00453154|Etoposide|etoposide|mesh-list
44630870|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
44630871|NCT00453154|Sunitinib|sunitinib|mesh-list
44630872|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
44630873|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630874|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44630875|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44630876|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44630877|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630878|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630879|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44630880|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44630881|NCT00453154|Growth Substances|growth substances|mesh-ancestor
44630882|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630883|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44630884|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630885|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
44630886|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630887|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44630888|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44630889|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44630890|NCT00453102|Rituximab|rituximab|mesh-list
44630891|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44630892|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630893|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
44630894|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630895|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630896|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
44630897|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630898|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630899|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630900|NCT00452790|Vaccines|vaccines|mesh-list
44630901|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44630902|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
44630903|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630904|NCT00452699|Fluticasone|fluticasone|mesh-list
44630905|NCT00452699|Xhance|xhance|mesh-list
44630906|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44630907|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630908|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630909|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
44630910|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630911|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630912|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630913|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630914|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630915|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630916|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44630917|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44630918|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44630919|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
44630920|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44630921|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630922|NCT00452673|Capecitabine|capecitabine|mesh-list
44630923|NCT00452673|Dasatinib|dasatinib|mesh-list
44630924|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44630925|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
44630926|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630927|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630928|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630929|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630931|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
44630932|NCT00452530|Apixaban|apixaban|mesh-list
44630933|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
44630934|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44630935|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44630936|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630937|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44630938|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
44630939|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44630940|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
44630941|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630942|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44630943|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
44630944|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630945|NCT00452439|Vitamin D|vitamin d|mesh-list
44630946|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
44630947|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
44630948|NCT00452439|Calcium|calcium|mesh-list
44630949|NCT00452439|Vitamins|vitamins|mesh-ancestor
44630951|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630952|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44630953|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44630954|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44630955|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44630956|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630957|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44630958|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630959|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44630960|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630961|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630962|NCT00452400|Olodaterol|olodaterol|mesh-list
44630963|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630964|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
44630965|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630966|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630967|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630968|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630969|NCT00452361|Cyclosporine|cyclosporine|mesh-list
44630970|NCT00452361|Sirolimus|sirolimus|mesh-list
44630971|NCT00452361|Tacrolimus|tacrolimus|mesh-list
44630972|NCT00452361|Cyclosporins|cyclosporins|mesh-list
44630973|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44630974|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44630975|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
44630976|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630977|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44630978|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44630979|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
44630980|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44630981|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630982|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44630983|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44630984|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44630985|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44630986|NCT00452348|Fluticasone|fluticasone|mesh-list
44630987|NCT00452348|Xhance|xhance|mesh-list
44630988|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44630989|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44630990|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44630991|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44630992|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
44630993|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44630994|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44630995|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44630996|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
44630997|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44630998|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44630999|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44631000|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44631001|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44182442|NCT00325325|Everolimus|everolimus|mesh-list
44631002|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631003|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631004|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631005|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
44631006|NCT00452348|Hormones|hormones|mesh-ancestor
44631007|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631008|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
44631009|NCT00451958|Leuprolide|leuprolide|mesh-list
44631010|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44631011|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
44631012|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44631013|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631014|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44631015|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631016|NCT00451906|Bevacizumab|bevacizumab|mesh-list
44631017|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631018|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631019|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631020|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631021|NCT00451906|Growth Substances|growth substances|mesh-ancestor
44631022|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631023|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631024|NCT00451555|Fulvestrant|fulvestrant|mesh-list
44631025|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44631026|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631027|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44631028|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44631029|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
44631030|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631031|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631032|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
44631033|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44631034|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
44631035|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631036|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631037|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
44631038|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631039|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44631040|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631041|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
44631042|NCT00451217|Neostigmine|neostigmine|mesh-list
44631043|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44631044|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631045|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631046|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
44631047|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631048|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631049|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44631050|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
44631051|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631052|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44631053|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44631054|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44631055|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
44631056|NCT00451204|Estrogens|estrogens|mesh-list
44631057|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
44631058|NCT00451204|Hormones|hormones|mesh-ancestor
44631059|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631060|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631061|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44631062|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
44631063|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631064|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631065|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
44631066|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44631067|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44631068|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44631069|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631070|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631071|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
44631072|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631073|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631074|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44631075|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631076|NCT00451178|Prednisone|prednisone|mesh-list
44631077|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
44182528|NCT00325767|Albuterol|albuterol|mesh-list
44631078|NCT00451178|Rituximab|rituximab|mesh-list
44631079|NCT00451178|Doxorubicin|doxorubicin|mesh-list
44631080|NCT00451178|Vincristine|vincristine|mesh-list
44631081|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631082|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
44631083|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631084|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631085|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631086|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
44631087|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631088|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631089|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631090|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631091|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631092|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44631093|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44631094|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631095|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631096|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
44631098|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631099|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44631100|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44631101|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631102|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631103|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631104|NCT00451035|Panobinostat|panobinostat|mesh-list
44631105|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631106|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44631107|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631108|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631109|NCT00450866|Epothilones|epothilones|mesh-list
44631110|NCT00450866|Epothilone B|epothilone b|mesh-list
44631111|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631112|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631113|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631114|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631115|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631116|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
44631117|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631118|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
44631119|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631120|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631121|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631122|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
44631123|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631124|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631125|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631126|NCT00450801|Leucovorin|leucovorin|mesh-list
44631127|NCT00450801|Cytarabine|cytarabine|mesh-list
44631128|NCT00450801|Thalidomide|thalidomide|mesh-list
44631129|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
44631130|NCT00450801|Ifosfamide|ifosfamide|mesh-list
44631131|NCT00450801|Rituximab|rituximab|mesh-list
44631132|NCT00450801|Doxorubicin|doxorubicin|mesh-list
44631133|NCT00450801|Methotrexate|methotrexate|mesh-list
44631134|NCT00450801|Etoposide|etoposide|mesh-list
44631135|NCT00450801|Vincristine|vincristine|mesh-list
44631136|NCT00450801|Granisetron|granisetron|mesh-list
44631137|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631138|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
44631139|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631140|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631141|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631142|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
44631143|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631144|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631145|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631146|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631147|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631148|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44631149|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44631150|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631151|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44631152|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
44631153|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44631154|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631155|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
44631156|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631157|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44631158|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44631159|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44631160|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
44631161|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631162|NCT00450801|Antidotes|antidotes|mesh-ancestor
44631163|NCT00450801|Protective Agents|protective agents|mesh-ancestor
44631164|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
44631165|NCT00450801|Vitamins|vitamins|mesh-ancestor
44631166|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
44631167|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631168|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631169|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631170|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
44631171|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
44631172|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631173|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631174|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
44631175|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631176|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631177|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631178|NCT00450801|Growth Substances|growth substances|mesh-ancestor
44631179|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631180|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44631181|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
44631182|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631183|NCT00450749|Lycopene|lycopene|mesh-list
44631184|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631185|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
44631186|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631187|NCT00450749|Protective Agents|protective agents|mesh-ancestor
44631188|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631189|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44631190|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44631191|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631192|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44631193|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44631194|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631195|NCT00450658|Ibuprofen|ibuprofen|mesh-list
44631196|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631197|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631198|NCT00450658|Analgesics|analgesics|mesh-ancestor
44631199|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
44631200|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631201|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631202|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631203|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631204|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44631205|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631206|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631207|NCT00450619|Metronidazole|metronidazole|mesh-list
44631208|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44631209|NCT00450619|Vaccines|vaccines|mesh-list
44631210|NCT00450619|Sargramostim|sargramostim|mesh-list
44631211|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
44631212|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631213|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631214|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631215|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44631216|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44631217|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631218|NCT00450619|Analgesics|analgesics|mesh-ancestor
44631219|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
44631220|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631221|NCT00450580|Ritonavir|ritonavir|mesh-list
44631222|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
44631223|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44631224|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44631225|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
44631226|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631227|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631228|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44182661|NCT00326235|Buspirone|buspirone|mesh-list
44631229|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44631230|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
44631231|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631232|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44631233|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44631234|NCT00450450|Lenograstim|lenograstim|mesh-list
44631235|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44631236|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
44631237|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631238|NCT00450385|Prednisone|prednisone|mesh-list
44631239|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
44631240|NCT00450385|Rituximab|rituximab|mesh-list
44631241|NCT00450385|Doxorubicin|doxorubicin|mesh-list
44631242|NCT00450385|Vincristine|vincristine|mesh-list
44631243|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631244|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
44631245|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631246|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631247|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631248|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
44631249|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631251|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631252|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631253|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631254|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44631255|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44631256|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631257|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631258|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
44631259|NCT00450385|Hormones|hormones|mesh-ancestor
44631260|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631261|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44631262|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44631263|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631264|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631265|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631266|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
44631267|NCT00450333|Hematinics|hematinics|mesh-ancestor
44631268|NCT00450255|Aflibercept|aflibercept|mesh-list
44631269|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
44631270|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631271|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631272|NCT00450255|Growth Substances|growth substances|mesh-ancestor
44631273|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631274|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631275|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631276|NCT00450216|Ibuprofen|ibuprofen|mesh-list
44631277|NCT00450216|Famotidine|famotidine|mesh-list
44631278|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631279|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631280|NCT00450216|Analgesics|analgesics|mesh-ancestor
44631281|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
44631282|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631283|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631284|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631285|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631286|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44631287|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631288|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631289|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44631290|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631291|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44631292|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
44631293|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
44631294|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631295|NCT00449956|Timolol|timolol|mesh-list
44631296|NCT00449956|Dorzolamide|dorzolamide|mesh-list
44631297|NCT00449956|Maleic acid|maleic acid|mesh-list
44631298|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44631299|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44631300|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631301|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631302|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631303|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631304|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44182733|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44631305|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44631306|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631307|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44631308|NCT00449930|Metformin|metformin|mesh-list
44631309|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44631310|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44631311|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631312|NCT00449930|Incretins|incretins|mesh-ancestor
44631313|NCT00449930|Hormones|hormones|mesh-ancestor
44631314|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631315|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44631316|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44631317|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631318|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631319|NCT00449787|Naproxen|naproxen|mesh-list
44631320|NCT00449787|Sumatriptan|sumatriptan|mesh-list
44631321|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631322|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631323|NCT00449787|Analgesics|analgesics|mesh-ancestor
44631324|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
44631325|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631326|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631327|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631328|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631329|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
44631330|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44631331|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631332|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631333|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44631334|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44631335|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44631336|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
44631337|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631338|NCT00449761|Panobinostat|panobinostat|mesh-list
44631339|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631340|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44631341|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631342|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631344|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
44631345|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631346|NCT00449644|Bedaquiline|bedaquiline|mesh-list
44631347|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
44631348|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631349|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631350|NCT00449176|Oxycodone|oxycodone|mesh-list
44631351|NCT00449176|Tapentadol|tapentadol|mesh-list
44631352|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44631353|NCT00449176|Narcotics|narcotics|mesh-ancestor
44631354|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44631355|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631356|NCT00449176|Analgesics|analgesics|mesh-ancestor
44631357|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
44631358|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631359|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44631360|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44631361|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631362|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631363|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631364|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631365|NCT00449163|Leucovorin|leucovorin|mesh-list
44631366|NCT00449163|Bevacizumab|bevacizumab|mesh-list
44631367|NCT00449163|Irinotecan|irinotecan|mesh-list
44631368|NCT00449163|Floxuridine|floxuridine|mesh-list
44631369|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
44631370|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631371|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631372|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631373|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631374|NCT00449163|Growth Substances|growth substances|mesh-ancestor
44631375|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631376|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631377|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44631378|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44631379|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182736|NCT00326456|Paclitaxel|paclitaxel|mesh-list
44631380|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631381|NCT00449163|Antidotes|antidotes|mesh-ancestor
44631382|NCT00449163|Protective Agents|protective agents|mesh-ancestor
44631383|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
44631384|NCT00449163|Vitamins|vitamins|mesh-ancestor
44631385|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
44631386|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631387|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
44631388|NCT00449150|Cetrorelix|cetrorelix|mesh-list
44631389|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44631390|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
44631391|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44631392|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631393|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
44631394|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631395|NCT00449072|Loratadine|loratadine|mesh-list
44631396|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
44631397|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631398|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44631399|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44631400|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44631401|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
44631402|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
44631403|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631404|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631405|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631406|NCT00449033|Gemcitabine|gemcitabine|mesh-list
44631408|NCT00449033|Sorafenib|sorafenib|mesh-list
44631409|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631410|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631411|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
44631412|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631413|NCT00449033|Antiviral Agents|antiviral agents|mesh-ancestor
44631414|NCT00449033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631415|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631416|NCT00449033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631417|NCT00449033|Immunologic Factors|immunologic factors|mesh-ancestor
44631418|NCT00449033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631419|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631420|NCT00448916|Pregabalin|pregabalin|mesh-list
44631421|NCT00448916|Analgesics|analgesics|mesh-ancestor
44631422|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
44631423|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631424|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631425|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
44631426|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44631427|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631428|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631429|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44631430|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44631431|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44631432|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44631433|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44631434|NCT00448864|Ecallantide|ecallantide|mesh-list
44631435|NCT00448864|Analgesics|analgesics|mesh-ancestor
44631436|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
44631437|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631438|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631439|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631440|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631441|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631442|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631443|NCT00448760|Leucovorin|leucovorin|mesh-list
44631444|NCT00448760|Docetaxel|docetaxel|mesh-list
44631445|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
44631446|NCT00448760|Floxuridine|floxuridine|mesh-list
44631447|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631448|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631449|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631450|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631451|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631452|NCT00448760|Antidotes|antidotes|mesh-ancestor
44631453|NCT00448760|Protective Agents|protective agents|mesh-ancestor
44631454|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631455|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
44631456|NCT00448760|Vitamins|vitamins|mesh-ancestor
44631457|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
44631458|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631459|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
44631460|NCT00448708|Paclitaxel|paclitaxel|mesh-list
44631461|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44631462|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44631463|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631464|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631465|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631466|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631467|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631468|NCT00448669|Tenofovir|tenofovir|mesh-list
44631469|NCT00448669|Emtricitabine|emtricitabine|mesh-list
44631470|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
44631471|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631472|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44631473|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44631475|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631476|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44631477|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44631478|NCT00448591|Bevacizumab|bevacizumab|mesh-list
44631479|NCT00448591|Taxane|taxane|mesh-list
44631480|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631481|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631482|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631483|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631484|NCT00448591|Growth Substances|growth substances|mesh-ancestor
44631485|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631486|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631487|NCT00448539|Rufinamide|rufinamide|mesh-list
44631488|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
44631489|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44631490|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44631491|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631492|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631493|NCT00448435|Fluticasone|fluticasone|mesh-list
44631494|NCT00448435|Xhance|xhance|mesh-list
44631495|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44631496|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44631497|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631498|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44631499|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
44631500|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631501|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631502|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44631503|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44631504|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631505|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44631506|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44631507|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44631508|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44631509|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631510|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631511|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631512|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
44631513|NCT00448435|Hormones|hormones|mesh-ancestor
44631514|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631515|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
44182887|NCT00327327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631516|NCT00448279|Trastuzumab|trastuzumab|mesh-list
44631517|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631518|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631519|NCT00448136|Bevacizumab|bevacizumab|mesh-list
44631520|NCT00448136|Streptozocin|streptozocin|mesh-list
44631521|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631522|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631523|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631524|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631525|NCT00448136|Growth Substances|growth substances|mesh-ancestor
44631526|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631527|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631528|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631529|NCT00448123|Tamsulosin|tamsulosin|mesh-list
44631530|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44631531|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44631532|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44631533|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631534|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631535|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631536|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631537|NCT00448123|Urological Agents|urological agents|mesh-ancestor
44631538|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
44631539|NCT00448019|Bevacizumab|bevacizumab|mesh-list
44631540|NCT00448019|Rituximab|rituximab|mesh-list
44631541|NCT00448019|Fludarabine|fludarabine|mesh-list
44631542|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
44631543|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631544|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
44631545|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631546|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631547|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631548|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
44631549|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631550|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631551|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631552|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631553|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631554|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631555|NCT00448019|Growth Substances|growth substances|mesh-ancestor
44631556|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631557|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631558|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
44631560|NCT00447902|Tipranavir|tipranavir|mesh-list
44631561|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44631562|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44631563|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
44631564|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631565|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631566|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44631567|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44631568|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
44631569|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631570|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44631571|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44631572|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
44631573|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44631574|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44631575|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44631576|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631577|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631578|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
44631579|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631580|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631581|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44631582|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631583|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
44631584|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44631585|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44631586|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44631587|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631588|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631589|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
44631590|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631591|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631592|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44631593|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631594|NCT00447694|Deferasirox|deferasirox|mesh-list
44631595|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44631596|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
44631597|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
44631598|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631599|NCT00447603|Losartan|losartan|mesh-list
44631600|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44631601|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44631602|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44631603|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44631604|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44631605|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631606|NCT00447603|Diuretics|diuretics|mesh-ancestor
44631607|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
44631608|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631609|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44631610|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631611|NCT00447499|Lanreotide|lanreotide|mesh-list
44631612|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631613|NCT00447421|Cisplatin|cisplatin|mesh-list
44631614|NCT00447421|Pemetrexed|pemetrexed|mesh-list
44631615|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631616|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631617|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027227|NCT00000290|Cocaine|cocaine|mesh-list
44631618|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44631619|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44631620|NCT00447382|Insulin|insulin|mesh-list
44631621|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44631622|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
44631623|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
44631624|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44631625|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631626|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44631627|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44631628|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44631629|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631630|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631631|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44631632|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631633|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631634|NCT00447265|Etanercept|etanercept|mesh-list
44631635|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631636|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631637|NCT00447265|Analgesics|analgesics|mesh-ancestor
44631638|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
44631639|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631640|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631641|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631642|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631643|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631644|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631645|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
44631646|NCT00447226|Lapatinib|lapatinib|mesh-list
44631647|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631648|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631649|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631650|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631651|NCT00447057|Pemetrexed|pemetrexed|mesh-list
44631652|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44631653|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631654|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631655|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631656|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44631657|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44631658|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631659|NCT00447005|Axitinib|axitinib|mesh-list
44631660|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631661|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631662|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631663|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631664|NCT00446992|Olanzapine|olanzapine|mesh-list
44631665|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
44631666|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
44631667|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631668|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631669|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631670|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44631671|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44631672|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44631673|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44631674|NCT00446992|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44631675|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44631676|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631677|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631678|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631679|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
44631680|NCT00446849|Mesalamine|mesalamine|mesh-list
44631681|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631682|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631683|NCT00446849|Analgesics|analgesics|mesh-ancestor
44631684|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
44631685|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631686|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631687|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631688|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631689|NCT00446797|Celecoxib|celecoxib|mesh-list
44631690|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631691|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631693|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
44631694|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631695|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631696|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631697|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631698|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44631699|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44631700|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631701|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631702|NCT00446641|Cilostazol|cilostazol|mesh-list
44631703|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44631704|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
44631705|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631706|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631707|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44631708|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
44631709|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43899593|NCT03102723|Cangrelor|cangrelor|mesh-list
44631710|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44631711|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631712|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44631713|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
44631714|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44631715|NCT00446641|Protective Agents|protective agents|mesh-ancestor
44631716|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44631717|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44631718|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631719|NCT00446563|Losartan|losartan|mesh-list
44631720|NCT00446563|Amlodipine|amlodipine|mesh-list
44631721|NCT00446563|Valsartan|valsartan|mesh-list
44631722|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44631723|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44631724|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44631725|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631726|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631727|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44631728|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631729|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
44631730|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44631731|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44631732|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44631733|NCT00446563|Diuretics|diuretics|mesh-ancestor
44631734|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
44631735|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44631736|NCT00446511|Valsartan|valsartan|mesh-list
44631737|NCT00446511|Enalapril|enalapril|mesh-list
44631738|NCT00446511|Enalaprilat|enalaprilat|mesh-list
44631739|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44631740|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44631741|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44631742|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631743|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44631744|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
44631745|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631746|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
44631747|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631748|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631749|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44631750|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
44631751|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631752|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631753|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631754|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631755|NCT00446446|Panitumumab|panitumumab|mesh-list
44631756|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631757|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631758|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
44631759|NCT00446251|Rituximab|rituximab|mesh-list
44631760|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631761|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631762|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
44631763|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631764|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631765|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631766|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44631767|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
44631768|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631769|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631770|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631771|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631773|NCT00446199|Estradiol|estradiol|mesh-list
44631774|NCT00446199|Estrogens|estrogens|mesh-ancestor
44631775|NCT00446199|Hormones|hormones|mesh-ancestor
44631776|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631777|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631778|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44631779|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
44631780|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44631781|NCT00446199|Diuretics|diuretics|mesh-ancestor
44631782|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
44631783|NCT00446134|Ribavirin|ribavirin|mesh-list
44631784|NCT00446134|Taribavirin|taribavirin|mesh-list
44631785|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
44631786|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631787|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
44631788|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631789|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
44631790|NCT00446030|Bevacizumab|bevacizumab|mesh-list
44631791|NCT00446030|Carboplatin|carboplatin|mesh-list
44631792|NCT00446030|Docetaxel|docetaxel|mesh-list
44631793|NCT00446030|Doxorubicin|doxorubicin|mesh-list
44631794|NCT00446030|Trastuzumab|trastuzumab|mesh-list
44631795|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631796|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
44631797|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631798|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631799|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44631800|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
44631801|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631802|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631803|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44631804|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631805|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631806|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631807|NCT00446030|Growth Substances|growth substances|mesh-ancestor
44631808|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631809|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631810|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631811|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631812|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44631813|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44631814|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44631815|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631816|NCT00445978|Verapamil|verapamil|mesh-list
44631817|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44631818|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44631819|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631820|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631821|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44631822|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631823|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44631824|NCT00445939|Adalimumab|adalimumab|mesh-list
44631825|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631826|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631827|NCT00445848|Bevacizumab|bevacizumab|mesh-list
44631828|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44631829|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631830|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631831|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631832|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631833|NCT00445848|Growth Substances|growth substances|mesh-ancestor
44631834|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631835|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631836|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631837|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631838|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631839|NCT00445770|Etanercept|etanercept|mesh-list
44631840|NCT00445770|Methotrexate|methotrexate|mesh-list
44631841|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44631842|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
44631843|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44631844|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631845|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631846|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
44631847|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631848|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631849|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631850|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631851|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44631852|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631853|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
44631854|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631855|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44631856|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44631857|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44631858|NCT00445770|Analgesics|analgesics|mesh-ancestor
44631859|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
44631860|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631861|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631862|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631863|NCT00445692|Clarithromycin|clarithromycin|mesh-list
44631864|NCT00445692|Dexamethasone|dexamethasone|mesh-list
44631865|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
44631866|NCT00445692|Lenalidomide|lenalidomide|mesh-list
44631867|NCT00445692|Ichthammol|ichthammol|mesh-list
44631868|NCT00445692|BB 1101|bb 1101|mesh-list
44631869|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631870|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
44631871|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
44631872|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44631873|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631874|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44631875|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
44631876|NCT00445692|Hormones|hormones|mesh-ancestor
44631877|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631878|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44631879|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631880|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
44631881|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631882|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631883|NCT00445692|Growth Substances|growth substances|mesh-ancestor
44631884|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631885|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44631886|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631887|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44631888|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631889|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631890|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44631891|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44631892|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44631893|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44631894|NCT00445679|Paroxetine|paroxetine|mesh-list
44631895|NCT00445679|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44631896|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44631897|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44631898|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631899|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631900|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
44631901|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631902|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44631903|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
44631904|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44631905|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44631906|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44631907|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631908|NCT00445601|Gemcitabine|gemcitabine|mesh-list
44631909|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44631910|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
44631911|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631912|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631913|NCT00445601|Antiviral Agents|antiviral agents|mesh-ancestor
44631914|NCT00445601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631915|NCT00445601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631916|NCT00445601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631917|NCT00445601|Immunologic Factors|immunologic factors|mesh-ancestor
44631918|NCT00445601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631920|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44631921|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631922|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
44631923|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
44631924|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
44631925|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631926|NCT00445432|Adalimumab|adalimumab|mesh-list
44631927|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631928|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631929|NCT00445341|Alvocidib|alvocidib|mesh-list
44631930|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631931|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631932|NCT00445341|Growth Substances|growth substances|mesh-ancestor
44631933|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631934|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44631935|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631936|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631937|NCT00445328|Heparin|heparin|mesh-list
44631938|NCT00445328|Calcium heparin|calcium heparin|mesh-list
44631939|NCT00445328|Dalteparin|dalteparin|mesh-list
44631940|NCT00445328|Tinzaparin|tinzaparin|mesh-list
44631941|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44631942|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
44631943|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44631944|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44631945|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631946|NCT00445146|Elvitegravir|elvitegravir|mesh-list
44631947|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44631948|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44631949|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
44631950|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44631951|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44631952|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899748|NCT01960530|Hormones|hormones|mesh-ancestor
44631953|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631954|NCT00445068|Panobinostat|panobinostat|mesh-list
44631955|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631956|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44631957|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631958|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631959|NCT00445003|Triamcinolone|triamcinolone|mesh-list
44631960|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44631961|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44631962|NCT00445003|Ranibizumab|ranibizumab|mesh-list
44631963|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44631964|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44631965|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44631966|NCT00445003|Growth Substances|growth substances|mesh-ancestor
44631967|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631968|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
44631969|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631970|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44631971|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
44631972|NCT00445003|Hormones|hormones|mesh-ancestor
44631973|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44631974|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44631975|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
44631976|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44631977|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631978|NCT00444951|Vaccines|vaccines|mesh-list
44631979|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
44631980|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631981|NCT00444925|Fesoterodine|fesoterodine|mesh-list
44631982|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44631983|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44631984|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44631985|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
44631986|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44631987|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44631988|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631989|NCT00444925|Urological Agents|urological agents|mesh-ancestor
44631990|NCT00444912|Plerixafor|plerixafor|mesh-list
44631991|NCT00444912|Rituximab|rituximab|mesh-list
44631992|NCT00444912|Lenograstim|lenograstim|mesh-list
44631993|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44631994|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44631995|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
44631996|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44631997|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44631998|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44631999|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632000|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632001|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
44632002|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632003|NCT00444795|Sunitinib|sunitinib|mesh-list
44632004|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632005|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632006|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632007|NCT00444795|Growth Substances|growth substances|mesh-ancestor
44632008|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632009|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632010|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632011|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632012|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632013|NCT00444678|Capecitabine|capecitabine|mesh-list
44632014|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
44632015|NCT00444678|Cetuximab|cetuximab|mesh-list
44632016|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632017|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
44632018|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632019|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632020|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632021|NCT00444626|Lidocaine|lidocaine|mesh-list
44632022|NCT00444626|Prilocaine|prilocaine|mesh-list
44632023|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44632024|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
44632025|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
44632026|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
44632027|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632028|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632029|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
44632030|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632031|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44632032|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44632033|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44632034|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632035|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632036|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44632037|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
44632039|NCT00444626|Protective Agents|protective agents|mesh-ancestor
44632040|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44632041|NCT00444600|Triamcinolone|triamcinolone|mesh-list
44632042|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44632043|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44632044|NCT00444600|Ranibizumab|ranibizumab|mesh-list
44632045|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44632046|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632047|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632048|NCT00444600|Growth Substances|growth substances|mesh-ancestor
44632049|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632050|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632051|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632052|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632053|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
44632054|NCT00444600|Hormones|hormones|mesh-ancestor
44632055|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632056|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632057|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
44632058|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632059|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632061|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632062|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632063|NCT00444535|Bevacizumab|bevacizumab|mesh-list
44632064|NCT00444535|Lapatinib|lapatinib|mesh-list
44632065|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632066|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632067|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632068|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632069|NCT00444535|Growth Substances|growth substances|mesh-ancestor
44632070|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899881|NCT00015847|Interferons|interferons|mesh-list
44632071|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632072|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632073|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632074|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632075|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44632076|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
44632077|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632078|NCT00444275|Esomeprazole|esomeprazole|mesh-list
44632079|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44632080|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632081|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44632082|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632083|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632084|NCT00444145|Lansoprazole|lansoprazole|mesh-list
44632085|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44632086|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632087|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44632088|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632089|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632090|NCT00444106|Artesunate|artesunate|mesh-list
44632091|NCT00444106|Lumefantrine|lumefantrine|mesh-list
44632092|NCT00444106|Artemether|artemether|mesh-list
44632093|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44632094|NCT00444106|Mefloquine|mefloquine|mesh-list
44632095|NCT00444106|Atovaquone|atovaquone|mesh-list
44632096|NCT00444106|Proguanil|proguanil|mesh-list
44632097|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44632098|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
44632099|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44632100|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44632101|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632102|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632103|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
44632104|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
44632105|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44632106|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
44632107|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632108|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632109|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
44632110|NCT00443898|Terbinafine|terbinafine|mesh-list
44632111|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
44632112|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632113|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632114|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632115|NCT00443872|Selegiline|selegiline|mesh-list
44632116|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
44632117|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632118|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44632119|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44632120|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44632121|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632122|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632123|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44632124|NCT00443872|Protective Agents|protective agents|mesh-ancestor
44632125|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632126|NCT00443820|Terbinafine|terbinafine|mesh-list
44632127|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
44632128|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632129|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632130|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899936|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
44632132|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632133|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632134|NCT00443755|Metformin|metformin|mesh-list
44632135|NCT00443755|Pioglitazone|pioglitazone|mesh-list
44632136|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44632137|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632138|NCT00443729|Ritonavir|ritonavir|mesh-list
44632139|NCT00443729|Lopinavir|lopinavir|mesh-list
44632140|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
44632141|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44632142|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44632143|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632144|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632145|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632146|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632147|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632148|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
44632149|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632150|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44632151|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632152|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44632153|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44632154|NCT00443703|Ritonavir|ritonavir|mesh-list
44632155|NCT00443703|Lopinavir|lopinavir|mesh-list
44632156|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
44632157|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44632158|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44632159|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632160|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632161|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632162|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632163|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632164|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
44632165|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632166|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44632167|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632168|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44632169|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44632170|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44632171|NCT00443651|Rituximab|rituximab|mesh-list
44632172|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632173|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632174|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
44632175|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632176|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632177|NCT00443599|Insulin|insulin|mesh-list
44632178|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44632179|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44632180|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632181|NCT00443560|Fentanyl|fentanyl|mesh-list
44632182|NCT00443560|Bupivacaine|bupivacaine|mesh-list
44632183|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
44632184|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
44632185|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632186|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632187|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
44632188|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632190|NCT00443560|Narcotics|narcotics|mesh-ancestor
44632191|NCT00443560|Analgesics|analgesics|mesh-ancestor
44632192|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44632193|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44632194|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
44632195|NCT00443534|Sunitinib|sunitinib|mesh-list
44632196|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632197|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632198|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632199|NCT00443534|Growth Substances|growth substances|mesh-ancestor
44632200|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632201|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632202|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632203|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632204|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632205|NCT00443456|Amlodipine|amlodipine|mesh-list
44632206|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44632207|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44027756|NCT00000353|Naloxone|naloxone|mesh-list
44632208|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632209|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632210|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44632211|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632212|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
44632214|NCT00443430|Prednisolone|prednisolone|mesh-list
44632215|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44632216|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
44632217|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44632218|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
44632219|NCT00443430|Etanercept|etanercept|mesh-list
44632220|NCT00443430|Methotrexate|methotrexate|mesh-list
44632221|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44632222|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
44632223|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632224|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
44632225|NCT00443430|Hormones|hormones|mesh-ancestor
44632226|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632227|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632228|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632229|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632230|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44632231|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
44632232|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44632233|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632234|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
44632235|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632236|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632237|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632238|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44632239|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632240|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
44632241|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632242|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632243|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
44632244|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
44632245|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632246|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632247|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44632248|NCT00443430|Protective Agents|protective agents|mesh-ancestor
44632249|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44632250|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44632251|NCT00443430|Analgesics|analgesics|mesh-ancestor
44632252|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
44632253|NCT00443261|Cisplatin|cisplatin|mesh-list
44632254|NCT00443261|Azacitidine|azacitidine|mesh-list
44632255|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632256|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632257|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
44632258|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632259|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632260|NCT00443209|Rizatriptan|rizatriptan|mesh-list
44632261|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44632262|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
44632263|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632264|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632265|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632266|NCT00443053|PENTA|penta|mesh-list
44632267|NCT00443053|Fondaparinux|fondaparinux|mesh-list
44632268|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44632269|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
44632270|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44632271|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632272|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632273|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632274|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
44632275|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44632276|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44632277|NCT00442962|Tenofovir|tenofovir|mesh-list
44632278|NCT00442962|Emtricitabine|emtricitabine|mesh-list
44632279|NCT00442962|Efavirenz|efavirenz|mesh-list
44632280|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44632281|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
44632282|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632283|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44632284|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632285|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632286|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632287|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632288|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632289|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44632290|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632291|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44632292|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44632293|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44632294|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44632295|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
44632296|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
44632297|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44632298|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44632299|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
44632300|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632301|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632302|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632303|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632304|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44632305|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632306|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
44632307|NCT00442702|Hematinics|hematinics|mesh-ancestor
44632308|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44632309|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
44632310|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632311|NCT00442559|Montelukast|montelukast|mesh-list
44632312|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44632313|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
44632314|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44632315|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
44632316|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632317|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632318|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44632319|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44632320|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632322|NCT00442546|Analgesics|analgesics|mesh-ancestor
44632323|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
44632324|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632325|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632326|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
44632327|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44632328|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632329|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632330|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44632331|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44632332|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44632333|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632334|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632335|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
44632336|NCT00442416|Hematinics|hematinics|mesh-ancestor
44632337|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
44632338|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632339|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632340|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44632341|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
44632342|NCT00442117|Budesonide|budesonide|mesh-list
44632343|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632344|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44632345|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
44632346|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632347|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632348|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44632349|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44632350|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
44632351|NCT00442117|Hormones|hormones|mesh-ancestor
44632352|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632353|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632354|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44632355|NCT00441974|Adefovir|adefovir|mesh-list
44632356|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44632357|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
44632358|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632359|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44632360|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632361|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632362|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632364|NCT00441792|Etomidate|etomidate|mesh-list
44632365|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44632366|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44632367|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632368|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632369|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44632370|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44632371|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632372|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44632373|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
44632374|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
44632375|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
44632376|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
44632377|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632378|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632379|NCT00441727|Esomeprazole|esomeprazole|mesh-list
44632380|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44632381|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632382|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44632383|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632384|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632386|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44632387|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
44632388|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
44632389|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632390|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
44632391|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632392|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
44632393|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632394|NCT00441545|Sevelamer|sevelamer|mesh-list
44632395|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
44632396|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
44632397|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632398|NCT00441441|Fluticasone|fluticasone|mesh-list
44632399|NCT00441441|Xhance|xhance|mesh-list
44632400|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44632401|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632402|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44632403|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
44632404|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632405|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632406|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44632407|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
44632408|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632409|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44632410|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44632411|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44632412|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44632413|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
44632414|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632415|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632416|NCT00441363|Bromocriptine|bromocriptine|mesh-list
44632417|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44632418|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44632419|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
44632420|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632421|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632422|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
44632423|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
44632424|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632425|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632426|NCT00441337|Nivolumab|nivolumab|mesh-list
43900230|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632427|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632428|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632429|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44632430|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632431|NCT00441272|Pioglitazone|pioglitazone|mesh-list
44632432|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44632433|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632434|NCT00441168|Dexamethasone|dexamethasone|mesh-list
44632435|NCT00441168|Vincristine|vincristine|mesh-list
44632436|NCT00441168|Doxorubicin|doxorubicin|mesh-list
44632437|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44632438|NCT00441168|Bortezomib|bortezomib|mesh-list
44632439|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632440|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
44632441|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
44632442|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632443|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632444|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632445|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
44632446|NCT00441168|Hormones|hormones|mesh-ancestor
44632447|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632448|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632449|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632450|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44632451|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632452|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632453|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632454|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632455|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44632456|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44632457|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632458|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183772|NCT01691833|Vitamin D|vitamin d|mesh-list
44632459|NCT00441142|Temozolomide|temozolomide|mesh-list
44632460|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44632461|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
44632462|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632463|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632464|NCT00441129|Insulin|insulin|mesh-list
44632465|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44632466|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632467|NCT00441116|Dutasteride|dutasteride|mesh-list
44632468|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44632469|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44632470|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632471|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632472|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
44632473|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632474|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632475|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
44632476|NCT00441103|Interferon-beta|interferon-beta|mesh-list
44632477|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44632478|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
44632479|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632480|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632481|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
44632482|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632483|NCT00440999|Artesunate|artesunate|mesh-list
44632484|NCT00440999|Chloroquine|chloroquine|mesh-list
44632485|NCT00440999|Pyronaridine|pyronaridine|mesh-list
44632486|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
44632487|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44632488|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44632489|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632490|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632491|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
44632492|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
44632493|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44632494|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
44632495|NCT00440999|Amebicides|amebicides|mesh-ancestor
44632496|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632497|NCT00440947|Ritonavir|ritonavir|mesh-list
44632498|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44632499|NCT00440947|Lamivudine|lamivudine|mesh-list
44632500|NCT00440947|Abacavir|abacavir|mesh-list
44632501|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
44632502|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44632503|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44632504|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632505|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632506|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632507|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632508|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632509|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
44632510|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632511|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44632512|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632513|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44632514|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632515|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
44632516|NCT00440726|Cytarabine|cytarabine|mesh-list
44632517|NCT00440726|Dexamethasone|dexamethasone|mesh-list
44632518|NCT00440726|Doxorubicin|doxorubicin|mesh-list
44632519|NCT00440726|Methotrexate|methotrexate|mesh-list
44632520|NCT00440726|Vincristine|vincristine|mesh-list
44632521|NCT00440726|Bortezomib|bortezomib|mesh-list
44632522|NCT00440726|Asparaginase|asparaginase|mesh-list
44632523|NCT00440726|Pegaspargase|pegaspargase|mesh-list
44632524|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632525|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
44632526|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
44632527|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632528|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632529|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632530|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
44632531|NCT00440726|Hormones|hormones|mesh-ancestor
44632532|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632533|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632534|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632535|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44632536|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44632537|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632538|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632539|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632540|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44632541|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
44632542|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44632543|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632544|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
44632545|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632546|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44632547|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632548|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
44632549|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632550|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632551|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
44632552|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632553|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44632554|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632555|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632556|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632557|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
44632558|NCT00440557|Hematinics|hematinics|mesh-ancestor
44632559|NCT00440518|Lacosamide|lacosamide|mesh-list
44632560|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
44632561|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44632562|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44632563|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632564|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632565|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
44632566|NCT00440466|Hematinics|hematinics|mesh-ancestor
44632567|NCT00440401|Thrombin|thrombin|mesh-list
44632568|NCT00440401|Hemostatics|hemostatics|mesh-list
44632569|NCT00440401|Coagulants|coagulants|mesh-ancestor
44632570|NCT00440310|Talaporfin|talaporfin|mesh-list
44632571|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632572|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44632573|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632574|NCT00440271|Ritonavir|ritonavir|mesh-list
44632575|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
44632576|NCT00440271|Maraviroc|maraviroc|mesh-list
44632577|NCT00440271|Tipranavir|tipranavir|mesh-list
44632578|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
44632579|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44632580|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44632581|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44632582|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632583|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632584|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632585|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44632586|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44632587|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
44632588|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632589|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44632590|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632591|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44632592|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44632593|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44632594|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44632595|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44632596|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632597|NCT00440232|Frovatriptan|frovatriptan|mesh-list
44632598|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44632599|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
44632600|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632601|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632602|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632603|NCT00440193|Enoxaparin|enoxaparin|mesh-list
44632604|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
44632605|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44632606|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
44632607|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44632608|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632609|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632610|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632611|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
44632612|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44632613|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44632614|NCT00440115|Bupropion|bupropion|mesh-list
44632615|NCT00440115|Nicotine|nicotine|mesh-list
44632616|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44632617|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
44632618|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632619|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632620|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44632621|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44632622|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
44632623|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632624|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632625|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44632626|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
44632627|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632628|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44632629|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44632630|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632631|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
44632632|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44632633|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44632634|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632635|NCT00440011|Bimatoprost|bimatoprost|mesh-list
44632636|NCT00440011|Travoprost|travoprost|mesh-list
44632637|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44632638|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44632639|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44632640|NCT00439777|Enoxaparin|enoxaparin|mesh-list
44632641|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
44632642|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44632643|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
44632644|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44632645|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632646|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632647|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632648|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
44632649|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44632650|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44632651|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
44632652|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44632653|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
44632654|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44632655|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
44632656|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632657|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632658|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
44632659|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
44632660|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44632661|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632662|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44632663|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632664|NCT00439556|Cytarabine|cytarabine|mesh-list
44632665|NCT00439556|Rituximab|rituximab|mesh-list
44632666|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44632667|NCT00439556|Methotrexate|methotrexate|mesh-list
44632668|NCT00439556|Etoposide|etoposide|mesh-list
44632669|NCT00439556|Bortezomib|bortezomib|mesh-list
44632670|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
44632671|NCT00439556|Melphalan|melphalan|mesh-list
44632672|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
44632673|NCT00439556|Carmustine|carmustine|mesh-list
44632674|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
44632675|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44632676|NCT00439556|Antibodies|antibodies|mesh-list
44632677|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
44632678|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44632679|NCT00439556|Tacrolimus|tacrolimus|mesh-list
44632680|NCT00439556|Lenograstim|lenograstim|mesh-list
44632681|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
44632682|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44632683|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
44632684|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632685|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632686|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632687|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44632688|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
44632689|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44632690|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632691|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
44632692|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632693|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632694|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632695|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44632696|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632697|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44632698|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44632699|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44632700|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632701|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
44632702|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632703|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44632704|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44632705|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44632706|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
44632707|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44632708|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
44632709|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632710|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632711|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632712|NCT00439517|Cetuximab|cetuximab|mesh-list
44632713|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632714|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632715|NCT00439309|Thrombin|thrombin|mesh-list
44632716|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44632717|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
44632718|NCT00439309|Coagulants|coagulants|mesh-ancestor
44632719|NCT00439270|Docetaxel|docetaxel|mesh-list
44632720|NCT00439270|Dasatinib|dasatinib|mesh-list
44632721|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632722|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632723|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632724|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632725|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632726|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632727|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632728|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
44632729|NCT00439244|Teriparatide|teriparatide|mesh-list
44632730|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44632731|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632732|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44632733|NCT00439231|Lenalidomide|lenalidomide|mesh-list
44632734|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
44632735|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632736|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632737|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632738|NCT00439231|Growth Substances|growth substances|mesh-ancestor
44632739|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632740|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632741|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44632742|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632744|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44632745|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44632746|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44632747|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632748|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632749|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
44632750|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632751|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632752|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44632753|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632754|NCT00438815|Complement C1s|complement c1s|mesh-list
44632755|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44632756|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44632757|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
44632758|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632759|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44632760|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632761|NCT00438672|Dexamethasone|dexamethasone|mesh-list
44632762|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632763|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
44632764|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
44632765|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632766|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632767|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44632768|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
44632769|NCT00438672|Hormones|hormones|mesh-ancestor
44632770|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632771|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632772|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632773|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
44632774|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632775|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632776|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44632777|NCT00438464|Finasteride|finasteride|mesh-list
44632778|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44632779|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44632780|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632781|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632782|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
44632783|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632784|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632785|NCT00438464|Urological Agents|urological agents|mesh-ancestor
44632786|NCT00438360|Cyclosporine|cyclosporine|mesh-list
44632787|NCT00438360|Cyclosporins|cyclosporins|mesh-list
44632788|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632789|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632790|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632791|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
44632792|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632793|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
44632794|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632795|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632796|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632797|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44632798|NCT00438256|Capecitabine|capecitabine|mesh-list
44632799|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632800|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
44632801|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632802|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632803|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44632804|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
44632805|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44632806|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44632807|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44632808|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
44632809|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44632810|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632811|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44632812|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44632813|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44632814|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632815|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632816|NCT00437645|Amlodipine|amlodipine|mesh-list
44632817|NCT00437645|Valsartan|valsartan|mesh-list
44632818|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44632819|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44632820|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632821|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632822|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44632823|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632824|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
44632825|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44632826|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44632827|NCT00437489|Insulin|insulin|mesh-list
44632828|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44632829|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44632830|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632831|NCT00437294|Capecitabine|capecitabine|mesh-list
44632832|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632833|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
44632834|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632835|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632836|NCT00437281|Pregabalin|pregabalin|mesh-list
44632837|NCT00437281|Analgesics|analgesics|mesh-ancestor
44632838|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
44632839|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632840|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632841|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
44632842|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44632843|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632844|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632845|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44632846|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44632847|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44632848|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44632849|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632850|NCT00437268|Irinotecan|irinotecan|mesh-list
44632851|NCT00437268|Cetuximab|cetuximab|mesh-list
44632852|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44632853|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632854|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632855|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632856|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632857|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632858|NCT00437203|Gemcitabine|gemcitabine|mesh-list
44632859|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632860|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
44632861|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632862|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632863|NCT00437203|Antiviral Agents|antiviral agents|mesh-ancestor
44632864|NCT00437203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632865|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632866|NCT00437203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632867|NCT00437203|Immunologic Factors|immunologic factors|mesh-ancestor
44632868|NCT00437203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632869|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44632870|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44632871|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44632872|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44632873|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632874|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44632875|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632876|NCT00437125|Analgesics|analgesics|mesh-ancestor
44632877|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
44632878|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632879|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
44632880|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44632881|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
44632882|NCT00437073|Capecitabine|capecitabine|mesh-list
44632883|NCT00437073|Topotecan|topotecan|mesh-list
44632884|NCT00437073|Lapatinib|lapatinib|mesh-list
44632885|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44632886|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
44632887|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632888|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632889|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44632890|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632891|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632892|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632893|NCT00437034|Aflibercept|aflibercept|mesh-list
43900690|NCT00053703|Olanzapine|olanzapine|mesh-list
44632894|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
44632895|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632896|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632897|NCT00437034|Growth Substances|growth substances|mesh-ancestor
44632898|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632899|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632900|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632901|NCT00436956|Prednisone|prednisone|mesh-list
44632902|NCT00436956|Cediranib|cediranib|mesh-list
44632903|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44632904|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
44632905|NCT00436956|Hormones|hormones|mesh-ancestor
44632906|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632907|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632908|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44632909|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632910|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632911|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632912|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632913|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
44632914|NCT00436917|Letrozole|letrozole|mesh-list
44632915|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632916|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44632917|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44632918|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632919|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632920|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44632921|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
44632922|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44632923|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632924|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44632925|NCT00436826|Interferons|interferons|mesh-list
44632926|NCT00436826|Interferon-beta|interferon-beta|mesh-list
44632928|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
44632929|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632930|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
44632931|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44632932|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
44632933|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632934|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632935|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44632936|NCT00436644|Topotecan|topotecan|mesh-list
44632937|NCT00436644|Lapatinib|lapatinib|mesh-list
44632938|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44632939|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632940|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632941|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632942|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632943|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632944|NCT00436618|Everolimus|everolimus|mesh-list
44632945|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632946|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632947|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
44632948|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632949|NCT00436605|Dasatinib|dasatinib|mesh-list
44632950|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632951|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632952|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900740|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44632953|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632954|NCT00436566|Paclitaxel|paclitaxel|mesh-list
44632955|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
44632956|NCT00436566|Doxorubicin|doxorubicin|mesh-list
44632957|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44632958|NCT00436566|Trastuzumab|trastuzumab|mesh-list
44632959|NCT00436566|Lapatinib|lapatinib|mesh-list
44632960|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44632961|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632962|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632963|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632964|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632965|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632966|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44632967|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
44632968|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632969|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44632970|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44632971|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
44632972|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44632973|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44632974|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44632975|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44632976|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44632977|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44632978|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44632979|NCT00436553|Ranibizumab|ranibizumab|mesh-list
44632980|NCT00436553|Verteporfin|verteporfin|mesh-list
44632981|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632982|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632983|NCT00436553|Growth Substances|growth substances|mesh-ancestor
44632984|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44632985|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
44632986|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632987|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44632988|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
44632989|NCT00436501|Docetaxel|docetaxel|mesh-list
44632990|NCT00436501|Aflibercept|aflibercept|mesh-list
44632991|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
44632992|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44632993|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
44632994|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
44632995|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
44632996|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44632997|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44632998|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44632999|NCT00436501|Growth Substances|growth substances|mesh-ancestor
44633000|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633001|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633003|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44633004|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633005|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
44633006|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633007|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633008|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633009|NCT00436345|Remifentanil|remifentanil|mesh-list
44633010|NCT00436345|Propofol|propofol|mesh-list
44633011|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44633012|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633013|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633014|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44633015|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
44633016|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
44633017|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44633018|NCT00436345|Narcotics|narcotics|mesh-ancestor
44633019|NCT00436345|Analgesics|analgesics|mesh-ancestor
44633020|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
44633021|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633022|NCT00436332|Bevacizumab|bevacizumab|mesh-list
44633023|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44633024|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633025|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633026|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633027|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633028|NCT00436332|Growth Substances|growth substances|mesh-ancestor
44633029|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633030|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633031|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633032|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633033|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633034|NCT00436280|Gemcitabine|gemcitabine|mesh-list
44633035|NCT00436280|Rituximab|rituximab|mesh-list
44633036|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
44633037|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633038|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633039|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
44633040|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633041|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633042|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633043|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
44633044|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633045|NCT00436280|Antiviral Agents|antiviral agents|mesh-ancestor
44633046|NCT00436280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633047|NCT00436280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633048|NCT00436280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633049|NCT00436215|Bevacizumab|bevacizumab|mesh-list
44633050|NCT00436215|Sorafenib|sorafenib|mesh-list
44633051|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633052|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633053|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633054|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633055|NCT00436215|Growth Substances|growth substances|mesh-ancestor
44633056|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633057|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633058|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633059|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633060|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633061|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44633062|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
44633063|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633064|NCT00436007|Vaccines|vaccines|mesh-list
44184309|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
44633065|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
44633066|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633067|NCT00435994|Epinephrine|epinephrine|mesh-list
44633068|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44633069|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44633070|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
44633071|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633072|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633073|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633074|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44633075|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44633076|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
44633077|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633078|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44633079|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
44633080|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
44633081|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
44633082|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44633083|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44633084|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
44633085|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633086|NCT00435487|Heparin|heparin|mesh-list
44633087|NCT00435487|Calcium heparin|calcium heparin|mesh-list
44633088|NCT00435487|Dalteparin|dalteparin|mesh-list
44633089|NCT00435487|Tinzaparin|tinzaparin|mesh-list
44633090|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44633091|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
44633092|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44633093|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44633094|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633095|NCT00435461|Fluticasone|fluticasone|mesh-list
44633096|NCT00435461|Xhance|xhance|mesh-list
44633097|NCT00435461|Fexofenadine|fexofenadine|mesh-list
44633098|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44633099|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44633100|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
44633101|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633102|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633103|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44633104|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
44633105|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
44633106|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44633107|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44633108|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44633109|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
44633110|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
44633111|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633112|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633114|NCT00435409|Sunitinib|sunitinib|mesh-list
44633115|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633116|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
44633117|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633118|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633119|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633120|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633121|NCT00435409|Growth Substances|growth substances|mesh-ancestor
44633122|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633123|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633124|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633125|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633126|NCT00435370|Tropisetron|tropisetron|mesh-list
44633127|NCT00435370|Risperidone|risperidone|mesh-list
44633128|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44633129|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
44633130|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633131|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633132|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633133|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44633134|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44633135|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633136|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44633137|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44633138|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
44633139|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
44633140|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
44633141|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633142|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44633143|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44633144|NCT00435162|Valsartan|valsartan|mesh-list
44633145|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633146|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44633147|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44633148|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633149|NCT00435045|Atorvastatin|atorvastatin|mesh-list
44633150|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44633151|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44633152|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
44633153|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633154|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44633155|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44633156|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633157|NCT00435019|Insulin|insulin|mesh-list
44633158|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44633159|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
44633160|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
44633161|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
44633162|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
44633163|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
44633164|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44633165|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633166|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44633167|NCT00434967|Candesartan|candesartan|mesh-list
44633168|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
44633169|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633170|NCT00434967|Diuretics|diuretics|mesh-ancestor
44633171|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
44633172|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633173|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44633174|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633175|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633176|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44633177|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44633178|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
44633179|NCT00434954|Exenatide|exenatide|mesh-list
44633180|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44633181|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633182|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44633183|NCT00434954|Incretins|incretins|mesh-ancestor
44633184|NCT00434954|Hormones|hormones|mesh-ancestor
44028652|NCT00000633|Vaccines|vaccines|mesh-list
44633185|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633186|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44633187|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44633188|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44633189|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44633190|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44633191|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633192|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633194|NCT00434642|Bevacizumab|bevacizumab|mesh-list
44633195|NCT00434642|Carboplatin|carboplatin|mesh-list
44633196|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633197|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633198|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633199|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633200|NCT00434642|Growth Substances|growth substances|mesh-ancestor
44633201|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633202|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633203|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633204|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
44633205|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633206|NCT00434642|Antiviral Agents|antiviral agents|mesh-ancestor
44633207|NCT00434642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633208|NCT00434642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633209|NCT00434642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633210|NCT00434642|Immunologic Factors|immunologic factors|mesh-ancestor
44633211|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
44633212|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633213|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633214|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900997|NCT00060424|Cyclosporine|cyclosporine|mesh-list
44633215|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
44633216|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633217|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633218|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633219|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633220|NCT00434577|Vaccines|vaccines|mesh-list
44633221|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
44633222|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633223|NCT00434304|Ropinirole|ropinirole|mesh-list
44633224|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44633225|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44633226|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
44633227|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
44633228|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633229|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633230|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633231|NCT00434252|Paclitaxel|paclitaxel|mesh-list
44633232|NCT00434252|Bevacizumab|bevacizumab|mesh-list
44633233|NCT00434252|Carboplatin|carboplatin|mesh-list
44633234|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633235|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633236|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633237|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633238|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633239|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633240|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633241|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633242|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633243|NCT00434252|Growth Substances|growth substances|mesh-ancestor
44633244|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633245|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633246|NCT00434213|Methylphenidate|methylphenidate|mesh-list
44633247|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44633248|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633249|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44633250|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44633251|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633252|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633253|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
44633254|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633255|NCT00434148|Pasireotide|pasireotide|mesh-list
44633256|NCT00434148|Hormones|hormones|mesh-ancestor
44633257|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633258|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633260|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633261|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633262|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633263|NCT00434109|Growth Substances|growth substances|mesh-ancestor
44633264|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633265|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633266|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633267|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633268|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633269|NCT00433966|Paclitaxel|paclitaxel|mesh-list
44633270|NCT00433966|Heparin|heparin|mesh-list
44633271|NCT00433966|Calcium heparin|calcium heparin|mesh-list
44633272|NCT00433966|Bivalirudin|bivalirudin|mesh-list
44633273|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633274|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633275|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633276|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633277|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633278|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633279|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
44633280|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44633281|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44633282|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
44633283|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44633284|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44633285|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633286|NCT00433914|Vaccines|vaccines|mesh-list
44633287|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
44633288|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633289|NCT00433836|Valsartan|valsartan|mesh-list
44633290|NCT00433836|Enalapril|enalapril|mesh-list
44633291|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633292|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44633293|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44633294|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633295|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44633296|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
44633297|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633299|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
44633300|NCT00433537|Rituximab|rituximab|mesh-list
44633301|NCT00433537|Doxorubicin|doxorubicin|mesh-list
44633302|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44633303|NCT00433537|Vincristine|vincristine|mesh-list
44633304|NCT00433537|Bortezomib|bortezomib|mesh-list
44633305|NCT00433537|Lenograstim|lenograstim|mesh-list
44633306|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633307|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
44633308|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633309|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633310|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633311|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
44633312|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633313|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633314|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633315|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633316|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44633317|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
44633318|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
44633319|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633320|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44633321|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
44633322|NCT00433537|Hormones|hormones|mesh-ancestor
44633323|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633324|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633325|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633326|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44633327|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44633328|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633329|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44633330|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633331|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633332|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633333|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633334|NCT00433446|Siltuximab|siltuximab|mesh-list
44633335|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633337|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44633338|NCT00433381|Irinotecan|irinotecan|mesh-list
44633339|NCT00433381|Temozolomide|temozolomide|mesh-list
44633340|NCT00433381|Camptothecin|camptothecin|mesh-list
44633341|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
44633342|NCT00433381|Antibodies|antibodies|mesh-list
44633343|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
44633344|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44633345|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
44633346|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633347|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633348|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633349|NCT00433381|Growth Substances|growth substances|mesh-ancestor
44633350|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633351|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633352|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
44633353|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44633354|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44633355|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633356|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633357|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633358|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
44633359|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633360|NCT00433329|Bosentan|bosentan|mesh-list
44633361|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
44633362|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
44633363|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44633364|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44633365|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633366|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633367|NCT00433329|Urological Agents|urological agents|mesh-ancestor
44633368|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633369|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44633370|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44633371|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44633372|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44633374|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633375|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633376|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633377|NCT00433290|Analgesics|analgesics|mesh-ancestor
44633378|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
44633379|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633380|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
44633381|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44633382|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
44633383|NCT00433199|Testosterone|testosterone|mesh-list
44633384|NCT00433199|Androgens|androgens|mesh-ancestor
44633385|NCT00433199|Hormones|hormones|mesh-ancestor
44633386|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633387|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633388|NCT00433160|Teriparatide|teriparatide|mesh-list
44633389|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44633390|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633391|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44633392|NCT00433017|Ranibizumab|ranibizumab|mesh-list
44633393|NCT00433017|Verteporfin|verteporfin|mesh-list
44633394|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633395|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633396|NCT00433017|Growth Substances|growth substances|mesh-ancestor
44633397|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633398|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633399|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633400|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44633401|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44633402|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
44633403|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44633404|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
44633405|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44633406|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633407|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44633408|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44633409|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44633410|NCT00432991|Ephedrine|ephedrine|mesh-list
44633411|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44633412|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633413|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
44633414|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
44633415|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633416|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44633417|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
44633418|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633419|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633420|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44633421|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44633422|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633423|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633424|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44633425|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633426|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633427|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44633428|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633429|NCT00432562|Vinorelbine|vinorelbine|mesh-list
44633430|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633431|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633432|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633433|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633434|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633435|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633436|NCT00432276|Metformin|metformin|mesh-list
44633437|NCT00432276|Pioglitazone|pioglitazone|mesh-list
44633438|NCT00432276|Alogliptin|alogliptin|mesh-list
44633439|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44633440|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633441|NCT00432276|Incretins|incretins|mesh-ancestor
44633442|NCT00432276|Hormones|hormones|mesh-ancestor
44184734|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
44633443|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633444|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44633445|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
44633446|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633447|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633448|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
44633449|NCT00432172|Carboplatin|carboplatin|mesh-list
44633451|NCT00432172|Epirubicin|epirubicin|mesh-list
44633452|NCT00432172|Exemestane|exemestane|mesh-list
44633453|NCT00432172|Goserelin|goserelin|mesh-list
44633454|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633455|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
44633456|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633457|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633458|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633459|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
44633460|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633461|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633462|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633463|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633464|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633465|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633466|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633467|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44633468|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44633469|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633470|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44633471|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44633472|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44633473|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44633474|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633475|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633476|NCT00431964|Azithromycin|azithromycin|mesh-list
44633477|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633478|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633479|NCT00431847|Anesthetics|anesthetics|mesh-list
44633480|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633481|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633482|NCT00431496|Cinacalcet|cinacalcet|mesh-list
44028943|NCT00000668|Ganciclovir|ganciclovir|mesh-list
44633483|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44633484|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633485|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44633486|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
44633487|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633488|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
44633489|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44633490|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44633491|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633492|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44633493|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
43901279|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44633494|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633495|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44633496|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44633497|NCT00431067|Afatinib|afatinib|mesh-list
44633498|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633499|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633500|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633501|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633502|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
44633503|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44633504|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
44633505|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
44633506|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633507|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633508|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44633509|NCT00430989|Analgesics|analgesics|mesh-ancestor
44633510|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
44633511|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633512|NCT00430937|Vancomycin|vancomycin|mesh-list
44633513|NCT00430937|Daptomycin|daptomycin|mesh-list
44633514|NCT00430937|Teicoplanin|teicoplanin|mesh-list
44633515|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44184808|NCT00331188|Vapreotide|vapreotide|mesh-list
44633516|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633518|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633519|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633520|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633521|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633522|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
44633523|NCT00430716|Citric Acid|citric acid|mesh-list
44633524|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
44633525|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
44633526|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44633527|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
44633528|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
44633529|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633530|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44633531|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44633532|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44633533|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633534|NCT00430716|Urological Agents|urological agents|mesh-ancestor
44633535|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
44633536|NCT00430677|Prednisone|prednisone|mesh-list
44633537|NCT00430677|Prednisolone|prednisolone|mesh-list
44633538|NCT00430677|Abatacept|abatacept|mesh-list
44633539|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44633540|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
44633541|NCT00430677|Hormones|hormones|mesh-ancestor
44633542|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633543|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633544|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633545|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633546|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633547|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44633548|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
44633549|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633550|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633551|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633552|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633553|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44633554|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633555|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
44633556|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633557|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44633558|NCT00430638|Olmesartan|olmesartan|mesh-list
44633559|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44633560|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633561|NCT00430638|Diuretics|diuretics|mesh-ancestor
44633562|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
44633563|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633564|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44633565|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633566|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633567|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44633568|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44633569|NCT00430573|Cycloserine|cycloserine|mesh-list
44633570|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44633571|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633572|NCT00430573|Renal Agents|renal agents|mesh-ancestor
44633573|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44633574|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
44633575|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633576|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
44633577|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633578|NCT00430521|Vaccines|vaccines|mesh-list
44633579|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
44633580|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633581|NCT00430352|Rituximab|rituximab|mesh-list
44633582|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633583|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633584|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
44633585|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633586|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633587|NCT00430248|Allopurinol|allopurinol|mesh-list
44633588|NCT00430248|Febuxostat|febuxostat|mesh-list
44633589|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
44633590|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633591|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633592|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
44633593|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633594|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44633595|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
44633596|NCT00430248|Protective Agents|protective agents|mesh-ancestor
44633597|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633598|NCT00430027|Capecitabine|capecitabine|mesh-list
44633599|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
44633600|NCT00430027|Cetuximab|cetuximab|mesh-list
44633601|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633602|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
44633603|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633604|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633605|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633606|NCT00429858|Gemcitabine|gemcitabine|mesh-list
44633607|NCT00429858|Tegafur|tegafur|mesh-list
44633608|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633609|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
43901411|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633610|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633611|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633612|NCT00429858|Antiviral Agents|antiviral agents|mesh-ancestor
44633613|NCT00429858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633614|NCT00429858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633615|NCT00429858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633616|NCT00429858|Immunologic Factors|immunologic factors|mesh-ancestor
44633617|NCT00429858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633618|NCT00429793|Sirolimus|sirolimus|mesh-list
44633619|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633620|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633621|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633622|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633623|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
44633624|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633625|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
44633626|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633627|NCT00429572|Fludarabine|fludarabine|mesh-list
44633628|NCT00429572|Melphalan|melphalan|mesh-list
44633629|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633630|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633631|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633632|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
44633633|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633634|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633635|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
44633636|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633637|NCT00429494|Leuprolide|leuprolide|mesh-list
44633638|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44633639|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
44633640|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44633641|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633642|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633643|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633644|NCT00429416|Cytarabine|cytarabine|mesh-list
44633645|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
44633646|NCT00429416|Fludarabine|fludarabine|mesh-list
44633647|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
44633648|NCT00429416|Molgramostim|molgramostim|mesh-list
44633649|NCT00429416|Tacrolimus|tacrolimus|mesh-list
44633650|NCT00429416|Sargramostim|sargramostim|mesh-list
44633651|NCT00429416|Mesna|mesna|mesh-list
44633652|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633653|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
44633654|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633655|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633656|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633657|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
44633658|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633659|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633660|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633661|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633662|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
44633663|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
44633664|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633665|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44633666|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184961|NCT00331825|Olanzapine|olanzapine|mesh-list
44633667|NCT00429416|Protective Agents|protective agents|mesh-ancestor
44633669|NCT00429364|Atenolol|atenolol|mesh-list
44633670|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44633671|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633672|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44633673|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44633674|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633675|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
44633676|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
44633677|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633678|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633679|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44633680|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44633681|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44633682|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44633683|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633684|NCT00429299|Paclitaxel|paclitaxel|mesh-list
44633685|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
44633686|NCT00429299|Fluorouracil|fluorouracil|mesh-list
44633687|NCT00429299|Trastuzumab|trastuzumab|mesh-list
44633688|NCT00429299|Lapatinib|lapatinib|mesh-list
44633689|NCT00429299|Epirubicin|epirubicin|mesh-list
44633690|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633691|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633692|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633693|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633694|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633695|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633696|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633697|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
44633698|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633699|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633700|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633701|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
44633702|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633703|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
44633704|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44633705|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633706|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633707|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633708|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633709|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44633710|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44633711|NCT00429273|Guanfacine|guanfacine|mesh-list
44633712|NCT00429273|Methylphenidate|methylphenidate|mesh-list
44633713|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44633714|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44633715|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633716|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44633717|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44633718|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633719|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633720|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
44633721|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633722|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44633723|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44633724|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44633725|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44633726|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
44633727|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
44633728|NCT00429182|Thiotepa|thiotepa|mesh-list
44633729|NCT00429182|Carboplatin|carboplatin|mesh-list
44633730|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633731|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
44633732|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633733|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633734|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633735|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
44633736|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633737|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633738|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633739|NCT00429169|Bupropion|bupropion|mesh-list
44633740|NCT00429169|Paroxetine|paroxetine|mesh-list
44633741|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44633742|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
44633743|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44633744|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44633745|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44633746|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633747|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633748|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
44633749|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633750|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633751|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44633752|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44633753|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633754|NCT00429169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44633755|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
44633756|NCT00429104|Trastuzumab|trastuzumab|mesh-list
44633757|NCT00429104|Sargramostim|sargramostim|mesh-list
44633758|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633759|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633760|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
44633761|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633762|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
44633764|NCT00429026|Fludarabine|fludarabine|mesh-list
44633765|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633766|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
44633767|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633768|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633769|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44633770|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
44633771|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633772|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633773|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44633774|NCT00428948|Tolvaptan|tolvaptan|mesh-list
44633775|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44633776|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633777|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
44633778|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633779|NCT00428844|Vancomycin|vancomycin|mesh-list
44633780|NCT00428844|Daptomycin|daptomycin|mesh-list
44633781|NCT00428844|Teicoplanin|teicoplanin|mesh-list
44633782|NCT00428844|Floxacillin|floxacillin|mesh-list
44633783|NCT00428844|Oxacillin|oxacillin|mesh-list
44633785|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44633786|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633787|NCT00428792|Methylphenidate|methylphenidate|mesh-list
44633788|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44633789|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633790|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43901577|NCT00075335|Plerixafor|plerixafor|mesh-list
44633791|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44633792|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633793|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633794|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
44633795|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633796|NCT00428597|Sunitinib|sunitinib|mesh-list
44633797|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633798|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633799|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633800|NCT00428597|Growth Substances|growth substances|mesh-ancestor
44633801|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633802|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633803|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633804|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633805|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633806|NCT00428441|Warfarin|warfarin|mesh-list
44633807|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
44633808|NCT00428389|Rivastigmine|rivastigmine|mesh-list
44633809|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44633810|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633811|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633812|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
44633813|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185107|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44633814|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633815|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44633816|NCT00428389|Protective Agents|protective agents|mesh-ancestor
44633818|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633819|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44633820|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44633821|NCT00428220|Growth Substances|growth substances|mesh-ancestor
44633822|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633823|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
44633824|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633825|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633826|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633827|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
44633828|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44633829|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633830|NCT00427999|Pioglitazone|pioglitazone|mesh-list
44633831|NCT00427999|Dexamethasone|dexamethasone|mesh-list
44633832|NCT00427999|Etoricoxib|etoricoxib|mesh-list
44633833|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
44633834|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
44633835|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44633836|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
44633837|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
44633838|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633839|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633840|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44633841|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
44633842|NCT00427999|Hormones|hormones|mesh-ancestor
44633843|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633844|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633845|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633846|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44633847|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633848|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633849|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633850|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44633851|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44633852|NCT00427999|Analgesics|analgesics|mesh-ancestor
44633853|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
43901647|NCT00078559|Tacrolimus|tacrolimus|mesh-list
44633854|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633855|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44633856|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44633857|NCT00427960|Atorvastatin|atorvastatin|mesh-list
44633858|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44633859|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44633860|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44633861|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
44633862|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633863|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44633864|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44633865|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633866|NCT00427934|Maraviroc|maraviroc|mesh-list
44633867|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44633868|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44633869|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633870|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44633871|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44633872|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
44633873|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633874|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44633875|NCT00427921|Adalimumab|adalimumab|mesh-list
44633876|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44633877|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44633878|NCT00427895|Vaccines|vaccines|mesh-list
44633879|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44633880|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
44633881|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633882|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44633883|NCT00427700|Clomiphene|clomiphene|mesh-list
44633884|NCT00427700|Enclomiphene|enclomiphene|mesh-list
44633885|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
44633886|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44633887|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
44633888|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44633889|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633891|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
44633892|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44633893|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44633894|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44633895|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44633896|NCT00427648|Lidocaine|lidocaine|mesh-list
44633897|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
44633898|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
44633899|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44633900|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633901|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
44633902|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633903|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44633904|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44633905|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44633906|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44633907|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633908|NCT00427635|Esomeprazole|esomeprazole|mesh-list
44633909|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44633910|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44633911|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44633912|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633913|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633914|NCT00427349|Octreotide|octreotide|mesh-list
44633915|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
44633916|NCT00427349|Imetelstat|imetelstat|mesh-list
44633917|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44633918|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44633919|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633920|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44633921|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633922|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633923|NCT00426842|Midodrine|midodrine|mesh-list
44633924|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
44633925|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
44633926|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44633927|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633928|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44633929|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44633930|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44633931|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44633932|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
44633933|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44633934|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633935|NCT00426764|Romidepsin|romidepsin|mesh-list
44633936|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633937|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633938|NCT00426751|Abciximab|abciximab|mesh-list
44633939|NCT00426751|Eptifibatide|eptifibatide|mesh-list
44633940|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
44633941|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44633942|NCT00426660|Maraviroc|maraviroc|mesh-list
44633943|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44633944|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44633945|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633946|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44633947|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44633948|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
44633949|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44633950|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44633951|NCT00426556|Paclitaxel|paclitaxel|mesh-list
44633952|NCT00426556|Trastuzumab|trastuzumab|mesh-list
44633953|NCT00426556|Everolimus|everolimus|mesh-list
44633954|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44633955|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633956|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633957|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633958|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633959|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633960|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44633961|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44633962|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
44633963|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633964|NCT00426361|Vaccines|vaccines|mesh-list
44633965|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
44633966|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633967|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
44633968|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
44633969|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633970|NCT00426127|Docetaxel|docetaxel|mesh-list
44633971|NCT00426127|Doxorubicin|doxorubicin|mesh-list
44633972|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44633973|NCT00426127|Enoxaparin|enoxaparin|mesh-list
44633974|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633975|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44633976|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44633977|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44633978|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633979|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44633980|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44633981|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44633982|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633983|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
44633984|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44633985|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44633986|NCT00425945|Pycnogenols|pycnogenols|mesh-list
44633987|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44633988|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
44633989|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44633990|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
44633991|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633992|NCT00425945|Protective Agents|protective agents|mesh-ancestor
44633993|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44633994|NCT00425854|Afatinib|afatinib|mesh-list
44633995|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44633996|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44185326|NCT00332852|Letrozole|letrozole|mesh-list
44633997|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44633998|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44633999|NCT00425750|Docetaxel|docetaxel|mesh-list
44634000|NCT00425750|Bortezomib|bortezomib|mesh-list
44634001|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634002|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44634003|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44634004|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44634005|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634006|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
44634007|NCT00425698|Hematinics|hematinics|mesh-ancestor
44634009|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634010|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634011|NCT00425555|Panobinostat|panobinostat|mesh-list
44634012|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634013|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44634014|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634015|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634016|NCT00425503|Bortezomib|bortezomib|mesh-list
44634017|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634018|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
44634019|NCT00425438|Prednisolone|prednisolone|mesh-list
44634020|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
44634021|NCT00425438|Azathioprine|azathioprine|mesh-list
44634022|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634023|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
44634024|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634025|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634026|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44634027|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
44634028|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634029|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634030|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44634031|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634032|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44634033|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
44634034|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634035|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634036|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634037|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634038|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
44634039|NCT00425438|Hormones|hormones|mesh-ancestor
44634040|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634041|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634042|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
44634043|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634044|NCT00425373|Amlodipine|amlodipine|mesh-list
44634045|NCT00425373|Valsartan|valsartan|mesh-list
44634046|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44634047|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44634048|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634049|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634050|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44634051|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634052|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
44634053|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44634054|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44634055|NCT00425308|Cyclosporine|cyclosporine|mesh-list
44634056|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
44634057|NCT00425308|Everolimus|everolimus|mesh-list
44634058|NCT00425308|Cyclosporins|cyclosporins|mesh-list
44634059|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634060|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634061|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634062|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
44634063|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634064|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
44634065|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634066|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634067|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634068|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44634069|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634070|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634071|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44634072|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
44634073|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634074|NCT00425113|Metronidazole|metronidazole|mesh-list
44634075|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634076|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634077|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634078|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44634079|NCT00424827|Gemcitabine|gemcitabine|mesh-list
44634080|NCT00424827|Fluorouracil|fluorouracil|mesh-list
44634081|NCT00424827|Cetuximab|cetuximab|mesh-list
44235781|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
44634082|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634083|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
44634084|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634085|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634086|NCT00424827|Antiviral Agents|antiviral agents|mesh-ancestor
44634087|NCT00424827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634088|NCT00424827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634089|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634090|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
44634091|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634092|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634093|NCT00424775|Vorinostat|vorinostat|mesh-list
44634094|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634095|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44634096|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634097|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634098|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
44634099|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44634100|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634101|NCT00424749|Prednisone|prednisone|mesh-list
44634102|NCT00424749|Rituximab|rituximab|mesh-list
44634103|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634104|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634105|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
44634106|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634107|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634108|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634109|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
44634110|NCT00424749|Hormones|hormones|mesh-ancestor
44634111|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634112|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634113|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44634114|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44634115|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44634116|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634117|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634118|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634119|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634120|NCT00424593|Analgesics|analgesics|mesh-ancestor
44634121|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
44634122|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634123|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44634124|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44634125|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
44634126|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
44634127|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
44634128|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44634129|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
44634130|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634131|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634132|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44634133|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
44634134|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
44634135|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44634136|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
44634137|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634138|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634139|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44634140|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44634141|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44634142|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634143|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
44634144|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634145|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634146|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634147|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634148|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
44634149|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44634150|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44634151|NCT00424489|Prednisolone|prednisolone|mesh-list
44634152|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
44634153|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
44634154|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44634155|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
44634156|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634157|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
44634158|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634159|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634160|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44634161|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
44634162|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634163|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634164|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44634165|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634166|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
44634167|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
44634168|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634169|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634170|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
44634171|NCT00424489|Hormones|hormones|mesh-ancestor
44634172|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634173|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44634174|NCT00424489|Protective Agents|protective agents|mesh-ancestor
44634175|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634176|NCT00424476|Belimumab|belimumab|mesh-list
44634177|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634178|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
44634179|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634180|NCT00424463|Edaravone|edaravone|mesh-list
44634181|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44634182|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
44634183|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634184|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44634185|NCT00424463|Protective Agents|protective agents|mesh-ancestor
44634186|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634187|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
44634188|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44634189|NCT00424385|Sorafenib|sorafenib|mesh-list
44634190|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
44634191|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634192|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634193|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634194|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634195|NCT00424372|Pregabalin|pregabalin|mesh-list
44634196|NCT00424372|Analgesics|analgesics|mesh-ancestor
44634197|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
44634198|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634199|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634200|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
44634201|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44634202|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634203|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634204|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44634205|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44634206|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44634207|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44634208|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44634209|NCT00424294|Celecoxib|celecoxib|mesh-list
44634210|NCT00424294|Methotrexate|methotrexate|mesh-list
44634211|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44634212|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
44634213|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44634214|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634215|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634216|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
44634217|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634218|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634219|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634220|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634221|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44634222|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634223|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
44634225|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44634226|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634227|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634228|NCT00424294|Analgesics|analgesics|mesh-ancestor
44634229|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
44634230|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634231|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634232|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44634233|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44634234|NCT00424255|Lapatinib|lapatinib|mesh-list
44634235|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634236|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634237|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634238|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634239|NCT00424190|Vancomycin|vancomycin|mesh-list
44634240|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44634241|NCT00424190|Aztreonam|aztreonam|mesh-list
44634242|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634243|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634244|NCT00424047|Dexamethasone|dexamethasone|mesh-list
44634245|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
44634246|NCT00424047|Lenalidomide|lenalidomide|mesh-list
44634247|NCT00424047|BB 1101|bb 1101|mesh-list
44634248|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634249|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
44634250|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
44634251|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634252|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634253|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634254|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
44634255|NCT00424047|Hormones|hormones|mesh-ancestor
44634256|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634257|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634258|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634259|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44634260|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634261|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634262|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
44634263|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44634264|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44634265|NCT00424047|Growth Substances|growth substances|mesh-ancestor
44634266|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
44634267|NCT00424021|Ambrisentan|ambrisentan|mesh-list
44634268|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44634269|NCT00424008|Fluticasone|fluticasone|mesh-list
44634271|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
44634272|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
44634273|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44634274|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44634275|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634276|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44634277|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
44634278|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634279|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634280|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44634281|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44634282|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634283|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44634284|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44634285|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44634286|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44634287|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634288|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634289|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634290|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
44634291|NCT00424008|Hormones|hormones|mesh-ancestor
44634292|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634293|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
44634294|NCT00423943|Modafinil|modafinil|mesh-list
44634295|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44634296|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634297|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44634298|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44634299|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44634300|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634302|NCT00423930|Cisplatin|cisplatin|mesh-list
43902094|NCT00089102|Gemcitabine|gemcitabine|mesh-list
44634303|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634304|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634305|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44634306|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44634307|NCT00423930|Growth Substances|growth substances|mesh-ancestor
44634308|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634309|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44634310|NCT00423917|Bevacizumab|bevacizumab|mesh-list
44634311|NCT00423917|Fulvestrant|fulvestrant|mesh-list
44634312|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634313|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634314|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44634315|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44634316|NCT00423917|Growth Substances|growth substances|mesh-ancestor
44634317|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634318|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44634319|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634320|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44634321|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44634322|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
44634323|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634324|NCT00423891|Entecavir|entecavir|mesh-list
44634325|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
44634326|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634327|NCT00423852|Paclitaxel|paclitaxel|mesh-list
44634328|NCT00423852|Carboplatin|carboplatin|mesh-list
44634329|NCT00423852|Ifosfamide|ifosfamide|mesh-list
44634330|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44634331|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634332|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44634333|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44634334|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44634335|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634336|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44634337|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
44634338|NCT00423800|Interferons|interferons|mesh-list
44634339|NCT00423800|Ribavirin|ribavirin|mesh-list
44634340|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
44634341|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
44634342|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44634343|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634344|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
44634345|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634346|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
44634347|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634348|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
44634349|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634350|NCT00423735|Dasatinib|dasatinib|mesh-list
44634351|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634352|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634353|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634354|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634355|NCT00423670|Ribavirin|ribavirin|mesh-list
44634356|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44634357|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
44634358|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634359|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
44634360|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634361|NCT00423657|Vancomycin|vancomycin|mesh-list
44634362|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44634363|NCT00423657|Aztreonam|aztreonam|mesh-list
44634364|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634365|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634366|NCT00423592|Ambrisentan|ambrisentan|mesh-list
44634367|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44634368|NCT00423488|Simvastatin|simvastatin|mesh-list
44634369|NCT00423488|Ezetimibe|ezetimibe|mesh-list
44634370|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44634371|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44634372|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
44634373|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634374|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44634375|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44634376|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634377|NCT00423449|Gemcitabine|gemcitabine|mesh-list
44634378|NCT00423449|Vorinostat|vorinostat|mesh-list
44634379|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634380|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
44634381|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634382|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634383|NCT00423449|Antiviral Agents|antiviral agents|mesh-ancestor
44634384|NCT00423449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634385|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634386|NCT00423449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634387|NCT00423449|Immunologic Factors|immunologic factors|mesh-ancestor
44634388|NCT00423449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634389|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44634390|NCT00423332|Cediranib|cediranib|mesh-list
44634391|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634392|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634393|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634394|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634395|NCT00423319|Enoxaparin|enoxaparin|mesh-list
44634396|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
44634397|NCT00423319|Apixaban|apixaban|mesh-list
44634398|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
44634399|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44634400|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44634401|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634402|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44634403|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
44634404|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44634405|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
44634406|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634407|NCT00423293|Fluorouracil|fluorouracil|mesh-list
44634408|NCT00423293|Mitomycins|mitomycins|mesh-list
44634409|NCT00423293|Mitomycin|mitomycin|mesh-list
44634410|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
44634411|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634412|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634413|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634414|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634415|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
44634416|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634417|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634418|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
44634419|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44634420|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634421|NCT00423267|Fluconazole|fluconazole|mesh-list
44634422|NCT00423267|Posaconazole|posaconazole|mesh-list
44634423|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
44634424|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634425|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44634426|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44634427|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634428|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634429|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44634430|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
44634431|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634432|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634433|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44634434|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44634435|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44634436|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634437|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44634438|NCT00423189|Ranibizumab|ranibizumab|mesh-list
44634439|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44634440|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44634441|NCT00423189|Growth Substances|growth substances|mesh-ancestor
44634442|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634443|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44634444|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634445|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44634446|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44634447|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634448|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
44185764|NCT00334360|Analgesics|analgesics|mesh-ancestor
44634449|NCT00423150|Temozolomide|temozolomide|mesh-list
43902255|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634450|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44634451|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
44634452|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634453|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634454|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
44634456|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
44634457|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44634458|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44634459|NCT00423098|Prednisolone|prednisolone|mesh-list
44634460|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
44634461|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44634462|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
44634463|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634464|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
44634465|NCT00423098|Hormones|hormones|mesh-ancestor
44634466|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634467|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634468|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634469|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634470|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634471|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44634472|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
44634473|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634474|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634475|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634476|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634477|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
44634478|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
44634479|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634480|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634481|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44634482|NCT00423098|Protective Agents|protective agents|mesh-ancestor
44634483|NCT00423085|Rivastigmine|rivastigmine|mesh-list
44634484|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44634485|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634486|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634487|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
44634488|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634489|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634490|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44634491|NCT00423085|Protective Agents|protective agents|mesh-ancestor
44634492|NCT00422942|Rituximab|rituximab|mesh-list
44634493|NCT00422942|Methotrexate|methotrexate|mesh-list
44634494|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634495|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634496|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
44634497|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634498|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634499|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44634500|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
44634501|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44634502|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634503|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
44634504|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634505|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634506|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634507|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44634508|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634509|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44634510|NCT00422903|Letrozole|letrozole|mesh-list
44634511|NCT00422903|Lapatinib|lapatinib|mesh-list
44634512|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634513|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44634514|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44634515|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634516|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634517|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44634518|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
44634519|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634520|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634521|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44185835|NCT00334529|Oseltamivir|oseltamivir|mesh-list
44634523|NCT00422799|Bortezomib|bortezomib|mesh-list
44634524|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634525|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634526|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
44634527|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029998|NCT00000834|Lamivudine|lamivudine|mesh-list
44634528|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634530|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
44634531|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44634532|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44634533|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634534|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634535|NCT00422734|Urological Agents|urological agents|mesh-ancestor
44634536|NCT00422591|Cytarabine|cytarabine|mesh-list
44634537|NCT00422591|Idarubicin|idarubicin|mesh-list
44634538|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634539|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
44634540|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634541|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634542|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
44634543|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634544|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634545|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
44634546|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634547|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634548|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44634549|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44634550|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634551|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
44634552|NCT00422513|Hematinics|hematinics|mesh-ancestor
44634553|NCT00422422|Brivaracetam|brivaracetam|mesh-list
44634554|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
44634555|NCT00422383|Rituximab|rituximab|mesh-list
44634556|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44634557|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634558|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
44634559|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634560|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634561|NCT00422292|Vaccines|vaccines|mesh-list
44634562|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
44634563|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634564|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
44634565|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
44634566|NCT00422227|Etanercept|etanercept|mesh-list
44634567|NCT00422227|Methotrexate|methotrexate|mesh-list
44634568|NCT00422227|Leflunomide|leflunomide|mesh-list
44634569|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44634570|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
44634571|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44634572|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634573|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634574|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
44634575|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634576|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634577|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634578|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634579|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44634580|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634581|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
44634582|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634583|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44634584|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
44634585|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634586|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44634587|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634588|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634589|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634590|NCT00422227|Analgesics|analgesics|mesh-ancestor
44634591|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
44634592|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634593|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634594|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634595|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44634596|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44634597|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44634598|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634599|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634600|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634601|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634602|NCT00422162|Analgesics|analgesics|mesh-ancestor
44634603|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
44634604|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634605|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
44634606|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44634607|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
44634608|NCT00422097|Epothilones|epothilones|mesh-list
44634609|NCT00422097|Famotidine|famotidine|mesh-list
44634610|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44634611|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44634612|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44634613|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634614|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634615|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44634616|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634617|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44634618|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
44634619|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
44634620|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634621|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634622|NCT00422084|Artesunate|artesunate|mesh-list
44634623|NCT00422084|Lumefantrine|lumefantrine|mesh-list
44634624|NCT00422084|Artemether|artemether|mesh-list
44634625|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44634626|NCT00422084|Pyronaridine|pyronaridine|mesh-list
44634627|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
44634628|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634629|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44634630|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634631|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634632|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
44634633|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
44634634|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44634635|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
44634636|NCT00422058|Liraglutide|liraglutide|mesh-list
44634637|NCT00422058|Orlistat|orlistat|mesh-list
44634638|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44634639|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634640|NCT00422058|Incretins|incretins|mesh-ancestor
44634641|NCT00422058|Hormones|hormones|mesh-ancestor
44634642|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634643|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634644|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634645|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44634646|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44634647|NCT00421993|Adapalene|adapalene|mesh-list
44634648|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44634649|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44634650|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634651|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634652|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634653|NCT00421993|Analgesics|analgesics|mesh-ancestor
44634654|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
43902450|NCT00100841|Antidotes|antidotes|mesh-ancestor
44634655|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634656|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634657|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634658|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634659|NCT00421928|Oxycodone|oxycodone|mesh-list
44634660|NCT00421928|Tapentadol|tapentadol|mesh-list
44634661|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44634662|NCT00421928|Narcotics|narcotics|mesh-ancestor
44634663|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44634664|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634665|NCT00421928|Analgesics|analgesics|mesh-ancestor
44634666|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
44634667|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634668|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44634669|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44634670|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634671|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634672|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634673|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634690|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44634691|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
44634692|NCT00421343|Vitamin D|vitamin d|mesh-list
44634693|NCT00421343|Alendronate|alendronate|mesh-list
44634694|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
44634695|NCT00421343|Calcium|calcium|mesh-list
44634696|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44634697|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634698|NCT00421343|Vitamins|vitamins|mesh-ancestor
44634699|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
44634700|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44634701|NCT00421343|Antacids|antacids|mesh-ancestor
44634702|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634703|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634704|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
44634705|NCT00421174|Etanercept|etanercept|mesh-list
44634706|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634707|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
44634708|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
44634709|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634710|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634711|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634712|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
44634713|NCT00421174|Hormones|hormones|mesh-ancestor
44634714|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634715|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44634716|NCT00421174|Protective Agents|protective agents|mesh-ancestor
44634717|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634718|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634719|NCT00421174|Analgesics|analgesics|mesh-ancestor
44634720|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
44634721|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634722|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634723|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
44634724|NCT00421148|Bromides|bromides|mesh-list
44634725|NCT00421148|Rocuronium|rocuronium|mesh-list
44634726|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
44634727|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44634728|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44634729|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44634730|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634731|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634732|NCT00420927|Adalimumab|adalimumab|mesh-list
44634733|NCT00420927|Methotrexate|methotrexate|mesh-list
44634734|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44634735|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
44634736|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44634737|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634738|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44634739|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
44634740|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634741|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634742|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634743|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634744|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44634745|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634746|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
44634747|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634748|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44634749|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634750|NCT00420849|Dexamethasone|dexamethasone|mesh-list
44634751|NCT00420849|Lenalidomide|lenalidomide|mesh-list
44634752|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634753|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
44634754|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
44634755|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634756|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634757|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634758|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
44634759|NCT00420849|Hormones|hormones|mesh-ancestor
44634760|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634761|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634762|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634763|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
44634764|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44634765|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44634766|NCT00420849|Growth Substances|growth substances|mesh-ancestor
44634767|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
44634768|NCT00420784|Interferons|interferons|mesh-list
44634769|NCT00420784|Ribavirin|ribavirin|mesh-list
44634770|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
44634771|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
44634772|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44634773|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634774|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
44634775|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634776|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
44634777|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634778|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
44634779|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634780|NCT00420641|Paroxetine|paroxetine|mesh-list
44634781|NCT00420641|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44634782|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44634783|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634784|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634785|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634786|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
44634787|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634788|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44634789|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
44634790|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44634791|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44634792|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44634793|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634794|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44634795|NCT00420628|Tobramycin|tobramycin|mesh-list
44634796|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634797|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634798|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44634799|NCT00420511|Metformin|metformin|mesh-list
44634800|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44634801|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44634802|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634803|NCT00420511|Incretins|incretins|mesh-ancestor
44634804|NCT00420511|Hormones|hormones|mesh-ancestor
44634805|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634806|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44634807|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
44634808|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634809|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634810|NCT00420407|Vasopressins|vasopressins|mesh-list
44634811|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
44634812|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
44634813|NCT00420407|Coagulants|coagulants|mesh-ancestor
44634814|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44634815|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44634816|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
44634817|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634818|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44634819|NCT00420342|Drospirenone|drospirenone|mesh-list
44634820|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44634821|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44634822|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
44634823|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44634824|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44634825|NCT00420342|Estradiol|estradiol|mesh-list
44634826|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44634827|NCT00420342|Estrogens|estrogens|mesh-ancestor
44634828|NCT00420342|Hormones|hormones|mesh-ancestor
44634829|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634830|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634831|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44634832|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
44634833|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44634834|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44634835|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44634836|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44634837|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44634838|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44634839|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634840|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634841|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44634842|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
44634843|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44634844|NCT00420342|Diuretics|diuretics|mesh-ancestor
44634845|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
44634846|NCT00420303|Etanercept|etanercept|mesh-list
44634847|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634848|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634849|NCT00420303|Analgesics|analgesics|mesh-ancestor
44634850|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
44634851|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634852|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634853|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634854|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634855|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634856|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634857|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
44634858|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44634859|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634861|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44634862|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44634863|NCT00420238|Analgesics|analgesics|mesh-ancestor
44634864|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
44634865|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634866|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634867|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634868|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634869|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44634870|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634871|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
44634872|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44634873|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634874|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634875|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
44634876|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634877|NCT00420199|Abatacept|abatacept|mesh-list
44634878|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44634879|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634880|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634881|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634882|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
44634883|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634884|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634885|NCT00420095|Insulin|insulin|mesh-list
44634886|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44138337|NCT00170924|Valsartan|valsartan|mesh-list
44634887|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
44634888|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44634889|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634890|NCT00420056|Palbociclib|palbociclib|mesh-list
44634891|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634892|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44634893|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634894|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634895|NCT00420004|Citalopram|citalopram|mesh-list
44634896|NCT00420004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44634897|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44634898|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44634899|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634900|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634901|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
44634902|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634903|NCT00420004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44634904|NCT00420004|Antidepressive Agents|antidepressive agents|mesh-ancestor
44634905|NCT00420004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44634906|NCT00419952|Budesonide|budesonide|mesh-list
44634907|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
44634908|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44634909|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634910|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44634911|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
44634912|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634913|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634914|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44634915|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
44634916|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
44634917|NCT00419952|Hormones|hormones|mesh-ancestor
44634918|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634919|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44634920|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44634921|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44634922|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634923|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634924|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634926|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
44634927|NCT00419926|Prednisone|prednisone|mesh-list
44634928|NCT00419926|Cyclosporins|cyclosporins|mesh-list
44634929|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634930|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
44634931|NCT00419926|Hormones|hormones|mesh-ancestor
44634932|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634933|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634934|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44634935|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44634936|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44634937|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634938|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44634939|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
44634940|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
44634941|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634942|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
44634943|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44634944|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44634945|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44634946|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44634947|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
44634948|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634949|NCT00419770|Amphotericin B|amphotericin b|mesh-list
44634950|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44634951|NCT00419770|Deferasirox|deferasirox|mesh-list
44634952|NCT00419770|Amebicides|amebicides|mesh-ancestor
44634953|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44634954|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44634955|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44634956|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44634957|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
44634958|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44634959|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
44634960|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
44634961|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634962|NCT00419757|Budesonide|budesonide|mesh-list
44634963|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
44634964|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44634965|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634966|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44634967|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
44634968|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634969|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634970|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44634971|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44634972|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
44634973|NCT00419757|Hormones|hormones|mesh-ancestor
44634974|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634975|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44634976|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44634977|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44634978|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634979|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634980|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44634981|NCT00419744|Budesonide|budesonide|mesh-list
44634982|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
44634983|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44634984|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44634985|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44634986|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
44634987|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44634988|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44634989|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44634990|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
44634991|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
44634992|NCT00419744|Hormones|hormones|mesh-ancestor
44634993|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44634994|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44634995|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44634996|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44634997|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
44634998|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44634999|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635001|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44635002|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635003|NCT00419393|Levetiracetam|levetiracetam|mesh-list
44635004|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
44635005|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
44635006|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
44635007|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44635008|NCT00419341|Antibodies|antibodies|mesh-list
44635009|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
44635010|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635011|NCT00419263|Peramivir|peramivir|mesh-list
44635012|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
44635013|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635014|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635015|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635016|NCT00419159|Everolimus|everolimus|mesh-list
44635017|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635018|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635019|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
44635020|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635021|NCT00419094|Levetiracetam|levetiracetam|mesh-list
44635022|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
44635023|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
44635024|NCT00419003|Lamotrigine|lamotrigine|mesh-list
44635025|NCT00419003|Ketamine|ketamine|mesh-list
44635026|NCT00419003|Riluzole|riluzole|mesh-list
44635027|NCT00419003|Analgesics|analgesics|mesh-ancestor
44635028|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
44635029|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635030|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635031|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44635032|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44635033|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
44635034|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
44635035|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635036|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44635037|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44635038|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635039|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635040|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
44635041|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635042|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635043|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635044|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44635045|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635046|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635047|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44635048|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44635049|NCT00419003|Protective Agents|protective agents|mesh-ancestor
44635050|NCT00418938|Leucovorin|leucovorin|mesh-list
44635051|NCT00418938|Bevacizumab|bevacizumab|mesh-list
44635052|NCT00418938|Panitumumab|panitumumab|mesh-list
44635053|NCT00418938|Fluorouracil|fluorouracil|mesh-list
44635054|NCT00418938|Irinotecan|irinotecan|mesh-list
44635055|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635056|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635057|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635058|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635059|NCT00418938|Growth Substances|growth substances|mesh-ancestor
44635060|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635061|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635062|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
44635063|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635064|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635065|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635066|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
44635067|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44635068|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635069|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030471|NCT00000913|Ritonavir|ritonavir|mesh-list
44635070|NCT00418938|Antidotes|antidotes|mesh-ancestor
44635071|NCT00418938|Protective Agents|protective agents|mesh-ancestor
44635072|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
44635073|NCT00418938|Vitamins|vitamins|mesh-ancestor
44635074|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
44635075|NCT00418886|Pemetrexed|pemetrexed|mesh-list
44635076|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635077|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902802|NCT00113321|Decitabine|decitabine|mesh-list
44635078|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635079|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44635080|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635081|NCT00418717|Etanercept|etanercept|mesh-list
44635082|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44635083|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44635084|NCT00418717|Analgesics|analgesics|mesh-ancestor
44635085|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
44635086|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635087|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635088|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635089|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635090|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635091|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635092|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
44635093|NCT00418691|Methylphenidate|methylphenidate|mesh-list
44635094|NCT00418691|Modafinil|modafinil|mesh-list
44635095|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44635096|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635097|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44635098|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44635099|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635100|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635101|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
44635102|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635103|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44635104|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44635105|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44635106|NCT00418522|Insulin|insulin|mesh-list
44635107|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44635108|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
44635109|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44635110|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635111|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
44635112|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635113|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
44635114|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44635115|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44635116|NCT00418145|Prednisolone|prednisolone|mesh-list
44635117|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
44635118|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44635119|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
44635120|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635121|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
44635122|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
44635123|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635124|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635125|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635126|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
44635127|NCT00418145|Hormones|hormones|mesh-ancestor
44635128|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635129|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44635130|NCT00418145|Protective Agents|protective agents|mesh-ancestor
44635131|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902845|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
44635132|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635133|NCT00417976|Gemcitabine|gemcitabine|mesh-list
44635134|NCT00417976|Bevacizumab|bevacizumab|mesh-list
44635135|NCT00417976|Fluorouracil|fluorouracil|mesh-list
44635136|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635137|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635138|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635139|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635140|NCT00417976|Growth Substances|growth substances|mesh-ancestor
44635141|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635142|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635143|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635145|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635146|NCT00417976|Antiviral Agents|antiviral agents|mesh-ancestor
44635147|NCT00417976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635148|NCT00417976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635149|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635150|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
44635151|NCT00417885|Sunitinib|sunitinib|mesh-list
44635152|NCT00417885|Exemestane|exemestane|mesh-list
44635153|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186481|NCT00336765|XL647|xl647|mesh-list
44635154|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635155|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635156|NCT00417885|Growth Substances|growth substances|mesh-ancestor
44635157|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635158|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635159|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635160|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635161|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635162|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44635163|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44635164|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44635165|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
44635166|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635167|NCT00417482|Risperidone|risperidone|mesh-list
44635168|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44635169|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
44635170|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635171|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635172|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635173|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44635174|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635175|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635176|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635177|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44635178|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
44635179|NCT00417248|Cisplatin|cisplatin|mesh-list
44635180|NCT00417248|Etoposide|etoposide|mesh-list
44635181|NCT00417248|Sorafenib|sorafenib|mesh-list
44635182|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635183|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44635184|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44635185|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635186|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635187|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635188|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635189|NCT00417170|Amlodipine|amlodipine|mesh-list
44635190|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635191|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635192|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635193|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635194|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635195|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635196|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635197|NCT00417079|Prednisone|prednisone|mesh-list
44635198|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
44635199|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635200|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
44635201|NCT00417079|Hormones|hormones|mesh-ancestor
44635202|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635203|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635204|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44635205|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635206|NCT00417079|Analgesics|analgesics|mesh-ancestor
44635207|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
44635208|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635209|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44635210|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635211|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635212|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635213|NCT00416884|Fludarabine|fludarabine|mesh-list
44635214|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
44635215|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635216|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635217|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
44635218|NCT00416715|Vitamin D|vitamin d|mesh-list
44635219|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
44635220|NCT00416715|Letrozole|letrozole|mesh-list
44635221|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
44635222|NCT00416715|Citric Acid|citric acid|mesh-list
44635223|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
44635224|NCT00416715|Calcium|calcium|mesh-list
44635225|NCT00416715|Vitamins|vitamins|mesh-ancestor
44635226|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
44635227|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635228|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635229|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44635230|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
44635231|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44635232|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
44635233|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
44635234|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635235|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635236|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44635237|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44635238|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635239|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44635240|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
44635241|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635242|NCT00416715|Antacids|antacids|mesh-ancestor
44635243|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635244|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
44635245|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
44635246|NCT00416624|Hematinics|hematinics|mesh-ancestor
44635247|NCT00416598|Cytarabine|cytarabine|mesh-list
44635248|NCT00416598|Etoposide|etoposide|mesh-list
44635249|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
44635250|NCT00416598|Daunorubicin|daunorubicin|mesh-list
44635251|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
44635252|NCT00416598|Busulfan|busulfan|mesh-list
44635253|NCT00416598|Decitabine|decitabine|mesh-list
44635254|NCT00416598|Lenograstim|lenograstim|mesh-list
44635255|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44635256|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635257|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44635258|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635259|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635260|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635261|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635262|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
44635263|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
44635264|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635265|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635266|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
44635267|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635268|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44635269|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
44635270|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44635271|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44635272|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44635273|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
44635274|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44635275|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
44635276|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
44635277|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
44635278|NCT00416520|Sevelamer|sevelamer|mesh-list
44635279|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
44635280|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
44635281|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635282|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44635283|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44635284|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635285|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
44635286|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635287|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635288|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635289|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635290|NCT00415636|Pemetrexed|pemetrexed|mesh-list
44635291|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635292|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635293|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635294|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44635295|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635296|NCT00415610|Nicardipine|nicardipine|mesh-list
44635297|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635298|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635299|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635300|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635301|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635302|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635303|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635304|NCT00415597|Naltrexone|naltrexone|mesh-list
44635305|NCT00415597|Morphine|morphine|mesh-list
44635307|NCT00415597|Narcotics|narcotics|mesh-ancestor
44635308|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635309|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635310|NCT00415597|Analgesics|analgesics|mesh-ancestor
44635311|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
44635312|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635313|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44635314|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44635315|NCT00415519|Edaravone|edaravone|mesh-list
44635316|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44635317|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
44635318|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635319|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44635320|NCT00415519|Protective Agents|protective agents|mesh-ancestor
44635321|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635322|NCT00415194|Cisplatin|cisplatin|mesh-list
44635323|NCT00415194|Pemetrexed|pemetrexed|mesh-list
44635324|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635325|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635326|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635327|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44635328|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635329|NCT00415168|Cisplatin|cisplatin|mesh-list
44635330|NCT00415168|Pemetrexed|pemetrexed|mesh-list
44635331|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635332|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635333|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635334|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44635335|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635336|NCT00414973|Teriparatide|teriparatide|mesh-list
44635337|NCT00414973|Calcitonin|calcitonin|mesh-list
44635338|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
44635339|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44635340|NCT00414973|Katacalcin|katacalcin|mesh-list
44635341|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635342|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635343|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44635344|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635345|NCT00414908|Pancrelipase|pancrelipase|mesh-list
44635346|NCT00414908|Pancreatin|pancreatin|mesh-list
44635347|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635348|NCT00414765|Aldesleukin|aldesleukin|mesh-list
44635349|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635350|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44635351|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44635352|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
44635353|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635354|NCT00414661|Tofacitinib|tofacitinib|mesh-list
44635355|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635356|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635357|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635358|NCT00414466|Gabapentin|gabapentin|mesh-list
44635359|NCT00414466|Analgesics|analgesics|mesh-ancestor
43903081|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
44635360|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
44635361|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635362|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635363|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
44635364|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44635365|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635366|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635367|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635368|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44635369|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44635370|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635371|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635373|NCT00414453|Lidocaine|lidocaine|mesh-list
44635374|NCT00414453|Oxycodone|oxycodone|mesh-list
44635375|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
44635376|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
44635377|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635378|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635379|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
44635380|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635381|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44635382|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44635384|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635385|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635386|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44635387|NCT00414453|Narcotics|narcotics|mesh-ancestor
44635388|NCT00414453|Analgesics|analgesics|mesh-ancestor
44635389|NCT00414440|Everolimus|everolimus|mesh-list
44635390|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635391|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635392|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
44635393|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635394|NCT00414388|Sorafenib|sorafenib|mesh-list
44635395|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635396|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635397|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635398|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635399|NCT00414310|Decitabine|decitabine|mesh-list
44635400|NCT00414310|Valproic Acid|valproic acid|mesh-list
44635401|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635402|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
44635403|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635404|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635405|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635406|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
44635407|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
44635408|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635409|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635410|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
44635411|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635412|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635413|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635414|NCT00414076|Letrozole|letrozole|mesh-list
44635415|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635416|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44635417|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44635418|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635419|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635420|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44635421|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
44635422|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635423|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635424|NCT00414050|Vaccines|vaccines|mesh-list
44635425|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
44635426|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635427|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
44635428|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
44635429|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635430|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635431|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44635432|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635433|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635434|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635435|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635436|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44635437|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44635438|NCT00413972|Simvastatin|simvastatin|mesh-list
44635439|NCT00413972|Ezetimibe|ezetimibe|mesh-list
44635440|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44635441|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44635442|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
44635443|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635444|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44635445|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44635446|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635447|NCT00413959|Dexamethasone|dexamethasone|mesh-list
44635448|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
44635449|NCT00413959|Rituximab|rituximab|mesh-list
44635450|NCT00413959|Bortezomib|bortezomib|mesh-list
44635451|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635452|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
44635453|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635454|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635455|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44635456|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
44635457|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635458|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635459|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44635460|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635461|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635462|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
44635463|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
44635464|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635465|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635466|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
44635467|NCT00413959|Hormones|hormones|mesh-ancestor
44635468|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635469|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44635470|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
44635471|NCT00413920|Prednisone|prednisone|mesh-list
44635472|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635473|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
44635474|NCT00413920|Hormones|hormones|mesh-ancestor
44635475|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635476|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635477|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44635478|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635479|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44635480|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44635481|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
44635482|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635483|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635484|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635485|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635486|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
44635487|NCT00413894|Hematinics|hematinics|mesh-ancestor
44635488|NCT00413777|Tolvaptan|tolvaptan|mesh-list
44635489|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44635490|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635491|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
44635492|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635493|NCT00413699|Tofacitinib|tofacitinib|mesh-list
44635494|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635495|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635496|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635497|NCT00413660|Tofacitinib|tofacitinib|mesh-list
44635498|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635499|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635500|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635501|NCT00413413|Amlodipine|amlodipine|mesh-list
44635502|NCT00413413|Valsartan|valsartan|mesh-list
44635503|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635504|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635505|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635506|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635507|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635508|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635509|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635510|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44635511|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44635512|NCT00413374|Enoxaparin|enoxaparin|mesh-list
44635513|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
44635514|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44635515|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44635516|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635517|NCT00413283|Gemcitabine|gemcitabine|mesh-list
44635518|NCT00413283|Cisplatin|cisplatin|mesh-list
44635519|NCT00413283|Carboplatin|carboplatin|mesh-list
44635520|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635521|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635522|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
44635523|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635524|NCT00413283|Antiviral Agents|antiviral agents|mesh-ancestor
44635525|NCT00413283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635526|NCT00413283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635527|NCT00413283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635528|NCT00413283|Immunologic Factors|immunologic factors|mesh-ancestor
44635529|NCT00413283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635530|NCT00413244|Testosterone|testosterone|mesh-list
44635531|NCT00413244|Androgens|androgens|mesh-ancestor
44635532|NCT00413244|Hormones|hormones|mesh-ancestor
44635533|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635534|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635536|NCT00413218|Caspofungin|caspofungin|mesh-list
44635537|NCT00413218|Isavuconazole|isavuconazole|mesh-list
44635538|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
44635539|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635540|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44635541|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44635542|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635543|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635544|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44635545|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
44635546|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635547|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635548|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44635549|NCT00413153|Ritonavir|ritonavir|mesh-list
44635550|NCT00413153|Lopinavir|lopinavir|mesh-list
44635551|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44635552|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44635553|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44635554|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
44635555|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635556|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635557|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44635558|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44635559|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
44635560|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635561|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44635562|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44635563|NCT00413049|Amlodipine|amlodipine|mesh-list
44635564|NCT00413049|Valsartan|valsartan|mesh-list
44635565|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635566|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635567|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635568|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635569|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635570|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635571|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635572|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44635573|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44635574|NCT00413036|Lenalidomide|lenalidomide|mesh-list
44635575|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
44635576|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635577|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635578|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635579|NCT00413036|Growth Substances|growth substances|mesh-ancestor
44635580|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635581|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635582|NCT00413010|Pregabalin|pregabalin|mesh-list
44635583|NCT00413010|Analgesics|analgesics|mesh-ancestor
44635584|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
44635585|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635586|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635587|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
44635588|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635589|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635590|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635591|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635592|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44635593|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635594|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635595|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635596|NCT00412984|Warfarin|warfarin|mesh-list
44635597|NCT00412984|Apixaban|apixaban|mesh-list
44635598|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
44635599|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44635600|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
44635601|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44635602|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
44635603|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635604|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635605|NCT00412958|Plasminogen|plasminogen|mesh-list
44635606|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
44635607|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44635608|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44635609|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635610|NCT00412893|Voriconazole|voriconazole|mesh-list
44635611|NCT00412893|Isavuconazole|isavuconazole|mesh-list
44635612|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
44635613|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635614|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44635615|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44635616|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635617|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635618|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44635619|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
44635620|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635621|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635622|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44635623|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44635624|NCT00412750|Telbivudine|telbivudine|mesh-list
44635625|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
44635626|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635627|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635628|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635629|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635630|NCT00412737|Oseltamivir|oseltamivir|mesh-list
44635631|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
44635632|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635633|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635634|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635635|NCT00412542|Thalidomide|thalidomide|mesh-list
44635636|NCT00412542|Irinotecan|irinotecan|mesh-list
44635637|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44635638|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44635639|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635640|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635641|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635642|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635643|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
44635644|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635645|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
44635646|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635647|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635648|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635649|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635650|NCT00412542|Growth Substances|growth substances|mesh-ancestor
44635651|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635652|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44635653|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44635654|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44635655|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635656|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635657|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635658|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44635659|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44635660|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
44635661|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635662|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635663|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44635664|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44635665|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
44635666|NCT00412360|Cyclosporine|cyclosporine|mesh-list
44635667|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
44635668|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
44635669|NCT00412360|Fludarabine|fludarabine|mesh-list
44635670|NCT00412360|Cyclosporins|cyclosporins|mesh-list
44635671|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635672|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
44635673|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635674|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635675|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44635676|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
44635677|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635678|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635679|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44635680|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635681|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
44635683|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
44635684|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44635685|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44635686|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44635687|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
44635688|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635689|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44635690|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635691|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635692|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635693|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635694|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
44635695|NCT00412113|Amlodipine|amlodipine|mesh-list
44635696|NCT00412113|Atorvastatin|atorvastatin|mesh-list
44635697|NCT00412113|Calcium|calcium|mesh-list
44635698|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44635699|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635700|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44635701|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44635702|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44635703|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
44635704|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635705|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44635706|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44635707|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635708|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635709|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44635710|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635711|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
44635712|NCT00412061|Everolimus|everolimus|mesh-list
44635713|NCT00412061|Octreotide|octreotide|mesh-list
44635714|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635715|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635716|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
44635717|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635718|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635719|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44635720|NCT00411788|Sirolimus|sirolimus|mesh-list
44635721|NCT00411788|Trastuzumab|trastuzumab|mesh-list
44635722|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635723|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635724|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635725|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635726|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44635727|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
44635728|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635729|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
44635730|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635731|NCT00411762|Capecitabine|capecitabine|mesh-list
44635732|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635733|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
44635734|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635735|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635736|NCT00411671|Sorafenib|sorafenib|mesh-list
44635737|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635738|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635739|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635740|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635741|NCT00411645|Maribavir|maribavir|mesh-list
44635742|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
44635743|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031160|NCT00001024|Zidovudine|zidovudine|mesh-list
44635744|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44635745|NCT00411632|Bexarotene|bexarotene|mesh-list
44635746|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635747|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635748|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635749|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635750|NCT00411554|Inositol|inositol|mesh-list
44635751|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44635752|NCT00411554|Voglibose|voglibose|mesh-list
44635753|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44635754|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635755|NCT00411554|Incretins|incretins|mesh-ancestor
44635756|NCT00411554|Hormones|hormones|mesh-ancestor
44635757|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635758|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44635759|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
44635760|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635761|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635762|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44635763|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
44635764|NCT00411554|Vitamins|vitamins|mesh-ancestor
44635765|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
44635766|NCT00411450|Panitumumab|panitumumab|mesh-list
44635767|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44635768|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635769|NCT00411151|Sunitinib|sunitinib|mesh-list
44635770|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635771|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635772|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635773|NCT00411151|Growth Substances|growth substances|mesh-ancestor
44635774|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635775|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635776|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635777|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635778|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635779|NCT00410813|Dasatinib|dasatinib|mesh-list
44635780|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635781|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635782|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635783|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635784|NCT00410605|Dexamethasone|dexamethasone|mesh-list
44635785|NCT00410605|Bevacizumab|bevacizumab|mesh-list
44635786|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44635787|NCT00410605|Lenalidomide|lenalidomide|mesh-list
44635788|NCT00410605|Antibodies|antibodies|mesh-list
44635789|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
44635790|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44635791|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635792|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635793|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635794|NCT00410605|Growth Substances|growth substances|mesh-ancestor
44635795|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635796|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
44635797|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
44635798|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635799|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
44635800|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
44635801|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635802|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635803|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
44635804|NCT00410605|Hormones|hormones|mesh-ancestor
44635805|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44635806|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44635807|NCT00410514|Mirabegron|mirabegron|mesh-list
44635808|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44635809|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44635810|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44635811|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
44635812|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635813|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635814|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635815|NCT00410514|Urological Agents|urological agents|mesh-ancestor
44635816|NCT00410410|Abatacept|abatacept|mesh-list
44635817|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44031236|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44635818|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635819|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635820|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635821|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
44635822|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635823|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635824|NCT00410384|Belimumab|belimumab|mesh-list
44635825|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635826|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
44635827|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635828|NCT00410202|Tenofovir|tenofovir|mesh-list
44635829|NCT00410202|Lamivudine|lamivudine|mesh-list
44635830|NCT00410202|Entecavir|entecavir|mesh-list
44635831|NCT00410202|Adefovir|adefovir|mesh-list
44454676|NCT01660763|Dsuvia|dsuvia|mesh-list
44635832|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
44635833|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635834|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44635835|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635836|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635837|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635838|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44635839|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44635840|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
44635841|NCT00410163|Fludarabine|fludarabine|mesh-list
44635842|NCT00410163|Ofatumumab|ofatumumab|mesh-list
44635843|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44635844|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635845|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
44635846|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635847|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635848|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44635849|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
44635850|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635851|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635852|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44635853|NCT00410124|Everolimus|everolimus|mesh-list
44635854|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635855|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635856|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
44635857|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635858|NCT00410072|Tenofovir|tenofovir|mesh-list
44635859|NCT00410072|Entecavir|entecavir|mesh-list
44635860|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
44635861|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635862|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44635863|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635864|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635865|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635866|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44635867|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44635868|NCT00410046|Etanercept|etanercept|mesh-list
44635869|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44635870|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44635871|NCT00410046|Analgesics|analgesics|mesh-ancestor
44635872|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
44635873|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635874|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635875|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635876|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635877|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44635878|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635879|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
44635880|NCT00409838|Methotrexate|methotrexate|mesh-list
44635881|NCT00409838|Abatacept|abatacept|mesh-list
44635882|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44635883|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
44635884|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44635885|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635886|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44635887|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
44635888|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635889|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635890|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44635891|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635892|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43774034|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
44635893|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635894|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
44635895|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635896|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635897|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44635898|NCT00409747|Minocycline|minocycline|mesh-list
44635899|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44635900|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44635901|NCT00409708|Methylphenidate|methylphenidate|mesh-list
44635902|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44635903|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635904|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44635905|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44635906|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635907|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635908|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
44635909|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635911|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635912|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635913|NCT00409617|Adalimumab|adalimumab|mesh-list
44635914|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44635915|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635916|NCT00409578|Valsartan|valsartan|mesh-list
44635917|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44635918|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43903597|NCT00140556|Growth Substances|growth substances|mesh-ancestor
44635919|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44635920|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635921|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
44635922|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44635923|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44635924|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635925|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44635926|NCT00409344|Analgesics|analgesics|mesh-ancestor
44635927|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
44635928|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635929|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44635930|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44635931|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44635932|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
44635933|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635934|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635935|NCT00409331|Amifostine|amifostine|mesh-list
44635936|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44635937|NCT00409331|Protective Agents|protective agents|mesh-ancestor
44635938|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635939|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
44635940|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44635941|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
44635942|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635943|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44635944|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44635945|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
44635946|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635947|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635948|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44635949|NCT00409006|Cisplatin|cisplatin|mesh-list
44635950|NCT00409006|Pemetrexed|pemetrexed|mesh-list
44635951|NCT00409006|Gefitinib|gefitinib|mesh-list
44635952|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635953|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44635954|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635955|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44635956|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44635957|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44635958|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44635959|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44635960|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44635961|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635962|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44635963|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635964|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635965|NCT00408993|Analgesics|analgesics|mesh-ancestor
44635966|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
44635967|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635968|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
44635969|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635970|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
44635971|NCT00408928|Bortezomib|bortezomib|mesh-list
44635972|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635973|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43903663|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44635974|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44635975|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44635976|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44635977|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187187|NCT00342381|Amifampridine|amifampridine|mesh-list
44635978|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44635979|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44635980|NCT00408876|Analgesics|analgesics|mesh-ancestor
44635981|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
44635982|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44635983|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44635984|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44635985|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
44635986|NCT00408694|Bevacizumab|bevacizumab|mesh-list
44635987|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44635988|NCT00408694|Cisplatin|cisplatin|mesh-list
44635989|NCT00408694|Fluorouracil|fluorouracil|mesh-list
44635990|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
44635991|NCT00408694|Antibodies|antibodies|mesh-list
44635992|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
44635993|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44635994|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
44635995|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44635996|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44635997|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44635998|NCT00408694|Growth Substances|growth substances|mesh-ancestor
44635999|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636000|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636001|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
44636002|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
44636003|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636004|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636005|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636006|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
44636007|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636008|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636009|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636010|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636011|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
44636012|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636013|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636014|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636015|NCT00408629|Adalimumab|adalimumab|mesh-list
44636016|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636017|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636018|NCT00408499|Cetuximab|cetuximab|mesh-list
44636019|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44636020|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636021|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636022|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44636023|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636024|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636025|NCT00408434|Efatutazone|efatutazone|mesh-list
44636026|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636027|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44636028|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636029|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636030|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636031|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636032|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636033|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636034|NCT00408421|Analgesics|analgesics|mesh-ancestor
44636035|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
44636036|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903715|NCT00145418|Docetaxel|docetaxel|mesh-list
44636037|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636038|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636040|NCT00408408|Gemcitabine|gemcitabine|mesh-list
44636041|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
44636042|NCT00408408|Bevacizumab|bevacizumab|mesh-list
44636043|NCT00408408|Docetaxel|docetaxel|mesh-list
44636044|NCT00408408|Doxorubicin|doxorubicin|mesh-list
44636045|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44636046|NCT00408408|Capecitabine|capecitabine|mesh-list
44636047|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636048|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
44636049|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636050|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636051|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636052|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
44187261|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
44636053|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636054|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636055|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44636056|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636057|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636058|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636059|NCT00408408|Growth Substances|growth substances|mesh-ancestor
44636060|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636061|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636062|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
44636063|NCT00408408|Antiviral Agents|antiviral agents|mesh-ancestor
44636064|NCT00408408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636065|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636066|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636067|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636068|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636069|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44636070|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44636071|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636072|NCT00408317|Pancrelipase|pancrelipase|mesh-list
44636074|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636075|NCT00407797|Pregabalin|pregabalin|mesh-list
44636076|NCT00407797|Analgesics|analgesics|mesh-ancestor
44636077|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
44636078|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636079|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636080|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
44636081|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636082|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636083|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636084|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636085|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44636086|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636087|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636088|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636089|NCT00407745|Pregabalin|pregabalin|mesh-list
44636090|NCT00407745|Analgesics|analgesics|mesh-ancestor
44636091|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
44636092|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636093|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636094|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
44636095|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636096|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636097|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636098|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636099|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44636100|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636101|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636102|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636103|NCT00407563|Paclitaxel|paclitaxel|mesh-list
44636104|NCT00407563|Bevacizumab|bevacizumab|mesh-list
44636105|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44636106|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44636107|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636108|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636109|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636110|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636111|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636112|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636113|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636114|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636115|NCT00407563|Growth Substances|growth substances|mesh-ancestor
44636116|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636117|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636118|NCT00407550|Gemcitabine|gemcitabine|mesh-list
44636120|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636121|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
44636122|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636123|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636124|NCT00407550|Antiviral Agents|antiviral agents|mesh-ancestor
44636125|NCT00407550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636126|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636127|NCT00407550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636128|NCT00407550|Immunologic Factors|immunologic factors|mesh-ancestor
44636129|NCT00407550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636130|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44636131|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44636133|NCT00407537|Atorvastatin|atorvastatin|mesh-list
44636134|NCT00407537|Calcium|calcium|mesh-list
44636135|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636136|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636137|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44636138|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44636139|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
44636140|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636141|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44636142|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44636143|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636144|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44636145|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636146|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636147|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
44636148|NCT00407511|Pregabalin|pregabalin|mesh-list
44636149|NCT00407511|Analgesics|analgesics|mesh-ancestor
44636150|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
44636151|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636152|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636153|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
44636154|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636155|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636156|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636157|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636158|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44636159|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636160|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636161|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636162|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44636163|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44636164|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44636165|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636166|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636167|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44636168|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636169|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636170|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
44636171|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636172|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44636173|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636174|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636175|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636176|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636177|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636178|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636179|NCT00406848|Analgesics|analgesics|mesh-ancestor
44636180|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
44636181|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636182|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636183|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636184|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
44636185|NCT00406692|Zonisamide|zonisamide|mesh-list
44636187|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636188|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636189|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636190|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636191|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636192|NCT00406653|Abatacept|abatacept|mesh-list
44636193|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44636194|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636195|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636196|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636197|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
44636198|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636199|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636200|NCT00406640|Citalopram|citalopram|mesh-list
44636201|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44636202|NCT00406640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44636203|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636204|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636205|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636206|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636207|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
44636208|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636209|NCT00406640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44636210|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636211|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636212|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636213|NCT00406419|Methotrexate|methotrexate|mesh-list
44636214|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
44636215|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44636216|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
44636217|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44636218|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903904|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636219|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636220|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
44636221|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636222|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636223|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
44636224|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636225|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44636226|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636227|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
44636228|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636229|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44636230|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44636231|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44636232|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636233|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636234|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44636235|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636236|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636237|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
44636238|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636239|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44636240|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44636241|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636242|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636243|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636244|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
44636245|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636246|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636247|NCT00406315|Ziprasidone|ziprasidone|mesh-list
44636248|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44636249|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
44636250|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636251|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636252|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636253|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44636254|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44031623|NCT00001115|Acyclovir|acyclovir|mesh-list
44636255|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636256|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636257|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44636258|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
44636259|NCT00406029|Levodopa|levodopa|mesh-list
44636260|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44636261|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44636262|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
44636263|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636264|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636265|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636266|NCT00405821|Acyclovir|acyclovir|mesh-list
44636267|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
44636268|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636269|NCT00405756|Aspirin|aspirin|mesh-list
44636270|NCT00405756|Prednisone|prednisone|mesh-list
44636271|NCT00405756|Lenalidomide|lenalidomide|mesh-list
44636272|NCT00405756|Melphalan|melphalan|mesh-list
44636273|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636274|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
44636275|NCT00405756|Hormones|hormones|mesh-ancestor
44636276|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636277|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636278|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44636279|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636280|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44636281|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44636282|NCT00405756|Analgesics|analgesics|mesh-ancestor
44636283|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
44636284|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636285|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636286|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44636287|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44636288|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636289|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44636290|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44636291|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636292|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
44636293|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
44636294|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636295|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636296|NCT00405756|Growth Substances|growth substances|mesh-ancestor
44636297|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636298|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636299|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
44636300|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44636301|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636302|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
44636303|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44636304|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636305|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44636306|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
44636307|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44636308|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636309|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636310|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636311|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44636312|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
44636313|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636314|NCT00405587|Vemurafenib|vemurafenib|mesh-list
44636315|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636316|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44636317|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636318|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636319|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44636320|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
44636321|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636322|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
44636323|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44636324|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636325|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
44636326|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
44636327|NCT00405275|Etanercept|etanercept|mesh-list
44636328|NCT00405275|Methotrexate|methotrexate|mesh-list
44636329|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44636330|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
44636331|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44636332|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636333|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636334|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
44636335|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636336|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636337|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
44636338|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636339|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44636340|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636341|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
44636342|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636343|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187556|NCT00344006|Dapsone|dapsone|mesh-list
44636344|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
44636345|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44636346|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44636347|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636348|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44636349|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44636350|NCT00405275|Analgesics|analgesics|mesh-ancestor
44636351|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
44636352|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636353|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636354|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636355|NCT00405067|Ezetimibe|ezetimibe|mesh-list
44636356|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44636357|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44636358|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
44636359|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636360|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44636361|NCT00404820|Vitamin D|vitamin d|mesh-list
44636362|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
44636363|NCT00404820|Alendronate|alendronate|mesh-list
44636364|NCT00404820|Calcium|calcium|mesh-list
44636365|NCT00404820|Vitamins|vitamins|mesh-ancestor
44636366|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
44636367|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636368|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636369|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44636370|NCT00404755|Citalopram|citalopram|mesh-list
44636371|NCT00404755|Bupropion|bupropion|mesh-list
44636372|NCT00404755|Imipramine|imipramine|mesh-list
44636373|NCT00404755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44636374|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636375|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636376|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636377|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636378|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
44636379|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636380|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44636381|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636382|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636383|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44636384|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
44636385|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44636386|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44636387|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636388|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44636389|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44636390|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
44636391|NCT00404651|Vaccines|vaccines|mesh-list
44636392|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
43904054|NCT00168298|BB 1101|bb 1101|mesh-list
44636393|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636394|NCT00404547|Ciclesonide|ciclesonide|mesh-list
44636395|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
44636397|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636398|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636399|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44636400|NCT00404495|Irinotecan|irinotecan|mesh-list
44636401|NCT00404495|Temozolomide|temozolomide|mesh-list
44636402|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44636403|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636404|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636405|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636407|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636408|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
44636409|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
44636410|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44636411|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
44636412|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636413|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636414|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
44636415|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636416|NCT00404235|Paclitaxel|paclitaxel|mesh-list
44636417|NCT00404235|Carboplatin|carboplatin|mesh-list
44636418|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44636419|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44636420|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636421|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636422|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636423|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636424|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636425|NCT00404092|Caspofungin|caspofungin|mesh-list
44636426|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
44636427|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636428|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636429|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636430|NCT00404066|Dexamethasone|dexamethasone|mesh-list
44636431|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
44636432|NCT00404066|Docetaxel|docetaxel|mesh-list
44636433|NCT00404066|Doxorubicin|doxorubicin|mesh-list
44636434|NCT00404066|Trastuzumab|trastuzumab|mesh-list
44636435|NCT00404066|Lapatinib|lapatinib|mesh-list
44636436|NCT00404066|Lenograstim|lenograstim|mesh-list
44636437|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636438|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
44636439|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636440|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636441|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636442|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
44636443|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636444|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636445|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44636446|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636447|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
44636448|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
43904106|NCT00168389|Hormones|hormones|mesh-ancestor
44636449|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636450|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636451|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
44636452|NCT00404066|Hormones|hormones|mesh-ancestor
44636453|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636454|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44636455|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636456|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636457|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636458|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44636459|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44636460|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636461|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636462|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636463|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44636464|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44636465|NCT00403767|Warfarin|warfarin|mesh-list
44187706|NCT00344526|Dexamethasone|dexamethasone|mesh-list
44636466|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
44636467|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
44636468|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44636469|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
44636470|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44636471|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
44636472|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636473|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636474|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44636475|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44636476|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
44636477|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636478|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636479|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44636480|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44636481|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44636482|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44636483|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44636484|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44636485|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636486|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636487|NCT00403585|Adefovir|adefovir|mesh-list
44636488|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44636489|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
44636490|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636491|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44636492|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44636493|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636494|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636495|NCT00403559|Ketoconazole|ketoconazole|mesh-list
44636496|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
44636497|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
44636498|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636499|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44636500|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44636501|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636502|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636503|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44636504|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
44636505|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636506|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636507|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44636508|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44636509|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44636510|NCT00403559|Analgesics|analgesics|mesh-ancestor
44636511|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
44636512|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636513|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636514|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636515|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44636516|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636517|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
44636518|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44636519|NCT00403546|Ziprasidone|ziprasidone|mesh-list
44636520|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44636521|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
44636522|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636523|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636524|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636525|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44636526|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636527|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636528|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636529|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44636530|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
44636531|NCT00403494|Verapamil|verapamil|mesh-list
44636532|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44636533|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636534|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636535|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636536|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636537|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636538|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
44636539|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44636540|NCT00403481|Olmesartan|olmesartan|mesh-list
44636541|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44187783|NCT00344760|Tenofovir|tenofovir|mesh-list
44636542|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44636543|NCT00403481|Diuretics|diuretics|mesh-ancestor
44636544|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
44636545|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636546|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44636547|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636548|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636549|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44636550|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44636551|NCT00403455|Paroxetine|paroxetine|mesh-list
43774397|NCT02352597|Estrogens|estrogens|mesh-ancestor
44636552|NCT00403455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44636553|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636554|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636555|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636556|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636557|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
44636558|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636559|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44636560|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636561|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636562|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44636563|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44636564|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636565|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
44636566|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44636567|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44636568|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44636569|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636570|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636571|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
44636572|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636573|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636574|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44636575|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636576|NCT00403260|Artesunate|artesunate|mesh-list
44636577|NCT00403260|Mefloquine|mefloquine|mesh-list
44636578|NCT00403260|Pyronaridine|pyronaridine|mesh-list
44636579|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
44636580|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44636581|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44636582|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636583|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636584|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
44636585|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
44636586|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44636587|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
44636588|NCT00403234|Buprenorphine|buprenorphine|mesh-list
44636589|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44636590|NCT00403234|Narcotics|narcotics|mesh-ancestor
44636591|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636592|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636593|NCT00403234|Analgesics|analgesics|mesh-ancestor
44636594|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
44636595|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636596|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44636597|NCT00403130|Gemcitabine|gemcitabine|mesh-list
44636598|NCT00403130|Paclitaxel|paclitaxel|mesh-list
44636599|NCT00403130|Bevacizumab|bevacizumab|mesh-list
44636600|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44636601|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636602|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636603|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636604|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636605|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636606|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636607|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636608|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636609|NCT00403130|Growth Substances|growth substances|mesh-ancestor
44636610|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636611|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636612|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636613|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
44636614|NCT00403130|Antiviral Agents|antiviral agents|mesh-ancestor
44636615|NCT00403130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636616|NCT00403130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636617|NCT00403130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636618|NCT00403130|Immunologic Factors|immunologic factors|mesh-ancestor
44636619|NCT00402987|Celecoxib|celecoxib|mesh-list
44636620|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44636621|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44636622|NCT00402987|Analgesics|analgesics|mesh-ancestor
44636623|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
44636624|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636625|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636626|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636627|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636628|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44636629|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44636630|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636631|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636632|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44636633|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636634|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44636635|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636636|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636637|NCT00402727|Amoxicillin|amoxicillin|mesh-list
44636638|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
44636639|NCT00402727|Tazobactam|tazobactam|mesh-list
44636640|NCT00402727|Piperacillin|piperacillin|mesh-list
44636641|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
44636642|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
44636643|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44636644|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44636645|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44636646|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636647|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44636648|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636649|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636650|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636651|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636652|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44636653|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
44636654|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44636655|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636656|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44636657|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44636658|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44636659|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44636660|NCT00402688|Levofloxacin|levofloxacin|mesh-list
44636661|NCT00402688|Ofloxacin|ofloxacin|mesh-list
44636662|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44636663|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636664|NCT00402688|Renal Agents|renal agents|mesh-ancestor
44636665|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44636666|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44636667|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636668|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636669|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636670|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636671|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44636672|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44636673|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
44636674|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44636675|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
44636676|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44636677|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44636678|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636679|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636680|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
44636681|NCT00402337|Linaclotide|linaclotide|mesh-list
44636682|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44636683|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
44636684|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636685|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636686|NCT00402324|Valproic Acid|valproic acid|mesh-list
44636687|NCT00402324|Olanzapine|olanzapine|mesh-list
44636688|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
44636689|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
44187927|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
44636691|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636692|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636693|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44636694|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636695|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636696|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636697|NCT00402324|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44636698|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636699|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636700|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636701|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636702|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
44636703|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
44636704|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636706|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
44636707|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44636708|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
44636709|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636710|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636711|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
44636712|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636713|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636714|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44636715|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636716|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636717|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44636718|NCT00402285|Lycopene|lycopene|mesh-list
44636719|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636720|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
44636721|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636722|NCT00402285|Protective Agents|protective agents|mesh-ancestor
44636723|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636724|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44636725|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44636726|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636727|NCT00402233|Pramipexole|pramipexole|mesh-list
44636728|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
44636729|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636730|NCT00402233|Protective Agents|protective agents|mesh-ancestor
44636731|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636732|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44636733|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44636734|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
44636735|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
44636736|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636737|NCT00402168|Cyclosporine|cyclosporine|mesh-list
44636738|NCT00402168|Abatacept|abatacept|mesh-list
44636739|NCT00402168|Tacrolimus|tacrolimus|mesh-list
44636740|NCT00402168|Cyclosporins|cyclosporins|mesh-list
44636741|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636742|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
44636743|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636744|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44636745|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636746|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636747|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
44636748|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636749|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44636750|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636751|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44636752|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636753|NCT00402116|Temozolomide|temozolomide|mesh-list
44636754|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636755|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
44636756|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636757|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636758|NCT00402103|Amlodipine|amlodipine|mesh-list
44636759|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44636760|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44636761|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636762|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187940|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
44636763|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636764|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636765|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636767|NCT00402103|Diuretics|diuretics|mesh-ancestor
44636768|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
44636769|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44636770|NCT00402051|Cisplatin|cisplatin|mesh-list
44636771|NCT00402051|Carboplatin|carboplatin|mesh-list
44636772|NCT00402051|Pemetrexed|pemetrexed|mesh-list
44636773|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636774|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636775|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636776|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44636777|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44636778|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44636779|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636780|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636781|NCT00401973|Metformin|metformin|mesh-list
44636782|NCT00401973|Amantadine|amantadine|mesh-list
44636783|NCT00401973|Zonisamide|zonisamide|mesh-list
44636784|NCT00401973|Olanzapine|olanzapine|mesh-list
44636785|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44636786|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636787|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
44636788|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
44636789|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636790|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636791|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44636792|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44636793|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44636794|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636795|NCT00401973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44636796|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636797|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636798|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636799|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636800|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
44636801|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44636802|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44636803|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
44636804|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636805|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
44636806|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44636807|NCT00401973|Analgesics|analgesics|mesh-ancestor
44636808|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
44636809|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
44636810|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44636811|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44636812|NCT00401960|Daptomycin|daptomycin|mesh-list
44636813|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44636814|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636815|NCT00401843|Dexamethasone|dexamethasone|mesh-list
44636816|NCT00401843|Bortezomib|bortezomib|mesh-list
44636817|NCT00401843|Siltuximab|siltuximab|mesh-list
44636818|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636819|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
44636820|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
44636821|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636822|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636823|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636824|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
44636825|NCT00401843|Hormones|hormones|mesh-ancestor
44636826|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636827|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44636828|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636829|NCT00401830|Lacosamide|lacosamide|mesh-list
44636830|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
43904502|NCT00183339|Fluoxetine|fluoxetine|mesh-list
44636831|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44636832|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44636833|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636834|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636835|NCT00401752|Esomeprazole|esomeprazole|mesh-list
44636836|NCT00401752|Ranitidine|ranitidine|mesh-list
44636837|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44636838|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44636839|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636840|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44636841|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636842|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636843|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44636844|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
44636845|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
44636846|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636847|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636848|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44636849|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636850|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636851|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636852|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636853|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636854|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636855|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44636856|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636857|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636858|NCT00401544|Dextrans|dextrans|mesh-list
44636859|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
44636860|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
44636861|NCT00401544|Hematinics|hematinics|mesh-ancestor
44636862|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
44636863|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
44636864|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
44636865|NCT00401531|Vaccines|vaccines|mesh-list
44636866|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44636867|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
44636868|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636869|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
44636870|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44636871|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636872|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
44636873|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636874|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44636875|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636876|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636877|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636878|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636879|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636880|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636881|NCT00401258|Analgesics|analgesics|mesh-ancestor
44636882|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
44636883|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636884|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636885|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636886|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
44636887|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44636888|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44636889|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44636890|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44636891|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636892|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44636893|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636894|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
44636895|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44636896|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
44636897|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44636898|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44636899|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636900|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
44636901|NCT00401193|Coagulants|coagulants|mesh-ancestor
44636902|NCT00400946|Leucovorin|leucovorin|mesh-list
44636903|NCT00400946|Cytarabine|cytarabine|mesh-list
44636904|NCT00400946|Dexamethasone|dexamethasone|mesh-list
44636905|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
44636906|NCT00400946|Prednisolone|prednisolone|mesh-list
44636907|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
44636908|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44636909|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44636910|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44636911|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
44636912|NCT00400946|Doxorubicin|doxorubicin|mesh-list
44636913|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44636914|NCT00400946|Methotrexate|methotrexate|mesh-list
44636915|NCT00400946|Etoposide|etoposide|mesh-list
44636916|NCT00400946|Vincristine|vincristine|mesh-list
44636917|NCT00400946|Asparaginase|asparaginase|mesh-list
44636918|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
44636919|NCT00400946|Pegaspargase|pegaspargase|mesh-list
44636920|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
44636921|NCT00400946|Razoxane|razoxane|mesh-list
44636922|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
44636923|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636924|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
44636925|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636926|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636927|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44636928|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
44636929|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636930|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636931|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44636932|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44636933|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
44636934|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
43904589|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
44636935|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44636936|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44636937|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
44636938|NCT00400946|Hormones|hormones|mesh-ancestor
44636939|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44636940|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44636941|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44636942|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44636943|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44636944|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636945|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44636946|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
44636947|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44636948|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44636949|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
44636950|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44636951|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44636952|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44636953|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44636954|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
44636955|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636956|NCT00400946|Antidotes|antidotes|mesh-ancestor
44636957|NCT00400946|Protective Agents|protective agents|mesh-ancestor
44636958|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
44636959|NCT00400946|Vitamins|vitamins|mesh-ancestor
44636960|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
44636961|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44636962|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44636963|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44636964|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44636965|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44636966|NCT00400764|Rituximab|rituximab|mesh-list
44636967|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44636968|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636969|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
44636970|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636971|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44636972|NCT00400569|Sunitinib|sunitinib|mesh-list
44636973|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636974|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636975|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636976|NCT00400569|Growth Substances|growth substances|mesh-ancestor
44636977|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636978|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636979|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44636980|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44636981|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44636982|NCT00400517|Thalidomide|thalidomide|mesh-list
44636983|NCT00400517|Sargramostim|sargramostim|mesh-list
44636984|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44636985|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
44636986|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44636987|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
44188194|NCT00346749|Xhance|xhance|mesh-list
44636988|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44636989|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44636990|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44636991|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44636992|NCT00400517|Growth Substances|growth substances|mesh-ancestor
44636993|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
44636994|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636995|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
44636996|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44636997|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44636998|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44636999|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
44637000|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637001|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637002|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637003|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637004|NCT00400179|Cisplatin|cisplatin|mesh-list
44637005|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637006|NCT00400153|Ipratropium|ipratropium|mesh-list
44637007|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44637008|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
44637009|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637010|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637011|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44637012|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
44637013|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44637014|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
44637015|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637016|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637017|NCT00399893|Octreotide|octreotide|mesh-list
44637018|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44637019|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44637020|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637021|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44637022|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44637023|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44637024|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637025|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637026|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637027|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637028|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637029|NCT00399568|Acetaminophen|acetaminophen|mesh-list
43904687|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
44637030|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44637031|NCT00399568|Analgesics|analgesics|mesh-ancestor
44637032|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
44637033|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637034|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637035|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
44637036|NCT00399542|Lubiprostone|lubiprostone|mesh-list
44637037|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44637038|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637039|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637040|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
44637041|NCT00399529|Trastuzumab|trastuzumab|mesh-list
44637042|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637043|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
44637044|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637045|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637046|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44637047|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
44637048|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637049|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637050|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44637051|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637052|NCT00399490|Tanezumab|tanezumab|mesh-list
44637053|NCT00399490|Analgesics|analgesics|mesh-ancestor
44637054|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
44637055|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637056|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637057|NCT00399360|Metformin|metformin|mesh-list
44637058|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637059|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637060|NCT00399035|Leucovorin|leucovorin|mesh-list
44637061|NCT00399035|Fluorouracil|fluorouracil|mesh-list
44637062|NCT00399035|Capecitabine|capecitabine|mesh-list
44637063|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
44637064|NCT00399035|Cediranib|cediranib|mesh-list
44637065|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
44637066|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
44637067|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637068|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637069|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637070|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637071|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
44637072|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637073|NCT00399035|Antidotes|antidotes|mesh-ancestor
44637074|NCT00399035|Protective Agents|protective agents|mesh-ancestor
44637075|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
44637076|NCT00399035|Vitamins|vitamins|mesh-ancestor
44637077|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
44637078|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637079|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637080|NCT00398866|Triamcinolone|triamcinolone|mesh-list
44637081|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44637082|NCT00398866|Bupivacaine|bupivacaine|mesh-list
44637083|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
44637084|NCT00398866|Hylan|hylan|mesh-list
44637085|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
44637086|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
44637087|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637088|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637089|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
44637090|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637091|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44637092|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
44637093|NCT00398866|Hormones|hormones|mesh-ancestor
44637094|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637095|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637096|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
44637097|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44637098|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
44637099|NCT00398866|Protective Agents|protective agents|mesh-ancestor
44637100|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44637101|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44637102|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44637103|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637104|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637105|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637106|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637107|NCT00398632|Analgesics|analgesics|mesh-ancestor
44637108|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
44637109|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637110|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44637111|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637112|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
44637113|NCT00398567|Trastuzumab|trastuzumab|mesh-list
44637114|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637115|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637116|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
44637117|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637118|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637119|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44637120|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637121|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637122|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637123|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637124|NCT00398320|Bevacizumab|bevacizumab|mesh-list
44637125|NCT00398320|Capecitabine|capecitabine|mesh-list
44637126|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
44637127|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637128|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637129|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637130|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637131|NCT00398320|Growth Substances|growth substances|mesh-ancestor
44637132|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637133|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637134|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637135|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
44637136|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637137|NCT00398216|Edoxaban|edoxaban|mesh-list
44637138|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
44637139|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
44637140|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44637141|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44637142|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637143|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637144|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
44637145|NCT00398138|Sargramostim|sargramostim|mesh-list
44637146|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
44637147|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
44637148|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637149|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44637150|NCT00398112|Sunitinib|sunitinib|mesh-list
44637152|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637153|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637154|NCT00398112|Growth Substances|growth substances|mesh-ancestor
44637155|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637156|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637157|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637158|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637159|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637160|NCT00398086|Gemcitabine|gemcitabine|mesh-list
44637161|NCT00398086|Paclitaxel|paclitaxel|mesh-list
44637162|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44637163|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44637164|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637165|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637166|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637167|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637168|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637169|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637170|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
44637171|NCT00398086|Antiviral Agents|antiviral agents|mesh-ancestor
44637172|NCT00398086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637173|NCT00398086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637174|NCT00398086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637175|NCT00398086|Immunologic Factors|immunologic factors|mesh-ancestor
44637176|NCT00398086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637177|NCT00398047|Mitogens|mitogens|mesh-list
44637178|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637179|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637180|NCT00397982|Sirolimus|sirolimus|mesh-list
44637181|NCT00397982|Bevacizumab|bevacizumab|mesh-list
44637182|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44637183|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
44637184|NCT00397982|Antibodies|antibodies|mesh-list
44637185|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
44637186|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44637187|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
44637188|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637189|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637190|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637191|NCT00397982|Growth Substances|growth substances|mesh-ancestor
44637192|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637193|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637194|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
44637195|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637196|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637197|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44637198|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
44637199|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637200|NCT00397943|Vaccines|vaccines|mesh-list
44637201|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
44637202|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637203|NCT00397631|Pioglitazone|pioglitazone|mesh-list
44637204|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44637205|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637206|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637207|NCT00397631|Incretins|incretins|mesh-ancestor
44637208|NCT00397631|Hormones|hormones|mesh-ancestor
44637209|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637210|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44637211|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
44637212|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637213|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637214|NCT00397488|Sunitinib|sunitinib|mesh-list
44637215|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637216|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637217|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637218|NCT00397488|Growth Substances|growth substances|mesh-ancestor
44637219|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637220|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637221|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637222|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637223|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637224|NCT00397189|Melatonin|melatonin|mesh-list
44637225|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
44637226|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637227|NCT00397189|Protective Agents|protective agents|mesh-ancestor
44637228|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637229|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637230|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44637231|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44637232|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44637233|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637234|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637235|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637236|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44637237|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44637238|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
44637239|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637240|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637241|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44637242|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44637243|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
44637244|NCT00396877|Clopidogrel|clopidogrel|mesh-list
44637245|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44637246|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44637247|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44637248|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44637249|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
44637250|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637251|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637252|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637253|NCT00396812|Rituximab|rituximab|mesh-list
44637254|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637255|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637256|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
44637257|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637258|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637259|NCT00396656|Atenolol|atenolol|mesh-list
44637260|NCT00396656|Valsartan|valsartan|mesh-list
44637261|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44637262|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44637263|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44637264|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44637265|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637266|NCT00396656|Diuretics|diuretics|mesh-ancestor
44637267|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
44637268|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637269|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44637270|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637271|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44637272|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
44637273|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
44637274|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637275|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44637276|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44637277|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44637278|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637279|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637280|NCT00396591|Aflibercept|aflibercept|mesh-list
44637281|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637282|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637283|NCT00396591|Growth Substances|growth substances|mesh-ancestor
44637284|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637285|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637286|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637287|NCT00396565|Olanzapine|olanzapine|mesh-list
44637288|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44637289|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
44637290|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
44637291|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637292|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637293|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44637294|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44637295|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44637296|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637297|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637298|NCT00396565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44637299|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44637300|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637301|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637302|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637303|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
44637304|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44637305|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44637306|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44637307|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44637308|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
44637309|NCT00396409|Omalizumab|omalizumab|mesh-list
44637310|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44637311|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44637312|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44637313|NCT00396383|Plerixafor|plerixafor|mesh-list
44637314|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44637315|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44637316|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
44637317|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637318|NCT00396331|Plerixafor|plerixafor|mesh-list
44637319|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44637320|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44637321|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
44637322|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637323|NCT00396318|Tenecteplase|tenecteplase|mesh-list
44637324|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44637325|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44637326|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637327|NCT00396253|Tenecteplase|tenecteplase|mesh-list
44637328|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44637329|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44637330|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637331|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
44637332|NCT00396084|Levofloxacin|levofloxacin|mesh-list
44637333|NCT00396084|Ofloxacin|ofloxacin|mesh-list
44637334|NCT00396084|Isoniazid|isoniazid|mesh-list
44637335|NCT00396084|Linezolid|linezolid|mesh-list
44637336|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
44637337|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637338|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637339|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44637340|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637341|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637342|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637343|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637344|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44637345|NCT00396084|Renal Agents|renal agents|mesh-ancestor
44637346|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44637347|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44637348|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
44637349|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44637350|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44637351|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
44637352|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44637353|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44637354|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44188485|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
44637355|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44637357|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44637358|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44637359|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
44637360|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637361|NCT00395850|Disulfiram|disulfiram|mesh-list
44637362|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44637363|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44637364|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637365|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637366|NCT00395746|Liraglutide|liraglutide|mesh-list
44637367|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637368|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637369|NCT00395746|Incretins|incretins|mesh-ancestor
44637370|NCT00395746|Hormones|hormones|mesh-ancestor
44637371|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637372|NCT00395694|Lamotrigine|lamotrigine|mesh-list
44637373|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
44637374|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44637375|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637376|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637377|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44637378|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637380|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44637381|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637382|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637383|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44637384|NCT00395629|Deferasirox|deferasirox|mesh-list
44637385|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44637386|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
44637387|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
44637388|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637389|NCT00395512|Pioglitazone|pioglitazone|mesh-list
44637390|NCT00395512|Alogliptin|alogliptin|mesh-list
44637391|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637392|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637393|NCT00395512|Incretins|incretins|mesh-ancestor
44637394|NCT00395512|Hormones|hormones|mesh-ancestor
44637395|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637396|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44637397|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
44637398|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637399|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637400|NCT00395486|Atorvastatin|atorvastatin|mesh-list
44637401|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44637402|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44637403|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44637404|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
44637405|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637406|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44637407|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44637408|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637409|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44637410|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637411|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637412|NCT00395343|Incretins|incretins|mesh-ancestor
44637413|NCT00395343|Hormones|hormones|mesh-ancestor
44637414|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637415|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44637416|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
44637417|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637418|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637419|NCT00395304|Fluticasone|fluticasone|mesh-list
44637420|NCT00395304|Xhance|xhance|mesh-list
44637421|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44637422|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44637423|NCT00395304|Montelukast|montelukast|mesh-list
44637424|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44637425|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44637426|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
44637427|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637428|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188584|NCT00347971|Rituximab|rituximab|mesh-list
44637429|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44637430|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
44637431|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
44637432|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44637433|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44637434|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44637435|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44637436|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637437|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637438|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637439|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44637440|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
44637441|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637442|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44637443|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44637444|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
44637445|NCT00395304|Hormones|hormones|mesh-ancestor
44637446|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
44637447|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
44637449|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637450|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
44637451|NCT00395018|Entecavir|entecavir|mesh-list
44637452|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
44637453|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637454|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
44637455|NCT00394953|Hematinics|hematinics|mesh-ancestor
44637456|NCT00394914|Pleconaril|pleconaril|mesh-list
44637457|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
44637458|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637459|NCT00394901|Pregabalin|pregabalin|mesh-list
44637460|NCT00394901|Analgesics|analgesics|mesh-ancestor
44637461|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
44637462|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637463|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637464|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
44637465|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44637466|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637467|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637468|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44637469|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44637470|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44637471|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637472|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637473|NCT00394836|Ofatumumab|ofatumumab|mesh-list
44637474|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44637475|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637476|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
44637477|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637478|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44637479|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44637480|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
44637481|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44637482|NCT00394771|Estradiol|estradiol|mesh-list
44637483|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44637484|NCT00394771|Estrogens|estrogens|mesh-ancestor
44637485|NCT00394771|Hormones|hormones|mesh-ancestor
44637486|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637487|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637488|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44637489|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
44637490|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44637491|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44637492|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44637493|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44637494|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44637495|NCT00394589|Infliximab|infliximab|mesh-list
44637496|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44637497|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44637498|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637499|NCT00394524|Insulin|insulin|mesh-list
44637500|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637501|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637502|NCT00394472|Lesogaberan|lesogaberan|mesh-list
44637503|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44637504|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44188643|NCT00348192|Donepezil|donepezil|mesh-list
44637505|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
44637506|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
44637507|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637508|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637509|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637510|NCT00394433|Bevacizumab|bevacizumab|mesh-list
44637511|NCT00394433|Cisplatin|cisplatin|mesh-list
44637512|NCT00394433|Docetaxel|docetaxel|mesh-list
44637513|NCT00394433|Irinotecan|irinotecan|mesh-list
44637514|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637515|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637516|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637517|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637518|NCT00394433|Growth Substances|growth substances|mesh-ancestor
44637519|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637520|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637521|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637522|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032786|NCT00001989|Zidovudine|zidovudine|mesh-list
44637524|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637525|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44637526|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637527|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637528|NCT00394251|Paclitaxel|paclitaxel|mesh-list
44637529|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
44637530|NCT00394251|Bevacizumab|bevacizumab|mesh-list
44637531|NCT00394251|Doxorubicin|doxorubicin|mesh-list
44637532|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44637533|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44637534|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44637535|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637536|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637537|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637538|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637539|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637540|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637541|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
44637542|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637543|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637544|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44637545|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
44637546|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44637547|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637548|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637549|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637550|NCT00394251|Growth Substances|growth substances|mesh-ancestor
44637551|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637552|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44637553|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44637554|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637555|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637556|NCT00394095|Topiramate|topiramate|mesh-list
44637557|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
44637558|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637559|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637560|NCT00394082|Paclitaxel|paclitaxel|mesh-list
44637561|NCT00394082|Bevacizumab|bevacizumab|mesh-list
44637562|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44637563|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44637564|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637565|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637566|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637567|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637568|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637569|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637570|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637571|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637572|NCT00394082|Growth Substances|growth substances|mesh-ancestor
44637573|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637574|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637575|NCT00393939|Docetaxel|docetaxel|mesh-list
44637576|NCT00393939|Sunitinib|sunitinib|mesh-list
44637577|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637578|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637579|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44188716|NCT00348387|Vaccines|vaccines|mesh-list
44637580|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637581|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637582|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637583|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637584|NCT00393939|Growth Substances|growth substances|mesh-ancestor
44637585|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637586|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637587|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637588|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637589|NCT00393861|Bevacizumab|bevacizumab|mesh-list
44637590|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
44637591|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637592|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637593|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637594|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637595|NCT00393861|Growth Substances|growth substances|mesh-ancestor
44637596|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637597|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637598|NCT00393848|Ketoconazole|ketoconazole|mesh-list
44637599|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
44637600|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637601|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44637602|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44637603|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637604|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637605|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44637606|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
44637607|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637608|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637609|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44637610|NCT00393718|Liraglutide|liraglutide|mesh-list
44637611|NCT00393718|Glyburide|glyburide|mesh-list
44637612|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637613|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637614|NCT00393718|Incretins|incretins|mesh-ancestor
44637615|NCT00393718|Hormones|hormones|mesh-ancestor
44637616|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637617|NCT00393705|Insulin|insulin|mesh-list
44637618|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44637619|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
44637620|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637621|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637622|NCT00393484|Lamivudine|lamivudine|mesh-list
44637623|NCT00393484|Entecavir|entecavir|mesh-list
44637624|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44637625|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44637626|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637627|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637628|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
44637629|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637630|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44637631|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44637632|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
44637633|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44637634|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
44637635|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637636|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637637|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44637638|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
44637639|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44637640|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44637641|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44637642|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637643|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637644|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637645|NCT00393367|Prednisone|prednisone|mesh-list
44637646|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
44637647|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44637648|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44637649|NCT00393367|Prednisolone|prednisolone|mesh-list
44637650|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
44637651|NCT00393367|Budesonide|budesonide|mesh-list
44637652|NCT00393367|Bromides|bromides|mesh-list
44637653|NCT00393367|Albuterol|albuterol|mesh-list
44637654|NCT00393367|Ipratropium|ipratropium|mesh-list
44188791|NCT00348452|Narcotics|narcotics|mesh-ancestor
44637655|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44637656|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
44637657|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44637659|NCT00393367|Hormones|hormones|mesh-ancestor
44637660|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637661|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637662|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44637663|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637664|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
44637665|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
44637666|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637667|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44637668|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44637669|NCT00393367|Protective Agents|protective agents|mesh-ancestor
44637670|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44637672|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
44637673|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
44637674|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
44637675|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44637676|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44637677|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44637678|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44637679|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637680|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637681|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637682|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44637683|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
44637684|NCT00393094|Bevacizumab|bevacizumab|mesh-list
44637685|NCT00393094|Irinotecan|irinotecan|mesh-list
44637686|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637687|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637688|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637689|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637690|NCT00393094|Growth Substances|growth substances|mesh-ancestor
44637691|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637692|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637693|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44637694|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637695|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637696|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637697|NCT00393042|Amphetamine|amphetamine|mesh-list
44637698|NCT00393042|Adderall|adderall|mesh-list
44637699|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44637700|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44637701|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637702|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
44637703|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
44637704|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637705|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
44637706|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637707|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637708|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637709|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44637710|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44637711|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637712|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44637713|NCT00393029|Aldesleukin|aldesleukin|mesh-list
44637714|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
44637715|NCT00393029|Fludarabine|fludarabine|mesh-list
43905308|NCT00206336|Topiramate|topiramate|mesh-list
44637716|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
44637717|NCT00393029|Interleukin-2|interleukin-2|mesh-list
44637718|NCT00393029|Lenograstim|lenograstim|mesh-list
44637719|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637720|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
44637721|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637722|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637723|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44637724|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
44637725|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637726|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637727|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44637728|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637729|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
44637730|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44637731|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44637733|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
44637734|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637735|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44637736|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44637737|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
44637738|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637739|NCT00392990|Cytarabine|cytarabine|mesh-list
44637740|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
44637741|NCT00392990|Ifosfamide|ifosfamide|mesh-list
44637742|NCT00392990|Rituximab|rituximab|mesh-list
44637743|NCT00392990|Doxorubicin|doxorubicin|mesh-list
44637744|NCT00392990|Methotrexate|methotrexate|mesh-list
44637745|NCT00392990|Etoposide|etoposide|mesh-list
44637746|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
44637747|NCT00392990|Vincristine|vincristine|mesh-list
44637748|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44637749|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
44637750|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637751|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
44637752|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637753|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637754|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44637755|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
44637756|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637757|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637758|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43905354|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637759|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637760|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44637761|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44637762|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637763|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637764|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44637765|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
44637766|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44637767|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637768|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
44637769|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
44637770|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44637771|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44637772|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44637773|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
44637774|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637775|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637776|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637777|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637778|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
44637779|NCT00392925|Pramlintide|pramlintide|mesh-list
44637780|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44637781|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44637782|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637783|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
44637784|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44637785|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44637786|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637787|NCT00392769|Cetuximab|cetuximab|mesh-list
44637788|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637789|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637790|NCT00392665|Sulindac|sulindac|mesh-list
44637791|NCT00392665|Bevacizumab|bevacizumab|mesh-list
44637792|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44637793|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44637794|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637795|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44637796|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44637797|NCT00392665|Growth Substances|growth substances|mesh-ancestor
44637798|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637799|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
44637800|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637801|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637802|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637803|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44637804|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44637805|NCT00392665|Analgesics|analgesics|mesh-ancestor
43905394|NCT00211692|Interferons|interferons|mesh-list
44637806|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
44637807|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637808|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44637809|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44637810|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44637811|NCT00392379|Nicotine|nicotine|mesh-list
44637812|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44637813|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
44637814|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637815|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637816|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44637817|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44637818|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
44637819|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637820|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637821|NCT00392288|Ciclesonide|ciclesonide|mesh-list
44637822|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
44637823|NCT00392288|Hormones|hormones|mesh-ancestor
44637824|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637825|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637826|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44637827|NCT00392223|Azithromycin|azithromycin|mesh-list
44637828|NCT00392223|Minocycline|minocycline|mesh-list
44637829|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637830|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637831|NCT00392197|Aripiprazole|aripiprazole|mesh-list
44637832|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
44637833|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637834|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44637835|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44637836|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44637837|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637838|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
44637839|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
44637840|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637841|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637842|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44637843|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44637844|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
44637845|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44637846|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44637847|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44637848|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44637849|NCT00392171|Temozolomide|temozolomide|mesh-list
44637850|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44637851|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
44637852|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637853|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637854|NCT00391976|Tobramycin|tobramycin|mesh-list
44637855|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44637856|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637857|NCT00391898|Levodopa|levodopa|mesh-list
44637858|NCT00391898|Carbidopa|carbidopa|mesh-list
44637859|NCT00391898|Entacapone|entacapone|mesh-list
44637860|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44637861|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44637862|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
44637863|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637864|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637865|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637866|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44637867|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637868|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44637869|NCT00391872|Clopidogrel|clopidogrel|mesh-list
44637870|NCT00391872|Ticagrelor|ticagrelor|mesh-list
44637871|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44637872|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44637873|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44637874|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44637875|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
44637876|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637877|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637878|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637879|NCT00391846|Metoprolol|metoprolol|mesh-list
44188958|NCT00349128|Metformin|metformin|mesh-list
44637881|NCT00391846|Carvedilol|carvedilol|mesh-list
44637882|NCT00391846|Candesartan|candesartan|mesh-list
44637883|NCT00391846|Ramipril|ramipril|mesh-list
44637884|NCT00391846|Enalapril|enalapril|mesh-list
44637885|NCT00391846|Lisinopril|lisinopril|mesh-list
44637886|NCT00391846|Eplerenone|eplerenone|mesh-list
44637887|NCT00391846|Bisoprolol|bisoprolol|mesh-list
44637888|NCT00391846|Captopril|captopril|mesh-list
44637889|NCT00391846|Trandolapril|trandolapril|mesh-list
44637890|NCT00391846|Spironolactone|spironolactone|mesh-list
44637891|NCT00391846|Diuretics|diuretics|mesh-list
44637892|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44637893|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44637894|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44637895|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637896|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44637897|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
44235796|NCT00556127|Hormones|hormones|mesh-ancestor
44637898|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
44637899|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44637900|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637901|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44637902|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44637903|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44637904|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
44637905|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637906|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44637907|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44637908|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637909|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44637910|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
44637911|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
44637912|NCT00391846|Protective Agents|protective agents|mesh-ancestor
44637913|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44637914|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637915|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44637916|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
44637917|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44637918|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44637919|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44637920|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44637921|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637922|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44637923|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44637924|NCT00391807|Norethindrone|norethindrone|mesh-list
44637925|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
44637926|NCT00391807|Estradiol|estradiol|mesh-list
44637927|NCT00391807|Estrogens|estrogens|mesh-ancestor
44637928|NCT00391807|Hormones|hormones|mesh-ancestor
44637929|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44637930|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637931|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44637932|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
44637933|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44637934|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44637935|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44637936|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44637937|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44637938|NCT00391768|Oseltamivir|oseltamivir|mesh-list
44637939|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
44637940|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637941|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637942|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637943|NCT00391586|Gemcitabine|gemcitabine|mesh-list
44637944|NCT00391586|Paclitaxel|paclitaxel|mesh-list
44637945|NCT00391586|Etoposide|etoposide|mesh-list
44637946|NCT00391586|Vinorelbine|vinorelbine|mesh-list
44637947|NCT00391586|Docetaxel|docetaxel|mesh-list
44637948|NCT00391586|Irinotecan|irinotecan|mesh-list
44637949|NCT00391586|Pemetrexed|pemetrexed|mesh-list
44637950|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44637951|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44637952|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637953|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637954|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637955|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637956|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637957|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44637958|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
44637959|NCT00391586|Antiviral Agents|antiviral agents|mesh-ancestor
44637960|NCT00391586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44637961|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637962|NCT00391586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44637963|NCT00391586|Immunologic Factors|immunologic factors|mesh-ancestor
44637964|NCT00391586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637965|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44637966|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44637967|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44637968|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44637969|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44637970|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44637972|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
44637973|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44637974|NCT00391430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44637975|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44637976|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44637977|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637978|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637980|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637981|NCT00391391|Vaccines|vaccines|mesh-list
44637982|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
44637983|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44637984|NCT00391274|Docetaxel|docetaxel|mesh-list
44637985|NCT00391274|Pemetrexed|pemetrexed|mesh-list
44637986|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44637987|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44637988|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44637989|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44637990|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44637991|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44637992|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44637993|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44637994|NCT00391222|Olanzapine|olanzapine|mesh-list
44637995|NCT00391222|Risperidone|risperidone|mesh-list
44637996|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44637997|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
44637998|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44637999|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638000|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638001|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44638002|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638003|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638004|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638005|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44638006|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
44638007|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
44638008|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
44638009|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638010|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44638011|NCT00391222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44638012|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638013|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638014|NCT00391170|Dexamethasone|dexamethasone|mesh-list
44638015|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638016|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
44638017|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
44638018|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638019|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638020|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44638021|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
44638022|NCT00391170|Hormones|hormones|mesh-ancestor
44638023|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638024|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44638025|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638026|NCT00391118|Paclitaxel|paclitaxel|mesh-list
44638027|NCT00391118|Carboplatin|carboplatin|mesh-list
44638028|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44638029|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638030|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638031|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638032|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638033|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638034|NCT00391092|Bevacizumab|bevacizumab|mesh-list
44638035|NCT00391092|Trastuzumab|trastuzumab|mesh-list
44638036|NCT00391092|Docetaxel|docetaxel|mesh-list
44638037|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44638038|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638039|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638040|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638041|NCT00391092|Growth Substances|growth substances|mesh-ancestor
44638042|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638043|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638044|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638045|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638046|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700451|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
44638047|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638048|NCT00391053|Vaccines|vaccines|mesh-list
44638049|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
44638050|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638051|NCT00391027|Insulin|insulin|mesh-list
44638052|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44638053|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
44638054|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44638055|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638056|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44638057|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
44638058|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638059|NCT00390884|Vaccines|vaccines|mesh-list
44638060|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
44638061|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638062|NCT00390858|Deferasirox|deferasirox|mesh-list
44638063|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44638064|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
44638065|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
44638066|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638067|NCT00390806|Topotecan|topotecan|mesh-list
44638068|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44638069|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638070|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638071|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638072|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638073|NCT00390780|Clotrimazole|clotrimazole|mesh-list
44638074|NCT00390780|Miconazole|miconazole|mesh-list
44638075|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44638076|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638077|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
44638078|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44638079|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44638080|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638081|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638082|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44638083|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
44638084|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638085|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638086|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44638087|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44638088|NCT00390689|Pramipexole|pramipexole|mesh-list
44638089|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
44638090|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638091|NCT00390689|Protective Agents|protective agents|mesh-ancestor
44638092|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638093|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44638094|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44638095|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
44638096|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
44638097|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638098|NCT00390546|Propranolol|propranolol|mesh-list
44638099|NCT00390546|Digoxin|digoxin|mesh-list
44638100|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44638101|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44638102|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44638103|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638104|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638105|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638106|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44638107|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44638108|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44638109|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44638110|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638111|NCT00390546|Protective Agents|protective agents|mesh-ancestor
44638112|NCT00390455|Fulvestrant|fulvestrant|mesh-list
44638113|NCT00390455|Lapatinib|lapatinib|mesh-list
44638114|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44638115|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638116|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44638117|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44638118|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
44638119|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638120|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638122|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638123|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638124|NCT00390416|Leucovorin|leucovorin|mesh-list
44638125|NCT00390416|Bevacizumab|bevacizumab|mesh-list
44638126|NCT00390416|Cisplatin|cisplatin|mesh-list
44638127|NCT00390416|Docetaxel|docetaxel|mesh-list
44638128|NCT00390416|Fluorouracil|fluorouracil|mesh-list
44638129|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44638130|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638131|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638132|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638133|NCT00390416|Growth Substances|growth substances|mesh-ancestor
44638134|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638135|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638136|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638137|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638138|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638139|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638140|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
44638141|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638142|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638143|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
44638144|NCT00390416|Antidotes|antidotes|mesh-ancestor
44638145|NCT00390416|Protective Agents|protective agents|mesh-ancestor
44638146|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638147|NCT00390416|Vitamins|vitamins|mesh-ancestor
44638148|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
44638150|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638151|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
44638152|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638153|NCT00390013|Gabapentin|gabapentin|mesh-list
44638154|NCT00390013|Analgesics|analgesics|mesh-ancestor
44638155|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
44638156|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638157|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638158|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
44638159|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44638160|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638161|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638162|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638163|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44638164|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44638165|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638166|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638167|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
44638168|NCT00389831|Rotigotine|rotigotine|mesh-list
44638169|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
44638170|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
44638171|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638172|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638173|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638174|NCT00389519|Ramipril|ramipril|mesh-list
44638175|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44638176|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44638177|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638178|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638179|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44638180|NCT00389441|Axitinib|axitinib|mesh-list
44638181|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638182|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638183|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638184|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638185|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
44638186|NCT00389324|Antibodies|antibodies|mesh-list
44638187|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
44638188|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44638189|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44638190|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
44638191|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
44638192|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638193|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44638194|NCT00389207|Nevirapine|nevirapine|mesh-list
44638195|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44638196|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44638197|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
44638199|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638200|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44638201|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44638202|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
44638203|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638204|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44638205|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44638206|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44638207|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44638208|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44638209|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638210|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638211|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44638212|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638213|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638214|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638215|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44638216|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638217|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638218|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44638219|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638220|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189330|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
44638221|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638222|NCT00388674|Entecavir|entecavir|mesh-list
44638223|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
44638224|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638225|NCT00388583|Vaccines|vaccines|mesh-list
44638226|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
43905780|NCT00226577|Gemcitabine|gemcitabine|mesh-list
44638227|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638228|NCT00388505|Tobramycin|tobramycin|mesh-list
44638229|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44638230|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638231|NCT00388362|Sirolimus|sirolimus|mesh-list
44638232|NCT00388362|Prednisone|prednisone|mesh-list
44638233|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638234|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
44638235|NCT00388362|Hormones|hormones|mesh-ancestor
44638236|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638237|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638238|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44638239|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638240|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44638241|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638242|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44638243|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
44638244|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638245|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
44638246|NCT00388349|Gemcitabine|gemcitabine|mesh-list
44638247|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
44638248|NCT00388349|Carmustine|carmustine|mesh-list
44638249|NCT00388349|Etoposide|etoposide|mesh-list
44638250|NCT00388349|Vinorelbine|vinorelbine|mesh-list
44638251|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638252|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
44638253|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638254|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638255|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44638256|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
44638257|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638258|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638259|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44638260|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638261|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
44638262|NCT00388349|Antiviral Agents|antiviral agents|mesh-ancestor
44638263|NCT00388349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638264|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638265|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44638266|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44638267|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638268|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638269|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638270|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638271|NCT00388154|Gemcitabine|gemcitabine|mesh-list
44638272|NCT00388154|Cisplatin|cisplatin|mesh-list
44638273|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638274|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638275|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
44638276|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905857|NCT00227617|Antidotes|antidotes|mesh-ancestor
44638277|NCT00388154|Antiviral Agents|antiviral agents|mesh-ancestor
44638278|NCT00388154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638279|NCT00388154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638280|NCT00388154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638281|NCT00388154|Immunologic Factors|immunologic factors|mesh-ancestor
44638282|NCT00388154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638283|NCT00388037|Sunitinib|sunitinib|mesh-list
44638284|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638285|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638286|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638287|NCT00388037|Growth Substances|growth substances|mesh-ancestor
44638288|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638289|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638290|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638291|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638292|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638293|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44638294|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638295|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638296|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638297|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638298|NCT00387881|Naproxen|naproxen|mesh-list
44638299|NCT00387881|Sumatriptan|sumatriptan|mesh-list
44638300|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44638301|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44638303|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
44638304|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638305|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638306|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638307|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638308|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
44638309|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44638310|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638311|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638312|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44638313|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44638314|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44638315|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
44638316|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638317|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
44638318|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638319|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44638320|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44638321|NCT00387647|Azacitidine|azacitidine|mesh-list
44638322|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638323|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
44638324|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638325|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638326|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638327|NCT00387465|Azacitidine|azacitidine|mesh-list
44638328|NCT00387465|Entinostat|entinostat|mesh-list
44638329|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44638330|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638331|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
44638332|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638333|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638334|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638335|NCT00387426|Sunitinib|sunitinib|mesh-list
44638336|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638337|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638338|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638339|NCT00387426|Growth Substances|growth substances|mesh-ancestor
44638340|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638341|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638342|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638343|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638344|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638346|NCT00387348|Citalopram|citalopram|mesh-list
44638347|NCT00387348|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44638348|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638349|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638350|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638351|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638352|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
44638353|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638354|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44638355|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638356|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638357|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44638358|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44638359|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
44638360|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
44638361|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638362|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44638363|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44638364|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
44638365|NCT00387127|Cisplatin|cisplatin|mesh-list
44638366|NCT00387127|Lapatinib|lapatinib|mesh-list
44638367|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638368|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638369|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638370|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189419|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
44638371|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
44638372|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44638373|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
44638374|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638375|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638376|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44638377|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
44638378|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
44638379|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44638380|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
44638381|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638382|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638384|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44638385|NCT00387010|Narcotics|narcotics|mesh-ancestor
44638386|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638387|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638388|NCT00387010|Analgesics|analgesics|mesh-ancestor
44638389|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
44638390|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638391|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44638392|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44638393|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
44638394|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
44638395|NCT00386607|Valsartan|valsartan|mesh-list
44638396|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44638397|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44638398|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44638399|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44638400|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638401|NCT00386607|Diuretics|diuretics|mesh-ancestor
44638402|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
44638403|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638404|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44638405|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638406|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44638407|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638408|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
44638409|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44638410|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638411|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638412|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44638413|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638414|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44638415|NCT00386334|Eszopiclone|eszopiclone|mesh-list
44638416|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44033663|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638417|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638418|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638419|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
44638420|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44638421|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44638422|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638423|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
44638424|NCT00386308|Coagulants|coagulants|mesh-ancestor
44638425|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
44638426|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
44638427|NCT00386152|Hematinics|hematinics|mesh-ancestor
44638428|NCT00386100|Metformin|metformin|mesh-list
44638429|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44638430|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638431|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44638432|NCT00386022|Estrogens|estrogens|mesh-list
43906004|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
44638433|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
44638434|NCT00386022|Hormones|hormones|mesh-ancestor
44638435|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638436|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638437|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44638438|NCT00386009|Tadalafil|tadalafil|mesh-list
44638439|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
44638440|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44638441|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44638442|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638443|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638444|NCT00386009|Urological Agents|urological agents|mesh-ancestor
44638445|NCT00385944|Clopidogrel|clopidogrel|mesh-list
44638447|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44638448|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44638449|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44638450|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44638451|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
44638452|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638453|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638454|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638455|NCT00385827|Prednisone|prednisone|mesh-list
44638456|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
44638457|NCT00385827|Siltuximab|siltuximab|mesh-list
44638458|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638459|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
44638460|NCT00385827|Hormones|hormones|mesh-ancestor
44638461|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638462|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638463|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44638464|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638465|NCT00385827|Analgesics|analgesics|mesh-ancestor
44638466|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
44638467|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638468|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44638469|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638470|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638471|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638472|NCT00385762|Paroxetine|paroxetine|mesh-list
44638473|NCT00385762|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44638474|NCT00385762|Serotonin|serotonin|mesh-list
44638475|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638476|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638477|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638478|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638479|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
44638480|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638481|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44638482|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638483|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638484|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44638485|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44638486|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638487|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44638488|NCT00385736|Adalimumab|adalimumab|mesh-list
44638489|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638491|NCT00385684|Acetaminophen|acetaminophen|mesh-list
44638492|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44638493|NCT00385684|Hydrocodone|hydrocodone|mesh-list
44638494|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44638495|NCT00385684|Narcotics|narcotics|mesh-ancestor
44638496|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638497|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638498|NCT00385684|Analgesics|analgesics|mesh-ancestor
44638499|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
44638500|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638501|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
44638502|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44638503|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44638504|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
44638505|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44638506|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638507|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638508|NCT00385671|Pregabalin|pregabalin|mesh-list
44638509|NCT00385671|Gabapentin|gabapentin|mesh-list
44638510|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44638511|NCT00385671|Analgesics|analgesics|mesh-ancestor
44638512|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
44638513|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638514|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638515|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
44638516|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44638517|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638518|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638519|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44638521|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638522|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638523|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638524|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44638525|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44638526|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638527|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
44638528|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44638529|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638530|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638531|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
44638532|NCT00385593|Budesonide|budesonide|mesh-list
44638533|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
44638534|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44638535|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638536|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44638537|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
44638538|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638539|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638540|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44638541|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
44638542|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
44638543|NCT00385593|Hormones|hormones|mesh-ancestor
44638544|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638545|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44638546|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44638547|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44638548|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
44638549|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638550|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638551|NCT00385541|Morphine|morphine|mesh-list
44638552|NCT00385541|Hydromorphone|hydromorphone|mesh-list
44638553|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44638554|NCT00385541|Narcotics|narcotics|mesh-ancestor
44638555|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638556|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638557|NCT00385541|Analgesics|analgesics|mesh-ancestor
44638558|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
44638559|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638560|NCT00385203|Cediranib|cediranib|mesh-list
44638561|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638562|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638563|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033810|NCT00002111|Saquinavir|saquinavir|mesh-list
44638564|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638565|NCT00384956|Azacitidine|azacitidine|mesh-list
44638566|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638567|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
44638568|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638569|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638570|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638571|NCT00384930|Tadalafil|tadalafil|mesh-list
44638572|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
44638573|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44638574|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44638575|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638576|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638577|NCT00384930|Urological Agents|urological agents|mesh-ancestor
44638578|NCT00384839|Azacitidine|azacitidine|mesh-list
44638579|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638580|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
44638581|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638582|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638583|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638584|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44638585|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
44638586|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638587|NCT00384332|Olanzapine|olanzapine|mesh-list
44638588|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
44638589|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
44638590|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189651|NCT00351975|Belinostat|belinostat|mesh-list
44638591|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638592|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44638593|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44638594|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638595|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638596|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638597|NCT00384332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44638598|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638599|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638600|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638601|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638602|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
44638604|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44638605|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
44638606|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638607|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44638608|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
44638609|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638610|NCT00384293|Vitamins|vitamins|mesh-ancestor
44638611|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
44638612|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638613|NCT00384189|Ciclesonide|ciclesonide|mesh-list
44638614|NCT00384189|Albuterol|albuterol|mesh-list
44638615|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44638616|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
44638617|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638618|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638619|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44638620|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44638621|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
44638622|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44638623|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44638624|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44638625|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44638626|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
44638627|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638628|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638629|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
44638630|NCT00384189|Hormones|hormones|mesh-ancestor
44638631|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638632|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44638633|NCT00384176|Leucovorin|leucovorin|mesh-list
44638634|NCT00384176|Bevacizumab|bevacizumab|mesh-list
44638635|NCT00384176|Fluorouracil|fluorouracil|mesh-list
44638636|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
44638637|NCT00384176|Cediranib|cediranib|mesh-list
44638638|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44638640|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638641|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638642|NCT00384176|Growth Substances|growth substances|mesh-ancestor
44638643|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638644|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638645|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
44638646|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638647|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638648|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638649|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
44638650|NCT00384176|Antidotes|antidotes|mesh-ancestor
44638651|NCT00384176|Protective Agents|protective agents|mesh-ancestor
44638652|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638653|NCT00384176|Vitamins|vitamins|mesh-ancestor
44638654|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
44638655|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638656|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638657|NCT00384085|Insulin|insulin|mesh-list
44638658|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44638659|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
44638660|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
44638661|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44638662|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638663|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44638664|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
44638665|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638666|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44638667|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44638668|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44638669|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44638670|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638671|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638672|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638673|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638675|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
44638676|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638677|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
44638678|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638679|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
44638680|NCT00383786|Vofopitant|vofopitant|mesh-list
44638681|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
44638682|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
44638683|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638684|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638685|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44638686|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44638687|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638688|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638689|NCT00383708|Lanreotide|lanreotide|mesh-list
44638690|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638691|NCT00383331|Gemcitabine|gemcitabine|mesh-list
44638692|NCT00383331|Pemetrexed|pemetrexed|mesh-list
44638693|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638694|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
44638695|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638696|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638697|NCT00383331|Antiviral Agents|antiviral agents|mesh-ancestor
44638698|NCT00383331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638699|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638700|NCT00383331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638701|NCT00383331|Immunologic Factors|immunologic factors|mesh-ancestor
44638702|NCT00383331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638703|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44638704|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44638705|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
44638706|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
44638707|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44638708|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
44638709|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638710|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638711|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44638712|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44033960|NCT00002125|Foscarnet|foscarnet|mesh-list
44638713|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44638714|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44638715|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44638716|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44638717|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638718|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638719|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638720|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
44638721|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44638722|NCT00383162|Naproxen|naproxen|mesh-list
44638723|NCT00383162|Sumatriptan|sumatriptan|mesh-list
44638724|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44638725|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44638726|NCT00383162|Analgesics|analgesics|mesh-ancestor
44638727|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
44638728|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638729|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638730|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638731|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638732|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
44638733|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44638734|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638735|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638736|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44638737|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44638738|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44638739|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
44638740|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638741|NCT00383149|Cetuximab|cetuximab|mesh-list
44638742|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44638743|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638744|NCT00383019|Latanoprost|latanoprost|mesh-list
44638745|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44638746|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44638747|NCT00382993|Naproxen|naproxen|mesh-list
44638748|NCT00382993|Sumatriptan|sumatriptan|mesh-list
44638749|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44638750|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44638751|NCT00382993|Analgesics|analgesics|mesh-ancestor
44638752|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
44638753|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638754|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638755|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638756|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638757|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
44638758|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44638759|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638760|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638761|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44638762|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44638763|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44638764|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
44638765|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44638766|NCT00382733|Topotecan|topotecan|mesh-list
44638767|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44638768|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638769|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638770|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638771|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638772|NCT00382720|Docetaxel|docetaxel|mesh-list
44638773|NCT00382720|Capecitabine|capecitabine|mesh-list
44638774|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
44638775|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638776|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638777|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638778|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638779|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638780|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638781|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
44638782|NCT00382109|Sirolimus|sirolimus|mesh-list
44638783|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
44638784|NCT00382109|Thiotepa|thiotepa|mesh-list
44638785|NCT00382109|Methotrexate|methotrexate|mesh-list
44638786|NCT00382109|Tacrolimus|tacrolimus|mesh-list
44638787|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638788|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
44638789|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638790|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638791|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44638792|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
44638793|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638794|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638795|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44638796|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44638797|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
44638798|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44638799|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638800|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
44638801|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
44638802|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638803|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44638804|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44638805|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44638806|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44638807|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638808|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44638809|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
44638810|NCT00381940|Bortezomib|bortezomib|mesh-list
44638811|NCT00381940|Vinorelbine|vinorelbine|mesh-list
44638812|NCT00381940|Ifosfamide|ifosfamide|mesh-list
44638813|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638814|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44638815|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638816|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638817|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638818|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638819|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44638820|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
44638821|NCT00381888|PENTA|penta|mesh-list
44638822|NCT00381888|Fondaparinux|fondaparinux|mesh-list
44638823|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44638824|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
44638825|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44638826|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44638827|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638828|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638829|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
44638830|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44638831|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44638832|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
44638833|NCT00381797|Bevacizumab|bevacizumab|mesh-list
44638834|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44638835|NCT00381797|Irinotecan|irinotecan|mesh-list
44638836|NCT00381797|Camptothecin|camptothecin|mesh-list
44638837|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
44638838|NCT00381797|Antibodies|antibodies|mesh-list
44638839|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
44638840|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44638841|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
44638842|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44638843|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638844|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638845|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638846|NCT00381797|Growth Substances|growth substances|mesh-ancestor
44638847|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638848|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638849|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
44638850|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44638851|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638852|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638853|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638854|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44638855|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44638856|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
44638857|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
44638858|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638859|NCT00381706|Leucovorin|leucovorin|mesh-list
44638860|NCT00381706|Cisplatin|cisplatin|mesh-list
44638861|NCT00381706|Fluorouracil|fluorouracil|mesh-list
44638862|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
44638863|NCT00381706|Irinotecan|irinotecan|mesh-list
44638864|NCT00381706|Cetuximab|cetuximab|mesh-list
44638866|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638867|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
44638868|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638869|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638870|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638871|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
44638872|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638873|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44638874|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638875|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638876|NCT00381706|Antidotes|antidotes|mesh-ancestor
44638877|NCT00381706|Protective Agents|protective agents|mesh-ancestor
44638878|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638879|NCT00381706|Vitamins|vitamins|mesh-ancestor
44638880|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
44638881|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44638882|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44638883|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44638884|NCT00381693|Azacitidine|azacitidine|mesh-list
44638885|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638886|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
44638887|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638888|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638889|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638890|NCT00381680|Leucovorin|leucovorin|mesh-list
44638891|NCT00381680|Cytarabine|cytarabine|mesh-list
44638892|NCT00381680|Dexamethasone|dexamethasone|mesh-list
44638893|NCT00381680|Prednisone|prednisone|mesh-list
44638894|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
44638895|NCT00381680|Doxorubicin|doxorubicin|mesh-list
44638896|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44638897|NCT00381680|Methotrexate|methotrexate|mesh-list
44638898|NCT00381680|Etoposide|etoposide|mesh-list
44638899|NCT00381680|Vincristine|vincristine|mesh-list
44638900|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
44638901|NCT00381680|Asparaginase|asparaginase|mesh-list
44638902|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
44638903|NCT00381680|Pegaspargase|pegaspargase|mesh-list
44638904|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
44638905|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44638906|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
44638907|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638908|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44638909|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44638910|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
44638911|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638912|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638913|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44638914|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44638915|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
44638916|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
44638917|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638918|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44638919|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
44638920|NCT00381680|Hormones|hormones|mesh-ancestor
44638921|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44638922|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44638923|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44638924|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44638925|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44638926|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638927|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44638928|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44638929|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44638930|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44638931|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
44638932|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44638933|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44638934|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44638935|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44638936|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
44638937|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638938|NCT00381680|Antidotes|antidotes|mesh-ancestor
44638939|NCT00381680|Protective Agents|protective agents|mesh-ancestor
44638940|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
44638941|NCT00381680|Vitamins|vitamins|mesh-ancestor
44638942|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
44638943|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
44638944|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
44638945|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
44638946|NCT00381641|Sunitinib|sunitinib|mesh-list
44638947|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44638948|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44638949|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44638950|NCT00381641|Growth Substances|growth substances|mesh-ancestor
44638951|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638952|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
44638953|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44638954|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638955|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638956|NCT00381615|Vaccines|vaccines|mesh-list
44638957|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
44638958|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638959|NCT00381303|Ritonavir|ritonavir|mesh-list
44638960|NCT00381303|Darunavir|darunavir|mesh-list
44638961|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44638962|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44638963|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
44638964|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44638965|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638966|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44638967|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44638968|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
44638969|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44638970|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44638971|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44638972|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
44638973|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44638974|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638975|NCT00381095|Pregabalin|pregabalin|mesh-list
44638976|NCT00381095|Analgesics|analgesics|mesh-ancestor
44638977|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
44638978|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638979|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638980|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
44638981|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44638982|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44638983|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44638984|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44638985|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44638986|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44638987|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638988|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44638989|NCT00381043|Acamprosate|acamprosate|mesh-list
44638990|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44638991|NCT00380978|Narcotics|narcotics|mesh-list
44638992|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44638993|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44638994|NCT00380978|Analgesics|analgesics|mesh-ancestor
44638995|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
44638996|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44638997|NCT00380874|Pregabalin|pregabalin|mesh-list
44638998|NCT00380874|Analgesics|analgesics|mesh-ancestor
44638999|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
44639000|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639001|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639002|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
44639003|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44639004|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639005|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639006|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44639007|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44639008|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44639009|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639010|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44639011|NCT00380718|Pemetrexed|pemetrexed|mesh-list
44639012|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639013|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639014|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639015|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44639016|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639017|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44639018|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44639019|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44639020|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639021|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639022|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44639023|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639024|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639025|NCT00380588|Gemcitabine|gemcitabine|mesh-list
44639026|NCT00380588|Cisplatin|cisplatin|mesh-list
44639027|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639028|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639029|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
44639030|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639031|NCT00380588|Antiviral Agents|antiviral agents|mesh-ancestor
44190049|NCT00353379|Guanfacine|guanfacine|mesh-list
44639032|NCT00380588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639033|NCT00380588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639034|NCT00380588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639035|NCT00380588|Immunologic Factors|immunologic factors|mesh-ancestor
44639036|NCT00380588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639037|NCT00380393|Vaccines|vaccines|mesh-list
44639038|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
44639039|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639040|NCT00380250|Lubiprostone|lubiprostone|mesh-list
44639041|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44639042|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639043|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639044|NCT00380081|Zolpidem|zolpidem|mesh-list
44639045|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44639046|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44639047|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639048|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639049|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44639050|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
44639051|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
44639052|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639053|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639054|NCT00380068|Ambrisentan|ambrisentan|mesh-list
44639055|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44639056|NCT00379912|Azacitidine|azacitidine|mesh-list
44639057|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
44639058|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639059|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
44639060|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639061|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639062|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639063|NCT00379912|Hematinics|hematinics|mesh-ancestor
44639064|NCT00379899|Vitamin D|vitamin d|mesh-list
44639065|NCT00379899|Cinacalcet|cinacalcet|mesh-list
44639066|NCT00379899|Vitamins|vitamins|mesh-ancestor
43906565|NCT00256217|Anastrozole|anastrozole|mesh-list
44639067|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
44639068|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639069|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44639070|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44639071|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44639072|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
44639073|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639074|NCT00379834|Timolol|timolol|mesh-list
44639075|NCT00379834|Dorzolamide|dorzolamide|mesh-list
44639076|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44639077|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44639078|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44639079|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639080|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639081|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639082|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44639083|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44639084|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44639085|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639086|NCT00379808|Montelukast|montelukast|mesh-list
44639087|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44639088|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44639089|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44639091|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639092|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639093|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44639094|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44639095|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639096|NCT00379795|Ranibizumab|ranibizumab|mesh-list
44639097|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639098|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639099|NCT00379795|Growth Substances|growth substances|mesh-ancestor
44639100|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639101|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639102|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639103|NCT00379769|Metformin|metformin|mesh-list
44639104|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
44639105|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44639106|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639107|NCT00379639|Gemcitabine|gemcitabine|mesh-list
44639108|NCT00379639|Romidepsin|romidepsin|mesh-list
44639109|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639110|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
44639111|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639112|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639113|NCT00379639|Antiviral Agents|antiviral agents|mesh-ancestor
44639114|NCT00379639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639115|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639116|NCT00379639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639117|NCT00379639|Immunologic Factors|immunologic factors|mesh-ancestor
44639118|NCT00379639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639119|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639120|NCT00379587|Rituximab|rituximab|mesh-list
44639121|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639122|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639123|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
44639124|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639125|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639126|NCT00379353|Thalidomide|thalidomide|mesh-list
44639127|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639128|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
44639129|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639130|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
44639131|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639132|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639133|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639134|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639135|NCT00379353|Growth Substances|growth substances|mesh-ancestor
44639136|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639137|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639138|NCT00378703|Sirolimus|sirolimus|mesh-list
44639139|NCT00378703|Bevacizumab|bevacizumab|mesh-list
44639140|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44639141|NCT00378703|Sorafenib|sorafenib|mesh-list
44639142|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
44639143|NCT00378703|Antibodies|antibodies|mesh-list
44639144|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
44639145|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44639146|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
44639147|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639148|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639149|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639150|NCT00378703|Growth Substances|growth substances|mesh-ancestor
44639151|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639152|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639153|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
44639154|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639155|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639156|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639157|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639158|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639159|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639160|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
44639161|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639162|NCT00378599|Interferons|interferons|mesh-list
44639163|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
44639164|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
44639165|NCT00378599|Ribavirin|ribavirin|mesh-list
44639166|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44639167|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639168|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
44639169|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639170|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
44639171|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639172|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
44639173|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639174|NCT00378573|Gemcitabine|gemcitabine|mesh-list
44639175|NCT00378573|Bevacizumab|bevacizumab|mesh-list
44639176|NCT00378573|Docetaxel|docetaxel|mesh-list
44639177|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639178|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639179|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639180|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639181|NCT00378573|Growth Substances|growth substances|mesh-ancestor
44639182|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639183|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639184|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639185|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
44639186|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639187|NCT00378573|Antiviral Agents|antiviral agents|mesh-ancestor
44639188|NCT00378573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639189|NCT00378573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639190|NCT00378573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639191|NCT00378573|Immunologic Factors|immunologic factors|mesh-ancestor
44639192|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44639193|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44639194|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44639195|NCT00378534|Cyclosporine|cyclosporine|mesh-list
44639196|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
44639197|NCT00378534|Fludarabine|fludarabine|mesh-list
44639198|NCT00378534|Cyclosporins|cyclosporins|mesh-list
44639199|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639200|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
44639201|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639202|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639203|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44639204|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
44639205|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639206|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639207|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44639208|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639209|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
44639210|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639211|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
44639212|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44639213|NCT00378209|Dexamethasone|dexamethasone|mesh-list
44639214|NCT00378209|Lenalidomide|lenalidomide|mesh-list
44639215|NCT00378209|Bortezomib|bortezomib|mesh-list
44639216|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639217|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
44639218|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
44639219|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639220|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639221|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639222|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
44639223|NCT00378209|Hormones|hormones|mesh-ancestor
44639224|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639225|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639226|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639227|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
44639228|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639229|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639230|NCT00378209|Growth Substances|growth substances|mesh-ancestor
44639231|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639232|NCT00378105|Dexamethasone|dexamethasone|mesh-list
44639233|NCT00378105|Lenalidomide|lenalidomide|mesh-list
44639234|NCT00378105|Bortezomib|bortezomib|mesh-list
44639235|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639236|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
44639237|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
44639238|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639239|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639240|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639241|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
44639242|NCT00378105|Hormones|hormones|mesh-ancestor
44639243|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639244|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639245|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639246|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
44639247|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639248|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639249|NCT00378105|Growth Substances|growth substances|mesh-ancestor
44639250|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639251|NCT00378079|Methadone|methadone|mesh-list
44639252|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44639253|NCT00378079|Narcotics|narcotics|mesh-ancestor
44639254|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639255|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639256|NCT00378079|Analgesics|analgesics|mesh-ancestor
44639257|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
44190197|NCT00354276|Cytarabine|cytarabine|mesh-list
44639258|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639259|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
44639260|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44639261|NCT00378014|Everolimus|everolimus|mesh-list
44639262|NCT00378014|Basiliximab|basiliximab|mesh-list
44639263|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639264|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639265|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
44639266|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639267|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
44639268|NCT00377962|Everolimus|everolimus|mesh-list
44639269|NCT00377962|Azathioprine|azathioprine|mesh-list
44639270|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44639271|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639272|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639273|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
44639274|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639275|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639276|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639277|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
44639278|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639279|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639280|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639281|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44639282|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
44639283|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639284|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639285|NCT00377858|Insulin|insulin|mesh-list
44639286|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44639287|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
44639288|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
44639289|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44639290|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639291|NCT00377819|Denosumab|denosumab|mesh-list
44639292|NCT00377819|Alendronate|alendronate|mesh-list
44639293|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44639294|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639295|NCT00377676|Bromocriptine|bromocriptine|mesh-list
44639296|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44639297|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44639298|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
44639299|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639300|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639301|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
44639302|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
44639303|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639304|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639305|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
44639306|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
44639307|NCT00377637|Azathioprine|azathioprine|mesh-list
44639308|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639309|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
44639310|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639311|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639312|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44639313|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
44639314|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639315|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639316|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44639317|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639319|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
44639320|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639321|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639322|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639323|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
44639324|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639325|NCT00377520|Pemetrexed|pemetrexed|mesh-list
44639326|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639327|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639328|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639329|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44639330|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639331|NCT00377455|Bosentan|bosentan|mesh-list
44639332|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44639333|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44190275|NCT00354406|Abciximab|abciximab|mesh-list
44639334|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639335|NCT00377429|Catumaxomab|catumaxomab|mesh-list
44639336|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639337|NCT00377403|Acetaminophen|acetaminophen|mesh-list
44639338|NCT00377403|Amoxicillin|amoxicillin|mesh-list
44639339|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
44639340|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
44639341|NCT00377403|Ephedrine|ephedrine|mesh-list
44639342|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
44639343|NCT00377403|Guaifenesin|guaifenesin|mesh-list
44639344|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44639345|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44639346|NCT00377403|Analgesics|analgesics|mesh-ancestor
44639347|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
44639348|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639349|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639350|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
44639351|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639352|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639353|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
44639354|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
44639355|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44639356|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44639357|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639358|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639359|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44639360|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
44639361|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44639362|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
44639363|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44639364|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44639365|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
44639366|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
44639367|NCT00377403|Expectorants|expectorants|mesh-ancestor
44639368|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44639369|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44639370|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
44639371|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44639372|NCT00377364|Acetaminophen|acetaminophen|mesh-list
44639373|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44639374|NCT00377364|Analgesics|analgesics|mesh-ancestor
44639375|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
44639376|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639377|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639378|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
44639379|NCT00377312|Hormones|hormones|mesh-list
44639380|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
44639381|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639382|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639383|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44639384|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44639385|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
44639386|NCT00377260|Amoxicillin|amoxicillin|mesh-list
44639387|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
44639388|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
44639389|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44639390|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639391|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639392|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44639394|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639395|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
44639396|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
44639397|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44639398|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639399|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639400|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44639401|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639402|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44639403|NCT00376961|Prednisone|prednisone|mesh-list
44639404|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
44639405|NCT00376961|Rituximab|rituximab|mesh-list
44639406|NCT00376961|Doxorubicin|doxorubicin|mesh-list
44639407|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44639408|NCT00376961|Vincristine|vincristine|mesh-list
44639409|NCT00376961|Bortezomib|bortezomib|mesh-list
44639410|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639411|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
44639412|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639413|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639414|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44639415|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
44639416|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639417|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639418|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44639419|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639420|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639421|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44639422|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44639423|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639424|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639425|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
44639426|NCT00376961|Hormones|hormones|mesh-ancestor
44639427|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639428|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639429|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44639430|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44639431|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44639432|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44639433|NCT00376688|Sirolimus|sirolimus|mesh-list
44639434|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639435|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639436|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639437|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639438|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
44639439|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639440|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
44639441|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639442|NCT00376675|Methylphenidate|methylphenidate|mesh-list
44639443|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44639444|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639445|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44639446|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44639447|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639448|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639449|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
44639450|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639451|NCT00376259|Adefovir|adefovir|mesh-list
44639452|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44639453|NCT00376259|Telbivudine|telbivudine|mesh-list
44639454|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
44639455|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639456|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44639457|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639458|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639459|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639460|NCT00376246|Ezetimibe|ezetimibe|mesh-list
44639461|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44639462|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44639463|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
44639464|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639465|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44639466|NCT00376220|Riluzole|riluzole|mesh-list
44639467|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
44639468|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44639469|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44639470|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639471|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639472|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639473|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44639474|NCT00376220|Protective Agents|protective agents|mesh-ancestor
44639475|NCT00375934|Diclofenac|diclofenac|mesh-list
44639476|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44639477|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44639478|NCT00375934|Analgesics|analgesics|mesh-ancestor
44639479|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
44639480|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639481|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639482|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639483|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639484|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44639485|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639486|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639487|NCT00375752|Letrozole|letrozole|mesh-list
44639488|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639489|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44639490|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44639491|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639492|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639493|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44639494|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
44639495|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639496|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639497|NCT00375674|Sunitinib|sunitinib|mesh-list
44639498|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639499|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639500|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639501|NCT00375674|Growth Substances|growth substances|mesh-ancestor
44639502|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639503|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639504|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639505|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639506|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639507|NCT00375609|Enoxaparin|enoxaparin|mesh-list
44639508|NCT00375609|Betrixaban|betrixaban|mesh-list
44639509|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
44639510|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44639511|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44639512|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639513|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44639514|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
44639515|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44639516|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
44639517|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639518|NCT00375518|Atorvastatin|atorvastatin|mesh-list
44639519|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44639520|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44639521|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
44639522|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639523|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44639524|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44639525|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639526|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
44639527|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44639528|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639529|NCT00375492|Exenatide|exenatide|mesh-list
44639530|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44639531|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639532|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44639533|NCT00375492|Incretins|incretins|mesh-ancestor
44639534|NCT00375492|Hormones|hormones|mesh-ancestor
44639535|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639536|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
44639537|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44639538|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639539|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
44639540|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44639541|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639542|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44639543|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639544|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639545|NCT00374907|Metformin|metformin|mesh-list
44639546|NCT00374907|Saxagliptin|saxagliptin|mesh-list
44639547|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44639548|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639549|NCT00374907|Incretins|incretins|mesh-ancestor
44639550|NCT00374907|Hormones|hormones|mesh-ancestor
44639551|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639552|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44639553|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44639554|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639555|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639556|NCT00374868|Cisplatin|cisplatin|mesh-list
44639557|NCT00374868|Pemetrexed|pemetrexed|mesh-list
44639558|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639559|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639560|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639561|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44639562|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639563|NCT00374556|Eszopiclone|eszopiclone|mesh-list
44639564|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44639565|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639566|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639567|NCT00374322|Lapatinib|lapatinib|mesh-list
44639568|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639569|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639570|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639571|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639572|NCT00374140|Everolimus|everolimus|mesh-list
44639573|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639574|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639575|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
44639576|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639577|NCT00373958|Vaccines|vaccines|mesh-list
44639578|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44639579|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
44639580|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639581|NCT00373880|Cocaine|cocaine|mesh-list
44639582|NCT00373880|Aripiprazole|aripiprazole|mesh-list
44639583|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
44639584|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44639585|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44639586|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43907092|NCT00278863|Capecitabine|capecitabine|mesh-list
44639587|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639588|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639589|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
44639590|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
44639591|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639592|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639593|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44639594|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44639595|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
44639596|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44639597|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44639598|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44639599|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44639600|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
44639601|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
44639602|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
44639603|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639604|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44639605|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44639606|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44639607|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639608|NCT00373685|Celecoxib|celecoxib|mesh-list
44639609|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44639610|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44639611|NCT00373685|Analgesics|analgesics|mesh-ancestor
44639612|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
44639613|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639614|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639615|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639616|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639617|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44639618|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44639619|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639620|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639621|NCT00373529|Clofarabine|clofarabine|mesh-list
44639622|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639623|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
44639624|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639625|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639626|NCT00373490|Vorinostat|vorinostat|mesh-list
44639627|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639628|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44639629|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639630|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639631|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44639632|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639633|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639634|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639635|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639636|NCT00373295|Baclofen|baclofen|mesh-list
44639637|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44639638|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639639|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44639640|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639641|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44639642|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
44639643|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
44639644|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639645|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639646|NCT00373256|Paclitaxel|paclitaxel|mesh-list
44639647|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44639648|NCT00373256|Bevacizumab|bevacizumab|mesh-list
44639649|NCT00373256|Sunitinib|sunitinib|mesh-list
44639650|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44639651|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639652|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44639653|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44639654|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44639655|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639656|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639657|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639658|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639659|NCT00373256|Growth Substances|growth substances|mesh-ancestor
44639660|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639661|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639662|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639663|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639664|NCT00373113|Capecitabine|capecitabine|mesh-list
44639665|NCT00373113|Sunitinib|sunitinib|mesh-list
44639666|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639667|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
44639668|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639669|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639670|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639671|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639672|NCT00373113|Growth Substances|growth substances|mesh-ancestor
44639673|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639674|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639675|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639676|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639677|NCT00372996|Fulvestrant|fulvestrant|mesh-list
44639678|NCT00372996|Exemestane|exemestane|mesh-list
44639679|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639680|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639681|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44639682|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44639683|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
44639684|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639685|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639686|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44639687|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44639688|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639689|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639691|NCT00372905|Bortezomib|bortezomib|mesh-list
44639692|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44639693|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639694|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639695|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
44639696|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639697|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639698|NCT00372775|Sunitinib|sunitinib|mesh-list
44639699|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639700|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639701|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639702|NCT00372775|Growth Substances|growth substances|mesh-ancestor
43907175|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
44639703|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639716|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
44639717|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44639718|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639719|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639720|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
44639721|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639722|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639723|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
44639724|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639725|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44639726|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639727|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
44639728|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639729|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639730|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
44639731|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639733|NCT00372593|Etoposide|etoposide|mesh-list
44639734|NCT00372593|Daunorubicin|daunorubicin|mesh-list
44639735|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
44639736|NCT00372593|Asparaginase|asparaginase|mesh-list
44639737|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
44639738|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44639739|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639740|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44639741|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44639742|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639743|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639744|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44639745|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
44639746|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
44639747|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639748|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639749|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
44639750|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639751|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639752|NCT00372593|Analgesics|analgesics|mesh-ancestor
44639753|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
44639754|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639755|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639756|NCT00372567|Sunitinib|sunitinib|mesh-list
44639757|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
44639758|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639759|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639760|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639761|NCT00372567|Growth Substances|growth substances|mesh-ancestor
44639762|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639763|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639764|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639765|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639766|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639767|NCT00372528|Pregabalin|pregabalin|mesh-list
44639768|NCT00372528|Analgesics|analgesics|mesh-ancestor
44639769|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
44639770|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639771|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639772|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
44639773|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44639774|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44639775|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639776|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44639777|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44639778|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44639779|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44639780|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44639781|NCT00372424|Docetaxel|docetaxel|mesh-list
44639782|NCT00372424|Trastuzumab|trastuzumab|mesh-list
44639783|NCT00372424|Sunitinib|sunitinib|mesh-list
44639784|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907229|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
44639785|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44639786|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44639787|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44639788|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639789|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639790|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639791|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639792|NCT00372424|Growth Substances|growth substances|mesh-ancestor
44639793|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639794|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639795|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639796|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190802|NCT00356460|Antibodies|antibodies|mesh-list
44639797|NCT00372385|Interferons|interferons|mesh-list
44639798|NCT00372385|Ribavirin|ribavirin|mesh-list
44639799|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
44639800|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
44639801|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44639802|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639803|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
44639804|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639805|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
44639806|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639807|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
44639808|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639809|NCT00372229|Valganciclovir|valganciclovir|mesh-list
44639810|NCT00372229|Ganciclovir|ganciclovir|mesh-list
44639811|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44639812|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
44639813|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639814|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639815|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639816|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639817|NCT00372060|Pioglitazone|pioglitazone|mesh-list
44639818|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44639819|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44639820|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639821|NCT00372060|Incretins|incretins|mesh-ancestor
44639822|NCT00372060|Hormones|hormones|mesh-ancestor
44639823|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639824|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44639825|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44639826|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639827|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639828|NCT00371826|Cyclosporine|cyclosporine|mesh-list
44639829|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
44639830|NCT00371826|Prednisone|prednisone|mesh-list
44639831|NCT00371826|Everolimus|everolimus|mesh-list
44639832|NCT00371826|Cyclosporins|cyclosporins|mesh-list
44639833|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44639834|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44639835|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
44639836|NCT00371826|Hormones|hormones|mesh-ancestor
44639837|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44639838|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639839|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44639840|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639841|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639842|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639843|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44639844|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
44639845|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
44639846|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639847|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44639848|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639849|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44639850|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44639851|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
44639852|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44639853|NCT00371761|Interferons|interferons|mesh-list
44639854|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
44639855|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
44639856|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44639857|NCT00371761|Adefovir|adefovir|mesh-list
44639858|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44639859|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639860|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
44639861|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639862|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
44639863|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639864|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44639865|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639866|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639867|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639868|NCT00371683|Enoxaparin|enoxaparin|mesh-list
44639869|NCT00371683|Apixaban|apixaban|mesh-list
44639870|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
44639871|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44639872|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44639873|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639874|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44639875|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
44639876|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44639877|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44639878|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639880|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639881|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639882|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639883|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639884|NCT00371345|Dasatinib|dasatinib|mesh-list
44639885|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639886|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639887|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639888|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639889|NCT00371254|Dasatinib|dasatinib|mesh-list
44639890|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639891|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44639892|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639893|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639894|NCT00371150|Entecavir|entecavir|mesh-list
44639895|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
44639896|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639897|NCT00370682|Vaccines|vaccines|mesh-list
44639898|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
44639899|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639900|NCT00370552|Paclitaxel|paclitaxel|mesh-list
44639901|NCT00370552|Epothilones|epothilones|mesh-list
44639902|NCT00370552|Bevacizumab|bevacizumab|mesh-list
44639903|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44639904|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639905|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44639906|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44639907|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44639908|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639909|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639910|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44639911|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44639912|NCT00370552|Growth Substances|growth substances|mesh-ancestor
44639913|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639914|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44639915|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44639916|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
44639917|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639918|NCT00370292|Pemetrexed|pemetrexed|mesh-list
44639919|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639920|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639921|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639922|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44639923|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639924|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44639925|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639926|NCT00370071|Interferons|interferons|mesh-list
44639927|NCT00370071|Interferon-beta|interferon-beta|mesh-list
44639928|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
44639929|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639930|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
44639931|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639932|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
44639933|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639934|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44639935|NCT00370032|Alosetron|alosetron|mesh-list
44639936|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639937|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44639938|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
44639939|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639940|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639941|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639942|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
44639943|NCT00369967|NuvaRing|nuvaring|mesh-list
44639944|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44639945|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639946|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44639947|NCT00369941|Tenofovir|tenofovir|mesh-list
44639948|NCT00369941|Emtricitabine|emtricitabine|mesh-list
44639949|NCT00369941|Efavirenz|efavirenz|mesh-list
44639950|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
44639951|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44639952|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
44639953|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44639954|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44639955|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44639956|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639957|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639958|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44639959|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44639960|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44639961|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44639962|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44639963|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44639964|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44639965|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44639966|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44639967|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44639968|NCT00369915|Scopolamine|scopolamine|mesh-list
44639969|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44639970|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44639971|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
44639972|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
44639973|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44639974|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639975|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44639976|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
44639977|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44639978|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
44639979|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639980|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639981|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44639982|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
44639983|NCT00369785|Donepezil|donepezil|mesh-list
44639984|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44639985|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44639986|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44639987|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
44639988|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44639989|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639990|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
44639991|NCT00369707|Rituximab|rituximab|mesh-list
44639992|NCT00369707|Bortezomib|bortezomib|mesh-list
44639993|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44639994|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44639995|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
44639996|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44639997|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44639998|NCT00369681|Rituximab|rituximab|mesh-list
44639999|NCT00369681|Doxorubicin|doxorubicin|mesh-list
44640000|NCT00369681|Dacarbazine|dacarbazine|mesh-list
44640001|NCT00369681|Bleomycin|bleomycin|mesh-list
44640002|NCT00369681|Vinblastine|vinblastine|mesh-list
44640003|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640004|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640005|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
44640006|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640007|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640008|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44640009|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44640010|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44640011|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640012|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640013|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44640014|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
44640015|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44640016|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44640017|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44640018|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640019|NCT00369655|Aflibercept|aflibercept|mesh-list
44640020|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
44640021|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640022|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191035|NCT00357318|Sunitinib|sunitinib|mesh-list
44640023|NCT00369655|Growth Substances|growth substances|mesh-ancestor
44640024|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640025|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640026|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640027|NCT00369629|Gemcitabine|gemcitabine|mesh-list
44640028|NCT00369629|Pemetrexed|pemetrexed|mesh-list
44640029|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640030|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
44640031|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640032|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640033|NCT00369629|Antiviral Agents|antiviral agents|mesh-ancestor
44640034|NCT00369629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640035|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640036|NCT00369629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640037|NCT00369629|Immunologic Factors|immunologic factors|mesh-ancestor
44640038|NCT00369629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640039|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44640040|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44640041|NCT00369577|Loxapine|loxapine|mesh-list
44640042|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44640043|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44640044|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640045|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640046|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640047|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44640048|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
44640049|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640050|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640051|NCT00369486|Triamcinolone|triamcinolone|mesh-list
44640052|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44640053|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44640054|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44640055|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640056|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
44640057|NCT00369486|Hormones|hormones|mesh-ancestor
44640058|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640059|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640060|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640061|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
44640062|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640063|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640064|NCT00369382|Cyclosporine|cyclosporine|mesh-list
44640065|NCT00369382|Sirolimus|sirolimus|mesh-list
44640066|NCT00369382|Tacrolimus|tacrolimus|mesh-list
44640067|NCT00369382|Cyclosporins|cyclosporins|mesh-list
44640068|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640069|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
44640070|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640071|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44640072|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640073|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640074|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
44640075|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640076|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44640077|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640078|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640079|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44640080|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640081|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44640082|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44640083|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640084|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640085|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640086|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640087|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640088|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
44640089|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640090|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
44640091|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44640092|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640093|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44640094|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
44640095|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640096|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640097|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640098|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640099|NCT00369265|Lansoprazole|lansoprazole|mesh-list
44640100|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
44640101|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44640102|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640103|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44640104|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640105|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640106|NCT00369161|Everolimus|everolimus|mesh-list
44640107|NCT00369161|Tacrolimus|tacrolimus|mesh-list
44640108|NCT00369161|Basiliximab|basiliximab|mesh-list
44640109|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640110|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
44640111|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640112|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44640113|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640114|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640115|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640116|NCT00369122|Bevacizumab|bevacizumab|mesh-list
44640117|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44640118|NCT00369122|Cisplatin|cisplatin|mesh-list
44640119|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
44640120|NCT00369122|Antibodies|antibodies|mesh-list
44640121|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
44640122|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44640123|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
44640124|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640125|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640126|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640127|NCT00369122|Growth Substances|growth substances|mesh-ancestor
44640128|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640129|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640130|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
44640131|NCT00368992|Paclitaxel|paclitaxel|mesh-list
44640132|NCT00368992|Bevacizumab|bevacizumab|mesh-list
44640133|NCT00368992|Cetuximab|cetuximab|mesh-list
44640134|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44640135|NCT00368992|Antibodies|antibodies|mesh-list
44640136|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
44640137|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44640138|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44640139|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640140|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44640141|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44640142|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640143|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640144|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640145|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640146|NCT00368992|Growth Substances|growth substances|mesh-ancestor
44640147|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640148|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640149|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
44640150|NCT00368979|Dutasteride|dutasteride|mesh-list
44640151|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44640152|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44640153|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640154|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640155|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907602|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640156|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640157|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640158|NCT00368966|Vaccines|vaccines|mesh-list
44640159|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44640160|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
44640161|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640162|NCT00368927|Sulindac|sulindac|mesh-list
44640163|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44640164|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44640165|NCT00368927|Analgesics|analgesics|mesh-ancestor
44640166|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
44640167|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640168|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640169|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640170|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640171|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640172|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44640173|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640174|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640175|NCT00368875|Paclitaxel|paclitaxel|mesh-list
44640176|NCT00368875|Bevacizumab|bevacizumab|mesh-list
44640177|NCT00368875|Vorinostat|vorinostat|mesh-list
44640178|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44640179|NCT00368875|Antibodies|antibodies|mesh-list
44640180|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
44640181|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44640182|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44640183|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640184|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44640185|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44640186|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640187|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640188|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640189|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640190|NCT00368875|Growth Substances|growth substances|mesh-ancestor
44640191|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640192|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640193|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
44640194|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44640195|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640196|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44640197|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44640198|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640199|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640200|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640201|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640202|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640203|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640204|NCT00368745|Pregabalin|pregabalin|mesh-list
44640205|NCT00368745|Analgesics|analgesics|mesh-ancestor
44640206|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
44640207|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640208|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640209|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
44640210|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44640211|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640212|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640213|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44640214|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44640215|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44640216|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640217|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640218|NCT00368641|Icodextrin|icodextrin|mesh-list
44640219|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
44640220|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44640221|NCT00368550|Sertraline|sertraline|mesh-list
44640222|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
44640223|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640224|NCT00368550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44640225|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640226|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640227|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640228|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640229|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
44640230|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640231|NCT00368537|Ampicillin|ampicillin|mesh-list
44640232|NCT00368537|Tigecycline|tigecycline|mesh-list
44640233|NCT00368537|Sulbactam|sulbactam|mesh-list
44640234|NCT00368537|Sultamicillin|sultamicillin|mesh-list
44640235|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640236|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640237|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44640238|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640239|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640240|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44640241|NCT00368355|Cytarabine|cytarabine|mesh-list
44640242|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
44640243|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
44640244|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640245|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
44640246|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640247|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640248|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44640249|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
44640250|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640251|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640252|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44640253|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640255|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
44640256|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640257|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640258|NCT00368277|Amlodipine|amlodipine|mesh-list
44640259|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44640260|NCT00368277|Ramipril|ramipril|mesh-list
44640261|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44640262|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44640263|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640264|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640265|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44640266|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640267|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
44640268|NCT00368277|Diuretics|diuretics|mesh-ancestor
44640269|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
44640270|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44640271|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44640272|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44640273|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640274|NCT00368251|Brivaracetam|brivaracetam|mesh-list
44640275|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
44640276|NCT00368069|Levetiracetam|levetiracetam|mesh-list
44640277|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
44640278|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
44640279|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
44640280|NCT00367991|Hematinics|hematinics|mesh-ancestor
44640281|NCT00367835|Guanfacine|guanfacine|mesh-list
44640282|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44640283|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44640284|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44640285|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44640286|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640287|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640288|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640289|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640290|NCT00367770|Bosentan|bosentan|mesh-list
44640291|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44640292|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44640293|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640294|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
44640295|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640296|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640297|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
44640298|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640299|NCT00367484|Interferons|interferons|mesh-list
44640300|NCT00367484|Interferon-beta|interferon-beta|mesh-list
44640301|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
44640302|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640303|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
44640304|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640305|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
44640306|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640307|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44640308|NCT00367458|Atorvastatin|atorvastatin|mesh-list
44640309|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44640310|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44640311|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
44640312|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640313|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44640314|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44640315|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640316|NCT00367432|Levetiracetam|levetiracetam|mesh-list
44640317|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
44640318|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
44640320|NCT00367341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44640321|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640322|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640323|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640324|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640325|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
44640326|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640327|NCT00367341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44640328|NCT00367341|Antidepressive Agents|antidepressive agents|mesh-ancestor
44640329|NCT00367341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640330|NCT00367237|Methotrexate|methotrexate|mesh-list
44640331|NCT00367237|Infliximab|infliximab|mesh-list
44640332|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44640333|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
44640334|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44640335|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640336|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640337|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
44640338|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640339|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640340|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
44640341|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640342|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44640343|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640344|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
44640345|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640346|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44640347|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640348|NCT00367133|Triamcinolone|triamcinolone|mesh-list
44640349|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44640350|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44640351|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44640352|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640353|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
44640354|NCT00367133|Hormones|hormones|mesh-ancestor
44640355|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640356|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640357|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640358|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
44640359|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640360|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640361|NCT00367055|Metformin|metformin|mesh-list
44640362|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
44640363|NCT00367055|Gliclazide|gliclazide|mesh-list
44640364|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640365|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640366|NCT00366899|Vaccines|vaccines|mesh-list
44640367|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44640368|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
44640369|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640370|NCT00366678|Vaccines|vaccines|mesh-list
44640371|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44640372|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
44640373|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640374|NCT00366548|Vaccines|vaccines|mesh-list
44640375|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44640376|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
44640377|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640378|NCT00366535|Neurotropin|neurotropin|mesh-list
44640379|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44640380|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
44640381|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640382|NCT00366535|Analgesics|analgesics|mesh-ancestor
44640383|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
44640384|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640385|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
44640386|NCT00366457|Gemcitabine|gemcitabine|mesh-list
44640387|NCT00366457|Bevacizumab|bevacizumab|mesh-list
44640388|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44640389|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640390|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640391|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640392|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640393|NCT00366457|Growth Substances|growth substances|mesh-ancestor
44640394|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640395|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640396|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640397|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
44640398|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640399|NCT00366457|Antiviral Agents|antiviral agents|mesh-ancestor
44640400|NCT00366457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640401|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640402|NCT00366457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640403|NCT00366457|Immunologic Factors|immunologic factors|mesh-ancestor
44640404|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44640405|NCT00366444|Diclofenac|diclofenac|mesh-list
44640406|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44640407|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44640408|NCT00366444|Analgesics|analgesics|mesh-ancestor
44640409|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
44640410|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640411|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640412|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640413|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907828|NCT00301756|Belinostat|belinostat|mesh-list
44640414|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44640415|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640416|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640417|NCT00366340|Vaccines|vaccines|mesh-list
44640418|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44640419|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
44640420|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640421|NCT00366301|Metformin|metformin|mesh-list
44640422|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
44640423|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640424|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640425|NCT00366249|Ertapenem|ertapenem|mesh-list
44640426|NCT00366249|Tigecycline|tigecycline|mesh-list
44640427|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640428|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640429|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44640430|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640431|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640432|NCT00365976|Eszopiclone|eszopiclone|mesh-list
44640433|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44640434|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640435|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640436|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
44640437|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640438|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640439|NCT00365794|Testosterone|testosterone|mesh-list
44640440|NCT00365794|Androgens|androgens|mesh-ancestor
44640441|NCT00365794|Hormones|hormones|mesh-ancestor
44640442|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640443|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640444|NCT00365716|Vaccines|vaccines|mesh-list
44640446|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640447|NCT00365547|Bevacizumab|bevacizumab|mesh-list
44640448|NCT00365547|Topotecan|topotecan|mesh-list
44640449|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640450|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640451|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640452|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640453|NCT00365547|Growth Substances|growth substances|mesh-ancestor
44640454|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640455|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640456|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44640457|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44640458|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640459|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640460|NCT00365508|Nicotine|nicotine|mesh-list
44640461|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44640462|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
44640463|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640464|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640465|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44640466|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44640467|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
44640468|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640469|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640470|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
44640471|NCT00365456|Hormones|hormones|mesh-list
44191484|NCT00359164|Bevacizumab|bevacizumab|mesh-list
44640472|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
44640473|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640474|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640475|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44640476|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640477|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640478|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44640479|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44640480|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
44640481|NCT00365365|Bevacizumab|bevacizumab|mesh-list
44640482|NCT00365365|Carboplatin|carboplatin|mesh-list
44640483|NCT00365365|Docetaxel|docetaxel|mesh-list
44640484|NCT00365365|Doxorubicin|doxorubicin|mesh-list
44640485|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44640486|NCT00365365|Trastuzumab|trastuzumab|mesh-list
44640487|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640488|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
44640489|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640490|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640491|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44640492|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
44640493|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640494|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640495|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44640496|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640497|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640498|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640499|NCT00365365|Growth Substances|growth substances|mesh-ancestor
44640500|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640501|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
44640502|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
44640503|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640504|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44640505|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44640506|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44640507|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640508|NCT00365352|Gabapentin|gabapentin|mesh-list
44640509|NCT00365352|Analgesics|analgesics|mesh-ancestor
44640510|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
44640511|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640512|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640513|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
44640514|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44640515|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44640516|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640517|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640518|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44640519|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44640520|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640521|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640522|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
44640523|NCT00365300|Pantoprazole|pantoprazole|mesh-list
44640524|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44640525|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640526|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44640527|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640528|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640529|NCT00365105|Vitamin D|vitamin d|mesh-list
44640530|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
44640531|NCT00365105|Calcium|calcium|mesh-list
44640532|NCT00365105|Vitamins|vitamins|mesh-ancestor
44640533|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
44640534|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640535|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907951|NCT05267288|Afatinib|afatinib|mesh-list
44640536|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44640537|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44640538|NCT00364923|Aminopterin|aminopterin|mesh-list
44640539|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44640540|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640541|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640542|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640543|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
44640544|NCT00364845|Hematinics|hematinics|mesh-ancestor
44640545|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
44640546|NCT00364832|Hematinics|hematinics|mesh-ancestor
44640547|NCT00364793|Emtricitabine|emtricitabine|mesh-list
44640548|NCT00364793|Efavirenz|efavirenz|mesh-list
44640549|NCT00364793|Didanosine|didanosine|mesh-list
44640550|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
44640551|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640552|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44640553|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44640554|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640555|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640556|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44640557|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44640558|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44640559|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44640560|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44640561|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44640562|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44640563|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44640564|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
44640565|NCT00364689|Rifaximin|rifaximin|mesh-list
44640566|NCT00364689|Lactulose|lactulose|mesh-list
44640567|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640568|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640569|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640570|NCT00364611|Bevacizumab|bevacizumab|mesh-list
44640571|NCT00364611|Trastuzumab|trastuzumab|mesh-list
44640572|NCT00364611|Docetaxel|docetaxel|mesh-list
44640573|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640574|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640575|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640576|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640577|NCT00364611|Growth Substances|growth substances|mesh-ancestor
44640578|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640579|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640580|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44640581|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44640582|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640583|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640584|NCT00364533|Oxycodone|oxycodone|mesh-list
44640585|NCT00364533|Tapentadol|tapentadol|mesh-list
44640586|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44640587|NCT00364533|Narcotics|narcotics|mesh-ancestor
44640588|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640589|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640590|NCT00364533|Analgesics|analgesics|mesh-ancestor
44640591|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
44640592|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640593|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43775587|NCT02344823|Urological Agents|urological agents|mesh-ancestor
44640594|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640595|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640596|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640597|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640598|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640599|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44640600|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640601|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44640602|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640603|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640605|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640606|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44640607|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640608|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640609|NCT00364156|Nicotine|nicotine|mesh-list
44640610|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44640611|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
44640612|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640613|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640614|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44640615|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44640616|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
44640617|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640618|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640619|NCT00363896|Bromides|bromides|mesh-list
44640620|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
44640621|NCT00363649|Interferons|interferons|mesh-list
44640622|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
44640623|NCT00363649|Sargramostim|sargramostim|mesh-list
44640624|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640625|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
44640626|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640627|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
44640628|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640629|NCT00363545|Vaccines|vaccines|mesh-list
44640630|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
44640631|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640632|NCT00363480|Fluticasone|fluticasone|mesh-list
44640633|NCT00363480|Albuterol|albuterol|mesh-list
44640634|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44640635|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640636|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44640637|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
44640638|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640639|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640640|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44640641|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
44640642|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
44640643|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44640644|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44640645|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44640646|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44640647|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640648|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640649|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640650|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
44640651|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44640652|NCT00363467|Busulfan|busulfan|mesh-list
44640653|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
44640654|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640655|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640656|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
44640657|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640658|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44640659|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640660|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44640661|NCT00363415|Carboplatin|carboplatin|mesh-list
44640662|NCT00363415|Etoposide|etoposide|mesh-list
44640663|NCT00363415|Pemetrexed|pemetrexed|mesh-list
44640664|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640665|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44640666|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44640667|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44640668|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640669|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640671|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44640672|NCT00363311|Dutasteride|dutasteride|mesh-list
44640673|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44640674|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44640675|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640676|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640677|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44640678|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640679|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640680|NCT00363298|Caffeine|caffeine|mesh-list
44640681|NCT00363298|Amphetamine|amphetamine|mesh-list
44640682|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
44640683|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44640684|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640685|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44640686|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640687|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640688|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44640689|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44640690|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
44640691|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640692|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
44640693|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
44640694|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640695|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
44640696|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640697|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44640698|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640699|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640700|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44640702|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
44640703|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44640704|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44640705|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
44640706|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640707|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640708|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44640709|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44640710|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
44640711|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640712|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44640713|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44640714|NCT00363129|Vitamin E|vitamin e|mesh-list
44640715|NCT00363129|Vitamins|vitamins|mesh-ancestor
44640716|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
44640717|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640718|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
44640719|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640720|NCT00363129|Protective Agents|protective agents|mesh-ancestor
44640721|NCT00363051|Everolimus|everolimus|mesh-list
44640722|NCT00363051|Octreotide|octreotide|mesh-list
44640723|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640724|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640725|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
44640726|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640727|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640728|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44640729|NCT00362609|Pantoprazole|pantoprazole|mesh-list
44640730|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44640731|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640732|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44640733|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640734|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640735|NCT00362414|Mitogens|mitogens|mesh-list
44640736|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44640737|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640738|NCT00362297|Valacyclovir|valacyclovir|mesh-list
44640739|NCT00362297|Acyclovir|acyclovir|mesh-list
44640740|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
44640741|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640742|NCT00362232|Enoxaparin|enoxaparin|mesh-list
44640743|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
44640744|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
44640745|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44640746|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
44640747|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44640748|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
44640749|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640750|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640751|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
44640752|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44640753|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44640754|NCT00362180|Mipomersen|mipomersen|mesh-list
44640755|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44640756|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44640757|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
44640758|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640759|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44640760|NCT00362115|Olmesartan|olmesartan|mesh-list
44640761|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44640762|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44640763|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44640764|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44640765|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640766|NCT00361842|Irinotecan|irinotecan|mesh-list
44640767|NCT00361842|Floxuridine|floxuridine|mesh-list
44640768|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44640769|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44640770|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640771|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640772|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640773|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640774|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
44640775|NCT00361634|Etanercept|etanercept|mesh-list
44640776|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44640777|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44640778|NCT00361634|Analgesics|analgesics|mesh-ancestor
44640779|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
44640780|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640781|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640782|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640783|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640784|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44640785|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640786|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
44640787|NCT00361569|Estrogens|estrogens|mesh-list
44640788|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44640789|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
44640790|NCT00361569|Hormones|hormones|mesh-ancestor
44640791|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640792|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640793|NCT00361504|Oxycodone|oxycodone|mesh-list
44640794|NCT00361504|Tapentadol|tapentadol|mesh-list
44640795|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44640796|NCT00361504|Narcotics|narcotics|mesh-ancestor
44640797|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44640798|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640799|NCT00361504|Analgesics|analgesics|mesh-ancestor
44640800|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
44640801|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640802|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44640803|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640804|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640805|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640806|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640807|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640808|NCT00361335|Golimumab|golimumab|mesh-list
44640809|NCT00361335|Methotrexate|methotrexate|mesh-list
44640810|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44640811|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
44640812|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44640813|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640814|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640815|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
44640816|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640817|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640818|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44640819|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640820|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44640821|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640822|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
44640823|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44640824|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44640825|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44640826|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44640827|NCT00361283|Atorvastatin|atorvastatin|mesh-list
44640828|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44640829|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44640830|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
44640831|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640832|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44640833|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44640834|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640835|NCT00361270|Complement Factor H|complement factor h|mesh-list
44640836|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44640837|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640838|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
44640839|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640840|NCT00361231|Gemcitabine|gemcitabine|mesh-list
44640841|NCT00361231|Bevacizumab|bevacizumab|mesh-list
44640842|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
44640843|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44640844|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640845|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44640846|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44640847|NCT00361231|Growth Substances|growth substances|mesh-ancestor
44640848|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640849|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
44640850|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44640851|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
44640852|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640853|NCT00361231|Antiviral Agents|antiviral agents|mesh-ancestor
44640854|NCT00361231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640855|NCT00361231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640856|NCT00361231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640857|NCT00361231|Immunologic Factors|immunologic factors|mesh-ancestor
44640858|NCT00361218|Citalopram|citalopram|mesh-list
44640859|NCT00361218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44640860|NCT00361218|Serotonin|serotonin|mesh-list
44640861|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640862|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640863|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640864|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640865|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
44640866|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640867|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44640868|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
44640869|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44640870|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44640871|NCT00360698|Insulin|insulin|mesh-list
44640872|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44640873|NCT00360698|Metformin|metformin|mesh-list
44640874|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
44640875|NCT00360698|Glimepiride|glimepiride|mesh-list
44640876|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
44640877|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640878|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640879|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44640880|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640881|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
44640882|NCT00360568|Levodopa|levodopa|mesh-list
44640883|NCT00360568|Carbidopa|carbidopa|mesh-list
44640884|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44640885|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44640886|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44640887|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
44640888|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640889|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640890|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036052|NCT00002348|Mitoguazone|mitoguazone|mesh-list
44640891|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44640892|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640893|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44640894|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
44640895|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
44640896|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44640897|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
44640898|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
44640899|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44640900|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
44640901|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44640902|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640903|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44640904|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44640905|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44640906|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44640907|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44640908|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44640909|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44640910|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
44640911|NCT00360334|Exenatide|exenatide|mesh-list
44640912|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640913|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640914|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44640915|NCT00360334|Incretins|incretins|mesh-ancestor
44640916|NCT00360334|Hormones|hormones|mesh-ancestor
44640917|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640918|NCT00360282|Rizatriptan|rizatriptan|mesh-list
44640919|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44640920|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
44640921|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191858|NCT00361322|Analgesics|analgesics|mesh-ancestor
44640922|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640923|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640924|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44640925|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44640926|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44640927|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44640928|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640929|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640930|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640931|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640932|NCT00360230|Vaccines|vaccines|mesh-list
44640933|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
44640934|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640935|NCT00359801|Insulin|insulin|mesh-list
44640936|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44640937|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640938|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640939|NCT00359788|Albuterol|albuterol|mesh-list
44640940|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
44640941|NCT00359788|Ipratropium|ipratropium|mesh-list
44640942|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44640943|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
44640944|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44640945|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640946|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44640947|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44640948|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
44640949|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44640950|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
44640951|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44640952|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640953|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
44640954|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44640955|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44640956|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44640957|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44640958|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
44640959|NCT00359762|Exenatide|exenatide|mesh-list
44640960|NCT00359762|Glimepiride|glimepiride|mesh-list
44640961|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44640962|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640963|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44640964|NCT00359762|Incretins|incretins|mesh-ancestor
44640965|NCT00359762|Hormones|hormones|mesh-ancestor
44640966|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44640967|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44640968|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44640969|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
44640970|NCT00359632|Linezolid|linezolid|mesh-list
44640971|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44640972|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44640973|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44640974|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640975|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640976|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44640977|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44640978|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43908351|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44640979|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640980|NCT00359281|Niacin|niacin|mesh-list
44640981|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
44640982|NCT00359281|Atorvastatin|atorvastatin|mesh-list
44640983|NCT00359281|Simvastatin|simvastatin|mesh-list
44640984|NCT00359281|Ezetimibe|ezetimibe|mesh-list
44640985|NCT00359281|Fenofibrate|fenofibrate|mesh-list
44640986|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44640987|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44640988|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
44640989|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44640990|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44640991|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44640992|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44640993|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
44640994|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
44640995|NCT00359281|Vitamins|vitamins|mesh-ancestor
44640996|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
44640997|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44640998|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
44640999|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641000|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44641001|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44641002|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641003|NCT00359073|Montelukast|montelukast|mesh-list
44641004|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44641005|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641006|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44641007|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
44641008|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641009|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641010|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44641011|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44641012|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641013|NCT00359021|Etravirine|etravirine|mesh-list
44641014|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44641015|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641016|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641017|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641018|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
44641019|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641020|NCT00358917|Ritonavir|ritonavir|mesh-list
44641021|NCT00358917|Lopinavir|lopinavir|mesh-list
44641022|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44641023|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44641024|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44641025|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
44641026|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641027|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641028|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44641029|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44641030|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
44641031|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641032|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44641033|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44641034|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641035|NCT00358826|Atreleuton|atreleuton|mesh-list
44641036|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44641037|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641038|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641040|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641041|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641042|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641043|NCT00358644|Decitabine|decitabine|mesh-list
44641044|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641045|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
44641046|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641047|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641048|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641049|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
44641050|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641051|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641052|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44641053|NCT00358436|Bromides|bromides|mesh-list
44641054|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
44641055|NCT00358150|Eliglustat|eliglustat|mesh-list
44641056|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641057|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641058|NCT00357994|Levodopa|levodopa|mesh-list
44641059|NCT00357994|Carbidopa|carbidopa|mesh-list
44641060|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44641061|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44641062|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44641063|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
44641064|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641065|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641066|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641067|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44641068|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641069|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44641070|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
44191995|NCT00361868|Metformin|metformin|mesh-list
44641071|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
44641072|NCT00357968|Clopidogrel|clopidogrel|mesh-list
44641073|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44641074|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44641075|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44641076|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44641077|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44641078|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
44641079|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641080|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641081|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641083|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44641084|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44641085|NCT00357903|Analgesics|analgesics|mesh-ancestor
44641086|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
44641087|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641088|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641089|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641090|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641091|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641092|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641093|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
44641094|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
44641095|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44641096|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44641097|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641098|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
44641099|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641100|NCT00357760|Aflibercept|aflibercept|mesh-list
44641101|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
44641102|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641103|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641104|NCT00357760|Growth Substances|growth substances|mesh-ancestor
44641105|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641106|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641107|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641108|NCT00357656|Factor VIII|factor viii|mesh-list
44641109|NCT00357656|Coagulants|coagulants|mesh-ancestor
44641110|NCT00357552|Ritonavir|ritonavir|mesh-list
44641111|NCT00357552|Lopinavir|lopinavir|mesh-list
44641112|NCT00357552|Tenofovir|tenofovir|mesh-list
44641113|NCT00357552|Emtricitabine|emtricitabine|mesh-list
44641114|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44641116|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44641117|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44641118|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641119|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641120|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44641121|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44641122|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
44641123|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641124|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44641125|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44641126|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44641127|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641128|NCT00357500|Thalidomide|thalidomide|mesh-list
44641129|NCT00357500|Celecoxib|celecoxib|mesh-list
44641130|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
44641131|NCT00357500|Etoposide|etoposide|mesh-list
44641132|NCT00357500|Fenofibrate|fenofibrate|mesh-list
44641133|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641134|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
44641135|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641136|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641137|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44641138|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
44641139|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641140|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641141|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44641142|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44641143|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44641144|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44641145|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641146|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44641147|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44641148|NCT00357500|Analgesics|analgesics|mesh-ancestor
44641149|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
44641150|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641151|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641152|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44641153|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44641154|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
44641155|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641156|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641157|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641158|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641159|NCT00357500|Growth Substances|growth substances|mesh-ancestor
44641160|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641161|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44641162|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
44641163|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44641164|NCT00357396|Melphalan|melphalan|mesh-list
44641165|NCT00357396|Busulfan|busulfan|mesh-list
44641166|NCT00357396|Thiotepa|thiotepa|mesh-list
44641167|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44641168|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
44641169|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641170|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641171|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44641172|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641173|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
44641174|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641175|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
44641176|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43908466|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
44641177|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641178|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44641179|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641180|NCT00357110|Fulvestrant|fulvestrant|mesh-list
44641181|NCT00357110|Anastrozole|anastrozole|mesh-list
44641182|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44641183|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641184|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44641185|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44641186|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44641187|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641188|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641189|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44641190|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44641191|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641192|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641194|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44641195|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44641196|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
44641197|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
44641198|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641199|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641200|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641201|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44641202|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44641203|NCT00357006|Estradiol|estradiol|mesh-list
44641204|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44641205|NCT00357006|Estrogens|estrogens|mesh-ancestor
44641206|NCT00357006|Hormones|hormones|mesh-ancestor
44641207|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641208|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641209|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44641210|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
44641211|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44641212|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44641213|NCT00356915|Itraconazole|itraconazole|mesh-list
44641214|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44641215|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
44641216|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641217|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44641218|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44641219|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641220|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641221|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44641222|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
44641223|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641224|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641225|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44641226|NCT00356889|Bevacizumab|bevacizumab|mesh-list
44641227|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44641228|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44641229|NCT00356889|Antibodies|antibodies|mesh-list
44641230|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
44641231|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44641232|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641233|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641234|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641235|NCT00356889|Growth Substances|growth substances|mesh-ancestor
44641236|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641237|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641238|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
44641239|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44641240|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641241|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641242|NCT00356811|Paclitaxel|paclitaxel|mesh-list
44641243|NCT00356811|Lapatinib|lapatinib|mesh-list
44641244|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44641245|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641246|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641247|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641248|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641249|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641250|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44641251|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641252|NCT00356759|Warfarin|warfarin|mesh-list
44641253|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
44641254|NCT00356603|Sumatriptan|sumatriptan|mesh-list
44641255|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44641256|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44641257|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44641258|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
44036449|NCT00002388|Abacavir|abacavir|mesh-list
44641259|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641260|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641261|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641262|NCT00356590|Etanercept|etanercept|mesh-list
44641263|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44641264|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44641265|NCT00356590|Analgesics|analgesics|mesh-ancestor
44641266|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
44641267|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641268|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641269|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641270|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641271|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641272|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641273|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
44641274|NCT00356525|Gemcitabine|gemcitabine|mesh-list
44641275|NCT00356525|Carboplatin|carboplatin|mesh-list
44641276|NCT00356525|Pemetrexed|pemetrexed|mesh-list
44641277|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641278|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641279|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
44641280|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641281|NCT00356525|Antiviral Agents|antiviral agents|mesh-ancestor
44641282|NCT00356525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641283|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641284|NCT00356525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641285|NCT00356525|Immunologic Factors|immunologic factors|mesh-ancestor
44641286|NCT00356525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641287|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44641288|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641289|NCT00356421|Insulin|insulin|mesh-list
44641290|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44641291|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
44641292|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44641293|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641294|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
44641295|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641296|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
44641297|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641298|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641299|NCT00356278|Cycloserine|cycloserine|mesh-list
44641300|NCT00356278|Alprazolam|alprazolam|mesh-list
44641301|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44641302|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641303|NCT00356278|Renal Agents|renal agents|mesh-ancestor
44641304|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44641305|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
44641306|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641307|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
44641308|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641309|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44641310|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641311|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641312|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44641313|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641314|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641315|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
44641316|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
44641317|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641318|NCT00356265|Phenylephrine|phenylephrine|mesh-list
44641319|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
44641320|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44641321|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
44641322|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
44641323|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641324|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641325|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
44641326|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44641327|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
44641328|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641329|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44641330|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44641331|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44641332|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
44641333|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641334|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641336|NCT00356200|Fluphenazine|fluphenazine|mesh-list
44641337|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
44641338|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44641339|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44641340|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641341|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641342|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641343|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641344|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44641345|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
44641346|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641347|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641348|NCT00356148|Ampicillin|ampicillin|mesh-list
44641349|NCT00356148|Sulbactam|sulbactam|mesh-list
44641350|NCT00356148|Sultamicillin|sultamicillin|mesh-list
44641351|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641352|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641353|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44641354|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641355|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641356|NCT00356135|Clopidogrel|clopidogrel|mesh-list
44641357|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44641358|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44641359|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44641360|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44641361|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44641362|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
44641363|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641364|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641365|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641366|NCT00356122|Bevacizumab|bevacizumab|mesh-list
44641367|NCT00356122|Docetaxel|docetaxel|mesh-list
44641368|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
44641369|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44641370|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641371|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641372|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641373|NCT00356122|Growth Substances|growth substances|mesh-ancestor
44641374|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641375|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641376|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641377|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641378|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641379|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641380|NCT00355784|Hormones|hormones|mesh-list
44641381|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641382|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641383|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44641384|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44641385|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44641386|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
44641387|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641388|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44641389|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44641390|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641391|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
44641392|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641393|NCT00355368|Rocuronium|rocuronium|mesh-list
44641394|NCT00355368|Succinylcholine|succinylcholine|mesh-list
44641395|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44641396|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44641397|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44641398|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641399|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641400|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44641401|NCT00355342|Fluticasone|fluticasone|mesh-list
44641403|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44641404|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641405|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44641406|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
44641407|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641408|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641410|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641411|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641412|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44641413|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44641414|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44641415|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44641416|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
44641417|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908715|NCT00549978|Cilostazol|cilostazol|mesh-list
44641418|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641419|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44641420|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44641421|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641422|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641423|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
44641424|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641425|NCT00355121|Vaccines|vaccines|mesh-list
44641426|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
44641427|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641428|NCT00355082|Lamotrigine|lamotrigine|mesh-list
44641429|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
44641430|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44641431|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641432|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641433|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44641434|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641435|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44641436|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641437|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641438|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641439|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44641440|NCT00355030|Leuprolide|leuprolide|mesh-list
44641441|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44641442|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
44641443|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44641444|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641445|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44641446|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641447|NCT00354744|Dactinomycin|dactinomycin|mesh-list
44641448|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
44641449|NCT00354744|Ifosfamide|ifosfamide|mesh-list
44641450|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
44641451|NCT00354744|Doxorubicin|doxorubicin|mesh-list
44641452|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44641453|NCT00354744|Irinotecan|irinotecan|mesh-list
44641454|NCT00354744|Etoposide|etoposide|mesh-list
44641455|NCT00354744|Vincristine|vincristine|mesh-list
44641456|NCT00354744|Camptothecin|camptothecin|mesh-list
44641457|NCT00354744|Lenograstim|lenograstim|mesh-list
44641458|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641459|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
44641460|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641461|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641462|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44641463|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
44641464|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641465|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641466|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44641467|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44641468|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44641469|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44641470|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641471|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44641472|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44641473|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44641474|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641475|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641476|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641477|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641478|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641479|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44641480|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641481|NCT00354679|Bevacizumab|bevacizumab|mesh-list
44641482|NCT00354679|Cisplatin|cisplatin|mesh-list
44641483|NCT00354679|Irinotecan|irinotecan|mesh-list
44641485|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641486|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641487|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641488|NCT00354679|Growth Substances|growth substances|mesh-ancestor
44641489|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641490|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641491|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44641492|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44641493|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641494|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641495|NCT00354601|Docetaxel|docetaxel|mesh-list
44641496|NCT00354601|Capecitabine|capecitabine|mesh-list
44641497|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641498|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641499|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641500|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641501|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641502|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641503|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
44641504|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44641505|NCT00354432|Caseins|caseins|mesh-list
44641506|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44641507|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44641508|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641509|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641510|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641511|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641512|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44641513|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
44641514|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641515|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
44641516|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
44641517|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
44641518|NCT00354341|Hematinics|hematinics|mesh-ancestor
44641519|NCT00354172|Cyclosporine|cyclosporine|mesh-list
44641520|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
44641521|NCT00354172|Aldesleukin|aldesleukin|mesh-list
44641522|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
44641523|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44641524|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44641525|NCT00354172|Prednisolone|prednisolone|mesh-list
44641526|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
44641527|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
44641528|NCT00354172|Fludarabine|fludarabine|mesh-list
44641529|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
44641530|NCT00354172|Interleukin-2|interleukin-2|mesh-list
44641531|NCT00354172|Cyclosporins|cyclosporins|mesh-list
44641532|NCT00354172|Lenograstim|lenograstim|mesh-list
44641533|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44641534|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
44641535|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641536|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
44641537|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641538|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641539|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44641540|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
44641541|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641542|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641543|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44641544|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641545|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
44641546|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44641547|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641548|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
44641549|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641550|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641551|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44641552|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44641553|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44641554|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
44641555|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641556|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641557|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
44641558|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
44641559|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641560|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641561|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
44641562|NCT00354172|Hormones|hormones|mesh-ancestor
44641563|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641564|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44641565|NCT00354172|Protective Agents|protective agents|mesh-ancestor
44641566|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44641567|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44641568|NCT00354172|Analgesics|analgesics|mesh-ancestor
44641569|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
44641570|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44641571|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44641572|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
44641573|NCT00354107|Cytarabine|cytarabine|mesh-list
44641574|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
44641575|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44641576|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44641577|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44641578|NCT00354107|Carboplatin|carboplatin|mesh-list
44641579|NCT00354107|Methotrexate|methotrexate|mesh-list
44641580|NCT00354107|Etoposide|etoposide|mesh-list
44641581|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
44641582|NCT00354107|Ifosfamide|ifosfamide|mesh-list
44641583|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44641584|NCT00354107|Antibodies|antibodies|mesh-list
44641585|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44641586|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
44641587|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641588|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641589|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44641590|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
44641591|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44641592|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641593|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
44641594|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641595|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641596|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641597|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44641598|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641599|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641600|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641601|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44641602|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192578|NCT00363935|Analgesics|analgesics|mesh-ancestor
44641603|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44641604|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
44641605|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641606|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641607|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44641608|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
44641609|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44641610|NCT00354029|Ketamine|ketamine|mesh-list
44641611|NCT00354029|Analgesics|analgesics|mesh-ancestor
44641612|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
44641613|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641614|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641615|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44641616|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44641617|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
44641618|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
44641619|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641620|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44641621|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44641622|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641623|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641624|NCT00353873|Fluticasone|fluticasone|mesh-list
44641625|NCT00353873|Xhance|xhance|mesh-list
44641626|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44641627|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641628|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44641629|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
44641630|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641631|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641632|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44641633|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641634|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641635|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44641636|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44641637|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44641638|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44641639|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
44641640|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641641|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641642|NCT00353704|Pregabalin|pregabalin|mesh-list
44641643|NCT00353704|Morphine|morphine|mesh-list
44641644|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44641645|NCT00353704|Narcotics|narcotics|mesh-ancestor
44641646|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641647|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641648|NCT00353704|Analgesics|analgesics|mesh-ancestor
44641649|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
44641650|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641651|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
44641652|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44641653|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641654|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641655|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44641656|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44641657|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641658|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641659|NCT00353262|Capecitabine|capecitabine|mesh-list
44641660|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
44641661|NCT00353262|Bevacizumab|bevacizumab|mesh-list
44641662|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641663|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
44641664|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641665|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641666|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44641667|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641668|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641669|NCT00353262|Growth Substances|growth substances|mesh-ancestor
44641670|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641671|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641672|NCT00352885|Citalopram|citalopram|mesh-list
44641673|NCT00352885|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44641674|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44641675|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641676|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641677|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641678|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
44192649|NCT00364429|Lorazepam|lorazepam|mesh-list
44641679|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641680|NCT00352885|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44641681|NCT00352885|Antidepressive Agents|antidepressive agents|mesh-ancestor
44641682|NCT00352885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641683|NCT00352846|Vitamin D|vitamin d|mesh-list
44641684|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
44641685|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
44641686|NCT00352846|Calcium|calcium|mesh-list
44641687|NCT00352846|Vitamins|vitamins|mesh-ancestor
44641688|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
44641689|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641690|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44641691|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44641692|NCT00352846|Antacids|antacids|mesh-ancestor
44641693|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641694|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641695|NCT00352755|Leucovorin|leucovorin|mesh-list
44641696|NCT00352755|Fluorouracil|fluorouracil|mesh-list
44641697|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
44641698|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
44641699|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641700|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641701|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641702|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641703|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
44641704|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641705|NCT00352755|Antidotes|antidotes|mesh-ancestor
44641706|NCT00352755|Protective Agents|protective agents|mesh-ancestor
44641707|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
44641708|NCT00352755|Vitamins|vitamins|mesh-ancestor
44641709|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
44641710|NCT00352690|Paclitaxel|paclitaxel|mesh-list
44641711|NCT00352690|Carboplatin|carboplatin|mesh-list
44641712|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44641713|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44641714|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641715|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641716|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641717|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641718|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641719|NCT00352664|Donepezil|donepezil|mesh-list
44641720|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44641721|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641722|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641723|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
44641724|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641725|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641726|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
44641727|NCT00352417|Atreleuton|atreleuton|mesh-list
44641728|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44641729|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641730|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641731|NCT00352365|Lenalidomide|lenalidomide|mesh-list
44641732|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
44641733|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641734|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44641735|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44641736|NCT00352365|Growth Substances|growth substances|mesh-ancestor
44641737|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
44641738|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641739|NCT00352118|Cisplatin|cisplatin|mesh-list
44641740|NCT00352118|Docetaxel|docetaxel|mesh-list
44641741|NCT00352118|Fluorouracil|fluorouracil|mesh-list
44641742|NCT00352118|Lenograstim|lenograstim|mesh-list
44641743|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641744|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44641745|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44641746|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44641747|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641748|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
44641749|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641750|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641751|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
44192749|NCT00364871|Naltrexone|naltrexone|mesh-list
44641752|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641753|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44641754|NCT00352105|Cisplatin|cisplatin|mesh-list
44641755|NCT00352105|Fluorouracil|fluorouracil|mesh-list
44641756|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641757|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
44641758|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641759|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44641760|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641761|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
44641762|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641763|NCT00352053|Tenofovir|tenofovir|mesh-list
44641764|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
44641765|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641766|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44641767|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641768|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641769|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641770|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44641771|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44641772|NCT00351819|Testosterone|testosterone|mesh-list
44641773|NCT00351819|Androgens|androgens|mesh-ancestor
44641774|NCT00351819|Hormones|hormones|mesh-ancestor
44641775|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641776|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641777|NCT00351611|Pregabalin|pregabalin|mesh-list
44641778|NCT00351611|Analgesics|analgesics|mesh-ancestor
44641779|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
44641780|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641781|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641783|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44641784|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641785|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909023|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
44641786|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44641787|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44641788|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641789|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641790|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641791|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
44641792|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44641793|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641794|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44641795|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
44641796|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641797|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641798|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641799|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641800|NCT00351273|Azithromycin|azithromycin|mesh-list
44641801|NCT00351273|Doxycycline|doxycycline|mesh-list
44641802|NCT00351273|Rifampin|rifampin|mesh-list
44641803|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641804|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641805|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
44641806|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44641807|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44641808|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44641809|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
44641810|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
44641811|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641812|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641813|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641814|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44641815|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44641816|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44641817|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44641818|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44641819|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44641820|NCT00350870|Disulfiram|disulfiram|mesh-list
44641821|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44641822|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44641823|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641824|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641825|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
44641826|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641827|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
44641828|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641829|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641830|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641831|NCT00350792|Carboplatin|carboplatin|mesh-list
44641832|NCT00350792|Pemetrexed|pemetrexed|mesh-list
44641833|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641834|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641835|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641836|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44641837|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641838|NCT00350779|Metformin|metformin|mesh-list
44641839|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44641840|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
44641841|NCT00350779|Glipizide|glipizide|mesh-list
44641842|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44641843|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641844|NCT00350779|Incretins|incretins|mesh-ancestor
44641845|NCT00350779|Hormones|hormones|mesh-ancestor
44641846|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641847|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44641848|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
44641849|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641850|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641851|NCT00350727|Lapatinib|lapatinib|mesh-list
44641852|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641853|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44641854|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641855|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641856|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
44641858|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
44641859|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
44641860|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641861|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641862|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44641863|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44641864|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
44641865|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641866|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641867|NCT00350636|Urological Agents|urological agents|mesh-ancestor
44641868|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44641869|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641870|NCT00350636|Renal Agents|renal agents|mesh-ancestor
44641871|NCT00350545|Cyclosporine|cyclosporine|mesh-list
44641872|NCT00350545|Prednisone|prednisone|mesh-list
44641873|NCT00350545|Rituximab|rituximab|mesh-list
44641874|NCT00350545|Tacrolimus|tacrolimus|mesh-list
44641875|NCT00350545|Cyclosporins|cyclosporins|mesh-list
44641876|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44641877|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641878|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
44641879|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641880|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641881|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44641882|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
44641883|NCT00350545|Hormones|hormones|mesh-ancestor
44641884|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44641885|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44641886|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641887|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44641888|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641889|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641890|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
44641891|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641892|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
44641893|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
44641894|NCT00350519|Hematinics|hematinics|mesh-ancestor
44641895|NCT00350272|Tenofovir|tenofovir|mesh-list
44641896|NCT00350272|Lamivudine|lamivudine|mesh-list
44641897|NCT00350272|Efavirenz|efavirenz|mesh-list
44641898|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
44641899|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
44641900|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641901|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44641902|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44641903|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641904|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641905|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44641906|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43909145|NCT00320749|Gemcitabine|gemcitabine|mesh-list
44641907|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44641908|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44641909|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44641910|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44641911|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44641912|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44641913|NCT00350207|Bromides|bromides|mesh-list
44641914|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
44641915|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44641916|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44641917|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
44641918|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641919|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641920|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44641921|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
44641922|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
44641923|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44641924|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
44641925|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641926|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641927|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44641928|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44641930|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
44641931|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
44641932|NCT00349973|Dipyridamole|dipyridamole|mesh-list
44641933|NCT00349973|Olanzapine|olanzapine|mesh-list
44641934|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
44641935|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
44641936|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641937|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641938|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641939|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44641940|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44641941|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44641942|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44641943|NCT00349973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44641944|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44641945|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44641946|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641947|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641948|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
44641949|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44641950|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44641951|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44641952|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
44641953|NCT00349921|Adenosine|adenosine|mesh-list
44641954|NCT00349921|Clonidine|clonidine|mesh-list
44641955|NCT00349921|Analgesics|analgesics|mesh-ancestor
44641956|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
44641957|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44641958|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641959|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44641960|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
44641961|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
44641962|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44641963|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44641964|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44641965|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
44641966|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44641967|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641968|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44641969|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
44641970|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44641971|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
44641972|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
44641973|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
44641974|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44641975|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
44641976|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641977|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44641978|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
44455228|NCT01650246|Lesinurad|lesinurad|mesh-list
44641979|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44641980|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44641981|NCT00349349|Ofatumumab|ofatumumab|mesh-list
44641982|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44641983|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
44641984|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
44641985|NCT00348933|Betaine|betaine|mesh-list
44641986|NCT00348933|Vitamins|vitamins|mesh-ancestor
44641987|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
44641988|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44641989|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
44641990|NCT00348933|Hematinics|hematinics|mesh-ancestor
44641991|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44641992|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
44641993|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44641994|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
44641995|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44641996|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44641997|NCT00348881|Vaccines|vaccines|mesh-list
44641998|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
44641999|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642000|NCT00348816|Prednisone|prednisone|mesh-list
44642001|NCT00348816|Docetaxel|docetaxel|mesh-list
44642002|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642003|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642004|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642005|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642006|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642007|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642008|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
44642009|NCT00348816|Hormones|hormones|mesh-ancestor
44642010|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642011|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642012|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44642013|NCT00348790|Vatalanib|vatalanib|mesh-list
44642014|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642015|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642016|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642017|NCT00348686|Felodipine|felodipine|mesh-list
44642018|NCT00348686|Candesartan|candesartan|mesh-list
44642019|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
44642020|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44642021|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44642022|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44642023|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642024|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44642025|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44642026|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642027|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44642028|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642029|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44642030|NCT00348595|Lenalidomide|lenalidomide|mesh-list
44642031|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
44642032|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642033|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642034|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642035|NCT00348595|Growth Substances|growth substances|mesh-ancestor
44642036|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642037|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642038|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44642039|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
44642040|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642041|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
44642042|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44642043|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642044|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
44642045|NCT00348348|Besifloxacin|besifloxacin|mesh-list
44642046|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642047|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642048|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642049|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642050|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642051|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642052|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642053|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
44642054|NCT00348309|Donepezil|donepezil|mesh-list
44642055|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44642056|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642057|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642058|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
44642059|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642060|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642062|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44642063|NCT00348283|Adalimumab|adalimumab|mesh-list
44642064|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642065|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642066|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
44642067|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44642068|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642069|NCT00347932|Besifloxacin|besifloxacin|mesh-list
44642070|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642071|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642072|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642073|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642074|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642075|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642076|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642077|NCT00347919|Lapatinib|lapatinib|mesh-list
44642078|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642079|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642080|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642081|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642082|NCT00347776|Azithromycin|azithromycin|mesh-list
44642083|NCT00347776|Tetracycline|tetracycline|mesh-list
44642084|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642085|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642086|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44642087|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642088|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642089|NCT00347438|Capecitabine|capecitabine|mesh-list
44642090|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642091|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
44642092|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642093|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642094|NCT00347360|Carvedilol|carvedilol|mesh-list
44642095|NCT00347360|Lisinopril|lisinopril|mesh-list
44642096|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44642097|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44642098|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
44642099|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642100|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642101|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642102|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44642103|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
44642104|NCT00347360|Protective Agents|protective agents|mesh-ancestor
44642105|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44642106|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642107|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44642108|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
44642109|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44642110|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44642111|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44642112|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642113|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642114|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44642115|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
44642116|NCT00347009|Adefovir|adefovir|mesh-list
44642117|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44642118|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
44642119|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642120|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44642121|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43909364|NCT00326872|Cediranib|cediranib|mesh-list
44642122|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642123|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642124|NCT00346775|Beclomethasone|beclomethasone|mesh-list
44642125|NCT00346775|Flunisolide|flunisolide|mesh-list
44642126|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642127|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
44642128|NCT00346775|Hormones|hormones|mesh-ancestor
44193029|NCT00366093|Zopiclone|zopiclone|mesh-list
44642129|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642130|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642131|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44642132|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
44642133|NCT00346268|Parecoxib|parecoxib|mesh-list
44642134|NCT00346268|Morphine|morphine|mesh-list
44642135|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44642136|NCT00346268|Narcotics|narcotics|mesh-ancestor
44642137|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642138|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642139|NCT00346268|Analgesics|analgesics|mesh-ancestor
44642140|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
44642141|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642142|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44642143|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44642144|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642145|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642146|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44642147|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44642148|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642149|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642150|NCT00346216|Ibuprofen|ibuprofen|mesh-list
44642151|NCT00346216|Celecoxib|celecoxib|mesh-list
44642152|NCT00346216|Naproxen|naproxen|mesh-list
44642153|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44642154|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44642155|NCT00346216|Analgesics|analgesics|mesh-ancestor
44642156|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
44642157|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642158|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642159|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642160|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642161|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44642162|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642163|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642164|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44642165|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
44642166|NCT00346164|Doxorubicin|doxorubicin|mesh-list
44642167|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44642168|NCT00346164|Ifosfamide|ifosfamide|mesh-list
44642169|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642170|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642171|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642172|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642173|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642174|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642175|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44642176|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
44642177|NCT00346151|Sirolimus|sirolimus|mesh-list
44642178|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
44642179|NCT00346151|Abatacept|abatacept|mesh-list
44642180|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
44642181|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44642182|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
44642183|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
44642184|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642185|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642186|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642187|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642188|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
43909399|NCT00328614|Analgesics|analgesics|mesh-ancestor
44642189|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642190|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
44642191|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642192|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642193|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
44642194|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
44642195|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642196|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642197|NCT00346151|Hormones|hormones|mesh-ancestor
44642198|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642199|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44642200|NCT00346151|Protective Agents|protective agents|mesh-ancestor
44193099|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
44642201|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44642202|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642204|NCT00346034|Pregabalin|pregabalin|mesh-list
44642205|NCT00346034|Analgesics|analgesics|mesh-ancestor
44642206|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
44642207|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642208|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642209|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
44642210|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44642211|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642212|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642213|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44642214|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44642215|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44642216|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642217|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642218|NCT00345878|Vaccines|vaccines|mesh-list
44642219|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
44642220|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642221|NCT00345683|Vaccines|vaccines|mesh-list
44642222|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
44642223|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642224|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44642225|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642226|NCT00345579|PENTA|penta|mesh-list
44642227|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
44642228|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44642229|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44642230|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642231|NCT00345540|Carboplatin|carboplatin|mesh-list
44642232|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642233|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44642234|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
44642235|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642236|NCT00345046|Prednisolone|prednisolone|mesh-list
44642237|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44642238|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
44642239|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44642240|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
44642241|NCT00345046|Prednisone|prednisone|mesh-list
44642242|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44642243|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
44642244|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642245|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
44642246|NCT00345046|Hormones|hormones|mesh-ancestor
44642247|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642248|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642249|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44642250|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642251|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
44642252|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
44642253|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642254|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642255|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44642256|NCT00345046|Protective Agents|protective agents|mesh-ancestor
44642257|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44642258|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642259|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
44642260|NCT00344968|Hormones|hormones|mesh-ancestor
44642261|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642262|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642263|NCT00344773|Gefitinib|gefitinib|mesh-list
44642264|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642265|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642266|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642267|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642268|NCT00344461|Tenofovir|tenofovir|mesh-list
44642269|NCT00344461|Nevirapine|nevirapine|mesh-list
44642270|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
44642271|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642272|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44642273|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44642274|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642275|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642276|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44642277|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44642278|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44642279|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44642280|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44642281|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
44642282|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642283|NCT00344305|Vaccines|vaccines|mesh-list
44642284|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
44642285|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642286|NCT00344032|Vaccines|vaccines|mesh-list
44642287|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
44642288|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642289|NCT00344019|Atorvastatin|atorvastatin|mesh-list
44642290|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44642291|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44642292|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
44642293|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642294|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909516|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44642295|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44642296|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642297|NCT00343889|Vaccines|vaccines|mesh-list
44642298|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
44642299|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642300|NCT00343512|Docetaxel|docetaxel|mesh-list
44642301|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642302|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642303|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642304|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642305|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642306|NCT00343382|Pilocarpine|pilocarpine|mesh-list
44642307|NCT00343382|Miotics|miotics|mesh-ancestor
44642308|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
44642309|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642310|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642311|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44642312|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44642313|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44642314|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642315|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642316|NCT00343291|Paclitaxel|paclitaxel|mesh-list
44642317|NCT00343291|Bevacizumab|bevacizumab|mesh-list
44642318|NCT00343291|Carboplatin|carboplatin|mesh-list
44642319|NCT00343291|Cetuximab|cetuximab|mesh-list
44642320|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642321|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642322|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642323|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642324|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642325|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642326|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642327|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642328|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642329|NCT00343291|Growth Substances|growth substances|mesh-ancestor
44642330|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642331|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642332|NCT00343252|Teriparatide|teriparatide|mesh-list
44642333|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
44642334|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
44642335|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44642336|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642337|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44642338|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44642339|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642340|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642341|NCT00342628|Vaccines|vaccines|mesh-list
44642342|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
44642343|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642344|NCT00340834|Interferons|interferons|mesh-list
44642345|NCT00340834|Interferon-beta|interferon-beta|mesh-list
44642346|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
44642347|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44642348|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642349|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
44642350|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642351|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44642352|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642353|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642354|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
44642355|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642356|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44642357|NCT00340704|Tamsulosin|tamsulosin|mesh-list
44642358|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44642359|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44642360|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44642361|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
44642362|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642363|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642364|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642365|NCT00340704|Urological Agents|urological agents|mesh-ancestor
44642366|NCT00340678|Losartan|losartan|mesh-list
44642367|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44642368|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44642369|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44642370|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44642371|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642372|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44642373|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44642374|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44642375|NCT00339833|Analgesics|analgesics|mesh-ancestor
44642376|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
44642377|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642378|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642379|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642380|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642381|NCT00339183|Panitumumab|panitumumab|mesh-list
44642382|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642383|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642384|NCT00339144|Dasatinib|dasatinib|mesh-list
44642385|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642386|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642387|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642388|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642389|NCT00338962|Naltrexone|naltrexone|mesh-list
44642390|NCT00338962|Paroxetine|paroxetine|mesh-list
44642391|NCT00338962|Desipramine|desipramine|mesh-list
44642392|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44642393|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44642394|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642395|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
44642396|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642397|NCT00338962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44642398|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44642399|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642400|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642401|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642402|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
44642403|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44642404|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
44642405|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642406|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44642407|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44642408|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642409|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44642410|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44642411|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44642412|NCT00338949|Olanzapine|olanzapine|mesh-list
44642413|NCT00338949|Risperidone|risperidone|mesh-list
44642414|NCT00338949|Ziprasidone|ziprasidone|mesh-list
44642415|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44642416|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
44642417|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642418|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642419|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642420|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44642421|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44642422|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642423|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642424|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44642425|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
44642426|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
44642427|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
44642428|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642429|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642430|NCT00338949|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44642431|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44642432|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642433|NCT00338884|Sunitinib|sunitinib|mesh-list
44642434|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642435|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642436|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642437|NCT00338884|Growth Substances|growth substances|mesh-ancestor
44642438|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642439|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642440|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642441|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642442|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642443|NCT00338728|Letrozole|letrozole|mesh-list
44642444|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
44642445|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642446|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44642447|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44642448|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037595|NCT00002489|Vitamins|vitamins|mesh-ancestor
44642449|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642450|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44642451|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44642452|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642453|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642454|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642455|NCT00338455|Dobutamine|dobutamine|mesh-list
44642456|NCT00338455|Milrinone|milrinone|mesh-list
44642457|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44642458|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44642459|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
44642460|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
44642461|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642462|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642463|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44642464|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44642465|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44642466|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
44642467|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642468|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642469|NCT00338455|Protective Agents|protective agents|mesh-ancestor
44642470|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
44642471|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44642472|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
44642473|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44642474|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44642475|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642476|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
44642477|NCT00338286|Hematinics|hematinics|mesh-ancestor
44642478|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
44642479|NCT00337935|Hematinics|hematinics|mesh-ancestor
44642480|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
44642481|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
44642482|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44642483|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
44642484|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642485|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642486|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642487|NCT00337727|Dexamethasone|dexamethasone|mesh-list
44642488|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
44642489|NCT00337727|Ondansetron|ondansetron|mesh-list
44642490|NCT00337727|Aprepitant|aprepitant|mesh-list
44642491|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
44642492|NCT00337727|BB 1101|bb 1101|mesh-list
44642493|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642494|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
44642495|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
44642496|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642497|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642498|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642499|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
44642500|NCT00337727|Hormones|hormones|mesh-ancestor
44642501|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642502|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44642503|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642504|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642505|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642506|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642507|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
44642508|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
44642509|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44642510|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
44642511|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642512|NCT00337727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44642513|NCT00337727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44642514|NCT00337727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642515|NCT00337727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642516|NCT00337727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44642517|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44642518|NCT00337675|Montelukast|montelukast|mesh-list
44642519|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44642520|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
44642521|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44642522|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
44642523|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037705|NCT00002496|Cobalt|cobalt|mesh-list
44642524|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642525|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44642526|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44642527|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642529|NCT00337662|Risperidone|risperidone|mesh-list
44642530|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44642531|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
44642532|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642533|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642534|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642535|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44642536|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44642537|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642538|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642539|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44642540|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
44642541|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
44642542|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
44642543|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642544|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642545|NCT00337662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44642546|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44642547|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642548|NCT00337610|Metformin|metformin|mesh-list
44642549|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44642550|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44642551|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642552|NCT00337610|Incretins|incretins|mesh-ancestor
44642553|NCT00337610|Hormones|hormones|mesh-ancestor
44642554|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642555|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43909788|NCT00342355|Ritonavir|ritonavir|mesh-list
44642556|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642557|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642558|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642559|NCT00337571|Aripiprazole|aripiprazole|mesh-list
44642560|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44642561|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44642562|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44642563|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44642564|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642565|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642566|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
44642567|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
44642568|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642569|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642570|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44642571|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44642572|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
44642573|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44642574|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44642575|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44642576|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44642577|NCT00337467|Ritonavir|ritonavir|mesh-list
44642578|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44642579|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44642580|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44642581|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642582|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642583|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642584|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44642585|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44642586|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
44642587|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642588|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44642589|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44642590|NCT00337428|Vaccines|vaccines|mesh-list
44642591|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
44642592|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642593|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44642594|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44642595|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642596|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44642597|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44642598|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642599|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642600|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
44642601|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642602|NCT00337207|Bevacizumab|bevacizumab|mesh-list
44642603|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642604|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642605|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642606|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642607|NCT00337207|Growth Substances|growth substances|mesh-ancestor
44642608|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642609|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642610|NCT00337194|Gemcitabine|gemcitabine|mesh-list
44642611|NCT00337194|Doxorubicin|doxorubicin|mesh-list
44642612|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44642613|NCT00337194|Vinorelbine|vinorelbine|mesh-list
44642614|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44642615|NCT00337194|Antibodies|antibodies|mesh-list
44642616|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44642617|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
44642618|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642619|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642620|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
44642621|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642622|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642623|NCT00337194|Antiviral Agents|antiviral agents|mesh-ancestor
44642624|NCT00337194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642625|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642626|NCT00337194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642627|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642628|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642629|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642630|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642631|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642632|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642633|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642634|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642635|NCT00337168|Cytarabine|cytarabine|mesh-list
44642636|NCT00337168|Clofarabine|clofarabine|mesh-list
44642637|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642638|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
44642639|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642640|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642641|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
44642642|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642643|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642644|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
44642645|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642646|NCT00337103|Capecitabine|capecitabine|mesh-list
44642647|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642648|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
44642649|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642650|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642651|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
44642652|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642653|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642654|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44642655|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
44642656|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642657|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642658|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642659|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642660|NCT00336856|Irinotecan|irinotecan|mesh-list
44642661|NCT00336856|Cetuximab|cetuximab|mesh-list
44642662|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44642663|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642664|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642665|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642666|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642667|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642668|NCT00336583|Cytarabine|cytarabine|mesh-list
44642669|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
44642670|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
44642671|NCT00336583|Etoposide|etoposide|mesh-list
44642672|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642673|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642674|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642675|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642676|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642677|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193592|NCT00368602|Timolol|timolol|mesh-list
44642678|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642679|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
44642680|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
44642681|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642682|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642683|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
44642684|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642685|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642686|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
44642687|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
44642688|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642689|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642690|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
44642691|NCT00336583|Hormones|hormones|mesh-ancestor
44642692|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642693|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44642694|NCT00336583|Protective Agents|protective agents|mesh-ancestor
44642695|NCT00336544|Clarithromycin|clarithromycin|mesh-list
44642696|NCT00336544|Cethromycin|cethromycin|mesh-list
44642697|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642698|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642699|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44642700|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642701|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642702|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44642703|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44642704|NCT00336505|Clarithromycin|clarithromycin|mesh-list
44642705|NCT00336505|Cethromycin|cethromycin|mesh-list
44642706|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642707|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642708|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44642709|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642710|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642711|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44642712|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44642713|NCT00336492|Infliximab|infliximab|mesh-list
44642714|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
44642715|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642716|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642717|NCT00336479|Interferons|interferons|mesh-list
44642718|NCT00336479|Ribavirin|ribavirin|mesh-list
44642719|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
44642720|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
44642721|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44642722|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642723|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
44642724|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642725|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
44642726|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642727|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
44642728|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642729|NCT00336024|Leucovorin|leucovorin|mesh-list
44642730|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
44642731|NCT00336024|Thiotepa|thiotepa|mesh-list
44642732|NCT00336024|Carboplatin|carboplatin|mesh-list
44642733|NCT00336024|Methotrexate|methotrexate|mesh-list
44642734|NCT00336024|Etoposide|etoposide|mesh-list
44642735|NCT00336024|Vincristine|vincristine|mesh-list
44642736|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
44642737|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
44642738|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642739|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
44642740|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642741|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909987|NCT00345384|Analgesics|analgesics|mesh-ancestor
44642742|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44642743|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
44642744|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642745|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642746|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44642747|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44642748|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
44642749|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44642750|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642751|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
44642752|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
44642753|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642754|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44642755|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44642756|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642757|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642758|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642760|NCT00336024|Protective Agents|protective agents|mesh-ancestor
44642761|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
44642762|NCT00336024|Vitamins|vitamins|mesh-ancestor
44642763|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
44642764|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642765|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642766|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642767|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
44642768|NCT00335972|Remifentanil|remifentanil|mesh-list
44642769|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44642770|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44642771|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642772|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44642773|NCT00335972|Analgesics|analgesics|mesh-ancestor
44642774|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
44642775|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642776|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44642777|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44642778|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44642779|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
44642780|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642781|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642782|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44642783|NCT00335972|Narcotics|narcotics|mesh-ancestor
44642784|NCT00335959|Capecitabine|capecitabine|mesh-list
44642785|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
44642786|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642787|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
44642788|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642789|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642790|NCT00335829|Bevacizumab|bevacizumab|mesh-list
44642791|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642792|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642793|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642794|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642795|NCT00335829|Growth Substances|growth substances|mesh-ancestor
44642796|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642797|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642798|NCT00335764|Sirolimus|sirolimus|mesh-list
44642799|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44642800|NCT00335764|Sorafenib|sorafenib|mesh-list
44642801|NCT00335764|Tipifarnib|tipifarnib|mesh-list
44642802|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642803|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44642804|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642805|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642806|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642807|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642808|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642809|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
44642810|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642811|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
44642812|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642813|NCT00335738|Carboplatin|carboplatin|mesh-list
44642814|NCT00335738|Etoposide|etoposide|mesh-list
44642815|NCT00335738|Vincristine|vincristine|mesh-list
44642816|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
44642817|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642818|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642819|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44235822|NCT00556205|Bevacizumab|bevacizumab|mesh-list
44642820|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642821|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642822|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642823|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642824|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642825|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642826|NCT00335556|Dactinomycin|dactinomycin|mesh-list
44642827|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
44642828|NCT00335556|Carboplatin|carboplatin|mesh-list
44642829|NCT00335556|Doxorubicin|doxorubicin|mesh-list
44642830|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44642831|NCT00335556|Irinotecan|irinotecan|mesh-list
44642832|NCT00335556|Etoposide|etoposide|mesh-list
44642833|NCT00335556|Vincristine|vincristine|mesh-list
44642834|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642835|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
44642836|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642837|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642838|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44642839|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
44642840|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642841|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642842|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44642843|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44642844|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642845|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642846|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642847|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44642848|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642849|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642850|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642851|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642852|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44642853|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642854|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44642855|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44642856|NCT00335452|Clopidogrel|clopidogrel|mesh-list
44642857|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44642858|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44642859|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44642860|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44642861|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
44642862|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642863|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642864|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642865|NCT00335322|Ritonavir|ritonavir|mesh-list
44642866|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44642867|NCT00335322|Tenofovir|tenofovir|mesh-list
44642868|NCT00335322|Zidovudine|zidovudine|mesh-list
44642869|NCT00335322|Emtricitabine|emtricitabine|mesh-list
44642870|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44642871|NCT00335322|Abacavir|abacavir|mesh-list
44642872|NCT00335322|Efavirenz|efavirenz|mesh-list
44642873|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44642874|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44642875|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642876|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642877|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642878|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44642879|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44642880|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
44642881|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642882|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44642883|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44642884|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44642885|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44642886|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
44642887|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44642888|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44642889|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44642890|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44642891|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44642892|NCT00335153|Levodopa|levodopa|mesh-list
44642893|NCT00335153|Carbidopa|carbidopa|mesh-list
44642894|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44642896|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44642897|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
44642898|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44642899|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642900|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642901|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44642902|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642903|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44642904|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
44642905|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
44642906|NCT00335140|Leucovorin|leucovorin|mesh-list
44642907|NCT00335140|Cytarabine|cytarabine|mesh-list
44642908|NCT00335140|Dexamethasone|dexamethasone|mesh-list
44642909|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
44642910|NCT00335140|Rituximab|rituximab|mesh-list
44642911|NCT00335140|Methotrexate|methotrexate|mesh-list
44642912|NCT00335140|Vincristine|vincristine|mesh-list
44642913|NCT00335140|Procarbazine|procarbazine|mesh-list
44642914|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44642915|NCT00335140|BB 1101|bb 1101|mesh-list
44642916|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
44642917|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44642918|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642919|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
44642920|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642921|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44642922|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44642923|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
44642924|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
44642925|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44642926|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44642927|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
44642928|NCT00335140|Hormones|hormones|mesh-ancestor
44642929|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44642930|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44642931|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
44642932|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642933|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642934|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44642935|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
44642936|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44642937|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44642938|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
44642939|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
44642940|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44642941|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44642942|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44642943|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
44642944|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44642945|NCT00335140|Antidotes|antidotes|mesh-ancestor
44642946|NCT00335140|Protective Agents|protective agents|mesh-ancestor
44642947|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
44642948|NCT00335140|Vitamins|vitamins|mesh-ancestor
44642949|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
44642950|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642951|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642952|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642953|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642954|NCT00334958|Rufinamide|rufinamide|mesh-list
44642955|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
44642956|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44642957|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44642958|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44642959|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642960|NCT00334815|Bevacizumab|bevacizumab|mesh-list
44642961|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44642962|NCT00334815|Cisplatin|cisplatin|mesh-list
44642963|NCT00334815|Docetaxel|docetaxel|mesh-list
44642964|NCT00334815|Etoposide|etoposide|mesh-list
44642965|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
44642966|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
44642967|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
44642968|NCT00334815|Antibodies|antibodies|mesh-list
44642969|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
44642970|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44642971|NCT00334815|Lenograstim|lenograstim|mesh-list
44642972|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
44642973|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642974|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44642975|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44642976|NCT00334815|Growth Substances|growth substances|mesh-ancestor
44642977|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44642978|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44642979|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
44642980|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642981|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642982|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642983|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642984|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642985|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44642986|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44642987|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44642988|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44642989|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
44642990|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44642991|NCT00334802|Gemcitabine|gemcitabine|mesh-list
44642992|NCT00334802|Paclitaxel|paclitaxel|mesh-list
44642993|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44642994|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44642995|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
44642996|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
44642997|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
44642998|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44642999|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643000|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
44643001|NCT00334802|Antiviral Agents|antiviral agents|mesh-ancestor
44643002|NCT00334802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643003|NCT00334802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643004|NCT00334802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643005|NCT00334802|Immunologic Factors|immunologic factors|mesh-ancestor
44643006|NCT00334802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643007|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
44643008|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
44643009|NCT00334737|Hematinics|hematinics|mesh-ancestor
44643010|NCT00334542|Simvastatin|simvastatin|mesh-list
44643011|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44643012|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44643013|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
44643014|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643015|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44643016|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44643017|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643018|NCT00334295|Fulvestrant|fulvestrant|mesh-list
44643019|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44643020|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643021|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44643022|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44643023|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
44643024|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643025|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643026|NCT00333866|Pregabalin|pregabalin|mesh-list
44643027|NCT00333866|Analgesics|analgesics|mesh-ancestor
44643028|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
44643029|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643030|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643031|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
44643032|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44643033|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643034|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643035|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44643036|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44643037|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44643038|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643039|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643040|NCT00333840|Interferons|interferons|mesh-list
44643041|NCT00333840|Cytarabine|cytarabine|mesh-list
44643042|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
44643043|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
44643044|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
44643045|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643046|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
44643047|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643048|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643049|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
44643050|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643051|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643052|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
44643053|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643054|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643055|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643056|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
44643057|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643058|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
44193932|NCT00370266|Hormones|hormones|mesh-ancestor
44643059|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643060|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643061|NCT00333775|Bevacizumab|bevacizumab|mesh-list
44643062|NCT00333775|Docetaxel|docetaxel|mesh-list
44643063|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643064|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643065|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643066|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643067|NCT00333775|Growth Substances|growth substances|mesh-ancestor
44643068|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643069|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643070|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643071|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643072|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643073|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643074|NCT00333359|Gabapentin|gabapentin|mesh-list
44643075|NCT00333359|Analgesics|analgesics|mesh-ancestor
44643076|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
44643077|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643078|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643079|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
44643080|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44643081|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44643082|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643083|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643084|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44643085|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44643086|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643087|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643088|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
44643089|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
44643090|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44643091|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643092|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44643093|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44643094|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643095|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643096|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
44643097|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643098|NCT00332839|Cyclosporine|cyclosporine|mesh-list
44643099|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
44643100|NCT00332839|Everolimus|everolimus|mesh-list
44643101|NCT00332839|Tacrolimus|tacrolimus|mesh-list
44643102|NCT00332839|Cyclosporins|cyclosporins|mesh-list
44643103|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643104|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
44643105|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643106|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44643107|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643108|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643109|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
44643110|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643111|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44643112|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643113|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643114|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44643115|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44643116|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
43775588|NCT02344810|Leucovorin|leucovorin|mesh-list
44643117|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44643119|NCT00332709|Letrozole|letrozole|mesh-list
44643120|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643121|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44643122|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44643123|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643124|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643125|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44643126|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44643127|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643128|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643129|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44643130|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
44643131|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44643132|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44643133|NCT00332696|Prednisolone|prednisolone|mesh-list
44643134|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
44643136|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44643137|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
44643138|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44643139|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
44643140|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
44643141|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643142|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643143|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643144|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
44643145|NCT00332696|Hormones|hormones|mesh-ancestor
44643146|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643147|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44643148|NCT00332696|Protective Agents|protective agents|mesh-ancestor
44643149|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44643150|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643151|NCT00332488|Insulin|insulin|mesh-list
44643152|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44643153|NCT00332488|Metformin|metformin|mesh-list
44643154|NCT00332488|Secretagogues|secretagogues|mesh-list
44643155|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643156|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643157|NCT00332462|Cyclosporine|cyclosporine|mesh-list
44643158|NCT00332462|Cyclosporins|cyclosporins|mesh-list
44643159|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643160|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643161|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643162|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
44643163|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643164|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
44643165|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643166|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
44643167|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643168|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44643169|NCT00332332|Etanercept|etanercept|mesh-list
44643170|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44643171|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44643172|NCT00332332|Analgesics|analgesics|mesh-ancestor
44643173|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
44643174|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643175|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643176|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44643177|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643178|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643179|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643180|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
44643181|NCT00332241|Aripiprazole|aripiprazole|mesh-list
44643182|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
44643183|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643184|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44643185|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44643186|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643187|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643188|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
44643189|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
44643190|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643191|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643192|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44643193|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44643194|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
44643195|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44643196|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44643197|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44643198|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44643200|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44643201|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44643202|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643203|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643204|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44643205|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643206|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
44643207|NCT00331864|Ranibizumab|ranibizumab|mesh-list
44643208|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643209|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643210|NCT00331864|Growth Substances|growth substances|mesh-ancestor
44643211|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643212|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643213|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643214|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44643215|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44643216|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44643217|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643218|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643219|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643220|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643221|NCT00331799|Analgesics|analgesics|mesh-ancestor
44643222|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
44643223|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643224|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
44643225|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643226|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
44643227|NCT00331760|Cisplatin|cisplatin|mesh-list
44643228|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643229|NCT00331682|Docetaxel|docetaxel|mesh-list
44643230|NCT00331682|Alvocidib|alvocidib|mesh-list
44643231|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643232|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643233|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643234|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643235|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643236|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643237|NCT00331682|Growth Substances|growth substances|mesh-ancestor
44643238|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643239|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643240|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643241|NCT00331630|Paclitaxel|paclitaxel|mesh-list
44194170|NCT00370799|Hormones|hormones|mesh-ancestor
44643242|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44643243|NCT00331630|Lapatinib|lapatinib|mesh-list
44643244|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643245|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643246|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643247|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643248|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643249|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643250|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643251|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643252|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
44643253|NCT00331552|Doxorubicin|doxorubicin|mesh-list
44643254|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44643255|NCT00331552|Trastuzumab|trastuzumab|mesh-list
44643256|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44643257|NCT00331552|Antibodies|antibodies|mesh-list
44643258|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
44643259|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44643260|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643261|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
44643262|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643263|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643264|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44643265|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
44149469|NCT00208143|Risperidone|risperidone|mesh-list
44643266|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643267|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643268|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44643269|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44643270|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44643271|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44643272|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643273|NCT00331422|Paclitaxel|paclitaxel|mesh-list
44643274|NCT00331422|Carboplatin|carboplatin|mesh-list
44643275|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643276|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643277|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643278|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643279|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643280|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643281|NCT00331409|Everolimus|everolimus|mesh-list
44643282|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
44643283|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643284|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643285|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
44643286|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643287|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643288|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643289|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643290|NCT00331344|Prednisone|prednisone|mesh-list
44643291|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
44643292|NCT00331344|Epothilone B|epothilone b|mesh-list
44643293|NCT00331344|Epothilones|epothilones|mesh-list
44643294|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44643295|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
44643296|NCT00331344|Hormones|hormones|mesh-ancestor
43910573|NCT00360399|Analgesics|analgesics|mesh-ancestor
44643297|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643298|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643299|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44643300|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643301|NCT00331344|Analgesics|analgesics|mesh-ancestor
44643302|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
44643303|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643304|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44643305|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44643306|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643307|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643308|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643309|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643310|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643311|NCT00331136|Artesunate|artesunate|mesh-list
44643312|NCT00331136|Pyronaridine|pyronaridine|mesh-list
44643313|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
44643314|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44643315|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44643316|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643317|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643318|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
44643319|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
44643320|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44643321|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
44643322|NCT00331006|Rituximab|rituximab|mesh-list
44643323|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643324|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643325|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
44643326|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643327|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643328|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44643329|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44643330|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44643331|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44643332|NCT00330681|Edaravone|edaravone|mesh-list
44643333|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44643334|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
44643335|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643336|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44643337|NCT00330681|Protective Agents|protective agents|mesh-ancestor
44643338|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643339|NCT00330668|Mecasermin|mecasermin|mesh-list
44643340|NCT00330668|Growth Substances|growth substances|mesh-ancestor
44643341|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643342|NCT00330460|Denosumab|denosumab|mesh-list
44643343|NCT00330460|Alendronate|alendronate|mesh-list
44643344|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44643345|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643346|NCT00330343|Naloxone|naloxone|mesh-list
44643347|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44643348|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643349|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
44643350|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643351|NCT00330187|Bupropion|bupropion|mesh-list
44643352|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44643353|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
44643354|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643355|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44643356|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44643357|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643358|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643359|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
44643360|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643361|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643362|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44643363|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44643364|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643365|NCT00330174|Acamprosate|acamprosate|mesh-list
44643366|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44643367|NCT00329901|Vaccines|vaccines|mesh-list
44643368|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
44643369|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643370|NCT00329849|Vaccines|vaccines|mesh-list
44643371|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
44643372|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643373|NCT00329797|Vitamin D|vitamin d|mesh-list
44643374|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
44643375|NCT00329797|Calcium|calcium|mesh-list
44643376|NCT00329797|Vitamins|vitamins|mesh-ancestor
44643377|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
44643378|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643379|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44643380|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44643381|NCT00329719|Sirolimus|sirolimus|mesh-list
44643382|NCT00329719|Sorafenib|sorafenib|mesh-list
44643383|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643384|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643385|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643386|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643387|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44643388|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643389|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44643390|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
44643391|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643392|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
44643393|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643394|NCT00329641|Paclitaxel|paclitaxel|mesh-list
44643396|NCT00329641|Sorafenib|sorafenib|mesh-list
44643397|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643398|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643399|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643400|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643401|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643402|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643403|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643404|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643405|NCT00329602|Ropinirole|ropinirole|mesh-list
44643406|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44643407|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44643408|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
44643409|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
44643410|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643411|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643412|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643413|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
44643414|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643415|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
44643416|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643417|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038532|NCT00002548|Carmustine|carmustine|mesh-list
44643418|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
44643419|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643420|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
44643421|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643422|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643423|NCT00329407|Topiramate|topiramate|mesh-list
44643424|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
44643425|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643426|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643427|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
44643428|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643429|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
44643430|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643431|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643432|NCT00329238|Warfarin|warfarin|mesh-list
44643433|NCT00329238|Dabigatran|dabigatran|mesh-list
44643434|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
44643435|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
44643436|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44643437|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
44643438|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643439|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643440|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44643441|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44643442|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44643443|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
44643444|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643445|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44643446|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44643447|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643448|NCT00329108|Olanzapine|olanzapine|mesh-list
44643449|NCT00329108|Ziprasidone|ziprasidone|mesh-list
44643450|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
44643451|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
44643452|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643453|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643454|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643455|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44643456|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44643457|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643458|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643459|NCT00329108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44643460|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44643461|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643462|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643463|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643464|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
44643465|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44643466|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44643467|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
44643468|NCT00329030|Rituximab|rituximab|mesh-list
44643469|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
44643470|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643471|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643472|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
44643473|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643474|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643475|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44643477|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44643478|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643479|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643480|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44643481|NCT00328627|Pioglitazone|pioglitazone|mesh-list
44643482|NCT00328627|Alogliptin|alogliptin|mesh-list
44643483|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643484|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643485|NCT00328627|Incretins|incretins|mesh-ancestor
44643486|NCT00328627|Hormones|hormones|mesh-ancestor
44643487|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643488|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44643489|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
44643490|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643491|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643492|NCT00328562|Gefitinib|gefitinib|mesh-list
44643493|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643494|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643495|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643496|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643497|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
44643498|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643499|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643500|NCT00328172|Metformin|metformin|mesh-list
44643501|NCT00328172|Linagliptin|linagliptin|mesh-list
44643502|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643503|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643504|NCT00328172|Incretins|incretins|mesh-ancestor
44643505|NCT00328172|Hormones|hormones|mesh-ancestor
44643506|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643507|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44643508|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
44643509|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643510|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643511|NCT00328094|Insulin|insulin|mesh-list
44643512|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44643513|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643514|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643515|NCT00327717|Zonisamide|zonisamide|mesh-list
44643516|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
44643517|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44643518|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643519|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643520|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44643521|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643522|NCT00327444|Aflibercept|aflibercept|mesh-list
44643523|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643524|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643525|NCT00327444|Growth Substances|growth substances|mesh-ancestor
44643526|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643527|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643528|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643529|NCT00327340|Docetaxel|docetaxel|mesh-list
44643530|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
44643531|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643532|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643533|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643534|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643535|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643536|NCT00327340|Analgesics|analgesics|mesh-ancestor
44643537|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
44643538|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643539|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643540|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44643541|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44643542|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643543|NCT00327171|Aflibercept|aflibercept|mesh-list
44643544|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643545|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643546|NCT00327171|Growth Substances|growth substances|mesh-ancestor
44643547|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643548|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643549|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643550|NCT00327015|Metformin|metformin|mesh-list
44643551|NCT00327015|Pioglitazone|pioglitazone|mesh-list
44643552|NCT00327015|Saxagliptin|saxagliptin|mesh-list
44643553|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643554|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643555|NCT00327015|Incretins|incretins|mesh-ancestor
44643556|NCT00327015|Hormones|hormones|mesh-ancestor
44643557|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643558|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44643559|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
44643560|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643561|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643562|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
44643563|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44643564|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44235828|NCT00556205|Growth Substances|growth substances|mesh-ancestor
44643565|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643566|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643567|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643568|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
44643569|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643570|NCT00326911|Gemcitabine|gemcitabine|mesh-list
44643571|NCT00326911|Bevacizumab|bevacizumab|mesh-list
44643572|NCT00326911|Cetuximab|cetuximab|mesh-list
44643573|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643574|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643575|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643576|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643577|NCT00326911|Growth Substances|growth substances|mesh-ancestor
44643578|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643579|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643580|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643581|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
44643582|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643583|NCT00326911|Antiviral Agents|antiviral agents|mesh-ancestor
44643584|NCT00326911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643585|NCT00326911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643586|NCT00326911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643587|NCT00326911|Immunologic Factors|immunologic factors|mesh-ancestor
44643588|NCT00326898|Sorafenib|sorafenib|mesh-list
44643589|NCT00326898|Sunitinib|sunitinib|mesh-list
44643590|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643591|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643592|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643593|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643594|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643595|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643596|NCT00326898|Growth Substances|growth substances|mesh-ancestor
44643597|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643598|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643599|NCT00326885|Catumaxomab|catumaxomab|mesh-list
44643600|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643601|NCT00326716|Ritonavir|ritonavir|mesh-list
44643602|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44643603|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44643604|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44643605|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44643606|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
44643607|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643608|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643609|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643610|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643611|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
44643612|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643613|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44643614|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44643615|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44643616|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643617|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
44643618|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
44643619|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44643620|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
44643621|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643622|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643623|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643624|NCT00326612|Midazolam|midazolam|mesh-list
44643625|NCT00326612|Diazepam|diazepam|mesh-list
44643626|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44643627|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44643628|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643629|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643630|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44643631|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44643632|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643633|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44643634|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
44643635|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
44643636|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
44643637|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
44643638|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643639|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643640|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
44643641|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
44643642|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
44643643|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643644|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643645|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44643646|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44643647|NCT00326599|Gemcitabine|gemcitabine|mesh-list
44643648|NCT00326599|Carboplatin|carboplatin|mesh-list
44643649|NCT00326599|Cediranib|cediranib|mesh-list
44643650|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643651|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643652|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
44643653|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643654|NCT00326599|Antiviral Agents|antiviral agents|mesh-ancestor
44643655|NCT00326599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643656|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643657|NCT00326599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643658|NCT00326599|Immunologic Factors|immunologic factors|mesh-ancestor
44643659|NCT00326599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643660|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643661|NCT00326495|Cetuximab|cetuximab|mesh-list
44643662|NCT00326495|Sorafenib|sorafenib|mesh-list
44643663|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643664|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643665|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643666|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643667|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643668|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
44643669|NCT00326417|Fludarabine|fludarabine|mesh-list
44643670|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643671|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
44643672|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643673|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643674|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44643675|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
44643676|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643677|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643678|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44643679|NCT00326209|Mesalamine|mesalamine|mesh-list
44643680|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44643681|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44643682|NCT00326209|Analgesics|analgesics|mesh-ancestor
44643683|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
44643684|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643685|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643686|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44643687|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44643688|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44643689|NCT00325897|Azithromycin|azithromycin|mesh-list
44643690|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643691|NCT00325819|Acetaminophen|acetaminophen|mesh-list
44643692|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44643693|NCT00325819|Analgesics|analgesics|mesh-ancestor
44643694|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
44643695|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643696|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643697|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
44643698|NCT00325468|Denosumab|denosumab|mesh-list
44643699|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44643700|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643701|NCT00325416|Melphalan|melphalan|mesh-list
44643702|NCT00325416|Topotecan|topotecan|mesh-list
44643703|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44643704|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
44643705|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643706|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643707|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44643708|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643709|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
44643710|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643711|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44643712|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44643713|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643714|NCT00325234|Gemcitabine|gemcitabine|mesh-list
44643715|NCT00325234|Carboplatin|carboplatin|mesh-list
44643716|NCT00325234|Pemetrexed|pemetrexed|mesh-list
44643717|NCT00325234|Vinorelbine|vinorelbine|mesh-list
44643718|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643719|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643720|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
44643721|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643722|NCT00325234|Antiviral Agents|antiviral agents|mesh-ancestor
44643723|NCT00325234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643724|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643725|NCT00325234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643726|NCT00325234|Immunologic Factors|immunologic factors|mesh-ancestor
44643727|NCT00325234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643728|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44643729|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643730|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643731|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643732|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643733|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643734|NCT00325143|Edetic Acid|edetic acid|mesh-list
44643735|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
44643736|NCT00325143|Antidotes|antidotes|mesh-ancestor
44643737|NCT00325143|Protective Agents|protective agents|mesh-ancestor
44643738|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643739|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
44643740|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
44643741|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643742|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44643743|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
44643744|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44643745|NCT00324987|Bevacizumab|bevacizumab|mesh-list
44643746|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44643747|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
44643748|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
44643749|NCT00324987|Antibodies|antibodies|mesh-list
44643750|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
44643751|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44643752|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
44643753|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643754|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643755|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643756|NCT00324987|Growth Substances|growth substances|mesh-ancestor
44643757|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643758|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643759|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
44643760|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643761|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643762|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643763|NCT00324961|Adefovir|adefovir|mesh-list
44643764|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44643765|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
44643766|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643767|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44643768|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643769|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643770|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643771|NCT00324740|Vorinostat|vorinostat|mesh-list
44643772|NCT00324740|Isotretinoin|isotretinoin|mesh-list
44643773|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643774|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44643776|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643777|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
44643778|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
44643779|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643780|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643781|NCT00324649|Lamivudine|lamivudine|mesh-list
44643782|NCT00324649|Zidovudine|zidovudine|mesh-list
44643783|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44643784|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44643785|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643786|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138854|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
44643787|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643788|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
44643789|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643790|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643791|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643792|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
44643793|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44643794|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643795|NCT00324155|Ipilimumab|ipilimumab|mesh-list
44643796|NCT00324155|Dacarbazine|dacarbazine|mesh-list
44643797|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643798|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643799|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44643800|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643801|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44643802|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
44643803|NCT00324038|Acetaminophen|acetaminophen|mesh-list
44643804|NCT00324038|Buprenorphine|buprenorphine|mesh-list
44643805|NCT00324038|Codeine|codeine|mesh-list
44643806|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44643807|NCT00324038|Analgesics|analgesics|mesh-ancestor
44643808|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
44643809|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643810|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643811|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
44643812|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44643813|NCT00324038|Narcotics|narcotics|mesh-ancestor
44643814|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44643815|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44643816|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
44643817|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
44643818|NCT00323882|Ipilimumab|ipilimumab|mesh-list
44643819|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643820|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643821|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44643822|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643823|NCT00323869|Gemcitabine|gemcitabine|mesh-list
44643824|NCT00323869|Bevacizumab|bevacizumab|mesh-list
44643825|NCT00323869|Carboplatin|carboplatin|mesh-list
44643826|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44643827|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643828|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44643829|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44643830|NCT00323869|Growth Substances|growth substances|mesh-ancestor
43911006|NCT05287256|Dronabinol|dronabinol|mesh-list
44643831|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643832|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
44643833|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643834|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
44643835|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643836|NCT00323869|Antiviral Agents|antiviral agents|mesh-ancestor
44643837|NCT00323869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643838|NCT00323869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643839|NCT00323869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643840|NCT00323869|Immunologic Factors|immunologic factors|mesh-ancestor
44643841|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
44643842|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
44643843|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44643844|NCT00323622|Amodiaquine|amodiaquine|mesh-list
44643845|NCT00323622|Vaccines|vaccines|mesh-list
44643846|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
44643847|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643848|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
44643850|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44643851|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643852|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44643853|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643854|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643855|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44643856|NCT00323622|Renal Agents|renal agents|mesh-ancestor
44643857|NCT00323557|Molgramostim|molgramostim|mesh-list
44643858|NCT00323557|Sargramostim|sargramostim|mesh-list
44643859|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44643860|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
44643861|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643862|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643863|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44643864|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44643865|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44643866|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643867|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643868|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
44643869|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643870|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643871|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643872|NCT00323479|Anastrozole|anastrozole|mesh-list
44643873|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44643874|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643875|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44643876|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44643877|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643878|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643879|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44643880|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
44643881|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44643882|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643883|NCT00323297|Bosentan|bosentan|mesh-list
44643884|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
44643885|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643886|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
44643887|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44643888|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44643889|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643890|NCT00323297|Urological Agents|urological agents|mesh-ancestor
44643891|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44643892|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44643893|NCT00323115|Temozolomide|temozolomide|mesh-list
44643894|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44643895|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
44643896|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643897|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643898|NCT00323063|Gemcitabine|gemcitabine|mesh-list
44643899|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
44643900|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44643901|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
44643902|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643903|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643904|NCT00323063|Antiviral Agents|antiviral agents|mesh-ancestor
44643905|NCT00323063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643906|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643907|NCT00323063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44643908|NCT00323063|Immunologic Factors|immunologic factors|mesh-ancestor
44643909|NCT00323063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643910|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643911|NCT00322881|Paclitaxel|paclitaxel|mesh-list
44643912|NCT00322881|Carboplatin|carboplatin|mesh-list
44643913|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643914|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643915|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643916|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643917|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643918|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643919|NCT00322868|Pioglitazone|pioglitazone|mesh-list
44643920|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44643921|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643922|NCT00322842|Plerixafor|plerixafor|mesh-list
44643923|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643924|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643925|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
44643926|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643927|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44643928|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44643929|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44643930|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44643931|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643932|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643933|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643934|NCT00322621|Analgesics|analgesics|mesh-ancestor
44643935|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
44643936|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44643937|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
44643938|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44643939|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
44643940|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
44643941|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44643942|NCT00322556|Antibodies|antibodies|mesh-list
44643943|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
44643944|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643945|NCT00322491|Plerixafor|plerixafor|mesh-list
44643946|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643947|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643948|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
44643949|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643950|NCT00322452|Paclitaxel|paclitaxel|mesh-list
44643951|NCT00322452|Carboplatin|carboplatin|mesh-list
44643952|NCT00322452|Gefitinib|gefitinib|mesh-list
44643953|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44643954|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643955|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643956|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643957|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643958|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643959|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44643960|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643961|NCT00322387|Plerixafor|plerixafor|mesh-list
44643962|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44643963|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44643964|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
44643965|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44643966|NCT00322374|Epirubicin|epirubicin|mesh-list
44643967|NCT00322374|Epothilones|epothilones|mesh-list
44194858|NCT00373893|Lidocaine|lidocaine|mesh-list
44643968|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44643969|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643970|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44643971|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44643972|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643973|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643974|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44643975|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44643976|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44643978|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44643979|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44643980|NCT00322153|Memantine|memantine|mesh-list
44643981|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44643982|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44643983|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
44643984|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44643985|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643986|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643987|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44643988|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44643989|NCT00322049|Vaccines|vaccines|mesh-list
44643990|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
44643991|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44643992|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
44643993|NCT00321984|Lansoprazole|lansoprazole|mesh-list
44643994|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44643995|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44643996|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44643997|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44643998|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44643999|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
44644000|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
44644001|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
44644002|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
44644003|NCT00321932|Calcium|calcium|mesh-list
44644004|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644005|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644006|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44644007|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644008|NCT00321932|Vitamins|vitamins|mesh-ancestor
44644009|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
44644010|NCT00321932|Antacids|antacids|mesh-ancestor
44644011|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644012|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
44644013|NCT00321919|Hematinics|hematinics|mesh-ancestor
44644014|NCT00321906|Sirolimus|sirolimus|mesh-list
44644015|NCT00321906|Azathioprine|azathioprine|mesh-list
44644016|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644017|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644018|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644019|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644020|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
44644021|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644022|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
44644023|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644024|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
44644025|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644026|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644027|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644028|NCT00321893|Budesonide|budesonide|mesh-list
44644029|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644030|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44644031|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
44644032|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644033|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644034|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44644035|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
44644036|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
44644037|NCT00321893|Hormones|hormones|mesh-ancestor
44138866|NCT00172068|Vitamin D|vitamin d|mesh-list
44644038|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644039|NCT00321854|Pramipexole|pramipexole|mesh-list
44644040|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
44644041|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644042|NCT00321854|Protective Agents|protective agents|mesh-ancestor
44644043|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194940|NCT00374387|NuvaRing|nuvaring|mesh-list
44644044|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44644045|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44644046|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
44644047|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
44644048|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644049|NCT00321828|Leucovorin|leucovorin|mesh-list
44644050|NCT00321828|Bevacizumab|bevacizumab|mesh-list
44644051|NCT00321828|Fluorouracil|fluorouracil|mesh-list
44644052|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
44644053|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
44644054|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44644055|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644056|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44644057|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44644058|NCT00321828|Growth Substances|growth substances|mesh-ancestor
44644059|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644060|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
44644061|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
44644062|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644063|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644064|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644065|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
44644066|NCT00321828|Antidotes|antidotes|mesh-ancestor
44644067|NCT00321828|Protective Agents|protective agents|mesh-ancestor
44644068|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
44644069|NCT00321828|Vitamins|vitamins|mesh-ancestor
44644070|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
44644071|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
44644072|NCT00321737|Lansoprazole|lansoprazole|mesh-list
44644073|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44644074|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644075|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44644076|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644077|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644078|NCT00321711|Azacitidine|azacitidine|mesh-list
44644079|NCT00321711|Decitabine|decitabine|mesh-list
44644080|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644081|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
44644082|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644083|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644084|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644085|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
44644086|NCT00321685|Leucovorin|leucovorin|mesh-list
44644087|NCT00321685|Folic Acid|folic acid|mesh-list
44644088|NCT00321685|Bevacizumab|bevacizumab|mesh-list
44644089|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44644090|NCT00321685|Fluorouracil|fluorouracil|mesh-list
44644091|NCT00321685|Capecitabine|capecitabine|mesh-list
44644092|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
44644093|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
44644094|NCT00321685|Antibodies|antibodies|mesh-list
44644095|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
44644096|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44644097|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
44644098|NCT00321685|Calcium|calcium|mesh-list
44644099|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
44644100|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644101|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44644102|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44644103|NCT00321685|Growth Substances|growth substances|mesh-ancestor
44644104|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644105|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
44644106|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
44644107|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644108|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44644109|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
44644110|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644111|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644112|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644113|NCT00321685|Antidotes|antidotes|mesh-ancestor
44644114|NCT00321685|Protective Agents|protective agents|mesh-ancestor
44644115|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
44644116|NCT00321685|Vitamins|vitamins|mesh-ancestor
44644117|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
44644118|NCT00321685|Hematinics|hematinics|mesh-ancestor
44644119|NCT00321672|Capsaicin|capsaicin|mesh-list
44644120|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
44644121|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44644122|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
44644123|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644124|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644125|NCT00321646|Bevacizumab|bevacizumab|mesh-list
44644126|NCT00321646|Docetaxel|docetaxel|mesh-list
44644127|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44644128|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644129|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44644130|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44644131|NCT00321646|Growth Substances|growth substances|mesh-ancestor
44644132|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644133|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
44644134|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644135|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644136|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644137|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644138|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
44644139|NCT00321620|Denosumab|denosumab|mesh-list
44644140|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44644141|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644142|NCT00321555|Immunotoxins|immunotoxins|mesh-list
44644143|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
44644144|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644145|NCT00320801|Buprenorphine|buprenorphine|mesh-list
44644146|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644147|NCT00320801|Narcotics|narcotics|mesh-ancestor
44644148|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644149|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644150|NCT00320801|Analgesics|analgesics|mesh-ancestor
44644151|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
44644152|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644153|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644154|NCT00320788|Aflibercept|aflibercept|mesh-list
44644155|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44644156|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44644157|NCT00320788|Growth Substances|growth substances|mesh-ancestor
44644158|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644159|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
44644160|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644161|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
44644162|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44644163|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644164|NCT00320541|Gemcitabine|gemcitabine|mesh-list
44644165|NCT00320541|Paclitaxel|paclitaxel|mesh-list
44644166|NCT00320541|Bevacizumab|bevacizumab|mesh-list
44644167|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644168|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644169|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644170|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644171|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644172|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644173|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43775589|NCT02344810|Fluorouracil|fluorouracil|mesh-list
44644174|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44644175|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44644176|NCT00320541|Growth Substances|growth substances|mesh-ancestor
43911290|NCT04892186|Inositol|inositol|mesh-list
44644177|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644178|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
44644179|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644181|NCT00320541|Antiviral Agents|antiviral agents|mesh-ancestor
44644182|NCT00320541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644183|NCT00320541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644184|NCT00320541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644185|NCT00320541|Immunologic Factors|immunologic factors|mesh-ancestor
44644186|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44644187|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44644188|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44644189|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644190|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644191|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
44644192|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644193|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644194|NCT00320515|Cisplatin|cisplatin|mesh-list
44644195|NCT00320515|Pemetrexed|pemetrexed|mesh-list
44644196|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644197|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644198|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644199|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44644200|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44644201|NCT00320489|Olanzapine|olanzapine|mesh-list
44644202|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
44644203|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
44644204|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911313|NCT04600141|Calcium heparin|calcium heparin|mesh-list
44644205|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644206|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644207|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44644208|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644209|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644210|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644211|NCT00320489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44644212|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44644213|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644214|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644215|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644216|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
44644217|NCT00320424|PENTA|penta|mesh-list
44644218|NCT00320424|Fondaparinux|fondaparinux|mesh-list
44644219|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44644220|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
44644221|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44644222|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644223|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644224|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644225|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
44644226|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44644227|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44644228|NCT00320411|Lapatinib|lapatinib|mesh-list
44644229|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644230|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138922|NCT00173667|Nifedipine|nifedipine|mesh-list
44644231|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644232|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644233|NCT00320398|PENTA|penta|mesh-list
44644234|NCT00320398|Fondaparinux|fondaparinux|mesh-list
44644235|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44644236|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
44644237|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44644238|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644239|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644240|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644241|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
44644242|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44644243|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44644244|NCT00320385|Trastuzumab|trastuzumab|mesh-list
44644245|NCT00320385|Lapatinib|lapatinib|mesh-list
44644246|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44644247|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644248|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44644249|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644250|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644251|NCT00320255|Apixaban|apixaban|mesh-list
44644252|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44644253|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
44644254|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44644255|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644256|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644257|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644258|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
44644259|NCT00320216|Ustekinumab|ustekinumab|mesh-list
44644260|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44644261|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
44644262|NCT00320190|Dasatinib|dasatinib|mesh-list
44644263|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644264|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44644265|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644266|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644267|NCT00319982|Diltiazem|diltiazem|mesh-list
44644268|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44644269|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44644270|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644271|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644272|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644273|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644274|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
44644276|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644277|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644278|NCT00319839|Paclitaxel|paclitaxel|mesh-list
44644279|NCT00319839|Cetuximab|cetuximab|mesh-list
44644280|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44644281|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644282|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644283|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644284|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644285|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644286|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644287|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44644288|NCT00319696|Bosentan|bosentan|mesh-list
44644289|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44644290|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44644291|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644292|NCT00319592|Vaccines|vaccines|mesh-list
44644293|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
44644294|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644295|NCT00319501|Diazepam|diazepam|mesh-list
44644296|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44644297|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
44644298|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
44644299|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
44644300|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644301|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644302|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644303|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44644304|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644305|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44644306|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44644307|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44644308|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644309|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644310|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44644311|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
44644312|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
44644313|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
44644314|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
44644315|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644316|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644317|NCT00319449|Atorvastatin|atorvastatin|mesh-list
44644318|NCT00319449|Ezetimibe|ezetimibe|mesh-list
44644319|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44644320|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44644321|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
44644322|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644323|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44039452|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644324|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44644325|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644327|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44644328|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44644329|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644330|NCT00319046|Miglustat|miglustat|mesh-list
44644331|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644332|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644333|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44644334|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44644335|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
44644336|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644337|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44644338|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44644339|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644340|NCT00319020|Bosentan|bosentan|mesh-list
44644341|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44644342|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44644343|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644344|NCT00318643|Mitomycins|mitomycins|mesh-list
44644345|NCT00318643|Mitomycin|mitomycin|mesh-list
44644346|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644347|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644348|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
44644349|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644350|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44644351|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644353|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44644354|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43911357|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644355|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644356|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644357|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44644358|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
44644359|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644360|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644361|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644362|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644363|NCT00318461|Metformin|metformin|mesh-list
44644364|NCT00318461|Liraglutide|liraglutide|mesh-list
44644365|NCT00318461|Glimepiride|glimepiride|mesh-list
44644366|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44644367|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644368|NCT00318461|Incretins|incretins|mesh-ancestor
44644369|NCT00318461|Hormones|hormones|mesh-ancestor
44644370|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644371|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44644372|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644373|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
44644374|NCT00318370|Farletuzumab|farletuzumab|mesh-list
44644375|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644376|NCT00318149|Vaccines|vaccines|mesh-list
44644377|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
44644378|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644379|NCT00317772|Topotecan|topotecan|mesh-list
44644380|NCT00317772|Gefitinib|gefitinib|mesh-list
44644381|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44644382|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644383|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644384|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644385|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644386|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44644387|NCT00317642|Cytarabine|cytarabine|mesh-list
44644388|NCT00317642|Clofarabine|clofarabine|mesh-list
44644389|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644390|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
44644391|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644392|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644393|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
44644394|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644395|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644396|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
44644397|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644398|NCT00317473|Vaccines|vaccines|mesh-list
44644399|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
44644401|NCT00317044|Esomeprazole|esomeprazole|mesh-list
44644402|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44644403|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644404|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44644405|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644406|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644407|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
44644408|NCT00316914|Calcium|calcium|mesh-list
44644409|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644410|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644411|NCT00316914|Analgesics|analgesics|mesh-ancestor
44644412|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
44644413|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644414|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
44644415|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644416|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44644417|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
44644418|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44644419|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644420|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644421|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
44644422|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44644423|NCT00316719|Lamivudine|lamivudine|mesh-list
44644424|NCT00316719|Adefovir|adefovir|mesh-list
44644425|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44644426|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44644427|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44644428|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644429|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644430|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
44644431|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644432|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44644433|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44644434|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
44644435|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644436|NCT00316277|Narcotics|narcotics|mesh-ancestor
44644437|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644438|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644439|NCT00316277|Analgesics|analgesics|mesh-ancestor
44644440|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
44644441|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644442|NCT00316264|Palivizumab|palivizumab|mesh-list
44644443|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
44644444|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644445|NCT00316225|Pemetrexed|pemetrexed|mesh-list
44644446|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644447|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644448|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644449|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44644450|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44644451|NCT00316199|Gemcitabine|gemcitabine|mesh-list
44644452|NCT00316199|Paclitaxel|paclitaxel|mesh-list
44644453|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644454|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644455|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644456|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644457|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644458|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644459|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644460|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
44644461|NCT00316199|Antiviral Agents|antiviral agents|mesh-ancestor
44644462|NCT00316199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644463|NCT00316199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644464|NCT00316199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644465|NCT00316199|Immunologic Factors|immunologic factors|mesh-ancestor
44644466|NCT00316199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644467|NCT00316186|Carboplatin|carboplatin|mesh-list
44644468|NCT00316186|Topotecan|topotecan|mesh-list
44644469|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644470|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44644471|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644472|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644473|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644474|NCT00316173|Carboplatin|carboplatin|mesh-list
44644475|NCT00316173|Topotecan|topotecan|mesh-list
44644476|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644477|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44644478|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644479|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644480|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644481|NCT00316082|Metformin|metformin|mesh-list
44644482|NCT00316082|Saxagliptin|saxagliptin|mesh-list
44644483|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44644484|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644485|NCT00316082|Incretins|incretins|mesh-ancestor
44644486|NCT00316082|Hormones|hormones|mesh-ancestor
44644487|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644488|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44644489|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644490|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644491|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644492|NCT00316017|Dextrans|dextrans|mesh-list
44644493|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
44644494|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
44644495|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
44644496|NCT00316004|Dextrans|dextrans|mesh-list
44644497|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
44644498|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
44644499|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
44644500|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
44644501|NCT00315705|Etoposide|etoposide|mesh-list
44644502|NCT00315705|Clofarabine|clofarabine|mesh-list
44644504|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
44644505|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644506|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644507|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44644508|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
44644509|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644510|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644511|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44644512|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644513|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44644514|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644515|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644516|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644517|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
44644518|NCT00315458|Buprenorphine|buprenorphine|mesh-list
44644519|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644520|NCT00315458|Narcotics|narcotics|mesh-ancestor
44644521|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644522|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644523|NCT00315458|Analgesics|analgesics|mesh-ancestor
44644524|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
44644525|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644526|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644527|NCT00315445|Acetaminophen|acetaminophen|mesh-list
44644528|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44644529|NCT00315445|Oxycodone|oxycodone|mesh-list
44644530|NCT00315445|Buprenorphine|buprenorphine|mesh-list
44644531|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644532|NCT00315445|Analgesics|analgesics|mesh-ancestor
44644533|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
44644534|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644535|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644536|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
44644537|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644538|NCT00315445|Narcotics|narcotics|mesh-ancestor
44644539|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911578|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44644540|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644541|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44644542|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644543|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644544|NCT00315055|Vaccines|vaccines|mesh-list
44644545|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
44644546|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644547|NCT00314951|Vancomycin|vancomycin|mesh-list
44644548|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
44644549|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644550|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644551|NCT00314808|Dronabinol|dronabinol|mesh-list
44644552|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
44644553|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644554|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644555|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644556|NCT00314808|Analgesics|analgesics|mesh-ancestor
44644557|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
44644558|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644559|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44644560|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44644561|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644562|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644563|NCT00314808|Hormones|hormones|mesh-ancestor
44644564|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644565|NCT00314574|Omalizumab|omalizumab|mesh-list
44644566|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44644567|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44644568|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
44644569|NCT00314340|Acetaminophen|acetaminophen|mesh-list
44644570|NCT00314340|Morphine|morphine|mesh-list
44644571|NCT00314340|Hydrocodone|hydrocodone|mesh-list
44644572|NCT00314340|Phenobarbital|phenobarbital|mesh-list
44644573|NCT00314340|Amphetamine|amphetamine|mesh-list
44644574|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644575|NCT00314340|Narcotics|narcotics|mesh-ancestor
44644576|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644577|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644578|NCT00314340|Analgesics|analgesics|mesh-ancestor
44644579|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
44644580|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644581|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644582|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
44644583|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
44644584|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
44644585|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44644586|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
44644587|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
44644588|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
44644589|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644590|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644591|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44644592|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44644593|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44644594|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644595|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44644596|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
44644597|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44644598|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44644599|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44644600|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
43636446|NCT04910061|Niacin|niacin|mesh-list
44644602|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44644603|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44644604|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44644605|NCT00314327|Risperidone|risperidone|mesh-list
44644606|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44644607|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
44644608|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644609|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644610|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644611|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44644612|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644613|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644614|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644615|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44644616|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
44644617|NCT00314262|Celecoxib|celecoxib|mesh-list
44644618|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44644619|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644620|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44644621|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644622|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644623|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44644624|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44039831|NCT00002642|Cobalt|cobalt|mesh-list
44644626|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
44644627|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911670|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
44644628|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644629|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644630|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644631|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44644632|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44644633|NCT00314249|Milnacipran|milnacipran|mesh-list
44644634|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
44644635|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44644636|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44644637|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644638|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644639|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644640|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644641|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644642|NCT00314249|Analgesics|analgesics|mesh-ancestor
44644643|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
44644644|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644645|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
44644646|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644647|NCT00313846|Buprenorphine|buprenorphine|mesh-list
44644648|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644649|NCT00313846|Narcotics|narcotics|mesh-ancestor
44644650|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644651|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644652|NCT00313846|Analgesics|analgesics|mesh-ancestor
44644653|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
44644654|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644655|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644656|NCT00313820|Pregabalin|pregabalin|mesh-list
44644657|NCT00313820|Analgesics|analgesics|mesh-ancestor
44644658|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
44644659|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644660|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644661|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
44644662|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44644663|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644664|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644665|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644666|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44644667|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644668|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644669|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644670|NCT00313781|Prednisone|prednisone|mesh-list
44644671|NCT00313781|Docetaxel|docetaxel|mesh-list
44138979|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644672|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644673|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644674|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644675|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644676|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644677|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644678|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
44644679|NCT00313781|Hormones|hormones|mesh-ancestor
44644680|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644681|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644682|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44644683|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
44644684|NCT00313716|Hematinics|hematinics|mesh-ancestor
44644685|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
44644686|NCT00313612|Topotecan|topotecan|mesh-list
44644687|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644688|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44644689|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644690|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644691|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644692|NCT00313586|Azacitidine|azacitidine|mesh-list
44644693|NCT00313586|Entinostat|entinostat|mesh-list
44644694|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44644695|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44644696|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
44157336|NCT00234195|Bupropion|bupropion|mesh-list
44157358|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644697|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039840|NCT00002642|Trace Elements|trace elements|mesh-ancestor
44644698|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644699|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644701|NCT00313313|Saxagliptin|saxagliptin|mesh-list
44644702|NCT00313313|Glyburide|glyburide|mesh-list
44644703|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44644704|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644705|NCT00313313|Incretins|incretins|mesh-ancestor
44644706|NCT00313313|Hormones|hormones|mesh-ancestor
44644707|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644708|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44644709|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644710|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644711|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644712|NCT00313300|Apixaban|apixaban|mesh-list
44644713|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44644714|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
44644715|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44644716|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44644717|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157359|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644718|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644719|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
44644720|NCT00313170|Fulvestrant|fulvestrant|mesh-list
44644721|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44644722|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644723|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44644724|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44644725|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44644726|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644727|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644728|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
44644729|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44644730|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644731|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644732|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44644733|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44644734|NCT00313014|Oxycodone|oxycodone|mesh-list
44644735|NCT00313014|Buprenorphine|buprenorphine|mesh-list
44644736|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644737|NCT00313014|Narcotics|narcotics|mesh-ancestor
44644738|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644739|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644740|NCT00313014|Analgesics|analgesics|mesh-ancestor
44644741|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
44644742|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195598|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
44644743|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644744|NCT00312858|Vaccines|vaccines|mesh-list
44644745|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44644746|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
44644747|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644748|NCT00312845|Rituximab|rituximab|mesh-list
44644749|NCT00312845|Bortezomib|bortezomib|mesh-list
44644750|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44644751|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644752|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
44644753|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644754|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644755|NCT00312572|Buprenorphine|buprenorphine|mesh-list
44644756|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644757|NCT00312572|Narcotics|narcotics|mesh-ancestor
44644758|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644759|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644760|NCT00312572|Analgesics|analgesics|mesh-ancestor
44644761|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
44644762|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644763|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644764|NCT00312494|Ziprasidone|ziprasidone|mesh-list
44644765|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44644766|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
44644767|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644768|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644769|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644770|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44644771|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644772|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644773|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644774|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44644775|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
44644776|NCT00312377|Docetaxel|docetaxel|mesh-list
44644777|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644778|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644779|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644780|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644781|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644782|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
44644783|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44644784|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644785|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644786|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44644787|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644788|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644789|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644790|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644791|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44644792|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
44644793|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911796|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44644794|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644795|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44644796|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44644797|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44644798|NCT00312221|Oxycodone|oxycodone|mesh-list
44644799|NCT00312221|Buprenorphine|buprenorphine|mesh-list
44644800|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644801|NCT00312221|Narcotics|narcotics|mesh-ancestor
44644802|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644803|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644804|NCT00312221|Analgesics|analgesics|mesh-ancestor
44644805|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
44644806|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644807|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644808|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
44644809|NCT00312208|Docetaxel|docetaxel|mesh-list
44644810|NCT00312208|Doxorubicin|doxorubicin|mesh-list
44644811|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44644812|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644813|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
44644814|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644815|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644816|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44644817|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
44644818|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644820|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44644821|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644822|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644823|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644824|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644825|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44644826|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644827|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644828|NCT00312195|Buprenorphine|buprenorphine|mesh-list
44644829|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44644830|NCT00312195|Narcotics|narcotics|mesh-ancestor
44644831|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644832|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644833|NCT00312195|Analgesics|analgesics|mesh-ancestor
44644834|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
44644835|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644836|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44644837|NCT00311623|Sirolimus|sirolimus|mesh-list
44644838|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644839|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644840|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644841|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644842|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
44644843|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644844|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
44644845|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644846|NCT00311584|Irinotecan|irinotecan|mesh-list
44040005|NCT00002658|Cytarabine|cytarabine|mesh-list
44644847|NCT00311584|Temozolomide|temozolomide|mesh-list
44644848|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43911853|NCT02271230|Vitamin D|vitamin d|mesh-list
44644849|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44644850|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644851|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644852|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644853|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44644854|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
44644855|NCT00311402|Aspirin|aspirin|mesh-list
44644856|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44644857|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44644858|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644859|NCT00311402|Analgesics|analgesics|mesh-ancestor
44644860|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
44644861|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644862|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644863|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644864|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644865|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44644866|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44644867|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644868|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44644869|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44644870|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644871|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
44644872|NCT00311363|Gabapentin|gabapentin|mesh-list
44644873|NCT00311363|Analgesics|analgesics|mesh-ancestor
44644874|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
44644875|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644876|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644877|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
44644878|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44644879|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44644880|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44644881|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44644882|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44644883|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44644884|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44644885|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644886|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
44644887|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
44644888|NCT00311311|Sirolimus|sirolimus|mesh-list
44644889|NCT00311311|Prednisone|prednisone|mesh-list
44195746|NCT00377780|Docetaxel|docetaxel|mesh-list
44644890|NCT00311311|Tacrolimus|tacrolimus|mesh-list
44644891|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644892|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
44644893|NCT00311311|Hormones|hormones|mesh-ancestor
44644894|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644895|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644896|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44644897|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644898|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644899|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
44644900|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44644901|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644902|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644903|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44644904|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44644905|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
44644906|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44644907|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44644908|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
44644909|NCT00311155|Amlodipine|amlodipine|mesh-list
44644910|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44644911|NCT00311155|Olmesartan|olmesartan|mesh-list
44644912|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44644913|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44644914|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44644915|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644916|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644917|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44644918|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644919|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
44644920|NCT00311155|Diuretics|diuretics|mesh-ancestor
44644921|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
44644922|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44644923|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44644924|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44644925|NCT00310856|Vaccines|vaccines|mesh-list
44644926|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
44644927|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644928|NCT00310817|Vaccines|vaccines|mesh-list
44644929|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
44644930|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644931|NCT00310804|Vaccines|vaccines|mesh-list
44644932|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
44644933|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644934|NCT00310388|Ezogabine|ezogabine|mesh-list
44644935|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
44644936|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644937|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644938|NCT00310375|Ezogabine|ezogabine|mesh-list
44644939|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
44644940|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44644941|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644942|NCT00310037|Bortezomib|bortezomib|mesh-list
44644943|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644944|NCT00309959|Paclitaxel|paclitaxel|mesh-list
44644945|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44644946|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44644947|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644948|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44644949|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44644950|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44644951|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644952|NCT00309946|Cediranib|cediranib|mesh-list
44644953|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44644954|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644955|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644956|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44644957|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
44644958|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44644959|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44644960|NCT00309907|Prednisolone|prednisolone|mesh-list
44644961|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
44644962|NCT00309907|Etanercept|etanercept|mesh-list
44644963|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44644964|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
44644965|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44644966|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
44644967|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
44195841|NCT00378027|PENTA|penta|mesh-list
44644968|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44644969|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644970|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44644971|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
44644972|NCT00309907|Hormones|hormones|mesh-ancestor
44644973|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44644974|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44644975|NCT00309907|Protective Agents|protective agents|mesh-ancestor
44644976|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44644977|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644978|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44644979|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44644980|NCT00309907|Analgesics|analgesics|mesh-ancestor
44644981|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
44644982|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644983|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644984|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
44644985|NCT00309842|Cyclosporine|cyclosporine|mesh-list
44644986|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
44644987|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
44644988|NCT00309842|Fludarabine|fludarabine|mesh-list
44644989|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
44644990|NCT00309842|Cyclosporins|cyclosporins|mesh-list
44644991|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44644992|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
44644993|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44644994|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44644995|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44644996|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
44644997|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44644998|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44644999|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645000|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645001|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
44645002|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645003|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
44645004|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645005|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645006|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44645007|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645008|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44645009|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
44645010|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645011|NCT00309777|Simvastatin|simvastatin|mesh-list
44645012|NCT00309777|Pitavastatin|pitavastatin|mesh-list
44645013|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44645014|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44645015|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
44645016|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645017|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44645018|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44645019|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645020|NCT00309608|Glimepiride|glimepiride|mesh-list
44645021|NCT00309608|Linagliptin|linagliptin|mesh-list
44645022|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44645023|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645024|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645025|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645026|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
44645027|NCT00309608|Incretins|incretins|mesh-ancestor
44645028|NCT00309608|Hormones|hormones|mesh-ancestor
44645029|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645030|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44645031|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
44645032|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645033|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645034|NCT00309244|Insulin|insulin|mesh-list
44645035|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44645036|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
44645037|NCT00309244|Protamines|protamines|mesh-list
44645038|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645039|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645040|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
44645041|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645042|NCT00309244|Coagulants|coagulants|mesh-ancestor
44645043|NCT00309166|Vaccines|vaccines|mesh-list
44645044|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
44645045|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645046|NCT00308750|Carboplatin|carboplatin|mesh-list
44645047|NCT00308750|Docetaxel|docetaxel|mesh-list
44645048|NCT00308750|Pemetrexed|pemetrexed|mesh-list
44645049|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645050|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645051|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645052|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645053|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645054|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645055|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44645056|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645057|NCT00308737|Insulin|insulin|mesh-list
44645058|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645059|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645060|NCT00308711|Misoprostol|misoprostol|mesh-list
43912090|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645061|NCT00308711|Dinoprostone|dinoprostone|mesh-list
44645062|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44645063|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
44645064|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645065|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645066|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44645067|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645068|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
44645069|NCT00308685|Albuterol|albuterol|mesh-list
44645070|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44645071|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
44645072|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645073|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645074|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44645075|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
44645076|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
44645077|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645078|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44645079|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44645080|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44645081|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44645082|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645083|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645084|NCT00308620|Chloroquine|chloroquine|mesh-list
44645085|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44645086|NCT00308620|Amebicides|amebicides|mesh-ancestor
44645087|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44645088|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44645089|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645090|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
44645091|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645092|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44645093|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44645094|NCT00308620|Analgesics|analgesics|mesh-ancestor
44645095|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
44645096|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645097|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645098|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645099|NCT00308620|Filaricides|filaricides|mesh-ancestor
44645100|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
44645101|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
44645102|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
44645103|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645104|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
44645105|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645106|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645107|NCT00308308|Insulin|insulin|mesh-list
44645108|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645109|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645110|NCT00308139|Exenatide|exenatide|mesh-list
44645111|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645112|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645113|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44645114|NCT00308139|Incretins|incretins|mesh-ancestor
44645115|NCT00308139|Hormones|hormones|mesh-ancestor
44645116|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645117|NCT00308113|Ubiquinone|ubiquinone|mesh-list
44645118|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
44645119|NCT00308113|Prednisone|prednisone|mesh-list
44645120|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645121|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
44645122|NCT00308113|Hormones|hormones|mesh-ancestor
44645123|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645124|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645125|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645126|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645127|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
44645128|NCT00308113|Vitamins|vitamins|mesh-ancestor
44645129|NCT00308087|Rituximab|rituximab|mesh-list
44645130|NCT00308087|Molgramostim|molgramostim|mesh-list
44645131|NCT00308087|Sargramostim|sargramostim|mesh-list
44645132|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645133|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645134|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
44645135|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645136|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645137|NCT00308074|Aripiprazole|aripiprazole|mesh-list
44645138|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
44645139|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44645140|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44645141|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44645142|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645143|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645144|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
44645145|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
44645146|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645147|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645148|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44645149|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44645150|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
44645151|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44645152|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44645153|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44645154|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44645155|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
44645156|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645157|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
44645158|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645159|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645160|NCT00307801|Dienogest|dienogest|mesh-list
44645161|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44645162|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44645163|NCT00307801|Estradiol|estradiol|mesh-list
44645164|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44645165|NCT00307801|Estrogens|estrogens|mesh-ancestor
44645166|NCT00307801|Hormones|hormones|mesh-ancestor
44645167|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645168|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645169|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44645170|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
44645171|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645172|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44645173|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44645174|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44645175|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44645176|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
44645177|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645178|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645179|NCT00307736|Bevacizumab|bevacizumab|mesh-list
44645180|NCT00307736|Fluorouracil|fluorouracil|mesh-list
44645181|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44645182|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645183|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645184|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44645185|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44645186|NCT00307736|Growth Substances|growth substances|mesh-ancestor
44645187|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645188|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
44645189|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
44645190|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645191|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645192|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645193|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
44645194|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44645195|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645196|NCT00307684|Methylphenidate|methylphenidate|mesh-list
44645197|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44645198|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645199|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44645200|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44645201|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44645202|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645203|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
44645204|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645205|NCT00307489|Tenofovir|tenofovir|mesh-list
44645206|NCT00307489|Emtricitabine|emtricitabine|mesh-list
44645207|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
44645208|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645209|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44645210|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645211|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645212|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645213|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44645214|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44645215|NCT00307437|Ustekinumab|ustekinumab|mesh-list
44645216|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645217|NCT00307294|Thalidomide|thalidomide|mesh-list
44645218|NCT00307294|Doxorubicin|doxorubicin|mesh-list
44645219|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645220|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645221|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645222|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645223|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645224|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645225|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645226|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
44645227|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645228|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
44645229|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645230|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645231|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44645232|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44645233|NCT00307294|Growth Substances|growth substances|mesh-ancestor
44645234|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44645235|NCT00307151|Ritonavir|ritonavir|mesh-list
44645236|NCT00307151|Lopinavir|lopinavir|mesh-list
44645237|NCT00307151|Lamivudine|lamivudine|mesh-list
44645238|NCT00307151|Zidovudine|zidovudine|mesh-list
44645239|NCT00307151|Nevirapine|nevirapine|mesh-list
44645240|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44645241|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44645242|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
44645243|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645244|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645245|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44645246|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44645247|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
44645248|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645249|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44645250|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44645251|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44645252|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645253|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
44645254|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44645255|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44645256|NCT00307125|Rituximab|rituximab|mesh-list
44645257|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645258|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645259|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
44645260|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645261|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645262|NCT00307086|Bortezomib|bortezomib|mesh-list
44645263|NCT00307086|Melphalan|melphalan|mesh-list
44645264|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645265|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645266|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
44645267|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645268|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645269|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645270|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
44645271|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645272|NCT00307047|Paclitaxel|paclitaxel|mesh-list
44645273|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44645274|NCT00307047|Everolimus|everolimus|mesh-list
44645275|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44645276|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645277|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645278|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645279|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645280|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645281|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645282|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
44645283|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645284|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44645285|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
44645286|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645287|NCT00306891|Cediranib|cediranib|mesh-list
44645288|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645289|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44645290|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645291|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645292|NCT00306852|Mitomycins|mitomycins|mesh-list
44645293|NCT00306852|Mitomycin|mitomycin|mesh-list
44645294|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645295|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645296|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
44645297|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645298|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645299|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645300|NCT00306787|Valacyclovir|valacyclovir|mesh-list
44645301|NCT00306787|Famciclovir|famciclovir|mesh-list
44645302|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
44645303|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645304|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645305|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645306|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645307|NCT00306670|Prednisone|prednisone|mesh-list
44645308|NCT00306670|Rituximab|rituximab|mesh-list
44645309|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645310|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645311|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
44645312|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645313|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645314|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645315|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
44645316|NCT00306670|Hormones|hormones|mesh-ancestor
44645317|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645318|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645319|NCT00306592|Natalizumab|natalizumab|mesh-list
44645320|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
44645321|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645322|NCT00306527|Vaccines|vaccines|mesh-list
44645323|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
44645324|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645325|NCT00306384|Alogliptin|alogliptin|mesh-list
43912354|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
44645326|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645327|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645328|NCT00306384|Incretins|incretins|mesh-ancestor
44645329|NCT00306384|Hormones|hormones|mesh-ancestor
44645330|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645331|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44645332|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
44645333|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645334|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645335|NCT00306293|Valacyclovir|valacyclovir|mesh-list
44645336|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
44645337|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645339|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44645340|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645341|NCT00305877|Gemcitabine|gemcitabine|mesh-list
44645342|NCT00305877|Bevacizumab|bevacizumab|mesh-list
44645343|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44645344|NCT00305877|Cetuximab|cetuximab|mesh-list
44645345|NCT00305877|Capecitabine|capecitabine|mesh-list
44645346|NCT00305877|Antibodies|antibodies|mesh-list
44645347|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
44645348|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44645349|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645350|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44645351|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44645352|NCT00305877|Growth Substances|growth substances|mesh-ancestor
44645353|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645354|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
44645355|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
44645356|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645357|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
44645358|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645359|NCT00305877|Antiviral Agents|antiviral agents|mesh-ancestor
44645360|NCT00305877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645361|NCT00305877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645362|NCT00305877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645363|NCT00305864|Temozolomide|temozolomide|mesh-list
44645364|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
44645365|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645366|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
44645367|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645368|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645369|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44645370|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645371|NCT00305773|Vorinostat|vorinostat|mesh-list
44645372|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645373|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44645374|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645375|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645376|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
44645377|NCT00305695|Imidazole|imidazole|mesh-list
44645378|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44645379|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645380|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645381|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645382|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44645383|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645384|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645385|NCT00305604|Incretins|incretins|mesh-ancestor
44645386|NCT00305604|Hormones|hormones|mesh-ancestor
44645387|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645388|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44645389|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
44645390|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645391|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645392|NCT00305448|Fulvestrant|fulvestrant|mesh-list
44645393|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645394|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645395|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44645396|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44645397|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
44645398|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645399|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645400|NCT00305110|Hydromorphone|hydromorphone|mesh-list
44645401|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44645402|NCT00305110|Narcotics|narcotics|mesh-ancestor
44645403|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645404|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645405|NCT00305110|Analgesics|analgesics|mesh-ancestor
44645406|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
44645407|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645408|NCT00305058|Morphine|morphine|mesh-list
44645409|NCT00305058|Hydromorphone|hydromorphone|mesh-list
44645410|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44645411|NCT00305058|Narcotics|narcotics|mesh-ancestor
44196234|NCT00379067|Tamsulosin|tamsulosin|mesh-list
44645412|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645413|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645414|NCT00305058|Analgesics|analgesics|mesh-ancestor
44645415|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
44645416|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645417|NCT00304954|Sirolimus|sirolimus|mesh-list
44645418|NCT00304954|Infliximab|infliximab|mesh-list
44645419|NCT00304954|Daclizumab|daclizumab|mesh-list
44645420|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645421|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645422|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645423|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645424|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
44645425|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645426|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
44645427|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645428|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645429|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645430|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645431|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
44645432|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44645433|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645434|NCT00304278|Cisplatin|cisplatin|mesh-list
44645435|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44645436|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645437|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44645438|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645439|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645440|NCT00304083|Doxorubicin|doxorubicin|mesh-list
44645441|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44645442|NCT00304083|Etoposide|etoposide|mesh-list
44645443|NCT00304083|Ifosfamide|ifosfamide|mesh-list
44645444|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645445|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645446|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645447|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645448|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645449|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645450|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44645451|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645452|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
44645453|NCT00304031|Temozolomide|temozolomide|mesh-list
44645454|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645455|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
44645456|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645457|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645458|NCT00303953|Belinostat|belinostat|mesh-list
44645459|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645460|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44645461|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645462|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645463|NCT00303719|Cyclosporine|cyclosporine|mesh-list
44645464|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
43912446|NCT00381862|Hormones|hormones|mesh-ancestor
44645465|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
44645466|NCT00303719|Fludarabine|fludarabine|mesh-list
44645467|NCT00303719|Cyclosporins|cyclosporins|mesh-list
44645468|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44645469|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645470|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
44645471|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645472|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645473|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645474|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
44645475|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645476|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645477|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645478|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645479|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
44645480|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645481|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645482|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44645483|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645484|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44645485|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
44645486|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645487|NCT00303667|Vidarabine|vidarabine|mesh-list
44645488|NCT00303667|Aldesleukin|aldesleukin|mesh-list
44645489|NCT00303667|Cyclosporine|cyclosporine|mesh-list
44645490|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
44645491|NCT00303667|Fludarabine|fludarabine|mesh-list
44645492|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
44645493|NCT00303667|Interleukin-2|interleukin-2|mesh-list
44645494|NCT00303667|Cyclosporins|cyclosporins|mesh-list
44645495|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
44645496|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645497|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
44645498|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645499|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645500|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645501|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
44645502|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645503|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645504|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645505|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645506|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
44645507|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
44645508|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645509|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645510|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
44645511|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645512|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44645513|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44645514|NCT00303667|Analgesics|analgesics|mesh-ancestor
44645515|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
44645516|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645517|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44645518|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44645519|NCT00303628|Leucovorin|leucovorin|mesh-list
44645520|NCT00303628|Bevacizumab|bevacizumab|mesh-list
44645521|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44645522|NCT00303628|Fluorouracil|fluorouracil|mesh-list
44645523|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
44645524|NCT00303628|Antibodies|antibodies|mesh-list
44645525|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
44645526|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44645527|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
44645528|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645529|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44645530|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44645531|NCT00303628|Growth Substances|growth substances|mesh-ancestor
44645532|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645533|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
44645534|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
44645536|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645537|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645538|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645539|NCT00303628|Antidotes|antidotes|mesh-ancestor
44645540|NCT00303628|Protective Agents|protective agents|mesh-ancestor
44645541|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
44645542|NCT00303628|Vitamins|vitamins|mesh-ancestor
44645543|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
44645544|NCT00303602|Olanzapine|olanzapine|mesh-list
44645545|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
44645546|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
44645547|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645548|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645549|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645550|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44645551|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44645552|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645553|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44645554|NCT00303602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43912518|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44645555|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44645556|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44645557|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645558|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645559|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
44645560|NCT00303485|Vitamin D|vitamin d|mesh-list
44645561|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
44645562|NCT00303485|Calcium|calcium|mesh-list
44645563|NCT00303485|Vitamins|vitamins|mesh-ancestor
44645564|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
44645565|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645566|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44645567|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44645568|NCT00303459|Bosentan|bosentan|mesh-list
44645569|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44645570|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44645571|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645572|NCT00303446|Dutasteride|dutasteride|mesh-list
44645573|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44645574|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44645575|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645576|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645577|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
44645578|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645579|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645580|NCT00303329|Deferasirox|deferasirox|mesh-list
44645581|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44645582|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
44645583|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
44645584|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645585|NCT00303316|Vaccines|vaccines|mesh-list
44645586|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
44645587|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645588|NCT00303108|Carboplatin|carboplatin|mesh-list
44645589|NCT00303108|Doxorubicin|doxorubicin|mesh-list
44645590|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44645591|NCT00303108|Trastuzumab|trastuzumab|mesh-list
44645592|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645593|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645594|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645595|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645596|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645597|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645598|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645599|NCT00302952|Lovastatin|lovastatin|mesh-list
44645600|NCT00302952|L 647318|l 647318|mesh-list
44645601|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
44645602|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44645603|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44645604|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
44645605|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645606|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44645607|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44645608|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645609|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44645610|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44645611|NCT00302731|Hormones|hormones|mesh-list
44645612|NCT00302731|Estradiol|estradiol|mesh-list
44645613|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44645614|NCT00302731|Progesterone|progesterone|mesh-list
44645615|NCT00302731|Estrogens|estrogens|mesh-list
44645616|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645617|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645618|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44645619|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
44645620|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645621|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44645622|NCT00302731|Progestins|progestins|mesh-ancestor
44645623|NCT00302458|Methylphenidate|methylphenidate|mesh-list
44645624|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44645625|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645626|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44645627|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44645628|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44645629|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645630|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
44645631|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645632|NCT00302211|Bosentan|bosentan|mesh-list
44645633|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
44645634|NCT00302211|Iloprost|iloprost|mesh-list
44645635|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
44645636|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44645637|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44645638|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645639|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645640|NCT00302211|Urological Agents|urological agents|mesh-ancestor
44645641|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44645642|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44645643|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44645644|NCT00302159|Temozolomide|temozolomide|mesh-list
44645645|NCT00302159|Valproic Acid|valproic acid|mesh-list
44645646|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645647|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
44645648|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645649|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645650|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
44645651|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645652|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
44645653|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645654|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645655|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
44645656|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44645657|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645658|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44645659|NCT00302107|Mirtazapine|mirtazapine|mesh-list
44645660|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
44645661|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44645662|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44645663|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
44645664|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
44645665|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645666|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645667|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645668|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44645669|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44645670|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645671|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44645672|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44645673|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44645674|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
44645675|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43775590|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
44645676|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44645678|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44645680|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44645681|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
44645682|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
44645683|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645684|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
44645685|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645686|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
44645687|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645688|NCT00302003|Cytarabine|cytarabine|mesh-list
44645689|NCT00302003|Dexamethasone|dexamethasone|mesh-list
44645690|NCT00302003|Prednisone|prednisone|mesh-list
44645691|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
44645692|NCT00302003|Ifosfamide|ifosfamide|mesh-list
44645693|NCT00302003|Doxorubicin|doxorubicin|mesh-list
44645694|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44645695|NCT00302003|Etoposide|etoposide|mesh-list
44645696|NCT00302003|Vincristine|vincristine|mesh-list
44645697|NCT00302003|Vinorelbine|vinorelbine|mesh-list
44645698|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
44645699|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645700|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
44645701|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645702|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645703|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645704|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
44645705|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645706|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645707|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645708|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645709|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
44645710|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
44645711|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645712|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645713|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
44645714|NCT00302003|Hormones|hormones|mesh-ancestor
44645715|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645716|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645717|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645718|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645719|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645720|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645721|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44645722|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645723|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
44645724|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
44645725|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645726|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645727|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645728|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645729|NCT00301964|Bevacizumab|bevacizumab|mesh-list
44645730|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44645731|NCT00301964|Antibodies|antibodies|mesh-list
44645732|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
44645733|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44645734|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645735|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44645736|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44645737|NCT00301964|Growth Substances|growth substances|mesh-ancestor
44645738|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645739|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
44645740|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
44645741|NCT00301834|Cyclosporine|cyclosporine|mesh-list
44645742|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
44645743|NCT00301834|Methotrexate|methotrexate|mesh-list
44645744|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
44645745|NCT00301834|Fludarabine|fludarabine|mesh-list
44645746|NCT00301834|Busulfan|busulfan|mesh-list
44645747|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
44645748|NCT00301834|Cyclosporins|cyclosporins|mesh-list
44645749|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44645750|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
44645751|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645752|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645753|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645754|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
44645755|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645757|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645758|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645759|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44645760|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645761|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
44645762|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645763|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645764|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
44645765|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645766|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44645767|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645768|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
44645769|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
44645770|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645771|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645772|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
44645773|NCT00301834|Hormones|hormones|mesh-ancestor
44645774|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645775|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44645776|NCT00301834|Protective Agents|protective agents|mesh-ancestor
44645777|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
44645778|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645779|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645780|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645781|NCT00301821|Prednisone|prednisone|mesh-list
44645782|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
44645783|NCT00301821|Rituximab|rituximab|mesh-list
44645784|NCT00301821|Doxorubicin|doxorubicin|mesh-list
44645785|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44645786|NCT00301821|Vincristine|vincristine|mesh-list
44645787|NCT00301821|Epratuzumab|epratuzumab|mesh-list
44645788|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645789|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
44645790|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196553|NCT00380913|Nabilone|nabilone|mesh-list
44645791|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645792|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645793|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
44645794|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645796|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645797|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645798|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645799|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645800|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645801|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645802|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645803|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
44645804|NCT00301821|Hormones|hormones|mesh-ancestor
44645805|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645806|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645807|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44645808|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645809|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645810|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645811|NCT00301808|Cisplatin|cisplatin|mesh-list
44645812|NCT00301808|Docetaxel|docetaxel|mesh-list
44645813|NCT00301808|Pemetrexed|pemetrexed|mesh-list
44645814|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645815|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645816|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645817|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645818|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645819|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645820|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44645821|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44645822|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
44645823|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44645824|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645825|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645826|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44645827|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44645828|NCT00301080|Cycloserine|cycloserine|mesh-list
44645829|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44645830|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645831|NCT00301080|Renal Agents|renal agents|mesh-ancestor
44645832|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44645833|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
44645834|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645835|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
44645836|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645837|NCT00301067|Calcitriol|calcitriol|mesh-list
44645838|NCT00301067|Temozolomide|temozolomide|mesh-list
44645839|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645840|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
44645841|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645842|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645843|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44645844|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645845|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44645846|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44645847|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44645848|NCT00301067|Vitamins|vitamins|mesh-ancestor
44645849|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
44645850|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44645851|NCT00300885|Paclitaxel|paclitaxel|mesh-list
44645852|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44645853|NCT00300885|Carboplatin|carboplatin|mesh-list
44645854|NCT00300885|Sorafenib|sorafenib|mesh-list
44645855|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44645856|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645857|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44645858|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44645859|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44645860|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645861|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44645862|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645863|NCT00300755|Pantoprazole|pantoprazole|mesh-list
44645864|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44645865|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645866|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44645867|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645868|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645870|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44645871|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
44645872|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44645873|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44645874|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645875|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44645876|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44645877|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44645878|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645879|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44645880|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44645881|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44645882|NCT00300365|Aspirin|aspirin|mesh-list
44645883|NCT00300365|Niacin|niacin|mesh-list
44645884|NCT00300365|Pioglitazone|pioglitazone|mesh-list
44645885|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44645886|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44645887|NCT00300365|Analgesics|analgesics|mesh-ancestor
44645888|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
44645889|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645890|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645891|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645892|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645893|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44645894|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44645895|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138999|NCT00174226|Buspirone|buspirone|mesh-list
44645896|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44645897|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44645898|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645899|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
44645900|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44645901|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44645902|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
44645903|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44645904|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
44645905|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
44645906|NCT00300365|Vitamins|vitamins|mesh-ancestor
44645907|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
44645908|NCT00300274|Cyclosporine|cyclosporine|mesh-list
44645909|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
44645910|NCT00300274|Everolimus|everolimus|mesh-list
44645911|NCT00300274|Cyclosporins|cyclosporins|mesh-list
44645912|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645913|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645914|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645915|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
44645916|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645917|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
44645918|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44645919|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44645920|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645921|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44645922|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645923|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645924|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44645925|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
44645926|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44645927|NCT00300053|Lenograstim|lenograstim|mesh-list
44645928|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44645929|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
44645930|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645931|NCT00299702|Aripiprazole|aripiprazole|mesh-list
44645932|NCT00299702|Risperidone|risperidone|mesh-list
44645933|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44645934|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44645935|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44645936|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44645937|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44645938|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645939|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
44645940|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
44645941|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44645942|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645943|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44645944|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44645945|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
44645946|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44645947|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44645948|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44645949|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44645950|NCT00299546|Golimumab|golimumab|mesh-list
44645951|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44645952|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44645953|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645954|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645955|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
44645956|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645957|NCT00299494|Rituximab|rituximab|mesh-list
44645958|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44645959|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645960|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645961|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
44645962|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645963|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645964|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645965|NCT00299182|Cytarabine|cytarabine|mesh-list
44645966|NCT00299182|Dexamethasone|dexamethasone|mesh-list
44645967|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
44645968|NCT00299182|Rituximab|rituximab|mesh-list
44645969|NCT00299182|Doxorubicin|doxorubicin|mesh-list
44645970|NCT00299182|Methotrexate|methotrexate|mesh-list
44645971|NCT00299182|Vincristine|vincristine|mesh-list
44645972|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44645973|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
44645974|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44645975|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44645976|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44645977|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
43912944|NCT00390364|Everolimus|everolimus|mesh-list
44645978|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44645979|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44645980|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44645981|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44645982|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44645983|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
44645984|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
44645985|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44645986|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44645987|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
44645988|NCT00299182|Hormones|hormones|mesh-ancestor
44645989|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44645990|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44645991|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44645992|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44645993|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44645994|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44645995|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44645996|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
44645997|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44645998|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44645999|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
44646000|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646001|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646002|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646003|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
44646004|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646005|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44646006|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646007|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646008|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646009|NCT00299156|Clofarabine|clofarabine|mesh-list
44646010|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646011|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
44646012|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646013|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646014|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
44646015|NCT00299130|Rituximab|rituximab|mesh-list
44646016|NCT00299130|Methotrexate|methotrexate|mesh-list
44646017|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44196776|NCT00381914|Vitamins|vitamins|mesh-list
43912979|NCT00391079|Nabiximols|nabiximols|mesh-list
44646019|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
44646020|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646021|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646022|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44646023|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
44646024|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646025|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646026|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
44646027|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646028|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646029|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646030|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646031|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646032|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646033|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646034|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
44646035|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
44646036|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646037|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646038|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
44646039|NCT00299130|Hormones|hormones|mesh-ancestor
44646040|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646041|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646042|NCT00299130|Protective Agents|protective agents|mesh-ancestor
44646043|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
44646044|NCT00299104|Rituximab|rituximab|mesh-list
44646045|NCT00299104|Methotrexate|methotrexate|mesh-list
44646046|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646047|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646048|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
44646049|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646050|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646051|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44646052|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
44646053|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646054|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646055|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
43700452|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913020|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646056|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646057|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646058|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646059|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646060|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646061|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646062|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646064|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
44646065|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646066|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646067|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
44646068|NCT00299104|Hormones|hormones|mesh-ancestor
44646069|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646070|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646071|NCT00299104|Protective Agents|protective agents|mesh-ancestor
44646072|NCT00298831|Rocuronium|rocuronium|mesh-list
44646073|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44646074|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44646075|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44646076|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646077|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646078|NCT00298766|Bortezomib|bortezomib|mesh-list
44646079|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646080|NCT00298740|Insulin|insulin|mesh-list
44646081|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44646082|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646083|NCT00298363|Tenofovir|tenofovir|mesh-list
44646084|NCT00298363|Emtricitabine|emtricitabine|mesh-list
44646085|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44646086|NCT00298363|Entecavir|entecavir|mesh-list
44646087|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
44646088|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646089|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44646090|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646091|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646092|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646093|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44646094|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44646095|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
44646096|NCT00298272|Adalimumab|adalimumab|mesh-list
44646097|NCT00298272|Etanercept|etanercept|mesh-list
44646098|NCT00298272|Rituximab|rituximab|mesh-list
44646099|NCT00298272|Methotrexate|methotrexate|mesh-list
44646100|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646101|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646102|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
44646103|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646104|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646105|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44646106|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
44646107|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646108|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646109|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
44646110|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646111|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646112|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646113|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646114|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646115|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646116|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646117|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
44646118|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
44646119|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646120|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646121|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
44646122|NCT00298272|Hormones|hormones|mesh-ancestor
44646123|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646124|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646125|NCT00298272|Protective Agents|protective agents|mesh-ancestor
44646126|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646127|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646128|NCT00298272|Analgesics|analgesics|mesh-ancestor
44646129|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
44646130|NCT00298038|Rifaximin|rifaximin|mesh-list
44646131|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44646132|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646133|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646135|NCT00297882|Lumefantrine|lumefantrine|mesh-list
44646136|NCT00297882|Artemether|artemether|mesh-list
44646137|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44646138|NCT00297882|Amodiaquine|amodiaquine|mesh-list
44646139|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
44646140|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44646141|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44646142|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646143|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646144|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
44646145|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
44646146|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44646147|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
44646148|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
44646149|NCT00297830|Alendronate|alendronate|mesh-list
44646150|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44646151|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646152|NCT00297778|Pramipexole|pramipexole|mesh-list
44646153|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
44646154|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646155|NCT00297778|Protective Agents|protective agents|mesh-ancestor
44646156|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646157|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44646158|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44646159|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
44646160|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
44646161|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646162|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
44646163|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646164|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
44646165|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646166|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646167|NCT00297492|Nicotine|nicotine|mesh-list
44646168|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44646169|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
44646170|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646171|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646172|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44646173|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44646174|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
44646175|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646176|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646177|NCT00297479|Nicotine|nicotine|mesh-list
44646178|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44646179|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
44646180|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646181|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646182|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44646183|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44646184|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
44646185|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646186|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646187|NCT00297232|Natalizumab|natalizumab|mesh-list
44646188|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
43913156|NCT00393380|Hormones|hormones|mesh-list
44646189|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646190|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
44646191|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646192|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646193|NCT00297037|Analgesics|analgesics|mesh-ancestor
44646194|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
44646195|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646196|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646197|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646198|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646199|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646200|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646201|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
44646202|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44646203|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646204|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646205|NCT00296816|Bevacizumab|bevacizumab|mesh-list
44646206|NCT00296816|Docetaxel|docetaxel|mesh-list
44646207|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
44646208|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646209|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646210|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44646211|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44646212|NCT00296816|Growth Substances|growth substances|mesh-ancestor
44646213|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646214|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
44646215|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646216|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646217|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646218|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646219|NCT00296725|Fluoxetine|fluoxetine|mesh-list
44646220|NCT00296725|Imipramine|imipramine|mesh-list
44646221|NCT00296725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44646222|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44646223|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44646224|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646225|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646226|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
44646227|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913188|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646228|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44646229|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
44646230|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646231|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44646232|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44646233|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646234|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44646235|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44646236|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
44646237|NCT00296647|Bupropion|bupropion|mesh-list
44646238|NCT00296647|Nicotine|nicotine|mesh-list
44646239|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44646240|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
44646241|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646242|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646243|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44646244|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44646245|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
44646246|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646247|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646248|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44646249|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
44646250|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646251|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44646252|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44646253|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44646254|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
44646255|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44646256|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44646257|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646258|NCT00296517|Bupropion|bupropion|mesh-list
44646259|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44646260|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
44646261|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646262|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44646263|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44646264|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44646265|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646266|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
44646267|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646268|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646269|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44646270|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44646271|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646272|NCT00296504|Ritonavir|ritonavir|mesh-list
44646273|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
44646274|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44646275|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44646276|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
44646277|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646278|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646279|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44646280|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44646282|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646283|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44646284|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44646285|NCT00296491|Fluticasone|fluticasone|mesh-list
44646286|NCT00296491|Xhance|xhance|mesh-list
44646287|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44646288|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44646289|NCT00296491|Montelukast|montelukast|mesh-list
44646290|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646291|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44646292|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
44646293|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646294|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646295|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44646296|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
44646297|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646298|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44646299|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44646300|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44646301|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44646302|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
44646303|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646304|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646305|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44646306|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
44646307|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646308|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44646309|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44646310|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
44646311|NCT00296491|Hormones|hormones|mesh-ancestor
44646312|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
44646313|NCT00296400|Atorvastatin|atorvastatin|mesh-list
44646314|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44646315|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44646316|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44646317|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
44646318|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646319|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44646320|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44646321|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646322|NCT00296374|Atorvastatin|atorvastatin|mesh-list
44646323|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44646324|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44646325|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44646326|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
44646327|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646328|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44646329|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44646330|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646331|NCT00296335|Cisplatin|cisplatin|mesh-list
44646332|NCT00296335|Mitomycins|mitomycins|mesh-list
44646333|NCT00296335|Mitomycin|mitomycin|mesh-list
44646334|NCT00296335|Doxifluridine|doxifluridine|mesh-list
44646335|NCT00296335|Floxuridine|floxuridine|mesh-list
44646336|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646337|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44646338|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
44646339|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646340|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646341|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646342|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646343|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
44646344|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646345|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
44646346|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646347|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
44646348|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44646349|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
44646350|NCT00296244|Prednisone|prednisone|mesh-list
44646351|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
44646352|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44646353|NCT00296244|Tacrolimus|tacrolimus|mesh-list
44646354|NCT00296244|Basiliximab|basiliximab|mesh-list
44646355|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646357|NCT00296244|Hormones|hormones|mesh-ancestor
44646358|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646359|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646360|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646361|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646362|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646363|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
44646364|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44646365|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646366|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646367|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
44646368|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
44646369|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646370|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646371|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646372|NCT00296244|Protective Agents|protective agents|mesh-ancestor
44646373|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44646374|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44646375|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
44646376|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44646377|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646378|NCT00296036|Pyridoxine|pyridoxine|mesh-list
44646379|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
44646380|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
44646381|NCT00296036|Vitamins|vitamins|mesh-ancestor
44646382|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
44646383|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646384|NCT00295932|Prednisone|prednisone|mesh-list
44646385|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
44646386|NCT00295932|Rituximab|rituximab|mesh-list
44646387|NCT00295932|Bortezomib|bortezomib|mesh-list
44646388|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646389|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
44646390|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646391|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646392|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44646393|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
44646394|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646395|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646396|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44646397|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646398|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646400|NCT00295932|Hormones|hormones|mesh-ancestor
44646401|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646402|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646403|NCT00295750|Leuprolide|leuprolide|mesh-list
44646404|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44646405|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
44646406|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646407|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646408|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646409|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646410|NCT00295633|Metformin|metformin|mesh-list
44646411|NCT00295633|Pioglitazone|pioglitazone|mesh-list
44646412|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
44646413|NCT00295633|Saxagliptin|saxagliptin|mesh-list
44646414|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44646415|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646416|NCT00295633|Incretins|incretins|mesh-ancestor
44646417|NCT00295633|Hormones|hormones|mesh-ancestor
44646418|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646419|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44646420|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
44646421|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646422|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646423|NCT00295620|Anastrozole|anastrozole|mesh-list
44646424|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646425|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646426|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44646427|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44646428|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646429|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646430|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44646432|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646433|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646434|NCT00295022|Montelukast|montelukast|mesh-list
44646435|NCT00295022|Levocetirizine|levocetirizine|mesh-list
44646436|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44646437|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44646438|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44646439|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44646440|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646441|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646442|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44646443|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44646444|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646445|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44646446|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44646447|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
44646448|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
44646449|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646450|NCT00294762|Paclitaxel|paclitaxel|mesh-list
44646451|NCT00294762|Carboplatin|carboplatin|mesh-list
44646452|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44646453|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44646454|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646455|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646456|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646457|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646458|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646459|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44646460|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646461|NCT00294723|Liraglutide|liraglutide|mesh-list
44646462|NCT00294723|Glimepiride|glimepiride|mesh-list
44646463|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44646464|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646465|NCT00294723|Incretins|incretins|mesh-ancestor
44646466|NCT00294723|Hormones|hormones|mesh-ancestor
44646467|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646468|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44646469|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646470|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
44646471|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
44646472|NCT00294684|Prednisolone|prednisolone|mesh-list
44646473|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646474|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
44646475|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
44646476|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646477|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646478|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646479|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
44646480|NCT00294684|Hormones|hormones|mesh-ancestor
44646481|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646482|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646483|NCT00294684|Protective Agents|protective agents|mesh-ancestor
44646484|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646485|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646486|NCT00294671|Diflunisal|diflunisal|mesh-list
44646487|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646488|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646489|NCT00294671|Analgesics|analgesics|mesh-ancestor
44646490|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
44646491|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646492|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646493|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646494|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646495|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44646496|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646497|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646499|NCT00294658|Prednisolone|prednisolone|mesh-list
44646500|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646501|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
44646502|NCT00294658|Hormones|hormones|mesh-ancestor
44646503|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769424|NCT02387138|Irinotecan|irinotecan|mesh-list
44646504|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646505|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646506|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646507|NCT00294554|Memantine|memantine|mesh-list
44646508|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44646509|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44646510|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
44646511|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646512|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646513|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646514|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44646515|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44646516|NCT00294398|Fluticasone|fluticasone|mesh-list
44646518|NCT00294398|Budesonide|budesonide|mesh-list
44646519|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646520|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44646521|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
44646522|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646523|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646524|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44646525|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
44646526|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646527|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44646528|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
44646529|NCT00294398|Hormones|hormones|mesh-ancestor
44646530|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646531|NCT00293813|Denosumab|denosumab|mesh-list
44646532|NCT00293813|Alendronate|alendronate|mesh-list
44646533|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44646534|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646535|NCT00293722|Etanercept|etanercept|mesh-list
44646536|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646537|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646538|NCT00293722|Analgesics|analgesics|mesh-ancestor
44646539|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
44646540|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646541|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646542|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646543|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646544|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646545|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646546|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
44646547|NCT00293709|Etanercept|etanercept|mesh-list
44646548|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646549|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646550|NCT00293709|Analgesics|analgesics|mesh-ancestor
44646551|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
44646552|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646553|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646554|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646555|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646556|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646557|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646558|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
44646559|NCT00293579|Pemetrexed|pemetrexed|mesh-list
44646560|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646561|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646562|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646563|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646564|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646565|NCT00293462|Sargramostim|sargramostim|mesh-list
44646566|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
44646567|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646568|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
44646569|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44646570|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
44646571|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646572|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913518|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
44646573|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646574|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
44646575|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646576|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
44646577|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44646578|NCT00293423|Protective Agents|protective agents|mesh-ancestor
44646580|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44646581|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44646582|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646583|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44646584|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44646585|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646586|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646587|NCT00293384|Dexamethasone|dexamethasone|mesh-list
44646588|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
44646589|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
44646591|NCT00293384|Granisetron|granisetron|mesh-list
44646592|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44646593|NCT00293384|BB 1101|bb 1101|mesh-list
44646594|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646595|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
44646596|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646597|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646598|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44646599|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
44646600|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646601|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646602|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44646603|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646604|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
44646605|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
44646606|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646607|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646608|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
44646609|NCT00293384|Hormones|hormones|mesh-ancestor
44646610|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646611|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646612|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
44646613|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646614|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44646615|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646616|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44646617|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
44646618|NCT00293293|Taxane|taxane|mesh-list
44646619|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646620|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
44646621|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44646622|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44646623|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
44646624|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646625|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44646626|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44646627|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646628|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646629|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
44646630|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44646631|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44646632|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
44646633|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646634|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44646635|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44646636|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646637|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646638|NCT00293202|Etanercept|etanercept|mesh-list
44646639|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44646640|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44646641|NCT00293202|Analgesics|analgesics|mesh-ancestor
44646642|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
44646643|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646644|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646645|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646646|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646647|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646648|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646649|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
44646651|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44646652|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44646653|NCT00293059|Estradiol|estradiol|mesh-list
44646654|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44646655|NCT00293059|Estrogens|estrogens|mesh-ancestor
44646656|NCT00293059|Hormones|hormones|mesh-ancestor
44646657|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646658|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646659|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44646660|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
44646661|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646662|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44646663|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44646664|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44646665|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44646666|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
44646667|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646668|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646669|NCT00293033|Fentanyl|fentanyl|mesh-list
44646670|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44646671|NCT00293033|Narcotics|narcotics|mesh-ancestor
44646672|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44646673|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646674|NCT00293033|Analgesics|analgesics|mesh-ancestor
44646675|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
44646676|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646677|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44646678|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44646679|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
44646680|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
44646681|NCT00293020|Fentanyl|fentanyl|mesh-list
44646682|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44646683|NCT00293020|Narcotics|narcotics|mesh-ancestor
44646684|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44646685|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646686|NCT00293020|Analgesics|analgesics|mesh-ancestor
44646687|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
44646688|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646689|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44646690|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44646691|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
44646692|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
44646693|NCT00292981|Complement C1s|complement c1s|mesh-list
44646694|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44646695|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44646696|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
44646697|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646698|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44646699|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646700|NCT00292942|Artesunate|artesunate|mesh-list
44646701|NCT00292942|Mannitol|mannitol|mesh-list
44646702|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
44646703|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44646704|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44646705|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913659|NCT00408200|Sotalol|sotalol|mesh-list
44646706|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646707|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
44646708|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
44646709|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44646710|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
44646711|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44646712|NCT00292942|Diuretics|diuretics|mesh-ancestor
44646713|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
44646714|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646715|NCT00292461|Lamotrigine|lamotrigine|mesh-list
44646716|NCT00292461|Zonisamide|zonisamide|mesh-list
44646717|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
44646718|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44646719|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44646720|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646721|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44646722|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646723|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44197419|NCT00384631|Bevacizumab|bevacizumab|mesh-list
44646724|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44646725|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44646726|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646727|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44646728|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44646729|NCT00292370|Paroxetine|paroxetine|mesh-list
44646730|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
44646731|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646732|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44646733|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44646734|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44646735|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646736|NCT00292370|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44646737|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44646738|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43913694|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646739|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646740|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646741|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
44646742|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44646743|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44646744|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44646745|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646746|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
44646747|NCT00292227|Rotigotine|rotigotine|mesh-list
44646748|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44646749|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646750|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44646751|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44646752|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646753|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646754|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646755|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646756|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
44646757|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
44646758|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646759|NCT00292188|Pregabalin|pregabalin|mesh-list
44646760|NCT00292188|Analgesics|analgesics|mesh-ancestor
44646761|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
44646762|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646763|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646764|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
44646765|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44646766|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44646767|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646768|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44646769|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44646770|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44646771|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44646772|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44646773|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
44646774|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646775|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
44646776|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646777|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646778|NCT00291642|Cetirizine|cetirizine|mesh-list
44646779|NCT00291642|Levocetirizine|levocetirizine|mesh-list
44646780|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44646781|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44646782|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43825745|NCT05095116|Xhance|xhance|mesh-list
44646783|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
44646784|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
44646785|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44646786|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646787|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646788|NCT00291577|Docetaxel|docetaxel|mesh-list
44646789|NCT00291577|Sunitinib|sunitinib|mesh-list
44646790|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646791|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646792|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646793|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646794|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646795|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44646796|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44646797|NCT00291577|Growth Substances|growth substances|mesh-ancestor
44646798|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646799|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
44646800|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44646801|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646803|NCT00291486|Antibodies|antibodies|mesh-list
44646804|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44646805|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
44646806|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646807|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646808|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
44646809|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646810|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646811|NCT00291330|Warfarin|warfarin|mesh-list
44646812|NCT00291330|Dabigatran|dabigatran|mesh-list
44646813|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
44646814|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
44646815|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44646816|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
44646817|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646818|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646819|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
44646820|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
44646821|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646822|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44646823|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646824|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646825|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
44646826|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646827|NCT00290758|Genistein|genistein|mesh-list
44646828|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44646829|NCT00290758|Protective Agents|protective agents|mesh-ancestor
44646830|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646831|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646832|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44646833|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646834|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646835|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
44646836|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44646837|NCT00290758|Estrogens|estrogens|mesh-ancestor
44646838|NCT00290758|Hormones|hormones|mesh-ancestor
44646839|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646840|NCT00290745|Tamoxifen|tamoxifen|mesh-list
44646841|NCT00290745|Letrozole|letrozole|mesh-list
44646842|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646843|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646844|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44646845|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44646846|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646847|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44646848|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
44646849|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646850|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646851|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646852|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44646853|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44646854|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44646855|NCT00290732|Doxorubicin|doxorubicin|mesh-list
44646856|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44646857|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44646858|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646859|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44646860|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44646861|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646862|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646863|NCT00290706|Gemcitabine|gemcitabine|mesh-list
44646864|NCT00290706|Bortezomib|bortezomib|mesh-list
44646865|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646866|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
44646867|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646868|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646869|NCT00290706|Antiviral Agents|antiviral agents|mesh-ancestor
44646870|NCT00290706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646871|NCT00290706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646872|NCT00290706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646873|NCT00290706|Immunologic Factors|immunologic factors|mesh-ancestor
44646874|NCT00290706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646875|NCT00290693|Docetaxel|docetaxel|mesh-list
44646876|NCT00290693|Capecitabine|capecitabine|mesh-list
44646877|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646878|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646879|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646880|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
43775591|NCT02344810|Calcium|calcium|mesh-list
44646881|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646882|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646883|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
44646884|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
44646885|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44646886|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44646887|NCT00290589|Prednisolone|prednisolone|mesh-list
44646888|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
44646889|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44646890|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
44646891|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646892|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
44646893|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
44646894|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646895|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646896|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646897|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
44646898|NCT00290589|Hormones|hormones|mesh-ancestor
44646899|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646900|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44646901|NCT00290589|Protective Agents|protective agents|mesh-ancestor
44646902|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646903|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646904|NCT00290511|Dexamethasone|dexamethasone|mesh-list
44646905|NCT00290511|Rituximab|rituximab|mesh-list
44646906|NCT00290511|Fludarabine|fludarabine|mesh-list
44646907|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
44646908|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
44646909|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646910|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646911|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
44646912|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646913|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646914|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646915|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
44646916|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
44646917|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646918|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646919|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
44646920|NCT00290511|Hormones|hormones|mesh-ancestor
44646921|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646922|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646923|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646924|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
44646925|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646926|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646927|NCT00290511|Analgesics|analgesics|mesh-ancestor
44646928|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
44646929|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44646930|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44646931|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646932|NCT00290498|Cytarabine|cytarabine|mesh-list
44646933|NCT00290498|Dexamethasone|dexamethasone|mesh-list
44646934|NCT00290498|Prednisone|prednisone|mesh-list
44646935|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
44646936|NCT00290498|Rituximab|rituximab|mesh-list
44646937|NCT00290498|Doxorubicin|doxorubicin|mesh-list
44646938|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44646939|NCT00290498|Methotrexate|methotrexate|mesh-list
44646940|NCT00290498|Vincristine|vincristine|mesh-list
44646941|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646942|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
44646943|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646944|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646945|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44646946|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
44197650|NCT00385554|UC-781|uc-781|mesh-list
44646947|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646948|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913915|NCT00412464|PENTA|penta|mesh-list
44646949|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44646950|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44646951|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646952|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
44646953|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
44646954|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646955|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646956|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
44646957|NCT00290498|Hormones|hormones|mesh-ancestor
44646958|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44646959|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44646960|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44646961|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44646962|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44646963|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44646964|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44646965|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
44646966|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44646967|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44646968|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
44646969|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44646970|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44646971|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44646972|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
44646973|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44646974|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44646975|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
44646976|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
44646977|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
44646979|NCT00290433|Dexamethasone|dexamethasone|mesh-list
44646980|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
44646981|NCT00290433|Doxorubicin|doxorubicin|mesh-list
44646982|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44646983|NCT00290433|Methotrexate|methotrexate|mesh-list
44646984|NCT00290433|Vincristine|vincristine|mesh-list
44646985|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44646986|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
44646987|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44646988|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44646989|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44646990|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
44646991|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44646992|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44646993|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44646994|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44646995|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
44646996|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
44646997|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44646998|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44646999|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
44647000|NCT00290433|Hormones|hormones|mesh-ancestor
44647001|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647002|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647003|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647004|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44647005|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44647006|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647007|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44647008|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
44647009|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44647010|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647011|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
44647012|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
44647013|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44647014|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44647015|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
44647016|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647017|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44647018|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647019|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647020|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647021|NCT00290407|Rituximab|rituximab|mesh-list
44647022|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647023|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647025|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647026|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647027|NCT00290342|Edetic Acid|edetic acid|mesh-list
44647028|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
44647029|NCT00290342|Antidotes|antidotes|mesh-ancestor
44647030|NCT00290342|Protective Agents|protective agents|mesh-ancestor
44647031|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647032|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
44647033|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
44647034|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647035|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44647036|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
44647037|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44647038|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
44647039|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
44647040|NCT00290290|Povidone|povidone|mesh-list
44647041|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44647042|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647043|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
44647044|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
44647045|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
44647046|NCT00289991|Itraconazole|itraconazole|mesh-list
44647047|NCT00289991|Voriconazole|voriconazole|mesh-list
44647048|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
44647049|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647050|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44647051|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44647052|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647053|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647054|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44647055|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
44647056|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647057|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647058|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44647059|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44647060|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44647061|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647062|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647063|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
44647064|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647065|NCT00289900|Atorvastatin|atorvastatin|mesh-list
44647066|NCT00289900|Simvastatin|simvastatin|mesh-list
44647067|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44647068|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44647069|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
44647070|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647071|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44647072|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44647073|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647074|NCT00289887|Losartan|losartan|mesh-list
44647075|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44647076|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44647077|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44647078|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44647079|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647080|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44647081|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647082|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647083|NCT00289848|Incretins|incretins|mesh-ancestor
44647084|NCT00289848|Hormones|hormones|mesh-ancestor
44647085|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647086|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647087|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647088|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647089|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647090|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44647091|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
44647092|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647093|NCT00289536|Factor VIII|factor viii|mesh-list
44647094|NCT00289536|Coagulants|coagulants|mesh-ancestor
44647095|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44197804|NCT00386230|Zidovudine|zidovudine|mesh-list
44647096|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647097|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647099|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647100|NCT00288639|Pregabalin|pregabalin|mesh-list
44647101|NCT00288639|Analgesics|analgesics|mesh-ancestor
44647102|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
44647103|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647104|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647105|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
44647106|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44647107|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647108|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647109|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44647110|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44647111|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647112|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647113|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647114|NCT00288626|Cytarabine|cytarabine|mesh-list
44647115|NCT00288626|Prednisone|prednisone|mesh-list
44647116|NCT00288626|Etoposide|etoposide|mesh-list
44647117|NCT00288626|Melphalan|melphalan|mesh-list
44647118|NCT00288626|Carmustine|carmustine|mesh-list
44647119|NCT00288626|Lenograstim|lenograstim|mesh-list
44647120|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647121|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
44647122|NCT00288626|Hormones|hormones|mesh-ancestor
44647123|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647124|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647125|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647126|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647127|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44647128|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44647129|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44647130|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647131|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647132|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647133|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
44647134|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
44647135|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647136|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647137|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
44647138|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647139|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
44647140|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647141|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44647142|NCT00288587|Diuretics|diuretics|mesh-list
44647143|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44647144|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
44647145|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647146|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647147|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647148|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
44647149|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44647150|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44647151|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44647152|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647153|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647154|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
44647155|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647156|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647157|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44647158|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647159|NCT00288080|Dexamethasone|dexamethasone|mesh-list
44647160|NCT00288080|Prednisone|prednisone|mesh-list
44647161|NCT00288080|Docetaxel|docetaxel|mesh-list
44647162|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
44647163|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647164|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
44647165|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
44647166|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647167|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647168|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44647169|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
44647170|NCT00288080|Hormones|hormones|mesh-ancestor
44647171|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647173|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647174|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647175|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647176|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647177|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914125|NCT00418951|Voriconazole|voriconazole|mesh-list
44647178|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44647179|NCT00288054|Docetaxel|docetaxel|mesh-list
44647180|NCT00288054|Cetuximab|cetuximab|mesh-list
44647181|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647182|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647183|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647184|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647185|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647186|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647187|NCT00288015|Bevacizumab|bevacizumab|mesh-list
44647188|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647189|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647190|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647191|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647192|NCT00288015|Growth Substances|growth substances|mesh-ancestor
44647193|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647194|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647195|NCT00287690|Genistein|genistein|mesh-list
44647196|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44647197|NCT00287690|Protective Agents|protective agents|mesh-ancestor
44647198|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647199|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647200|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647201|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647202|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647203|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
44647204|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44647205|NCT00287690|Estrogens|estrogens|mesh-ancestor
44647206|NCT00287690|Hormones|hormones|mesh-ancestor
44647207|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647208|NCT00287586|Testosterone|testosterone|mesh-list
44647209|NCT00287586|Androgens|androgens|mesh-ancestor
44647210|NCT00287586|Hormones|hormones|mesh-ancestor
44647211|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647212|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647213|NCT00286494|Pioglitazone|pioglitazone|mesh-list
44647214|NCT00286494|Alogliptin|alogliptin|mesh-list
44647215|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647216|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647217|NCT00286494|Incretins|incretins|mesh-ancestor
44647218|NCT00286494|Hormones|hormones|mesh-ancestor
44647219|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647220|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647221|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647222|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647223|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647224|NCT00286468|Alogliptin|alogliptin|mesh-list
44647225|NCT00286468|Glyburide|glyburide|mesh-list
44647226|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647227|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647228|NCT00286468|Incretins|incretins|mesh-ancestor
44647229|NCT00286468|Hormones|hormones|mesh-ancestor
44647230|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647231|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647232|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647233|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647234|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647236|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647237|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647238|NCT00286455|Incretins|incretins|mesh-ancestor
44647239|NCT00286455|Hormones|hormones|mesh-ancestor
44647240|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647241|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647242|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647243|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647244|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647245|NCT00286442|Metformin|metformin|mesh-list
44647246|NCT00286442|Alogliptin|alogliptin|mesh-list
44647247|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647248|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647249|NCT00286442|Incretins|incretins|mesh-ancestor
44647250|NCT00286442|Hormones|hormones|mesh-ancestor
44647251|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647252|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647253|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647254|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647255|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647256|NCT00286429|Insulin|insulin|mesh-list
44647257|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44647259|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647260|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647261|NCT00286429|Incretins|incretins|mesh-ancestor
44647262|NCT00286429|Hormones|hormones|mesh-ancestor
44647263|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647264|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44647265|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
44647266|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647267|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647268|NCT00286234|Niacin|niacin|mesh-list
44647269|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
44647270|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44647271|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
44647272|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647273|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44647274|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
44647275|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
44647276|NCT00286234|Vitamins|vitamins|mesh-ancestor
44647277|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
44647278|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647279|NCT00286221|Fentanyl|fentanyl|mesh-list
44647280|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44647281|NCT00286221|Narcotics|narcotics|mesh-ancestor
44647282|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647283|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647284|NCT00286221|Analgesics|analgesics|mesh-ancestor
44647285|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
44647286|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647287|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44647288|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44647289|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
44647290|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
44647291|NCT00286156|Sirolimus|sirolimus|mesh-list
44647292|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647293|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647294|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647295|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647296|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
44647297|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647298|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
44647299|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647300|NCT00286091|Denosumab|denosumab|mesh-list
44647301|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44647302|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647303|NCT00285857|Lovastatin|lovastatin|mesh-list
44647304|NCT00285857|L 647318|l 647318|mesh-list
44647305|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
44647306|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44647307|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
43914268|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647308|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647309|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44647310|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44647314|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44647315|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
44647316|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44647317|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647318|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44647319|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44647320|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44647321|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
44647322|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44647323|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44647324|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
44647325|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647326|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
44647327|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44647328|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44647330|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44647331|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44647332|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647333|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44647334|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44647335|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647336|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647338|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647339|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647340|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44647341|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44647342|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647343|NCT00285012|Varenicline|varenicline|mesh-list
44647344|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44647345|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44647346|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
44647347|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647348|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647349|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647350|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
44647351|NCT00284934|Prednisone|prednisone|mesh-list
44647352|NCT00284934|Tacrolimus|tacrolimus|mesh-list
44647353|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647354|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
44647355|NCT00284934|Hormones|hormones|mesh-ancestor
44647356|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647357|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647358|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647359|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647360|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647361|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
44647362|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647363|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914321|NCT00424840|Bevacizumab|bevacizumab|mesh-list
44647364|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647365|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647366|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44647367|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
44647368|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647369|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647370|NCT00284856|Fluticasone|fluticasone|mesh-list
44647371|NCT00284856|Montelukast|montelukast|mesh-list
44647372|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647373|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44647374|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
44647375|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647376|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647377|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44647378|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198094|NCT00387413|Niacinamide|niacinamide|mesh-list
44647380|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44647381|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44647382|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
44647383|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647384|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44647385|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44647386|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647387|NCT00284141|Aflibercept|aflibercept|mesh-list
44647388|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647389|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647390|NCT00284141|Growth Substances|growth substances|mesh-ancestor
44647391|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647392|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647393|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647394|NCT00284089|Ranibizumab|ranibizumab|mesh-list
44647395|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647396|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647397|NCT00284089|Growth Substances|growth substances|mesh-ancestor
44647398|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647399|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647400|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647401|NCT00284050|Ranibizumab|ranibizumab|mesh-list
44647402|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647403|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647404|NCT00284050|Growth Substances|growth substances|mesh-ancestor
44647405|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647406|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647407|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647408|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
44647409|NCT00283803|Hormones|hormones|mesh-list
44647410|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44647411|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
44647412|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647413|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647414|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647415|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
44647416|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44647417|NCT00283803|Protective Agents|protective agents|mesh-ancestor
44647418|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44647419|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647420|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647421|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44647422|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44647423|NCT00283803|Analgesics|analgesics|mesh-ancestor
44647424|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
44647425|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647426|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647427|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647428|NCT00283712|Infliximab|infliximab|mesh-list
44647429|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
44647430|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44647431|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647432|NCT00283686|Telmisartan|telmisartan|mesh-list
44647433|NCT00283686|Lisinopril|lisinopril|mesh-list
44647434|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44647435|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44647436|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44647437|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44647438|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647439|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
43914396|NCT00426283|Xhance|xhance|mesh-list
44647440|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647441|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44647442|NCT00283686|Protective Agents|protective agents|mesh-ancestor
44647443|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647444|NCT00283595|Hormones|hormones|mesh-list
44647445|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647446|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647447|NCT00283387|Betaine|betaine|mesh-list
44647448|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44647449|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
44647450|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44647451|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
44647452|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647453|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44647454|NCT00283244|Gemcitabine|gemcitabine|mesh-list
44647455|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44647456|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647457|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
44647458|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647459|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647460|NCT00283244|Antiviral Agents|antiviral agents|mesh-ancestor
44647461|NCT00283244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647462|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647463|NCT00283244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647464|NCT00283244|Immunologic Factors|immunologic factors|mesh-ancestor
43914429|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
44647465|NCT00283244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647466|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647467|NCT00283062|Docetaxel|docetaxel|mesh-list
44647468|NCT00283062|Leuprolide|leuprolide|mesh-list
44647469|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647470|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647471|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647472|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647473|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647474|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44647475|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
44647476|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44647477|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647478|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647479|NCT00283049|Insulin|insulin|mesh-list
44647480|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44647481|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
44647482|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
44647483|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647484|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647485|NCT00282984|Varenicline|varenicline|mesh-list
44647486|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44647487|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44647488|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44647489|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647490|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647491|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647492|NCT00282919|Azithromycin|azithromycin|mesh-list
44647493|NCT00282919|Chloroquine|chloroquine|mesh-list
44647494|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647495|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647496|NCT00282919|Amebicides|amebicides|mesh-ancestor
44647497|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44647498|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44647499|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
44647500|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647501|NCT00282568|Tacrolimus|tacrolimus|mesh-list
44647502|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647503|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
44647504|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647505|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647506|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647507|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647508|NCT00282464|Ziprasidone|ziprasidone|mesh-list
44647509|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44647510|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
44647511|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647512|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647513|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647514|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647515|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647516|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647517|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647518|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44647519|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
44647520|NCT00282412|Cyclosporine|cyclosporine|mesh-list
44647521|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
44647522|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
44647523|NCT00282412|Fludarabine|fludarabine|mesh-list
44647524|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
44647525|NCT00282412|Cyclosporins|cyclosporins|mesh-list
44647526|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647527|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
44647528|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647529|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647530|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647531|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
44647532|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647533|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647534|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647535|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647536|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
44647537|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647538|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44647539|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647540|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647541|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44647542|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
44647543|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647544|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647545|NCT00282347|Acetaminophen|acetaminophen|mesh-list
44647546|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
44647547|NCT00282347|Promethazine|promethazine|mesh-list
44647548|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
44647549|NCT00282347|Prednisone|prednisone|mesh-list
44647550|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
44647551|NCT00282347|Rituximab|rituximab|mesh-list
44647552|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647553|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647554|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
44647555|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647556|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647557|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647558|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
44647559|NCT00282347|Hormones|hormones|mesh-ancestor
44647560|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647561|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647562|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44647563|NCT00282347|Analgesics|analgesics|mesh-ancestor
44647564|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
44647565|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647566|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
44647567|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647568|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44647569|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
44647570|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647571|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647572|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647573|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647574|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
44647575|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
44647576|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44647577|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44647578|NCT00282347|Protective Agents|protective agents|mesh-ancestor
44647579|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44647580|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44647581|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647582|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44647583|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
44647584|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44647585|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
44647586|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
44647587|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647588|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44647589|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
44647590|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
44647591|NCT00282308|Rituximab|rituximab|mesh-list
44647592|NCT00282308|Methotrexate|methotrexate|mesh-list
44647593|NCT00282308|Vaccines|vaccines|mesh-list
44647594|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44647595|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44647596|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
44647597|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647598|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647599|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647600|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647601|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44647602|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
44647603|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44647604|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647605|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
44647606|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647607|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
44647608|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647609|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44647610|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647611|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44647612|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44647614|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647615|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
44647616|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647617|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647618|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647619|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647620|NCT00282243|Tacrolimus|tacrolimus|mesh-list
44647621|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647622|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
44647623|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647624|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647625|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647626|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647627|NCT00282087|Gemcitabine|gemcitabine|mesh-list
44647628|NCT00282087|Docetaxel|docetaxel|mesh-list
44647629|NCT00282087|Doxorubicin|doxorubicin|mesh-list
44647630|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647631|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
44647632|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647633|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647634|NCT00282087|Antiviral Agents|antiviral agents|mesh-ancestor
44647635|NCT00282087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647636|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647637|NCT00282087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647638|NCT00282087|Immunologic Factors|immunologic factors|mesh-ancestor
44647639|NCT00282087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647640|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647641|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647642|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914580|NCT00429143|Tacrolimus|tacrolimus|mesh-list
44647643|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647644|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44647645|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44647646|NCT00282048|Axitinib|axitinib|mesh-list
44647647|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647648|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647649|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647650|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647651|NCT00281957|Sirolimus|sirolimus|mesh-list
44647652|NCT00281957|Sorafenib|sorafenib|mesh-list
44647653|NCT00281957|Tipifarnib|tipifarnib|mesh-list
44647654|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647655|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647656|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647657|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647658|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647659|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647660|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647661|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
44647662|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647663|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
44647664|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647665|NCT00281840|Bevacizumab|bevacizumab|mesh-list
44647666|NCT00281840|Docetaxel|docetaxel|mesh-list
44647667|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647668|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647669|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647670|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647671|NCT00281840|Growth Substances|growth substances|mesh-ancestor
44647672|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647673|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647674|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647675|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647676|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647677|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647678|NCT00281697|Bevacizumab|bevacizumab|mesh-list
44198368|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647680|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647681|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647682|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647683|NCT00281697|Growth Substances|growth substances|mesh-ancestor
44647684|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647685|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647686|NCT00281580|Amlodipine|amlodipine|mesh-list
44647687|NCT00281580|Telmisartan|telmisartan|mesh-list
44647688|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44647689|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44647690|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647691|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647692|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44647693|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647694|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
44647695|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44647696|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44647697|NCT00281528|Paclitaxel|paclitaxel|mesh-list
44647698|NCT00281528|Bevacizumab|bevacizumab|mesh-list
44647699|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44647700|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44647701|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647702|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647703|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647704|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647705|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647706|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647707|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647708|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647709|NCT00281528|Growth Substances|growth substances|mesh-ancestor
44647710|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647711|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647712|NCT00281320|Asenapine|asenapine|mesh-list
44647713|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647714|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647715|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647716|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647717|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647718|NCT00280748|Pemetrexed|pemetrexed|mesh-list
44647719|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647720|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647721|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647722|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44647723|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44647724|NCT00280735|Carboplatin|carboplatin|mesh-list
44647725|NCT00280735|Docetaxel|docetaxel|mesh-list
44647726|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647727|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647728|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647729|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647730|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647731|NCT00280566|Ziprasidone|ziprasidone|mesh-list
44647732|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44647733|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
44647734|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647735|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647736|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647737|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647738|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647739|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647740|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647741|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44647742|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
44647743|NCT00280397|Lenvatinib|lenvatinib|mesh-list
44647744|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647745|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647746|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647747|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647748|NCT00280293|Lamotrigine|lamotrigine|mesh-list
44647749|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
44647750|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44647751|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647752|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647753|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44647754|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647755|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647756|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647757|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647758|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647759|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44647760|NCT00280150|Paclitaxel|paclitaxel|mesh-list
44647761|NCT00280150|Bevacizumab|bevacizumab|mesh-list
44647762|NCT00280150|Carboplatin|carboplatin|mesh-list
44647763|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44647764|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44647765|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647766|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647767|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647768|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647769|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647770|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647771|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647772|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647773|NCT00280150|Growth Substances|growth substances|mesh-ancestor
44647774|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647775|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647776|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647777|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647778|NCT00280059|Pregabalin|pregabalin|mesh-list
44647779|NCT00280059|Lamotrigine|lamotrigine|mesh-list
44647780|NCT00280059|Analgesics|analgesics|mesh-ancestor
44647781|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
44647782|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647783|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647784|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
44647785|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44647786|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647787|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647788|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44647789|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44647790|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647791|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647792|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647793|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647794|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44647795|NCT00279916|Triamcinolone|triamcinolone|mesh-list
44647796|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44647797|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44647798|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44647799|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647800|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
44647801|NCT00279916|Hormones|hormones|mesh-ancestor
44647802|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647803|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647804|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647805|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
44647806|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647807|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647808|NCT00279812|Selenium|selenium|mesh-list
44647809|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
43914761|NCT00434356|Growth Substances|growth substances|mesh-ancestor
44647810|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647811|NCT00279812|Protective Agents|protective agents|mesh-ancestor
44647812|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647813|NCT00279812|Trace Elements|trace elements|mesh-ancestor
44647814|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
44647815|NCT00279708|Atorvastatin|atorvastatin|mesh-list
44647816|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44647817|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44647818|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
44647819|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647820|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44647821|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44647822|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647823|NCT00279305|Rituximab|rituximab|mesh-list
44647824|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647825|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647826|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
44647827|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647828|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647829|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44647830|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647831|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
44647832|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
44647833|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
44647834|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
44647835|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44647836|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44647837|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647838|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
44647839|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44647840|NCT00278954|Antibodies|antibodies|mesh-list
44647841|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
44647842|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44647843|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
44647844|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647845|NCT00278889|Leucovorin|leucovorin|mesh-list
44647846|NCT00278889|Bevacizumab|bevacizumab|mesh-list
44647847|NCT00278889|Fluorouracil|fluorouracil|mesh-list
44647848|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
44647849|NCT00278889|Cediranib|cediranib|mesh-list
44647850|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647851|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647852|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44647853|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44647854|NCT00278889|Growth Substances|growth substances|mesh-ancestor
44647855|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647856|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44647857|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
44647858|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647859|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647860|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647861|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
44647862|NCT00278889|Antidotes|antidotes|mesh-ancestor
44647863|NCT00278889|Protective Agents|protective agents|mesh-ancestor
44647864|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
44647865|NCT00278889|Vitamins|vitamins|mesh-ancestor
44647866|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
44647867|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647868|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647869|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
44647870|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44647871|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44647872|NCT00278564|Prednisolone|prednisolone|mesh-list
44647873|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
44647874|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
44647875|NCT00278564|Rituximab|rituximab|mesh-list
44647876|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44647877|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
44647878|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647879|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
44647880|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647881|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647882|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647883|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
44647884|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647885|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647886|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647887|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647888|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44647889|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
44647890|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
44647891|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44647892|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44647893|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
44647894|NCT00278564|Hormones|hormones|mesh-ancestor
44647895|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44647896|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44647897|NCT00278564|Protective Agents|protective agents|mesh-ancestor
44647898|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44647899|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
44647900|NCT00278512|Fludarabine|fludarabine|mesh-list
44647901|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
44647902|NCT00278512|Tacrolimus|tacrolimus|mesh-list
44647903|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
44647904|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647905|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
44647906|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647907|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647908|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647909|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
44647910|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647911|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647912|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647913|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44647914|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647915|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647916|NCT00278395|Vorinostat|vorinostat|mesh-list
44647917|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647918|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44647919|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647920|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647921|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
44647922|NCT00278161|Rituximab|rituximab|mesh-list
44647923|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647924|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
44647925|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647926|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647927|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647928|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
44647929|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647930|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647931|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647932|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44647934|NCT00278148|Carboplatin|carboplatin|mesh-list
44647935|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44647936|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44647937|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647938|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
44647939|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
44647940|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44647941|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647942|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44647943|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647944|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
44647945|NCT00278109|Doxorubicin|doxorubicin|mesh-list
44647946|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44647947|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
44647948|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647949|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44647950|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44647951|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
44647952|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647953|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647954|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44647955|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44647956|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44647957|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44647958|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44647959|NCT00277355|Minocycline|minocycline|mesh-list
44647960|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44647961|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44647962|NCT00277212|Lamotrigine|lamotrigine|mesh-list
44647963|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
44647964|NCT00277212|Aripiprazole|aripiprazole|mesh-list
44647965|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
44647966|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44647967|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44647968|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44647969|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44647970|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44647971|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
44647972|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
44647973|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44647974|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647975|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44647976|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44647977|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
44647978|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44647979|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44647980|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44647981|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44647982|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44647983|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44647984|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44647985|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44647986|NCT00276744|Gemcitabine|gemcitabine|mesh-list
44647987|NCT00276744|Sirolimus|sirolimus|mesh-list
44647988|NCT00276744|Capecitabine|capecitabine|mesh-list
44647989|NCT00276744|Docetaxel|docetaxel|mesh-list
44647990|NCT00276744|Irinotecan|irinotecan|mesh-list
44647991|NCT00276744|Cetuximab|cetuximab|mesh-list
44647992|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44647993|NCT00276744|Mitomycins|mitomycins|mesh-list
44647994|NCT00276744|Mitomycin|mitomycin|mesh-list
44647995|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44647996|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
44647997|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44647998|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44647999|NCT00276744|Antiviral Agents|antiviral agents|mesh-ancestor
44648000|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648001|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648002|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648003|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
44648004|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648005|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44648006|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648007|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648008|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44648009|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648010|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648011|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648012|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44648013|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44648014|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
44648015|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
44648016|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648018|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648019|NCT00276484|Atorvastatin|atorvastatin|mesh-list
44648020|NCT00276484|Ezetimibe|ezetimibe|mesh-list
44648021|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44648022|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44648023|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
44648024|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648025|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44648026|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44648027|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648028|NCT00276458|Atorvastatin|atorvastatin|mesh-list
44648029|NCT00276458|Ezetimibe|ezetimibe|mesh-list
44648030|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44648031|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44648032|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
44648033|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648034|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44648035|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44648036|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648037|NCT00276419|Diclofenac|diclofenac|mesh-list
44648038|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44648039|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44648040|NCT00276419|Analgesics|analgesics|mesh-ancestor
44648041|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
44648042|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648043|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648044|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648045|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648046|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44648047|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648048|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648049|NCT00276380|Aspirin|aspirin|mesh-list
44648050|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44648051|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44648052|NCT00276380|Analgesics|analgesics|mesh-ancestor
44648053|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
44648054|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648055|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648056|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648057|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648058|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44648059|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44648060|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648061|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44648062|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44648063|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648064|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
44648065|NCT00276094|Tamoxifen|tamoxifen|mesh-list
44648066|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44648067|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44648068|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648069|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648070|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648071|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648072|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44648073|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44648074|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44648075|NCT00276016|Phenylephrine|phenylephrine|mesh-list
44648076|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
44648077|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
44648078|NCT00276016|Ephedrine|ephedrine|mesh-list
44043259|NCT00002908|Vincristine|vincristine|mesh-list
44648079|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44648080|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
44648081|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
44648082|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648083|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648084|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
44648085|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44648086|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
44648087|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44648088|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44648089|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44648090|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44648091|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44648092|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648093|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648094|NCT00276016|Protective Agents|protective agents|mesh-ancestor
44648095|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44648096|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44648097|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44648098|NCT00275821|Ranibizumab|ranibizumab|mesh-list
44648099|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648100|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648101|NCT00275821|Growth Substances|growth substances|mesh-ancestor
44648102|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648103|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648104|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648105|NCT00275561|Fluticasone|fluticasone|mesh-list
44648106|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648107|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44648108|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
44648109|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648110|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648111|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44648112|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
44648113|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648114|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44648115|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
44648116|NCT00275509|Dexamethasone|dexamethasone|mesh-list
44648117|NCT00275509|Prednisone|prednisone|mesh-list
44648118|NCT00275509|Tacrolimus|tacrolimus|mesh-list
44648119|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
44648120|NCT00275509|Daclizumab|daclizumab|mesh-list
44648121|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648122|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
44648123|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
44648124|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648125|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648126|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44648127|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
44648128|NCT00275509|Hormones|hormones|mesh-ancestor
44648129|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648130|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648131|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648132|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648133|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
44648134|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44648135|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648136|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648137|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44648138|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44648139|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
44648140|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43915030|NCT00440830|Nicotine|nicotine|mesh-list
43915064|NCT00442364|Polidocanol|polidocanol|mesh-list
44648141|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648142|NCT00275301|Olanzapine|olanzapine|mesh-list
44648143|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
44648144|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
44648145|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648146|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648147|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44648148|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648149|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648150|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648151|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648152|NCT00275301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44648153|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44648154|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648155|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648156|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648157|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
44198873|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
44648159|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44648160|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
44648161|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648162|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648163|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648164|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648165|NCT00275028|Cediranib|cediranib|mesh-list
44648166|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648167|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648168|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648169|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648170|NCT00275002|Temozolomide|temozolomide|mesh-list
44648171|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44648172|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648173|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
43915065|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44648174|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648175|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648176|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648177|NCT00274937|Cisplatin|cisplatin|mesh-list
44648178|NCT00274937|Fluorouracil|fluorouracil|mesh-list
44648179|NCT00274937|Amifostine|amifostine|mesh-list
44648180|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648181|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
44648182|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648183|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648184|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648185|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
44648186|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648187|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44648188|NCT00274937|Protective Agents|protective agents|mesh-ancestor
44648189|NCT00274924|Prednisone|prednisone|mesh-list
44648190|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
44648191|NCT00274924|Ifosfamide|ifosfamide|mesh-list
44648192|NCT00274924|Rituximab|rituximab|mesh-list
44648193|NCT00274924|Carboplatin|carboplatin|mesh-list
44648194|NCT00274924|Doxorubicin|doxorubicin|mesh-list
44648195|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44648196|NCT00274924|Etoposide|etoposide|mesh-list
44648197|NCT00274924|Vincristine|vincristine|mesh-list
44648198|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
44648199|NCT00274924|Lenograstim|lenograstim|mesh-list
44648200|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648201|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
44648202|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648203|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648204|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648205|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
44648206|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648207|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648208|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44648209|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648210|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44648211|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44648212|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648213|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648214|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648215|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
44648216|NCT00274924|Hormones|hormones|mesh-ancestor
44648217|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648218|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648219|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44648220|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44648221|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915104|NCT00442689|Diuretics|diuretics|mesh-ancestor
44648222|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648223|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648224|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
44648225|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648226|NCT00274846|Aldesleukin|aldesleukin|mesh-list
44648227|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
44648228|NCT00274846|Fludarabine|fludarabine|mesh-list
44648229|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
44648230|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648231|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
44648232|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648233|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648234|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648235|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
44648236|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648237|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648238|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44648239|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648241|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44648242|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44648243|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
44648244|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648245|NCT00274742|Blinatumomab|blinatumomab|mesh-list
44648246|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44648247|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648248|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
44648249|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648250|NCT00274651|Belinostat|belinostat|mesh-list
44648251|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648252|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44648253|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648254|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648255|NCT00274469|Fulvestrant|fulvestrant|mesh-list
44648256|NCT00274469|Anastrozole|anastrozole|mesh-list
44648257|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648258|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648259|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44648260|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44648261|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
44648262|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648263|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648264|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44648265|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44648266|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648267|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648268|NCT00274456|Paclitaxel|paclitaxel|mesh-list
44648269|NCT00274456|Docetaxel|docetaxel|mesh-list
44648270|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44648271|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44648272|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648273|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44648274|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648275|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648276|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648277|NCT00274287|Sargramostim|sargramostim|mesh-list
44648278|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
44648279|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648280|NCT00274261|Nonoxynol|nonoxynol|mesh-list
44648281|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44648282|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44648283|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648284|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44648285|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
44648286|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648287|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44648288|NCT00273052|Metoprolol|metoprolol|mesh-list
44648289|NCT00273052|Carvedilol|carvedilol|mesh-list
44648290|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44648291|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44648292|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
44648293|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
44648294|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648295|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648296|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44648297|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44648298|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44648299|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
44648300|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915190|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
44648301|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648302|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
44648303|NCT00273052|Protective Agents|protective agents|mesh-ancestor
44648304|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44648305|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648306|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44648307|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
44648308|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44648309|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44648311|NCT00272987|Trastuzumab|trastuzumab|mesh-list
44648312|NCT00272987|Lapatinib|lapatinib|mesh-list
44648313|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44648314|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648315|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
44648316|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648317|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648318|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648319|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648320|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648321|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648322|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
44648323|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44648324|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44648325|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648326|NCT00272792|Verapamil|verapamil|mesh-list
44648327|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44648328|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44648329|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648330|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648331|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44648332|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648333|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
44648334|NCT00272779|Emtricitabine|emtricitabine|mesh-list
44648335|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44648336|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
44648337|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648338|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44648339|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648340|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648341|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648342|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44648343|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44648344|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44648345|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44648346|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
44648347|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44648348|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648349|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648350|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648351|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648352|NCT00271609|Bevacizumab|bevacizumab|mesh-list
44648353|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648354|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648355|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648356|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648357|NCT00271609|Growth Substances|growth substances|mesh-ancestor
44648358|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648359|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648360|NCT00271596|Citalopram|citalopram|mesh-list
44648361|NCT00271596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44648362|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44648363|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648364|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648365|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648366|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
44648367|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648368|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44648369|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
44648370|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648371|NCT00271505|Bevacizumab|bevacizumab|mesh-list
44648372|NCT00271505|Carboplatin|carboplatin|mesh-list
44648373|NCT00271505|Docetaxel|docetaxel|mesh-list
44648374|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648375|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648376|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648377|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648378|NCT00271505|Growth Substances|growth substances|mesh-ancestor
44648379|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648380|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648381|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915285|NCT00448227|Famciclovir|famciclovir|mesh-list
44648382|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648383|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648384|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648385|NCT00271024|Naltrexone|naltrexone|mesh-list
44648386|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44648387|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44648388|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648389|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
44648390|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648391|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
44648392|NCT00270894|Docetaxel|docetaxel|mesh-list
44648393|NCT00270894|Trastuzumab|trastuzumab|mesh-list
44648394|NCT00270894|Epirubicin|epirubicin|mesh-list
44648395|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648396|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
44648397|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648398|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648399|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648400|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
44648401|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648402|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648403|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44648404|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
44648405|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648406|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648407|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648408|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44648409|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44648410|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648411|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648412|NCT00270413|Sunitinib|sunitinib|mesh-list
44648413|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648414|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648415|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648416|NCT00270413|Growth Substances|growth substances|mesh-ancestor
44648417|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648418|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648419|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648420|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648421|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648422|NCT00270257|Buprenorphine|buprenorphine|mesh-list
44648423|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44648424|NCT00270257|Naloxone|naloxone|mesh-list
44648425|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44648426|NCT00270257|Narcotics|narcotics|mesh-ancestor
44648427|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648428|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648429|NCT00270257|Analgesics|analgesics|mesh-ancestor
44648430|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
44648431|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648432|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44648433|NCT00270231|Naltrexone|naltrexone|mesh-list
44648434|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44648435|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44648436|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648437|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
44648438|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648439|NCT00269919|Risperidone|risperidone|mesh-list
44648440|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44648441|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
44648442|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648443|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648444|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648445|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648446|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648447|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648448|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648449|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44648450|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
44648451|NCT00269399|Vancomycin|vancomycin|mesh-list
44648452|NCT00269399|Rifaximin|rifaximin|mesh-list
44648453|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44648454|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648455|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44648456|NCT00269152|Cisplatin|cisplatin|mesh-list
44648457|NCT00269152|Carboplatin|carboplatin|mesh-list
44648458|NCT00269152|Pemetrexed|pemetrexed|mesh-list
44648459|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648460|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648461|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648462|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648463|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648464|NCT00269113|Rituximab|rituximab|mesh-list
44648465|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648466|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648467|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
44648468|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648469|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648470|NCT00269087|Fluticasone|fluticasone|mesh-list
44648471|NCT00269087|Xhance|xhance|mesh-list
44648472|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44648473|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648474|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44648475|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
44648476|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648477|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648478|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44648479|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44648480|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648481|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44648482|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44648483|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44648484|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44648485|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
44648486|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648487|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648488|NCT00268983|Iodine|iodine|mesh-list
44648489|NCT00268983|Rituximab|rituximab|mesh-list
44648490|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
44648491|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44648492|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648493|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648494|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
44648495|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648496|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648497|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44648498|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648499|NCT00268983|Trace Elements|trace elements|mesh-ancestor
44648500|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
44648501|NCT00268905|Carboplatin|carboplatin|mesh-list
44648502|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648503|NCT00268463|Capecitabine|capecitabine|mesh-list
44648504|NCT00268463|Floxuridine|floxuridine|mesh-list
44648505|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
44648506|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648507|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
44648508|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648509|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648510|NCT00268437|Carboplatin|carboplatin|mesh-list
44648511|NCT00268437|Pemetrexed|pemetrexed|mesh-list
44648512|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648513|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648514|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648515|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648516|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648517|NCT00268346|Gefitinib|gefitinib|mesh-list
44648518|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648519|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648520|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648521|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648522|NCT00268242|Gemcitabine|gemcitabine|mesh-list
44648523|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
44648524|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648525|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
44648526|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648527|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648529|NCT00268242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648530|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648531|NCT00268242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648532|NCT00268242|Immunologic Factors|immunologic factors|mesh-ancestor
44648533|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648534|NCT00268242|Analgesics|analgesics|mesh-ancestor
44648535|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
44648536|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648537|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44648538|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648539|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
44648540|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648541|NCT00267969|Ustekinumab|ustekinumab|mesh-list
44648542|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648543|NCT00267956|Ustekinumab|ustekinumab|mesh-list
44648544|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648545|NCT00267865|Leucovorin|leucovorin|mesh-list
44648546|NCT00267865|Rituximab|rituximab|mesh-list
44648547|NCT00267865|Methotrexate|methotrexate|mesh-list
44648548|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648549|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648550|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
44648551|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648552|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648553|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44648554|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
44648555|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648556|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648557|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
44648558|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648559|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648560|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648561|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648562|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648563|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648564|NCT00267865|Antidotes|antidotes|mesh-ancestor
44648565|NCT00267865|Protective Agents|protective agents|mesh-ancestor
44648566|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
44648567|NCT00267865|Vitamins|vitamins|mesh-ancestor
44648568|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
44648569|NCT00267748|Sunitinib|sunitinib|mesh-list
44648570|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648571|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648572|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648573|NCT00267748|Growth Substances|growth substances|mesh-ancestor
44648574|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648575|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648576|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648577|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648578|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648579|NCT00267488|Topotecan|topotecan|mesh-list
43915460|NCT00452387|Analgesics|analgesics|mesh-ancestor
44648580|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44648581|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648582|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648583|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648584|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648585|NCT00267202|Omalizumab|omalizumab|mesh-list
44648586|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
44648587|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648588|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44648589|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44648590|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
44648591|NCT00267189|Cyclosporine|cyclosporine|mesh-list
44648592|NCT00267189|Everolimus|everolimus|mesh-list
44648593|NCT00267189|Azathioprine|azathioprine|mesh-list
44648594|NCT00267189|Tacrolimus|tacrolimus|mesh-list
44648595|NCT00267189|Cyclosporins|cyclosporins|mesh-list
44648596|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44648597|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648598|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648599|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
44648600|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648601|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648602|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648603|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648604|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
44648605|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648606|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199288|NCT00393198|Misoprostol|misoprostol|mesh-list
44648607|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
44648608|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648609|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
44648610|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44648611|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648612|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44648613|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
44648614|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44648615|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648616|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648617|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648619|NCT00267046|Doxorubicin|doxorubicin|mesh-list
44648620|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44648621|NCT00267046|Vincristine|vincristine|mesh-list
44648622|NCT00267046|Ifosfamide|ifosfamide|mesh-list
44648623|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648624|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43915510|NCT00453336|Trioxsalen|trioxsalen|mesh-list
44648625|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44648626|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648627|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648628|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648629|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44648630|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44648631|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44648632|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44648633|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648634|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
44648635|NCT00267020|Gemcitabine|gemcitabine|mesh-list
44648636|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648637|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
44648638|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648639|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648640|NCT00267020|Antiviral Agents|antiviral agents|mesh-ancestor
44648641|NCT00267020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648642|NCT00267020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648643|NCT00267020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648644|NCT00267020|Immunologic Factors|immunologic factors|mesh-ancestor
44648645|NCT00267020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648646|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
44648647|NCT00267007|Hematinics|hematinics|mesh-ancestor
44648648|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
44648649|NCT00266864|Testosterone|testosterone|mesh-list
44648650|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
44648651|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
44648652|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44648653|NCT00266864|Androgens|androgens|mesh-ancestor
44648654|NCT00266864|Hormones|hormones|mesh-ancestor
44648655|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648656|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648657|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648658|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648659|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
44648660|NCT00266812|Temozolomide|temozolomide|mesh-list
44648661|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648662|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
44648663|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648664|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648665|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
44648666|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
44648667|NCT00266708|Diphosphonates|diphosphonates|mesh-list
44648668|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44648669|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648670|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648671|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44648672|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648673|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44648674|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
44648675|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648676|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648677|NCT00266656|Hormones|hormones|mesh-list
44648678|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648679|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648680|NCT00266630|Carbamazepine|carbamazepine|mesh-list
44648681|NCT00266630|Valproic Acid|valproic acid|mesh-list
44648682|NCT00266630|Olanzapine|olanzapine|mesh-list
44648683|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
44199361|NCT00393393|Hylan|hylan|mesh-list
44648684|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
44648685|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648686|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648687|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44648688|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648689|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648690|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648691|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648692|NCT00266630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44648693|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44648694|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648695|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648696|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648697|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
44648698|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648699|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
44648700|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
44648702|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44648703|NCT00266630|Analgesics|analgesics|mesh-ancestor
44648704|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
44648705|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44648706|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44648707|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44648708|NCT00266409|Alprazolam|alprazolam|mesh-list
44648709|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44648710|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648711|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648712|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44648713|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648714|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648715|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
44648716|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
44648717|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648718|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648719|NCT00266227|Rituximab|rituximab|mesh-list
44648720|NCT00266227|Methotrexate|methotrexate|mesh-list
44648721|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44648722|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648723|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
44648724|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648725|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648726|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44648727|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
44648728|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648729|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648730|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
44648731|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648732|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648733|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648734|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648735|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648736|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648737|NCT00266032|Drospirenone|drospirenone|mesh-list
44648738|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44648739|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44648740|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915620|NCT00456508|Ecallantide|ecallantide|mesh-list
44648741|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648742|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44648744|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
44648745|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
44648746|NCT00265889|Melphalan|melphalan|mesh-list
44648747|NCT00265889|Busulfan|busulfan|mesh-list
44648748|NCT00265889|Etoposide|etoposide|mesh-list
44648749|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648750|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
44648751|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648752|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648753|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44648754|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
44648755|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648756|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648757|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44648758|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44648759|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44648760|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44648761|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648762|NCT00265785|Pemetrexed|pemetrexed|mesh-list
44648763|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648764|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648765|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648766|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648767|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648768|NCT00265759|Letrozole|letrozole|mesh-list
44648769|NCT00265759|Anastrozole|anastrozole|mesh-list
44648770|NCT00265759|Exemestane|exemestane|mesh-list
44648771|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648772|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44648773|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44648774|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648775|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648776|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44648777|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
44648778|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44648779|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648780|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44648781|NCT00265395|Interferons|interferons|mesh-list
44648782|NCT00265395|Ribavirin|ribavirin|mesh-list
44648783|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
44648784|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
44648785|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44648786|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648787|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
44648788|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648789|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
44648790|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648791|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
44648792|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648793|NCT00265382|Ziprasidone|ziprasidone|mesh-list
44648794|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44648795|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
44648796|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648797|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648798|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648799|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648800|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648801|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648802|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648803|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44648804|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
44648805|NCT00265343|Olanzapine|olanzapine|mesh-list
44648806|NCT00265343|Asenapine|asenapine|mesh-list
44648807|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
44648808|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
44648809|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648810|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648811|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44648812|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648813|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648814|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648815|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648816|NCT00265343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44458782|NCT01590758|Pexiganan|pexiganan|mesh-list
44648817|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44648818|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648819|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648820|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648821|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
44648822|NCT00265330|Ziprasidone|ziprasidone|mesh-list
44648823|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44648824|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
44648825|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648826|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648827|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648828|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44648829|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648830|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648831|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648832|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44648833|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
44648834|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43915724|NCT00458822|Hormones|hormones|mesh-ancestor
44648836|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648837|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648838|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648839|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648840|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44648841|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44648842|NCT00265317|Growth Substances|growth substances|mesh-ancestor
44648843|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648844|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
44648845|NCT00265239|Edaravone|edaravone|mesh-list
44648846|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44648847|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
44648848|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648849|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44648850|NCT00265239|Protective Agents|protective agents|mesh-ancestor
44648851|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648852|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
44648853|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44648854|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648855|NCT00265122|Ustekinumab|ustekinumab|mesh-list
44648856|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648857|NCT00265109|Levetiracetam|levetiracetam|mesh-list
44648858|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
44648859|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
44648860|NCT00265096|Golimumab|golimumab|mesh-list
44648861|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44648862|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44648863|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648864|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648865|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
44648866|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648867|NCT00265083|Golimumab|golimumab|mesh-list
44648868|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44648869|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44648870|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648871|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648872|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
44648873|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648874|NCT00264875|Pregabalin|pregabalin|mesh-list
44648875|NCT00264875|Analgesics|analgesics|mesh-ancestor
44648876|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
44648877|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648878|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648879|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
44648880|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44648881|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648882|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648883|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44648884|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44648885|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44648886|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44648887|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44648888|NCT00264849|Omalizumab|omalizumab|mesh-list
44648889|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44648890|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44648891|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
44648892|NCT00264797|Methylphenidate|methylphenidate|mesh-list
44648893|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44648894|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648895|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44648896|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44648897|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44648898|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648900|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648901|NCT00264550|Golimumab|golimumab|mesh-list
44648902|NCT00264550|Methotrexate|methotrexate|mesh-list
44648903|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44648904|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44648905|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
44648906|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648907|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648908|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648909|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
44648910|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648911|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648912|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648913|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648914|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648915|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648916|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
44648917|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648918|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648919|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44648920|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648921|NCT00264537|Golimumab|golimumab|mesh-list
44648922|NCT00264537|Methotrexate|methotrexate|mesh-list
44648923|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44648924|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44648925|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
44648926|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44648927|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648928|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648929|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
44648930|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648931|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648932|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
44648933|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648934|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44648935|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648936|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
44648937|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648938|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44648939|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44648940|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648941|NCT00264498|Gemcitabine|gemcitabine|mesh-list
44648942|NCT00264498|Carboplatin|carboplatin|mesh-list
44648943|NCT00264498|Gefitinib|gefitinib|mesh-list
44648944|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648945|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44648946|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
44648947|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648948|NCT00264498|Antiviral Agents|antiviral agents|mesh-ancestor
44648949|NCT00264498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44648950|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648951|NCT00264498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44648952|NCT00264498|Immunologic Factors|immunologic factors|mesh-ancestor
44648953|NCT00264498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648954|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648955|NCT00264303|Levocetirizine|levocetirizine|mesh-list
44648956|NCT00264303|Desloratadine|desloratadine|mesh-list
44648957|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44648958|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44648959|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
44648960|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
44648961|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648962|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648963|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648964|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44648965|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
44648966|NCT00264290|Valganciclovir|valganciclovir|mesh-list
44648967|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
44648968|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199638|NCT00395239|Budesonide|budesonide|mesh-list
44648970|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44648971|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44648972|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
44648973|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44648974|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648975|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648976|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44648977|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44648978|NCT00264147|Diclofenac|diclofenac|mesh-list
44648979|NCT00264147|Etoricoxib|etoricoxib|mesh-list
44648980|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44648981|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44648982|NCT00264147|Analgesics|analgesics|mesh-ancestor
44648983|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
44648984|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44648985|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44648986|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44648987|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44648988|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44648989|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648990|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648991|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44648992|NCT00264004|Cediranib|cediranib|mesh-list
44648993|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44648994|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44648995|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44648996|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44648997|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
44648998|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44648999|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649000|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649001|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44649002|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44649003|NCT00263588|Lapatinib|lapatinib|mesh-list
44649004|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649005|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649006|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649007|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649008|NCT00263575|Fentanyl|fentanyl|mesh-list
44649009|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44649010|NCT00263575|Narcotics|narcotics|mesh-ancestor
44649011|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649012|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649013|NCT00263575|Analgesics|analgesics|mesh-ancestor
44649014|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
44649015|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649016|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44649017|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44649018|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
44649019|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
44649020|NCT00263328|Tacrolimus|tacrolimus|mesh-list
44649021|NCT00263328|Tofacitinib|tofacitinib|mesh-list
44649022|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915898|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
44649023|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
44649024|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649025|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44649026|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649027|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649028|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649029|NCT00263211|Aspirin|aspirin|mesh-list
44649030|NCT00263211|Clopidogrel|clopidogrel|mesh-list
44649031|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44649032|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44649033|NCT00263211|Analgesics|analgesics|mesh-ancestor
44649034|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
44649035|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649036|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649037|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649038|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649039|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44649040|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44649041|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649042|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44649043|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44649044|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649045|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
44649046|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44649047|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44649048|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44649049|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
44649050|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649051|NCT00262951|Interferons|interferons|mesh-list
44649052|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
44649053|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
44649054|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44649055|NCT00262951|Cisplatin|cisplatin|mesh-list
43601879|NCT03260283|Fentanyl|fentanyl|mesh-list
44649056|NCT00262951|Fluorouracil|fluorouracil|mesh-list
44649057|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649058|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
44649059|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649060|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649061|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649062|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
44649063|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649064|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
44649065|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649066|NCT00262925|Leucovorin|leucovorin|mesh-list
44649067|NCT00262925|Dexamethasone|dexamethasone|mesh-list
44649068|NCT00262925|Methotrexate|methotrexate|mesh-list
44649069|NCT00262925|Vincristine|vincristine|mesh-list
44649070|NCT00262925|Asparaginase|asparaginase|mesh-list
44649071|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
44649072|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
44649073|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44649074|NCT00262925|Antibodies|antibodies|mesh-list
44649075|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
44649076|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44649077|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
44649078|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
44649079|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649080|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649081|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
44649082|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
44649083|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649084|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649085|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
44649086|NCT00262925|Hormones|hormones|mesh-ancestor
44649087|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44649088|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44649089|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649090|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44649091|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
44649092|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44649093|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649094|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
44649095|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649096|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649097|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649098|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44649099|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649100|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649101|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44649102|NCT00262925|Antidotes|antidotes|mesh-ancestor
44649103|NCT00262925|Protective Agents|protective agents|mesh-ancestor
44649104|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
44649105|NCT00262925|Vitamins|vitamins|mesh-ancestor
44649106|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
44649107|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649108|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649109|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649110|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649111|NCT00262873|Bortezomib|bortezomib|mesh-list
44649112|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649113|NCT00262860|Gemcitabine|gemcitabine|mesh-list
44649114|NCT00262860|Bortezomib|bortezomib|mesh-list
44649115|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649116|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
44649117|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649118|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649119|NCT00262860|Antiviral Agents|antiviral agents|mesh-ancestor
44649120|NCT00262860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649121|NCT00262860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915978|NCT00463437|Vaccines|vaccines|mesh-list
44649122|NCT00262860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649123|NCT00262860|Immunologic Factors|immunologic factors|mesh-ancestor
44649124|NCT00262860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649125|NCT00262847|Paclitaxel|paclitaxel|mesh-list
44649126|NCT00262847|Bevacizumab|bevacizumab|mesh-list
44649127|NCT00262847|Carboplatin|carboplatin|mesh-list
44649128|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44649129|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44649130|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
44649131|NCT00262847|Antibodies|antibodies|mesh-list
44649132|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
44649133|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44649134|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
44649135|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649136|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649137|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649138|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649139|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649140|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649141|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44649142|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44649143|NCT00262847|Growth Substances|growth substances|mesh-ancestor
44649144|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649145|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
44649146|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
44649147|NCT00262834|Vorinostat|vorinostat|mesh-list
44649148|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649149|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44649150|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649151|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649152|NCT00262821|Cisplatin|cisplatin|mesh-list
44649153|NCT00262821|Tirapazamine|tirapazamine|mesh-list
44649154|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649155|NCT00262600|Warfarin|warfarin|mesh-list
44649156|NCT00262600|Dabigatran|dabigatran|mesh-list
44649157|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
44649158|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
44649159|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44649160|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
44649161|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649162|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649163|NCT00262522|Ritonavir|ritonavir|mesh-list
44649164|NCT00262522|Lopinavir|lopinavir|mesh-list
44649165|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44649166|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44649167|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44649168|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
44649169|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649170|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649171|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44649172|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44649173|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
44649174|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649175|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44649176|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44649177|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44649178|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44649179|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44649180|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649181|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
44649182|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649183|NCT00262223|Sertraline|sertraline|mesh-list
44649184|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
44649185|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649186|NCT00262223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44649187|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649188|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649189|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649190|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649191|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
44649192|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649193|NCT00262080|Ecallantide|ecallantide|mesh-list
44649194|NCT00262080|Analgesics|analgesics|mesh-ancestor
44649195|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
44649196|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649197|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649198|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44649199|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44649200|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649201|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649202|NCT00262067|Bevacizumab|bevacizumab|mesh-list
44649203|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649204|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649205|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44649206|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44649207|NCT00262067|Growth Substances|growth substances|mesh-ancestor
44649208|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649209|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44649210|NCT00262041|Vaccines|vaccines|mesh-list
44649211|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
44649212|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649213|NCT00262028|Vaccines|vaccines|mesh-list
44649214|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
44649215|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649216|NCT00262002|Vaccines|vaccines|mesh-list
44649217|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
44649218|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649219|NCT00261950|Cinacalcet|cinacalcet|mesh-list
44649220|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44649221|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649222|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44649223|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
44649224|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44649225|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
44649226|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44649227|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649228|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649229|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44649230|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44649231|NCT00261495|Oxycodone|oxycodone|mesh-list
44649232|NCT00261495|Hydromorphone|hydromorphone|mesh-list
44649233|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44649234|NCT00261495|Narcotics|narcotics|mesh-ancestor
44649235|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649236|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649237|NCT00261495|Analgesics|analgesics|mesh-ancestor
44649238|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
44649239|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649240|NCT00261443|Valproic Acid|valproic acid|mesh-list
44649241|NCT00261443|Aripiprazole|aripiprazole|mesh-list
44649242|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
44649243|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
44649244|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649245|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44649246|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649247|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649248|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649249|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
44649250|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
44649251|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649252|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649253|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44649254|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44649255|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
44649256|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44649257|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44649258|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44649259|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44649260|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649261|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
44649262|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
44649263|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
44649264|NCT00260832|Cytarabine|cytarabine|mesh-list
44649265|NCT00260832|Decitabine|decitabine|mesh-list
44649266|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649267|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
44649268|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649269|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649270|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
44649271|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649272|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649273|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
44649274|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649276|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44649277|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44649278|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649279|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649280|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649281|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44649282|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649283|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649284|NCT00260208|Cyclosporine|cyclosporine|mesh-list
44649285|NCT00260208|Tacrolimus|tacrolimus|mesh-list
44649286|NCT00260208|Cyclosporins|cyclosporins|mesh-list
44649287|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649288|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
44649289|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649290|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44649291|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649292|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649293|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
44649294|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649295|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649296|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649297|NCT00260065|Decitabine|decitabine|mesh-list
44649298|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649299|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
44649300|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649301|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649302|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649303|NCT00259857|Alendronate|alendronate|mesh-list
44649304|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44649305|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649306|NCT00259740|Denosumab|denosumab|mesh-list
44649307|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44649308|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649309|NCT00259649|Eletriptan|eletriptan|mesh-list
44649310|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44649311|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
44649312|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649313|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649314|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649315|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
44649316|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
44649317|NCT00259610|Etanercept|etanercept|mesh-list
44649318|NCT00259610|Methotrexate|methotrexate|mesh-list
44649319|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44649320|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
44649321|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44649322|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649323|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649324|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
44649325|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649326|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649327|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649328|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649329|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44649330|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649331|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
44649332|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649333|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44649334|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
44649335|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44649336|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44649337|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649338|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44649339|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44649340|NCT00259610|Analgesics|analgesics|mesh-ancestor
44649341|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
44649342|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649343|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649344|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649345|NCT00259298|Teriparatide|teriparatide|mesh-list
44649346|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44200007|NCT00396747|Hormones|hormones|mesh-ancestor
44649347|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649348|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44649349|NCT00259272|Olanzapine|olanzapine|mesh-list
44649350|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
44649351|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
44649352|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649353|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649354|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649355|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44649356|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649357|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649358|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649359|NCT00259272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44649360|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649361|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649362|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649363|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649364|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
44649365|NCT00259012|Pantoprazole|pantoprazole|mesh-list
44649366|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649367|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649368|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649369|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649370|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649371|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
44649372|NCT00258960|Doxorubicin|doxorubicin|mesh-list
44649373|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44649374|NCT00258960|Trastuzumab|trastuzumab|mesh-list
44649375|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649376|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
44649377|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649378|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649379|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44649380|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
44649381|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649382|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649383|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44649384|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916262|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
44649385|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44649386|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44649387|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649388|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649389|NCT00258856|Vaccines|vaccines|mesh-list
44649390|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
44649391|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649392|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
44649393|NCT00258440|Hematinics|hematinics|mesh-ancestor
44649394|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44649395|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649396|NCT00257920|Vitamins|vitamins|mesh-ancestor
44649397|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
44649398|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44649399|NCT00257725|Methylphenidate|methylphenidate|mesh-list
44649400|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44649401|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649402|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44649403|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649404|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649405|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649406|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
44649407|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649408|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
44649409|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44649410|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44649411|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44649412|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649413|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649414|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
44649415|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649416|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649418|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649419|NCT00257608|Bevacizumab|bevacizumab|mesh-list
44649420|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44649421|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649422|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649423|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44649424|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44649425|NCT00257608|Growth Substances|growth substances|mesh-ancestor
44649426|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649427|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
44649428|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649429|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649430|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649431|NCT00257556|Menotropins|menotropins|mesh-list
44649432|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44649433|NCT00257556|Hormones|hormones|mesh-ancestor
44649434|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44649435|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649436|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44649437|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
44649438|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44649439|NCT00257192|Ziprasidone|ziprasidone|mesh-list
44649440|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44649441|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
44649442|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649443|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649444|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649445|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44649446|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649447|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649448|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649449|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44649450|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
44649451|NCT00257166|Ziprasidone|ziprasidone|mesh-list
44649452|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44649453|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
44649454|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649455|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649456|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649457|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44649458|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649459|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649460|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649461|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44649462|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
44649463|NCT00257010|Almotriptan|almotriptan|mesh-list
44649464|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44649465|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
44649466|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649467|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649468|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649469|NCT00256997|Risperidone|risperidone|mesh-list
44649470|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
44649471|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44649472|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
44649473|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649474|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649475|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649476|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649477|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649478|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649479|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44649480|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
44649481|NCT00256854|Ropinirole|ropinirole|mesh-list
44649482|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43916358|NCT00474851|Estrogens|estrogens|mesh-list
44649483|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44649484|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
44649485|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
44649486|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649487|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649488|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649489|NCT00256750|Cyclosporine|cyclosporine|mesh-list
44649490|NCT00256750|Abatacept|abatacept|mesh-list
44649492|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649493|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649494|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649495|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
44649496|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649497|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
44649498|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649499|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649500|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649501|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44649502|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44649503|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649504|NCT00256698|Fulvestrant|fulvestrant|mesh-list
44649505|NCT00256698|Anastrozole|anastrozole|mesh-list
44649506|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44649507|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649508|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44649509|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44649510|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
44649511|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44649512|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649513|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44649514|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44649515|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649516|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649517|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
44649518|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649519|NCT00256295|Gemcitabine|gemcitabine|mesh-list
44649520|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
44649521|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649522|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
44649523|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649524|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649525|NCT00256295|Antiviral Agents|antiviral agents|mesh-ancestor
44649526|NCT00256295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649527|NCT00256295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649528|NCT00256295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649529|NCT00256295|Immunologic Factors|immunologic factors|mesh-ancestor
44649530|NCT00256295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649531|NCT00256282|Docetaxel|docetaxel|mesh-list
44649532|NCT00256282|Vinorelbine|vinorelbine|mesh-list
44649533|NCT00256282|Sargramostim|sargramostim|mesh-list
44649534|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649535|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649536|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649537|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649538|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649539|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649540|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
44649541|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649542|NCT00256243|Paclitaxel|paclitaxel|mesh-list
44649543|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
44649544|NCT00256243|Carboplatin|carboplatin|mesh-list
44649545|NCT00256243|Doxorubicin|doxorubicin|mesh-list
44649546|NCT00256243|Trastuzumab|trastuzumab|mesh-list
44649547|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649548|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649549|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649550|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649551|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649552|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649553|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649554|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
44649555|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649556|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649557|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44649558|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
44649559|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44649560|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44649561|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44649562|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44649563|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649564|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649565|NCT00256204|Rasagiline|rasagiline|mesh-list
44649567|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649568|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916441|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
44649569|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44649570|NCT00256204|Protective Agents|protective agents|mesh-ancestor
44649571|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649572|NCT00255840|Ritonavir|ritonavir|mesh-list
44649573|NCT00255840|Lopinavir|lopinavir|mesh-list
44649574|NCT00255840|Lamivudine|lamivudine|mesh-list
44649575|NCT00255840|Nevirapine|nevirapine|mesh-list
44649576|NCT00255840|Stavudine|stavudine|mesh-list
44649577|NCT00255840|Efavirenz|efavirenz|mesh-list
44649578|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44649579|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44649580|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
44649581|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649582|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649583|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44649584|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44649585|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
44649586|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649587|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44649588|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44649589|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44649590|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44649591|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44649592|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44649593|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44649594|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44649595|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44649596|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
44649597|NCT00255723|Carboplatin|carboplatin|mesh-list
44649598|NCT00255723|Etoposide|etoposide|mesh-list
44649599|NCT00255723|Ifosfamide|ifosfamide|mesh-list
44649600|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649601|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649602|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44649603|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44649604|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649605|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649606|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44649607|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
44649608|NCT00255346|Dasatinib|dasatinib|mesh-list
44649609|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649610|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649611|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649612|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649613|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
44649614|NCT00255190|Lansoprazole|lansoprazole|mesh-list
44649615|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649616|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649617|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649618|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649619|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649620|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
44649621|NCT00255164|Lansoprazole|lansoprazole|mesh-list
44649622|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649623|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649624|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649625|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649626|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649627|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
44649628|NCT00255151|Lansoprazole|lansoprazole|mesh-list
44649629|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649630|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649631|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649632|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649633|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649634|NCT00255086|Memantine|memantine|mesh-list
44649635|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44649636|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44649637|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
44649638|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649639|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649640|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649641|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44649642|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44649643|NCT00255034|Ribavirin|ribavirin|mesh-list
44649644|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44200289|NCT00397956|Ertapenem|ertapenem|mesh-list
44649645|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
44649646|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
44649647|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649648|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
44649649|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649650|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
44649651|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649652|NCT00255008|Ribavirin|ribavirin|mesh-list
44649653|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44649654|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
44649655|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
44649656|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649657|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
44649658|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649659|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
44649660|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649661|NCT00254982|Infliximab|infliximab|mesh-list
44649662|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649663|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649664|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649665|NCT00254566|Azithromycin|azithromycin|mesh-list
44649666|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
44649667|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44649668|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44649669|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649670|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44649671|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44649672|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649673|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649674|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649675|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44649676|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
44649677|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44649678|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649679|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44649680|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44649681|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44649682|NCT00254540|Sunitinib|sunitinib|mesh-list
44649683|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649684|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44649685|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44649686|NCT00254540|Growth Substances|growth substances|mesh-ancestor
43916575|NCT00478192|Conivaptan|conivaptan|mesh-list
44649687|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649688|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
44649689|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649690|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649691|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649692|NCT00254397|Leuprolide|leuprolide|mesh-list
44649693|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44649694|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
44649695|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44649696|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649697|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44649698|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649699|NCT00254293|Abatacept|abatacept|mesh-list
44649700|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44649701|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44649702|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649703|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649704|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649705|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
44649706|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649707|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649708|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
44649709|NCT00254163|Rituximab|rituximab|mesh-list
44649710|NCT00254163|Fludarabine|fludarabine|mesh-list
44649711|NCT00254163|Pentostatin|pentostatin|mesh-list
44649712|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649713|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
44649714|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649716|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44649717|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
44649718|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649719|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649720|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44649721|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649722|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44649723|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649724|NCT00253747|Methylphenidate|methylphenidate|mesh-list
44649725|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44649726|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649727|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44649728|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649729|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649730|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649731|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
44649732|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649733|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44649734|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
44649735|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649736|NCT00253643|Protective Agents|protective agents|mesh-ancestor
44649737|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649738|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44649739|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44649740|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649741|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44649742|NCT00253630|Vorinostat|vorinostat|mesh-list
44649743|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649744|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44649745|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649746|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649747|NCT00253370|Cisplatin|cisplatin|mesh-list
44649748|NCT00253370|Docetaxel|docetaxel|mesh-list
44649749|NCT00253370|Sorafenib|sorafenib|mesh-list
44649750|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649751|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649752|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649753|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649754|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649755|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649756|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649757|NCT00252733|Candesartan|candesartan|mesh-list
44649758|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
44649759|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44649760|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44649761|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44649762|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649763|NCT00252720|Candesartan|candesartan|mesh-list
44649764|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44649765|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44649766|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44649767|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649768|NCT00252694|Candesartan|candesartan|mesh-list
44649769|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44649770|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44649771|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44649772|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649773|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
44649774|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
44649775|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649776|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649777|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649778|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
44649779|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649780|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649781|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649782|NCT00252564|Leucovorin|leucovorin|mesh-list
44649783|NCT00252564|Bevacizumab|bevacizumab|mesh-list
44649784|NCT00252564|Cetuximab|cetuximab|mesh-list
44649785|NCT00252564|Fluorouracil|fluorouracil|mesh-list
44649786|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
44649788|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649789|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44649790|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44649791|NCT00252564|Growth Substances|growth substances|mesh-ancestor
44649792|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649793|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
44649794|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
44649795|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649796|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649797|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649798|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
44649799|NCT00252564|Antidotes|antidotes|mesh-ancestor
44649800|NCT00252564|Protective Agents|protective agents|mesh-ancestor
44649801|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
44649802|NCT00252564|Vitamins|vitamins|mesh-ancestor
44649803|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
44649804|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
44649805|NCT00252499|Fenofibrate|fenofibrate|mesh-list
44649806|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44649807|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649808|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44649809|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
44649810|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649811|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44649812|NCT00252239|Plasminogen|plasminogen|mesh-list
44649813|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44649814|NCT00252239|Tenecteplase|tenecteplase|mesh-list
44649815|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43916716|NCT00480740|Analgesics|analgesics|mesh-ancestor
44649816|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44649817|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649818|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44649819|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
44649820|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649821|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44649822|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
44649823|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649824|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649825|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
44649826|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649827|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649828|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44649829|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44649830|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44649831|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
44649832|NCT00251979|Esomeprazole|esomeprazole|mesh-list
44649833|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649834|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649835|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649836|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649837|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649838|NCT00251927|Esomeprazole|esomeprazole|mesh-list
44649839|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649840|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649841|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649842|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649843|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649844|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
44649845|NCT00251758|Lansoprazole|lansoprazole|mesh-list
44649846|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649847|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649848|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649849|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649850|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649851|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
44649852|NCT00251745|Lansoprazole|lansoprazole|mesh-list
44649853|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649854|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649855|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649856|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649857|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649858|NCT00251719|Lansoprazole|lansoprazole|mesh-list
44649859|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
44649860|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649861|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649862|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649863|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649864|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649865|NCT00251693|Lansoprazole|lansoprazole|mesh-list
44649866|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
44649867|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44649868|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649869|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44649870|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649871|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649872|NCT00251641|Methotrexate|methotrexate|mesh-list
44649873|NCT00251641|Infliximab|infliximab|mesh-list
44649874|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44649875|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
44649876|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43916769|NCT00482911|Lenalidomide|lenalidomide|mesh-list
44649877|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649878|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649879|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
44649880|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649881|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649882|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649883|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649884|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44649885|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649886|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
44649887|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649888|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44649889|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649890|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44649891|NCT00251589|Vorinostat|vorinostat|mesh-list
44649892|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649893|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44649894|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649895|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649896|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44649897|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
44649898|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
44649899|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649900|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649901|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649902|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
44649903|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649904|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649905|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649906|NCT00251004|Cyclosporine|cyclosporine|mesh-list
44649907|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
44649908|NCT00251004|Everolimus|everolimus|mesh-list
44649909|NCT00251004|Cyclosporins|cyclosporins|mesh-list
44649910|NCT00251004|Basiliximab|basiliximab|mesh-list
44649911|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649912|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649913|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44649914|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
44649915|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649916|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
44649917|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649918|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44649919|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649920|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44649921|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649922|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44200593|NCT00399048|Narcotics|narcotics|mesh-ancestor
44649923|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44649924|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
44649925|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43916819|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
44649926|NCT00250835|Celecoxib|celecoxib|mesh-list
44649927|NCT00250835|Capecitabine|capecitabine|mesh-list
44649928|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
44649929|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44649930|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
44649931|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649932|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649933|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44649934|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44649936|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
44649937|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649938|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649939|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649940|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649941|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44649942|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44649943|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649944|NCT00250718|Levofloxacin|levofloxacin|mesh-list
44649945|NCT00250718|Ofloxacin|ofloxacin|mesh-list
44649946|NCT00250718|Dexamethasone|dexamethasone|mesh-list
44649947|NCT00250718|Rituximab|rituximab|mesh-list
44649948|NCT00250718|Etoposide|etoposide|mesh-list
44649949|NCT00250718|Vincristine|vincristine|mesh-list
44649950|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44649951|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44649952|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
44649953|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649954|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44649955|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44649956|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
44649957|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
44649958|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44649959|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44649960|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
44649961|NCT00250718|Hormones|hormones|mesh-ancestor
44649962|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44649963|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44649964|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44649965|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44649966|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44649967|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44649968|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649969|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
44649970|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
44649971|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
44649972|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44649973|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44649974|NCT00250718|Renal Agents|renal agents|mesh-ancestor
44649975|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44649976|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44649977|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44649978|NCT00250705|Aripiprazole|aripiprazole|mesh-list
44649979|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
44649980|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44649981|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44649982|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44649983|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44649984|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44649985|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
44649986|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
44649987|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44649988|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44649989|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44649990|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44649991|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
44649992|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44649993|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44649994|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44649995|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44649996|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
44649997|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44649998|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
44649999|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650000|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650001|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44650002|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
44650003|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44650004|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44650005|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44650006|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
44650007|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44045108|NCT00003116|Cyclosporine|cyclosporine|mesh-list
44650008|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650010|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
44650011|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650012|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650013|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650014|NCT00249873|Clopidogrel|clopidogrel|mesh-list
44650015|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44650016|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44650017|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44650018|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44650019|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
44650020|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650021|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650022|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650023|NCT00249808|Antibodies|antibodies|mesh-list
44650024|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44650025|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
44650026|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650027|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
44650028|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44650029|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
44650030|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650031|NCT00248625|Expectorants|expectorants|mesh-ancestor
44650032|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
44650033|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44650034|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
44650035|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650036|NCT00248625|Protective Agents|protective agents|mesh-ancestor
44650037|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650038|NCT00248625|Antidotes|antidotes|mesh-ancestor
44650039|NCT00247676|Sunitinib|sunitinib|mesh-list
44650040|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650041|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650042|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650043|NCT00247676|Growth Substances|growth substances|mesh-ancestor
44650044|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650045|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650046|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650047|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650048|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650049|NCT00246571|Sunitinib|sunitinib|mesh-list
44650050|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650051|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650052|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650053|NCT00246571|Growth Substances|growth substances|mesh-ancestor
44650054|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650055|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650056|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650057|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650058|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650059|NCT00246337|Rizatriptan|rizatriptan|mesh-list
44650060|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44650061|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
44650062|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916948|NCT00489086|Tazarotene|tazarotene|mesh-list
43916952|NCT00489281|Sirolimus|sirolimus|mesh-list
44650063|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650064|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650065|NCT00243503|Trastuzumab|trastuzumab|mesh-list
44650066|NCT00243503|Sunitinib|sunitinib|mesh-list
44650067|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650068|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650069|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650070|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650071|NCT00243503|Growth Substances|growth substances|mesh-ancestor
44650072|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650073|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650074|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650075|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650076|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650077|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
44650078|NCT00242710|Estrogens|estrogens|mesh-list
44650079|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44650080|NCT00242710|Hormones|hormones|mesh-ancestor
44045185|NCT00003125|Aldesleukin|aldesleukin|mesh-list
44650081|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650082|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650083|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44650084|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44650085|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
44650086|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44650087|NCT00242216|Ritonavir|ritonavir|mesh-list
44650088|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44650089|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
44650090|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44650091|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44650092|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44650093|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650094|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650095|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44650096|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44650097|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
44650098|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650099|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44650100|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44650101|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
44650102|NCT00240994|Sirolimus|sirolimus|mesh-list
44650103|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
44650104|NCT00240994|Tacrolimus|tacrolimus|mesh-list
44650105|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650106|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
44650107|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650108|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44650109|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650110|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650111|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44650112|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650113|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44650114|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
44650115|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44650116|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650117|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
44650118|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650119|NCT00240110|Valproic Acid|valproic acid|mesh-list
44650120|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
44650121|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650122|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650123|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650124|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650125|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
44650126|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650127|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650128|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650129|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
44650130|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
44650131|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650132|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
44650133|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
44650134|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650135|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650136|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44650137|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44650138|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44650139|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
44650140|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650141|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44650142|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44650143|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650144|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
44650145|NCT00239590|Testosterone|testosterone|mesh-list
44650146|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
44650147|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
44650148|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44650149|NCT00239590|Androgens|androgens|mesh-ancestor
44650150|NCT00239590|Hormones|hormones|mesh-ancestor
44650151|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650152|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650153|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44650154|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650155|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
44650156|NCT00239356|Aripiprazole|aripiprazole|mesh-list
44650157|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650158|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650159|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650160|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650161|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650162|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650163|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
44650164|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
44650165|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650166|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650167|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44650168|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44650169|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
44650170|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44650171|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650172|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44650173|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44650174|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
44650175|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44650176|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650177|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44650178|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
44650179|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44650180|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650181|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650182|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650183|NCT00238433|Melphalan|melphalan|mesh-list
44650184|NCT00238433|Busulfan|busulfan|mesh-list
44650185|NCT00238433|Thiotepa|thiotepa|mesh-list
44650186|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
44650187|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650188|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44650189|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
44650190|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650191|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650192|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44650193|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650194|NCT00238303|Vorinostat|vorinostat|mesh-list
44650195|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650196|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44650197|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917098|NCT00492206|Cetuximab|cetuximab|mesh-list
44650198|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650199|NCT00238238|Rituximab|rituximab|mesh-list
44650200|NCT00238238|Lenalidomide|lenalidomide|mesh-list
44650201|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650202|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650203|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
44650204|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650205|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650206|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650207|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650208|NCT00238238|Growth Substances|growth substances|mesh-ancestor
44650209|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650210|NCT00238121|Sorafenib|sorafenib|mesh-list
44650211|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650212|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650213|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650214|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650215|NCT00237458|Lacosamide|lacosamide|mesh-list
44650216|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
44650217|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44650218|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44650219|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650220|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650221|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
44650222|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650223|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650224|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650225|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650226|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
44650227|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44650228|NCT00237042|Estradiol|estradiol|mesh-list
44650229|NCT00237042|Estrogens|estrogens|mesh-ancestor
44650230|NCT00237042|Hormones|hormones|mesh-ancestor
44650231|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650232|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650233|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44650234|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
44650235|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44650236|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44650237|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44650238|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44650239|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44650240|NCT00236899|Gemcitabine|gemcitabine|mesh-list
44650241|NCT00236899|Paclitaxel|paclitaxel|mesh-list
44650242|NCT00236899|Docetaxel|docetaxel|mesh-list
44650243|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44650244|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650245|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44650246|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44650247|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44650248|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650249|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650250|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
44650251|NCT00236899|Antiviral Agents|antiviral agents|mesh-ancestor
44650252|NCT00236899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650253|NCT00236899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650254|NCT00236899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650255|NCT00236899|Immunologic Factors|immunologic factors|mesh-ancestor
44650256|NCT00236899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650257|NCT00236197|Rabeprazole|rabeprazole|mesh-list
44650258|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44650259|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650260|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44650261|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650262|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650263|NCT00236184|Rabeprazole|rabeprazole|mesh-list
44650264|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44650265|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650266|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44650267|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650268|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650269|NCT00236080|Modafinil|modafinil|mesh-list
44650270|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44650271|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650272|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44650273|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44650274|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44650275|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650276|NCT00235989|Interferons|interferons|mesh-list
44650277|NCT00235989|Interferon-beta|interferon-beta|mesh-list
44650278|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
44650279|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650280|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
44650281|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650282|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
44650283|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650284|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44650285|NCT00235872|Adalimumab|adalimumab|mesh-list
44650286|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650287|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650288|NCT00235755|Ezogabine|ezogabine|mesh-list
44650289|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
44650290|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650291|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650292|NCT00235716|Vitamins|vitamins|mesh-list
44650293|NCT00235716|Vitamin E|vitamin e|mesh-list
44650294|NCT00235716|Tocopherols|tocopherols|mesh-list
44650295|NCT00235716|Tocotrienols|tocotrienols|mesh-list
44650296|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
44650297|NCT00235716|Memantine|memantine|mesh-list
44650298|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
44650299|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650300|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
44650301|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650302|NCT00235716|Protective Agents|protective agents|mesh-ancestor
44650303|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43775592|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
44650304|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44650305|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
44650306|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650307|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44650308|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44650309|NCT00235443|Lacosamide|lacosamide|mesh-list
44650310|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
43917214|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
44650311|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44650312|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44650313|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650314|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650315|NCT00235391|Deferasirox|deferasirox|mesh-list
44650316|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44650317|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
44650318|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
44650319|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650320|NCT00234494|Gemcitabine|gemcitabine|mesh-list
44650321|NCT00234494|Bevacizumab|bevacizumab|mesh-list
44650322|NCT00234494|Cisplatin|cisplatin|mesh-list
44650323|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650324|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650325|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650326|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650327|NCT00234494|Growth Substances|growth substances|mesh-ancestor
44650328|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650329|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650330|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650331|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
44650332|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650333|NCT00234494|Antiviral Agents|antiviral agents|mesh-ancestor
44650334|NCT00234494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650335|NCT00234494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650336|NCT00234494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650337|NCT00234494|Immunologic Factors|immunologic factors|mesh-ancestor
44650338|NCT00234104|Tolvaptan|tolvaptan|mesh-list
44650339|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44650340|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650341|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
44650342|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650343|NCT00234065|Aspirin|aspirin|mesh-list
44650344|NCT00234065|Cilostazol|cilostazol|mesh-list
44650345|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44650346|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44650347|NCT00234065|Analgesics|analgesics|mesh-ancestor
44650348|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
44650349|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917250|NCT00496379|Sagopilone|sagopilone|mesh-list
44650350|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650351|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650352|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650353|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44650354|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44650355|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650356|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44650357|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44650358|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650359|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
44650360|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44650361|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
44650362|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44650363|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
44650364|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44650365|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44650366|NCT00234065|Protective Agents|protective agents|mesh-ancestor
44650367|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44650368|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44650369|NCT00234052|Bevacizumab|bevacizumab|mesh-list
44650370|NCT00234052|Carboplatin|carboplatin|mesh-list
44650371|NCT00234052|Pemetrexed|pemetrexed|mesh-list
44650372|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650373|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650374|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650375|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650376|NCT00234052|Growth Substances|growth substances|mesh-ancestor
44650377|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650378|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650379|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650380|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650381|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44650382|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44650383|NCT00234039|Gemcitabine|gemcitabine|mesh-list
44650384|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650385|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
44650386|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650387|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650388|NCT00234039|Antiviral Agents|antiviral agents|mesh-ancestor
44650389|NCT00234039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650390|NCT00234039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650391|NCT00234039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650392|NCT00234039|Immunologic Factors|immunologic factors|mesh-ancestor
44650393|NCT00234039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650394|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
44650395|NCT00233987|Melphalan|melphalan|mesh-list
44650396|NCT00233987|Carmustine|carmustine|mesh-list
44650397|NCT00233987|Etoposide|etoposide|mesh-list
44650398|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650399|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
44650400|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650401|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650402|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44650403|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
44650404|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650405|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650406|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44650407|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44650408|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44650409|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44650410|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650411|NCT00233948|Nelfinavir|nelfinavir|mesh-list
44650412|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44650413|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44650414|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
44650415|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650416|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650417|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44650418|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44650419|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
44650420|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650421|NCT00233480|Atorvastatin|atorvastatin|mesh-list
44650422|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44650423|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44650424|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
44650425|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650426|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44650427|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44650428|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650429|NCT00233454|Midostaurin|midostaurin|mesh-list
44650430|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650431|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650432|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650433|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650434|NCT00233389|Rebamipide|rebamipide|mesh-list
44650435|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44650436|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650437|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
44650438|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650439|NCT00233389|Protective Agents|protective agents|mesh-ancestor
44650440|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650441|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650442|NCT00233363|Rebamipide|rebamipide|mesh-list
44650443|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44650444|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650445|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
44650446|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201093|NCT00400855|Xhance|xhance|mesh-list
44650447|NCT00233363|Protective Agents|protective agents|mesh-ancestor
44650448|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650449|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650450|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44650451|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44650452|NCT00233064|Palivizumab|palivizumab|mesh-list
44650453|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
44650454|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650455|NCT00232596|Ezogabine|ezogabine|mesh-list
44650456|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
44650457|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650458|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650459|NCT00232180|Eplerenone|eplerenone|mesh-list
44650460|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44650461|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
44650462|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650463|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650464|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44650465|NCT00232180|Diuretics|diuretics|mesh-ancestor
44650466|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
44650467|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44650468|NCT00231894|Pioglitazone|pioglitazone|mesh-list
44650469|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44650470|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650471|NCT00231842|Cisplatin|cisplatin|mesh-list
44650472|NCT00231842|Ifosfamide|ifosfamide|mesh-list
44650473|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650474|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44650475|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
44650476|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650477|NCT00231777|Ondansetron|ondansetron|mesh-list
44650478|NCT00231777|Aprepitant|aprepitant|mesh-list
44650479|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
44650480|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
44650481|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650482|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650483|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650484|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
44650485|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44650486|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650487|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
44650488|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650489|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650490|NCT00231777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650491|NCT00231777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650492|NCT00231777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650493|NCT00231777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650494|NCT00231777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44650495|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44650496|NCT00231478|Granisetron|granisetron|mesh-list
44650497|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
44650498|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
44650499|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650500|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650501|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650502|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650503|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
44650504|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139125|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44650505|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650506|NCT00231465|Docetaxel|docetaxel|mesh-list
44650507|NCT00231465|Gefitinib|gefitinib|mesh-list
44650508|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650509|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
44650510|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
44650511|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
44650512|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650513|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650514|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650515|NCT00230971|Metronidazole|metronidazole|mesh-list
44650516|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
44650517|NCT00230971|Tigecycline|tigecycline|mesh-list
44650518|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650519|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44650520|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44650521|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44650522|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44650523|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650524|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650525|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
44650526|NCT00230282|Fludarabine|fludarabine|mesh-list
44650527|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
44650528|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650529|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
44650530|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650531|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650532|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44650533|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
44650534|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650535|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650536|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44650537|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650539|NCT00230178|Rasburicase|rasburicase|mesh-list
44650540|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
44650541|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650542|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650543|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
44650544|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650545|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44650546|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
44650547|NCT00230178|Protective Agents|protective agents|mesh-ancestor
44650548|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650549|NCT00229931|Triamcinolone|triamcinolone|mesh-list
44650550|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44650551|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44650552|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44650553|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650554|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
44650555|NCT00229931|Hormones|hormones|mesh-ancestor
44650556|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650557|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650558|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650559|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
44650560|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650561|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650562|NCT00229723|Cisplatin|cisplatin|mesh-list
44650563|NCT00229723|Gefitinib|gefitinib|mesh-list
44650564|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650565|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650566|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650567|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650568|NCT00229658|Pramlintide|pramlintide|mesh-list
44650569|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44650570|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650571|NCT00228813|Lenograstim|lenograstim|mesh-list
44650572|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44650573|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
44650574|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650575|NCT00228566|Modafinil|modafinil|mesh-list
44650576|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44650577|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650578|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44650579|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44650580|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44650581|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650582|NCT00228553|Modafinil|modafinil|mesh-list
44650583|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44650584|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650585|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44650586|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44650587|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44650588|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650589|NCT00228423|Clopidogrel|clopidogrel|mesh-list
44650590|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43917409|NCT00500578|Ribavirin|ribavirin|mesh-list
44650591|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44650592|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44650593|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44650594|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
44650595|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650596|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650597|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650598|NCT00227721|Gemcitabine|gemcitabine|mesh-list
44650599|NCT00227721|Docetaxel|docetaxel|mesh-list
44650600|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650601|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
43775771|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
44650602|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650603|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650604|NCT00227721|Antiviral Agents|antiviral agents|mesh-ancestor
44650605|NCT00227721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650606|NCT00227721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650607|NCT00227721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650608|NCT00227721|Immunologic Factors|immunologic factors|mesh-ancestor
44650609|NCT00227721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201242|NCT00401596|Omalizumab|omalizumab|mesh-list
44650611|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
44650612|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
44650613|NCT00227591|Prednisone|prednisone|mesh-list
44650614|NCT00227591|Lenalidomide|lenalidomide|mesh-list
44650615|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650616|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
44650617|NCT00227591|Hormones|hormones|mesh-ancestor
44650618|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650619|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650620|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44650621|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650622|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
44650623|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650624|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650625|NCT00227591|Growth Substances|growth substances|mesh-ancestor
44650626|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650627|NCT00227539|Cisplatin|cisplatin|mesh-list
44650628|NCT00227539|Pemetrexed|pemetrexed|mesh-list
44650629|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44650630|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650631|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650632|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650633|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44650634|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44650635|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44650636|NCT00227370|Valganciclovir|valganciclovir|mesh-list
44650637|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
44650638|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650639|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44650640|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44650641|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650642|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650643|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650644|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650645|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650646|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650647|NCT00227266|Valproic Acid|valproic acid|mesh-list
44650648|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
44650649|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650650|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650651|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
44650652|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650653|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650654|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
44650655|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650656|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650657|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650658|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
44650659|NCT00226941|Promethazine|promethazine|mesh-list
44650660|NCT00226941|Capecitabine|capecitabine|mesh-list
44650661|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
44650662|NCT00226941|Cetuximab|cetuximab|mesh-list
44650663|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650664|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
44650665|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650666|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650667|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650668|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44650669|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44650670|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650671|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917509|NCT00502905|Fludarabine|fludarabine|mesh-list
44650672|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44650673|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
44650674|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
44650675|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650676|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
44650677|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
44650678|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650680|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
44650681|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
44650682|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650683|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44650684|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
44650685|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44650686|NCT00226811|Sunitinib|sunitinib|mesh-list
44650687|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650688|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650689|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650690|NCT00226811|Growth Substances|growth substances|mesh-ancestor
44650691|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650692|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650693|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650694|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650695|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650696|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44650697|NCT00226655|Hormones|hormones|mesh-ancestor
44650698|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44650699|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650700|NCT00225758|Lapatinib|lapatinib|mesh-list
43917537|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650701|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650702|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44650703|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650704|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650705|NCT00225277|Pioglitazone|pioglitazone|mesh-list
44650706|NCT00225277|Glimepiride|glimepiride|mesh-list
44650707|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44650708|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650709|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44650710|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650711|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
44650712|NCT00225251|Bupropion|bupropion|mesh-list
44650713|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44650714|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650715|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650716|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44650717|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44650718|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650719|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650720|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
44650721|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650722|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650723|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44650724|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44650725|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650726|NCT00225212|Rituximab|rituximab|mesh-list
44650727|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650728|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650729|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
44650730|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917585|NCT00504751|Rituximab|rituximab|mesh-list
44650731|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650732|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44650733|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44650734|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650735|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
44650736|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650737|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
44650738|NCT00224874|Etanercept|etanercept|mesh-list
44650739|NCT00224874|Pentostatin|pentostatin|mesh-list
44650740|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
44650741|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44650742|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650743|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44650744|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
44650745|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44650746|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650747|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650748|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650749|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44650750|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44650751|NCT00224874|Analgesics|analgesics|mesh-ancestor
44650752|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
44650753|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650754|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650755|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650756|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44650757|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650758|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650759|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
44650760|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44650761|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44650762|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44650763|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44650764|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650765|NCT00224484|Vaccines|vaccines|mesh-list
44650766|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
44650767|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650768|NCT00224133|Silodosin|silodosin|mesh-list
44650769|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44650770|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44650771|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44650772|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
44650773|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650774|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650775|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650776|NCT00224133|Urological Agents|urological agents|mesh-ancestor
44650777|NCT00224120|Silodosin|silodosin|mesh-list
44650778|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44650779|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44650780|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44650781|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44650782|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650783|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650784|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650785|NCT00224120|Urological Agents|urological agents|mesh-ancestor
44650786|NCT00224107|Silodosin|silodosin|mesh-list
44650787|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44650788|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44650789|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44650790|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
44650791|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650792|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650793|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650794|NCT00224107|Urological Agents|urological agents|mesh-ancestor
44650795|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
44650796|NCT00224055|Hematinics|hematinics|mesh-ancestor
44650797|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
44650798|NCT00224042|Hematinics|hematinics|mesh-ancestor
44650799|NCT00224029|Oxybutynin|oxybutynin|mesh-list
44650800|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
44650801|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
44650802|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650803|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650804|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44650805|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44650806|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
44650807|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650808|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650809|NCT00224029|Urological Agents|urological agents|mesh-ancestor
44650810|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
44650811|NCT00224016|Oxybutynin|oxybutynin|mesh-list
44650812|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
44650813|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
44650814|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650815|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650816|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44650817|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44650818|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
44650819|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650820|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650821|NCT00224016|Urological Agents|urological agents|mesh-ancestor
44650822|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44650823|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650824|NCT00224016|Renal Agents|renal agents|mesh-ancestor
44650825|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
44650826|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
44650827|NCT00223977|Hematinics|hematinics|mesh-ancestor
44650828|NCT00223496|Aripiprazole|aripiprazole|mesh-list
44650829|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650830|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650831|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650832|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650833|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650834|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650835|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
44650836|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
44650837|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650838|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650839|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44650840|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44650841|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
44650842|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44650843|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650844|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44650845|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44650846|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44650847|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
44650848|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650849|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44650850|NCT00223080|Antacids|antacids|mesh-ancestor
44650851|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650852|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650853|NCT00222729|Bevacizumab|bevacizumab|mesh-list
44650854|NCT00222729|Pemetrexed|pemetrexed|mesh-list
44650855|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44650856|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650857|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917691|NCT00506597|Asparaginase|asparaginase|mesh-list
44650858|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650859|NCT00222729|Growth Substances|growth substances|mesh-ancestor
44650860|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650861|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650862|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650863|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650864|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44650865|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44650866|NCT00222105|Thalidomide|thalidomide|mesh-list
44650867|NCT00222105|Dexamethasone|dexamethasone|mesh-list
44650868|NCT00222105|Doxorubicin|doxorubicin|mesh-list
44650869|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44650870|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44650871|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
44650872|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
44650873|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650874|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650875|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44650876|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
44650877|NCT00222105|Hormones|hormones|mesh-ancestor
44650878|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917734|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
44650879|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44650880|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44650881|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44650882|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44650883|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44650884|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650885|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650886|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44650887|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
44650888|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
44650889|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44650890|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44650891|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44650892|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44650893|NCT00222105|Growth Substances|growth substances|mesh-ancestor
44650894|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
44650895|NCT00221403|Valproic Acid|valproic acid|mesh-list
44650896|NCT00221403|Risperidone|risperidone|mesh-list
44650897|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44650898|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650899|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
44650900|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650901|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650902|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650903|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650904|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650905|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44650906|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650907|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44201545|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650908|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
44650909|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
44650910|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650911|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
44650912|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
44650913|NCT00221195|Thrombin|thrombin|mesh-list
44650914|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
44650915|NCT00221195|Coagulants|coagulants|mesh-ancestor
44650916|NCT00221104|Pravastatin|pravastatin|mesh-list
44650917|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44650918|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44650919|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
44650920|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650921|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44650922|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44650923|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44650924|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
44650925|NCT00220805|Antibodies|antibodies|mesh-list
44650926|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
44650927|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44650928|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44650929|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
44650930|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
44650931|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650932|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
44650933|NCT00220779|Antibodies|antibodies|mesh-list
44650934|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
44650935|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44650936|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44650937|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
44650938|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
44650939|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650940|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
44650941|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44650942|NCT00220740|Antibodies|antibodies|mesh-list
44650943|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
44650944|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44650945|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
44650946|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
44650947|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650948|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
44650949|NCT00220727|Antibodies|antibodies|mesh-list
44650950|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
44650951|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44650952|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44650953|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
44650954|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
44650955|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650956|NCT00220701|Dexetimide|dexetimide|mesh-list
44650957|NCT00220701|Citalopram|citalopram|mesh-list
44650958|NCT00220701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44650959|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44650960|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44650961|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650962|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650963|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
44650964|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650965|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44650966|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650967|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650968|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44650969|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44650970|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
44650971|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
44650972|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44650973|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44650974|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44650975|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
44650976|NCT00220636|Aripiprazole|aripiprazole|mesh-list
44650977|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
44650978|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44650979|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44650980|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44650981|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201622|NCT00402623|Protective Agents|protective agents|mesh-ancestor
44650982|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44650983|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
44650984|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
44650985|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44650986|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650987|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44650988|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44650990|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44650991|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44650992|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44650993|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44650994|NCT00219557|Gemcitabine|gemcitabine|mesh-list
44650995|NCT00219557|Axitinib|axitinib|mesh-list
44650996|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44650997|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
44650998|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44650999|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651000|NCT00219557|Antiviral Agents|antiviral agents|mesh-ancestor
44651001|NCT00219557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651002|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651003|NCT00219557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651004|NCT00219557|Immunologic Factors|immunologic factors|mesh-ancestor
44651005|NCT00219557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651006|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44651007|NCT00219544|Pregabalin|pregabalin|mesh-list
44651008|NCT00219544|Analgesics|analgesics|mesh-ancestor
44651009|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
44651010|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651011|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651012|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
44651013|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44651014|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651015|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651016|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44651017|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44651018|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651019|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651020|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651021|NCT00219141|Losartan|losartan|mesh-list
44651022|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44651023|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44651024|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44651025|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44651026|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651027|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44651028|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44651029|NCT00213135|Cladribine|cladribine|mesh-list
44651030|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651031|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651032|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
44651033|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651034|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44651035|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44651036|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651037|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651038|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651039|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651040|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651041|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44651042|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651043|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651044|NCT00211081|Spironolactone|spironolactone|mesh-list
44651045|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44651046|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
44651047|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651048|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651049|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44651051|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
44651052|NCT00209560|Fospropofol|fospropofol|mesh-list
44651053|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44651054|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651055|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651056|NCT00209170|Citalopram|citalopram|mesh-list
44651057|NCT00209170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44651058|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651059|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651060|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651061|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651062|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
44651063|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651064|NCT00209170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44651065|NCT00209170|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651066|NCT00209170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651067|NCT00209131|Tamsulosin|tamsulosin|mesh-list
44651068|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44651069|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44651070|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44651071|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651072|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651073|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651074|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651075|NCT00209131|Urological Agents|urological agents|mesh-ancestor
44651076|NCT00209092|Docetaxel|docetaxel|mesh-list
44651077|NCT00209092|Capecitabine|capecitabine|mesh-list
44651078|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651079|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651080|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651081|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651082|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651083|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651084|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
44651085|NCT00209027|Aripiprazole|aripiprazole|mesh-list
44651086|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651087|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651088|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651089|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651090|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651091|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651092|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
44651093|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
44651094|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651095|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651096|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44651097|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44651098|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
44651099|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44651100|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44651101|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44651102|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44651103|NCT00208767|Valsartan|valsartan|mesh-list
44651104|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43917967|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651105|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44651106|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44651107|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651108|NCT00207740|Golimumab|golimumab|mesh-list
44651109|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44651110|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651111|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651112|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
44651113|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651114|NCT00207727|Ustekinumab|ustekinumab|mesh-list
44651115|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651116|NCT00207714|Golimumab|golimumab|mesh-list
44651117|NCT00207714|Infliximab|infliximab|mesh-list
44651118|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651119|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651120|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651121|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44651122|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651123|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651124|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
44651125|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651126|NCT00207142|Ritonavir|ritonavir|mesh-list
44651127|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44651128|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44651129|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44651130|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
44651131|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651132|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651133|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44651134|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44651135|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
44651136|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917987|NCT00515021|Eplerenone|eplerenone|mesh-list
44651137|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44651138|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44651139|NCT00207090|Rifampin|rifampin|mesh-list
44651140|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44651141|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
44651142|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44651143|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651144|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
44651145|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44651146|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651147|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651148|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44651149|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44651150|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44651151|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44651152|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44651153|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44651154|NCT00206726|Fludarabine|fludarabine|mesh-list
44651155|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
44651156|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651157|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651158|NCT00206518|Docetaxel|docetaxel|mesh-list
44651159|NCT00206518|Doxorubicin|doxorubicin|mesh-list
44651160|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44651161|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
44651162|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651163|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651164|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651165|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651166|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651167|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651168|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44651169|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44651170|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651171|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651172|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
44651173|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651174|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651175|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651176|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
44651177|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44651178|NCT00206440|Esomeprazole|esomeprazole|mesh-list
44651179|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44651180|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651181|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44651182|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651183|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651184|NCT00206427|Lapatinib|lapatinib|mesh-list
44651185|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651186|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44651187|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651188|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651189|NCT00206375|Hormones|hormones|mesh-list
44651190|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651191|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651192|NCT00206323|Topiramate|topiramate|mesh-list
44651193|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
44651194|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44651195|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651196|NCT00206102|Risperidone|risperidone|mesh-list
44651197|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44651198|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44651199|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
44651200|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651201|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651202|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651203|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651204|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651205|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651206|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651207|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44651209|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651210|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
44651211|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651212|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651213|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44651214|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
44651215|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44651216|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651217|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651218|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651219|NCT00205803|Vaccines|vaccines|mesh-list
44651220|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44651221|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
44651222|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651223|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
44651224|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44651225|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44651226|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
44651227|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651228|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918108|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44651229|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44651230|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
44651231|NCT00205712|Ketamine|ketamine|mesh-list
44651232|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44651233|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651234|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651235|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651236|NCT00205712|Analgesics|analgesics|mesh-ancestor
44651237|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
44651238|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651239|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44651240|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44651241|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44651242|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651243|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918109|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918110|NCT00517010|Ranibizumab|ranibizumab|mesh-list
44651244|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651245|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44651246|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44651247|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
44651248|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
44651249|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44651250|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44651251|NCT00205699|Olanzapine|olanzapine|mesh-list
44651252|NCT00205699|Risperidone|risperidone|mesh-list
44651253|NCT00205699|Aripiprazole|aripiprazole|mesh-list
44651254|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44651255|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
44651256|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651257|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651258|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651259|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651260|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651261|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651262|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651263|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44651264|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
44651265|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
44651266|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
44651267|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651268|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651269|NCT00205699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44651270|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651271|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651272|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651273|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
44651274|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44651275|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44651276|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44201927|NCT00403858|Lactulose|lactulose|mesh-list
44651277|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44651279|NCT00203996|Leuprolide|leuprolide|mesh-list
44651280|NCT00203996|Estrogens|estrogens|mesh-list
44651281|NCT00203996|Progestins|progestins|mesh-list
44651282|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44651283|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651284|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44651285|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
44651286|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44651287|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651288|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651289|NCT00203996|Hormones|hormones|mesh-ancestor
44651290|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651291|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
44651292|NCT00203502|Bevacizumab|bevacizumab|mesh-list
44651293|NCT00203502|Docetaxel|docetaxel|mesh-list
44651294|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651295|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
44651296|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651297|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651298|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651299|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
44651300|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651301|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651302|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44651303|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651304|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44651305|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44651306|NCT00203502|Growth Substances|growth substances|mesh-ancestor
44651307|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
44651308|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651309|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651310|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651311|NCT00203476|Niacin|niacin|mesh-list
44651312|NCT00203476|Ezetimibe|ezetimibe|mesh-list
44651313|NCT00203476|Colestipol|colestipol|mesh-list
44651314|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44651315|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44651316|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
44651317|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651318|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44651319|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
44651320|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
44651321|NCT00203476|Vitamins|vitamins|mesh-ancestor
44651322|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
44651323|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651324|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
44651325|NCT00203424|Bevacizumab|bevacizumab|mesh-list
44651326|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44651327|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651328|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651329|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44651330|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44651331|NCT00203424|Growth Substances|growth substances|mesh-ancestor
44651332|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651333|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
44651334|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44651335|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651336|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651337|NCT00203411|Bevacizumab|bevacizumab|mesh-list
44651338|NCT00203411|Capecitabine|capecitabine|mesh-list
44651339|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651340|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651341|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44651342|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44651343|NCT00203411|Growth Substances|growth substances|mesh-ancestor
44651344|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651345|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
44651346|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651347|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
44651348|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651350|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
44651351|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
44651352|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651353|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651354|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651355|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651356|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651357|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651358|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651359|NCT00203307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44651360|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651361|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651362|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651363|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651364|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
44651365|NCT00203294|Triamcinolone|triamcinolone|mesh-list
44651366|NCT00203294|Lidocaine|lidocaine|mesh-list
44651367|NCT00203294|Bupivacaine|bupivacaine|mesh-list
44651368|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
44651369|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
44651370|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651371|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651372|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
44651373|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651374|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44651375|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44651376|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44651377|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651378|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651379|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651380|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
44651381|NCT00203294|Hormones|hormones|mesh-ancestor
44651382|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651383|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
44651384|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44651385|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
44651386|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
44651387|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651388|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651389|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651390|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651391|NCT00203268|Analgesics|analgesics|mesh-ancestor
44651392|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
44651393|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651394|NCT00203242|Valproic Acid|valproic acid|mesh-list
44651395|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
44651396|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651397|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651398|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
44651399|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651400|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651401|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
44651402|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651403|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651404|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651405|NCT00203047|Prednisone|prednisone|mesh-list
44651406|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
44651407|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
44651408|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651409|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
44651410|NCT00203047|Hormones|hormones|mesh-ancestor
44651411|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651412|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651413|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651414|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651415|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651416|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
44651417|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651418|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651419|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
44651420|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
44202069|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651421|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651422|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
44651423|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651424|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651425|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651426|NCT00202878|Simvastatin|simvastatin|mesh-list
44651427|NCT00202878|Ezetimibe|ezetimibe|mesh-list
44651428|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44651429|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44651430|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44651431|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
44651432|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651433|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918220|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651434|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44651435|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651436|NCT00202839|Ribavirin|ribavirin|mesh-list
44651437|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44651438|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
44651439|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
44651440|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651441|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
44651442|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651443|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
44651444|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651445|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
44651446|NCT00202644|Anagrelide|anagrelide|mesh-list
44651447|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651448|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
44651449|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651450|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651451|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44651452|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44651453|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44651454|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44651455|NCT00201851|Tamoxifen|tamoxifen|mesh-list
44651456|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44651457|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
43918270|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44651458|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651459|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651460|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651461|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651462|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44651463|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44651464|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44651465|NCT00201643|Dexamethasone|dexamethasone|mesh-list
44651466|NCT00201643|Betamethasone|betamethasone|mesh-list
44651467|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651468|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
44651469|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
44651470|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651471|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651472|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651473|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
44651474|NCT00201643|Hormones|hormones|mesh-ancestor
44651475|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651476|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651477|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651478|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44651479|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
44651480|NCT00200967|Beclomethasone|beclomethasone|mesh-list
44651481|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44651482|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43918297|NCT00524576|Vaccines|vaccines|mesh-list
44651483|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
44651484|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651485|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651486|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44651487|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
44651488|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44651489|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44651490|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44651491|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651492|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651493|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651494|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651495|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
44651496|NCT00200967|Hormones|hormones|mesh-ancestor
44651497|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651498|NCT00200356|Ozagrel|ozagrel|mesh-list
44651499|NCT00200356|Edaravone|edaravone|mesh-list
44651500|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44651501|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
44651502|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651503|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44651504|NCT00200356|Protective Agents|protective agents|mesh-ancestor
44651505|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651506|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651507|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44651508|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44651509|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
44651510|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
44651511|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651512|NCT00195819|Adalimumab|adalimumab|mesh-list
44651513|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651514|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651515|NCT00195442|Factor VIII|factor viii|mesh-list
44651516|NCT00195442|Coagulants|coagulants|mesh-ancestor
44651517|NCT00195338|Etanercept|etanercept|mesh-list
44651518|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44651519|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651520|NCT00195338|Analgesics|analgesics|mesh-ancestor
44651521|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
44651522|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651523|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651524|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651525|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651526|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651527|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651528|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
44651529|NCT00194025|Valproic Acid|valproic acid|mesh-list
44651530|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
44651531|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918347|NCT00525603|Fludarabine|fludarabine|mesh-list
44651532|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651533|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
44651534|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651535|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651536|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
44651537|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651538|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651539|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651540|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44651541|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44651542|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651543|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651544|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651545|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651546|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651547|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651548|NCT00191477|Gemcitabine|gemcitabine|mesh-list
44651549|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651550|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
44651551|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651552|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651553|NCT00191477|Antiviral Agents|antiviral agents|mesh-ancestor
44651554|NCT00191477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651555|NCT00191477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651556|NCT00191477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651557|NCT00191477|Immunologic Factors|immunologic factors|mesh-ancestor
44651558|NCT00191477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651559|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44651560|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44651561|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
44651562|NCT00191113|Estradiol|estradiol|mesh-list
44651563|NCT00191113|Hormones|hormones|mesh-ancestor
44651564|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651565|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651566|NCT00191113|Estrogens|estrogens|mesh-ancestor
44149656|NCT00208533|Aripiprazole|aripiprazole|mesh-list
44651567|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43918382|NCT00525798|Calcitonin|calcitonin|mesh-list
44651568|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
44651569|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44651570|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44651571|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44651572|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44651573|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44651574|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44651575|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651576|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651577|NCT00191100|Gemcitabine|gemcitabine|mesh-list
44651578|NCT00191100|Cisplatin|cisplatin|mesh-list
44651579|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651580|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651581|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
44651582|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651583|NCT00191100|Antiviral Agents|antiviral agents|mesh-ancestor
44651584|NCT00191100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651585|NCT00191100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651586|NCT00191100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651587|NCT00191100|Immunologic Factors|immunologic factors|mesh-ancestor
44651588|NCT00191100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651589|NCT00189488|Methotrexate|methotrexate|mesh-list
44651590|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44651591|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
44651592|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44651593|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651594|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651595|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
44651596|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651597|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651598|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651599|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651600|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44651601|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651602|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
44651603|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651604|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44651605|NCT00189462|Montelukast|montelukast|mesh-list
44651606|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44651607|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
44651608|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44651609|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
44651610|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651611|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651612|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44651613|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44651614|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651615|NCT00189306|Imiquimod|imiquimod|mesh-list
44651616|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651617|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
44651618|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651619|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651620|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
44651621|NCT00189202|Sirolimus|sirolimus|mesh-list
44651622|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44651623|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651624|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651625|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651626|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
44651627|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651628|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
44651629|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651630|NCT00187889|Eplerenone|eplerenone|mesh-list
44651631|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44651632|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
44651633|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651634|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651635|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44651636|NCT00187889|Diuretics|diuretics|mesh-ancestor
44651637|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
44651638|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44651639|NCT00187486|Temozolomide|temozolomide|mesh-list
44651640|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44651641|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651642|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
44651643|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651644|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918449|NCT00527124|Cediranib|cediranib|mesh-list
44651645|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44651646|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651647|NCT00187135|Fentanyl|fentanyl|mesh-list
44651648|NCT00187135|Propofol|propofol|mesh-list
44651649|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44651650|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651651|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651652|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44651653|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
44651654|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
44651655|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44651656|NCT00187135|Narcotics|narcotics|mesh-ancestor
44651657|NCT00187135|Analgesics|analgesics|mesh-ancestor
44651658|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
44651659|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651660|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44651661|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
44651662|NCT00187096|Fludarabine|fludarabine|mesh-list
44651663|NCT00187096|Etoposide|etoposide|mesh-list
44651664|NCT00187096|Interleukin-2|interleukin-2|mesh-list
44651665|NCT00187096|Clofarabine|clofarabine|mesh-list
44651666|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651667|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
44651668|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651669|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651670|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651671|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
44651672|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651673|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651674|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44651675|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651676|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
44651677|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44651678|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44651679|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44651680|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651681|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651682|NCT00187096|Analgesics|analgesics|mesh-ancestor
44651683|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
44651684|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651685|NCT00186901|Vitamin D|vitamin d|mesh-list
44651686|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
44651687|NCT00186901|Calcium|calcium|mesh-list
44651688|NCT00186901|Vitamins|vitamins|mesh-ancestor
44651689|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
44651690|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651691|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44651692|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44651693|NCT00186901|Antacids|antacids|mesh-ancestor
44651694|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651695|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651696|NCT00186628|Acetaminophen|acetaminophen|mesh-list
44651697|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
44651698|NCT00186628|Promethazine|promethazine|mesh-list
44651699|NCT00186628|Cyclosporine|cyclosporine|mesh-list
44651700|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
44651701|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
44651702|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44651703|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44651704|NCT00186628|Prednisolone|prednisolone|mesh-list
44651705|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
44651706|NCT00186628|Rituximab|rituximab|mesh-list
44651707|NCT00186628|Granisetron|granisetron|mesh-list
44651708|NCT00186628|Lenograstim|lenograstim|mesh-list
44651709|NCT00186628|Cyclosporins|cyclosporins|mesh-list
44651710|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
44651711|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44651712|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44651713|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
44651714|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651715|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651716|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
44651717|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651718|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651719|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651720|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651721|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651722|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651723|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
44651725|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651726|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44651727|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44651728|NCT00186628|Analgesics|analgesics|mesh-ancestor
44651729|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
44651730|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651731|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
44651732|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651733|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
44651734|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
44651735|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651736|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
44651737|NCT00186628|Hormones|hormones|mesh-ancestor
44651738|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651739|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44651740|NCT00186628|Protective Agents|protective agents|mesh-ancestor
44651741|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651742|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44651743|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44651744|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651745|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
44651746|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
44651747|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44651748|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
44651749|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
44651750|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651751|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44651752|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
44651753|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44651754|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
44651755|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
44651756|NCT00186537|Fenofibrate|fenofibrate|mesh-list
44651757|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44651758|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651759|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44651760|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
44651761|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651762|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44651763|NCT00186186|Valproic Acid|valproic acid|mesh-list
44651764|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
44651765|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651766|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651767|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
44651768|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651769|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651770|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
44651771|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651772|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651773|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651774|NCT00186121|Anastrozole|anastrozole|mesh-list
44651775|NCT00186121|Goserelin|goserelin|mesh-list
44651776|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651777|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651778|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44651779|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44651780|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651781|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651782|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44651783|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
44651784|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651785|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651786|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44651787|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
44651788|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651789|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651790|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651791|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651792|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651794|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44651795|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44651796|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
44651797|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651798|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44651799|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44651800|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651801|NCT00185640|Cyclosporine|cyclosporine|mesh-list
44651802|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
44651803|NCT00185640|Lenograstim|lenograstim|mesh-list
44651804|NCT00185640|Cyclosporins|cyclosporins|mesh-list
44651805|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
44651806|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44651807|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651808|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
44651809|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651810|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651811|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651812|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651813|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
44651814|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651815|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651816|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651817|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44651818|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651819|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651820|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44651821|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
44651822|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44651823|NCT00185614|Cyclosporine|cyclosporine|mesh-list
44651824|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
44651825|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
44651826|NCT00185614|Melphalan|melphalan|mesh-list
44651827|NCT00185614|Cyclosporins|cyclosporins|mesh-list
44651828|NCT00185614|Lenograstim|lenograstim|mesh-list
44651829|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651830|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
44651831|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651832|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651833|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651834|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
44651835|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651836|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918650|NCT00531453|Bortezomib|bortezomib|mesh-list
44651837|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44651838|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651839|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651840|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
44651841|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651842|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44651843|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44651844|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651845|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44651846|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
44651847|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44651848|NCT00185588|Gemcitabine|gemcitabine|mesh-list
44651849|NCT00185588|Vatalanib|vatalanib|mesh-list
44651850|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651851|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
43918673|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918674|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651852|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651853|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651854|NCT00185588|Antiviral Agents|antiviral agents|mesh-ancestor
44651855|NCT00185588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651856|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651857|NCT00185588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651858|NCT00185588|Immunologic Factors|immunologic factors|mesh-ancestor
44651859|NCT00185588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651860|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44651861|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
44651862|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44651863|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
44651864|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44651865|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651866|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44458795|NCT01590433|Hormones|hormones|mesh-ancestor
44651867|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44651868|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44651870|NCT00185211|Interferon-beta|interferon-beta|mesh-list
44651871|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
44651872|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651873|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
44651874|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651875|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
44651876|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651877|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44651878|NCT00184600|Insulin|insulin|mesh-list
44651879|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44651880|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
44651881|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
44651882|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44651883|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
44651884|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
44651885|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44651886|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651887|NCT00184093|Gemcitabine|gemcitabine|mesh-list
44651888|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44651889|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
43918691|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
44651890|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651891|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651892|NCT00184093|Antiviral Agents|antiviral agents|mesh-ancestor
44651893|NCT00184093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44651894|NCT00184093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651895|NCT00184093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651896|NCT00184093|Immunologic Factors|immunologic factors|mesh-ancestor
44651897|NCT00184093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651898|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
44651899|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
44651900|NCT00184054|Vitamins|vitamins|mesh-ancestor
44651901|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
44651902|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651903|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
44651904|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651905|NCT00184054|Protective Agents|protective agents|mesh-ancestor
44651906|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651907|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
44651908|NCT00184028|Docetaxel|docetaxel|mesh-list
44651909|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651910|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651911|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651912|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651913|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651914|NCT00184002|Prednisone|prednisone|mesh-list
44651915|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
44651916|NCT00184002|Doxorubicin|doxorubicin|mesh-list
44651917|NCT00184002|Vincristine|vincristine|mesh-list
44651918|NCT00184002|Rituximab|rituximab|mesh-list
44651919|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44651920|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
44651921|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651922|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44651923|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44651924|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
44651925|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651926|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651927|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44651928|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44651929|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44651930|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44651931|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651932|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44651933|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
44651934|NCT00184002|Hormones|hormones|mesh-ancestor
44651935|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44651936|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44651937|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44651938|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651939|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651940|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651941|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44651942|NCT00183872|Docetaxel|docetaxel|mesh-list
44651943|NCT00183872|Irinotecan|irinotecan|mesh-list
44651944|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44651945|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44651946|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44651947|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44651948|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651949|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44651950|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44651951|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44651952|NCT00183625|Olanzapine|olanzapine|mesh-list
44651953|NCT00183625|Risperidone|risperidone|mesh-list
44651954|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44651955|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
44651956|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918762|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651957|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651958|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651959|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44651960|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44651961|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44651962|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44651963|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44651964|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
44651965|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
44651966|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
44651967|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44651968|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44651969|NCT00183625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44651970|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651971|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651972|NCT00183430|Prazosin|prazosin|mesh-list
44651973|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44651974|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44651975|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44651976|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44651977|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651978|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651979|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651980|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651981|NCT00183391|Methylphenidate|methylphenidate|mesh-list
44651982|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44651983|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44651984|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44651985|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44651986|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44651987|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44651988|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44651989|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
44651990|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44651991|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44651992|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44651993|NCT00183274|Norepinephrine|norepinephrine|mesh-list
44651994|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44651995|NCT00183274|Serotonin|serotonin|mesh-list
44651996|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
44651997|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44651998|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44651999|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652000|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652001|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652002|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652003|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
44652004|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
44652005|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652006|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44652007|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652008|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652009|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44652010|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652011|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652012|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44652013|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
44652014|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
44652015|NCT00183248|Sirolimus|sirolimus|mesh-list
44652016|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
44652018|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652019|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
44652020|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652021|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652022|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918824|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44652023|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652024|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652025|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652026|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44652027|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
44652028|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44652029|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652030|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
44652031|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652032|NCT00183196|Naltrexone|naltrexone|mesh-list
44652033|NCT00183196|Gabapentin|gabapentin|mesh-list
44652034|NCT00183196|Analgesics|analgesics|mesh-ancestor
44652035|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
44652036|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652037|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652038|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
44652039|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44652040|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652041|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652042|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652043|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44652044|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43918853|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652045|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652046|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652047|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
44652048|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44652049|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44652050|NCT00182689|Sorafenib|sorafenib|mesh-list
44652051|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652052|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44652053|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652054|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652055|NCT00182637|Bortezomib|bortezomib|mesh-list
44652056|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652057|NCT00182091|Hormones|hormones|mesh-list
44652058|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652059|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652060|NCT00182078|Sertraline|sertraline|mesh-list
44652061|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652062|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918877|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
43918878|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44166956|NCT00266253|Metformin|metformin|mesh-list
44652063|NCT00182078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652064|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652065|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652066|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652067|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652068|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
44652069|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652070|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44652071|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652072|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652073|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652074|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652075|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652076|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652077|NCT00181844|Lamotrigine|lamotrigine|mesh-list
44652078|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
44652079|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44652080|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652081|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652082|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44652083|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652084|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652085|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652086|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652087|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652088|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44652089|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44652090|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44652091|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652092|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652093|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652094|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652095|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652096|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652097|NCT00181155|Allopurinol|allopurinol|mesh-list
44652098|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
44652099|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652100|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652101|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
44652102|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652103|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44652104|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
44652105|NCT00181155|Protective Agents|protective agents|mesh-ancestor
44652106|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652107|NCT00180713|Simvastatin|simvastatin|mesh-list
44652108|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44652109|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44652110|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
44652111|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652112|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44652113|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44652114|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652115|NCT00180674|Warfarin|warfarin|mesh-list
44652116|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
44652117|NCT00180479|Paclitaxel|paclitaxel|mesh-list
44652118|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44652119|NCT00180479|Everolimus|everolimus|mesh-list
44652120|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44652121|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652122|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652123|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652124|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652125|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652126|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652127|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
44652128|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652129|NCT00179621|Lenalidomide|lenalidomide|mesh-list
44652130|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
44652131|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652132|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44652133|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44652134|NCT00179621|Growth Substances|growth substances|mesh-ancestor
44652135|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
44652136|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652137|NCT00179309|Docetaxel|docetaxel|mesh-list
44652138|NCT00179309|Sargramostim|sargramostim|mesh-list
44652139|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652140|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652141|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652142|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652143|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652144|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
44652145|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652146|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44652147|NCT00177671|Donepezil|donepezil|mesh-list
44652148|NCT00177671|Citalopram|citalopram|mesh-list
44652149|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44652150|NCT00177671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652151|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652152|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652153|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652154|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652155|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
44652156|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652157|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44652158|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652159|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652160|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652161|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652162|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44652163|NCT00177671|Analgesics|analgesics|mesh-ancestor
44139205|NCT00174629|Gemcitabine|gemcitabine|mesh-list
44652164|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
44652165|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
44652166|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44652167|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652168|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
44652169|NCT00175916|Brivaracetam|brivaracetam|mesh-list
44652170|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
44652171|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
44652172|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652173|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
44652174|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652175|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652177|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44652178|NCT00174447|Ziprasidone|ziprasidone|mesh-list
44652179|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44652180|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
44652181|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652182|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652183|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652184|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652185|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652186|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652187|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652188|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44652189|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
44652190|NCT00174382|Donepezil|donepezil|mesh-list
44652191|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44652192|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652193|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652194|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652195|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652196|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652197|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
44652198|NCT00171730|Pasireotide|pasireotide|mesh-list
44652199|NCT00171730|Hormones|hormones|mesh-ancestor
44652200|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652201|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652202|NCT00170950|Amlodipine|amlodipine|mesh-list
44652203|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44652204|NCT00170950|Benazepril|benazepril|mesh-list
44652205|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44652206|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44652207|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652208|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652209|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44652210|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652211|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
44652212|NCT00170950|Diuretics|diuretics|mesh-ancestor
44652213|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
44652214|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44652215|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44652216|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
44652217|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652218|NCT00169104|Trastuzumab|trastuzumab|mesh-list
44652219|NCT00169104|Vinorelbine|vinorelbine|mesh-list
44652220|NCT00169104|Lenograstim|lenograstim|mesh-list
44652221|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652222|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652223|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44652224|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
44652225|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652226|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44652227|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652228|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652229|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652230|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652231|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
44652232|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44652233|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
44652234|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652235|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652236|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44652237|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
44652238|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
44652239|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44652240|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652241|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652242|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652243|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
44652244|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44652245|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
44652246|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652247|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652248|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44652249|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
44652250|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
44652251|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44652252|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652253|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652254|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652256|NCT00168818|Dabigatran|dabigatran|mesh-list
44652257|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
44652258|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44652259|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44652260|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652261|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
44652262|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44652263|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44652264|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652266|NCT00168805|Dabigatran|dabigatran|mesh-list
44652267|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
44652268|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44652269|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44652270|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652271|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
44652272|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44652273|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44652274|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652275|NCT00168103|Complement C1s|complement c1s|mesh-list
44652276|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44652277|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44652278|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
44652279|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652280|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44652281|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652282|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
44652283|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44652284|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
44652285|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652286|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44652287|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652288|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
44652289|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44652290|NCT00168038|Antibodies|antibodies|mesh-list
44652291|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
44652292|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652293|NCT00167245|Topiramate|topiramate|mesh-list
44652294|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
44652295|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44652296|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652297|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
44652298|NCT00166712|Sirolimus|sirolimus|mesh-list
44652299|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
44652300|NCT00166712|Tacrolimus|tacrolimus|mesh-list
44652301|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652302|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
44652303|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652304|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652305|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652306|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652307|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652308|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652309|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44652310|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
44652311|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44652312|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652313|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
44652314|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652315|NCT00166439|Cytarabine|cytarabine|mesh-list
44652317|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
44652318|NCT00166439|Rituximab|rituximab|mesh-list
44652319|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652320|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
44652321|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
44652322|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652323|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652324|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652325|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
44652326|NCT00166439|Hormones|hormones|mesh-ancestor
44652327|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652328|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44652329|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652330|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652331|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
44652332|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652333|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44652334|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
44652335|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652336|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
44652337|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652338|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652339|NCT00166296|Citalopram|citalopram|mesh-list
44652340|NCT00166296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652341|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652342|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652343|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652344|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652345|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
44652346|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652347|NCT00166296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44652348|NCT00166296|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652349|NCT00166296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652350|NCT00166114|Citalopram|citalopram|mesh-list
44652351|NCT00166114|Desipramine|desipramine|mesh-list
44652352|NCT00166114|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652353|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43919128|NCT00538850|Analgesics|analgesics|mesh-ancestor
44652354|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652355|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652356|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652357|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
44652358|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652359|NCT00166114|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44652360|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652361|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652362|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44652363|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652364|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44652365|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652366|NCT00165841|Rabeprazole|rabeprazole|mesh-list
44652367|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44652368|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652369|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44652370|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652371|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652372|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44652373|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
44652374|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44652375|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44652376|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44652377|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652378|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652379|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652380|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652381|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652382|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44652383|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652384|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44652385|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
44652386|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44652387|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44047516|NCT00003391|Antibodies|antibodies|mesh-list
44652388|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652389|NCT00165698|Vitamins|vitamins|mesh-ancestor
44652390|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
44652391|NCT00165672|Rabeprazole|rabeprazole|mesh-list
44652392|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44652393|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652394|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44652395|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652396|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652397|NCT00165646|Rabeprazole|rabeprazole|mesh-list
44652398|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44652399|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652400|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44652401|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652402|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652403|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
44652404|NCT00165503|Cisplatin|cisplatin|mesh-list
44652405|NCT00165503|Pemetrexed|pemetrexed|mesh-list
44652406|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652407|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652408|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652409|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44652410|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44652411|NCT00165503|Antidotes|antidotes|mesh-ancestor
44652412|NCT00165503|Protective Agents|protective agents|mesh-ancestor
44652413|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652414|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
44652415|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
44652416|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44652417|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652418|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
44652419|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
44652421|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
44652422|NCT00163657|Tacrolimus|tacrolimus|mesh-list
44652423|NCT00163657|Cyclosporins|cyclosporins|mesh-list
44652424|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652425|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
44652426|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652427|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652428|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652429|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652430|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
44652431|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652432|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44652433|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652434|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652435|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652436|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44652437|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
44652438|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44652439|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44652440|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44652441|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44652442|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
44652443|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652444|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652445|NCT00163020|Progestins|progestins|mesh-ancestor
44652446|NCT00163020|Hormones|hormones|mesh-ancestor
44652447|NCT00162981|Clobazam|clobazam|mesh-list
44652448|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
44652449|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44652450|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652451|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652452|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652453|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652454|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44652455|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
44652456|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
44652457|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652458|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652459|NCT00162773|Omalizumab|omalizumab|mesh-list
44652460|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44652461|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44652462|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44652463|NCT00162266|Abatacept|abatacept|mesh-list
44652464|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44652465|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652466|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652467|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652468|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
44652469|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652470|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652471|NCT00162123|Ipilimumab|ipilimumab|mesh-list
44652472|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652473|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652474|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44652475|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652476|NCT00162097|Efavirenz|efavirenz|mesh-list
44652477|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44652478|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44652479|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44652480|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652481|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652482|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
44652483|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652484|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44652485|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44652486|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44652487|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44652488|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44652489|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44652490|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44652492|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652493|NCT00161213|Gemcitabine|gemcitabine|mesh-list
44652494|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
44652495|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44652496|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
44652497|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652498|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652499|NCT00161213|Antiviral Agents|antiviral agents|mesh-ancestor
44652500|NCT00161213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652501|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652502|NCT00161213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652503|NCT00161213|Immunologic Factors|immunologic factors|mesh-ancestor
44652504|NCT00161213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652505|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44652506|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
44652507|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652508|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
44652509|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652510|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652511|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
44652512|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652513|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
44652514|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652515|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652516|NCT00160680|Levocetirizine|levocetirizine|mesh-list
44652517|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44652518|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44652519|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
44652520|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
44652521|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652522|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652523|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652524|NCT00160667|Brivaracetam|brivaracetam|mesh-list
44652525|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
44652526|NCT00160654|Levetiracetam|levetiracetam|mesh-list
44652527|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
44652528|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
44652529|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
44652530|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652531|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
44652532|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652533|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652534|NCT00160615|Levetiracetam|levetiracetam|mesh-list
44652535|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
44652536|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
43919351|NCT00544778|Ifosfamide|ifosfamide|mesh-list
44652537|NCT00160563|Levocetirizine|levocetirizine|mesh-list
44652538|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44652539|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44652540|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
44652541|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
44652542|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652543|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652544|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652545|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
44652546|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652547|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
44652548|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652549|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652550|NCT00160251|Ribavirin|ribavirin|mesh-list
44652551|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44652552|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
44652553|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652554|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
44652555|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652556|NCT00160199|Progesterone|progesterone|mesh-list
44652557|NCT00160199|Progestins|progestins|mesh-ancestor
44652558|NCT00160199|Hormones|hormones|mesh-ancestor
44652559|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652560|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652561|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
44652562|NCT00159913|Citric Acid|citric acid|mesh-list
44652563|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
44652564|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
44652565|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44652566|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
44652567|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
44652568|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652569|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
44652570|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44652571|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44652572|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652573|NCT00159913|Urological Agents|urological agents|mesh-ancestor
44652574|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
44652575|NCT00159874|Citric Acid|citric acid|mesh-list
44652576|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
44652577|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
44652578|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44652579|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
44652580|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
44652581|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652582|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
44652583|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44652584|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44652585|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652586|NCT00159874|Urological Agents|urological agents|mesh-ancestor
44652587|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
44652588|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652589|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
44652590|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44652591|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44652592|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652593|NCT00159861|Urological Agents|urological agents|mesh-ancestor
44652594|NCT00159822|Voriconazole|voriconazole|mesh-list
44652595|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
44652596|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652597|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44652598|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44652599|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652600|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652601|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44652602|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
44652603|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652604|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652605|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44652606|NCT00158262|Propranolol|propranolol|mesh-list
44652607|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44652608|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44652609|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652610|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652611|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652612|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652613|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44652614|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44652615|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44652616|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
44652617|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652618|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
44652619|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652620|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652621|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44652622|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
43919405|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652623|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652624|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652625|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44652626|NCT00157157|Factor VIII|factor viii|mesh-list
44652627|NCT00157157|Coagulants|coagulants|mesh-ancestor
44652628|NCT00156819|Fluticasone|fluticasone|mesh-list
44652629|NCT00156819|Xhance|xhance|mesh-list
44652630|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44652631|NCT00156819|Montelukast|montelukast|mesh-list
44652632|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652633|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44652634|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
44652635|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652636|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652637|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44652638|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
44652639|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44652640|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44652641|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44652642|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44652643|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44652644|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652645|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652646|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652647|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44652648|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
44652649|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652650|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44652651|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44652652|NCT00154310|Cyclosporine|cyclosporine|mesh-list
44652653|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
44652654|NCT00154310|Everolimus|everolimus|mesh-list
44652655|NCT00154310|Cyclosporins|cyclosporins|mesh-list
44652656|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652657|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652658|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652659|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
44652660|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652661|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
44652662|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652663|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44652664|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652665|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652666|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652667|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652668|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44652669|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
44652670|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44652671|NCT00153816|Vitamin D|vitamin d|mesh-list
44652672|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
44652673|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
44652674|NCT00153816|Calcium|calcium|mesh-list
44652675|NCT00153816|Vitamins|vitamins|mesh-ancestor
44652676|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
44652677|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652678|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44652679|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44652680|NCT00153816|Antacids|antacids|mesh-ancestor
44652681|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652682|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652683|NCT00153101|Telmisartan|telmisartan|mesh-list
44652684|NCT00153101|Ramipril|ramipril|mesh-list
44652685|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44652686|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44652687|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43700453|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44652688|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652689|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44652690|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44652691|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652692|NCT00153062|Telmisartan|telmisartan|mesh-list
44652693|NCT00153062|Clopidogrel|clopidogrel|mesh-list
44652694|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44652695|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44652696|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43919532|NCT00550277|Panobinostat|panobinostat|mesh-list
44652697|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44652698|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44652699|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
44652700|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652701|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652702|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652703|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44652704|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44652705|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44652706|NCT00152516|Levetiracetam|levetiracetam|mesh-list
44652707|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
44652708|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
44652709|NCT00151476|Celecoxib|celecoxib|mesh-list
44652710|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44652711|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44652712|NCT00151476|Analgesics|analgesics|mesh-ancestor
44652713|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
44652714|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652715|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652716|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652717|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652718|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44652719|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44652720|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652721|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652722|NCT00150969|Vitamin K|vitamin k|mesh-list
44652723|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
44652724|NCT00150969|Vitamins|vitamins|mesh-ancestor
44652725|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
43919533|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652726|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652727|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44652728|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44652729|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652730|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
44652731|NCT00150969|Coagulants|coagulants|mesh-ancestor
44652732|NCT00150800|Brivaracetam|brivaracetam|mesh-list
44652733|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
44652734|NCT00150592|Guanfacine|guanfacine|mesh-list
44652735|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44652736|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44652737|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44652738|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44652739|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44652740|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652741|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652742|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652743|NCT00150345|Voriconazole|voriconazole|mesh-list
44652744|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
44652745|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652746|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44652747|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44652748|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652749|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652750|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44652751|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
43919562|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919563|NCT00551707|Prednisolone|prednisolone|mesh-list
44652752|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652753|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652754|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44652755|NCT00149994|Cyclosporine|cyclosporine|mesh-list
44652756|NCT00149994|Prednisone|prednisone|mesh-list
44652757|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
44652758|NCT00149994|Tacrolimus|tacrolimus|mesh-list
44652759|NCT00149994|Cyclosporins|cyclosporins|mesh-list
44652760|NCT00149994|Basiliximab|basiliximab|mesh-list
44652761|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652762|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
44652763|NCT00149994|Hormones|hormones|mesh-ancestor
44652764|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652765|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652766|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44652767|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652768|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652769|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
44652770|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652771|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652772|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652773|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
44652774|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652775|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44652776|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652777|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
44652778|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
44652779|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652780|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652781|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44652782|NCT00149994|Protective Agents|protective agents|mesh-ancestor
44652783|NCT00149890|Cyclosporine|cyclosporine|mesh-list
44652784|NCT00149890|Cyclosporins|cyclosporins|mesh-list
44652785|NCT00149890|Basiliximab|basiliximab|mesh-list
44652786|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203414|NCT00409383|Temozolomide|temozolomide|mesh-list
44652787|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652788|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652789|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
44652790|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652791|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
44652792|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652793|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
44652794|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652795|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44652797|NCT00149825|Citalopram|citalopram|mesh-list
44652798|NCT00149825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652799|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652800|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652801|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652802|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652803|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
44652804|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652805|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44652806|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44652807|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652808|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44652809|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44652810|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
44652811|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
44652812|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652813|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44652814|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44652815|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
44652816|NCT00149630|Disulfiram|disulfiram|mesh-list
44652817|NCT00149630|Methadone|methadone|mesh-list
44652818|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44652819|NCT00149630|Narcotics|narcotics|mesh-ancestor
44652820|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652821|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652822|NCT00149630|Analgesics|analgesics|mesh-ancestor
44652823|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
44652824|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652825|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
44652826|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
44652827|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44652828|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44652829|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652830|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652831|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
44652832|NCT00149214|Docetaxel|docetaxel|mesh-list
44652833|NCT00149214|Doxorubicin|doxorubicin|mesh-list
44652834|NCT00149214|Pemetrexed|pemetrexed|mesh-list
44652835|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652836|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
44652837|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652838|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652839|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44652840|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
44652841|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652842|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652843|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44652844|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652845|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652846|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652847|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652848|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44652849|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44652850|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652851|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44652852|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44652853|NCT00148941|Vaccines|vaccines|mesh-list
44652854|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
44652855|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652856|NCT00148317|Dexamethasone|dexamethasone|mesh-list
44652857|NCT00148317|Doxorubicin|doxorubicin|mesh-list
44652858|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44652859|NCT00148317|Bortezomib|bortezomib|mesh-list
44652860|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652861|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
44652862|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
44652863|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652864|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652865|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652866|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
44652867|NCT00148317|Hormones|hormones|mesh-ancestor
44652868|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652869|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44652870|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652871|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652872|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44652873|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44652874|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652875|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652876|NCT00148122|Docetaxel|docetaxel|mesh-list
44652877|NCT00148122|Capecitabine|capecitabine|mesh-list
44652878|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652879|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652880|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652881|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652882|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652883|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44652884|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
44652885|NCT00148109|Cetuximab|cetuximab|mesh-list
44652886|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44652887|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652888|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
44652889|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44652890|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44652891|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652892|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44652893|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44652894|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
44652895|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652896|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44652897|NCT00147537|Paclitaxel|paclitaxel|mesh-list
44652898|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44652899|NCT00147537|Carboplatin|carboplatin|mesh-list
44652900|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44652901|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44652902|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44652903|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652904|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
44652905|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
44652906|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
44652907|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652908|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44652909|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652910|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
44652911|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652913|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44652914|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652915|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652916|NCT00147225|Carboplatin|carboplatin|mesh-list
44652917|NCT00147225|Doxorubicin|doxorubicin|mesh-list
44652918|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44652919|NCT00147225|Ifosfamide|ifosfamide|mesh-list
44652920|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652921|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44652922|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44652923|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44652924|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44652925|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652926|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44652927|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
44652928|NCT00146640|Prednisone|prednisone|mesh-list
44652929|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44652930|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
44652931|NCT00146640|Hormones|hormones|mesh-ancestor
44652932|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44652933|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652934|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44652935|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652936|NCT00146328|Tipranavir|tipranavir|mesh-list
44652937|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44652938|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44652940|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44652941|NCT00145977|Vitamin D|vitamin d|mesh-list
44652942|NCT00145977|Alendronate|alendronate|mesh-list
44652943|NCT00145977|Calcium|calcium|mesh-list
44652944|NCT00145977|Vitamins|vitamins|mesh-ancestor
44652945|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
44652946|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652947|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44652948|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44652949|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
44652950|NCT00145626|Melphalan|melphalan|mesh-list
44652951|NCT00145626|Thiotepa|thiotepa|mesh-list
44652952|NCT00145626|Fludarabine|fludarabine|mesh-list
44652953|NCT00145626|Antibodies|antibodies|mesh-list
44652954|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44652955|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
44652956|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652957|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44652958|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44652959|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
44652960|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652961|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44652962|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44652963|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44652964|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44652965|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44652966|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
44652967|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652968|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44652969|NCT00145509|Asenapine|asenapine|mesh-list
44652970|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652971|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652972|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652973|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652974|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652975|NCT00145496|Olanzapine|olanzapine|mesh-list
44652976|NCT00145496|Asenapine|asenapine|mesh-list
44652977|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
44652978|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
44652979|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44652980|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652981|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44652982|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652983|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652984|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44048111|NCT00003437|Cytarabine|cytarabine|mesh-list
43919731|NCT00554970|Budesonide|budesonide|mesh-list
44652985|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652986|NCT00145496|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44652987|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44652988|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44652989|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44652990|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44652991|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
44652992|NCT00145470|Asenapine|asenapine|mesh-list
44652993|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44652994|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44652995|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44652996|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44652997|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44652998|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
44652999|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44653000|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653002|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44653003|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
44653004|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653005|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
44653006|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44653007|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
44653008|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653009|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653010|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44653011|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
44653012|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
44653013|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44653014|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
44653015|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653016|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653017|NCT00144300|Pramipexole|pramipexole|mesh-list
44653018|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
44653019|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653020|NCT00144300|Protective Agents|protective agents|mesh-ancestor
44653021|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653022|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44653023|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44653024|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
44653025|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
44653026|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653027|NCT00144170|Ritonavir|ritonavir|mesh-list
44653028|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44653029|NCT00144170|Tipranavir|tipranavir|mesh-list
44653030|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
44653031|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44653032|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653033|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653034|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44653035|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44653036|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
44653037|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653038|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44653039|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44653040|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
44653041|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653042|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653043|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653044|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43919798|NCT00555464|Protective Agents|protective agents|mesh-ancestor
44653045|NCT00143455|Cisplatin|cisplatin|mesh-list
44653046|NCT00143455|Irinotecan|irinotecan|mesh-list
44653047|NCT00143455|Etoposide|etoposide|mesh-list
44653048|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653049|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44653050|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44653051|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653052|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653053|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653054|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44653055|NCT00143403|Leucovorin|leucovorin|mesh-list
44653056|NCT00143403|Folic Acid|folic acid|mesh-list
44653057|NCT00143403|Irinotecan|irinotecan|mesh-list
44653058|NCT00143403|Fluorouracil|fluorouracil|mesh-list
44653059|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
44653060|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43919820|NCT00555893|Oseltamivir|oseltamivir|mesh-list
44653061|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44653062|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653063|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653064|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653065|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
44653066|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653067|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653068|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
44653069|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653070|NCT00143403|Antidotes|antidotes|mesh-ancestor
44653071|NCT00143403|Protective Agents|protective agents|mesh-ancestor
44653072|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
44653073|NCT00143403|Vitamins|vitamins|mesh-ancestor
44653074|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
44653075|NCT00143403|Hematinics|hematinics|mesh-ancestor
44653076|NCT00143390|Anastrozole|anastrozole|mesh-list
44653077|NCT00143390|Exemestane|exemestane|mesh-list
44653078|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653079|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653080|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44653081|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44653082|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653083|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653084|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44653085|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44653086|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653087|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653088|NCT00143312|Voriconazole|voriconazole|mesh-list
44653089|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
44653090|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653091|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44653092|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44653093|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653094|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653095|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43919830|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653096|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
44653097|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653098|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653099|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44653100|NCT00143247|Insulin|insulin|mesh-list
44653101|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653102|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653103|NCT00142909|Lofexidine|lofexidine|mesh-list
44653104|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44653105|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44653106|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653107|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
44653108|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653109|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44653110|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44653111|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44653112|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
44653113|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653114|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653115|NCT00142584|Metoprolol|metoprolol|mesh-list
44653116|NCT00142584|Nebivolol|nebivolol|mesh-list
44653117|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44653118|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44653119|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
44653120|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
44653121|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653122|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653123|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44653124|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44653125|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44653126|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44653127|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653128|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653129|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
44653130|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44653131|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44653132|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44653134|NCT00142519|Methadone|methadone|mesh-list
44653135|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44653136|NCT00142519|Narcotics|narcotics|mesh-ancestor
44653137|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653138|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653139|NCT00142519|Analgesics|analgesics|mesh-ancestor
44653140|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
44653141|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653142|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
44653143|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
44653144|NCT00142298|Telbivudine|telbivudine|mesh-list
44653145|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
44653146|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653147|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653148|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653149|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653150|NCT00141921|Etanercept|etanercept|mesh-list
44653151|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44653152|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44653153|NCT00141921|Analgesics|analgesics|mesh-ancestor
44653154|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
44653155|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653156|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653157|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653158|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653159|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653160|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653161|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
44653162|NCT00141817|Pantoprazole|pantoprazole|mesh-list
44653163|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44653164|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653165|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44653166|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653167|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653168|NCT00141778|Ramipril|ramipril|mesh-list
44653169|NCT00141778|Spironolactone|spironolactone|mesh-list
44653170|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44653171|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44653172|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44653173|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
44653174|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44653175|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653176|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653177|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44653178|NCT00141778|Diuretics|diuretics|mesh-ancestor
44653179|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
44653180|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
44653181|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653182|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44653183|NCT00141778|Hormones|hormones|mesh-ancestor
44653184|NCT00141726|Etanercept|etanercept|mesh-list
44653185|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44653186|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44653187|NCT00141726|Analgesics|analgesics|mesh-ancestor
44653188|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
44653189|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653190|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653191|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653192|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653193|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653194|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653195|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
44653196|NCT00141518|Levodopa|levodopa|mesh-list
44653197|NCT00141518|Carbidopa|carbidopa|mesh-list
44653198|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44653199|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44653200|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44653201|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
44653202|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653203|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653204|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653205|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44653206|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653207|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44653208|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
44653209|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
44653210|NCT00141453|Olmesartan|olmesartan|mesh-list
44653211|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44653212|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44653213|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44653214|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44653215|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653216|NCT00141297|Palbociclib|palbociclib|mesh-list
44653217|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653218|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653219|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653220|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653221|NCT00141271|Ziprasidone|ziprasidone|mesh-list
44653222|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44653223|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
44653224|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653225|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653226|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653227|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44653228|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653229|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653230|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653231|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44653232|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
44653234|NCT00141219|Analgesics|analgesics|mesh-ancestor
44653235|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
44653236|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653237|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653238|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
44653239|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44653240|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44653241|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653242|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44653243|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44653244|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653245|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653246|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653247|NCT00141102|Celecoxib|celecoxib|mesh-list
44653248|NCT00141102|Diclofenac|diclofenac|mesh-list
44653249|NCT00141102|Omeprazole|omeprazole|mesh-list
44653250|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44653251|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44653252|NCT00141102|Analgesics|analgesics|mesh-ancestor
44653253|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
44653254|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653255|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653256|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653257|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653258|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44653259|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44653260|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653261|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653262|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44653263|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653264|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44653265|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
44653266|NCT00141037|Trimethoprim|trimethoprim|mesh-list
44653267|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
44653268|NCT00141037|Valganciclovir|valganciclovir|mesh-list
44653269|NCT00141037|Ganciclovir|ganciclovir|mesh-list
44653270|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44653271|NCT00141037|Prednisone|prednisone|mesh-list
44653272|NCT00141037|Tacrolimus|tacrolimus|mesh-list
44653273|NCT00141037|Daclizumab|daclizumab|mesh-list
44653274|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653275|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
44653276|NCT00141037|Hormones|hormones|mesh-ancestor
44653277|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653278|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653279|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653280|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653281|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653282|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
44653283|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44653284|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653285|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653286|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44653287|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44653288|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
44653289|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44653290|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653291|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44653292|NCT00141037|Renal Agents|renal agents|mesh-ancestor
44653293|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
44653294|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44653295|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44653296|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43920039|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44653297|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44653298|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44653299|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44653300|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
44653301|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653302|NCT00140426|Risperidone|risperidone|mesh-list
44653303|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44653304|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
44653305|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653306|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653307|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653308|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44653309|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653310|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653311|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653312|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44653313|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
44653314|NCT00140140|Paclitaxel|paclitaxel|mesh-list
44653315|NCT00140140|Vinorelbine|vinorelbine|mesh-list
44653316|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44653317|NCT00140140|Trastuzumab|trastuzumab|mesh-list
44653318|NCT00140140|Lenograstim|lenograstim|mesh-list
44653319|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653320|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653321|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653322|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653323|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653324|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653325|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653326|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44653327|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
44653328|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653329|NCT00139776|Celecoxib|celecoxib|mesh-list
44653330|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44653331|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44653332|NCT00139776|Analgesics|analgesics|mesh-ancestor
44653333|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
44653334|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653335|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653336|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653337|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653338|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44653339|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44653340|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653341|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653342|NCT00139737|Ziprasidone|ziprasidone|mesh-list
44653343|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44653344|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
44653345|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700454|NCT02731534|Hematinics|hematinics|mesh-ancestor
44653346|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653347|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653348|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44653349|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653350|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653351|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653352|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44653354|NCT00139659|Insulin|insulin|mesh-list
44653355|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44653356|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653357|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653358|NCT00139477|Metformin|metformin|mesh-list
44653359|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653360|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653361|NCT00138671|Insulin|insulin|mesh-list
44653362|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44653363|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653364|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653365|NCT00138424|Cidofovir|cidofovir|mesh-list
44653366|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
44653367|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653368|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653369|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653370|NCT00138151|Interferons|interferons|mesh-list
44653371|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
44653372|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
44653373|NCT00138151|Paclitaxel|paclitaxel|mesh-list
44203963|NCT00411333|Hormones|hormones|mesh-ancestor
44653374|NCT00138151|Isotretinoin|isotretinoin|mesh-list
44653375|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653376|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653378|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653379|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653380|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653381|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
44653382|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653383|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
44653384|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653385|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44653386|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44653387|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653388|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653389|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653390|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653391|NCT00137449|Sunitinib|sunitinib|mesh-list
44653392|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653393|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44653394|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44653395|NCT00137449|Growth Substances|growth substances|mesh-ancestor
44653396|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653397|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44653398|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653399|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653400|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653401|NCT00137436|Prednisone|prednisone|mesh-list
44653402|NCT00137436|Docetaxel|docetaxel|mesh-list
44653403|NCT00137436|Sunitinib|sunitinib|mesh-list
44653404|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653405|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653406|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653407|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653408|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653409|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653410|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
44653411|NCT00137436|Hormones|hormones|mesh-ancestor
44653412|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653413|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653414|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653415|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44653416|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44653417|NCT00137436|Growth Substances|growth substances|mesh-ancestor
44653418|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
44653419|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653420|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653421|NCT00137423|Sunitinib|sunitinib|mesh-list
44653422|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795138|NCT05196945|Amoxicillin|amoxicillin|mesh-list
44653423|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44653424|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44653425|NCT00137423|Growth Substances|growth substances|mesh-ancestor
44653426|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653427|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44653428|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653429|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653430|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653432|NCT00137111|Dexamethasone|dexamethasone|mesh-list
44653433|NCT00137111|Prednisone|prednisone|mesh-list
44653434|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
44653435|NCT00137111|Doxorubicin|doxorubicin|mesh-list
44653436|NCT00137111|Methotrexate|methotrexate|mesh-list
44653437|NCT00137111|Etoposide|etoposide|mesh-list
44653438|NCT00137111|Vincristine|vincristine|mesh-list
44653439|NCT00137111|Daunorubicin|daunorubicin|mesh-list
44653440|NCT00137111|Asparaginase|asparaginase|mesh-list
44653441|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
44653442|NCT00137111|Pegaspargase|pegaspargase|mesh-list
44653443|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653444|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
44653445|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653446|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653447|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653448|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
43920184|NCT04747236|Romidepsin|romidepsin|mesh-list
44653449|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653450|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653451|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44653452|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653453|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
44653454|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
44653455|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653456|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653457|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
44653458|NCT00137111|Hormones|hormones|mesh-ancestor
44653459|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653460|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653461|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44653462|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44653463|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44653464|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653465|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44653466|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
44653467|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44653468|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653469|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
44653470|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
44653471|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44653472|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653473|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653474|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
44653475|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653476|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920237|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
44653477|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653478|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653479|NCT00137046|Insulin|insulin|mesh-list
44653480|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44653481|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653482|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653483|NCT00136955|Irinotecan|irinotecan|mesh-list
44653484|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44653485|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44653486|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653487|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653488|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653489|NCT00136916|Insulin|insulin|mesh-list
44653490|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44653491|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653492|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653493|NCT00136318|Ribavirin|ribavirin|mesh-list
44653494|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44653495|NCT00136318|Citalopram|citalopram|mesh-list
44653496|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
44653497|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653498|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
44653499|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653500|NCT00136318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44653501|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44653502|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44653503|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653504|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
44653505|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653506|NCT00136318|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44653507|NCT00136318|Antidepressive Agents|antidepressive agents|mesh-ancestor
44653508|NCT00136318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653509|NCT00136084|Cytarabine|cytarabine|mesh-list
44653510|NCT00136084|Dexamethasone|dexamethasone|mesh-list
44653511|NCT00136084|Prednisone|prednisone|mesh-list
44653512|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
44653513|NCT00136084|Methotrexate|methotrexate|mesh-list
44653514|NCT00136084|Etoposide|etoposide|mesh-list
44653515|NCT00136084|Vincristine|vincristine|mesh-list
44653516|NCT00136084|Daunorubicin|daunorubicin|mesh-list
44653517|NCT00136084|Asparaginase|asparaginase|mesh-list
44653518|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
44653519|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
44653520|NCT00136084|Cladribine|cladribine|mesh-list
44653521|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
44653522|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653523|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
44653524|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653525|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653526|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653527|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
44653528|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653529|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653530|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44653531|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653532|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
44653533|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
44653534|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653535|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653536|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
44653537|NCT00136084|Hormones|hormones|mesh-ancestor
44653538|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653539|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653540|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44653541|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
44653542|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44653543|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653544|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
44653545|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
44653546|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653547|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44653548|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653549|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653550|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44653551|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44653552|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
44653553|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653554|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653555|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653556|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653557|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44653558|NCT00136084|Analgesics|analgesics|mesh-ancestor
44653559|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
44653560|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653561|NCT00135707|Vitamins|vitamins|mesh-list
44653562|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
44653563|NCT00135707|Vitamin E|vitamin e|mesh-list
44653564|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
44653565|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
44653566|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653567|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
44653568|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653569|NCT00135707|Protective Agents|protective agents|mesh-ancestor
44653570|NCT00135694|Prednisone|prednisone|mesh-list
44653571|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44653572|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653573|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
44653574|NCT00135694|Hormones|hormones|mesh-ancestor
44653575|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920289|NCT04245865|Leucovorin|leucovorin|mesh-list
44653576|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653577|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653578|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653579|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653580|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653581|NCT00135512|Bupropion|bupropion|mesh-list
44653582|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44653583|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
44653584|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653585|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44653586|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44653587|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44653588|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653589|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
44653590|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653591|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653592|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44653593|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44653594|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653595|NCT00135356|Ritonavir|ritonavir|mesh-list
44653596|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44653597|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44653598|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44653599|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
44653600|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44653601|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653602|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653603|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44653604|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44653605|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
44653606|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653607|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44653608|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44653609|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653610|NCT00135330|Exenatide|exenatide|mesh-list
44653611|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
44653612|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653613|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653614|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44653615|NCT00135330|Incretins|incretins|mesh-ancestor
44653616|NCT00135330|Hormones|hormones|mesh-ancestor
44653617|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653618|NCT00134901|Memantine|memantine|mesh-list
44653619|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44653620|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44653621|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
44653622|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653623|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653624|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653625|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44653626|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44653627|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44653628|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
44653629|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653630|NCT00134563|Teriflunomide|teriflunomide|mesh-list
44653631|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44653632|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44653633|NCT00134563|Analgesics|analgesics|mesh-ancestor
44653634|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
44653635|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653636|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653637|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653638|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653639|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653640|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
44653641|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
44653642|NCT00134082|Rituximab|rituximab|mesh-list
44653643|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653644|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
44653645|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653646|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653647|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653648|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
44653649|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653650|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653651|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43920382|NCT03620123|Docetaxel|docetaxel|mesh-list
44653652|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653653|NCT00134056|Prednisone|prednisone|mesh-list
44653654|NCT00134056|Docetaxel|docetaxel|mesh-list
44653655|NCT00134056|Atrasentan|atrasentan|mesh-list
44653656|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653657|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653658|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653659|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653660|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653661|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653662|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
44653663|NCT00134056|Hormones|hormones|mesh-ancestor
44653664|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653665|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653666|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653667|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44653668|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44653669|NCT00133991|Leucovorin|leucovorin|mesh-list
44653670|NCT00133991|Cytarabine|cytarabine|mesh-list
44653671|NCT00133991|Prednisone|prednisone|mesh-list
44653672|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
44653673|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
44653674|NCT00133991|Rituximab|rituximab|mesh-list
44653675|NCT00133991|Methotrexate|methotrexate|mesh-list
44653676|NCT00133991|Vincristine|vincristine|mesh-list
44653677|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653678|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
44653679|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653680|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653681|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653682|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
44653683|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653684|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653685|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44653686|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653687|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653688|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
44653690|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653691|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653692|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44653693|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
44653694|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43920428|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44653695|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653696|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
44653697|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
44653698|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653699|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44653700|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653701|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
44653702|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653703|NCT00133991|Antidotes|antidotes|mesh-ancestor
44653704|NCT00133991|Protective Agents|protective agents|mesh-ancestor
44653705|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
44653706|NCT00133991|Vitamins|vitamins|mesh-ancestor
44653707|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
44653708|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44653709|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653710|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653711|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653712|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
44653713|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653714|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653715|NCT00133705|Mifepristone|mifepristone|mesh-list
44653716|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44653717|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
44653718|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44653719|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653720|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44653721|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44653722|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44653723|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
44653724|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44653725|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44653726|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
44653727|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653728|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
44653729|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44653730|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44653731|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
44653732|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44653733|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44653734|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
44653735|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
44653736|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653737|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653738|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
44653739|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44653740|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653741|NCT00132769|MK 0873|mk 0873|mesh-list
44653742|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44653743|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44653744|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653745|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653746|NCT00132730|MK 0873|mk 0873|mesh-list
44653747|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44653748|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44653749|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653750|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653751|NCT00132691|Cyclosporine|cyclosporine|mesh-list
44653752|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
44653753|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44653755|NCT00132691|Chlorambucil|chlorambucil|mesh-list
44653756|NCT00132691|Methotrexate|methotrexate|mesh-list
44653757|NCT00132691|Azathioprine|azathioprine|mesh-list
44653758|NCT00132691|Infliximab|infliximab|mesh-list
44653759|NCT00132691|Tacrolimus|tacrolimus|mesh-list
44653760|NCT00132691|Cyclosporins|cyclosporins|mesh-list
44653761|NCT00132691|Daclizumab|daclizumab|mesh-list
44653762|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44653763|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
44653764|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
44653765|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653766|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44653767|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653768|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653769|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653770|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44653771|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44653772|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
44653773|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44653774|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653775|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
44653776|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44653777|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653778|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44653779|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653780|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44653781|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
44653782|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653783|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44653784|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44653785|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
44653786|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44653787|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653788|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653789|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
44653790|NCT00132691|Hormones|hormones|mesh-ancestor
44653791|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653792|NCT00132678|Risperidone|risperidone|mesh-list
44653793|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44653794|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
44653795|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653796|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653797|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653798|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44653799|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653800|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653801|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653802|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44653803|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
44653804|NCT00132496|Rabeprazole|rabeprazole|mesh-list
44653805|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44653806|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653807|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44653808|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653809|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653810|NCT00132314|Risperidone|risperidone|mesh-list
44653811|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
44653812|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44653813|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
44653814|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653815|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653816|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653817|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44653818|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44653819|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44653820|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44653821|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
44653822|NCT00132301|Prednisone|prednisone|mesh-list
44653823|NCT00132301|Docetaxel|docetaxel|mesh-list
44653824|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653825|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
44653826|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44653827|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
44653828|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653829|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44653830|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
44653831|NCT00132301|Hormones|hormones|mesh-ancestor
44653832|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44653833|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653834|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44653835|NCT00132028|Vorinostat|vorinostat|mesh-list
44653836|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653837|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43920580|NCT00557349|Omeprazole|omeprazole|mesh-list
44653838|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653839|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653840|NCT00131937|Sorafenib|sorafenib|mesh-list
44653841|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653842|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653843|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653844|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653845|NCT00131911|Sorafenib|sorafenib|mesh-list
44653846|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653847|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653848|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653849|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653850|NCT00131664|Metformin|metformin|mesh-list
44653851|NCT00131664|Glimepiride|glimepiride|mesh-list
44653852|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
44653853|NCT00131664|Maleic acid|maleic acid|mesh-list
44653854|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653855|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653856|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653857|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653858|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44653859|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653860|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
44653861|NCT00131469|Teriparatide|teriparatide|mesh-list
43920617|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653862|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44653863|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653864|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44653866|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
44653867|NCT00131352|Protective Agents|protective agents|mesh-ancestor
44653868|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653869|NCT00131248|Metoclopramide|metoclopramide|mesh-list
44653870|NCT00131248|Ranitidine|ranitidine|mesh-list
44653871|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44653872|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
44653873|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
43920618|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43920619|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653874|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653875|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653876|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44653877|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44653879|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
44653880|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653881|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653882|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44653883|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44653884|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
44653885|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
44653886|NCT00130832|Vaccines|vaccines|mesh-list
44653887|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
44653888|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653889|NCT00130793|Vaccines|vaccines|mesh-list
44653890|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
44653891|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653892|NCT00130728|Bevacizumab|bevacizumab|mesh-list
44653893|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44653894|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653895|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653896|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44653897|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44653898|NCT00130728|Growth Substances|growth substances|mesh-ancestor
44653899|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653900|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
44653901|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653902|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653903|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653904|NCT00130689|Cetuximab|cetuximab|mesh-list
44653905|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653906|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653907|NCT00130637|Daclizumab|daclizumab|mesh-list
44653908|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653909|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
44653910|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653911|NCT00130533|Capecitabine|capecitabine|mesh-list
44653912|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653913|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
44653914|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653915|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653916|NCT00130520|Bevacizumab|bevacizumab|mesh-list
44653917|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44653918|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44653919|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653920|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44653921|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44653922|NCT00130520|Growth Substances|growth substances|mesh-ancestor
44653923|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653924|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
44653925|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44653926|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653927|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653928|NCT00130442|Dacarbazine|dacarbazine|mesh-list
44653929|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44653930|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
44653931|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653932|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653933|NCT00130247|Rifampin|rifampin|mesh-list
44653934|NCT00130247|Isoniazid|isoniazid|mesh-list
44653935|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
44653936|NCT00130247|Ethambutol|ethambutol|mesh-list
44653937|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44653938|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
44653939|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44653940|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653941|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
44653942|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44653943|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653944|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653945|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44653946|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44653947|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44653948|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44653949|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44653950|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44653951|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44653952|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44653953|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
44653954|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44653955|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44653957|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44653958|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
44653959|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653960|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44653961|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44653962|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44653963|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44653964|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653965|NCT00130039|Cilostazol|cilostazol|mesh-list
44653966|NCT00130039|Clopidogrel|clopidogrel|mesh-list
44653967|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44653968|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44653969|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44653970|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44653971|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
44653972|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44653973|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653974|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44653975|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44653976|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
44653977|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44653978|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44653979|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44653980|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44653981|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44653982|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
44653983|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44653984|NCT00130039|Protective Agents|protective agents|mesh-ancestor
44653985|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44653986|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44653987|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653988|NCT00129974|Gemcitabine|gemcitabine|mesh-list
44653989|NCT00129974|Pemetrexed|pemetrexed|mesh-list
44653990|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44653991|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
44653992|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44653993|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44653994|NCT00129974|Antiviral Agents|antiviral agents|mesh-ancestor
44653995|NCT00129974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44653996|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44653997|NCT00129974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44653998|NCT00129974|Immunologic Factors|immunologic factors|mesh-ancestor
44653999|NCT00129974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654000|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44654001|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654002|NCT00129961|Cyclosporine|cyclosporine|mesh-list
44654003|NCT00129961|Sirolimus|sirolimus|mesh-list
44654004|NCT00129961|Tacrolimus|tacrolimus|mesh-list
44654005|NCT00129961|Cyclosporins|cyclosporins|mesh-list
44654006|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654007|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
44654008|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654009|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44654010|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654011|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654012|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
44654013|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654014|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654015|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654016|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44654017|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654018|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654019|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
44654020|NCT00129935|Docetaxel|docetaxel|mesh-list
44654021|NCT00129935|Capecitabine|capecitabine|mesh-list
44654022|NCT00129935|Epirubicin|epirubicin|mesh-list
44654023|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654024|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
44654025|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654026|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654027|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654029|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654030|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654031|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654032|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654033|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654034|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654035|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654036|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
44654037|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654038|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654039|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654040|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654041|NCT00129766|Palivizumab|palivizumab|mesh-list
44654042|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
44654043|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654044|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
44654045|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44654046|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654047|NCT00129545|Warfarin|warfarin|mesh-list
44654048|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
44654049|NCT00129467|Methylphenidate|methylphenidate|mesh-list
44654050|NCT00129467|Serotonin|serotonin|mesh-list
44654051|NCT00129467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44654052|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44654053|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654054|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44654055|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44654056|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44654057|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654058|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
44654059|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920736|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
44654060|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44654061|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
44654062|NCT00129402|Simvastatin|simvastatin|mesh-list
44654063|NCT00129402|Ezetimibe|ezetimibe|mesh-list
44654064|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44654065|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44654066|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
44654067|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654068|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44654069|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44654070|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654071|NCT00129389|Paclitaxel|paclitaxel|mesh-list
44654072|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
44654073|NCT00129389|Doxorubicin|doxorubicin|mesh-list
44654074|NCT00129389|Fluorouracil|fluorouracil|mesh-list
44654075|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44654076|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654077|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654078|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654079|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654080|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654081|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654082|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
44654083|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654084|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654085|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654086|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
44654087|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654088|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654089|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654090|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654091|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654092|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
44654093|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654094|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
44654095|NCT00129376|Docetaxel|docetaxel|mesh-list
44654096|NCT00129376|Doxorubicin|doxorubicin|mesh-list
44654097|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654098|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
44654099|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654100|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654101|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654102|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
44654103|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654104|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204665|NCT00415285|Docetaxel|docetaxel|mesh-list
44654105|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654106|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654107|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654108|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654109|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654110|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654111|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654112|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654113|NCT00129311|Selegiline|selegiline|mesh-list
44654114|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
44654115|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654116|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44654117|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43920800|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
44654118|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44654119|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654120|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654121|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44654122|NCT00129311|Protective Agents|protective agents|mesh-ancestor
44654123|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654124|NCT00129272|Bupropion|bupropion|mesh-list
44654125|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44654126|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
44654127|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654128|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44654129|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44654130|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44654131|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654132|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
44654133|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654134|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654135|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44654136|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44654137|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654139|NCT00129259|Trace Elements|trace elements|mesh-ancestor
44654140|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
44654141|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654142|NCT00129220|Haloperidol|haloperidol|mesh-list
44654143|NCT00129220|Olanzapine|olanzapine|mesh-list
44654144|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
44654145|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
44654146|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
44654147|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654148|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654149|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920830|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654150|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44654151|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44654152|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44654153|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654154|NCT00129220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44654155|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44654156|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44654157|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654158|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654159|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
44654160|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44654161|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
44654162|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44654163|NCT00129129|Vaccines|vaccines|mesh-list
44654164|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
44654165|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654166|NCT00129116|Vaccines|vaccines|mesh-list
44654167|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
44654168|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654169|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44654170|NCT00128830|Etravirine|etravirine|mesh-list
44654171|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
44654172|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44654173|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
44654174|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654175|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654176|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204733|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44654178|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654179|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44654180|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654181|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654182|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44654183|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44654184|NCT00128661|Vaccines|vaccines|mesh-list
44654185|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
44654186|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654187|NCT00128206|Rifampin|rifampin|mesh-list
44654188|NCT00128206|Isoniazid|isoniazid|mesh-list
44654189|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44654190|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
44654191|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44654192|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654193|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
44654194|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654195|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654196|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654197|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44654198|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44654199|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44654200|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44654201|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44654202|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44654203|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43920855|NCT05418777|Trimethoprim|trimethoprim|mesh-list
44139359|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654204|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44654205|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
44654206|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44654207|NCT00128102|Vorinostat|vorinostat|mesh-list
44654208|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654209|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44654210|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654211|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654212|NCT00127933|Capecitabine|capecitabine|mesh-list
44654213|NCT00127933|Docetaxel|docetaxel|mesh-list
44654214|NCT00127933|Trastuzumab|trastuzumab|mesh-list
44654215|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654216|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
44654217|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654218|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654219|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654220|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654221|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654222|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654223|NCT00127855|Vaccines|vaccines|mesh-list
44654224|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44654225|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
44654226|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654227|NCT00127842|Etanercept|etanercept|mesh-list
44654228|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44654229|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44654230|NCT00127842|Analgesics|analgesics|mesh-ancestor
44654231|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
44654232|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654233|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654234|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654235|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139381|NCT00174993|Pioglitazone|pioglitazone|mesh-list
44654236|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44654237|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654238|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
44654239|NCT00127803|Vaccines|vaccines|mesh-list
44654240|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
44654241|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654242|NCT00127712|Amiodarone|amiodarone|mesh-list
44654243|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44654244|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
44654245|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44654246|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44654247|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654248|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43920892|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654249|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44654250|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44654251|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654252|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44654253|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44654254|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44654255|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
44654256|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
44654257|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
44654258|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44654259|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654260|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44654261|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44654262|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654263|NCT00127192|Incretins|incretins|mesh-ancestor
44654264|NCT00127192|Hormones|hormones|mesh-ancestor
44654265|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654266|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44654267|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
44654268|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654269|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654270|NCT00127166|Fluticasone|fluticasone|mesh-list
44654271|NCT00127166|Xhance|xhance|mesh-list
44654272|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44654273|NCT00127166|Montelukast|montelukast|mesh-list
44654274|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654275|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44654276|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
44654277|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920921|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43920922|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44654278|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654279|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44654280|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
44654281|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654282|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44654283|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44654284|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44654285|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44654286|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
44654287|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654288|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654289|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44654290|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
44654291|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654292|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44654293|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44654294|NCT00127127|Vorinostat|vorinostat|mesh-list
44654295|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654296|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44654297|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654298|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654299|NCT00127101|Vorinostat|vorinostat|mesh-list
44654300|NCT00127101|Bexarotene|bexarotene|mesh-list
44654301|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654302|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44654303|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654304|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654305|NCT00127036|Bevacizumab|bevacizumab|mesh-list
44654306|NCT00127036|Capecitabine|capecitabine|mesh-list
44654307|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
44654308|NCT00127036|Irinotecan|irinotecan|mesh-list
44654309|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654310|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654311|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654312|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654313|NCT00127036|Growth Substances|growth substances|mesh-ancestor
44654314|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654315|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920961|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920962|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920963|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
43920964|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920965|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43920966|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654316|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654317|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
44654318|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654319|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44654320|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654321|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654322|NCT00126672|Sirolimus|sirolimus|mesh-list
44654323|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44654324|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654325|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204882|NCT00416325|Protective Agents|protective agents|mesh-ancestor
44654326|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654327|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
44654328|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654329|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
44654330|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654332|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654333|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654334|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654335|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654336|NCT00126594|Interferons|interferons|mesh-list
44654337|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
44654338|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
44654339|NCT00126594|Sorafenib|sorafenib|mesh-list
44654340|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654341|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
44654342|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654343|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43920992|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
44654344|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654345|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654346|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
44654347|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654348|NCT00126581|Paclitaxel|paclitaxel|mesh-list
44654349|NCT00126581|Carboplatin|carboplatin|mesh-list
44654350|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44654351|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44654352|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44654353|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654354|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654355|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654356|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654357|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654358|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654359|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654360|NCT00126568|Sorafenib|sorafenib|mesh-list
44654361|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654362|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654363|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654364|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654365|NCT00126555|Gefitinib|gefitinib|mesh-list
44654366|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654367|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654368|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654369|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654370|NCT00126503|Bevacizumab|bevacizumab|mesh-list
44654371|NCT00126503|Sorafenib|sorafenib|mesh-list
44654372|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654373|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654374|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654375|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654376|NCT00126503|Growth Substances|growth substances|mesh-ancestor
44654377|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654378|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44654379|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654380|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921008|NCT05028075|Cobalt|cobalt|mesh-list
44654381|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654382|NCT00126490|Aldesleukin|aldesleukin|mesh-list
44654383|NCT00126490|Bevacizumab|bevacizumab|mesh-list
44654384|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44654385|NCT00126490|Interleukin-2|interleukin-2|mesh-list
44654386|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
44654387|NCT00126490|Antibodies|antibodies|mesh-list
44654388|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
44654389|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44654390|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
44654391|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654392|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654393|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654394|NCT00126490|Growth Substances|growth substances|mesh-ancestor
44654395|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654396|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
44654397|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
44654398|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44654399|NCT00126490|Analgesics|analgesics|mesh-ancestor
44654400|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
44204957|NCT00416507|Antiviral Agents|antiviral agents|mesh-ancestor
44654401|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654402|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654403|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654404|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
44654405|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654406|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44654407|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654408|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654409|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654410|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44654411|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44654412|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654413|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654414|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654415|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44654416|NCT00126191|Leucovorin|leucovorin|mesh-list
44654417|NCT00126191|Cytarabine|cytarabine|mesh-list
44654418|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
44654419|NCT00126191|Ifosfamide|ifosfamide|mesh-list
44654420|NCT00126191|Rituximab|rituximab|mesh-list
44654421|NCT00126191|Doxorubicin|doxorubicin|mesh-list
44654422|NCT00126191|Methotrexate|methotrexate|mesh-list
44654423|NCT00126191|Etoposide|etoposide|mesh-list
44654424|NCT00126191|Vincristine|vincristine|mesh-list
44654425|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654426|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
44654427|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654428|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654429|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654430|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
43921036|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
44654431|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654432|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654433|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654434|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654435|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654436|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654437|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654438|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654439|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44654440|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
44654441|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44654442|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654443|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
44654444|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654445|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44654446|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654447|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44654448|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
44654449|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654450|NCT00126191|Antidotes|antidotes|mesh-ancestor
44654451|NCT00126191|Protective Agents|protective agents|mesh-ancestor
44654452|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
44654453|NCT00126191|Vitamins|vitamins|mesh-ancestor
44654454|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
44654455|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654456|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654457|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654458|NCT00125853|Atenolol|atenolol|mesh-list
44654459|NCT00125853|Nebivolol|nebivolol|mesh-list
44654460|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44654461|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44654462|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
44654463|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
44654464|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654465|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654466|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44654467|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44654468|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44654469|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
44654470|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654471|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654472|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
44654473|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44654474|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44654475|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44654477|NCT00125359|Bexarotene|bexarotene|mesh-list
44654478|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654479|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654480|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654481|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654483|NCT00125190|Growth Substances|growth substances|mesh-ancestor
44654484|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654485|NCT00125164|Mecasermin|mecasermin|mesh-list
44654486|NCT00125164|Growth Substances|growth substances|mesh-ancestor
44654487|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654488|NCT00125138|Metylperon|metylperon|mesh-list
44654489|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44654490|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44654491|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44654492|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654493|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654494|NCT00124982|Abatacept|abatacept|mesh-list
44654495|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
44654496|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44654497|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654498|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654499|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654500|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
44654501|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654502|NCT00124943|Paclitaxel|paclitaxel|mesh-list
44654503|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44654504|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44654505|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654506|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654507|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654508|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654509|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654510|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
44654511|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654512|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654513|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654514|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654515|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
44654516|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44654517|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44654518|NCT00124709|Analgesics|analgesics|mesh-ancestor
43921075|NCT04904965|Propofol|propofol|mesh-list
44654519|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
44654520|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654521|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654522|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654523|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654524|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654525|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654526|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
44654527|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44654528|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654529|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654530|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44654531|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654532|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654533|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654534|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654535|NCT00124618|Cetuximab|cetuximab|mesh-list
44654536|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654537|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654538|NCT00124449|Abatacept|abatacept|mesh-list
44654539|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44654540|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654541|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654542|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654543|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
44654544|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654545|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654546|NCT00124072|Folic Acid|folic acid|mesh-list
44654547|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
44654548|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
44654549|NCT00124072|Simvastatin|simvastatin|mesh-list
43921124|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654550|NCT00124072|Vitamins|vitamins|mesh-ancestor
44456130|NCT01634178|Apremilast|apremilast|mesh-list
44654551|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
44654552|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654553|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44654554|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44654555|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
44654556|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654557|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44654558|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44654559|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654560|NCT00124072|Hematinics|hematinics|mesh-ancestor
44654561|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
44654562|NCT00124020|Vancomycin|vancomycin|mesh-list
44654563|NCT00124020|Telavancin|telavancin|mesh-list
44654564|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44654565|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654566|NCT00123955|Spironolactone|spironolactone|mesh-list
44654567|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44654568|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
44654569|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654570|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654571|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44654572|NCT00123955|Diuretics|diuretics|mesh-ancestor
44654573|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
44654574|NCT00123487|Dasatinib|dasatinib|mesh-list
44654575|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654576|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654577|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654578|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654579|NCT00123474|Dasatinib|dasatinib|mesh-list
44654580|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654581|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654582|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654583|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654584|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
44654585|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654586|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
44654587|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654588|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654589|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654590|NCT00122681|Vaccines|vaccines|mesh-list
44654591|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
44654592|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654593|NCT00122460|Cisplatin|cisplatin|mesh-list
44654594|NCT00122460|Carboplatin|carboplatin|mesh-list
44654595|NCT00122460|Fluorouracil|fluorouracil|mesh-list
44654596|NCT00122460|Cetuximab|cetuximab|mesh-list
44654597|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654598|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
44654599|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654600|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654601|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654602|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
44654603|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654604|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654605|NCT00122382|Methotrexate|methotrexate|mesh-list
44654606|NCT00122382|Abatacept|abatacept|mesh-list
44654607|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44654608|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
44654609|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44654610|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654611|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654612|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
44654613|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654614|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654615|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654616|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654617|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44654618|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654619|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
44654620|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654621|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654622|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44654623|NCT00122317|Eculizumab|eculizumab|mesh-list
44654624|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44654626|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
44654627|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654628|NCT00122278|Dexamethasone|dexamethasone|mesh-list
44654629|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654630|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
44654631|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
44654632|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654633|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654634|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44654635|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
44654636|NCT00122278|Hormones|hormones|mesh-ancestor
44654637|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654638|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44654639|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654640|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
44654641|NCT00121992|Docetaxel|docetaxel|mesh-list
44654642|NCT00121992|Doxorubicin|doxorubicin|mesh-list
44654643|NCT00121992|Fluorouracil|fluorouracil|mesh-list
44654644|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654645|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
44654646|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654647|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654648|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654649|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
44654650|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654651|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654652|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654653|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654654|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654655|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654656|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654657|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654658|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654659|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654660|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
44654661|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654662|NCT00121667|Metformin|metformin|mesh-list
44654663|NCT00121667|Pioglitazone|pioglitazone|mesh-list
44654664|NCT00121667|Saxagliptin|saxagliptin|mesh-list
44654665|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44654666|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654667|NCT00121667|Incretins|incretins|mesh-ancestor
44654668|NCT00121667|Hormones|hormones|mesh-ancestor
44654669|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654670|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44654671|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
44654672|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654673|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654674|NCT00121641|Metformin|metformin|mesh-list
44654675|NCT00121641|Saxagliptin|saxagliptin|mesh-list
44654676|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44654677|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654678|NCT00121641|Incretins|incretins|mesh-ancestor
44654679|NCT00121641|Hormones|hormones|mesh-ancestor
43921247|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
44654680|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654681|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44654682|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
44654683|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654684|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654685|NCT00121199|Prednisone|prednisone|mesh-list
44654686|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
44654687|NCT00121199|Bevacizumab|bevacizumab|mesh-list
44654688|NCT00121199|Rituximab|rituximab|mesh-list
44654689|NCT00121199|Doxorubicin|doxorubicin|mesh-list
44654690|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44654691|NCT00121199|Vincristine|vincristine|mesh-list
44654692|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44654693|NCT00121199|Antibodies|antibodies|mesh-list
44654694|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
44654695|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44139470|NCT00175396|Flutamide|flutamide|mesh-list
44654696|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654697|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
44654698|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654699|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654700|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654701|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
44654702|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654703|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654704|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654705|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654706|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654707|NCT00121199|Growth Substances|growth substances|mesh-ancestor
44654708|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44654709|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654710|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654711|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654712|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654713|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654714|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
44654715|NCT00121199|Hormones|hormones|mesh-ancestor
44654716|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654717|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44654718|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44654719|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44654720|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44654721|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44654722|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
44654723|NCT00121134|Bevacizumab|bevacizumab|mesh-list
44654724|NCT00121134|Capecitabine|capecitabine|mesh-list
44654725|NCT00121134|Methotrexate|methotrexate|mesh-list
44654726|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654727|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
44654728|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654729|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654730|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654731|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
44654732|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654733|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654734|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654735|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44654736|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654737|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654738|NCT00121134|Growth Substances|growth substances|mesh-ancestor
44654739|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
44654740|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654741|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
44654742|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44654743|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
44654744|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44654745|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654746|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654747|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44654748|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654749|NCT00120874|Memantine|memantine|mesh-list
44654750|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44654751|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44654752|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
44654753|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654754|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654755|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654756|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44654757|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44654758|NCT00120289|Niacin|niacin|mesh-list
44654759|NCT00120289|Simvastatin|simvastatin|mesh-list
44654760|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44654761|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44654762|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
44654763|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654764|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44654765|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44654766|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654767|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
44654768|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
44654769|NCT00120289|Vitamins|vitamins|mesh-ancestor
44654770|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
44654771|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654772|NCT00120250|Eszopiclone|eszopiclone|mesh-list
44654773|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44654774|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921316|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921317|NCT03586453|Osimertinib|osimertinib|mesh-list
44654775|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654776|NCT00119678|Prednisone|prednisone|mesh-list
44654777|NCT00119678|Abatacept|abatacept|mesh-list
44654778|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654779|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
44654780|NCT00119678|Hormones|hormones|mesh-ancestor
44654781|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654782|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654783|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44654784|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654785|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44654786|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654787|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654788|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
44654789|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654790|NCT00119379|Tenofovir|tenofovir|mesh-list
44654791|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
44654792|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654793|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44654794|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654795|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654796|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654797|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654798|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654799|NCT00119262|Tamoxifen|tamoxifen|mesh-list
44654800|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
44654801|NCT00119262|Bevacizumab|bevacizumab|mesh-list
44654802|NCT00119262|Doxorubicin|doxorubicin|mesh-list
44654803|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44654804|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44654805|NCT00119262|Antibodies|antibodies|mesh-list
44654806|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
44654807|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44654808|NCT00119262|Lenograstim|lenograstim|mesh-list
44654809|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44654810|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654811|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654812|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654813|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
44654814|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654815|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654816|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44654817|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
44654818|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44654819|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44654820|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44654821|NCT00119262|Growth Substances|growth substances|mesh-ancestor
44654822|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44654823|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654824|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44654825|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44654826|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654827|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44654828|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44654829|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
44654830|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654831|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44654832|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44654833|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44654834|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44654835|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44654836|NCT00119106|Tenofovir|tenofovir|mesh-list
44654837|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
44654838|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654839|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44654840|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654841|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654842|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654843|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654844|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654845|NCT00119015|Fluticasone|fluticasone|mesh-list
44654846|NCT00119015|Xhance|xhance|mesh-list
44654847|NCT00119015|Montelukast|montelukast|mesh-list
44654848|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654849|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44654851|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654852|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654853|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44654854|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
44654855|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654856|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44654857|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44654858|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
44654859|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654860|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44654861|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44654862|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654863|NCT00118898|Ritonavir|ritonavir|mesh-list
44654864|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44654865|NCT00118898|Tenofovir|tenofovir|mesh-list
44654866|NCT00118898|Lamivudine|lamivudine|mesh-list
44654867|NCT00118898|Emtricitabine|emtricitabine|mesh-list
44654868|NCT00118898|Abacavir|abacavir|mesh-list
44654869|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44654870|NCT00118898|Efavirenz|efavirenz|mesh-list
44654871|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
44654872|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44654873|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44205410|NCT00417911|Bortezomib|bortezomib|mesh-list
44654874|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
44654875|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654876|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654877|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654878|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654879|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
44654880|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654881|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44654882|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44654883|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44654884|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654885|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44654886|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44654887|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44654888|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44654889|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44654890|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
44654891|NCT00118716|Fluticasone|fluticasone|mesh-list
44654892|NCT00118716|Xhance|xhance|mesh-list
44654893|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44654894|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654895|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44654896|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
44654897|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654898|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654899|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44654900|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
44654901|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
44654902|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44654903|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44654904|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44654905|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44654906|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
44654907|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654908|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654909|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
44654910|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654911|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
44654912|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654913|NCT00118417|Clonazepam|clonazepam|mesh-list
44654914|NCT00118417|Sertraline|sertraline|mesh-list
44654915|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
44654916|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44654917|NCT00118417|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44654918|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44654919|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44654920|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921486|NCT02871687|Simvastatin|simvastatin|mesh-list
43921487|NCT02871687|Pravastatin|pravastatin|mesh-list
43921488|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43921489|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43921490|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
43921491|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921492|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43921493|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43921494|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921495|NCT02812212|Diuretics|diuretics|mesh-list
44654921|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44654922|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
44654923|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654924|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
44654925|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
44654926|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
44654927|NCT00118287|Etanercept|etanercept|mesh-list
44654928|NCT00118287|Azacitidine|azacitidine|mesh-list
44654929|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44654930|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
44654931|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654932|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654933|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654934|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44654935|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44654936|NCT00118287|Analgesics|analgesics|mesh-ancestor
44654937|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
44654938|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44654939|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654940|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44654941|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44654942|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44654943|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654944|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
44654945|NCT00118157|Tamoxifen|tamoxifen|mesh-list
44654946|NCT00118157|Lapatinib|lapatinib|mesh-list
44205495|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
44654947|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654948|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44654949|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
44654950|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654951|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654952|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44654953|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654954|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44654955|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44654956|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44654957|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654958|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654959|NCT00118040|Genistein|genistein|mesh-list
43921526|NCT02247349|Nivolumab|nivolumab|mesh-list
43921527|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921528|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921529|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921530|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667759|NCT04721457|Eusol|eusol|mesh-list
43796028|NCT04092179|Venetoclax|venetoclax|mesh-list
44169137|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169138|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169139|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169156|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169157|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169158|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169159|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169161|NCT00274092|Ipratropium|ipratropium|mesh-list
44169162|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169163|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
44169164|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169165|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169166|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169167|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
44654960|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44654961|NCT00118040|Protective Agents|protective agents|mesh-ancestor
44654962|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44654963|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654964|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654965|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654966|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654967|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
44654968|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44654969|NCT00118040|Estrogens|estrogens|mesh-ancestor
44654970|NCT00118040|Hormones|hormones|mesh-ancestor
44654971|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44654972|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
44654973|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654974|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44654975|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44654976|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44654977|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44654978|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654979|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654980|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
44654981|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654982|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44654983|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44654984|NCT00117637|Interferons|interferons|mesh-list
44654985|NCT00117637|Sorafenib|sorafenib|mesh-list
44654986|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654987|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
44654988|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921560|NCT01033552|Cyclosporine|cyclosporine|mesh-list
43921561|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
43921562|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
43921563|NCT01033552|Fludarabine|fludarabine|mesh-list
43921564|NCT01033552|Cyclosporins|cyclosporins|mesh-list
43921565|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44654989|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44654990|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44654991|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44654992|NCT00117598|Sirolimus|sirolimus|mesh-list
44654993|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44654994|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44654995|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44654996|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44654997|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
44654998|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44654999|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
44655000|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655001|NCT00117572|Cisplatin|cisplatin|mesh-list
44655002|NCT00117572|Docetaxel|docetaxel|mesh-list
44655003|NCT00117572|Fluorouracil|fluorouracil|mesh-list
44655004|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
44655005|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655006|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655007|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655008|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655009|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655010|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
44655011|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655012|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655013|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
44655014|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655015|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
44655016|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655017|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655018|NCT00117507|Deferasirox|deferasirox|mesh-list
44655019|NCT00117507|Chelating Agents|chelating agents|mesh-list
44655020|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44655021|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
44655022|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655023|NCT00117338|Montelukast|montelukast|mesh-list
44655024|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44655025|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
44655026|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44655027|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
44655028|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655029|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655030|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44655031|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44655032|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655034|NCT00117156|Fludarabine|fludarabine|mesh-list
44655035|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655036|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655037|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
43921566|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655038|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655039|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655040|NCT00116844|Valacyclovir|valacyclovir|mesh-list
44655041|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
44655042|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655043|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
44655044|NCT00116831|Glipizide|glipizide|mesh-list
44655045|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44655046|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655047|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44655048|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44655049|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44655050|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655051|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655052|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655053|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
44655054|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655055|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44655056|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44655057|NCT00116649|Imiquimod|imiquimod|mesh-list
44655058|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44655059|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
44655060|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655061|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655062|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
44655063|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44655064|NCT00116272|Etanercept|etanercept|mesh-list
44655065|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44655066|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44655067|NCT00116272|Analgesics|analgesics|mesh-ancestor
44655068|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
44655069|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655070|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655071|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655072|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655073|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655074|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921614|NCT00634166|Miconazole|miconazole|mesh-list
44655075|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
44655076|NCT00115804|Fluoxetine|fluoxetine|mesh-list
44655077|NCT00115804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44655078|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44655079|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44655080|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655081|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655082|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
44655083|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655084|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44655085|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655086|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655087|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44655088|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44655089|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655090|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
44655091|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44655092|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
44655093|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44655094|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
44655095|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655096|NCT00115765|Bevacizumab|bevacizumab|mesh-list
44655097|NCT00115765|Panitumumab|panitumumab|mesh-list
44655098|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
44655099|NCT00115765|Irinotecan|irinotecan|mesh-list
44655100|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655101|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655102|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44655103|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44655104|NCT00115765|Growth Substances|growth substances|mesh-ancestor
44655105|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655106|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
44655107|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44655108|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44655109|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655110|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655111|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
44655112|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655113|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655114|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655115|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655116|NCT00115349|Deferiprone|deferiprone|mesh-list
44655117|NCT00115349|Deferoxamine|deferoxamine|mesh-list
44655118|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44655119|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
44655120|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
44655121|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655122|NCT00115349|Siderophores|siderophores|mesh-ancestor
44655123|NCT00115336|Ibuprofen|ibuprofen|mesh-list
44655124|NCT00115336|Ketorolac|ketorolac|mesh-list
44655125|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44655126|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44655127|NCT00115336|Analgesics|analgesics|mesh-ancestor
44655128|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
44655129|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655130|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655131|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655132|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655133|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44655134|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655135|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655136|NCT00115063|Orlistat|orlistat|mesh-list
44655137|NCT00115063|Sibutramine|sibutramine|mesh-list
44655138|NCT00115063|Diethylpropion|diethylpropion|mesh-list
44655139|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655140|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655141|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44655142|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44655143|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655144|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655145|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
44655146|NCT00115037|Naltrexone|naltrexone|mesh-list
44655147|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44655148|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44655149|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655150|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
44655151|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655152|NCT00114972|Paclitaxel|paclitaxel|mesh-list
44655153|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44655154|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655155|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655156|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655157|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655158|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655159|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655160|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
44655161|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
44655162|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655163|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655164|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655165|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655166|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655167|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44655168|NCT00114777|Cyclosporine|cyclosporine|mesh-list
44205683|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655169|NCT00114777|Abatacept|abatacept|mesh-list
44655170|NCT00114777|Cyclosporins|cyclosporins|mesh-list
44655171|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655172|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655173|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655174|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
44655175|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655176|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
44655177|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655178|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44655179|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655180|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44655181|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44655182|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655183|NCT00114738|Rituximab|rituximab|mesh-list
44655184|NCT00114738|Bortezomib|bortezomib|mesh-list
44655185|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655186|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655187|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
44655188|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655189|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655190|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
44655191|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655192|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
44655193|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655194|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655195|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655196|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
44655197|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655198|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655199|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44655200|NCT00114244|Gemcitabine|gemcitabine|mesh-list
44655201|NCT00114244|Sorafenib|sorafenib|mesh-list
44655202|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655203|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
44655204|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655205|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655206|NCT00114244|Antiviral Agents|antiviral agents|mesh-ancestor
44655207|NCT00114244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655208|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655209|NCT00114244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655210|NCT00114244|Immunologic Factors|immunologic factors|mesh-ancestor
44655211|NCT00114244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655212|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655213|NCT00114231|Capecitabine|capecitabine|mesh-list
44655214|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
44655215|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655217|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655218|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655219|NCT00114218|Gemcitabine|gemcitabine|mesh-list
44655220|NCT00114218|Docetaxel|docetaxel|mesh-list
44655221|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655222|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
44655223|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655224|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655225|NCT00114218|Antiviral Agents|antiviral agents|mesh-ancestor
44655226|NCT00114218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655227|NCT00114218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655228|NCT00114218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655229|NCT00114218|Immunologic Factors|immunologic factors|mesh-ancestor
44655230|NCT00114218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655231|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655232|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655233|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655234|NCT00114166|Topotecan|topotecan|mesh-list
44655235|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44655236|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44655237|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655238|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655239|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655240|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44655241|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44655242|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44655243|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44655244|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655245|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655246|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655247|NCT00114127|Analgesics|analgesics|mesh-ancestor
44655248|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
44655249|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655250|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655251|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655252|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
44655253|NCT00113919|Busulfan|busulfan|mesh-list
44655254|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
44655255|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655256|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655257|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
44655258|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655259|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655260|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655261|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44655262|NCT00113841|Curcumin|curcumin|mesh-list
44655263|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44655264|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44655265|NCT00113841|Analgesics|analgesics|mesh-ancestor
44655266|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
44655267|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655268|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655269|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655270|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655271|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655272|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655273|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655274|NCT00113607|Dexamethasone|dexamethasone|mesh-list
44655275|NCT00113607|Trabectedin|trabectedin|mesh-list
44655276|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655277|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
44655278|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
44655279|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655280|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655281|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655282|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
44655283|NCT00113607|Hormones|hormones|mesh-ancestor
44655284|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655285|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655286|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655287|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655288|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
44655289|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655290|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
44655291|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44655292|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44655293|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655295|NCT00113568|Coagulants|coagulants|mesh-ancestor
44655296|NCT00113529|Sunitinib|sunitinib|mesh-list
44655297|NCT00113529|Gefitinib|gefitinib|mesh-list
44655298|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655299|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44655300|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44655301|NCT00113529|Growth Substances|growth substances|mesh-ancestor
44655302|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655303|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44655304|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655305|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655306|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655307|NCT00113516|Paclitaxel|paclitaxel|mesh-list
44655308|NCT00113516|Carboplatin|carboplatin|mesh-list
44655309|NCT00113516|Sunitinib|sunitinib|mesh-list
44655310|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655311|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655312|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655313|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655314|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655315|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205828|NCT00419653|Olanzapine|olanzapine|mesh-list
44655316|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44655317|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44655318|NCT00113516|Growth Substances|growth substances|mesh-ancestor
44655319|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655320|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44655321|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655322|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655323|NCT00113490|Palivizumab|palivizumab|mesh-list
44655324|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
44655325|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655326|NCT00113399|Paclitaxel|paclitaxel|mesh-list
44655327|NCT00113399|Docetaxel|docetaxel|mesh-list
44655328|NCT00113399|Cisplatin|cisplatin|mesh-list
44655329|NCT00113399|Fluorouracil|fluorouracil|mesh-list
44655330|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655331|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655332|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655333|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655334|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655335|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655336|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
43921802|NCT00567320|Varenicline|varenicline|mesh-list
44655337|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655338|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655339|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
44655340|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655341|NCT00113386|Cisplatin|cisplatin|mesh-list
44655342|NCT00113386|Docetaxel|docetaxel|mesh-list
44655343|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655344|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655345|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655346|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655347|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655348|NCT00113373|Lapatinib|lapatinib|mesh-list
44655349|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655350|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655351|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655352|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655353|NCT00113360|Everolimus|everolimus|mesh-list
44655354|NCT00113360|Octreotide|octreotide|mesh-list
44655355|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655356|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655357|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
44655358|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655359|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655360|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655361|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44655362|NCT00113295|Paroxetine|paroxetine|mesh-list
44655363|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655364|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655365|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44655366|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44655367|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44655368|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655369|NCT00113295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44655370|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44655371|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44655372|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655373|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655374|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
44655375|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44655376|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44655377|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44655378|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655379|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
44655380|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
44655381|NCT00113269|Tacrolimus|tacrolimus|mesh-list
44655382|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
44655383|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44655384|NCT00113269|Basiliximab|basiliximab|mesh-list
44655385|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655386|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
44655387|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655388|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44655389|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655390|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655391|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655392|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655393|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44655394|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
44655395|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655396|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655397|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655398|NCT00113087|Enalapril|enalapril|mesh-list
44655399|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44655400|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
44655401|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655402|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655403|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44655404|NCT00112905|Sorafenib|sorafenib|mesh-list
44655405|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655406|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655407|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655408|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655409|NCT00112736|Sirolimus|sirolimus|mesh-list
44655410|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44655411|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655412|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655413|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655414|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655415|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655416|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655417|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655418|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
44655419|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655420|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
44655421|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655422|NCT00112580|Ipilimumab|ipilimumab|mesh-list
44655423|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655424|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655425|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44655426|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655427|NCT00112502|Thalidomide|thalidomide|mesh-list
44655428|NCT00112502|Celecoxib|celecoxib|mesh-list
44655429|NCT00112502|Temozolomide|temozolomide|mesh-list
44655430|NCT00112502|Isotretinoin|isotretinoin|mesh-list
44655431|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655432|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
44655433|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655434|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655435|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44655436|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44655438|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
44655439|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655440|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655441|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655442|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655443|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44655444|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44655445|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655446|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655447|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
44655448|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
44655449|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655450|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655451|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44655452|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44655453|NCT00112502|Growth Substances|growth substances|mesh-ancestor
44655454|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
44655455|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
44655456|NCT00112489|Paclitaxel|paclitaxel|mesh-list
44655457|NCT00112489|Carboplatin|carboplatin|mesh-list
44655458|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655459|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655460|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655461|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655462|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655463|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655464|NCT00112463|Romidepsin|romidepsin|mesh-list
44456241|NCT01632891|Ritonavir|ritonavir|mesh-list
44655465|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655466|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655467|NCT00112437|Vitamin D|vitamin d|mesh-list
44655468|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
44655469|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
44655470|NCT00112437|Calcium|calcium|mesh-list
44655471|NCT00112437|Vitamins|vitamins|mesh-ancestor
44655472|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
44655473|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655474|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44655475|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43921957|NCT05362188|Niacin|niacin|mesh-list
43921958|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
43921959|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
43921960|NCT05362188|Vitamins|vitamins|mesh-ancestor
43921961|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
43921983|NCT05361772|Colchicine|colchicine|mesh-list
44655476|NCT00112437|Antacids|antacids|mesh-ancestor
44655477|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655478|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655479|NCT00112385|Etanercept|etanercept|mesh-list
44655480|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44655481|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44655482|NCT00112385|Analgesics|analgesics|mesh-ancestor
44655483|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
44655484|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655485|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655486|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655487|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655488|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655489|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655490|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
44655491|NCT00112294|Paclitaxel|paclitaxel|mesh-list
44655492|NCT00112294|Docetaxel|docetaxel|mesh-list
44655493|NCT00112294|Carboplatin|carboplatin|mesh-list
44655494|NCT00112294|Cetuximab|cetuximab|mesh-list
44655495|NCT00112294|Taxane|taxane|mesh-list
44655496|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655497|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655498|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655499|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655500|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655501|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655502|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655503|NCT00112047|Tenofovir|tenofovir|mesh-list
44655504|NCT00112047|Lamivudine|lamivudine|mesh-list
44655505|NCT00112047|Zidovudine|zidovudine|mesh-list
44655506|NCT00112047|Emtricitabine|emtricitabine|mesh-list
44655507|NCT00112047|Efavirenz|efavirenz|mesh-list
44655508|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44655509|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
44655510|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655511|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44655512|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655513|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655514|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655515|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44655516|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44655517|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
44655518|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44655519|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44655520|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44655521|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44655522|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44655523|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44655524|NCT00111917|Infliximab|infliximab|mesh-list
44655525|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
44655526|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655527|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655528|NCT00111839|Pemetrexed|pemetrexed|mesh-list
44655529|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655530|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655531|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655532|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44655533|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655534|NCT00111813|Bortezomib|bortezomib|mesh-list
44655535|NCT00111813|Vorinostat|vorinostat|mesh-list
44655536|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655537|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44205999|NCT00420524|Epothilone B|epothilone b|mesh-list
44655538|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655539|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655540|NCT00111761|Leucovorin|leucovorin|mesh-list
44655541|NCT00111761|Fluorouracil|fluorouracil|mesh-list
44655542|NCT00111761|Irinotecan|irinotecan|mesh-list
44655543|NCT00111761|Panitumumab|panitumumab|mesh-list
44655544|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
44655545|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655546|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655547|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655548|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655549|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
44655550|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655551|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43922030|NCT05355311|Vitamins|vitamins|mesh-ancestor
44655552|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44655553|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655554|NCT00111761|Antidotes|antidotes|mesh-ancestor
44655555|NCT00111761|Protective Agents|protective agents|mesh-ancestor
44655556|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
44655557|NCT00111761|Vitamins|vitamins|mesh-ancestor
44655558|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
44655559|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655560|NCT00111241|Letrozole|letrozole|mesh-list
44655561|NCT00111241|Anastrozole|anastrozole|mesh-list
44655562|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44655563|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655564|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44655565|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655566|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655567|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44655568|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
44655569|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655570|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655571|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655572|NCT00111007|Paclitaxel|paclitaxel|mesh-list
44655573|NCT00111007|Carboplatin|carboplatin|mesh-list
44139521|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139534|NCT00175643|Imiquimod|imiquimod|mesh-list
44655574|NCT00111007|Sorafenib|sorafenib|mesh-list
44655575|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655576|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655577|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655578|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655579|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655580|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655581|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655582|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655583|NCT00110994|Sorafenib|sorafenib|mesh-list
44655584|NCT00110994|Dacarbazine|dacarbazine|mesh-list
44655585|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655586|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655587|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655588|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655589|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655590|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
44655592|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44655593|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655594|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44655595|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
44655596|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655597|NCT00110812|Aldesleukin|aldesleukin|mesh-list
44655598|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655599|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44655600|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44655601|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
44655602|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655603|NCT00110617|Deferasirox|deferasirox|mesh-list
44655604|NCT00110617|Deferoxamine|deferoxamine|mesh-list
44655605|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44655606|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
44655607|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
44655608|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655609|NCT00110617|Siderophores|siderophores|mesh-ancestor
44206071|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44655610|NCT00110396|Interferons|interferons|mesh-list
44655611|NCT00110396|Interferon-beta|interferon-beta|mesh-list
44655612|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
44655613|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655614|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
44655615|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655616|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
44655617|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655618|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44655619|NCT00110357|Irinotecan|irinotecan|mesh-list
44655620|NCT00110357|Cetuximab|cetuximab|mesh-list
44655621|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44655622|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44655623|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655624|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655625|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655626|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655627|NCT00110305|Efavirenz|efavirenz|mesh-list
44655628|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44655629|NCT00110305|Rilpivirine|rilpivirine|mesh-list
44655630|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655631|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655632|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655633|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
44655634|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655635|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44655636|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44655637|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44655638|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44655639|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44655640|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44655641|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44655642|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44655643|NCT00110266|Deferasirox|deferasirox|mesh-list
44655644|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44655645|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
44655646|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
44655647|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655648|NCT00110214|Prednisone|prednisone|mesh-list
44655649|NCT00110214|Bevacizumab|bevacizumab|mesh-list
44655650|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44655651|NCT00110214|Docetaxel|docetaxel|mesh-list
44655652|NCT00110214|Antibodies|antibodies|mesh-list
44655653|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
44655654|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44655655|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655656|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44655657|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44655658|NCT00110214|Growth Substances|growth substances|mesh-ancestor
44655659|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655660|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
44655661|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
44655662|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655663|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655664|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655665|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655666|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655667|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
44655668|NCT00110214|Hormones|hormones|mesh-ancestor
44655669|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655670|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655671|NCT00110149|Rituximab|rituximab|mesh-list
44655672|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655673|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655674|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
44655675|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655676|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655677|NCT00110084|Gemcitabine|gemcitabine|mesh-list
44655678|NCT00110084|Paclitaxel|paclitaxel|mesh-list
44655679|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44655680|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655681|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655682|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655683|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655684|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655685|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655686|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655687|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
44655688|NCT00110084|Antiviral Agents|antiviral agents|mesh-ancestor
44655689|NCT00110084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655690|NCT00110084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655691|NCT00110084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655692|NCT00110084|Immunologic Factors|immunologic factors|mesh-ancestor
44655693|NCT00110084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655694|NCT00110019|Paclitaxel|paclitaxel|mesh-list
44655695|NCT00110019|Carboplatin|carboplatin|mesh-list
44655696|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44655697|NCT00110019|Sorafenib|sorafenib|mesh-list
44655698|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44655699|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655700|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
44655701|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
44655702|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
44655703|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655704|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655705|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655706|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44655707|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
44655708|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655710|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44655711|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
44655712|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655713|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44655714|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
44655715|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
44655716|NCT00108485|Vitamins|vitamins|mesh-ancestor
44655717|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
44655718|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655719|NCT00108433|Vancomycin|vancomycin|mesh-list
44655720|NCT00108433|Cefazolin|cefazolin|mesh-list
44655721|NCT00108433|Linezolid|linezolid|mesh-list
44655722|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655723|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655724|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44655725|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655726|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655727|NCT00108355|Octreotide|octreotide|mesh-list
44655728|NCT00108355|Midodrine|midodrine|mesh-list
44655729|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655730|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655731|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655732|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
44655733|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
44655734|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655735|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655736|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44655737|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44655738|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44655739|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44655740|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44655741|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655742|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655744|NCT00108069|Bortezomib|bortezomib|mesh-list
44655745|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655746|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44655747|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
44655748|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655749|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655750|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655751|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44655752|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44655753|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44655754|NCT00107783|Nitisinone|nitisinone|mesh-list
44655755|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655756|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655757|NCT00107653|Ribavirin|ribavirin|mesh-list
44206215|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
44655758|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44655759|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
44655760|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
44655761|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655762|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
44655763|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655764|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
44655765|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655766|NCT00106704|Pioglitazone|pioglitazone|mesh-list
44655767|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44655768|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44655769|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655770|NCT00106704|Incretins|incretins|mesh-ancestor
44655771|NCT00106704|Hormones|hormones|mesh-ancestor
44655772|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655773|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44655774|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
44655775|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655776|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655777|NCT00106639|Tacrolimus|tacrolimus|mesh-list
44655778|NCT00106639|Tofacitinib|tofacitinib|mesh-list
44655779|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655780|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
44655781|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655782|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44655783|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655784|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655785|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655786|NCT00106353|Sirolimus|sirolimus|mesh-list
44655787|NCT00106353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655788|NCT00106353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655789|NCT00106353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655790|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655791|NCT00106353|Antifungal Agents|antifungal agents|mesh-ancestor
44655792|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655793|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
44655794|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655795|NCT00105469|Tobramycin|tobramycin|mesh-list
44655796|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655797|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655798|NCT00105235|Cyclosporine|cyclosporine|mesh-list
44655799|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
44655800|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
44655801|NCT00105235|Tacrolimus|tacrolimus|mesh-list
44655802|NCT00105235|Cyclosporins|cyclosporins|mesh-list
44655803|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655804|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
44655805|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655806|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44655807|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655808|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655809|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
44655810|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655811|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44655812|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655813|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655814|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655815|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44655816|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
44655817|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655818|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655820|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655821|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655822|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44655823|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44655824|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44655825|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655826|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
44655827|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
44655828|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655829|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655830|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44655831|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44655832|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
44655833|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44655834|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44655835|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44655836|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44655837|NCT00105066|Metformin|metformin|mesh-list
44655838|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44655839|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655840|NCT00104572|Vitamin D|vitamin d|mesh-list
44655841|NCT00104572|Anastrozole|anastrozole|mesh-list
44655842|NCT00104572|Calcium|calcium|mesh-list
44655843|NCT00104572|Testosterone|testosterone|mesh-list
44655844|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44655845|NCT00104572|Vitamins|vitamins|mesh-ancestor
44655846|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
44655847|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655848|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44655849|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44655850|NCT00104572|Androgens|androgens|mesh-ancestor
44655851|NCT00104572|Hormones|hormones|mesh-ancestor
44655852|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655853|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655854|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655855|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44655856|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655857|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655858|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44655859|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
44655860|NCT00104299|Prednisone|prednisone|mesh-list
44655861|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
44655862|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
44655863|NCT00104299|Rituximab|rituximab|mesh-list
44655864|NCT00104299|Azathioprine|azathioprine|mesh-list
44655865|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
44655866|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655867|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
44655868|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655869|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44655870|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44655871|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
44655872|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655873|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655874|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44655875|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44655876|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44655877|NCT00104299|Hormones|hormones|mesh-ancestor
44655878|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655879|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44655880|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
44655881|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
44655882|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44655883|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44655884|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44655885|NCT00104299|Protective Agents|protective agents|mesh-ancestor
44655886|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
44655887|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44655889|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44655890|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44655891|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44655892|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655893|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44655894|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655895|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
44655896|NCT00103857|Metformin|metformin|mesh-list
44655897|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44655898|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44655899|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655900|NCT00103857|Incretins|incretins|mesh-ancestor
44655901|NCT00103857|Hormones|hormones|mesh-ancestor
44655902|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44655903|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44655904|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
44655905|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655906|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655907|NCT00103402|Alfuzosin|alfuzosin|mesh-list
44655908|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44655909|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44655910|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44655911|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44655912|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655913|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655914|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655915|NCT00103402|Urological Agents|urological agents|mesh-ancestor
44655917|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
44655918|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655919|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44655920|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44655921|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44655922|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655923|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
44655924|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
44655925|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655926|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655927|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44655928|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44655929|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
44655930|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44655931|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44655932|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44655933|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44655934|NCT00101400|Sorafenib|sorafenib|mesh-list
44655935|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655936|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44655937|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655938|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655939|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
44655940|NCT00100178|Daclizumab|daclizumab|mesh-list
44655941|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44655942|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44655943|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44655944|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
44655945|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44655946|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655947|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655948|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655949|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44655950|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
44655951|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655952|NCT00099983|Risperidone|risperidone|mesh-list
44655953|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44655954|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
44655955|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44655956|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655957|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44655958|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44655959|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44655960|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44655961|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44655962|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44655963|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
44655965|NCT00099632|Lopinavir|lopinavir|mesh-list
44655966|NCT00099632|Tenofovir|tenofovir|mesh-list
44655967|NCT00099632|Lamivudine|lamivudine|mesh-list
44655968|NCT00099632|Zidovudine|zidovudine|mesh-list
44655969|NCT00099632|Emtricitabine|emtricitabine|mesh-list
44655970|NCT00099632|Nevirapine|nevirapine|mesh-list
44655971|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44655972|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44655973|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44655974|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44655975|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
44655976|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655977|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655978|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44655979|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44655980|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
44655981|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655982|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44655983|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44655984|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44655985|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655986|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
44655987|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44655988|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44655990|NCT00099359|Zidovudine|zidovudine|mesh-list
44655991|NCT00099359|Nevirapine|nevirapine|mesh-list
44655992|NCT00099359|Nelfinavir|nelfinavir|mesh-list
44655993|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44655994|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44655995|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44655996|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44655997|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
44655998|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44655999|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656000|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656001|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
44656002|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44656003|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44656004|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44656005|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44656006|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656007|NCT00099268|Levodopa|levodopa|mesh-list
44656008|NCT00099268|Carbidopa|carbidopa|mesh-list
44656009|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44656010|NCT00099268|Entacapone|entacapone|mesh-list
44656011|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44656012|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44656013|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
44656014|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44656015|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656016|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656017|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44656018|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656019|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44656020|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
44656021|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
44656022|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44656023|NCT00098865|Thalidomide|thalidomide|mesh-list
44656024|NCT00098865|Temozolomide|temozolomide|mesh-list
44656025|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656026|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
44656027|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656028|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656029|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656030|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
44656031|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656032|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
44656033|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44656034|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656035|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656036|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656037|NCT00098865|Growth Substances|growth substances|mesh-ancestor
44656038|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656039|NCT00098839|Leucovorin|leucovorin|mesh-list
44656040|NCT00098839|Cytarabine|cytarabine|mesh-list
44656041|NCT00098839|Prednisone|prednisone|mesh-list
44656042|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
44656043|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44656044|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44656045|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44656046|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
44656047|NCT00098839|Doxorubicin|doxorubicin|mesh-list
44656048|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44656049|NCT00098839|Methotrexate|methotrexate|mesh-list
44656050|NCT00098839|Etoposide|etoposide|mesh-list
44656051|NCT00098839|Vincristine|vincristine|mesh-list
44656052|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
44656053|NCT00098839|Asparaginase|asparaginase|mesh-list
44656054|NCT00098839|Pegaspargase|pegaspargase|mesh-list
44656055|NCT00098839|Epratuzumab|epratuzumab|mesh-list
44656056|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
44656057|NCT00098839|Razoxane|razoxane|mesh-list
44656058|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
44656059|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656060|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
44656061|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656062|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656063|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656064|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
44656065|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656066|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656067|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44656068|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44656069|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44656070|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656071|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656072|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44656073|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
44656074|NCT00098839|Hormones|hormones|mesh-ancestor
43922414|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44656075|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656076|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44656077|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44656078|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
44656079|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44656080|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656081|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
44656082|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656083|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44656084|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656085|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656086|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
44656087|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656088|NCT00098839|Antidotes|antidotes|mesh-ancestor
44656089|NCT00098839|Protective Agents|protective agents|mesh-ancestor
44656090|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656091|NCT00098839|Vitamins|vitamins|mesh-ancestor
44656092|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
44656093|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656094|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656095|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656096|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656097|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44656098|NCT00098813|Romidepsin|romidepsin|mesh-list
44656099|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44656100|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656101|NCT00098787|Leucovorin|leucovorin|mesh-list
44656102|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
44656103|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44656104|NCT00098787|Bevacizumab|bevacizumab|mesh-list
44656105|NCT00098787|Fluorouracil|fluorouracil|mesh-list
44656106|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
44656107|NCT00098787|Irinotecan|irinotecan|mesh-list
44656108|NCT00098787|Camptothecin|camptothecin|mesh-list
44656109|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
44656110|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656111|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656112|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656113|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656114|NCT00098787|Growth Substances|growth substances|mesh-ancestor
44656115|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656116|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656118|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656119|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656120|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656121|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
44656122|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44656123|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656124|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656125|NCT00098787|Antidotes|antidotes|mesh-ancestor
44656126|NCT00098787|Protective Agents|protective agents|mesh-ancestor
44656127|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656128|NCT00098787|Vitamins|vitamins|mesh-ancestor
44656129|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
44656130|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656131|NCT00098774|Leucovorin|leucovorin|mesh-list
44656132|NCT00098774|Cytarabine|cytarabine|mesh-list
44656133|NCT00098774|Rituximab|rituximab|mesh-list
44656134|NCT00098774|Methotrexate|methotrexate|mesh-list
44656135|NCT00098774|Etoposide|etoposide|mesh-list
44656136|NCT00098774|Temozolomide|temozolomide|mesh-list
44656137|NCT00098774|Calcium|calcium|mesh-list
44656138|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
44206549|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
44656139|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656141|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
44656142|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656143|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656144|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44656145|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44656146|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
44656147|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44656148|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656149|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
44656150|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656151|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656152|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656153|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44656154|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656155|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656156|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656157|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44656158|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656159|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
44656160|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656161|NCT00098774|Antidotes|antidotes|mesh-ancestor
44656162|NCT00098774|Protective Agents|protective agents|mesh-ancestor
44656163|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656164|NCT00098774|Vitamins|vitamins|mesh-ancestor
44656165|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
44656166|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656167|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
44656168|NCT00098748|Maraviroc|maraviroc|mesh-list
44656169|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44656170|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44656171|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656172|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656173|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656174|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
44656175|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656176|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44656177|NCT00098722|Maraviroc|maraviroc|mesh-list
44656178|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44656179|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44656180|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656181|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656182|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656183|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
44656184|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656185|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44656186|NCT00098306|Maraviroc|maraviroc|mesh-list
44656187|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44656188|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44656189|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656190|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656191|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656192|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
44656193|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656194|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44656195|NCT00098293|Lamivudine|lamivudine|mesh-list
44656196|NCT00098293|Zidovudine|zidovudine|mesh-list
44656197|NCT00098293|Efavirenz|efavirenz|mesh-list
44656198|NCT00098293|Maraviroc|maraviroc|mesh-list
44656199|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44656200|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656201|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656202|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656203|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
44656204|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656205|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656206|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656207|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
44656208|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44656209|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44656210|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44656211|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44656212|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44206633|NCT00423163|Micafungin|micafungin|mesh-list
44656213|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44656214|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44656215|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44656216|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44656217|NCT00098254|Sorafenib|sorafenib|mesh-list
44656218|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656219|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656220|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656221|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656222|NCT00098020|Isotretinoin|isotretinoin|mesh-list
44656223|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656224|NCT00097981|Thalidomide|thalidomide|mesh-list
44656225|NCT00097981|Dexamethasone|dexamethasone|mesh-list
44656226|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44656227|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
44656228|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
44656229|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44656230|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656231|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44656232|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
44656233|NCT00097981|Hormones|hormones|mesh-ancestor
44656234|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656235|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44656236|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656237|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656238|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
44656239|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
44656240|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44656241|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656242|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656243|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656244|NCT00097981|Growth Substances|growth substances|mesh-ancestor
44656245|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656246|NCT00097786|Nateglinide|nateglinide|mesh-list
44656247|NCT00097786|Valsartan|valsartan|mesh-list
44656248|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44656249|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44656250|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44656251|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656252|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656253|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656254|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
44656255|NCT00097773|Tobramycin|tobramycin|mesh-list
44656256|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44656257|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656258|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44656259|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656260|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656261|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656262|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051341|NCT00003868|Antibodies|antibodies|mesh-list
44656263|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44656264|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44656266|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44656267|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44656268|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44656269|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44656270|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44656271|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
44656272|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44656273|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656274|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656275|NCT00097500|Metformin|metformin|mesh-list
44656276|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
44656277|NCT00097500|Exenatide|exenatide|mesh-list
44656278|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656279|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656280|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44656281|NCT00097500|Incretins|incretins|mesh-ancestor
44656282|NCT00097500|Hormones|hormones|mesh-ancestor
44656283|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656284|NCT00096993|Gemcitabine|gemcitabine|mesh-list
44656285|NCT00096993|Pertuzumab|pertuzumab|mesh-list
44656286|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206706|NCT00423696|Leucovorin|leucovorin|mesh-list
44656287|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
44656288|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656289|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656290|NCT00096993|Antiviral Agents|antiviral agents|mesh-ancestor
44656291|NCT00096993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656292|NCT00096993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656293|NCT00096993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656294|NCT00096993|Immunologic Factors|immunologic factors|mesh-ancestor
44656295|NCT00096993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656296|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656297|NCT00096954|Omalizumab|omalizumab|mesh-list
44656298|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44656299|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44656300|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
44656301|NCT00096941|Pertuzumab|pertuzumab|mesh-list
44656302|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656303|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656304|NCT00096785|Entecavir|entecavir|mesh-list
44656305|NCT00096785|Adefovir|adefovir|mesh-list
44656306|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
44656307|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656308|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44656309|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656310|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656311|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656312|NCT00096538|Valganciclovir|valganciclovir|mesh-list
44656313|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
44656314|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656315|NCT00096486|Everolimus|everolimus|mesh-list
44656316|NCT00096486|Gefitinib|gefitinib|mesh-list
44656317|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656318|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656319|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
44656320|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656321|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656322|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656323|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656324|NCT00096447|Lapatinib|lapatinib|mesh-list
44656325|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656326|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656327|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656328|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656329|NCT00096382|Aldesleukin|aldesleukin|mesh-list
44656330|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
44656331|NCT00096382|Fludarabine|fludarabine|mesh-list
44656332|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
44656333|NCT00096382|Interleukin-2|interleukin-2|mesh-list
44656334|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656335|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
44656336|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656337|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656338|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656340|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656341|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656342|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44656343|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656344|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
44656345|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44656346|NCT00096382|Analgesics|analgesics|mesh-ancestor
44656347|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
44656348|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44656349|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656350|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656351|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
44656352|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656353|NCT00096356|Vitamins|vitamins|mesh-list
44656354|NCT00096356|Vitamin E|vitamin e|mesh-list
44656355|NCT00096356|Tocopherols|tocopherols|mesh-list
44656356|NCT00096356|Tocotrienols|tocotrienols|mesh-list
44656357|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
44656358|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
44656359|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206777|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656360|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
44656361|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656362|NCT00096356|Protective Agents|protective agents|mesh-ancestor
44656363|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
44656364|NCT00096278|Leucovorin|leucovorin|mesh-list
44656365|NCT00096278|Folic Acid|folic acid|mesh-list
44656366|NCT00096278|Bevacizumab|bevacizumab|mesh-list
44656367|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44656368|NCT00096278|Fluorouracil|fluorouracil|mesh-list
44656369|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
44656370|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
44656371|NCT00096278|Antibodies|antibodies|mesh-list
44656372|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
44656373|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44656374|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
44656375|NCT00096278|Calcium|calcium|mesh-list
44656376|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
44656377|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656378|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656379|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656380|NCT00096278|Growth Substances|growth substances|mesh-ancestor
44656381|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656382|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656383|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
44656384|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44656385|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44656386|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
44656387|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656388|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656389|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656390|NCT00096278|Antidotes|antidotes|mesh-ancestor
44656391|NCT00096278|Protective Agents|protective agents|mesh-ancestor
44656392|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656393|NCT00096278|Vitamins|vitamins|mesh-ancestor
44656394|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
44656395|NCT00096278|Hematinics|hematinics|mesh-ancestor
44656396|NCT00096265|Temozolomide|temozolomide|mesh-list
44656397|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44656398|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656399|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
44656400|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656401|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656402|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656403|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656404|NCT00096226|Paclitaxel|paclitaxel|mesh-list
44656405|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44656406|NCT00096226|Carboplatin|carboplatin|mesh-list
44656407|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656408|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656409|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656410|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656411|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656412|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656413|NCT00096200|Paclitaxel|paclitaxel|mesh-list
44656414|NCT00096200|Carboplatin|carboplatin|mesh-list
44656415|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44656417|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656418|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656419|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656420|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656421|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656422|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656423|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656424|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656425|NCT00096174|Cisplatin|cisplatin|mesh-list
44656426|NCT00096174|Cetuximab|cetuximab|mesh-list
44656427|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656428|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656429|NCT00096135|Leucovorin|leucovorin|mesh-list
44656430|NCT00096135|Cytarabine|cytarabine|mesh-list
44656431|NCT00096135|Dexamethasone|dexamethasone|mesh-list
44656432|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
44656433|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44656434|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44656435|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44656436|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
44656437|NCT00096135|Methotrexate|methotrexate|mesh-list
44656438|NCT00096135|Etoposide|etoposide|mesh-list
44656439|NCT00096135|Vincristine|vincristine|mesh-list
44656440|NCT00096135|Daunorubicin|daunorubicin|mesh-list
44656441|NCT00096135|Asparaginase|asparaginase|mesh-list
44656442|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
44656443|NCT00096135|Pegaspargase|pegaspargase|mesh-list
44656444|NCT00096135|Lenograstim|lenograstim|mesh-list
44656445|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
44656446|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656447|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
44656448|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656449|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656450|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656451|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
44656452|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656453|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656454|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44656455|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44656456|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
44656457|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
44656458|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44656459|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44656460|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
44656461|NCT00096135|Hormones|hormones|mesh-ancestor
44656462|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656463|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44656464|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44656465|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
44656466|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44656467|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656468|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
44656469|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656470|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656471|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44656472|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656473|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656474|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44656475|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656476|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
44656477|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656478|NCT00096135|Antidotes|antidotes|mesh-ancestor
44656479|NCT00096135|Protective Agents|protective agents|mesh-ancestor
44656480|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656481|NCT00096135|Vitamins|vitamins|mesh-ancestor
44656482|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
44656483|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44656484|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656485|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656486|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656487|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44656488|NCT00096044|Rituximab|rituximab|mesh-list
44656489|NCT00096044|Lenalidomide|lenalidomide|mesh-list
44656490|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656491|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656492|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
44656494|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922769|NCT00569530|Calfactant|calfactant|mesh-list
44656495|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656496|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656497|NCT00096044|Growth Substances|growth substances|mesh-ancestor
44656498|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656499|NCT00096031|Cetuximab|cetuximab|mesh-list
44656500|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656501|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656502|NCT00096018|Thalidomide|thalidomide|mesh-list
44656503|NCT00096018|Fludarabine|fludarabine|mesh-list
44656504|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
44656505|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656506|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656507|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
44656508|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656509|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656510|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
44656511|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656512|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
44656513|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44656514|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656515|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656516|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656517|NCT00096018|Growth Substances|growth substances|mesh-ancestor
44656518|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656519|NCT00095979|Epothilones|epothilones|mesh-list
44656520|NCT00095979|Epothilone B|epothilone b|mesh-list
44656521|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656522|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656523|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656524|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656525|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656526|NCT00095940|Lapatinib|lapatinib|mesh-list
44656527|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656528|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656529|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656530|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656531|NCT00095836|Gefitinib|gefitinib|mesh-list
44656532|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656533|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656534|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656535|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656536|NCT00095498|Denosumab|denosumab|mesh-list
44656537|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44656538|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656539|NCT00095238|Irbesartan|irbesartan|mesh-list
44656540|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44656541|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44656542|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44656543|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656544|NCT00095212|Testosterone|testosterone|mesh-list
44656545|NCT00095212|Androgens|androgens|mesh-ancestor
44656546|NCT00095212|Hormones|hormones|mesh-ancestor
44656547|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656548|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656549|NCT00095199|Docetaxel|docetaxel|mesh-list
44656550|NCT00095199|Pemetrexed|pemetrexed|mesh-list
44656551|NCT00095199|Cetuximab|cetuximab|mesh-list
44656552|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656553|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656554|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656555|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656556|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656557|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656558|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44656559|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656560|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656561|NCT00095173|Abatacept|abatacept|mesh-list
44656562|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44656563|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656564|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656565|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656566|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
44656567|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656568|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656569|NCT00095147|Methotrexate|methotrexate|mesh-list
44656570|NCT00095147|Abatacept|abatacept|mesh-list
44656571|NCT00095147|Infliximab|infliximab|mesh-list
44656572|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44656573|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
44656574|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44656575|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656576|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656577|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
44656578|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656579|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656580|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656581|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656582|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44656583|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656584|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
44656585|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656586|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656587|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44656588|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44656589|NCT00095121|Lamivudine|lamivudine|mesh-list
44656590|NCT00095121|Adefovir|adefovir|mesh-list
44656591|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44656592|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44656593|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44206984|NCT00424801|Vitamins|vitamins|mesh-ancestor
44656594|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656595|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656596|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
44656597|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656598|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656599|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656600|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44656601|NCT00095056|Glipizide|glipizide|mesh-list
44656602|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656603|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656604|NCT00095056|Incretins|incretins|mesh-ancestor
44656605|NCT00095056|Hormones|hormones|mesh-ancestor
44656606|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656607|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44656608|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656609|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656610|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656611|NCT00094861|Paclitaxel|paclitaxel|mesh-list
44656612|NCT00094861|Carboplatin|carboplatin|mesh-list
44656613|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656614|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656615|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656616|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656617|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656618|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656619|NCT00094835|Paclitaxel|paclitaxel|mesh-list
44656620|NCT00094835|Carboplatin|carboplatin|mesh-list
44656621|NCT00094835|Panitumumab|panitumumab|mesh-list
44656622|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
44656623|NCT00094835|Imetelstat|imetelstat|mesh-list
44656624|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656625|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656626|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656627|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656628|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656629|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656630|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656631|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656632|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656633|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44656634|NCT00094770|Glipizide|glipizide|mesh-list
44656635|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656636|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656637|NCT00094770|Incretins|incretins|mesh-ancestor
44656638|NCT00094770|Hormones|hormones|mesh-ancestor
44656639|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656640|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44656641|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656642|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656643|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656644|NCT00094757|Pioglitazone|pioglitazone|mesh-list
44656645|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44656646|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656647|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656648|NCT00094757|Incretins|incretins|mesh-ancestor
44656649|NCT00094757|Hormones|hormones|mesh-ancestor
44656650|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656651|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44656652|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656653|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656654|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207056|NCT00425009|Metformin|metformin|mesh-list
44656655|NCT00094653|Ipilimumab|ipilimumab|mesh-list
44656656|NCT00094653|Vaccines|vaccines|mesh-list
44656657|NCT00094653|Antibodies|antibodies|mesh-list
44656658|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44656659|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
44656660|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656661|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656662|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656663|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44656664|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656665|NCT00094458|Azathioprine|azathioprine|mesh-list
44656666|NCT00094458|Infliximab|infliximab|mesh-list
44656667|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44656668|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44656669|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656670|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
44656671|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656672|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656673|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656674|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656675|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
44656676|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656677|NCT00094445|Curcumin|curcumin|mesh-list
44656678|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44656679|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44656680|NCT00094445|Analgesics|analgesics|mesh-ancestor
44656681|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
44656682|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44656683|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656684|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44656685|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656686|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656687|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656688|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656689|NCT00094328|Anastrozole|anastrozole|mesh-list
44656690|NCT00094328|Bicalutamide|bicalutamide|mesh-list
44656691|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44656692|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656693|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44656694|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44656695|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656696|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656697|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44656698|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
44656699|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656700|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656701|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
44656702|NCT00094302|Spironolactone|spironolactone|mesh-list
44656703|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44656704|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
44656705|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656706|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656707|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44656708|NCT00094302|Diuretics|diuretics|mesh-ancestor
44656709|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
44656710|NCT00094172|Atorvastatin|atorvastatin|mesh-list
44656711|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44656712|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44656713|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
44656714|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656715|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44656716|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44656717|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656719|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656720|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656721|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656722|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656723|NCT00094094|Axitinib|axitinib|mesh-list
44656724|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656725|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656726|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656727|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656728|NCT00094055|Axitinib|axitinib|mesh-list
44656729|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656730|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656731|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656732|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656733|NCT00093808|Capecitabine|capecitabine|mesh-list
44656734|NCT00093808|Trastuzumab|trastuzumab|mesh-list
44656735|NCT00093808|Vinorelbine|vinorelbine|mesh-list
44656736|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656737|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
44656738|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656739|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656740|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656741|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656742|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656743|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656744|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656745|NCT00093795|Gemcitabine|gemcitabine|mesh-list
44656746|NCT00093795|Paclitaxel|paclitaxel|mesh-list
44656747|NCT00093795|Docetaxel|docetaxel|mesh-list
44656748|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
44656749|NCT00093795|Doxorubicin|doxorubicin|mesh-list
44656750|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656751|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656752|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656753|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656754|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656755|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656756|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656757|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
44656758|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656759|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656760|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656761|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
44656762|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44656763|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656764|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
44656765|NCT00093795|Antiviral Agents|antiviral agents|mesh-ancestor
44656766|NCT00093795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656767|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656768|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44656769|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44656770|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44656771|NCT00093496|Gemcitabine|gemcitabine|mesh-list
44656772|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656773|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
44656774|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656775|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656776|NCT00093496|Antiviral Agents|antiviral agents|mesh-ancestor
44656777|NCT00093496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656778|NCT00093496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656779|NCT00093496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656780|NCT00093496|Immunologic Factors|immunologic factors|mesh-ancestor
44656781|NCT00093496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656782|NCT00093470|Tipifarnib|tipifarnib|mesh-list
44656783|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656784|NCT00093145|Paclitaxel|paclitaxel|mesh-list
44656785|NCT00093145|Carboplatin|carboplatin|mesh-list
44656786|NCT00093145|Trastuzumab|trastuzumab|mesh-list
44656787|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44656788|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44656789|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656790|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656791|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656792|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656793|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656794|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44656795|NCT00092677|Simvastatin|simvastatin|mesh-list
44656796|NCT00092677|Ezetimibe|ezetimibe|mesh-list
44656797|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44656798|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44656799|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
44656800|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656801|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44656802|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44656803|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656804|NCT00092534|Vaccines|vaccines|mesh-list
44656805|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
44656806|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656808|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
44656809|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656810|NCT00091949|Pioglitazone|pioglitazone|mesh-list
44656811|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44656812|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656813|NCT00091832|Denosumab|denosumab|mesh-list
44656814|NCT00091832|Diphosphonates|diphosphonates|mesh-list
44656815|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44656816|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656817|NCT00091819|Vancomycin|vancomycin|mesh-list
44656818|NCT00091819|Telavancin|telavancin|mesh-list
44656819|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44656820|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656821|NCT00091793|Denosumab|denosumab|mesh-list
44656822|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44656823|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656824|NCT00091572|Temozolomide|temozolomide|mesh-list
44656825|NCT00091572|Dacarbazine|dacarbazine|mesh-list
44656826|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656827|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
44656828|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656829|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656830|NCT00091442|Docetaxel|docetaxel|mesh-list
44656831|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44656832|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656833|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656834|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656835|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656836|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656837|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44656838|NCT00091026|Gemcitabine|gemcitabine|mesh-list
44656839|NCT00091026|Bevacizumab|bevacizumab|mesh-list
44656840|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44656841|NCT00091026|Cetuximab|cetuximab|mesh-list
44656842|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44656843|NCT00091026|Antibodies|antibodies|mesh-list
44656844|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
44656845|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44656846|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656847|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656848|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656849|NCT00091026|Growth Substances|growth substances|mesh-ancestor
44656850|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656851|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656852|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
44656853|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44656854|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
44656855|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656856|NCT00091026|Antiviral Agents|antiviral agents|mesh-ancestor
44656857|NCT00091026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656858|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656859|NCT00091026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656860|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656861|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
44656862|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656863|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656864|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656865|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656866|NCT00090857|Letrozole|letrozole|mesh-list
44656867|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656868|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44656869|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44656870|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656871|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656872|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44656873|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44656874|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656875|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656876|NCT00090779|Ritonavir|ritonavir|mesh-list
44656877|NCT00090779|Lopinavir|lopinavir|mesh-list
44656878|NCT00090779|Tenofovir|tenofovir|mesh-list
44656879|NCT00090779|Emtricitabine|emtricitabine|mesh-list
44656880|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44656881|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44656882|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44656883|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656884|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656885|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656886|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656887|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656888|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
44656889|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656890|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44656891|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44656892|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44656893|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656894|NCT00090766|Valganciclovir|valganciclovir|mesh-list
44656895|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
44656896|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656897|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
44656898|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
44656899|NCT00090753|Hematinics|hematinics|mesh-ancestor
44656900|NCT00090610|Carboplatin|carboplatin|mesh-list
44656901|NCT00090610|Docetaxel|docetaxel|mesh-list
44656902|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656903|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44656904|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44656905|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44656906|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656907|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44656908|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44656909|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44656910|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
44656911|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44656912|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656913|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656914|NCT00090584|Urological Agents|urological agents|mesh-ancestor
44656915|NCT00090545|Sorafenib|sorafenib|mesh-list
44656916|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656917|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656918|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656919|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656920|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
44656921|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656922|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656923|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
44656924|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
44656925|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656926|NCT00090402|Protective Agents|protective agents|mesh-ancestor
44656927|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656928|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
44656929|NCT00090402|Vitamins|vitamins|mesh-ancestor
44656930|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
44656931|NCT00090259|Losartan|losartan|mesh-list
44656932|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44656933|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44656934|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44656935|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44656936|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656937|NCT00090103|Tamsulosin|tamsulosin|mesh-list
44656938|NCT00090103|Dutasteride|dutasteride|mesh-list
44656939|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44656940|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44656941|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44656942|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
44656943|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44656944|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656945|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656946|NCT00090103|Urological Agents|urological agents|mesh-ancestor
44656947|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44656948|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44656949|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656950|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
44656951|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44656953|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44656954|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656955|NCT00089648|Sunitinib|sunitinib|mesh-list
44656956|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44656957|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44656958|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44656959|NCT00089648|Growth Substances|growth substances|mesh-ancestor
44656960|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656961|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44656962|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44656963|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656964|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656965|NCT00089505|Ritonavir|ritonavir|mesh-list
44656966|NCT00089505|Lopinavir|lopinavir|mesh-list
44656967|NCT00089505|Tenofovir|tenofovir|mesh-list
44656968|NCT00089505|Emtricitabine|emtricitabine|mesh-list
44656969|NCT00089505|Nevirapine|nevirapine|mesh-list
44656970|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44656971|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44656972|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44656973|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
44656974|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44656975|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44656976|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44656977|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44656978|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
44656979|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44656980|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44656981|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44656982|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44656983|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44656984|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44656985|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44656986|NCT00088530|Gemcitabine|gemcitabine|mesh-list
44656987|NCT00088530|Prednisone|prednisone|mesh-list
44656988|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
44656989|NCT00088530|Rituximab|rituximab|mesh-list
44656990|NCT00088530|Etoposide|etoposide|mesh-list
44656991|NCT00088530|Vincristine|vincristine|mesh-list
44656992|NCT00088530|Vinorelbine|vinorelbine|mesh-list
44656993|NCT00088530|Pixantrone|pixantrone|mesh-list
44656994|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44656995|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
44656996|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44656997|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44656998|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44656999|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
44657000|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657001|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657002|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923207|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
44657003|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657004|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657005|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
44657006|NCT00088530|Antiviral Agents|antiviral agents|mesh-ancestor
44657007|NCT00088530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657008|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657009|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657010|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
44657011|NCT00088530|Hormones|hormones|mesh-ancestor
44657012|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657013|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657014|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657015|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657017|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657018|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657019|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657020|NCT00088413|Molgramostim|molgramostim|mesh-list
44657021|NCT00088413|Sargramostim|sargramostim|mesh-list
44657022|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
44657023|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657024|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657025|NCT00087607|Ribavirin|ribavirin|mesh-list
44657026|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44657027|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44657028|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
44657029|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923259|NCT00578539|Cytarabine|cytarabine|mesh-list
44657030|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
44657031|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657032|NCT00087490|Vancomycin|vancomycin|mesh-list
44657033|NCT00087490|Linezolid|linezolid|mesh-list
44657034|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657035|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657036|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44657037|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657038|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657039|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
44657040|NCT00087178|Doxorubicin|doxorubicin|mesh-list
44657041|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44657042|NCT00087178|Fluorouracil|fluorouracil|mesh-list
44657043|NCT00087178|Epirubicin|epirubicin|mesh-list
44657044|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657045|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
44657046|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657047|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657048|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657049|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
44657050|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657051|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657052|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657053|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657054|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657055|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657056|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657057|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
44657058|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657059|NCT00086580|Vidarabine|vidarabine|mesh-list
44657060|NCT00086580|Fludarabine|fludarabine|mesh-list
44657061|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
44657062|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
44657063|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657064|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657065|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
44657066|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657067|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657068|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
44657069|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657070|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
44657071|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657072|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657073|NCT00086515|Metformin|metformin|mesh-list
44657074|NCT00086515|Pioglitazone|pioglitazone|mesh-list
44657075|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44657076|NCT00086515|Glipizide|glipizide|mesh-list
44657077|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44657078|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657079|NCT00086515|Incretins|incretins|mesh-ancestor
44657080|NCT00086515|Hormones|hormones|mesh-ancestor
44657081|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657082|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44657083|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657084|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657085|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657086|NCT00086502|Metformin|metformin|mesh-list
44657087|NCT00086502|Pioglitazone|pioglitazone|mesh-list
44657088|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44657089|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44052149|NCT00003970|Irinotecan|irinotecan|mesh-list
44657090|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657091|NCT00086502|Incretins|incretins|mesh-ancestor
44657092|NCT00086502|Hormones|hormones|mesh-ancestor
44657093|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657094|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44657095|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657096|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657097|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657098|NCT00086411|Bupropion|bupropion|mesh-list
44657099|NCT00086411|Nicotine|nicotine|mesh-list
44657100|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44657101|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
44657102|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657103|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657104|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44657105|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44657106|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
44657107|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657108|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657109|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44657110|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
44657111|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44657112|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44657113|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44657114|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44657115|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
44657116|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44657117|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657118|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657119|NCT00086385|Bupropion|bupropion|mesh-list
44657120|NCT00086385|Nicotine|nicotine|mesh-list
44657121|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44657122|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
44657123|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657124|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657125|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44657126|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44657127|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
44657128|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657129|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657130|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44657131|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
44657132|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44657133|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44657134|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44657135|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44657136|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
44657137|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44657138|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657139|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657140|NCT00086307|Pramipexole|pramipexole|mesh-list
44657141|NCT00086307|Citalopram|citalopram|mesh-list
44657142|NCT00086307|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44657143|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44657144|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44657145|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657146|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657147|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
44657148|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657149|NCT00086307|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44657150|NCT00086307|Antidepressive Agents|antidepressive agents|mesh-ancestor
44657151|NCT00086307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44657152|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44657153|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44657154|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
44657155|NCT00086307|Protective Agents|protective agents|mesh-ancestor
44657156|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
44657157|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
44657158|NCT00086190|Paroxetine|paroxetine|mesh-list
44657159|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44657160|NCT00086190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44657161|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44657162|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44657163|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657164|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657165|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
44657166|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657167|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44657168|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
44657169|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44657170|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44657171|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657172|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657173|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44657174|NCT00085644|Adalimumab|adalimumab|mesh-list
44657175|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657176|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657177|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
44657178|NCT00085202|Cisplatin|cisplatin|mesh-list
44657179|NCT00085202|Vincristine|vincristine|mesh-list
44657180|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657181|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
44657182|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657183|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657184|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657185|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
44657186|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657187|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657188|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657189|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657190|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657191|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657192|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657193|NCT00084799|Antibodies|antibodies|mesh-list
44657194|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44657195|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
44657196|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657197|NCT00084656|Ipilimumab|ipilimumab|mesh-list
44657198|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657199|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657200|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44657201|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657202|NCT00084266|Vancomycin|vancomycin|mesh-list
44657203|NCT00084266|Linezolid|linezolid|mesh-list
44657204|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657205|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657206|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44657207|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657208|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657209|NCT00084136|Tenofovir|tenofovir|mesh-list
44657210|NCT00084136|Lamivudine|lamivudine|mesh-list
44657211|NCT00084136|Zidovudine|zidovudine|mesh-list
44657212|NCT00084136|Emtricitabine|emtricitabine|mesh-list
44657213|NCT00084136|Efavirenz|efavirenz|mesh-list
44657214|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44657215|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44657216|NCT00084136|Didanosine|didanosine|mesh-list
44657217|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44657218|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
44657219|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657220|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43923423|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923441|NCT00580073|Cetuximab|cetuximab|mesh-list
44657221|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657222|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657223|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657224|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44657225|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44657226|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
44657227|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44657228|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657229|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44657230|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44657231|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657232|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657233|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44657234|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44657235|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657236|NCT00083889|Interferons|interferons|mesh-list
44657238|NCT00083889|Sunitinib|sunitinib|mesh-list
44657239|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657240|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
44657241|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657242|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
44657243|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657244|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44657245|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44657246|NCT00083889|Growth Substances|growth substances|mesh-ancestor
44657247|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44657248|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657249|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657250|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657251|NCT00082433|Capecitabine|capecitabine|mesh-list
44657252|NCT00082433|Epothilones|epothilones|mesh-list
44657253|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657254|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
44657255|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657256|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657257|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657258|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657259|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657260|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
44657261|NCT00082407|Exenatide|exenatide|mesh-list
44657262|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
44657263|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44657264|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657265|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44657266|NCT00082407|Incretins|incretins|mesh-ancestor
44657267|NCT00082407|Hormones|hormones|mesh-ancestor
43923442|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
44657268|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657269|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
44657270|NCT00082381|Exenatide|exenatide|mesh-list
44657271|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44657272|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657273|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44657274|NCT00082381|Incretins|incretins|mesh-ancestor
44657275|NCT00082381|Hormones|hormones|mesh-ancestor
44657276|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657277|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44657278|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44657279|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44657280|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657281|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
44657282|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657283|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657284|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657285|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657286|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657287|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657288|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657289|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
44657290|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44657291|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44657292|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44657293|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657294|NCT00080301|Capecitabine|capecitabine|mesh-list
44657295|NCT00080301|Epothilones|epothilones|mesh-list
44657296|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657297|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
44657298|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657299|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657300|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657301|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657302|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657303|NCT00080119|Isoniazid|isoniazid|mesh-list
44657304|NCT00080119|Trimethoprim|trimethoprim|mesh-list
44657305|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
44657306|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
44657307|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657308|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657309|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44657310|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44657311|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
44657312|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657313|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44657314|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44657315|NCT00080119|Renal Agents|renal agents|mesh-ancestor
44657316|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
44657317|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44657318|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44657319|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44657320|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657321|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44657322|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44657323|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657324|NCT00079937|Fluticasone|fluticasone|mesh-list
44657325|NCT00079937|Omalizumab|omalizumab|mesh-list
44657326|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657327|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44657328|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
44657329|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657330|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657331|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44657332|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44657333|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44657334|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44657335|NCT00079677|Modafinil|modafinil|mesh-list
44657336|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44657337|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657338|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44657339|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657340|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657341|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657342|NCT00079417|Iodine|iodine|mesh-list
44657343|NCT00079417|Carboplatin|carboplatin|mesh-list
44657344|NCT00079417|Vincristine|vincristine|mesh-list
44657345|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657346|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657347|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657348|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657349|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657350|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657351|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44657352|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657353|NCT00079417|Trace Elements|trace elements|mesh-ancestor
44657354|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
44657355|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657356|NCT00079339|Tipifarnib|tipifarnib|mesh-list
44657357|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657358|NCT00079274|Leucovorin|leucovorin|mesh-list
44657359|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44657360|NCT00079274|Cetuximab|cetuximab|mesh-list
44657361|NCT00079274|Fluorouracil|fluorouracil|mesh-list
44657362|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
44657363|NCT00079274|Irinotecan|irinotecan|mesh-list
44657364|NCT00079274|Antibodies|antibodies|mesh-list
44657365|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
44657366|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44657367|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
44657368|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
44657369|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657370|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657371|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
44657372|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657373|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657374|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657375|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44657376|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657377|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657378|NCT00079274|Antidotes|antidotes|mesh-ancestor
44657379|NCT00079274|Protective Agents|protective agents|mesh-ancestor
44657380|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
44657381|NCT00079274|Vitamins|vitamins|mesh-ancestor
44657382|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
44657383|NCT00079183|Sirolimus|sirolimus|mesh-list
44657384|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657385|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657386|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657387|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657388|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
44657389|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657390|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
44657391|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657392|NCT00079040|Bevacizumab|bevacizumab|mesh-list
43923569|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
44657393|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44657394|NCT00079040|Cisplatin|cisplatin|mesh-list
44657395|NCT00079040|Etoposide|etoposide|mesh-list
44657396|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
44657397|NCT00079040|Antibodies|antibodies|mesh-list
44657398|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
44657399|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44657400|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657401|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44657402|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44657403|NCT00079040|Growth Substances|growth substances|mesh-ancestor
44657404|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657405|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
44207804|NCT00428064|Cyclosporine|cyclosporine|mesh-list
44657406|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
44657407|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657408|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657409|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657410|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657411|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657412|NCT00078949|Gemcitabine|gemcitabine|mesh-list
44657413|NCT00078949|Cytarabine|cytarabine|mesh-list
44657414|NCT00078949|Dexamethasone|dexamethasone|mesh-list
44657415|NCT00078949|Rituximab|rituximab|mesh-list
44657416|NCT00078949|Cisplatin|cisplatin|mesh-list
44657417|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657418|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657419|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
44657420|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657421|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657422|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657423|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
44657424|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
44657425|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657426|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657427|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
44657428|NCT00078949|Hormones|hormones|mesh-ancestor
44657429|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657430|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657431|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657432|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
44657433|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657434|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
44657435|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657436|NCT00078949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657437|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657438|NCT00078819|Etanercept|etanercept|mesh-list
44657439|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44657440|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44657441|NCT00078819|Analgesics|analgesics|mesh-ancestor
44657442|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
44657443|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657444|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657445|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657446|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657447|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657448|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657449|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
44657450|NCT00078806|Etanercept|etanercept|mesh-list
44657451|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44657452|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44657453|NCT00078806|Analgesics|analgesics|mesh-ancestor
44657454|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
44657455|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657456|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657457|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657458|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657459|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657460|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657461|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
44657462|NCT00078767|Sertraline|sertraline|mesh-list
44657463|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
44657464|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44657465|NCT00078767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44657466|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44657467|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44657468|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657469|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657470|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
44657471|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657472|NCT00078377|Modafinil|modafinil|mesh-list
44657473|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44657474|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657475|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44657476|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657477|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657478|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657479|NCT00078338|Interferons|interferons|mesh-list
44657480|NCT00078338|Interferon-beta|interferon-beta|mesh-list
44657481|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
44657483|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
44657484|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657485|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
44657486|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657487|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
44657488|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657489|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44657490|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657491|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657492|NCT00078325|Modafinil|modafinil|mesh-list
44657493|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44657494|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657495|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44657496|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657497|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657498|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657499|NCT00078312|Modafinil|modafinil|mesh-list
44657500|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44657501|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657502|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44657503|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657504|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657505|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657506|NCT00077974|Sunitinib|sunitinib|mesh-list
44657507|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657508|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44657509|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44657510|NCT00077974|Growth Substances|growth substances|mesh-ancestor
44657511|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657512|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
44657513|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657514|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657515|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657516|NCT00077857|Docetaxel|docetaxel|mesh-list
44657517|NCT00077857|Capecitabine|capecitabine|mesh-list
44657518|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657519|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657520|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657521|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657522|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657523|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657524|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
44657525|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
44657526|NCT00077766|Hematinics|hematinics|mesh-ancestor
44657527|NCT00077675|Vancomycin|vancomycin|mesh-list
44657528|NCT00077675|Penicillins|penicillins|mesh-list
44657529|NCT00077675|Telavancin|telavancin|mesh-list
44657530|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657531|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657532|NCT00077649|Ribavirin|ribavirin|mesh-list
44657533|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44657534|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
44657535|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
44657536|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44657537|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
44657538|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657539|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
44657540|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657541|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
44657542|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657543|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657544|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44657545|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
44657546|NCT00077636|Ribavirin|ribavirin|mesh-list
44657547|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
44657548|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657549|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
44657550|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657551|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
44657552|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657553|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
44657554|NCT00077623|Hematinics|hematinics|mesh-ancestor
44657555|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
44657556|NCT00077610|Hematinics|hematinics|mesh-ancestor
44657557|NCT00077376|Carboplatin|carboplatin|mesh-list
44657558|NCT00077376|Trastuzumab|trastuzumab|mesh-list
44657559|NCT00077376|Epothilone B|epothilone b|mesh-list
44657560|NCT00077376|Epothilones|epothilones|mesh-list
44657561|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657562|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657563|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657564|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657565|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657566|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657567|NCT00077207|Carboplatin|carboplatin|mesh-list
44657568|NCT00077207|Vincristine|vincristine|mesh-list
44657569|NCT00077207|Temozolomide|temozolomide|mesh-list
44657570|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657571|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657572|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657573|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657574|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657575|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657576|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657577|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
44657578|NCT00077064|Captopril|captopril|mesh-list
44657579|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44657580|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657581|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657582|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657583|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44657584|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44657585|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
44657586|NCT00076752|Promethazine|promethazine|mesh-list
44657587|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
44657588|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
44657589|NCT00076752|Rituximab|rituximab|mesh-list
44657590|NCT00076752|Fludarabine|fludarabine|mesh-list
44657591|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
44657592|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657593|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
44657594|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657595|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657596|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657597|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
44657598|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657599|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657600|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923775|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657601|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657602|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657603|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
44657604|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657605|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
44657606|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
44657607|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657608|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657609|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
44657610|NCT00076752|Hormones|hormones|mesh-ancestor
44657611|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657612|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44657613|NCT00076752|Protective Agents|protective agents|mesh-ancestor
44657614|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44657615|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44657616|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44657617|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
44657618|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
44657619|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
44657620|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44657621|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
44657622|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
44657623|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44657624|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44657625|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
44657626|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
44657627|NCT00076570|Sirolimus|sirolimus|mesh-list
44657628|NCT00076570|Tacrolimus|tacrolimus|mesh-list
44657629|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657630|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
44657631|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657632|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44657633|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923811|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923812|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
44657634|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657635|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657636|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657637|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657638|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657639|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
44657640|NCT00076336|Lamivudine|lamivudine|mesh-list
44657641|NCT00076336|Telbivudine|telbivudine|mesh-list
44657642|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44657643|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657644|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657645|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657646|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
44657647|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657648|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44657649|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44657650|NCT00076102|Pirfenidone|pirfenidone|mesh-list
44657651|NCT00076102|Analgesics|analgesics|mesh-ancestor
44657652|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
44657653|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657654|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657655|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44657656|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44657657|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657658|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657659|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657660|NCT00076024|Docetaxel|docetaxel|mesh-list
44657661|NCT00076024|Axitinib|axitinib|mesh-list
44657662|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657663|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657664|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657665|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657666|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657667|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657668|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657669|NCT00076011|Mitogens|mitogens|mesh-list
44657670|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
44657671|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657672|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657673|NCT00076011|Growth Substances|growth substances|mesh-ancestor
44657674|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657675|NCT00075881|Bortezomib|bortezomib|mesh-list
44657676|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657677|NCT00075764|Fulvestrant|fulvestrant|mesh-list
44657678|NCT00075764|Anastrozole|anastrozole|mesh-list
44657679|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657680|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657681|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44657682|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44657683|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
44657684|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657685|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657686|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44657687|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44657688|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657689|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657690|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
44657691|NCT00075725|Leucovorin|leucovorin|mesh-list
44657692|NCT00075725|Folic Acid|folic acid|mesh-list
44657693|NCT00075725|Cytarabine|cytarabine|mesh-list
44657694|NCT00075725|Dexamethasone|dexamethasone|mesh-list
44657695|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
44657696|NCT00075725|Prednisone|prednisone|mesh-list
44657697|NCT00075725|Cortisone|cortisone|mesh-list
44657698|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
44657699|NCT00075725|Doxorubicin|doxorubicin|mesh-list
44657700|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44657701|NCT00075725|Methotrexate|methotrexate|mesh-list
44657702|NCT00075725|Vincristine|vincristine|mesh-list
44657703|NCT00075725|Daunorubicin|daunorubicin|mesh-list
44657704|NCT00075725|Asparaginase|asparaginase|mesh-list
44657705|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
44657706|NCT00075725|Pegaspargase|pegaspargase|mesh-list
44657707|NCT00075725|Thioguanine|thioguanine|mesh-list
44657708|NCT00075725|BB 1101|bb 1101|mesh-list
44657709|NCT00075725|Calcium|calcium|mesh-list
44657710|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
44657711|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
44657712|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657713|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
44657714|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657715|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657716|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657717|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
44657718|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657719|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657720|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657721|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44657722|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
44657723|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
44657724|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44657725|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657726|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
44657727|NCT00075725|Hormones|hormones|mesh-ancestor
43923894|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
44657728|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657729|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657730|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657731|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657732|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657733|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657734|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657735|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44657736|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44657737|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44657738|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
44657739|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44657740|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657741|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
44657742|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44657743|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44657744|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657745|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
44657746|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657747|NCT00075725|Antidotes|antidotes|mesh-ancestor
44657748|NCT00075725|Protective Agents|protective agents|mesh-ancestor
44657749|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
44657750|NCT00075725|Vitamins|vitamins|mesh-ancestor
44657751|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
44657752|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657753|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657754|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657755|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657756|NCT00075725|Hematinics|hematinics|mesh-ancestor
44657757|NCT00075582|Dactinomycin|dactinomycin|mesh-list
44657758|NCT00075582|Cactinomycin|cactinomycin|mesh-list
44657759|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
44657760|NCT00075582|Vincristine|vincristine|mesh-list
44657761|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657762|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
44139781|NCT00176475|Rituximab|rituximab|mesh-list
44139810|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44657763|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657764|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657765|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657766|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
44657767|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657768|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657769|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657770|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657771|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657772|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657773|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657774|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657775|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657776|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657777|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44139811|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44139826|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44657778|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657779|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657780|NCT00075504|Gemcitabine|gemcitabine|mesh-list
44657781|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657782|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
44657783|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657784|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657785|NCT00075504|Antiviral Agents|antiviral agents|mesh-ancestor
44657786|NCT00075504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657787|NCT00075504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657788|NCT00075504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657789|NCT00075504|Immunologic Factors|immunologic factors|mesh-ancestor
44657790|NCT00075504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657791|NCT00075478|Cyclosporine|cyclosporine|mesh-list
44657792|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
44657793|NCT00075478|Fludarabine|fludarabine|mesh-list
44657794|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
44657795|NCT00075478|Cyclosporins|cyclosporins|mesh-list
44657796|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657797|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657798|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
44657799|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657800|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657801|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
44657802|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657803|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657804|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
44657805|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657806|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44657807|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657808|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44657809|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657810|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44657811|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
44657812|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657813|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
44657814|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657815|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657816|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657817|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657818|NCT00075270|Paclitaxel|paclitaxel|mesh-list
44657819|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44657820|NCT00075270|Lapatinib|lapatinib|mesh-list
44657821|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657822|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208247|NCT00429897|Diuretics|diuretics|mesh-ancestor
44657823|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657824|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657825|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923957|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657826|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657827|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657829|NCT00075218|Sunitinib|sunitinib|mesh-list
44657830|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657831|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44657832|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44657833|NCT00075218|Growth Substances|growth substances|mesh-ancestor
44657834|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657835|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
44657836|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44657837|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657838|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657839|NCT00075023|Thalidomide|thalidomide|mesh-list
44657840|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657841|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
44657842|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657843|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
44657844|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44657845|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657846|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44657847|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44657848|NCT00075023|Growth Substances|growth substances|mesh-ancestor
44657849|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
44657850|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657851|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
44657852|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
44657854|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44657855|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657856|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44657857|NCT00074711|Antacids|antacids|mesh-ancestor
44657858|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657859|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44657860|NCT00074581|Ritonavir|ritonavir|mesh-list
44657861|NCT00074581|Lopinavir|lopinavir|mesh-list
44657862|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44657863|NCT00074581|Tenofovir|tenofovir|mesh-list
44657864|NCT00074581|Lamivudine|lamivudine|mesh-list
44657865|NCT00074581|Zidovudine|zidovudine|mesh-list
44657866|NCT00074581|Emtricitabine|emtricitabine|mesh-list
44657867|NCT00074581|Nevirapine|nevirapine|mesh-list
44657868|NCT00074581|Stavudine|stavudine|mesh-list
44657869|NCT00074581|Didanosine|didanosine|mesh-list
44657870|NCT00074581|Efavirenz|efavirenz|mesh-list
44657871|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44657872|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44657873|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44657874|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657875|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657876|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44657877|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44657878|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
44657879|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657880|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44657881|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44657882|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44657883|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657884|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
44657885|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44657886|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44657887|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44657888|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657889|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43924017|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44657890|NCT00074490|Prednisone|prednisone|mesh-list
44657891|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
44657892|NCT00074490|Rituximab|rituximab|mesh-list
44657893|NCT00074490|Doxorubicin|doxorubicin|mesh-list
44657894|NCT00074490|Fludarabine|fludarabine|mesh-list
44657895|NCT00074490|Etoposide|etoposide|mesh-list
44657896|NCT00074490|Vincristine|vincristine|mesh-list
44657897|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657898|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
44657899|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657900|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657901|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657902|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
44657903|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657904|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657905|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657906|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657907|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657908|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657909|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657911|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924047|NCT05220917|Canagliflozin|canagliflozin|mesh-list
44657912|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
44657913|NCT00074490|Hormones|hormones|mesh-ancestor
44657914|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44657915|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44657916|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657917|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657918|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657919|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657920|NCT00074412|Nevirapine|nevirapine|mesh-list
44657921|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44657922|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44657923|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657924|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657925|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
44657926|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657927|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44657928|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44657929|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44657930|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44657931|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
44657932|NCT00074282|Rituximab|rituximab|mesh-list
44657933|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
44657934|NCT00074282|Pentostatin|pentostatin|mesh-list
44657935|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657936|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
44657937|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657938|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657939|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657940|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
44657941|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657942|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657943|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657944|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657945|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44657946|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657947|NCT00073983|Gemcitabine|gemcitabine|mesh-list
44657948|NCT00073983|Docetaxel|docetaxel|mesh-list
44657949|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44657950|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
44657951|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657952|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657953|NCT00073983|Antiviral Agents|antiviral agents|mesh-ancestor
44657954|NCT00073983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657955|NCT00073983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657956|NCT00073983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657957|NCT00073983|Immunologic Factors|immunologic factors|mesh-ancestor
44657958|NCT00073983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657959|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44657960|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44657961|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44657962|NCT00073918|Iodine|iodine|mesh-list
44657963|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
44657964|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
44657965|NCT00073918|Etoposide|etoposide|mesh-list
44657966|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
44657967|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
44657968|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44657969|NCT00073918|Antibodies|antibodies|mesh-list
44657970|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
44657971|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44657972|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44657973|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
44657974|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44657975|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44657976|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44657977|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
44657978|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44657979|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657980|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44657981|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44657982|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44657983|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44657984|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657985|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44657986|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44657987|NCT00073918|Trace Elements|trace elements|mesh-ancestor
44657988|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
44657989|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44657990|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44657991|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657992|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44657994|NCT00073528|Lapatinib|lapatinib|mesh-list
44657995|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44657996|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44657997|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44657998|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44657999|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658000|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658001|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658002|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658003|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658004|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658006|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658007|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658008|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658009|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658010|NCT00073021|Mesalamine|mesalamine|mesh-list
44658011|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44658012|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44658013|NCT00073021|Analgesics|analgesics|mesh-ancestor
44658014|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
44658015|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658016|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658017|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658018|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658019|NCT00073008|Lapatinib|lapatinib|mesh-list
44658020|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658021|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658022|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658023|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658024|NCT00072475|Vatalanib|vatalanib|mesh-list
44658025|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658026|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658027|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658028|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44658029|NCT00072410|Antibodies|antibodies|mesh-list
44658030|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
44658031|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44658032|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
44658033|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658034|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658035|NCT00072384|Carboplatin|carboplatin|mesh-list
44658036|NCT00072384|Etoposide|etoposide|mesh-list
44658037|NCT00072384|Vincristine|vincristine|mesh-list
44658038|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
44658039|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658040|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658041|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658042|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658043|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658044|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658045|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658046|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658047|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658048|NCT00072280|Dactinomycin|dactinomycin|mesh-list
44658049|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
44658050|NCT00072280|Ifosfamide|ifosfamide|mesh-list
44658051|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
44658052|NCT00072280|Etoposide|etoposide|mesh-list
44658054|NCT00072280|Lenograstim|lenograstim|mesh-list
44658055|NCT00072280|Mesna|mesna|mesh-list
44658056|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658057|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
44658058|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658059|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658060|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658061|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
44658062|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658063|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658064|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658065|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658066|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658067|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658068|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658069|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658070|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658071|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658072|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658073|NCT00072280|Protective Agents|protective agents|mesh-ancestor
44658075|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658076|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658077|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44658078|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44658079|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44658080|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658081|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658082|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658083|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658084|NCT00072176|Sirolimus|sirolimus|mesh-list
44658085|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658086|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658087|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658088|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658089|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
44658090|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658091|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
44658092|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658093|NCT00071981|Molgramostim|molgramostim|mesh-list
44658094|NCT00071981|Vaccines|vaccines|mesh-list
44658095|NCT00071981|Sargramostim|sargramostim|mesh-list
44658096|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
44658097|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
44658098|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658099|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658100|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658101|NCT00071812|Belimumab|belimumab|mesh-list
44658102|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658103|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
44658104|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658105|NCT00071799|Cytarabine|cytarabine|mesh-list
44658106|NCT00071799|Azacitidine|azacitidine|mesh-list
44658107|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658108|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
44658109|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658110|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658111|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
44658112|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658113|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658114|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
44658115|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658116|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658117|NCT00071760|Ritonavir|ritonavir|mesh-list
44658118|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
44658119|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44658120|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44658121|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44658122|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658123|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658124|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44658125|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44658126|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
44658127|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658128|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44658129|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44658130|NCT00071487|Belimumab|belimumab|mesh-list
43924228|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
44658131|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658132|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
44658133|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658134|NCT00071396|Rituximab|rituximab|mesh-list
44658135|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
44658136|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658137|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658138|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
44658139|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658140|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658141|NCT00071006|Axitinib|axitinib|mesh-list
44658142|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658143|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658144|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658145|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658146|NCT00070941|Citalopram|citalopram|mesh-list
44658147|NCT00070941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44658148|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44053151|NCT00004112|Hormones|hormones|mesh-ancestor
44658149|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44658150|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658151|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44658152|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
44658153|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658154|NCT00070941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44658155|NCT00070941|Antidepressive Agents|antidepressive agents|mesh-ancestor
44658156|NCT00070941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44658157|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
44658158|NCT00070707|Albuterol|albuterol|mesh-list
44658159|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44658160|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
44658161|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658162|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658163|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44658164|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
44658165|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
44658166|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658167|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44658168|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44658169|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44658170|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44658171|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44658172|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658173|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658174|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658175|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44658176|NCT00070317|Methylene Blue|methylene blue|mesh-list
44658177|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44658178|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658179|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658180|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44658181|NCT00070291|Cyclosporine|cyclosporine|mesh-list
44658182|NCT00070291|Cyclosporins|cyclosporins|mesh-list
44658183|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924276|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
44658184|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658185|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658186|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
44658187|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658188|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
44658189|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658190|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658191|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658192|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44658193|NCT00070109|Trabectedin|trabectedin|mesh-list
44658194|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658195|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
44658196|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658197|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658198|NCT00069953|Paclitaxel|paclitaxel|mesh-list
44658199|NCT00069953|Cisplatin|cisplatin|mesh-list
44658200|NCT00069953|Fluorouracil|fluorouracil|mesh-list
44658201|NCT00069953|Lenograstim|lenograstim|mesh-list
44658202|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658203|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658204|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658205|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658206|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658207|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658208|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
44658209|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658210|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658211|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
44658212|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658213|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658214|NCT00069823|Esomeprazole|esomeprazole|mesh-list
44658215|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44658216|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44658217|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44658218|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658219|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658220|NCT00069784|Insulin|insulin|mesh-list
44658221|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44658222|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
44658223|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44658224|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658225|NCT00069121|Leucovorin|leucovorin|mesh-list
44658226|NCT00069121|Fluorouracil|fluorouracil|mesh-list
44658227|NCT00069121|Capecitabine|capecitabine|mesh-list
44658228|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
44658229|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
44658230|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658231|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658232|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658233|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658234|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
44658235|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658236|NCT00069121|Antidotes|antidotes|mesh-ancestor
44658237|NCT00069121|Protective Agents|protective agents|mesh-ancestor
44658238|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
44658239|NCT00069121|Vitamins|vitamins|mesh-ancestor
44658240|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
44658241|NCT00069108|Leucovorin|leucovorin|mesh-list
44658242|NCT00069108|Capecitabine|capecitabine|mesh-list
44658243|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
44658244|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658245|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
44658246|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658247|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658248|NCT00069108|Antidotes|antidotes|mesh-ancestor
44658249|NCT00069108|Protective Agents|protective agents|mesh-ancestor
44658250|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658251|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
44658252|NCT00069108|Vitamins|vitamins|mesh-ancestor
44658253|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
44658254|NCT00069095|Leucovorin|leucovorin|mesh-list
44658255|NCT00069095|Bevacizumab|bevacizumab|mesh-list
44658256|NCT00069095|Fluorouracil|fluorouracil|mesh-list
44658257|NCT00069095|Capecitabine|capecitabine|mesh-list
44658258|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
44658259|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658260|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658261|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44658262|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44658263|NCT00069095|Growth Substances|growth substances|mesh-ancestor
44658264|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658265|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
44658266|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
44658267|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658268|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658269|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658270|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
44658271|NCT00069095|Antidotes|antidotes|mesh-ancestor
44658272|NCT00069095|Protective Agents|protective agents|mesh-ancestor
44658273|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
44658274|NCT00069095|Vitamins|vitamins|mesh-ancestor
44658275|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
44658276|NCT00068692|Leucovorin|leucovorin|mesh-list
44658277|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
44658278|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44658279|NCT00068692|Fluorouracil|fluorouracil|mesh-list
44208686|NCT00431275|Ipilimumab|ipilimumab|mesh-list
44658280|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
44658281|NCT00068692|Irinotecan|irinotecan|mesh-list
44658282|NCT00068692|Camptothecin|camptothecin|mesh-list
44658283|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
44658284|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658285|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
44658286|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658287|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658288|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658289|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658290|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
44658291|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44658292|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658293|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658294|NCT00068692|Antidotes|antidotes|mesh-ancestor
44658295|NCT00068692|Protective Agents|protective agents|mesh-ancestor
44658296|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
44658297|NCT00068692|Vitamins|vitamins|mesh-ancestor
44658298|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
44658299|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658300|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
44658301|NCT00068601|Goserelin|goserelin|mesh-list
44658302|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658303|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
44658304|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658305|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658306|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658307|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
44658308|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658309|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658310|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658311|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658312|NCT00068588|Capecitabine|capecitabine|mesh-list
44658313|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658314|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
44658315|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924353|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
44658316|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658317|NCT00068445|Lamotrigine|lamotrigine|mesh-list
44658318|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
44658319|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44658320|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44658321|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658322|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44658323|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658324|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44658325|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44658326|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44658327|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44658328|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44658329|NCT00068419|Tamoxifen|tamoxifen|mesh-list
44658330|NCT00068419|Sulindac|sulindac|mesh-list
44658331|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658332|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658333|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658334|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658335|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658336|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658337|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658338|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44658339|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44658340|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44658341|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44658342|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44658343|NCT00068419|Analgesics|analgesics|mesh-ancestor
44658344|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
44658345|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658346|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658347|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658348|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924413|NCT04142502|Propofol|propofol|mesh-list
44658349|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658350|NCT00068406|Cisplatin|cisplatin|mesh-list
44658351|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658352|NCT00068393|Gemcitabine|gemcitabine|mesh-list
44658353|NCT00068393|Doxorubicin|doxorubicin|mesh-list
44658354|NCT00068393|Lenograstim|lenograstim|mesh-list
44658355|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658356|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
44658378|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658379|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
44658380|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658381|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658382|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44658383|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
44658384|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658385|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658386|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
44658387|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658388|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658389|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658390|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44658391|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658392|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44658393|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658394|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
44658395|NCT00067990|Losartan|losartan|mesh-list
44658396|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44658397|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44658398|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44658399|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44658400|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658401|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
44658402|NCT00067002|Melphalan|melphalan|mesh-list
44658403|NCT00067002|Thiotepa|thiotepa|mesh-list
44658404|NCT00067002|Rituximab|rituximab|mesh-list
44658405|NCT00067002|Fludarabine|fludarabine|mesh-list
44658406|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
44208833|NCT00431769|Bortezomib|bortezomib|mesh-list
44658407|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658408|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
44658409|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658410|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658411|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658412|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
44658413|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924444|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658414|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658415|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658416|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658417|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658418|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
44658420|NCT00066807|Epirubicin|epirubicin|mesh-list
44658421|NCT00066807|Exemestane|exemestane|mesh-list
44658422|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44658423|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658424|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658425|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658426|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658427|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658428|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658429|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658430|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658431|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658432|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658433|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658434|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44658435|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44658436|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44658437|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44658438|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44658439|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
44658440|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44658441|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
44658442|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658443|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44658444|NCT00066742|Cisplatin|cisplatin|mesh-list
44658445|NCT00066742|Etoposide|etoposide|mesh-list
44658446|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
44658447|NCT00066742|Tirapazamine|tirapazamine|mesh-list
44658448|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658449|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658450|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658451|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658452|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658453|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658454|NCT00066703|Tamoxifen|tamoxifen|mesh-list
44658455|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44658456|NCT00066703|Exemestane|exemestane|mesh-list
44658457|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658458|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658459|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658460|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658461|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658462|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658463|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44658464|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44658465|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44658466|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44658467|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44658468|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700455|NCT02731287|Timolol|timolol|mesh-list
44658469|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658470|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
44658471|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44658472|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
44658473|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658474|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44658476|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44658477|NCT00066690|Exemestane|exemestane|mesh-list
44658478|NCT00066690|Tryptophan|tryptophan|mesh-list
44658479|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658480|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658481|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658482|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658483|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658484|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658485|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658486|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44658487|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44658488|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43924528|NCT03729401|Aspirin|aspirin|mesh-list
44658489|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44658490|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44658491|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658492|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
44658493|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44658494|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
44658495|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658496|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44658497|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44658498|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
44658499|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44658500|NCT00066573|Anastrozole|anastrozole|mesh-list
44658501|NCT00066573|Exemestane|exemestane|mesh-list
44658502|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658503|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658504|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44658505|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44658506|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658507|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658508|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658509|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658510|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658511|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658512|NCT00066469|Prednisone|prednisone|mesh-list
44658513|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
44658514|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44658515|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44658516|NCT00066469|Prednisolone|prednisolone|mesh-list
44658517|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
44658518|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
44658519|NCT00066469|Rituximab|rituximab|mesh-list
44658520|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44658521|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
44658522|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658523|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
44658524|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658525|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658526|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658527|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
44658528|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658529|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658530|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658531|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658532|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658533|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
44658534|NCT00066469|Hormones|hormones|mesh-ancestor
44658535|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658536|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658537|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
44658538|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
44658539|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658540|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44053531|NCT00004174|Thiotepa|thiotepa|mesh-list
44658542|NCT00066469|Protective Agents|protective agents|mesh-ancestor
44658543|NCT00066365|Molgramostim|molgramostim|mesh-list
44658544|NCT00066365|Sargramostim|sargramostim|mesh-list
44658545|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
44658546|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658547|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658548|NCT00066222|Cisplatin|cisplatin|mesh-list
44658549|NCT00066222|Etoposide|etoposide|mesh-list
44658550|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658551|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658552|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658553|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658554|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658555|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658556|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
44658557|NCT00066170|Modafinil|modafinil|mesh-list
44658558|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44658559|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658560|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44658561|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44658562|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44658563|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658564|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44658565|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44658566|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
44658567|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
44658568|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44658569|NCT00066066|Amoxicillin|amoxicillin|mesh-list
44658570|NCT00066066|Metronidazole|metronidazole|mesh-list
44658571|NCT00066066|Doxycycline|doxycycline|mesh-list
44658572|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658573|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658574|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44658575|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44658576|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
44658577|NCT00065507|Entecavir|entecavir|mesh-list
44658578|NCT00065507|Adefovir|adefovir|mesh-list
44658579|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
44658580|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658581|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44658582|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44658583|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658584|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658585|NCT00065468|Interferons|interferons|mesh-list
44658586|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
44658587|NCT00065468|Sirolimus|sirolimus|mesh-list
44658588|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658589|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
44658590|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658591|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
44658592|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658593|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658594|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658595|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
44658596|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924569|NCT03708354|Vitamins|vitamins|mesh-ancestor
44658597|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44658598|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658599|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658600|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658601|NCT00065260|Cyclosporine|cyclosporine|mesh-list
44658602|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
44658603|NCT00065260|Cyclosporins|cyclosporins|mesh-list
44658604|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
44658605|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44658606|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658607|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658608|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658609|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
44658610|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658611|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
44658612|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658613|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658614|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658615|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44658616|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658617|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658619|NCT00065182|Topotecan|topotecan|mesh-list
44658620|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658621|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658622|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658623|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658624|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658625|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44658626|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658627|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658628|NCT00065156|Lenalidomide|lenalidomide|mesh-list
44658629|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
44658630|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209078|NCT00432978|Bosentan|bosentan|mesh-list
44658631|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44658632|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44658633|NCT00065156|Growth Substances|growth substances|mesh-ancestor
44658634|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44658635|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658636|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
44658637|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44658638|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658639|NCT00064987|Hormones|hormones|mesh-list
43924600|NCT03376646|Paclitaxel|paclitaxel|mesh-list
43924637|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
44658640|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44658641|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658642|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658643|NCT00064792|Simvastatin|simvastatin|mesh-list
44658644|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44658645|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44658646|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
44658647|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658648|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44658649|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44658650|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658651|NCT00064701|Cyclosporine|cyclosporine|mesh-list
44658652|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
44658653|NCT00064701|Tacrolimus|tacrolimus|mesh-list
44658654|NCT00064701|Cyclosporins|cyclosporins|mesh-list
44658655|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658656|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
44658657|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658658|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44658659|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658660|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658661|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
44658662|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658663|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658664|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658665|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658666|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658667|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44658668|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
44658669|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658670|NCT00064350|Sorafenib|sorafenib|mesh-list
44658671|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658672|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658673|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658674|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658675|NCT00064337|Thalidomide|thalidomide|mesh-list
44658676|NCT00064337|Dexamethasone|dexamethasone|mesh-list
44658677|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
44658678|NCT00064337|Melphalan|melphalan|mesh-list
44658679|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658680|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
44658681|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658682|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658683|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658684|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
44658685|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658686|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658687|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658688|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658689|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
44658690|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
44235876|NCT00556361|Analgesics|analgesics|mesh-ancestor
44658691|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658692|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44658693|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
44658694|NCT00064337|Hormones|hormones|mesh-ancestor
44658695|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658696|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658697|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
44658698|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658699|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658700|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44658701|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44658702|NCT00064337|Growth Substances|growth substances|mesh-ancestor
44658703|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44658704|NCT00064259|Cisplatin|cisplatin|mesh-list
44658705|NCT00064259|Fluorouracil|fluorouracil|mesh-list
44658706|NCT00064259|Oblimersen|oblimersen|mesh-list
44209147|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
44658707|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658708|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
44658709|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658710|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658711|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658712|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
44658713|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658715|NCT00064077|Paclitaxel|paclitaxel|mesh-list
44658716|NCT00064077|Vinorelbine|vinorelbine|mesh-list
44658717|NCT00064077|Cisplatin|cisplatin|mesh-list
44658718|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44658719|NCT00064077|Topotecan|topotecan|mesh-list
44658720|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658721|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658722|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658723|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658724|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658725|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658726|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658727|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
44658728|NCT00064077|Antiviral Agents|antiviral agents|mesh-ancestor
44658729|NCT00064077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658730|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658731|NCT00064077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658732|NCT00064077|Immunologic Factors|immunologic factors|mesh-ancestor
44658733|NCT00064077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924709|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
43924742|NCT02394795|Vitamins|vitamins|mesh-ancestor
44658734|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44658735|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658736|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44658737|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
44658738|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44658739|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44658740|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44658741|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
44658742|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658743|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658744|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44658745|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44658746|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44658747|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658748|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658749|NCT00063999|Paclitaxel|paclitaxel|mesh-list
44658750|NCT00063999|Cisplatin|cisplatin|mesh-list
44658751|NCT00063999|Carboplatin|carboplatin|mesh-list
44658752|NCT00063999|Doxorubicin|doxorubicin|mesh-list
44658753|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44658754|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44658755|NCT00063999|Lenograstim|lenograstim|mesh-list
44658756|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658757|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658758|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658759|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658760|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658761|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658762|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658763|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658764|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658765|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658766|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658767|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
44658768|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658769|NCT00063934|Docetaxel|docetaxel|mesh-list
44658770|NCT00063934|Doxorubicin|doxorubicin|mesh-list
44658771|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44658772|NCT00063934|Oblimersen|oblimersen|mesh-list
44658773|NCT00063934|Lenograstim|lenograstim|mesh-list
44658774|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658775|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658776|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658777|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658778|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658779|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658780|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658781|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658782|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658783|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44658784|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
44658785|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658787|NCT00063258|Carboplatin|carboplatin|mesh-list
44658788|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44658789|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658790|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658791|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658792|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658793|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658794|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658795|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658796|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658797|NCT00063154|Pertuzumab|pertuzumab|mesh-list
44658798|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658799|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658800|NCT00062751|Sirolimus|sirolimus|mesh-list
44658801|NCT00062751|Letrozole|letrozole|mesh-list
44658802|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658803|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44658804|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44658805|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658806|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658807|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44658808|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
44658809|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658810|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658811|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658812|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924771|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
44658813|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658814|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
44658815|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658816|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
44658817|NCT00062647|Vancomycin|vancomycin|mesh-list
44658818|NCT00062647|Cloxacillin|cloxacillin|mesh-list
44658819|NCT00062647|Oxacillin|oxacillin|mesh-list
44658820|NCT00062647|Telavancin|telavancin|mesh-list
44658821|NCT00062647|Nafcillin|nafcillin|mesh-list
44658822|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658823|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658824|NCT00062439|Cisplatin|cisplatin|mesh-list
44658825|NCT00062439|Docetaxel|docetaxel|mesh-list
44658826|NCT00062439|Etoposide|etoposide|mesh-list
44658827|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658828|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658829|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658830|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658831|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658832|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658833|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658834|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658835|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658836|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
44658837|NCT00062374|Alovudine|alovudine|mesh-list
44658838|NCT00062374|Cisplatin|cisplatin|mesh-list
44658839|NCT00062374|Irinotecan|irinotecan|mesh-list
44658840|NCT00062374|Camptothecin|camptothecin|mesh-list
44658841|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44658842|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658843|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44658844|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658845|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658846|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658847|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44658848|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658849|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
44658850|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
44658851|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658852|NCT00062010|Interferons|interferons|mesh-list
44658853|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
44658854|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
44209296|NCT00433576|Resveratrol|resveratrol|mesh-list
44658855|NCT00062010|Paclitaxel|paclitaxel|mesh-list
44658856|NCT00062010|Tretinoin|tretinoin|mesh-list
44658857|NCT00062010|Isotretinoin|isotretinoin|mesh-list
44658858|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658859|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658860|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658861|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658862|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658863|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658865|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658866|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
44658867|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658868|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
44658869|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658870|NCT00061945|Leucovorin|leucovorin|mesh-list
44658871|NCT00061945|Cytarabine|cytarabine|mesh-list
44658872|NCT00061945|Acyclovir|acyclovir|mesh-list
44658873|NCT00061945|Trimethoprim|trimethoprim|mesh-list
44658874|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
44658875|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44658876|NCT00061945|Dexamethasone|dexamethasone|mesh-list
44658877|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
44658878|NCT00061945|Methotrexate|methotrexate|mesh-list
44658879|NCT00061945|Vincristine|vincristine|mesh-list
44658880|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
44658881|NCT00061945|Daunorubicin|daunorubicin|mesh-list
44658882|NCT00061945|Asparaginase|asparaginase|mesh-list
44658883|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
44658884|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
44658885|NCT00061945|Allopurinol|allopurinol|mesh-list
44658886|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
44658887|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44658888|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
44658889|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658890|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44658891|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658892|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
44658893|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658894|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658895|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44658896|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658897|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
44658898|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
44658899|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658900|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44658901|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
44658902|NCT00061945|Hormones|hormones|mesh-ancestor
44658903|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658904|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658905|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44658906|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
44658907|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44658908|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44658909|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
44658910|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
44658911|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658912|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44658913|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44658914|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
44658915|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658916|NCT00061945|Antidotes|antidotes|mesh-ancestor
44658917|NCT00061945|Protective Agents|protective agents|mesh-ancestor
44658918|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
43924904|NCT00771160|Montelukast|montelukast|mesh-list
43924905|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43924906|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
43924907|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43924908|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924909|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658919|NCT00061945|Vitamins|vitamins|mesh-ancestor
44658920|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
44658921|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44658922|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44658923|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44658924|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44658925|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44658926|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44658927|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44658928|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658929|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658930|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
44658931|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44658932|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
44658933|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44658934|NCT00061945|Renal Agents|renal agents|mesh-ancestor
44658935|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
44658936|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44658937|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44658938|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44658939|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44658940|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44658941|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658942|NCT00061932|Irinotecan|irinotecan|mesh-list
44658943|NCT00061932|Bortezomib|bortezomib|mesh-list
44658944|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44658945|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44658946|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658947|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658948|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658949|NCT00061633|Vancomycin|vancomycin|mesh-list
44658950|NCT00061633|Penicillins|penicillins|mesh-list
44658951|NCT00061633|Telavancin|telavancin|mesh-list
44658952|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44658953|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44658954|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
44658955|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44658956|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658957|NCT00060944|Dexamethasone|dexamethasone|mesh-list
44658958|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
44658959|NCT00060944|Trabectedin|trabectedin|mesh-list
44658960|NCT00060944|BB 1101|bb 1101|mesh-list
44658961|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44658962|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
44658963|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
44658964|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658965|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658966|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44658967|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
44658968|NCT00060944|Hormones|hormones|mesh-ancestor
44658969|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44658970|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44658971|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44658972|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44658973|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44658974|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658975|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44658976|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
44658977|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
44658978|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44658979|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
44658980|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44658981|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44658982|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44658983|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44658984|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44658985|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
44658986|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44658987|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44658988|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44658989|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
44658990|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
44658991|NCT00060840|Protective Agents|protective agents|mesh-ancestor
44658992|NCT00059839|Prednisone|prednisone|mesh-list
44658993|NCT00059839|Doxorubicin|doxorubicin|mesh-list
44658994|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44658995|NCT00059839|Methotrexate|methotrexate|mesh-list
44658996|NCT00059839|Vincristine|vincristine|mesh-list
44658997|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
44658998|NCT00059839|Vinblastine|vinblastine|mesh-list
44658999|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659000|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659001|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659002|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659003|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659004|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659005|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659006|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
44659007|NCT00059839|Hormones|hormones|mesh-ancestor
44659008|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659009|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659010|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209422|NCT00434031|Trastuzumab|trastuzumab|mesh-list
44659011|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659012|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659013|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659014|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659015|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
44659016|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659017|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659018|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659019|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
43924945|NCT00700661|Montelukast|montelukast|mesh-list
44659020|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659021|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659022|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659023|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659024|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659025|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659026|NCT00059787|Paclitaxel|paclitaxel|mesh-list
44659027|NCT00059787|Carboplatin|carboplatin|mesh-list
44659028|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44659029|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659030|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659031|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659032|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659033|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659034|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659035|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659036|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659037|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
44659038|NCT00059332|Analgesics|analgesics|mesh-ancestor
44659039|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
44659040|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44659041|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659042|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
44659043|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44659044|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44659045|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
44659046|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44659047|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44659048|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659049|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44659050|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
44659051|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659052|NCT00059215|Clopidogrel|clopidogrel|mesh-list
44659053|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44659054|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44659055|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44659056|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44659057|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44659058|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
44659059|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659060|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659061|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659062|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44659063|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44659064|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44659065|NCT00058825|Cyclosporine|cyclosporine|mesh-list
44659066|NCT00058825|Fludarabine|fludarabine|mesh-list
44659067|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
44659068|NCT00058825|Tacrolimus|tacrolimus|mesh-list
44659069|NCT00058825|Cyclosporins|cyclosporins|mesh-list
44659070|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659071|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659072|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659073|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
44659074|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659075|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659076|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659077|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
44659078|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659079|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659080|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659081|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659082|NCT00058552|Pertuzumab|pertuzumab|mesh-list
44659083|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659084|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659085|NCT00058539|Pertuzumab|pertuzumab|mesh-list
44659086|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659087|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209499|NCT00434174|Pemetrexed|pemetrexed|mesh-list
44659088|NCT00058422|Prednisone|prednisone|mesh-list
44659089|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
44659090|NCT00058422|Rituximab|rituximab|mesh-list
44659091|NCT00058422|Doxorubicin|doxorubicin|mesh-list
44659092|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44659093|NCT00058422|Vincristine|vincristine|mesh-list
44659094|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
44659095|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44659096|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659097|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
44659098|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659099|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659100|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659101|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
43925032|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659102|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659103|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659104|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659105|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659106|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659107|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659108|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659109|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659110|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659111|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
44659112|NCT00058422|Hormones|hormones|mesh-ancestor
44659113|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659114|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659115|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659116|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659117|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659118|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659119|NCT00058422|Hematinics|hematinics|mesh-ancestor
44659120|NCT00058123|Poly ICLC|poly iclc|mesh-list
44659121|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
44659122|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
44659123|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659124|NCT00057954|Cyclosporine|cyclosporine|mesh-list
44659125|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
44659126|NCT00057954|Methotrexate|methotrexate|mesh-list
44659127|NCT00057954|Pentostatin|pentostatin|mesh-list
44659128|NCT00057954|Cyclosporins|cyclosporins|mesh-list
44659129|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659130|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659131|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659132|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659133|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659134|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
44659135|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659136|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659137|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659138|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659139|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659140|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659141|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
44659142|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659143|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659144|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
44659145|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659146|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659147|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659148|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44659149|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
44659150|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659151|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44659152|NCT00057941|Fulvestrant|fulvestrant|mesh-list
44659153|NCT00057941|Anastrozole|anastrozole|mesh-list
44659154|NCT00057941|Gefitinib|gefitinib|mesh-list
44659155|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659156|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659157|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44659158|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44659159|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44659160|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659161|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659162|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659163|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659164|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659165|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44659166|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44659167|NCT00057876|Gemcitabine|gemcitabine|mesh-list
44659168|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659169|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
44659170|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659171|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659172|NCT00057876|Antiviral Agents|antiviral agents|mesh-ancestor
44659173|NCT00057876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659174|NCT00057876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659175|NCT00057876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659176|NCT00057876|Immunologic Factors|immunologic factors|mesh-ancestor
44659177|NCT00057876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659178|NCT00057863|Paclitaxel|paclitaxel|mesh-list
44659179|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
44659180|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659181|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659182|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659183|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659184|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659185|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659186|NCT00057837|Cisplatin|cisplatin|mesh-list
44659187|NCT00057837|Irinotecan|irinotecan|mesh-list
44659188|NCT00057837|Etoposide|etoposide|mesh-list
44659189|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
44659190|NCT00057837|Topotecan|topotecan|mesh-list
44659191|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
44659192|NCT00057837|Camptothecin|camptothecin|mesh-list
44659193|NCT00057837|Lenograstim|lenograstim|mesh-list
44659194|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659195|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44659196|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659197|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659198|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659199|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659200|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659201|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44659202|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
44659203|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659204|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
44659205|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659206|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659207|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659208|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659209|NCT00057811|Leucovorin|leucovorin|mesh-list
44659210|NCT00057811|Cytarabine|cytarabine|mesh-list
44659211|NCT00057811|Prednisone|prednisone|mesh-list
44659212|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
44659213|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44659214|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44659215|NCT00057811|Prednisolone|prednisolone|mesh-list
44659216|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
44659217|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
44659218|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44659219|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44659220|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44659221|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
44659222|NCT00057811|Rituximab|rituximab|mesh-list
44659223|NCT00057811|Doxorubicin|doxorubicin|mesh-list
44659224|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44659226|NCT00057811|Etoposide|etoposide|mesh-list
44659227|NCT00057811|Vincristine|vincristine|mesh-list
44659228|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
44659229|NCT00057811|Rasburicase|rasburicase|mesh-list
44659230|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44659231|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
44659232|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
44659233|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659234|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
44659235|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659236|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209646|NCT00435305|Linezolid|linezolid|mesh-list
44659237|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659238|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
44659239|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659240|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659241|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659242|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659243|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659244|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659245|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659246|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659247|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659248|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
44659249|NCT00057811|Hormones|hormones|mesh-ancestor
44659250|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659251|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659252|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659253|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659254|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659255|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659256|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
44659257|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659258|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659259|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659260|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659261|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
44659262|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659263|NCT00057811|Antidotes|antidotes|mesh-ancestor
44659264|NCT00057811|Protective Agents|protective agents|mesh-ancestor
44659265|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
44659266|NCT00057811|Vitamins|vitamins|mesh-ancestor
44659267|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
44659268|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659269|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659270|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659271|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
44659272|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
44659273|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44659274|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44659275|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44659276|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
44659277|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
44659278|NCT00057330|Vaccines|vaccines|mesh-list
44659279|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
44659280|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
44659281|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659282|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44659283|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659284|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659285|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
44659286|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659287|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
44659288|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44659289|NCT00057330|Protective Agents|protective agents|mesh-ancestor
44659290|NCT00056862|Ribavirin|ribavirin|mesh-list
44659291|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44659292|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
44659293|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
44659294|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659295|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
44659296|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659297|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
44659298|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659299|NCT00056407|Dutasteride|dutasteride|mesh-list
44659300|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44659301|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44659302|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659303|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659304|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
44659305|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659306|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659308|NCT00056160|Lenalidomide|lenalidomide|mesh-list
44659309|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659310|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
44659311|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
44659312|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44659313|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659314|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44659315|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
44659316|NCT00056160|Hormones|hormones|mesh-ancestor
44659317|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659318|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659319|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659320|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
44659321|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44659322|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44659323|NCT00056160|Growth Substances|growth substances|mesh-ancestor
44659324|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
44659325|NCT00055601|Gemcitabine|gemcitabine|mesh-list
44659326|NCT00055601|Paclitaxel|paclitaxel|mesh-list
44659327|NCT00055601|Cisplatin|cisplatin|mesh-list
44659328|NCT00055601|Fluorouracil|fluorouracil|mesh-list
44659329|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659330|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659331|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659332|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659333|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659334|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659335|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659336|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
44659337|NCT00055601|Antiviral Agents|antiviral agents|mesh-ancestor
44659338|NCT00055601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659339|NCT00055601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659340|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659341|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
44659342|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659343|NCT00055497|Adalimumab|adalimumab|mesh-list
44659344|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659345|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659346|NCT00054717|Ritonavir|ritonavir|mesh-list
44659347|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44659348|NCT00054717|Tipranavir|tipranavir|mesh-list
44659349|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
44659350|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44659351|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659352|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659353|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44659354|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44659355|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
44659356|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659357|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44659358|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44659359|NCT00054704|Riluzole|riluzole|mesh-list
44659360|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
44659361|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44659362|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44659363|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659364|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659365|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659366|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44659367|NCT00054704|Protective Agents|protective agents|mesh-ancestor
44659368|NCT00054691|Gefitinib|gefitinib|mesh-list
44659369|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659370|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659371|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659372|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659373|NCT00054639|Rituximab|rituximab|mesh-list
44659374|NCT00054639|Oblimersen|oblimersen|mesh-list
44659375|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659376|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659377|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
44659378|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659379|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659380|NCT00054327|Cytarabine|cytarabine|mesh-list
44659381|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
44659382|NCT00054327|Busulfan|busulfan|mesh-list
44659383|NCT00054327|Etoposide|etoposide|mesh-list
44659384|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
44659385|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659386|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
44659387|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659388|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659389|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659390|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
44659391|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659392|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659393|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659394|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659395|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659396|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659397|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659398|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659399|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
44659400|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
44659401|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659402|NCT00054275|Docetaxel|docetaxel|mesh-list
44659403|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44659404|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659405|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659406|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659407|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659408|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659409|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659410|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659411|NCT00054132|Bevacizumab|bevacizumab|mesh-list
44659412|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44659413|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44659414|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
44659415|NCT00054132|Antibodies|antibodies|mesh-list
44659416|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
44659417|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44659418|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
44659419|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659420|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44659421|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44659422|NCT00054132|Growth Substances|growth substances|mesh-ancestor
44659423|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659424|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44659425|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
44659426|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659427|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659428|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659429|NCT00053898|Tamoxifen|tamoxifen|mesh-list
44659430|NCT00053898|Anastrozole|anastrozole|mesh-list
44659431|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659432|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44659433|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44659434|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659435|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659436|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659437|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659438|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44659439|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44659440|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659441|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44659442|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44659443|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659444|NCT00053846|Buspirone|buspirone|mesh-list
44659445|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44659446|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44659447|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44659448|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659449|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44659451|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
44659452|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659453|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659454|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
44659455|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44659456|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44659457|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659458|NCT00053365|Irofulven|irofulven|mesh-list
44659459|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659460|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
44659461|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659462|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659463|NCT00053352|Cisplatin|cisplatin|mesh-list
44659464|NCT00053352|Etoposide|etoposide|mesh-list
44659465|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
44659466|NCT00053352|Bleomycin|bleomycin|mesh-list
44659467|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659468|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659469|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659470|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659471|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659472|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925427|NCT00590863|Citalopram|citalopram|mesh-list
44659473|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659474|NCT00052715|Poly ICLC|poly iclc|mesh-list
44659475|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
44659476|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
44659477|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659478|NCT00051636|Vitamin D|vitamin d|mesh-list
44659479|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
44659480|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
44659481|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
44659482|NCT00051636|Calcium|calcium|mesh-list
44659483|NCT00051636|Vitamins|vitamins|mesh-ancestor
44659484|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
44659485|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659486|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44659487|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659488|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44659489|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44659490|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659491|NCT00051558|Alendronate|alendronate|mesh-list
44659492|NCT00051558|Teriparatide|teriparatide|mesh-list
44659493|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659494|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659495|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44659496|NCT00051311|Cyclosporine|cyclosporine|mesh-list
44659497|NCT00051311|Prednisone|prednisone|mesh-list
44659498|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
44659499|NCT00051311|Doxorubicin|doxorubicin|mesh-list
44659500|NCT00051311|Methotrexate|methotrexate|mesh-list
44659501|NCT00051311|Fludarabine|fludarabine|mesh-list
44659502|NCT00051311|Etoposide|etoposide|mesh-list
44659503|NCT00051311|Vincristine|vincristine|mesh-list
44659504|NCT00051311|Cyclosporins|cyclosporins|mesh-list
44659505|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659506|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
44659507|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659508|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659509|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659510|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
44659511|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659512|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659513|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659514|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659515|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659516|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659517|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659518|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659519|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
44659520|NCT00051311|Hormones|hormones|mesh-ancestor
44659521|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659522|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659523|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659524|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659525|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659526|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659527|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
44659528|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659529|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659530|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659531|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659532|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659533|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659534|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659535|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
44659536|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659537|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659538|NCT00050960|Paclitaxel|paclitaxel|mesh-list
44659539|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44659540|NCT00050960|Carboplatin|carboplatin|mesh-list
44659541|NCT00050960|Bexarotene|bexarotene|mesh-list
44659542|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659543|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209922|NCT00436839|Hormones|hormones|mesh-ancestor
44659544|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659545|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659546|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659547|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659548|NCT00050778|Interferons|interferons|mesh-list
44659549|NCT00050778|Interferon-beta|interferon-beta|mesh-list
44659550|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
44659551|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
44659552|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659553|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
44659554|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659555|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659556|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
44659557|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659558|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44659559|NCT00050622|Methylphenidate|methylphenidate|mesh-list
44659560|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44659561|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659562|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44659563|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44659564|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44659565|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659566|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
44659567|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659568|NCT00050167|Paclitaxel|paclitaxel|mesh-list
44659569|NCT00050167|Docetaxel|docetaxel|mesh-list
44659570|NCT00050167|Capecitabine|capecitabine|mesh-list
44659571|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659572|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659573|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659574|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659575|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659576|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659577|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659578|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
44659579|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
44659580|NCT00050011|Letrozole|letrozole|mesh-list
44659581|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659582|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44659583|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44659584|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659585|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659586|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44659587|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
44659588|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659589|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659590|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659591|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44659592|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
44659593|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659594|NCT00049673|Thalidomide|thalidomide|mesh-list
44659595|NCT00049673|Prednisone|prednisone|mesh-list
44659596|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659597|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
44659598|NCT00049673|Hormones|hormones|mesh-ancestor
44659599|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659600|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659601|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659602|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659603|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659604|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
44659605|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
44659606|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659607|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659608|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925531|NCT00592488|Vitamins|vitamins|mesh-ancestor
44659609|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44659610|NCT00049673|Growth Substances|growth substances|mesh-ancestor
44659611|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44659612|NCT00049543|Gefitinib|gefitinib|mesh-list
44659613|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659614|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659615|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659616|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209992|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
44659617|NCT00049530|Interferons|interferons|mesh-list
44659618|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
44659619|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
44659620|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44659621|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659622|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
44659623|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659624|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
44659625|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659626|NCT00049517|Cytarabine|cytarabine|mesh-list
44659627|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
44659628|NCT00049517|Busulfan|busulfan|mesh-list
44659629|NCT00049517|Daunorubicin|daunorubicin|mesh-list
44659630|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
44659631|NCT00049517|Sargramostim|sargramostim|mesh-list
44659632|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659633|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
44659634|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659635|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659636|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659637|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
44659638|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659639|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659640|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659641|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659642|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
44659643|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
44659644|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659645|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43925564|NCT00593866|Gemcitabine|gemcitabine|mesh-list
44659646|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659647|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659648|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659649|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659650|NCT00049322|Bevacizumab|bevacizumab|mesh-list
44659651|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659652|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659653|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44659654|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44659655|NCT00049322|Growth Substances|growth substances|mesh-ancestor
44659656|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659657|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44659658|NCT00049257|Paclitaxel|paclitaxel|mesh-list
44659659|NCT00049257|Carboplatin|carboplatin|mesh-list
44659660|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659661|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659662|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659663|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659664|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659665|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659666|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
44659667|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659668|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659669|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659670|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659671|NCT00048932|Abatacept|abatacept|mesh-list
44659672|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44659673|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659674|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659675|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659676|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
44659677|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659678|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659679|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44659680|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
44659681|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659683|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44659684|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659685|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659686|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659687|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
44659688|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659689|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659690|NCT00048568|Methotrexate|methotrexate|mesh-list
44659691|NCT00048568|Abatacept|abatacept|mesh-list
44659692|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659693|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659694|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659695|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659696|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659697|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
44659698|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659699|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659700|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659701|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659702|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659703|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659704|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
44659705|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659706|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659707|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44659708|NCT00048542|Adalimumab|adalimumab|mesh-list
44659709|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659710|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659711|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
44659712|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44659713|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
44659714|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659715|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659716|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
44659717|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659718|NCT00048165|Cyclosporine|cyclosporine|mesh-list
44659719|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
44659720|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
44659721|NCT00048165|Cyclosporins|cyclosporins|mesh-list
44659722|NCT00048165|Daclizumab|daclizumab|mesh-list
44659723|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659724|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659725|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659726|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
44659727|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659728|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
44659729|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659730|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659731|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659732|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659733|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43925642|NCT00595270|Vaccines|vaccines|mesh-list
44659734|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659735|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44659736|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
44659737|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659738|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659739|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
44659740|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
44659741|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44659742|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44659743|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
44659744|NCT00048165|Hormones|hormones|mesh-ancestor
44659745|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659746|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44659747|NCT00048165|Protective Agents|protective agents|mesh-ancestor
44659749|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659750|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659751|NCT00048061|Vitamin D|vitamin d|mesh-list
44659752|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
44659753|NCT00048061|Calcium|calcium|mesh-list
44659754|NCT00048061|Vitamins|vitamins|mesh-ancestor
44659755|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
44659756|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659757|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44659758|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44659759|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
44659760|NCT00048048|Hematinics|hematinics|mesh-ancestor
44659761|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
44659762|NCT00048035|Hematinics|hematinics|mesh-ancestor
44659763|NCT00047879|Interferons|interferons|mesh-list
44659764|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
44659765|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
44659766|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44659767|NCT00047879|Thalidomide|thalidomide|mesh-list
44659768|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659769|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
44659770|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659771|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
44659772|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659773|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659774|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
44659775|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659776|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44659777|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44659778|NCT00047879|Growth Substances|growth substances|mesh-ancestor
44659779|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
44659780|NCT00047320|Carboplatin|carboplatin|mesh-list
44659781|NCT00047320|Etoposide|etoposide|mesh-list
44659782|NCT00047320|Ifosfamide|ifosfamide|mesh-list
44659783|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
44659784|NCT00047320|Thiotepa|thiotepa|mesh-list
44659785|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659786|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659787|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659788|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659789|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659790|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659791|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659792|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
44659793|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659794|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659795|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
44659796|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659797|NCT00046930|Cytarabine|cytarabine|mesh-list
44659798|NCT00046930|Daunorubicin|daunorubicin|mesh-list
44659799|NCT00046930|Molgramostim|molgramostim|mesh-list
44659800|NCT00046930|Lenograstim|lenograstim|mesh-list
44659801|NCT00046930|Sargramostim|sargramostim|mesh-list
44659802|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659803|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
44659804|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659805|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659806|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
44659807|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659808|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659809|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
44659810|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659811|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44659812|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659813|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659814|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659815|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659816|NCT00046839|Celecoxib|celecoxib|mesh-list
44659817|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
44659818|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44659819|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44659820|NCT00046839|Analgesics|analgesics|mesh-ancestor
44659821|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
44659822|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44659823|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659824|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659826|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44659827|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659828|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659829|NCT00045942|Itraconazole|itraconazole|mesh-list
44659830|NCT00045942|Midostaurin|midostaurin|mesh-list
44659831|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
44659832|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659833|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44659834|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44659835|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659836|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659837|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44659838|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44659839|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659840|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659841|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43925790|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659842|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659843|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659844|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
44659845|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659846|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659847|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659848|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659849|NCT00045708|Epothilones|epothilones|mesh-list
44659850|NCT00045708|Epothilone B|epothilone b|mesh-list
44659851|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
44659852|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659853|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659854|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659855|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659856|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659857|NCT00045630|Gemcitabine|gemcitabine|mesh-list
44659859|NCT00045630|Carboplatin|carboplatin|mesh-list
44659860|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659861|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659862|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659863|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659864|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659865|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659866|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659867|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
44659868|NCT00045630|Antiviral Agents|antiviral agents|mesh-ancestor
44659869|NCT00045630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659870|NCT00045630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659871|NCT00045630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659872|NCT00045630|Immunologic Factors|immunologic factors|mesh-ancestor
44659873|NCT00045630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659874|NCT00045305|Cyclosporine|cyclosporine|mesh-list
44659875|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
44659876|NCT00045305|Methotrexate|methotrexate|mesh-list
44659877|NCT00045305|Pentostatin|pentostatin|mesh-list
44659878|NCT00045305|Methoxsalen|methoxsalen|mesh-list
44659879|NCT00045305|Cyclosporins|cyclosporins|mesh-list
44659880|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44659881|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
44659882|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44659883|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659884|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659885|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
44659886|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659887|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659888|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659889|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659890|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44659891|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659892|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
44659893|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659894|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44659895|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
44659896|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659897|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659898|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659900|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
44659901|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659902|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44659903|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44659904|NCT00045162|Cisplatin|cisplatin|mesh-list
44659905|NCT00045162|Irinotecan|irinotecan|mesh-list
44659906|NCT00045162|Etoposide|etoposide|mesh-list
44659907|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659908|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44659909|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659910|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659911|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659912|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44659913|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659914|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44659915|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659916|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659917|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659918|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659920|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44659921|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659922|NCT00044512|Sorafenib|sorafenib|mesh-list
44659923|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659924|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44659925|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659926|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659927|NCT00044213|Vitamins|vitamins|mesh-list
44659928|NCT00044213|Edetic Acid|edetic acid|mesh-list
44659929|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
44659930|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
44659931|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659932|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
44659933|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44659934|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
44659935|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
44659936|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659937|NCT00044213|Antidotes|antidotes|mesh-ancestor
44659938|NCT00044213|Protective Agents|protective agents|mesh-ancestor
44659939|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44659940|NCT00044083|Tolcapone|tolcapone|mesh-list
44659941|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44659942|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44659943|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44659944|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659945|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659946|NCT00043979|Cyclosporine|cyclosporine|mesh-list
44659947|NCT00043979|Sirolimus|sirolimus|mesh-list
44659948|NCT00043979|Prednisone|prednisone|mesh-list
44659949|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
44659950|NCT00043979|Melphalan|melphalan|mesh-list
44659951|NCT00043979|Doxorubicin|doxorubicin|mesh-list
44659952|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44659953|NCT00043979|Fludarabine|fludarabine|mesh-list
44659954|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
44659955|NCT00043979|Etoposide|etoposide|mesh-list
44659956|NCT00043979|Vincristine|vincristine|mesh-list
44659957|NCT00043979|Tacrolimus|tacrolimus|mesh-list
44659958|NCT00043979|Cyclosporins|cyclosporins|mesh-list
44659959|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44659960|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44659961|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
44659962|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44659963|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44659964|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44659965|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
44659966|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659967|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44659968|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44659969|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44659970|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44659971|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44659972|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44659973|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44659974|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
44659975|NCT00043979|Hormones|hormones|mesh-ancestor
44659976|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44659977|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44659978|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44659979|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
44659980|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44054872|NCT00004404|Clotrimazole|clotrimazole|mesh-list
44659981|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44659982|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44659983|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44659984|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44659985|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
44659986|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44659987|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
44659988|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44659989|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44659990|NCT00043550|Sertraline|sertraline|mesh-list
44659991|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44659992|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
44659993|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44659994|NCT00043550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44659995|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44659996|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44659997|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44659998|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44659999|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
44660000|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660001|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44660002|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44660003|NCT00043186|Denosumab|denosumab|mesh-list
44660004|NCT00043186|Alendronate|alendronate|mesh-list
44660005|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44660006|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660007|NCT00042991|Gefitinib|gefitinib|mesh-list
44660008|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660009|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660010|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660011|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660012|NCT00042939|Docetaxel|docetaxel|mesh-list
44660013|NCT00042939|Irinotecan|irinotecan|mesh-list
44660014|NCT00042939|Cetuximab|cetuximab|mesh-list
44660015|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660016|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660017|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660018|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660019|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660020|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44660021|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660022|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660023|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660024|NCT00042432|Cinacalcet|cinacalcet|mesh-list
44660025|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44660026|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660027|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44660028|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
43925878|NCT00601926|Growth Substances|growth substances|mesh-ancestor
44660029|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660030|NCT00042289|Ritonavir|ritonavir|mesh-list
44660031|NCT00042289|Lopinavir|lopinavir|mesh-list
44660032|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44660033|NCT00042289|Darunavir|darunavir|mesh-list
44660034|NCT00042289|Nelfinavir|nelfinavir|mesh-list
44660035|NCT00042289|Indinavir|indinavir|mesh-list
44660036|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
44660037|NCT00042289|Amprenavir|amprenavir|mesh-list
44660038|NCT00042289|Tenofovir|tenofovir|mesh-list
44660039|NCT00042289|Emtricitabine|emtricitabine|mesh-list
44660040|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
44660041|NCT00042289|Nevirapine|nevirapine|mesh-list
44660042|NCT00042289|Maraviroc|maraviroc|mesh-list
44660043|NCT00042289|Dolutegravir|dolutegravir|mesh-list
44660044|NCT00042289|Abacavir|abacavir|mesh-list
44660045|NCT00042289|Didanosine|didanosine|mesh-list
44660046|NCT00042289|Cobicistat|cobicistat|mesh-list
44660047|NCT00042289|Rilpivirine|rilpivirine|mesh-list
44660048|NCT00042289|Tipranavir|tipranavir|mesh-list
44660049|NCT00042289|Elvitegravir|elvitegravir|mesh-list
44660050|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44660051|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
44660052|NCT00042289|Efavirenz|efavirenz|mesh-list
44660053|NCT00042289|Rifampin|rifampin|mesh-list
44660054|NCT00042289|Isoniazid|isoniazid|mesh-list
44660055|NCT00042289|Linezolid|linezolid|mesh-list
44660057|NCT00042289|Amikacin|amikacin|mesh-list
44660058|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
44660059|NCT00042289|Ethambutol|ethambutol|mesh-list
44660060|NCT00042289|Bedaquiline|bedaquiline|mesh-list
44660061|NCT00042289|Etravirine|etravirine|mesh-list
44660062|NCT00042289|Clofazimine|clofazimine|mesh-list
44660063|NCT00042289|Ofloxacin|ofloxacin|mesh-list
44660064|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44660065|NCT00042289|Ethionamide|ethionamide|mesh-list
44660066|NCT00042289|Kanamycin|kanamycin|mesh-list
44660067|NCT00042289|Capreomycin|capreomycin|mesh-list
44660068|NCT00042289|Prothionamide|prothionamide|mesh-list
44660069|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44660070|NCT00042289|Etonogestrel|etonogestrel|mesh-list
44660071|NCT00042289|Estradiol|estradiol|mesh-list
44660072|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44660073|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44660074|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
44660075|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660076|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660077|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44660078|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44660079|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
44660080|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660081|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44660082|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660083|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44660084|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660085|NCT00042289|Estrogens|estrogens|mesh-ancestor
44660086|NCT00042289|Hormones|hormones|mesh-ancestor
44660087|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660088|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660089|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44660090|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
44660091|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660092|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44660093|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660094|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660095|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660096|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660097|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44660098|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44660099|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44660100|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44660101|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44660102|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44660103|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44660104|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44660105|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44660106|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44660107|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
44660108|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
44660109|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44660110|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44660111|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44660112|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44660113|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44660114|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
44660115|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44660116|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44660117|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44660118|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44660119|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44660120|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44660121|NCT00042289|Renal Agents|renal agents|mesh-ancestor
44660122|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660123|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44660124|NCT00041470|Paclitaxel|paclitaxel|mesh-list
44660125|NCT00041470|Vinorelbine|vinorelbine|mesh-list
44660126|NCT00041470|Trastuzumab|trastuzumab|mesh-list
44660127|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660128|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660129|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660130|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660131|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660132|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660133|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660135|NCT00041132|Cytarabine|cytarabine|mesh-list
44660136|NCT00041132|Dexamethasone|dexamethasone|mesh-list
44660137|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
44660138|NCT00041132|Rituximab|rituximab|mesh-list
44660139|NCT00041132|Doxorubicin|doxorubicin|mesh-list
44660140|NCT00041132|Methotrexate|methotrexate|mesh-list
44660141|NCT00041132|Vincristine|vincristine|mesh-list
44660142|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
44660143|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660144|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
44660145|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660146|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660147|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660148|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
44660149|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660150|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660151|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660152|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660153|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660154|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
44660155|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
44660156|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660157|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44660158|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
44660159|NCT00041132|Hormones|hormones|mesh-ancestor
44660160|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660161|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660162|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660163|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660164|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660165|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660166|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44660167|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
44660168|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660169|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660170|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
44660171|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660172|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44660173|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660174|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
44660175|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660176|NCT00041132|Antidotes|antidotes|mesh-ancestor
44660177|NCT00041132|Protective Agents|protective agents|mesh-ancestor
44660178|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
44660179|NCT00041132|Vitamins|vitamins|mesh-ancestor
44660180|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
44660181|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660182|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660183|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660184|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660185|NCT00041080|Tamoxifen|tamoxifen|mesh-list
44660186|NCT00041080|Thalidomide|thalidomide|mesh-list
44660187|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44660188|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660189|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660190|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660191|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660192|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660193|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44660194|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44660195|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44660196|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660197|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
44660198|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
44660199|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660200|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660201|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44660202|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44660203|NCT00041080|Growth Substances|growth substances|mesh-ancestor
44660204|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
44660205|NCT00041067|Docetaxel|docetaxel|mesh-list
44660206|NCT00041067|Trastuzumab|trastuzumab|mesh-list
44660207|NCT00041067|Vinorelbine|vinorelbine|mesh-list
44660208|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660209|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660210|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660211|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660212|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660213|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660214|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660216|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
44660217|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44660218|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44660219|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
44660220|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660221|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660222|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44660223|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44660224|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
44660225|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660226|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44660227|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660228|NCT00040365|Amifostine|amifostine|mesh-list
44660229|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44660230|NCT00040365|Protective Agents|protective agents|mesh-ancestor
44660231|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660232|NCT00039871|Ribavirin|ribavirin|mesh-list
44660233|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44660234|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
44660235|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
44660236|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660237|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
44660238|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660239|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
44660240|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660241|NCT00039377|Leucovorin|leucovorin|mesh-list
44660242|NCT00039377|Cytarabine|cytarabine|mesh-list
44660243|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
44660244|NCT00039377|Methotrexate|methotrexate|mesh-list
44660245|NCT00039377|Etoposide|etoposide|mesh-list
44660246|NCT00039377|Vincristine|vincristine|mesh-list
44660247|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
44660248|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
44660249|NCT00039377|Tacrolimus|tacrolimus|mesh-list
44660250|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
44660251|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660252|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
44660253|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660254|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660255|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660256|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
44660257|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660258|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660259|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660260|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44660261|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
44660262|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660263|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660264|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
44660265|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660266|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660267|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44660268|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660269|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660270|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660271|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660272|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
44660273|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660274|NCT00039377|Antidotes|antidotes|mesh-ancestor
44660275|NCT00039377|Protective Agents|protective agents|mesh-ancestor
44660276|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
44660277|NCT00039377|Vitamins|vitamins|mesh-ancestor
44660278|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
44660279|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44660280|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660281|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660282|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660283|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660284|NCT00039130|Leucovorin|leucovorin|mesh-list
44660285|NCT00039130|Cytarabine|cytarabine|mesh-list
44660288|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
44660289|NCT00039130|Ifosfamide|ifosfamide|mesh-list
44660290|NCT00039130|Rituximab|rituximab|mesh-list
44660291|NCT00039130|Doxorubicin|doxorubicin|mesh-list
44660292|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44660293|NCT00039130|Methotrexate|methotrexate|mesh-list
44660294|NCT00039130|Etoposide|etoposide|mesh-list
44660295|NCT00039130|Vincristine|vincristine|mesh-list
44660296|NCT00039130|Allopurinol|allopurinol|mesh-list
44660297|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
44660298|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660299|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
44660300|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660301|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660302|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660303|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
44660304|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660305|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660306|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660307|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660308|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660309|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
44660310|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
44660311|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660312|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44660313|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
44660314|NCT00039130|Hormones|hormones|mesh-ancestor
44660315|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660316|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660317|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660318|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660319|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660320|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660321|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44660322|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
44660323|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660324|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660325|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
44660326|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660327|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44660328|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660329|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660330|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
44660331|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660332|NCT00039130|Antidotes|antidotes|mesh-ancestor
44660333|NCT00039130|Protective Agents|protective agents|mesh-ancestor
44660334|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
44660335|NCT00039130|Vitamins|vitamins|mesh-ancestor
44660336|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
44660337|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660338|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660339|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660340|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
44660341|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44660342|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
44660343|NCT00038948|Cyclosporine|cyclosporine|mesh-list
44660344|NCT00038948|Sirolimus|sirolimus|mesh-list
44660345|NCT00038948|Tacrolimus|tacrolimus|mesh-list
44660346|NCT00038948|Cyclosporins|cyclosporins|mesh-list
44660347|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660348|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
44660349|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660350|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44660351|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660352|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660353|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
44660354|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660355|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660356|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660357|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660358|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660359|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660360|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
44660361|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660362|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660364|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660365|NCT00038467|Tamoxifen|tamoxifen|mesh-list
44660366|NCT00038467|Exemestane|exemestane|mesh-list
44660367|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44660368|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660369|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660370|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660371|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660372|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660373|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44660374|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44660375|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44660376|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44660377|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44660378|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660379|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660380|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
44660381|NCT00038142|Doxorubicin|doxorubicin|mesh-list
44660382|NCT00038142|Vincristine|vincristine|mesh-list
44660383|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
44660384|NCT00038142|Razoxane|razoxane|mesh-list
44660385|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660386|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
44660387|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660388|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660389|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660390|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
44660391|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660392|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660393|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660394|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660395|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660396|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660397|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660398|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660399|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660400|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660401|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660402|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44660403|NCT00038142|Protective Agents|protective agents|mesh-ancestor
44660404|NCT00038103|Celecoxib|celecoxib|mesh-list
44660405|NCT00038103|Exemestane|exemestane|mesh-list
44660406|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44660407|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44660408|NCT00038103|Analgesics|analgesics|mesh-ancestor
44660409|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
44660410|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660411|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660412|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660413|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660414|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44660415|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44660416|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660417|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660418|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660419|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44660420|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44660421|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44660422|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660423|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660424|NCT00036270|Tamoxifen|tamoxifen|mesh-list
44660425|NCT00036270|Exemestane|exemestane|mesh-list
44660426|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44660427|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660428|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660429|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660430|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660431|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660432|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44660433|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44660434|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44660435|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44660436|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44660437|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660438|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660440|NCT00035932|Lopinavir|lopinavir|mesh-list
44660441|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44660442|NCT00035932|Saquinavir|saquinavir|mesh-list
44660443|NCT00035932|Tenofovir|tenofovir|mesh-list
44660444|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44660445|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44660446|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44660447|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660448|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660449|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44660450|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44660451|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
44660452|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660453|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44660454|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660455|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44660456|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660457|NCT00035815|Mitogens|mitogens|mesh-list
44660458|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660459|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660460|NCT00035555|Cyclosporine|cyclosporine|mesh-list
44660461|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
44660462|NCT00035555|Abatacept|abatacept|mesh-list
44660463|NCT00035555|Cyclosporins|cyclosporins|mesh-list
44660464|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660465|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660466|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660467|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
44660468|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660469|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
43926317|NCT00610883|Methotrexate|methotrexate|mesh-list
44660470|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660471|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660472|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660473|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44660474|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660475|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660476|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44660477|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
44660478|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660479|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44660480|NCT00033657|Paclitaxel|paclitaxel|mesh-list
44660481|NCT00033657|Camptothecin|camptothecin|mesh-list
44660482|NCT00033657|Cisplatin|cisplatin|mesh-list
44660483|NCT00033657|Irinotecan|irinotecan|mesh-list
44660484|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660485|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660486|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660487|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660488|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660489|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660490|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44660491|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660492|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660493|NCT00033540|Gemcitabine|gemcitabine|mesh-list
44660494|NCT00033540|Capecitabine|capecitabine|mesh-list
44660495|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660496|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
44660497|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660498|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660499|NCT00033540|Antiviral Agents|antiviral agents|mesh-ancestor
44660500|NCT00033540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926355|NCT00611351|Busulfan|busulfan|mesh-list
44660501|NCT00033540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660502|NCT00033540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660503|NCT00033540|Immunologic Factors|immunologic factors|mesh-ancestor
44660504|NCT00033540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660505|NCT00033514|Trastuzumab|trastuzumab|mesh-list
44660506|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44660507|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660508|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660509|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660510|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660511|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660512|NCT00033371|Eflornithine|eflornithine|mesh-list
44660513|NCT00033371|Celecoxib|celecoxib|mesh-list
44660514|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44660515|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44660516|NCT00033371|Analgesics|analgesics|mesh-ancestor
44660517|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
44660518|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055357|NCT00004575|Miconazole|miconazole|mesh-list
44660519|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660520|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660521|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660522|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44660523|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44660524|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660525|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660526|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660527|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44660528|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44660529|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44660530|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660531|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44660532|NCT00032487|Metformin|metformin|mesh-list
44660533|NCT00032487|Glimepiride|glimepiride|mesh-list
44660534|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
44660535|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44660536|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660537|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44660538|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660539|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
44660540|NCT00031694|Paclitaxel|paclitaxel|mesh-list
44660541|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
44660542|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660543|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660544|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660545|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660546|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660547|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660548|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44660549|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
44660550|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660551|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
44660552|NCT00031590|Lomustine|lomustine|mesh-list
44660553|NCT00031590|Cisplatin|cisplatin|mesh-list
44660554|NCT00031590|Etoposide|etoposide|mesh-list
44660555|NCT00031590|Vincristine|vincristine|mesh-list
44660556|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660557|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
44660558|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660559|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660560|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660561|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
44660562|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660563|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660564|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660565|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660566|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660567|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926450|NCT00612235|Carbamazepine|carbamazepine|mesh-list
44660568|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660569|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660570|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660571|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660572|NCT00031551|Etanercept|etanercept|mesh-list
44660573|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44660574|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44660575|NCT00031551|Analgesics|analgesics|mesh-ancestor
44660576|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
44660577|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660578|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660579|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660580|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660581|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44660582|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660583|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
44660584|NCT00031486|Valacyclovir|valacyclovir|mesh-list
44660585|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
44660586|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660587|NCT00031460|Acyclovir|acyclovir|mesh-list
44660588|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
44660589|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660590|NCT00031447|Acyclovir|acyclovir|mesh-list
44660591|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
44660592|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660593|NCT00030901|Selenium|selenium|mesh-list
44660594|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
44235883|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
44660596|NCT00030901|Protective Agents|protective agents|mesh-ancestor
44660597|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660598|NCT00030901|Trace Elements|trace elements|mesh-ancestor
44660599|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
44660600|NCT00028769|Paclitaxel|paclitaxel|mesh-list
44660601|NCT00028769|Etoposide|etoposide|mesh-list
44660602|NCT00028769|Leuprolide|leuprolide|mesh-list
44660603|NCT00028769|Goserelin|goserelin|mesh-list
44660604|NCT00028769|Bicalutamide|bicalutamide|mesh-list
44660605|NCT00028769|Flutamide|flutamide|mesh-list
44660606|NCT00028769|Estramustine|estramustine|mesh-list
44660607|NCT00028769|Nilutamide|nilutamide|mesh-list
44660608|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660609|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660610|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660611|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660612|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660613|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660614|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660615|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660616|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660617|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44660618|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
44660619|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660620|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660621|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660622|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
44660623|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660624|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660625|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660626|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
44660627|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
44660628|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660629|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660630|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660631|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660632|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
44660633|NCT00027846|Carboplatin|carboplatin|mesh-list
44660634|NCT00027846|Etoposide|etoposide|mesh-list
44660635|NCT00027846|Vincristine|vincristine|mesh-list
44660636|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
44660637|NCT00027846|Lenograstim|lenograstim|mesh-list
44660638|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660639|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
44660640|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660641|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660642|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660643|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
44660644|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660645|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660646|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660647|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660648|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660649|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660650|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660651|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44660652|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660653|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660654|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660655|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
44660656|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660657|NCT00027560|Cyclosporine|cyclosporine|mesh-list
44660658|NCT00027560|Fludarabine|fludarabine|mesh-list
44660659|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
44660660|NCT00027560|Melphalan|melphalan|mesh-list
44660661|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
44660662|NCT00027560|Cyclosporins|cyclosporins|mesh-list
44211022|NCT00441051|Diclofenac|diclofenac|mesh-list
44660663|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660664|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660665|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
44660666|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660667|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660668|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
44660669|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660671|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
44660672|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660673|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660674|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660675|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44660676|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660677|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
44660678|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660679|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660680|NCT00027378|Fluoxetine|fluoxetine|mesh-list
44660681|NCT00027378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44660682|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44660683|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44660684|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660685|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44660686|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
44660687|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660688|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44660689|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44660690|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44660691|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44660692|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660693|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660694|NCT00027027|Pertuzumab|pertuzumab|mesh-list
44660695|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660696|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660697|NCT00026494|Temozolomide|temozolomide|mesh-list
44660698|NCT00026494|Vinorelbine|vinorelbine|mesh-list
44660699|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660700|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
44660701|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660702|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660703|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660704|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660705|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660706|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660707|NCT00026208|Prednisone|prednisone|mesh-list
44660708|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
44660709|NCT00026208|Doxorubicin|doxorubicin|mesh-list
44660710|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44660711|NCT00026208|Etoposide|etoposide|mesh-list
44660712|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
44660713|NCT00026208|Vincristine|vincristine|mesh-list
44660714|NCT00026208|Bleomycin|bleomycin|mesh-list
44660715|NCT00026208|Vinblastine|vinblastine|mesh-list
44660716|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660717|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
44660718|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660719|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660720|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660721|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
44660722|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660723|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660724|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660725|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660726|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660727|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660728|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660729|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660730|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
44660731|NCT00026208|Hormones|hormones|mesh-ancestor
44660732|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660733|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660734|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660735|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660736|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660737|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660738|NCT00025662|Interleukin-2|interleukin-2|mesh-list
44660739|NCT00025662|Immunotoxins|immunotoxins|mesh-list
44211071|NCT00441298|Tenofovir|tenofovir|mesh-list
44660740|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660741|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44660742|NCT00025662|Analgesics|analgesics|mesh-ancestor
44660744|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660745|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660746|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
44660747|NCT00025506|Thalidomide|thalidomide|mesh-list
44660748|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660749|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
44660750|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660751|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
44660752|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660753|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660754|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44660755|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44660756|NCT00025506|Growth Substances|growth substances|mesh-ancestor
44660757|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44660758|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660759|NCT00025259|Cytarabine|cytarabine|mesh-list
44660760|NCT00025259|Dexamethasone|dexamethasone|mesh-list
44660761|NCT00025259|Prednisone|prednisone|mesh-list
44660762|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
44660763|NCT00025259|Cortisone|cortisone|mesh-list
44660764|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
44660765|NCT00025259|Cisplatin|cisplatin|mesh-list
44660766|NCT00025259|Doxorubicin|doxorubicin|mesh-list
44660767|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44660768|NCT00025259|Etoposide|etoposide|mesh-list
44660769|NCT00025259|Vincristine|vincristine|mesh-list
44660770|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
44660771|NCT00025259|Bleomycin|bleomycin|mesh-list
44660772|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
44660773|NCT00025259|Lenograstim|lenograstim|mesh-list
44660774|NCT00025259|BB 1101|bb 1101|mesh-list
44660775|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660776|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
44660777|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660778|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660779|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660780|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
44660781|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660782|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660783|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660784|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660785|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
44660786|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
44660787|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660788|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44660789|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
44660790|NCT00025259|Hormones|hormones|mesh-ancestor
44660791|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660792|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660793|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660794|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660795|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660796|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660797|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660798|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660799|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
44660800|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
44660801|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660802|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44660803|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660804|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660805|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660806|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
44660807|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
44660808|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660809|NCT00025233|Bevacizumab|bevacizumab|mesh-list
44660810|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44660811|NCT00025233|Antibodies|antibodies|mesh-list
44660812|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
44660813|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44660814|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660815|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44660816|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44660817|NCT00025233|Growth Substances|growth substances|mesh-ancestor
44660818|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926641|NCT00615472|Propofol|propofol|mesh-list
44660819|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
44660820|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
44660822|NCT00025155|Epothilone B|epothilone b|mesh-list
44660823|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660824|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660825|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660826|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660827|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660828|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
44660829|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660830|NCT00024167|Ketoconazole|ketoconazole|mesh-list
44660831|NCT00024167|Dexamethasone|dexamethasone|mesh-list
44660832|NCT00024167|Prednisone|prednisone|mesh-list
44660833|NCT00024167|Estramustine|estramustine|mesh-list
44660834|NCT00024167|Docetaxel|docetaxel|mesh-list
44660835|NCT00024167|Doxorubicin|doxorubicin|mesh-list
44660836|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44660837|NCT00024167|Vinblastine|vinblastine|mesh-list
44660838|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44660839|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
44660840|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
44660841|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44660842|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660843|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44660844|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
44660845|NCT00024167|Hormones|hormones|mesh-ancestor
44660846|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660847|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660848|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660849|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660850|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660851|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660852|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660853|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43926656|NCT00615589|Busulfan|busulfan|mesh-list
44660854|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660855|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660856|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660857|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
44660858|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660859|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44660860|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44660861|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44660862|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660863|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44660864|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660865|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660866|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
44660867|NCT00023764|Bortezomib|bortezomib|mesh-list
44660868|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660869|NCT00023712|Bortezomib|bortezomib|mesh-list
44660870|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660871|NCT00023673|Paclitaxel|paclitaxel|mesh-list
44660872|NCT00023673|Carboplatin|carboplatin|mesh-list
44660873|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660874|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660875|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660876|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660877|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660878|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660879|NCT00023452|Isoniazid|isoniazid|mesh-list
44660880|NCT00023452|Rifapentine|rifapentine|mesh-list
44660881|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
44660882|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44660883|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660884|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44660885|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44660886|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
44660887|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660888|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44660889|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44660890|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
44660891|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44660892|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
44660893|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660894|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
44211187|NCT00441909|UC-781|uc-781|mesh-list
44660895|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44660896|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44660897|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660898|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44660899|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44660900|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
44660901|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660902|NCT00022698|Capecitabine|capecitabine|mesh-list
44660903|NCT00022698|Irinotecan|irinotecan|mesh-list
44660904|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660905|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
44660906|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660907|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660908|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44660909|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660910|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660911|NCT00022672|Trastuzumab|trastuzumab|mesh-list
44660912|NCT00022672|Anastrozole|anastrozole|mesh-list
44660913|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660914|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660915|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44660916|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44660917|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44660918|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926726|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44660919|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660920|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44660921|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
44660922|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44660923|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660924|NCT00022659|Bevacizumab|bevacizumab|mesh-list
44660925|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44660926|NCT00022659|Antibodies|antibodies|mesh-list
44660927|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
44660928|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44660929|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660930|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44660931|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44660932|NCT00022659|Growth Substances|growth substances|mesh-ancestor
44660933|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660934|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
44660935|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
44660936|NCT00022633|Gemcitabine|gemcitabine|mesh-list
44660937|NCT00022633|Paclitaxel|paclitaxel|mesh-list
44660938|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44660939|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660940|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660941|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660942|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660943|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660944|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660945|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
44660946|NCT00022633|Antiviral Agents|antiviral agents|mesh-ancestor
44660947|NCT00022633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44660948|NCT00022633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660949|NCT00022633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660950|NCT00022633|Immunologic Factors|immunologic factors|mesh-ancestor
44660951|NCT00022633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660952|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
44660953|NCT00022516|Methotrexate|methotrexate|mesh-list
44660954|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660955|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
44660956|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660957|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660958|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660959|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
44660960|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660961|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660962|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660963|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44660964|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
44660965|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44660966|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44660967|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
44660968|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
44660969|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660970|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43776160|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660971|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44660973|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660974|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
44660975|NCT00021255|Carboplatin|carboplatin|mesh-list
44660976|NCT00021255|Docetaxel|docetaxel|mesh-list
44660977|NCT00021255|Doxorubicin|doxorubicin|mesh-list
44660978|NCT00021255|Trastuzumab|trastuzumab|mesh-list
44660979|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44660980|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
44660981|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44660982|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44660983|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44660984|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
44660985|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44660986|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660987|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44660988|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
44660989|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
44660990|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
44660991|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44660992|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44660993|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44660994|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44660995|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44660996|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
44660997|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44660998|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44660999|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661000|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661001|NCT00015457|Amlodipine|amlodipine|mesh-list
44661002|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
44661003|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44661004|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44661005|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661006|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
43926813|NCT00618917|Carboplatin|carboplatin|mesh-list
44661007|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44661008|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661009|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44661010|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44661011|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44661012|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
44661013|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
44661014|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44661015|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661016|NCT00009737|Leucovorin|leucovorin|mesh-list
44661017|NCT00009737|Fluorouracil|fluorouracil|mesh-list
44661018|NCT00009737|Capecitabine|capecitabine|mesh-list
44661019|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
44661020|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661021|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661022|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661023|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661024|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
44661025|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661026|NCT00009737|Antidotes|antidotes|mesh-ancestor
44661027|NCT00009737|Protective Agents|protective agents|mesh-ancestor
44661028|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
44661029|NCT00009737|Vitamins|vitamins|mesh-ancestor
44661030|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
44661031|NCT00008385|Selenium|selenium|mesh-list
44661032|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
44661033|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661034|NCT00008385|Protective Agents|protective agents|mesh-ancestor
44661035|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661036|NCT00008385|Trace Elements|trace elements|mesh-ancestor
44661037|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
44661038|NCT00008138|Paclitaxel|paclitaxel|mesh-list
44661039|NCT00008138|Carboplatin|carboplatin|mesh-list
44661040|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661041|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661042|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661043|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661044|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661045|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661046|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
44661047|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661048|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
44661049|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661050|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661051|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661052|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
44661053|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661054|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661055|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661057|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661058|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661059|NCT00007020|Cholic Acids|cholic acids|mesh-list
44661060|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44661061|NCT00006916|Bleomycin|bleomycin|mesh-list
44661062|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661063|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661064|NCT00006903|Fulvestrant|fulvestrant|mesh-list
44661065|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661066|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661067|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44661068|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44661069|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
44661070|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661071|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661072|NCT00006721|Prednisone|prednisone|mesh-list
44661073|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
44661074|NCT00006721|Rituximab|rituximab|mesh-list
44661075|NCT00006721|Doxorubicin|doxorubicin|mesh-list
44661077|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661078|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
44661079|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661080|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661081|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661082|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
44661083|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661084|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661085|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661086|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44661087|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661088|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661089|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661090|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661091|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661092|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
44661093|NCT00006721|Hormones|hormones|mesh-ancestor
43926886|NCT00619723|Choline|choline|mesh-list
44661094|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661095|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661096|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661097|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661098|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661099|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661100|NCT00006604|Ritonavir|ritonavir|mesh-list
44661101|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44661102|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44661103|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
44661104|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661105|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661106|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661107|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661108|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
44661109|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661110|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44661111|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44661112|NCT00006489|Naltrexone|naltrexone|mesh-list
44661113|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44661114|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44661115|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661116|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
44661117|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661118|NCT00006478|Sargramostim|sargramostim|mesh-list
44661119|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44661120|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
44661121|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661123|NCT00006436|Prednisone|prednisone|mesh-list
44661124|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
44661125|NCT00006436|Rituximab|rituximab|mesh-list
44661126|NCT00006436|Doxorubicin|doxorubicin|mesh-list
44661127|NCT00006436|Etoposide|etoposide|mesh-list
44661128|NCT00006436|Vincristine|vincristine|mesh-list
44661129|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661130|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661131|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
44661132|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661133|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661134|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661135|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
44661136|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661137|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661138|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661139|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44661140|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661141|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661142|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661143|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661144|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661145|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
44661146|NCT00006436|Hormones|hormones|mesh-ancestor
44661147|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661148|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661149|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661150|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661151|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661152|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661153|NCT00006392|Vitamins|vitamins|mesh-list
44661154|NCT00006392|Vitamin E|vitamin e|mesh-list
44661155|NCT00006392|Tocopherols|tocopherols|mesh-list
44661156|NCT00006392|Tocotrienols|tocotrienols|mesh-list
44661157|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
44661158|NCT00006392|Selenium|selenium|mesh-list
44661159|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
44661160|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661161|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
43926976|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44661162|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661163|NCT00006392|Protective Agents|protective agents|mesh-ancestor
44661164|NCT00006392|Trace Elements|trace elements|mesh-ancestor
44661165|NCT00006389|Cisplatin|cisplatin|mesh-list
44661166|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
44661167|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661168|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661169|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
44661170|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661171|NCT00006305|Biguanides|biguanides|mesh-list
44661172|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44661173|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
44661174|NCT00006305|Calcium|calcium|mesh-list
44661175|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44661176|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44661177|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44661178|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44661179|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661180|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44661181|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44661182|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
44661183|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44661184|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661185|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
44661186|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661187|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44661188|NCT00006289|Neurotropin|neurotropin|mesh-list
44661189|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661190|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
44661191|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661192|NCT00006289|Analgesics|analgesics|mesh-ancestor
44661193|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
44661194|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661195|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
44661196|NCT00006237|Interferons|interferons|mesh-list
44661197|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
44661198|NCT00006237|Aldesleukin|aldesleukin|mesh-list
44661200|NCT00006237|Interleukin-2|interleukin-2|mesh-list
44661201|NCT00006237|Dacarbazine|dacarbazine|mesh-list
44661202|NCT00006237|Vinblastine|vinblastine|mesh-list
44661203|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661204|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
44661205|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661206|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
44661207|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661208|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44661209|NCT00006237|Analgesics|analgesics|mesh-ancestor
43927003|NCT00623012|Sirolimus|sirolimus|mesh-list
44661210|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
44661211|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661212|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661213|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661214|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661215|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
44661216|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661217|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661218|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661219|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661220|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661221|NCT00006184|Cyclosporine|cyclosporine|mesh-list
44661222|NCT00006184|Prednisone|prednisone|mesh-list
44661223|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
44661224|NCT00006184|Doxorubicin|doxorubicin|mesh-list
44661225|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661226|NCT00006184|Methotrexate|methotrexate|mesh-list
44661227|NCT00006184|Fludarabine|fludarabine|mesh-list
44661228|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
44661229|NCT00006184|Etoposide|etoposide|mesh-list
44661232|NCT00006184|Molgramostim|molgramostim|mesh-list
44661233|NCT00006184|Cyclosporins|cyclosporins|mesh-list
44661234|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
44661235|NCT00006184|Lenograstim|lenograstim|mesh-list
44661236|NCT00006184|Sargramostim|sargramostim|mesh-list
44661237|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44661238|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661239|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
44661240|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661241|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661242|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661243|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
44661244|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661245|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661246|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661247|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661248|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661249|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661250|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661251|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661252|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
44661253|NCT00006184|Hormones|hormones|mesh-ancestor
44661254|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661255|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661256|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44661257|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
44661258|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661259|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661260|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
44661261|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661262|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661263|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661264|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661265|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661266|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661267|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661268|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
44661269|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661270|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44661271|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661272|NCT00006164|Ribavirin|ribavirin|mesh-list
44661273|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44661274|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
44661275|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
44661276|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927080|NCT00624559|Celecoxib|celecoxib|mesh-list
44661277|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
44661279|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
44661280|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661282|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44661283|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
44661284|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661285|NCT00006011|Paclitaxel|paclitaxel|mesh-list
44661286|NCT00006011|Cisplatin|cisplatin|mesh-list
44661287|NCT00006011|Doxorubicin|doxorubicin|mesh-list
44661288|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661289|NCT00006011|Lenograstim|lenograstim|mesh-list
44661290|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661291|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661292|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661293|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661294|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661295|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661296|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661297|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661298|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661299|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661300|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661301|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
44661302|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661303|NCT00005937|Cyclosporine|cyclosporine|mesh-list
44661304|NCT00005937|Cyclosporins|cyclosporins|mesh-list
44661305|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44661306|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661307|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661308|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661309|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
44661310|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661311|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
44661312|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661313|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661314|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661315|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44661316|NCT00005908|Tamoxifen|tamoxifen|mesh-list
44661317|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
44661318|NCT00005908|Docetaxel|docetaxel|mesh-list
44661319|NCT00005908|Doxorubicin|doxorubicin|mesh-list
44661320|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661321|NCT00005908|Capecitabine|capecitabine|mesh-list
44661322|NCT00005908|Anastrozole|anastrozole|mesh-list
44661323|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661324|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
44661325|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661326|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661327|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661328|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
44661329|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661330|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661331|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661332|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661333|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661334|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661335|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661336|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661337|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661338|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661339|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661340|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
44661341|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44661342|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
44661343|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661344|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661345|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44661346|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44661347|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44661348|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44661349|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44661350|NCT00005906|Octreotide|octreotide|mesh-list
44661351|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44661352|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661354|NCT00005047|Cisplatin|cisplatin|mesh-list
44661355|NCT00005047|Doxorubicin|doxorubicin|mesh-list
44661356|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661357|NCT00005047|Methotrexate|methotrexate|mesh-list
44661358|NCT00005047|Vinblastine|vinblastine|mesh-list
44661359|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661360|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661361|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661362|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661363|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661364|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661365|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44661366|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
44661367|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661368|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661369|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661370|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
44661371|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661372|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661373|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661374|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
44661375|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661376|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661377|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661378|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661379|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211629|NCT00444041|Growth Substances|growth substances|mesh-ancestor
44661380|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661381|NCT00004978|Aldesleukin|aldesleukin|mesh-list
44661382|NCT00004978|Interleukin-2|interleukin-2|mesh-list
44661383|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661384|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44661385|NCT00004978|Analgesics|analgesics|mesh-ancestor
44661386|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
44661387|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661388|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661389|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661390|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661391|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
44661392|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661393|NCT00004888|Docetaxel|docetaxel|mesh-list
44661394|NCT00004888|Doxorubicin|doxorubicin|mesh-list
44661395|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661396|NCT00004888|Trastuzumab|trastuzumab|mesh-list
44661397|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661398|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661399|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661400|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661401|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661402|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661403|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661404|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661405|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661406|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44661407|NCT00004859|Thalidomide|thalidomide|mesh-list
44661408|NCT00004859|Paclitaxel|paclitaxel|mesh-list
44661409|NCT00004859|Carboplatin|carboplatin|mesh-list
44661410|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661411|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661412|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661413|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661414|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661415|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661416|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661417|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
44661418|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661419|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
44661420|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661421|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661422|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44661423|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44661424|NCT00004859|Growth Substances|growth substances|mesh-ancestor
44661425|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
44661426|NCT00004635|Thalidomide|thalidomide|mesh-list
44661427|NCT00004635|Leuprolide|leuprolide|mesh-list
44661428|NCT00004635|Goserelin|goserelin|mesh-list
44661429|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661430|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
44661431|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661432|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
44661433|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661434|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661435|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44661436|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44661437|NCT00004635|Growth Substances|growth substances|mesh-ancestor
44661438|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
44661439|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661440|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44661441|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
44661442|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661443|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661444|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
44661445|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661446|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
44661447|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661448|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661449|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661450|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
44661451|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661452|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211720|NCT00444418|Naltrexone|naltrexone|mesh-list
44661453|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661454|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44661455|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44661456|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44661457|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44661458|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
44661459|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44661460|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44661461|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661462|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661463|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44661464|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
44661465|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927274|NCT00628498|Defibrotide|defibrotide|mesh-list
44661467|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661468|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
44661469|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661470|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661471|NCT00004228|Leucovorin|leucovorin|mesh-list
44661472|NCT00004228|Cytarabine|cytarabine|mesh-list
44661473|NCT00004228|Dexamethasone|dexamethasone|mesh-list
44661474|NCT00004228|Prednisone|prednisone|mesh-list
44661475|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
44661476|NCT00004228|Doxorubicin|doxorubicin|mesh-list
44661477|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661478|NCT00004228|Methotrexate|methotrexate|mesh-list
44661479|NCT00004228|Vincristine|vincristine|mesh-list
44661480|NCT00004228|Daunorubicin|daunorubicin|mesh-list
44661481|NCT00004228|Asparaginase|asparaginase|mesh-list
44661482|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
44661483|NCT00004228|Thioguanine|thioguanine|mesh-list
44661484|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
44661485|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661486|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
44661487|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661488|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661489|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661490|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
44661491|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661492|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661493|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661494|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661495|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
44661496|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
44661497|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661498|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44661499|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
44661500|NCT00004228|Hormones|hormones|mesh-ancestor
44661501|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661502|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661503|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43776563|NCT02338089|Oxytocin|oxytocin|mesh-list
44661504|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661505|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661506|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661507|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44661508|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
44661509|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661510|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927294|NCT00629122|Nystatin|nystatin|mesh-list
44661511|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
44661512|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661513|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661514|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661515|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
44661516|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661517|NCT00004228|Antidotes|antidotes|mesh-ancestor
44661518|NCT00004228|Protective Agents|protective agents|mesh-ancestor
44661519|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
44661520|NCT00004228|Vitamins|vitamins|mesh-ancestor
44661521|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
44661522|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661523|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661524|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661525|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661526|NCT00004088|Pamidronate|pamidronate|mesh-list
44661527|NCT00004088|Interferons|interferons|mesh-list
44661528|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
44661529|NCT00004088|Thalidomide|thalidomide|mesh-list
44661530|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
44661531|NCT00004088|Melphalan|melphalan|mesh-list
44661532|NCT00004088|Busulfan|busulfan|mesh-list
44661533|NCT00004088|Lenograstim|lenograstim|mesh-list
44661534|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661535|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
44661536|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661537|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661538|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661539|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
44661540|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661541|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661542|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661543|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
44661544|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661545|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661546|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
44661547|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661548|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44661549|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44661550|NCT00004088|Growth Substances|growth substances|mesh-ancestor
44661551|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44661552|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44661553|NCT00004031|Prednisone|prednisone|mesh-list
44661554|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
44661555|NCT00004031|Carmustine|carmustine|mesh-list
44661556|NCT00004031|Rituximab|rituximab|mesh-list
44661557|NCT00004031|Doxorubicin|doxorubicin|mesh-list
44661558|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661559|NCT00004031|Etoposide|etoposide|mesh-list
44661560|NCT00004031|Vincristine|vincristine|mesh-list
44661561|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661562|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
44661563|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661564|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661565|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661566|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
44661567|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661568|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661569|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661570|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44661571|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661572|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661573|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661574|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661575|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661576|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
44661577|NCT00004031|Hormones|hormones|mesh-ancestor
44661578|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661579|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661580|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661581|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661583|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661584|NCT00003907|Cisplatin|cisplatin|mesh-list
44661585|NCT00003907|Doxorubicin|doxorubicin|mesh-list
44661586|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661587|NCT00003907|Mitomycins|mitomycins|mesh-list
44661588|NCT00003907|Mitomycin|mitomycin|mesh-list
44661589|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661590|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661591|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661592|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661593|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661594|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661595|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
44661596|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661597|NCT00003896|Paclitaxel|paclitaxel|mesh-list
44661598|NCT00003896|Cisplatin|cisplatin|mesh-list
44661599|NCT00003896|Doxorubicin|doxorubicin|mesh-list
44661600|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661601|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661602|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661603|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661604|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661605|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661606|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661607|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661608|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661609|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661610|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661611|NCT00003875|Aldesleukin|aldesleukin|mesh-list
44661612|NCT00003875|Etoposide|etoposide|mesh-list
44661613|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
44661614|NCT00003875|Busulfan|busulfan|mesh-list
44661615|NCT00003875|Interleukin-2|interleukin-2|mesh-list
44661616|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661617|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661618|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661619|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661620|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661621|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661622|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
44661623|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661624|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
44661625|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661626|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661627|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661628|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44661629|NCT00003875|Analgesics|analgesics|mesh-ancestor
44661630|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
44661631|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661632|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661633|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661634|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
44661635|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661636|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44661637|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661638|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44661639|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44661640|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661641|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44661642|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661643|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
44661644|NCT00003782|Docetaxel|docetaxel|mesh-list
44661645|NCT00003782|Doxorubicin|doxorubicin|mesh-list
44661646|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661647|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
44661648|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661649|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661650|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661651|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
44661652|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661653|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661654|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661655|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661656|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661657|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661658|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661659|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661660|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661661|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661663|NCT00003702|Cactinomycin|cactinomycin|mesh-list
44661664|NCT00003702|Methotrexate|methotrexate|mesh-list
44661665|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44661666|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
44661667|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661668|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661669|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661670|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
44661671|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661672|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661673|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661674|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661675|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661676|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661677|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
44661678|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661679|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661680|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661681|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661682|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661683|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44661684|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
44211901|NCT00445185|Vaccines|vaccines|mesh-list
44661685|NCT00003659|Rituximab|rituximab|mesh-list
44661686|NCT00003659|Fludarabine|fludarabine|mesh-list
44661687|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
44661688|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661689|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
44661690|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661691|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661692|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661693|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
44661694|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661695|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661696|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661697|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44661698|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661699|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
44661700|NCT00003656|Interferons|interferons|mesh-list
44661701|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
44661702|NCT00003656|Tretinoin|tretinoin|mesh-list
44661703|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661704|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
44661705|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661706|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
44661707|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661708|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
44661709|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661710|NCT00003645|Leuprolide|leuprolide|mesh-list
44661711|NCT00003645|Goserelin|goserelin|mesh-list
44661712|NCT00003645|Flutamide|flutamide|mesh-list
44661713|NCT00003645|Bicalutamide|bicalutamide|mesh-list
44661714|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44661715|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
44661716|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661717|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661718|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661719|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661720|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
44661721|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
44661722|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661723|NCT00003631|Cytarabine|cytarabine|mesh-list
44661724|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
44661725|NCT00003631|Melphalan|melphalan|mesh-list
44661726|NCT00003631|Ifosfamide|ifosfamide|mesh-list
44661727|NCT00003631|Carmustine|carmustine|mesh-list
44661728|NCT00003631|Carboplatin|carboplatin|mesh-list
44661729|NCT00003631|Etoposide|etoposide|mesh-list
44661730|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661731|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
44661732|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661733|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661734|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661735|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
44661736|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661737|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661738|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661739|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661740|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661741|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661742|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661743|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661744|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
44661745|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
44661746|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661747|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
44661748|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661749|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
44661750|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661751|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661752|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661753|NCT00003389|Prednisone|prednisone|mesh-list
44661754|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
44661755|NCT00003389|Dacarbazine|dacarbazine|mesh-list
44661756|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
44661757|NCT00003389|Doxorubicin|doxorubicin|mesh-list
44661758|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44211974|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661759|NCT00003389|Etoposide|etoposide|mesh-list
44661760|NCT00003389|Vincristine|vincristine|mesh-list
44661761|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
44661762|NCT00003389|Bleomycin|bleomycin|mesh-list
44661763|NCT00003389|Vinblastine|vinblastine|mesh-list
44661764|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
44661765|NCT00003389|Imidazole|imidazole|mesh-list
44661766|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661767|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
44661768|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661769|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661770|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661771|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
44661772|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661773|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661774|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661775|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661776|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661777|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661778|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661779|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661780|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
44661781|NCT00003389|Hormones|hormones|mesh-ancestor
44661782|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661783|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661784|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661785|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661786|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661787|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661788|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
44661789|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661790|NCT00003377|Paclitaxel|paclitaxel|mesh-list
44661791|NCT00003377|Cisplatin|cisplatin|mesh-list
44661792|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661793|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661794|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661795|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661796|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661797|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661798|NCT00003298|Leucovorin|leucovorin|mesh-list
44661799|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
44661800|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44661801|NCT00003298|Paclitaxel|paclitaxel|mesh-list
44661802|NCT00003298|Cisplatin|cisplatin|mesh-list
44661803|NCT00003298|Fluorouracil|fluorouracil|mesh-list
44661804|NCT00003298|Calcium|calcium|mesh-list
44661805|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
44661806|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661807|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661808|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661809|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661810|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661811|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661812|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44661813|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661814|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
44661815|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661816|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661817|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
44661818|NCT00003298|Antidotes|antidotes|mesh-ancestor
44661819|NCT00003298|Protective Agents|protective agents|mesh-ancestor
44661820|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
44661821|NCT00003298|Vitamins|vitamins|mesh-ancestor
44661822|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
44661823|NCT00003222|Aldesleukin|aldesleukin|mesh-list
44661824|NCT00003222|Interleukin-2|interleukin-2|mesh-list
44661825|NCT00003222|Sargramostim|sargramostim|mesh-list
44661826|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
44661827|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661828|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44661829|NCT00003222|Analgesics|analgesics|mesh-ancestor
44661830|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
44661831|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661832|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661833|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
44661834|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661835|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661836|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
44661837|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661838|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44212053|NCT00446069|Morphine|morphine|mesh-list
44661839|NCT00003199|Tamoxifen|tamoxifen|mesh-list
44661840|NCT00003199|Aldesleukin|aldesleukin|mesh-list
44661841|NCT00003199|Melphalan|melphalan|mesh-list
44661842|NCT00003199|Busulfan|busulfan|mesh-list
44661843|NCT00003199|Thiotepa|thiotepa|mesh-list
44661844|NCT00003199|Interleukin-2|interleukin-2|mesh-list
44661845|NCT00003199|Sargramostim|sargramostim|mesh-list
44661846|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661847|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661848|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
44661849|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661850|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661851|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661852|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
44661853|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661854|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44661855|NCT00003199|Analgesics|analgesics|mesh-ancestor
44661856|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
44661857|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661858|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44661859|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
44661860|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661861|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661862|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44661863|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44661864|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43927638|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
44661865|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44661866|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44661867|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
44661868|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661869|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
44661870|NCT00003138|Lenograstim|lenograstim|mesh-list
44661871|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44661872|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
44661873|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661874|NCT00003138|Hematinics|hematinics|mesh-ancestor
44661875|NCT00003102|Antibodies|antibodies|mesh-list
44661876|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44661877|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
44661878|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661879|NCT00002931|Paclitaxel|paclitaxel|mesh-list
44661880|NCT00002931|Etoposide|etoposide|mesh-list
44661881|NCT00002931|Carboplatin|carboplatin|mesh-list
44661882|NCT00002931|Ifosfamide|ifosfamide|mesh-list
44661883|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661884|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661885|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661886|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661887|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661888|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661889|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661890|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661891|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661892|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661893|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
44661894|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
44661895|NCT00002850|Ofloxacin|ofloxacin|mesh-list
44661896|NCT00002850|Trimethoprim|trimethoprim|mesh-list
44661897|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
44661898|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661899|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661900|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661901|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661902|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661903|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661904|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661905|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44661906|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44661907|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44661908|NCT00002850|Renal Agents|renal agents|mesh-ancestor
44661909|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
44661910|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44661911|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44661912|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661913|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44661914|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44661915|NCT00002842|Leucovorin|leucovorin|mesh-list
44661916|NCT00002842|Fluorouracil|fluorouracil|mesh-list
44661917|NCT00002842|Floxuridine|floxuridine|mesh-list
44661918|NCT00002842|Calcium|calcium|mesh-list
44661920|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44661921|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661922|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
44661923|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661924|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661925|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661926|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661927|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
44661928|NCT00002842|Antidotes|antidotes|mesh-ancestor
44661929|NCT00002842|Protective Agents|protective agents|mesh-ancestor
44661930|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
44661931|NCT00002842|Vitamins|vitamins|mesh-ancestor
44661932|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
44661933|NCT00002766|Cytarabine|cytarabine|mesh-list
44661934|NCT00002766|Dactinomycin|dactinomycin|mesh-list
44661935|NCT00002766|Prednisone|prednisone|mesh-list
44661936|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
44661937|NCT00002766|Carmustine|carmustine|mesh-list
44661938|NCT00002766|Doxorubicin|doxorubicin|mesh-list
44661939|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44661940|NCT00002766|Methotrexate|methotrexate|mesh-list
44661941|NCT00002766|Etoposide|etoposide|mesh-list
44661942|NCT00002766|Vincristine|vincristine|mesh-list
44661943|NCT00002766|Daunorubicin|daunorubicin|mesh-list
44661944|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
44661945|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
44661946|NCT00002766|Pegaspargase|pegaspargase|mesh-list
44661947|NCT00002766|Sargramostim|sargramostim|mesh-list
44661948|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44661949|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
44661950|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661951|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44661952|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44661953|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
44661954|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44661955|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661956|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44661957|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44661958|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44661959|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44661960|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44661961|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44661962|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
44661963|NCT00002766|Hormones|hormones|mesh-ancestor
44661964|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661965|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661966|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44661967|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
43776564|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
44661968|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661969|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44661970|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
44661971|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
44661972|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44661973|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44661974|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44661975|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
44661976|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44661977|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
44661978|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
44661979|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
44661980|NCT00002766|Analgesics|analgesics|mesh-ancestor
44661981|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
44661982|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44661983|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44661984|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44661985|NCT00002651|Goserelin|goserelin|mesh-list
44661986|NCT00002651|Bicalutamide|bicalutamide|mesh-list
44661987|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44661988|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44661989|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
44661990|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
44661991|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44661992|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44661994|NCT00002597|Goserelin|goserelin|mesh-list
44661995|NCT00002597|Flutamide|flutamide|mesh-list
44661996|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44661997|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
44661998|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44661999|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662000|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927725|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
44662001|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662002|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
44662003|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
44662004|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662005|NCT00002558|Paclitaxel|paclitaxel|mesh-list
44662006|NCT00002558|Etoposide|etoposide|mesh-list
44662007|NCT00002558|Carboplatin|carboplatin|mesh-list
44662008|NCT00002558|Ifosfamide|ifosfamide|mesh-list
44662009|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662010|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662011|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662012|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662013|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662014|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662015|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662016|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662017|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662018|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44662019|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
44662020|NCT00002525|Leucovorin|leucovorin|mesh-list
44662021|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
44662022|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44662023|NCT00002525|Fluorouracil|fluorouracil|mesh-list
44662024|NCT00002525|Calcium|calcium|mesh-list
44662025|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
44662026|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44662027|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662028|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
44662029|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662030|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662031|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662032|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662033|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
44662034|NCT00002525|Antidotes|antidotes|mesh-ancestor
44662035|NCT00002525|Protective Agents|protective agents|mesh-ancestor
44662036|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
44662037|NCT00002525|Vitamins|vitamins|mesh-ancestor
44662038|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
44662039|NCT00001962|Daclizumab|daclizumab|mesh-list
44662040|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662041|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
44662042|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662043|NCT00001959|Pirfenidone|pirfenidone|mesh-list
44662044|NCT00001959|Analgesics|analgesics|mesh-ancestor
44662045|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
44662046|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662047|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662048|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44662049|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44662050|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662051|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662052|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662053|NCT00001941|Daclizumab|daclizumab|mesh-list
44662054|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662055|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
44662056|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662057|NCT00001880|Cyclosporine|cyclosporine|mesh-list
44662058|NCT00001880|Methotrexate|methotrexate|mesh-list
44662059|NCT00001880|Cyclosporins|cyclosporins|mesh-list
44662060|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44662061|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
44662062|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44662063|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662064|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662065|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
44662066|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662067|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662068|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
44662069|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662071|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662072|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
44662073|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662074|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44662075|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
44662076|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662077|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44662078|NCT00001849|Edetic Acid|edetic acid|mesh-list
44662079|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
44662080|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662081|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662082|NCT00001849|Antidotes|antidotes|mesh-ancestor
44662083|NCT00001849|Protective Agents|protective agents|mesh-ancestor
44662084|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
44662085|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
44662086|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44662087|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
44662088|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44662089|NCT05627648|Mitogens|mitogens|mesh-list
44662090|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662091|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662092|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
44662093|NCT05627635|Leucovorin|leucovorin|mesh-list
44662094|NCT05627635|Folic Acid|folic acid|mesh-list
44662095|NCT05627635|Bevacizumab|bevacizumab|mesh-list
44662096|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44662097|NCT05627635|Fluorouracil|fluorouracil|mesh-list
44662098|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
44662099|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
44662100|NCT05627635|Antibodies|antibodies|mesh-list
44662101|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
44662102|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44662103|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
44662104|NCT05627635|Calcium|calcium|mesh-list
44662105|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
44662106|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662107|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662108|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662109|NCT05627635|Growth Substances|growth substances|mesh-ancestor
44662110|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662111|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662112|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
44662113|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44662114|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44662115|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
44662116|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662117|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662118|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662119|NCT05627635|Antidotes|antidotes|mesh-ancestor
44662120|NCT05627635|Protective Agents|protective agents|mesh-ancestor
44662121|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
44662122|NCT05627635|Vitamins|vitamins|mesh-ancestor
44662123|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
44662124|NCT05627635|Hematinics|hematinics|mesh-ancestor
44662125|NCT05627596|Nicotine|nicotine|mesh-list
44662126|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44662127|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
44662128|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662129|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662130|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44662131|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44662132|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
44662133|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662134|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662135|NCT05626140|Diclofenac|diclofenac|mesh-list
44662136|NCT05626140|Lacosamide|lacosamide|mesh-list
44662137|NCT05626140|Codeine|codeine|mesh-list
44662138|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44662139|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44662140|NCT05626140|Analgesics|analgesics|mesh-ancestor
44662141|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
44662142|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662143|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662144|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662145|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662146|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44662147|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662148|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662149|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
44662150|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44662151|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44662152|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662153|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44662154|NCT05626140|Narcotics|narcotics|mesh-ancestor
44662155|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662156|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
44662157|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
44662158|NCT05626101|Gemcitabine|gemcitabine|mesh-list
44662159|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662160|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
44662161|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662162|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662163|NCT05626101|Antiviral Agents|antiviral agents|mesh-ancestor
44662164|NCT05626101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662165|NCT05626101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662166|NCT05626101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662167|NCT05626101|Immunologic Factors|immunologic factors|mesh-ancestor
44662168|NCT05626101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662169|NCT05625893|Bevacizumab|bevacizumab|mesh-list
44662170|NCT05625893|Atezolizumab|atezolizumab|mesh-list
44662171|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662172|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662173|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662174|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662175|NCT05625893|Growth Substances|growth substances|mesh-ancestor
44662176|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662177|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662178|NCT05625854|Cocaine|cocaine|mesh-list
44662179|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
44662180|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
44662181|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662182|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662183|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
44662184|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662185|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44662186|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44662187|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44662188|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662189|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662190|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
44662191|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662192|NCT05625841|Propolis|propolis|mesh-list
44662193|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662194|NCT05625724|Aspirin|aspirin|mesh-list
44662195|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44662196|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44662197|NCT05625724|Analgesics|analgesics|mesh-ancestor
44662198|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
44662199|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662200|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662201|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662202|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662203|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44662204|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44662205|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662206|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44662207|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44662208|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662209|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
44662210|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
44662211|NCT05625581|Tofacitinib|tofacitinib|mesh-list
44662212|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662213|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
44662214|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662215|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662216|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44662217|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
44662218|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662219|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662220|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44212372|NCT00447681|Fezakinumab|fezakinumab|mesh-list
44662221|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44662222|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662224|NCT05625503|Nicardipine|nicardipine|mesh-list
44662225|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
44662226|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44662227|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662228|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44662229|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662230|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662231|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
44662232|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44662233|NCT05624099|Paclitaxel|paclitaxel|mesh-list
44662234|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662235|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662236|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662237|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662238|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662239|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662240|NCT05619887|Fentanyl|fentanyl|mesh-list
44662241|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44662242|NCT05619887|Narcotics|narcotics|mesh-ancestor
44662243|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662244|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662245|NCT05619887|Analgesics|analgesics|mesh-ancestor
44662246|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
44662247|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662248|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44662249|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44662250|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
44662251|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
44662252|NCT05617118|Baclofen|baclofen|mesh-list
44662253|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
44662254|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44662255|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44662256|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44662257|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662258|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662259|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
44662260|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662261|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662262|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44662263|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662264|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44662265|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44662266|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
44662267|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
44662268|NCT05595460|Carboplatin|carboplatin|mesh-list
44662269|NCT05595460|Etoposide|etoposide|mesh-list
44662270|NCT05595460|Atezolizumab|atezolizumab|mesh-list
44662271|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662272|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662273|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662274|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662275|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662276|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662277|NCT05568407|Avelumab|avelumab|mesh-list
44662278|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662279|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662280|NCT05562466|Budesonide|budesonide|mesh-list
44662281|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662282|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44662283|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
44662284|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662285|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662286|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44662287|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44662288|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
44662289|NCT05562466|Hormones|hormones|mesh-ancestor
44662290|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662291|NCT05527834|Ceftibuten|ceftibuten|mesh-list
44662292|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44662293|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662294|NCT05515601|Mirikizumab|mirikizumab|mesh-list
44662295|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212448|NCT00448110|Analgesics|analgesics|mesh-ancestor
44662296|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44662297|NCT05515601|Analgesics|analgesics|mesh-ancestor
44662298|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
44662299|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662300|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662301|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662302|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662303|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44662304|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44662305|NCT05513768|Protein C|protein c|mesh-list
44662306|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
44662307|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44662308|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44662309|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212525|NCT00448552|Capecitabine|capecitabine|mesh-list
44662310|NCT05497557|Omeprazole|omeprazole|mesh-list
44662311|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44662312|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44662313|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44662314|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662315|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662316|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
44662317|NCT05485480|Narcotics|narcotics|mesh-ancestor
44662318|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662319|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662320|NCT05485480|Analgesics|analgesics|mesh-ancestor
44662321|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
44662322|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662323|NCT05475678|Carboplatin|carboplatin|mesh-list
44662324|NCT05475678|Docetaxel|docetaxel|mesh-list
44662325|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662326|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662327|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662328|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662329|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662330|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
44662331|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662332|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
44662333|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662334|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662335|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44662336|NCT05467514|Liraglutide|liraglutide|mesh-list
44662337|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44662338|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662339|NCT05467514|Incretins|incretins|mesh-ancestor
44662340|NCT05467514|Hormones|hormones|mesh-ancestor
44662341|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662342|NCT05415267|Vaccines|vaccines|mesh-list
44662343|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
44662344|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662345|NCT05386706|Metformin|metformin|mesh-list
44662346|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44662347|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662353|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662358|NCT05321394|Ritonavir|ritonavir|mesh-list
44662359|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44662360|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44662361|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44662362|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928072|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
44662363|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662364|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44662365|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44662366|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
44662367|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662368|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44662369|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44662370|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
44662371|NCT05296772|Antibodies|antibodies|mesh-list
44662372|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
44662373|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
44662374|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662375|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662376|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662377|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44662378|NCT05276895|Quercetin|quercetin|mesh-list
44662379|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
44662380|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662381|NCT05276895|Protective Agents|protective agents|mesh-ancestor
44662382|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662383|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662384|NCT05224401|Amoxicillin|amoxicillin|mesh-list
44662385|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
44662386|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44662387|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
44662388|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
44662389|NCT05224401|Ertapenem|ertapenem|mesh-list
44662390|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
44662391|NCT05224401|Trimethoprim|trimethoprim|mesh-list
44662392|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
44662393|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44662394|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662395|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662396|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662397|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662398|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662399|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662400|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44662401|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44662402|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44662403|NCT05224401|Renal Agents|renal agents|mesh-ancestor
44662404|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
44662405|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44662406|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44662407|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44662408|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44662409|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44662410|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44662411|NCT05223075|Lidocaine|lidocaine|mesh-list
44662412|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44662413|NCT05223075|Carticaine|carticaine|mesh-list
44662414|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
44662415|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
44662416|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662417|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662418|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
44662419|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662420|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44662421|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44662422|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43777645|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44662423|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662424|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662426|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
44662427|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662428|NCT05201066|Azacitidine|azacitidine|mesh-list
44662429|NCT05201066|Decitabine|decitabine|mesh-list
44662430|NCT05201066|Venetoclax|venetoclax|mesh-list
44662431|NCT05201066|Spartalizumab|spartalizumab|mesh-list
44662432|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662433|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
44662434|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662435|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662436|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662437|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44662438|NCT05171166|Leucovorin|leucovorin|mesh-list
44662439|NCT05171166|Fluorouracil|fluorouracil|mesh-list
44662440|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
44662441|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
44662442|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
44662443|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662444|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662445|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662446|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662447|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
44662448|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662449|NCT05171166|Antidotes|antidotes|mesh-ancestor
44662450|NCT05171166|Protective Agents|protective agents|mesh-ancestor
44662451|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
44662452|NCT05171166|Vitamins|vitamins|mesh-ancestor
44662453|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
44662454|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44662455|NCT05171166|Estrogens|estrogens|mesh-ancestor
44662456|NCT05171166|Hormones|hormones|mesh-ancestor
44662457|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662458|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44662459|NCT05098574|Drospirenone|drospirenone|mesh-list
44662460|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44662461|NCT05098574|Estradiol|estradiol|mesh-list
44662462|NCT05098574|Estrogens|estrogens|mesh-ancestor
44662463|NCT05098574|Hormones|hormones|mesh-ancestor
44662464|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928140|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44662465|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662466|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44662468|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44662469|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44662470|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44662471|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44662472|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44662473|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
44662474|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44662475|NCT05098574|Diuretics|diuretics|mesh-ancestor
44662476|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
44662477|NCT05092360|Gemcitabine|gemcitabine|mesh-list
44662478|NCT05092360|Paclitaxel|paclitaxel|mesh-list
44662479|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44662480|NCT05092360|Doxorubicin|doxorubicin|mesh-list
44662481|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44662482|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
44662483|NCT05092360|Topotecan|topotecan|mesh-list
44662484|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662485|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662486|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662487|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662488|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662489|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662490|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662491|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
44662492|NCT05092360|Antiviral Agents|antiviral agents|mesh-ancestor
44662493|NCT05092360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662494|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662495|NCT05092360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662496|NCT05092360|Immunologic Factors|immunologic factors|mesh-ancestor
44662497|NCT05092360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662498|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44662499|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662500|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662502|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44662503|NCT05078866|Vaccines|vaccines|mesh-list
44662504|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
44662505|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662506|NCT05039801|Paclitaxel|paclitaxel|mesh-list
44662507|NCT05039801|Bevacizumab|bevacizumab|mesh-list
44662508|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662509|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662510|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662511|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662512|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662513|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662514|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662515|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662516|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662517|NCT05039801|Growth Substances|growth substances|mesh-ancestor
44662518|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662519|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662520|NCT05016895|Azithromycin|azithromycin|mesh-list
44662521|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44662522|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662523|NCT04987203|Nivolumab|nivolumab|mesh-list
44662524|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662525|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928189|NCT00654511|Fentanyl|fentanyl|mesh-list
44662526|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44662527|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662529|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
44662530|NCT04972110|Olaparib|olaparib|mesh-list
44662531|NCT04972110|Niraparib|niraparib|mesh-list
44662532|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44662533|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662534|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662535|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662536|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
44662537|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44662538|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44662539|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44662540|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44662541|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662542|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662543|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44662544|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662545|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662546|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44662547|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662548|NCT04934579|Rituximab|rituximab|mesh-list
44662549|NCT04934579|Methotrexate|methotrexate|mesh-list
44662550|NCT04934579|Lenalidomide|lenalidomide|mesh-list
44662551|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662552|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662553|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
44662554|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662555|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662556|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44662557|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
44662558|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44662559|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662560|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
44662561|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662562|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44662563|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662564|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44662565|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662566|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44662567|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662568|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662569|NCT04934579|Growth Substances|growth substances|mesh-ancestor
44662570|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662571|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
44662572|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662573|NCT04907682|Ribavirin|ribavirin|mesh-list
44662574|NCT04907682|Favipiravir|favipiravir|mesh-list
44662575|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
44662576|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662577|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
44662578|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662579|NCT04899921|Nivolumab|nivolumab|mesh-list
44662580|NCT04899921|Ipilimumab|ipilimumab|mesh-list
44662581|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662582|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662583|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44662584|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662585|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44662586|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44662587|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662588|NCT04813614|Lidocaine|lidocaine|mesh-list
44662589|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
44662590|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
44662591|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662592|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662593|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
44662594|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662595|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44662596|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44662597|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44662598|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662599|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662600|NCT04760717|Spironolactone|spironolactone|mesh-list
44662601|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44662602|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
44662603|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662604|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662605|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44662606|NCT04760717|Diuretics|diuretics|mesh-ancestor
44662607|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
44662608|NCT04744883|Naloxone|naloxone|mesh-list
44662609|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44662610|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662611|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
44662612|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662613|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
44662614|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44662615|NCT04728425|Antibodies|antibodies|mesh-list
44662616|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
44662617|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44662618|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
44662619|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
44662620|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662621|NCT04682405|Melphalan|melphalan|mesh-list
44662622|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44662623|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
44662624|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662625|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662626|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44662627|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662628|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
44662629|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662630|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43928312|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
44662631|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
44662632|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
44662633|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44662634|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44662635|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
44662636|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662637|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
44662638|NCT04668131|Protective Agents|protective agents|mesh-ancestor
44662639|NCT04661150|Capecitabine|capecitabine|mesh-list
44662640|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
44662641|NCT04661150|Trastuzumab|trastuzumab|mesh-list
44662642|NCT04661150|Atezolizumab|atezolizumab|mesh-list
44662643|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662644|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
44662645|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662646|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662647|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662648|NCT04660812|Bevacizumab|bevacizumab|mesh-list
44662649|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778071|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44662655|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662656|NCT04633889|Deferoxamine|deferoxamine|mesh-list
44662657|NCT04633889|Siderophores|siderophores|mesh-ancestor
44662658|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44662659|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
44662660|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
44662661|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662667|NCT04591353|Lidocaine|lidocaine|mesh-list
44662668|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
44662669|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
44662670|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662671|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662672|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
44662673|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662674|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44662675|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44662676|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44212899|NCT00450203|Epirubicin|epirubicin|mesh-list
44662678|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662679|NCT04587791|Cannabidiol|cannabidiol|mesh-list
44662680|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
44662681|NCT04549168|Lemborexant|lemborexant|mesh-list
44662682|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44662683|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662684|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662685|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44662686|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44662687|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44662688|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662689|NCT04542824|Gemcitabine|gemcitabine|mesh-list
44662690|NCT04542824|Prednisone|prednisone|mesh-list
44662691|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
44662692|NCT04542824|Rituximab|rituximab|mesh-list
44662693|NCT04542824|Doxorubicin|doxorubicin|mesh-list
43928384|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
44662694|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
44662695|NCT04542824|Vincristine|vincristine|mesh-list
44662696|NCT04542824|Lenalidomide|lenalidomide|mesh-list
44662697|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662698|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
44662699|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662700|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662701|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44662702|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
44662703|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662704|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662705|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44662706|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662707|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662708|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
44662709|NCT04542824|Antiviral Agents|antiviral agents|mesh-ancestor
44662710|NCT04542824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662711|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662712|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44662713|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662714|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662715|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662716|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
44662717|NCT04542824|Hormones|hormones|mesh-ancestor
44662718|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662719|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44662720|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662721|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662722|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662723|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662724|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44662725|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44662726|NCT04542824|Growth Substances|growth substances|mesh-ancestor
44662727|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
44662729|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44662730|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
44662731|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
44662732|NCT04537923|Tirzepatide|tirzepatide|mesh-list
44662733|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44662734|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662735|NCT04537923|Incretins|incretins|mesh-ancestor
44662736|NCT04537923|Hormones|hormones|mesh-ancestor
44662737|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662738|NCT04523493|Lenvatinib|lenvatinib|mesh-list
44662739|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662740|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44662741|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662742|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662743|NCT04497116|Gemcitabine|gemcitabine|mesh-list
44662744|NCT04497116|Talazoparib|talazoparib|mesh-list
44662745|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662746|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
44662747|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662748|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662749|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
44662750|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662751|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662752|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662753|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
44662754|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928435|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44662755|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44662756|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44662757|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662758|NCT04482621|Decitabine|decitabine|mesh-list
44662759|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662760|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
44662761|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662762|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662763|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662764|NCT04464122|Somatostatin|somatostatin|mesh-list
44662765|NCT04464122|Hormones|hormones|mesh-ancestor
44662766|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662767|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662768|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
44662769|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662770|NCT04312841|Acetic Acid|acetic acid|mesh-list
44662771|NCT04312841|Letermovir|letermovir|mesh-list
44662772|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44662773|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662774|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662775|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662776|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662777|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44662778|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
44662779|NCT04305327|Ustekinumab|ustekinumab|mesh-list
44662780|NCT04305327|Brodalumab|brodalumab|mesh-list
44662781|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44662782|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
44662783|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44662784|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662785|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662786|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662787|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662788|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662789|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662791|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662792|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662793|NCT04253262|Rucaparib|rucaparib|mesh-list
44662794|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44662795|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662796|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662797|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662798|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
44662799|NCT04130516|Antibodies|antibodies|mesh-list
44662801|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662802|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662803|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662804|NCT04097028|Trifluridine|trifluridine|mesh-list
44662805|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
44662806|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662807|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
44662808|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662809|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
44662810|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662811|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
44662812|NCT03994172|Vitamin D|vitamin d|mesh-list
44662813|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
44662814|NCT03994172|Teriparatide|teriparatide|mesh-list
44662815|NCT03994172|Citric Acid|citric acid|mesh-list
44662816|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
44662817|NCT03994172|Calcium|calcium|mesh-list
44662818|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
44662819|NCT03994172|Cinacalcet|cinacalcet|mesh-list
44662820|NCT03994172|Hormones|hormones|mesh-list
44662821|NCT03994172|Vitamins|vitamins|mesh-ancestor
44662822|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
44662823|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662824|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44662825|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44662826|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
44662827|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44662828|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
44662829|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
44662830|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662831|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662832|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44662833|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44662834|NCT03971500|Ticagrelor|ticagrelor|mesh-list
44662835|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662836|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662837|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44662838|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44662839|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44662840|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44662841|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
44662842|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662843|NCT03961971|Spartalizumab|spartalizumab|mesh-list
44662844|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44662845|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662846|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662847|NCT03892642|Avelumab|avelumab|mesh-list
44662848|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662849|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662850|NCT03881696|Omalizumab|omalizumab|mesh-list
44662851|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
44662852|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44662853|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662854|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44662855|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44662856|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
44662857|NCT03863223|Docetaxel|docetaxel|mesh-list
44662858|NCT03863223|Trastuzumab|trastuzumab|mesh-list
44662859|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662860|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662861|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662862|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662863|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662864|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662865|NCT03856658|Floxuridine|floxuridine|mesh-list
44662866|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44662868|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662869|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662870|NCT03750136|Furosemide|furosemide|mesh-list
44662871|NCT03750136|Diuretics|diuretics|mesh-ancestor
44662872|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
44662873|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662874|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44662875|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662876|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662877|NCT03726775|Durvalumab|durvalumab|mesh-list
44662878|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662879|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662880|NCT03677141|Prednisone|prednisone|mesh-list
44662881|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
44662882|NCT03677141|Doxorubicin|doxorubicin|mesh-list
44662883|NCT03677141|Vincristine|vincristine|mesh-list
44662884|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44662885|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
44662886|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662887|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662888|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44662889|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
44662890|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662891|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662892|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44662893|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44662894|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44662895|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662896|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662897|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662898|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
44662899|NCT03677141|Hormones|hormones|mesh-ancestor
44662900|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44662901|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44662902|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44662903|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44662904|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44662905|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44662906|NCT03638999|Ketorolac|ketorolac|mesh-list
44662907|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44662908|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44662909|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44662910|NCT03638999|Analgesics|analgesics|mesh-ancestor
44662911|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
44662912|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44662913|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662914|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44662915|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662916|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44662917|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662918|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662919|NCT03576664|Carvedilol|carvedilol|mesh-list
44662920|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44662921|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44662922|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44662923|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44662924|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662925|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662926|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44662927|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
44662928|NCT03576664|Protective Agents|protective agents|mesh-ancestor
44662929|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44662930|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662931|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44662932|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
44662933|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44662934|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44662935|NCT03345849|Upadacitinib|upadacitinib|mesh-list
44662936|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44662937|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213195|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
44662938|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662939|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662940|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44662941|NCT03263429|Irinotecan|irinotecan|mesh-list
44662942|NCT03263429|Panitumumab|panitumumab|mesh-list
44662943|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44662944|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662945|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662946|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662947|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662948|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662950|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662951|NCT03107416|Bumetanide|bumetanide|mesh-list
44662952|NCT03107416|Diuretics|diuretics|mesh-ancestor
44662953|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
44662954|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662955|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44662956|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44662957|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662958|NCT03088813|Irinotecan|irinotecan|mesh-list
44662959|NCT03088813|Topotecan|topotecan|mesh-list
44662960|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44662961|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44662962|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662963|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662964|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662965|NCT03067571|Daratumumab|daratumumab|mesh-list
44662966|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662967|NCT03011307|Oxytocin|oxytocin|mesh-list
44662968|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
44662969|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44662970|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662971|NCT02951052|Rilpivirine|rilpivirine|mesh-list
44662972|NCT02951052|Cabotegravir|cabotegravir|mesh-list
44662973|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44662974|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44662975|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662976|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662977|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
44662978|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44662979|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44662980|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44662981|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44662982|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44662983|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
44662984|NCT02947438|Hematinics|hematinics|mesh-ancestor
44662985|NCT02791334|Ramucirumab|ramucirumab|mesh-list
44662986|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44662987|NCT02603809|Lisinopril|lisinopril|mesh-list
44662988|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44662989|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
44662990|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44662991|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44662992|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44662993|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44662994|NCT02603809|Protective Agents|protective agents|mesh-ancestor
44662995|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44662996|NCT02492711|Trastuzumab|trastuzumab|mesh-list
44662997|NCT02492711|Margetuximab|margetuximab|mesh-list
44662998|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44662999|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663000|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
44663001|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44663002|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44663003|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663004|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
44663005|NCT02257580|Coagulants|coagulants|mesh-ancestor
44663006|NCT01947140|Romidepsin|romidepsin|mesh-list
44663007|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44663008|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663009|NCT01848639|Spironolactone|spironolactone|mesh-list
44663010|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44663011|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
44663012|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663013|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663014|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44663015|NCT01848639|Diuretics|diuretics|mesh-ancestor
44663016|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
44663017|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44663018|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44663019|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44663020|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663021|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057737|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663022|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44663023|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663024|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663025|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44663026|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663028|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44663029|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44663030|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44663031|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44663032|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
44663033|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663034|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663035|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663036|NCT01015222|Paclitaxel|paclitaxel|mesh-list
44663037|NCT01015222|Bevacizumab|bevacizumab|mesh-list
44663038|NCT01015222|Dasatinib|dasatinib|mesh-list
44663039|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44663040|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663041|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44663042|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44663043|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44663044|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663045|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44663046|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663047|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663048|NCT01015222|Growth Substances|growth substances|mesh-ancestor
44663049|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663050|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44663051|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44663052|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663053|NCT00745134|Curcumin|curcumin|mesh-list
44663054|NCT00745134|Capecitabine|capecitabine|mesh-list
44663055|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663056|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
44663057|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663058|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663059|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44663060|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663061|NCT00745134|Analgesics|analgesics|mesh-ancestor
44663062|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
44663063|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663064|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663065|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663066|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663067|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663068|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
44663069|NCT00130286|Hormones|hormones|mesh-list
44663070|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663071|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663072|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663073|NCT00127335|Atorvastatin|atorvastatin|mesh-list
44663074|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44663075|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663076|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
44663077|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663078|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663079|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44663080|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663081|NCT00076310|Cisplatin|cisplatin|mesh-list
44663082|NCT00076310|Docetaxel|docetaxel|mesh-list
44663083|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44663084|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663085|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44663086|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44663087|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44663088|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663089|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44663090|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663091|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44663092|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44663093|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44663094|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663095|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663096|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663097|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663098|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663099|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
44663100|NCT01207739|Doxycycline|doxycycline|mesh-list
44663101|NCT01207739|Clarithromycin|clarithromycin|mesh-list
44663102|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
44663103|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44663104|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44663105|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663106|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663107|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663108|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663109|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663110|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44663111|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44663112|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44663113|NCT01207921|Lenalidomide|lenalidomide|mesh-list
44663114|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
44663115|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663116|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663117|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663118|NCT01207921|Growth Substances|growth substances|mesh-ancestor
44663119|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
44663120|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663121|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44663122|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663123|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44663124|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44663125|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663126|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663127|NCT01207947|Urological Agents|urological agents|mesh-ancestor
44663128|NCT01208012|Liraglutide|liraglutide|mesh-list
44663129|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663130|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663131|NCT01208012|Incretins|incretins|mesh-ancestor
44663132|NCT01208012|Hormones|hormones|mesh-ancestor
44663133|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663134|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
44663135|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663136|NCT01208285|Ivacaftor|ivacaftor|mesh-list
44663137|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44663138|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663139|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663140|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44663141|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44663142|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
44663143|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
44663144|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663145|NCT01208441|Letrozole|letrozole|mesh-list
44663146|NCT01208441|R04929097|r04929097|mesh-list
44663147|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663148|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44663149|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44663150|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663151|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663152|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44663153|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
44663154|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663155|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663156|NCT01208454|Vitamin A|vitamin a|mesh-list
44663157|NCT01208454|Vorinostat|vorinostat|mesh-list
44663158|NCT01208454|Tretinoin|tretinoin|mesh-list
44663159|NCT01208454|Isotretinoin|isotretinoin|mesh-list
44663160|NCT01208454|Vitamins|vitamins|mesh-ancestor
44663161|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
44663162|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663163|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663164|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44663165|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663166|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663167|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
44663168|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663169|NCT01208480|Carboplatin|carboplatin|mesh-list
44663170|NCT01208480|Docetaxel|docetaxel|mesh-list
44663171|NCT01208480|Bevacizumab|bevacizumab|mesh-list
44663172|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663173|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
44663174|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
44663175|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
44663176|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663177|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44663178|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663179|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663180|NCT01208480|Growth Substances|growth substances|mesh-ancestor
44663181|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663182|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
44663183|NCT01208649|Exenatide|exenatide|mesh-list
44663184|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663185|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663186|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44663187|NCT01208649|Incretins|incretins|mesh-ancestor
44663188|NCT01208649|Hormones|hormones|mesh-ancestor
44663189|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663190|NCT01208701|Atorvastatin|atorvastatin|mesh-list
44663191|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44663192|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663193|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
44663194|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663195|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663196|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44663197|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663198|NCT01208740|Metformin|metformin|mesh-list
44663199|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663200|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663201|NCT01208766|Dexamethasone|dexamethasone|mesh-list
44663202|NCT01208766|Prednisone|prednisone|mesh-list
44663203|NCT01208766|Lenalidomide|lenalidomide|mesh-list
44663204|NCT01208766|Bortezomib|bortezomib|mesh-list
44663205|NCT01208766|Melphalan|melphalan|mesh-list
44663206|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663207|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
44663208|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
44663209|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663210|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663211|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663212|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
44663213|NCT01208766|Hormones|hormones|mesh-ancestor
44663214|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663215|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44663216|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663217|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
44663218|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663219|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663220|NCT01208766|Growth Substances|growth substances|mesh-ancestor
44663221|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
44663222|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44663223|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
44663224|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663225|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44663226|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663227|NCT01208818|Dexamethasone|dexamethasone|mesh-list
44663228|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
44663229|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
44663230|NCT01208818|Bortezomib|bortezomib|mesh-list
44663231|NCT01208818|BB 1101|bb 1101|mesh-list
44663232|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663233|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
44663234|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663235|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663236|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44663237|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
44663238|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663239|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663240|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44663241|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663243|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
44663244|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663245|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663246|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
44663247|NCT01208818|Hormones|hormones|mesh-ancestor
43928932|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44663248|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663249|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44663250|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44663251|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663253|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44663254|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
44663255|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663256|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663257|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44663258|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44663259|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
44663260|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663261|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663262|NCT01209026|Fluticasone|fluticasone|mesh-list
44663263|NCT01209026|Xhance|xhance|mesh-list
44663264|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
44663265|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44663266|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663267|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44663268|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
44663269|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663270|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663271|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44663272|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
44663273|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663274|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44663275|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663276|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663277|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44663278|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44663279|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663280|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663281|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663282|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44663283|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
44663284|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44663285|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44663286|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44663287|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44663288|NCT01209065|Ritonavir|ritonavir|mesh-list
44663289|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
44663290|NCT01209065|Dolutegravir|dolutegravir|mesh-list
44663291|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44663292|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44663293|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
44663294|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663295|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663296|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44663297|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44663298|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
44663299|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663300|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44663301|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44663302|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44663303|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44663304|NCT01209130|Rituximab|rituximab|mesh-list
44663305|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44663306|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663307|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
44663308|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663309|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663310|NCT01209208|Budesonide|budesonide|mesh-list
44663311|NCT01209208|Mesalamine|mesalamine|mesh-list
44663312|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663313|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44663314|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
44663315|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663316|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058012|NCT00005584|Prednisone|prednisone|mesh-list
44663317|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44663318|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
44663319|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
44663320|NCT01209208|Hormones|hormones|mesh-ancestor
44663321|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663322|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44663323|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663324|NCT01209208|Analgesics|analgesics|mesh-ancestor
44663325|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
44663326|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663327|NCT01209351|Teduglutide|teduglutide|mesh-list
44663328|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663329|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44663330|NCT01209351|Protective Agents|protective agents|mesh-ancestor
44663331|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663332|NCT01209403|Insulin|insulin|mesh-list
44663333|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
44663334|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663335|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663336|NCT01209416|Acipimox|acipimox|mesh-list
44663337|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663338|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
44663339|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663340|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663341|NCT01209429|Hormones|hormones|mesh-list
44663342|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663343|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663344|NCT01209455|Acetaminophen|acetaminophen|mesh-list
44663345|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
44663346|NCT01209455|Ranitidine|ranitidine|mesh-list
44663347|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44663348|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663349|NCT01209455|Analgesics|analgesics|mesh-ancestor
44663350|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
44663351|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663352|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663353|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
44663354|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44663355|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663356|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44663357|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
44663358|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
44663359|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663360|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663361|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
44663362|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663363|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44663364|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44663365|NCT01209533|Iloprost|iloprost|mesh-list
44663366|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44663367|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663368|NCT01209650|Afatinib|afatinib|mesh-list
44663369|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663370|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44663371|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928964|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44663372|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663373|NCT01209715|Fluticasone|fluticasone|mesh-list
44663374|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44663375|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44663376|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663377|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44663378|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
44663379|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663380|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663381|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44663382|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44663383|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663384|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44663385|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44663386|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44663387|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44663388|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663389|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663390|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663391|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
44663392|NCT01209715|Hormones|hormones|mesh-ancestor
44663393|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663394|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
44663395|NCT01209728|Ethanol|ethanol|mesh-list
44663396|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44663397|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663398|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663399|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663400|NCT01209806|Simethicone|simethicone|mesh-list
44213665|NCT00453908|Alfuzosin|alfuzosin|mesh-list
44663401|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
44663402|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44663403|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44663404|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
44663405|NCT01209806|TEMPO|tempo|mesh-list
44663406|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
44663407|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663408|NCT01209806|Emollients|emollients|mesh-ancestor
44663409|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663410|NCT01209806|Antacids|antacids|mesh-ancestor
44663411|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663412|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44663413|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
44663414|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663415|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
44663416|NCT01209806|Protective Agents|protective agents|mesh-ancestor
44663417|NCT01209845|Ketamine|ketamine|mesh-list
44663418|NCT01209845|Analgesics|analgesics|mesh-ancestor
43929002|NCT00669019|Saracatinib|saracatinib|mesh-list
44663419|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
44663420|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663421|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663422|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44663423|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44663424|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
44663425|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
44663426|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663427|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44663428|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44663429|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663430|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663431|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44663432|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44663433|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44663434|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
44663435|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44663436|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663437|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44663438|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44663439|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44663440|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44663441|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44663442|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44663443|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44663444|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44663445|NCT01209988|Tamsulosin|tamsulosin|mesh-list
44663446|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44663447|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44663448|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44663449|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663450|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663451|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663452|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663453|NCT01209988|Urological Agents|urological agents|mesh-ancestor
44663454|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
44663455|NCT01210014|Astringents|astringents|mesh-ancestor
44663456|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663457|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663458|NCT01210040|Folic Acid|folic acid|mesh-list
44663459|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
44663460|NCT01210040|Hematinics|hematinics|mesh-ancestor
44663461|NCT01210040|Vitamins|vitamins|mesh-ancestor
44663462|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
44663463|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663464|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44663465|NCT01210066|Fentanyl|fentanyl|mesh-list
44663466|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
44663467|NCT01210066|Narcotics|narcotics|mesh-ancestor
44663468|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663469|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663470|NCT01210066|Analgesics|analgesics|mesh-ancestor
44663471|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
44663472|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663473|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44663474|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44663475|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
44663476|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
44663478|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44663479|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44663480|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663481|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663482|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
44663483|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663484|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44663485|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44663486|NCT01210339|Esomeprazole|esomeprazole|mesh-list
44663487|NCT01210339|Clopidogrel|clopidogrel|mesh-list
44663488|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44663489|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44663490|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44663491|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44663492|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
44663493|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663494|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663495|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663496|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44663497|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663498|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44663499|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663500|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
44663501|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663502|NCT01210391|Caseins|caseins|mesh-list
44663503|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
44663504|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
44663505|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663506|NCT01210430|Vitamins|vitamins|mesh-list
44663507|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
44663508|NCT01210430|Losartan|losartan|mesh-list
44663509|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
44663510|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663511|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44663512|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663513|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44663514|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44663515|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663516|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
44663517|NCT01210430|Protective Agents|protective agents|mesh-ancestor
44663518|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
44663519|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44663520|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
44663521|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663522|NCT01210456|Expectorants|expectorants|mesh-ancestor
44663523|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44663524|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44663525|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
44663526|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663527|NCT01210456|Protective Agents|protective agents|mesh-ancestor
44663528|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663529|NCT01210456|Antidotes|antidotes|mesh-ancestor
44663530|NCT01210482|Sirolimus|sirolimus|mesh-list
44663531|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663532|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663533|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44663534|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663535|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
44663536|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663537|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
44663538|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663539|NCT01210521|Vitamin D|vitamin d|mesh-list
44663540|NCT01210521|Vitamins|vitamins|mesh-ancestor
44663541|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
44663542|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663543|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44663544|NCT01210599|Pamidronate|pamidronate|mesh-list
44663545|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44663546|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663547|NCT01210638|Oxymorphone|oxymorphone|mesh-list
44213776|NCT00454662|Amlodipine|amlodipine|mesh-list
44663548|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44663549|NCT01210638|Narcotics|narcotics|mesh-ancestor
44663550|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663551|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663552|NCT01210638|Analgesics|analgesics|mesh-ancestor
44663553|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
44663554|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663555|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44663556|NCT01210677|Prednisone|prednisone|mesh-list
44663557|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663558|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
44663559|NCT01210677|Hormones|hormones|mesh-ancestor
44663560|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663561|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663562|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44663563|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663564|NCT01210742|Hylan|hylan|mesh-list
44663565|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
44663566|NCT01210742|Protective Agents|protective agents|mesh-ancestor
44663567|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663568|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
44663569|NCT01210755|Dabigatran|dabigatran|mesh-list
43929166|NCT00672594|Sunitinib|sunitinib|mesh-list
44663570|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44663571|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
44663572|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44663573|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
44663574|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663575|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663576|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
44663577|NCT01210911|Metformin|metformin|mesh-list
44663578|NCT01210911|Gemcitabine|gemcitabine|mesh-list
44663579|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44663580|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663581|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
44663582|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663583|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663584|NCT01210911|Antiviral Agents|antiviral agents|mesh-ancestor
44663585|NCT01210911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663586|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663587|NCT01210911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663588|NCT01210911|Immunologic Factors|immunologic factors|mesh-ancestor
44663589|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663590|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663591|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44663592|NCT01210976|Simendan|simendan|mesh-list
44663593|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44663594|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663595|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44663596|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44663597|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663598|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663599|NCT01210976|Protective Agents|protective agents|mesh-ancestor
44663600|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663601|NCT01211002|Endostatins|endostatins|mesh-list
44663602|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663603|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663604|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663605|NCT01211002|Growth Substances|growth substances|mesh-ancestor
44663606|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663607|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
44663608|NCT01211080|Propranolol|propranolol|mesh-list
44663609|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44663610|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44663611|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663612|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663613|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663614|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663615|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44663616|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663617|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663618|NCT01211158|Ketamine|ketamine|mesh-list
44663619|NCT01211158|Propofol|propofol|mesh-list
44663620|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44663621|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663622|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663623|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44663624|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
44663625|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
44663626|NCT01211158|Analgesics|analgesics|mesh-ancestor
44663627|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
44663628|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663629|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44663630|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44663631|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44663632|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663633|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663634|NCT01211171|Telmisartan|telmisartan|mesh-list
44663635|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663636|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44663637|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44663638|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663640|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
44663641|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
44663642|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663643|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663644|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663645|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663646|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
44663647|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663648|NCT01211223|Amoxicillin|amoxicillin|mesh-list
44663649|NCT01211223|Metronidazole|metronidazole|mesh-list
44663650|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663651|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663652|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44663653|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44663654|NCT01211275|Cisplatin|cisplatin|mesh-list
44663655|NCT01211275|Pemetrexed|pemetrexed|mesh-list
44663656|NCT01211275|Axitinib|axitinib|mesh-list
44663657|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663658|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663659|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663660|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44663661|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44663662|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44663663|NCT01211314|Enalapril|enalapril|mesh-list
44663664|NCT01211314|Lercanidipine|lercanidipine|mesh-list
44663665|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44663666|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
44663667|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663668|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663669|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663670|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44663671|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663672|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44663673|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663674|NCT01211327|Cyclosporine|cyclosporine|mesh-list
44663675|NCT01211327|Dexamethasone|dexamethasone|mesh-list
44663676|NCT01211327|Cyclosporins|cyclosporins|mesh-list
44663677|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663678|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
44663679|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
44663680|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663681|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663682|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663683|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
44663684|NCT01211327|Hormones|hormones|mesh-ancestor
44663685|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663686|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44663687|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663688|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663689|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663690|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663691|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
44663692|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
44663693|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663694|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44663695|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663696|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44663697|NCT01211457|Decitabine|decitabine|mesh-list
44663698|NCT01211457|Venetoclax|venetoclax|mesh-list
44663699|NCT01211457|Sapacitabine|sapacitabine|mesh-list
44663700|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663701|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
44663702|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663703|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663704|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663705|NCT01211470|Daptomycin|daptomycin|mesh-list
44663706|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663707|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663708|NCT01211496|Methamphetamine|methamphetamine|mesh-list
44663709|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44663710|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663711|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
44663712|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
44663713|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663714|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
44663715|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663716|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663717|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663718|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44663719|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44663720|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663721|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44663722|NCT01211509|Montelukast|montelukast|mesh-list
44663723|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44663724|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
44663725|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44663726|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
44663727|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663728|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663729|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44663730|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44663731|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663732|NCT01211561|Selenium|selenium|mesh-list
44663733|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
44663734|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663735|NCT01211561|Protective Agents|protective agents|mesh-ancestor
44663736|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663737|NCT01211561|Trace Elements|trace elements|mesh-ancestor
44663738|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
44663739|NCT01211691|Antibodies|antibodies|mesh-list
44663740|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44663741|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
44663742|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663743|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44663744|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44663745|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44663746|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663747|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663748|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44663749|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44663750|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44663751|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
44663752|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663753|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663754|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44663755|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44663756|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
44663757|NCT01211795|Ketoprofen|ketoprofen|mesh-list
44663758|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44663759|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663760|NCT01211795|Analgesics|analgesics|mesh-ancestor
44663761|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
44663762|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663763|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663764|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663765|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663766|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44663767|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663768|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663769|NCT01211808|Diltiazem|diltiazem|mesh-list
44663770|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663771|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44663772|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663773|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663774|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44663775|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663776|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663777|NCT01211821|Metoprolol|metoprolol|mesh-list
44663778|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44663779|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43929392|NCT00675987|Losartan|losartan|mesh-list
44663780|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
44663781|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
44663782|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663783|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663784|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44663785|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44663786|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44663787|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663788|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663789|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663790|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
44663791|NCT01211847|Diazoxide|diazoxide|mesh-list
44663792|NCT01211847|Choline|choline|mesh-list
44663793|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
44663794|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663795|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
44663796|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663797|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663798|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663799|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
44663800|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663801|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663802|NCT01211860|Diazoxide|diazoxide|mesh-list
44663803|NCT01211860|Choline|choline|mesh-list
44663804|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
44663805|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663806|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
44663807|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663808|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44663809|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663810|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
44663811|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663812|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
44663813|NCT01211912|Acetaminophen|acetaminophen|mesh-list
44663814|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663815|NCT01211912|Analgesics|analgesics|mesh-ancestor
44663816|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
44663817|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663818|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663819|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
44663820|NCT01211925|Aspirin|aspirin|mesh-list
44663821|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44663822|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44663823|NCT01211925|Analgesics|analgesics|mesh-ancestor
44663824|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
44663825|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663826|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663827|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663828|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663829|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44663830|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44663831|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663832|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44663833|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44663834|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44663835|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
44663836|NCT01211938|Cetuximab|cetuximab|mesh-list
44663837|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44663838|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663839|NCT01212133|Liraglutide|liraglutide|mesh-list
44663840|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663841|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663842|NCT01212133|Incretins|incretins|mesh-ancestor
44663843|NCT01212133|Hormones|hormones|mesh-ancestor
44663844|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663845|NCT01212250|Carvedilol|carvedilol|mesh-list
44663846|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44663847|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44663848|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
44663849|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44663850|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663851|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663852|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44663853|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
44663854|NCT01212250|Protective Agents|protective agents|mesh-ancestor
44663855|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44663856|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44663857|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44663858|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
44214151|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
44663859|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44663860|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44663861|NCT01212315|Triclosan|triclosan|mesh-list
44663862|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44663864|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44663865|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44663866|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
44663867|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663868|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44663869|NCT01212367|Interferons|interferons|mesh-list
44663870|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
44663871|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
44663872|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44663873|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663874|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
44663875|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663876|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
44663877|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663878|NCT01212406|Vitamin D|vitamin d|mesh-list
44663879|NCT01212406|Vitamins|vitamins|mesh-ancestor
44663880|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
44663881|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663882|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44663883|NCT01212432|Daptomycin|daptomycin|mesh-list
44663884|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44663885|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663886|NCT01212523|Propofol|propofol|mesh-list
44663887|NCT01212523|Isoflurane|isoflurane|mesh-list
44663888|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44663889|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663890|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663891|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44663892|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
44663893|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
44663894|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44663895|NCT01212653|Golimumab|golimumab|mesh-list
44663896|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44663897|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44663898|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663899|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
44663900|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663901|NCT01212666|Ropivacaine|ropivacaine|mesh-list
44663902|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
44663903|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
44663904|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663905|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663906|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
44663907|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44663908|NCT01212679|Mitogens|mitogens|mesh-list
44663909|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44663910|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663911|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
44663912|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44663913|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
44663914|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663915|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
44663916|NCT01212809|Protective Agents|protective agents|mesh-ancestor
44663917|NCT01212887|Aldesleukin|aldesleukin|mesh-list
44663918|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
44663919|NCT01212887|Fludarabine|fludarabine|mesh-list
44663920|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
44663921|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663922|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
44663923|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140206|NCT00178048|Paroxetine|paroxetine|mesh-list
44663924|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663925|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44663926|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
44663927|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663928|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663929|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44663930|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663931|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
44663932|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44663933|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44663934|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
44663935|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44663936|NCT01212913|Insulin|insulin|mesh-list
44663937|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44663938|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
44663939|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
44663940|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
44663941|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44663942|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44663943|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663944|NCT01212965|Selenium|selenium|mesh-list
44663945|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
44663946|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663947|NCT01212965|Protective Agents|protective agents|mesh-ancestor
44663948|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663949|NCT01212965|Trace Elements|trace elements|mesh-ancestor
44663950|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
44663951|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
44663952|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44663953|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
44663954|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663955|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663956|NCT01213095|Rituximab|rituximab|mesh-list
44663957|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44663958|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663959|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
44663960|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663961|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44663962|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44663963|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
44663964|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929531|NCT00681265|Glycerol|glycerol|mesh-list
44663965|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44663966|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44663967|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44663968|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663969|NCT01213147|Clomiphene|clomiphene|mesh-list
44663970|NCT01213147|Enclomiphene|enclomiphene|mesh-list
44663971|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
44663972|NCT01213147|Buserelin|buserelin|mesh-list
44663973|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44663974|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
44663975|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44663976|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663977|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44663978|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
44663979|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44663980|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44663981|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44663982|NCT01213238|Bevacizumab|bevacizumab|mesh-list
44663983|NCT01213238|Capecitabine|capecitabine|mesh-list
44663984|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
44663985|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778072|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44663986|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44663987|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44663988|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44663989|NCT01213238|Growth Substances|growth substances|mesh-ancestor
44663990|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44663991|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929573|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44663992|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44663993|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
44663994|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44663995|NCT01213355|Scopolamine|scopolamine|mesh-list
44663996|NCT01213355|Donepezil|donepezil|mesh-list
44663997|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44663998|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44663999|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664000|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664001|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44664002|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664003|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664004|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
44664005|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44664006|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
44664007|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
44664008|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664009|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664010|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
44664011|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44664012|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44664013|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
44664014|NCT01213368|Dronedarone|dronedarone|mesh-list
44664015|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664016|NCT01213381|Gemcitabine|gemcitabine|mesh-list
44664017|NCT01213381|Carboplatin|carboplatin|mesh-list
44664018|NCT01213381|Iniparib|iniparib|mesh-list
44664019|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664020|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44664021|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
44664022|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664023|NCT01213381|Antiviral Agents|antiviral agents|mesh-ancestor
44664024|NCT01213381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664025|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664026|NCT01213381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664027|NCT01213381|Immunologic Factors|immunologic factors|mesh-ancestor
44664028|NCT01213381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664029|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44664030|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
44664031|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44664032|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664033|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44664034|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
44664035|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664036|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664037|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664038|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664039|NCT01213407|Temozolomide|temozolomide|mesh-list
44664040|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44664041|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
44664042|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664043|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664044|NCT01213433|Artesunate|artesunate|mesh-list
44664045|NCT01213433|Amodiaquine|amodiaquine|mesh-list
44664046|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
44664047|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44664048|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44664049|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664050|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664051|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
44664052|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
44664053|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44664054|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
44664055|NCT01213498|Atorvastatin|atorvastatin|mesh-list
44664056|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44664057|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44664058|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
44664059|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664060|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44664061|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44664062|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664064|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44664065|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44664066|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664067|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
44664068|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44664069|NCT01213563|Insulin|insulin|mesh-list
44664070|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44664071|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
44664072|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
44664073|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44664074|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664075|NCT01213667|Ranibizumab|ranibizumab|mesh-list
44664076|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664077|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664078|NCT01213667|Growth Substances|growth substances|mesh-ancestor
44664079|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664080|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664081|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664082|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44664083|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
44664084|NCT01213680|Hematinics|hematinics|mesh-ancestor
44664085|NCT01213693|Fluticasone|fluticasone|mesh-list
44664086|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44664087|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664088|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44664089|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
44664090|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664091|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664092|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44664093|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664094|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44664095|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44664096|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44664097|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44664098|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44664099|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44664100|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664101|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664102|NCT01213719|Betaine|betaine|mesh-list
44664103|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664104|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
44664105|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44664106|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
44664107|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664108|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44664109|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44664110|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664111|NCT01213849|Fluticasone|fluticasone|mesh-list
44214415|NCT00457470|Rucaparib|rucaparib|mesh-list
44664112|NCT01213849|Xhance|xhance|mesh-list
44664113|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664114|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44664115|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
44664116|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664117|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664118|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44664119|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664120|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44664121|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44664122|NCT01213888|Trientine|trientine|mesh-list
44664123|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
44664124|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
44664125|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664126|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
44664127|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44664128|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664129|NCT01213979|Iron|iron|mesh-list
44664130|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44664131|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
44664132|NCT01213979|Trace Elements|trace elements|mesh-ancestor
44664133|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
44664134|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664135|NCT01213979|Hematinics|hematinics|mesh-ancestor
44664136|NCT01213992|Iron|iron|mesh-list
44664137|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44664138|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
44664139|NCT01213992|Trace Elements|trace elements|mesh-ancestor
44664140|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
44664141|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664142|NCT01213992|Hematinics|hematinics|mesh-ancestor
44664143|NCT01214122|Warfarin|warfarin|mesh-list
44664144|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
44664145|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
44664146|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44664147|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664148|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664149|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44664150|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44664151|NCT01214226|Protective Agents|protective agents|mesh-ancestor
44664152|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664153|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
44664154|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44664155|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
44664156|NCT01214291|Toremifene|toremifene|mesh-list
44664157|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664158|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664159|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44664160|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44664161|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
44664162|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664163|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664164|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44664165|NCT01214343|Sorafenib|sorafenib|mesh-list
44664166|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664167|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664168|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664169|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664170|NCT01214382|Sertraline|sertraline|mesh-list
44664171|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
44664172|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44664173|NCT01214382|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44664174|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44664175|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664176|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664177|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664178|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
44664179|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664180|NCT01214408|Pantoprazole|pantoprazole|mesh-list
44664181|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44664182|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664183|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44664184|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929747|NCT00687076|Analgesics|analgesics|mesh-ancestor
44664185|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664186|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
44664187|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44664188|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44664189|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
44664190|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664191|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44664192|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44664193|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664194|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664195|NCT01214746|Atorvastatin|atorvastatin|mesh-list
44664196|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44664197|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44664198|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
44664199|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664200|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44664201|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44664202|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664203|NCT01214772|Heparin|heparin|mesh-list
44664204|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
44664205|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44664206|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44664207|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664208|NCT01214889|Vaccines|vaccines|mesh-list
44664209|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
44058906|NCT00005796|Vincristine|vincristine|mesh-list
44664210|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664211|NCT01214928|Vitamin D|vitamin d|mesh-list
44664212|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
44664213|NCT01214928|Vitamins|vitamins|mesh-ancestor
44664214|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
44664215|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664216|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44664217|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44664218|NCT01214941|Itraconazole|itraconazole|mesh-list
44664219|NCT01214941|Ticlopidine|ticlopidine|mesh-list
44664220|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
44664221|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664222|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44664223|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44664224|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664225|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664226|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44664227|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44664228|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664229|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664230|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44664231|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44664232|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44664233|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44664234|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44664235|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44664236|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44664237|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
44664238|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664239|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44664240|NCT01214993|Dolutegravir|dolutegravir|mesh-list
44664241|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44664242|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44664243|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664244|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664245|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44664246|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44664247|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
44664248|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664249|NCT01215019|Mannitol|mannitol|mesh-list
44664250|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44664251|NCT01215019|Diuretics|diuretics|mesh-ancestor
44664252|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
44664253|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664254|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
44664255|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44664256|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664257|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664258|NCT01215136|Paclitaxel|paclitaxel|mesh-list
44664259|NCT01215136|Everolimus|everolimus|mesh-list
44664260|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44664261|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664262|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
44664263|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
44664264|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
44664265|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664266|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664267|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
44664268|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664269|NCT01215149|Vaccines|vaccines|mesh-list
44664270|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
44664271|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664272|NCT01215214|Midazolam|midazolam|mesh-list
44664273|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44664274|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44664275|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664276|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664277|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44664278|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44664279|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44664280|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44664281|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
44058967|NCT00005800|Docetaxel|docetaxel|mesh-list
44664283|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
44664284|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
44664285|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664286|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664287|NCT01215266|Sorafenib|sorafenib|mesh-list
44664288|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664289|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664290|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664291|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664292|NCT01215331|Insulin|insulin|mesh-list
44664293|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44664294|NCT01215331|Metformin|metformin|mesh-list
44664295|NCT01215331|Glyburide|glyburide|mesh-list
44664296|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44664297|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664298|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44664299|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44664300|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44664301|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44664302|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214629|NCT00458458|Leuprolide|leuprolide|mesh-list
44664303|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664304|NCT01215409|Urological Agents|urological agents|mesh-ancestor
44664305|NCT01215539|Panitumumab|panitumumab|mesh-list
44664306|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664307|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664308|NCT01215565|Sunitinib|sunitinib|mesh-list
44664309|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664310|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664311|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664312|NCT01215565|Growth Substances|growth substances|mesh-ancestor
44664313|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664314|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664315|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664316|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664317|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664318|NCT01215578|Sunitinib|sunitinib|mesh-list
44664319|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664320|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664321|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664322|NCT01215578|Growth Substances|growth substances|mesh-ancestor
44664323|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664324|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664325|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664326|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664327|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664328|NCT01215669|Vaccines|vaccines|mesh-list
44664329|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
44664330|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664331|NCT01215682|Vitamin D|vitamin d|mesh-list
44664332|NCT01215682|Vitamins|vitamins|mesh-ancestor
43929898|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
44664333|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
44664334|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664335|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44664336|NCT01215708|Tamsulosin|tamsulosin|mesh-list
44664337|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44664338|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44664339|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44664340|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44664341|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664342|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664343|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664344|NCT01215708|Urological Agents|urological agents|mesh-ancestor
44664345|NCT01215799|Bafetinib|bafetinib|mesh-list
44664346|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664347|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664348|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664349|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
44664350|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44664351|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664352|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235900|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44664353|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44664354|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664355|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44664356|NCT01216007|Propofol|propofol|mesh-list
44664357|NCT01216007|Sevoflurane|sevoflurane|mesh-list
44664358|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44664359|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664360|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664361|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44664362|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
44664363|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
44664364|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44664365|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44664366|NCT01216020|Cisplatin|cisplatin|mesh-list
44664367|NCT01216020|Cetuximab|cetuximab|mesh-list
44664368|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664369|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664370|NCT01216046|Ivacaftor|ivacaftor|mesh-list
44664371|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44664372|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664373|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664374|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
44664375|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664376|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664377|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664378|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664379|NCT01216111|Paclitaxel|paclitaxel|mesh-list
44664380|NCT01216111|Docetaxel|docetaxel|mesh-list
44664381|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
44664382|NCT01216111|Cisplatin|cisplatin|mesh-list
44664383|NCT01216111|Fluorouracil|fluorouracil|mesh-list
44664384|NCT01216111|Epirubicin|epirubicin|mesh-list
44664385|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44664386|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664387|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44664388|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44664389|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44664390|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664391|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664392|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
44664393|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664394|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44664395|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44664396|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
44664397|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44664398|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
44664399|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44664400|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44664401|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44664402|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44664403|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664404|NCT01216124|Docetaxel|docetaxel|mesh-list
44664405|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
44664406|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664407|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
44664408|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
44664409|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
44664410|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664411|NCT01216267|Lansoprazole|lansoprazole|mesh-list
44664412|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
44664413|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44664414|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664415|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44664416|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664417|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664418|NCT01216293|Esomeprazole|esomeprazole|mesh-list
44664419|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
44664420|NCT01216293|Lansoprazole|lansoprazole|mesh-list
44664421|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44664422|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664423|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44664424|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664425|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664426|NCT01216345|Gemcitabine|gemcitabine|mesh-list
44664427|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
44664429|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44664430|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
44664431|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664432|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664433|NCT01216345|Antiviral Agents|antiviral agents|mesh-ancestor
44664434|NCT01216345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664435|NCT01216345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664436|NCT01216345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664437|NCT01216345|Immunologic Factors|immunologic factors|mesh-ancestor
44664438|NCT01216345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664439|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664440|NCT01216371|Sunitinib|sunitinib|mesh-list
44664441|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664442|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664443|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664444|NCT01216371|Growth Substances|growth substances|mesh-ancestor
44664445|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664446|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664447|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664448|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664449|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664450|NCT01216449|Citalopram|citalopram|mesh-list
44664451|NCT01216449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44664452|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44664453|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664454|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664455|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664456|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
44664457|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664458|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44664459|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
44664460|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44664461|NCT01216488|Lidocaine|lidocaine|mesh-list
44664462|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
44664463|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
44664464|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664465|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664466|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
44664467|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664468|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664469|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44664470|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44664471|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664472|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664473|NCT01216579|Mannitol|mannitol|mesh-list
44664474|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44664475|NCT01216579|Diuretics|diuretics|mesh-ancestor
44664476|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
44664477|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664478|NCT01216605|Oxytocin|oxytocin|mesh-list
44664479|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
44664480|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44664481|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664482|NCT01216644|Leucovorin|leucovorin|mesh-list
44664483|NCT01216644|Cisplatin|cisplatin|mesh-list
44664484|NCT01216644|Docetaxel|docetaxel|mesh-list
44664485|NCT01216644|Fluorouracil|fluorouracil|mesh-list
44664486|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
44664487|NCT01216644|Epirubicin|epirubicin|mesh-list
44664488|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664489|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
44664490|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
44664491|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
44664492|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664493|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
44664494|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44664495|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664496|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
44664497|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664498|NCT01216644|Antidotes|antidotes|mesh-ancestor
44664499|NCT01216644|Protective Agents|protective agents|mesh-ancestor
44664500|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
44664501|NCT01216644|Vitamins|vitamins|mesh-ancestor
44664502|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
44664503|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44664504|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44664505|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44664506|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664507|NCT01216657|Sunitinib|sunitinib|mesh-list
44664508|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664509|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664510|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664511|NCT01216657|Growth Substances|growth substances|mesh-ancestor
44664512|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664513|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664514|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664515|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664516|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664517|NCT01216696|Ipilimumab|ipilimumab|mesh-list
44664518|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664519|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664520|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44664521|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664522|NCT01216709|Iron|iron|mesh-list
44664523|NCT01216709|Trace Elements|trace elements|mesh-ancestor
44664524|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
44664525|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664526|NCT01216787|R04929097|r04929097|mesh-list
44664527|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664528|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664529|NCT01216826|Everolimus|everolimus|mesh-list
44664530|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664531|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664532|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
44664533|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664534|NCT01216839|Everolimus|everolimus|mesh-list
44664535|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664536|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664537|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
44664538|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664539|NCT01216852|Losartan|losartan|mesh-list
44664540|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664541|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664542|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664543|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664544|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664545|NCT01216878|Losartan|losartan|mesh-list
44664546|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664547|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664548|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664549|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664550|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664551|NCT01216904|Nicotine|nicotine|mesh-list
44664552|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44664553|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
44664554|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664555|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664556|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44664557|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44664558|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
44664559|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664560|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664561|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
44664562|NCT01216956|Niacin|niacin|mesh-list
44664563|NCT01216956|Niacinamide|niacinamide|mesh-list
44664564|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
44664565|NCT01216956|Vitamins|vitamins|mesh-ancestor
44664566|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
44664567|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664568|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44664569|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
44664570|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664571|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44664572|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
44664573|NCT01217034|Sorafenib|sorafenib|mesh-list
44664574|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
44664575|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664576|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664577|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664578|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664579|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44664580|NCT01217034|Estrogens|estrogens|mesh-ancestor
44664581|NCT01217034|Hormones|hormones|mesh-ancestor
43778073|NCT02327663|Emtricitabine|emtricitabine|mesh-list
44664582|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664583|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664584|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664585|NCT01217086|Infliximab|infliximab|mesh-list
44664586|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44664587|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664588|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44664589|NCT01217099|Azithromycin|azithromycin|mesh-list
44664590|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
44664591|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44664592|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44664593|NCT01217099|Prednisolone|prednisolone|mesh-list
44664594|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
44664595|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44664596|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
44664597|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664598|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
44664599|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
44664600|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664601|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664602|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664603|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
44664604|NCT01217099|Hormones|hormones|mesh-ancestor
44664605|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664606|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44664607|NCT01217099|Protective Agents|protective agents|mesh-ancestor
44664608|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664609|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664610|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664611|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664612|NCT01217125|Sirolimus|sirolimus|mesh-list
44664613|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664614|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664615|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44664616|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664617|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
44664618|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664619|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
44664620|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664621|NCT01217138|Epinephrine|epinephrine|mesh-list
44664622|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44664623|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44664624|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44664625|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664626|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664627|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664628|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44664629|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44664630|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
44664631|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664632|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44664633|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664634|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
44664635|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
44664636|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44664637|NCT01217177|Everolimus|everolimus|mesh-list
44664638|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664639|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664640|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
44664641|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664642|NCT01217203|Lenalidomide|lenalidomide|mesh-list
44664643|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
44664644|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664645|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664646|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664647|NCT01217203|Growth Substances|growth substances|mesh-ancestor
44664648|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664649|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664650|NCT01217294|Morphine|morphine|mesh-list
44664651|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44664652|NCT01217294|Narcotics|narcotics|mesh-ancestor
44664653|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664654|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664656|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
44664657|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664658|NCT01217359|Interferons|interferons|mesh-list
44664659|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
44664660|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
44664661|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664662|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
44664663|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664664|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
44664665|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664666|NCT01217398|Bevacizumab|bevacizumab|mesh-list
44664667|NCT01217398|Temozolomide|temozolomide|mesh-list
44664668|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664669|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664670|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664671|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664672|NCT01217398|Growth Substances|growth substances|mesh-ancestor
44664673|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664674|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664675|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44664676|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
44664677|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664678|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44664679|NCT01217450|Cetuximab|cetuximab|mesh-list
44664680|NCT01217450|Antibodies|antibodies|mesh-list
44664681|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
44664682|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44664683|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
44664684|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664685|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664686|NCT01217580|Ropivacaine|ropivacaine|mesh-list
44664687|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
44664688|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
44664689|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664690|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664691|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
44664692|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664693|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44664694|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664695|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664696|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664697|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664698|NCT01217632|Entecavir|entecavir|mesh-list
44664699|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
44664700|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664701|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
44664702|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44664703|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664704|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664705|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43930233|NCT00699010|Analgesics|analgesics|mesh-ancestor
44664706|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44664707|NCT01217697|Prednisone|prednisone|mesh-list
44664708|NCT01217697|Prednisolone|prednisolone|mesh-list
44664709|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
44664710|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664711|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
44664712|NCT01217697|Hormones|hormones|mesh-ancestor
44664713|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664714|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664715|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664716|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664717|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44664718|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664719|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664720|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
44664721|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44664722|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
44664723|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44664724|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
44664725|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664726|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44664727|NCT01217879|Telmisartan|telmisartan|mesh-list
44664728|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664729|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664730|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664731|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664733|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44664734|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
44664735|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664736|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664737|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44664738|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664739|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44664740|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664741|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664742|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44664743|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
44664744|NCT01218022|Losartan|losartan|mesh-list
44664745|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664746|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664747|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664748|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664749|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664750|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
44664751|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44664752|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664753|NCT01218217|Rifampin|rifampin|mesh-list
44664754|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44664755|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
44664756|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664757|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664758|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
44664759|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44664760|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664761|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664762|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44664763|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44664764|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44664765|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44664766|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44664767|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44664768|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
44664769|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44664770|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44664771|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44664772|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
44664773|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664774|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44664775|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44664776|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664777|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44664778|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44664779|NCT01218386|Estradiol|estradiol|mesh-list
44664780|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44664781|NCT01218386|Estrogens|estrogens|mesh-ancestor
44664782|NCT01218386|Hormones|hormones|mesh-ancestor
44664783|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664784|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664785|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44664786|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
44664787|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44664788|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44664789|NCT01218425|Levodopa|levodopa|mesh-list
44664790|NCT01218425|Carbidopa|carbidopa|mesh-list
44664791|NCT01218425|Domperidone|domperidone|mesh-list
44664792|NCT01218425|Methylphenidate|methylphenidate|mesh-list
43930367|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664793|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44664794|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664795|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44664796|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44664797|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664798|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664799|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
44664800|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664801|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44664802|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44664803|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44664804|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664805|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
44664806|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
44664807|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664808|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664809|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44664810|NCT01218451|Vaccines|vaccines|mesh-list
44664811|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
44664812|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664813|NCT01218529|Lapatinib|lapatinib|mesh-list
44664814|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664815|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44664816|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664817|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664818|NCT01218568|Rifaximin|rifaximin|mesh-list
44664819|NCT01218568|Lactulose|lactulose|mesh-list
44664820|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664821|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664822|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664823|NCT01218581|Letrozole|letrozole|mesh-list
44664824|NCT01218581|Goserelin|goserelin|mesh-list
44664825|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664826|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44664827|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44664829|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664830|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44664831|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
44664832|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664833|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664834|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664835|NCT01218607|Bosentan|bosentan|mesh-list
44664836|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664837|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44664838|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664839|NCT01218620|Tolbutamide|tolbutamide|mesh-list
44664840|NCT01218620|Rifampin|rifampin|mesh-list
44664841|NCT01218620|Ketoconazole|ketoconazole|mesh-list
44664842|NCT01218620|Midazolam|midazolam|mesh-list
44664843|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
44664844|NCT01218620|Omeprazole|omeprazole|mesh-list
44664845|NCT01218620|R04929097|r04929097|mesh-list
44664846|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44664847|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44664848|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664849|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664850|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44664851|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44664852|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44664853|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44664854|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
44664855|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
44664856|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
44664857|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
44664858|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44664859|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664860|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44664861|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664862|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44664863|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664864|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44664865|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
44664866|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664867|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664868|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
44664869|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44664870|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44664871|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44664872|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44664873|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44664874|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44664875|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44664876|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
44664877|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44664878|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44664879|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44664880|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
44664881|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664882|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44664883|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
44664884|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664885|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44664886|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44664887|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44664888|NCT01218698|Losartan|losartan|mesh-list
44664889|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664890|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664891|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664892|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664893|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664894|NCT01218711|Losartan|losartan|mesh-list
44664895|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44664896|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664897|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664898|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44456884|NCT01621880|Hormones|hormones|mesh-ancestor
44664899|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664900|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664901|NCT01218711|Diuretics|diuretics|mesh-ancestor
44664902|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
44664903|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664904|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44664905|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664906|NCT01218724|Losartan|losartan|mesh-list
44664907|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44664908|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44664909|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44664910|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44664911|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44664912|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664913|NCT01218724|Diuretics|diuretics|mesh-ancestor
44664914|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
44664915|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664916|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44664917|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44664918|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
44664919|NCT01218737|Prednisolone|prednisolone|mesh-list
44664920|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44664921|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
44664922|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44664923|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
44664924|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44664925|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
44664926|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664927|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
44664928|NCT01218737|Hormones|hormones|mesh-ancestor
44664929|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664930|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664931|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44664932|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664933|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
44664934|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
44664935|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664936|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44664937|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44664938|NCT01218737|Protective Agents|protective agents|mesh-ancestor
44664939|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44664940|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664941|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44664942|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44664943|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44664944|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44664945|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664946|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664947|NCT01218750|Bevacizumab|bevacizumab|mesh-list
44664948|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44664949|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664950|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44664951|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44664952|NCT01218750|Growth Substances|growth substances|mesh-ancestor
44664953|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664954|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
44664955|NCT01218893|Chloroquine|chloroquine|mesh-list
44664956|NCT01218893|Proguanil|proguanil|mesh-list
44664957|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44664958|NCT01218893|Amebicides|amebicides|mesh-ancestor
44664959|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44664960|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44664961|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44664962|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
44664963|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44664964|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
44664965|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664966|NCT01219010|Siltuximab|siltuximab|mesh-list
44664967|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44664968|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
44664969|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44664970|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
43930548|NCT00705874|Vitamins|vitamins|mesh-ancestor
44664971|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44664972|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44664973|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44664974|NCT01219023|Urological Agents|urological agents|mesh-ancestor
44664975|NCT01219036|Budesonide|budesonide|mesh-list
44664976|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44664977|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44664978|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
44664979|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664980|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664981|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44664982|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
44664983|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
44664984|NCT01219036|Hormones|hormones|mesh-ancestor
44664985|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44664986|NCT01219062|Morphine|morphine|mesh-list
44664987|NCT01219062|Bupivacaine|bupivacaine|mesh-list
44664988|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
44664989|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
44664990|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44664991|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44664992|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
44664993|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44664994|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44664995|NCT01219062|Narcotics|narcotics|mesh-ancestor
44664996|NCT01219062|Analgesics|analgesics|mesh-ancestor
44664997|NCT01219088|Morphine|morphine|mesh-list
44664998|NCT01219088|Bupivacaine|bupivacaine|mesh-list
44664999|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
44665000|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
44665001|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665002|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665003|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
44665004|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665005|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44665006|NCT01219088|Narcotics|narcotics|mesh-ancestor
44665007|NCT01219088|Analgesics|analgesics|mesh-ancestor
44665008|NCT01219101|Citric Acid|citric acid|mesh-list
44665009|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
44665010|NCT01219101|Clomiphene|clomiphene|mesh-list
44665011|NCT01219101|Enclomiphene|enclomiphene|mesh-list
44665012|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
44665013|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
44665014|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44665015|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
44665016|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
44665017|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665018|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44665019|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665020|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665021|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665022|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44665023|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
44665024|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44665025|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44665026|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44665027|NCT01219153|Letrozole|letrozole|mesh-list
44665028|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
44665029|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44665030|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665031|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44665032|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44665033|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665034|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665035|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44665036|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665037|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665038|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665040|NCT01219205|Bevacizumab|bevacizumab|mesh-list
44665041|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44665042|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665043|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44665044|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930595|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
44665045|NCT01219205|Growth Substances|growth substances|mesh-ancestor
44665046|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665047|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44665048|NCT01219244|Resveratrol|resveratrol|mesh-list
44665049|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
44665050|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665051|NCT01219244|Protective Agents|protective agents|mesh-ancestor
44665052|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665053|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665054|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44665055|NCT01219400|Vildagliptin|vildagliptin|mesh-list
44665056|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665057|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665058|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44665059|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44665060|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665061|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665062|NCT01219413|Perindopril|perindopril|mesh-list
44665063|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44665064|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
44665065|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665066|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665067|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44665068|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44665069|NCT01219556|Olmesartan|olmesartan|mesh-list
44665070|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44665071|NCT01219556|Diuretics|diuretics|mesh-ancestor
44665072|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
44665073|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665074|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44665075|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665076|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665077|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44665078|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44665079|NCT01219569|Propofol|propofol|mesh-list
44665080|NCT01219569|Sevoflurane|sevoflurane|mesh-list
44665081|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44665082|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665083|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665084|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44665085|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
44665086|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
44665087|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44665088|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44665089|NCT01219582|Metformin|metformin|mesh-list
44665090|NCT01219582|Acarbose|acarbose|mesh-list
44665091|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665092|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665093|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44665094|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665095|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665096|NCT01219686|Pindolol|pindolol|mesh-list
44665097|NCT01219686|Dexetimide|dexetimide|mesh-list
44665098|NCT01219686|Citalopram|citalopram|mesh-list
44059777|NCT00005889|Glucagon|glucagon|mesh-list
44665099|NCT01219686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44665100|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44665101|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665102|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665103|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665104|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
44665105|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665106|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44665107|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
44665108|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665109|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44665110|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44665111|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
44665112|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
44665113|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665114|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44665115|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44665116|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
44665117|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44665118|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44665119|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
44665120|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44665121|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44665122|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665123|NCT01219699|Fulvestrant|fulvestrant|mesh-list
44665124|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44665125|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665126|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44665127|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44665128|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665129|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665130|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665131|NCT01219712|Simendan|simendan|mesh-list
44665132|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44665133|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665134|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44665135|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44665136|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665137|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665138|NCT01219712|Protective Agents|protective agents|mesh-ancestor
44665139|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665140|NCT01219751|Sunitinib|sunitinib|mesh-list
44665141|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665142|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44665143|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44665144|NCT01219751|Growth Substances|growth substances|mesh-ancestor
44665145|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665146|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
44665147|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44665148|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665149|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665150|NCT01219764|Amoxicillin|amoxicillin|mesh-list
44665151|NCT01219764|Metronidazole|metronidazole|mesh-list
44665152|NCT01219764|Clarithromycin|clarithromycin|mesh-list
44665153|NCT01219764|Rabeprazole|rabeprazole|mesh-list
44665154|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665155|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665156|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44665157|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44665158|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44665159|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665160|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665161|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44665162|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44665163|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44665164|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665165|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44665166|NCT01219816|Epratuzumab|epratuzumab|mesh-list
44665167|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44665168|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215521|NCT00463112|Sibutramine|sibutramine|mesh-list
44665169|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
44665170|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665171|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
44665172|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665173|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665174|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44665175|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
44665176|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665177|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675470|NCT02884128|Vitamins|vitamins|mesh-ancestor
44665178|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44665180|NCT01219920|Irinotecan|irinotecan|mesh-list
44665181|NCT01219920|Antidotes|antidotes|mesh-ancestor
44665182|NCT01219920|Protective Agents|protective agents|mesh-ancestor
44665183|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665184|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665185|NCT01219920|Vitamins|vitamins|mesh-ancestor
44665186|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
44665187|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665188|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665189|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44665190|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44665191|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665192|NCT01220063|Irinotecan|irinotecan|mesh-list
44665193|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44665194|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44665195|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665196|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665197|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665198|NCT01220076|Tamoxifen|tamoxifen|mesh-list
44665199|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44665200|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665201|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665202|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665203|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44665204|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665205|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44665206|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44665207|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44665208|NCT01220102|Adapalene|adapalene|mesh-list
44665209|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44665210|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44665211|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44665212|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665213|NCT01220102|Analgesics|analgesics|mesh-ancestor
44665214|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
44665215|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665216|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140256|NCT00178451|Abciximab|abciximab|mesh-list
44665217|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665218|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665219|NCT01220154|Paclitaxel|paclitaxel|mesh-list
44665220|NCT01220154|Bevacizumab|bevacizumab|mesh-list
44665221|NCT01220154|Carboplatin|carboplatin|mesh-list
44665222|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665223|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665224|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665225|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665226|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665227|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665228|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44665229|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44665230|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44665231|NCT01220154|Growth Substances|growth substances|mesh-ancestor
44665232|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665233|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44665234|NCT01220219|Pregabalin|pregabalin|mesh-list
44665235|NCT01220219|Analgesics|analgesics|mesh-ancestor
44665236|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
44665237|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665238|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665239|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
44665240|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44665241|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665242|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665243|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44665244|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44665245|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665246|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665247|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665248|NCT01220232|Lamivudine|lamivudine|mesh-list
44665249|NCT01220232|Abacavir|abacavir|mesh-list
44665250|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
44665251|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44665252|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44665253|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140289|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665254|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665255|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
44665256|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665257|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44665258|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44665259|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
44665260|NCT01220245|Heparin|heparin|mesh-list
44665261|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
44665262|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44665263|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44665264|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665265|NCT01220258|Azithromycin|azithromycin|mesh-list
44665266|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44665267|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44665268|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665269|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665270|NCT01220284|Vinorelbine|vinorelbine|mesh-list
44665271|NCT01220284|Satraplatin|satraplatin|mesh-list
44665272|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665273|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665274|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665275|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665276|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665277|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665278|NCT01220362|Fentanyl|fentanyl|mesh-list
44665279|NCT01220362|Bupivacaine|bupivacaine|mesh-list
44665280|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
44665281|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
44665282|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665283|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665284|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
44665285|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665286|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44665287|NCT01220362|Narcotics|narcotics|mesh-ancestor
44665288|NCT01220362|Analgesics|analgesics|mesh-ancestor
44665289|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44665290|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44665291|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
44665292|NCT01220375|Plerixafor|plerixafor|mesh-list
44665293|NCT01220375|Vinorelbine|vinorelbine|mesh-list
44665294|NCT01220375|Lenograstim|lenograstim|mesh-list
44665295|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44665296|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
44665297|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665298|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665299|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665300|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665301|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665302|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665303|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665304|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44665305|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44665306|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
44665307|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665308|NCT01220440|Methylphenidate|methylphenidate|mesh-list
44665309|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
44059956|NCT00005940|Iodine|iodine|mesh-list
44665310|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44665311|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665312|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44665313|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44665314|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665315|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665317|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665318|NCT01220518|Infliximab|infliximab|mesh-list
44665319|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
44665320|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665321|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665323|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44665324|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665325|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665326|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44665327|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665328|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
44665329|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665330|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
44665331|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665332|NCT01220596|Interferons|interferons|mesh-list
44665333|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44665334|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
44665335|NCT01220596|Entecavir|entecavir|mesh-list
44665336|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665337|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
44665338|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665339|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
44665340|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665341|NCT01220622|Nimodipine|nimodipine|mesh-list
44665342|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44665343|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44665344|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665345|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665346|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44665347|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665348|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665349|NCT01220648|Interferons|interferons|mesh-list
44665350|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
44665351|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665352|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
44665353|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665354|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
44665355|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665356|NCT01220661|Cefotetan|cefotetan|mesh-list
44665357|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665358|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665359|NCT01220791|Progesterone|progesterone|mesh-list
44665360|NCT01220791|Progestins|progestins|mesh-ancestor
44665361|NCT01220791|Hormones|hormones|mesh-ancestor
44665362|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665363|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665364|NCT01220843|Sevelamer|sevelamer|mesh-list
44665365|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
44665366|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
44665367|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665368|NCT01221025|Parecoxib|parecoxib|mesh-list
44665369|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44665370|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44665371|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665372|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665373|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44665374|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665375|NCT01221025|Analgesics|analgesics|mesh-ancestor
44665376|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
44665377|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665378|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665379|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665380|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665381|NCT01221103|Dexamethasone|dexamethasone|mesh-list
44665382|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44665383|NCT01221103|Ofatumumab|ofatumumab|mesh-list
44665384|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44665385|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665386|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
44665387|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
44665388|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665389|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665390|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665391|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
44665392|NCT01221103|Hormones|hormones|mesh-ancestor
44665393|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665394|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44665395|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665396|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44665397|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
44665398|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665399|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
44665400|NCT01221116|Simendan|simendan|mesh-list
44665401|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44665402|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665403|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44665404|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44665405|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665406|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665407|NCT01221116|Protective Agents|protective agents|mesh-ancestor
43930889|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43930901|NCT00716742|Travoprost|travoprost|mesh-list
44665408|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665409|NCT01221129|Zinc|zinc|mesh-list
44665410|NCT01221129|Trace Elements|trace elements|mesh-ancestor
44665411|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
44665412|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665413|NCT01221337|Heparin|heparin|mesh-list
44665414|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
44665415|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44665416|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44665417|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665418|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
44665419|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665420|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44665421|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665422|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665423|NCT01221402|Niacin|niacin|mesh-list
44665424|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44665425|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
44665426|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665427|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44665428|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665429|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665430|NCT01221402|Vitamins|vitamins|mesh-ancestor
44665431|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
43930919|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665432|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665433|NCT01221558|Lycopene|lycopene|mesh-list
44665434|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665435|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
44665436|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665437|NCT01221558|Protective Agents|protective agents|mesh-ancestor
44665438|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665439|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44665440|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44665441|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665442|NCT01221636|Abatacept|abatacept|mesh-list
44665443|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44665444|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665445|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665446|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665447|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
44665448|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665449|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665450|NCT01221675|Antibodies|antibodies|mesh-list
44665451|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
44665452|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665453|NCT01221740|Milnacipran|milnacipran|mesh-list
44665454|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
44665455|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44665456|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44665457|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665458|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665459|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665460|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665461|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665462|NCT01221740|Analgesics|analgesics|mesh-ancestor
44665463|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
44665464|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665465|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
44665466|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665467|NCT01221792|Carvedilol|carvedilol|mesh-list
44665468|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44665469|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44665470|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
44665471|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665472|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665473|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665474|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44665475|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
44665476|NCT01221792|Protective Agents|protective agents|mesh-ancestor
44665477|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44665478|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665479|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44665480|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
44665481|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44665482|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44665483|NCT01221831|Dienogest|dienogest|mesh-list
44665484|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44665485|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44665486|NCT01221831|Estradiol|estradiol|mesh-list
44665487|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44665488|NCT01221831|Estrogens|estrogens|mesh-ancestor
44665489|NCT01221831|Hormones|hormones|mesh-ancestor
44665490|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665491|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665492|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44665493|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
44665494|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44665495|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44665496|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44665497|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44665498|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44665499|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665500|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44665501|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665502|NCT01221883|Diazepam|diazepam|mesh-list
44665503|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44665504|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
44665505|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
44665506|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
44665507|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665508|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665509|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665510|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44665511|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665512|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44665513|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44665514|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44665515|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665516|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665517|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44665518|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
44665519|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
44665520|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
44665521|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
44665522|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665523|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665524|NCT01221896|Choline|choline|mesh-list
44665525|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
44665526|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44665527|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
44665528|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665529|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665530|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44665531|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
44665532|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
44665533|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44665534|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44665535|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665537|NCT01221909|Coagulants|coagulants|mesh-ancestor
44665538|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44665539|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
44665540|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44665541|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44665542|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665543|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665544|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665545|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
44665546|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665547|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
44665548|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665549|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44665550|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665551|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665552|NCT01222026|Vitamin D|vitamin d|mesh-list
44665553|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
44665554|NCT01222026|Vitamins|vitamins|mesh-ancestor
44665555|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
44665556|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665557|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44665558|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
44665559|NCT01222052|Docetaxel|docetaxel|mesh-list
44665560|NCT01222052|Fluorouracil|fluorouracil|mesh-list
44665561|NCT01222052|Epirubicin|epirubicin|mesh-list
44665562|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665563|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
44665564|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665565|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665566|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44665567|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
44665568|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665569|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665570|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44665571|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665572|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665573|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665574|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
44665575|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44665576|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44665577|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44665578|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44665579|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665580|NCT01222169|Propofol|propofol|mesh-list
44665581|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44665582|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665583|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931065|NCT00720629|Tacrolimus|tacrolimus|mesh-list
44665584|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44665585|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
44665586|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
44665587|NCT01222182|Atorvastatin|atorvastatin|mesh-list
44665588|NCT01222182|Simvastatin|simvastatin|mesh-list
44665589|NCT01222182|Pravastatin|pravastatin|mesh-list
44665590|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44665591|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44665592|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
44665593|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665594|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44665595|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44665596|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665597|NCT01222221|Temozolomide|temozolomide|mesh-list
44665598|NCT01222221|Sargramostim|sargramostim|mesh-list
44665599|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44665600|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
44665601|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665602|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665603|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
44665604|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665605|NCT01222312|Cisplatin|cisplatin|mesh-list
44665606|NCT01222312|Docetaxel|docetaxel|mesh-list
44665607|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
44665608|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665609|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665610|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665611|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665612|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665613|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
44665614|NCT01222442|AZD-3199|azd-3199|mesh-list
44665615|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665616|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665617|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44215910|NCT00465257|Artesunate|artesunate|mesh-list
44665618|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43931100|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665619|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665620|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665621|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665622|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665623|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44665624|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44665625|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44665626|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44665627|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665628|NCT01222468|Nabilone|nabilone|mesh-list
44665629|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
44665630|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
44665631|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665632|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665633|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44665634|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44665635|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665636|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665637|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665638|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
44665639|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44665640|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44665641|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
44665642|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665643|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665644|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44665645|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44665646|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
44665647|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665648|NCT01222650|Silodosin|silodosin|mesh-list
44665649|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44665650|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44665651|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44665652|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
44665653|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665654|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665655|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665656|NCT01222650|Urological Agents|urological agents|mesh-ancestor
44665657|NCT01222676|Gemcitabine|gemcitabine|mesh-list
44665658|NCT01222676|Cisplatin|cisplatin|mesh-list
44665659|NCT01222676|Sorafenib|sorafenib|mesh-list
44665660|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44665661|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665662|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44665663|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
44665664|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665665|NCT01222676|Antiviral Agents|antiviral agents|mesh-ancestor
44665666|NCT01222676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665667|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665668|NCT01222676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665669|NCT01222676|Immunologic Factors|immunologic factors|mesh-ancestor
44665670|NCT01222676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665671|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44665672|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44665673|NCT01222780|Vincristine|vincristine|mesh-list
44665674|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665675|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665676|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665677|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665678|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665679|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665680|NCT01222819|Lenograstim|lenograstim|mesh-list
44665681|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44665682|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
44665683|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665684|NCT01222897|Valacyclovir|valacyclovir|mesh-list
44665686|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665687|NCT01222910|Valacyclovir|valacyclovir|mesh-list
44665688|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
44665689|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665690|NCT01222923|Risperidone|risperidone|mesh-list
44665691|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44665692|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
44665693|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665694|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665695|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665696|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44665697|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665698|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665699|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665700|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44665701|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
44665702|NCT01222936|Panobinostat|panobinostat|mesh-list
44665703|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665704|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44665705|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665706|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665707|NCT01222975|Risperidone|risperidone|mesh-list
44665708|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44665709|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
44665710|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665711|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665712|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665713|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44665714|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665715|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665716|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665717|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44665718|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
44665719|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44665720|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
44665721|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44665722|NCT01223053|Ketoprofen|ketoprofen|mesh-list
44665723|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44665724|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665725|NCT01223053|Analgesics|analgesics|mesh-ancestor
44665726|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
44665727|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665728|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665729|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665730|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665731|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44665732|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665733|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665734|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44665735|NCT01223079|Hormones|hormones|mesh-ancestor
44665736|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665737|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665738|NCT01223131|Insulin|insulin|mesh-list
44665739|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44665740|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
44665741|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
44665742|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
44665743|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
44665744|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665745|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665746|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
44665747|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44665748|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
44665749|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665750|NCT01223326|Expectorants|expectorants|mesh-ancestor
44665751|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
44665752|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44665753|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
44665754|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665755|NCT01223326|Protective Agents|protective agents|mesh-ancestor
44665756|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665757|NCT01223326|Antidotes|antidotes|mesh-ancestor
44665758|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
44665759|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44665760|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665761|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665762|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665763|NCT01223443|Paclitaxel|paclitaxel|mesh-list
44665764|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665765|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665766|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665767|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665768|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665769|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665770|NCT01223534|Isoniazid|isoniazid|mesh-list
44665771|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
44665772|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665773|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665774|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44665775|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44665776|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
44665777|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665778|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44665779|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
44665780|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665781|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665782|NCT01223612|Ranibizumab|ranibizumab|mesh-list
44665783|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44665784|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44665785|NCT01223612|Growth Substances|growth substances|mesh-ancestor
44140354|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
44665786|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665787|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
44665788|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665789|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44665790|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44665791|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44665792|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
44665793|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665794|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44665795|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44665796|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665797|NCT01223690|Clarithromycin|clarithromycin|mesh-list
44665798|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665799|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665800|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44665801|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665802|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665803|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44665804|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44665805|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
44665806|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665807|NCT01223729|Vitamins|vitamins|mesh-ancestor
44665808|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
44665809|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665810|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
44665811|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
44665812|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665813|NCT01223742|Vitamins|vitamins|mesh-ancestor
44665814|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
44665815|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665816|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
44665817|NCT01223755|Sirolimus|sirolimus|mesh-list
44665818|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44665819|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665820|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44665821|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665822|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
44665823|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665824|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
44665825|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665826|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
44665827|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665828|NCT01223768|Vitamins|vitamins|mesh-ancestor
43931292|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43931293|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
44665829|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
44665830|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665831|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
44665832|NCT01223820|Capsaicin|capsaicin|mesh-list
44665833|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
44665834|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
44665835|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
44665836|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665837|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665838|NCT01224028|Tacrolimus|tacrolimus|mesh-list
44665839|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665840|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
44665841|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665842|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44665843|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665844|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665845|NCT01224041|Tacrolimus|tacrolimus|mesh-list
44665846|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665847|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
44665848|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665849|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44665850|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665851|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665852|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44665853|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
44665854|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44665855|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44665856|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44665857|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665858|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665859|NCT01224093|Rituximab|rituximab|mesh-list
44665860|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44665861|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665862|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
44665863|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665864|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665865|NCT01224197|Simeprevir|simeprevir|mesh-list
43931301|NCT00725361|Ambrisentan|ambrisentan|mesh-list
44665866|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
44665867|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44665868|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
44665869|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665870|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665871|NCT01224301|Vaccines|vaccines|mesh-list
44665872|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
44665873|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665874|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
44665875|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44665876|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
44665877|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
44665878|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665879|NCT01224353|Protective Agents|protective agents|mesh-ancestor
44665880|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665881|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
44665882|NCT01224353|Vitamins|vitamins|mesh-ancestor
44665883|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
44665884|NCT01224366|Vildagliptin|vildagliptin|mesh-list
44665885|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44665886|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665887|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44665888|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44665889|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665890|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665891|NCT01224392|Capecitabine|capecitabine|mesh-list
44665892|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44665893|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
44665894|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665895|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665896|NCT01224405|Docetaxel|docetaxel|mesh-list
44665897|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665898|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665899|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665900|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665901|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665902|NCT01224418|Tacrolimus|tacrolimus|mesh-list
44665903|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44665904|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
44665905|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665906|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44665907|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665908|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665910|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
44665911|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44665912|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665913|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665914|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44665915|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44665916|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665917|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665918|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
44665919|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
44665920|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44665921|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44665922|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44665923|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
44665924|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44665925|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665926|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665927|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665928|NCT01224470|Analgesics|analgesics|mesh-ancestor
44665929|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
44665930|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665931|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44665932|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44665933|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44665934|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
44665935|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44665936|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665937|NCT01224509|Mifepristone|mifepristone|mesh-list
44665938|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44665939|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
44665940|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44665941|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665942|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44665943|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44665944|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44665945|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
44665946|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44665947|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44665948|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
44665949|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44665950|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
44665951|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44665952|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44665953|NCT01224535|Micronutrients|micronutrients|mesh-list
44665954|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665955|NCT01224613|Vaccines|vaccines|mesh-list
44665956|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
44665957|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665958|NCT01224652|Paclitaxel|paclitaxel|mesh-list
44665959|NCT01224652|Irinotecan|irinotecan|mesh-list
44665960|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44665961|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665962|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
44665963|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
44665964|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
44665965|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665966|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44665967|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44665968|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44665969|NCT01224717|Teriparatide|teriparatide|mesh-list
44665970|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44665971|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665972|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44665973|NCT01224756|Tinoridine|tinoridine|mesh-list
44665974|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44665975|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44665976|NCT01224756|Analgesics|analgesics|mesh-ancestor
44665977|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
44665978|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44665979|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665980|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44665981|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665983|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44665984|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44665985|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44665986|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
44665987|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665988|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44665989|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44665990|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
44665991|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44665992|NCT01224847|Lidocaine|lidocaine|mesh-list
44665993|NCT01224847|Cocaine|cocaine|mesh-list
44665994|NCT01224847|Tetracaine|tetracaine|mesh-list
44665995|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44665996|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
44665997|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44665998|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44665999|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
44666000|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666001|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44666002|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44666003|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44666004|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666005|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666006|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44666007|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44666008|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44666009|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
44666010|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666011|NCT01224860|Losartan|losartan|mesh-list
44666012|NCT01224860|Telmisartan|telmisartan|mesh-list
44666013|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44666014|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44666015|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44666016|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44666017|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666018|NCT01224951|Beclomethasone|beclomethasone|mesh-list
44666019|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666020|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
44666022|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666023|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666024|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44666025|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
44666026|NCT01224964|Montelukast|montelukast|mesh-list
44666027|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44666028|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
44666029|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44666030|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
44666031|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666032|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666033|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44666034|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44666035|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666036|NCT01224977|Azithromycin|azithromycin|mesh-list
44666037|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666038|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666039|NCT01225081|Pioglitazone|pioglitazone|mesh-list
44666040|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
44666041|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44666042|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666043|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44666044|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666045|NCT01225094|Curcumin|curcumin|mesh-list
44666046|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666047|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666048|NCT01225094|Analgesics|analgesics|mesh-ancestor
44666049|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
44666050|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666051|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666052|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666053|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666054|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666055|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666056|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666057|NCT01225198|Vitamins|vitamins|mesh-list
44666058|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
44666059|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666060|NCT01225224|Peficitinib|peficitinib|mesh-list
44666061|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666062|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666063|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666064|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
44666065|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666066|NCT01225237|Ramosetron|ramosetron|mesh-list
43931535|NCT00731198|Drotaverin|drotaverin|mesh-list
44666067|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
44666068|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
44666069|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666070|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666071|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44666072|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44666073|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
44666074|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666075|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666076|NCT01225302|Paclitaxel|paclitaxel|mesh-list
44666077|NCT01225302|Carboplatin|carboplatin|mesh-list
44666078|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666079|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666080|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666081|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666082|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666083|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666084|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44666085|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44666086|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44666087|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666088|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666089|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44666090|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666091|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666092|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
44666093|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666094|NCT01225406|Tenofovir|tenofovir|mesh-list
44666095|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
44666096|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666097|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44666098|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44666099|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666100|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666101|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44666102|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44666103|NCT01225419|Plerixafor|plerixafor|mesh-list
44666104|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44666105|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44666106|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
44666107|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666108|NCT01225445|Ramipril|ramipril|mesh-list
44666109|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44666110|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
44666111|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666112|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666113|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44666114|NCT01225484|Ropivacaine|ropivacaine|mesh-list
44666115|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
44666116|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
44666117|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666118|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666119|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
44666120|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666121|NCT01225523|Paclitaxel|paclitaxel|mesh-list
44666122|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44666124|NCT01225523|Fluorouracil|fluorouracil|mesh-list
44666125|NCT01225523|Capecitabine|capecitabine|mesh-list
44666126|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666127|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666128|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666129|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666130|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666131|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666132|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
44666133|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666134|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666135|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
44666136|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666138|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44666139|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44666140|NCT01225705|Ritonavir|ritonavir|mesh-list
44666141|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44666142|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
44666143|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44666144|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44666145|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
44666146|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666147|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666148|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44666149|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44666150|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
44666151|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666152|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44666153|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44666154|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44666155|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44666156|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
44666157|NCT01225744|Irinotecan|irinotecan|mesh-list
44666158|NCT01225744|Cetuximab|cetuximab|mesh-list
44666159|NCT01225744|Tegafur|tegafur|mesh-list
44666160|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666161|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44666162|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666163|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666164|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666165|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666166|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666167|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
44666168|NCT01225874|Cytarabine|cytarabine|mesh-list
44666169|NCT01225874|Dexamethasone|dexamethasone|mesh-list
44666170|NCT01225874|Prednisone|prednisone|mesh-list
44666171|NCT01225874|Methotrexate|methotrexate|mesh-list
44666172|NCT01225874|Vincristine|vincristine|mesh-list
44666173|NCT01225874|Daunorubicin|daunorubicin|mesh-list
44666174|NCT01225874|Asparaginase|asparaginase|mesh-list
44666175|NCT01225874|Pegaspargase|pegaspargase|mesh-list
44666176|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666177|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
44666178|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
44666179|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666180|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666181|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44666182|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
44666183|NCT01225874|Hormones|hormones|mesh-ancestor
44666184|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666185|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44666186|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666187|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44666188|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
44666189|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666190|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666191|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
44666192|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666193|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666194|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666195|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44666196|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666197|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
44235929|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
44666199|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44666200|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
44666201|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666202|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666203|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666204|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666205|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666206|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44666207|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44666208|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666209|NCT01225913|Fluticasone|fluticasone|mesh-list
44216487|NCT00468520|Oxytocin|oxytocin|mesh-list
44666210|NCT01225913|Xhance|xhance|mesh-list
44666211|NCT01225913|Budesonide|budesonide|mesh-list
44666212|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
44666213|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44666214|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44666215|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44666216|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666217|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44666218|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
44666219|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666220|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666221|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44666222|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
44666223|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666224|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44666225|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
44666226|NCT01225913|Hormones|hormones|mesh-ancestor
44666227|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666228|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44666229|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44666230|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44666231|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44666232|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666233|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666234|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
44666235|NCT01226017|Oxytocin|oxytocin|mesh-list
44666236|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
44666237|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666238|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666239|NCT01226056|Everolimus|everolimus|mesh-list
44666240|NCT01226056|Sorafenib|sorafenib|mesh-list
44666241|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666242|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666243|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
44666244|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666245|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666246|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666247|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666248|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
44666249|NCT01226069|Glycerol|glycerol|mesh-list
44666250|NCT01226069|Analgesics|analgesics|mesh-ancestor
44666251|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
44666252|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666253|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666254|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
44666255|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666256|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44666257|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
44666258|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44666259|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666260|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666261|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44666262|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
44666263|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666264|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44666265|NCT01226069|Protective Agents|protective agents|mesh-ancestor
44666266|NCT01226186|Morphine|morphine|mesh-list
44666267|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44666268|NCT01226186|Narcotics|narcotics|mesh-ancestor
44666269|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666270|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666271|NCT01226186|Analgesics|analgesics|mesh-ancestor
44666272|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
44666273|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666274|NCT01226212|Sulfalene|sulfalene|mesh-list
44666275|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666276|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44666277|NCT01226212|Renal Agents|renal agents|mesh-ancestor
44666278|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
44666279|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44666280|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44666281|NCT01226303|Tretinoin|tretinoin|mesh-list
44666282|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666283|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
44666284|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666285|NCT01226355|Sirolimus|sirolimus|mesh-list
44666286|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666287|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666288|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44666289|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666290|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
44666291|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666292|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
44666293|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666294|NCT01226446|Vitamin D|vitamin d|mesh-list
44666295|NCT01226446|Vitamins|vitamins|mesh-ancestor
44666296|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
44666297|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666298|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44666299|NCT01226602|Ticagrelor|ticagrelor|mesh-list
44666300|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44666301|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44666302|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44666303|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44666304|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
44666305|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666306|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666307|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666308|NCT01226667|Pregabalin|pregabalin|mesh-list
44666309|NCT01226667|Analgesics|analgesics|mesh-ancestor
44666310|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
44666311|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666312|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666313|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
44666314|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44666315|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666316|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666317|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44666318|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44666319|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44666320|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666321|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44666322|NCT01226680|Tofacitinib|tofacitinib|mesh-list
44666323|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666324|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931741|NCT00735826|Vorinostat|vorinostat|mesh-list
44666325|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666326|NCT01226771|Ribavirin|ribavirin|mesh-list
44666327|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
44666328|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666329|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
44666330|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666331|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44666332|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44666333|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44666334|NCT01226849|Rituximab|rituximab|mesh-list
44666335|NCT01226849|Carboplatin|carboplatin|mesh-list
44666336|NCT01226849|Etoposide|etoposide|mesh-list
44666337|NCT01226849|Bortezomib|bortezomib|mesh-list
44666338|NCT01226849|Ifosfamide|ifosfamide|mesh-list
44666339|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666340|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666341|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
44666342|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666343|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666344|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666345|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43784336|NCT03435939|Losartan|losartan|mesh-list
44666346|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666347|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666348|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666349|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44666350|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
44666351|NCT01226901|Niraparib|niraparib|mesh-list
44666352|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44666353|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666354|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666355|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666356|NCT01226966|Liraglutide|liraglutide|mesh-list
44666357|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43931786|NCT00737178|Copper|copper|mesh-list
44666358|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666359|NCT01226966|Incretins|incretins|mesh-ancestor
44666360|NCT01226966|Hormones|hormones|mesh-ancestor
44666361|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666362|NCT01226992|Vancomycin|vancomycin|mesh-list
44666363|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666364|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666365|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
44666366|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
44666367|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666368|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666369|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666370|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666371|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
44666372|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44666373|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44666374|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666375|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666376|NCT01227148|Insulin|insulin|mesh-list
44666377|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44666378|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666379|NCT01227174|Propofol|propofol|mesh-list
44666380|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44666381|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666382|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666383|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44666384|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
44666385|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
44666386|NCT01227200|Tramadol|tramadol|mesh-list
44666387|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44666388|NCT01227200|Narcotics|narcotics|mesh-ancestor
44666389|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666390|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666391|NCT01227200|Analgesics|analgesics|mesh-ancestor
44666392|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
44666393|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666394|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
44666395|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44666396|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44666397|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
44666398|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666399|NCT01227356|Interferons|interferons|mesh-list
44666400|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
44666401|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140359|NCT00179023|Ephedrine|ephedrine|mesh-list
44666402|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
44666403|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666404|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666405|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666406|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666407|NCT01227408|Paclitaxel|paclitaxel|mesh-list
44666408|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
44666409|NCT01227408|Doxorubicin|doxorubicin|mesh-list
44666410|NCT01227408|Capecitabine|capecitabine|mesh-list
44666411|NCT01227408|Methotrexate|methotrexate|mesh-list
44666412|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44666413|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666414|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666415|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666416|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666417|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666418|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666419|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666420|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
44666421|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666422|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666423|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44666424|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
44666425|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44666426|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44666427|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44666428|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666429|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666430|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666431|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
44666432|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44666433|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
44666434|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666435|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666436|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43931858|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
44666437|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44666438|NCT01227590|Ritonavir|ritonavir|mesh-list
44666439|NCT01227590|Lopinavir|lopinavir|mesh-list
44666440|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44666441|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44666442|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44666443|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666444|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666445|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44666446|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44666447|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
44666448|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666449|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44666450|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44666451|NCT01227603|Candesartan|candesartan|mesh-list
44666452|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
44666453|NCT01227603|Nifedipine|nifedipine|mesh-list
44666454|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44666455|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44666456|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44666457|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666458|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44666459|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666460|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44666461|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666462|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
44666463|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
44666464|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666465|NCT01227720|Nicotine|nicotine|mesh-list
44666466|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44666467|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
44666468|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666469|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666470|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44666471|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44666472|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
44666473|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666474|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666475|NCT01227759|Tyrothricin|tyrothricin|mesh-list
44666476|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44666477|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666478|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666479|NCT01227798|Interferons|interferons|mesh-list
44666480|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
44666481|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666482|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
44666483|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666484|NCT01227811|Darifenacin|darifenacin|mesh-list
44666485|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44666486|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
44666487|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44666488|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666489|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666490|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666491|NCT01227811|Urological Agents|urological agents|mesh-ancestor
44666492|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
44666493|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666494|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235933|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44666495|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44666496|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666497|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666498|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666499|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
44666500|NCT01227915|Hormones|hormones|mesh-ancestor
44666501|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666502|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666503|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44666504|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43931932|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
44666505|NCT01227941|Doxorubicin|doxorubicin|mesh-list
44666506|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44666507|NCT01227941|Niraparib|niraparib|mesh-list
44666508|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44666509|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666510|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44666511|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666512|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666513|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666514|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44666515|NCT01228045|Cisplatin|cisplatin|mesh-list
44666516|NCT01228045|Trastuzumab|trastuzumab|mesh-list
44666517|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666518|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666519|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
44666520|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666521|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
44666522|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44666523|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44666524|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666525|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
44666526|NCT01228136|Coagulants|coagulants|mesh-ancestor
44666527|NCT01228214|Aspirin|aspirin|mesh-list
44666528|NCT01228214|Amiloride|amiloride|mesh-list
44666529|NCT01228214|Clopidogrel|clopidogrel|mesh-list
44666530|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666531|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666532|NCT01228214|Analgesics|analgesics|mesh-ancestor
44666533|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
44666534|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666535|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666536|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666537|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666538|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44666539|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44666540|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666541|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44666542|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44666543|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666544|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
44666545|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44666546|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44666547|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44666548|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
44666549|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666550|NCT01228214|Diuretics|diuretics|mesh-ancestor
44666551|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
44666552|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44666553|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44666554|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666555|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44666556|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44666558|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44666559|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44666560|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44666561|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
44666562|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666563|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44666564|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44666565|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666566|NCT01228240|Metformin|metformin|mesh-list
44666567|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44666568|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666569|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44666570|NCT01228279|Icodextrin|icodextrin|mesh-list
44666571|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
44666572|NCT01228292|Heparin|heparin|mesh-list
44666573|NCT01228292|Calcium heparin|calcium heparin|mesh-list
44666574|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
44666575|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44666576|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44666577|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666578|NCT01228305|Acetaminophen|acetaminophen|mesh-list
44666579|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666580|NCT01228305|Analgesics|analgesics|mesh-ancestor
44666581|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
44666582|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666583|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666584|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
44666585|NCT01228344|Lumefantrine|lumefantrine|mesh-list
44666586|NCT01228344|Artemether|artemether|mesh-list
44666587|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44666588|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
44666589|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44666590|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44666591|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666592|NCT01228357|Milnacipran|milnacipran|mesh-list
44666593|NCT01228357|Mirtazapine|mirtazapine|mesh-list
44666594|NCT01228357|Sertraline|sertraline|mesh-list
44666595|NCT01228357|Fluoxetine|fluoxetine|mesh-list
44666596|NCT01228357|Paroxetine|paroxetine|mesh-list
44666597|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44666598|NCT01228357|Nortriptyline|nortriptyline|mesh-list
44666599|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
44666600|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44666601|NCT01228357|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44666602|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44666603|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666604|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666605|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666606|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
44666607|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666608|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44666609|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44666610|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44666611|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666612|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44666613|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44666614|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
44666615|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
43932008|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
44666616|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44666617|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44666618|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666619|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44666620|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44666621|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44666622|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44666623|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44666624|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44666625|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44666626|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666627|NCT01228357|Analgesics|analgesics|mesh-ancestor
44666628|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
44666629|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666630|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44666631|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44666632|NCT01228370|Silodosin|silodosin|mesh-list
44666633|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44666634|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44666635|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44666636|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
44666637|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666638|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666639|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666640|NCT01228370|Urological Agents|urological agents|mesh-ancestor
44666641|NCT01228409|Acitretin|acitretin|mesh-list
44666642|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
44666643|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666644|NCT01228422|Interferons|interferons|mesh-list
44666646|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
44666647|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666648|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
44666649|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666650|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
44666651|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666652|NCT01228552|Ketoprofen|ketoprofen|mesh-list
44666653|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666654|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666655|NCT01228552|Analgesics|analgesics|mesh-ancestor
44666656|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
44666657|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666658|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932105|NCT00744965|Glyburide|glyburide|mesh-list
44666659|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666660|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666661|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44666662|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666663|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666664|NCT01228565|Cetuximab|cetuximab|mesh-list
44666665|NCT01228565|OTD70DERM|otd70derm|mesh-list
44666666|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666667|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666668|NCT01228565|Protective Agents|protective agents|mesh-ancestor
44666669|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666670|NCT01228604|Methylphenidate|methylphenidate|mesh-list
44666671|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44666672|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666673|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44666674|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44666675|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44666676|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666677|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
44666678|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666679|NCT01228617|Nicotine|nicotine|mesh-list
44666680|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44666681|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
44666682|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666683|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666684|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44666685|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44666686|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
44666687|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666688|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666689|NCT01228630|Loratadine|loratadine|mesh-list
44666690|NCT01228630|Fexofenadine|fexofenadine|mesh-list
44666691|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
44666692|NCT01228630|Ephedrine|ephedrine|mesh-list
44666693|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
44666694|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666695|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44666696|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44666697|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44666698|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
44666699|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
44666700|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666701|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666702|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666703|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44666704|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
44666705|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666706|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44666707|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
44666708|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
44666709|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44666710|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44666712|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
44666713|NCT01228682|Tolvaptan|tolvaptan|mesh-list
44666714|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44666715|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666716|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
44666717|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666718|NCT01228994|Baclofen|baclofen|mesh-list
44150304|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
44666720|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666721|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44666722|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666723|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44666724|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
44666725|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
44666726|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666727|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666728|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
44666729|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
44666730|NCT01229046|Ticarcillin|ticarcillin|mesh-list
44666731|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44666732|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666733|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666734|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666735|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666736|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44666737|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
44666738|NCT01229085|Salicylates|salicylates|mesh-list
44666739|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932156|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
44666740|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
44666741|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
44666742|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666743|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666744|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666745|NCT01229085|Analgesics|analgesics|mesh-ancestor
44666746|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
44666747|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666748|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666749|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666750|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666751|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44666752|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666753|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666754|NCT01229189|Vitamin D|vitamin d|mesh-list
44666755|NCT01229189|Vitamins|vitamins|mesh-ancestor
44666756|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
44666757|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666758|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44666759|NCT01229202|Bevacizumab|bevacizumab|mesh-list
44666760|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666761|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666762|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44666763|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44666764|NCT01229202|Growth Substances|growth substances|mesh-ancestor
44666765|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666766|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
44666767|NCT01229241|Anesthetics|anesthetics|mesh-list
44666768|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
44666769|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666770|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666771|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
44666772|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666773|NCT01229280|Darifenacin|darifenacin|mesh-list
44666774|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44666775|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
44666776|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44666777|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666778|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666779|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666780|NCT01229280|Urological Agents|urological agents|mesh-ancestor
44666781|NCT01229319|Imiquimod|imiquimod|mesh-list
44666782|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44666783|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
44666784|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666785|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666786|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
44666788|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44666789|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44666790|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
44666791|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666792|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666793|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666794|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44666795|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666796|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
44666797|NCT01229579|Astringents|astringents|mesh-ancestor
44666798|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666799|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666800|NCT01229592|Ethanol|ethanol|mesh-list
44666801|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44666802|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666803|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44666804|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666805|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
44666806|NCT01229605|Docetaxel|docetaxel|mesh-list
44666807|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666808|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
44666809|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666810|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666811|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44666812|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
44666813|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666814|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666815|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44666816|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666817|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666818|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666819|NCT01229761|Trimethoprim|trimethoprim|mesh-list
44666820|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44666821|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
44666822|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44666823|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666824|NCT01229761|Renal Agents|renal agents|mesh-ancestor
44666825|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
44666826|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43932242|NCT00750815|Bortezomib|bortezomib|mesh-list
44666827|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44666828|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44666829|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666830|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666831|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44666832|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44666833|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44666834|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44666835|NCT01229774|Diclofenac|diclofenac|mesh-list
44666836|NCT01229774|Etoricoxib|etoricoxib|mesh-list
44666837|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666838|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666839|NCT01229774|Analgesics|analgesics|mesh-ancestor
44666840|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
44666841|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666842|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666843|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666844|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666845|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44666846|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666847|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666848|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44666849|NCT01229813|Bevacizumab|bevacizumab|mesh-list
44666850|NCT01229813|Capecitabine|capecitabine|mesh-list
44666851|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44666852|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666853|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666854|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44666855|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44666856|NCT01229813|Growth Substances|growth substances|mesh-ancestor
44666857|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666858|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44217238|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44666859|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666860|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
44666861|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666862|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666863|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666864|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
44666865|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
44666866|NCT01229930|Paclitaxel|paclitaxel|mesh-list
44666867|NCT01229930|Carboplatin|carboplatin|mesh-list
44666868|NCT01229930|Cediranib|cediranib|mesh-list
44666869|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666870|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666871|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666872|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666873|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666874|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666875|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666876|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666877|NCT01230034|Ramipril|ramipril|mesh-list
44666878|NCT01230034|Imidapril|imidapril|mesh-list
44666879|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44666880|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
44666881|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666882|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666883|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44666884|NCT01230359|Pyridoxine|pyridoxine|mesh-list
44666885|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
44666886|NCT01230359|Vitamins|vitamins|mesh-ancestor
44666887|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
44666888|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666889|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
44666890|NCT01230463|Ketorolac|ketorolac|mesh-list
44666891|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44666892|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44666893|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44666894|NCT01230463|Analgesics|analgesics|mesh-ancestor
44666895|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
44666896|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44666897|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666898|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666899|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666900|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44666901|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666902|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666903|NCT01230476|Cetuximab|cetuximab|mesh-list
44666904|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44666905|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666906|NCT01230541|Udenafil|udenafil|mesh-list
44666907|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44666908|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44666909|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666910|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666911|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44666912|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44666913|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
44666914|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
44666915|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666916|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666917|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666918|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44666919|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44666920|NCT01230697|Sorafenib|sorafenib|mesh-list
44666921|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666922|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44666923|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666924|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666925|NCT01230723|Everolimus|everolimus|mesh-list
44666926|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666927|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666928|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
44666929|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666930|NCT01230736|Timolol|timolol|mesh-list
44666931|NCT01230736|Travoprost|travoprost|mesh-list
44666932|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44666933|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44666934|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44666935|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44666936|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
44666937|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44666938|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666939|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666940|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44666941|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44666942|NCT01230775|Anagrelide|anagrelide|mesh-list
44666943|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44666944|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44666945|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666946|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44666948|NCT01230983|Cytarabine|cytarabine|mesh-list
44666949|NCT01230983|Prednisone|prednisone|mesh-list
44666950|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
44666951|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44666952|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44666953|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44666954|NCT01230983|Doxorubicin|doxorubicin|mesh-list
44666955|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44666956|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
44666957|NCT01230983|Methotrexate|methotrexate|mesh-list
44666958|NCT01230983|Vincristine|vincristine|mesh-list
44666959|NCT01230983|Asparaginase|asparaginase|mesh-list
44666960|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
44666961|NCT01230983|Razoxane|razoxane|mesh-list
44666962|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
44666963|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44666964|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44666965|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44666966|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44666967|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44666968|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44666969|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44666970|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44666971|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
44666972|NCT01230983|Hormones|hormones|mesh-ancestor
44666973|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44666974|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44666975|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44666976|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
44666977|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44666978|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44666979|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
44666980|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44666981|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44666982|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44666983|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
44666984|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44666985|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44666986|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
44666987|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44666988|NCT01230983|Antidotes|antidotes|mesh-ancestor
44666989|NCT01230983|Protective Agents|protective agents|mesh-ancestor
44666990|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
44666991|NCT01230983|Vitamins|vitamins|mesh-ancestor
44666992|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
44666993|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44666994|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44666995|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44666996|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44666997|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44666998|NCT01230996|Cisplatin|cisplatin|mesh-list
44666999|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667000|NCT01231074|Metformin|metformin|mesh-list
44667001|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667002|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667003|NCT01231113|Artesunate|artesunate|mesh-list
44667004|NCT01231113|Piperaquine|piperaquine|mesh-list
44667005|NCT01231113|Amodiaquine|amodiaquine|mesh-list
44667006|NCT01231113|Artenimol|artenimol|mesh-list
44667007|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
44667008|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44667009|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44667010|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667011|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667012|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
44667013|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
44667014|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44667015|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
44667016|NCT01231126|Misoprostol|misoprostol|mesh-list
44667017|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44667018|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
43932373|NCT00754845|Letrozole|letrozole|mesh-list
44667019|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44667020|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667021|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44667022|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667023|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
44667024|NCT01231139|Acetaminophen|acetaminophen|mesh-list
44667025|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667026|NCT01231139|Analgesics|analgesics|mesh-ancestor
44667027|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
44667028|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667029|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667030|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
44667031|NCT01231165|Aspirin|aspirin|mesh-list
44667032|NCT01231165|Amiloride|amiloride|mesh-list
44667033|NCT01231165|Clopidogrel|clopidogrel|mesh-list
44667034|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44667035|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44667036|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667037|NCT01231165|Analgesics|analgesics|mesh-ancestor
44667038|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
44667039|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667040|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667041|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667042|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667043|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44667044|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44667045|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667046|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44667047|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44667048|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667049|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
44667050|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44667051|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44667052|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43932403|NCT00755755|Iron|iron|mesh-list
44667053|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
44667054|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667055|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44667056|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44667057|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
44667058|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44667059|NCT01231165|Diuretics|diuretics|mesh-ancestor
44667060|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
44667061|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44667062|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44667063|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667064|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44667065|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44667066|NCT01231191|Acetaminophen|acetaminophen|mesh-list
44667067|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667068|NCT01231191|Analgesics|analgesics|mesh-ancestor
44667069|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
44667070|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667071|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667072|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
44667073|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44667074|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44667075|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667076|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
44667077|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44667078|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667079|NCT01231490|Naproxen|naproxen|mesh-list
44667080|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44667081|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667082|NCT01231490|Analgesics|analgesics|mesh-ancestor
44667083|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
44667084|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667085|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667086|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667087|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667088|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
44667089|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44667090|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667091|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667092|NCT01231529|Dolutegravir|dolutegravir|mesh-list
44667093|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44667095|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667096|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667097|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667098|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667099|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
44667100|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667101|NCT01231542|Rifampin|rifampin|mesh-list
44667102|NCT01231542|Rifabutin|rifabutin|mesh-list
44667103|NCT01231542|Dolutegravir|dolutegravir|mesh-list
44667104|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44667105|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
44217483|NCT00473551|Rituximab|rituximab|mesh-list
44667106|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44667107|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667108|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
44667109|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44667110|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667111|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667112|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44667113|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44667114|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44667115|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44667116|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44667117|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44667118|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44667119|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44667120|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667121|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667122|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
44667123|NCT01231594|Trametinib|trametinib|mesh-list
44667124|NCT01231594|Dabrafenib|dabrafenib|mesh-list
44667125|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
44667126|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44667127|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667128|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667129|NCT01231685|Ritonavir|ritonavir|mesh-list
44667130|NCT01231685|Lopinavir|lopinavir|mesh-list
44667131|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44667132|NCT01231685|Darunavir|darunavir|mesh-list
44667133|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44667134|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
44667135|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
44667136|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44667137|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667138|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667139|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667140|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667141|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
44667142|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667143|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44667144|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44667145|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44667146|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44667147|NCT01231698|Esmolol|esmolol|mesh-list
44667148|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44667149|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44667150|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44667151|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44667152|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667153|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667154|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667155|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
44667156|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44667157|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667158|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44667159|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44667160|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667161|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667162|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667163|NCT01231802|Leucovorin|leucovorin|mesh-list
44667164|NCT01231802|Fluorouracil|fluorouracil|mesh-list
44667165|NCT01231802|Capecitabine|capecitabine|mesh-list
44667166|NCT01231802|Eniluracil|eniluracil|mesh-list
44667167|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
44667168|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667169|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667170|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667171|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667173|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667174|NCT01231802|Antidotes|antidotes|mesh-ancestor
44667175|NCT01231802|Protective Agents|protective agents|mesh-ancestor
44667176|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
44667177|NCT01231802|Vitamins|vitamins|mesh-ancestor
44667178|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
44667179|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667180|NCT01231828|Lactulose|lactulose|mesh-list
44667181|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667182|NCT01231854|Cyclosporine|cyclosporine|mesh-list
44667183|NCT01231854|Alitretinoin|alitretinoin|mesh-list
44667184|NCT01231854|Cyclosporins|cyclosporins|mesh-list
44667185|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667186|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667187|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667188|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
44667189|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667190|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
44667191|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667192|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44667193|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667194|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44667195|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667196|NCT01231880|Piperaquine|piperaquine|mesh-list
44667197|NCT01231880|Artenimol|artenimol|mesh-list
44667198|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
44667199|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44667200|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44667201|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667202|NCT01231997|Udenafil|udenafil|mesh-list
44667203|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44667204|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44667205|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667206|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667207|NCT01232010|Mirodenafil|mirodenafil|mesh-list
44667208|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44667209|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44667210|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667211|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667212|NCT01232023|Indobufen|indobufen|mesh-list
44667213|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44667214|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44667215|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667216|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667217|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44667218|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667219|NCT01232023|Analgesics|analgesics|mesh-ancestor
44667220|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
44667221|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667222|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667223|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667224|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667225|NCT01232036|Metformin|metformin|mesh-list
44667226|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667227|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667228|NCT01232075|Letrozole|letrozole|mesh-list
44667229|NCT01232075|Citric Acid|citric acid|mesh-list
44667230|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
44667231|NCT01232075|Clomiphene|clomiphene|mesh-list
44667232|NCT01232075|Enclomiphene|enclomiphene|mesh-list
44667233|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
44667234|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
44667235|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44667236|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
44667237|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
44667238|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667239|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667240|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44667241|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44667242|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667243|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44667244|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
44667245|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667246|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667247|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44667248|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
44667249|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44667250|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44667251|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44667252|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44667253|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667254|NCT01232244|Glucagon|glucagon|mesh-list
44667255|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44217632|NCT00474591|PENTA|penta|mesh-list
44667256|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667257|NCT01232244|Hormones|hormones|mesh-ancestor
44667258|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667259|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667260|NCT01232244|Incretins|incretins|mesh-ancestor
44667261|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
44667262|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44667263|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
44667264|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667265|NCT01232257|Expectorants|expectorants|mesh-ancestor
44667266|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44667267|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44667268|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
44667269|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667270|NCT01232257|Protective Agents|protective agents|mesh-ancestor
44667271|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667272|NCT01232257|Antidotes|antidotes|mesh-ancestor
44667273|NCT01232270|Propofol|propofol|mesh-list
44667274|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44667275|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667276|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667277|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44667278|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
44667279|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
44667280|NCT01232374|Cisplatin|cisplatin|mesh-list
44667281|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
44667282|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667283|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44667284|NCT01232400|Esmolol|esmolol|mesh-list
44667285|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44667286|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44667287|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44667288|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
44667289|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667290|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667291|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667292|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
44667293|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
44667294|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44667295|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667296|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43932642|NCT00761085|Analgesics|analgesics|mesh-ancestor
44667297|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44667298|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667299|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667300|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667301|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667302|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44667303|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667304|NCT01232439|Aticaprant|aticaprant|mesh-list
44667305|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667306|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
44667307|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667308|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44667309|NCT01232647|Vitamins|vitamins|mesh-list
44667310|NCT01232647|Vitamin K|vitamin k|mesh-list
44667311|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
44667312|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
44667313|NCT01232647|Menatetrenone|menatetrenone|mesh-list
44667314|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
44667315|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667316|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44667317|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44667318|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667319|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
44667320|NCT01232647|Coagulants|coagulants|mesh-ancestor
44667321|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
44667322|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
44667323|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44667324|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44667325|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667326|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667327|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667328|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667329|NCT01232777|Bevacizumab|bevacizumab|mesh-list
44667330|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44217676|NCT00474773|Celecoxib|celecoxib|mesh-list
44667331|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932681|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
44667332|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44667333|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44667334|NCT01232777|Growth Substances|growth substances|mesh-ancestor
44667335|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667336|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
44667337|NCT01232803|Tenofovir|tenofovir|mesh-list
44667338|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
44667339|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667340|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44667341|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44667342|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667343|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667344|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667345|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667346|NCT01233167|Clopidogrel|clopidogrel|mesh-list
44667347|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44667348|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44667349|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44667350|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44667351|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
44667352|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667353|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667354|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667355|NCT01233206|Metformin|metformin|mesh-list
44667356|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667357|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667358|NCT01233219|Morphine|morphine|mesh-list
44667359|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667360|NCT01233219|Narcotics|narcotics|mesh-ancestor
44667361|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667362|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667363|NCT01233219|Analgesics|analgesics|mesh-ancestor
44667364|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
44667365|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667366|NCT01233245|Interferons|interferons|mesh-list
44667367|NCT01233245|Interferon-beta|interferon-beta|mesh-list
44667368|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
44667369|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667370|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
44667371|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667372|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
44667373|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667374|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44667375|NCT01233362|Vaccines|vaccines|mesh-list
44667376|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
44667377|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667378|NCT01233453|Umirolimus|umirolimus|mesh-list
44667379|NCT01233453|Everolimus|everolimus|mesh-list
44667380|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667381|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667382|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
44667383|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667384|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667385|NCT01233492|Mannitol|mannitol|mesh-list
44667386|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44667387|NCT01233492|Diuretics|diuretics|mesh-ancestor
44667388|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
44667389|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667390|NCT01233505|Capecitabine|capecitabine|mesh-list
44667392|NCT01233505|Veliparib|veliparib|mesh-list
44667393|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667394|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
44667395|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667396|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667397|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44667398|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667399|NCT01233570|Tacrolimus|tacrolimus|mesh-list
44667400|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667401|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
43932750|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667402|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667403|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44667404|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667405|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667406|NCT01233583|Adalimumab|adalimumab|mesh-list
44667407|NCT01233583|Etanercept|etanercept|mesh-list
44667408|NCT01233583|Infliximab|infliximab|mesh-list
44667409|NCT01233583|Acitretin|acitretin|mesh-list
44667410|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667411|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667412|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44667413|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667414|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44667415|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667416|NCT01233583|Analgesics|analgesics|mesh-ancestor
44667417|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
44667418|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667419|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667420|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667421|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
44667422|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
44667423|NCT01233622|Vildagliptin|vildagliptin|mesh-list
44667424|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667425|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667426|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44667427|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
44667428|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667429|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667430|NCT01233635|Losartan|losartan|mesh-list
44667431|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44667432|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44667433|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44667434|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44667435|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667436|NCT01233752|Morphine|morphine|mesh-list
44667437|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667438|NCT01233752|Narcotics|narcotics|mesh-ancestor
44667439|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667440|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667441|NCT01233752|Analgesics|analgesics|mesh-ancestor
44667442|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
44667443|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667444|NCT01233791|Diazepam|diazepam|mesh-list
43932788|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44667445|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44667446|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
44667447|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
44667448|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
44667449|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667450|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667451|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667452|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44667453|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667454|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44667455|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44667456|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44667457|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44667458|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44667459|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44667460|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
44667461|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
44667462|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
44667463|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
44667464|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667465|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667466|NCT01233843|Carboplatin|carboplatin|mesh-list
44667467|NCT01233843|Fluorouracil|fluorouracil|mesh-list
44667468|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667469|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
44667470|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667471|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667472|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667473|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
44667474|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667475|NCT01233895|Bortezomib|bortezomib|mesh-list
44667476|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667477|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
44667478|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44667479|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44667480|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
44667481|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
44667482|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667483|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667484|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667485|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
44667486|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44667487|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44667488|NCT01233947|Fulvestrant|fulvestrant|mesh-list
44667489|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44667490|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667491|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44667492|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44667493|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
44667494|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667495|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667496|NCT01234051|Docetaxel|docetaxel|mesh-list
44217896|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667497|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
44667498|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667499|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
44667500|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
44667501|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44667502|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667503|NCT01234116|Tenofovir|tenofovir|mesh-list
44667504|NCT01234116|Emtricitabine|emtricitabine|mesh-list
44667505|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44667506|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
44667507|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667508|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44667509|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44667510|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667511|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667512|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667513|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667514|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
44667515|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44667516|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667517|NCT01234142|Varenicline|varenicline|mesh-list
44667518|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44667519|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44667520|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44667521|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667522|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667523|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667524|NCT01234194|Remifentanil|remifentanil|mesh-list
44667525|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667526|NCT01234194|Narcotics|narcotics|mesh-ancestor
44667527|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667528|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667529|NCT01234194|Analgesics|analgesics|mesh-ancestor
44667530|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
44667531|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667532|NCT01234272|Morphine|morphine|mesh-list
44667533|NCT01234272|Ropivacaine|ropivacaine|mesh-list
44667534|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667535|NCT01234272|Narcotics|narcotics|mesh-ancestor
44667536|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667537|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667538|NCT01234272|Analgesics|analgesics|mesh-ancestor
44667539|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
44667540|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667541|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
44667542|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
44667543|NCT01234285|Heparin|heparin|mesh-list
44667544|NCT01234285|Calcium heparin|calcium heparin|mesh-list
44667545|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
44667546|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44667547|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44667548|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667549|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44667550|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44667551|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667552|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44667553|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44667554|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667555|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667556|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
44667557|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667558|NCT01234324|Cisplatin|cisplatin|mesh-list
44667559|NCT01234324|Capecitabine|capecitabine|mesh-list
44667560|NCT01234324|Epirubicin|epirubicin|mesh-list
44667561|NCT01234324|Panitumumab|panitumumab|mesh-list
44667562|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667563|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667564|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
44667565|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667566|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44667567|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44667568|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44667569|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667570|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44667571|NCT01234454|Olanzapine|olanzapine|mesh-list
44667572|NCT01234454|Risperidone|risperidone|mesh-list
44667573|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44667574|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
44667575|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667576|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667577|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667578|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44667579|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44667580|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667581|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44667582|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44667583|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
44667584|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
44667585|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
44667586|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667587|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667588|NCT01234454|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44667589|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44667590|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667591|NCT01234506|Vitamin D|vitamin d|mesh-list
44667592|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
44667593|NCT01234506|Vitamins|vitamins|mesh-ancestor
44667594|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
44667595|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667596|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44667597|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
44667598|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44667599|NCT01234506|Estrogens|estrogens|mesh-ancestor
44667600|NCT01234506|Hormones|hormones|mesh-ancestor
44667601|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667602|NCT01234597|Insulin|insulin|mesh-list
44667603|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44667604|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
44667605|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
44667606|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667607|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667608|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44667609|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44667610|NCT01234701|Liver Extracts|liver extracts|mesh-list
44667611|NCT01234701|Hematinics|hematinics|mesh-ancestor
44667612|NCT01234740|Bafetinib|bafetinib|mesh-list
44667613|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44667614|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667615|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667616|NCT01234792|Nicotine|nicotine|mesh-list
44667617|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44667618|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
44667619|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667620|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667621|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44667622|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44667623|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
44667624|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667625|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667626|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
44667627|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44667628|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
44667629|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44667630|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667631|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44667632|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44667633|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44667634|NCT01234857|Sirolimus|sirolimus|mesh-list
44667635|NCT01234857|Exemestane|exemestane|mesh-list
44667636|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44667637|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667638|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44667639|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44667640|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667641|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667642|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44667643|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44667644|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667645|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667646|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44140469|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140470|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
44667647|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667648|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44667649|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
44667650|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667651|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
44667652|NCT01234896|Nicotine|nicotine|mesh-list
44667653|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44667654|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
44667655|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667656|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667657|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44667658|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44667659|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
44667660|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667661|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667662|NCT01234935|Gemcitabine|gemcitabine|mesh-list
44667663|NCT01234935|Dasatinib|dasatinib|mesh-list
44667664|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667665|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
44667666|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667667|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667668|NCT01234935|Antiviral Agents|antiviral agents|mesh-ancestor
44667669|NCT01234935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667670|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667671|NCT01234935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667672|NCT01234935|Immunologic Factors|immunologic factors|mesh-ancestor
44667673|NCT01234935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667674|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44667675|NCT01234974|Everolimus|everolimus|mesh-list
44667676|NCT01234974|Pasireotide|pasireotide|mesh-list
44667677|NCT01234974|Somatostatin|somatostatin|mesh-list
44667678|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667679|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667680|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
44667681|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667682|NCT01234974|Hormones|hormones|mesh-ancestor
44667683|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667684|NCT01235013|Maraviroc|maraviroc|mesh-list
44667685|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43932975|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
44667686|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44667687|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667688|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667690|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
44667691|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667692|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44667693|NCT01235117|Azacitidine|azacitidine|mesh-list
44667694|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667695|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
44667696|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667697|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667698|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667699|NCT01235143|Sevoflurane|sevoflurane|mesh-list
44667700|NCT01235143|Desflurane|desflurane|mesh-list
44667701|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43933011|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44426796|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476070|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476071|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476072|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476073|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44476074|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44476075|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44476076|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
44476077|NCT04020380|Azithromycin|azithromycin|mesh-list
44476078|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476079|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476080|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44476081|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476083|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476084|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476085|NCT04020328|Prednisone|prednisone|mesh-list
44476086|NCT04020328|Leflunomide|leflunomide|mesh-list
44476087|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476088|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
44476089|NCT04020328|Hormones|hormones|mesh-ancestor
44476090|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476091|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476092|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476093|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476094|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476095|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476096|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476097|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
44476098|NCT04020263|Simendan|simendan|mesh-list
44476099|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44476100|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
44476101|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44476102|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44476103|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476104|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476105|NCT04020263|Protective Agents|protective agents|mesh-ancestor
44476106|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476107|NCT04020094|Atezolizumab|atezolizumab|mesh-list
44476108|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476109|NCT04020016|Nalbuphine|nalbuphine|mesh-list
44476110|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44476111|NCT04020016|Narcotics|narcotics|mesh-ancestor
44476112|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476113|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476114|NCT04020016|Analgesics|analgesics|mesh-ancestor
44476115|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
44476116|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476117|NCT04020133|Epinephrine|epinephrine|mesh-list
44476118|NCT04020133|Bupivacaine|bupivacaine|mesh-list
44476119|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
44476120|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
44476121|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476122|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476123|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
44476124|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476125|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44476126|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44476127|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476128|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476129|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476130|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44476131|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476132|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
44476133|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476134|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476135|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
44476136|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
44476137|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44476138|NCT04020809|Atezolizumab|atezolizumab|mesh-list
44476139|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476140|NCT04022226|Ketamine|ketamine|mesh-list
44476141|NCT04022226|Methohexital|methohexital|mesh-list
44476142|NCT04022226|Analgesics|analgesics|mesh-ancestor
44476143|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
44476144|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476145|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476146|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44476147|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44476148|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
44476149|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
44476150|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476151|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44476152|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44476153|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870867|NCT03531918|Cytarabine|cytarabine|mesh-list
44426800|NCT02208063|Penicillins|penicillins|mesh-list
44426801|NCT02208063|Cloxacillin|cloxacillin|mesh-list
44426802|NCT02208063|Oxacillin|oxacillin|mesh-list
44426803|NCT02208063|Telavancin|telavancin|mesh-list
44426804|NCT02208063|Nafcillin|nafcillin|mesh-list
44426805|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426806|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426807|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
44426808|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44426809|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426826|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
44426827|NCT02207907|Protective Agents|protective agents|mesh-ancestor
44426828|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476154|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476155|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
44476156|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44476157|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
44476158|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
44476159|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476160|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476162|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
44476163|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44476164|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476165|NCT04023110|Carvedilol|carvedilol|mesh-list
44476166|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44476167|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44476168|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476169|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476170|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476171|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476172|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44476173|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
44476174|NCT04023110|Protective Agents|protective agents|mesh-ancestor
44476175|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44476176|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476177|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44476178|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
44476179|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44476180|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44476181|NCT04029610|Lidocaine|lidocaine|mesh-list
44476182|NCT04029610|Epinephrine|epinephrine|mesh-list
44476183|NCT04029610|Racepinephrine|racepinephrine|mesh-list
44476184|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
44476185|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
44476186|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
44476187|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476188|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476189|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
44476190|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476191|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44236606|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43624076|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
43624077|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
43624078|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624079|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624080|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
43624081|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624082|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43624083|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43624103|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
43624104|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624105|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624106|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624107|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624108|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624109|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624111|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624112|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624113|NCT05403749|Aflibercept|aflibercept|mesh-list
44476192|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44476193|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44476194|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476195|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476196|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44476197|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44476198|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476199|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476200|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44476201|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476202|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
44476203|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476204|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476205|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
44476206|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
44476207|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44476208|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
44476209|NCT04029038|Fludarabine|fludarabine|mesh-list
44476210|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476211|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
44476212|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476213|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476214|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44476215|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
44476216|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476217|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476218|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44476219|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
44476220|NCT04025216|Fludarabine|fludarabine|mesh-list
44476221|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476222|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
44476223|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476224|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476225|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44476226|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
44476227|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174245|NCT00295919|Ketoconazole|ketoconazole|mesh-list
43624513|NCT04090697|Hormones|hormones|mesh-ancestor
43624514|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624515|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849429|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624571|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43624573|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43624574|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476228|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476229|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44476230|NCT04025775|Insulin|insulin|mesh-list
44476231|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476232|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476233|NCT04025372|Bicalutamide|bicalutamide|mesh-list
44476234|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
43933196|NCT00771875|Analgesics|analgesics|mesh-ancestor
44476235|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
44476236|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476237|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476238|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476239|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
44476240|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476241|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
44476242|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476243|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476244|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476245|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476246|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44476247|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
44476248|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476249|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295141|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
44476250|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44476252|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
44476253|NCT04022161|Protective Agents|protective agents|mesh-ancestor
44476254|NCT04028765|Misoprostol|misoprostol|mesh-list
44476255|NCT04028765|Oxytocin|oxytocin|mesh-list
44476256|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
44476257|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44476258|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476259|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44476260|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
44476261|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44476262|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44476263|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
44476264|NCT04026880|Testosterone|testosterone|mesh-list
44476265|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
44476266|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
44476267|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44476268|NCT04026880|Androgens|androgens|mesh-ancestor
44476269|NCT04026880|Hormones|hormones|mesh-ancestor
44476270|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476271|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476272|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476273|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476274|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
44735920|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871017|NCT03145558|Doxorubicin|doxorubicin|mesh-list
44233868|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
44233869|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44233870|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
44233871|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233872|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233873|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44233874|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44233875|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
44233876|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44233877|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
44233878|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233879|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735921|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
44234051|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735922|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735923|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735924|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735925|NCT04877522|Niacinamide|niacinamide|mesh-list
44735926|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
44735928|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735929|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735930|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735931|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735932|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
44735933|NCT04877522|Vitamins|vitamins|mesh-ancestor
44735934|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
44735935|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735936|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44735937|NCT04855266|Hematinics|hematinics|mesh-ancestor
44735938|NCT04817241|Cytarabine|cytarabine|mesh-list
44735939|NCT04817241|Decitabine|decitabine|mesh-list
44735940|NCT04817241|Daunorubicin|daunorubicin|mesh-list
44735941|NCT04817241|Venetoclax|venetoclax|mesh-list
44735942|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735943|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
44735944|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735945|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735946|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
44735947|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735948|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735949|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
44735950|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735951|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44735952|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44735953|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735954|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735955|NCT04784559|Favipiravir|favipiravir|mesh-list
44735956|NCT04784559|Remdesivir|remdesivir|mesh-list
44735957|NCT04784559|Dexamethasone|dexamethasone|mesh-list
43933277|NCT00773422|Naltrexone|naltrexone|mesh-list
44735958|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44735959|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
44735960|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
44735961|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735962|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735963|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44735964|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
44735965|NCT04784559|Hormones|hormones|mesh-ancestor
44735966|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44735967|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44735968|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735969|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
44735970|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735971|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
44476275|NCT04026958|Clarithromycin|clarithromycin|mesh-list
44476276|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476277|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476278|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44476279|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476280|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476281|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44476282|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44476284|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44476285|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
44476286|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476288|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44476289|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
44476290|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476291|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476292|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44476293|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44476294|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
44476295|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476296|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476297|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
44476298|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44476299|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
44234632|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476300|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476301|NCT04023266|Expectorants|expectorants|mesh-ancestor
44476302|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476303|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44476304|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
44476305|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476306|NCT04023266|Protective Agents|protective agents|mesh-ancestor
44476307|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476308|NCT04023266|Antidotes|antidotes|mesh-ancestor
44476309|NCT04022135|Folic Acid|folic acid|mesh-list
44476310|NCT04022135|Hematinics|hematinics|mesh-ancestor
44476311|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
44476312|NCT04022135|Vitamins|vitamins|mesh-ancestor
44476313|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
44476314|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476315|NCT04027348|Dexamethasone|dexamethasone|mesh-list
44476316|NCT04027348|Octreotide|octreotide|mesh-list
44476317|NCT04027348|Metoclopramide|metoclopramide|mesh-list
44476318|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476319|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
44476320|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
44476321|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476322|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476323|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44476324|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
44476325|NCT04027348|Hormones|hormones|mesh-ancestor
44476326|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476327|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476328|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476329|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44476330|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44476331|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
44476332|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476333|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476334|NCT04028141|Ketamine|ketamine|mesh-list
44476335|NCT04028141|Propofol|propofol|mesh-list
44476336|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44476337|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476338|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476339|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44476340|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
44476341|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
44476342|NCT04028141|Analgesics|analgesics|mesh-ancestor
44476343|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
44476344|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476345|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44476346|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44476347|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44476348|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476349|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295292|NCT00801528|Analgesics|analgesics|mesh-ancestor
44476350|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44476351|NCT04026282|Hormones|hormones|mesh-ancestor
44476352|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476353|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476354|NCT04025671|Naloxone|naloxone|mesh-list
44476355|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44476356|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476357|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
44476358|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476359|NCT04024254|Folic Acid|folic acid|mesh-list
44476360|NCT04024254|Hematinics|hematinics|mesh-ancestor
44476361|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
44476362|NCT04024254|Vitamins|vitamins|mesh-ancestor
44476363|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
44476364|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476365|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44476366|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
44476367|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476368|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
44476369|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476370|NCT02704208|Nicotine|nicotine|mesh-list
44476371|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44476372|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
44476373|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476374|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476375|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44476376|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44476377|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
44476378|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476379|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476380|NCT02704390|Methylphenidate|methylphenidate|mesh-list
44476381|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44476382|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476383|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44476384|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44476385|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476386|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476387|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
44476388|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476389|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
44476390|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44476391|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
44476392|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476393|NCT02703623|Prednisone|prednisone|mesh-list
44476394|NCT02703623|Cortisone|cortisone|mesh-list
44476395|NCT02703623|Carboplatin|carboplatin|mesh-list
44476396|NCT02703623|Ipilimumab|ipilimumab|mesh-list
44476397|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
44476398|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476399|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476400|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
44476401|NCT02703623|Hormones|hormones|mesh-ancestor
44476402|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933416|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44476403|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476404|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476405|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476406|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44476407|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476408|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44476409|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476410|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44476411|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44476412|NCT02700451|Acetaminophen|acetaminophen|mesh-list
44476413|NCT02700451|Ketorolac|ketorolac|mesh-list
44476414|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476415|NCT02700451|Analgesics|analgesics|mesh-ancestor
44476416|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
44476417|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476418|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476419|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
44476420|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44476421|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476422|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476423|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44476424|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476425|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476426|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
44476427|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44476428|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
44476429|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476430|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
44476431|NCT02708706|Protective Agents|protective agents|mesh-ancestor
44476432|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44476433|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44476434|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44476435|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476436|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476437|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44476438|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476439|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476440|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
44476441|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476442|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
44476443|NCT02703714|Sargramostim|sargramostim|mesh-list
44476444|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476445|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476446|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
44476447|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476448|NCT02700529|Ubenimex|ubenimex|mesh-list
44476449|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44476450|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
44476451|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476452|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476453|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476454|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44476455|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476456|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
44476457|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476458|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476459|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44476460|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44476461|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
44476462|NCT02708680|Atezolizumab|atezolizumab|mesh-list
44476463|NCT02708680|Entinostat|entinostat|mesh-list
44476464|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933465|NCT00777335|Panobinostat|panobinostat|mesh-list
44476465|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44476466|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476467|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476468|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44476469|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
44476470|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476471|NCT04149587|Brodalumab|brodalumab|mesh-list
44476472|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44476473|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
44476474|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476475|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476476|NCT04142749|Oltipraz|oltipraz|mesh-list
44476477|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
44476478|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476479|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
44476480|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44476481|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
44476482|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44476483|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44476484|NCT04142749|Protective Agents|protective agents|mesh-ancestor
44476485|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476486|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476487|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44476488|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44476489|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476490|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476491|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
44476492|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44476493|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44476494|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933524|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
44476495|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476496|NCT04149964|Acetaminophen|acetaminophen|mesh-list
44476497|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44476498|NCT04149964|Oxycodone|oxycodone|mesh-list
44476499|NCT04149964|Hydrocodone|hydrocodone|mesh-list
44476500|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476502|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
44476503|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476504|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476505|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
44476506|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44476507|NCT04149964|Narcotics|narcotics|mesh-ancestor
44476508|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476509|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
44476510|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476511|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44476512|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476513|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476514|NCT04145700|Gemcitabine|gemcitabine|mesh-list
44476515|NCT04145700|Docetaxel|docetaxel|mesh-list
44476516|NCT04145700|Ramucirumab|ramucirumab|mesh-list
44476517|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44476518|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
44476519|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476520|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476521|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
44476522|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476523|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476524|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476525|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
44476526|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476527|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44476528|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44476529|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44476531|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476532|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476533|NCT04143204|Insulin|insulin|mesh-list
44476534|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476535|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735972|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735973|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
44735974|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
44735975|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44735976|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44735977|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
44735978|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735979|NCT04764643|Expectorants|expectorants|mesh-ancestor
44735980|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
44735981|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44735982|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
44735983|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735984|NCT04764643|Protective Agents|protective agents|mesh-ancestor
44735985|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735986|NCT04764643|Antidotes|antidotes|mesh-ancestor
44735987|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
44735988|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44735989|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
44735990|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
44735991|NCT04739800|Paclitaxel|paclitaxel|mesh-list
44735992|NCT04739800|Doxorubicin|doxorubicin|mesh-list
44735993|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44735994|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44735995|NCT04739800|Durvalumab|durvalumab|mesh-list
44735996|NCT04739800|Topotecan|topotecan|mesh-list
44735997|NCT04739800|Olaparib|olaparib|mesh-list
44735998|NCT04739800|Cediranib|cediranib|mesh-list
44735999|NCT04739800|Maleic acid|maleic acid|mesh-list
44736000|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
44736001|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44736002|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
44736003|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736004|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736005|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736006|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736007|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736008|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736009|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44736010|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44736011|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44736012|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736013|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476536|NCT04145518|Naproxen|naproxen|mesh-list
44476537|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44476538|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476539|NCT04145518|Analgesics|analgesics|mesh-ancestor
44476540|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
44476541|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476542|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476543|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476544|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476545|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
44476546|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44476547|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476548|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476549|NCT04143477|Peficitinib|peficitinib|mesh-list
44476550|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476551|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476552|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476553|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
44476554|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476555|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
44476556|NCT04144153|Anesthetics|anesthetics|mesh-list
44476557|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476558|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476559|NCT04144153|Narcotics|narcotics|mesh-ancestor
44476560|NCT04144153|Analgesics|analgesics|mesh-ancestor
44476561|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
44476562|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476563|NCT04149938|Lidocaine|lidocaine|mesh-list
44476564|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
44476565|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
44476566|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476567|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476568|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
44476569|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476570|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44476571|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44476572|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44476573|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476574|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476575|NCT04149483|Atorvastatin|atorvastatin|mesh-list
44476576|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44476577|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44476578|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
44476579|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476580|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44476581|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44476582|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476583|NCT04149678|Cyclosporine|cyclosporine|mesh-list
44476584|NCT04149678|Cyclosporins|cyclosporins|mesh-list
44476585|NCT04149678|Ozanimod|ozanimod|mesh-list
44476586|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476587|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476588|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476589|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
44476590|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476591|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
44476592|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476593|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
44476594|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476595|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44476596|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44476597|NCT04149626|Midazolam|midazolam|mesh-list
44476598|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
44476599|NCT04149626|Remifentanil|remifentanil|mesh-list
44476600|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44476601|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476602|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476603|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476604|NCT04149626|Analgesics|analgesics|mesh-ancestor
44476605|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
44476606|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476607|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44476608|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44476609|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44476610|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476611|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476612|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476613|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44476614|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44476615|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44476616|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44476617|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44476618|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
44476619|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
44476620|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
44476621|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
44476622|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44476623|NCT04149626|Narcotics|narcotics|mesh-ancestor
44476624|NCT04149444|Trifluridine|trifluridine|mesh-list
44476625|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
44476626|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476627|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
44476628|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476629|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
44476630|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476631|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476633|NCT04149275|Ipilimumab|ipilimumab|mesh-list
44476634|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476635|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476636|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44476637|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476638|NCT04148963|Loxapine|loxapine|mesh-list
44476639|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44476640|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44476641|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476642|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476643|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44476644|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44476645|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
44476646|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476647|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476648|NCT04149327|Amoxicillin|amoxicillin|mesh-list
44476649|NCT04149327|Metronidazole|metronidazole|mesh-list
44476650|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476651|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476652|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44476653|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44476654|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44476655|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
44476656|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476657|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476658|NCT04149067|Incretins|incretins|mesh-ancestor
44476659|NCT04149067|Hormones|hormones|mesh-ancestor
44476660|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476661|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44476662|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
44476663|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476664|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476665|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44476666|NCT04149015|Paclitaxel|paclitaxel|mesh-list
44476667|NCT04149015|Fluorouracil|fluorouracil|mesh-list
44476668|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
44476669|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44476670|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476671|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44476672|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44476673|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44476674|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476675|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
44476676|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44476677|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476678|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
44476679|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476680|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
44476681|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44476682|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44476683|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476684|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
44476685|NCT04149171|Coagulants|coagulants|mesh-ancestor
44476686|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
44476687|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476688|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
44476689|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476690|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476691|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476692|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476693|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44476694|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
44476695|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476696|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476697|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44476698|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44476699|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
44476700|NCT04149132|Protective Agents|protective agents|mesh-ancestor
44476701|NCT04148898|Bevacizumab|bevacizumab|mesh-list
44476702|NCT04148898|Osimertinib|osimertinib|mesh-list
44476703|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44476704|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476705|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44476706|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44476707|NCT04148898|Growth Substances|growth substances|mesh-ancestor
44476708|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476709|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44476710|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44476711|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476712|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476713|NCT04148885|Paclitaxel|paclitaxel|mesh-list
44476714|NCT04148885|Carboplatin|carboplatin|mesh-list
44476715|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44476716|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476717|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44476718|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44476719|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44476720|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476721|NCT04148820|Aspirin|aspirin|mesh-list
44476722|NCT04148820|Perindopril|perindopril|mesh-list
44476723|NCT04148820|Atorvastatin|atorvastatin|mesh-list
44476724|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44476725|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476726|NCT04148820|Analgesics|analgesics|mesh-ancestor
44476727|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
44476728|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476729|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476730|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476731|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476732|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44476733|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44476734|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476735|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44476736|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44476737|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476738|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
44476739|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44476740|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44476741|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
44476742|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44476743|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44476744|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44476745|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
44476746|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44476747|NCT04148599|Lidocaine|lidocaine|mesh-list
44476748|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
44476749|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
44476750|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
44476751|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476752|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476753|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
44476754|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476755|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44476756|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44476757|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44476758|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44476759|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476760|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44476761|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476762|NCT04148599|Analgesics|analgesics|mesh-ancestor
44476763|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44476764|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44476765|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44476766|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476767|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476768|NCT04148846|Dexamethasone|dexamethasone|mesh-list
44476769|NCT04148846|Ketoprofen|ketoprofen|mesh-list
44476770|NCT04148846|Theophylline|theophylline|mesh-list
44476771|NCT04148846|Gabapentin|gabapentin|mesh-list
44476772|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476773|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
44476774|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
44476775|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476776|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476777|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44476778|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
44476779|NCT04148846|Hormones|hormones|mesh-ancestor
44476780|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476781|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476782|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476783|NCT04148846|Analgesics|analgesics|mesh-ancestor
44476784|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
44476785|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
44476786|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44476787|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44476788|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476789|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44476790|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44476791|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44476792|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476793|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476794|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
44476795|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44476796|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44476797|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44476798|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44476799|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476800|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476801|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476802|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476803|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44476804|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
44476805|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44476806|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44476807|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
44476809|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44476810|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44476811|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44476812|NCT04148261|Epinephrine|epinephrine|mesh-list
44476813|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44476814|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44476815|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476816|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476817|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476818|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476819|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44476820|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476821|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
44476822|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476823|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476824|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476825|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
44476826|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
44476827|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44476828|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476829|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
44476830|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44476831|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
44295805|NCT00803907|Imiquimod|imiquimod|mesh-list
44476832|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476833|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476834|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44476835|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
44476836|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
44476837|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44476838|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
44476839|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476840|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476841|NCT04147806|Dexamethasone|dexamethasone|mesh-list
44476842|NCT04147806|Tamsulosin|tamsulosin|mesh-list
44476843|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44476844|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
44476845|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
44476846|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476847|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476848|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44476849|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
44476850|NCT04147806|Hormones|hormones|mesh-ancestor
44476851|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476852|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44476853|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476854|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44476855|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44234679|NCT00550784|Topotecan|topotecan|mesh-list
44476857|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
44476858|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44476859|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476860|NCT04147806|Urological Agents|urological agents|mesh-ancestor
44476861|NCT04147754|Morphine|morphine|mesh-list
44476862|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476863|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476864|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44476865|NCT04147754|Narcotics|narcotics|mesh-ancestor
44476866|NCT04147754|Analgesics|analgesics|mesh-ancestor
44476867|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
44476868|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736014|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
44736015|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736016|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44736017|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44736018|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736019|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
44736020|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736021|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736022|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
44736023|NCT04736706|Lenvatinib|lenvatinib|mesh-list
44736024|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736025|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736026|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736027|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736028|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736029|NCT04708782|Treprostinil|treprostinil|mesh-list
44736030|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44736031|NCT04706429|Trientine|trientine|mesh-list
44736032|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
44736033|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
44736034|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736035|NCT04625803|Apatinib|apatinib|mesh-list
44736036|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736037|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736038|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736039|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736040|NCT04603807|Crizotinib|crizotinib|mesh-list
44736041|NCT04603807|Entrectinib|entrectinib|mesh-list
44736042|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736043|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736044|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736045|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736046|NCT04597437|Zanamivir|zanamivir|mesh-list
44736047|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
44736048|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736049|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736050|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295818|NCT00803946|Ibuprofen|ibuprofen|mesh-list
44476869|NCT04147286|Atorvastatin|atorvastatin|mesh-list
44476870|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44476871|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44476872|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
44476873|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476874|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44476875|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44476876|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476877|NCT04147208|Ritonavir|ritonavir|mesh-list
44476878|NCT04147208|Entecavir|entecavir|mesh-list
44476879|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44476880|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44476881|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
44476882|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476883|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476884|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44476885|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44476886|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
44476887|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476888|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44476889|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44476891|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
44476892|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476893|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476894|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
44476895|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476896|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
44476897|NCT04147390|Tacrolimus|tacrolimus|mesh-list
44476898|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44476899|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
44476900|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476901|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44476902|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476903|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476904|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44476905|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476906|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44476907|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
44476908|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476909|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476910|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
44476911|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44476912|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476913|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44476914|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44476915|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476916|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476917|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476918|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44476919|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44476920|NCT04146610|Antibodies|antibodies|mesh-list
44476921|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
44476922|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
44476923|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476924|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
44476925|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44476926|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44476927|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476928|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
44476929|NCT04146376|Coagulants|coagulants|mesh-ancestor
43934039|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44476930|NCT04146493|Heparin|heparin|mesh-list
44476931|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
44476932|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44476933|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44476934|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476935|NCT04146155|Liraglutide|liraglutide|mesh-list
44476936|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476937|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476938|NCT04146155|Incretins|incretins|mesh-ancestor
44476939|NCT04146155|Hormones|hormones|mesh-ancestor
44476940|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476941|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
44476942|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44295891|NCT00804336|Everolimus|everolimus|mesh-list
44476943|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
44476944|NCT04146259|Calcium|calcium|mesh-list
44476945|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44476946|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476947|NCT04146259|Antacids|antacids|mesh-ancestor
44476948|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476949|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44476950|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44476951|NCT04146259|Vitamins|vitamins|mesh-ancestor
44476952|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
44476953|NCT04145856|Simethicone|simethicone|mesh-list
44476954|NCT04145856|Alverine|alverine|mesh-list
44476955|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
44476956|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476957|NCT04145856|Emollients|emollients|mesh-ancestor
44476958|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
44476959|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
44476960|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
44476961|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44476962|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476963|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
44476965|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
44476966|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
44476967|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44476968|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476969|NCT04145804|Insulin|insulin|mesh-list
44476970|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44476971|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476972|NCT04145583|Voriconazole|voriconazole|mesh-list
44476973|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
44476974|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44476975|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44476976|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44476977|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476978|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476979|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44476980|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
44476981|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44476982|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476983|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44476984|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44476985|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44476986|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44476987|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44476988|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44476989|NCT04145492|Vitamin D|vitamin d|mesh-list
44476990|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
44476991|NCT04145492|Calcifediol|calcifediol|mesh-list
44476992|NCT04145492|Vitamins|vitamins|mesh-list
44476993|NCT04145492|Vitamin K|vitamin k|mesh-list
44476994|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
44476995|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
44476996|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44476997|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44476998|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44476999|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44477000|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44477001|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477002|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
44477003|NCT04145492|Coagulants|coagulants|mesh-ancestor
44477004|NCT04145921|Tacrine|tacrine|mesh-list
44477005|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44477006|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477007|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477008|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
44477009|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477010|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477011|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44477012|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
44477013|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477014|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
44477015|NCT04145687|Metformin|metformin|mesh-list
44477016|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44477017|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477018|NCT04145193|Leucovorin|leucovorin|mesh-list
44477019|NCT04145193|Fluorouracil|fluorouracil|mesh-list
44477020|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
44477021|NCT04145193|Durvalumab|durvalumab|mesh-list
44477022|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44477023|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
44477024|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477025|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477026|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477027|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477028|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
44477029|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477030|NCT04145193|Antidotes|antidotes|mesh-ancestor
44477031|NCT04145193|Protective Agents|protective agents|mesh-ancestor
44477032|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
44477033|NCT04145193|Vitamins|vitamins|mesh-ancestor
44477034|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
44477035|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477036|NCT04145102|Propolis|propolis|mesh-list
44477037|NCT04145102|Fluorides|fluorides|mesh-list
44477038|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
44477039|NCT04145102|Protective Agents|protective agents|mesh-ancestor
44477055|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477057|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
44477058|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477059|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
44477060|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44477061|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
44736070|NCT04576104|Metformin|metformin|mesh-list
44736071|NCT04576104|Megestrol|megestrol|mesh-list
44736072|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
44736073|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44736074|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736075|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44736076|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44736077|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44736078|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
44736079|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44736080|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44736081|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44736082|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44736083|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736084|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
44736085|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44736086|NCT04558892|Enoxaparin|enoxaparin|mesh-list
44736087|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
44736088|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44477062|NCT04144712|Caffeine|caffeine|mesh-list
44477063|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
44477064|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477065|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44477066|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477067|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44477068|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477069|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44477070|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44477071|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
44477072|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477073|NCT04144933|Acetaminophen|acetaminophen|mesh-list
44477074|NCT04144933|Dexamethasone|dexamethasone|mesh-list
44477075|NCT04144933|Lidocaine|lidocaine|mesh-list
44477076|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
44477077|NCT04144933|Sufentanil|sufentanil|mesh-list
44477078|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
44477079|NCT04144933|Ketamine|ketamine|mesh-list
44477080|NCT04144933|Gabapentin|gabapentin|mesh-list
44477081|NCT04144933|Dsuvia|dsuvia|mesh-list
44477082|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
44477083|NCT04144933|Ondansetron|ondansetron|mesh-list
44477084|NCT04144933|Sevoflurane|sevoflurane|mesh-list
44477085|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44477086|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477087|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
44477088|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
44477089|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477090|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477091|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477092|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
44477093|NCT04144933|Hormones|hormones|mesh-ancestor
44477094|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477095|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44477096|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477097|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
44477098|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
44477099|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477100|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
44477101|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477102|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44477103|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44477104|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477105|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477106|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44477107|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477108|NCT04144933|Analgesics|analgesics|mesh-ancestor
44477109|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44477110|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44477111|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44477112|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477113|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477114|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44477115|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44477116|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
44477117|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44477118|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44477119|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
43934192|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
44477120|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44477121|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44477122|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
44477123|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44477124|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44477125|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477126|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
44477127|NCT04144933|Narcotics|narcotics|mesh-ancestor
44477128|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
44477129|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
44477130|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44477131|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
44477132|NCT04144933|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44477133|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44477134|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44477135|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
44477136|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44477137|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44477138|NCT04144439|Butyric Acid|butyric acid|mesh-list
44477139|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
44477140|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
44477141|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477142|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477143|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477144|NCT04144218|Lacosamide|lacosamide|mesh-list
44477145|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
44477146|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44477147|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44477148|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477149|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477150|NCT04144101|Etoricoxib|etoricoxib|mesh-list
44477151|NCT04144101|Aceclofenac|aceclofenac|mesh-list
44477152|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44477153|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477154|NCT04144101|Analgesics|analgesics|mesh-ancestor
44477155|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
44477156|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477158|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477159|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477160|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44477161|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44477162|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477163|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477164|NCT04143880|Progesterone|progesterone|mesh-list
44477165|NCT04143880|Progestins|progestins|mesh-ancestor
44477166|NCT04143880|Hormones|hormones|mesh-ancestor
44477167|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477168|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477169|NCT04143906|Gemcitabine|gemcitabine|mesh-list
44477170|NCT04143906|Carboplatin|carboplatin|mesh-list
44477171|NCT04143906|Vinorelbine|vinorelbine|mesh-list
44477172|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477173|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477174|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
44477175|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477176|NCT04143906|Antiviral Agents|antiviral agents|mesh-ancestor
44477177|NCT04143906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477178|NCT04143906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477179|NCT04143906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477180|NCT04143906|Immunologic Factors|immunologic factors|mesh-ancestor
44477181|NCT04143906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477182|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44477183|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477184|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44477185|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477186|NCT04144192|Lidocaine|lidocaine|mesh-list
44477187|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
44477188|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
44477189|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477190|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477191|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
44477192|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477193|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477194|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44477195|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44477196|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477197|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477198|NCT04143685|Misoprostol|misoprostol|mesh-list
44477199|NCT04143685|Oxytocin|oxytocin|mesh-list
44477200|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
44477201|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44477202|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477203|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44477204|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
44477205|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44477206|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477207|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
44477208|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44477209|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44477210|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44477211|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477212|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296195|NCT00805519|Hormones|hormones|mesh-ancestor
44477213|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
44477214|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477215|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477216|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44477217|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477218|NCT04143581|Empagliflozin|empagliflozin|mesh-list
44477219|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44477220|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477221|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44477222|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477223|NCT04143451|Imiquimod|imiquimod|mesh-list
44477224|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44477225|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
44477226|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477227|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477228|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
44477229|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
44477230|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44477231|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44477232|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44477233|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477234|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477235|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
44477236|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477237|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477238|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44477239|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477240|NCT04143321|Empagliflozin|empagliflozin|mesh-list
44477241|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44477242|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477243|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44477244|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477245|NCT04143165|Lidocaine|lidocaine|mesh-list
44477246|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
44477247|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
44477248|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477249|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477250|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
44477251|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477252|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477253|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44477254|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44477255|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477256|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477257|NCT04143256|Menthol|menthol|mesh-list
44477258|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
44477259|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
44477260|NCT04143412|Ramipril|ramipril|mesh-list
44477261|NCT04143412|Eplerenone|eplerenone|mesh-list
44477262|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44477263|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
44477264|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477265|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477266|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44477267|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44477268|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
44477269|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477270|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477271|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44477272|NCT04143412|Diuretics|diuretics|mesh-ancestor
44477273|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
44477274|NCT04143191|Sorafenib|sorafenib|mesh-list
44477275|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477276|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477277|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477278|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477279|NCT04142931|Nivolumab|nivolumab|mesh-list
44477280|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477281|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477282|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44477283|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296262|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44477284|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
44477285|NCT04142840|Propofol|propofol|mesh-list
44477286|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44477287|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477288|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477289|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44477290|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
44477291|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
44477292|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477293|NCT04142840|Analgesics|analgesics|mesh-ancestor
44477294|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
44477295|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477296|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44477297|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44477298|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44477299|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477300|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477301|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477302|NCT04142762|Itraconazole|itraconazole|mesh-list
44477303|NCT04142762|Rifampin|rifampin|mesh-list
44477304|NCT04142762|Midazolam|midazolam|mesh-list
44477305|NCT04142762|Esomeprazole|esomeprazole|mesh-list
44477306|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
44477307|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44477308|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44477309|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
44477310|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
44477311|NCT04142762|Estradiol|estradiol|mesh-list
44477312|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44477313|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44477314|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477315|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477316|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44477317|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44477318|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477319|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44477320|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
44477321|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
44477322|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
44477323|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
44477324|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477325|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477326|NCT04142762|Estrogens|estrogens|mesh-ancestor
44477327|NCT04142762|Hormones|hormones|mesh-ancestor
44477328|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477329|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44477330|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44477331|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44477332|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44477333|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477334|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44477335|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477336|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
44477337|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477338|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44477339|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44477340|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44477341|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
44477342|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44477343|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44477344|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44477345|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
44477346|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477347|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
44477348|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44477349|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44477350|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44477351|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44477352|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44477353|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44477354|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44477355|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44477356|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44477357|NCT04142151|Aspirin|aspirin|mesh-list
44296281|NCT00805857|Tipranavir|tipranavir|mesh-list
44477358|NCT04142151|Clopidogrel|clopidogrel|mesh-list
44477359|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44477360|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477361|NCT04142151|Analgesics|analgesics|mesh-ancestor
44477362|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
44477363|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477364|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477365|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477366|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477367|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44477368|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44477369|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477370|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44477371|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44477372|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477374|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44477375|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44477376|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44477377|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
44477378|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477379|NCT04141995|Leucovorin|leucovorin|mesh-list
44477380|NCT04141995|Fluorouracil|fluorouracil|mesh-list
44477381|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
44477382|NCT04141995|Irinotecan|irinotecan|mesh-list
44477383|NCT04141995|Camptothecin|camptothecin|mesh-list
44477384|NCT04141995|Digoxin|digoxin|mesh-list
44477385|NCT04141995|Calcium|calcium|mesh-list
44477386|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
43934479|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44477387|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44477388|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477389|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
44477390|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477391|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477392|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477393|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477394|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
44477395|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44477396|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44477397|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477398|NCT04141995|Antidotes|antidotes|mesh-ancestor
44477399|NCT04141995|Protective Agents|protective agents|mesh-ancestor
44477400|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
44477401|NCT04141995|Vitamins|vitamins|mesh-ancestor
44477402|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
44477403|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477404|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44477405|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736089|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44736090|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736091|NCT04551885|Aldesleukin|aldesleukin|mesh-list
44736092|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
44736093|NCT04551885|Fludarabine|fludarabine|mesh-list
44736094|NCT04551885|Avelumab|avelumab|mesh-list
44736095|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736096|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
44736097|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736098|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736099|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736100|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
44736101|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736102|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736103|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44736104|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44736105|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44736106|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
44736107|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736108|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736109|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
44736110|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
44736111|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
44736112|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44736113|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736114|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
43934496|NCT00800345|Topotecan|topotecan|mesh-list
44736115|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
44296361|NCT00806754|Ciclesonide|ciclesonide|mesh-list
44736116|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477406|NCT04141410|Simendan|simendan|mesh-list
44477407|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44477408|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
44477409|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44477410|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44477411|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477412|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477413|NCT04141410|Protective Agents|protective agents|mesh-ancestor
44477414|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477415|NCT04141553|Diltiazem|diltiazem|mesh-list
44477416|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44477417|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44477418|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477419|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477420|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44477421|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477422|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
44477423|NCT04141163|Metformin|metformin|mesh-list
44477424|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44477425|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477426|NCT04140578|Ertapenem|ertapenem|mesh-list
44477427|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477428|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477429|NCT04140487|Azacitidine|azacitidine|mesh-list
44477430|NCT04140487|Venetoclax|venetoclax|mesh-list
44477431|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477432|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
44477433|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477434|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477435|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477436|NCT04140448|Ranibizumab|ranibizumab|mesh-list
44477437|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43934533|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477438|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44477439|NCT04140448|Growth Substances|growth substances|mesh-ancestor
44477440|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477441|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44477442|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477443|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
44477444|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44477445|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44477446|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477447|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
44477448|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
44477449|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477450|NCT04140461|Amphotericin B|amphotericin b|mesh-list
44477451|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44477452|NCT04140461|Flucytosine|flucytosine|mesh-list
44477453|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477454|NCT04140461|Amebicides|amebicides|mesh-ancestor
44477455|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44477456|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44477457|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477458|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
44477459|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
44477460|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477461|NCT04140591|Propranolol|propranolol|mesh-list
44477462|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44477463|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44477464|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44477465|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477466|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477467|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477468|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477469|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477470|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44477471|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
44477472|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477473|NCT04140409|Octreotide|octreotide|mesh-list
44477474|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477475|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44477476|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477477|NCT04140318|Paclitaxel|paclitaxel|mesh-list
44477478|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44477479|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477480|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477481|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
43934568|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
44477482|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477483|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477484|NCT04140006|Alendronate|alendronate|mesh-list
44477485|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44477486|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477487|NCT04140058|Ondansetron|ondansetron|mesh-list
44477488|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
44477489|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
44477490|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477491|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477492|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477493|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
44477494|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
44477495|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44477496|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
44477497|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477498|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477499|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44477500|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44477501|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477502|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477503|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44477504|NCT04140201|Simvastatin|simvastatin|mesh-list
44477505|NCT04140201|Fenofibrate|fenofibrate|mesh-list
44477506|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44477507|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44477508|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
44477509|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477510|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44477511|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44477512|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477513|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
44477514|NCT04146298|Fludarabine|fludarabine|mesh-list
44477516|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44477517|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477518|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
44477519|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477520|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477521|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44477522|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
44477523|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477524|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477525|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44477526|NCT04147351|Bevacizumab|bevacizumab|mesh-list
44477527|NCT04147351|Atezolizumab|atezolizumab|mesh-list
44477528|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477529|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477530|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44477531|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44477532|NCT04147351|Growth Substances|growth substances|mesh-ancestor
44477533|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477534|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44477535|NCT04140396|Lidocaine|lidocaine|mesh-list
44477536|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
44477537|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
44477538|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477539|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477540|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
44477541|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477542|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477543|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44477544|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44477545|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477546|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477547|NCT04145674|Methadone|methadone|mesh-list
44477548|NCT04145674|D-methadone|d-methadone|mesh-list
44477549|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44477550|NCT04145674|Narcotics|narcotics|mesh-ancestor
44477551|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477552|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477553|NCT04145674|Analgesics|analgesics|mesh-ancestor
44477554|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
44477555|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477556|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
44477557|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
44477558|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477559|NCT04146324|Nivolumab|nivolumab|mesh-list
44477560|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477561|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477562|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44477563|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477564|NCT04141579|Evolocumab|evolocumab|mesh-list
44477565|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44477566|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44477567|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
44477568|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477569|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43888550|NCT04536662|Hormones|hormones|mesh-ancestor
44477570|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
44477571|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
44477572|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44477573|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44477574|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477575|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477576|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477577|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477578|NCT04144582|Docetaxel|docetaxel|mesh-list
44477579|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477580|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477581|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44477582|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477583|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477584|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44477585|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
44477586|NCT04146038|Azacitidine|azacitidine|mesh-list
44477587|NCT04146038|Decitabine|decitabine|mesh-list
44477588|NCT04146038|Venetoclax|venetoclax|mesh-list
44477589|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477590|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
44477591|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477592|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477593|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477594|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44477595|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477596|NCT04146038|Analgesics|analgesics|mesh-ancestor
44477597|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
44477598|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477599|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477600|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477601|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477602|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44477603|NCT04148495|Acetaminophen|acetaminophen|mesh-list
44477604|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477605|NCT04148495|Analgesics|analgesics|mesh-ancestor
44477606|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
44477607|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477608|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477609|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
44477610|NCT04140786|Gentamicins|gentamicins|mesh-list
44477611|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477612|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477613|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44477614|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477615|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736117|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736118|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44736119|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
44736120|NCT04544436|Hormones|hormones|mesh-ancestor
43934711|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736121|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736122|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44736123|NCT04544436|Protective Agents|protective agents|mesh-ancestor
44736124|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
44736125|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
44736126|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736127|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736128|NCT04524000|Fulvestrant|fulvestrant|mesh-list
44736129|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44736130|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465123|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
44736131|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44477616|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44477617|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44477618|NCT04140136|Tocotrienols|tocotrienols|mesh-list
44477619|NCT04140136|Vitamin E|vitamin e|mesh-list
44477620|NCT04140136|Tocopherols|tocopherols|mesh-list
44477621|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
44477622|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477623|NCT04140136|Protective Agents|protective agents|mesh-ancestor
44477624|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477625|NCT04140136|Vitamins|vitamins|mesh-ancestor
44477626|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
44477627|NCT04146532|Aspirin|aspirin|mesh-list
44477628|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44477629|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477631|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
44477632|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477633|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477634|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477635|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477636|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44477637|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43934753|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
44477638|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477639|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44477640|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44477641|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477642|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
44477643|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44477644|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44477645|NCT04147845|Triamcinolone|triamcinolone|mesh-list
44477646|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44477647|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44477648|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44477649|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477650|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
44477651|NCT04147845|Hormones|hormones|mesh-ancestor
44477652|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477653|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477654|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477655|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
44477656|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477657|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477658|NCT05582265|Paclitaxel|paclitaxel|mesh-list
44477659|NCT05582265|Cisplatin|cisplatin|mesh-list
44477660|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44477661|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477662|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477663|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
44477664|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477665|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477666|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
44477667|NCT05586477|Promethazine|promethazine|mesh-list
44477668|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44477669|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44477670|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477671|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477672|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
44477673|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
44477674|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
44477675|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477676|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
44477677|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
44477678|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477679|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44477680|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
44477681|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
44477682|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477683|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477684|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44477685|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
44477686|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
44477687|NCT05586438|Colistin|colistin|mesh-list
44477688|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477689|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477690|NCT05581719|Nivolumab|nivolumab|mesh-list
44477691|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736132|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44477692|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477693|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44477694|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477695|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44477696|NCT05581706|Calcium|calcium|mesh-list
44477697|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44477698|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477699|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477700|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
44477701|NCT05581420|Trace Elements|trace elements|mesh-ancestor
44477702|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
44477703|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477704|NCT05581030|Rituximab|rituximab|mesh-list
44477705|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477706|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477707|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
44477708|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477709|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477710|NCT05580887|Paclitaxel|paclitaxel|mesh-list
44477711|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
44477712|NCT05580887|Carboplatin|carboplatin|mesh-list
44477713|NCT05580887|Doxorubicin|doxorubicin|mesh-list
44477714|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44477715|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477716|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477717|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44477718|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477719|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477720|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477721|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
44477722|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477723|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477724|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44477725|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
44477726|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44477727|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44477728|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44477729|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44477730|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477731|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
44477732|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477733|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44477734|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44477735|NCT05580861|Analgesics|analgesics|mesh-ancestor
44477736|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
44477737|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477738|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477739|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477740|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477741|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477742|NCT05580822|Tenecteplase|tenecteplase|mesh-list
44477743|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44477744|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44477745|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477746|NCT05580666|Azithromycin|azithromycin|mesh-list
44477747|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44477748|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44477749|NCT05580094|Anesthetics|anesthetics|mesh-list
44477750|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477751|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477752|NCT05589766|Niacinamide|niacinamide|mesh-list
44477753|NCT05589766|Niacin|niacin|mesh-list
44477754|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
44477755|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
44477756|NCT05589766|Vitamins|vitamins|mesh-ancestor
44477757|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
44477758|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477759|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44477760|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
44477761|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477762|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44477763|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
44477764|NCT05587608|Anesthetics|anesthetics|mesh-list
44477765|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477766|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736133|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44477767|NCT05586100|Cetuximab|cetuximab|mesh-list
44477768|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477769|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477770|NCT05580562|TIC10 compound|tic10 compound|mesh-list
44477771|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477772|NCT05586009|Cisplatin|cisplatin|mesh-list
44477773|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477774|NCT05585086|Peppermint oil|peppermint oil|mesh-list
44477775|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
44477776|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
44477777|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477778|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477779|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477780|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
44477781|NCT05583552|Imetelstat|imetelstat|mesh-list
44477782|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
44477783|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477784|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477785|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477786|NCT05583474|Carteolol|carteolol|mesh-list
44477787|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44477788|NCT05583474|Latanoprost|latanoprost|mesh-list
44477789|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44477790|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44477791|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44477792|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477793|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477794|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477795|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477796|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44477797|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44477798|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
44477799|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
44477800|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477801|NCT05583409|Osimertinib|osimertinib|mesh-list
44477802|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477803|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477804|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477805|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477806|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
44477807|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44477808|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477809|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477810|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44477811|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44477812|NCT05583266|Protective Agents|protective agents|mesh-ancestor
44477813|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477814|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
44477815|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44477816|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
44477817|NCT05583175|Venetoclax|venetoclax|mesh-list
44477818|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477819|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
44477820|NCT05583149|Fludarabine|fludarabine|mesh-list
44477821|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
44477822|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477823|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
44477824|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477825|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477826|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44477827|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
44477828|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477829|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477830|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44477831|NCT05583071|Rituximab|rituximab|mesh-list
44477832|NCT05583071|Methotrexate|methotrexate|mesh-list
44477833|NCT05583071|Lenalidomide|lenalidomide|mesh-list
44477834|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477835|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477836|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
44477837|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477838|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477839|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44477840|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
44477841|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44477842|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44477843|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
44477844|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477845|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44477846|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477847|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44477848|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477849|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44477850|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44477851|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44477852|NCT05583071|Growth Substances|growth substances|mesh-ancestor
44477853|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
44477854|NCT05583058|Hormones|hormones|mesh-list
44477855|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477856|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477857|NCT05582993|Factor VIII|factor viii|mesh-list
44477858|NCT05582993|Coagulants|coagulants|mesh-ancestor
44477859|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44477860|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44477861|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477862|NCT05582837|Topiramate|topiramate|mesh-list
44477863|NCT05582837|Nortriptyline|nortriptyline|mesh-list
44477864|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
44477865|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44477866|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477867|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44477868|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
44477869|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477870|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44477871|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44477872|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44477873|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477874|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
44477875|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44477876|NCT05582811|Riociguat|riociguat|mesh-list
44477877|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
44477878|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477879|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
44477880|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44477881|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477882|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477883|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44477884|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44477885|NCT05582577|Bevacizumab|bevacizumab|mesh-list
44477886|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477887|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477888|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44477889|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44477890|NCT05582577|Growth Substances|growth substances|mesh-ancestor
44477891|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477892|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
44477893|NCT05582499|Paclitaxel|paclitaxel|mesh-list
44477894|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
44477895|NCT05582499|Carboplatin|carboplatin|mesh-list
44477896|NCT05582499|Trastuzumab|trastuzumab|mesh-list
44477897|NCT05582499|Letrozole|letrozole|mesh-list
44477898|NCT05582499|Epirubicin|epirubicin|mesh-list
44477899|NCT05582499|Pertuzumab|pertuzumab|mesh-list
44477900|NCT05582499|Goserelin|goserelin|mesh-list
43935033|NCT00810576|Bortezomib|bortezomib|mesh-list
44477901|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44477902|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477903|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44477904|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44477905|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44477906|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477907|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44477908|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
44477909|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477910|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44477911|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44477912|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
44477913|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44477914|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44477915|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44477916|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44477917|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477918|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44477919|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
44477920|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477921|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44477922|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44477923|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44477924|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44477925|NCT05582317|Simvastatin|simvastatin|mesh-list
44477926|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44477927|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44477928|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
44477929|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477930|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44477931|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44477932|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477933|NCT05582278|Lenvatinib|lenvatinib|mesh-list
44477934|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44477935|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477936|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477937|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477938|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477939|NCT05582213|Anesthetics|anesthetics|mesh-list
44477940|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477941|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477942|NCT05582135|Morphine|morphine|mesh-list
44477943|NCT05582135|Esketamine|esketamine|mesh-list
44477944|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44477945|NCT05582135|Narcotics|narcotics|mesh-ancestor
44477946|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44477947|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477948|NCT05582135|Analgesics|analgesics|mesh-ancestor
44477949|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
44477950|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477951|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
44477952|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477953|NCT05582109|Lenvatinib|lenvatinib|mesh-list
44477954|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477955|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477956|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477957|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477958|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44477959|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44477960|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477961|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477962|NCT05581992|Omeprazole|omeprazole|mesh-list
44477963|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44477964|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477965|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44477966|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44477967|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477968|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44477969|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44477970|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477971|NCT05581875|Dexamethasone|dexamethasone|mesh-list
44477972|NCT05581875|Daratumumab|daratumumab|mesh-list
44477973|NCT05581875|Pomalidomide|pomalidomide|mesh-list
44477974|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44477975|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
44477976|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
44477977|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44477978|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477979|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44477980|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
44477981|NCT05581875|Hormones|hormones|mesh-ancestor
44477982|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44477983|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44477984|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44477985|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
44477986|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44477987|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44477988|NCT05581875|Growth Substances|growth substances|mesh-ancestor
44477989|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
44477990|NCT05581797|Psilocybin|psilocybin|mesh-list
44477991|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
44477992|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44477993|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44477994|NCT05586360|Simvastatin|simvastatin|mesh-list
44477995|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44477996|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44477997|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
44477998|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44477999|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44234684|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736167|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736168|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736169|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736171|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
44736172|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44736173|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736174|NCT04402073|Cisplatin|cisplatin|mesh-list
44736175|NCT04402073|Vincristine|vincristine|mesh-list
44736176|NCT04402073|Lomustine|lomustine|mesh-list
44736177|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736178|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736179|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736180|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736181|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736182|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736183|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736184|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
44736185|NCT04396873|11C-PS13|11c-ps13|mesh-list
44736186|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44736187|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736188|NCT04381832|Docetaxel|docetaxel|mesh-list
44736189|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736190|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736191|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736192|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736193|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478008|NCT05582421|Diclofenac|diclofenac|mesh-list
44478009|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478010|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478011|NCT05582421|Analgesics|analgesics|mesh-ancestor
44478012|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
44478013|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478014|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478015|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478016|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478017|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44478018|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478019|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478020|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
44478021|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44478022|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478023|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
44478024|NCT03580473|Dexamethasone|dexamethasone|mesh-list
44478025|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44478026|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478027|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
44478028|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
44478029|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478030|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478031|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478032|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
44478033|NCT03580473|Hormones|hormones|mesh-ancestor
44478034|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478035|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44478036|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478037|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478038|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478039|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478040|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478041|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44478042|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44478043|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44478044|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
44478045|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478046|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44478047|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44478048|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44478049|NCT03584711|Panitumumab|panitumumab|mesh-list
44478050|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478051|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478052|NCT03582475|Cisplatin|cisplatin|mesh-list
44478053|NCT03582475|Carboplatin|carboplatin|mesh-list
44478054|NCT03582475|Docetaxel|docetaxel|mesh-list
44478055|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
44478056|NCT03582475|Etoposide|etoposide|mesh-list
44478057|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
44478058|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
44478059|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478060|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478061|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478062|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478063|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478064|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478065|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478066|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44478067|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44478068|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478069|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
44478070|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478071|NCT03581487|Durvalumab|durvalumab|mesh-list
44478072|NCT03581487|Ipilimumab|ipilimumab|mesh-list
44478073|NCT03581487|Tremelimumab|tremelimumab|mesh-list
44478074|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
44478075|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44478076|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
44478077|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478078|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478079|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
44478080|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478081|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44478082|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297031|NCT00810316|Clonazepam|clonazepam|mesh-list
44478083|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
44478084|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44478085|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
44478086|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
44478087|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44478088|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478089|NCT03589898|Gabapentin|gabapentin|mesh-list
44478090|NCT03589898|Analgesics|analgesics|mesh-ancestor
44478091|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
44478092|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478093|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478094|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
44478095|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44478096|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44478097|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478098|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44478099|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44478100|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44478101|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478102|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478103|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
44478104|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
44478105|NCT03585465|Capecitabine|capecitabine|mesh-list
44478106|NCT03585465|Nivolumab|nivolumab|mesh-list
44478107|NCT03585465|Vinblastine|vinblastine|mesh-list
44478108|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44478109|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
44478110|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478111|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478112|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44478113|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
44478114|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478115|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478116|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44478117|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478118|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
44478119|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478120|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44478121|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478122|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478123|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478124|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478125|NCT03582137|Cannabidiol|cannabidiol|mesh-list
44478126|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
44478127|NCT03584152|Acetaminophen|acetaminophen|mesh-list
44478128|NCT03584152|Ibuprofen|ibuprofen|mesh-list
44478129|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478130|NCT03584152|Analgesics|analgesics|mesh-ancestor
44478131|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
44478132|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478133|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478134|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
44478135|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478136|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478137|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478138|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44478139|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478140|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478141|NCT03589729|Cytarabine|cytarabine|mesh-list
44478142|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44478143|NCT03589729|Idarubicin|idarubicin|mesh-list
44478144|NCT03589729|Cladribine|cladribine|mesh-list
44478145|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
44478146|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
44478147|NCT03589729|Razoxane|razoxane|mesh-list
44478148|NCT03589729|Calicheamicins|calicheamicins|mesh-list
44478149|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478150|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
44478151|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478152|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478153|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
44478154|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478155|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44478156|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
44478157|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478158|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44478159|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44478160|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44478161|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478162|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478163|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44478164|NCT03589729|Protective Agents|protective agents|mesh-ancestor
44478165|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478166|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478168|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44478169|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
44478170|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
44478171|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478172|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
44478173|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44478174|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44478175|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
44478176|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
44478177|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478178|NCT03589690|Protective Agents|protective agents|mesh-ancestor
44478179|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478180|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
44478181|NCT03589690|Vitamins|vitamins|mesh-ancestor
44478182|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
44478183|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
44478184|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44478185|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
44478186|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478187|NCT03589495|Expectorants|expectorants|mesh-ancestor
44478188|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
44478189|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44478190|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
44478191|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478192|NCT03589495|Protective Agents|protective agents|mesh-ancestor
44478193|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478194|NCT03589495|Antidotes|antidotes|mesh-ancestor
44478195|NCT03589430|Protein C|protein c|mesh-list
44478196|NCT03589430|Antithrombins|antithrombins|mesh-list
44478197|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
44478198|NCT03589430|Protein S|protein s|mesh-list
44478199|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44478200|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
44478201|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478202|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478203|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
44478204|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44478205|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44478206|NCT03589222|Dexamethasone|dexamethasone|mesh-list
44478207|NCT03589222|Bortezomib|bortezomib|mesh-list
44478208|NCT03589222|Daratumumab|daratumumab|mesh-list
44478209|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478210|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
44478211|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
44478212|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478213|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478214|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478215|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
44478216|NCT03589222|Hormones|hormones|mesh-ancestor
44478217|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478218|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44478219|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478220|NCT03589066|Rotigotine|rotigotine|mesh-list
44478221|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
44478222|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
44478223|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478224|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478225|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478226|NCT03589040|Darunavir|darunavir|mesh-list
44478227|NCT03589040|Rilpivirine|rilpivirine|mesh-list
44478228|NCT03589040|Etonogestrel|etonogestrel|mesh-list
44478229|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44478230|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44478231|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44478232|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478233|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478234|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44478235|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44478236|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
44478237|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478238|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44478239|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44478240|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44478241|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
44478242|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478243|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478258|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44478259|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44478260|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44478261|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
44478262|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478263|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478264|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44478265|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44478266|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44478267|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44478268|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44478269|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
44478270|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44478271|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478272|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478273|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478274|NCT03588988|Analgesics|analgesics|mesh-ancestor
44478275|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
44478276|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478277|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44478278|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44478279|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44478280|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44478281|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935406|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478282|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478284|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478285|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478286|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44478287|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736213|NCT04336943|Durvalumab|durvalumab|mesh-list
44736214|NCT04336943|Olaparib|olaparib|mesh-list
44736215|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44736216|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
44478288|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44478289|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44478290|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478291|NCT03588715|Interferons|interferons|mesh-list
44478292|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
44478293|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
44478294|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43889204|NCT04529811|Rifaximin|rifaximin|mesh-list
44478295|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
44478296|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478297|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
44478298|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478299|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
44478300|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478301|NCT03588689|Ropivacaine|ropivacaine|mesh-list
44478302|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
44478303|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
44478304|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478305|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478306|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
44478307|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478308|NCT03588676|Melatonin|melatonin|mesh-list
44478309|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
44478310|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478311|NCT03588676|Protective Agents|protective agents|mesh-ancestor
44478312|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478313|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478314|NCT03588611|Hirudins|hirudins|mesh-list
44478315|NCT03588611|Bivalirudin|bivalirudin|mesh-list
44478316|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
44478317|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44478318|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
44478319|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478320|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478321|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
44478322|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44478323|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43611920|NCT03169504|Xhance|xhance|mesh-list
44478324|NCT03588533|Cisplatin|cisplatin|mesh-list
44478325|NCT03588533|Capecitabine|capecitabine|mesh-list
44478326|NCT03588533|Trastuzumab|trastuzumab|mesh-list
44478327|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478328|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478329|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
44478330|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478331|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478332|NCT03588494|Endostar protein|endostar protein|mesh-list
44478333|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44478334|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44478335|NCT03588494|Growth Substances|growth substances|mesh-ancestor
44478336|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478337|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
44478338|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478339|NCT03588429|Sevoflurane|sevoflurane|mesh-list
44478340|NCT03588429|Isoflurane|isoflurane|mesh-list
44478341|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44478342|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44478343|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
44478344|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
44478345|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478346|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478347|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
44478348|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44478349|NCT03588351|Chitosan|chitosan|mesh-list
44478350|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44478351|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478352|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
44478353|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478354|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44478355|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44478356|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
44478357|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478358|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44478359|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
44478360|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
44478361|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
44478362|NCT03588351|Coagulants|coagulants|mesh-ancestor
44478363|NCT03588338|Acetaminophen|acetaminophen|mesh-list
44478364|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478365|NCT03588338|Analgesics|analgesics|mesh-ancestor
44478366|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
44478367|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478368|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478369|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
44478370|NCT03588273|Amoxicillin|amoxicillin|mesh-list
44478371|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478372|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478374|NCT03588091|Trastuzumab|trastuzumab|mesh-list
44478375|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478376|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478377|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478378|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478379|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478380|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478381|NCT03588039|Paclitaxel|paclitaxel|mesh-list
44478382|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
44478383|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478384|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478385|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478386|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478387|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478388|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478389|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478390|NCT03587779|Sevoflurane|sevoflurane|mesh-list
44478391|NCT03587779|Desflurane|desflurane|mesh-list
44478392|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44478393|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44478394|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
44478395|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
44478396|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478397|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478398|NCT03587558|Flecainide|flecainide|mesh-list
44478399|NCT03587558|Carvedilol|carvedilol|mesh-list
44478400|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44478401|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44478402|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
44478403|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478404|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478405|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478406|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44478407|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
44478408|NCT03587558|Protective Agents|protective agents|mesh-ancestor
44478409|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44478410|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44478411|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44478412|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
44478413|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44478414|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44478415|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44478416|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44478417|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44478418|NCT03587324|Clopidogrel|clopidogrel|mesh-list
44478419|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44478420|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44478421|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44478422|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44478423|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
44478424|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478425|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478426|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478427|NCT03587285|Goserelin|goserelin|mesh-list
44478428|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
44478429|NCT03587285|Bicalutamide|bicalutamide|mesh-list
44478430|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44478431|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478432|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44478433|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478434|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478435|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
44478436|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478437|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297359|NCT00811876|Leuprolide|leuprolide|mesh-list
44478438|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44478439|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
44478441|NCT03587220|Capsaicin|capsaicin|mesh-list
44478442|NCT03587220|Histamine|histamine|mesh-list
44478443|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
44478444|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
44478445|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624575|NCT03919435|Renal Agents|renal agents|mesh-ancestor
44478446|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478447|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
44478448|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478449|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44478450|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44478451|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44478452|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44478453|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478454|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
44478455|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935540|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
44478456|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
44478457|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
44478458|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478459|NCT03587194|Apremilast|apremilast|mesh-list
44478460|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478461|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478462|NCT03587194|Analgesics|analgesics|mesh-ancestor
44478463|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
44478464|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478465|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478466|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478467|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478468|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44478469|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44478470|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478471|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478472|NCT03587129|Apatinib|apatinib|mesh-list
44478473|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478474|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44478475|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478476|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478477|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44478478|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44478479|NCT03586869|Leucovorin|leucovorin|mesh-list
44478480|NCT03586869|Paclitaxel|paclitaxel|mesh-list
44478481|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
44478482|NCT03586869|Bevacizumab|bevacizumab|mesh-list
44478483|NCT03586869|Fluorouracil|fluorouracil|mesh-list
44478484|NCT03586869|Capecitabine|capecitabine|mesh-list
44478485|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
44478486|NCT03586869|Avelumab|avelumab|mesh-list
44478487|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478488|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478489|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478490|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478491|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478492|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478493|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140577|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
44478494|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
44478495|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478496|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478497|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44478498|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
44478499|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44478500|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478501|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44478502|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44478503|NCT03586869|Growth Substances|growth substances|mesh-ancestor
44478504|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
44478505|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
44478506|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478507|NCT03586869|Antidotes|antidotes|mesh-ancestor
44478508|NCT03586869|Protective Agents|protective agents|mesh-ancestor
44478509|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
44478510|NCT03586869|Vitamins|vitamins|mesh-ancestor
44478511|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
44478512|NCT03586817|Palonosetron|palonosetron|mesh-list
44478513|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
44478514|NCT03586817|Aprepitant|aprepitant|mesh-list
44478516|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
44478517|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478518|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478519|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478520|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44478521|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44478522|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
44478523|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478524|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478525|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44478526|NCT03586791|Anesthetics|anesthetics|mesh-list
44478527|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478528|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478529|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44478530|NCT03586674|Fenofibrate|fenofibrate|mesh-list
44478531|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44478532|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
44478533|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478534|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44478535|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44478536|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478537|NCT03586466|Buprenorphine|buprenorphine|mesh-list
44478538|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44478539|NCT03586466|Naloxone|naloxone|mesh-list
44478540|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44478541|NCT03586466|Narcotics|narcotics|mesh-ancestor
44478542|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478543|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478544|NCT03586466|Analgesics|analgesics|mesh-ancestor
44478545|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
44478546|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478547|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44736217|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44736218|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
44736219|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736220|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736221|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
44736222|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736223|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736224|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736225|NCT04304820|Cyclosporine|cyclosporine|mesh-list
44736226|NCT04304820|Cyclosporins|cyclosporins|mesh-list
44736227|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44736228|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736229|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736230|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736231|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
44736232|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736233|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
44736234|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736235|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
44736236|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736237|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44736238|NCT04284774|Tipifarnib|tipifarnib|mesh-list
44736239|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478548|NCT03586323|Lidocaine|lidocaine|mesh-list
44478549|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
44478550|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
44478551|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478552|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478553|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
44478554|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478556|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44478557|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44478558|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44478559|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478560|NCT03586141|Chrysarobin|chrysarobin|mesh-list
44478561|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478562|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478563|NCT03586141|Analgesics|analgesics|mesh-ancestor
44478564|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
44478565|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478566|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478567|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478568|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478569|NCT03586089|Diazepam|diazepam|mesh-list
44478570|NCT03586089|Phenobarbital|phenobarbital|mesh-list
44478571|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
44478572|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44478573|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478574|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478575|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44478576|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44478577|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478578|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478579|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
44478580|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
44478581|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44478582|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44478583|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44478584|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44478585|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
44478586|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
44478587|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478588|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478589|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44478590|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44478591|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44478592|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44478593|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44478594|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44478595|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
44478596|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
44478597|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
44478598|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478599|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478600|NCT03585998|Cisplatin|cisplatin|mesh-list
44478601|NCT03585998|Etoposide|etoposide|mesh-list
44478602|NCT03585998|Durvalumab|durvalumab|mesh-list
44478603|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478604|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478605|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44478606|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44478607|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478608|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478609|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44478610|NCT03585829|Prednisolone|prednisolone|mesh-list
44478611|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
44478612|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478613|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
44478614|NCT03585829|Hormones|hormones|mesh-ancestor
44478615|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478616|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478617|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44478618|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478619|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44478620|NCT03585751|Simvastatin|simvastatin|mesh-list
44478621|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478622|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44478623|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44478625|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478626|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44478627|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44478628|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478629|NCT03585738|Folic Acid|folic acid|mesh-list
44478630|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
44478631|NCT03585738|Inositol|inositol|mesh-list
44478632|NCT03585738|Hematinics|hematinics|mesh-ancestor
44478633|NCT03585738|Vitamins|vitamins|mesh-ancestor
44478634|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
44478635|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478636|NCT03585725|Ribavirin|ribavirin|mesh-list
44478637|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
44478638|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478639|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
44478640|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478641|NCT03585686|Cytarabine|cytarabine|mesh-list
44478642|NCT03585686|Vemurafenib|vemurafenib|mesh-list
44478643|NCT03585686|Cladribine|cladribine|mesh-list
44478644|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478645|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
44478646|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478647|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478648|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
44478649|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478650|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44478651|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
44478652|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478653|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44478654|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478655|NCT03585673|Docetaxel|docetaxel|mesh-list
44478656|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
44478657|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478658|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478659|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478660|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478661|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478662|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44478663|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44478664|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44478665|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44478666|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478667|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
44478668|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478669|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478670|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44478671|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478672|NCT03585556|Prednisolone|prednisolone|mesh-list
44478673|NCT03585556|Ranibizumab|ranibizumab|mesh-list
44478674|NCT03585556|Aflibercept|aflibercept|mesh-list
44478675|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478676|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44478677|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44478678|NCT03585556|Growth Substances|growth substances|mesh-ancestor
44478679|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478680|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
44478681|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935747|NCT04603248|Nivolumab|nivolumab|mesh-list
44478682|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
44478683|NCT03585556|Hormones|hormones|mesh-ancestor
44478684|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478685|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44478686|NCT03585530|Raltitrexed|raltitrexed|mesh-list
44478687|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478688|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
44478689|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478690|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478691|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44478692|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478693|NCT03585426|Vancomycin|vancomycin|mesh-list
44478694|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478695|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478696|NCT03585374|Acetaminophen|acetaminophen|mesh-list
44478697|NCT03585374|Ketoprofen|ketoprofen|mesh-list
44478698|NCT03585374|Morphine|morphine|mesh-list
44478699|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
44478700|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44478701|NCT03585374|Narcotics|narcotics|mesh-ancestor
44478702|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478703|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478704|NCT03585374|Analgesics|analgesics|mesh-ancestor
44478705|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
44478706|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478707|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478708|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
44478709|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478710|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478711|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478712|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44478713|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478714|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478715|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44478716|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
44478717|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
44478718|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
44478719|NCT03585179|Hydroquinone|hydroquinone|mesh-list
44478720|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44478721|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44478722|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478723|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
44478724|NCT03585179|Coagulants|coagulants|mesh-ancestor
44478725|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
44478726|NCT03585179|Protective Agents|protective agents|mesh-ancestor
44478727|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478728|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44478729|NCT03585140|Doxycycline|doxycycline|mesh-list
44478731|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478732|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478733|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
44478734|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44478735|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44478736|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478737|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478738|NCT03585140|Analgesics|analgesics|mesh-ancestor
44478739|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
44478740|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478741|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478742|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478743|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478744|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478745|NCT03585101|Grazoprevir|grazoprevir|mesh-list
44478746|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44478747|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
44478748|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478749|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44478750|NCT03585036|Tramadol|tramadol|mesh-list
44478751|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44478752|NCT03585036|Narcotics|narcotics|mesh-ancestor
44478753|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478754|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478755|NCT03585036|Analgesics|analgesics|mesh-ancestor
44478756|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
44478757|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478758|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478759|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478760|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478761|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478762|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44478763|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
44478764|NCT03584984|Coagulants|coagulants|mesh-ancestor
44478765|NCT03584919|Doxycycline|doxycycline|mesh-list
44478766|NCT03584919|Cefuroxime|cefuroxime|mesh-list
44478767|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
44478768|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478769|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478770|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
44478771|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44478772|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44478773|NCT03584854|Carboprost|carboprost|mesh-list
44478774|NCT03584854|Dinoprost|dinoprost|mesh-list
44478775|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
44478776|NCT03584854|Methylergonovine|methylergonovine|mesh-list
44478777|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44478778|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
44478779|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478780|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478782|NCT03584841|Pilocarpine|pilocarpine|mesh-list
44478783|NCT03584841|Miotics|miotics|mesh-ancestor
44478784|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
44136815|NCT00165490|Cisplatin|cisplatin|mesh-list
44478785|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478786|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478788|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44478789|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
44478790|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478791|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478792|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
44478793|NCT03584698|Misoprostol|misoprostol|mesh-list
44478794|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44478795|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
44478796|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478797|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478798|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44478799|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478800|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
44478801|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478802|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43935833|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935834|NCT04037683|Misoprostol|misoprostol|mesh-list
43935835|NCT04037683|Oxytocin|oxytocin|mesh-list
43935836|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
43935837|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478803|NCT03584698|Analgesics|analgesics|mesh-ancestor
44478804|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
44478805|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478806|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478807|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478808|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44478809|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
44478810|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478811|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44478812|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478813|NCT03584178|Budesonide|budesonide|mesh-list
44478814|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478815|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44478816|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
44478817|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478818|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478819|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44478820|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
44478821|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
44478822|NCT03584178|Hormones|hormones|mesh-ancestor
44478823|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44478824|NCT03584087|Terlipressin|terlipressin|mesh-list
44478825|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44478826|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44478827|NCT03584074|Celecoxib|celecoxib|mesh-list
44478828|NCT03584074|Pregabalin|pregabalin|mesh-list
44478829|NCT03584074|Analgesics|analgesics|mesh-ancestor
44478830|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
44478831|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478832|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478833|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
44478834|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44478835|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44478836|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478837|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44478838|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44478839|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44478840|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478841|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44478842|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478843|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478844|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478845|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478846|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44478847|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44478848|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478849|NCT03583892|Gabapentin|gabapentin|mesh-list
44478850|NCT03583892|Analgesics|analgesics|mesh-ancestor
44478851|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
44478852|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478853|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478855|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44478856|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44478857|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478858|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889786|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
44736271|NCT04231877|Rituximab|rituximab|mesh-list
44736272|NCT04231877|Doxorubicin|doxorubicin|mesh-list
44736273|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44736274|NCT04231877|Etoposide|etoposide|mesh-list
44736275|NCT04231877|Daunorubicin|daunorubicin|mesh-list
44736276|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
44736277|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44736278|NCT04231877|Antibodies|antibodies|mesh-list
44736279|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
44736280|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44736281|NCT04231877|Lenograstim|lenograstim|mesh-list
44736282|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
44736283|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736284|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
44736285|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736286|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736287|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736288|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
44736289|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736290|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736291|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44736292|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43935877|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736293|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44736294|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44736295|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736296|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736297|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
44736298|NCT04231877|Hormones|hormones|mesh-ancestor
44736299|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736300|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44736301|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736302|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44736303|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
44736304|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
44736305|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736306|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736307|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736308|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
44736309|NCT04221035|Temozolomide|temozolomide|mesh-list
43935910|NCT03541486|Antiviral Agents|antiviral agents|mesh-ancestor
43935911|NCT03541486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736310|NCT04221035|Melphalan|melphalan|mesh-list
44736311|NCT04221035|Busulfan|busulfan|mesh-list
44736312|NCT04221035|Ifosfamide|ifosfamide|mesh-list
44736313|NCT04221035|Thiotepa|thiotepa|mesh-list
44736314|NCT04221035|Dacarbazine|dacarbazine|mesh-list
44736315|NCT04221035|Carboplatin|carboplatin|mesh-list
44736316|NCT04221035|Doxorubicin|doxorubicin|mesh-list
44736317|NCT04221035|Irinotecan|irinotecan|mesh-list
44736318|NCT04221035|Etoposide|etoposide|mesh-list
44736319|NCT04221035|Vincristine|vincristine|mesh-list
44736320|NCT04221035|Vindesine|vindesine|mesh-list
44736321|NCT04221035|Dinutuximab|dinutuximab|mesh-list
44736322|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736323|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
44736324|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736325|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736326|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736327|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
44478864|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44478865|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44478866|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478867|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
44478868|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
44478869|NCT03583567|Ranitidine|ranitidine|mesh-list
44478870|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44478871|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44478872|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478873|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44478874|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
44478875|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
44478876|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478877|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478878|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478879|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
44478880|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478881|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44478882|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44478883|NCT03583489|Ondansetron|ondansetron|mesh-list
44478884|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
44478885|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
44478886|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478887|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478888|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478889|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
44478890|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478891|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44478892|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
44478893|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478894|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478895|NCT03583489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44478896|NCT03583489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44478897|NCT03583489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478898|NCT03583489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44478899|NCT03583489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44478900|NCT03583476|Amoxicillin|amoxicillin|mesh-list
44478901|NCT03583476|Metronidazole|metronidazole|mesh-list
44478902|NCT03583476|Clarithromycin|clarithromycin|mesh-list
44478903|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44478904|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44478905|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478906|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44478907|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44478908|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44478909|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478910|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478911|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44478912|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44478913|NCT03583424|Cytarabine|cytarabine|mesh-list
44478914|NCT03583424|Etoposide|etoposide|mesh-list
44478915|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
44478916|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
44478917|NCT03583424|Melphalan|melphalan|mesh-list
44478918|NCT03583424|Venetoclax|venetoclax|mesh-list
44478919|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
44478920|NCT03583424|Carmustine|carmustine|mesh-list
44478921|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44478922|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44478923|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478924|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44478925|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44478926|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478927|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478928|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44478929|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
44478930|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
44478931|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478932|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44478933|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
44478934|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478935|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44478936|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
44478937|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44478938|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
44478939|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44478940|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44478941|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44478942|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44478943|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44478944|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44478945|NCT03583242|Growth Substances|growth substances|mesh-ancestor
44478946|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478947|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44478948|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44478949|NCT03583138|Buprenorphine|buprenorphine|mesh-list
44478950|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44478951|NCT03583138|Narcotics|narcotics|mesh-ancestor
44478952|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44478953|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478954|NCT03583138|Analgesics|analgesics|mesh-ancestor
44478955|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
44478956|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478957|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44478958|NCT03583021|Neostigmine|neostigmine|mesh-list
44478959|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44478960|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478961|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478962|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
44478963|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44478964|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478965|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44478966|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
44478967|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478968|NCT03582332|Indomethacin|indomethacin|mesh-list
44478970|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44478971|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44478972|NCT03582332|Analgesics|analgesics|mesh-ancestor
44478973|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
44478974|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44478975|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478976|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44478977|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44478978|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
44478979|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
44478980|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44478981|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44478982|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44478983|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478984|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44478985|NCT03582319|Formaldehyde|formaldehyde|mesh-list
44478986|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
44478987|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44478988|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
44478989|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44478990|NCT03582306|Protective Agents|protective agents|mesh-ancestor
44478991|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478992|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
44478993|NCT03582280|Calcium|calcium|mesh-list
44478994|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44478995|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44478996|NCT03582280|Antacids|antacids|mesh-ancestor
44478997|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44478998|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44478999|NCT03582098|Rituximab|rituximab|mesh-list
44479000|NCT03582098|Idelalisib|idelalisib|mesh-list
44479001|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479002|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479003|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
44479004|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479005|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479006|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479007|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479008|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44479009|NCT03582007|Murepavadin|murepavadin|mesh-list
44479010|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479011|NCT03581968|Pancrelipase|pancrelipase|mesh-list
44479012|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479013|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
44479014|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44479015|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298036|NCT00815048|Narcotics|narcotics|mesh-ancestor
44479017|NCT03581773|Hematinics|hematinics|mesh-ancestor
44479018|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
44479019|NCT03581773|Vitamins|vitamins|mesh-ancestor
44479020|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
44479021|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479022|NCT03581630|Naltrexone|naltrexone|mesh-list
44479023|NCT03581630|Bupropion|bupropion|mesh-list
44479024|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44479025|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44479026|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479027|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
44479028|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479029|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44479030|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
44479031|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44479032|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44479033|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44479034|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44479035|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479036|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
44479037|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479038|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44479039|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44479040|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479041|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44479042|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44479043|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479044|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
44479045|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
44479046|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
44479047|NCT03581149|Laxatives|laxatives|mesh-list
44479048|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479049|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
44479050|NCT03581149|Protective Agents|protective agents|mesh-ancestor
44479051|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479052|NCT03581149|Vitamins|vitamins|mesh-ancestor
44479053|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
44479054|NCT03581149|Cathartics|cathartics|mesh-ancestor
44479055|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44736328|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736329|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736330|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44736331|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44736332|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44736333|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44736334|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736335|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44736336|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736337|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736338|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736339|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736340|NCT04214262|Atezolizumab|atezolizumab|mesh-list
44736341|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44736342|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736343|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
44736344|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736345|NCT04203498|Nabiximols|nabiximols|mesh-list
44736346|NCT04203498|Analgesics|analgesics|mesh-ancestor
44736347|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
44736348|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736349|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736350|NCT04199728|Liraglutide|liraglutide|mesh-list
44736351|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44736352|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736353|NCT04199728|Incretins|incretins|mesh-ancestor
44736354|NCT04199728|Hormones|hormones|mesh-ancestor
44736355|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736356|NCT04195555|Ivosidenib|ivosidenib|mesh-list
44736357|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736358|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736359|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298116|NCT00815503|Ropivacaine|ropivacaine|mesh-list
44479056|NCT03580980|Acetaminophen|acetaminophen|mesh-list
44479057|NCT03580980|Ketamine|ketamine|mesh-list
44479058|NCT03580980|Morphine|morphine|mesh-list
44479059|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
44479060|NCT03580980|Analgesics|analgesics|mesh-ancestor
44479061|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
44479062|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479063|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479064|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44479065|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44479067|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
44479068|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479069|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44479070|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44479071|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479072|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479073|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479074|NCT03580980|Narcotics|narcotics|mesh-ancestor
44479075|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479076|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
44479077|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
44479078|NCT03580876|Azathioprine|azathioprine|mesh-list
44479079|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
44479080|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479081|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479082|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479083|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479084|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
44479085|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479086|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479087|NCT03580733|Caspofungin|caspofungin|mesh-list
44479088|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
44479089|NCT03580733|Clotrimazole|clotrimazole|mesh-list
44479090|NCT03580733|Miconazole|miconazole|mesh-list
44479091|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479092|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479093|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479094|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44479095|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44479096|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44479097|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44479098|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
44479099|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479100|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479101|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44479102|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44479103|NCT03580694|Cemiplimab|cemiplimab|mesh-list
44479104|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479105|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479106|NCT03580681|Vitamin E|vitamin e|mesh-list
44479107|NCT03580681|Vitamins|vitamins|mesh-ancestor
44479108|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
44479109|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479110|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
44479111|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479112|NCT03580681|Protective Agents|protective agents|mesh-ancestor
44479113|NCT03580590|Diltiazem|diltiazem|mesh-list
44479114|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
44479115|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44479116|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44479117|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479118|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
44479119|NCT03580590|Coagulants|coagulants|mesh-ancestor
44479120|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44479121|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44479122|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44479123|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479124|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479125|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
44479126|NCT03580395|Paclitaxel|paclitaxel|mesh-list
44479127|NCT03580395|Cisplatin|cisplatin|mesh-list
44479128|NCT03580395|Apatinib|apatinib|mesh-list
44479129|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479130|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479131|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479133|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479134|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479135|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479136|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479137|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
44479138|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44479139|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479140|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44479141|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
44479142|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479143|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479144|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479145|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479147|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479148|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479149|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
44479150|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479151|NCT03580135|Propolis|propolis|mesh-list
44479152|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479153|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
44479154|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44479155|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44479156|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479157|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
44479158|NCT03580018|Coagulants|coagulants|mesh-ancestor
44479159|NCT03583164|Olorofim|olorofim|mesh-list
44479160|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
44479161|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479162|NCT03589326|Cytarabine|cytarabine|mesh-list
44479163|NCT03589326|Dexamethasone|dexamethasone|mesh-list
44479164|NCT03589326|Prednisone|prednisone|mesh-list
44479165|NCT03589326|Methotrexate|methotrexate|mesh-list
44479166|NCT03589326|Vincristine|vincristine|mesh-list
44479167|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
44479168|NCT03589326|Ponatinib|ponatinib|mesh-list
44479169|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479170|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
44479171|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
44479172|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479173|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479174|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479175|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
44479176|NCT03589326|Hormones|hormones|mesh-ancestor
44479177|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479178|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44479179|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479180|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44479181|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
44479182|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44479183|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479184|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
44479185|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479186|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479187|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479188|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44479189|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479190|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
44479191|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479192|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44479193|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
44479194|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479195|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479196|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479197|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479198|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479199|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479200|NCT03583255|Dexamethasone|dexamethasone|mesh-list
44479201|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
44479202|NCT03583255|Ichthammol|ichthammol|mesh-list
44479203|NCT03583255|BB 1101|bb 1101|mesh-list
44479204|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479205|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
44479206|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
44479207|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479208|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479209|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479210|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
44479211|NCT03583255|Hormones|hormones|mesh-ancestor
44479212|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479213|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44479214|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479215|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
44479216|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479217|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479218|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479219|NCT03580499|Vitamins|vitamins|mesh-list
44479220|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
44479221|NCT03580499|Pyridoxal|pyridoxal|mesh-list
44479222|NCT03580499|Pyridoxine|pyridoxine|mesh-list
44479223|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
44479224|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
44479225|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479226|NCT03583866|Candesartan|candesartan|mesh-list
44479227|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44479228|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44479229|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44479230|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479231|NCT03583333|Linezolid|linezolid|mesh-list
44479232|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479233|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479234|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44479235|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479236|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479237|NCT03587038|Temozolomide|temozolomide|mesh-list
44479238|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44479239|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
44479240|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479241|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479242|NCT03582124|Panitumumab|panitumumab|mesh-list
44479243|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479244|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479245|NCT03589976|Sirolimus|sirolimus|mesh-list
44479246|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479247|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479248|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44479249|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479250|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
44479251|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479252|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
44479253|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479254|NCT03586947|Vitamin D|vitamin d|mesh-list
44479255|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
44479256|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
44479257|NCT03586947|Vitamins|vitamins|mesh-list
44479258|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
44479259|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479260|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44479261|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479262|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
44479263|NCT03586219|Narcotics|narcotics|mesh-ancestor
44479264|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479265|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479266|NCT03586219|Analgesics|analgesics|mesh-ancestor
44479267|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
44479268|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479269|NCT03584529|Vitamin D|vitamin d|mesh-list
44479270|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
44479271|NCT03584529|Vitamins|vitamins|mesh-ancestor
44479272|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
44479273|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479274|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44479275|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479276|NCT03581903|Vaccines|vaccines|mesh-list
44479277|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
44479278|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479279|NCT03158389|Sirolimus|sirolimus|mesh-list
44479280|NCT03158389|Atezolizumab|atezolizumab|mesh-list
44479281|NCT03158389|Palbociclib|palbociclib|mesh-list
44479282|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479283|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479284|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298310|NCT00816543|Docetaxel|docetaxel|mesh-list
44479285|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479286|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479287|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479288|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44479289|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
44479290|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479306|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
44479307|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479308|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479309|NCT03159936|Tofacitinib|tofacitinib|mesh-list
44479310|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479311|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479312|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479313|NCT03156816|Colchicine|colchicine|mesh-list
44479314|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
44479315|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479316|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479317|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479318|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479319|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479320|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479321|NCT03158805|Liraglutide|liraglutide|mesh-list
44479322|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44479323|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479324|NCT03158805|Incretins|incretins|mesh-ancestor
44479325|NCT03158805|Hormones|hormones|mesh-ancestor
44479326|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479327|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44479328|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44479329|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
44736378|NCT04172675|Gemcitabine|gemcitabine|mesh-list
44736379|NCT04172675|Mitomycins|mitomycins|mesh-list
44736380|NCT04172675|Mitomycin|mitomycin|mesh-list
44736381|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44736382|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
44736383|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736384|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736385|NCT04172675|Antiviral Agents|antiviral agents|mesh-ancestor
44736386|NCT04172675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736387|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736388|NCT04172675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736389|NCT04172675|Immunologic Factors|immunologic factors|mesh-ancestor
44736390|NCT04172675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736391|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44736392|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
44736393|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44479330|NCT03159598|Urethane|urethane|mesh-list
44479331|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479332|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44479333|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
44479334|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
44479335|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479336|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479337|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44479338|NCT03159754|Metronidazole|metronidazole|mesh-list
44479339|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
44479341|NCT03159754|Piperacillin|piperacillin|mesh-list
44479342|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44479343|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479344|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44479345|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44479346|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44479347|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44479348|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479349|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479350|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479351|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44479352|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44479353|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44479354|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44479355|NCT03159559|Alprostadil|alprostadil|mesh-list
44479356|NCT03159559|Clopidogrel|clopidogrel|mesh-list
44479357|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479358|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479359|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44479360|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44479361|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44479362|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44479363|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
44479364|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479365|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
44479366|NCT03159559|Urological Agents|urological agents|mesh-ancestor
44479367|NCT03159403|Oritavancin|oritavancin|mesh-list
44479368|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479369|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479370|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
44479371|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479372|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
44479373|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479374|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479375|NCT03159234|Epinephrine|epinephrine|mesh-list
44479376|NCT03159234|Racepinephrine|racepinephrine|mesh-list
44479377|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
44479378|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44479379|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44479380|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44479381|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479382|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479383|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479384|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43936467|NCT00825344|Etanercept|etanercept|mesh-list
44479385|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44479386|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
44479387|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479388|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479389|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44479390|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
44479391|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
44479392|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44479393|NCT03158935|Aldesleukin|aldesleukin|mesh-list
44479394|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
44479395|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
44479396|NCT03158935|Fludarabine|fludarabine|mesh-list
44479397|NCT03158935|Interleukin-2|interleukin-2|mesh-list
44479398|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479399|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
44479400|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479401|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479402|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44479403|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
44479404|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479405|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479406|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44479407|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479408|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479409|NCT03158935|Analgesics|analgesics|mesh-ancestor
44479410|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
44479411|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479413|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44479414|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
44479415|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479416|NCT03158584|Morphine|morphine|mesh-list
44479417|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479418|NCT03158584|Narcotics|narcotics|mesh-ancestor
44479419|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479420|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479421|NCT03158584|Analgesics|analgesics|mesh-ancestor
44479422|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
44479423|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479424|NCT03158792|Enoxaparin|enoxaparin|mesh-list
44479425|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
44479426|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
44479427|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44479428|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44479429|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479430|NCT03158142|Atropine|atropine|mesh-list
44479431|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44479432|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44479433|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44479434|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
44479435|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479436|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479437|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479438|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
44479439|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
44479440|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
44479441|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44479442|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44479443|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44479444|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479445|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479446|NCT03158246|Vitamin D|vitamin d|mesh-list
44479447|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
44479448|NCT03158246|Calcium|calcium|mesh-list
44479449|NCT03158246|Vitamins|vitamins|mesh-ancestor
44479450|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
44479451|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479452|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43936487|NCT00825500|Loxapine|loxapine|mesh-list
44479453|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44479454|NCT03158025|Zolpidem|zolpidem|mesh-list
44479455|NCT03158025|Suvorexant|suvorexant|mesh-list
44479456|NCT03158025|Lemborexant|lemborexant|mesh-list
44479457|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44479458|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44479459|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479460|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479461|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44479462|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
44479463|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
44479464|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479465|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479466|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44479467|NCT03157843|Heparin|heparin|mesh-list
44479468|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44479469|NCT03157843|Tinzaparin|tinzaparin|mesh-list
44479470|NCT03157843|Dalteparin|dalteparin|mesh-list
44479471|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
44479472|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44479473|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44479474|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479475|NCT03157791|Simethicone|simethicone|mesh-list
44479476|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
44479477|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479478|NCT03157791|Emollients|emollients|mesh-ancestor
44479479|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479480|NCT03157479|Anesthetics|anesthetics|mesh-list
44298546|NCT00817375|Analgesics|analgesics|mesh-ancestor
44479481|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44479482|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234687|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
44736412|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44736413|NCT04118920|Insulin|insulin|mesh-list
44736414|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44736415|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
44736416|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44736417|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736418|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44736419|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44479492|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479493|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479494|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479495|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479496|NCT03157388|Vancomycin|vancomycin|mesh-list
44479497|NCT03157388|Gentamicins|gentamicins|mesh-list
44479498|NCT03157388|Meropenem|meropenem|mesh-list
44479499|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479500|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479501|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44479502|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479503|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479504|NCT03156855|Bismuth|bismuth|mesh-list
44479505|NCT03156855|Antacids|antacids|mesh-ancestor
44479506|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479507|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479508|NCT03156920|Sumatriptan|sumatriptan|mesh-list
44479509|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44479510|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44479511|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44479512|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
44479513|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479514|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479515|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479516|NCT03156842|Amlodipine|amlodipine|mesh-list
44479517|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44479518|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44479519|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44479520|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44479521|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479522|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479523|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479524|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
44479525|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44479526|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44479527|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
44479528|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44479529|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44479530|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479531|NCT03156907|Buprenorphine|buprenorphine|mesh-list
44479532|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479533|NCT03156907|Narcotics|narcotics|mesh-ancestor
44479534|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479535|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479536|NCT03156907|Analgesics|analgesics|mesh-ancestor
44479537|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
44479538|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479539|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44479540|NCT03156829|Betamethasone|betamethasone|mesh-list
44140697|NCT00180128|Analgesics|analgesics|mesh-ancestor
44479541|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479542|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
44479543|NCT03156829|Hormones|hormones|mesh-ancestor
44479544|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479545|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479546|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479547|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44479548|NCT03156439|Huperzine A|huperzine a|mesh-list
44479549|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44479550|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479551|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479552|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44479553|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479554|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479555|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44479556|NCT03156439|Protective Agents|protective agents|mesh-ancestor
44479557|NCT03156361|Insulin|insulin|mesh-list
44479558|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44479559|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
44479560|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44479561|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479562|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
44479563|NCT03156296|Bupivacaine|bupivacaine|mesh-list
44479564|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44479565|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
44479566|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479567|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479568|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
44479569|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479570|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44479571|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479572|NCT03156296|Analgesics|analgesics|mesh-ancestor
44479573|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44479574|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44479575|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44479576|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44479577|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479578|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479579|NCT03156322|Fentanyl|fentanyl|mesh-list
44479580|NCT03156322|Bupivacaine|bupivacaine|mesh-list
44479581|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
44479582|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
44479583|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479584|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479585|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
44479586|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479587|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479588|NCT03156322|Narcotics|narcotics|mesh-ancestor
44479589|NCT03156322|Analgesics|analgesics|mesh-ancestor
44479590|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44479591|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44479592|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
44479593|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44479594|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479595|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479596|NCT03156036|Capecitabine|capecitabine|mesh-list
44479597|NCT03156036|Temozolomide|temozolomide|mesh-list
44479598|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479599|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
44479600|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479601|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479602|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44479603|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
44479604|NCT03156179|Calcium|calcium|mesh-list
44479605|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479606|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479607|NCT03156153|Bumetanide|bumetanide|mesh-list
44479608|NCT03156153|Diuretics|diuretics|mesh-ancestor
44479609|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
44479610|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479611|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44479612|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44479613|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479614|NCT03156231|Acetazolamide|acetazolamide|mesh-list
44479615|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
44479616|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44479617|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479618|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479619|NCT03156231|Diuretics|diuretics|mesh-ancestor
44479620|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
44479621|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479622|NCT03155971|Paclitaxel|paclitaxel|mesh-list
44479623|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479624|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479625|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479626|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479627|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479628|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479629|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
44479630|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
44479631|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44479632|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479633|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479634|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44479635|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44479636|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479637|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479638|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479639|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44479640|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
44479641|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44479642|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479643|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44479644|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44479645|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44479646|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
44479647|NCT03155984|Antibodies|antibodies|mesh-list
44479648|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
44479649|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479650|NCT03155568|Bupivacaine|bupivacaine|mesh-list
44479651|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
44479652|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
44479653|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479654|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479655|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
44479656|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479657|NCT03155646|Clonidine|clonidine|mesh-list
44479658|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
44479659|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
44479660|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44479661|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479662|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479663|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479664|NCT03155646|Analgesics|analgesics|mesh-ancestor
44479665|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
44479666|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479667|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44479668|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44479669|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44479670|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
44479671|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479672|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479673|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44479674|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
44479675|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
44479676|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44479677|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
44479678|NCT03155087|Metformin|metformin|mesh-list
44479679|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44479680|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736464|NCT04077515|Sirolimus|sirolimus|mesh-list
44736465|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44736466|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736467|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44736468|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736469|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
44736470|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736471|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
44736472|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736476|NCT04037527|Gemcitabine|gemcitabine|mesh-list
44736477|NCT04037527|Docetaxel|docetaxel|mesh-list
44736478|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44736479|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
44736480|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736481|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736482|NCT04037527|Antiviral Agents|antiviral agents|mesh-ancestor
44736483|NCT04037527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736484|NCT04037527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736485|NCT04037527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736486|NCT04037527|Immunologic Factors|immunologic factors|mesh-ancestor
44736487|NCT04037527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736488|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736489|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736490|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298779|NCT00818610|Cefuroxime|cefuroxime|mesh-list
44234689|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479682|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44479683|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
44479684|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479685|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479686|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479687|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44479688|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
44479689|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44479690|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44479691|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479692|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479693|NCT03155048|Estradiol|estradiol|mesh-list
44479694|NCT03155048|Estrogens|estrogens|mesh-list
44479695|NCT03155048|Hormones|hormones|mesh-ancestor
44479696|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479697|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479698|NCT03154827|Atezolizumab|atezolizumab|mesh-list
44479699|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479700|NCT03155035|Vitamin D|vitamin d|mesh-list
44479701|NCT03155035|Albendazole|albendazole|mesh-list
44479702|NCT03155035|Calcium|calcium|mesh-list
44479703|NCT03155035|Vitamins|vitamins|mesh-ancestor
44479704|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
44479705|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479706|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479707|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44479708|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
44479709|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44479710|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479711|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
44479712|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44479713|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44479714|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479715|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479716|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479717|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479718|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479719|NCT03154814|Urinastatin|urinastatin|mesh-list
44479720|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44479721|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44479722|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44479723|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479724|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479725|NCT03154723|Vitamin A|vitamin a|mesh-list
44479726|NCT03154723|Vitamins|vitamins|mesh-ancestor
44479727|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
44479728|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479729|NCT03154918|Gemcitabine|gemcitabine|mesh-list
44479730|NCT03154918|Dexamethasone|dexamethasone|mesh-list
44479731|NCT03154918|Etoposide|etoposide|mesh-list
44479732|NCT03154918|Ifosfamide|ifosfamide|mesh-list
44479733|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479734|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
44479735|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
44479736|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479737|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479738|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479739|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
44479740|NCT03154918|Hormones|hormones|mesh-ancestor
44479741|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479742|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44479743|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479744|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479745|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479746|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479747|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
44479748|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
44479749|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479750|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44479751|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
44479752|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479753|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44479754|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624576|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
44479755|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44479756|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
44479757|NCT03154983|Docetaxel|docetaxel|mesh-list
44479759|NCT03154983|Tegafur|tegafur|mesh-list
44479760|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479761|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479762|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479763|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479764|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479765|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44479766|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479767|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479768|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
44479769|NCT03154567|Yohimbine|yohimbine|mesh-list
44479770|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
44479771|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
44479772|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479773|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479774|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44479775|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44479776|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44479777|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44479778|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479779|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479780|NCT03154567|Urological Agents|urological agents|mesh-ancestor
44479781|NCT03154645|Ibuprofen|ibuprofen|mesh-list
44479782|NCT03154645|Acetazolamide|acetazolamide|mesh-list
44479783|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44479784|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479785|NCT03154645|Analgesics|analgesics|mesh-ancestor
44479786|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
44479787|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479788|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479789|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479790|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936850|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
44479791|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44479792|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479793|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479794|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
44479795|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44479796|NCT03154645|Diuretics|diuretics|mesh-ancestor
44479797|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
44479798|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
44479799|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
44479800|NCT03154528|Vitamin D|vitamin d|mesh-list
44479801|NCT03154528|Vitamins|vitamins|mesh-ancestor
44479802|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
44479803|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479804|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44479805|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
44479806|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
44479807|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479808|NCT03154372|Metronidazole|metronidazole|mesh-list
44479809|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479810|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479811|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44479812|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44479813|NCT03154294|Paclitaxel|paclitaxel|mesh-list
44479814|NCT03154294|Serabelisib|serabelisib|mesh-list
44479815|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479816|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479817|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479818|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479819|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479820|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479821|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479822|NCT03154606|Calcium|calcium|mesh-list
44479823|NCT03154606|Caseins|caseins|mesh-list
44479824|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44479825|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479826|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
44479827|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
44479828|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479829|NCT03154281|Everolimus|everolimus|mesh-list
44479830|NCT03154281|Niraparib|niraparib|mesh-list
44479831|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479832|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298903|NCT00819520|Ivermectin|ivermectin|mesh-list
44479833|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
44479834|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479835|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44479836|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140717|NCT00180310|Everolimus|everolimus|mesh-list
44479837|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479838|NCT03153813|Capsaicin|capsaicin|mesh-list
44479839|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
44479840|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479841|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
44479842|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479843|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479844|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
44479845|NCT03153917|Melatonin|melatonin|mesh-list
44479846|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
44479847|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479848|NCT03153917|Protective Agents|protective agents|mesh-ancestor
44479849|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479850|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479851|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479852|NCT03153657|Piroxicam|piroxicam|mesh-list
44479853|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
44479854|NCT03153657|Betadex|betadex|mesh-list
44479855|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44479856|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44479857|NCT03153657|Analgesics|analgesics|mesh-ancestor
44479858|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
44479859|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479860|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479861|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44479862|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44479863|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44479864|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479865|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479866|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
44479867|NCT03153267|Doxycycline|doxycycline|mesh-list
44479868|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44479869|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44479870|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
44479871|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44479872|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44479873|NCT03152942|Aminophylline|aminophylline|mesh-list
44479874|NCT03152942|Progesterone|progesterone|mesh-list
44479875|NCT03152942|Progestins|progestins|mesh-ancestor
44479876|NCT03152942|Hormones|hormones|mesh-ancestor
44479877|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44479878|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479879|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44479880|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
44479881|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479882|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44479883|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44479884|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44479885|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44479886|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479887|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479888|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44479889|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44479890|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
44479891|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479892|NCT03152942|Protective Agents|protective agents|mesh-ancestor
44479893|NCT03153072|Amiodarone|amiodarone|mesh-list
44479894|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44479895|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
44479896|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44479897|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44479898|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479899|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44479900|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44479901|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44479902|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44479903|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44479904|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44479905|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44479906|NCT03152981|Remifentanil|remifentanil|mesh-list
44479907|NCT03152981|Propofol|propofol|mesh-list
44479908|NCT03152981|Desflurane|desflurane|mesh-list
44479909|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44479910|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479911|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479912|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44479913|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
44479914|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
44479915|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479916|NCT03152981|Narcotics|narcotics|mesh-ancestor
44479917|NCT03152981|Analgesics|analgesics|mesh-ancestor
44479918|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
44479919|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479920|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44479921|NCT03153163|Trastuzumab|trastuzumab|mesh-list
44479922|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44479923|NCT03153163|Maytansine|maytansine|mesh-list
44479924|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479925|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479926|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44479927|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44479928|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44479929|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44479930|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479931|NCT03153085|Ipilimumab|ipilimumab|mesh-list
44479932|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479933|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479934|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44479935|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736497|NCT04009044|Afimoxifene|afimoxifene|mesh-list
44736498|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44736499|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
44736500|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736501|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736502|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44736503|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736504|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44736505|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44736506|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44736507|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
44736508|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736509|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44736510|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736511|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736512|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
44736513|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736514|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736515|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44736516|NCT03980769|Fludarabine|fludarabine|mesh-list
44736517|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
44736518|NCT03980769|Thiotepa|thiotepa|mesh-list
44736519|NCT03980769|Treosulfan|treosulfan|mesh-list
44736520|NCT03980769|Busulfan|busulfan|mesh-list
44736521|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44736522|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
44736523|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736524|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44736525|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
44736526|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736527|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736528|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
44736529|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736530|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736531|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
44736532|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44736533|NCT03980184|Guanfacine|guanfacine|mesh-list
44736534|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44736535|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44736536|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44736537|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44736538|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44736539|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736540|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736541|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736542|NCT03975829|Trametinib|trametinib|mesh-list
44479936|NCT03152955|Sufentanil|sufentanil|mesh-list
44479937|NCT03152955|Ketamine|ketamine|mesh-list
44479938|NCT03152955|Ondansetron|ondansetron|mesh-list
44479939|NCT03152955|Analgesics|analgesics|mesh-ancestor
44479940|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
44479941|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479942|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479943|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44479944|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44479945|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
44479946|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
44479947|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44479948|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44479949|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44479950|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44479951|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479952|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
44479953|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
44479954|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44479955|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
44479956|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479957|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44479958|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
44479959|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44479960|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44479961|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44479962|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44479963|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44479964|NCT03152955|Narcotics|narcotics|mesh-ancestor
43937063|NCT00838162|TMC-310911|tmc-310911|mesh-list
44479965|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44479966|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
44479967|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44479968|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
44479969|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479970|NCT03152565|Avelumab|avelumab|mesh-list
44479971|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44479972|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479973|NCT03152890|Insulin|insulin|mesh-list
44479974|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44479975|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479976|NCT03152578|Capsaicin|capsaicin|mesh-list
44479977|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
44479978|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44479979|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
44479980|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44479981|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479982|NCT03152370|Leucovorin|leucovorin|mesh-list
44479983|NCT03152370|Folic Acid|folic acid|mesh-list
44479984|NCT03152370|Capecitabine|capecitabine|mesh-list
44479985|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
44479986|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
44479987|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44479988|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
44479989|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44479990|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44479991|NCT03152370|Antidotes|antidotes|mesh-ancestor
44479992|NCT03152370|Protective Agents|protective agents|mesh-ancestor
44479993|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44479994|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
44479995|NCT03152370|Vitamins|vitamins|mesh-ancestor
44479996|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
44479997|NCT03152370|Hematinics|hematinics|mesh-ancestor
44479998|NCT03152409|Aspirin|aspirin|mesh-list
44479999|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
44480000|NCT03152409|Salicylates|salicylates|mesh-list
44480001|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44480002|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480003|NCT03152409|Analgesics|analgesics|mesh-ancestor
44480004|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
44480005|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480006|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480007|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480008|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480009|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44480010|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44480011|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480012|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44480013|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44480014|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480015|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
44480016|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480017|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
44480018|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
44480019|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44480020|NCT03152474|Vitamin A|vitamin a|mesh-list
44480021|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
44480022|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44480023|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44480024|NCT03152474|Prednisolone|prednisolone|mesh-list
44480025|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
44480026|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44480027|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
44480028|NCT03152474|Vitamins|vitamins|mesh-ancestor
44480029|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
44480030|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480031|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480032|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
44480033|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
44480034|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480035|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480036|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
44480037|NCT03152474|Hormones|hormones|mesh-ancestor
44480038|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480039|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44480040|NCT03152474|Protective Agents|protective agents|mesh-ancestor
44480041|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44480042|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480043|NCT03150576|Paclitaxel|paclitaxel|mesh-list
44480044|NCT03150576|Carboplatin|carboplatin|mesh-list
44480045|NCT03150576|Olaparib|olaparib|mesh-list
44480046|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44480047|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480048|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44480049|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44480050|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44480051|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480052|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44480053|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480054|NCT03153111|Macitentan|macitentan|mesh-list
44480055|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44480056|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43937179|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44480057|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480058|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44480059|NCT03151057|Idelalisib|idelalisib|mesh-list
44480060|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480061|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480062|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480063|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
44480064|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480065|NCT01670071|Risperidone|risperidone|mesh-list
44480066|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44480067|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44480068|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
44480069|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480070|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480071|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480072|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44480073|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480074|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480075|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480076|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44480077|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
44480078|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44480079|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44480080|NCT01670084|Leucovorin|leucovorin|mesh-list
44480081|NCT01670084|Cytarabine|cytarabine|mesh-list
44480082|NCT01670084|Dexamethasone|dexamethasone|mesh-list
44480083|NCT01670084|Prednisone|prednisone|mesh-list
44480084|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
44480085|NCT01670084|Rituximab|rituximab|mesh-list
44480086|NCT01670084|Doxorubicin|doxorubicin|mesh-list
44480087|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44480089|NCT01670084|Vincristine|vincristine|mesh-list
44480090|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
44480091|NCT01670084|Mesna|mesna|mesh-list
44480092|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480093|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
44480094|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480095|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480096|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44480097|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
44480098|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480099|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480100|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44480101|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480102|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480103|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
44480104|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
44480105|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480106|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480107|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
44480108|NCT01670084|Hormones|hormones|mesh-ancestor
44480109|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480110|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44480111|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480112|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44480113|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44480114|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480115|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44480116|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
44480117|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44480118|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44480119|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
44480120|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
44480121|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44480122|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44480123|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
44480124|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480125|NCT01670084|Antidotes|antidotes|mesh-ancestor
44480126|NCT01670084|Protective Agents|protective agents|mesh-ancestor
44480127|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
44480128|NCT01670084|Vitamins|vitamins|mesh-ancestor
44480129|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
44480130|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44480131|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44480132|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44480133|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44480134|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
44480135|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480136|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44480137|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44480138|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480139|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480140|NCT01670136|Urological Agents|urological agents|mesh-ancestor
44480141|NCT01670162|Aflibercept|aflibercept|mesh-list
44480142|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44480143|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44480144|NCT01670162|Growth Substances|growth substances|mesh-ancestor
44480145|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480146|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
44480147|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480148|NCT01670175|Sirolimus|sirolimus|mesh-list
44480149|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
44480150|NCT01670175|Topotecan|topotecan|mesh-list
44480151|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480152|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
44480153|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480154|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480155|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44480156|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
44480157|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480158|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480159|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44480160|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480161|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624577|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44480162|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480163|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
44480164|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44480165|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44480166|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480168|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480169|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480170|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
44480171|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
44480172|NCT01670318|Chromium|chromium|mesh-list
44480173|NCT01670318|Everolimus|everolimus|mesh-list
44157474|NCT00234572|Lanreotide|lanreotide|mesh-list
44480174|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480175|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480176|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
44480177|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480178|NCT01670318|Trace Elements|trace elements|mesh-ancestor
44480179|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
44480180|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
44480181|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480182|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480183|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44480184|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44480185|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480186|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480187|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480188|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44480189|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44480190|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44480191|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44480192|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44480193|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480194|NCT01670669|Prucalopride|prucalopride|mesh-list
44480195|NCT01670669|Laxatives|laxatives|mesh-ancestor
44480196|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480197|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44480198|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44480199|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
44480200|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480201|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480202|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480203|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44480204|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44480205|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480206|NCT01670773|Analgesics|analgesics|mesh-ancestor
44480207|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
44480208|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480209|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480210|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480211|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480212|NCT01670890|Cisplatin|cisplatin|mesh-list
43937258|NCT00845000|Levodopa|levodopa|mesh-list
44480213|NCT01670890|Temozolomide|temozolomide|mesh-list
44480214|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480215|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44480216|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
44480217|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480218|NCT01670929|Progesterone|progesterone|mesh-list
44480219|NCT01670929|Progestins|progestins|mesh-ancestor
44480220|NCT01670929|Hormones|hormones|mesh-ancestor
44480221|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480222|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736543|NCT03975829|Dabrafenib|dabrafenib|mesh-list
44736544|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736545|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736546|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736547|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736548|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44736549|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736550|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
44736551|NCT03953898|Olaparib|olaparib|mesh-list
44736552|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44736553|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736554|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736555|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480229|NCT01671384|Valproic Acid|valproic acid|mesh-list
44480230|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
44480231|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480232|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480233|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
44480234|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480235|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480236|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
44480237|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480238|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480239|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480240|NCT01671410|Morphine|morphine|mesh-list
44480241|NCT01671410|Buprenorphine|buprenorphine|mesh-list
44480242|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44480243|NCT01671410|Narcotics|narcotics|mesh-ancestor
44480244|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480245|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480246|NCT01671410|Analgesics|analgesics|mesh-ancestor
44480247|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
44480248|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480249|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44480250|NCT01671709|Montelukast|montelukast|mesh-list
44480251|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44480252|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480253|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44480254|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480255|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937316|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44480256|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480257|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44480258|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44480259|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480260|NCT01671722|Montelukast|montelukast|mesh-list
44480261|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44480262|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480263|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44480264|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480265|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480266|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480267|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44480268|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44480269|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480270|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
44480271|NCT01671774|Interleukin-2|interleukin-2|mesh-list
44480272|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480273|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480274|NCT01671774|Analgesics|analgesics|mesh-ancestor
44480275|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
44480276|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480277|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480278|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44480279|NCT01671787|Tenofovir|tenofovir|mesh-list
44480280|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
44480281|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480282|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44480283|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44480284|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480285|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480286|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44480287|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44480288|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44480289|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
44480290|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480291|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480292|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
44480293|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480294|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
44480295|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480296|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44480297|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44480298|NCT01671891|Capecitabine|capecitabine|mesh-list
44480299|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
44480300|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44480301|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
44480302|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480303|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480304|NCT01671904|Rituximab|rituximab|mesh-list
44480305|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
44480306|NCT01671904|Venetoclax|venetoclax|mesh-list
44480307|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44480308|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480309|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480310|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
44480311|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480312|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480313|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44480314|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
44480315|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480316|NCT01671982|Tenofovir|tenofovir|mesh-list
44480317|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
44480318|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480319|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44480320|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44480321|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480322|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480323|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44480324|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44480325|NCT01672047|Vitamin D|vitamin d|mesh-list
44480326|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
44480327|NCT01672047|Vitamins|vitamins|mesh-ancestor
44480328|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
44480329|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480330|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44480331|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44480332|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
44480333|NCT01672086|Antacids|antacids|mesh-ancestor
44480334|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480335|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480336|NCT01672112|Oxycodone|oxycodone|mesh-list
44480337|NCT01672112|Codeine|codeine|mesh-list
44480338|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44480339|NCT01672112|Narcotics|narcotics|mesh-ancestor
44480340|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480341|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480342|NCT01672112|Analgesics|analgesics|mesh-ancestor
44480343|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
44480344|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480345|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
44480346|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480347|NCT01672151|Sirolimus|sirolimus|mesh-list
44480348|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480349|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480350|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480351|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480352|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
44480353|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480354|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
44480355|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480356|NCT01672229|Bortezomib|bortezomib|mesh-list
44480357|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480358|NCT01672307|Minoxidil|minoxidil|mesh-list
44480359|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480360|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480361|NCT01672346|Adenosine|adenosine|mesh-list
44480362|NCT01672346|Analgesics|analgesics|mesh-ancestor
44480363|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
44480364|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480365|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480366|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480367|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480368|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44480369|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
44480370|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
44480371|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480372|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480373|NCT01672450|Ipilimumab|ipilimumab|mesh-list
44480374|NCT01672450|Interleukin-2|interleukin-2|mesh-list
44480375|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480376|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480377|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44480378|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480379|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480380|NCT01672450|Analgesics|analgesics|mesh-ancestor
44480381|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
44480382|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480383|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480384|NCT01672476|Valsartan|valsartan|mesh-list
44480385|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480386|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44480387|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44480388|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480389|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43937461|NCT00852761|Clobetasol|clobetasol|mesh-list
44480390|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
44480391|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480392|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44480393|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480394|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480395|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480396|NCT01672580|Vitamins|vitamins|mesh-list
44480397|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
44480398|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480399|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44480400|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480401|NCT01672606|Rocuronium|rocuronium|mesh-list
44480402|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44480403|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44480404|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44480405|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480406|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480407|NCT01672671|Paclitaxel|paclitaxel|mesh-list
44480408|NCT01672671|Cisplatin|cisplatin|mesh-list
44480409|NCT01672671|Doxorubicin|doxorubicin|mesh-list
44480410|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44480411|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480412|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44480413|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44480414|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44480415|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480416|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480417|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44480418|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44480419|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480420|NCT01672814|Riboflavin|riboflavin|mesh-list
44480421|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44480422|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44480423|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
44480424|NCT01672814|Vitamins|vitamins|mesh-ancestor
44480425|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
44480426|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480427|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44480428|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44736563|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44736564|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736565|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736566|NCT03921008|Paclitaxel|paclitaxel|mesh-list
44736567|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736568|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736569|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736570|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736571|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736572|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736573|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
44736574|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44736575|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
44736576|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44736577|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
44736578|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736579|NCT03914612|Paclitaxel|paclitaxel|mesh-list
44736580|NCT03914612|Carboplatin|carboplatin|mesh-list
44736581|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
44299495|NCT00822614|Morphine|morphine|mesh-list
44736582|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44480429|NCT01673087|Dexamethasone|dexamethasone|mesh-list
44480430|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44480431|NCT01673087|Cosyntropin|cosyntropin|mesh-list
44480432|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44480433|NCT01673087|Metyrapone|metyrapone|mesh-list
44480434|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480435|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
44480436|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
44480437|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480438|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480439|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480440|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
44480441|NCT01673087|Hormones|hormones|mesh-ancestor
44480442|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480443|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44480444|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480445|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
44480446|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480447|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480448|NCT01673204|Calcitriol|calcitriol|mesh-list
44480449|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44480450|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480451|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44480452|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480453|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480454|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44480455|NCT01673204|Vitamins|vitamins|mesh-ancestor
44480456|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
44480457|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44480458|NCT01673399|Atosiban|atosiban|mesh-list
44480459|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480460|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480461|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480462|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
44480463|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937581|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
44480464|NCT01673542|Lidocaine|lidocaine|mesh-list
44480465|NCT01673542|Prilocaine|prilocaine|mesh-list
44480466|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44480467|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44480468|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
44480469|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480470|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480471|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
44480472|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480473|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480474|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44480475|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44480476|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480477|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480478|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44480479|NCT01673724|Pramipexole|pramipexole|mesh-list
44480480|NCT01673724|Bromocriptine|bromocriptine|mesh-list
44480481|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
44480482|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480483|NCT01673724|Protective Agents|protective agents|mesh-ancestor
44480484|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480485|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44480486|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44480487|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
44480488|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
44480489|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480490|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480491|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480492|NCT01673997|Metoprolol|metoprolol|mesh-list
44480493|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480494|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480495|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
44480497|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480498|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480499|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44480500|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44480501|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44480502|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
44480503|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480504|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480506|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480507|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
44480508|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
44480509|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480510|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480511|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44480512|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44480513|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44480514|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
44480515|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480516|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480517|NCT01674166|Prucalopride|prucalopride|mesh-list
44480518|NCT01674166|Laxatives|laxatives|mesh-ancestor
44480519|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480520|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44480521|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44480522|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
44480523|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480524|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480525|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480526|NCT01674192|Prucalopride|prucalopride|mesh-list
44480527|NCT01674192|Laxatives|laxatives|mesh-ancestor
44480528|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480529|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44480530|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44480531|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
44480532|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480533|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480534|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480535|NCT01674205|Vaccines|vaccines|mesh-list
44480536|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
44480537|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480538|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
44480539|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480540|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480541|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44480542|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44480543|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480544|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480545|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480546|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44480547|NCT01674257|Fluorides|fluorides|mesh-list
44480548|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
44480549|NCT01674257|Protective Agents|protective agents|mesh-ancestor
44480550|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480551|NCT01674257|Hematinics|hematinics|mesh-ancestor
44480552|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44480553|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44480554|NCT01674270|Bicalutamide|bicalutamide|mesh-list
44480555|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
44480556|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480557|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480558|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480559|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480560|NCT01674283|Glucagon|glucagon|mesh-list
44480561|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480562|NCT01674283|Hormones|hormones|mesh-ancestor
44480563|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480564|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480565|NCT01674413|Adalimumab|adalimumab|mesh-list
44480566|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480567|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480568|NCT01674504|Montelukast|montelukast|mesh-list
43624578|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44480569|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44480570|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480571|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44480572|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480573|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480574|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480575|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43937629|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44480576|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44480577|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480578|NCT01674517|Montelukast|montelukast|mesh-list
44480579|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44480580|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480581|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44480582|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480583|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480584|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480585|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44480586|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44480587|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480588|NCT01674530|Lubiprostone|lubiprostone|mesh-list
44480589|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44480590|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480591|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480592|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
44480593|NCT01674686|Atorvastatin|atorvastatin|mesh-list
44480594|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44480595|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44480596|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
44480597|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480598|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44480599|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44480600|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480601|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44480602|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44480603|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44480604|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44480605|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
44480606|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480607|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480608|NCT01674738|Bevacizumab|bevacizumab|mesh-list
44480609|NCT01674738|Cisplatin|cisplatin|mesh-list
44480610|NCT01674738|Pemetrexed|pemetrexed|mesh-list
44480611|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480612|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480613|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44480614|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44480615|NCT01674738|Growth Substances|growth substances|mesh-ancestor
44480616|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480617|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
44480618|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480619|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480620|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44480621|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44480622|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
44480623|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44480624|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480625|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44480626|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480627|NCT01674842|Cisplatin|cisplatin|mesh-list
44480628|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480629|NCT01674855|Lenograstim|lenograstim|mesh-list
44480630|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44480631|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
44480632|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480633|NCT01674868|Fluoxetine|fluoxetine|mesh-list
44480634|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44480635|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44480636|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480637|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480638|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480639|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
44480640|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480641|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44480642|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
44480643|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480644|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44480645|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44480646|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480648|NCT01674933|Fluorides|fluorides|mesh-list
44480649|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
44480650|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44480651|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
44480652|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
44480653|NCT01674933|Protective Agents|protective agents|mesh-ancestor
44480654|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480655|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44480656|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480657|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44480658|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
44480659|NCT01674946|Cathartics|cathartics|mesh-ancestor
44480660|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480661|NCT01675024|Rotigotine|rotigotine|mesh-list
44480662|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
44480663|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
44480664|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480665|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480666|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480667|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
44480668|NCT01675076|Apixaban|apixaban|mesh-list
44480669|NCT01675076|Dabigatran|dabigatran|mesh-list
44480670|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44480671|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
44480672|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44480673|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
44480674|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480675|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480676|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
44480677|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
44480678|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44480679|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736583|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736584|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736585|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736586|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736587|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736588|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736589|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736590|NCT03912428|Celecoxib|celecoxib|mesh-list
44736591|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44736592|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44736593|NCT03912428|Analgesics|analgesics|mesh-ancestor
44736594|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
44736595|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736596|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736597|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736598|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736599|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44736600|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44736601|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937756|NCT00860171|Trace Elements|trace elements|mesh-ancestor
44736602|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736603|NCT03893955|Paclitaxel|paclitaxel|mesh-list
44736604|NCT03893955|Carboplatin|carboplatin|mesh-list
44736605|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736606|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736607|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736608|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736609|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736610|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736611|NCT03871257|Carboplatin|carboplatin|mesh-list
44736612|NCT03871257|Vincristine|vincristine|mesh-list
44736613|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736614|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44736615|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
44736616|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
44736617|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736618|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736619|NCT03841110|Aldesleukin|aldesleukin|mesh-list
44736620|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
44736621|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
44736622|NCT03841110|Nivolumab|nivolumab|mesh-list
44736623|NCT03841110|Fludarabine|fludarabine|mesh-list
44736624|NCT03841110|Atezolizumab|atezolizumab|mesh-list
44736625|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299745|NCT00824135|Rituximab|rituximab|mesh-list
44480680|NCT01675206|Vitamin K|vitamin k|mesh-list
44480681|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
44480682|NCT01675206|Vitamins|vitamins|mesh-ancestor
44480683|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
44480684|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480685|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44480686|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44480687|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480688|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
44480689|NCT01675206|Coagulants|coagulants|mesh-ancestor
44480690|NCT01675219|Mitomycins|mitomycins|mesh-list
44480691|NCT01675219|Mitomycin|mitomycin|mesh-list
44480692|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480693|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480694|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
44480695|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480696|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44480697|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480698|NCT01675362|Selenium|selenium|mesh-list
44480699|NCT01675362|Losartan|losartan|mesh-list
44480700|NCT01675362|Verapamil|verapamil|mesh-list
44480701|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
44480702|NCT01675362|Calcium|calcium|mesh-list
44480703|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44480704|NCT01675362|Antioxidants|antioxidants|mesh-list
44480705|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44480706|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480707|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480708|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480709|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44480710|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480711|NCT01675362|Protective Agents|protective agents|mesh-ancestor
44480712|NCT01675362|Trace Elements|trace elements|mesh-ancestor
44480713|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
44480714|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480715|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480716|NCT01675466|Anesthetics|anesthetics|mesh-list
44480717|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480718|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480719|NCT01675518|ASP7991|asp7991|mesh-list
44480720|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44480721|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
44480722|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480723|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480724|NCT01675557|Vitamin D|vitamin d|mesh-list
44480725|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
44480726|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
44480727|NCT01675557|Vitamins|vitamins|mesh-list
44480728|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
44480729|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480730|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44480731|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44480732|NCT01675648|Lofexidine|lofexidine|mesh-list
44480733|NCT01675648|Clonidine|clonidine|mesh-list
44480734|NCT01675648|Diazepam|diazepam|mesh-list
44480735|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44480736|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
44480737|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
44480738|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
44480739|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480740|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480741|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480742|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44480743|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480744|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44480745|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44480746|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44480747|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480748|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480749|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44480750|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
44480751|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
44299812|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
44480752|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
43937873|NCT00863551|Trospium chloride|trospium chloride|mesh-list
44480753|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
44480754|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480755|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480756|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480757|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44480758|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
44480759|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44480760|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44480761|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44480762|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
44480764|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
44480765|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
44480766|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480767|NCT01675804|Methylphenidate|methylphenidate|mesh-list
44480768|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44480769|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480770|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44480771|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44480772|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480773|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480774|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
44480775|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480776|NCT01675895|Lidocaine|lidocaine|mesh-list
44480777|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
44480778|NCT01675895|Anesthetics|anesthetics|mesh-list
44480779|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
44480780|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480781|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480782|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
44480783|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480784|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480785|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44480786|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44480787|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480788|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480789|NCT01675947|Sirolimus|sirolimus|mesh-list
44480790|NCT01675947|Lidocaine|lidocaine|mesh-list
44480791|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44480792|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
44480793|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480794|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480795|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
44480796|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480797|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480798|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44480799|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44480800|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480801|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480802|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480803|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480804|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44480805|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480806|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
44480807|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480808|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
44480809|NCT01675973|Ranolazine|ranolazine|mesh-list
44480810|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44480811|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480812|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480813|NCT01675986|Pregabalin|pregabalin|mesh-list
44480814|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
44480815|NCT01675986|Analgesics|analgesics|mesh-ancestor
44480816|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
44480817|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480818|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480819|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
44480820|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44480821|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480822|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480823|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44480825|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480826|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480827|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480828|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
44480829|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
44480830|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44480831|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
44480832|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
44480833|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480834|NCT01675999|Leucovorin|leucovorin|mesh-list
44480835|NCT01675999|Cetuximab|cetuximab|mesh-list
44480836|NCT01675999|Fluorouracil|fluorouracil|mesh-list
44480837|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
44480838|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480839|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480840|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
44480841|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480842|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44480843|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480844|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
44480845|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480846|NCT01675999|Antidotes|antidotes|mesh-ancestor
44480847|NCT01675999|Protective Agents|protective agents|mesh-ancestor
44480848|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
44480849|NCT01675999|Vitamins|vitamins|mesh-ancestor
44480850|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
44480851|NCT01676233|Insulin|insulin|mesh-list
44480852|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44480853|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
44480854|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44480855|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480856|NCT01676246|Flupirtine|flupirtine|mesh-list
44480857|NCT01676246|Analgesics|analgesics|mesh-ancestor
44480858|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
44480859|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480860|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480861|NCT01676259|Gemcitabine|gemcitabine|mesh-list
44480862|NCT01676259|Paclitaxel|paclitaxel|mesh-list
44480863|NCT01676259|Folfirinox|folfirinox|mesh-list
44480864|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44480865|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480866|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44480867|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44480868|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44480869|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480870|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44480871|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
44480872|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
44480873|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480874|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480875|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44480876|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
44480877|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480878|NCT01676285|Metoprolol|metoprolol|mesh-list
44480879|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44480880|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480881|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
44480882|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
44480883|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480884|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480885|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44480886|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44480887|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44480888|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
44480889|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480890|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480891|NCT01676363|Diflunisal|diflunisal|mesh-list
44480892|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44480893|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44480894|NCT01676363|Analgesics|analgesics|mesh-ancestor
44480895|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
44480896|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480897|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480898|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44480899|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480900|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44480901|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480902|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480903|NCT01676493|Codeine|codeine|mesh-list
44480904|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44480905|NCT01676493|Narcotics|narcotics|mesh-ancestor
44480906|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480907|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480908|NCT01676493|Analgesics|analgesics|mesh-ancestor
44480909|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
44480910|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480911|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
44480912|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
44480913|NCT01676506|Ranibizumab|ranibizumab|mesh-list
44480914|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44480915|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44480916|NCT01676506|Growth Substances|growth substances|mesh-ancestor
44480917|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480918|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44480919|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480920|NCT01676558|Rituximab|rituximab|mesh-list
44480921|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44480922|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44480923|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
44480924|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480925|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44480926|NCT01676571|Vortioxetine|vortioxetine|mesh-list
44480927|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44480928|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44480929|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44480930|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480931|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480932|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480933|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44480934|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44480935|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44480936|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480937|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480938|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
44480939|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44480940|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44480941|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44480942|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44480943|NCT01676597|Rifaximin|rifaximin|mesh-list
44480944|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
44480945|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44480946|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44480947|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44480948|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44480949|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44480950|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480951|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44480952|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44480953|NCT01676597|Protective Agents|protective agents|mesh-ancestor
44480954|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480955|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
44480956|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44480957|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
44480958|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44480959|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
44480960|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
44480961|NCT01676844|Protective Agents|protective agents|mesh-ancestor
44480962|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480963|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44480964|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
44480965|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480966|NCT01677104|Liraglutide|liraglutide|mesh-list
44480967|NCT01677104|Exenatide|exenatide|mesh-list
44480968|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44480969|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44480970|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480971|NCT01677104|Incretins|incretins|mesh-ancestor
44480973|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44480974|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44480975|NCT01677143|Bupivacaine|bupivacaine|mesh-list
44480976|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
44480977|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
44480978|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44480979|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480980|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
44480981|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480982|NCT01677273|Caseins|caseins|mesh-list
44480983|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
44480984|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
44480985|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44480986|NCT01677351|Clonidine|clonidine|mesh-list
44480987|NCT01677351|Analgesics|analgesics|mesh-ancestor
44480988|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
44480989|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44480990|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44480991|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44480992|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
44480993|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
44480994|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43938101|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44480995|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44480996|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44480997|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
44480998|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44480999|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481000|NCT01677364|Oxytocin|oxytocin|mesh-list
44481001|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
44481002|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44481003|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481004|NCT01677390|Everolimus|everolimus|mesh-list
44481005|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481006|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481007|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
44481008|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481009|NCT01677403|Tobramycin|tobramycin|mesh-list
44481010|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481011|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481012|NCT01677442|Anesthetics|anesthetics|mesh-list
44481013|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481014|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481015|NCT01677468|Doxorubicin|doxorubicin|mesh-list
44481016|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44481017|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44481018|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481019|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481020|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481021|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481022|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481023|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481024|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
44481025|NCT01677468|Coagulants|coagulants|mesh-ancestor
44481026|NCT01677546|Insulin|insulin|mesh-list
44481027|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44481028|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481029|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481030|NCT01677559|Paclitaxel|paclitaxel|mesh-list
44481031|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481032|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481033|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481034|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481035|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481036|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481037|NCT01677598|Ustekinumab|ustekinumab|mesh-list
44481038|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481039|NCT01677611|Resveratrol|resveratrol|mesh-list
44481040|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
44481041|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481042|NCT01677611|Protective Agents|protective agents|mesh-ancestor
44481043|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481044|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481045|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44481046|NCT01677702|Lactoferrin|lactoferrin|mesh-list
44481047|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481049|NCT01677884|Capecitabine|capecitabine|mesh-list
44481050|NCT01677884|Irinotecan|irinotecan|mesh-list
44481051|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43938179|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44481052|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481053|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44481054|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481055|NCT01677884|Growth Substances|growth substances|mesh-ancestor
44481056|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300089|NCT00825864|Analgesics|analgesics|mesh-ancestor
44481057|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
44481058|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481059|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
44481060|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481061|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44481062|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481063|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481064|NCT01677897|Metformin|metformin|mesh-list
44481065|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481066|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481067|NCT01677923|Metformin|metformin|mesh-list
44481068|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481069|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481070|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
44481071|NCT01677949|Etoposide|etoposide|mesh-list
44481072|NCT01677949|Clofarabine|clofarabine|mesh-list
44481073|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481074|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
44481075|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481076|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481077|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481078|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
44481079|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481080|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481081|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44481082|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481083|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481084|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481085|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481086|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481087|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
44481088|NCT01677962|Poly ICLC|poly iclc|mesh-list
44481089|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
44481090|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
44481091|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481092|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44481093|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44481094|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481095|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481096|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44481097|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44481098|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481099|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44481100|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481101|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
44481102|NCT01678079|Calcium|calcium|mesh-list
44481103|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44481104|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481105|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44481106|NCT01678092|Omalizumab|omalizumab|mesh-list
44481107|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44481108|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44481109|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
44481110|NCT01678235|Insulin|insulin|mesh-list
44481111|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44481112|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
44481113|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
44481114|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481115|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481116|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
44481117|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44481118|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481119|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481120|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481121|NCT01678352|Imiquimod|imiquimod|mesh-list
43938225|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44481123|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
44481124|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481125|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481126|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
44481127|NCT01678365|Metronidazole|metronidazole|mesh-list
44481128|NCT01678365|Gentamicins|gentamicins|mesh-list
44481129|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
44481130|NCT01678365|Ampicillin|ampicillin|mesh-list
44481131|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481132|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481133|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44481134|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44481135|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44481136|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481137|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481138|NCT01678404|Rituximab|rituximab|mesh-list
44481139|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481140|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481141|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
44481142|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481143|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481144|NCT01678417|Rituximab|rituximab|mesh-list
44481145|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481146|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481147|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
44481148|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481149|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481150|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44481151|NCT01678430|Chlorambucil|chlorambucil|mesh-list
44481152|NCT01678430|Ofatumumab|ofatumumab|mesh-list
44481153|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481154|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
44481155|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481156|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481157|NCT01678495|Plasminogen|plasminogen|mesh-list
44481158|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44481159|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44481160|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44481161|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481162|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
44481163|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481164|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44481165|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481166|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481167|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
44481168|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481169|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481170|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44481171|NCT01678599|Benzonidazole|benzonidazole|mesh-list
44481172|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481173|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
44481174|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481175|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44481176|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44481177|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44481178|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481179|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44481180|NCT01678651|Hormones|hormones|mesh-ancestor
44481181|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481182|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481183|NCT01678664|Doxorubicin|doxorubicin|mesh-list
44481184|NCT01678664|Everolimus|everolimus|mesh-list
44481185|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481186|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481187|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481188|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481189|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481190|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481191|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481192|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
44481193|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481194|NCT01678677|Vaccines|vaccines|mesh-list
44481195|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
44481196|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481197|NCT01678690|Gemcitabine|gemcitabine|mesh-list
44481198|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481199|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
44481200|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481201|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481202|NCT01678690|Antiviral Agents|antiviral agents|mesh-ancestor
44481203|NCT01678690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481204|NCT01678690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481205|NCT01678690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481206|NCT01678690|Immunologic Factors|immunologic factors|mesh-ancestor
44736626|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
44481207|NCT01678690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481208|NCT01678703|Misoprostol|misoprostol|mesh-list
44481209|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44481210|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
44481211|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44481212|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481213|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44481214|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481215|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
44481216|NCT01678716|Micronutrients|micronutrients|mesh-list
44481217|NCT01678716|Trace Elements|trace elements|mesh-list
44481218|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481219|NCT01678963|Squalamine|squalamine|mesh-list
44481220|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481221|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481222|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44481223|NCT01678963|Protective Agents|protective agents|mesh-ancestor
44481224|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481225|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481226|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44481227|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481228|NCT01678963|Growth Substances|growth substances|mesh-ancestor
44481229|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
44481230|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
44481231|NCT01679080|Teriparatide|teriparatide|mesh-list
44481232|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44481233|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481234|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44481235|NCT01679106|Fentanyl|fentanyl|mesh-list
44481236|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44481237|NCT01679106|Narcotics|narcotics|mesh-ancestor
44481238|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481239|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481240|NCT01679106|Analgesics|analgesics|mesh-ancestor
44481241|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
44481242|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481243|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44481244|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44481245|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
44481246|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
44736627|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736628|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736629|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44736630|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
44736631|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736632|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736633|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44736634|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736635|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44736636|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44736637|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44736638|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
44736639|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736640|NCT03810313|Aflibercept|aflibercept|mesh-list
44736641|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44736642|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44736643|NCT03810313|Growth Substances|growth substances|mesh-ancestor
44736644|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736645|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
44736646|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736647|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
44736648|NCT03809624|Antibodies|antibodies|mesh-list
44736649|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
44736650|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736651|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736652|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736654|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44736655|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44736656|NCT03802630|Growth Substances|growth substances|mesh-ancestor
44736657|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736658|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44736659|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736660|NCT03785691|Ondansetron|ondansetron|mesh-list
44736661|NCT03785691|Mirtazapine|mirtazapine|mesh-list
44736662|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
44736663|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
44481248|NCT01679327|Leucovorin|leucovorin|mesh-list
44481249|NCT01679327|Bevacizumab|bevacizumab|mesh-list
44481250|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
44481251|NCT01679327|Calcium|calcium|mesh-list
44481252|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
44481253|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481254|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481255|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44481256|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481257|NCT01679327|Growth Substances|growth substances|mesh-ancestor
44481258|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481259|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44481260|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44481261|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44481262|NCT01679327|Antidotes|antidotes|mesh-ancestor
44481263|NCT01679327|Protective Agents|protective agents|mesh-ancestor
44481264|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
44481265|NCT01679327|Vitamins|vitamins|mesh-ancestor
44481266|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
44481267|NCT01679340|Cisplatin|cisplatin|mesh-list
44481268|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
44481269|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481270|NCT01679392|Ropivacaine|ropivacaine|mesh-list
44481271|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44481272|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
44481273|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481274|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481275|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
44481276|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481277|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44481278|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44481279|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44481280|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44481281|NCT01679574|Metformin|metformin|mesh-list
44481282|NCT01679574|Letrozole|letrozole|mesh-list
44481283|NCT01679574|Clomiphene|clomiphene|mesh-list
44481284|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481285|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481286|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481287|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44481288|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44481289|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481290|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481291|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44481292|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
44481293|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481294|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44481295|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
44481296|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44481297|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44481298|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44481299|NCT01679639|Rifampin|rifampin|mesh-list
44481300|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44481301|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
44481302|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481303|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481304|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
44481305|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44481306|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481307|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481308|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44481309|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43892191|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
44481310|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44481311|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44481312|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44481313|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44481314|NCT01679652|Nebivolol|nebivolol|mesh-list
44481315|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44481316|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
44481317|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44481318|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44481319|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44481320|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
44481321|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481322|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481323|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481324|NCT01679691|Anesthetics|anesthetics|mesh-list
44481325|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481326|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481328|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
44481329|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
44481330|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481331|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481332|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44140771|NCT00180843|Ipratropium|ipratropium|mesh-list
44481333|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44481334|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481335|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44481336|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
44481337|NCT01679795|Hormones|hormones|mesh-ancestor
44481338|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
44481339|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
44481340|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481341|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481342|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481343|NCT01679899|Vildagliptin|vildagliptin|mesh-list
44481344|NCT01679899|Gliclazide|gliclazide|mesh-list
44481345|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481346|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481347|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44481348|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
44481349|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481350|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481351|NCT01670409|Cisplatin|cisplatin|mesh-list
44481352|NCT01670409|Fluorouracil|fluorouracil|mesh-list
44481353|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481354|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
44481355|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481356|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481357|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481358|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
44481359|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481360|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
44481361|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44481362|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481363|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481364|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481365|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
44481366|NCT01670565|Belimumab|belimumab|mesh-list
44481367|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481368|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481369|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44481370|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
44481371|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481372|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481373|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481374|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481375|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481376|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
44481377|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481378|NCT01679951|Methotrexate|methotrexate|mesh-list
44481379|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44481380|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
44481381|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44481382|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624867|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938509|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43938523|NCT00880997|Doxazosin|doxazosin|mesh-list
44481383|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481384|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
44481385|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481386|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481387|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481388|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481389|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44481390|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481391|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
44481392|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481393|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44481394|NCT01677754|Memantine|memantine|mesh-list
44481396|NCT01677754|Donepezil|donepezil|mesh-list
44481397|NCT01677754|Galantamine|galantamine|mesh-list
44481398|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44481399|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481400|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481401|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
44481402|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481403|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481404|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
44481405|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44481406|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44481407|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
44481408|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44481409|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44481410|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44481411|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
44481412|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481413|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44481414|NCT01677754|Protective Agents|protective agents|mesh-ancestor
43938532|NCT00882102|Decitabine|decitabine|mesh-list
44481415|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44481416|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44481417|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481418|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44481419|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44481420|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44481421|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44481422|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44481423|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44481424|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481425|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481426|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481427|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
44481428|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44481429|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481430|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44481431|NCT01670799|Ketorolac|ketorolac|mesh-list
44481432|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44481433|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44481434|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44481435|NCT01670799|Analgesics|analgesics|mesh-ancestor
44481436|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
44481437|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481438|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481439|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44481440|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481441|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44481442|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481443|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481444|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
44481445|NCT01670500|Cisplatin|cisplatin|mesh-list
44481446|NCT01670500|Doxorubicin|doxorubicin|mesh-list
44481447|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481448|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
44481449|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938562|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44481450|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481451|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481452|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
44481453|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481454|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481455|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44481456|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481457|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481458|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481459|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481460|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44481461|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481462|NCT01678612|Copper|copper|mesh-list
44481463|NCT01678612|Trace Elements|trace elements|mesh-ancestor
44481464|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
44481465|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481466|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
44481467|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44481468|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44481469|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
44481470|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481471|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44481472|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44481473|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481474|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481475|NCT02404935|Cetuximab|cetuximab|mesh-list
44481476|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481477|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481478|NCT02402920|Cisplatin|cisplatin|mesh-list
44481479|NCT02402920|Carboplatin|carboplatin|mesh-list
44481480|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
44481481|NCT02402920|Etoposide|etoposide|mesh-list
44481482|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
44481483|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
44481484|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481485|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481486|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481487|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481488|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481489|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481490|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481491|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
44481492|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481493|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481494|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481495|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481496|NCT02408861|Nivolumab|nivolumab|mesh-list
44481497|NCT02408861|Ipilimumab|ipilimumab|mesh-list
44481498|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481499|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481500|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44481501|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481502|NCT02403193|Spartalizumab|spartalizumab|mesh-list
44481503|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44481504|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481505|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481506|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
44481507|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44481508|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44481509|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481510|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
44481511|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
44481512|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481513|NCT02403323|Etrolizumab|etrolizumab|mesh-list
44481514|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481515|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
44481516|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481517|NCT02401035|Pantoprazole|pantoprazole|mesh-list
44481518|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44481519|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481520|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44481521|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481522|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481523|NCT02406209|Prednisolone|prednisolone|mesh-list
44481524|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44481525|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
44481526|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44481527|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
44481528|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44481529|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
44481530|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44481531|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
44481532|NCT02406209|Hormones|hormones|mesh-ancestor
44481533|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481534|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481535|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44481536|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481537|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
44481538|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
44481539|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481540|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481541|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44481542|NCT02406209|Protective Agents|protective agents|mesh-ancestor
44481543|NCT02405585|Leucovorin|leucovorin|mesh-list
44481544|NCT02405585|Gemcitabine|gemcitabine|mesh-list
44300578|NCT00829023|Ethanol|ethanol|mesh-list
44481545|NCT02405585|Fluorouracil|fluorouracil|mesh-list
44481546|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
44481547|NCT02405585|Irinotecan|irinotecan|mesh-list
44481548|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481549|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
44481550|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481551|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481552|NCT02405585|Antiviral Agents|antiviral agents|mesh-ancestor
44481553|NCT02405585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481554|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481555|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481556|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
44481557|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481558|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44481559|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481560|NCT02405585|Antidotes|antidotes|mesh-ancestor
44481561|NCT02405585|Protective Agents|protective agents|mesh-ancestor
44481562|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
44481563|NCT02405585|Vitamins|vitamins|mesh-ancestor
44481564|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
44481565|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44481566|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481567|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481568|NCT02405260|Incretins|incretins|mesh-ancestor
44481569|NCT02405260|Hormones|hormones|mesh-ancestor
44481570|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481571|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44481572|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
44481573|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481574|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481575|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44481576|NCT02402270|Laxatives|laxatives|mesh-ancestor
44481577|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481578|NCT02401815|Sunitinib|sunitinib|mesh-list
44481579|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481580|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43938708|NCT00886626|Hormones|hormones|mesh-ancestor
44481581|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481582|NCT02401815|Growth Substances|growth substances|mesh-ancestor
44481583|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481584|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44481585|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44481586|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481587|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481588|NCT02401750|Naltrexone|naltrexone|mesh-list
44481589|NCT02401750|Oxycodone|oxycodone|mesh-list
44481590|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44481591|NCT02401750|Narcotics|narcotics|mesh-ancestor
44481592|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481593|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481594|NCT02401750|Analgesics|analgesics|mesh-ancestor
44481595|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
44481596|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481597|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44481598|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44481599|NCT02409342|Gemcitabine|gemcitabine|mesh-list
44481600|NCT02409342|Cisplatin|cisplatin|mesh-list
44481601|NCT02409342|Carboplatin|carboplatin|mesh-list
44481602|NCT02409342|Pemetrexed|pemetrexed|mesh-list
44481603|NCT02409342|Atezolizumab|atezolizumab|mesh-list
44481604|NCT02409342|Antibodies|antibodies|mesh-list
44481605|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44481606|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
44481607|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481608|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481609|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481610|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
44426829|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44481611|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481612|NCT02409342|Antiviral Agents|antiviral agents|mesh-ancestor
44481613|NCT02409342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481614|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481615|NCT02409342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481616|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44481617|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44481619|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481620|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44481621|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481622|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481623|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
44481624|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
44481625|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
44481626|NCT00089843|Testosterone|testosterone|mesh-list
44481627|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
44481628|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
44481629|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44481630|NCT00089843|Androgens|androgens|mesh-ancestor
44481631|NCT00089843|Hormones|hormones|mesh-ancestor
44481632|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481633|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481634|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44481635|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481636|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
44481637|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44481638|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44481639|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481640|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44481641|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44481642|NCT00089778|Aldesleukin|aldesleukin|mesh-list
44481643|NCT00089778|Interleukin-2|interleukin-2|mesh-list
44481644|NCT00089778|Mitogens|mitogens|mesh-list
44481645|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481646|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44481647|NCT00089778|Analgesics|analgesics|mesh-ancestor
44481648|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
44481649|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481650|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481651|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481652|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481653|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44481654|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44481655|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
44481656|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481657|NCT00089661|Denosumab|denosumab|mesh-list
44481658|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44481659|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481660|NCT00089583|Ritonavir|ritonavir|mesh-list
44481661|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
44481662|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44481663|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44481664|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
44481665|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481666|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481667|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44481668|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44481669|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
44481670|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481671|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44481672|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44481673|NCT00089544|Thalidomide|thalidomide|mesh-list
44481674|NCT00089544|Doxorubicin|doxorubicin|mesh-list
44481675|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44481676|NCT00089544|Ifosfamide|ifosfamide|mesh-list
44481677|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
44481678|NCT00089544|Dacarbazine|dacarbazine|mesh-list
44481679|NCT00089544|Imidazole|imidazole|mesh-list
44481680|NCT00089544|Lenograstim|lenograstim|mesh-list
44481681|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481682|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481683|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481684|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481685|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481686|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481687|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44481688|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
44481689|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481690|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481691|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
44481692|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481693|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
44481694|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481695|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481696|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44481697|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44481698|NCT00089544|Growth Substances|growth substances|mesh-ancestor
44481699|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
44481700|NCT00089479|Capecitabine|capecitabine|mesh-list
44481702|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481703|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
44481704|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481705|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481706|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481707|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481708|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481709|NCT00089297|Paclitaxel|paclitaxel|mesh-list
44481710|NCT00089297|Carboplatin|carboplatin|mesh-list
44481711|NCT00089297|Cetuximab|cetuximab|mesh-list
44481712|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481713|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481714|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481715|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481716|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481717|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481718|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481719|NCT00089284|Rituximab|rituximab|mesh-list
44481720|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
44481721|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481722|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481723|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
44481724|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481725|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481726|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44481727|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481728|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44481729|NCT00089076|Ipilimumab|ipilimumab|mesh-list
44481730|NCT00089076|Antibodies|antibodies|mesh-list
44481731|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
44481732|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44481733|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
44481734|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481735|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481736|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44481737|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481738|NCT00088907|Docetaxel|docetaxel|mesh-list
44481739|NCT00088907|Gefitinib|gefitinib|mesh-list
44481740|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481741|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481742|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481743|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481744|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481745|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44481746|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481747|NCT00088881|Prednisone|prednisone|mesh-list
44481748|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
44481749|NCT00088881|Rituximab|rituximab|mesh-list
44481750|NCT00088881|Doxorubicin|doxorubicin|mesh-list
44481751|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44481752|NCT00088881|Vincristine|vincristine|mesh-list
44481753|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481754|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
44481755|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481756|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481757|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481758|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
44481759|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481760|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481761|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44481762|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481763|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481764|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481765|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481766|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481767|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44481768|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
44481769|NCT00088881|Hormones|hormones|mesh-ancestor
44481770|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481771|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44481772|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481773|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481774|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481775|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481776|NCT00088829|Paclitaxel|paclitaxel|mesh-list
44481777|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44481778|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481779|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481780|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481781|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481782|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481783|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481784|NCT00088595|Pasireotide|pasireotide|mesh-list
44481785|NCT00088595|Hormones|hormones|mesh-ancestor
44481786|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481787|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481788|NCT00088465|Olanzapine|olanzapine|mesh-list
44481789|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
44481790|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
44481791|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44481792|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481793|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44481794|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44481795|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44481796|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481797|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44481798|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44481799|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44481800|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44481801|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481802|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481803|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
44481804|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44481805|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44481806|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481807|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44481808|NCT00088166|Hormones|hormones|mesh-ancestor
44481809|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481810|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481811|NCT00088153|Progesterone|progesterone|mesh-list
44481812|NCT00088153|Estrogens|estrogens|mesh-list
44481813|NCT00088153|Progestins|progestins|mesh-ancestor
44481814|NCT00088153|Hormones|hormones|mesh-ancestor
44481815|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481816|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481817|NCT00087698|Cisplatin|cisplatin|mesh-list
44481818|NCT00087698|Pemetrexed|pemetrexed|mesh-list
44481819|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481820|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481821|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481822|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44481823|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44481824|NCT00087685|Everolimus|everolimus|mesh-list
44481825|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481826|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481827|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
44481828|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481829|NCT00087646|Ribavirin|ribavirin|mesh-list
44481830|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44481831|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
44481832|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
44481833|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481834|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
44481835|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481836|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
44481837|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481838|NCT00087594|Ribavirin|ribavirin|mesh-list
44481839|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44481840|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
44481841|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481842|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
44481843|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481844|NCT00087568|Ribavirin|ribavirin|mesh-list
44481845|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44481846|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
44481847|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481848|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
44481849|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481851|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44481852|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44481853|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44481854|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
44481855|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
44481856|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481857|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481858|NCT00087529|Rituximab|rituximab|mesh-list
44481859|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481860|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481861|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
44481862|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481863|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481864|NCT00087516|Metformin|metformin|mesh-list
44481865|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44481866|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44481867|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481868|NCT00087516|Incretins|incretins|mesh-ancestor
44481869|NCT00087516|Hormones|hormones|mesh-ancestor
44481870|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44481871|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44481872|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
44481873|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481874|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481875|NCT00087152|Capecitabine|capecitabine|mesh-list
44481876|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
44481877|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481878|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
44481879|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481880|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481881|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44481882|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481883|NCT00087139|Epothilones|epothilones|mesh-list
44481884|NCT00087139|Epothilone B|epothilone b|mesh-list
44481885|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481886|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481887|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481888|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481889|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481890|NCT00087126|Topotecan|topotecan|mesh-list
44481891|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44481892|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481893|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481894|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481895|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481896|NCT00086996|Fluorouracil|fluorouracil|mesh-list
44481897|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
44481898|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
44481899|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481900|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481901|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481902|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481903|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
44481904|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481905|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
44481906|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
44481907|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
44481908|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481909|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44481910|NCT00086346|Cyclosporine|cyclosporine|mesh-list
44481911|NCT00086346|Sirolimus|sirolimus|mesh-list
44481912|NCT00086346|Tacrolimus|tacrolimus|mesh-list
44481913|NCT00086346|Cyclosporins|cyclosporins|mesh-list
44481914|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481915|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
44481916|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481917|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44481918|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481919|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481920|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
44481921|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481922|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
44481923|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481924|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44481925|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481926|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481927|NCT00086281|Zolpidem|zolpidem|mesh-list
44481928|NCT00086281|Modafinil|modafinil|mesh-list
44481929|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44481930|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481931|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44481932|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44481933|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44481934|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481935|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44481936|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44481937|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44481938|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44481939|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
44481940|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
44481941|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44481942|NCT00085917|Interferons|interferons|mesh-list
44481943|NCT00085917|Ribavirin|ribavirin|mesh-list
44481944|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
44481945|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44481946|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481947|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
44481948|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481949|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
44481950|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481951|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
44481952|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481953|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
44481954|NCT00085735|Lomustine|lomustine|mesh-list
44481955|NCT00085735|Cisplatin|cisplatin|mesh-list
44481956|NCT00085735|Vincristine|vincristine|mesh-list
44481957|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481958|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
44481959|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481960|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44481961|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44481962|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
44481963|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481964|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481965|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44481966|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44481967|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481968|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
44481969|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
44481970|NCT00085709|Cytarabine|cytarabine|mesh-list
44481971|NCT00085709|Daunorubicin|daunorubicin|mesh-list
44481972|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
44481973|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44481974|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
44481975|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481976|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481977|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
44481978|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44481979|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481980|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
44481981|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481982|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44481983|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44481984|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44481985|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892792|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
44481986|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44481987|NCT00085631|Cisplatin|cisplatin|mesh-list
44481988|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481989|NCT00085566|Everolimus|everolimus|mesh-list
44481990|NCT00085566|Gefitinib|gefitinib|mesh-list
44481991|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44481992|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44481993|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
44481994|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44481995|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44481996|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44481997|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44481998|NCT00085540|Romidepsin|romidepsin|mesh-list
44481999|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482000|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482001|NCT00085423|Aldesleukin|aldesleukin|mesh-list
44482002|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
44482003|NCT00085423|Fludarabine|fludarabine|mesh-list
44482004|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
44482005|NCT00085423|Interleukin-2|interleukin-2|mesh-list
44482006|NCT00085423|Molgramostim|molgramostim|mesh-list
44482007|NCT00085423|Sargramostim|sargramostim|mesh-list
44482008|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482009|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
44482010|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482011|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482012|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482013|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
44482014|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482015|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482016|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482017|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482018|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
44482019|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482020|NCT00085423|Analgesics|analgesics|mesh-ancestor
44482021|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
44482022|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482023|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44482024|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44482025|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
44482026|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482027|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
44482028|NCT00085098|Cisplatin|cisplatin|mesh-list
44482029|NCT00085098|Carboplatin|carboplatin|mesh-list
44482030|NCT00085098|Etoposide|etoposide|mesh-list
44482031|NCT00085098|Lenograstim|lenograstim|mesh-list
44482032|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482033|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
44482034|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482035|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482036|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482037|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
44482038|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482039|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482040|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482041|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482042|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44482043|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482044|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482045|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44482046|NCT00084864|Calcitriol|calcitriol|mesh-list
44482047|NCT00084864|Dexamethasone|dexamethasone|mesh-list
44482048|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482049|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
44482050|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
44482051|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482052|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482053|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44482054|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
44482055|NCT00084864|Hormones|hormones|mesh-ancestor
44482056|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482057|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482058|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482059|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44482060|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44482061|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482062|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482063|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44482064|NCT00084864|Vitamins|vitamins|mesh-ancestor
44482065|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
44482066|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44482067|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
44482068|NCT00084838|Leucovorin|leucovorin|mesh-list
44482069|NCT00084838|Cytarabine|cytarabine|mesh-list
44482070|NCT00084838|Dactinomycin|dactinomycin|mesh-list
44482071|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
44482072|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44482073|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44482074|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44482075|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
44482076|NCT00084838|Temozolomide|temozolomide|mesh-list
44482077|NCT00084838|Cisplatin|cisplatin|mesh-list
44482078|NCT00084838|Doxorubicin|doxorubicin|mesh-list
44482079|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44482080|NCT00084838|Methotrexate|methotrexate|mesh-list
44482081|NCT00084838|Etoposide|etoposide|mesh-list
44482082|NCT00084838|Vincristine|vincristine|mesh-list
44482083|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
44482084|NCT00084838|Razoxane|razoxane|mesh-list
44482085|NCT00084838|Lenograstim|lenograstim|mesh-list
44482086|NCT00084838|Calcium|calcium|mesh-list
44482087|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
44482088|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482089|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
44482090|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482091|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482092|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482093|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
44482094|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482095|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482096|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482097|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482098|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44482099|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482100|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482101|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44482102|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44482103|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44482104|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
44482105|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44482106|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482107|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
44482108|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44482109|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44482110|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44482111|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482112|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
44482113|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482114|NCT00084838|Antidotes|antidotes|mesh-ancestor
44482115|NCT00084838|Protective Agents|protective agents|mesh-ancestor
44482116|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
44482117|NCT00084838|Vitamins|vitamins|mesh-ancestor
44482118|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
44482119|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44482120|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482121|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482122|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482123|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482124|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482125|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44482126|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44482127|NCT00084747|Bortezomib|bortezomib|mesh-list
44482128|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482129|NCT00084682|Romidepsin|romidepsin|mesh-list
44482130|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482131|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482132|NCT00084617|Capecitabine|capecitabine|mesh-list
44482133|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
44482134|NCT00084617|Irinotecan|irinotecan|mesh-list
44482135|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482136|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
44482137|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482138|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482139|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44482140|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482141|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482142|NCT00084318|Cisplatin|cisplatin|mesh-list
44482143|NCT00084318|Docetaxel|docetaxel|mesh-list
44482144|NCT00084318|Cetuximab|cetuximab|mesh-list
44482145|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482146|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482147|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482148|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482149|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482150|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482151|NCT00083915|Thalidomide|thalidomide|mesh-list
44482152|NCT00083915|Dexamethasone|dexamethasone|mesh-list
44482153|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
44482154|NCT00083915|Melphalan|melphalan|mesh-list
44482155|NCT00083915|Cisplatin|cisplatin|mesh-list
44482156|NCT00083915|Doxorubicin|doxorubicin|mesh-list
44482157|NCT00083915|Etoposide|etoposide|mesh-list
44482158|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44482159|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482160|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
44482161|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482162|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482163|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482164|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
44482165|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482166|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482167|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482168|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482169|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
44482170|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
44482171|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482172|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44482173|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
44482174|NCT00083915|Hormones|hormones|mesh-ancestor
44482175|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482176|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482177|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482178|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44482179|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482180|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482181|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482182|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
44482183|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482184|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482185|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44482186|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44482187|NCT00083915|Growth Substances|growth substances|mesh-ancestor
44482188|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
44482189|NCT00083616|Panitumumab|panitumumab|mesh-list
44482190|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482191|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482192|NCT00083226|Doxorubicin|doxorubicin|mesh-list
44482193|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44482194|NCT00083226|Bortezomib|bortezomib|mesh-list
44482195|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482196|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482197|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44482198|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482199|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482200|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482201|NCT00082888|Tipifarnib|tipifarnib|mesh-list
44482202|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482203|NCT00082810|Fulvestrant|fulvestrant|mesh-list
44482204|NCT00082810|Tipifarnib|tipifarnib|mesh-list
44482205|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482206|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482207|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44482208|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44482209|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
44482210|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482211|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482212|NCT00082758|Interleukin-2|interleukin-2|mesh-list
44482213|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
44482214|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482215|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482216|NCT00082758|Analgesics|analgesics|mesh-ancestor
44482217|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
44482218|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482219|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482220|NCT00082628|Hormones|hormones|mesh-list
44482221|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482222|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482223|NCT00081770|Ribavirin|ribavirin|mesh-list
44482224|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44482225|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
44482226|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44482227|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
44482228|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482229|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
44482230|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482231|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
44301171|NCT00832884|Lacosamide|lacosamide|mesh-list
44482232|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482233|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
44482234|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44482235|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482236|NCT00081458|Teduglutide|teduglutide|mesh-list
44482237|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44482238|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44482239|NCT00081458|Protective Agents|protective agents|mesh-ancestor
44482240|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482242|NCT00081289|Folic Acid|folic acid|mesh-list
44482243|NCT00081289|Fluorouracil|fluorouracil|mesh-list
44482244|NCT00081289|Capecitabine|capecitabine|mesh-list
44482245|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
44482246|NCT00081289|Irinotecan|irinotecan|mesh-list
44482247|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
44482248|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
44482249|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482250|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482251|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482252|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482253|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
44482254|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482255|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44482256|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482257|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482258|NCT00081289|Antidotes|antidotes|mesh-ancestor
44482259|NCT00081289|Protective Agents|protective agents|mesh-ancestor
44482260|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
44482261|NCT00081289|Vitamins|vitamins|mesh-ancestor
44482262|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
44482263|NCT00081289|Hematinics|hematinics|mesh-ancestor
44482264|NCT00081263|Celecoxib|celecoxib|mesh-list
44482265|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
44482266|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44482267|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482268|NCT00081263|Analgesics|analgesics|mesh-ancestor
44482269|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
44482270|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482271|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482272|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482273|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482274|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44482275|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44482276|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482277|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482278|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44482279|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
44482281|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44482282|NCT00081159|Leuprolide|leuprolide|mesh-list
44482283|NCT00081159|Goserelin|goserelin|mesh-list
44482284|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482285|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482286|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44482287|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44482288|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939388|NCT00904488|Metolazone|metolazone|mesh-list
44482289|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482290|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44482291|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482292|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44482293|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
44482294|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44482295|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482296|NCT00080938|Temozolomide|temozolomide|mesh-list
44482297|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482298|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
44482299|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482300|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482301|NCT00080899|Fenretinide|fenretinide|mesh-list
44482302|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482303|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44482304|NCT00080899|Protective Agents|protective agents|mesh-ancestor
44482305|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482306|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
44482307|NCT00080483|Testosterone|testosterone|mesh-list
44482308|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
44482309|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
44482310|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44482311|NCT00080483|Androgens|androgens|mesh-ancestor
44482313|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482314|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482315|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482316|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482317|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
44482318|NCT00080288|Modafinil|modafinil|mesh-list
44482319|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44482320|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482321|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44482322|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44482323|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44482324|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482325|NCT00080223|Pirfenidone|pirfenidone|mesh-list
44482326|NCT00080223|Analgesics|analgesics|mesh-ancestor
44482327|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
44482328|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482329|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482330|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44482331|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482332|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482333|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482334|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482335|NCT00089635|Panitumumab|panitumumab|mesh-list
44482336|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482337|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482338|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
44482339|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482340|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482341|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44482342|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
44482343|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482344|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482345|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482346|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482347|NCT00086723|Captopril|captopril|mesh-list
44482348|NCT00086723|Plasminogen|plasminogen|mesh-list
44482349|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44482350|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44482351|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44482352|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482353|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44482354|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
44482355|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482356|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44482357|NCT00086671|Antibodies|antibodies|mesh-list
44482358|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44482359|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
44482360|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482361|NCT00084344|Afimoxifene|afimoxifene|mesh-list
44482362|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482363|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44482364|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
44482365|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482366|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939491|NCT00909064|PENTA|penta|mesh-list
44482367|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44482368|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44482369|NCT00084253|Ritonavir|ritonavir|mesh-list
44482370|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44482371|NCT00084253|Lamivudine|lamivudine|mesh-list
44482372|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44482373|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44482374|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
44482375|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482376|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482377|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44482378|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44482379|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
44482380|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482381|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44482382|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44482383|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44482384|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44482385|NCT00083941|Interleukin-2|interleukin-2|mesh-list
44482386|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482387|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482388|NCT00083941|Analgesics|analgesics|mesh-ancestor
44482389|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
44482390|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482391|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482392|NCT00083759|Natalizumab|natalizumab|mesh-list
44482393|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
44482394|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482395|NCT00081510|Anastrozole|anastrozole|mesh-list
44482397|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482398|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482399|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44482400|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44482401|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482402|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482403|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44482404|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
44482405|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482406|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482407|NCT00089609|Thalidomide|thalidomide|mesh-list
44482408|NCT00089609|Prednisone|prednisone|mesh-list
44482409|NCT00089609|Bevacizumab|bevacizumab|mesh-list
44482410|NCT00089609|Docetaxel|docetaxel|mesh-list
44482411|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482412|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482413|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44482414|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44482415|NCT00089609|Growth Substances|growth substances|mesh-ancestor
44482416|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482417|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44482418|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482419|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482420|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482421|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482422|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482423|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
44482424|NCT00089609|Hormones|hormones|mesh-ancestor
44482425|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482426|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482427|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482428|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
44482429|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
44482430|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482431|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482432|NCT00088452|Lamotrigine|lamotrigine|mesh-list
44482433|NCT00088452|Valproic Acid|valproic acid|mesh-list
44482434|NCT00088452|Ethosuximide|ethosuximide|mesh-list
44482435|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
44482436|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44482437|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482438|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482439|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44482440|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482441|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44482442|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44482443|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482444|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44482445|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44482446|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482447|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
44482448|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482449|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
44482450|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44482451|NCT03084523|Hematinics|hematinics|mesh-ancestor
44482452|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44482453|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44482454|NCT03089866|Midazolam|midazolam|mesh-list
44482455|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44482456|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44482457|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482458|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482459|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44482460|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44482461|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44482462|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44482463|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
44482464|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
44482465|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
44482466|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
44482467|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482468|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482469|NCT03086993|Gemcitabine|gemcitabine|mesh-list
44482470|NCT03086993|Cisplatin|cisplatin|mesh-list
44482471|NCT03086993|Melphalan|melphalan|mesh-list
44482472|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482473|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482474|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
44482475|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482476|NCT03086993|Antiviral Agents|antiviral agents|mesh-ancestor
44482477|NCT03086993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482478|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482479|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482480|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
44482481|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482482|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482483|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
44482484|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482485|NCT03085485|Ivacaftor|ivacaftor|mesh-list
44482486|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44482487|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482488|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482489|NCT03083197|Azithromycin|azithromycin|mesh-list
44482490|NCT03083197|Doxycycline|doxycycline|mesh-list
44482491|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482492|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482493|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
44482494|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44482495|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44736664|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736665|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736666|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44736667|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
44736668|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44736669|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44736670|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
44736671|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736675|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44736677|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44736678|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44736679|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44736680|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
44736681|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
44736682|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44736683|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44736684|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44736685|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44736686|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44736687|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44736688|NCT03780829|Cycloserine|cycloserine|mesh-list
44736689|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44736690|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736691|NCT03780829|Renal Agents|renal agents|mesh-ancestor
44736692|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44736693|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
44736694|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44736695|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
44736696|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482497|NCT03088059|Palbociclib|palbociclib|mesh-list
44482498|NCT03088059|Niraparib|niraparib|mesh-list
44482499|NCT03088059|Afatinib|afatinib|mesh-list
44482500|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482501|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482502|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482503|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482504|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482505|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44482506|NCT03084549|Ropivacaine|ropivacaine|mesh-list
44482507|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
44482508|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
44482509|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482510|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482511|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
44482512|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482513|NCT03083405|Opipramol|opipramol|mesh-list
44482514|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44482515|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
44482516|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44482517|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44482518|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44482519|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482520|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482521|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44482522|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482523|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482524|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44482525|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482526|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
44482527|NCT03082534|Cetuximab|cetuximab|mesh-list
44482528|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482529|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482530|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
44482531|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482532|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482533|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
44482534|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482535|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482536|NCT03085056|Paclitaxel|paclitaxel|mesh-list
44482537|NCT03085056|Trametinib|trametinib|mesh-list
44482538|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482539|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482540|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482541|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482542|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482543|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482544|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482545|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482547|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44482548|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482549|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482550|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482551|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44482552|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44482553|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482554|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
44482555|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482556|NCT03081858|Paclitaxel|paclitaxel|mesh-list
44482557|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482558|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482559|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482560|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482561|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482562|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482563|NCT03086486|Linezolid|linezolid|mesh-list
44482564|NCT03086486|Bedaquiline|bedaquiline|mesh-list
44482565|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482566|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482567|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44482568|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482569|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482570|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
44482571|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44482572|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482573|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482574|NCT03089957|Urinastatin|urinastatin|mesh-list
44482575|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44482576|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44482577|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
44482578|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482579|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482580|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44482581|NCT03089671|Vitamins|vitamins|mesh-list
44482582|NCT03089671|Riboflavin|riboflavin|mesh-list
44482583|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
44482584|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
44482585|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482586|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44482587|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44482588|NCT03089645|Docetaxel|docetaxel|mesh-list
44482589|NCT03089645|Durvalumab|durvalumab|mesh-list
44482590|NCT03089645|Tremelimumab|tremelimumab|mesh-list
44482591|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44482592|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482593|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482594|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482595|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482596|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482597|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482598|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
44482599|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482600|NCT03089567|Listerine|listerine|mesh-list
44482601|NCT03089567|Fluorides|fluorides|mesh-list
44482602|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
44482603|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
44482604|NCT03089567|Protective Agents|protective agents|mesh-ancestor
44482605|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482606|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44482607|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482608|NCT03089658|Avelumab|avelumab|mesh-list
44482609|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482610|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482611|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
44482612|NCT03089333|Glyburide|glyburide|mesh-list
44482613|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44482614|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482615|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44482616|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482618|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
44482619|NCT03089073|Coagulants|coagulants|mesh-ancestor
44482620|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44482621|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
44482622|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482623|NCT03088891|Antioxidants|antioxidants|mesh-list
44482624|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482625|NCT03088891|Protective Agents|protective agents|mesh-ancestor
44482626|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482627|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
44482628|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44482629|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482630|NCT03088631|Metformin|metformin|mesh-list
44482631|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44482632|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482633|NCT03088670|Metformin|metformin|mesh-list
44482634|NCT03088670|Vildagliptin|vildagliptin|mesh-list
44482635|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44482636|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482637|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44482638|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
44482639|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482640|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482641|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
44482642|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
44482643|NCT03088709|Tacrolimus|tacrolimus|mesh-list
44482644|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482645|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
44482646|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482647|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44482648|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482649|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
44482650|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482651|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482652|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44482653|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44482654|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482655|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482656|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44482657|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
44482658|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482659|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482660|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
44482661|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44482662|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482663|NCT03088358|Enoxaparin|enoxaparin|mesh-list
44482664|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
44482665|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44482666|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44482667|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482668|NCT03088254|Amlodipine|amlodipine|mesh-list
44482669|NCT03088254|Telmisartan|telmisartan|mesh-list
44482670|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44482671|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44482672|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44482673|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667702|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44482674|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482675|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44482676|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482677|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44482678|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44482679|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44482680|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
44482681|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44482682|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44482683|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482684|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44482685|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44482686|NCT03088371|Lidocaine|lidocaine|mesh-list
44482687|NCT03088371|Bupivacaine|bupivacaine|mesh-list
44482688|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
44482689|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
44482690|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301627|NCT00836628|Busulfan|busulfan|mesh-list
44482700|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
44482701|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482702|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482703|NCT03088306|Acetaminophen|acetaminophen|mesh-list
44482704|NCT03088306|Fentanyl|fentanyl|mesh-list
44482705|NCT03088306|Ketamine|ketamine|mesh-list
44482706|NCT03088306|Gabapentin|gabapentin|mesh-list
44482707|NCT03088306|Hydromorphone|hydromorphone|mesh-list
44482708|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
44482709|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482710|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482711|NCT03088306|Analgesics|analgesics|mesh-ancestor
44482712|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
44482713|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482714|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44482715|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44482716|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
44482717|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44482718|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44482719|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482720|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482721|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44482722|NCT03088306|Narcotics|narcotics|mesh-ancestor
44482723|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44482724|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482725|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
44482726|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
44482727|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44482728|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44482729|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44482730|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
44482731|NCT03087968|Prednisolone|prednisolone|mesh-list
44482732|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482733|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
44482734|NCT03087968|Hormones|hormones|mesh-ancestor
44482735|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482736|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482737|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482738|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482739|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
44482740|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44482741|NCT03087942|Growth Substances|growth substances|mesh-ancestor
44482742|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482743|NCT03088046|Progesterone|progesterone|mesh-list
44482744|NCT03088046|Progestins|progestins|mesh-ancestor
44482745|NCT03088046|Hormones|hormones|mesh-ancestor
44482746|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482747|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482749|NCT03088384|Analgesics|analgesics|mesh-ancestor
44482750|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
44482751|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482752|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482753|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44482754|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44482755|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
44482756|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
44482757|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482758|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44482759|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44482760|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482761|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482762|NCT03088176|Trametinib|trametinib|mesh-list
44482763|NCT03088176|Dabrafenib|dabrafenib|mesh-list
44482764|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44482765|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482766|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482767|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482768|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482769|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482770|NCT03087877|Acetaminophen|acetaminophen|mesh-list
44482771|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44482772|NCT03087877|Analgesics|analgesics|mesh-ancestor
44482773|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
44667703|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
43939892|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
44482774|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482775|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482776|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
44482777|NCT03087864|Paclitaxel|paclitaxel|mesh-list
44482778|NCT03087864|Carboplatin|carboplatin|mesh-list
44482779|NCT03087864|Atezolizumab|atezolizumab|mesh-list
44482780|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44482781|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482782|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44482783|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44482784|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44482785|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482786|NCT03087669|Norepinephrine|norepinephrine|mesh-list
44482787|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44482788|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44482789|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
44482790|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482791|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482792|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482793|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
44482794|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
44482795|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482796|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44482797|NCT03087539|Abciximab|abciximab|mesh-list
44482798|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
44482799|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44482800|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
44482801|NCT03087032|Liraglutide|liraglutide|mesh-list
44482802|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44482803|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482804|NCT03087032|Incretins|incretins|mesh-ancestor
44482805|NCT03087032|Hormones|hormones|mesh-ancestor
44482806|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482807|NCT03087149|Vitamin D|vitamin d|mesh-list
44482808|NCT03087149|Vitamins|vitamins|mesh-ancestor
44482809|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
44482810|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482811|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44482812|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
44482813|NCT03087136|Antibodies|antibodies|mesh-list
44482814|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
44482815|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482816|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44482817|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482818|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482819|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
44482820|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482821|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
44482822|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44482823|NCT03087136|Protective Agents|protective agents|mesh-ancestor
44482824|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44482826|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
44482827|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482828|NCT03086681|Cisplatin|cisplatin|mesh-list
44482829|NCT03086681|Endostar protein|endostar protein|mesh-list
44482830|NCT03086681|Endostatins|endostatins|mesh-list
44482831|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482832|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44482833|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44482834|NCT03086681|Growth Substances|growth substances|mesh-ancestor
44482835|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482836|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44482837|NCT03086759|Triamcinolone|triamcinolone|mesh-list
44482838|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44482839|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44482840|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44482841|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44482842|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
44482843|NCT03086759|Hormones|hormones|mesh-ancestor
44482844|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482845|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482846|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482847|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
44482848|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482849|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482850|NCT03086733|Metformin|metformin|mesh-list
44482851|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44482852|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482854|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482855|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482856|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482857|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482858|NCT03086382|Lacosamide|lacosamide|mesh-list
44482859|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
44482860|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44482861|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44482862|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44482863|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482864|NCT03086226|Itraconazole|itraconazole|mesh-list
44482865|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
44482866|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482867|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44482868|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44482869|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482870|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482871|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44482872|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
44482873|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482874|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482875|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44482876|NCT03086291|Simvastatin|simvastatin|mesh-list
44482877|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44482878|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44482879|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
44482880|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482881|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44482882|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44482883|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482884|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
44482885|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44482886|NCT03086564|Estrogens|estrogens|mesh-ancestor
44482887|NCT03086564|Hormones|hormones|mesh-ancestor
44482888|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44482889|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482890|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44482891|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482892|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
44482893|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482894|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482895|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44482903|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44482904|NCT03085992|Growth Substances|growth substances|mesh-ancestor
44482905|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482906|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
44482907|NCT03086070|Omeprazole|omeprazole|mesh-list
44482908|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44482909|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44482910|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44482911|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482912|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482913|NCT03086148|Ketamine|ketamine|mesh-list
44482914|NCT03086148|Analgesics|analgesics|mesh-ancestor
44482915|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
44482916|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44482917|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482918|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44482919|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44482920|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
44482921|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
44482922|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482923|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44301844|NCT00837941|Pregabalin|pregabalin|mesh-list
44482924|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44482925|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44482926|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736723|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44736724|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736725|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736726|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736727|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736728|NCT03710564|Aflibercept|aflibercept|mesh-list
44736729|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44736730|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44736731|NCT03710564|Growth Substances|growth substances|mesh-ancestor
44736732|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736733|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
44736734|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736735|NCT03703492|Estradiol|estradiol|mesh-list
44736736|NCT03703492|Estrogens|estrogens|mesh-ancestor
44736737|NCT03703492|Hormones|hormones|mesh-ancestor
44736738|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736739|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624868|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
44736770|NCT03624127|Apremilast|apremilast|mesh-list
44736771|NCT03624127|BMS-986165|bms-986165|mesh-list
44736772|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44736773|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44736774|NCT03624127|Analgesics|analgesics|mesh-ancestor
44736775|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
44736776|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736777|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736778|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736779|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736780|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44736781|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44736782|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736783|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736784|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
44736785|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736786|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
44736787|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
44736788|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
44736789|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736790|NCT03597568|Resveratrol|resveratrol|mesh-list
44736791|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
44736792|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482927|NCT03085654|Oxytocin|oxytocin|mesh-list
44482928|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
44482929|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44482930|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482931|NCT03085823|Sirolimus|sirolimus|mesh-list
44482932|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44482933|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482934|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44482935|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482936|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
44482937|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482938|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
44482939|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482940|NCT03085225|Durvalumab|durvalumab|mesh-list
44482941|NCT03085225|Trabectedin|trabectedin|mesh-list
44482942|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482943|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482944|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44482945|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
44482946|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482947|NCT03085368|Trastuzumab|trastuzumab|mesh-list
44482948|NCT03085368|Lapatinib|lapatinib|mesh-list
44482949|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44482950|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482951|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482952|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667704|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
44482953|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482954|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44482955|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44482956|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
44482957|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44482958|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44482959|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482960|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
44482961|NCT03085394|Coagulants|coagulants|mesh-ancestor
44482962|NCT03085186|Crizotinib|crizotinib|mesh-list
44482963|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482964|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44482965|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44482966|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482967|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44482968|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44482969|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44482970|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44482971|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44482972|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44482973|NCT03084978|Anesthetics|anesthetics|mesh-list
44482974|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44482975|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482976|NCT03085030|Antioxidants|antioxidants|mesh-list
44482977|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482978|NCT03085030|Protective Agents|protective agents|mesh-ancestor
44482979|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482980|NCT03084809|Leucovorin|leucovorin|mesh-list
44482981|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
44482982|NCT03084809|Fluorouracil|fluorouracil|mesh-list
44482983|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
44482984|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44482985|NCT03084809|Antidotes|antidotes|mesh-ancestor
44482986|NCT03084809|Protective Agents|protective agents|mesh-ancestor
44482987|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44482988|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
44482989|NCT03084809|Vitamins|vitamins|mesh-ancestor
44482990|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
44482991|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
44482992|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44482993|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44482994|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44482995|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
44482996|NCT03084588|Methadone|methadone|mesh-list
44482997|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44482998|NCT03084588|Narcotics|narcotics|mesh-ancestor
44482999|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483000|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483001|NCT03084588|Analgesics|analgesics|mesh-ancestor
44483002|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
44301993|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
44483003|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483004|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
44483005|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
44483007|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44483008|NCT03084575|Protective Agents|protective agents|mesh-ancestor
44483009|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483010|NCT03084250|Tenofovir|tenofovir|mesh-list
44483011|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44483012|NCT03084250|Entecavir|entecavir|mesh-list
44483013|NCT03084250|Adefovir|adefovir|mesh-list
44483014|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
44483015|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483016|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44483017|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44483018|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483019|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483020|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44483021|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44483022|NCT03084419|Abatacept|abatacept|mesh-list
44483023|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44483024|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483025|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483026|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483027|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
44483028|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483029|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483030|NCT03084328|Vitamin D|vitamin d|mesh-list
44483031|NCT03084328|Vitamins|vitamins|mesh-ancestor
44483032|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
43940148|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44483033|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483034|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44483035|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
44483036|NCT03084380|Fludarabine|fludarabine|mesh-list
44483037|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483038|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
44483039|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483040|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483041|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44483042|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
44483043|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483044|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483045|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44483046|NCT03084601|Calcium|calcium|mesh-list
44483047|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483048|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483049|NCT03084029|Oxytocin|oxytocin|mesh-list
44483050|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
44483051|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44483052|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483053|NCT03083782|Cyclosporine|cyclosporine|mesh-list
44483054|NCT03083782|Apixaban|apixaban|mesh-list
44483055|NCT03083782|Tacrolimus|tacrolimus|mesh-list
44483056|NCT03083782|Cyclosporins|cyclosporins|mesh-list
44483057|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483058|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
44483059|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483060|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44483061|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483062|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483063|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
44483064|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483065|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
44483066|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483067|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44483068|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
44483069|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44483070|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
44483071|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
44483072|NCT03083834|Cosyntropin|cosyntropin|mesh-list
44483073|NCT03083834|Hormones|hormones|mesh-ancestor
44483074|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483075|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483076|NCT03083613|Paclitaxel|paclitaxel|mesh-list
44483077|NCT03083613|Raltitrexed|raltitrexed|mesh-list
44302068|NCT00839085|Protective Agents|protective agents|mesh-ancestor
44483078|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44483079|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483080|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44483081|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44483082|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44483083|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483084|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483086|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44483087|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483088|NCT03083691|Nivolumab|nivolumab|mesh-list
44483089|NCT03083691|Ipilimumab|ipilimumab|mesh-list
44483090|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483091|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483092|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44483093|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483094|NCT03083704|Enoxaparin|enoxaparin|mesh-list
44483095|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
44483096|NCT03083704|Apixaban|apixaban|mesh-list
44483097|NCT03083704|Edoxaban|edoxaban|mesh-list
44483098|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
44483099|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44483100|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
44483101|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44483102|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
44483103|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483104|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483105|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
44483106|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44483107|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44483108|NCT03083457|Anesthetics|anesthetics|mesh-list
44483109|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
44483110|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483111|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736793|NCT03597568|Protective Agents|protective agents|mesh-ancestor
44736794|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736795|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736796|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44736797|NCT03526250|Palbociclib|palbociclib|mesh-list
44736798|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736799|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736800|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736801|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736802|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44736803|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
44736804|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736805|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
44736806|NCT03504241|Sirolimus|sirolimus|mesh-list
44736807|NCT03504241|Prednisone|prednisone|mesh-list
44736808|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
44736809|NCT03504241|Abatacept|abatacept|mesh-list
44736810|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736811|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
44736812|NCT03504241|Hormones|hormones|mesh-ancestor
44736813|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736814|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736815|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44736816|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736817|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44736818|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44736819|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
44736820|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44736821|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44736822|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736823|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736824|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
44736825|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736826|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
44736827|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736828|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44736829|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736830|NCT03502733|Nivolumab|nivolumab|mesh-list
44736831|NCT03502733|Ipilimumab|ipilimumab|mesh-list
44736832|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736833|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302155|NCT00839397|Paroxetine|paroxetine|mesh-list
44736834|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44483112|NCT03083210|Lanreotide|lanreotide|mesh-list
44483113|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483114|NCT03083184|Ethanol|ethanol|mesh-list
44483115|NCT03083184|Enoxaparin|enoxaparin|mesh-list
44483116|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
44483117|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44483118|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44483119|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483120|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44483121|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483122|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483123|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483124|NCT03083041|Apatinib|apatinib|mesh-list
44483125|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483126|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483127|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483128|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483129|NCT03083080|Epinephrine|epinephrine|mesh-list
44483130|NCT03083080|Ropivacaine|ropivacaine|mesh-list
44483131|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483132|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
44483133|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483134|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483135|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
44483136|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483137|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44483138|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44483139|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483140|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483141|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483142|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44483143|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44483144|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
44483145|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44483146|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
44483147|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
44483148|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
44483149|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44483150|NCT03082885|Thymalfasin|thymalfasin|mesh-list
44483151|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44483152|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
44483153|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483154|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44483155|NCT03082742|Furosemide|furosemide|mesh-list
44483156|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44483157|NCT03082742|Diuretics|diuretics|mesh-ancestor
44483158|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
44483159|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483160|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44483161|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483162|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483163|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44483165|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483166|NCT03082300|Naquotinib|naquotinib|mesh-list
44483167|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483168|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483169|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483170|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483171|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44483172|NCT03082573|Hormones|hormones|mesh-ancestor
44483173|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483174|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483175|NCT03082352|Metoprolol|metoprolol|mesh-list
44483176|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44483177|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44483178|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
44483179|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
44483180|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483181|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483182|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44483183|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44483184|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44483185|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483186|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483187|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483188|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
44483189|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44483190|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44483191|NCT03082092|Prednisolone|prednisolone|mesh-list
44483192|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
44483193|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44483194|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
44483195|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483196|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
44483197|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
44483198|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483199|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483200|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483201|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
44483202|NCT03082092|Hormones|hormones|mesh-ancestor
44483203|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483204|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44483205|NCT03082092|Protective Agents|protective agents|mesh-ancestor
44483206|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44483207|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483208|NCT03082183|Rifampin|rifampin|mesh-list
44483209|NCT03082183|BI 425809|bi 425809|mesh-list
44483210|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44483211|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
44483212|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483213|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483214|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
44483215|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44483216|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483217|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483218|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44483219|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44483220|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44483221|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44483222|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44483223|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44483224|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
44483225|NCT03082053|Capecitabine|capecitabine|mesh-list
44483226|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483227|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
44483228|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483229|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894084|NCT04679623|Midazolam|midazolam|mesh-list
44483230|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44483232|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
44483233|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44483234|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483235|NCT03082482|Nicotine|nicotine|mesh-list
44483236|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44483237|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
44483238|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483239|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483240|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44483241|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44483242|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44483243|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483244|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483245|NCT03081494|Spartalizumab|spartalizumab|mesh-list
44483246|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44483247|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483248|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483249|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
44483250|NCT03081702|Itraconazole|itraconazole|mesh-list
44483251|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
44483252|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44483253|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44483254|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483255|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483256|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483257|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483258|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
44483259|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44483260|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44483261|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44483262|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
44483263|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483264|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483265|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44483266|NCT03081728|Acetaminophen|acetaminophen|mesh-list
44483267|NCT03081728|Diclofenac|diclofenac|mesh-list
44483268|NCT03081728|Ropivacaine|ropivacaine|mesh-list
44483269|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483270|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
44483271|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483272|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483273|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
44483274|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483275|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44483276|NCT03081728|Analgesics|analgesics|mesh-ancestor
44483277|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
44483278|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44483279|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483280|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483281|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44483282|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483283|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736835|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736836|NCT03499899|Carboplatin|carboplatin|mesh-list
44736837|NCT03499899|Spartalizumab|spartalizumab|mesh-list
44736838|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736839|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44736840|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736841|NCT03481634|Aflibercept|aflibercept|mesh-list
44736842|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44736843|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44736844|NCT03481634|Growth Substances|growth substances|mesh-ancestor
44736845|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736846|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
44736847|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736848|NCT03476642|Epinephrine|epinephrine|mesh-list
43940477|NCT00936663|Hormones|hormones|mesh-ancestor
44736849|NCT03476642|Ropivacaine|ropivacaine|mesh-list
44736850|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
44736851|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
44736852|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44736853|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736854|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
44736855|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736856|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44736857|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44736858|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44736859|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736860|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736861|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44736862|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44736863|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
44736864|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44736865|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44736866|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
44736867|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
44736868|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44736869|NCT03460756|Ganaxolone|ganaxolone|mesh-list
44736870|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
44736871|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736872|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736873|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736874|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
44736875|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
44736876|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
44736877|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736878|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736879|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44736880|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
44736881|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736882|NCT03375307|Olaparib|olaparib|mesh-list
44736883|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44736884|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302372|NCT00840606|Buspirone|buspirone|mesh-list
44483284|NCT03081039|Gemcitabine|gemcitabine|mesh-list
44483285|NCT03081039|Cisplatin|cisplatin|mesh-list
44483286|NCT03081039|Carboplatin|carboplatin|mesh-list
44483287|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483288|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483289|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
44483290|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483291|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
44483292|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483293|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483294|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483295|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
44483296|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483297|NCT03081169|Heparin|heparin|mesh-list
44483298|NCT03081169|Enoxaparin|enoxaparin|mesh-list
44483299|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
44483300|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
44483301|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44483302|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44483303|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483304|NCT03081442|Misoprostol|misoprostol|mesh-list
44483305|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
44483306|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44483307|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
44483308|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44483309|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483310|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44483311|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483312|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
44483313|NCT03080675|Vitamins|vitamins|mesh-list
44483314|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
44483315|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483316|NCT03080740|Metronidazole|metronidazole|mesh-list
44483317|NCT03080740|Clindamycin|clindamycin|mesh-list
44483318|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
44483319|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
44483320|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483321|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483322|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44483323|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44483324|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44483325|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483326|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483327|NCT03080766|Decitabine|decitabine|mesh-list
44483328|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483329|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
44483330|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483331|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483332|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483333|NCT03080805|Capecitabine|capecitabine|mesh-list
44483334|NCT03080805|Lapatinib|lapatinib|mesh-list
44483335|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483336|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
44483337|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483338|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483339|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483340|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483341|NCT03080363|Lidocaine|lidocaine|mesh-list
44483342|NCT03080363|Bupivacaine|bupivacaine|mesh-list
44483343|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483344|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
44483345|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483346|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483347|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
44483348|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483349|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44483350|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44483351|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44483352|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483353|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483354|NCT03080324|Fentanyl|fentanyl|mesh-list
44483355|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44483356|NCT03080324|Narcotics|narcotics|mesh-ancestor
44483357|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483358|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483359|NCT03080324|Analgesics|analgesics|mesh-ancestor
44483360|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
44483361|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483362|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44483363|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44483364|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
44483365|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
44483367|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44483368|NCT03080350|Narcotics|narcotics|mesh-ancestor
44483369|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483370|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483371|NCT03080350|Analgesics|analgesics|mesh-ancestor
44483372|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
44483373|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483374|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44483375|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44483376|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
44483377|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
44483378|NCT03080181|Pasireotide|pasireotide|mesh-list
44483379|NCT03080181|Hormones|hormones|mesh-ancestor
44483380|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940538|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44483381|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483382|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44483383|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44483384|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44483385|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483386|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483387|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44483388|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44483389|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44483390|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
44483391|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483392|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483393|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44483394|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44483395|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
44483396|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
44483397|NCT03088293|Infliximab|infliximab|mesh-list
44483398|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483399|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
44483400|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483401|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483402|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44483403|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
43894252|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
44483404|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483405|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483406|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44483407|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44483408|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483409|NCT03083353|Isradipine|isradipine|mesh-list
44483410|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44483411|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44483412|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483413|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483414|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483415|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483416|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483417|NCT03086096|Irinotecan|irinotecan|mesh-list
44483418|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44483419|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44483420|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483421|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483422|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483423|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
44483424|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44483425|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
44483426|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483427|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483428|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44483429|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
44483430|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44483431|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
44483432|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483433|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302505|NCT00841438|Abciximab|abciximab|mesh-list
44483434|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44483435|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483436|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
44483437|NCT03081052|Protective Agents|protective agents|mesh-ancestor
44483438|NCT05689047|Artesunate|artesunate|mesh-list
44483439|NCT05689047|Pyronaridine|pyronaridine|mesh-list
44483440|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
44483441|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44483442|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44483443|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483444|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483445|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
44483446|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
44483447|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44483448|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
44483449|NCT05689021|Prednisone|prednisone|mesh-list
44483450|NCT05689021|Cortisone|cortisone|mesh-list
44483451|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
44483452|NCT05689021|Niraparib|niraparib|mesh-list
44483453|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483454|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
44483455|NCT05689021|Hormones|hormones|mesh-ancestor
44483456|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483457|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483458|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44483459|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483460|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44483461|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483462|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483463|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
44483464|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44483465|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44483466|NCT05688943|Anesthetics|anesthetics|mesh-list
44483467|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483468|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483469|NCT05688904|Imipramine|imipramine|mesh-list
44483470|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44483471|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
44483472|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44483473|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44483474|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44483475|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483476|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483479|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483481|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483482|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483483|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44483484|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483485|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736885|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736886|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736889|NCT03301506|Seladelpar|seladelpar|mesh-list
44736890|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44736891|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
44736892|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736893|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44736894|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44736895|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736896|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736897|NCT03289910|Carboplatin|carboplatin|mesh-list
44736898|NCT03289910|Topotecan|topotecan|mesh-list
44736899|NCT03289910|Veliparib|veliparib|mesh-list
44736900|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940678|NCT00940927|Albuterol|albuterol|mesh-list
44736901|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44736902|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44736903|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736904|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736905|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44302508|NCT00841477|Vaccines|vaccines|mesh-list
44483486|NCT05688735|Isosorbide|isosorbide|mesh-list
44483487|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44483488|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44483489|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44483490|NCT05688735|Diuretics|diuretics|mesh-ancestor
44483491|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
44483492|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483493|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483494|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44483495|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483496|NCT05688670|Anesthetics|anesthetics|mesh-list
44483497|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483498|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483499|NCT05688631|Antioxidants|antioxidants|mesh-list
44483500|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483501|NCT05688631|Protective Agents|protective agents|mesh-ancestor
44483502|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483503|NCT05688579|Spironolactone|spironolactone|mesh-list
44483504|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44483505|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
44483506|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483507|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483508|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44483509|NCT05688579|Diuretics|diuretics|mesh-ancestor
44483510|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
44483511|NCT05688488|Curcumin|curcumin|mesh-list
44483512|NCT05688488|Mitomycins|mitomycins|mesh-list
44483513|NCT05688488|Mitomycin|mitomycin|mesh-list
44483514|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44483515|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483516|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
44483517|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483518|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44483519|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483520|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44483521|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44483522|NCT05688488|Analgesics|analgesics|mesh-ancestor
44483523|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
44483524|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483525|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483526|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483527|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483529|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483530|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
44483531|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
44483532|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483533|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940725|NCT00942578|Bevacizumab|bevacizumab|mesh-list
44140843|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483534|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483535|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
44483536|NCT05688475|Hormones|hormones|mesh-ancestor
44483537|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483538|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44483539|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483540|NCT05688449|Fentanyl|fentanyl|mesh-list
44483541|NCT05688449|Bupivacaine|bupivacaine|mesh-list
44483542|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483543|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
44483544|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483545|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483546|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
44483547|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483548|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44483549|NCT05688449|Narcotics|narcotics|mesh-ancestor
44483550|NCT05688449|Analgesics|analgesics|mesh-ancestor
44483551|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44483552|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44483553|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
44483554|NCT05688436|Interferons|interferons|mesh-list
44483555|NCT05688436|Interferon-beta|interferon-beta|mesh-list
44483556|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
44483557|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
44483558|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
44483559|NCT05688436|Natalizumab|natalizumab|mesh-list
44483560|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44483561|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
44483562|NCT05688436|Siponimod|siponimod|mesh-list
44483563|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483564|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
44483565|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483566|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483567|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
44483568|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483569|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43940768|NCT00943800|Fludarabine|fludarabine|mesh-list
44483570|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483571|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483572|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44483573|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44483574|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
44483575|NCT05688371|Morphine|morphine|mesh-list
44483576|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44483577|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483578|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483579|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44483580|NCT05688371|Analgesics|analgesics|mesh-ancestor
44483581|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
44483582|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483583|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44483584|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44483585|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44483586|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483587|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483588|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483589|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44483590|NCT05688371|Narcotics|narcotics|mesh-ancestor
44483591|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
44483592|NCT05688345|Propofol|propofol|mesh-list
44483593|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44483594|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483595|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483596|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44483597|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
44483598|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
44483599|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44483600|NCT05688345|Analgesics|analgesics|mesh-ancestor
44483601|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
44483602|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483603|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44483604|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44483606|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483607|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483608|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483609|NCT05688306|Oprelvekin|oprelvekin|mesh-list
44483610|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483611|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
44483612|NCT05688215|Leucovorin|leucovorin|mesh-list
44483613|NCT05688215|Folic Acid|folic acid|mesh-list
44483614|NCT05688215|Fluorouracil|fluorouracil|mesh-list
44483615|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
44483616|NCT05688215|Irinotecan|irinotecan|mesh-list
44483617|NCT05688215|Calcium|calcium|mesh-list
44483618|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
44483619|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483620|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483621|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44483622|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
44483623|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483624|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44483625|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483626|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44483627|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
44483628|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44483629|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44483630|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483631|NCT05688215|Antidotes|antidotes|mesh-ancestor
44483632|NCT05688215|Protective Agents|protective agents|mesh-ancestor
44483633|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
44483634|NCT05688215|Vitamins|vitamins|mesh-ancestor
44483635|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
44483636|NCT05688215|Hematinics|hematinics|mesh-ancestor
44302660|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
44483637|NCT05688202|Acetaminophen|acetaminophen|mesh-list
44483638|NCT05688202|Lidocaine|lidocaine|mesh-list
44483650|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483651|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483652|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44483653|NCT05688202|Analgesics|analgesics|mesh-ancestor
44483654|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
44483655|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44483656|NCT05688124|Esomeprazole|esomeprazole|mesh-list
44483657|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44483658|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483659|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44483660|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483661|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483663|NCT05688098|Irbesartan|irbesartan|mesh-list
44483664|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44483665|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44483666|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483667|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483668|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483669|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483670|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483671|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44483672|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44483684|NCT05688020|Epinephrine|epinephrine|mesh-list
44483685|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
44483686|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44483687|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44483688|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483689|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
44483690|NCT05688020|Coagulants|coagulants|mesh-ancestor
44483691|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44483692|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44483693|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483694|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483695|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483696|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44483697|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44483698|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
44483699|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483700|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44483701|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
44483702|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
44483703|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
44483704|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44483706|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
44483707|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483708|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483709|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483710|NCT05687981|Dexamethasone|dexamethasone|mesh-list
44302743|NCT00842595|Prednisone|prednisone|mesh-list
44483711|NCT05687981|Bupivacaine|bupivacaine|mesh-list
44483712|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44483713|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
44483714|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
44483715|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483716|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483717|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483718|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
44483719|NCT05687981|Hormones|hormones|mesh-ancestor
44483720|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483721|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44483722|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483723|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483724|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
44483725|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483726|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
44483727|NCT05687760|Calcium|calcium|mesh-list
44483728|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483729|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483730|NCT05687747|FAPI-46|fapi-46|mesh-list
44483731|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44483732|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483733|NCT05687721|Avelumab|avelumab|mesh-list
44483734|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483735|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483736|NCT05687669|Phentolamine|phentolamine|mesh-list
44483737|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
44483738|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44483739|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44483740|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
44483741|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483742|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483743|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483744|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44483745|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483746|NCT05687500|Glyburide|glyburide|mesh-list
44483747|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44483748|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483749|NCT05687409|Entecavir|entecavir|mesh-list
44483750|NCT05687409|Lactulose|lactulose|mesh-list
44483751|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44483752|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
44483753|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483754|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483755|NCT05687357|Paclitaxel|paclitaxel|mesh-list
44483756|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
44483757|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44483758|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483759|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
44483760|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
43940934|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
44483761|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
44483762|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483763|NCT05687344|Nifedipine|nifedipine|mesh-list
44483764|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44483765|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483766|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483767|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483768|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483769|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483770|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
44483771|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44483772|NCT05687266|Paclitaxel|paclitaxel|mesh-list
44483773|NCT05687266|Cisplatin|cisplatin|mesh-list
44483774|NCT05687266|Carboplatin|carboplatin|mesh-list
44483775|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
44483776|NCT05687266|Pemetrexed|pemetrexed|mesh-list
44483777|NCT05687266|Durvalumab|durvalumab|mesh-list
44483778|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44483780|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
44483781|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
44483782|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
44483783|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483784|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483785|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483786|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44736906|NCT03245151|Everolimus|everolimus|mesh-list
44483787|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44483789|NCT05687253|Rocuronium|rocuronium|mesh-list
44483790|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
44483791|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44483792|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44483793|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44483794|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483795|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483796|NCT05687136|Peposertib|peposertib|mesh-list
44483797|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483798|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483799|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483800|NCT05687123|Sunitinib|sunitinib|mesh-list
44483801|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44483802|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483803|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44483804|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44483805|NCT05687123|Growth Substances|growth substances|mesh-ancestor
44483806|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483807|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
44483808|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483809|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483810|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483811|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44483812|NCT05687110|Novobiocin|novobiocin|mesh-list
44483813|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483814|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483815|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483816|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483817|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44736907|NCT03245151|Lenvatinib|lenvatinib|mesh-list
44736908|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736909|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44736910|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
44736911|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736912|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736913|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736914|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736915|NCT03223883|Curcumin|curcumin|mesh-list
44736916|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44736917|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44736918|NCT03223883|Analgesics|analgesics|mesh-ancestor
44736919|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
44736920|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44736921|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736922|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44736923|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44736924|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736925|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736926|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736927|NCT03220035|Vemurafenib|vemurafenib|mesh-list
44736928|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736929|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736930|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736931|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736932|NCT03171025|Nivolumab|nivolumab|mesh-list
44736933|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736934|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736935|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44736936|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736937|NCT03149003|Bevacizumab|bevacizumab|mesh-list
44736938|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44736939|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736940|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44736941|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44736942|NCT03149003|Growth Substances|growth substances|mesh-ancestor
44736943|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736944|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
44736945|NCT03148275|Trametinib|trametinib|mesh-list
44736946|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736947|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736948|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483818|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44483819|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44483820|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
44483821|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483822|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44483823|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483824|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44483825|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483826|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44483827|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483828|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483829|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44483830|NCT05686993|Nifedipine|nifedipine|mesh-list
44483831|NCT05686993|Cinnarizine|cinnarizine|mesh-list
44483832|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44483833|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483834|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483835|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44483836|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483837|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44483838|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
44483839|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44483840|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44483841|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
44483842|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
44483843|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483844|NCT05686915|Cobalt|cobalt|mesh-list
44483845|NCT05686915|Chromium|chromium|mesh-list
44483846|NCT05686915|Trace Elements|trace elements|mesh-ancestor
44483847|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
44483848|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483849|NCT05686863|Remifentanil|remifentanil|mesh-list
44483850|NCT05686863|Propofol|propofol|mesh-list
44483851|NCT05686863|Esketamine|esketamine|mesh-list
44483852|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44483853|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483854|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483855|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44483856|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
44483857|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
44483858|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44483859|NCT05686863|Narcotics|narcotics|mesh-ancestor
44483860|NCT05686863|Analgesics|analgesics|mesh-ancestor
44483861|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
44483862|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483863|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
44483864|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44483865|NCT05686772|Dopamine|dopamine|mesh-list
44483866|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44483867|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
44483868|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
44483869|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483870|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483871|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
44483872|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483873|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483874|NCT05686772|Protective Agents|protective agents|mesh-ancestor
44483875|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
44483876|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44483877|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483878|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44483879|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483880|NCT05686564|Choline|choline|mesh-list
44483881|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
44483882|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44483884|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483885|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44483886|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44483887|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
44483888|NCT05686434|Osimertinib|osimertinib|mesh-list
44483889|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483890|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44483891|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483892|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483893|NCT05686408|Tianeptine|tianeptine|mesh-list
44483894|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44483895|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
44483896|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44483897|NCT05686395|Bupivacaine|bupivacaine|mesh-list
44483898|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
44483899|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
44483900|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44483901|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483902|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
44483903|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44483904|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
44483905|NCT05686356|Bedaquiline|bedaquiline|mesh-list
44483906|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44483907|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
44483908|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483909|NCT05686356|Expectorants|expectorants|mesh-ancestor
44483910|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
44483911|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44483912|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
44483913|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483914|NCT05686356|Protective Agents|protective agents|mesh-ancestor
44483915|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483916|NCT05686356|Antidotes|antidotes|mesh-ancestor
44483917|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
44483918|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483919|NCT05686044|Phenserine|phenserine|mesh-list
44483920|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43941122|NCT00951561|Ibuprofen|ibuprofen|mesh-list
44483921|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483922|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483923|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44483924|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44483925|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483926|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
44483927|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44483928|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44483929|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483930|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
44483931|NCT05686005|Coagulants|coagulants|mesh-ancestor
44483932|NCT05685953|Vaccines|vaccines|mesh-list
44483933|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
44483934|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483935|NCT05685836|Bevacizumab|bevacizumab|mesh-list
44483936|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44483937|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44483938|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483939|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44483940|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44483941|NCT05685836|Growth Substances|growth substances|mesh-ancestor
44483942|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483943|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
44483944|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44483945|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483946|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44483947|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44483948|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483949|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44483950|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44483951|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44483952|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483953|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
44483954|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44736949|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483955|NCT05685719|Itraconazole|itraconazole|mesh-list
44483956|NCT05685719|Rifampin|rifampin|mesh-list
44483957|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
44483958|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483959|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44483960|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44483961|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44483962|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44483963|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44483964|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
44483965|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44483966|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483967|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44483968|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44483969|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
44483970|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483971|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
44483972|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44483973|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44483974|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44483975|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44483976|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44483977|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44483978|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44483979|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
44483980|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44483981|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
44483982|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483983|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
44483984|NCT05685667|Protective Agents|protective agents|mesh-ancestor
44483985|NCT05685628|Charcoal|charcoal|mesh-list
44483986|NCT05685628|Antidotes|antidotes|mesh-ancestor
44483987|NCT05685628|Protective Agents|protective agents|mesh-ancestor
44483988|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44483989|NCT05685615|Polymyxins|polymyxins|mesh-list
44483990|NCT05685615|Polymyxin B|polymyxin b|mesh-list
44483991|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44483992|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44483993|NCT05685602|Gemcitabine|gemcitabine|mesh-list
44483994|NCT05685602|Paclitaxel|paclitaxel|mesh-list
44483995|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43941205|NCT00953199|Lidocaine|lidocaine|mesh-list
44483996|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44483997|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44483998|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
44483999|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
44484000|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
44484001|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484002|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484003|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
44484004|NCT05685602|Antiviral Agents|antiviral agents|mesh-ancestor
44484005|NCT05685602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484006|NCT05685602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484007|NCT05685602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484008|NCT05685602|Immunologic Factors|immunologic factors|mesh-ancestor
44484009|NCT05685602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484010|NCT05685537|Simendan|simendan|mesh-list
44484011|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44484012|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
44484013|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44484014|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44484015|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484016|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484017|NCT05685537|Protective Agents|protective agents|mesh-ancestor
44484018|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484019|NCT05685407|Caffeine|caffeine|mesh-list
44484020|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44484021|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484022|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44484023|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484024|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484025|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44484026|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44484027|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
44484028|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484029|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
44484030|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44484031|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484032|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44484033|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484034|NCT05685342|Acetaminophen|acetaminophen|mesh-list
44484035|NCT05685342|Ibuprofen|ibuprofen|mesh-list
44484036|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484037|NCT05685342|Analgesics|analgesics|mesh-ancestor
44484038|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
44484039|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484040|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484041|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
44484042|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44484043|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484044|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484045|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44484046|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484047|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484048|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44484049|NCT05685277|Ramipril|ramipril|mesh-list
44484050|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44484051|NCT05685277|Diuretics|diuretics|mesh-ancestor
44484052|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
44484053|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484054|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44484055|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44484056|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484057|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44484058|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44484059|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484060|NCT05685004|Temozolomide|temozolomide|mesh-list
44484061|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44484062|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
44484063|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484064|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484065|NCT05684848|Resveratrol|resveratrol|mesh-list
44484066|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
44484067|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484068|NCT05684848|Protective Agents|protective agents|mesh-ancestor
44484069|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484070|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484071|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44484072|NCT05684718|Itraconazole|itraconazole|mesh-list
44484073|NCT05684718|Rifabutin|rifabutin|mesh-list
44484074|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
44484075|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484076|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43941293|NCT00955266|Calcium|calcium|mesh-list
44484077|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484078|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484079|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484080|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44484081|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44484082|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484083|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484084|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44484085|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484086|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44484087|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
44484089|NCT05684484|Salicylates|salicylates|mesh-list
44484090|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484091|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
44484092|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
44484093|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44484094|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44484095|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484096|NCT05684484|Analgesics|analgesics|mesh-ancestor
44484097|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
44484098|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484099|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484100|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484101|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484102|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44484103|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484104|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484105|NCT05684276|Paclitaxel|paclitaxel|mesh-list
44484106|NCT05684276|Carboplatin|carboplatin|mesh-list
44484107|NCT05684276|Nivolumab|nivolumab|mesh-list
44484108|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44484109|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484110|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44484111|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44484112|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44484113|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484114|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484115|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44484116|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
44484117|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
44484118|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941325|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
44484119|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484120|NCT05683691|Analgesics|analgesics|mesh-ancestor
44484121|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
44484122|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484123|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484124|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484125|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484126|NCT05680454|Vaccines|vaccines|mesh-list
44484127|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
44484128|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484129|NCT05679492|Meplazumab|meplazumab|mesh-list
44484130|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
44484131|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484132|NCT05679479|Meplazumab|meplazumab|mesh-list
44484133|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
44484134|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484135|NCT05678673|Nivolumab|nivolumab|mesh-list
44484136|NCT05678673|Sunitinib|sunitinib|mesh-list
44484137|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484138|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484139|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44484140|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484141|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44484142|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44484143|NCT05678673|Growth Substances|growth substances|mesh-ancestor
44484144|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484145|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44484146|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44484147|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484148|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
44484149|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44484150|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484151|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484152|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44484153|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44484154|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484155|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484156|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484157|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44484158|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
44484159|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44484160|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484161|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44484162|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44484163|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44484164|NCT05667324|Dexamethasone|dexamethasone|mesh-list
44484165|NCT05667324|Ropivacaine|ropivacaine|mesh-list
44484166|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484167|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
44484168|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
44484169|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484170|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484171|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484172|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
44484173|NCT05667324|Hormones|hormones|mesh-ancestor
44484174|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484175|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484176|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484177|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
44484178|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
44484179|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484180|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
44736965|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
44736966|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44736967|NCT03106454|Norethindrone|norethindrone|mesh-list
44736968|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
44736969|NCT03106454|Estradiol|estradiol|mesh-list
44736970|NCT03106454|Estrogens|estrogens|mesh-ancestor
44736971|NCT03106454|Hormones|hormones|mesh-ancestor
44736972|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44736973|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44736974|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44736975|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
44736976|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44736977|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44736978|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44736979|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44736980|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44736981|NCT03106454|Trace Elements|trace elements|mesh-ancestor
44736982|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
44736983|NCT03040973|Gefitinib|gefitinib|mesh-list
44736984|NCT03040973|Osimertinib|osimertinib|mesh-list
44736985|NCT03040973|Nazartinib|nazartinib|mesh-list
44736986|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44736987|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44736988|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44736989|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44736990|NCT02997228|Leucovorin|leucovorin|mesh-list
44736991|NCT02997228|Bevacizumab|bevacizumab|mesh-list
44736992|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44736993|NCT02997228|Fluorouracil|fluorouracil|mesh-list
44736994|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
44736995|NCT02997228|Atezolizumab|atezolizumab|mesh-list
44736996|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
44736997|NCT02997228|Antibodies|antibodies|mesh-list
44736998|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
44736999|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737000|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
44737001|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737002|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44737003|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44737004|NCT02997228|Growth Substances|growth substances|mesh-ancestor
44737005|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737006|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44737007|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
44737008|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
44737009|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737010|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737011|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737012|NCT02997228|Antidotes|antidotes|mesh-ancestor
44737013|NCT02997228|Protective Agents|protective agents|mesh-ancestor
44737014|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
44737015|NCT02997228|Vitamins|vitamins|mesh-ancestor
44737016|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
44737017|NCT02990806|Infliximab|infliximab|mesh-list
44737018|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737019|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44737023|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44737025|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737026|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737027|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44737028|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
44737029|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737030|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737031|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484181|NCT05665725|Siltuximab|siltuximab|mesh-list
44484182|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44484183|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484184|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
44484185|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484186|NCT05665647|Ritonavir|ritonavir|mesh-list
44484187|NCT05665647|Itraconazole|itraconazole|mesh-list
44484188|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44484189|NCT05665647|Rifampin|rifampin|mesh-list
44484190|NCT05665647|Midazolam|midazolam|mesh-list
44484191|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44484192|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484193|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484194|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484195|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44484196|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484197|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484198|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44484199|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
44484200|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
44484201|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
44484202|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
44484203|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484204|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484205|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44484206|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44484207|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44484208|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484209|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44484210|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44484211|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
44484212|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484213|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44484214|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484215|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
44484216|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44484217|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44484218|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
44484219|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484220|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44484221|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
44484222|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484223|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
44484224|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44484225|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44484226|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44484227|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44484228|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44484229|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44484230|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44484231|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44484232|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44484233|NCT05665270|Prednisolone|prednisolone|mesh-list
44484234|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44484235|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
44484236|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44484237|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
44484238|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43895109|NCT05384574|Vitamin D|vitamin d|mesh-list
44484239|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
44484240|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484241|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
44484242|NCT05665270|Hormones|hormones|mesh-ancestor
44484243|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484244|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484245|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484246|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484247|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
44484248|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
44484249|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484250|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484251|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44484252|NCT05665270|Protective Agents|protective agents|mesh-ancestor
44484253|NCT05661578|Atezolizumab|atezolizumab|mesh-list
44484254|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484255|NCT05657613|Fluconazole|fluconazole|mesh-list
44303397|NCT00848796|Heparin|heparin|mesh-list
44484256|NCT05657613|Bosentan|bosentan|mesh-list
44484257|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
44484258|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484259|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44484260|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484261|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484262|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484263|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44484264|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
44484265|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484266|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484267|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44484268|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44484269|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44484270|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44484271|NCT05645900|Vaccines|vaccines|mesh-list
44484272|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
44484273|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484274|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
44484275|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
44484276|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44484277|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44484278|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
44484279|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484280|NCT05644340|Methamphetamine|methamphetamine|mesh-list
44484281|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44484282|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484283|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
44484284|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
44484285|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484286|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
44484287|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484288|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484289|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44484290|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44484291|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44484292|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44484293|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44484294|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
44484295|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484296|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
44484297|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484298|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44484299|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44484300|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484301|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
44484302|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44484303|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
44484304|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
44484305|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484306|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484307|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44484308|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44484309|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
44484310|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426830|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484311|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484313|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44484314|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484315|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484316|NCT05635110|Rifampin|rifampin|mesh-list
44484317|NCT05635110|Omeprazole|omeprazole|mesh-list
44484318|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44484319|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484320|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44484321|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484322|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484323|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44484324|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
44484325|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484326|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484327|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
44484328|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44484329|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44484330|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44484331|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44484332|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44484333|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44484334|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44484335|NCT05634967|Ofatumumab|ofatumumab|mesh-list
44484336|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484337|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
44484338|NCT05633615|Fludarabine|fludarabine|mesh-list
44484339|NCT05633615|Antibodies|antibodies|mesh-list
44484340|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
44484341|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
44484342|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43941600|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
43941663|NCT00967551|Zinc|zinc|mesh-list
44484343|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44484344|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484345|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
44484346|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484347|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484348|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44484349|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
44484350|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484351|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484352|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44484353|NCT05632211|Golimumab|golimumab|mesh-list
44484354|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44484355|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484356|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484357|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
44484358|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484359|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
44484360|NCT05629585|Durvalumab|durvalumab|mesh-list
44484361|NCT05629585|Capecitabine|capecitabine|mesh-list
44484362|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484363|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484364|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484365|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
44484366|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484367|NCT05627375|Anticoagulants|anticoagulants|mesh-list
44484368|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
44484369|NCT05627232|Promethazine|promethazine|mesh-list
44484370|NCT05627232|Cytarabine|cytarabine|mesh-list
44484371|NCT05627232|Daunorubicin|daunorubicin|mesh-list
44484372|NCT05627232|Palbociclib|palbociclib|mesh-list
44484373|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484374|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
44484375|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484376|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484377|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
44484378|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484379|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484380|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
44484381|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484382|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44484383|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44484384|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44484385|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484400|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484401|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44484402|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
44484403|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
44484404|NCT05626803|Vaccines|vaccines|mesh-list
44484408|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44484409|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484410|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484411|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484412|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
44484413|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484414|NCT05624606|Vaccines|vaccines|mesh-list
44484415|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
44484416|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484417|NCT05623995|Evolocumab|evolocumab|mesh-list
44484418|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44484419|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44484420|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44484421|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
44484422|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484423|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44484424|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484425|NCT05617963|Durvalumab|durvalumab|mesh-list
44484426|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484427|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484428|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
44484429|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484430|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484431|NCT05615467|Metformin|metformin|mesh-list
44484432|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44484433|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484434|NCT05615220|Ecopipam|ecopipam|mesh-list
44484435|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44484436|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484437|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484438|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484439|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484440|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44484441|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
44484442|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484443|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484444|NCT05613153|Peppermint oil|peppermint oil|mesh-list
44484445|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
44484446|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
44484447|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484448|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484449|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484450|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
44303606|NCT00849602|Chloroquine|chloroquine|mesh-list
44484454|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44484455|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
44484456|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484457|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484458|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44484459|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44484460|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44484461|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
44484462|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484463|NCT05604742|Belimumab|belimumab|mesh-list
44484464|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484465|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
44484466|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484467|NCT05604599|Fentanyl|fentanyl|mesh-list
44484468|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
44484469|NCT05604599|Propofol|propofol|mesh-list
44484470|NCT05604599|Isoflurane|isoflurane|mesh-list
44484471|NCT05604599|Atracurium|atracurium|mesh-list
44484472|NCT05604599|Cisatracurium|cisatracurium|mesh-list
44484473|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484474|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484475|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484476|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44484477|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
44484478|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
44484479|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484480|NCT05604599|Analgesics|analgesics|mesh-ancestor
44484481|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
44484482|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484483|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44484484|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44484485|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44484486|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44484487|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484488|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484489|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44484490|NCT05604599|Narcotics|narcotics|mesh-ancestor
44484491|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44484492|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44484493|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44484494|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44484495|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44484496|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44484497|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44484498|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
44484499|NCT05603104|Lamotrigine|lamotrigine|mesh-list
44484500|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44484501|NCT05603104|Valproic Acid|valproic acid|mesh-list
44484502|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44484503|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
44484504|NCT05603104|Clozapine|clozapine|mesh-list
44484505|NCT05603104|Citalopram|citalopram|mesh-list
44484506|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44484507|NCT05603104|Sertraline|sertraline|mesh-list
44484508|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
44484509|NCT05603104|Esketamine|esketamine|mesh-list
44484510|NCT05603104|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44484511|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44484512|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44484513|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484514|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484515|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
44484516|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484517|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44484518|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484519|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484520|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484521|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484522|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44484523|NCT05603104|Analgesics|analgesics|mesh-ancestor
44484524|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
44484525|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
44303685|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484526|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484527|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
44484528|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
44484529|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44484530|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44484531|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44484532|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
44484533|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44484534|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
44484535|NCT05602636|Midazolam|midazolam|mesh-list
44484536|NCT05602636|Bupivacaine|bupivacaine|mesh-list
44484537|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
44484538|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
44484539|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484540|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484541|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
44484542|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484543|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44484544|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484545|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44484546|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484547|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484548|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44484549|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
44484550|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
44484551|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
44484552|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484553|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484554|NCT05602597|Itraconazole|itraconazole|mesh-list
44484555|NCT05602597|Fluconazole|fluconazole|mesh-list
44484556|NCT05602597|Rifampin|rifampin|mesh-list
44484557|NCT05602597|Rabeprazole|rabeprazole|mesh-list
44484558|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
44484559|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484560|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44484561|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484562|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484563|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484564|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44484565|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
44484566|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484567|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941800|NCT00972335|Growth Substances|growth substances|mesh-ancestor
44484568|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44484569|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44484570|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484571|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44484572|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44484573|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
44484574|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484575|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
44484576|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44484577|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44484578|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44484579|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44484580|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44484581|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44484582|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44484583|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44484584|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44484585|NCT05602519|Fentanyl|fentanyl|mesh-list
44484586|NCT05602519|Propofol|propofol|mesh-list
44484587|NCT05602519|Rocuronium|rocuronium|mesh-list
44484588|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484589|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484590|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484591|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44484592|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
44484593|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
44484594|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44484595|NCT05602519|Narcotics|narcotics|mesh-ancestor
44484596|NCT05602519|Analgesics|analgesics|mesh-ancestor
44484597|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
44484598|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484599|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44484600|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44484601|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44484602|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44484603|NCT05600426|Cyclosporine|cyclosporine|mesh-list
44484604|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
44484606|NCT05600426|Fludarabine|fludarabine|mesh-list
44484607|NCT05600426|Cyclosporins|cyclosporins|mesh-list
44484608|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
44484609|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44484610|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44484611|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
44484612|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484613|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484614|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44484615|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
44484616|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484617|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484618|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44484619|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44484620|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
44484621|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44484622|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484623|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
44484624|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
44484625|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484626|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43941854|NCT00973752|Vincristine|vincristine|mesh-list
44484627|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44484628|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
44484629|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484630|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44484631|NCT05600062|Racecadotril|racecadotril|mesh-list
44484632|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
44484633|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484634|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
44484635|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484636|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484637|NCT05599295|Oritavancin|oritavancin|mesh-list
44484638|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484639|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484640|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
44484641|NCT05598606|Denosumab|denosumab|mesh-list
44484642|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44484643|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484644|NCT05596955|Naltrexone|naltrexone|mesh-list
44484645|NCT05596955|Buprenorphine|buprenorphine|mesh-list
44484646|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44484647|NCT05596955|Narcotics|narcotics|mesh-ancestor
44484648|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484649|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484650|NCT05596955|Analgesics|analgesics|mesh-ancestor
44484651|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
44484652|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484653|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44484654|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44484655|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44484656|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
44484657|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44484658|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
44484659|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44484660|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484661|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44484662|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484663|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484664|NCT05590468|Niacinamide|niacinamide|mesh-list
44484665|NCT05590468|Niacin|niacin|mesh-list
44484666|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
44484667|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
44484668|NCT05590468|Vitamins|vitamins|mesh-ancestor
44484669|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
44484670|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484671|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44484672|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
44484673|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484674|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44484675|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
44484677|NCT05586815|Colistin|colistin|mesh-list
44303770|NCT00851513|Lidocaine|lidocaine|mesh-list
44484678|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44484679|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484680|NCT05582538|Paclitaxel|paclitaxel|mesh-list
44484681|NCT05582538|Durvalumab|durvalumab|mesh-list
44484682|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44484683|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484684|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
44484685|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
44484686|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
44484687|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484688|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484689|NCT05581823|Carbamazepine|carbamazepine|mesh-list
44484690|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
44484691|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
44484692|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484693|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484694|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484695|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484696|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484697|NCT05581823|Analgesics|analgesics|mesh-ancestor
44484698|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
44484699|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484700|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44484701|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44484702|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484703|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44484704|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44484705|NCT05577715|Farletuzumab|farletuzumab|mesh-list
44484706|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484707|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
44484708|NCT05571072|Narcotics|narcotics|mesh-ancestor
44484709|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484710|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484711|NCT05571072|Analgesics|analgesics|mesh-ancestor
44484712|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
44484713|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484714|NCT05568615|Edaravone|edaravone|mesh-list
44484715|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44484716|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
44484717|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484718|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44484719|NCT05568615|Protective Agents|protective agents|mesh-ancestor
44484720|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484721|NCT05567458|Luspatercept|luspatercept|mesh-list
44484722|NCT05567458|Hematinics|hematinics|mesh-ancestor
44484723|NCT05564650|Azacitidine|azacitidine|mesh-list
44484724|NCT05564650|Decitabine|decitabine|mesh-list
44484725|NCT05564650|Venetoclax|venetoclax|mesh-list
44484726|NCT05564650|Navitoclax|navitoclax|mesh-list
44484727|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484728|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
44484729|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484730|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484731|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484732|NCT05564390|Cytarabine|cytarabine|mesh-list
44484733|NCT05564390|Azacitidine|azacitidine|mesh-list
44484734|NCT05564390|Daunorubicin|daunorubicin|mesh-list
44484735|NCT05564390|Venetoclax|venetoclax|mesh-list
44484736|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484737|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
44484738|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484739|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484740|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
44484741|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484742|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484743|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
44484744|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484745|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484746|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44484747|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44484748|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44484749|NCT05564039|Dulaglutide|dulaglutide|mesh-list
44484750|NCT05564039|Tirzepatide|tirzepatide|mesh-list
44484751|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44484752|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484753|NCT05564039|Incretins|incretins|mesh-ancestor
44484754|NCT05564039|Hormones|hormones|mesh-ancestor
44484755|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484756|NCT05563766|Itraconazole|itraconazole|mesh-list
44484757|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
44484758|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484759|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44484760|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44484761|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484762|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484763|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44484764|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
44484765|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484766|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484767|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44484768|NCT05555732|Cisplatin|cisplatin|mesh-list
44484769|NCT05555732|Carboplatin|carboplatin|mesh-list
44484770|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
44484771|NCT05555732|Pemetrexed|pemetrexed|mesh-list
44484772|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484773|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484774|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484775|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484776|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44484777|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44484778|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44484779|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
44484780|NCT05553132|Coagulants|coagulants|mesh-ancestor
44484781|NCT05550194|Valacyclovir|valacyclovir|mesh-list
44484782|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
44484783|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484784|NCT05548582|Acetaminophen|acetaminophen|mesh-list
44484785|NCT05548582|Ibuprofen|ibuprofen|mesh-list
44484786|NCT05548582|Oxycodone|oxycodone|mesh-list
44484787|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484788|NCT05548582|Analgesics|analgesics|mesh-ancestor
44484789|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
44484790|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484791|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484792|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
44484793|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44484794|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484795|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484796|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44484797|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484798|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484799|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44484800|NCT05548582|Narcotics|narcotics|mesh-ancestor
44484801|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484802|NCT05547386|Edetic Acid|edetic acid|mesh-list
44484803|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44484804|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
44484805|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
44484806|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484807|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
44484808|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44484809|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44484810|NCT05540522|Vaccines|vaccines|mesh-list
44484811|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
43941992|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
44484812|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484813|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
44484814|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484815|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484816|NCT05536804|Tirzepatide|tirzepatide|mesh-list
44484817|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44484818|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484819|NCT05536804|Incretins|incretins|mesh-ancestor
44484820|NCT05536804|Hormones|hormones|mesh-ancestor
44484821|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484836|NCT05525858|Entrectinib|entrectinib|mesh-list
44484837|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484838|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484839|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44484840|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44484841|NCT05525858|Growth Substances|growth substances|mesh-ancestor
44484842|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484843|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
44484844|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44484845|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484846|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484847|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44484848|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
44484849|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
44484850|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737079|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44737080|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737081|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737082|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737083|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
44737084|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737085|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
44737086|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737087|NCT02971501|Bevacizumab|bevacizumab|mesh-list
44737088|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44737089|NCT02971501|Osimertinib|osimertinib|mesh-list
44737090|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
44737091|NCT02971501|Antibodies|antibodies|mesh-list
44737092|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
44737093|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737094|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
44737095|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737096|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44737097|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44737098|NCT02971501|Growth Substances|growth substances|mesh-ancestor
44737099|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737100|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
44737101|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
43942029|NCT00977769|Oxytocin|oxytocin|mesh-list
44737102|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737103|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737104|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737105|NCT02965703|Aspirin|aspirin|mesh-list
44737106|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44737107|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44737108|NCT02965703|Analgesics|analgesics|mesh-ancestor
44737109|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
44737110|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737114|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44737115|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44737116|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737117|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44737118|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44737119|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737120|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
44484853|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44484855|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484856|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44484857|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44484858|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484859|NCT05519085|Dexamethasone|dexamethasone|mesh-list
44484860|NCT05519085|Bortezomib|bortezomib|mesh-list
44484861|NCT05519085|Pomalidomide|pomalidomide|mesh-list
44484862|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484863|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
44484864|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
44484865|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484866|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484867|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484868|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
44484869|NCT05519085|Hormones|hormones|mesh-ancestor
44484870|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484871|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484872|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484873|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
44484874|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44484875|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44484876|NCT05519085|Growth Substances|growth substances|mesh-ancestor
44484877|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
44484878|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
44484879|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44484880|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484881|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44484882|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484883|NCT05512962|Triamcinolone|triamcinolone|mesh-list
44484884|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44484885|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44484886|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44484887|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484888|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
44484889|NCT05512962|Hormones|hormones|mesh-ancestor
44484890|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484891|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484892|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44484893|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
44484894|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484895|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484896|NCT05509777|Mirikizumab|mirikizumab|mesh-list
44484897|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44484898|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44484899|NCT05509777|Analgesics|analgesics|mesh-ancestor
44484900|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
44484901|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484902|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484903|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484904|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484905|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44484906|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484907|NCT05502146|Norepinephrine|norepinephrine|mesh-list
44484908|NCT05502146|Bupivacaine|bupivacaine|mesh-list
44484909|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
44484910|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
44484911|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484912|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484913|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
44484914|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484916|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44484917|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44484918|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737124|NCT02938442|Paclitaxel|paclitaxel|mesh-list
44737125|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44737126|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
44737127|NCT02938442|Doxorubicin|doxorubicin|mesh-list
43942124|NCT00980785|Ramipril|ramipril|mesh-list
44484919|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484920|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
44484921|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
44484922|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44484923|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
44484924|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484925|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484926|NCT05500599|Fentanyl|fentanyl|mesh-list
44484927|NCT05500599|Midazolam|midazolam|mesh-list
44484928|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44484929|NCT05500599|Narcotics|narcotics|mesh-ancestor
44484930|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44484931|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484932|NCT05500599|Analgesics|analgesics|mesh-ancestor
44484933|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
44484934|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484935|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44484936|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44484937|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
44484938|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
44484939|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44484940|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44484941|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44484942|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44484943|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
44484944|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
44484945|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44484946|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484947|NCT05500443|Vitamin K|vitamin k|mesh-list
44484948|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
44484949|NCT05500443|Vitamin MK 7|vitamin mk 7|mesh-list
44484950|NCT05500443|Vitamins|vitamins|mesh-ancestor
44484951|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
44484952|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484953|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44484954|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44484955|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484956|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
44484957|NCT05500443|Coagulants|coagulants|mesh-ancestor
44484958|NCT05498272|Olaparib|olaparib|mesh-list
44484959|NCT05498272|Leuprolide|leuprolide|mesh-list
44484960|NCT05498272|Goserelin|goserelin|mesh-list
44484961|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44484962|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44484963|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942160|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44484964|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484965|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484966|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44484967|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
44484968|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44484969|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484970|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484971|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
44484972|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44484973|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
44484974|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44484975|NCT05498220|Gemcitabine|gemcitabine|mesh-list
44484976|NCT05498220|Dexamethasone|dexamethasone|mesh-list
44484977|NCT05498220|Rituximab|rituximab|mesh-list
44484978|NCT05498220|Cisplatin|cisplatin|mesh-list
44484979|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44484980|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44484981|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
44484982|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44484983|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44484984|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44484985|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
44484986|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
44484987|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44484988|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44484989|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
44484990|NCT05498220|Hormones|hormones|mesh-ancestor
44484991|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44484992|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44484993|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44484994|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
44484995|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44484996|NCT05498220|Antiviral Agents|antiviral agents|mesh-ancestor
44484997|NCT05498220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44484998|NCT05498220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44484999|NCT05498220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485000|NCT05498129|Micronutrients|micronutrients|mesh-list
44485001|NCT05498129|Trace Elements|trace elements|mesh-list
44485002|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485003|NCT05491330|Ritonavir|ritonavir|mesh-list
44485004|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44485005|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44485006|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
44485007|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485008|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485009|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44485010|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44485011|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
44485012|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485013|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44485014|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44485015|NCT05489211|Leucovorin|leucovorin|mesh-list
44485016|NCT05489211|Bevacizumab|bevacizumab|mesh-list
44485017|NCT05489211|Nivolumab|nivolumab|mesh-list
44485018|NCT05489211|Durvalumab|durvalumab|mesh-list
44485019|NCT05489211|Carboplatin|carboplatin|mesh-list
44485020|NCT05489211|Fluorouracil|fluorouracil|mesh-list
44485021|NCT05489211|Capecitabine|capecitabine|mesh-list
44485022|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485023|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485024|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485025|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485026|NCT05489211|Growth Substances|growth substances|mesh-ancestor
44485027|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485028|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485029|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
44485030|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485031|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44485032|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485033|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
44485034|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44485035|NCT05489211|Antidotes|antidotes|mesh-ancestor
44485036|NCT05489211|Protective Agents|protective agents|mesh-ancestor
44485037|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
44485038|NCT05489211|Vitamins|vitamins|mesh-ancestor
44485039|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
44485040|NCT05487235|Atezolizumab|atezolizumab|mesh-list
44485041|NCT05487235|Omeprazole|omeprazole|mesh-list
44485042|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485043|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43942248|NCT00982592|Antidotes|antidotes|mesh-ancestor
44485044|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485045|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44485046|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485047|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485048|NCT05477875|Acetaminophen|acetaminophen|mesh-list
44485049|NCT05477875|Codeine|codeine|mesh-list
44485050|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44485051|NCT05477875|Analgesics|analgesics|mesh-ancestor
44485052|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
44485053|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485054|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485055|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
44485056|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44485057|NCT05477875|Narcotics|narcotics|mesh-ancestor
44485058|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485059|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
44485060|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44485061|NCT05473715|Aflibercept|aflibercept|mesh-list
44485062|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485063|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485064|NCT05473715|Growth Substances|growth substances|mesh-ancestor
44485065|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485066|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485068|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44485069|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
44485070|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44485071|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
44485072|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44485073|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485074|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44485075|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485076|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485077|NCT05457972|Estradiol|estradiol|mesh-list
44485078|NCT05457972|Estrogens|estrogens|mesh-ancestor
44485079|NCT05457972|Hormones|hormones|mesh-ancestor
44485080|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485081|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485082|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
44485083|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44485084|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485085|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44485086|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485087|NCT05452070|Lidocaine|lidocaine|mesh-list
44485088|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
44485089|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
44485090|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485091|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485092|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
44485093|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485094|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44485095|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44485096|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44485097|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485098|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485099|NCT05441280|Pimavanserin|pimavanserin|mesh-list
44485100|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44485101|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44485102|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44485103|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44485104|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485105|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485106|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44485107|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44485108|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44485109|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
44485110|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485111|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485112|NCT05440786|Irinotecan|irinotecan|mesh-list
44485113|NCT05440786|Temozolomide|temozolomide|mesh-list
44485114|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44485115|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485116|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485117|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485118|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485119|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44485120|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
44485121|NCT05428826|Prednisone|prednisone|mesh-list
44485122|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485123|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
44485124|NCT05428826|Hormones|hormones|mesh-ancestor
44485125|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485126|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485127|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485128|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737128|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44737129|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44737130|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
44737131|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737132|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737133|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737134|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737135|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737136|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737137|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737138|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
44737139|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737140|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737141|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737142|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
44737143|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737144|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737145|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44737146|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485129|NCT05415657|Denosumab|denosumab|mesh-list
44485130|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44485131|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485132|NCT05411081|Atezolizumab|atezolizumab|mesh-list
44485133|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44485134|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485135|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
44485136|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485137|NCT05405166|Dexamethasone|dexamethasone|mesh-list
44485138|NCT05405166|Pomalidomide|pomalidomide|mesh-list
44485139|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44485140|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485141|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
44485142|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
44485143|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942363|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
44485144|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485145|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485146|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
44485147|NCT05405166|Hormones|hormones|mesh-ancestor
44485148|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485149|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485150|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485151|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
44485152|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485153|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485154|NCT05405166|Growth Substances|growth substances|mesh-ancestor
44485155|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485156|NCT05384119|Palbociclib|palbociclib|mesh-list
44485157|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44485158|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485159|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485160|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485161|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485162|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44485163|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44485164|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485165|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485166|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485167|NCT05380388|Vaccines|vaccines|mesh-list
44485168|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
44485169|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485170|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
44485171|NCT05379634|Hormones|hormones|mesh-ancestor
44485172|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485173|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485174|NCT05375747|Propofol|propofol|mesh-list
44485175|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44485176|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485177|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485178|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44485179|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
44485180|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
44485181|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44485182|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
44485183|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485184|NCT05364008|Protective Agents|protective agents|mesh-ancestor
44485185|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485186|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44485187|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44485188|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485189|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44485190|NCT05362760|Fulvestrant|fulvestrant|mesh-list
44485191|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44485192|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485193|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485194|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44485196|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485197|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485198|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485199|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44485200|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485201|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485202|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
44485203|NCT05347485|Fludarabine|fludarabine|mesh-list
44485204|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485205|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
44485206|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485207|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44485208|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44485209|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
44485210|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485211|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485212|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44485213|NCT05345171|Prednisolone|prednisolone|mesh-list
44485214|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485215|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
44485216|NCT05345171|Hormones|hormones|mesh-ancestor
44485217|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485218|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485219|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485220|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485221|NCT05343455|Doxycycline|doxycycline|mesh-list
44485222|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485223|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485224|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
44485225|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44485226|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44485227|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44485228|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485229|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485230|NCT05338619|Lazertinib|lazertinib|mesh-list
44485231|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485232|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485233|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485234|NCT05338086|Vitamin D|vitamin d|mesh-list
44485235|NCT05338086|Denosumab|denosumab|mesh-list
44485236|NCT05338086|Calcium|calcium|mesh-list
44485237|NCT05338086|Vitamins|vitamins|mesh-ancestor
44485238|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
44485239|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485240|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44485241|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44485242|NCT05320731|Lidocaine|lidocaine|mesh-list
44485243|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
44485244|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
44485245|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485246|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485247|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
44485248|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485249|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44485250|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44485251|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44485252|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485253|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485254|NCT05312970|Polidocanol|polidocanol|mesh-list
44485255|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44485256|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44485257|NCT05306340|Dexamethasone|dexamethasone|mesh-list
44485258|NCT05306340|Everolimus|everolimus|mesh-list
44485259|NCT05306340|Exemestane|exemestane|mesh-list
44485260|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485261|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
44485262|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
44485263|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485264|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485265|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485266|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
44485267|NCT05306340|Hormones|hormones|mesh-ancestor
44485268|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485269|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485270|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485271|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485272|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
44485273|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44485274|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44485275|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304446|NCT00855088|Ritonavir|ritonavir|mesh-list
44485276|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485277|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44485278|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485279|NCT05306223|Levofloxacin|levofloxacin|mesh-list
44485280|NCT05306223|Ofloxacin|ofloxacin|mesh-list
44485281|NCT05306223|Cycloserine|cycloserine|mesh-list
44485282|NCT05306223|Linezolid|linezolid|mesh-list
44485283|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
44485284|NCT05306223|Bedaquiline|bedaquiline|mesh-list
44485285|NCT05306223|Clofazimine|clofazimine|mesh-list
44485286|NCT05306223|Prothionamide|prothionamide|mesh-list
44485287|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44485288|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485289|NCT05306223|Renal Agents|renal agents|mesh-ancestor
44485290|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485291|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44485292|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485293|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485294|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485295|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485296|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44485297|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44485298|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44485299|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44485300|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
44485301|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
44485302|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485303|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
44485304|NCT05305924|Fulvestrant|fulvestrant|mesh-list
44485305|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485306|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485307|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44485308|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44485309|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485310|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485311|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737147|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737148|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44737149|NCT02890329|Ipilimumab|ipilimumab|mesh-list
44737150|NCT02890329|Decitabine|decitabine|mesh-list
44737151|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737152|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737153|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44737154|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737155|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737156|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
44737157|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737158|NCT02858310|Aldesleukin|aldesleukin|mesh-list
44737159|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
44737160|NCT02858310|Fludarabine|fludarabine|mesh-list
44737161|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737162|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
44737163|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737164|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737165|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942522|NCT00991081|Nicotine|nicotine|mesh-list
44737166|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
44737167|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737168|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737169|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737170|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44737171|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44737172|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
44737173|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737174|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
44737175|NCT02828358|Leucovorin|leucovorin|mesh-list
44737176|NCT02828358|Folic Acid|folic acid|mesh-list
44737177|NCT02828358|Cytarabine|cytarabine|mesh-list
44737178|NCT02828358|Dexamethasone|dexamethasone|mesh-list
44737179|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
44737180|NCT02828358|Prednisolone|prednisolone|mesh-list
44737182|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
44737183|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44737184|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
44737185|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
44737186|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44737187|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44737188|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44737189|NCT02828358|Cortisone|cortisone|mesh-list
44737190|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
44485312|NCT05299073|Denosumab|denosumab|mesh-list
44485313|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44485314|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485315|NCT05296837|Doxycycline|doxycycline|mesh-list
44485316|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485317|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485318|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
44485319|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44485320|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44485321|NCT05296798|Paclitaxel|paclitaxel|mesh-list
44485322|NCT05296798|Docetaxel|docetaxel|mesh-list
44485323|NCT05296798|Trastuzumab|trastuzumab|mesh-list
44485324|NCT05296798|Pertuzumab|pertuzumab|mesh-list
44485325|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44485326|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485327|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44485328|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44485329|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
44485330|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942557|NCT00991809|Promethazine|promethazine|mesh-list
44485331|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485332|NCT05294263|Varenicline|varenicline|mesh-list
44485333|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44485334|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44485335|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
44485336|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485337|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485338|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485339|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44485340|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44485341|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485342|NCT05277623|Mannitol|mannitol|mesh-list
44485343|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44485344|NCT05277623|Diuretics|diuretics|mesh-ancestor
44485345|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
44485346|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485347|NCT05275023|Tenofovir|tenofovir|mesh-list
44485348|NCT05275023|Entecavir|entecavir|mesh-list
44485349|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44485350|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
44485351|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485352|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44485353|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44485354|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485355|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485356|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44485357|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44485358|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485359|NCT05263947|Bevacizumab|bevacizumab|mesh-list
44485360|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485361|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485362|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485363|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485364|NCT05263947|Growth Substances|growth substances|mesh-ancestor
44485365|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485366|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485367|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44485368|NCT05263388|Hormones|hormones|mesh-ancestor
44485369|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485370|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485371|NCT05261399|Cisplatin|cisplatin|mesh-list
44485372|NCT05261399|Carboplatin|carboplatin|mesh-list
44485373|NCT05261399|Pemetrexed|pemetrexed|mesh-list
44485374|NCT05261399|Osimertinib|osimertinib|mesh-list
44485375|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485376|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485377|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485378|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44485379|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44485380|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485381|NCT05261269|Niraparib|niraparib|mesh-list
44485382|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44485383|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485384|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304570|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485385|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485386|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
44485388|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
44485389|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44485390|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44485391|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485392|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
44485393|NCT05259046|Coagulants|coagulants|mesh-ancestor
44485394|NCT05259046|Vitamins|vitamins|mesh-ancestor
44485395|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
44485396|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485397|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
44485398|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44485399|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485400|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44485401|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
44485402|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485403|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485404|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485405|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485406|NCT05246514|Trastuzumab|trastuzumab|mesh-list
44485407|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485408|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485409|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
44485410|NCT05246371|Propofol|propofol|mesh-list
44485411|NCT05246371|Desflurane|desflurane|mesh-list
44485412|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44485413|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44485414|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485415|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44485416|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
44485417|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
44485418|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44485419|NCT05246371|Analgesics|analgesics|mesh-ancestor
44485420|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
44485421|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485422|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44485423|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44485424|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44485425|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44485426|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485427|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485428|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44485429|NCT05243342|Daratumumab|daratumumab|mesh-list
44485430|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485431|NCT05242484|Golimumab|golimumab|mesh-list
44485432|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44485433|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485434|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485435|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
44485436|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485437|NCT05242471|Golimumab|golimumab|mesh-list
44485438|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44485439|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485440|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485441|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
44485442|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485443|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
44485444|NCT05232825|Promethazine|promethazine|mesh-list
44485445|NCT05232825|Dexamethasone|dexamethasone|mesh-list
44485446|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
44485447|NCT05232825|Desloratadine|desloratadine|mesh-list
44485448|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
44485449|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485450|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
44485451|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
44485452|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485453|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485454|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485455|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
44485457|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485458|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485459|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485460|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44304649|NCT00856622|Timolol|timolol|mesh-list
44485461|NCT05232825|Protective Agents|protective agents|mesh-ancestor
44485462|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44485475|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
44485476|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
44485477|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44485478|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
44485479|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44485480|NCT05225805|Lefamulin|lefamulin|mesh-list
44485481|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485482|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485483|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
44485484|NCT05223088|Apatinib|apatinib|mesh-list
44485485|NCT05223088|Tegafur|tegafur|mesh-list
44485486|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485487|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485488|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485489|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485490|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44485491|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
44485492|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
44485493|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
44485494|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44485495|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44485496|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485497|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485498|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485499|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44485511|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44485512|NCT05205577|Iodine|iodine|mesh-list
44485513|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44485514|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485515|NCT05205577|Trace Elements|trace elements|mesh-ancestor
44485516|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
44485517|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485518|NCT05204563|Imipenem|imipenem|mesh-list
44485519|NCT05204563|Relebactam|relebactam|mesh-list
44485520|NCT05204563|Cilastatin|cilastatin|mesh-list
44485521|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485522|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485523|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
44485524|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485525|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485526|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44737191|NCT02828358|Methotrexate|methotrexate|mesh-list
44737192|NCT02828358|Vincristine|vincristine|mesh-list
44737193|NCT02828358|Azacitidine|azacitidine|mesh-list
44737194|NCT02828358|Daunorubicin|daunorubicin|mesh-list
44737195|NCT02828358|Asparaginase|asparaginase|mesh-list
44737196|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
44737197|NCT02828358|Pegaspargase|pegaspargase|mesh-list
44737198|NCT02828358|Thioguanine|thioguanine|mesh-list
44737199|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44737200|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
44304718|NCT00857077|Renal Agents|renal agents|mesh-ancestor
44737201|NCT02828358|BB 1101|bb 1101|mesh-list
44737202|NCT02828358|Calcium|calcium|mesh-list
44737203|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
44737204|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
44485540|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
44485541|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44485542|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44485543|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485544|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
44485545|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44485546|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44485547|NCT05198050|Urological Agents|urological agents|mesh-ancestor
44485548|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44485549|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
44485550|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485551|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44485552|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44485553|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
44485554|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485555|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485557|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
44485558|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44485559|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485560|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485561|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485562|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44485563|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
44485564|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485565|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485566|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44485567|NCT05169905|Vaccines|vaccines|mesh-list
44485568|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
44485569|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485570|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
44485571|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485572|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485587|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
44485588|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485589|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485590|NCT05162027|Erenumab|erenumab|mesh-list
44485591|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44485592|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485593|NCT05162027|Analgesics|analgesics|mesh-ancestor
44485594|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
44485595|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485596|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485597|NCT05161936|Lumasiran|lumasiran|mesh-list
44485598|NCT05161936|Renal Agents|renal agents|mesh-ancestor
44485599|NCT05155579|Vaccines|vaccines|mesh-list
44485600|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
44485601|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485602|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
44485603|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485604|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485605|NCT05155137|Amlodipine|amlodipine|mesh-list
44485606|NCT05155137|Valsartan|valsartan|mesh-list
44485607|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44485608|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44485609|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44485610|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485611|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485612|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44485613|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485614|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
44485615|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44485616|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44485617|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
44485618|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44485619|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44485620|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485621|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44485622|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44485623|NCT05153915|Tacrolimus|tacrolimus|mesh-list
44485624|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485625|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
44485626|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485627|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44485628|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485629|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485630|NCT05153239|Irinotecan|irinotecan|mesh-list
44485631|NCT05153239|Topotecan|topotecan|mesh-list
44485632|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44485633|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485634|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485635|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485636|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485637|NCT05147220|Teriflunomide|teriflunomide|mesh-list
44485638|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44485639|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44485640|NCT05147220|Analgesics|analgesics|mesh-ancestor
44485641|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
44485642|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485643|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485644|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485645|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44485646|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485647|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
44485648|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
44485650|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485651|NCT05139316|Prednisolone|prednisolone|mesh-list
44485652|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485653|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
44485654|NCT05139316|Hormones|hormones|mesh-ancestor
44485655|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485656|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485657|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485658|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485659|NCT05139004|Fludarabine|fludarabine|mesh-list
44485660|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
44485661|NCT05139004|Melphalan|melphalan|mesh-list
44485662|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
44485663|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44485664|NCT05139004|Basiliximab|basiliximab|mesh-list
44485665|NCT05139004|Mitogens|mitogens|mesh-list
44485666|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44485667|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485668|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44485669|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
44485670|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485671|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485672|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
44485673|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485674|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44485675|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
44485676|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44485677|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44485678|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
44485679|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
44485680|NCT05136677|Cisplatin|cisplatin|mesh-list
44485681|NCT05136677|Carboplatin|carboplatin|mesh-list
44485682|NCT05136677|Nivolumab|nivolumab|mesh-list
44485683|NCT05136677|Pemetrexed|pemetrexed|mesh-list
44485684|NCT05136677|Ipilimumab|ipilimumab|mesh-list
44485685|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485686|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485687|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44485688|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485689|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485690|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44485691|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44485692|NCT05123599|Tenofovir|tenofovir|mesh-list
44485693|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
44485694|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485695|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44485696|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44485697|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485698|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485699|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44485700|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44485701|NCT05121246|Palivizumab|palivizumab|mesh-list
44485702|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
44485703|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485704|NCT05113251|Paclitaxel|paclitaxel|mesh-list
44485705|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
44485706|NCT05113251|Doxorubicin|doxorubicin|mesh-list
44485707|NCT05113251|Trastuzumab|trastuzumab|mesh-list
44485708|NCT05113251|Pertuzumab|pertuzumab|mesh-list
44485709|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44485710|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485711|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44485712|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44485713|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44485714|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485715|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485716|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
44485717|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485718|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896491|NCT04346914|Etoposide|etoposide|mesh-list
44485719|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44485720|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
44485721|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44485722|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44485723|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44485724|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485725|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485726|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485727|NCT05112939|Cabotegravir|cabotegravir|mesh-list
44485728|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44485729|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44485730|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485731|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485732|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942912|NCT01000285|Doxorubicin|doxorubicin|mesh-list
44485733|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44485734|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
44485735|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485736|NCT05111145|Ivacaftor|ivacaftor|mesh-list
44485737|NCT05111145|Elexacaftor|elexacaftor|mesh-list
44485738|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44485739|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485740|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485741|NCT05103605|Osimertinib|osimertinib|mesh-list
44485742|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485743|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485744|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485745|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485746|NCT05103332|Amlodipine|amlodipine|mesh-list
44485747|NCT05103332|Olmesartan|olmesartan|mesh-list
44485748|NCT05103332|Indapamide|indapamide|mesh-list
44485749|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44485750|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44485751|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485752|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485753|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44485754|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485755|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
44485756|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44485757|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44485758|NCT05103332|Diuretics|diuretics|mesh-ancestor
44485759|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
44485760|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44737205|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737206|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
44737207|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737208|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737209|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737210|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
44737211|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737212|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942954|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
44737213|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737214|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737215|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
44737216|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
44737217|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737218|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44737219|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
44737220|NCT02828358|Hormones|hormones|mesh-ancestor
44737221|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737222|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44737223|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
44737224|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737225|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44737226|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44737227|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44737228|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
44737229|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44737230|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737231|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
44737232|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737233|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44737234|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737235|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
44737236|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737238|NCT02828358|Protective Agents|protective agents|mesh-ancestor
44737239|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
44737240|NCT02828358|Vitamins|vitamins|mesh-ancestor
44737241|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
44737242|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737243|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737244|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737245|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737246|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44737247|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737248|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44737249|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44737250|NCT02828358|Hematinics|hematinics|mesh-ancestor
44737251|NCT02814916|Dalbavancin|dalbavancin|mesh-list
44737252|NCT02814916|Teicoplanin|teicoplanin|mesh-list
44737253|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44737254|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737255|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
44737256|NCT02811263|Hematinics|hematinics|mesh-ancestor
44737257|NCT02684058|Carboplatin|carboplatin|mesh-list
44737258|NCT02684058|Vincristine|vincristine|mesh-list
44737259|NCT02684058|Trametinib|trametinib|mesh-list
44737260|NCT02684058|Dabrafenib|dabrafenib|mesh-list
44737261|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737262|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737263|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737264|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737265|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737266|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737267|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737268|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737269|NCT02650271|Tenofovir|tenofovir|mesh-list
44737270|NCT02650271|Entecavir|entecavir|mesh-list
44737271|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
44485761|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
44485762|NCT05096195|Vitamin D|vitamin d|mesh-list
44485763|NCT05096195|Denosumab|denosumab|mesh-list
44485764|NCT05096195|Calcium|calcium|mesh-list
44485765|NCT05096195|Vitamins|vitamins|mesh-ancestor
44485766|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
44485767|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485768|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44485769|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44485770|NCT05090371|Ofatumumab|ofatumumab|mesh-list
44485771|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485772|NCT05086107|Rifabutin|rifabutin|mesh-list
44485773|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44485774|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485775|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44485776|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
44485777|NCT05084638|Ofatumumab|ofatumumab|mesh-list
44485778|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485779|NCT05083169|Dexamethasone|dexamethasone|mesh-list
44485780|NCT05083169|Bortezomib|bortezomib|mesh-list
44485781|NCT05083169|Daratumumab|daratumumab|mesh-list
44485782|NCT05083169|Pomalidomide|pomalidomide|mesh-list
44485783|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485784|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
44485785|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
44485786|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485787|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485788|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485789|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
44485790|NCT05083169|Hormones|hormones|mesh-ancestor
44485791|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485792|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485793|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485794|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
44485795|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485796|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485797|NCT05083169|Growth Substances|growth substances|mesh-ancestor
44485798|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485799|NCT05079230|Azacitidine|azacitidine|mesh-list
44485800|NCT05079230|Venetoclax|venetoclax|mesh-list
44485801|NCT05079230|Magrolimab|magrolimab|mesh-list
44485802|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44485803|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
44485804|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896619|NCT03974854|Gemcitabine|gemcitabine|mesh-list
44485805|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485806|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485807|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485808|NCT05071664|Golimumab|golimumab|mesh-list
44485809|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44485810|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485811|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485812|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
44485813|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485814|NCT05071053|Ramucirumab|ramucirumab|mesh-list
44485815|NCT05071053|Maytansine|maytansine|mesh-list
44485816|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485817|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44485818|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44485819|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44485820|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44485821|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485822|NCT05066997|Dexamethasone|dexamethasone|mesh-list
44485823|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
44485824|NCT05066997|BB 1101|bb 1101|mesh-list
44485825|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943064|NCT01003301|Omalizumab|omalizumab|mesh-list
44485826|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
44485827|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
44485828|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485829|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485830|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485831|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
44485832|NCT05066997|Hormones|hormones|mesh-ancestor
44485833|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485834|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485835|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485836|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
44485837|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485838|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485839|NCT05062044|Folic Acid|folic acid|mesh-list
44485840|NCT05062044|Hematinics|hematinics|mesh-ancestor
44485841|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
44485842|NCT05062044|Vitamins|vitamins|mesh-ancestor
44485843|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
44485844|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485845|NCT05059873|Prednisone|prednisone|mesh-list
44485846|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485847|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
44485848|NCT05059873|Hormones|hormones|mesh-ancestor
44485849|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485850|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485851|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44485852|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485853|NCT05050097|Lenalidomide|lenalidomide|mesh-list
44485854|NCT05050097|Pomalidomide|pomalidomide|mesh-list
44485855|NCT05050097|Daratumumab|daratumumab|mesh-list
44485856|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
44485857|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485858|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44485859|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44485860|NCT05050097|Growth Substances|growth substances|mesh-ancestor
44485861|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
44485862|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485863|NCT05044819|Cannabidiol|cannabidiol|mesh-list
44485864|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
44485865|NCT05044611|Amiloride|amiloride|mesh-list
44485866|NCT05044611|Diuretics|diuretics|mesh-ancestor
44485867|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
44485868|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485869|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44485870|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44485871|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44485872|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485873|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44485874|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44485875|NCT05037929|Astegolimab|astegolimab|mesh-list
44485876|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44485877|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485878|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
44485879|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485880|NCT05033041|Metoclopramide|metoclopramide|mesh-list
44485881|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
44485882|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
44485883|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485884|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485885|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44485886|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44485887|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44485888|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
44485889|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485890|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485891|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
44485892|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44485893|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
44485894|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44485895|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
44485896|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485897|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485898|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
44485899|NCT05025033|Paclitaxel|paclitaxel|mesh-list
44485900|NCT05025033|Irinotecan|irinotecan|mesh-list
44485901|NCT05025033|Apatinib|apatinib|mesh-list
44485902|NCT05025033|Antibodies|antibodies|mesh-list
44485903|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
43943135|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44485904|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44485905|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485906|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44485907|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44485908|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44485909|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485910|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
44485911|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485912|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44485913|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44485914|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485915|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44485916|NCT05009069|Fluorouracil|fluorouracil|mesh-list
44485917|NCT05009069|Capecitabine|capecitabine|mesh-list
44485918|NCT05009069|Atezolizumab|atezolizumab|mesh-list
44485919|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
44485920|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485921|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44485922|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485923|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485924|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
44485925|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485926|NCT05000294|Atezolizumab|atezolizumab|mesh-list
44485927|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485928|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
44485929|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44485930|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44485931|NCT04998604|Omalizumab|omalizumab|mesh-list
44485932|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44485933|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44485934|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
44485935|NCT04998032|Metformin|metformin|mesh-list
44485936|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44485937|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485938|NCT04997993|Leflunomide|leflunomide|mesh-list
44485939|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485940|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485941|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44485942|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
44485943|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485944|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44485945|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44485946|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44485947|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44485948|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485949|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485950|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
44485951|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44485952|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44485953|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44485954|NCT04990284|Levodopa|levodopa|mesh-list
44485955|NCT04990284|Opicapone|opicapone|mesh-list
44485956|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44485957|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44485959|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485960|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485961|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485962|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44485963|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485964|NCT04989413|Dronabinol|dronabinol|mesh-list
44485965|NCT04989413|Cannabidiol|cannabidiol|mesh-list
44485966|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
44485967|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
44485968|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485969|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44485970|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44485971|NCT04989413|Analgesics|analgesics|mesh-ancestor
44485972|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
44485973|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485974|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44485975|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44485976|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44485977|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485978|NCT04989413|Hormones|hormones|mesh-ancestor
44485979|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44485980|NCT04986839|Acetaminophen|acetaminophen|mesh-list
44485981|NCT04986839|Ibuprofen|ibuprofen|mesh-list
44485982|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44485983|NCT04986839|Analgesics|analgesics|mesh-ancestor
44485984|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
44485985|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44485986|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44485987|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
44485988|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44485989|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44485990|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44485991|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44485992|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44485993|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44485994|NCT04976855|Buprenorphine|buprenorphine|mesh-list
44485995|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44485996|NCT04976855|Naloxone|naloxone|mesh-list
44485997|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44485998|NCT04976855|Narcotics|narcotics|mesh-ancestor
44485999|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486000|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486001|NCT04976855|Analgesics|analgesics|mesh-ancestor
44486002|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
44486003|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486004|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44737272|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737273|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44737274|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737275|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737276|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737277|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44737278|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44737279|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
44737280|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44737281|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44737282|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737283|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
44737284|NCT02606045|Coagulants|coagulants|mesh-ancestor
44737285|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
44737286|NCT02601313|Fludarabine|fludarabine|mesh-list
44737287|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737288|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
44737289|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737290|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737291|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737292|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
44737293|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737294|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737295|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737296|NCT02567409|Gemcitabine|gemcitabine|mesh-list
44737297|NCT02567409|Cisplatin|cisplatin|mesh-list
44737298|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737299|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737300|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
44737301|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737302|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
44737303|NCT02567409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737304|NCT02567409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737305|NCT02567409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737306|NCT02567409|Immunologic Factors|immunologic factors|mesh-ancestor
44737307|NCT02567409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737308|NCT02503722|Osimertinib|osimertinib|mesh-list
44737309|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737310|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737311|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737312|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737313|NCT02496663|Osimertinib|osimertinib|mesh-list
44737314|NCT02496663|Necitumumab|necitumumab|mesh-list
44737315|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737316|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737317|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737318|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737319|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737320|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737321|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
44737322|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737323|NCT02420821|Bevacizumab|bevacizumab|mesh-list
44737324|NCT02420821|Sunitinib|sunitinib|mesh-list
44737325|NCT02420821|Atezolizumab|atezolizumab|mesh-list
44737326|NCT02420821|Antibodies|antibodies|mesh-list
44737327|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737328|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737329|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737330|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44737331|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44737332|NCT02420821|Growth Substances|growth substances|mesh-ancestor
44486020|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486021|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486023|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44486024|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44486025|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
44486026|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486027|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486028|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486029|NCT04952779|Insulin|insulin|mesh-list
44486030|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44486031|NCT04952779|Liraglutide|liraglutide|mesh-list
44486032|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
44486033|NCT04952779|Xultophy|xultophy|mesh-list
44486034|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44486035|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486036|NCT04952779|Incretins|incretins|mesh-ancestor
44486037|NCT04952779|Hormones|hormones|mesh-ancestor
44486038|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486039|NCT04950764|Seladelpar|seladelpar|mesh-list
44486040|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44486041|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
44486042|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486043|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44486044|NCT04940065|Ofatumumab|ofatumumab|mesh-list
44486045|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486080|NCT04926818|Ofatumumab|ofatumumab|mesh-list
44486081|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44486082|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44486083|NCT04926818|Siponimod|siponimod|mesh-list
44486084|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486085|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
44486086|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486087|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44486088|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486089|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486104|NCT04908189|Apremilast|apremilast|mesh-list
44486105|NCT04908189|BMS-986165|bms-986165|mesh-list
44486106|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44486107|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44486108|NCT04908189|Analgesics|analgesics|mesh-ancestor
44486109|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
44486110|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486111|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486112|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486113|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44486114|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44486115|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44486116|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486117|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486118|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44486119|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44486120|NCT04901377|Dienogest|dienogest|mesh-list
44486121|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44486122|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44486123|NCT04901377|Estradiol|estradiol|mesh-list
44486124|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44486125|NCT04901377|Estrogens|estrogens|mesh-ancestor
44486126|NCT04901377|Hormones|hormones|mesh-ancestor
44486127|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486128|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486129|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44486130|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
44486131|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44486132|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44486133|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44486134|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44486135|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44486136|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44486137|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486138|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486139|NCT04885972|Triamcinolone|triamcinolone|mesh-list
44486140|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44486141|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44486142|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44486143|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486144|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
44486145|NCT04885972|Hormones|hormones|mesh-ancestor
44486146|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486147|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486148|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486149|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
44486150|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486151|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486152|NCT04869358|Ofatumumab|ofatumumab|mesh-list
44486153|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486154|NCT04858854|Sulforaphane|sulforaphane|mesh-list
44486155|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44486156|NCT04858854|Protective Agents|protective agents|mesh-ancestor
44486157|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486158|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486159|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44486160|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
44486161|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
44486162|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486163|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486164|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
44486165|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486166|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44486180|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486181|NCT04852679|Lanreotide|lanreotide|mesh-list
44486182|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486211|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44486212|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44486213|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737333|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737334|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44737335|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
44737336|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737337|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737338|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737339|NCT02398773|Estradiol|estradiol|mesh-list
44737340|NCT02398773|Estrogens|estrogens|mesh-ancestor
44737341|NCT02398773|Hormones|hormones|mesh-ancestor
44737342|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737343|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486214|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
44486215|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486216|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486217|NCT04826393|Cemiplimab|cemiplimab|mesh-list
44486218|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486219|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486220|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
44486221|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486222|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486223|NCT04820309|Xanomeline|xanomeline|mesh-list
44486225|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
44486226|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
44486227|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486228|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486229|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44486230|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44486231|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
44486232|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486233|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486234|NCT04820309|Urological Agents|urological agents|mesh-ancestor
44486235|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44486236|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44486237|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44486238|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44486239|NCT04818632|Everolimus|everolimus|mesh-list
44486240|NCT04818632|Palbociclib|palbociclib|mesh-list
44486241|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486242|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486243|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
44486244|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486245|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44486246|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486247|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486248|NCT04810078|Nivolumab|nivolumab|mesh-list
44486249|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486250|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486251|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44486252|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486253|NCT04809220|Dulaglutide|dulaglutide|mesh-list
44486254|NCT04809220|Biguanides|biguanides|mesh-list
44486255|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44486256|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44486257|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44486258|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486259|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486260|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486261|NCT04808843|Dienogest|dienogest|mesh-list
44486262|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44486263|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
44486264|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44486265|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486266|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44486267|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44486268|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44486269|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44486270|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
44486271|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486272|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486273|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486274|NCT04805944|Dolutegravir|dolutegravir|mesh-list
44486275|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44486276|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44486277|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486278|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486279|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486280|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486281|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
44486282|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486283|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44486284|NCT04797013|Plasminogen|plasminogen|mesh-list
44486285|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44486286|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43943436|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44486287|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486288|NCT04790903|Prednisone|prednisone|mesh-list
44486306|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486307|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486308|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
44486310|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486311|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486312|NCT04790370|Heparin|heparin|mesh-list
44486313|NCT04790370|Calcium heparin|calcium heparin|mesh-list
44486314|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
44486315|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44486316|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44486317|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486319|NCT04785924|Relebactam|relebactam|mesh-list
44486320|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44486321|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486322|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44486323|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486324|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486325|NCT04784715|Trastuzumab|trastuzumab|mesh-list
44486326|NCT04784715|Pertuzumab|pertuzumab|mesh-list
44486327|NCT04784715|Taxane|taxane|mesh-list
44486328|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486329|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486348|NCT04782258|Tolvaptan|tolvaptan|mesh-list
44486349|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44486350|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486351|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
44486352|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486353|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44486354|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44486355|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486356|NCT04778397|Cytarabine|cytarabine|mesh-list
44486357|NCT04778397|Azacitidine|azacitidine|mesh-list
44486358|NCT04778397|Daunorubicin|daunorubicin|mesh-list
44486359|NCT04778397|Venetoclax|venetoclax|mesh-list
44486360|NCT04778397|Idarubicin|idarubicin|mesh-list
44486361|NCT04778397|Magrolimab|magrolimab|mesh-list
44486362|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44486363|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44486364|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
44486365|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486366|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486368|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486369|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486370|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
44486371|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486372|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486373|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44486374|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44486375|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43943497|NCT01011075|Paclitaxel|paclitaxel|mesh-list
44486376|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44486377|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486378|NCT04777643|Cannabidiol|cannabidiol|mesh-list
44486379|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
44486380|NCT04775225|Lidocaine|lidocaine|mesh-list
44486381|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
44486382|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
44486383|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486384|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486385|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
44486386|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486387|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44486388|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44486389|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44486390|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44486391|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486392|NCT04775173|Sirolimus|sirolimus|mesh-list
44486393|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44486394|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486395|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44486396|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486397|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
44486398|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486399|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
44486400|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486401|NCT04774380|Cisplatin|cisplatin|mesh-list
44486402|NCT04774380|Carboplatin|carboplatin|mesh-list
44486403|NCT04774380|Etoposide|etoposide|mesh-list
44486404|NCT04774380|Durvalumab|durvalumab|mesh-list
44486405|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486406|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486407|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44486408|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44486409|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486410|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486411|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486412|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
44486413|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44486414|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
44486415|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486416|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
44486417|NCT04769453|Protective Agents|protective agents|mesh-ancestor
44486418|NCT04765059|Cisplatin|cisplatin|mesh-list
44486419|NCT04765059|Carboplatin|carboplatin|mesh-list
44486420|NCT04765059|Pemetrexed|pemetrexed|mesh-list
44486421|NCT04765059|Osimertinib|osimertinib|mesh-list
44486422|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486423|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486424|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486425|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44486426|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44486427|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44486428|NCT04763343|Ketamine|ketamine|mesh-list
44486429|NCT04763343|Analgesics|analgesics|mesh-ancestor
44486430|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
44486431|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486432|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486433|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44486434|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44486435|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
44486436|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
44486437|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486438|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44305670|NCT00863096|Vaccines|vaccines|mesh-list
44486439|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44486440|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486441|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486442|NCT04761848|Cilostazol|cilostazol|mesh-list
44486443|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44486444|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
44486445|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486446|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486447|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44486448|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
44486449|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44486450|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44486451|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486452|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44486453|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
44486454|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44486455|NCT04761848|Protective Agents|protective agents|mesh-ancestor
44486456|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44486457|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44486458|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486459|NCT04757571|Paroxetine|paroxetine|mesh-list
44486460|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44486461|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44486462|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44486463|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486464|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486465|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
44486466|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486467|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44486468|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44486469|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44486470|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44486471|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44486472|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486473|NCT04756804|Ethanol|ethanol|mesh-list
44486474|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
44486475|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44486476|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44486477|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486478|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486479|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486480|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
44486481|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
44486482|NCT04746183|Ritonavir|ritonavir|mesh-list
44486483|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
44486484|NCT04746183|Favipiravir|favipiravir|mesh-list
44486485|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44486486|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44486487|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
44486488|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486489|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486490|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486491|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486492|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
44486493|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486494|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44486495|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44486496|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44486497|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
44486498|NCT04740294|Analgesics|analgesics|mesh-ancestor
44486499|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
44486500|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486501|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486502|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
44486503|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486504|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44486505|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
44486506|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44486507|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44486508|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943623|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486509|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44486510|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
44486511|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44486513|NCT04731467|Paclitaxel|paclitaxel|mesh-list
44486514|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44486515|NCT04731467|Nivolumab|nivolumab|mesh-list
44486516|NCT04731467|Fluorouracil|fluorouracil|mesh-list
44486517|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486518|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486519|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486520|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486521|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486522|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486523|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44486524|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
44486525|NCT04731467|Antiviral Agents|antiviral agents|mesh-ancestor
44486526|NCT04731467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486527|NCT04731467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486528|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486529|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
44486530|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486531|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486532|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44486533|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
44486534|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44486535|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486536|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486537|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44486538|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44486539|NCT04722146|Lenalidomide|lenalidomide|mesh-list
44486540|NCT04722146|Pomalidomide|pomalidomide|mesh-list
44486541|NCT04722146|Bortezomib|bortezomib|mesh-list
44486542|NCT04722146|Daratumumab|daratumumab|mesh-list
44486543|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
44486544|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486545|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44486546|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44486547|NCT04722146|Growth Substances|growth substances|mesh-ancestor
44486548|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
44486549|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486550|NCT04718181|Omeprazole|omeprazole|mesh-list
44486551|NCT04718181|Risdiplam|risdiplam|mesh-list
44486552|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44486553|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44486554|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44486555|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486556|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486557|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44486558|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486559|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486560|NCT04704999|Chloroquine|chloroquine|mesh-list
44486561|NCT04704999|Lumefantrine|lumefantrine|mesh-list
44486562|NCT04704999|Artemether|artemether|mesh-list
44486563|NCT04704999|Tafenoquine|tafenoquine|mesh-list
44486564|NCT04704999|Amebicides|amebicides|mesh-ancestor
44486565|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44486566|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44486567|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486568|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
44486569|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44486570|NCT04704934|Paclitaxel|paclitaxel|mesh-list
44486571|NCT04704934|Trastuzumab|trastuzumab|mesh-list
44486572|NCT04704934|Ramucirumab|ramucirumab|mesh-list
44486573|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486574|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486575|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486576|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486577|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486578|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486579|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486580|NCT04704024|Tenofovir|tenofovir|mesh-list
44486581|NCT04704024|Lamivudine|lamivudine|mesh-list
44486582|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
44486583|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486584|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44486585|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44305813|NCT00863733|Acetic Acid|acetic acid|mesh-list
44486586|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486587|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486588|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486589|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486590|NCT04702880|Carboplatin|carboplatin|mesh-list
44486592|NCT04702880|Etoposide|etoposide|mesh-list
44486593|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486594|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486595|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44486596|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486597|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486598|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44486599|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44486600|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486601|NCT04695080|Cladribine|cladribine|mesh-list
44486602|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486603|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486604|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
44486605|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486606|NCT04691986|Niacinamide|niacinamide|mesh-list
44486607|NCT04691986|Niacin|niacin|mesh-list
44486608|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
44486609|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
44486610|NCT04691986|Vitamins|vitamins|mesh-ancestor
44486611|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
44486612|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486613|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44486614|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
44486615|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486616|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44486617|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
44737355|NCT02356159|Rituximab|rituximab|mesh-list
44737356|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737357|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737358|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
44737359|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737360|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737361|NCT02229084|Paclitaxel|paclitaxel|mesh-list
44737362|NCT02229084|Docetaxel|docetaxel|mesh-list
44737363|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
44737364|NCT02229084|Doxorubicin|doxorubicin|mesh-list
44737365|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44737366|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
44737367|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737368|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737369|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737370|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737371|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737372|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737373|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737374|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
44737375|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737376|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737377|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737378|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
44737379|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737380|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737381|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44737382|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44737383|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737384|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44486618|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
44486619|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486620|NCT04685538|Tetracaine|tetracaine|mesh-list
44486621|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
44486622|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
44486623|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
44486624|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486625|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486626|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
43943764|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
44486627|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486628|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44486629|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
44486630|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486631|NCT04675827|Trastuzumab|trastuzumab|mesh-list
44486632|NCT04675827|Pertuzumab|pertuzumab|mesh-list
44486633|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44486634|NCT04675827|Maytansine|maytansine|mesh-list
44486635|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486636|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486637|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486638|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486639|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486640|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486641|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486642|NCT04672382|Morphine|morphine|mesh-list
44486643|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44486644|NCT04672382|Narcotics|narcotics|mesh-ancestor
44486645|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486646|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486647|NCT04672382|Analgesics|analgesics|mesh-ancestor
44486648|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
44486649|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486650|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44486651|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44486652|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486653|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486654|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
44486655|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486656|NCT04667104|Tenofovir|tenofovir|mesh-list
44486657|NCT04667104|Entecavir|entecavir|mesh-list
44486658|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44486659|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
44486660|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486661|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44486662|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44486663|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486664|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486665|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486666|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486667|NCT04657289|Ranibizumab|ranibizumab|mesh-list
44486668|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44486669|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44486670|NCT04657289|Growth Substances|growth substances|mesh-ancestor
44486671|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486672|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44486673|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486674|NCT04639310|Ezogabine|ezogabine|mesh-list
44486675|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
44486676|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141049|NCT00181818|Bupropion|bupropion|mesh-list
44486677|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486678|NCT04634539|Gemcitabine|gemcitabine|mesh-list
44486679|NCT04634539|Paclitaxel|paclitaxel|mesh-list
44486680|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486681|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486682|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486683|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486684|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486685|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486686|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44486687|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
44486688|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
44486689|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305943|NCT00864045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44486690|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486691|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486692|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
44486693|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486694|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
44486695|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486696|NCT04630145|Clarithromycin|clarithromycin|mesh-list
44486698|NCT04630145|Ethambutol|ethambutol|mesh-list
44486699|NCT04630145|Rifabutin|rifabutin|mesh-list
44486700|NCT04630145|Bedaquiline|bedaquiline|mesh-list
44486701|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44486702|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486703|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44486704|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486705|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486706|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44486707|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44486708|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44486709|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
44486710|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
44486711|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44486712|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44486713|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44486714|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44486715|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44486716|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44486717|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44486718|NCT04628026|Venetoclax|venetoclax|mesh-list
44486719|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486720|NCT04613024|Topiramate|topiramate|mesh-list
44486721|NCT04613024|Gabapentin|gabapentin|mesh-list
44486722|NCT04613024|Analgesics|analgesics|mesh-ancestor
44486723|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
44486724|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486725|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486726|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
44486727|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44486728|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44486729|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44486730|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44486731|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44486732|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44486733|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486734|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486735|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
44486736|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44486737|NCT04612725|Benralizumab|benralizumab|mesh-list
44486738|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44486739|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
44486740|NCT04606797|Nicotine|nicotine|mesh-list
44486741|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44486742|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
44486743|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486744|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486745|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44486746|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44486747|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
44486748|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486749|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486750|NCT04606316|Nivolumab|nivolumab|mesh-list
44486751|NCT04606316|Ipilimumab|ipilimumab|mesh-list
44486752|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486753|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486754|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44486755|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486756|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44486757|NCT04604132|Paclitaxel|paclitaxel|mesh-list
44486758|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44486759|NCT04604132|Atezolizumab|atezolizumab|mesh-list
44486760|NCT04604132|Ramucirumab|ramucirumab|mesh-list
44486761|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44486762|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486763|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486764|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486765|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486766|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486767|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486768|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
44486769|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486771|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486772|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
44486773|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
44486774|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486775|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44486776|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486777|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
44486778|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486779|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
44486780|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486781|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
44486782|NCT04591210|Giapreza|giapreza|mesh-list
44486783|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44486784|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
44486785|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44486786|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44486787|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486788|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44486789|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44486790|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
44486791|NCT04589845|Trastuzumab|trastuzumab|mesh-list
44486792|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44486793|NCT04589845|Atezolizumab|atezolizumab|mesh-list
44486794|NCT04589845|Maytansine|maytansine|mesh-list
44486795|NCT04589845|Pralsetinib|pralsetinib|mesh-list
44486796|NCT04589845|Entrectinib|entrectinib|mesh-list
44486797|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486798|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486799|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486800|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486801|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486802|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486803|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486804|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44486805|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486806|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44486807|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486808|NCT04585789|Tenofovir|tenofovir|mesh-list
44486809|NCT04585789|Entecavir|entecavir|mesh-list
44486810|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
44486811|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44486812|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
44486813|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486814|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44486815|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44486816|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486817|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486818|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486819|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486820|NCT04584125|Riboflavin|riboflavin|mesh-list
44486821|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
44486822|NCT04584125|Dextrans|dextrans|mesh-list
44486823|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44486824|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44486825|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
44486826|NCT04584125|Vitamins|vitamins|mesh-ancestor
44486827|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
44486828|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486829|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44486830|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
44486831|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
44486832|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
44486833|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
44486834|NCT04582968|Capecitabine|capecitabine|mesh-list
44486835|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44486836|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
44486837|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486838|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486839|NCT04577833|Prednisone|prednisone|mesh-list
44486840|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
44486841|NCT04577833|Niraparib|niraparib|mesh-list
44486842|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486843|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
44486844|NCT04577833|Hormones|hormones|mesh-ancestor
44486845|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486846|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486847|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486848|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486849|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44486850|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486851|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486852|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
44486853|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44486854|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44486855|NCT04567303|Ranibizumab|ranibizumab|mesh-list
44486856|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44486857|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44486858|NCT04567303|Growth Substances|growth substances|mesh-ancestor
44486859|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486860|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
44486861|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486862|NCT04558918|Eculizumab|eculizumab|mesh-list
44486863|NCT04558918|Ravulizumab|ravulizumab|mesh-list
44486864|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44486865|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486866|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
44486867|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486868|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
44486869|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44486870|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44486871|NCT04551144|Estradiol|estradiol|mesh-list
44486872|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44486873|NCT04551144|Testosterone|testosterone|mesh-list
44486874|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
44486875|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
44486876|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44486877|NCT04551144|Estrogens|estrogens|mesh-ancestor
44486878|NCT04551144|Hormones|hormones|mesh-ancestor
44486879|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486880|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486881|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44486882|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
44486883|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44486884|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44486885|NCT04551144|Androgens|androgens|mesh-ancestor
44486886|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486887|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486888|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
44486889|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
44486890|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
44486891|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
44486903|NCT04548999|Protective Agents|protective agents|mesh-ancestor
44486904|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
44486905|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
44486906|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44486907|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486909|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44486910|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486911|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
44486912|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486913|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
44486914|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44486915|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486916|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44486917|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486918|NCT04538742|Paclitaxel|paclitaxel|mesh-list
44486919|NCT04538742|Trastuzumab|trastuzumab|mesh-list
44486920|NCT04538742|Durvalumab|durvalumab|mesh-list
44486921|NCT04538742|Pertuzumab|pertuzumab|mesh-list
44486922|NCT04538742|Tucatinib|tucatinib|mesh-list
44486923|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44486924|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486925|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
44486926|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
44486927|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
44486928|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486929|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44486930|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44486931|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486932|NCT04535544|Tenofovir|tenofovir|mesh-list
44486933|NCT04535544|Entecavir|entecavir|mesh-list
44486934|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
44486935|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486936|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44486937|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44486938|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486939|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486940|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44486941|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44486942|NCT04534881|Progesterone|progesterone|mesh-list
44486943|NCT04534881|Progestins|progestins|mesh-ancestor
44486944|NCT04534881|Hormones|hormones|mesh-ancestor
44486945|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486946|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486947|NCT04533347|Tafenoquine|tafenoquine|mesh-list
44486948|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
44486949|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44486950|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44486951|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44486952|NCT04530565|Cytarabine|cytarabine|mesh-list
44486953|NCT04530565|Dexamethasone|dexamethasone|mesh-list
44486954|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
44486955|NCT04530565|Prednisone|prednisone|mesh-list
44486957|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
44486958|NCT04530565|Doxorubicin|doxorubicin|mesh-list
44486959|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44486960|NCT04530565|Methotrexate|methotrexate|mesh-list
44486961|NCT04530565|Vincristine|vincristine|mesh-list
44486962|NCT04530565|Dasatinib|dasatinib|mesh-list
44486963|NCT04530565|Blinatumomab|blinatumomab|mesh-list
44486964|NCT04530565|Ponatinib|ponatinib|mesh-list
44486965|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44486966|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
44486967|NCT04530565|Antibodies|antibodies|mesh-list
44486968|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
44486969|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44486970|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44486971|NCT04530565|BB 1101|bb 1101|mesh-list
44486972|NCT04530565|Mesna|mesna|mesh-list
44486973|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44486974|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
44486975|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44486976|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44486977|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44486978|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
44486979|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44486980|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44486981|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44486982|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44486983|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
44486984|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
44486985|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44486986|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44486987|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
44486988|NCT04530565|Hormones|hormones|mesh-ancestor
44486989|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44486990|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44486991|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44486992|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44486993|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44486994|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44486995|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44486996|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44486997|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
44486998|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44486999|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487000|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
44487001|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44487002|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44487003|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44487004|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
44487005|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487006|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44487007|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
44487008|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44487009|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44487010|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44487011|NCT04530565|Protective Agents|protective agents|mesh-ancestor
44487012|NCT04523207|Relugolix|relugolix|mesh-list
44487013|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
44487014|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
44487015|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487016|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487017|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44487018|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487019|NCT04519619|Aflibercept|aflibercept|mesh-list
44487020|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487021|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487022|NCT04519619|Growth Substances|growth substances|mesh-ancestor
44487023|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487024|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487025|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487026|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
44487027|NCT04515615|Tegafur|tegafur|mesh-list
44487028|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487029|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487030|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
44487031|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487032|NCT04503694|Nivolumab|nivolumab|mesh-list
44487033|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487035|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487036|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487037|NCT04498117|Paclitaxel|paclitaxel|mesh-list
44487038|NCT04498117|Carboplatin|carboplatin|mesh-list
44487039|NCT04498117|Oregovomab|oregovomab|mesh-list
44487040|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44487041|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487042|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
44487043|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
44487044|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
44487045|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487046|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487047|NCT04497844|Prednisone|prednisone|mesh-list
44487048|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
44487049|NCT04497844|Niraparib|niraparib|mesh-list
44487050|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487051|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
44487052|NCT04497844|Hormones|hormones|mesh-ancestor
44487053|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487054|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487055|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487056|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487057|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44487058|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306320|NCT00864890|Dexetimide|dexetimide|mesh-list
44487059|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487060|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
44487061|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44487062|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44487063|NCT04493216|Dolutegravir|dolutegravir|mesh-list
43944086|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
44487064|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44487065|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44487066|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487067|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487068|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44487069|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44487070|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
44487071|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487072|NCT04472949|Carboplatin|carboplatin|mesh-list
44487073|NCT04472949|Etoposide|etoposide|mesh-list
44487074|NCT04472949|Durvalumab|durvalumab|mesh-list
44487075|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487076|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44487077|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44487078|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44487079|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487080|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487081|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487082|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44487083|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
44487084|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487085|NCT04458831|Dexamethasone|dexamethasone|mesh-list
44487086|NCT04458831|Pomalidomide|pomalidomide|mesh-list
44487087|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487088|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
44487089|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
44487090|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487091|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487092|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487093|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
44487094|NCT04458831|Hormones|hormones|mesh-ancestor
44487095|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487096|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487097|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944118|NCT04320342|Beclomethasone|beclomethasone|mesh-list
44487098|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
44487099|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487100|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487101|NCT04458831|Growth Substances|growth substances|mesh-ancestor
44487102|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487103|NCT04457245|Fluorides|fluorides|mesh-list
44487104|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
44487105|NCT04457245|Protective Agents|protective agents|mesh-ancestor
44487106|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487108|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44487109|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44487110|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487111|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487112|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487113|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
44487114|NCT04445714|Saxagliptin|saxagliptin|mesh-list
44487115|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44487116|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487117|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487118|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487119|NCT04445714|Incretins|incretins|mesh-ancestor
44487120|NCT04445714|Hormones|hormones|mesh-ancestor
44487121|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487122|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44487123|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487124|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487125|NCT04440007|Abivertinib|abivertinib|mesh-list
44487126|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487127|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487128|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44487129|NCT04439539|Tenofovir|tenofovir|mesh-list
44487130|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
44487131|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44487132|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
44306382|NCT00865007|Ritonavir|ritonavir|mesh-list
44487133|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487134|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44487135|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44487136|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487137|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487138|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44487139|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44487140|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
44487141|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44487142|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487143|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487144|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44487145|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44487146|NCT04433988|Protective Agents|protective agents|mesh-ancestor
44487147|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487148|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
44487149|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44487150|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
44487151|NCT04416633|Durvalumab|durvalumab|mesh-list
44487152|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487153|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487154|NCT04410913|Psilocybin|psilocybin|mesh-list
44487155|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
44487156|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487157|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487158|NCT04410341|Vildagliptin|vildagliptin|mesh-list
44487159|NCT04410341|Citalopram|citalopram|mesh-list
44487160|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44487161|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44487162|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44487163|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487164|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487165|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
44487166|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487167|NCT04410341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44487168|NCT04410341|Antidepressive Agents|antidepressive agents|mesh-ancestor
44487169|NCT04410341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487170|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487171|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44487172|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487173|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487174|NCT04407442|Dexamethasone|dexamethasone|mesh-list
44487175|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
44487176|NCT04407442|Azacitidine|azacitidine|mesh-list
44487177|NCT04407442|Daratumumab|daratumumab|mesh-list
44487178|NCT04407442|Ichthammol|ichthammol|mesh-list
44487179|NCT04407442|BB 1101|bb 1101|mesh-list
44487180|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487181|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
44487182|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
44487183|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487184|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487185|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487186|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
44487187|NCT04407442|Hormones|hormones|mesh-ancestor
44487188|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487189|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487190|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487191|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487192|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487193|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487194|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487195|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
44487196|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
44487197|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
44487198|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487199|NCT04401761|Aspirin|aspirin|mesh-list
44487200|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
44487201|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44487202|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44487203|NCT04401761|Analgesics|analgesics|mesh-ancestor
44487204|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
44487205|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487206|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487207|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487208|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487209|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44487210|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44487211|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487212|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44487213|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44487214|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487215|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
44487216|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44487217|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
44487218|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44487219|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487220|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
44487221|NCT04396574|Lasmiditan|lasmiditan|mesh-list
44487222|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44487223|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
44487224|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487225|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944158|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
44487226|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487227|NCT04396236|Lasmiditan|lasmiditan|mesh-list
44487228|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44487229|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
44487230|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487231|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487232|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487233|NCT04392375|Nifedipine|nifedipine|mesh-list
44487234|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44487235|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44487236|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487237|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44487238|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487239|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
44487240|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
44487241|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44487242|NCT04387617|Cannabidiol|cannabidiol|mesh-list
44487243|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
44487244|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44487245|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44487246|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44487247|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44487248|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487249|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487250|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44487251|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44487252|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44487253|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44487254|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487255|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487256|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44487257|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44487259|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44487260|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44487261|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
44487262|NCT04379596|Cisplatin|cisplatin|mesh-list
44487263|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
44487264|NCT04379596|Fluorouracil|fluorouracil|mesh-list
44487265|NCT04379596|Capecitabine|capecitabine|mesh-list
44487266|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
44487267|NCT04379596|Trastuzumab|trastuzumab|mesh-list
44487268|NCT04379596|Durvalumab|durvalumab|mesh-list
44487269|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487270|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487271|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
44487272|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487273|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487274|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487275|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
44487276|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487277|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44487278|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
44487279|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487280|NCT04375033|Buprenorphine|buprenorphine|mesh-list
44487281|NCT04375033|Naloxone|naloxone|mesh-list
44487282|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44487283|NCT04375033|Narcotics|narcotics|mesh-ancestor
44487284|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44487285|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487286|NCT04375033|Analgesics|analgesics|mesh-ancestor
44487287|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
44487288|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487289|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44487290|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
44487291|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44487292|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44487293|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487294|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
44487295|NCT04372940|Coagulants|coagulants|mesh-ancestor
44487296|NCT04372108|Ustekinumab|ustekinumab|mesh-list
44487297|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737418|NCT02188121|Losartan|losartan|mesh-list
44737419|NCT02188121|Simvastatin|simvastatin|mesh-list
44737420|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44737421|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44737422|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
44737423|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737424|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44737425|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44737426|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737427|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44737428|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44737429|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44737430|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44737431|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
44737432|NCT02101853|Leucovorin|leucovorin|mesh-list
44737433|NCT02101853|Folic Acid|folic acid|mesh-list
44737434|NCT02101853|Cytarabine|cytarabine|mesh-list
44737435|NCT02101853|Dexamethasone|dexamethasone|mesh-list
44737436|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
44737437|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
44737438|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44737439|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44737440|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44737441|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
44737442|NCT02101853|Methotrexate|methotrexate|mesh-list
44737443|NCT02101853|Etoposide|etoposide|mesh-list
44737444|NCT02101853|Vincristine|vincristine|mesh-list
44737445|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
44737446|NCT02101853|Asparaginase|asparaginase|mesh-list
44737447|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
44737448|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
44737449|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
44737450|NCT02101853|Pegaspargase|pegaspargase|mesh-list
44737451|NCT02101853|Thioguanine|thioguanine|mesh-list
44737452|NCT02101853|Blinatumomab|blinatumomab|mesh-list
44737453|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44737454|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
44737455|NCT02101853|Antibodies|antibodies|mesh-list
44737456|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
44737457|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737458|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44737459|NCT02101853|BB 1101|bb 1101|mesh-list
44737460|NCT02101853|Calcium|calcium|mesh-list
44737461|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
44737462|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
44737463|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737464|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
44737465|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737466|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737467|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737468|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
44737469|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737470|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737471|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737472|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737473|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
44737474|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
44737475|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737476|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44737477|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
44737478|NCT02101853|Hormones|hormones|mesh-ancestor
44737479|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737480|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44737481|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487299|NCT04362761|Elexacaftor|elexacaftor|mesh-list
44487300|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44487301|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44487302|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487303|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
44487304|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
44487305|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44487306|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44487307|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487308|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487309|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487310|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487311|NCT04353492|Ofatumumab|ofatumumab|mesh-list
44487312|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944319|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
44487313|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44487314|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487315|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487316|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487317|NCT04344873|Abatacept|abatacept|mesh-list
44487318|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487319|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487320|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487321|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487322|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
44487323|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487324|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487325|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
44487326|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487327|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
44487328|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44487329|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44487330|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487331|NCT04344678|Urological Agents|urological agents|mesh-ancestor
44487332|NCT04337827|Rituximab|rituximab|mesh-list
44487333|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
44487334|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487335|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487336|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
44487337|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487338|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487339|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
44487340|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
44487341|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44487342|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44487343|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487344|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44487345|NCT04333407|Aspirin|aspirin|mesh-list
44487346|NCT04333407|Omeprazole|omeprazole|mesh-list
44487347|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
44487348|NCT04333407|Clopidogrel|clopidogrel|mesh-list
44487349|NCT04333407|Atorvastatin|atorvastatin|mesh-list
44487350|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44487351|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44487352|NCT04333407|Analgesics|analgesics|mesh-ancestor
44487353|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
44487354|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487355|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487356|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487357|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487358|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44487359|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44487360|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487361|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44487362|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44487363|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487364|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
44487365|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44487366|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44487367|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
44487368|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44487369|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44487370|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44487371|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44487380|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44487381|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487382|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44487383|NCT04332341|Niacinamide|niacinamide|mesh-list
44487384|NCT04332341|Niacin|niacin|mesh-list
44487385|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
44487386|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
44487387|NCT04332341|Vitamins|vitamins|mesh-ancestor
44487388|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
44487389|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487390|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44487391|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
44487392|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487393|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44487394|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
44487395|NCT04317404|Triamcinolone|triamcinolone|mesh-list
44487396|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44487397|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44487398|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44487399|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487400|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
44487401|NCT04317404|Hormones|hormones|mesh-ancestor
44487402|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487403|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487404|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487405|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
44487406|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487407|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487408|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
44487409|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
44487410|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944395|NCT02000596|Pertuzumab|pertuzumab|mesh-list
44487411|NCT04305106|Dexamethasone|dexamethasone|mesh-list
44487412|NCT04305106|Dexamethasone acetate|dexamethasone acetate|mesh-list
44487413|NCT04305106|Bevacizumab|bevacizumab|mesh-list
44487414|NCT04305106|Heparin|heparin|mesh-list
44487415|NCT04305106|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44487416|NCT04305106|Tinzaparin|tinzaparin|mesh-list
44487417|NCT04305106|Dalteparin|dalteparin|mesh-list
44487418|NCT04305106|Anticoagulants|anticoagulants|mesh-list
44487419|NCT04305106|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44487420|NCT04305106|BB 1101|bb 1101|mesh-list
44487421|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487422|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487423|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487424|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487425|NCT04305106|Growth Substances|growth substances|mesh-ancestor
44487426|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487427|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487428|NCT04305106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487429|NCT04305106|Antiemetics|antiemetics|mesh-ancestor
44487430|NCT04305106|Autonomic Agents|autonomic agents|mesh-ancestor
44487431|NCT04305106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487432|NCT04305106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487433|NCT04305106|Glucocorticoids|glucocorticoids|mesh-ancestor
44487434|NCT04305106|Hormones|hormones|mesh-ancestor
44487435|NCT04305106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487436|NCT04305106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487437|NCT04305106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44487438|NCT04305106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487439|NCT04305106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487440|NCT04305106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44487441|NCT04305106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44487462|NCT04300920|Expectorants|expectorants|mesh-ancestor
44487463|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
44487464|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44487465|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
44487466|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487467|NCT04300920|Protective Agents|protective agents|mesh-ancestor
44487468|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487469|NCT04300920|Antidotes|antidotes|mesh-ancestor
44487470|NCT04300140|Nivolumab|nivolumab|mesh-list
44487471|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487472|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487473|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487474|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487475|NCT04294810|Atezolizumab|atezolizumab|mesh-list
44487476|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487477|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
44487478|NCT04287829|Lenvatinib|lenvatinib|mesh-list
44487479|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487480|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487481|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44487482|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487483|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487484|NCT04283617|Insulin|insulin|mesh-list
44487485|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487486|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487487|NCT04276090|Dexamethasone|dexamethasone|mesh-list
44487488|NCT04276090|Floxuridine|floxuridine|mesh-list
44487489|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487490|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
44487491|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
44487492|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487493|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487494|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487495|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
44487496|NCT04276090|Hormones|hormones|mesh-ancestor
44487497|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487498|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487499|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487500|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487501|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
44487502|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487503|NCT04250155|Atezolizumab|atezolizumab|mesh-list
44487504|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487505|NCT04248998|Metformin|metformin|mesh-list
44487506|NCT04248998|Paclitaxel|paclitaxel|mesh-list
44487507|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
44487508|NCT04248998|Doxorubicin|doxorubicin|mesh-list
44487509|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44487510|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487511|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44487512|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44487513|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44487514|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487515|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487516|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
44487517|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487518|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487519|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44487520|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
44487521|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44487522|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487523|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44487524|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44487525|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44487526|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487527|NCT04248335|Midazolam|midazolam|mesh-list
44487528|NCT04248335|Pantoprazole|pantoprazole|mesh-list
44487529|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44487530|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44487531|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44487532|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487533|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44487534|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44487535|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487536|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44487537|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
44487538|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
44487539|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
44487540|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
44487541|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487542|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487543|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44487544|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487545|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44487546|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487547|NCT04226248|Rivastigmine|rivastigmine|mesh-list
44487548|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44487549|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487550|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487551|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
44487552|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487553|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487554|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44487555|NCT04226248|Protective Agents|protective agents|mesh-ancestor
44487556|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44487557|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
44487558|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487559|NCT04217694|Memantine|memantine|mesh-list
44487560|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44487561|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44487562|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
44487563|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487564|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487565|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487566|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44487567|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44487568|NCT04209595|Rucaparib|rucaparib|mesh-list
44487569|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44487570|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487571|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487572|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487573|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
44487574|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
44487575|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44487576|NCT04205786|Vitamins|vitamins|mesh-ancestor
44487577|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
43944521|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
44487578|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487579|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
44487580|NCT04205786|Hematinics|hematinics|mesh-ancestor
44487581|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44487582|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487583|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487584|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44487585|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
44487586|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487587|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
44487588|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44487589|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487590|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44487591|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44487592|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487593|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487594|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487604|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44487606|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44487607|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44487609|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44487610|NCT04197713|Adavosertib|adavosertib|mesh-list
44487611|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487612|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487613|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487614|NCT04196283|Paclitaxel|paclitaxel|mesh-list
44487615|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44487616|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487617|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
44487618|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
44487619|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
44487620|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487621|NCT04195776|Tenofovir|tenofovir|mesh-list
44487622|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
44487623|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487624|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44487625|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44487626|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487627|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487628|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44487629|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44487640|NCT04183868|Empagliflozin|empagliflozin|mesh-list
44487641|NCT04183868|Glimepiride|glimepiride|mesh-list
44487642|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44487643|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487644|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487645|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487646|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44487647|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487648|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
44487649|NCT04181827|Dexamethasone|dexamethasone|mesh-list
44487650|NCT04181827|Bortezomib|bortezomib|mesh-list
44487651|NCT04181827|Daratumumab|daratumumab|mesh-list
44487652|NCT04181827|Pomalidomide|pomalidomide|mesh-list
44487653|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487654|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
44487655|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
44487656|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487657|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487658|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487659|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
44487660|NCT04181827|Hormones|hormones|mesh-ancestor
44487661|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487662|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487663|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487664|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
44487665|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487666|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487667|NCT04181827|Growth Substances|growth substances|mesh-ancestor
44487668|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487669|NCT04176419|Acetaminophen|acetaminophen|mesh-list
44487670|NCT04176419|Celecoxib|celecoxib|mesh-list
44487671|NCT04176419|Lidocaine|lidocaine|mesh-list
44487682|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44487683|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44487684|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487685|NCT04176419|Analgesics|analgesics|mesh-ancestor
44487686|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44487687|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44487688|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
44487689|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44487690|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44487691|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487692|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44487693|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
44487694|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44487695|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487696|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487697|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44487698|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44487699|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487700|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
44487701|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44487702|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44487703|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44487704|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
44487716|NCT04168931|Trastuzumab|trastuzumab|mesh-list
44487717|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487718|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487719|NCT04166773|Tirzepatide|tirzepatide|mesh-list
44487720|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43944625|NCT01023477|Analgesics|analgesics|mesh-ancestor
44487721|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487722|NCT04166773|Incretins|incretins|mesh-ancestor
44487723|NCT04166773|Hormones|hormones|mesh-ancestor
44487724|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487725|NCT04165967|Nivolumab|nivolumab|mesh-list
44487726|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487727|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487728|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487729|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487730|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
44487731|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487732|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
44487733|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487734|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487735|NCT04161885|Azacitidine|azacitidine|mesh-list
44487736|NCT04161885|Venetoclax|venetoclax|mesh-list
44487737|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44487738|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
44487739|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487740|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487741|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487742|NCT04157335|Benralizumab|benralizumab|mesh-list
44487743|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44487744|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
44487745|NCT04156347|Topotecan|topotecan|mesh-list
44487746|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44487747|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44487748|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487749|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487750|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737482|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487751|NCT04137120|Aflibercept|aflibercept|mesh-list
44487752|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487753|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487754|NCT04137120|Growth Substances|growth substances|mesh-ancestor
44487755|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487756|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487757|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487762|NCT04130802|Dexamethasone|dexamethasone|mesh-list
44487763|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487764|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
44487765|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
44487766|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487767|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487768|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487769|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
44487770|NCT04130802|Hormones|hormones|mesh-ancestor
44487771|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487772|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487773|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487774|NCT04125472|Lumasiran|lumasiran|mesh-list
44487775|NCT04125472|Renal Agents|renal agents|mesh-ancestor
44487776|NCT04121260|Daratumumab|daratumumab|mesh-list
44487777|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487778|NCT04115384|Insulin|insulin|mesh-list
44487779|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44487780|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487781|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487782|NCT04108208|Androgens|androgens|mesh-list
44487783|NCT04108208|Hormones|hormones|mesh-ancestor
44487784|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487785|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487786|NCT04108195|Daratumumab|daratumumab|mesh-list
44487787|NCT04108195|Pomalidomide|pomalidomide|mesh-list
44487788|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487789|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
44487790|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487791|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44487792|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44487793|NCT04108195|Growth Substances|growth substances|mesh-ancestor
44487794|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487795|NCT04098744|Artesunate|artesunate|mesh-list
44487796|NCT04098744|Artemisinins|artemisinins|mesh-list
44487797|NCT04098744|Artemisinin|artemisinin|mesh-list
44487798|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
44487799|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44487800|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44487801|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487802|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487803|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
44487804|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
44487805|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44487806|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
44487807|NCT04086745|Adalimumab|adalimumab|mesh-list
44487808|NCT04086745|Etanercept|etanercept|mesh-list
44487809|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44487810|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487811|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487812|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44487813|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44487814|NCT04086745|Analgesics|analgesics|mesh-ancestor
44487815|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
44487816|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487817|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487818|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487819|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487820|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
44487821|NCT04084951|Nivolumab|nivolumab|mesh-list
44487822|NCT04084951|Ipilimumab|ipilimumab|mesh-list
44487823|NCT04084951|Atezolizumab|atezolizumab|mesh-list
44487834|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487835|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
44487836|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44487837|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487838|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44487839|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487840|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
44487841|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
44487842|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487843|NCT04075110|Montelukast|montelukast|mesh-list
44487844|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44487845|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44487846|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44487847|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44487848|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487849|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487850|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44487851|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44487852|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487853|NCT04073797|Colchicine|colchicine|mesh-list
44487854|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
44487855|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44487856|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
44487857|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
44487858|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
44487859|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487860|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487861|NCT04056962|Tacrolimus|tacrolimus|mesh-list
44487862|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44487863|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
44487864|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487865|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44487866|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487867|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487868|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44487869|NCT04039750|Clindamycin|clindamycin|mesh-list
44487870|NCT04039750|Gentamicins|gentamicins|mesh-list
44487871|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487872|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44487873|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487874|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487875|NCT04039607|Nivolumab|nivolumab|mesh-list
44487876|NCT04039607|Ipilimumab|ipilimumab|mesh-list
44487877|NCT04039607|Sorafenib|sorafenib|mesh-list
44487878|NCT04039607|Lenvatinib|lenvatinib|mesh-list
44487879|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44487880|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487881|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44487882|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487883|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44487884|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307161|NCT00868426|Antidotes|antidotes|mesh-ancestor
44487903|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44487904|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44487905|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44487906|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487907|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
44487908|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44487909|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44487910|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44487911|NCT03994627|Olaratumab|olaratumab|mesh-list
44487912|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487913|NCT03989414|Dexamethasone|dexamethasone|mesh-list
44487914|NCT03989414|Bortezomib|bortezomib|mesh-list
44487915|NCT03989414|Daratumumab|daratumumab|mesh-list
44487916|NCT03989414|Elotuzumab|elotuzumab|mesh-list
44487917|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487918|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
44487919|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
44487920|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487921|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487922|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44487923|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
44487924|NCT03989414|Hormones|hormones|mesh-ancestor
44487925|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487926|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487927|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487928|NCT03985540|Methamphetamine|methamphetamine|mesh-list
44487929|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44487930|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487931|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
44487932|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
44487933|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487934|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
44487935|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487936|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487937|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44487938|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44487939|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44487940|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44487941|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44487942|NCT03962894|Prednisolone|prednisolone|mesh-list
44487943|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487944|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
44487945|NCT03962894|Hormones|hormones|mesh-ancestor
44487946|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487947|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487948|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44487949|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487950|NCT03954899|Melatonin|melatonin|mesh-list
44487951|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
44487952|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487953|NCT03954899|Protective Agents|protective agents|mesh-ancestor
44487954|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487955|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44487956|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44487957|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737483|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44737484|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44737485|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44737486|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
44737487|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44737488|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737489|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
44737490|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737491|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44737492|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737493|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737494|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44737495|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44737497|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737498|NCT02101853|Antidotes|antidotes|mesh-ancestor
44737499|NCT02101853|Protective Agents|protective agents|mesh-ancestor
44487969|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
44487970|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44487971|NCT03934307|Irbesartan|irbesartan|mesh-list
44487972|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44487973|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44487974|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44487975|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487976|NCT03932201|Factor VIII|factor viii|mesh-list
44487977|NCT03932201|Coagulants|coagulants|mesh-ancestor
44487978|NCT03924635|Budesonide|budesonide|mesh-list
44487979|NCT03924635|Albuterol|albuterol|mesh-list
44487980|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
44487981|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44487982|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44487983|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44487984|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
44487985|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44487986|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44487987|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44487988|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
44487989|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
44487990|NCT03924635|Hormones|hormones|mesh-ancestor
44487991|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44487992|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44487993|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44487994|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44487995|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
44487996|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44487997|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44487998|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
44487999|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44488000|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
44488001|NCT03918798|Procaine|procaine|mesh-list
44488002|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44488003|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
44488004|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
44488005|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44488006|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488007|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
44488008|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488009|NCT03915405|Avelumab|avelumab|mesh-list
44488010|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488011|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488012|NCT03914300|Nivolumab|nivolumab|mesh-list
44488013|NCT03914300|Ipilimumab|ipilimumab|mesh-list
44488014|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488015|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488016|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488017|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737500|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
44307236|NCT00868829|Chromium|chromium|mesh-list
44488033|NCT03910452|Busulfan|busulfan|mesh-list
44488034|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
44488035|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488036|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
44488037|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488038|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488039|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44488040|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
44488041|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488042|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488043|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44488044|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44488045|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488046|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44488047|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
44488048|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488049|NCT03907969|AZD7648|azd7648|mesh-list
44488050|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488051|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898663|NCT05586516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488052|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488053|NCT03906292|Niacinamide|niacinamide|mesh-list
44488054|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
44488055|NCT03906292|Dasatinib|dasatinib|mesh-list
44488056|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488057|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488058|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488059|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488060|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
44488061|NCT03906292|Vitamins|vitamins|mesh-ancestor
44488062|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
44488063|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488064|NCT03905694|Lumasiran|lumasiran|mesh-list
44488065|NCT03905694|Renal Agents|renal agents|mesh-ancestor
44488066|NCT03901963|Lenalidomide|lenalidomide|mesh-list
44488067|NCT03901963|Daratumumab|daratumumab|mesh-list
44488068|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
44488069|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488070|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488071|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488072|NCT03901963|Growth Substances|growth substances|mesh-ancestor
44488073|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488074|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488075|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
44488076|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44488077|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
44488078|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44488079|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
44488080|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488081|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488082|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
44488083|NCT03879629|Carvedilol|carvedilol|mesh-list
44488084|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44488085|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44488086|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44488087|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488088|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488089|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488090|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44488091|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
44488092|NCT03879629|Protective Agents|protective agents|mesh-ancestor
44488093|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44488094|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44488095|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44488096|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44488097|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44488098|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44488099|NCT03873116|Berotralstat|berotralstat|mesh-list
44488100|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488101|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488102|NCT03870399|Tamoxifen|tamoxifen|mesh-list
44488103|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44488104|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44737501|NCT02101853|Vitamins|vitamins|mesh-ancestor
44488105|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488106|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488107|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488108|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488109|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44488110|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44488111|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44488112|NCT03867201|Erenumab|erenumab|mesh-list
44488113|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44488114|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488115|NCT03867201|Analgesics|analgesics|mesh-ancestor
44488116|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
44488117|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488118|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488119|NCT03847649|Prednisone|prednisone|mesh-list
44488120|NCT03847649|Durvalumab|durvalumab|mesh-list
44488121|NCT03847649|Tremelimumab|tremelimumab|mesh-list
44488122|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488123|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
44488124|NCT03847649|Hormones|hormones|mesh-ancestor
44488125|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488126|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488127|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488128|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488129|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488130|NCT03837925|Atorvastatin|atorvastatin|mesh-list
44488131|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44488132|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44488133|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
44488134|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488135|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44488136|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44488137|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488139|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
44488140|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
44488141|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488142|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488143|NCT03830333|Metronidazole|metronidazole|mesh-list
44488144|NCT03830333|Meropenem|meropenem|mesh-list
44488145|NCT03830333|Tazobactam|tazobactam|mesh-list
44488146|NCT03830333|Ceftolozane|ceftolozane|mesh-list
44488147|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44488148|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488149|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44488150|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44488151|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44488152|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44488153|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488154|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488155|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44488156|NCT03830333|Renal Agents|renal agents|mesh-ancestor
44488157|NCT03829462|Irinotecan|irinotecan|mesh-list
44488158|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44488159|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44488160|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488161|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488162|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488163|NCT03828799|Folfirinox|folfirinox|mesh-list
44488164|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488165|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44488166|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
44488167|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488168|NCT03819465|Gemcitabine|gemcitabine|mesh-list
44488169|NCT03819465|Paclitaxel|paclitaxel|mesh-list
44488170|NCT03819465|Cisplatin|cisplatin|mesh-list
44488171|NCT03819465|Carboplatin|carboplatin|mesh-list
44488172|NCT03819465|Pemetrexed|pemetrexed|mesh-list
44488173|NCT03819465|Durvalumab|durvalumab|mesh-list
44488174|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488175|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488176|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488177|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488178|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488179|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488180|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488181|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
44488182|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
44488183|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488184|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488185|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488186|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
44488187|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488188|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44488189|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44488190|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488191|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43945090|NCT05593653|Suvorexant|suvorexant|mesh-list
44488192|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
44488193|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488194|NCT03818802|Niacinamide|niacinamide|mesh-list
44488195|NCT03818802|Niacin|niacin|mesh-list
44488196|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
44488197|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
44488198|NCT03818802|Vitamins|vitamins|mesh-ancestor
44488199|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
44488200|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488201|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44488202|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
44488203|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488204|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44488206|NCT03816358|Gemcitabine|gemcitabine|mesh-list
44488207|NCT03816358|Nivolumab|nivolumab|mesh-list
44488208|NCT03816358|Ipilimumab|ipilimumab|mesh-list
44488209|NCT03816358|Maytansine|maytansine|mesh-list
44488210|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488211|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
44488212|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488213|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488214|NCT03816358|Antiviral Agents|antiviral agents|mesh-ancestor
44488215|NCT03816358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488216|NCT03816358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488217|NCT03816358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488218|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
44488219|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488220|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488221|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488222|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488223|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488224|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488225|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488226|NCT03816345|Nivolumab|nivolumab|mesh-list
44488227|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488228|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488229|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488230|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488231|NCT03816332|Prednisone|prednisone|mesh-list
44488232|NCT03816332|Cortisone|cortisone|mesh-list
44488233|NCT03816332|Nivolumab|nivolumab|mesh-list
44488234|NCT03816332|Ipilimumab|ipilimumab|mesh-list
44488235|NCT03816332|Tacrolimus|tacrolimus|mesh-list
44488236|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488237|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
44488238|NCT03816332|Hormones|hormones|mesh-ancestor
44488239|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488240|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488241|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488242|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488243|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488244|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488245|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488246|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488247|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
44488248|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44488249|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488250|NCT03816176|Isavuconazole|isavuconazole|mesh-list
44488251|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
44488252|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488269|NCT03810287|Domperidone|domperidone|mesh-list
44488270|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
44488271|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
44488272|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488273|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488274|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488275|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44488276|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
44488277|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488278|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488279|NCT03781414|Tacrolimus|tacrolimus|mesh-list
44488280|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488281|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
44488282|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488283|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44488284|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488285|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488286|NCT03767244|Androgens|androgens|mesh-list
44488287|NCT03767244|Hormones|hormones|mesh-ancestor
44488288|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488289|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488290|NCT03764098|Guanfacine|guanfacine|mesh-list
44488291|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44488292|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44488293|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44488294|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44488295|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44488296|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488297|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488298|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488299|NCT03761173|Anticoagulants|anticoagulants|mesh-list
44488300|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
44488301|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44488302|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
44488303|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44488304|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
44488305|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488306|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488307|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
44488308|NCT03729349|Golimumab|golimumab|mesh-list
44488309|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44488310|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488311|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488312|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
44488313|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488314|NCT03708588|Ticagrelor|ticagrelor|mesh-list
44488315|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44488316|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44488317|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44488318|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44488319|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
44488320|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488321|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488322|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488323|NCT03708224|Atezolizumab|atezolizumab|mesh-list
44488324|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488325|NCT03696355|GDC-0084|gdc-0084|mesh-list
44488326|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488327|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737502|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
44737503|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737504|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737505|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488328|NCT03682068|Gemcitabine|gemcitabine|mesh-list
44488329|NCT03682068|Cisplatin|cisplatin|mesh-list
44488330|NCT03682068|Carboplatin|carboplatin|mesh-list
44488331|NCT03682068|Durvalumab|durvalumab|mesh-list
44488332|NCT03682068|Tremelimumab|tremelimumab|mesh-list
44488333|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945193|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44488334|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488335|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
44488336|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488337|NCT03682068|Antiviral Agents|antiviral agents|mesh-ancestor
44488338|NCT03682068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488339|NCT03682068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488340|NCT03682068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488341|NCT03682068|Immunologic Factors|immunologic factors|mesh-ancestor
44488342|NCT03682068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488343|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488344|NCT03681184|Lumasiran|lumasiran|mesh-list
44488345|NCT03681184|Renal Agents|renal agents|mesh-ancestor
44488346|NCT03672487|Benzonidazole|benzonidazole|mesh-list
44488347|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488348|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
44488349|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488351|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44488352|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44488353|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488354|NCT03652064|Dexamethasone|dexamethasone|mesh-list
44488355|NCT03652064|Lenalidomide|lenalidomide|mesh-list
44488356|NCT03652064|Bortezomib|bortezomib|mesh-list
44488357|NCT03652064|Daratumumab|daratumumab|mesh-list
44488358|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488359|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
44488360|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
44488361|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488362|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488363|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488364|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
44488365|NCT03652064|Hormones|hormones|mesh-ancestor
44488366|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488367|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488368|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488369|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
44488370|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488371|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488372|NCT03652064|Growth Substances|growth substances|mesh-ancestor
44488373|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488374|NCT03650114|Ofatumumab|ofatumumab|mesh-list
44488375|NCT03650114|Vaccines|vaccines|mesh-list
44488376|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44488377|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44488378|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
44488379|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488380|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488381|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44488382|NCT03646461|Nivolumab|nivolumab|mesh-list
44488383|NCT03646461|Cetuximab|cetuximab|mesh-list
43945252|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945253|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
43945254|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
43945255|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945256|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945258|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
44488384|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488385|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488386|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488387|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488388|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
44488389|NCT03643796|Ketamine|ketamine|mesh-list
44488390|NCT03643796|Remifentanil|remifentanil|mesh-list
44488391|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44488392|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44488393|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488394|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44488395|NCT03643796|Analgesics|analgesics|mesh-ancestor
44488396|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
44488397|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488398|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44488399|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44488400|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44488401|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
44488402|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488403|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488404|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44307568|NCT00870714|Docetaxel|docetaxel|mesh-list
44488405|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44488406|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
44488408|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44488409|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44488410|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44488411|NCT03643796|Narcotics|narcotics|mesh-ancestor
44488412|NCT03621904|Tamoxifen|tamoxifen|mesh-list
44488413|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
44488414|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
44488415|NCT03621904|Progesterone|progesterone|mesh-list
44488416|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44488417|NCT03621904|Progestins|progestins|mesh-ancestor
44488418|NCT03621904|Hormones|hormones|mesh-ancestor
44488419|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488420|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488421|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44488422|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44488423|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44488424|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43898979|NCT04634578|Bevacizumab|bevacizumab|mesh-list
44488426|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44488427|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488428|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488429|NCT03620162|Vaccines|vaccines|mesh-list
44488430|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
44488431|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488432|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
44488433|NCT03613727|Vitamins|vitamins|mesh-ancestor
44488434|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
44488435|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488436|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
44488437|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488438|NCT03613727|Protective Agents|protective agents|mesh-ancestor
44488439|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
44488440|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
44488441|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488442|NCT03598309|Curcumin|curcumin|mesh-list
44488443|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44488444|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44488445|NCT03598309|Analgesics|analgesics|mesh-ancestor
44488446|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
44488447|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488448|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488449|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488450|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488451|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488452|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488453|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488454|NCT03595059|Paclitaxel|paclitaxel|mesh-list
44488455|NCT03595059|Docetaxel|docetaxel|mesh-list
44488456|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488457|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488458|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488459|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488460|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488461|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488462|NCT03588754|Propranolol|propranolol|mesh-list
44488463|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43945331|NCT05385042|Thiamine|thiamine|mesh-list
43945332|NCT05385042|Vitamins|vitamins|mesh-ancestor
43945333|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
43945334|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945335|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
43945336|NCT05385042|Hematinics|hematinics|mesh-ancestor
43945352|NCT05340582|Acetaminophen|acetaminophen|mesh-list
43945353|NCT05340582|Ibuprofen|ibuprofen|mesh-list
43945354|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945355|NCT05340582|Analgesics|analgesics|mesh-ancestor
43945356|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
43945357|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945358|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945359|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
43945360|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44488464|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44488465|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44488466|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488467|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488468|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488469|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44488470|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44488471|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
44488472|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44488473|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44488474|NCT03568708|Estradiol|estradiol|mesh-list
44488475|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44488476|NCT03568708|Estrogens|estrogens|mesh-list
44488477|NCT03568708|Hormones|hormones|mesh-ancestor
44488478|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488479|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488480|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44488481|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
44488482|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44488483|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44488484|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
44488485|NCT03539900|Naltrexone|naltrexone|mesh-list
44488486|NCT03539900|Bupropion|bupropion|mesh-list
44488487|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44488488|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44488489|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488490|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
44488491|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488492|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44488493|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44488494|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44488495|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44488496|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44488497|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44488498|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488500|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488501|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44488502|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44488503|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945361|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488504|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44488505|NCT03539744|Dexamethasone|dexamethasone|mesh-list
44488506|NCT03539744|Venetoclax|venetoclax|mesh-list
44488507|NCT03539744|Pomalidomide|pomalidomide|mesh-list
44488508|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488509|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
44488510|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
44488511|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488512|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488513|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488514|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
44488515|NCT03539744|Hormones|hormones|mesh-ancestor
44488516|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488517|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488518|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488519|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
44488520|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488521|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488522|NCT03539744|Growth Substances|growth substances|mesh-ancestor
44488523|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488524|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
44488525|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
44488526|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488527|NCT03518203|Eculizumab|eculizumab|mesh-list
44488528|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44488529|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488530|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
44488531|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488532|NCT03504397|Leucovorin|leucovorin|mesh-list
44488533|NCT03504397|Folic Acid|folic acid|mesh-list
44488534|NCT03504397|Fluorouracil|fluorouracil|mesh-list
44488535|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
44488536|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
44488537|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
44488538|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488539|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488540|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488541|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488542|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
44488543|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488544|NCT03504397|Antidotes|antidotes|mesh-ancestor
44488545|NCT03504397|Protective Agents|protective agents|mesh-ancestor
44488546|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
44488547|NCT03504397|Vitamins|vitamins|mesh-ancestor
44488548|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
44488549|NCT03504397|Hematinics|hematinics|mesh-ancestor
44488550|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
44488551|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44488552|NCT03492112|Velpatasvir|velpatasvir|mesh-list
44488553|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
44488554|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488555|NCT03485911|Berotralstat|berotralstat|mesh-list
44488556|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488557|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488558|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44488559|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44488560|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44488561|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44488562|NCT03474107|Paclitaxel|paclitaxel|mesh-list
44488563|NCT03474107|Docetaxel|docetaxel|mesh-list
44488564|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488565|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488566|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488567|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488568|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488569|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488570|NCT03467789|Vitamin D|vitamin d|mesh-list
44488571|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
44488572|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
44488573|NCT03467789|Vitamins|vitamins|mesh-list
44488574|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
43899131|NCT04192253|Paclitaxel|paclitaxel|mesh-list
44488575|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488576|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44488577|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44488578|NCT03451851|Etanercept|etanercept|mesh-list
44488579|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44488580|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44488581|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44488582|NCT03451851|Analgesics|analgesics|mesh-ancestor
44488583|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
44488584|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488585|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488586|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488587|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488588|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488589|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488590|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
44488591|NCT03451045|Dronabinol|dronabinol|mesh-list
44488592|NCT03451045|Lenabasum|lenabasum|mesh-list
44488593|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44488594|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44488595|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488596|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488597|NCT03451045|Hormones|hormones|mesh-ancestor
44488598|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488599|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488600|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
44488601|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44488602|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44488603|NCT03451045|Analgesics|analgesics|mesh-ancestor
44488604|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
44488605|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488606|NCT03430843|Paclitaxel|paclitaxel|mesh-list
44488607|NCT03430843|Docetaxel|docetaxel|mesh-list
44488608|NCT03430843|Irinotecan|irinotecan|mesh-list
44488609|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488610|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488611|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488612|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488613|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488614|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488615|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44488616|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44488617|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488618|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44488619|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488620|NCT03412565|Dexamethasone|dexamethasone|mesh-list
44488621|NCT03412565|Prednisone|prednisone|mesh-list
44488622|NCT03412565|Lenalidomide|lenalidomide|mesh-list
44488623|NCT03412565|Bortezomib|bortezomib|mesh-list
44488624|NCT03412565|Melphalan|melphalan|mesh-list
44488625|NCT03412565|Daratumumab|daratumumab|mesh-list
44488626|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488627|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
44488628|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
44488629|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307800|NCT00872144|Nabiximols|nabiximols|mesh-list
44488630|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488631|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488632|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
44488635|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488636|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488637|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
44488638|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488639|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488640|NCT03412565|Growth Substances|growth substances|mesh-ancestor
44488641|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488642|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44488643|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
44488644|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488645|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44488646|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488647|NCT03400332|Nivolumab|nivolumab|mesh-list
44488648|NCT03400332|Ipilimumab|ipilimumab|mesh-list
44488649|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488650|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488651|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43945470|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
44488652|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488653|NCT03392376|Haloperidol|haloperidol|mesh-list
44488654|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
44488655|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
44488656|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
44488657|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488658|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488659|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488660|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44488661|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44488662|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44488663|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44488664|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44488665|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
44488666|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488667|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488668|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44488669|NCT03384641|Bedaquiline|bedaquiline|mesh-list
44488670|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44488671|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44488672|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488673|NCT03374085|Dexamethasone|dexamethasone|mesh-list
44488674|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488675|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
44488676|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
44488677|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488678|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488679|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488680|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
44488681|NCT03374085|Hormones|hormones|mesh-ancestor
44488682|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488683|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488684|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488685|NCT03350451|Lumasiran|lumasiran|mesh-list
44488686|NCT03350451|Renal Agents|renal agents|mesh-ancestor
44488689|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
44488690|NCT03331484|Ticagrelor|ticagrelor|mesh-list
44488691|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44488692|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44488693|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44488694|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44488695|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
44488696|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44488697|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488698|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488699|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44488700|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
44488701|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44488702|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
44488703|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488704|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
44488705|NCT03310619|Nivolumab|nivolumab|mesh-list
44488706|NCT03310619|Durvalumab|durvalumab|mesh-list
44488707|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488708|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488709|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488710|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488711|NCT03306901|Cisplatin|cisplatin|mesh-list
44488712|NCT03306901|Fluorouracil|fluorouracil|mesh-list
44488713|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488714|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
44488715|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488716|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488717|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488718|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
44488719|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488720|NCT03304717|Tenofovir|tenofovir|mesh-list
44488721|NCT03304717|Emtricitabine|emtricitabine|mesh-list
44488722|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
44488723|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488724|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44488725|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44488726|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234724|NCT00550927|Growth Substances|growth substances|mesh-ancestor
44488727|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488728|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44488729|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44488730|NCT03301220|Daratumumab|daratumumab|mesh-list
44488731|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488732|NCT03290794|Aflibercept|aflibercept|mesh-list
44488733|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488734|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488735|NCT03290794|Growth Substances|growth substances|mesh-ancestor
44488736|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488737|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488738|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488739|NCT03286842|Olaparib|olaparib|mesh-list
44488740|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44488741|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488742|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488743|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488744|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
44488745|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488746|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488747|NCT03269994|Tazobactam|tazobactam|mesh-list
44488748|NCT03269994|Piperacillin|piperacillin|mesh-list
44488749|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44488750|NCT03269994|Cefoxitin|cefoxitin|mesh-list
44488751|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44488752|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488753|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44488754|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488755|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488756|NCT03260920|Oxytocin|oxytocin|mesh-list
44488757|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
44488758|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44488759|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488760|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
44488761|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
44488762|NCT03258385|Vitamins|vitamins|mesh-ancestor
44488763|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
44488764|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488765|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
44488766|NCT03258385|Hematinics|hematinics|mesh-ancestor
44488767|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
44488768|NCT03253133|Oxycodone|oxycodone|mesh-list
44488769|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488770|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44488771|NCT03253133|Narcotics|narcotics|mesh-ancestor
44488772|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44488773|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488774|NCT03253133|Analgesics|analgesics|mesh-ancestor
44488775|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
44488776|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737506|NCT02101853|Hematinics|hematinics|mesh-ancestor
44737507|NCT02101853|Analgesics|analgesics|mesh-ancestor
44737508|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
44737509|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
44737510|NCT02066181|Sorafenib|sorafenib|mesh-list
44307926|NCT00872781|Quinapril|quinapril|mesh-list
44737511|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737512|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737513|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488777|NCT03234972|Dexamethasone|dexamethasone|mesh-list
44488778|NCT03234972|Bortezomib|bortezomib|mesh-list
44488779|NCT03234972|Daratumumab|daratumumab|mesh-list
44488780|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44488781|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
44488782|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
44488783|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488784|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488785|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44488786|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
44488787|NCT03234972|Hormones|hormones|mesh-ancestor
44488788|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488789|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488790|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488791|NCT03226756|Nivolumab|nivolumab|mesh-list
44488792|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488793|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488794|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43899285|NCT03300544|Leucovorin|leucovorin|mesh-list
44488795|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488796|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
44488797|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
44488798|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488799|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488800|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
44488801|NCT03197506|Temozolomide|temozolomide|mesh-list
44488802|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488803|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488804|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44488805|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
44488806|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488807|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
44488808|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488809|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488810|NCT03091192|Sunitinib|sunitinib|mesh-list
44488811|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488812|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44488813|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44488814|NCT03091192|Growth Substances|growth substances|mesh-ancestor
44488815|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488816|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
44488817|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488818|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488819|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488820|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
44488821|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
44488822|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488823|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44488824|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488825|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488826|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
44488827|NCT03049449|Fludarabine|fludarabine|mesh-list
44488828|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488829|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
44488830|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488831|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488832|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44488833|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
44488834|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488835|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488836|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44488837|NCT03049189|Everolimus|everolimus|mesh-list
44488838|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44488839|NCT03049189|Edotreotide|edotreotide|mesh-list
44488840|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
44488841|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488842|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488843|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
44488844|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488845|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44488846|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488847|NCT03036098|Gemcitabine|gemcitabine|mesh-list
44488848|NCT03036098|Cisplatin|cisplatin|mesh-list
44488849|NCT03036098|Carboplatin|carboplatin|mesh-list
44488850|NCT03036098|Nivolumab|nivolumab|mesh-list
44488851|NCT03036098|Ipilimumab|ipilimumab|mesh-list
44308007|NCT00873262|Estradiol|estradiol|mesh-list
44488852|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488853|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44488854|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
44488855|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488856|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
44488857|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488858|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488859|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488860|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
44488861|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488862|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488863|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44488864|NCT03026790|Buprenorphine|buprenorphine|mesh-list
44488865|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44488866|NCT03026790|Naloxone|naloxone|mesh-list
44488867|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44488868|NCT03026790|Narcotics|narcotics|mesh-ancestor
44488869|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44488870|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488871|NCT03026790|Analgesics|analgesics|mesh-ancestor
44488872|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
44488873|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44488874|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44488875|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
43945657|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488876|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488877|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488878|NCT03012529|Riboflavin|riboflavin|mesh-list
44488879|NCT03012529|Rifampin|rifampin|mesh-list
44488880|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44488881|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
44488882|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44488883|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44488884|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
44488885|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44488886|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488887|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488888|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44488889|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44488890|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44488891|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44488892|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44488893|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44488894|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
44488895|NCT03012529|Vitamins|vitamins|mesh-ancestor
44488896|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
44488897|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488898|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44488899|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
44488900|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
44488901|NCT03006926|Lenvatinib|lenvatinib|mesh-list
44488902|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488903|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488904|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488905|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488906|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488907|NCT03003546|Paclitaxel|paclitaxel|mesh-list
44488908|NCT03003546|Rituximab|rituximab|mesh-list
44141321|NCT00182572|Naltrexone|naltrexone|mesh-list
44488909|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44488910|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44488911|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488912|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
44488913|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
44488914|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
44488915|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488916|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44488917|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
44488918|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488919|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44488920|NCT02989857|Ivosidenib|ivosidenib|mesh-list
44488921|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488922|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488923|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488924|NCT02972840|Rituximab|rituximab|mesh-list
44488925|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44488926|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
44488957|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488959|NCT02941783|Coagulants|coagulants|mesh-ancestor
44488960|NCT02915783|Everolimus|everolimus|mesh-list
44488961|NCT02915783|Lenvatinib|lenvatinib|mesh-list
44488962|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488963|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44488964|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
44488965|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488966|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488967|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488968|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488969|NCT02914158|Tamoxifen|tamoxifen|mesh-list
44488970|NCT02914158|Leuprolide|leuprolide|mesh-list
44488971|NCT02914158|Goserelin|goserelin|mesh-list
44488972|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44488973|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44488974|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
44488975|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44488976|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44488977|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44488978|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488979|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44488980|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44488981|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44488982|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44488983|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
44488984|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44488985|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44488986|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488987|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488988|NCT02890784|Dasatinib|dasatinib|mesh-list
44488989|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44488990|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44488991|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44488992|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488993|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
44488994|NCT02870829|Vitamin K|vitamin k|mesh-list
44488995|NCT02870829|Vitamin MK 7|vitamin mk 7|mesh-list
44488996|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44488997|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945691|NCT04308330|Vorinostat|vorinostat|mesh-list
44488998|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44488999|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
44489000|NCT02870829|Coagulants|coagulants|mesh-ancestor
44489001|NCT02870829|Vitamins|vitamins|mesh-ancestor
44489013|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489014|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489015|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489016|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
44489017|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489018|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489019|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44489020|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44489021|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
44489034|NCT02674958|Aspirin|aspirin|mesh-list
44489035|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44489036|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44489037|NCT02674958|Analgesics|analgesics|mesh-ancestor
44489038|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
44489039|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489040|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489041|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489042|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489043|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44489044|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44489045|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489046|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44489047|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44489048|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489049|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
44489050|NCT02669953|Aflibercept|aflibercept|mesh-list
44489051|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489052|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489053|NCT02669953|Growth Substances|growth substances|mesh-ancestor
44489054|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489055|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489056|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489057|NCT02650401|Entrectinib|entrectinib|mesh-list
44489058|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489059|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489060|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489061|NCT02647203|Fluorides|fluorides|mesh-list
44489062|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
44489063|NCT02647203|Protective Agents|protective agents|mesh-ancestor
44489064|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489065|NCT02592317|Pioglitazone|pioglitazone|mesh-list
44489066|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44489067|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44489068|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44489069|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
44489070|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489071|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44489072|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44489074|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44489075|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489076|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44489077|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489078|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489079|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
44489080|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945749|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
44489081|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489082|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
44489083|NCT02546986|Azacitidine|azacitidine|mesh-list
44489084|NCT02546986|Cc-486|cc-486|mesh-list
44489085|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489086|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489087|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489088|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
44489089|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489090|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489091|NCT02531516|Bicalutamide|bicalutamide|mesh-list
44489092|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
44489093|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489094|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489095|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489096|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489097|NCT02530437|Paclitaxel|paclitaxel|mesh-list
44489098|NCT02530437|Carboplatin|carboplatin|mesh-list
44489099|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44489100|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489101|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489102|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489103|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489104|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489105|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489106|NCT02520362|Denosumab|denosumab|mesh-list
44489107|NCT02520362|Diphosphonates|diphosphonates|mesh-list
44489108|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44489109|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489110|NCT02519452|Daratumumab|daratumumab|mesh-list
44489111|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489112|NCT02519348|Bevacizumab|bevacizumab|mesh-list
44489113|NCT02519348|Durvalumab|durvalumab|mesh-list
44489114|NCT02519348|Tremelimumab|tremelimumab|mesh-list
44489115|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489116|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489117|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489118|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489119|NCT02519348|Growth Substances|growth substances|mesh-ancestor
44489120|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489121|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44737514|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737515|NCT02059265|Dasatinib|dasatinib|mesh-list
44737516|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737517|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44737518|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737519|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737520|NCT02039063|Quetmolimab|quetmolimab|mesh-list
44737521|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44737522|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737523|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
44737524|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737525|NCT01970410|Teriflunomide|teriflunomide|mesh-list
44737526|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44737527|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44737528|NCT01970410|Analgesics|analgesics|mesh-ancestor
44737529|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
44737530|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737531|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737532|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737533|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737534|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737535|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
44737536|NCT01950520|Topiramate|topiramate|mesh-list
44737537|NCT01950520|Phentermine|phentermine|mesh-list
44737539|NCT01950520|Propranolol|propranolol|mesh-list
44737540|NCT01950520|Pindolol|pindolol|mesh-list
44737541|NCT01950520|Naltrexone|naltrexone|mesh-list
44737542|NCT01950520|Caffeine|caffeine|mesh-list
44737543|NCT01950520|Dantrolene|dantrolene|mesh-list
44737544|NCT01950520|Mirabegron|mirabegron|mesh-list
44737545|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44737546|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44737547|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489122|NCT02511106|Osimertinib|osimertinib|mesh-list
44489123|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489124|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489125|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489126|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489127|NCT02505984|Oxytocin|oxytocin|mesh-list
44489128|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
44489129|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44489130|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489131|NCT02494986|Rilpivirine|rilpivirine|mesh-list
44489132|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44489133|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44489134|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489135|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489136|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
44489137|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489138|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44489139|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44489140|NCT02488135|Hemostatics|hemostatics|mesh-list
44489141|NCT02488135|Coagulants|coagulants|mesh-ancestor
44489142|NCT02421939|Cytarabine|cytarabine|mesh-list
44489143|NCT02421939|Fludarabine|fludarabine|mesh-list
44489144|NCT02421939|Etoposide|etoposide|mesh-list
44489145|NCT02421939|Azacitidine|azacitidine|mesh-list
44489146|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
44489147|NCT02421939|Idarubicin|idarubicin|mesh-list
44489148|NCT02421939|Lenograstim|lenograstim|mesh-list
44489149|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489150|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489151|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
44489152|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489153|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489154|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
44489155|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489156|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489157|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44489158|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44489159|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489160|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
44489161|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489162|NCT02421939|Analgesics|analgesics|mesh-ancestor
44489163|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
44489164|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489165|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44489166|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489167|NCT02367040|Rituximab|rituximab|mesh-list
44489168|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489169|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489170|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
44489171|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489172|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489173|NCT02354014|Bedaquiline|bedaquiline|mesh-list
44489174|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
44489175|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
44489176|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489177|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489178|NCT02316106|Daratumumab|daratumumab|mesh-list
44489179|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44489180|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489181|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
44489182|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489183|NCT02312258|Ixazomib|ixazomib|mesh-list
44489184|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489185|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
44489186|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489187|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489188|NCT02307812|Paclitaxel|paclitaxel|mesh-list
44489189|NCT02307812|Ramucirumab|ramucirumab|mesh-list
44489190|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489191|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489192|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489193|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489194|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489195|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489197|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489198|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489199|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44489200|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489201|NCT02288377|Lanreotide|lanreotide|mesh-list
44489202|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489203|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
44489204|NCT02287311|Fludarabine|fludarabine|mesh-list
44489205|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489206|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
44489207|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489208|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489209|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489210|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
44489211|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489212|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489213|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489214|NCT02277444|Golimumab|golimumab|mesh-list
44489215|NCT02277444|Methotrexate|methotrexate|mesh-list
44489216|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44489217|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
44489218|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44489219|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489220|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489221|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
44489222|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489223|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489224|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
44489225|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489226|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44489227|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489228|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
44489229|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489230|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44489231|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44489232|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489233|NCT02252172|Dexamethasone|dexamethasone|mesh-list
44489234|NCT02252172|Lenalidomide|lenalidomide|mesh-list
44489235|NCT02252172|Daratumumab|daratumumab|mesh-list
44489236|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44489237|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489238|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
44489239|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
44489240|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489241|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489242|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489243|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
44489244|NCT02252172|Hormones|hormones|mesh-ancestor
44489245|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489246|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489247|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489248|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
44489249|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489250|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489251|NCT02252172|Growth Substances|growth substances|mesh-ancestor
44489252|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489253|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
44489254|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
44489255|NCT02220985|Thiotepa|thiotepa|mesh-list
44489256|NCT02220985|Methotrexate|methotrexate|mesh-list
44489257|NCT02220985|Fludarabine|fludarabine|mesh-list
44489258|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
44489259|NCT02220985|Tacrolimus|tacrolimus|mesh-list
44489260|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489261|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
44489262|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489263|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489264|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489265|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
43899678|NCT02308202|Doxazosin|doxazosin|mesh-list
43945980|NCT03705559|Narcotics|narcotics|mesh-ancestor
44489266|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489267|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489268|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489269|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44489271|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44489272|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489273|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
44308407|NCT00874744|Hormones|hormones|mesh-ancestor
44489274|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
44489275|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489276|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44489277|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44489278|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44489279|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489280|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44489281|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
44489282|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489283|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489284|NCT02197234|Osimertinib|osimertinib|mesh-list
44489285|NCT02197234|Simvastatin|simvastatin|mesh-list
44489286|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44489287|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44489288|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
44489289|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489290|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44489291|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44489292|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489293|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489294|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489295|NCT02195479|Dexamethasone|dexamethasone|mesh-list
44489296|NCT02195479|Prednisone|prednisone|mesh-list
44489297|NCT02195479|Melphalan|melphalan|mesh-list
44489298|NCT02195479|Bortezomib|bortezomib|mesh-list
44489299|NCT02195479|Daratumumab|daratumumab|mesh-list
44489300|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44489301|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489302|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
44489303|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
44489304|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489305|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489306|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489307|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
44489308|NCT02195479|Hormones|hormones|mesh-ancestor
44489309|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489310|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489311|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489312|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489313|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
44489314|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489315|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489316|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489317|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
44489318|NCT02163733|Osimertinib|osimertinib|mesh-list
44489319|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489320|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489321|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489322|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489323|NCT02157883|Itraconazole|itraconazole|mesh-list
44489324|NCT02157883|Osimertinib|osimertinib|mesh-list
44489325|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
44489326|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489327|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44489328|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44489329|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489330|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489331|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44489332|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489333|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489334|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489335|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44489336|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489337|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489338|NCT02136134|Dexamethasone|dexamethasone|mesh-list
44489339|NCT02136134|Bortezomib|bortezomib|mesh-list
44489340|NCT02136134|Daratumumab|daratumumab|mesh-list
44489341|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489342|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
44489343|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
44489344|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489345|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489346|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489347|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
44489348|NCT02136134|Hormones|hormones|mesh-ancestor
44489349|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489350|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489351|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489352|NCT02134301|Oritavancin|oritavancin|mesh-list
44489353|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489354|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489355|NCT02085148|Irinotecan|irinotecan|mesh-list
44489356|NCT02085148|Vincristine|vincristine|mesh-list
44489357|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44489358|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44489359|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489360|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489361|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489362|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489363|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489364|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489365|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489366|NCT02076009|Dexamethasone|dexamethasone|mesh-list
44489367|NCT02076009|Lenalidomide|lenalidomide|mesh-list
44489368|NCT02076009|Daratumumab|daratumumab|mesh-list
44489369|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489370|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
44489371|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
44489372|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489373|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489374|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489375|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
44489376|NCT02076009|Hormones|hormones|mesh-ancestor
44489377|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489378|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489379|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489380|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
44489381|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489382|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489383|NCT02076009|Growth Substances|growth substances|mesh-ancestor
44489384|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489385|NCT02067416|Paclitaxel|paclitaxel|mesh-list
44489386|NCT02067416|Docetaxel|docetaxel|mesh-list
44489387|NCT02067416|Epirubicin|epirubicin|mesh-list
44489389|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489390|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946077|NCT03295487|Estrogens|estrogens|mesh-list
44489391|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489392|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489393|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489394|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489395|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489396|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44489397|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44489398|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489399|NCT02065765|Ramucirumab|ramucirumab|mesh-list
44489400|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489401|NCT02008656|Leucovorin|leucovorin|mesh-list
44489402|NCT02008656|Fluorouracil|fluorouracil|mesh-list
44489403|NCT02008656|Capecitabine|capecitabine|mesh-list
44489404|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
44489405|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
44489406|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489407|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489408|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489409|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489410|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
44489411|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489412|NCT02008656|Antidotes|antidotes|mesh-ancestor
44489413|NCT02008656|Protective Agents|protective agents|mesh-ancestor
44489414|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
44489415|NCT02008656|Vitamins|vitamins|mesh-ancestor
44489416|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
44489417|NCT01998971|Acetaminophen|acetaminophen|mesh-list
44489418|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
44489419|NCT01998971|Promethazine|promethazine|mesh-list
44489420|NCT01998971|Thalidomide|thalidomide|mesh-list
44489421|NCT01998971|Dexamethasone|dexamethasone|mesh-list
44489422|NCT01998971|Prednisone|prednisone|mesh-list
44308530|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
44489423|NCT01998971|Lenalidomide|lenalidomide|mesh-list
44489424|NCT01998971|Melphalan|melphalan|mesh-list
44489425|NCT01998971|Bortezomib|bortezomib|mesh-list
44489426|NCT01998971|Daratumumab|daratumumab|mesh-list
44489427|NCT01998971|Pomalidomide|pomalidomide|mesh-list
44489428|NCT01998971|Montelukast|montelukast|mesh-list
44489429|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489430|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
44489431|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
44489432|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489433|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489434|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489435|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
44489437|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489438|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489439|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489440|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
44489441|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489442|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489443|NCT01998971|Growth Substances|growth substances|mesh-ancestor
44489444|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489445|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44489446|NCT01998971|Analgesics|analgesics|mesh-ancestor
44489447|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
44489448|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
44489449|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489450|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
44489451|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489452|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489453|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489454|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
44489455|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489456|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489457|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44489458|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
44489459|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44489460|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489461|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44489462|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44489463|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44489464|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44489465|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44489466|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
44489467|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
44489468|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44489469|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
44489470|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
44489471|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489472|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44489473|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
44489474|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
44489475|NCT01993719|Vidarabine|vidarabine|mesh-list
44489476|NCT01993719|Aldesleukin|aldesleukin|mesh-list
44489477|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
44489478|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
44489479|NCT01993719|Fludarabine|fludarabine|mesh-list
44489480|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
44489481|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489482|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
44489483|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489484|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489485|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489486|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
44489487|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489488|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489489|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489490|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489491|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489492|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
44489493|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
44489494|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489495|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44489496|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44489497|NCT01900574|Golimumab|golimumab|mesh-list
44489498|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44489499|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489500|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489501|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
44489502|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489503|NCT01892722|Interferons|interferons|mesh-list
44489504|NCT01892722|Interferon-beta|interferon-beta|mesh-list
44489505|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
44489506|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44489507|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489508|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
44489509|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489510|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
44489511|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489512|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44489513|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44489514|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489515|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489516|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44489517|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489518|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44489519|NCT01858740|Methotrexate|methotrexate|mesh-list
44489520|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
44489521|NCT01858740|Fludarabine|fludarabine|mesh-list
44489523|NCT01858740|Tacrolimus|tacrolimus|mesh-list
44489524|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44489525|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
44489526|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44489527|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489528|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489529|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
44489530|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489531|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489532|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
44489533|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489534|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44489535|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489536|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
44489537|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489538|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44489539|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44489540|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489541|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
44489542|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489543|NCT01847274|Niraparib|niraparib|mesh-list
44489544|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44489545|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489546|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489547|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489548|NCT01812252|Azacitidine|azacitidine|mesh-list
44489549|NCT01812252|Decitabine|decitabine|mesh-list
44489550|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489551|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
44489552|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489553|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489554|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489555|NCT01792687|Prednisone|prednisone|mesh-list
44489556|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
44489557|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489558|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
44489559|NCT01792687|Hormones|hormones|mesh-ancestor
44489560|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489561|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489562|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489563|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489564|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44489565|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489566|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489567|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489568|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44489570|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
44489571|NCT01787409|Vitamins|vitamins|mesh-ancestor
44489572|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
44489573|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489574|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44489575|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44489576|NCT01757535|Azacitidine|azacitidine|mesh-list
44308677|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
44489577|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44489578|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
44489579|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489580|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489581|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489582|NCT01625286|Paclitaxel|paclitaxel|mesh-list
44489583|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44489584|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489585|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489586|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489587|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489588|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489589|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489590|NCT01615029|Dexamethasone|dexamethasone|mesh-list
44489591|NCT01615029|Lenalidomide|lenalidomide|mesh-list
44489592|NCT01615029|Daratumumab|daratumumab|mesh-list
44489593|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44489594|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489595|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
44489596|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
44489597|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489598|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489599|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489600|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
44489601|NCT01615029|Hormones|hormones|mesh-ancestor
44489602|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489603|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489604|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141359|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
44489605|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
44489606|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489607|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489608|NCT01615029|Growth Substances|growth substances|mesh-ancestor
44489609|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489610|NCT01583322|Nintedanib|nintedanib|mesh-list
44489611|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489612|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489613|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489614|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489615|NCT01216683|Rituximab|rituximab|mesh-list
44489616|NCT01216683|Lenalidomide|lenalidomide|mesh-list
44489617|NCT01216683|Bortezomib|bortezomib|mesh-list
44489618|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44489619|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489620|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489621|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
44489622|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489623|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489624|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489625|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489626|NCT01216683|Growth Substances|growth substances|mesh-ancestor
44489627|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489628|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489629|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
44489630|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489631|NCT01176474|Nivolumab|nivolumab|mesh-list
44489632|NCT01176474|Ipilimumab|ipilimumab|mesh-list
44489633|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44489634|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
44489635|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489636|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489637|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489638|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44489639|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489640|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44489641|NCT01176461|Nivolumab|nivolumab|mesh-list
44489642|NCT01176461|Vaccines|vaccines|mesh-list
44489643|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44489644|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
44489645|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489646|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489647|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489648|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43946297|NCT01035658|Doxorubicin|doxorubicin|mesh-list
44489649|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489650|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44489651|NCT01076868|Primaquine|primaquine|mesh-list
44489652|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
44489653|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44489654|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44489655|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489656|NCT01065454|Riociguat|riociguat|mesh-list
44489657|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
44489658|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489659|NCT01064466|Etoposide|etoposide|mesh-list
44489660|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
44489661|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489662|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489663|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44489664|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44489665|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489666|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489667|NCT00980538|Etravirine|etravirine|mesh-list
44489668|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44489669|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44489670|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489671|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489672|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
44489673|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737548|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
44737549|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737550|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44737551|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44737552|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737553|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737554|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44737555|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44737556|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
44737557|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737558|NCT01950520|Analgesics|analgesics|mesh-ancestor
44737559|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
43946340|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737560|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44737561|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44737562|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
44737563|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44737564|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44737565|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44737566|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
44737567|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44737568|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44737569|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44737570|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44737571|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44737572|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44737573|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44737574|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44737575|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44737576|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44737577|NCT01950520|Urological Agents|urological agents|mesh-ancestor
44737578|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
44737579|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44737580|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
44737581|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
44737582|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44737583|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
44737584|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44737585|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44737586|NCT01861314|Bortezomib|bortezomib|mesh-list
44737587|NCT01861314|Sorafenib|sorafenib|mesh-list
44737588|NCT01861314|Decitabine|decitabine|mesh-list
44737589|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737590|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43900115|NCT00036738|Fludarabine|fludarabine|mesh-list
44737591|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737592|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737593|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737594|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
44737595|NCT01746173|Gemcitabine|gemcitabine|mesh-list
44737596|NCT01746173|Plerixafor|plerixafor|mesh-list
44737597|NCT01746173|Prednisone|prednisone|mesh-list
44737598|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
44737599|NCT01746173|Melphalan|melphalan|mesh-list
44737600|NCT01746173|Busulfan|busulfan|mesh-list
44737601|NCT01746173|Doxorubicin|doxorubicin|mesh-list
44489674|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
44489675|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
44489676|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44489677|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44489678|NCT00882895|Prednisolone|prednisolone|mesh-list
44489679|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
44489680|NCT00882895|Tacrolimus|tacrolimus|mesh-list
44489681|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
44489682|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44489683|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44489684|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
44489685|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489686|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
44489687|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489688|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44489689|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489690|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489691|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489692|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489693|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44489694|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
44489695|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44489696|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489697|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489698|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
44489699|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
44489700|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489701|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489702|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
44489703|NCT00882895|Hormones|hormones|mesh-ancestor
44489704|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489705|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44489706|NCT00882895|Protective Agents|protective agents|mesh-ancestor
44489707|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489708|NCT00861705|Paclitaxel|paclitaxel|mesh-list
44489709|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
44489710|NCT00861705|Bevacizumab|bevacizumab|mesh-list
44489711|NCT00861705|Carboplatin|carboplatin|mesh-list
44489712|NCT00861705|Doxorubicin|doxorubicin|mesh-list
44489713|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44489714|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44489715|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44489716|NCT00861705|Antibodies|antibodies|mesh-list
44489717|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
44489718|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44489719|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
44489720|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
44489721|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44489722|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489723|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489724|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489725|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489726|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489727|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489728|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
44489729|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489730|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489731|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489732|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
44489733|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44489734|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44489735|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44489736|NCT00861705|Growth Substances|growth substances|mesh-ancestor
44489737|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
44489738|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44489739|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44489741|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489742|NCT00719966|Letrozole|letrozole|mesh-list
44489743|NCT00719966|Anastrozole|anastrozole|mesh-list
44489744|NCT00719966|Exemestane|exemestane|mesh-list
44489745|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489746|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44489747|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44489748|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489749|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489750|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44489751|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489752|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946457|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
44489753|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489754|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489755|NCT00694850|Riociguat|riociguat|mesh-list
44489756|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
44489757|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489758|NCT00676715|Interferons|interferons|mesh-list
44489759|NCT00676715|Interferon-beta|interferon-beta|mesh-list
44489760|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
44489761|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489762|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
44489763|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489764|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
44489765|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489766|NCT00667121|Tamoxifen|tamoxifen|mesh-list
44489767|NCT00667121|Gabapentin|gabapentin|mesh-list
44489768|NCT00667121|Dexetimide|dexetimide|mesh-list
44489769|NCT00667121|Citalopram|citalopram|mesh-list
44489770|NCT00667121|Sertraline|sertraline|mesh-list
44489771|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44489772|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489773|NCT00667121|Analgesics|analgesics|mesh-ancestor
44489774|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
44489775|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489776|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489777|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
44489778|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44489779|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44489780|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44489781|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44489782|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44489783|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44489784|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489785|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
44489786|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44489787|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44489788|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44489789|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
44489790|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44489791|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
44489792|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44489793|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44489794|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
44489795|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
44489796|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44489797|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44489798|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
44489799|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44489800|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489801|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489802|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489803|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489804|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44489805|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44489806|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44489807|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44489808|NCT00512317|Ganaxolone|ganaxolone|mesh-list
44489809|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
44489810|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489811|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489812|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489820|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44489821|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
44489822|NCT00114517|Hormones|hormones|mesh-list
44489823|NCT00114517|Estradiol|estradiol|mesh-list
44489824|NCT00114517|Estrogens|estrogens|mesh-list
44489825|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489826|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489827|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44489828|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44489829|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44489830|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44489831|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489832|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489833|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489834|NCT00071708|Analgesics|analgesics|mesh-ancestor
44489835|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
44489836|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489837|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
44489838|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44489839|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
44489840|NCT00055731|Aspirin|aspirin|mesh-list
44489841|NCT00055731|Docetaxel|docetaxel|mesh-list
44489842|NCT00055731|Goserelin|goserelin|mesh-list
44489843|NCT00055731|Bicalutamide|bicalutamide|mesh-list
44489844|NCT00055731|Estramustine|estramustine|mesh-list
44489845|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489846|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
44489847|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
44489848|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
44489849|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489850|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44489851|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44489852|NCT00055731|Analgesics|analgesics|mesh-ancestor
44489853|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
44489854|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489855|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489856|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489857|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489858|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44489859|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44489860|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44489861|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44489862|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489863|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
44489864|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489865|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
44489866|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489867|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489868|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489869|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
44489870|NCT00002644|Tamoxifen|tamoxifen|mesh-list
44489871|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44489872|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
44489873|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489874|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489875|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489876|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489877|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44489878|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44489879|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44489880|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
44489881|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44489882|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489883|NCT03086343|Abatacept|abatacept|mesh-list
44489884|NCT03086343|Upadacitinib|upadacitinib|mesh-list
44489885|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44489886|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489887|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489888|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44489889|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
44489890|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489891|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489892|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44489893|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44489894|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489896|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
44489897|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44489898|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44737602|NCT01746173|Etoposide|etoposide|mesh-list
44489899|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44489900|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489901|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44489902|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44489903|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44489904|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44489905|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
44489906|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
44489907|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
44489908|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
44489909|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489910|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489911|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44489912|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44489913|NCT03085563|Analgesics|analgesics|mesh-ancestor
44489914|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
44489915|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489916|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44489917|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44489918|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
44489919|NCT03087162|Lansoprazole|lansoprazole|mesh-list
44489920|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44489921|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489922|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44489923|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489924|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489925|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
44489926|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
44489927|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44489928|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44489929|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489930|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489931|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489932|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489933|NCT03085628|Oxytocin|oxytocin|mesh-list
44489934|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
44489935|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44489936|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489937|NCT03083821|Entecavir|entecavir|mesh-list
44489938|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
44489939|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44489940|NCT03082846|Temozolomide|temozolomide|mesh-list
44489941|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44489942|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
44489943|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489944|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489945|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
43946627|NCT01047241|Sufentanil|sufentanil|mesh-list
44489946|NCT03081416|Dexamethasone|dexamethasone|mesh-list
44489947|NCT03081416|Ketorolac|ketorolac|mesh-list
44489948|NCT03081416|Ketamine|ketamine|mesh-list
44489949|NCT03081416|Metoclopramide|metoclopramide|mesh-list
44489950|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44489951|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
44489952|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
44489953|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489954|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489955|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44489956|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
44489957|NCT03081416|Hormones|hormones|mesh-ancestor
44489958|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44489959|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44489960|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44489961|NCT03081416|Analgesics|analgesics|mesh-ancestor
44489962|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
43900443|NCT00046228|Reteplase|reteplase|mesh-list
44489964|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44489965|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
44489966|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
44489967|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44489968|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44489969|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44489970|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489971|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489972|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44489973|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44489974|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44489975|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44489976|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44489977|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44489978|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44489979|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
44489980|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44489981|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44489982|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44489983|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44489984|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
44489985|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
44489986|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44489988|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
44489989|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
44489990|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44489991|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44489992|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44489993|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44489994|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44489995|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44489996|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
44489997|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44489998|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44489999|NCT03080545|Calcitriol|calcitriol|mesh-list
44490000|NCT03080545|Betamethasone|betamethasone|mesh-list
44490001|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44490002|NCT03080545|Calcipotriene|calcipotriene|mesh-list
44490003|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490004|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
44490005|NCT03080545|Hormones|hormones|mesh-ancestor
44490006|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490007|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490008|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44490009|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490010|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44490011|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44490012|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44490013|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490014|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44490015|NCT03080545|Vitamins|vitamins|mesh-ancestor
44490016|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
44490017|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44490018|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
44490019|NCT05243628|Insulin|insulin|mesh-list
44490020|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44490021|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44490022|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490023|NCT05249478|Fentanyl|fentanyl|mesh-list
44490024|NCT05249478|Bupivacaine|bupivacaine|mesh-list
44490025|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490026|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
44490027|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490028|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490029|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
44490030|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490031|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490032|NCT05249478|Narcotics|narcotics|mesh-ancestor
44490033|NCT05249478|Analgesics|analgesics|mesh-ancestor
44490034|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44490035|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44490036|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
44490037|NCT05247619|Paclitaxel|paclitaxel|mesh-list
44490039|NCT05247619|Cisplatin|cisplatin|mesh-list
44490040|NCT05247619|Carboplatin|carboplatin|mesh-list
44490041|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490042|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490043|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490044|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490045|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490046|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490047|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490048|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490049|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490050|NCT05247619|Growth Substances|growth substances|mesh-ancestor
44490051|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490052|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490053|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
44490054|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
44490055|NCT05249751|Coagulants|coagulants|mesh-ancestor
44490056|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44490057|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44490058|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
44490059|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490060|NCT05244252|Bupivacaine|bupivacaine|mesh-list
44490061|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490062|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
44490063|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490064|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490065|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
44490066|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490067|NCT05243251|Olanzapine|olanzapine|mesh-list
44490068|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
44490069|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
44490070|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490071|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490072|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490073|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44490074|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44490075|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490076|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44490077|NCT05243251|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44490078|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44490079|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44490080|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490081|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490082|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
44737603|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
44737604|NCT01746173|Vincristine|vincristine|mesh-list
44737605|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737606|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
44737607|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737608|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737609|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737610|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
44737611|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737612|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737613|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737614|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737615|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
44737616|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
44737617|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737618|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737619|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44737620|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44737621|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44737622|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44737623|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
44737624|NCT01746173|Hormones|hormones|mesh-ancestor
44737625|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737626|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44737627|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737628|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737629|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737630|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737631|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44737632|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44737633|NCT01694004|Benzocaine|benzocaine|mesh-list
44737634|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
44737635|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
44737636|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44737637|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737638|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
44737639|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44737640|NCT01545843|Fluoxetine|fluoxetine|mesh-list
44737641|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44737642|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44737643|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44737644|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309191|NCT00879892|Xenon|xenon|mesh-list
44490083|NCT05242705|Cystatins|cystatins|mesh-list
44490084|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44490085|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
44490086|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490087|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490088|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44141390|NCT00182715|Leucovorin|leucovorin|mesh-list
44490089|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44490090|NCT05244018|Vitamin D|vitamin d|mesh-list
44490091|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
44490092|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
44490093|NCT05244018|Vitamins|vitamins|mesh-list
44490094|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
44490095|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490096|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44490097|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44490098|NCT05249920|Edaravone|edaravone|mesh-list
44490099|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44490100|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
44490101|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490102|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44490103|NCT05249920|Protective Agents|protective agents|mesh-ancestor
44490104|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490105|NCT05245669|Denosumab|denosumab|mesh-list
44490106|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44490107|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490108|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
44490109|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
44490110|NCT05243147|Coagulants|coagulants|mesh-ancestor
44490111|NCT05248633|Dexamethasone|dexamethasone|mesh-list
44490112|NCT05248633|Lenalidomide|lenalidomide|mesh-list
44490113|NCT05248633|Bortezomib|bortezomib|mesh-list
44490114|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490115|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
44490116|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
44490117|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490118|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490119|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490120|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
44490121|NCT05248633|Hormones|hormones|mesh-ancestor
44490122|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490123|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490124|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490125|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
44490126|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490127|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490128|NCT05248633|Growth Substances|growth substances|mesh-ancestor
44490129|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490130|NCT05244109|Antibodies|antibodies|mesh-list
44490131|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
44490132|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
44490133|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490134|NCT05248932|Norepinephrine|norepinephrine|mesh-list
44490135|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44490136|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44490137|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
44490138|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490139|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490140|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490141|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
44490142|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
44490143|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490144|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44490145|NCT05246865|Androgens|androgens|mesh-list
44490146|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44490147|NCT05246865|Hormones|hormones|mesh-ancestor
44490148|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490149|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490150|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44490151|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
44490152|NCT05245708|Oxytocin|oxytocin|mesh-list
44490153|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
44490154|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490155|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490156|NCT05244525|Epinephrine|epinephrine|mesh-list
44490157|NCT05244525|Bupivacaine|bupivacaine|mesh-list
44490158|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490159|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
44490160|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490161|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490162|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
44490163|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490164|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44490166|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
44490167|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490168|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490169|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44490170|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44490171|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
44490172|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44490173|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490174|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
44490175|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
44490176|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44490177|NCT05245760|Paclitaxel|paclitaxel|mesh-list
44490178|NCT05245760|Carboplatin|carboplatin|mesh-list
44490179|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490180|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490181|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490182|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490183|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490184|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490185|NCT05249725|Irsogladine|irsogladine|mesh-list
44490186|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
44490187|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490188|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44490189|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490190|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490191|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44490192|NCT05249725|Protective Agents|protective agents|mesh-ancestor
44490193|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490194|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44490195|NCT05249725|Antacids|antacids|mesh-ancestor
44490196|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
44490197|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490198|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490199|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44490200|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44490201|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490202|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490203|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490204|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44490205|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490206|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44490207|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490208|NCT05241249|Gemcitabine|gemcitabine|mesh-list
44490209|NCT05241249|Paclitaxel|paclitaxel|mesh-list
44490210|NCT05241249|Bethanechol|bethanechol|mesh-list
44490211|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490212|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490213|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490214|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490215|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
43946898|NCT01054625|Zalutumumab|zalutumumab|mesh-list
44490216|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490217|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44490218|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
44490219|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
44490220|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490221|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490222|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490223|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
44490224|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490225|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44490226|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
44490227|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490228|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44490229|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44490230|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
44490231|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490232|NCT05241132|Paclitaxel|paclitaxel|mesh-list
44490233|NCT05241132|Cisplatin|cisplatin|mesh-list
44309348|NCT00880815|Rituximab|rituximab|mesh-list
44490234|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490235|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490236|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490237|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490238|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490239|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490240|NCT05241093|Cytarabine|cytarabine|mesh-list
44490241|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44490242|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
44490243|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490244|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490245|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
44490246|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490247|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490248|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
44490249|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490250|NCT05241054|Acetaminophen|acetaminophen|mesh-list
44490251|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
44490252|NCT05241054|Fentanyl|fentanyl|mesh-list
44490253|NCT05241054|Bupivacaine|bupivacaine|mesh-list
44490254|NCT05241054|Propofol|propofol|mesh-list
44490255|NCT05241054|Sevoflurane|sevoflurane|mesh-list
44490256|NCT05241054|Atracurium|atracurium|mesh-list
44490257|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490258|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
44490259|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490260|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946937|NCT01055184|Vaccines|vaccines|mesh-list
44490261|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
44490262|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490263|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44490264|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44490265|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
44490266|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490267|NCT05241054|Narcotics|narcotics|mesh-ancestor
44490268|NCT05241054|Analgesics|analgesics|mesh-ancestor
44490269|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44490270|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490271|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
44490272|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44490273|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44490274|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
44490275|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44490276|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44490277|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44490278|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44490279|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44490280|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
44490281|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490282|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490283|NCT05241028|Ensartinib|ensartinib|mesh-list
44490284|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490285|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490286|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490287|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490288|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
44490289|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44490290|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
44490291|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
44490292|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
44490293|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44490294|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
44490295|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490296|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490297|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490298|NCT05240456|Urological Agents|urological agents|mesh-ancestor
44490299|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44737645|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44737646|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
44737647|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737648|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44737649|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
44737650|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44737651|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44737652|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44737653|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490300|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44490301|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
44490302|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44490303|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44490304|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44490305|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490306|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490307|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44490308|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490310|NCT05245786|Antibodies|antibodies|mesh-list
44490311|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44490312|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
44490313|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490314|NCT05245786|Trace Elements|trace elements|mesh-ancestor
44490315|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
43947018|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
44490316|NCT05241496|Lidocaine|lidocaine|mesh-list
44490317|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490318|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
44490319|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490320|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490321|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
44490322|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490323|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44490324|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44490325|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44490326|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44490327|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490328|NCT05249569|Avelumab|avelumab|mesh-list
44490329|NCT05249569|Bavituximab|bavituximab|mesh-list
44490330|NCT05249569|Axitinib|axitinib|mesh-list
44490331|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490332|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490333|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490334|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490335|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490336|NCT05244954|Chloroquine|chloroquine|mesh-list
44490337|NCT05244954|Piperaquine|piperaquine|mesh-list
44490338|NCT05244954|Artenimol|artenimol|mesh-list
44490339|NCT05244954|Amebicides|amebicides|mesh-ancestor
44490340|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44490341|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44490342|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490343|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
44490344|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490345|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
44490346|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44490347|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
44490348|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490349|NCT05241262|Expectorants|expectorants|mesh-ancestor
44490350|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490351|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44490352|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
44490353|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490354|NCT05241262|Protective Agents|protective agents|mesh-ancestor
44490355|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490356|NCT05241262|Antidotes|antidotes|mesh-ancestor
44490357|NCT05246293|Tofacitinib|tofacitinib|mesh-list
44490358|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490359|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490360|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490361|NCT05242081|Sufentanil|sufentanil|mesh-list
44490362|NCT05242081|Ketamine|ketamine|mesh-list
44490363|NCT05242081|Esketamine|esketamine|mesh-list
44490364|NCT05242081|Analgesics|analgesics|mesh-ancestor
44490365|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
44490366|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490367|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490368|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44490369|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44490370|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
44490371|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
44490372|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490373|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44490374|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44490375|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490376|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490388|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44490389|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
44490390|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
44490391|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490392|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44490393|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44490394|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490395|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490396|NCT05240274|Metformin|metformin|mesh-list
44490397|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44490398|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490399|NCT02397226|Anesthetics|anesthetics|mesh-list
44490400|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490401|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490402|NCT02398825|Ponatinib|ponatinib|mesh-list
44490403|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490404|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490405|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490406|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490407|NCT02393625|Nivolumab|nivolumab|mesh-list
44490408|NCT02393625|Ceritinib|ceritinib|mesh-list
44490409|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490410|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490411|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44490412|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490413|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490414|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490415|NCT02393183|Selenium|selenium|mesh-list
44490416|NCT02393183|Antioxidants|antioxidants|mesh-list
44490417|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490418|NCT02393183|Protective Agents|protective agents|mesh-ancestor
44490419|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490420|NCT02393183|Trace Elements|trace elements|mesh-ancestor
44490421|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
44490422|NCT02397083|Everolimus|everolimus|mesh-list
44490423|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
44490424|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490425|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490426|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
44490427|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490428|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44490429|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
44490430|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490431|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44490432|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44490433|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44490445|NCT02399943|Panitumumab|panitumumab|mesh-list
44490446|NCT02399943|Trametinib|trametinib|mesh-list
44490447|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490448|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490449|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490450|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490451|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490461|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490462|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490463|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490464|NCT02393937|Metronidazole|metronidazole|mesh-list
44490465|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490466|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490467|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44490468|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44490469|NCT02392026|Metronidazole|metronidazole|mesh-list
44490470|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490471|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490472|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44490473|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44490475|NCT02391571|Oxycodone|oxycodone|mesh-list
44490476|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490477|NCT02391571|Narcotics|narcotics|mesh-ancestor
44490478|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490479|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490480|NCT02391571|Analgesics|analgesics|mesh-ancestor
44490481|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
44490482|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490483|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44490484|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44490485|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
44490486|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
44490487|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44490488|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44490489|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490490|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490491|NCT02390960|Urological Agents|urological agents|mesh-ancestor
44490492|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44490493|NCT02395614|Gentamicins|gentamicins|mesh-list
44490494|NCT02395614|Cefazolin|cefazolin|mesh-list
44490495|NCT02395614|Bacitracin|bacitracin|mesh-list
44490496|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
44490497|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490498|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44490499|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
44490500|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44490501|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490502|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490503|NCT02392637|Gemcitabine|gemcitabine|mesh-list
44490504|NCT02392637|Paclitaxel|paclitaxel|mesh-list
44490505|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44490506|NCT02392637|Cisplatin|cisplatin|mesh-list
44490507|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490508|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490509|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490510|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490511|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490512|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490513|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44490514|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
44490515|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
44490516|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490517|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490518|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490519|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
44490520|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490521|NCT00632853|Cisplatin|cisplatin|mesh-list
44490522|NCT00632853|Carboplatin|carboplatin|mesh-list
44490523|NCT00632853|Etoposide|etoposide|mesh-list
44490524|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490525|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490526|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44490527|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44490528|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490529|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490530|NCT00637832|Prednisolone|prednisolone|mesh-list
44490532|NCT00637832|Rituximab|rituximab|mesh-list
44490533|NCT00637832|Doxorubicin|doxorubicin|mesh-list
44490534|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44490535|NCT00637832|Vincristine|vincristine|mesh-list
44490536|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490537|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
44490538|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490539|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490540|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490541|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
44490542|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490543|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490544|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44490545|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490546|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44490547|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44490548|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44490549|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490550|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490551|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490552|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490553|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490554|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490555|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
44490556|NCT00637832|Hormones|hormones|mesh-ancestor
44490557|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490558|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490559|NCT00639769|Cisplatin|cisplatin|mesh-list
44490560|NCT00639769|Irinotecan|irinotecan|mesh-list
44490561|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490562|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44490563|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44490564|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490565|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490566|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44490567|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
44490568|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490569|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44490570|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
44490571|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490572|NCT00639457|Pioglitazone|pioglitazone|mesh-list
44490573|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44490574|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490575|NCT00639223|Pravastatin|pravastatin|mesh-list
44490576|NCT00639223|Red yeast rice|red yeast rice|mesh-list
44490577|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44490578|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44490579|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
44490580|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490581|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44490582|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44490583|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490584|NCT00639002|Dexamethasone|dexamethasone|mesh-list
44490585|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490586|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
44490587|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
44490588|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490589|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490590|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490591|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
44490592|NCT00639002|Hormones|hormones|mesh-ancestor
44490593|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490594|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490595|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490596|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44490597|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
44490598|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490599|NCT00638963|Temozolomide|temozolomide|mesh-list
44490600|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490601|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
44490602|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490603|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737654|NCT01319565|Aldesleukin|aldesleukin|mesh-list
44490605|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44490606|NCT00638508|Ropivacaine|ropivacaine|mesh-list
44490607|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
44490608|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
44490609|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490610|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490611|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
44490612|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490613|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44490614|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490615|NCT00638508|Analgesics|analgesics|mesh-ancestor
44490616|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490617|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490618|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44490619|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490620|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490621|NCT00638456|Budesonide|budesonide|mesh-list
44490623|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
44490624|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490625|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44490626|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
43947279|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490627|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490628|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490629|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44490630|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490631|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
44490632|NCT00638456|Hormones|hormones|mesh-ancestor
44490633|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490634|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44490635|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490636|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44490637|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490638|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490639|NCT00638157|Gentamicins|gentamicins|mesh-list
44490640|NCT00638157|Daptomycin|daptomycin|mesh-list
44490641|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490642|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490643|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44490644|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490645|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490646|NCT00638027|Memantine|memantine|mesh-list
44490647|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44490648|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44490649|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
44490650|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490651|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490652|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490653|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44490654|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44490655|NCT00637806|Megestrol|megestrol|mesh-list
44490656|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
44490657|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44490658|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44490659|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44490660|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
44490661|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490662|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490663|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44490664|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44490665|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490666|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490667|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
44490668|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44490669|NCT00637728|Megestrol|megestrol|mesh-list
44490670|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
44490671|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44490672|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44490673|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44490674|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
44490675|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490676|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490677|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44490678|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44490679|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490680|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490681|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
44490682|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44490683|NCT00637572|Megestrol|megestrol|mesh-list
44490684|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
43947322|NCT01069354|Lidocaine|lidocaine|mesh-list
44490685|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44490686|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44490687|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44490688|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
44490689|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490690|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490691|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44490692|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44490693|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490694|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490696|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44490697|NCT00637416|Lansoprazole|lansoprazole|mesh-list
44490698|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
44490699|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44490700|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44490701|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44490702|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490703|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490704|NCT00637377|Ranibizumab|ranibizumab|mesh-list
44490705|NCT00637377|Aflibercept|aflibercept|mesh-list
44490706|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490707|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490708|NCT00637377|Growth Substances|growth substances|mesh-ancestor
44490709|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490710|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490711|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490712|NCT00637273|Pioglitazone|pioglitazone|mesh-list
44490713|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44490714|NCT00637273|Exenatide|exenatide|mesh-list
44490715|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44490716|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490717|NCT00637273|Incretins|incretins|mesh-ancestor
44490718|NCT00637273|Hormones|hormones|mesh-ancestor
44490719|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490720|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44490721|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
44490722|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490723|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490724|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44490725|NCT00637195|Vaccines|vaccines|mesh-list
44490726|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
44490727|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490728|NCT00637000|Buprenorphine|buprenorphine|mesh-list
44490729|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44490730|NCT00637000|Naloxone|naloxone|mesh-list
43947340|NCT01069510|Diuretics|diuretics|mesh-ancestor
44490731|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490732|NCT00637000|Narcotics|narcotics|mesh-ancestor
44490733|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490734|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490735|NCT00637000|Analgesics|analgesics|mesh-ancestor
44490736|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
44490737|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490738|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44490739|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44490740|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44490741|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44490742|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44490743|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490744|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
44490745|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490746|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490747|NCT00636792|Rituximab|rituximab|mesh-list
44490748|NCT00636792|Bortezomib|bortezomib|mesh-list
44490749|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44309857|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
44490750|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490751|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490752|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
44490753|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490754|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490755|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490756|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
44490757|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490759|NCT00636636|Analgesics|analgesics|mesh-ancestor
44490760|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
44490761|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490762|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490763|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
44490764|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44490765|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44490766|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490767|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44490768|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44490769|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44490770|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490771|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490772|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
44490773|NCT00636610|Bevacizumab|bevacizumab|mesh-list
44490774|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490775|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490776|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490777|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490778|NCT00636610|Growth Substances|growth substances|mesh-ancestor
44490779|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490780|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490781|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
44490782|NCT00636441|Docetaxel|docetaxel|mesh-list
44490783|NCT00636441|Doxorubicin|doxorubicin|mesh-list
44490784|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44490785|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490786|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
44490787|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490788|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490789|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490790|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
44490791|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490792|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490793|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44490794|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490795|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490796|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490797|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43947421|NCT01074463|Pramipexole|pramipexole|mesh-list
44490798|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44490799|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44490800|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490801|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44490802|NCT00636207|Montelukast|montelukast|mesh-list
44490803|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44490804|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490805|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44490806|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
44490807|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490808|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490809|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44490810|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44490811|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490812|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44490813|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
44490814|NCT00636155|Rituximab|rituximab|mesh-list
44490815|NCT00636155|Fludarabine|fludarabine|mesh-list
44490816|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490817|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
44490818|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490819|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490820|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490821|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
44490822|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490823|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490824|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44490825|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490826|NCT00635648|Caspofungin|caspofungin|mesh-list
44490827|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
44490828|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490829|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490830|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490831|NCT00635349|Acetaminophen|acetaminophen|mesh-list
44490832|NCT00635349|Meloxicam|meloxicam|mesh-list
44490833|NCT00635349|Aceclofenac|aceclofenac|mesh-list
44490834|NCT00635349|Tramadol|tramadol|mesh-list
44490835|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490836|NCT00635349|Analgesics|analgesics|mesh-ancestor
44490837|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
44490838|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490839|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490840|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
44490841|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490842|NCT00635349|Narcotics|narcotics|mesh-ancestor
44490843|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490844|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44490845|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44490846|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490847|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44490848|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44490849|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490850|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490851|NCT00635102|Cycloserine|cycloserine|mesh-list
44490852|NCT00635102|Glycine|glycine|mesh-list
44490853|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44490854|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490855|NCT00635102|Renal Agents|renal agents|mesh-ancestor
44490856|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44490857|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
44490858|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490859|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
44490860|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490861|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
44490862|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490863|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490864|NCT00635089|Reslizumab|reslizumab|mesh-list
44490865|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44490866|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44490867|NCT00635050|Paclitaxel|paclitaxel|mesh-list
44490868|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
44490869|NCT00635050|Bevacizumab|bevacizumab|mesh-list
44490870|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44490871|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490872|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44490873|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44490874|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44490875|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490876|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490877|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
44490878|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490879|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490880|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490881|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
44490882|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44490883|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44490884|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44490885|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44490886|NCT00635050|Growth Substances|growth substances|mesh-ancestor
44490887|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
44490888|NCT00635024|Melphalan|melphalan|mesh-list
44490889|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44490890|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44490891|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
44490892|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490893|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490894|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44490895|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490896|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
44490897|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490898|NCT00634920|Cyclosporine|cyclosporine|mesh-list
44310004|NCT00883883|Cefdinir|cefdinir|mesh-list
44490899|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
44490900|NCT00634920|Prednisolone|prednisolone|mesh-list
44490901|NCT00634920|Everolimus|everolimus|mesh-list
44490902|NCT00634920|Cyclosporins|cyclosporins|mesh-list
44490903|NCT00634920|Basiliximab|basiliximab|mesh-list
44490904|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490905|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490906|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490907|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
44490908|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490909|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
44490910|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44490911|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44490912|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490913|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44490914|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490915|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44490916|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44490917|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
44490918|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44490920|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
44490921|NCT00634920|Hormones|hormones|mesh-ancestor
44490922|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44490923|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44490924|NCT00634907|Warfarin|warfarin|mesh-list
44490925|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
44490926|NCT00634842|Insulin|insulin|mesh-list
44490927|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44490928|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
44490929|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43947592|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
44490930|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490931|NCT00634803|Buprenorphine|buprenorphine|mesh-list
44490932|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490933|NCT00634803|Narcotics|narcotics|mesh-ancestor
44490934|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490935|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490936|NCT00634803|Analgesics|analgesics|mesh-ancestor
44490937|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
44490938|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490939|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44490940|NCT00634751|Capecitabine|capecitabine|mesh-list
44490941|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
44490942|NCT00634751|Sorafenib|sorafenib|mesh-list
44490943|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44490944|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
44490945|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490946|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490947|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44490948|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490949|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
44490950|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44490951|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44490952|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
44490953|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490954|NCT00634543|Acetaminophen|acetaminophen|mesh-list
44490955|NCT00634543|Gabapentin|gabapentin|mesh-list
44490956|NCT00634543|Tramadol|tramadol|mesh-list
44490957|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44490958|NCT00634543|Analgesics|analgesics|mesh-ancestor
44490959|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
44490960|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44490961|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490962|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
44490963|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
44490964|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44490965|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44490966|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44490967|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44490968|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44490969|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44490970|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44490971|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490972|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
44490973|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44490974|NCT00634543|Narcotics|narcotics|mesh-ancestor
44490975|NCT00634504|Leucovorin|leucovorin|mesh-list
44490976|NCT00634504|Methotrexate|methotrexate|mesh-list
44490977|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
44737655|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
44490978|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44490979|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
44490980|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44490981|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44490982|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44490983|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
44490984|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44490985|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44490986|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44490987|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44490988|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44490989|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44490990|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
44490991|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44490992|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44490993|NCT00634504|Antidotes|antidotes|mesh-ancestor
44490994|NCT00634504|Protective Agents|protective agents|mesh-ancestor
44490995|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
44490996|NCT00634504|Vitamins|vitamins|mesh-ancestor
44490997|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
44490998|NCT00634244|Cytarabine|cytarabine|mesh-list
44490999|NCT00634244|Sirolimus|sirolimus|mesh-list
44491000|NCT00634244|Carboplatin|carboplatin|mesh-list
44491001|NCT00634244|Etoposide|etoposide|mesh-list
44491002|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
44491003|NCT00634244|Topotecan|topotecan|mesh-list
43947645|NCT01081041|Cisplatin|cisplatin|mesh-list
44491004|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
44491005|NCT00634244|Alvocidib|alvocidib|mesh-list
44491006|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491007|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44491008|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491009|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491010|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491011|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491012|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491013|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
44491014|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
44491015|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491016|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491017|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
44491018|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491019|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491020|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491021|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
44491022|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44491023|NCT00634244|Analgesics|analgesics|mesh-ancestor
44491024|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
44491025|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491026|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491027|NCT00634244|Growth Substances|growth substances|mesh-ancestor
44491028|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44491029|NCT00634179|Prednisone|prednisone|mesh-list
44491030|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
44491031|NCT00634179|Rituximab|rituximab|mesh-list
44491032|NCT00634179|Doxorubicin|doxorubicin|mesh-list
44491033|NCT00634179|Vincristine|vincristine|mesh-list
44491034|NCT00634179|Bortezomib|bortezomib|mesh-list
44491035|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491036|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
44491037|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491038|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491039|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44491040|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
44491041|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491042|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491043|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44491044|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491045|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491046|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491047|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491048|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491049|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491050|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
44491051|NCT00634179|Hormones|hormones|mesh-ancestor
44491052|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491053|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44491054|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44491055|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491056|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491057|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491058|NCT00634114|Esomeprazole|esomeprazole|mesh-list
44491060|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44491061|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491062|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44491063|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491064|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491065|NCT00634088|Capecitabine|capecitabine|mesh-list
44491066|NCT00634088|Lapatinib|lapatinib|mesh-list
44491067|NCT00634088|Epothilones|epothilones|mesh-list
44491068|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491069|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
44491070|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947705|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
44491071|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491072|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44491073|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491074|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491075|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491076|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491077|NCT00634049|Isavuconazole|isavuconazole|mesh-list
44491078|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
44491079|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491080|NCT00634036|Pioglitazone|pioglitazone|mesh-list
44491081|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491082|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491083|NCT00634010|Morphine|morphine|mesh-list
44491084|NCT00634010|Methadone|methadone|mesh-list
44491085|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44491086|NCT00634010|Narcotics|narcotics|mesh-ancestor
44491087|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491088|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491089|NCT00634010|Analgesics|analgesics|mesh-ancestor
44491090|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
44491091|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491092|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
44491093|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491094|NCT00633984|Cycloserine|cycloserine|mesh-list
44491095|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44491096|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491097|NCT00633984|Renal Agents|renal agents|mesh-ancestor
44491098|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44491099|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
44491100|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491101|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
44491102|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491103|NCT00633945|Lenalidomide|lenalidomide|mesh-list
44491104|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
44491105|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491106|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491107|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44491108|NCT00633945|Growth Substances|growth substances|mesh-ancestor
44491109|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491110|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491111|NCT00633932|Esomeprazole|esomeprazole|mesh-list
44491112|NCT00633932|Omeprazole|omeprazole|mesh-list
44491113|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44491114|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491115|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44491116|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491117|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491118|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44491119|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491120|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44491121|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947726|NCT01084148|V0034CR|v0034cr|mesh-list
44491122|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491123|NCT00633464|Cetuximab|cetuximab|mesh-list
44491124|NCT00633464|Epothilones|epothilones|mesh-list
44491125|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491126|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491127|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491128|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
44310222|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
44491129|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491130|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491132|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44491133|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44491134|NCT00633360|Estradiol|estradiol|mesh-list
44491135|NCT00633360|Estrogens|estrogens|mesh-ancestor
44491136|NCT00633360|Hormones|hormones|mesh-ancestor
44491137|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491138|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491139|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44491140|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
44491141|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491142|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44491143|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44491144|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44491145|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44491146|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44491147|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44491148|NCT00633360|Diuretics|diuretics|mesh-ancestor
44491149|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
44491150|NCT00633217|Fluticasone|fluticasone|mesh-list
44491151|NCT00633217|Xhance|xhance|mesh-list
44491152|NCT00633217|Norflurane|norflurane|mesh-list
44491153|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44491154|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44491155|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491156|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44491157|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
44491158|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491159|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491160|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44491161|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491162|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
44491163|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44491164|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44491165|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44491166|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491167|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491168|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491169|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491170|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
44491171|NCT00633217|Hormones|hormones|mesh-ancestor
44491172|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491173|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
44491174|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
44491175|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491176|NCT00633152|Linezolid|linezolid|mesh-list
44491177|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44491178|NCT00633152|Cephalosporins|cephalosporins|mesh-list
44491179|NCT00633152|Aztreonam|aztreonam|mesh-list
44491180|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491181|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491182|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44491183|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491184|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491185|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44491186|NCT00633126|Cephalosporins|cephalosporins|mesh-list
44491187|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491188|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491189|NCT00633074|Vaccines|vaccines|mesh-list
44491190|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
44491191|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491192|NCT00633061|Enoxaparin|enoxaparin|mesh-list
44491193|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
44491194|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44491195|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44491196|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491197|NCT00632931|Vorinostat|vorinostat|mesh-list
44491198|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491199|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44491200|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491201|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491202|NCT00632827|Leucovorin|leucovorin|mesh-list
44491203|NCT00632827|Gemcitabine|gemcitabine|mesh-list
44491204|NCT00632827|Cytarabine|cytarabine|mesh-list
44491205|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
44491206|NCT00632827|Carmustine|carmustine|mesh-list
44491207|NCT00632827|Doxorubicin|doxorubicin|mesh-list
44491208|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44491209|NCT00632827|Methotrexate|methotrexate|mesh-list
44491211|NCT00632827|Vincristine|vincristine|mesh-list
44491212|NCT00632827|Vinorelbine|vinorelbine|mesh-list
44491213|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
44491214|NCT00632827|Lenograstim|lenograstim|mesh-list
44491215|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491216|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
44491217|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491218|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491219|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44491220|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
44491221|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491222|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491223|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44491224|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491225|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
44491226|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
44491227|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491229|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43947790|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491230|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491231|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491232|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44491233|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
44491234|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491235|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44491236|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44491237|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44491238|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44491239|NCT00632827|Antidotes|antidotes|mesh-ancestor
44491240|NCT00632827|Protective Agents|protective agents|mesh-ancestor
44491241|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
44491242|NCT00632827|Vitamins|vitamins|mesh-ancestor
44491243|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
44491244|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491245|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491246|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491247|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44491248|NCT00632749|Cytarabine|cytarabine|mesh-list
44491249|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491250|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
44491251|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491252|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491253|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
44491254|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491255|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491256|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
44491257|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491258|NCT00632736|Ropinirole|ropinirole|mesh-list
44491259|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44491260|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44491261|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
44491262|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
44491263|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491264|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491265|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491266|NCT00632541|Bevacizumab|bevacizumab|mesh-list
44491267|NCT00632541|Sorafenib|sorafenib|mesh-list
44491268|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491269|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491270|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491271|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44491272|NCT00632541|Growth Substances|growth substances|mesh-ancestor
44491273|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491274|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491275|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44491276|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491277|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491278|NCT00632359|Lenalidomide|lenalidomide|mesh-list
44491279|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
44491280|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491281|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491282|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310359|NCT00886002|Fentanyl|fentanyl|mesh-list
44491283|NCT00632359|Growth Substances|growth substances|mesh-ancestor
44491284|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491285|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491286|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44491287|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44491288|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44491289|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491290|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491291|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44491292|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44491293|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44491294|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
44491295|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491296|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491297|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44491298|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44491299|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
44491300|NCT00632203|Temozolomide|temozolomide|mesh-list
44234739|NCT00550992|Methotrexate|methotrexate|mesh-list
44491301|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44491302|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
44491303|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491304|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491305|NCT00632099|Progesterone|progesterone|mesh-list
44491306|NCT00632099|Progestins|progestins|mesh-ancestor
44491307|NCT00632099|Hormones|hormones|mesh-ancestor
44491308|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491309|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491310|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44491311|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
44491312|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44491313|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44491314|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491315|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491316|NCT00631969|Urological Agents|urological agents|mesh-ancestor
44491317|NCT00631657|Mirtazapine|mirtazapine|mesh-list
44491318|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
44491319|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44491320|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44491321|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
44491322|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
44491323|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491324|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491325|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491326|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44491327|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44491328|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491329|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44491330|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44491331|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44491332|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491333|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44491334|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44491335|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
43947864|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44491336|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44491337|NCT00631488|Metformin|metformin|mesh-list
44491338|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44491339|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491340|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491341|NCT00631488|Incretins|incretins|mesh-ancestor
44491342|NCT00631488|Hormones|hormones|mesh-ancestor
44491343|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491344|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44491345|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44491346|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491347|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491348|NCT00631475|Bosentan|bosentan|mesh-list
44491349|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491350|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44491351|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491352|NCT00631189|Atorvastatin|atorvastatin|mesh-list
44491353|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44491354|NCT00631189|Pravastatin|pravastatin|mesh-list
44491355|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44491356|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44491357|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
44491358|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491359|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44491360|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44491361|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491362|NCT00631163|Deferasirox|deferasirox|mesh-list
44491363|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44491364|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
44491365|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
44491366|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491367|NCT00631137|Testosterone|testosterone|mesh-list
44491368|NCT00631137|Androgens|androgens|mesh-ancestor
44491369|NCT00631137|Hormones|hormones|mesh-ancestor
44491370|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491371|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491372|NCT00631007|Pioglitazone|pioglitazone|mesh-list
44491373|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491374|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491375|NCT00630994|Decitabine|decitabine|mesh-list
44491376|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491377|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
44491378|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491379|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491380|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491381|NCT00630877|Aspirin|aspirin|mesh-list
44491382|NCT00630877|Niacin|niacin|mesh-list
44491383|NCT00630877|Niacinamide|niacinamide|mesh-list
44491384|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
44491385|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44491386|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491387|NCT00630877|Analgesics|analgesics|mesh-ancestor
44491388|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
44491389|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491390|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491391|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491392|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491393|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44491394|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44491395|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491396|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44491397|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44491398|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491399|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
44491400|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44491401|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
44491402|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44491403|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
44491404|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
44491405|NCT00630877|Vitamins|vitamins|mesh-ancestor
44491406|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
44491407|NCT00630825|Dulaglutide|dulaglutide|mesh-list
44491408|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491409|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491410|NCT00630786|Panitumumab|panitumumab|mesh-list
44491411|NCT00630786|Conatumumab|conatumumab|mesh-list
44491412|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947970|NCT01093417|Vitamin D|vitamin d|mesh-list
44491413|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491414|NCT00630539|Tamoxifen|tamoxifen|mesh-list
44491415|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44491416|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
44491417|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491418|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491419|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44491420|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491421|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44491422|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44491423|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44491424|NCT00630396|Minocycline|minocycline|mesh-list
44491425|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491426|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491427|NCT00630344|Everolimus|everolimus|mesh-list
44491428|NCT00630344|Bicalutamide|bicalutamide|mesh-list
44491429|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491430|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491431|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
44491432|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491433|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
44491434|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
44491435|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44737656|NCT01319565|Fludarabine|fludarabine|mesh-list
44737657|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737658|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
44737659|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737660|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737661|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737662|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
44737663|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737664|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737665|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737666|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44737667|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44737668|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
44737669|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737670|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
44737671|NCT01176006|Busulfan|busulfan|mesh-list
44737672|NCT01176006|Fludarabine|fludarabine|mesh-list
44737673|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
44737674|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737675|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
44737676|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737677|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737678|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737679|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
44737680|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737681|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737682|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737683|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737684|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
44737685|NCT00843791|Pioglitazone|pioglitazone|mesh-list
44737686|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44737687|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44737688|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737689|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44737690|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
44737691|NCT00596154|Busulfan|busulfan|mesh-list
44737692|NCT00596154|Thiotepa|thiotepa|mesh-list
44737693|NCT00596154|Rituximab|rituximab|mesh-list
44737694|NCT00596154|Methotrexate|methotrexate|mesh-list
43948062|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737695|NCT00596154|Vincristine|vincristine|mesh-list
44737696|NCT00596154|Procarbazine|procarbazine|mesh-list
44737697|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44737698|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
44737699|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737700|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44737701|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44737702|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
44737703|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737704|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44737705|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44737706|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44737707|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44737708|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
44737709|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44737710|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44737711|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
44737712|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
44737713|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44737714|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44737715|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44737716|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44737717|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44737718|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44737719|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44737720|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44737721|NCT00018057|Fluoxetine|fluoxetine|mesh-list
44737722|NCT00018057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44737723|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44737724|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44737725|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737726|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491437|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
44491438|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491439|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
44491440|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
44491441|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44491442|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44491443|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
44491444|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491445|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
44491446|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491447|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491448|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
44491449|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
44491450|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44491451|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
44491452|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491453|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491454|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44491455|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491456|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44491457|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44491458|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491459|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491460|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491461|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491462|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491463|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
44491464|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44491466|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44491467|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44491468|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491469|NCT00637052|Filanesib|filanesib|mesh-list
44491470|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491471|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491472|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491473|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491474|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
44491475|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44491476|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44491477|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491478|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
44491479|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
44491480|NCT00635505|Albuterol|albuterol|mesh-list
44491481|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44491482|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
44491483|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491484|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491485|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44491486|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491487|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
44491488|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491489|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44491490|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44491491|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491492|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491493|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667705|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491494|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491495|NCT00635193|Doxorubicin|doxorubicin|mesh-list
44491496|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44491497|NCT00635193|Volociximab|volociximab|mesh-list
44491498|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44491499|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491500|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491501|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491502|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491503|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491504|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491505|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491506|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44491507|NCT00635193|Growth Substances|growth substances|mesh-ancestor
44491508|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491509|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491510|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
44491511|NCT00634829|Albuterol|albuterol|mesh-list
44491512|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44491513|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
44491514|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491515|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491516|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44491517|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491518|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
44491519|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491520|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44491521|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44491522|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491523|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491524|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491525|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491526|NCT00634517|Albuterol|albuterol|mesh-list
44491527|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44491528|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
44491529|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491530|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491531|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44491532|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
44491534|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491535|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44491536|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44491537|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491538|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491539|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491540|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491541|NCT00633997|Vildagliptin|vildagliptin|mesh-list
44491542|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491543|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491544|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44491545|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
44491546|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491547|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491548|NCT00631111|Aspirin|aspirin|mesh-list
44491549|NCT00631111|Ascorbic Acid|ascorbic acid|mesh-list
44491550|NCT00631111|Ibuprofen|ibuprofen|mesh-list
44491551|NCT00631111|Vitamins|vitamins|mesh-ancestor
44491552|NCT00631111|Micronutrients|micronutrients|mesh-ancestor
44491553|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491554|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44491555|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491556|NCT00631111|Analgesics|analgesics|mesh-ancestor
44491557|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
44491558|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491559|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491560|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491561|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44491562|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44491563|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491564|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44491565|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44491566|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491567|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
44491568|NCT00631111|Antioxidants|antioxidants|mesh-ancestor
44491569|NCT00631111|Protective Agents|protective agents|mesh-ancestor
44491570|NCT00630799|Leuprolide|leuprolide|mesh-list
44491571|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44491572|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
44491573|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44491574|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491575|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44491576|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491577|NCT00630552|Conatumumab|conatumumab|mesh-list
44491578|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491579|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491580|NCT00630201|Buprenorphine|buprenorphine|mesh-list
44491581|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44491582|NCT00630201|Narcotics|narcotics|mesh-ancestor
44491583|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491584|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310699|NCT00887757|Navitoclax|navitoclax|mesh-list
44491585|NCT00630201|Analgesics|analgesics|mesh-ancestor
44491586|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
44491587|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491588|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44491589|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
44491590|NCT00630032|Docetaxel|docetaxel|mesh-list
44491591|NCT00630032|Fluorouracil|fluorouracil|mesh-list
44491592|NCT00630032|Epirubicin|epirubicin|mesh-list
44491593|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491594|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
44491595|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491596|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948209|NCT01099618|Metformin|metformin|mesh-list
44491597|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44491598|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
44491599|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491600|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491601|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44491602|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491603|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491604|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491605|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
44491606|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491607|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491608|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491610|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491611|NCT01924273|Talaporfin|talaporfin|mesh-list
44491612|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491613|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44491614|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44491615|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
44491616|NCT01920113|Remifentanil|remifentanil|mesh-list
44491617|NCT01920113|Propofol|propofol|mesh-list
44491618|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44491619|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491620|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491621|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44491622|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
44491623|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
44491624|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491625|NCT01920113|Analgesics|analgesics|mesh-ancestor
44491626|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
44491627|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491628|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44491629|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44491630|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491631|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491632|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491633|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491634|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44491635|NCT01920113|Narcotics|narcotics|mesh-ancestor
44491636|NCT01920191|Poly ICLC|poly iclc|mesh-list
44491637|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
44491638|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
44491639|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491640|NCT01920204|Midostaurin|midostaurin|mesh-list
44491641|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491642|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44491643|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491644|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491645|NCT01920269|Mitomycins|mitomycins|mesh-list
44491646|NCT01920269|Mitomycin|mitomycin|mesh-list
44491647|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491648|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491649|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
44491650|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491651|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44491652|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491653|NCT01920334|Zolpidem|zolpidem|mesh-list
44491654|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44491655|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44491656|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491657|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491658|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44491659|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
44310775|NCT00888602|Psyllium|psyllium|mesh-list
44491660|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
44491661|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491662|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491663|NCT01920386|Acetaminophen|acetaminophen|mesh-list
44491664|NCT01920386|Tramadol|tramadol|mesh-list
44491665|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491666|NCT01920386|Analgesics|analgesics|mesh-ancestor
44491667|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
44491668|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491669|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491670|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
44491671|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44491672|NCT01920386|Narcotics|narcotics|mesh-ancestor
44491673|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491674|NCT01920503|Doxorubicin|doxorubicin|mesh-list
44491675|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491676|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491677|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44491678|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44491679|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491680|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491681|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
44491682|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44491683|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491684|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491685|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491687|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
44491688|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491689|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44491690|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44491691|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491692|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491693|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491694|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491695|NCT01920919|Dexamethasone|dexamethasone|mesh-list
44491696|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491697|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
44491698|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
44491699|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491700|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491701|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491702|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
44491703|NCT01920919|Hormones|hormones|mesh-ancestor
44491704|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491705|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44491706|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491707|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44491708|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44491709|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44491710|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491711|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491712|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44491713|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44491714|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491715|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
44491716|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491717|NCT01921010|Niacin|niacin|mesh-list
44491718|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
44491719|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44491720|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
44491721|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491722|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44491723|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44491724|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
44491725|NCT01921010|Vitamins|vitamins|mesh-ancestor
44491726|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
44491727|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491728|NCT01921192|Folic Acid|folic acid|mesh-list
44491729|NCT01921192|Hematinics|hematinics|mesh-ancestor
44491730|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
44491731|NCT01921192|Vitamins|vitamins|mesh-ancestor
44491732|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
44491733|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491734|NCT01921231|Bupivacaine|bupivacaine|mesh-list
44491735|NCT01921231|Prilocaine|prilocaine|mesh-list
44310847|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
44491736|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
44491737|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
44491738|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491739|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491740|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
44491741|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491742|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
44491743|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
44491744|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44491745|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491746|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491747|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491748|NCT01921361|Analgesics|analgesics|mesh-ancestor
44491749|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
44491750|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491751|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44491752|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44491753|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44491754|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491755|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491756|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491757|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
44491758|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
44491759|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
44491760|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
44491761|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491762|NCT01921426|Protective Agents|protective agents|mesh-ancestor
44491763|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491764|NCT01921582|Methylphenidate|methylphenidate|mesh-list
44491765|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44491766|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491767|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44491768|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44491769|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44491770|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491771|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
44491772|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491773|NCT01921647|Amoxicillin|amoxicillin|mesh-list
44491774|NCT01921647|Clarithromycin|clarithromycin|mesh-list
44491775|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491776|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491777|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44491778|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948368|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
44491779|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491780|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44491781|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44491782|NCT01921673|Docetaxel|docetaxel|mesh-list
44491783|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491784|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44491785|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44491786|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44491787|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44737727|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
44737728|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44737729|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44737730|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44737731|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44737732|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44737733|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44737734|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491788|NCT01921738|Azithromycin|azithromycin|mesh-list
44491789|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491790|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491791|NCT01921790|Gemcitabine|gemcitabine|mesh-list
44491792|NCT01921790|Dexamethasone|dexamethasone|mesh-list
44491793|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
44491794|NCT01921790|Bevacizumab|bevacizumab|mesh-list
44491795|NCT01921790|Pegaspargase|pegaspargase|mesh-list
44491796|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491797|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
44491798|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
44491799|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491800|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491801|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491802|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
44491803|NCT01921790|Hormones|hormones|mesh-ancestor
44491804|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491805|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44491806|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491807|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44491808|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
43948412|NCT01105117|Epoprostenol|epoprostenol|mesh-list
44491809|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491810|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
44491811|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491812|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491813|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44491814|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
44491815|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44491816|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491817|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44491818|NCT01921790|Growth Substances|growth substances|mesh-ancestor
44491819|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44491820|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
44491821|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44491822|NCT01921920|Omeprazole|omeprazole|mesh-list
44491823|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44491824|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491825|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44491826|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491827|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491828|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44491829|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44491830|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44491831|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
44491832|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491833|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44491834|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44491835|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491836|NCT01921985|Terlipressin|terlipressin|mesh-list
44491837|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491838|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44491839|NCT01922141|Amlodipine|amlodipine|mesh-list
44491840|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44491841|NCT01922141|Ramipril|ramipril|mesh-list
44491842|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491843|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44491844|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44491845|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491846|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44491847|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491848|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
44491849|NCT01922141|Diuretics|diuretics|mesh-ancestor
44491850|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
44491851|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44491852|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44491853|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
44491854|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491855|NCT01922154|Ranibizumab|ranibizumab|mesh-list
44491856|NCT01922154|Mitomycin|mitomycin|mesh-list
44491857|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44491858|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44491859|NCT01922154|Growth Substances|growth substances|mesh-ancestor
44491860|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491861|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311005|NCT00889525|Cabergoline|cabergoline|mesh-list
44491862|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491863|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
44491864|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491865|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491866|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44491867|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491868|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44491869|NCT01922193|Hormones|hormones|mesh-ancestor
44491870|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491871|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491872|NCT01922375|Naftopidil|naftopidil|mesh-list
44491873|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44491874|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44491875|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
44491876|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44491877|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491878|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491879|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491880|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44491881|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44491882|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44491883|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44491885|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44491886|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491887|NCT01922427|Analgesics|analgesics|mesh-ancestor
44491888|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
44491889|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491890|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491891|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491892|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491893|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44491894|NCT01922466|Loxoprofen|loxoprofen|mesh-list
44491895|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44491896|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44491897|NCT01922466|Analgesics|analgesics|mesh-ancestor
44491898|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
44491899|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491900|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491901|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44491902|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44491903|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44491904|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491905|NCT01922596|Ropivacaine|ropivacaine|mesh-list
44491906|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
44491907|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
44491908|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491909|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491910|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
44491911|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44491912|NCT01922687|Amlodipine|amlodipine|mesh-list
44491913|NCT01922687|Atorvastatin|atorvastatin|mesh-list
44491914|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44491915|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44491916|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
44491917|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491918|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44491919|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44491920|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491921|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44491922|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44491923|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44491924|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44491925|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491926|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
44491927|NCT01922713|Vitamin A|vitamin a|mesh-list
44491928|NCT01922713|Beta Carotene|beta carotene|mesh-list
44491929|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
44491930|NCT01922713|Vitamins|vitamins|mesh-ancestor
44491931|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
44491932|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491933|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
44491934|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491935|NCT01922713|Protective Agents|protective agents|mesh-ancestor
44311020|NCT00889616|Antacids|antacids|mesh-ancestor
44491936|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44491937|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491938|NCT01922713|Provitamins|provitamins|mesh-ancestor
44491939|NCT01922765|Amoxicillin|amoxicillin|mesh-list
44491940|NCT01922765|Metronidazole|metronidazole|mesh-list
44491941|NCT01922765|Clarithromycin|clarithromycin|mesh-list
44491942|NCT01922765|Rabeprazole|rabeprazole|mesh-list
44491943|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44491944|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491945|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44491946|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44491947|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44491948|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491949|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491950|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44491951|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44491952|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44491953|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44491954|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44491955|NCT01922804|Vitamins|vitamins|mesh-list
44491956|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
44491957|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491959|NCT01922817|Incretins|incretins|mesh-ancestor
44491960|NCT01922817|Hormones|hormones|mesh-ancestor
44491961|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44491962|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491963|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44491964|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
44491965|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44491966|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491967|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44491968|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
44491969|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44491970|NCT01922921|Trastuzumab|trastuzumab|mesh-list
44491971|NCT01922921|Pertuzumab|pertuzumab|mesh-list
44491972|NCT01922921|Antibodies|antibodies|mesh-list
44491973|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
44491974|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44491975|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
44491976|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491977|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44491978|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44491979|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44491980|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
44491981|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44491982|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
44491983|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44491984|NCT01922921|Protective Agents|protective agents|mesh-ancestor
44491985|NCT01922999|Melatonin|melatonin|mesh-list
44491986|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
44491987|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491988|NCT01922999|Protective Agents|protective agents|mesh-ancestor
44491989|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491990|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44491991|NCT01923012|Vitamin K|vitamin k|mesh-list
44491992|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
44491993|NCT01923012|Vitamins|vitamins|mesh-ancestor
44491994|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
44491995|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44491996|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44491997|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44491998|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44491999|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
44492000|NCT01923012|Coagulants|coagulants|mesh-ancestor
44492001|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44492002|NCT01923077|Simvastatin|simvastatin|mesh-list
44492003|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44492004|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44492005|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
44492006|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492007|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492008|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44492009|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492010|NCT01923090|Finasteride|finasteride|mesh-list
44492011|NCT01923090|Dutasteride|dutasteride|mesh-list
44492012|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44492013|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44492014|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234756|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
44492015|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492016|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492017|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492018|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492019|NCT01923090|Urological Agents|urological agents|mesh-ancestor
44492020|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44492021|NCT01923194|Hormones|hormones|mesh-ancestor
44492022|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492023|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492024|NCT01923259|Donepezil|donepezil|mesh-list
44492025|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44492026|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492027|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492028|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
44492029|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492030|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492031|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
44492032|NCT01923337|Irinotecan|irinotecan|mesh-list
44492033|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44492034|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44492035|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492036|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492037|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492038|NCT01923376|Lactulose|lactulose|mesh-list
44492039|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44492040|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492041|NCT01923376|Laxatives|laxatives|mesh-ancestor
44492042|NCT01923545|Lenograstim|lenograstim|mesh-list
44492043|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44492044|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
44492045|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492046|NCT01923558|Donepezil|donepezil|mesh-list
44492047|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44492048|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492049|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492050|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
44492051|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492052|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492053|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
44492054|NCT01923584|Ubiquinone|ubiquinone|mesh-list
44492055|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
44492056|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492057|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44492058|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
44492059|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492060|NCT01923597|Protective Agents|protective agents|mesh-ancestor
44492061|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492062|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44492063|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44492064|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492065|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44492066|NCT01923623|Ropivacaine|ropivacaine|mesh-list
44492067|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
44492068|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
44492069|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492070|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492071|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
44492072|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492073|NCT01923818|Aspirin|aspirin|mesh-list
44492074|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
44492075|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492076|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492077|NCT01923818|Analgesics|analgesics|mesh-ancestor
44492078|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
44492079|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492080|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492081|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492082|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492083|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44492084|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44492085|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492086|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44492087|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44492088|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492089|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
44492090|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44492091|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
44492092|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44492093|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44492094|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
44492095|NCT01923831|Dexamethasone|dexamethasone|mesh-list
44492096|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
44492097|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492098|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
44492099|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
44492100|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492101|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948677|NCT01112358|Progestins|progestins|mesh-ancestor
44492102|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492103|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
44492104|NCT01923831|Hormones|hormones|mesh-ancestor
44492105|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492106|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44492107|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492108|NCT01923831|Analgesics|analgesics|mesh-ancestor
44492109|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
44492110|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
44492111|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492112|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44492113|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
44492114|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44492115|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44492116|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492117|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492118|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
44492119|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492120|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44492121|NCT01923844|Beractant|beractant|mesh-list
44492122|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492123|NCT01923857|Enclomiphene|enclomiphene|mesh-list
44492124|NCT01923857|Clomiphene|clomiphene|mesh-list
44492125|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
44492126|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44492127|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492128|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492129|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492130|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44492131|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
43948748|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492132|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492133|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44492134|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44492135|NCT01923870|Enclomiphene|enclomiphene|mesh-list
44492136|NCT01923870|Clomiphene|clomiphene|mesh-list
44492137|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
44492138|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44492139|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492140|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492141|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492142|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44492143|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
44492144|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492145|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44492146|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44492147|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44492148|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492149|NCT01923948|Pregabalin|pregabalin|mesh-list
44492150|NCT01923948|Analgesics|analgesics|mesh-ancestor
44234779|NCT00550992|Antidotes|antidotes|mesh-ancestor
44492151|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
44492152|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492153|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492154|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
44492155|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44492156|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44492157|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492158|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492159|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44492160|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44492161|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492162|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44492164|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44492165|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492166|NCT01924000|Minoxidil|minoxidil|mesh-list
44492167|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492168|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
44492169|NCT01924065|Anticoagulants|anticoagulants|mesh-list
44492170|NCT01924078|Capecitabine|capecitabine|mesh-list
44492171|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44492172|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44492173|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
44492174|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492175|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492176|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44492177|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492178|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44492179|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492180|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492181|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492182|NCT01924091|Dapivirine|dapivirine|mesh-list
44492183|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44492184|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44492185|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
44492186|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492187|NCT01924104|Aspirin|aspirin|mesh-list
44492188|NCT01924104|Heparin|heparin|mesh-list
44492189|NCT01924104|Calcium heparin|calcium heparin|mesh-list
44492190|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44492191|NCT01924104|Tinzaparin|tinzaparin|mesh-list
44492192|NCT01924104|Dalteparin|dalteparin|mesh-list
44492193|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492194|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492195|NCT01924104|Analgesics|analgesics|mesh-ancestor
44492196|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
44492197|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492198|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492199|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492200|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492201|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44492202|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44492203|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948823|NCT01115101|Pirinitramide|pirinitramide|mesh-list
44492204|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44492205|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44492206|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492207|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
44492208|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
44492209|NCT01924234|Morphine|morphine|mesh-list
44492210|NCT01924234|Remifentanil|remifentanil|mesh-list
44492211|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44492212|NCT01924234|Narcotics|narcotics|mesh-ancestor
44492213|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492214|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492215|NCT01924234|Analgesics|analgesics|mesh-ancestor
44492216|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
44492217|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492218|NCT01924286|Prednisone|prednisone|mesh-list
44492219|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492220|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
44492221|NCT01924286|Hormones|hormones|mesh-ancestor
44492222|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492223|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492224|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44492225|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492226|NCT01924325|Aspirin|aspirin|mesh-list
44492227|NCT01924325|Apixaban|apixaban|mesh-list
44492228|NCT01924325|Clopidogrel|clopidogrel|mesh-list
44492229|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492230|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492231|NCT01924325|Analgesics|analgesics|mesh-ancestor
44492232|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
44492233|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492234|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492235|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492236|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492237|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44492238|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44492239|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492240|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44492241|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44492242|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492243|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
44492244|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44492245|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44492246|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44492247|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
44492248|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492249|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44492250|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
44492251|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44492252|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
44492253|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
44492254|NCT01924468|Haloperidol|haloperidol|mesh-list
44492255|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
44492256|NCT01924468|Methylphenidate|methylphenidate|mesh-list
44492257|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44492258|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492259|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44492260|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44492261|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44492262|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492263|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
44492264|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492265|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
44492266|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
44492267|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492268|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492269|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44492270|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44492271|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492272|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44492273|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44492274|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44492275|NCT01924481|Theobromine|theobromine|mesh-list
44492276|NCT01924481|Caffeine|caffeine|mesh-list
44492277|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44492278|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492279|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44492280|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492281|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492282|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44492283|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44492284|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
44492285|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492286|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44492287|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
44492288|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492289|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44492290|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492291|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
44492292|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44492293|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44492294|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44492295|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44492296|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44492297|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311396|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
44492298|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492299|NCT01924624|Thalidomide|thalidomide|mesh-list
44492300|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492301|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
44492302|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492303|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
44492304|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492305|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492306|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44492307|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44492308|NCT01924624|Growth Substances|growth substances|mesh-ancestor
44492309|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
44492310|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492311|NCT01924637|Insulin|insulin|mesh-list
44492312|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44492313|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
44492314|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
44492315|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44492316|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44492317|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492318|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44492319|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44492320|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492321|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
44492322|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492323|NCT01924910|Vitamin D|vitamin d|mesh-list
44492324|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
44492325|NCT01924910|Vitamins|vitamins|mesh-ancestor
44492326|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
43948891|NCT01118091|Aldesleukin|aldesleukin|mesh-list
44492327|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492328|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44492329|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492330|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44492331|NCT01925092|Mifepristone|mifepristone|mesh-list
44492332|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44492333|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
44492334|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492335|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492336|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44492337|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44492338|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44492339|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
44492340|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44492341|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44492342|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492343|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492344|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
44492345|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44492346|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44492347|NCT01925287|Curcumin|curcumin|mesh-list
44492348|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492349|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492350|NCT01925287|Analgesics|analgesics|mesh-ancestor
44492351|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
44492352|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492353|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492354|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492355|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492356|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492357|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492358|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492359|NCT01925300|Bisoprolol|bisoprolol|mesh-list
44492360|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44492361|NCT01925300|Calcium|calcium|mesh-list
44492362|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492363|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492364|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44492365|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44492366|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
44492367|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492368|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492369|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44492370|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492371|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492372|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
44492373|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
44492374|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492375|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44492376|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44492377|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44492378|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
44492379|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492380|NCT01925352|Mitogens|mitogens|mesh-list
44492381|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44492382|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492383|NCT01925378|Nelfinavir|nelfinavir|mesh-list
44492384|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44492385|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44492386|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44492387|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492388|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492389|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44492390|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44492391|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
44492392|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492393|NCT01925456|Fesoterodine|fesoterodine|mesh-list
44492394|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44492395|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44492396|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
44492397|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492398|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492399|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492400|NCT01925456|Urological Agents|urological agents|mesh-ancestor
44492401|NCT01925547|Curcumin|curcumin|mesh-list
44492402|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492403|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492404|NCT01925547|Analgesics|analgesics|mesh-ancestor
44492405|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
44492406|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492407|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492408|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492409|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492410|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492411|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492412|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492413|NCT01925638|Ketoconazole|ketoconazole|mesh-list
44492414|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
44492415|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492416|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44492417|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44492418|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492419|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492420|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44492421|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492422|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492423|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492424|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44492425|NCT01925729|Phenylephrine|phenylephrine|mesh-list
44492426|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
44492427|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
44492428|NCT01925729|Ephedrine|ephedrine|mesh-list
44492429|NCT01925729|Histamine|histamine|mesh-list
44492430|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44492431|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
44492432|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492433|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492434|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44492435|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492436|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
44492437|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44492438|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44492439|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
44492440|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44492441|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492442|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492443|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44492444|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44492445|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44492446|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
44492447|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44492448|NCT01925729|Protective Agents|protective agents|mesh-ancestor
44492449|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
44492450|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
44492451|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
44492452|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44492453|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
44492454|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44492455|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
44492456|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492457|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492458|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
44492459|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44492460|NCT01925820|Entecavir|entecavir|mesh-list
44492461|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
44492462|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492463|NCT01925859|Dexamethasone|dexamethasone|mesh-list
44492464|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
44492465|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44492466|NCT01925859|BB 1101|bb 1101|mesh-list
44492467|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492468|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
44492469|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
44492470|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492471|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492472|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492473|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
44492474|NCT01925859|Hormones|hormones|mesh-ancestor
44492475|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492476|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44492477|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492478|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44492479|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492480|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492481|NCT01925898|Midazolam|midazolam|mesh-list
44492482|NCT01925898|Ketamine|ketamine|mesh-list
44492483|NCT01925898|Analgesics|analgesics|mesh-ancestor
44492484|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
44492485|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492486|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492487|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44492488|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44492489|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
44492490|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
44492491|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492492|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44492493|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44492494|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492495|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492496|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44492497|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44492498|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44492499|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44492500|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44492501|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
44492502|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
44492503|NCT01925911|Midazolam|midazolam|mesh-list
44492504|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44492505|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949117|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44492506|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492507|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492508|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44492509|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44492510|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44492511|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44492512|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
44492513|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
44492514|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
44492515|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
44492516|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492517|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492518|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
44492519|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
44492520|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492521|NCT01926132|Protective Agents|protective agents|mesh-ancestor
44492522|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492523|NCT01926132|Vitamins|vitamins|mesh-ancestor
44492524|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
44492525|NCT01926210|Letrozole|letrozole|mesh-list
44492526|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492527|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44492528|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44492529|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492530|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492531|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44492532|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492533|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949121|NCT05307835|Molgramostim|molgramostim|mesh-list
44492534|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492535|NCT01926236|Leucovorin|leucovorin|mesh-list
44492536|NCT01926236|Folic Acid|folic acid|mesh-list
44492537|NCT01926236|Fluorouracil|fluorouracil|mesh-list
44492538|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
44492539|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
44492540|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
44492541|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492542|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44492543|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492544|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492545|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
44492546|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492547|NCT01926236|Antidotes|antidotes|mesh-ancestor
44492548|NCT01926236|Protective Agents|protective agents|mesh-ancestor
44492549|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
44492550|NCT01926236|Vitamins|vitamins|mesh-ancestor
44492551|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
44492552|NCT01926236|Hematinics|hematinics|mesh-ancestor
44492553|NCT01926288|Entecavir|entecavir|mesh-list
44492554|NCT01926288|Maleic acid|maleic acid|mesh-list
44492555|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492556|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492557|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
44492558|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492559|NCT01926379|Isoniazid|isoniazid|mesh-list
44492560|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
44492561|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492562|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492563|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44492564|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44492565|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
44492566|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492567|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492568|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
44492569|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44492570|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492571|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492572|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44492573|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44492574|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
43949169|NCT05307458|Naloxone|naloxone|mesh-list
44492575|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44492576|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
44492577|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492578|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44492579|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492580|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492581|NCT01926587|Azacitidine|azacitidine|mesh-list
44492582|NCT01926587|ON 01910|on 01910|mesh-list
44492583|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44492584|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
44492585|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492586|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492587|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492588|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44492589|NCT01926639|Rituximab|rituximab|mesh-list
43903061|NCT00119392|Cyclosporins|cyclosporins|mesh-list
44492590|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44492591|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492592|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
44492593|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492594|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492595|NCT01926652|Amlodipine|amlodipine|mesh-list
44492596|NCT01926652|Candesartan|candesartan|mesh-list
44492597|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
44492598|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492599|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44492600|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44492601|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492602|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492603|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492604|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
44492605|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44492606|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44492607|NCT01926665|Dexamethasone|dexamethasone|mesh-list
44492608|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492609|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
44492610|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
44492611|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492612|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492613|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492614|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
44492615|NCT01926665|Hormones|hormones|mesh-ancestor
44492616|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492617|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44492618|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492619|NCT01926769|Metformin|metformin|mesh-list
44492620|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44492621|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492622|NCT01926821|Sizofiran|sizofiran|mesh-list
44492623|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44492624|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
44492625|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492626|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44492627|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492628|NCT01926847|Riociguat|riociguat|mesh-list
44492629|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
44492630|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492631|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44492632|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
44492633|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492634|NCT01926899|Bortezomib|bortezomib|mesh-list
44492635|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492636|NCT01927029|Progesterone|progesterone|mesh-list
44492637|NCT01927029|Progestins|progestins|mesh-ancestor
44492638|NCT01927029|Hormones|hormones|mesh-ancestor
44492639|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492640|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492641|NCT01927224|Nifurtimox|nifurtimox|mesh-list
44492642|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44492643|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44492644|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44492645|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492646|NCT01927263|Infliximab|infliximab|mesh-list
44492647|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
44492648|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492649|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492650|NCT01927315|Fenofibrate|fenofibrate|mesh-list
44492651|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44492652|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
44492653|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492654|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492655|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44492656|NCT01927328|Hematinics|hematinics|mesh-ancestor
44492657|NCT01927406|Timolol|timolol|mesh-list
44492658|NCT01927406|Bimatoprost|bimatoprost|mesh-list
44492659|NCT01927406|Travoprost|travoprost|mesh-list
44492660|NCT01927406|Latanoprost|latanoprost|mesh-list
44492661|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44492662|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44492663|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
44492664|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492665|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492666|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492667|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44492668|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492669|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44311741|NCT00892801|Everolimus|everolimus|mesh-list
44492670|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44492671|NCT01927484|Methotrexate|methotrexate|mesh-list
44492672|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44492673|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
44492674|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492675|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492676|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44492677|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
44492678|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492679|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492680|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44492681|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492682|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44492683|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492684|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
44492685|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492686|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44492687|NCT01927588|Prednisone|prednisone|mesh-list
44492688|NCT01927588|Everolimus|everolimus|mesh-list
44492689|NCT01927588|Tacrolimus|tacrolimus|mesh-list
44492690|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492691|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
44492692|NCT01927588|Hormones|hormones|mesh-ancestor
44492693|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492694|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492695|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44492696|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492697|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492698|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
44492699|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44492700|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492701|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492702|NCT01927835|Vaccines|vaccines|mesh-list
44492703|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
44492704|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492705|NCT01927874|Bupivacaine|bupivacaine|mesh-list
44492706|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
44492707|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
44492708|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492709|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492710|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
44492711|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492712|NCT01927913|Deferasirox|deferasirox|mesh-list
44492713|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44492714|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
44492715|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
44492716|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492717|NCT01928043|Curcumin|curcumin|mesh-list
44492718|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44492719|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492720|NCT01928043|Analgesics|analgesics|mesh-ancestor
44492721|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
44492722|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492723|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492724|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44492725|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44492726|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492727|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492728|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492729|NCT01928056|Montelukast|montelukast|mesh-list
44492730|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44492731|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492732|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44492733|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492734|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492735|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492736|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44492737|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44492738|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492739|NCT01928069|Montelukast|montelukast|mesh-list
44492740|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44492741|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492742|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44492743|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492744|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492745|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492746|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44492747|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44492748|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492749|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
44492750|NCT01928134|Calcium|calcium|mesh-list
44492751|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492752|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492753|NCT01928134|Antacids|antacids|mesh-ancestor
44492754|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492755|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311883|NCT00893373|Sorafenib|sorafenib|mesh-list
44492757|NCT01928160|Carboplatin|carboplatin|mesh-list
44492758|NCT01928160|Pemetrexed|pemetrexed|mesh-list
44492759|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44492760|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492761|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492762|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492763|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44492764|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44492765|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44492766|NCT01928316|Mizolastine|mizolastine|mesh-list
44492767|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44492768|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44492769|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
44492770|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
44492771|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492772|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492773|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492774|NCT01928459|Infigratinib|infigratinib|mesh-list
44492775|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492776|NCT01928498|Paclitaxel|paclitaxel|mesh-list
44492777|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44492778|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492779|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
44492780|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
44492781|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
44492782|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492784|NCT01928511|Tenofovir|tenofovir|mesh-list
44492785|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
44492786|NCT01928511|Lamivudine|lamivudine|mesh-list
44492787|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
44492788|NCT01928511|Entecavir|entecavir|mesh-list
44492789|NCT01928511|Adefovir|adefovir|mesh-list
44492790|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44492791|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492792|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
44492793|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492794|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44492795|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44492796|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492797|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492798|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44492799|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44492800|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
44492801|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492802|NCT01928537|ON 01910|on 01910|mesh-list
44492803|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492804|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44492805|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492806|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492807|NCT01928563|Udenafil|udenafil|mesh-list
44492808|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44492809|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44492810|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492811|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492812|NCT01928628|Valsartan|valsartan|mesh-list
44492813|NCT01928628|Lercanidipine|lercanidipine|mesh-list
44492814|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492815|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44492816|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44492817|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492818|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44492819|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667706|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949425|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
43949426|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141612|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
44141613|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141614|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141615|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44141616|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141617|NCT00183846|Irinotecan|irinotecan|mesh-list
44141618|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44141619|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44492820|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44492821|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492822|NCT01928823|Cycloserine|cycloserine|mesh-list
44492823|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44492824|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492825|NCT01928823|Renal Agents|renal agents|mesh-ancestor
44492826|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44492827|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
44492828|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492829|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
44311986|NCT00893711|Vitamin D|vitamin d|mesh-list
44492830|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492831|NCT01928888|Famotidine|famotidine|mesh-list
44492832|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
44492833|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44492834|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492835|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44492836|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
44492837|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
44492838|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492839|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492840|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492841|NCT01928888|Antacids|antacids|mesh-ancestor
44492842|NCT01928901|Thymol|thymol|mesh-list
44492843|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492844|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44492845|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
44492846|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
44492847|NCT01928914|Tafenoquine|tafenoquine|mesh-list
44492848|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492849|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492850|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44492851|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44492852|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492853|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492854|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492855|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
44492856|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44492857|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44492858|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44492859|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44492860|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44141620|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492861|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
44492862|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492863|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492864|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44492865|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492866|NCT01929096|Edaravone|edaravone|mesh-list
44492867|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44492868|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
44492869|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492870|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44492871|NCT01929096|Protective Agents|protective agents|mesh-ancestor
44492872|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492873|NCT01929161|Oxytocin|oxytocin|mesh-list
44492874|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
44492875|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44492876|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492877|NCT01929187|Amorolfine|amorolfine|mesh-list
44492878|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
44492879|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492880|NCT01929213|Bosentan|bosentan|mesh-list
44492881|NCT01929213|Udenafil|udenafil|mesh-list
44492882|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44492883|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44492884|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492885|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44492886|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44492887|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492888|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
44492889|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
44492890|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44492891|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44492892|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492893|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44492894|NCT01929252|Analgesics|analgesics|mesh-ancestor
44492895|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
44492896|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492897|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44492898|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44492899|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44492900|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
44492901|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44492902|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492903|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
44492904|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
44492905|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44492906|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44492907|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
44492908|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492909|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492910|NCT01929278|Clindamycin|clindamycin|mesh-list
44492911|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
44492912|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
44492913|NCT01929278|Tretinoin|tretinoin|mesh-list
44492914|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492915|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492916|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44492917|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492918|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492919|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492920|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
44492921|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
44492922|NCT01929330|Dutasteride|dutasteride|mesh-list
44492923|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44492924|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44492925|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492926|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492927|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44492928|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44492929|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492930|NCT01929421|Gemcitabine|gemcitabine|mesh-list
44492931|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44492932|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
44492933|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492934|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492935|NCT01929421|Antiviral Agents|antiviral agents|mesh-ancestor
44492936|NCT01929421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492937|NCT01929421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492938|NCT01929421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492939|NCT01929421|Immunologic Factors|immunologic factors|mesh-ancestor
44492940|NCT01929421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492941|NCT01929512|Metformin|metformin|mesh-list
44492942|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44492943|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44492944|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492945|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44492946|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44492947|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
44492948|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492949|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44492950|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44492951|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492952|NCT01929577|Peficitinib|peficitinib|mesh-list
44492953|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492954|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492955|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492956|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
44492957|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492958|NCT01929603|Rifampin|rifampin|mesh-list
44492959|NCT01929603|Olaparib|olaparib|mesh-list
44492960|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44492961|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44492962|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492963|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492964|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44492965|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
44492966|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44492967|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44492968|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
44492969|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44492970|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44492971|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44492972|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44492973|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44492974|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44492975|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44492976|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44492977|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44492978|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
44492979|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
44492980|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44492981|NCT01929668|Protective Agents|protective agents|mesh-ancestor
44492982|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492983|NCT01929668|Vitamins|vitamins|mesh-ancestor
44492984|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
44492985|NCT01929746|Daclizumab|daclizumab|mesh-list
44492986|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44492987|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
44492988|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492989|NCT01929798|Pancrelipase|pancrelipase|mesh-list
44492990|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44492991|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
44492992|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44492993|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
44492994|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44492995|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44492996|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44492997|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44492998|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44492999|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
44493000|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493001|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493002|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44493003|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493004|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
44493005|NCT01929824|Protective Agents|protective agents|mesh-ancestor
44493006|NCT01929941|Gemcitabine|gemcitabine|mesh-list
44493007|NCT01929941|Paclitaxel|paclitaxel|mesh-list
44493008|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44493009|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493010|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493011|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493012|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493013|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493014|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493015|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
44493016|NCT01929941|Antiviral Agents|antiviral agents|mesh-ancestor
44493017|NCT01929941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493018|NCT01929941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493019|NCT01929941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493020|NCT01929941|Immunologic Factors|immunologic factors|mesh-ancestor
44493021|NCT01929941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493022|NCT01920737|Leucovorin|leucovorin|mesh-list
44493023|NCT01920737|Cytarabine|cytarabine|mesh-list
44493024|NCT01920737|Dexamethasone|dexamethasone|mesh-list
44493025|NCT01920737|Prednisone|prednisone|mesh-list
44493026|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
44493027|NCT01920737|Methotrexate|methotrexate|mesh-list
44493028|NCT01920737|Vincristine|vincristine|mesh-list
44493029|NCT01920737|Daunorubicin|daunorubicin|mesh-list
44493030|NCT01920737|Asparaginase|asparaginase|mesh-list
44493031|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
44493032|NCT01920737|Pegaspargase|pegaspargase|mesh-list
44493033|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493034|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
44493035|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493036|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493037|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44493038|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
44493039|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493040|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493041|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44493042|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493043|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
44493044|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
44493045|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493046|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493047|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
44493048|NCT01920737|Hormones|hormones|mesh-ancestor
44493049|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493050|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44493051|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44493052|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
44493053|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44312185|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493054|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493055|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
44493056|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493057|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493058|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44234839|NCT00551109|SA 4503|sa 4503|mesh-list
44493059|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44493060|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
44493061|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493062|NCT01920737|Antidotes|antidotes|mesh-ancestor
44493063|NCT01920737|Protective Agents|protective agents|mesh-ancestor
44493064|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
44493066|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
44493067|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44493068|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493069|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493070|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493071|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44493072|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44493073|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44493074|NCT01927198|Verinurad|verinurad|mesh-list
44493075|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
44493076|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493077|NCT01922843|Calcitriol|calcitriol|mesh-list
44493078|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44493079|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493080|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44493081|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493082|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493083|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44493084|NCT01922843|Vitamins|vitamins|mesh-ancestor
44493085|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
44493086|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44493087|NCT01921218|Cyclosporine|cyclosporine|mesh-list
44493088|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
44493089|NCT01921218|Prednisone|prednisone|mesh-list
44493090|NCT01921218|Abatacept|abatacept|mesh-list
44493091|NCT01921218|Tacrolimus|tacrolimus|mesh-list
44493092|NCT01921218|Cyclosporins|cyclosporins|mesh-list
44493093|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44493094|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493095|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
44493096|NCT01921218|Hormones|hormones|mesh-ancestor
44493097|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493098|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493099|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44493100|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493101|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493102|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
44493103|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493104|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493105|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
44493106|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493107|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493108|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493109|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44493110|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44493111|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
44493112|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493113|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44493114|NCT01926197|Leucovorin|leucovorin|mesh-list
44493115|NCT01926197|Fluorouracil|fluorouracil|mesh-list
44493116|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
44493117|NCT01926197|Irinotecan|irinotecan|mesh-list
44493118|NCT01926197|Camptothecin|camptothecin|mesh-list
44493119|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
44493120|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493121|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493122|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493123|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493124|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
44493125|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493126|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44493127|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44493128|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493129|NCT01926197|Antidotes|antidotes|mesh-ancestor
44493130|NCT01926197|Protective Agents|protective agents|mesh-ancestor
44493131|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
44493132|NCT01926197|Vitamins|vitamins|mesh-ancestor
44493133|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
44493134|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44493135|NCT01922076|Adavosertib|adavosertib|mesh-list
43903576|NCT00138125|Fulvestrant|fulvestrant|mesh-list
44493136|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493137|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493138|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
44493139|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
44493141|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
44493142|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493143|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
44493144|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
44493145|NCT01923064|Polidocanol|polidocanol|mesh-list
44493146|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493147|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44493148|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44493149|NCT01925027|Sirolimus|sirolimus|mesh-list
44493150|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493151|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493152|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44493153|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493154|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
44493155|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493156|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
44493157|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493158|NCT01925937|Ubiquinone|ubiquinone|mesh-list
44493159|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
44493160|NCT01925937|Atorvastatin|atorvastatin|mesh-list
44493161|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44493162|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44493163|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
44493164|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493165|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44493166|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44493167|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493168|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
44493169|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493170|NCT01925937|Vitamins|vitamins|mesh-ancestor
44493171|NCT01926041|Varenicline|varenicline|mesh-list
44493172|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44493173|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44493174|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
44493175|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493176|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493177|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493178|NCT01926158|Denosumab|denosumab|mesh-list
44493179|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44493180|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493181|NCT01929382|Interferons|interferons|mesh-list
44493182|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
44493183|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493184|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
44493185|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493186|NCT00981890|Sunitinib|sunitinib|mesh-list
44493187|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493188|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44493189|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44493190|NCT00981890|Growth Substances|growth substances|mesh-ancestor
44493191|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493192|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
44493193|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44493194|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493195|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493196|NCT00988260|Ganirelix|ganirelix|mesh-list
44493197|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
44493198|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493199|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493200|NCT00989963|Beraprost|beraprost|mesh-list
44493201|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44493202|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493203|NCT00989950|Methylphenidate|methylphenidate|mesh-list
44493204|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44493205|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493206|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44493207|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493208|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493209|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493210|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
44312408|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493211|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493212|NCT00989781|Dexamethasone|dexamethasone|mesh-list
44493213|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44493214|NCT00989781|Hormones|hormones|mesh-list
44493215|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44493216|NCT00989781|Cosyntropin|cosyntropin|mesh-list
44493217|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44493218|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44493219|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
44493220|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493221|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
44493222|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
44493223|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493224|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493225|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493226|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
44493227|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493228|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44493229|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493230|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44493231|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949734|NCT03465527|Prednisolone|prednisolone|mesh-list
44493232|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493233|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
44493234|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493235|NCT00989235|Abatacept|abatacept|mesh-list
44493236|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44493237|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493238|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493239|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493240|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
44493241|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493242|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493243|NCT00989196|Factor VIII|factor viii|mesh-list
44493244|NCT00989196|Coagulants|coagulants|mesh-ancestor
44493245|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
44493246|NCT00989092|Hematinics|hematinics|mesh-ancestor
44493248|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493249|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493250|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493251|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44493252|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44493253|NCT00988559|Imiquimod|imiquimod|mesh-list
44493254|NCT00988559|Vaccines|vaccines|mesh-list
44493255|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
44493256|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493257|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44493258|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493259|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
44493260|NCT00988533|Ivermectin|ivermectin|mesh-list
44493261|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44493262|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493263|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44493264|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493265|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44493266|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493267|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493268|NCT00988117|Rivastigmine|rivastigmine|mesh-list
44493269|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44493270|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493271|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493272|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
44493273|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493274|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493275|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44493276|NCT00988117|Protective Agents|protective agents|mesh-ancestor
44493277|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
44493278|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44493279|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
44667707|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
44493280|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493281|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
44493282|NCT00988091|Protective Agents|protective agents|mesh-ancestor
44493283|NCT00987935|Sorafenib|sorafenib|mesh-list
44493284|NCT00987935|Nintedanib|nintedanib|mesh-list
44493285|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493286|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44493287|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493288|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493289|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
44493290|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44493291|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493292|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
44493293|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
44493294|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493295|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493296|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493297|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
44493298|NCT00987831|Hormones|hormones|mesh-ancestor
44493299|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493300|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44493301|NCT00987831|Protective Agents|protective agents|mesh-ancestor
44493302|NCT00987467|Cyclosporine|cyclosporine|mesh-list
44493303|NCT00987467|Cyclosporins|cyclosporins|mesh-list
44493304|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493305|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493306|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493307|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
44493308|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493309|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
44493310|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493311|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493312|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493313|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44493315|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44493316|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493317|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493318|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493319|NCT00986986|Niacin|niacin|mesh-list
44493320|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44493321|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
44493322|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493323|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44493324|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493325|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
44493326|NCT00986986|Vitamins|vitamins|mesh-ancestor
44493327|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
44493328|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493329|NCT00986921|Mifepristone|mifepristone|mesh-list
44493330|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44493331|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
44493332|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44493333|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493334|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44493335|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43949791|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
44493336|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44493337|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
44493338|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44493339|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44493340|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
44493341|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493342|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
44493343|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44493344|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44493345|NCT00986674|Paclitaxel|paclitaxel|mesh-list
44493346|NCT00986674|Carboplatin|carboplatin|mesh-list
44493347|NCT00986674|Cetuximab|cetuximab|mesh-list
44493348|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44493349|NCT00986674|Antibodies|antibodies|mesh-list
44493350|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
44493351|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44493352|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44493353|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493354|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493355|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493356|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493357|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493358|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
44493359|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493360|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
44493361|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44493362|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44493363|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44493364|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493365|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493366|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
44493367|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493368|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493369|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44493370|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493371|NCT00986440|Efatutazone|efatutazone|mesh-list
44493372|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493373|NCT00986427|Cyclosporine|cyclosporine|mesh-list
44493374|NCT00986427|Cyclosporins|cyclosporins|mesh-list
44493375|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234898|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493376|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493378|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
44493379|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493380|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
44493381|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493382|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493383|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493384|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44493385|NCT00986258|Tapentadol|tapentadol|mesh-list
44493386|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493387|NCT00986258|Narcotics|narcotics|mesh-ancestor
44493388|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493389|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493390|NCT00986258|Analgesics|analgesics|mesh-ancestor
44493391|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
44493392|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493393|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44493394|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493395|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493396|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493397|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
44493398|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493399|NCT00986180|Oxycodone|oxycodone|mesh-list
44493400|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493401|NCT00986180|Narcotics|narcotics|mesh-ancestor
44493402|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493403|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493404|NCT00986180|Analgesics|analgesics|mesh-ancestor
44493405|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
44493406|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493407|NCT00986102|Doripenem|doripenem|mesh-list
44493408|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493409|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493410|NCT00985959|Prednisolone|prednisolone|mesh-list
44493411|NCT00985959|Bortezomib|bortezomib|mesh-list
44493412|NCT00985959|Melphalan|melphalan|mesh-list
44493413|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493414|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44493415|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
44493416|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493417|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44493418|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493419|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
44493420|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493421|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493422|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
44493423|NCT00985959|Hormones|hormones|mesh-ancestor
44493424|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493425|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44493426|NCT00985946|Panobinostat|panobinostat|mesh-list
44493427|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493428|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44493429|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493430|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493431|NCT00985751|Vaccines|vaccines|mesh-list
44493432|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44493433|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
44493434|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493435|NCT00985738|Dutasteride|dutasteride|mesh-list
44493436|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44493437|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44493438|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493439|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493440|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
44493441|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493442|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493443|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44493444|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44493445|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493446|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44493447|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493448|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493449|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493451|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493452|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
44493453|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44493454|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493455|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44493456|NCT00985504|Citalopram|citalopram|mesh-list
44493457|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44493458|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493459|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949903|NCT02410512|Atezolizumab|atezolizumab|mesh-list
44493460|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493461|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493462|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
44493463|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493464|NCT00985504|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44493465|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
44493466|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44493467|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493468|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44493469|NCT00985504|Analgesics|analgesics|mesh-ancestor
44493470|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
44493471|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
44493472|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44493473|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
44493474|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493475|NCT00985439|Celecoxib|celecoxib|mesh-list
44493476|NCT00985439|Diclofenac|diclofenac|mesh-list
44493477|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44493478|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44493479|NCT00985439|Analgesics|analgesics|mesh-ancestor
44493480|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
44493481|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493482|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493483|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493484|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493485|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44493486|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44493487|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493488|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493489|NCT00985426|Vaccines|vaccines|mesh-list
44493490|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
44493491|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493492|NCT00985192|Everolimus|everolimus|mesh-list
44493493|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493494|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493495|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
44493496|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493497|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
44493498|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44493499|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493500|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44493501|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493502|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44493503|NCT00984568|Prednisolone|prednisolone|mesh-list
44493504|NCT00984568|Mesalamine|mesalamine|mesh-list
44493505|NCT00984568|Azathioprine|azathioprine|mesh-list
44493506|NCT00984568|Infliximab|infliximab|mesh-list
44493507|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493508|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
44493509|NCT00984568|Hormones|hormones|mesh-ancestor
44493510|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493511|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493512|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44493513|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493514|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493515|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493516|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493517|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493518|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
44493519|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234909|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493520|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493521|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493522|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
44493523|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44493524|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44493525|NCT00984568|Analgesics|analgesics|mesh-ancestor
44493526|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
44493527|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
44493528|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493529|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493530|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44493531|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44493532|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
44493533|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493534|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493535|NCT00984256|Atovaquone|atovaquone|mesh-list
44493536|NCT00984256|Proguanil|proguanil|mesh-list
44493537|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44493538|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493539|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
44493540|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44493541|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44493542|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493543|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493544|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
44493545|NCT00984061|Clarithromycin|clarithromycin|mesh-list
44493546|NCT00984061|Colchicine|colchicine|mesh-list
44493547|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493548|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493549|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44493550|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493551|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493552|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44493553|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44493554|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
44493555|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493556|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493557|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493558|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493559|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493560|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44493561|NCT00984022|Laxatives|laxatives|mesh-ancestor
44493562|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493563|NCT00984009|Colchicine|colchicine|mesh-list
44493564|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
44493565|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493566|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493567|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493568|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493569|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493570|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493571|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
44493572|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44493573|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44493574|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
44493575|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44493576|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493577|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44493578|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44493579|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44493580|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493581|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493582|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44493583|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44493584|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493585|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493586|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493587|NCT00983931|Cyclosporine|cyclosporine|mesh-list
44493588|NCT00983931|Colchicine|colchicine|mesh-list
44493589|NCT00983931|Cyclosporins|cyclosporins|mesh-list
44493590|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493591|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493592|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493593|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
44493594|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493595|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
44493596|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493597|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493598|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493599|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44493600|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
44493601|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493602|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493603|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493604|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493605|NCT00983918|Propofol|propofol|mesh-list
44493606|NCT00983918|Sevoflurane|sevoflurane|mesh-list
44493607|NCT00983918|Desflurane|desflurane|mesh-list
44493608|NCT00983918|Isoflurane|isoflurane|mesh-list
44493609|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44493610|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493611|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493612|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44493613|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
44493614|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
44493615|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44493616|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44493617|NCT00983905|Colchicine|colchicine|mesh-list
44493618|NCT00983905|Theophylline|theophylline|mesh-list
44493619|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
44493620|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493621|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493622|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493623|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493624|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493625|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493626|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44493627|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
44493628|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493629|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493630|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44493631|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
44493632|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44493633|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493634|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493635|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44493636|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44493637|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
44493638|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493639|NCT00983853|Ribavirin|ribavirin|mesh-list
44493640|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44493641|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
44493642|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493643|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
44493644|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493645|NCT00983580|Aspirin|aspirin|mesh-list
44493646|NCT00983580|Eflornithine|eflornithine|mesh-list
44493647|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44493648|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44493649|NCT00983580|Analgesics|analgesics|mesh-ancestor
44493650|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
44493651|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493652|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493653|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493654|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950091|NCT01133158|Dexamethasone|dexamethasone|mesh-list
44493655|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44493656|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44493657|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493658|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44493659|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44493660|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493661|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
44493662|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493663|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44493664|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44493665|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44493666|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493667|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44493668|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
44493669|NCT00983528|Clofarabine|clofarabine|mesh-list
44493670|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44493671|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493672|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493673|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
44493674|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493675|NCT00983515|Ritonavir|ritonavir|mesh-list
44493676|NCT00983515|Colchicine|colchicine|mesh-list
44493677|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44493678|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44493679|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44493680|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493681|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493682|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44493683|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44493684|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
44493685|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493686|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44493687|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44493688|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
44493689|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493690|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493691|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493692|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493693|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493694|NCT00983372|Colchicine|colchicine|mesh-list
44493695|NCT00983372|Diltiazem|diltiazem|mesh-list
44493696|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
44493697|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493698|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493699|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493700|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493701|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493702|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493703|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44493704|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44493705|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493706|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44493707|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493708|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493709|NCT00983294|Azithromycin|azithromycin|mesh-list
44493710|NCT00983294|Colchicine|colchicine|mesh-list
44493711|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493712|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493713|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
44493714|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493715|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
44493716|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
44493717|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493718|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493719|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493720|NCT00983073|Tapentadol|tapentadol|mesh-list
44493721|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493722|NCT00983073|Narcotics|narcotics|mesh-ancestor
44493723|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493724|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493725|NCT00983073|Analgesics|analgesics|mesh-ancestor
44493726|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
44493727|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493728|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44493729|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493730|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493731|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493732|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
44493733|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493734|NCT00982930|Tobramycin|tobramycin|mesh-list
44493735|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493736|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493737|NCT00982878|Maraviroc|maraviroc|mesh-list
44493738|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44493739|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44493740|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493741|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44493742|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44493743|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
44493744|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493745|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44493746|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
43950202|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
44493747|NCT00982488|Dasatinib|dasatinib|mesh-list
44493748|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493749|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44493750|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493751|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493752|NCT00982280|Tapentadol|tapentadol|mesh-list
44493753|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493754|NCT00982280|Narcotics|narcotics|mesh-ancestor
44493755|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493756|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493757|NCT00982280|Analgesics|analgesics|mesh-ancestor
44493758|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
44493759|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493760|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44493761|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493762|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493763|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493764|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
44493765|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493766|NCT00982020|Olanzapine|olanzapine|mesh-list
44493767|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
44493768|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
44493769|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493770|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493771|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493772|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44493773|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44493774|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493775|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44493776|NCT00982020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44493777|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493778|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493779|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493780|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493781|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
44493782|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
43950228|NCT01137890|Zonisamide|zonisamide|mesh-list
44493783|NCT00981799|Methotrexate|methotrexate|mesh-list
44493784|NCT00981799|Etoposide|etoposide|mesh-list
44493785|NCT00981799|Lenograstim|lenograstim|mesh-list
44493786|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44493787|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
44493788|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493789|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493790|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44493791|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
44493792|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493793|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493794|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44493795|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44493796|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
44493797|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44493798|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44493799|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
44493800|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493801|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493802|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44493803|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44493804|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44493805|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44493806|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44493807|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44493808|NCT00981747|Losartan|losartan|mesh-list
44493809|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
44493810|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
44493811|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44493812|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44493813|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493814|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493815|NCT00981747|Urological Agents|urological agents|mesh-ancestor
44493816|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44493817|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44493818|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44493819|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44493820|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44493821|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44493822|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493823|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493824|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493825|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493826|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493827|NCT00981149|Analgesics|analgesics|mesh-ancestor
44493828|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
44493829|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493830|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
44493831|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44493832|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
44493833|NCT00981084|Modafinil|modafinil|mesh-list
44493834|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44493835|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493836|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44493837|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44312961|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
44493838|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44493839|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493840|NCT00980798|Hydromorphone|hydromorphone|mesh-list
44493841|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493842|NCT00980798|Narcotics|narcotics|mesh-ancestor
44493843|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493844|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493845|NCT00980798|Analgesics|analgesics|mesh-ancestor
44493846|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
44493847|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493848|NCT00980330|Ribavirin|ribavirin|mesh-list
44493849|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44493850|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
44493851|NCT00980330|Simeprevir|simeprevir|mesh-list
44493852|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
44493853|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493854|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
43950309|NCT01139515|Eletriptan|eletriptan|mesh-list
44493855|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493856|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493857|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
44493858|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493859|NCT00980174|Denosumab|denosumab|mesh-list
44493860|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44493861|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493862|NCT00980148|Azithromycin|azithromycin|mesh-list
44493863|NCT00980148|Doxycycline|doxycycline|mesh-list
44493864|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44493865|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44493866|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
44493867|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44493868|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44493869|NCT00980044|Tramadol|tramadol|mesh-list
44493870|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44493871|NCT00980044|Narcotics|narcotics|mesh-ancestor
44493872|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493873|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493874|NCT00980044|Analgesics|analgesics|mesh-ancestor
44493875|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
44493876|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493877|NCT00988247|Beclomethasone|beclomethasone|mesh-list
44493878|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493879|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
44493880|NCT00988247|Hormones|hormones|mesh-ancestor
44493881|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44493882|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493883|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44493884|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
44493885|NCT00983437|Modafinil|modafinil|mesh-list
44493886|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44493887|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493888|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44493889|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44493890|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44493891|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493892|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44493893|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44493894|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44493895|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44493896|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44493897|NCT00987272|Analgesics|analgesics|mesh-ancestor
44493898|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
44493899|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493900|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493901|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493902|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493903|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44493904|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44493905|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44493906|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
44493907|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
44493908|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493909|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493910|NCT00986882|Ibuprofen|ibuprofen|mesh-list
44493911|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313027|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
44493912|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44493914|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
44493915|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493916|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493917|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493918|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493919|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44493920|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493921|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493922|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
44493923|NCT00982696|Mitogens|mitogens|mesh-list
44493924|NCT00982696|Enkephalins|enkephalins|mesh-list
44493925|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
44493926|NCT00982696|Narcotics|narcotics|mesh-ancestor
44493927|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493928|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493929|NCT00982696|Analgesics|analgesics|mesh-ancestor
44493930|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
44493931|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493932|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44493933|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493934|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493935|NCT00981617|ALKS-33|alks-33|mesh-list
44493936|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44493937|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493938|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
44493939|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493940|NCT00984659|Fluticasone|fluticasone|mesh-list
44493941|NCT00984659|Xhance|xhance|mesh-list
44493942|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44493943|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44493944|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44493945|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
44493946|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493947|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493948|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44493949|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
44493950|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
44493951|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44493952|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44493953|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44493954|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44493955|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
44493956|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493957|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493958|NCT00981526|Telmisartan|telmisartan|mesh-list
44493959|NCT00981526|Olanzapine|olanzapine|mesh-list
44493960|NCT00981526|Clozapine|clozapine|mesh-list
44493961|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
44493962|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
44493963|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44493964|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493965|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44493966|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44493967|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44493968|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44493969|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44493970|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44493971|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44493972|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44493973|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493974|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493975|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
44493976|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44493977|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44493978|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44493979|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44493980|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
44493981|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
44493982|NCT00983814|Carbidopa|carbidopa|mesh-list
44493983|NCT00983814|Droxidopa|droxidopa|mesh-list
44493984|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44493985|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44493986|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
44313109|NCT00901875|Buprenorphine|buprenorphine|mesh-list
44493987|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44493988|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44493989|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493990|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44493991|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44493992|NCT00983619|Rituximab|rituximab|mesh-list
44493993|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44493994|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44493995|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
44493996|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44493997|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44493999|NCT00981656|Fluorouracil|fluorouracil|mesh-list
44494000|NCT00981656|Mitomycins|mitomycins|mesh-list
44494001|NCT00981656|Mitomycin|mitomycin|mesh-list
44494002|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494003|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
44494004|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494005|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494006|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494007|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
44494008|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494009|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44494010|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
44494011|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44494012|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494013|NCT04557163|Itraconazole|itraconazole|mesh-list
44494014|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
44494015|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494016|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44494017|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44494018|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494019|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950471|NCT01144338|Exenatide|exenatide|mesh-list
44494020|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44494021|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494022|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494023|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494024|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44494025|NCT04552808|Yimitasvir|yimitasvir|mesh-list
44494026|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
44494027|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494028|NCT04553003|Prednisone|prednisone|mesh-list
44494029|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
44494030|NCT04553003|Choline|choline|mesh-list
44494031|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
44494032|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
44494033|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494034|NCT04553003|Hormones|hormones|mesh-ancestor
44494035|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494036|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494037|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494038|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494039|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
44494040|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
44494041|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494042|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494043|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44494044|NCT04553003|Protective Agents|protective agents|mesh-ancestor
44494045|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
44494046|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44494047|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
44494048|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494049|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44494050|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
44494051|NCT04555291|Ropivacaine|ropivacaine|mesh-list
44494052|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494053|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
44494054|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494055|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494056|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
44494057|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494058|NCT04556370|Norepinephrine|norepinephrine|mesh-list
44494059|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44494060|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44494061|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
44494062|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494063|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494064|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494065|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
44494066|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
44494067|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494068|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44494069|NCT04559347|Bupivacaine|bupivacaine|mesh-list
44494070|NCT04559347|Ropivacaine|ropivacaine|mesh-list
44494071|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494072|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
44494073|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494074|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494075|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
44494076|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494077|NCT04557085|Cenobamate|cenobamate|mesh-list
44494078|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
44494079|NCT04552782|Ethanol|ethanol|mesh-list
44494080|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44494081|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494082|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494083|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494084|NCT04555811|Rituximab|rituximab|mesh-list
44494085|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494086|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494087|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
44494088|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494089|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494090|NCT04558502|Amoxicillin|amoxicillin|mesh-list
44494091|NCT04558502|Clarithromycin|clarithromycin|mesh-list
44494092|NCT04558502|Minocycline|minocycline|mesh-list
44494093|NCT04558502|Esomeprazole|esomeprazole|mesh-list
44494094|NCT04558502|Bismuth|bismuth|mesh-list
44494095|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494096|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494097|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44494098|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494099|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44494100|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494101|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494102|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44494103|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44494104|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44494105|NCT04558502|Antacids|antacids|mesh-ancestor
44494106|NCT04553419|Cephalexin|cephalexin|mesh-list
44494107|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494108|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494109|NCT04557449|Letrozole|letrozole|mesh-list
44494110|NCT04557449|Fulvestrant|fulvestrant|mesh-list
44494111|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494112|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44494113|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44494114|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494115|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494116|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44494117|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494118|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494119|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494120|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494121|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44494122|NCT04559646|Hemostatics|hemostatics|mesh-list
44494123|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44494124|NCT04559646|Coagulants|coagulants|mesh-ancestor
44313195|NCT00902460|Midazolam|midazolam|mesh-list
44494125|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44494126|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44494127|NCT04557956|Trametinib|trametinib|mesh-list
44494128|NCT04557956|Dabrafenib|dabrafenib|mesh-list
44494129|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44494130|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494131|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494132|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494133|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494134|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44494135|NCT04557956|Protective Agents|protective agents|mesh-ancestor
44494136|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494137|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44494138|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
44494139|NCT04550520|Glucagon|glucagon|mesh-list
44494140|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494141|NCT04550520|Hormones|hormones|mesh-ancestor
44494142|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494143|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494144|NCT04553705|Quinine|quinine|mesh-list
44494145|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
44494146|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44494147|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44494148|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494149|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44494150|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494151|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44494152|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494153|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494154|NCT04553705|Analgesics|analgesics|mesh-ancestor
44494155|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
44494156|NCT04556084|Blinatumomab|blinatumomab|mesh-list
44494157|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494158|NCT04554888|Doxepin|doxepin|mesh-list
44494159|NCT04554888|Histamine|histamine|mesh-list
44494160|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
44494161|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
44494162|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494163|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494164|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494165|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44494166|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44494167|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494168|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44494169|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
44494170|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494171|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
44494172|NCT04551963|Clarithromycin|clarithromycin|mesh-list
44494173|NCT04551963|Fluconazole|fluconazole|mesh-list
44494174|NCT04551963|Voriconazole|voriconazole|mesh-list
44494175|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
44494176|NCT04551963|Diltiazem|diltiazem|mesh-list
44494177|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494178|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494179|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44494180|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494181|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494182|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44494183|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44494184|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
44494185|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44494186|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44494187|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494188|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494189|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494190|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44494191|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44494192|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44494193|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44494194|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494195|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44494196|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
44494197|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494198|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494199|NCT04557189|Ondansetron|ondansetron|mesh-list
44494200|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
44494201|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
44494202|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494203|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494204|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494205|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
44494206|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44494207|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44494208|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
44494209|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494210|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494211|NCT04557189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44494212|NCT04557189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44494213|NCT04557189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494214|NCT04557189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494215|NCT04557189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44494216|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
44494217|NCT04550624|Lenvatinib|lenvatinib|mesh-list
44494218|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494219|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494220|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494221|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494222|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494223|NCT04550546|Nystatin|nystatin|mesh-list
44494224|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494225|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494226|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
44494227|NCT04550546|Ionophores|ionophores|mesh-ancestor
44494228|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494229|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494230|NCT04552535|Afatinib|afatinib|mesh-list
44494231|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494232|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494233|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494234|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494235|NCT05607615|Betadex|betadex|mesh-list
44494236|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
44494237|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494238|NCT05603741|Lidocaine|lidocaine|mesh-list
44494239|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494240|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
44494241|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494242|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494243|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
44494244|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494245|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44494246|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44494247|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44494248|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494249|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494250|NCT05601999|Tenecteplase|tenecteplase|mesh-list
44494251|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44494252|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44494253|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494254|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44494255|NCT05601973|Lazertinib|lazertinib|mesh-list
44494256|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494257|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494258|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494259|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494260|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494261|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
44494262|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44494263|NCT05601960|Protective Agents|protective agents|mesh-ancestor
44494264|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494265|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
44494266|NCT05601830|Cytarabine|cytarabine|mesh-list
44494267|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
44494268|NCT05601830|Fludarabine|fludarabine|mesh-list
44494269|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494270|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
44494271|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494272|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494273|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44494274|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
44494275|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494276|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494277|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44494278|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494279|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
44494280|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
44494281|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494282|NCT05601817|Tocopherols|tocopherols|mesh-list
44494284|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
44494285|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
44494286|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494287|NCT05601817|Protective Agents|protective agents|mesh-ancestor
44494288|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494289|NCT05601817|Vitamins|vitamins|mesh-ancestor
44494290|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
44494291|NCT05601752|Nivolumab|nivolumab|mesh-list
44494292|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494293|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494294|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44494295|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494296|NCT05601700|Paclitaxel|paclitaxel|mesh-list
44494297|NCT05601700|Carboplatin|carboplatin|mesh-list
44494298|NCT05601700|Letrozole|letrozole|mesh-list
44494299|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44494300|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494301|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44494302|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44494303|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44494304|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494305|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44494306|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44494307|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494308|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44494309|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494310|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494311|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494312|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
44494313|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
44494314|NCT05601479|Vitamins|vitamins|mesh-ancestor
44494315|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
44494316|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494317|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
44494318|NCT05601466|Cytarabine|cytarabine|mesh-list
44494319|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
44494320|NCT05601466|Fludarabine|fludarabine|mesh-list
44494321|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494322|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
44494323|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494324|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494325|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44494326|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
44494327|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494328|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494329|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44494330|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494331|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
44494332|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
44494333|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494334|NCT05601336|Metformin|metformin|mesh-list
44494335|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
44494336|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44494337|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494338|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44494339|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494340|NCT05601271|Allopurinol|allopurinol|mesh-list
44494341|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
44494342|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494343|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494344|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
44494345|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494346|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44494347|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
44494348|NCT05601271|Protective Agents|protective agents|mesh-ancestor
44494349|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494351|NCT05600894|Venetoclax|venetoclax|mesh-list
44494352|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494353|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
44494354|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494355|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494356|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494357|NCT05600881|Methylphenidate|methylphenidate|mesh-list
44494358|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44494359|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494360|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44494361|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44494362|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494363|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494364|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
44494365|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494366|NCT05607940|Chrysarobin|chrysarobin|mesh-list
44494367|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44494368|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494369|NCT05607940|Analgesics|analgesics|mesh-ancestor
44494370|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
44494371|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494372|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494373|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494374|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494375|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
44494376|NCT05607901|Tacrolimus|tacrolimus|mesh-list
44494377|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494378|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
44494379|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494380|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44494381|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494382|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494383|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494384|NCT05607810|Aflibercept|aflibercept|mesh-list
44494385|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44494386|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44494387|NCT05607810|Growth Substances|growth substances|mesh-ancestor
44494388|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494389|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
44494390|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494391|NCT05607641|Ketorolac|ketorolac|mesh-list
44494392|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44494393|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44494394|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44494395|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494396|NCT05607641|Analgesics|analgesics|mesh-ancestor
44494397|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
44494398|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494399|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494400|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494401|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494402|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44494403|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494404|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494405|NCT05607446|Montelukast|montelukast|mesh-list
44494406|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44494407|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
44494408|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44494409|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494410|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494411|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494412|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44494413|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44494414|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494416|NCT05607303|Hormones|hormones|mesh-ancestor
44494417|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494418|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494419|NCT05607199|Calcium|calcium|mesh-list
44494420|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44494421|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494422|NCT05607017|Losartan|losartan|mesh-list
44494423|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44494424|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43950810|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
44494425|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44494426|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44494427|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494428|NCT05606913|Dulaglutide|dulaglutide|mesh-list
44494429|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44494430|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494431|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44494432|NCT05606796|Latanoprost|latanoprost|mesh-list
44494433|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44494434|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
44494435|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44494436|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494437|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44313570|NCT00904202|Lidocaine|lidocaine|mesh-list
44494438|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494439|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
44494440|NCT05609578|Adagrasib|adagrasib|mesh-list
44494441|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494442|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494443|NCT05600387|Empagliflozin|empagliflozin|mesh-list
44494444|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44494445|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494446|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44494447|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494448|NCT05600114|Cannabidiol|cannabidiol|mesh-list
44494449|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44494450|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
44494451|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44494452|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494453|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494454|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44494455|NCT05603039|Bevacizumab|bevacizumab|mesh-list
44494456|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494457|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494458|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44494459|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44494460|NCT05603039|Growth Substances|growth substances|mesh-ancestor
44494461|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494462|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44494463|NCT05603013|Vinorelbine|vinorelbine|mesh-list
44494464|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44494465|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44494466|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494467|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44494468|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44494469|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44494470|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494471|NCT05602428|Anesthetics|anesthetics|mesh-list
44494472|NCT05602428|Esketamine|esketamine|mesh-list
44494473|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494474|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494475|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
44494476|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494477|NCT05602194|Asparaginase|asparaginase|mesh-list
44494478|NCT05602194|Pegaspargase|pegaspargase|mesh-list
44494479|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494480|NCT05602129|Heparin|heparin|mesh-list
44494481|NCT05602129|Calcium heparin|calcium heparin|mesh-list
44494482|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
44494483|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44494484|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44494485|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494486|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43904901|NCT00193453|Gemcitabine|gemcitabine|mesh-list
44494496|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494497|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44494498|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494499|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494500|NCT05609903|Paclitaxel|paclitaxel|mesh-list
44494501|NCT05609903|Atezolizumab|atezolizumab|mesh-list
44494502|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44494503|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494504|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
44494505|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
44494506|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
44494507|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494517|NCT05609630|Upadacitinib|upadacitinib|mesh-list
44494518|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44494519|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494520|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494521|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494522|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494523|NCT05609500|Warfarin|warfarin|mesh-list
44494524|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
44494525|NCT05609253|Itraconazole|itraconazole|mesh-list
44494526|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44494527|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
44494528|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494529|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44494530|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44494531|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494532|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494533|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44494534|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494535|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494536|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494537|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44494538|NCT05608837|Dexamethasone|dexamethasone|mesh-list
44494539|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494540|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
44494541|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
44494542|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494543|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313689|NCT00904605|Celecoxib|celecoxib|mesh-list
44494544|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494545|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
44494546|NCT05608837|Hormones|hormones|mesh-ancestor
44494547|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494548|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494549|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494550|NCT05608785|Capecitabine|capecitabine|mesh-list
44494551|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
44494552|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494553|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
44494554|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494555|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494556|NCT05608642|Prednisolone|prednisolone|mesh-list
44494558|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494559|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
44494560|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494561|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494562|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
44494563|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494564|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44494565|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44494566|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44494567|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494568|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950943|NCT01158820|Analgesics|analgesics|mesh-ancestor
44494569|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494570|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
44494571|NCT05608642|Hormones|hormones|mesh-ancestor
44494572|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494573|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494574|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494575|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
44494576|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494577|NCT05608564|Amoxicillin|amoxicillin|mesh-list
44494578|NCT05608564|Metronidazole|metronidazole|mesh-list
44494579|NCT05608564|Tazobactam|tazobactam|mesh-list
44494580|NCT05608564|Piperacillin|piperacillin|mesh-list
44494581|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494582|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494583|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44494584|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44494585|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44494586|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494587|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494588|NCT05608499|Clobetasol|clobetasol|mesh-list
44494589|NCT05608499|Halobetasol|halobetasol|mesh-list
44494590|NCT05608499|Tazarotene|tazarotene|mesh-list
44494591|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44494592|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
44494593|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44494594|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494595|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
44494596|NCT05608499|Hormones|hormones|mesh-ancestor
44494597|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494598|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494599|NCT05608369|Cisplatin|cisplatin|mesh-list
44494600|NCT05608369|Vorinostat|vorinostat|mesh-list
44494601|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494602|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44494603|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494604|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494605|NCT05608252|Fulvestrant|fulvestrant|mesh-list
44494606|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494607|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494608|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44494609|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44494610|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
44667708|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44494611|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494612|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494613|NCT05608213|Lenvatinib|lenvatinib|mesh-list
44494614|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494615|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494616|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494617|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494618|NCT05608200|Lenvatinib|lenvatinib|mesh-list
44494619|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494620|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44494621|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494622|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494623|NCT05608070|Oxytocin|oxytocin|mesh-list
44494624|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
44494625|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44494626|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494627|NCT05606965|Vaccines|vaccines|mesh-list
44494628|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
44494629|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494630|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44494631|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44494632|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44494633|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494634|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494635|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44494636|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494637|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494638|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
44494639|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494640|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44494641|NCT05604898|Antibodies|antibodies|mesh-list
44494642|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
44494643|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44494644|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
44494645|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494646|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494647|NCT05604300|Vitamin E|vitamin e|mesh-list
44494648|NCT05604300|Vitamins|vitamins|mesh-ancestor
43951040|NCT01160380|Modafinil|modafinil|mesh-list
44494649|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
44494650|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494651|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
44494652|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494653|NCT05604300|Protective Agents|protective agents|mesh-ancestor
44494654|NCT05601167|Ritonavir|ritonavir|mesh-list
44494655|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44494656|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44494657|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
44494658|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494659|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494660|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44494661|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44494662|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
44494663|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494664|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44494665|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44494666|NCT05600660|Rituximab|rituximab|mesh-list
44494667|NCT05600660|Methotrexate|methotrexate|mesh-list
44494668|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44494669|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494670|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
44494671|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494672|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313833|NCT00905190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494673|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44494674|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
44494675|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44494676|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494677|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
44494678|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494679|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
44494680|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494681|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44494682|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494683|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44494684|NCT05606692|Propofol|propofol|mesh-list
44494685|NCT05606692|Sevoflurane|sevoflurane|mesh-list
44494686|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44494687|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494688|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494689|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44494690|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
44494691|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
44494692|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44494693|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44494694|NCT05609565|Bupivacaine|bupivacaine|mesh-list
44494695|NCT05609565|Prilocaine|prilocaine|mesh-list
44494696|NCT05609565|Anesthetics|anesthetics|mesh-list
44494697|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494698|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494699|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494700|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
44494701|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494702|NCT05609240|Cefuroxime|cefuroxime|mesh-list
44494703|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
44494704|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494705|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494706|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44494707|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44494708|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
44494709|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494710|NCT05607407|Methimazole|methimazole|mesh-list
44494711|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
44494712|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
44494713|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494714|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494727|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44494728|NCT05605613|Antibodies|antibodies|mesh-list
44494729|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
44494730|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494731|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494732|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494733|NCT05602259|Dimercaprol|dimercaprol|mesh-list
44494734|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
44494735|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
44494736|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494737|NCT05602480|Vaccines|vaccines|mesh-list
44494738|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
44494739|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494740|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
44494741|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44494742|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
44494743|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494744|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494745|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
44494746|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313908|NCT00905853|Amiodarone|amiodarone|mesh-list
44494748|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44494749|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
44494750|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494751|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494752|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494753|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
44494754|NCT05604859|Heparin|heparin|mesh-list
44141819|NCT00184574|Metformin|metformin|mesh-list
44494755|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44494756|NCT05604859|Tinzaparin|tinzaparin|mesh-list
44494757|NCT05604859|Dalteparin|dalteparin|mesh-list
44494758|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
44494759|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44494760|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
44494761|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44494762|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494763|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
44494764|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
44494765|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494766|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494767|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494768|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
44494769|NCT05604859|Hormones|hormones|mesh-ancestor
44494770|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494771|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44494772|NCT05604859|Protective Agents|protective agents|mesh-ancestor
44494773|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
44494774|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43951101|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44494775|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44494776|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494777|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
44494778|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
44494779|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44494780|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44494781|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44494782|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44494783|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494784|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
44494785|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494786|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494787|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44494788|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494789|NCT05604638|Tenecteplase|tenecteplase|mesh-list
44494790|NCT05604638|Tirofiban|tirofiban|mesh-list
44494791|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44494792|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44494793|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494794|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44494795|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
44494796|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44494797|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
44494798|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494799|NCT05604586|Expectorants|expectorants|mesh-ancestor
44494800|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44494801|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44494802|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
44494803|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494804|NCT05604586|Protective Agents|protective agents|mesh-ancestor
44494805|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494806|NCT05604586|Antidotes|antidotes|mesh-ancestor
44494808|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44494809|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494810|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44494811|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494812|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494813|NCT05604118|Aspirin|aspirin|mesh-list
44494814|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44494815|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494816|NCT05604118|Analgesics|analgesics|mesh-ancestor
44494817|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
44494818|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494819|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494820|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494821|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494822|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44494823|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44494824|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494825|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44494826|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44494828|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
44494829|NCT05603975|Esketamine|esketamine|mesh-list
44494830|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
44494831|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494832|NCT05603884|Cytarabine|cytarabine|mesh-list
44494833|NCT05603884|Azacitidine|azacitidine|mesh-list
44494834|NCT05603884|Venetoclax|venetoclax|mesh-list
44494835|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
44494836|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44494837|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
44494838|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494839|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494840|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
44494841|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494842|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494843|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
44494844|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494845|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494846|NCT05603884|Analgesics|analgesics|mesh-ancestor
44494847|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
44494848|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494849|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44494850|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44494851|NCT05603715|Bromides|bromides|mesh-list
44494852|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44494853|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
44494854|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44494855|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494856|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494857|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
44494858|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494859|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494860|NCT05603650|Listerine|listerine|mesh-list
44494861|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44494862|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494863|NCT05602064|Acetaminophen|acetaminophen|mesh-list
44494864|NCT05602064|Ibuprofen|ibuprofen|mesh-list
44494865|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44494866|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494867|NCT05602064|Analgesics|analgesics|mesh-ancestor
44494868|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
44494869|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494870|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494871|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494872|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494873|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44494874|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494875|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494876|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
44494877|NCT05604794|Ketamine|ketamine|mesh-list
44494878|NCT05604794|Analgesics|analgesics|mesh-ancestor
44494879|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
44494880|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494881|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314055|NCT00906269|Urological Agents|urological agents|mesh-ancestor
44494882|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44494883|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44494884|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
44494885|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
44494886|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494887|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44494888|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44494889|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494890|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494891|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44494893|NCT04120454|Ramucirumab|ramucirumab|mesh-list
44494894|NCT04120454|Antibodies|antibodies|mesh-list
44494895|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
44494896|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44494897|NCT04120454|Lexatumumab|lexatumumab|mesh-list
44494898|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
44494899|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494900|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494901|NCT04129437|Ibuprofen|ibuprofen|mesh-list
44494902|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44494903|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494904|NCT04129437|Analgesics|analgesics|mesh-ancestor
44494905|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
44494906|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494907|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494908|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494909|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494910|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44494911|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494912|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494913|NCT04126278|Dexamethasone|dexamethasone|mesh-list
44494914|NCT04126278|Cortisone|cortisone|mesh-list
44494915|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494916|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
44494917|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
44494918|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494919|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494920|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494921|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
44494922|NCT04126278|Hormones|hormones|mesh-ancestor
44494923|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494924|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494925|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494926|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
44494927|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43951211|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
43951270|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
44494928|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44494929|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494930|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494931|NCT04124497|Dexamethasone|dexamethasone|mesh-list
44494932|NCT04124497|Daratumumab|daratumumab|mesh-list
44494933|NCT04124497|Pomalidomide|pomalidomide|mesh-list
44494934|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44494935|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
44494936|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
44494937|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494938|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494939|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494940|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
44494941|NCT04124497|Hormones|hormones|mesh-ancestor
44494942|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44494943|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44494944|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494945|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
44494946|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44494947|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44494948|NCT04124497|Growth Substances|growth substances|mesh-ancestor
44494949|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
44494950|NCT04123314|Psilocybin|psilocybin|mesh-list
44494951|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
44494952|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494953|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44494954|NCT04127851|Cyclosporine|cyclosporine|mesh-list
44494955|NCT04127851|Cyclosporins|cyclosporins|mesh-list
44494956|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44494957|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44494959|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
44494960|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494961|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
44494962|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494963|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44494964|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905335|NCT00208975|Rituximab|rituximab|mesh-list
44494965|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44494966|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
44494967|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44494968|NCT04126096|Lactams|lactams|mesh-list
44494969|NCT04126096|beta-Lactams|beta-lactams|mesh-list
44494970|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44494971|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494972|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
44494973|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44494974|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
44494975|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494976|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44494977|NCT04124588|Hemostatics|hemostatics|mesh-list
44494978|NCT04124588|Coagulants|coagulants|mesh-ancestor
44494979|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44494980|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44494981|NCT04122755|Buprenorphine|buprenorphine|mesh-list
44494982|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44494983|NCT04122755|Narcotics|narcotics|mesh-ancestor
44494984|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44494985|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44494986|NCT04122755|Analgesics|analgesics|mesh-ancestor
44494987|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
44494988|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44494989|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44494990|NCT04129788|Bisacodyl|bisacodyl|mesh-list
44494991|NCT04129788|Cathartics|cathartics|mesh-ancestor
44494992|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44494993|NCT04129788|Laxatives|laxatives|mesh-ancestor
44494994|NCT04129697|Dexamethasone|dexamethasone|mesh-list
44494995|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
44494996|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43951299|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44494997|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44494998|NCT04129697|Prednisolone|prednisolone|mesh-list
44494999|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
44495000|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44495001|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
44495002|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495003|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
44495004|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
44495005|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495006|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495007|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495008|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
44495009|NCT04129697|Hormones|hormones|mesh-ancestor
44495010|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495011|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495012|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495013|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44495014|NCT04129697|Protective Agents|protective agents|mesh-ancestor
44495015|NCT04129710|Rituximab|rituximab|mesh-list
44495016|NCT04129710|Methotrexate|methotrexate|mesh-list
44495017|NCT04129710|Etoposide|etoposide|mesh-list
44495018|NCT04129710|Lenalidomide|lenalidomide|mesh-list
44495019|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495020|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495021|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
44495022|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495023|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495024|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44495025|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
44495026|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44495027|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495028|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
44495029|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495030|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44495031|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495032|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44314181|NCT00907114|Ketorolac|ketorolac|mesh-list
44495033|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495034|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44495035|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44495036|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44495037|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44495038|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495039|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495040|NCT04129710|Growth Substances|growth substances|mesh-ancestor
44495041|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495042|NCT04129424|Insulin|insulin|mesh-list
44495043|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495044|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495045|NCT04129255|Octreotide|octreotide|mesh-list
44495046|NCT04129255|Somatostatin|somatostatin|mesh-list
44495047|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495048|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495049|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495050|NCT04129255|Hormones|hormones|mesh-ancestor
44495051|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495052|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495053|NCT04129489|Cannabidiol|cannabidiol|mesh-list
44495054|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
44314240|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
44495055|NCT04128787|Omeprazole|omeprazole|mesh-list
44495056|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44495057|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495058|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44495059|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495060|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495061|NCT04128800|Apatinib|apatinib|mesh-list
44495062|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495063|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495064|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495065|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495066|NCT04129008|Aspirin|aspirin|mesh-list
44495067|NCT04129008|Indobufen|indobufen|mesh-list
44495068|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44495069|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495070|NCT04129008|Analgesics|analgesics|mesh-ancestor
44495071|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
44495072|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495073|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495074|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495075|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495076|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44495077|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44495078|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495079|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44495080|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44495081|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495082|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
44495083|NCT04129112|Propofol|propofol|mesh-list
44495084|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
44495085|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495086|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495087|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44495088|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44495089|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
44495090|NCT04128878|Sotalol|sotalol|mesh-list
44495091|NCT04128878|Dofetilide|dofetilide|mesh-list
44495092|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44495093|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44495094|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
44495095|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495096|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495097|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495098|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44495099|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
44495100|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
44495101|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495102|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44495103|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44495104|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
44495105|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495106|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
44495107|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495108|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495109|NCT04128254|Apixaban|apixaban|mesh-list
43951416|NCT01171118|Miotics|miotics|mesh-ancestor
44495110|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44495111|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
44495112|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44495113|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
44495114|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495115|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495116|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
44495117|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
44495118|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495119|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44495120|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495121|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495122|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
44495123|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495124|NCT04128020|Nivolumab|nivolumab|mesh-list
44495125|NCT04128020|Azacitidine|azacitidine|mesh-list
44495126|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495127|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495128|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495129|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495130|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495131|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
44495132|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495133|NCT04127721|Methotrexate|methotrexate|mesh-list
44495134|NCT04127721|Fludarabine|fludarabine|mesh-list
44495135|NCT04127721|Busulfan|busulfan|mesh-list
44495136|NCT04127721|Tacrolimus|tacrolimus|mesh-list
44495137|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44495138|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
44495139|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44495140|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495141|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495142|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
44495143|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495144|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495145|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
44495146|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495147|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44495148|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495149|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
44495150|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495151|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44495152|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44495153|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
44495154|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495155|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44495156|NCT04127396|Sorafenib|sorafenib|mesh-list
44495157|NCT04127396|Lenvatinib|lenvatinib|mesh-list
44495158|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
44495159|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495160|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495161|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495162|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495163|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44495164|NCT04127396|Estrogens|estrogens|mesh-ancestor
44495165|NCT04127396|Hormones|hormones|mesh-ancestor
44495166|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495167|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495168|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495169|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
44495170|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44495171|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495172|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495173|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495174|NCT04127500|Analgesics|analgesics|mesh-ancestor
44495175|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
44495176|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495177|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44495178|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44495179|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44495180|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
44495181|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495182|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495183|NCT04127357|Fluorides|fluorides|mesh-list
44495184|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
44495185|NCT04127357|Protective Agents|protective agents|mesh-ancestor
44495186|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495187|NCT04126941|Calcium|calcium|mesh-list
44495188|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495189|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495190|NCT04127058|Iloperidone|iloperidone|mesh-list
44495191|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44495192|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44495193|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495194|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495195|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44495196|NCT04127019|Paclitaxel|paclitaxel|mesh-list
44495197|NCT04127019|Docetaxel|docetaxel|mesh-list
44495198|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
44495199|NCT04127019|Fluorouracil|fluorouracil|mesh-list
44495200|NCT04127019|Epirubicin|epirubicin|mesh-list
44495201|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44495202|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314388|NCT00908167|Clofarabine|clofarabine|mesh-list
44495203|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
44495204|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
44495205|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
44495206|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495207|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495208|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
44495209|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495210|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495211|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495212|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
44495213|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44495214|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
44495215|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495216|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44495217|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44495218|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44495219|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495220|NCT04126993|Apatinib|apatinib|mesh-list
44495221|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495222|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495223|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495224|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495225|NCT04127227|Gemcitabine|gemcitabine|mesh-list
44495226|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
44495227|NCT04127227|Pegaspargase|pegaspargase|mesh-list
44495228|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495229|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
44495230|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495231|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495232|NCT04127227|Antiviral Agents|antiviral agents|mesh-ancestor
44495233|NCT04127227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495234|NCT04127227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495235|NCT04127227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495236|NCT04127227|Immunologic Factors|immunologic factors|mesh-ancestor
44495237|NCT04127227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495238|NCT04126811|Apatinib|apatinib|mesh-list
44495239|NCT04126811|Ifosfamide|ifosfamide|mesh-list
44495240|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
44495241|NCT04126811|Pirarubicin|pirarubicin|mesh-list
44495242|NCT04126811|Doxorubicin|doxorubicin|mesh-list
44495243|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495244|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495245|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495246|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495247|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495248|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
44495249|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44495250|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44495251|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44495252|NCT04126668|Vorolanib|vorolanib|mesh-list
44495253|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495254|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495255|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495256|NCT04126330|Vitamin D|vitamin d|mesh-list
44495257|NCT04126330|Vitamins|vitamins|mesh-ancestor
44495258|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
44495259|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495260|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44495261|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44495262|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44495263|NCT04126720|Vitamin E|vitamin e|mesh-list
44495264|NCT04126720|Vitamins|vitamins|mesh-ancestor
44495265|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
44495266|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495267|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
44495268|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495269|NCT04126720|Protective Agents|protective agents|mesh-ancestor
44495270|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
44495271|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495272|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
44495273|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44495274|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44495275|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495276|NCT04126252|Urological Agents|urological agents|mesh-ancestor
44495277|NCT04126044|Bevacizumab|bevacizumab|mesh-list
44495278|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495279|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495280|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43951572|NCT01175980|Vorinostat|vorinostat|mesh-list
44495281|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495282|NCT04126044|Growth Substances|growth substances|mesh-ancestor
44495283|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495284|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495285|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44495286|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44495287|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495288|NCT04125719|Nivolumab|nivolumab|mesh-list
44495289|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495290|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495291|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495292|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495293|NCT04125706|Metronidazole|metronidazole|mesh-list
44495294|NCT04125706|Minocycline|minocycline|mesh-list
44495295|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495296|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44495297|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44495298|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44495299|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44495300|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44495301|NCT04125082|Insulin|insulin|mesh-list
44495302|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44495303|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495304|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495305|NCT04124991|Durvalumab|durvalumab|mesh-list
44495306|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495307|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495308|NCT04124822|Prednisolone|prednisolone|mesh-list
44495309|NCT04124822|Piroxicam|piroxicam|mesh-list
44495310|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495311|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
44495312|NCT04124822|Hormones|hormones|mesh-ancestor
44495313|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495314|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495315|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495316|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495317|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951618|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44495318|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44495319|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495320|NCT04124822|Analgesics|analgesics|mesh-ancestor
44495321|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
44495322|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495323|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44495324|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495325|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495326|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
44495327|NCT04124887|Listerine|listerine|mesh-list
44495328|NCT04124887|Calcium|calcium|mesh-list
44495329|NCT04124887|Fluorides|fluorides|mesh-list
44495330|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
44495331|NCT04124887|Caseins|caseins|mesh-list
44495332|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495333|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495334|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44495335|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
44495336|NCT04124887|Protective Agents|protective agents|mesh-ancestor
44495337|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44495338|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495339|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
44495340|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
44495341|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495342|NCT04124913|Progesterone|progesterone|mesh-list
44495343|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
44495344|NCT04124913|Progestins|progestins|mesh-ancestor
44495345|NCT04124913|Hormones|hormones|mesh-ancestor
44495346|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495347|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495348|NCT04124302|Insulin|insulin|mesh-list
44495349|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44495350|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
44495351|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
44495352|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
44495353|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495354|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495355|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44495356|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44495357|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44495358|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
44495359|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495360|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44495361|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44495362|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495363|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
44495364|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44495365|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495366|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
44495367|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495368|NCT04124016|Protective Agents|protective agents|mesh-ancestor
44495369|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495370|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44495371|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44495372|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495373|NCT04124094|Fluticasone|fluticasone|mesh-list
44495374|NCT04124094|Xhance|xhance|mesh-list
44495375|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44495376|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44495377|NCT04124094|Charcoal|charcoal|mesh-list
44495378|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495379|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44495380|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
44495381|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495382|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495383|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44495384|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
44495385|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
44495386|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44495387|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44495388|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44495389|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44495390|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44495391|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495392|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495393|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
44495394|NCT04124094|Hormones|hormones|mesh-ancestor
44495395|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495396|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
44495397|NCT04124094|Antidotes|antidotes|mesh-ancestor
44495398|NCT04124094|Protective Agents|protective agents|mesh-ancestor
44495399|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44495400|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44495401|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495402|NCT04124081|Entecavir|entecavir|mesh-list
44495403|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
44495404|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495405|NCT04123925|Nivolumab|nivolumab|mesh-list
44495406|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495407|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495408|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495409|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495410|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44495411|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495412|NCT04123717|Acetaminophen|acetaminophen|mesh-list
44495413|NCT04123717|Ibuprofen|ibuprofen|mesh-list
44495414|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495415|NCT04123717|Analgesics|analgesics|mesh-ancestor
44495416|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
44495417|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495418|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495419|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
43951708|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495420|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44495421|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495422|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495423|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44495424|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495425|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495426|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
44495427|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44495428|NCT04123743|Protective Agents|protective agents|mesh-ancestor
44495429|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495430|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
44495431|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
44495432|NCT04123392|Busulfan|busulfan|mesh-list
44495434|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495435|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
44495436|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495437|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495438|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495439|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
44495440|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495441|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495442|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44495443|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495444|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
44495445|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495446|NCT04123288|ACT-709478|act-709478|mesh-list
44495447|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44495448|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44495449|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495450|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495451|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495452|NCT04123210|Vitamin A|vitamin a|mesh-list
44495453|NCT04123210|Vitamins|vitamins|mesh-ancestor
44495454|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
44495455|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495456|NCT04123249|Propofol|propofol|mesh-list
44495457|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44495458|NCT04123249|Anesthetics|anesthetics|mesh-list
44495459|NCT04123249|Sevoflurane|sevoflurane|mesh-list
44495460|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44495461|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495462|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495463|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
44495464|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44495465|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44495466|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
44495467|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495468|NCT04122911|Temozolomide|temozolomide|mesh-list
44495469|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495470|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
44495471|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495472|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495473|NCT04122599|Melatonin|melatonin|mesh-list
44495474|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
44495475|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495476|NCT04122599|Protective Agents|protective agents|mesh-ancestor
44495477|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495478|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495479|NCT04122560|Fluconazole|fluconazole|mesh-list
44495480|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
44495481|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495482|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44495483|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44495484|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495485|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495486|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44495487|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
44495488|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495489|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495490|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44495491|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44495493|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
44495494|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495495|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
44495496|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
44495497|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44495498|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44495499|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495500|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495501|NCT04122105|Urological Agents|urological agents|mesh-ancestor
44495502|NCT04121975|Cisplatin|cisplatin|mesh-list
44495503|NCT04121975|Endostar protein|endostar protein|mesh-list
44495504|NCT04121975|Endostatins|endostatins|mesh-list
44495505|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495506|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495507|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495508|NCT04121975|Growth Substances|growth substances|mesh-ancestor
44495509|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495510|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495511|NCT04121910|Itraconazole|itraconazole|mesh-list
44495512|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
44495513|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495514|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44495515|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44495516|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495517|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495518|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44495519|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
44495520|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495521|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495522|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44495523|NCT04121767|Warfarin|warfarin|mesh-list
44495524|NCT04121767|Edoxaban|edoxaban|mesh-list
44495525|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
44495526|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44495527|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
44495528|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44495529|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
44495530|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495531|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495532|NCT04121689|Caseins|caseins|mesh-list
44495533|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
44495534|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
44495535|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495536|NCT04121819|Cytarabine|cytarabine|mesh-list
44495537|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495538|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
44495539|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495540|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495541|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
44495542|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495543|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495544|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
44495545|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495546|NCT04121780|Hormones|hormones|mesh-list
44495547|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951832|NCT01183481|Aprepitant|aprepitant|mesh-list
44495548|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495549|NCT04121533|Vitamin D|vitamin d|mesh-list
44495550|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
44495551|NCT04121533|Vitamins|vitamins|mesh-ancestor
44495552|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
44495553|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495554|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44495555|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495556|NCT04121416|Sufentanil|sufentanil|mesh-list
44495557|NCT04121416|Oxycodone|oxycodone|mesh-list
44495558|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44495559|NCT04121416|Narcotics|narcotics|mesh-ancestor
44495560|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495561|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495562|NCT04121416|Analgesics|analgesics|mesh-ancestor
44495563|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
44495564|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495565|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44495566|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44495567|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
44495568|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
44495569|NCT04121039|Apatinib|apatinib|mesh-list
44495570|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495571|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495572|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495573|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495574|NCT04121338|Bupivacaine|bupivacaine|mesh-list
44495575|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
44495576|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
44495577|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495578|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495579|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
44495580|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495581|NCT04121091|Pramipexole|pramipexole|mesh-list
44495582|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
44495583|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495584|NCT04121091|Protective Agents|protective agents|mesh-ancestor
44495585|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495586|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44495587|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44495588|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
44495589|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
44495590|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495591|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
44495592|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
44495593|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44495594|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44495595|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495596|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495597|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495598|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495599|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44495600|NCT04120987|Lifitegrast|lifitegrast|mesh-list
44495601|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44495602|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
44495603|NCT04120922|Calcium|calcium|mesh-list
44495604|NCT04120922|Sevelamer|sevelamer|mesh-list
44495605|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495606|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495607|NCT04120922|Antacids|antacids|mesh-ancestor
43951889|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
43951949|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495608|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495609|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495610|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
44495611|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
44495612|NCT04120831|Abatacept|abatacept|mesh-list
44495613|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495614|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
44495615|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495616|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495617|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495618|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495619|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495620|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
44495621|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
44495622|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495623|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495624|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44495625|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495626|NCT04120311|Dexamethasone|dexamethasone|mesh-list
44495627|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
44495628|NCT04120311|BB 1101|bb 1101|mesh-list
44495629|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495630|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
44495631|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
44495632|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495633|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495634|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495635|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
44495636|NCT04120311|Hormones|hormones|mesh-ancestor
44314813|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
44495637|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495638|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495639|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495640|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
44495641|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495642|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495643|NCT04120259|Metformin|metformin|mesh-list
44495644|NCT04120259|Acetic Acid|acetic acid|mesh-list
44495645|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495646|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495647|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44495648|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495649|NCT04120350|Rituximab|rituximab|mesh-list
44495650|NCT04120350|Methotrexate|methotrexate|mesh-list
44495651|NCT04120350|Lenalidomide|lenalidomide|mesh-list
44495652|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495653|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495654|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
44495655|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495656|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495657|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44495658|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
44495659|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44495660|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495661|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
44495662|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495663|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
44495664|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495665|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44495666|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495667|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44495668|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495669|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495670|NCT04120350|Growth Substances|growth substances|mesh-ancestor
44495671|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495672|NCT04120519|Thalidomide|thalidomide|mesh-list
44495673|NCT04120519|Dexamethasone|dexamethasone|mesh-list
44495674|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
44495675|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495676|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
44495677|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495678|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495679|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495680|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
44495681|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495682|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495683|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44495684|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495685|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
44495686|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
44495687|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495688|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495689|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
44495690|NCT04120519|Hormones|hormones|mesh-ancestor
44495691|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495692|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495693|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
44495694|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44495695|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495696|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495697|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495698|NCT04120519|Growth Substances|growth substances|mesh-ancestor
44495699|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495700|NCT04129086|Ketamine|ketamine|mesh-list
44495701|NCT04129086|Analgesics|analgesics|mesh-ancestor
44495702|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
44495703|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495704|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495705|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44495706|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44495707|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
44495708|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
44495709|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495710|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44495711|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44495712|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495713|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495714|NCT04127968|Vitamin A|vitamin a|mesh-list
44495715|NCT04127968|Vitamins|vitamins|mesh-ancestor
44495716|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
44495717|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495718|NCT04129996|Paclitaxel|paclitaxel|mesh-list
44495719|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44495720|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495721|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44495722|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
44495723|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44314963|NCT00910897|Bortezomib|bortezomib|mesh-list
44495724|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495725|NCT04129216|Tamoxifen|tamoxifen|mesh-list
44495726|NCT04129216|Letrozole|letrozole|mesh-list
44495727|NCT04129216|Exemestane|exemestane|mesh-list
44235037|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
44495728|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495729|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952014|NCT01188421|Clonidine|clonidine|mesh-list
44495730|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44495731|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44495732|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495733|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44495734|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
44495735|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495736|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495737|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495738|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44495739|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44495740|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44495742|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
44495743|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
44495744|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44495745|NCT04124614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44495746|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44495747|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44495748|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495749|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495750|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
44495751|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495752|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
44495753|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
44495754|NCT04123379|Nivolumab|nivolumab|mesh-list
44495755|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495756|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495757|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495758|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495759|NCT04120753|Amlodipine|amlodipine|mesh-list
44495760|NCT04120753|Olmesartan|olmesartan|mesh-list
44495761|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44495762|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44495763|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44495764|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495765|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495766|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495767|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
44495768|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44495769|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44495770|NCT04121455|Bevacizumab|bevacizumab|mesh-list
44495771|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
44495772|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495773|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495774|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495775|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495776|NCT04121455|Growth Substances|growth substances|mesh-ancestor
44495777|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495778|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495779|NCT04126083|Lofexidine|lofexidine|mesh-list
44495780|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44495781|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44495782|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495783|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
44495784|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495785|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44495786|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44495787|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44495788|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44495789|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495790|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495792|NCT04120363|Testosterone|testosterone|mesh-list
44495793|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
44495794|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
44495795|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44495796|NCT04120363|Androgens|androgens|mesh-ancestor
44495797|NCT04120363|Hormones|hormones|mesh-ancestor
44495798|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495799|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495800|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495801|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495802|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
44495803|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
44495804|NCT04120064|Vitamin D|vitamin d|mesh-list
44495805|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44495806|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495807|NCT04120064|Vitamins|vitamins|mesh-ancestor
44495808|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
44495809|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44495810|NCT04125745|CXA-10|cxa-10|mesh-list
44495811|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495812|NCT04126733|Nivolumab|nivolumab|mesh-list
44495813|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495814|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495815|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495816|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495817|NCT04120974|Insulin|insulin|mesh-list
44495818|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44495819|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495820|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
44495821|NCT03825289|Trametinib|trametinib|mesh-list
44495822|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
44495823|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44495824|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44495825|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495826|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495827|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495828|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495829|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495830|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44495831|NCT03826563|Melatonin|melatonin|mesh-list
44495832|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
44495833|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495834|NCT03826563|Protective Agents|protective agents|mesh-ancestor
44495835|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495836|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495837|NCT03824327|Papaverine|papaverine|mesh-list
44495838|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44495839|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495840|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495841|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
44495842|NCT03824327|Urological Agents|urological agents|mesh-ancestor
44495843|NCT03825367|Nivolumab|nivolumab|mesh-list
44495844|NCT03825367|Azacitidine|azacitidine|mesh-list
44495845|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495846|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495847|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495848|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495849|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44495850|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
44495851|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495852|NCT03821246|Atezolizumab|atezolizumab|mesh-list
44495853|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44235056|NCT00552656|Sirolimus|sirolimus|mesh-list
44495854|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495855|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
44495856|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495857|NCT03829371|Dexamethasone|dexamethasone|mesh-list
44495858|NCT03829371|Prednisone|prednisone|mesh-list
44495859|NCT03829371|Lenalidomide|lenalidomide|mesh-list
44495860|NCT03829371|Melphalan|melphalan|mesh-list
44495861|NCT03829371|Bortezomib|bortezomib|mesh-list
44495862|NCT03829371|Daratumumab|daratumumab|mesh-list
44495863|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495864|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
44495865|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
44495866|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495867|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495868|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495869|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
44495870|NCT03829371|Hormones|hormones|mesh-ancestor
44495871|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495872|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44495873|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495874|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
44495875|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44495876|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44495877|NCT03829371|Growth Substances|growth substances|mesh-ancestor
44495878|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44495879|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44495880|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
44495881|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495882|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44495883|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44495884|NCT03827889|Fluorides|fluorides|mesh-list
44495885|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
44495886|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
44495887|NCT03827889|Protective Agents|protective agents|mesh-ancestor
44495888|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495889|NCT03824522|BAX 855|bax 855|mesh-list
44495890|NCT03824522|Coagulants|coagulants|mesh-ancestor
44495891|NCT03820466|Aspirin|aspirin|mesh-list
44495892|NCT03820466|Atorvastatin|atorvastatin|mesh-list
44235060|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495893|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44495894|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495895|NCT03820466|Analgesics|analgesics|mesh-ancestor
44495896|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
44495897|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495898|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495899|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495900|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495901|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44495902|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44495903|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495904|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44495905|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44495906|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495907|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
44495908|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44495909|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44495910|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
44495911|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44495912|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44495913|NCT03829111|Nivolumab|nivolumab|mesh-list
44495914|NCT03829111|Ipilimumab|ipilimumab|mesh-list
44495915|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44495916|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495917|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44495918|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495919|NCT03822962|Acetaminophen|acetaminophen|mesh-list
44495920|NCT03822962|Ibuprofen|ibuprofen|mesh-list
44495921|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44495922|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495923|NCT03822962|Analgesics|analgesics|mesh-ancestor
44495924|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
44495925|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495926|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495927|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44495928|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44495929|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44495930|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44495931|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495932|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
44495933|NCT03829696|Misoprostol|misoprostol|mesh-list
44495934|NCT03829696|Mifepristone|mifepristone|mesh-list
44495935|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
44495936|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44495937|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
44495938|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44495939|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495940|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44495941|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495942|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
44495943|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44495944|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44495945|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44495946|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44495947|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
44495948|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44495949|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44495950|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
44495951|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44495952|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
44495953|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44495954|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44495955|NCT03829839|Lorazepam|lorazepam|mesh-list
44495956|NCT03829839|Oxytocin|oxytocin|mesh-list
44495957|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
44495958|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44495959|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495960|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
44495961|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
44495962|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
44495963|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495964|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44495965|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44495966|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44495967|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44495968|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44495969|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44495970|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
44495971|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
44495972|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44495973|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44495974|NCT03829774|Acetaminophen|acetaminophen|mesh-list
44495975|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44495976|NCT03829774|Analgesics|analgesics|mesh-ancestor
44495977|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
44495978|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44495979|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44495980|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
44495981|NCT03829917|Paromomycin|paromomycin|mesh-list
44495982|NCT03829917|Miltefosine|miltefosine|mesh-list
44495983|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44495984|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44495985|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44495986|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44495987|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
44495988|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44495989|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
44495990|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44495991|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44495992|NCT03829566|Prednisolone|prednisolone|mesh-list
44495993|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
44495994|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
44495995|NCT03829566|Rituximab|rituximab|mesh-list
44495996|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
44495997|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44495998|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44495999|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
44496000|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496001|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
44496002|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496003|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496004|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44496005|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
44496006|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496007|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496008|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44496009|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496010|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496011|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
44496012|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
44496013|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496014|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496015|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
44496016|NCT03829566|Hormones|hormones|mesh-ancestor
44496017|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496018|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44496019|NCT03829566|Protective Agents|protective agents|mesh-ancestor
44496020|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44496021|NCT03829592|Misoprostol|misoprostol|mesh-list
44496022|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44496023|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
44496024|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44496025|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496026|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44496027|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496028|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
44496029|NCT03829345|Olaparib|olaparib|mesh-list
44496030|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44496031|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496032|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496033|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496034|NCT03829124|Ketamine|ketamine|mesh-list
44496035|NCT03829124|Propofol|propofol|mesh-list
44496036|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44496037|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496038|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496039|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44496040|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
44496041|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
44496042|NCT03829124|Analgesics|analgesics|mesh-ancestor
44496043|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
44496044|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496045|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44496046|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44496047|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44496048|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496049|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496050|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44496051|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
44496052|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496053|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
44496054|NCT03828682|Prednisone|prednisone|mesh-list
44496055|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
44496056|NCT03828682|Tacrolimus|tacrolimus|mesh-list
44496057|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
44496058|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44496059|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496060|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
44496061|NCT03828682|Hormones|hormones|mesh-ancestor
44496062|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496063|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496064|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44496065|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496066|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496067|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
44496068|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44496069|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496070|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496071|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44496072|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44496073|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
44496074|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44496075|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496076|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
44496077|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
44496078|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496079|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496080|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44496081|NCT03828682|Protective Agents|protective agents|mesh-ancestor
44496082|NCT03828474|Acetazolamide|acetazolamide|mesh-list
44496083|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
44496084|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44496085|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496086|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496087|NCT03828474|Diuretics|diuretics|mesh-ancestor
44496088|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
44496089|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496090|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44235118|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44496091|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44496092|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496093|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
44496094|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496095|NCT03828175|Anesthetics|anesthetics|mesh-list
44496096|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496097|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496098|NCT03828227|Bevacizumab|bevacizumab|mesh-list
44496099|NCT03828227|Capecitabine|capecitabine|mesh-list
44496100|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496101|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496102|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44496103|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44496104|NCT03828227|Growth Substances|growth substances|mesh-ancestor
44496105|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496106|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
44496107|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496108|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
44496109|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496110|NCT03828032|Mannitol|mannitol|mesh-list
44496111|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44496112|NCT03828032|Diuretics|diuretics|mesh-ancestor
44496113|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
44496114|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496115|NCT03827876|Calcitriol|calcitriol|mesh-list
44496116|NCT03827876|Betamethasone|betamethasone|mesh-list
44496117|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44496118|NCT03827876|Calcipotriene|calcipotriene|mesh-list
44496119|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496120|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
44496121|NCT03827876|Hormones|hormones|mesh-ancestor
44496122|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496123|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496124|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44496125|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496126|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44496127|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44496128|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496129|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496130|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44496131|NCT03827876|Vitamins|vitamins|mesh-ancestor
44496132|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
44496133|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44496134|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496135|NCT03828084|Decitabine|decitabine|mesh-list
44496136|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
44496137|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496138|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
44496139|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496140|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496141|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496142|NCT03828058|Tacrolimus|tacrolimus|mesh-list
44496143|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496144|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
44496145|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496146|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44496147|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496148|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496149|NCT03827642|Naloxone|naloxone|mesh-list
44496150|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44496151|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496152|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
44496153|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496154|NCT03827629|Naloxone|naloxone|mesh-list
44496155|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44496156|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496157|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
44496158|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496159|NCT03827070|Afatinib|afatinib|mesh-list
44496160|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496161|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44496162|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496163|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496164|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44496165|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44496166|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44496167|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496168|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496169|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44496170|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496171|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496172|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
44496173|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496174|NCT03827200|Ambrisentan|ambrisentan|mesh-list
44496175|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44496176|NCT03827278|Itraconazole|itraconazole|mesh-list
44496177|NCT03827278|Voriconazole|voriconazole|mesh-list
44496178|NCT03827278|Amphotericin B|amphotericin b|mesh-list
44496179|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
44496180|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496181|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44496182|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44496183|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496184|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496185|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44496186|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
44496187|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496188|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496189|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44496190|NCT03827278|Amebicides|amebicides|mesh-ancestor
44496191|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44496192|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44496193|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44496194|NCT03826589|Avelumab|avelumab|mesh-list
44496195|NCT03826589|Axitinib|axitinib|mesh-list
44496196|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496197|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496198|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44496199|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496200|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315497|NCT00913588|Fluoxetine|fluoxetine|mesh-list
44496201|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
44496202|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
44496203|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496205|NCT03826615|Analgesics|analgesics|mesh-ancestor
44496206|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
44496207|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496208|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496209|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
44496210|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44496211|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44496212|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496213|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496214|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44496215|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44496216|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496217|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496218|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
44496219|NCT03826602|Metformin|metformin|mesh-list
44496220|NCT03826602|Tucatinib|tucatinib|mesh-list
44496221|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44496222|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496223|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496224|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44496225|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496226|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496227|NCT03826485|Pranlukast|pranlukast|mesh-list
44496228|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44496229|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496230|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44496231|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
44496232|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496233|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496234|NCT03826524|Epinephrine|epinephrine|mesh-list
44496235|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44496236|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44496237|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496238|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496239|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496240|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496241|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44496242|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44496243|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
44496244|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496245|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44496246|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496247|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
44496248|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
44496249|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44496250|NCT03826368|Cannabidiol|cannabidiol|mesh-list
44496251|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
44496252|NCT03826316|Nalbuphine|nalbuphine|mesh-list
44496253|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496254|NCT03826316|Narcotics|narcotics|mesh-ancestor
44496255|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496256|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496257|NCT03826316|Analgesics|analgesics|mesh-ancestor
44496258|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
44496259|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496260|NCT03825887|Morphine|morphine|mesh-list
44496261|NCT03825887|Nalbuphine|nalbuphine|mesh-list
44496262|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496263|NCT03825887|Narcotics|narcotics|mesh-ancestor
44496264|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496265|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496266|NCT03825887|Analgesics|analgesics|mesh-ancestor
44496267|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
44496268|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496269|NCT03826004|Clemastine|clemastine|mesh-list
44496270|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
44496271|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496272|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44496273|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
44496274|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
44496275|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496276|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496277|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496278|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44496280|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496281|NCT03825809|Acetaminophen|acetaminophen|mesh-list
44496282|NCT03825809|Celecoxib|celecoxib|mesh-list
44496283|NCT03825809|Ketorolac|ketorolac|mesh-list
44496284|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44496285|NCT03825809|Diazepam|diazepam|mesh-list
44496286|NCT03825809|Gabapentin|gabapentin|mesh-list
44496287|NCT03825809|Hydrocodone|hydrocodone|mesh-list
44496288|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496289|NCT03825809|Analgesics|analgesics|mesh-ancestor
44496290|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
44496291|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496292|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496293|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
44496294|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496295|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496296|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496297|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44496298|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496299|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496300|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496301|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
44496302|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44496303|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44496304|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496305|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496306|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44496307|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44496308|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496309|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
44496310|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496312|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
44496313|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496314|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44496315|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
44496316|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
44496317|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496318|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44496319|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44496320|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44496321|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44496322|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
44496323|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
44496324|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
44496325|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
44496326|NCT03825601|Flumazenil|flumazenil|mesh-list
44496327|NCT03825601|Antidotes|antidotes|mesh-ancestor
44496328|NCT03825601|Protective Agents|protective agents|mesh-ancestor
44496329|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496330|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
44496331|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
44496332|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496333|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496334|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
44496335|NCT03825471|Anesthetics|anesthetics|mesh-list
44496336|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496337|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496338|NCT03825471|Narcotics|narcotics|mesh-ancestor
44496339|NCT03825471|Analgesics|analgesics|mesh-ancestor
44496340|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
44496341|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496342|NCT03825380|Bimatoprost|bimatoprost|mesh-list
44496343|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44496344|NCT03825250|Valproic Acid|valproic acid|mesh-list
44496345|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
44496346|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496347|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496348|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
44496349|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496350|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496351|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
44496352|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44496353|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496354|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496355|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44496356|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44496357|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496358|NCT03825328|Gemcitabine|gemcitabine|mesh-list
44496359|NCT03825328|Paclitaxel|paclitaxel|mesh-list
44496360|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
44496361|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44496362|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44496363|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496364|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44496365|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44496366|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44496367|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496368|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496369|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
44496370|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
44496371|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496372|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496373|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496374|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
44496375|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496376|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
44496377|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44496378|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44496379|NCT03824925|Zinc|zinc|mesh-list
44496380|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
44496381|NCT03824925|Trace Elements|trace elements|mesh-ancestor
44496382|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
44496383|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496384|NCT03824925|Astringents|astringents|mesh-ancestor
44496385|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496386|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44496387|NCT03825081|Pilocarpine|pilocarpine|mesh-list
44496388|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44496389|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44496390|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44496391|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44496392|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496393|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496394|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496395|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496396|NCT03825081|Miotics|miotics|mesh-ancestor
44496397|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
44496398|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496399|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44496400|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44496401|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44496402|NCT03825068|Anesthetics|anesthetics|mesh-list
44496403|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
44496404|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496405|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496406|NCT03824665|Fentanyl|fentanyl|mesh-list
44496407|NCT03824665|Nalbuphine|nalbuphine|mesh-list
44496408|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496409|NCT03824665|Narcotics|narcotics|mesh-ancestor
44496410|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496411|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496412|NCT03824665|Analgesics|analgesics|mesh-ancestor
44496413|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
44496414|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496415|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44496416|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44496417|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
44496418|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
44496419|NCT03825016|Diclofenac|diclofenac|mesh-list
44496420|NCT03825016|Lidocaine|lidocaine|mesh-list
44496421|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
44496422|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
44496423|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496424|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496425|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
44496426|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496427|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44496428|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44496429|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44496430|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43693310|NCT02774993|Doxycycline|doxycycline|mesh-list
44496431|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496432|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496433|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496434|NCT03825016|Analgesics|analgesics|mesh-ancestor
44496435|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496436|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496437|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496438|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496439|NCT03824717|Ropivacaine|ropivacaine|mesh-list
44496440|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
44496441|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
44496442|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496443|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496444|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
44496445|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496447|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496448|NCT03824834|Narcotics|narcotics|mesh-ancestor
44496449|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496450|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496451|NCT03824834|Analgesics|analgesics|mesh-ancestor
44496452|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
44496453|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496454|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44496455|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
44496456|NCT03824379|Cathartics|cathartics|mesh-ancestor
44496457|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496458|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496459|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
44496460|NCT03824171|Vitamin D|vitamin d|mesh-list
44496461|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44496462|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44496463|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496464|NCT03824171|Vitamins|vitamins|mesh-ancestor
44496465|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
44496466|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44496467|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44496468|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
44496469|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496470|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44496471|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44496472|NCT03824314|Fentanyl|fentanyl|mesh-list
44496473|NCT03824314|Midazolam|midazolam|mesh-list
44496474|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496475|NCT03824314|Narcotics|narcotics|mesh-ancestor
44496476|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496477|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496478|NCT03824314|Analgesics|analgesics|mesh-ancestor
44496479|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
44496480|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496481|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44496482|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44496483|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
44496484|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
44496485|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44496486|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44496487|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44496488|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496489|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
44496490|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
44496491|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496492|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496493|NCT03824340|Doxycycline|doxycycline|mesh-list
44496494|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44496495|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496496|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
44496497|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44496498|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44496499|NCT03824002|Insulin|insulin|mesh-list
44496500|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44496501|NCT03824002|Metformin|metformin|mesh-list
44496502|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
44496503|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
44496504|NCT03824002|Dulaglutide|dulaglutide|mesh-list
44315764|NCT00914472|Heparin|heparin|mesh-list
44496505|NCT03824002|Repaglinide|repaglinide|mesh-list
44496506|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
44496507|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44496508|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44496509|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496511|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44496512|NCT03823846|Parecoxib|parecoxib|mesh-list
44496513|NCT03823846|Dezocine|dezocine|mesh-list
44496514|NCT03823846|Analgesics|analgesics|mesh-ancestor
44496515|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
44496516|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496517|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496518|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496519|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496520|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496521|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496522|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496523|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496524|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496525|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44496526|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496527|NCT03823846|Narcotics|narcotics|mesh-ancestor
44496528|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496529|NCT03823976|Anesthetics|anesthetics|mesh-list
44496530|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496531|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315841|NCT00914693|Estrogens|estrogens|mesh-ancestor
44496533|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44496534|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
44496535|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496536|NCT03823612|Calcium|calcium|mesh-list
44496537|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44496538|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496539|NCT03823638|Mannitol|mannitol|mesh-list
44496540|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44496541|NCT03823638|Diuretics|diuretics|mesh-ancestor
44496542|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
44496543|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496544|NCT03823625|Nivolumab|nivolumab|mesh-list
44496545|NCT03823625|Ipilimumab|ipilimumab|mesh-list
44496546|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496547|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496548|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44496549|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496550|NCT03823781|Milrinone|milrinone|mesh-list
44496551|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44496552|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44496553|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
44496554|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44496555|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44496556|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496557|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496558|NCT03823781|Protective Agents|protective agents|mesh-ancestor
44496559|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496560|NCT03823339|Liraglutide|liraglutide|mesh-list
44496561|NCT03823339|Xultophy|xultophy|mesh-list
44496562|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44496563|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496564|NCT03823339|Incretins|incretins|mesh-ancestor
44496565|NCT03823339|Hormones|hormones|mesh-ancestor
44496566|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496567|NCT03823079|Irinotecan|irinotecan|mesh-list
44496568|NCT03823079|Raltitrexed|raltitrexed|mesh-list
44496569|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44496570|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44496571|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496572|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496573|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496574|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496575|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
44496576|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44496577|NCT03823040|Oxiconazole|oxiconazole|mesh-list
44496578|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
44496579|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496580|NCT03823248|Folic Acid|folic acid|mesh-list
44496581|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
44496582|NCT03823248|Hematinics|hematinics|mesh-ancestor
44496583|NCT03823248|Vitamins|vitamins|mesh-ancestor
44496584|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
44496585|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496586|NCT03822936|Fluorouracil|fluorouracil|mesh-list
44496587|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
44496588|NCT03822936|Irinotecan|irinotecan|mesh-list
44496589|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
44496590|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496591|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496592|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496593|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496594|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
44496595|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496596|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44496597|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44496598|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496599|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44496600|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44496601|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496602|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496603|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44496604|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
44496605|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496606|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496608|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44496609|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44496610|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44496611|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44496612|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496613|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496614|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496615|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496616|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44496617|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44496618|NCT03822546|Nicotine|nicotine|mesh-list
44496619|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44496620|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
44496621|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496622|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496623|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44496624|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44496625|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
44496626|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496627|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496628|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
44496629|NCT03822520|Celecoxib|celecoxib|mesh-list
44496630|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44496631|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496632|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44496633|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44496634|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496635|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496636|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496637|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496638|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496639|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496640|NCT03822520|Analgesics|analgesics|mesh-ancestor
44496641|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
44496642|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496643|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496644|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496645|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44496646|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496647|NCT03822091|Terlipressin|terlipressin|mesh-list
44496648|NCT03822091|Norepinephrine|norepinephrine|mesh-list
44496649|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44496650|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44496651|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44496652|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44496653|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496654|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496655|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496656|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496657|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
44496658|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
44496659|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496660|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44496661|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44496662|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44496663|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496664|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496665|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496666|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496667|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
44496668|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496669|NCT03822169|Choline|choline|mesh-list
44496670|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
44496671|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44496672|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
44496673|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496674|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496675|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44496676|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
44496677|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
44496678|NCT03821987|Busulfan|busulfan|mesh-list
44496679|NCT03821987|Fludarabine|fludarabine|mesh-list
44496680|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
44496681|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496683|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496684|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496685|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44496686|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
44496687|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496688|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496689|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44496690|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44496691|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44496692|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496693|NCT03821714|Vitamins|vitamins|mesh-list
44496694|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
44496695|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44496696|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44496697|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44496698|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
44496699|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
44496700|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496701|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496702|NCT03821714|Hormones|hormones|mesh-ancestor
44496703|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496704|NCT03821415|Estradiol|estradiol|mesh-list
44496705|NCT03821415|Estrogens|estrogens|mesh-ancestor
44496706|NCT03821415|Hormones|hormones|mesh-ancestor
44496707|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496708|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496709|NCT03821454|Capecitabine|capecitabine|mesh-list
44496710|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496711|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
44496712|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496713|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496714|NCT03821168|Bevacizumab|bevacizumab|mesh-list
44496715|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
44496716|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496717|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496718|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44496719|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44496720|NCT03821168|Growth Substances|growth substances|mesh-ancestor
44496721|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496722|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
44496723|NCT03821168|Hematinics|hematinics|mesh-ancestor
44316063|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496725|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44496726|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44496727|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496728|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44496729|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44496730|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44496731|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496732|NCT03820518|Calcitriol|calcitriol|mesh-list
44496733|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44496734|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496735|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44496736|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496737|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496738|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44496739|NCT03820518|Vitamins|vitamins|mesh-ancestor
44496740|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
44496741|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44496743|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496744|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
44496745|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496746|NCT03820245|Protective Agents|protective agents|mesh-ancestor
44496747|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496748|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44496749|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44496750|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496751|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
44496752|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44496753|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44496754|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496755|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
44496756|NCT03820206|Coagulants|coagulants|mesh-ancestor
44496757|NCT03820193|Acetaminophen|acetaminophen|mesh-list
44496758|NCT03820193|Celecoxib|celecoxib|mesh-list
44496759|NCT03820193|Ketorolac|ketorolac|mesh-list
44496760|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44496761|NCT03820193|Diazepam|diazepam|mesh-list
44496762|NCT03820193|Gabapentin|gabapentin|mesh-list
44496763|NCT03820193|Hydrocodone|hydrocodone|mesh-list
44496764|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496765|NCT03820193|Analgesics|analgesics|mesh-ancestor
44496766|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
44496767|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496768|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496769|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
44496770|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496771|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496772|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496773|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44496774|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496775|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496776|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496777|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
44496778|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44496779|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44496780|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44496781|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496782|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44496783|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44496784|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496785|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
44496786|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44496787|NCT03820193|Narcotics|narcotics|mesh-ancestor
44496788|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
44496789|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496790|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44496791|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
44496792|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
44496793|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496794|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44496795|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44496796|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44496797|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44496798|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
44496799|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
44496800|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
44496801|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
44496802|NCT03820037|Opicapone|opicapone|mesh-list
44496803|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44496804|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496805|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496806|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44496807|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44496808|NCT03820908|Bisantrene|bisantrene|mesh-list
44496809|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44496810|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496811|NCT03823989|Mitomycins|mitomycins|mesh-list
44496812|NCT03823989|Mitomycin|mitomycin|mesh-list
44496813|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44496814|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496815|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
44496816|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496817|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44496818|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496820|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44496821|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496822|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496823|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
44496824|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496825|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
44496826|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44496827|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496828|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
44496829|NCT03822637|Albuterol|albuterol|mesh-list
44496830|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43953050|NCT01215643|Ribavirin|ribavirin|mesh-list
44496831|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44496832|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
44496833|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496834|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496835|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44496836|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496837|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
44496838|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44496839|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44496840|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44496841|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44496842|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496843|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496844|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496845|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
44496846|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496847|NCT03822637|Expectorants|expectorants|mesh-ancestor
44496848|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44496849|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
44496850|NCT03822637|Protective Agents|protective agents|mesh-ancestor
44496851|NCT03822637|Antidotes|antidotes|mesh-ancestor
44496852|NCT03822351|Durvalumab|durvalumab|mesh-list
44496853|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44496854|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496855|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496856|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
44496857|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496858|NCT03829436|Nivolumab|nivolumab|mesh-list
44496859|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496860|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496861|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44496862|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496863|NCT03826875|Fluoxetine|fluoxetine|mesh-list
44496864|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44496865|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44496866|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496867|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496868|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496869|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
44496870|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496871|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44496872|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
44496873|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44496874|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44496875|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44496876|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496877|NCT03828006|Red yeast rice|red yeast rice|mesh-list
44496878|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44496879|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44496880|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44496881|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
44496882|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496883|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496884|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44496885|NCT03828019|Cyclosporine|cyclosporine|mesh-list
44496886|NCT03828019|Adalimumab|adalimumab|mesh-list
44496887|NCT03828019|Methotrexate|methotrexate|mesh-list
44496888|NCT03828019|Azathioprine|azathioprine|mesh-list
44496889|NCT03828019|Tacrolimus|tacrolimus|mesh-list
44496890|NCT03828019|Cyclosporins|cyclosporins|mesh-list
44496891|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44496892|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
44496893|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44496894|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496895|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44496896|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
44496897|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496898|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496899|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496900|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496901|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44496902|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44496903|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
44496904|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496905|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44496906|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44496907|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
44496908|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44496909|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496910|NCT03828929|Ascorbic Acid|ascorbic acid|mesh-list
44496911|NCT03828929|Thiamine|thiamine|mesh-list
44496912|NCT03828929|Vitamins|vitamins|mesh-ancestor
44496913|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
44496914|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496915|NCT03828929|Antioxidants|antioxidants|mesh-ancestor
44496916|NCT03828929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496917|NCT03828929|Protective Agents|protective agents|mesh-ancestor
44496918|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
44496919|NCT03826550|Diclofenac|diclofenac|mesh-list
44496920|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44496921|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44496922|NCT03826550|Analgesics|analgesics|mesh-ancestor
44496923|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
44496924|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496925|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496926|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496927|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496928|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44496929|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496930|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496931|NCT03820180|Fluticasone|fluticasone|mesh-list
44496932|NCT03820180|Xhance|xhance|mesh-list
44496933|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44496934|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44496935|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496936|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44496937|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
44496938|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44496939|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496940|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44496941|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44496942|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
44496943|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44496944|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44496945|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44496946|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44496947|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
44496948|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44496949|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496950|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
44496952|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496953|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
44496954|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
44496955|NCT03829332|Lenvatinib|lenvatinib|mesh-list
44496956|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44496957|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496958|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44496959|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44496960|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496961|NCT03827018|Prednisone|prednisone|mesh-list
44496962|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
44496963|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44496964|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
44496965|NCT03827018|Hormones|hormones|mesh-ancestor
44496966|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44496967|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496968|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44496969|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44496970|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44496971|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
44496972|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
44496973|NCT03824587|Calcium|calcium|mesh-list
44496974|NCT03824587|Sevelamer|sevelamer|mesh-list
44496975|NCT03824587|Calcium acetate|calcium acetate|mesh-list
44496976|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44496977|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496978|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44496979|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
44496980|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
44496981|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496982|NCT03824587|Antacids|antacids|mesh-ancestor
44496983|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44496984|NCT01450046|Vitamin E|vitamin e|mesh-list
44496985|NCT01450046|Tocopherols|tocopherols|mesh-list
44496986|NCT01450046|Tocotrienols|tocotrienols|mesh-list
44496987|NCT01450046|Vitamins|vitamins|mesh-ancestor
44496988|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
44496989|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44496990|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
44496991|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496992|NCT01450046|Protective Agents|protective agents|mesh-ancestor
44496993|NCT01450111|Lacosamide|lacosamide|mesh-list
44496994|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
44496995|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44496996|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44496997|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44496998|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44496999|NCT01450124|Boswellic acid|boswellic acid|mesh-list
44497000|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497001|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497002|NCT01450124|Analgesics|analgesics|mesh-ancestor
44497003|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
44497004|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497005|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497006|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497007|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497008|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44497009|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
44497010|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44497011|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44497012|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497013|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497014|NCT01450176|Analgesics|analgesics|mesh-ancestor
44497015|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
44497016|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497017|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497018|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497019|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497020|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44497021|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44497022|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44497023|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
44497024|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
44497025|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497026|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497027|NCT01450215|Lenalidomide|lenalidomide|mesh-list
44497028|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
44497029|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497030|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44497031|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44497032|NCT01450215|Growth Substances|growth substances|mesh-ancestor
44497033|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
44497034|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497035|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44497036|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497037|NCT01450345|Pregabalin|pregabalin|mesh-list
44497038|NCT01450345|Analgesics|analgesics|mesh-ancestor
44497039|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
44497040|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235155|NCT00553345|Vitamins|vitamins|mesh-ancestor
44497041|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497043|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44497044|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44497045|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497046|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44497047|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44497048|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44497049|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497050|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44497051|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44497052|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497053|NCT01450384|Pemetrexed|pemetrexed|mesh-list
44497054|NCT01450384|Sorafenib|sorafenib|mesh-list
44497055|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497056|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497057|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497058|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44497059|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44497060|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44497061|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
44497062|NCT01450410|Niacin|niacin|mesh-list
44497063|NCT01450410|Niacinamide|niacinamide|mesh-list
44497064|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
44497065|NCT01450410|Vitamins|vitamins|mesh-ancestor
44497066|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
44497067|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497068|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44497069|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
44667709|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44497070|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497071|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44497072|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
44497073|NCT01450462|Vitamin D|vitamin d|mesh-list
44497074|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
44497075|NCT01450462|Vitamins|vitamins|mesh-ancestor
44497076|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
44497077|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497078|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44497079|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44497080|NCT01450514|Pipamperone|pipamperone|mesh-list
44497081|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44497082|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
44497083|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497084|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497085|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497086|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44497087|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44497088|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497089|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44497090|NCT01450566|Lidocaine|lidocaine|mesh-list
44497091|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
44497092|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
44497093|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497094|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497095|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
44497096|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497097|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497098|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44497099|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44497100|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44497101|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497102|NCT01450774|Beclomethasone|beclomethasone|mesh-list
44497103|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
44497104|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44497105|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
44497106|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497107|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497108|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44497109|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497110|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44497111|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44497112|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497113|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497114|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497115|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497116|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497117|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
44497118|NCT01450774|Hormones|hormones|mesh-ancestor
44497119|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497120|NCT01450865|Flupirtine|flupirtine|mesh-list
44497121|NCT01450865|Analgesics|analgesics|mesh-ancestor
44497122|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
44497123|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497124|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497125|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
44497126|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44497127|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44497128|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44497129|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497130|NCT01451060|Ephedrine|ephedrine|mesh-list
44497131|NCT01451060|Metaraminol|metaraminol|mesh-list
43953302|NCT01221207|Calpastatin|calpastatin|mesh-list
44497132|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44497133|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497134|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
44497135|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
44497136|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497137|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44497138|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497139|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497140|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497141|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44497142|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44497143|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497144|NCT01451086|Vaccines|vaccines|mesh-list
44497145|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
44497146|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497147|NCT01451229|Higenamine|higenamine|mesh-list
44497148|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44497149|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497150|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497151|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497152|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497153|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497154|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497155|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497156|NCT01451229|Analgesics|analgesics|mesh-ancestor
44497157|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
44497158|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497159|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497160|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497161|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44497162|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44497163|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44497164|NCT01451229|Protective Agents|protective agents|mesh-ancestor
44497165|NCT01451268|Panobinostat|panobinostat|mesh-list
44497166|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497167|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44497168|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497169|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497170|NCT01451294|Phenylephrine|phenylephrine|mesh-list
44497171|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
44497172|NCT01451294|Ephedrine|ephedrine|mesh-list
44497173|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44497174|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
44497175|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
44497176|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497177|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497178|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
44497179|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44497180|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
44497181|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497182|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44497183|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44497184|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497185|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497186|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497187|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497188|NCT01451294|Protective Agents|protective agents|mesh-ancestor
44497189|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44497190|NCT01451333|Efavirenz|efavirenz|mesh-list
44497191|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44497192|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44497193|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497194|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497195|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
44497196|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497197|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44497198|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44497199|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44497200|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44497201|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44497202|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44497203|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44497204|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44497205|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497206|NCT01451593|Phenytoin|phenytoin|mesh-list
44497207|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
44497208|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44497209|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44497210|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44497211|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497212|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44497213|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44497214|NCT01451658|Propranolol|propranolol|mesh-list
44497215|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44497216|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44497217|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497218|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497219|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497220|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497221|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497222|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44497223|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
44497224|NCT01451710|Prednisone|prednisone|mesh-list
44497225|NCT01451710|Prednisolone|prednisolone|mesh-list
44497226|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44497227|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
44497228|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44497229|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
44497230|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44497231|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
44497232|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497233|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
44497234|NCT01451710|Hormones|hormones|mesh-ancestor
44497235|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953442|NCT01224626|Linezolid|linezolid|mesh-list
44497236|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497237|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497238|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497239|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
44497240|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
44497241|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497242|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497243|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44497244|NCT01451710|Protective Agents|protective agents|mesh-ancestor
44497245|NCT01451788|Thrombin|thrombin|mesh-list
44497246|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
44497247|NCT01451788|Coagulants|coagulants|mesh-ancestor
44497248|NCT01451840|Lidocaine|lidocaine|mesh-list
44497249|NCT01451840|Remifentanil|remifentanil|mesh-list
44497250|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
44497251|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
44497252|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497253|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497254|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
44497255|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497256|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497257|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44497258|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44497259|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44497260|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497261|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44497263|NCT01451840|Analgesics|analgesics|mesh-ancestor
44497264|NCT01451879|Miglustat|miglustat|mesh-list
44497265|NCT01451879|Rituximab|rituximab|mesh-list
44497266|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44497267|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497268|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
44497269|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497270|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497271|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497272|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497273|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44497274|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44497275|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
44497276|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497277|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44497278|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497279|NCT01451905|Liraglutide|liraglutide|mesh-list
44497280|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497281|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497282|NCT01451905|Incretins|incretins|mesh-ancestor
44497283|NCT01451905|Hormones|hormones|mesh-ancestor
44497284|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497285|NCT01451918|Resveratrol|resveratrol|mesh-list
44497286|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
44497287|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497288|NCT01451918|Protective Agents|protective agents|mesh-ancestor
44497289|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497290|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497291|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497292|NCT01452009|Travoprost|travoprost|mesh-list
44497293|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44497294|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44497295|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44497296|NCT01452100|Prednisone|prednisone|mesh-list
44497297|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953484|NCT01225289|Vitamin A|vitamin a|mesh-list
44497298|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
44497299|NCT01452100|Hormones|hormones|mesh-ancestor
44497300|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497301|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497302|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497303|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497304|NCT01452113|Vildagliptin|vildagliptin|mesh-list
44497305|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497306|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497307|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44497308|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
44497309|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497310|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497311|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44497312|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497313|NCT01452217|Secretin|secretin|mesh-list
44497314|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497315|NCT01452217|Hormones|hormones|mesh-ancestor
44497316|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497317|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316623|NCT00919243|Prednisone|prednisone|mesh-list
44497318|NCT01452334|BMS-936559|bms-936559|mesh-list
44497319|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44497320|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497321|NCT01452477|Tanshinone|tanshinone|mesh-list
44497322|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497323|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497324|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497325|NCT01452477|Analgesics|analgesics|mesh-ancestor
44497326|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
44426831|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
44497327|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497328|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497329|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497330|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497331|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
44497332|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44497333|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497334|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497335|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
44497336|NCT01452542|Eliglustat|eliglustat|mesh-list
44497337|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953535|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44497338|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497339|NCT01452568|Aspirin|aspirin|mesh-list
44497340|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
44497341|NCT01452568|Salicylates|salicylates|mesh-list
44497342|NCT01452568|Warfarin|warfarin|mesh-list
44497343|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497344|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497345|NCT01452568|Analgesics|analgesics|mesh-ancestor
44497346|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
44497347|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497348|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497349|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497350|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497351|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44497352|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44497353|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497354|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497355|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44497356|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497357|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
44497358|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
44497359|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497360|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
44497361|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
44497362|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44497363|NCT01452633|Bupivacaine|bupivacaine|mesh-list
44497364|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44497365|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
44497366|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497367|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497368|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
44497369|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497370|NCT01452659|Relugolix|relugolix|mesh-list
44497371|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
44497372|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
44497373|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497374|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497375|NCT01452685|Leuprolide|leuprolide|mesh-list
44497376|NCT01452685|Relugolix|relugolix|mesh-list
44497377|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44497378|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
44497379|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44497380|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497381|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497382|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497383|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
44497384|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
44497385|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497386|NCT01452698|Lansoprazole|lansoprazole|mesh-list
44497387|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
44497388|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497389|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497390|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497391|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497392|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316698|NCT00919438|Diuretics|diuretics|mesh-list
44497393|NCT01452711|Lansoprazole|lansoprazole|mesh-list
44497394|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
44497395|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497396|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497397|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497398|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497399|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497400|NCT01452724|Lansoprazole|lansoprazole|mesh-list
44497402|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497403|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497404|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497405|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497406|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497407|NCT01452737|Bisacodyl|bisacodyl|mesh-list
44497408|NCT01452737|Cathartics|cathartics|mesh-ancestor
44497409|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497410|NCT01452737|Laxatives|laxatives|mesh-ancestor
44497411|NCT01452750|Lansoprazole|lansoprazole|mesh-list
44497412|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
44497413|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497414|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497415|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497416|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497417|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497418|NCT01452763|Lansoprazole|lansoprazole|mesh-list
44497419|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
44497420|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497421|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497422|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497423|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497424|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497425|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
44497426|NCT01452828|Tedizolid|tedizolid|mesh-list
44497427|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
44497428|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44497429|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497430|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44497431|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497432|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497433|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
44497434|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44497435|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497436|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
44497437|NCT01452880|Remifentanil|remifentanil|mesh-list
44497438|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44497439|NCT01452880|Narcotics|narcotics|mesh-ancestor
44497440|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497441|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497442|NCT01452880|Analgesics|analgesics|mesh-ancestor
44497443|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
43953622|NCT01229527|Meperidine|meperidine|mesh-list
44497444|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497445|NCT01452906|Omeprazole|omeprazole|mesh-list
44497446|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497447|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497448|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497449|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497450|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497451|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
44497452|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44497453|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44497454|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
44497455|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497456|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44497457|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44497458|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497459|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497460|NCT01453400|Aspirin|aspirin|mesh-list
44497461|NCT01453400|Acetaminophen|acetaminophen|mesh-list
44497462|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497463|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497464|NCT01453400|Analgesics|analgesics|mesh-ancestor
44497465|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
44497466|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497467|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497468|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497469|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497470|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44497471|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44497472|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497473|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497474|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44497475|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497476|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
44497478|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
44497479|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497480|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
44497481|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497482|NCT01453504|Everolimus|everolimus|mesh-list
44497483|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497484|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497485|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
44497486|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497487|NCT01453582|Propolis|propolis|mesh-list
44497488|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497489|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
44497490|NCT01453686|Clobetasol|clobetasol|mesh-list
44497491|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497492|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
44497493|NCT01453686|Hormones|hormones|mesh-ancestor
44497494|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497495|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497496|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
44497497|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44497498|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44497499|NCT01453881|Beclomethasone|beclomethasone|mesh-list
44497500|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
44497501|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44497502|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
44497503|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497504|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497505|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44497506|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497507|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44497508|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44497509|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497510|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497511|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497512|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497513|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497514|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
44497515|NCT01453881|Hormones|hormones|mesh-ancestor
44497516|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497517|NCT01453920|Ranibizumab|ranibizumab|mesh-list
44497518|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44497519|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44497520|NCT01453920|Growth Substances|growth substances|mesh-ancestor
44497521|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497522|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44497523|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497524|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
44497525|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44497526|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44497527|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
44497528|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497529|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44497530|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44497531|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497532|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497533|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
44497534|NCT01454011|Testosterone|testosterone|mesh-list
44497535|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
44497536|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
44497537|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44497538|NCT01454011|Androgens|androgens|mesh-ancestor
44497539|NCT01454011|Hormones|hormones|mesh-ancestor
44497540|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497541|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497542|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497543|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497544|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
44497545|NCT01454154|Glyburide|glyburide|mesh-list
44497546|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497547|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497549|NCT01454180|Gemcitabine|gemcitabine|mesh-list
44497550|NCT01454180|Capecitabine|capecitabine|mesh-list
44497551|NCT01454180|Fluorouracil|fluorouracil|mesh-list
44497552|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44497553|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
44497554|NCT01454180|Folfirinox|folfirinox|mesh-list
44497556|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
44497557|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497558|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497559|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
44497560|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497561|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497562|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497563|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
44497564|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497565|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44497566|NCT01454180|Antidotes|antidotes|mesh-ancestor
44497567|NCT01454180|Protective Agents|protective agents|mesh-ancestor
44497568|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
44497569|NCT01454180|Vitamins|vitamins|mesh-ancestor
44497570|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
44316903|NCT00920244|Atropine|atropine|mesh-list
44497571|NCT01454440|Eptifibatide|eptifibatide|mesh-list
44497572|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497573|NCT01454479|Lapatinib|lapatinib|mesh-list
44497574|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497575|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44497576|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497577|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497578|NCT01454518|Anesthetics|anesthetics|mesh-list
44497579|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
44497580|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497581|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497582|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
44497583|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497584|NCT01454609|Clonidine|clonidine|mesh-list
44497585|NCT01454609|Bupivacaine|bupivacaine|mesh-list
44497586|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
44497587|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
44497588|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497589|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497590|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
44497591|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497592|NCT01454609|Analgesics|analgesics|mesh-ancestor
44497593|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44497594|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
44497595|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
44497596|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44497597|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44497598|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497599|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497600|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497601|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497602|NCT01454622|Metformin|metformin|mesh-list
44497603|NCT01454622|Canagliflozin|canagliflozin|mesh-list
44497604|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497605|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497606|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44497607|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497608|NCT01454804|Trastuzumab|trastuzumab|mesh-list
44497609|NCT01454804|Lapatinib|lapatinib|mesh-list
44497610|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44497611|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497612|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44497613|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497614|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497615|NCT01455025|Plerixafor|plerixafor|mesh-list
44497616|NCT01455025|Lenograstim|lenograstim|mesh-list
44497617|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44497618|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
44497619|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497620|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44497621|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44497622|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
44497623|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497624|NCT01455103|BMS-936559|bms-936559|mesh-list
44497625|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44235170|NCT00553488|Insulin|insulin|mesh-list
44497626|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44497627|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497628|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
44497629|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497630|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
44497631|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44497632|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
44497633|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497634|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497635|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44497636|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497637|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
44497638|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44497639|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
44497640|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497641|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497642|NCT01455142|Insulin|insulin|mesh-list
44497643|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
44497644|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497645|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497646|NCT01455246|Meropenem|meropenem|mesh-list
44497648|NCT01455246|Ceftazidime|ceftazidime|mesh-list
44497649|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44497650|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497651|NCT01455441|Liraglutide|liraglutide|mesh-list
44497652|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497653|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497654|NCT01455441|Incretins|incretins|mesh-ancestor
44497655|NCT01455441|Hormones|hormones|mesh-ancestor
44497656|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497657|NCT01455506|Fludarabine|fludarabine|mesh-list
44497658|NCT01455506|Busulfan|busulfan|mesh-list
44497659|NCT01455506|Decitabine|decitabine|mesh-list
44497660|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497661|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44497662|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
44497663|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497664|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497665|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
44497666|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497667|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
44497668|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44497669|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44497670|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497671|NCT01455532|Gemcitabine|gemcitabine|mesh-list
44497672|NCT01455532|Carboplatin|carboplatin|mesh-list
44497673|NCT01455532|Doxorubicin|doxorubicin|mesh-list
44497674|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44497675|NCT01455532|Iniparib|iniparib|mesh-list
44497676|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497677|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44497678|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
44497679|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497680|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
44497681|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497682|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497683|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497684|NCT01455532|Immunologic Factors|immunologic factors|mesh-ancestor
44497685|NCT01455532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497686|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44497687|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44497688|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44497689|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44497690|NCT01455649|Cyclosporine|cyclosporine|mesh-list
44497691|NCT01455649|Everolimus|everolimus|mesh-list
44497692|NCT01455649|Tacrolimus|tacrolimus|mesh-list
44497693|NCT01455649|Cyclosporins|cyclosporins|mesh-list
44497694|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44497695|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497696|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
44497697|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497698|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497699|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497700|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
44497701|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497702|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
44497703|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497704|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497705|NCT01455831|Tinzaparin|tinzaparin|mesh-list
44497706|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44497707|NCT01455831|Dalteparin|dalteparin|mesh-list
44497708|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
44497709|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44497710|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44497711|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497712|NCT01455883|Glimepiride|glimepiride|mesh-list
44497713|NCT01455883|Exenatide|exenatide|mesh-list
44497714|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497715|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497716|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497717|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497718|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
44497719|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44497720|NCT01455883|Incretins|incretins|mesh-ancestor
44497721|NCT01455883|Hormones|hormones|mesh-ancestor
44497722|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497723|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44497724|NCT01455909|Exenatide|exenatide|mesh-list
44497725|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497726|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497727|NCT01455909|Incretins|incretins|mesh-ancestor
44497728|NCT01455909|Hormones|hormones|mesh-ancestor
44497729|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497730|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44497731|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
44497732|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497733|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497734|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44497735|NCT01455922|Glimepiride|glimepiride|mesh-list
44497736|NCT01455922|Exenatide|exenatide|mesh-list
44497737|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497738|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497739|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497740|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497741|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
44497742|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44497743|NCT01455922|Incretins|incretins|mesh-ancestor
44497744|NCT01455922|Hormones|hormones|mesh-ancestor
44497745|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497746|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44497747|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44497748|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44497749|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497750|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
44497751|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44497752|NCT01456117|Pioglitazone|pioglitazone|mesh-list
44497753|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497754|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497755|NCT01456208|Norepinephrine|norepinephrine|mesh-list
44497756|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
44497757|NCT01456208|Giapreza|giapreza|mesh-list
44497758|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
44497759|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44497760|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497761|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497762|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497763|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497764|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497765|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
44497766|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
44497767|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497768|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44497769|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44497770|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
44497771|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497772|NCT01456234|Oseltamivir|oseltamivir|mesh-list
44497773|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
44497774|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497775|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497776|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497777|NCT01456247|Lansoprazole|lansoprazole|mesh-list
44497778|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
44497779|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497780|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497781|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497782|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497783|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497784|NCT01456260|Lansoprazole|lansoprazole|mesh-list
44497785|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
44497786|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44497787|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44497788|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44497789|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497790|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497791|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44497792|NCT01456312|Entecavir|entecavir|mesh-list
44497793|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
44497794|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497795|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44497796|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953986|NCT01237041|Vitamins|vitamins|mesh-ancestor
44497797|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317117|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
44497798|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497799|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497801|NCT01456351|Fludarabine|fludarabine|mesh-list
44497802|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44497803|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44497804|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497805|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
44497806|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497807|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497808|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497809|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44497810|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
44497811|NCT01456364|Ticagrelor|ticagrelor|mesh-list
44497812|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44497813|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497814|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44497815|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44497816|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44497817|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
44497818|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497819|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497820|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497821|NCT01456468|Tretinoin|tretinoin|mesh-list
44497822|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497823|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
44497824|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
44497825|NCT01456546|Proguanil|proguanil|mesh-list
44497826|NCT01456546|Clopidogrel|clopidogrel|mesh-list
44497827|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44497828|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44497829|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44497830|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44497831|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
44497832|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497833|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497834|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497835|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
44497836|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44497837|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44497838|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497839|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
44497841|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44497842|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44497843|NCT01456611|Analgesics|analgesics|mesh-ancestor
44497844|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
44497845|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497846|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497847|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497848|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497849|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44497850|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497851|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497852|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
44497853|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44497854|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497855|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
44497856|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44497857|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497858|NCT01456689|Midazolam|midazolam|mesh-list
44497859|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44497860|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44497861|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44497862|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497863|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44497864|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44497865|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44497866|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44497867|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
44497868|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
44497869|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
44497870|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
44497871|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497872|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497873|NCT01456715|Vaccines|vaccines|mesh-list
44497874|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
44497875|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497876|NCT01457001|Vitamin D|vitamin d|mesh-list
44497877|NCT01457001|Vitamins|vitamins|mesh-list
44497878|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
44497879|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497880|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44497881|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
44497882|NCT01457131|Fludarabine|fludarabine|mesh-list
44497883|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497884|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
44497885|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497886|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497887|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44497888|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
44497889|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497890|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497891|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44497892|NCT01457261|Albuterol|albuterol|mesh-list
44497893|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44497894|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
44497895|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497896|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497897|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44497898|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497899|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
44497900|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44497901|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44497902|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44497903|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497904|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497905|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497906|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497907|NCT01457469|Nicotine|nicotine|mesh-list
44497908|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44497909|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
44497910|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497911|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497912|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44497913|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44497914|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
44497915|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497916|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497917|NCT01457495|Edetic Acid|edetic acid|mesh-list
44497918|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
44497919|NCT01457495|Antidotes|antidotes|mesh-ancestor
44497920|NCT01457495|Protective Agents|protective agents|mesh-ancestor
44497921|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497922|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
44497923|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
44497924|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497925|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44497926|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
44497927|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44497928|NCT01457547|Edetic Acid|edetic acid|mesh-list
44497929|NCT01457547|Vaccines|vaccines|mesh-list
44497930|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
44497931|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
44497932|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497933|NCT01457547|Antidotes|antidotes|mesh-ancestor
44497934|NCT01457547|Protective Agents|protective agents|mesh-ancestor
44497945|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
44497946|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497947|NCT01457690|Protective Agents|protective agents|mesh-ancestor
44497948|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497949|NCT01457690|Vitamins|vitamins|mesh-ancestor
44497950|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
44497951|NCT01457716|Budesonide|budesonide|mesh-list
44497952|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
44497953|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44497954|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44497955|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
44497956|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44497957|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497958|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44497959|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
44497960|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
44497962|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44497963|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44497964|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44497965|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44497966|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
44497967|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44497968|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497969|NCT01457820|Allopurinol|allopurinol|mesh-list
44497970|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
44497971|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497972|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44497973|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
44497974|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44497975|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44497976|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
44497977|NCT01457820|Protective Agents|protective agents|mesh-ancestor
44497978|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497979|NCT01457859|Triclosan|triclosan|mesh-list
44497980|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44497981|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44497982|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44497983|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44497984|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
44497985|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44497986|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44497987|NCT01457911|Metformin|metformin|mesh-list
44497988|NCT01457911|Glimepiride|glimepiride|mesh-list
44497989|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44497990|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44497991|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44497992|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44497993|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
44497994|NCT01457937|Interferons|interferons|mesh-list
44497995|NCT01457937|Ribavirin|ribavirin|mesh-list
44497996|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44497997|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44497998|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
44497999|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498000|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
44498001|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498002|NCT01457989|Ezogabine|ezogabine|mesh-list
44498003|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
44498004|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498005|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498006|NCT01458015|Oxycodone|oxycodone|mesh-list
44498007|NCT01458015|Tapentadol|tapentadol|mesh-list
44498008|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44498009|NCT01458015|Narcotics|narcotics|mesh-ancestor
44498010|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498011|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498012|NCT01458015|Analgesics|analgesics|mesh-ancestor
44498013|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
44498014|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498015|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44498016|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44498017|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498018|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498019|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498020|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498021|NCT01458041|Iloprost|iloprost|mesh-list
44498022|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498023|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498024|NCT01458054|Ritonavir|ritonavir|mesh-list
44498025|NCT01458054|Omeprazole|omeprazole|mesh-list
44498026|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44498027|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44498028|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
44498029|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498030|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498031|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44498032|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44498033|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
44498034|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498035|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44498036|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44498037|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44498038|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44498039|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44498040|NCT01458067|GSK2636771|gsk2636771|mesh-list
44498041|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498042|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44498043|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498044|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498045|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44498046|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44498047|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498048|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
44498049|NCT01458236|Beraprost|beraprost|mesh-list
44498050|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498051|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498052|NCT01458301|Leuprolide|leuprolide|mesh-list
44498053|NCT01458301|Relugolix|relugolix|mesh-list
44498054|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44498055|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
44498056|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44498057|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498058|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44498059|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498060|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
44498061|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
44498062|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498063|NCT01458470|Memantine|memantine|mesh-list
44498064|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44498065|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44498066|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
44498067|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498068|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498069|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498070|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44498071|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44498072|NCT01458548|Rituximab|rituximab|mesh-list
44498073|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498074|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498075|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
44498076|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498077|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498078|NCT01458600|Diclofenac|diclofenac|mesh-list
44498079|NCT01458600|Propranolol|propranolol|mesh-list
44498080|NCT01458600|Metoprolol|metoprolol|mesh-list
44498081|NCT01458600|Methimazole|methimazole|mesh-list
44498082|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44498083|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44498084|NCT01458600|Analgesics|analgesics|mesh-ancestor
44498085|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
44498086|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498087|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498088|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498089|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498090|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44498091|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498092|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498093|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44498094|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44498095|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498096|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498097|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498098|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498099|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498100|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
44498101|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
44498102|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44498103|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
44498104|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
44498105|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498106|NCT01458626|Mirtazapine|mirtazapine|mesh-list
44498107|NCT01458626|Paroxetine|paroxetine|mesh-list
44498108|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44498109|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44498110|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498111|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498112|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498113|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
44498114|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498115|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44498116|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
44498117|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498118|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44498119|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44498120|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498121|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44498122|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
44498123|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
44498124|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44498125|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498126|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498127|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44498128|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44498129|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44498130|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498131|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44498132|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44498133|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44498134|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44498135|NCT01458743|Cephalosporins|cephalosporins|mesh-list
44498136|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44498137|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498138|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44498139|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44498140|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44498141|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
44498142|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498143|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498144|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44498145|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44498146|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
44498147|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317439|NCT05501769|Everolimus|everolimus|mesh-list
44498148|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44498150|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
44498151|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498152|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44498153|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498154|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498155|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498156|NCT01458977|Tenofovir|tenofovir|mesh-list
44498157|NCT01458977|Emtricitabine|emtricitabine|mesh-list
44498158|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44498159|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
44498160|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498161|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44498162|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44498163|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498164|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498165|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44498166|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44498167|NCT01459081|Zanamivir|zanamivir|mesh-list
44498168|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
44498169|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498170|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498171|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498172|NCT01459133|Insulin|insulin|mesh-list
44498173|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498174|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498175|NCT01459146|Lumefantrine|lumefantrine|mesh-list
44498176|NCT01459146|Artemether|artemether|mesh-list
44498177|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44498178|NCT01459146|Albendazole|albendazole|mesh-list
44498179|NCT01459146|Praziquantel|praziquantel|mesh-list
44498180|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
44498181|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44498182|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44498183|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498184|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
44498185|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
44498186|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44498187|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44498188|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44498189|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44235198|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498190|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498191|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498192|NCT01459198|Vaccines|vaccines|mesh-list
44498193|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
44498194|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498195|NCT01459211|Dexamethasone|dexamethasone|mesh-list
44498196|NCT01459211|Lenalidomide|lenalidomide|mesh-list
44498197|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498198|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
44498199|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
44498200|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498201|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498202|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44498203|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
44498204|NCT01459211|Hormones|hormones|mesh-ancestor
44498205|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498206|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44498207|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498208|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
44498209|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44498210|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44498211|NCT01459211|Growth Substances|growth substances|mesh-ancestor
44498212|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
44498213|NCT01459250|S 20098|s 20098|mesh-list
44498214|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44498215|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498216|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498217|NCT01459315|Dolutegravir|dolutegravir|mesh-list
44498218|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44498219|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44498220|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498221|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498222|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44317514|NCT05429970|Etodolac|etodolac|mesh-list
44498223|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44498224|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
44498225|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498226|NCT01459367|Lansoprazole|lansoprazole|mesh-list
44498227|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
44498228|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44498229|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44498230|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44498231|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498232|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498233|NCT01459380|Bevacizumab|bevacizumab|mesh-list
44141930|NCT00184899|Heparin|heparin|mesh-list
44498234|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44498235|NCT01459380|Carboplatin|carboplatin|mesh-list
44498236|NCT01459380|Doxorubicin|doxorubicin|mesh-list
44498237|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44498238|NCT01459380|Veliparib|veliparib|mesh-list
44498239|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
44498240|NCT01459380|Antibodies|antibodies|mesh-list
44498241|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
44498242|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44498243|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
44498244|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498245|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44498246|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44498247|NCT01459380|Growth Substances|growth substances|mesh-ancestor
44498248|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498249|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
44498250|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
44498251|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44498252|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44498253|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44498254|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498255|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498256|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44498258|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498259|NCT01459419|Antibodies|antibodies|mesh-list
44498260|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44498261|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
44498262|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498263|NCT01459601|Cabergoline|cabergoline|mesh-list
44498264|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44498265|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44498266|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
44498267|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
44498268|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498269|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498270|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498271|NCT01459627|Ticagrelor|ticagrelor|mesh-list
44498272|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44498273|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498274|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44498275|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44498276|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44498277|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
44498278|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498279|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498280|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498281|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
44498282|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44498283|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
44498284|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498285|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
44498286|NCT01459640|Protective Agents|protective agents|mesh-ancestor
44498287|NCT01459809|Metformin|metformin|mesh-list
44498288|NCT01459809|Glimepiride|glimepiride|mesh-list
44498289|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498290|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498291|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498292|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498293|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
44498294|NCT01459887|Prednisone|prednisone|mesh-list
44498295|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
44498296|NCT01459887|Doxorubicin|doxorubicin|mesh-list
44498297|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44498298|NCT01459887|Vincristine|vincristine|mesh-list
44498299|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498300|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
44498301|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498302|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498303|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44498304|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
44498305|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498306|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498307|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44498308|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44498309|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44498310|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44498311|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498312|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498313|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
44498315|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498316|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44498317|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44498318|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44498319|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44498320|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44498321|NCT01456481|Midodrine|midodrine|mesh-list
44498322|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
44498323|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
44498324|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498325|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498326|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44498327|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44498328|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44498329|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44498330|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498331|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498332|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498333|NCT01453660|Cisplatin|cisplatin|mesh-list
44498334|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498335|NCT01451736|Risperidone|risperidone|mesh-list
44498336|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44498337|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44498338|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
44498339|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426832|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44498340|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498341|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498342|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44498343|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498344|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498345|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498346|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44498348|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44498349|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44498350|NCT01450956|Sevoflurane|sevoflurane|mesh-list
44498351|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498352|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44498353|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
44498354|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
44498355|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498356|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498357|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
44498358|NCT01453530|Neostigmine|neostigmine|mesh-list
44498359|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44498360|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498361|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498362|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
44498363|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498364|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498365|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44498366|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
44498367|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498368|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44498369|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44498370|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44498371|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
44498372|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498373|NCT01454635|Sertraline|sertraline|mesh-list
44498374|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
44498375|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498376|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44498377|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44498378|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498379|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498380|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498381|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
44498382|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498383|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
44498384|NCT01455233|Besifloxacin|besifloxacin|mesh-list
44498385|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43954505|NCT01251536|Cetuximab|cetuximab|mesh-list
44498386|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44498387|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44498388|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44498389|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498390|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44498391|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44498392|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498393|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498394|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498395|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44498396|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
44498397|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44498398|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498399|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44498400|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44498401|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44498402|NCT01455337|Prednisolone|prednisolone|mesh-list
44498403|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
44498404|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498405|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
44498406|NCT01455337|Hormones|hormones|mesh-ancestor
44498407|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498408|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498409|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44498410|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498411|NCT01455337|Protective Agents|protective agents|mesh-ancestor
44498412|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44498413|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498414|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498415|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498416|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44498417|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498418|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44498419|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
44498420|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
44498421|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44498422|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
44498423|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498424|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498425|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44498426|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44498427|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44498428|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
44498429|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498430|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498431|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44498432|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498433|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
44498434|NCT01457781|Protective Agents|protective agents|mesh-ancestor
44498435|NCT01453946|Budesonide|budesonide|mesh-list
44498436|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498437|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44498438|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
44498439|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498440|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498441|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44498442|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44498443|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
44498444|NCT01453946|Hormones|hormones|mesh-ancestor
44498445|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498446|NCT01455597|Estradiol|estradiol|mesh-list
44498447|NCT01455597|Estrogens|estrogens|mesh-ancestor
44498448|NCT01455597|Hormones|hormones|mesh-ancestor
44498449|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498450|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498452|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44498453|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44498454|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
44498455|NCT01459679|Vitamins|vitamins|mesh-ancestor
44498456|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
44498457|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498458|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44498459|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
44498460|NCT01455896|Exenatide|exenatide|mesh-list
44498461|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498462|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498463|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44498464|NCT01455896|Incretins|incretins|mesh-ancestor
44498465|NCT01455896|Hormones|hormones|mesh-ancestor
44498466|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498467|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44498468|NCT01455870|Exenatide|exenatide|mesh-list
44498469|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498470|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498471|NCT01455870|Incretins|incretins|mesh-ancestor
44498472|NCT01455870|Hormones|hormones|mesh-ancestor
44498473|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498474|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44498475|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
44498476|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498477|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498478|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44498479|NCT01455857|Exenatide|exenatide|mesh-list
44498480|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498481|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498482|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44498483|NCT01455857|Incretins|incretins|mesh-ancestor
44498484|NCT01455857|Hormones|hormones|mesh-ancestor
44498485|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498486|NCT01454089|Gemcitabine|gemcitabine|mesh-list
44498487|NCT01454089|Cisplatin|cisplatin|mesh-list
44498488|NCT01454089|Carboplatin|carboplatin|mesh-list
44498489|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498490|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498491|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
44498492|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498493|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
44498494|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498495|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498496|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498497|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
44498498|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498499|NCT01452451|Exenatide|exenatide|mesh-list
44498500|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498501|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498502|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44498503|NCT01452451|Incretins|incretins|mesh-ancestor
44498504|NCT01452451|Hormones|hormones|mesh-ancestor
44498505|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498506|NCT01453101|Fludarabine|fludarabine|mesh-list
44498507|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
44498508|NCT01453101|Bortezomib|bortezomib|mesh-list
44498509|NCT01453101|Melphalan|melphalan|mesh-list
44498510|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498511|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498512|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
44498513|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498514|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498515|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
44498516|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498517|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44498518|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
44498519|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44498520|NCT04847752|Aspirin|aspirin|mesh-list
44498521|NCT04847752|Warfarin|warfarin|mesh-list
44498522|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
44498523|NCT04847752|Dabigatran|dabigatran|mesh-list
44498524|NCT04847752|Anticoagulants|anticoagulants|mesh-list
44498525|NCT04847752|Clopidogrel|clopidogrel|mesh-list
44498526|NCT04847752|Atorvastatin|atorvastatin|mesh-list
44498527|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44498528|NCT04847752|Evolocumab|evolocumab|mesh-list
44498529|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44498530|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44498531|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44498532|NCT04847752|Analgesics|analgesics|mesh-ancestor
44498533|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
44498534|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498535|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498536|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44498537|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498538|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44498539|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44498540|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498541|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44498542|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44498543|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498544|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
44498545|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44498546|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44498547|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
44498548|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44498549|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44498550|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44498551|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44498552|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
44498553|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498554|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44498555|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
44498556|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44498557|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
44498558|NCT04847193|Xanthohumol|xanthohumol|mesh-list
44498559|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498560|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44498561|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44498562|NCT04847193|Growth Substances|growth substances|mesh-ancestor
44498563|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498564|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44498565|NCT04843631|Ustekinumab|ustekinumab|mesh-list
44498566|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44498567|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
44498568|NCT04848519|Propranolol|propranolol|mesh-list
44498569|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498570|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498571|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44498572|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44498573|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498574|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498575|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498576|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498577|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498578|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498579|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498580|NCT04843046|Pioglitazone|pioglitazone|mesh-list
44498581|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44498582|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498583|NCT04849364|Capecitabine|capecitabine|mesh-list
44498584|NCT04849364|Atezolizumab|atezolizumab|mesh-list
44498585|NCT04849364|Talazoparib|talazoparib|mesh-list
44498586|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498587|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
44498588|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498589|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498590|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44498591|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498592|NCT04845737|Vitamin D|vitamin d|mesh-list
44498593|NCT04845737|Vitamins|vitamins|mesh-ancestor
44498594|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
44498595|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317806|NCT04899115|Vancomycin|vancomycin|mesh-list
44498596|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44498597|NCT04849715|Rituximab|rituximab|mesh-list
44498598|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44498599|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498600|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498601|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
44498602|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498603|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498604|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44498605|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
44498606|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498607|NCT04849650|Amisulpride|amisulpride|mesh-list
44498608|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44498609|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498610|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498611|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498612|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498613|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44498614|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
44498615|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498616|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498617|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44498618|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
44498619|NCT04843423|Cariprazine|cariprazine|mesh-list
44498620|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44498621|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498622|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498623|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498624|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426833|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
44498625|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44498626|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
44498627|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
44498628|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498629|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498630|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
44498631|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498632|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498633|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44498634|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44498635|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498636|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498638|NCT04845035|Methotrexate|methotrexate|mesh-list
44498639|NCT04845035|Dasatinib|dasatinib|mesh-list
44498640|NCT04845035|Ponatinib|ponatinib|mesh-list
44498641|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44498642|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
44498643|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44498644|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498645|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498646|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
44498647|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498648|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498649|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44498650|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498651|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44498652|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498653|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
44498654|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498655|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44498656|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
44498657|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498658|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44498659|NCT04844268|Vaccines|vaccines|mesh-list
44498660|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
44498661|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498662|NCT04842552|Hydralazine|hydralazine|mesh-list
44498663|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498664|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498665|NCT04842422|Imiquimod|imiquimod|mesh-list
44498666|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44498667|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
44498668|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498669|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317885|NCT04802759|Trastuzumab|trastuzumab|mesh-list
44498670|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
44498671|NCT04840641|Efavirenz|efavirenz|mesh-list
44498672|NCT04840641|Floxacillin|floxacillin|mesh-list
44498673|NCT04840641|Losartan|losartan|mesh-list
44498674|NCT04840641|Metoprolol|metoprolol|mesh-list
44498675|NCT04840641|Midazolam|midazolam|mesh-list
44498676|NCT04840641|Caffeine|caffeine|mesh-list
44498677|NCT04840641|Omeprazole|omeprazole|mesh-list
44498678|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44498679|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44498680|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498681|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498682|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44498683|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44498684|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44498685|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44498686|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
44498687|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
44498688|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
44498689|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
44498690|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498691|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498692|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498693|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498694|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44498695|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44498696|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44498697|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44498698|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44498699|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498700|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44498701|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44498702|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44498703|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44498704|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
44498705|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44498706|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44498707|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
44498708|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498709|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44498710|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44498711|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44498712|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44498713|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44498714|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44498715|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
44498716|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
44498717|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498718|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44498719|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44498720|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44498721|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498722|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44498723|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44498724|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44498726|NCT04840264|Fluorouracil|fluorouracil|mesh-list
44498727|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
44498728|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498729|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
44498730|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
44498731|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
44498732|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498733|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
44498734|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498735|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498736|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
44498737|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498738|NCT04844905|Ivermectin|ivermectin|mesh-list
44498739|NCT04844905|Piperaquine|piperaquine|mesh-list
44498740|NCT04844905|Artenimol|artenimol|mesh-list
44498741|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44498742|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498743|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
44498744|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44498745|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44498746|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
44498748|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498749|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
44498750|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498751|NCT04841434|Methotrexate|methotrexate|mesh-list
44498752|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44498753|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
44498754|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44498755|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498756|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498757|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
44498758|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498759|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498760|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954874|NCT01267136|Acetaminophen|acetaminophen|mesh-list
44498761|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498762|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44498763|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498764|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
44498765|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498766|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44498767|NCT04840862|Rifabutin|rifabutin|mesh-list
44498768|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44498769|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498770|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44498771|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
44498772|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
44498773|NCT04840238|Vitamin D|vitamin d|mesh-list
44498774|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44498775|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498776|NCT04840238|Vitamins|vitamins|mesh-ancestor
44498777|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
44498778|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44498779|NCT04840602|Rituximab|rituximab|mesh-list
44498780|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44498781|NCT04840602|Venetoclax|venetoclax|mesh-list
44498782|NCT04840602|Antibodies|antibodies|mesh-list
44498783|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
44498784|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44498785|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
44498786|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498787|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498788|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44498789|NCT04844957|Vitamin D|vitamin d|mesh-list
44498790|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
44498791|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
44498792|NCT04844957|Vitamins|vitamins|mesh-list
44498793|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
44498794|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498795|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44498796|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44318042|NCT04624243|Risperidone|risperidone|mesh-list
44498797|NCT04846478|Talazoparib|talazoparib|mesh-list
44498798|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44498799|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498800|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498801|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498802|NCT04842071|Listerine|listerine|mesh-list
44498803|NCT04842071|Fluorides|fluorides|mesh-list
44498804|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
44498805|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
44498806|NCT04842071|Protective Agents|protective agents|mesh-ancestor
44498807|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498808|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44498809|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498810|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44498811|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498812|NCT04840342|Amlodipine|amlodipine|mesh-list
44498813|NCT04840342|Eplerenone|eplerenone|mesh-list
44498814|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498815|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44498816|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498817|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498818|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44498819|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498820|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
44498821|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44498822|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
44498823|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498824|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44498825|NCT04840342|Diuretics|diuretics|mesh-ancestor
44498826|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
44498827|NCT05027919|Lofexidine|lofexidine|mesh-list
44498828|NCT05027919|Clonidine|clonidine|mesh-list
44498829|NCT05027919|Morphine|morphine|mesh-list
44498830|NCT05027919|Naloxone|naloxone|mesh-list
44498831|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44498832|NCT05027919|Narcotics|narcotics|mesh-ancestor
44498833|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498834|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498835|NCT05027919|Analgesics|analgesics|mesh-ancestor
44498836|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
44498837|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498838|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44498839|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44498840|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44498841|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44498842|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44498843|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44498844|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498845|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498846|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
44498847|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
44498848|NCT05020782|Belimumab|belimumab|mesh-list
44498849|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498850|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
44498851|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498852|NCT05027646|Granisetron|granisetron|mesh-list
44498853|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
44498854|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
44498855|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498856|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498857|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44498858|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44498859|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
44498860|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44498861|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498862|NCT05022901|Melphalan|melphalan|mesh-list
44498863|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44498864|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
44498865|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498866|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498867|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44498868|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498869|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
44498870|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498871|NCT05021809|Calcium|calcium|mesh-list
44318112|NCT04563520|Coagulants|coagulants|mesh-list
44498872|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44498873|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498874|NCT05028062|Naltrexone|naltrexone|mesh-list
44498875|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44498876|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44498877|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498878|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
44498879|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498880|NCT05025488|Poly ICLC|poly iclc|mesh-list
44498881|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
44498882|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
44498883|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498884|NCT05022342|Fulvestrant|fulvestrant|mesh-list
44498885|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44498886|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498887|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44498888|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44498889|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
44498890|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44498891|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498892|NCT05027204|Docetaxel|docetaxel|mesh-list
44498893|NCT05027204|Nivolumab|nivolumab|mesh-list
44498894|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498895|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44498896|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44498897|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44498898|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498899|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498900|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44498901|NCT05021926|Lidocaine|lidocaine|mesh-list
44498902|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
44498903|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
44498904|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
44498905|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498906|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498907|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
44498908|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498909|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498910|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44498911|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44498912|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498913|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498914|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44498915|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
44498916|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
44498917|NCT05021926|Protective Agents|protective agents|mesh-ancestor
44498918|NCT05021913|Lidocaine|lidocaine|mesh-list
44498919|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
44498920|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
44498921|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
44498922|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498923|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498924|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
44498925|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498926|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44498927|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44498928|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44498929|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44498930|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498931|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44498932|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
44498933|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
44498934|NCT05021913|Protective Agents|protective agents|mesh-ancestor
44498935|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
44498936|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44498937|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498938|NCT05023343|Ropivacaine|ropivacaine|mesh-list
44498939|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
44498940|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
44498941|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44498942|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498943|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
44498944|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498945|NCT05025423|Venetoclax|venetoclax|mesh-list
44498946|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44498947|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498948|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44498949|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
44498950|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498952|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
44498953|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498954|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44498955|NCT05024188|Metronidazole|metronidazole|mesh-list
44498956|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
44498957|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44498958|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44498959|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44498960|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44498961|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44498962|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44498963|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498964|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498965|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44498966|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44498967|NCT05027425|Durvalumab|durvalumab|mesh-list
44498968|NCT05027425|Tremelimumab|tremelimumab|mesh-list
44498969|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498970|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498971|NCT05024513|Fluorouracil|fluorouracil|mesh-list
44498972|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
44498973|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
44498974|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44498975|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44498976|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498977|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44498978|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
44498979|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498980|NCT05029960|Brivaracetam|brivaracetam|mesh-list
44498981|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
44498982|NCT05022927|Bevacizumab|bevacizumab|mesh-list
44498983|NCT05022927|Atezolizumab|atezolizumab|mesh-list
44498984|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44498985|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44498986|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44498987|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44498988|NCT05022927|Growth Substances|growth substances|mesh-ancestor
44498989|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498990|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
44498991|NCT05025644|Dobutamine|dobutamine|mesh-list
44498992|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44498994|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
44498995|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44498996|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44498997|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44498998|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44498999|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499000|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499001|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499002|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499003|NCT05025644|Protective Agents|protective agents|mesh-ancestor
44499004|NCT05026125|Remifentanil|remifentanil|mesh-list
44499005|NCT05026125|Anesthetics|anesthetics|mesh-list
44499006|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499007|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499008|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44499009|NCT05026125|Narcotics|narcotics|mesh-ancestor
44499010|NCT05026125|Analgesics|analgesics|mesh-ancestor
44499011|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
44499012|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499013|NCT05023070|Cannabidiol|cannabidiol|mesh-list
44499014|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
44499015|NCT05023369|Dexamethasone|dexamethasone|mesh-list
44499016|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499017|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
44499018|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
44499019|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499020|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499021|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44499022|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
44499023|NCT05023369|Hormones|hormones|mesh-ancestor
44499024|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499025|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44499026|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499027|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
44499028|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44499029|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
44499030|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499031|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
44499032|NCT05025865|Protective Agents|protective agents|mesh-ancestor
44499033|NCT05027100|Irinotecan|irinotecan|mesh-list
44499034|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44499035|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44499036|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499037|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499038|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499039|NCT05024214|Sunitinib|sunitinib|mesh-list
44499040|NCT05024214|Lenvatinib|lenvatinib|mesh-list
44499041|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499042|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499043|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44499044|NCT05024214|Growth Substances|growth substances|mesh-ancestor
44499045|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499046|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499047|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44499048|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499049|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499055|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499056|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44499057|NCT05028673|Antacids|antacids|mesh-list
44499058|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44499059|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44499060|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
44499061|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499062|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499063|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44499064|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
44499065|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44499066|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499067|NCT05020028|Cannabidiol|cannabidiol|mesh-list
44499068|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
44499069|NCT05027516|Azithromycin|azithromycin|mesh-list
44499070|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
44499071|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499072|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499073|NCT05028725|Lugol's solution|lugol's solution|mesh-list
44499074|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
44499075|NCT05028725|Coagulants|coagulants|mesh-ancestor
44499080|NCT05028153|Azithromycin|azithromycin|mesh-list
44499081|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499082|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499083|NCT05024552|Cytarabine|cytarabine|mesh-list
44499084|NCT05024552|Daunorubicin|daunorubicin|mesh-list
44499085|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44499086|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
44499087|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499088|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499089|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
44499090|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499091|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499092|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
44499093|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499094|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44499095|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44499096|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44499097|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499098|NCT05024422|Pyridoxine|pyridoxine|mesh-list
44499099|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
44499100|NCT05024422|Cabergoline|cabergoline|mesh-list
44499101|NCT05024422|Vitamins|vitamins|mesh-ancestor
44499102|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
44499103|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499104|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
44499105|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44499106|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44499107|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
44499108|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
44499109|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499110|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499111|NCT05020574|Cephalexin|cephalexin|mesh-list
44499112|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499113|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499114|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
44499115|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44499116|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44499117|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499118|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
44499119|NCT05024253|Coagulants|coagulants|mesh-ancestor
44499120|NCT05022758|Warfarin|warfarin|mesh-list
44499121|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
44499122|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
44318396|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499123|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44499124|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
44499125|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44499126|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499127|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499128|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499129|NCT05026593|Cisplatin|cisplatin|mesh-list
44499130|NCT05026593|Carboplatin|carboplatin|mesh-list
44499131|NCT05026593|Etoposide|etoposide|mesh-list
44499132|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499133|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44499134|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44499135|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44499136|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499137|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499138|NCT05026567|Midazolam|midazolam|mesh-list
44499139|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44499140|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44499141|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499142|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499143|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44499144|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44499145|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499146|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44499147|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
44499149|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
44499150|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
44499151|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499152|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499153|NCT05021978|Pramoxine|pramoxine|mesh-list
44499154|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
44499155|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
44499156|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499157|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499158|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
44499159|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499160|NCT05026398|Fenfluramine|fenfluramine|mesh-list
44499161|NCT05026398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44499162|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44499163|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44499164|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499165|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499166|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
44499167|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499168|NCT01891747|Ascorbic Acid|ascorbic acid|mesh-list
44499169|NCT01891747|Bevacizumab|bevacizumab|mesh-list
44499170|NCT01891747|Temozolomide|temozolomide|mesh-list
44499171|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44499172|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499173|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499174|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44499175|NCT01891747|Growth Substances|growth substances|mesh-ancestor
44499176|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499177|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499178|NCT01891747|Vitamins|vitamins|mesh-ancestor
44499179|NCT01891747|Micronutrients|micronutrients|mesh-ancestor
44499180|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44499181|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
44499182|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499183|NCT01891747|Antioxidants|antioxidants|mesh-ancestor
44499184|NCT01891747|Protective Agents|protective agents|mesh-ancestor
44499185|NCT01890005|Aspirin|aspirin|mesh-list
44499186|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499187|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499188|NCT01890005|Analgesics|analgesics|mesh-ancestor
44499189|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
44499190|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499191|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499192|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499193|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499194|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44499195|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44499196|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499197|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44499198|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44499199|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499200|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
44499201|NCT01890200|Ribavirin|ribavirin|mesh-list
44499202|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44499203|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
43955259|NCT01280058|Paclitaxel|paclitaxel|mesh-list
44499204|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499205|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
44499206|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499207|NCT01890408|Ropivacaine|ropivacaine|mesh-list
44499208|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
44499209|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
44499210|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499211|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499212|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
44499213|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499214|NCT01890629|Metformin|metformin|mesh-list
44499215|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44499216|NCT01890629|Glimepiride|glimepiride|mesh-list
44499217|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44499218|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499219|NCT01890629|Incretins|incretins|mesh-ancestor
44499220|NCT01890629|Hormones|hormones|mesh-ancestor
44499221|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909202|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499222|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44499223|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499224|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499225|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499226|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44499227|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499228|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
44499229|NCT01890772|Vitamin D|vitamin d|mesh-list
44499230|NCT01890772|Ribavirin|ribavirin|mesh-list
44499231|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44499232|NCT01890772|Vitamins|vitamins|mesh-ancestor
44499233|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
44499234|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499235|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44499236|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
44499237|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499238|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
44499239|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499241|NCT01890863|Xhance|xhance|mesh-list
44499242|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44499243|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44499244|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499245|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499246|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
44499247|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499248|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499249|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499250|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499251|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499252|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44499253|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44499254|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44499255|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499256|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499257|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499258|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499259|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
44499260|NCT01890863|Hormones|hormones|mesh-ancestor
44499261|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499262|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
44499263|NCT01890889|Ezetimibe|ezetimibe|mesh-list
44499264|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44499265|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44499266|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
44499267|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955285|NCT01281007|Acyclovir|acyclovir|mesh-list
44499268|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44499269|NCT01890902|Ketoprofen|ketoprofen|mesh-list
44499270|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499271|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499272|NCT01890902|Analgesics|analgesics|mesh-ancestor
44499273|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
44499274|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499275|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499276|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499277|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499278|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44499279|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499280|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499281|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44499282|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44499283|NCT01890993|Liraglutide|liraglutide|mesh-list
44499284|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44499285|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499286|NCT01890993|Incretins|incretins|mesh-ancestor
44499287|NCT01890993|Hormones|hormones|mesh-ancestor
44499288|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499289|NCT01891019|Thalidomide|thalidomide|mesh-list
44499290|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499291|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
44499292|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499293|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
44499294|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499295|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499296|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499297|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44499298|NCT01891019|Growth Substances|growth substances|mesh-ancestor
44499299|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499300|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499301|NCT01891084|Acetaminophen|acetaminophen|mesh-list
44499302|NCT01891084|Ibuprofen|ibuprofen|mesh-list
44499303|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499304|NCT01891084|Analgesics|analgesics|mesh-ancestor
44499305|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
44499306|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499307|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499308|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
44499309|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499310|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499311|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499312|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44499313|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318549|NCT03721068|Fludarabine|fludarabine|mesh-list
44499314|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499315|NCT01891175|Anesthetics|anesthetics|mesh-list
44499316|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499317|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499318|NCT01891201|Oxytocin|oxytocin|mesh-list
44499319|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
44499320|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44499321|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499322|NCT01891227|Capecitabine|capecitabine|mesh-list
44499323|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44499324|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44499325|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
44499326|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499327|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499328|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44499329|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
44499330|NCT01891435|Acetaminophen|acetaminophen|mesh-list
44499331|NCT01891435|Diclofenac|diclofenac|mesh-list
44499332|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499333|NCT01891435|Analgesics|analgesics|mesh-ancestor
44499334|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
44499335|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499336|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499337|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
44499338|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499339|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499340|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499341|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44499342|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499343|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499344|NCT01891461|Hemostatics|hemostatics|mesh-list
44499345|NCT01891461|Coagulants|coagulants|mesh-ancestor
44499346|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
44499347|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499348|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
44499349|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499350|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499351|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499352|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499353|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44499354|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
44499355|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499356|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499357|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44499358|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
44499359|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
44499360|NCT01891500|Protective Agents|protective agents|mesh-ancestor
44499361|NCT01891513|Losartan|losartan|mesh-list
44499362|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44499363|NCT01891513|Perindopril|perindopril|mesh-list
44499364|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44499365|NCT01891513|Diuretics|diuretics|mesh-list
44499366|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44499367|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44499368|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44499369|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44499370|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44499371|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499372|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
44499373|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499374|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44499375|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499376|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499377|NCT01891526|Tretinoin|tretinoin|mesh-list
44499378|NCT01891526|Alitretinoin|alitretinoin|mesh-list
44499379|NCT01891526|Isotretinoin|isotretinoin|mesh-list
44499380|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499381|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
44499382|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499383|NCT01891708|Bevacizumab|bevacizumab|mesh-list
44499384|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44499385|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499386|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499387|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318564|NCT03713294|Dexamethasone|dexamethasone|mesh-list
44499388|NCT01891708|Growth Substances|growth substances|mesh-ancestor
44499389|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499390|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499391|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
44499392|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44499393|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
44499394|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
44499395|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499396|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499397|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499398|NCT01891812|Analgesics|analgesics|mesh-ancestor
44499399|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
44499400|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499401|NCT01891851|Ritonavir|ritonavir|mesh-list
44499402|NCT01891851|Simeprevir|simeprevir|mesh-list
44499403|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44499404|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44499405|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499406|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499407|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499408|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43955411|NCT01285050|Tenofovir|tenofovir|mesh-list
44499409|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44499410|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
44499411|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499412|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44499413|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44499414|NCT01891916|Caseins|caseins|mesh-list
44499415|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
44499416|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
44499417|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499418|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
44499419|NCT01892098|Astringents|astringents|mesh-ancestor
44499420|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499421|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499422|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
44499423|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44499424|NCT01892150|Protective Agents|protective agents|mesh-ancestor
44499425|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499426|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499427|NCT01892176|Ubiquinone|ubiquinone|mesh-list
44499428|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
44499429|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
44499430|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499431|NCT01892176|Vitamins|vitamins|mesh-ancestor
44499432|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44499433|NCT01892241|Entecavir|entecavir|mesh-list
44499434|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
44499435|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499436|NCT01892254|Metformin|metformin|mesh-list
44499437|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44499438|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499439|NCT01892332|Lidocaine|lidocaine|mesh-list
44499440|NCT01892332|Fentanyl|fentanyl|mesh-list
44499441|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
44499442|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
44499443|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499444|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499445|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
44499446|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499447|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43624869|NCT00495508|Lumefantrine|lumefantrine|mesh-list
44499448|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44499449|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44499450|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44499451|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499452|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44499453|NCT01892332|Narcotics|narcotics|mesh-ancestor
44499454|NCT01892332|Analgesics|analgesics|mesh-ancestor
44499455|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44499456|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44499457|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
44499458|NCT01892384|BI 409306|bi 409306|mesh-list
44499459|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44499460|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499461|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499462|NCT01892488|Sultamicillin|sultamicillin|mesh-list
44499463|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44499464|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499465|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499466|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499467|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499468|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44499469|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
44499470|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499471|NCT01892644|Deferasirox|deferasirox|mesh-list
44499472|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44499473|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
44499474|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
44499475|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499476|NCT01892683|Propofol|propofol|mesh-list
44499477|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
44499478|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499479|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499480|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44499481|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44499482|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
44499483|NCT01892748|Vitamin D|vitamin d|mesh-list
44499484|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
44499485|NCT01892748|Vitamins|vitamins|mesh-ancestor
44499486|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
44499487|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499488|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44499489|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44499490|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
44499491|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44499492|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499493|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
44499494|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499495|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499496|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499497|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499498|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44499499|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44499500|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499501|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499502|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499503|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499504|NCT01892813|Bupropion|bupropion|mesh-list
44499505|NCT01892813|Nicotine|nicotine|mesh-list
44499506|NCT01892813|Varenicline|varenicline|mesh-list
44499507|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44499508|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
44499509|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499510|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499511|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44499512|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44499513|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
44499514|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499515|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499516|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44499517|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44499518|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499519|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44499520|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44499521|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44499522|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
44499523|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44499524|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44499525|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499526|NCT01892995|Ketamine|ketamine|mesh-list
44499527|NCT01892995|Analgesics|analgesics|mesh-ancestor
44499528|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
44499529|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499530|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499531|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44499532|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44499533|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
44499534|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
44499535|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499536|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44499537|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44499538|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499539|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499540|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
44499541|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44499542|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
44499543|NCT01893060|Povidone|povidone|mesh-list
44499544|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44499545|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499546|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
44499547|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499548|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
44499549|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
44499550|NCT01893099|Sorafenib|sorafenib|mesh-list
44499551|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499552|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44499553|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499554|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499555|NCT01893177|Vaccines|vaccines|mesh-list
44499556|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
44499557|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499558|NCT01893294|Gemcitabine|gemcitabine|mesh-list
44499559|NCT01893294|Fluorouracil|fluorouracil|mesh-list
44499560|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44499561|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
44499562|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499563|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499564|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
44499565|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499566|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499567|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499568|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
44499569|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499570|NCT01893385|Vitamin D|vitamin d|mesh-list
44499571|NCT01893385|Vitamins|vitamins|mesh-ancestor
44499572|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
44499573|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499574|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44499575|NCT01893424|Dronabinol|dronabinol|mesh-list
44499576|NCT01893424|Nabiximols|nabiximols|mesh-list
44499577|NCT01893424|Cannabidiol|cannabidiol|mesh-list
44499578|NCT01893424|Piperine|piperine|mesh-list
44499579|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
44499580|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
44499581|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499582|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499583|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499584|NCT01893424|Analgesics|analgesics|mesh-ancestor
44499585|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
44499586|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499587|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44499588|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44499589|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499590|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499591|NCT01893424|Hormones|hormones|mesh-ancestor
43955572|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
44499592|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499593|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44499594|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499595|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
44499596|NCT01893450|Bromocriptine|bromocriptine|mesh-list
44499597|NCT01893450|Methimazole|methimazole|mesh-list
44499598|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44499599|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499600|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499601|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44499602|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44499603|NCT01893450|Protective Agents|protective agents|mesh-ancestor
44499604|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499605|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
44499606|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44499607|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
44499608|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44499609|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44499610|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
44499611|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499612|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
44499613|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
44499614|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499615|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
44499616|NCT01893541|Propranolol|propranolol|mesh-list
44499617|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44499618|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44499619|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499620|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499621|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499622|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499623|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44499624|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44499625|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
44499626|NCT01893658|Omalizumab|omalizumab|mesh-list
44499627|NCT01893658|Prednisone|prednisone|mesh-list
44499628|NCT01893658|Prednisolone|prednisolone|mesh-list
44499629|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499630|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
44499631|NCT01893658|Hormones|hormones|mesh-ancestor
44499632|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499633|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499634|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44499635|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499636|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44499637|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499638|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499639|NCT01893723|Remifentanil|remifentanil|mesh-list
44499640|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44499641|NCT01893723|Narcotics|narcotics|mesh-ancestor
44499642|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499643|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499644|NCT01893723|Analgesics|analgesics|mesh-ancestor
44499645|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
44499646|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499647|NCT01893788|Eplerenone|eplerenone|mesh-list
44499648|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44499649|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
44499650|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499651|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499652|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44499653|NCT01893788|Diuretics|diuretics|mesh-ancestor
44499654|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
44499655|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44499656|NCT01893996|Adalimumab|adalimumab|mesh-list
44499657|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499658|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499659|NCT01894035|Iloprost|iloprost|mesh-list
44499660|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44499661|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
44499662|NCT01894048|Beclomethasone|beclomethasone|mesh-list
44499663|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499664|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
44499665|NCT01894048|Hormones|hormones|mesh-ancestor
44499666|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499667|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499668|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499669|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499670|NCT01894061|Bevacizumab|bevacizumab|mesh-list
44499671|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44499672|NCT01894061|Antibodies|antibodies|mesh-list
44499673|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
44499674|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44499675|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499676|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499677|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44499678|NCT01894061|Growth Substances|growth substances|mesh-ancestor
44499679|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499680|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499681|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
44499682|NCT01894295|Vitamin D|vitamin d|mesh-list
44499683|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44499684|NCT01894295|Vitamins|vitamins|mesh-ancestor
44499685|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
44499686|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499687|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44499688|NCT01894334|Edaravone|edaravone|mesh-list
44499689|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
44499690|NCT01894334|Urinastatin|urinastatin|mesh-list
44499691|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44499692|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44499693|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499694|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
44499695|NCT01894334|Coagulants|coagulants|mesh-ancestor
44499696|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44499697|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
44499698|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44499699|NCT01894334|Protective Agents|protective agents|mesh-ancestor
44499700|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499701|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44499702|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44499703|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499704|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499705|NCT01894360|Belimumab|belimumab|mesh-list
44499706|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499707|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
44499708|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499709|NCT01894412|Etanercept|etanercept|mesh-list
44499710|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499711|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499712|NCT01894412|Analgesics|analgesics|mesh-ancestor
44499713|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
44499714|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499715|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499716|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499717|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499718|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44499719|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499720|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
44499721|NCT01894451|Bevacizumab|bevacizumab|mesh-list
44499722|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44499723|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44499724|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499725|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44499726|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44499727|NCT01894451|Growth Substances|growth substances|mesh-ancestor
44499728|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499729|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
44499730|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44499731|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499732|NCT01894633|Chloroquine|chloroquine|mesh-list
44499733|NCT01894633|Amebicides|amebicides|mesh-ancestor
44499734|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44499735|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44499736|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499737|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
44499738|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499739|NCT01894685|Mesalamine|mesalamine|mesh-list
44499740|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44499741|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499742|NCT01894685|Analgesics|analgesics|mesh-ancestor
44499743|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
44499744|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499745|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499746|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499747|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499748|NCT01894711|Trastuzumab|trastuzumab|mesh-list
44499749|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44499750|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499751|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
44499752|NCT01894867|Antacids|antacids|mesh-ancestor
44499753|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499754|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44499755|NCT01895010|Tropisetron|tropisetron|mesh-list
44499757|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
44499758|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499759|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499760|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44499761|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44499762|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44499763|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
44499764|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499765|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499766|NCT01895023|Midazolam|midazolam|mesh-list
44499767|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
44499768|NCT01895023|GABA Modulators|gaba modulators|mesh-list
44499769|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44499770|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499771|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499772|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499773|NCT01895023|Analgesics|analgesics|mesh-ancestor
44499774|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
44499775|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499776|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43955730|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
44499777|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44499778|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499779|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499780|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499781|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499782|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44499783|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44499784|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44499785|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499786|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44499787|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
44499788|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
44499789|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
44499790|NCT01895075|Budesonide|budesonide|mesh-list
44499791|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499792|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499793|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
44499794|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499795|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499796|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499797|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499798|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
44499799|NCT01895075|Hormones|hormones|mesh-ancestor
44499800|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499801|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44499802|NCT01895205|Hematinics|hematinics|mesh-ancestor
44499803|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44499804|NCT01895218|Hematinics|hematinics|mesh-ancestor
44499805|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44499806|NCT01895231|Hematinics|hematinics|mesh-ancestor
44499807|NCT01895257|Leucovorin|leucovorin|mesh-list
44499808|NCT01895257|Fluorouracil|fluorouracil|mesh-list
44499809|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
44499810|NCT01895257|Antidotes|antidotes|mesh-ancestor
44499811|NCT01895257|Protective Agents|protective agents|mesh-ancestor
44499812|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499813|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
44499814|NCT01895257|Vitamins|vitamins|mesh-ancestor
44499815|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
44499816|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
44499817|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499818|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44499819|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499820|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499821|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
44499822|NCT01895296|Pasireotide|pasireotide|mesh-list
44499823|NCT01895296|Hormones|hormones|mesh-ancestor
44499824|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499825|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499826|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
44499827|NCT01895348|Remifentanil|remifentanil|mesh-list
44499828|NCT01895348|Propofol|propofol|mesh-list
44499829|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44499830|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499831|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499832|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43955796|NCT01295112|Hormones|hormones|mesh-ancestor
44499833|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
44499834|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
44499835|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44499836|NCT01895348|Analgesics|analgesics|mesh-ancestor
44499837|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
44499838|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499839|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44499840|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44499841|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499842|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499843|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499844|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499845|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44499846|NCT01895348|Narcotics|narcotics|mesh-ancestor
44499847|NCT01895400|Cilostazol|cilostazol|mesh-list
44499848|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499849|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
44499850|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499851|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499852|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499853|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499854|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44499855|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44499856|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499857|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44499858|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
44499859|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44499860|NCT01895400|Protective Agents|protective agents|mesh-ancestor
44499861|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44499862|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44499863|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499864|NCT01895569|Metformin|metformin|mesh-list
44499865|NCT01895569|Pioglitazone|pioglitazone|mesh-list
44499866|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44499867|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44499868|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499869|NCT01895569|Incretins|incretins|mesh-ancestor
44499870|NCT01895569|Hormones|hormones|mesh-ancestor
44499871|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499872|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44499873|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44499874|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499875|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499876|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
44499877|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
44499878|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499880|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499881|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
44499882|NCT01895621|Vitamins|vitamins|mesh-ancestor
44499883|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
44499884|NCT01895764|Adalimumab|adalimumab|mesh-list
44499885|NCT01895764|Methotrexate|methotrexate|mesh-list
44499886|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44499887|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
44499888|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44499889|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499890|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44499891|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
44499892|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499893|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499894|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
44499895|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499896|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44499897|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44499898|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
44499899|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44499900|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44499901|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44499902|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44499903|NCT01895829|Hematinics|hematinics|mesh-ancestor
44499904|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44499905|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44499906|NCT01895881|Estradiol|estradiol|mesh-list
44499907|NCT01895881|Estrogens|estrogens|mesh-ancestor
44499908|NCT01895881|Hormones|hormones|mesh-ancestor
44499909|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499910|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499911|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
43955888|NCT01297348|Norinyl|norinyl|mesh-list
44499912|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44499913|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44499914|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44499915|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
44499916|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44499917|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499918|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499919|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499920|NCT01895998|Albuterol|albuterol|mesh-list
44499921|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44499922|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
44499923|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44499924|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499925|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44499926|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
44499927|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
44499928|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44499929|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44499930|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44499931|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44499932|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44499933|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499934|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499935|NCT01896011|Teriparatide|teriparatide|mesh-list
44499936|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44499937|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499938|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44499939|NCT01896180|Latanoprost|latanoprost|mesh-list
44499940|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44499941|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44499942|NCT01896245|Sevoflurane|sevoflurane|mesh-list
44499943|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44499944|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44499945|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
44499946|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
44499947|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499948|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499949|NCT01896323|Ketoconazole|ketoconazole|mesh-list
44499950|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
44499951|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44499952|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44499953|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44499954|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44499955|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499956|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44499957|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
44499958|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44499959|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499960|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44499961|NCT01896336|Zolpidem|zolpidem|mesh-list
44142140|NCT00185237|Estradiol|estradiol|mesh-list
44499962|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44499963|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44499964|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499965|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499966|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44499967|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
44499968|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
44499969|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499970|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499971|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44499972|NCT01896349|Amitriptyline|amitriptyline|mesh-list
44499973|NCT01896349|Risperidone|risperidone|mesh-list
44499974|NCT01896349|Sulpiride|sulpiride|mesh-list
44499975|NCT01896349|Mirtazapine|mirtazapine|mesh-list
44499976|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
44499977|NCT01896349|Trazodone|trazodone|mesh-list
44499978|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
44499979|NCT01896349|Citalopram|citalopram|mesh-list
44499980|NCT01896349|Bupropion|bupropion|mesh-list
44499981|NCT01896349|Sertraline|sertraline|mesh-list
44499982|NCT01896349|Fluoxetine|fluoxetine|mesh-list
44499983|NCT01896349|Paroxetine|paroxetine|mesh-list
44499984|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44499985|NCT01896349|Nortriptyline|nortriptyline|mesh-list
44499986|NCT01896349|Imipramine|imipramine|mesh-list
44499987|NCT01896349|Clomipramine|clomipramine|mesh-list
44499988|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
44499989|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44499990|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
44499991|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44499992|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44499993|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44499994|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44499995|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44499996|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44499997|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44499998|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44499999|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
43955941|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
44500000|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44500001|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44500002|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500003|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44500004|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500005|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44500006|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44500007|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44500008|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500009|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44500010|NCT01896349|Analgesics|analgesics|mesh-ancestor
44500011|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
44500012|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44500013|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
44500014|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
44500015|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44500016|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44500017|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44500018|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44500019|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500020|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44500021|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44500022|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44500023|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500024|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44500025|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44319228|NCT00921388|Varenicline|varenicline|mesh-list
44500026|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44500027|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44500028|NCT01896388|Ifenprodil|ifenprodil|mesh-list
44500029|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44500030|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44500031|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500032|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500033|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500034|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500035|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500036|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44500037|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44500038|NCT01896440|Ondansetron|ondansetron|mesh-list
44500039|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
44500040|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
44500041|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500042|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500043|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500044|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
44500045|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500046|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44500047|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
44500048|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500049|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500050|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44500051|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44500052|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500053|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500054|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44500056|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44500057|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
44500058|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500059|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500060|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44500061|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44500062|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
44500063|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500064|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500065|NCT01896609|Interferons|interferons|mesh-list
44500066|NCT01896609|Ribavirin|ribavirin|mesh-list
44500067|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
44500068|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
44500069|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44500070|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
44500071|NCT01896609|Complement Factor H|complement factor h|mesh-list
44500072|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500073|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
44500074|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500075|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
44500076|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500077|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
44500078|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500079|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44500080|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500081|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44500082|NCT01896661|Amlodipine|amlodipine|mesh-list
44500083|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
44500084|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
44500085|NCT01896661|Amiloride|amiloride|mesh-list
44500086|NCT01896661|Calcium|calcium|mesh-list
44500087|NCT01896661|Diuretics|diuretics|mesh-list
44500088|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44500089|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500090|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500091|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500092|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500093|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500094|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
44500095|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44500096|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44500097|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44500098|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44500099|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44500100|NCT01896739|Vaccines|vaccines|mesh-list
44319305|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
44500102|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500103|NCT01896960|Fentanyl|fentanyl|mesh-list
44500104|NCT01896960|Bupivacaine|bupivacaine|mesh-list
44500105|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
44500106|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
44500107|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500108|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500109|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
44500110|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500111|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44500112|NCT01896960|Narcotics|narcotics|mesh-ancestor
44500113|NCT01896960|Analgesics|analgesics|mesh-ancestor
44500114|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44500115|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44500116|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
44500117|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44500118|NCT01897012|Romidepsin|romidepsin|mesh-list
44500119|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500120|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44500121|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500122|NCT01897038|Sorafenib|sorafenib|mesh-list
44500123|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500124|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956065|NCT01304589|Analgesics|analgesics|mesh-ancestor
44500125|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500126|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500127|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
44500128|NCT01897116|Vemurafenib|vemurafenib|mesh-list
44500129|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
44500130|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44500131|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44500132|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500133|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500134|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500135|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500136|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500137|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44500138|NCT01897324|Hormones|hormones|mesh-list
44500139|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500140|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500141|NCT01897337|Aprepitant|aprepitant|mesh-list
44500142|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
44500143|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
44500144|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500145|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500146|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500147|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44500148|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500149|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500150|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
44500151|NCT01897428|Salicylates|salicylates|mesh-list
44500152|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44500153|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44500154|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500155|NCT01897428|Analgesics|analgesics|mesh-ancestor
44500156|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
44500157|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500158|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500159|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500160|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500161|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44500162|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500163|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500164|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44500165|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500166|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500167|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500168|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500169|NCT01897844|Somatostatin|somatostatin|mesh-list
44500170|NCT01897844|Hormones|hormones|mesh-ancestor
44500171|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500172|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500173|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
44500174|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44500175|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500176|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
44500177|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
44500178|NCT01898039|Vaccines|vaccines|mesh-list
44500179|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
44500180|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500181|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500182|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500183|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44500184|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
44500185|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500186|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500187|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44500188|NCT01898052|Anesthetics|anesthetics|mesh-list
44500189|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
44500190|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500191|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500192|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
44500193|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
44500194|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500195|NCT01898169|Nicotine|nicotine|mesh-list
44500196|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44500197|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
44500198|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500199|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500200|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44500201|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44500202|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44500203|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500204|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500205|NCT01898182|Kinetin|kinetin|mesh-list
44500206|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44500207|NCT01898182|Growth Substances|growth substances|mesh-ancestor
44500208|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500209|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
44500210|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
44500211|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44500212|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500213|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44500214|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
44500215|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500216|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500217|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500218|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500219|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44500220|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44500221|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44500222|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500223|NCT01898507|Nicotine|nicotine|mesh-list
44500224|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44500225|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
44500226|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500227|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500228|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44500229|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44500230|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44500231|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500232|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500233|NCT01898585|Vemurafenib|vemurafenib|mesh-list
44500234|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500235|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44500236|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500237|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500238|NCT01898624|Mirabegron|mirabegron|mesh-list
44500239|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44500240|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44500241|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44500242|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500243|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500244|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500245|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500246|NCT01898624|Urological Agents|urological agents|mesh-ancestor
44500247|NCT01898676|Valproic Acid|valproic acid|mesh-list
44500248|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
44500249|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500250|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500251|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
44500252|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500253|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500254|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
44500255|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44500256|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500257|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500258|NCT01898728|Iodine|iodine|mesh-list
44500259|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
44500260|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
44500261|NCT01898728|Povidone|povidone|mesh-list
44500262|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44500263|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44500264|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44500265|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500266|NCT01898728|Trace Elements|trace elements|mesh-ancestor
44500267|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
44500268|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500269|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
44500270|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
44500271|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
44500273|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500274|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500275|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500276|NCT01898819|Analgesics|analgesics|mesh-ancestor
44500277|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
44500278|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500279|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44500280|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44500281|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44500282|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500283|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500284|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500285|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44319460|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
44500287|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44500288|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
44500289|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500290|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44500291|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44500292|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500293|NCT01899066|Carboplatin|carboplatin|mesh-list
44500294|NCT01899066|Etoposide|etoposide|mesh-list
44500295|NCT01899066|Vincristine|vincristine|mesh-list
44500296|NCT01899066|Ranibizumab|ranibizumab|mesh-list
44500297|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500298|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44500299|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44500300|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500301|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500302|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500303|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
44500304|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
44500305|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
44500306|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44500307|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44500308|NCT01899066|Growth Substances|growth substances|mesh-ancestor
44500309|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500310|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
44500311|NCT01899118|Capecitabine|capecitabine|mesh-list
44500312|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
44500313|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
44500314|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44500315|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
44500316|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500317|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500318|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44500319|NCT01899170|Carfentanil|carfentanil|mesh-list
44500320|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44500321|NCT01899170|Narcotics|narcotics|mesh-ancestor
44500322|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500323|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500324|NCT01899170|Analgesics|analgesics|mesh-ancestor
44500325|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
44500326|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500327|NCT01899248|Sevoflurane|sevoflurane|mesh-list
44500328|NCT01899248|Desflurane|desflurane|mesh-list
44500329|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44500330|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44500331|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
44500332|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
44500333|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500334|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500335|NCT01899326|Desipramine|desipramine|mesh-list
44500336|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500337|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44500338|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
44500339|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500340|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500341|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500342|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44500343|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44500344|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500345|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500346|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500347|NCT01899430|Metformin|metformin|mesh-list
44500348|NCT01899430|Liraglutide|liraglutide|mesh-list
44500349|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500350|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500351|NCT01899430|Incretins|incretins|mesh-ancestor
44500352|NCT01899430|Hormones|hormones|mesh-ancestor
44500353|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500354|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44500355|NCT01899690|Clindamycin|clindamycin|mesh-list
44500356|NCT01899690|Cephalexin|cephalexin|mesh-list
44500357|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500358|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44500359|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500360|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500361|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44500362|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44500363|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500364|NCT01899755|Adalimumab|adalimumab|mesh-list
44500365|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44500366|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500367|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500368|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44500369|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500370|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
44500371|NCT01899794|Oxybutynin|oxybutynin|mesh-list
44500372|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
44500373|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
44500374|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500375|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500376|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44500377|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44500378|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
44500379|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500380|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500381|NCT01899794|Urological Agents|urological agents|mesh-ancestor
44500382|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44500383|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500384|NCT01899794|Renal Agents|renal agents|mesh-ancestor
44500385|NCT01899820|Lumefantrine|lumefantrine|mesh-list
44500386|NCT01899820|Artemether|artemether|mesh-list
44500387|NCT01899820|Piperaquine|piperaquine|mesh-list
44500388|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44500389|NCT01899820|Artenimol|artenimol|mesh-list
44500390|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
44500391|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44500392|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44500393|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500394|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44500395|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44500396|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956335|NCT01311895|Analgesics|analgesics|mesh-ancestor
44500397|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44500398|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44500399|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44500400|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44500401|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500402|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500403|NCT01899846|Progestins|progestins|mesh-ancestor
44500404|NCT01899846|Hormones|hormones|mesh-ancestor
44500405|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
44500406|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44500407|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44500408|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500409|NCT01899144|Albuterol|albuterol|mesh-list
44500410|NCT01899144|Procaterol|procaterol|mesh-list
44500411|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44500412|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
44500413|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500414|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500415|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44500416|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44500417|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
44500418|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500419|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44500420|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44500421|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44500422|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500423|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500424|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500425|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
44500426|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
44500427|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44500428|NCT01896284|Aflibercept|aflibercept|mesh-list
44500429|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44500430|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44500431|NCT01896284|Growth Substances|growth substances|mesh-ancestor
44500432|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500433|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44500434|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500435|NCT01898494|Cisplatin|cisplatin|mesh-list
44500436|NCT01898494|Carboplatin|carboplatin|mesh-list
44500437|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500438|NCT01891643|Dexamethasone|dexamethasone|mesh-list
44500439|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
44500440|NCT01891643|Lenalidomide|lenalidomide|mesh-list
44500441|NCT01891643|Elotuzumab|elotuzumab|mesh-list
44500442|NCT01891643|BB 1101|bb 1101|mesh-list
44500443|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500444|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
44500445|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
44500446|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500447|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500448|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500449|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
44500450|NCT01891643|Hormones|hormones|mesh-ancestor
44500451|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500452|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44500453|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500454|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
44500455|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500456|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500457|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
44500458|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44500459|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44500460|NCT01891643|Growth Substances|growth substances|mesh-ancestor
44500461|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44500462|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
44500463|NCT01899521|Astringents|astringents|mesh-ancestor
44500464|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500465|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500466|NCT01790009|Acetaminophen|acetaminophen|mesh-list
44500467|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500468|NCT01790009|Analgesics|analgesics|mesh-ancestor
44500469|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
44500470|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500471|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500472|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
44500473|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
44500474|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44500475|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44500476|NCT01790022|Prednisolone|prednisolone|mesh-list
44500477|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
44500478|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44500479|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
44500480|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500481|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
44500482|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
44500483|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500484|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500485|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500486|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
44500487|NCT01790022|Hormones|hormones|mesh-ancestor
44500488|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500489|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44500490|NCT01790022|Protective Agents|protective agents|mesh-ancestor
44500491|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44500492|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500493|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
44500494|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500495|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319614|NCT00924430|Simvastatin|simvastatin|mesh-list
44500496|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44500497|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500498|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500499|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500500|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500501|NCT01790139|Simethicone|simethicone|mesh-list
44500502|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
44500503|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500504|NCT01790139|Emollients|emollients|mesh-ancestor
44500505|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500506|NCT01790308|Liraglutide|liraglutide|mesh-list
44500507|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500508|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500509|NCT01790308|Incretins|incretins|mesh-ancestor
44500510|NCT01790308|Hormones|hormones|mesh-ancestor
44500511|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500512|NCT01790464|Lidocaine|lidocaine|mesh-list
44500513|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
44500514|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
44500515|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500516|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500517|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
44500518|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500519|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44500520|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44500521|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44500522|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500523|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500524|NCT01790529|Metronidazole|metronidazole|mesh-list
44500525|NCT01790529|Cefuroxime|cefuroxime|mesh-list
44500526|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
44500527|NCT01790529|Anesthetics|anesthetics|mesh-list
44500528|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500529|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500530|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500531|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500532|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44500533|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44500534|NCT01790542|Iron|iron|mesh-list
44500535|NCT01790542|Trace Elements|trace elements|mesh-ancestor
44500536|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
44500537|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500538|NCT01790555|Diazepam|diazepam|mesh-list
44500539|NCT01790555|Dronabinol|dronabinol|mesh-list
44500540|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44500541|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
44500542|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
44500543|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
44500544|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500545|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500546|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500547|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44500548|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500549|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44500550|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44500551|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44500552|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44500553|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500554|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44500555|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
44500556|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
44500557|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
44500558|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
44500559|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500560|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500561|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
44500562|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500563|NCT01790555|Analgesics|analgesics|mesh-ancestor
44500564|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
44500565|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44500566|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44500567|NCT01790555|Hormones|hormones|mesh-ancestor
44500568|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500569|NCT01790672|Ethanol|ethanol|mesh-list
44500570|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44500571|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500572|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500573|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500574|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
44500575|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500576|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
44500577|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500578|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500579|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44500580|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
44500581|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500582|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500583|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44500584|NCT01790893|Aflibercept|aflibercept|mesh-list
44500585|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44500586|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44500587|NCT01790893|Growth Substances|growth substances|mesh-ancestor
44500588|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500589|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
44500590|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319770|NCT00926016|Pioglitazone|pioglitazone|mesh-list
44500592|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44500593|NCT01790971|Narcotics|narcotics|mesh-ancestor
44500594|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500595|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500596|NCT01790971|Analgesics|analgesics|mesh-ancestor
44500597|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
44500598|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500600|NCT01790997|Clopidogrel|clopidogrel|mesh-list
44500601|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44500602|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500603|NCT01790997|Analgesics|analgesics|mesh-ancestor
44500604|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
44500605|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500606|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500607|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500608|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500609|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44500610|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44500611|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500612|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44500613|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44500614|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500615|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
44500616|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44500617|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44500618|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44500619|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
44500620|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500621|NCT01791088|Sirolimus|sirolimus|mesh-list
44500622|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500623|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500624|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44500625|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500626|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
44500627|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500628|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
44500629|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500630|NCT01791114|Propranolol|propranolol|mesh-list
44500631|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44500632|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44500633|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500634|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500635|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500636|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500637|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44500638|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500639|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500640|NCT01791166|Antibodies|antibodies|mesh-list
44500641|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
44500642|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500643|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44500644|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44500645|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500646|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500647|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
44500648|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500649|NCT01791231|Canagliflozin|canagliflozin|mesh-list
44500650|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44500651|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500652|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43956517|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500653|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500654|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
44500655|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44500656|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500657|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500658|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500659|NCT01791296|Analgesics|analgesics|mesh-ancestor
44500660|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
44500661|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500662|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44500663|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44500664|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44500665|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500666|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500667|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500668|NCT01791309|Panitumumab|panitumumab|mesh-list
44500669|NCT01791309|Vemurafenib|vemurafenib|mesh-list
44500670|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44500671|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500672|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44500673|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500674|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500675|NCT01791374|Rilotumumab|rilotumumab|mesh-list
44500676|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44500677|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44500678|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500679|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
44500680|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500681|NCT01791400|Sumatriptan|sumatriptan|mesh-list
44500682|NCT01791400|Metoclopramide|metoclopramide|mesh-list
44500683|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
44500684|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
44500685|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500686|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500687|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500688|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44500689|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44500690|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
44500691|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500692|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500693|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44500694|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44500695|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44500696|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
44500697|NCT01791439|Lidocaine|lidocaine|mesh-list
44500698|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
44500699|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
44500700|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500701|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500702|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
44500703|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500704|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44500705|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44500706|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44500707|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500708|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500709|NCT01791608|Zinc|zinc|mesh-list
44500710|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
44500711|NCT01791608|Trace Elements|trace elements|mesh-ancestor
44500712|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
44500713|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500714|NCT01791608|Astringents|astringents|mesh-ancestor
44500715|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500716|NCT01791647|Inositol|inositol|mesh-list
44500717|NCT01791647|Metformin|metformin|mesh-list
44500718|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500719|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500720|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
44500721|NCT01791647|Vitamins|vitamins|mesh-ancestor
44500722|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
44500723|NCT01791699|Moxonidine|moxonidine|mesh-list
44500724|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500725|NCT01791751|Clomiphene|clomiphene|mesh-list
44500726|NCT01791751|Enclomiphene|enclomiphene|mesh-list
44500727|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
44500728|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44500729|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
44500730|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500731|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500732|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44500733|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
44500734|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500735|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44500736|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44500737|NCT01791868|Valproic Acid|valproic acid|mesh-list
44500738|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
44500739|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500740|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500741|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
44500742|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500743|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500744|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
44500745|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44500746|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500747|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500748|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
44500749|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44500750|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44500751|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44500752|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500753|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500754|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
44500755|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500756|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500757|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44500758|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500759|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
44500760|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44500761|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44500762|NCT01792037|Prednisolone|prednisolone|mesh-list
44500763|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
44500764|NCT01792037|Midazolam|midazolam|mesh-list
44500765|NCT01792037|Etomidate|etomidate|mesh-list
44500766|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44500767|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
44500768|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44500769|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44500770|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500771|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500772|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44500773|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44500774|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44500775|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44500776|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
44500777|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
44500778|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
44500779|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
44500780|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500781|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500782|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500783|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
44500784|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
44500785|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500786|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500787|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
44500788|NCT01792037|Hormones|hormones|mesh-ancestor
44500789|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500790|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44500791|NCT01792037|Protective Agents|protective agents|mesh-ancestor
44500792|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44500793|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500794|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
44500795|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500796|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500797|NCT01792375|Dinoprostone|dinoprostone|mesh-list
44500798|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
44500799|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500800|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500801|NCT01792388|Vitamin D|vitamin d|mesh-list
44500802|NCT01792388|Vitamins|vitamins|mesh-ancestor
44500803|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
44500804|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500805|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44500806|NCT01792505|Imiquimod|imiquimod|mesh-list
44500807|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44500808|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
44500809|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500810|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500811|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
44500812|NCT01792557|Phenol|phenol|mesh-list
44500813|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44500814|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500815|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
44500816|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44500817|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44500818|NCT01792700|Amoxicillin|amoxicillin|mesh-list
44500819|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
44500820|NCT01792700|Metronidazole|metronidazole|mesh-list
44500821|NCT01792700|Tetracycline|tetracycline|mesh-list
44500822|NCT01792700|Esomeprazole|esomeprazole|mesh-list
44500823|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44500824|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500825|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44500826|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500827|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500828|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500829|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500830|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44500831|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44500832|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44500833|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500834|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44500835|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44500836|NCT01792713|Sertaconazole|sertaconazole|mesh-list
44500837|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
44500838|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500839|NCT01792934|Bevacizumab|bevacizumab|mesh-list
44500840|NCT01792934|Irinotecan|irinotecan|mesh-list
44500841|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44500842|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500843|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44500844|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44500845|NCT01792934|Growth Substances|growth substances|mesh-ancestor
44500846|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500847|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44500848|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44500849|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500850|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500851|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320073|NCT00927407|Malathion|malathion|mesh-list
44500852|NCT01793077|Leuprolide|leuprolide|mesh-list
44500853|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44500854|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
44500855|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500856|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500857|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44500858|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500859|NCT01793259|Methotrexate|methotrexate|mesh-list
44500860|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44500861|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
44500862|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44500863|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500864|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44500865|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
44500866|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500867|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500868|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500869|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500870|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44500871|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500872|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
44500873|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500874|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44500876|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44500877|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500878|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500879|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44500880|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44500881|NCT01793272|Protective Agents|protective agents|mesh-ancestor
44500882|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500883|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500884|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44500885|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
44500886|NCT01793350|Benphothiamine|benphothiamine|mesh-list
44500887|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44500888|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
44500889|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500890|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
44500891|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
44500892|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500893|NCT01793480|Methadone|methadone|mesh-list
44500894|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44500895|NCT01793480|Narcotics|narcotics|mesh-ancestor
44500896|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500897|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500898|NCT01793480|Analgesics|analgesics|mesh-ancestor
44500899|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
44500900|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500901|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
44500902|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
44500903|NCT01793519|Adalimumab|adalimumab|mesh-list
44500904|NCT01793519|Etanercept|etanercept|mesh-list
44500905|NCT01793519|Infliximab|infliximab|mesh-list
44500906|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44500907|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44500908|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44500909|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44500910|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44500911|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44500912|NCT01793519|Analgesics|analgesics|mesh-ancestor
44500913|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
44500914|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500915|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500916|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500917|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
44500918|NCT01793636|Everolimus|everolimus|mesh-list
44500919|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500920|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500921|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
44500922|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500923|NCT01793753|Propofol|propofol|mesh-list
44500924|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44500925|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44500926|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320130|NCT00927602|PENTA|penta|mesh-list
44500927|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44500928|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
44500930|NCT01793870|Carvedilol|carvedilol|mesh-list
44500931|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44500932|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44500933|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
44500934|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500935|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500936|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500937|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500938|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
44500939|NCT01793870|Protective Agents|protective agents|mesh-ancestor
44500940|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44500941|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44500942|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44235270|NCT00553995|Analgesics|analgesics|mesh-ancestor
44500943|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500944|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44500945|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44500946|NCT01793948|Metformin|metformin|mesh-list
44500947|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44500948|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500949|NCT01794078|Ambrisentan|ambrisentan|mesh-list
44500950|NCT01794078|Aminophylline|aminophylline|mesh-list
44500951|NCT01794078|Theophylline|theophylline|mesh-list
44500952|NCT01794078|Ethylene|ethylene|mesh-list
44500953|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44500954|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
44500955|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44500956|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500957|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44500958|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44500959|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44500960|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500961|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500962|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44500963|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44500964|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44500965|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
44500966|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44500967|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500968|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44500969|NCT01794078|Protective Agents|protective agents|mesh-ancestor
44500970|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44500971|NCT01794078|Growth Substances|growth substances|mesh-ancestor
44500972|NCT01794091|Eplerenone|eplerenone|mesh-list
44500973|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44500974|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
44500975|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44500976|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500977|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44500978|NCT01794091|Diuretics|diuretics|mesh-ancestor
44500979|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
44500980|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44500981|NCT01794169|Cytarabine|cytarabine|mesh-list
44500982|NCT01794169|Azacitidine|azacitidine|mesh-list
44500983|NCT01794169|Daunorubicin|daunorubicin|mesh-list
44500984|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44500985|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
44500986|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44500987|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44500988|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
44500989|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44500990|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44500991|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
44500992|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44500993|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44500994|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44500995|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44500996|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44500997|NCT01794273|Phenylephrine|phenylephrine|mesh-list
44500998|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
44500999|NCT01794273|Ephedrine|ephedrine|mesh-list
44501000|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44501001|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
44501002|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
44501003|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501004|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501005|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
44501006|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44501007|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
44501008|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
44501009|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44501010|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44501011|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44501012|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501013|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501014|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501015|NCT01794273|Protective Agents|protective agents|mesh-ancestor
44501016|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44501017|NCT01794351|Resveratrol|resveratrol|mesh-list
44501018|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
44501019|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501020|NCT01794351|Protective Agents|protective agents|mesh-ancestor
44501021|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501022|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501023|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44501024|NCT01794507|Dexamethasone|dexamethasone|mesh-list
44501025|NCT01794507|Bortezomib|bortezomib|mesh-list
44501026|NCT01794507|Venetoclax|venetoclax|mesh-list
44501027|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501028|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
44501029|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
44501030|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501031|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501032|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501033|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
44501034|NCT01794507|Hormones|hormones|mesh-ancestor
44501035|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501036|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44501037|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501038|NCT01794533|Lidocaine|lidocaine|mesh-list
44501039|NCT01794533|Epinephrine|epinephrine|mesh-list
44501040|NCT01794533|Racepinephrine|racepinephrine|mesh-list
44501041|NCT01794533|Fentanyl|fentanyl|mesh-list
44501042|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
44501043|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
44501044|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
44501045|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501046|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501047|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
44501048|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501049|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501050|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44501051|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44501052|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501053|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501054|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44501055|NCT01794533|Narcotics|narcotics|mesh-ancestor
44501056|NCT01794533|Analgesics|analgesics|mesh-ancestor
44501057|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44501058|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44501059|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
44501060|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44501061|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44501062|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501063|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501064|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44501065|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44501066|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
44501067|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44501068|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
44501069|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
44501070|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
44501071|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44501072|NCT01794572|Melphalan|melphalan|mesh-list
44501073|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44501074|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
44501075|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501076|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501077|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44501078|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501079|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
44501080|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501081|NCT01794767|Heparin|heparin|mesh-list
44501082|NCT01794767|Calcium heparin|calcium heparin|mesh-list
44501083|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
44501084|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44501085|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44501086|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501087|NCT01794897|Valacyclovir|valacyclovir|mesh-list
44501088|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
44501089|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501090|NCT01794975|Ketamine|ketamine|mesh-list
44501091|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44501092|NCT01794975|Analgesics|analgesics|mesh-ancestor
44501093|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
44501094|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501095|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501096|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44501097|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44501098|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
44501099|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
44501100|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501101|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44501102|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44501103|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501104|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501105|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44501106|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44501107|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501108|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501109|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
44501110|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501111|NCT01795144|Glucagon|glucagon|mesh-list
44501112|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44501113|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501114|NCT01795144|Hormones|hormones|mesh-ancestor
44501115|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501116|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501117|NCT01795144|Incretins|incretins|mesh-ancestor
44501118|NCT01795170|Pyridoxine|pyridoxine|mesh-list
44501119|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
44501120|NCT01795170|Vitamins|vitamins|mesh-ancestor
44501121|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
44501122|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501123|NCT01795183|Amisulpride|amisulpride|mesh-list
44501124|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44501125|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44501126|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501127|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501128|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44501129|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44501130|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
44501131|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501132|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501133|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44501134|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
44501135|NCT01795209|Ranibizumab|ranibizumab|mesh-list
44501136|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44501137|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44501138|NCT01795209|Growth Substances|growth substances|mesh-ancestor
44501139|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501140|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
44501141|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501142|NCT01795222|Midazolam|midazolam|mesh-list
44501143|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44501144|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44501145|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501146|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501147|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44501148|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44501149|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43957025|NCT01332253|Analgesics|analgesics|mesh-ancestor
44501150|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44501151|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
44501152|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
44501153|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
44501154|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
44501155|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501156|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501157|NCT01795235|Atenolol|atenolol|mesh-list
44501158|NCT01795235|Glucagon|glucagon|mesh-list
44501159|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44501160|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501161|NCT01795235|Hormones|hormones|mesh-ancestor
44501162|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501163|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501164|NCT01795235|Incretins|incretins|mesh-ancestor
44501165|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501166|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44501167|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
44501168|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
44501169|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501170|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44501171|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44501172|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44501173|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501174|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501175|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501176|NCT01795287|Anesthetics|anesthetics|mesh-list
44501177|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501178|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501179|NCT01795430|Etoposide|etoposide|mesh-list
44501180|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
44501181|NCT01795430|Melphalan|melphalan|mesh-list
44501182|NCT01795430|Busulfan|busulfan|mesh-list
44501183|NCT01795430|Topotecan|topotecan|mesh-list
44501184|NCT01795430|Ifosfamide|ifosfamide|mesh-list
44501185|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44501186|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501187|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44501188|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44501189|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501190|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501191|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44501192|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
44501193|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44501194|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501195|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
44501196|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501197|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44501198|NCT01795599|Mifepristone|mifepristone|mesh-list
44501199|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44501200|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
44501201|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44501202|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501203|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44501204|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44501205|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44501206|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
44501207|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44501208|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44501209|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
44501210|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501211|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
44501212|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44501213|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44501214|NCT01795664|Fluticasone|fluticasone|mesh-list
44501215|NCT01795664|Xhance|xhance|mesh-list
44501216|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44501217|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44501218|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501219|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44501220|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
44501221|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501222|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501223|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44501224|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
44501225|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
44501226|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44501227|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44501228|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44501229|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44501230|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501231|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501232|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501233|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
44501234|NCT01795664|Hormones|hormones|mesh-ancestor
44501235|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501236|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
44501237|NCT01795703|Prednisolone|prednisolone|mesh-list
44501238|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501239|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
44501240|NCT01795703|Hormones|hormones|mesh-ancestor
44501241|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501242|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501243|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44501244|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501245|NCT01795794|Omeprazole|omeprazole|mesh-list
44501246|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44501247|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501248|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44501249|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501250|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501251|NCT01795820|Ticagrelor|ticagrelor|mesh-list
44501252|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44501253|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44501254|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44501255|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44501256|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
44501257|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501258|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320491|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44501259|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501260|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
44501261|NCT01795976|Fludarabine|fludarabine|mesh-list
44501262|NCT01795976|Interleukin-2|interleukin-2|mesh-list
44501263|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501264|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
44501265|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501266|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501267|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44501268|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
44501269|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501270|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501271|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44501272|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44501273|NCT01795976|Analgesics|analgesics|mesh-ancestor
44501274|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
44501275|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501276|NCT01796028|Metformin|metformin|mesh-list
44501277|NCT01796028|Docetaxel|docetaxel|mesh-list
44501278|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501279|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501280|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501281|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44501282|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501283|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501284|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501285|NCT01796093|Digoxin|digoxin|mesh-list
44501286|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501287|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44501288|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501289|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501290|NCT01796093|Protective Agents|protective agents|mesh-ancestor
44501291|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501292|NCT01796106|Fluorides|fluorides|mesh-list
44501293|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
44501294|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
44501295|NCT01796106|Protective Agents|protective agents|mesh-ancestor
44501296|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501297|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44501298|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501299|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44501300|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501301|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501302|NCT01796366|Insulin|insulin|mesh-list
44501303|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44501304|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
44501305|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501306|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501307|NCT01796405|Clofarabine|clofarabine|mesh-list
44501308|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501309|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
44501310|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501311|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501312|NCT01796444|Hormones|hormones|mesh-list
44501313|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501314|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501315|NCT01796483|Clonidine|clonidine|mesh-list
44501316|NCT01796483|Analgesics|analgesics|mesh-ancestor
44501317|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
44501318|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501319|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501320|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44501321|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
44501322|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
44501323|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44501324|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44501325|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44501326|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501327|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501328|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501329|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44501330|NCT01796613|Desogestrel|desogestrel|mesh-list
44501331|NCT01796613|Etonogestrel|etonogestrel|mesh-list
44501332|NCT01796613|NuvaRing|nuvaring|mesh-list
44501333|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44320609|NCT00930839|Niacin|niacin|mesh-list
44501334|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44501335|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44501336|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
44501337|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44501338|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501339|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44501340|NCT01796613|Estrogens|estrogens|mesh-ancestor
44501341|NCT01796613|Hormones|hormones|mesh-ancestor
44501342|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501343|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44501344|NCT01796613|Progestins|progestins|mesh-ancestor
44501345|NCT01796782|Capecitabine|capecitabine|mesh-list
44501346|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501347|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
44501348|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501349|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501350|NCT01796899|Brivaracetam|brivaracetam|mesh-list
44501351|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
44501352|NCT01796938|Lacosamide|lacosamide|mesh-list
44501353|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
44501354|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44501355|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44501356|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501357|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501358|NCT01796951|Aspirin|aspirin|mesh-list
44501359|NCT01796951|Celecoxib|celecoxib|mesh-list
44501360|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44501361|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44501362|NCT01796951|Analgesics|analgesics|mesh-ancestor
44501363|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
44501364|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501365|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501366|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501367|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501368|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44501369|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44501370|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501371|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44501372|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44501373|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501374|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
44501375|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44501376|NCT01797107|Azithromycin|azithromycin|mesh-list
44501377|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44501378|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501379|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44501380|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44501381|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501382|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
44501383|NCT01797198|Repaglinide|repaglinide|mesh-list
44501384|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
44501385|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501386|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501387|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44501388|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
44501389|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501390|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44501391|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44501392|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44501393|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501395|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44501396|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501397|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44501398|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501399|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
44501400|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501401|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
44501402|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501403|NCT01797341|Tacrolimus|tacrolimus|mesh-list
44501404|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501405|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
44501406|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501407|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44501408|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501409|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501410|NCT01797601|Insulin|insulin|mesh-list
44501411|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44501412|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501413|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501414|NCT01797666|Pioglitazone|pioglitazone|mesh-list
44501415|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501416|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501417|NCT01797757|Orlistat|orlistat|mesh-list
44501418|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501419|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501420|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44501421|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44501422|NCT01797848|Ribavirin|ribavirin|mesh-list
44501423|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44501424|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
44501425|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501426|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
44501427|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501428|NCT01797900|Paclitaxel|paclitaxel|mesh-list
44501429|NCT01797900|Cisplatin|cisplatin|mesh-list
44501430|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43957300|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
44501431|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501432|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44501433|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501434|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501435|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501436|NCT01797913|Gemcitabine|gemcitabine|mesh-list
44501437|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501438|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
44501439|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501440|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501441|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
44501442|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501443|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501444|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501445|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
44501446|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501447|NCT01797926|Losartan|losartan|mesh-list
44501448|NCT01797926|Amlodipine|amlodipine|mesh-list
44501449|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44501450|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44501451|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501452|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501453|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44501454|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501455|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
44501456|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501457|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44501458|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44501459|NCT01797978|Methylene Blue|methylene blue|mesh-list
44501460|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501461|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501462|NCT01797991|Dexamethasone|dexamethasone|mesh-list
44501463|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
44501464|NCT01797991|BB 1101|bb 1101|mesh-list
44501465|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501466|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
44501467|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
44501468|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501469|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501470|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501471|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
44501472|NCT01797991|Hormones|hormones|mesh-ancestor
44501473|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501474|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44501475|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501476|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44501477|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501478|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501479|NCT01798017|Misoprostol|misoprostol|mesh-list
44501480|NCT01798017|Mifepristone|mifepristone|mesh-list
44501481|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44501482|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
44501483|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44501484|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501485|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44501486|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501488|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44501489|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44501490|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44501491|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44501492|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
44501493|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44501494|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44501495|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
44501496|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501497|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
44501498|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44501499|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44501500|NCT01798030|Vitamin D|vitamin d|mesh-list
44501501|NCT01798030|Vitamins|vitamins|mesh-ancestor
44501502|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
44501503|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501504|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44501505|NCT01798251|Capecitabine|capecitabine|mesh-list
44501506|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
44501507|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501508|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
44501509|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501510|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501511|NCT01798277|Amiodarone|amiodarone|mesh-list
44501512|NCT01798277|Sotalol|sotalol|mesh-list
44501513|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501514|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
44501515|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44501516|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501517|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501518|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44501519|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44501520|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44501521|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501522|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44501523|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44501524|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44501525|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44501526|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44501527|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957410|NCT01339936|Glycerol|glycerol|mesh-list
44501528|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501529|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501530|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
44501531|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
44501532|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501533|NCT01798459|Methylphenidate|methylphenidate|mesh-list
44501534|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44501535|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501536|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44501537|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44501538|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501539|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501540|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
44501541|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501542|NCT01798472|Cimetidine|cimetidine|mesh-list
44501543|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44501544|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501545|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44501546|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
44501547|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
44501548|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501549|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501550|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501551|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44501552|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44501553|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501554|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
44501555|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44501556|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
44501557|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501558|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
44501559|NCT01798498|Protective Agents|protective agents|mesh-ancestor
44501561|NCT01798537|Colistin|colistin|mesh-list
44501562|NCT01798537|Neomycin|neomycin|mesh-list
44501563|NCT01798537|Nystatin|nystatin|mesh-list
44501564|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44501565|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501566|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43957444|NCT01341730|Atorvastatin|atorvastatin|mesh-list
44501567|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501568|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501569|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
44501570|NCT01798537|Ionophores|ionophores|mesh-ancestor
44501571|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501572|NCT01798576|Interferons|interferons|mesh-list
44501573|NCT01798576|Ribavirin|ribavirin|mesh-list
44501574|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
44501575|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
44501576|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44501577|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501578|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
44501579|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501580|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
44501581|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501582|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
44501583|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501584|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44501585|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44501586|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44501587|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
44501588|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501589|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44501590|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44501591|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501592|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
44501593|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501594|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44501595|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501596|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501597|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
44501598|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501599|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501600|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44501601|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44501602|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44501603|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
44501604|NCT01798875|Metformin|metformin|mesh-list
44501605|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
44501606|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
44501607|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501608|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501609|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44501610|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44501611|NCT01798914|Insulin|insulin|mesh-list
44501612|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501613|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501614|NCT01798940|Pioglitazone|pioglitazone|mesh-list
44501615|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501616|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501617|NCT01798979|Midazolam|midazolam|mesh-list
44501618|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44501619|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44501620|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501621|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501622|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44501623|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44501624|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44501625|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44501626|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
44501627|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
44501628|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
44501629|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
44501630|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501631|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501632|NCT01799005|Micronutrients|micronutrients|mesh-list
44501633|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501635|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501636|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501637|NCT01799083|Decitabine|decitabine|mesh-list
44501638|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501639|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
44501640|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501641|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501642|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501643|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
44501644|NCT01799109|Albuterol|albuterol|mesh-list
44501645|NCT01799109|Analgesics|analgesics|mesh-ancestor
44501646|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
44501647|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501648|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501649|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
44501650|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501651|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44501652|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
44501653|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44501654|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44501655|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501656|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44501657|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
44501658|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44501659|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44501660|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
44501661|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44501662|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
44501663|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44501664|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44501665|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44501666|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
44501667|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501668|NCT01799161|Theophylline|theophylline|mesh-list
44501669|NCT01799161|Vaccines|vaccines|mesh-list
44501670|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
44501671|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501672|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44501673|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
44501674|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501675|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44501676|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44501677|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44501678|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501679|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501680|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
44501681|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44501682|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44501683|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
44501684|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501685|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44501686|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
44501687|NCT01799356|Metronidazole|metronidazole|mesh-list
44501688|NCT01799356|Ofloxacin|ofloxacin|mesh-list
44501689|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44501690|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501691|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
44501692|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44501693|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44501694|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501695|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501696|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501697|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44501698|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44501699|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44501700|NCT01799356|Renal Agents|renal agents|mesh-ancestor
44501701|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44501702|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44501703|NCT01799486|Adefovir|adefovir|mesh-list
44501704|NCT01799486|Telbivudine|telbivudine|mesh-list
44501705|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
44501706|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501707|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44501708|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44501709|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501710|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501711|NCT01799603|Simeprevir|simeprevir|mesh-list
44501712|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
44501713|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501714|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44501715|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501716|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501717|NCT01799616|Pamidronate|pamidronate|mesh-list
44501718|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44501719|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501720|NCT01799798|Denosumab|denosumab|mesh-list
44501721|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44501722|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501723|NCT01799850|Pioglitazone|pioglitazone|mesh-list
44501724|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44501725|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501726|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
44501727|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44501728|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44501729|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
44501730|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501731|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501732|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501733|NCT01799902|Urological Agents|urological agents|mesh-ancestor
44501734|NCT01799954|Vaccines|vaccines|mesh-list
44501735|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
44501736|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501737|NCT01790282|Estradiol|estradiol|mesh-list
44501738|NCT01790282|Progesterone|progesterone|mesh-list
44501739|NCT01790282|Estrogens|estrogens|mesh-ancestor
44501740|NCT01790282|Hormones|hormones|mesh-ancestor
44501741|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501742|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501743|NCT01790282|Progestins|progestins|mesh-ancestor
44501744|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
44501745|NCT01798004|Melphalan|melphalan|mesh-list
44501746|NCT01798004|Busulfan|busulfan|mesh-list
44501747|NCT01798004|Doxorubicin|doxorubicin|mesh-list
44501748|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44501749|NCT01798004|Etoposide|etoposide|mesh-list
44501750|NCT01798004|Vincristine|vincristine|mesh-list
44501751|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
44501752|NCT01798004|Topotecan|topotecan|mesh-list
44501753|NCT01798004|Mesna|mesna|mesh-list
44501754|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501755|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
44501756|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501757|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501758|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44501759|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
44501760|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501761|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501762|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44501763|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44501764|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44501765|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44501766|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957595|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
44501767|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44501768|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44501769|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501770|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501771|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44501772|NCT01798004|Protective Agents|protective agents|mesh-ancestor
44501773|NCT01796301|Teriparatide|teriparatide|mesh-list
44501774|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44501775|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501776|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44501777|NCT01795911|Interferons|interferons|mesh-list
44501779|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501780|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
44501781|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501782|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
44501783|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501784|NCT01792050|Paclitaxel|paclitaxel|mesh-list
44501785|NCT01792050|Docetaxel|docetaxel|mesh-list
44501786|NCT01792050|Tryptophan|tryptophan|mesh-list
44501787|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44501788|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501789|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44501790|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501791|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501792|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501793|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44501794|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
44501795|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44501796|NCT01790100|Ribavirin|ribavirin|mesh-list
44501797|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
44501798|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501799|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
44501800|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501801|NCT01790165|Terbinafine|terbinafine|mesh-list
44501802|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
44501803|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501804|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501805|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501806|NCT01792102|Dexamethasone|dexamethasone|mesh-list
44501807|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501808|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
44501809|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
44501810|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501811|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501812|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501813|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
44501814|NCT01792102|Hormones|hormones|mesh-ancestor
44501815|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501816|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44501817|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501818|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
44501819|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
44501820|NCT01795131|Vitamins|vitamins|mesh-ancestor
44501821|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
44501822|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501823|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
44501824|NCT01795131|Hematinics|hematinics|mesh-ancestor
44501825|NCT01799317|Vitamin D|vitamin d|mesh-list
44501826|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
44501827|NCT01799317|Vitamins|vitamins|mesh-ancestor
44501828|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
44501829|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501830|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44501831|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44501832|NCT01799460|Cyclosporine|cyclosporine|mesh-list
44501833|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
44501834|NCT01799460|Tacrolimus|tacrolimus|mesh-list
44501835|NCT01799460|Cyclosporins|cyclosporins|mesh-list
44501836|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44501837|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
44501838|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
44501839|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501840|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501841|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44501842|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
44501843|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501844|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501845|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44501846|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44501848|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
44501849|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501850|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44501851|NCT01799460|Hormones|hormones|mesh-ancestor
44501852|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44501853|NCT02998047|Lintuzumab|lintuzumab|mesh-list
44501854|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44501855|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501856|NCT02998268|Paclitaxel|paclitaxel|mesh-list
44501857|NCT02998268|Carboplatin|carboplatin|mesh-list
44501858|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
43957705|NCT01352182|Pioglitazone|pioglitazone|mesh-list
44501859|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44501860|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501861|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321180|NCT00933426|Paclitaxel|paclitaxel|mesh-list
44501862|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501863|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501864|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501865|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44501866|NCT02996825|Gemcitabine|gemcitabine|mesh-list
44501867|NCT02996825|Maytansine|maytansine|mesh-list
44501868|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501869|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
44501870|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501871|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501872|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
44501873|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501874|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501875|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501876|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
44501877|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501878|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44501879|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44501880|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44501881|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44501882|NCT02999230|Listerine|listerine|mesh-list
44501883|NCT02999230|Fluorides|fluorides|mesh-list
44501884|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
44501885|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
44501886|NCT02999230|Protective Agents|protective agents|mesh-ancestor
44501887|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501888|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44501889|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501890|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
44501891|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501892|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44501893|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44501894|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44501895|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501896|NCT02990078|Urological Agents|urological agents|mesh-ancestor
44501897|NCT02998645|Cyclosporine|cyclosporine|mesh-list
44501898|NCT02998645|Cyclosporins|cyclosporins|mesh-list
44501899|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501900|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501901|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501902|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
44501903|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501904|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
44501905|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501906|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
44501907|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501908|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44501909|NCT02999087|Cisplatin|cisplatin|mesh-list
44501910|NCT02999087|Cetuximab|cetuximab|mesh-list
44501911|NCT02999087|Avelumab|avelumab|mesh-list
44501912|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957732|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
44501913|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44501914|NCT02998385|Cisplatin|cisplatin|mesh-list
44501915|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501916|NCT02995252|Tenofovir|tenofovir|mesh-list
44501917|NCT02995252|Liver Extracts|liver extracts|mesh-list
44501918|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
44501919|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501920|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44501921|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44501922|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501923|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501924|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44501925|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44501926|NCT02995252|Hematinics|hematinics|mesh-ancestor
44501927|NCT02992015|Gemcitabine|gemcitabine|mesh-list
44501928|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44501929|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
44501930|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501931|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501932|NCT02992015|Antiviral Agents|antiviral agents|mesh-ancestor
44501933|NCT02992015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44501934|NCT02992015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44501935|NCT02992015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501936|NCT02992015|Immunologic Factors|immunologic factors|mesh-ancestor
44501937|NCT02992015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501938|NCT02991495|Vaccines|vaccines|mesh-list
44501939|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
44501940|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501941|NCT02997657|Nicotine|nicotine|mesh-list
44501942|NCT02997657|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44501943|NCT02997657|Autonomic Agents|autonomic agents|mesh-ancestor
44501944|NCT02997657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501945|NCT02997657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501946|NCT02997657|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44501947|NCT02997657|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44501948|NCT02997657|Cholinergic Agents|cholinergic agents|mesh-ancestor
44501949|NCT02997657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501950|NCT02997657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501951|NCT02999776|Etanercept|etanercept|mesh-list
44501952|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44501953|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44501954|NCT02999776|Analgesics|analgesics|mesh-ancestor
44501955|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
44501956|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501957|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501958|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44501959|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44501960|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44501961|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44501962|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
44501963|NCT02999906|Treprostinil|treprostinil|mesh-list
43957779|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
44501964|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44501965|NCT02999724|Gabapentin|gabapentin|mesh-list
44501966|NCT02999724|Analgesics|analgesics|mesh-ancestor
44501967|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
44501968|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501969|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501970|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
44501971|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44501972|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44501973|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501974|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44501975|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44501976|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44501977|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44501978|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501979|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
44501980|NCT02999919|Bupivacaine|bupivacaine|mesh-list
44501981|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
44501982|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
44501983|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44501984|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44501985|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
44501986|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44501987|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44501988|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44501989|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501990|NCT02999295|Nivolumab|nivolumab|mesh-list
44501991|NCT02999295|Ramucirumab|ramucirumab|mesh-list
44501992|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44501993|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44501994|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44501995|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44501996|NCT02998905|Aspirin|aspirin|mesh-list
44501997|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44501998|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44501999|NCT02998905|Analgesics|analgesics|mesh-ancestor
44502000|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
44502001|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502002|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502003|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502004|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502005|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44502006|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44502007|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502008|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44502009|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44502010|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502011|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
44502012|NCT02998437|Amoxicillin|amoxicillin|mesh-list
44502013|NCT02998437|Clarithromycin|clarithromycin|mesh-list
44502014|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502015|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502016|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44502017|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502018|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502019|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44502020|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44502021|NCT02998424|Propofol|propofol|mesh-list
44502022|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44502023|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502024|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502025|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43957898|NCT01360450|Clonidine|clonidine|mesh-list
44502026|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
44502027|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
44502028|NCT02998242|Apatinib|apatinib|mesh-list
44502029|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502030|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44502031|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502032|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502033|NCT02998398|Infliximab|infliximab|mesh-list
44502034|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44502035|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502036|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502037|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44502038|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44502039|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44502040|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
44502041|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502042|NCT02997969|Vaccines|vaccines|mesh-list
44502043|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44502044|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
44502045|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502046|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44502047|NCT02997995|Durvalumab|durvalumab|mesh-list
44502048|NCT02997995|Tremelimumab|tremelimumab|mesh-list
44502049|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502050|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502051|NCT02997800|Labetalol|labetalol|mesh-list
44502052|NCT02997800|Fentanyl|fentanyl|mesh-list
44502053|NCT02997800|Esmolol|esmolol|mesh-list
44502054|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44502055|NCT02997800|Narcotics|narcotics|mesh-ancestor
44502056|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502057|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502058|NCT02997800|Analgesics|analgesics|mesh-ancestor
44502059|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
44502060|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502061|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44502062|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502063|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
44502064|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
44502065|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44502066|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44502067|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44502068|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44502069|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502070|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502071|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502072|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
44502073|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
44502074|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44502075|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44502076|NCT02997982|Valacyclovir|valacyclovir|mesh-list
44502077|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
44502078|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502079|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44502080|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44502081|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502082|NCT02997332|Cisplatin|cisplatin|mesh-list
44502083|NCT02997332|Docetaxel|docetaxel|mesh-list
44502084|NCT02997332|Fluorouracil|fluorouracil|mesh-list
44502085|NCT02997332|Durvalumab|durvalumab|mesh-list
44502086|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502087|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44502088|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44502089|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44502090|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502091|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
44502092|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44502093|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502094|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
44502095|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502096|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502097|NCT02997215|Lidocaine|lidocaine|mesh-list
44502098|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
44502099|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
44502100|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502101|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502102|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
44502103|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502104|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44502105|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44502106|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44502107|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502108|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502109|NCT02996916|Amlodipine|amlodipine|mesh-list
44502110|NCT02996916|Olmesartan|olmesartan|mesh-list
44502111|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502112|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44502113|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502114|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502115|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44502116|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502117|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
44502118|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44502119|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44502120|NCT02996942|Factor VIII|factor viii|mesh-list
44502121|NCT02996942|Coagulants|coagulants|mesh-ancestor
44502122|NCT02997059|Fluconazole|fluconazole|mesh-list
44502123|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
44502124|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502125|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44502126|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44502127|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502128|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502129|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44502130|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
44502131|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502132|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502133|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44502134|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44502135|NCT02996734|Denosumab|denosumab|mesh-list
44502136|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44502137|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502138|NCT02996695|Artesunate|artesunate|mesh-list
44502139|NCT02996695|Chloroquine|chloroquine|mesh-list
44502140|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
44502141|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44502142|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44502143|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502144|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502146|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
44502147|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44502148|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
44502149|NCT02996695|Amebicides|amebicides|mesh-ancestor
44502150|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502151|NCT02996513|Vitamin A|vitamin a|mesh-list
44502152|NCT02996513|Vitamins|vitamins|mesh-ancestor
44502153|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
44502154|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502155|NCT02996487|Vancomycin|vancomycin|mesh-list
44502156|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502157|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502158|NCT02996227|Bupivacaine|bupivacaine|mesh-list
44502159|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
44502160|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
44502161|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502162|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502163|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
44502164|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502165|NCT02996214|Gemcitabine|gemcitabine|mesh-list
44502166|NCT02996214|Paclitaxel|paclitaxel|mesh-list
44502167|NCT02996214|Cisplatin|cisplatin|mesh-list
44502168|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44502169|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502170|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44502171|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44502172|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44502173|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502174|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44502175|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
44502176|NCT02996214|Antiviral Agents|antiviral agents|mesh-ancestor
44502177|NCT02996214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502178|NCT02996214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502179|NCT02996214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502180|NCT02996214|Immunologic Factors|immunologic factors|mesh-ancestor
44502181|NCT02996214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502182|NCT02995954|Amlodipine|amlodipine|mesh-list
44502183|NCT02995954|Perindopril|perindopril|mesh-list
44502184|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502185|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44502186|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502187|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502188|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44502189|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502190|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
44502191|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44502192|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44502193|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502194|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
44502195|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44502196|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502197|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502198|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44502199|NCT02996058|Analgesics|analgesics|mesh-ancestor
44502200|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
44502201|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502202|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44502203|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44502204|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44502205|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44502206|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502207|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502208|NCT02996019|Etrolizumab|etrolizumab|mesh-list
44502209|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502210|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
44502211|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502212|NCT02995720|Amlodipine|amlodipine|mesh-list
44502213|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44502214|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502215|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44502216|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502217|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502218|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44235274|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502219|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502220|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
44502221|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44502222|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44502223|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
44502224|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44502225|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44502226|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502227|NCT02995512|Colchicine|colchicine|mesh-list
44502228|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
44502229|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502230|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
44502231|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
44502232|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
44502233|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502234|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502235|NCT02995655|Azacitidine|azacitidine|mesh-list
44502236|NCT02995655|Heparin|heparin|mesh-list
44502237|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44502238|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
44502239|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502240|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502241|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502242|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
44502243|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44502244|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44502245|NCT02995291|Phentolamine|phentolamine|mesh-list
44502246|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44502247|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44502248|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
44502249|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502250|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502251|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502252|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502253|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
44502254|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
44502255|NCT02995330|Testosterone|testosterone|mesh-list
44502256|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
44502257|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
44502258|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44502259|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502260|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
44502261|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502262|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502263|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44502264|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
44502265|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502266|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502267|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44502268|NCT02995330|Androgens|androgens|mesh-ancestor
44502269|NCT02995330|Hormones|hormones|mesh-ancestor
44502270|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502271|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502272|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
44502273|NCT02995187|Apatinib|apatinib|mesh-list
44502274|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502275|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44502276|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502277|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502278|NCT02995057|Nickel|nickel|mesh-list
44502279|NCT02995057|Trace Elements|trace elements|mesh-ancestor
44502280|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
44502281|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502282|NCT02995304|Midazolam|midazolam|mesh-list
44502283|NCT02995304|Morphine|morphine|mesh-list
44502284|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44502285|NCT02995304|Narcotics|narcotics|mesh-ancestor
44502286|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502287|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502288|NCT02995304|Analgesics|analgesics|mesh-ancestor
44502289|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
44502290|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502291|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44502292|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44502293|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44502294|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44502295|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44502296|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502297|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
44502298|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
44502299|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
44502300|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
44502301|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502302|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502303|NCT02994953|Avelumab|avelumab|mesh-list
44502304|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44502305|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502306|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502307|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
44502308|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502309|NCT02994745|Atorvastatin|atorvastatin|mesh-list
44502310|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44502311|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44502312|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
44502313|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502314|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44502315|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44502316|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502317|NCT02994888|Cetuximab|cetuximab|mesh-list
44502318|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502319|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502320|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
44502321|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44502322|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
44502323|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502324|NCT02994875|Expectorants|expectorants|mesh-ancestor
44502325|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44502326|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44502327|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
44502328|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502329|NCT02994875|Protective Agents|protective agents|mesh-ancestor
44502330|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502331|NCT02994875|Antidotes|antidotes|mesh-ancestor
44502332|NCT02994381|Ozanimod|ozanimod|mesh-list
44502333|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44502334|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502335|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502336|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
44502337|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502338|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
44502339|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44502340|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
44502341|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
44502342|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502343|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502344|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44502345|NCT02994433|Analgesics|analgesics|mesh-ancestor
44502346|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
44502347|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502348|NCT02994485|Simvastatin|simvastatin|mesh-list
44321713|NCT00935571|Narcotics|narcotics|mesh-ancestor
44502349|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44502350|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44502351|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
44502352|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502353|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44502354|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44502355|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502357|NCT02994173|Oxycodone|oxycodone|mesh-list
44502358|NCT02994173|Esketamine|esketamine|mesh-list
44502359|NCT02994173|Analgesics|analgesics|mesh-ancestor
44502360|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
44502361|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502362|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502363|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44502364|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502365|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
44502366|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
44502367|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502368|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44502369|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44502370|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502371|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502372|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44502373|NCT02994173|Narcotics|narcotics|mesh-ancestor
44502374|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
44502375|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44502376|NCT02994082|Bupropion|bupropion|mesh-list
44502377|NCT02994082|Nicotine|nicotine|mesh-list
44502378|NCT02994082|Varenicline|varenicline|mesh-list
44502379|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44502380|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
44502381|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502382|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502383|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44502384|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44502385|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
44502386|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502387|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502388|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43958169|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
44502389|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
44502390|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44502391|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44502392|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44502393|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502394|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
44502395|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44502396|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44502397|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502398|NCT02995096|Sirolimus|sirolimus|mesh-list
44502399|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502400|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502401|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44502402|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502403|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
44502404|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502405|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
44502406|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502407|NCT02993991|Durvalumab|durvalumab|mesh-list
44502408|NCT02993991|Mocetinostat|mocetinostat|mesh-list
44502409|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502410|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502411|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44502412|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502413|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502414|NCT02993835|Iron|iron|mesh-list
44502415|NCT02993835|Trace Elements|trace elements|mesh-ancestor
44502416|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
44502417|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502418|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
44502419|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
44502420|NCT02993718|Propofol|propofol|mesh-list
44502421|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44502422|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502423|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502424|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502425|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
44502426|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
44502427|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44502428|NCT02993718|Analgesics|analgesics|mesh-ancestor
44502429|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
44502430|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502431|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44502432|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44502433|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44502434|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
44502435|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502436|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502437|NCT02993575|Floxacillin|floxacillin|mesh-list
44502438|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502439|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502440|NCT02993640|Vasopressins|vasopressins|mesh-list
44502441|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
44502442|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
44502443|NCT02993640|Coagulants|coagulants|mesh-ancestor
44502444|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44502446|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
44502447|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502448|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44502449|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44502450|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44502451|NCT02993367|Protective Agents|protective agents|mesh-ancestor
44502452|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502454|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
44502455|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502456|NCT02993588|Protective Agents|protective agents|mesh-ancestor
44502457|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502458|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502459|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
44502460|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44502461|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44502462|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502463|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
44502464|NCT02993341|Coagulants|coagulants|mesh-ancestor
44502465|NCT02993094|Carboplatin|carboplatin|mesh-list
44502466|NCT02993094|Ixazomib|ixazomib|mesh-list
44502467|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502468|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44502469|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502470|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502471|NCT02993159|Tamoxifen|tamoxifen|mesh-list
44502472|NCT02993159|Afimoxifene|afimoxifene|mesh-list
44502473|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44502474|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
43958266|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44502475|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502476|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502477|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502478|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502479|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44502480|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44502481|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44502482|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
44502483|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44502484|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502485|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44502486|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
44502487|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502488|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502489|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502490|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502491|NCT02992938|Acetazolamide|acetazolamide|mesh-list
44502492|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
44502493|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44502494|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321841|NCT00936234|Vildagliptin|vildagliptin|mesh-list
44502495|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502496|NCT02992938|Diuretics|diuretics|mesh-ancestor
44502497|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
44502498|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502500|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
44502501|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502502|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
44502503|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44502504|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502505|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502506|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44502507|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44502508|NCT02992678|Protective Agents|protective agents|mesh-ancestor
44502509|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502510|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
44502511|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44235282|NCT00554125|Sirolimus|sirolimus|mesh-list
44502512|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
44502514|NCT02992912|Antibodies|antibodies|mesh-list
44502515|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
44502516|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502517|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502518|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44502519|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
44502520|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502521|NCT02992496|Midazolam|midazolam|mesh-list
44502522|NCT02992496|Ketamine|ketamine|mesh-list
44502523|NCT02992496|Analgesics|analgesics|mesh-ancestor
44502524|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
44502525|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502526|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502527|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44502528|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502529|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
44502530|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
44502531|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502532|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44502533|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44502534|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502535|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502536|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44502537|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44502538|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44502539|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44502540|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44502541|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
44502542|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
44502543|NCT02992665|Ionophores|ionophores|mesh-list
44502544|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502545|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502546|NCT02992548|Pravastatin|pravastatin|mesh-list
44502547|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44502548|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44502549|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
44502550|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502551|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44502552|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44502553|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502554|NCT02992652|Allopurinol|allopurinol|mesh-list
44502555|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
44502556|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502557|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502558|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
44502559|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502560|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44502561|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
44502562|NCT02992652|Protective Agents|protective agents|mesh-ancestor
44502563|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502564|NCT02992457|Interferons|interferons|mesh-list
44502565|NCT02992457|Ribavirin|ribavirin|mesh-list
44502566|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
44502567|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
44502568|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44502569|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
44502570|NCT02992457|Ledipasvir|ledipasvir|mesh-list
44502571|NCT02992457|Simeprevir|simeprevir|mesh-list
44502572|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44502573|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502574|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
44502575|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502576|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
44502577|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502578|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
44502579|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502580|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
44502581|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502582|NCT02992392|Dextrans|dextrans|mesh-list
44502583|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
44502584|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
44502585|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
44502586|NCT02992340|Gemcitabine|gemcitabine|mesh-list
44502587|NCT02992340|Cisplatin|cisplatin|mesh-list
44502588|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502589|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44502590|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
44502591|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502592|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
44502593|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502594|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502595|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502596|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
44502597|NCT02992340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502598|NCT02991950|Parnaparin|parnaparin|mesh-list
44502599|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
44502600|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44502601|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44502602|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502603|NCT02991781|Varenicline|varenicline|mesh-list
44502604|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44502605|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44502606|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
44502607|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958404|NCT01370460|Coagulants|coagulants|mesh-ancestor
44502608|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502609|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502610|NCT02991768|Budesonide|budesonide|mesh-list
44502611|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502612|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44502613|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
44502614|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502615|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502616|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44502617|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
44502618|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
44502619|NCT02991768|Hormones|hormones|mesh-ancestor
44502620|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502621|NCT02991612|Rifaximin|rifaximin|mesh-list
44502622|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502623|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502624|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502625|NCT02991339|Dexamethasone|dexamethasone|mesh-list
44502626|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
44502627|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44502628|NCT02991339|BB 1101|bb 1101|mesh-list
44502629|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502630|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
44502631|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
44502632|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502633|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502634|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502635|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
44502636|NCT02991339|Hormones|hormones|mesh-ancestor
44502637|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502638|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502639|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502640|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
44502641|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502642|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502643|NCT02991196|Nivolumab|nivolumab|mesh-list
44502644|NCT02991196|DS-8273a|ds-8273a|mesh-list
44502645|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502646|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502647|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44502648|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502649|NCT02991131|Linezolid|linezolid|mesh-list
44502650|NCT02991131|Tedizolid|tedizolid|mesh-list
44502651|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
44502652|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502653|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502654|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44502655|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502656|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502657|NCT02991157|Nimodipine|nimodipine|mesh-list
44502658|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44502659|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44502660|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502661|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502662|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44502663|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502664|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322061|NCT00937417|Docetaxel|docetaxel|mesh-list
44502665|NCT02990728|Metformin|metformin|mesh-list
44502666|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44502667|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502668|NCT02990702|Bupivacaine|bupivacaine|mesh-list
44502669|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
44502670|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
44502671|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502672|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502673|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
44502674|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502675|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
44502676|NCT02990845|Leuprolide|leuprolide|mesh-list
44502677|NCT02990845|Exemestane|exemestane|mesh-list
44502678|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502679|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502680|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44502681|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
44502682|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44502683|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502684|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502685|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44502686|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44502687|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502688|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502689|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44502690|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
44502691|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502692|NCT02990884|Ketamine|ketamine|mesh-list
44502693|NCT02990884|Analgesics|analgesics|mesh-ancestor
44502694|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
44502695|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502696|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502697|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44502698|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44502699|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
44502700|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
44502701|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502702|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44502703|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44502704|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502705|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502706|NCT02990858|Leronlimab|leronlimab|mesh-list
44502707|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44502708|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44502709|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502710|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44502711|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44502712|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
44502713|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502714|NCT02990403|Aspirin|aspirin|mesh-list
44502715|NCT02990403|Prednisone|prednisone|mesh-list
44502716|NCT02990403|Heparin|heparin|mesh-list
44502717|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
44502718|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
44502719|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44502720|NCT02990403|Antibodies|antibodies|mesh-list
44502721|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502722|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
44502723|NCT02990403|Hormones|hormones|mesh-ancestor
44502724|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502725|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502726|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502727|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502728|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44502729|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44502730|NCT02990403|Analgesics|analgesics|mesh-ancestor
44502731|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
44502732|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502733|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502734|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44502735|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44502736|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502737|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44502738|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44502739|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502740|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
44502741|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
44502742|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
44502743|NCT02990403|Progestins|progestins|mesh-ancestor
44502745|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44502746|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
44502747|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502748|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502749|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44502750|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44502751|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
44502752|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502753|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502754|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
44502755|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502756|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502757|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
44502758|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44502759|NCT02990507|Testosterone|testosterone|mesh-list
44502760|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
44502761|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
44502762|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502763|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502764|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
44502765|NCT02990507|Hormones|hormones|mesh-ancestor
44502766|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502767|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502768|NCT02990507|Androgens|androgens|mesh-ancestor
44502769|NCT02990546|Midodrine|midodrine|mesh-list
44502770|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
44502771|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
44502772|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502773|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502774|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44502775|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44502776|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44502777|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44502778|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44502779|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502780|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502781|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
44502782|NCT02990286|Rituximab|rituximab|mesh-list
44502783|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44502784|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502785|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
44502786|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502787|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502788|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44502789|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44502790|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
44502791|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502792|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502793|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502794|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502795|NCT02990312|Sirolimus|sirolimus|mesh-list
44502796|NCT02990312|Maraviroc|maraviroc|mesh-list
44502797|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502798|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502799|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44502800|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502801|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
44502802|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502803|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
44502804|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502805|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44502806|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44502807|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502808|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44502809|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44502810|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
44502811|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44502812|NCT02996656|Cefazolin|cefazolin|mesh-list
44502813|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
43912508|NCT00382824|Ubiquinone|ubiquinone|mesh-list
44502814|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502815|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502816|NCT02996409|Lidocaine|lidocaine|mesh-list
44502817|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
44502818|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
44502819|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502820|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502821|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
44502822|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502823|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44502824|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44502825|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44502826|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502827|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502828|NCT02999633|Acetaminophen|acetaminophen|mesh-list
44502829|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
44502830|NCT02999633|Promethazine|promethazine|mesh-list
44502831|NCT02999633|Dexamethasone|dexamethasone|mesh-list
44502832|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
44502833|NCT02999633|Ranitidine|ranitidine|mesh-list
44502834|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44502835|NCT02999633|BB 1101|bb 1101|mesh-list
44502836|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502837|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
44502838|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
44502839|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502840|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502841|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502842|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
44502843|NCT02999633|Hormones|hormones|mesh-ancestor
44502844|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502845|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502846|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502847|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
44502848|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502849|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502850|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44502851|NCT02999633|Analgesics|analgesics|mesh-ancestor
44502852|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
44502853|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
44502854|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44502855|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43958662|NCT01380366|Hormones|hormones|mesh-list
44502856|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502857|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44502858|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
44502859|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44502860|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
44502861|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
44502862|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44502863|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44502864|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
44502865|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
44502866|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44502867|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44502868|NCT02992418|Vaccines|vaccines|mesh-list
44502869|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
44502870|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502871|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
44502872|NCT02992743|Fludarabine|fludarabine|mesh-list
44502873|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502874|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
44502875|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502876|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502877|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44502878|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
44502879|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502880|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502881|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44502882|NCT02991599|Vaccines|vaccines|mesh-list
44502883|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
44502884|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502885|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
44502886|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502887|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
44502888|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502889|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624871|NCT00495508|Quinine|quinine|mesh-list
44502890|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44502891|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
44502892|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502893|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502894|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44502895|NCT02991937|Tazobactam|tazobactam|mesh-list
44502896|NCT02991937|Piperacillin|piperacillin|mesh-list
44502897|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44502898|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502899|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502900|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44502901|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502902|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502903|NCT02997501|Osimertinib|osimertinib|mesh-list
44142281|NCT00186082|Cefoxitin|cefoxitin|mesh-list
44502904|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502905|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44502906|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44502907|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502908|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
44502909|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
44502910|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
44502911|NCT02999958|Antioxidants|antioxidants|mesh-list
44502912|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44502913|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502914|NCT02999958|Protective Agents|protective agents|mesh-ancestor
44502915|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502916|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
44502917|NCT02999958|Vitamins|vitamins|mesh-ancestor
44502918|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
44502919|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
44502920|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
44502921|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502922|NCT02999958|Expectorants|expectorants|mesh-ancestor
44502923|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
44502924|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44502925|NCT02999958|Antidotes|antidotes|mesh-ancestor
44502926|NCT02999594|Tramadol|tramadol|mesh-list
44502927|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44502928|NCT02999594|Narcotics|narcotics|mesh-ancestor
44502929|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502930|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502931|NCT02999594|Analgesics|analgesics|mesh-ancestor
44502932|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
44502933|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502934|NCT02998827|Thalidomide|thalidomide|mesh-list
44502935|NCT02998827|Azathioprine|azathioprine|mesh-list
44502936|NCT02998827|Infliximab|infliximab|mesh-list
44502937|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44502938|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502939|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502940|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502941|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
44502942|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502943|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
44502944|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502945|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502946|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44502947|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44502948|NCT02998827|Growth Substances|growth substances|mesh-ancestor
44502949|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
44502950|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502951|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
44502952|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502953|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44502954|NCT02995707|Thalidomide|thalidomide|mesh-list
44502955|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44502956|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
44502957|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502958|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
44502959|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502960|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44502961|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44502962|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44502963|NCT02995707|Growth Substances|growth substances|mesh-ancestor
44502964|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44502965|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502966|NCT02995746|Dexamethasone|dexamethasone|mesh-list
44502967|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502968|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
44502969|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
44502970|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502971|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502972|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44502973|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
44502974|NCT02995746|Hormones|hormones|mesh-ancestor
44502975|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44502976|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44502977|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44502978|NCT02990364|Lidocaine|lidocaine|mesh-list
44502979|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
44502980|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44502981|NCT02990364|Anesthetics|anesthetics|mesh-list
44502982|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44502983|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44502984|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
44502985|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44502986|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44502987|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44502988|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44502989|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44502990|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44502991|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44502992|NCT01270035|Adalimumab|adalimumab|mesh-list
44502993|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44502994|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44502995|NCT01270074|Azithromycin|azithromycin|mesh-list
44502996|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44502998|NCT01270087|Adalimumab|adalimumab|mesh-list
44502999|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503000|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503001|NCT01270165|Telbivudine|telbivudine|mesh-list
44503002|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
44503003|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503004|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44503005|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503006|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503007|NCT01270178|Entecavir|entecavir|mesh-list
44503008|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
44503009|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503010|NCT01270191|Exenatide|exenatide|mesh-list
44503011|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
44503012|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503013|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503014|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44503015|NCT01270191|Incretins|incretins|mesh-ancestor
44503016|NCT01270191|Hormones|hormones|mesh-ancestor
44503017|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503018|NCT01270308|Lansoprazole|lansoprazole|mesh-list
44503019|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
44503020|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44503021|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503022|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44503023|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503024|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503025|NCT01270386|Apatinib|apatinib|mesh-list
44503026|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503027|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503028|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503029|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503030|NCT01270412|Mitogens|mitogens|mesh-list
44503031|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
44503032|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
44503033|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503034|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44503035|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
44503036|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503037|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
44503038|NCT01270412|Protective Agents|protective agents|mesh-ancestor
44503039|NCT01270438|Leucovorin|leucovorin|mesh-list
44503040|NCT01270438|Bevacizumab|bevacizumab|mesh-list
44503041|NCT01270438|Fluorouracil|fluorouracil|mesh-list
44503042|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
44503043|NCT01270438|Calcium|calcium|mesh-list
44503044|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
44503045|NCT01270438|R04929097|r04929097|mesh-list
44503046|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44503047|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503048|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503049|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503050|NCT01270438|Growth Substances|growth substances|mesh-ancestor
44503051|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503052|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503053|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503054|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
44503055|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503056|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503057|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503058|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
44503059|NCT01270438|Antidotes|antidotes|mesh-ancestor
44503060|NCT01270438|Protective Agents|protective agents|mesh-ancestor
44503061|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
44503062|NCT01270438|Vitamins|vitamins|mesh-ancestor
44503063|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
44503064|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503065|NCT01270451|Insulin|insulin|mesh-list
44503066|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503067|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503068|NCT01270490|Interferons|interferons|mesh-list
44503069|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
44503070|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503071|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
44503072|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503073|NCT01270672|Carvedilol|carvedilol|mesh-list
44503074|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44503075|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44503076|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44503077|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503078|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503079|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503080|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503081|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503082|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
44503083|NCT01270672|Protective Agents|protective agents|mesh-ancestor
44503084|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44503085|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503086|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503087|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
44503088|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44503089|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44503090|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
44503091|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503092|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
44503093|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44503094|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44503095|NCT01270724|Gemcitabine|gemcitabine|mesh-list
44503096|NCT01270724|Paclitaxel|paclitaxel|mesh-list
44503097|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
44503098|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44503099|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503100|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44503101|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44503102|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44503103|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503104|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503105|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
44503106|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
44503107|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503108|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958877|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
44503109|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503110|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
44503111|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503112|NCT01270750|Bosentan|bosentan|mesh-list
44503113|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503114|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44503115|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503116|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
44503117|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44503118|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44503119|NCT01270932|Dexamethasone|dexamethasone|mesh-list
44503120|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
44503121|NCT01270932|Lenalidomide|lenalidomide|mesh-list
44503122|NCT01270932|BB 1101|bb 1101|mesh-list
44503123|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503124|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
44503125|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
44503126|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503127|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503128|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503129|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
44503130|NCT01270932|Hormones|hormones|mesh-ancestor
44503131|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503132|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503133|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503134|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44503135|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503136|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503137|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
44503138|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503139|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503140|NCT01270932|Growth Substances|growth substances|mesh-ancestor
44503141|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503142|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
44503143|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503144|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503145|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503146|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503147|NCT01270997|Etanercept|etanercept|mesh-list
44503148|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44503149|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44503150|NCT01270997|Analgesics|analgesics|mesh-ancestor
44503151|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
44503152|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503153|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503154|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503155|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503156|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503157|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503158|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
44503159|NCT01271023|Insulin|insulin|mesh-list
44503160|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503161|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503163|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44503164|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
43958946|NCT01390870|Alfuzosin|alfuzosin|mesh-list
44503165|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503166|NCT01271088|Expectorants|expectorants|mesh-ancestor
44503167|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
44503168|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44503169|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
44503170|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503171|NCT01271088|Protective Agents|protective agents|mesh-ancestor
44503172|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503173|NCT01271088|Antidotes|antidotes|mesh-ancestor
44503174|NCT01271114|Terlipressin|terlipressin|mesh-list
44503175|NCT01271114|Norepinephrine|norepinephrine|mesh-list
44503176|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44503177|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44503178|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503179|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503180|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503181|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503182|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
44503183|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
44503184|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503185|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44503186|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503187|NCT01271140|Insulin|insulin|mesh-list
44503188|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503189|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503190|NCT01271153|Dobutamine|dobutamine|mesh-list
44503191|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44503192|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
44503193|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
44503194|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503195|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625028|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
44503196|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44503197|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44503198|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44503199|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503200|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503201|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503202|NCT01271153|Protective Agents|protective agents|mesh-ancestor
44503203|NCT01271166|Leucovorin|leucovorin|mesh-list
44503204|NCT01271166|Bevacizumab|bevacizumab|mesh-list
44503205|NCT01271166|Fluorouracil|fluorouracil|mesh-list
44503206|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
44503207|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
44503208|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44503209|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503210|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503211|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503212|NCT01271166|Growth Substances|growth substances|mesh-ancestor
44503213|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503214|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503215|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
44503216|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503217|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503218|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503219|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
44503220|NCT01271166|Antidotes|antidotes|mesh-ancestor
44503221|NCT01271166|Protective Agents|protective agents|mesh-ancestor
44503222|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
44503223|NCT01271166|Vitamins|vitamins|mesh-ancestor
44503224|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
44503225|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503226|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503227|NCT01271257|Misoprostol|misoprostol|mesh-list
44503228|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44503229|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
44503230|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44503231|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503232|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44503233|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503234|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
44503235|NCT01271283|Lenalidomide|lenalidomide|mesh-list
44503236|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
44503237|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503238|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503239|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503240|NCT01271283|Growth Substances|growth substances|mesh-ancestor
44503241|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503242|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503243|NCT01271374|Losartan|losartan|mesh-list
44503244|NCT01271374|Amlodipine|amlodipine|mesh-list
44503245|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44503246|NCT01271374|Olmesartan|olmesartan|mesh-list
44503247|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
44503248|NCT01271374|Spironolactone|spironolactone|mesh-list
44503249|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503250|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44503251|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503252|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503253|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503254|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503255|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
44503256|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44503257|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44503258|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44503259|NCT01271374|Diuretics|diuretics|mesh-ancestor
44503260|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
44503261|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44503262|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44503263|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
44503264|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503265|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44503266|NCT01271439|Cetuximab|cetuximab|mesh-list
44503267|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44503268|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503269|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
44503270|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
44503272|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503273|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503274|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44503275|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
44503276|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
44503277|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503278|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503279|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44503280|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
44503281|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44503282|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44503283|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44503284|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503285|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503286|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503287|NCT01271569|Fospropofol|fospropofol|mesh-list
44503288|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44503289|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503290|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503291|NCT01271582|Leucovorin|leucovorin|mesh-list
44503292|NCT01271582|Irinotecan|irinotecan|mesh-list
44503293|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44503294|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44503295|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503296|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503297|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503298|NCT01271582|Antidotes|antidotes|mesh-ancestor
44503299|NCT01271582|Protective Agents|protective agents|mesh-ancestor
44503300|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503301|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
44503302|NCT01271582|Vitamins|vitamins|mesh-ancestor
44503303|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
44503304|NCT01271660|Pregabalin|pregabalin|mesh-list
44503305|NCT01271660|Analgesics|analgesics|mesh-ancestor
44503306|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
44503307|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503308|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503309|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
44503310|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44503311|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503312|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503313|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503314|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44503315|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44503316|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503317|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503318|NCT01271894|Efavirenz|efavirenz|mesh-list
44503319|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44503320|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44503321|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503322|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503323|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
44503324|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503325|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44503326|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44503327|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44503328|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44503329|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44503330|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44503331|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
43959122|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
44503332|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44503333|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503334|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44503335|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44503336|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44503337|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44503338|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44503339|NCT01272089|Analgesics|analgesics|mesh-ancestor
44503340|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
44503341|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913038|NCT00392496|Sunitinib|sunitinib|mesh-list
44503342|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503343|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503344|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503345|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44503346|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44503347|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44503348|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
44503349|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
44503350|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503351|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503352|NCT01272128|Interferons|interferons|mesh-list
44503353|NCT01272128|Interferon-beta|interferon-beta|mesh-list
44503354|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
44503355|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503356|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
44503357|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503358|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
44503359|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503360|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44503361|NCT01272258|Leronlimab|leronlimab|mesh-list
44503362|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44503363|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44503364|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503365|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44503366|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44503367|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
44503368|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503369|NCT01272310|Interferons|interferons|mesh-list
44503370|NCT01272310|Ribavirin|ribavirin|mesh-list
44503371|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
44503372|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
44503373|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44503374|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
44503375|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503376|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
44503377|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503378|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
44503379|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503380|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
44503381|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503382|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
44503383|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44503384|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44503385|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503386|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503387|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
44503388|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44503389|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44503390|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44503391|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503392|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503393|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
44503394|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503395|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503396|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44503397|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503398|NCT01272531|Valproic Acid|valproic acid|mesh-list
44503399|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
44503400|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
44503401|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503402|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503403|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
44503404|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503405|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503406|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
44503407|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44503408|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503409|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503410|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
44503411|NCT01272557|Doxorubicin|doxorubicin|mesh-list
44503412|NCT01272557|Sorafenib|sorafenib|mesh-list
44503413|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44503414|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503415|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44503416|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44503417|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625029|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
44503418|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503419|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503420|NCT01272609|Timolol|timolol|mesh-list
44503421|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44503422|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44503423|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503424|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503425|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503426|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503427|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44503428|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503429|NCT01272778|Lorazepam|lorazepam|mesh-list
44503430|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
44503431|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
44503432|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
44503433|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503434|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503435|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503436|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44503437|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503438|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44503439|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44503440|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503441|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
44503442|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
44503443|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503444|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503445|NCT01272856|Abatacept|abatacept|mesh-list
44503446|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44503447|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503448|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503449|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503450|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
44503451|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503452|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503453|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
44503454|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
44503455|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503456|NCT01273051|Capecitabine|capecitabine|mesh-list
44503457|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503458|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
44503459|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503460|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503461|NCT01273090|Imetelstat|imetelstat|mesh-list
44503462|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
44503463|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503464|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503465|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503466|NCT01273233|Vaccines|vaccines|mesh-list
44503467|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
44503468|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503469|NCT01273246|Vaccines|vaccines|mesh-list
44503470|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
44503471|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503472|NCT01273298|Bisoprolol|bisoprolol|mesh-list
44503473|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503474|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
44142331|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44503475|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
44503476|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503477|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503478|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44503479|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44503480|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44503481|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503482|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503483|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503484|NCT01273454|Hydromorphone|hydromorphone|mesh-list
44503485|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44503486|NCT01273454|Narcotics|narcotics|mesh-ancestor
44503487|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503488|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503489|NCT01273454|Analgesics|analgesics|mesh-ancestor
44503490|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
44503491|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503492|NCT01273493|Dexamethasone|dexamethasone|mesh-list
44503493|NCT01273493|Trabectedin|trabectedin|mesh-list
44503494|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503495|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
44503496|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
44503497|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503498|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503499|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503500|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
44503501|NCT01273493|Hormones|hormones|mesh-ancestor
44503502|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503503|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503504|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503505|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44503506|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
44503507|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503508|NCT01273506|Tapentadol|tapentadol|mesh-list
44503509|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44503510|NCT01273506|Narcotics|narcotics|mesh-ancestor
44503511|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503512|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503513|NCT01273506|Analgesics|analgesics|mesh-ancestor
44503514|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
44503515|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503516|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44503517|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44503518|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503519|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503520|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503521|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503522|NCT01273532|Tapentadol|tapentadol|mesh-list
44503523|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44503524|NCT01273532|Narcotics|narcotics|mesh-ancestor
44503525|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503526|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503527|NCT01273532|Analgesics|analgesics|mesh-ancestor
44503528|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
44503529|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503530|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44503531|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44503532|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503533|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503534|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
44503535|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503536|NCT01273558|Canagliflozin|canagliflozin|mesh-list
44503537|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44503538|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503539|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503540|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503541|NCT01273571|Metformin|metformin|mesh-list
44503542|NCT01273571|Canagliflozin|canagliflozin|mesh-list
44503543|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503544|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503545|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44503546|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503547|NCT01273662|Axitinib|axitinib|mesh-list
44503548|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503549|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503550|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503551|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503552|NCT01273727|Dexamethasone|dexamethasone|mesh-list
44503553|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
44503554|NCT01273727|BB 1101|bb 1101|mesh-list
44503555|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503556|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
44503557|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
44503558|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503559|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503560|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503561|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
44503562|NCT01273727|Hormones|hormones|mesh-ancestor
44503563|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503564|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503565|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503566|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44503567|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503568|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503569|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
44503570|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503571|NCT01273831|Cisatracurium|cisatracurium|mesh-list
44503572|NCT01273831|Atracurium|atracurium|mesh-list
44503573|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44503574|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44503575|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503576|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503577|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44503578|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44503579|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44503580|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
44503581|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503582|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503583|NCT01273844|Bortezomib|bortezomib|mesh-list
44503584|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503585|NCT01273948|Interferons|interferons|mesh-list
44503586|NCT01273948|Bavituximab|bavituximab|mesh-list
44503587|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503588|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
44503589|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503590|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44503591|NCT01273974|Vaccines|vaccines|mesh-list
44503592|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
44503593|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503594|NCT01274000|Ramosetron|ramosetron|mesh-list
44503595|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
44503596|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
44503597|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503598|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503599|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503600|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44503601|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
44503602|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503603|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503604|NCT01274026|Verapamil|verapamil|mesh-list
44503605|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44503606|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44503607|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503608|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503609|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503610|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503611|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
44503612|NCT01274039|Acetazolamide|acetazolamide|mesh-list
44503613|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
44503614|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44503615|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503616|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503617|NCT01274039|Diuretics|diuretics|mesh-ancestor
43959355|NCT01403376|Interferons|interferons|mesh-list
44503618|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
44503619|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503620|NCT01274104|Vitamin D|vitamin d|mesh-list
44503621|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
44503622|NCT01274104|Vitamins|vitamins|mesh-ancestor
44503623|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
44503624|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503625|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44503626|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44503627|NCT01274130|Metformin|metformin|mesh-list
44503628|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44503629|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503630|NCT01274195|Busulfan|busulfan|mesh-list
44503631|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
44503632|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503633|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503634|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
44503635|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503636|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44503637|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503638|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44503639|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44503640|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44503641|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503642|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44503643|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44503644|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503645|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503647|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503648|NCT01274247|Benzocaine|benzocaine|mesh-list
44503649|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
44503650|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
44503651|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503652|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503653|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
44503654|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503655|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
44503656|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44503657|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44503658|NCT01274260|Prednisolone|prednisolone|mesh-list
44503659|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
44503660|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44503661|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
44503662|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503663|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
44503664|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
44503665|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503666|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503667|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503668|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
44503669|NCT01274260|Hormones|hormones|mesh-ancestor
44503670|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503671|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44503672|NCT01274260|Protective Agents|protective agents|mesh-ancestor
44503673|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503674|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503675|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44503676|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44503677|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
44503678|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503679|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503680|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44503681|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
44503682|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
44503683|NCT01274325|Hormones|hormones|mesh-ancestor
44503684|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503685|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
44503686|NCT01274403|Thalidomide|thalidomide|mesh-list
44503687|NCT01274403|Prednisone|prednisone|mesh-list
44503688|NCT01274403|Melphalan|melphalan|mesh-list
44503689|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503690|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
44503691|NCT01274403|Hormones|hormones|mesh-ancestor
44503692|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503693|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503694|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503695|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503696|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44503697|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
44503698|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503699|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44503700|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503701|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
44503702|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
44503703|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44503704|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503705|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503706|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503707|NCT01274403|Growth Substances|growth substances|mesh-ancestor
44503708|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503709|NCT01274481|Iloprost|iloprost|mesh-list
44503710|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44503711|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
44503712|NCT01274624|Leucovorin|leucovorin|mesh-list
44503713|NCT01274624|Bevacizumab|bevacizumab|mesh-list
44503714|NCT01274624|Fluorouracil|fluorouracil|mesh-list
44503715|NCT01274624|Irinotecan|irinotecan|mesh-list
44503716|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44503717|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503718|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44503719|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44503720|NCT01274624|Growth Substances|growth substances|mesh-ancestor
44503721|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503722|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
44503723|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
44503724|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503725|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503726|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503727|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
44503728|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44503729|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44503730|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503731|NCT01274624|Antidotes|antidotes|mesh-ancestor
44503732|NCT01274624|Protective Agents|protective agents|mesh-ancestor
44503733|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
44503734|NCT01274624|Vitamins|vitamins|mesh-ancestor
44503735|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
44503736|NCT01274793|Mosapride|mosapride|mesh-list
44503737|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503738|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503739|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44503740|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
44503741|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503742|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503743|NCT01275014|Dexamethasone|dexamethasone|mesh-list
44503744|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503745|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
44503746|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
44503747|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503748|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503749|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503750|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
44503751|NCT01275014|Hormones|hormones|mesh-ancestor
44503752|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503753|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44503754|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503755|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
44503756|NCT01275183|Cisplatin|cisplatin|mesh-list
44503757|NCT01275183|Docetaxel|docetaxel|mesh-list
44503758|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503759|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44503760|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44503761|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44503762|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503763|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44503764|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44503765|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
44503766|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503767|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44503768|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44503769|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503770|NCT01275248|Ondansetron|ondansetron|mesh-list
44503771|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
44503772|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
44503773|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503774|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503775|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503776|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
44503777|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44503778|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44503779|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
44503780|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503781|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503782|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44503783|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44503784|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503785|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503786|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44503788|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503789|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
44503790|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44503791|NCT01275287|Eculizumab|eculizumab|mesh-list
43959509|NCT01409239|Insulin|insulin|mesh-list
44503792|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44503793|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503794|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
44503795|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503796|NCT01275352|Eplerenone|eplerenone|mesh-list
44503797|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44503798|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
44503799|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503800|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503801|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44503802|NCT01275352|Diuretics|diuretics|mesh-ancestor
44503803|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
44503804|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503805|NCT01275443|Rilpivirine|rilpivirine|mesh-list
44503806|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44503807|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44503808|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503809|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503810|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
44503811|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503812|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44503813|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44503814|NCT01275547|Midazolam|midazolam|mesh-list
44503815|NCT01275547|Ketamine|ketamine|mesh-list
44503816|NCT01275547|Morphine|morphine|mesh-list
44503817|NCT01275547|Esketamine|esketamine|mesh-list
44503818|NCT01275547|Analgesics|analgesics|mesh-ancestor
44503819|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
44503820|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503821|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503822|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44503823|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44503824|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
44503825|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
44503826|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503827|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44503828|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44503829|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503830|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503831|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44503832|NCT01275547|Narcotics|narcotics|mesh-ancestor
44503833|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44503834|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44503835|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44503836|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44503837|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44503838|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
44503839|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
44503840|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44503841|NCT01275560|Metronidazole|metronidazole|mesh-list
44503842|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503843|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44503844|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44503845|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44503846|NCT01275599|Buprenorphine|buprenorphine|mesh-list
44503847|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44503848|NCT01275599|Naloxone|naloxone|mesh-list
44503849|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44503850|NCT01275599|Narcotics|narcotics|mesh-ancestor
44503851|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44503852|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503853|NCT01275599|Analgesics|analgesics|mesh-ancestor
44503854|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
44503855|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503856|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44503857|NCT01275729|Furosemide|furosemide|mesh-list
44503858|NCT01275729|Diuretics|diuretics|mesh-ancestor
44503859|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
44503860|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503861|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44503862|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503863|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503864|NCT01275859|Letrozole|letrozole|mesh-list
44503865|NCT01275859|Lapatinib|lapatinib|mesh-list
44503866|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503867|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44503868|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44503869|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503870|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503871|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44503872|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
44503873|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44503874|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503875|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503876|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
44503877|NCT01275885|Vitamin D|vitamin d|mesh-list
44503878|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959611|NCT01412710|Vitamin D|vitamin d|mesh-list
44503879|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503880|NCT01275885|Vitamins|vitamins|mesh-ancestor
44503881|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
44503882|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44503883|NCT01275937|Esomeprazole|esomeprazole|mesh-list
44503884|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44503885|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44503886|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44503887|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503888|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503889|NCT01275976|Complement C1s|complement c1s|mesh-list
44323481|NCT00944723|Zinc|zinc|mesh-list
44503890|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44503891|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44503892|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
44503893|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503894|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44503895|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503896|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
44503897|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44503898|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44503899|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44503900|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503901|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503902|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
44503903|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503904|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503905|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44503906|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503907|NCT01276067|Donepezil|donepezil|mesh-list
44503908|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44503909|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503910|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503911|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
44503912|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503913|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503914|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
44503915|NCT01276080|Donepezil|donepezil|mesh-list
44503916|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44503917|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503918|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503919|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
44503920|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44503921|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503922|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
44503923|NCT01276093|Amiodarone|amiodarone|mesh-list
44503924|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44503925|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
44503926|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44503927|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44503928|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503929|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44503930|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44503931|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44503932|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503933|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44503934|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44503935|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44503936|NCT01276210|Sorafenib|sorafenib|mesh-list
44503937|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503938|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44503939|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503940|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503941|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
44503942|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44503943|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44503944|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
44503945|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44503946|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503947|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44503948|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44503949|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44503950|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44503951|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44503952|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44503953|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44503954|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44503955|NCT01276496|Paclitaxel|paclitaxel|mesh-list
44503956|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44503957|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44503958|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503959|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44323506|NCT00944853|Zinc|zinc|mesh-list
44503960|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44503961|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44503962|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503964|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503965|NCT01276613|Gemcitabine|gemcitabine|mesh-list
44503966|NCT01276613|Losartan|losartan|mesh-list
44503967|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44503968|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
44503969|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503970|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44503971|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
44503972|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44503973|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503974|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44503975|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
44503976|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503977|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44503978|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44503979|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44503980|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44503981|NCT01276691|Aspirin|aspirin|mesh-list
44503982|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44503983|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44503984|NCT01276691|Analgesics|analgesics|mesh-ancestor
44503985|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
44503986|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44503987|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44503988|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44503989|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44503990|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44503991|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44503992|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44503993|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44503994|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44503995|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44503996|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
44503997|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
44503998|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
44503999|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44504000|NCT01276704|Estrogens|estrogens|mesh-ancestor
44504001|NCT01276704|Hormones|hormones|mesh-ancestor
44504002|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504003|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504004|NCT01276717|Vorinostat|vorinostat|mesh-list
44504005|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504006|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44504007|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504008|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504009|NCT01276730|Interferons|interferons|mesh-list
44504010|NCT01276730|Cisplatin|cisplatin|mesh-list
44504011|NCT01276730|Tretinoin|tretinoin|mesh-list
44504012|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504014|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504015|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
44504016|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
44504017|NCT01276769|Paclitaxel|paclitaxel|mesh-list
44504018|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44504019|NCT01276769|Carboplatin|carboplatin|mesh-list
44504020|NCT01276769|Epirubicin|epirubicin|mesh-list
44504021|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44504022|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504023|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44504024|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44504025|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
44504026|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504027|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44504028|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44504029|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44504030|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504031|NCT01276834|Everolimus|everolimus|mesh-list
44504032|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959766|NCT01421186|Hormones|hormones|mesh-ancestor
44504033|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504034|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
44323579|NCT00945308|Eptifibatide|eptifibatide|mesh-list
44504035|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504036|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44504037|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504038|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
44504039|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504040|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504041|NCT01276925|Bupivacaine|bupivacaine|mesh-list
44504042|NCT01276925|Ropivacaine|ropivacaine|mesh-list
44504043|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
44504044|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
44504045|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504046|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504047|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
44504048|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504049|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
44504050|NCT01276977|Eletriptan|eletriptan|mesh-list
44504051|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44504052|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44504053|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
44504054|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504055|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504056|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504057|NCT01277107|Zaleplon|zaleplon|mesh-list
44504058|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
44504059|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44504060|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504061|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504062|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
44504063|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
44504064|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504065|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504066|NCT01277172|Rituximab|rituximab|mesh-list
44504067|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44504068|NCT01277172|Antibodies|antibodies|mesh-list
44504069|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
44504070|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44504071|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
44504072|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504073|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504074|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504075|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
44504076|NCT01277185|Calcium|calcium|mesh-list
44504077|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504078|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504079|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44504080|NCT01277289|Dexamethasone|dexamethasone|mesh-list
44504081|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504082|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
44504083|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
44504084|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504085|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504086|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504087|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
44504088|NCT01277289|Hormones|hormones|mesh-ancestor
44504089|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504091|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504092|NCT01277497|Calcium|calcium|mesh-list
44504093|NCT01277497|Sevelamer|sevelamer|mesh-list
44504094|NCT01277497|Calcium acetate|calcium acetate|mesh-list
44504095|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504096|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504097|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
44504098|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
44504099|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504100|NCT01277627|Efavirenz|efavirenz|mesh-list
44504101|NCT01277627|Nevirapine|nevirapine|mesh-list
44504102|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44504103|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
44504104|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44504105|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44504106|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504107|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504108|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
44504109|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504110|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44504111|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43959845|NCT01422434|Calcitriol|calcitriol|mesh-list
44504112|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44504113|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44504114|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44504115|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44504116|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44504117|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44504118|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44323702|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44504119|NCT01277640|Dapivirine|dapivirine|mesh-list
44504120|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44504121|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44504122|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
44504123|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504124|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
44504125|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44504126|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44504127|NCT01277731|Prednisolone|prednisolone|mesh-list
44504128|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
44504129|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44504130|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
44504131|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504132|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
44504133|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
44504134|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504135|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504136|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504137|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
44504138|NCT01277731|Hormones|hormones|mesh-ancestor
44504139|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504140|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44504141|NCT01277731|Protective Agents|protective agents|mesh-ancestor
44504142|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504143|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504144|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
44504145|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44504146|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
44504147|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504148|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504149|NCT01277835|Lidocaine|lidocaine|mesh-list
43959873|NCT01423162|Vitamins|vitamins|mesh-ancestor
44504150|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
44504151|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
44504152|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504153|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504154|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
44504155|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504156|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44504157|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44504158|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44504159|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504160|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504161|NCT01277913|Vitamin D|vitamin d|mesh-list
44504162|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
44504163|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
44504164|NCT01277913|Vitamins|vitamins|mesh-list
44504165|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
44504166|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504167|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44504168|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504169|NCT01278004|Ethosuximide|ethosuximide|mesh-list
44504170|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
44504171|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
44504172|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44504173|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504174|NCT01278056|Deferasirox|deferasirox|mesh-list
44504175|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44504176|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
44504177|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
44504178|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504179|NCT01278238|Phenylephrine|phenylephrine|mesh-list
44504180|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
44504181|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44504182|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
44504183|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
44504184|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504185|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504186|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
44504187|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44504188|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
44504189|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504190|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44504191|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44504192|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44504193|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
44504194|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504195|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504197|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44504198|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44504199|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
44504200|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44504201|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
44504202|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44504203|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504204|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44504205|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504206|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504207|NCT01278290|Hormones|hormones|mesh-ancestor
44504208|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504209|NCT01278446|Caseins|caseins|mesh-list
44504210|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
44504211|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
44504212|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504213|NCT01278459|Atorvastatin|atorvastatin|mesh-list
44504214|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44504215|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44504216|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
44504217|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504218|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44504219|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44504220|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504221|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
44504222|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44504223|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44504224|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44504225|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504226|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504227|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
44504228|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504229|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504230|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44504231|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504232|NCT01278602|Rituximab|rituximab|mesh-list
44504233|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504234|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504235|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
44504236|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504237|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504238|NCT01278758|Vadimezan|vadimezan|mesh-list
44504239|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504240|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
44504241|NCT01278784|Chitosan|chitosan|mesh-list
44504242|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44504243|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44504244|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44504245|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
44504246|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504247|NCT01278784|Expectorants|expectorants|mesh-ancestor
44504248|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504249|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44504250|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
44504251|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504252|NCT01278784|Protective Agents|protective agents|mesh-ancestor
44504253|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504254|NCT01278784|Antidotes|antidotes|mesh-ancestor
44504255|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44504256|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44504257|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
44504258|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44504259|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
44504260|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
44504261|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
44504262|NCT01278784|Coagulants|coagulants|mesh-ancestor
44504263|NCT01278849|Vadimezan|vadimezan|mesh-list
44504264|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504265|NCT01279096|Dexamethasone|dexamethasone|mesh-list
44504266|NCT01279096|Etoposide|etoposide|mesh-list
44504267|NCT01279096|Asparaginase|asparaginase|mesh-list
44504268|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
44504269|NCT01279096|Clofarabine|clofarabine|mesh-list
44504270|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504271|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
44504272|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
44504273|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959981|NCT01428245|Estradiol|estradiol|mesh-list
44504274|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504275|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504276|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
44504278|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504279|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504280|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504281|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504282|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504283|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44504284|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44504285|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44504286|NCT01279096|Analgesics|analgesics|mesh-ancestor
44504287|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
44504288|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44504289|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
44504290|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44504291|NCT01279213|Clozapine|clozapine|mesh-list
44504292|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44504293|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44504294|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504295|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504296|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44504297|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44504298|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44504299|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
44504300|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504301|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504302|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44504303|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44504304|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
44504305|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
44504306|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
44504307|NCT01279252|Metronidazole|metronidazole|mesh-list
44504308|NCT01279252|Clarithromycin|clarithromycin|mesh-list
44504309|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
44504310|NCT01279252|Lansoprazole|lansoprazole|mesh-list
44504311|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
44504312|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504313|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44504314|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44504315|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44504316|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44504317|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504318|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504319|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44504320|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44504321|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44504322|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44504323|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504324|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44504325|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44504326|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504327|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44504328|NCT01279291|Gemcitabine|gemcitabine|mesh-list
44504329|NCT01279291|Paclitaxel|paclitaxel|mesh-list
44504330|NCT01279291|Carboplatin|carboplatin|mesh-list
44504331|NCT01279291|Doxorubicin|doxorubicin|mesh-list
44504332|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44504333|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44504334|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504335|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44504336|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44504337|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44504338|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504339|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44504340|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
44504341|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
44504342|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504343|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504344|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504345|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
44504346|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323935|NCT00947141|Valganciclovir|valganciclovir|mesh-list
44504347|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44504348|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44504349|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44504350|NCT01279434|Vitamins|vitamins|mesh-list
44504351|NCT01279434|Vitamin E|vitamin e|mesh-list
44504352|NCT01279434|Tocopherols|tocopherols|mesh-list
44504353|NCT01279434|Tocotrienols|tocotrienols|mesh-list
44504354|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
44504355|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
44504356|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504357|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
44504358|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504359|NCT01279434|Protective Agents|protective agents|mesh-ancestor
44504360|NCT01279499|Remifentanil|remifentanil|mesh-list
44504361|NCT01279499|Propofol|propofol|mesh-list
44504362|NCT01279499|Sevoflurane|sevoflurane|mesh-list
44504363|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44504364|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504365|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504366|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44504367|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
44504368|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
44504369|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44504370|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44504371|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44504372|NCT01279499|Narcotics|narcotics|mesh-ancestor
44504373|NCT01279499|Analgesics|analgesics|mesh-ancestor
44504374|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
44504375|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504376|NCT01279512|Metformin|metformin|mesh-list
44504377|NCT01279512|Acarbose|acarbose|mesh-list
44504378|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504379|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504380|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44504381|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504382|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504383|NCT01279551|Lidocaine|lidocaine|mesh-list
44504384|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
44504385|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
44504386|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
44504387|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504388|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504389|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
44504390|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504391|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44504392|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44504393|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44504394|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504395|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504396|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44504397|NCT01279629|Tazarotene|tazarotene|mesh-list
44504398|NCT01279629|Calcipotriene|calcipotriene|mesh-list
44504399|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
44504400|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
44504401|NCT01279668|Montelukast|montelukast|mesh-list
44504402|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44504403|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504404|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44504405|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44504406|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504407|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504408|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44504409|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44504410|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504411|NCT01279694|Prednisone|prednisone|mesh-list
44504412|NCT01279694|Melphalan|melphalan|mesh-list
44504413|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504414|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
44504415|NCT01279694|Hormones|hormones|mesh-ancestor
44504416|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504417|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504418|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504419|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504420|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44504421|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
44504422|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504423|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44504424|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504425|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
44504427|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
44504428|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504429|NCT01279876|Protective Agents|protective agents|mesh-ancestor
44504430|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504431|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504432|NCT01279902|Rituximab|rituximab|mesh-list
44504433|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504434|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504435|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
44504436|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504437|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504438|NCT01279915|Linaclotide|linaclotide|mesh-list
44504439|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44504440|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
44504441|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504442|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504443|NCT01279681|Leucovorin|leucovorin|mesh-list
44504444|NCT01279681|Bevacizumab|bevacizumab|mesh-list
44504445|NCT01279681|Fluorouracil|fluorouracil|mesh-list
44504446|NCT01279681|Capecitabine|capecitabine|mesh-list
44504447|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
44504448|NCT01279681|Calcium|calcium|mesh-list
44504449|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
44504450|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504451|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504452|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44504453|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44504454|NCT01279681|Growth Substances|growth substances|mesh-ancestor
44504455|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504456|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44504457|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504458|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
44504459|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504460|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44504461|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504462|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
44504463|NCT01279681|Antidotes|antidotes|mesh-ancestor
44504464|NCT01279681|Protective Agents|protective agents|mesh-ancestor
44504465|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
44504466|NCT01279681|Vitamins|vitamins|mesh-ancestor
44504467|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
44504468|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
44504469|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
44504470|NCT01279616|Busulfan|busulfan|mesh-list
44504471|NCT01279616|Rituximab|rituximab|mesh-list
44504472|NCT01279616|Fludarabine|fludarabine|mesh-list
44504473|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
44504474|NCT01279616|Tacrolimus|tacrolimus|mesh-list
44504475|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
44504476|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504477|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
44504478|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504479|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504480|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44504481|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
44504482|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142383|NCT00186862|Analgesics|analgesics|mesh-ancestor
44504483|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504484|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44504485|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504486|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44504487|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
44504488|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44504489|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504490|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44504491|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44504492|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
44504493|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44504494|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504495|NCT01279343|Misoprostol|misoprostol|mesh-list
44504496|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44504497|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
44504498|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44504499|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504500|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44504501|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504502|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
44504503|NCT01279057|Fluticasone|fluticasone|mesh-list
44504505|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504506|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44504507|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
44504508|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504509|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504510|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44504511|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504512|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44504513|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44504514|NCT01278797|Amlodipine|amlodipine|mesh-list
44504515|NCT01278797|Telmisartan|telmisartan|mesh-list
44504516|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44504517|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44504518|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44504519|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504520|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504521|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504522|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504523|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
44504524|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44504525|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44504526|NCT01278745|Rituximab|rituximab|mesh-list
44504527|NCT01278745|Tacrolimus|tacrolimus|mesh-list
44504528|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504529|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504530|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
44504531|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504532|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504533|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504534|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44504535|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504536|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504537|NCT01278407|Donepezil|donepezil|mesh-list
44504538|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44504539|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504540|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504541|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
44504542|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504543|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504544|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
44504546|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
44504547|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504548|NCT01278342|Octreotide|octreotide|mesh-list
44504549|NCT01278342|Cabergoline|cabergoline|mesh-list
44504550|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504551|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504552|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504553|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44142443|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
44504554|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44504555|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
44504556|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
44504557|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504558|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504559|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504560|NCT01278173|Vigabatrin|vigabatrin|mesh-list
44504561|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
44504562|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504563|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504564|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
44504565|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504566|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504567|NCT01278160|Insulin|insulin|mesh-list
44504568|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44504569|NCT01278160|Metformin|metformin|mesh-list
44504570|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
44504571|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
44504572|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44504573|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
44504574|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44504575|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
44504576|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504577|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504578|NCT01277861|Fentanyl|fentanyl|mesh-list
44504579|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44504580|NCT01277861|Narcotics|narcotics|mesh-ancestor
44504581|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504582|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504583|NCT01277861|Analgesics|analgesics|mesh-ancestor
44504584|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
44504585|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504586|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44504587|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44504588|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
44504589|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
44504590|NCT01277822|Losartan|losartan|mesh-list
44504591|NCT01277822|Amlodipine|amlodipine|mesh-list
44504592|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44504593|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44504594|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504595|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504596|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44504597|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504598|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
44504599|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44504600|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44504601|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44504602|NCT01277718|Rabeprazole|rabeprazole|mesh-list
44504603|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44504604|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504605|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44504606|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504607|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504608|NCT01277302|Ranibizumab|ranibizumab|mesh-list
44504609|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44504610|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44504611|NCT01277302|Growth Substances|growth substances|mesh-ancestor
44504612|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504613|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
44504614|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504615|NCT01276847|Etanercept|etanercept|mesh-list
44504616|NCT01276847|Ustekinumab|ustekinumab|mesh-list
43914290|NCT00424502|Rituximab|rituximab|mesh-list
44504617|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44504618|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44504619|NCT01276847|Analgesics|analgesics|mesh-ancestor
44504620|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
44504621|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504622|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504623|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504624|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504625|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504626|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504627|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
44504628|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44504629|NCT01276821|Epinephrine|epinephrine|mesh-list
44504630|NCT01276821|Racepinephrine|racepinephrine|mesh-list
44504631|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
44504632|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44504633|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44504634|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44504635|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504636|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504637|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504638|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44504639|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44504640|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
44504641|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504642|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43960330|NCT01436799|Alfentanil|alfentanil|mesh-list
44504643|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504644|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
44504645|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
44504646|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44504647|NCT01276756|Interferons|interferons|mesh-list
44504648|NCT01276756|Ribavirin|ribavirin|mesh-list
44504649|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
44504650|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
44504651|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44504652|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
44504653|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504654|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
44504655|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504656|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
44504657|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504658|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
44504659|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504660|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44504661|NCT01276457|Cyclosporine|cyclosporine|mesh-list
44504662|NCT01276457|Everolimus|everolimus|mesh-list
44504663|NCT01276457|Cyclosporins|cyclosporins|mesh-list
44504664|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504665|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504666|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504667|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
44504668|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504669|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
44504670|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504671|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44504672|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504673|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44504674|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504675|NCT01276353|Donepezil|donepezil|mesh-list
44504676|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44504677|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504678|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504679|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
44504680|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504681|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504682|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
44504683|NCT01276327|Pioglitazone|pioglitazone|mesh-list
44504684|NCT01276327|Linagliptin|linagliptin|mesh-list
44504685|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504686|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504687|NCT01276327|Incretins|incretins|mesh-ancestor
44504688|NCT01276327|Hormones|hormones|mesh-ancestor
44504689|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504690|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44504691|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
44504692|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504693|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504694|NCT01276288|Empagliflozin|empagliflozin|mesh-list
44504695|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44504696|NCT01276288|Torsemide|torsemide|mesh-list
44504697|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44504698|NCT01276288|Diuretics|diuretics|mesh-ancestor
44504699|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
44504700|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504701|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44504702|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44504703|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504704|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44504705|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504706|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44504707|NCT01276236|Maraviroc|maraviroc|mesh-list
44504708|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44504709|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44504710|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504711|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44504712|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44504713|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
44504714|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504715|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44504716|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
44504717|NCT01276223|Difluprednate|difluprednate|mesh-list
44504718|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
44504719|NCT01276223|Hormones|hormones|mesh-ancestor
44504720|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504721|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504722|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504723|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44504724|NCT01276054|Methylene Blue|methylene blue|mesh-list
44504725|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44504726|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504727|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504728|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44504729|NCT01275222|Everolimus|everolimus|mesh-list
44504730|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
44504731|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504732|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504733|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
44504734|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504735|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44504736|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504737|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504738|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
44504739|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504740|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44504741|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504742|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504743|NCT01275170|Imipenem|imipenem|mesh-list
44504744|NCT01275170|Relebactam|relebactam|mesh-list
44504745|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44504746|NCT01275170|Midazolam|midazolam|mesh-list
44504747|NCT01275170|Caffeine|caffeine|mesh-list
44504748|NCT01275170|Omeprazole|omeprazole|mesh-list
44504749|NCT01275170|Cilastatin|cilastatin|mesh-list
44504750|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44504751|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44504752|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504753|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504754|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44504755|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44504756|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44504757|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44504758|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
44504759|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
44504760|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
44504761|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
44504762|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504763|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504764|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44504765|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504766|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44504767|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504768|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44504769|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44504770|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44504771|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44504772|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
44504773|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44504774|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504775|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
44504776|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44504777|NCT01275144|Lorazepam|lorazepam|mesh-list
44504778|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
44504779|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
44504780|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
44504781|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504782|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504783|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504784|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44504785|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504786|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44504787|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44504788|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44504789|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
44504790|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
44504791|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44504792|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504793|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
44504794|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504795|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504796|NCT01274559|Niacin|niacin|mesh-list
44504797|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44504798|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
43960436|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44504799|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504800|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44504801|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
44504802|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
44504803|NCT01274559|Vitamins|vitamins|mesh-ancestor
44504804|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
44324352|NCT00949832|Vitamin D|vitamin d|mesh-list
44504805|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504806|NCT01274533|Lenalidomide|lenalidomide|mesh-list
44504807|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
44504808|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504809|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44504810|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44504811|NCT01274533|Growth Substances|growth substances|mesh-ancestor
44504812|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
44504813|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504814|NCT01274182|Rituximab|rituximab|mesh-list
44504815|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504816|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504817|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
44504818|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504819|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504820|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
44504821|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
44504822|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44504823|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44504824|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504825|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504826|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504827|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504828|NCT01273181|Aldesleukin|aldesleukin|mesh-list
44504829|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
44504830|NCT01273181|Fludarabine|fludarabine|mesh-list
44504831|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504832|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
44504833|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504834|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504835|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44504836|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
44504837|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504838|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504839|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44504840|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44504841|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44504842|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
44504843|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504844|NCT01273064|Interferons|interferons|mesh-list
44504845|NCT01273064|Ribavirin|ribavirin|mesh-list
44504846|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504847|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
44504848|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504849|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
44504850|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504851|NCT01272947|Diclofenac|diclofenac|mesh-list
44504852|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44504853|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44504854|NCT01272947|Analgesics|analgesics|mesh-ancestor
44504855|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
44504856|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504857|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504858|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504859|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504860|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44504861|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504862|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504863|NCT01272934|Diclofenac|diclofenac|mesh-list
44504864|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44504865|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44504866|NCT01272934|Analgesics|analgesics|mesh-ancestor
44504867|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
44504868|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504869|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504870|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504871|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504872|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44504873|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504874|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504875|NCT01272921|Bupivacaine|bupivacaine|mesh-list
44504876|NCT01272921|Ropivacaine|ropivacaine|mesh-list
44504877|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
44504878|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
44504879|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504880|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504881|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
44504882|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504883|NCT01272908|Rituximab|rituximab|mesh-list
44504884|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504885|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504886|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
44504887|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504888|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504889|NCT01272635|Azithromycin|azithromycin|mesh-list
44504890|NCT01272635|Prednisolone|prednisolone|mesh-list
44504891|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44504892|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
44504893|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44504894|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
44504895|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44504896|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
44504897|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504898|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
44504899|NCT01272635|Hormones|hormones|mesh-ancestor
44504900|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504901|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504902|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44504903|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504904|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
44504905|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
44504906|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44504907|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44504908|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44504909|NCT01272635|Protective Agents|protective agents|mesh-ancestor
44504910|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44504911|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504912|NCT01272232|Liraglutide|liraglutide|mesh-list
44504913|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504914|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504915|NCT01272232|Incretins|incretins|mesh-ancestor
44504916|NCT01272232|Hormones|hormones|mesh-ancestor
44504917|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504918|NCT01272219|Liraglutide|liraglutide|mesh-list
44504919|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44504920|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504921|NCT01272219|Incretins|incretins|mesh-ancestor
44504922|NCT01272219|Hormones|hormones|mesh-ancestor
44504923|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44504924|NCT01272180|Vaccines|vaccines|mesh-list
44504925|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
44504926|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504927|NCT01271504|Sorafenib|sorafenib|mesh-list
44504928|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504929|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44504930|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504931|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504932|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
44504933|NCT01271010|Rituximab|rituximab|mesh-list
44504934|NCT01271010|Fludarabine|fludarabine|mesh-list
44504935|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44504936|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
44504937|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504938|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44504939|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44504940|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
44504941|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504942|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44504943|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44504944|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44504945|NCT01270971|Tavaborole|tavaborole|mesh-list
44504946|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44504947|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
44504948|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504949|NCT01270841|Enclomiphene|enclomiphene|mesh-list
44504950|NCT01270841|Clomiphene|clomiphene|mesh-list
44504951|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
44504952|NCT01270841|Testosterone|testosterone|mesh-list
44504953|NCT01270841|Androgens|androgens|mesh-ancestor
44504954|NCT01270841|Hormones|hormones|mesh-ancestor
44504955|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960582|NCT01447849|Lubiprostone|lubiprostone|mesh-list
44504956|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504957|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44504958|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
44504959|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44504960|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
44504961|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44504962|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44504963|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44504964|NCT01270802|Tenofovir|tenofovir|mesh-list
44504965|NCT01270802|Emtricitabine|emtricitabine|mesh-list
44504966|NCT01270802|Efavirenz|efavirenz|mesh-list
44504967|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
44504968|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
44504969|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44504970|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44504971|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44504972|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44504973|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44504974|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44504975|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44504976|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44504977|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44504978|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44504979|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44504980|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44504981|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44504982|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44504983|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44504984|NCT01270620|Propofol|propofol|mesh-list
44504985|NCT01270620|Desflurane|desflurane|mesh-list
44504986|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44504987|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44504988|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44504989|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44504990|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
44504991|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
44504992|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44504993|NCT01270464|Reslizumab|reslizumab|mesh-list
44504994|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44504995|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44504996|NCT01270256|Budesonide|budesonide|mesh-list
44504997|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44504998|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44504999|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
44505000|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505001|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505002|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44505003|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44505004|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
44505005|NCT01270256|Hormones|hormones|mesh-ancestor
44505006|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505007|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
44505008|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44505009|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44505010|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44505011|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505012|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505013|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44505014|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505015|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505016|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44505017|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505018|NCT01277211|NuvaRing|nuvaring|mesh-list
44505019|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44505020|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
44505021|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44505022|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505023|NCT01279590|Atorvastatin|atorvastatin|mesh-list
44505024|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44505025|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44505026|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
44505027|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505028|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44505029|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44505030|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505031|NCT01278134|Ritonavir|ritonavir|mesh-list
44505032|NCT01278134|Ribavirin|ribavirin|mesh-list
44505033|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44505034|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44505035|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44505036|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
44505037|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505038|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505039|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44505040|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44505041|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
44505042|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505043|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44142465|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
44505044|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44505045|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
44505046|NCT01276587|Vitamin D|vitamin d|mesh-list
44505047|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
44505048|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
44505049|NCT01276587|Vitamins|vitamins|mesh-list
44505050|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
44505051|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505052|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44505053|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44505054|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44505055|NCT01275105|Phenylephrine|phenylephrine|mesh-list
44505056|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
44505057|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505058|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44505059|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44505060|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44505061|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505062|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505063|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505064|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505065|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
44505066|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
44505067|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505068|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
44505069|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44505070|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44505071|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44505072|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
44505073|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44505074|NCT01275105|Protective Agents|protective agents|mesh-ancestor
44505075|NCT01272791|Gemcitabine|gemcitabine|mesh-list
44505076|NCT01272791|Bavituximab|bavituximab|mesh-list
44505077|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505078|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
44505079|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505080|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505081|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
44505082|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505084|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505085|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
44505086|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505087|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505088|NCT01271920|Trastuzumab|trastuzumab|mesh-list
44505089|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505090|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505091|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44505092|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
44505093|NCT01271790|Ribavirin|ribavirin|mesh-list
44505094|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
44505095|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505096|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
44505097|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505098|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
44505099|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505100|NCT01270347|Levofloxacin|levofloxacin|mesh-list
44505101|NCT01270347|Ofloxacin|ofloxacin|mesh-list
44505102|NCT01270347|Tobramycin|tobramycin|mesh-list
44505103|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44505104|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44505105|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505106|NCT01270347|Renal Agents|renal agents|mesh-ancestor
44505107|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44505108|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44505109|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505110|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505111|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505112|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505113|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44505114|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44505115|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
44505116|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
44505117|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505118|NCT01270152|Protective Agents|protective agents|mesh-ancestor
44505119|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505120|NCT01270152|Vitamins|vitamins|mesh-ancestor
44505121|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
44505122|NCT01271348|Etoricoxib|etoricoxib|mesh-list
44505123|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44505124|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505125|NCT01271348|Analgesics|analgesics|mesh-ancestor
44505126|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
44505127|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505128|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505129|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505130|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505131|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44505132|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44505133|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505134|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505135|NCT01274988|Methadone|methadone|mesh-list
44505136|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44505137|NCT01274988|Narcotics|narcotics|mesh-ancestor
44505138|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505139|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505140|NCT01274988|Analgesics|analgesics|mesh-ancestor
44505141|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
44505142|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505143|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
44505144|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
44505145|NCT01275638|Prednisolone|prednisolone|mesh-list
44505146|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44505147|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
44505148|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44505149|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
44505150|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44505151|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
44505152|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505153|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
44505154|NCT01275638|Hormones|hormones|mesh-ancestor
44505155|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505156|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505157|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44505158|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505159|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
44505160|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
44505161|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505162|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44505163|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44505164|NCT01275638|Protective Agents|protective agents|mesh-ancestor
44505165|NCT01278498|Citalopram|citalopram|mesh-list
44505166|NCT01278498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44505167|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44505168|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505169|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505170|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505171|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
44505172|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505173|NCT01278498|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44505174|NCT01278498|Antidepressive Agents|antidepressive agents|mesh-ancestor
44505175|NCT01278498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505176|NCT01279083|Timolol|timolol|mesh-list
44505177|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44505178|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44505179|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44505180|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505181|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505182|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505183|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505184|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44505185|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505186|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44505187|NCT01279707|Epratuzumab|epratuzumab|mesh-list
44505188|NCT01279707|Veltuzumab|veltuzumab|mesh-list
44505189|NCT01279707|Antibodies|antibodies|mesh-list
44505190|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
44505191|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44505192|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
44505193|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505194|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505195|NCT01279980|Anesthetics|anesthetics|mesh-list
44505196|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
44505197|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505198|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505199|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
44505200|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505201|NCT01279954|Abatacept|abatacept|mesh-list
44505202|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44505203|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505204|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505205|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505206|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
44505207|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505208|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505209|NCT01277744|Cisplatin|cisplatin|mesh-list
44505210|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505211|NCT01276379|Leucovorin|leucovorin|mesh-list
44505212|NCT01276379|Folic Acid|folic acid|mesh-list
44505213|NCT01276379|Fluorouracil|fluorouracil|mesh-list
44505214|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
44505215|NCT01276379|Irinotecan|irinotecan|mesh-list
44505216|NCT01276379|Cetuximab|cetuximab|mesh-list
44505217|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
44505218|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
44505219|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505220|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505221|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505222|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505223|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
44505224|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505225|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44505226|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505227|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505228|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505230|NCT01276379|Protective Agents|protective agents|mesh-ancestor
44505231|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
44505232|NCT01276379|Vitamins|vitamins|mesh-ancestor
44505233|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
44505234|NCT01276379|Hematinics|hematinics|mesh-ancestor
44505235|NCT01276041|Paclitaxel|paclitaxel|mesh-list
44505236|NCT01276041|Trastuzumab|trastuzumab|mesh-list
44505237|NCT01276041|Pertuzumab|pertuzumab|mesh-list
44505238|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44505239|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505240|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44505241|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44505242|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44505243|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505244|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505245|NCT01275339|Tadalafil|tadalafil|mesh-list
44505246|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505247|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44505248|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44505249|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505250|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505251|NCT01275339|Urological Agents|urological agents|mesh-ancestor
44505252|NCT01271803|Vemurafenib|vemurafenib|mesh-list
44505253|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505254|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505255|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505256|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505257|NCT01271725|Paclitaxel|paclitaxel|mesh-list
44505258|NCT01271725|Vinorelbine|vinorelbine|mesh-list
44505259|NCT01271725|Afatinib|afatinib|mesh-list
44505260|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44505261|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505262|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
44505263|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
44505264|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
44505265|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505266|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505267|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505268|NCT01270321|Everolimus|everolimus|mesh-list
44505269|NCT01270321|Pasireotide|pasireotide|mesh-list
44505270|NCT01270321|Somatostatin|somatostatin|mesh-list
44505271|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505272|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505273|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
44505274|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505275|NCT01270321|Hormones|hormones|mesh-ancestor
44505276|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505277|NCT00240916|Vaccines|vaccines|mesh-list
44505278|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
44505279|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505280|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44505281|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44505282|NCT00249834|Hormones|hormones|mesh-ancestor
44505283|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505284|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505285|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44505286|NCT00249795|Irbesartan|irbesartan|mesh-list
44505287|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505288|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44505289|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44505290|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505291|NCT00249769|Vaccines|vaccines|mesh-list
44505292|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
44505293|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505294|NCT00249444|Mirtazapine|mirtazapine|mesh-list
44505295|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
44505296|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505297|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44505298|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
44505299|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
44505300|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505301|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505302|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505303|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44505304|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44505305|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505306|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44505307|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44324807|NCT00953303|Dexamethasone|dexamethasone|mesh-list
44505308|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44505309|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505310|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44505311|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44505312|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
44505313|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44505315|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
44505316|NCT00249288|Hematinics|hematinics|mesh-ancestor
44505318|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
44505319|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505320|NCT00249002|Paclitaxel|paclitaxel|mesh-list
44505321|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44505322|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44505323|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505324|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
44505325|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
44505326|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
44505327|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505328|NCT00248833|Vaccines|vaccines|mesh-list
44505329|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
44505330|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505331|NCT00248651|Amitriptyline|amitriptyline|mesh-list
44505332|NCT00248651|Citalopram|citalopram|mesh-list
44505333|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44505334|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44505335|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505336|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505337|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505338|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
44505339|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505340|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44505341|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
44505342|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505343|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505344|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44505345|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505346|NCT00248651|Analgesics|analgesics|mesh-ancestor
44505347|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
44505348|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44505349|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505350|NCT00248495|Cisplatin|cisplatin|mesh-list
44505351|NCT00248495|Pemetrexed|pemetrexed|mesh-list
44505352|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505353|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505354|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505355|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44505356|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44505357|NCT00248170|Letrozole|letrozole|mesh-list
44505358|NCT00248170|Anastrozole|anastrozole|mesh-list
44505359|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505360|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44505361|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44505362|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505363|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505364|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44505365|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44505366|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505367|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505368|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44505369|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
44505370|NCT00247962|Etanercept|etanercept|mesh-list
44505371|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44505373|NCT00247962|Analgesics|analgesics|mesh-ancestor
44505374|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
44505375|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505376|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505377|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505378|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505379|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44505380|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505381|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
44324890|NCT00953550|Rocuronium|rocuronium|mesh-list
44505382|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505383|NCT00247416|Gemcitabine|gemcitabine|mesh-list
44505384|NCT00247416|Dexamethasone|dexamethasone|mesh-list
44505385|NCT00247416|Carboplatin|carboplatin|mesh-list
44505386|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505387|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
44505388|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
44505389|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505390|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505391|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44505392|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
44505393|NCT00247416|Hormones|hormones|mesh-ancestor
44505394|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505395|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44505396|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505397|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505398|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
44505399|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505400|NCT00247416|Antiviral Agents|antiviral agents|mesh-ancestor
44505401|NCT00247416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505402|NCT00247416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505403|NCT00247416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505404|NCT00247416|Immunologic Factors|immunologic factors|mesh-ancestor
44505405|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
44505406|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
44505407|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44505408|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505409|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505410|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44505411|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505412|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44505413|NCT00246753|Lapatinib|lapatinib|mesh-list
43961001|NCT01467999|Guanfacine|guanfacine|mesh-list
44505414|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505415|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505416|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505417|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505418|NCT00246740|Doxycycline|doxycycline|mesh-list
44505419|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44505420|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505421|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
44505422|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44505423|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44505424|NCT00246376|Niacin|niacin|mesh-list
44505425|NCT00246376|Fenofibrate|fenofibrate|mesh-list
44505426|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44505427|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
44505428|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505429|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44505430|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505431|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
44505432|NCT00246376|Vitamins|vitamins|mesh-ancestor
44505433|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
44505434|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505435|NCT00246259|Risperidone|risperidone|mesh-list
44505436|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
44505437|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44505438|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
44505439|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505440|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505441|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505442|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44505443|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505445|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44505446|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
44505447|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
44505448|NCT00246129|Daclizumab|daclizumab|mesh-list
44505449|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505450|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505451|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505452|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
44505453|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505454|NCT00246025|Dabigatran|dabigatran|mesh-list
44505455|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
44505456|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44505457|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
44505458|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505459|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505460|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
44505461|NCT00246012|Dacarbazine|dacarbazine|mesh-list
44505462|NCT00246012|Intetumumab|intetumumab|mesh-list
44505463|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44505464|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
44505465|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505466|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505467|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505468|NCT00245856|Dalteparin|dalteparin|mesh-list
44505469|NCT00245856|Tinzaparin|tinzaparin|mesh-list
44505470|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44505471|NCT00245856|Warfarin|warfarin|mesh-list
44505472|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
44505473|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44505474|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44505475|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505476|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
44505477|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505478|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
44505479|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505480|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505481|NCT00245583|Topiramate|topiramate|mesh-list
44505482|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
44505483|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44505484|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505485|NCT00245102|Sorafenib|sorafenib|mesh-list
44505486|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505487|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505488|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505489|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505490|NCT00245063|Cediranib|cediranib|mesh-list
44505491|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505492|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505493|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505494|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505495|NCT00245050|Pyridoxine|pyridoxine|mesh-list
44505496|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
44505497|NCT00245050|Doxorubicin|doxorubicin|mesh-list
44505498|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44505499|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44505500|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505501|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44505502|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505503|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505504|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505505|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
44505506|NCT00245050|Vitamins|vitamins|mesh-ancestor
44505507|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
44505508|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505509|NCT00245011|Ifosfamide|ifosfamide|mesh-list
44505510|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44505511|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505512|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44505513|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
44505514|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505515|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505516|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505517|NCT00245011|Analgesics|analgesics|mesh-ancestor
44505518|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
44505519|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505520|NCT00244933|Gemcitabine|gemcitabine|mesh-list
44505521|NCT00244933|Genistein|genistein|mesh-list
44505522|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505523|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
44505524|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505525|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505526|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
44505527|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505528|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505529|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505530|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
44505531|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325035|NCT00954603|Haloperidol|haloperidol|mesh-list
44505532|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44505533|NCT00244933|Protective Agents|protective agents|mesh-ancestor
44505534|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505535|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
44505536|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44505537|NCT00244933|Estrogens|estrogens|mesh-ancestor
44505538|NCT00244933|Hormones|hormones|mesh-ancestor
44505539|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505540|NCT00244881|Cediranib|cediranib|mesh-list
44505541|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505542|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505543|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505544|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505545|NCT00244855|Dexamethasone|dexamethasone|mesh-list
44505546|NCT00244855|Rituximab|rituximab|mesh-list
44505547|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505548|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505549|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
44505550|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505551|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505552|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505553|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
44505554|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
44505555|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505556|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44505557|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
44505558|NCT00244855|Hormones|hormones|mesh-ancestor
44505559|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505560|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44505561|NCT00244725|Warfarin|warfarin|mesh-list
44505562|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
44505563|NCT00244712|Tenofovir|tenofovir|mesh-list
44505564|NCT00244712|Lamivudine|lamivudine|mesh-list
44505565|NCT00244712|Emtricitabine|emtricitabine|mesh-list
44505566|NCT00244712|Abacavir|abacavir|mesh-list
44505567|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
44505568|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505569|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44505570|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44505571|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505572|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505573|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44505574|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44505575|NCT00244621|Candesartan|candesartan|mesh-list
44505576|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
44505577|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505578|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44505579|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44505580|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505581|NCT00243932|Ubiquinone|ubiquinone|mesh-list
44505582|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
44505583|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
44505584|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505585|NCT00243932|Vitamins|vitamins|mesh-ancestor
44505586|NCT00243659|Factor VIII|factor viii|mesh-list
44505587|NCT00243659|Coagulants|coagulants|mesh-ancestor
44505588|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
44505589|NCT00243412|Rituximab|rituximab|mesh-list
44505590|NCT00243412|Methotrexate|methotrexate|mesh-list
44505591|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505592|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505593|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
44505594|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505595|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505596|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44505597|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
44505598|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44505599|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505600|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
44505601|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505602|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44505603|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505604|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44505605|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505606|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44505607|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325106|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
44505608|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
44505609|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
44505610|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505611|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44505612|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
44505613|NCT00243412|Hormones|hormones|mesh-ancestor
44505614|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505615|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44505616|NCT00243412|Protective Agents|protective agents|mesh-ancestor
44505617|NCT00243386|Factor VIII|factor viii|mesh-list
44505618|NCT00243386|Coagulants|coagulants|mesh-ancestor
44505619|NCT00243347|Cediranib|cediranib|mesh-list
44505620|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505621|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505622|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505623|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505624|NCT00243074|Cediranib|cediranib|mesh-list
44505625|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505626|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505627|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505628|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44505629|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
44505630|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
44505631|NCT00243022|Vitamins|vitamins|mesh-ancestor
44505632|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
44505633|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505634|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
44505635|NCT00243022|Hematinics|hematinics|mesh-ancestor
44505636|NCT00242580|Triamcinolone|triamcinolone|mesh-list
44505637|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44505638|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44505639|NCT00242580|Verteporfin|verteporfin|mesh-list
44505640|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44505641|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505642|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
44505643|NCT00242580|Hormones|hormones|mesh-ancestor
44505644|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505645|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505646|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505647|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
44505648|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505649|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505650|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44505651|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44505652|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
44505653|NCT00242567|Androgens|androgens|mesh-list
44505654|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44505655|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505656|NCT00242567|Hormones|hormones|mesh-ancestor
44505657|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505658|NCT00241644|Vaccines|vaccines|mesh-list
44505659|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
44505660|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505661|NCT00241631|Fluticasone|fluticasone|mesh-list
44505662|NCT00241631|Xhance|xhance|mesh-list
44505663|NCT00241631|Theophylline|theophylline|mesh-list
44505664|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505665|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44505666|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
44505667|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505668|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505669|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44505670|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
44505671|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44505672|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44505674|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505675|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505676|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505677|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44505678|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44505679|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
44505680|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505681|NCT00241358|Plerixafor|plerixafor|mesh-list
44505682|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44505683|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44325115|NCT00955162|Buprenorphine|buprenorphine|mesh-list
44505684|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
44505685|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505687|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44505688|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44505689|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
44505690|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505691|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44505692|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44505693|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505694|NCT00240097|Carboplatin|carboplatin|mesh-list
44505695|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
44505696|NCT00240097|Irinotecan|irinotecan|mesh-list
44505697|NCT00240097|Etoposide|etoposide|mesh-list
44505698|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505699|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44505700|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505701|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505702|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505703|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44505704|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44505705|NCT00240071|Tamoxifen|tamoxifen|mesh-list
44505706|NCT00240071|Bevacizumab|bevacizumab|mesh-list
44505707|NCT00240071|Letrozole|letrozole|mesh-list
44505708|NCT00240071|Exemestane|exemestane|mesh-list
44505709|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505710|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505711|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44505712|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44505713|NCT00240071|Growth Substances|growth substances|mesh-ancestor
44505714|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505715|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
44505716|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44505717|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44505718|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505719|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505720|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44505721|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
44505722|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505723|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44505724|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44505725|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44505726|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44505727|NCT00243867|Paclitaxel|paclitaxel|mesh-list
44505728|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44505729|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505730|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44505731|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44505732|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44505733|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505734|NCT00245037|Cyclosporine|cyclosporine|mesh-list
44505735|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
44505736|NCT00245037|Methotrexate|methotrexate|mesh-list
44505737|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
44505738|NCT00245037|Fludarabine|fludarabine|mesh-list
44505739|NCT00245037|Busulfan|busulfan|mesh-list
44505740|NCT00245037|Phenytoin|phenytoin|mesh-list
44505741|NCT00245037|Cyclosporins|cyclosporins|mesh-list
44505742|NCT00245037|Lenograstim|lenograstim|mesh-list
44505743|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44505744|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
44505745|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44505746|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505747|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44505749|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505750|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505751|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
44505752|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505753|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44505754|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44505755|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
44505756|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505757|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44505758|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
44505759|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505760|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44505761|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44505762|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44505763|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
44505764|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44505765|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
44505766|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44505767|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44505768|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44505769|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
44505770|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44505771|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44505772|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505773|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44505774|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44505775|NCT00241839|Allopurinol|allopurinol|mesh-list
44505776|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
44505777|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
44325267|NCT00956176|Cidofovir|cidofovir|mesh-list
44505778|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505779|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505780|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
44505781|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505782|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44505783|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
44505784|NCT00241839|Protective Agents|protective agents|mesh-ancestor
44505785|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505786|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505787|NCT00241839|Diuretics|diuretics|mesh-ancestor
44505788|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
44505789|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44505790|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505791|NCT00248287|Carboplatin|carboplatin|mesh-list
44505792|NCT00248287|Irinotecan|irinotecan|mesh-list
44505793|NCT00248287|Cetuximab|cetuximab|mesh-list
44505794|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505795|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44505796|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505797|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505798|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505799|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505800|NCT03809013|Trastuzumab|trastuzumab|mesh-list
44505801|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505802|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505803|NCT03807921|Aspirin|aspirin|mesh-list
44505804|NCT03807921|Warfarin|warfarin|mesh-list
44505805|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44505806|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505807|NCT03807921|Analgesics|analgesics|mesh-ancestor
44505808|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
44505809|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505810|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505811|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505812|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44505813|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44505814|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44505815|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505816|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44505817|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44505818|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505819|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
44505820|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
44505821|NCT03809923|Lidocaine|lidocaine|mesh-list
44505822|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
44505823|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
44505824|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
44505825|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505826|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505827|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
44505828|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505829|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44505830|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44505831|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44505832|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505833|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505834|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44505835|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505836|NCT03809923|Analgesics|analgesics|mesh-ancestor
44505837|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44505838|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44505839|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44505840|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505841|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505842|NCT03808961|Vitamins|vitamins|mesh-list
44505843|NCT03808961|Niacin|niacin|mesh-list
44505844|NCT03808961|Niacinamide|niacinamide|mesh-list
44505845|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
44505846|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
44505847|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
44505848|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505849|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44505850|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
44505851|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505852|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44505853|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505854|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
44325336|NCT00956397|Rifaximin|rifaximin|mesh-list
44505855|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505856|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505857|NCT03809637|Cisplatin|cisplatin|mesh-list
44505858|NCT03809637|Pemetrexed|pemetrexed|mesh-list
44505859|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505860|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505861|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505862|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44505863|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44505864|NCT03802071|Doxorubicin|doxorubicin|mesh-list
44505865|NCT03802071|Durvalumab|durvalumab|mesh-list
44505866|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44505867|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44505868|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44505869|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44505870|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44505871|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505872|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44505873|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
44505874|NCT03809884|Diuretics|diuretics|mesh-ancestor
44505875|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
44505876|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505877|NCT03809884|Expectorants|expectorants|mesh-ancestor
44505878|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
44505879|NCT03809793|Acipimox|acipimox|mesh-list
44505880|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44505881|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
44505882|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505883|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44505884|NCT03809702|Pregabalin|pregabalin|mesh-list
44505885|NCT03809702|Analgesics|analgesics|mesh-ancestor
44505886|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
44505887|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961419|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44505888|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505889|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
44505890|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44505891|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44505892|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505893|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44505894|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44505895|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43625189|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
44505896|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505897|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505898|NCT03809650|Macitentan|macitentan|mesh-list
44505899|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44505900|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44505901|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505902|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44505903|NCT03809546|Dronabinol|dronabinol|mesh-list
44505904|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
44505905|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505906|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505907|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44505908|NCT03809546|Analgesics|analgesics|mesh-ancestor
44505909|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
44505910|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505911|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44505912|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44505913|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505914|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505915|NCT03809546|Hormones|hormones|mesh-ancestor
44505916|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44505917|NCT03809312|Amoxicillin|amoxicillin|mesh-list
44505918|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
44505919|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
44505920|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44505921|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505922|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961472|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
44505923|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505924|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44505925|NCT03809455|Fentanyl|fentanyl|mesh-list
44505926|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44505927|NCT03809455|Narcotics|narcotics|mesh-ancestor
44505928|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505929|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505930|NCT03809455|Analgesics|analgesics|mesh-ancestor
44505931|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
44505932|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505933|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44505934|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44505935|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
44505936|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
44505937|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44505938|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44505939|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44505940|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505941|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505942|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44505943|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44505944|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44505945|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
44505946|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505947|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505948|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44505949|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44505950|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
44505951|NCT03809260|Metformin|metformin|mesh-list
44505952|NCT03809260|Vancomycin|vancomycin|mesh-list
44505953|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44505954|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505955|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44505956|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44505957|NCT03809273|Trimetazidine|trimetazidine|mesh-list
44505958|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505959|NCT03809065|Labetalol|labetalol|mesh-list
44505960|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
44505961|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44505962|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44505963|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44505964|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44505965|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44505966|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505967|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505968|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505969|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
44505970|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
44505971|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505972|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44505973|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44505974|NCT03809143|Buprenorphine|buprenorphine|mesh-list
44505975|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44505976|NCT03809143|Narcotics|narcotics|mesh-ancestor
44505977|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505978|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505979|NCT03809143|Analgesics|analgesics|mesh-ancestor
44505980|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
44505981|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44505982|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44505983|NCT03809156|Ambrisentan|ambrisentan|mesh-list
44505984|NCT03809156|Riociguat|riociguat|mesh-list
44505985|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
44505986|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505987|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44505988|NCT03808844|Propofol|propofol|mesh-list
44505989|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44505990|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44505991|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44505992|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44505993|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
44505994|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
44505995|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44505996|NCT03809078|Bombesin|bombesin|mesh-list
44505997|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44505998|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44505999|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506000|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506001|NCT03808805|Aprepitant|aprepitant|mesh-list
44506002|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
44506003|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
44506004|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
44506005|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
44506006|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506007|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506008|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506009|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44506010|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506011|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506012|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
44506013|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44506014|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44506015|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
44506016|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
44506017|NCT03808649|Mannitol|mannitol|mesh-list
44506018|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44506019|NCT03808649|Diuretics|diuretics|mesh-ancestor
44506020|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
44506021|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506022|NCT03808168|Nivolumab|nivolumab|mesh-list
44506023|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506024|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506025|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44506026|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506027|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
44506028|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44506029|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
44506030|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506031|NCT03808259|Ketamine|ketamine|mesh-list
44506032|NCT03808259|Esketamine|esketamine|mesh-list
44506033|NCT03808259|Analgesics|analgesics|mesh-ancestor
44506034|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
44506035|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506036|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506037|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44506038|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506039|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
44506040|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
44506041|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506042|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44506043|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44506044|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506045|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506046|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44506048|NCT03808129|Lidocaine|lidocaine|mesh-list
44506049|NCT03808129|Bupivacaine|bupivacaine|mesh-list
44506050|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506051|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
44506052|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506053|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506054|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
44506055|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506056|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506057|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44506058|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44506059|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506060|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506061|NCT03808155|Tamsulosin|tamsulosin|mesh-list
44506062|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44506063|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44506064|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44506065|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506066|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506067|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506068|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506069|NCT03808155|Urological Agents|urological agents|mesh-ancestor
44506070|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
44506071|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44506072|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
44506073|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506074|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
44506075|NCT03807596|Protective Agents|protective agents|mesh-ancestor
44506076|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
44506077|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
44506078|NCT03807297|Propofol|propofol|mesh-list
44506079|NCT03807297|Sevoflurane|sevoflurane|mesh-list
44506080|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961628|NCT01485393|Zolpidem|zolpidem|mesh-list
44506081|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506082|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506083|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506084|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
44506085|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
44506086|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506087|NCT03807297|Analgesics|analgesics|mesh-ancestor
44506088|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
44506089|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506090|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44506091|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506092|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506093|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506094|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506095|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506096|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44506097|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44506098|NCT03807362|CC-11050|cc-11050|mesh-list
44506099|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44506100|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44506101|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506102|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506103|NCT03807011|Fentanyl|fentanyl|mesh-list
44506104|NCT03807011|Remifentanil|remifentanil|mesh-list
44506105|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506106|NCT03807011|Narcotics|narcotics|mesh-ancestor
44506107|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506108|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506109|NCT03807011|Analgesics|analgesics|mesh-ancestor
44506110|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
44506111|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506112|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44506113|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506114|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
44506115|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
44506116|NCT03806673|Bupivacaine|bupivacaine|mesh-list
44506117|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506118|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
44506119|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506120|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915780|NCT00459732|Zinc|zinc|mesh-list
44506122|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506123|NCT03806595|Lidocaine|lidocaine|mesh-list
44506124|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44506125|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506126|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
44506127|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506128|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506129|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
44506130|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506131|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506132|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44506133|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44506134|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506135|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506136|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
44506137|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506138|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506139|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506140|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506141|NCT03806777|Analgesics|analgesics|mesh-ancestor
44506142|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
44506143|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506144|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44506145|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506146|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506147|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506148|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506149|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506150|NCT03806582|Norepinephrine|norepinephrine|mesh-list
44506151|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506152|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506153|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506154|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506155|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506156|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506157|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
44506158|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
44506159|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506160|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44506161|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
44506162|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506163|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506164|NCT03806062|Domperidone|domperidone|mesh-list
44506165|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
44506166|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
44506167|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506168|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506169|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506170|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44506171|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
44506172|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506173|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506174|NCT03806036|Vitamin D|vitamin d|mesh-list
44506175|NCT03806036|Clomiphene|clomiphene|mesh-list
44506176|NCT03806036|Enclomiphene|enclomiphene|mesh-list
44506177|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
44506178|NCT03806036|Vitamins|vitamins|mesh-ancestor
44506179|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
44506180|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506181|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44506182|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44506183|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
44506184|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506185|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44506186|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
44506187|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44506188|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44506189|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44506190|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
44506191|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506192|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506193|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506194|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506195|NCT03805945|Analgesics|analgesics|mesh-ancestor
44506196|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
44506197|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506198|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44506199|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506200|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506201|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506202|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506203|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506204|NCT03806374|Lidocaine|lidocaine|mesh-list
44506205|NCT03806374|Fentanyl|fentanyl|mesh-list
44506206|NCT03806374|Ketamine|ketamine|mesh-list
44506207|NCT03806374|Propofol|propofol|mesh-list
44506208|NCT03806374|Cisatracurium|cisatracurium|mesh-list
44506209|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506210|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
44506211|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506212|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506213|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
44506214|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506215|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506216|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44506217|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44506218|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506219|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506220|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506221|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506222|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
44506223|NCT03806374|Analgesics|analgesics|mesh-ancestor
44506224|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44506225|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44506226|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44506227|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506228|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506229|NCT03806374|Narcotics|narcotics|mesh-ancestor
44506230|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44506231|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44506232|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44506233|NCT03806049|Paclitaxel|paclitaxel|mesh-list
44506234|NCT03806049|Bevacizumab|bevacizumab|mesh-list
44506235|NCT03806049|Carboplatin|carboplatin|mesh-list
44506236|NCT03806049|Niraparib|niraparib|mesh-list
44506237|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506238|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506239|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506240|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506241|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506242|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506243|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506244|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44506245|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44506246|NCT03806049|Growth Substances|growth substances|mesh-ancestor
44506247|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506248|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44506249|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44506250|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506251|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
44506252|NCT03805568|Remifentanil|remifentanil|mesh-list
44506253|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506254|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506255|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506256|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506257|NCT03805568|Analgesics|analgesics|mesh-ancestor
44506258|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
44506259|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506260|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44506261|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506262|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506263|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506264|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506265|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506266|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506267|NCT03805568|Narcotics|narcotics|mesh-ancestor
44506268|NCT03805633|Pancrelipase|pancrelipase|mesh-list
44506269|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506270|NCT03805282|Lidocaine|lidocaine|mesh-list
44506271|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506272|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
44506273|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506274|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506275|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
44506276|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506277|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506278|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44506279|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44506280|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506281|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506282|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
44506283|NCT03805503|Procaine|procaine|mesh-list
44506284|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506285|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
44506286|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506287|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506288|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
44506289|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506290|NCT03805178|Abatacept|abatacept|mesh-list
44506291|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44506292|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506293|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506294|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44506295|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
44506296|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506297|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506300|NCT03804931|Mesalamine|mesalamine|mesh-list
44506301|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506302|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
44506303|NCT03804931|Hormones|hormones|mesh-ancestor
44506304|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506305|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506306|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44506307|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506308|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44506309|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506310|NCT03804931|Analgesics|analgesics|mesh-ancestor
44506311|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
44506312|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506313|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506314|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
44506315|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506316|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506317|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44506318|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44506319|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44506320|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506321|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506322|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
44506323|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506324|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506325|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44506326|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506327|NCT03804866|Doxorubicin|doxorubicin|mesh-list
44506328|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44506329|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44506330|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506331|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44506332|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44506333|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506334|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506335|NCT03804840|Dronabinol|dronabinol|mesh-list
44506336|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
44506337|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506338|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44506339|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506340|NCT03804840|Analgesics|analgesics|mesh-ancestor
44506341|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
44506342|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506343|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44506344|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44506345|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506346|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506348|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506349|NCT03804749|Suramin|suramin|mesh-list
44506350|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
44506351|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
44506352|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44506353|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506354|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506355|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44506356|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44506357|NCT03804372|Tenofovir|tenofovir|mesh-list
44506358|NCT03804372|Rituximab|rituximab|mesh-list
44506359|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506360|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506361|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
44506362|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506363|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506364|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
44506365|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506366|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44506367|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44506368|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506369|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506370|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44506371|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44506372|NCT03804723|Prednisone|prednisone|mesh-list
44506373|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506374|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
44506375|NCT03804723|Hormones|hormones|mesh-ancestor
44506376|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506377|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506378|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44506379|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506380|NCT03804359|Rituximab|rituximab|mesh-list
44506381|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506382|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506383|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
44506384|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506385|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506386|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44506387|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44506388|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44506389|NCT03804229|Protective Agents|protective agents|mesh-ancestor
44506390|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506391|NCT03803553|Fluorouracil|fluorouracil|mesh-list
44506392|NCT03803553|Nivolumab|nivolumab|mesh-list
44506393|NCT03803553|Irinotecan|irinotecan|mesh-list
44506394|NCT03803553|Cetuximab|cetuximab|mesh-list
44506395|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
44506396|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506397|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44506398|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506399|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44506400|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
44506401|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506402|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506403|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44506404|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44506405|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44506406|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506407|NCT03803787|Budesonide|budesonide|mesh-list
44506408|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506409|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44506410|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
44506411|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506412|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506413|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44506414|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
44506415|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
44506416|NCT03803787|Hormones|hormones|mesh-ancestor
44506417|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506418|NCT03803449|Fentanyl|fentanyl|mesh-list
44506419|NCT03803449|Midazolam|midazolam|mesh-list
44506420|NCT03803449|Propofol|propofol|mesh-list
44506421|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506422|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506423|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506424|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506425|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
44506426|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
44506427|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506428|NCT03803449|Narcotics|narcotics|mesh-ancestor
44506429|NCT03803449|Analgesics|analgesics|mesh-ancestor
44506430|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
44506431|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506432|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44506433|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44506434|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44506435|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44506436|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
44506437|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
44506438|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506439|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506440|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
44506441|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44506442|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506443|NCT03803254|Lenvatinib|lenvatinib|mesh-list
44506444|NCT03803254|Antibodies|antibodies|mesh-list
44506445|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
44506446|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506447|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506448|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44506449|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506450|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506451|NCT03803124|Tolvaptan|tolvaptan|mesh-list
44506452|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44506453|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506454|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
44506455|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506456|NCT03803267|Fentanyl|fentanyl|mesh-list
44506457|NCT03803267|Propofol|propofol|mesh-list
44506458|NCT03803267|Atracurium|atracurium|mesh-list
44506459|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
44506460|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506461|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506462|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506463|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44506464|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
44506465|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506466|NCT03803267|Narcotics|narcotics|mesh-ancestor
44506467|NCT03803267|Analgesics|analgesics|mesh-ancestor
44506468|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
44506469|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506470|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44506471|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44506472|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44506473|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44506474|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44506475|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44506476|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
44506477|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506478|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506479|NCT03803215|Theophylline|theophylline|mesh-list
44506480|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44506481|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
44506482|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506483|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506484|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44506485|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
44506486|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44506487|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506488|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506489|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
44506490|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44506491|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44506492|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
44506493|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506494|NCT03803163|Treprostinil|treprostinil|mesh-list
44506495|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44506496|NCT03802747|Durvalumab|durvalumab|mesh-list
44506497|NCT03802747|Tremelimumab|tremelimumab|mesh-list
44506498|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44506499|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506500|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506501|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
44506502|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506503|NCT03802838|Amisulpride|amisulpride|mesh-list
44506504|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44506505|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44506506|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506507|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506508|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44506509|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44506510|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
44506511|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506512|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506513|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44506514|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
44506515|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
44506516|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44506517|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
44506518|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506519|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506520|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44506521|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
44506522|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506523|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506524|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44506526|NCT03802552|Cefadroxil|cefadroxil|mesh-list
44506527|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506528|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506530|NCT03802318|Rabeprazole|rabeprazole|mesh-list
44506531|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506532|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506533|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44506534|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506535|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44506536|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506537|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506538|NCT03802032|Lidocaine|lidocaine|mesh-list
44506539|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506540|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
44506541|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506542|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506543|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
44506544|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506545|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506546|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44506547|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44506548|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506549|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506550|NCT03802214|Vedolizumab|vedolizumab|mesh-list
44506551|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506552|NCT03802162|Memantine|memantine|mesh-list
44506553|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44506554|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44506555|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
44506556|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506557|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506558|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506559|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44506560|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44506561|NCT03801746|Cyclosporine|cyclosporine|mesh-list
44506562|NCT03801746|Rifampin|rifampin|mesh-list
44506563|NCT03801746|Probenecid|probenecid|mesh-list
44506564|NCT03801746|Cyclosporins|cyclosporins|mesh-list
44506565|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506566|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506567|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44506568|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
44506569|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506570|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
44506571|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506572|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44506573|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506574|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44506575|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44506576|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
44506577|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506578|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
44506579|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44506580|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44506581|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44506582|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44506583|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43962054|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
44506584|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44506585|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44506586|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
44506587|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
44506588|NCT03801746|Renal Agents|renal agents|mesh-ancestor
44506589|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
44506590|NCT03801733|Atorvastatin|atorvastatin|mesh-list
44506591|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44506592|NCT03801733|Simvastatin|simvastatin|mesh-list
44506593|NCT03801733|Pravastatin|pravastatin|mesh-list
44506594|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44506595|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44506596|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
44506597|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506598|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44506599|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44506600|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506601|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506602|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44506604|NCT03801733|Analgesics|analgesics|mesh-ancestor
44506605|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
44506606|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506607|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506608|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506609|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506610|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506611|NCT03801668|Paclitaxel|paclitaxel|mesh-list
44506612|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
44506613|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44506614|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506615|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506616|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506617|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506618|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506619|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506620|NCT03801629|Morphine|morphine|mesh-list
44506621|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44506622|NCT03801629|Narcotics|narcotics|mesh-ancestor
44506623|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506624|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506625|NCT03801629|Analgesics|analgesics|mesh-ancestor
44506626|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
44506627|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506628|NCT03801590|Riboflavin|riboflavin|mesh-list
44506629|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
44506630|NCT03801590|Vitamins|vitamins|mesh-ancestor
44506631|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
44506632|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506633|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44506634|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
44506635|NCT03801759|Adefovir|adefovir|mesh-list
44506636|NCT03801759|Digoxin|digoxin|mesh-list
44506637|NCT03801759|Furosemide|furosemide|mesh-list
44506638|NCT03801759|Diuretics|diuretics|mesh-ancestor
44506639|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
44506640|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506641|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44506642|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506643|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506644|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44506645|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44506646|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506647|NCT03801759|Protective Agents|protective agents|mesh-ancestor
44506649|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506650|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44506651|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44506652|NCT03801499|Lenvatinib|lenvatinib|mesh-list
44506653|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506654|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44506655|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506656|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506657|NCT03801252|Azithromycin|azithromycin|mesh-list
44506658|NCT03801252|Cefazolin|cefazolin|mesh-list
44506659|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506660|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506661|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
44506662|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44506663|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506664|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
44506665|NCT03801226|Calcium|calcium|mesh-list
44506666|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44506667|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506668|NCT03800953|Avelumab|avelumab|mesh-list
44506669|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506670|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506671|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44506672|NCT03800745|Laxatives|laxatives|mesh-ancestor
44506673|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44506674|NCT03800550|Clarithromycin|clarithromycin|mesh-list
44506675|NCT03800550|Bedaquiline|bedaquiline|mesh-list
44506676|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44506677|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506678|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44506679|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506680|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506681|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44506682|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44506683|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
44506684|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
44506685|NCT03800264|Bisoprolol|bisoprolol|mesh-list
44506686|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506687|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44506688|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
44506689|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
44506690|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506691|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506692|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44506693|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44506694|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44506695|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506696|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506697|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506698|NCT03800797|Loxoprofen|loxoprofen|mesh-list
44506699|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44506700|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506701|NCT03800797|Analgesics|analgesics|mesh-ancestor
44506702|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
44506703|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506704|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506705|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506706|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506707|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
44506708|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44506709|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506710|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506711|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44506712|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44506713|NCT03800433|Protective Agents|protective agents|mesh-ancestor
44506714|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506715|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44506716|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44506717|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
44506718|NCT03809767|Antibodies|antibodies|mesh-list
44506721|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506722|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44506723|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44506724|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506725|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506728|NCT03801863|Ropivacaine|ropivacaine|mesh-list
44506729|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
44506730|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
44506731|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506732|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506733|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
44506734|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506735|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
44506736|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44506737|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506738|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506739|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506740|NCT03800641|Analgesics|analgesics|mesh-ancestor
44506741|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
44506742|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506743|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44506744|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44506745|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506746|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506747|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506748|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506749|NCT03806335|Anesthetics|anesthetics|mesh-list
44506750|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506751|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506752|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
44506753|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506754|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44506755|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962208|NCT01504854|Protective Agents|protective agents|mesh-ancestor
44506756|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506757|NCT03800290|Clenbuterol|clenbuterol|mesh-list
44506758|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44506759|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44506760|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
44506761|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506762|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506763|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506764|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44506765|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
44506766|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506767|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44506768|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
44506769|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
44506770|NCT03808818|Nicotine|nicotine|mesh-list
44506771|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44506772|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
44506773|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506774|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506775|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44506776|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44506777|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
44506778|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506779|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506780|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44506781|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
44506782|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506783|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
44506784|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44506785|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44506786|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44506787|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44506788|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506789|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506790|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
44506791|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506792|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506793|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44506794|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506795|NCT03805750|Dronabinol|dronabinol|mesh-list
44506796|NCT03805750|Cannabidiol|cannabidiol|mesh-list
44506797|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
44506798|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
44506799|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506800|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44506801|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506802|NCT03805750|Analgesics|analgesics|mesh-ancestor
44506803|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
44506804|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506805|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44506806|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44506807|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506808|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506809|NCT03805750|Hormones|hormones|mesh-ancestor
44506810|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506811|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44506812|NCT03804268|Pilocarpine|pilocarpine|mesh-list
44506813|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44506814|NCT03804268|Miotics|miotics|mesh-ancestor
44506815|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
44506816|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506817|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506818|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44506819|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44506820|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
44506821|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44506822|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506823|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44506824|NCT03809221|Hormones|hormones|mesh-list
44506825|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44506826|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506827|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506828|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
44506829|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44506830|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
44506831|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44506832|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44506833|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44506834|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506835|NCT03807999|Gemcitabine|gemcitabine|mesh-list
44506836|NCT03807999|Paclitaxel|paclitaxel|mesh-list
44506837|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506838|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506839|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506840|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506841|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506842|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506843|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44506844|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
44506845|NCT03807999|Antiviral Agents|antiviral agents|mesh-ancestor
44506846|NCT03807999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506847|NCT03807999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506848|NCT03807999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44506849|NCT03807999|Immunologic Factors|immunologic factors|mesh-ancestor
44506850|NCT03807999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506851|NCT03805360|Ropivacaine|ropivacaine|mesh-list
44506852|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
44506853|NCT03805360|Anesthetics|anesthetics|mesh-list
44506854|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506855|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506856|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
44506857|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506858|NCT03802565|Tolperisone|tolperisone|mesh-list
44506859|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44506860|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506861|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44506862|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506863|NCT05316428|Ethanol|ethanol|mesh-list
44506864|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44506865|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44506866|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44506867|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506869|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506870|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506871|NCT05310968|Aspirin|aspirin|mesh-list
44506872|NCT05310968|Tirofiban|tirofiban|mesh-list
44506873|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44506874|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506875|NCT05310968|Analgesics|analgesics|mesh-ancestor
44506876|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
44506877|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506878|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506879|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506880|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506881|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44506882|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44506883|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506884|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44506885|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44506886|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506887|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
44506888|NCT05318443|Paclitaxel|paclitaxel|mesh-list
44506889|NCT05318443|Carboplatin|carboplatin|mesh-list
44506890|NCT05318443|Bevacizumab|bevacizumab|mesh-list
44506891|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506892|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506893|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506894|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506895|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506896|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506897|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506898|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44506899|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44506900|NCT05318443|Growth Substances|growth substances|mesh-ancestor
44506901|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506902|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44506903|NCT05318339|Trastuzumab|trastuzumab|mesh-list
44506904|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506905|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506906|NCT05312892|Amlodipine|amlodipine|mesh-list
44506907|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
44506908|NCT05312892|Moxonidine|moxonidine|mesh-list
44506909|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44506910|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44506911|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962356|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
44506912|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44506913|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506914|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
44506915|NCT05313529|Metformin|metformin|mesh-list
44506916|NCT05313529|Liraglutide|liraglutide|mesh-list
44506917|NCT05313529|Empagliflozin|empagliflozin|mesh-list
44506918|NCT05313529|Linagliptin|linagliptin|mesh-list
44506919|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44506920|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506921|NCT05313529|Incretins|incretins|mesh-ancestor
44506922|NCT05313529|Hormones|hormones|mesh-ancestor
44506923|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44506924|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44506925|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506926|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44506927|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
44506928|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506929|NCT05315479|Meloxicam|meloxicam|mesh-list
44506930|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44506931|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44506932|NCT05315479|Analgesics|analgesics|mesh-ancestor
44506933|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
44506934|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44506935|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506936|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44506937|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44506938|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44506939|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44506940|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506941|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506942|NCT05312671|Cisplatin|cisplatin|mesh-list
44506943|NCT05312671|Carboplatin|carboplatin|mesh-list
44506944|NCT05312671|Etoposide|etoposide|mesh-list
44506945|NCT05312671|Atezolizumab|atezolizumab|mesh-list
44506946|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
44506947|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506948|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506949|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44506950|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44506951|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506952|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142654|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
44506953|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
44506954|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44506955|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506956|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506957|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506958|NCT05310344|Paclitaxel|paclitaxel|mesh-list
44506959|NCT05310344|Bevacizumab|bevacizumab|mesh-list
44506960|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44506961|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506962|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506963|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506964|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506965|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506966|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506967|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506968|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44506969|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44506970|NCT05310344|Growth Substances|growth substances|mesh-ancestor
44506971|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506972|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44506973|NCT05310331|Paclitaxel|paclitaxel|mesh-list
44506974|NCT05310331|Antibodies|antibodies|mesh-list
44506975|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44506976|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506977|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
44506978|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
44506979|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
44506980|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506981|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
44506982|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506984|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
44506985|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506986|NCT05310643|Nivolumab|nivolumab|mesh-list
44506987|NCT05310643|Ipilimumab|ipilimumab|mesh-list
44506988|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44506989|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506990|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44506991|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44506992|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
44506993|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44506994|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44506995|NCT05313282|Apatinib|apatinib|mesh-list
44506996|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44506997|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44506998|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44506999|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507000|NCT05318105|Diuretics|diuretics|mesh-list
44507001|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44507002|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
44507003|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507004|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44507005|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507006|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
44507007|NCT05311813|Enoxaparin|enoxaparin|mesh-list
44507008|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
44507009|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44507010|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44507011|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507012|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507013|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507014|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44507015|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
44507016|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44507017|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44507018|NCT05314127|Fluorouracil|fluorouracil|mesh-list
44507019|NCT05314127|Imiquimod|imiquimod|mesh-list
44507020|NCT05314127|Tazarotene|tazarotene|mesh-list
44507021|NCT05314127|Petrolatum|petrolatum|mesh-list
44507022|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
44507023|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507024|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507025|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507026|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507027|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
44507028|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507029|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44507030|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
44507031|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
44507032|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
44507033|NCT05314127|Emollients|emollients|mesh-ancestor
44507034|NCT05319639|Leucovorin|leucovorin|mesh-list
44507035|NCT05319639|Paclitaxel|paclitaxel|mesh-list
44507036|NCT05319639|Fluorouracil|fluorouracil|mesh-list
44507037|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
44507038|NCT05319639|Irinotecan|irinotecan|mesh-list
44507039|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
44507040|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44507041|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507042|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
44507043|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
44507044|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
44507045|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507046|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
44507047|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44507048|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507049|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
44507050|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507051|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44507052|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44507053|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507054|NCT05319639|Antidotes|antidotes|mesh-ancestor
44507055|NCT05319639|Protective Agents|protective agents|mesh-ancestor
44507056|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
44326656|NCT00960635|Vitamins|vitamins|mesh-ancestor
44507057|NCT05319639|Vitamins|vitamins|mesh-ancestor
44507058|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
44507059|NCT05317546|Cannabidiol|cannabidiol|mesh-list
44507061|NCT05312541|Bupivacaine|bupivacaine|mesh-list
44507062|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
44507063|NCT05312541|Anesthetics|anesthetics|mesh-list
44507064|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507065|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507066|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
44507067|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507068|NCT05312398|Irinotecan|irinotecan|mesh-list
44507069|NCT05312398|Cetuximab|cetuximab|mesh-list
44507070|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44507071|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44507072|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44507073|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507074|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507075|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507076|NCT05312294|Vaccines|vaccines|mesh-list
44507077|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
44507078|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507079|NCT05312112|Venetoclax|venetoclax|mesh-list
44507080|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507081|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
44507082|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44507083|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
44507084|NCT05311722|Ketamine|ketamine|mesh-list
44507085|NCT05311722|Tramadol|tramadol|mesh-list
44507086|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44507087|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507088|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507089|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507090|NCT05311722|Analgesics|analgesics|mesh-ancestor
44507091|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
44507092|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507093|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44507094|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44507095|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44507096|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507097|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507098|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507099|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44507100|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44507101|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
44507102|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
44507103|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44507104|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44507105|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44507106|NCT05311722|Narcotics|narcotics|mesh-ancestor
44507107|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44507108|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44507109|NCT05311254|Fosfomycin|fosfomycin|mesh-list
44507110|NCT05311254|Calcium|calcium|mesh-list
44507111|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44507112|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962499|NCT01512251|Vemurafenib|vemurafenib|mesh-list
44507113|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507114|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507115|NCT05311228|Azithromycin|azithromycin|mesh-list
44507116|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507117|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507118|NCT05311189|Trastuzumab|trastuzumab|mesh-list
44507119|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507120|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507121|NCT05310929|Labetalol|labetalol|mesh-list
44507122|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
44507123|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44507124|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44507125|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44507126|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507127|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507128|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507129|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507130|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44507131|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
44326731|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44507132|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
44507133|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507134|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44507135|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44507136|NCT05310591|Nivolumab|nivolumab|mesh-list
44507137|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44507138|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507139|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44507140|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507141|NCT05314569|Fentanyl|fentanyl|mesh-list
44507142|NCT05314569|Midazolam|midazolam|mesh-list
44507143|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
44507144|NCT05314569|Ketamine|ketamine|mesh-list
44507145|NCT05314569|Isoflurane|isoflurane|mesh-list
44507146|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44507147|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44507148|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507149|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44507150|NCT05314569|Analgesics|analgesics|mesh-ancestor
44507151|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
44507152|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507153|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44507154|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44507155|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44507156|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44507157|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507158|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507159|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44507160|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44507161|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
44507162|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
43962558|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
44507163|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44507164|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44507165|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44507166|NCT05314569|Narcotics|narcotics|mesh-ancestor
44507167|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44507168|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44507170|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507171|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
44507172|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
44507173|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44507174|NCT05312151|Psilocybin|psilocybin|mesh-list
44507175|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
44507176|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507177|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44507178|NCT05316493|Megestrol|megestrol|mesh-list
44507179|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
44507180|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
44507181|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
44507182|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44507183|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507184|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44507185|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44507186|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44507187|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44507188|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44507189|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44507190|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507191|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
44507192|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44507193|NCT05311085|Nicotine|nicotine|mesh-list
44507194|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44507195|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
44507196|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44507197|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507198|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44507199|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44507200|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
44507201|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44507202|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44507203|NCT03216733|Sirolimus|sirolimus|mesh-list
44507204|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44507205|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44507206|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44507207|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44507208|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
44507209|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44507210|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
44507211|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44507212|NCT03215940|Dronabinol|dronabinol|mesh-list
44507213|NCT03215940|Cannabidiol|cannabidiol|mesh-list
44507214|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
44507215|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
44731472|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731473|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731474|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731475|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44731476|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731477|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731478|NCT01592032|Vancomycin|vancomycin|mesh-list
44731479|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44731481|NCT01592032|Daptomycin|daptomycin|mesh-list
44731482|NCT01592032|Tigecycline|tigecycline|mesh-list
44731483|NCT01592032|Teicoplanin|teicoplanin|mesh-list
44731484|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
44731485|NCT01592032|Heparin|heparin|mesh-list
44731486|NCT01592032|Calcium heparin|calcium heparin|mesh-list
44731487|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44731488|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
44731489|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44731490|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44731491|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731492|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44731493|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731494|NCT01592136|Ponatinib|ponatinib|mesh-list
44731495|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731496|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44731497|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731498|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731499|NCT01592162|Remifentanil|remifentanil|mesh-list
44731500|NCT01592162|Propofol|propofol|mesh-list
44731501|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44731502|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731503|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731504|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44731505|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
44731506|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
44731507|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44731508|NCT01592162|Narcotics|narcotics|mesh-ancestor
44731509|NCT01592162|Analgesics|analgesics|mesh-ancestor
44731510|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
44731511|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731512|NCT01592201|Olanzapine|olanzapine|mesh-list
44731513|NCT01592201|Risperidone|risperidone|mesh-list
44731514|NCT01592201|Aripiprazole|aripiprazole|mesh-list
44731515|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
44731516|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44731517|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
44731518|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731519|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731520|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731521|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44731522|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731523|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44731524|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44731525|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
44731526|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
44731527|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
44731528|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731529|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731530|NCT01592201|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44731531|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44731532|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731533|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
44731534|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
44731535|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44731536|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44731537|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44731538|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44731539|NCT01592214|Benzocaine|benzocaine|mesh-list
44731540|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731541|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
44731542|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731543|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731544|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
44731545|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731546|NCT01592227|Acetaminophen|acetaminophen|mesh-list
44731547|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44731548|NCT01592227|Analgesics|analgesics|mesh-ancestor
44731549|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
44731550|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731551|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731552|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
44731553|NCT01592253|Sirolimus|sirolimus|mesh-list
44731554|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731555|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731556|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44731557|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731558|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
44731559|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731560|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
44731561|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731562|NCT01592279|Liraglutide|liraglutide|mesh-list
44731563|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731564|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731565|NCT01592279|Incretins|incretins|mesh-ancestor
44731566|NCT01592279|Hormones|hormones|mesh-ancestor
44731567|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731568|NCT01592305|Ritonavir|ritonavir|mesh-list
44731569|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44731570|NCT01592305|Tenofovir|tenofovir|mesh-list
44731571|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44731572|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44731573|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
44731574|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731575|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731576|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44731577|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44731578|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
44731579|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731580|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44731581|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44731582|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44731583|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44731584|NCT01592318|Ritonavir|ritonavir|mesh-list
44731585|NCT01592318|Lactams|lactams|mesh-list
44731586|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44731587|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44731588|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
44731589|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731590|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731591|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44731592|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44731593|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
44731594|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731595|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44731596|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44731597|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731598|NCT01592526|Nicotine|nicotine|mesh-list
44731599|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44731600|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
44731601|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731602|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731603|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44731604|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44731605|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
44731606|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731607|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731608|NCT01592630|Ropivacaine|ropivacaine|mesh-list
44731609|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731610|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
44731611|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731612|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731613|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
44731614|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731615|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
44731616|NCT01592981|Rituximab|rituximab|mesh-list
44731617|NCT01592981|Fludarabine|fludarabine|mesh-list
44731618|NCT01592981|Bortezomib|bortezomib|mesh-list
44731619|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731620|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
44731621|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731622|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731623|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44731624|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
44731625|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731626|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731627|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44731628|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44731629|NCT01593033|Micronutrients|micronutrients|mesh-list
44731630|NCT01593033|Trace Elements|trace elements|mesh-list
44426676|NCT02213094|Vitamins|vitamins|mesh-list
44731631|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731632|NCT01593046|Cabotegravir|cabotegravir|mesh-list
44731633|NCT01593046|Rilpivirine|rilpivirine|mesh-list
44731634|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44731635|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44731636|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731637|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731638|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44731639|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44731640|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
44731641|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731642|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44731643|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44731644|NCT01593124|Imiquimod|imiquimod|mesh-list
44731645|NCT01593124|Nonoxynol|nonoxynol|mesh-list
44731646|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44731647|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
44731648|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731649|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731650|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
44731651|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44731652|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44731653|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44731654|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
44731655|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44731656|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44731657|NCT01593137|Metformin|metformin|mesh-list
44731658|NCT01593137|Liraglutide|liraglutide|mesh-list
44731659|NCT01593137|Glimepiride|glimepiride|mesh-list
44731660|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731661|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731663|NCT01593137|Hormones|hormones|mesh-ancestor
44731664|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731665|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44731666|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731667|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
44731668|NCT01593150|Dabigatran|dabigatran|mesh-list
44731669|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
43701730|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
44731670|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44731671|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44731672|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731673|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731674|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
44731676|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44731677|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44731678|NCT01593163|Analgesics|analgesics|mesh-ancestor
44731679|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
44731680|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731681|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731682|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731683|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731684|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44731685|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731686|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731687|NCT01593280|Morphine|morphine|mesh-list
44731688|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44731689|NCT01593280|Narcotics|narcotics|mesh-ancestor
44731690|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731691|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731692|NCT01593280|Analgesics|analgesics|mesh-ancestor
44731693|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
44731694|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731695|NCT01593293|Pemetrexed|pemetrexed|mesh-list
44731696|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731697|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731698|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731699|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44731700|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44731701|NCT01593306|Paclitaxel|paclitaxel|mesh-list
44731702|NCT01593306|Cisplatin|cisplatin|mesh-list
44731703|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731704|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731705|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731706|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731707|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731708|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731709|NCT01593319|Ropivacaine|ropivacaine|mesh-list
44731710|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731711|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
44731712|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731713|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731714|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
44731715|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731717|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44731718|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731719|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
44731720|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731721|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731722|NCT01593371|Metformin|metformin|mesh-list
44731723|NCT01593371|Pioglitazone|pioglitazone|mesh-list
44731724|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731725|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731726|NCT01593397|Fentanyl|fentanyl|mesh-list
44731727|NCT01593397|Propofol|propofol|mesh-list
44731728|NCT01593397|Anesthetics|anesthetics|mesh-list
44731729|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44731730|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731731|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731732|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44731733|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
44731734|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44731735|NCT01593397|Narcotics|narcotics|mesh-ancestor
44731736|NCT01593397|Analgesics|analgesics|mesh-ancestor
44731737|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
44731738|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731739|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44731740|NCT01593410|Dexamethasone|dexamethasone|mesh-list
44731741|NCT01593410|Lenalidomide|lenalidomide|mesh-list
44731742|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731743|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
44731744|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
44731745|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731746|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731747|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731748|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
44731749|NCT01593410|Hormones|hormones|mesh-ancestor
44731750|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731751|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44731752|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731753|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
44731754|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44731755|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44731756|NCT01593410|Growth Substances|growth substances|mesh-ancestor
44731757|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44731758|NCT01593488|Cytarabine|cytarabine|mesh-list
44731759|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44731760|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
44731761|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731762|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731763|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
44731764|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731765|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731766|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
44731767|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731768|NCT01593501|Vitamin D|vitamin d|mesh-list
44731769|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
44731770|NCT01593501|Vitamins|vitamins|mesh-ancestor
44731771|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
44731772|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731773|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44731774|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44731775|NCT01593514|Lactitol|lactitol|mesh-list
44731776|NCT01593514|Vaccines|vaccines|mesh-list
44731777|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
44731778|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731779|NCT01593514|Cathartics|cathartics|mesh-ancestor
44731780|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731781|NCT01593566|Bupivacaine|bupivacaine|mesh-list
44731782|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731783|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
44731784|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731785|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860528|NCT02965027|Prazosin|prazosin|mesh-list
44731786|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
44731787|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731788|NCT01593605|Resveratrol|resveratrol|mesh-list
44731789|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
44731790|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731791|NCT01593605|Protective Agents|protective agents|mesh-ancestor
44731792|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731793|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731794|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44731795|NCT01593644|Adenosine|adenosine|mesh-list
44731796|NCT01593644|Dipyridamole|dipyridamole|mesh-list
44731797|NCT01593644|Analgesics|analgesics|mesh-ancestor
44731798|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
44731799|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731800|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731801|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44731802|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44731803|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44731804|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
44731805|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
44731806|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731807|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731808|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44731809|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731810|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44731811|NCT01593774|Melatonin|melatonin|mesh-list
44731812|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
44731813|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731814|NCT01593774|Protective Agents|protective agents|mesh-ancestor
44731815|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731816|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731817|NCT01593826|Budesonide|budesonide|mesh-list
44731818|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
44731819|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44731820|NCT01593826|Charcoal|charcoal|mesh-list
44731821|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731822|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44731823|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
44731824|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731825|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731826|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44731827|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
44731828|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
44731829|NCT01593826|Hormones|hormones|mesh-ancestor
44731830|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731831|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44731832|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44731833|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44731834|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44731835|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731836|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731837|NCT01593826|Antidotes|antidotes|mesh-ancestor
44731838|NCT01593826|Protective Agents|protective agents|mesh-ancestor
44731839|NCT01593930|Lidocaine|lidocaine|mesh-list
44731840|NCT01593930|Carticaine|carticaine|mesh-list
44731841|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731842|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
44731843|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731844|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731845|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
44731846|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731847|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44731848|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44731849|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44731850|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731851|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731852|NCT01593995|Mitogens|mitogens|mesh-list
44731853|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731854|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731855|NCT01594047|Ketamine|ketamine|mesh-list
44731856|NCT01594047|Methadone|methadone|mesh-list
44731857|NCT01594047|Analgesics|analgesics|mesh-ancestor
44731858|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
44731859|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731860|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731861|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44731862|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44731863|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
44731864|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
44731865|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731866|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44731867|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44731868|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731869|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731870|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44731871|NCT01594047|Narcotics|narcotics|mesh-ancestor
44731872|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
44731873|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44731874|NCT01594060|Insulin|insulin|mesh-list
44731875|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44731876|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
44731877|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
44731878|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731879|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731880|NCT01594099|Paclitaxel|paclitaxel|mesh-list
44731881|NCT01594099|Cisplatin|cisplatin|mesh-list
44731882|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731883|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731884|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731885|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731886|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731887|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731888|NCT01594177|Paclitaxel|paclitaxel|mesh-list
44731889|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
44731890|NCT01594177|Trastuzumab|trastuzumab|mesh-list
44731891|NCT01594177|Epirubicin|epirubicin|mesh-list
44731892|NCT01594177|Afatinib|afatinib|mesh-list
44731893|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731894|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731895|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731896|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731897|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731898|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731899|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731900|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
44731901|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731902|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731904|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
44731905|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44731906|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44731907|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44731908|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44731909|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44731910|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731911|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44731912|NCT01594229|Rituximab|rituximab|mesh-list
44731913|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44731914|NCT01594229|Venetoclax|venetoclax|mesh-list
44731915|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44731916|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731917|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
44731918|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731919|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731920|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44731921|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
44731922|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731923|NCT01594242|Bortezomib|bortezomib|mesh-list
44731924|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731925|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
44731926|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731927|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731928|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44731929|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44731930|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731931|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731932|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731933|NCT01594268|Everolimus|everolimus|mesh-list
44731934|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731935|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731936|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
44731937|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731939|NCT01594346|Tocopherols|tocopherols|mesh-list
44731940|NCT01594346|Tocotrienols|tocotrienols|mesh-list
44731941|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
44731942|NCT01594346|Vitamins|vitamins|mesh-ancestor
44731943|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
44731944|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731945|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
44731946|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731947|NCT01594346|Protective Agents|protective agents|mesh-ancestor
44731948|NCT01594489|Aminophylline|aminophylline|mesh-list
43963052|NCT01530243|Terazosin|terazosin|mesh-list
44731949|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44731950|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
44731951|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731952|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731953|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44731954|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44731955|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44731956|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44731957|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731958|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731959|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44731960|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44731961|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
44731962|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731963|NCT01594489|Protective Agents|protective agents|mesh-ancestor
44731964|NCT01594502|Dutasteride|dutasteride|mesh-list
44731965|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44731966|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44731967|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731968|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731969|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
44731970|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731971|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731972|NCT01594619|Diltiazem|diltiazem|mesh-list
44731973|NCT01594619|Naloxegol|naloxegol|mesh-list
44731974|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44731975|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44731976|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731977|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731978|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44731979|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731981|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44731982|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
44731983|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731984|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
44731985|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44731986|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44731987|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731988|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
44731989|NCT01594671|Coagulants|coagulants|mesh-ancestor
44731990|NCT01594697|Metformin|metformin|mesh-list
44731991|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731992|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731993|NCT01594775|Oxytocin|oxytocin|mesh-list
44731994|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
44731995|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44731996|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731997|NCT01594866|Dexetimide|dexetimide|mesh-list
44731998|NCT01594866|Citalopram|citalopram|mesh-list
44731999|NCT01594866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44732000|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44732001|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732002|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732003|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732004|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
44732005|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732006|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44732007|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44732008|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44732009|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44732010|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44732011|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
44732012|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
44732013|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732014|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44732015|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44732016|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
44732017|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
44732018|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44732019|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
44732020|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732021|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732022|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44732023|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44732024|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44732025|NCT01594905|Tenofovir|tenofovir|mesh-list
44732026|NCT01594905|Entecavir|entecavir|mesh-list
44732027|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
44732028|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732029|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44732030|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732031|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732032|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732033|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732034|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732035|NCT01594918|Prednisone|prednisone|mesh-list
44732036|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
44732037|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732038|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
44732039|NCT01594918|Hormones|hormones|mesh-ancestor
44732040|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732041|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732042|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44732043|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732044|NCT01594918|Analgesics|analgesics|mesh-ancestor
44732045|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
44732046|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732047|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44732048|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44732049|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732050|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732051|NCT01595009|Everolimus|everolimus|mesh-list
44732052|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732053|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732054|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
44732055|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732056|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
44732057|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
44732058|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732059|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732060|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44732061|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44732062|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44732063|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44732064|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
44732065|NCT01595152|Fesoterodine|fesoterodine|mesh-list
44732066|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44732067|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44732068|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
44732069|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732070|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732071|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732072|NCT01595152|Urological Agents|urological agents|mesh-ancestor
44732073|NCT01595334|Cetrorelix|cetrorelix|mesh-list
44732074|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44732075|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
44732076|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732077|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732078|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
44732079|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732080|NCT01595399|Atropine|atropine|mesh-list
44732081|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44732082|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44732083|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44732084|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
44732085|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732086|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732087|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44732088|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732089|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
44732090|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
44732091|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44732092|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44732093|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
44732094|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732095|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732096|NCT01595425|Esomeprazole|esomeprazole|mesh-list
44732097|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44732098|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732099|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44732100|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732101|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732102|NCT01595594|Doxycycline|doxycycline|mesh-list
44732103|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44732104|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732105|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
44732106|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44732107|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44732108|NCT01595633|Tenofovir|tenofovir|mesh-list
44732109|NCT01595633|Adefovir|adefovir|mesh-list
44732110|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
44732111|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732112|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44732113|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732114|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732115|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732116|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732117|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732118|NCT01595685|Entecavir|entecavir|mesh-list
44732119|NCT01595685|Telbivudine|telbivudine|mesh-list
44732120|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
44732121|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732122|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732123|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732124|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732125|NCT01595724|Dienogest|dienogest|mesh-list
44732126|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44732127|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
44732128|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732129|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732130|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44732131|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44732132|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44732133|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44732134|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44732135|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732136|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44732137|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732138|NCT01595737|Simendan|simendan|mesh-list
44732139|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44732140|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
44732141|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44732142|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44732143|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732144|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732145|NCT01595737|Protective Agents|protective agents|mesh-ancestor
44732146|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732147|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
44732148|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44732149|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44732150|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732151|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
44732152|NCT01595763|Coagulants|coagulants|mesh-ancestor
44732153|NCT01595789|Liraglutide|liraglutide|mesh-list
44732154|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44732155|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732156|NCT01595789|Incretins|incretins|mesh-ancestor
44732158|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732160|NCT01595815|Ionophores|ionophores|mesh-list
44732161|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
44732162|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44732163|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732164|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732165|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732166|NCT01595828|Pitavastatin|pitavastatin|mesh-list
44732167|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44732168|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44732169|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44732170|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
44732171|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732172|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732173|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44732175|NCT01595867|Morphine|morphine|mesh-list
44732176|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44732177|NCT01595867|Narcotics|narcotics|mesh-ancestor
44732178|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732179|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732180|NCT01595867|Analgesics|analgesics|mesh-ancestor
44732181|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
44732182|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732183|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44732184|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44732185|NCT01595880|Metformin|metformin|mesh-list
44732186|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44732187|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732188|NCT01595893|Vitamin D|vitamin d|mesh-list
44732189|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
44732190|NCT01595893|Vitamins|vitamins|mesh-ancestor
44732191|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
44732192|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732193|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44732194|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44732195|NCT01595958|Cyclosporine|cyclosporine|mesh-list
44732196|NCT01595958|Cyclosporins|cyclosporins|mesh-list
44732197|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732198|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732199|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732200|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
44732201|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732202|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
44732203|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732204|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
44732205|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732206|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44732207|NCT01595984|Cyclosporine|cyclosporine|mesh-list
44732208|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
44732209|NCT01595984|Everolimus|everolimus|mesh-list
44732210|NCT01595984|Cyclosporins|cyclosporins|mesh-list
44732211|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732212|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732213|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732214|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
44732215|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732216|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
44732217|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732218|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
44732219|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732220|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44732221|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732222|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44732223|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44732224|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
44732225|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44732226|NCT01596010|Norethindrone|norethindrone|mesh-list
44732227|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
44732228|NCT01596010|Estradiol|estradiol|mesh-list
44732229|NCT01596010|Estrogens|estrogens|mesh-ancestor
44732230|NCT01596010|Hormones|hormones|mesh-ancestor
44732231|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732232|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732233|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44732235|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732236|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44732237|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44732238|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44732239|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44732240|NCT01596075|Cannabidiol|cannabidiol|mesh-list
44732241|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
44732242|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
44732243|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
44732244|NCT01596114|Protective Agents|protective agents|mesh-ancestor
44732245|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732246|NCT01596140|Sirolimus|sirolimus|mesh-list
44732247|NCT01596140|Everolimus|everolimus|mesh-list
44732248|NCT01596140|Vemurafenib|vemurafenib|mesh-list
44732249|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732250|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732251|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
44732252|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732253|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732254|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44732255|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732256|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44732257|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
44732258|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44732259|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732260|NCT01596166|Ketorolac|ketorolac|mesh-list
44732261|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44732262|NCT01596166|Metoclopramide|metoclopramide|mesh-list
44732263|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732264|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732265|NCT01596166|Analgesics|analgesics|mesh-ancestor
44732266|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
44732267|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732268|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732269|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732270|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732271|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44732272|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732273|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732274|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
44732275|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
44732276|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732277|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44732278|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44732279|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
44732280|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732281|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44732282|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44732283|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732284|NCT01596296|Dinoprostone|dinoprostone|mesh-list
44732285|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
44732286|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732287|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732288|NCT01596387|Propofol|propofol|mesh-list
44732289|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44732290|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732291|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732292|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44732293|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
44732294|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
44732295|NCT01596400|Granisetron|granisetron|mesh-list
44732296|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
44732297|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
44732298|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732299|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732300|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732301|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44732302|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
44732303|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732304|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732305|NCT01596413|Granisetron|granisetron|mesh-list
44732306|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
44732307|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
44732308|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732309|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732310|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732311|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44732312|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
44732313|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732314|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732315|NCT01596426|Granisetron|granisetron|mesh-list
44732316|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
44732317|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
44732318|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732319|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732320|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732321|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44732322|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
44732323|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732324|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732325|NCT01596517|Ribavirin|ribavirin|mesh-list
44732326|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44732327|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
44732328|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
44732329|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732330|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
44732331|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732332|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
44732333|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732334|NCT01596556|Nicotine|nicotine|mesh-list
44732335|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44732336|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
44732337|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732338|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732339|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44732340|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44732341|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44732342|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732343|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732344|NCT01596634|Lactoferrin|lactoferrin|mesh-list
44732345|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732346|NCT01596647|Diclofenac|diclofenac|mesh-list
44732347|NCT01596647|Midazolam|midazolam|mesh-list
44732348|NCT01596647|Caffeine|caffeine|mesh-list
44732349|NCT01596647|Omeprazole|omeprazole|mesh-list
44732350|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44732351|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44732352|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732353|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732354|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44732355|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44732356|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44732357|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44732358|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
44732359|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
44732360|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
44732361|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
44732362|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732363|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732364|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44732365|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732366|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44732367|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732368|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44732369|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44732370|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44732371|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44732372|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
44732373|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732374|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732375|NCT01596647|Analgesics|analgesics|mesh-ancestor
44732376|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
44732377|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732378|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732379|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732380|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44732381|NCT01596660|Bupivacaine|bupivacaine|mesh-list
44732382|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
44732383|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
44732384|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732385|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732386|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
44732387|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732388|NCT01596673|Hydrocodone|hydrocodone|mesh-list
44732389|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44732390|NCT01596673|Narcotics|narcotics|mesh-ancestor
44732391|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732392|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732393|NCT01596673|Analgesics|analgesics|mesh-ancestor
44732394|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
44732395|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732396|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
44732397|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732398|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
44732399|NCT01596686|Cathartics|cathartics|mesh-ancestor
44732400|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732401|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
44732402|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44732403|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44732404|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732405|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
44732406|NCT01596738|Coagulants|coagulants|mesh-ancestor
44732407|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
44732408|NCT01596764|Naloxone|naloxone|mesh-list
44732409|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
44732410|NCT01596764|Loperamide|loperamide|mesh-list
44732411|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
44732412|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44732413|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732414|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
44732415|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732416|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732417|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732418|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732419|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732420|NCT01596764|Analgesics|analgesics|mesh-ancestor
44732421|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732422|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732423|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
44732424|NCT01596777|Naltrexone|naltrexone|mesh-list
44732425|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
44732426|NCT01596777|Loperamide|loperamide|mesh-list
44732427|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
44732428|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732429|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732430|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732431|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732432|NCT01596777|Analgesics|analgesics|mesh-ancestor
44732433|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
44732434|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732435|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732436|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732437|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732438|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44732439|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44732440|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
44732441|NCT01596803|Vitamin E|vitamin e|mesh-list
44732442|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
44732443|NCT01596803|Tocopherols|tocopherols|mesh-list
44732444|NCT01596803|Antioxidants|antioxidants|mesh-list
44732445|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732446|NCT01596803|Protective Agents|protective agents|mesh-ancestor
44732447|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732448|NCT01596803|Vitamins|vitamins|mesh-ancestor
44732449|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
44732450|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
44732451|NCT01596855|Hematinics|hematinics|mesh-ancestor
44732452|NCT01596868|Gemcitabine|gemcitabine|mesh-list
44732453|NCT01596868|Cisplatin|cisplatin|mesh-list
44732454|NCT01596868|Docetaxel|docetaxel|mesh-list
44732455|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732456|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44732457|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
44732458|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732459|NCT01596868|Antiviral Agents|antiviral agents|mesh-ancestor
44732460|NCT01596868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732461|NCT01596868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732462|NCT01596868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732463|NCT01596868|Immunologic Factors|immunologic factors|mesh-ancestor
44732464|NCT01596868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732465|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
44732466|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
44732467|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44732468|NCT01596894|Azithromycin|azithromycin|mesh-list
44732469|NCT01596894|Metronidazole|metronidazole|mesh-list
44732470|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44732471|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732472|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44732473|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44732474|NCT01596907|Ephedrine|ephedrine|mesh-list
44732475|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
44732476|NCT01596907|Caffeine|caffeine|mesh-list
44732477|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44732478|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732479|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44732480|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732481|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732482|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44732483|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44732484|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
44732485|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284608|NCT00751699|Mesalamine|mesalamine|mesh-list
44732486|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
44732487|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
44732488|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732489|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44732491|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44732492|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44732493|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732494|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
44732495|NCT01596998|Epinephrine|epinephrine|mesh-list
44732496|NCT01596998|Racepinephrine|racepinephrine|mesh-list
44732497|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
44732498|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
44732499|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44732500|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44732501|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44732502|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732503|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732504|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732505|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44732506|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44732507|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
44732508|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732509|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44732510|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732511|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
44732512|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
44732513|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44732514|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
44732515|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
44732516|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732517|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
44732518|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44732519|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
44732520|NCT01597011|Coagulants|coagulants|mesh-ancestor
44732521|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
44732522|NCT01597167|Analgesics|analgesics|mesh-ancestor
44732523|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
44732524|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732525|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732526|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
44732527|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732528|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44732529|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
44732530|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44732531|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732532|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732533|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44732534|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
44732535|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732537|NCT01597206|Trace Elements|trace elements|mesh-ancestor
44732538|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
44732539|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732540|NCT01597232|Chrysarobin|chrysarobin|mesh-list
44732541|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732542|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732543|NCT01597232|Analgesics|analgesics|mesh-ancestor
44732544|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
44732545|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732546|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732547|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732548|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732549|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
44732550|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44732551|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732552|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732553|NCT01597310|Pramipexole|pramipexole|mesh-list
44732554|NCT01597310|Warfarin|warfarin|mesh-list
44732555|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
44732556|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
44732557|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732558|NCT01597310|Protective Agents|protective agents|mesh-ancestor
44732559|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732560|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44732561|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44732562|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
44732563|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
44732564|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732565|NCT01597336|Plasminogen|plasminogen|mesh-list
44732566|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44732567|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44732568|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44732569|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732570|NCT01597427|Clonidine|clonidine|mesh-list
44732571|NCT01597427|Analgesics|analgesics|mesh-ancestor
44732572|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
44732573|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732574|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732575|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44732576|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
44732577|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
44732578|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44732579|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44732580|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44732581|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
44732582|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732583|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732584|NCT01597518|Riluzole|riluzole|mesh-list
44732585|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
44732586|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44732587|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44732588|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732589|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732590|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732591|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44732592|NCT01597518|Protective Agents|protective agents|mesh-ancestor
44732593|NCT01597531|Liraglutide|liraglutide|mesh-list
44732594|NCT01597531|Orlistat|orlistat|mesh-list
44732595|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44732596|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732597|NCT01597531|Incretins|incretins|mesh-ancestor
44732598|NCT01597531|Hormones|hormones|mesh-ancestor
44732599|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732600|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732601|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732602|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44732603|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44732604|NCT01597609|Sibutramine|sibutramine|mesh-list
44732605|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
44732606|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44732607|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
44732608|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44732609|NCT01597648|Maraviroc|maraviroc|mesh-list
44732610|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44732611|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44732612|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44732613|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732614|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732615|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732617|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732618|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44732619|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44732620|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732621|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732622|NCT01597661|Bupropion|bupropion|mesh-list
44732623|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
44732624|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44732625|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44732626|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44732627|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44732628|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732629|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732630|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
44732631|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732632|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732633|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44732634|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44732635|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732636|NCT01597700|Ezetimibe|ezetimibe|mesh-list
44732637|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44732638|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44732639|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
44732640|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732642|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
44732643|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44732644|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732645|NCT01597726|Misoprostol|misoprostol|mesh-list
44732646|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44732647|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
44732648|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732649|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732650|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44732651|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732652|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
44732653|NCT01597765|Vitamins|vitamins|mesh-list
44732654|NCT01597765|Vitamin E|vitamin e|mesh-list
44732655|NCT01597765|Tocopherols|tocopherols|mesh-list
44732656|NCT01597765|Tocotrienols|tocotrienols|mesh-list
44732657|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
44732658|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
44732659|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44732660|NCT01597765|Deferiprone|deferiprone|mesh-list
44732661|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
44732662|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732663|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
44732664|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732665|NCT01597765|Expectorants|expectorants|mesh-ancestor
44732666|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44732667|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44732668|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
44732669|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732670|NCT01597765|Protective Agents|protective agents|mesh-ancestor
44732671|NCT01597765|Antidotes|antidotes|mesh-ancestor
43963755|NCT01550705|Isoniazid|isoniazid|mesh-list
44732672|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44732673|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
44732674|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
44732675|NCT01597817|Chitosan|chitosan|mesh-list
44732676|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44732677|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44732678|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
44732679|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732680|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44732681|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
44732682|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
44732683|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
44732684|NCT01597817|Coagulants|coagulants|mesh-ancestor
44732685|NCT01597895|Maraviroc|maraviroc|mesh-list
44732686|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44732687|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44732688|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732689|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732690|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732691|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
43861388|NCT02811510|Dronabinol|dronabinol|mesh-list
44732692|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732693|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44732694|NCT01597934|Tenofovir|tenofovir|mesh-list
44732695|NCT01597934|Entecavir|entecavir|mesh-list
44732696|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44732697|NCT01597934|Adefovir|adefovir|mesh-list
44732698|NCT01597934|Lamivudine|lamivudine|mesh-list
44732699|NCT01597934|Telbivudine|telbivudine|mesh-list
44732700|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
44732701|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732702|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44732703|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732704|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732705|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732706|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732707|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732708|NCT01597986|Isavuconazole|isavuconazole|mesh-list
44732709|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44732710|NCT01597986|Norethindrone|norethindrone|mesh-list
44732711|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
44732712|NCT01597986|Norinyl|norinyl|mesh-list
44732713|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
44732714|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
44732715|NCT01597986|Estradiol|estradiol|mesh-list
44732716|NCT01597986|Estrogens|estrogens|mesh-ancestor
44284823|NCT00752479|Cyclosporine|cyclosporine|mesh-list
44732717|NCT01597986|Hormones|hormones|mesh-ancestor
44732718|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732719|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732720|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44732721|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732722|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44732723|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44732724|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44732725|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
44732726|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732727|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44732728|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
44732729|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732730|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732731|NCT01598012|Analgesics|analgesics|mesh-ancestor
44732732|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
44732733|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732734|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732735|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732736|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732737|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44732738|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732739|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732740|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
44732741|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44732742|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
44732743|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44732744|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
44732745|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732746|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732747|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
44732748|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
44732749|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44732750|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
44732751|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44732752|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
44732753|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732754|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732755|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
44732756|NCT01598259|Melatonin|melatonin|mesh-list
44732757|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
44732758|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732759|NCT01598259|Protective Agents|protective agents|mesh-ancestor
44732760|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732761|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732762|NCT01598337|Aspirin|aspirin|mesh-list
44732763|NCT01598337|Tirofiban|tirofiban|mesh-list
44732764|NCT01598337|Clopidogrel|clopidogrel|mesh-list
44732765|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44732766|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44732767|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732769|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
44732770|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732771|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732772|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732773|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732774|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44732775|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44732776|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732777|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44732778|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44732779|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732780|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
44732781|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44732782|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44732783|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44732784|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
44732785|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732786|NCT01598363|Digoxin|digoxin|mesh-list
44732787|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44732788|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44732789|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44732790|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
44732791|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732792|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44732793|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44732794|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732795|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44732796|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44732797|NCT01598363|Protective Agents|protective agents|mesh-ancestor
44732798|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732799|NCT01598402|Amoxicillin|amoxicillin|mesh-list
44732800|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
44732801|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
44732802|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44732803|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732804|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732805|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732806|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44732807|NCT01598441|Iloprost|iloprost|mesh-list
44732808|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44732809|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
44732810|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
44732811|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44732812|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44732813|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44732814|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
44732815|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44732816|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44732817|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44732818|NCT01598558|Rituximab|rituximab|mesh-list
44732819|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44732820|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732821|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
44732822|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732823|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44732824|NCT01598584|Gemcitabine|gemcitabine|mesh-list
44732825|NCT01598584|Mirtazapine|mirtazapine|mesh-list
44732826|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44732827|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
44732828|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732829|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732830|NCT01598584|Antiviral Agents|antiviral agents|mesh-ancestor
44732831|NCT01598584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732832|NCT01598584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732833|NCT01598584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732834|NCT01598584|Immunologic Factors|immunologic factors|mesh-ancestor
44732835|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732836|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44732837|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44732838|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44732839|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
44732840|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
44732841|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732842|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44732843|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44732844|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44732845|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44732846|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44732847|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44732848|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44732849|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44732850|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44732851|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
44732852|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44732853|NCT01598623|Oxytocin|oxytocin|mesh-list
44732854|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
44732855|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44732856|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732857|NCT01598649|Mannitol|mannitol|mesh-list
44732858|NCT01598649|Caseins|caseins|mesh-list
44732859|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44732860|NCT01598649|Diuretics|diuretics|mesh-ancestor
44732861|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
44732862|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732863|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
44732864|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
44732865|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732866|NCT01598675|Methamphetamine|methamphetamine|mesh-list
44732867|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44732868|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732869|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
44732870|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
44732871|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732872|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
44732873|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44732874|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732875|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
44732876|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44732877|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44732878|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44732879|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44732880|NCT01598883|Heparin|heparin|mesh-list
44732881|NCT01598883|Calcium heparin|calcium heparin|mesh-list
44732882|NCT01598883|Antithrombins|antithrombins|mesh-list
44732883|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
44732884|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44732885|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44732886|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732887|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44732888|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44732889|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732890|NCT01598948|Mipomersen|mipomersen|mesh-list
44732891|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44732892|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44732893|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
44732894|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732895|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44732896|NCT01599000|Lumefantrine|lumefantrine|mesh-list
44732897|NCT01599000|Artemether|artemether|mesh-list
44732898|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44732899|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
44732900|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44732901|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44732902|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732903|NCT01599013|Gemcitabine|gemcitabine|mesh-list
44732904|NCT01599013|Carboplatin|carboplatin|mesh-list
44732905|NCT01599013|Vinblastine|vinblastine|mesh-list
44732906|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732907|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44732908|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
44732909|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732910|NCT01599013|Antiviral Agents|antiviral agents|mesh-ancestor
44732911|NCT01599013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732912|NCT01599013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732913|NCT01599013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44732914|NCT01599013|Immunologic Factors|immunologic factors|mesh-ancestor
44732915|NCT01599013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732916|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44732917|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44732918|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44732919|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44732921|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44732922|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732923|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44732924|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44732925|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44732926|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732927|NCT01599117|Udenafil|udenafil|mesh-list
44732928|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44732929|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44732930|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732931|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732932|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44732933|NCT01599130|Entecavir|entecavir|mesh-list
44732934|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
44732935|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732936|NCT01599273|Triamcinolone|triamcinolone|mesh-list
44732937|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732938|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
44732939|NCT01599273|Hormones|hormones|mesh-ancestor
44732940|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732941|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732942|NCT01599312|Cobalt|cobalt|mesh-list
43963999|NCT01560624|Treprostinil|treprostinil|mesh-list
44732943|NCT01599312|Trace Elements|trace elements|mesh-ancestor
44732944|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
44732945|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732946|NCT01599338|Liraglutide|liraglutide|mesh-list
44732947|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44732948|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732949|NCT01599338|Incretins|incretins|mesh-ancestor
44732950|NCT01599338|Hormones|hormones|mesh-ancestor
44732951|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732952|NCT01599364|Ritonavir|ritonavir|mesh-list
44732953|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44732954|NCT01599364|Lamivudine|lamivudine|mesh-list
44732955|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44732956|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44732957|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
44732958|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732959|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732960|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44732961|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44732962|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
44732963|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44732964|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44732965|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44732966|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44732967|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44732968|NCT01599377|Tofacitinib|tofacitinib|mesh-list
44732969|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44732970|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44732971|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732972|NCT05691088|Acetaminophen|acetaminophen|mesh-list
44732973|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44732974|NCT05691088|Analgesics|analgesics|mesh-ancestor
44732975|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
44732976|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732977|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732978|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
44732980|NCT05691010|Carboplatin|carboplatin|mesh-list
44732981|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44732982|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44732983|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44732984|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44732985|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44732986|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44732987|NCT05690984|Dexamethasone|dexamethasone|mesh-list
44732988|NCT05690984|Lenalidomide|lenalidomide|mesh-list
44732989|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44732990|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
44732991|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
44732992|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44732993|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44732994|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44732995|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
44732996|NCT05690984|Hormones|hormones|mesh-ancestor
44732997|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44732998|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44732999|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733000|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
44733001|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44733002|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733003|NCT05690984|Growth Substances|growth substances|mesh-ancestor
44733004|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733005|NCT05690815|Tenofovir|tenofovir|mesh-list
44733006|NCT05690815|Emtricitabine|emtricitabine|mesh-list
44733007|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44733008|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
44733009|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733010|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44733011|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44733012|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733013|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733014|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733015|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733016|NCT05690802|Palonosetron|palonosetron|mesh-list
44733017|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
44733018|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
44733019|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733020|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733021|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733022|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44733023|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44733024|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
44733025|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733026|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733027|NCT05690698|Haloperidol|haloperidol|mesh-list
44733028|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
44733029|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
44733030|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
44733031|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733032|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733033|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733034|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44733035|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44733036|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733037|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44733038|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44733039|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
44733040|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733041|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733042|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44733043|NCT05690646|Ritonavir|ritonavir|mesh-list
44733044|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44733045|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44733046|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44733047|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
44733048|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733049|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733050|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733051|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733052|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
44733053|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733054|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44733055|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44733056|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44733057|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285241|NCT00754351|Gemcitabine|gemcitabine|mesh-list
44733058|NCT05690321|Opium|opium|mesh-list
44733059|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44733060|NCT05690321|Narcotics|narcotics|mesh-ancestor
44733061|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733062|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733063|NCT05690321|Analgesics|analgesics|mesh-ancestor
44733064|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
44733065|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733066|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
44733067|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733068|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
44733069|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
44733070|NCT05690282|Acetaminophen|acetaminophen|mesh-list
44733072|NCT05690282|Gabapentin|gabapentin|mesh-list
44733073|NCT05690282|Bupivacaine|bupivacaine|mesh-list
44733074|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
44733075|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
44733076|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733077|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733078|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
44733079|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733080|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44733081|NCT05690282|Analgesics|analgesics|mesh-ancestor
44733082|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
44733083|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44733084|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733085|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733086|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44733087|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733088|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733089|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
44733090|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44733091|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44733092|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44733093|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44733094|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44733095|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733096|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
44733097|NCT05690204|Colchicine|colchicine|mesh-list
44733098|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
44733099|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733100|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733101|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733102|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733103|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733104|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733105|NCT05690191|Rituximab|rituximab|mesh-list
44733106|NCT05690191|Lenalidomide|lenalidomide|mesh-list
44733107|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733108|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733109|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
44733110|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733111|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733112|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44733113|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733114|NCT05690191|Growth Substances|growth substances|mesh-ancestor
44733115|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733116|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44733117|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44733118|NCT05689983|Budesonide|budesonide|mesh-list
44733119|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
44733120|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733121|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44733122|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
44733123|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733124|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733125|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44733126|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
44733127|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
44733128|NCT05689983|Hormones|hormones|mesh-ancestor
44733129|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733130|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44733131|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44733132|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44733133|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733134|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733135|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733137|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44733138|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44733139|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44733140|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733141|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733142|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
44733143|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44733144|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
44733145|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733146|NCT05689671|Paclitaxel|paclitaxel|mesh-list
44733147|NCT05689671|Cisplatin|cisplatin|mesh-list
44733148|NCT05689671|Carboplatin|carboplatin|mesh-list
44733149|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
44733150|NCT05689671|Pemetrexed|pemetrexed|mesh-list
44733151|NCT05689671|Atezolizumab|atezolizumab|mesh-list
44733152|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733153|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733154|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733155|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733156|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733157|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733158|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733159|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733160|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44733161|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44733162|NCT05689632|Vitamin D|vitamin d|mesh-list
44733163|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
44733164|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
44733165|NCT05689632|Vitamins|vitamins|mesh-list
44733166|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
44733167|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733168|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44733169|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44733170|NCT05689619|Silybin|silybin|mesh-list
44733171|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733172|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733173|NCT05689619|Protective Agents|protective agents|mesh-ancestor
44733174|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733175|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
44733176|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44733177|NCT05689463|Antibodies|antibodies|mesh-list
44733178|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
44733179|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733180|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
44733181|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733182|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733183|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
44733184|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
44733185|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44733186|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44733187|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733188|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733189|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733190|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733191|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
44733192|NCT05689242|Nalbuphine|nalbuphine|mesh-list
44733193|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44733194|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733195|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733196|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44733197|NCT05689242|Analgesics|analgesics|mesh-ancestor
44733198|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
44733199|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733200|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44733201|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44733202|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44733203|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733204|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733205|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733206|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44733207|NCT05689242|Narcotics|narcotics|mesh-ancestor
44733208|NCT05689229|Colistin|colistin|mesh-list
44733209|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44285390|NCT00755053|Miconazole|miconazole|mesh-list
44733212|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44733213|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733214|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733215|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44733216|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44733217|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733218|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733219|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733220|NCT05688046|Growth Substances|growth substances|mesh-ancestor
44733221|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733222|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733223|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44733224|NCT05677295|Imipramine|imipramine|mesh-list
44733225|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44733226|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44733227|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44733228|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733229|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733230|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733231|NCT05677295|Analgesics|analgesics|mesh-ancestor
44733232|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
44733233|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733234|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
44733235|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44733236|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
44733237|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44733238|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44733239|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733240|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
44733241|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44733242|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733243|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733244|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44733245|NCT05658510|Analgesics|analgesics|mesh-ancestor
44733246|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
44733247|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733248|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44733249|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44733250|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44733251|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733252|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733253|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733254|NCT05646563|Eculizumab|eculizumab|mesh-list
44733255|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44733256|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733257|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
44733258|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733259|NCT05639972|Aldesleukin|aldesleukin|mesh-list
44733260|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733261|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733262|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733263|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
44733264|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733265|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44733266|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
44733267|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733268|NCT05618366|Venetoclax|venetoclax|mesh-list
44733269|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733270|NCT05618132|Acetylcholine|acetylcholine|mesh-list
44733271|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44733272|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44733273|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
44733274|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733275|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733276|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733277|NCT05615974|Rituximab|rituximab|mesh-list
44733278|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733279|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733280|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
44733281|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733282|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733283|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
44733284|NCT05610072|Hydromorphone|hydromorphone|mesh-list
44733285|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44733286|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
44733287|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733288|NCT05610072|Expectorants|expectorants|mesh-ancestor
44733289|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44733290|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44733291|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
44733292|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733293|NCT05610072|Protective Agents|protective agents|mesh-ancestor
44426677|NCT02213094|Niacinamide|niacinamide|mesh-list
44733294|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733296|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44285541|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
44733297|NCT05610072|Narcotics|narcotics|mesh-ancestor
44733298|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733299|NCT05610072|Analgesics|analgesics|mesh-ancestor
44733300|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
44733301|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733302|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
44733303|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733304|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44733305|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733306|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733307|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
44733308|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733309|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733310|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44733311|NCT05584657|Amoxicillin|amoxicillin|mesh-list
44733312|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
44733313|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
44733314|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44733316|NCT05584657|Probenecid|probenecid|mesh-list
44733317|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733318|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733319|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44733320|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733321|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733322|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
44733323|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
44733324|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733325|NCT05584657|Renal Agents|renal agents|mesh-ancestor
44733326|NCT05583110|Trastuzumab|trastuzumab|mesh-list
44733327|NCT05583110|Vinorelbine|vinorelbine|mesh-list
44733328|NCT05583110|Tucatinib|tucatinib|mesh-list
44733329|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733330|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733331|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733332|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733333|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733334|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733335|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733336|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44733337|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733338|NCT05574400|Caffeine|caffeine|mesh-list
44733339|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
44733340|NCT05574400|Citric Acid|citric acid|mesh-list
44733341|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
44733342|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
44733343|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44733344|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
44733345|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
44733346|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733347|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43964332|NCT01571557|Dexamethasone|dexamethasone|mesh-list
44733348|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733349|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44733350|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733351|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44733352|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44733353|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
44733354|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733355|NCT05553808|Docetaxel|docetaxel|mesh-list
44733356|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733357|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733358|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733359|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733360|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733361|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44733362|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
44733363|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733364|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44733365|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44733366|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
44733367|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236578|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
44733368|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733369|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44733370|NCT05547542|Carfentanil|carfentanil|mesh-list
44733371|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44733372|NCT05547542|Narcotics|narcotics|mesh-ancestor
44733373|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733374|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733375|NCT05547542|Analgesics|analgesics|mesh-ancestor
44733376|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
44733377|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733378|NCT05540184|Allopurinol|allopurinol|mesh-list
44733379|NCT05540184|Trimetazidine|trimetazidine|mesh-list
44733380|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
44733381|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733382|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733383|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
44733384|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733385|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44733386|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
44733387|NCT05540184|Protective Agents|protective agents|mesh-ancestor
44733388|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733389|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
44733390|NCT05502315|Nivolumab|nivolumab|mesh-list
44733391|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733392|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733393|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44733394|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733395|NCT05500508|Eflornithine|eflornithine|mesh-list
44733396|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733397|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44733398|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44733399|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44733400|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733401|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44733402|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733403|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733404|NCT05493761|Denosumab|denosumab|mesh-list
44733405|NCT05493761|Alendronate|alendronate|mesh-list
44733406|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44733407|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733408|NCT05475483|Bevantolol|bevantolol|mesh-list
44733409|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44733410|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44733411|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44733412|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733413|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733414|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733415|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733416|NCT05473195|Isoniazid|isoniazid|mesh-list
44733417|NCT05473195|Ethionamide|ethionamide|mesh-list
44733418|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
44733419|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733420|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733421|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44733422|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44733423|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
44733424|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733425|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44733426|NCT05455697|Prednisone|prednisone|mesh-list
44733427|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
44733428|NCT05455697|Rituximab|rituximab|mesh-list
44733429|NCT05455697|Doxorubicin|doxorubicin|mesh-list
44733430|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44733431|NCT05455697|Vincristine|vincristine|mesh-list
44733432|NCT05455697|Daunorubicin|daunorubicin|mesh-list
44733433|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
44733434|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733435|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
44733436|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733437|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733438|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733439|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
44733440|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733441|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733442|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44426679|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
44733453|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733454|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733455|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733456|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733457|NCT05442216|Azacitidine|azacitidine|mesh-list
44733458|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733459|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
44733460|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733461|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733462|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733463|NCT05433584|Tirzepatide|tirzepatide|mesh-list
44733464|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44733465|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733466|NCT05433584|Incretins|incretins|mesh-ancestor
44733467|NCT05433584|Hormones|hormones|mesh-ancestor
44733468|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733469|NCT05422053|Insulin|insulin|mesh-list
44733470|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733471|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733472|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44733473|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44733474|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733475|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
44733476|NCT05419505|Coagulants|coagulants|mesh-ancestor
44733477|NCT05414240|Ibudilast|ibudilast|mesh-list
44733478|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44733479|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
44733480|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733481|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733482|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44733483|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44733484|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44733485|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733486|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733487|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44733488|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
44733489|NCT05403502|Insulin|insulin|mesh-list
44733490|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733491|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733492|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
44733493|NCT05400122|Fludarabine|fludarabine|mesh-list
44733494|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
44733495|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733496|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
44733497|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733498|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285750|NCT00756340|Bevacizumab|bevacizumab|mesh-list
44733499|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733500|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
44733501|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733502|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733503|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44733504|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733505|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
44733534|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733535|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733536|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44733537|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44733538|NCT05344911|Remifentanil|remifentanil|mesh-list
44733539|NCT05344911|Alfentanil|alfentanil|mesh-list
44733540|NCT05344911|Propofol|propofol|mesh-list
44733541|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44733542|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733543|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733544|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44733545|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
44733546|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
44733547|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44733548|NCT05344911|Narcotics|narcotics|mesh-ancestor
44733549|NCT05344911|Analgesics|analgesics|mesh-ancestor
44733550|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
44733551|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733552|NCT05344417|Iodine|iodine|mesh-list
44733553|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44733554|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733555|NCT05344417|Trace Elements|trace elements|mesh-ancestor
44733556|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
44733557|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733558|NCT05338021|Vancomycin|vancomycin|mesh-list
44733559|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733560|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733561|NCT05338008|Vancomycin|vancomycin|mesh-list
44733562|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733563|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733564|NCT05281328|Octreotide|octreotide|mesh-list
44733565|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733566|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733567|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733568|NCT05267626|Aldesleukin|aldesleukin|mesh-list
44733569|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733570|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733571|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733572|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
44733573|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733574|NCT05265208|Capecitabine|capecitabine|mesh-list
44733575|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733576|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
44733577|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733578|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733579|NCT05260021|Tirzepatide|tirzepatide|mesh-list
44733580|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733581|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733582|NCT05260021|Incretins|incretins|mesh-ancestor
44733583|NCT05260021|Hormones|hormones|mesh-ancestor
44733584|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733585|NCT05257408|Paclitaxel|paclitaxel|mesh-list
43964525|NCT01578317|Vaccines|vaccines|mesh-list
44733586|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44733587|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733588|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733589|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733590|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733591|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733592|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733593|NCT05251376|Morphine|morphine|mesh-list
44733594|NCT05251376|Methadone|methadone|mesh-list
44236579|NCT00559858|Vitamins|vitamins|mesh-ancestor
44733595|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44733597|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733598|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733599|NCT05251376|Analgesics|analgesics|mesh-ancestor
44733600|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
44733601|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733602|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
44733603|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
44733604|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44733605|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733606|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733607|NCT05191797|Atezolizumab|atezolizumab|mesh-list
44733608|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
44733609|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44733610|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
44733611|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733612|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
44733613|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733614|NCT05191446|Ethanol|ethanol|mesh-list
44733615|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44733616|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733617|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44733618|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733619|NCT05189483|Paclitaxel|paclitaxel|mesh-list
44733620|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44733621|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44733622|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733623|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
44733624|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44733625|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
44733626|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733627|NCT05188820|Cortisone|cortisone|mesh-list
44733628|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733629|NCT05177055|Methamphetamine|methamphetamine|mesh-list
44733630|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44733631|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733632|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
44733633|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
44733634|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733635|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
44733636|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733637|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733638|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733639|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44733640|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44733641|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44733642|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44733643|NCT05156281|Teriflunomide|teriflunomide|mesh-list
44733644|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44733645|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44733646|NCT05156281|Analgesics|analgesics|mesh-ancestor
44733647|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
44733648|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733649|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733650|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733651|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44733652|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733653|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
44733654|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44733655|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
44733656|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733657|NCT05125016|Cemiplimab|cemiplimab|mesh-list
44733658|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733659|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733660|NCT05121974|Azithromycin|azithromycin|mesh-list
44733661|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
44733662|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733663|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733664|NCT05119855|Vaccines|vaccines|mesh-list
44733665|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
44733666|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733667|NCT05115110|Risdiplam|risdiplam|mesh-list
44733668|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44733669|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733670|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733671|NCT05106192|Triamcinolone|triamcinolone|mesh-list
44733672|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44733673|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44733674|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
44733675|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44733676|NCT05106192|Bexarotene|bexarotene|mesh-list
44733677|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44733678|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733679|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
44733680|NCT05106192|Hormones|hormones|mesh-ancestor
44733681|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733682|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733683|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733684|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
44733685|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733686|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733687|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
44733688|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733689|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733690|NCT05090566|Dexamethasone|dexamethasone|mesh-list
44733691|NCT05090566|Lenalidomide|lenalidomide|mesh-list
44733692|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733693|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
44733694|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
44733695|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733696|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733697|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733698|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
44733699|NCT05090566|Hormones|hormones|mesh-ancestor
44733700|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733701|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733702|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733703|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
44733704|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44733705|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733706|NCT05090566|Growth Substances|growth substances|mesh-ancestor
44733707|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733708|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
44733709|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733710|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733711|NCT05065866|Azacitidine|azacitidine|mesh-list
44733713|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733714|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
44733715|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733716|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733717|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733718|NCT05064878|Fenfluramine|fenfluramine|mesh-list
44733719|NCT05064878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44733720|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44733721|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44733722|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733723|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733724|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
44733725|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733726|NCT05063565|Durvalumab|durvalumab|mesh-list
44733727|NCT05063565|Tremelimumab|tremelimumab|mesh-list
44733728|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
44733729|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733730|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733731|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733732|NCT05020236|Dexamethasone|dexamethasone|mesh-list
44733733|NCT05020236|Daratumumab|daratumumab|mesh-list
44733734|NCT05020236|Pomalidomide|pomalidomide|mesh-list
44733735|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733736|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
44733737|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
44733738|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733739|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733740|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733741|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
44733742|NCT05020236|Hormones|hormones|mesh-ancestor
44733743|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733744|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733745|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733762|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733763|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733764|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
44733765|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733766|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44733767|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733768|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
44733769|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733770|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44733771|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44733772|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733774|NCT04994808|Clofarabine|clofarabine|mesh-list
44733775|NCT04994808|Treosulfan|treosulfan|mesh-list
44733776|NCT04994808|Busulfan|busulfan|mesh-list
44733777|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733778|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733779|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
44733780|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733781|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44733782|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
44733783|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733784|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733785|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
44733786|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44733787|NCT04985266|Tamoxifen|tamoxifen|mesh-list
44733788|NCT04985266|Letrozole|letrozole|mesh-list
44733789|NCT04985266|Fulvestrant|fulvestrant|mesh-list
44733790|NCT04985266|Palbociclib|palbociclib|mesh-list
44733791|NCT04985266|Anastrozole|anastrozole|mesh-list
44733792|NCT04985266|Exemestane|exemestane|mesh-list
44733793|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733794|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44733795|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44733796|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964715|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44733797|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733798|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44733799|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
44733800|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733801|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733802|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733803|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44733804|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44733805|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44733806|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44733807|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44286095|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
44733809|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
44733810|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733811|NCT04965077|Antibodies|antibodies|mesh-list
44733812|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44733813|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
44733814|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733815|NCT04950426|Propranolol|propranolol|mesh-list
44733816|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44733817|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44733818|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
44733819|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44733820|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426680|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
44733821|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733822|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44733823|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44733824|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
44733825|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
44733826|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733827|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733828|NCT04925479|Niacinamide|niacinamide|mesh-list
44733829|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
44733830|NCT04925479|Vitamins|vitamins|mesh-ancestor
44733831|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
44733832|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733833|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
44733834|NCT04900792|Temozolomide|temozolomide|mesh-list
44733835|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44733836|NCT04900792|Vitamins|vitamins|mesh-ancestor
44733837|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
44733838|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733839|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44733840|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
44733841|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733842|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733843|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
44733844|NCT04900792|Protective Agents|protective agents|mesh-ancestor
44733845|NCT04900792|Hematinics|hematinics|mesh-ancestor
44733846|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44733847|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44733848|NCT04896320|Tucatinib|tucatinib|mesh-list
44733849|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733850|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44733851|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733852|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733853|NCT04886531|Trastuzumab|trastuzumab|mesh-list
44733854|NCT04886531|Letrozole|letrozole|mesh-list
44733855|NCT04886531|Anastrozole|anastrozole|mesh-list
44733856|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733857|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733858|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44733859|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44733860|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733861|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733862|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44733863|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
43964746|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
44733864|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733865|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733866|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733867|NCT04884815|Prednisolone|prednisolone|mesh-list
44733868|NCT04884815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733869|NCT04884815|Glucocorticoids|glucocorticoids|mesh-ancestor
44733870|NCT04884815|Hormones|hormones|mesh-ancestor
44733871|NCT04884815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733872|NCT04884815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733873|NCT04884815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733874|NCT04884815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733875|NCT04873557|Copper|copper|mesh-list
44733876|NCT04873557|Trace Elements|trace elements|mesh-ancestor
44733877|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
44733878|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733879|NCT04856566|Ethanol|ethanol|mesh-list
44733880|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44733881|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733882|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286175|NCT05427825|Anesthetics|anesthetics|mesh-list
44733883|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733884|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
44733885|NCT04848337|Lenvatinib|lenvatinib|mesh-list
44733886|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44733887|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733888|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44733889|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733890|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733891|NCT04844528|Niacinamide|niacinamide|mesh-list
44733893|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
44733894|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
44733895|NCT04844528|Vitamins|vitamins|mesh-ancestor
44733896|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
44733897|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733898|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44733900|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733901|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44733902|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
44733903|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
44733904|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44733905|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44733906|NCT04826588|Prednisolone|prednisolone|mesh-list
44733907|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
44733908|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44733909|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
44733910|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
44733911|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44733912|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
44733913|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
44733914|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44733915|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733916|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44733917|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
44733918|NCT04826588|Hormones|hormones|mesh-ancestor
44733919|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44733920|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44733921|NCT04826588|Protective Agents|protective agents|mesh-ancestor
44733922|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44733923|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733924|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
44733925|NCT04821622|Talazoparib|talazoparib|mesh-list
44733926|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44733927|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733928|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733929|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733930|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
44733931|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44733932|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733933|NCT04808505|Miglustat|miglustat|mesh-list
44733934|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733935|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733936|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733937|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733938|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
44733939|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733940|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44733941|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44733942|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733943|NCT04789616|Maraviroc|maraviroc|mesh-list
44733944|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44733945|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44733946|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733947|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44733948|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44733949|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
44733950|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733951|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44733952|NCT04785300|Dasatinib|dasatinib|mesh-list
44733953|NCT04785300|Quercetin|quercetin|mesh-list
44733954|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286210|NCT05343156|Dexamethasone|dexamethasone|mesh-list
44733955|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44733956|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733957|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733958|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
44733959|NCT04785300|Protective Agents|protective agents|mesh-ancestor
44733960|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733961|NCT04774094|Ceftazidime|ceftazidime|mesh-list
44733962|NCT04774094|Avibactam|avibactam|mesh-list
44733963|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44733964|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44733965|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44733966|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44733967|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733968|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733969|NCT04753216|Bevacizumab|bevacizumab|mesh-list
44733970|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44733971|NCT04753216|Irinotecan|irinotecan|mesh-list
44733972|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
44733973|NCT04753216|Antibodies|antibodies|mesh-list
44733974|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
44733975|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44733976|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
44733977|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733978|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44733979|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44733980|NCT04753216|Growth Substances|growth substances|mesh-ancestor
44733981|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44733982|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
44733983|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
44733984|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44733985|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44733986|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733987|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733988|NCT04742634|Decitabine|decitabine|mesh-list
44733989|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733990|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
44733991|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733992|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733993|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44733994|NCT04734990|Azacitidine|azacitidine|mesh-list
44733995|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44733996|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
44733997|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44733998|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44733999|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734000|NCT04733118|Trastuzumab|trastuzumab|mesh-list
44734001|NCT04733118|Pertuzumab|pertuzumab|mesh-list
44734002|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44734003|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734004|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734005|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734006|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734007|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734008|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734009|NCT04714619|Letrozole|letrozole|mesh-list
44734010|NCT04714619|Anastrozole|anastrozole|mesh-list
44734011|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734012|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44734013|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734014|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734015|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734016|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734017|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734018|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734019|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734020|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734021|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
44734022|NCT04710628|Lenvatinib|lenvatinib|mesh-list
44734023|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734024|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734025|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44734026|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734027|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734028|NCT04690855|Atezolizumab|atezolizumab|mesh-list
44734029|NCT04690855|Talazoparib|talazoparib|mesh-list
44734030|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734031|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734032|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734033|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734034|NCT04689945|Morphine|morphine|mesh-list
44734035|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44734036|NCT04689945|Narcotics|narcotics|mesh-ancestor
44734037|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734038|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734039|NCT04689945|Analgesics|analgesics|mesh-ancestor
44734040|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
44734041|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734042|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44734043|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
44734044|NCT04670068|Fludarabine|fludarabine|mesh-list
44734046|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
44734047|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734048|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734049|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734050|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
44734051|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734052|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734053|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734054|NCT04658849|Pioglitazone|pioglitazone|mesh-list
44734055|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44734056|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734057|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
44734058|NCT04643574|Fludarabine|fludarabine|mesh-list
44734059|NCT04643574|Interleukin-2|interleukin-2|mesh-list
44734060|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734061|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
44734062|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734063|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734064|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734065|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
44734066|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734067|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734068|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734069|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44734070|NCT04643574|Analgesics|analgesics|mesh-ancestor
44734071|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
44734072|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734073|NCT04633252|Prednisone|prednisone|mesh-list
44734074|NCT04633252|Docetaxel|docetaxel|mesh-list
44734075|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734076|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734077|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734078|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734079|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734080|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734081|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
44734082|NCT04633252|Hormones|hormones|mesh-ancestor
44734083|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734084|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734085|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734086|NCT04603183|Paclitaxel|paclitaxel|mesh-list
44734087|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44734088|NCT04603183|Letrozole|letrozole|mesh-list
44734089|NCT04603183|Fulvestrant|fulvestrant|mesh-list
44734090|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734091|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734092|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734093|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734094|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734095|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734096|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44734097|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734098|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734099|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734100|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734101|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734102|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734103|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734104|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44734105|NCT04583501|Omalizumab|omalizumab|mesh-list
44734106|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44734107|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44734108|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
44734109|NCT04563494|Dexamethasone|dexamethasone|mesh-list
44734110|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734111|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
44734112|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
44734113|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734114|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734115|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734116|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
44734117|NCT04563494|Hormones|hormones|mesh-ancestor
44734118|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734120|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734121|NCT04552288|Benralizumab|benralizumab|mesh-list
44734122|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44734123|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44734124|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
44734125|NCT04546399|Leucovorin|leucovorin|mesh-list
44734126|NCT04546399|Folic Acid|folic acid|mesh-list
44734127|NCT04546399|Cytarabine|cytarabine|mesh-list
44734128|NCT04546399|Dexamethasone|dexamethasone|mesh-list
44734129|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
44734130|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
44734131|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44734132|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44734133|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44734134|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
44734135|NCT04546399|Methotrexate|methotrexate|mesh-list
44734136|NCT04546399|Nivolumab|nivolumab|mesh-list
44734137|NCT04546399|Etoposide|etoposide|mesh-list
44734138|NCT04546399|Vincristine|vincristine|mesh-list
44734139|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
44734140|NCT04546399|Asparaginase|asparaginase|mesh-list
44734141|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
44734142|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
44734143|NCT04546399|Pegaspargase|pegaspargase|mesh-list
44734144|NCT04546399|Thioguanine|thioguanine|mesh-list
44734145|NCT04546399|Blinatumomab|blinatumomab|mesh-list
44734146|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44734147|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
44734148|NCT04546399|Antibodies|antibodies|mesh-list
44734149|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
44734150|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44734151|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44734152|NCT04546399|BB 1101|bb 1101|mesh-list
44734153|NCT04546399|Calcium|calcium|mesh-list
44734154|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
44734155|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
44734156|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734157|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
44734158|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734159|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734160|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734161|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
44734162|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734163|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734164|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734165|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734166|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
44734167|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
44734168|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734169|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734170|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
44734171|NCT04546399|Hormones|hormones|mesh-ancestor
44734172|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734173|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734174|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
44734175|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734176|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44734177|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44734178|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44734179|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
44734180|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44734181|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734182|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
44734183|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
44734184|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44734185|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44734186|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44734187|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734188|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44734189|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44734190|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
44734191|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734192|NCT04546399|Antidotes|antidotes|mesh-ancestor
44734193|NCT04546399|Protective Agents|protective agents|mesh-ancestor
44734194|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
44734195|NCT04546399|Vitamins|vitamins|mesh-ancestor
44734196|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
44734197|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734199|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734200|NCT04546399|Hematinics|hematinics|mesh-ancestor
44734201|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
44734202|NCT04541173|Bevacizumab|bevacizumab|mesh-list
44734203|NCT04541173|Atezolizumab|atezolizumab|mesh-list
44734204|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734205|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734206|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44734207|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44734208|NCT04541173|Growth Substances|growth substances|mesh-ancestor
44734209|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734210|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
44734211|NCT04530747|Metformin|metformin|mesh-list
44734212|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44734213|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734214|NCT04486716|Ofatumumab|ofatumumab|mesh-list
44734215|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734216|NCT04477850|Luspatercept|luspatercept|mesh-list
44734217|NCT04477850|Hematinics|hematinics|mesh-ancestor
44734218|NCT04464174|Gemcitabine|gemcitabine|mesh-list
44734219|NCT04464174|Carboplatin|carboplatin|mesh-list
44734220|NCT04464174|Capecitabine|capecitabine|mesh-list
44734221|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734222|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734223|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
44734224|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734225|NCT04464174|Antiviral Agents|antiviral agents|mesh-ancestor
44734226|NCT04464174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734227|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734228|NCT04464174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734229|NCT04464174|Immunologic Factors|immunologic factors|mesh-ancestor
44734230|NCT04464174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734231|NCT04463498|Methamphetamine|methamphetamine|mesh-list
44734232|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44734233|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734234|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
44734235|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
44734236|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734237|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
44734238|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734239|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734240|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
44734241|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44734242|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44734243|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44734244|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44734245|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
44734246|NCT04456296|Testosterone|testosterone|mesh-list
44734247|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
44734248|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
44734249|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44734250|NCT04456296|Androgens|androgens|mesh-ancestor
44734251|NCT04456296|Hormones|hormones|mesh-ancestor
44734252|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734253|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734254|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734255|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734256|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
44734257|NCT04420598|Trastuzumab|trastuzumab|mesh-list
44734258|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734259|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734260|NCT04408118|Paclitaxel|paclitaxel|mesh-list
44734261|NCT04408118|Atezolizumab|atezolizumab|mesh-list
44734262|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734263|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734264|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734265|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734266|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734267|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734268|NCT04403321|Tacrolimus|tacrolimus|mesh-list
44734269|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734270|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
44734271|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734272|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44734273|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734274|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734276|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734277|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734278|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734279|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734280|NCT04313504|Niraparib|niraparib|mesh-list
44734281|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734282|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734283|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734284|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734285|NCT04265755|Erenumab|erenumab|mesh-list
44734286|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44734287|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734288|NCT04265755|Analgesics|analgesics|mesh-ancestor
44734289|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
44734290|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734291|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734292|NCT04246372|Tofacitinib|tofacitinib|mesh-list
44734293|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44734294|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734295|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734296|NCT04240106|Niraparib|niraparib|mesh-list
44734297|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44734298|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734299|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734300|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734301|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734302|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734303|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734304|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734305|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734306|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734307|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
44734308|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44734309|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44734310|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
44734311|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
44734312|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734313|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734314|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
44734315|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734316|NCT04217278|Cytarabine|cytarabine|mesh-list
44734317|NCT04217278|Fludarabine|fludarabine|mesh-list
44734318|NCT04217278|Busulfan|busulfan|mesh-list
44734319|NCT04217278|Thiotepa|thiotepa|mesh-list
44734320|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734321|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734322|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
44734323|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734324|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734325|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
44734326|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734327|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
44734328|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734329|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
44734330|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734331|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734332|NCT04188548|Trastuzumab|trastuzumab|mesh-list
44734333|NCT04188548|Pertuzumab|pertuzumab|mesh-list
44734334|NCT04188548|Everolimus|everolimus|mesh-list
44734335|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44734336|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734337|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734338|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734339|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
44734340|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734341|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734342|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734343|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734344|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734345|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734346|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734349|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734350|NCT04182334|Protective Agents|protective agents|mesh-ancestor
44734351|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734352|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
44734353|NCT04145349|Vinorelbine|vinorelbine|mesh-list
44734354|NCT04145349|Ramucirumab|ramucirumab|mesh-list
44734355|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734356|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
44734357|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734358|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734359|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734360|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
44734361|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734362|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734363|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734364|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734365|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734366|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734367|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734368|NCT04143724|Luspatercept|luspatercept|mesh-list
44734369|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44734370|NCT04143724|Hematinics|hematinics|mesh-ancestor
44734371|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
44734372|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286690|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
44734374|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44734375|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
44734376|NCT04098250|Erenumab|erenumab|mesh-list
44734377|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44734378|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734379|NCT04098250|Analgesics|analgesics|mesh-ancestor
44734380|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
44734381|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734382|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734383|NCT04003103|Islatravir|islatravir|mesh-list
44734384|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
44734385|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734386|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734387|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734388|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44734389|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44734390|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44734391|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
44734392|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
44734393|NCT04002115|Busulfan|busulfan|mesh-list
44734394|NCT04002115|Fludarabine|fludarabine|mesh-list
44734395|NCT04002115|Clofarabine|clofarabine|mesh-list
44734396|NCT04002115|Tacrolimus|tacrolimus|mesh-list
44734397|NCT04002115|Lenograstim|lenograstim|mesh-list
44734398|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734399|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
44734400|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734401|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734402|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734403|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
44734404|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734405|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734406|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734407|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734408|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
44734409|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44734410|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734411|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44734412|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44734413|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
44734414|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44734415|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734416|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44734417|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
44734418|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44734419|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734420|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734421|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44734422|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
44734423|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734424|NCT03978598|Etonogestrel|etonogestrel|mesh-list
44734425|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44734426|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
44734427|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44734428|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734429|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44734430|NCT03967197|Lidocaine|lidocaine|mesh-list
44734431|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
44734432|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
44734433|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734434|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734435|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
44734436|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734437|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44734438|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44734439|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44734440|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44734441|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734442|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
44734443|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44734444|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44734445|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44286765|NCT02287818|Febuxostat|febuxostat|mesh-list
44734446|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44734447|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734448|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
44734449|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734450|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734451|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44734452|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734453|NCT03935646|Adderall|adderall|mesh-list
44734454|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44734455|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734456|NCT03931551|Trastuzumab|trastuzumab|mesh-list
44734457|NCT03931551|Olaparib|olaparib|mesh-list
44734458|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734459|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734460|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734461|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734462|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734463|NCT03926026|Fluticasone|fluticasone|mesh-list
44734464|NCT03926026|Xhance|xhance|mesh-list
44734465|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734466|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44734467|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
44734468|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734469|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734470|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44734471|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
44734472|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44734473|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44734474|NCT03875573|Durvalumab|durvalumab|mesh-list
44734475|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734476|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734477|NCT03871153|Paclitaxel|paclitaxel|mesh-list
44734478|NCT03871153|Carboplatin|carboplatin|mesh-list
44734479|NCT03871153|Durvalumab|durvalumab|mesh-list
44734480|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734481|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734482|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734483|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734484|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734485|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734486|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734487|NCT03840967|Niraparib|niraparib|mesh-list
44734488|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734489|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734490|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734491|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734492|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
44734493|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734494|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734495|NCT03672630|Azithromycin|azithromycin|mesh-list
44734497|NCT03672630|Ethambutol|ethambutol|mesh-list
44734498|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44734499|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734500|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44734501|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
44734502|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
44734503|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44734504|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734505|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734506|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44734507|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44734508|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44734509|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44734510|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44734511|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44734512|NCT03580044|Aztreonam|aztreonam|mesh-list
44734513|NCT03580044|Avibactam|avibactam|mesh-list
44734514|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44734515|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734516|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44734517|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734518|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734519|NCT03547999|Nivolumab|nivolumab|mesh-list
44734520|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734521|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734522|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44734523|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734524|NCT03536728|Eflornithine|eflornithine|mesh-list
44734525|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734526|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44734527|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44734528|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44734529|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734530|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44734531|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734532|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734533|NCT03519945|Mirikizumab|mirikizumab|mesh-list
43965346|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734534|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44734535|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44734536|NCT03519945|Analgesics|analgesics|mesh-ancestor
44734537|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
44734538|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734539|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734540|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734541|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734542|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44734543|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734544|NCT03517423|Brivaracetam|brivaracetam|mesh-list
44734545|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
44734546|NCT03470675|Ketamine|ketamine|mesh-list
44734547|NCT03470675|Morphine|morphine|mesh-list
44734548|NCT03470675|Analgesics|analgesics|mesh-ancestor
44734549|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
44734550|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734551|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734552|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44734553|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44734554|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
44734555|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
44734556|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734557|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44734558|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44734559|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734560|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734561|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44734562|NCT03470675|Narcotics|narcotics|mesh-ancestor
44734563|NCT03462251|Paclitaxel|paclitaxel|mesh-list
44734564|NCT03462251|Bevacizumab|bevacizumab|mesh-list
44734565|NCT03462251|Capecitabine|capecitabine|mesh-list
44734566|NCT03462251|Fulvestrant|fulvestrant|mesh-list
44734567|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44734568|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734569|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734570|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734571|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734572|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734573|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734574|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734575|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44734576|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44734577|NCT03462251|Growth Substances|growth substances|mesh-ancestor
44734578|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734579|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
44734580|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734581|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
44734582|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734583|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44734584|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734585|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734586|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734587|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734588|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734589|NCT03418038|Vitamins|vitamins|mesh-list
44734590|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
44734591|NCT03418038|Gemcitabine|gemcitabine|mesh-list
44734592|NCT03418038|Cytarabine|cytarabine|mesh-list
44734593|NCT03418038|Dexamethasone|dexamethasone|mesh-list
44734594|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
44734595|NCT03418038|Rituximab|rituximab|mesh-list
44734596|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44734597|NCT03418038|Cisplatin|cisplatin|mesh-list
44734598|NCT03418038|Carboplatin|carboplatin|mesh-list
44734599|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
44734600|NCT03418038|Etoposide|etoposide|mesh-list
44734601|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
44734602|NCT03418038|Ifosfamide|ifosfamide|mesh-list
44734603|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
44734604|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
44734605|NCT03418038|Antibodies|antibodies|mesh-list
44734606|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
43965387|NCT05404919|Tenofovir|tenofovir|mesh-list
44734607|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44734608|NCT03418038|BB 1101|bb 1101|mesh-list
44734609|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
44734610|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734611|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
44734612|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734613|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734614|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734615|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
44734616|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
44734617|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734618|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734619|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
44734620|NCT03418038|Hormones|hormones|mesh-ancestor
44734621|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734622|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734623|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44734624|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734625|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734626|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734627|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
44734628|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
44734629|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734630|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734631|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734632|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44734633|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44734634|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
44734635|NCT03418038|Protective Agents|protective agents|mesh-ancestor
44734636|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734637|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
44734638|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
44734639|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
44734640|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734641|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734642|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734643|NCT03409718|Cimetidine|cimetidine|mesh-list
44734644|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44734645|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734646|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44734647|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
44734649|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734650|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734651|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734652|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44734653|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44734654|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734655|NCT03404778|Cimetidine|cimetidine|mesh-list
44734656|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44734657|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734658|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44734659|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
44734660|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
44734661|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734662|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734663|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734664|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44734665|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44734666|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734667|NCT03392246|Osimertinib|osimertinib|mesh-list
44734668|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734669|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44734670|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734671|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734672|NCT03367689|Olaparib|olaparib|mesh-list
44734673|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44734674|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734675|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734676|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734677|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
43965459|NCT05169112|Leuprolide|leuprolide|mesh-list
44734678|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44734679|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44734680|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734681|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
44734682|NCT03364491|Coagulants|coagulants|mesh-ancestor
44734683|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
44734684|NCT03340766|Blinatumomab|blinatumomab|mesh-list
44734685|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734686|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734688|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44734689|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44734690|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734691|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734692|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734693|NCT03317457|Doxorubicin|doxorubicin|mesh-list
44734694|NCT03317457|Durvalumab|durvalumab|mesh-list
44734695|NCT03317457|Tremelimumab|tremelimumab|mesh-list
44734696|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44734697|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734698|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44734699|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44734700|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734701|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734702|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734703|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
44734704|NCT03294954|Fludarabine|fludarabine|mesh-list
44734705|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734706|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
44734707|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734708|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734709|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44734710|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
44734711|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734712|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734713|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44734714|NCT03274414|Cisplatin|cisplatin|mesh-list
44734715|NCT03274414|Etoposide|etoposide|mesh-list
44734716|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734717|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734718|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44734719|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44734720|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734721|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734722|NCT03272685|Nicotine|nicotine|mesh-list
44734723|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44734724|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
44734725|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734726|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734727|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44734728|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44734729|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
44734730|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734731|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734732|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
44734733|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734734|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734735|NCT03258281|Evolocumab|evolocumab|mesh-list
44734736|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44734737|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44734738|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
44734739|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734740|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44734741|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44734742|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
44734743|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44734745|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734746|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44734747|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44734748|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734749|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734750|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44734751|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
44734752|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734753|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734754|NCT05705492|Olanzapine|olanzapine|mesh-list
44734755|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
44734756|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
44734757|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734758|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734759|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734760|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44734761|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44734762|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734763|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44734764|NCT05705492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44734765|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44734766|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44734767|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734768|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734769|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
44734770|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
44734771|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734772|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734773|NCT05705427|Tenofovir|tenofovir|mesh-list
44734774|NCT05705427|Vaccines|vaccines|mesh-list
44734775|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
44734776|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734777|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
44734778|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734779|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44734780|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44734781|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734782|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734783|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44734784|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44734785|NCT05705388|Liraglutide|liraglutide|mesh-list
44734786|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44734787|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734788|NCT05705388|Incretins|incretins|mesh-ancestor
44734789|NCT05705388|Hormones|hormones|mesh-ancestor
44734790|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734791|NCT05705349|Islatravir|islatravir|mesh-list
44734792|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
44734793|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734794|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734795|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734810|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
44734811|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734826|NCT05705089|Warfarin|warfarin|mesh-list
44734827|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
44734828|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
44734829|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44734830|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
44734831|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44734832|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
44734833|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734834|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734835|NCT05705050|Aminophylline|aminophylline|mesh-list
44734836|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44734837|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
44734838|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734839|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734840|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44734841|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44734842|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44734843|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44734844|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734845|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734846|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44734847|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44734848|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
44734849|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734850|NCT05705050|Protective Agents|protective agents|mesh-ancestor
44734851|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
44734852|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44734853|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
44734854|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44734855|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734856|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734857|NCT05704985|Paclitaxel|paclitaxel|mesh-list
44734858|NCT05704985|Carboplatin|carboplatin|mesh-list
44734859|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
44734860|NCT05704985|Fluorouracil|fluorouracil|mesh-list
44734861|NCT05704985|Capecitabine|capecitabine|mesh-list
44734862|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
44734863|NCT05704985|Nivolumab|nivolumab|mesh-list
44734864|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44734865|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44734866|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734867|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44734868|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44734869|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44734870|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734872|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
44734873|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44734874|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44734875|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
44734876|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734877|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
44734878|NCT05704959|Povidone|povidone|mesh-list
44734879|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
44734880|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
44734881|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44734882|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44734883|NCT05704933|Nivolumab|nivolumab|mesh-list
44734884|NCT05704933|Ipilimumab|ipilimumab|mesh-list
44734885|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734886|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734887|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44734888|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734889|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
44734890|NCT05704894|Hematinics|hematinics|mesh-ancestor
44734891|NCT05704829|Trastuzumab|trastuzumab|mesh-list
44734892|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734893|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734894|NCT05704816|Anesthetics|anesthetics|mesh-list
44734895|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734896|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734897|NCT05704725|Aflibercept|aflibercept|mesh-list
44734898|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44734899|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44734900|NCT05704725|Growth Substances|growth substances|mesh-ancestor
44734901|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734902|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
44734903|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734904|NCT05704673|Morphine|morphine|mesh-list
44734905|NCT05704673|Nalbuphine|nalbuphine|mesh-list
44734906|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44734907|NCT05704673|Narcotics|narcotics|mesh-ancestor
44734908|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734909|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734910|NCT05704673|Analgesics|analgesics|mesh-ancestor
44734911|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
44734912|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734913|NCT05704647|Nivolumab|nivolumab|mesh-list
44734914|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734915|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734916|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44734917|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734918|NCT05704634|Cemiplimab|cemiplimab|mesh-list
44734919|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734920|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734921|NCT05704595|Diuretics|diuretics|mesh-list
44734922|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
44734923|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734924|NCT05704543|Buprenorphine|buprenorphine|mesh-list
44734925|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44734926|NCT05704543|Narcotics|narcotics|mesh-ancestor
44734927|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734928|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734929|NCT05704543|Analgesics|analgesics|mesh-ancestor
44734930|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
44734931|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734932|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44734933|NCT05704400|Rituximab|rituximab|mesh-list
44734934|NCT05704400|Daratumumab|daratumumab|mesh-list
44734935|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44734936|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734937|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
44734938|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734939|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734940|NCT05704374|Pregabalin|pregabalin|mesh-list
44734941|NCT05704374|Analgesics|analgesics|mesh-ancestor
44734942|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
44734943|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734944|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734945|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
44734946|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44734947|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44734948|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734949|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44734950|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44734951|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44734952|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44734953|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44734954|NCT05704166|Pirfenidone|pirfenidone|mesh-list
44734955|NCT05704166|Analgesics|analgesics|mesh-ancestor
44734956|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
44734957|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734958|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734959|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44734960|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44734961|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734962|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44734963|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734964|NCT05704114|Tazarotene|tazarotene|mesh-list
44734965|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
44734966|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
44734967|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
44734968|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44734969|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734970|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44734971|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734972|NCT05704049|Dexamethasone|dexamethasone|mesh-list
44734973|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
44734975|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44734976|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
44734977|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
44734978|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44734979|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734980|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44734981|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
44734982|NCT05704049|Hormones|hormones|mesh-ancestor
44734983|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734984|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44734985|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734986|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44734987|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44734988|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44734989|NCT05704036|Estradiol|estradiol|mesh-list
44734990|NCT05704036|Estrogens|estrogens|mesh-list
44734991|NCT05704036|Progesterone|progesterone|mesh-list
44734992|NCT05704036|Hormones|hormones|mesh-ancestor
44734993|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44734994|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44734995|NCT05704036|Progestins|progestins|mesh-ancestor
44734996|NCT05703997|Atezolizumab|atezolizumab|mesh-list
44734997|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44734998|NCT05703984|Metformin|metformin|mesh-list
44734999|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44735000|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735001|NCT05703971|Atezolizumab|atezolizumab|mesh-list
44735002|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735003|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
44735004|NCT05703854|Fludarabine|fludarabine|mesh-list
44735005|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
44735006|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735007|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
44735008|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735009|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735010|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735011|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
44735012|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735013|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735014|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735015|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735016|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
44735017|NCT05703672|Varenicline|varenicline|mesh-list
44735018|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44735019|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44735020|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
44735021|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735022|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735023|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735024|NCT05703659|Sulfalene|sulfalene|mesh-list
44735025|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735026|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44735027|NCT05703659|Renal Agents|renal agents|mesh-ancestor
44735028|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
44735029|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44735030|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44735031|NCT05703555|Maytansine|maytansine|mesh-list
44735032|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735033|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735034|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735035|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735036|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735037|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735038|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
44735039|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735040|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44735041|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44735042|NCT05703425|Analgesics|analgesics|mesh-ancestor
44735043|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
44735044|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735045|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735046|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44735047|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735048|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44735049|NCT05703373|Micronutrients|micronutrients|mesh-list
44735050|NCT05703373|Trace Elements|trace elements|mesh-list
44735051|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735052|NCT05703074|Niacinamide|niacinamide|mesh-list
44735053|NCT05703074|Niacin|niacin|mesh-list
44735054|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
44735055|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
44735056|NCT05703074|Vitamins|vitamins|mesh-ancestor
44735057|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
44735058|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735059|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44735060|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
44735061|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735062|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44735063|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
44735064|NCT05702190|Opium|opium|mesh-list
44735065|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44735066|NCT05702190|Narcotics|narcotics|mesh-ancestor
44735067|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44735068|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735069|NCT05702190|Analgesics|analgesics|mesh-ancestor
44735070|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
44735071|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735072|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
44735073|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44735074|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
44735075|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44735076|NCT05701124|Ranibizumab|ranibizumab|mesh-list
44735077|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44735078|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44735079|NCT05701124|Growth Substances|growth substances|mesh-ancestor
44735080|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735081|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
44735082|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735083|NCT05700422|Varenicline|varenicline|mesh-list
44735084|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44735085|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44735086|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
44735087|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735088|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735089|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735090|NCT05692869|Propranolol|propranolol|mesh-list
44735091|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
44735092|NCT05692869|Ephedrine|ephedrine|mesh-list
44735093|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44735094|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44735095|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
44735096|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735097|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735098|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735100|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44735101|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
44735102|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44735103|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
44735104|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735105|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44735106|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
44735107|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
44735108|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44735109|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44735110|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
44735114|NCT05688085|Amlodipine|amlodipine|mesh-list
44735115|NCT05688085|Irbesartan|irbesartan|mesh-list
44735116|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44735117|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44735118|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44735119|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735120|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44735121|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735122|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
44735123|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44735124|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44735125|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44735126|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735127|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735140|NCT05647551|Lidocaine|lidocaine|mesh-list
44735141|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44735142|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
44735143|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
44735144|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44735145|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735146|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
44735147|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735148|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44735149|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44735150|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44735151|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44735152|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735153|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44735154|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44735155|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44735156|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735157|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
44735158|NCT05645380|Carboplatin|carboplatin|mesh-list
44735159|NCT05645380|Docetaxel|docetaxel|mesh-list
44735160|NCT05645380|Doxorubicin|doxorubicin|mesh-list
44735161|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
44735162|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735163|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
44735164|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735165|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735166|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735167|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
44735168|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735169|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735170|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735171|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735176|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735177|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735178|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735183|NCT05641246|Diclofenac|diclofenac|mesh-list
44735184|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44735185|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44735186|NCT05641246|Analgesics|analgesics|mesh-ancestor
44735187|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
44735188|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735189|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735190|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44735191|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735192|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44287397|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468556|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
44468557|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468558|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468560|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44468561|NCT01435577|Narcotics|narcotics|mesh-ancestor
44468562|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468563|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468564|NCT01435577|Analgesics|analgesics|mesh-ancestor
44468565|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
44468566|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468567|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44468568|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468569|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468570|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468571|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468572|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468573|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44468574|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44468575|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468576|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44468577|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44468578|NCT01435460|Analgesics|analgesics|mesh-ancestor
44468579|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
44468580|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468581|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468582|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468583|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468584|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44468585|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44468586|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
44468587|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
44468588|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468589|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468590|NCT01435382|Bococizumab|bococizumab|mesh-list
44468591|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44468592|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44468593|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
44468594|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468595|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44468596|NCT01435122|Axitinib|axitinib|mesh-list
44468597|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468598|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44468599|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468600|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468601|NCT01435018|Tenofovir|tenofovir|mesh-list
44468602|NCT01435018|Emtricitabine|emtricitabine|mesh-list
44468603|NCT01435018|Efavirenz|efavirenz|mesh-list
44468604|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44468605|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44468606|NCT01435018|Paclitaxel|paclitaxel|mesh-list
44468607|NCT01435018|Etoposide|etoposide|mesh-list
44468608|NCT01435018|Vincristine|vincristine|mesh-list
44468609|NCT01435018|Bleomycin|bleomycin|mesh-list
44468610|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44468611|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468612|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44468613|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44468614|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44468615|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468616|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44468617|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44468618|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468619|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
44468620|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468621|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44468622|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44468623|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44468624|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44468625|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44468626|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44464363|NCT01496807|Ipilimumab|ipilimumab|mesh-list
44468627|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44468628|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44468629|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44468630|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44468631|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44468632|NCT01433991|Lenvatinib|lenvatinib|mesh-list
44468633|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468634|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44468635|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965943|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468636|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468637|NCT01433978|Maleic acid|maleic acid|mesh-list
44468638|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468639|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468640|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44468641|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
44468642|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468643|NCT01433055|Minocycline|minocycline|mesh-list
44468644|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44468645|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468646|NCT01432938|Dulaglutide|dulaglutide|mesh-list
44468647|NCT01432938|Warfarin|warfarin|mesh-list
44468648|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
44468649|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468650|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468651|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44468652|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468653|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468654|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468655|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44468656|NCT01432600|Dexamethasone|dexamethasone|mesh-list
44468657|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
44468658|NCT01432600|Pomalidomide|pomalidomide|mesh-list
44468659|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44468660|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
44468661|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468662|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468663|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44468664|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
44468665|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468666|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468667|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44468668|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468669|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
44468670|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
44468671|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468672|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44468673|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
44468674|NCT01432600|Hormones|hormones|mesh-ancestor
44468675|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468676|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44468677|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44468678|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44468679|NCT01432600|Growth Substances|growth substances|mesh-ancestor
44468680|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
44468681|NCT01432574|Vaccines|vaccines|mesh-list
44468683|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468684|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44468685|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44468686|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468687|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468688|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468689|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468690|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468691|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468692|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468693|NCT01432444|Aripiprazole|aripiprazole|mesh-list
44468694|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468695|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468696|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468697|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468698|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468699|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468700|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
44287474|NCT00763165|Triclosan|triclosan|mesh-list
44468701|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
44468702|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468703|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468704|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44468705|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44468706|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
44468707|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44468708|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44468709|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44468710|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44468711|NCT01432275|Insulin|insulin|mesh-list
44468712|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468713|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468714|NCT01432262|Vaccines|vaccines|mesh-list
44468715|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44468716|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
44468717|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468718|NCT01432171|Lacosamide|lacosamide|mesh-list
44468719|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
44468720|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44468721|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44468722|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468723|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468724|NCT01431976|Lamotrigine|lamotrigine|mesh-list
44468725|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
44468726|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44468727|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468728|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468729|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468730|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468731|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468732|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468733|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468734|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468735|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44468736|NCT01431963|Lamotrigine|lamotrigine|mesh-list
44468737|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
44468738|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44468739|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468740|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468741|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468742|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468743|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468744|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468745|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468746|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468747|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44468748|NCT01431950|Fluticasone|fluticasone|mesh-list
44468749|NCT01431950|Xhance|xhance|mesh-list
44468750|NCT01431950|Albuterol|albuterol|mesh-list
44468751|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468752|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468753|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
44468754|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468755|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468756|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468757|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468758|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468759|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468760|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
44468761|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44468762|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43966072|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468763|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44468764|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468765|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468766|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468767|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468768|NCT01431716|Epoprostenol|epoprostenol|mesh-list
44468769|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44468770|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44468771|NCT01431521|Pioglitazone|pioglitazone|mesh-list
44468772|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468773|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468774|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
44468776|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468777|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
44468778|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468779|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468780|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468781|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468782|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
44468783|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44468784|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
44468785|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468786|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468787|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
44468788|NCT01431274|Olodaterol|olodaterol|mesh-list
44468789|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468790|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
44468791|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468792|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468793|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468794|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468795|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
44468796|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44468797|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
44468798|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468799|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468800|NCT01430611|Vaccines|vaccines|mesh-list
44468801|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
44468802|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468803|NCT01430585|Letrozole|letrozole|mesh-list
44468804|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468805|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44468806|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44468807|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468808|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468809|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44468810|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
44468811|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468812|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468813|NCT01430559|Meloxicam|meloxicam|mesh-list
44468814|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44468815|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44468816|NCT01430559|Analgesics|analgesics|mesh-ancestor
44468817|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
44468818|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468819|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468820|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468821|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468822|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43966140|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
44468823|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44468824|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468825|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468826|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
44468827|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468829|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44468830|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468831|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468832|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44468833|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468834|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468835|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468836|NCT01430403|Fluticasone|fluticasone|mesh-list
44468837|NCT01430403|Xhance|xhance|mesh-list
44468838|NCT01430403|Omalizumab|omalizumab|mesh-list
44468839|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44468840|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468841|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468842|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
44468843|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468844|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468845|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468846|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468847|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468848|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468849|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
44468850|NCT01430104|Teriparatide|teriparatide|mesh-list
44468851|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468852|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468853|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44468854|NCT01429792|Ribavirin|ribavirin|mesh-list
44468855|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44468856|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
44468857|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468858|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
44468859|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468860|NCT01429584|Bupivacaine|bupivacaine|mesh-list
44468861|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
44468862|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
44468863|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468864|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468865|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
44468866|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468867|NCT01429298|Hydromorphone|hydromorphone|mesh-list
44468868|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44468869|NCT01429298|Narcotics|narcotics|mesh-ancestor
44468870|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468871|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468872|NCT01429298|Analgesics|analgesics|mesh-ancestor
44468873|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
44468874|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468875|NCT01429285|Hydromorphone|hydromorphone|mesh-list
44468876|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44468877|NCT01429285|Narcotics|narcotics|mesh-ancestor
44468878|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468879|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468880|NCT01429285|Analgesics|analgesics|mesh-ancestor
44468881|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
44468882|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468883|NCT01429077|Levodopa|levodopa|mesh-list
44468884|NCT01429077|Carbidopa|carbidopa|mesh-list
44468885|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44468886|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44468887|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
44468888|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468889|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468890|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468891|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44468892|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468893|NCT01429051|Fentanyl|fentanyl|mesh-list
44468894|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44468895|NCT01429051|Narcotics|narcotics|mesh-ancestor
44468896|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468897|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468898|NCT01429051|Analgesics|analgesics|mesh-ancestor
44468899|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
44468900|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468901|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44468902|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44468904|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
44468905|NCT01428882|Midazolam|midazolam|mesh-list
44468906|NCT01428882|Propofol|propofol|mesh-list
44468907|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44468908|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468909|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468910|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44468911|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
44468912|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
44468913|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44468914|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44468915|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468916|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468917|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
44468918|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
44468919|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468920|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468921|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
44468922|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
44468923|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
44287704|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
44468924|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44468925|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44468926|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44468927|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468928|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
44468929|NCT01428713|Coagulants|coagulants|mesh-ancestor
44468930|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44468931|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468932|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44468933|NCT01428583|Naltrexone|naltrexone|mesh-list
44468934|NCT01428583|Oxycodone|oxycodone|mesh-list
44468935|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44468936|NCT01428583|Narcotics|narcotics|mesh-ancestor
44468937|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468938|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468939|NCT01428583|Analgesics|analgesics|mesh-ancestor
44468940|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
44468941|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468942|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44468943|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44468944|NCT01428258|Coal Tar|coal tar|mesh-list
43966193|NCT05029921|Ustekinumab|ustekinumab|mesh-list
44468945|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
44468946|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468947|NCT01428193|Flutamide|flutamide|mesh-list
44468948|NCT01428193|Estradiol|estradiol|mesh-list
44468949|NCT01428193|Progesterone|progesterone|mesh-list
44468950|NCT01428193|Estrogens|estrogens|mesh-ancestor
44468951|NCT01428193|Hormones|hormones|mesh-ancestor
44468952|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468953|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468954|NCT01428193|Progestins|progestins|mesh-ancestor
44468955|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
44468956|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44468957|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44468958|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468959|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
44468960|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468961|NCT01428076|Polidocanol|polidocanol|mesh-list
44468962|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44468963|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44468964|NCT01428063|Interferons|interferons|mesh-list
44468965|NCT01428063|Ribavirin|ribavirin|mesh-list
44468966|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
44468967|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
44468968|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44468969|NCT01428063|Asunaprevir|asunaprevir|mesh-list
44468970|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468971|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
44468972|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468973|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
44468974|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468975|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
44468976|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468977|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
44468978|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468979|NCT01427972|Eplerenone|eplerenone|mesh-list
44468980|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44468982|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468983|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468984|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44468985|NCT01427972|Diuretics|diuretics|mesh-ancestor
44468986|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
44468987|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44468988|NCT01427933|Ramucirumab|ramucirumab|mesh-list
44468989|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468990|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
44468991|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
44468992|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44468993|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468994|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468995|NCT01427907|Calcium|calcium|mesh-list
44468996|NCT01427907|Sevelamer|sevelamer|mesh-list
44468997|NCT01427907|Calcium acetate|calcium acetate|mesh-list
44468998|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468999|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469000|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
44469001|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
44287775|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44469002|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469003|NCT01427803|Naproxen|naproxen|mesh-list
44469004|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469005|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469006|NCT01427803|Analgesics|analgesics|mesh-ancestor
44469007|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
44469008|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469009|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469010|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469011|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469012|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
44469013|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44469014|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469015|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469016|NCT01427751|Dexamethasone|dexamethasone|mesh-list
44469017|NCT01427751|Ranibizumab|ranibizumab|mesh-list
44469018|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469019|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
44469020|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
44469021|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469022|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469023|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469024|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
44469025|NCT01427751|Hormones|hormones|mesh-ancestor
44469026|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469027|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44469028|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469029|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44469030|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44469031|NCT01427751|Growth Substances|growth substances|mesh-ancestor
44469032|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
44469033|NCT01427738|Nystatin|nystatin|mesh-list
44469034|NCT01427738|Gentian Violet|gentian violet|mesh-list
44469035|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44469036|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469037|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
44469038|NCT01427738|Ionophores|ionophores|mesh-ancestor
44469039|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469040|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469041|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44469042|NCT01427608|Olanzapine|olanzapine|mesh-list
44469043|NCT01427608|Sertraline|sertraline|mesh-list
44469044|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
44469045|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
44469046|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469047|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469048|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469049|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469050|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469051|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469052|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469053|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44469054|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44469055|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469056|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469057|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469058|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
44469059|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469060|NCT01427309|Vaccines|vaccines|mesh-list
44469061|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
44469062|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469063|NCT01426958|Ritonavir|ritonavir|mesh-list
44469064|NCT01426958|Afatinib|afatinib|mesh-list
44469065|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44469066|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44469067|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
44469068|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469069|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469070|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44469071|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44469072|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
44469073|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469074|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44469075|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44469076|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469077|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44469078|NCT01426854|Nepafenac|nepafenac|mesh-list
44469079|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44469080|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44469081|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469082|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469083|NCT01426854|Analgesics|analgesics|mesh-ancestor
44469084|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
44469085|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469086|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469087|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469088|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469089|NCT01426438|Aspirin|aspirin|mesh-list
44469090|NCT01426438|Niacin|niacin|mesh-list
44469091|NCT01426438|Fenofibrate|fenofibrate|mesh-list
44469092|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469093|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469094|NCT01426438|Analgesics|analgesics|mesh-ancestor
44469095|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
44469096|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469097|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469098|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469099|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469100|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44469101|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44469102|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469103|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44469104|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44469105|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469106|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
44469107|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44469108|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
44469109|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44469110|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
44469111|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
44469112|NCT01426438|Vitamins|vitamins|mesh-ancestor
44469113|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
44469114|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44469115|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
44469116|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469117|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
44469118|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44469119|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469120|NCT01426347|Vitamin D|vitamin d|mesh-list
44469121|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
44469122|NCT01426347|Vitamins|vitamins|mesh-ancestor
44469123|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
44469124|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469125|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44469126|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44469127|NCT01426269|Metronidazole|metronidazole|mesh-list
44469128|NCT01426269|Doxycycline|doxycycline|mesh-list
44469129|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469130|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44735208|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287932|NCT00765427|Protective Agents|protective agents|mesh-ancestor
44735209|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735210|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735211|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
44469135|NCT01426113|Bimatoprost|bimatoprost|mesh-list
44469136|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44469137|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44469138|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44469139|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44469140|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469141|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469142|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469143|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469144|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44469145|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44469146|NCT01426009|Bromides|bromides|mesh-list
44469147|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
44469148|NCT01426009|Ipratropium|ipratropium|mesh-list
44469149|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44469150|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
44469151|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469152|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469153|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44469154|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469155|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
44469156|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44469157|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
44469158|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469159|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469160|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
44469161|NCT01425801|Albuterol|albuterol|mesh-list
44469162|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44469163|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
44469164|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469165|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469166|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44469167|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469168|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
44469169|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469170|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44469171|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44469172|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44469173|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469174|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469175|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469176|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
44469177|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44469178|NCT01425463|Glycine|glycine|mesh-list
44469179|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
44469180|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469181|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469182|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469183|NCT01425359|Ranolazine|ranolazine|mesh-list
44469184|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44469185|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469186|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469187|NCT01425281|Everolimus|everolimus|mesh-list
44469188|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469189|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469190|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
44469191|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469192|NCT01425203|Ribavirin|ribavirin|mesh-list
44469193|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44469194|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
44469195|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469196|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
44469197|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469198|NCT01424930|Prednisone|prednisone|mesh-list
44469199|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469200|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
44469201|NCT01424930|Hormones|hormones|mesh-ancestor
44469202|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469203|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469204|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44469205|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469206|NCT01424813|Albuterol|albuterol|mesh-list
44469207|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44469208|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
44469209|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469210|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469211|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44469212|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469213|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
44469214|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469215|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44469216|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44469217|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44469218|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469219|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469220|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469221|NCT01424644|Vaccines|vaccines|mesh-list
44469222|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
44469223|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469224|NCT01424566|Nabiximols|nabiximols|mesh-list
44469225|NCT01424566|Analgesics|analgesics|mesh-ancestor
44469226|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
44469227|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469228|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469229|NCT01424228|Prucalopride|prucalopride|mesh-list
44469230|NCT01424228|Laxatives|laxatives|mesh-ancestor
44469231|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469232|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44469233|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469234|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
44469235|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469236|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469237|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469238|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
44469239|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44469240|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469241|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44469242|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44469243|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469244|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469245|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469246|NCT01423812|Ritonavir|ritonavir|mesh-list
44469247|NCT01423812|Darunavir|darunavir|mesh-list
44469248|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44469249|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44469250|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
44469251|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469252|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469253|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44469254|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44469255|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
44469256|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469257|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44469258|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44469259|NCT01423604|Capecitabine|capecitabine|mesh-list
44469260|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44469262|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469263|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469264|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44469265|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469266|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469267|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469268|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469269|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469270|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44469271|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44469272|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44469273|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469274|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469275|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469276|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469277|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469278|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
44469279|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469280|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469281|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
44469282|NCT01422915|Colestipol|colestipol|mesh-list
44469283|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44469284|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
44469285|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469286|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44469287|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
44469288|NCT01422876|Linagliptin|linagliptin|mesh-list
44469289|NCT01422876|Empagliflozin|empagliflozin|mesh-list
44469290|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44469291|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469292|NCT01422876|Incretins|incretins|mesh-ancestor
44469293|NCT01422876|Hormones|hormones|mesh-ancestor
44469294|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469295|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44469296|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
44469297|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469298|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469299|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44469300|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44469301|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
44469302|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44469303|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44469304|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469305|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469306|NCT01422538|Mannitol|mannitol|mesh-list
44469307|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44469308|NCT01422538|Diuretics|diuretics|mesh-ancestor
44469309|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
44469310|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469311|NCT01422408|Fluocinonide|fluocinonide|mesh-list
44469312|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469313|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
44469314|NCT01422408|Hormones|hormones|mesh-ancestor
44469315|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469316|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469317|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44469318|NCT01422382|Diltiazem|diltiazem|mesh-list
44469319|NCT01422382|Pitavastatin|pitavastatin|mesh-list
44469320|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44469321|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44469322|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469323|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469324|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44469325|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469326|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
44469327|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44469328|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44469329|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44469330|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
44469331|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426681|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
44469332|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44469333|NCT01422304|Atropine|atropine|mesh-list
44469334|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
44469335|NCT01422304|Neostigmine|neostigmine|mesh-list
44469336|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44469337|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44469338|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44469339|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
44469340|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469341|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469342|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44469343|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469344|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
44469345|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
44469346|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44469347|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44469348|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
44469349|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469350|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469351|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44469352|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469353|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44469354|NCT01422213|Vortioxetine|vortioxetine|mesh-list
44469355|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469356|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469357|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44469358|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469359|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469360|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469361|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44469362|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44469363|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469364|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469365|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469366|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
44469367|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44469368|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469369|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44469370|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469371|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44469372|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44469373|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469374|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469375|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44469376|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469377|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469378|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
44469379|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469380|NCT01421667|Rituximab|rituximab|mesh-list
44469381|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44469382|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469383|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469384|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
44469385|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469386|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469387|NCT01421641|Lidocaine|lidocaine|mesh-list
44469388|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
44469389|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
44469390|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469391|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469392|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
44469393|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469394|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44469395|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44469396|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44469397|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469398|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469399|NCT01421511|Linezolid|linezolid|mesh-list
44469400|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44469401|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469402|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44469403|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469404|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469405|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
44469406|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44469407|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469409|NCT01421342|Bupropion|bupropion|mesh-list
44469410|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
44469411|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44469412|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469413|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44469414|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44469415|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469416|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469417|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
44469418|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469419|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469420|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44469421|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44469422|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469423|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469424|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469425|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469426|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
44469427|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44469428|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469430|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469431|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469432|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469433|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469434|NCT01421303|Etanercept|etanercept|mesh-list
44469435|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469436|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469437|NCT01421303|Analgesics|analgesics|mesh-ancestor
44469438|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
44469439|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469440|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469441|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469442|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469443|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469444|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469445|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
44469446|NCT01421225|Insulin|insulin|mesh-list
44469447|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44469448|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44469449|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469450|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
44469451|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44469452|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469453|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44469454|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469455|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469456|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469457|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469458|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469459|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44469460|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44469461|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44469462|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469463|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469464|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469465|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469466|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469467|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
44469468|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469469|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469470|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
44469471|NCT01421069|Etanercept|etanercept|mesh-list
44469472|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469473|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469474|NCT01421069|Analgesics|analgesics|mesh-ancestor
44469475|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
44469476|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469477|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469478|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469479|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469480|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469481|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469482|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
44469483|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
44469484|NCT01421017|Imiquimod|imiquimod|mesh-list
44469485|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469486|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
44469487|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469488|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469489|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469490|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
44469491|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469492|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469493|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469494|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44469495|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
44469496|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
44469497|NCT01420965|Antibodies|antibodies|mesh-list
44469498|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
44469499|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469500|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
44469501|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469502|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288290|NCT00767559|PENTA|penta|mesh-list
44469503|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469504|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
44469505|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469506|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469507|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469508|NCT01420926|Bortezomib|bortezomib|mesh-list
44469509|NCT01420926|Decitabine|decitabine|mesh-list
44469510|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469511|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44469512|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
44469513|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469514|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469515|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44469516|NCT01420679|Aminopterin|aminopterin|mesh-list
44469517|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44469518|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469519|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469520|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469521|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44469522|NCT01420549|Simvastatin|simvastatin|mesh-list
44469523|NCT01420549|Ezetimibe|ezetimibe|mesh-list
44469524|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44469525|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44469526|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
44469527|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469528|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44469529|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44469530|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469531|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
44469532|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469533|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
44469534|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
44469535|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469536|NCT01420081|Gedatolisib|gedatolisib|mesh-list
44469537|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44469538|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469539|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469540|NCT01419717|Denosumab|denosumab|mesh-list
44469541|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44469542|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469543|NCT01419665|Rituximab|rituximab|mesh-list
44469544|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966775|NCT03864042|Losartan|losartan|mesh-list
44469545|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469546|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
44469547|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469548|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469549|NCT01419535|Mifepristone|mifepristone|mesh-list
44469550|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44469551|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
44469552|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469553|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469554|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44469555|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44469556|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44469557|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
44469558|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44469559|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44469560|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
44469561|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469562|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
44469563|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44469564|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44469565|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44469566|NCT01419236|Testosterone|testosterone|mesh-list
44469567|NCT01419236|Androgens|androgens|mesh-ancestor
44469568|NCT01419236|Hormones|hormones|mesh-ancestor
44469569|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469570|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469571|NCT01419197|Trastuzumab|trastuzumab|mesh-list
44469572|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44469573|NCT01419197|Maytansine|maytansine|mesh-list
44469574|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469575|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469576|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44469578|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44469579|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44469580|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469581|NCT01419184|Vancomycin|vancomycin|mesh-list
44469582|NCT01419184|Daptomycin|daptomycin|mesh-list
44469583|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44469584|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469585|NCT01418365|Metronidazole|metronidazole|mesh-list
44469586|NCT01418365|Mesalamine|mesalamine|mesh-list
44469587|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469588|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44469589|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44469590|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44469591|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44469592|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469593|NCT01418365|Analgesics|analgesics|mesh-ancestor
44469594|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
44469595|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469596|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469597|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469598|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469599|NCT01418352|Aripiprazole|aripiprazole|mesh-list
44469600|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469601|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469602|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469603|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469604|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469605|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469606|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
44469607|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
44469608|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469609|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469610|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44469611|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469612|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
44469613|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469614|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469615|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469616|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469617|NCT01418339|Aripiprazole|aripiprazole|mesh-list
44469618|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469619|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469620|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469621|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469622|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469623|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469624|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
44469625|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
44469626|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236585|NCT00560079|Allopurinol|allopurinol|mesh-list
44469627|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469628|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44469629|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469630|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
44469631|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469632|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469633|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469634|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469635|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44469636|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44469637|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44469638|NCT01418209|Estradiol|estradiol|mesh-list
44469639|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44469640|NCT01418209|Progesterone|progesterone|mesh-list
44469641|NCT01418209|Estrogens|estrogens|mesh-ancestor
44469642|NCT01418209|Hormones|hormones|mesh-ancestor
44469643|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469644|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469645|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44469646|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
44469647|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469648|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44469649|NCT01418209|Progestins|progestins|mesh-ancestor
44469650|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44469651|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44469652|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469653|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469654|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469655|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44469656|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469657|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469658|NCT01417481|Glycine|glycine|mesh-list
44469659|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
44469660|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469661|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469662|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469663|NCT01417195|Menotropins|menotropins|mesh-list
44469664|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44469665|NCT01417195|Hormones|hormones|mesh-ancestor
44469666|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469667|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469668|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44469669|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
44469670|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469671|NCT01417156|Nintedanib|nintedanib|mesh-list
44469672|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469673|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44469674|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469675|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469676|NCT01417078|Diazepam|diazepam|mesh-list
44469677|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44469678|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
44469679|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
44469680|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
44469681|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469682|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469683|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469684|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44469685|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469686|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44469687|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44469688|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44469689|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469690|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469691|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44469692|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
44469693|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
44469694|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
44469695|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
44469696|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469697|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469698|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
44469699|NCT01417000|Pancrelipase|pancrelipase|mesh-list
44469700|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469706|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469708|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469709|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469710|NCT01416831|Interleukin-2|interleukin-2|mesh-list
44469711|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469712|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44469713|NCT01416831|Analgesics|analgesics|mesh-ancestor
44469714|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
44469715|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469716|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469717|NCT01416441|Aripiprazole|aripiprazole|mesh-list
44469718|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
44469719|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44469720|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44469721|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44469722|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44469723|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469724|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
44469725|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
44469726|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469727|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469728|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44469729|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44469730|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
44469731|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44469732|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44469733|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44469734|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44469735|NCT01416389|Lenograstim|lenograstim|mesh-list
44469736|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44469737|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
44469738|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469739|NCT01416181|Natalizumab|natalizumab|mesh-list
44469740|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
44469741|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735212|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735213|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735214|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735215|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44735216|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735217|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44735218|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44735219|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
44735220|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44735221|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735222|NCT05610735|Doxorubicin|doxorubicin|mesh-list
44735223|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44735224|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44735225|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735226|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44735227|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735228|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735229|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735230|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
44735231|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735232|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735239|NCT05601440|Gemcitabine|gemcitabine|mesh-list
44735240|NCT05601440|Fulvestrant|fulvestrant|mesh-list
44735241|NCT05601440|Niraparib|niraparib|mesh-list
44735242|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735243|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
44735244|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735248|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735249|NCT05601440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735250|NCT05601440|Immunologic Factors|immunologic factors|mesh-ancestor
44735251|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735252|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44735253|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44735254|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44735255|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
44735256|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44735257|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44735259|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
44735260|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735261|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44735262|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
44735263|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735268|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
44288557|NCT00768911|Temozolomide|temozolomide|mesh-list
44469742|NCT01416155|Natalizumab|natalizumab|mesh-list
44469743|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
44469744|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469745|NCT01415986|Temoporfin|temoporfin|mesh-list
44469746|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469747|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44469748|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469749|NCT01415921|Bromides|bromides|mesh-list
44469750|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44469751|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
44469752|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44469753|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469754|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469755|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
44469756|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469757|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469758|NCT01415531|Nebivolol|nebivolol|mesh-list
44469759|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44469760|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
44469761|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44469762|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44469763|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44469764|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469765|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469766|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469767|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469768|NCT01415518|Budesonide|budesonide|mesh-list
44469769|NCT01415518|Theophylline|theophylline|mesh-list
44469770|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
44469771|NCT01415518|Ipratropium|ipratropium|mesh-list
44469772|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44469773|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469774|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44469775|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
44469776|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469777|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469778|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44469779|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469780|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
44469781|NCT01415518|Hormones|hormones|mesh-ancestor
44469782|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469783|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44469784|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44469785|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44469786|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469787|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469788|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469789|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44469790|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
44469791|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44469792|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469793|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
44469794|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44469795|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44469796|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
44469797|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44469798|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44469799|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469800|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44469801|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44469802|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44469803|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469804|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
44469805|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469807|NCT01415401|Brinzolamide|brinzolamide|mesh-list
44469808|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44469809|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44469810|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469811|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469812|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469813|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469814|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44469815|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44469816|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469817|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44469818|NCT01415349|Omeprazole|omeprazole|mesh-list
44469819|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44469820|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469821|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44469822|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469823|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469824|NCT01414855|Prednisone|prednisone|mesh-list
44469825|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
44469826|NCT01414855|Doxorubicin|doxorubicin|mesh-list
44469827|NCT01414855|Vincristine|vincristine|mesh-list
44469828|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
44469829|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469830|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
44469831|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469832|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469833|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469834|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
44469835|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469836|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469837|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469838|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44469839|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44469840|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44469841|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469842|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469843|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
44469844|NCT01414855|Hormones|hormones|mesh-ancestor
44469845|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469846|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44469847|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44469848|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44469849|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44469850|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44469851|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469852|NCT01414257|Methotrexate|methotrexate|mesh-list
44469853|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44469854|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
44469855|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469856|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469857|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44469858|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
44469859|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469860|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469861|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469862|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469863|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44469864|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469865|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
44469866|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469867|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44469869|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469870|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469871|NCT01414075|Iron|iron|mesh-list
44469872|NCT01414075|Trace Elements|trace elements|mesh-ancestor
44469873|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
44469874|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469875|NCT01413958|Loratadine|loratadine|mesh-list
44469876|NCT01413958|Phenylephrine|phenylephrine|mesh-list
44469877|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
44469878|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44469879|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
44469880|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
44469881|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469882|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469883|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
44469884|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44469885|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
44469886|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
44469887|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44469888|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44469889|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44469890|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
44469891|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469892|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469893|NCT01413958|Protective Agents|protective agents|mesh-ancestor
44469894|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
44469895|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469896|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44469897|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44469898|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44469899|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
44469900|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
44469901|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44469902|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44469903|NCT01413542|Enalaprilat|enalaprilat|mesh-list
44469904|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44469905|NCT01413542|Bradykinin|bradykinin|mesh-list
44469906|NCT01413542|Glucagon|glucagon|mesh-list
44469907|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44469908|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44469909|NCT01413542|Substance P|substance p|mesh-list
44469910|NCT01413542|Neurokinin A|neurokinin a|mesh-list
44469911|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44469912|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469913|NCT01413542|Incretins|incretins|mesh-ancestor
44469914|NCT01413542|Hormones|hormones|mesh-ancestor
44469915|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469916|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
44469917|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469918|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469919|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469920|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
44469921|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
44469922|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44469923|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44469924|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44469925|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469926|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469927|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469928|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44469929|NCT01413360|Vitamins|vitamins|mesh-list
44469930|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
44469931|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
44469932|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469933|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
44469934|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469935|NCT01413360|Protective Agents|protective agents|mesh-ancestor
44469936|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44469937|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
44469938|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469939|NCT01413178|Melphalan|melphalan|mesh-list
44469940|NCT01413178|Busulfan|busulfan|mesh-list
44469941|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469942|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
44469943|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469944|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469945|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469946|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469947|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
44469948|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469950|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469951|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469952|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44469953|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
44469954|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469955|NCT01412879|Leucovorin|leucovorin|mesh-list
44469956|NCT01412879|Cytarabine|cytarabine|mesh-list
44469957|NCT01412879|Dexamethasone|dexamethasone|mesh-list
44469958|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
44469959|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44469960|NCT01412879|Rituximab|rituximab|mesh-list
44469961|NCT01412879|Doxorubicin|doxorubicin|mesh-list
44469962|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44469963|NCT01412879|Methotrexate|methotrexate|mesh-list
44469964|NCT01412879|Vincristine|vincristine|mesh-list
44469965|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
44469966|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44469967|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
44469968|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44469969|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44469970|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44469971|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
44469972|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44469973|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44469974|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44469975|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44469976|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44469977|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
44469978|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
44469979|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44469980|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44469981|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
44469982|NCT01412879|Hormones|hormones|mesh-ancestor
44469983|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44469984|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44469985|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44469986|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44469987|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44469988|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44469989|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44469990|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
44469991|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44469992|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44469993|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
44469994|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
44469995|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44469996|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44469997|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
44469998|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44469999|NCT01412879|Antidotes|antidotes|mesh-ancestor
44470000|NCT01412879|Protective Agents|protective agents|mesh-ancestor
44470001|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
44470002|NCT01412879|Vitamins|vitamins|mesh-ancestor
44470003|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
44470004|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44470005|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
44470006|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
44470007|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44470008|NCT01412424|Octreotide|octreotide|mesh-list
44470009|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470010|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470011|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470012|NCT01412229|Paclitaxel|paclitaxel|mesh-list
44470013|NCT01412229|Carboplatin|carboplatin|mesh-list
44470014|NCT01412229|Cetuximab|cetuximab|mesh-list
44470015|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44470016|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470017|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
44470018|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
44470019|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
44470020|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470021|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470022|NCT01412060|Cariprazine|cariprazine|mesh-list
44470023|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44470024|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44470025|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470026|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470027|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44470028|NCT01411995|Lidocaine|lidocaine|mesh-list
44470029|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
44470030|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
44470031|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470032|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470033|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
44470034|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470035|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470036|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470037|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470038|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470039|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470040|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
44470041|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44470042|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470043|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
44288854|NCT00770640|Insulin|insulin|mesh-list
44470044|NCT01411774|Cycloserine|cycloserine|mesh-list
44470045|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44470046|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470047|NCT01411774|Renal Agents|renal agents|mesh-ancestor
44470048|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470049|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470050|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470051|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
44470052|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470053|NCT01411215|Etanercept|etanercept|mesh-list
44470054|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44470055|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44470056|NCT01411215|Analgesics|analgesics|mesh-ancestor
44470057|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
44470058|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470059|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470060|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470061|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470062|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470063|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470064|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
44470065|NCT01411085|Risperidone|risperidone|mesh-list
44470066|NCT01411085|Desipramine|desipramine|mesh-list
44470067|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44470068|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
44470069|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470070|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470071|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470072|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44470073|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44470074|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470075|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44470076|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44470077|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
44470078|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44470079|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44470080|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470081|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44470082|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44470083|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470084|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44470085|NCT01410799|Hormones|hormones|mesh-list
44470086|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44470087|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470088|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470089|NCT01410604|Metformin|metformin|mesh-list
44470090|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44470091|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470092|NCT01410448|Cyclosporine|cyclosporine|mesh-list
44470093|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
44470094|NCT01410448|Everolimus|everolimus|mesh-list
44470095|NCT01410448|Cyclosporins|cyclosporins|mesh-list
44470096|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470097|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470098|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470099|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
44470100|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470101|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
44470102|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470103|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470104|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470105|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44470106|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470107|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44470108|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470109|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470110|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470111|NCT01410240|Hemostatics|hemostatics|mesh-list
44470112|NCT01410240|Coagulants|coagulants|mesh-ancestor
44470113|NCT01410227|Factor VIII|factor viii|mesh-list
44470114|NCT01410227|Coagulants|coagulants|mesh-ancestor
44470115|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
44470116|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44470117|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44470118|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44470119|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470120|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470121|NCT01409993|Urological Agents|urological agents|mesh-ancestor
44470122|NCT01409915|Molgramostim|molgramostim|mesh-list
44470123|NCT01409915|Sargramostim|sargramostim|mesh-list
44470124|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
44470125|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470126|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470127|NCT01409837|Lisinopril|lisinopril|mesh-list
44470128|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44470129|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
44470130|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470131|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470132|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44470133|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44470134|NCT01409837|Protective Agents|protective agents|mesh-ancestor
44470135|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470136|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
44470137|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44470138|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470139|NCT01409564|Cilostazol|cilostazol|mesh-list
44470140|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470141|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
44470142|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470143|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470144|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470145|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470146|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44470147|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44470148|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470149|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44470150|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
44470151|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44470152|NCT01409564|Protective Agents|protective agents|mesh-ancestor
44470153|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44470154|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44470155|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470156|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
44470157|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
44470158|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44470159|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44470160|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470161|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470162|NCT01409031|Urological Agents|urological agents|mesh-ancestor
44470163|NCT01408914|Rifampin|rifampin|mesh-list
44470164|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470165|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470166|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470167|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470168|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
44470169|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44470170|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470171|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470172|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44470173|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44470174|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44470175|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44470176|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44470177|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44470178|NCT01408901|Molgramostim|molgramostim|mesh-list
44470179|NCT01408901|Sargramostim|sargramostim|mesh-list
44470180|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
44470181|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470182|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470183|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44470184|NCT01408888|Dulaglutide|dulaglutide|mesh-list
44470185|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44470186|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470187|NCT01408888|Incretins|incretins|mesh-ancestor
44470188|NCT01408888|Hormones|hormones|mesh-ancestor
44470189|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470190|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44470191|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44470192|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470193|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470194|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
44470195|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44470196|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44470198|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
44470199|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44470200|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470201|NCT01408628|Insulin|insulin|mesh-list
44470202|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44470203|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470204|NCT01408576|Epratuzumab|epratuzumab|mesh-list
44470205|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470206|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470207|NCT01408563|Fludarabine|fludarabine|mesh-list
44470208|NCT01408563|Melphalan|melphalan|mesh-list
44470209|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470210|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470211|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470212|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
44470213|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470214|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44470215|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
44470216|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44470217|NCT01408043|Plerixafor|plerixafor|mesh-list
44470218|NCT01408043|Etoposide|etoposide|mesh-list
44470219|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
44470220|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44470221|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470222|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44470223|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44470224|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470225|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470226|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44470227|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44470228|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
44470229|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470230|NCT01408030|Bevacizumab|bevacizumab|mesh-list
44470231|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
44470232|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
44470233|NCT01408030|Estrogens|estrogens|mesh-list
44470234|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470235|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470236|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470237|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470238|NCT01408030|Growth Substances|growth substances|mesh-ancestor
44470239|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470240|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620665|NCT03798054|Lixisenatide|lixisenatide|mesh-list
44470241|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44470242|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44470243|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470244|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
44470245|NCT01408030|Coagulants|coagulants|mesh-ancestor
44470246|NCT01408030|Hormones|hormones|mesh-ancestor
44470247|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470248|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44470249|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
44470250|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470251|NCT01406873|Mexiletine|mexiletine|mesh-list
44470252|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470253|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470254|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470255|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470256|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470257|NCT01406795|Heparin|heparin|mesh-list
44470258|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
44470259|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44470260|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44470261|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470262|NCT01406015|Spironolactone|spironolactone|mesh-list
44470263|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44470264|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
44470265|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470266|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470267|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44470268|NCT01406015|Diuretics|diuretics|mesh-ancestor
44470269|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
44470270|NCT01405950|Clonidine|clonidine|mesh-list
44470271|NCT01405950|Tizanidine|tizanidine|mesh-list
44470272|NCT01405950|Analgesics|analgesics|mesh-ancestor
44470273|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
44470274|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470275|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470276|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
44470277|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44143146|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
44470278|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44470279|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
44470280|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
44470281|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44470282|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44470283|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44470284|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
44470285|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470286|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470287|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44470288|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
44470289|NCT01405924|Dexamethasone|dexamethasone|mesh-list
44470290|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
44470291|NCT01405924|Aprepitant|aprepitant|mesh-list
44470292|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470293|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
44470294|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
44470295|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470296|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470297|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470298|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
44470299|NCT01405924|Hormones|hormones|mesh-ancestor
44470300|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470301|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470302|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470303|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44470304|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470305|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470306|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44470307|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44470308|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470309|NCT01405911|Incretins|incretins|mesh-ancestor
44470310|NCT01405911|Hormones|hormones|mesh-ancestor
44470311|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470312|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44470313|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
44470314|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470315|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470316|NCT01405820|Natalizumab|natalizumab|mesh-list
44470317|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
44470318|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470319|NCT01405768|Lidocaine|lidocaine|mesh-list
44470320|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
44470321|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
44470322|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470323|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470324|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
44470325|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470326|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470327|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470328|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470329|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470330|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470331|NCT01405742|Factor VIII|factor viii|mesh-list
44470332|NCT01405742|Coagulants|coagulants|mesh-ancestor
44470333|NCT01405560|Ribavirin|ribavirin|mesh-list
44470334|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
44470335|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470336|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
44470337|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470338|NCT01405508|Brivaracetam|brivaracetam|mesh-list
44470339|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
44735269|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
44735270|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44735271|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470340|NCT01405456|Eplerenone|eplerenone|mesh-list
44470341|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44470342|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
44470343|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967569|NCT04594733|Minocycline|minocycline|mesh-list
44470344|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470345|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44470346|NCT01405456|Diuretics|diuretics|mesh-ancestor
44470347|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
44470348|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44470349|NCT01405053|Rufinamide|rufinamide|mesh-list
44470350|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
44470351|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470352|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470353|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470354|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470355|NCT01405027|Interferons|interferons|mesh-list
44470356|NCT01405027|Ribavirin|ribavirin|mesh-list
44470357|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
44470358|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
44470359|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44470360|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44470361|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470362|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
44470363|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470364|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
44470365|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470366|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
44470367|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470368|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
44470369|NCT01404949|Tretinoin|tretinoin|mesh-list
44470370|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470371|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
44470372|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470373|NCT01404325|Everolimus|everolimus|mesh-list
44470374|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470375|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470376|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
44470377|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470378|NCT01404208|Cycloserine|cycloserine|mesh-list
44470379|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44470380|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470381|NCT01404208|Renal Agents|renal agents|mesh-ancestor
44470382|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470383|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470384|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470385|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
44470386|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426682|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470387|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44470388|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
44470389|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470390|NCT01403610|Bevacizumab|bevacizumab|mesh-list
44470391|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
44470392|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470393|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470394|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470395|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470396|NCT01403610|Growth Substances|growth substances|mesh-ancestor
44470397|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470398|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470399|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44470400|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
44470401|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470402|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
44470403|NCT01403116|Testosterone|testosterone|mesh-list
44470404|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
44470405|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
44470406|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44470407|NCT01403116|Androgens|androgens|mesh-ancestor
44470408|NCT01403116|Hormones|hormones|mesh-ancestor
44470409|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470410|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470411|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470412|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470413|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
44470414|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
44470416|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
44470417|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
44470418|NCT01403051|Vitamins|vitamins|mesh-list
44470419|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
44470420|NCT01403051|Calcium|calcium|mesh-list
44470421|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
44470422|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470423|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44470424|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44470425|NCT01403051|Antacids|antacids|mesh-ancestor
44470426|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470427|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470428|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44470429|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
44470430|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470431|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
44470432|NCT01402947|Mesalamine|mesalamine|mesh-list
44470433|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470434|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470435|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44470436|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44470437|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470438|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470439|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470440|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44470441|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44470442|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44470443|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44470444|NCT01402947|Analgesics|analgesics|mesh-ancestor
44470445|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
44470446|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470447|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470448|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470449|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470450|NCT01402869|Lidocaine|lidocaine|mesh-list
44470451|NCT01402869|Epinephrine|epinephrine|mesh-list
44470452|NCT01402869|Prilocaine|prilocaine|mesh-list
44470453|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
44470454|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
44470455|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470456|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470457|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
44470458|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470459|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470460|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470461|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44426683|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44470462|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470463|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470464|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44470465|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44470466|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
44470467|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470468|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44470469|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470470|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
44470471|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470472|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470473|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
44470474|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
44470475|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44470476|NCT01402817|Sunitinib|sunitinib|mesh-list
44470477|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470478|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470479|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470480|NCT01402817|Growth Substances|growth substances|mesh-ancestor
44470481|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470482|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470483|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44470484|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470485|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470486|NCT01402544|Ranibizumab|ranibizumab|mesh-list
44470487|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470488|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470489|NCT01402544|Growth Substances|growth substances|mesh-ancestor
44470490|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470491|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470492|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470493|NCT01402492|Naltrexone|naltrexone|mesh-list
44470494|NCT01402492|Buprenorphine|buprenorphine|mesh-list
44470495|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44470496|NCT01402492|Naloxone|naloxone|mesh-list
44470497|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44470498|NCT01402492|Narcotics|narcotics|mesh-ancestor
44470499|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470500|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470501|NCT01402492|Analgesics|analgesics|mesh-ancestor
44470502|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
44470503|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470504|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44470505|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44470506|NCT01402284|Dexamethasone|dexamethasone|mesh-list
44470507|NCT01402284|Lenalidomide|lenalidomide|mesh-list
44470508|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470509|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
44470510|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
44470511|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470512|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470513|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470514|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
44470515|NCT01402284|Hormones|hormones|mesh-ancestor
44470516|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470517|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470518|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470519|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
44470520|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470521|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470522|NCT01402284|Growth Substances|growth substances|mesh-ancestor
44470523|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470524|NCT01402063|Temozolomide|temozolomide|mesh-list
44470525|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44470526|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44470527|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
44470528|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470529|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470530|NCT01402011|Lidocaine|lidocaine|mesh-list
44470531|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
44470532|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
44470533|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470534|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470535|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
44470536|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470537|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470538|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470539|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470540|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470541|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470542|NCT01401959|Trastuzumab|trastuzumab|mesh-list
44470543|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470544|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470545|NCT01401647|Lidocaine|lidocaine|mesh-list
44470546|NCT01401647|Amiodarone|amiodarone|mesh-list
44470547|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
44470548|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
44470549|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470550|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470551|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
44470552|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470553|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44470554|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44470555|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44470556|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470557|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470558|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
44470559|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44470560|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44470561|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44470562|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470563|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44470564|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44470565|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44470566|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
44470567|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470568|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
44470569|NCT01401465|Ciclesonide|ciclesonide|mesh-list
44470570|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470571|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470572|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44470573|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
44470575|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470576|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470577|NCT01401322|Lenalidomide|lenalidomide|mesh-list
44470578|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
44470579|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470580|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470581|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470582|NCT01401322|Growth Substances|growth substances|mesh-ancestor
44470583|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470584|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470585|NCT01401010|Doripenem|doripenem|mesh-list
44470586|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470587|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470588|NCT01400958|Modafinil|modafinil|mesh-list
44470589|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44470590|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470591|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44470592|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44470593|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44470594|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470595|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44470596|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470597|NCT01400516|Vitamin D|vitamin d|mesh-list
44470598|NCT01400516|Teriparatide|teriparatide|mesh-list
44470599|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44470600|NCT01400516|Calcium|calcium|mesh-list
44470601|NCT01400516|Vitamins|vitamins|mesh-ancestor
44470602|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
44470603|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470604|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44470605|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44470606|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470607|NCT01400503|Siltuximab|siltuximab|mesh-list
44470608|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470609|NCT01400451|Ipilimumab|ipilimumab|mesh-list
44470610|NCT01400451|Vemurafenib|vemurafenib|mesh-list
44470611|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470612|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470613|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44470614|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470615|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44470616|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470617|NCT01400412|Ritonavir|ritonavir|mesh-list
44470618|NCT01400412|Darunavir|darunavir|mesh-list
44470619|NCT01400412|Tenofovir|tenofovir|mesh-list
44470620|NCT01400412|Emtricitabine|emtricitabine|mesh-list
44470621|NCT01400412|Maraviroc|maraviroc|mesh-list
44470622|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44470623|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44470624|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
44470625|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470626|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470627|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44470628|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44470629|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
44470630|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470631|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44470632|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44470633|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44470634|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44470635|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44470636|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44470637|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44289353|NCT00773058|Hormones|hormones|mesh-ancestor
44470638|NCT01400243|Nicotine|nicotine|mesh-list
44470639|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44470640|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
44470641|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470642|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470643|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44470644|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44470645|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
44470646|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470647|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470648|NCT01400139|Hydrocodone|hydrocodone|mesh-list
44470649|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44470650|NCT01400139|Narcotics|narcotics|mesh-ancestor
44470651|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470652|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470653|NCT01400139|Analgesics|analgesics|mesh-ancestor
44470654|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
44470655|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470656|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
44470657|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470658|NCT01400113|Asenapine|asenapine|mesh-list
44470659|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44470660|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44470661|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470662|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470663|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44470664|NCT01399905|Carbidopa|carbidopa|mesh-list
44470665|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44470666|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44470667|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
44470668|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470669|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470670|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470671|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44470672|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470673|NCT01399723|Amoxicillin|amoxicillin|mesh-list
44470674|NCT01399723|Penicillins|penicillins|mesh-list
44470675|NCT01399723|Penicillin G|penicillin g|mesh-list
44470676|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44470677|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
44470678|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470679|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470680|NCT01399697|Methotrexate|methotrexate|mesh-list
44470681|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44470682|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
44470683|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44470684|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470685|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44470686|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
44426684|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
44470687|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470688|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470689|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470690|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470691|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44470692|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470693|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
44470694|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470695|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44470696|NCT01399593|Eculizumab|eculizumab|mesh-list
44470697|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44470698|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470699|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
44470700|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470701|NCT01399372|Cytarabine|cytarabine|mesh-list
44470702|NCT01399372|Rituximab|rituximab|mesh-list
44470703|NCT01399372|Methotrexate|methotrexate|mesh-list
44470704|NCT01399372|Vincristine|vincristine|mesh-list
44470705|NCT01399372|Procarbazine|procarbazine|mesh-list
44470706|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470707|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470708|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
44470709|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470710|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470711|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44470712|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
44470713|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44470714|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44470715|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
44470716|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470717|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470718|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470719|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44470720|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44470721|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44470722|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
44470723|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470724|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44470725|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44470726|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44470727|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44470728|NCT01399190|Bevacizumab|bevacizumab|mesh-list
44470729|NCT01399190|Capecitabine|capecitabine|mesh-list
44470730|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
44470731|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470732|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470733|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470734|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470735|NCT01399190|Growth Substances|growth substances|mesh-ancestor
44470736|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470737|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470738|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44470739|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
44470740|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470741|NCT01399125|Rivastigmine|rivastigmine|mesh-list
44470742|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44470743|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470744|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470745|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
44470746|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470747|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470748|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44470749|NCT01399125|Protective Agents|protective agents|mesh-ancestor
44470750|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
44470751|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44470752|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470753|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470754|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470755|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470756|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470757|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470758|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470759|NCT01398956|Levetiracetam|levetiracetam|mesh-list
44236587|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
44470760|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
44470761|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
44470762|NCT01398514|Citalopram|citalopram|mesh-list
44470763|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44470764|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44470765|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44470766|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470767|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470768|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
44470769|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470770|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44470771|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
44470772|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44470773|NCT01398410|Rabeprazole|rabeprazole|mesh-list
44470774|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44470775|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470776|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44470777|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470778|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470779|NCT01397890|Budesonide|budesonide|mesh-list
44470780|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
44470781|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
44470782|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44470783|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470784|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470785|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
44470786|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735272|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289497|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470787|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470788|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470789|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470790|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
44470791|NCT01397890|Hormones|hormones|mesh-ancestor
44470792|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470793|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44470794|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44470795|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44470796|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44470797|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470798|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470799|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
44470800|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44470801|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
44470802|NCT01397825|Rituximab|rituximab|mesh-list
44470803|NCT01397825|Vincristine|vincristine|mesh-list
44470804|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470805|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470806|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
44470807|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470808|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44470809|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44470810|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44470811|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44470812|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44470813|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470814|NCT01397552|Dexamethasone|dexamethasone|mesh-list
44470815|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
44470816|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44470817|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44470818|NCT01397552|Prednisolone|prednisolone|mesh-list
44470819|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
44470820|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44470821|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
44470822|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470823|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
44470824|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
44470825|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470826|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470827|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470828|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
44470829|NCT01397552|Hormones|hormones|mesh-ancestor
44470830|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470831|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470832|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470833|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44470834|NCT01397552|Protective Agents|protective agents|mesh-ancestor
44470836|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470837|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470838|NCT01397448|Rabeprazole|rabeprazole|mesh-list
44470839|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44470840|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470841|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44470842|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470843|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470844|NCT01397422|Amantadine|amantadine|mesh-list
44470845|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44470846|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44470847|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
44470848|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470849|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
44470850|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470851|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470852|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470853|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44470854|NCT01397422|Analgesics|analgesics|mesh-ancestor
44470855|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
44470856|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470857|NCT01397409|Ranibizumab|ranibizumab|mesh-list
44470858|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470859|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470860|NCT01397409|Growth Substances|growth substances|mesh-ancestor
44470861|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470866|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470867|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470869|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470870|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470871|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470872|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470873|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470874|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44470875|NCT01397162|Fluticasone|fluticasone|mesh-list
44470876|NCT01397162|Xhance|xhance|mesh-list
44470877|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470878|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470879|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
44470880|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470881|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470882|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470883|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470884|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470885|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44470886|NCT01397084|Esomeprazole|esomeprazole|mesh-list
44470887|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44470888|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470889|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44470890|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470891|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470892|NCT01396512|Vaccines|vaccines|mesh-list
44470893|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
43968023|NCT01598207|Analgesics|analgesics|mesh-ancestor
44470894|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470895|NCT01396447|Cariprazine|cariprazine|mesh-list
44470896|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44470897|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44470898|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470899|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470900|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44470901|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44470902|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
44470903|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470904|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
44470905|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
44470906|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44470907|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470908|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470909|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
44470913|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44470914|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
44470915|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
44470917|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
44470918|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470919|NCT01396278|Fluticasone|fluticasone|mesh-list
44470920|NCT01396278|Xhance|xhance|mesh-list
44470921|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470922|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44470923|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
44470924|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470925|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470926|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44470927|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44470928|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
44470929|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44470930|NCT01396265|Rifampin|rifampin|mesh-list
44470931|NCT01396265|Afatinib|afatinib|mesh-list
44470932|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44470933|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
44470934|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44470935|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44470936|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
44470937|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44470938|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470939|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470940|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44470941|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44470942|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44470943|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44470944|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44470945|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44470946|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470947|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735273|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735274|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44735275|NCT05552976|Dexamethasone|dexamethasone|mesh-list
44735276|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44735277|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
44735278|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
44735279|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735280|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735281|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44735282|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
44735283|NCT05552976|Hormones|hormones|mesh-ancestor
44735284|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44735285|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44735286|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735287|NCT05541471|Digoxin|digoxin|mesh-list
44735288|NCT05541471|Midazolam|midazolam|mesh-list
44735289|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44735290|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44735291|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44735292|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735293|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44735294|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44735295|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44735296|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44735297|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
44735298|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
44735299|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
44735300|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
44735301|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735302|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735303|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44735304|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44735305|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735306|NCT05541471|Protective Agents|protective agents|mesh-ancestor
43866024|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
44735331|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44735332|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
44735333|NCT05505630|Anesthetics|anesthetics|mesh-ancestor
44735334|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44470949|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470950|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470951|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470952|NCT01396148|Growth Substances|growth substances|mesh-ancestor
44470953|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470954|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470955|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44470956|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44470957|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44470958|NCT01396083|Dexamethasone|dexamethasone|mesh-list
44470959|NCT01396083|Ranibizumab|ranibizumab|mesh-list
44470960|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470961|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
44470962|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
44470963|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470964|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470965|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470966|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
44470967|NCT01396083|Hormones|hormones|mesh-ancestor
44470968|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470969|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470970|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470971|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470972|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470973|NCT01396083|Growth Substances|growth substances|mesh-ancestor
44470974|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470975|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44470976|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44470977|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470978|NCT01396057|Dexamethasone|dexamethasone|mesh-list
44470979|NCT01396057|Ranibizumab|ranibizumab|mesh-list
44470980|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44470981|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
44470982|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
44470983|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44470984|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44470985|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44470986|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
44470987|NCT01396057|Hormones|hormones|mesh-ancestor
44470988|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44470989|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44470990|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44470991|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44470992|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44470993|NCT01396057|Growth Substances|growth substances|mesh-ancestor
44470994|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
44470995|NCT01396005|Buprenorphine|buprenorphine|mesh-list
44470996|NCT01396005|Methadone|methadone|mesh-list
44470997|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44470998|NCT01396005|Naloxone|naloxone|mesh-list
44470999|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44471000|NCT01396005|Narcotics|narcotics|mesh-ancestor
44471001|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471002|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471003|NCT01396005|Analgesics|analgesics|mesh-ancestor
44471004|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
44471005|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471006|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44471007|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
44471008|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
44471009|NCT01395901|Ondansetron|ondansetron|mesh-list
44471010|NCT01395901|Palonosetron|palonosetron|mesh-list
44471011|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
44471012|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
44471013|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471014|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471015|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471016|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
44471017|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471018|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44471019|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
44471020|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471021|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471022|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44471023|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44471024|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471025|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471026|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44471027|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44471028|NCT01395888|Fluticasone|fluticasone|mesh-list
44471029|NCT01395888|Xhance|xhance|mesh-list
44471030|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
44471031|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471032|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44471033|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
44471034|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471035|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471036|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44471037|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
44471038|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471039|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44471040|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
44471041|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44471042|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471043|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471044|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471045|NCT01395823|Vitamin D|vitamin d|mesh-list
44471046|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
44471047|NCT01395823|Vitamins|vitamins|mesh-ancestor
44471048|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
44471049|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471050|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44471051|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44471052|NCT01395784|Pioglitazone|pioglitazone|mesh-list
44471053|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471054|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471055|NCT01395758|Gemcitabine|gemcitabine|mesh-list
44471056|NCT01395758|Docetaxel|docetaxel|mesh-list
44471057|NCT01395758|Pemetrexed|pemetrexed|mesh-list
44471058|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44471059|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44471060|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
44471061|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471062|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471063|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
44471064|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471065|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471066|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471067|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
44471068|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471069|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44471070|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44471071|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44471072|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44471073|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471074|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471076|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44471077|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471078|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
44471079|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471080|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
44471081|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471082|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471083|NCT01395030|Choline|choline|mesh-list
44471084|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
44471085|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44471086|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
44471087|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471088|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471089|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44471090|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
44471091|NCT01395017|Dasatinib|dasatinib|mesh-list
44471092|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471093|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471094|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471095|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471096|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
44471097|NCT01394991|Hematinics|hematinics|mesh-ancestor
44471098|NCT01394952|Dulaglutide|dulaglutide|mesh-list
44471099|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471100|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471101|NCT01394939|Irinotecan|irinotecan|mesh-list
44471102|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44471103|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44471104|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471105|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471106|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471107|NCT01394718|Acetaminophen|acetaminophen|mesh-list
44471108|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471109|NCT01394718|Analgesics|analgesics|mesh-ancestor
44471110|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
44471111|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471112|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471113|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
44471114|NCT01394627|Eplerenone|eplerenone|mesh-list
44471115|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44471116|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
44471117|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471118|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471119|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44471120|NCT01394627|Diuretics|diuretics|mesh-ancestor
44471121|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
44471122|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44471123|NCT01394523|Bupivacaine|bupivacaine|mesh-list
44471124|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
44471125|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
44471126|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471127|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471128|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
44471129|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471130|NCT01394250|Lidocaine|lidocaine|mesh-list
44471131|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
44471132|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
44471133|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471134|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471135|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
44471136|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471137|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44471138|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44471139|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43968308|NCT01607853|Vitamins|vitamins|mesh-ancestor
44471140|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471141|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471142|NCT01394185|Dronabinol|dronabinol|mesh-list
44471143|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
44471144|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471145|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471146|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471147|NCT01394185|Analgesics|analgesics|mesh-ancestor
44471148|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
43866250|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
44471149|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471150|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44471151|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44471152|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471153|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471154|NCT01394185|Hormones|hormones|mesh-ancestor
44471155|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471156|NCT01393990|Tamoxifen|tamoxifen|mesh-list
44471157|NCT01393990|Midazolam|midazolam|mesh-list
44471158|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44471159|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44471160|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471161|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471162|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44471163|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44471164|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471165|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44471166|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
44471167|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
44471168|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
44471169|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
44471170|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471171|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471172|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44471173|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
44471174|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471175|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471176|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471177|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44471178|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44471179|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44471180|NCT01393964|Dexamethasone|dexamethasone|mesh-list
44471181|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
44471182|NCT01393964|Lenalidomide|lenalidomide|mesh-list
44471183|NCT01393964|Elotuzumab|elotuzumab|mesh-list
44471184|NCT01393964|BB 1101|bb 1101|mesh-list
44471185|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471186|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
44471187|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
44471188|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471189|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471190|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471191|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
44471192|NCT01393964|Hormones|hormones|mesh-ancestor
44471193|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471194|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471195|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471196|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471197|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471198|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471199|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
44471200|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44471201|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44471202|NCT01393964|Growth Substances|growth substances|mesh-ancestor
44471203|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
44471204|NCT01393899|Tofacitinib|tofacitinib|mesh-list
44471205|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471206|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471207|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471208|NCT01393730|Prednisone|prednisone|mesh-list
44471209|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
44471210|NCT01393730|Dutasteride|dutasteride|mesh-list
44471211|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471212|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
44471213|NCT01393730|Hormones|hormones|mesh-ancestor
44471214|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471215|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471216|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471217|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471218|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44471219|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471220|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471221|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
44471222|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44471223|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44471224|NCT01393626|Tofacitinib|tofacitinib|mesh-list
44471225|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471226|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471227|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471228|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
44471229|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44471230|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44471231|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471232|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471233|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
44471234|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471235|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471236|NCT01393405|Methotrexate|methotrexate|mesh-list
44471237|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44471238|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
44471239|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44471240|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471241|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44471242|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
44471243|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471244|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471245|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471246|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289961|NCT00775879|Sevoflurane|sevoflurane|mesh-list
44471247|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44471248|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471249|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
44471250|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471251|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471252|NCT01393158|Apremilast|apremilast|mesh-list
44471253|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44471254|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471255|NCT01393158|Analgesics|analgesics|mesh-ancestor
44471256|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
44471257|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471258|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471259|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471260|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471261|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44471262|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44471263|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471264|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471265|NCT01393106|Idelalisib|idelalisib|mesh-list
44471266|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471267|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471268|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471269|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
44471270|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44471271|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44471272|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44471273|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471274|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471275|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471276|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471277|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471278|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44471279|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471280|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
44471281|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44471282|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471283|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471284|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471285|NCT01392573|Insulin|insulin|mesh-list
44471286|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44471287|NCT01392573|Liraglutide|liraglutide|mesh-list
44471288|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
44471289|NCT01392573|Xultophy|xultophy|mesh-list
44471290|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471291|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471292|NCT01392573|Incretins|incretins|mesh-ancestor
44471293|NCT01392573|Hormones|hormones|mesh-ancestor
44471294|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471296|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44471297|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471298|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471299|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471300|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
44471301|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471302|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471303|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471304|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471305|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
44471306|NCT01392469|Bosentan|bosentan|mesh-list
44471307|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
44471308|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471309|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471310|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471311|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471312|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
44471313|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44471314|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44471315|NCT01392469|Urological Agents|urological agents|mesh-ancestor
44471316|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44471317|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44471318|NCT01392378|Acetaminophen|acetaminophen|mesh-list
44471319|NCT01392378|Ibuprofen|ibuprofen|mesh-list
44471320|NCT01392378|Vaccines|vaccines|mesh-list
44471321|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44471322|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
44471323|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471324|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44471325|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471326|NCT01392378|Analgesics|analgesics|mesh-ancestor
44471327|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
44471328|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471329|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471330|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471331|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44471332|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471333|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471334|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
44471335|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44471336|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
44471337|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471338|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44471339|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44471340|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471341|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471342|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44471343|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471344|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471345|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471346|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471347|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
44471348|NCT01392183|Sirolimus|sirolimus|mesh-list
44471349|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44471350|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471351|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44471352|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471353|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
44471354|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471355|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
44471356|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471357|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44471358|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44471359|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471360|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
44471361|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
44471362|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
44471363|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471364|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
44471365|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
44471366|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471368|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
44471369|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
44471370|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471371|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471372|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44471373|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44471374|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
44471375|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471376|NCT01391793|Dexamethasone|dexamethasone|mesh-list
44471377|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471378|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
44471379|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
44471380|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471381|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471382|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471383|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
44471384|NCT01391793|Hormones|hormones|mesh-ancestor
44471385|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471386|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471387|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471388|NCT01391663|Alogliptin|alogliptin|mesh-list
44471389|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471390|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471391|NCT01391663|Incretins|incretins|mesh-ancestor
44471392|NCT01391663|Hormones|hormones|mesh-ancestor
44471393|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471394|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44471395|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471396|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471397|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471398|NCT01391130|Sunitinib|sunitinib|mesh-list
44471399|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471400|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44471401|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44471402|NCT01391130|Growth Substances|growth substances|mesh-ancestor
44471403|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471404|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44471405|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44471406|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471407|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471408|NCT01390948|Bevacizumab|bevacizumab|mesh-list
44471409|NCT01390948|Temozolomide|temozolomide|mesh-list
43968575|NCT01620190|Paclitaxel|paclitaxel|mesh-list
44471410|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471411|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471412|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44471413|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44471414|NCT01390948|Growth Substances|growth substances|mesh-ancestor
44471415|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471416|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
44471417|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44471418|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
44471419|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471420|NCT01390857|Valacyclovir|valacyclovir|mesh-list
44471421|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
44471422|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471423|NCT01390844|Ribavirin|ribavirin|mesh-list
44471424|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44471425|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
44471426|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471427|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
44471428|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471429|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44471430|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
44471431|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471432|NCT01390584|Prednisone|prednisone|mesh-list
44471433|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
44471434|NCT01390584|Dacarbazine|dacarbazine|mesh-list
44471435|NCT01390584|Doxorubicin|doxorubicin|mesh-list
44471436|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44471437|NCT01390584|Etoposide|etoposide|mesh-list
44471438|NCT01390584|Vincristine|vincristine|mesh-list
44471439|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
44471440|NCT01390584|Bleomycin|bleomycin|mesh-list
44471441|NCT01390584|Vinblastine|vinblastine|mesh-list
44471442|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
44471443|NCT01390584|Procarbazine|procarbazine|mesh-list
44471444|NCT01390584|Imidazole|imidazole|mesh-list
44471445|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471446|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
44471447|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471448|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471449|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44471450|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
44471451|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471452|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471453|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44471454|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44471455|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44471456|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44471457|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471458|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471459|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
44471460|NCT01390584|Hormones|hormones|mesh-ancestor
44471461|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471462|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471463|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44471464|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44471465|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44471466|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
44290138|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
44471467|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
44471468|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471469|NCT01390441|Acetaminophen|acetaminophen|mesh-list
44471470|NCT01390441|Loratadine|loratadine|mesh-list
44471471|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
44471472|NCT01390441|Rituximab|rituximab|mesh-list
44471473|NCT01390441|Methotrexate|methotrexate|mesh-list
44471474|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471475|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471476|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
44471477|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471478|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471479|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44471480|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
44471481|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44471482|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44471483|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
44471484|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471485|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471486|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471487|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44471488|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471489|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471490|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471491|NCT01390441|Analgesics|analgesics|mesh-ancestor
44471492|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
44471493|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471494|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
44471495|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471496|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
44471497|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
44471498|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471499|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
44471500|NCT01390441|Hormones|hormones|mesh-ancestor
44471501|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471502|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44471503|NCT01390441|Protective Agents|protective agents|mesh-ancestor
44471504|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
44471505|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44471506|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44471507|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44471508|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
44471509|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
44471510|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471511|NCT01390428|Grazoprevir|grazoprevir|mesh-list
44471512|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
44471513|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471514|NCT01390402|Aldesleukin|aldesleukin|mesh-list
44471515|NCT01390402|Methotrexate|methotrexate|mesh-list
44471516|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
44471517|NCT01390402|Fludarabine|fludarabine|mesh-list
44471519|NCT01390402|Interleukin-2|interleukin-2|mesh-list
44471520|NCT01390402|Tacrolimus|tacrolimus|mesh-list
44471521|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
44471522|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44471523|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44471524|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
44471525|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44471526|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471527|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44471528|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
44471529|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471530|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471531|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471532|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471533|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44471534|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471535|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
44471536|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471537|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471538|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
44471539|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471540|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44471541|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
44471542|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44471543|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44471544|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471545|NCT01390402|Analgesics|analgesics|mesh-ancestor
44471546|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
44471547|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471549|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44471550|NCT01390389|Ubiquinone|ubiquinone|mesh-list
44471551|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
44471552|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
44471553|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471554|NCT01390389|Vitamins|vitamins|mesh-ancestor
44471555|NCT01390220|Midazolam|midazolam|mesh-list
44471556|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44471557|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44471558|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471559|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471560|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44471561|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44471562|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471563|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44471564|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
44471565|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
44471566|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
44471567|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
44471568|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471569|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471570|NCT01390181|Losartan|losartan|mesh-list
44471571|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44471572|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44471573|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44471574|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44471575|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471576|NCT01389973|Ustekinumab|ustekinumab|mesh-list
44471577|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471578|NCT01389752|Charcoal|charcoal|mesh-list
44471579|NCT01389752|Antidotes|antidotes|mesh-ancestor
44471580|NCT01389752|Protective Agents|protective agents|mesh-ancestor
44471581|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471582|NCT01389596|Pregabalin|pregabalin|mesh-list
44471583|NCT01389596|Analgesics|analgesics|mesh-ancestor
44471584|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
44471585|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471586|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471587|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
44471588|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44471589|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471590|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471591|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44471592|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44471593|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43866658|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
44471594|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471595|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471597|NCT01389323|Ribavirin|ribavirin|mesh-list
44471598|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
44471599|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
44471600|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44471601|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471602|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
44471603|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471604|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
44471605|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471606|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
44471607|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471608|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44471609|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44471610|NCT01389102|Estradiol|estradiol|mesh-list
44471611|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44471612|NCT01389102|Estrogens|estrogens|mesh-ancestor
44471613|NCT01389102|Hormones|hormones|mesh-ancestor
44471614|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471615|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471616|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44471617|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
44471618|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44471619|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44471620|NCT01388985|Vaccines|vaccines|mesh-list
44471621|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
44471622|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471623|NCT01388790|Cisplatin|cisplatin|mesh-list
44471624|NCT01388790|Cetuximab|cetuximab|mesh-list
44471625|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471626|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471627|NCT01388647|Carboplatin|carboplatin|mesh-list
44471628|NCT01388647|Trastuzumab|trastuzumab|mesh-list
44471629|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471630|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471631|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44471632|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44471633|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44471634|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471635|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471636|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471637|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44471638|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44471639|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
44471640|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471641|NCT01388478|Pramipexole|pramipexole|mesh-list
44471642|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
44471643|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471644|NCT01388478|Protective Agents|protective agents|mesh-ancestor
44471645|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471646|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44471647|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44471648|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
44471649|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
44471650|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471651|NCT01388361|Insulin|insulin|mesh-list
44471652|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44471653|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
44471654|NCT01388361|Liraglutide|liraglutide|mesh-list
44471655|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471656|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471657|NCT01388361|Incretins|incretins|mesh-ancestor
44471658|NCT01388361|Hormones|hormones|mesh-ancestor
44471659|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471660|NCT01388335|Warfarin|warfarin|mesh-list
44471661|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
44735335|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44735336|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44735337|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735338|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735339|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44735340|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44735341|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44735342|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43866668|NCT01702831|Busulfan|busulfan|mesh-list
44735343|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44735344|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
44735345|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
44735346|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
44735347|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
44735348|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735349|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735350|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735351|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
44735352|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
44735353|NCT05476939|Everolimus|everolimus|mesh-list
44735354|NCT05476939|TIC10 compound|tic10 compound|mesh-list
44735355|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735356|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735357|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
44735358|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735369|NCT05458674|Trastuzumab|trastuzumab|mesh-list
44735370|NCT05458674|Tucatinib|tucatinib|mesh-list
44735371|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735372|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290365|NCT00777673|Paclitaxel|paclitaxel|mesh-list
44735373|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735374|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471662|NCT01387932|Doxorubicin|doxorubicin|mesh-list
44471663|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
44471664|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44471665|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471666|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44471667|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44471668|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471669|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471671|NCT01387607|Analgesics|analgesics|mesh-ancestor
44471672|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
44471673|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471674|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471675|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
44471676|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44471677|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471678|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471679|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44471680|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44471681|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44471682|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471683|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471684|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44471685|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44471686|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44471687|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471688|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471689|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44471690|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44471691|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44471692|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
44471693|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471694|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471695|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44471696|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44471697|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
44471698|NCT01387516|Nicotine|nicotine|mesh-list
44471699|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44471700|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
44471701|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471702|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471703|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44471704|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44471705|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471706|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471707|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471708|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44471709|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44471710|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
44471711|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44471712|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44471713|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44471714|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471715|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471716|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471717|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471718|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471719|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44471720|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471721|NCT01387022|Tenofovir|tenofovir|mesh-list
44471722|NCT01387022|Lamivudine|lamivudine|mesh-list
44471723|NCT01387022|Efavirenz|efavirenz|mesh-list
44471724|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
44471725|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471726|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44471727|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471728|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471729|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471730|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44471731|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44471732|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44471733|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44471734|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44471735|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44471736|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44471737|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44471739|NCT01386970|Zidovudine|zidovudine|mesh-list
44471740|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44471741|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44471742|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471743|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471744|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471745|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
44471746|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471747|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44471748|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44471749|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
44471750|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
44471751|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44471752|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
44471753|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471754|NCT01386645|Expectorants|expectorants|mesh-ancestor
44471755|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
44471756|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44471757|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
44471758|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471759|NCT01386645|Protective Agents|protective agents|mesh-ancestor
44471760|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471761|NCT01386645|Antidotes|antidotes|mesh-ancestor
44471762|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
44471763|NCT01386606|Enclomiphene|enclomiphene|mesh-list
44471764|NCT01386606|Clomiphene|clomiphene|mesh-list
44471765|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
44471766|NCT01386606|Testosterone|testosterone|mesh-list
44471767|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
44471768|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
44471769|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44471770|NCT01386606|Androgens|androgens|mesh-ancestor
44471771|NCT01386606|Hormones|hormones|mesh-ancestor
44471772|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471773|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471774|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471775|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471776|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
44471777|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44471778|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
44471779|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44471780|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
44471781|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44471782|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44471783|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44471784|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44471785|NCT01386554|Hormones|hormones|mesh-ancestor
44471786|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471787|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471788|NCT01386385|Paclitaxel|paclitaxel|mesh-list
44471789|NCT01386385|Carboplatin|carboplatin|mesh-list
44471790|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44471791|NCT01386385|Veliparib|veliparib|mesh-list
44471792|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44471793|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471794|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44471795|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44471796|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44471797|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471798|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44471799|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471800|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
44471801|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471802|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
44471803|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44471804|NCT01385748|Clonidine|clonidine|mesh-list
44471805|NCT01385748|Analgesics|analgesics|mesh-ancestor
44471806|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
44471807|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471808|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968952|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471809|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44471810|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
44471811|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
44471812|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44471813|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44471814|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44471815|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
44471816|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471817|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471818|NCT01385566|Vaccines|vaccines|mesh-list
44471819|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
44471820|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471821|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
44471822|NCT01385098|Vitamin D|vitamin d|mesh-list
44471823|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
44471824|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
44471825|NCT01385098|Vitamins|vitamins|mesh-list
44471826|NCT01385098|Calcium|calcium|mesh-list
44471827|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
44471828|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471829|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44471830|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44471831|NCT01384877|Lidocaine|lidocaine|mesh-list
44471832|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
44471833|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
44471834|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44471835|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471836|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
44471837|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471838|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44471839|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44471840|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44471841|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44471842|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471843|NCT01384734|Ritonavir|ritonavir|mesh-list
44471844|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44471845|NCT01384734|Tenofovir|tenofovir|mesh-list
44471846|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
44471847|NCT01384734|Fostemsavir|fostemsavir|mesh-list
44471848|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44471849|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44471850|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471851|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471852|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471853|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44471854|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44471855|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
44471856|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471857|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44471858|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44471859|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44471860|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44471861|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44471862|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44471863|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44471864|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44471865|NCT01384292|Naloxegol|naloxegol|mesh-list
44471866|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44471867|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471868|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
44471869|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471870|NCT01383993|Voriconazole|voriconazole|mesh-list
44471871|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
44471872|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471873|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44471874|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44471875|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471876|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471877|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44471878|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
44471879|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471880|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471881|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44471882|NCT01383954|Diclofenac|diclofenac|mesh-list
44471883|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44471884|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471886|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
44471887|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471888|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471889|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471890|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471891|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44471892|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471893|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471894|NCT01383928|Dexamethasone|dexamethasone|mesh-list
44471895|NCT01383928|Lenalidomide|lenalidomide|mesh-list
44471896|NCT01383928|Ixazomib|ixazomib|mesh-list
44471897|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471898|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
44471899|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
44471900|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471901|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471902|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44471903|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
44471904|NCT01383928|Hormones|hormones|mesh-ancestor
44471905|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471906|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44471907|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471908|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
44471909|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44471910|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44471911|NCT01383928|Growth Substances|growth substances|mesh-ancestor
44471912|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
44471913|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471914|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471915|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471916|NCT01383707|Leucovorin|leucovorin|mesh-list
44471917|NCT01383707|Bevacizumab|bevacizumab|mesh-list
44471918|NCT01383707|Fluorouracil|fluorouracil|mesh-list
44471919|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
44471920|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
44471921|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44471922|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471923|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44471924|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44471925|NCT01383707|Growth Substances|growth substances|mesh-ancestor
44471926|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471927|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44471928|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
44471929|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471930|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44471931|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44471932|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
44471933|NCT01383707|Antidotes|antidotes|mesh-ancestor
44471934|NCT01383707|Protective Agents|protective agents|mesh-ancestor
44471935|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
44471936|NCT01383707|Vitamins|vitamins|mesh-ancestor
44471937|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
44471938|NCT01383499|Bromides|bromides|mesh-list
44471939|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
44471940|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44471941|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
44471942|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471943|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471944|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44471945|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44471946|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
44471947|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44471948|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44471949|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44471950|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471951|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
44471952|NCT01383486|Naproxen|naproxen|mesh-list
44471953|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44471954|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471955|NCT01383486|Analgesics|analgesics|mesh-ancestor
44471956|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
44471957|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471958|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471959|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471960|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471961|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
44471962|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44471963|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471964|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471965|NCT01383356|Metformin|metformin|mesh-list
44471966|NCT01383356|Linagliptin|linagliptin|mesh-list
44471967|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44471968|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471969|NCT01383356|Incretins|incretins|mesh-ancestor
44471970|NCT01383356|Hormones|hormones|mesh-ancestor
44471971|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44471972|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44471973|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
44471974|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471975|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471976|NCT01383161|Curcumin|curcumin|mesh-list
44471977|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44471978|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44471979|NCT01383161|Analgesics|analgesics|mesh-ancestor
44471980|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
44471981|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44471982|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44471983|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44471984|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44471985|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44471986|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44471987|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44471988|NCT01383096|Artefenomel|artefenomel|mesh-list
44471989|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44471990|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
44471991|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44471992|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44471993|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44471994|NCT01382940|Acetaminophen|acetaminophen|mesh-list
44471995|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
44471996|NCT01382940|Rituximab|rituximab|mesh-list
44471997|NCT01382940|Methotrexate|methotrexate|mesh-list
44471998|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
44471999|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44472000|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472001|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472002|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
44472003|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472004|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472005|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44472006|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
44472007|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44472008|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472009|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
44472010|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472011|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472012|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472013|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44472014|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472015|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44472016|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472017|NCT01382940|Analgesics|analgesics|mesh-ancestor
44472018|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
44472019|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472020|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
44472021|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472022|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
44472023|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
44472024|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472025|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
44472026|NCT01382940|Hormones|hormones|mesh-ancestor
44472027|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472028|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44472029|NCT01382940|Protective Agents|protective agents|mesh-ancestor
44472030|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
44472031|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472032|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
44472033|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44472034|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44472035|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472036|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
44472037|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472038|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44472039|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
44472040|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44472041|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44472042|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
44472043|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472044|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
44472045|NCT01382225|Protective Agents|protective agents|mesh-ancestor
44472046|NCT01381926|Exenatide|exenatide|mesh-list
44472047|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44472048|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472049|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44472050|NCT01381926|Incretins|incretins|mesh-ancestor
44472051|NCT01381926|Hormones|hormones|mesh-ancestor
44472052|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472053|NCT01381900|Metformin|metformin|mesh-list
44472054|NCT01381900|Canagliflozin|canagliflozin|mesh-list
44472055|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44472056|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472057|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44472058|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472059|NCT01381874|Prednisone|prednisone|mesh-list
44472060|NCT01381874|Prednisolone|prednisolone|mesh-list
44472061|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44472062|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
44472063|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44472064|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
44472065|NCT01381874|Exemestane|exemestane|mesh-list
44472066|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
44472067|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44472068|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
44472069|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472070|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
44472071|NCT01381874|Hormones|hormones|mesh-ancestor
44472072|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472073|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472074|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472075|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472076|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
44472077|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
44472078|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472079|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472080|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44472081|NCT01381874|Protective Agents|protective agents|mesh-ancestor
44472082|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44472083|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44472084|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472085|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472086|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44472087|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472088|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44472089|NCT01381718|Modafinil|modafinil|mesh-list
44472090|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44472091|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472092|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44472093|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44472094|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44472095|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472096|NCT01381692|Sirolimus|sirolimus|mesh-list
44472097|NCT01381692|Dexamethasone|dexamethasone|mesh-list
44472098|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
44472099|NCT01381692|Rituximab|rituximab|mesh-list
44472100|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44472101|NCT01381692|Bortezomib|bortezomib|mesh-list
44472102|NCT01381692|Antibodies|antibodies|mesh-list
44472103|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
44472104|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44472105|NCT01381692|BB 1101|bb 1101|mesh-list
44472106|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
44472107|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472108|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472109|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472110|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472111|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
44472112|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
44472113|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472114|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472115|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
44472116|NCT01381692|Hormones|hormones|mesh-ancestor
44472117|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472118|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472119|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44472120|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472121|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472122|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472123|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472124|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44472125|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
44472126|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472127|NCT01381679|Ezetimibe|ezetimibe|mesh-list
44472128|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44472129|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44472130|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
44472131|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472132|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44472133|NCT01381562|Meropenem|meropenem|mesh-list
44472134|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472135|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472136|NCT01381549|Imipenem|imipenem|mesh-list
44472137|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44472138|NCT01381549|Cilastatin|cilastatin|mesh-list
44472139|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472140|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472141|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
44472142|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472143|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472144|NCT01381016|Hormones|hormones|mesh-list
44472145|NCT01381016|Estradiol|estradiol|mesh-list
44472146|NCT01381016|Progesterone|progesterone|mesh-list
44472147|NCT01381016|Estrogens|estrogens|mesh-list
44472148|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472149|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472150|NCT01381016|Progestins|progestins|mesh-ancestor
44472151|NCT01380990|Busulfan|busulfan|mesh-list
44472152|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
44472153|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472154|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472155|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
44472156|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472157|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44472159|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44472160|NCT01380782|Nintedanib|nintedanib|mesh-list
44472161|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472162|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44472163|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472164|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472165|NCT01380730|Evolocumab|evolocumab|mesh-list
44472166|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44472167|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44472168|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44472169|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
44472170|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472171|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44472172|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
44472173|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472174|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
44472175|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44472176|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472177|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
44472178|NCT01380535|Methoxsalen|methoxsalen|mesh-list
44472179|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44472180|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472181|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
44472182|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472183|NCT01380184|Sirolimus|sirolimus|mesh-list
44472184|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472185|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472186|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44472187|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472188|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
44472189|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472190|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
44472191|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472192|NCT05364385|Budesonide|budesonide|mesh-list
44472193|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44472194|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472195|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44472196|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
44472197|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472198|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472199|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44472200|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
44472201|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
44472202|NCT05364385|Hormones|hormones|mesh-ancestor
44472203|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472204|NCT05368805|Dabigatran|dabigatran|mesh-list
44472205|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44472206|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44472207|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44472208|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
44472209|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472210|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44472211|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44472212|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472213|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
44472214|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44472215|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44472216|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
44472217|NCT05368623|Mydriatics|mydriatics|mesh-list
44472218|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
44472219|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472220|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472221|NCT05363436|Oxycodone|oxycodone|mesh-list
44472222|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44472223|NCT05363436|Narcotics|narcotics|mesh-ancestor
44472224|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472225|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472226|NCT05363436|Analgesics|analgesics|mesh-ancestor
44472227|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
44472228|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472229|NCT05362955|Fluorouracil|fluorouracil|mesh-list
44472230|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
44472231|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472232|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472233|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472234|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472235|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
44472236|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735375|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735377|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
44735378|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44735379|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44735380|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735381|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735382|NCT05458232|Urological Agents|urological agents|mesh-ancestor
44735383|NCT05456256|Carboplatin|carboplatin|mesh-list
44735384|NCT05456256|Pemetrexed|pemetrexed|mesh-list
44735385|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735386|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735387|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735388|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44735389|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44735390|NCT05444530|Ipilimumab|ipilimumab|mesh-list
44735391|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735392|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735393|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44735394|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735395|NCT05429502|Temozolomide|temozolomide|mesh-list
44735396|NCT05429502|Topotecan|topotecan|mesh-list
44735397|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735398|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
44735399|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735400|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735401|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44472237|NCT05364190|Empagliflozin|empagliflozin|mesh-list
44472238|NCT05364190|Canagliflozin|canagliflozin|mesh-list
44472239|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44472240|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472241|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44472242|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472243|NCT05363553|Caseins|caseins|mesh-list
44472244|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
44472245|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
44472246|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472247|NCT05367869|Methylene Blue|methylene blue|mesh-list
44472248|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472249|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472250|NCT05368376|Metoprolol|metoprolol|mesh-list
44472251|NCT05368376|Labetalol|labetalol|mesh-list
44472252|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44472253|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44472254|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
44472255|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
44472256|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472257|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472258|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44472259|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44472260|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44472261|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44472262|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472263|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472264|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
44472265|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44472266|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44472267|NCT05366777|Acetaminophen|acetaminophen|mesh-list
44472268|NCT05366777|Ibuprofen|ibuprofen|mesh-list
44472269|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472270|NCT05366777|Analgesics|analgesics|mesh-ancestor
44472271|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
44472272|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472273|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472274|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
44472275|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44472276|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472277|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472278|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44472279|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472280|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472281|NCT05362916|Letermovir|letermovir|mesh-list
43969402|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472282|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44472283|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472284|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472285|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472286|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
44472287|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472288|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
44472289|NCT05366595|Astringents|astringents|mesh-ancestor
44472290|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472291|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472292|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
44472293|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
44472294|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472295|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
44472296|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472297|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472298|NCT05365464|Progesterone|progesterone|mesh-list
44472299|NCT05365464|Progestins|progestins|mesh-ancestor
44472300|NCT05365464|Hormones|hormones|mesh-ancestor
44472301|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472302|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472303|NCT05365178|Fulvestrant|fulvestrant|mesh-list
44472304|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472305|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472306|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44472307|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44472308|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472309|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472310|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472311|NCT05365165|Sevoflurane|sevoflurane|mesh-list
44472312|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44472313|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44472314|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
44472315|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
44472316|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472317|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472318|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
44472319|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
44472320|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
44472321|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472322|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472323|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
44472324|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472326|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44472327|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44472328|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
44472329|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472330|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472331|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44472332|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44472333|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
44472334|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472335|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44472336|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44472337|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
44472338|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44472339|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472340|NCT05368012|Dexamethasone|dexamethasone|mesh-list
44472341|NCT05368012|Bupivacaine|bupivacaine|mesh-list
44472342|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472343|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
44472344|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
44472345|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472346|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472347|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472348|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
44472349|NCT05368012|Hormones|hormones|mesh-ancestor
44472350|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472351|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472352|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472353|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44472354|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
44472355|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472356|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
44472357|NCT05366166|Cisplatin|cisplatin|mesh-list
44472358|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
44472359|NCT05366166|Olaparib|olaparib|mesh-list
44472360|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472361|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472362|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44472363|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472364|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472365|NCT05360615|Empagliflozin|empagliflozin|mesh-list
44472366|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44472367|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472368|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44472369|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472370|NCT05369819|Midazolam|midazolam|mesh-list
44472371|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44472372|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44472373|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472374|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472375|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44472376|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44472377|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472378|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44472379|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
44472380|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
44472381|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
44472382|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
44472383|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472384|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735402|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44472386|NCT05360576|Etonogestrel|etonogestrel|mesh-list
44472387|NCT05360576|NuvaRing|nuvaring|mesh-list
44472388|NCT05360576|Estradiol|estradiol|mesh-list
44472389|NCT05360576|Estrogens|estrogens|mesh-ancestor
44472390|NCT05360576|Hormones|hormones|mesh-ancestor
44472391|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472392|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472393|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44472394|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
44472395|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44472396|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44472397|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44472398|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44472399|NCT05369676|Ritonavir|ritonavir|mesh-list
44472400|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44472401|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44472402|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
44472403|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472404|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472405|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44472406|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44472407|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
44472408|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472409|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44472410|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44472411|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44472412|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
44472413|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472414|NCT05361330|Fluoxetine|fluoxetine|mesh-list
44472415|NCT05361330|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44472416|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44472417|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472418|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472419|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472420|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
44472421|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969549|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
44472422|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44472423|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
44472424|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472425|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44472426|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44472427|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472429|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472430|NCT05367245|Butyric Acid|butyric acid|mesh-list
44472431|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472432|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
44472433|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
44472434|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472435|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472436|NCT05365035|Cytarabine|cytarabine|mesh-list
44472437|NCT05365035|Azacitidine|azacitidine|mesh-list
44472438|NCT05365035|Venetoclax|venetoclax|mesh-list
44472439|NCT05365035|Cladribine|cladribine|mesh-list
44472440|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472441|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
44472442|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472443|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472444|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
44472445|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472446|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472447|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
44472448|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472449|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472450|NCT05366101|Valsartan|valsartan|mesh-list
44472451|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44472452|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44472453|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44472454|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44472455|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472456|NCT05365555|Anesthetics|anesthetics|mesh-list
44472457|NCT05365555|Ropivacaine|ropivacaine|mesh-list
44472458|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
44472459|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472460|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472461|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
44472462|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472463|NCT05630638|Dolutegravir|dolutegravir|mesh-list
44472464|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44472465|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44472466|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472467|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472468|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44472469|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44472470|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
44472471|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472472|NCT05630534|Minocycline|minocycline|mesh-list
44472473|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472474|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472475|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
44472476|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472477|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472478|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44472479|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44472480|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472481|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472482|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472483|NCT05630222|Acetaminophen|acetaminophen|mesh-list
44472484|NCT05630222|Ibuprofen|ibuprofen|mesh-list
44472485|NCT05630222|Morphine|morphine|mesh-list
44472486|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44472487|NCT05630222|Narcotics|narcotics|mesh-ancestor
44472488|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472489|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472490|NCT05630222|Analgesics|analgesics|mesh-ancestor
44472491|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
44472492|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472493|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472494|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
43969618|NCT01658228|Citalopram|citalopram|mesh-list
44472495|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44472496|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472497|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472498|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44472499|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472500|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472501|NCT05632692|Menthol|menthol|mesh-list
44472502|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
44735413|NCT05403086|Hallucinogens|hallucinogens|mesh-list
44735414|NCT05403086|Analgesics|analgesics|mesh-ancestor
44735415|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
44735416|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735417|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735418|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44735419|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44735420|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
44735421|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
44735422|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44735423|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44735424|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44735425|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735426|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735427|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472510|NCT05632328|Paclitaxel|paclitaxel|mesh-list
44472511|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44472512|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472513|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472514|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472515|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472516|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472517|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472518|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472519|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
44472520|NCT05632328|Antiviral Agents|antiviral agents|mesh-ancestor
44472521|NCT05632328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472522|NCT05632328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472523|NCT05632328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472524|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
44472525|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472526|NCT05632224|Aprepitant|aprepitant|mesh-list
44472527|NCT05632224|Granisetron|granisetron|mesh-list
44472528|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
44472529|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
44472530|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472531|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472532|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472533|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44472534|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472535|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472536|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44472537|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
44472538|NCT05632159|Anesthetics|anesthetics|mesh-list
44472539|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472540|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472541|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
44472542|NCT05631912|Fludarabine|fludarabine|mesh-list
44472543|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
44472544|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472545|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
44472546|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472547|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472548|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44472549|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
44472550|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472551|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472552|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44472553|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472555|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
44472556|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44472557|NCT05631899|Paclitaxel|paclitaxel|mesh-list
44472558|NCT05631899|Antibodies|antibodies|mesh-list
44472559|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
44472560|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
44472561|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472562|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
44472563|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472564|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472565|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44472566|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
44472567|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472568|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472569|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44472570|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472571|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472572|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472573|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472574|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
44472575|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44472576|NCT05631886|Paclitaxel|paclitaxel|mesh-list
44472577|NCT05631886|Antibodies|antibodies|mesh-list
44472578|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
44472579|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
44472580|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472581|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
44472582|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472583|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472584|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44472585|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
44472586|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472587|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472588|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44472589|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472590|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472591|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472592|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472593|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44472594|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44472595|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44472596|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472597|NCT05631795|Fulvestrant|fulvestrant|mesh-list
44472598|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472599|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472600|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44472601|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44472602|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472603|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472604|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472605|NCT05631704|Midazolam|midazolam|mesh-list
44472606|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44472607|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44472608|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472609|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472610|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44472611|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44472612|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472613|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44472614|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
44472615|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
44472616|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
44472617|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
44472618|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472619|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472620|NCT05631678|Itraconazole|itraconazole|mesh-list
44472621|NCT05631678|Rifampin|rifampin|mesh-list
44472622|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
44472623|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472624|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44472625|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44472626|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236590|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
44472627|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472628|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44472629|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472630|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472631|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472632|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44472633|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44472634|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
44472635|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44472636|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
44472637|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44472638|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44472639|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44472640|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44472641|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44472642|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44472643|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44472644|NCT05631405|Dexamethasone|dexamethasone|mesh-list
44472645|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472646|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
44472647|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
44472648|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472649|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472650|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472651|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
44472652|NCT05631405|Hormones|hormones|mesh-ancestor
44472653|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472654|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472655|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472656|NCT05631236|Methamphetamine|methamphetamine|mesh-list
44472657|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44472658|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472659|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
44472660|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
44472661|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472662|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
44472663|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472664|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472665|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
44472666|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44472667|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44472668|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472669|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44472670|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
44472671|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44472672|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472673|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472674|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472675|NCT05631028|Analgesics|analgesics|mesh-ancestor
44472676|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
44472677|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472678|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44472679|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44472680|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44472681|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44472682|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472683|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472684|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
44472685|NCT05630989|Mitogens|mitogens|mesh-list
44472686|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
44472687|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44472688|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44472689|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472690|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472691|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472692|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472693|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472694|NCT05630976|Isavuconazole|isavuconazole|mesh-list
44472695|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
44472696|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472697|NCT05630872|Lamivudine|lamivudine|mesh-list
44472698|NCT05630872|Dolutegravir|dolutegravir|mesh-list
44472699|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44472700|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44472701|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472702|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472703|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
44472704|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44472705|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44472706|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44472707|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44472708|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44472709|NCT05630846|Vaccines|vaccines|mesh-list
44472710|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
44472711|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472712|NCT05630768|Vitamin D|vitamin d|mesh-list
44472713|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
44472714|NCT05630768|Calcium|calcium|mesh-list
44472715|NCT05630768|Vitamins|vitamins|mesh-ancestor
44472716|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
44472717|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472718|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44472719|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44472720|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44472721|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472722|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472723|NCT05634057|Anisodamine|anisodamine|mesh-list
44472724|NCT05634057|Heparin|heparin|mesh-list
44472725|NCT05634057|Calcium heparin|calcium heparin|mesh-list
44472726|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
44472727|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44472728|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44472729|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472730|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44472731|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44472732|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
44472733|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472734|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472735|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44472736|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44472737|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472738|NCT05634057|Analgesics|analgesics|mesh-ancestor
44472739|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
44472740|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472741|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472742|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472743|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44472744|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472745|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
44472746|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
44472747|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
44472748|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44472749|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
44472750|NCT05634057|Protective Agents|protective agents|mesh-ancestor
44472752|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472753|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472754|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472755|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472756|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472757|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472758|NCT05633771|Adalimumab|adalimumab|mesh-list
44472759|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472760|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472761|NCT05633758|Metolazone|metolazone|mesh-list
44472762|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44472763|NCT05633758|Diuretics|diuretics|mesh-ancestor
44472764|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
44472765|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472766|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44472767|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472768|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472769|NCT05633719|Cisplatin|cisplatin|mesh-list
44472770|NCT05633719|Carboplatin|carboplatin|mesh-list
44143403|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472771|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472772|NCT05633667|Paclitaxel|paclitaxel|mesh-list
44472773|NCT05633667|Docetaxel|docetaxel|mesh-list
44472774|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44472795|NCT00219349|Citalopram|citalopram|mesh-list
44472796|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44472797|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44472798|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472799|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472800|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472801|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
44472802|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472803|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44472804|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
44472805|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472806|NCT00219284|Levodopa|levodopa|mesh-list
44472807|NCT00219284|Carbidopa|carbidopa|mesh-list
44472808|NCT00219284|Entacapone|entacapone|mesh-list
44472809|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44472810|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44472811|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44472812|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
44472813|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472814|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472815|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472816|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44472817|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472818|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44472819|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44472820|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
44472821|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
44472822|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44472823|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44472824|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44472825|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44472826|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472827|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
43867861|NCT01061411|Sunitinib|sunitinib|mesh-list
44472828|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472829|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472830|NCT00218296|Lobeline|lobeline|mesh-list
44472831|NCT00218296|Nicotine|nicotine|mesh-list
44472832|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44472833|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
44472834|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472835|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472836|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44472837|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44472838|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
44472839|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472840|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472841|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44472842|NCT00218257|Progesterone|progesterone|mesh-list
44472843|NCT00218257|Progestins|progestins|mesh-ancestor
44472844|NCT00218257|Hormones|hormones|mesh-ancestor
44472845|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472846|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472847|NCT00217971|Dronabinol|dronabinol|mesh-list
44472848|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
44472849|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472850|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472851|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44472852|NCT00217971|Analgesics|analgesics|mesh-ancestor
44472853|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
44472854|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472855|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44472856|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44472857|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472858|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472859|NCT00217971|Hormones|hormones|mesh-ancestor
44472860|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472861|NCT00217672|Bevacizumab|bevacizumab|mesh-list
44472862|NCT00217672|Docetaxel|docetaxel|mesh-list
44472863|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472864|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472865|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44472866|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44472867|NCT00217672|Growth Substances|growth substances|mesh-ancestor
44472868|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472869|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
44472870|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472871|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472872|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472873|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472874|NCT00217620|Sorafenib|sorafenib|mesh-list
44472875|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472876|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44472877|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472878|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472879|NCT00217581|Bevacizumab|bevacizumab|mesh-list
44472880|NCT00217581|Docetaxel|docetaxel|mesh-list
44472881|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
44472882|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472883|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472884|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44472885|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44472886|NCT00217581|Growth Substances|growth substances|mesh-ancestor
44472887|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472888|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44472889|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472890|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472891|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472892|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472893|NCT00217464|Fulvestrant|fulvestrant|mesh-list
44472894|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472895|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472896|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44472897|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44472898|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
44472899|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472900|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472901|NCT00217425|Prednisone|prednisone|mesh-list
44472902|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
44472903|NCT00217425|Bevacizumab|bevacizumab|mesh-list
44472904|NCT00217425|Doxorubicin|doxorubicin|mesh-list
44472905|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44472906|NCT00217425|Vincristine|vincristine|mesh-list
44472907|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44472908|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
44472909|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472910|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44472911|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44472912|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
44472913|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472914|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472915|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44472916|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472917|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44472918|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44472919|NCT00217425|Growth Substances|growth substances|mesh-ancestor
44472920|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
44472921|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44472922|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44472923|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44472924|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472925|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472926|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
44472927|NCT00217425|Hormones|hormones|mesh-ancestor
44472928|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472929|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472930|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44472931|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
44472932|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
44472933|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44472934|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44472935|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472936|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
44472937|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44472938|NCT00216736|Dexamethasone|dexamethasone|mesh-list
44472939|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44472940|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
44472941|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
44472942|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44472943|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472944|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44472945|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
44472947|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44472948|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44472949|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472950|NCT00216671|Risperidone|risperidone|mesh-list
44472951|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44472952|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
44472953|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472954|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472955|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472956|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44472957|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44472958|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472959|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472960|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44472961|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
44472962|NCT00216476|Risperidone|risperidone|mesh-list
44472963|NCT00216476|Aripiprazole|aripiprazole|mesh-list
44472964|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44472965|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44472966|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
44472967|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44472968|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472969|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44472970|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44472971|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44472972|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44472973|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44472974|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44472975|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
44472976|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
44472977|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
44472978|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44472979|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44472980|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44472981|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44472982|NCT00216203|Pemetrexed|pemetrexed|mesh-list
44472983|NCT00216203|Cetuximab|cetuximab|mesh-list
44472984|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472985|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472986|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472987|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44472988|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44472989|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44472990|NCT00216086|Capecitabine|capecitabine|mesh-list
44472991|NCT00216086|Irinotecan|irinotecan|mesh-list
44472992|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44472993|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
44472994|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44472995|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44472996|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44472997|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44472998|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44472999|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
44473000|NCT00215943|Thalidomide|thalidomide|mesh-list
44473001|NCT00215943|Dexamethasone|dexamethasone|mesh-list
44473002|NCT00215943|Doxorubicin|doxorubicin|mesh-list
44473003|NCT00215943|Vincristine|vincristine|mesh-list
44473004|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44473005|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473006|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
44473007|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
44473008|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473009|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291693|NCT00784290|Orantinib|orantinib|mesh-list
44473010|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473011|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
44473012|NCT00215943|Hormones|hormones|mesh-ancestor
44473013|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473014|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473015|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473016|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44473017|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44473018|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473019|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473020|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473021|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44473022|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44473023|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44473024|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44473025|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473026|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
44473027|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
44473028|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44473029|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473030|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44473031|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44473032|NCT00215943|Growth Substances|growth substances|mesh-ancestor
44473033|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
44473034|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44473035|NCT00215644|Cisplatin|cisplatin|mesh-list
44473036|NCT00215644|Capecitabine|capecitabine|mesh-list
44473037|NCT00215644|Epirubicin|epirubicin|mesh-list
44473038|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473039|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44473040|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
44473041|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473042|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44473043|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44473044|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473045|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473046|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44473047|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473048|NCT00215150|Ziprasidone|ziprasidone|mesh-list
44473049|NCT00215150|Sertraline|sertraline|mesh-list
44473050|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
44473051|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44473052|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44473053|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44473054|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473055|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473056|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473057|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
44473058|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473059|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44473060|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44473061|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44473062|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473063|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44473064|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
44473066|NCT00215137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44473067|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44473068|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473069|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473070|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473071|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
44473072|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473073|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44473074|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
44473075|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44473076|NCT00214461|Vaccines|vaccines|mesh-list
44473077|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
44473078|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473079|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44473080|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473081|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473082|NCT00214019|Fluticasone|fluticasone|mesh-list
44473083|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44473084|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44473085|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473086|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473087|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
44473088|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473089|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473090|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473091|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473092|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473093|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44473094|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44473095|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44473096|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473097|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473098|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473099|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473100|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
44473101|NCT00214019|Hormones|hormones|mesh-ancestor
44473102|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473103|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
44473104|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
44473105|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44473106|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473107|NCT00213148|Anastrozole|anastrozole|mesh-list
44473108|NCT00213148|Citric Acid|citric acid|mesh-list
44473109|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
44473110|NCT00213148|Clomiphene|clomiphene|mesh-list
44473111|NCT00213148|Enclomiphene|enclomiphene|mesh-list
44473112|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
44473113|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
44473114|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44473115|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
44473116|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
44473117|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473118|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473119|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473120|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44473121|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44473122|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473123|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44473124|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
44236593|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
44473125|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473126|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473127|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44473128|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
44473129|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44473130|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44473131|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44473132|NCT00212758|Hormones|hormones|mesh-list
44473133|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473134|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473135|NCT00211887|Interferons|interferons|mesh-list
44473136|NCT00211887|Interferon-beta|interferon-beta|mesh-list
44473137|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
44473138|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
44473139|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
44473140|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473141|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
44473142|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473143|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
44473144|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473145|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44473146|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473147|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473148|NCT00211757|Valproic Acid|valproic acid|mesh-list
44473149|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
44473150|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473151|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473152|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
44473153|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473154|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473155|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
44473156|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44473157|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473158|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44473159|NCT00211536|Insulin|insulin|mesh-list
44473160|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44473161|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44473162|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473163|NCT00211510|Insulin|insulin|mesh-list
44473164|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44473165|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473166|NCT00211185|Prednisone|prednisone|mesh-list
44473167|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
44473168|NCT00211185|Doxorubicin|doxorubicin|mesh-list
44473169|NCT00211185|Vincristine|vincristine|mesh-list
44473170|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
44473171|NCT00211185|Lenograstim|lenograstim|mesh-list
44473172|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473173|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
44473174|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473175|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473176|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44473177|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
44473178|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473179|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473180|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44473181|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44473182|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44473183|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473184|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473185|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473186|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
44473187|NCT00211185|Hormones|hormones|mesh-ancestor
44473188|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473189|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473190|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44473191|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
44473192|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
44473193|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
44473194|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44473195|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44473196|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44473197|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473198|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868283|NCT00789399|PENTA|penta|mesh-list
44473199|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473200|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473202|NCT00210626|Hematinics|hematinics|mesh-ancestor
44473203|NCT00210184|Leucovorin|leucovorin|mesh-list
44473204|NCT00210184|Fluorouracil|fluorouracil|mesh-list
44473205|NCT00210184|Irinotecan|irinotecan|mesh-list
44473206|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
44473207|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473208|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44473209|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473210|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473211|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
44473212|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473213|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44473214|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473215|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473216|NCT00210184|Antidotes|antidotes|mesh-ancestor
44473217|NCT00210184|Protective Agents|protective agents|mesh-ancestor
44473218|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
44473219|NCT00210184|Vitamins|vitamins|mesh-ancestor
44473220|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
44473221|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
44473222|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473223|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44473224|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473225|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473226|NCT00219297|Epothilone B|epothilone b|mesh-list
44473227|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473228|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44473229|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44473230|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44473231|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473232|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
44473233|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
44473234|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473235|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
44473236|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473237|NCT00214968|Modafinil|modafinil|mesh-list
44473238|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44473239|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473240|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44473241|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44473242|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44473243|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473244|NCT00210964|Linezolid|linezolid|mesh-list
44473245|NCT00210964|Ceftazidime|ceftazidime|mesh-list
44473246|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
44473247|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44473248|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44473249|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473250|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44473251|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473252|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473253|NCT00217022|Budesonide|budesonide|mesh-list
44473254|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473255|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473256|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
44473257|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473258|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473259|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473260|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473261|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
44473262|NCT00217022|Hormones|hormones|mesh-ancestor
44473263|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473264|NCT03592212|Albuterol|albuterol|mesh-list
44473265|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473266|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
44473267|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473268|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473269|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473270|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473271|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
44473272|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44473273|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44473275|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473276|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473277|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473278|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473279|NCT03599791|Fluticasone|fluticasone|mesh-list
44473280|NCT03599791|Xhance|xhance|mesh-list
44473281|NCT03599791|Azelastine|azelastine|mesh-list
44473282|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473283|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473284|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
44473285|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473286|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473287|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473288|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473289|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473290|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44473291|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44473292|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473293|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473294|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44473295|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44473296|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
44473297|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
44473298|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473299|NCT03593434|Xenon|xenon|mesh-list
44473300|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44473301|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
44473302|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
44473303|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473304|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473305|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
44473306|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473307|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473308|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
44473309|NCT03596424|Ketamine|ketamine|mesh-list
44473310|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44473311|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473312|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473313|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44473314|NCT03596424|Analgesics|analgesics|mesh-ancestor
44473315|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
44473316|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473317|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44473318|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44473319|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473320|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473321|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473322|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473323|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44473324|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473325|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
44473326|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
44473327|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44473328|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44473329|NCT03596385|Metoprolol|metoprolol|mesh-list
44473330|NCT03596385|Atenolol|atenolol|mesh-list
44473331|NCT03596385|Carvedilol|carvedilol|mesh-list
44473332|NCT03596385|Bisoprolol|bisoprolol|mesh-list
44473333|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44473334|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44473335|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44473336|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
44473337|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
44473338|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473339|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473340|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44473341|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44473342|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473343|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473344|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473345|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
44473346|NCT03596385|Protective Agents|protective agents|mesh-ancestor
44473347|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44473348|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473359|NCT03590652|Dexamethasone|dexamethasone|mesh-list
44473360|NCT03590652|Daratumumab|daratumumab|mesh-list
44473361|NCT03590652|Pomalidomide|pomalidomide|mesh-list
44473362|NCT03590652|Ixazomib|ixazomib|mesh-list
44473363|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473364|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
44473365|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
44473366|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473367|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473368|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473369|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
44473370|NCT03590652|Hormones|hormones|mesh-ancestor
44473371|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473372|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473373|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473374|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
44473375|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44473376|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44473377|NCT03590652|Growth Substances|growth substances|mesh-ancestor
44473378|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
44473379|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
44473380|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473381|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473382|NCT03597997|Propofol|propofol|mesh-list
44473383|NCT03597997|Sevoflurane|sevoflurane|mesh-list
44473384|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44473385|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473386|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464772|NCT01490086|RP5063|rp5063|mesh-list
44473387|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473388|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
44473389|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
44473390|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44473391|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44473392|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
44473393|NCT03594162|Fludarabine|fludarabine|mesh-list
44473394|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473395|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
44473396|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473397|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473398|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44473399|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
44473400|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473401|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473402|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735462|NCT05379595|Leucovorin|leucovorin|mesh-list
44735463|NCT05379595|Fluorouracil|fluorouracil|mesh-list
44735464|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
44735465|NCT05379595|Irinotecan|irinotecan|mesh-list
44735466|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
44735467|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
44735468|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735469|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735470|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735471|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735482|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735483|NCT05377034|Bevacizumab|bevacizumab|mesh-list
44735484|NCT05377034|Atezolizumab|atezolizumab|mesh-list
44735485|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735486|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735487|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44735488|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44735489|NCT05377034|Growth Substances|growth substances|mesh-ancestor
44735490|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735491|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
44735501|NCT05361915|Abivertinib|abivertinib|mesh-list
44735502|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735503|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735504|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735505|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
44735506|NCT05353439|Topotecan|topotecan|mesh-list
44735507|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735508|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292121|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
44735509|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44473417|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
44473418|NCT03590054|Abexinostat|abexinostat|mesh-list
44473419|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473420|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473421|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44473422|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473423|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473424|NCT03598426|Dexamethasone|dexamethasone|mesh-list
44473425|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473426|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
44473427|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
44473428|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473429|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473430|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473431|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
44473432|NCT03598426|Hormones|hormones|mesh-ancestor
44473433|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473434|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473435|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473436|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
44473437|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473438|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473439|NCT03590210|Nivolumab|nivolumab|mesh-list
44473440|NCT03590210|Trabectedin|trabectedin|mesh-list
44473441|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473442|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473443|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44473444|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473445|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44473446|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
44473447|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44473448|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44473449|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473450|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
44473451|NCT03593811|Ondansetron|ondansetron|mesh-list
44473452|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
44473453|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
44473454|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473455|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473456|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473457|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
44473458|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473459|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44473460|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
44473461|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473462|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473463|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44473464|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44473465|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473466|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44473467|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44473468|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44473469|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
44473470|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
44473471|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44473472|NCT03597594|Fludarabine|fludarabine|mesh-list
44473473|NCT03597594|Busulfan|busulfan|mesh-list
44473474|NCT03597594|Thiotepa|thiotepa|mesh-list
44473475|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
44473476|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44473477|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735510|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473478|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473479|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473480|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
44473481|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473482|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
44473483|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44473484|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44473485|NCT03592693|Vitamins|vitamins|mesh-list
44473486|NCT03592693|Ascorbic Acid|ascorbic acid|mesh-list
44473487|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
44473488|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
44473489|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473490|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473491|NCT03592693|Antioxidants|antioxidants|mesh-ancestor
44473492|NCT03592693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473493|NCT03592693|Protective Agents|protective agents|mesh-ancestor
44473494|NCT03596905|Plecanatide|plecanatide|mesh-list
44473495|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44473496|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
44473497|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473498|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473499|NCT03596164|Teduglutide|teduglutide|mesh-list
44473500|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473501|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44473502|NCT03596164|Protective Agents|protective agents|mesh-ancestor
44473503|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473504|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
44473505|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44473506|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44473507|NCT03599778|Apatinib|apatinib|mesh-list
44473508|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473509|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44473510|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473511|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473512|NCT03599726|Donepezil|donepezil|mesh-list
44473513|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44473514|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473515|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473516|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
44473517|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473518|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473519|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
44473520|NCT03599609|Simvastatin|simvastatin|mesh-list
44473521|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44473522|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44473523|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
44473524|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473525|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44473526|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44473527|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473528|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
44473529|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
44473530|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44473531|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
44473532|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44473533|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44473534|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473535|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44473536|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473537|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473538|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44473539|NCT03599596|Renal Agents|renal agents|mesh-ancestor
44473540|NCT03599466|Lisinopril|lisinopril|mesh-list
44473541|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44473542|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
44473543|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473544|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473545|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44473546|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44473547|NCT03599466|Protective Agents|protective agents|mesh-ancestor
44473548|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473549|NCT03599427|Lidocaine|lidocaine|mesh-list
44473550|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473551|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
44473552|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473553|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473554|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
44473555|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473556|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44473557|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44473558|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44473559|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473560|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473561|NCT03599284|Clopidogrel|clopidogrel|mesh-list
44473562|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44473563|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44473564|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44473565|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44473566|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
44473567|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473568|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473569|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473570|NCT03598868|Vortioxetine|vortioxetine|mesh-list
44473571|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
44473572|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44473573|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44473574|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44473575|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473576|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473577|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44473578|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44473579|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473580|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473581|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473582|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
44473583|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44473584|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44473585|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44473586|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44473587|NCT03598816|Durvalumab|durvalumab|mesh-list
44473588|NCT03598816|Tremelimumab|tremelimumab|mesh-list
44473589|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473590|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473591|NCT03598738|Esomeprazole|esomeprazole|mesh-list
44473592|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44473593|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473594|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44473595|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473596|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473597|NCT03598725|Prednisone|prednisone|mesh-list
44473598|NCT03598725|Rituximab|rituximab|mesh-list
44473599|NCT03598725|Factor VIII|factor viii|mesh-list
44473600|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473601|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473602|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
44473603|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473604|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473605|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473606|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
44473607|NCT03598725|Hormones|hormones|mesh-ancestor
44473608|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473609|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473610|NCT03598725|Coagulants|coagulants|mesh-ancestor
44473611|NCT03598673|Nebivolol|nebivolol|mesh-list
44473612|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44473613|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
44473614|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44473615|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44473616|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473617|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473618|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473619|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473620|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473621|NCT03598634|Riboflavin|riboflavin|mesh-list
44473622|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
44473623|NCT03598634|Vitamins|vitamins|mesh-ancestor
44473624|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
44473625|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473626|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44473627|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473629|NCT03598582|Hematinics|hematinics|mesh-ancestor
44473630|NCT03598556|Vitamin D|vitamin d|mesh-list
44473631|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
44473632|NCT03598556|Vitamins|vitamins|mesh-ancestor
44473633|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
44473634|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473635|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44473636|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44473637|NCT03598374|Folic Acid|folic acid|mesh-list
44473638|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
44473639|NCT03598374|Inositol|inositol|mesh-list
44473640|NCT03598374|Hematinics|hematinics|mesh-ancestor
44473641|NCT03598374|Vitamins|vitamins|mesh-ancestor
44473642|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
44473643|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473644|NCT03598348|Capecitabine|capecitabine|mesh-list
44473645|NCT03598348|Apatinib|apatinib|mesh-list
44473646|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44473647|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
44473648|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473649|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473650|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44473651|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473652|NCT03598192|Sufentanil|sufentanil|mesh-list
44473653|NCT03598192|Dsuvia|dsuvia|mesh-list
44473654|NCT03598192|Ropivacaine|ropivacaine|mesh-list
44473655|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473656|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
44473657|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473658|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473659|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
44473660|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473661|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44473662|NCT03598192|Narcotics|narcotics|mesh-ancestor
44473663|NCT03598192|Analgesics|analgesics|mesh-ancestor
44473664|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44473665|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473666|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
44735511|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735512|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735536|NCT05298423|Carboplatin|carboplatin|mesh-list
44735537|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
44735538|NCT05298423|Pemetrexed|pemetrexed|mesh-list
44735539|NCT05298423|Durvalumab|durvalumab|mesh-list
44735540|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735541|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735542|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735543|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735544|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735545|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735546|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735547|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44735548|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473668|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44473669|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473670|NCT03597919|Vaccines|vaccines|mesh-list
44473671|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
44473672|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473673|NCT03597893|Oxytocin|oxytocin|mesh-list
44473674|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
44473675|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44473676|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473677|NCT03597867|Diclofenac|diclofenac|mesh-list
44473678|NCT03597867|Indomethacin|indomethacin|mesh-list
44473679|NCT03597867|Nepafenac|nepafenac|mesh-list
44473680|NCT03597867|Bromfenac|bromfenac|mesh-list
44473681|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44473682|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44473683|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44473684|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44473685|NCT03597867|Analgesics|analgesics|mesh-ancestor
44473686|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
44473687|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473688|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473689|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473690|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473691|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44473692|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473693|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473694|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
44473695|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
44473696|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44473697|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
44473698|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44473699|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473700|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
44473701|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
44473702|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473703|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473704|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
44473705|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44473706|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473707|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473708|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44473709|NCT03597477|Analgesics|analgesics|mesh-ancestor
44473710|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
44473711|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473712|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44473713|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44473714|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473715|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473716|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473717|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473718|NCT03597308|Acetaminophen|acetaminophen|mesh-list
44473719|NCT03597308|Ibuprofen|ibuprofen|mesh-list
44473720|NCT03597308|Oxycodone|oxycodone|mesh-list
44473721|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44473722|NCT03597308|Analgesics|analgesics|mesh-ancestor
44473723|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
44473724|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473725|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473726|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
44473727|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44473728|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473729|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473730|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44473731|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473732|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473733|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44473734|NCT03597308|Narcotics|narcotics|mesh-ancestor
44473735|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473736|NCT03597282|Nivolumab|nivolumab|mesh-list
44473737|NCT03597282|Ipilimumab|ipilimumab|mesh-list
44473738|NCT03597282|Poly ICLC|poly iclc|mesh-list
44473739|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473740|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473741|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44473742|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473743|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
44473744|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
44473745|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473746|NCT03596970|Everolimus|everolimus|mesh-list
44473747|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473748|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473749|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
44473750|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473751|NCT03596957|Tolvaptan|tolvaptan|mesh-list
44473752|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44473753|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473754|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
44473755|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473756|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
44473757|NCT03596892|Busulfan|busulfan|mesh-list
44473758|NCT03596892|Decitabine|decitabine|mesh-list
44473759|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44473760|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
44473761|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473762|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44473763|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44473764|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
44473765|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473766|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473767|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44473768|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44473769|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
44473770|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473771|NCT03596502|Warfarin|warfarin|mesh-list
44473772|NCT03596502|Anticoagulants|anticoagulants|mesh-list
44473773|NCT03596294|Rifampin|rifampin|mesh-list
44473774|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44473775|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
44473776|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44473777|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473778|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
44473779|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44473780|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473781|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473782|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44473783|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44473784|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44473785|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44473786|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44473787|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44473788|NCT03596281|Bevacizumab|bevacizumab|mesh-list
44473789|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
44473790|NCT03596281|Doxorubicin|doxorubicin|mesh-list
44473791|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44473792|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473793|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473794|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44473800|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44473801|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44473802|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473803|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473805|NCT03596099|Retinol acetate|retinol acetate|mesh-list
44473806|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44473807|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44473808|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44473809|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
44473810|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473811|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44473812|NCT03596099|Protective Agents|protective agents|mesh-ancestor
44473813|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473814|NCT03596060|Fentanyl|fentanyl|mesh-list
44473815|NCT03596060|Morphine|morphine|mesh-list
44473816|NCT03596060|Propofol|propofol|mesh-list
44473817|NCT03596060|Rocuronium|rocuronium|mesh-list
44292558|NCT00788606|Rituximab|rituximab|mesh-list
44473818|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44473819|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473820|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473821|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473822|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
44473823|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
44473824|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44473825|NCT03596060|Narcotics|narcotics|mesh-ancestor
44473826|NCT03596060|Analgesics|analgesics|mesh-ancestor
44473827|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
44473828|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473829|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44473830|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44473831|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44473832|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44473833|NCT03595930|Fluticasone|fluticasone|mesh-list
44473834|NCT03595930|Xhance|xhance|mesh-list
44473835|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473836|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473837|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
44473838|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473839|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473840|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473841|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473842|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473843|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44473844|NCT03595852|Cefazolin|cefazolin|mesh-list
44473845|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44473846|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735549|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735550|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44735551|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44735557|NCT05279417|Methotrexate|methotrexate|mesh-list
44735558|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44735559|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
44735560|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44735561|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735562|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44735563|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
44735564|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735565|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735566|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44735567|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735568|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44735569|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735570|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
44735571|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735572|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44735573|NCT05274243|Phenol|phenol|mesh-list
44735574|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44735575|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735576|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
44735577|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44735578|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44735579|NCT05270733|Ustekinumab|ustekinumab|mesh-list
44735580|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44735581|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
44735582|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
44735583|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735584|NCT05253417|Cannabidiol|cannabidiol|mesh-list
44735585|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
44735586|NCT05242965|Vaccines|vaccines|mesh-list
44735587|NCT05242965|Sargramostim|sargramostim|mesh-list
44735588|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
44735589|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735590|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
44735591|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735592|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735593|NCT05226598|Paclitaxel|paclitaxel|mesh-list
44735594|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44735595|NCT05226598|Cisplatin|cisplatin|mesh-list
44735596|NCT05226598|Carboplatin|carboplatin|mesh-list
44292636|NCT00789308|Cyclosporine|cyclosporine|mesh-list
44473847|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
44473848|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473849|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473850|NCT03595514|Dexamethasone|dexamethasone|mesh-list
44473852|NCT03595514|Epinephrine|epinephrine|mesh-list
44473853|NCT03595514|Bupivacaine|bupivacaine|mesh-list
44473854|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473855|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
44473856|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
44473857|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473858|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473859|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473860|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
44473861|NCT03595514|Hormones|hormones|mesh-ancestor
44473862|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473863|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473864|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473865|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473866|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
44473867|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473868|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
44473869|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44473870|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44473871|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44473872|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473873|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473874|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44473875|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44473876|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
44473877|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473878|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44473879|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473880|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473881|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473882|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
44473883|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
44473884|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44473885|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
44473886|NCT03595397|Fentanyl|fentanyl|mesh-list
44473887|NCT03595397|Bupivacaine|bupivacaine|mesh-list
44473888|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473889|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
44473890|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473891|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473892|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
44473893|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473894|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44473895|NCT03595397|Narcotics|narcotics|mesh-ancestor
44473896|NCT03595397|Analgesics|analgesics|mesh-ancestor
44473897|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44473898|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44473899|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
44473900|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44473902|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44473903|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44473904|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473905|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44473906|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
44473907|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44473908|NCT03595371|Dapansutrile|dapansutrile|mesh-list
43970994|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
44473909|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473910|NCT03595319|Sevoflurane|sevoflurane|mesh-list
44473911|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44473912|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44473913|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
44473914|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
44473915|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473916|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473917|NCT03595254|Nicotine|nicotine|mesh-list
44473918|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44473919|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
44473920|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473921|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473922|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44473923|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44473924|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
44473925|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44473926|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473927|NCT03595189|Cilastatin|cilastatin|mesh-list
44473928|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
44473929|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473930|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473931|NCT03595046|Dexamethasone|dexamethasone|mesh-list
44473932|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
44473933|NCT03595046|Ropivacaine|ropivacaine|mesh-list
44473934|NCT03595046|BB 1101|bb 1101|mesh-list
44473935|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473936|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
44473937|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
44473938|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473939|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473940|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44473941|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
44473942|NCT03595046|Hormones|hormones|mesh-ancestor
44473943|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473944|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44473945|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473946|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
44473947|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473948|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473949|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
44473950|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
44473951|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473952|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
44473953|NCT03594968|Progesterone|progesterone|mesh-list
44473954|NCT03594968|Progestins|progestins|mesh-ancestor
44473955|NCT03594968|Hormones|hormones|mesh-ancestor
44473956|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44473957|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473958|NCT03594565|Fluticasone|fluticasone|mesh-list
44473959|NCT03594565|Xhance|xhance|mesh-list
44473960|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44473961|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44473962|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
44473963|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44473964|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473965|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44473966|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
44473967|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44473968|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44473969|NCT03594461|Aflibercept|aflibercept|mesh-list
44473970|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44473971|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44473972|NCT03594461|Growth Substances|growth substances|mesh-ancestor
44473973|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473974|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
44473975|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473977|NCT03594396|Olaparib|olaparib|mesh-list
44473978|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44473979|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44473980|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44473981|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44473982|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44473983|NCT03594240|Folic Acid|folic acid|mesh-list
44473984|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
44473985|NCT03594240|Vitamins|vitamins|mesh-ancestor
44473986|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
44473987|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473988|NCT03594240|Hematinics|hematinics|mesh-ancestor
44473989|NCT03594214|Vitamin D|vitamin d|mesh-list
44473990|NCT03594214|Vitamins|vitamins|mesh-ancestor
44473991|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
44473992|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473993|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44473994|NCT03594188|Anesthetics|anesthetics|mesh-list
44473995|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44473996|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44473997|NCT03594149|Levofloxacin|levofloxacin|mesh-list
44292788|NCT00789971|Hormones|hormones|mesh-ancestor
44473998|NCT03594149|Ofloxacin|ofloxacin|mesh-list
44735597|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
44473999|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44474000|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474001|NCT03594149|Renal Agents|renal agents|mesh-ancestor
44474002|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474003|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44474004|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44474005|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474006|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474007|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474008|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44474009|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474010|NCT03593954|Ritonavir|ritonavir|mesh-list
44474011|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44474012|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44474013|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474014|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474015|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474016|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44474017|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44474018|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
44474019|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474020|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44474021|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474022|NCT03593668|Metformin|metformin|mesh-list
44474023|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474024|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474025|NCT03593447|Ribavirin|ribavirin|mesh-list
44474026|NCT03593447|Yimitasvir|yimitasvir|mesh-list
44474027|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
44474028|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474029|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
44474030|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474031|NCT03593304|Vitamins|vitamins|mesh-list
44474032|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
44474033|NCT03593304|Pyridoxine|pyridoxine|mesh-list
44474034|NCT03593304|Pyridoxal|pyridoxal|mesh-list
44474035|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
44474036|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
44474037|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
44474038|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474039|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44474040|NCT03593291|Dalteparin|dalteparin|mesh-list
44474041|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
44474042|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44474043|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44474044|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474045|NCT03593135|Metformin|metformin|mesh-list
44474046|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44474047|NCT03593135|Acetic Acid|acetic acid|mesh-list
44474048|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474049|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474050|NCT03593135|Incretins|incretins|mesh-ancestor
44474051|NCT03593135|Hormones|hormones|mesh-ancestor
44474052|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474053|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44474055|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474056|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474057|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474058|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735598|NCT05226598|Pemetrexed|pemetrexed|mesh-list
44735599|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735600|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735601|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735602|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735603|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735604|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735605|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735606|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735607|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44735608|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44735609|NCT05224141|Cisplatin|cisplatin|mesh-list
44735610|NCT05224141|Carboplatin|carboplatin|mesh-list
44735611|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
44735612|NCT05224141|Etoposide|etoposide|mesh-list
44735613|NCT05224141|Atezolizumab|atezolizumab|mesh-list
44735614|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474059|NCT03592992|Morphine|morphine|mesh-list
44474060|NCT03592992|Hydromorphone|hydromorphone|mesh-list
44474061|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44474062|NCT03592992|Narcotics|narcotics|mesh-ancestor
44474063|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474064|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474065|NCT03592992|Analgesics|analgesics|mesh-ancestor
44474066|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
44474067|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474068|NCT03592901|Anesthetics|anesthetics|mesh-list
44474069|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474070|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474071|NCT03592836|Furosemide|furosemide|mesh-list
44474072|NCT03592836|Diuretics|diuretics|mesh-list
44474073|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44474074|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
44474075|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474076|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44474077|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474078|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
44474079|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
44474080|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44474081|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44474082|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474083|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474084|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474085|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44474086|NCT03592680|Ascorbic Acid|ascorbic acid|mesh-list
44474087|NCT03592680|Vitamins|vitamins|mesh-ancestor
44474088|NCT03592680|Micronutrients|micronutrients|mesh-ancestor
44474089|NCT03592680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474090|NCT03592680|Antioxidants|antioxidants|mesh-ancestor
44474091|NCT03592680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474092|NCT03592680|Protective Agents|protective agents|mesh-ancestor
44474093|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
44474094|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44143467|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
44474095|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474096|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474097|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474098|NCT03592485|Acetaminophen|acetaminophen|mesh-list
44474099|NCT03592485|Oxycodone|oxycodone|mesh-list
44474100|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474101|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474102|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44474103|NCT03592485|Analgesics|analgesics|mesh-ancestor
44474104|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
44474105|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474106|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
44474107|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44474108|NCT03592485|Narcotics|narcotics|mesh-ancestor
44474109|NCT03592342|Clobetasol|clobetasol|mesh-list
44474110|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474111|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
44474112|NCT03592342|Hormones|hormones|mesh-ancestor
44474113|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474114|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474115|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44474116|NCT03592082|Bismuth|bismuth|mesh-list
44474117|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44474118|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474119|NCT03592082|Antacids|antacids|mesh-ancestor
44474120|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474121|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474122|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
44474123|NCT03592069|Amoxicillin|amoxicillin|mesh-list
44474124|NCT03592069|Metronidazole|metronidazole|mesh-list
44474125|NCT03592069|Clarithromycin|clarithromycin|mesh-list
44474126|NCT03592069|Esomeprazole|esomeprazole|mesh-list
44474127|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474128|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474129|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44474130|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44474131|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44474132|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474133|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44474134|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474135|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474136|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44474137|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44474138|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474140|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44474141|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474142|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474143|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474144|NCT03591913|Misoprostol|misoprostol|mesh-list
44474145|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44474146|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
44474147|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474148|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474149|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44474150|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474151|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
44474152|NCT03591900|Insulin|insulin|mesh-list
44474153|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474154|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474155|NCT03591757|Tolcapone|tolcapone|mesh-list
44474156|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44474157|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44474158|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44474159|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474160|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474161|NCT03591744|Dexamethasone|dexamethasone|mesh-list
44474162|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
44474163|NCT03591744|Doxorubicin|doxorubicin|mesh-list
44474164|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44474165|NCT03591744|Lenalidomide|lenalidomide|mesh-list
44474166|NCT03591744|Bortezomib|bortezomib|mesh-list
44474167|NCT03591744|Daratumumab|daratumumab|mesh-list
44474168|NCT03591744|Ichthammol|ichthammol|mesh-list
44474169|NCT03591744|BB 1101|bb 1101|mesh-list
44474170|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474171|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
44474172|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
44474173|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474174|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474175|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474176|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
44474177|NCT03591744|Hormones|hormones|mesh-ancestor
44474178|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474179|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474180|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474181|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44474182|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44474183|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44474184|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474185|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474186|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
44474187|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44474188|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44474189|NCT03591744|Growth Substances|growth substances|mesh-ancestor
44474190|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
44474191|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474192|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44474193|NCT03591679|Oxytocin|oxytocin|mesh-list
44474194|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
44474195|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474196|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474197|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44474198|NCT03591575|Deferiprone|deferiprone|mesh-list
44474199|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44474200|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
44474201|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
44474202|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474203|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
44474204|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44474205|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474206|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474207|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44474208|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44474209|NCT03591536|Protective Agents|protective agents|mesh-ancestor
44474210|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474211|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
44474212|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44474213|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
44474214|NCT03591471|Prednisone|prednisone|mesh-list
44474215|NCT03591471|Benazepril|benazepril|mesh-list
44474216|NCT03591471|Heparin|heparin|mesh-list
44474217|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44474218|NCT03591471|Tinzaparin|tinzaparin|mesh-list
44474219|NCT03591471|Dalteparin|dalteparin|mesh-list
44474220|NCT03591471|Calcium heparin|calcium heparin|mesh-list
44474221|NCT03591471|Dipyridamole|dipyridamole|mesh-list
44474222|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474223|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474224|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
44474225|NCT03591471|Hormones|hormones|mesh-ancestor
44474226|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474227|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474228|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474229|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
44474230|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44474231|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44474232|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474233|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44474234|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474235|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474236|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44474237|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44474238|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44474239|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
44474240|NCT03591341|Melatonin|melatonin|mesh-list
44474241|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
44474242|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474243|NCT03591341|Protective Agents|protective agents|mesh-ancestor
44474244|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474245|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474246|NCT03591289|Bromides|bromides|mesh-list
44474247|NCT03591289|Rocuronium|rocuronium|mesh-list
44474248|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
44474249|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44474250|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44474251|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44474252|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474253|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474254|NCT03591172|Propolis|propolis|mesh-list
44474255|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474256|NCT03591003|Antibodies|antibodies|mesh-list
44474257|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
44474258|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
44474259|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474260|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
44474261|NCT03590912|Cetirizine|cetirizine|mesh-list
44474262|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44474263|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
44474264|NCT03590912|Prednisolone|prednisolone|mesh-list
44474265|NCT03590912|Phenylephrine|phenylephrine|mesh-list
44474266|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
44474267|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
44474268|NCT03590912|Levocetirizine|levocetirizine|mesh-list
44474269|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
44474270|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44474271|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474272|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474273|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
44474274|NCT03590912|Hormones|hormones|mesh-ancestor
44474275|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474276|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474277|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474278|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474279|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
44474280|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474281|NCT03590912|Protective Agents|protective agents|mesh-ancestor
44474282|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
44474283|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44474284|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44474285|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
44474286|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474287|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474288|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44474289|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44474290|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
44474291|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
44474292|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44474293|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
44474294|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44474295|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
44474296|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44735615|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735616|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44735617|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44735618|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44735619|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735620|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735621|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
43971387|NCT01721564|Bosentan|bosentan|mesh-list
44735622|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44735623|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44735624|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44735625|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44735626|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735627|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
44735628|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44735629|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735630|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44735631|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735632|NCT05184803|Docetaxel|docetaxel|mesh-list
44735633|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
44735634|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735635|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735636|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735637|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735638|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735639|NCT05169437|Niraparib|niraparib|mesh-list
44735640|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44735641|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735642|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735643|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735644|NCT05168163|Atezolizumab|atezolizumab|mesh-list
44735645|NCT05168163|Lenvatinib|lenvatinib|mesh-list
44735646|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44735647|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735648|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735649|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735650|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735651|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
44735652|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735653|NCT05151640|Nintedanib|nintedanib|mesh-list
44735654|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735655|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735656|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735657|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735659|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44735660|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
44735661|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735662|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44735663|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735664|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735665|NCT05112601|Nivolumab|nivolumab|mesh-list
44735666|NCT05112601|Ipilimumab|ipilimumab|mesh-list
44735667|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735668|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735669|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44735670|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735671|NCT05088980|Lidocaine|lidocaine|mesh-list
44735672|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
44735673|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
44735674|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44735675|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735676|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
44735677|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44735678|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44735679|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44474297|NCT03590873|Vasopressins|vasopressins|mesh-list
44474298|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
44474299|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474300|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
44474301|NCT03590873|Coagulants|coagulants|mesh-ancestor
44474302|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44474303|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44474304|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
44474305|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44474306|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474307|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
44474308|NCT03590587|Hormones|hormones|mesh-ancestor
44474309|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474310|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474311|NCT03590444|Ranibizumab|ranibizumab|mesh-list
44474312|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44474313|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44474314|NCT03590444|Growth Substances|growth substances|mesh-ancestor
44474315|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474316|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
44474317|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474318|NCT03590431|Iodine|iodine|mesh-list
44474319|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
44474320|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44474321|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474322|NCT03590431|Trace Elements|trace elements|mesh-ancestor
44474323|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
44474324|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474325|NCT03590262|Metformin|metformin|mesh-list
44474326|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474327|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474328|NCT03590171|Bortezomib|bortezomib|mesh-list
44474329|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474330|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
44474331|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44474332|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44474333|NCT03590080|Prednisolone|prednisolone|mesh-list
44474334|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
44474335|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44474336|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
44474337|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474338|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
44474339|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
44474340|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474341|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474342|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474343|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
44474344|NCT03590080|Hormones|hormones|mesh-ancestor
44474345|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474346|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44474347|NCT03590080|Protective Agents|protective agents|mesh-ancestor
44474348|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474349|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474351|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
44474352|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474353|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474354|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474355|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
44474356|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
44474357|NCT03599323|Clotrimazole|clotrimazole|mesh-list
44474358|NCT03599323|Miconazole|miconazole|mesh-list
44474359|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44474360|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474361|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
44474362|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44474363|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474364|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474365|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474366|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44474367|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474368|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293217|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
44474369|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474370|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44474371|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44474373|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44474374|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44474375|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44474376|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44474377|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474378|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474379|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474380|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
44474381|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44474382|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44474383|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44474384|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44474385|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474386|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
44474387|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474388|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474389|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44474390|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474391|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44474392|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44474393|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44474394|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44474395|NCT03597035|Spironolactone|spironolactone|mesh-list
44474396|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44474397|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474398|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474399|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474400|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44474401|NCT03597035|Diuretics|diuretics|mesh-ancestor
44474402|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
44474403|NCT03593213|Cariprazine|cariprazine|mesh-list
44474404|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44474405|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44474406|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474407|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474408|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44474409|NCT03599518|Gefitinib|gefitinib|mesh-list
44474410|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474411|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44474412|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474413|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474414|NCT03595163|Folic Acid|folic acid|mesh-list
44474415|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
44474416|NCT03595163|Propofol|propofol|mesh-list
44474417|NCT03595163|Sevoflurane|sevoflurane|mesh-list
44474418|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44474419|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869501|NCT04778813|Artesunate|artesunate|mesh-list
44474420|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474421|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44474422|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
44474424|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44474425|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44474426|NCT03595163|Hematinics|hematinics|mesh-ancestor
44474427|NCT03595163|Vitamins|vitamins|mesh-ancestor
44474428|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
44474429|NCT04199819|Entecavir|entecavir|mesh-list
44474430|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
44474431|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474432|NCT04192331|Paclitaxel|paclitaxel|mesh-list
44474433|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44474434|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44474435|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474436|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
44474437|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
44474438|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
44474439|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474440|NCT04191135|Gemcitabine|gemcitabine|mesh-list
44474441|NCT04191135|Carboplatin|carboplatin|mesh-list
44474442|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
44293302|NCT00792181|Midazolam|midazolam|mesh-list
44474443|NCT04191135|Olaparib|olaparib|mesh-list
44474444|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474445|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44474446|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
44474453|NCT04191135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474454|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44474455|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44474462|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
44474463|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474464|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44474465|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735680|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44735681|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44735682|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735683|NCT05070364|Interferons|interferons|mesh-list
44735684|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735685|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
44735686|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735687|NCT05063552|Bevacizumab|bevacizumab|mesh-list
44735688|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44735689|NCT05063552|Cetuximab|cetuximab|mesh-list
44735690|NCT05063552|Cisplatin|cisplatin|mesh-list
44735691|NCT05063552|Carboplatin|carboplatin|mesh-list
44735692|NCT05063552|Docetaxel|docetaxel|mesh-list
44735693|NCT05063552|Atezolizumab|atezolizumab|mesh-list
44735694|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
44735695|NCT05063552|Antibodies|antibodies|mesh-list
44735696|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
44735697|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44735698|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
44735699|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735700|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44735701|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44735702|NCT05063552|Growth Substances|growth substances|mesh-ancestor
44735703|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735704|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44735705|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
44735706|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735707|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44735708|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44735709|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735710|NCT05062083|11C-PS13|11c-ps13|mesh-list
44735711|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44735712|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735713|NCT05035407|Aldesleukin|aldesleukin|mesh-list
44735714|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
44735715|NCT05035407|Fludarabine|fludarabine|mesh-list
44735716|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44735717|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
44735718|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44735719|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44735720|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44735721|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
44735722|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735723|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735724|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44735725|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44735726|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44735727|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
44735728|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44735729|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
44735731|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44735732|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735733|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44735734|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44735735|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735736|NCT05028634|Vaccines|vaccines|mesh-list
44474467|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
44474468|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474469|NCT04191928|Apixaban|apixaban|mesh-list
44474470|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44474471|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
44474472|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44474473|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474474|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474475|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474476|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
44474477|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44474478|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474479|NCT04199325|Uric Acid|uric acid|mesh-list
44474480|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
44474481|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474482|NCT04199325|Protective Agents|protective agents|mesh-ancestor
44474483|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474484|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
44474485|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44474486|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
44474487|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
44474488|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474489|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474490|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44474491|NCT04199143|Analgesics|analgesics|mesh-ancestor
44474492|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
44474493|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474494|NCT04199013|Fentanyl|fentanyl|mesh-list
44474495|NCT04199013|Ropivacaine|ropivacaine|mesh-list
44474496|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
44474497|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
44474498|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474499|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474500|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
44474501|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474502|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44474503|NCT04199013|Narcotics|narcotics|mesh-ancestor
44474504|NCT04199013|Analgesics|analgesics|mesh-ancestor
44474505|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44474506|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44474507|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
44474508|NCT04198844|Warfarin|warfarin|mesh-list
44474509|NCT04198844|Apixaban|apixaban|mesh-list
44474510|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
44474511|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44474512|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
44474513|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44474514|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474515|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474516|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474517|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44474518|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474519|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474520|NCT04198636|Denosumab|denosumab|mesh-list
44474521|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44474522|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474523|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
44474524|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44474525|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
44474526|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474527|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
44474528|NCT04198467|Protective Agents|protective agents|mesh-ancestor
44474529|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44474530|NCT04198129|Amoxicillin|amoxicillin|mesh-list
44474532|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
44474533|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
44474534|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44474535|NCT04198129|Ampicillin|ampicillin|mesh-list
44474536|NCT04198129|Sultamicillin|sultamicillin|mesh-list
44474537|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44474538|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474539|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
44474540|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44474541|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293401|NCT00792714|Mannitol|mannitol|mesh-list
44474542|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474543|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44474544|NCT04198233|Diazepam|diazepam|mesh-list
44474545|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44474546|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
44474547|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
44474548|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
44474549|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474550|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474551|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44474552|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44474553|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474554|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44474555|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44474556|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44474557|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44474558|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44474559|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44474560|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
44474561|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
44474562|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
44474563|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
44474564|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474565|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474566|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44474567|NCT04197817|Antibodies|antibodies|mesh-list
44474568|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
44474569|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44474570|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
44474571|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474572|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474573|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
44474574|NCT04197570|Analgesics|analgesics|mesh-list
44474575|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
44474576|NCT04197570|Anesthetics|anesthetics|mesh-list
44474577|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474578|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474579|NCT04197570|Narcotics|narcotics|mesh-ancestor
44474580|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
44474581|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474582|NCT04197882|Molgramostim|molgramostim|mesh-list
44474583|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474584|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44474585|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44474586|NCT04197622|Diuretics|diuretics|mesh-ancestor
44474587|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
44474588|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474589|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44474590|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44474591|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474592|NCT04197739|Amikacin|amikacin|mesh-list
44474593|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474594|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474595|NCT04197323|Alprostadil|alprostadil|mesh-list
44474596|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44474597|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
44474598|NCT04197323|Urological Agents|urological agents|mesh-ancestor
44474599|NCT04197349|Sumatriptan|sumatriptan|mesh-list
44474600|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44474601|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44474602|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44474603|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
44474604|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474605|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474612|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
44474613|NCT04196829|Protective Agents|protective agents|mesh-ancestor
44143547|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474614|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474615|NCT04196946|Fentanyl|fentanyl|mesh-list
44474616|NCT04196946|Alfentanil|alfentanil|mesh-list
44474617|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44474618|NCT04196946|Narcotics|narcotics|mesh-ancestor
44474619|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474620|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474621|NCT04196946|Analgesics|analgesics|mesh-ancestor
44474622|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
44474623|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474624|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44474625|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44474626|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
44474627|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
44474628|NCT04197115|Vitamins|vitamins|mesh-list
44474629|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
44474630|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
44474631|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
44474632|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44474633|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44474634|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44474635|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
44474636|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474637|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474638|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
44474639|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474640|NCT04197115|Protective Agents|protective agents|mesh-ancestor
44474641|NCT04196998|Tenofovir|tenofovir|mesh-list
44474642|NCT04196998|Entecavir|entecavir|mesh-list
44474643|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
44474644|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474645|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44474646|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44474647|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474648|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474649|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44474650|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44474651|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
44474652|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44474653|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44474654|NCT04196452|Ipilimumab|ipilimumab|mesh-list
44474655|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44474656|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474657|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44474658|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474659|NCT04196426|Calcium|calcium|mesh-list
44474660|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44474661|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474662|NCT04196309|Heparin|heparin|mesh-list
44474663|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44474664|NCT04196309|Tinzaparin|tinzaparin|mesh-list
44474665|NCT04196309|Dalteparin|dalteparin|mesh-list
44474666|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
44474667|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44474668|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134767|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
44474669|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474671|NCT04196608|Imipenem|imipenem|mesh-list
44474672|NCT04196608|Ceftolozane|ceftolozane|mesh-list
44474673|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44474674|NCT04196608|Relebactam|relebactam|mesh-list
44474675|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474676|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474677|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44474678|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474679|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474680|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44474681|NCT04196608|Renal Agents|renal agents|mesh-ancestor
44474682|NCT04196270|Ropivacaine|ropivacaine|mesh-list
44474683|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
44474684|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
44474685|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474686|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474687|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
43971787|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44474688|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474689|NCT04196231|Insulin|insulin|mesh-list
44474690|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44474691|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474692|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474693|NCT04195997|Heparin|heparin|mesh-list
44474694|NCT04195997|Bivalirudin|bivalirudin|mesh-list
44474695|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
44474696|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44474697|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44474698|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474699|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
44474700|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44474701|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474702|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474703|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44474704|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44474705|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
44474706|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474707|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474708|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44474709|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
44474710|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44474711|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44474712|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44474713|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
44474714|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474715|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474716|NCT04195373|Flucytosine|flucytosine|mesh-list
44474717|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
44474718|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474719|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
44474720|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474721|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
44474722|NCT04195243|Empagliflozin|empagliflozin|mesh-list
44474723|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44474724|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474725|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474726|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474727|NCT04195321|Phenylephrine|phenylephrine|mesh-list
44474728|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
44474729|NCT04195321|Norepinephrine|norepinephrine|mesh-list
44474730|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44474731|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
44474732|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
44474733|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474734|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474735|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
44474736|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44474737|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
44474738|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
44474739|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44474740|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44474741|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44474742|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
44474743|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44474751|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44474753|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474754|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44474755|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44474756|NCT04194827|Adalimumab|adalimumab|mesh-list
44474757|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474758|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293626|NCT00793858|Hormones|hormones|mesh-ancestor
44474759|NCT04194957|Fluorouracil|fluorouracil|mesh-list
44474761|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
44474762|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474763|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44474764|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474765|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44474766|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
44474767|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474768|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44474769|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44474770|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
44474771|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44474772|NCT04194905|Estradiol|estradiol|mesh-list
44474773|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44474774|NCT04194905|Estrogens|estrogens|mesh-ancestor
44474775|NCT04194905|Hormones|hormones|mesh-ancestor
44474776|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474777|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474778|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44474779|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
44474780|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474781|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44474782|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44474783|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44474784|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44474785|NCT04194658|Letrozole|letrozole|mesh-list
44474786|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474787|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44474788|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44474789|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474790|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474791|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44474792|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474793|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474794|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474795|NCT04194684|Paclitaxel|paclitaxel|mesh-list
44474796|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44474797|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474798|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
44474799|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
44474800|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
44474801|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474802|NCT04194515|Metformin|metformin|mesh-list
44474803|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44474804|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474805|NCT04194359|Capecitabine|capecitabine|mesh-list
44474806|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
44474807|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474808|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44474809|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
44474810|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44735766|NCT05007106|Fluorouracil|fluorouracil|mesh-list
44735767|NCT05007106|Capecitabine|capecitabine|mesh-list
44735768|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
44735769|NCT05007106|Lenvatinib|lenvatinib|mesh-list
44735770|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44735771|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
44735772|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293672|NCT00794235|Sorafenib|sorafenib|mesh-list
44735773|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
44474811|NCT04194294|Lidocaine|lidocaine|mesh-list
44474812|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
44474813|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
44474814|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44474815|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474816|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
44474817|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474818|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44474819|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44474820|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44474821|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44474822|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474823|NCT04194086|Posaconazole|posaconazole|mesh-list
44474824|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
44474825|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474826|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44474827|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44474828|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44474829|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44474830|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474831|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474832|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474833|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44474834|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474835|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474836|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474837|NCT04194216|Clindamycin|clindamycin|mesh-list
44474838|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
44474839|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
44474840|NCT04194216|Cephalexin|cephalexin|mesh-list
44474841|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44474842|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474843|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44474844|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474845|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474846|NCT04194034|Flucytosine|flucytosine|mesh-list
44474847|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
44474848|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474849|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
44474850|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474851|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
44474852|NCT04194255|Trace Elements|trace elements|mesh-ancestor
44474853|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
44474854|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474855|NCT04193930|Letrozole|letrozole|mesh-list
44474856|NCT04193930|Menotropins|menotropins|mesh-list
44474857|NCT04193930|Hormones|hormones|mesh-list
44474858|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44474859|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474860|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474861|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474862|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44474863|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44474864|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474865|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474866|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44474867|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474868|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44474869|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
44474870|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474871|NCT04193982|Vitamin E|vitamin e|mesh-list
44474872|NCT04193982|Vitamins|vitamins|mesh-ancestor
44474873|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
44474874|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474875|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
44474876|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474877|NCT04193982|Protective Agents|protective agents|mesh-ancestor
44474878|NCT04193852|Dienogest|dienogest|mesh-list
44474879|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44474880|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44474881|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44474882|NCT04193852|Estradiol|estradiol|mesh-list
44474883|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44474884|NCT04193852|Nandrolone|nandrolone|mesh-list
44474885|NCT04193852|Estrogens|estrogens|mesh-ancestor
44474886|NCT04193852|Hormones|hormones|mesh-ancestor
44474887|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474888|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971932|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474889|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44474890|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
44474891|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44474892|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44474893|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44474894|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44474895|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44474896|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474897|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44474898|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474899|NCT04193852|Androgens|androgens|mesh-ancestor
44474900|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
44474901|NCT04193592|Pirfenidone|pirfenidone|mesh-list
44474902|NCT04193592|Analgesics|analgesics|mesh-ancestor
44474903|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
44474904|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44474905|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474906|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44474907|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44474908|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44474909|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44474910|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474911|NCT04193553|Lenvatinib|lenvatinib|mesh-list
44474912|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474913|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44474914|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474915|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474916|NCT04193319|Fluconazole|fluconazole|mesh-list
44474917|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
44474918|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44474919|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44474920|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44474921|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474922|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474923|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44474924|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
44474925|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44474926|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44474927|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44474928|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44474929|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
44474930|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44474931|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44474932|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44474933|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474934|NCT04193137|Captopril|captopril|mesh-list
44474935|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44474936|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
44474937|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44474938|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44474939|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44474940|NCT04193059|Paclitaxel|paclitaxel|mesh-list
44474941|NCT04193059|Docetaxel|docetaxel|mesh-list
44474942|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
44474943|NCT04193059|Carboplatin|carboplatin|mesh-list
44474944|NCT04193059|Trastuzumab|trastuzumab|mesh-list
44236687|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44236688|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236689|NCT00560443|Analgesics|analgesics|mesh-ancestor
44236690|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
44236691|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894670|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43894671|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894672|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43894673|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894674|NCT04729296|Golimumab|golimumab|mesh-list
43894675|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43894676|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894677|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894678|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
43894679|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894680|NCT04649060|Dexamethasone|dexamethasone|mesh-list
43894681|NCT04649060|Melphalan|melphalan|mesh-list
43894682|NCT04649060|Daratumumab|daratumumab|mesh-list
43894683|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894718|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894719|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894720|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43894721|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43894722|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43894750|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43894751|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43894752|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43894753|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
43894754|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894755|NCT04462471|Vemurafenib|vemurafenib|mesh-list
43894756|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894757|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43894758|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894759|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894760|NCT04392505|Durvalumab|durvalumab|mesh-list
43894761|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894762|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894763|NCT04308694|Methadone|methadone|mesh-list
43894764|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43894765|NCT04308694|Narcotics|narcotics|mesh-ancestor
43894766|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894767|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894768|NCT04308694|Analgesics|analgesics|mesh-ancestor
43894769|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
43894770|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894799|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
43894800|NCT04078737|Aspirin|aspirin|mesh-list
43894801|NCT04078737|Clopidogrel|clopidogrel|mesh-list
43894802|NCT04078737|Ticagrelor|ticagrelor|mesh-list
43894803|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43894804|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894805|NCT04078737|Analgesics|analgesics|mesh-ancestor
43894806|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
43894807|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894808|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894809|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894810|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894811|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43894812|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43894813|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894814|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43894815|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43894816|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894817|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
43894818|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43894842|NCT03892369|Ethanol|ethanol|mesh-list
43894843|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43894844|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894845|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44236692|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972056|NCT04790175|Tolvaptan|tolvaptan|mesh-list
44236693|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236694|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236695|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44236696|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236697|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134994|NCT00159731|Pregabalin|pregabalin|mesh-list
43894846|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894847|NCT03803605|Vorinostat|vorinostat|mesh-list
43894848|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894849|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43894850|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894851|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894852|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
43894853|NCT03514901|Nivolumab|nivolumab|mesh-list
43894854|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894855|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894856|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43894857|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894858|NCT03338647|Doxorubicin|doxorubicin|mesh-list
43894859|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43894860|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894861|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43894862|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43894863|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894864|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894865|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
43894866|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43894867|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894868|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43894869|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43894870|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894871|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43894904|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
43894905|NCT02427724|Lidocaine|lidocaine|mesh-list
43894906|NCT02427724|Tetracaine|tetracaine|mesh-list
43894907|NCT02427724|Prilocaine|prilocaine|mesh-list
43894908|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
43894909|NCT02427724|Anesthetics|anesthetics|mesh-list
43625326|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
43894910|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894911|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894927|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43894928|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137548|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137550|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
44137551|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44137552|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137553|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44137554|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137555|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137556|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44137557|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44137558|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44137559|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137560|NCT00168584|Vitamin A|vitamin a|mesh-list
44137561|NCT00168584|Vitamins|vitamins|mesh-ancestor
44137562|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
44137563|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137564|NCT00168597|Vitamin A|vitamin a|mesh-list
44137565|NCT00168597|Vitamins|vitamins|mesh-ancestor
44137566|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
44137567|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137568|NCT00168610|Vitamin A|vitamin a|mesh-list
44137569|NCT00168610|Vitamins|vitamins|mesh-ancestor
44137570|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
44137571|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137572|NCT00168623|Vitamin A|vitamin a|mesh-list
44137573|NCT00168623|Vitamins|vitamins|mesh-ancestor
44137574|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
44236699|NCT00560443|Narcotics|narcotics|mesh-ancestor
44236700|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44236701|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
44236702|NCT00560547|Hematinics|hematinics|mesh-ancestor
44236703|NCT00560586|Budesonide|budesonide|mesh-list
44236704|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871253|NCT01946477|Hormones|hormones|mesh-ancestor
44137575|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137576|NCT00168636|Vitamin A|vitamin a|mesh-list
44137577|NCT00168636|Vitamins|vitamins|mesh-ancestor
44137578|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
43894929|NCT02043847|Melphalan|melphalan|mesh-list
43894930|NCT02043847|Lenograstim|lenograstim|mesh-list
43894931|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43894932|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
43894933|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894934|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894935|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
43894936|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894937|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894938|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894939|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894940|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
43894941|NCT01976286|Salicylates|salicylates|mesh-list
43894942|NCT01976286|Glycolic acid|glycolic acid|mesh-list
43894978|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894979|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
43894980|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894981|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777628|NCT02330796|Colchicine|colchicine|mesh-list
43895010|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895011|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43895012|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
43895013|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895014|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
43895015|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
43895016|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895017|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895018|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
43895019|NCT00258427|Hormones|hormones|mesh-ancestor
43895020|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895021|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43895022|NCT00258427|Protective Agents|protective agents|mesh-ancestor
43895023|NCT00250341|Beclomethasone|beclomethasone|mesh-list
43895024|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43895025|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895026|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
43895027|NCT00250341|Hormones|hormones|mesh-ancestor
43895028|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895029|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895061|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895062|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
43895063|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895064|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895065|NCT00002601|Cisplatin|cisplatin|mesh-list
43895066|NCT00002601|Doxorubicin|doxorubicin|mesh-list
43895067|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43895068|NCT00002601|Melphalan|melphalan|mesh-list
43895069|NCT00002601|Ifosfamide|ifosfamide|mesh-list
43895070|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895071|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43895072|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43895073|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43895074|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895101|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895102|NCT05384743|Rituximab|rituximab|mesh-list
43895103|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895104|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895105|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
43611522|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
44236705|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44236706|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
44236707|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236708|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236709|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236710|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236711|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
44236712|NCT00560586|Hormones|hormones|mesh-ancestor
44236713|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236714|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
44236715|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44236716|NCT00560599|Mupirocin|mupirocin|mesh-list
44236717|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44285625|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
43895106|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895107|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895108|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
43895110|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43895111|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895112|NCT05384574|Vitamins|vitamins|mesh-ancestor
43895113|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
43895114|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895115|NCT05384483|Cariprazine|cariprazine|mesh-list
43895116|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43895117|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43646364|NCT03193684|Empagliflozin|empagliflozin|mesh-list
43895151|NCT05383820|Ketorolac|ketorolac|mesh-list
43895152|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43895153|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895154|NCT05383820|Analgesics|analgesics|mesh-ancestor
43895155|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
43777731|NCT02330406|Anagliptin|anagliptin|mesh-list
43895180|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895181|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43895182|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43895183|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43895185|NCT05383313|Ketamine|ketamine|mesh-list
43895186|NCT05383313|Psilocybin|psilocybin|mesh-list
43895187|NCT05383313|Analgesics|analgesics|mesh-ancestor
43895188|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
43895189|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895190|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895191|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43895192|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43895193|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
43895194|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
43895195|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895196|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43895197|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43895198|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895199|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895200|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43895201|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43895202|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43895203|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43895204|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895205|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
44137589|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895221|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895222|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895223|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895224|NCT05376111|Azacitidine|azacitidine|mesh-list
43895225|NCT05376111|Venetoclax|venetoclax|mesh-list
44236718|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236720|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44236721|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44236722|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44236723|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236724|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236725|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43895226|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43895227|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
43895228|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895229|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895230|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895231|NCT05364489|Bevacizumab|bevacizumab|mesh-list
43895232|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
43895233|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895234|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895235|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43895236|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43895237|NCT05364489|Growth Substances|growth substances|mesh-ancestor
43895238|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895239|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
43895240|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
43895241|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895242|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895243|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895244|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895245|NCT05310110|Lidocaine|lidocaine|mesh-list
43895246|NCT05310110|Propofol|propofol|mesh-list
43895247|NCT05310110|Cisatracurium|cisatracurium|mesh-list
43895248|NCT05310110|Atracurium|atracurium|mesh-list
43895249|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
43895285|NCT05262244|Bevacizumab|bevacizumab|mesh-list
43895286|NCT05262244|Vedolizumab|vedolizumab|mesh-list
43895318|NCT05205486|Cefazolin|cefazolin|mesh-list
43895319|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895320|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895321|NCT05144529|Nivolumab|nivolumab|mesh-list
43895322|NCT05144529|Ipilimumab|ipilimumab|mesh-list
43895323|NCT05144529|Evolocumab|evolocumab|mesh-list
43895324|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895325|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895326|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43895327|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895359|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43895361|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895362|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
43895363|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
43895364|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895365|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895366|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895367|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
43895368|NCT04940338|Hormones|hormones|mesh-ancestor
43895369|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137590|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
43895370|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839022|NCT04801589|Midazolam|midazolam|mesh-list
43895405|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43895406|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43895407|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
43895408|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895410|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43895411|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
43895436|NCT04405102|Ozanimod|ozanimod|mesh-list
43895437|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43895438|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895439|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895440|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
44236726|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44236727|NCT00560690|Metformin|metformin|mesh-list
44236728|NCT00560690|Interferons|interferons|mesh-list
44236729|NCT00560690|Ribavirin|ribavirin|mesh-list
44236730|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236731|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236732|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236733|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
44236734|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236735|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
43895441|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895442|NCT04328844|Cisplatin|cisplatin|mesh-list
43895443|NCT04328844|Pemetrexed|pemetrexed|mesh-list
43895444|NCT04328844|Avelumab|avelumab|mesh-list
43895445|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895446|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895447|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895448|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43895449|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43895450|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895451|NCT04310059|Folic Acid|folic acid|mesh-list
43895452|NCT04310059|Hematinics|hematinics|mesh-ancestor
43895453|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
43895454|NCT04310059|Vitamins|vitamins|mesh-ancestor
43895455|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
43895456|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895457|NCT04287062|Suvorexant|suvorexant|mesh-list
43895458|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43895459|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43895460|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777982|NCT02328079|Acyclovir|acyclovir|mesh-list
43895494|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895495|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895496|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
43895497|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895498|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137591|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137592|NCT00168714|Interferons|interferons|mesh-list
43895514|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895515|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43895516|NCT04163458|Menotropins|menotropins|mesh-list
43895517|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43895518|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
43895519|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43895520|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895521|NCT04141501|Psilocybin|psilocybin|mesh-list
43895522|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
43895557|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
43895558|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895559|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
43895560|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895561|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895562|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895563|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
43871138|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895596|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895597|NCT03874286|Liver Extracts|liver extracts|mesh-list
43895598|NCT03874286|Hematinics|hematinics|mesh-ancestor
43895599|NCT03857139|Nicotine|nicotine|mesh-list
43895600|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43895601|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
43895624|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43895625|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
43895626|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43895627|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43895628|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895629|NCT03755765|Amoxicillin|amoxicillin|mesh-list
43895630|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
43895631|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
44236736|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236737|NCT00560820|Deferasirox|deferasirox|mesh-list
44236738|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44236739|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
44236740|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
44236741|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895632|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43895633|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895634|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895635|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43895636|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895637|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895638|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
43895639|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43895640|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43895641|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43895642|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895643|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895644|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
43895645|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895646|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895647|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43895648|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895649|NCT03640377|Praziquantel|praziquantel|mesh-list
43895650|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
43895651|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43895681|NCT03387475|Deferasirox|deferasirox|mesh-list
43895682|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43895683|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
43895684|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
43895685|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895686|NCT03363503|Fluticasone|fluticasone|mesh-list
43895688|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43895689|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895690|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43895691|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
43895692|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895693|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895694|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43895695|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43895696|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895697|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43778189|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
43895727|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895728|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
43895729|NCT03210688|Hormones|hormones|mesh-ancestor
43895730|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895731|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895732|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43895733|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895734|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895735|NCT03210688|Vitamins|vitamins|mesh-ancestor
43895736|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
43895737|NCT03174847|Eplerenone|eplerenone|mesh-list
43895738|NCT03174847|Amiloride|amiloride|mesh-list
43895739|NCT03174847|Spironolactone|spironolactone|mesh-list
43895740|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43895741|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
43895742|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
43778234|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
43895777|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895779|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43895780|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
43778281|NCT02327234|Analgesics|analgesics|mesh-ancestor
43895804|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
43895805|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895806|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236742|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44236743|NCT00560924|Estradiol|estradiol|mesh-list
44236744|NCT00560924|Estrogens|estrogens|mesh-ancestor
44236745|NCT00560924|Hormones|hormones|mesh-ancestor
44236746|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236747|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236748|NCT00560963|Everolimus|everolimus|mesh-list
44236749|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236750|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236751|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
44236752|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236753|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44236754|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
44236755|NCT00560976|Hematinics|hematinics|mesh-ancestor
43895807|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895808|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895809|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43895837|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895838|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895839|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
43895840|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43895841|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895842|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895843|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43895844|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43895845|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43895846|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43895847|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43895848|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43895849|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43895850|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43895851|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
43895852|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43895853|NCT02172651|Vitamin D|vitamin d|mesh-list
43895854|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
43895855|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
43895856|NCT02172651|Vitamins|vitamins|mesh-list
43895857|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
43895858|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895859|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43778331|NCT02327091|Vitamins|vitamins|mesh-ancestor
43895893|NCT00003224|Vaccines|vaccines|mesh-list
43895894|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
43895895|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
43895896|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895897|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43895921|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895922|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895923|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
43895925|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895926|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43895927|NCT00003270|Protective Agents|protective agents|mesh-ancestor
43895928|NCT05235100|Apatinib|apatinib|mesh-list
43895929|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895930|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895931|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895932|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895933|NCT05234840|Triamcinolone|triamcinolone|mesh-list
43895934|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895935|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
43895936|NCT05234840|Hormones|hormones|mesh-ancestor
43895937|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236756|NCT00561028|Antibodies|antibodies|mesh-list
44236757|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
44236758|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236759|NCT00561054|Cetuximab|cetuximab|mesh-list
44236760|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895938|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895939|NCT05234619|Ketorolac|ketorolac|mesh-list
43895940|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43895941|NCT05234619|Lidocaine|lidocaine|mesh-list
43895942|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
43895943|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
43895944|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895945|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895946|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
43895947|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895948|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43895949|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43895950|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43895960|NCT05233735|Betamethasone|betamethasone|mesh-list
43895961|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895962|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
43895963|NCT05233735|Hormones|hormones|mesh-ancestor
43895964|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895965|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895966|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43895967|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
43895968|NCT05233579|Sulforaphane|sulforaphane|mesh-list
43895969|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43895970|NCT05233579|Protective Agents|protective agents|mesh-ancestor
43895971|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895972|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895973|NCT05233514|Metformin|metformin|mesh-list
43895974|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43895975|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895976|NCT05233462|Bupivacaine|bupivacaine|mesh-list
43895977|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
43895978|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
43895979|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895980|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895981|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
43895982|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895983|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
43895984|NCT05233358|Nivolumab|nivolumab|mesh-list
43895985|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43895986|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895987|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895988|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895989|NCT05233332|Vemurafenib|vemurafenib|mesh-list
43895990|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895991|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895992|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895993|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895994|NCT05233202|Simendan|simendan|mesh-list
43895995|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43895996|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
43895997|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43895998|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43895999|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896000|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896001|NCT05233202|Protective Agents|protective agents|mesh-ancestor
43896002|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896003|NCT05233124|Aspirin|aspirin|mesh-list
43896004|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
43896005|NCT05233124|Clopidogrel|clopidogrel|mesh-list
43896006|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43896007|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896008|NCT05233124|Analgesics|analgesics|mesh-ancestor
43896009|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
43896010|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896011|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896012|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236762|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
44236763|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44236764|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44236765|NCT00561067|Prednisolone|prednisolone|mesh-list
44236766|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
44236767|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
44236768|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44236769|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
44236770|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236771|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
44236772|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
43896013|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896014|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44137643|NCT00168792|Tenecteplase|tenecteplase|mesh-list
44137644|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44137645|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44137646|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137647|NCT00168857|Losartan|losartan|mesh-list
44137648|NCT00168857|Telmisartan|telmisartan|mesh-list
44137649|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44137677|NCT00168896|Carboplatin|carboplatin|mesh-list
44137678|NCT00168896|Irinotecan|irinotecan|mesh-list
44137679|NCT00168896|Etoposide|etoposide|mesh-list
44137680|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137681|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44137682|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43896031|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
43896032|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896033|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896034|NCT05232370|Losartan|losartan|mesh-list
43896035|NCT05232370|Enalapril|enalapril|mesh-list
43896036|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43896037|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43896038|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43896039|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43896040|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43896041|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43896042|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896043|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
43896044|NCT05232227|Primaquine|primaquine|mesh-list
43896065|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
43896066|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896067|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896068|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896069|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
43896070|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43896071|NCT05230797|Protective Agents|protective agents|mesh-ancestor
43896072|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
43896073|NCT05230654|Aprepitant|aprepitant|mesh-list
43896074|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
43896075|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
43896076|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896077|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896078|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896079|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43896080|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896081|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896082|NCT05230472|Simvastatin|simvastatin|mesh-list
43896083|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43896084|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43896085|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
43896086|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896087|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43896088|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44236773|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236774|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236775|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236776|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
44236777|NCT00561067|Hormones|hormones|mesh-ancestor
44236778|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236779|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43871728|NCT04763876|Analgesics|analgesics|mesh-ancestor
43896089|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896090|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
43896091|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896092|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
43896093|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
43896094|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896095|NCT05209555|Pilocarpine|pilocarpine|mesh-list
43896096|NCT05209555|Miotics|miotics|mesh-ancestor
43896097|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
43896098|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896099|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896100|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43896101|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43896102|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
43896103|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778576|NCT05076461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137700|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44137701|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137702|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137703|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44137704|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137705|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137707|NCT00169000|Capecitabine|capecitabine|mesh-list
44137708|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137709|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137710|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
44137711|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137712|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137713|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44137714|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
44137715|NCT00169013|Gabapentin|gabapentin|mesh-list
44137716|NCT00169013|Analgesics|analgesics|mesh-ancestor
44137717|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
44137718|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137719|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137720|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
44137721|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44137722|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137723|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137724|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137725|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44137726|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44137727|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137728|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137729|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
44137730|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
44137731|NCT00169026|Clozapine|clozapine|mesh-list
43896135|NCT05093296|Naltrexone|naltrexone|mesh-list
43896136|NCT05093296|Oxytocin|oxytocin|mesh-list
43896137|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
43896138|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43896139|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896140|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43896141|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43896142|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
43896143|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896144|NCT05075876|Granisetron|granisetron|mesh-list
43896145|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
43896146|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
43896147|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896148|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236780|NCT00561067|Protective Agents|protective agents|mesh-ancestor
44236781|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44236782|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236783|NCT00561067|Hematinics|hematinics|mesh-ancestor
44236784|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44236785|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
43896149|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896150|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43896151|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
43896152|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896153|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896184|NCT05014230|Analgesics|analgesics|mesh-ancestor
43896185|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
43896186|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896187|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43896188|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43896189|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896190|NCT05004805|Methylene Blue|methylene blue|mesh-list
43896191|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896192|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896193|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43896194|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
43896195|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896196|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896229|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896230|NCT05370729|Protective Agents|protective agents|mesh-ancestor
43896231|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896232|NCT05370729|Antidotes|antidotes|mesh-ancestor
43896233|NCT05370599|Losartan|losartan|mesh-list
43896234|NCT05370599|Amlodipine|amlodipine|mesh-list
43896235|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
43896236|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
43778729|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896264|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
43896265|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896266|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43896267|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43896268|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43896269|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43896270|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896271|NCT05369481|Minoxidil|minoxidil|mesh-list
43896272|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
43896273|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
43896274|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43896275|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43896276|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896277|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896278|NCT05369481|Urological Agents|urological agents|mesh-ancestor
43896279|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43896280|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
43896293|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43896294|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
43896295|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896296|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896297|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
43896298|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896299|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896300|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896301|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896302|NCT05369364|Dexamethasone|dexamethasone|mesh-list
43896303|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
43896304|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896305|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
43896306|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
43896307|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896308|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896309|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896310|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
43896311|NCT05369364|Hormones|hormones|mesh-ancestor
44236786|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44236787|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236788|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236789|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236790|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44236791|NCT00561093|Protective Agents|protective agents|mesh-ancestor
44236792|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236793|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
44236794|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44236795|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
43896312|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896313|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43896314|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896315|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896316|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896317|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896318|NCT05369234|Sucralfate|sucralfate|mesh-list
43896319|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43896320|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137733|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137734|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137735|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137736|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137737|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
44137738|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137739|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137740|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
44137741|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
44137742|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
44137743|NCT00169039|Clozapine|clozapine|mesh-list
44137744|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137745|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
44137746|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137747|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137748|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137749|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137750|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137751|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137752|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137753|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
43896329|NCT05369052|Linezolid|linezolid|mesh-list
43896330|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43896331|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896332|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43896333|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896334|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896335|NCT05369039|Prednisolone|prednisolone|mesh-list
43896336|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896337|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
43896338|NCT05369039|Hormones|hormones|mesh-ancestor
43871139|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
43896339|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896340|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896341|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43896342|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896343|NCT05363514|Naltrexone|naltrexone|mesh-list
43896344|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43896345|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43896346|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896347|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
43896348|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896349|NCT05355155|Bevacizumab|bevacizumab|mesh-list
43896350|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236796|NCT00561106|Valacyclovir|valacyclovir|mesh-list
44236797|NCT00561106|Prednisone|prednisone|mesh-list
44236798|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236799|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
44236800|NCT00561106|Hormones|hormones|mesh-ancestor
44236801|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896351|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896352|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896353|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896354|NCT05355155|Growth Substances|growth substances|mesh-ancestor
43896355|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896384|NCT05271240|Bevacizumab|bevacizumab|mesh-list
43896385|NCT05271240|Temozolomide|temozolomide|mesh-list
43896386|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896387|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896388|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896389|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896390|NCT05271240|Growth Substances|growth substances|mesh-ancestor
43896391|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896392|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896393|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43896394|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
43972735|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896395|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896397|NCT05269030|Budesonide|budesonide|mesh-list
43896398|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896399|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43896400|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
43896401|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896402|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896403|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43896404|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
43896405|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
43896415|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896416|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43896417|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43896418|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896419|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43896420|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
43896421|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896422|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43896423|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
43896424|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
43896425|NCT05269017|Hormones|hormones|mesh-ancestor
43896426|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896427|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
43896428|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43896429|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
43896430|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896431|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896432|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43896433|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
43896434|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
43896435|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43896436|NCT04735822|Belumosudil|belumosudil|mesh-list
43896437|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896438|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896439|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896440|NCT04726618|Xenon|xenon|mesh-list
43896441|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43896442|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
43896443|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
43896444|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896445|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236802|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236803|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44236804|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896446|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43896448|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43896449|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43896450|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43896451|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896452|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896453|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
43896454|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896455|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43896456|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
43896457|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896458|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896459|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43896460|NCT04697693|Analgesics|analgesics|mesh-ancestor
43896461|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
43896462|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
43896463|NCT04610736|Temozolomide|temozolomide|mesh-list
43896464|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43896465|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
43896466|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896467|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896468|NCT04444492|Ranibizumab|ranibizumab|mesh-list
43896469|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896470|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896471|NCT04444492|Growth Substances|growth substances|mesh-ancestor
43896493|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43896494|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
43896495|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896496|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896497|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43896498|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43896499|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43896500|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896501|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896502|NCT04294459|Acetaminophen|acetaminophen|mesh-list
43896503|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
43896504|NCT04294459|Promethazine|promethazine|mesh-list
43896505|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
43896506|NCT04294459|Ranitidine|ranitidine|mesh-list
43896507|NCT04294459|Montelukast|montelukast|mesh-list
43896508|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896509|NCT04294459|Analgesics|analgesics|mesh-ancestor
43896510|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
43896511|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896512|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896513|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
43896514|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896515|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
43896516|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
43896517|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896518|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
43896519|NCT04294459|Hormones|hormones|mesh-ancestor
43896520|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896521|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43896522|NCT04294459|Protective Agents|protective agents|mesh-ancestor
43896523|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43896524|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
43896525|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43896526|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
43896527|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43896528|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43896549|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896550|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
43896551|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896552|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43896553|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801417|NCT05104866|Gemcitabine|gemcitabine|mesh-list
44236805|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
43896554|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896555|NCT04266977|Dexamethasone|dexamethasone|mesh-list
43896556|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896557|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
43896558|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
43896559|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896560|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896561|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896562|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
43896563|NCT04266977|Hormones|hormones|mesh-ancestor
43896564|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896565|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43896566|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896567|NCT04266340|Midazolam|midazolam|mesh-list
43896568|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
43896569|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43896570|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896571|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896572|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896573|NCT04266340|Analgesics|analgesics|mesh-ancestor
43896574|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
43896575|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896576|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43896577|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43896578|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43896579|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
43896580|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896581|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896582|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43896583|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43896584|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43896585|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896601|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896602|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896603|NCT03976245|Etanercept|etanercept|mesh-list
43896604|NCT03976245|Tofacitinib|tofacitinib|mesh-list
43896626|NCT03974854|Antiviral Agents|antiviral agents|mesh-ancestor
43896627|NCT03974854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896628|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896629|NCT03974854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896630|NCT03974854|Immunologic Factors|immunologic factors|mesh-ancestor
43896631|NCT03974854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896632|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43896633|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43896634|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
43896635|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896636|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
43896637|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
43896638|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896639|NCT03813108|Lumefantrine|lumefantrine|mesh-list
43896640|NCT03813108|Artemether|artemether|mesh-list
43896641|NCT03813108|Mefloquine|mefloquine|mesh-list
43896642|NCT03813108|Atovaquone|atovaquone|mesh-list
43896643|NCT03813108|Proguanil|proguanil|mesh-list
43896644|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43896645|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43896646|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
43896647|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43896648|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43896649|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896650|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896651|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896652|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
43896653|NCT03800602|Metformin|metformin|mesh-list
43896654|NCT03800602|Nivolumab|nivolumab|mesh-list
43896655|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43896656|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896657|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896658|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896659|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43896660|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896696|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
43896697|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
43896698|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236806|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236807|NCT00561119|Gemcitabine|gemcitabine|mesh-list
44236808|NCT00561119|Paclitaxel|paclitaxel|mesh-list
44236809|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44236810|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236811|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
44236812|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
44236813|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236814|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896699|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896700|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896701|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43896724|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896725|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896727|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896728|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896729|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
43896730|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896731|NCT03483649|Bevacizumab|bevacizumab|mesh-list
43896732|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896733|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896734|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896735|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896736|NCT03483649|Growth Substances|growth substances|mesh-ancestor
43896737|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896738|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896739|NCT03405714|Brivaracetam|brivaracetam|mesh-list
43896740|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
43896741|NCT03361436|Halichondrin B|halichondrin b|mesh-list
43896742|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
43896743|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
43896744|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
43896745|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896746|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896747|NCT03282344|Nivolumab|nivolumab|mesh-list
43896748|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896749|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896750|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44137792|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
43896751|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896752|NCT03272139|Bupivacaine|bupivacaine|mesh-list
43896779|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43896780|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
43896781|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896782|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43896783|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43896784|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896785|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896786|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43896787|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896788|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896789|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
43896790|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896792|NCT02553642|Ipilimumab|ipilimumab|mesh-list
43896793|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896794|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896795|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43896796|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137793|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137794|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137795|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137796|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137815|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44137816|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
44137817|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236815|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236817|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
44236818|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236819|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236820|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137818|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137819|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44137820|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137821|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43896798|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896799|NCT02138955|Curcumin|curcumin|mesh-list
43896800|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43896801|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896802|NCT02138955|Analgesics|analgesics|mesh-ancestor
43896803|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
43896804|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896805|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896806|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896807|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896808|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896809|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896810|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896811|NCT02121405|Capecitabine|capecitabine|mesh-list
43896812|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
43896813|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43896814|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
43896815|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896816|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896817|NCT01929915|Fentanyl|fentanyl|mesh-list
43896818|NCT01929915|Morphine|morphine|mesh-list
43896819|NCT01929915|Bupivacaine|bupivacaine|mesh-list
43896820|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896821|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
43896822|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896823|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896824|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
43896825|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896826|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43896827|NCT01929915|Narcotics|narcotics|mesh-ancestor
43896828|NCT01929915|Analgesics|analgesics|mesh-ancestor
43896829|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43896830|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43896842|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896844|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896845|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896846|NCT00555555|Factor VIII|factor viii|mesh-list
43896847|NCT00555555|Coagulants|coagulants|mesh-ancestor
43896848|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
43896849|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896850|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896851|NCT04852003|Morphine|morphine|mesh-list
43896852|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43896853|NCT04852003|Narcotics|narcotics|mesh-ancestor
43896854|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896855|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896856|NCT04852003|Analgesics|analgesics|mesh-ancestor
43896857|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
43896858|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896859|NCT04761861|Vildagliptin|vildagliptin|mesh-list
43896860|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43896861|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896862|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43896863|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
43896864|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896865|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896866|NCT04761094|Insulin|insulin|mesh-list
43896867|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43896868|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896869|NCT04756271|Antibodies|antibodies|mesh-list
44236821|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
44236822|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236823|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
44236824|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
44236825|NCT00561132|Antacids|antacids|mesh-ancestor
44236826|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236827|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236828|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236829|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236830|NCT00561184|Vaccines|vaccines|mesh-list
44236831|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
44236832|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135137|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
43896870|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
43896871|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
43647876|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
43896872|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896873|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
43896874|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896875|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896876|NCT04718350|Simendan|simendan|mesh-list
43896877|NCT04718350|Milrinone|milrinone|mesh-list
43896878|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43896879|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
43896880|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43896881|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43896882|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896883|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896884|NCT04718350|Protective Agents|protective agents|mesh-ancestor
43896885|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896886|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43896887|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
43896888|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43896889|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
43896890|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896891|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896893|NCT04714710|Diuretics|diuretics|mesh-ancestor
43839129|NCT04796584|Antibodies|antibodies|mesh-list
43896914|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
43896915|NCT04677816|Vitamin D|vitamin d|mesh-list
43896916|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
43896917|NCT04677816|Vitamins|vitamins|mesh-ancestor
43896918|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
43896919|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896920|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43896921|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43896922|NCT04674774|Lansoprazole|lansoprazole|mesh-list
43896923|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
43896924|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43896925|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896926|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43896927|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896928|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896929|NCT04672512|Prednisone|prednisone|mesh-list
43896930|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896931|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
43896932|NCT04672512|Hormones|hormones|mesh-ancestor
43896933|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896934|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896935|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43896936|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896937|NCT04650217|Levodopa|levodopa|mesh-list
43896938|NCT04650217|Carbidopa|carbidopa|mesh-list
44236833|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
44236834|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44236835|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236836|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43896939|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43896940|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43896941|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43896942|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
43896943|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896944|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896945|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137822|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43896946|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43896947|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896948|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43896959|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896960|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896961|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
43896962|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
43896963|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43896964|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
43896965|NCT04608266|Camostat|camostat|mesh-list
43896966|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
43896967|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896968|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896969|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43896970|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43896971|NCT04599816|Simendan|simendan|mesh-list
43896972|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43896973|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
43896974|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43973137|NCT01737593|Acetaminophen|acetaminophen|mesh-list
43896975|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43896976|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896977|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896978|NCT04599816|Protective Agents|protective agents|mesh-ancestor
43896979|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137823|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137824|NCT00169143|Rituximab|rituximab|mesh-list
44137825|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137826|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137827|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
44137828|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137829|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137830|NCT00169156|Prednisone|prednisone|mesh-list
44137831|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
44137832|NCT00169156|Rituximab|rituximab|mesh-list
44137833|NCT00169156|Doxorubicin|doxorubicin|mesh-list
44137834|NCT00169156|Vincristine|vincristine|mesh-list
44137835|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137836|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
44137837|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137838|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137839|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44137840|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
44137841|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137842|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137843|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44137844|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137845|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137846|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44137847|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44137848|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137849|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137850|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
44137851|NCT00169156|Hormones|hormones|mesh-ancestor
44137852|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137853|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44137854|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44137855|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137856|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
44236838|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44236839|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236840|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44236841|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44236842|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44137857|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137858|NCT00169169|Rituximab|rituximab|mesh-list
44137859|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896994|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896995|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
43896996|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896997|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
43896998|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896999|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
43897000|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897001|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897002|NCT04504864|Aspirin|aspirin|mesh-list
43897003|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43897004|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897005|NCT04504864|Analgesics|analgesics|mesh-ancestor
43897006|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
43897007|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897008|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897009|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897010|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897011|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43897012|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43897013|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897014|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43897015|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43897016|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897017|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
43897018|NCT04497155|Norepinephrine|norepinephrine|mesh-list
43897019|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43897020|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43897021|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
43897022|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897023|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897024|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897025|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
43897026|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
43897027|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897028|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43897043|NCT04483505|Fulvestrant|fulvestrant|mesh-list
43897044|NCT04483505|Palbociclib|palbociclib|mesh-list
43897045|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897046|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897047|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43897048|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43897049|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897050|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897051|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897052|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43648034|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
43897053|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897054|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897056|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
43801418|NCT05104866|Capecitabine|capecitabine|mesh-list
44236844|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236846|NCT00561288|Acetaminophen|acetaminophen|mesh-list
44236847|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236848|NCT00561288|Analgesics|analgesics|mesh-ancestor
44135153|NCT00160355|Melphalan|melphalan|mesh-list
43897057|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43897058|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897059|NCT04378959|Lidocaine|lidocaine|mesh-list
43897060|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
43897061|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
43897062|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897063|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897064|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
43897065|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897066|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43897067|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43897068|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43897069|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43897070|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897072|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897073|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897074|NCT04347486|Atropine|atropine|mesh-list
43897075|NCT04347486|Neostigmine|neostigmine|mesh-list
43897076|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43897077|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43897078|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43897079|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
43897080|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897081|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897082|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43897083|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897084|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
43897085|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
43897086|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43897087|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897088|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897089|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897090|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897091|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43897092|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897093|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43897094|NCT04338698|Azithromycin|azithromycin|mesh-list
43897095|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
43897096|NCT04338698|Oseltamivir|oseltamivir|mesh-list
43897097|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43897098|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897127|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648117|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
43897128|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897129|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897130|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897131|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897132|NCT04288427|Urological Agents|urological agents|mesh-ancestor
43897134|NCT04263090|ON 01910|on 01910|mesh-list
43897135|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897136|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897137|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43897138|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897139|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897140|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897141|NCT04203927|Empagliflozin|empagliflozin|mesh-list
43897142|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43779493|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897165|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43897166|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897167|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897168|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236849|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
44285626|NCT00755859|Prednisolone|prednisolone|mesh-list
43897169|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897170|NCT03952299|Urological Agents|urological agents|mesh-ancestor
43897171|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43897172|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897174|NCT03948464|Morphine|morphine|mesh-list
43897175|NCT03948464|Methadone|methadone|mesh-list
43897176|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43897177|NCT03948464|Narcotics|narcotics|mesh-ancestor
43897178|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897179|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897180|NCT03948464|Analgesics|analgesics|mesh-ancestor
43897181|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
43897182|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897183|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
43897184|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897185|NCT03933384|Tenofovir|tenofovir|mesh-list
43897186|NCT03933384|Entecavir|entecavir|mesh-list
43897187|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
43897188|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897189|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43897190|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43897191|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897192|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897193|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43897194|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43897195|NCT03845543|Paclitaxel|paclitaxel|mesh-list
43897196|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44137879|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44137880|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
44137881|NCT00169195|Gemcitabine|gemcitabine|mesh-list
44137882|NCT00169195|Rituximab|rituximab|mesh-list
44137883|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
44137884|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137885|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137886|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
44137887|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137888|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137889|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44137890|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
44137891|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137892|NCT00169195|Antiviral Agents|antiviral agents|mesh-ancestor
44137893|NCT00169195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137894|NCT00169195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137895|NCT00169195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137896|NCT00169208|Rituximab|rituximab|mesh-list
44137897|NCT00169208|Fludarabine|fludarabine|mesh-list
44137898|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
44137899|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137900|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137901|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
44137902|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137903|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137904|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137905|NCT00169208|Analgesics|analgesics|mesh-ancestor
44137906|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
44137907|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137908|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44137909|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44137910|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897212|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
43897213|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897214|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897215|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
43897216|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897217|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43897218|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897219|NCT03828292|Dexamethasone|dexamethasone|mesh-list
43897220|NCT03828292|Bortezomib|bortezomib|mesh-list
43897221|NCT03828292|Pomalidomide|pomalidomide|mesh-list
43897222|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897223|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
43897224|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
43897225|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236850|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236851|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236853|NCT00561327|Losartan|losartan|mesh-list
44236854|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44236855|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236856|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44236857|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44285627|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
43897260|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897261|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43897262|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
43897263|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
43897264|NCT03656081|Itraconazole|itraconazole|mesh-list
43897265|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43897266|NCT03656081|Amphotericin B|amphotericin b|mesh-list
43897296|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
43897297|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897298|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897299|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
43897300|NCT03623828|Apomorphine|apomorphine|mesh-list
43897301|NCT03623828|Emetics|emetics|mesh-ancestor
43897302|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897303|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
43897304|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897305|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43897306|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
43897307|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
43897308|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897326|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43897327|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
43897328|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43897329|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43897330|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897331|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897332|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897333|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43897334|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43897335|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43897336|NCT03476317|Laxatives|laxatives|mesh-ancestor
43897337|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43897339|NCT03416153|Carboplatin|carboplatin|mesh-list
43897340|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897341|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897342|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897343|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897344|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897345|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897346|NCT03397004|Doxycycline|doxycycline|mesh-list
43897347|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43897348|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897349|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
43897350|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43897351|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43897352|NCT03346668|Gabapentin|gabapentin|mesh-list
43897353|NCT03346668|Analgesics|analgesics|mesh-ancestor
43897354|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
43897355|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648384|NCT03559114|Dalteparin|dalteparin|mesh-list
43897356|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897357|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
43897358|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43897359|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43897360|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897361|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43897362|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44236858|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236859|NCT00561379|Rituximab|rituximab|mesh-list
44236860|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872582|NCT04750603|Albuterol|albuterol|mesh-list
43897363|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43897364|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897390|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897391|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897392|NCT03153280|Capecitabine|capecitabine|mesh-list
43897393|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
43897394|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897395|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
43897396|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897397|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897398|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
43897399|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43897400|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43897401|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897402|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
43897403|NCT03113253|Coagulants|coagulants|mesh-ancestor
43897404|NCT03111992|Spartalizumab|spartalizumab|mesh-list
43897405|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43897406|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897407|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897408|NCT03101046|Docetaxel|docetaxel|mesh-list
43897409|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897410|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897411|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897412|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897435|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897436|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897437|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897439|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43897440|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897441|NCT02899078|Nivolumab|nivolumab|mesh-list
43897442|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897443|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897444|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43897445|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897446|NCT02895373|Alprostadil|alprostadil|mesh-list
43897447|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43897448|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
43897449|NCT02895373|Urological Agents|urological agents|mesh-ancestor
43897450|NCT02788591|Esomeprazole|esomeprazole|mesh-list
43897451|NCT02788591|Omeprazole|omeprazole|mesh-list
43897452|NCT02788591|Pantoprazole|pantoprazole|mesh-list
43897453|NCT02788591|Lansoprazole|lansoprazole|mesh-list
43897454|NCT02788591|Sucralfate|sucralfate|mesh-list
43897455|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43897456|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43897457|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43897458|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897459|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137937|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44137938|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44137939|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44137940|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137941|NCT00169416|Valacyclovir|valacyclovir|mesh-list
44137960|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137961|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137962|NCT00169546|Fluticasone|fluticasone|mesh-list
44137963|NCT00169546|Xhance|xhance|mesh-list
44137964|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44137965|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137966|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44137967|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
44137968|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137969|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137970|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44137971|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44137972|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
44236861|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236863|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236864|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236865|NCT00561496|Tenofovir|tenofovir|mesh-list
44236866|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
44137973|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44137974|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44137975|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44137976|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44137977|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137978|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137979|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137980|NCT00169559|Fenofibrate|fenofibrate|mesh-list
44137981|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44137982|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
44158388|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897461|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43897462|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
43897463|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43897464|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897465|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897466|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897467|NCT02728050|Cytarabine|cytarabine|mesh-list
43897468|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43897469|NCT02728050|Sorafenib|sorafenib|mesh-list
43897470|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
43897471|NCT02728050|Cladribine|cladribine|mesh-list
43897472|NCT02728050|Lenograstim|lenograstim|mesh-list
43897473|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897474|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
43897475|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897476|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897477|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
43897513|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897514|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897516|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
43897544|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897545|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897546|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43897547|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43897548|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897549|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897550|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897551|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43973473|NCT01747330|Pancreatin|pancreatin|mesh-list
43897552|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897553|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897554|NCT02570503|Ketorolac|ketorolac|mesh-list
43897555|NCT02570503|Clonidine|clonidine|mesh-list
43897556|NCT02570503|Epinephrine|epinephrine|mesh-list
43897557|NCT02570503|Ropivacaine|ropivacaine|mesh-list
43897558|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
43897559|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
43897560|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897561|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897562|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
43897563|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897572|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43897573|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897574|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
43897575|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
43897576|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43897577|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43897578|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897579|NCT02570503|Analgesics|analgesics|mesh-ancestor
43897580|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897581|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897582|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43897583|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897584|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236867|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236868|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44285628|NCT00755859|Azathioprine|azathioprine|mesh-list
43897585|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
43897586|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43897587|NCT02564068|Oxytocin|oxytocin|mesh-list
43897588|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
43897589|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43897590|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897591|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
43897592|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43897593|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897594|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897595|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897596|NCT02492269|Analgesics|analgesics|mesh-ancestor
43897597|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
43897598|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897599|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43897600|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43897601|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43897602|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
43897603|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897604|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897605|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43897606|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897607|NCT02469753|Analgesics|analgesics|mesh-ancestor
43897608|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
43897609|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897610|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897611|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897612|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897613|NCT02467153|Vitamin D|vitamin d|mesh-list
43897614|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
43897615|NCT02467153|Vitamins|vitamins|mesh-ancestor
43897616|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
43897617|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897618|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43897619|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43897620|NCT02459457|Paclitaxel|paclitaxel|mesh-list
43897621|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43897622|NCT02459457|Cisplatin|cisplatin|mesh-list
43897623|NCT02459457|Carboplatin|carboplatin|mesh-list
43897624|NCT02459457|Fluorouracil|fluorouracil|mesh-list
43897625|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897626|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897627|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897628|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897629|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779909|NCT02983006|Nivolumab|nivolumab|mesh-list
43779925|NCT02659813|Copper|copper|mesh-list
43897637|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43897638|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43897639|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
43897640|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
43897641|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897642|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897643|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
43897644|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897645|NCT02299505|Ceritinib|ceritinib|mesh-list
43897646|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897647|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897648|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897649|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897650|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43897651|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43897652|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897653|NCT02250014|Sargramostim|sargramostim|mesh-list
43897654|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
43897655|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897656|NCT02235701|Ifosfamide|ifosfamide|mesh-list
43897657|NCT02235701|Doxorubicin|doxorubicin|mesh-list
43897658|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897659|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
44236869|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44236870|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872753|NCT04747080|BB 1101|bb 1101|mesh-list
43897660|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897661|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897662|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43897663|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897664|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897665|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897666|NCT02235688|Gemcitabine|gemcitabine|mesh-list
43897667|NCT02235688|Doxorubicin|doxorubicin|mesh-list
43897668|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897669|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
43897670|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897671|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897672|NCT02235688|Antiviral Agents|antiviral agents|mesh-ancestor
43897673|NCT02235688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897674|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897675|NCT02235688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897676|NCT02235688|Immunologic Factors|immunologic factors|mesh-ancestor
43897677|NCT02235688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897678|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43897679|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897680|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897681|NCT02115074|Celecoxib|celecoxib|mesh-list
43897682|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43897683|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897684|NCT02115074|Analgesics|analgesics|mesh-ancestor
43897685|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
43897686|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897687|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897688|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897689|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897690|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43897691|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43897692|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897693|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897694|NCT01923298|Estradiol|estradiol|mesh-list
43897695|NCT01923298|Estrogens|estrogens|mesh-ancestor
43897696|NCT01923298|Hormones|hormones|mesh-ancestor
43897711|NCT01473108|Eplerenone|eplerenone|mesh-list
43897712|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43973633|NCT01749501|Rocuronium|rocuronium|mesh-list
43897713|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897714|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897715|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897716|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43897717|NCT01473108|Diuretics|diuretics|mesh-ancestor
43897718|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
43897719|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43897720|NCT01379989|Carboplatin|carboplatin|mesh-list
43897721|NCT01379989|Doxorubicin|doxorubicin|mesh-list
43897722|NCT01379989|Trabectedin|trabectedin|mesh-list
43897723|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897724|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43897725|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897726|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897727|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897728|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897729|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897730|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
43897731|NCT01345656|Spironolactone|spironolactone|mesh-list
43897732|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43897733|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897734|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897735|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897736|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43897737|NCT01345656|Diuretics|diuretics|mesh-ancestor
43897738|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
43897739|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43897740|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43897741|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
44236871|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236872|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44236873|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43897742|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897743|NCT01101464|Asenapine|asenapine|mesh-list
43897744|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43897745|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43897746|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897747|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897748|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43897749|NCT00945035|Etoricoxib|etoricoxib|mesh-list
43897750|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43897751|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897752|NCT00945035|Analgesics|analgesics|mesh-ancestor
43897753|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
43897754|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897755|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897756|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897757|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897778|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43897779|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
43897781|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897782|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897783|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897784|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897785|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897786|NCT00723736|Desloratadine|desloratadine|mesh-list
43897787|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897788|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897789|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897790|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897791|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897792|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43897793|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43897794|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
43897795|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
43897796|NCT00705081|Ezetimibe|ezetimibe|mesh-list
43897797|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43897798|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43897799|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
43897800|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897801|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43897802|NCT00704769|Desloratadine|desloratadine|mesh-list
43897803|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897804|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897805|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897806|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897807|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897808|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43897809|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43897810|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
43897811|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
43897845|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43897846|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
43897847|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
43897848|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897849|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897850|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897851|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43780043|NCT05083247|Gemcitabine|gemcitabine|mesh-list
43897876|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897877|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897878|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897879|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
43897880|NCT00003816|Melphalan|melphalan|mesh-list
43897881|NCT00003816|Busulfan|busulfan|mesh-list
43897882|NCT00003816|Thiotepa|thiotepa|mesh-list
43897883|NCT00003816|Carboplatin|carboplatin|mesh-list
43897884|NCT00003816|Fludarabine|fludarabine|mesh-list
43897885|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
43897886|NCT00003816|Etoposide|etoposide|mesh-list
43897887|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44236874|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
44236875|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236876|NCT00561522|Capecitabine|capecitabine|mesh-list
44236877|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897888|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897889|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
43897890|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897891|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897892|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897893|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
43897894|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897895|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897896|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43897897|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897898|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
43897899|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897900|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897901|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897902|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897903|NCT00003820|Rituximab|rituximab|mesh-list
43897904|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897905|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897906|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
43897935|NCT00004054|Paclitaxel|paclitaxel|mesh-list
43897936|NCT00004054|Etoposide|etoposide|mesh-list
43897937|NCT00004054|Bicalutamide|bicalutamide|mesh-list
43897938|NCT00004054|Flutamide|flutamide|mesh-list
43897939|NCT00004054|Estramustine|estramustine|mesh-list
43897940|NCT00004054|Warfarin|warfarin|mesh-list
43897941|NCT00004054|Hormones|hormones|mesh-list
43897942|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43897943|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897944|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897945|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897946|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897947|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897948|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897949|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897950|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897951|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973759|NCT01753362|Incretins|incretins|mesh-ancestor
43897952|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897953|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897956|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897957|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897958|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897959|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
43897960|NCT00004092|Paclitaxel|paclitaxel|mesh-list
43897961|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
43897962|NCT00004092|Carboplatin|carboplatin|mesh-list
43897963|NCT00004092|Doxorubicin|doxorubicin|mesh-list
43897964|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43897965|NCT00004092|Thiotepa|thiotepa|mesh-list
43897966|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897967|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897968|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897969|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897970|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897971|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897972|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897973|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
43897974|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897975|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897976|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897977|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
43897978|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43897979|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43897980|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897981|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897982|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897983|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
43897984|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897985|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236879|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236880|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236881|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44236882|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
44236883|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236884|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44236885|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43897986|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
43897987|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897988|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43897989|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43897990|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897991|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43897992|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137983|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137984|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44137986|NCT00169572|Ondansetron|ondansetron|mesh-list
44137987|NCT00169572|Aprepitant|aprepitant|mesh-list
44137988|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
44137989|NCT00169572|Casopitant|casopitant|mesh-list
44137990|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137991|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
44137992|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
44137993|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137994|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137995|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137996|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
44137997|NCT00169572|Hormones|hormones|mesh-ancestor
44137998|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137999|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138000|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138001|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
44138002|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44138003|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44138004|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
44138005|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138006|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138007|NCT00169572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44138008|NCT00169572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44138009|NCT00169572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138010|NCT00169572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44138011|NCT00169572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44138012|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44138013|NCT00169585|Levofloxacin|levofloxacin|mesh-list
44138014|NCT00169585|Ofloxacin|ofloxacin|mesh-list
44138015|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44138016|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138017|NCT00169585|Renal Agents|renal agents|mesh-ancestor
44138018|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44138038|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138039|NCT00169728|Vaccines|vaccines|mesh-list
44138040|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44138041|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
44138042|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157264|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157265|NCT00233935|Protective Agents|protective agents|mesh-ancestor
44157266|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157267|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44157268|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44157269|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897993|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43897994|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897995|NCT00004547|Paclitaxel|paclitaxel|mesh-list
43897996|NCT00004547|Cisplatin|cisplatin|mesh-list
43897997|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897998|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236886|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44236887|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236888|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
44236889|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44236890|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236891|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44236892|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
43872959|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
43897999|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898000|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898001|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898002|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898004|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43898005|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898006|NCT00005803|Cytarabine|cytarabine|mesh-list
43898007|NCT00005803|Cyclosporine|cyclosporine|mesh-list
43898008|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
43898009|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
43898010|NCT00005803|Melphalan|melphalan|mesh-list
43898011|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
43898013|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43898014|NCT00005803|Fludarabine|fludarabine|mesh-list
43898015|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
43898016|NCT00005803|Etoposide|etoposide|mesh-list
43898017|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
43898018|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
43898040|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43898041|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43898042|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
43898043|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43898044|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
43898045|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898046|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898047|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898049|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898050|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898051|NCT00006101|Eflornithine|eflornithine|mesh-list
43898052|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898053|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43898054|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43898055|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43898056|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898057|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43898058|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898059|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898060|NCT00006110|Paclitaxel|paclitaxel|mesh-list
43898061|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
43898062|NCT00006110|Doxorubicin|doxorubicin|mesh-list
43898063|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43898064|NCT00006110|Trastuzumab|trastuzumab|mesh-list
43898065|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898066|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898067|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898068|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898069|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898070|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839312|NCT04786548|Analgesics|analgesics|mesh-ancestor
43898095|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43898097|NCT05347641|Cytarabine|cytarabine|mesh-list
43898098|NCT05347641|Methotrexate|methotrexate|mesh-list
43898099|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898100|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
43898101|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898102|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898103|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43898104|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
43898105|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43898106|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236893|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44236894|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
44236895|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236896|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236897|NCT00561704|Losartan|losartan|mesh-list
44236898|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44236899|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43898107|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
43898108|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898109|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
43898110|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898111|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43898112|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898113|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43898114|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
43898115|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898116|NCT05347498|Febuxostat|febuxostat|mesh-list
43898117|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
43898118|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649063|NCT03032315|Diuretics|diuretics|mesh-ancestor
43898144|NCT05347134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898145|NCT05347134|Immunologic Factors|immunologic factors|mesh-ancestor
43898146|NCT05347134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898147|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898148|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898149|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898150|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898151|NCT05346952|Carboplatin|carboplatin|mesh-list
43898152|NCT05346952|Pemetrexed|pemetrexed|mesh-list
43898153|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898154|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898155|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898156|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43898157|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43898158|NCT05346926|Calpastatin|calpastatin|mesh-list
43898159|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43898160|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
43898161|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898162|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898163|NCT05346861|Trastuzumab|trastuzumab|mesh-list
43898164|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898165|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898166|NCT05346562|Cannabidiol|cannabidiol|mesh-list
43898167|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
43898186|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898187|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898188|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43898189|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898190|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898191|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898192|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898194|NCT05346159|Hormones|hormones|mesh-ancestor
43898195|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898196|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898197|NCT05346146|Gemcitabine|gemcitabine|mesh-list
43898198|NCT05346146|Paclitaxel|paclitaxel|mesh-list
43898199|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898200|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898201|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898202|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898203|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898204|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898205|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898206|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
43898207|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
43898208|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898209|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898210|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236900|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44236901|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44236902|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898211|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
43898212|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898213|NCT05346107|Paclitaxel|paclitaxel|mesh-list
43898214|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
43898215|NCT05346107|Doxorubicin|doxorubicin|mesh-list
43898216|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43898217|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898218|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898219|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898220|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898221|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898222|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898246|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43898247|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43898248|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43898250|NCT05345808|Hormones|hormones|mesh-ancestor
43898251|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898252|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898253|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898254|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
43898255|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898256|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898257|NCT05345639|Ropivacaine|ropivacaine|mesh-list
43898258|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
43898259|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898260|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898261|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
43898262|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
43898263|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898264|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
43898265|NCT05345574|Remifentanil|remifentanil|mesh-list
43898266|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43898267|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898268|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898269|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898270|NCT05345574|Analgesics|analgesics|mesh-ancestor
43898271|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
43780400|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43898294|NCT05185024|Iron|iron|mesh-list
43898295|NCT05185024|Trace Elements|trace elements|mesh-ancestor
43898296|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
43898297|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898298|NCT05168865|Letrozole|letrozole|mesh-list
43898299|NCT05168865|Estradiol|estradiol|mesh-list
43898300|NCT05168865|Progesterone|progesterone|mesh-list
43898301|NCT05168865|Estrogens|estrogens|mesh-ancestor
43898302|NCT05168865|Hormones|hormones|mesh-ancestor
43898303|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898304|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898305|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898306|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43898307|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43898308|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898309|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898310|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43898311|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898312|NCT05168865|Progestins|progestins|mesh-ancestor
43898313|NCT05167734|Dextrans|dextrans|mesh-list
43898314|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
43898315|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
43898316|NCT05167734|Hematinics|hematinics|mesh-ancestor
43898317|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
43898318|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
43898319|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
43898320|NCT05158062|Paclitaxel|paclitaxel|mesh-list
43898321|NCT05158062|Docetaxel|docetaxel|mesh-list
43898322|NCT05158062|Bevacizumab|bevacizumab|mesh-list
43898323|NCT05158062|Carboplatin|carboplatin|mesh-list
43898324|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
43898325|NCT05158062|Olaparib|olaparib|mesh-list
43700725|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236903|NCT00561717|Cetirizine|cetirizine|mesh-list
44236904|NCT00561717|Loratadine|loratadine|mesh-list
44236905|NCT00561717|Azelastine|azelastine|mesh-list
44236906|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44236907|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44236908|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43898331|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898332|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898333|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898334|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898335|NCT05158062|Growth Substances|growth substances|mesh-ancestor
43898336|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898337|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898338|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43898339|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898340|NCT05078827|Fluorouracil|fluorouracil|mesh-list
43898341|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
43898342|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898343|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898344|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898345|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898346|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
43898347|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898348|NCT05051566|Esomeprazole|esomeprazole|mesh-list
43898349|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43898350|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898351|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43898352|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898353|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898354|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
43898355|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898356|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
43898357|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898358|NCT04373785|Temozolomide|temozolomide|mesh-list
43898359|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43898360|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
43898361|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898362|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898363|NCT04218565|Golimumab|golimumab|mesh-list
43898364|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43898365|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43898366|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898367|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
43898368|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898369|NCT04161599|Metronidazole|metronidazole|mesh-list
43898370|NCT04161599|Cefuroxime|cefuroxime|mesh-list
43898371|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
43898372|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
43898373|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
43898374|NCT04161599|Citric Acid|citric acid|mesh-list
43898375|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
43898376|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898377|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43898378|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43898379|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43898380|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
43898381|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43898382|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
43898383|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
43898384|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898385|NCT04161599|Cathartics|cathartics|mesh-ancestor
43898386|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898387|NCT04161599|Antacids|antacids|mesh-ancestor
43898388|NCT04134936|Lenalidomide|lenalidomide|mesh-list
43898389|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
43898390|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898391|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898392|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898393|NCT04134936|Growth Substances|growth substances|mesh-ancestor
43898394|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898395|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236909|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
44236910|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
44236911|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236912|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236913|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236914|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
44236915|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
44236916|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44236917|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
44236918|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236919|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236920|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236921|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44236922|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898396|NCT04073784|Gemcitabine|gemcitabine|mesh-list
43898418|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43898419|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
43898420|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898421|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898422|NCT03898934|Vitamin D|vitamin d|mesh-list
43898423|NCT03898934|Vitamins|vitamins|mesh-ancestor
43898424|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
43898425|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898426|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898427|NCT03884556|Gemcitabine|gemcitabine|mesh-list
43898428|NCT03884556|Paclitaxel|paclitaxel|mesh-list
43898429|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
43898430|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898431|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898432|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898433|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898434|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898435|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898436|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898437|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
43898438|NCT03884556|Antiviral Agents|antiviral agents|mesh-ancestor
43898439|NCT03884556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898440|NCT03884556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898441|NCT03884556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898442|NCT03884556|Immunologic Factors|immunologic factors|mesh-ancestor
43898443|NCT03884556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898444|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898445|NCT03859869|Pancrelipase|pancrelipase|mesh-list
43898446|NCT03859869|Pancreatin|pancreatin|mesh-list
44138044|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
43898447|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898448|NCT03798639|Nivolumab|nivolumab|mesh-list
43898474|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898475|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898476|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898477|NCT03629483|Analgesics|analgesics|mesh-ancestor
43898478|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
43898479|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898480|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43898481|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43898482|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43898483|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
43898484|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898485|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898486|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
43898487|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
43898488|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
44236923|NCT00561756|Vaccines|vaccines|mesh-list
44236924|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
44236925|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898489|NCT03622788|Fludarabine|fludarabine|mesh-list
43898490|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43898491|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898492|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
43898493|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898494|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898495|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43898496|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
43898497|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138050|NCT00169845|Vitamin E|vitamin e|mesh-list
44138051|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
44138052|NCT00169845|Beta Carotene|beta carotene|mesh-list
44138053|NCT00169845|Carotenoids|carotenoids|mesh-list
44138054|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
44138055|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138056|NCT00169845|Protective Agents|protective agents|mesh-ancestor
44138057|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138058|NCT00169845|Vitamins|vitamins|mesh-ancestor
44138059|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
44138060|NCT00169845|Provitamins|provitamins|mesh-ancestor
44138061|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
44138062|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44138063|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138064|NCT00169949|Aripiprazole|aripiprazole|mesh-list
44138065|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
44138066|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44138067|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44138068|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43898500|NCT03553810|Valsartan|valsartan|mesh-list
43898501|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43898502|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43898503|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43898504|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43898505|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898506|NCT03527264|Cisplatin|cisplatin|mesh-list
43898507|NCT03527264|Nivolumab|nivolumab|mesh-list
43898508|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898509|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898510|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43898511|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898512|NCT03519308|Gemcitabine|gemcitabine|mesh-list
43898513|NCT03519308|Paclitaxel|paclitaxel|mesh-list
43898514|NCT03519308|Nivolumab|nivolumab|mesh-list
43898515|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898516|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898517|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898518|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898519|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898520|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898521|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898522|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
43898523|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
43898524|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898525|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898526|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898527|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
43898528|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898529|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898530|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43898531|NCT05587062|Aflibercept|aflibercept|mesh-list
43898532|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898533|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898534|NCT05587062|Growth Substances|growth substances|mesh-ancestor
43898535|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898536|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898537|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898538|NCT05587036|Rifaximin|rifaximin|mesh-list
43898539|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43898540|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898541|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898542|NCT05586919|Ethanol|ethanol|mesh-list
44236926|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
44236927|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44236928|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
44236929|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898543|NCT05586919|Polidocanol|polidocanol|mesh-list
43898555|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898556|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898557|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43898558|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898559|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43898560|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43898561|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898562|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898563|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43898564|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898565|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43898566|NCT05586789|Tryptophan|tryptophan|mesh-list
43898567|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43898568|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
43898569|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43898570|NCT05586763|Promethazine|promethazine|mesh-list
43898571|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
43898572|NCT05586763|Metoclopramide|metoclopramide|mesh-list
43898573|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
43898574|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
44158389|NCT00236652|Levofloxacin|levofloxacin|mesh-list
43898575|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898576|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898577|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898578|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43898579|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43898580|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
43898581|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898582|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898583|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
43898584|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
43898585|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43898586|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
43898587|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
43898588|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43898589|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43898590|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43898591|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898592|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
43898594|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
43898595|NCT05586750|Atorvastatin|atorvastatin|mesh-list
43898596|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43898597|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43898598|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
43898599|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898600|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43898601|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43898602|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898603|NCT05586711|Estradiol|estradiol|mesh-list
43898604|NCT05586711|Estrogens|estrogens|mesh-ancestor
43898605|NCT05586711|Hormones|hormones|mesh-ancestor
43898606|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898607|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898608|NCT05586620|Mitomycins|mitomycins|mesh-list
43898637|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43898638|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43898639|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43898640|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43898641|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43898642|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43898643|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43898644|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
43898645|NCT05586529|Vitamin D|vitamin d|mesh-list
43898646|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898647|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236930|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898648|NCT05586529|Vitamins|vitamins|mesh-ancestor
43898649|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
43898650|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898651|NCT05586516|Gemcitabine|gemcitabine|mesh-list
43898661|NCT05586516|Antiviral Agents|antiviral agents|mesh-ancestor
43898662|NCT05586516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43629561|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
43898664|NCT05586516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898665|NCT05586516|Immunologic Factors|immunologic factors|mesh-ancestor
43898666|NCT05586516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898668|NCT05586464|Antacids|antacids|mesh-ancestor
43898669|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898670|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898671|NCT05586373|Dipyrone|dipyrone|mesh-list
43898672|NCT05586373|Ibuprofen|ibuprofen|mesh-list
43898673|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43898674|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898675|NCT05586373|Analgesics|analgesics|mesh-ancestor
43898676|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
43898677|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898678|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898679|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43898680|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898681|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43898682|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898683|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898684|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
43898685|NCT05586347|Nicardipine|nicardipine|mesh-list
43898686|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43898687|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43898688|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43898689|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898690|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898691|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898692|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
43898693|NCT05586126|Sevoflurane|sevoflurane|mesh-list
43898694|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43898695|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43898696|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
43898697|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
43898698|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898699|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898700|NCT05586074|Cytarabine|cytarabine|mesh-list
43898701|NCT05586074|Fludarabine|fludarabine|mesh-list
43898702|NCT05586074|Azacitidine|azacitidine|mesh-list
43898703|NCT05586074|Decitabine|decitabine|mesh-list
43898704|NCT05586074|Idarubicin|idarubicin|mesh-list
43898705|NCT05586074|Lenograstim|lenograstim|mesh-list
43898706|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898707|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898708|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
43898709|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898710|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898711|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
43898712|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898713|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
43898714|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898715|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898716|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43898717|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43898738|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898739|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898740|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898741|NCT05585814|Growth Substances|growth substances|mesh-ancestor
43898742|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898743|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898744|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898745|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
43898746|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898747|NCT05585736|Mydriatics|mydriatics|mesh-list
43898748|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
43898749|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898750|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898751|NCT05585671|Belimumab|belimumab|mesh-list
44236931|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236932|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236933|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44236934|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43898752|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898753|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
43898754|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898755|NCT05585580|Paclitaxel|paclitaxel|mesh-list
43898756|NCT05585580|Lenvatinib|lenvatinib|mesh-list
43898757|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898758|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898759|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898760|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898761|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898762|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898763|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43898764|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898765|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
43898766|NCT05583643|Atorvastatin|atorvastatin|mesh-list
43898767|NCT05583643|Calcium|calcium|mesh-list
43898768|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898769|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898770|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898771|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43898772|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43898773|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
44138074|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138076|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138077|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
44138078|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44138079|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44138080|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44138081|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44138082|NCT00169988|Risperidone|risperidone|mesh-list
44138083|NCT00169988|Sertraline|sertraline|mesh-list
44138084|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44138085|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
44138086|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138087|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138088|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138089|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43898778|NCT05580445|Gemcitabine|gemcitabine|mesh-list
43898779|NCT05580445|Conteltinib|conteltinib|mesh-list
43898780|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898781|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
43898782|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898783|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898784|NCT05580445|Antiviral Agents|antiviral agents|mesh-ancestor
43898785|NCT05580445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898786|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898787|NCT05580445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898788|NCT05580445|Immunologic Factors|immunologic factors|mesh-ancestor
43898789|NCT05580445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898790|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43898791|NCT05578950|Itraconazole|itraconazole|mesh-list
43898792|NCT05578950|Terbinafine|terbinafine|mesh-list
43898793|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
43898794|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898795|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43898796|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43898797|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898798|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898799|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43898800|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898801|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898802|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898803|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43898804|NCT05577442|Trastuzumab|trastuzumab|mesh-list
43898805|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236935|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44236936|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236937|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873449|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43898806|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898808|NCT05571644|Fluorouracil|fluorouracil|mesh-list
43898809|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
43898810|NCT05571644|Irinotecan|irinotecan|mesh-list
43898811|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
43898812|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
43898813|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898814|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43848179|NCT04044131|Sorbitol|sorbitol|mesh-list
43898843|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898845|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43898846|NCT05300035|Antibodies|antibodies|mesh-list
43898847|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43898848|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
43898849|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898850|NCT05261321|Dronabinol|dronabinol|mesh-list
43898851|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
43898852|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898853|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43898854|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898855|NCT05261321|Analgesics|analgesics|mesh-ancestor
43898856|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
43898857|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898858|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43898859|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43898860|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898861|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898891|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
43898892|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
43898893|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43898894|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
43898895|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898896|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898897|NCT05098067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43898898|NCT05098067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43898899|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898900|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43898901|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43898902|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
43898903|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43898904|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43898905|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
43898906|NCT05080192|Fenofibrate|fenofibrate|mesh-list
43898907|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43898908|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
43898909|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898910|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43898911|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
43898928|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898929|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898930|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898931|NCT04868708|Paclitaxel|paclitaxel|mesh-list
43898932|NCT04868708|Bevacizumab|bevacizumab|mesh-list
43898933|NCT04868708|Cisplatin|cisplatin|mesh-list
43898934|NCT04868708|Carboplatin|carboplatin|mesh-list
43898935|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898936|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898937|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898938|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898939|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898940|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898941|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898942|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898943|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898944|NCT04868708|Growth Substances|growth substances|mesh-ancestor
43898945|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898946|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898947|NCT04862260|Atorvastatin|atorvastatin|mesh-list
44236938|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236940|NCT00561899|Amodiaquine|amodiaquine|mesh-list
44236941|NCT00561899|Artenimol|artenimol|mesh-list
44236942|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
44236943|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44236944|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44236945|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236946|NCT00561964|Irbesartan|irbesartan|mesh-list
44236947|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236948|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43873524|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
43898948|NCT04862260|Ezetimibe|ezetimibe|mesh-list
43898949|NCT04862260|Evolocumab|evolocumab|mesh-list
43898950|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43898951|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43898952|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
43898953|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898954|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43898955|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43898956|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898957|NCT04839042|Cloricromen|cloricromen|mesh-list
43898958|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43898959|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
43898960|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138090|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44138091|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138092|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44138093|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44138094|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
44138095|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
44138096|NCT00169988|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44138097|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44138098|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138099|NCT00170001|Esomeprazole|esomeprazole|mesh-list
44138100|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44138126|NCT00170209|Isoniazid|isoniazid|mesh-list
44138127|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44138128|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
44138129|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44138130|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138131|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
44138132|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44138133|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138134|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158390|NCT00236652|Ofloxacin|ofloxacin|mesh-list
43898961|NCT04705662|Lactulose|lactulose|mesh-list
43898962|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898963|NCT04643379|Carboplatin|carboplatin|mesh-list
43898964|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
43898965|NCT04643379|Olaparib|olaparib|mesh-list
43898966|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898967|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898968|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43898969|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898970|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898971|NCT04634604|Bevacizumab|bevacizumab|mesh-list
43898972|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898973|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898974|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898992|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43898993|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898994|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898995|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44236949|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44236950|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236951|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
44236952|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236953|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236954|NCT00562055|Reboxetine|reboxetine|mesh-list
44236955|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43898996|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898997|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898998|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898999|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43899000|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43899001|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899002|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43899003|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
43899005|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899006|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899007|NCT04444167|Lenvatinib|lenvatinib|mesh-list
43899008|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899009|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899010|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899011|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899012|NCT04348370|Vaccines|vaccines|mesh-list
43899013|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
43899014|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
43899015|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899016|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43899017|NCT04310995|Nicorandil|nicorandil|mesh-list
43899018|NCT04310995|Diltiazem|diltiazem|mesh-list
43899019|NCT04310995|Isosorbide|isosorbide|mesh-list
43899020|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43899021|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43899022|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43899023|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43899024|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43899025|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899026|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43899027|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899028|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
43899029|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43899030|NCT04310995|Diuretics|diuretics|mesh-ancestor
43899031|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
43780896|NCT02316236|Analgesics|analgesics|mesh-ancestor
43899062|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43899063|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899065|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43899066|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43899067|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899068|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899069|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
43899070|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43899071|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43899072|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43899073|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43899074|NCT04283656|Tenofovir|tenofovir|mesh-list
43899075|NCT04283656|Lamivudine|lamivudine|mesh-list
43899076|NCT04283656|Spironolactone|spironolactone|mesh-list
43899077|NCT04283656|Estradiol|estradiol|mesh-list
43899078|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
43899079|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899107|NCT04205266|Hematinics|hematinics|mesh-ancestor
43899108|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43899109|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43899110|NCT04198727|Capecitabine|capecitabine|mesh-list
43899111|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899113|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236957|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236958|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236959|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236960|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236961|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135397|NCT00161291|Bevacizumab|bevacizumab|mesh-list
43899114|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899115|NCT04194554|Leuprolide|leuprolide|mesh-list
43899116|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
43899117|NCT04194554|Niraparib|niraparib|mesh-list
43899118|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43899119|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
43899120|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43899121|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899122|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899123|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899124|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43899125|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781000|NCT04631393|Analgesics|analgesics|mesh-ancestor
43899159|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43899160|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899161|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
43899162|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899163|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899164|NCT04038619|Loperamide|loperamide|mesh-list
43899172|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899173|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
43899174|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899175|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899176|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
43899177|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899178|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899179|NCT03969420|Growth Substances|growth substances|mesh-ancestor
43899180|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899181|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899182|NCT03925480|Azithromycin|azithromycin|mesh-list
43899183|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43899184|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899185|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43899186|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43899188|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43899189|NCT03815929|Estrogens|estrogens|mesh-ancestor
43899190|NCT03815929|Hormones|hormones|mesh-ancestor
43899191|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899192|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899193|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43899194|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
43899195|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43899196|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43630168|NCT03054168|Goserelin|goserelin|mesh-list
43899197|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43899198|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
43899199|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899200|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43899201|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899202|NCT03699995|Lidocaine|lidocaine|mesh-list
43899203|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
43899204|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
43899205|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43899206|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899207|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
43899208|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899209|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43899210|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43899211|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43899212|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43830587|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44236962|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236963|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
44236964|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43899213|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899214|NCT03584516|Prednisone|prednisone|mesh-list
43899215|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
43899216|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43899217|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43899218|NCT03584516|Prednisolone|prednisolone|mesh-list
43899219|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
43899220|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43899221|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
43899222|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899223|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
43899224|NCT03584516|Hormones|hormones|mesh-ancestor
43899225|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899226|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899227|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899228|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899229|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
43899230|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
43899231|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899232|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899265|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899266|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
43899267|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138135|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44138136|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44138137|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44138138|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44138139|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44138140|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44138141|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44138142|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44138154|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44138155|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138156|NCT00170404|Vitamins|vitamins|mesh-list
44138157|NCT00170404|Folic Acid|folic acid|mesh-list
44138158|NCT00170404|Vitamin A|vitamin a|mesh-list
44138159|NCT00170404|Thiamine|thiamine|mesh-list
44138160|NCT00170404|Selenium|selenium|mesh-list
44138161|NCT00170404|Micronutrients|micronutrients|mesh-list
44138162|NCT00170404|Trace Elements|trace elements|mesh-list
44138163|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138164|NCT00170404|Hematinics|hematinics|mesh-ancestor
44138165|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
44138166|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
44138167|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138168|NCT00170404|Protective Agents|protective agents|mesh-ancestor
44138169|NCT00170430|Fluconazole|fluconazole|mesh-list
44138170|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
44138171|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138172|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44138173|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44138174|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138175|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138176|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44138177|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
44138178|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44138179|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138180|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44138181|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44138182|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44138183|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44138184|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
44138185|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138186|NCT00170456|Antacids|antacids|mesh-ancestor
44138187|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236966|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
44236967|NCT00562068|Doxorubicin|doxorubicin|mesh-list
44236968|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44236969|NCT00562068|Vincristine|vincristine|mesh-list
44236970|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
44236971|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236972|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
44236973|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138188|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138189|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44138190|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44138191|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
44138192|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138193|NCT00170469|Antacids|antacids|mesh-ancestor
44138194|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138195|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138196|NCT00170547|Vaccines|vaccines|mesh-list
44138197|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
44138198|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138199|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44138200|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44138201|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138202|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43899268|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43899269|NCT03364348|Trastuzumab|trastuzumab|mesh-list
43899270|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43899271|NCT03364348|Maytansine|maytansine|mesh-list
43899272|NCT03364348|Antibodies|antibodies|mesh-list
43899273|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
43899274|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43899275|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
43899276|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
43899302|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899303|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
43899304|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43899305|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43899306|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899308|NCT03287336|Coagulants|coagulants|mesh-ancestor
43899309|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
43899310|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43899311|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43899312|NCT03249844|Prednisolone|prednisolone|mesh-list
43899313|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
43899314|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43899315|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
43899316|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899317|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
43899318|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
43899319|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899320|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899321|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899322|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
43899323|NCT03249844|Hormones|hormones|mesh-ancestor
43899324|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899325|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43899326|NCT03249844|Protective Agents|protective agents|mesh-ancestor
43899327|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899328|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899345|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899347|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899348|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899349|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899350|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899351|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899352|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
43899353|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43899354|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899355|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43899356|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236974|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236975|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899357|NCT03013998|Cytarabine|cytarabine|mesh-list
43899358|NCT03013998|Azacitidine|azacitidine|mesh-list
43899359|NCT03013998|Decitabine|decitabine|mesh-list
43899360|NCT03013998|Daunorubicin|daunorubicin|mesh-list
43899361|NCT03013998|Venetoclax|venetoclax|mesh-list
43899362|NCT03013998|AZD5991|azd5991|mesh-list
43899363|NCT03013998|Pevonedistat|pevonedistat|mesh-list
43899364|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899365|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
43899366|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899367|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899368|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
43899369|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899370|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899371|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
43899372|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899373|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899374|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899375|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899376|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43899377|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
43899378|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
43899379|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
43899380|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
43899381|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43899382|NCT02950051|Rituximab|rituximab|mesh-list
43899383|NCT02950051|Fludarabine|fludarabine|mesh-list
43899384|NCT02950051|Venetoclax|venetoclax|mesh-list
43899385|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
43899386|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899387|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
43839498|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899403|NCT02763137|Levodopa|levodopa|mesh-list
43899404|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43899405|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
43899406|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899407|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43899408|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43899409|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
43899410|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
43899411|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899412|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899413|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43899414|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899415|NCT02759835|Osimertinib|osimertinib|mesh-list
43899416|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899417|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899418|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899419|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899420|NCT02664155|Vitamin K|vitamin k|mesh-list
43899421|NCT02664155|Heparin|heparin|mesh-list
43899422|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
43899423|NCT02664155|Apixaban|apixaban|mesh-list
43899424|NCT02664155|Vitamins|vitamins|mesh-ancestor
43899425|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
43899426|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899427|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
43899428|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43899429|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43899430|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899431|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43899432|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
43899433|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43899434|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
43899435|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899436|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43899437|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
43899438|NCT02664155|Coagulants|coagulants|mesh-ancestor
43899439|NCT02568566|Vaccines|vaccines|mesh-list
43899440|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
43899441|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899442|NCT02505750|Capecitabine|capecitabine|mesh-list
43899443|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899444|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
43899445|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236976|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
44236977|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236978|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236979|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44236980|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44236981|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899479|NCT02390284|Methazolamide|methazolamide|mesh-list
43899480|NCT02390284|Latanoprost|latanoprost|mesh-list
43899481|NCT02390284|Brinzolamide|brinzolamide|mesh-list
43899482|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43899483|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43899484|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899485|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899486|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899487|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899510|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143864|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
43899512|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899513|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
43899514|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43899515|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899516|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43899517|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43899518|NCT00984399|Estradiol|estradiol|mesh-list
43899519|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43899520|NCT00984399|Estrogens|estrogens|mesh-ancestor
43899521|NCT00984399|Hormones|hormones|mesh-ancestor
43899522|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899523|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899524|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43899525|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
43899526|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43899527|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43899528|NCT00585559|Acetaminophen|acetaminophen|mesh-list
43899529|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
43899530|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43899531|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899532|NCT00585559|Analgesics|analgesics|mesh-ancestor
43899533|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
43899534|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899535|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899536|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
43899537|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
43899538|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899539|NCT00585559|Expectorants|expectorants|mesh-ancestor
43899540|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
43899541|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43899542|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
43899543|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899544|NCT00585559|Protective Agents|protective agents|mesh-ancestor
43899580|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43899581|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43899582|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899583|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899584|NCT03172897|Analgesics|analgesics|mesh-ancestor
43899585|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
43899586|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899587|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43899588|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43899602|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
43899604|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43899605|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43899606|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899607|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899608|NCT03012984|Analgesics|analgesics|mesh-ancestor
43899609|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
43899610|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236982|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44236983|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236984|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44236985|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
44236986|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
43873896|NCT04948892|Anesthetics|anesthetics|mesh-list
43899611|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43899612|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43899613|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43899614|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899615|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899616|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899617|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43899618|NCT03012984|Narcotics|narcotics|mesh-ancestor
43899620|NCT02957019|Interleukin-2|interleukin-2|mesh-list
43899621|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899622|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899623|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
43899624|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899625|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899626|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899627|NCT02957019|Analgesics|analgesics|mesh-ancestor
43899628|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
43899629|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899630|NCT02938793|Durvalumab|durvalumab|mesh-list
43899631|NCT02938793|Tremelimumab|tremelimumab|mesh-list
43899632|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899633|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899634|NCT02744430|Mirabegron|mirabegron|mesh-list
43899635|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43899636|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43899637|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43899638|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899639|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899640|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899641|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899642|NCT02744430|Urological Agents|urological agents|mesh-ancestor
43899643|NCT02668562|Ticagrelor|ticagrelor|mesh-list
43899644|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43899645|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43899646|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43899647|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44138221|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44138222|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
44138223|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138224|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138225|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138226|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
44138227|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138228|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44138229|NCT00170729|Prednisolone|prednisolone|mesh-list
44138230|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44138231|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
44138232|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44138233|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
44138234|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44138235|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
44138236|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138237|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
44138238|NCT00170729|Hormones|hormones|mesh-ancestor
44138239|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44138240|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138241|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138242|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138243|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
44138244|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
44138245|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138246|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236988|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236989|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
44236990|NCT00562068|Hormones|hormones|mesh-ancestor
43873964|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44138247|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44138248|NCT00170729|Protective Agents|protective agents|mesh-ancestor
44138249|NCT00170742|Octreotide|octreotide|mesh-list
44138250|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138266|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138267|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44138268|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44138269|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138270|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138271|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138272|NCT00170768|Urological Agents|urological agents|mesh-ancestor
44138273|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
44138274|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44138275|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138276|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899652|NCT02538744|Doxazosin|doxazosin|mesh-list
43899653|NCT02538744|Cocaine|cocaine|mesh-list
43899654|NCT02538744|Modafinil|modafinil|mesh-list
43899655|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43899656|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899657|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43899658|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43899659|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43899660|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899661|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
43899662|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
43899663|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43899664|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
43899665|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899666|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43899667|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43899668|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43899669|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43899670|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
43899671|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899672|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43899673|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43899674|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43899675|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43899676|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899677|NCT02308202|Perindopril|perindopril|mesh-list
43899679|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43899680|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
43899681|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899682|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899683|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43899684|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43899700|NCT02119468|Glycine|glycine|mesh-list
43899701|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43899702|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899703|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
43899704|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
43899705|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899706|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899707|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899708|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
43899709|NCT02119468|Hormones|hormones|mesh-ancestor
43899710|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899711|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899712|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899713|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899714|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
43899715|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43899716|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44236991|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236992|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44236993|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236995|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44236996|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
44236997|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236998|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236999|NCT00562172|Metformin|metformin|mesh-list
44237000|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
44237001|NCT00562172|Glimepiride|glimepiride|mesh-list
44237002|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237003|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237004|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44237005|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237006|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
44237007|NCT00562185|Carboplatin|carboplatin|mesh-list
44237008|NCT00562185|Doxorubicin|doxorubicin|mesh-list
44237009|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43874008|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
43899717|NCT02119468|Growth Substances|growth substances|mesh-ancestor
43899718|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899719|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
43899720|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899721|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
43899722|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899723|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
43899724|NCT02106572|Mitomycins|mitomycins|mesh-list
43899725|NCT02106572|Mitomycin|mitomycin|mesh-list
43899726|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899727|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899728|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
43899729|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899730|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899731|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899732|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43899733|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899734|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
43899735|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899736|NCT01960530|Dexamethasone|dexamethasone|mesh-list
43899737|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
43899738|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43899739|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43899740|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43899741|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899742|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
43899743|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
43899744|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899745|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899746|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899751|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899752|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43899753|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
43899754|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899755|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
43899756|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899757|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899758|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237010|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237011|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237012|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237013|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237014|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237015|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237016|NCT00562198|Carbidopa|carbidopa|mesh-list
43899759|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899760|NCT01062451|Candesartan|candesartan|mesh-list
43899761|NCT01062451|Perindopril|perindopril|mesh-list
43899762|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43899763|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43899764|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43899765|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899766|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43899767|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
43899768|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899769|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
43899770|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43899771|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43899772|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43899773|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899775|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
43899776|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43899777|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899778|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899779|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899780|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
43899781|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899782|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
43899783|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899784|NCT00006227|Paclitaxel|paclitaxel|mesh-list
43899785|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899786|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899787|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899788|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899789|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899790|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899791|NCT00006244|Interferons|interferons|mesh-list
43899792|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
43899793|NCT00006244|Aldesleukin|aldesleukin|mesh-list
43899794|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
43899795|NCT00006244|Melphalan|melphalan|mesh-list
43899796|NCT00006244|Interleukin-2|interleukin-2|mesh-list
43899797|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899798|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
43899799|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899800|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899801|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
43650424|NCT03014804|Nivolumab|nivolumab|mesh-list
43899802|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899803|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43899804|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899805|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
43899806|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899807|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899808|NCT00006244|Analgesics|analgesics|mesh-ancestor
43899809|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
43899810|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899811|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43899812|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899813|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
43899814|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899815|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
43899816|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899830|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899831|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899832|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
44237017|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44237018|NCT00562198|Entacapone|entacapone|mesh-list
43899833|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899834|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899835|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
43899836|NCT00011986|Antiviral Agents|antiviral agents|mesh-ancestor
43899837|NCT00011986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899838|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899839|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899840|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
43899841|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899842|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899843|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899844|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43899845|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43899846|NCT00012298|Rituximab|rituximab|mesh-list
43899847|NCT00012298|Oprelvekin|oprelvekin|mesh-list
43899848|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43899849|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899850|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899851|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
43899852|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899853|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899854|NCT00014222|Paclitaxel|paclitaxel|mesh-list
43899855|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
43899856|NCT00014222|Doxorubicin|doxorubicin|mesh-list
43899857|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43899858|NCT00014222|Fluorouracil|fluorouracil|mesh-list
43899859|NCT00014222|Epirubicin|epirubicin|mesh-list
43899860|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
43899861|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899862|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899863|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899864|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899865|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899866|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899867|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899868|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
43899869|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899870|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899871|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899872|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
43899873|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43899874|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899875|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899876|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43899877|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899878|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
43899879|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899880|NCT00014222|Hematinics|hematinics|mesh-ancestor
43899901|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43899902|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899903|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43899904|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43899905|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43899906|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43899907|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43899908|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43899909|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
43899910|NCT00016913|Paclitaxel|paclitaxel|mesh-list
43899911|NCT00016913|Carboplatin|carboplatin|mesh-list
43899912|NCT00016913|Leuprolide|leuprolide|mesh-list
43899913|NCT00016913|Goserelin|goserelin|mesh-list
43899914|NCT00016913|Estramustine|estramustine|mesh-list
43899915|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899916|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899917|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899918|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899919|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899920|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899921|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43899922|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
43899923|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43899924|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237019|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44237020|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44237021|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
44237022|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237023|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237024|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237025|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43899925|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899926|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899927|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
43899928|NCT00017563|Docetaxel|docetaxel|mesh-list
43899929|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
43899930|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899931|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899932|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899933|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899934|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899935|NCT00017563|Analgesics|analgesics|mesh-ancestor
43781627|NCT04122196|Pregabalin|pregabalin|mesh-list
43899950|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899952|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43650496|NCT03013439|Hematinics|hematinics|mesh-ancestor
43899953|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899955|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899956|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
43899957|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899958|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43899959|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
43899960|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899961|NCT00022490|Cytarabine|cytarabine|mesh-list
43899962|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
43899963|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899964|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
43899965|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899966|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899967|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
43899968|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899969|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899970|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
43899971|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899972|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899973|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899974|NCT00023309|Lamivudine|lamivudine|mesh-list
43899975|NCT00023309|Adefovir|adefovir|mesh-list
43899976|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43899977|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43899978|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899979|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899980|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899981|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
43899982|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899983|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43899984|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899985|NCT00024102|Doxorubicin|doxorubicin|mesh-list
43899986|NCT00024102|Capecitabine|capecitabine|mesh-list
43899987|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43899988|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899989|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899990|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43899991|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899992|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899993|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899994|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
43899995|NCT00026221|Interferons|interferons|mesh-list
43899996|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
43899997|NCT00026221|Bevacizumab|bevacizumab|mesh-list
43900030|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900033|NCT00030147|Estrogens|estrogens|mesh-ancestor
43900034|NCT00030147|Hormones|hormones|mesh-ancestor
44237027|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43900035|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900036|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900037|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43900038|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
43900049|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
43900050|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900051|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900052|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900053|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900054|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43900055|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900056|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
43900057|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900058|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43900059|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900060|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900061|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900062|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900063|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
43900064|NCT00030992|Promethazine|promethazine|mesh-list
43900066|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43900067|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43900068|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43900069|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900070|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900071|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
43900072|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
43900073|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
43900074|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900075|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
43900076|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
43900077|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900078|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43900079|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
43900080|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
43900081|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900082|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900083|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43900084|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
43900085|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900086|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43900087|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43900088|NCT00032591|Thrombin|thrombin|mesh-list
43900089|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
43900090|NCT00032591|Coagulants|coagulants|mesh-ancestor
43900091|NCT00033917|Indomethacin|indomethacin|mesh-list
43900092|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43900093|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43900094|NCT00033917|Analgesics|analgesics|mesh-ancestor
43900095|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
43900096|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900097|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900098|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900099|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900100|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
43900101|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
43900102|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43900103|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43900104|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900121|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900122|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
43900123|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900124|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900125|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
43900126|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900127|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900128|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
43900129|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900130|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900131|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900132|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900133|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237028|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
44237029|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
44237030|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44237031|NCT00562224|Abexinostat|abexinostat|mesh-list
43900134|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900135|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900136|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900137|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43900138|NCT00038610|Cytarabine|cytarabine|mesh-list
43900139|NCT00038610|Dexamethasone|dexamethasone|mesh-list
43900140|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
43900141|NCT00038610|Doxorubicin|doxorubicin|mesh-list
43900142|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900143|NCT00038610|Methotrexate|methotrexate|mesh-list
43900144|NCT00038610|Vincristine|vincristine|mesh-list
43900145|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
43900146|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900147|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
43900148|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900149|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900150|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900151|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
43900152|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900153|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900154|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900155|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900156|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
43900157|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
43900158|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900159|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900160|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
43900161|NCT00038610|Hormones|hormones|mesh-ancestor
43900162|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900163|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900164|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900165|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900166|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900167|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900181|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900182|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43900184|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900185|NCT00038857|Melphalan|melphalan|mesh-list
43900186|NCT00038857|Thiotepa|thiotepa|mesh-list
43900187|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
43900188|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43900189|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900190|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900191|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
43900192|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900193|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900194|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
43900195|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900196|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900197|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
43900198|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900199|NCT00039195|Prednisone|prednisone|mesh-list
43900200|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
43900201|NCT00039195|Ifosfamide|ifosfamide|mesh-list
43900202|NCT00039195|Rituximab|rituximab|mesh-list
43900203|NCT00039195|Carboplatin|carboplatin|mesh-list
43900204|NCT00039195|Doxorubicin|doxorubicin|mesh-list
43900205|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900206|NCT00039195|Etoposide|etoposide|mesh-list
43900207|NCT00039195|Vincristine|vincristine|mesh-list
43900208|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900209|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
43900210|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900211|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900212|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900213|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
43900214|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900215|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900216|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900217|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44237032|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44237034|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237035|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
44237036|NCT00562250|Glimepiride|glimepiride|mesh-list
44237037|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44237038|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237039|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237040|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900218|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900219|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900220|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900221|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900222|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900223|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
43900224|NCT00039195|Hormones|hormones|mesh-ancestor
43900225|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900226|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900227|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900228|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900229|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900240|NCT00040846|Cyclosporins|cyclosporins|mesh-list
43900241|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
43900242|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900243|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900244|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900245|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
43900246|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900247|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900248|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900249|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
43900250|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900251|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900252|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900253|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900254|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900255|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900256|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900257|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900258|NCT00040937|Thalidomide|thalidomide|mesh-list
43900259|NCT00040937|Dexamethasone|dexamethasone|mesh-list
43900260|NCT00040937|Prednisone|prednisone|mesh-list
43900261|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
43900262|NCT00040937|Melphalan|melphalan|mesh-list
43900263|NCT00040937|Sargramostim|sargramostim|mesh-list
43900264|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900265|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
43900266|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900267|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900269|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
43900270|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900271|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900272|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900273|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900274|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
43900275|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
43900276|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900277|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900278|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
43900279|NCT00040937|Hormones|hormones|mesh-ancestor
43900280|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900281|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900282|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
44237041|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44237042|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237043|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
44237044|NCT00562289|Aspirin|aspirin|mesh-list
44237045|NCT00562289|Dipyridamole|dipyridamole|mesh-list
44237046|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
44237047|NCT00562289|Apixaban|apixaban|mesh-list
44237048|NCT00562289|Dabigatran|dabigatran|mesh-list
44237049|NCT00562289|Antivitamins K|antivitamins k|mesh-list
44237050|NCT00562289|Clopidogrel|clopidogrel|mesh-list
44237051|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44237052|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44237053|NCT00562289|Analgesics|analgesics|mesh-ancestor
44237054|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
43900283|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900284|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900285|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43900286|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43900287|NCT00040937|Growth Substances|growth substances|mesh-ancestor
43900288|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
43900289|NCT00041119|Paclitaxel|paclitaxel|mesh-list
43900290|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
43900291|NCT00041119|Doxorubicin|doxorubicin|mesh-list
43900292|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900293|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900294|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900295|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900296|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900297|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900298|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781870|NCT05089383|Progestins|progestins|mesh-ancestor
43900334|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
43900335|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900336|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900347|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900349|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900350|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43900351|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43900352|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43900353|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
43900354|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900355|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900356|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43900357|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900358|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
43900359|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43900360|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900361|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
43900362|NCT00044044|Haloperidol|haloperidol|mesh-list
43900363|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
43900364|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43900365|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
43900366|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
43900367|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900368|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900369|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900370|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900371|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900372|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900373|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900374|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900375|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
43900376|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900377|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237055|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237056|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237057|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900378|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43900379|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43900380|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43900381|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43900382|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
43900383|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43900384|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900386|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43900387|NCT00044655|Olanzapine|olanzapine|mesh-list
43900388|NCT00044655|Risperidone|risperidone|mesh-list
43900389|NCT00044655|Aripiprazole|aripiprazole|mesh-list
43900390|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43900391|NCT00044655|Ziprasidone|ziprasidone|mesh-list
43900392|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900393|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
43900394|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900395|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900396|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900397|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900398|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900399|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900400|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900407|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43650867|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
43900408|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43900409|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900410|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
43900411|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
43900412|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43900413|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43900414|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43900415|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43900416|NCT00045435|Cyclosporine|cyclosporine|mesh-list
43900417|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
43900418|NCT00045435|Fludarabine|fludarabine|mesh-list
43900419|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900420|NCT00045435|Cyclosporins|cyclosporins|mesh-list
43900421|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900422|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900423|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
43900424|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900425|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900426|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
43900427|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900428|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900429|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
43900430|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900431|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900432|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900433|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900434|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900435|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900436|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900437|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900438|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43900439|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900440|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43900441|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900442|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900444|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43900445|NCT00046228|Abciximab|abciximab|mesh-list
43900446|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
43900447|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43900448|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43900449|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43900450|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900451|NCT00046475|Midodrine|midodrine|mesh-list
44237059|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44237060|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44237061|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237062|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44237063|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43874589|NCT01156545|Afatinib|afatinib|mesh-list
43900452|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
43900453|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
43900454|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900455|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900456|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43900457|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43900458|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43900459|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43900460|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
43900461|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900462|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900463|NCT00046566|Caseins|caseins|mesh-list
43900464|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
43900465|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
43900466|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900467|NCT00047060|Cyclosporine|cyclosporine|mesh-list
43900468|NCT00047060|Fludarabine|fludarabine|mesh-list
43900469|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
43900470|NCT00047060|Cyclosporins|cyclosporins|mesh-list
43900488|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900489|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900491|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
43900493|NCT00048737|Fludarabine|fludarabine|mesh-list
43900494|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900495|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900496|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
43900497|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900498|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900499|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900500|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
43900501|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900502|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900503|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900504|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900505|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900506|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
43900507|NCT00048815|Citalopram|citalopram|mesh-list
43900508|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43900509|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43900510|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900511|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900512|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900513|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
43900514|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900515|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43900516|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
43900517|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900518|NCT00048893|Metronidazole|metronidazole|mesh-list
43900519|NCT00048893|Paclitaxel|paclitaxel|mesh-list
43900520|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
43900521|NCT00048893|Doxorubicin|doxorubicin|mesh-list
43900522|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900523|NCT00048893|Fludarabine|fludarabine|mesh-list
43900524|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900525|NCT00048893|Vaccines|vaccines|mesh-list
43900526|NCT00048893|Sargramostim|sargramostim|mesh-list
43900527|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
43900548|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43900549|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43900551|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
43900552|NCT00049036|Rituximab|rituximab|mesh-list
44237064|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237065|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
44237066|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44237067|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44237068|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44237069|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
44237070|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237071|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44237072|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
44237073|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44237074|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
44237075|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
44237076|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44237077|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
44458856|NCT01589094|Gemcitabine|gemcitabine|mesh-list
44458857|NCT01589094|Cisplatin|cisplatin|mesh-list
44458858|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458859|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44458860|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
44458861|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458862|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
44458863|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458864|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458865|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458866|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
44458867|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458868|NCT01588990|Leucovorin|leucovorin|mesh-list
44458869|NCT01588990|Bevacizumab|bevacizumab|mesh-list
44458870|NCT01588990|Capecitabine|capecitabine|mesh-list
44458871|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
44458872|NCT01588990|Irinotecan|irinotecan|mesh-list
44458873|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458874|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458875|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458876|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44458877|NCT01588990|Growth Substances|growth substances|mesh-ancestor
44458878|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900553|NCT00049036|Doxorubicin|doxorubicin|mesh-list
43900554|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900555|NCT00049036|Etoposide|etoposide|mesh-list
43900556|NCT00049036|Vincristine|vincristine|mesh-list
43900557|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
44458879|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44458880|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44458881|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
44458882|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458883|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44458884|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44458885|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458886|NCT01588990|Antidotes|antidotes|mesh-ancestor
44458887|NCT01588990|Protective Agents|protective agents|mesh-ancestor
44458888|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
43900558|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900559|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
43900560|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900561|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900562|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900563|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
43900564|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900565|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900566|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900567|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900568|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900569|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900570|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900571|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900572|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900573|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
43900575|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900576|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900577|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900578|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900579|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900580|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900581|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
43900592|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900593|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900594|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900595|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900596|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
43900597|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900598|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900599|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900600|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900601|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900602|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900603|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900604|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43900605|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
43900606|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900607|NCT00050986|Temozolomide|temozolomide|mesh-list
43900608|NCT00050986|Tipifarnib|tipifarnib|mesh-list
43900609|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900610|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
43900611|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900612|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900613|NCT00051168|Travoprost|travoprost|mesh-list
43900614|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43900615|NCT00052078|Sertraline|sertraline|mesh-list
43900616|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
43900617|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900618|NCT00052078|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43900619|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43900620|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900621|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900622|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900623|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
43900624|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900625|NCT00052429|Cisplatin|cisplatin|mesh-list
43900626|NCT00052429|Fluorouracil|fluorouracil|mesh-list
43900627|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900628|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
43900629|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900630|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900631|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900632|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
43900633|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900634|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
43900635|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900636|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43900637|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900638|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900640|NCT00052910|Cisplatin|cisplatin|mesh-list
43900641|NCT00052910|Fluorouracil|fluorouracil|mesh-list
43900642|NCT00052910|Epirubicin|epirubicin|mesh-list
43900643|NCT00052910|Calcium|calcium|mesh-list
43900644|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
43900645|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900646|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43900647|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900648|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
43900660|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900662|NCT00053014|Cyclosporine|cyclosporine|mesh-list
43900663|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
43900664|NCT00053014|Fludarabine|fludarabine|mesh-list
43900665|NCT00053014|Cyclosporins|cyclosporins|mesh-list
43900666|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900667|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900668|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900669|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
43900670|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900671|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900672|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
43900673|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900674|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900675|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900676|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900677|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900678|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900679|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900680|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900681|NCT00053482|Vaccines|vaccines|mesh-list
43900682|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
43900683|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138277|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138278|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138279|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138280|NCT00170781|Analgesics|analgesics|mesh-ancestor
44138281|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
44138282|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138283|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138284|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138285|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138286|NCT00170794|Everolimus|everolimus|mesh-list
44138287|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138288|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138289|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
44138290|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138291|NCT00170820|Everolimus|everolimus|mesh-list
44138292|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138293|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138294|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
44138295|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138296|NCT00170833|Everolimus|everolimus|mesh-list
44138297|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138298|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138299|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
44138300|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138301|NCT00170859|Everolimus|everolimus|mesh-list
44458891|NCT01588951|Cytarabine|cytarabine|mesh-list
44458892|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44138302|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138303|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138304|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
43900684|NCT00053677|Naltrexone|naltrexone|mesh-list
43900685|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43900708|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43900709|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43900710|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900711|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
43900712|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
43900713|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
43900714|NCT00053989|Fludarabine|fludarabine|mesh-list
43900715|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900716|NCT00053989|Tacrolimus|tacrolimus|mesh-list
43900717|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43900718|NCT00053989|Sargramostim|sargramostim|mesh-list
43900719|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900720|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
43900721|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900722|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900723|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900724|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
43900725|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900726|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900727|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900728|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900729|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
43900730|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900731|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900732|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900733|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900734|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900735|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900736|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900737|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900738|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
43900739|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
43900755|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
43900757|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43900758|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900759|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43900760|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43900761|NCT00054353|Cyclosporine|cyclosporine|mesh-list
43900762|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
43900763|NCT00054353|Fludarabine|fludarabine|mesh-list
43900764|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900765|NCT00054353|Melphalan|melphalan|mesh-list
43900766|NCT00054353|Cyclosporins|cyclosporins|mesh-list
43900767|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900768|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900769|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
43900770|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900771|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900772|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
43900773|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900774|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900775|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
43900776|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900777|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900778|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900779|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900780|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900781|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43900782|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
43900783|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900784|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900785|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
43900786|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900787|NCT00054665|Prednisone|prednisone|mesh-list
43900788|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
43900789|NCT00054665|Doxorubicin|doxorubicin|mesh-list
43900790|NCT00054665|Etoposide|etoposide|mesh-list
43900791|NCT00054665|Vincristine|vincristine|mesh-list
43900792|NCT00054665|Bortezomib|bortezomib|mesh-list
43900793|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458893|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
44458894|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458895|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458896|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
43900794|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
43900795|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900796|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900797|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900798|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
43900799|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900800|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900810|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900811|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900812|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900813|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900814|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900815|NCT00054756|Hormones|hormones|mesh-list
43900816|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
43900817|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900818|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900819|NCT00055237|Bevacizumab|bevacizumab|mesh-list
43900820|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900821|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900822|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43900823|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43900824|NCT00055237|Growth Substances|growth substances|mesh-ancestor
43900825|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900826|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
43900827|NCT00055692|Bevacizumab|bevacizumab|mesh-list
43900828|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43900829|NCT00055692|Antibodies|antibodies|mesh-list
43900830|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
43900831|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43900832|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900833|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43900834|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43900835|NCT00055692|Growth Substances|growth substances|mesh-ancestor
43900836|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900837|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
43900838|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
43900839|NCT00056472|Olanzapine|olanzapine|mesh-list
43900840|NCT00056472|Sertraline|sertraline|mesh-list
43900841|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
43900842|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
43900843|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900844|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900845|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900846|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900847|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900848|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900849|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900850|NCT00056472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43900851|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43900852|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900853|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900854|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900855|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
43900856|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
43900857|NCT00056498|Risperidone|risperidone|mesh-list
43900858|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900859|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
43900860|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900861|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900862|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900863|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900864|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900865|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900873|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458897|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458898|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458899|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
44458900|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458901|NCT01588496|Evolocumab|evolocumab|mesh-list
44458902|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44458903|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44458904|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
44458905|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458906|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44458907|NCT01588405|Treprostinil|treprostinil|mesh-list
43900874|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900875|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
43900876|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
43900877|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900878|NCT00057681|Valproic Acid|valproic acid|mesh-list
43900879|NCT00057681|Risperidone|risperidone|mesh-list
43900880|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
43900881|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900882|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
43900883|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900884|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900885|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900886|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900887|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900888|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900889|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900890|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900891|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
43900892|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
43900893|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900894|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
43900895|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
43900896|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
43900897|NCT00057785|Cisplatin|cisplatin|mesh-list
43900898|NCT00057785|Fluorouracil|fluorouracil|mesh-list
43900899|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900900|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
43900901|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900902|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900903|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900904|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
43900905|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900906|NCT00058019|Epothilones|epothilones|mesh-list
43900907|NCT00058019|Epothilone B|epothilone b|mesh-list
43900908|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900909|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900910|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900911|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900912|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900913|NCT00058240|Alvocidib|alvocidib|mesh-list
43900914|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900915|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
43900916|NCT00058240|Growth Substances|growth substances|mesh-ancestor
43900917|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900918|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43900919|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900920|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900921|NCT00058370|Cisplatin|cisplatin|mesh-list
43900922|NCT00058370|Vincristine|vincristine|mesh-list
43900923|NCT00058370|Lomustine|lomustine|mesh-list
43900924|NCT00058370|Antibodies|antibodies|mesh-list
43900925|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43900926|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
43900927|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900928|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458908|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44458909|NCT01588184|Bevacizumab|bevacizumab|mesh-list
44458910|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458911|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458912|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458913|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43900929|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900930|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900931|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900932|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900933|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900934|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900935|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
43900936|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43900956|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900957|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43900958|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
43900959|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900960|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
43900961|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900962|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
43900963|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43900964|NCT00059475|Protective Agents|protective agents|mesh-ancestor
43900965|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43900966|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43900967|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900968|NCT00060346|Prednisone|prednisone|mesh-list
43900969|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
43900970|NCT00060346|Rituximab|rituximab|mesh-list
43900971|NCT00060346|Doxorubicin|doxorubicin|mesh-list
43900972|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43900973|NCT00060346|Vincristine|vincristine|mesh-list
43900974|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900975|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
43900976|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900977|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900978|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900979|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
43900980|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900981|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900982|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900983|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900984|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900985|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900986|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900987|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900988|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900989|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
43900990|NCT00060346|Hormones|hormones|mesh-ancestor
43900991|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900992|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43900999|NCT00060424|Fludarabine|fludarabine|mesh-list
43901000|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
43901001|NCT00060424|Cyclosporins|cyclosporins|mesh-list
43901002|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901003|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901004|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
43901005|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901006|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901007|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
43901008|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901009|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901010|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
43901011|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901012|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
43901013|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901014|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43901015|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44458915|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458916|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
44458917|NCT01587989|Methotrexate|methotrexate|mesh-list
44458918|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44237078|NCT00562406|Ranibizumab|ranibizumab|mesh-list
44237079|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901016|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43901017|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
43901018|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901019|NCT00060528|Metronidazole|metronidazole|mesh-list
43901020|NCT00060528|Molgramostim|molgramostim|mesh-list
43901021|NCT00060528|Sargramostim|sargramostim|mesh-list
43901022|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
43901023|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901024|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901025|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901026|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901027|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43901028|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43901030|NCT00061373|Tinzaparin|tinzaparin|mesh-list
43901031|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43901032|NCT00061373|Dalteparin|dalteparin|mesh-list
43901033|NCT00061373|Eptifibatide|eptifibatide|mesh-list
43901034|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43901035|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901036|NCT00061373|Analgesics|analgesics|mesh-ancestor
43901037|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
43901038|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901039|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901040|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901041|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901042|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43901043|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43901044|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901045|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43901046|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43901047|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901048|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
43901049|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
43901050|NCT00061893|Celecoxib|celecoxib|mesh-list
43901051|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
43901052|NCT00061893|Ifosfamide|ifosfamide|mesh-list
43901053|NCT00061893|Doxorubicin|doxorubicin|mesh-list
43901054|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43901055|NCT00061893|Etoposide|etoposide|mesh-list
43901056|NCT00061893|Vincristine|vincristine|mesh-list
43901057|NCT00061893|Vinblastine|vinblastine|mesh-list
43901058|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901059|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
43901060|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901061|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901062|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901063|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
43901064|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901090|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
43901091|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901092|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43901093|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901094|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901095|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43901096|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901097|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901098|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43901099|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43901100|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
43901101|NCT00062764|Pioglitazone|pioglitazone|mesh-list
43901102|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43901103|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901104|NCT00063232|Metformin|metformin|mesh-list
43901105|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237080|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44237081|NCT00562406|Growth Substances|growth substances|mesh-ancestor
44237082|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237083|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
44237084|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237086|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44237087|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237088|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875091|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901106|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901107|NCT00063362|Lamotrigine|lamotrigine|mesh-list
43901108|NCT00063362|Valproic Acid|valproic acid|mesh-list
43901109|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
43901110|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901111|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901112|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901148|NCT00063622|Protective Agents|protective agents|mesh-ancestor
43901149|NCT00063635|Vitamin E|vitamin e|mesh-list
43901150|NCT00063635|Metformin|metformin|mesh-list
43901151|NCT00063635|Vitamins|vitamins|mesh-ancestor
43901168|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901170|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901171|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
43901172|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901173|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901174|NCT00064038|Growth Substances|growth substances|mesh-ancestor
43901175|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901176|NCT00064844|Nicotine|nicotine|mesh-list
43901177|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43901178|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
43901179|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901180|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901181|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43901182|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43901183|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
43901184|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901185|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901186|NCT00065611|Dexamethasone|dexamethasone|mesh-list
43901187|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901188|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
43901189|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
43901190|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901191|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901192|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901193|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
43901194|NCT00065611|Hormones|hormones|mesh-ancestor
43901195|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901196|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43901197|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901198|NCT00065806|Atorvastatin|atorvastatin|mesh-list
43901199|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43901200|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43901201|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
43901202|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901203|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43901204|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43901205|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901206|NCT00066677|Docetaxel|docetaxel|mesh-list
43901207|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901208|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901209|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901210|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901218|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
43901219|NCT00066781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901220|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901221|NCT00066781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237089|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237090|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237091|NCT00562458|Anastrozole|anastrozole|mesh-list
44237092|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44237093|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237094|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44237095|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44237096|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237097|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237098|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43901222|NCT00066781|Immunologic Factors|immunologic factors|mesh-ancestor
43901223|NCT00066781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901224|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43901225|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43901228|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43901229|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901230|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901231|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43901232|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901233|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901234|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901235|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43901236|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901237|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901238|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43901239|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43901240|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
43901241|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
43901242|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901243|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43901244|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43901245|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
43901246|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43901247|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
43901249|NCT00067028|Clofarabine|clofarabine|mesh-list
43901250|NCT00067028|Idarubicin|idarubicin|mesh-list
43901251|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901252|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
43901253|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901254|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901255|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
43901256|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901257|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901258|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
43901259|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901260|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43901261|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43901262|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43901263|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901264|NCT00067808|Decitabine|decitabine|mesh-list
43901265|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901266|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
43901267|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901268|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901269|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901270|NCT00068341|Carboplatin|carboplatin|mesh-list
43901271|NCT00068341|Docetaxel|docetaxel|mesh-list
43901272|NCT00068341|Trastuzumab|trastuzumab|mesh-list
43901273|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901274|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901275|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901276|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901277|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237099|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
44237100|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237101|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237102|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
43875198|NCT04727684|Cetrorelix|cetrorelix|mesh-list
43901278|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901287|NCT00068575|Cisplatin|cisplatin|mesh-list
43901288|NCT00068575|Fluorouracil|fluorouracil|mesh-list
43901289|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901290|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
43901291|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901292|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901293|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901294|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
43901295|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901296|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
43901297|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901298|NCT00068770|Celecoxib|celecoxib|mesh-list
43901299|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43901300|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901301|NCT00068770|Analgesics|analgesics|mesh-ancestor
43901302|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
43901303|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901304|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901305|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901306|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901307|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43901308|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43901309|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901310|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901311|NCT00069160|Docetaxel|docetaxel|mesh-list
43901312|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43901313|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901314|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901315|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901316|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901317|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901318|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43901319|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43901320|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901321|NCT00070135|Methotrexate|methotrexate|mesh-list
43901322|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
43901323|NCT00070135|Fludarabine|fludarabine|mesh-list
43901324|NCT00070135|Busulfan|busulfan|mesh-list
43901325|NCT00070135|Tacrolimus|tacrolimus|mesh-list
43901326|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43901327|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43901328|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
43901329|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43901330|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901331|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901332|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
43901333|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901334|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901335|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
43901336|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901337|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43901338|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901339|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
43901340|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901341|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43901342|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43901343|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
43901344|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43839816|NCT04748822|Ethanol|ethanol|mesh-list
43901357|NCT00071890|Aldesleukin|aldesleukin|mesh-list
43901358|NCT00071890|Interleukin-2|interleukin-2|mesh-list
43901359|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901360|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901361|NCT00071890|Analgesics|analgesics|mesh-ancestor
44237104|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44237105|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
44237106|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237107|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44237108|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44237109|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237110|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237111|NCT00562523|Sorafenib|sorafenib|mesh-list
44237112|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237113|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44237114|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285629|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43901362|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
43901363|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901364|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901365|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43901366|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43901367|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
43901368|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901369|NCT00072449|Rituximab|rituximab|mesh-list
43901370|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901371|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901372|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
43901373|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901374|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901375|NCT00072514|Gemcitabine|gemcitabine|mesh-list
43901376|NCT00072514|Dexamethasone|dexamethasone|mesh-list
43901378|NCT00072514|Carboplatin|carboplatin|mesh-list
43901379|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901380|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901381|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
43901382|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901383|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901384|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901385|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
43901386|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
43901387|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901388|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901389|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
43901390|NCT00072514|Hormones|hormones|mesh-ancestor
43901391|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901392|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43901393|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901394|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
43901395|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901396|NCT00072514|Antiviral Agents|antiviral agents|mesh-ancestor
43901397|NCT00072514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901398|NCT00072514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901399|NCT00072514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901400|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
43901401|NCT00072566|Bevacizumab|bevacizumab|mesh-list
43901402|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43901403|NCT00072566|Antibodies|antibodies|mesh-list
43901404|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
43901405|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43901406|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
43901407|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
43901408|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901409|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
43901410|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901433|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901434|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237115|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237116|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
44237117|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237118|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
44237119|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237120|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237121|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901435|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43901436|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
43901437|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901439|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901440|NCT00073957|Cytarabine|cytarabine|mesh-list
43901441|NCT00073957|Rituximab|rituximab|mesh-list
43901442|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901443|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901444|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
43901445|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901446|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901447|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901448|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
43901449|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901450|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
43901451|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901452|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901454|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901455|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43901456|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901457|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901458|NCT00074165|Cytarabine|cytarabine|mesh-list
43901459|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
43901460|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
43901461|NCT00074165|Rituximab|rituximab|mesh-list
43901462|NCT00074165|Carboplatin|carboplatin|mesh-list
43901463|NCT00074165|Etoposide|etoposide|mesh-list
43901464|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
43782793|NCT03564821|Ivosidenib|ivosidenib|mesh-list
43901484|NCT00074165|Protective Agents|protective agents|mesh-ancestor
43901486|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
43901487|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901488|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
43901489|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
43901490|NCT00074269|Cyclosporine|cyclosporine|mesh-list
43901491|NCT00074269|Methotrexate|methotrexate|mesh-list
43901492|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
43901493|NCT00074269|Fludarabine|fludarabine|mesh-list
43901494|NCT00074269|Melphalan|melphalan|mesh-list
43901495|NCT00074269|Cyclosporins|cyclosporins|mesh-list
43901496|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43901497|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43901498|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
43901499|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43901500|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901501|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901502|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
43901503|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901504|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901505|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
43901506|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901507|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43901508|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901509|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
43901510|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901511|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43901512|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
43901513|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901514|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43901515|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901516|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
44237122|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
44237123|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237124|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237125|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44237126|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44237127|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
44237128|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237129|NCT00562705|Hormones|hormones|mesh-list
44237130|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237131|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237132|NCT00562770|Valacyclovir|valacyclovir|mesh-list
44237133|NCT00562770|Valganciclovir|valganciclovir|mesh-list
44237134|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
44237135|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237136|NCT00562809|Irbesartan|irbesartan|mesh-list
44237137|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237138|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237139|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237140|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237141|NCT00562835|Thiamine|thiamine|mesh-list
44237142|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
44237143|NCT00562835|Vitamins|vitamins|mesh-ancestor
44237144|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
44237145|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237146|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237147|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
44237148|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
44237149|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237150|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890218|NCT05278728|Irinotecan|irinotecan|mesh-list
44237151|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
44237153|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237154|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44237155|NCT00562835|Protective Agents|protective agents|mesh-ancestor
44237156|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
44237157|NCT00562913|Sorafenib|sorafenib|mesh-list
44237158|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875398|NCT04725591|Insulin|insulin|mesh-list
43801419|NCT05104866|Vinorelbine|vinorelbine|mesh-list
44237159|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44237160|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237161|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237162|NCT00562939|Vaccines|vaccines|mesh-list
44237163|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44237164|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
44237165|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237166|NCT00562952|Telmisartan|telmisartan|mesh-list
44237167|NCT00562952|Bisoprolol|bisoprolol|mesh-list
44237168|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976552|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
44237169|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237170|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237171|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237172|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
44237173|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
43901517|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43901518|NCT00074308|Bevacizumab|bevacizumab|mesh-list
43782831|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901536|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901537|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901538|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901539|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901540|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
43901541|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901542|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43901543|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901544|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901545|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43901546|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901547|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901548|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
43901549|NCT00074815|Citalopram|citalopram|mesh-list
43901550|NCT00074815|Fluoxetine|fluoxetine|mesh-list
43901551|NCT00074815|Paroxetine|paroxetine|mesh-list
43901552|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43901553|NCT00074815|Sertraline|sertraline|mesh-list
43901554|NCT00074815|Clomipramine|clomipramine|mesh-list
43901555|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43901556|NCT00074815|Serotonin|serotonin|mesh-list
43901557|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901558|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901559|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901560|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901561|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
43901562|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901563|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43901564|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901565|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901566|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43901567|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901568|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901569|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43901570|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43901571|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43901572|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43901573|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901574|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43901582|NCT00075829|Thalidomide|thalidomide|mesh-list
44237174|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285630|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
43901583|NCT00075829|Dexamethasone|dexamethasone|mesh-list
43901584|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901585|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
43901586|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
43901587|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901588|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901589|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901590|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
43901591|NCT00075829|Hormones|hormones|mesh-ancestor
43901592|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901593|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43901594|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901595|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901596|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
43901597|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
43901598|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901599|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901600|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901601|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901602|NCT00075829|Growth Substances|growth substances|mesh-ancestor
43901603|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901604|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
43901605|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901606|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
43901607|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43901608|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43901609|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43901610|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901611|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901612|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
43901613|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901614|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901615|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43901616|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901618|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901619|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901620|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43901621|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901622|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901623|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901624|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901625|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
43901626|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901627|NCT00078403|Ribavirin|ribavirin|mesh-list
43901628|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43901629|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
43901630|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901631|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
43901632|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901633|NCT00078559|Acetaminophen|acetaminophen|mesh-list
43901634|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
43901635|NCT00078559|Promethazine|promethazine|mesh-list
43901636|NCT00078559|Sirolimus|sirolimus|mesh-list
43901637|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43901638|NCT00078559|Nystatin|nystatin|mesh-list
43901639|NCT00078559|Clotrimazole|clotrimazole|mesh-list
43901640|NCT00078559|Miconazole|miconazole|mesh-list
43901641|NCT00078559|Pentamidine|pentamidine|mesh-list
43901642|NCT00078559|Trimethoprim|trimethoprim|mesh-list
43901643|NCT00078559|Acyclovir|acyclovir|mesh-list
43901644|NCT00078559|Valganciclovir|valganciclovir|mesh-list
43901645|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
43901657|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901658|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
43901659|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901660|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901661|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43901662|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901663|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
43901664|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901665|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
43901666|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
43901667|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237175|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237176|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44237177|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44237178|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44237179|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237180|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237181|NCT00563017|Risperidone|risperidone|mesh-list
44237182|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44237183|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
44237184|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237185|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237186|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901668|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
43901669|NCT00078559|Hormones|hormones|mesh-ancestor
43901670|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901671|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43901672|NCT00078559|Protective Agents|protective agents|mesh-ancestor
43901673|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901674|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43901675|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43901676|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901677|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
43901678|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
43901679|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43901680|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
43901681|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
43901682|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901683|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43901684|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
43901685|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
43901686|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43901687|NCT00078559|Renal Agents|renal agents|mesh-ancestor
43901688|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
43901689|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43901690|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43901691|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43901692|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43901693|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43901694|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901695|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
43901696|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43901697|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43901698|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43901699|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
43901700|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43901701|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43901702|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43901703|NCT00078559|Ionophores|ionophores|mesh-ancestor
43901704|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901705|NCT00078715|Yohimbine|yohimbine|mesh-list
43901706|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
43901707|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
43901708|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901709|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901710|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43901723|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901724|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
43901725|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901726|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43901727|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901728|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237187|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44237188|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44237189|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237190|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237191|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44237192|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
44237193|NCT00563056|Fluticasone|fluticasone|mesh-list
44237194|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
44237195|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44237196|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
44237197|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237198|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237199|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44237200|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44237201|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44237202|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44237203|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44237204|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237205|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237206|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237207|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237208|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44237209|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44237211|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43901729|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43901730|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901731|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901732|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
43901733|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
43901734|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
43901735|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43901736|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901737|NCT00078897|Selenium|selenium|mesh-list
43901738|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
43901739|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901740|NCT00078897|Protective Agents|protective agents|mesh-ancestor
43901741|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901742|NCT00078897|Trace Elements|trace elements|mesh-ancestor
43901743|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
43901744|NCT00079001|Vitamin D|vitamin d|mesh-list
43901745|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
43901746|NCT00079001|Calcium|calcium|mesh-list
43901747|NCT00079001|Androgens|androgens|mesh-list
43901748|NCT00079001|Vitamins|vitamins|mesh-ancestor
43651850|NCT03005184|Enalapril|enalapril|mesh-list
43901749|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
43901750|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901751|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43901752|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43901753|NCT00079001|Hormones|hormones|mesh-ancestor
43901754|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237212|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44237213|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237214|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237215|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44237216|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44237217|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237218|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44237219|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
44237220|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
44237221|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
44237222|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
44237223|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237224|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237225|NCT00563095|Interferons|interferons|mesh-list
44237226|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237227|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
44237228|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237229|NCT00563108|Basiliximab|basiliximab|mesh-list
44237230|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237231|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
44237232|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237233|NCT00563147|Sirolimus|sirolimus|mesh-list
44237234|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901755|NCT00079326|Trastuzumab|trastuzumab|mesh-list
43901756|NCT00079326|Epothilone B|epothilone b|mesh-list
43901757|NCT00079326|Epothilones|epothilones|mesh-list
43976760|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901758|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901759|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901760|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901761|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901762|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901763|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901764|NCT00081328|Metformin|metformin|mesh-list
43901765|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
43901766|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43901767|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901768|NCT00081861|Bevacizumab|bevacizumab|mesh-list
43901769|NCT00081861|Rituximab|rituximab|mesh-list
43901770|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901771|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901772|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901788|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901789|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901790|NCT00081939|Growth Substances|growth substances|mesh-ancestor
43901791|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901792|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
43901793|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901794|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901795|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901796|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901797|NCT00082329|Plerixafor|plerixafor|mesh-list
43901798|NCT00082329|Lenograstim|lenograstim|mesh-list
43901799|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43901800|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
43901801|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237235|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237236|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237237|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237238|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
44237239|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237240|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
44237241|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237243|NCT00563160|Carboplatin|carboplatin|mesh-list
44237244|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237245|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237246|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
44285631|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
43901802|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43901803|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43901804|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
43901805|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138305|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138306|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
44138307|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44138308|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138309|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138310|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138311|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138312|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138313|NCT00170872|Analgesics|analgesics|mesh-ancestor
44138314|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
44138315|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138316|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138317|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138318|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138319|NCT00170885|Everolimus|everolimus|mesh-list
44138320|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138321|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138322|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
44138323|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901806|NCT00083122|Cisplatin|cisplatin|mesh-list
43901807|NCT00083122|Alvocidib|alvocidib|mesh-list
43901808|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901809|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901810|NCT00083122|Growth Substances|growth substances|mesh-ancestor
43901811|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901812|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901813|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782999|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
43901830|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
43901831|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901832|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901833|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901834|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901835|NCT00083382|Growth Substances|growth substances|mesh-ancestor
43901836|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901837|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901838|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43901839|NCT00083551|Interferons|interferons|mesh-list
43901840|NCT00083551|Cytarabine|cytarabine|mesh-list
43901841|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
43901842|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
43901843|NCT00083551|Thalidomide|thalidomide|mesh-list
43901844|NCT00083551|Dexamethasone|dexamethasone|mesh-list
43901845|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
43901846|NCT00083551|Melphalan|melphalan|mesh-list
43901847|NCT00083551|Carmustine|carmustine|mesh-list
43901848|NCT00083551|Cisplatin|cisplatin|mesh-list
43901849|NCT00083551|Doxorubicin|doxorubicin|mesh-list
43901850|NCT00083551|Etoposide|etoposide|mesh-list
43901851|NCT00083551|Vincristine|vincristine|mesh-list
44237247|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237248|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
44237249|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237250|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237251|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237252|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
44237253|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237254|NCT00563212|Interferons|interferons|mesh-list
44237255|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
44237256|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237257|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
44237258|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237259|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
44237260|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237261|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237262|NCT00563238|Metoprolol|metoprolol|mesh-list
44237263|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44237264|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237265|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
44237266|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
44237267|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237268|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237269|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44237270|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44237271|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43901852|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901853|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
43901854|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901855|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901856|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901857|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
43901858|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901859|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901860|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43901861|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901862|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
43901863|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
43901864|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901865|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901866|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
43901867|NCT00083551|Hormones|hormones|mesh-ancestor
43901868|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901869|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43901870|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43901871|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43901872|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43901889|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901891|NCT00084149|Ritonavir|ritonavir|mesh-list
43901892|NCT00084149|Lopinavir|lopinavir|mesh-list
43901893|NCT00084149|Lamivudine|lamivudine|mesh-list
43901894|NCT00084149|Zidovudine|zidovudine|mesh-list
44237272|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237273|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237274|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237275|NCT00563251|Azithromycin|azithromycin|mesh-list
44237276|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237277|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237278|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
44237279|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237280|NCT00563342|Ethanol|ethanol|mesh-list
44237281|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43901895|NCT00084149|Abacavir|abacavir|mesh-list
43901896|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43901897|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43901898|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
43901899|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901900|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901901|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43901902|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43901903|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
43901904|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901905|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43901906|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43901907|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43901908|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43901909|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
43901910|NCT00084409|Iloprost|iloprost|mesh-list
43901911|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43901912|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
43901913|NCT00085254|Temozolomide|temozolomide|mesh-list
43901914|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901915|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
43901916|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901917|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901918|NCT00085293|Decitabine|decitabine|mesh-list
43901919|NCT00085293|Azacitidine|azacitidine|mesh-list
43901920|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43901921|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901922|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
43901923|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901924|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901925|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901926|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43901927|NCT00085410|Bortezomib|bortezomib|mesh-list
43901928|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901929|NCT00085436|Interferons|interferons|mesh-list
43901930|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
43901931|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
43901932|NCT00085436|Aldesleukin|aldesleukin|mesh-list
43901933|NCT00085436|Vaccines|vaccines|mesh-list
43901946|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901947|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901948|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901949|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901950|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901951|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901952|NCT00086138|Sertraline|sertraline|mesh-list
43901953|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
43901954|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901955|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43901956|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901957|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901958|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901959|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901960|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
43901961|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901962|NCT00086957|Docetaxel|docetaxel|mesh-list
43901963|NCT00086957|Trastuzumab|trastuzumab|mesh-list
44237282|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237283|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237284|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237285|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
44237286|NCT00563355|Hematinics|hematinics|mesh-ancestor
44237288|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44237289|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237290|NCT00563394|Renal Agents|renal agents|mesh-ancestor
44237291|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237292|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237293|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237294|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237295|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237296|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901964|NCT00086957|Gefitinib|gefitinib|mesh-list
43901965|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901966|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901967|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901968|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901969|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901970|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901971|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901972|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901973|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43901974|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
43901975|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901976|NCT00087672|Lenalidomide|lenalidomide|mesh-list
43901977|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
43901978|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901979|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901980|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901981|NCT00087672|Growth Substances|growth substances|mesh-ancestor
43901982|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901983|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901984|NCT00088218|Cytarabine|cytarabine|mesh-list
43901985|NCT00088218|Clofarabine|clofarabine|mesh-list
43901986|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901987|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
43901988|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901989|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901990|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
43901991|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901992|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901993|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
43901994|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901995|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43901996|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43901997|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902025|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43902026|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43902027|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
43902028|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43902029|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43902030|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
43902032|NCT00088699|Analgesics|analgesics|mesh-ancestor
43902033|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
43902034|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902035|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902036|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43801585|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
44237298|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44237299|NCT00563433|Ofloxacin|ofloxacin|mesh-list
44237300|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44237301|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237302|NCT00563433|Renal Agents|renal agents|mesh-ancestor
44237303|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237304|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237305|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237306|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237307|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237308|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237309|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44237310|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44237311|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
44237313|NCT00563472|Desogestrel|desogestrel|mesh-list
43902037|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43902038|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
43902039|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
43902040|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902062|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902064|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902065|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902066|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902067|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902068|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902069|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902070|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902071|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902072|NCT00089024|Leucovorin|leucovorin|mesh-list
43902073|NCT00089024|Gemcitabine|gemcitabine|mesh-list
43902074|NCT00089024|Fluorouracil|fluorouracil|mesh-list
43902075|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
43902076|NCT00089024|Calcium|calcium|mesh-list
43902077|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
43902078|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902079|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
43902080|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902081|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902082|NCT00089024|Antiviral Agents|antiviral agents|mesh-ancestor
43902083|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902084|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902085|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902086|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
43902087|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902088|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43902089|NCT00089024|Antidotes|antidotes|mesh-ancestor
43902090|NCT00089024|Protective Agents|protective agents|mesh-ancestor
43902091|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
43902092|NCT00089024|Vitamins|vitamins|mesh-ancestor
43902093|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
43902119|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902120|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43902121|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902122|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902123|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
43902124|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43902125|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
43902126|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44237314|NCT00563472|Progesterone|progesterone|mesh-list
44237315|NCT00563472|Progestins|progestins|mesh-ancestor
44237316|NCT00563472|Hormones|hormones|mesh-ancestor
44237317|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237318|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237319|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44237320|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44237321|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44237322|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
44237323|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44237324|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44237325|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44237326|NCT00563485|Doxazosin|doxazosin|mesh-list
44237327|NCT00563485|Terazosin|terazosin|mesh-list
44237328|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237329|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44237330|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44237331|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44237332|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237333|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237334|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237335|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902127|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
43902128|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43902129|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902130|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43902131|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902132|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902133|NCT00091260|Dexamethasone|dexamethasone|mesh-list
43902134|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
43902135|NCT00091260|Lenalidomide|lenalidomide|mesh-list
43902136|NCT00091260|BB 1101|bb 1101|mesh-list
43902137|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902138|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
43902139|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
43902140|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902141|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783274|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
43902152|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902153|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902154|NCT00091260|Growth Substances|growth substances|mesh-ancestor
43902155|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902156|NCT00091273|Sargramostim|sargramostim|mesh-list
43902157|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
43902158|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
43902159|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902160|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43902161|NCT00091507|Insulin|insulin|mesh-list
43902162|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43902163|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902164|NCT00093041|Zalutumumab|zalutumumab|mesh-list
43902165|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902166|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237337|NCT00563524|Fezakinumab|fezakinumab|mesh-list
44237338|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44237339|NCT00563589|Cyclosporine|cyclosporine|mesh-list
44237340|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
44237341|NCT00563589|Methotrexate|methotrexate|mesh-list
44237342|NCT00563589|Cyclosporins|cyclosporins|mesh-list
44237343|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44237344|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
44237345|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44237346|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237347|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237348|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
44237349|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237350|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237351|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44237352|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237353|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44237354|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237355|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
44237356|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902167|NCT00093379|Capecitabine|capecitabine|mesh-list
43902168|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
43902169|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902170|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
43902171|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902172|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902173|NCT00093756|Paclitaxel|paclitaxel|mesh-list
43902174|NCT00093756|Carboplatin|carboplatin|mesh-list
43902175|NCT00093756|Bortezomib|bortezomib|mesh-list
43902176|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43902177|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902178|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
43902179|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
43902180|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
43902181|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902182|NCT00093782|Sirolimus|sirolimus|mesh-list
43902183|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902184|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902185|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902186|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902187|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
43902188|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902189|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
43902190|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902191|NCT00094497|Cisplatin|cisplatin|mesh-list
43902192|NCT00094497|Doxorubicin|doxorubicin|mesh-list
43902193|NCT00094497|Etoposide|etoposide|mesh-list
43902194|NCT00094497|Mitotane|mitotane|mesh-list
43902195|NCT00094497|Streptozocin|streptozocin|mesh-list
43902196|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902197|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902198|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43902199|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902200|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902201|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237357|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44237358|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
44237359|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237360|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44237361|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237362|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44237363|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
44237364|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237365|NCT00563615|Tegaserod|tegaserod|mesh-list
44237366|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44237367|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
43875989|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
43902202|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43902203|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902204|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
43902205|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43902206|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
43902238|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
43902239|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902240|NCT00096122|Cytarabine|cytarabine|mesh-list
43902241|NCT00096122|Idarubicin|idarubicin|mesh-list
43902242|NCT00096122|Tipifarnib|tipifarnib|mesh-list
43902243|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902244|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
43902245|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902246|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902247|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
43902248|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902249|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902250|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
43783390|NCT04999631|Ethanol|ethanol|mesh-list
43902286|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902287|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
43902288|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902289|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902290|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43902324|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902325|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902326|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
43902327|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
43902328|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839926|NCT04741698|Propranolol|propranolol|mesh-list
43902352|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
43902353|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
43902354|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902355|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902356|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902357|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902358|NCT00098059|Famciclovir|famciclovir|mesh-list
43902359|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
43902360|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902361|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43902362|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902363|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902364|NCT00098371|Alvocidib|alvocidib|mesh-list
43902365|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902366|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902367|NCT00098371|Growth Substances|growth substances|mesh-ancestor
43902368|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902369|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902370|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902371|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902372|NCT00098670|Rituximab|rituximab|mesh-list
43902373|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43902374|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
44237368|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977145|NCT04923776|Carboplatin|carboplatin|mesh-list
44237369|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237370|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237371|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44237372|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
44237374|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44237375|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43890408|NCT05325008|Antibodies|antibodies|mesh-list
44237376|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44237377|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
43902375|NCT00098670|Fludarabine|fludarabine|mesh-list
43902376|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902377|NCT00098670|Antibodies|antibodies|mesh-list
43902378|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
43902379|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43902380|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
43902381|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902382|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902390|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43902391|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902392|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902393|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902394|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902395|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902397|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43902398|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902399|NCT00099047|Celecoxib|celecoxib|mesh-list
43902400|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43902401|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43902402|NCT00099047|Analgesics|analgesics|mesh-ancestor
43902403|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
43902404|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902405|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902406|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902407|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902408|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43902409|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43902410|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902411|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902412|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
43902413|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43902414|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43902415|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
43902416|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902417|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902418|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902419|NCT00100659|Interferons|interferons|mesh-list
43902420|NCT00100659|Ribavirin|ribavirin|mesh-list
43902421|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902422|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
43902423|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902424|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
43902425|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902426|NCT00100698|Hormones|hormones|mesh-list
43902427|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902428|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902429|NCT00100841|Leucovorin|leucovorin|mesh-list
43902430|NCT00100841|Bevacizumab|bevacizumab|mesh-list
43902431|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43902432|NCT00100841|Cetuximab|cetuximab|mesh-list
43902433|NCT00100841|Fluorouracil|fluorouracil|mesh-list
43902434|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
43902435|NCT00100841|Antibodies|antibodies|mesh-list
44237378|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237379|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237380|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237381|NCT00563654|Urological Agents|urological agents|mesh-ancestor
44237382|NCT00563758|Tegaserod|tegaserod|mesh-list
44237383|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44237384|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
44237385|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977212|NCT04807894|Testosterone|testosterone|mesh-list
44237386|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237387|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237388|NCT00563771|Rasburicase|rasburicase|mesh-list
44237389|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
43902436|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
43902437|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43902438|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
43902439|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902440|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902441|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902442|NCT00100841|Growth Substances|growth substances|mesh-ancestor
43902443|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902444|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902445|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
43902446|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
43902447|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902448|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902449|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902480|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902482|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902483|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902484|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902485|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902486|NCT00102518|Aripiprazole|aripiprazole|mesh-list
43902487|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
43902488|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902489|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43902490|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902491|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902492|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902493|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
43902494|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
43902508|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902509|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902510|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902511|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902512|NCT00103376|Bortezomib|bortezomib|mesh-list
43902513|NCT00103376|Androgens|androgens|mesh-list
43902514|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43902515|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902516|NCT00103376|Hormones|hormones|mesh-ancestor
43902517|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902518|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902519|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
43902520|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
43902521|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
43902522|NCT00103844|Dasatinib|dasatinib|mesh-list
43902523|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902524|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902525|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902526|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902527|NCT00104858|Cyclosporine|cyclosporine|mesh-list
43902528|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
43902529|NCT00104858|Rituximab|rituximab|mesh-list
44237390|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237391|NCT00563823|Vatalanib|vatalanib|mesh-list
44237392|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44237393|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237394|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237395|NCT00563836|Catumaxomab|catumaxomab|mesh-list
44237396|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237397|NCT00563849|Leflunomide|leflunomide|mesh-list
43902530|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43902531|NCT00104858|Fludarabine|fludarabine|mesh-list
43902532|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902533|NCT00104858|Antibodies|antibodies|mesh-list
43902534|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
43902535|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43902536|NCT00104858|Cyclosporins|cyclosporins|mesh-list
43902537|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
43902538|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902539|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902540|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902541|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902542|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
43902543|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902544|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902545|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902546|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
43902547|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902548|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902549|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902550|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902551|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902552|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902553|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902554|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
43902555|NCT00105001|Sirolimus|sirolimus|mesh-list
43902556|NCT00105001|Fludarabine|fludarabine|mesh-list
43633679|NCT05699148|Ivacaftor|ivacaftor|mesh-list
43902571|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902572|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902573|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
43902575|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43902576|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43902577|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43902578|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902579|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
43902580|NCT00105027|Hormones|hormones|mesh-ancestor
43902581|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902582|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902583|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902584|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
43902585|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902586|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902587|NCT00106106|Acamprosate|acamprosate|mesh-list
43902588|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43902589|NCT00106392|Tacrolimus|tacrolimus|mesh-list
43902590|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902591|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
43902592|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902593|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902594|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902595|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902596|NCT00106431|Romidepsin|romidepsin|mesh-list
43902597|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902598|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902599|NCT00106535|Methotrexate|methotrexate|mesh-list
43902600|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43902601|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
43902602|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43902603|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902604|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237398|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237399|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237400|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237401|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
44237402|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237403|NCT00563862|Cisplatin|cisplatin|mesh-list
44237404|NCT00563862|Fluorouracil|fluorouracil|mesh-list
44237405|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237406|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
44237407|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237408|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237409|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237410|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
44237411|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237412|NCT00563875|Aspirin|aspirin|mesh-list
44237413|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44237414|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43902605|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
43902606|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902607|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902608|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902609|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902610|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43902611|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902612|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
43902613|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902614|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43902642|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902644|NCT00109005|Lenalidomide|lenalidomide|mesh-list
43902645|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
43902646|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902647|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902648|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902649|NCT00109005|Growth Substances|growth substances|mesh-ancestor
43902650|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902651|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902652|NCT00109473|Prednisone|prednisone|mesh-list
43902653|NCT00109473|Hormones|hormones|mesh-list
43902654|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902655|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
43902656|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902657|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902658|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902659|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138326|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138351|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44138353|NCT00170963|Amlodipine|amlodipine|mesh-list
44138354|NCT00170963|Valsartan|valsartan|mesh-list
44138355|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138356|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138357|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138358|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138359|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138360|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138361|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138362|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237415|NCT00563875|Analgesics|analgesics|mesh-ancestor
44237416|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
44237417|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237418|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237419|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237420|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237421|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44237422|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44237423|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237424|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44237425|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44237426|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138363|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138364|NCT00170976|Amlodipine|amlodipine|mesh-list
44138365|NCT00170976|Valsartan|valsartan|mesh-list
44138366|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138367|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138368|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138369|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138370|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43783647|NCT03079999|Aspirin|aspirin|mesh-list
43902689|NCT00112151|Testosterone|testosterone|mesh-list
43902690|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
43902691|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
43902692|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43902693|NCT00112151|Androgens|androgens|mesh-ancestor
43902694|NCT00112151|Hormones|hormones|mesh-ancestor
43902724|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902725|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902727|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902728|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902729|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902730|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902731|NCT00112723|Alvocidib|alvocidib|mesh-list
43902732|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902733|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902734|NCT00112723|Growth Substances|growth substances|mesh-ancestor
43902735|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902736|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902737|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902738|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902754|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902755|NCT00112827|Growth Substances|growth substances|mesh-ancestor
43902756|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902757|NCT00112918|Leucovorin|leucovorin|mesh-list
43902758|NCT00112918|Bevacizumab|bevacizumab|mesh-list
43902759|NCT00112918|Fluorouracil|fluorouracil|mesh-list
43902760|NCT00112918|Capecitabine|capecitabine|mesh-list
43902761|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
43902762|NCT00112918|Calcium|calcium|mesh-list
43902763|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
43902764|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902765|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902766|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902767|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902768|NCT00112918|Growth Substances|growth substances|mesh-ancestor
43902769|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902770|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902771|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43902772|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
43902773|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902774|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902775|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237427|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
44237428|NCT00563914|Amodiaquine|amodiaquine|mesh-list
44237429|NCT00563914|Ferroquine|ferroquine|mesh-list
44237430|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
44237431|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44237432|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43902776|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
43902777|NCT00112918|Antidotes|antidotes|mesh-ancestor
43902778|NCT00112918|Protective Agents|protective agents|mesh-ancestor
43902779|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
43902780|NCT00112918|Vitamins|vitamins|mesh-ancestor
43902781|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
43902782|NCT00113217|Bevacizumab|bevacizumab|mesh-list
43902783|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902784|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902785|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902786|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902787|NCT00113217|Growth Substances|growth substances|mesh-ancestor
43902788|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902789|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902790|NCT00113230|Bevacizumab|bevacizumab|mesh-list
43902791|NCT00113230|Capecitabine|capecitabine|mesh-list
43902792|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902793|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902794|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902795|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43902796|NCT00113230|Growth Substances|growth substances|mesh-ancestor
43902797|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902798|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
43902799|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902800|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
43840025|NCT04733040|Felzartamab|felzartamab|mesh-list
43902828|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
43902829|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902830|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902831|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43902832|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43902833|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902835|NCT00116207|Allopurinol|allopurinol|mesh-list
43902837|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
43902838|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902839|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902840|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
43902841|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902842|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43902843|NCT00116207|Protective Agents|protective agents|mesh-ancestor
43902844|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902864|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902865|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43902866|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43902867|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
43902868|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902869|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
43902870|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
43902871|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43902872|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43902873|NCT00117962|Carboplatin|carboplatin|mesh-list
43902874|NCT00117962|Pemetrexed|pemetrexed|mesh-list
43902875|NCT00117962|Cetuximab|cetuximab|mesh-list
43902876|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902877|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902878|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902879|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43902880|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43902881|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902882|NCT00118131|Cisplatin|cisplatin|mesh-list
43902883|NCT00118131|Docetaxel|docetaxel|mesh-list
43902884|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902885|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
43902886|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
43902887|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44237433|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237434|NCT00563927|Cisplatin|cisplatin|mesh-list
44237435|NCT00563927|Fluorouracil|fluorouracil|mesh-list
44237436|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237437|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
44237438|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237439|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237440|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237441|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
44237442|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237443|NCT00563953|Doxorubicin|doxorubicin|mesh-list
44237444|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237445|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237446|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237447|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237448|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876358|NCT04713787|Albendazole|albendazole|mesh-list
43902888|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902889|NCT00118144|Bortezomib|bortezomib|mesh-list
43902890|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902891|NCT00118209|Prednisone|prednisone|mesh-list
43902892|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
43902893|NCT00118209|Rituximab|rituximab|mesh-list
43902894|NCT00118209|Doxorubicin|doxorubicin|mesh-list
43902895|NCT00118209|Etoposide|etoposide|mesh-list
43902896|NCT00118209|Vincristine|vincristine|mesh-list
43902897|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902898|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
43902899|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902900|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902901|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144249|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43902927|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43902928|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
43902929|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902930|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902931|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43902932|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43902934|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
43902935|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43902936|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
43902937|NCT00118352|Fludarabine|fludarabine|mesh-list
43902938|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902939|NCT00118352|Antibodies|antibodies|mesh-list
43902940|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
43902941|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43902942|NCT00118352|Cyclosporins|cyclosporins|mesh-list
43902943|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
43902944|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902945|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902946|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902947|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
43902948|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902949|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902950|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902951|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
43902980|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43902981|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902982|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43902983|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43801586|NCT04705727|Budesonide|budesonide|mesh-list
44237449|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237450|NCT00563992|Valproic Acid|valproic acid|mesh-list
44237451|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237452|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237453|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237454|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
44237455|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44237456|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902984|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43902985|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902987|NCT00118404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43902988|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43902989|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43902990|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902991|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902992|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
43902993|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902994|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903030|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903032|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903033|NCT00119158|Fluticasone|fluticasone|mesh-list
43903034|NCT00119158|Xhance|xhance|mesh-list
43903068|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903069|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
43903070|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903071|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903072|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903073|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
43903074|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903075|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903076|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903077|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43903078|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43903079|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
43903106|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
43903107|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903108|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903109|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903110|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903111|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43903112|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903113|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
43903114|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903115|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43903116|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903117|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903118|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
43903119|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43903120|NCT00121225|Vorinostat|vorinostat|mesh-list
43903121|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903122|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43903123|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903124|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903125|NCT00121251|Gemcitabine|gemcitabine|mesh-list
43903126|NCT00121251|Capecitabine|capecitabine|mesh-list
43903127|NCT00121251|Sorafenib|sorafenib|mesh-list
43903157|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
43903158|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903159|NCT00121836|Bevacizumab|bevacizumab|mesh-list
43903160|NCT00121836|Capecitabine|capecitabine|mesh-list
43903161|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903162|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237457|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237458|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
44237459|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
44237460|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237461|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44237462|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
44237463|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44237464|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
44237465|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44237466|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237467|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44237468|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44237469|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903163|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43903164|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903165|NCT00121836|Growth Substances|growth substances|mesh-ancestor
43903166|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903167|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903168|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903169|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
43903170|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903171|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43903196|NCT00122447|Protective Agents|protective agents|mesh-ancestor
43903197|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
43903199|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
43903200|NCT00123110|Metformin|metformin|mesh-list
43903201|NCT00123110|Leuprolide|leuprolide|mesh-list
43903202|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43903203|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903204|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43903205|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
43903206|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43903207|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903208|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903209|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
43903210|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43903211|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43903212|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903213|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
43903214|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903215|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
43903216|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903217|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
43903218|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43903219|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43903220|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903221|NCT00123162|Urological Agents|urological agents|mesh-ancestor
43903222|NCT00123604|Metoprolol|metoprolol|mesh-list
43903223|NCT00123604|Carvedilol|carvedilol|mesh-list
43903241|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
43903242|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43903243|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43903244|NCT00123630|Omalizumab|omalizumab|mesh-list
43903245|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43903246|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43903247|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43903248|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
43903249|NCT00123643|Glyburide|glyburide|mesh-list
43903250|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43903251|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903252|NCT00124176|Albuterol|albuterol|mesh-list
43903253|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43903254|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
44237470|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237471|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44237472|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44237473|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44237474|NCT00564057|Candesartan|candesartan|mesh-list
44237475|NCT00564057|Lercanidipine|lercanidipine|mesh-list
44237476|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237477|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237478|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237479|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237480|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44237481|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237482|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44237483|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237484|NCT00564148|Bevacizumab|bevacizumab|mesh-list
44237485|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44237486|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237487|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44237488|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44237489|NCT00564148|Growth Substances|growth substances|mesh-ancestor
44237490|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237491|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
44237492|NCT00564174|Aspirin|aspirin|mesh-list
44237493|NCT00564174|Heparin|heparin|mesh-list
44237494|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44237495|NCT00564174|Tinzaparin|tinzaparin|mesh-list
44237496|NCT00564174|Dalteparin|dalteparin|mesh-list
44237517|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237518|NCT00564200|Dexamethasone|dexamethasone|mesh-list
44237519|NCT00564200|Fludarabine|fludarabine|mesh-list
43903255|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903256|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903257|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43903258|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43903259|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
43903260|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43903261|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43903262|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43903263|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43903264|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43903265|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903266|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903267|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43903268|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
43903269|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43903270|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
43903271|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43903272|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903273|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43903274|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903275|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903277|NCT00124579|Dexamethasone|dexamethasone|mesh-list
43903279|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903280|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
43903281|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
43903293|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903294|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903295|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43977678|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
43903296|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903297|NCT00124579|Growth Substances|growth substances|mesh-ancestor
43903298|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903299|NCT00124735|Rocuronium|rocuronium|mesh-list
43903300|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43903301|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43903302|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43903303|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903304|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903305|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
43903306|NCT00125034|Cetuximab|cetuximab|mesh-list
43903307|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903308|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903309|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43903310|NCT00125372|Bexarotene|bexarotene|mesh-list
43903311|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903312|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43903313|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903314|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903315|NCT00125515|Naltrexone|naltrexone|mesh-list
43903316|NCT00125515|Memantine|memantine|mesh-list
43903317|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43903318|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43903319|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903320|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
43903321|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903322|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43903323|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43903324|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
43903325|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903326|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903327|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43903328|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43903329|NCT00125528|Cycloserine|cycloserine|mesh-list
43903330|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43903331|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903332|NCT00125528|Renal Agents|renal agents|mesh-ancestor
43903333|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43903334|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
43903335|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903336|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
44237520|NCT00564200|Bortezomib|bortezomib|mesh-list
44237521|NCT00564200|Melphalan|melphalan|mesh-list
44237522|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237523|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
44237524|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
44237525|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237526|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237527|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237528|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
44237529|NCT00564200|Hormones|hormones|mesh-ancestor
44237530|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903337|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903339|NCT00125593|Ezetimibe|ezetimibe|mesh-list
43903340|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43903341|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43903342|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
43903343|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903344|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43784136|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903361|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43903362|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903363|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903364|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903365|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
43903366|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903367|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903368|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43903369|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43903370|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903372|NCT00127218|Atorvastatin|atorvastatin|mesh-list
43903373|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43903374|NCT00127218|Simvastatin|simvastatin|mesh-list
43903375|NCT00127218|Pravastatin|pravastatin|mesh-list
43903376|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43903377|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43903378|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
43903379|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903380|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43903381|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43903382|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903383|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
43903384|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
43903385|NCT00127218|Vitamins|vitamins|mesh-ancestor
43903386|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
43903387|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903388|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
43903389|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43903390|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903391|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903392|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
43903393|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43903394|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43903395|NCT00128180|Prednisolone|prednisolone|mesh-list
43903396|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
43903397|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43903398|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
43903399|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903400|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
43903401|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
43903402|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903413|NCT00130780|Cisplatin|cisplatin|mesh-list
43903414|NCT00130780|Docetaxel|docetaxel|mesh-list
43903415|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903416|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903417|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44237531|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44237532|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237533|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237534|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237535|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
44237536|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903418|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903419|NCT00130780|Growth Substances|growth substances|mesh-ancestor
43903420|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903421|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903422|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903423|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903424|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903425|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903427|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43903428|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
43903429|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903430|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903431|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903432|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43903433|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43903434|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903435|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903436|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43903437|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
43903438|NCT00131378|Hormones|hormones|mesh-list
43903439|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903440|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903441|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43903442|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43903443|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903444|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903445|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903446|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903447|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903448|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903449|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903450|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44138376|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138377|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138378|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138379|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138380|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138381|NCT00170989|Diuretics|diuretics|mesh-ancestor
44138382|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138383|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138384|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44138385|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138386|NCT00171002|Amlodipine|amlodipine|mesh-list
44138387|NCT00171002|Valsartan|valsartan|mesh-list
44138388|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138389|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138390|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138402|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138403|NCT00171015|Diuretics|diuretics|mesh-ancestor
44138404|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138405|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138406|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43903452|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
43903453|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903454|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43903455|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43903456|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237537|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
44237538|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44237539|NCT00564213|Mitomycins|mitomycins|mesh-list
44237540|NCT00564213|Mitomycin|mitomycin|mesh-list
44237541|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237542|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237543|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
44237544|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237545|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44237546|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903457|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903458|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43903459|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43903460|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
43903461|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43903462|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
43903463|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43903464|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903465|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43903466|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43903467|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43903468|NCT00132002|Vorinostat|vorinostat|mesh-list
43903469|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903470|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43903471|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903472|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903473|NCT00133575|Vaccines|vaccines|mesh-list
43903474|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
43903475|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903476|NCT00133978|Selenium|selenium|mesh-list
43903477|NCT00133978|Antioxidants|antioxidants|mesh-list
43903478|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903479|NCT00133978|Protective Agents|protective agents|mesh-ancestor
43903480|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903481|NCT00133978|Trace Elements|trace elements|mesh-ancestor
43903482|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
43903483|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
43903484|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
43903485|NCT00134004|Fludarabine|fludarabine|mesh-list
43903486|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
43903487|NCT00134004|Tacrolimus|tacrolimus|mesh-list
43903488|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903489|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
43903490|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903491|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903492|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903493|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
43903494|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903495|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903513|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
43903514|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903515|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903516|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43903517|NCT00134043|Vorinostat|vorinostat|mesh-list
43903518|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903519|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43903520|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903521|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903522|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43903523|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
43903524|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903525|NCT00136760|Bupropion|bupropion|mesh-list
43903526|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903527|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903528|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237548|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44237549|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44237550|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237551|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237552|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
44237553|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237554|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237555|NCT00564252|Urological Agents|urological agents|mesh-ancestor
44237556|NCT00564330|Esomeprazole|esomeprazole|mesh-list
43903529|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43903530|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903531|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903532|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903533|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
43903534|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903535|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903536|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43903537|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43903538|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903539|NCT00137969|Acetaminophen|acetaminophen|mesh-list
43903540|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
43903541|NCT00137969|Promethazine|promethazine|mesh-list
43903543|NCT00137969|Rituximab|rituximab|mesh-list
43903544|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903545|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903546|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
43903547|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903548|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903549|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903550|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
43903551|NCT00137969|Hormones|hormones|mesh-ancestor
43840087|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
43903587|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43903588|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903589|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903590|NCT00140556|Bevacizumab|bevacizumab|mesh-list
43903591|NCT00140556|Cisplatin|cisplatin|mesh-list
43903601|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903602|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903603|NCT00141115|Levetiracetam|levetiracetam|mesh-list
43903604|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
43903605|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
43903607|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43903608|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903609|NCT00141739|Analgesics|analgesics|mesh-ancestor
43903610|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
43903611|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903612|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903613|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903614|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903615|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903616|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903617|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
43903618|NCT00142116|Thalidomide|thalidomide|mesh-list
43903619|NCT00142116|Rituximab|rituximab|mesh-list
43903620|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903621|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903622|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
43903623|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903624|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903625|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903626|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
43903627|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237557|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44237558|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237559|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44237560|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237561|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237562|NCT00564408|Carbachol|carbachol|mesh-list
43903628|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903629|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43903630|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903631|NCT00142116|Growth Substances|growth substances|mesh-ancestor
43903632|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903633|NCT00142168|Rituximab|rituximab|mesh-list
43903634|NCT00142168|Lenalidomide|lenalidomide|mesh-list
43903635|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903636|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903637|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
43903638|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903639|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903640|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43903641|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903642|NCT00142168|Growth Substances|growth substances|mesh-ancestor
43903643|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903644|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
43903645|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903646|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
43903647|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43903648|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43903649|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903650|NCT00142506|Urological Agents|urological agents|mesh-ancestor
43903651|NCT00142818|Naltrexone|naltrexone|mesh-list
43903652|NCT00142818|Modafinil|modafinil|mesh-list
43903653|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43903654|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43903655|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903656|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
43784392|NCT03023124|Doxorubicin|doxorubicin|mesh-list
43903673|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903674|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
43903675|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
43903676|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903677|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903678|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903679|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
43903680|NCT00144963|Hormones|hormones|mesh-ancestor
43978003|NCT01893879|Ketoprofen|ketoprofen|mesh-list
43903681|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903682|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903683|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903684|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43903685|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903686|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903687|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903688|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903689|NCT00145041|Vincristine|vincristine|mesh-list
43903690|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43903691|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903692|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903693|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903694|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903695|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903696|NCT00145249|Fluconazole|fluconazole|mesh-list
43903697|NCT00145249|Amphotericin B|amphotericin b|mesh-list
43903698|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43903699|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
43903700|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903701|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43903702|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43903703|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903704|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903705|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44237563|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44237564|NCT00564408|Miotics|miotics|mesh-ancestor
44237565|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
44237566|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237567|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903706|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
43903707|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903708|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903709|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43903710|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43903711|NCT00145249|Amebicides|amebicides|mesh-ancestor
43903721|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903723|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
43903724|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903725|NCT00147199|Treprostinil|treprostinil|mesh-list
43903726|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43903727|NCT00147212|Trabectedin|trabectedin|mesh-list
43903728|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903729|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
43903730|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903731|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903732|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43903733|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43903734|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43903735|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903736|NCT00147966|Rituximab|rituximab|mesh-list
43903737|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903738|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903739|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
43903740|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903741|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903742|NCT00148668|Carboplatin|carboplatin|mesh-list
43903743|NCT00148668|Docetaxel|docetaxel|mesh-list
43903744|NCT00148668|Trastuzumab|trastuzumab|mesh-list
43903745|NCT00148668|Vinorelbine|vinorelbine|mesh-list
43903746|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903747|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903748|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903749|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903750|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903751|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903752|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43903753|NCT00148798|Cisplatin|cisplatin|mesh-list
43903754|NCT00148798|Cetuximab|cetuximab|mesh-list
43903755|NCT00148798|Vinorelbine|vinorelbine|mesh-list
43903756|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903757|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903758|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43903759|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903760|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903761|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903762|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903763|NCT00149227|Valsartan|valsartan|mesh-list
43903764|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
43903765|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43903766|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43903767|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903768|NCT00149643|Fluoxetine|fluoxetine|mesh-list
43903769|NCT00149643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43903770|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903771|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903772|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903773|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903774|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
43903775|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903776|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903809|NCT00149799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903810|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
44237568|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44237569|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
44237570|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237571|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237572|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44237573|NCT00564408|Analgesics|analgesics|mesh-ancestor
44237574|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
44237575|NCT00564408|Protective Agents|protective agents|mesh-ancestor
44237576|NCT00564460|Finasteride|finasteride|mesh-list
44237577|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44237578|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44237579|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237580|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237581|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
44237582|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237583|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237584|NCT00564460|Urological Agents|urological agents|mesh-ancestor
44237585|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
44237586|NCT00564512|Rituximab|rituximab|mesh-list
44237587|NCT00564512|Fludarabine|fludarabine|mesh-list
44237588|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
44237589|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237590|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
44237591|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237592|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237593|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44237594|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
44237595|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237596|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237597|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44237598|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44237599|NCT00564525|Amitriptyline|amitriptyline|mesh-list
44237600|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44237601|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
44237602|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237603|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903811|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903812|NCT00151320|Rituximab|rituximab|mesh-list
44237604|NCT00564525|Analgesics|analgesics|mesh-ancestor
44237605|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
44237606|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237607|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237608|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43978146|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
44237609|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44237610|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237611|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237612|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237613|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237614|NCT00564538|Tacrolimus|tacrolimus|mesh-list
44237615|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
44237616|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43903813|NCT00151320|Bortezomib|bortezomib|mesh-list
43903814|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903815|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903816|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
43903817|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903844|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
43903845|NCT00153985|Busulfan|busulfan|mesh-list
43903846|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903847|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903848|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903849|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
43903850|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903851|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903852|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
43903853|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903854|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43903855|NCT00156013|Clofarabine|clofarabine|mesh-list
43903856|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903857|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
43903858|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903859|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903860|NCT00156247|Acitretin|acitretin|mesh-list
43903861|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
43903862|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903863|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43903864|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
43784556|NCT05060666|Ivermectin|ivermectin|mesh-list
43903901|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903902|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43903903|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
43903923|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903924|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903925|NCT00158743|Protective Agents|protective agents|mesh-ancestor
43903926|NCT00159263|Budesonide|budesonide|mesh-list
43903927|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
43903928|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903929|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43903930|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
43903931|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903932|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903933|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43903934|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
43903935|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
43903936|NCT00159263|Hormones|hormones|mesh-ancestor
43903937|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903938|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43903939|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43903940|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43903941|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237617|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237618|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
44237619|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237620|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44237621|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237622|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237623|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
44237624|NCT00564551|Calcium|calcium|mesh-list
44237625|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44237626|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237627|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44237628|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43903942|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903943|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903944|NCT00159419|Alendronate|alendronate|mesh-list
43903945|NCT00159419|Pamidronate|pamidronate|mesh-list
43903946|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43903947|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903948|NCT00159965|Sertraline|sertraline|mesh-list
43903949|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903950|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903951|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43903952|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903953|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903954|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903955|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903956|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
43903957|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903958|NCT00161473|Prazosin|prazosin|mesh-list
43903978|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903979|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43903980|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43903981|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903982|NCT00166166|Fluconazole|fluconazole|mesh-list
43903983|NCT00166166|Nitroprusside|nitroprusside|mesh-list
43903984|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
43903985|NCT00166166|Acetylcholine|acetylcholine|mesh-list
43903986|NCT00166166|Bradykinin|bradykinin|mesh-list
43903987|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43903988|NCT00166166|Kininogens|kininogens|mesh-list
43903989|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
43903990|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903991|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43903992|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43903993|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903994|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903995|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43903996|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
43903997|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903998|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903999|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43904000|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43904001|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43904002|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
43904003|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43904004|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43904005|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904006|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904007|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43904008|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
43801587|NCT04705727|Terbutaline|terbutaline|mesh-list
44237629|NCT00564564|Clomipramine|clomipramine|mesh-list
44237630|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
44237631|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237632|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44237633|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44237634|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237635|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237636|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44237637|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44237638|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44237639|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237640|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237641|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237642|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
44237643|NCT00564590|Melatonin|melatonin|mesh-list
44237644|NCT00564590|Omeprazole|omeprazole|mesh-list
44237645|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
44237646|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237647|NCT00564590|Protective Agents|protective agents|mesh-ancestor
44237648|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237649|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237650|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44237651|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237652|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44237653|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237654|NCT00564603|Dexamethasone|dexamethasone|mesh-list
44237655|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
44237656|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44237657|NCT00564603|BB 1101|bb 1101|mesh-list
44237658|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237659|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
44237660|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
43877076|NCT04705948|Ketamine|ketamine|mesh-list
43904009|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43904010|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904011|NCT00167102|Alefacept|alefacept|mesh-list
43904012|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
43904013|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
43784663|NCT04552327|Diclofenac|diclofenac|mesh-list
44138416|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138417|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138418|NCT00171067|Valsartan|valsartan|mesh-list
44138419|NCT00171067|Lisinopril|lisinopril|mesh-list
44138420|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237662|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237663|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237664|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
44237665|NCT00564603|Hormones|hormones|mesh-ancestor
44237666|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237667|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44237668|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237669|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44237670|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237671|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237673|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44237674|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
44237675|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237676|NCT00564642|Expectorants|expectorants|mesh-ancestor
44237677|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44237678|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44237679|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
44237680|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237681|NCT00564642|Protective Agents|protective agents|mesh-ancestor
44138421|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138422|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138423|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138424|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44138425|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
44138426|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138427|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44138428|NCT00171067|Protective Agents|protective agents|mesh-ancestor
44138429|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138430|NCT00171080|Valsartan|valsartan|mesh-list
44138431|NCT00171080|Irbesartan|irbesartan|mesh-list
44138432|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138433|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138434|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43653651|NCT02982850|Aspirin|aspirin|mesh-list
43904016|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904017|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
43904018|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904019|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904020|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904021|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
43904022|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904023|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904024|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904025|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
43904026|NCT00167206|Fludarabine|fludarabine|mesh-list
43904027|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904028|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
43904029|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904030|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904031|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904032|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
44237682|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237683|NCT00564642|Antidotes|antidotes|mesh-ancestor
44237684|NCT00564655|Epinephrine|epinephrine|mesh-list
44237685|NCT00564655|Racepinephrine|racepinephrine|mesh-list
44237686|NCT00564655|Bupivacaine|bupivacaine|mesh-list
44237687|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
44237688|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
44237689|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
43877168|NCT04705428|Fluorides|fluorides|mesh-list
43904033|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904034|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904035|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904036|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
43904037|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904038|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
43904039|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904040|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904041|NCT00167934|Valproic Acid|valproic acid|mesh-list
43904042|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
43904043|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904044|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904045|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
43904046|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904047|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904065|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904066|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
43904067|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904068|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904069|NCT00168324|Dexamethasone|dexamethasone|mesh-list
43904070|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
43904071|NCT00168324|BB 1101|bb 1101|mesh-list
43904072|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904073|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
43904074|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
43904075|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904076|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904077|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904078|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
43904079|NCT00168324|Hormones|hormones|mesh-ancestor
43904080|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904081|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904082|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904083|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
43904084|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904085|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904086|NCT00168337|Dexamethasone|dexamethasone|mesh-list
43904087|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904088|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
43904089|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
43904090|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904091|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904093|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
43904094|NCT00168337|Hormones|hormones|mesh-ancestor
43904095|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904096|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904097|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904098|NCT00168389|Dexamethasone|dexamethasone|mesh-list
43904099|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904100|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
43904101|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
43904102|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904103|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904104|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904105|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
43904126|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904127|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43978376|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
43904128|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904129|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904130|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44237690|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237691|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237692|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
44237693|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237694|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44237695|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44237696|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237697|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237698|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237699|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44237700|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44237701|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
44237702|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44237703|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44237704|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
44237705|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
44237706|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44237707|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
44237708|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
44237709|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237710|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237711|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
44237712|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44237713|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44237714|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44237715|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237716|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904131|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904133|NCT00170157|Leuprolide|leuprolide|mesh-list
43904134|NCT00170157|Goserelin|goserelin|mesh-list
43904135|NCT00170157|Bicalutamide|bicalutamide|mesh-list
43904136|NCT00170157|Flutamide|flutamide|mesh-list
43904137|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904138|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904139|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43904140|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904141|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43904142|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
43904143|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904144|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904145|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904146|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
43904147|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
43904148|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904149|NCT00170625|Topotecan|topotecan|mesh-list
43904150|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44237718|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237719|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237720|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44237721|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237722|NCT00564720|Gemcitabine|gemcitabine|mesh-list
44237723|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
44237724|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44237725|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237726|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
44237727|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237728|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237729|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
44237730|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237731|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904151|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904152|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904153|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904154|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904155|NCT00176202|Valproic Acid|valproic acid|mesh-list
43904156|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
43904157|NCT00176202|Risperidone|risperidone|mesh-list
43904191|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904193|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978443|NCT01911065|Vaccines|vaccines|mesh-list
43904194|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904195|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43904196|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43904197|NCT00176423|Galantamine|galantamine|mesh-list
43904228|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
43904229|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904230|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904231|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
43904232|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904233|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904234|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904235|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904237|NCT00176839|Melphalan|melphalan|mesh-list
43904238|NCT00176839|Busulfan|busulfan|mesh-list
43904239|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904240|NCT00176839|Lenograstim|lenograstim|mesh-list
43904241|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904242|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
43904267|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904268|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904269|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
43904270|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
43904271|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904272|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904273|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904274|NCT00176865|Cyclosporine|cyclosporine|mesh-list
43904275|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
43904276|NCT00176865|Fludarabine|fludarabine|mesh-list
43904277|NCT00176865|Melphalan|melphalan|mesh-list
43904278|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
43904279|NCT00176865|Cyclosporins|cyclosporins|mesh-list
43904280|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904281|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
43904282|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43904283|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
43904284|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43904285|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237732|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237733|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
44237734|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237735|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44237736|NCT00564772|Ritonavir|ritonavir|mesh-list
44237737|NCT00564772|Lopinavir|lopinavir|mesh-list
44237738|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
44237739|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44237740|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44237741|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44237742|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237743|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237744|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44237745|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44237746|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
44237747|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904286|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904287|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904288|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
43904289|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904290|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904291|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
43904292|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904293|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
43904294|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904326|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
43904327|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904328|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904329|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904330|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
43904331|NCT00176917|Busulfan|busulfan|mesh-list
43904332|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
43904333|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904334|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
43904335|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904336|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904337|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904371|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904372|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904373|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904374|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
43904375|NCT00178178|Bupivacaine|bupivacaine|mesh-list
43904376|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
43904377|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
43904378|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784959|NCT04426591|Biotin|biotin|mesh-list
43904405|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904407|NCT00178919|Trimethaphan|trimethaphan|mesh-list
43904408|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
43904409|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904410|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43904411|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43904412|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43904413|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
43904414|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904415|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904416|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43904417|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43904418|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904419|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237749|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44237750|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44237751|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44237752|NCT00564824|Caffeine|caffeine|mesh-list
44237753|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44237754|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237755|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44237756|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237757|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237758|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44237759|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43877374|NCT04702061|Anesthetics|anesthetics|mesh-list
43904420|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
43904421|NCT00179478|Interferons|interferons|mesh-list
43904422|NCT00179478|Interferon-beta|interferon-beta|mesh-list
43904423|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
43904457|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904458|NCT00182754|Octreotide|octreotide|mesh-list
43904459|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904460|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904461|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904462|NCT00182767|Doxorubicin|doxorubicin|mesh-list
43785031|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
43904500|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904501|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904533|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43904534|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904535|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157270|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43654041|NCT02979548|Aprepitant|aprepitant|mesh-list
43904536|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43904537|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904538|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43904539|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904540|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904541|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904568|NCT00183794|Docetaxel|docetaxel|mesh-list
43904569|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904570|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
43904571|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904572|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904573|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
43904574|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904575|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904576|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904577|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
43904578|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904579|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904580|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904581|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904582|NCT00185692|Acetaminophen|acetaminophen|mesh-list
43904583|NCT00185692|Cyclosporine|cyclosporine|mesh-list
43904584|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
43904585|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
43904586|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43904587|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43904588|NCT00185692|Prednisolone|prednisolone|mesh-list
43840272|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
43904607|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237760|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
44237761|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237762|NCT00564941|Deferasirox|deferasirox|mesh-list
44237763|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44237764|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
44237765|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
44237766|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237767|NCT00564993|Dobutamine|dobutamine|mesh-list
44237768|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44237769|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
44237770|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
44237771|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237772|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237773|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44237774|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44237775|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44237776|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237777|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237778|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237817|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44237818|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237820|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44237821|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44237822|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44237823|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
44237824|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
44237825|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904608|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43904609|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43904610|NCT00185692|Analgesics|analgesics|mesh-ancestor
43904611|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
43904612|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904613|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
43904614|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43904615|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904616|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43904617|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
43904618|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904619|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904620|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
43904621|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
43904622|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904623|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
43904624|NCT00185692|Hormones|hormones|mesh-ancestor
43904625|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904626|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43904627|NCT00185692|Protective Agents|protective agents|mesh-ancestor
43904628|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904629|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904630|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
43904631|NCT00185900|Nifedipine|nifedipine|mesh-list
43904633|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
43904634|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904635|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904636|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
43904637|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904638|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43904639|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
43904640|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43904641|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904642|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904643|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43904644|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
43904645|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904646|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
43904680|NCT00186069|Analgesics|analgesics|mesh-ancestor
43904681|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
43904682|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904683|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904684|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
43904701|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904702|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
43904703|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904704|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904705|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43904706|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43904707|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904708|NCT00186498|Memantine|memantine|mesh-list
43904709|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43904710|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43904711|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
43904712|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237826|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237827|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237828|NCT00565188|Adenosine|adenosine|mesh-list
44237829|NCT00565188|Analgesics|analgesics|mesh-ancestor
44237830|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
44237831|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237832|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877483|NCT04700943|Anesthetics|anesthetics|mesh-list
43904713|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904714|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904715|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43904716|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43904717|NCT00186875|Cytarabine|cytarabine|mesh-list
43904718|NCT00186875|Dexamethasone|dexamethasone|mesh-list
43904719|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
43904720|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
43904721|NCT00186875|Methotrexate|methotrexate|mesh-list
43904722|NCT00186875|Etoposide|etoposide|mesh-list
43904723|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
43904724|NCT00186875|Vincristine|vincristine|mesh-list
43904725|NCT00186875|Asparaginase|asparaginase|mesh-list
43904726|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
43904727|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
43904728|NCT00186875|Vinblastine|vinblastine|mesh-list
43904729|NCT00186875|Pegaspargase|pegaspargase|mesh-list
43904730|NCT00186875|Teniposide|teniposide|mesh-list
43904731|NCT00186875|BB 1101|bb 1101|mesh-list
43904732|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904733|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
43904734|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904735|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904736|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904737|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
43904738|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904739|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904740|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904741|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904742|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
43904763|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
43904764|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904765|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904766|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904767|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904768|NCT00186875|Analgesics|analgesics|mesh-ancestor
43904769|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
43904771|NCT00187655|Cefoxitin|cefoxitin|mesh-list
43904772|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904773|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904774|NCT00187681|Metformin|metformin|mesh-list
43904775|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43904776|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904777|NCT00187720|Metformin|metformin|mesh-list
43904778|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43904779|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904780|NCT00189098|Trimethoprim|trimethoprim|mesh-list
43904781|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43904782|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
43904783|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43904784|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904785|NCT00189098|Renal Agents|renal agents|mesh-ancestor
43904786|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
43904787|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43904788|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43904789|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43904790|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904791|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904792|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43904793|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43904794|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43904813|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44237833|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44237834|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
44237835|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44237836|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
44237837|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
44237838|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237839|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237840|NCT00565214|Vitamins|vitamins|mesh-list
44237841|NCT00565214|Vitamin E|vitamin e|mesh-list
44237842|NCT00565214|Selenium|selenium|mesh-list
44237843|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
44237844|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237845|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
43877543|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904814|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904815|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904816|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904817|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
43904819|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43904820|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43904821|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
43904822|NCT00189436|Budesonide|budesonide|mesh-list
43904823|NCT00189436|Albuterol|albuterol|mesh-list
43904824|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904825|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43904826|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
43904827|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904828|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904829|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43904830|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
43904831|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
43904832|NCT00189436|Hormones|hormones|mesh-ancestor
43904833|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904834|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
43654280|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904835|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904836|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43904837|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43904838|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43904839|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
43904840|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904841|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904842|NCT00189475|Montelukast|montelukast|mesh-list
43904843|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43904844|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
43904845|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43904846|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
43904847|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904848|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904849|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43904850|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43904862|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904863|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904864|NCT00193128|Docetaxel|docetaxel|mesh-list
43904865|NCT00193128|Capecitabine|capecitabine|mesh-list
43904866|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
43904867|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904868|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904869|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904870|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904871|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904872|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237846|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237847|NCT00565214|Protective Agents|protective agents|mesh-ancestor
44237848|NCT00565214|Trace Elements|trace elements|mesh-ancestor
44237849|NCT00565227|Docetaxel|docetaxel|mesh-list
44237850|NCT00565227|Vorinostat|vorinostat|mesh-list
44237851|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237852|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44237853|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44237854|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44237855|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237856|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44237857|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237858|NCT00565240|Letrozole|letrozole|mesh-list
44237859|NCT00565240|NuvaRing|nuvaring|mesh-list
44237860|NCT00565240|Desogestrel|desogestrel|mesh-list
44237861|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237862|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44237863|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44237864|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237865|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237866|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44237867|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
43877606|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904873|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
43904874|NCT00193258|Bevacizumab|bevacizumab|mesh-list
43904875|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43904876|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
43904877|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904878|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904879|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43904880|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43904881|NCT00193258|Growth Substances|growth substances|mesh-ancestor
43904882|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904883|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
43904884|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43904885|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904886|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904887|NCT00193375|Bevacizumab|bevacizumab|mesh-list
43904888|NCT00193375|Carboplatin|carboplatin|mesh-list
43904889|NCT00193375|Irinotecan|irinotecan|mesh-list
43904890|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904891|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904892|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43904893|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43904894|NCT00193375|Growth Substances|growth substances|mesh-ancestor
43904895|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904896|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
43904897|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43904898|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904899|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636377|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
43904900|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904902|NCT00193453|Docetaxel|docetaxel|mesh-list
43904903|NCT00193453|Cetuximab|cetuximab|mesh-list
44237868|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237869|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237870|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44237871|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
44237872|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44237873|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44237874|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44237875|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44237876|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44237877|NCT00565240|Progestins|progestins|mesh-ancestor
44237878|NCT00565240|Hormones|hormones|mesh-ancestor
44237879|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
44237880|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44237881|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
44237882|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237883|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904904|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904905|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
43904906|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904907|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904908|NCT00193453|Antiviral Agents|antiviral agents|mesh-ancestor
43904909|NCT00193453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904910|NCT00193453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904911|NCT00193453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904912|NCT00193453|Immunologic Factors|immunologic factors|mesh-ancestor
43904913|NCT00193453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904914|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904946|NCT00193596|Immunologic Factors|immunologic factors|mesh-ancestor
43904947|NCT00193596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904948|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43904949|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904950|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904951|NCT00194116|Valproic Acid|valproic acid|mesh-list
43904952|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
43904953|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904954|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904955|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
43904956|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904957|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904958|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
43904959|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904960|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138438|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44138439|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44138440|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
44138441|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138442|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44138443|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44138444|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138445|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138446|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138447|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138448|NCT00171106|Valsartan|valsartan|mesh-list
44138449|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138450|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138451|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237884|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978917|NCT01930487|Antioxidants|antioxidants|mesh-list
44237885|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
44237886|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44237887|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
44237888|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237889|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237890|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44237891|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44237892|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
44237893|NCT00565253|Protective Agents|protective agents|mesh-ancestor
44237894|NCT00565292|Anacetrapib|anacetrapib|mesh-list
43877709|NCT04697732|Anesthetics|anesthetics|mesh-list
44138452|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138469|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138470|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44138471|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
44138472|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
44138473|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138474|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44138475|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44138476|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44138477|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
44138478|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138479|NCT00171145|Darifenacin|darifenacin|mesh-list
44138480|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44138481|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44138482|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138483|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138484|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636539|NCT04887831|Gemcitabine|gemcitabine|mesh-list
44138485|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138486|NCT00171145|Urological Agents|urological agents|mesh-ancestor
44138487|NCT00171171|Deferasirox|deferasirox|mesh-list
44138488|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44138489|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
44138490|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
44138491|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138492|NCT00171184|Darifenacin|darifenacin|mesh-list
44138493|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44138494|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44138495|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138496|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138497|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138498|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138499|NCT00171184|Urological Agents|urological agents|mesh-ancestor
44138500|NCT00171288|Ezetimibe|ezetimibe|mesh-list
44138501|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44138502|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44138503|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
43654378|NCT02976246|Vitamin K|vitamin k|mesh-list
43904987|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
43904988|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43904989|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43904990|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905006|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905008|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905009|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905010|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905011|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905012|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905013|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
43905014|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905015|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237895|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44237896|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43890873|NCT01837862|Piperazine|piperazine|mesh-list
44237897|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
44237898|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237899|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44237900|NCT00565318|Benphothiamine|benphothiamine|mesh-list
44237901|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44237902|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
44237903|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905016|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905017|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
43905018|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43905019|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43905020|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43905021|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43905022|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905023|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905024|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
43905025|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43905026|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
43905027|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43905028|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
43905029|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43905030|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905031|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905032|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43905033|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43905034|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43905035|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
43905036|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905037|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905038|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43905039|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43905040|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43905041|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
43905042|NCT00194896|Glyburide|glyburide|mesh-list
43905043|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43905044|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905045|NCT00195039|Antibodies|antibodies|mesh-list
43905046|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43905047|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
43905048|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905049|NCT00195403|Etanercept|etanercept|mesh-list
43905050|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905074|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905075|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905076|NCT00195702|Adalimumab|adalimumab|mesh-list
43905077|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905078|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905079|NCT00197184|Vaccines|vaccines|mesh-list
43905080|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
43905081|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905082|NCT00198081|Celecoxib|celecoxib|mesh-list
43905083|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43905084|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905085|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905086|NCT00198081|Analgesics|analgesics|mesh-ancestor
43905087|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
43905088|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905089|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905090|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905091|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905092|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43905093|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237904|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
44237905|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
43877839|NCT04695925|Carboplatin|carboplatin|mesh-list
43905094|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905095|NCT00200161|Temozolomide|temozolomide|mesh-list
43905096|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905097|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
43905098|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905099|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905100|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43785539|NCT04701060|Apatinib|apatinib|mesh-list
43905122|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
43905123|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905124|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
43905125|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905127|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
43905128|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905129|NCT00201734|Paclitaxel|paclitaxel|mesh-list
43905130|NCT00201734|Carboplatin|carboplatin|mesh-list
43905131|NCT00201734|Capecitabine|capecitabine|mesh-list
43905132|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905133|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905134|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905135|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905136|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905137|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905138|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905140|NCT00201760|Gemcitabine|gemcitabine|mesh-list
43905141|NCT00201760|Cisplatin|cisplatin|mesh-list
43905142|NCT00201760|Trastuzumab|trastuzumab|mesh-list
43905143|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905144|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905145|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
43905146|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905147|NCT00201760|Antiviral Agents|antiviral agents|mesh-ancestor
43905148|NCT00201760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905149|NCT00201760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905150|NCT00201760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905151|NCT00201760|Immunologic Factors|immunologic factors|mesh-ancestor
43905152|NCT00201760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905153|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905185|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905187|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905188|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905189|NCT00201838|Antiviral Agents|antiviral agents|mesh-ancestor
43905190|NCT00201838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905191|NCT00201838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905192|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905193|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
43905194|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905195|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905226|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905227|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905228|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905229|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905231|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905232|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43905233|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
43905234|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905235|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43905236|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43905237|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785594|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
43905257|NCT00203216|Levetiracetam|levetiracetam|mesh-list
43905258|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
43905259|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
43905260|NCT00203229|Lamotrigine|lamotrigine|mesh-list
43905261|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
43905262|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43905263|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905264|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237906|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237908|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44237909|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237910|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
44237911|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237912|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237913|NCT00565383|Fentanyl|fentanyl|mesh-list
44237914|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44237915|NCT00565383|Narcotics|narcotics|mesh-ancestor
44237916|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44237917|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237918|NCT00565383|Analgesics|analgesics|mesh-ancestor
44237919|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
44237920|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237921|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43905265|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43905266|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905267|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43905268|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43905269|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905270|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905271|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43905272|NCT00203931|Pemetrexed|pemetrexed|mesh-list
43905273|NCT00203931|Cetuximab|cetuximab|mesh-list
43905274|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905275|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905276|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905277|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43905278|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905279|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905280|NCT00204373|Lansoprazole|lansoprazole|mesh-list
43905281|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
43905282|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43905283|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905284|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43905285|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905286|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905288|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
43905289|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905290|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905291|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905292|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
43905293|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43905294|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43905312|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
43905313|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905314|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905315|NCT00208026|Analgesics|analgesics|mesh-ancestor
43905316|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
43905317|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905318|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905319|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905320|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905321|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
43905322|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905323|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
43905324|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44237922|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44237923|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
44237924|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
44237925|NCT00565396|Losartan|losartan|mesh-list
44237926|NCT00565396|Fosinopril|fosinopril|mesh-list
43905325|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905326|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905327|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
43905328|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43905329|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905330|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905331|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
43905332|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905333|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905334|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
43905336|NCT00208975|Fludarabine|fludarabine|mesh-list
43905337|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
43905338|NCT00208975|Sargramostim|sargramostim|mesh-list
43905339|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905340|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
43905341|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905342|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905343|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905344|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
43979198|NCT01941927|Trametinib|trametinib|mesh-list
43905345|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905346|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905347|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43905348|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905349|NCT00208975|Analgesics|analgesics|mesh-ancestor
43905350|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
43905351|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905385|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905387|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
43905388|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905389|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905390|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
43905391|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
43905392|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785721|NCT03522246|Rucaparib|rucaparib|mesh-list
43905420|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905421|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43905422|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43905423|NCT00215787|Lansoprazole|lansoprazole|mesh-list
43905424|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
43905425|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43905426|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905427|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43905428|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905429|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905430|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
43905431|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43905432|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905433|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905434|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43905435|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905436|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43905437|NCT00216099|Folic Acid|folic acid|mesh-list
43905438|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
43905439|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
43905440|NCT00216099|Pemetrexed|pemetrexed|mesh-list
43905441|NCT00216099|Vitamins|vitamins|mesh-ancestor
43905442|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
43905468|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905470|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43905471|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43905472|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43905473|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
43905474|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905475|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905476|NCT00217438|Melphalan|melphalan|mesh-list
43905477|NCT00217438|Amifostine|amifostine|mesh-list
44237928|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237929|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237930|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237931|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237932|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44237933|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
44237934|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237935|NCT00565422|Citalopram|citalopram|mesh-list
44237936|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44237937|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44237938|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44237939|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237940|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237941|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
43878016|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
43905478|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905479|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
43905480|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905481|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905482|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43905483|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905484|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
43905485|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905486|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43905487|NCT00217438|Protective Agents|protective agents|mesh-ancestor
43905488|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
43905489|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905490|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905491|NCT00218023|Naltrexone|naltrexone|mesh-list
43905492|NCT00218023|Levodopa|levodopa|mesh-list
43905527|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905528|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905529|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43905530|NCT00218387|Modafinil|modafinil|mesh-list
43905554|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43905555|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43905556|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905557|NCT00218465|Glycine|glycine|mesh-list
43905558|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
43905559|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905560|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905561|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905562|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
43905563|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43905564|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
43905565|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905566|NCT00218491|Expectorants|expectorants|mesh-ancestor
43637218|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
43905567|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
43905568|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43905569|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
43905570|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905571|NCT00218491|Protective Agents|protective agents|mesh-ancestor
43905572|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905573|NCT00218491|Antidotes|antidotes|mesh-ancestor
43905574|NCT00220961|Pioglitazone|pioglitazone|mesh-list
44237942|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878072|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905575|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43905576|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905577|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
43905604|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905605|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43905606|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905607|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905608|NCT00223236|Choline|choline|mesh-list
43905609|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43905610|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
43905611|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43905612|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
43905613|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905614|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905615|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43905616|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
43905617|NCT00223262|Lamotrigine|lamotrigine|mesh-list
43905618|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
43905619|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43905620|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905621|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905622|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43905658|NCT00223704|Analgesics|analgesics|mesh-ancestor
43905659|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
43905671|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
43905672|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905673|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905674|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43905675|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43905676|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
43905677|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905678|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905679|NCT00223821|Urological Agents|urological agents|mesh-ancestor
43905680|NCT00224289|Latanoprost|latanoprost|mesh-list
43905681|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43905682|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43905683|NCT00224952|Carbamazepine|carbamazepine|mesh-list
43905684|NCT00224952|Valproic Acid|valproic acid|mesh-list
43905685|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
43905686|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905687|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905688|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
43905689|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905690|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905691|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
43905692|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43905693|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905694|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905695|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905696|NCT00224952|Analgesics|analgesics|mesh-ancestor
43905697|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
43905698|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905699|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43905700|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905701|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43905702|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43905703|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43905704|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43905705|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43905706|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43905707|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
43905708|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905709|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905710|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43905711|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
43905712|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905713|NCT00225420|Docetaxel|docetaxel|mesh-list
43905714|NCT00225420|Leuprolide|leuprolide|mesh-list
43905715|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905716|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905717|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
44237943|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44237944|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
44237945|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44237946|NCT00565461|Vaccines|vaccines|mesh-list
44237947|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
44237948|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237949|NCT00565487|Capecitabine|capecitabine|mesh-list
44237950|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44237951|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44237952|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
44237953|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237954|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237955|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44237956|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905718|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905719|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905720|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43905721|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
43905722|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43905723|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905724|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905737|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43905738|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
43905739|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
43905740|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
43905741|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905742|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905743|NCT00225498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43905744|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905745|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905746|NCT00225732|Ibuprofen|ibuprofen|mesh-list
43905747|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905748|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905749|NCT00225732|Analgesics|analgesics|mesh-ancestor
43905750|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
43905751|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905752|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905753|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905754|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905755|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43905756|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905757|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905758|NCT00225784|Gemcitabine|gemcitabine|mesh-list
43905759|NCT00225784|Cetuximab|cetuximab|mesh-list
43905760|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905761|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
43905762|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905763|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905764|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
43905765|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905766|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905767|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905768|NCT00225784|Immunologic Factors|immunologic factors|mesh-ancestor
43905769|NCT00225784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905770|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905771|NCT00226239|Cisplatin|cisplatin|mesh-list
43905772|NCT00226239|Docetaxel|docetaxel|mesh-list
43905773|NCT00226239|Cetuximab|cetuximab|mesh-list
43905774|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905775|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905776|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
44237957|NCT00565500|Ibuprofen|ibuprofen|mesh-list
44237958|NCT00565500|Celecoxib|celecoxib|mesh-list
44237959|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44237960|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44237961|NCT00565500|Analgesics|analgesics|mesh-ancestor
44237962|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
44237963|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237964|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237965|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237966|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237967|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44237968|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237969|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237970|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44237972|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237973|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
44237974|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237975|NCT00565591|Albuterol|albuterol|mesh-list
44237976|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44237977|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
44136069|NCT00163254|Abciximab|abciximab|mesh-list
43905777|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905778|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905779|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905784|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905785|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905786|NCT00226577|Antiviral Agents|antiviral agents|mesh-ancestor
43905787|NCT00226577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905788|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905789|NCT00226577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905790|NCT00226577|Immunologic Factors|immunologic factors|mesh-ancestor
43905791|NCT00226577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905792|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43905793|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905794|NCT00226590|Gemcitabine|gemcitabine|mesh-list
43905795|NCT00226590|Paclitaxel|paclitaxel|mesh-list
43905796|NCT00226590|Carboplatin|carboplatin|mesh-list
43905797|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905798|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905799|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905800|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905801|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905802|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905803|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905804|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
43905805|NCT00226590|Antiviral Agents|antiviral agents|mesh-ancestor
43905806|NCT00226590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905807|NCT00226590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905808|NCT00226590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905809|NCT00226590|Immunologic Factors|immunologic factors|mesh-ancestor
43905810|NCT00226590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905811|NCT00227019|Vitamins|vitamins|mesh-list
43905812|NCT00227019|Folic Acid|folic acid|mesh-list
43905813|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
43905814|NCT00227019|Hydroxocobalamin|hydroxocobalamin|mesh-list
43905815|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
44237978|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237979|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237980|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44237981|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
43905816|NCT00227019|Dexamethasone|dexamethasone|mesh-list
43905817|NCT00227019|Bevacizumab|bevacizumab|mesh-list
43905818|NCT00227019|Pemetrexed|pemetrexed|mesh-list
43905819|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905820|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905821|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43905822|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43905823|NCT00227019|Growth Substances|growth substances|mesh-ancestor
43905824|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905825|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
43905826|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
43905827|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905828|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
43905829|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
43905830|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905831|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905832|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
43905833|NCT00227019|Hormones|hormones|mesh-ancestor
43905834|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905835|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905836|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905837|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905838|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43905839|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905840|NCT00227019|Hematinics|hematinics|mesh-ancestor
43905841|NCT00227617|Leucovorin|leucovorin|mesh-list
43905842|NCT00227617|Bevacizumab|bevacizumab|mesh-list
43905843|NCT00227617|Fluorouracil|fluorouracil|mesh-list
43905844|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
43905845|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905846|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905847|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43905848|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43905849|NCT00227617|Growth Substances|growth substances|mesh-ancestor
43905850|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905851|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
43905852|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
43786065|NCT04169828|Vitamins|vitamins|mesh-ancestor
43905878|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
43905879|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905881|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43905882|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
43905883|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905884|NCT00229619|Rituximab|rituximab|mesh-list
43905885|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905886|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905887|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
43905888|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905889|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905890|NCT00215930|Gemcitabine|gemcitabine|mesh-list
43905891|NCT00215930|Carboplatin|carboplatin|mesh-list
43905892|NCT00215930|Docetaxel|docetaxel|mesh-list
43905893|NCT00215930|Vinorelbine|vinorelbine|mesh-list
43905894|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905895|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905896|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
43905897|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905898|NCT00215930|Antiviral Agents|antiviral agents|mesh-ancestor
43905899|NCT00215930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905900|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905901|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905902|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
43905903|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905928|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905929|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905930|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
43801588|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
44237982|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
44237983|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43905931|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905933|NCT00232479|Docetaxel|docetaxel|mesh-list
43905934|NCT00232479|Trastuzumab|trastuzumab|mesh-list
43905935|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905936|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905937|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905938|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905939|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905940|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905941|NCT00232505|Carboplatin|carboplatin|mesh-list
43905942|NCT00232505|Cetuximab|cetuximab|mesh-list
43905943|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905944|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905945|NCT00232583|Metformin|metformin|mesh-list
43905946|NCT00232583|Pioglitazone|pioglitazone|mesh-list
43905947|NCT00232583|Glyburide|glyburide|mesh-list
43905948|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43905949|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905950|NCT00232739|Sirolimus|sirolimus|mesh-list
43905951|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43905952|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905953|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43905983|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905984|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905985|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
43905986|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
43905987|NCT00235573|Vitamins|vitamins|mesh-ancestor
43905988|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
43905989|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905990|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
43905991|NCT00235573|Hematinics|hematinics|mesh-ancestor
43905992|NCT00235833|Adalimumab|adalimumab|mesh-list
43905993|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905994|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905995|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
43905996|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43905997|NCT00236938|Hematinics|hematinics|mesh-ancestor
43905998|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
43905999|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43906000|NCT00236951|Hematinics|hematinics|mesh-ancestor
43906001|NCT00236977|Iron|iron|mesh-list
43906002|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43906003|NCT00236977|Trace Elements|trace elements|mesh-ancestor
43906016|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906017|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43906018|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
43906019|NCT00237718|Vitamin E|vitamin e|mesh-list
43906020|NCT00237718|Tocopherols|tocopherols|mesh-list
43906021|NCT00237718|Tocotrienols|tocotrienols|mesh-list
43906022|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
43906023|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
43906024|NCT00237718|Vitamins|vitamins|mesh-ancestor
43906025|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
43906026|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906027|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
43906028|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906029|NCT00237718|Protective Agents|protective agents|mesh-ancestor
43906030|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
43655226|NCT02970539|Paclitaxel|paclitaxel|mesh-list
43906031|NCT00238108|Melatonin|melatonin|mesh-list
43906032|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
43906033|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906034|NCT00238108|Protective Agents|protective agents|mesh-ancestor
43906035|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906036|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906037|NCT00238355|Voriconazole|voriconazole|mesh-list
43906038|NCT00238355|Caspofungin|caspofungin|mesh-list
43906039|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
43906040|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906041|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43906042|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43906043|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906044|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906045|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43906046|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
43801626|NCT04626128|Aflibercept|aflibercept|mesh-list
44237984|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44237985|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44237986|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44237987|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
44237988|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44237989|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237990|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
44237991|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44237992|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237993|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237994|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906047|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906048|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906049|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43906050|NCT00238615|Carboplatin|carboplatin|mesh-list
43906052|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906053|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
43906054|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906055|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906056|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906057|NCT00239642|Iron|iron|mesh-list
43906058|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43906059|NCT00239642|Trace Elements|trace elements|mesh-ancestor
43906060|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
43906061|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906062|NCT00239642|Hematinics|hematinics|mesh-ancestor
43906063|NCT00240162|Vatalanib|vatalanib|mesh-list
43906064|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906065|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906066|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906067|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
43906091|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906093|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906094|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906095|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43906096|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906097|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906098|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906099|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
43906100|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
43906101|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906102|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906103|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43906104|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43906105|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
43906106|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43906107|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43655234|NCT02970604|Aspirin|aspirin|mesh-list
43906108|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43906109|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43906110|NCT00241904|Propranolol|propranolol|mesh-list
43906111|NCT00241904|Metoprolol|metoprolol|mesh-list
43906112|NCT00241904|Atenolol|atenolol|mesh-list
43906113|NCT00241904|Lisinopril|lisinopril|mesh-list
43906114|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43906115|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43906116|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43906117|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43906142|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906143|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43906144|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906145|NCT00242502|Growth Substances|growth substances|mesh-ancestor
44237995|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237996|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237997|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237998|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237999|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44238000|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
44238001|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44238002|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238003|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44238004|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43906146|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906147|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
43906148|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906149|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906150|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906151|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
43906152|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43906153|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906155|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43906156|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43906157|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
43906158|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906159|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906160|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906161|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43906162|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43906164|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906165|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906183|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906184|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906186|NCT00244985|Doxorubicin|doxorubicin|mesh-list
43906187|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43906188|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906189|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906190|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
43979667|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
43906191|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906192|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906193|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43906194|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906195|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906196|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906197|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906198|NCT00245557|Sertraline|sertraline|mesh-list
43906199|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906200|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906201|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906202|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906203|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906204|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906205|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906206|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
43906207|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906208|NCT00245635|Fluoxetine|fluoxetine|mesh-list
43906209|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906210|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906211|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906212|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906213|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906214|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
43906215|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238005|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44238007|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906216|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43906217|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906218|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786322|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
43906243|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906244|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43906245|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906246|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906247|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43906248|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
43906249|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
43906250|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906251|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43906252|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43906253|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43906254|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
43906255|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906256|NCT00247624|Eszopiclone|eszopiclone|mesh-list
43906257|NCT00247624|Fluoxetine|fluoxetine|mesh-list
43906258|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906259|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43979733|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906260|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906261|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906262|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906263|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
43637972|NCT04352101|Citalopram|citalopram|mesh-list
43906265|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43906266|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906276|NCT00248534|Prednisolone|prednisolone|mesh-list
43906277|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
43906278|NCT00248534|Rituximab|rituximab|mesh-list
43906279|NCT00248534|Temozolomide|temozolomide|mesh-list
43906280|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43906281|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
43906282|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906283|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906284|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
43906285|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906286|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906287|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906288|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
43906289|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906290|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906291|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
43906292|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
43906293|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906294|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906295|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
43906296|NCT00248534|Hormones|hormones|mesh-ancestor
43906297|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906298|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43906299|NCT00248534|Protective Agents|protective agents|mesh-ancestor
43906300|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906302|NCT00248547|Ondansetron|ondansetron|mesh-list
43906303|NCT00248547|Aprepitant|aprepitant|mesh-list
43906304|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906305|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
43906306|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
43906307|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906308|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906309|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906310|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
43906311|NCT00248547|Hormones|hormones|mesh-ancestor
43906312|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906313|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906314|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906315|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
43906316|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238008|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238009|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238010|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238011|NCT00565656|Growth Substances|growth substances|mesh-ancestor
43878495|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43906317|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43906318|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
43906319|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906320|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906321|NCT00248547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43906322|NCT00248547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906323|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906324|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906325|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43906326|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43906327|NCT00248560|Gemcitabine|gemcitabine|mesh-list
43906328|NCT00248560|Docetaxel|docetaxel|mesh-list
43906329|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906330|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
43906331|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906332|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906357|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906358|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43906359|NCT00249249|Atorvastatin|atorvastatin|mesh-list
43906360|NCT00249249|Pitavastatin|pitavastatin|mesh-list
43906361|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43906362|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43906363|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
43906364|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906365|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43906366|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43906367|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906368|NCT00249379|Acamprosate|acamprosate|mesh-list
43906369|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43906370|NCT00250926|Dexamethasone|dexamethasone|mesh-list
43906371|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
43906373|NCT00250926|Bortezomib|bortezomib|mesh-list
43906374|NCT00250926|BB 1101|bb 1101|mesh-list
43906375|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906376|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906377|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
43906378|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906379|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906380|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906381|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
43906390|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906391|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906392|NCT00251225|Docetaxel|docetaxel|mesh-list
43906393|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
43906394|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906395|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
43906396|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906397|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906398|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906399|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906400|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906401|NCT00251303|Riluzole|riluzole|mesh-list
43906402|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
43906403|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43906404|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43906405|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906406|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906407|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906408|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43906409|NCT00251303|Protective Agents|protective agents|mesh-ancestor
43906410|NCT00252967|Atorvastatin|atorvastatin|mesh-list
43906411|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43906412|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43906413|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
43906414|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238012|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906415|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43906416|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43906417|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138508|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138509|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138510|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138512|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138513|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138514|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138515|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157272|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44157273|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
44157274|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157275|NCT00234000|Azacitidine|azacitidine|mesh-list
44157276|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
44157277|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157278|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
44157279|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157280|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157281|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157282|NCT00234026|Gemcitabine|gemcitabine|mesh-list
44157283|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157284|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
44157285|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157286|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157287|NCT00234026|Antiviral Agents|antiviral agents|mesh-ancestor
44157288|NCT00234026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157289|NCT00234026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157290|NCT00234026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157291|NCT00234026|Immunologic Factors|immunologic factors|mesh-ancestor
44157308|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
44157309|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157310|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44157311|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157312|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44157313|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157314|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
44157315|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44157316|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44157317|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44157318|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44157319|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44157321|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44157322|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44157323|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43906418|NCT00253435|Carboplatin|carboplatin|mesh-list
43906419|NCT00253435|Etoposide|etoposide|mesh-list
43906420|NCT00253435|Melphalan|melphalan|mesh-list
43906421|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906422|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43906423|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906424|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906425|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906426|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906427|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
43906428|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906429|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906430|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
43906431|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906432|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906433|NCT00253513|Fludarabine|fludarabine|mesh-list
43906434|NCT00253513|Treosulfan|treosulfan|mesh-list
43906435|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906436|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906437|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906438|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
43906439|NCT00253890|Trazodone|trazodone|mesh-list
43906440|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43906441|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238013|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238014|NCT00565682|Etoricoxib|etoricoxib|mesh-list
44238015|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238016|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238017|NCT00565682|Analgesics|analgesics|mesh-ancestor
44238018|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
44238019|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238020|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238021|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238022|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238023|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44238024|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44238025|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878577|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43906442|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906443|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906444|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906445|NCT00253890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906446|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906473|NCT00254488|Valproic Acid|valproic acid|mesh-list
43906474|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906475|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906476|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906477|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
43906478|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906479|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906480|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906481|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
43906482|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
43906483|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906484|NCT00254592|Paclitaxel|paclitaxel|mesh-list
43906485|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43906486|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
43906487|NCT00254592|Bevacizumab|bevacizumab|mesh-list
43906488|NCT00254592|Carboplatin|carboplatin|mesh-list
43906489|NCT00254592|Doxorubicin|doxorubicin|mesh-list
43906490|NCT00254592|Trastuzumab|trastuzumab|mesh-list
43906491|NCT00254592|Sargramostim|sargramostim|mesh-list
43906492|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43906493|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906494|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
43786600|NCT03096041|Analgesics|analgesics|mesh-list
43906504|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906505|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906506|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43906507|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906508|NCT00254592|Growth Substances|growth substances|mesh-ancestor
43906510|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43906511|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906512|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906513|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906514|NCT00255177|Mifepristone|mifepristone|mesh-list
43906515|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43906516|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
43906517|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43906518|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906519|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43906520|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43906521|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43906522|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
43906523|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43801627|NCT04626128|Axitinib|axitinib|mesh-list
44238026|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458920|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44458921|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458922|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44458923|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
44458924|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458925|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458926|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458927|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458928|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458929|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458930|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
43906524|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43906525|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
43906526|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906527|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
43906528|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43906529|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43906530|NCT00255684|Cyclosporine|cyclosporine|mesh-list
43906531|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
43906532|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
43906533|NCT00255684|Fludarabine|fludarabine|mesh-list
43906534|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
43906535|NCT00255684|Cyclosporins|cyclosporins|mesh-list
43906536|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906537|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
43906538|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906539|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906540|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906541|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
43906542|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906543|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906544|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906545|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906546|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
43906547|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906548|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
43906549|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906550|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
43906551|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43906552|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43906553|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43906554|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
43906555|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43906556|NCT00255801|Doxorubicin|doxorubicin|mesh-list
43906557|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43906558|NCT00255801|Bexarotene|bexarotene|mesh-list
43786648|NCT02680561|Xhance|xhance|mesh-list
43906564|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906566|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906567|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906568|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43906569|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43906570|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906571|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906572|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43906573|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
43906574|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906575|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906577|NCT00256451|Naltrexone|naltrexone|mesh-list
43906578|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44458931|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458932|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44458934|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43878692|NCT04681937|Prednisolone|prednisolone|mesh-list
43906579|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906580|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906581|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906582|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43906583|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43906584|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
43906585|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906586|NCT00256776|Thalidomide|thalidomide|mesh-list
43906587|NCT00256776|Dexamethasone|dexamethasone|mesh-list
43906588|NCT00256776|Bortezomib|bortezomib|mesh-list
43906589|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906590|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
43906591|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
43906592|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906593|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906594|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906595|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
43906596|NCT00256776|Hormones|hormones|mesh-ancestor
43906597|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906598|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906599|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906600|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906601|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
43906602|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
43906603|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43906604|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906605|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43906606|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906607|NCT00256776|Growth Substances|growth substances|mesh-ancestor
43906608|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
43906609|NCT00257309|Tenecteplase|tenecteplase|mesh-list
43906610|NCT00257309|Clopidogrel|clopidogrel|mesh-list
43906611|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43906612|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43906613|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43906614|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43906615|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
43906616|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906617|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906618|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906619|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43906620|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43906621|NCT00257686|Pravastatin|pravastatin|mesh-list
43906622|NCT00257686|Pitavastatin|pitavastatin|mesh-list
43906623|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43906624|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43906625|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
43906626|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786717|NCT02384577|Hormones|hormones|mesh-ancestor
43906631|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906632|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43906633|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43906634|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906635|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43906636|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
43906638|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906639|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906640|NCT00257933|Prednisolone|prednisolone|mesh-list
43906641|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43906642|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
43906643|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43906644|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
43906645|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43906646|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
43906647|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906648|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
43891046|NCT05003258|Hormones|hormones|mesh-ancestor
44238028|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238029|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238030|NCT00565708|Analgesics|analgesics|mesh-ancestor
44238031|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
44238032|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238033|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238034|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238035|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238036|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44238037|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43906650|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906651|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906652|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906653|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906654|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
43906655|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
43906656|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906657|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906658|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43906659|NCT00257933|Protective Agents|protective agents|mesh-ancestor
43906660|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43906661|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43906662|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43906663|NCT00258128|Analgesics|analgesics|mesh-ancestor
43906664|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
43906665|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906666|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906667|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906668|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906669|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
43906670|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906671|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
43906672|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906673|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906674|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906675|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
43906676|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906677|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906678|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906679|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
43906680|NCT00258206|Rituximab|rituximab|mesh-list
43906681|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906682|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
43906683|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906684|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906685|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906686|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
43906687|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906688|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906689|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906690|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906691|NCT00258310|Capecitabine|capecitabine|mesh-list
43906692|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906693|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
43906694|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906695|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906696|NCT00258349|Trastuzumab|trastuzumab|mesh-list
43906724|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906725|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44238038|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238039|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44238040|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44238041|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238042|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
44238043|NCT00565955|Montelukast|montelukast|mesh-list
44238044|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44238045|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238046|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44238047|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
43906726|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43906727|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906728|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906729|NCT00259285|Cisplatin|cisplatin|mesh-list
43906730|NCT00259285|Pemetrexed|pemetrexed|mesh-list
43906731|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906732|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906733|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906734|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43906735|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43906736|NCT00260689|Cyclosporine|cyclosporine|mesh-list
43906737|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
43906738|NCT00260689|Cyclosporins|cyclosporins|mesh-list
43906739|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43906740|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
43906741|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906742|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906751|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906752|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906754|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
43906755|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
43906756|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906757|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906758|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906759|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43906760|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906761|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906762|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906763|NCT00260962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906764|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906765|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906766|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906767|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906768|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
43906769|NCT00262639|Gabapentin|gabapentin|mesh-list
43906770|NCT00262639|Flumazenil|flumazenil|mesh-list
43906771|NCT00262639|Analgesics|analgesics|mesh-ancestor
43906772|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
43906773|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906774|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906775|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
43906776|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43906777|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906778|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906779|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906780|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43906781|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43906782|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906783|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906784|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
43906785|NCT00262639|Antidotes|antidotes|mesh-ancestor
43906786|NCT00262639|Protective Agents|protective agents|mesh-ancestor
43906787|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
43906788|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
43906789|NCT00262730|Temozolomide|temozolomide|mesh-list
44238048|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238049|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906790|NCT00262730|Poly ICLC|poly iclc|mesh-list
43906791|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906792|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
43906793|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906794|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906795|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
43906796|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
43906797|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906798|NCT00262964|Niacin|niacin|mesh-list
43906799|NCT00262964|Fenofibrate|fenofibrate|mesh-list
43906800|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43906801|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
43906802|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906803|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43906804|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
43906805|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
43906806|NCT00262964|Vitamins|vitamins|mesh-ancestor
43906807|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
43906808|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906809|NCT00264381|Dalteparin|dalteparin|mesh-list
43906810|NCT00264381|Tinzaparin|tinzaparin|mesh-list
43906814|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43906815|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906817|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43906818|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43906819|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906820|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
43906821|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43906822|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906823|NCT00265616|Pentobarbital|pentobarbital|mesh-list
43906824|NCT00265616|Thiopental|thiopental|mesh-list
43906825|NCT00265616|Propofol|propofol|mesh-list
43906826|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43906827|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906828|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906829|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43906830|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
43906831|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
43906832|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
43906833|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
43906834|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
43906835|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906836|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906837|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43906838|NCT00265850|Leucovorin|leucovorin|mesh-list
43906839|NCT00265850|Folic Acid|folic acid|mesh-list
43906840|NCT00265850|Bevacizumab|bevacizumab|mesh-list
43906841|NCT00265850|Cetuximab|cetuximab|mesh-list
43906842|NCT00265850|Fluorouracil|fluorouracil|mesh-list
43906843|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
43906844|NCT00265850|Irinotecan|irinotecan|mesh-list
43906845|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
43906846|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906847|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906848|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43906849|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906850|NCT00265850|Growth Substances|growth substances|mesh-ancestor
43906851|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906852|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
43906853|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
43906854|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906855|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906856|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906857|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
43906858|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43906859|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906860|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906861|NCT00265850|Antidotes|antidotes|mesh-ancestor
43906862|NCT00265850|Protective Agents|protective agents|mesh-ancestor
43906863|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
43906864|NCT00265850|Vitamins|vitamins|mesh-ancestor
43906865|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
43906866|NCT00265850|Hematinics|hematinics|mesh-ancestor
43906867|NCT00266110|Trastuzumab|trastuzumab|mesh-list
44238050|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43906868|NCT00266110|Vinorelbine|vinorelbine|mesh-list
43906869|NCT00266110|Sargramostim|sargramostim|mesh-list
43906870|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906871|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906872|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43906873|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
43906874|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906875|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906876|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906877|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
43906878|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906879|NCT00266279|Capecitabine|capecitabine|mesh-list
43906880|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
43906881|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906882|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
43906883|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906884|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906885|NCT00266799|Doxorubicin|doxorubicin|mesh-list
43906897|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43906898|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906899|NCT00267059|Lenalidomide|lenalidomide|mesh-list
43906900|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
43906901|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906902|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43906903|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906904|NCT00267059|Growth Substances|growth substances|mesh-ancestor
43906905|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
43906906|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906907|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
43906908|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906909|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906910|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906911|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906912|NCT00267111|Tetracaine|tetracaine|mesh-list
43906913|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
43906914|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
43906915|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906916|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906917|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
43906918|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906919|NCT00267293|Acetaminophen|acetaminophen|mesh-list
43906920|NCT00267293|Ibuprofen|ibuprofen|mesh-list
43906921|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43906922|NCT00267293|Analgesics|analgesics|mesh-ancestor
43906923|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
43906924|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906925|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906926|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
43906927|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43906928|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43906929|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906930|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43906931|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906932|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906933|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
43906934|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43906935|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906936|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906937|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43906938|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43906939|NCT00267670|Protective Agents|protective agents|mesh-ancestor
43906940|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906941|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
43906942|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43906943|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
43906944|NCT00267696|Gemcitabine|gemcitabine|mesh-list
43906945|NCT00267696|Bevacizumab|bevacizumab|mesh-list
43906946|NCT00267696|Carboplatin|carboplatin|mesh-list
43906947|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906948|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906949|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238051|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44238052|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238053|NCT00565968|Sorafenib|sorafenib|mesh-list
44238054|NCT00565968|Melphalan|melphalan|mesh-list
44238055|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906956|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906958|NCT00267696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906959|NCT00267696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906960|NCT00267696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906961|NCT00267696|Immunologic Factors|immunologic factors|mesh-ancestor
43906962|NCT00268762|Argatroban|argatroban|mesh-list
43906963|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
43906964|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43906965|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
43906966|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906967|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906968|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
43906969|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43906970|NCT00270296|Ritonavir|ritonavir|mesh-list
43906971|NCT00270296|Lopinavir|lopinavir|mesh-list
43906972|NCT00270296|Lamivudine|lamivudine|mesh-list
43906973|NCT00270296|Zidovudine|zidovudine|mesh-list
43906974|NCT00270296|Nevirapine|nevirapine|mesh-list
43906975|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43906976|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43906977|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43906978|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
43906979|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906980|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906981|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43906982|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43906983|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
43906984|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906985|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43906986|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43906987|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43906988|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43906989|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
43906990|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43906991|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43906992|NCT00270634|Tacrolimus|tacrolimus|mesh-list
43906993|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906994|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
43906995|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906996|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43906997|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906998|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906999|NCT00270790|Carboplatin|carboplatin|mesh-list
43907000|NCT00270790|Amifostine|amifostine|mesh-list
43907001|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907002|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43907003|NCT00270790|Protective Agents|protective agents|mesh-ancestor
43907004|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907005|NCT00271219|Buprenorphine|buprenorphine|mesh-list
43907006|NCT00271219|Methadone|methadone|mesh-list
43907007|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43907009|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43907010|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907011|NCT00271219|Analgesics|analgesics|mesh-ancestor
43907012|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
43907013|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907014|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43907015|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
43907016|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
43907017|NCT00271570|Infliximab|infliximab|mesh-list
43907018|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
43907019|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43907025|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
43907026|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907027|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907029|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238056|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238057|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238058|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238059|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44238060|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
44238061|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44238062|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907030|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907031|NCT00272311|Analgesics|analgesics|mesh-ancestor
43907032|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
43907033|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907034|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907035|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907036|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907037|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43907038|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43907039|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907040|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43907041|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43907042|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907043|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
43907044|NCT00272337|Aspirin|aspirin|mesh-list
43907045|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43907046|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907047|NCT00272337|Analgesics|analgesics|mesh-ancestor
43907048|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
43907049|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907050|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907051|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907052|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907053|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43907054|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43907055|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907056|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43907057|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43907058|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907059|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
43907060|NCT00273754|Caffeine|caffeine|mesh-list
43907061|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43907062|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907063|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43907064|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907065|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907066|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43907067|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43907068|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
43907069|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907070|NCT00273910|Imiquimod|imiquimod|mesh-list
43907071|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43907072|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43907073|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
43907074|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907075|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907076|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
43907077|NCT00274768|Capecitabine|capecitabine|mesh-list
43907078|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907079|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
43907080|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907081|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907082|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
43907083|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
43907084|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907085|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907086|NCT00277394|Heparin|heparin|mesh-list
43907087|NCT00277394|Tinzaparin|tinzaparin|mesh-list
43907088|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
43907100|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238063|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
44238064|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238065|NCT00565981|Fludarabine|fludarabine|mesh-list
44238066|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
43907101|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907102|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
43907103|NCT00280241|Rituximab|rituximab|mesh-list
43907104|NCT00280241|Fludarabine|fludarabine|mesh-list
43907105|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907106|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
43907107|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907108|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907109|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43907110|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
43907111|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907112|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907113|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43907114|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907115|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43907116|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
43907117|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43907118|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43907119|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43907120|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907121|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907122|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
43907123|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907124|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907125|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43907126|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907127|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44138516|NCT00171366|Amlodipine|amlodipine|mesh-list
44138517|NCT00171366|Benazepril|benazepril|mesh-list
44138518|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138519|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138520|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138521|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138522|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138523|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138524|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138525|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44138526|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44138527|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138528|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
44138529|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44138530|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138531|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44138532|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
44138533|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44138534|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138535|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840505|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138553|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138554|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
44138555|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138556|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907128|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43907130|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907131|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907132|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907133|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907134|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43907135|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43907136|NCT00281021|Protective Agents|protective agents|mesh-ancestor
43907137|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907138|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43907139|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
43907140|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907141|NCT00281827|Gemcitabine|gemcitabine|mesh-list
44238067|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
44238068|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907142|NCT00281827|Thalidomide|thalidomide|mesh-list
43907143|NCT00281827|Carboplatin|carboplatin|mesh-list
43907144|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907145|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907146|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
43907147|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907148|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
43907149|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907150|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907151|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907152|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
43907153|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907154|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
43907155|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907156|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907157|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907158|NCT00281827|Growth Substances|growth substances|mesh-ancestor
43907159|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907160|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
43907161|NCT00281918|Rituximab|rituximab|mesh-list
43907162|NCT00281918|Fludarabine|fludarabine|mesh-list
43907163|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
43907176|NCT00282282|Sirolimus|sirolimus|mesh-list
43907177|NCT00282282|Fludarabine|fludarabine|mesh-list
43907178|NCT00282282|Busulfan|busulfan|mesh-list
43907179|NCT00282282|Tacrolimus|tacrolimus|mesh-list
43907180|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907181|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907182|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907183|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
43907184|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907185|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43907186|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907187|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907188|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907189|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43907190|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
43907191|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
43907192|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43907193|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43907195|NCT00282828|Sertraline|sertraline|mesh-list
43907196|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43907197|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
43907198|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907199|NCT00282828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43907200|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907201|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907202|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907203|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907204|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
43907205|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907206|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43907207|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43907208|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
43907209|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
43907210|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
43907211|NCT00282971|Insulin|insulin|mesh-list
43907212|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43907213|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907214|NCT00283504|Omalizumab|omalizumab|mesh-list
43907215|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43907216|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43907217|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
43907218|NCT00283816|Metformin|metformin|mesh-list
43907219|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
43907220|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
43907221|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43907222|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43907223|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907224|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43907225|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43907226|NCT00284180|Trastuzumab|trastuzumab|mesh-list
44238069|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44238070|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
44238071|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238072|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238073|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
44238074|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238075|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879288|NCT04674423|Tenofovir|tenofovir|mesh-list
43907232|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43907233|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907234|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907235|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
43907236|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907237|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907238|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43907239|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907240|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43907241|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43907242|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43907243|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907245|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
43907246|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
43907247|NCT00285467|Vitamins|vitamins|mesh-ancestor
43907248|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
43907249|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907250|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144512|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907251|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907252|NCT00285779|Etanercept|etanercept|mesh-list
43907253|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43907254|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907255|NCT00285779|Analgesics|analgesics|mesh-ancestor
43907256|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
43907257|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907258|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907259|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907260|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907261|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907262|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907263|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
43907265|NCT00286182|Hematinics|hematinics|mesh-ancestor
43907266|NCT00286325|Rituximab|rituximab|mesh-list
43907267|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907268|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907269|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
43907270|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907271|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907272|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43907273|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43907274|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907275|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907276|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907277|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
43907278|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907279|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907281|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
43907282|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907283|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907284|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
43907285|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907286|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907287|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
43907288|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43907289|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43907290|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238076|NCT00566046|Levetiracetam|levetiracetam|mesh-list
44238077|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
44238078|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
44238079|NCT00566124|Insulin|insulin|mesh-list
44238080|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44238081|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
44238082|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
44238083|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
43907291|NCT00287222|Bevacizumab|bevacizumab|mesh-list
43907292|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43907293|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907294|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907295|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907296|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907301|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907302|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907303|NCT00287287|Lenalidomide|lenalidomide|mesh-list
43907304|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
43907305|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907306|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907307|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907308|NCT00287287|Growth Substances|growth substances|mesh-ancestor
43907309|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907310|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907311|NCT00287339|Esomeprazole|esomeprazole|mesh-list
43907312|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43907313|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907314|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43907315|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907316|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907317|NCT00287716|Pirfenidone|pirfenidone|mesh-list
43907318|NCT00287716|Analgesics|analgesics|mesh-ancestor
43907319|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
43907320|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907321|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907322|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43907323|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907324|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907325|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907326|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907327|NCT00287729|Pirfenidone|pirfenidone|mesh-list
43907328|NCT00287729|Analgesics|analgesics|mesh-ancestor
43907329|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
43907330|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907331|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907332|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43907333|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907334|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907335|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907336|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907338|NCT00287872|Bortezomib|bortezomib|mesh-list
43907339|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907340|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907341|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
43907342|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907343|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
43907344|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907345|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907346|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907347|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907348|NCT00287872|Growth Substances|growth substances|mesh-ancestor
43907349|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907350|NCT00287989|Paclitaxel|paclitaxel|mesh-list
43907351|NCT00287989|Carboplatin|carboplatin|mesh-list
43907352|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43907353|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43907354|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907355|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
43907356|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
43907357|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44238084|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
44238085|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
44238086|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43907358|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907359|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907360|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907362|NCT00288067|Fenretinide|fenretinide|mesh-list
43907363|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907364|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907365|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
43907366|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907367|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907368|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43907385|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43907386|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43907387|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43907388|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43907389|NCT00288574|Fluoxetine|fluoxetine|mesh-list
43907390|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43907391|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907392|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907393|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907394|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907395|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
43907396|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907397|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43907398|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
43907399|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907400|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43907401|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43907402|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907403|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43907404|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
43907405|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43907406|NCT00288600|Antibodies|antibodies|mesh-list
43907407|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
43907408|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43907409|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
43907410|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907411|NCT00289211|Complement C1s|complement c1s|mesh-list
43907412|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43907413|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43907414|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
43907415|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907416|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43907417|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907418|NCT00289653|Nicotine|nicotine|mesh-list
43907419|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43907420|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
43907421|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907422|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907423|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43907424|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43907425|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
43907426|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907454|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907455|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907456|NCT00290615|Growth Substances|growth substances|mesh-ancestor
43907457|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907458|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907459|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907460|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
43907461|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907463|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43907464|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907465|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907466|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907467|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43907468|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238087|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238089|NCT00566241|Growth Substances|growth substances|mesh-ancestor
43907469|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43907470|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43907471|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907472|NCT00290810|Bevacizumab|bevacizumab|mesh-list
43907473|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43907488|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907489|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907490|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43907491|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907492|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907493|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907494|NCT00291226|Glycine|glycine|mesh-list
43907495|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
43907496|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907497|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907498|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907499|NCT00291655|Levetiracetam|levetiracetam|mesh-list
43907500|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
43907501|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
43656447|NCT02961816|Vitamins|vitamins|mesh-ancestor
43907502|NCT00291694|Celecoxib|celecoxib|mesh-list
43907503|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43907504|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43907505|NCT00291694|Analgesics|analgesics|mesh-ancestor
43907506|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
43907507|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907508|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907509|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43907510|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907511|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43907512|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43907513|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907514|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907515|NCT00292162|Metoprolol|metoprolol|mesh-list
43907516|NCT00292162|Carvedilol|carvedilol|mesh-list
43907517|NCT00292162|Ramipril|ramipril|mesh-list
43907518|NCT00292162|Enalapril|enalapril|mesh-list
43907519|NCT00292162|Lisinopril|lisinopril|mesh-list
43907520|NCT00292162|Bisoprolol|bisoprolol|mesh-list
43907521|NCT00292162|Perindopril|perindopril|mesh-list
43907522|NCT00292162|Captopril|captopril|mesh-list
43907523|NCT00292162|Spironolactone|spironolactone|mesh-list
43907524|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43907525|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43907526|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43907527|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43907528|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43907529|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
43907530|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
43907531|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907532|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907533|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43907534|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43907535|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
43907536|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787412|NCT01758614|Aspirin|aspirin|mesh-list
43907545|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43907546|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907547|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907548|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
43907549|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43907550|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43907551|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
43907552|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907553|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43907554|NCT00292591|Vitamin D|vitamin d|mesh-list
43907555|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
43907556|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
43907557|NCT00292591|Vitamins|vitamins|mesh-list
43907558|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
43907559|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238090|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238092|NCT00566267|Ezetimibe|ezetimibe|mesh-list
44238093|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44238094|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44238095|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
44238096|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879538|NCT04669821|Propofol|propofol|mesh-list
43907560|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907561|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907562|NCT00293540|Tamoxifen|tamoxifen|mesh-list
43907563|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43907564|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907565|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907566|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907567|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43907568|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907569|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43907570|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43907571|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907572|NCT00294515|Valganciclovir|valganciclovir|mesh-list
43907573|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
43907574|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907575|NCT00294632|Rituximab|rituximab|mesh-list
43907576|NCT00294632|Lenalidomide|lenalidomide|mesh-list
43656509|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
43907577|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907578|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907579|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
43907580|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907581|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907582|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907583|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907584|NCT00294632|Growth Substances|growth substances|mesh-ancestor
43907585|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907586|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
43907587|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43907588|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
43907589|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907590|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907591|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43907592|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43907593|NCT00295503|Bevacizumab|bevacizumab|mesh-list
43907594|NCT00295503|Cisplatin|cisplatin|mesh-list
43907595|NCT00295503|Pemetrexed|pemetrexed|mesh-list
43907596|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907597|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907598|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907599|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907600|NCT00295503|Growth Substances|growth substances|mesh-ancestor
43907601|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907612|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
43907613|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907614|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907615|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907616|NCT00296296|Cyclosporine|cyclosporine|mesh-list
43907617|NCT00296296|Tacrolimus|tacrolimus|mesh-list
43907618|NCT00296296|Cyclosporins|cyclosporins|mesh-list
43907619|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907620|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
43907621|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907622|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43907623|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907624|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907625|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
43907626|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907627|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
43907628|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238097|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44238098|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44238099|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238100|NCT00566332|Fludarabine|fludarabine|mesh-list
44238102|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238103|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136314|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
43907629|NCT00296322|Cisplatin|cisplatin|mesh-list
43907630|NCT00296322|Mitomycins|mitomycins|mesh-list
43907631|NCT00296322|Mitomycin|mitomycin|mesh-list
43907632|NCT00296322|Doxifluridine|doxifluridine|mesh-list
43907633|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907634|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43907635|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
43907636|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907637|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43907638|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907639|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907640|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
43907641|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907642|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
43907643|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907644|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
43907645|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43907646|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
43907647|NCT00297596|Trastuzumab|trastuzumab|mesh-list
43907648|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907649|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907650|NCT00298155|Ketoconazole|ketoconazole|mesh-list
43907651|NCT00298155|Goserelin|goserelin|mesh-list
43907652|NCT00298155|Bicalutamide|bicalutamide|mesh-list
43907654|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43907655|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907656|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
43907657|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907658|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43907659|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43907660|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907661|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907662|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43907663|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907664|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907665|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787541|NCT04995874|Micronutrients|micronutrients|mesh-list
43907678|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43907679|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
43907680|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43907681|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43907682|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907683|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907684|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
43907685|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
43907686|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43907687|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
43907688|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907689|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907690|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
43907691|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43907692|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43907693|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
43907694|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907695|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907696|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43907697|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43907698|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43907699|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
44238104|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44238105|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
44238106|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43879596|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907700|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43907701|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43907702|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907703|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43907704|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43907705|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
43907707|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907708|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
43907709|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907710|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43907711|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907712|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907713|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43907714|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907715|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43907716|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
43907717|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907718|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907719|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
43907720|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907721|NCT00299741|Sunitinib|sunitinib|mesh-list
43907722|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907723|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907724|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907725|NCT00299741|Growth Substances|growth substances|mesh-ancestor
43656642|NCT02959554|Nivolumab|nivolumab|mesh-list
43907726|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907727|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907738|NCT00300391|Haloperidol|haloperidol|mesh-list
43907739|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
43907740|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
43907741|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
43907742|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907743|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907744|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907745|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43907746|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43907747|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43907748|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907749|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43907750|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
43907751|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907752|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907753|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43907754|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
43907755|NCT00300430|Atorvastatin|atorvastatin|mesh-list
43907756|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43907757|NCT00300430|Simvastatin|simvastatin|mesh-list
43907758|NCT00300430|Fenofibrate|fenofibrate|mesh-list
43907759|NCT00300430|Calcium|calcium|mesh-list
43907760|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907761|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907762|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907763|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43907764|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43907765|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
43907766|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907767|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43907768|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43907769|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138557|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138558|NCT00171457|Tegaserod|tegaserod|mesh-list
44138559|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138560|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
44138561|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238107|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44238108|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44238109|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238110|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238111|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238112|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238113|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238114|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44238115|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44238116|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
43879670|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
44138562|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138563|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138564|NCT00171470|Tegaserod|tegaserod|mesh-list
44138565|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138566|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
44138567|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138568|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138569|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138570|NCT00171483|Tegaserod|tegaserod|mesh-list
44138571|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138572|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
44138573|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138574|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138575|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138576|NCT00171496|Cyclosporine|cyclosporine|mesh-list
44138577|NCT00171496|Tacrolimus|tacrolimus|mesh-list
44138578|NCT00171496|Cyclosporins|cyclosporins|mesh-list
44138579|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138585|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
44138586|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138587|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43907771|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43907772|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43907773|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
43907774|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907775|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43907776|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43907777|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907778|NCT00300469|Atorvastatin|atorvastatin|mesh-list
43907779|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43907780|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43907781|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
43907782|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907783|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43907784|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43907785|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907786|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43907787|NCT00300482|Calcium|calcium|mesh-list
43907788|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43907789|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907790|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43907791|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43907792|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
43907793|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907794|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43907795|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43907796|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907797|NCT00300677|Voriconazole|voriconazole|mesh-list
43907798|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
43907799|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238117|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238118|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
44238119|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44238120|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238121|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
43879739|NCT04666675|Upadacitinib|upadacitinib|mesh-list
43907800|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43907801|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43907802|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907803|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907804|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43907805|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907806|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907807|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907808|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43907809|NCT00300742|Topiramate|topiramate|mesh-list
43907810|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
43907811|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43907812|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907813|NCT00301028|Paclitaxel|paclitaxel|mesh-list
43907814|NCT00301028|Carboplatin|carboplatin|mesh-list
43907815|NCT00301028|Cetuximab|cetuximab|mesh-list
43907816|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43907817|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907818|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
43907819|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
43907820|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
43907821|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907822|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907823|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43907824|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907825|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907826|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907827|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656771|NCT02958800|Olanzapine|olanzapine|mesh-list
43907841|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907842|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907843|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907844|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
43907845|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907846|NCT00302133|Naltrexone|naltrexone|mesh-list
43907847|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43907848|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43907849|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907850|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
43907851|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907852|NCT00302848|Drospirenone|drospirenone|mesh-list
43907853|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
43907854|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
43907855|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
43907856|NCT00302848|Progestins|progestins|mesh-list
43907857|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43907858|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907859|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43907860|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43907861|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43907862|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43907863|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907864|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907865|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43907866|NCT00302848|Diuretics|diuretics|mesh-ancestor
43907867|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
43907868|NCT00302848|Hormones|hormones|mesh-ancestor
43907869|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43907870|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
43907871|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907872|NCT00303823|Protective Agents|protective agents|mesh-ancestor
43802348|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238122|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238123|NCT00566553|Protective Agents|protective agents|mesh-ancestor
44238124|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907873|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907874|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43907875|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43907876|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907877|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43907878|NCT00303862|Cediranib|cediranib|mesh-list
43907879|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907880|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907881|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907882|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907883|NCT00303966|Sorafenib|sorafenib|mesh-list
43907884|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907885|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907886|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787746|NCT02969837|Lenalidomide|lenalidomide|mesh-list
43907900|NCT00304187|Erythromycin|erythromycin|mesh-list
43907901|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
43907902|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43907903|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
43907904|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907905|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907906|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907907|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43907908|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907909|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907910|NCT00304707|Bupropion|bupropion|mesh-list
43907911|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43907912|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
43907913|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907914|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43907915|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907916|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907917|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907918|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
43907919|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907920|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907921|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43907922|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43907923|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907925|NCT00304746|Androgens|androgens|mesh-ancestor
43907926|NCT00304746|Hormones|hormones|mesh-ancestor
43907927|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907928|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907929|NCT05267847|Anesthetics|anesthetics|mesh-list
43907930|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43907931|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907932|NCT05267457|Vanadium|vanadium|mesh-list
43907933|NCT05267457|Trace Elements|trace elements|mesh-ancestor
43907934|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
43907935|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907936|NCT05267392|Durvalumab|durvalumab|mesh-list
43907937|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907938|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907939|NCT05267366|Bevacizumab|bevacizumab|mesh-list
43907940|NCT05267366|Cisplatin|cisplatin|mesh-list
43907941|NCT05267366|Carboplatin|carboplatin|mesh-list
43907942|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43907943|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907944|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907957|NCT05266937|Carboplatin|carboplatin|mesh-list
43907958|NCT05266937|Atezolizumab|atezolizumab|mesh-list
43907959|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43907960|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907961|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
43907962|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
43907963|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
43907964|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238126|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44238127|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238128|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879834|NCT04665284|Empagliflozin|empagliflozin|mesh-list
43907965|NCT05266820|Thalidomide|thalidomide|mesh-list
43907966|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907967|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
43907968|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907969|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
43907970|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907971|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907972|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907973|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907974|NCT05266820|Growth Substances|growth substances|mesh-ancestor
43907975|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907976|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907978|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
43907979|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
43907980|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907981|NCT05266794|Protective Agents|protective agents|mesh-ancestor
43907982|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907983|NCT05266794|Trace Elements|trace elements|mesh-ancestor
43907984|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
43907985|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
43907986|NCT05266794|Vitamins|vitamins|mesh-ancestor
43907987|NCT05266716|Methamphetamine|methamphetamine|mesh-list
43907988|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43907989|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907990|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
43907991|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
43907992|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43907993|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
43907994|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907995|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907996|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
43907997|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43907998|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907999|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43908000|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43908001|NCT05266690|Dextrans|dextrans|mesh-list
43908002|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
43908003|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
43908004|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
43908005|NCT05266651|Tadalafil|tadalafil|mesh-list
43908006|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908007|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43908008|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43908016|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43908017|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
43908018|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
43908019|NCT05266534|Terlipressin|terlipressin|mesh-list
43908020|NCT05266534|Carbetocin|carbetocin|mesh-list
43908021|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43908022|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43908023|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
43908024|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43908025|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908026|NCT05266274|Azacitidine|azacitidine|mesh-list
43908027|NCT05266274|Antibodies|antibodies|mesh-list
43908028|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43908029|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
43908030|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908031|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908032|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
43908033|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908034|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908035|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908036|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
43908037|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
43908038|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
43908039|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44238129|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238130|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
44238131|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44238132|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
44238133|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44238134|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238135|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43908040|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908042|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
43908043|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43908044|NCT05266261|Antacids|antacids|mesh-ancestor
43908045|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908046|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43908047|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
43908048|NCT05266196|Topotecan|topotecan|mesh-list
43908049|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908050|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
43908051|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908052|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908053|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908054|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
43908055|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908056|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908057|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908058|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43908059|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908060|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908061|NCT05266105|Palbociclib|palbociclib|mesh-list
43908062|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908063|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908064|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908065|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908066|NCT05266040|Valacyclovir|valacyclovir|mesh-list
43908067|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
43908068|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908069|NCT05265962|Decitabine|decitabine|mesh-list
43908070|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908071|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
43908072|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908073|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908074|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908075|NCT05265819|Hormones|hormones|mesh-list
44138592|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138593|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138594|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
44138595|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138596|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
44138597|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138598|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44138599|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138600|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44138601|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44138602|NCT00171522|Tegaserod|tegaserod|mesh-list
44138603|NCT00171522|Laxatives|laxatives|mesh-ancestor
44138604|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138605|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138606|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
44138607|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138608|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138609|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138610|NCT00171535|Amlodipine|amlodipine|mesh-list
44138611|NCT00171535|Valsartan|valsartan|mesh-list
44138612|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138613|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138614|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138615|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238136|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44238137|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44238139|NCT00566683|Diazepam|diazepam|mesh-list
44238140|NCT00566683|Alfentanil|alfentanil|mesh-list
44238141|NCT00566683|Propofol|propofol|mesh-list
44238142|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44238143|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238144|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155857|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
44138616|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138617|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138618|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138619|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138620|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138621|NCT00171561|Valsartan|valsartan|mesh-list
44138622|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138623|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138624|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138625|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138626|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138627|NCT00171561|Diuretics|diuretics|mesh-ancestor
44138628|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138629|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138630|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44138631|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138632|NCT00171574|Valsartan|valsartan|mesh-list
44138633|NCT00171574|Lisinopril|lisinopril|mesh-list
44138634|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138635|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138636|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138637|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138638|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44138639|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
44138640|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138641|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43908088|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
43908089|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908090|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
43908091|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908092|NCT05237596|Acetaminophen|acetaminophen|mesh-list
43908093|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43908094|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43908095|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908096|NCT05237596|Analgesics|analgesics|mesh-ancestor
43908097|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
43908098|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908099|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908100|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
43908101|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908102|NCT05211804|Ranibizumab|ranibizumab|mesh-list
43908103|NCT05211804|Aflibercept|aflibercept|mesh-list
43908104|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908105|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43908106|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43908107|NCT05211804|Growth Substances|growth substances|mesh-ancestor
43908108|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908109|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
43908110|NCT05201430|Capecitabine|capecitabine|mesh-list
43908111|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
43908112|NCT05201430|Irinotecan|irinotecan|mesh-list
43908113|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908114|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
43908115|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908116|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908117|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44238145|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44238146|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
44238147|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
44238148|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44238149|NCT00566683|Narcotics|narcotics|mesh-ancestor
44238150|NCT00566683|Analgesics|analgesics|mesh-ancestor
44238151|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
44238152|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879986|NCT04662866|Incretins|incretins|mesh-ancestor
43908118|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908119|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908120|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
43908121|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908122|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908123|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43908124|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908125|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908126|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908127|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908128|NCT05185973|Micronutrients|micronutrients|mesh-list
43908129|NCT05185973|Trace Elements|trace elements|mesh-list
43908130|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908131|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
43908132|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908133|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
43908134|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908135|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908136|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43908137|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908138|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
43908139|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43908140|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
43908141|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908142|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908143|NCT05156060|Ketamine|ketamine|mesh-list
43908144|NCT05156060|Gabapentin|gabapentin|mesh-list
43908145|NCT05156060|Analgesics|analgesics|mesh-ancestor
43908146|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
43908147|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908148|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908149|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43908150|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43908151|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
43908152|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
43908162|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
43908163|NCT05117034|Morphine|morphine|mesh-list
43908164|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43908165|NCT05117034|Narcotics|narcotics|mesh-ancestor
43908166|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908167|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908168|NCT05117034|Analgesics|analgesics|mesh-ancestor
43908169|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
43908170|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908171|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43908172|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43908173|NCT04974216|Rituximab|rituximab|mesh-list
43908174|NCT04974216|Lenalidomide|lenalidomide|mesh-list
43908175|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908176|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908177|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
43908178|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908179|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908180|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43908181|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43908182|NCT04974216|Growth Substances|growth substances|mesh-ancestor
43908183|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
43908184|NCT04641507|Tadalafil|tadalafil|mesh-list
43908185|NCT04641507|Tamsulosin|tamsulosin|mesh-list
43908186|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908187|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44238153|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44238154|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
44238155|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
44238156|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
44238157|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43908188|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43908189|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908190|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908191|NCT04641507|Urological Agents|urological agents|mesh-ancestor
43908192|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43908193|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43908194|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43908195|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
43908196|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908197|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908198|NCT04617457|Leucovorin|leucovorin|mesh-list
43908199|NCT04617457|Folic Acid|folic acid|mesh-list
43908200|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
43908201|NCT04617457|Irinotecan|irinotecan|mesh-list
43908202|NCT04617457|Fluorouracil|fluorouracil|mesh-list
43908203|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
43908204|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908205|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43908206|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908207|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908208|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908209|NCT04617457|Antidotes|antidotes|mesh-ancestor
43908210|NCT04617457|Protective Agents|protective agents|mesh-ancestor
43908211|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908212|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
43908213|NCT04617457|Vitamins|vitamins|mesh-ancestor
43908214|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
43908215|NCT04617457|Hematinics|hematinics|mesh-ancestor
43908216|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
43908217|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908218|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908219|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
43908228|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908229|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908230|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
43908231|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43908232|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908233|NCT04528212|Analgesics|analgesics|mesh-ancestor
43908234|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
43908235|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908236|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43908237|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908238|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908239|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908240|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908241|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908242|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
43908243|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908244|NCT04489173|Trifluridine|trifluridine|mesh-list
43908245|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
43908246|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908247|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
43908248|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908249|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
43908250|NCT04476511|Vitamin D|vitamin d|mesh-list
43908251|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43908252|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908253|NCT04476511|Vitamins|vitamins|mesh-ancestor
43908254|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
43908255|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43908256|NCT04445662|Varenicline|varenicline|mesh-list
43908257|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43908258|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43908259|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
43908260|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908261|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238158|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44238159|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44238160|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44238161|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238162|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238163|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
44238164|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
44238165|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880127|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43908262|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908263|NCT04413617|Tofacitinib|tofacitinib|mesh-list
43908264|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908265|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908266|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908267|NCT04339426|Azithromycin|azithromycin|mesh-list
43908268|NCT04339426|Atovaquone|atovaquone|mesh-list
43908269|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908270|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908271|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
43908272|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43908273|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43908274|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908275|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908276|NCT04298463|Vancomycin|vancomycin|mesh-list
43908277|NCT04298463|Daptomycin|daptomycin|mesh-list
43908278|NCT04298463|Teicoplanin|teicoplanin|mesh-list
43908279|NCT04298463|Dalbavancin|dalbavancin|mesh-list
43908280|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908281|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908282|NCT04260854|Bupivacaine|bupivacaine|mesh-list
43908283|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
43908284|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
43908285|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908286|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908287|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
43908288|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908304|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
43908305|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908306|NCT04221750|Metformin|metformin|mesh-list
43908307|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43908308|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908309|NCT04209686|Paclitaxel|paclitaxel|mesh-list
43908310|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
43908311|NCT04209686|Olaparib|olaparib|mesh-list
43908312|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43908313|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908314|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
43908315|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
43908316|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
43908317|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908318|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908319|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43908320|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908322|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43908323|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908324|NCT04207944|Analgesics|analgesics|mesh-ancestor
43908325|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
43908326|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908327|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908328|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43908329|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908330|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908331|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43908332|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908333|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908334|NCT04177758|Vitamin D|vitamin d|mesh-list
43908335|NCT04177758|Vitamins|vitamins|mesh-ancestor
43908336|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
43802361|NCT01697527|Vaccines|vaccines|mesh-list
44238166|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238167|NCT00566761|Triamcinolone|triamcinolone|mesh-list
44238168|NCT00566761|Bevacizumab|bevacizumab|mesh-list
44238169|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238170|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908337|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908338|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43908339|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43908340|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43908341|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908343|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43908344|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
43908345|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
43908346|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908347|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908348|NCT04128722|Sirolimus|sirolimus|mesh-list
43908349|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908350|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908375|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43908376|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908377|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43908378|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908379|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908380|NCT04061590|Cisplatin|cisplatin|mesh-list
43908381|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
43908382|NCT04061590|Pemetrexed|pemetrexed|mesh-list
43908383|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908384|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908385|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908386|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908387|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43908388|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43908389|NCT04016142|Paclitaxel|paclitaxel|mesh-list
43908390|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43908391|NCT04016142|Carboplatin|carboplatin|mesh-list
43908392|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43908393|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908394|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
43908395|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
43908396|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
43908397|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138643|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138644|NCT00171587|Vatalanib|vatalanib|mesh-list
44138645|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138646|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788162|NCT04497883|Maribavir|maribavir|mesh-list
44138655|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
44138656|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138657|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44138658|NCT00171600|Protective Agents|protective agents|mesh-ancestor
44138659|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138660|NCT00171613|Octreotide|octreotide|mesh-list
44138661|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138662|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138663|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138664|NCT00171626|Diclofenac|diclofenac|mesh-list
44138665|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138666|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138667|NCT00171626|Analgesics|analgesics|mesh-ancestor
44138668|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
44138669|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138670|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138671|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138672|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138673|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138674|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138675|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138676|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
43802362|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44238171|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238172|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238173|NCT00566761|Growth Substances|growth substances|mesh-ancestor
44238174|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891149|NCT04258046|Trametinib|trametinib|mesh-list
44238175|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238176|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238177|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
44238178|NCT00566761|Hormones|hormones|mesh-ancestor
44238179|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238180|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44238181|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238182|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238183|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238184|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238185|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
44238186|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44238187|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
44238188|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238189|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44238190|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44138677|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138678|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138679|NCT00171652|Diclofenac|diclofenac|mesh-list
44138680|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138681|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138682|NCT00171652|Analgesics|analgesics|mesh-ancestor
44138683|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
44138684|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138685|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138686|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138687|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138688|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138689|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138690|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138691|NCT00171665|Diclofenac|diclofenac|mesh-list
44138692|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138693|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138694|NCT00171665|Analgesics|analgesics|mesh-ancestor
44138695|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
44138696|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138697|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138698|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138699|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138700|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138701|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138702|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138703|NCT00171678|Diclofenac|diclofenac|mesh-list
44138704|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138705|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138706|NCT00171678|Analgesics|analgesics|mesh-ancestor
44138707|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
44238191|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44238192|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238193|NCT00566891|Tirofiban|tirofiban|mesh-list
44238194|NCT00566891|Clopidogrel|clopidogrel|mesh-list
44238195|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44238196|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44238197|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44238198|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44238199|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
44238200|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880303|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
43908398|NCT03934567|Abexinostat|abexinostat|mesh-list
43908399|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43908400|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908411|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908412|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43908413|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43908414|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43908415|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908416|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908417|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
43908418|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908419|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43908420|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43908421|NCT03783416|Ixazomib|ixazomib|mesh-list
43908422|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908423|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
43908424|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908425|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908426|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43908427|NCT03734692|Cisplatin|cisplatin|mesh-list
43908428|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
43908429|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908430|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908431|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
43908432|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908433|NCT03709914|Fosfomycin|fosfomycin|mesh-list
43908434|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908435|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908436|NCT03706053|Midodrine|midodrine|mesh-list
43908437|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
43908438|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
43908439|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908440|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908441|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43908442|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43908443|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43908444|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43908445|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
43908446|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908447|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908448|NCT03587272|Sirolimus|sirolimus|mesh-list
43908449|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
43908450|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908451|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908452|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908453|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908454|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
43908455|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908456|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
43908457|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908458|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908459|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
43908460|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
44238201|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238202|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238203|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44238204|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44238205|NCT00566904|Aspirin|aspirin|mesh-list
44238206|NCT00566904|Lidocaine|lidocaine|mesh-list
44238207|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
44238208|NCT00566904|Anesthetics|anesthetics|mesh-list
44238209|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908461|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
43908462|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43908463|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43908464|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788288|NCT04023253|Mirabegron|mirabegron|mesh-list
43908475|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908476|NCT03366415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908477|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908478|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
43908479|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908480|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
43908481|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908482|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908483|NCT03239015|Trastuzumab|trastuzumab|mesh-list
43908484|NCT03239015|Everolimus|everolimus|mesh-list
43908485|NCT03239015|Olaparib|olaparib|mesh-list
43908486|NCT03239015|Palbociclib|palbociclib|mesh-list
43908487|NCT03239015|Gefitinib|gefitinib|mesh-list
43908488|NCT03239015|Afatinib|afatinib|mesh-list
43908489|NCT03239015|Vemurafenib|vemurafenib|mesh-list
43908490|NCT03239015|Dabrafenib|dabrafenib|mesh-list
43908491|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43908492|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908493|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908494|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908495|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
43908496|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908497|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908498|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908499|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908500|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43908501|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43908502|NCT03239015|Growth Substances|growth substances|mesh-ancestor
43908503|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
43908504|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
43908505|NCT03161379|Nivolumab|nivolumab|mesh-list
43908506|NCT03161379|Pancrelipase|pancrelipase|mesh-list
43908507|NCT03161379|Vaccines|vaccines|mesh-list
43908508|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
43908509|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908510|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908511|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908512|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908513|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
43908514|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908515|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908516|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908517|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908518|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43908519|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43908520|NCT03079921|Propranolol|propranolol|mesh-list
43908521|NCT03079921|Phentolamine|phentolamine|mesh-list
43908522|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43908523|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43908524|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
43908525|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908526|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908527|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908528|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44238210|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238211|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
44238212|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238213|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44238214|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44238215|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44238216|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238217|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880429|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43908529|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43908530|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908531|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43908532|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
43908533|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908549|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
43908550|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908551|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908552|NCT03017131|Analgesics|analgesics|mesh-ancestor
43908553|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
43908554|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908555|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43908556|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43908557|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
43908558|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908559|NCT03013933|Cyclosporine|cyclosporine|mesh-list
43908560|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43908561|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43908562|NCT03013933|Verapamil|verapamil|mesh-list
43908563|NCT03013933|Antibodies|antibodies|mesh-list
43908564|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
43908565|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43908566|NCT03013933|Cyclosporins|cyclosporins|mesh-list
43908567|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
43908568|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
43908569|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908570|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908571|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908572|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908573|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908574|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
43908575|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908576|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
43908577|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908578|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43908579|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908580|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43908581|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43908582|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43908583|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908584|NCT03007238|Aldesleukin|aldesleukin|mesh-list
43908585|NCT03007238|Interleukin-2|interleukin-2|mesh-list
43908586|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908587|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908588|NCT03007238|Analgesics|analgesics|mesh-ancestor
43908589|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
43908590|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908591|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908592|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43908593|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43908594|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
43908595|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908603|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908604|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43908605|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43908606|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238218|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238220|NCT00566904|Analgesics|analgesics|mesh-ancestor
44238221|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238222|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238223|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44238224|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43981835|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
44238225|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44155891|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
43908607|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908608|NCT02779257|Diazoxide|diazoxide|mesh-list
43908609|NCT02779257|Pasireotide|pasireotide|mesh-list
43908610|NCT02779257|Hormones|hormones|mesh-ancestor
43908611|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43908612|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908613|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43908614|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908615|NCT02660411|Propofol|propofol|mesh-list
43908616|NCT02660411|Sevoflurane|sevoflurane|mesh-list
43908617|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43908618|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908619|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908620|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43908621|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
43908622|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
43908623|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43908624|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43908625|NCT02633137|Cytarabine|cytarabine|mesh-list
43908626|NCT02633137|Lenalidomide|lenalidomide|mesh-list
43908627|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908628|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
43908629|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908630|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908631|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
43908632|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908633|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908634|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
43908635|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908636|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43908637|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43908638|NCT02633137|Growth Substances|growth substances|mesh-ancestor
43908639|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
43908640|NCT02578732|Leucovorin|leucovorin|mesh-list
43908641|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
43908642|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908643|NCT02578732|Antidotes|antidotes|mesh-ancestor
43908644|NCT02578732|Protective Agents|protective agents|mesh-ancestor
43908645|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908646|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
43908647|NCT02578732|Vitamins|vitamins|mesh-ancestor
43908648|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
43908649|NCT02501434|Heparin|heparin|mesh-list
43908650|NCT02501434|Calcium heparin|calcium heparin|mesh-list
43908651|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
43908652|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43908653|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43908654|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908655|NCT02478255|Xenon|xenon|mesh-list
43908656|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43908657|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
43908658|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
43908659|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908660|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908661|NCT01880541|Anesthetics|anesthetics|mesh-list
43908662|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908663|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908664|NCT01650350|Naltrexone|naltrexone|mesh-list
43908665|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44238226|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44238227|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238228|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
44238229|NCT00567034|Naltrexone|naltrexone|mesh-list
44238230|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44238231|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44238232|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238233|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
43908697|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43908698|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908699|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
43908700|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908701|NCT01345136|Everolimus|everolimus|mesh-list
43908702|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908703|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908704|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
43908705|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908706|NCT01000467|Probucol|probucol|mesh-list
43908707|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43908708|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908709|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
43908710|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908711|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908712|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
43908720|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908722|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908723|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43908724|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43908725|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908726|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43908727|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
43908728|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43908729|NCT00549978|Protective Agents|protective agents|mesh-ancestor
43908730|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43908731|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43908732|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908733|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43908734|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908735|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
43908736|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908737|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
43908738|NCT00198328|Bleomycin|bleomycin|mesh-list
43908739|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908740|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908741|NCT00198315|Bleomycin|bleomycin|mesh-list
43908742|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908743|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908744|NCT00305084|Doxorubicin|doxorubicin|mesh-list
43908745|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908746|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908747|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43908748|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908749|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908750|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908751|NCT00305162|Clopidogrel|clopidogrel|mesh-list
43908752|NCT00305162|Cangrelor|cangrelor|mesh-list
43908753|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43908754|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43908755|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43908756|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43908757|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
43908758|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908759|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908760|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908761|NCT00305578|Memantine|memantine|mesh-list
43908762|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43908763|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43908764|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
44238234|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238235|NCT00567047|Vildagliptin|vildagliptin|mesh-list
44238236|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238237|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238238|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44238239|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44238240|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908765|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908766|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908767|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908768|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43908769|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43908770|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
43908771|NCT00305682|Sirolimus|sirolimus|mesh-list
43908772|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
43908773|NCT00305682|Fludarabine|fludarabine|mesh-list
43908774|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43908775|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908776|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
43908777|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908778|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908779|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908780|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
44138710|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138711|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138712|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138713|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138714|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138716|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138717|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138718|NCT00171691|Analgesics|analgesics|mesh-ancestor
44138719|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
44138720|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138721|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138722|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138723|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138724|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44138725|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138726|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138727|NCT00171717|Cyclosporine|cyclosporine|mesh-list
44138728|NCT00171717|Cyclosporins|cyclosporins|mesh-list
44138729|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138730|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138731|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138732|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
44138733|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138734|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
44138735|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138736|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
44138737|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138738|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44138739|NCT00171743|Cyclosporine|cyclosporine|mesh-list
44138740|NCT00171743|Cyclosporins|cyclosporins|mesh-list
44138741|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138742|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138743|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138744|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
44138745|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138746|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
44138747|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138748|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
44138749|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138750|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44138751|NCT00171756|Atenolol|atenolol|mesh-list
44138752|NCT00171756|Valsartan|valsartan|mesh-list
43982054|NCT02061969|Hormones|hormones|mesh-ancestor
44138753|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138754|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43802524|NCT04981379|Favipiravir|favipiravir|mesh-list
44238241|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238242|NCT00567060|Piracetam|piracetam|mesh-list
44238243|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44238244|NCT00567060|Protective Agents|protective agents|mesh-ancestor
44238245|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238246|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
44238247|NCT00567099|Aripiprazole|aripiprazole|mesh-list
44238248|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
44238249|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44138755|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138756|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138757|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908795|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908796|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908797|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908798|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908799|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
43908800|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908801|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908802|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908803|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908805|NCT00305942|Topotecan|topotecan|mesh-list
43908806|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908807|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43908808|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43908809|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908810|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908811|NCT00306163|Fluticasone|fluticasone|mesh-list
43908812|NCT00306163|Ciclesonide|ciclesonide|mesh-list
43908813|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43908814|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908815|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
43908816|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908817|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908818|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43908819|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908820|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
43908821|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43908822|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
43908823|NCT00306163|Hormones|hormones|mesh-ancestor
43908824|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43908825|NCT00306202|Dasatinib|dasatinib|mesh-list
43908826|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908827|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908828|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908829|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908830|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43908841|NCT00309738|Simvastatin|simvastatin|mesh-list
43908842|NCT00309738|Pitavastatin|pitavastatin|mesh-list
43908843|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43908844|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908845|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
43908846|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908847|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908848|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43908849|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908850|NCT00309751|Atorvastatin|atorvastatin|mesh-list
43908851|NCT00309751|Pitavastatin|pitavastatin|mesh-list
43908852|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43908853|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908854|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
43908855|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908856|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908857|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43908858|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238250|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44238251|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238252|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238253|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238254|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
44238255|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
44238256|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238257|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238258|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43908860|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908861|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908862|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908863|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43908864|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43908865|NCT00310076|Thalidomide|thalidomide|mesh-list
43908866|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908867|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
43908868|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908869|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
43908870|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908871|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908872|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43908873|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43908874|NCT00310076|Growth Substances|growth substances|mesh-ancestor
43908875|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
43908876|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908878|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908879|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
43908880|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908881|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908882|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43908883|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908884|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
43908885|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43908886|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43908887|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43908888|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43908889|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43908890|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908891|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908892|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
43908893|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43908894|NCT00310791|Hormones|hormones|mesh-list
43908895|NCT00310791|Estradiol|estradiol|mesh-list
43908896|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43908907|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43908908|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43908909|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43908910|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
43908911|NCT00311246|Adalimumab|adalimumab|mesh-list
43908912|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43908913|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908914|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
43908915|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43908916|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43908917|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43908918|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43908919|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908920|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
43908921|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908922|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908923|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43908924|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908926|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44238259|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44238260|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
44238261|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44238262|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43880793|NCT04652323|Calcium|calcium|mesh-list
43908927|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43908928|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
43908929|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908930|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43908931|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43908932|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43908933|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908934|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908935|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908936|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908937|NCT00313729|Temozolomide|temozolomide|mesh-list
43908938|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908939|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
44157324|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908940|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908941|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908943|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
43908944|NCT00314106|Fludarabine|fludarabine|mesh-list
43908945|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908946|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
43908947|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908948|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908949|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908950|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
43908951|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908952|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908953|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908954|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43908955|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43908956|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
43908957|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908958|NCT00315146|Pioglitazone|pioglitazone|mesh-list
43908959|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43908960|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908975|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908976|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908977|NCT00315328|Atropine|atropine|mesh-list
43908978|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43908979|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908980|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908981|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
43908982|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908983|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908984|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43908985|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908986|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
43908987|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
43908988|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43908989|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43908990|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
43908991|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908992|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908993|NCT00315341|Buprenorphine|buprenorphine|mesh-list
43908994|NCT00315341|Methadone|methadone|mesh-list
43908995|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43908996|NCT00315341|Naloxone|naloxone|mesh-list
43908997|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43908998|NCT00315341|Narcotics|narcotics|mesh-ancestor
43908999|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909000|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909001|NCT00315341|Analgesics|analgesics|mesh-ancestor
43909002|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
43909003|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909004|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43909005|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
44238263|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44238264|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44238265|NCT00567177|Cyclosporine|cyclosporine|mesh-list
44238266|NCT00567177|Cyclosporins|cyclosporins|mesh-list
44238267|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238268|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238269|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238270|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
44238271|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238272|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
44238273|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238274|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238275|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238276|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238277|NCT00567216|Nadolol|nadolol|mesh-list
44238278|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43909006|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
43909007|NCT00316862|Cisplatin|cisplatin|mesh-list
43909008|NCT00316862|Irinotecan|irinotecan|mesh-list
43909009|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909010|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43909011|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43909012|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909013|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909014|NCT00317720|Trastuzumab|trastuzumab|mesh-list
43909015|NCT00317720|Everolimus|everolimus|mesh-list
43909016|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909017|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909018|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909019|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
43909020|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909021|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
43909022|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43909038|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909039|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909040|NCT00318292|Epinephrine|epinephrine|mesh-list
43909041|NCT00318292|Bupivacaine|bupivacaine|mesh-list
43909042|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
43909043|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
43909044|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909045|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909046|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
43909047|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909048|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43909049|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43909050|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
43909051|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909052|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909053|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43909054|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43909055|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
43909056|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43909057|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
43909059|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
43909060|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43909061|NCT00318409|Bupropion|bupropion|mesh-list
43909062|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43909063|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909064|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909065|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44238280|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238281|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238282|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238283|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238284|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44238285|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44238286|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
44238287|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
44238288|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238289|NCT00567372|Bevacizumab|bevacizumab|mesh-list
44238290|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238291|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238292|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238293|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238294|NCT00567372|Growth Substances|growth substances|mesh-ancestor
44238295|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238296|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238297|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44238298|NCT00567411|Apraclonidine|apraclonidine|mesh-list
44238299|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44238300|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44238301|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44238302|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43909066|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43909067|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909068|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909069|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
43909070|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909071|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909072|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43909073|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43909074|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909075|NCT00318708|Fluticasone|fluticasone|mesh-list
43909077|NCT00318708|Clarithromycin|clarithromycin|mesh-list
43909078|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909079|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43909080|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
43909081|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909092|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43909093|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43909095|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43909096|NCT00318812|Trace Elements|trace elements|mesh-ancestor
43909097|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
43909098|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909099|NCT00318812|Hematinics|hematinics|mesh-ancestor
43909100|NCT00318929|Valproic Acid|valproic acid|mesh-list
43909101|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
43909102|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238303|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238304|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238305|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238306|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238307|NCT00567450|Ropivacaine|ropivacaine|mesh-list
44238308|NCT00567450|Mepivacaine|mepivacaine|mesh-list
43909103|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909104|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
43909105|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909106|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909107|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
43909108|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909109|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909110|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909111|NCT00319644|Dimercaprol|dimercaprol|mesh-list
43909112|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
43909113|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
43909114|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909115|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
43909116|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43909117|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43909118|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43909119|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909120|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909121|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
43909122|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909123|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909124|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43909125|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909126|NCT00320671|Risperidone|risperidone|mesh-list
43909127|NCT00320671|Aripiprazole|aripiprazole|mesh-list
43909128|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909129|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
43909130|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909131|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909132|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909133|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909134|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909135|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909136|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909137|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909138|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
43909139|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909140|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
43909141|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43909142|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43909143|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43788797|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909162|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909163|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43909164|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909165|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909166|NCT00322101|Cyclosporine|cyclosporine|mesh-list
43909167|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
43909168|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
43909170|NCT00322101|Methotrexate|methotrexate|mesh-list
43909171|NCT00322101|Fludarabine|fludarabine|mesh-list
43909172|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
43909173|NCT00322101|Tacrolimus|tacrolimus|mesh-list
43909174|NCT00322101|Cyclosporins|cyclosporins|mesh-list
43909175|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909176|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
43909177|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909178|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909179|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43909180|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
43909181|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909182|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238309|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
44238310|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
44238311|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238312|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909183|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43909184|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43909185|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
43909186|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43909187|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909188|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
43909189|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909190|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909191|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43909192|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43909193|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43909194|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
43909195|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909196|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909197|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43909198|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
43909199|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909200|NCT00322309|Mirtazapine|mirtazapine|mesh-list
43909201|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909203|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43909224|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909226|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43909227|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43909228|NCT00322439|Analgesics|analgesics|mesh-ancestor
43909229|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
43909230|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909231|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909232|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909233|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909234|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909235|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909236|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
43909237|NCT00322465|Azithromycin|azithromycin|mesh-list
43909238|NCT00322465|Doxycycline|doxycycline|mesh-list
43909239|NCT00322465|Tinidazole|tinidazole|mesh-list
43909240|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909241|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909242|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
43909243|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43909244|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43909245|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
43909246|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909247|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43909248|NCT00323362|Gemcitabine|gemcitabine|mesh-list
43909249|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
43909250|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909251|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
43909252|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909253|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909254|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
43909255|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909256|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909280|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43909281|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43909282|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909283|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909284|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909285|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
43909286|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909287|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909288|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909289|NCT00324415|Cisplatin|cisplatin|mesh-list
43909290|NCT00324415|Fluorouracil|fluorouracil|mesh-list
43909291|NCT00324415|Cetuximab|cetuximab|mesh-list
43909292|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909293|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
43909294|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238313|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
44238314|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238315|NCT00567463|Fluticasone|fluticasone|mesh-list
44238316|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238317|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238318|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
44238319|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909295|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909296|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909297|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
43909298|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909299|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909300|NCT00324870|Bevacizumab|bevacizumab|mesh-list
43909301|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43909303|NCT00324870|Antibodies|antibodies|mesh-list
43909304|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
43909305|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43909306|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909307|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909308|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909309|NCT00324870|Growth Substances|growth substances|mesh-ancestor
43909333|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909335|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909336|NCT00326170|Azacitidine|azacitidine|mesh-list
43909337|NCT00326170|Tretinoin|tretinoin|mesh-list
43909338|NCT00326170|Valproic Acid|valproic acid|mesh-list
43909339|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909340|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
43909341|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909342|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909343|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909344|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
43909345|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909346|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
43909347|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
43909348|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909349|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909350|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
43909351|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909352|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909353|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909354|NCT00326781|Nicotine|nicotine|mesh-list
43909355|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43909356|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
43909357|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909358|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909359|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43909360|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43909361|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
43909362|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138782|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138783|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138784|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138785|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138786|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138787|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44138788|NCT00171795|Protective Agents|protective agents|mesh-ancestor
44138790|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138791|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44138792|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44138793|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658073|NCT02947620|Metformin|metformin|mesh-list
43909370|NCT00327392|Fospropofol|fospropofol|mesh-list
43909371|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43909372|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909373|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909374|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
43909375|NCT00328614|Goserelin|goserelin|mesh-list
43909376|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
44238320|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238321|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44238322|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238323|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909378|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
43909379|NCT00328614|Androgens|androgens|mesh-list
43909380|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43909381|NCT00328614|Ethylene|ethylene|mesh-list
43909382|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43909383|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909384|NCT00328614|Hormones|hormones|mesh-ancestor
43909385|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909386|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909387|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
43909388|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909389|NCT00328614|Protective Agents|protective agents|mesh-ancestor
43909390|NCT00328614|Vitamins|vitamins|mesh-ancestor
43909391|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
43909392|NCT00328614|Estrogens|estrogens|mesh-ancestor
43909393|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
43909394|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
43909395|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
43909396|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43909397|NCT00328614|Growth Substances|growth substances|mesh-ancestor
43909398|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43909407|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
43909408|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909409|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
43909410|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909411|NCT00328861|Aldesleukin|aldesleukin|mesh-list
43909412|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
43909413|NCT00328861|Fludarabine|fludarabine|mesh-list
43909414|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909415|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
43909416|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909417|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909418|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43909419|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
43909420|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909421|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909422|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43909423|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43909424|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43909425|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
43909426|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909427|NCT00329433|Heparin|heparin|mesh-list
43909428|NCT00329433|Desirudin|desirudin|mesh-list
43909429|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
43909430|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43909431|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43909432|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909433|NCT00330161|Vorinostat|vorinostat|mesh-list
43909434|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909435|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43909436|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909437|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909438|NCT00330421|Sorafenib|sorafenib|mesh-list
43909439|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909440|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43909441|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909442|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909443|NCT00330551|Risperidone|risperidone|mesh-list
43909444|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909445|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
43658137|NCT02947672|Hormones|hormones|mesh-ancestor
43909446|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909447|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909448|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909449|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909450|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909451|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238324|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44238326|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238327|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238328|NCT00567528|Analgesics|analgesics|mesh-ancestor
43909452|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909453|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909454|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
43909455|NCT00330564|Sunitinib|sunitinib|mesh-list
43909456|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909457|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909458|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909459|NCT00330564|Growth Substances|growth substances|mesh-ancestor
43909460|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909461|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909462|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43909463|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909464|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909465|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43909492|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
43909493|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909494|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909495|NCT00330863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43909496|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43909497|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909498|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909499|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
43909500|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43909501|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43909502|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43909503|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43909504|NCT00330876|Pitavastatin|pitavastatin|mesh-list
43909505|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43909506|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909507|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909508|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
43909509|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909510|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909511|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909512|NCT00330915|Pemetrexed|pemetrexed|mesh-list
43909513|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909514|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909531|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909532|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909533|NCT00332579|Naltrexone|naltrexone|mesh-list
43909534|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43909535|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43909536|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909537|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
43909538|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909539|NCT00332644|Bupropion|bupropion|mesh-list
43909540|NCT00332644|Nicotine|nicotine|mesh-list
43909541|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43909542|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
43909543|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909544|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909545|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43909546|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43909547|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
43909548|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909549|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909550|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43909551|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909552|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909553|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43909554|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43909555|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909556|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
43909557|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43909558|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44238329|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
44238330|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238331|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238332|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238333|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238334|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44238335|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909559|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909560|NCT00333177|Risperidone|risperidone|mesh-list
43909561|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909562|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
43909563|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909564|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909565|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909566|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909567|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909568|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909569|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909570|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909571|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
43909609|NCT00334633|Metronidazole|metronidazole|mesh-list
43909633|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909634|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909635|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
43909636|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909637|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909638|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43909639|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909640|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43909641|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43909642|NCT00335504|Analgesics|analgesics|mesh-ancestor
43909643|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
43909644|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909645|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909646|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909647|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909648|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43909649|NCT00335725|Hormones|hormones|mesh-list
43909650|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43909651|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909652|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909653|NCT00336232|Vitamin K|vitamin k|mesh-list
43909654|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
43909655|NCT00336232|Vitamins|vitamins|mesh-ancestor
43909656|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
43909657|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909658|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43909659|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43909660|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909661|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
43909677|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
43909678|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909679|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909680|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909681|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
43909682|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909683|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43909684|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
43909685|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909686|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909687|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43909688|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
43909689|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909690|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909691|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909692|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909693|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
44238336|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238337|NCT00567554|Paclitaxel|paclitaxel|mesh-list
44238338|NCT00567554|Docetaxel|docetaxel|mesh-list
44238339|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44238340|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
44238341|NCT00567554|Bevacizumab|bevacizumab|mesh-list
43881286|NCT04643483|Adalimumab|adalimumab|mesh-list
43909694|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43909695|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909696|NCT00337987|Prednisone|prednisone|mesh-list
43909697|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
43909698|NCT00337987|Vincristine|vincristine|mesh-list
43909699|NCT00337987|Doxorubicin|doxorubicin|mesh-list
43909700|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43909701|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
43909702|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909703|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
43909704|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909706|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43909707|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
43909708|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909709|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909710|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43909711|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909712|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
43909713|NCT00337987|Hormones|hormones|mesh-ancestor
43909714|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909715|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43909716|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43909717|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
43909718|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
43909719|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
43909720|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909721|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43909733|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909734|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909735|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909736|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
43909737|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909738|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909739|NCT00338598|Glycine|glycine|mesh-list
43909740|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
43909741|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909742|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909743|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909744|NCT00338988|Capecitabine|capecitabine|mesh-list
43909745|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
43909746|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909748|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909749|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909750|NCT00339079|Fluoxetine|fluoxetine|mesh-list
43909751|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43909752|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43909753|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909754|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909755|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909756|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
43909757|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909758|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43909759|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909760|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909761|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43909762|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43909763|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909764|NCT00340379|Haloperidol|haloperidol|mesh-list
43909765|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
43909766|NCT00340379|Ziprasidone|ziprasidone|mesh-list
43909767|NCT00340379|Sertraline|sertraline|mesh-list
43909768|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
44238343|NCT00567554|Everolimus|everolimus|mesh-list
44238344|NCT00567554|Epirubicin|epirubicin|mesh-list
44238345|NCT00567554|Lapatinib|lapatinib|mesh-list
44238346|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44238347|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909769|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909770|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43909771|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43909772|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43909773|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909774|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909775|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
43909776|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909777|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
43909778|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
43909779|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909780|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909781|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909782|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909783|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909784|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909785|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
43789257|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
43909811|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43909812|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43909813|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43909814|NCT00342563|Mecamylamine|mecamylamine|mesh-list
43909815|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43909816|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43909817|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
43909818|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909819|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909820|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43909821|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43909822|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
43909823|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909824|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909825|NCT00343044|Bevacizumab|bevacizumab|mesh-list
43909826|NCT00343044|Topotecan|topotecan|mesh-list
43909827|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909828|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909829|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909830|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909831|NCT00343044|Growth Substances|growth substances|mesh-ancestor
43909832|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909833|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909834|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43909835|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43909836|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909851|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
43909852|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
43909853|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909854|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909855|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909856|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
43909857|NCT00343460|Hormones|hormones|mesh-ancestor
43909858|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909859|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43909860|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909861|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43909862|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909863|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
43909864|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909865|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909866|NCT00343785|Cyclosporine|cyclosporine|mesh-list
43909867|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
43909868|NCT00343785|Methotrexate|methotrexate|mesh-list
43909869|NCT00343785|Cyclosporins|cyclosporins|mesh-list
43909870|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
44238348|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
44238349|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
44238350|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
44238351|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238352|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909871|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43909872|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
43909873|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909874|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
43909875|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909876|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909877|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43909878|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
43909879|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909880|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909881|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43909882|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43909883|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
43909884|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43909885|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909886|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
43909887|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909888|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909889|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43909890|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43909891|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
43909892|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909893|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43909894|NCT00343863|Dexamethasone|dexamethasone|mesh-list
43909895|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
43909896|NCT00343863|Doxorubicin|doxorubicin|mesh-list
43909897|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43909898|NCT00343863|Ondansetron|ondansetron|mesh-list
43909904|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909905|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43909906|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
43909907|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909908|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909909|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43909910|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909911|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
43909912|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909913|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909914|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
43909915|NCT00343863|Hormones|hormones|mesh-ancestor
43909916|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909917|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43909918|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909919|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43909920|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43909921|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909922|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
43909923|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909924|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909925|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
43909926|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909927|NCT00343863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909928|NCT00343863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909929|NCT00343863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909930|NCT00343863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909931|NCT00343863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43909932|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43909933|NCT00344175|Simvastatin|simvastatin|mesh-list
43909934|NCT00344175|Pitavastatin|pitavastatin|mesh-list
43909935|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909936|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909937|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
43909938|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909939|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43802525|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
44238353|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
44238354|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238355|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238356|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44238357|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
44238358|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44238359|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238360|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238361|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238362|NCT00567554|Growth Substances|growth substances|mesh-ancestor
44238363|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909940|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43909941|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909942|NCT00344370|Atorvastatin|atorvastatin|mesh-list
43909943|NCT00344370|Pitavastatin|pitavastatin|mesh-list
43909944|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909945|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909946|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
43909947|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909948|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43909949|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43909950|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909951|NCT00344682|Memantine|memantine|mesh-list
43909952|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43909953|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43909954|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
43909955|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909956|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909957|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909958|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43982938|NCT02090374|Poly ICLC|poly iclc|mesh-list
43909959|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43909960|NCT00345033|Aripiprazole|aripiprazole|mesh-list
43909961|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
43909962|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909963|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909964|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909965|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909966|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909967|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
43909968|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
43909988|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
43909989|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909990|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43909991|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43909992|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43909993|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
43909994|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909995|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909997|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
43909998|NCT00345865|Carmustine|carmustine|mesh-list
43909999|NCT00345865|Etoposide|etoposide|mesh-list
43910000|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910001|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
43910002|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910003|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910004|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910005|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
43910006|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910007|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910008|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910009|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43910010|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44238364|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44238365|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44238366|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44238367|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238368|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238369|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
44238370|NCT00567606|Calcium|calcium|mesh-list
43910011|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910012|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910013|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910014|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
43910015|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
43910016|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910017|NCT00345969|Testosterone|testosterone|mesh-list
43910018|NCT00345969|Androgens|androgens|mesh-ancestor
43910019|NCT00345969|Hormones|hormones|mesh-ancestor
43910020|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910021|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910022|NCT00348946|Androgens|androgens|mesh-list
43910023|NCT00348946|Oxandrolone|oxandrolone|mesh-list
43910024|NCT00348946|Hormones|hormones|mesh-ancestor
43910032|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910033|NCT00349336|Growth Substances|growth substances|mesh-ancestor
43910034|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910035|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910036|NCT00349388|Mesalamine|mesalamine|mesh-list
43910037|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43910038|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43910039|NCT00349388|Analgesics|analgesics|mesh-ancestor
43910040|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
43910041|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910042|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910043|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910044|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910045|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
43910046|NCT00349778|Melphalan|melphalan|mesh-list
43910047|NCT00349778|Carmustine|carmustine|mesh-list
43910048|NCT00349778|Etoposide|etoposide|mesh-list
43910049|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
43910050|NCT00349778|Lenograstim|lenograstim|mesh-list
43910051|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910052|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
43983011|NCT02096029|Nicotine|nicotine|mesh-list
43910053|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910054|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910055|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910056|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
43910057|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910058|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910059|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910060|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43910061|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910062|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910063|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910064|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43910065|NCT00350025|Paclitaxel|paclitaxel|mesh-list
43910066|NCT00350025|Cetuximab|cetuximab|mesh-list
43910067|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43910068|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910069|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
43910070|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
43910071|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
43910072|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910073|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910074|NCT00350142|Gemcitabine|gemcitabine|mesh-list
43910075|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910076|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
43910077|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910078|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910079|NCT00350142|Antiviral Agents|antiviral agents|mesh-ancestor
43910080|NCT00350142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238371|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44238372|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238373|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44238374|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238375|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910081|NCT00350142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910082|NCT00350142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910083|NCT00350142|Immunologic Factors|immunologic factors|mesh-ancestor
43910084|NCT00350142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910086|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910087|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910088|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43910089|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43910090|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910091|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910092|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910113|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910114|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910115|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43910116|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43910117|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910118|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910119|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43910120|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
43910121|NCT00351039|Bevacizumab|bevacizumab|mesh-list
43910122|NCT00351039|Pemetrexed|pemetrexed|mesh-list
43910123|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910124|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910125|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910126|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910127|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910128|NCT00351039|Growth Substances|growth substances|mesh-ancestor
43910129|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910130|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910131|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910132|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910133|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43910134|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43910135|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910136|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
43910137|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43910138|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910139|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910140|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43910141|NCT00351299|Analgesics|analgesics|mesh-ancestor
43910142|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
43910143|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910144|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43910145|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43910167|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910168|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
43910169|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
43910170|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910171|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910172|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43910173|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43910174|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
43910175|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43910176|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43910177|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43910178|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43910179|NCT00352001|Lenalidomide|lenalidomide|mesh-list
43910180|NCT00352001|Azacitidine|azacitidine|mesh-list
43910181|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
43910182|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910183|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238376|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44238377|NCT00567658|Esomeprazole|esomeprazole|mesh-list
44238378|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44238379|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44238380|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44238381|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910184|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910185|NCT00352001|Growth Substances|growth substances|mesh-ancestor
43910186|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910187|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910188|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910189|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
43910190|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910192|NCT00352612|Clindamycin|clindamycin|mesh-list
43910193|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
43910194|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
43910195|NCT00352612|Cephalexin|cephalexin|mesh-list
43910196|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910197|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910198|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43910234|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43910235|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43910236|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
43910237|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910255|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43910256|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
43910257|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910258|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910259|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910260|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
44138794|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138795|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44138796|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
43658769|NCT02942888|Niacin|niacin|mesh-list
43910261|NCT00353119|Etanercept|etanercept|mesh-list
43910262|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43910263|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43910264|NCT00353119|Analgesics|analgesics|mesh-ancestor
43910265|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
43910266|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910267|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910268|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910269|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910270|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43910271|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910272|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
43910273|NCT00353301|Sirolimus|sirolimus|mesh-list
43910274|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910275|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910276|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910277|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910278|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910279|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910280|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910281|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910282|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
43910283|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910284|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
43910285|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910286|NCT00353418|Ribavirin|ribavirin|mesh-list
43910287|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43910288|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
43910289|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910290|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
43910291|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910308|NCT00353652|Diuretics|diuretics|mesh-ancestor
43910309|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
43910310|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43910311|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44238382|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238383|NCT00567697|Ranibizumab|ranibizumab|mesh-list
44238384|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910312|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43910313|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910314|NCT00353834|Insulin|insulin|mesh-list
43910315|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43910316|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
43910317|NCT00353834|Exenatide|exenatide|mesh-list
43910318|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43910319|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910320|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43910321|NCT00353834|Incretins|incretins|mesh-ancestor
43910322|NCT00353834|Hormones|hormones|mesh-ancestor
43910323|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910324|NCT00353977|Vaccines|vaccines|mesh-list
43910325|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
43910326|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910327|NCT00354224|Capecitabine|capecitabine|mesh-list
43910328|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
43910329|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910330|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
43910331|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910332|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910333|NCT00354640|Anastrozole|anastrozole|mesh-list
43910334|NCT00354640|Simvastatin|simvastatin|mesh-list
43910335|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43910336|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43910338|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910339|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43910340|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43910341|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910342|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43910343|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910344|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43910345|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43910346|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43910347|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
43910348|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910349|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910358|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910359|NCT00354770|Protective Agents|protective agents|mesh-ancestor
43910360|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910361|NCT00354770|Antidotes|antidotes|mesh-ancestor
43910362|NCT00354887|Capecitabine|capecitabine|mesh-list
43910363|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
43910364|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910365|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
43910366|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910367|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910368|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
43910369|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
43910370|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910371|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910372|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910373|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910374|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
43910375|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43910376|NCT00354978|Leucovorin|leucovorin|mesh-list
43910377|NCT00354978|Bevacizumab|bevacizumab|mesh-list
43910378|NCT00354978|Fluorouracil|fluorouracil|mesh-list
43910379|NCT00354978|Irinotecan|irinotecan|mesh-list
43910380|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910381|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910382|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910383|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910384|NCT00354978|Growth Substances|growth substances|mesh-ancestor
43910385|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910386|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910387|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
43910388|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238385|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238386|NCT00567697|Growth Substances|growth substances|mesh-ancestor
44238387|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238388|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
44156140|NCT00229697|Tamoxifen|tamoxifen|mesh-list
43910389|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910390|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910391|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
43910392|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43910393|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910394|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910395|NCT00354978|Antidotes|antidotes|mesh-ancestor
43910396|NCT00354978|Protective Agents|protective agents|mesh-ancestor
43910397|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
43910398|NCT00354978|Vitamins|vitamins|mesh-ancestor
43910399|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
43910400|NCT00355199|Rituximab|rituximab|mesh-list
43910401|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910402|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910403|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
43910404|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910405|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910406|NCT00355394|Metoclopramide|metoclopramide|mesh-list
43910407|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
43910408|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
43910409|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910410|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910411|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43910412|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43910413|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43910414|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
43910415|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910416|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910417|NCT00356031|Bevacizumab|bevacizumab|mesh-list
43910418|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910437|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43910438|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910439|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910441|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910442|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43910443|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910444|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910445|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
43910446|NCT00357331|Diuretics|diuretics|mesh-ancestor
43910447|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
43910448|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910449|NCT00357331|Expectorants|expectorants|mesh-ancestor
43910450|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
43910451|NCT00357734|Gefitinib|gefitinib|mesh-list
43910452|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910453|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910454|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910455|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910456|NCT00358462|Azithromycin|azithromycin|mesh-list
43910457|NCT00358462|Doxycycline|doxycycline|mesh-list
43910458|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910459|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910460|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
43910461|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43910462|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43910463|NCT00358501|Defibrotide|defibrotide|mesh-list
43910464|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43910465|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43910466|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910467|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43910468|NCT00358579|Vasopressins|vasopressins|mesh-list
43910469|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
43910470|NCT00358579|Epinephrine|epinephrine|mesh-list
43910471|NCT00358579|Racepinephrine|racepinephrine|mesh-list
43910472|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
43910473|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910474|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44238389|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238390|NCT00567710|Risperidone|risperidone|mesh-list
43910475|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43910506|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910507|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910508|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
43910509|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43910510|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910511|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910512|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43910513|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
43910514|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910515|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910516|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
43910517|NCT00358735|Enoxaparin|enoxaparin|mesh-list
43910518|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
43910519|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43910520|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43910521|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910522|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
43910545|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43910546|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910547|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
43910548|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
43910549|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
43910550|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910551|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910552|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910553|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910554|NCT00360360|Growth Substances|growth substances|mesh-ancestor
43910555|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910556|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910557|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910558|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910559|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43910560|NCT00360399|Citalopram|citalopram|mesh-list
43910561|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43910562|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43658981|NCT02941601|Necitumumab|necitumumab|mesh-list
43910563|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43910564|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910565|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910566|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
43910567|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910568|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43910569|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
43910570|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910571|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910572|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43910599|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
43910600|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910601|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43910602|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43910603|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910604|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43910605|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
43910606|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910607|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910608|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43910609|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43910610|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43910611|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43910612|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910613|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910614|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910615|NCT00360724|Analgesics|analgesics|mesh-ancestor
43910616|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
43910617|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910618|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
43910619|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238391|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44238392|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
44238393|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238394|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910620|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
43910621|NCT00360828|Irinotecan|irinotecan|mesh-list
43910622|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43910640|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910641|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910642|NCT00361257|Minocycline|minocycline|mesh-list
43910643|NCT00361257|Tetracycline|tetracycline|mesh-list
43910644|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910645|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910646|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43910647|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910648|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910649|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
43910650|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910651|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
43910652|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43910653|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
43910654|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43910655|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910656|NCT00361972|Lansoprazole|lansoprazole|mesh-list
43910657|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
43910658|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43910659|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43910660|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43910661|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910662|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910663|NCT00362440|Metformin|metformin|mesh-list
43910664|NCT00362440|Pioglitazone|pioglitazone|mesh-list
43910665|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43910666|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910667|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
43910668|NCT00362466|Dasatinib|dasatinib|mesh-list
43910669|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910670|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910671|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910672|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910673|NCT00362817|Carboplatin|carboplatin|mesh-list
43910674|NCT00362817|Temozolomide|temozolomide|mesh-list
43910675|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910676|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910677|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
43910678|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910679|NCT00362882|Docetaxel|docetaxel|mesh-list
43910680|NCT00362882|Bortezomib|bortezomib|mesh-list
43910681|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910682|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
43910683|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
43910692|NCT00363168|Growth Substances|growth substances|mesh-ancestor
43910693|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910694|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910695|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910697|NCT00363779|Cyclosporins|cyclosporins|mesh-list
43910698|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910699|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910700|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910701|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
43910702|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910703|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
43910704|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910705|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
43910706|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910707|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43910708|NCT00363883|Vorinostat|vorinostat|mesh-list
43910709|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910710|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43910711|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910712|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910713|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44238395|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238396|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43891405|NCT03349268|Xenon|xenon|mesh-list
44238397|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238398|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910714|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43910715|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910716|NCT00364377|Incretins|incretins|mesh-ancestor
43910717|NCT00364377|Hormones|hormones|mesh-ancestor
43910718|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910719|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43910720|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
43910721|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910722|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910723|NCT00364819|Rituximab|rituximab|mesh-list
43910724|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910725|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910726|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
43910727|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910728|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910729|NCT00365053|Belinostat|belinostat|mesh-list
43910730|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910731|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43910732|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910733|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910734|NCT00365144|Bevacizumab|bevacizumab|mesh-list
43910735|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910736|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910737|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910738|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910739|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910740|NCT00365144|Growth Substances|growth substances|mesh-ancestor
43910741|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910742|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910743|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910744|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910745|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910746|NCT00365209|Curcumin|curcumin|mesh-list
43910747|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43910748|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43910767|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43910768|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910769|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
43910770|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910771|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910772|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910773|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
43910774|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910775|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910776|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910777|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910778|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910779|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910780|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910781|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910782|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
43910783|NCT00365274|Hormones|hormones|mesh-ancestor
43659149|NCT02940301|Nivolumab|nivolumab|mesh-list
44158391|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43910784|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910785|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43910786|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43910787|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
43910788|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
43910789|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
43910790|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910791|NCT00365391|Bevacizumab|bevacizumab|mesh-list
43910792|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44238399|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238400|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44238401|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
44238403|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238404|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
43881944|NCT04629144|Belimumab|belimumab|mesh-list
43910793|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910794|NCT00365391|Antibodies|antibodies|mesh-list
43910795|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
43910796|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43910797|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910798|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910799|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910800|NCT00365391|Growth Substances|growth substances|mesh-ancestor
43910801|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910802|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910803|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
43910840|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910841|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910856|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
43910857|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
43910858|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910859|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910860|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43910861|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43910862|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
43910863|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43910864|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43910865|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43910866|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43910867|NCT00366106|Dexamethasone|dexamethasone|mesh-list
43910868|NCT00366106|Doxorubicin|doxorubicin|mesh-list
43910869|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43910871|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910872|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
43910873|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
43910874|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910875|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910876|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43910877|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
43910878|NCT00366106|Hormones|hormones|mesh-ancestor
43910879|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910880|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43910881|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910882|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910883|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910884|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910885|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910886|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910887|NCT00366626|Naltrexone|naltrexone|mesh-list
43910888|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43910889|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43910890|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910891|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
43910892|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910893|NCT00367016|Omalizumab|omalizumab|mesh-list
43910894|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43910895|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43910896|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
43910897|NCT00367601|Bevacizumab|bevacizumab|mesh-list
43910898|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910899|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790194|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
43910915|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910917|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43910918|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
43910919|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802526|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44238405|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238406|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238407|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238408|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910920|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910921|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43910922|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43910923|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43910924|NCT00369226|Methotrexate|methotrexate|mesh-list
43910926|NCT00369226|Tacrolimus|tacrolimus|mesh-list
43910927|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43910928|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
43910929|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659219|NCT02940366|Atorvastatin|atorvastatin|mesh-list
43910930|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910931|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910932|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
43910933|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910934|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910935|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
43910936|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910937|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43910938|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910939|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
43910940|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910941|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43910942|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44138797|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44138798|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138799|NCT00171821|Deferasirox|deferasirox|mesh-list
44138800|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44138801|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
44138802|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
44138803|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138804|NCT00171847|Trastuzumab|trastuzumab|mesh-list
44138805|NCT00171847|Letrozole|letrozole|mesh-list
44138806|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44138807|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138832|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138833|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138834|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138835|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
44138836|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138837|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138838|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138839|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138840|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
44138841|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138842|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138843|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
44138844|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138845|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138846|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138847|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138848|NCT00171990|Famciclovir|famciclovir|mesh-list
44138849|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
44138850|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138851|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44138852|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138853|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910964|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43910965|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
43910966|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910967|NCT05287633|Esomeprazole|esomeprazole|mesh-list
43910968|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43910969|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43910970|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44238409|NCT00567775|Insulin|insulin|mesh-list
44238410|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44238411|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238412|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910971|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910972|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910973|NCT05287607|Bilirubin|bilirubin|mesh-list
43910974|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
43910975|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910976|NCT05287607|Protective Agents|protective agents|mesh-ancestor
43910977|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910978|NCT05287503|Ambroxol|ambroxol|mesh-list
43910979|NCT05287503|Expectorants|expectorants|mesh-ancestor
43910980|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43910981|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
43910982|NCT05287425|Gentamicins|gentamicins|mesh-list
43910983|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43910984|NCT05287425|Povidone|povidone|mesh-list
43910985|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43910986|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910987|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910988|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910989|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910990|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910991|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790358|NCT04930991|Omeprazole|omeprazole|mesh-list
43911022|NCT05287191|Amiodarone|amiodarone|mesh-list
43911023|NCT05287191|Analgesics|analgesics|mesh-ancestor
43911024|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
43911025|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911026|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911027|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
43911028|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911029|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43911030|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
43911031|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43911032|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43911033|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911034|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43911054|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43911055|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43911056|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43911057|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
43911058|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911059|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911060|NCT05287035|Dexamethasone|dexamethasone|mesh-list
43911061|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
43911062|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911063|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
43911064|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
43911065|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911066|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911067|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911068|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
43911069|NCT05287035|Hormones|hormones|mesh-ancestor
43911070|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911071|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911072|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911073|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
43911074|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911075|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911076|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911077|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911078|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911079|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911080|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911081|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43911082|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43911083|NCT05286346|Tenofovir|tenofovir|mesh-list
43911084|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
43911085|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238414|NCT00567788|Latanoprost|latanoprost|mesh-list
44238415|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44238416|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44238417|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44238418|NCT00567814|Oxazepam|oxazepam|mesh-list
44238419|NCT00567814|Metyrapone|metyrapone|mesh-list
44238420|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
44238421|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238422|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238423|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44238424|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238425|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238426|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882152|NCT04626752|Fludarabine|fludarabine|mesh-list
43911086|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43911087|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43911088|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138856|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911122|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911123|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43911124|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
43911125|NCT05285787|Vitamin MK 7|vitamin mk 7|mesh-list
43911126|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
43911127|NCT05285787|Coagulants|coagulants|mesh-ancestor
43911128|NCT05250050|Amoxicillin|amoxicillin|mesh-list
43911129|NCT05250050|Metronidazole|metronidazole|mesh-list
43911130|NCT05250050|Clarithromycin|clarithromycin|mesh-list
43911161|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43911162|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43659448|NCT02938260|Metoprolol|metoprolol|mesh-list
43911163|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911164|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911165|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43911166|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43911167|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911168|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43911169|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
43911170|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
43911171|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
43911172|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
43911173|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911174|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138857|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
43790440|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44138870|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
44138871|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138872|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138873|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138874|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
44138875|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138876|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138877|NCT00172172|Calcium|calcium|mesh-list
44138878|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
44138879|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138880|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138881|NCT00172302|Ascorbic Acid|ascorbic acid|mesh-list
44138882|NCT00172302|Vitamins|vitamins|mesh-ancestor
44138883|NCT00172302|Micronutrients|micronutrients|mesh-ancestor
44138884|NCT00172302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138885|NCT00172302|Antioxidants|antioxidants|mesh-ancestor
44138886|NCT00172302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238427|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238428|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238429|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
44238430|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
44238431|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458936|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44138887|NCT00172302|Protective Agents|protective agents|mesh-ancestor
44138888|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
44138889|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138890|NCT00172367|Lycopene|lycopene|mesh-list
44138891|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138892|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
44138893|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138894|NCT00172367|Protective Agents|protective agents|mesh-ancestor
44138895|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138896|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44138897|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44138898|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138899|NCT00172380|Docetaxel|docetaxel|mesh-list
44138900|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138901|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
44138902|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
44138903|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
44138904|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138905|NCT00172419|Atorvastatin|atorvastatin|mesh-list
44138906|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44138907|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44138908|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
44138909|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138910|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44138911|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44138912|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157325|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157326|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
44157327|NCT00234143|Hematinics|hematinics|mesh-ancestor
44157328|NCT00234182|Interferons|interferons|mesh-list
44157329|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
44157330|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
44157331|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157332|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
44157333|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911185|NCT05187286|Apixaban|apixaban|mesh-list
43911186|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43911187|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
43911188|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43911189|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
43911190|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911191|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911192|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
43911193|NCT05143502|Fluticasone|fluticasone|mesh-list
43911194|NCT05143502|Xhance|xhance|mesh-list
43911195|NCT05143502|Prednisolone|prednisolone|mesh-list
43911196|NCT05143502|Montelukast|montelukast|mesh-list
43911197|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911198|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43911199|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
43911200|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911201|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911202|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43911203|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
43911204|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
43911205|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43911206|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
43911207|NCT05143502|Hormones|hormones|mesh-ancestor
43911208|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911209|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911210|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911211|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43911212|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
43911213|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43911214|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43802527|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458937|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458938|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458940|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44458941|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44458942|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44458943|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44458944|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44458945|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
44458946|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458947|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911215|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911216|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
43911217|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
43911218|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911219|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911220|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911221|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
43911222|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43911223|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911224|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911225|NCT05113784|Meplazumab|meplazumab|mesh-list
43911226|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
43911227|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911228|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
43911229|NCT05109429|Narcotics|narcotics|mesh-ancestor
43911230|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911231|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911232|NCT05109429|Analgesics|analgesics|mesh-ancestor
43911233|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
43911234|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911235|NCT05081492|Antibodies|antibodies|mesh-list
43911236|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
43911237|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
43911238|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911271|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43911273|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911274|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911275|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43911276|NCT04901975|Diuretics|diuretics|mesh-ancestor
43911277|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
43911278|NCT04899388|Fentanyl|fentanyl|mesh-list
43911279|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43911280|NCT04899388|Narcotics|narcotics|mesh-ancestor
44138959|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138960|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138961|NCT00173888|Gemcitabine|gemcitabine|mesh-list
44138962|NCT00173888|Cisplatin|cisplatin|mesh-list
44138963|NCT00173888|Docetaxel|docetaxel|mesh-list
44138964|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138965|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44138966|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
44138967|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138968|NCT00173888|Antiviral Agents|antiviral agents|mesh-ancestor
44138969|NCT00173888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138970|NCT00173888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138971|NCT00173888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138972|NCT00173888|Immunologic Factors|immunologic factors|mesh-ancestor
44138973|NCT00173888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138974|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44138975|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44138976|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44138977|NCT00173901|Ceftazidime|ceftazidime|mesh-list
43983936|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
44458948|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458950|NCT01587274|Naproxen|naproxen|mesh-list
44458951|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44458952|NCT01587274|Oxycodone|oxycodone|mesh-list
44458953|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
44138978|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911338|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
43911339|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
43911340|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43911341|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43911342|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911343|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911344|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911345|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911346|NCT04288895|Vortioxetine|vortioxetine|mesh-list
43911347|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
43911348|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911349|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43911350|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43911351|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911352|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911353|NCT04288895|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43911354|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43911355|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43790650|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43911364|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
43911365|NCT04259060|Hematinics|hematinics|mesh-ancestor
43911366|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
43911368|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
43911369|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911370|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
43911371|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43911372|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911373|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43911374|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911375|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
43911376|NCT04163107|Dexamethasone|dexamethasone|mesh-list
43911377|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911378|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
43911379|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
43911380|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911381|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911382|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911383|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
43911384|NCT04163107|Hormones|hormones|mesh-ancestor
43911385|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911386|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911387|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911388|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
43911389|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43911390|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43911391|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911392|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911393|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911394|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911395|NCT04080284|Niraparib|niraparib|mesh-list
43911396|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43911397|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911398|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911399|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911400|NCT04072107|Capecitabine|capecitabine|mesh-list
43911401|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911402|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
44144700|NCT00192777|Capecitabine|capecitabine|mesh-list
43911403|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911404|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911405|NCT03984240|Midazolam|midazolam|mesh-list
43911406|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
43911407|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43842568|NCT04521881|Coagulants|coagulants|mesh-ancestor
44458955|NCT01587274|Analgesics|analgesics|mesh-ancestor
44458956|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
44458957|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911408|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911409|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911410|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43659764|NCT02935790|Nivolumab|nivolumab|mesh-list
43911411|NCT03984240|Analgesics|analgesics|mesh-ancestor
43911412|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
43911413|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911414|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43911415|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43911416|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43911417|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43911418|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911419|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790705|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
43911495|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911544|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43911545|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911546|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911547|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43911548|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43911549|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
43911550|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911551|NCT03636503|Rituximab|rituximab|mesh-list
43911552|NCT03636503|Avelumab|avelumab|mesh-list
43911553|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911554|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911555|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
43911556|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911641|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911642|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43911643|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43911644|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911645|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911646|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43911729|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911730|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911731|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911732|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911733|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911734|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911735|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911736|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911737|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911738|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
43911739|NCT02432963|Vaccines|vaccines|mesh-list
43911740|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
43911741|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911742|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911743|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911763|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911765|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911766|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911767|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911768|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
43911769|NCT02405676|Hormones|hormones|mesh-ancestor
43911770|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911771|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911772|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43911773|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
43911774|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911775|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911777|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
43911778|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911779|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43842569|NCT04521582|Amlodipine|amlodipine|mesh-list
44458958|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458959|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
44458960|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43911780|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43911781|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911782|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911783|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911784|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
43911785|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911786|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911787|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911788|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911789|NCT02342782|Cytarabine|cytarabine|mesh-list
43911790|NCT02342782|Etoposide|etoposide|mesh-list
43911791|NCT02342782|Melphalan|melphalan|mesh-list
43911792|NCT02342782|Carmustine|carmustine|mesh-list
43911793|NCT02342782|Basiliximab|basiliximab|mesh-list
43911794|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911795|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790944|NCT03520231|Vitamin D|vitamin d|mesh-list
43911890|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43911891|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911892|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
43911894|NCT01936831|Pyridoxal|pyridoxal|mesh-list
43911895|NCT01936831|Pyridoxine|pyridoxine|mesh-list
43911896|NCT01936831|Isoniazid|isoniazid|mesh-list
43911897|NCT01936831|Vitamins|vitamins|mesh-ancestor
43911898|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
43911899|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911900|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
43911901|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
43911902|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911903|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911904|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43911905|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43911906|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
43911907|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911908|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43911909|NCT01730833|Paclitaxel|paclitaxel|mesh-list
43911910|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43911911|NCT01730833|Trastuzumab|trastuzumab|mesh-list
43911912|NCT01730833|Pertuzumab|pertuzumab|mesh-list
43911913|NCT01730833|Antibodies|antibodies|mesh-list
43911914|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
43911915|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911916|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911917|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911918|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911919|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911920|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911921|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
43911922|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911923|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911924|NCT01653223|Simvastatin|simvastatin|mesh-list
43911925|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43911926|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43911927|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
43911928|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911929|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43911930|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43911931|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911932|NCT01512407|Cisplatin|cisplatin|mesh-list
43911933|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
43911934|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911935|NCT01494662|Capecitabine|capecitabine|mesh-list
43911990|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911991|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
43911992|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911993|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911994|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
43911995|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911996|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43911997|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911998|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911999|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458961|NCT01587274|Narcotics|narcotics|mesh-ancestor
44458962|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458963|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43912000|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912001|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
43912031|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
43912033|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
43912034|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912035|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
43912036|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912037|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912038|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912039|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
43912040|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912041|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912042|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912043|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912044|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43912045|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912078|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43912079|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
43912080|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912081|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912082|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
43912083|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
43912084|NCT00371176|Cycloserine|cycloserine|mesh-list
43912085|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43912086|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912087|NCT00371176|Renal Agents|renal agents|mesh-ancestor
43912088|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43912089|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
43912154|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912155|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
43912156|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43912157|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912158|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912159|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912160|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43912161|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
43912162|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912163|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912164|NCT00374244|Pimozide|pimozide|mesh-list
43912165|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43912166|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912167|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791170|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43912181|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912182|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912183|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912184|NCT00375713|Cetirizine|cetirizine|mesh-list
43912185|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
43912186|NCT00375713|Levocetirizine|levocetirizine|mesh-list
43912187|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912188|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43912189|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43912190|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43912191|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
43912192|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
43912193|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912194|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912195|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912196|NCT00375830|Diphosphonates|diphosphonates|mesh-list
43912197|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
43912198|NCT00375830|Listerine|listerine|mesh-list
43912199|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
43912200|NCT00375830|Fluorides|fluorides|mesh-list
43912201|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
43912202|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43912203|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
43912204|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
43912205|NCT00375830|Protective Agents|protective agents|mesh-ancestor
43912206|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458964|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458965|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458966|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
44458967|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44458968|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458969|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458970|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43882607|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
43912207|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43912208|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912209|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43912210|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912211|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
43912212|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
43912213|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43912214|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43912215|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43912216|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43912217|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43912218|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912219|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912220|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912221|NCT00375973|Analgesics|analgesics|mesh-ancestor
43912222|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
43912223|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912224|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
43912225|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912226|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
43912227|NCT00375999|Docetaxel|docetaxel|mesh-list
43912228|NCT00375999|Epirubicin|epirubicin|mesh-list
43912257|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912258|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
43912259|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912260|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912261|NCT00376948|Antiviral Agents|antiviral agents|mesh-ancestor
43912262|NCT00376948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912263|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912264|NCT00376948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912265|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
43912266|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912267|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912268|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43912269|NCT00376948|Protective Agents|protective agents|mesh-ancestor
43912270|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
43912271|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43912272|NCT00376948|Estrogens|estrogens|mesh-ancestor
43912273|NCT00376948|Hormones|hormones|mesh-ancestor
43912274|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912275|NCT00377572|Omalizumab|omalizumab|mesh-list
43912314|NCT00379574|Doxorubicin|doxorubicin|mesh-list
43912315|NCT00379574|Vincristine|vincristine|mesh-list
43912382|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912383|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
43912385|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
43912386|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912387|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912388|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
43912389|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912390|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912391|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
43912392|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912393|NCT00381810|Acetaminophen|acetaminophen|mesh-list
43912394|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
43912395|NCT00381810|Promethazine|promethazine|mesh-list
43912396|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
43912397|NCT00381810|Rituximab|rituximab|mesh-list
43912429|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458971|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
44458972|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458973|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44458974|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44458975|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912431|NCT00381862|Dexamethasone|dexamethasone|mesh-list
43912432|NCT00381862|Fluorouracil|fluorouracil|mesh-list
43912433|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
43912434|NCT00381862|Irinotecan|irinotecan|mesh-list
43912435|NCT00381862|Camptothecin|camptothecin|mesh-list
43912436|NCT00381862|Aprepitant|aprepitant|mesh-list
43912437|NCT00381862|Palonosetron|palonosetron|mesh-list
43912438|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
43912439|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912440|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
43912441|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
43912442|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912465|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43912466|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43912467|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
43912468|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912469|NCT00382031|Zalutumumab|zalutumumab|mesh-list
43912470|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43912471|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912472|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912473|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
43912474|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912476|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43912477|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43912478|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
43912479|NCT00382265|Tamsulosin|tamsulosin|mesh-list
43912480|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43912481|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43912482|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43912483|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43912484|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912485|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912486|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912487|NCT00382265|Urological Agents|urological agents|mesh-ancestor
44138980|NCT00174174|Modafinil|modafinil|mesh-list
44138981|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44138982|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138983|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44138984|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43791337|NCT04311710|Nivolumab|nivolumab|mesh-list
43912509|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
43912510|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
43912511|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912512|NCT00382824|Vitamins|vitamins|mesh-ancestor
43912513|NCT00383266|Carboplatin|carboplatin|mesh-list
43912514|NCT00383266|Pemetrexed|pemetrexed|mesh-list
43912515|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912516|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791387|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
43912547|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912548|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
43912549|NCT00383643|Zolpidem|zolpidem|mesh-list
43912550|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43912551|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43912552|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912553|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912554|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43912555|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
43912556|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
43912557|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912558|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912559|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43912560|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43791430|NCT02370589|Vaccines|vaccines|mesh-list
43912587|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912589|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
43912590|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912591|NCT00384774|Lasmiditan|lasmiditan|mesh-list
44238432|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43882725|NCT04620031|Propofol|propofol|mesh-list
43912592|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43912593|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
43912594|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912595|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912596|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912597|NCT00384865|Aspirin|aspirin|mesh-list
43912598|NCT00384865|Simvastatin|simvastatin|mesh-list
43912599|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43912600|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912601|NCT00384865|Analgesics|analgesics|mesh-ancestor
43912602|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
43912603|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912604|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912605|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912606|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912607|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43912608|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43912639|NCT00385138|Clopidogrel|clopidogrel|mesh-list
43660728|NCT02929576|Paclitaxel|paclitaxel|mesh-list
43912640|NCT00385138|Cangrelor|cangrelor|mesh-list
43912641|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43912642|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43912643|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43912644|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43912645|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
43912646|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912647|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912648|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912649|NCT00385216|Nicotine|nicotine|mesh-list
43912650|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43912662|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912663|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912664|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912665|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912666|NCT00385788|Gemcitabine|gemcitabine|mesh-list
43912667|NCT00385788|Methotrexate|methotrexate|mesh-list
43912668|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
43912669|NCT00385788|Fludarabine|fludarabine|mesh-list
43912670|NCT00385788|Melphalan|melphalan|mesh-list
43912671|NCT00385788|Tacrolimus|tacrolimus|mesh-list
43912672|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
43912673|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43912674|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912675|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
43912676|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912677|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912678|NCT00385788|Antiviral Agents|antiviral agents|mesh-ancestor
43912679|NCT00385788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912680|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912681|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912682|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
43912683|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912684|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43912685|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
43912686|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43912687|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
43912688|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43912689|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912690|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43912691|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43912692|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912693|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
43912694|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912695|NCT00385801|Risperidone|risperidone|mesh-list
43912696|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43912697|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
43912698|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912699|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912700|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238434|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238435|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44238436|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238437|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238438|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238439|NCT00567918|Tacrolimus|tacrolimus|mesh-list
44238440|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238441|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
44238442|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238443|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238444|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238445|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238446|NCT00567931|Tryptophan|tryptophan|mesh-list
43882797|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912701|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43912702|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912703|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912704|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912705|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43912706|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
43912707|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43912708|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912709|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912710|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912711|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912712|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
43912713|NCT00386243|Analgesics|analgesics|mesh-list
43912714|NCT00386243|Narcotics|narcotics|mesh-ancestor
44138998|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
43912780|NCT00387829|Estradiol|estradiol|mesh-list
43912781|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43912782|NCT00387829|Estrogens|estrogens|mesh-ancestor
43912783|NCT00387829|Hormones|hormones|mesh-ancestor
43912784|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912785|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912786|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43912787|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
43912788|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43912789|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43912790|NCT00387959|Cyclosporine|cyclosporine|mesh-list
43912791|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
43912792|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
43912793|NCT00387959|Rituximab|rituximab|mesh-list
43912808|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
43912809|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912810|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
43912811|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912812|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984411|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
43912813|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43912814|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912815|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43912816|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
43912817|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912818|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43912819|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43912820|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43912821|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43912822|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912823|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238447|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44238448|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
44238449|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912824|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912826|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
43912827|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912828|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
43912829|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912830|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
43912831|NCT00388804|Leuprolide|leuprolide|mesh-list
43912832|NCT00388804|Goserelin|goserelin|mesh-list
43912833|NCT00388804|Flutamide|flutamide|mesh-list
43912834|NCT00388804|Bicalutamide|bicalutamide|mesh-list
43912835|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43912836|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
43912837|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43912838|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912839|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43912840|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912841|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
43912842|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
43912843|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912844|NCT00389168|Atenolol|atenolol|mesh-list
43912845|NCT00389168|Irbesartan|irbesartan|mesh-list
43912846|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43912847|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43912848|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43912849|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912850|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43912851|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
43912852|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
43912853|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912886|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43912887|NCT00389818|Vincristine|vincristine|mesh-list
43912888|NCT00389818|Sargramostim|sargramostim|mesh-list
43912889|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912890|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
43912891|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912892|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912893|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912894|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
43912895|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912896|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912897|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912925|NCT00390182|Gemcitabine|gemcitabine|mesh-list
43912926|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912927|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
43912928|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912929|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912930|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
43912931|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912932|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912933|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912934|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
43912935|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912936|NCT00390234|Aflibercept|aflibercept|mesh-list
43912937|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
43912938|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43912939|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43912940|NCT00390234|Growth Substances|growth substances|mesh-ancestor
43912941|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912942|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913009|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43913010|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913011|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661043|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
43913013|NCT00392392|Paclitaxel|paclitaxel|mesh-list
43913014|NCT00392392|Bevacizumab|bevacizumab|mesh-list
43913015|NCT00392392|Trastuzumab|trastuzumab|mesh-list
43913016|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913017|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913018|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
44238450|NCT00567957|Remifentanil|remifentanil|mesh-list
44238451|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44238452|NCT00567957|Narcotics|narcotics|mesh-ancestor
43913019|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913054|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913055|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913056|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913057|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913058|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43913090|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913092|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
43913093|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913094|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43913095|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
43913096|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43913097|NCT00392834|Leucovorin|leucovorin|mesh-list
43913098|NCT00392834|Cytarabine|cytarabine|mesh-list
43913099|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
43913100|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43913101|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43913129|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913130|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
43913131|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
43913132|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43913133|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43913134|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913135|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
43913136|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913137|NCT00392834|Antidotes|antidotes|mesh-ancestor
43913138|NCT00392834|Protective Agents|protective agents|mesh-ancestor
43913139|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
43913140|NCT00392834|Vitamins|vitamins|mesh-ancestor
43913141|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
43913142|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913143|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913144|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913145|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913146|NCT00392951|Sirolimus|sirolimus|mesh-list
43913147|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43913148|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913149|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913150|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913151|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
43913185|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43913186|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43913187|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913222|NCT00395044|Analgesics|analgesics|mesh-ancestor
43913223|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
43913224|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913225|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913226|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
43913227|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43913228|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43913260|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913261|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913262|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913263|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
43913264|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43913265|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913266|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913267|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43913268|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43913269|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43913270|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
43913271|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913272|NCT00396032|Tenecteplase|tenecteplase|mesh-list
44139005|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44139006|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139007|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139008|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44139009|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139010|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139011|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139012|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44238453|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238454|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238455|NCT00567957|Analgesics|analgesics|mesh-ancestor
44238456|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
44238457|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238458|NCT00567983|Cyclosporine|cyclosporine|mesh-list
44238459|NCT00567983|Cyclosporins|cyclosporins|mesh-list
44238460|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238461|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238462|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238463|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
44238464|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238465|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
44238466|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882933|NCT04617613|Omeprazole|omeprazole|mesh-list
44139013|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
43913300|NCT00397813|Cyclosporine|cyclosporine|mesh-list
43913301|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
43913368|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913369|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913370|NCT00400205|Cisplatin|cisplatin|mesh-list
43913371|NCT00400205|Docetaxel|docetaxel|mesh-list
43913372|NCT00400205|Fluorouracil|fluorouracil|mesh-list
43913373|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913374|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913375|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913376|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913377|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913378|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
43913379|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913380|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913381|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
43913382|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913383|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
43913384|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43913385|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43913419|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913421|NCT00401817|Rituximab|rituximab|mesh-list
43913422|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913423|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913424|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913425|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913426|NCT00401817|Growth Substances|growth substances|mesh-ancestor
43913427|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913428|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913429|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
43913430|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913431|NCT00401882|Metoprolol|metoprolol|mesh-list
43913461|NCT00402714|Methoxsalen|methoxsalen|mesh-list
43913462|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913463|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43913464|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913465|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913466|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43913467|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
43913468|NCT00402896|Mitogens|mitogens|mesh-list
43913469|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
43913470|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913471|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913472|NCT00402896|Growth Substances|growth substances|mesh-ancestor
43913473|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913474|NCT00403117|Naltrexone|naltrexone|mesh-list
44238467|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238468|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238469|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238470|NCT00568048|Bevacizumab|bevacizumab|mesh-list
44238471|NCT00568048|Temozolomide|temozolomide|mesh-list
44238472|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238473|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238474|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238475|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238476|NCT00568048|Growth Substances|growth substances|mesh-ancestor
44238477|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238478|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238479|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44238480|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
44238481|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238482|NCT00568074|Repaglinide|repaglinide|mesh-list
44238483|NCT00568074|Acarbose|acarbose|mesh-list
44238484|NCT00568074|Gliquidone|gliquidone|mesh-list
44238485|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238486|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238487|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44238488|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238489|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238490|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
44238491|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44238492|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
44238493|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238494|NCT00568113|Expectorants|expectorants|mesh-ancestor
44238495|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238496|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44238502|NCT00568152|Aspirin|aspirin|mesh-list
44238512|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44238513|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238514|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44238515|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43791787|NCT04400695|Paclitaxel|paclitaxel|mesh-list
43913507|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913508|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913509|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43913510|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913511|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
43913512|NCT00405522|Remifentanil|remifentanil|mesh-list
43913513|NCT00405522|Propofol|propofol|mesh-list
43913514|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43913515|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913516|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913517|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43913545|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913546|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913547|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913548|NCT00405938|Growth Substances|growth substances|mesh-ancestor
43913549|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913550|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913551|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43913552|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43913553|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43913554|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
43913555|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913556|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43913557|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43913558|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913559|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913561|NCT00406276|Everolimus|everolimus|mesh-list
43913562|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913563|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913600|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43913601|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
43913602|NCT00407888|Doxorubicin|doxorubicin|mesh-list
43913634|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913635|NCT00407966|Analgesics|analgesics|mesh-ancestor
43913636|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
43913637|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913638|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913639|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913640|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913641|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913642|NCT00407966|Growth Substances|growth substances|mesh-ancestor
43913643|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913644|NCT00408070|Paclitaxel|paclitaxel|mesh-list
43913645|NCT00408070|Bevacizumab|bevacizumab|mesh-list
43913646|NCT00408070|Carboplatin|carboplatin|mesh-list
43913673|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43913675|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43913676|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43913677|NCT00408460|Paclitaxel|paclitaxel|mesh-list
43913678|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
43913679|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913680|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913681|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913682|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913683|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913684|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913685|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913686|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913687|NCT00408564|Gemcitabine|gemcitabine|mesh-list
43913688|NCT00408564|Capecitabine|capecitabine|mesh-list
43913689|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
43913690|NCT00408564|Cetuximab|cetuximab|mesh-list
43913691|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913692|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
43913693|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238516|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238517|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
44238518|NCT00568217|Acetaminophen|acetaminophen|mesh-list
44238519|NCT00568217|Ibuprofen|ibuprofen|mesh-list
44238520|NCT00568217|Diclofenac|diclofenac|mesh-list
43883089|NCT04615702|Metronidazole|metronidazole|mesh-list
43913756|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
43913757|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913758|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913759|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
43913760|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913762|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
43913763|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913764|NCT00410488|Dexamethasone|dexamethasone|mesh-list
43913765|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
43913766|NCT00410488|Doxorubicin|doxorubicin|mesh-list
43913767|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43913768|NCT00410488|Vincristine|vincristine|mesh-list
43913769|NCT00410488|Ifosfamide|ifosfamide|mesh-list
43913770|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
43913771|NCT00410488|Palonosetron|palonosetron|mesh-list
43913773|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913774|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
43791990|NCT02582697|Cisplatin|cisplatin|mesh-list
43913798|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43913799|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
43913800|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913801|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43913803|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43913804|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913805|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913806|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913807|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913808|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
43913809|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43913810|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913811|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43913812|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43913813|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913814|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913815|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913816|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913817|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913818|NCT00410904|Pemetrexed|pemetrexed|mesh-list
43913819|NCT00410904|Cediranib|cediranib|mesh-list
43913820|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913821|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913822|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913823|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43913854|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
43913855|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913856|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43913857|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43913858|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913859|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913861|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913862|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913863|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
43913864|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913865|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
43913866|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43913898|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913899|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
43913901|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
43913902|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
43913903|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913904|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913905|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43913906|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43913907|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43913908|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
43913909|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913973|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
44238521|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238522|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238523|NCT00568217|Analgesics|analgesics|mesh-ancestor
44238524|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
44238525|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913974|NCT00413478|Azacitidine|azacitidine|mesh-list
43913975|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913976|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
43913977|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914006|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43914007|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
43914008|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914009|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914011|NCT00414271|Capecitabine|capecitabine|mesh-list
43914012|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914013|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914014|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914015|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914016|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914017|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914018|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
43914019|NCT00414518|Ritonavir|ritonavir|mesh-list
43914020|NCT00414518|Lopinavir|lopinavir|mesh-list
43914021|NCT00414518|Tenofovir|tenofovir|mesh-list
43914046|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
43914047|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914048|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914049|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914050|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914051|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914052|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
43914053|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914055|NCT00416494|Capecitabine|capecitabine|mesh-list
43914056|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
43914057|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914058|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914059|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914060|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914061|NCT00416494|Growth Substances|growth substances|mesh-ancestor
43914062|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914063|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914064|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914065|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
43914066|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914067|NCT00416793|Carboplatin|carboplatin|mesh-list
43914068|NCT00416793|Bortezomib|bortezomib|mesh-list
43914069|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914070|NCT00417274|Quinacrine|quinacrine|mesh-list
43914071|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
43914072|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43914073|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
43914098|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914099|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914100|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
43914101|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914102|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
43914103|NCT00418093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914104|NCT00418093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914105|NCT00418093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914106|NCT00418093|Immunologic Factors|immunologic factors|mesh-ancestor
43914107|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43914108|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43914109|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43914110|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914111|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914112|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
43914113|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914114|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914115|NCT00418457|Anesthetics|anesthetics|mesh-list
44238526|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238527|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238528|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238529|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43914116|NCT00418457|Propofol|propofol|mesh-list
43914117|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914118|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914119|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43914120|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43914121|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
43914122|NCT00418574|Abagovomab|abagovomab|mesh-list
43914123|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914152|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914153|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43914154|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914155|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914156|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43914157|NCT00419666|Vitamins|vitamins|mesh-ancestor
43914158|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
43914159|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914160|NCT00420017|Amiodarone|amiodarone|mesh-list
43914161|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43914162|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
43914163|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43914164|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792197|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914264|NCT00423878|Aripiprazole|aripiprazole|mesh-list
43914265|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43914266|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43914267|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
43914377|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914378|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914379|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914380|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914381|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
43914382|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914383|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
43914384|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914385|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914386|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43914387|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43914388|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43914389|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
43914390|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792287|NCT05304559|Ketamine|ketamine|mesh-list
43914464|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43914465|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
43914466|NCT00427336|Fludarabine|fludarabine|mesh-list
43914467|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
43914468|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
43914469|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43914470|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914471|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
43914472|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914473|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914474|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914475|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
43914476|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914477|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914478|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914479|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914480|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
43914481|NCT00427557|Rituximab|rituximab|mesh-list
43914482|NCT00427557|Fludarabine|fludarabine|mesh-list
43914483|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
43914484|NCT00427557|Melphalan|melphalan|mesh-list
43914485|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914486|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914487|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
43914488|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914489|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914490|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44238530|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238531|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238532|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
44238533|NCT00568295|Acetaminophen|acetaminophen|mesh-list
43914491|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
43914492|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914493|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914494|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914495|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
43914496|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914497|NCT00427661|Cyclosporine|cyclosporine|mesh-list
43914498|NCT00427661|Fludarabine|fludarabine|mesh-list
43914499|NCT00427661|Busulfan|busulfan|mesh-list
43914500|NCT00427661|Cyclosporins|cyclosporins|mesh-list
43914501|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914502|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914503|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914504|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
43914505|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914506|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914507|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
43914508|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914509|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914510|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914511|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43914512|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
43914513|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914514|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914515|NCT00427765|Melphalan|melphalan|mesh-list
43914516|NCT00427765|Busulfan|busulfan|mesh-list
43914517|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914518|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
43914519|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914520|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914548|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914549|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914550|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914551|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914552|NCT00428298|Valacyclovir|valacyclovir|mesh-list
43914553|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
43914554|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914555|NCT00428584|Interferons|interferons|mesh-list
43914556|NCT00428584|Interferon-beta|interferon-beta|mesh-list
43914557|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
43914558|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914559|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
43914560|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914561|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
43914562|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914563|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43914564|NCT00428922|Bevacizumab|bevacizumab|mesh-list
43914565|NCT00428922|Trastuzumab|trastuzumab|mesh-list
43914566|NCT00428922|Docetaxel|docetaxel|mesh-list
43914567|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914581|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914582|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
43914583|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914584|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914585|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914586|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
43914587|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914588|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914589|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914590|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43914591|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914592|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43914593|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43914595|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43914596|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914598|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43914599|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914600|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44238534|NCT00568295|Rofecoxib|rofecoxib|mesh-list
44238535|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238536|NCT00568295|Analgesics|analgesics|mesh-ancestor
43914601|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43914602|NCT00429507|Analgesics|analgesics|mesh-ancestor
43914603|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
43914604|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914605|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914606|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
43914607|NCT00429702|Promethazine|promethazine|mesh-list
43914608|NCT00429702|Dexamethasone|dexamethasone|mesh-list
43914609|NCT00429702|Lorazepam|lorazepam|mesh-list
43914610|NCT00429702|Ondansetron|ondansetron|mesh-list
43914611|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43914612|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
43914613|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
43914614|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914615|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914616|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914617|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
43914618|NCT00429702|Hormones|hormones|mesh-ancestor
43914619|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914620|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43914621|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914622|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914623|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
43914624|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914625|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43914626|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
43914627|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914628|NCT00429702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43914629|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914630|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914662|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43914663|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
43914664|NCT00431041|Oxybutynin|oxybutynin|mesh-list
43914665|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43914666|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43914667|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
43914668|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914669|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914670|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914671|NCT00431041|Urological Agents|urological agents|mesh-ancestor
43914672|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
43914673|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
43914674|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914675|NCT00431132|Estradiol|estradiol|mesh-list
43914699|NCT00431184|Analgesics|analgesics|mesh-ancestor
43914700|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
43914701|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43914702|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43914703|NCT00431626|Dutasteride|dutasteride|mesh-list
43914704|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43914705|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43914706|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914707|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914708|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
43914709|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914710|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914711|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
43914712|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43914713|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43914714|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43914715|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914716|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914717|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
43914718|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914719|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914720|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43914721|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914722|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
43914723|NCT00432458|Thalidomide|thalidomide|mesh-list
43914724|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238537|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
44238538|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238539|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914725|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
43914726|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792455|NCT05302232|Prednisolone|prednisolone|mesh-list
43914795|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
43914796|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914797|NCT00435929|Ritonavir|ritonavir|mesh-list
43914798|NCT00435929|Saquinavir|saquinavir|mesh-list
43914799|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43914800|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43914811|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914812|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
43914813|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914814|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
43914815|NCT00436475|Vitamin D|vitamin d|mesh-list
43914816|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
43914817|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
43914818|NCT00436475|Vitamins|vitamins|mesh-list
43914819|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
43914820|NCT00436475|Calcium|calcium|mesh-list
43914821|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
43914822|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914823|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914824|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914825|NCT00436475|Antacids|antacids|mesh-ancestor
43914826|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914827|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914828|NCT00436904|Rituximab|rituximab|mesh-list
43914829|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
43914830|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914831|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914832|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
43914833|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914834|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914835|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
43914836|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43914837|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
43914838|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914839|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
43914840|NCT00436969|Protective Agents|protective agents|mesh-ancestor
43914841|NCT00438100|Capecitabine|capecitabine|mesh-list
43914842|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914843|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
43914844|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914845|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914846|NCT00438204|Gemcitabine|gemcitabine|mesh-list
43914847|NCT00438204|Bevacizumab|bevacizumab|mesh-list
43914848|NCT00438204|Pemetrexed|pemetrexed|mesh-list
43914849|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914850|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914851|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914852|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914853|NCT00438204|Growth Substances|growth substances|mesh-ancestor
43914854|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914855|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914856|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914857|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
43914858|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914859|NCT00438204|Antiviral Agents|antiviral agents|mesh-ancestor
43914860|NCT00438204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914861|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914862|NCT00438204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914863|NCT00438204|Immunologic Factors|immunologic factors|mesh-ancestor
43914864|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43914865|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43914866|NCT00438451|Lamotrigine|lamotrigine|mesh-list
44139017|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44139018|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44139019|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
44139020|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802669|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238540|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
44238541|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44238542|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44238543|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238544|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238545|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238546|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238547|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238548|NCT00568347|Fluticasone|fluticasone|mesh-list
44238549|NCT00568347|Xhance|xhance|mesh-list
44238550|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44238551|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44139021|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139022|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139023|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44139024|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139025|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
44139026|NCT00174304|Amlodipine|amlodipine|mesh-list
44139027|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44139028|NCT00174304|Atorvastatin|atorvastatin|mesh-list
44139029|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44139030|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44139031|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
44139032|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139033|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44139034|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44139035|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139036|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44139037|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44139038|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792541|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
44139065|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44139066|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44139067|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139068|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44139069|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139070|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139071|NCT00174343|Exemestane|exemestane|mesh-list
44139072|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139073|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44139074|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44139075|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139076|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139077|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44139078|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
44139079|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914892|NCT00438854|Dasatinib|dasatinib|mesh-list
43914893|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914894|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914895|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914925|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
43914926|NCT00439296|Thioguanine|thioguanine|mesh-list
43914927|NCT00439296|Pegaspargase|pegaspargase|mesh-list
43914928|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914929|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
43914930|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914931|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914932|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914933|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
43914934|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914935|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238552|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238553|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238554|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
43914936|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914937|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43914938|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
43914939|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
43914940|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914941|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914942|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
43914943|NCT00439296|Hormones|hormones|mesh-ancestor
43792616|NCT05229055|Ketamine|ketamine|mesh-list
43914972|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
43914974|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43914975|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43914976|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43914977|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914978|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914979|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43914980|NCT00439413|Protective Agents|protective agents|mesh-ancestor
43914981|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914982|NCT00439608|Paclitaxel|paclitaxel|mesh-list
43914983|NCT00439608|Carboplatin|carboplatin|mesh-list
43914984|NCT00439608|Cetuximab|cetuximab|mesh-list
43914985|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43914986|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915018|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915020|NCT00440505|Nicotine|nicotine|mesh-list
43915021|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43915022|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
43915023|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915024|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915025|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43915026|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43915027|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
43792655|NCT05192798|Paclitaxel|paclitaxel|mesh-list
43915123|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915124|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915125|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915126|NCT00443352|Analgesics|analgesics|mesh-ancestor
43915127|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
43915128|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915130|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915131|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
43915132|NCT00444028|Loxapine|loxapine|mesh-list
43915133|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43915134|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43915135|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915136|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915137|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915138|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43915139|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
43915140|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915141|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915142|NCT00444964|Hormones|hormones|mesh-list
43915143|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915173|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915174|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915175|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915176|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
43915177|NCT00445744|Busulfan|busulfan|mesh-list
43915178|NCT00445744|Methotrexate|methotrexate|mesh-list
43915179|NCT00445744|Tacrolimus|tacrolimus|mesh-list
43915180|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915181|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
43915182|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915183|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915184|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43915185|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
43915186|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915187|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915188|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43915189|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44238555|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238556|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238557|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43915256|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915257|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915258|NCT00448175|Urological Agents|urological agents|mesh-ancestor
43915259|NCT00448201|Methotrexate|methotrexate|mesh-list
43915260|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
43915261|NCT00448201|Fludarabine|fludarabine|mesh-list
43915262|NCT00448201|Busulfan|busulfan|mesh-list
43915263|NCT00448201|Tacrolimus|tacrolimus|mesh-list
43915264|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43915265|NCT00448201|Sargramostim|sargramostim|mesh-list
43915266|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43662834|NCT02911480|Oxytocin|oxytocin|mesh-list
43792801|NCT04989660|Phenol|phenol|mesh-list
43915298|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43915300|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915301|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915302|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915303|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
43915304|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915305|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915306|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915307|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915308|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43915349|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
43915350|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915351|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915352|NCT00449748|Everolimus|everolimus|mesh-list
43915353|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915354|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915356|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915357|NCT00450073|Vitamin D|vitamin d|mesh-list
43915358|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
43915359|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
43915360|NCT00450073|Vitamins|vitamins|mesh-list
43915361|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
43915362|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915363|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43915364|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43915365|NCT00450242|Lidocaine|lidocaine|mesh-list
43915366|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
43915367|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
43915368|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915369|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915370|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
43915371|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915372|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43915373|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43915374|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43915375|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915376|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915377|NCT00450463|Metronidazole|metronidazole|mesh-list
43915378|NCT00450463|Molgramostim|molgramostim|mesh-list
43915379|NCT00450463|Flutamide|flutamide|mesh-list
43915380|NCT00450463|Sargramostim|sargramostim|mesh-list
43915381|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
43915382|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915383|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915384|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915385|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43915386|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43915387|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43915388|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
43915389|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
43915390|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915391|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915392|NCT00450983|Methotrexate|methotrexate|mesh-list
43915393|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
43985290|NCT02189213|Sertraline|sertraline|mesh-list
43915394|NCT00450983|Fludarabine|fludarabine|mesh-list
44238558|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238559|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238560|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44238561|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44238562|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44238563|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44238564|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238565|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915395|NCT00450983|Thiotepa|thiotepa|mesh-list
43915396|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
43915397|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43915398|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
43915399|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915400|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915401|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915402|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
43915403|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915404|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915405|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915406|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915407|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43915408|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915438|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
43915439|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915440|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915441|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915443|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915444|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915445|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
43915446|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915447|NCT00452387|Prednisone|prednisone|mesh-list
43915448|NCT00452387|Sorafenib|sorafenib|mesh-list
43915449|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
43915450|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915451|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
43915452|NCT00452387|Hormones|hormones|mesh-ancestor
43915453|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915454|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915455|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792913|NCT04813562|Vaccines|vaccines|mesh-list
43915481|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915482|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43915483|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915484|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915485|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43915486|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43915487|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
43915488|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
43915489|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915490|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43915491|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43915492|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915493|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43915494|NCT00452868|Donepezil|donepezil|mesh-list
43985353|NCT02193347|Temozolomide|temozolomide|mesh-list
43915495|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43915496|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915497|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915498|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915499|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915500|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915501|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
43915502|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
43915503|NCT00453193|Pentostatin|pentostatin|mesh-list
43915504|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915535|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43915536|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43915537|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44238566|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238567|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
44238568|NCT00568347|Hormones|hormones|mesh-ancestor
44238569|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915538|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
43915539|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43915541|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915542|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915543|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915544|NCT00453895|Growth Substances|growth substances|mesh-ancestor
43915545|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915546|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915547|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915548|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915549|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915559|NCT00455650|Mecamylamine|mecamylamine|mesh-list
43915560|NCT00455650|Varenicline|varenicline|mesh-list
43915561|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43915562|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43915563|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915564|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915565|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915566|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915567|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43915568|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43915569|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
43915570|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915571|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43915572|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43915573|NCT00455689|Leuprolide|leuprolide|mesh-list
43915574|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43915575|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
43915576|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915577|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915578|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915579|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915580|NCT00455702|Cycloserine|cycloserine|mesh-list
43915581|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43915582|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915583|NCT00455702|Renal Agents|renal agents|mesh-ancestor
43915584|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43915585|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
43915586|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43915587|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
43915588|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915589|NCT00455962|Estradiol|estradiol|mesh-list
43915590|NCT00455962|Progesterone|progesterone|mesh-list
43915591|NCT00455962|Estrogens|estrogens|mesh-ancestor
43915592|NCT00455962|Hormones|hormones|mesh-ancestor
43915593|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915594|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915595|NCT00455962|Progestins|progestins|mesh-ancestor
43915596|NCT00455975|Bevacizumab|bevacizumab|mesh-list
43915597|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915598|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915599|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915600|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915601|NCT00455975|Growth Substances|growth substances|mesh-ancestor
43915602|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915603|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915604|NCT00456014|Citalopram|citalopram|mesh-list
43915605|NCT00456014|Desipramine|desipramine|mesh-list
43915606|NCT00456014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43915607|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915608|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915609|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915610|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915611|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
43915612|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802791|NCT04977843|Dimercaprol|dimercaprol|mesh-list
44238570|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
44238572|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238573|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238574|NCT00568412|Analgesics|analgesics|mesh-ancestor
44238575|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
43883755|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
43915613|NCT00456014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43915614|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915615|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915639|NCT00456885|Incretins|incretins|mesh-ancestor
43915640|NCT00456885|Hormones|hormones|mesh-ancestor
43915641|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915642|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43915643|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915644|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915645|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43915646|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43915647|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915648|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915650|NCT00457366|Haloperidol|haloperidol|mesh-list
43915651|NCT00457366|Benztropine|benztropine|mesh-list
43915652|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43915653|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
43915654|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915655|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915656|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43915657|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43915658|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915659|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915660|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
43915661|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
43915662|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915663|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43915664|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43915665|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
43915666|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915667|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915668|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43915669|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
43915694|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
43915695|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43915696|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43915697|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43915698|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43915699|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43915700|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
43915701|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915702|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915703|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915704|NCT00457977|Vaccines|vaccines|mesh-list
43915705|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43915706|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
43915707|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915708|NCT00458237|Trastuzumab|trastuzumab|mesh-list
43915709|NCT00458237|Everolimus|everolimus|mesh-list
43915710|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915711|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915712|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915713|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
43915714|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915715|NCT00458822|Dexamethasone|dexamethasone|mesh-list
43915716|NCT00458822|Bortezomib|bortezomib|mesh-list
43915717|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915718|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
43915750|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
43915751|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915752|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915753|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802792|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
44238576|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238577|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915754|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43915755|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915756|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
43915757|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915758|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915759|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43915760|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43915761|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43915762|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915763|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139095|NCT00174434|Paclitaxel|paclitaxel|mesh-list
43915781|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
43915782|NCT00459732|Trace Elements|trace elements|mesh-ancestor
43915783|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
43915784|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915785|NCT00459732|Astringents|astringents|mesh-ancestor
43915786|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915787|NCT00459810|Paclitaxel|paclitaxel|mesh-list
43915788|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
43915789|NCT00459810|Estradiol|estradiol|mesh-list
43915790|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43915791|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915792|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793016|NCT04656470|Analgesics|analgesics|mesh-ancestor
43915829|NCT00461773|Letrozole|letrozole|mesh-list
43915830|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793037|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
43915840|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915842|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
43915843|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915844|NCT00461851|Gemcitabine|gemcitabine|mesh-list
43915845|NCT00461851|Carboplatin|carboplatin|mesh-list
43915846|NCT00461851|Sorafenib|sorafenib|mesh-list
43915847|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915848|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915849|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
43915850|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915851|NCT00461851|Antiviral Agents|antiviral agents|mesh-ancestor
43915852|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915853|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915854|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915855|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
43915856|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915857|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915858|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43915859|NCT00462020|Metronidazole|metronidazole|mesh-list
43915860|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
43915861|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
43915862|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
43915863|NCT00462020|Ampicillin|ampicillin|mesh-list
43915864|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43915865|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915866|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
43915867|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43915868|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43915869|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915870|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915871|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43915872|NCT00462072|Infliximab|infliximab|mesh-list
43915873|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915874|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43915875|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915876|NCT00462228|Memantine|memantine|mesh-list
43915877|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43915878|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43915879|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
43915880|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915881|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915882|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915883|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43915884|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43915885|NCT00462280|Lovastatin|lovastatin|mesh-list
43915886|NCT00462280|L 647318|l 647318|mesh-list
44238578|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238580|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238581|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915887|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
43915888|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43915889|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43915890|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
43915891|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915892|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43915893|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43915894|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915895|NCT00462332|Vidarabine|vidarabine|mesh-list
43915896|NCT00462332|Fludarabine|fludarabine|mesh-list
43915931|NCT00462644|Narcotics|narcotics|mesh-ancestor
43915932|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915933|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915934|NCT00462644|Analgesics|analgesics|mesh-ancestor
43915935|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
43915936|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915937|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43915981|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915982|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43915983|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
43915984|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
43915986|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
43915987|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43915988|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43915989|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915990|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43915991|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43915992|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915993|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915994|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915995|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43915996|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
43915997|NCT00464646|Bevacizumab|bevacizumab|mesh-list
43915998|NCT00464646|Docetaxel|docetaxel|mesh-list
43915999|NCT00464646|Trastuzumab|trastuzumab|mesh-list
43916000|NCT00464646|Epirubicin|epirubicin|mesh-list
43916001|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916002|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
43916003|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916004|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916005|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916006|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
43916007|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663354|NCT04965155|Hormones|hormones|mesh-ancestor
43916008|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916009|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916010|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43916011|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916012|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43916013|NCT00464646|Growth Substances|growth substances|mesh-ancestor
43916014|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916015|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916016|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916017|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916018|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916019|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916020|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916021|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916023|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916024|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
43916025|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
43916026|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916027|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916028|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916029|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
43916031|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916032|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802793|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
44238582|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
44238583|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238584|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238585|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238586|NCT00568477|Rituximab|rituximab|mesh-list
43916033|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916034|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43793099|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
43916067|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43916068|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43916070|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
43916071|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
43916072|NCT00465088|Vitamins|vitamins|mesh-ancestor
43916073|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
43793161|NCT04273165|Etravirine|etravirine|mesh-list
43916110|NCT00466661|Acamprosate|acamprosate|mesh-list
43916111|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43916112|NCT00466752|Sorafenib|sorafenib|mesh-list
43916113|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916148|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43916149|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916150|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916151|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
43916152|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916153|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916154|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
43916187|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916188|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916189|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916190|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
43916191|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916192|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916193|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916194|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916195|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916196|NCT00470392|Clobetasol|clobetasol|mesh-list
43916197|NCT00470392|Imiquimod|imiquimod|mesh-list
43916198|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43916215|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916216|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916217|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43916218|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43916219|NCT00470600|Ibuprofen|ibuprofen|mesh-list
43916220|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916221|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916222|NCT00470600|Analgesics|analgesics|mesh-ancestor
43916223|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
43916224|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916225|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916226|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916227|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916228|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43916229|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916230|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916231|NCT00471068|Timolol|timolol|mesh-list
43916232|NCT00471068|Travoprost|travoprost|mesh-list
43916233|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43916234|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43916235|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
43916236|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916237|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916238|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916239|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43916240|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43916241|NCT00471380|Timolol|timolol|mesh-list
43916242|NCT00471380|Travoprost|travoprost|mesh-list
43916243|NCT00471380|Dorzolamide|dorzolamide|mesh-list
43916244|NCT00471380|Brinzolamide|brinzolamide|mesh-list
43916245|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43916246|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43916247|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238587|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238588|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238589|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
44238590|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238591|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238592|NCT00568503|Bromides|bromides|mesh-list
44238593|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
43884006|NCT04603729|Prednisolone|prednisolone|mesh-list
43916248|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916249|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916250|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916251|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43916252|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43916253|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43916254|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916255|NCT00471705|Miltefosine|miltefosine|mesh-list
43916256|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
43916257|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
43916291|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43916293|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916294|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916295|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
43916296|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916297|NCT00472849|Cytarabine|cytarabine|mesh-list
43916298|NCT00472849|Rituximab|rituximab|mesh-list
43916299|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
43916300|NCT00472849|Fludarabine|fludarabine|mesh-list
43793310|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
43916326|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916327|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
43916328|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916329|NCT00474123|Simvastatin|simvastatin|mesh-list
43916330|NCT00474123|Ezetimibe|ezetimibe|mesh-list
43916331|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43916332|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43916333|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
43916334|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916335|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43916336|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43916337|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916338|NCT00474201|Ritonavir|ritonavir|mesh-list
43916339|NCT00474201|Lopinavir|lopinavir|mesh-list
43916340|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
43916341|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43916342|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43916343|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
43916344|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916345|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916346|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43916347|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43916348|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
43916349|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793338|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
43916374|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916376|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
43916377|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916378|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916379|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916380|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
43916381|NCT00475085|Hormones|hormones|mesh-ancestor
43916382|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916383|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916384|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916385|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43916386|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916387|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916388|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43916389|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43916390|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
44238594|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238596|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238597|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238598|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44238599|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238600|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
43916391|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43916392|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43916393|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916394|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916395|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43916396|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
43916397|NCT00475150|Cediranib|cediranib|mesh-list
43916398|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841271|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916430|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43916431|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916432|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916433|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
43916434|NCT00475501|Urological Agents|urological agents|mesh-ancestor
43916436|NCT00475878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43916437|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43916438|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916439|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916471|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43916472|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43916473|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
43916474|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916475|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916476|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916477|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43916478|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43916479|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43916480|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43916481|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
43916511|NCT00477191|Analgesics|analgesics|mesh-ancestor
43916512|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
43916513|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916514|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916515|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916516|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916517|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916518|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916519|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
43916520|NCT00477204|Simvastatin|simvastatin|mesh-list
43916522|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43916523|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43916524|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43916525|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
43793462|NCT05332795|Metformin|metformin|mesh-list
43916593|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
43916594|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
43916595|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916596|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916597|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
43916697|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43916698|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
43916699|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916700|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
43916701|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43916891|NCT00486824|Nifedipine|nifedipine|mesh-list
43916892|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43916893|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916894|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916895|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916896|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238601|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44238602|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
44238603|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238604|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238605|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
43916897|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
43916898|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
44139099|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916899|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43916900|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916901|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916902|NCT00486824|Analgesics|analgesics|mesh-ancestor
43916903|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
43916904|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916905|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916906|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916907|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
43916944|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916945|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43916946|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917013|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43917014|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917015|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
43917016|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
43917017|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
43917090|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43917091|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917092|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43985862|NCT02212106|Vaccines|vaccines|mesh-list
43917093|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917094|NCT00492089|Growth Substances|growth substances|mesh-ancestor
43917272|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
43917273|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43917274|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43917275|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43917276|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43917277|NCT00497081|Mirtazapine|mirtazapine|mesh-list
43917307|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917308|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917309|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43917310|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43917311|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917312|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43917313|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
43917314|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
43917315|NCT00498615|Fasudil|fasudil|mesh-list
43917316|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43917317|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43917318|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139114|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44139115|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139116|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139117|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44139118|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
44139119|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139120|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139121|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44139122|NCT00174486|Tadalafil|tadalafil|mesh-list
44139123|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139124|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43841338|NCT04629729|Analgesics|analgesics|mesh-ancestor
43917400|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917401|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43917402|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43917403|NCT00500240|Insulin|insulin|mesh-list
43917404|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43917405|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
43917406|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
43917407|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43917408|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238606|NCT00568529|Capecitabine|capecitabine|mesh-list
44238607|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
43884203|NCT04601675|Hormones|hormones|mesh-ancestor
43917438|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
43917439|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917440|NCT00501891|Bevacizumab|bevacizumab|mesh-list
43917441|NCT00501891|Temozolomide|temozolomide|mesh-list
43917442|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917443|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917444|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917445|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917447|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917448|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917449|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917450|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
43917451|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917452|NCT00501943|Interferons|interferons|mesh-list
43917453|NCT00501943|Interferon-beta|interferon-beta|mesh-list
43917454|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
43917455|NCT00501943|Riluzole|riluzole|mesh-list
43917483|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917484|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
43917485|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917486|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43917487|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43917488|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
43917489|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917490|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917492|NCT00502853|Methotrexate|methotrexate|mesh-list
43917493|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917494|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917495|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
43917496|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917497|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917498|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43917499|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
43917500|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793908|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
43917630|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
43917631|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917632|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917634|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43917635|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917636|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917637|NCT00505635|Growth Substances|growth substances|mesh-ancestor
43917638|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917639|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917640|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917641|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917642|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917643|NCT00505895|Rituximab|rituximab|mesh-list
43917644|NCT00505895|Fludarabine|fludarabine|mesh-list
43917645|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
43917646|NCT00505895|Melphalan|melphalan|mesh-list
43917647|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917678|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43917679|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917680|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
43917681|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917682|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43917683|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917684|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
43917685|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917686|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43917687|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917688|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917723|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917724|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917725|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917726|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917727|NCT00508118|Nicardipine|nicardipine|mesh-list
43917728|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43917729|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44238608|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44238610|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238611|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884283|NCT04600648|Insulin|insulin|mesh-list
43917779|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
43917780|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917781|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917782|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917783|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
43917784|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917785|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917786|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917787|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43917788|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43917789|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
43917790|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917791|NCT00509496|Aldesleukin|aldesleukin|mesh-list
43917792|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
43917793|NCT00509496|Fludarabine|fludarabine|mesh-list
43917794|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
43917795|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917813|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917814|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
43917815|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917816|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917817|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
43917818|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917819|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917820|NCT00509665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917822|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917823|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43917824|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917825|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917827|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43917828|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43917829|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43917830|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917831|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917832|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917833|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917834|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917835|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917836|NCT00510224|Octreotide|octreotide|mesh-list
43917837|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917838|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43917839|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917840|NCT00510809|Ethanol|ethanol|mesh-list
43917841|NCT00510809|Policosanol|policosanol|mesh-list
43917842|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43917843|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43917844|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917845|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917846|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917847|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43917848|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43917849|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
43917850|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917851|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917852|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43917853|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43917854|NCT00511173|Warfarin|warfarin|mesh-list
43917878|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917879|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917880|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917881|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917882|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917883|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43802954|NCT04975360|Caffeine|caffeine|mesh-list
44238613|NCT00568542|Hematinics|hematinics|mesh-ancestor
44238614|NCT00568568|Hormones|hormones|mesh-list
44238615|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238616|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238617|NCT00568672|Olanzapine|olanzapine|mesh-list
44238618|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
44238619|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
44238620|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238621|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238622|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44238623|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44238624|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238625|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238626|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238627|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44238628|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43884354|NCT04600492|Riociguat|riociguat|mesh-list
43917884|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917885|NCT00511992|Growth Substances|growth substances|mesh-ancestor
43917886|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917887|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917888|NCT00512278|Infliximab|infliximab|mesh-list
43917889|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917890|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917891|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917892|NCT00512876|Bevacizumab|bevacizumab|mesh-list
43917893|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917894|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917895|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917896|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917897|NCT00512876|Growth Substances|growth substances|mesh-ancestor
43917898|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917899|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917901|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
43917902|NCT00513292|Trastuzumab|trastuzumab|mesh-list
43917903|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43917904|NCT00513292|Epirubicin|epirubicin|mesh-list
43917905|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43917906|NCT00513292|Antibodies|antibodies|mesh-list
43917907|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
43917908|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43794122|NCT03864094|Propofol|propofol|mesh-list
44139161|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44139162|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44139163|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139164|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139165|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139166|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
44139167|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139168|NCT00174577|Risperidone|risperidone|mesh-list
44139169|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43918243|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43918245|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
43918246|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
43918247|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918248|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43918249|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43918250|NCT00521989|Protective Agents|protective agents|mesh-ancestor
44238629|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238630|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238631|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238632|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
44238633|NCT00568711|Doxycycline|doxycycline|mesh-list
44238634|NCT00568711|Rifampin|rifampin|mesh-list
44238635|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918251|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43918252|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918253|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918254|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43918255|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
43918256|NCT00522795|Paclitaxel|paclitaxel|mesh-list
43918257|NCT00522795|Cisplatin|cisplatin|mesh-list
43918258|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
43918259|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43918260|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918261|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
43918262|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
43918263|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
43918264|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918265|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
43918266|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43918267|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43918268|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
43918269|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918404|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918405|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918406|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43918436|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
43918437|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918438|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918439|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43918441|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43918442|NCT00526591|Everolimus|everolimus|mesh-list
43918443|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918444|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918445|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
43918446|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918447|NCT00527124|Prednisone|prednisone|mesh-list
43918448|NCT00527124|Docetaxel|docetaxel|mesh-list
43918486|NCT00527878|Ranitidine|ranitidine|mesh-list
43918514|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918515|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
43918516|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918517|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918518|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
43918519|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918520|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918521|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
43918522|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918523|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43918524|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43918525|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43918526|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918527|NCT00528450|Idarubicin|idarubicin|mesh-list
43918528|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
43918529|NCT00528450|Tretinoin|tretinoin|mesh-list
43918530|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43918531|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918599|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918600|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918602|NCT00530634|Cisplatin|cisplatin|mesh-list
43918636|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918637|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918639|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918640|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43918641|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44238636|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238637|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
44238638|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44238639|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44238640|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44238641|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
44238642|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
44238643|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44238644|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238645|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238646|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44238647|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44238648|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44238649|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44238650|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44238651|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44238652|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44238653|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238654|NCT00568750|Dasatinib|dasatinib|mesh-list
44238655|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238656|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238657|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918642|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43918643|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918723|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43918823|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918988|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
43918989|NCT00536601|Melphalan|melphalan|mesh-list
43918990|NCT00536601|Busulfan|busulfan|mesh-list
43918991|NCT00536601|Thiotepa|thiotepa|mesh-list
43919027|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919028|NCT00537290|Rituximab|rituximab|mesh-list
43919029|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919086|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919087|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919088|NCT00538642|Ziprasidone|ziprasidone|mesh-list
43919089|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43919090|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
43919091|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986215|NCT02227316|Acetaminophen|acetaminophen|mesh-list
43919092|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794605|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
43919150|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43919152|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
43919153|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919154|NCT00539526|Bimatoprost|bimatoprost|mesh-list
43919155|NCT00539526|Travoprost|travoprost|mesh-list
43919156|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43919157|NCT00539526|Latanoprost|latanoprost|mesh-list
43919158|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43919159|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43919160|NCT00539695|Aldesleukin|aldesleukin|mesh-list
43919161|NCT00539695|Interleukin-2|interleukin-2|mesh-list
44238658|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238659|NCT00568763|Sargramostim|sargramostim|mesh-list
44238660|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
44238661|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238662|NCT00568789|Zolpidem|zolpidem|mesh-list
43884474|NCT04597203|Hydroquinone|hydroquinone|mesh-list
43919162|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919163|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43919164|NCT00539695|Analgesics|analgesics|mesh-ancestor
43919165|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
43919166|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919167|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919168|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43919169|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43919170|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
43919171|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919172|NCT00539942|PENTA|penta|mesh-list
43919173|NCT00539942|Fondaparinux|fondaparinux|mesh-list
43919174|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43919175|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
43919176|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43919177|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
43919178|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919179|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919207|NCT00540722|Acetic Acid|acetic acid|mesh-list
43919208|NCT00540722|Retinol acetate|retinol acetate|mesh-list
43919209|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
43919210|NCT00540722|Gossypol|gossypol|mesh-list
43919211|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43919212|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919213|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43919214|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
43919215|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919216|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43919217|NCT00540722|Protective Agents|protective agents|mesh-ancestor
43919218|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919219|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43919220|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
43919221|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43919222|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919223|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43919224|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43919225|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43794696|NCT02021006|Cefixime|cefixime|mesh-list
43919250|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
43919251|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
43919252|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43919253|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
43919254|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
43919255|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919256|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919257|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919258|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43986216|NCT02227316|Ibuprofen|ibuprofen|mesh-list
43919260|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919261|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919262|NCT00542620|Insulin|insulin|mesh-list
43919263|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43919264|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
43919265|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
43919266|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43919267|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
43919268|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43919269|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919270|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
43919271|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43919272|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
43919273|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919274|NCT00542750|Expectorants|expectorants|mesh-ancestor
43919275|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919276|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43919311|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44238663|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44238664|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44238665|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238666|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238667|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44238668|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
44238669|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
44238670|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238671|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238672|NCT00568815|Rituximab|rituximab|mesh-list
44238673|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238674|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238675|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
44238676|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238677|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238678|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44238679|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238680|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238681|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238682|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238683|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
44238684|NCT00568880|Bortezomib|bortezomib|mesh-list
44238685|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238686|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
44238687|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44238688|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44238689|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238690|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238691|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238692|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238693|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44238694|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238695|NCT00568971|Cisplatin|cisplatin|mesh-list
44238705|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238707|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44238708|NCT00569088|Diuretics|diuretics|mesh-ancestor
44238709|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
44238710|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238711|NCT00569101|Tacrolimus|tacrolimus|mesh-list
44238712|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238713|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
44238714|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238715|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44238716|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238717|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238718|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44238719|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44238720|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238721|NCT00569296|Aldesleukin|aldesleukin|mesh-list
44238722|NCT00569296|Sargramostim|sargramostim|mesh-list
43986281|NCT02228824|Nicotine|nicotine|mesh-list
43919312|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919313|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43919314|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43919315|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
43919316|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919400|NCT00546156|Paclitaxel|paclitaxel|mesh-list
43919401|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
43919402|NCT00546156|Bevacizumab|bevacizumab|mesh-list
43919403|NCT00546156|Doxorubicin|doxorubicin|mesh-list
43919404|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919433|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919434|NCT00546897|Lenalidomide|lenalidomide|mesh-list
43919435|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
43919436|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919437|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919438|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919439|NCT00546897|Growth Substances|growth substances|mesh-ancestor
43919440|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919441|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919442|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43919443|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919444|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919445|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919446|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919447|NCT00547586|Bromides|bromides|mesh-list
43919448|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
43919449|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
43919450|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43919451|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919452|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
43919453|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919454|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
43919455|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43919611|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919612|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
43919613|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919614|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43919615|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44238723|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
44238724|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238725|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238726|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44238727|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44238728|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
44238729|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238730|NCT00569335|Bevacizumab|bevacizumab|mesh-list
43919616|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43919617|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919618|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919619|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
43919620|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43919621|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
43919622|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919623|NCT00552786|Expectorants|expectorants|mesh-ancestor
43919624|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919625|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43919626|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
43919627|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919628|NCT00552786|Protective Agents|protective agents|mesh-ancestor
43919629|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919630|NCT00552786|Antidotes|antidotes|mesh-ancestor
43919631|NCT00553098|Cyclosporine|cyclosporine|mesh-list
43919632|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
43919633|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43919634|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
43919635|NCT00553098|Fludarabine|fludarabine|mesh-list
43919636|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
43919637|NCT00553098|Antibodies|antibodies|mesh-list
43919638|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
43919639|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43919640|NCT00553098|Cyclosporins|cyclosporins|mesh-list
43919641|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
43919642|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919643|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919644|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919645|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
43919646|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139238|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139240|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44139241|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139242|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139266|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139267|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44139268|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
44139269|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139270|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139271|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44139272|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139273|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139274|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139275|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44139276|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
44139277|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44139278|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919659|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919660|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43919661|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43919662|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919663|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919664|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43919665|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
43919666|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919667|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919668|NCT00553735|Cyclosporine|cyclosporine|mesh-list
43919669|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
44238731|NCT00569335|Irinotecan|irinotecan|mesh-list
44458977|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44238732|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238733|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238734|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238735|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238736|NCT00569335|Growth Substances|growth substances|mesh-ancestor
44238737|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238738|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238739|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44238740|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44238741|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919670|NCT00553735|Cyclosporins|cyclosporins|mesh-list
43919671|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986414|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43919672|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919673|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794885|NCT05105139|Triclosan|triclosan|mesh-list
43919701|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
43919702|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919703|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919704|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919705|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43919706|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
43919707|NCT00553969|Protective Agents|protective agents|mesh-ancestor
43919708|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43919709|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919710|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43919711|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
43919712|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43919713|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43919714|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43919715|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
43919716|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919717|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43919718|NCT00554463|Cisplatin|cisplatin|mesh-list
43919719|NCT00554463|Etoposide|etoposide|mesh-list
43919720|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919788|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919790|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
43919791|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
43919792|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919793|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
43919794|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
43919795|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919796|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919890|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919891|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
43919892|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919893|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43919894|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43919895|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43919896|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919897|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919898|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43919899|NCT00556491|Minocycline|minocycline|mesh-list
43919900|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43919901|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919902|NCT00556504|Ribavirin|ribavirin|mesh-list
43919903|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43919904|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43919905|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
43919906|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238742|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238743|NCT00569400|Insulin|insulin|mesh-list
44238744|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44238745|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238746|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919907|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
43919908|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919909|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
43919910|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43919911|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919912|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919958|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919959|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919960|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
43919994|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43919995|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43919996|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919997|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43919998|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43919999|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920000|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920036|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
43920037|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43920114|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
43920115|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
43920116|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920117|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920118|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920119|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
43920120|NCT05293249|Hormones|hormones|mesh-ancestor
43920121|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920122|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43920123|NCT05293249|Protective Agents|protective agents|mesh-ancestor
43920124|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920125|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920126|NCT05292209|Riluzole|riluzole|mesh-list
43920127|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
43920128|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43920129|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43920130|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920131|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920132|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920133|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43920134|NCT05292209|Protective Agents|protective agents|mesh-ancestor
43920135|NCT05265065|Vaccines|vaccines|mesh-list
43920136|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
43920137|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920138|NCT05161806|Aflibercept|aflibercept|mesh-list
43920139|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920140|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920141|NCT05161806|Growth Substances|growth substances|mesh-ancestor
43920142|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920143|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920144|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920265|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43920266|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43920267|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920268|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920269|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43920270|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43920271|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920272|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
43920273|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920274|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
43920275|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
43920276|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920277|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920278|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
44238747|NCT00569452|Insulin|insulin|mesh-list
44238748|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44238749|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43920279|NCT04345341|Bupivacaine|bupivacaine|mesh-list
43920280|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
43920281|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
43920306|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920307|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43920309|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
43920310|NCT04245865|Antidotes|antidotes|mesh-ancestor
43920311|NCT04245865|Protective Agents|protective agents|mesh-ancestor
43920312|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
43920313|NCT04245865|Vitamins|vitamins|mesh-ancestor
43920314|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
43920315|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
43920316|NCT04221529|Atezolizumab|atezolizumab|mesh-list
43920317|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920318|NCT04149574|Nivolumab|nivolumab|mesh-list
43920319|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
43920320|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920321|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920322|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43920323|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920324|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43920325|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
43920326|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920327|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
43920328|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
43920329|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43920330|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
43920331|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43920332|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920333|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43920367|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43920368|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920369|NCT03754725|Deferiprone|deferiprone|mesh-list
43920370|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43920371|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
43920372|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
43920373|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920374|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
43920375|NCT03693014|Nivolumab|nivolumab|mesh-list
43920376|NCT03693014|Ipilimumab|ipilimumab|mesh-list
43920377|NCT03693014|Atezolizumab|atezolizumab|mesh-list
43920378|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920532|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920533|NCT00887380|Anastrozole|anastrozole|mesh-list
43920534|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920535|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920536|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43920537|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43920538|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920539|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920540|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43920541|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
43920542|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920543|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920544|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
43920545|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43920546|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920547|NCT00115700|Prednisolone|prednisolone|mesh-list
43920548|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
43920549|NCT00115700|Rituximab|rituximab|mesh-list
43920550|NCT00115700|Vincristine|vincristine|mesh-list
43920551|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666807|NCT02916316|Doxorubicin|doxorubicin|mesh-list
43920552|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
43920553|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920554|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920555|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43920556|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
43920687|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
43920688|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920689|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44238750|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238752|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44238753|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
44238754|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44238755|NCT00569465|Expectorants|expectorants|mesh-ancestor
44238756|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
43920690|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43920691|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43920692|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920693|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920695|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920696|NCT05560516|Analgesics|analgesics|mesh-ancestor
43920697|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
43920698|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920699|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
43920700|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43920701|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
43920702|NCT05560373|Huperzine A|huperzine a|mesh-list
43920703|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43920704|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920705|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920706|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
43920707|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139304|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139305|NCT00174772|Cisplatin|cisplatin|mesh-list
44139306|NCT00174772|Docetaxel|docetaxel|mesh-list
44139307|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139308|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139309|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139310|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139311|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139312|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44139313|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44139314|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44139315|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
44139316|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139317|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139318|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139319|NCT00174798|Urological Agents|urological agents|mesh-ancestor
44139320|NCT00174811|Telithromycin|telithromycin|mesh-list
44139321|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44139322|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139323|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
44139324|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44139325|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139326|NCT00174863|SR 31747|sr 31747|mesh-list
44139327|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139328|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139329|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139330|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
44139331|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139332|NCT00174876|Aripiprazole|aripiprazole|mesh-list
44139333|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44139334|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139335|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43920793|NCT05533580|Cisatracurium|cisatracurium|mesh-list
43920794|NCT05533580|Atracurium|atracurium|mesh-list
43920795|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43920796|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795510|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
43920866|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920867|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43920868|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43920869|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43920870|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43986598|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
43920872|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238757|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44238758|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
44238759|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920873|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43920874|NCT05415397|Analgesics|analgesics|mesh-ancestor
43920875|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
43920876|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920877|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920878|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43920879|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920880|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43920881|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43920882|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920883|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920884|NCT05409716|Hemostatics|hemostatics|mesh-list
43920885|NCT05409716|Coagulants|coagulants|mesh-ancestor
44139343|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44139344|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44139345|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
44139346|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44139347|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44139348|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44139349|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44139350|NCT00174902|Aspirin|aspirin|mesh-list
44139351|NCT00174902|Propranolol|propranolol|mesh-list
44139352|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139353|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139354|NCT00174902|Analgesics|analgesics|mesh-ancestor
44139355|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
44139356|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139357|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139358|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139399|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139400|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44139401|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139402|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139403|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
44139404|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44139405|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
44139406|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44139407|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139408|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44139409|NCT00175045|Lansoprazole|lansoprazole|mesh-list
44139410|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
44139411|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44139412|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139413|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44139414|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139415|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139416|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44139417|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44139418|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44139419|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139420|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139421|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44139439|NCT00175266|Infliximab|infliximab|mesh-list
44139440|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
44139441|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139442|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139443|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44139444|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139445|NCT00175305|Octreotide|octreotide|mesh-list
44139446|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139447|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44139448|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139449|NCT00175357|Methadone|methadone|mesh-list
44139450|NCT00175357|Heroin|heroin|mesh-list
44139451|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44139452|NCT00175357|Narcotics|narcotics|mesh-ancestor
44139453|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139454|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139455|NCT00175357|Analgesics|analgesics|mesh-ancestor
44238760|NCT00569465|Protective Agents|protective agents|mesh-ancestor
44238761|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238762|NCT00569465|Antidotes|antidotes|mesh-ancestor
44238763|NCT00569621|Moxaverine|moxaverine|mesh-list
44238764|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
44238765|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
44238766|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238767|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238768|NCT00569699|Bevacizumab|bevacizumab|mesh-list
44238769|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238770|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238771|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43884894|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139456|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
44139457|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921053|NCT04912115|Midazolam|midazolam|mesh-list
43921054|NCT04912115|Ketamine|ketamine|mesh-list
43921055|NCT04912115|Analgesics|analgesics|mesh-ancestor
43921056|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
43921057|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921058|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921059|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43921060|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43921061|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
43921062|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
43921063|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921064|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43921065|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43921066|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921067|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921068|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43921069|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43921070|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43921071|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43921072|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43921073|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
43921074|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
43921198|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921199|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
44139458|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
43921201|NCT04132388|Adalimumab|adalimumab|mesh-list
43921202|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921203|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921204|NCT04125563|Capsaicin|capsaicin|mesh-list
43921205|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
43921206|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921207|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
43921208|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921209|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921210|NCT04081688|Atezolizumab|atezolizumab|mesh-list
43921211|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43921212|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
43921213|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
43921214|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921215|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
43921293|NCT03667846|Topiramate|topiramate|mesh-list
43921294|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
43921295|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921296|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921297|NCT03649321|Gemcitabine|gemcitabine|mesh-list
43921298|NCT03649321|Paclitaxel|paclitaxel|mesh-list
43921299|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43921300|NCT03649321|Cisplatin|cisplatin|mesh-list
43921301|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43921302|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238772|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238773|NCT00569699|Growth Substances|growth substances|mesh-ancestor
44238774|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921303|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921304|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921305|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921306|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921307|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921308|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
43921309|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
43921310|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921311|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921312|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921313|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
43921314|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921315|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43962677|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43921448|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
43921449|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921450|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43921451|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43921452|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43921453|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43921454|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921580|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43921581|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43921582|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
43921583|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43921584|NCT00997906|Gemcitabine|gemcitabine|mesh-list
43921585|NCT00997906|Paclitaxel|paclitaxel|mesh-list
43921586|NCT00997906|Cisplatin|cisplatin|mesh-list
43921587|NCT00997906|Carboplatin|carboplatin|mesh-list
43921588|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43921589|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921590|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921591|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921592|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921593|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921594|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921595|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
43921596|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
43921597|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921598|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921599|NCT00997906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921600|NCT00997906|Immunologic Factors|immunologic factors|mesh-ancestor
43921601|NCT00997906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921602|NCT00754208|Methylphenidate|methylphenidate|mesh-list
43921603|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43921697|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
43921698|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921699|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
43921701|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921702|NCT00565370|Cisplatin|cisplatin|mesh-list
43921703|NCT00565370|Capecitabine|capecitabine|mesh-list
43921704|NCT00565370|Sorafenib|sorafenib|mesh-list
43921705|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921706|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921707|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
43921708|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921709|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43921710|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139483|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921752|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43921753|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796169|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
44238776|NCT00569712|Budesonide|budesonide|mesh-list
44238777|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
44238778|NCT00569712|Dimercaprol|dimercaprol|mesh-list
44238779|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238780|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238781|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
44238782|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238783|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921782|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43921783|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43921784|NCT00567008|Varenicline|varenicline|mesh-list
43921785|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43921786|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43921787|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921788|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921789|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921790|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921791|NCT00567229|Rituximab|rituximab|mesh-list
43921792|NCT00567229|Lenalidomide|lenalidomide|mesh-list
43921793|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921794|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921795|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
43921796|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921797|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921798|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43921799|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43921800|NCT00567229|Growth Substances|growth substances|mesh-ancestor
43921801|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
43921902|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43921903|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43921904|NCT05362851|Analgesics|analgesics|mesh-ancestor
43921905|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
43921906|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921907|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921908|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921909|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921910|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43921911|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43921912|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921913|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921946|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
43921947|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921948|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
43921949|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43921950|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43921951|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921952|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43921953|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43921954|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921955|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921956|NCT05362188|Niacinamide|niacinamide|mesh-list
43922014|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139516|NCT00175617|Minoxidil|minoxidil|mesh-list
43922015|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922016|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
43922017|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
43922018|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922019|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
43922020|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43922021|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43922022|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43922023|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922024|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
43922025|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44238785|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
43922080|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43796383|NCT05069779|Diazepam|diazepam|mesh-list
43922229|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43922230|NCT04925648|Dasatinib|dasatinib|mesh-list
43922231|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922232|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922233|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922234|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922235|NCT04341311|Panobinostat|panobinostat|mesh-list
43922236|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922237|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44139587|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139588|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
43922266|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43922267|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43922268|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
43922269|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
43922270|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922271|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922272|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922273|NCT04224194|Adalimumab|adalimumab|mesh-list
43922274|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922275|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922276|NCT04200833|Golimumab|golimumab|mesh-list
43922277|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43922278|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922279|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922280|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
43922281|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922282|NCT04191889|Apatinib|apatinib|mesh-list
43922283|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922284|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922285|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922354|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922356|NCT03840421|Cisplatin|cisplatin|mesh-list
43922357|NCT03840421|Fluorouracil|fluorouracil|mesh-list
43922358|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922359|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922360|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
43922361|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922362|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
43922363|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922364|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922365|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922366|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
43922367|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922396|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43922397|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43922398|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922399|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922400|NCT03642366|Urological Agents|urological agents|mesh-ancestor
43922401|NCT03641846|Tadalafil|tadalafil|mesh-list
43922402|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43922403|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43922404|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43922405|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922406|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922407|NCT03641846|Urological Agents|urological agents|mesh-ancestor
44139592|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44139593|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
44139594|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144991|NCT00193388|Topotecan|topotecan|mesh-list
44139595|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44139596|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139597|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44139598|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139599|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44139600|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44139601|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
44139602|NCT00175838|Aspirin|aspirin|mesh-list
43922515|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
44238786|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
44238788|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238789|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44238790|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43922516|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922517|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922518|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922519|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
43922520|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922521|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922522|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922556|NCT03072771|Melphalan|melphalan|mesh-list
43922557|NCT03072771|Carmustine|carmustine|mesh-list
43922558|NCT03072771|Blinatumomab|blinatumomab|mesh-list
43922559|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43922560|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922561|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922562|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922563|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922564|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922565|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922597|NCT03001882|Nivolumab|nivolumab|mesh-list
43922598|NCT03001882|Ipilimumab|ipilimumab|mesh-list
43922599|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922600|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922601|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43922602|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922603|NCT02958514|Tobramycin|tobramycin|mesh-list
43922604|NCT02958514|Dexamethasone|dexamethasone|mesh-list
43922605|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922606|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
43922607|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
43922608|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922609|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922610|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796564|NCT05063513|Rituximab|rituximab|mesh-list
43922665|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922667|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43922668|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922669|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
43922670|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922671|NCT02471391|Venetoclax|venetoclax|mesh-list
43796608|NCT05063071|Tenofovir|tenofovir|mesh-list
43922705|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
43922706|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922707|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43922708|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
43668862|NCT02324283|Propofol|propofol|mesh-list
43922710|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43922711|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43922712|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139664|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139665|NCT00175981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44139666|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44139667|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139668|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139669|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
44139670|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44139671|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44139672|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44139673|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44139674|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44139675|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
44139676|NCT00176020|Niacin|niacin|mesh-list
43922735|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796688|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238791|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44238792|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
44238793|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238794|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922797|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43922835|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922836|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796736|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
43922866|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
43922867|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922868|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922869|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
43922870|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922871|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922872|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
43922873|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922874|NCT00571961|Ritonavir|ritonavir|mesh-list
43922875|NCT00571961|Lopinavir|lopinavir|mesh-list
43922876|NCT00571961|Buprenorphine|buprenorphine|mesh-list
43922877|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43922878|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43922879|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
43922880|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922881|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922882|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43922883|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43922884|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
43922896|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43922897|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43922898|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
43922899|NCT00572117|Topiramate|topiramate|mesh-list
43922900|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
43922901|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43796797|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
43922956|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43922957|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922958|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922959|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43922960|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43922961|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43922962|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922963|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922965|NCT00573287|Clozapine|clozapine|mesh-list
43922966|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43922967|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
43922968|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922969|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922970|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922971|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43922972|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43922973|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922974|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922975|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43922976|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
43796837|NCT05058209|Hormones|hormones|mesh-ancestor
43923042|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923043|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923044|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923045|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923046|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923047|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
43923048|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923049|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923050|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923051|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
43923052|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43796867|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43923079|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923080|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43923081|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923083|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
44238795|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
44238796|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
44238797|NCT00569751|Paclitaxel|paclitaxel|mesh-list
44238798|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44238799|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885248|NCT04586465|Cisplatin|cisplatin|mesh-list
43923084|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43923085|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43923086|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43923087|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
43923088|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923089|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923090|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43923091|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43923092|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43923093|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923094|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
43923095|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43923096|NCT00575367|Azithromycin|azithromycin|mesh-list
43841810|NCT04590326|Cemiplimab|cemiplimab|mesh-list
43923124|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923125|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43923126|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43923127|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923128|NCT00576251|Tobramycin|tobramycin|mesh-list
43923129|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43923130|NCT00576251|Dexamethasone|dexamethasone|mesh-list
43923131|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923132|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
43923133|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
43923134|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923135|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923136|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923137|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
43923138|NCT00576251|Hormones|hormones|mesh-ancestor
43923139|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43923140|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43796897|NCT05056519|Vaccines|vaccines|mesh-list
43923156|NCT00577135|Diuretics|diuretics|mesh-list
43923157|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43923158|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
43923159|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923160|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923161|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923162|NCT00577590|Metformin|metformin|mesh-list
43923163|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
43923164|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43923165|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923166|NCT00578071|Capecitabine|capecitabine|mesh-list
43923167|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
43923168|NCT00578071|Panitumumab|panitumumab|mesh-list
43923169|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923171|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923172|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923173|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923174|NCT00578214|Midazolam|midazolam|mesh-list
43923175|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
43923176|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923177|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923178|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43923179|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43923180|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43923181|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43923182|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923183|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43923184|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
43923185|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
43923186|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
43923187|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238800|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
44238801|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
44238802|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156726|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923188|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923189|NCT00578279|Ethanol|ethanol|mesh-list
43923190|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43923191|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923192|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923193|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923194|NCT00578305|Folic Acid|folic acid|mesh-list
43923195|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
43923196|NCT00578305|Rituximab|rituximab|mesh-list
43923197|NCT00578305|Methotrexate|methotrexate|mesh-list
43923198|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923199|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923200|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
43923201|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923202|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923234|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923235|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923236|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923237|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43923238|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43923239|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43923240|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
43923241|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
43923242|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923243|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923245|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
43923305|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44139775|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
44139776|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139777|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139778|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44139779|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923318|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43923319|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
43923321|NCT00578903|Methotrexate|methotrexate|mesh-list
43923322|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
43923323|NCT00578903|Tacrolimus|tacrolimus|mesh-list
43923324|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923325|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
43923326|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923327|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923328|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923329|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
43923330|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923365|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43923366|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
43923367|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
43923389|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923390|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923392|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43923393|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
43923394|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923395|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43923396|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43923397|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923398|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923399|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
43923400|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923401|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923402|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
43923403|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923404|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
43923405|NCT00579813|Pioglitazone|pioglitazone|mesh-list
43923406|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43923407|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923408|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
43923409|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
43923410|NCT00579878|Methotrexate|methotrexate|mesh-list
44238803|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238805|NCT00569790|Irinotecan|irinotecan|mesh-list
44238806|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44238807|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238808|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238809|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238810|NCT00569790|Growth Substances|growth substances|mesh-ancestor
43923411|NCT00579878|Leflunomide|leflunomide|mesh-list
43923412|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43923413|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
43923414|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923415|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923416|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923417|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
43923418|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923419|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923420|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
43923421|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923422|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43797058|NCT05051137|Infliximab|infliximab|mesh-list
43923468|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923470|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923471|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
43923472|NCT00580229|Hormones|hormones|mesh-ancestor
43923473|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43923474|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923475|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43923476|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923477|NCT00580294|Oxymorphone|oxymorphone|mesh-list
43923478|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43923479|NCT00580294|Narcotics|narcotics|mesh-ancestor
43923480|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923481|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923482|NCT00580294|Analgesics|analgesics|mesh-ancestor
43923483|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
43923484|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923485|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43923486|NCT00580333|Paclitaxel|paclitaxel|mesh-list
43923487|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
43923518|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923519|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
43923520|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923521|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923522|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923523|NCT00580398|Varenicline|varenicline|mesh-list
43923524|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43923525|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43923526|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923527|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923528|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923529|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923530|NCT00580645|Varenicline|varenicline|mesh-list
43797141|NCT05049603|Atorvastatin|atorvastatin|mesh-list
43923565|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923566|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923567|NCT00581048|Vitamin E|vitamin e|mesh-list
43923568|NCT00581048|Tocopherols|tocopherols|mesh-list
43923602|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923603|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923604|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923605|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923606|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43923607|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43923608|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238811|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238812|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238813|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44238814|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44238815|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885390|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43923641|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923642|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923643|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
43923644|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923645|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923646|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
43923647|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923648|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923686|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43923687|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923688|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43923689|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43923717|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923718|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923719|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43923720|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43923721|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
43923722|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43923723|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
43923724|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923725|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923726|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43923727|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
43923728|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43923729|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
43923730|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923731|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923732|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43923733|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139780|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923766|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43923768|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923769|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923770|NCT00585650|Analgesics|analgesics|mesh-ancestor
43923771|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
43923772|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923773|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923774|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923863|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43923864|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43923865|NCT00587678|Simvastatin|simvastatin|mesh-list
43923866|NCT00587678|Ezetimibe|ezetimibe|mesh-list
43923867|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43923868|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43923869|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
43923870|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923871|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43923872|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43923873|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923874|NCT00587769|Bupropion|bupropion|mesh-list
43923875|NCT00587769|Varenicline|varenicline|mesh-list
43923876|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43923877|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
43923878|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923879|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43923880|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43923881|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923882|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238816|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238817|NCT00569816|Sevoflurane|sevoflurane|mesh-list
44238818|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44238819|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44238820|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
44238821|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
44238822|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885462|NCT04583267|Tenofovir|tenofovir|mesh-list
43923883|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
43923884|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923885|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923886|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43923887|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923888|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923889|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43923890|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43923891|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923892|NCT05247424|Heparin|heparin|mesh-list
43923893|NCT05247424|Calcium heparin|calcium heparin|mesh-list
43923928|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43924090|NCT05204368|Meropenem|meropenem|mesh-list
43924091|NCT05204368|Imipenem|imipenem|mesh-list
43924092|NCT05204368|Cilastatin|cilastatin|mesh-list
43924093|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43924094|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924095|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
43924096|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924097|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924098|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
43924099|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43924100|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43924101|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43924102|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924103|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924104|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
43924105|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924106|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924107|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43924108|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924109|NCT05175768|Niacinamide|niacinamide|mesh-list
43924110|NCT05175768|Niacin|niacin|mesh-list
43924111|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
43924112|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
43924113|NCT05175768|Vitamins|vitamins|mesh-ancestor
43924114|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
43924115|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924116|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924117|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
43924118|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924119|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924120|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
43924121|NCT05145010|Infigratinib|infigratinib|mesh-list
43924122|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924123|NCT05121350|Epirubicin|epirubicin|mesh-list
43924159|NCT04929392|Lenvatinib|lenvatinib|mesh-list
43924160|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43924161|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924162|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
43924163|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
43924164|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
43924165|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924166|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44139870|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139871|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139872|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139873|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
44139874|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139875|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44238823|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458978|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44458979|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885504|NCT04583020|Temozolomide|temozolomide|mesh-list
44139876|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44139877|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139878|NCT00176774|Antidotes|antidotes|mesh-ancestor
44139879|NCT00176774|Protective Agents|protective agents|mesh-ancestor
44139880|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
44139881|NCT00176774|Vitamins|vitamins|mesh-ancestor
44139882|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
44139883|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
44139884|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
44139885|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44139886|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44139887|NCT00176774|Growth Substances|growth substances|mesh-ancestor
44139888|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
44139889|NCT00176787|Capecitabine|capecitabine|mesh-list
44139890|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139891|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
43841930|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924209|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924210|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924211|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43924212|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
43924213|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43924214|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43924215|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43924216|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43924217|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924218|NCT04603391|Cannabidiol|cannabidiol|mesh-list
43924219|NCT04603391|Methylphenidate|methylphenidate|mesh-list
43924220|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43797591|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43924343|NCT04417569|Estradiol|estradiol|mesh-list
43924344|NCT04417569|Progesterone|progesterone|mesh-list
43924345|NCT04417569|Hormones|hormones|mesh-ancestor
43924346|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924347|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924348|NCT04417569|Estrogens|estrogens|mesh-ancestor
43924349|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43924350|NCT04417569|Progestins|progestins|mesh-ancestor
43924351|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43924352|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
43924376|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924377|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924379|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
43924380|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924381|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
43924382|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
43924383|NCT04233567|Infigratinib|infigratinib|mesh-list
43924384|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924385|NCT04220684|Cytarabine|cytarabine|mesh-list
43924386|NCT04220684|Fludarabine|fludarabine|mesh-list
43924387|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924388|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924389|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
43924390|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924391|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924392|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
43924393|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924394|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
43924395|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924396|NCT04159974|Durvalumab|durvalumab|mesh-list
43924397|NCT04159974|Tremelimumab|tremelimumab|mesh-list
43924398|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43924399|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924400|NCT04157725|Clomiphene|clomiphene|mesh-list
43924401|NCT04157725|Enclomiphene|enclomiphene|mesh-list
43924402|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
43924403|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43924404|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924405|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924406|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458980|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458981|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458982|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
44458983|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44458984|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
43885572|NCT04581876|Paclitaxel|paclitaxel|mesh-list
43924470|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924471|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924472|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924473|NCT04027361|Amphetamine|amphetamine|mesh-list
43924474|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43924475|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924476|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
43924477|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
43924478|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924479|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
43924480|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924481|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924482|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
43924483|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43924516|NCT03793439|Prednisone|prednisone|mesh-list
43924517|NCT03793439|Tofacitinib|tofacitinib|mesh-list
43924518|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924519|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
43924520|NCT03793439|Hormones|hormones|mesh-ancestor
43924521|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924522|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924523|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797764|NCT05037695|Empagliflozin|empagliflozin|mesh-list
44139925|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
44139926|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139927|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139928|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
44139929|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
44139930|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44139931|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44139932|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139933|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924564|NCT03708354|Tocopherols|tocopherols|mesh-list
43924565|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
43924566|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924567|NCT03708354|Protective Agents|protective agents|mesh-ancestor
43962679|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43924627|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924628|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43924629|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924630|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924631|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43924632|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
43924633|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924634|NCT03177122|Inositol|inositol|mesh-list
43924635|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
43924636|NCT03177122|Vitamins|vitamins|mesh-ancestor
43924767|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
43924768|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43924769|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
43797957|NCT05035147|Antiviral Agents|antiviral agents|mesh-ancestor
43924804|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924805|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
43924806|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43924807|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
43962680|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43924822|NCT01740648|Trametinib|trametinib|mesh-list
43924823|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
43924824|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924825|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924826|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924827|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924828|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
44458985|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458986|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458987|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44458988|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44458989|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
44458990|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44458991|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
43924829|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924830|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924831|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924832|NCT01685424|Etoricoxib|etoricoxib|mesh-list
43924833|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924834|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924835|NCT01685424|Analgesics|analgesics|mesh-ancestor
43924836|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
43924837|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924838|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924839|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924840|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924841|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43924842|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924843|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924844|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924845|NCT01587235|Simvastatin|simvastatin|mesh-list
43924846|NCT01587235|Ezetimibe|ezetimibe|mesh-list
43924847|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43924848|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924849|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924850|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
43924851|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924852|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924853|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43924854|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924855|NCT01571128|Tenofovir|tenofovir|mesh-list
43924856|NCT01571128|Emtricitabine|emtricitabine|mesh-list
43924857|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
43924858|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924859|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43924860|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43924861|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924862|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924863|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43924864|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43924865|NCT01429168|Etoricoxib|etoricoxib|mesh-list
43924866|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924901|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924902|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924903|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924926|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
43924927|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924928|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43924929|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924930|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
43924931|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43924932|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43924933|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
43924934|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924935|NCT00755794|Montelukast|montelukast|mesh-list
43924936|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43924937|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
43924938|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43924939|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
43798067|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
43924955|NCT00653276|Cyclosporine|cyclosporine|mesh-list
43924956|NCT00653276|Ezetimibe|ezetimibe|mesh-list
43924957|NCT00653276|Cyclosporins|cyclosporins|mesh-list
43924958|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803778|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
44458992|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458993|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458994|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
44458995|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44458996|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
44458997|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458998|NCT01587001|Expectorants|expectorants|mesh-ancestor
44458999|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459000|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44459001|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
44459002|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459003|NCT01587001|Protective Agents|protective agents|mesh-ancestor
43924959|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924960|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924961|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
43924962|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924963|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
43924964|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924965|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
43924966|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924967|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43924968|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924969|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924970|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
43924971|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924972|NCT00652847|Ezetimibe|ezetimibe|mesh-list
43924973|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924974|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924975|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
43924976|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924977|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924978|NCT00652717|Simvastatin|simvastatin|mesh-list
43924979|NCT00652717|Ezetimibe|ezetimibe|mesh-list
43924980|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924981|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924982|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
43924983|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924984|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43987570|NCT02292082|Cefazolin|cefazolin|mesh-list
43924985|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43924986|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924987|NCT00652444|Simvastatin|simvastatin|mesh-list
43924988|NCT00652444|Ezetimibe|ezetimibe|mesh-list
43924989|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924990|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924991|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
43924992|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924993|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43962681|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
43925060|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925061|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
43925062|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925063|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925064|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925065|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925066|NCT00489346|Fluticasone|fluticasone|mesh-list
43925067|NCT00489346|Xhance|xhance|mesh-list
43925068|NCT00489346|Montelukast|montelukast|mesh-list
43925069|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925070|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43925071|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
43925072|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925073|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670788|NCT05425368|Fluorides|fluorides|mesh-list
43925074|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459004|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459005|NCT01587001|Antidotes|antidotes|mesh-ancestor
44459006|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
44459007|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43925075|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925076|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925172|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925173|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925174|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925175|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925176|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925177|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925178|NCT00242489|Diclofenac|diclofenac|mesh-list
43925179|NCT00242489|Etoricoxib|etoricoxib|mesh-list
43925180|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925181|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925182|NCT00242489|Analgesics|analgesics|mesh-ancestor
43925183|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
43925184|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925185|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925186|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925200|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925201|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139967|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139968|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
44139969|NCT00177060|Hydromorphone|hydromorphone|mesh-list
44139970|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44139971|NCT00177060|Narcotics|narcotics|mesh-ancestor
44139972|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139973|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139974|NCT00177060|Analgesics|analgesics|mesh-ancestor
44139975|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
44139976|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139977|NCT00177086|Alfuzosin|alfuzosin|mesh-list
44139978|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44139979|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44139980|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44139981|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44139982|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139983|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139984|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139985|NCT00177086|Urological Agents|urological agents|mesh-ancestor
44139986|NCT00177099|Tacrolimus|tacrolimus|mesh-list
44139987|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987641|NCT02295553|Ketamine|ketamine|mesh-list
43925203|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925204|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925205|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
43925206|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925207|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925208|NCT00092716|Atorvastatin|atorvastatin|mesh-list
43925209|NCT00092716|Ezetimibe|ezetimibe|mesh-list
43925210|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925211|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925212|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
43925213|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925214|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925215|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925216|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925217|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
43925218|NCT00588159|Promethazine|promethazine|mesh-list
43925219|NCT00588159|Gabapentin|gabapentin|mesh-list
43925220|NCT00588159|Analgesics|analgesics|mesh-ancestor
43925221|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
43925222|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925223|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925224|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
43925225|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43925226|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43925227|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43925228|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925253|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
43925254|NCT00588406|Hormones|hormones|mesh-ancestor
44459008|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459009|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459010|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459011|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459012|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459013|NCT01586806|Dexamethasone|dexamethasone|mesh-list
44459014|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
44459015|NCT01586806|Bupivacaine|bupivacaine|mesh-list
44459016|NCT01586806|BB 1101|bb 1101|mesh-list
44459017|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459018|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
44459019|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
43925255|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43925256|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925257|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43925258|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925259|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43925260|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
43925261|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925262|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43925263|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925264|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
43925265|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
43925266|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43925267|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43925268|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43925269|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43925270|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
43925271|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925272|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925273|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43925274|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
43925275|NCT00588536|Leucovorin|leucovorin|mesh-list
43925276|NCT00588536|Methotrexate|methotrexate|mesh-list
43925277|NCT00588536|Thioguanine|thioguanine|mesh-list
43925278|NCT00588536|Calcium|calcium|mesh-list
43925279|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
43925280|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43925281|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925282|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43925283|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
43925284|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43925306|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925308|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43925309|NCT00588965|Propranolol|propranolol|mesh-list
43925310|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43925311|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43925312|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
43925313|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925314|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925315|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925316|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43925317|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43925318|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
43925319|NCT00589056|Nelfinavir|nelfinavir|mesh-list
43925320|NCT00589056|Cisplatin|cisplatin|mesh-list
43925321|NCT00589056|Etoposide|etoposide|mesh-list
43925322|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925323|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43925324|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925325|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925326|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925327|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459020|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459021|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459023|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
44459024|NCT01586806|Hormones|hormones|mesh-ancestor
44459025|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885860|NCT04575779|Cyclosporine|cyclosporine|mesh-list
43925328|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43925329|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43925330|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
43925331|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43925332|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43925333|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
43925334|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925335|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43925336|NCT00589329|Metronidazole|metronidazole|mesh-list
43925337|NCT00589329|Erythromycin|erythromycin|mesh-list
43925338|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
43925339|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43925368|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43925369|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925371|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925372|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925373|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43925374|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43925375|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43925376|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925377|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925378|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43925379|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925380|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925381|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43925382|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
43925383|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43925384|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43925385|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43925420|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43925421|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925422|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43925423|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43925424|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925425|NCT00590863|Dexetimide|dexetimide|mesh-list
43925426|NCT00590863|Mirtazapine|mirtazapine|mesh-list
43925450|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43925451|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43925453|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43925454|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43925455|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
43925456|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
43925457|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43925458|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43925459|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43925460|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43925461|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43925462|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43925463|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
43925464|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43925465|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43925466|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43925467|NCT00591019|Modafinil|modafinil|mesh-list
43925468|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43925469|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925470|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43925471|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43804141|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
44459026|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459027|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459028|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44459029|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459030|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459031|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
44459033|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459034|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
44459035|NCT01586338|Hylan|hylan|mesh-list
44459036|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
44238824|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
44238825|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
44238826|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44238827|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925472|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43925473|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925474|NCT00591123|Leucovorin|leucovorin|mesh-list
43925475|NCT00591123|Fluorouracil|fluorouracil|mesh-list
43925501|NCT00591825|Renal Agents|renal agents|mesh-ancestor
43925502|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43925503|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
43925504|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925505|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
43925506|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925508|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
43925509|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925510|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43925511|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43925512|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925513|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925514|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43925515|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43925516|NCT00592176|Bevacizumab|bevacizumab|mesh-list
43925517|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925518|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925519|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925520|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925521|NCT00592176|Growth Substances|growth substances|mesh-ancestor
43925522|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925523|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925525|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43798479|NCT05023863|Vitamins|vitamins|mesh-ancestor
43925636|NCT00595231|Rufinamide|rufinamide|mesh-list
43925637|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
43925638|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43925662|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925663|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43925664|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43925665|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
43925666|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
43925667|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43925668|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43925669|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43925670|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925671|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925672|NCT00595556|Zonisamide|zonisamide|mesh-list
43925673|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
43925674|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43925675|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44238828|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44238830|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885984|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
43925676|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925677|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43925678|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925679|NCT00595790|Vaccines|vaccines|mesh-list
43925680|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
43925681|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925682|NCT00595946|Lubiprostone|lubiprostone|mesh-list
43925683|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43925684|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925685|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925697|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925698|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43925699|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43925700|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43925702|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
43925703|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925705|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43925706|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
43925707|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925708|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925709|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43925710|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43925711|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
43925712|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925713|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925714|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
43925715|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925716|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925717|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925718|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925719|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925720|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925721|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925722|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43925723|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43925724|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
43925725|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925726|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925727|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925728|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925729|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
43925730|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43925731|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43925732|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925733|NCT00597038|Dasatinib|dasatinib|mesh-list
43925734|NCT00597038|Dacarbazine|dacarbazine|mesh-list
43925735|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925736|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43925737|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925738|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925739|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925740|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
43925741|NCT00597402|Bevacizumab|bevacizumab|mesh-list
43925742|NCT00597402|Irinotecan|irinotecan|mesh-list
43925743|NCT00597402|Temozolomide|temozolomide|mesh-list
43925744|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925745|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925746|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925747|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925748|NCT00597402|Growth Substances|growth substances|mesh-ancestor
43925749|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925782|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
43925783|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925784|NCT00597896|Protective Agents|protective agents|mesh-ancestor
44238831|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238832|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238833|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44238834|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44238835|NCT00569920|Dexamethasone|dexamethasone|mesh-list
44238836|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
44238838|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238839|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
43925785|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925786|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43925787|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43925788|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
43925789|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
43925824|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139989|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139990|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44139991|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139992|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139993|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
44140024|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44140025|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140026|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44140027|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44140028|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
44140029|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44140030|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44140031|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44140032|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44140033|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
44140034|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44140035|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43925825|NCT00601627|Gemcitabine|gemcitabine|mesh-list
43925826|NCT00601627|Fluorouracil|fluorouracil|mesh-list
43925827|NCT00601627|Capecitabine|capecitabine|mesh-list
43925828|NCT00601627|Panitumumab|panitumumab|mesh-list
43798729|NCT05018182|Antidotes|antidotes|mesh-ancestor
43925854|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925855|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925856|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925857|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
43925858|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43925859|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
43925861|NCT00601796|Vaccines|vaccines|mesh-list
43925862|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
43925863|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925864|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925865|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925866|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925867|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
43925868|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925869|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925870|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43925871|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
43925872|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925873|NCT00601926|Bevacizumab|bevacizumab|mesh-list
43925874|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925875|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925876|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43798757|NCT05017311|Citalopram|citalopram|mesh-list
43925899|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925901|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
43925902|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925903|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925904|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
43925905|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238840|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
44238841|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238842|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238843|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44238844|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
43925906|NCT00602290|Methylphenidate|methylphenidate|mesh-list
43925907|NCT00602290|Citalopram|citalopram|mesh-list
43925908|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43925909|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925910|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43925911|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43925912|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925913|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925914|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
43925915|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925916|NCT00602290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43925917|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
43925918|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43925919|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925920|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925921|NCT00602355|Sertraline|sertraline|mesh-list
43925922|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925957|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43925958|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925959|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925960|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925961|NCT00602836|Growth Substances|growth substances|mesh-ancestor
43925962|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925985|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925987|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925988|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925989|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43925990|NCT00603187|Acyline|acyline|mesh-list
43925991|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
43925992|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43925993|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925994|NCT00603408|Cisplatin|cisplatin|mesh-list
43925995|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925996|NCT00603720|Phenylephrine|phenylephrine|mesh-list
43925997|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
43925998|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
43925999|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43926000|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
43926001|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
43926002|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926003|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926004|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
43926005|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43926006|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
43926007|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
43926008|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43926009|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43926010|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43926011|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926012|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962683|NCT01516684|Fentanyl|fentanyl|mesh-list
43926032|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
43926033|NCT00604019|Protective Agents|protective agents|mesh-ancestor
43926034|NCT00604461|Bevacizumab|bevacizumab|mesh-list
43926035|NCT00604461|Carboplatin|carboplatin|mesh-list
43926036|NCT00604461|Pemetrexed|pemetrexed|mesh-list
43926037|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926038|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926039|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926040|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926041|NCT00604461|Growth Substances|growth substances|mesh-ancestor
43926042|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926043|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926044|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926045|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238845|NCT00569920|Hormones|hormones|mesh-ancestor
44238846|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238847|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44238848|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238849|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
44238850|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238851|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886169|NCT04571437|Letrozole|letrozole|mesh-list
43926046|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43926047|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926048|NCT00604968|Doxorubicin|doxorubicin|mesh-list
43926049|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43926050|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43926051|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926052|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43926053|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926054|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926055|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926056|NCT00605072|Metoprolol|metoprolol|mesh-list
43926057|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43926058|NCT00605072|Candesartan|candesartan|mesh-list
43926059|NCT00605072|Lisinopril|lisinopril|mesh-list
43926060|NCT00605072|Nifedipine|nifedipine|mesh-list
43926061|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43926062|NCT00605072|Diuretics|diuretics|mesh-ancestor
43926063|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
43926064|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926065|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43926066|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926067|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926068|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43926069|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
43926070|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
43926103|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43926104|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926105|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926106|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926107|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43926108|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43926109|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43926110|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926111|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
43926147|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926148|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43926149|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926150|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926151|NCT00607113|Bevacizumab|bevacizumab|mesh-list
43926220|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43926221|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926222|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
43926223|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926224|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926225|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
43926226|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926227|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
43926228|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43926229|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926230|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
43926231|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
43926232|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926233|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926267|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
43926268|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926269|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
43926270|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
43926271|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
43926272|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238852|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
44238853|NCT00569985|Carmustine|carmustine|mesh-list
44238854|NCT00569985|Etoposide|etoposide|mesh-list
44238855|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
44238856|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44238857|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
44238858|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238859|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238860|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44238861|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
44238862|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238863|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238864|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44238865|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44238866|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44238867|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44238868|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238869|NCT00570050|Insulin|insulin|mesh-list
44238870|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44238871|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238872|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238873|NCT00570180|Bortezomib|bortezomib|mesh-list
44238874|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238875|NCT00570193|Ranibizumab|ranibizumab|mesh-list
44238876|NCT00570193|Verteporfin|verteporfin|mesh-list
44238877|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238878|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238879|NCT00570193|Growth Substances|growth substances|mesh-ancestor
44238880|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238881|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238882|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238883|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44238884|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44238885|NCT00570219|Valproic Acid|valproic acid|mesh-list
44238886|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
44238887|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238888|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238889|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
43886236|NCT04570592|Hormones|hormones|mesh-ancestor
44238890|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238891|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238892|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
44238893|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44238894|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44238895|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44238896|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
44238897|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238898|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
44238899|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926273|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926274|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926275|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926313|NCT00610740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926389|NCT00611442|Lubiprostone|lubiprostone|mesh-list
43926390|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43926391|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926392|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926393|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43926395|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926396|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926397|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926398|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926399|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43926400|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926401|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
43926402|NCT00611897|Ketamine|ketamine|mesh-list
43926403|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43926404|NCT00611897|Analgesics|analgesics|mesh-ancestor
43926405|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
43926406|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926407|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926408|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43926409|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43926410|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
43926411|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
43926412|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926413|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43926414|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43926415|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926416|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926417|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
43926418|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926419|NCT00611897|Expectorants|expectorants|mesh-ancestor
43926420|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
43926421|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43926422|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
43926423|NCT00611897|Protective Agents|protective agents|mesh-ancestor
43926424|NCT00611897|Antidotes|antidotes|mesh-ancestor
43926425|NCT00612222|Aldesleukin|aldesleukin|mesh-list
43926426|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
43926427|NCT00612222|Fludarabine|fludarabine|mesh-list
43926428|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
43926429|NCT00612222|Interleukin-2|interleukin-2|mesh-list
43926430|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926431|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
43926432|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926433|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926434|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926435|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
43926436|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926437|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926438|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926439|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926440|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
44238900|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238901|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44238902|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238903|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44238904|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
43886319|NCT04570254|Antidotes|antidotes|mesh-ancestor
43926441|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926442|NCT00612222|Analgesics|analgesics|mesh-ancestor
43926443|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
43926444|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926445|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43926446|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43926447|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
43926448|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926449|NCT00612235|Lamotrigine|lamotrigine|mesh-list
43926477|NCT00612339|Growth Substances|growth substances|mesh-ancestor
43926478|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926479|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926480|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926481|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
43926482|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926483|NCT00612430|Bevacizumab|bevacizumab|mesh-list
43926485|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
43926486|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926487|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926488|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926489|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926490|NCT00612430|Growth Substances|growth substances|mesh-ancestor
43926491|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926492|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926493|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43926518|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
43926519|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926520|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926521|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926522|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
43926523|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926524|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926525|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926527|NCT00613028|Etoposide|etoposide|mesh-list
43926528|NCT00613028|Temozolomide|temozolomide|mesh-list
43926529|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926530|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926531|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926532|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926533|NCT00613028|Growth Substances|growth substances|mesh-ancestor
43926534|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926535|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926536|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43926537|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43926538|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926539|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926540|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926541|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926577|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
43962685|NCT01516684|Prilocaine|prilocaine|mesh-list
44157438|NCT00234455|Sirolimus|sirolimus|mesh-list
44157439|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157440|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157441|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157442|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157443|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
44157444|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157445|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
44157446|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157447|NCT00234468|Gefitinib|gefitinib|mesh-list
44157448|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804584|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
44238905|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238906|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238907|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44157449|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157450|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926614|NCT00615433|Olanzapine|olanzapine|mesh-list
43926648|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
43926649|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43926650|NCT00615472|Narcotics|narcotics|mesh-ancestor
43926651|NCT00615472|Analgesics|analgesics|mesh-ancestor
43926652|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
43926653|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926654|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43926725|NCT00617058|Metformin|metformin|mesh-list
43926774|NCT00617942|Trastuzumab|trastuzumab|mesh-list
43926775|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43926776|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926777|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
43926778|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
43926779|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
43926780|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926781|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926782|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
43926783|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926784|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
43926785|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43926786|NCT00618436|Phenytoin|phenytoin|mesh-list
43926787|NCT00618436|Levetiracetam|levetiracetam|mesh-list
43926788|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
43926789|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
43926790|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43926791|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43926792|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926793|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926794|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43926795|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43926796|NCT00618540|Fludarabine|fludarabine|mesh-list
43926797|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
43926798|NCT00618540|Melphalan|melphalan|mesh-list
43926799|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
43926800|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926801|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926802|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
43926803|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926804|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926806|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926807|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926808|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
43926809|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926810|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926811|NCT00618917|Manganese|manganese|mesh-list
43926812|NCT00618917|Paclitaxel|paclitaxel|mesh-list
43926881|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926882|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926883|NCT00619684|Growth Substances|growth substances|mesh-ancestor
43926884|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926885|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926914|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43926915|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
43926916|NCT00621049|Bevacizumab|bevacizumab|mesh-list
43926917|NCT00621049|Carboplatin|carboplatin|mesh-list
43926919|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43926920|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926921|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926922|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926923|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926924|NCT00621049|Growth Substances|growth substances|mesh-ancestor
43926925|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926926|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926927|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
43926928|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
43926929|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44238908|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
44238909|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
44238910|NCT00570245|Protective Agents|protective agents|mesh-ancestor
43926930|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926931|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926932|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926933|NCT00621179|Leuprolide|leuprolide|mesh-list
43926964|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926965|NCT00621946|Dexetimide|dexetimide|mesh-list
43926966|NCT00621946|Citalopram|citalopram|mesh-list
43926967|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43926968|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43926969|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926970|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926971|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926972|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
43926973|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926974|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43926975|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927027|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927029|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43927030|NCT00624013|Sertraline|sertraline|mesh-list
43927031|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927032|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927033|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43927034|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927035|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927036|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927037|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927038|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
43927039|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927041|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43927042|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43927043|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43927044|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927045|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927105|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
43927106|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927107|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927108|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927109|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927175|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
43927176|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927177|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927210|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927211|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
43927212|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927213|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43927214|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
43927215|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927216|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43927217|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927218|NCT00626886|Bupivacaine|bupivacaine|mesh-list
43927219|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
43927220|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
43927221|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927254|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
43927255|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927256|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927257|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43927258|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43927259|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43927260|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927261|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927262|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927263|NCT00628134|Calfactant|calfactant|mesh-list
43927264|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43927323|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927325|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
44238911|NCT00570284|Panobinostat|panobinostat|mesh-list
44238912|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238913|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44238914|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238915|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927326|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927327|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927328|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927329|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
43927330|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927331|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43927332|NCT00629525|Everolimus|everolimus|mesh-list
43927333|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927334|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927335|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
43842159|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43927350|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927352|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927353|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927354|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
43927355|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927356|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927357|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43927358|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43927359|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43927360|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
43927361|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927362|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927364|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
43927365|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927366|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927367|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
43927368|NCT00630253|Hormones|hormones|mesh-ancestor
43927369|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927370|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43927371|NCT00630253|Protective Agents|protective agents|mesh-ancestor
43927372|NCT00630409|Gemcitabine|gemcitabine|mesh-list
43927373|NCT00630409|Doxorubicin|doxorubicin|mesh-list
43927374|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927375|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
43927376|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927377|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927378|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
43927379|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927380|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927381|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927382|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
43927383|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927384|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43927385|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43927386|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140042|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44140043|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
44140044|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44140045|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140046|NCT00177411|Hormones|hormones|mesh-list
44140047|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
44140048|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44140049|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140050|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140051|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44140052|NCT00177424|Sertraline|sertraline|mesh-list
44140085|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140086|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140087|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44140088|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672634|NCT02179151|CKD732|ckd732|mesh-list
43927387|NCT00630734|Ritonavir|ritonavir|mesh-list
43927388|NCT00630734|Darunavir|darunavir|mesh-list
44238916|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44238917|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238918|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44238919|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238920|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927389|NCT00630734|Pravastatin|pravastatin|mesh-list
43927390|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43927391|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43927392|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
43927393|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927430|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
43927454|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43927455|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
43927456|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43927457|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43927458|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927459|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927460|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43927461|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927462|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927463|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927464|NCT00632411|Nicotine|nicotine|mesh-list
43927465|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43927466|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
43927467|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927468|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927469|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43927470|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43927471|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
43927472|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927473|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927474|NCT00632489|Capecitabine|capecitabine|mesh-list
43927475|NCT00632489|Lapatinib|lapatinib|mesh-list
43927476|NCT00632489|Panobinostat|panobinostat|mesh-list
43927477|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927478|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
43927479|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927480|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927481|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43927482|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927538|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927539|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927540|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927541|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43927542|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
43927544|NCT00633919|Budesonide|budesonide|mesh-list
43927545|NCT00633919|Albuterol|albuterol|mesh-list
43927546|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
43927547|NCT00633919|Desloratadine|desloratadine|mesh-list
43927548|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927549|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
43927550|NCT00633919|Hormones|hormones|mesh-ancestor
43927551|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927552|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927553|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927554|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927555|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43927556|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
43927557|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927558|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43927559|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927560|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43927561|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43927562|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43927563|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927564|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927565|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927688|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
43927689|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
43927690|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238921|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
44238922|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44238923|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
44238924|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
44238925|NCT00570440|Estradiol|estradiol|mesh-list
44238926|NCT00570440|Estrogens|estrogens|mesh-ancestor
44238927|NCT00570440|Hormones|hormones|mesh-ancestor
43886538|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43927691|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
43927692|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927693|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43927694|NCT00638651|Imiquimod|imiquimod|mesh-list
43927695|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43927696|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
43927697|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927698|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927699|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
43927700|NCT00638820|Busulfan|busulfan|mesh-list
43927701|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
43927702|NCT00638820|Clofarabine|clofarabine|mesh-list
43927703|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
43927704|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927705|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927706|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
43927707|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927708|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927709|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927710|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927711|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43927712|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927713|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
43927714|NCT00638937|Saracatinib|saracatinib|mesh-list
43927715|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927716|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927717|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927718|NCT00639158|Choline|choline|mesh-list
43927719|NCT00639158|Atorvastatin|atorvastatin|mesh-list
43927720|NCT00639158|Ezetimibe|ezetimibe|mesh-list
43927721|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
43927722|NCT00639158|Fenofibrate|fenofibrate|mesh-list
43927723|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43927724|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43927761|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43800158|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
43927825|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927826|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43927827|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927828|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927829|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927830|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43927831|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
43927832|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43927833|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43927834|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43927835|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
43672918|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
43927836|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43927837|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43927838|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
43927841|NCT00641797|Lorazepam|lorazepam|mesh-list
43927842|NCT00641797|Ondansetron|ondansetron|mesh-list
43927843|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
43927844|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
43927845|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927846|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927847|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927885|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
43927886|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927887|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43927888|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927918|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238928|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238929|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238930|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44238931|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44238932|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44238933|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44238934|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44238935|NCT00570479|Anecortave|anecortave|mesh-list
44238936|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238937|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238938|NCT00570479|Growth Substances|growth substances|mesh-ancestor
43927919|NCT00644189|Clofarabine|clofarabine|mesh-list
43927920|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927921|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
43927922|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927923|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927924|NCT00644592|Fenofibrate|fenofibrate|mesh-list
43927925|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43927926|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
43927927|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927928|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43927929|NCT00644657|Clopidogrel|clopidogrel|mesh-list
43927930|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43927931|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43927932|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43927998|NCT00646763|Sargramostim|sargramostim|mesh-list
43927999|NCT00646763|Mitogens|mitogens|mesh-list
43928000|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43928001|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
43928002|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928003|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
43928004|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928005|NCT00647400|Adalimumab|adalimumab|mesh-list
43928006|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928007|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928008|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
43928009|NCT00647998|Hematinics|hematinics|mesh-ancestor
43928010|NCT00648375|Propranolol|propranolol|mesh-list
43928011|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43928012|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43928013|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928014|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800262|NCT04994236|Antidotes|antidotes|mesh-ancestor
43928033|NCT00648648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928034|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
43928035|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43928036|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928037|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928038|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
43928039|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43928040|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928041|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928042|NCT00649961|Melatonin|melatonin|mesh-list
43928043|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
43928044|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928045|NCT00649961|Protective Agents|protective agents|mesh-ancestor
43928046|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928047|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928048|NCT00650078|Prednisone|prednisone|mesh-list
43928049|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928050|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
43928051|NCT00650078|Hormones|hormones|mesh-ancestor
44238939|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238940|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238941|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238942|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
44238943|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44238944|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
44238945|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238946|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238947|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44238948|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
44238949|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
44238950|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43928052|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928053|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928054|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928055|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928056|NCT00650546|Exenatide|exenatide|mesh-list
43928057|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43928058|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928059|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43928060|NCT00650546|Incretins|incretins|mesh-ancestor
43928061|NCT00650546|Hormones|hormones|mesh-ancestor
43928062|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928063|NCT00650858|Plasminogen|plasminogen|mesh-list
43928064|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43928065|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43928066|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43928067|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928068|NCT00651040|Prednisone|prednisone|mesh-list
43928069|NCT00651040|Prednisolone|prednisolone|mesh-list
43928070|NCT00651040|Methotrexate|methotrexate|mesh-list
43928101|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
44140089|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140091|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44140092|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
44140093|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
44140094|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
44140095|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140096|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44140097|NCT00177567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140098|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140099|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140100|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140116|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44140117|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44140118|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44140119|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44140120|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44140121|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44140122|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
44140123|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43928103|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43928104|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43928105|NCT00652145|Analgesics|analgesics|mesh-ancestor
43928106|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
43928107|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928108|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928109|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928110|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928111|NCT00652314|Thrombin|thrombin|mesh-list
43928112|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
43928113|NCT00652314|Coagulants|coagulants|mesh-ancestor
43928114|NCT00653861|Lidocaine|lidocaine|mesh-list
44238951|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
44238952|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44238953|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238954|NCT00570622|Pioglitazone|pioglitazone|mesh-list
43928115|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
43928116|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
43928117|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928118|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928119|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
43928120|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928121|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43928122|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43928123|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43928124|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928125|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928126|NCT00654030|Vaccines|vaccines|mesh-list
43928127|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
43928128|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928129|NCT00654069|Niacin|niacin|mesh-list
43928130|NCT00654069|Niacinamide|niacinamide|mesh-list
43928131|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
43928132|NCT00654069|Oxycodone|oxycodone|mesh-list
43928133|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43928134|NCT00654069|Narcotics|narcotics|mesh-ancestor
43928135|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928136|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928137|NCT00654069|Analgesics|analgesics|mesh-ancestor
43928138|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
43928172|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928173|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673224|NCT01989325|Hormones|hormones|mesh-ancestor
43928175|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
43928176|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928177|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43928178|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43928179|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43928180|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928181|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928198|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43928199|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43928201|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928202|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928203|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928204|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43928205|NCT00654511|Narcotics|narcotics|mesh-ancestor
43928206|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43928207|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43928208|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
43928209|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
43928210|NCT00654784|Idebenone|idebenone|mesh-list
43928211|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
43928212|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928213|NCT00654784|Protective Agents|protective agents|mesh-ancestor
43928214|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928215|NCT00654836|Bevacizumab|bevacizumab|mesh-list
43928216|NCT00654836|Carboplatin|carboplatin|mesh-list
43928217|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43928218|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928219|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928220|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43928221|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43928222|NCT00654836|Growth Substances|growth substances|mesh-ancestor
43928223|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928224|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43928225|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
43928226|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43928227|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928228|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928229|NCT00654953|Gabapentin|gabapentin|mesh-list
43928230|NCT00654953|Sertraline|sertraline|mesh-list
43928231|NCT00654953|Analgesics|analgesics|mesh-ancestor
44238955|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44238956|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238957|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
44238958|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44238959|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
44238960|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238961|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
44238962|NCT00570648|Protective Agents|protective agents|mesh-ancestor
44238963|NCT00570726|Ranibizumab|ranibizumab|mesh-list
44238964|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238965|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238966|NCT00570726|Growth Substances|growth substances|mesh-ancestor
44238967|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238968|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238969|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238970|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44238971|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238972|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
44238973|NCT00570830|Hormones|hormones|mesh-ancestor
44459037|NCT01586338|Protective Agents|protective agents|mesh-ancestor
43928232|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
43928233|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928234|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928235|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
43928236|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43928237|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43928238|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928239|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928240|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43928241|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43928249|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
43928250|NCT00655083|MEN 11420|men 11420|mesh-list
43928251|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43928252|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
43928253|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928254|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928255|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43928256|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
43928257|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
43928258|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43928259|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43928260|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
43928261|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928262|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43928263|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
43928264|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43928265|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43928266|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
43928267|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928268|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43928269|NCT00655642|Promethazine|promethazine|mesh-list
43928270|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
43928271|NCT00655642|Ondansetron|ondansetron|mesh-list
43928272|NCT00655642|Metoclopramide|metoclopramide|mesh-list
43928273|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
43928274|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
43928275|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928276|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238974|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44238975|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238976|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
43928277|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928278|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
43928279|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928280|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43928281|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
43928282|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928283|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928284|NCT00655642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43928285|NCT00655642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43928286|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928287|NCT00655642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928288|NCT00655642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43928289|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43928290|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43928291|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
43928292|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43928293|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
43928294|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
43928295|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43928296|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43928297|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43928298|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
43928299|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
43928300|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
43928301|NCT00655811|Capsaicin|capsaicin|mesh-list
43928302|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
43928303|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928304|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
43928305|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928306|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928307|NCT00656201|Progesterone|progesterone|mesh-list
43928308|NCT00656201|Progestins|progestins|mesh-ancestor
43928309|NCT00656201|Hormones|hormones|mesh-ancestor
43800481|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
43928345|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928346|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928521|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43928522|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928600|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43928602|NCT00661674|Palonosetron|palonosetron|mesh-list
43928603|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
43928604|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
43928605|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
43928606|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928607|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928608|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928609|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43928610|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43928611|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
43928612|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928613|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928614|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
43928615|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928616|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43928617|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
43928618|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
43928619|NCT00661895|Metoprolol|metoprolol|mesh-list
43928620|NCT00661895|Atenolol|atenolol|mesh-list
43928621|NCT00661895|Amlodipine|amlodipine|mesh-list
43928622|NCT00661895|Valsartan|valsartan|mesh-list
43928648|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928649|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928650|NCT00661895|Analgesics|analgesics|mesh-ancestor
43928651|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
43928652|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43928653|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43928654|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43928655|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
43928656|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44238977|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44238978|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44238979|NCT00570856|Folic Acid|folic acid|mesh-list
44238980|NCT00570856|Hematinics|hematinics|mesh-ancestor
44238981|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
44238982|NCT00570856|Vitamins|vitamins|mesh-ancestor
43928657|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43928658|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928659|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928660|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43928661|NCT00661895|Protective Agents|protective agents|mesh-ancestor
43928662|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43928663|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43928664|NCT00661960|Efavirenz|efavirenz|mesh-list
43928665|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
43928666|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43928667|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43928668|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928669|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928670|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
43800641|NCT04987567|Antioxidants|antioxidants|mesh-list
43928721|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928722|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
43928723|NCT00663039|Oxytocin|oxytocin|mesh-list
43928724|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
43928725|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43928726|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928727|NCT00663169|Dexamethasone|dexamethasone|mesh-list
43928728|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
43928729|NCT00663169|BB 1101|bb 1101|mesh-list
43928730|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43928731|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928732|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
43928733|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
43928734|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928735|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928736|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928737|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
43928738|NCT00663169|Hormones|hormones|mesh-ancestor
43928739|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928740|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928741|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928742|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928743|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928744|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928745|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
43928746|NCT00663403|Daptomycin|daptomycin|mesh-list
43928747|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43928748|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928749|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
43928750|NCT00663793|Finasteride|finasteride|mesh-list
43928751|NCT00663793|Testosterone|testosterone|mesh-list
43928752|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
43928753|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
43928754|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43928755|NCT00663793|Acyline|acyline|mesh-list
43928756|NCT00663793|Androgens|androgens|mesh-ancestor
43928757|NCT00663793|Hormones|hormones|mesh-ancestor
43928758|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928759|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928760|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928761|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928762|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
43928763|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43928764|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43928765|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928766|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928767|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
43928768|NCT00663793|Urological Agents|urological agents|mesh-ancestor
43928769|NCT00664430|Calcitriol|calcitriol|mesh-list
43928770|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44238983|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
44238984|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238985|NCT00570882|Sunitinib|sunitinib|mesh-list
44238986|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238987|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44238988|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238989|NCT00570882|Growth Substances|growth substances|mesh-ancestor
44238990|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238991|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
44238992|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43928800|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43928801|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
43928802|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928803|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928804|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43928805|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
43928806|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
43928807|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
43928808|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43928809|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43928810|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43928811|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928812|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43928813|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
43928814|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43928880|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928881|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928882|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43928883|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43928884|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928886|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43928887|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43928888|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928889|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43928890|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928891|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928892|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962686|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43928930|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44140164|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140166|NCT00177853|Irinotecan|irinotecan|mesh-list
44140167|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44140168|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140169|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140170|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140171|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140172|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44140173|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44140174|NCT00177853|Analgesics|analgesics|mesh-ancestor
44140175|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
44140176|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140177|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140178|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140179|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140180|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44140181|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44140182|NCT00177996|Sertraline|sertraline|mesh-list
44140183|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140184|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140185|NCT00177996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140186|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140187|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800821|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
44238993|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44238994|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238995|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
44238996|NCT00570895|Vitamins|vitamins|mesh-ancestor
43929001|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929027|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43929029|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929030|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
43929031|NCT00669383|Hormones|hormones|mesh-ancestor
43929032|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929033|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929034|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43929035|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
43929036|NCT00669578|Pomalidomide|pomalidomide|mesh-list
43929037|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
43929038|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929039|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929040|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929041|NCT00669578|Growth Substances|growth substances|mesh-ancestor
43929042|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929043|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929044|NCT00670202|Fasudil|fasudil|mesh-list
43929045|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43929046|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929047|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929048|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43962687|NCT01516684|Propofol|propofol|mesh-list
43929083|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
43929084|NCT00670956|Hormones|hormones|mesh-ancestor
43929085|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929086|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929087|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43800926|NCT05635370|Cilostazol|cilostazol|mesh-list
43929187|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43929188|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
43929189|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43929190|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43929191|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
43929192|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929193|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43929194|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43929195|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929196|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929198|NCT00673075|Nebivolol|nebivolol|mesh-list
43929233|NCT00673153|Vorinostat|vorinostat|mesh-list
43929234|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
43929287|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43929288|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
43929289|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929290|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929291|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
43929292|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929293|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929294|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929295|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
43929296|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929297|NCT00674219|Memantine|memantine|mesh-list
43929298|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43929299|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43929300|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
43929301|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929302|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962688|NCT01516684|Anesthetics|anesthetics|mesh-list
43929332|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
43929333|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
43929334|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
43929335|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929336|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929337|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929338|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44238997|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
44238998|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238999|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
44239000|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929339|NCT00675259|Growth Substances|growth substances|mesh-ancestor
43929340|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929341|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929342|NCT00675584|Budesonide|budesonide|mesh-list
43929343|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929344|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43929345|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
43929346|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929347|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929348|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43929349|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
43842396|NCT04530877|Infliximab|infliximab|mesh-list
43929440|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929441|NCT00678015|Protective Agents|protective agents|mesh-ancestor
43929442|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929443|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43929444|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929445|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43929446|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43929447|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43929449|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
43929508|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140194|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140195|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140196|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140197|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140198|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
44140199|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140200|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140201|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140202|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140203|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43801248|NCT05431270|Antibodies|antibodies|mesh-list
43929564|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929565|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929566|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929568|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
43929569|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929570|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
43929571|NCT00682357|Hormones|hormones|mesh-ancestor
43962690|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929627|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929628|NCT00683852|Aripiprazole|aripiprazole|mesh-list
43929629|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
43929630|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929631|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43929632|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43929633|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929634|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929635|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
43929636|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
43929637|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929638|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929639|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43929640|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43929641|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
43929642|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43929643|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43929644|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43929645|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43929646|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
43929715|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
43929716|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929717|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44239001|NCT00570895|Protective Agents|protective agents|mesh-ancestor
44239002|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
43887106|NCT04558268|Vitamins|vitamins|mesh-ancestor
43929718|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43929719|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
43929720|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
43929721|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43842469|NCT04529785|Ethanol|ethanol|mesh-list
43929778|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929779|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43929780|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929781|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43929782|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43929783|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43929784|NCT00687167|Zonisamide|zonisamide|mesh-list
43929785|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
43929786|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43801347|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929892|NCT00690495|Propofol|propofol|mesh-list
43929923|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929924|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43929926|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
43929927|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43929928|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43929929|NCT00691197|Glycerol|glycerol|mesh-list
43929930|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43929931|NCT00691197|Protective Agents|protective agents|mesh-ancestor
43929932|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929933|NCT00691197|Laxatives|laxatives|mesh-ancestor
43929934|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929935|NCT00691600|Trimethoprim|trimethoprim|mesh-list
43929936|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
43929937|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43929974|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
43929975|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929990|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929991|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929992|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929993|NCT00692978|Fluticasone|fluticasone|mesh-list
43929994|NCT00692978|Xhance|xhance|mesh-list
43929995|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929996|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43929998|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929999|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930000|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43930001|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
43930002|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930003|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43930004|NCT00693160|Ketorolac|ketorolac|mesh-list
43930005|NCT00693160|Remifentanil|remifentanil|mesh-list
43930006|NCT00693160|Capsaicin|capsaicin|mesh-list
43930007|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43930008|NCT00693160|Narcotics|narcotics|mesh-ancestor
43930009|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930010|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930011|NCT00693160|Analgesics|analgesics|mesh-ancestor
43930012|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
43930013|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930014|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43930015|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43930016|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930017|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930018|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43930019|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930020|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930021|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
43930022|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930023|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43930024|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930025|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43930026|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43930027|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43930028|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930029|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239003|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
44239004|NCT00570934|Vitamin D|vitamin d|mesh-list
44239005|NCT00570934|Calcium|calcium|mesh-list
44239006|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44239007|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239008|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44239009|NCT00570934|Vitamins|vitamins|mesh-ancestor
44239010|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
44239011|NCT00570999|Mitogens|mitogens|mesh-list
44239012|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239013|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930030|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930031|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930032|NCT00693719|Irinotecan|irinotecan|mesh-list
43930033|NCT00693719|Etoposide|etoposide|mesh-list
43930034|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43930035|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43930036|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930073|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
44140240|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44140241|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44140242|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140243|NCT00178269|Docetaxel|docetaxel|mesh-list
43674938|NCT02888327|Digoxin|digoxin|mesh-list
43930076|NCT00695292|Carboplatin|carboplatin|mesh-list
43930077|NCT00695292|Irinotecan|irinotecan|mesh-list
43930078|NCT00695292|Sunitinib|sunitinib|mesh-list
43930079|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930080|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43930081|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43930082|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930083|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930084|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930121|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
43930122|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930123|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842479|NCT04528173|Ketorolac|ketorolac|mesh-list
43930193|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43930230|NCT00699010|Narcotics|narcotics|mesh-ancestor
43930231|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930264|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930265|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
43930266|NCT00699803|Hormones|hormones|mesh-ancestor
43930267|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930268|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930269|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43930270|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930271|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
43930272|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
43930273|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930274|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43930275|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43930276|NCT00699803|Protective Agents|protective agents|mesh-ancestor
43930304|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930305|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930306|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930307|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930309|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930311|NCT00701714|Hematinics|hematinics|mesh-ancestor
43930312|NCT00701896|Nicotine|nicotine|mesh-list
43930313|NCT00701896|Varenicline|varenicline|mesh-list
43930314|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43930315|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
43930316|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930317|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930318|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44239014|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
43930319|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930320|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930321|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930322|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930323|NCT00701935|Exenatide|exenatide|mesh-list
43930324|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43930325|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930358|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43930359|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43930360|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43930361|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930362|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930363|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930364|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930365|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930366|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43930401|NCT00703664|Bortezomib|bortezomib|mesh-list
43930402|NCT00703664|Vorinostat|vorinostat|mesh-list
43930403|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801817|NCT04166318|Mitomycin|mitomycin|mesh-list
43930433|NCT00704353|Hematinics|hematinics|mesh-ancestor
43930434|NCT00704379|Sertraline|sertraline|mesh-list
43930435|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930436|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930437|NCT00704379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43930438|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930439|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930440|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930441|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930442|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
43930443|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930444|NCT00704717|Ribavirin|ribavirin|mesh-list
43930445|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43930446|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
43930447|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
43675226|NCT02885727|Durvalumab|durvalumab|mesh-list
43930448|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930449|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
43801858|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
43930457|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43930458|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930459|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43930460|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
43930461|NCT00704912|Orlistat|orlistat|mesh-list
43930462|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
43930463|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
43930464|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
43930465|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43930466|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930467|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43930468|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930469|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930470|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43930471|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43930472|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43930473|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43930474|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43930475|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
43930476|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43930477|NCT00704938|Aldesleukin|aldesleukin|mesh-list
43930478|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
43930479|NCT00704938|Fludarabine|fludarabine|mesh-list
43930480|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
43930481|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930482|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
43930483|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930484|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930485|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43930486|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
43930487|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930488|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930489|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44239015|NCT00571116|Disulfiram|disulfiram|mesh-list
44239016|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239017|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44239018|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43930490|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930491|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
43930492|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43930493|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43930494|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
43930495|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930496|NCT00705003|Melatonin|melatonin|mesh-list
43930497|NCT00705003|Buspirone|buspirone|mesh-list
43930498|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
43930499|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930500|NCT00705003|Protective Agents|protective agents|mesh-ancestor
43930501|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930502|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930503|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43930504|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43930505|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930506|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43930507|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
43930508|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930509|NCT00705107|Ribavirin|ribavirin|mesh-list
43930510|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43930511|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
43930512|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
43930513|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930514|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
43930515|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930516|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
43930517|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930616|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43930617|NCT00706719|Enclomiphene|enclomiphene|mesh-list
43930618|NCT00706719|Clomiphene|clomiphene|mesh-list
43930619|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
43930620|NCT00706719|Testosterone|testosterone|mesh-list
43930621|NCT00706719|Androgens|androgens|mesh-ancestor
43930622|NCT00706719|Hormones|hormones|mesh-ancestor
43930623|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930624|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930684|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
43930685|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43930686|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930723|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43930724|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
43802013|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
44140285|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140286|NCT00178763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140287|NCT00178763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140288|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
43930762|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930763|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43930799|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
43930800|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43930801|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
43930802|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930839|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43930840|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43930841|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43930842|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930843|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43802153|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930876|NCT00716079|Analgesics|analgesics|mesh-ancestor
43930877|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
43930878|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43930879|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43930880|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43930881|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43930882|NCT00716079|Protective Agents|protective agents|mesh-ancestor
43930883|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
43930884|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43930885|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44239019|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239020|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239022|NCT00571129|Mitomycin|mitomycin|mesh-list
43887313|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930886|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
43930887|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43930888|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930992|NCT00719134|Rizatriptan|rizatriptan|mesh-list
43930993|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43930994|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
43930995|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930996|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930997|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930998|NCT00719160|Esomeprazole|esomeprazole|mesh-list
43930999|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43931000|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931001|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43931002|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931003|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931004|NCT00719186|Letrozole|letrozole|mesh-list
43931005|NCT00719186|Clomiphene|clomiphene|mesh-list
43931006|NCT00719186|Enclomiphene|enclomiphene|mesh-list
43931007|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
43931008|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931009|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931010|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43931011|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43931012|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931013|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43931014|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
43931015|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931016|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931017|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43931018|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
43931019|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931020|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43931021|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43931022|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
43931023|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43931024|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931025|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
43931026|NCT00720330|Lidocaine|lidocaine|mesh-list
43931027|NCT00720330|Ketamine|ketamine|mesh-list
43931028|NCT00720330|Ropivacaine|ropivacaine|mesh-list
43931029|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
43931030|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
43931031|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931032|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931033|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
43931034|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931194|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43931195|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
43931197|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43931198|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
43931199|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931200|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931201|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931202|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43931203|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43931204|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931205|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931206|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43931207|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
43931208|NCT00723632|Ribavirin|ribavirin|mesh-list
43931209|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43931210|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
43931211|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931212|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
43931213|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931214|NCT00723749|Buprenorphine|buprenorphine|mesh-list
44239023|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44239024|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931215|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44140322|NCT00178828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140323|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
44140325|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44140326|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
44140327|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140328|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140329|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140330|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44140331|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140332|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140333|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140334|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44140335|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
44140336|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
44140337|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44140338|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44140339|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44140340|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140341|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140342|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140343|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140344|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140345|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44140346|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140347|NCT00178971|Buspirone|buspirone|mesh-list
44140348|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44140349|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140350|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931282|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43931283|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931284|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931285|NCT00725270|Mifepristone|mifepristone|mesh-list
43931286|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43931287|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
43931288|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931289|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931290|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43931291|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43931396|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43931397|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43931398|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43931399|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43931400|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43931401|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
43931402|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43931403|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43931435|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43931436|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931437|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931438|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931439|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43931440|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
43931441|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
43931442|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931443|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43931444|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43931445|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43931446|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43931447|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43931448|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43931518|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43931519|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931520|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931521|NCT00730522|Vigabatrin|vigabatrin|mesh-list
43931522|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
43931523|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805109|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
44239025|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
44239026|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239027|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44239028|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239029|NCT00571142|Bevacizumab|bevacizumab|mesh-list
44239030|NCT00571142|Temazepam|temazepam|mesh-list
44239031|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239032|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239033|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44239034|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44239035|NCT00571142|Growth Substances|growth substances|mesh-ancestor
44239036|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239037|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
44239038|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44239039|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239040|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44239041|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44239042|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239043|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
44239044|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
44239045|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239046|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239047|NCT00571155|Levetiracetam|levetiracetam|mesh-list
44239048|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
44239049|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
44239050|NCT00571246|Topiramate|topiramate|mesh-list
44239052|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
44239053|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239054|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239055|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44239056|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44239057|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239058|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44239059|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44239060|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43931524|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931525|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
43931526|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931527|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239061|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931529|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43931530|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43931531|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
43931532|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931617|NCT00733278|Copper|copper|mesh-list
43931618|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
43931619|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931620|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931621|NCT00733278|Trace Elements|trace elements|mesh-ancestor
43931622|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
43931623|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43931624|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43931625|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931626|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43931627|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931628|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931629|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931637|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931638|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931639|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43931640|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43931641|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
43931642|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931643|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
43931644|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
43931645|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931646|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
43931647|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
43931648|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43931649|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931650|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931651|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43931652|NCT00734344|Tenofovir|tenofovir|mesh-list
43931653|NCT00734344|Efavirenz|efavirenz|mesh-list
43931654|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
43931655|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
43931656|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931657|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43931658|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931659|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931660|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931661|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43931662|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43931663|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43989656|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931664|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43931665|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43931666|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43931667|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43931668|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43931669|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43931670|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43931671|NCT00734500|Anidulafungin|anidulafungin|mesh-list
43931672|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
43931673|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931674|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
43931675|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43931676|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931677|NCT00734968|Renal Agents|renal agents|mesh-ancestor
43931678|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43931679|NCT00735306|Bevacizumab|bevacizumab|mesh-list
43931680|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43931681|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931682|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931683|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931684|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931685|NCT00735306|Growth Substances|growth substances|mesh-ancestor
43931686|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931687|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931688|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43931689|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239062|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239063|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44239064|NCT00571285|Vitamin D|vitamin d|mesh-list
44239065|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
44239066|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
44239067|NCT00571285|Vitamins|vitamins|mesh-list
44239068|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
44239069|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239070|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44239071|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44239072|NCT00571298|Gemcitabine|gemcitabine|mesh-list
44239073|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
43931690|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931691|NCT00735436|Bevacizumab|bevacizumab|mesh-list
43931692|NCT00735436|Irinotecan|irinotecan|mesh-list
43931693|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931694|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931695|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931696|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931728|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43931729|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43931730|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931731|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931732|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931733|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931734|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931735|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43931736|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
43931737|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931738|NCT00735787|Adalimumab|adalimumab|mesh-list
43931767|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43931768|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931769|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43931770|NCT00736229|Incretins|incretins|mesh-ancestor
43931771|NCT00736229|Hormones|hormones|mesh-ancestor
43931772|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931773|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43931774|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
43931775|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
43931776|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931777|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931778|NCT00736632|Vitamin D|vitamin d|mesh-list
43931779|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
43931780|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
43931781|NCT00736632|Vitamins|vitamins|mesh-list
43931782|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
43931783|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989725|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
43931784|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43931847|NCT00739960|Abatacept|abatacept|mesh-list
43931848|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43931849|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931850|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931851|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931852|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
43931853|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931854|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931855|NCT00739999|Atorvastatin|atorvastatin|mesh-list
43931856|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43931857|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43931928|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931929|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43931930|NCT00741468|Tolbutamide|tolbutamide|mesh-list
43931931|NCT00741468|Midazolam|midazolam|mesh-list
43931994|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931995|NCT00742872|Mosapride|mosapride|mesh-list
44239074|NCT00571298|Cisplatin|cisplatin|mesh-list
44239075|NCT00571298|Amifostine|amifostine|mesh-list
44239076|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158605|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
43931996|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931997|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931998|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43931999|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
43932000|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932001|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932002|NCT00743093|Acetaminophen|acetaminophen|mesh-list
43932003|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932004|NCT00743093|Analgesics|analgesics|mesh-ancestor
43932005|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
43932015|NCT00743574|Calcium|calcium|mesh-list
43932016|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
43932017|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932018|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932019|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43932020|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43932021|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43932022|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43932023|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
43932024|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43932025|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43932026|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43932027|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43932028|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43932029|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932030|NCT00743717|Cobalt|cobalt|mesh-list
43932031|NCT00743717|Trace Elements|trace elements|mesh-ancestor
43932032|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
43932033|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932034|NCT00743730|Morphine|morphine|mesh-list
43932035|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43932036|NCT00743730|Narcotics|narcotics|mesh-ancestor
43932037|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932038|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932039|NCT00743730|Analgesics|analgesics|mesh-ancestor
43932040|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
43932041|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932042|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
43932043|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43932044|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932045|NCT00744380|Midazolam|midazolam|mesh-list
43932046|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
43932047|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43932048|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157463|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
43932049|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932050|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932051|NCT00744380|Analgesics|analgesics|mesh-ancestor
43932052|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
43932053|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932054|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43932055|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43932056|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43932057|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932058|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932059|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932060|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43932061|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43932062|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43932063|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932064|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43932065|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
43932066|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
43932067|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
43932068|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
43932069|NCT00744692|Fludarabine|fludarabine|mesh-list
43932070|NCT00744692|Melphalan|melphalan|mesh-list
43932071|NCT00744692|Thiotepa|thiotepa|mesh-list
43932072|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
43932073|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239077|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44239078|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
44239079|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239080|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
44239081|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239082|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239083|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239084|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
44239085|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932104|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43932106|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43932107|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932108|NCT00745290|Bupivacaine|bupivacaine|mesh-list
43932109|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43932110|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
43932111|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932112|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932113|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
43932114|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932115|NCT00746395|Lubiprostone|lubiprostone|mesh-list
43932116|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43932150|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932151|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
43932152|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932153|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932155|NCT00746954|Buspirone|buspirone|mesh-list
43932189|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43932190|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
43932191|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932192|NCT00748657|Bevacizumab|bevacizumab|mesh-list
43932193|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43932194|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
43932195|NCT00748657|Antibodies|antibodies|mesh-list
43932196|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
43932197|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43932198|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
43802984|NCT04974944|Paclitaxel|paclitaxel|mesh-list
43932230|NCT00749515|Siderophores|siderophores|mesh-ancestor
43932231|NCT00749749|Bupivacaine|bupivacaine|mesh-list
43932232|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
43932233|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
43932234|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932235|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932236|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
43932237|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932238|NCT00750815|Dexamethasone|dexamethasone|mesh-list
43932239|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
43932240|NCT00750815|Doxorubicin|doxorubicin|mesh-list
43932241|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43932272|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932273|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932274|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43932275|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
43932276|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43932277|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43932278|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
43932279|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932280|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43932281|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43932282|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932283|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932285|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
43932318|NCT00753337|Cobalt|cobalt|mesh-list
43932319|NCT00753337|Trace Elements|trace elements|mesh-ancestor
43932320|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
43932321|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932322|NCT00753636|Isradipine|isradipine|mesh-list
43932323|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44239086|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44239087|NCT00571298|Protective Agents|protective agents|mesh-ancestor
43932324|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43932325|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932326|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140399|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140400|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140402|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
44140403|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44140404|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44140405|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44140406|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932363|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932364|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932365|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43932366|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
43932455|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
43932456|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932457|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932458|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932459|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
43932460|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932461|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43932462|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
43932463|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932464|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932465|NCT00757822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43932466|NCT00757822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43932467|NCT00757822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932468|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932469|NCT00757822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43932470|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
43932471|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932472|NCT00757822|Analgesics|analgesics|mesh-ancestor
43932473|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
43932474|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43932475|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43932476|NCT00757822|Hormones|hormones|mesh-ancestor
43932477|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932478|NCT00758342|Travoprost|travoprost|mesh-list
43932479|NCT00758342|Brinzolamide|brinzolamide|mesh-list
43932480|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932481|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43932482|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932483|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932484|NCT00758420|Polidocanol|polidocanol|mesh-list
43932485|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43932486|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932487|NCT00758667|Mesna|mesna|mesh-list
43932488|NCT00758667|Protective Agents|protective agents|mesh-ancestor
43932489|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932490|NCT00758784|Bromfenac|bromfenac|mesh-list
43932491|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43932492|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932493|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932494|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932495|NCT00758784|Analgesics|analgesics|mesh-ancestor
43932496|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
43932497|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932498|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932534|NCT00759330|Analgesics|analgesics|mesh-ancestor
43932535|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
43932536|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932537|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932538|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932539|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932540|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932541|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932542|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43932576|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43932577|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239089|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
44239090|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
44239091|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239092|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
44239093|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
44239094|NCT00571337|Infliximab|infliximab|mesh-list
44239095|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239096|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239097|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239098|NCT00571506|Pioglitazone|pioglitazone|mesh-list
44239099|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
44239100|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158820|NCT00237731|Morphine|morphine|mesh-list
43932578|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932579|NCT00759772|Teriparatide|teriparatide|mesh-list
43932580|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932581|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932631|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932632|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932633|NCT00760578|Pioglitazone|pioglitazone|mesh-list
43932634|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43932635|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932636|NCT00761085|Morphine|morphine|mesh-list
43932637|NCT00761085|Methadone|methadone|mesh-list
43932638|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43932639|NCT00761085|Narcotics|narcotics|mesh-ancestor
43932640|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803218|NCT04970069|Analgesics|analgesics|mesh-list
43932675|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932676|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932677|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932678|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
43932679|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932680|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43932818|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932819|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932820|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932821|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932822|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932824|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932825|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932826|NCT00763061|Timolol|timolol|mesh-list
43932827|NCT00763061|Travoprost|travoprost|mesh-list
43932828|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43932829|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43932830|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43932866|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932867|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932868|NCT00764738|Ranibizumab|ranibizumab|mesh-list
43932932|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932933|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932934|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
43932936|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932937|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
43932938|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932939|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43932940|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932944|NCT00765856|Narcotics|narcotics|mesh-ancestor
43932945|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932946|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932947|NCT00765856|Analgesics|analgesics|mesh-ancestor
43932948|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
43932949|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239101|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239102|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44239103|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44239104|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239105|NCT00571636|Fentanyl|fentanyl|mesh-list
44239106|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44239107|NCT00571636|Narcotics|narcotics|mesh-ancestor
44239108|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239109|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239110|NCT00571636|Analgesics|analgesics|mesh-ancestor
44239111|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
44158883|NCT00237900|Antidotes|antidotes|mesh-ancestor
43932950|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43932951|NCT00765895|Nortriptyline|nortriptyline|mesh-list
43932952|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43932953|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
43932954|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932955|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43932956|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43932957|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932958|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932959|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932960|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932961|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932962|NCT00765947|Amlodipine|amlodipine|mesh-list
43932963|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43932964|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932965|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43932966|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932967|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932968|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932969|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932970|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
43932971|NCT00765947|Diuretics|diuretics|mesh-ancestor
43932972|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
43932973|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44140433|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
44140434|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44140435|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
44140436|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
44140437|NCT00179244|Bupropion|bupropion|mesh-list
44140438|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140439|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140440|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140441|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44140442|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140443|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140444|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140445|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
44140446|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140447|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140448|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44140449|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140450|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140451|NCT00179257|Sertraline|sertraline|mesh-list
44140452|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140453|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140454|NCT00179257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140455|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140456|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140457|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140458|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239112|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239113|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44239114|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44239115|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
44140459|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
44140460|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140462|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44140463|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140464|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140465|NCT00179283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140466|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140467|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140468|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933008|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43933009|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
43933010|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933032|NCT00768118|Analgesics|analgesics|mesh-ancestor
43933033|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
43933034|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933035|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933036|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933037|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933038|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933039|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933040|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933041|NCT00768261|Memantine|memantine|mesh-list
43933042|NCT00768261|Donepezil|donepezil|mesh-list
43933043|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43933044|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933045|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933046|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
43933047|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933048|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933049|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
43933050|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43933051|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43933052|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
43933053|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43933054|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43933055|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43933056|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43933057|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43933058|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
43933059|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933060|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933061|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933062|NCT00768521|Urological Agents|urological agents|mesh-ancestor
43933063|NCT00768599|Econazole|econazole|mesh-list
43933064|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
43933065|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933066|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43933067|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43933068|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933069|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933070|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43933071|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
43933072|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933073|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933074|NCT00768716|Acetaminophen|acetaminophen|mesh-list
43933075|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933076|NCT00768716|Analgesics|analgesics|mesh-ancestor
43933077|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
43933078|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933079|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933080|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
43933081|NCT00769314|Acyclovir|acyclovir|mesh-list
43933082|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
44239116|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
44239117|NCT00571675|Prednisone|prednisone|mesh-list
44239118|NCT00571675|Docetaxel|docetaxel|mesh-list
44239119|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933083|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933084|NCT00769392|Lidocaine|lidocaine|mesh-list
43933085|NCT00769392|Tetracaine|tetracaine|mesh-list
43933086|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
43933087|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
43933088|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
43933089|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933090|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933091|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
43933092|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933093|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43933094|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43933095|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43933096|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43933123|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933124|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43933125|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43933126|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43933127|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
43933128|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
43933129|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43933130|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
43933132|NCT00770133|Naphazoline|naphazoline|mesh-list
43933133|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
43933134|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933135|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43933136|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
43933137|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
43933138|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933139|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933140|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848643|NCT04005170|Paclitaxel|paclitaxel|mesh-list
43933171|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43933172|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933173|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933174|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933175|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933176|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
43933177|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43933178|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
43933179|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933180|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933181|NCT00771875|Acetaminophen|acetaminophen|mesh-list
43933182|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
43933183|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
43933184|NCT00771875|Rituximab|rituximab|mesh-list
43933185|NCT00771875|Bortezomib|bortezomib|mesh-list
43933186|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
43933187|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43933217|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933218|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43933219|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43933221|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43933222|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933223|NCT00772304|Analgesics|analgesics|mesh-ancestor
43933224|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
43933225|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933226|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933227|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933228|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933229|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43933230|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43933231|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43933232|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
43933264|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933265|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933266|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43933267|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
43933268|NCT00772915|Hormones|hormones|mesh-ancestor
44239120|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239121|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239122|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
43933269|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933270|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43933271|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933272|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
43933273|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933274|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933275|NCT00772915|Growth Substances|growth substances|mesh-ancestor
43933276|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933304|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933306|NCT00773955|Retinol acetate|retinol acetate|mesh-list
43933307|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
43933308|NCT00773955|Gossypol|gossypol|mesh-list
43933309|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43933310|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933311|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43933312|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
43933313|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933314|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43933315|NCT00773955|Protective Agents|protective agents|mesh-ancestor
43933316|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933317|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43933318|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
43933319|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43933320|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43933321|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43803516|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
43933343|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43933344|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
43933345|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
43933346|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
43933347|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43933348|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43933349|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
43933350|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933351|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933352|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43933353|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43933354|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43933355|NCT00775229|Naltrexone|naltrexone|mesh-list
43933356|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43933357|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43933358|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933359|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
43933360|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933361|NCT00775411|Dexamethasone|dexamethasone|mesh-list
43933362|NCT00775411|Ranibizumab|ranibizumab|mesh-list
43933363|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933364|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
43933365|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
43933366|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933367|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933368|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43933369|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
43933370|NCT00775411|Hormones|hormones|mesh-ancestor
43933371|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933372|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43933373|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803545|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
43933408|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43933410|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43933411|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
43933412|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933413|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933414|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
43933442|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
43933443|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700921|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239123|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239124|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892218|NCT04979338|Bupivacaine|bupivacaine|mesh-list
44239126|NCT00571675|Hormones|hormones|mesh-ancestor
44159169|NCT00238368|Hormones|hormones|mesh-ancestor
43933444|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933445|NCT00776594|Bevacizumab|bevacizumab|mesh-list
43933446|NCT00776594|Bicalutamide|bicalutamide|mesh-list
43933447|NCT00776594|Androgens|androgens|mesh-list
43933448|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933449|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933450|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933451|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933452|NCT00776594|Growth Substances|growth substances|mesh-ancestor
43933453|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933454|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933455|NCT00776594|Hormones|hormones|mesh-ancestor
43933456|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933457|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
43933458|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
43933460|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43933461|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43933462|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803628|NCT04962958|Vitamins|vitamins|mesh-ancestor
43933474|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
43933475|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43933476|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933477|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
43933478|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43933479|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933480|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933481|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43933482|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43933483|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43933484|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43933485|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43933486|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43933487|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43933488|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43933489|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933490|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43933491|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933492|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933493|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
43677739|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43933494|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933495|NCT00778310|Methylphenidate|methylphenidate|mesh-list
43933496|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43933497|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933498|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43933499|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43933500|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43933501|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933502|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
43933503|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933505|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933506|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43933507|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933509|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43933510|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43933511|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933512|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43933513|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43933514|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933515|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933516|NCT00779311|Bevacizumab|bevacizumab|mesh-list
43933517|NCT00779311|Sorafenib|sorafenib|mesh-list
44239127|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239128|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239129|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44239130|NCT00571714|Ribavirin|ribavirin|mesh-list
44239131|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44239132|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
44239133|NCT00571714|Betaine|betaine|mesh-list
44239134|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
44239135|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239136|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
44239137|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239138|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
44239139|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239140|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239141|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
44239142|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44239143|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44239144|NCT00571727|Mecasermin|mecasermin|mesh-list
44239145|NCT00571727|Growth Substances|growth substances|mesh-ancestor
44239146|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933518|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933519|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933520|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933521|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933522|NCT00779311|Growth Substances|growth substances|mesh-ancestor
43933523|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933582|NCT00780715|Gliclazide|gliclazide|mesh-list
43933583|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43933584|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933585|NCT00780715|Incretins|incretins|mesh-ancestor
43933586|NCT00780715|Hormones|hormones|mesh-ancestor
43933587|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933588|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43933589|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
43933590|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933591|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933592|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
43933593|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43933594|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
43933595|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933596|NCT00780962|Expectorants|expectorants|mesh-ancestor
43933597|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
43803670|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933628|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
43933629|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933630|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933631|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933632|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933633|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
43933634|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43933635|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933636|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43933637|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43933638|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
43933639|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239148|NCT00571740|Bevacizumab|bevacizumab|mesh-list
44239149|NCT00571740|Cetuximab|cetuximab|mesh-list
44239150|NCT00571740|Fluorouracil|fluorouracil|mesh-list
44239151|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
44239152|NCT00571740|Calcium|calcium|mesh-list
44239153|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
44239154|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239155|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239156|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44239157|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44239158|NCT00571740|Growth Substances|growth substances|mesh-ancestor
44239159|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239160|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
44159289|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
43933640|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933641|NCT00782756|Bevacizumab|bevacizumab|mesh-list
43933643|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933644|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933645|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933646|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933647|NCT00782756|Growth Substances|growth substances|mesh-ancestor
43933648|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933649|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933650|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933651|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
43933652|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933653|NCT00782821|Rituximab|rituximab|mesh-list
43933654|NCT00782821|Bortezomib|bortezomib|mesh-list
43933655|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
43933656|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43933657|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933658|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933659|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
43933660|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933661|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933662|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933663|NCT00783614|Aspirin|aspirin|mesh-list
43933664|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43933665|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43933666|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933667|NCT00783614|Analgesics|analgesics|mesh-ancestor
43933668|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
43933669|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933670|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933671|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933672|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933673|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43933674|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43933675|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933676|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43933677|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43933678|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933679|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
43933680|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
43933681|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933682|NCT00783965|Tazarotene|tazarotene|mesh-list
43933683|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933684|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
44140486|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140487|NCT00179608|Lenalidomide|lenalidomide|mesh-list
44140488|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
44140489|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140490|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44239161|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44239162|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
44239163|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239164|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44239165|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239166|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
44239167|NCT00571740|Antidotes|antidotes|mesh-ancestor
44140491|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140492|NCT00179608|Growth Substances|growth substances|mesh-ancestor
43933690|NCT00784225|Selenium|selenium|mesh-list
43933691|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
43933692|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933693|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
43933694|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933695|NCT00784225|Protective Agents|protective agents|mesh-ancestor
43933696|NCT00784225|Trace Elements|trace elements|mesh-ancestor
43933697|NCT00784303|Lenvatinib|lenvatinib|mesh-list
43933698|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990409|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
43933699|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43933700|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933701|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933702|NCT00784524|Aldesleukin|aldesleukin|mesh-list
43933703|NCT00784524|Interleukin-2|interleukin-2|mesh-list
43933704|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933705|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933706|NCT00784524|Analgesics|analgesics|mesh-ancestor
43933743|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43933744|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43933813|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933814|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
43933815|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933816|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933817|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933818|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
43933886|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933887|NCT00788892|Cytarabine|cytarabine|mesh-list
43933888|NCT00788892|Daunorubicin|daunorubicin|mesh-list
43933889|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933924|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933925|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
43933926|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933951|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43933953|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933954|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43933955|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43933956|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
43933957|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933958|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43933959|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
43933960|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
43933961|NCT00789776|Fludarabine|fludarabine|mesh-list
43933962|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
43933964|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933965|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
43933966|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933967|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933968|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933969|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
43933970|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933971|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933972|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933973|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933974|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
43933975|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43933976|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933977|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43933992|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239168|NCT00571740|Protective Agents|protective agents|mesh-ancestor
44239169|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
44239170|NCT00571740|Vitamins|vitamins|mesh-ancestor
44239171|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
43933993|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933994|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933995|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
43933996|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43933997|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933998|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933999|NCT00789997|Levofloxacin|levofloxacin|mesh-list
43934000|NCT00789997|Ofloxacin|ofloxacin|mesh-list
43934001|NCT00789997|Prednisone|prednisone|mesh-list
43934002|NCT00789997|Etanercept|etanercept|mesh-list
43934003|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934004|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
43934005|NCT00789997|Hormones|hormones|mesh-ancestor
43934006|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934007|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934008|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934009|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934010|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934011|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934012|NCT00789997|Analgesics|analgesics|mesh-ancestor
43934013|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
43934014|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934015|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934016|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934017|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934018|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
43934019|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43934020|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934021|NCT00789997|Renal Agents|renal agents|mesh-ancestor
43934022|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934023|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43934024|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43934025|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934026|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934027|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43934028|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43934030|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
43934031|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43934032|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934033|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43934034|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43934035|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
43934036|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934037|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934038|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934068|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
43934069|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934070|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43934071|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43934072|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934073|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934074|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43934075|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934076|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934077|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
43934109|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
43934110|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934111|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934112|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43934113|NCT00791323|Ketorolac|ketorolac|mesh-list
43934114|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43934115|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
43934116|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43842956|NCT04500275|Vancomycin|vancomycin|mesh-list
43934155|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934287|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934289|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44239172|NCT00571753|Isoniazid|isoniazid|mesh-list
44239173|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
44239174|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239175|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239176|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44239177|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44239178|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
44239179|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239180|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44239181|NCT00571805|Varenicline|varenicline|mesh-list
44239182|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44239183|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44239184|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
44239185|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239186|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239187|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459038|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459039|NCT01586195|Vemurafenib|vemurafenib|mesh-list
43934290|NCT00795210|Hormones|hormones|mesh-list
43934291|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43934292|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934293|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804175|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
43934323|NCT00795366|Vasopressins|vasopressins|mesh-list
43934324|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
43934325|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
43934326|NCT00795366|Coagulants|coagulants|mesh-ancestor
43934327|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43934328|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43934329|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
43934330|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934331|NCT00795769|Ondansetron|ondansetron|mesh-list
43934332|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
43934333|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
43934334|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934335|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934336|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934337|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
43934421|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934422|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934423|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934424|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934425|NCT00797797|Analgesics|analgesics|mesh-ancestor
43934426|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
43934427|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934428|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
43934429|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934430|NCT00798018|Lidocaine|lidocaine|mesh-list
43934431|NCT00798018|Tetracaine|tetracaine|mesh-list
43934432|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
43934433|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
43934434|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934435|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678457|NCT02861378|Phentolamine|phentolamine|mesh-list
43934436|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
43934437|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934438|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43934439|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44459040|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459041|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459042|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459043|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459044|NCT01586156|Carvedilol|carvedilol|mesh-list
44159541|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934440|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43934441|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934442|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934444|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43934445|NCT00798720|Bortezomib|bortezomib|mesh-list
43934446|NCT00798720|Vorinostat|vorinostat|mesh-list
43934447|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934448|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43934449|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934450|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934451|NCT00799227|Dexamethasone|dexamethasone|mesh-list
43934452|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934453|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
43934454|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
43934455|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934456|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934457|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934458|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
43934517|NCT00801138|Dexamethasone|dexamethasone|mesh-list
43934518|NCT00801138|Bupivacaine|bupivacaine|mesh-list
43934519|NCT00801138|Ropivacaine|ropivacaine|mesh-list
43934520|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934521|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
43934522|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
43934523|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934524|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934525|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934526|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
43934527|NCT00801138|Hormones|hormones|mesh-ancestor
43934528|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934529|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934530|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934531|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
43934532|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
43934599|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934600|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43934601|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43934603|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934604|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43934605|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43934606|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934607|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
43934608|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
43934609|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934610|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934611|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934612|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934616|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934618|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934619|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
43934620|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
43934621|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
43934623|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43934624|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43934625|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43934626|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43934627|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43934628|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934629|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43934630|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43934631|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
43934632|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43934633|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44459045|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44459046|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44459047|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459048|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459049|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934634|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
43934635|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43934636|NCT00802113|Fludarabine|fludarabine|mesh-list
43934637|NCT00802113|Busulfan|busulfan|mesh-list
43934638|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43934639|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934640|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934641|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934642|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
43934643|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934644|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
43934645|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934646|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934647|NCT00802412|Topiramate|topiramate|mesh-list
43934648|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
43934649|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934650|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934651|NCT00802685|Ibuprofen|ibuprofen|mesh-list
43934652|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934653|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934655|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
43934656|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934657|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934658|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934659|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934660|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43934661|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934662|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934663|NCT00802880|Dacarbazine|dacarbazine|mesh-list
43934664|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934665|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
43934666|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934667|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934668|NCT00802919|Varenicline|varenicline|mesh-list
43934669|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43934670|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43934671|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
43934672|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934673|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934674|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934675|NCT00803010|Sirolimus|sirolimus|mesh-list
43934676|NCT00803010|Methotrexate|methotrexate|mesh-list
43934677|NCT00803010|Tacrolimus|tacrolimus|mesh-list
43934678|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43934679|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
43934680|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43934681|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934682|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43934683|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
43804351|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
43934744|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43934745|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934746|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934747|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
43934748|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934750|NCT00803647|Protective Agents|protective agents|mesh-ancestor
43934751|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
43934752|NCT00803647|Vitamins|vitamins|mesh-ancestor
43804432|NCT04945694|Fentanyl|fentanyl|mesh-list
43934803|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934804|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934806|NCT00805493|Protective Agents|protective agents|mesh-ancestor
43934808|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
43934809|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44459050|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459051|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44459052|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
44459053|NCT01586156|Protective Agents|protective agents|mesh-ancestor
44459054|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44239188|NCT00571870|Cetrorelix|cetrorelix|mesh-list
44239189|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44239190|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
44239191|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44159704|NCT00239512|Ibuprofen|ibuprofen|mesh-list
43934810|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43934811|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934812|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43934813|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934814|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43934815|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934816|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934817|NCT00806078|Analgesics|analgesics|mesh-ancestor
43934818|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
43934819|NCT00806221|Emollients|emollients|mesh-list
43934820|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934821|NCT00806234|Metformin|metformin|mesh-list
43934822|NCT00806234|Olanzapine|olanzapine|mesh-list
43934823|NCT00806234|Risperidone|risperidone|mesh-list
43934824|NCT00806234|Aripiprazole|aripiprazole|mesh-list
43934825|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43934826|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43934827|NCT00806234|Ziprasidone|ziprasidone|mesh-list
43934828|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43934829|NCT00806234|Asenapine|asenapine|mesh-list
43934830|NCT00806234|Iloperidone|iloperidone|mesh-list
43934831|NCT00806234|Perphenazine|perphenazine|mesh-list
43934832|NCT00806234|Fluoxetine|fluoxetine|mesh-list
43934833|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934834|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934835|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43934836|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
43934837|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934838|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934839|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934840|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934841|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934842|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934843|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934844|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
43842988|NCT04495179|Durvalumab|durvalumab|mesh-list
43934871|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
43934872|NCT00806598|Cyclosporins|cyclosporins|mesh-list
43934873|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
43934874|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43934875|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43934876|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
43934877|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934878|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934879|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934880|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
43934881|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934882|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
43934883|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934884|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934885|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934886|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43934887|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934888|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
43934889|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
43804527|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934921|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
43934922|NCT00807586|Hormones|hormones|mesh-ancestor
43934923|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934924|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239192|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239193|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
44239194|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239195|NCT00571935|Insulin|insulin|mesh-list
44239196|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43934925|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43934926|NCT00807586|Protective Agents|protective agents|mesh-ancestor
43934927|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934928|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934929|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
43934930|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
43934931|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934932|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934934|NCT00807768|Carboplatin|carboplatin|mesh-list
43934935|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43934964|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43934965|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43934966|NCT00808405|Acyclovir|acyclovir|mesh-list
43934967|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
43934968|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934969|NCT00808470|Ascorbic Acid|ascorbic acid|mesh-list
43934970|NCT00808470|Beta Carotene|beta carotene|mesh-list
43934971|NCT00808470|Carotenoids|carotenoids|mesh-list
43934972|NCT00808470|Vitamins|vitamins|mesh-ancestor
43934973|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
43934974|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934975|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
43934976|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934977|NCT00808470|Protective Agents|protective agents|mesh-ancestor
43934978|NCT00808470|Provitamins|provitamins|mesh-ancestor
43934979|NCT00809055|Caffeine|caffeine|mesh-list
43934980|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
43934981|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934982|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43935176|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43935177|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
43935178|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43935179|NCT00814255|Protective Agents|protective agents|mesh-ancestor
43935180|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935215|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43935216|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43935217|NCT00815360|Growth Substances|growth substances|mesh-ancestor
43804733|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
43935222|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
43935223|NCT00815360|Hormones|hormones|mesh-ancestor
43935224|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935225|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935226|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
43935227|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935228|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140524|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140525|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140526|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140527|NCT00179712|Growth Substances|growth substances|mesh-ancestor
44140528|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140530|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44140531|NCT00179725|Lenalidomide|lenalidomide|mesh-list
44140532|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44140533|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140534|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140535|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140536|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140537|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140538|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
44140539|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140540|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140541|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140542|NCT00179725|Growth Substances|growth substances|mesh-ancestor
44140543|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140544|NCT00179738|Lenalidomide|lenalidomide|mesh-list
44239197|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
44239198|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239199|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239200|NCT00572013|Rituximab|rituximab|mesh-list
44239201|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239202|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239203|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
44140545|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
44140546|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140547|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140548|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140549|NCT00179738|Growth Substances|growth substances|mesh-ancestor
44140550|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140551|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140552|NCT00179751|Gemcitabine|gemcitabine|mesh-list
43679080|NCT02856789|Hemostatics|hemostatics|mesh-list
43935229|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
43935230|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43935232|NCT00816751|Vasopressins|vasopressins|mesh-list
43935233|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
43935234|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
43935235|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
43935236|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935237|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935238|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
43935239|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935240|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43935241|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43935242|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43990856|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
43935243|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935244|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935245|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
43935246|NCT00816751|Coagulants|coagulants|mesh-ancestor
43935247|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43935248|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43935249|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
43935250|NCT00816829|Fenofibrate|fenofibrate|mesh-list
43935251|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935252|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
43935253|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935254|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935255|NCT00816907|Metformin|metformin|mesh-list
43935256|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43935257|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935258|NCT00817219|Betamethasone|betamethasone|mesh-list
43935259|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
43935260|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43935294|NCT00818324|Rebamipide|rebamipide|mesh-list
43935295|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43935296|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935297|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
43935298|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935299|NCT00818324|Protective Agents|protective agents|mesh-ancestor
43935300|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935301|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935302|NCT00818337|Aspirin|aspirin|mesh-list
43935405|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
44140554|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140555|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
44140556|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140557|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140558|NCT00179751|Antiviral Agents|antiviral agents|mesh-ancestor
44140559|NCT00179751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140560|NCT00179751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140561|NCT00179751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140562|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
44140563|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140564|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140565|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140566|NCT00179751|Growth Substances|growth substances|mesh-ancestor
44239204|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239205|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239206|NCT00572026|Methylphenidate|methylphenidate|mesh-list
44239207|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44239208|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239209|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44239210|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44239211|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44239212|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239213|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
44239214|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239216|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
44239217|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44239218|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
44239219|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140567|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140568|NCT00179764|Busulfan|busulfan|mesh-list
44140569|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
44140570|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140571|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140572|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
43935579|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
43935611|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43935612|NCT04994431|Tamsulosin|tamsulosin|mesh-list
43935613|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43935614|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43935615|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44145320|NCT00194649|Miglustat|miglustat|mesh-list
43935616|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935617|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935618|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935619|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935620|NCT04994431|Urological Agents|urological agents|mesh-ancestor
43935621|NCT04918407|Empagliflozin|empagliflozin|mesh-list
43935622|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43843021|NCT04491682|Megestrol|megestrol|mesh-list
43935696|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
43935697|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935698|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935699|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935732|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935734|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43935735|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43935736|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935737|NCT04608201|Nicotine|nicotine|mesh-list
43935738|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43935739|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
43935740|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935741|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935742|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43935743|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43935772|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
43935773|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935774|NCT04501705|Apatinib|apatinib|mesh-list
43935775|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935776|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935777|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239220|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239221|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
44239222|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239223|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159931|NCT00240214|Sirolimus|sirolimus|mesh-list
43935778|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935779|NCT04342975|Niacinamide|niacinamide|mesh-list
43935780|NCT04342975|Niacin|niacin|mesh-list
43935781|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
43935782|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
43935783|NCT04342975|Vitamins|vitamins|mesh-ancestor
43935784|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
43935785|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935786|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935787|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
43935788|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935789|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43805130|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
44140662|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
44140663|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140664|NCT00180102|Analgesics|analgesics|mesh-ancestor
44140665|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
44140666|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140667|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140668|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43935791|NCT04294069|Azithromycin|azithromycin|mesh-list
43935792|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43935793|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935794|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
43935832|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935865|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43935866|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43935867|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935868|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935869|NCT03839446|Analgesics|analgesics|mesh-ancestor
43935870|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
43935871|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935872|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935873|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935874|NCT03781986|Carboplatin|carboplatin|mesh-list
43935875|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935876|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
43935988|NCT02845596|Cyclosporine|cyclosporine|mesh-list
43935989|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
43935990|NCT02845596|Methotrexate|methotrexate|mesh-list
43935991|NCT02845596|Fludarabine|fludarabine|mesh-list
43935992|NCT02845596|Cyclosporins|cyclosporins|mesh-list
43935993|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
43935994|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43935995|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43935996|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
43935997|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935998|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935999|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936000|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
43936001|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936002|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805204|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
43936034|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43936035|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43936036|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43936037|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936074|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936076|NCT02641236|Polymyxins|polymyxins|mesh-list
43936077|NCT02641236|Polymyxin B|polymyxin b|mesh-list
43936078|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936079|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936080|NCT02487797|Oxytocin|oxytocin|mesh-list
43936119|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43805317|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
43936194|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
43936195|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239224|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
44239225|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239226|NCT00572078|Sorafenib|sorafenib|mesh-list
44239227|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239228|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44239229|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239230|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239231|NCT00572208|Gabapentin|gabapentin|mesh-list
44239232|NCT00572208|Analgesics|analgesics|mesh-ancestor
44239233|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
44239234|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239235|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239236|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
44239237|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44239238|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44239239|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936196|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936197|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43936198|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
43936199|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43936200|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43936201|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43936202|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
43936203|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936204|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936205|NCT01149850|Bevacizumab|bevacizumab|mesh-list
43936206|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43936207|NCT01149850|Temozolomide|temozolomide|mesh-list
43936208|NCT01149850|Antibodies|antibodies|mesh-list
43936209|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
43936210|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43936211|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936212|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936213|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936214|NCT01149850|Growth Substances|growth substances|mesh-ancestor
43936215|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936216|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936217|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
43936218|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936219|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
43936220|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936221|NCT01090089|Dexamethasone|dexamethasone|mesh-list
43936222|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
43936223|NCT01090089|Lenalidomide|lenalidomide|mesh-list
43936224|NCT01090089|BB 1101|bb 1101|mesh-list
43936225|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936226|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
43936227|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
43936228|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936229|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936230|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936231|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
43936232|NCT01090089|Hormones|hormones|mesh-ancestor
43936233|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936234|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43936235|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936236|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
43936237|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936238|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239240|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239241|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44239242|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44239243|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239244|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239245|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
44239246|NCT00572299|Alendronate|alendronate|mesh-list
44239247|NCT00572299|Prednisone|prednisone|mesh-list
44239248|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239249|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
44239250|NCT00572299|Hormones|hormones|mesh-ancestor
44160053|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43936239|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
43936240|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936241|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936242|NCT01090089|Growth Substances|growth substances|mesh-ancestor
43936243|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936244|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
43936245|NCT00692939|Melphalan|melphalan|mesh-list
43936246|NCT00692939|Thiotepa|thiotepa|mesh-list
43936247|NCT00692939|Rituximab|rituximab|mesh-list
43936248|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
43936249|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
43936250|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43936251|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936252|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
43936253|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805333|NCT04932187|Capecitabine|capecitabine|mesh-list
43936277|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43936278|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43936279|NCT00821795|Insulin|insulin|mesh-list
43936280|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
43936281|NCT00821795|Protamines|protamines|mesh-list
43936282|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936283|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936284|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
43936285|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936286|NCT00821795|Coagulants|coagulants|mesh-ancestor
43936287|NCT00821821|Edaravone|edaravone|mesh-list
43936288|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43936289|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
43936290|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936291|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43936292|NCT00821821|Protective Agents|protective agents|mesh-ancestor
43936293|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936294|NCT00821886|Carboplatin|carboplatin|mesh-list
43936295|NCT00821886|Trastuzumab|trastuzumab|mesh-list
43936296|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936297|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936298|NCT00821951|Vorinostat|vorinostat|mesh-list
43936299|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936300|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43936301|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936302|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936303|NCT00821964|Paclitaxel|paclitaxel|mesh-list
43936304|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43936305|NCT00821964|Imiquimod|imiquimod|mesh-list
43936335|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936336|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936337|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
43936338|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936339|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936340|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43936341|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936342|NCT00823043|Timolol|timolol|mesh-list
43936343|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44239251|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936344|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43936345|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
43936346|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936347|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936381|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936382|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936383|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
43936384|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936385|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43936386|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43936409|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43936410|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
43936411|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936412|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936413|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43936414|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43936415|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43936416|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43936417|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43936418|NCT00824460|Iron|iron|mesh-list
43936419|NCT00824460|Sevelamer|sevelamer|mesh-list
43936420|NCT00824460|Trace Elements|trace elements|mesh-ancestor
43936421|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
43936422|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936423|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
43936424|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
43936425|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936426|NCT00824538|Sunitinib|sunitinib|mesh-list
43936427|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936428|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936429|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936430|NCT00824538|Growth Substances|growth substances|mesh-ancestor
43936431|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936432|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936433|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936434|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936435|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936436|NCT00824733|Trastuzumab|trastuzumab|mesh-list
43843163|NCT04483739|Dexamethasone|dexamethasone|mesh-list
43936496|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936498|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936499|NCT00825734|Sorafenib|sorafenib|mesh-list
43936500|NCT00825734|Epothilones|epothilones|mesh-list
43936501|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936502|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936503|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936504|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936505|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936506|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936507|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936508|NCT00825786|Ropivacaine|ropivacaine|mesh-list
43936509|NCT00825786|Mepivacaine|mepivacaine|mesh-list
43936510|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
43936511|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
43936512|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936513|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936514|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
43936515|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936516|NCT00826800|Bevacizumab|bevacizumab|mesh-list
43936517|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936518|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936519|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936520|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936521|NCT00826800|Growth Substances|growth substances|mesh-ancestor
43936522|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936523|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936524|NCT00827073|Lidocaine|lidocaine|mesh-list
43936525|NCT00827073|Tetracaine|tetracaine|mesh-list
43936526|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
43936527|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
43936528|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239252|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239253|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44239254|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936529|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936530|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
43936531|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936532|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43936533|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43936534|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43936535|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936536|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936537|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
43936538|NCT00827099|Fludarabine|fludarabine|mesh-list
43936539|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
43936540|NCT00827099|Melphalan|melphalan|mesh-list
43936541|NCT00827099|Tacrolimus|tacrolimus|mesh-list
43936542|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43936543|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936544|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43936545|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
44157465|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43936546|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936547|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936548|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
43936549|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936550|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43936551|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805524|NCT04927936|Vaccines|vaccines|mesh-list
44140677|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140678|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
44140679|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140680|NCT00180128|Cytarabine|cytarabine|mesh-list
44140681|NCT00180128|Daunorubicin|daunorubicin|mesh-list
44140682|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
44140683|NCT00180128|Idarubicin|idarubicin|mesh-list
44140684|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140685|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
44140686|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140687|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140688|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
44140689|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140690|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140691|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
44140692|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936583|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43936584|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936585|NCT00828074|Sorafenib|sorafenib|mesh-list
43936586|NCT00828074|Vinorelbine|vinorelbine|mesh-list
43936587|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936588|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936589|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936590|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936591|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43936592|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936593|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936594|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936595|NCT00828191|Progesterone|progesterone|mesh-list
43936596|NCT00828191|Progestins|progestins|mesh-ancestor
43936597|NCT00828191|Hormones|hormones|mesh-ancestor
43936631|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43936632|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43936634|NCT00828542|Progestins|progestins|mesh-ancestor
43936635|NCT00828542|Hormones|hormones|mesh-ancestor
43936636|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936637|NCT00828841|Gemcitabine|gemcitabine|mesh-list
43936638|NCT00828841|Paclitaxel|paclitaxel|mesh-list
43936744|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936746|NCT00832338|Docetaxel|docetaxel|mesh-list
43936747|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
43843217|NCT04478084|Vaccines|vaccines|mesh-list
43936782|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936783|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43936784|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
43700922|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
44239255|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44239257|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44239258|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44239259|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
44239260|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160259|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
43936785|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936796|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936797|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936798|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43936799|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43936800|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43680368|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
43936801|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
43936802|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43936803|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43936804|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
43936805|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936806|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
43936807|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43936808|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43936809|NCT00833365|Ibuprofen|ibuprofen|mesh-list
43936810|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43936811|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43936812|NCT00833365|Analgesics|analgesics|mesh-ancestor
43936813|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
43936814|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936815|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936816|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936817|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936818|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43936819|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936820|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936821|NCT00833443|Bupropion|bupropion|mesh-list
43936822|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43936823|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
43936824|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43936825|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43936826|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43936827|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936828|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936829|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
43936830|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936831|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936832|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43936833|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43936834|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936835|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43936836|NCT00834171|Tobramycin|tobramycin|mesh-list
43936837|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936838|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936839|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43936840|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
43936841|NCT00834210|Dapsone|dapsone|mesh-list
43936842|NCT00834210|Tazarotene|tazarotene|mesh-list
43936843|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936844|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
43936845|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43936846|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43936847|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43936848|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936895|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
43936896|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936897|NCT00834886|Protective Agents|protective agents|mesh-ancestor
43936898|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239261|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44239262|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44239263|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239264|NCT00572364|Olaparib|olaparib|mesh-list
43936899|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936900|NCT00835159|Rivastigmine|rivastigmine|mesh-list
43936901|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43936902|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936903|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936904|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
43936905|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936906|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936907|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43936908|NCT00835159|Protective Agents|protective agents|mesh-ancestor
43936909|NCT00835185|Leucovorin|leucovorin|mesh-list
43936910|NCT00835185|Folic Acid|folic acid|mesh-list
43936911|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
43936970|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936971|NCT00835900|Varenicline|varenicline|mesh-list
43936972|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43936973|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43805791|NCT04921111|Vaccines|vaccines|mesh-list
43937040|NCT00837590|Analgesics|analgesics|mesh-ancestor
43937041|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
43937042|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937043|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937044|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937045|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937046|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43937047|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937048|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937049|NCT00837902|Atenolol|atenolol|mesh-list
43937050|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43937123|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937124|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937126|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43937127|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43937128|NCT00841204|Analgesics|analgesics|mesh-ancestor
43937129|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
43937130|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937158|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
43937159|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
43937160|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43937161|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937162|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937163|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937164|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937165|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937166|NCT00841971|Fluconazole|fluconazole|mesh-list
43937167|NCT00841971|Anidulafungin|anidulafungin|mesh-list
43937168|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
43937169|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937170|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43937171|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43937172|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937173|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937174|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43937175|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
43937176|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937177|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937178|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43937198|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937200|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43937201|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
43937202|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937203|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937204|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43937205|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
43937206|NCT00842751|Finasteride|finasteride|mesh-list
43937207|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44239265|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44239266|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937208|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43937209|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937210|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937211|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
43937212|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937213|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937214|NCT00842751|Urological Agents|urological agents|mesh-ancestor
44140718|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44140719|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140720|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44140721|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44140722|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44140723|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140724|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140725|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
44140726|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157466|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44157467|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157468|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157469|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
44157470|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157471|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157488|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937216|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43937217|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937218|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937219|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
43937220|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937221|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937222|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937223|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937224|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
43937225|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43937226|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43937227|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
43937228|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937229|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43937230|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43937231|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937232|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937233|NCT00844090|Methylphenidate|methylphenidate|mesh-list
43937234|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43937235|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937236|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43937237|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43937238|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937239|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937240|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
43937241|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937242|NCT00844298|Cytarabine|cytarabine|mesh-list
43937243|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937244|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
43937245|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937246|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937247|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
43937248|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937249|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937250|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
43937251|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937252|NCT00844714|Rituximab|rituximab|mesh-list
43937253|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43937254|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937255|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
43937256|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937257|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239267|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239268|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239269|NCT00572390|Estrogens|estrogens|mesh-list
44239270|NCT00572390|Hormones|hormones|mesh-ancestor
44239271|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160470|NCT00241423|Exenatide|exenatide|mesh-list
43937292|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937293|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937294|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937295|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937296|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43937297|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43937354|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43937355|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43937356|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43937358|NCT00848783|Capecitabine|capecitabine|mesh-list
43937359|NCT00848783|Irinotecan|irinotecan|mesh-list
43937360|NCT00848783|Floxuridine|floxuridine|mesh-list
43937361|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937362|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937363|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
43937364|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937365|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43937366|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937367|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937368|NCT00849121|Vaccines|vaccines|mesh-list
43937369|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
43937370|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937371|NCT00849251|Dexamethasone|dexamethasone|mesh-list
43937372|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
43937373|NCT00849251|Doxorubicin|doxorubicin|mesh-list
43937374|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43937375|NCT00849251|Bortezomib|bortezomib|mesh-list
43937376|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937377|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
43937378|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937379|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937380|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43937381|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
43937382|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937383|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937384|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43937385|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937386|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
43937387|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
43937388|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937389|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43937390|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
43937391|NCT00849251|Hormones|hormones|mesh-ancestor
43937392|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937393|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43937394|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937395|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937396|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937397|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937398|NCT00849810|Metoprolol|metoprolol|mesh-list
43937399|NCT00849810|Nebivolol|nebivolol|mesh-list
43937400|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43937401|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43937402|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
43937403|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
43937404|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937405|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937406|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43937407|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43937408|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43937409|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
43937410|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937411|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239272|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239273|NCT00572559|Vancomycin|vancomycin|mesh-list
44239274|NCT00572559|Linezolid|linezolid|mesh-list
44239275|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239276|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239277|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44239278|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239279|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239280|NCT00572637|Delanzomib|delanzomib|mesh-list
44239281|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
44239282|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44239283|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239284|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239285|NCT00572650|Vildagliptin|vildagliptin|mesh-list
43937412|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
43937413|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43937414|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43937415|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43937416|NCT00850096|Insulin|insulin|mesh-list
43937417|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937418|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937479|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937480|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43937481|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43937482|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43937483|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
43937642|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
43937643|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43937644|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43937645|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
43937646|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937647|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43937648|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43937649|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937650|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937651|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
43937653|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43937654|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937655|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937656|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43937657|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937658|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43937659|NCT00859040|Pasireotide|pasireotide|mesh-list
43937660|NCT00859040|Hormones|hormones|mesh-ancestor
43937661|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937662|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937663|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
43937664|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43937665|NCT00859131|Daclizumab|daclizumab|mesh-list
43937666|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
43937667|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937668|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937669|NCT00859339|Gemcitabine|gemcitabine|mesh-list
43937670|NCT00859339|Cisplatin|cisplatin|mesh-list
43937671|NCT00859339|Sunitinib|sunitinib|mesh-list
43937672|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937673|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937674|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
43937675|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937676|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
43937677|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239286|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239287|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160597|NCT00242203|Trastuzumab|trastuzumab|mesh-list
43937678|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937679|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937680|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
43937681|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937682|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43937683|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43937684|NCT00859339|Growth Substances|growth substances|mesh-ancestor
43937685|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
43937686|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937687|NCT00859495|Cisplatin|cisplatin|mesh-list
43937688|NCT00859495|Doxorubicin|doxorubicin|mesh-list
43937689|NCT00859495|Pemetrexed|pemetrexed|mesh-list
43937690|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937691|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937725|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43937726|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
43937727|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
43937728|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937729|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937730|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43937731|NCT00860015|Gemcitabine|gemcitabine|mesh-list
43937732|NCT00860015|Pemetrexed|pemetrexed|mesh-list
43937733|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937734|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
43937765|NCT00860457|Rituximab|rituximab|mesh-list
43937766|NCT00860457|Fludarabine|fludarabine|mesh-list
43937767|NCT00860457|Lenalidomide|lenalidomide|mesh-list
43937768|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43937769|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937770|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
43937771|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937772|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937773|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43937774|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43937776|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
43937777|NCT00860847|Ubiquinone|ubiquinone|mesh-list
43937778|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
43937779|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
43937780|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937781|NCT00860847|Vitamins|vitamins|mesh-ancestor
43937782|NCT00860938|Budesonide|budesonide|mesh-list
43937783|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937784|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43937785|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
43937786|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937787|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937788|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43937789|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
43937790|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
43937791|NCT00860938|Hormones|hormones|mesh-ancestor
43937792|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140729|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44140730|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
44140731|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140732|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140733|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140734|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140735|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44140736|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
44140737|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140738|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140739|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44140740|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
44140741|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
44140742|NCT00180622|Protective Agents|protective agents|mesh-ancestor
44140743|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
44140744|NCT00180635|Pimagedine|pimagedine|mesh-list
44140745|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140746|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140747|NCT00180791|Cisplatin|cisplatin|mesh-list
44140748|NCT00180791|Carboplatin|carboplatin|mesh-list
44140749|NCT00180791|Etoposide|etoposide|mesh-list
44239288|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44239290|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239291|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239292|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
44239293|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44239294|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
44239295|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239296|NCT00572663|Expectorants|expectorants|mesh-ancestor
44239297|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239298|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44239299|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
44239300|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239301|NCT00572663|Protective Agents|protective agents|mesh-ancestor
44239302|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239303|NCT00572663|Antidotes|antidotes|mesh-ancestor
44239304|NCT00572689|Exenatide|exenatide|mesh-list
44140750|NCT00180791|Melphalan|melphalan|mesh-list
44140751|NCT00180791|Thiotepa|thiotepa|mesh-list
43937793|NCT00862563|Topiramate|topiramate|mesh-list
43937794|NCT00862563|Zonisamide|zonisamide|mesh-list
43937795|NCT00862563|Levetiracetam|levetiracetam|mesh-list
43937796|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
43937797|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937798|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937799|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
43937800|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43843278|NCT04467957|Xenon|xenon|mesh-list
43937832|NCT00862810|Vaccines|vaccines|mesh-list
43937833|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
43937834|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937835|NCT00863109|Ribavirin|ribavirin|mesh-list
43937836|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43937837|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
43937838|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937839|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
43937840|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937841|NCT00863122|Lapatinib|lapatinib|mesh-list
43937842|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937843|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937844|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937845|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937846|NCT00863265|Ezetimibe|ezetimibe|mesh-list
43937932|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43937933|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
43937934|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43937935|NCT00865969|Belinostat|belinostat|mesh-list
43937936|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937937|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43937938|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937948|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
43937949|NCT00866749|Doxorubicin|doxorubicin|mesh-list
43937950|NCT00866749|Methotrexate|methotrexate|mesh-list
43937951|NCT00866749|Vincristine|vincristine|mesh-list
43937952|NCT00866749|Daunorubicin|daunorubicin|mesh-list
43937953|NCT00866749|Asparaginase|asparaginase|mesh-list
43937954|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
43937955|NCT00866749|Thioguanine|thioguanine|mesh-list
43937956|NCT00866749|Pegaspargase|pegaspargase|mesh-list
43937957|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937958|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
43937959|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937960|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239305|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239306|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239307|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44239308|NCT00572689|Incretins|incretins|mesh-ancestor
44239309|NCT00572689|Hormones|hormones|mesh-ancestor
44160726|NCT00242775|Fluticasone|fluticasone|mesh-list
43937961|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43991665|NCT02494180|Meperidine|meperidine|mesh-list
43937962|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
43937963|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937964|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937965|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43937966|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937967|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937968|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937969|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937970|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43937971|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
43937972|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937973|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937974|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
43937975|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
43937976|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43937977|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43937978|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
43937979|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937980|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43937981|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43937982|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43937983|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43937984|NCT00866879|Sirolimus|sirolimus|mesh-list
43937985|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43937986|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937987|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937988|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937989|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
43937990|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937991|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
43937992|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937993|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
43937994|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937995|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
43937996|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937997|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937998|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43937999|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
43938000|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938001|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938002|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43938037|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
43938038|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938040|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
43938041|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938042|NCT00867451|Protective Agents|protective agents|mesh-ancestor
43938043|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938044|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938045|NCT00867529|Rituximab|rituximab|mesh-list
43938064|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
43938065|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43938066|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43938067|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43938068|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938069|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938070|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43938071|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43938072|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43938073|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938074|NCT00867932|Eculizumab|eculizumab|mesh-list
43700923|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
44239310|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239311|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
44239312|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
44239313|NCT00572741|Vitamins|vitamins|mesh-ancestor
44239314|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
44239315|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239316|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
43938075|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43938076|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938077|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
43938078|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938079|NCT00868140|Pioglitazone|pioglitazone|mesh-list
43938080|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43938081|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938082|NCT00868309|Antivenins|antivenins|mesh-list
43938083|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
43938084|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938085|NCT00868348|Ketorolac|ketorolac|mesh-list
43938086|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43938087|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938088|NCT00868348|Analgesics|analgesics|mesh-ancestor
43938089|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
43938090|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938091|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938092|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938093|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938094|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43938095|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681231|NCT03923725|Artemether|artemether|mesh-list
43938096|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938097|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43938098|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
43938099|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938100|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43806464|NCT04912011|Diuretics|diuretics|mesh-ancestor
43938169|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43938170|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43938171|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938172|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938173|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938174|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938175|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43938176|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43806579|NCT04908982|Aspirin|aspirin|mesh-list
43938290|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938291|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43938292|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43938293|NCT00872027|Citalopram|citalopram|mesh-list
43938294|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43938295|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43938296|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43938297|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938298|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938299|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
43938300|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938301|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43938302|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
43938303|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938304|NCT00872534|Aspirin|aspirin|mesh-list
43938337|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
43938338|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43938339|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43938340|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938341|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938342|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43938343|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43938344|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239317|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938402|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43938403|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
43938404|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938405|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938406|NCT00876200|Minoxidil|minoxidil|mesh-list
43938407|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43938408|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
43938409|NCT00876915|Dalteparin|dalteparin|mesh-list
43938410|NCT00876915|Tinzaparin|tinzaparin|mesh-list
43938411|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43938412|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
43938413|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43938414|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43938415|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938416|NCT00876993|Bevacizumab|bevacizumab|mesh-list
43938417|NCT00876993|Irinotecan|irinotecan|mesh-list
43938418|NCT00876993|Temozolomide|temozolomide|mesh-list
43938419|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43938420|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938421|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43938422|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43938423|NCT00876993|Growth Substances|growth substances|mesh-ancestor
43938424|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938425|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
43938426|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43938427|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43938428|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938429|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938430|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43938431|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
43938432|NCT00877370|Ertapenem|ertapenem|mesh-list
43938433|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938434|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938435|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43938436|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43938437|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938438|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
43938439|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938456|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43938457|NCT00878436|Bicalutamide|bicalutamide|mesh-list
43938458|NCT00878436|Panobinostat|panobinostat|mesh-list
43938459|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
43938460|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
43938461|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938462|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938463|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938464|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43938465|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938466|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938467|NCT00878826|Enoxaparin|enoxaparin|mesh-list
43938468|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
43938469|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43938470|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43938471|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938472|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
43938473|NCT00879034|Pravastatin|pravastatin|mesh-list
43938474|NCT00879034|Lonafarnib|lonafarnib|mesh-list
43938475|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938476|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938477|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43938478|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43938628|NCT00883415|Hematinics|hematinics|mesh-ancestor
43938629|NCT00883675|Carboplatin|carboplatin|mesh-list
43938631|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938632|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938633|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938634|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
43938635|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938636|NCT00884052|Levetiracetam|levetiracetam|mesh-list
43938637|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
43938638|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
43938639|NCT00884585|Cyclosporine|cyclosporine|mesh-list
44239318|NCT00572741|Protective Agents|protective agents|mesh-ancestor
44239319|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
44239320|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239321|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239322|NCT00572819|Misoprostol|misoprostol|mesh-list
44160951|NCT00243711|Glycerol|glycerol|mesh-list
43938640|NCT00884585|Cyclosporins|cyclosporins|mesh-list
43938641|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938642|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938643|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938644|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
43938645|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938673|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
43938674|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938675|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938676|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
43938677|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43938678|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43938679|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938680|NCT00886236|Gabapentin|gabapentin|mesh-list
43938681|NCT00886236|Analgesics|analgesics|mesh-ancestor
43938682|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
43938683|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938684|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938685|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
43938686|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43938687|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938688|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938689|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938690|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43938691|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43938692|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962691|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
43938761|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938762|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938763|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43938764|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938765|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
43938766|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938767|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
43938768|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938769|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43938770|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43938771|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938772|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
43938817|NCT00888628|Analgesics|analgesics|mesh-ancestor
43938818|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
43938819|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938820|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938821|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938822|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938823|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938824|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938825|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
43938826|NCT00888979|Nicotine|nicotine|mesh-list
43938827|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43938828|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
43938829|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938830|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938831|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43938832|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43938833|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
43938834|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938835|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938836|NCT00889187|Capecitabine|capecitabine|mesh-list
43938837|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938838|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
43806812|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43938992|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938994|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991926|NCT02506634|Esomeprazole|esomeprazole|mesh-list
44239323|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44239324|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
44239325|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938995|NCT00892710|Bevacizumab|bevacizumab|mesh-list
43938996|NCT00892710|Carboplatin|carboplatin|mesh-list
43938997|NCT00892710|Pemetrexed|pemetrexed|mesh-list
43938998|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43938999|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939000|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43939001|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939002|NCT00892710|Growth Substances|growth substances|mesh-ancestor
43939003|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939004|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
43939037|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43939038|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43939039|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939040|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939041|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43939042|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43939043|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939044|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43939082|NCT00894699|Analgesics|analgesics|mesh-ancestor
43939210|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939211|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43939212|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939213|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939223|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
43939224|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
43939225|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
43939226|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939227|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
43939228|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939229|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939230|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
43939231|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939233|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43939234|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43939235|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939236|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939237|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939238|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
43939239|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939240|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43939241|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
43939242|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939243|NCT00896779|Ranibizumab|ranibizumab|mesh-list
43939244|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43939245|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939246|NCT00896779|Growth Substances|growth substances|mesh-ancestor
43939247|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939248|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
43939249|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939250|NCT00898222|Aspirin|aspirin|mesh-list
43939251|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43939252|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939253|NCT00898222|Analgesics|analgesics|mesh-ancestor
43939254|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
43939255|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939256|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939257|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939258|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939259|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43939260|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43939261|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939262|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43939263|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43939264|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939265|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
43939266|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44239326|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239327|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43939267|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
43939268|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43939269|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43939270|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939271|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939272|NCT00899470|Metformin|metformin|mesh-list
43939273|NCT00899470|Saxagliptin|saxagliptin|mesh-list
43939274|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43939275|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939276|NCT00899470|Incretins|incretins|mesh-ancestor
43939277|NCT00899470|Hormones|hormones|mesh-ancestor
43939278|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939279|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43939280|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
43939372|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939373|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43939374|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43939375|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
43939376|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43939377|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43939378|NCT00903448|Omeprazole|omeprazole|mesh-list
43939379|NCT00903448|Lansoprazole|lansoprazole|mesh-list
43939380|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43939381|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939382|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43939383|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939384|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939385|NCT00904345|Cetuximab|cetuximab|mesh-list
43939386|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939443|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43939444|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939445|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939446|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
43939447|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939448|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939449|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939450|NCT00905580|Pregabalin|pregabalin|mesh-list
43939451|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939452|NCT00905580|Analgesics|analgesics|mesh-ancestor
43939453|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
43939454|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939455|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
43939456|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43939457|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939458|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939459|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43939460|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43939506|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939507|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939509|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
43939510|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939511|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43939512|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
43939513|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939514|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43939515|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43939516|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939517|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43939518|NCT00909545|Isradipine|isradipine|mesh-list
43939519|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939520|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43939521|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939522|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939523|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43939524|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939525|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
43939526|NCT00910208|Morphine|morphine|mesh-list
43939527|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44239328|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239329|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
44239330|NCT00572884|Permethrin|permethrin|mesh-list
44239331|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239332|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939528|NCT00910208|Narcotics|narcotics|mesh-ancestor
43939529|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939530|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939531|NCT00910208|Analgesics|analgesics|mesh-ancestor
43939532|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
43939533|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939534|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
43939535|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43939536|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43939537|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43939538|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939539|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939540|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
43939541|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939542|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939543|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43939544|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939545|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
43939546|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43939547|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43939548|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43939549|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939550|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939551|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
43939552|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939553|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939554|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43939555|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939556|NCT00911326|Dextrans|dextrans|mesh-list
43939557|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
43939558|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
43939581|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939583|NCT00911742|Tramadol|tramadol|mesh-list
43939584|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43939585|NCT00911742|Narcotics|narcotics|mesh-ancestor
43939586|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939587|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939588|NCT00911742|Analgesics|analgesics|mesh-ancestor
43939589|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
43939590|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939591|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43939593|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939594|NCT00912873|Ropivacaine|ropivacaine|mesh-list
43939595|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
43939596|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
43939597|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939598|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939599|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
43939600|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939601|NCT00912990|Cisatracurium|cisatracurium|mesh-list
43939602|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43939603|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43939604|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939605|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939606|NCT00913003|Lidocaine|lidocaine|mesh-list
43939607|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
43939608|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
43939609|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939610|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939611|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
43939612|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939613|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939672|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939673|NCT00913913|Growth Substances|growth substances|mesh-ancestor
44239334|NCT00573001|Lopinavir|lopinavir|mesh-list
44239335|NCT00573001|Tenofovir|tenofovir|mesh-list
44239336|NCT00573001|Zidovudine|zidovudine|mesh-list
44239337|NCT00573001|Emtricitabine|emtricitabine|mesh-list
44459055|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44239338|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44285632|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939674|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939675|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140782|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44140783|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44140784|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
44140785|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140786|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140787|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44140788|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140789|NCT00180882|Rituximab|rituximab|mesh-list
44140790|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44140791|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140792|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
44140793|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140794|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140795|NCT00180895|Rituximab|rituximab|mesh-list
44140796|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44140797|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140798|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
44140799|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140800|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140801|NCT00180908|Doxorubicin|doxorubicin|mesh-list
44140802|NCT00180908|Etoposide|etoposide|mesh-list
44140803|NCT00180908|Methotrexate|methotrexate|mesh-list
44140804|NCT00180908|Ifosfamide|ifosfamide|mesh-list
44140805|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939694|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43939695|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939696|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
43939697|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
43939698|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
43939699|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939700|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939701|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43939702|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939703|NCT00915603|Growth Substances|growth substances|mesh-ancestor
43939704|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939705|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
43939706|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939707|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
43939708|NCT00915655|Ritonavir|ritonavir|mesh-list
43939709|NCT00915655|Darunavir|darunavir|mesh-list
43939710|NCT00915655|Lamivudine|lamivudine|mesh-list
43939711|NCT00915655|Zidovudine|zidovudine|mesh-list
43939712|NCT00915655|Abacavir|abacavir|mesh-list
43939713|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43939714|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43939715|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
43939716|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939717|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939718|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43682628|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939749|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
43939750|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939751|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939752|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43939753|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
43939754|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939755|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939756|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44239340|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44239342|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44239343|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44239344|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
44239345|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161287|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939757|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939758|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939759|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
43939760|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43939761|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939762|NCT00918931|Obatoclax|obatoclax|mesh-list
43939833|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939834|NCT00920075|Alendronate|alendronate|mesh-list
43939835|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43939836|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939837|NCT00921310|Sirolimus|sirolimus|mesh-list
43939838|NCT00921310|Pemetrexed|pemetrexed|mesh-list
43807527|NCT04897477|Azacitidine|azacitidine|mesh-list
43939862|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43939863|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939864|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
43939865|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43939866|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
43939867|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43939868|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939869|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43939870|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43939871|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43939872|NCT00923117|Sunitinib|sunitinib|mesh-list
43939873|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939874|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43939875|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939876|NCT00923117|Growth Substances|growth substances|mesh-ancestor
43939877|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939878|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
43939879|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43939880|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939881|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939882|NCT00923910|Acetaminophen|acetaminophen|mesh-list
43939883|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
43939884|NCT00923910|Promethazine|promethazine|mesh-list
43939885|NCT00923910|Interleukin-4|interleukin-4|mesh-list
43939886|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
43939887|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939888|NCT00923910|Analgesics|analgesics|mesh-ancestor
43939889|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
43807563|NCT04896125|Bimatoprost|bimatoprost|mesh-list
43939958|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939959|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939960|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
43939961|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43939962|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43939963|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43939964|NCT00924352|Dasatinib|dasatinib|mesh-list
43939965|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939966|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43939967|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939968|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939969|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
43939970|NCT00924612|Testosterone|testosterone|mesh-list
43939971|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
43939972|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
43939973|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43939974|NCT00924612|Androgens|androgens|mesh-ancestor
43939975|NCT00924612|Hormones|hormones|mesh-ancestor
43939976|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239346|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239347|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44239348|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44239349|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
44239350|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239351|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44239352|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44161355|NCT00244972|Tipifarnib|tipifarnib|mesh-list
43939977|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939978|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43939979|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939980|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
43939981|NCT00925119|Atenolol|atenolol|mesh-list
43939982|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939983|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939984|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
43939985|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
43939986|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939987|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939988|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43939989|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43939990|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43939991|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
43939992|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939993|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939994|NCT00925756|Maraviroc|maraviroc|mesh-list
43939995|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43939996|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43939997|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939998|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43939999|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43940000|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
43940001|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940002|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43940003|NCT00925782|Melphalan|melphalan|mesh-list
43940004|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940005|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
43940006|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940007|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940008|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43940009|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940010|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
43940011|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940012|NCT00925938|Misoprostol|misoprostol|mesh-list
43940019|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
43940020|NCT00926185|Lifitegrast|lifitegrast|mesh-list
43940021|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43940022|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43940023|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
43940024|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43940025|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940026|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940027|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43940028|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940029|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940030|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940031|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940032|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940033|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
43940034|NCT00926380|Denosumab|denosumab|mesh-list
43940035|NCT00926380|Teriparatide|teriparatide|mesh-list
43940036|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43940037|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940038|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43940039|NCT00926588|Analgesics|analgesics|mesh-list
43940040|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
44239353|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43940041|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940042|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940043|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43940044|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43940045|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
43940046|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
43940047|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
43940048|NCT00927849|Glycerol|glycerol|mesh-list
43940049|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43940050|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940051|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940052|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940053|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940054|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940055|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43940056|NCT00927849|Protective Agents|protective agents|mesh-ancestor
43940057|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
43940059|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
43940060|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
43940061|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940062|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940063|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
43940064|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940065|NCT00928083|Artefenomel|artefenomel|mesh-list
43940066|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
43940067|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43940068|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43940069|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940070|NCT00928174|Fluorides|fluorides|mesh-list
43940071|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
43940072|NCT00928174|Protective Agents|protective agents|mesh-ancestor
43940073|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940074|NCT00928200|Cytarabine|cytarabine|mesh-list
43940075|NCT00928200|Dexamethasone|dexamethasone|mesh-list
43940076|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
43940077|NCT00928200|Doxorubicin|doxorubicin|mesh-list
43940078|NCT00928200|Methotrexate|methotrexate|mesh-list
43940079|NCT00928200|Vincristine|vincristine|mesh-list
43940080|NCT00928200|Asparaginase|asparaginase|mesh-list
43940081|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
43940082|NCT00928200|Razoxane|razoxane|mesh-list
43940083|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43940084|NCT00928200|BB 1101|bb 1101|mesh-list
43807681|NCT04893733|Vitamins|vitamins|mesh-ancestor
43940135|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940136|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43940137|NCT00928694|Fenofibrate|fenofibrate|mesh-list
43940138|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43940139|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
43940140|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940141|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43940142|NCT00928772|Midazolam|midazolam|mesh-list
43940143|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43940144|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43940145|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940146|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940147|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43940252|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
43940253|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940254|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43940255|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43940256|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
43940257|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
43940258|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940259|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43940260|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43940261|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940262|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
43940263|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43940264|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43940265|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
43940266|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
43940267|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940268|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940269|NCT00931242|Thalidomide|thalidomide|mesh-list
43940270|NCT00931242|Apremilast|apremilast|mesh-list
43700924|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
44239354|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44239355|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
43940271|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43940272|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940273|NCT00931242|Analgesics|analgesics|mesh-ancestor
43940274|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
43940275|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940339|NCT00932438|Bevacizumab|bevacizumab|mesh-list
43940340|NCT00932438|Fluorouracil|fluorouracil|mesh-list
43940341|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
43940343|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940344|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940345|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940346|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940347|NCT00932438|Growth Substances|growth substances|mesh-ancestor
43940348|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940349|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940350|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
43940351|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940352|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43940353|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807864|NCT04891679|Misoprostol|misoprostol|mesh-list
43940369|NCT00932477|Protective Agents|protective agents|mesh-ancestor
43940370|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940371|NCT00932477|Laxatives|laxatives|mesh-ancestor
43940372|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940373|NCT00932620|Simvastatin|simvastatin|mesh-list
43940374|NCT00932620|Ezetimibe|ezetimibe|mesh-list
43940375|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43940376|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43940377|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
43940378|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940379|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43940380|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43940381|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940382|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
43940383|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940384|NCT00934024|Varenicline|varenicline|mesh-list
43940385|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43940386|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43940387|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940388|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940389|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940390|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940391|NCT00934375|Donepezil|donepezil|mesh-list
43940392|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43940393|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940394|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940395|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940396|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940397|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940398|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
43940399|NCT00934635|Risperidone|risperidone|mesh-list
43940400|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43940401|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43940402|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
43940403|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940404|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940405|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940406|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43940407|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940408|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940409|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940410|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43940411|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
43940412|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43683167|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
43940413|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43940415|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
43940430|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
43940431|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
43940432|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44239356|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44239357|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43940433|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940434|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940435|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43940436|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
43940437|NCT00935792|Everolimus|everolimus|mesh-list
43940438|NCT00935792|Antibodies|antibodies|mesh-list
43940439|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
43940440|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43940441|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
43940442|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940443|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940444|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940445|NCT00936299|Bupropion|bupropion|mesh-list
43940446|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43940447|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
43940448|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940449|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43940450|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43940451|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940452|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940453|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
43940454|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940455|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940456|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43940457|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43940458|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940459|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
43940460|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43940461|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940462|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940463|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940464|NCT00936377|Analgesics|analgesics|mesh-ancestor
43940465|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
43940466|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940467|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43940468|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43940469|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43940470|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
43940471|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940472|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940473|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43940474|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43940475|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940476|NCT00936663|Incretins|incretins|mesh-ancestor
43940489|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43940490|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43940491|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
43940492|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43940493|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43940494|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
43940495|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940496|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
43940497|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43940498|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43940500|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43940501|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43940502|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940503|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940504|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940505|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940506|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
43940507|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43940508|NCT00938314|Hematinics|hematinics|mesh-ancestor
43940509|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940510|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940511|NCT00938548|Pregabalin|pregabalin|mesh-list
43940512|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940513|NCT00938548|Analgesics|analgesics|mesh-ancestor
43940514|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
44239358|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44239359|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44239360|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44239361|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44161652|NCT00246064|Infliximab|infliximab|mesh-list
43940515|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940517|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43940518|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940519|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940520|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43940521|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43940522|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940523|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940524|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940525|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43940526|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
43940527|NCT00938704|Glycerol|glycerol|mesh-list
43940528|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43940529|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
43940530|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940531|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
43940532|NCT00938704|Protective Agents|protective agents|mesh-ancestor
43940533|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43940534|NCT00938704|Laxatives|laxatives|mesh-ancestor
43940535|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940536|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43940537|NCT00939120|Dutasteride|dutasteride|mesh-list
43940543|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940544|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940545|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43940546|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43940547|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940548|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940549|NCT00939120|Urological Agents|urological agents|mesh-ancestor
43940550|NCT00939159|Panobinostat|panobinostat|mesh-list
43940551|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940552|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43940553|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940554|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940555|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
43940556|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43940557|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
43940558|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940559|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940560|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43940561|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
43940562|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
43940563|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43940564|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940565|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940566|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940567|NCT00939367|Zolpidem|zolpidem|mesh-list
43940568|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43940569|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43940570|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940571|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940572|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43940573|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
43940574|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
43940575|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940576|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940577|NCT00939536|Zolpidem|zolpidem|mesh-list
43940578|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43940579|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43940580|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940581|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940582|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44239362|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239363|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239364|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
44239365|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239366|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44239367|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239368|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239369|NCT00573404|Sunitinib|sunitinib|mesh-list
43940583|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
43940584|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
43940585|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940586|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940587|NCT00939562|Doxycycline|doxycycline|mesh-list
43940588|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940589|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940590|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
43940591|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43940592|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43940593|NCT00939653|Cytarabine|cytarabine|mesh-list
43940594|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
43940595|NCT00939653|Etoposide|etoposide|mesh-list
43940596|NCT00939653|Clofarabine|clofarabine|mesh-list
43940597|NCT00939653|Lenograstim|lenograstim|mesh-list
43940598|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940599|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
43940600|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940601|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940602|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940603|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
43940604|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940605|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808006|NCT04889196|Fluorides|fluorides|mesh-list
43940624|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940626|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43940627|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43940628|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
43940629|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940630|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43940631|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43940632|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157489|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940633|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940634|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
43940635|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43940636|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940637|NCT00939952|Ertapenem|ertapenem|mesh-list
43940638|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940639|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940640|NCT00939991|Bevacizumab|bevacizumab|mesh-list
43940641|NCT00939991|Temozolomide|temozolomide|mesh-list
43940642|NCT00939991|Vorinostat|vorinostat|mesh-list
43940643|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940644|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940645|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940646|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940647|NCT00939991|Growth Substances|growth substances|mesh-ancestor
43940648|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940649|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940650|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940651|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
43940652|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940653|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43940654|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940655|NCT00940589|Melatonin|melatonin|mesh-list
43940656|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
43940657|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940658|NCT00940589|Protective Agents|protective agents|mesh-ancestor
43940659|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239370|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
44239371|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239372|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44239373|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44239374|NCT00573404|Growth Substances|growth substances|mesh-ancestor
44239375|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239376|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
44239377|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43940660|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940671|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
43940672|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
43940673|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43940674|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43940675|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940676|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940677|NCT00940901|Urological Agents|urological agents|mesh-ancestor
43940679|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43940680|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
43940681|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940682|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940683|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43940684|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
43940685|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
43940686|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940687|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43940688|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43940689|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43940690|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
43940691|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940692|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940693|NCT00941668|Triclosan|triclosan|mesh-list
43940694|NCT00941668|Fluorides|fluorides|mesh-list
43940695|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
43940696|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
43940697|NCT00941668|Protective Agents|protective agents|mesh-ancestor
43940698|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940699|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43940700|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940701|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43940702|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43940703|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
43940704|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940705|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683394|NCT04327063|Ropivacaine|ropivacaine|mesh-list
43940706|NCT00942149|Daptomycin|daptomycin|mesh-list
43940707|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940708|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940709|NCT00942305|Brincidofovir|brincidofovir|mesh-list
43940710|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
43940711|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940712|NCT00942448|Diclofenac|diclofenac|mesh-list
43940713|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43940714|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940715|NCT00942448|Analgesics|analgesics|mesh-ancestor
43940716|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
43940717|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940718|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940719|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940720|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940721|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43940722|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940723|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940724|NCT00942578|Prednisone|prednisone|mesh-list
43940746|NCT00942825|Pemetrexed|pemetrexed|mesh-list
43940747|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940748|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940749|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239379|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239380|NCT00573417|Modafinil|modafinil|mesh-list
44239381|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44239382|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239383|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44239384|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43940750|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43940751|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43940752|NCT00943098|Diclofenac|diclofenac|mesh-list
43940753|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43940754|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940755|NCT00943098|Analgesics|analgesics|mesh-ancestor
43940756|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
43940757|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940758|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940759|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940760|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940761|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43940762|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940763|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940764|NCT00943202|Vaccines|vaccines|mesh-list
43940765|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
43940766|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992731|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
44140830|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140831|NCT00180947|Vinorelbine|vinorelbine|mesh-list
44140832|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44140833|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140834|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44140835|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44140836|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44140837|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140838|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
44140839|NCT00180960|Irinotecan|irinotecan|mesh-list
44140840|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140841|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44140842|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940830|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
43940831|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
43940832|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43940833|NCT00944671|Famotidine|famotidine|mesh-list
43940834|NCT00944671|Calcium|calcium|mesh-list
43940835|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43940836|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940837|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43940838|NCT00944671|Antacids|antacids|mesh-ancestor
43940839|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940840|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940841|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43940842|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43940843|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
43940844|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
43940871|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
43940872|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940873|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43940875|NCT00945139|Doxorubicin|doxorubicin|mesh-list
43940876|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940877|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940878|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940879|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940880|NCT00945139|Growth Substances|growth substances|mesh-ancestor
43940881|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940882|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940883|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43940884|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43940885|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44239385|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44239386|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239387|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
44239388|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44239389|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44239390|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239391|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239393|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44239394|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44239395|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940886|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940887|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940888|NCT00945256|Nitroprusside|nitroprusside|mesh-list
43940889|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43940890|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
43940891|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43808237|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940925|NCT00945750|Famotidine|famotidine|mesh-list
43940926|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43940927|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940928|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43940929|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
43940930|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
43940931|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940999|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941000|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
43941001|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43941002|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941003|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941017|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941018|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941019|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941020|NCT00947765|Prednisolone|prednisolone|mesh-list
43941021|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43941022|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
43941023|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43941024|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
43941025|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43941026|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
43941027|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941028|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
43941029|NCT00947765|Hormones|hormones|mesh-ancestor
43941030|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941031|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941032|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43941033|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941034|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
43941035|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
43941036|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941037|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941038|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43941039|NCT00947765|Protective Agents|protective agents|mesh-ancestor
43941040|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
43941041|NCT00948090|Busulfan|busulfan|mesh-list
43941042|NCT00948090|Etoposide|etoposide|mesh-list
43941043|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941044|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
43941045|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941046|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941047|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43941048|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
43700925|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239396|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239397|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239398|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
44239399|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239400|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44239401|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44161983|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
43941049|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941050|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941051|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43941052|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43941053|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43941054|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43941055|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941057|NCT00948298|Vitamins|vitamins|mesh-ancestor
43941058|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
43941059|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941060|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43941061|NCT00948610|Infliximab|infliximab|mesh-list
43941062|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941063|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941064|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941065|NCT00948935|Gemcitabine|gemcitabine|mesh-list
43941066|NCT00948935|Irinotecan|irinotecan|mesh-list
43941067|NCT00948935|Panitumumab|panitumumab|mesh-list
43941095|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43941096|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
43941097|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941098|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43941099|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43941100|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43941101|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941102|NCT00950352|Choline|choline|mesh-list
43941103|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43941104|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
43941105|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43941106|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
43941107|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941108|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941109|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43941110|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
43941111|NCT00950365|Pemetrexed|pemetrexed|mesh-list
43941112|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43941113|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941114|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941136|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43941137|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941138|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43941139|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43941140|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
43941141|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941142|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43941143|NCT00952081|Clevidipine|clevidipine|mesh-list
43941144|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43941145|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941146|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941147|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43941148|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941149|NCT00952133|Dexamethasone|dexamethasone|mesh-list
43941150|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
43941151|NCT00952133|Palonosetron|palonosetron|mesh-list
43941153|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941154|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
43941155|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
43941156|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941157|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805229|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
44239402|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239403|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44239404|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44239405|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239406|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
44239408|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43941158|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941159|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
43941160|NCT00952133|Hormones|hormones|mesh-ancestor
43941161|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941162|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43941163|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941164|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
43941198|NCT00953121|Growth Substances|growth substances|mesh-ancestor
43941199|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941200|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
43941201|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43941202|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43941203|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843732|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
43941239|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43941240|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43941241|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43941271|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43941273|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941274|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
43941275|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941276|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941277|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43941278|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
43941279|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941280|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43941281|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43941282|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941283|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941284|NCT00955253|Guanfacine|guanfacine|mesh-list
43941319|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941320|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43941321|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941322|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941323|NCT00955747|Tagatose|tagatose|mesh-list
43941355|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941356|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941357|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43941358|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43941359|NCT00956254|Fentanyl|fentanyl|mesh-list
43941360|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43941361|NCT00956254|Narcotics|narcotics|mesh-ancestor
43941362|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941363|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941364|NCT00956254|Analgesics|analgesics|mesh-ancestor
43941365|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
43941366|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941367|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43808607|NCT04879030|Renal Agents|renal agents|mesh-ancestor
43941396|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941397|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43941399|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941400|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941402|NCT00957359|Psilocybin|psilocybin|mesh-list
43941403|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43941404|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43941405|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
43941406|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941407|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44239409|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44239410|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239411|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239412|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
44239413|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
44239414|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
44239415|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239416|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
44239417|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
44239418|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239419|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43941408|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
43941409|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
43941410|NCT00957359|Vitamins|vitamins|mesh-ancestor
43941411|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
43941412|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941413|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
43808632|NCT04878497|Warfarin|warfarin|mesh-list
43941434|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43941435|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43941436|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43941437|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941438|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43941439|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43941440|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941441|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941442|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
43941443|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941444|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
43941445|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
43941446|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43941447|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43941448|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941449|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
43941450|NCT00958581|Coagulants|coagulants|mesh-ancestor
43941451|NCT00958919|Naloxone|naloxone|mesh-list
43941452|NCT00958919|Endorphins|endorphins|mesh-list
43941453|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43808645|NCT04878016|Etoposide|etoposide|mesh-list
43941466|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
43941467|NCT00960622|Tenofovir|tenofovir|mesh-list
43941468|NCT00960622|Lamivudine|lamivudine|mesh-list
43941469|NCT00960622|Zidovudine|zidovudine|mesh-list
43941470|NCT00960622|Emtricitabine|emtricitabine|mesh-list
43941471|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43941472|NCT00960622|Abacavir|abacavir|mesh-list
43941473|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
43941474|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43941475|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
43941476|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941477|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43941478|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941479|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941480|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941481|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43941482|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43941483|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
43941484|NCT00960778|Nicotine|nicotine|mesh-list
43941485|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43941486|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
43941487|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941488|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941489|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43941490|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43941491|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
43941492|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239420|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
44239421|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
44239422|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239423|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239424|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44239425|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44239426|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44239427|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239428|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44239429|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
44239430|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44239431|NCT00573638|Latanoprost|latanoprost|mesh-list
44239432|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44239433|NCT00573664|Gabapentin|gabapentin|mesh-list
44239434|NCT00573664|Analgesics|analgesics|mesh-ancestor
44239435|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
44239436|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239437|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239438|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
44162185|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
43941493|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941494|NCT00961233|Budesonide|budesonide|mesh-list
43941495|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941496|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43941497|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
43941498|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941499|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941500|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43941501|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
43941502|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
43941503|NCT00961233|Hormones|hormones|mesh-ancestor
43941504|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941505|NCT00961441|Levetiracetam|levetiracetam|mesh-list
43941506|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
43941507|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
43941508|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43941509|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
43941510|NCT00961532|Coagulants|coagulants|mesh-ancestor
43941511|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43941512|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
43941513|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941514|NCT00961662|Tagatose|tagatose|mesh-list
43941515|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43941516|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
43941546|NCT00962949|Giapreza|giapreza|mesh-list
43941547|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
43941548|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43941549|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43941550|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
43941551|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941552|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941553|NCT00963105|Lenalidomide|lenalidomide|mesh-list
43941554|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
43941555|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941592|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941593|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941594|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941595|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44239439|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44239440|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44239441|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239442|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162230|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941596|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43941619|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43941620|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941622|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941623|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43941624|NCT00966641|Analgesics|analgesics|mesh-ancestor
43941625|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
43941626|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941627|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941628|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941629|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941630|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
43941631|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43941632|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941633|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941634|NCT00967044|Everolimus|everolimus|mesh-list
43941635|NCT00967044|Panobinostat|panobinostat|mesh-list
43941636|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941637|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941638|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
43941639|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941640|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43941641|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941642|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941643|NCT00967369|Carboplatin|carboplatin|mesh-list
43941644|NCT00967369|Etoposide|etoposide|mesh-list
43941645|NCT00967369|Bortezomib|bortezomib|mesh-list
43941646|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
43941647|NCT00967369|Ifosfamide|ifosfamide|mesh-list
43941648|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
43941649|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
43843797|NCT04426890|Omalizumab|omalizumab|mesh-list
43941665|NCT00967551|Micronutrients|micronutrients|mesh-list
43941666|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941667|NCT00968071|Decitabine|decitabine|mesh-list
43941668|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
43941669|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941670|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
43941671|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941672|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941673|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941674|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941675|NCT00968890|Vaccines|vaccines|mesh-list
43941676|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
43941677|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941678|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43941679|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43941680|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43941681|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
43941682|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941683|NCT00969878|Antacids|antacids|mesh-ancestor
43941684|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941685|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941686|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
43941687|NCT00970073|Tacrolimus|tacrolimus|mesh-list
43941688|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
43941689|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43941690|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941691|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
43941692|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941693|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43941694|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941695|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941696|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43941697|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941698|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44239443|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44239444|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44239446|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239447|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
44239448|NCT00573690|Cisplatin|cisplatin|mesh-list
43941699|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
43941700|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43941701|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941702|NCT00970203|Vaccines|vaccines|mesh-list
43941703|NCT00970203|Androgens|androgens|mesh-list
43941704|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
43941705|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941706|NCT00970203|Hormones|hormones|mesh-ancestor
43941707|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941708|NCT00970216|Telbivudine|telbivudine|mesh-list
43941739|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
43941740|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941741|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941742|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43941743|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
43941744|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941745|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43941746|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
43941747|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941748|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941749|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43941750|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43941751|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941752|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941779|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43941780|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941781|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
43941782|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
43941783|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
43941784|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941785|NCT00972205|Paclitaxel|paclitaxel|mesh-list
43941786|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43941787|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43941788|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941789|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
43941790|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
43941791|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
43941792|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941793|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43941794|NCT00972335|Bevacizumab|bevacizumab|mesh-list
43941795|NCT00972335|Everolimus|everolimus|mesh-list
43941796|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941797|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941798|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43941799|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43808939|NCT04469530|Etoposide|etoposide|mesh-list
43941821|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43941822|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43941823|NCT00972725|Chloroquine|chloroquine|mesh-list
43941824|NCT00972725|Amebicides|amebicides|mesh-ancestor
43941825|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43941826|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43941827|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941828|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
43941829|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941830|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
43941831|NCT00972959|Dexamethasone|dexamethasone|mesh-list
43941832|NCT00972959|Bortezomib|bortezomib|mesh-list
43941833|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941834|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
43941835|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
43941836|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941837|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941838|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239449|NCT00573690|Carboplatin|carboplatin|mesh-list
44239450|NCT00573690|Etoposide|etoposide|mesh-list
44239451|NCT00573690|Pemetrexed|pemetrexed|mesh-list
44239452|NCT00573690|Sorafenib|sorafenib|mesh-list
44239453|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941839|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
43941840|NCT00972959|Hormones|hormones|mesh-ancestor
43941841|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941842|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43941843|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941844|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43941845|NCT00973739|Lapatinib|lapatinib|mesh-list
43941846|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941847|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43941848|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941849|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941850|NCT00973752|Cytarabine|cytarabine|mesh-list
43941851|NCT00973752|Prednisone|prednisone|mesh-list
43941852|NCT00973752|Doxorubicin|doxorubicin|mesh-list
43941853|NCT00973752|Methotrexate|methotrexate|mesh-list
43941870|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43941871|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43941872|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
43941873|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43941874|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941875|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
43941876|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941877|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43941878|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941879|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
43941880|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941881|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941882|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
43941883|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941884|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43941885|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
43941886|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
43941887|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
44140849|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140850|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44140851|NCT00181012|Lidocaine|lidocaine|mesh-list
44140852|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44140853|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
44140854|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140855|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140856|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
44140857|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140858|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44140859|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44140860|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44140861|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140862|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140863|NCT00181025|Melphalan|melphalan|mesh-list
44140864|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140865|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
44140866|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140867|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140868|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44140869|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140870|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
44140871|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140902|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140903|NCT00181246|Analgesics|analgesics|mesh-ancestor
44140904|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
44140905|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140906|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44140907|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44140908|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
44140909|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
44140910|NCT00181272|Azithromycin|azithromycin|mesh-list
44140911|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239454|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44239455|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44239456|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44239457|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239458|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239459|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44239460|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44239461|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44239462|NCT00573742|Candesartan|candesartan|mesh-list
44239463|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44239464|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44239465|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44140912|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140913|NCT00181298|Memantine|memantine|mesh-list
44140914|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44140915|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43941889|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43941890|NCT00974051|Terbutaline|terbutaline|mesh-list
43941891|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
43941892|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809072|NCT03871049|Dexamethasone|dexamethasone|mesh-list
43941926|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
43941928|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941929|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
43941931|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
43941948|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43941949|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941950|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941951|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
43941952|NCT00974480|Tretinoin|tretinoin|mesh-list
43941953|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941954|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
43941955|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941956|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43941957|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43941958|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941959|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
43941960|NCT00974818|Mitomycins|mitomycins|mesh-list
43828593|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
43941961|NCT00974818|Mitomycin|mitomycin|mesh-list
43941962|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
43941963|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43941964|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941965|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
43941966|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941967|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941968|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941969|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43941970|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
43941971|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941973|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43941974|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941975|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
43941976|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941977|NCT00975650|Testosterone|testosterone|mesh-list
43941978|NCT00975650|Androgens|androgens|mesh-ancestor
43941979|NCT00975650|Hormones|hormones|mesh-ancestor
43941980|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941981|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941982|NCT00976183|Vorinostat|vorinostat|mesh-list
43941983|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941984|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44239466|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459056|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44459057|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
44459058|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44459059|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44459060|NCT01585987|Ipilimumab|ipilimumab|mesh-list
44459061|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459062|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459063|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44459064|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459065|NCT01585831|Testosterone|testosterone|mesh-list
44459066|NCT01585831|Androgens|androgens|mesh-ancestor
44459067|NCT01585831|Hormones|hormones|mesh-ancestor
43941985|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941986|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941987|NCT00976248|Everolimus|everolimus|mesh-list
43941988|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941989|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941990|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
43942027|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43942054|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942055|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942056|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43942057|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942058|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43942060|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43942061|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43942062|NCT00979615|Analgesics|analgesics|mesh-ancestor
43942063|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
43942064|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942065|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942066|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942067|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942068|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43942069|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43942070|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43942071|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
43942072|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
43942073|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942074|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942075|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43942103|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43942104|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942105|NCT00980395|Rituximab|rituximab|mesh-list
43942106|NCT00980395|Bortezomib|bortezomib|mesh-list
43942107|NCT00980395|Cladribine|cladribine|mesh-list
43942108|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43942109|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942110|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
43942111|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942112|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942113|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942114|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43942115|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
43942116|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
43942117|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942118|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43942119|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
44459068|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459069|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239467|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44239469|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239470|NCT00573885|Protective Agents|protective agents|mesh-ancestor
44239471|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239472|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44239473|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44239474|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942120|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43942121|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43942122|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962693|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942159|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942192|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942193|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43942194|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942195|NCT00982189|Lisinopril|lisinopril|mesh-list
43942196|NCT00982189|Pravastatin|pravastatin|mesh-list
43942197|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43942198|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942199|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
43942200|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942201|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942202|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43942203|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942239|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
43942240|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43942241|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942242|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
43809354|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
43942278|NCT00983242|Verapamil|verapamil|mesh-list
43942279|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
43942280|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942281|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
43942316|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942318|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942319|NCT00985543|Ritonavir|ritonavir|mesh-list
43942320|NCT00985543|Lopinavir|lopinavir|mesh-list
43942354|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942355|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942357|NCT00986583|Succinylcholine|succinylcholine|mesh-list
43942358|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43942359|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43942360|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43942361|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942397|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43942398|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43942399|NCT00987558|Simvastatin|simvastatin|mesh-list
43942400|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43942401|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942402|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
43942403|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942431|NCT00988143|Vaccines|vaccines|mesh-list
43942432|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
43942433|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942434|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43942435|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
43942436|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43942437|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43942438|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44239475|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44239476|NCT00573924|Lansoprazole|lansoprazole|mesh-list
44239477|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
44239478|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44162635|NCT00250068|Rubitecan|rubitecan|mesh-list
43942439|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942440|NCT00988325|Oseltamivir|oseltamivir|mesh-list
43942441|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
43942442|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942443|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942444|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140916|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
44140917|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140918|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140919|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140920|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44140940|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44140941|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44140942|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140943|NCT00181571|Methylphenidate|methylphenidate|mesh-list
44140944|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44140945|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140946|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44140947|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140948|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140949|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140950|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
44140951|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140952|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
44140953|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44140954|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140955|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
43942445|NCT00988832|Infliximab|infliximab|mesh-list
43942446|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942447|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942448|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942449|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43942450|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43942451|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43942452|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942453|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942454|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942455|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942456|NCT00989157|Analgesics|analgesics|mesh-ancestor
43942457|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
43942458|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942459|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
43942460|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43942461|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
43942493|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
43942494|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
43942495|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43942496|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43942497|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942498|NCT00990288|Thrombin|thrombin|mesh-list
43942499|NCT00990288|Hemostatics|hemostatics|mesh-list
43942500|NCT00990288|Coagulants|coagulants|mesh-ancestor
43942501|NCT00990561|Clobetasol|clobetasol|mesh-list
43942502|NCT00990561|Halobetasol|halobetasol|mesh-list
43942503|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43942504|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942505|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
43942506|NCT00990561|Hormones|hormones|mesh-ancestor
43942507|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942539|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43942540|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43942541|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942542|NCT00991458|Cyclosporine|cyclosporine|mesh-list
43942543|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44239479|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44239480|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239481|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239482|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239484|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44239485|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
44239486|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239487|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239488|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239489|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44162705|NCT00250354|Risperidone|risperidone|mesh-list
43942544|NCT00991458|Cyclosporins|cyclosporins|mesh-list
43942545|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942546|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809633|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
43942583|NCT00992602|Cytarabine|cytarabine|mesh-list
43942584|NCT00992602|Methotrexate|methotrexate|mesh-list
43942585|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43942586|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
43942587|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43942588|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809667|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
43942611|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942612|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942613|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942614|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942615|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942616|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
43942617|NCT00993200|Warfarin|warfarin|mesh-list
43942618|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
43942619|NCT00993226|Bupivacaine|bupivacaine|mesh-list
43942620|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
43942621|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
43942622|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942623|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942624|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
43942625|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942626|NCT00993655|Paclitaxel|paclitaxel|mesh-list
43942627|NCT00993655|Cisplatin|cisplatin|mesh-list
43942628|NCT00993655|Carboplatin|carboplatin|mesh-list
43942629|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43942630|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942631|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
43942632|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942633|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942634|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942636|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
43942637|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
43942638|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942639|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942640|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
43942641|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942670|NCT00994929|Oprelvekin|oprelvekin|mesh-list
43942671|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942672|NCT00995072|Metoprolol|metoprolol|mesh-list
43942673|NCT00995072|Nebivolol|nebivolol|mesh-list
43942674|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942675|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942676|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
43942677|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
43942678|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942679|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942680|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44239490|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44239491|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44239492|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239493|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44239494|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
44239495|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44239496|NCT00573950|Protective Agents|protective agents|mesh-ancestor
44239497|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44239498|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44239499|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239500|NCT00573963|Ropivacaine|ropivacaine|mesh-list
43942681|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43942682|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43942683|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43942684|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942685|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942686|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
43942687|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43942688|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43942724|NCT00995501|Cathartics|cathartics|mesh-ancestor
43942725|NCT00995722|Prednisone|prednisone|mesh-list
43942726|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942727|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
43942728|NCT00995722|Hormones|hormones|mesh-ancestor
43942729|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942730|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942731|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809768|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942763|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942764|NCT00997113|Alfentanil|alfentanil|mesh-list
43942765|NCT00997113|Propofol|propofol|mesh-list
43942766|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43942767|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942768|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942769|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43942770|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
43942771|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
43942772|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43942773|NCT00997113|Narcotics|narcotics|mesh-ancestor
43942774|NCT00997113|Analgesics|analgesics|mesh-ancestor
43942775|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
43942803|NCT00997620|Fluticasone|fluticasone|mesh-list
43942805|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942806|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43942807|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
43942808|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942809|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942810|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43942811|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
43942812|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942813|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43942814|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
43942815|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
43942816|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43942817|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942818|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942819|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
43685102|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843967|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
43942847|NCT00998205|Dobutamine|dobutamine|mesh-list
43942848|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43942849|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942850|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43942851|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
43942852|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239501|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
44239502|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
44239503|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162823|NCT00250861|Rituximab|rituximab|mesh-list
43942853|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942854|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43942855|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
43942856|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
43942857|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
43942858|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43942859|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43942860|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
43942861|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942862|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942863|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43942864|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
43942865|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43809832|NCT04869501|Atezolizumab|atezolizumab|mesh-list
43942897|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942898|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942899|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43942900|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43942901|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43942902|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
43942903|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942904|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942905|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
43942906|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43942907|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43942908|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43942909|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
43942910|NCT01000285|Prednisone|prednisone|mesh-list
43942911|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
43942947|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43942948|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942949|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43942950|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942951|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942952|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942988|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942990|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943059|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943060|NCT01003106|Growth Substances|growth substances|mesh-ancestor
43943061|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943062|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140975|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
44140976|NCT00181662|Curcumin|curcumin|mesh-list
44140977|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44140978|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44140979|NCT00181662|Analgesics|analgesics|mesh-ancestor
44140980|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
44140981|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140982|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140983|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140984|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140985|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140986|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140987|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140988|NCT00181675|Galantamine|galantamine|mesh-list
44140989|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44140990|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140991|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140992|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140993|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810008|NCT04866355|Scopolamine|scopolamine|mesh-list
43943091|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943092|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43943093|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43943094|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43943095|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43943096|NCT01003938|Topotecan|topotecan|mesh-list
44239504|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239505|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
44239506|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239508|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44239509|NCT00574015|Hydrocodone|hydrocodone|mesh-list
44239510|NCT00574015|Bupivacaine|bupivacaine|mesh-list
44239511|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
44239512|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
44239513|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239514|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239515|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
44239516|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943097|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943098|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43943168|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43810135|NCT04864977|Insulin|insulin|mesh-list
43810177|NCT04864509|Melatonin|melatonin|mesh-list
43943223|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
43943224|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943225|NCT01005459|Bupivacaine|bupivacaine|mesh-list
43943226|NCT01005459|Tetracaine|tetracaine|mesh-list
43943227|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
43943228|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
43943229|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943230|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943231|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
43943232|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943233|NCT01005576|Fludarabine|fludarabine|mesh-list
43943234|NCT01005576|Melphalan|melphalan|mesh-list
43943235|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
43943236|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943237|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943238|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943239|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
43943240|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943241|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943242|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
43943243|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43943244|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943245|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
43943246|NCT01005706|Sirolimus|sirolimus|mesh-list
43943247|NCT01005706|Tacrolimus|tacrolimus|mesh-list
43943248|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943249|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
43943250|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943251|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43943252|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943253|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943254|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943255|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943256|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43943257|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
43943258|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943259|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943260|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
43943261|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
43943262|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43943263|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
43844033|NCT04411654|Hormones|hormones|mesh-ancestor
43943275|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43943276|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
43943277|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239517|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44239518|NCT00574015|Analgesics|analgesics|mesh-ancestor
44239519|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
44239520|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44239521|NCT00574015|Narcotics|narcotics|mesh-ancestor
44239522|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
44239523|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239524|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44239525|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239526|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239527|NCT00574041|Interferons|interferons|mesh-list
44239528|NCT00574041|Interferon-beta|interferon-beta|mesh-list
44239529|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
44239530|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239531|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
44239532|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239533|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
44239534|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239535|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44239536|NCT00574093|Ranibizumab|ranibizumab|mesh-list
44239537|NCT00574093|Verteporfin|verteporfin|mesh-list
44239538|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943278|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43943279|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943280|NCT01006252|Paclitaxel|paclitaxel|mesh-list
43943281|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943282|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943283|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943284|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943285|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943286|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943287|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
43943288|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
43943289|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43943290|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43943291|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943292|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943293|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943294|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943295|NCT01006538|Ranibizumab|ranibizumab|mesh-list
43943296|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943297|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943298|NCT01006538|Growth Substances|growth substances|mesh-ancestor
43943299|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943300|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943301|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943302|NCT01006655|Beclomethasone|beclomethasone|mesh-list
43943303|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943304|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
43943305|NCT01006655|Hormones|hormones|mesh-ancestor
43943306|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943307|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943308|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43943309|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
43943310|NCT01007071|Hormones|hormones|mesh-list
43943311|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239540|NCT00574093|Growth Substances|growth substances|mesh-ancestor
44239541|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239542|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44239543|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239544|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44239545|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239546|NCT00574353|Misonidazole|misonidazole|mesh-list
44239547|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239548|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44239549|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44239550|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943312|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943313|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
43943314|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943315|NCT01007994|Propranolol|propranolol|mesh-list
43943317|NCT01007994|Isradipine|isradipine|mesh-list
43943318|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43943319|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43943320|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943321|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943322|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943323|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943324|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43943325|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943326|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
43943384|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
43943386|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943387|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
43943388|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943389|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943390|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943391|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
43943392|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943393|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943394|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43943395|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943396|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
43943397|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943398|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43943399|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943400|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943401|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
43943464|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943465|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43943466|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43943467|NCT01010477|Nicotine|nicotine|mesh-list
43943468|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43943469|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
43943470|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943471|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943472|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43943473|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43943474|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
43943475|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943476|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943477|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43943478|NCT01010568|Ofatumumab|ofatumumab|mesh-list
43943479|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43943480|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943481|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
43805463|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
44239551|NCT00574366|Everolimus|everolimus|mesh-list
44239552|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44239553|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239554|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239555|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
44239556|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239557|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44239558|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239559|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239560|NCT00574470|Infliximab|infliximab|mesh-list
44239561|NCT00574470|Daclizumab|daclizumab|mesh-list
44239562|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239563|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239564|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239565|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239566|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
44239567|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239568|NCT00574483|Quinacrine|quinacrine|mesh-list
43943482|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943483|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943484|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
43943506|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943507|NCT01011218|Modafinil|modafinil|mesh-list
43943508|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43943509|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943510|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43943511|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43943512|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43943513|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943514|NCT01011413|Efavirenz|efavirenz|mesh-list
43943515|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43943516|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43943517|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943518|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685726|NCT02833701|Vitamins|vitamins|mesh-list
43943519|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
43943520|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943521|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43943522|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43943523|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43943524|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43943525|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43943526|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43943527|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43943528|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
43943529|NCT01011816|Coagulants|coagulants|mesh-ancestor
43943530|NCT01011829|Varenicline|varenicline|mesh-list
43943531|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43943532|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43943560|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943561|NCT01012297|Growth Substances|growth substances|mesh-ancestor
43943562|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943563|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943564|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
43943565|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943566|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
43943567|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239569|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
44239570|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44239571|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
44239572|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44239573|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239574|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
44239575|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44239576|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
44239577|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943568|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
43943569|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943570|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943571|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943572|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943573|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943574|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943575|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43943576|NCT01012336|Dexamethasone|dexamethasone|mesh-list
43943578|NCT01012336|Ramosetron|ramosetron|mesh-list
43943579|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943580|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
43943581|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
43943582|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810404|NCT04860076|Nivolumab|nivolumab|mesh-list
43943614|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943615|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43943617|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
43943618|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943619|NCT01014351|Paclitaxel|paclitaxel|mesh-list
43943620|NCT01014351|Carboplatin|carboplatin|mesh-list
43943621|NCT01014351|Everolimus|everolimus|mesh-list
43943622|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943651|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43943652|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943653|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943654|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
43943655|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943656|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943657|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43943658|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943660|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43943661|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
43943662|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43943663|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43943664|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43943665|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943666|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943667|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
43810448|NCT04859556|Dipivefrin|dipivefrin|mesh-list
43943702|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
43943704|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943705|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943722|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943723|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
43943724|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943725|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943726|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943727|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
43943728|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943729|NCT01016678|Naproxen|naproxen|mesh-list
43943730|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43943731|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43943732|NCT01016678|Analgesics|analgesics|mesh-ancestor
43943733|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
43943734|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943735|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239578|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239579|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239580|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
44239581|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943736|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943737|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943738|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
43943739|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43943740|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943741|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943743|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943744|NCT01016769|Sirolimus|sirolimus|mesh-list
43943745|NCT01016769|Paclitaxel|paclitaxel|mesh-list
43943746|NCT01016769|Carboplatin|carboplatin|mesh-list
43943747|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943748|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943749|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943750|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943751|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943752|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943753|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943754|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943755|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943756|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
43943757|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943758|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
43943759|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943760|NCT01016834|Sumatriptan|sumatriptan|mesh-list
43943761|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43943762|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43943763|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44141031|NCT00181779|Aripiprazole|aripiprazole|mesh-list
44141032|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141033|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141034|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141035|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141036|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141037|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141038|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
44141039|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
44141040|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141041|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141042|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44141043|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44141044|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
44141045|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44141046|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141047|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43943786|NCT01017237|Ketamine|ketamine|mesh-list
43943787|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43943788|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943789|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943790|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43943791|NCT01017237|Analgesics|analgesics|mesh-ancestor
43943792|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
43943793|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943794|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43943795|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43943796|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43943797|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943798|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943799|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943800|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43943801|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43943802|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
43943803|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
43943804|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43943805|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44239582|NCT00574600|Vaccines|vaccines|mesh-list
44239583|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
44239584|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239585|NCT00574639|Alprazolam|alprazolam|mesh-list
44239586|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44239587|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239588|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943806|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43943807|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43943808|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43943809|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43943810|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
43943811|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
43943812|NCT01017250|Bevacizumab|bevacizumab|mesh-list
43943846|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943847|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943849|NCT01018420|Colchicine|colchicine|mesh-list
43943850|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943851|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943852|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43943853|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943880|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943881|NCT05395962|Carboplatin|carboplatin|mesh-list
43943882|NCT05395962|Bleomycin|bleomycin|mesh-list
43943883|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943884|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943885|NCT05395702|Interferons|interferons|mesh-list
43943886|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
43943887|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943888|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
43943889|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943890|NCT05395533|Antibodies|antibodies|mesh-list
43943891|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43943892|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
43943893|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943894|NCT05395299|Ethylene|ethylene|mesh-list
43943895|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43943896|NCT05395299|Growth Substances|growth substances|mesh-ancestor
43943897|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943898|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
43943899|NCT05395143|Astringents|astringents|mesh-ancestor
43943900|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943901|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
43943928|NCT05394740|Antidotes|antidotes|mesh-ancestor
43943929|NCT05394740|Protective Agents|protective agents|mesh-ancestor
43943930|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
43943931|NCT05394740|Vitamins|vitamins|mesh-ancestor
43943932|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
43943933|NCT05394727|Insulin|insulin|mesh-list
43943934|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43943935|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43943936|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943937|NCT05394493|Avelumab|avelumab|mesh-list
43943938|NCT05394493|Axitinib|axitinib|mesh-list
43943939|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943940|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943941|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43943942|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943943|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943944|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
43943945|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943946|NCT05394415|Paclitaxel|paclitaxel|mesh-list
43943947|NCT05394415|Carboplatin|carboplatin|mesh-list
43943948|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943949|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943950|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943951|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943952|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943953|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943954|NCT05394233|Bevacizumab|bevacizumab|mesh-list
44141079|NCT00181896|Bupropion|bupropion|mesh-list
44141080|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44239590|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44239591|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44239592|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
44239593|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
44239594|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239595|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239596|NCT00574652|Aldesleukin|aldesleukin|mesh-list
43994057|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44239597|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141081|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141082|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141083|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44141084|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141085|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141086|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141087|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
44141088|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844169|NCT04398719|Capsaicin|capsaicin|mesh-list
44141117|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
44141118|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
44141119|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
44141120|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141121|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141122|NCT00181935|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141123|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141124|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943996|NCT05386459|Interferons|interferons|mesh-list
43943997|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
43943998|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943999|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
43944000|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944001|NCT05250895|Misonidazole|misonidazole|mesh-list
43944002|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944003|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43944004|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43944005|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944073|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944074|NCT04434040|Atezolizumab|atezolizumab|mesh-list
43944075|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944077|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43944078|NCT04416269|Metformin|metformin|mesh-list
43944079|NCT04416269|Pioglitazone|pioglitazone|mesh-list
43944080|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43944081|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43944082|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944083|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
43944084|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810832|NCT04853901|Remdesivir|remdesivir|mesh-list
44141148|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141149|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
44141150|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141151|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141152|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141153|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141154|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141155|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141156|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141157|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44141158|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
44141159|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
44141160|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
44141161|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944186|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944187|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43944188|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43944189|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43944190|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239598|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44239599|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44239600|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
44239601|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239602|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44239603|NCT00574730|Rituximab|rituximab|mesh-list
44163402|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
43944191|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944192|NCT03941288|Cannabidiol|cannabidiol|mesh-list
43944193|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
43944194|NCT03933397|Morphine|morphine|mesh-list
43944195|NCT03933397|Hydromorphone|hydromorphone|mesh-list
43944196|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43944197|NCT03933397|Narcotics|narcotics|mesh-ancestor
43944198|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944199|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944200|NCT03933397|Analgesics|analgesics|mesh-ancestor
43944201|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
43944202|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944203|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
43944204|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944205|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944206|NCT03866837|Micronutrients|micronutrients|mesh-list
43944207|NCT03866837|Trace Elements|trace elements|mesh-list
43944208|NCT03866837|Lactoferrin|lactoferrin|mesh-list
43944230|NCT03404661|Hormones|hormones|mesh-ancestor
43944231|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944232|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944234|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
43944235|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43944236|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944237|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944238|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944239|NCT03115047|Analgesics|analgesics|mesh-ancestor
43944240|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
43944241|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944242|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43944243|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43944244|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43944245|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944246|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944247|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944248|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43944249|NCT03115047|Narcotics|narcotics|mesh-ancestor
43944250|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43944251|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
43944252|NCT02940509|Ketamine|ketamine|mesh-list
43944253|NCT02940509|Analgesics|analgesics|mesh-ancestor
43944254|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
43944255|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944256|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944257|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43944258|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43944259|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
43944260|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
43944261|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944262|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43944263|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43944264|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810943|NCT04850911|Analgesics|analgesics|mesh-ancestor
43944290|NCT02754141|Nivolumab|nivolumab|mesh-list
43944291|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944292|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944293|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43944294|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944295|NCT02709616|Vaccines|vaccines|mesh-list
43944296|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
43944297|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944298|NCT02662062|Cisplatin|cisplatin|mesh-list
43944299|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
44239604|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239605|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239606|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
44239607|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239608|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239609|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
44239610|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239611|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
44239612|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44239613|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239614|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44239615|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
44239616|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43892668|NCT04484428|Menthol|menthol|mesh-list
44239617|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944300|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944301|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944302|NCT02641028|Aticaprant|aticaprant|mesh-list
43944303|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43944304|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944305|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
43944306|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944307|NCT02530697|Miltefosine|miltefosine|mesh-list
43944308|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
43944309|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
43944310|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43944311|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944312|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944313|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43810998|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
43944349|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43944350|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
43944351|NCT02406222|Hormones|hormones|mesh-ancestor
43944352|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944353|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43944354|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44141209|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44141210|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141211|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44141212|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141213|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44141214|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44141215|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
43944358|NCT02187198|Buprenorphine|buprenorphine|mesh-list
43944359|NCT02187198|Naloxone|naloxone|mesh-list
43944360|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43944361|NCT02187198|Narcotics|narcotics|mesh-ancestor
43944362|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944363|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944364|NCT02187198|Analgesics|analgesics|mesh-ancestor
43944365|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
43944366|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944367|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43944368|NCT02150785|Streptokinase|streptokinase|mesh-list
43944369|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43944370|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43944371|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944372|NCT02144831|Aspirin|aspirin|mesh-list
43944373|NCT02144831|Clopidogrel|clopidogrel|mesh-list
43944374|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44239618|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239619|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239620|NCT00574756|Ranolazine|ranolazine|mesh-list
44239621|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44239622|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44239623|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239624|NCT00574769|Bevacizumab|bevacizumab|mesh-list
44239625|NCT00574769|Docetaxel|docetaxel|mesh-list
44239626|NCT00574769|Everolimus|everolimus|mesh-list
44239627|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239628|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239629|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44239630|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44239631|NCT00574769|Growth Substances|growth substances|mesh-ancestor
44239632|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239633|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
44239634|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239635|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239636|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944375|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944376|NCT02144831|Analgesics|analgesics|mesh-ancestor
43944377|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
43944378|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944379|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944380|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944381|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944382|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43944383|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43944384|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944432|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944435|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
43944436|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944437|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43944438|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
43944439|NCT01788020|Hormones|hormones|mesh-ancestor
43944440|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944441|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43944442|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
43944443|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944444|NCT01608893|Metoprolol|metoprolol|mesh-list
43944445|NCT01608893|Carvedilol|carvedilol|mesh-list
43944446|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43944447|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43944448|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
43944449|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
43944450|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944451|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944452|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43944453|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43944454|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43944455|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944456|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944457|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944458|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
43944459|NCT01608893|Protective Agents|protective agents|mesh-ancestor
43944460|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44239637|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239638|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239639|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
44239640|NCT00574925|Esomeprazole|esomeprazole|mesh-list
44239641|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44239642|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239643|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44239644|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163600|NCT00253396|Heparin|heparin|mesh-list
43944461|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43944462|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43944463|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
43944464|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43944465|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43944466|NCT01502917|Antibodies|antibodies|mesh-list
43944467|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43944468|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
43944469|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944470|NCT00929253|Buprenorphine|buprenorphine|mesh-list
43944471|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43944472|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43944473|NCT00929253|Narcotics|narcotics|mesh-ancestor
43944474|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944475|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944476|NCT00929253|Analgesics|analgesics|mesh-ancestor
43944477|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
43944478|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944479|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43944480|NCT00812032|Aspirin|aspirin|mesh-list
43944481|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944482|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944483|NCT00812032|Analgesics|analgesics|mesh-ancestor
43944484|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
43944519|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43944551|NCT00042341|Clofarabine|clofarabine|mesh-list
43944552|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43944553|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
43944554|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944555|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944556|NCT01021618|Dipyridamole|dipyridamole|mesh-list
43944557|NCT01021618|Regadenoson|regadenoson|mesh-list
43944558|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43944559|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43944560|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
43944561|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
43944562|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944563|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944564|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944565|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43944587|NCT01022190|Analgesics|analgesics|mesh-ancestor
43944588|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
43944589|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944590|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944591|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944592|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944593|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43944594|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43944595|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944596|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944597|NCT01022567|Ertapenem|ertapenem|mesh-list
43944598|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43944599|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944600|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43944601|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43944602|NCT01023178|Estradiol|estradiol|mesh-list
43944603|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44239645|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239646|NCT00574964|Temozolomide|temozolomide|mesh-list
44239647|NCT00574964|Carmustine|carmustine|mesh-list
44163657|NCT00253526|Gemcitabine|gemcitabine|mesh-list
43944604|NCT01023178|Estrogens|estrogens|mesh-list
43944605|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43944606|NCT01023178|Progesterone|progesterone|mesh-list
43944607|NCT01023178|Hormones|hormones|mesh-ancestor
43944608|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944609|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944610|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43944611|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
43944612|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43944613|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43944614|NCT01023178|Progestins|progestins|mesh-ancestor
43944615|NCT01023477|Chloroquine|chloroquine|mesh-list
43944616|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43944617|NCT01023477|Amebicides|amebicides|mesh-ancestor
43944618|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43944619|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43944620|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944647|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43944649|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944650|NCT01023776|Vaccines|vaccines|mesh-list
43944651|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
43944652|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944653|NCT01023841|Bimatoprost|bimatoprost|mesh-list
43944654|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43944655|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43944656|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43944657|NCT01024010|Vidarabine|vidarabine|mesh-list
43944658|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
43944659|NCT01024010|Ofatumumab|ofatumumab|mesh-list
43944660|NCT01024010|Pentostatin|pentostatin|mesh-list
43944661|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43944662|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944663|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
43944664|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944665|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944666|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944667|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
43944668|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944669|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944670|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43944706|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944707|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43944708|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43944709|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
43944710|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944711|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43944743|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
43944744|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944745|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
43944746|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944748|NCT01025830|Nevirapine|nevirapine|mesh-list
43944749|NCT01025830|Stavudine|stavudine|mesh-list
43944750|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
43944751|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43944752|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43944753|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944754|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944755|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
43944756|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811327|NCT04846634|Paclitaxel|paclitaxel|mesh-list
43944772|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
43944773|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43944774|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944775|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43944776|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944777|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944778|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
43944779|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44239648|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44239649|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
44239650|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239651|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239652|NCT00575068|Galiximab|galiximab|mesh-list
44239653|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239654|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239655|NCT00575224|Interferons|interferons|mesh-list
44239656|NCT00575224|Ribavirin|ribavirin|mesh-list
44239657|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239658|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
44239659|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239660|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
44239661|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239662|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43944780|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43944781|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944782|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944783|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43944784|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944785|NCT01027000|Sirolimus|sirolimus|mesh-list
43944786|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
43944787|NCT01027000|Busulfan|busulfan|mesh-list
43944788|NCT01027000|Rituximab|rituximab|mesh-list
43944789|NCT01027000|Methotrexate|methotrexate|mesh-list
43944790|NCT01027000|Fludarabine|fludarabine|mesh-list
43944791|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
43944792|NCT01027000|Tacrolimus|tacrolimus|mesh-list
43944793|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944794|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
43944795|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944796|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944797|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944798|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
43944799|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944800|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944801|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43944802|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944803|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43944804|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
43944805|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43944806|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43944807|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
43944808|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944809|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686879|NCT02824614|Erythritol|erythritol|mesh-list
43944810|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43944811|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43944812|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43944813|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43944814|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944815|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944816|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
43944817|NCT01027468|Bevacizumab|bevacizumab|mesh-list
43944869|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944870|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43944871|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43944872|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944873|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944874|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
43944875|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
43944876|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239664|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239665|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239666|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44239667|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44239668|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
44239669|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239670|NCT00575354|Sevoflurane|sevoflurane|mesh-list
44239671|NCT00575354|Isoflurane|isoflurane|mesh-list
44239672|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44239673|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44239674|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
44239675|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
44239676|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239677|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163782|NCT00253929|Acetylcholine|acetylcholine|mesh-list
43944877|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944878|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43944879|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43944880|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
43944881|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43686917|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
43944882|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43944883|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43944884|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43944886|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
43944887|NCT01029054|Lenalidomide|lenalidomide|mesh-list
43944888|NCT01029054|BB 1101|bb 1101|mesh-list
43944889|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944890|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
43944891|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
43944892|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944893|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944894|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43944895|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
43944896|NCT01029054|Hormones|hormones|mesh-ancestor
43944897|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944898|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43944899|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944900|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
43944901|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944902|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944903|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
43944904|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43944905|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43944940|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944942|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43944943|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
43944977|NCT01031498|Ondansetron|ondansetron|mesh-list
43944978|NCT01031498|Palonosetron|palonosetron|mesh-list
43944979|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
43944980|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
43944981|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944982|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944983|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994491|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945015|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945016|NCT01032694|Azithromycin|azithromycin|mesh-list
43945017|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43945018|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239678|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
44239679|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239681|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
44239682|NCT00575406|Rituximab|rituximab|mesh-list
43945019|NCT01032759|Memantine|memantine|mesh-list
43945020|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43945021|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43945022|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
43945023|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945024|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945025|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945089|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43945091|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43945092|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43945093|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945094|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945095|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43945096|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945097|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945098|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
43945130|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
43945131|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43945132|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43945133|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945134|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43945135|NCT05592860|Insulin|insulin|mesh-list
43945136|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43945137|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945138|NCT05592678|Donepezil|donepezil|mesh-list
43945139|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43945140|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945141|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945170|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43945171|NCT05571735|Vaccines|vaccines|mesh-list
43945172|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
43945173|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945174|NCT05539911|Fentanyl|fentanyl|mesh-list
43945175|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43945176|NCT05539911|Narcotics|narcotics|mesh-ancestor
43945177|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945178|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945179|NCT05539911|Analgesics|analgesics|mesh-ancestor
43945180|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
43945181|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945182|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43945183|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43945184|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
43945185|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
43945186|NCT05538767|Albendazole|albendazole|mesh-list
43945187|NCT05538767|Emodepside|emodepside|mesh-list
43945188|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
43945189|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43945190|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945191|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
43945192|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43945231|NCT05510089|Cytarabine|cytarabine|mesh-list
43945232|NCT05510089|Etoposide|etoposide|mesh-list
43945233|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43945234|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945235|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43945236|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43945237|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945238|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945239|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945240|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
43945241|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
43945242|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945243|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945244|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
43945245|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945246|NCT05509634|Dexamethasone|dexamethasone|mesh-list
44239685|NCT00575406|Vincristine|vincristine|mesh-list
44239686|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239687|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
44239688|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239689|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239690|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44239691|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
44239692|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239693|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945247|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
43945248|NCT05509634|Palonosetron|palonosetron|mesh-list
43945249|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
43945250|NCT05509634|Aprepitant|aprepitant|mesh-list
43945251|NCT05509634|BB 1101|bb 1101|mesh-list
43945286|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43945287|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43945288|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43945289|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43945325|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945326|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
43945327|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945328|NCT05402826|Protective Agents|protective agents|mesh-ancestor
43945329|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
43945330|NCT05385042|Hydroxocobalamin|hydroxocobalamin|mesh-list
43945365|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945366|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
43945367|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43945368|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945369|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945370|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
43945371|NCT05311033|Coagulants|coagulants|mesh-ancestor
43945372|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43945373|NCT05307003|Trazodone|trazodone|mesh-list
43945374|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
43945402|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
43945403|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43945404|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
43945405|NCT05232461|Celecoxib|celecoxib|mesh-list
43945406|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43945407|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945408|NCT05232461|Analgesics|analgesics|mesh-ancestor
43945409|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
43945410|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945411|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945412|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945413|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945414|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43945415|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43945416|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945417|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945418|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811817|NCT04838860|Siltuximab|siltuximab|mesh-list
43945442|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945443|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945444|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43945445|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945446|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43945447|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945448|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945449|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44239694|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44239695|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239696|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44239697|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44163981|NCT00254631|Oxycodone|oxycodone|mesh-list
43945450|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
43945451|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945452|NCT05150756|Lidocaine|lidocaine|mesh-list
43687345|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
43945453|NCT05150756|Morphine|morphine|mesh-list
43945454|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
43945455|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
43945456|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945457|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945458|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
43945459|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945460|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43945461|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43945462|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43945463|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945464|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945465|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43945466|NCT05150756|Narcotics|narcotics|mesh-ancestor
43945467|NCT05150756|Analgesics|analgesics|mesh-ancestor
43945468|NCT05136157|Insulin|insulin|mesh-list
43945469|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44141240|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44141241|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44141242|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
44141243|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
44141244|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141245|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141246|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141247|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44141248|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44141249|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44141250|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44141251|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44141252|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44141253|NCT00182442|Olanzapine|olanzapine|mesh-list
44141254|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43945502|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
43945503|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43945504|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945505|NCT05070650|Analgesics|analgesics|mesh-ancestor
43945506|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
43945507|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945508|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945509|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
43945510|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
43945511|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945512|NCT05070650|Expectorants|expectorants|mesh-ancestor
43945513|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
43945514|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43945515|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
43945516|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945517|NCT05070650|Protective Agents|protective agents|mesh-ancestor
43945518|NCT05070650|Antidotes|antidotes|mesh-ancestor
43945519|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43945520|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
43945521|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
43945522|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
43945523|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43945524|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
43945525|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43945526|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43945527|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43945528|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43945529|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945530|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43945531|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44239698|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44239699|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239700|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239701|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
44239703|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239704|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44239705|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44239706|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239707|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239708|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239709|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
44239710|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44239711|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
44239712|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239713|NCT00575419|Expectorants|expectorants|mesh-ancestor
44239714|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239715|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44239716|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
44239717|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239718|NCT00575419|Protective Agents|protective agents|mesh-ancestor
44239719|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239720|NCT00575419|Antidotes|antidotes|mesh-ancestor
44239721|NCT00575523|Atropine|atropine|mesh-list
44239722|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44239723|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44239724|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44239725|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
43945532|NCT04999449|Scopolamine|scopolamine|mesh-list
43945533|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43945534|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43945572|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945573|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
43945601|NCT04780061|Vitamins|vitamins|mesh-list
43945602|NCT04780061|Vitamin K|vitamin k|mesh-list
43945603|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
43945604|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
43945605|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945606|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43945607|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43945608|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945609|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43945610|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945612|NCT04780061|Coagulants|coagulants|mesh-ancestor
43945613|NCT04727242|Gemcitabine|gemcitabine|mesh-list
43945614|NCT04727242|Dacarbazine|dacarbazine|mesh-list
43945615|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945616|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
43945617|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945618|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239726|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239727|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239728|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239729|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239730|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
44239731|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
43945656|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141280|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
44141281|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141282|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141283|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141284|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141286|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141287|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141288|NCT00182507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141289|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141290|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141291|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141292|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141293|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
44141294|NCT00182520|Topiramate|topiramate|mesh-list
44141295|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
44141296|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141297|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141298|NCT00182533|Sertraline|sertraline|mesh-list
44141299|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141300|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141301|NCT00182533|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141302|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141303|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141304|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141305|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141306|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
44141307|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141308|NCT00182559|Cyclosporine|cyclosporine|mesh-list
44141309|NCT00182559|Tacrolimus|tacrolimus|mesh-list
44141310|NCT00182559|Cyclosporins|cyclosporins|mesh-list
44141311|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141312|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
44141313|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141314|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44141315|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141316|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945706|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945708|NCT04253561|Trastuzumab|trastuzumab|mesh-list
43945709|NCT04253561|Pertuzumab|pertuzumab|mesh-list
43945710|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945711|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945712|NCT04238767|Dolutegravir|dolutegravir|mesh-list
43945713|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43945714|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43945715|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945716|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945717|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43945718|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43945719|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
43945720|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945721|NCT04197310|Nivolumab|nivolumab|mesh-list
43945722|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945723|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945724|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43945725|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945726|NCT04171466|Metronidazole|metronidazole|mesh-list
43945727|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
43945728|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945729|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43945730|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43945731|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44239732|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44239733|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44239734|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
44239735|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239736|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239737|NCT00575549|Dobutamine|dobutamine|mesh-list
44239738|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43945732|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43945733|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43687587|NCT02818803|Propolis|propolis|mesh-list
43945734|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945735|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945736|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945737|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44157503|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43945738|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945739|NCT04150458|Choline|choline|mesh-list
43945740|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
43945741|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43945742|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
43945743|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945744|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945745|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43945746|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
43945747|NCT04130698|Nicotine|nicotine|mesh-list
43812111|NCT04834791|Letrozole|letrozole|mesh-list
43945762|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945763|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945764|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43945765|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
43945766|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945767|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945768|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43945770|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43945771|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994849|NCT03970252|Nivolumab|nivolumab|mesh-list
43945772|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945773|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43945774|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43945775|NCT04094207|Protective Agents|protective agents|mesh-ancestor
43945776|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945777|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
43945778|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43945779|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
43945780|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
43945781|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43945782|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43945783|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
43945784|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945785|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43945786|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
43945787|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945788|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945789|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43945790|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43945791|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945792|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43945793|NCT04041843|Apixaban|apixaban|mesh-list
43945794|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43945795|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
43945796|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43945797|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
43945798|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945799|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945800|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
43945801|NCT03968393|Anticoagulants|anticoagulants|mesh-list
43945802|NCT03913559|Acetaminophen|acetaminophen|mesh-list
43945803|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
44239739|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
44239740|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
44239741|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239742|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239743|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44239744|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44239745|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44239746|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
43945804|NCT03913559|Promethazine|promethazine|mesh-list
43945805|NCT03913559|Cytarabine|cytarabine|mesh-list
43945806|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
43945807|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43945827|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945828|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945830|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
43945831|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945832|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
43945833|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945834|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
43945835|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
43945836|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945837|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
43945838|NCT03913559|Hormones|hormones|mesh-ancestor
43945839|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945840|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43945841|NCT03913559|Protective Agents|protective agents|mesh-ancestor
43945842|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43945843|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43945844|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43945845|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945846|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
43945848|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43945849|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
43945850|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
43945851|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945852|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43945853|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
43945854|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945855|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43945856|NCT03869268|Aspirin|aspirin|mesh-list
43945857|NCT03869268|Ticagrelor|ticagrelor|mesh-list
43945858|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43945859|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945860|NCT03869268|Analgesics|analgesics|mesh-ancestor
43945861|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
43812153|NCT04834674|Apatinib|apatinib|mesh-list
43945891|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43945892|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43945893|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43945894|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945895|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945896|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
43945897|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43945898|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
43945899|NCT03850379|Levofloxacin|levofloxacin|mesh-list
43945900|NCT03850379|Ofloxacin|ofloxacin|mesh-list
43945901|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43945902|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945903|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43945904|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43945905|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945906|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812161|NCT04834427|Ketamine|ketamine|mesh-list
43945910|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43945912|NCT03839823|Gemcitabine|gemcitabine|mesh-list
43945913|NCT03839823|Paclitaxel|paclitaxel|mesh-list
43945914|NCT03839823|Vinorelbine|vinorelbine|mesh-list
43945915|NCT03839823|Docetaxel|docetaxel|mesh-list
43945916|NCT03839823|Capecitabine|capecitabine|mesh-list
43945917|NCT03839823|Letrozole|letrozole|mesh-list
44239747|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239748|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239749|NCT00575549|Protective Agents|protective agents|mesh-ancestor
43945918|NCT03839823|Anastrozole|anastrozole|mesh-list
43945919|NCT03839823|Goserelin|goserelin|mesh-list
43945920|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43945921|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945922|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
43945923|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
43945924|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
43945925|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945926|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945927|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
43945928|NCT03839823|Antiviral Agents|antiviral agents|mesh-ancestor
43945929|NCT03839823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945930|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945931|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945932|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
43945933|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945934|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43945935|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43945936|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43945937|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
43945938|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945939|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43945940|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
43945941|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945942|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945944|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945945|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945946|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43945947|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43945948|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
43945949|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945950|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43945951|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43945952|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945953|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43945954|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945955|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945956|NCT03811886|Natalizumab|natalizumab|mesh-list
43945957|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
43945958|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945959|NCT03805581|Defibrotide|defibrotide|mesh-list
43945960|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43945961|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945962|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945963|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43945965|NCT03753919|Tremelimumab|tremelimumab|mesh-list
43945966|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945967|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945968|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
43945969|NCT03743246|Fludarabine|fludarabine|mesh-list
43945970|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945971|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
43945972|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945973|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945974|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43945975|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
43945976|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945977|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945978|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43945979|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
44141330|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44141331|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44141332|NCT00182611|Cisplatin|cisplatin|mesh-list
44141333|NCT00182611|Tegafur|tegafur|mesh-list
44141334|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141335|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141336|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
43806116|NCT04916925|Vitamin D|vitamin d|mesh-list
44239750|NCT00575601|Simvastatin|simvastatin|mesh-list
44239751|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44141337|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141338|NCT00182650|Aldesleukin|aldesleukin|mesh-list
44141339|NCT00182650|Rituximab|rituximab|mesh-list
44141340|NCT00182650|Fludarabine|fludarabine|mesh-list
44141341|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
43946023|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43946024|NCT03587311|Growth Substances|growth substances|mesh-ancestor
43946025|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946026|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
43946027|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
43946028|NCT03539731|Piperazine|piperazine|mesh-list
43946029|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
43946030|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
43946031|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43946063|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946064|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
43946065|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946066|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946067|NCT03442673|Antiviral Agents|antiviral agents|mesh-ancestor
43946068|NCT03442673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946069|NCT03442673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946070|NCT03442673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946071|NCT03442673|Immunologic Factors|immunologic factors|mesh-ancestor
43946072|NCT03442673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946073|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43946074|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
43946075|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
43946076|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
43946111|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
43946112|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43946113|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
43946114|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43946141|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946142|NCT02673931|Exenatide|exenatide|mesh-list
43946143|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43946144|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946145|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43946146|NCT02673931|Incretins|incretins|mesh-ancestor
43946147|NCT02673931|Hormones|hormones|mesh-ancestor
43946148|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946149|NCT02623816|Omeprazole|omeprazole|mesh-list
43946150|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43995058|NCT02377492|Vasopressins|vasopressins|mesh-list
43946151|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946152|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43946153|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946154|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946155|NCT02595892|Gemcitabine|gemcitabine|mesh-list
43946156|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43687939|NCT02816905|Fluorometholone|fluorometholone|mesh-list
43946157|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
43946158|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946159|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946160|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
43946161|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812391|NCT04830579|Etoricoxib|etoricoxib|mesh-list
43946187|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43946188|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946189|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
43946190|NCT02251548|Rituximab|rituximab|mesh-list
43946191|NCT02251548|Fludarabine|fludarabine|mesh-list
43946192|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946193|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
43946194|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946195|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946196|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946197|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
43946198|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946199|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946200|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43946201|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946202|NCT01859819|Cytarabine|cytarabine|mesh-list
43946203|NCT01859819|Rituximab|rituximab|mesh-list
43946204|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239752|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44239753|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
44164442|NCT00256334|Resveratrol|resveratrol|mesh-list
43946205|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946206|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
43946207|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946208|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946209|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946210|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
43946211|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946219|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946220|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946221|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946222|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43946223|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43946224|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946225|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946226|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946227|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
43946229|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43946230|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
43946231|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687957|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
43946232|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946233|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
43946234|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
43946235|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946236|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43946237|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946238|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946239|NCT01130077|Poly ICLC|poly iclc|mesh-list
43946240|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
43946241|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
43946242|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946243|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
43946244|NCT01033864|Prednisone|prednisone|mesh-list
43946245|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946246|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
43946247|NCT01033864|Hormones|hormones|mesh-ancestor
43946248|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946249|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946250|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43946251|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946252|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43946253|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43946254|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
43946255|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946256|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946257|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946258|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946259|NCT01034111|Metformin|metformin|mesh-list
43946260|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43946261|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43946262|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946263|NCT01034111|Incretins|incretins|mesh-ancestor
43946264|NCT01034111|Hormones|hormones|mesh-ancestor
43946265|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946266|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43946267|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
43946268|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946269|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946271|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946272|NCT01034592|Lenalidomide|lenalidomide|mesh-list
43946273|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
43946274|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946275|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43946276|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43946277|NCT01034592|Growth Substances|growth substances|mesh-ancestor
43946278|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
43946279|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141358|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239754|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239755|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44239756|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44239757|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239758|NCT00575614|Prucalopride|prucalopride|mesh-list
43946286|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946287|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946288|NCT01035346|Analgesics|analgesics|mesh-ancestor
43946289|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
43946290|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946291|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946292|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946293|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946294|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946295|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848790|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946326|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946328|NCT01037790|Palbociclib|palbociclib|mesh-list
43946329|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946330|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43946331|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946332|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946333|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
43946334|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946335|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946336|NCT01037881|Analgesics|analgesics|mesh-ancestor
43946337|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
43946338|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946339|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946374|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43946376|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43946377|NCT01041781|Gemcitabine|gemcitabine|mesh-list
43946378|NCT01041781|Celecoxib|celecoxib|mesh-list
43946413|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43946414|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946415|NCT01042288|Carboplatin|carboplatin|mesh-list
43946416|NCT01042288|Pemetrexed|pemetrexed|mesh-list
43946417|NCT01042288|Panitumumab|panitumumab|mesh-list
43946418|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946419|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946455|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43946456|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43946491|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946493|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43946494|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43946495|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946496|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946529|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946530|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43946531|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43946532|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43946534|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946535|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43946536|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43946537|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43946571|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946572|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43946573|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946574|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43946575|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
43946576|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43946577|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43946578|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43946579|NCT01044966|Temozolomide|temozolomide|mesh-list
43946609|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946610|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946611|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43806117|NCT04916925|Vitamins|vitamins|mesh-ancestor
44239759|NCT00575614|Laxatives|laxatives|mesh-ancestor
44239760|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239761|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44239762|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44239763|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
44239764|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239765|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239766|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239767|NCT00575627|Interferons|interferons|mesh-list
43946612|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43946613|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946614|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946616|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
43946617|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
43946619|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946620|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946621|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43946622|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812751|NCT04823390|Fentanyl|fentanyl|mesh-list
43946637|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946638|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43946639|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43946640|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946641|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946642|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43946643|NCT01047241|Narcotics|narcotics|mesh-ancestor
43946644|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43946645|NCT01047358|Exemestane|exemestane|mesh-list
43946646|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946647|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43946648|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43946649|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946650|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946651|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43946652|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946653|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946654|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946655|NCT01047527|Nicotine|nicotine|mesh-list
43946656|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43946657|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
43946658|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946659|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946660|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43946661|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43946662|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
43946663|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946664|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946665|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
43946666|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43946667|NCT01048606|Estrogens|estrogens|mesh-ancestor
43946668|NCT01048606|Hormones|hormones|mesh-ancestor
43946669|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946670|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946671|NCT01048658|Sevoflurane|sevoflurane|mesh-list
43946672|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43946673|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43946674|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
43946675|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
43946676|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946677|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946678|NCT01048697|Ethambutol|ethambutol|mesh-list
43946679|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
43946680|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946681|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946682|NCT01048879|Oseltamivir|oseltamivir|mesh-list
43892804|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
44239769|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
44239770|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
44239771|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44239772|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239773|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
43946683|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
43946714|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
43946715|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946716|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
43946717|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946718|NCT01050153|Aspirin|aspirin|mesh-list
43946719|NCT01050153|Dalteparin|dalteparin|mesh-list
43946720|NCT01050153|Tinzaparin|tinzaparin|mesh-list
43946721|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43946722|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946723|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946724|NCT01050153|Analgesics|analgesics|mesh-ancestor
43946725|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
43946726|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946727|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946764|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43946765|NCT01050907|Miltefosine|miltefosine|mesh-list
43946788|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946789|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43946790|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946791|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
43946793|NCT01051596|Veliparib|veliparib|mesh-list
43946794|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946795|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
43946796|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946797|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946798|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43946799|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946800|NCT01051778|Aspirin|aspirin|mesh-list
43946801|NCT01051778|Heparin|heparin|mesh-list
43946802|NCT01051778|Enoxaparin|enoxaparin|mesh-list
43946803|NCT01051778|Calcium heparin|calcium heparin|mesh-list
43688501|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
43946804|NCT01051778|Calcium|calcium|mesh-list
43946805|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43946806|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946807|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946808|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946809|NCT01051778|Analgesics|analgesics|mesh-ancestor
43946810|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
43946811|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946812|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946813|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946814|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43946815|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141403|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141404|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
44141405|NCT00182715|Antidotes|antidotes|mesh-ancestor
44141406|NCT00182715|Protective Agents|protective agents|mesh-ancestor
44141407|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
44141408|NCT00182715|Vitamins|vitamins|mesh-ancestor
44141409|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
44141410|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141411|NCT00182741|Calcitriol|calcitriol|mesh-list
44141412|NCT00182741|Prednisone|prednisone|mesh-list
44141413|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
44141414|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44141415|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
44141416|NCT00182741|Hormones|hormones|mesh-ancestor
44141417|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141418|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141419|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141420|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141421|NCT00182741|Analgesics|analgesics|mesh-ancestor
44141422|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
44239774|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44239775|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
44239776|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239777|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
44239778|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141423|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141424|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44141425|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141426|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141427|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141428|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43946842|NCT01053078|Naltrexone|naltrexone|mesh-list
43946843|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43946844|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43946845|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946846|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
43946847|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946848|NCT01053156|Minocycline|minocycline|mesh-list
43946849|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946850|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946851|NCT01053312|Flutemetamol|flutemetamol|mesh-list
43812879|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
43946881|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946882|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946883|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946884|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
43946885|NCT01054079|Cinacalcet|cinacalcet|mesh-list
43946886|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43946887|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946888|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43946889|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946890|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946891|NCT01054404|Furosemide|furosemide|mesh-list
43946892|NCT01054404|Diuretics|diuretics|mesh-ancestor
43946893|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
43946894|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946895|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43946896|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43946964|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
43946965|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946966|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
43946967|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
43946968|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43946969|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43946970|NCT01055769|Linezolid|linezolid|mesh-list
43946971|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946972|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946973|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43946974|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946975|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946976|NCT01056601|Bortezomib|bortezomib|mesh-list
43946977|NCT01056601|Panobinostat|panobinostat|mesh-list
43946978|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947013|NCT01057277|Everolimus|everolimus|mesh-list
43947014|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947015|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947016|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
43947017|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947070|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947071|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43947072|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947073|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947074|NCT01059929|Fentanyl|fentanyl|mesh-list
43947075|NCT01059929|Midazolam|midazolam|mesh-list
43947076|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
43947077|NCT01059929|Propofol|propofol|mesh-list
43947078|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43947079|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947080|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239780|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44239781|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
44459070|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
44459071|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459072|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459073|NCT01585558|Tamoxifen|tamoxifen|mesh-list
44459074|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44459075|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
44459076|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459077|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459078|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459079|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459080|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44459081|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44459082|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43947081|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43947082|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
43947083|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
43947084|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947085|NCT01059929|Analgesics|analgesics|mesh-ancestor
43947086|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
43947087|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947088|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43947089|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43947090|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43947095|NCT01059929|Narcotics|narcotics|mesh-ancestor
43947096|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43947097|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43947098|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43947099|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43947100|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
43947101|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
43947102|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
43947103|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
43947104|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43947105|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43947106|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947107|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947108|NCT01059994|Urological Agents|urological agents|mesh-ancestor
43947109|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
43947110|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
43947111|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43947112|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43947113|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947114|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947115|NCT01060020|Urological Agents|urological agents|mesh-ancestor
43947116|NCT01060098|Adalimumab|adalimumab|mesh-list
43947117|NCT01060098|Etanercept|etanercept|mesh-list
43947118|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947119|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947120|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43947121|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947122|NCT01060098|Analgesics|analgesics|mesh-ancestor
43688796|NCT02809456|Nicorandil|nicorandil|mesh-list
43947123|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
43947124|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947125|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459083|NCT01585428|Aldesleukin|aldesleukin|mesh-list
44459084|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
44459085|NCT01585428|Fludarabine|fludarabine|mesh-list
44459086|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459087|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
44459088|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459089|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947126|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947127|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947128|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
43947129|NCT01061034|Aspirin|aspirin|mesh-list
43947130|NCT01061034|Omeprazole|omeprazole|mesh-list
43947131|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43947132|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947133|NCT01061034|Analgesics|analgesics|mesh-ancestor
43947134|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
43947135|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947136|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947137|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947138|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947139|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43947140|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43947141|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947142|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43947143|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43947144|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947145|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
43947146|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43947147|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947148|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43947149|NCT01061528|Nicotine|nicotine|mesh-list
43947150|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43947151|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
43947152|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947153|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947154|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43947155|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43947156|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
43947157|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947158|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947159|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
43947160|NCT01062009|Astringents|astringents|mesh-ancestor
43947161|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947241|NCT01064882|Bimatoprost|bimatoprost|mesh-list
43947242|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43947243|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43947244|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947245|NCT01065506|Nicotine|nicotine|mesh-list
43947246|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43947247|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
43947248|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947249|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947250|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43947251|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43947252|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
43947253|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947254|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947255|NCT01065558|Ecopipam|ecopipam|mesh-list
43947256|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43947257|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43947258|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947259|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947260|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43947261|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43947262|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
43947263|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947264|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947265|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
43947266|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43947267|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
44459091|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
44459092|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459093|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459094|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44459095|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44459096|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44459097|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
44459098|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459099|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43947268|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947269|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
43947270|NCT01066026|Protective Agents|protective agents|mesh-ancestor
43947271|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43947272|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43688949|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
43947273|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43947274|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
43947275|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947276|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43947278|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844659|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
44141442|NCT00182806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141443|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141444|NCT00182806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141445|NCT00182806|Immunologic Factors|immunologic factors|mesh-ancestor
44141446|NCT00182806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141447|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44141448|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141450|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44141451|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
43947367|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947368|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947369|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
43947370|NCT01072188|Calcium|calcium|mesh-list
43947371|NCT01072188|Fluorides|fluorides|mesh-list
43947372|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43947373|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947374|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
43947375|NCT01072188|Protective Agents|protective agents|mesh-ancestor
43947376|NCT01072188|Antacids|antacids|mesh-ancestor
43947377|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947378|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947379|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
43947380|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43947381|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947382|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689014|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
43947489|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
43947490|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947491|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947492|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43813364|NCT04814589|Ezetimibe|ezetimibe|mesh-list
43947526|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947527|NCT01077310|Naltrexone|naltrexone|mesh-list
43947528|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43995553|NCT02620774|Ceftolozane|ceftolozane|mesh-list
43947529|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43947530|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947531|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
43947532|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947533|NCT01077401|Ranibizumab|ranibizumab|mesh-list
43947534|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43947535|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43947536|NCT01077401|Growth Substances|growth substances|mesh-ancestor
44459100|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44459101|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459102|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459103|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
44459104|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459105|NCT01585272|Rivastigmine|rivastigmine|mesh-list
44459106|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44459107|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947561|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43947562|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947563|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947564|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947565|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947566|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43947567|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947568|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
43947569|NCT01077973|Ibuprofen|ibuprofen|mesh-list
43947570|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43947571|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947572|NCT01077973|Analgesics|analgesics|mesh-ancestor
43947573|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
43947574|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947575|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947576|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947577|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947578|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43947579|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947580|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947581|NCT01078363|Ramipril|ramipril|mesh-list
43947582|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43947583|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947584|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947612|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947613|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43947614|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43947615|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
43947616|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947618|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43947619|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
43947620|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947621|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947622|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
43947623|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947624|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947625|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947626|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
43947627|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947628|NCT01080677|Propranolol|propranolol|mesh-list
43947629|NCT01080677|Caffeine|caffeine|mesh-list
43947690|NCT01083368|Antibodies|antibodies|mesh-list
43947691|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
43947746|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43947747|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947748|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947749|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43947750|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
43947751|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947752|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947753|NCT01084759|Etoposide|etoposide|mesh-list
43947754|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
43947755|NCT01084759|Testosterone|testosterone|mesh-list
43947756|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
43947757|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
44145743|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
43947758|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43947759|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44459108|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459109|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459110|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459111|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459112|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44459113|NCT01585272|Protective Agents|protective agents|mesh-ancestor
44459114|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
44459115|NCT01585246|Urological Agents|urological agents|mesh-ancestor
44459116|NCT01585194|Nivolumab|nivolumab|mesh-list
44459117|NCT01585194|Ipilimumab|ipilimumab|mesh-list
44165044|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
43947760|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947761|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43947762|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43947763|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947764|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947765|NCT01084759|Androgens|androgens|mesh-ancestor
43947766|NCT01084759|Hormones|hormones|mesh-ancestor
43947767|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947768|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947769|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43947774|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947776|NCT01085006|Coagulants|coagulants|mesh-ancestor
44141483|NCT00183001|Coagulants|coagulants|mesh-ancestor
44141484|NCT00183040|Hormones|hormones|mesh-list
44141485|NCT00183040|Testosterone|testosterone|mesh-list
44141486|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141487|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141488|NCT00183040|Androgens|androgens|mesh-ancestor
44141489|NCT00183222|Naltrexone|naltrexone|mesh-list
44141490|NCT00183222|Ondansetron|ondansetron|mesh-list
44141491|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44141492|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44141493|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141494|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
44141495|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141496|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
44141497|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
44141498|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141499|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
44141500|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44141501|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141502|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
44141503|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141504|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141505|NCT00183222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141506|NCT00183222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141507|NCT00183222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141508|NCT00183222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141509|NCT00183222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44141510|NCT00183235|Aripiprazole|aripiprazole|mesh-list
44141511|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141512|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141513|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141514|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141515|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141516|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141517|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
44141518|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
44141519|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141520|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141521|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44141522|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44141523|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
44459118|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459119|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459120|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44459121|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459122|NCT01585168|Memantine|memantine|mesh-list
44459123|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44459124|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44459125|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
44459126|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459127|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165120|NCT00258739|Docetaxel|docetaxel|mesh-list
44141524|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44141525|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141526|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44141527|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44141528|NCT00183404|Olanzapine|olanzapine|mesh-list
44141529|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
44141530|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
44141531|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141532|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141533|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141534|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141535|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141536|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947777|NCT01085344|Factor VIII|factor viii|mesh-list
43947778|NCT01085344|Coagulants|coagulants|mesh-ancestor
43947779|NCT01085760|Metronidazole|metronidazole|mesh-list
43947780|NCT01085760|Vancomycin|vancomycin|mesh-list
43947781|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947782|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947783|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43947784|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43947785|NCT01085786|Amoxicillin|amoxicillin|mesh-list
43947786|NCT01085786|Metronidazole|metronidazole|mesh-list
43947787|NCT01085786|Clarithromycin|clarithromycin|mesh-list
43947788|NCT01085786|Esomeprazole|esomeprazole|mesh-list
43947789|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947850|NCT01089062|Analgesics|analgesics|mesh-ancestor
43947851|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
43947852|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947853|NCT01089517|Ranibizumab|ranibizumab|mesh-list
43947854|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43947855|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43947856|NCT01089517|Growth Substances|growth substances|mesh-ancestor
43947857|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947858|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
43947859|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947860|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
43947861|NCT01089569|Exenatide|exenatide|mesh-list
43947862|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43947863|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947872|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947873|NCT01089751|Trospium chloride|trospium chloride|mesh-list
43947874|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
43947875|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
43947876|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947877|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947878|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43947879|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43947880|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
43947881|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947882|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947883|NCT01089751|Urological Agents|urological agents|mesh-ancestor
43947885|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947886|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
43947887|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
44459128|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459129|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44459130|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44239782|NCT00575796|Vinblastine|vinblastine|mesh-list
44239783|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44239784|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239785|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239786|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239787|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239788|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947888|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947889|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947890|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947891|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
43947892|NCT01090180|Hormones|hormones|mesh-ancestor
43947893|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947894|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43947895|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947896|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
43947897|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43947898|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947899|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
43947900|NCT01090752|Metformin|metformin|mesh-list
43947901|NCT01090752|Pioglitazone|pioglitazone|mesh-list
43947902|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43947903|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947904|NCT01090921|Bortezomib|bortezomib|mesh-list
43947905|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947906|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
43947907|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43947908|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43947909|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947910|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43947911|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947912|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
43947913|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947914|NCT01092338|Vitamin D|vitamin d|mesh-list
43947915|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
43947916|NCT01092338|Vitamins|vitamins|mesh-ancestor
43947917|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
43947918|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947919|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43947920|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43947921|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
43947922|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43947923|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
43947924|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947925|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947926|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813726|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
43947962|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
43947963|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948001|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948002|NCT01093794|Metformin|metformin|mesh-list
43948089|NCT01095757|Plerixafor|plerixafor|mesh-list
43948090|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43948091|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43948092|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
43948093|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948094|NCT01095887|Eculizumab|eculizumab|mesh-list
43948095|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44239789|NCT00575835|Vitamin D|vitamin d|mesh-list
44239790|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
44239791|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
44239792|NCT00575835|Vitamins|vitamins|mesh-list
43948096|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948097|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
43948098|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948099|NCT01096290|Lubiprostone|lubiprostone|mesh-list
43948100|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43948101|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948102|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948103|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43948105|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43948106|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948107|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43948108|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43948139|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948140|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948141|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948142|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
43948143|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43948144|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43948145|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948146|NCT01097343|Clopidogrel|clopidogrel|mesh-list
43948147|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43948148|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43948149|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43948168|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43948169|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
43948170|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948171|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43948172|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43948173|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948174|NCT01098318|Sertraline|sertraline|mesh-list
43948175|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
43948176|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43948177|NCT01098318|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43948178|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43948179|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948180|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948181|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948182|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
43948183|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948184|NCT01098747|Ibuprofen|ibuprofen|mesh-list
43948185|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43948186|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948187|NCT01098747|Analgesics|analgesics|mesh-ancestor
43948188|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
43948189|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948190|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948191|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948192|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948193|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43948194|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948195|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948196|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
43948197|NCT01099202|Hematinics|hematinics|mesh-ancestor
43948198|NCT01099358|Cisplatin|cisplatin|mesh-list
43948199|NCT01099358|Fluorouracil|fluorouracil|mesh-list
43948200|NCT01099358|Cetuximab|cetuximab|mesh-list
43948201|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948202|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
43948203|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948204|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43948205|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948234|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948236|NCT01100242|Sorafenib|sorafenib|mesh-list
43948237|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948238|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43948239|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239793|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
44239794|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239795|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44239796|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44239797|NCT00575848|Glycine|glycine|mesh-list
44239798|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
44239799|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948240|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948241|NCT01100255|Ketamine|ketamine|mesh-list
43948242|NCT01100255|Analgesics|analgesics|mesh-ancestor
43948243|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
43948244|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948245|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948246|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43948247|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43948249|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
43948250|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948251|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43948289|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
43948290|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948293|NCT01101750|Vaccines|vaccines|mesh-list
43948294|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
43948295|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948296|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
43948297|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
43948298|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43948299|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948300|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948301|NCT01101880|Cytarabine|cytarabine|mesh-list
43948302|NCT01101880|Clofarabine|clofarabine|mesh-list
43844781|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
43948315|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43948316|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948317|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948318|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43948319|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43948320|NCT01102218|Protective Agents|protective agents|mesh-ancestor
43948321|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948322|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
43948323|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43948324|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
43948325|NCT01102270|Eszopiclone|eszopiclone|mesh-list
43948326|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43948327|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948328|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948329|NCT01103414|Pioglitazone|pioglitazone|mesh-list
43948330|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948331|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948332|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
43948333|NCT01103440|Tirofiban|tirofiban|mesh-list
43948334|NCT01103440|Ticlopidine|ticlopidine|mesh-list
43948335|NCT01103440|Abciximab|abciximab|mesh-list
43948336|NCT01103440|Clopidogrel|clopidogrel|mesh-list
43948337|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43948338|NCT01103440|Cangrelor|cangrelor|mesh-list
43948339|NCT01103440|Eptifibatide|eptifibatide|mesh-list
43948340|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43948341|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43948342|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43948343|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43948344|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
43948345|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948346|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948347|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948348|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
43948349|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43948350|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43948351|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44239800|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239801|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239802|NCT00575861|Zileuton|zileuton|mesh-list
44239803|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44239804|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44239805|NCT00575861|Analgesics|analgesics|mesh-ancestor
44239806|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
44239807|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239808|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239809|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239810|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239811|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44239812|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239813|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239814|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44239815|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44239816|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239817|NCT00575874|Pioglitazone|pioglitazone|mesh-list
44239818|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239819|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948352|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
43948353|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43948354|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948355|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
43948356|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948357|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
43948358|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43948359|NCT01103440|Protective Agents|protective agents|mesh-ancestor
43948360|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43948361|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43948362|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948363|NCT01103934|Vitamin D|vitamin d|mesh-list
43948364|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
43948365|NCT01103934|Fluticasone|fluticasone|mesh-list
43948367|NCT01103934|Vitamins|vitamins|mesh-ancestor
43948402|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948403|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948404|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43948405|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948406|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
43948407|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948408|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43948445|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948446|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
43948447|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948485|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
43948516|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948517|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
43948518|NCT01106950|Fludarabine|fludarabine|mesh-list
43948519|NCT01106950|Interleukin-2|interleukin-2|mesh-list
43948520|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
43948521|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806118|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
44239820|NCT00575913|Alfuzosin|alfuzosin|mesh-list
44239821|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44239822|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44239823|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44239824|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44165431|NCT00260143|Androgens|androgens|mesh-ancestor
43948523|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948524|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948525|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948526|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
43948527|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948528|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948529|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43948530|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948531|NCT01106950|Analgesics|analgesics|mesh-ancestor
43948532|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
43948560|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948561|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43948562|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43948563|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948564|NCT01108757|Renal Agents|renal agents|mesh-ancestor
43948565|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43948566|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
43948567|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43948568|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43948569|NCT01109056|Cyclosporine|cyclosporine|mesh-list
43948570|NCT01109056|Cyclosporins|cyclosporins|mesh-list
43948571|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948572|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948573|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948574|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
43948575|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948576|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
43948577|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948578|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948579|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948580|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43948609|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948610|NCT01110421|Amoxicillin|amoxicillin|mesh-list
43948611|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
43948612|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
43948614|NCT01110421|Doripenem|doripenem|mesh-list
43948615|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43948616|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43948617|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948618|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43948619|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948620|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948621|NCT01110434|Topiramate|topiramate|mesh-list
43948622|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
43948623|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948624|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948625|NCT01110499|Bimatoprost|bimatoprost|mesh-list
43948626|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43948627|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43814136|NCT04802785|Aspirin|aspirin|mesh-list
43948653|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948654|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948655|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948656|NCT01112241|Albuterol|albuterol|mesh-list
43948657|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
43948658|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43948659|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
43948660|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948661|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948662|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43948663|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948664|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
43948665|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44239825|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239826|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239827|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239828|NCT00575913|Urological Agents|urological agents|mesh-ancestor
44239830|NCT00575952|Cisplatin|cisplatin|mesh-list
44239831|NCT00575952|Doxorubicin|doxorubicin|mesh-list
44239832|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44239833|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44239834|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239835|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239836|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239837|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239838|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239839|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44239840|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44165500|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
43948666|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
43948667|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948668|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948669|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
43948671|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43948672|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43948673|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43948674|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
43948675|NCT01112358|Cetrorelix|cetrorelix|mesh-list
43948676|NCT01112358|Progesterone|progesterone|mesh-list
43814197|NCT04802122|Propofol|propofol|mesh-list
43948681|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43948682|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
43948683|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43948684|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
43948685|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43948687|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43948688|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43948689|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
43948690|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948691|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43948692|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43948693|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948694|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948695|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948696|NCT01112670|Incretins|incretins|mesh-ancestor
43948697|NCT01112670|Hormones|hormones|mesh-ancestor
43948698|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948699|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43948700|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
43948701|NCT01112683|Memantine|memantine|mesh-list
43948702|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43948703|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43948704|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
43948705|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948706|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948707|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948708|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43948709|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43948710|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43948711|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
44239841|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44239842|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44239843|NCT00575978|Hydralazine|hydralazine|mesh-list
44239844|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44239845|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44239846|NCT00576017|Fentanyl|fentanyl|mesh-list
44239847|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44239848|NCT00576017|Narcotics|narcotics|mesh-ancestor
44239849|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239850|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239851|NCT00576017|Analgesics|analgesics|mesh-ancestor
44239852|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
44239853|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239854|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44239855|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44239856|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
44239858|NCT00576069|Fluticasone|fluticasone|mesh-list
44239859|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
44239860|NCT00576069|Prednisone|prednisone|mesh-list
43948712|NCT01112735|Coagulants|coagulants|mesh-ancestor
43948713|NCT01113398|Bevacizumab|bevacizumab|mesh-list
43948714|NCT01113398|Rilotumumab|rilotumumab|mesh-list
43948715|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948716|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948717|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948718|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948719|NCT01113398|Growth Substances|growth substances|mesh-ancestor
43948720|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948721|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948722|NCT01113632|Ofatumumab|ofatumumab|mesh-list
43948723|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948724|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
43948725|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43948726|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43948727|NCT01114503|Prednisolone|prednisolone|mesh-list
43948728|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
43948729|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43948730|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
43948731|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948732|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
43948733|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
43948734|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948735|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948736|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948737|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
43948738|NCT01114503|Hormones|hormones|mesh-ancestor
43948739|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948740|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43948741|NCT01114503|Protective Agents|protective agents|mesh-ancestor
43948742|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948743|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948744|NCT01114555|Bevacizumab|bevacizumab|mesh-list
43948746|NCT01114555|Temozolomide|temozolomide|mesh-list
43948747|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814236|NCT04801303|Calcitriol|calcitriol|mesh-list
43948814|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43948815|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43948816|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814285|NCT04800081|Valsartan|valsartan|mesh-list
43948842|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
44239862|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
44239863|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44239864|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43948843|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948844|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43948845|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948846|NCT01115556|Ranibizumab|ranibizumab|mesh-list
43948847|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948848|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948849|NCT01115556|Growth Substances|growth substances|mesh-ancestor
43948850|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948851|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948852|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948853|NCT01115582|Cholic Acids|cholic acids|mesh-list
43948854|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948855|NCT01115673|Acetaminophen|acetaminophen|mesh-list
43948856|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948914|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43948915|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948916|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
43948917|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
43948918|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
43948919|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
43948920|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948921|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43948922|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
43948923|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
43948924|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948925|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43948926|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
43948927|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948929|NCT01118624|Folic Acid|folic acid|mesh-list
43948930|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
43948931|NCT01118624|Hydroxocobalamin|hydroxocobalamin|mesh-list
43948932|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
43948933|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
43948934|NCT01118624|Aminopterin|aminopterin|mesh-list
43948935|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
43948936|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948937|NCT01118624|Hematinics|hematinics|mesh-ancestor
43948963|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948964|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948965|NCT01119222|Analgesics|analgesics|mesh-ancestor
43948966|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
43948967|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948968|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
43948969|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43948970|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43948971|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43948972|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43948973|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43948974|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948975|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948976|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
43948977|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43948978|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43948979|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
43948980|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
43948981|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
43948982|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
43948983|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948984|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43948985|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
43948986|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
43948987|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43948988|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
43949015|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43949016|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
43949017|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949018|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949019|NCT01120704|Nicotine|nicotine|mesh-list
43949020|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43949021|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
44239865|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44239866|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239867|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
44239868|NCT00576069|Hormones|hormones|mesh-ancestor
44239869|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949022|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949023|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949024|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43949025|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43949026|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
43949027|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949028|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949029|NCT01120834|Azacitidine|azacitidine|mesh-list
43949030|NCT01120834|Vorinostat|vorinostat|mesh-list
43949031|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949032|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
43949033|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949034|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949035|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949036|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43949037|NCT01121211|Testosterone|testosterone|mesh-list
43949038|NCT01121211|Androgens|androgens|mesh-ancestor
43949039|NCT01121211|Hormones|hormones|mesh-ancestor
43949071|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949072|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43949073|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43949074|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
43949075|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949076|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949077|NCT01122316|Metformin|metformin|mesh-list
43949078|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949079|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949080|NCT01122901|R04929097|r04929097|mesh-list
43949081|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814551|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
43949116|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
43949179|NCT05307341|Dsuvia|dsuvia|mesh-list
43949180|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43949181|NCT05307341|Narcotics|narcotics|mesh-ancestor
43949182|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949242|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949243|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949244|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
43949245|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43949246|NCT05289856|Avelumab|avelumab|mesh-list
43949247|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949248|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949249|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
43949250|NCT05289167|Bortezomib|bortezomib|mesh-list
43949251|NCT05289167|Abatacept|abatacept|mesh-list
43949252|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949253|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
43949254|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949255|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949256|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43949257|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
43814586|NCT04793399|Atezolizumab|atezolizumab|mesh-list
43949350|NCT05042648|Narcotics|narcotics|mesh-ancestor
43949351|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949352|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949353|NCT05042648|Analgesics|analgesics|mesh-ancestor
43949354|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
43949355|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949356|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43949357|NCT05004025|Nivolumab|nivolumab|mesh-list
43949358|NCT05004025|Ipilimumab|ipilimumab|mesh-list
43949359|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949360|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949361|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43949362|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239870|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949363|NCT04974151|Folic Acid|folic acid|mesh-list
43949364|NCT04974151|Amlodipine|amlodipine|mesh-list
43949365|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43949366|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43949367|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949368|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949369|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43949370|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141633|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44141634|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
44141635|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141636|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141637|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141638|NCT00183898|Capecitabine|capecitabine|mesh-list
44141639|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
44141640|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949439|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949475|NCT04447534|Chloroquine|chloroquine|mesh-list
43949476|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43949477|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
43949514|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43949515|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949551|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949553|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949554|NCT04071977|Antioxidants|antioxidants|mesh-list
43949592|NCT03877991|Cannabidiol|cannabidiol|mesh-list
43949593|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
43949594|NCT03872947|Leucovorin|leucovorin|mesh-list
43949610|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949612|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949613|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
43949614|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
43949615|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949616|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949617|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949618|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
43949619|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43949620|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43949621|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43949623|NCT03872947|Protective Agents|protective agents|mesh-ancestor
43949624|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
43949625|NCT03872947|Vitamins|vitamins|mesh-ancestor
43949626|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
43949627|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43949628|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
43949629|NCT03835949|Atezolizumab|atezolizumab|mesh-list
43949630|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949631|NCT03809780|Dexamethasone|dexamethasone|mesh-list
43949632|NCT03809780|Lenalidomide|lenalidomide|mesh-list
43949633|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949634|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
43949635|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
43949636|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949637|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949638|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949639|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
43949640|NCT03809780|Hormones|hormones|mesh-ancestor
43949641|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949642|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949643|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949644|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
43949645|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43949646|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43949647|NCT03809780|Growth Substances|growth substances|mesh-ancestor
43949648|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
43949649|NCT03780543|Tenofovir|tenofovir|mesh-list
43949650|NCT03780543|Entecavir|entecavir|mesh-list
43949651|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
43949652|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949653|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43996283|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43949654|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43949655|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949656|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239871|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949658|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43949659|NCT03713528|Vancomycin|vancomycin|mesh-list
44141694|NCT00183989|Fludarabine|fludarabine|mesh-list
44141695|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
44141696|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141697|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141698|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
44141699|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141700|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141701|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141702|NCT00183989|Analgesics|analgesics|mesh-ancestor
44141703|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
44141704|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141705|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44141706|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141707|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141708|NCT00184015|Bevacizumab|bevacizumab|mesh-list
44141709|NCT00184015|Bortezomib|bortezomib|mesh-list
44141710|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141711|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141712|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43815026|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
44141741|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141742|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44141743|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141744|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
44141745|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141746|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43949743|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43949744|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949745|NCT03418805|Analgesics|analgesics|mesh-ancestor
43949746|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
43949747|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949748|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949749|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949750|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949751|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43949752|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949753|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949754|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
43949755|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627943|NCT03070405|Tenofovir|tenofovir|mesh-list
43949845|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949846|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949847|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
43949848|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
43949849|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949882|NCT02623426|Hormones|hormones|mesh-ancestor
43949883|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949884|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949885|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949886|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43949887|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
43949888|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949889|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949890|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
43949891|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949892|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
43949893|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815102|NCT04784910|Lansoprazole|lansoprazole|mesh-list
43949926|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949928|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43949929|NCT01924819|Cisplatin|cisplatin|mesh-list
43949930|NCT01924819|Docetaxel|docetaxel|mesh-list
43949931|NCT01924819|Fluorouracil|fluorouracil|mesh-list
43949932|NCT01924819|Capecitabine|capecitabine|mesh-list
43949933|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
43949934|NCT01924819|Epirubicin|epirubicin|mesh-list
43949935|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
43949936|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949937|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
43949938|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
43949939|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239872|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239873|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44239874|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
44239875|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239876|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239877|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239878|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239879|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44165905|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949940|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815151|NCT05471674|Nivolumab|nivolumab|mesh-list
43949972|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43949973|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43949974|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43949975|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43949976|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
43949977|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949978|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949979|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949980|NCT01126593|Bupivacaine|bupivacaine|mesh-list
43949981|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
43949982|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
43949983|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950021|NCT01129206|Docetaxel|docetaxel|mesh-list
43950022|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43950023|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950034|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950035|NCT01129245|Analgesics|analgesics|mesh-ancestor
43950036|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
43950037|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950038|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950039|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950040|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950041|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43950042|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43950043|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950044|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141747|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44141748|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
43950045|NCT01129440|Fluorides|fluorides|mesh-list
43950046|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
43950047|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
43950048|NCT01129440|Protective Agents|protective agents|mesh-ancestor
43950049|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950050|NCT01129778|Omeprazole|omeprazole|mesh-list
43950051|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43950052|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
43950053|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43950054|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950055|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950056|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950057|NCT01130844|Mesalamine|mesalamine|mesh-list
43950058|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950059|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950060|NCT01130844|Analgesics|analgesics|mesh-ancestor
43950061|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
43950062|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950063|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950064|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950065|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950066|NCT01131052|Insulin|insulin|mesh-list
43950067|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43950068|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
43950069|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
43950070|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950071|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145901|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
44239880|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44239881|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44239883|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
44239884|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239885|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239886|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
44239887|NCT00576173|Acetaminophen|acetaminophen|mesh-list
44239888|NCT00576173|Tramadol|tramadol|mesh-list
44239889|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44239890|NCT00576173|Analgesics|analgesics|mesh-ancestor
43950072|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
43950073|NCT01131065|Antibodies|antibodies|mesh-list
43950074|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
43950075|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43950076|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43950077|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
43950078|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950079|NCT01132846|Dopamine|dopamine|mesh-list
43950080|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43950081|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43950082|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
43950083|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
43950084|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950085|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950086|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
43950087|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950112|NCT01133158|Analgesics|analgesics|mesh-ancestor
43950113|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
43950114|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43950115|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43950116|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950117|NCT01134198|Mifepristone|mifepristone|mesh-list
43950118|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43950119|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
43950120|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950121|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950122|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43950123|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43950124|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43950125|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
43950126|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43950127|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43950128|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
43950129|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950130|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
43950131|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43950132|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43950133|NCT01134510|Complement C1s|complement c1s|mesh-list
43950134|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43950135|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43950146|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950147|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43950149|NCT01134952|Sirolimus|sirolimus|mesh-list
43950150|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43950151|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950152|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43950153|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
43950154|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950155|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950156|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950157|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950158|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
43950159|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950160|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
44239891|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
44239892|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44239893|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950161|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950162|NCT01135069|Tretinoin|tretinoin|mesh-list
43950163|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950164|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
43950165|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950166|NCT01135186|Verapamil|verapamil|mesh-list
43950167|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43950168|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43950169|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43950170|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950171|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43950172|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950173|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
43950174|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
43950175|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
43950176|NCT01135329|Busulfan|busulfan|mesh-list
43950177|NCT01135329|Fludarabine|fludarabine|mesh-list
43950178|NCT01135329|Tacrolimus|tacrolimus|mesh-list
43950179|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950180|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
43950181|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950182|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950183|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43950184|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
43950185|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950186|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950187|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43950188|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43950189|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950190|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43950191|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43950192|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
43950193|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950194|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950195|NCT01135368|Lansoprazole|lansoprazole|mesh-list
43950196|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
43950197|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43950198|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950199|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43950200|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950201|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815423|NCT04429022|Celecoxib|celecoxib|mesh-list
43950297|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950298|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950299|NCT01139190|Analgesics|analgesics|mesh-ancestor
43950300|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
43950301|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950302|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950303|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950304|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950363|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996479|NCT05414487|Ofatumumab|ofatumumab|mesh-list
43950364|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950365|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43950366|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950367|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
43950368|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43950369|NCT01141725|Idarubicin|idarubicin|mesh-list
43950370|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43950371|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
43950372|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950373|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950374|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43950375|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43950376|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43950377|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950378|NCT01142310|Lamotrigine|lamotrigine|mesh-list
43950379|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
43950380|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44239894|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
44239895|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44239896|NCT00576173|Narcotics|narcotics|mesh-ancestor
44239897|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239898|NCT00576225|Paclitaxel|paclitaxel|mesh-list
44239899|NCT00576225|Carboplatin|carboplatin|mesh-list
44239900|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44239901|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44239902|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239903|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44239904|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44239905|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44239906|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239907|NCT00576238|Betamethasone|betamethasone|mesh-list
44239908|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
44239909|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44239910|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
44239911|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44239912|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239913|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
44239914|NCT00576238|Hormones|hormones|mesh-ancestor
44239915|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239916|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239917|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239918|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239919|NCT00576329|Ketorolac|ketorolac|mesh-list
44239920|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950381|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43950382|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950383|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43950384|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950385|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43950386|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950451|NCT01144143|Prednisolone|prednisolone|mesh-list
43950452|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
43950453|NCT01144143|Infliximab|infliximab|mesh-list
43950454|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43950455|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
43950456|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950457|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
43950458|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
43950459|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950460|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950461|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950462|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
43950463|NCT01144143|Hormones|hormones|mesh-ancestor
43950464|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950465|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44239921|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44239922|NCT00576329|Analgesics|analgesics|mesh-ancestor
44239923|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
44239924|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158400|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158401|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158403|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
44158417|NCT00236717|Carbamazepine|carbamazepine|mesh-list
44158418|NCT00236717|Valproic Acid|valproic acid|mesh-list
44158419|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
44158420|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158421|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158422|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158423|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158424|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
44158425|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158426|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
44158427|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158428|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158429|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158430|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44158431|NCT00236717|Analgesics|analgesics|mesh-ancestor
43950512|NCT01144949|Silodosin|silodosin|mesh-list
43950513|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43950514|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43950515|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43950516|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950517|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950518|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950519|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950520|NCT01144949|Urological Agents|urological agents|mesh-ancestor
43950521|NCT01145001|Nicotine|nicotine|mesh-list
43950522|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43950523|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
43950524|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950525|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950526|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43950527|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43950528|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
43950529|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950530|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950531|NCT01145183|Doxazosin|doxazosin|mesh-list
43950532|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43950533|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43950534|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43950535|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43950536|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950537|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950538|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950539|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950541|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43950542|NCT01145638|Trace Elements|trace elements|mesh-ancestor
43950543|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
43950544|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950545|NCT01145638|Hematinics|hematinics|mesh-ancestor
43950546|NCT01146457|Morphine|morphine|mesh-list
43950547|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43950548|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43950578|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43950579|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
43950580|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950581|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950582|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43950583|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43950584|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43950585|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
43950586|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950587|NCT01147302|Complement C1s|complement c1s|mesh-list
43950588|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43950589|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43950590|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
44239925|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239926|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239927|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239928|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44239929|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996621|NCT05197270|Growth Substances|growth substances|mesh-ancestor
44239930|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239931|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
44239932|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239933|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239934|NCT00576394|Insulin|insulin|mesh-list
44239935|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44239936|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44239937|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239938|NCT00576433|Rituximab|rituximab|mesh-list
44239939|NCT00576433|Methotrexate|methotrexate|mesh-list
44166228|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950591|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815746|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
43950620|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43950621|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43950622|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43950623|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
43950624|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950625|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950626|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43950627|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43950628|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43950629|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950630|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950631|NCT01148524|Vaccines|vaccines|mesh-list
43950632|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
43950633|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950634|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43950635|NCT01148745|Hematinics|hematinics|mesh-ancestor
43950636|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43950637|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43950638|NCT01148836|Ubiquinone|ubiquinone|mesh-list
43950639|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
43950640|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
43950641|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950642|NCT01148836|Vitamins|vitamins|mesh-ancestor
43950675|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950676|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
43950677|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950678|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950679|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950680|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43950681|NCT01149785|Ketoconazole|ketoconazole|mesh-list
43950682|NCT01149785|Crizotinib|crizotinib|mesh-list
43950683|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
43950684|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815839|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
43950715|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
43950716|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950717|NCT01150760|Alvimopan|alvimopan|mesh-list
43950718|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950719|NCT01150838|Propofol|propofol|mesh-list
43950720|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43950721|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950722|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950723|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44239940|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44239941|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239942|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
44239943|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239944|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44239945|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44239946|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
44239947|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44239948|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44239949|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
44239950|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44239951|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
44239952|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950724|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
43950725|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
43950726|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
43845106|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
43950761|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
43996699|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950762|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950763|NCT01151813|Varenicline|varenicline|mesh-list
43950764|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43950765|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43815867|NCT02866643|Hormones|hormones|mesh-ancestor
43950798|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43950799|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43950801|NCT01153581|Estradiol|estradiol|mesh-list
43950802|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43950803|NCT01153581|Progesterone|progesterone|mesh-list
43950804|NCT01153581|Ganirelix|ganirelix|mesh-list
43950805|NCT01153581|Estrogens|estrogens|mesh-ancestor
43950806|NCT01153581|Hormones|hormones|mesh-ancestor
43815900|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43950836|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43950837|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43950838|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950839|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950840|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43950841|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
43950842|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950843|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950844|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43950846|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43950847|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950848|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
43950849|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
43950850|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950879|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950881|NCT01156597|Pioglitazone|pioglitazone|mesh-list
43950882|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950883|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950884|NCT01156701|Zanamivir|zanamivir|mesh-list
43950885|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
43950886|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950887|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950888|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950889|NCT01157416|Cycloserine|cycloserine|mesh-list
43950890|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43950891|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950892|NCT01157416|Renal Agents|renal agents|mesh-ancestor
43950893|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43950894|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
43950895|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44239953|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44239954|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44239955|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44239956|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44239957|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239958|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
44239959|NCT00576459|Hormones|hormones|mesh-ancestor
44239960|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239961|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239962|NCT00576511|Prucalopride|prucalopride|mesh-list
44239963|NCT00576511|Laxatives|laxatives|mesh-ancestor
44239964|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44239965|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44239966|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44239967|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
44239968|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44239969|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950924|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950925|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43950926|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43950927|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950928|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
43950929|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43950930|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43950931|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43950932|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
43950933|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950934|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
43950936|NCT01158820|Midazolam|midazolam|mesh-list
43950937|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
43950938|NCT01158820|Ketamine|ketamine|mesh-list
43950939|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43950940|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950941|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815996|NCT02412228|Dexamethasone|dexamethasone|mesh-list
43950978|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43950979|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
43950980|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950981|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950982|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951017|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951019|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43951020|NCT01159262|Analgesics|analgesics|mesh-ancestor
43951021|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
43951022|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951023|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43951024|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43951025|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43951026|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
44141770|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141771|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44141772|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141774|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44141806|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141807|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
44239970|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239971|NCT00576550|Betamethasone|betamethasone|mesh-list
44239972|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
44239973|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44239974|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
44239975|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44239976|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44239977|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
44239978|NCT00576550|Hormones|hormones|mesh-ancestor
44166420|NCT00264212|Irbesartan|irbesartan|mesh-list
44141808|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141809|NCT00184522|Esomeprazole|esomeprazole|mesh-list
44141810|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44141811|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141812|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44141813|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141814|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141815|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
44141816|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
44141817|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951070|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
43951071|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951072|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951073|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43951075|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43951076|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43951077|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
43951078|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43951079|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951080|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43951081|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951082|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
43951083|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43951084|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
43951085|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43951086|NCT01161862|Glucagon|glucagon|mesh-list
43951087|NCT01161862|Pancrelipase|pancrelipase|mesh-list
43951088|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951089|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951090|NCT01161862|Hormones|hormones|mesh-ancestor
43951091|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951092|NCT01162005|Tacrolimus|tacrolimus|mesh-list
43951093|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951094|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
43951095|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951096|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43951097|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951098|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951099|NCT01162551|Sirolimus|sirolimus|mesh-list
43951100|NCT01162551|Methotrexate|methotrexate|mesh-list
43845170|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43951141|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43951142|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43951143|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43951144|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
43951145|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951146|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
43951147|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43951148|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
43951149|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
43951150|NCT01163656|Cobalt|cobalt|mesh-list
43951151|NCT01163656|Trace Elements|trace elements|mesh-ancestor
43951152|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
43951153|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951154|NCT01164098|Rituximab|rituximab|mesh-list
43951155|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951156|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44239979|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44239980|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166478|NCT00264446|Eniluracil|eniluracil|mesh-list
43951157|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
43951158|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951159|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951160|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
43951161|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43951162|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
43951163|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951164|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951165|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43951166|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
43951167|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43951168|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
43951169|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951170|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951171|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43951172|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951173|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
43951223|NCT01166126|Sirolimus|sirolimus|mesh-list
43951224|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951225|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951226|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43951227|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951228|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
43951229|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951230|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
43951231|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951232|NCT01166997|Heparin|heparin|mesh-list
43951233|NCT01166997|Calcium heparin|calcium heparin|mesh-list
43951234|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
43951235|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43951236|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43951237|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951238|NCT01167452|Trimethoprim|trimethoprim|mesh-list
43951239|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43951240|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
43951241|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43951242|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951243|NCT01167452|Renal Agents|renal agents|mesh-ancestor
43951244|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
43951245|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43951246|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43951247|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43951248|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951249|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951250|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43951251|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43951252|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43951253|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951254|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
43951255|NCT01167569|Vitamins|vitamins|mesh-ancestor
43951256|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
43951257|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951258|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
43951259|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951260|NCT01167569|Protective Agents|protective agents|mesh-ancestor
43951261|NCT01167829|Testosterone|testosterone|mesh-list
43951262|NCT01167829|Acyline|acyline|mesh-list
43951263|NCT01167829|Androgens|androgens|mesh-ancestor
43951264|NCT01167829|Hormones|hormones|mesh-ancestor
43951265|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951266|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951267|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
43951268|NCT01168674|Ziprasidone|ziprasidone|mesh-list
43951269|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43816318|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
43951333|NCT01170247|Analgesics|analgesics|mesh-ancestor
43951367|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43951368|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951369|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44239981|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44239982|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44239983|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
44239984|NCT00576602|Hematinics|hematinics|mesh-ancestor
44239986|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44239987|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44239988|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239989|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44239990|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
44239991|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
44239992|NCT00576706|Misoprostol|misoprostol|mesh-list
44239993|NCT00576706|Rebamipide|rebamipide|mesh-list
44239994|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43951370|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951371|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951372|NCT01170715|Etanercept|etanercept|mesh-list
43816373|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43951510|NCT01174082|Sargramostim|sargramostim|mesh-list
43951511|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
43951512|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951513|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
43951514|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43951515|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43951516|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43951517|NCT01175148|Atorvastatin|atorvastatin|mesh-list
43951518|NCT01175148|Calcium|calcium|mesh-list
43951519|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951520|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951521|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43951522|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43951523|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
43951524|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951525|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43951526|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43951527|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951528|NCT01175343|R04929097|r04929097|mesh-list
43951529|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951530|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951531|NCT01175395|Triamcinolone|triamcinolone|mesh-list
43951567|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43951568|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43951569|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43951570|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43951597|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43951598|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
43951599|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43951600|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951601|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951603|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951604|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951605|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
43951606|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951607|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43951608|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951609|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
43951610|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951611|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43951612|NCT01177098|Timolol|timolol|mesh-list
43951613|NCT01177098|Bimatoprost|bimatoprost|mesh-list
43951614|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43951615|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43806408|NCT04912271|Granisetron|granisetron|mesh-list
44239996|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44239997|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44239998|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44239999|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240000|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
44240001|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
44166608|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951616|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43951617|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951655|NCT01178216|Rituximab|rituximab|mesh-list
43816578|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
43951678|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951679|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951680|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951681|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43951683|NCT01178528|Protective Agents|protective agents|mesh-ancestor
43951684|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43951685|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43951686|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951687|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951688|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43951689|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43951690|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
43951691|NCT01178827|Oxybutynin|oxybutynin|mesh-list
43951692|NCT01178827|Trospium chloride|trospium chloride|mesh-list
43951693|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
43951694|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
43951695|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951696|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951697|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43951698|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43951699|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
43951700|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951701|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951702|NCT01178827|Urological Agents|urological agents|mesh-ancestor
43951703|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43951704|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951705|NCT01178827|Renal Agents|renal agents|mesh-ancestor
43951706|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
43951707|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
43951732|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951733|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951734|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
43951735|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951736|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43951737|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
43951738|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951739|NCT01180036|Cyclosporine|cyclosporine|mesh-list
43951740|NCT01180036|Rituximab|rituximab|mesh-list
43951741|NCT01180036|Cyclosporins|cyclosporins|mesh-list
43951742|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951743|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951744|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
43951745|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951746|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996963|NCT03994601|Nivolumab|nivolumab|mesh-list
43951747|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951748|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951749|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951750|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
43951751|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951752|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43951753|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43951754|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43951763|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951765|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240002|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240003|NCT00576706|Protective Agents|protective agents|mesh-ancestor
44240004|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240005|NCT00576784|Pioglitazone|pioglitazone|mesh-list
44240006|NCT00576784|Glimepiride|glimepiride|mesh-list
44240007|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44240008|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951766|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
43951767|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951768|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951769|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43951770|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951771|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43951772|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
43951773|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
43951774|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951775|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951776|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
43951777|NCT01181258|Hormones|hormones|mesh-ancestor
43951778|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951779|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43951780|NCT01181258|Protective Agents|protective agents|mesh-ancestor
43951781|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43951782|NCT01181258|Analgesics|analgesics|mesh-ancestor
43951783|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
43951784|NCT01181323|Vaccines|vaccines|mesh-list
43951785|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
43951786|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951787|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43951788|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43951789|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951790|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951791|NCT01181674|Insulin|insulin|mesh-list
43951792|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43951793|NCT01181674|Metformin|metformin|mesh-list
43951794|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
43951795|NCT01181674|Acarbose|acarbose|mesh-list
43951796|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951797|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951798|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43951799|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951800|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951801|NCT01182376|Dronedarone|dronedarone|mesh-list
43951802|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43951803|NCT01182493|Insulin|insulin|mesh-list
43951804|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951805|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951806|NCT01182675|Plerixafor|plerixafor|mesh-list
43951807|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
43951808|NCT01182675|Lenograstim|lenograstim|mesh-list
43951809|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43951810|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
43951811|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951812|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951813|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951814|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43951815|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43951816|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
43951817|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951818|NCT01183169|Ribavirin|ribavirin|mesh-list
43951819|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43951820|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
43951821|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951822|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
43951823|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951824|NCT01183312|Flumazenil|flumazenil|mesh-list
43951825|NCT01183312|Antidotes|antidotes|mesh-ancestor
43951839|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43951840|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951841|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240009|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44240010|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240011|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
44240012|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
43951842|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43951843|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
43951844|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43951845|NCT01183533|Plasminogen|plasminogen|mesh-list
43951846|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43951847|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43951848|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951849|NCT01183559|Paclitaxel|paclitaxel|mesh-list
43951850|NCT01183559|Carboplatin|carboplatin|mesh-list
43951851|NCT01183559|Fluorouracil|fluorouracil|mesh-list
43951852|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43951853|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951854|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
43951855|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
43951856|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
43951857|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951858|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
43951859|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951860|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951861|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
43951862|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951863|NCT01183650|Tadalafil|tadalafil|mesh-list
43951864|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951865|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43951866|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43951867|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951868|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951869|NCT01183650|Urological Agents|urological agents|mesh-ancestor
43951870|NCT01184014|Insulin|insulin|mesh-list
43951871|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43951872|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
43951873|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
43951874|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
43951875|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
43951876|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
43951877|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951878|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951879|NCT01184417|Phenobarbital|phenobarbital|mesh-list
43951880|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
43951881|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43951882|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951883|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951884|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43951885|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43951886|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951887|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951905|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43951906|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
43951907|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43951908|NCT01184898|Cytarabine|cytarabine|mesh-list
43951909|NCT01184898|Sirolimus|sirolimus|mesh-list
43951910|NCT01184898|Etoposide|etoposide|mesh-list
43951911|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
43951912|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
43951913|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43951914|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951915|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43951916|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43951917|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951918|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951919|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951920|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
43951921|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
43951922|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951923|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951924|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
43951925|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951926|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44240014|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240015|NCT00576914|Endostatins|endostatins|mesh-list
44240016|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240017|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240018|NCT00576914|Growth Substances|growth substances|mesh-ancestor
44240019|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240020|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240021|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240022|NCT00577018|Prucalopride|prucalopride|mesh-list
44240023|NCT00577018|Laxatives|laxatives|mesh-ancestor
44240024|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240025|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44240026|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44240027|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
44240028|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240029|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951927|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43951928|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
43951929|NCT01184898|Analgesics|analgesics|mesh-ancestor
43951930|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
43951931|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951932|NCT01185028|Interferons|interferons|mesh-list
43951933|NCT01185028|Ribavirin|ribavirin|mesh-list
43951934|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
43951935|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951936|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
43951937|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951938|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
43951939|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951940|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43951941|NCT01186250|Pioglitazone|pioglitazone|mesh-list
43951942|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951943|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951944|NCT01186406|Bevacizumab|bevacizumab|mesh-list
43951945|NCT01186406|Temozolomide|temozolomide|mesh-list
43951946|NCT01186406|Carmustine|carmustine|mesh-list
43951947|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951948|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951960|NCT01186562|Incretins|incretins|mesh-ancestor
43951961|NCT01186562|Hormones|hormones|mesh-ancestor
43951962|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951963|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43951964|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
43951965|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951966|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951967|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
43951968|NCT01187017|Fludarabine|fludarabine|mesh-list
43951969|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951970|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
43951971|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951972|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951973|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43951974|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
43951975|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951976|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951977|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43951978|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43951979|NCT01187381|Trastuzumab|trastuzumab|mesh-list
44240030|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240032|NCT00577057|Fluorouracil|fluorouracil|mesh-list
44240033|NCT00577057|Capecitabine|capecitabine|mesh-list
44240034|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240035|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
43997183|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997261|NCT02369406|Zidovudine|zidovudine|mesh-list
43997262|NCT02369406|Nevirapine|nevirapine|mesh-list
44240036|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240037|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44240038|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240039|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
44240040|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240041|NCT00577109|Leucovorin|leucovorin|mesh-list
44240042|NCT00577109|Bevacizumab|bevacizumab|mesh-list
44240043|NCT00577109|Cetuximab|cetuximab|mesh-list
44240044|NCT00577109|Irinotecan|irinotecan|mesh-list
44240045|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240046|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240047|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240048|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240049|NCT00577109|Growth Substances|growth substances|mesh-ancestor
44240050|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240051|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240052|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44240053|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44240054|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240055|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240056|NCT00577109|Antidotes|antidotes|mesh-ancestor
44240057|NCT00577109|Protective Agents|protective agents|mesh-ancestor
44240058|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
44240059|NCT00577109|Vitamins|vitamins|mesh-ancestor
44240060|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
44240061|NCT00577161|Vidarabine|vidarabine|mesh-list
44240062|NCT00577161|Rituximab|rituximab|mesh-list
44240063|NCT00577161|Fludarabine|fludarabine|mesh-list
44240064|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
44240065|NCT00577161|Pixantrone|pixantrone|mesh-list
44240066|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240067|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240068|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
43951980|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240069|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240070|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240071|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44240072|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
44240073|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240074|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240075|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
44240076|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240077|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44240078|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44240079|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240080|NCT00577200|Midazolam|midazolam|mesh-list
43951981|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951982|NCT01187498|Oxybutynin|oxybutynin|mesh-list
43951983|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
43951984|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
43951985|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951986|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951987|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43951988|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43951989|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
43951990|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951991|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951992|NCT01187498|Urological Agents|urological agents|mesh-ancestor
43951993|NCT01188109|Gemcitabine|gemcitabine|mesh-list
43951994|NCT01188109|Cisplatin|cisplatin|mesh-list
43951995|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951996|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951997|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
43951998|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951999|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
43952000|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952001|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952002|NCT01188109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952003|NCT01188109|Immunologic Factors|immunologic factors|mesh-ancestor
43952004|NCT01188109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952005|NCT01188369|Simendan|simendan|mesh-list
43952006|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43952007|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
43952008|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43816884|NCT03660488|Cefixime|cefixime|mesh-list
43952021|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952022|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952024|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
43952025|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952026|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43952027|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43952028|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
43952029|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
43952030|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43952031|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43952032|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952033|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952034|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952035|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952036|NCT01188577|Epinephrine|epinephrine|mesh-list
43952037|NCT01188577|Racepinephrine|racepinephrine|mesh-list
43952038|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
43952039|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43952040|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952041|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952042|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952043|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240081|NCT00577200|Sufentanil|sufentanil|mesh-list
44240082|NCT00577200|Propofol|propofol|mesh-list
44240083|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44240084|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459131|NCT01585038|Efavirenz|efavirenz|mesh-list
44240085|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240086|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44240087|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
44240088|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
44240089|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44240090|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240091|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240092|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240093|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
44240094|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
44240095|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240096|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240097|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43952044|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952045|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43952046|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43952047|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
43952048|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952049|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952050|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952051|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
43952052|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
43952053|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43952054|NCT01188694|Methylene Blue|methylene blue|mesh-list
43952055|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952056|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952057|NCT01188876|Folic Acid|folic acid|mesh-list
43952058|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
43952059|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
43952060|NCT01188876|Carboplatin|carboplatin|mesh-list
43952061|NCT01188876|Vitamins|vitamins|mesh-ancestor
43952062|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
44146042|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
43952063|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952064|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952065|NCT01188876|Hematinics|hematinics|mesh-ancestor
43952066|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
43952067|NCT01188928|Betamethasone|betamethasone|mesh-list
43952068|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
43952069|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43952070|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
43952071|NCT01188928|Calcipotriene|calcipotriene|mesh-list
43952072|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43952073|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952118|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43952119|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43952120|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43952121|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952122|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952123|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43952124|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43952125|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952126|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952127|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952128|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43952129|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43952130|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44240098|NCT00577200|Narcotics|narcotics|mesh-ancestor
44240099|NCT00577200|Analgesics|analgesics|mesh-ancestor
44240100|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
44240101|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952131|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952132|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952133|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43952134|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43952135|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952136|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952137|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141827|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44141828|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44141829|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44141830|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141831|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44141832|NCT00184613|Insulin|insulin|mesh-list
44141833|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44141834|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
44141835|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
44141836|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141837|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141838|NCT00184626|Insulin|insulin|mesh-list
44141839|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44141840|NCT00184626|Metformin|metformin|mesh-list
44141841|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
44141842|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
44141843|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
44141844|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141845|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141846|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
44141847|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141848|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141849|NCT00184665|Insulin|insulin|mesh-list
44141850|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44141851|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
44141852|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
44141853|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
44141854|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
44141855|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
43952158|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43952159|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
43952160|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43952161|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43952172|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952174|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
43952175|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43952176|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43952177|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952178|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952179|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952180|NCT01191476|Propofol|propofol|mesh-list
43952181|NCT01191476|Sevoflurane|sevoflurane|mesh-list
43952182|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43952183|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952184|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952185|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43952186|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
43952187|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
43952188|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43952189|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43952190|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
43952191|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43952192|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952193|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43952194|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43952195|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952196|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952197|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952198|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
43952199|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43952200|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240103|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
44240105|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44240106|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
44240107|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
44240108|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240109|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952201|NCT01192139|Metformin|metformin|mesh-list
43952202|NCT01192139|Saxagliptin|saxagliptin|mesh-list
43952203|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43952204|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952205|NCT01192139|Incretins|incretins|mesh-ancestor
43952206|NCT01192139|Hormones|hormones|mesh-ancestor
43952207|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952208|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43952209|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
43952210|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952211|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952212|NCT01193049|Prednisone|prednisone|mesh-list
43952213|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952214|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
43952215|NCT01193049|Hormones|hormones|mesh-ancestor
43952216|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952217|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952218|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952219|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952220|NCT01193868|R04929097|r04929097|mesh-list
43952221|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952222|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952223|NCT01194089|Nicotine|nicotine|mesh-list
43952224|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43952225|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
43952232|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952234|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
43952235|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952237|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
43952238|NCT01194453|Hydroxocobalamin|hydroxocobalamin|mesh-list
43952239|NCT01194453|Gemcitabine|gemcitabine|mesh-list
43952240|NCT01194453|Dexamethasone|dexamethasone|mesh-list
43952241|NCT01194453|Cisplatin|cisplatin|mesh-list
43952242|NCT01194453|Vitamins|vitamins|mesh-ancestor
43952243|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
43952244|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952245|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952246|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
43952247|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
43952248|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952249|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43952250|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
43952251|NCT01194453|Hormones|hormones|mesh-ancestor
43952252|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952253|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952254|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952255|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43952256|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
43952257|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952258|NCT01194453|Antiviral Agents|antiviral agents|mesh-ancestor
43952259|NCT01194453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952260|NCT01194453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952261|NCT01194453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952262|NCT01194453|Immunologic Factors|immunologic factors|mesh-ancestor
43952263|NCT01194453|Hematinics|hematinics|mesh-ancestor
43952264|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
43952265|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
43952266|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43952267|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
43952268|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240110|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
44167171|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
43952269|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952270|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952271|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952272|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43952273|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43952274|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952275|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952276|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952277|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952278|NCT01194674|Plasminogen|plasminogen|mesh-list
43952279|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43952280|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43952281|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952282|NCT01195025|Chrysarobin|chrysarobin|mesh-list
43952283|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43952284|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43952285|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952286|NCT01195025|Analgesics|analgesics|mesh-ancestor
43952287|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
43952288|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157509|NCT00234819|Estrogens|estrogens|mesh-list
43952289|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952290|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952291|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952292|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
43952293|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
43952294|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
43952310|NCT01195467|Efavirenz|efavirenz|mesh-list
43952311|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
43952312|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43952313|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
43952314|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952315|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43952316|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43952317|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952318|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952319|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43952320|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43952321|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43952322|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43952323|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43952324|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43952325|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43952326|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43952327|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43952328|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43952329|NCT01195597|Nicotine|nicotine|mesh-list
43952330|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43952331|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
43952332|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952333|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952334|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43952335|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43997506|NCT02653872|Verapamil|verapamil|mesh-list
43952336|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952337|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952338|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952339|NCT01195779|Vaccines|vaccines|mesh-list
43952340|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
43952341|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952342|NCT01195922|Sirolimus|sirolimus|mesh-list
43952343|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43952344|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952345|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43952346|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952347|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
43952348|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952349|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
43952350|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952351|NCT01196377|Albuterol|albuterol|mesh-list
43817208|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
44240111|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240112|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240113|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240114|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240115|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952363|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952364|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952365|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952367|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43952368|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
43952369|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952370|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
43952371|NCT01197495|Protective Agents|protective agents|mesh-ancestor
43952372|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43952373|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43952374|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43952375|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952377|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952378|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43952379|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
43952380|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952381|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952382|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952383|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952384|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
43952385|NCT01197612|Hormones|hormones|mesh-ancestor
43952386|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952387|NCT01197833|Polidocanol|polidocanol|mesh-list
43952388|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43952389|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43952390|NCT01198158|Bevacizumab|bevacizumab|mesh-list
43952391|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43952392|NCT01198158|Everolimus|everolimus|mesh-list
43952393|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
43952394|NCT01198158|Antibodies|antibodies|mesh-list
43952395|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
43952396|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43952397|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
43952398|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952399|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952400|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952401|NCT01198158|Growth Substances|growth substances|mesh-ancestor
43952402|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952403|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952404|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
43952405|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952406|NCT01198327|Ranibizumab|ranibizumab|mesh-list
43952407|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952408|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952409|NCT01198327|Growth Substances|growth substances|mesh-ancestor
43952410|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952411|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952412|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952413|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
43952414|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952422|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
43952423|NCT01199237|Sevoflurane|sevoflurane|mesh-list
43952424|NCT01199237|Desflurane|desflurane|mesh-list
43952425|NCT01199237|Rocuronium|rocuronium|mesh-list
43952426|NCT01199237|Neostigmine|neostigmine|mesh-list
43952427|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43952428|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43952429|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
43952430|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
43952431|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952432|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952433|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43952434|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43952435|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44240116|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43952436|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952437|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43952438|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952439|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952440|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952441|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952442|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43952443|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
43952444|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43952445|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43952446|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43952448|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
43952449|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952450|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952451|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952452|NCT01199926|Vitamin D|vitamin d|mesh-list
43952453|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
43952454|NCT01199926|Vitamins|vitamins|mesh-ancestor
43952455|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
43952456|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952457|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43952458|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43952459|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
43952460|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43952461|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
43952462|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
43952463|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952464|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952465|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952466|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952467|NCT01199965|Analgesics|analgesics|mesh-ancestor
43952468|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
43952469|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952470|NCT01200160|Niacin|niacin|mesh-list
43952471|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43952472|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
43952473|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952474|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43952475|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
43952476|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
43952477|NCT01200160|Vitamins|vitamins|mesh-ancestor
43952478|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
43952479|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952480|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
43952481|NCT01200433|Propofol|propofol|mesh-list
43952482|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43952500|NCT01201863|Testosterone|testosterone|mesh-list
43952501|NCT01201863|Androgens|androgens|mesh-ancestor
43952502|NCT01201863|Hormones|hormones|mesh-ancestor
43952503|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952504|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952505|NCT01202071|Rabeprazole|rabeprazole|mesh-list
43952506|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43952507|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43952508|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43952509|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952510|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952512|NCT01202162|Desflurane|desflurane|mesh-list
44157722|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
43952513|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43952514|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43952515|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
43952516|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
43952517|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952518|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952519|NCT01202253|Anidulafungin|anidulafungin|mesh-list
43952520|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
43952521|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952522|NCT01202721|Atenolol|atenolol|mesh-list
43952523|NCT01202721|Telmisartan|telmisartan|mesh-list
43952524|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43952525|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43952526|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44240118|NCT00577668|Dexamethasone|dexamethasone|mesh-list
44240119|NCT00577668|Melphalan|melphalan|mesh-list
44240120|NCT00577668|Bortezomib|bortezomib|mesh-list
43952527|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952528|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43952529|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
43952530|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
43952531|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952532|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952533|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43952534|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43952535|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43952536|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952537|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952539|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43952550|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952551|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43952552|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
43952553|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952554|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952555|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43952556|NCT01203319|Vaccines|vaccines|mesh-list
43952557|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
43952558|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952559|NCT01203644|Bupivacaine|bupivacaine|mesh-list
43952560|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952561|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
43952562|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952563|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952564|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
43952565|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952566|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
43952567|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43952568|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952569|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
43952570|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43952571|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952572|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
43952573|NCT01204255|Promethazine|promethazine|mesh-list
43952574|NCT01204255|Lorazepam|lorazepam|mesh-list
43952575|NCT01204255|Haloperidol|haloperidol|mesh-list
43952576|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
43952577|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43952578|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43952579|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952580|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952581|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952582|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
43693239|NCT02775539|Urological Agents|urological agents|mesh-ancestor
43952583|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
43952584|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952585|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
43952586|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
43952587|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43952588|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43952589|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
43952590|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
43952591|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952592|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952593|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43952594|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
43952595|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
43952596|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43952597|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43952598|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43952599|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43952600|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
43952601|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43952602|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
43952603|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43952625|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43952626|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952627|NCT01205828|Temozolomide|temozolomide|mesh-list
43952628|NCT01205828|Veliparib|veliparib|mesh-list
44240121|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240123|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
44240124|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240125|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240126|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240127|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
44240128|NCT00577668|Hormones|hormones|mesh-ancestor
44240129|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240130|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44240131|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240132|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240133|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
44240134|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240135|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44240136|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952629|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43952630|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
43952631|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952632|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952633|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43952634|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141871|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44141872|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44141873|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44141874|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44141875|NCT00184821|Glyburide|glyburide|mesh-list
44141876|NCT00184821|Adenosine|adenosine|mesh-list
44141877|NCT00184821|Diazoxide|diazoxide|mesh-list
44141878|NCT00184821|Annexin A5|annexin a5|mesh-list
44141879|NCT00184821|Analgesics|analgesics|mesh-ancestor
44141880|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
44141881|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141882|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141883|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44141884|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
44141885|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44141886|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
44141887|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
44141888|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141889|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141890|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141891|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44141892|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952641|NCT01206452|Prednisone|prednisone|mesh-list
43952642|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952643|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
43952644|NCT01206452|Hormones|hormones|mesh-ancestor
43952645|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952646|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952647|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952648|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952649|NCT01206465|Fluorouracil|fluorouracil|mesh-list
43952650|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
43952651|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952652|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43952653|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240137|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
44240138|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
44240139|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44167517|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
43952654|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952655|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
43952656|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952657|NCT01206478|Megestrol|megestrol|mesh-list
43952658|NCT01206478|Amitriptyline|amitriptyline|mesh-list
43952659|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43952661|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43952662|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952663|NCT01206478|Analgesics|analgesics|mesh-ancestor
43952664|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
43952665|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952666|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952667|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43952668|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43952669|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43952670|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952671|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952672|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952673|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43952674|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43952675|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43952676|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
43952677|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43952678|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43952679|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43952680|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952681|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952682|NCT01206595|Bupivacaine|bupivacaine|mesh-list
43952683|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952684|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
43952685|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952686|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952687|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
43952688|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952689|NCT01206608|Bupivacaine|bupivacaine|mesh-list
43952690|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952691|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
43952692|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952693|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952694|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
43952695|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952696|NCT01206660|Desoximetasone|desoximetasone|mesh-list
43952697|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952698|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
43952712|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43952713|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952714|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43952715|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
43952716|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43952717|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43952718|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
43952719|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952720|NCT01207908|Mecasermin|mecasermin|mesh-list
43952721|NCT01207908|Growth Substances|growth substances|mesh-ancestor
43952722|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952723|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
43952724|NCT01208922|Rifamycins|rifamycins|mesh-list
43952725|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
43952726|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43952727|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952728|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43952729|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43952730|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952731|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952732|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952733|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43952734|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44240140|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240141|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240142|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240143|NCT00577668|Growth Substances|growth substances|mesh-ancestor
43952735|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952736|NCT01209195|Paclitaxel|paclitaxel|mesh-list
43952737|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43952738|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952739|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
43952740|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
43952741|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
43952742|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952743|NCT01209442|Bevacizumab|bevacizumab|mesh-list
43952744|NCT01209442|Temozolomide|temozolomide|mesh-list
43952745|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43952746|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952747|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952748|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952749|NCT01209442|Growth Substances|growth substances|mesh-ancestor
43952750|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952751|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952752|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43952753|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
43952754|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952755|NCT01210079|Gabapentin|gabapentin|mesh-list
43952756|NCT01210079|Analgesics|analgesics|mesh-ancestor
43952757|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
43845282|NCT04292743|Antidotes|antidotes|mesh-ancestor
43952768|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952769|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
43952770|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
43952771|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952772|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
43952773|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43952774|NCT01210560|Tolvaptan|tolvaptan|mesh-list
43952775|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43952776|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952777|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
43952778|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952779|NCT01211730|Insulin|insulin|mesh-list
43952780|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43952781|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43952782|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952783|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43952784|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
43952785|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
43952786|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952787|NCT01212302|Clopidogrel|clopidogrel|mesh-list
43952788|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952789|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952790|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43952791|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43952792|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43952793|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43952794|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
43952795|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952796|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43952797|NCT01212445|Laxatives|laxatives|mesh-list
43952798|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43952799|NCT01212471|Bromfenac|bromfenac|mesh-list
43952800|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43952801|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43952802|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43952803|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952804|NCT01212471|Analgesics|analgesics|mesh-ancestor
43952805|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
43952806|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952807|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240144|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240145|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44240146|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
44240147|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240148|NCT00577694|Clofarabine|clofarabine|mesh-list
44240149|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
44240150|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43952808|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952809|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952811|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43952812|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43952813|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
43952814|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952815|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952816|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952817|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43952818|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952819|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
43952820|NCT01212874|Esmolol|esmolol|mesh-list
43952837|NCT01212952|Bortezomib|bortezomib|mesh-list
43952838|NCT01212952|Pomalidomide|pomalidomide|mesh-list
43952839|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952840|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
43952841|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
43952842|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952843|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952844|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43952845|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
43952846|NCT01212952|Hormones|hormones|mesh-ancestor
43952847|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952848|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952849|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952850|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
43952851|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952852|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952853|NCT01212952|Growth Substances|growth substances|mesh-ancestor
43952854|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952855|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
43952856|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43952857|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952858|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952859|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43952860|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43952862|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43952863|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952864|NCT01213199|Analgesics|analgesics|mesh-ancestor
43952865|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
43952866|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952867|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952868|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952869|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952870|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
43952871|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
43952872|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43952873|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43952874|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
43952875|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952876|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43952877|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43952878|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952893|NCT01214057|Remifentanil|remifentanil|mesh-list
43952894|NCT01214057|Propofol|propofol|mesh-list
43952895|NCT01214057|Sevoflurane|sevoflurane|mesh-list
43952896|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43952897|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952898|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952899|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43952900|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
43952901|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
43952902|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44240152|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240153|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240154|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240155|NCT00577798|Doxorubicin|doxorubicin|mesh-list
44240156|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44240157|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44167732|NCT00269386|Clarithromycin|clarithromycin|mesh-list
43952903|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43952904|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43952905|NCT01214057|Narcotics|narcotics|mesh-ancestor
43952906|NCT01214057|Analgesics|analgesics|mesh-ancestor
43952907|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
43952908|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952909|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
43952910|NCT01214083|Naltrexone|naltrexone|mesh-list
43952911|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43952912|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43952913|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43952914|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952915|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
43952916|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952917|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
43952918|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952919|NCT01214083|Expectorants|expectorants|mesh-ancestor
43952920|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952921|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43952922|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
43952923|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952924|NCT01214083|Protective Agents|protective agents|mesh-ancestor
43952925|NCT01214083|Antidotes|antidotes|mesh-ancestor
43952926|NCT01214109|Pramipexole|pramipexole|mesh-list
43952927|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
43952928|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952929|NCT01214109|Protective Agents|protective agents|mesh-ancestor
43952930|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952931|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43952932|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43952933|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
43952934|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
43997935|NCT02679911|Ciclopirox|ciclopirox|mesh-list
43952935|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952936|NCT01214161|Lidocaine|lidocaine|mesh-list
43952937|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952938|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
43952939|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952940|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952941|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
43952942|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817677|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
43952977|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43952978|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43952979|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43817744|NCT05552729|Vitamin D|vitamin d|mesh-list
43952989|NCT01215123|Growth Substances|growth substances|mesh-ancestor
43952990|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952991|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952992|NCT01215292|Ketoconazole|ketoconazole|mesh-list
43952993|NCT01215292|Anastrozole|anastrozole|mesh-list
43952994|NCT01215292|Testosterone|testosterone|mesh-list
43952995|NCT01215292|Dutasteride|dutasteride|mesh-list
43952997|NCT01215292|Androgens|androgens|mesh-ancestor
43952998|NCT01215292|Hormones|hormones|mesh-ancestor
43952999|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953000|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953001|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43953002|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953003|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43953004|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43953005|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240158|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893222|NCT03546894|Ceritinib|ceritinib|mesh-list
44240159|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44240160|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43953006|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953007|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43953008|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
43953009|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
43953010|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953011|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43953012|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43953013|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43953014|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43953015|NCT01215318|Silicon|silicon|mesh-list
43953016|NCT01215318|Trace Elements|trace elements|mesh-ancestor
43953017|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
43953018|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953019|NCT01215344|Diphosphonates|diphosphonates|mesh-list
43953020|NCT01215344|Dexamethasone|dexamethasone|mesh-list
43953021|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
43953022|NCT01215344|Doxorubicin|doxorubicin|mesh-list
43953023|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43953024|NCT01215344|Lenalidomide|lenalidomide|mesh-list
43953025|NCT01215344|Bortezomib|bortezomib|mesh-list
43953026|NCT01215344|BB 1101|bb 1101|mesh-list
43953027|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953028|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
43953029|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
43953030|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953031|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953032|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953033|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
43953034|NCT01215344|Hormones|hormones|mesh-ancestor
43953035|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953036|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43953037|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953038|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953039|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953040|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953041|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43953042|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43953043|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43953044|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
43953045|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43953046|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43998007|NCT02683707|Narcotics|narcotics|mesh-ancestor
43953075|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953077|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953078|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953079|NCT01216397|Metformin|metformin|mesh-list
43953080|NCT01216397|Linagliptin|linagliptin|mesh-list
43953081|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43953082|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953083|NCT01216397|Incretins|incretins|mesh-ancestor
43953084|NCT01216397|Hormones|hormones|mesh-ancestor
43953085|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953086|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43953087|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953088|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953089|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953090|NCT01216410|Phenylephrine|phenylephrine|mesh-list
43953101|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43953102|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
43953103|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953104|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953105|NCT01216410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43953106|NCT01216410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43953107|NCT01216410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43953108|NCT01216410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43953109|NCT01216410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43953110|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43953111|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
43953112|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
44240161|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240162|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240163|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
44240164|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
44240165|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240166|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240167|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240168|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240169|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240170|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44240171|NCT00577850|Alendronate|alendronate|mesh-list
43953113|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43953114|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
43953115|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
43953116|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43953117|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43953118|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43953119|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953120|NCT01216410|Protective Agents|protective agents|mesh-ancestor
43953121|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43953122|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43953123|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
43953124|NCT01216735|Fluticasone|fluticasone|mesh-list
43953125|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953126|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43953127|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
43953128|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953129|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953130|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43953131|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
43953132|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953133|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43953135|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
43953136|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43953137|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
43953138|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
43953139|NCT01216761|Povidone|povidone|mesh-list
43953140|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43953141|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998086|NCT02689063|Ibuprofen|ibuprofen|mesh-list
43953142|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
43953143|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953144|NCT01216761|Trace Elements|trace elements|mesh-ancestor
43953145|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
43953146|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953147|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
43953148|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
43953149|NCT01216943|Timolol|timolol|mesh-list
43953150|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43953151|NCT01216943|Bimatoprost|bimatoprost|mesh-list
43953152|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43953153|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43953154|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43953155|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43953156|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953157|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953158|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953159|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817853|NCT05551247|Endostatins|endostatins|mesh-list
43953186|NCT01218048|Carboplatin|carboplatin|mesh-list
43953187|NCT01218048|Cetuximab|cetuximab|mesh-list
43953188|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953189|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953190|NCT01218399|Budesonide|budesonide|mesh-list
43953191|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44240172|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
44240173|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44240174|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240175|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240176|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240177|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167926|NCT00269841|Infliximab|infliximab|mesh-list
43953192|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953193|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43953194|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
43953195|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953196|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953197|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43953198|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
43953199|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
43953200|NCT01218399|Hormones|hormones|mesh-ancestor
43953201|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953202|NCT01218958|Naltrexone|naltrexone|mesh-list
43953203|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43953204|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43953205|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953206|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
43953207|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953208|NCT01218971|Naltrexone|naltrexone|mesh-list
43817921|NCT05550402|Bromides|bromides|mesh-list
43953221|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953223|NCT01218984|Narcotics|narcotics|mesh-ancestor
43953224|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43953225|NCT01218984|Analgesics|analgesics|mesh-ancestor
43953226|NCT01218997|Naltrexone|naltrexone|mesh-list
43953227|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43953228|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43953229|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953230|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
43953231|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953232|NCT01219738|Budesonide|budesonide|mesh-list
43953233|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953234|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43953235|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
43953236|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953237|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953238|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43953239|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43953240|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
43953241|NCT01219738|Hormones|hormones|mesh-ancestor
43953242|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953243|NCT01219777|Paclitaxel|paclitaxel|mesh-list
43953244|NCT01219777|Bevacizumab|bevacizumab|mesh-list
43953245|NCT01219777|Carboplatin|carboplatin|mesh-list
43953246|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43953247|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953248|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
43953249|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
43953250|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
43953251|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953252|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953253|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43953254|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43953255|NCT01219777|Growth Substances|growth substances|mesh-ancestor
43953256|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953257|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
43953258|NCT01219881|Sevoflurane|sevoflurane|mesh-list
43953259|NCT01219881|Desflurane|desflurane|mesh-list
43953260|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43953261|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43953262|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
43953263|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
43953264|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240178|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44167996|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
43953265|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953266|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
43953267|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43953268|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
43953269|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953270|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953271|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43953272|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141900|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141901|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44141902|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44141903|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
44141904|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141905|NCT00184847|Analgesics|analgesics|mesh-ancestor
44141906|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
44141907|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141908|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44141909|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
44141910|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44141911|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
44141912|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44141913|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
44141914|NCT00184886|Methotrexate|methotrexate|mesh-list
44141915|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44141916|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
44141917|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44141918|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141919|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141920|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
44141921|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141922|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141923|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
44141924|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141925|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43953281|NCT01220973|Celecoxib|celecoxib|mesh-list
43953282|NCT01220973|Atorvastatin|atorvastatin|mesh-list
43953283|NCT01220973|Calcium|calcium|mesh-list
43953284|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953285|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953286|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43953287|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43953288|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
43953289|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953290|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43953291|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43953292|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953293|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43953294|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43953295|NCT01220973|Analgesics|analgesics|mesh-ancestor
43953296|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
43953297|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953298|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953299|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953300|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43953301|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43953313|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953315|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43953316|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
43953317|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953318|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43953319|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43953320|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
43953321|NCT01222091|Propranolol|propranolol|mesh-list
43953322|NCT01222091|Remifentanil|remifentanil|mesh-list
43953323|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43953324|NCT01222091|Narcotics|narcotics|mesh-ancestor
43953325|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459133|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44459134|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43953326|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953327|NCT01222091|Analgesics|analgesics|mesh-ancestor
43953328|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
43953329|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953330|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43953331|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43953332|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953333|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953334|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953335|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953336|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953337|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
43953338|NCT01222117|Plasminogen|plasminogen|mesh-list
43953339|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43953340|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
43953341|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43953342|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43953343|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953344|NCT01222195|Lenalidomide|lenalidomide|mesh-list
43953345|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
43953346|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
43953347|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953348|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43953349|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43953350|NCT01222195|Growth Substances|growth substances|mesh-ancestor
43953351|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
43953352|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953353|NCT01222195|Hematinics|hematinics|mesh-ancestor
43953354|NCT01222234|Vitamin D|vitamin d|mesh-list
43953355|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
43953356|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
43953357|NCT01222234|Calcitriol|calcitriol|mesh-list
43953358|NCT01222234|Vitamins|vitamins|mesh-list
43953359|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
43953360|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953361|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953362|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953363|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43953364|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953365|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953375|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
43953376|NCT01222260|Hormones|hormones|mesh-ancestor
43953377|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953378|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43953379|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953380|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43953381|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
43953382|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953383|NCT01222273|Vitamin D|vitamin d|mesh-list
43953384|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
43953385|NCT01222273|Vitamins|vitamins|mesh-ancestor
43953386|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
43953387|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953388|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953389|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953390|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
43953391|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43953392|NCT01222572|Cisplatin|cisplatin|mesh-list
43953393|NCT01222572|Etoposide|etoposide|mesh-list
43953394|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953395|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43953396|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43953397|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43953398|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953399|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953400|NCT01222585|Metronidazole|metronidazole|mesh-list
43953401|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953402|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953403|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43953404|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843472|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459135|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459136|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459138|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459139|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44459140|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459141|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44459142|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44459143|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44459144|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44459145|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43953405|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43953406|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953407|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43953408|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953409|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953410|NCT01222832|Bacitracin|bacitracin|mesh-list
43953411|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43953412|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953413|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953414|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43953415|NCT01222884|Hematinics|hematinics|mesh-ancestor
43953416|NCT01223352|Bosentan|bosentan|mesh-list
43953417|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953418|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43953419|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953420|NCT01223378|Latanoprost|latanoprost|mesh-list
43953421|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43953422|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43953423|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43953424|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43953425|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43953426|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953427|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953428|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43953429|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953430|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953431|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43953465|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43953466|NCT01225068|Analgesics|analgesics|mesh-ancestor
43953467|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
43953468|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953469|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
43953470|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43953471|NCT01225263|Vitamin D|vitamin d|mesh-list
43953472|NCT01225263|Simvastatin|simvastatin|mesh-list
43953473|NCT01225263|Vitamins|vitamins|mesh-ancestor
43953488|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953490|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953491|NCT01225289|Protective Agents|protective agents|mesh-ancestor
43953492|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43953493|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953494|NCT01225354|Calcium|calcium|mesh-list
43953495|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953496|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953497|NCT01226420|Alefacept|alefacept|mesh-list
43953498|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953499|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
43953500|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953501|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
43953502|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43953503|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44459146|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44459147|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44459149|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459150|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
44168219|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
43953504|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43953505|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953506|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953507|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
43953508|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953509|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953510|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43953511|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953512|NCT01226719|Leucovorin|leucovorin|mesh-list
43953513|NCT01226719|Fluorouracil|fluorouracil|mesh-list
43953514|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
43953515|NCT01226719|Irinotecan|irinotecan|mesh-list
43953516|NCT01226719|Panitumumab|panitumumab|mesh-list
43953517|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
43953518|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953519|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43953520|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953521|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953522|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
43953523|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953524|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43953525|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43953526|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953527|NCT01226719|Antidotes|antidotes|mesh-ancestor
43953528|NCT01226719|Protective Agents|protective agents|mesh-ancestor
43953529|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
43953530|NCT01226719|Vitamins|vitamins|mesh-ancestor
43953531|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
43953532|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953533|NCT01227434|Palbociclib|palbociclib|mesh-list
43953534|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953565|NCT01228149|Acetazolamide|acetazolamide|mesh-list
43953566|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
43953567|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43953568|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953569|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953570|NCT01228149|Diuretics|diuretics|mesh-ancestor
43953571|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
43953572|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953573|NCT01228903|Allopurinol|allopurinol|mesh-list
43953574|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
43953575|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845426|NCT04279054|Morphine|morphine|mesh-list
43953611|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43953612|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43953613|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953614|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953615|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818220|NCT05547516|Epirubicin|epirubicin|mesh-list
43953627|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953628|NCT01229527|Analgesics|analgesics|mesh-ancestor
43953629|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
43953630|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953631|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43953632|NCT01229891|Vitamin D|vitamin d|mesh-list
43953633|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
43953634|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
43953635|NCT01229891|Vitamins|vitamins|mesh-list
43953636|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
43953637|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953638|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953639|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953640|NCT01230177|Etanercept|etanercept|mesh-list
43953641|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43953642|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459151|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44459153|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44459154|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459155|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953643|NCT01230177|Analgesics|analgesics|mesh-ancestor
43953644|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
43953645|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953646|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953647|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953648|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953649|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953650|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953651|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
43953652|NCT01230424|Triamcinolone|triamcinolone|mesh-list
43953653|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43953654|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43953655|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43953656|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953657|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
43953658|NCT01230424|Hormones|hormones|mesh-ancestor
43953659|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953660|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953661|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953662|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
43953663|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953664|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953665|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
43953666|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43953667|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953668|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43953669|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
43953670|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953671|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953672|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953673|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953674|NCT01230593|Tobramycin|tobramycin|mesh-list
43953675|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43953676|NCT01230593|Dexamethasone|dexamethasone|mesh-list
43953677|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
43953678|NCT01230593|BB 1101|bb 1101|mesh-list
43953679|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953680|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
43953692|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953693|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953694|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953695|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43953696|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43953697|NCT01231230|Fluticasone|fluticasone|mesh-list
43953698|NCT01231230|Xhance|xhance|mesh-list
43953699|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43953700|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43953701|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953702|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43953703|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
43953704|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953705|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953706|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43953707|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
43953708|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953709|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43953710|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43953711|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43953712|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43953713|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953714|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953715|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953716|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
43953717|NCT01231230|Hormones|hormones|mesh-ancestor
44459156|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459157|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459158|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459159|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44459160|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459161|NCT01584648|Trametinib|trametinib|mesh-list
44459162|NCT01584648|Dabrafenib|dabrafenib|mesh-list
44459163|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459164|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459165|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953718|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953719|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
43953720|NCT01231334|Clindamycin|clindamycin|mesh-list
43953721|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
43953722|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
43953723|NCT01231334|Dapsone|dapsone|mesh-list
43953724|NCT01231334|Adapalene|adapalene|mesh-list
43953725|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43953726|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953727|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953728|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43953729|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953730|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953731|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953732|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43953733|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43953734|NCT01231334|Analgesics|analgesics|mesh-ancestor
43953735|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
43953736|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953737|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953738|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953739|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953740|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
43953741|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43953742|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43953743|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43953744|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
43953745|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
43953747|NCT01231399|Fluorouracil|fluorouracil|mesh-list
43953782|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953783|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953784|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43953785|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43953786|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43953787|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
43953788|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953789|NCT01231633|Dexamethasone|dexamethasone|mesh-list
43953790|NCT01231633|Bevacizumab|bevacizumab|mesh-list
43953791|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953792|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953793|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43953814|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953815|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
43953816|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953817|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
43953818|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953819|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953820|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953821|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43953822|NCT01232205|Micronutrients|micronutrients|mesh-list
43953823|NCT01232205|Trace Elements|trace elements|mesh-list
43953824|NCT01232205|Antioxidants|antioxidants|mesh-list
43953825|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953826|NCT01232205|Protective Agents|protective agents|mesh-ancestor
43953827|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953828|NCT01232504|Molgramostim|molgramostim|mesh-list
43953829|NCT01232504|Lenograstim|lenograstim|mesh-list
43953830|NCT01232504|Sargramostim|sargramostim|mesh-list
44459166|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459167|NCT01584440|Quinidine|quinidine|mesh-list
44459168|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
44459169|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
44459170|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459171|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44459172|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44459173|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459174|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459175|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459176|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44459177|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44459178|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459179|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44459180|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
44459181|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44459182|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44459183|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459184|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240179|NCT00577967|Gabapentin|gabapentin|mesh-list
44240180|NCT00577967|Analgesics|analgesics|mesh-ancestor
44240181|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
43953831|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43953832|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
43953833|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953834|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953835|NCT01232829|R04929097|r04929097|mesh-list
43953836|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953837|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953838|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
43953839|NCT01232920|Methotrexate|methotrexate|mesh-list
43953840|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43953841|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
43953842|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43953843|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953844|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43953845|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
43953846|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953847|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953848|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953849|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141927|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
43953884|NCT01234870|Adenosine|adenosine|mesh-list
43953885|NCT01234870|Analgesics|analgesics|mesh-ancestor
43953886|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
43845494|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953908|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43953910|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953912|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
43953913|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43953914|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43953915|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43953916|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240182|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240183|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240184|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
43953917|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953918|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953919|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
43953920|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953922|NCT01235897|Trastuzumab|trastuzumab|mesh-list
43953923|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43953924|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953925|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
43953926|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
43953927|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
43953928|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953929|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953930|NCT01235910|Cyclosporine|cyclosporine|mesh-list
43953931|NCT01235910|Cyclosporins|cyclosporins|mesh-list
43953932|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953933|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953934|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953935|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
43953936|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953937|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
43953938|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953967|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953968|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
43953969|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953970|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
43953971|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
43953972|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
43953973|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43953974|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953975|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43953976|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43953978|NCT01237041|Niacinamide|niacinamide|mesh-list
43953979|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
43953980|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43953981|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
43953982|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953983|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43818447|NCT05545059|Diuretics|diuretics|mesh-ancestor
43954015|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43954016|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
43954017|NCT01238536|Dexamethasone|dexamethasone|mesh-list
43954018|NCT01238536|Betamethasone|betamethasone|mesh-list
43954019|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43954020|NCT01238536|Lidocaine|lidocaine|mesh-list
43954021|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
43954022|NCT01238536|Anesthetics|anesthetics|mesh-list
43954023|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954024|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
43954025|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
43954026|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954027|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954028|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954029|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
43954066|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43954081|NCT01242644|Ketorolac|ketorolac|mesh-list
43954082|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43954083|NCT01242644|Morphine|morphine|mesh-list
43954084|NCT01242644|Ropivacaine|ropivacaine|mesh-list
43954085|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43954086|NCT01242644|Narcotics|narcotics|mesh-ancestor
43954087|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954088|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954089|NCT01242644|Analgesics|analgesics|mesh-ancestor
43954090|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
43954091|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954092|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
43954093|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
43954094|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43954095|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954096|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240185|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240186|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240187|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240188|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240189|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44240190|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43954097|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43954098|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43954099|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954100|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954101|NCT01243112|Lidocaine|lidocaine|mesh-list
43954102|NCT01243112|Epinephrine|epinephrine|mesh-list
43954103|NCT01243112|Racepinephrine|racepinephrine|mesh-list
43954104|NCT01243112|Bupivacaine|bupivacaine|mesh-list
43954105|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
43954106|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
43954107|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
43954108|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954109|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954110|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
43954111|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954112|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954113|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43954114|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43954115|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954116|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954117|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43954118|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43954119|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
43954120|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954121|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43954122|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43954123|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
43954124|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43954125|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954126|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
43954127|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
43954128|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43845543|NCT04271332|Baclofen|baclofen|mesh-list
43954143|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
43954144|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954145|NCT01243567|Timolol|timolol|mesh-list
43954146|NCT01243567|Bimatoprost|bimatoprost|mesh-list
43954147|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43954148|NCT01243567|Latanoprost|latanoprost|mesh-list
43954149|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43954150|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43954151|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43954152|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
43954153|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954154|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954155|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954156|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954157|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43954158|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
43954159|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
43954160|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43954161|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
43954162|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954163|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954164|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43954165|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43954166|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954167|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43954168|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43954169|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954170|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954171|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843473|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
44240191|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240192|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240193|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
44240194|NCT00577980|Testosterone|testosterone|mesh-list
44240195|NCT00577980|Androgens|androgens|mesh-ancestor
44240196|NCT00577980|Hormones|hormones|mesh-ancestor
44240197|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240198|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240199|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
43954172|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43954173|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43954174|NCT01243593|Anesthetics|anesthetics|mesh-list
43954175|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954176|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954177|NCT01243957|Fluoxetine|fluoxetine|mesh-list
43954178|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43954179|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954180|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954181|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954182|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954183|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
43954184|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954185|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43954186|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954187|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954188|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43954222|NCT01244724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43954224|NCT01244724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954225|NCT01245595|Aminophylline|aminophylline|mesh-list
43818611|NCT05542589|Phenytoin|phenytoin|mesh-list
43954256|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
43954257|NCT01246063|Hormones|hormones|mesh-ancestor
43954258|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954259|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954260|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954261|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43954262|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43954263|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43954264|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954265|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954266|NCT01246076|Lenalidomide|lenalidomide|mesh-list
43954267|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
43954268|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954269|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43954298|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43954299|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43954300|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43954301|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43954302|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43954303|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43954304|NCT01247220|Ranibizumab|ranibizumab|mesh-list
43954305|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43954306|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43954307|NCT01247220|Growth Substances|growth substances|mesh-ancestor
43954308|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954309|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
43954310|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954311|NCT01247272|Fluoxetine|fluoxetine|mesh-list
43954312|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43954313|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954314|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954315|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954316|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240200|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44240201|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44240202|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43954317|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
43954318|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954350|NCT01248416|Anastrozole|anastrozole|mesh-list
43954351|NCT01248416|Hormones|hormones|mesh-list
43954352|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43954353|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954354|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954355|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954356|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43954357|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818679|NCT05541419|Budesonide|budesonide|mesh-list
43954376|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43954377|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
43954378|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954379|NCT01249872|Morphine|morphine|mesh-list
43954380|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
43954381|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43954382|NCT01249872|Narcotics|narcotics|mesh-ancestor
43954383|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954384|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954385|NCT01249872|Analgesics|analgesics|mesh-ancestor
43954386|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
43954387|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954388|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
43954389|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
43954390|NCT01250184|Lidocaine|lidocaine|mesh-list
43954391|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
43954392|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
43954393|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954394|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954395|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
43954396|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954397|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954398|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43954399|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43954400|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954401|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954402|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
43954403|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43954404|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43954405|NCT01250210|Estradiol|estradiol|mesh-list
43954406|NCT01250210|Estrogens|estrogens|mesh-ancestor
43954407|NCT01250210|Hormones|hormones|mesh-ancestor
43954408|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954409|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954410|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43954411|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
43954412|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954413|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44141961|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141962|NCT00184938|Analgesics|analgesics|mesh-ancestor
44141974|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44141976|NCT00184977|Fluticasone|fluticasone|mesh-list
44141977|NCT00184977|Xhance|xhance|mesh-list
44141978|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
44141979|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44141980|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44141981|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44141982|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
44141983|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141984|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141985|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44141986|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141987|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
44141988|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44141989|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
44141990|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141991|NCT00184977|Expectorants|expectorants|mesh-ancestor
44141992|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44141993|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
44240203|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240204|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240205|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
44240206|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954418|NCT01250717|Dexamethasone|dexamethasone|mesh-list
43954419|NCT01250717|Goserelin|goserelin|mesh-list
43954420|NCT01250717|Estramustine|estramustine|mesh-list
43954421|NCT01250717|Docetaxel|docetaxel|mesh-list
43954422|NCT01250717|Bicalutamide|bicalutamide|mesh-list
43954423|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954424|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
43954425|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
43954426|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954427|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954428|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954429|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
43954430|NCT01250717|Hormones|hormones|mesh-ancestor
43954431|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954432|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954433|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954434|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
43954435|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
43954436|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732759|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
43954437|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954438|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
43954439|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
43954440|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43954442|NCT01250730|Crizotinib|crizotinib|mesh-list
43954443|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954444|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43954445|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954446|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954447|NCT01250834|Dulaglutide|dulaglutide|mesh-list
43954448|NCT01250834|Atorvastatin|atorvastatin|mesh-list
43954449|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43954450|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43954451|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
43954482|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43954483|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
43954484|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954485|NCT01251315|Expectorants|expectorants|mesh-ancestor
43954486|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954487|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43954488|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
43954489|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694783|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
43954490|NCT01251315|Protective Agents|protective agents|mesh-ancestor
43954491|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954492|NCT01251315|Antidotes|antidotes|mesh-ancestor
43954493|NCT01251393|Biperiden|biperiden|mesh-list
43954494|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43954495|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43954496|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
43954528|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43954529|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
43954530|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43954531|NCT01251978|Ranibizumab|ranibizumab|mesh-list
43954532|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43954533|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43954534|NCT01251978|Growth Substances|growth substances|mesh-ancestor
43954535|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954536|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
43954537|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954539|NCT01252732|Oritavancin|oritavancin|mesh-list
43954540|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818854|NCT05539053|Antidotes|antidotes|mesh-ancestor
43954554|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
43954555|NCT01253460|Rituximab|rituximab|mesh-list
43954556|NCT01253460|Sapacitabine|sapacitabine|mesh-list
43954557|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43954558|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
43954559|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954560|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843517|NCT04447352|Docetaxel|docetaxel|mesh-list
44240207|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240208|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44240209|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240210|NCT00578149|Paclitaxel|paclitaxel|mesh-list
43954561|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43954562|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
43954563|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954564|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954565|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43954566|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43954567|NCT01253525|Paclitaxel|paclitaxel|mesh-list
43954568|NCT01253525|Ramucirumab|ramucirumab|mesh-list
43954569|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43954570|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954571|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
43954572|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
43954573|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
43954574|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954575|NCT01253642|Docetaxel|docetaxel|mesh-list
43954576|NCT01253642|Phenelzine|phenelzine|mesh-list
43954577|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954578|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
43954579|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
43954580|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
43954581|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954582|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954583|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954584|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43954585|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954586|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43954587|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43954588|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43954589|NCT01253824|Norethindrone|norethindrone|mesh-list
43954590|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
43954591|NCT01253824|Norinyl|norinyl|mesh-list
43954592|NCT01253824|Mestranol|mestranol|mesh-list
43954593|NCT01253824|Estradiol|estradiol|mesh-list
43954594|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43954595|NCT01253824|Estrogens|estrogens|mesh-ancestor
43954596|NCT01253824|Hormones|hormones|mesh-ancestor
43954597|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954598|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954599|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43954600|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
43954601|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954602|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43954603|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43954618|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43954619|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43954620|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954621|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954622|NCT01254396|Urological Agents|urological agents|mesh-ancestor
43954623|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43954624|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
43954625|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
43954626|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954627|NCT01254877|Ondansetron|ondansetron|mesh-list
43954628|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
43954629|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
43954630|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954631|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954632|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954633|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
43954634|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954635|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43954636|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
43954637|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954638|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954639|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43954640|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43807511|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44240211|NCT00578149|Bevacizumab|bevacizumab|mesh-list
44240212|NCT00578149|Carboplatin|carboplatin|mesh-list
44240213|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44240214|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240215|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44240216|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44240217|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44240218|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240219|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240220|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240221|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240222|NCT00578149|Growth Substances|growth substances|mesh-ancestor
44240223|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240224|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240225|NCT00578201|Cetuximab|cetuximab|mesh-list
44240226|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240227|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954641|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954642|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954643|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43954644|NCT01255137|Axitinib|axitinib|mesh-list
43954645|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954646|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43954647|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954648|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954649|NCT01255449|Albuterol|albuterol|mesh-list
43954650|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43954651|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
43954652|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954653|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954654|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43954655|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954656|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
43954657|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954658|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43954659|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43954660|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43954661|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
43954662|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954663|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954664|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43954704|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43954717|NCT01258855|Aldesleukin|aldesleukin|mesh-list
43954718|NCT01258855|Aflibercept|aflibercept|mesh-list
43954719|NCT01258855|Interleukin-2|interleukin-2|mesh-list
43954720|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
43954721|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43954722|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43954723|NCT01258855|Growth Substances|growth substances|mesh-ancestor
43954724|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954725|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
43954726|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954727|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954728|NCT01258855|Analgesics|analgesics|mesh-ancestor
43954729|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
43954730|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954731|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43954732|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44240228|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
44240229|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
44240230|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43954733|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
43954734|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954735|NCT01259063|Gemcitabine|gemcitabine|mesh-list
43954736|NCT01259063|Everolimus|everolimus|mesh-list
43954737|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43954738|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
43954739|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954740|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954741|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
43954742|NCT01259063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954743|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954744|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43954745|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
43954746|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954747|NCT01260454|Capsaicin|capsaicin|mesh-list
43954748|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
43954749|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954750|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
43954751|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954752|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954753|NCT01260649|Ketamine|ketamine|mesh-list
43954754|NCT01260649|Anesthetics|anesthetics|mesh-list
43954755|NCT01260649|Analgesics|analgesics|mesh-ancestor
43954756|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
43954757|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954758|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954759|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43954760|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43954761|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
43954762|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954763|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43954764|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43954765|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954766|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954767|NCT01260662|Ketamine|ketamine|mesh-list
43954768|NCT01260662|Propofol|propofol|mesh-list
43954793|NCT01260883|Analgesics|analgesics|mesh-ancestor
43954794|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
43954795|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954796|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694975|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
43954797|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954798|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43954799|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43954800|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954801|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954802|NCT01262118|Tofacitinib|tofacitinib|mesh-list
43954803|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43954804|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954805|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954806|NCT01263132|Thiamine|thiamine|mesh-list
43954807|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
43954808|NCT01263132|Gabapentin|gabapentin|mesh-list
43954809|NCT01263132|Analgesics|analgesics|mesh-ancestor
43954810|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
43954811|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954812|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954813|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
43954814|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43954815|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43954816|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954817|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954844|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43954845|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954846|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954847|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43954848|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
43954849|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954850|NCT01265446|Lidocaine|lidocaine|mesh-list
43954851|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
43954852|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
44240231|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
44240232|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240233|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240234|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240235|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
44240236|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240237|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240238|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44240239|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240240|NCT00578370|Cyclosporine|cyclosporine|mesh-list
44240241|NCT00578370|Betamethasone|betamethasone|mesh-list
44240242|NCT00578370|Calcipotriene|calcipotriene|mesh-list
44240243|NCT00578370|Cyclosporins|cyclosporins|mesh-list
43954853|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954854|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954855|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
43954856|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954857|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954858|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43954859|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43954860|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954861|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954862|NCT01266447|Topotecan|topotecan|mesh-list
43954863|NCT01266447|Veliparib|veliparib|mesh-list
43954864|NCT01266447|Lenograstim|lenograstim|mesh-list
44141994|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141996|NCT00184977|Antidotes|antidotes|mesh-ancestor
44141997|NCT00184990|Pimagedine|pimagedine|mesh-list
44141998|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141999|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142000|NCT00185003|Tolbutamide|tolbutamide|mesh-list
44142001|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
43999155|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44142002|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142004|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142005|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142006|NCT00185055|Valsartan|valsartan|mesh-list
44142007|NCT00185055|Olmesartan|olmesartan|mesh-list
44142008|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142009|NCT00185055|Irbesartan|irbesartan|mesh-list
44142010|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142011|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142012|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142013|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142014|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44142015|NCT00185068|Olmesartan|olmesartan|mesh-list
44142016|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142017|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142018|NCT00185068|Diuretics|diuretics|mesh-ancestor
44142019|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
44142020|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142021|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43819102|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
44142031|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142032|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142033|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142034|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142035|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
44142036|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
44142037|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142038|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807993|NCT04889781|Hormones|hormones|mesh-ancestor
44240244|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142039|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44142040|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44142041|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44142042|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44142043|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142044|NCT00185107|Simvastatin|simvastatin|mesh-list
44142045|NCT00185107|Ezetimibe|ezetimibe|mesh-list
44142046|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44142047|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44142048|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44142049|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
44142050|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142051|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44142052|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44142053|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695050|NCT02764359|Vancomycin|vancomycin|mesh-list
43954888|NCT01267240|Capecitabine|capecitabine|mesh-list
43954889|NCT01267240|Vorinostat|vorinostat|mesh-list
43954890|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43954891|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
43954892|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954893|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954894|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43954895|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954896|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
43954897|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43954898|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954899|NCT01267292|Buspirone|buspirone|mesh-list
43954900|NCT01267292|Methylphenidate|methylphenidate|mesh-list
43954901|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43954902|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954903|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43954904|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954905|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954906|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954907|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
43999172|NCT05439564|Morphine|morphine|mesh-list
43954908|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954909|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43954910|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43954911|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954912|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954913|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43954914|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
43954915|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43954916|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
43954917|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43954919|NCT01267864|Valproic Acid|valproic acid|mesh-list
43954920|NCT01267864|Metoclopramide|metoclopramide|mesh-list
43954953|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954954|NCT01268553|Treprostinil|treprostinil|mesh-list
43954955|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43954956|NCT01268943|Capecitabine|capecitabine|mesh-list
43954957|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43954958|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
43954959|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954960|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954962|NCT01269047|Pramlintide|pramlintide|mesh-list
43954963|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44142054|NCT00185120|Amlodipine|amlodipine|mesh-list
43954998|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954999|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43955010|NCT01270659|Analgesics|analgesics|mesh-ancestor
43955011|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
43955012|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955013|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43955014|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43955015|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
43955016|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
43955017|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955018|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
43955019|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955020|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955021|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955022|NCT01271244|Citalopram|citalopram|mesh-list
44240245|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240246|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240247|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
44240248|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240249|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
44240250|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240251|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
44240252|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43893365|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
44240253|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44240254|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240255|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
44240256|NCT00578370|Hormones|hormones|mesh-ancestor
44240257|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240258|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43955023|NCT01271244|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43955024|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43955025|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955026|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955027|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955028|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
43955029|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955030|NCT01271244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43955031|NCT01271244|Antidepressive Agents|antidepressive agents|mesh-ancestor
43955032|NCT01271244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43955033|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
43955034|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43955035|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43955036|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43955037|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955038|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955039|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955040|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955041|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955042|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43955043|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955044|NCT01271686|Bimatoprost|bimatoprost|mesh-list
43955045|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43955046|NCT01271855|Glycerol|glycerol|mesh-list
43955047|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955048|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43955049|NCT01271855|Protective Agents|protective agents|mesh-ancestor
43955050|NCT01271907|Aldesleukin|aldesleukin|mesh-list
43955051|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
43955052|NCT01271907|Fludarabine|fludarabine|mesh-list
43955053|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955054|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
43955055|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955056|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955057|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43955058|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
43955059|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955060|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955061|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43955062|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43955063|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43955064|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
43955086|NCT01272388|Urological Agents|urological agents|mesh-ancestor
43955087|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44240259|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240260|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
44240261|NCT00578435|Busulfan|busulfan|mesh-list
44240262|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240263|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
44240264|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240265|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240266|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240267|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
43955088|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955089|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955091|NCT01272583|Hormones|hormones|mesh-ancestor
43955092|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955093|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43955094|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
43955095|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955096|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955097|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
43955098|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43955099|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
43955100|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955101|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955102|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43955103|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43955104|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43955105|NCT01273207|Cyclosporine|cyclosporine|mesh-list
43955106|NCT01273207|Cyclosporins|cyclosporins|mesh-list
43955107|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955108|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955109|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955110|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
43955111|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955112|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
43955113|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955114|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
43955115|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819220|NCT05592197|Lenvatinib|lenvatinib|mesh-list
43955129|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955130|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955131|NCT01275300|Analgesics|analgesics|mesh-ancestor
43955132|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
43955133|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955134|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955135|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955136|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955137|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43955138|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43955139|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955140|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43955141|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43955142|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955143|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
43955144|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43955145|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
43955146|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43955147|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
43955148|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
43955149|NCT01275300|Vitamins|vitamins|mesh-ancestor
43955150|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
43955151|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
43955152|NCT01275365|Testosterone|testosterone|mesh-list
43955153|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
43955154|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
43955155|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43955156|NCT01275365|Androgens|androgens|mesh-ancestor
43955157|NCT01275365|Hormones|hormones|mesh-ancestor
43955158|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240269|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240270|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44240271|NCT00578526|Sunitinib|sunitinib|mesh-list
44240272|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240273|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240274|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240275|NCT00578526|Growth Substances|growth substances|mesh-ancestor
44240276|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240277|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240278|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44240279|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240280|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240281|NCT00578591|Rituximab|rituximab|mesh-list
44240282|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240283|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240284|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
44240285|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955159|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955160|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955161|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955162|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
43955163|NCT01275664|Dexamethasone|dexamethasone|mesh-list
43955164|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
43955165|NCT01275664|Cisplatin|cisplatin|mesh-list
43955166|NCT01275664|Carboplatin|carboplatin|mesh-list
43955167|NCT01275664|Aprepitant|aprepitant|mesh-list
43955168|NCT01275664|Granisetron|granisetron|mesh-list
43955169|NCT01275664|Ichthammol|ichthammol|mesh-list
43955170|NCT01275664|BB 1101|bb 1101|mesh-list
43955171|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955172|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
43955173|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
43955174|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955175|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955176|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955177|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
43955178|NCT01275664|Hormones|hormones|mesh-ancestor
43955179|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955180|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955181|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955182|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
43955193|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955195|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955196|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43955197|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43955198|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955199|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43955200|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
43955201|NCT01276314|Prednisolone|prednisolone|mesh-list
43955202|NCT01276314|Etanercept|etanercept|mesh-list
43955203|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955204|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
43955205|NCT01276314|Hormones|hormones|mesh-ancestor
43955206|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955207|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240286|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240287|NCT00578721|Aspirin|aspirin|mesh-list
44240288|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44240289|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44240290|NCT00578721|Analgesics|analgesics|mesh-ancestor
44240291|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
44240292|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240293|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240294|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240295|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240296|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43955208|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955209|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955210|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955211|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955212|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955213|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955214|NCT01276314|Analgesics|analgesics|mesh-ancestor
43955215|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
43955216|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955217|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955218|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
43955219|NCT01277081|Acetaminophen|acetaminophen|mesh-list
43955220|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955221|NCT01277081|Analgesics|analgesics|mesh-ancestor
43955222|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
43955223|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955224|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955225|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
43955226|NCT01277159|Dexamethasone|dexamethasone|mesh-list
43955227|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
43955228|NCT01277159|Buprenorphine|buprenorphine|mesh-list
43955229|NCT01277159|BB 1101|bb 1101|mesh-list
43955230|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955231|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
43955232|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
43955233|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955234|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955235|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955236|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
43955237|NCT01277159|Hormones|hormones|mesh-ancestor
43955238|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955239|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955240|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955241|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
43955242|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955243|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955244|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43955283|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845782|NCT04248595|Azacitidine|azacitidine|mesh-list
43955294|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43955296|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955297|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955298|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955299|NCT01281501|Scopolamine|scopolamine|mesh-list
43955300|NCT01281501|Pantoprazole|pantoprazole|mesh-list
43955301|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
43955302|NCT01281501|Antacids|antacids|mesh-list
43955303|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43955304|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955305|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43955306|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955307|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955308|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43955309|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
44240297|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44240298|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240299|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44240300|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44240301|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240303|NCT00578760|Aspirin|aspirin|mesh-list
44240304|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44240305|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44240306|NCT00578760|Analgesics|analgesics|mesh-ancestor
44240307|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
44240308|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240309|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240310|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240311|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240312|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43955310|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
43955311|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955312|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955313|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
43955314|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43955315|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955316|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955317|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43955318|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
43955319|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43955320|NCT01282138|Dextrans|dextrans|mesh-list
43955321|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43955322|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43955323|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
43955324|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
43955325|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
43955326|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955327|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955328|NCT01282138|Analgesics|analgesics|mesh-ancestor
43955329|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
43955330|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955331|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955332|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955333|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955334|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43955335|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43955336|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43955337|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
43955338|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
43955339|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955340|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955342|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43955343|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43955344|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955345|NCT01283555|Tenofovir|tenofovir|mesh-list
43955346|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
43955347|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955348|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43955349|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142063|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142064|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142065|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44240313|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44240314|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240315|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44240316|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44240317|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240319|NCT00578825|Ritonavir|ritonavir|mesh-list
44240320|NCT00578825|Lopinavir|lopinavir|mesh-list
44240321|NCT00578825|Ribavirin|ribavirin|mesh-list
44240322|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44240323|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44240324|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
44240325|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240326|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142066|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142067|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44142068|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44142069|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142070|NCT00185133|Amlodipine|amlodipine|mesh-list
44142071|NCT00185133|Olmesartan|olmesartan|mesh-list
44142072|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142073|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142074|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44142075|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142076|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142077|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44142078|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142079|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142080|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142081|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142082|NCT00185159|Olmesartan|olmesartan|mesh-list
44142083|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142084|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142085|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142086|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142087|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142088|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44142089|NCT00185172|Olmesartan|olmesartan|mesh-list
44142090|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142091|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142092|NCT00185172|Diuretics|diuretics|mesh-ancestor
44142093|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
44142094|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142095|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44142096|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142097|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142098|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142099|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142100|NCT00185185|Atenolol|atenolol|mesh-list
44142101|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44142102|NCT00185185|Olmesartan|olmesartan|mesh-list
44142103|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142104|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142105|NCT00185185|Diuretics|diuretics|mesh-ancestor
44142106|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
44142107|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142108|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44142109|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43819337|NCT05576272|Immunologic Factors|immunologic factors|mesh-ancestor
43955381|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
44240327|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44240328|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44240329|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
44240330|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240331|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44240332|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44240333|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
44240334|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
44240335|NCT00579046|Hematinics|hematinics|mesh-ancestor
44240336|NCT00579085|Ketamine|ketamine|mesh-list
43955382|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955383|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955384|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955385|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
43955386|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955387|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
43955388|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
43955389|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
43955390|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43955391|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
43955392|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43955393|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43955394|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43955395|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43955439|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43955440|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43955441|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955442|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955444|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955445|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955446|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43955447|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43955448|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955449|NCT01286454|Fesoterodine|fesoterodine|mesh-list
43955450|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43955451|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43955453|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955454|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955455|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955456|NCT01286454|Urological Agents|urological agents|mesh-ancestor
43955457|NCT01286805|Bupivacaine|bupivacaine|mesh-list
43955458|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
43955459|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
43955460|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955461|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955462|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
43955463|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955464|NCT01286818|Leucovorin|leucovorin|mesh-list
43955465|NCT01286818|Fluorouracil|fluorouracil|mesh-list
43955466|NCT01286818|Irinotecan|irinotecan|mesh-list
43955467|NCT01286818|Ramucirumab|ramucirumab|mesh-list
43955468|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43955469|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
43955470|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
43955471|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955472|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43955473|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955474|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955475|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
43955476|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955477|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43955478|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43955479|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955480|NCT01286818|Antidotes|antidotes|mesh-ancestor
43955481|NCT01286818|Protective Agents|protective agents|mesh-ancestor
43955482|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
44240337|NCT00579085|Analgesics|analgesics|mesh-ancestor
44240338|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
43955483|NCT01286818|Vitamins|vitamins|mesh-ancestor
43955484|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
43955485|NCT01287078|Cyclosporine|cyclosporine|mesh-list
43955486|NCT01287078|Cyclosporins|cyclosporins|mesh-list
43955487|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955488|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955489|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955490|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
43955491|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955492|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
43955493|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955494|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
43955495|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955496|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43955497|NCT01287377|Nicotine|nicotine|mesh-list
43955498|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43955499|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
43955567|NCT01289457|Fludarabine|fludarabine|mesh-list
43955568|NCT01289457|Idarubicin|idarubicin|mesh-list
43955569|NCT01289457|Clofarabine|clofarabine|mesh-list
43955570|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845826|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955605|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955606|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955607|NCT01290484|Urological Agents|urological agents|mesh-ancestor
43955608|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
43955609|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
43955610|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43955659|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955660|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43955661|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43955662|NCT01292304|Tolvaptan|tolvaptan|mesh-list
43955663|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43955664|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955665|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
43955666|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955667|NCT01292447|Lidocaine|lidocaine|mesh-list
43955668|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
43955669|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
43955670|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955671|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955672|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
43955673|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955674|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43955675|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43955676|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43955677|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955678|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955679|NCT01292642|Nicotine|nicotine|mesh-list
43955680|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43955681|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
43955682|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955683|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955711|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43955712|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955713|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43955714|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43955715|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
43955716|NCT01294098|Bupivacaine|bupivacaine|mesh-list
43955717|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
43955718|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
43955719|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955720|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955721|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
43955722|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955724|NCT01294163|Sevoflurane|sevoflurane|mesh-list
43955725|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43955726|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955727|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955728|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43955729|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
43819655|NCT04403347|Losartan|losartan|mesh-list
44240340|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240341|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44240342|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44240343|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
44240344|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
44240345|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240346|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44240347|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44240348|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240349|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240350|NCT00579475|Mifepristone|mifepristone|mesh-list
44240351|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44240352|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
44240353|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44240354|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240355|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44240356|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44240357|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44240358|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
44240359|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44240360|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44240361|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
44240362|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240363|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
43955744|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
43955745|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
43955746|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955747|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955748|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955749|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
43955750|NCT01294319|Hormones|hormones|mesh-ancestor
43955751|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955752|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955753|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955754|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
43955755|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955756|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955757|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43955758|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
43955759|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43955760|NCT01294319|Diuretics|diuretics|mesh-ancestor
43955761|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
43955762|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43955763|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
44240364|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44240365|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44240366|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
43955764|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955765|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43955766|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43955767|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43955768|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
43955769|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43955770|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43955771|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
43955772|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43955773|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43955774|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43955775|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43955776|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43955777|NCT01294384|Laxatives|laxatives|mesh-ancestor
43955778|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955779|NCT01295112|Dexamethasone|dexamethasone|mesh-list
43955780|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
43955781|NCT01295112|Bevacizumab|bevacizumab|mesh-list
43955782|NCT01295112|BB 1101|bb 1101|mesh-list
43955783|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43955784|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955785|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43955786|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43955787|NCT01295112|Growth Substances|growth substances|mesh-ancestor
43955788|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955789|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
43955790|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955791|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
43955812|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43955813|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
43955814|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955815|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955817|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
43955818|NCT01295879|Vitamins|vitamins|mesh-ancestor
43955819|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
43955820|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955821|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43955822|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43955823|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
43955824|NCT01296191|Besifloxacin|besifloxacin|mesh-list
43955825|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43955826|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955827|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43955828|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43955829|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955830|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955831|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955832|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
43955833|NCT01296542|Besifloxacin|besifloxacin|mesh-list
43955834|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43955835|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955836|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43955837|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43955838|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955839|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955840|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955842|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43955843|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43955844|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955845|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
43845863|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44142114|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
44142115|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
44142116|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142117|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44142118|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44142119|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44142120|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240368|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
44240369|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240370|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142121|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142122|NCT00185198|Testosterone|testosterone|mesh-list
44142123|NCT00185198|Androgens|androgens|mesh-ancestor
44142124|NCT00185198|Hormones|hormones|mesh-ancestor
44142125|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142126|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142148|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142149|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
44142150|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955909|NCT01298063|Afatinib|afatinib|mesh-list
43955910|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955911|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43955912|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955913|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955914|NCT01298128|NuvaRing|nuvaring|mesh-list
43955915|NCT01298128|Desogestrel|desogestrel|mesh-list
43955916|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43955917|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
43955918|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955919|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955920|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43955921|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43955922|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43955923|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43955924|NCT01298128|Progestins|progestins|mesh-ancestor
43955925|NCT01298128|Hormones|hormones|mesh-ancestor
43955926|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955927|NCT01298219|Lubiprostone|lubiprostone|mesh-list
43955928|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43955929|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955930|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955932|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43955933|NCT01301183|Estradiol|estradiol|mesh-list
43955934|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43955935|NCT01301183|Mecasermin|mecasermin|mesh-list
43955936|NCT01301183|Estrogens|estrogens|mesh-ancestor
43955937|NCT01301183|Hormones|hormones|mesh-ancestor
43955998|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43956000|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956001|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956002|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956003|NCT01303406|Idebenone|idebenone|mesh-list
43956004|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
43956005|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956006|NCT01303406|Protective Agents|protective agents|mesh-ancestor
43956007|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956008|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
43956009|NCT01303744|Analgesics|analgesics|mesh-ancestor
43956010|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
43956011|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956012|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956013|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43956014|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43956015|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956016|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956017|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43956018|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956019|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956020|NCT01303835|Naltrexone|naltrexone|mesh-list
43956021|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43819974|NCT00082706|Cisplatin|cisplatin|mesh-list
43956091|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956092|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956093|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
43956094|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43956095|NCT01305252|Treprostinil|treprostinil|mesh-list
43956096|NCT01305252|Tadalafil|tadalafil|mesh-list
43956097|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
43956098|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43820067|NCT05678933|Prednisone|prednisone|mesh-list
44240371|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
44240372|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240373|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956107|NCT01306175|Empagliflozin|empagliflozin|mesh-list
43956108|NCT01306175|Digoxin|digoxin|mesh-list
43956109|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43956110|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43956111|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956112|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956113|NCT01306175|Protective Agents|protective agents|mesh-ancestor
43956114|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956115|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43956116|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43956117|NCT01307007|Dextrans|dextrans|mesh-list
43956118|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
43956119|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
43956120|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
43956121|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
43956122|NCT01307007|Hematinics|hematinics|mesh-ancestor
43956123|NCT01307397|Vemurafenib|vemurafenib|mesh-list
43956124|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956125|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956126|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956127|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956128|NCT01307462|Fluticasone|fluticasone|mesh-list
43956129|NCT01307462|Xhance|xhance|mesh-list
43956130|NCT01307462|Azithromycin|azithromycin|mesh-list
43956131|NCT01307462|Montelukast|montelukast|mesh-list
43956132|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956133|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43956134|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
44142151|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
43956135|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956136|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956137|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43956138|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
43956139|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956140|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43956141|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43956142|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956143|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43956144|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
43956145|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956146|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43956147|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43956148|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956149|NCT01307618|Interleukin-12|interleukin-12|mesh-list
43956150|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43956151|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
43956152|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956153|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43999873|NCT04458545|Heroin|heroin|mesh-list
43956155|NCT01307618|Growth Substances|growth substances|mesh-ancestor
43956156|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956157|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956158|NCT01307930|Anidulafungin|anidulafungin|mesh-list
43956159|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
43956160|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956161|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
43956162|NCT01307956|Leucovorin|leucovorin|mesh-list
43956163|NCT01307956|Folic Acid|folic acid|mesh-list
43956164|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43956165|NCT01307956|Panitumumab|panitumumab|mesh-list
43956166|NCT01307956|Fluorouracil|fluorouracil|mesh-list
43956175|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956176|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43956177|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43956178|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
43956179|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956180|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956181|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956182|NCT01307956|Antidotes|antidotes|mesh-ancestor
43956183|NCT01307956|Protective Agents|protective agents|mesh-ancestor
43956184|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
43956185|NCT01307956|Vitamins|vitamins|mesh-ancestor
44240374|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44240375|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43956187|NCT01307956|Hematinics|hematinics|mesh-ancestor
43956188|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
43956189|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43956190|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43956191|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43956192|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956193|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956194|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956195|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956196|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956197|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43956198|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956199|NCT01308294|Vaccines|vaccines|mesh-list
43956200|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43956201|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
43956202|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956203|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43956204|NCT01308814|Estradiol|estradiol|mesh-list
43956205|NCT01308814|Estrogens|estrogens|mesh-ancestor
43956206|NCT01308814|Hormones|hormones|mesh-ancestor
43956207|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956208|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956209|NCT01308840|Gemcitabine|gemcitabine|mesh-list
43696262|NCT02757079|Protective Agents|protective agents|mesh-ancestor
43956210|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
43956211|NCT01308840|Panitumumab|panitumumab|mesh-list
43956212|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956213|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
43956214|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956215|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956216|NCT01308840|Antiviral Agents|antiviral agents|mesh-ancestor
43956217|NCT01308840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956218|NCT01308840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956219|NCT01308840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956220|NCT01308840|Immunologic Factors|immunologic factors|mesh-ancestor
43956221|NCT01308840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956222|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956223|NCT01309360|Midazolam|midazolam|mesh-list
43956224|NCT01309360|Prilocaine|prilocaine|mesh-list
43956225|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43956226|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43956227|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956228|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956229|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43956231|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956232|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43956233|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
43956234|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
43956235|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
43956236|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
43820139|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
43956286|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43956287|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
43956289|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956290|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956291|NCT01310855|Gefitinib|gefitinib|mesh-list
43956292|NCT01310855|Cediranib|cediranib|mesh-list
43956293|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956294|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956295|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956296|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956297|NCT01311102|Lidocaine|lidocaine|mesh-list
43956298|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
43956299|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
43956300|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956301|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956302|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
43956303|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956304|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43956305|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43956306|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43956307|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956308|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956309|NCT01311674|Vaccines|vaccines|mesh-list
43956310|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
43956311|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956312|NCT01311687|Dexamethasone|dexamethasone|mesh-list
43956313|NCT01311687|Pomalidomide|pomalidomide|mesh-list
43956314|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956315|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
43956316|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
43956317|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956318|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956319|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956320|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
43956321|NCT01311687|Hormones|hormones|mesh-ancestor
43956322|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956323|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43956324|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956325|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
43956326|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43956327|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956328|NCT01311687|Growth Substances|growth substances|mesh-ancestor
43956329|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956330|NCT01311895|Hydromorphone|hydromorphone|mesh-list
43956331|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43956332|NCT01311895|Narcotics|narcotics|mesh-ancestor
43956369|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956370|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
43956371|NCT01312818|Hormones|hormones|mesh-ancestor
43956372|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956373|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43956374|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845898|NCT04239313|Vaccines|vaccines|mesh-list
43956427|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956428|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956429|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956430|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43956432|NCT01314001|Varenicline|varenicline|mesh-list
43956433|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43956434|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
43956435|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956436|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956437|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43956438|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43956439|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956440|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956441|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956442|NCT01314417|Methotrexate|methotrexate|mesh-list
43956443|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43956444|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
43956445|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44000020|NCT04238754|Cannabidiol|cannabidiol|mesh-list
43956446|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956447|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956448|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
43956449|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956450|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956451|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956452|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956453|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43956454|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956455|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
43956456|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956457|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142152|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142153|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44142154|NCT00185302|Entinostat|entinostat|mesh-list
44142189|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44142190|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44142191|NCT00185510|Prednisolone|prednisolone|mesh-list
44142192|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
44142193|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
44142203|NCT00185510|Hormones|hormones|mesh-ancestor
44142204|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240377|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44240378|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240379|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170071|NCT00279266|Thiamine|thiamine|mesh-list
43956458|NCT01315002|Nicotine|nicotine|mesh-list
43956459|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43956460|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
43956461|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956462|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956463|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43956464|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43956465|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956466|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956467|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956468|NCT01315158|Fentanyl|fentanyl|mesh-list
43956469|NCT01315158|Midazolam|midazolam|mesh-list
43956470|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
43956471|NCT01315158|Propofol|propofol|mesh-list
43956472|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43956473|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956474|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956475|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43956476|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
43956477|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
43956478|NCT01315158|Narcotics|narcotics|mesh-ancestor
43956479|NCT01315158|Analgesics|analgesics|mesh-ancestor
43956480|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
43956481|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956482|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43956483|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43956484|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43956485|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956486|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
43956487|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
43956488|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956489|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956490|NCT01315574|Travoprost|travoprost|mesh-list
43956491|NCT01315574|Latanoprost|latanoprost|mesh-list
43956492|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43956493|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43956494|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43956495|NCT01315665|Sulforaphane|sulforaphane|mesh-list
43956496|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43956497|NCT01315665|Protective Agents|protective agents|mesh-ancestor
43956498|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956499|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956500|NCT01316042|Metformin|metformin|mesh-list
43956501|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43956502|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956503|NCT01316263|Olaratumab|olaratumab|mesh-list
43956504|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956505|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44000054|NCT04127578|Prednisone|prednisone|mesh-list
43956506|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43956507|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43956508|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956509|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956510|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956511|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956512|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
43956513|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956514|NCT01316341|Empagliflozin|empagliflozin|mesh-list
43956525|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956526|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
43956527|NCT01316770|Hormones|hormones|mesh-ancestor
43956528|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956529|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43956530|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956531|NCT01317667|Vaccines|vaccines|mesh-list
43956532|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
43956533|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956534|NCT01317901|Rituximab|rituximab|mesh-list
43956535|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43956536|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240380|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240381|NCT00579644|Minocycline|minocycline|mesh-list
44240382|NCT00579644|Methotrexate|methotrexate|mesh-list
44240383|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44240384|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
44170142|NCT00279565|Ribavirin|ribavirin|mesh-list
43956537|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956538|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
43956539|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956540|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956541|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43956542|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
43956543|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956544|NCT01318278|Dopamine|dopamine|mesh-list
43956545|NCT01318278|Vasopressins|vasopressins|mesh-list
43956546|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
43956547|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956548|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
43956549|NCT01318278|Coagulants|coagulants|mesh-ancestor
43956550|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43956551|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43956552|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
43956553|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43956554|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
43956555|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
43956556|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956557|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
43956558|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956559|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956560|NCT01318278|Protective Agents|protective agents|mesh-ancestor
43956562|NCT01318356|Tetracycline|tetracycline|mesh-list
43956563|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43956564|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956565|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
43956566|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43956567|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43956568|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43956569|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956570|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956571|NCT01318408|Levetiracetam|levetiracetam|mesh-list
43956572|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
43956573|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
43956574|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43956575|NCT01318694|Ribavirin|ribavirin|mesh-list
43956576|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43956577|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
43956578|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956579|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
43820520|NCT05575427|Levofloxacin|levofloxacin|mesh-list
43956614|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956615|NCT01321151|Protective Agents|protective agents|mesh-ancestor
43956616|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956617|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956618|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43956620|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956621|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820590|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43956692|NCT01322815|Growth Substances|growth substances|mesh-ancestor
43956693|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956694|NCT01322815|Antidotes|antidotes|mesh-ancestor
43956695|NCT01322815|Protective Agents|protective agents|mesh-ancestor
43956696|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
43956697|NCT01322815|Vitamins|vitamins|mesh-ancestor
43956698|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
43956699|NCT01323010|Albuterol|albuterol|mesh-list
43956700|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43820624|NCT05402020|Olodaterol|olodaterol|mesh-list
43956719|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
43956720|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43956721|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43956722|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
43956723|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240386|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240387|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44240388|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
44240389|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240390|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240391|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
44240392|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240393|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44240394|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240395|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
44240396|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170216|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956724|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43956725|NCT01323517|Dactinomycin|dactinomycin|mesh-list
43956726|NCT01323517|Ipilimumab|ipilimumab|mesh-list
43956727|NCT01323517|Melphalan|melphalan|mesh-list
43956728|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956729|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956730|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43956731|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956732|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43956733|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
43956734|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43956735|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956736|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
43956737|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956738|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43956739|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956740|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43956741|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43956742|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956743|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43956744|NCT01323595|Celecoxib|celecoxib|mesh-list
43956745|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43956746|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43956747|NCT01323595|Analgesics|analgesics|mesh-ancestor
43956748|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
43956749|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956750|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956751|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956752|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956753|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43956754|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43820671|NCT05362487|Bromides|bromides|mesh-list
43956782|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956783|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43956784|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43956785|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956786|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43956787|NCT01325181|Ranibizumab|ranibizumab|mesh-list
43956788|NCT01325181|Verteporfin|verteporfin|mesh-list
43956789|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43956790|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956791|NCT01325181|Growth Substances|growth substances|mesh-ancestor
43956792|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956793|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956794|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956795|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43956796|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956798|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
43956799|NCT01325311|Genistein|genistein|mesh-list
44240397|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44240398|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44240399|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240400|NCT00579956|Meropenem|meropenem|mesh-list
43956800|NCT01325311|Vitamins|vitamins|mesh-ancestor
43956801|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
43956802|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956803|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43956804|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43956817|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956818|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
43956819|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
43956820|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956821|NCT01327677|Fentanyl|fentanyl|mesh-list
43956822|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43956823|NCT01327677|Narcotics|narcotics|mesh-ancestor
43956824|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956825|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956826|NCT01327677|Analgesics|analgesics|mesh-ancestor
43956827|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
43956828|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956829|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43956830|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43956831|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
43956832|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
43956833|NCT01328184|Empagliflozin|empagliflozin|mesh-list
43956834|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
43956835|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43956836|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43956837|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43956838|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43956839|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
43956840|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956841|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956842|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43956843|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43956844|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43956845|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43956846|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956847|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43956848|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43956849|NCT01328184|Estrogens|estrogens|mesh-ancestor
43956850|NCT01328184|Hormones|hormones|mesh-ancestor
43956851|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956852|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43956853|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43956854|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43956855|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43956856|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
43956857|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43956858|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956859|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956860|NCT01328769|Febuxostat|febuxostat|mesh-list
43956861|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
43956862|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956863|NCT01328782|Acetaminophen|acetaminophen|mesh-list
43956864|NCT01328782|Oxycodone|oxycodone|mesh-list
43956865|NCT01328782|Bupivacaine|bupivacaine|mesh-list
43956866|NCT01328782|Ropivacaine|ropivacaine|mesh-list
43956892|NCT01328964|Hormones|hormones|mesh-ancestor
43956893|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956894|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43956895|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
43956896|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43956897|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43956898|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956899|NCT01329185|Valganciclovir|valganciclovir|mesh-list
43956900|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
43956901|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142205|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44240401|NCT00579956|Ceftazidime|ceftazidime|mesh-list
44142206|NCT00185510|Protective Agents|protective agents|mesh-ancestor
44142207|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142208|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157510|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44157511|NCT00234819|Hormones|hormones|mesh-ancestor
44157512|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157513|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157514|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44157515|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44157516|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
44157517|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43956902|NCT01330043|Bupropion|bupropion|mesh-list
43956903|NCT01330043|Nicotine|nicotine|mesh-list
43956904|NCT01330043|Varenicline|varenicline|mesh-list
43956905|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43956906|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
43956930|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956931|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43956932|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43956933|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43956934|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956935|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956937|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
43956938|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
43956939|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956940|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956941|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956942|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
43956943|NCT01330355|Besifloxacin|besifloxacin|mesh-list
43956944|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43956945|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956946|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43956947|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43956948|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43956949|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43956950|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956951|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956952|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956953|NCT01331213|Pregabalin|pregabalin|mesh-list
43956954|NCT01331213|Analgesics|analgesics|mesh-ancestor
43956955|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
43820848|NCT05189704|Analgesics|analgesics|mesh-ancestor
43956963|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43956964|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43956965|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956966|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956967|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43956968|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
43956969|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956970|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43956971|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43956972|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956973|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956974|NCT01331694|Fluticasone|fluticasone|mesh-list
43956976|NCT01331694|Albuterol|albuterol|mesh-list
43956977|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
43956978|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43956979|NCT01331694|Ipratropium|ipratropium|mesh-list
43956980|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43956981|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956982|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43956983|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
43956984|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956985|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956986|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43956987|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
43956988|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956989|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43956990|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
43956991|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43956992|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956993|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956994|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956995|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43956996|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43956997|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43956998|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
43956999|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
43957000|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
43957001|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957002|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
43957004|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957005|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
43957006|NCT01332071|Metformin|metformin|mesh-list
43957007|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
43957008|NCT01332071|Maleic acid|maleic acid|mesh-list
43957009|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957010|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957011|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957012|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957013|NCT01332188|Cetirizine|cetirizine|mesh-list
43957014|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43957015|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43957016|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43957017|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
43957018|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
43957019|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957020|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957021|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957022|NCT01332253|Ibuprofen|ibuprofen|mesh-list
43957059|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43957060|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957061|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44000384|NCT03033303|Isotretinoin|isotretinoin|mesh-list
43957078|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957079|NCT01332500|Analgesics|analgesics|mesh-ancestor
43957080|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
43957081|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957082|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957083|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957084|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957085|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
43957086|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957087|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957088|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957089|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43957090|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43957091|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43957092|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
43957093|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957094|NCT01332578|Acetaminophen|acetaminophen|mesh-list
43957095|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
43957096|NCT01332578|Phenylephrine|phenylephrine|mesh-list
43957097|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
43957098|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957099|NCT01332578|Analgesics|analgesics|mesh-ancestor
43957100|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
43957101|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957102|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957103|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
43957104|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
43957105|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957106|NCT01332578|Protective Agents|protective agents|mesh-ancestor
43957107|NCT01332578|Vitamins|vitamins|mesh-ancestor
43957108|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
43957109|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43957110|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
43957111|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
43957112|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
43957113|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43957114|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
43957115|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957116|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43957117|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43957118|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957119|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957120|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957121|NCT01332721|Bevacizumab|bevacizumab|mesh-list
43821001|NCT04978493|Ustekinumab|ustekinumab|mesh-list
43957132|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957133|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957134|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43957135|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43957136|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43957137|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
43957138|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43957139|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43957140|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
43957141|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957142|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
43957143|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43957144|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43957145|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
43957146|NCT01333488|Analgesics|analgesics|mesh-ancestor
43957147|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
43957148|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957149|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957150|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
43957151|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957152|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43957153|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
43957154|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43957155|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957156|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957157|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43957158|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
43957159|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957160|NCT01333592|Mitiglinide|mitiglinide|mesh-list
43957161|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957162|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957164|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
43957165|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
43957166|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957167|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957168|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957169|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43957170|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957171|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957172|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43957173|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957174|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957175|NCT01334229|Incretins|incretins|mesh-ancestor
43957176|NCT01334229|Hormones|hormones|mesh-ancestor
43957177|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957178|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43957179|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957180|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957181|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957182|NCT01334723|Finasteride|finasteride|mesh-list
43957183|NCT01334723|Dutasteride|dutasteride|mesh-list
43957197|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957198|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957199|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957200|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957201|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957202|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957203|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957205|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957206|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957207|NCT01334957|Analgesics|analgesics|mesh-ancestor
43957208|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
43957209|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957210|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957211|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957212|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957213|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957214|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957215|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957216|NCT01335204|Bavituximab|bavituximab|mesh-list
43957217|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43957218|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957219|NCT01335620|Tenofovir|tenofovir|mesh-list
43957220|NCT01335620|Emtricitabine|emtricitabine|mesh-list
43957222|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
43957223|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957224|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43957225|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43957226|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957227|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957228|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43957229|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43957230|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43957231|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43957232|NCT01335724|Diclofenac|diclofenac|mesh-list
43957233|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957234|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957235|NCT01335724|Analgesics|analgesics|mesh-ancestor
43957236|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
43957237|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957238|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957239|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957240|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957241|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957242|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846011|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
43957261|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957262|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957263|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
43957264|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43957265|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957266|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43957267|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
43957268|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957269|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957270|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957271|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957272|NCT01336933|Prednisone|prednisone|mesh-list
43957273|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
43957274|NCT01336933|Etoposide|etoposide|mesh-list
43957275|NCT01336933|Vincristine|vincristine|mesh-list
43957276|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
43957277|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957278|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
43957279|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957280|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957281|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43957282|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
43957283|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957284|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957285|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43957286|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957287|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
43957288|NCT01336933|Hormones|hormones|mesh-ancestor
43957289|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957290|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43957291|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43957292|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43957293|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43957294|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957295|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
43957296|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
43957297|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
43957298|NCT01337336|Fluticasone|fluticasone|mesh-list
43957299|NCT01337336|Xhance|xhance|mesh-list
43957332|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957333|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957334|NCT01337700|Analgesics|analgesics|mesh-ancestor
43957335|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
43957336|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957337|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
43957338|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43957339|NCT01338857|Sorafenib|sorafenib|mesh-list
43957340|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957355|NCT01339247|Halofantrine|halofantrine|mesh-list
43957356|NCT01339247|Paroxetine|paroxetine|mesh-list
43957357|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43957358|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44240402|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957359|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957360|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957361|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957362|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
43957363|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957364|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43957366|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43957367|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43957368|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43957369|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957370|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
43957371|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43957372|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43957373|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957374|NCT01339260|Dexamethasone|dexamethasone|mesh-list
43957375|NCT01339260|Palonosetron|palonosetron|mesh-list
43957376|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957377|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
43957378|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
43957379|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957380|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957381|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957382|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
43957383|NCT01339260|Hormones|hormones|mesh-ancestor
43957384|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957385|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43957386|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957387|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43957388|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43957389|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
43957390|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957391|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957392|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43957393|NCT01339299|Hormones|hormones|mesh-list
43957394|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957395|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957396|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957397|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
43957398|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43957399|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
43957400|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957401|NCT01339858|Expectorants|expectorants|mesh-ancestor
43957402|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957438|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43957439|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43957440|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
43957477|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957478|NCT01342549|Naltrexone|naltrexone|mesh-list
43957479|NCT01342549|Valproic Acid|valproic acid|mesh-list
43821321|NCT04480554|Naltrexone|naltrexone|mesh-list
43957500|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43957501|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957503|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957504|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957505|NCT01343004|Teriparatide|teriparatide|mesh-list
43957506|NCT01343004|Abaloparatide|abaloparatide|mesh-list
43957507|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43957508|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957509|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43957510|NCT01346072|Tolvaptan|tolvaptan|mesh-list
43957511|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43957512|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957513|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
43957514|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957515|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
43957516|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
43957517|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957518|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957519|NCT01346397|Cyclosporine|cyclosporine|mesh-list
43957521|NCT01346397|Cyclosporins|cyclosporins|mesh-list
43957522|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957523|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
44240403|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957524|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957525|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43957526|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957527|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957528|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
43957529|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957530|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957531|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142209|NCT00185562|Adalimumab|adalimumab|mesh-list
44142210|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821352|NCT04454476|Trametinib|trametinib|mesh-list
44142227|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142228|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142229|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142231|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142232|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44142233|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
44142234|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142235|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142236|NCT00185835|Cisplatin|cisplatin|mesh-list
44142237|NCT00185835|Gefitinib|gefitinib|mesh-list
44142238|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142239|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44142240|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142241|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142242|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
44142243|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142244|NCT00185887|Terbutaline|terbutaline|mesh-list
44142245|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44142246|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
44142247|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957532|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
43957533|NCT01347008|Citric Acid|citric acid|mesh-list
43957534|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
43957535|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
43957536|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43957537|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
43957538|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
43957539|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957540|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
43957541|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43957542|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43957543|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957544|NCT01347008|Urological Agents|urological agents|mesh-ancestor
43957545|NCT01347060|Fluticasone|fluticasone|mesh-list
43957546|NCT01347060|Xhance|xhance|mesh-list
43957547|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43957548|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957549|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43957551|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957552|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957586|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43957587|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43957589|NCT01349231|Analgesics|analgesics|mesh-ancestor
43957590|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
43957616|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957618|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
43957619|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957620|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957621|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
43957622|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957623|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43957624|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43957625|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43957627|NCT01349972|Analgesics|analgesics|mesh-ancestor
43957628|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
43957629|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957630|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
43957631|NCT01349972|Growth Substances|growth substances|mesh-ancestor
43957632|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43957633|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
43957634|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
43957635|NCT01350245|Tacrolimus|tacrolimus|mesh-list
43957636|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240404|NCT00579969|Timolol|timolol|mesh-list
43957637|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
43957638|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957639|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821476|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43957653|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
43957654|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957655|NCT01350947|Azacitidine|azacitidine|mesh-list
43957656|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43957657|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
43957658|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957659|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957660|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957661|NCT01351090|Ketorolac|ketorolac|mesh-list
43957662|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43957663|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957664|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957665|NCT01351090|Analgesics|analgesics|mesh-ancestor
43957666|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
43957667|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957668|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957669|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957670|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957671|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957672|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957673|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957674|NCT01351480|Abatacept|abatacept|mesh-list
43957675|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43957676|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957677|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957678|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957679|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
43957680|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957681|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957683|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43957684|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43957685|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43957686|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957687|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957688|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957689|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43957690|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43957691|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
43957692|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957693|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43957694|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43957695|NCT01351753|Metformin|metformin|mesh-list
43957696|NCT01351753|Topiramate|topiramate|mesh-list
43957697|NCT01351753|Orlistat|orlistat|mesh-list
43957698|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957699|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957700|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
43821529|NCT04111458|Trametinib|trametinib|mesh-list
43957746|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957747|NCT01354145|Analgesics|analgesics|mesh-ancestor
43957748|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
43957749|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957750|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957751|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957752|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957753|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43957754|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957755|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957756|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957758|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43957759|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43957760|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957761|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957762|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957763|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957764|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43957765|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
43957766|NCT01354444|Protective Agents|protective agents|mesh-ancestor
43957767|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43957768|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957769|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43957770|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
43957771|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43957772|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43957773|NCT01354652|Lamivudine|lamivudine|mesh-list
43957774|NCT01354652|Entecavir|entecavir|mesh-list
43957775|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43957776|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43957777|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957778|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957802|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43957803|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43957804|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43957805|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957806|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957807|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957808|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957809|NCT01355588|Analgesics|analgesics|mesh-ancestor
43957810|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957811|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957812|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957813|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957815|NCT01355705|Dexamethasone|dexamethasone|mesh-list
43957816|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
43957817|NCT01355705|Lenalidomide|lenalidomide|mesh-list
43957818|NCT01355705|Amrubicin|amrubicin|mesh-list
43957819|NCT01355705|BB 1101|bb 1101|mesh-list
43957820|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957821|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
43957822|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
43957823|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957824|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957825|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957826|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
43957827|NCT01355705|Hormones|hormones|mesh-ancestor
43957828|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957829|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821643|NCT03710824|Nintedanib|nintedanib|mesh-list
43957840|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43957841|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43957842|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957844|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
43957845|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43957846|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43957847|NCT01355705|Growth Substances|growth substances|mesh-ancestor
43957848|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
43957849|NCT01357135|Metformin|metformin|mesh-list
43957850|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43957851|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43957852|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957853|NCT01357135|Incretins|incretins|mesh-ancestor
43957854|NCT01357135|Hormones|hormones|mesh-ancestor
43957855|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957856|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43957857|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957858|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957859|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957860|NCT01357148|Metformin|metformin|mesh-list
43957861|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43957862|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957863|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957864|NCT01357148|Incretins|incretins|mesh-ancestor
43957865|NCT01357148|Hormones|hormones|mesh-ancestor
43957866|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957867|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43957868|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957869|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000834|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
43957870|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957871|NCT01358266|Sirolimus|sirolimus|mesh-list
43957872|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957873|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957874|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43957875|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240405|NCT00579969|Latanoprost|latanoprost|mesh-list
44240406|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44170944|NCT00282997|Analgesics|analgesics|mesh-ancestor
43957876|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
43957877|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957878|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
43957879|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957881|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
43957882|NCT01359007|Irinotecan|irinotecan|mesh-list
43957883|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957884|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43957885|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43957886|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957887|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957888|NCT01359007|Antidotes|antidotes|mesh-ancestor
43957889|NCT01359007|Protective Agents|protective agents|mesh-ancestor
43957890|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957891|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
43957892|NCT01359007|Vitamins|vitamins|mesh-ancestor
43957893|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
43957894|NCT01359735|Bacitracin|bacitracin|mesh-list
43957922|NCT01361217|Lovastatin|lovastatin|mesh-list
43957923|NCT01361217|L 647318|l 647318|mesh-list
43957924|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
43957925|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43957926|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43957927|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957928|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957929|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43957930|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43957931|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43957932|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43957933|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
43957934|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
43957935|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
43957936|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
43957937|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957938|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957939|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43957940|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957941|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43957942|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957943|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43821743|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
43957958|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43957959|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43957960|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43957962|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
43957963|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43957964|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43957965|NCT01361620|Aspirin|aspirin|mesh-list
43957966|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957967|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957968|NCT01361620|Analgesics|analgesics|mesh-ancestor
43957969|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
43957970|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957971|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957972|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957973|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957974|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43957975|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43957976|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957977|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43957978|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957979|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957980|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
43957981|NCT01361633|Cycloserine|cycloserine|mesh-list
43957982|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43957983|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957984|NCT01361633|Renal Agents|renal agents|mesh-ancestor
43957985|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43957986|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
43957987|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957988|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
43957989|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957990|NCT01362127|Cisplatin|cisplatin|mesh-list
43957991|NCT01362127|Carboplatin|carboplatin|mesh-list
43957992|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
43957993|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957994|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
43957995|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43957996|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43957997|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957998|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
43958000|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
43958001|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43821792|NCT03458260|Rituximab|rituximab|mesh-list
43958037|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958038|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958039|NCT01363050|Ketorolac|ketorolac|mesh-list
43958040|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43958065|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958067|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43958068|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
43958069|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958070|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958071|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43958072|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958073|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
43958074|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
43958075|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958076|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958077|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
43958078|NCT01363128|Hormones|hormones|mesh-ancestor
43958079|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958080|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958081|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43958082|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43958083|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43958084|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958085|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43958086|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
43958087|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43958088|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43958089|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
43958090|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958091|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43821883|NCT03172975|Albendazole|albendazole|mesh-list
44142274|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142275|NCT00185991|Gentamicins|gentamicins|mesh-list
43958110|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958111|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958112|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958113|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43958114|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43958115|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
43958116|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958117|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958120|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958121|NCT01363843|Antidotes|antidotes|mesh-ancestor
43958122|NCT01363843|Protective Agents|protective agents|mesh-ancestor
43958123|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958124|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
43958125|NCT01363843|Vitamins|vitamins|mesh-ancestor
43958126|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
43958127|NCT01363999|Atorvastatin|atorvastatin|mesh-list
43958128|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
43958129|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43958130|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43958131|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
43958132|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958133|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43958134|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43958135|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958136|NCT01364090|Interferons|interferons|mesh-list
43958137|NCT01364090|Ribavirin|ribavirin|mesh-list
43958138|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
43958139|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
43958140|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43958141|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958142|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
43958143|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958144|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
43958145|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958146|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
43958147|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958148|NCT01364259|Amifostine|amifostine|mesh-list
43958149|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43958150|NCT01364259|Protective Agents|protective agents|mesh-ancestor
43958151|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958152|NCT01364558|Diazepam|diazepam|mesh-list
43958153|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43958154|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
43958155|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
43958156|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
43958157|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958158|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958159|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958160|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43821973|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43958170|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
43958171|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
43958172|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958173|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958174|NCT01364584|Exenatide|exenatide|mesh-list
43958175|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43958176|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958177|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43958178|NCT01364584|Incretins|incretins|mesh-ancestor
43958179|NCT01364584|Hormones|hormones|mesh-ancestor
43958180|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958181|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
43958182|NCT01364623|Testosterone|testosterone|mesh-list
43958183|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
43958184|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
43958185|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43958186|NCT01364623|Androgens|androgens|mesh-ancestor
43958187|NCT01364623|Hormones|hormones|mesh-ancestor
43958188|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958189|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958190|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958191|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958192|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
43958193|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
43958194|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958196|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43958197|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43958198|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958199|NCT01365585|Urological Agents|urological agents|mesh-ancestor
43958200|NCT01365611|Fluticasone|fluticasone|mesh-list
43958202|NCT01365611|Ketorolac|ketorolac|mesh-list
43958203|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43958204|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958205|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958206|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
43958207|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958208|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958209|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958210|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958211|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958212|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43958213|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958214|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958215|NCT01365611|Analgesics|analgesics|mesh-ancestor
43958216|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
43958217|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958218|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43958219|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958220|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958221|NCT01365624|Ketorolac|ketorolac|mesh-list
43958222|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43958223|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958224|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958225|NCT01365624|Analgesics|analgesics|mesh-ancestor
43958226|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
43958227|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822032|NCT02889523|Doxorubicin|doxorubicin|mesh-list
43958265|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
43958294|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43958295|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43958296|NCT01366976|Acetaminophen|acetaminophen|mesh-list
43958297|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958298|NCT01366976|Analgesics|analgesics|mesh-ancestor
43958299|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
43958300|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958301|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958302|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
43958303|NCT01368263|Letrozole|letrozole|mesh-list
43958304|NCT01368263|Anastrozole|anastrozole|mesh-list
43958305|NCT01368263|Goserelin|goserelin|mesh-list
43958306|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958307|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43958308|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43958309|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958310|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958311|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43958312|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
43822130|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
43698055|NCT02749123|Lidocaine|lidocaine|mesh-list
43958328|NCT01368809|Narcotics|narcotics|mesh-ancestor
43958329|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958330|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958331|NCT01368809|Analgesics|analgesics|mesh-ancestor
43958332|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
43958333|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958334|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43958335|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43958336|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
43958338|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
43958339|NCT01369732|Hematinics|hematinics|mesh-ancestor
43958340|NCT01369745|Prednisone|prednisone|mesh-list
43958341|NCT01369745|Prednisolone|prednisolone|mesh-list
43958342|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43958343|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
43958344|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43958345|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
43958346|NCT01369745|Dipyridamole|dipyridamole|mesh-list
43958347|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43958348|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
43958349|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958350|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
43958351|NCT01369745|Hormones|hormones|mesh-ancestor
43958352|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958353|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958354|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958355|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958356|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
43958357|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
43958358|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958359|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958360|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43958361|NCT01369745|Protective Agents|protective agents|mesh-ancestor
43958362|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43958363|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958364|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958365|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43958366|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
43958367|NCT01369875|Aldesleukin|aldesleukin|mesh-list
43958368|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
43958369|NCT01369875|Fludarabine|fludarabine|mesh-list
43958370|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958371|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
43958372|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958438|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958439|NCT01372202|Paclitaxel|paclitaxel|mesh-list
43958440|NCT01372202|Cisplatin|cisplatin|mesh-list
43958441|NCT01372202|Fluorouracil|fluorouracil|mesh-list
43958442|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
43958443|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43958444|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958445|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
43958446|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
43958488|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43958490|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
43958491|NCT01375491|Doxycycline|doxycycline|mesh-list
43958492|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43958493|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958494|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
43958495|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43958496|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43958497|NCT01375660|Vitamin D|vitamin d|mesh-list
43958498|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
43958499|NCT01375660|Vitamins|vitamins|mesh-ancestor
43958500|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
43958501|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958502|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43958503|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43958504|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
43958505|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43958506|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958507|NCT01376297|Dexamethasone|dexamethasone|mesh-list
43958508|NCT01376297|Aprepitant|aprepitant|mesh-list
43958509|NCT01376297|Palonosetron|palonosetron|mesh-list
43958510|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958511|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
43958512|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
43958513|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958514|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958515|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958516|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
43958517|NCT01376297|Hormones|hormones|mesh-ancestor
43958518|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958519|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958520|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958521|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43958522|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958523|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958524|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43958525|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43958526|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
43958527|NCT01376362|Interferons|interferons|mesh-list
43958528|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
43958529|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958530|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
43958531|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958532|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43958533|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43958534|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958535|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43958536|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958537|NCT01377467|Denosumab|denosumab|mesh-list
43958538|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43958539|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958540|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
43822341|NCT01396408|Sunitinib|sunitinib|mesh-list
43958577|NCT01378299|Hormones|hormones|mesh-ancestor
43958578|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958579|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958615|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43958616|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958617|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958652|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
43958653|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958654|NCT01380197|Morphine|morphine|mesh-list
43958655|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43958656|NCT01380197|Narcotics|narcotics|mesh-ancestor
43958657|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958658|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958696|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43958717|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958719|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
43958720|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958721|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
43958722|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43958723|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958724|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958725|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43958727|NCT01382303|Protective Agents|protective agents|mesh-ancestor
43958728|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958729|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
43958730|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43958731|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
43958732|NCT01383200|Lidocaine|lidocaine|mesh-list
43958733|NCT01383200|Tetracaine|tetracaine|mesh-list
43958734|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
43958735|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
43958736|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958737|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958738|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
43958739|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958740|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43958776|NCT01384591|Losartan|losartan|mesh-list
43958777|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43958778|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43822533|NCT05533983|Nivolumab|nivolumab|mesh-list
43958801|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43958802|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43958803|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958804|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958805|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
43958806|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958807|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958808|NCT01386983|Urological Agents|urological agents|mesh-ancestor
43958810|NCT01387139|Propofol|propofol|mesh-list
43958811|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43958812|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958813|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958814|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43958815|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
43958816|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
43958817|NCT01387139|Analgesics|analgesics|mesh-ancestor
43958818|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
43958819|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958820|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43958821|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43958822|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43958823|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958824|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958825|NCT01387178|Fluticasone|fluticasone|mesh-list
43958826|NCT01387178|Xhance|xhance|mesh-list
43958827|NCT01387178|Bromides|bromides|mesh-list
43958828|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
43958829|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43958830|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958831|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958832|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
43958862|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958864|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
43958865|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
43958866|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958867|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958868|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
43958869|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958870|NCT01389076|Methotrexate|methotrexate|mesh-list
43958871|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
43958872|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43958873|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
43958874|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43958875|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822600|NCT05532878|Apixaban|apixaban|mesh-list
43958886|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43958887|NCT01389284|Naproxen|naproxen|mesh-list
43958888|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958889|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958890|NCT01389284|Analgesics|analgesics|mesh-ancestor
43958891|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
43958892|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958893|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958894|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958895|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958896|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
43958897|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43958898|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958899|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958901|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43958902|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43958903|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958904|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43958905|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43958906|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
43958907|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958908|NCT01390077|Nitisinone|nitisinone|mesh-list
43958909|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958910|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958911|NCT01390233|Dinoprostone|dinoprostone|mesh-list
43958912|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
43958913|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43958914|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958915|NCT01390246|Bupropion|bupropion|mesh-list
43958916|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43958917|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
43958918|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43958919|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43958920|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43958921|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958922|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698532|NCT02744703|Capecitabine|capecitabine|mesh-list
43958923|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
43958924|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958925|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958926|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43958927|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43958928|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958930|NCT01390818|Sirolimus|sirolimus|mesh-list
43958931|NCT01390818|Elafin|elafin|mesh-list
43958932|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
43958933|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958934|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958935|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
43958936|NCT01390818|Vitamins|vitamins|mesh-ancestor
43958937|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
43958938|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958959|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958960|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958961|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958962|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43958963|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43958964|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43958965|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43958966|NCT01391013|Ritonavir|ritonavir|mesh-list
43958967|NCT01391013|Darunavir|darunavir|mesh-list
43958968|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43958969|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43958970|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43958971|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
43958972|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958973|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958974|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43958975|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43958976|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
43958977|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958978|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43958979|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43958980|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43958981|NCT01391273|Bimatoprost|bimatoprost|mesh-list
43958982|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43958983|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43958984|NCT01391286|Bimatoprost|bimatoprost|mesh-list
43958985|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44240407|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44240408|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958986|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43958987|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
43958988|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43958989|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43958990|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43958991|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958992|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959029|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43822751|NCT05532072|Sirolimus|sirolimus|mesh-list
43959054|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43959056|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
43959057|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
43959058|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959059|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959060|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959061|NCT01392989|Cyclosporine|cyclosporine|mesh-list
43959062|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
43959063|NCT01392989|Cyclosporins|cyclosporins|mesh-list
43959064|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
43959065|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43959066|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959067|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959068|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959069|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
43959070|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698658|NCT02744495|Hormones|hormones|mesh-ancestor
43959071|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
43959072|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959073|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959074|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959075|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43959076|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43959111|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
43959112|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959113|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43959114|NCT01393717|Antibodies|antibodies|mesh-list
43959115|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
43959116|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43959117|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
43959118|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
43959119|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959120|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43959156|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
43959157|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43959158|NCT01395329|Metoprolol|metoprolol|mesh-list
43959159|NCT01395329|Nebivolol|nebivolol|mesh-list
43959160|NCT01395329|Nitroprusside|nitroprusside|mesh-list
43959161|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
43959163|NCT01395329|Acetylcholine|acetylcholine|mesh-list
43846193|NCT04215146|Paclitaxel|paclitaxel|mesh-list
43959194|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43959195|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959197|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43959198|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959199|NCT01396486|Inositol|inositol|mesh-list
43959200|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
43959201|NCT01396486|Vitamins|vitamins|mesh-ancestor
43959202|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
43959203|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959204|NCT01397591|Bortezomib|bortezomib|mesh-list
43959205|NCT01397591|Ofatumumab|ofatumumab|mesh-list
43959206|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959207|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
44142287|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142288|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44142289|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44142290|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142291|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142292|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142330|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43822972|NCT05529940|Folfirinox|folfirinox|mesh-list
43959272|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43959273|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
43959274|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240409|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959275|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959276|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43959277|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959278|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959279|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43959280|NCT01401023|Tigecycline|tigecycline|mesh-list
43959281|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959282|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959283|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43959284|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959285|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959286|NCT01401166|Trastuzumab|trastuzumab|mesh-list
43959287|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43959288|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959289|NCT01401543|Tadalafil|tadalafil|mesh-list
43959290|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
43959291|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43959292|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43959293|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823029|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43959310|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
43959311|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
43959312|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698885|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
43959313|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43959314|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43959316|NCT01402050|Dinoprostone|dinoprostone|mesh-list
43959317|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
43959318|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959319|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959320|NCT01402375|Acetaminophen|acetaminophen|mesh-list
43959321|NCT01402375|Oxycodone|oxycodone|mesh-list
43959322|NCT01402375|Hydrocodone|hydrocodone|mesh-list
43959323|NCT01402375|Codeine|codeine|mesh-list
43959324|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959325|NCT01402375|Analgesics|analgesics|mesh-ancestor
43959326|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
43959327|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959328|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959329|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
43959330|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43959331|NCT01402375|Narcotics|narcotics|mesh-ancestor
43959332|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959333|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
43959334|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959335|NCT01402427|Verapamil|verapamil|mesh-list
43959336|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43959337|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43959338|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959339|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959340|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959341|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959342|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
43959343|NCT01403246|Lenalidomide|lenalidomide|mesh-list
43959344|NCT01403246|Chlorambucil|chlorambucil|mesh-list
43959345|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
43959346|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959347|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43959348|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43959349|NCT01403246|Growth Substances|growth substances|mesh-ancestor
43959350|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
43959351|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959387|NCT01404429|Methotrexate|methotrexate|mesh-list
43959388|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43959389|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
43959390|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959391|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959421|NCT01404923|Alverine|alverine|mesh-list
43959422|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
43959423|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
43959424|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959425|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959426|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
43959427|NCT01404936|Interferons|interferons|mesh-list
43959428|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
44171627|NCT00286130|Leucovorin|leucovorin|mesh-list
43959429|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
43959430|NCT01404936|Doxorubicin|doxorubicin|mesh-list
43959431|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43959432|NCT01404936|Bleomycin|bleomycin|mesh-list
43959433|NCT01404936|Dacarbazine|dacarbazine|mesh-list
43959434|NCT01404936|Vinblastine|vinblastine|mesh-list
43959435|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43959436|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959437|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43959438|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43959439|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823170|NCT05527548|Alendronate|alendronate|mesh-list
43959446|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
43959447|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43959448|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959449|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959450|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959451|NCT01405937|Ribavirin|ribavirin|mesh-list
43959452|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
43959453|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959454|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
43959455|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959456|NCT01406223|Bupropion|bupropion|mesh-list
43959457|NCT01406223|Nicotine|nicotine|mesh-list
43959458|NCT01406223|Varenicline|varenicline|mesh-list
43959459|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43959460|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
43959461|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959462|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959463|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43959464|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43959465|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959466|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142347|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
43959467|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959468|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43959469|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
43959470|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43959471|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43959472|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43959473|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959474|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
43959475|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43959476|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43959477|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959478|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
43959479|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43959480|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959481|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959482|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959483|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959484|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43959485|NCT01407094|Sertraline|sertraline|mesh-list
43959486|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
43959487|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43959488|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43959489|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43959490|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959491|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959492|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959493|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
43959494|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959495|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
43959496|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
43959497|NCT01407523|Levetiracetam|levetiracetam|mesh-list
43959498|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
43959499|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
43959500|NCT01407575|Buprenorphine|buprenorphine|mesh-list
43959501|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43959502|NCT01407575|Narcotics|narcotics|mesh-ancestor
43959503|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959504|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959505|NCT01407575|Analgesics|analgesics|mesh-ancestor
43959523|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44171691|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43959524|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43959525|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43959526|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43959528|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43959529|NCT01410084|Vitamin D|vitamin d|mesh-list
43959530|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
43959531|NCT01410084|Vitamins|vitamins|mesh-list
43959532|NCT01410084|Vitamin E|vitamin e|mesh-list
43959533|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
43959534|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959535|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43959536|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959537|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
43959538|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959539|NCT01410084|Protective Agents|protective agents|mesh-ancestor
43959540|NCT01410409|Acetaminophen|acetaminophen|mesh-list
43959541|NCT01410409|Pantoprazole|pantoprazole|mesh-list
43959542|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959543|NCT01410409|Analgesics|analgesics|mesh-ancestor
43959544|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
43959545|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959546|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959547|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
43959548|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43959549|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959550|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43959551|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959552|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959553|NCT01410565|Apaziquone|apaziquone|mesh-list
43959554|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959555|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43959556|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43959557|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
43959558|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959559|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43959560|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43959561|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
43959562|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
43959598|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959599|NCT01412281|Vaccines|vaccines|mesh-list
43959600|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
43959601|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959602|NCT01412372|Mesalamine|mesalamine|mesh-list
43823288|NCT05526690|Metformin|metformin|mesh-list
43959630|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959631|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959632|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959633|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959634|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43959635|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959636|NCT01414010|Amoxicillin|amoxicillin|mesh-list
43959637|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959638|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959639|NCT01414153|Bevacizumab|bevacizumab|mesh-list
43959640|NCT01414153|Ranibizumab|ranibizumab|mesh-list
43959641|NCT01414153|Aflibercept|aflibercept|mesh-list
43959642|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43959643|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43959644|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959645|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43959646|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43959647|NCT01414153|Growth Substances|growth substances|mesh-ancestor
43959648|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959649|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
43959650|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
43959651|NCT01415583|Dexamethasone|dexamethasone|mesh-list
43959682|NCT01416584|Narcotics|narcotics|mesh-ancestor
43959683|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959684|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959685|NCT01416584|Analgesics|analgesics|mesh-ancestor
43959686|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
43959687|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959688|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
43959689|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959690|NCT01417026|Oxytocin|oxytocin|mesh-list
43959691|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
43959692|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959693|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959694|NCT01418001|Gemcitabine|gemcitabine|mesh-list
43959695|NCT01418001|Docetaxel|docetaxel|mesh-list
43959696|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43959697|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
43959698|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959699|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959700|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
43959701|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959702|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959703|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959704|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
43959705|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959706|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959707|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959708|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959709|NCT01419275|Xenon|xenon|mesh-list
43959710|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43959711|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
43959712|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
43959713|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959714|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959715|NCT01419639|Everolimus|everolimus|mesh-list
43959716|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959746|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959747|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959749|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43959750|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959751|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959752|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43959753|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959754|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959755|NCT01421186|Dexamethasone|dexamethasone|mesh-list
43959756|NCT01421186|Lenalidomide|lenalidomide|mesh-list
43959757|NCT01421186|Pomalidomide|pomalidomide|mesh-list
43959758|NCT01421186|Felzartamab|felzartamab|mesh-list
43959759|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959760|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
43959761|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
43959762|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959763|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959764|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959765|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
43959829|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43959830|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43959863|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959864|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43959866|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
43959867|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43959868|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
43959869|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
43959870|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959908|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959909|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959910|NCT01426763|Complement C1s|complement c1s|mesh-list
43959985|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959986|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959987|NCT01428245|Progestins|progestins|mesh-ancestor
43959988|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43959989|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43959990|NCT01428336|Cosyntropin|cosyntropin|mesh-list
43959991|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
43959992|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959994|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959995|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959996|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959997|NCT01429259|Meropenem|meropenem|mesh-list
43959998|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959999|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960000|NCT01429272|Aspirin|aspirin|mesh-list
43960001|NCT01429272|Minocycline|minocycline|mesh-list
43960002|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43960003|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43960004|NCT01429272|Analgesics|analgesics|mesh-ancestor
43960005|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
43960006|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960007|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960008|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960009|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960010|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43960011|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43960012|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960013|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43960014|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43960015|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960016|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
43960017|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960018|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960019|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43960020|NCT01429350|Plasminogen|plasminogen|mesh-list
43960021|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43960022|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43960023|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960024|NCT01429987|Plecanatide|plecanatide|mesh-list
43960025|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43960026|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
43960027|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960028|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960029|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43960030|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43960031|NCT01430182|Morphine|morphine|mesh-list
43960102|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
43960103|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960104|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960105|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960106|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960107|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
43960108|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
43960109|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960110|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960111|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960112|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
43960113|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43960128|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960129|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960130|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
43960131|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960132|NCT01431989|Amoxicillin|amoxicillin|mesh-list
43960133|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960134|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960135|NCT01432015|Aprepitant|aprepitant|mesh-list
43960136|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
43960137|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
43960138|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
43960139|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960140|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960141|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960142|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43960143|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960144|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960145|NCT01432145|Methotrexate|methotrexate|mesh-list
43960146|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
43960147|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43960148|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
43960149|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960150|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960151|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960152|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
43960153|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960154|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960155|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960156|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960157|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43960158|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960159|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
43960160|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960161|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43960162|NCT01432236|Pregabalin|pregabalin|mesh-list
43960163|NCT01432236|Analgesics|analgesics|mesh-ancestor
44240410|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960165|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960166|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960167|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
43960168|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43960169|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960170|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960171|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43960172|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43960173|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44142379|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44142381|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823576|NCT05521347|Caffeine|caffeine|mesh-list
43960229|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960230|NCT01434121|Protective Agents|protective agents|mesh-ancestor
43960231|NCT01434186|Metformin|metformin|mesh-list
43960232|NCT01434186|Saxagliptin|saxagliptin|mesh-list
43960233|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960234|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960235|NCT01434186|Incretins|incretins|mesh-ancestor
43960236|NCT01434186|Hormones|hormones|mesh-ancestor
43960237|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960238|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43960239|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
43960240|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960259|NCT01434472|Antibodies|antibodies|mesh-list
43960260|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
43960261|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43960262|NCT01434472|Cyclosporins|cyclosporins|mesh-list
43960263|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
43960264|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960265|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960266|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960267|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960268|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
43960269|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960270|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960271|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
43960272|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960273|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960274|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
43960275|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960276|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43960277|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43960278|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43960279|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
43960280|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960282|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
43960283|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43960284|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43960285|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960286|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960287|NCT01435824|Amoxicillin|amoxicillin|mesh-list
43960288|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960289|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960290|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
43960291|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960292|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960293|NCT01436266|Folic Acid|folic acid|mesh-list
43960294|NCT01436266|Misoprostol|misoprostol|mesh-list
43960295|NCT01436266|Vitamins|vitamins|mesh-ancestor
43960296|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
43960297|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960298|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43960299|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
43960300|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960353|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960354|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
43960355|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
43960356|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
43960357|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960358|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44240411|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240412|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43960359|NCT01437605|Poly I-C|poly i-c|mesh-list
43960360|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
43960361|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
43960362|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960363|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
43960364|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960365|NCT01438710|Tacrolimus|tacrolimus|mesh-list
43960366|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960367|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
43960368|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960369|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43960370|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960371|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960372|NCT01439672|Insulin|insulin|mesh-list
43960373|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960374|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960375|NCT01439815|Fluticasone|fluticasone|mesh-list
43960377|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960378|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43960379|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
43960380|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960381|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960382|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43960383|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
43960384|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960385|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43960386|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
43960387|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44001781|NCT04895410|Hormones|hormones|mesh-ancestor
43960388|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960389|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960390|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960391|NCT01440764|Furosemide|furosemide|mesh-list
43960392|NCT01440764|Diuretics|diuretics|mesh-ancestor
43960420|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960421|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960422|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43960423|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43960424|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960425|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960426|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
43960427|NCT01441570|Metoprolol|metoprolol|mesh-list
43960428|NCT01441570|Nebivolol|nebivolol|mesh-list
43960429|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43960430|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43960431|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
43960432|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
43960433|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960434|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960435|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43960459|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960460|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960461|NCT01441882|Dasatinib|dasatinib|mesh-list
43960462|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960463|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43960464|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960465|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960466|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43960467|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
43960468|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43960469|NCT01443546|Leuprolide|leuprolide|mesh-list
43960470|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43960471|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
43960472|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960473|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960474|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960475|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960476|NCT01444716|Ofatumumab|ofatumumab|mesh-list
43960477|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43960478|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960479|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
43960480|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960482|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
43960483|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
43960484|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960485|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960486|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
43960487|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960518|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
43960519|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960520|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960521|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
43960522|NCT01445821|Hormones|hormones|mesh-ancestor
43960523|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960524|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43960525|NCT01445821|Protective Agents|protective agents|mesh-ancestor
43960526|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960527|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
43960528|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43960529|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960530|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
43960531|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43642065|NCT05514990|Hormones|hormones|mesh-ancestor
43960557|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43960558|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960559|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960560|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43960561|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43960562|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43960563|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43960564|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43960565|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43960566|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
43960567|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43960568|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43960569|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43960570|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
43960571|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960572|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960573|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43960574|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43960575|NCT01447706|Paclitaxel|paclitaxel|mesh-list
43960576|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43960577|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960578|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
43960579|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
43960580|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
43960595|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43960596|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43960597|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
43960598|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960599|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43960600|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43960601|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960602|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960603|NCT01448525|Bimatoprost|bimatoprost|mesh-list
43960604|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43960605|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43960606|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43960607|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43960608|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
43960609|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
43960610|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960611|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43960612|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960613|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960614|NCT01449747|Incretins|incretins|mesh-ancestor
43960615|NCT01449747|Hormones|hormones|mesh-ancestor
43960616|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960617|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43960618|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
43960619|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240413|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44240414|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44240415|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44240416|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
44240417|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44240418|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
44240419|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240420|NCT00579995|Expectorants|expectorants|mesh-ancestor
44240421|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240422|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44240423|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
44240424|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240425|NCT00579995|Protective Agents|protective agents|mesh-ancestor
44240426|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240427|NCT00579995|Antidotes|antidotes|mesh-ancestor
44240428|NCT00580060|Molgramostim|molgramostim|mesh-list
44240429|NCT00580060|Sargramostim|sargramostim|mesh-list
44240430|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
44240431|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240432|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459185|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43960620|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960621|NCT01450189|Tenofovir|tenofovir|mesh-list
43960622|NCT01450189|Emtricitabine|emtricitabine|mesh-list
43960623|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
43960624|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43960625|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
43960626|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960627|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43960628|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43960629|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960630|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960631|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43960632|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43960633|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43960634|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43960635|NCT01450306|Cycloserine|cycloserine|mesh-list
43960636|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43960637|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960638|NCT01450306|Renal Agents|renal agents|mesh-ancestor
44142453|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142454|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142455|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142457|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
44142458|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142459|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142460|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
44142461|NCT00187005|Hormones|hormones|mesh-ancestor
44142486|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142488|NCT00187057|Cytarabine|cytarabine|mesh-list
44142489|NCT00187057|Dexamethasone|dexamethasone|mesh-list
44142490|NCT00187057|Prednisone|prednisone|mesh-list
44142491|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
44142492|NCT00187057|Doxorubicin|doxorubicin|mesh-list
44142493|NCT00187057|Methotrexate|methotrexate|mesh-list
44142494|NCT00187057|Etoposide|etoposide|mesh-list
44142495|NCT00187057|Vincristine|vincristine|mesh-list
44142496|NCT00187057|Daunorubicin|daunorubicin|mesh-list
44459186|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44459187|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459188|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44459189|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44172201|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
44142497|NCT00187057|Asparaginase|asparaginase|mesh-list
44142498|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
44142499|NCT00187057|Vinblastine|vinblastine|mesh-list
44142500|NCT00187057|Procarbazine|procarbazine|mesh-list
44142501|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142502|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
44142503|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142504|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142505|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142506|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
44142507|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699979|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44142508|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960666|NCT01451411|Conivaptan|conivaptan|mesh-list
43960667|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43960686|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960687|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43960688|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43960689|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43960690|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
43960691|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
43960692|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960693|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960694|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960695|NCT01452126|Ropivacaine|ropivacaine|mesh-list
43960696|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43960697|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
43960698|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960699|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960700|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
43960701|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960702|NCT01453075|Valacyclovir|valacyclovir|mesh-list
43960703|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
43960704|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960705|NCT01454362|Nicotine|nicotine|mesh-list
43960706|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43960707|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
43960708|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960709|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960710|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43960711|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43960712|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
43960713|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960714|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960715|NCT01454414|Permethrin|permethrin|mesh-list
43960716|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960717|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960718|NCT01454791|Diclofenac|diclofenac|mesh-list
43960719|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43960720|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43960721|NCT01454791|Analgesics|analgesics|mesh-ancestor
43960722|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
43960744|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960745|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960746|NCT01456299|Analgesics|analgesics|mesh-ancestor
43960747|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
43960748|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960749|NCT01457430|Icatibant|icatibant|mesh-list
43960750|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43960751|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43960752|NCT01457430|Analgesics|analgesics|mesh-ancestor
43960753|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
43960754|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960755|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960756|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459190|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459191|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44459192|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459193|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
43960757|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960758|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43960759|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43960760|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960761|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43960762|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960763|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
43960765|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43960766|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43960767|NCT01457521|Analgesics|analgesics|mesh-ancestor
43960768|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
43960769|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960770|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960771|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960772|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960773|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43960774|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642312|NCT05464940|Caffeine|caffeine|mesh-list
43960810|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960845|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43960846|NCT01460940|Growth Substances|growth substances|mesh-ancestor
43960847|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
43960848|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960849|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960850|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960851|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43960882|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
43960883|NCT01462253|Clofarabine|clofarabine|mesh-list
43960884|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960885|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
43960886|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960887|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960888|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43960889|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
43960890|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960919|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960920|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960921|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960922|NCT01462877|Fenofibrate|fenofibrate|mesh-list
43960923|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43960924|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
43960925|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960926|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43960927|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43960928|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
43960929|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43960930|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43960931|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43960932|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
43960933|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960934|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960935|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43960936|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43960937|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43960938|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960939|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960940|NCT01463384|Minocycline|minocycline|mesh-list
43642483|NCT05422612|Fluoxetine|fluoxetine|mesh-list
43960969|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960971|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43960972|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
43960973|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459195|NCT01584232|Biguanides|biguanides|mesh-list
44459196|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459197|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459198|NCT01583530|Belimumab|belimumab|mesh-list
44459199|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459200|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
44459201|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459202|NCT01583374|Thalidomide|thalidomide|mesh-list
44459203|NCT01583374|Apremilast|apremilast|mesh-list
44172328|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960974|NCT01464359|Analgesics|analgesics|mesh-ancestor
43960975|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
43960976|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960977|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
43960978|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
43960979|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960980|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
43960981|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43960982|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
43960983|NCT01464359|Protective Agents|protective agents|mesh-ancestor
43960984|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43960985|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960986|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43960987|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
43960988|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43961021|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961022|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43961023|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43961024|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
43961025|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
43961026|NCT01468337|Interferons|interferons|mesh-list
43823731|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
43642550|NCT05406466|Lenvatinib|lenvatinib|mesh-list
43961098|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
43961099|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43961100|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
43961101|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961102|NCT01470027|Protective Agents|protective agents|mesh-ancestor
43961103|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961104|NCT01470027|Antidotes|antidotes|mesh-ancestor
43961105|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43961106|NCT01470118|Dextrans|dextrans|mesh-list
43961144|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43961145|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961146|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
43961147|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142512|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
44142513|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142514|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142515|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
44142516|NCT00187057|Hormones|hormones|mesh-ancestor
44142517|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142518|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142519|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142520|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142521|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142522|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142523|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142524|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
44142525|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142526|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142527|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
44142528|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142529|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142530|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142531|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44459204|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44459205|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459206|NCT01583374|Analgesics|analgesics|mesh-ancestor
44459207|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
44459208|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459209|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459210|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459211|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459212|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44459213|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44459214|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285633|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142532|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
44142533|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142534|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142535|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142536|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142537|NCT00187070|Cytarabine|cytarabine|mesh-list
43961158|NCT01470651|Modafinil|modafinil|mesh-list
43961159|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43961160|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961161|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43961162|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43961163|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43961164|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961165|NCT01470859|Levodopa|levodopa|mesh-list
43961166|NCT01470859|Carbidopa|carbidopa|mesh-list
43961167|NCT01470859|Pramipexole|pramipexole|mesh-list
43961168|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43961169|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43961170|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43961171|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
43961172|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961173|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961174|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961175|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43961176|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961177|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
43961178|NCT01470859|Protective Agents|protective agents|mesh-ancestor
43961179|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
43961215|NCT01472874|Trientine|trientine|mesh-list
43961216|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
43961217|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
43961218|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961222|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43961223|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961224|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961225|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43961226|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961227|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961228|NCT01473745|Daminozide|daminozide|mesh-list
43961229|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43961230|NCT01473745|Growth Substances|growth substances|mesh-ancestor
43961231|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961232|NCT01474109|Macitentan|macitentan|mesh-list
43961233|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43961234|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43961235|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961236|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43961238|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43808375|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44459215|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459216|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459217|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
44459218|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
44459219|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44459220|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459221|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459222|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43613046|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
43961239|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43961240|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961241|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43961243|NCT01474200|Diuretics|diuretics|mesh-list
43961244|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43961245|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
43961246|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961247|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43961248|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961249|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
43961250|NCT01474213|Remifentanil|remifentanil|mesh-list
43961251|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961252|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961253|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961254|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961255|NCT01474213|Analgesics|analgesics|mesh-ancestor
43961256|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
43961257|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961258|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43961259|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961260|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961261|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961262|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961263|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961264|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43961265|NCT01474213|Narcotics|narcotics|mesh-ancestor
43961266|NCT01474590|Doxycycline|doxycycline|mesh-list
43961267|NCT01474590|Isotretinoin|isotretinoin|mesh-list
43961268|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961269|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961270|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
43961271|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43961272|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43961273|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961274|NCT01474915|Promethazine|promethazine|mesh-list
43961275|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
43961276|NCT01474915|Dexamethasone|dexamethasone|mesh-list
43961277|NCT01474915|Ondansetron|ondansetron|mesh-list
43961278|NCT01474915|Aprepitant|aprepitant|mesh-list
43961279|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961280|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
43961281|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
43961282|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961283|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961284|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961285|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
43961286|NCT01474915|Hormones|hormones|mesh-ancestor
43961287|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002220|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43961288|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961289|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961290|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
43961291|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961292|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43961301|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43961302|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43961303|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
43961304|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
44459223|NCT01583374|Growth Substances|growth substances|mesh-ancestor
44459224|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459225|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459226|NCT01583218|Enoxaparin|enoxaparin|mesh-list
43961305|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43961306|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43961307|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961308|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
43961310|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
43961311|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
43961312|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43961313|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961314|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961315|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43961316|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43961317|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961318|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961319|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961320|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43961321|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
43961322|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43961323|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961324|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43961325|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43961326|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43961327|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43961328|NCT01475643|Prednisolone|prednisolone|mesh-list
43961329|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43961330|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
43961331|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43961332|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
43961333|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43961334|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
43961335|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961336|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
43961338|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961339|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961340|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961341|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961342|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
43961343|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
43961344|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961345|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961346|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43961347|NCT01475643|Protective Agents|protective agents|mesh-ancestor
43961348|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43961349|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43961350|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43961351|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961352|NCT01476202|Nicotine|nicotine|mesh-list
43961353|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43961354|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
43961355|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961356|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961357|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43961358|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43961375|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961376|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
43961377|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961378|NCT01477320|Pantoprazole|pantoprazole|mesh-list
43961379|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43961380|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961381|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43961382|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961383|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961384|NCT01477463|Vitamin D|vitamin d|mesh-list
43961385|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
43961386|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
43961388|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
43961389|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961390|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43700926|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459227|NCT01583218|Betrixaban|betrixaban|mesh-list
44459228|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
44459229|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44459230|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44240433|NCT00580112|Dexamethasone|dexamethasone|mesh-list
44240434|NCT00580112|Trabectedin|trabectedin|mesh-list
44240435|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240436|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
44240437|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
44240438|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240439|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240440|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240441|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
44240442|NCT00580112|Hormones|hormones|mesh-ancestor
44240443|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240444|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44240445|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240446|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240447|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
44240448|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240449|NCT00580190|Alprazolam|alprazolam|mesh-list
44240450|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44240451|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240452|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240453|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240454|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240455|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43961391|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43961392|NCT01477762|Dexamethasone|dexamethasone|mesh-list
43961393|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961394|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
43961395|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
43961396|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961397|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961398|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961399|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
43961400|NCT01477762|Hormones|hormones|mesh-ancestor
43961401|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961402|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961403|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961404|NCT01478256|Erythromycin|erythromycin|mesh-list
43961405|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
43961406|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43961407|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
43961408|NCT01478256|Besifloxacin|besifloxacin|mesh-list
43961409|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961410|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961411|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961412|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44240456|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
44240457|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
44240458|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240459|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240460|NCT00580242|Lenalidomide|lenalidomide|mesh-list
44240461|NCT00580242|Bortezomib|bortezomib|mesh-list
44240462|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
44240463|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172652|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
43961413|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961414|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961415|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43961416|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43961417|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961418|NCT01478581|Dexamethasone|dexamethasone|mesh-list
43961440|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961441|NCT01479127|Trace Elements|trace elements|mesh-ancestor
43961442|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
43961444|NCT01479270|Ropivacaine|ropivacaine|mesh-list
43961445|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
43961446|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
43961447|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961448|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961449|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
43961450|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961451|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961452|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961453|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961454|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961455|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961456|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43961457|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43961458|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
43961459|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43961460|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
43961461|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
43961462|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
43961463|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43961464|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
43961465|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
43961466|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961467|NCT01479517|Tetracaine|tetracaine|mesh-list
43961468|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
43961469|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
43961470|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961471|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642957|NCT05235256|Hormones|hormones|mesh-ancestor
43961506|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961507|NCT01480297|Analgesics|analgesics|mesh-ancestor
43961508|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
43961534|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43961535|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961536|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
43961537|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43961538|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961539|NCT01481545|Antidotes|antidotes|mesh-ancestor
43961540|NCT01481545|Protective Agents|protective agents|mesh-ancestor
43961541|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
43961542|NCT01481545|Vitamins|vitamins|mesh-ancestor
43961543|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
43961544|NCT01481740|Phenylephrine|phenylephrine|mesh-list
43961545|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
43961546|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43961547|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
43961548|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
43961549|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961550|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961551|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
43961552|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43961553|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
44240464|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240465|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240466|NCT00580242|Growth Substances|growth substances|mesh-ancestor
44240467|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44240468|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240469|NCT00580320|Bortezomib|bortezomib|mesh-list
44240470|NCT00580320|Dacarbazine|dacarbazine|mesh-list
44240471|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240472|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240473|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
44240474|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240475|NCT00580359|Capecitabine|capecitabine|mesh-list
44240476|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44240477|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
44240478|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240479|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240480|NCT00580424|Norethindrone|norethindrone|mesh-list
44240481|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
44240482|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44002440|NCT03871036|Paclitaxel|paclitaxel|mesh-list
44240483|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44240484|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44240485|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
44240486|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44240487|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172710|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961554|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
43961555|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43961556|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961557|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961558|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961559|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961569|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961570|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43961571|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43961572|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
43961573|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
43961574|NCT01482715|Rucaparib|rucaparib|mesh-list
43961575|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43961576|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961577|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961578|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961579|NCT01483560|Metformin|metformin|mesh-list
43961580|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961581|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961582|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43961583|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43961584|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961585|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961586|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44240488|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44240489|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44240490|NCT00580437|Dobutamine|dobutamine|mesh-list
44240491|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44240492|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
44240493|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
44240494|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240495|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240496|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44240497|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43961587|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
43961588|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961589|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961590|NCT01484340|Nicotine|nicotine|mesh-list
43961591|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43961592|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
43961593|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961594|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961595|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43961596|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43961597|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
43961598|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961599|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961600|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43961601|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961602|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
43961603|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961604|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961605|NCT01485055|Infliximab|infliximab|mesh-list
43961606|NCT01485055|Basiliximab|basiliximab|mesh-list
43961607|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961608|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961609|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961610|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961611|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
43961612|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961613|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
43961614|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961615|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961616|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961617|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961618|NCT01485380|Analgesics|analgesics|mesh-ancestor
43961619|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
43961620|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961621|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43961622|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961623|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961624|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961659|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961660|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961661|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43961662|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43961663|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43961664|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
43961665|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
43961698|NCT01488279|BB 1101|bb 1101|mesh-list
43961699|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961700|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
43961701|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
43961702|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961703|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961704|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961705|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
43961706|NCT01488279|Hormones|hormones|mesh-ancestor
43962694|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44240498|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44240499|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240500|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240501|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961741|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43961742|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
43961743|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
43961744|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961745|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142555|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142556|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142557|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142558|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142559|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
44142560|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
44142561|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142562|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142563|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
44142564|NCT00187070|Hormones|hormones|mesh-ancestor
44142565|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142566|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142597|NCT00187083|Asparaginase|asparaginase|mesh-list
44142598|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
44142599|NCT00187083|Idarubicin|idarubicin|mesh-list
44142600|NCT00187083|Pegaspargase|pegaspargase|mesh-list
44142601|NCT00187083|Teniposide|teniposide|mesh-list
44142602|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142603|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
44142604|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
44142605|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142606|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142607|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142608|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
44142609|NCT00187083|Hormones|hormones|mesh-ancestor
44142610|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142611|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961761|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
43961762|NCT01490723|Rituximab|rituximab|mesh-list
43961763|NCT01490723|Methotrexate|methotrexate|mesh-list
43961764|NCT01490723|Fludarabine|fludarabine|mesh-list
43643353|NCT05083312|Xhance|xhance|mesh-list
43961794|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
43961795|NCT01490788|Amitriptyline|amitriptyline|mesh-list
43961796|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
43961797|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43961798|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
43961799|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43961800|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43961801|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961802|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43961803|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961804|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43961805|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961806|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961807|NCT01490788|Analgesics|analgesics|mesh-ancestor
43961808|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
43961812|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961813|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961814|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961815|NCT01490931|Ketorolac|ketorolac|mesh-list
43961816|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43961817|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961818|NCT01490931|Analgesics|analgesics|mesh-ancestor
43961819|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
43961820|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961821|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961822|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961823|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961824|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43961825|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961826|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240502|NCT00580437|Protective Agents|protective agents|mesh-ancestor
44240503|NCT00580450|Thymalfasin|thymalfasin|mesh-list
44240504|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44240505|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
43961827|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
43961828|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43961829|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43961830|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961831|NCT01491113|Levetiracetam|levetiracetam|mesh-list
43961832|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
43961833|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
43961834|NCT01491633|Dasatinib|dasatinib|mesh-list
43961835|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961836|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43961837|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961838|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961839|NCT01491958|Methotrexate|methotrexate|mesh-list
43961840|NCT01491958|Atorvastatin|atorvastatin|mesh-list
43961841|NCT01491958|Tacrolimus|tacrolimus|mesh-list
43961842|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43961843|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
43961844|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43961845|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961846|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43961847|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
43961848|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961849|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961850|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961851|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961852|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43961853|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961854|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
43961855|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961856|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43961857|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43961858|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43961859|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43961860|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43961861|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43961862|NCT01492582|Vaccines|vaccines|mesh-list
43961863|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
43961864|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961865|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
43961866|NCT01492673|Bevacizumab|bevacizumab|mesh-list
43961867|NCT01492673|Topotecan|topotecan|mesh-list
43961868|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961869|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
43961870|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961871|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961872|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961873|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
43961874|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961875|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961876|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43961877|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43961878|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43961910|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961912|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
43961913|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961914|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43961915|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961916|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961917|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961918|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961919|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961920|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43961921|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
43961922|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43643492|NCT05018221|Vitamins|vitamins|mesh-list
43961953|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808376|NCT04883034|Analgesics|analgesics|mesh-list
44240506|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173029|NCT00291382|Xhance|xhance|mesh-list
43961955|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43961956|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961957|NCT01495858|Analgesics|analgesics|mesh-ancestor
43961958|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
43961959|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961960|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961961|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961962|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961963|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
43961964|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43961965|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961966|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961967|NCT01495923|Gabapentin|gabapentin|mesh-list
43961968|NCT01495923|Analgesics|analgesics|mesh-ancestor
43962005|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43962030|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
43962031|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
43962032|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962033|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
43962034|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
43962035|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962036|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962037|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43962038|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43962039|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962040|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962041|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962042|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
43962043|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43962044|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43962045|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43962046|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962047|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962048|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962049|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962050|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962051|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
43962052|NCT01498588|Doxorubicin|doxorubicin|mesh-list
43962053|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643595|NCT04959812|Sufentanil|sufentanil|mesh-list
43962088|NCT01499147|Busulfan|busulfan|mesh-list
43962089|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
43962090|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002710|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
43962091|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43962092|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
43962695|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43962105|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43962106|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962107|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962108|NCT01499498|Urological Agents|urological agents|mesh-ancestor
43962109|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43962110|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43962111|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962112|NCT01501162|Ethanol|ethanol|mesh-list
43962113|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43962114|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962115|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701136|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43701137|NCT02726828|Narcotics|narcotics|mesh-ancestor
43701138|NCT02726503|Lenvatinib|lenvatinib|mesh-list
43701139|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701140|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43701141|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701142|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830593|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43962116|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962117|NCT01501929|Metoprolol|metoprolol|mesh-list
43962118|NCT01501929|Nebivolol|nebivolol|mesh-list
43962119|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962120|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44240508|NCT00580619|Trimethaphan|trimethaphan|mesh-list
44240509|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
44240510|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240511|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44240512|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
44240513|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
44240514|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240515|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240516|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44240517|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44240518|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44240519|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240520|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240521|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44240522|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44173054|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
43962121|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
43962122|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
43962123|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962124|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962125|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43962126|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43962127|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43962128|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962129|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962130|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962131|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
43962132|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43962133|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43962134|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43962136|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43962137|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
43962138|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962139|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962140|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43962141|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43962142|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
43962143|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962144|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962145|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
43962159|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43962160|NCT01502787|Metoprolol|metoprolol|mesh-list
43962161|NCT01502787|Nebivolol|nebivolol|mesh-list
43962162|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
43962163|NCT01502787|Giapreza|giapreza|mesh-list
43962164|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
43962165|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962166|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43962167|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
43962168|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
43962169|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962170|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962171|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43962172|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43962173|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43962174|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962175|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962176|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240523|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44240524|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44173099|NCT00291759|Tamoxifen|tamoxifen|mesh-list
43962177|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
43962178|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43962179|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43962180|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43962181|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43962182|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43962183|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
43962184|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962185|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43962186|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
43962187|NCT01503749|Lenograstim|lenograstim|mesh-list
43962188|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43962189|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
43962190|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962191|NCT01504477|Bortezomib|bortezomib|mesh-list
43962192|NCT01504477|Panitumumab|panitumumab|mesh-list
43962193|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962194|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43962195|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
43962196|NCT01504711|Aprepitant|aprepitant|mesh-list
43962197|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
43962198|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
43962199|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962200|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962201|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43962202|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43962203|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962204|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962205|NCT01504854|Resveratrol|resveratrol|mesh-list
43962206|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
43643750|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
43962237|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962238|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962239|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962240|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
43962241|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962242|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
43962243|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962244|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962245|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43962246|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
43962247|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962282|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43962283|NCT01507220|Narcotics|narcotics|mesh-ancestor
43962284|NCT01507220|Analgesics|analgesics|mesh-ancestor
43962286|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
43962287|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962288|NCT01508117|Axitinib|axitinib|mesh-list
43962289|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962290|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43962301|NCT01508455|Analgesics|analgesics|mesh-ancestor
43962302|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
43962303|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962304|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43962305|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43962306|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44002859|NCT03182426|Analgesics|analgesics|mesh-ancestor
43962307|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962308|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962309|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962310|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43962311|NCT01508455|Narcotics|narcotics|mesh-ancestor
43962312|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43962313|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43962314|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
43962315|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
43962316|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43962317|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43962318|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43962319|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
43962320|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
43962322|NCT01508832|Bupivacaine|bupivacaine|mesh-list
43962323|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962324|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
43962325|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962326|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962327|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
43962328|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962329|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962330|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43962331|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43962332|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962333|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962334|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43962335|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
43962336|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962337|NCT01509404|Valganciclovir|valganciclovir|mesh-list
43962338|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
43962339|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962340|NCT01509586|Lobeline|lobeline|mesh-list
43962341|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43962342|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
43962343|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962344|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962345|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43962346|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43962347|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
43962348|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962349|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962350|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
43962351|NCT01509625|Fulvestrant|fulvestrant|mesh-list
43962352|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43962353|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962354|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43962355|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44142613|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142615|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142616|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142617|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
44142618|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142619|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142620|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142621|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142622|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142623|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
44142624|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142625|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142626|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142627|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44002941|NCT03036488|Paclitaxel|paclitaxel|mesh-list
44142628|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142629|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142630|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142631|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142632|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44142633|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142634|NCT00187122|Cytarabine|cytarabine|mesh-list
44142635|NCT00187122|Dexamethasone|dexamethasone|mesh-list
44142636|NCT00187122|Prednisone|prednisone|mesh-list
44142637|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
44142638|NCT00187122|Methotrexate|methotrexate|mesh-list
44142639|NCT00187122|Etoposide|etoposide|mesh-list
44142640|NCT00187122|Vincristine|vincristine|mesh-list
44142641|NCT00187122|Asparaginase|asparaginase|mesh-list
44142642|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
44142643|NCT00187122|Daunorubicin|daunorubicin|mesh-list
44142644|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142645|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
44142646|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142647|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962392|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43962393|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43962394|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962395|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
43962396|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962397|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962398|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
43962399|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43962400|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44240525|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
44240526|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44240527|NCT00580814|Methylphenidate|methylphenidate|mesh-list
44240528|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44240529|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240530|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44240531|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44240532|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240533|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240534|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
44240535|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240537|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44240538|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44240539|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240540|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240541|NCT00580905|Adenosine|adenosine|mesh-list
44240542|NCT00580905|Nitroprusside|nitroprusside|mesh-list
44240543|NCT00580905|Analgesics|analgesics|mesh-ancestor
44240544|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
44240545|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240546|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240547|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44240548|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
44240549|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44240550|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
44240551|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
44240552|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240553|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240571|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240572|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44240573|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44240574|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240575|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240576|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240577|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
44240578|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240579|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240580|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
44240581|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240582|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002997|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240583|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44240584|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
44240585|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240587|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
44240588|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240589|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240590|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43962422|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962423|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43962424|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43962425|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43962426|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
43962427|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
43962428|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43962429|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43962430|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962431|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962432|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
43962433|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
43962434|NCT01510457|Milnacipran|milnacipran|mesh-list
43962435|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
43962436|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43962437|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43962438|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962439|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962440|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962441|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962442|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962443|NCT01510457|Analgesics|analgesics|mesh-ancestor
43962444|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
43962445|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962446|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
43962447|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43962448|NCT01511068|Sargramostim|sargramostim|mesh-list
43962449|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
43962450|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962451|NCT01511315|Ustekinumab|ustekinumab|mesh-list
43962452|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
43962453|NCT01511640|Pregabalin|pregabalin|mesh-list
43962454|NCT01511640|Analgesics|analgesics|mesh-ancestor
43962455|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
43962485|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240592|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240593|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240594|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240595|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44240596|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
44240597|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
44240598|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
44240599|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285634|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962486|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962488|NCT01512225|Maleic acid|maleic acid|mesh-list
43962489|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962490|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962491|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
43962492|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
43962493|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962494|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962495|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43962496|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43962497|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
43962514|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
43962515|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962516|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962517|NCT01513122|Ritonavir|ritonavir|mesh-list
43962518|NCT01513122|Lopinavir|lopinavir|mesh-list
43962519|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
43962520|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43962521|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43962522|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
43962523|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146616|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43962524|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962525|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43962526|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43962528|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962529|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43962530|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43962531|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43962532|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43962534|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43962535|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962536|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962537|NCT01514149|Metformin|metformin|mesh-list
43962538|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43962539|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962540|NCT01514513|Permethrin|permethrin|mesh-list
43962541|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962542|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962543|NCT01514734|Timolol|timolol|mesh-list
43962544|NCT01514734|Brinzolamide|brinzolamide|mesh-list
43962545|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43962546|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43962547|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962548|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962549|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962550|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962551|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962552|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43962553|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962554|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43962555|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
43962556|NCT01515046|Gemcitabine|gemcitabine|mesh-list
43962581|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43962582|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43962583|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
43962584|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240600|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240601|NCT00581165|Etanercept|etanercept|mesh-list
44240602|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44240603|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44240604|NCT00581165|Analgesics|analgesics|mesh-ancestor
44240605|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
44240606|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240607|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240608|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43962585|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962586|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962587|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43962588|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43962589|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
43962590|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962591|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962592|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962593|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
43962594|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
43962595|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962596|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962597|NCT01515540|Lidocaine|lidocaine|mesh-list
43962598|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962599|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
43962600|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701589|NCT02723500|Xenon|xenon|mesh-list
43962601|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962602|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
43962603|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962604|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962605|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43962606|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43962631|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43962632|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962633|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43962634|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43962635|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962636|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
43962637|NCT01515891|Opicapone|opicapone|mesh-list
43962638|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43962639|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962640|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962641|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962642|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962643|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
43962644|NCT01515995|Analgesics|analgesics|mesh-ancestor
43962645|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
43962646|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962647|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962648|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
43962649|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962650|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962651|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
43962652|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43962653|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962654|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962696|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962708|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
43962709|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
43962710|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962711|NCT01517074|Sirolimus|sirolimus|mesh-list
43962712|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962713|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240609|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240610|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240611|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240612|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
44240613|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44240614|NCT00581217|Laxatives|laxatives|mesh-ancestor
44240615|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240616|NCT00581425|Interferons|interferons|mesh-list
43962714|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43962715|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962716|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
43962717|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962718|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
43962719|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962720|NCT01519063|Naltrexone|naltrexone|mesh-list
43962721|NCT01519063|Memantine|memantine|mesh-list
43962722|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43962723|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43962724|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962725|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
43962726|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962727|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962728|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962729|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
43962730|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962731|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962732|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43962733|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43962734|NCT01519271|Rivastigmine|rivastigmine|mesh-list
43962735|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43962736|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962737|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962738|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
43962739|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962740|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962741|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43962742|NCT01519271|Protective Agents|protective agents|mesh-ancestor
43962743|NCT01519284|Levodopa|levodopa|mesh-list
43962744|NCT01519284|Carbidopa|carbidopa|mesh-list
43962745|NCT01519284|Opicapone|opicapone|mesh-list
43962746|NCT01519284|Entacapone|entacapone|mesh-list
43962747|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962748|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962749|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
43962750|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962751|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962752|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962753|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43962754|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962755|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43962757|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
43962758|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
43962759|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962760|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962761|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962762|NCT01520207|Mannitol|mannitol|mesh-list
43962776|NCT01520519|Rituximab|rituximab|mesh-list
43962777|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43962778|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962779|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
43962780|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962781|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962782|NCT01520688|Fluticasone|fluticasone|mesh-list
43962783|NCT01520688|Xhance|xhance|mesh-list
43962784|NCT01520688|Budesonide|budesonide|mesh-list
43962785|NCT01520688|Beclomethasone|beclomethasone|mesh-list
43962786|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43962787|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43962788|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
44240618|NCT00581425|Imiquimod|imiquimod|mesh-list
44240619|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962789|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962790|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962791|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43962792|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
43962793|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
43962794|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43962795|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
43962796|NCT01520688|Hormones|hormones|mesh-ancestor
43962797|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962798|NCT01520727|Opicapone|opicapone|mesh-list
43962799|NCT01520727|Entacapone|entacapone|mesh-list
43962800|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43962801|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962802|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962803|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962804|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962805|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
43962806|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43962807|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962808|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
43962809|NCT01521546|Eplerenone|eplerenone|mesh-list
43962810|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43962811|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
43962812|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962813|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962814|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43962815|NCT01521546|Diuretics|diuretics|mesh-ancestor
43962816|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
43962817|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43962818|NCT01522417|Tirofiban|tirofiban|mesh-list
43962819|NCT01522417|Eptifibatide|eptifibatide|mesh-list
43962820|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43962821|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43962822|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962823|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43962824|NCT01522963|Nicotine|nicotine|mesh-list
43962825|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43962833|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962835|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
43962836|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
43962837|NCT01523496|Calcifediol|calcifediol|mesh-list
43962838|NCT01523496|Vitamins|vitamins|mesh-list
43962839|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
43962840|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962841|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43962842|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43962843|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
43962844|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43962845|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962846|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962847|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43962848|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43962849|NCT01523834|Panobinostat|panobinostat|mesh-list
43962850|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962851|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43962852|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962853|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142664|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142665|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142666|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
44142667|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142668|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142669|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142670|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142671|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142672|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142673|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142674|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
44142675|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240621|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240622|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
44240623|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240624|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44240625|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
44240626|NCT00581607|Bosentan|bosentan|mesh-list
44240627|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44240628|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44240629|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240630|NCT00581685|Celecoxib|celecoxib|mesh-list
44240631|NCT00581685|Pregabalin|pregabalin|mesh-list
44240632|NCT00581685|Analgesics|analgesics|mesh-ancestor
44142676|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142677|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142678|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142679|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142680|NCT00187161|Cytarabine|cytarabine|mesh-list
44142681|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
44142682|NCT00187161|Doxorubicin|doxorubicin|mesh-list
44142683|NCT00187161|Methotrexate|methotrexate|mesh-list
44142684|NCT00187161|Etoposide|etoposide|mesh-list
44142685|NCT00187161|Vincristine|vincristine|mesh-list
44142686|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142687|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
44142688|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142689|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142690|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142691|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
44142692|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142693|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142694|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142695|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142696|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142697|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142698|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142699|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142700|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
44142701|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44003291|NCT01854255|Cisplatin|cisplatin|mesh-list
44142702|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142703|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
44142704|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142705|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142706|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142707|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142708|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
44142709|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142710|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142711|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
43962854|NCT01524302|Levofloxacin|levofloxacin|mesh-list
43962855|NCT01524302|Ofloxacin|ofloxacin|mesh-list
43962856|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43962857|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43962858|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962859|NCT01524302|Renal Agents|renal agents|mesh-ancestor
43962860|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962861|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43962862|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43962863|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962864|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962865|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962866|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43962867|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43962868|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44240633|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
44240634|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240635|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240637|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240638|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240639|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240640|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240641|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240642|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240643|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240644|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240645|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44240646|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44240647|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240648|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240649|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44240650|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44240651|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240652|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43962869|NCT01525173|Bimatoprost|bimatoprost|mesh-list
43962870|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43962871|NCT01525173|Latanoprost|latanoprost|mesh-list
43962872|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43962873|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
43962874|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43962875|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43962876|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43962877|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43962878|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962879|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962880|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962881|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962882|NCT01526213|Fexofenadine|fexofenadine|mesh-list
43962883|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43962884|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43962885|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43962886|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
43962887|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
43962888|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003350|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962889|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962890|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962892|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962893|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962894|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43962895|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962896|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
43962897|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962898|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
43962899|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962900|NCT01526538|Cycloserine|cycloserine|mesh-list
43962901|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44240653|NCT00581789|Sunitinib|sunitinib|mesh-list
44240654|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240655|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44240656|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240657|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240658|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43962902|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962903|NCT01526538|Renal Agents|renal agents|mesh-ancestor
43962904|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43962905|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
43962906|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962907|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
43962908|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962909|NCT01526577|Ticagrelor|ticagrelor|mesh-list
43962910|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43962911|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43962912|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43962913|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43962914|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
43962915|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962916|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962917|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962918|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
43962932|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962933|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962935|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962936|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
43962937|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962938|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
43962939|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962940|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43962941|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43962942|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43962943|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43962944|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43962945|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43962946|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43962947|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
43962948|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962949|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43962950|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
43962951|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43962952|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43962953|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962954|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962955|NCT01528592|Levodopa|levodopa|mesh-list
43962956|NCT01528592|Carbidopa|carbidopa|mesh-list
43962957|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43962958|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43962959|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43962960|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
43962961|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962962|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962963|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962964|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43962965|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962966|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43962967|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
43962968|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
43962969|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
43962970|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962971|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962972|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962973|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962974|NCT01528891|Analgesics|analgesics|mesh-ancestor
43962975|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
44240659|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43962976|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962977|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43962978|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43962979|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43962986|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43962987|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43962988|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43962989|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962990|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962991|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
43962992|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962993|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962994|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43962995|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962996|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
43962997|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43962998|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
43962999|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963000|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142712|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
43963001|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963002|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963003|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43963004|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
43963005|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963006|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963007|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43963008|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
43963009|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
43963010|NCT01529502|Protective Agents|protective agents|mesh-ancestor
43963011|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
43963012|NCT01529827|Methotrexate|methotrexate|mesh-list
43963013|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
43963014|NCT01529827|Fludarabine|fludarabine|mesh-list
43963015|NCT01529827|Melphalan|melphalan|mesh-list
43963016|NCT01529827|Tacrolimus|tacrolimus|mesh-list
43963017|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43963018|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
43963019|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43963020|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963021|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963022|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
43963023|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963024|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963025|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963026|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963027|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43963028|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963029|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
43963030|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963031|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43963032|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44003481|NCT05453851|Pancrelipase|pancrelipase|mesh-list
43963033|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43963034|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43963035|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
43963036|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963037|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963038|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963039|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
43963040|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43963041|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43963042|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43963043|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963044|NCT01530178|Incretins|incretins|mesh-ancestor
43963045|NCT01530178|Hormones|hormones|mesh-ancestor
43963046|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963054|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43963055|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
43963056|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700927|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
44240661|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240662|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459231|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459232|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44459233|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
44459234|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44459235|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
44459236|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459237|NCT01583179|Buprenorphine|buprenorphine|mesh-list
44459238|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44459239|NCT01583179|Narcotics|narcotics|mesh-ancestor
44459240|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963057|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963058|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963059|NCT01530243|Urological Agents|urological agents|mesh-ancestor
43963060|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43963061|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43963062|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43963063|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963064|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
43963065|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43963066|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43963067|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963068|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
43963069|NCT01530399|Coagulants|coagulants|mesh-ancestor
43963070|NCT01531439|Naloxone|naloxone|mesh-list
43963071|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43963072|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701978|NCT02720978|Oxytocin|oxytocin|mesh-list
43963073|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
43963074|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963075|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43963077|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
43963078|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
43963079|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963080|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963081|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43963082|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43963083|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43963084|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43963085|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963086|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963087|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963088|NCT01532089|Bevacizumab|bevacizumab|mesh-list
43963089|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43963090|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43963091|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
43963092|NCT01532089|Antibodies|antibodies|mesh-list
43963093|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
43963094|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43963095|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
43963096|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963097|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43963098|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43963099|NCT01532089|Growth Substances|growth substances|mesh-ancestor
43963100|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963101|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
43963102|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
43963103|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43963104|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963105|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963106|NCT01532128|Opicapone|opicapone|mesh-list
43963107|NCT01532128|Rasagiline|rasagiline|mesh-list
44459241|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459242|NCT01583179|Analgesics|analgesics|mesh-ancestor
44459243|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
44459244|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459245|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44459246|NCT01583166|Epinephrine|epinephrine|mesh-list
44459247|NCT01583166|Bupivacaine|bupivacaine|mesh-list
44459248|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
44459249|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
44459250|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459251|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459252|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
44459253|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459254|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44459255|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44459256|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459257|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459258|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459259|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44459260|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44459261|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
44459262|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459263|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459264|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
44459265|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
44459266|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44459267|NCT01582945|Ketamine|ketamine|mesh-list
44459268|NCT01582945|Analgesics|analgesics|mesh-ancestor
44459269|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
44459270|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459271|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459272|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44459273|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44459274|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
44459275|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
44459276|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173920|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
43963108|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43963109|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808571|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44459277|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44459278|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44459279|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459280|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459281|NCT01582854|Actovegin|actovegin|mesh-list
44459282|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44459283|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459284|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44459285|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459286|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
44459287|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459288|NCT01582854|Protective Agents|protective agents|mesh-ancestor
44459289|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44459290|NCT01582451|Insulin|insulin|mesh-list
44459291|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44459292|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
44459293|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459294|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459295|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44459296|NCT01582308|Vildagliptin|vildagliptin|mesh-list
44459297|NCT01582308|Saxagliptin|saxagliptin|mesh-list
44459298|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43963110|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963111|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43963112|NCT01532128|Protective Agents|protective agents|mesh-ancestor
43963113|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963124|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963125|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43963126|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963127|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963128|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
43963129|NCT01532349|Vitamin D|vitamin d|mesh-list
43963130|NCT01532349|Vitamins|vitamins|mesh-ancestor
43963131|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
43963132|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963133|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43963134|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43963135|NCT01532700|Ofatumumab|ofatumumab|mesh-list
43963136|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963137|NCT01533077|Levodopa|levodopa|mesh-list
43963138|NCT01533077|Carbidopa|carbidopa|mesh-list
43963139|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43963140|NCT01533077|Opicapone|opicapone|mesh-list
43963141|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963142|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963143|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
43963144|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963145|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963146|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963147|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43963148|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963149|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963150|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
44459299|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459300|NCT01582308|Incretins|incretins|mesh-ancestor
44459301|NCT01582308|Hormones|hormones|mesh-ancestor
44174010|NCT00295282|Antibodies|antibodies|mesh-list
43963151|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
43963152|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43963153|NCT01533116|Levodopa|levodopa|mesh-list
43963154|NCT01533116|Carbidopa|carbidopa|mesh-list
43963155|NCT01533116|Opicapone|opicapone|mesh-list
43963156|NCT01533116|Benserazide|benserazide|mesh-list
43963157|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963158|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963159|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
43963160|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963161|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963162|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963163|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43963164|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963165|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43963166|NCT01533207|Gemcitabine|gemcitabine|mesh-list
43963167|NCT01533207|Docetaxel|docetaxel|mesh-list
43963168|NCT01533207|Doxorubicin|doxorubicin|mesh-list
43963169|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43963170|NCT01533207|Lenograstim|lenograstim|mesh-list
43963171|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963172|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
43963173|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963174|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963175|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
43963176|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963177|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963178|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963179|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
43963188|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43963191|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
43963192|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963193|NCT01533597|Tamsulosin|tamsulosin|mesh-list
43963194|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
43963195|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43963196|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43963197|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43963198|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963199|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963200|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963201|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963202|NCT01533597|Urological Agents|urological agents|mesh-ancestor
43963203|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43963204|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43963205|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
43963206|NCT01533948|Axitinib|axitinib|mesh-list
43963207|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963208|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43963209|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963210|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963211|NCT01534013|Insulin|insulin|mesh-list
43963212|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43963213|NCT01534013|Pancrelipase|pancrelipase|mesh-list
43963214|NCT01534013|Pancreatin|pancreatin|mesh-list
43963215|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43963216|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963217|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963218|NCT01534416|Bupivacaine|bupivacaine|mesh-list
43963219|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
43963220|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
43963221|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963222|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963223|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
43963224|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963225|NCT01534897|Dabrafenib|dabrafenib|mesh-list
43963226|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963227|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43963228|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700928|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240665|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44240666|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44240667|NCT00582582|Docetaxel|docetaxel|mesh-list
44240668|NCT00582582|Vitamins|vitamins|mesh-ancestor
44240669|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
44240670|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240671|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240672|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44240673|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44240674|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44240675|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240676|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43963229|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963230|NCT01535001|Acetaminophen|acetaminophen|mesh-list
43963231|NCT01535001|Pantoprazole|pantoprazole|mesh-list
43963232|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43963233|NCT01535001|Analgesics|analgesics|mesh-ancestor
43963234|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
43963235|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963236|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963237|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
43963238|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43963239|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963240|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43963241|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963242|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963244|NCT01535573|Citalopram|citalopram|mesh-list
43963255|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963256|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963257|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
43963258|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
43963259|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963260|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43963261|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43963262|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43963263|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
43963264|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43963265|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963266|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963268|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43963269|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963270|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
43963271|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963272|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963273|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
43963274|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963275|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963276|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963277|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
43963278|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963279|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963280|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
43963281|NCT01535937|Midazolam|midazolam|mesh-list
43963282|NCT01535937|Ketamine|ketamine|mesh-list
43963283|NCT01535937|Analgesics|analgesics|mesh-ancestor
43963284|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
43963285|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963286|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963287|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43963288|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44240677|NCT00582634|Cisplatin|cisplatin|mesh-list
44240678|NCT00582634|Docetaxel|docetaxel|mesh-list
44240679|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240680|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
43963289|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
43963290|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
43963291|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963292|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43963293|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43963294|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963295|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963296|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43963297|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43963298|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43963299|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43963300|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43963301|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
43963302|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
43963303|NCT01535976|Ketamine|ketamine|mesh-list
43963304|NCT01535976|Analgesics|analgesics|mesh-ancestor
43963305|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
43963316|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963317|NCT01536366|Repaglinide|repaglinide|mesh-list
43963318|NCT01536366|Opicapone|opicapone|mesh-list
43963319|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43963320|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963321|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43963322|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003797|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
43963323|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963324|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963325|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963326|NCT01536886|Betamethasone|betamethasone|mesh-list
43963327|NCT01536886|Calcipotriene|calcipotriene|mesh-list
43963328|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963329|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
43963330|NCT01536886|Hormones|hormones|mesh-ancestor
43963331|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963332|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963333|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963334|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963335|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963336|NCT01536938|Calcitriol|calcitriol|mesh-list
43963337|NCT01536938|Betamethasone|betamethasone|mesh-list
43963338|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
43963339|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43963340|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
43963341|NCT01536938|Calcipotriene|calcipotriene|mesh-list
43963342|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43963343|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963344|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
43963345|NCT01536938|Hormones|hormones|mesh-ancestor
43963346|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963347|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963348|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963349|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963350|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963351|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43963352|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43963353|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963354|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963355|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43963356|NCT01536938|Vitamins|vitamins|mesh-ancestor
43963357|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
43963358|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43963359|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
43963360|NCT01537029|Doxorubicin|doxorubicin|mesh-list
43963361|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963362|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
43963363|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963364|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963365|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963366|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
43700929|NCT02728037|Lidocaine|lidocaine|mesh-list
44240681|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44240682|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44240683|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240684|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
44240685|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44240686|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240687|NCT00582985|Antibodies|antibodies|mesh-list
44240688|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
44240689|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240690|NCT00583063|Sirolimus|sirolimus|mesh-list
44240691|NCT00583063|Sunitinib|sunitinib|mesh-list
44240692|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240693|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44240694|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44240695|NCT00583063|Growth Substances|growth substances|mesh-ancestor
44240696|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963367|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963368|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963380|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43963381|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43963382|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963383|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963384|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963385|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963386|NCT01537666|Vancomycin|vancomycin|mesh-list
43963387|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963388|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963389|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
43963390|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43963391|NCT01537900|Grazoprevir|grazoprevir|mesh-list
43963392|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
43963393|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963394|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
43963395|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43963396|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
43963397|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963398|NCT01537926|Expectorants|expectorants|mesh-ancestor
43963399|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963400|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43963401|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
43963402|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963403|NCT01537926|Protective Agents|protective agents|mesh-ancestor
43963404|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963405|NCT01537926|Antidotes|antidotes|mesh-ancestor
43963406|NCT01538745|Ketamine|ketamine|mesh-list
43963407|NCT01538745|Morphine|morphine|mesh-list
43963408|NCT01538745|Analgesics|analgesics|mesh-ancestor
43963409|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
43963410|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963411|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963412|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43963413|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43963414|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
43963415|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
43963416|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963417|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43963418|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43963419|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963420|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963421|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44240698|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44240699|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240700|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240701|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44240702|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240703|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174283|NCT00295971|Thiotepa|thiotepa|mesh-list
43963422|NCT01538745|Narcotics|narcotics|mesh-ancestor
43963423|NCT01538862|Lenograstim|lenograstim|mesh-list
43963424|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963425|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
43963426|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963427|NCT01539135|Methylene Blue|methylene blue|mesh-list
43963428|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963429|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142713|NCT00187174|Everolimus|everolimus|mesh-list
44142714|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142715|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142716|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
44142717|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142729|NCT00187330|Antidotes|antidotes|mesh-ancestor
44157520|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44157521|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
44157522|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44157523|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157524|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963430|NCT01541358|Listerine|listerine|mesh-list
43963431|NCT01541358|Fluorides|fluorides|mesh-list
43963432|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
43963433|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
43963434|NCT01541358|Protective Agents|protective agents|mesh-ancestor
43963435|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963436|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43963437|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963438|NCT01541735|Pantoprazole|pantoprazole|mesh-list
43963439|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43963440|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963441|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43963442|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963443|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963444|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43963445|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43963446|NCT01542125|Lidocaine|lidocaine|mesh-list
43963447|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
43963448|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
43963449|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963450|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963451|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
43963452|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963453|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43963454|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43963455|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43963456|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963457|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963458|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
43963459|NCT01542255|Dacarbazine|dacarbazine|mesh-list
43963460|NCT01542255|Vinblastine|vinblastine|mesh-list
43963461|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963462|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
43963463|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963464|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963465|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963466|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
43963467|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963468|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963469|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44240705|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44240706|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
44240707|NCT00583180|Capsaicin|capsaicin|mesh-list
44240708|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
44240709|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963470|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43963471|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
43963472|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
43963473|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
43963474|NCT01542372|Prazosin|prazosin|mesh-list
43963475|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43963476|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43963490|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
43963492|NCT01542645|Narcotics|narcotics|mesh-ancestor
43963493|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963494|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963495|NCT01542645|Analgesics|analgesics|mesh-ancestor
43963496|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
43963497|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963498|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43963499|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43963500|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
43963501|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
43963502|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
43963503|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963504|NCT01542684|Azacitidine|azacitidine|mesh-list
43963505|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963506|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
43963507|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963508|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963509|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963511|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
43963512|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963513|NCT01543074|Protective Agents|protective agents|mesh-ancestor
43963514|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963515|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43963516|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963517|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43963518|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963519|NCT01543178|Rifaximin|rifaximin|mesh-list
43963520|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963521|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963522|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963523|NCT01543568|Aflibercept|aflibercept|mesh-list
43963524|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43963525|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43963526|NCT01543568|Growth Substances|growth substances|mesh-ancestor
43963527|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963528|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
43963529|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963530|NCT01544062|Acetaminophen|acetaminophen|mesh-list
43963531|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43963532|NCT01544062|Analgesics|analgesics|mesh-ancestor
43963533|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
43963534|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963535|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963536|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
43963537|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43963538|NCT01544998|Tadalafil|tadalafil|mesh-list
43963539|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
43963547|NCT01545141|Interferons|interferons|mesh-list
43963548|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
43963549|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
43963550|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43963551|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43963552|NCT01545141|Poly I-C|poly i-c|mesh-list
43963553|NCT01545141|Celecoxib|celecoxib|mesh-list
43963554|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963555|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
43963556|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963557|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
43963558|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240710|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
44240711|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240712|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240713|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44240714|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44240715|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44240716|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240717|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240718|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240719|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240720|NCT00583193|Analgesics|analgesics|mesh-ancestor
44240721|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
43963559|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43963560|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43963561|NCT01545141|Analgesics|analgesics|mesh-ancestor
43963562|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
43963563|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963564|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963565|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963566|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43963567|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43963568|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963569|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963570|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
43963571|NCT01545336|Anastrozole|anastrozole|mesh-list
43963572|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43963573|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963574|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43963575|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43963576|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963577|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963578|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43963579|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44142730|NCT00187408|Heparin|heparin|mesh-list
43702367|NCT02718079|Antidotes|antidotes|mesh-ancestor
43963580|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963581|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963582|NCT01545700|Dexamethasone|dexamethasone|mesh-list
43963583|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
43963584|NCT01545700|BB 1101|bb 1101|mesh-list
43963585|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963586|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
43963587|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
43963588|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963589|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963590|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963591|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
43963592|NCT01545700|Hormones|hormones|mesh-ancestor
43963593|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963594|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43963595|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963596|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
43963597|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963598|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963599|NCT01545765|Lidocaine|lidocaine|mesh-list
43963600|NCT01545765|Tetracaine|tetracaine|mesh-list
43963601|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
43963602|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
43963603|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700930|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
44240722|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240723|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
44240724|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240725|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
44240726|NCT00583258|Alfuzosin|alfuzosin|mesh-list
44240727|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44240728|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44240729|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44240730|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240731|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174472|NCT00296361|Tacrolimus|tacrolimus|mesh-list
43963637|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963639|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963640|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
43963641|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963642|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963643|NCT01546454|Leuprolide|leuprolide|mesh-list
43963644|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43963645|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43963646|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
43963647|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43963648|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43963649|NCT01546454|Estradiol|estradiol|mesh-list
43963650|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43963651|NCT01546454|Progesterone|progesterone|mesh-list
43963652|NCT01546454|Estrogens|estrogens|mesh-ancestor
43963654|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963655|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963656|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43963657|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
43963658|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43963659|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43963660|NCT01546454|Progestins|progestins|mesh-ancestor
43963661|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43963662|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
43963663|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43963664|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963665|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43963666|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43963667|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43963668|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43963670|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43963671|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43963672|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43963675|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963676|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963677|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963678|NCT01547806|Plerixafor|plerixafor|mesh-list
43963679|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43963680|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43963681|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
43963682|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963683|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
43963684|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963685|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
43963686|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963687|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963688|NCT01549223|Misoprostol|misoprostol|mesh-list
43963689|NCT01549223|Oxytocin|oxytocin|mesh-list
43963690|NCT01549223|Methylergonovine|methylergonovine|mesh-list
43963691|NCT01549223|Carboprost|carboprost|mesh-list
43963692|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
43963693|NCT01549223|Maleic acid|maleic acid|mesh-list
43963694|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
43963695|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44240732|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240733|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240734|NCT00583258|Urological Agents|urological agents|mesh-ancestor
44240735|NCT00583271|Ethanol|ethanol|mesh-list
44240736|NCT00583271|Triamcinolone|triamcinolone|mesh-list
44240737|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240738|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
44240739|NCT00583271|Hormones|hormones|mesh-ancestor
44240740|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240741|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240742|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44240743|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240744|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240745|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
43963696|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963697|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43963698|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
43963699|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43963700|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963701|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963702|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963703|NCT01549587|Listerine|listerine|mesh-list
43963704|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
43963705|NCT01549587|Fluorides|fluorides|mesh-list
43963706|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
43963707|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
43963708|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
43963709|NCT01549587|Protective Agents|protective agents|mesh-ancestor
43963710|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963711|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43963712|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963713|NCT01550224|Temozolomide|temozolomide|mesh-list
43963714|NCT01550224|Vorinostat|vorinostat|mesh-list
43963715|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963716|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
43963717|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963718|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963719|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43963720|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963721|NCT01550341|Buprenorphine|buprenorphine|mesh-list
43963722|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43963723|NCT01550341|Naloxone|naloxone|mesh-list
43963724|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43963725|NCT01550341|Narcotics|narcotics|mesh-ancestor
43963726|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963727|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963728|NCT01550341|Analgesics|analgesics|mesh-ancestor
43963729|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
43963730|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963731|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43963732|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
43963733|NCT01550367|Aldesleukin|aldesleukin|mesh-list
43963734|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
43963735|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43963736|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43963737|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963738|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963739|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963740|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963741|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240746|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240747|NCT00583349|Paclitaxel|paclitaxel|mesh-list
44240748|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44240749|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240750|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44240751|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44240752|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
43963742|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43963743|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43963744|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
43963745|NCT01550471|Ciclesonide|ciclesonide|mesh-list
43963746|NCT01550471|Beclomethasone|beclomethasone|mesh-list
43963747|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963748|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
43963749|NCT01550471|Hormones|hormones|mesh-ancestor
43963757|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963758|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963759|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43963760|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43963761|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
43963762|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963763|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43963764|NCT01551056|Cetirizine|cetirizine|mesh-list
43963765|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43963766|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43963767|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43963768|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
43963769|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
43963770|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963771|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963772|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963773|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
43963774|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43963775|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
43963776|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963777|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963778|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963779|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963780|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43963781|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43963782|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43963783|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963784|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963785|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963786|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43963787|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
43963788|NCT01552343|Coagulants|coagulants|mesh-ancestor
43963789|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43963790|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
43963791|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963792|NCT01553058|Adalimumab|adalimumab|mesh-list
43963793|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963794|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963795|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
43963796|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43963797|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963798|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963799|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
43963800|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963801|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963802|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43963803|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963804|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43963805|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43963806|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
43963807|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
43963808|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43963809|NCT01553708|Mitogens|mitogens|mesh-list
43963810|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44240753|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240754|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44240755|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
44240756|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44240757|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
44240758|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240759|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44240760|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44174664|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
43963811|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963812|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963813|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963814|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43963815|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43963817|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43963818|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
43963819|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963820|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
43963821|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963822|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963823|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43963824|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
43963825|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963826|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963827|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43963828|NCT01554488|Fluticasone|fluticasone|mesh-list
43963830|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963831|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43963832|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
43963833|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963834|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963835|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963836|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963837|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963838|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43963839|NCT01554683|Levetiracetam|levetiracetam|mesh-list
43963840|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
43963841|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
43963842|NCT01556347|Rituximab|rituximab|mesh-list
43963843|NCT01556347|Bortezomib|bortezomib|mesh-list
43963844|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
43963845|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43963846|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43963847|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43963848|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963849|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
43963850|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963851|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963852|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142731|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44142732|NCT00187408|Tinzaparin|tinzaparin|mesh-list
44142733|NCT00187408|Dalteparin|dalteparin|mesh-list
44142734|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
44142735|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44142736|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44142737|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142738|NCT00187447|Indomethacin|indomethacin|mesh-list
44142739|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44142740|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44142741|NCT00187447|Analgesics|analgesics|mesh-ancestor
44142742|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
44142743|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142744|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142745|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142746|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240761|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44240762|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44240763|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240764|NCT00583518|Hormones|hormones|mesh-list
44240765|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
44240766|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240767|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240768|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240769|NCT00583869|Pregabalin|pregabalin|mesh-list
44240770|NCT00583869|Analgesics|analgesics|mesh-ancestor
44142747|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
44142748|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
44142749|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142750|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44142751|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142752|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142753|NCT00187499|Fluticasone|fluticasone|mesh-list
44142754|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142755|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44142756|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
44142757|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142758|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963853|NCT01556425|Naltrexone|naltrexone|mesh-list
43963854|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43963855|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43963856|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963857|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
43963858|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963859|NCT01556594|Glucagon|glucagon|mesh-list
43963860|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43963861|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963862|NCT01556594|Hormones|hormones|mesh-ancestor
43963863|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963873|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
43963874|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963875|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963876|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
43963877|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963878|NCT01557322|Etanercept|etanercept|mesh-list
43963879|NCT01557322|Methotrexate|methotrexate|mesh-list
43963880|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43963881|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
43963882|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43963883|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963884|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43963885|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
43963886|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963887|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963888|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
43963889|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963890|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43963891|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43963892|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
43963893|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963894|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43963895|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43963896|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43963897|NCT01557322|Analgesics|analgesics|mesh-ancestor
43963898|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
43963899|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963900|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963901|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963902|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
43963903|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44240771|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
44240772|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240773|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240775|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240776|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240777|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240778|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240779|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240780|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240781|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240782|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43963904|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963905|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963906|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
43963907|NCT01557868|Hylan|hylan|mesh-list
43963908|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963909|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
43963910|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963911|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
43963912|NCT01557868|Protective Agents|protective agents|mesh-ancestor
43963913|NCT01557959|Cisplatin|cisplatin|mesh-list
43963914|NCT01557959|Docetaxel|docetaxel|mesh-list
43963915|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43963916|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963917|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
43963918|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
43963919|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
43963920|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963921|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43963922|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963923|NCT01558063|Ketamine|ketamine|mesh-list
43963924|NCT01558063|Analgesics|analgesics|mesh-ancestor
43963925|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
43963926|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963928|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43963929|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43963930|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
43963931|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
43963940|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43963941|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963942|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963943|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43963944|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43963945|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43963946|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963947|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43963948|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43963949|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43963950|NCT01558661|Axitinib|axitinib|mesh-list
43963951|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43963952|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43963953|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963954|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963955|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43963956|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43963957|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43963958|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963959|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240784|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43963960|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963961|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963962|NCT01558700|Analgesics|analgesics|mesh-ancestor
43963963|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
43963964|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963965|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
43963966|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43963967|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
43963968|NCT01559064|Lidocaine|lidocaine|mesh-list
43963969|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
43963970|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
43963971|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
43963972|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963973|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963974|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
43963975|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963976|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43963977|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43963978|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43963979|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963980|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963981|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963982|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
43963983|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
43963984|NCT01559064|Protective Agents|protective agents|mesh-ancestor
43963985|NCT01559857|Pioglitazone|pioglitazone|mesh-list
43963986|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43963987|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963988|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43963989|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
43963990|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43963991|NCT01559922|Protective Agents|protective agents|mesh-ancestor
43963992|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963993|NCT01560143|Tigecycline|tigecycline|mesh-list
43963994|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43964009|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964010|NCT01561469|Vancomycin|vancomycin|mesh-list
43964011|NCT01561469|Linezolid|linezolid|mesh-list
43964012|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43964013|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964014|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43964015|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964016|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964017|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43964018|NCT01561703|Amoxicillin|amoxicillin|mesh-list
43964019|NCT01561703|Azithromycin|azithromycin|mesh-list
43964020|NCT01561703|Clindamycin|clindamycin|mesh-list
43964021|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
43964022|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43964023|NCT01561703|Cephalexin|cephalexin|mesh-list
43964024|NCT01561703|Cefdinir|cefdinir|mesh-list
43964025|NCT01561703|Cefaclor|cefaclor|mesh-list
43964026|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964027|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43964028|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964029|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964030|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43964031|NCT01561833|Sorafenib|sorafenib|mesh-list
43964032|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964033|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43964034|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964035|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964036|NCT01562041|Ranolazine|ranolazine|mesh-list
43964037|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43964038|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964039|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964040|NCT01562132|Fluconazole|fluconazole|mesh-list
43964041|NCT01562132|Flucytosine|flucytosine|mesh-list
43964042|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
43964043|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964044|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43964045|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43964046|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240785|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
44240786|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240787|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240788|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44174927|NCT00297960|Olanzapine|olanzapine|mesh-list
43964047|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964048|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43964049|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
43964050|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964051|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964052|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43964053|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43964054|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
43964055|NCT01562678|Liraglutide|liraglutide|mesh-list
43964056|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43964057|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964058|NCT01562678|Incretins|incretins|mesh-ancestor
43964059|NCT01562678|Hormones|hormones|mesh-ancestor
43964060|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964061|NCT01562886|Rilpivirine|rilpivirine|mesh-list
43964062|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43964063|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43964064|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964065|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964066|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
43964067|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964068|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43964069|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43964070|NCT01563055|Ofatumumab|ofatumumab|mesh-list
43964071|NCT01563055|Chlorambucil|chlorambucil|mesh-list
43964072|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964073|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43964074|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
43964075|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964076|NCT01563081|Cetirizine|cetirizine|mesh-list
43964077|NCT01563081|Levocetirizine|levocetirizine|mesh-list
43964078|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43964079|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43964080|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
43964081|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
43964082|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964083|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964084|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964085|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43964086|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43964087|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964088|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964089|NCT01563406|Ethanol|ethanol|mesh-list
43964090|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
43964091|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43964092|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964093|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964094|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964095|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
43964096|NCT01564914|Bevacizumab|bevacizumab|mesh-list
43964097|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964098|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964099|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43964100|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43964101|NCT01564914|Growth Substances|growth substances|mesh-ancestor
43964102|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964103|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
43964104|NCT01565538|Pemetrexed|pemetrexed|mesh-list
43964105|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43964106|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964107|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964108|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964109|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44240789|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240790|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
44240791|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44240792|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44240793|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44240794|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44240795|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240796|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240797|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240798|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
44174997|NCT00298194|Z 338|z 338|mesh-list
43964110|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43964111|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43964112|NCT01565616|Fludarabine|fludarabine|mesh-list
43964113|NCT01565616|Busulfan|busulfan|mesh-list
43964114|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
43964115|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43964116|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964117|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964118|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964119|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
43964120|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964121|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
43964122|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43964123|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43964124|NCT01565902|Siponimod|siponimod|mesh-list
43964125|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43964126|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964127|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964137|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43964138|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43964139|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
43964140|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964141|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964142|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43964143|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43964144|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
43964145|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43964146|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43964147|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
43964148|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43964149|NCT01566409|Laxatives|laxatives|mesh-ancestor
43964150|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964151|NCT01566448|Ketamine|ketamine|mesh-list
43964152|NCT01566448|Analgesics|analgesics|mesh-ancestor
43964153|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
43964154|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964155|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964156|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43964157|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43964158|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
43964159|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
43964160|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964161|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43964162|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43964163|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964164|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964165|NCT01566526|Dexamethasone|dexamethasone|mesh-list
43964166|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964167|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
43964168|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
43964169|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964170|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240800|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44240801|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
44240802|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175062|NCT00298454|Furosemide|furosemide|mesh-list
43964171|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964172|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
43964173|NCT01566526|Hormones|hormones|mesh-ancestor
43964174|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964175|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43964176|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964177|NCT01566539|Vasopressins|vasopressins|mesh-list
43964178|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
43964179|NCT01566539|Lorazepam|lorazepam|mesh-list
43964180|NCT01566539|Oxytocin|oxytocin|mesh-list
43964181|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
43964182|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43964183|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964184|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
43964185|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
43964186|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
43964187|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964188|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964189|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43964190|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964191|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43964192|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43964202|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
43964203|NCT01566838|Bupivacaine|bupivacaine|mesh-list
43964204|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
43964205|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
43964206|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964207|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964208|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
43964209|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964210|NCT01568008|Bimatoprost|bimatoprost|mesh-list
43964211|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43964212|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43964213|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43964214|NCT01568073|Levodopa|levodopa|mesh-list
43964215|NCT01568073|Carbidopa|carbidopa|mesh-list
43964216|NCT01568073|Opicapone|opicapone|mesh-list
43964217|NCT01568073|Entacapone|entacapone|mesh-list
43964218|NCT01568073|Benserazide|benserazide|mesh-list
43964219|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43964220|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43964221|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
43964222|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964223|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964224|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964225|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43964226|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964227|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43964228|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
43964229|NCT01568255|Vitamin D|vitamin d|mesh-list
43964230|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43964231|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964232|NCT01568255|Vitamins|vitamins|mesh-ancestor
43964233|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
43964234|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43964235|NCT01568528|Oxytocin|oxytocin|mesh-list
43964236|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
43964237|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43964238|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964239|NCT01568905|Nicotine|nicotine|mesh-list
43964240|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43964241|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
43964242|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964243|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964244|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43964245|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43964246|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
43964247|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700931|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
44240803|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240804|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240805|NCT00584090|Urological Agents|urological agents|mesh-ancestor
43964248|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964249|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43964250|NCT01568944|Lansoprazole|lansoprazole|mesh-list
43964251|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964252|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43964253|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964254|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43964255|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964256|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964257|NCT01569087|Lenograstim|lenograstim|mesh-list
43964258|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43964259|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
43964260|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964261|NCT01569126|Fluoxetine|fluoxetine|mesh-list
43964270|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
43964271|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964272|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43964273|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43964274|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964275|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
43964276|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43964277|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
43964278|NCT01569191|Epinastine|epinastine|mesh-list
43964279|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43964280|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43964281|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
43964282|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
43964283|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964284|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964285|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964286|NCT01569451|Rituximab|rituximab|mesh-list
43964287|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
43964288|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
43964289|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964290|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964291|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
43964292|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964293|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964294|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43964295|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871140|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964296|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43964297|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43964298|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142759|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964299|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43964300|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43964301|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964302|NCT01570036|Trastuzumab|trastuzumab|mesh-list
43964303|NCT01570036|Molgramostim|molgramostim|mesh-list
43964304|NCT01570036|Sargramostim|sargramostim|mesh-list
43964305|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964306|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964307|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
43964308|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142760|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44142761|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142762|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44142763|NCT00187525|Memantine|memantine|mesh-list
44142764|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44142765|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44142766|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
44142767|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142768|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142769|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240808|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44240809|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44240810|NCT00584155|Renal Agents|renal agents|mesh-ancestor
44240811|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44240812|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44240813|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44240814|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240815|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240816|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240817|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44240818|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44240819|NCT00584168|Dexamethasone|dexamethasone|mesh-list
44240820|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240821|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
44240822|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
44240823|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240824|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240825|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240826|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
44240827|NCT00584168|Hormones|hormones|mesh-ancestor
44240828|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142770|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44142771|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44142772|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
44142781|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
44142782|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142783|NCT00187564|Protective Agents|protective agents|mesh-ancestor
44142784|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142785|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
44142786|NCT00187564|Vitamins|vitamins|mesh-ancestor
44142787|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
44142788|NCT00187577|Bimatoprost|bimatoprost|mesh-list
44142789|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44142790|NCT00187577|Latanoprost|latanoprost|mesh-list
44142791|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44142792|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142793|NCT00187707|Gabapentin|gabapentin|mesh-list
44142794|NCT00187707|Analgesics|analgesics|mesh-ancestor
44142795|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
44142796|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142797|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142798|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
44142799|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44142800|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44142801|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44142802|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142803|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44142804|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44142805|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142806|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142807|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
44142808|NCT00187746|Adefovir|adefovir|mesh-list
44240829|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44240830|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240831|NCT00584298|Octreotide|octreotide|mesh-list
44240832|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44240833|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44240834|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240835|NCT00584376|Pregabalin|pregabalin|mesh-list
44142809|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44142810|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
44142811|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142812|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44142813|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142814|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142815|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142816|NCT00187759|Cephalexin|cephalexin|mesh-list
44142817|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142818|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142819|NCT00187798|Metformin|metformin|mesh-list
44142820|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44142821|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142822|NCT00187915|Cyclosporine|cyclosporine|mesh-list
44142823|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
44142824|NCT00187915|Tacrolimus|tacrolimus|mesh-list
44142825|NCT00187915|Cyclosporins|cyclosporins|mesh-list
43964309|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
43964310|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
43964311|NCT01570348|Fludarabine|fludarabine|mesh-list
43964312|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
43964313|NCT01570348|Tacrolimus|tacrolimus|mesh-list
43964314|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964315|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
43964316|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964317|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964318|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43964319|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
43964320|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964321|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964322|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43964323|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43964324|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
43964338|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964339|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
43964341|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964342|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43964343|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964344|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
43964345|NCT01573052|Gabapentin|gabapentin|mesh-list
43964346|NCT01573052|Analgesics|analgesics|mesh-ancestor
43964347|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
43964348|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964349|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964350|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
43964351|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43964352|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43964353|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964354|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964355|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43964356|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43964357|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964358|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964359|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
43964360|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43964361|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43964362|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
43964363|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
43964364|NCT01573169|Enoxaparin|enoxaparin|mesh-list
43964365|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
43964366|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43964367|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43964368|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240837|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
44240838|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240839|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240840|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
44240841|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44240842|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240843|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240844|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44240845|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240846|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240847|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240848|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240849|NCT00584389|Rimonabant|rimonabant|mesh-list
43964369|NCT01573273|Oxytocin|oxytocin|mesh-list
43964370|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
43964371|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43964372|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964373|NCT01573533|Rituximab|rituximab|mesh-list
43964374|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964375|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964376|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
43964377|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964378|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964379|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43964380|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964381|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43964382|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964383|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964384|NCT01573949|Metformin|metformin|mesh-list
43964385|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43964386|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964388|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
43964389|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964390|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43964391|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43964392|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964393|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964394|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964395|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
43964396|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964397|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43964398|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43964399|NCT01574807|Lidocaine|lidocaine|mesh-list
43964400|NCT01574807|Mepivacaine|mepivacaine|mesh-list
43964401|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
43964402|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
43964403|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964404|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964405|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
43964406|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964407|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43964408|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43964409|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43964410|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964411|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964412|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43964413|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43964414|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
44240850|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44240851|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44240852|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44240853|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240854|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240855|NCT00584389|Hormones|hormones|mesh-ancestor
44240856|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240857|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240858|NCT00584493|Tremelimumab|tremelimumab|mesh-list
44240859|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240860|NCT00584532|Genistein|genistein|mesh-list
44240861|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44240862|NCT00584532|Protective Agents|protective agents|mesh-ancestor
44240863|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240864|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240865|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44240866|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240867|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240868|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
44240869|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44240870|NCT00584532|Estrogens|estrogens|mesh-ancestor
44240871|NCT00584532|Hormones|hormones|mesh-ancestor
44285635|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964415|NCT01576276|Ketorolac|ketorolac|mesh-list
43964416|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964417|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964418|NCT01576276|Analgesics|analgesics|mesh-ancestor
43964419|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
43964420|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964421|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964422|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964423|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964424|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43964425|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964426|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964427|NCT01576523|Complement C1s|complement c1s|mesh-list
43964428|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43964429|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43964430|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
43964431|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964432|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43964433|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964434|NCT01576588|Rituximab|rituximab|mesh-list
43964435|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
43964436|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964437|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964438|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
43964439|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964440|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964441|NCT01576588|Hormones|hormones|mesh-ancestor
43700932|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
44240872|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240874|NCT00584571|Citalopram|citalopram|mesh-list
44240875|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44240876|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44240877|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44240878|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240879|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240880|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
44240881|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964442|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964443|NCT01576809|Acetaminophen|acetaminophen|mesh-list
43964444|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
43964445|NCT01576809|Phenylephrine|phenylephrine|mesh-list
43964446|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
43964447|NCT01576809|Guaifenesin|guaifenesin|mesh-list
43964448|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
43964449|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964450|NCT01576809|Analgesics|analgesics|mesh-ancestor
43964451|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
43964452|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964454|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
43964455|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43964456|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
43964457|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
43964458|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
43964459|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43964460|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
43964477|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964478|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964479|NCT01576952|Analgesics|analgesics|mesh-ancestor
43964480|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
43964481|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964482|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964483|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964484|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964485|NCT01577706|Alprazolam|alprazolam|mesh-list
43964486|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
43964487|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43964488|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964489|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964490|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43964491|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43964492|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964493|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
43964494|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
43964495|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964496|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964497|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43964498|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43964499|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43964500|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964501|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
43964502|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
43964503|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964504|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964505|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964506|NCT01577966|Analgesics|analgesics|mesh-ancestor
43964507|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
43964508|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964509|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964510|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964511|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240882|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44240883|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44240884|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964512|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964513|NCT01578278|Fluticasone|fluticasone|mesh-list
43964515|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
43964516|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964517|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43964518|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
43964519|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964529|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964530|NCT01578772|Telmisartan|telmisartan|mesh-list
43964531|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43964532|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43964533|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142826|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964534|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964535|NCT01578980|Pancrelipase|pancrelipase|mesh-list
43964536|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964537|NCT01579162|Cholic Acids|cholic acids|mesh-list
43964538|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964540|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
43964541|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
43964542|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964543|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964544|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
43964545|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964546|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43964547|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43964548|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43964549|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964550|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964551|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
43964552|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43964553|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43964554|NCT01579513|Prednisolone|prednisolone|mesh-list
43964555|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
43964556|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43964557|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
43964558|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
43964559|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964560|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
43964561|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
43964562|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964563|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964564|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964565|NCT01579513|Hormones|hormones|mesh-ancestor
43964566|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964567|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43964568|NCT01579513|Protective Agents|protective agents|mesh-ancestor
43964569|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43964570|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964571|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
43964572|NCT01580410|Mitomycins|mitomycins|mesh-list
43964573|NCT01580410|Mitomycin|mitomycin|mesh-list
43964574|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964575|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43964576|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
43964577|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964578|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43964579|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964580|NCT01580423|Aprepitant|aprepitant|mesh-list
43964581|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
43964582|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
43964583|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964584|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964585|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964596|NCT01580618|Tenecteplase|tenecteplase|mesh-list
43964597|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43964598|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43964599|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240885|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43964600|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
43964601|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964603|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43964604|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964605|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43964606|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964608|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964609|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964610|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43964611|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
43964612|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964613|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964614|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43964615|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43964616|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964617|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
43964618|NCT01581970|Cetuximab|cetuximab|mesh-list
43964619|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964620|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
43964621|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964622|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964623|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43964624|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
43964625|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964626|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964627|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43964628|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964629|NCT01582477|Bupivacaine|bupivacaine|mesh-list
43964630|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
43964631|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
43964632|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964633|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964634|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
43964635|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964636|NCT01582490|Bupivacaine|bupivacaine|mesh-list
43964637|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43964638|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
43964639|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964640|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964641|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
43964642|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964643|NCT01582880|Riboflavin|riboflavin|mesh-list
43964644|NCT01582880|Vitamins|vitamins|mesh-ancestor
43964645|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
43964646|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964647|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
43964648|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43964658|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43964659|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
43964660|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964661|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964662|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43964663|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
43964664|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964665|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964666|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43964667|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43964668|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43964669|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
43964670|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964671|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
43964672|NCT01583985|Narcotics|narcotics|mesh-ancestor
43964673|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964674|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964675|NCT01583985|Analgesics|analgesics|mesh-ancestor
43964676|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
43964677|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964678|NCT01584388|Rituximab|rituximab|mesh-list
43964679|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43964680|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240886|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44240887|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
44240888|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
44240889|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240890|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44240891|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44240892|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
44240893|NCT00584610|Copper|copper|mesh-list
44240894|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
44240895|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44240896|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
44240897|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44240898|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240899|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44240900|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44240901|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44240902|NCT00584610|Trace Elements|trace elements|mesh-ancestor
44240903|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
44175649|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
43964681|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
43964682|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964683|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964684|NCT01584518|Furosemide|furosemide|mesh-list
43964685|NCT01584518|Diuretics|diuretics|mesh-ancestor
43964686|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
43964687|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964688|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43964689|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964690|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964691|NCT01584544|Capecitabine|capecitabine|mesh-list
43964692|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43964693|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
43964694|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964695|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964696|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43964697|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43964698|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964699|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
43964700|NCT01585207|Vigabatrin|vigabatrin|mesh-list
43964701|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
43964702|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964703|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964704|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
43964705|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964706|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964707|NCT01585324|Ribavirin|ribavirin|mesh-list
43964708|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43964709|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
43964710|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964711|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
43964712|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964713|NCT01585441|Finasteride|finasteride|mesh-list
43964714|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44142831|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142833|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142834|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142835|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459302|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459303|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44459304|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
44459305|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459306|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459308|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
44142836|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142837|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142838|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44142839|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
44142840|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142841|NCT00187928|Topiramate|topiramate|mesh-list
44142842|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
44142843|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44142844|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142845|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
44142846|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142847|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142848|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44142849|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
44142850|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142851|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142852|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142853|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142855|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142856|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142857|NCT00188006|Heparin|heparin|mesh-list
43703275|NCT02711449|Hormones|hormones|mesh-ancestor
43964722|NCT01586091|Fexofenadine|fexofenadine|mesh-list
43964723|NCT01586091|Levocetirizine|levocetirizine|mesh-list
43964724|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43964725|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43964726|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
43964727|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
43964728|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964729|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964730|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964731|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43964732|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
43964733|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43964734|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
43964735|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964736|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
43964737|NCT01586312|Protective Agents|protective agents|mesh-ancestor
43964738|NCT01586962|Acetaminophen|acetaminophen|mesh-list
43964739|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
43964741|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964742|NCT01586962|Analgesics|analgesics|mesh-ancestor
43964743|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
43964744|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964745|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964752|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43964753|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43964754|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
43964755|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
43964756|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964757|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964758|NCT01586975|Aspirin|aspirin|mesh-list
43964759|NCT01586975|Clopidogrel|clopidogrel|mesh-list
43964760|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964761|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964762|NCT01586975|Analgesics|analgesics|mesh-ancestor
43964763|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
43964764|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964765|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459309|NCT01582282|Cathartics|cathartics|mesh-ancestor
44459310|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459311|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
44459312|NCT01582243|Vildagliptin|vildagliptin|mesh-list
44459313|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459314|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459315|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44459316|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
44459317|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459318|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459319|NCT01582152|Bevacizumab|bevacizumab|mesh-list
44459320|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459321|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459322|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459323|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459324|NCT01582152|Growth Substances|growth substances|mesh-ancestor
44459325|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459326|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459327|NCT01582061|Pasireotide|pasireotide|mesh-list
44459328|NCT01582061|Hormones|hormones|mesh-ancestor
44459329|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459330|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459331|NCT01582009|Everolimus|everolimus|mesh-list
44459332|NCT01582009|Panobinostat|panobinostat|mesh-list
44459333|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44459334|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459335|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459336|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
44459337|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964766|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964767|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964768|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43964769|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43964770|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964771|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43964772|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43964773|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964774|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
43964775|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43964776|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43964777|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43964778|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
43964779|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964780|NCT01587027|Aminophylline|aminophylline|mesh-list
43964781|NCT01587027|Methazolamide|methazolamide|mesh-list
43964782|NCT01587027|Theophylline|theophylline|mesh-list
44459339|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459340|NCT01581931|Metformin|metformin|mesh-list
44459341|NCT01581931|Linagliptin|linagliptin|mesh-list
44459342|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459343|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459344|NCT01581931|Incretins|incretins|mesh-ancestor
44459345|NCT01581931|Hormones|hormones|mesh-ancestor
44459346|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459347|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44459348|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
44459349|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459350|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459351|NCT01581307|Leucovorin|leucovorin|mesh-list
44459352|NCT01581307|Folic Acid|folic acid|mesh-list
44459353|NCT01581307|Fluorouracil|fluorouracil|mesh-list
44459354|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
44459355|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
43623377|NCT04636671|Dexamethasone|dexamethasone|mesh-list
43964783|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43964784|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
43964785|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964786|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964787|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964788|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964789|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43964790|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964791|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964792|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
43964793|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43964794|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43964795|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
43964796|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964797|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43964798|NCT01587027|Protective Agents|protective agents|mesh-ancestor
43964799|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43964801|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
43964802|NCT01588158|Acetaminophen|acetaminophen|mesh-list
43964803|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43964804|NCT01588158|Hydrocodone|hydrocodone|mesh-list
43964805|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964806|NCT01588158|Analgesics|analgesics|mesh-ancestor
43964807|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
43964808|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964809|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964810|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
43964811|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43964812|NCT01588158|Narcotics|narcotics|mesh-ancestor
43964813|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964814|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
43964815|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964822|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43964823|NCT01588418|Incretins|incretins|mesh-ancestor
43964824|NCT01588418|Hormones|hormones|mesh-ancestor
43964825|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964826|NCT01588457|Lamotrigine|lamotrigine|mesh-list
43964827|NCT01588457|Valproic Acid|valproic acid|mesh-list
43964828|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44459356|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
44240905|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240906|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44240907|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
44240908|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240909|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240910|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44240911|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240912|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
44240913|NCT00584636|Hormones|hormones|mesh-ancestor
44240914|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44240915|NCT00584662|Phenylephrine|phenylephrine|mesh-list
44240916|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
44240917|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44240918|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44240919|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240920|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240921|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240922|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240923|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
44240924|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
44240925|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240926|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
44240927|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44240928|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240929|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44240930|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
44240931|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44240932|NCT00584662|Protective Agents|protective agents|mesh-ancestor
44240933|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44240940|NCT00584779|Gabapentin|gabapentin|mesh-list
44240948|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240949|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240950|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44240951|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44240952|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240953|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240954|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
44240955|NCT00585000|Tremelimumab|tremelimumab|mesh-list
44240956|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44240957|NCT00585091|Phenylephrine|phenylephrine|mesh-list
43964829|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
43964830|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
43964831|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964832|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43964833|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43964834|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964835|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964836|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964837|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964838|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
43964839|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
43964840|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43964841|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964842|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43964843|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43964844|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
43964845|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964846|NCT01588470|Pioglitazone|pioglitazone|mesh-list
43964847|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43964848|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964849|NCT01588561|Nicotine|nicotine|mesh-list
43964850|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43964851|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
43964852|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964853|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964854|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43964855|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43964856|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
43964857|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964858|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964859|NCT01589263|Tamsulosin|tamsulosin|mesh-list
43964860|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43964861|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43964862|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43964863|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
43964864|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964865|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964866|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964867|NCT01589263|Urological Agents|urological agents|mesh-ancestor
43964868|NCT01589510|Bimatoprost|bimatoprost|mesh-list
43964869|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43964870|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43964871|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43964872|NCT01589978|Aspirin|aspirin|mesh-list
43964873|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
43964874|NCT01589978|Salicylates|salicylates|mesh-list
43964875|NCT01589978|Ticlopidine|ticlopidine|mesh-list
43964876|NCT01589978|Clopidogrel|clopidogrel|mesh-list
43964877|NCT01589978|Ticagrelor|ticagrelor|mesh-list
43964878|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43964879|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964880|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964881|NCT01589978|Analgesics|analgesics|mesh-ancestor
43964882|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
43964883|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240958|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
44240959|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44240960|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
44240961|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
44240962|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240963|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240964|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
44285636|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
43964884|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964885|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964894|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43964895|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43964896|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43964897|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
43964898|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964899|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964900|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
43964901|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
43964902|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
43964903|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43964904|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43964905|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
43964906|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43964907|NCT01590875|Adenosine|adenosine|mesh-list
43964908|NCT01590875|Analgesics|analgesics|mesh-ancestor
43964909|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
43964910|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964911|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964912|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43964913|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
43964914|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43964915|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
43964916|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
43964917|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964918|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964919|NCT01590979|Ranolazine|ranolazine|mesh-list
43964920|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43964921|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964922|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964923|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43964924|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43964925|NCT01591733|Capecitabine|capecitabine|mesh-list
43964926|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
43964927|NCT01591733|Irinotecan|irinotecan|mesh-list
43964928|NCT01591733|Folfirinox|folfirinox|mesh-list
43964929|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43964930|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
43964931|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964932|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964933|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43964934|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43964935|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964936|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
43964937|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43964938|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43964939|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43964940|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964941|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964942|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
43964943|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964944|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964945|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43964946|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964947|NCT01591837|Vaccines|vaccines|mesh-list
43964948|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
43964949|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964950|NCT01592006|Ribavirin|ribavirin|mesh-list
43964969|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43964970|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
43964971|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964972|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964973|NCT01593215|Urological Agents|urological agents|mesh-ancestor
43964974|NCT01593592|Amoxicillin|amoxicillin|mesh-list
43964975|NCT01593592|Clarithromycin|clarithromycin|mesh-list
43964976|NCT01593592|Omeprazole|omeprazole|mesh-list
43964977|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43964978|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964979|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43964980|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43964981|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43964982|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964983|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964984|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43964985|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43964986|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43964987|NCT01593670|Decitabine|decitabine|mesh-list
43964988|NCT01593670|Interleukin-2|interleukin-2|mesh-list
43964989|NCT01593670|Vorinostat|vorinostat|mesh-list
43964990|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43964991|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
43964992|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964993|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964994|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964995|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43964996|NCT01593670|Analgesics|analgesics|mesh-ancestor
43964997|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
43964998|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964999|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965000|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43965001|NCT01593722|Ivermectin|ivermectin|mesh-list
43965002|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
43965003|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43965004|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965005|NCT01593722|Filaricides|filaricides|mesh-ancestor
43965006|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
43965007|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
43965008|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43965009|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965019|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965020|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965021|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
43965022|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965023|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
43965024|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
43965025|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
43965026|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
43965027|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43965028|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
43965029|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965030|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
43965031|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43965032|NCT01594424|Antibodies|antibodies|mesh-list
43965033|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
43965034|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43965035|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
43965036|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965037|NCT01595282|Ibuprofen|ibuprofen|mesh-list
43965038|NCT01595282|Ketorolac|ketorolac|mesh-list
43965039|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965040|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965041|NCT01595282|Analgesics|analgesics|mesh-ancestor
43965042|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
43965043|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965044|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965045|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965046|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965047|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43965048|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965049|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965050|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
43965051|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43965052|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965053|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
43965054|NCT01595516|Metoprolol|metoprolol|mesh-list
43965055|NCT01595516|Nebivolol|nebivolol|mesh-list
43965056|NCT01595516|Bradykinin|bradykinin|mesh-list
44240965|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44240966|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
44240967|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
44240968|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44240969|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44240970|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44240971|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44240972|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44240973|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240974|NCT00585091|Protective Agents|protective agents|mesh-ancestor
44240975|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43965058|NCT01595516|Vitamins|vitamins|mesh-ancestor
43965059|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
43965060|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965061|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
43965062|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965063|NCT01595516|Protective Agents|protective agents|mesh-ancestor
43965064|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43965065|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43965066|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
43965067|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
43965068|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965069|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43965070|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43965071|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43965072|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965073|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965074|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
43965075|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43965076|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43965087|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
43965088|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965089|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965090|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965091|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
43965092|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43965093|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
43965094|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965095|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
43965096|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
43965097|NCT01596088|Razoxane|razoxane|mesh-list
43965098|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965099|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43965100|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43965101|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43965102|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005604|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43965103|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965104|NCT01596088|Protective Agents|protective agents|mesh-ancestor
43965105|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965106|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
43965107|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
43965109|NCT01596699|Busulfan|busulfan|mesh-list
43965110|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
43965111|NCT01596699|Clofarabine|clofarabine|mesh-list
43965112|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965113|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965114|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
43965115|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965116|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965117|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
43965118|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965119|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
43965120|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44240976|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44240977|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44240978|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
43823980|NCT05517122|Niacin|niacin|mesh-list
44240979|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240980|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44240981|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44240982|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240984|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44240985|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44240986|NCT00585156|Analgesics|analgesics|mesh-ancestor
44240987|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
44240988|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240989|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240990|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44240991|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44240992|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44240993|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44240994|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44240995|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965121|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43965122|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965123|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
43965124|NCT01596842|Vitamin D|vitamin d|mesh-list
43965125|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43965126|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965127|NCT01596842|Vitamins|vitamins|mesh-ancestor
43965128|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
43965129|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43965130|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
43965131|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43965132|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
43965133|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965134|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965135|NCT05566743|Capecitabine|capecitabine|mesh-list
43965136|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965137|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
43965138|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965139|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965140|NCT05566665|Meropenem|meropenem|mesh-list
43965141|NCT05566665|Tazobactam|tazobactam|mesh-list
43965142|NCT05566665|Ceftazidime|ceftazidime|mesh-list
43965156|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965158|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965159|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965160|NCT05566301|Clopidogrel|clopidogrel|mesh-list
43965161|NCT05566301|Ticagrelor|ticagrelor|mesh-list
43965162|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43965163|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43965164|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43965165|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43965166|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
44240996|NCT00585260|Mannitol|mannitol|mesh-list
44240997|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44240998|NCT00585260|Diuretics|diuretics|mesh-ancestor
44240999|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
44241000|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241001|NCT00585442|Vitamin D|vitamin d|mesh-list
44241002|NCT00585442|Calcitriol|calcitriol|mesh-list
44241003|NCT00585442|Vitamins|vitamins|mesh-ancestor
44241004|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
44241005|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638066|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
43965167|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965168|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965169|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965170|NCT05566093|Ethanol|ethanol|mesh-list
43965171|NCT05566093|Polidocanol|polidocanol|mesh-list
43965172|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43965173|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965174|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965175|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965176|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43965177|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44142858|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
44142859|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44142860|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44142861|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142862|NCT00188045|Propranolol|propranolol|mesh-list
44142863|NCT00188045|Spironolactone|spironolactone|mesh-list
44142864|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44142865|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44142866|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
44142867|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142868|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142869|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142870|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44142871|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142872|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142873|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44142874|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
44142875|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142876|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44142877|NCT00188045|Diuretics|diuretics|mesh-ancestor
44142878|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
44142879|NCT00188071|Acetaminophen|acetaminophen|mesh-list
44142880|NCT00188071|Ketoprofen|ketoprofen|mesh-list
44142881|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44142882|NCT00188071|Analgesics|analgesics|mesh-ancestor
44142883|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
44142884|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142885|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142886|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
44142887|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44142888|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142889|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142890|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44142891|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142892|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142893|NCT00188136|Fludarabine|fludarabine|mesh-list
44142895|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142896|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142897|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142898|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
44142899|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142900|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142901|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
44142902|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241006|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44241007|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44241008|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44241009|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44241010|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241011|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44241012|NCT00585455|Sertraline|sertraline|mesh-list
44241013|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44241014|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142903|NCT00188227|Midazolam|midazolam|mesh-list
44142904|NCT00188227|Pirinitramide|pirinitramide|mesh-list
44142905|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44142906|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44142907|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44142908|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142909|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44142910|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44142911|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142912|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44142913|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
44142914|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
44142915|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
44142916|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
44142917|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142918|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142919|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44142920|NCT00188227|Narcotics|narcotics|mesh-ancestor
44142921|NCT00188227|Analgesics|analgesics|mesh-ancestor
44142922|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
44142923|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142924|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44142925|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
44142926|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142927|NCT00188266|Fluorouracil|fluorouracil|mesh-list
44142928|NCT00188266|Cisplatin|cisplatin|mesh-list
44142929|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
44142930|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157525|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
43965178|NCT05565976|Aspirin|aspirin|mesh-list
43965179|NCT05565976|Insulin|insulin|mesh-list
43965180|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43965181|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
43965182|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
43965183|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
43965184|NCT05565976|Biguanides|biguanides|mesh-list
43965185|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43965186|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43965187|NCT05565976|Meglitinide|meglitinide|mesh-list
43965188|NCT05565976|Clopidogrel|clopidogrel|mesh-list
43965189|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43965190|NCT05565976|Atorvastatin|atorvastatin|mesh-list
43965191|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43965192|NCT05565976|Pravastatin|pravastatin|mesh-list
43965193|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965194|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43965195|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43965196|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
43965197|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965198|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43965199|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43965200|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965201|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43965202|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43965203|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43965204|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
43965205|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965207|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965209|NCT05565976|Analgesics|analgesics|mesh-ancestor
44241015|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44241016|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44241017|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44241018|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241019|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241020|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
44241021|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241023|NCT00585520|Progestins|progestins|mesh-ancestor
44241024|NCT00585520|Hormones|hormones|mesh-ancestor
43965210|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
43965211|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965212|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965213|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965214|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43965215|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43965216|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43965217|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
43965218|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43965219|NCT05565924|Biguanides|biguanides|mesh-list
43965220|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965221|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965222|NCT05565729|Levocetirizine|levocetirizine|mesh-list
43965223|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43965224|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43965225|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
43965226|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
43965227|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965228|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965229|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965230|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
43965231|NCT05565664|Ketamine|ketamine|mesh-list
43965232|NCT05565664|Analgesics|analgesics|mesh-ancestor
43965233|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
43965234|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965235|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965236|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43965237|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43965238|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
43965239|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
43965240|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965241|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43965242|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43965243|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965244|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965245|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43965246|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
43965247|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43965248|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965249|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43965250|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
43965251|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703788|NCT02708511|Copper|copper|mesh-list
43965252|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
43965253|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43965254|NCT05565625|Protective Agents|protective agents|mesh-ancestor
43965255|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965256|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
43965257|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43965258|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
43965259|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
43965260|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43965261|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
43965262|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44241025|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241026|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241027|NCT00585741|Alovudine|alovudine|mesh-list
44241028|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
44241029|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241030|NCT00585754|Guanfacine|guanfacine|mesh-list
44241031|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241032|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44241033|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44241034|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44241035|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44241036|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241037|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241038|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241039|NCT00585871|Metoprolol|metoprolol|mesh-list
44241040|NCT00585871|Clonidine|clonidine|mesh-list
44241041|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44241042|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43965263|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965264|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43965265|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43965266|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43965267|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43965268|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43965269|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43965270|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965271|NCT05565495|Hydromorphone|hydromorphone|mesh-list
43965272|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43965273|NCT05565495|Narcotics|narcotics|mesh-ancestor
43965274|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965275|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965276|NCT05565495|Analgesics|analgesics|mesh-ancestor
43965285|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
43965286|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965287|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43965288|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43965289|NCT05565222|Meropenem|meropenem|mesh-list
43965290|NCT05565222|Tazobactam|tazobactam|mesh-list
43965291|NCT05565222|Piperacillin|piperacillin|mesh-list
43965292|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43965293|NCT05565222|Temocillin|temocillin|mesh-list
43965294|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43965295|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965296|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43965297|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965298|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965299|NCT05565001|Cromakalim|cromakalim|mesh-list
43965300|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43965301|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43965302|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
43965303|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965304|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965305|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43965306|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
43965307|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
43965308|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
43965309|NCT05564858|Antibodies|antibodies|mesh-list
44241044|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
44241045|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241046|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241047|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44241048|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44241049|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44241050|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44241051|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894253|NCT03418779|Hormones|hormones|mesh-ancestor
44241052|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241053|NCT00585871|Analgesics|analgesics|mesh-ancestor
44241054|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
44241055|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44241056|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44241057|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44241058|NCT00586092|Bevacizumab|bevacizumab|mesh-list
44241059|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241060|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241061|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44241062|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44241063|NCT00586092|Growth Substances|growth substances|mesh-ancestor
44241064|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241065|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44241067|NCT00586118|Sevoflurane|sevoflurane|mesh-list
44241068|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44241069|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965310|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43965311|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
43965312|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
43965313|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965314|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43965315|NCT05564832|Pilocarpine|pilocarpine|mesh-list
43965316|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43965317|NCT05564832|Miotics|miotics|mesh-ancestor
43965318|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
43965319|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965320|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965321|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43965322|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43965323|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
43965324|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965325|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965326|NCT05564819|Acetaminophen|acetaminophen|mesh-list
43965327|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965328|NCT05564819|Analgesics|analgesics|mesh-ancestor
43965329|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
44241070|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241071|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44241072|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
44241073|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
44241074|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44241075|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44241076|NCT00586131|Citric Acid|citric acid|mesh-list
44241077|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
44241078|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
44241079|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44241080|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
44241081|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
44241082|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241083|NCT00586274|Fludarabine|fludarabine|mesh-list
44241084|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
44241085|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241086|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241087|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
44241088|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
44241090|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44241091|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241092|NCT00586365|Analgesics|analgesics|mesh-ancestor
44241093|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
44241094|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965330|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965331|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965332|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
43965334|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
43965335|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
43965336|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965337|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965338|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
43965339|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965340|NCT05563168|Diltiazem|diltiazem|mesh-list
43965341|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43965342|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43965343|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965344|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965345|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43965356|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
43965357|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
43965358|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
43965359|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965360|NCT05556044|Empagliflozin|empagliflozin|mesh-list
43965361|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43965362|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965363|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965364|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965365|NCT05540743|Adalimumab|adalimumab|mesh-list
43965366|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241095|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241096|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241097|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241098|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
44241099|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44241100|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241101|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241102|NCT00586430|Lorazepam|lorazepam|mesh-list
44241103|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
44241104|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
44241105|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
44241106|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241107|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241108|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241109|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44241110|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241111|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44241112|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241113|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43965367|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965368|NCT05493540|Ibuprofen|ibuprofen|mesh-list
43965369|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965370|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965371|NCT05493540|Analgesics|analgesics|mesh-ancestor
43965372|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
43965373|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965374|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965375|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965376|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965377|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43965378|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965379|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142931|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142932|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142933|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142934|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
44142935|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142936|NCT00188383|Amantadine|amantadine|mesh-list
44142937|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44142938|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44142939|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
44142940|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142941|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
44142942|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142943|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142944|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142945|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44142946|NCT00188383|Analgesics|analgesics|mesh-ancestor
44142947|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
44142948|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142949|NCT00188396|Citalopram|citalopram|mesh-list
44142950|NCT00188396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44142951|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44142952|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142953|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241114|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
44241115|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
44241116|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241117|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241118|NCT00586443|Bevacizumab|bevacizumab|mesh-list
44241119|NCT00586443|Panitumumab|panitumumab|mesh-list
44241120|NCT00586443|Everolimus|everolimus|mesh-list
44241121|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241122|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241123|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44241124|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44241125|NCT00586443|Growth Substances|growth substances|mesh-ancestor
44241126|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241127|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44241128|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241129|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
44241130|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
44241131|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241132|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
44241133|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241134|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241135|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241136|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
44241137|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241138|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241139|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241140|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
44241141|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
44241142|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44241143|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44241144|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241158|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
44241159|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
44241160|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241161|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241162|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
44241163|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459357|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459358|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44459359|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459360|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459361|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
44459362|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459363|NCT01581307|Antidotes|antidotes|mesh-ancestor
44459364|NCT01581307|Protective Agents|protective agents|mesh-ancestor
44459365|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
44459366|NCT01581307|Vitamins|vitamins|mesh-ancestor
44459367|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
44459368|NCT01581307|Hematinics|hematinics|mesh-ancestor
44459369|NCT01581281|Topiramate|topiramate|mesh-list
44459370|NCT01581281|Amitriptyline|amitriptyline|mesh-list
44459371|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
44459372|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459373|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459374|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44459375|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
44459376|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459377|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459378|NCT01581281|Analgesics|analgesics|mesh-ancestor
43965380|NCT05406752|Acetaminophen|acetaminophen|mesh-list
43965381|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965382|NCT05406752|Analgesics|analgesics|mesh-ancestor
43965383|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
43965384|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965385|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965386|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
43965393|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43965394|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
43965395|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965396|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43965397|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43965398|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965399|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965400|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43965401|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43965402|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
43965403|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965404|NCT05365438|Atorvastatin|atorvastatin|mesh-list
44459379|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
44459380|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459381|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44459382|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44459383|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459384|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459385|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459386|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459387|NCT01580995|Valacyclovir|valacyclovir|mesh-list
44459388|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
44459389|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459390|NCT01580969|Minocycline|minocycline|mesh-list
44459391|NCT01580969|Bevacizumab|bevacizumab|mesh-list
44459392|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459393|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459394|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459395|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44241164|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
44241165|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241166|NCT00587119|Budesonide|budesonide|mesh-list
44241167|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241168|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44241169|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
44241170|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241171|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241172|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44241173|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
44241174|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
44241175|NCT00587119|Hormones|hormones|mesh-ancestor
44241176|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241177|NCT00587145|Docetaxel|docetaxel|mesh-list
44241178|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241179|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
43965405|NCT05365438|Ezetimibe|ezetimibe|mesh-list
43965406|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43965407|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43965408|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
43965409|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965410|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43965411|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43965412|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965413|NCT05365425|Choline|choline|mesh-list
44241180|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
44241181|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
44241182|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241183|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44241184|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44241185|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
44241186|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241187|NCT00587249|Antacids|antacids|mesh-ancestor
44241188|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241189|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241190|NCT00587327|Atosiban|atosiban|mesh-list
44241191|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44241192|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241193|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241194|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
44241195|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44241196|NCT00587379|Atorvastatin|atorvastatin|mesh-list
44241197|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44241198|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44241199|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
44241200|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241201|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44241202|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44241203|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241204|NCT00587444|Heparin|heparin|mesh-list
44241205|NCT00587444|Calcium heparin|calcium heparin|mesh-list
44241206|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
44241207|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44241208|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44241209|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241210|NCT00587470|Candesartan|candesartan|mesh-list
44241211|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
44241212|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241213|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44241214|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44241215|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241218|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44241219|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241220|NCT00587496|Analgesics|analgesics|mesh-ancestor
44241221|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
44241222|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241223|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241224|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241225|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241226|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44241227|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44241228|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241229|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44241230|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44241231|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241232|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
44241233|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
44241234|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241235|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
44241236|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44241237|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241238|NCT00587665|Ketamine|ketamine|mesh-list
44241239|NCT00587665|Analgesics|analgesics|mesh-ancestor
43965414|NCT05365425|Policosanol|policosanol|mesh-list
43965415|NCT05365425|Fenofibrate|fenofibrate|mesh-list
43965416|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43965417|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
43965418|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965419|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43965420|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
43965421|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43965422|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
43965423|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43965424|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43965425|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43965426|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43965427|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43965428|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43965429|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43965430|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43965431|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43965432|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965433|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965434|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965435|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965436|NCT05350371|Pirfenidone|pirfenidone|mesh-list
43965437|NCT05350371|Analgesics|analgesics|mesh-ancestor
43965438|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
43965439|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965440|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965441|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965442|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241242|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241243|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44241245|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
44241246|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
44241247|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241248|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44241249|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44241250|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241251|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241252|NCT00587717|Simvastatin|simvastatin|mesh-list
44241253|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44241254|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43965443|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965444|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965445|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965446|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43965447|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43965448|NCT05264506|Estradiol|estradiol|mesh-list
43965449|NCT05264506|Estrogens|estrogens|mesh-ancestor
43965450|NCT05264506|Hormones|hormones|mesh-ancestor
43871141|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965451|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43965452|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965454|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965455|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965456|NCT05183204|Metformin|metformin|mesh-list
43965457|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965462|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43965463|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965464|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43965465|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965466|NCT05161741|Insulin|insulin|mesh-list
43965467|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965468|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965469|NCT05140694|Empagliflozin|empagliflozin|mesh-list
43965470|NCT05140694|Dulaglutide|dulaglutide|mesh-list
43965471|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43965472|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43965473|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965474|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965475|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965476|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
43965480|NCT05672901|Estradiol|estradiol|mesh-list
43965481|NCT05672901|Estrogens|estrogens|mesh-ancestor
43965482|NCT05672901|Hormones|hormones|mesh-ancestor
43965483|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43965484|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965485|NCT05672836|Antihypertensive Agents|antihypertensive agents|mesh-list
43965486|NCT05672836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43965487|NCT05672836|Protease Inhibitors|protease inhibitors|mesh-ancestor
43965488|NCT05672836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965489|NCT05672836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241255|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
44241256|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241257|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44241258|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44241259|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241260|NCT00587873|Leucovorin|leucovorin|mesh-list
44241261|NCT00587873|Methotrexate|methotrexate|mesh-list
44241262|NCT00587873|Thioguanine|thioguanine|mesh-list
44241263|NCT00587873|Calcium|calcium|mesh-list
44241264|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
44241265|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44241266|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241267|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44241268|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
44241269|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44241270|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241271|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
44241272|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241273|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241274|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
44241275|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241276|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44241277|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241278|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
44241279|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241280|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44241281|NCT00587873|Antidotes|antidotes|mesh-ancestor
44241282|NCT00587873|Protective Agents|protective agents|mesh-ancestor
43965490|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
43965491|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43965492|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43965493|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965494|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
43965495|NCT05672810|Coagulants|coagulants|mesh-ancestor
43965496|NCT05672784|Acetaminophen|acetaminophen|mesh-list
43965497|NCT05672784|Meloxicam|meloxicam|mesh-list
43965498|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965499|NCT05672784|Analgesics|analgesics|mesh-ancestor
43965500|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
43965501|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965502|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965503|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
43965504|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965505|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965506|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965507|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43965508|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44241283|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
44241285|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
44241286|NCT00588003|Anastrozole|anastrozole|mesh-list
44241287|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44241288|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241289|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44241290|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44241291|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241292|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241293|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44241294|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
43965509|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965510|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965511|NCT05672680|Bupivacaine|bupivacaine|mesh-list
43965512|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
43965513|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
43965514|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965515|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965516|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
43965517|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965518|NCT05672667|Oxytocin|oxytocin|mesh-list
43965519|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
43965520|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43965521|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965522|NCT05672537|Gemcitabine|gemcitabine|mesh-list
43965523|NCT05672537|Cisplatin|cisplatin|mesh-list
43965524|NCT05672537|Durvalumab|durvalumab|mesh-list
43965525|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965526|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965527|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
43965528|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965529|NCT05672537|Antiviral Agents|antiviral agents|mesh-ancestor
43965538|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965539|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965540|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43965541|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965542|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965543|NCT05672472|Sivelestat|sivelestat|mesh-list
43965544|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43965545|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
43965546|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965547|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965548|NCT05672394|Lidocaine|lidocaine|mesh-list
43965549|NCT05672394|Epinephrine|epinephrine|mesh-list
43965550|NCT05672394|Bupivacaine|bupivacaine|mesh-list
43965551|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
43965552|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
43965553|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965554|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965555|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
43965556|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965557|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43965558|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43965559|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43965560|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965561|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965562|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43965563|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43965564|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965565|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965566|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43965567|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44241295|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241296|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241297|NCT00588016|Itraconazole|itraconazole|mesh-list
44241298|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
44241299|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241300|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44241301|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44241302|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241303|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965568|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
43965569|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43965570|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
43965571|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
43965572|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
43965573|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43965574|NCT05672355|Vaccines|vaccines|mesh-list
43965575|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
43965576|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965577|NCT05672342|Dronabinol|dronabinol|mesh-list
43965578|NCT05672342|Cannabidiol|cannabidiol|mesh-list
43965579|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
43965580|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
43965581|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965582|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43965583|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965584|NCT05672342|Analgesics|analgesics|mesh-ancestor
43965585|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
43965586|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965587|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43965588|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43965589|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965590|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965591|NCT05672342|Hormones|hormones|mesh-ancestor
43965592|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142954|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142955|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
44142956|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142965|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44142966|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142967|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142968|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43965593|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43965594|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43965595|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
43965596|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965597|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965598|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965599|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
43965600|NCT05672173|Nivolumab|nivolumab|mesh-list
43965601|NCT05672173|Fludarabine|fludarabine|mesh-list
43965602|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965603|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
43965604|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965605|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965606|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43965607|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
43965608|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965609|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965610|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43965611|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965612|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43965613|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
43965614|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44241304|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44241305|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44241306|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241307|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241308|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44241309|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
44241310|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44241311|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44241312|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241313|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
44241314|NCT00588133|Coagulants|coagulants|mesh-ancestor
44241315|NCT00588172|Metformin|metformin|mesh-list
44241316|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44241317|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241318|NCT00588302|Moexipril|moexipril|mesh-list
44241319|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44241320|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
44241321|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241322|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241323|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241324|NCT00588835|Dexamethasone|dexamethasone|mesh-list
44241325|NCT00588835|Ondansetron|ondansetron|mesh-list
44241326|NCT00588835|Aprepitant|aprepitant|mesh-list
44241327|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241328|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
44241329|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
44241330|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241331|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241332|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241333|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
44241334|NCT00588835|Hormones|hormones|mesh-ancestor
44241335|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241336|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44241337|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241338|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
44241339|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
44241340|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44241342|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241343|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241344|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44241345|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241346|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241347|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241348|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44241349|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44241350|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
44241351|NCT00588913|Aldesleukin|aldesleukin|mesh-list
44241352|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241353|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44241354|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44241355|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
44241356|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241357|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44241358|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241359|NCT00588926|Remifentanil|remifentanil|mesh-list
43965615|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43965616|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965617|NCT05672108|Mitomycins|mitomycins|mesh-list
43965618|NCT05672108|Mitomycin|mitomycin|mesh-list
43965619|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
43965620|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43965621|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965622|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
43965623|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965624|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43965625|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965626|NCT05672095|Selenium|selenium|mesh-list
43965627|NCT05672095|Niraparib|niraparib|mesh-list
43965628|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43965629|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965630|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965631|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965632|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
43965633|NCT05672095|Protective Agents|protective agents|mesh-ancestor
43965634|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965635|NCT05672095|Trace Elements|trace elements|mesh-ancestor
43965636|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
43965637|NCT05671991|Empagliflozin|empagliflozin|mesh-list
43965638|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43965639|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965640|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965641|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965642|NCT05671913|Ketamine|ketamine|mesh-list
43965643|NCT05671913|Analgesics|analgesics|mesh-ancestor
43965644|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
43965645|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965646|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965647|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43965648|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43965659|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
43871142|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43965660|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965661|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965662|NCT05671757|Daratumumab|daratumumab|mesh-list
44241360|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44241361|NCT00588926|Narcotics|narcotics|mesh-ancestor
44241362|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241363|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241364|NCT00588926|Analgesics|analgesics|mesh-ancestor
44241365|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
44241366|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241367|NCT00589082|Daunorubicin|daunorubicin|mesh-list
44241368|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241369|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241370|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44241371|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44241372|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241373|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241374|NCT00589134|Ganirelix|ganirelix|mesh-list
44241375|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
44241376|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241377|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459396|NCT01580969|Growth Substances|growth substances|mesh-ancestor
44459397|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459398|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459399|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44459400|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459401|NCT01580670|Infliximab|infliximab|mesh-list
44459402|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44006533|NCT04430959|Candesartan|candesartan|mesh-list
44459403|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459404|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241378|NCT00589186|Celecoxib|celecoxib|mesh-list
44241379|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44241380|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241381|NCT00589186|Analgesics|analgesics|mesh-ancestor
44241382|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
44241383|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241384|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241385|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241386|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241391|NCT00589238|Paclitaxel|paclitaxel|mesh-list
44241392|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
44241393|NCT00589238|Carboplatin|carboplatin|mesh-list
44241394|NCT00589238|Doxorubicin|doxorubicin|mesh-list
44241395|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44241396|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44241397|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241398|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
44241399|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
44241400|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
44241401|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241402|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241403|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
44241404|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241405|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241406|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241407|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
44241408|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241409|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241410|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44241411|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44241412|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241413|NCT00589251|Penicillins|penicillins|mesh-list
44241414|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44241415|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241417|NCT00589264|Trace Elements|trace elements|mesh-ancestor
44241418|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
43965663|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43965664|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965665|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
43965666|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965667|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43965668|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
43965669|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965670|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
43965671|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
43965672|NCT05671081|Analgesics|analgesics|mesh-list
43965673|NCT05671081|Narcotics|narcotics|mesh-list
43965674|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43965675|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965676|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965677|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965678|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
43965679|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965680|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43965681|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44241420|NCT00589316|Iodine|iodine|mesh-list
44241421|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
44241422|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
44241423|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
44241424|NCT00589316|Fludarabine|fludarabine|mesh-list
44241425|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
44241426|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44241427|NCT00589316|Tacrolimus|tacrolimus|mesh-list
44241428|NCT00589316|Antibodies|antibodies|mesh-list
44241429|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
44241430|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44241431|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241432|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
43965682|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43965683|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965684|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965685|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965686|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
43965687|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43965688|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
43965689|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43965690|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965691|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43965692|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
43965693|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43965694|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
43965695|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
43965696|NCT05669872|Hematinics|hematinics|mesh-ancestor
43965697|NCT05663866|Dexamethasone|dexamethasone|mesh-list
43965698|NCT05663866|Methotrexate|methotrexate|mesh-list
43965699|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43965700|NCT05663866|Montelukast|montelukast|mesh-list
43965701|NCT05663866|Lazertinib|lazertinib|mesh-list
43965702|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965703|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
43965704|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
43965705|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965706|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965707|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43965708|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
43965709|NCT05663866|Hormones|hormones|mesh-ancestor
43965710|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43965711|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43965712|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965720|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965721|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43965722|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965723|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
43965724|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965725|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43965726|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43965727|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
43965728|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43965729|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
43965730|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43965731|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43965732|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43965733|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965734|NCT05644249|Cisplatin|cisplatin|mesh-list
43965735|NCT05644249|Doxorubicin|doxorubicin|mesh-list
43965736|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965737|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241433|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241434|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241435|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241436|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
44241437|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241438|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965738|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43965739|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43965740|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965741|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965742|NCT05633381|Temozolomide|temozolomide|mesh-list
43965743|NCT05633381|Trabectedin|trabectedin|mesh-list
43965745|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43965746|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
43965747|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965748|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965749|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43965750|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965751|NCT05631093|Islatravir|islatravir|mesh-list
43965752|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
43965753|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965754|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965755|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965756|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43965757|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43965758|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43965759|NCT05610163|Leucovorin|leucovorin|mesh-list
43965760|NCT05610163|Fluorouracil|fluorouracil|mesh-list
43965761|NCT05610163|Capecitabine|capecitabine|mesh-list
43965762|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
43965763|NCT05610163|Irinotecan|irinotecan|mesh-list
43965764|NCT05610163|Calcium|calcium|mesh-list
43965765|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
43965766|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43965767|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965768|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
43965769|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965770|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965771|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965772|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965773|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
43965774|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43965775|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43965776|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965777|NCT05610163|Antidotes|antidotes|mesh-ancestor
43965778|NCT05610163|Protective Agents|protective agents|mesh-ancestor
43965779|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
43965780|NCT05610163|Vitamins|vitamins|mesh-ancestor
43965786|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965787|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43965788|NCT05597722|Amphetamine|amphetamine|mesh-list
43965789|NCT05597722|Adderall|adderall|mesh-list
43965790|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
43965791|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43965792|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965793|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
43965794|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
43965795|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965796|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
43965797|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965798|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965799|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965800|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43965801|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43965802|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43965803|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43965804|NCT05594290|Cisplatin|cisplatin|mesh-list
43965805|NCT05594290|Etoposide|etoposide|mesh-list
44241439|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241440|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241442|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44241443|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241444|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241445|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44241446|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
44241447|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44241448|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241449|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44241450|NCT00589316|Trace Elements|trace elements|mesh-ancestor
44241451|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
44241452|NCT00589381|Fenretinide|fenretinide|mesh-list
44241453|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241454|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44241455|NCT00589381|Protective Agents|protective agents|mesh-ancestor
44241456|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241457|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43965806|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965807|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43965808|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43965809|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43965810|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965811|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965812|NCT05594147|Sorafenib|sorafenib|mesh-list
43965813|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965814|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43965815|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965816|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965817|NCT05571345|Oxycodone|oxycodone|mesh-list
43965818|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43965819|NCT05571345|Narcotics|narcotics|mesh-ancestor
43965820|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965821|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965822|NCT05571345|Analgesics|analgesics|mesh-ancestor
43965823|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
43965824|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965825|NCT05568979|Vaccines|vaccines|mesh-list
43965826|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
43965827|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965828|NCT05568160|Vasopressins|vasopressins|mesh-list
43965829|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
43965830|NCT05568160|Norepinephrine|norepinephrine|mesh-list
43965831|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43965832|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43965833|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
43965834|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965835|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965836|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965837|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
43965838|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
43965839|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965840|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43965841|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
43965842|NCT05568160|Coagulants|coagulants|mesh-ancestor
44241458|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
44241459|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241461|NCT00589485|Trace Elements|trace elements|mesh-ancestor
43965843|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43965844|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
43965845|NCT05562492|Insulin|insulin|mesh-list
43965846|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43965847|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142969|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44142970|NCT00188552|Protective Agents|protective agents|mesh-ancestor
44142971|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142972|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142973|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44142980|NCT00188565|Analgesics|analgesics|mesh-ancestor
44142981|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
44142982|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142983|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142984|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142985|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142986|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44142987|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44142988|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142989|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142990|NCT00188604|Selenious Acid|selenious acid|mesh-list
44142991|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
44142992|NCT00188604|Trace Elements|trace elements|mesh-ancestor
44142993|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
44142994|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142995|NCT00188617|Gefitinib|gefitinib|mesh-list
44142996|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142997|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44142998|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142999|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143000|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
44143001|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44143002|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
44143003|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143004|NCT00188630|Expectorants|expectorants|mesh-ancestor
44143005|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
44143006|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44143007|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
44143008|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143009|NCT00188630|Protective Agents|protective agents|mesh-ancestor
44143010|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143011|NCT00188630|Antidotes|antidotes|mesh-ancestor
44143012|NCT00188643|Lamotrigine|lamotrigine|mesh-list
44143013|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44143014|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143015|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143016|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704274|NCT05225545|Iron|iron|mesh-list
43965848|NCT05562297|Gemcitabine|gemcitabine|mesh-list
43965849|NCT05562297|Paclitaxel|paclitaxel|mesh-list
43965850|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43965851|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965852|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
43965853|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
43965854|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
43965855|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965856|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965857|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
43965858|NCT05562297|Antiviral Agents|antiviral agents|mesh-ancestor
43965859|NCT05562297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965860|NCT05562297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965861|NCT05562297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965862|NCT05562297|Immunologic Factors|immunologic factors|mesh-ancestor
43965863|NCT05562297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965864|NCT05561764|Imipenem|imipenem|mesh-list
43965865|NCT05561764|Relebactam|relebactam|mesh-list
43965866|NCT05561764|Cilastatin|cilastatin|mesh-list
43965867|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43965868|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965869|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
44241463|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241464|NCT00589732|Valsartan|valsartan|mesh-list
44241465|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241466|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44241467|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44241468|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241469|NCT00589862|Clopidogrel|clopidogrel|mesh-list
44241470|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44241471|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44241472|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44241473|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44241474|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
44241475|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241476|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241477|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241478|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
44241479|NCT00589901|Capecitabine|capecitabine|mesh-list
44241480|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241481|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
43554409|NCT03572010|Fesoterodine|fesoterodine|mesh-list
43965870|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965871|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965872|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43965873|NCT05558410|Acetaminophen|acetaminophen|mesh-list
43965874|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965881|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965883|NCT05557877|Analgesics|analgesics|mesh-ancestor
43965884|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
43965885|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965886|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965887|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965888|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965889|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43965890|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43965891|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965892|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43965893|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43965894|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965895|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
43965896|NCT05553366|Acetaminophen|acetaminophen|mesh-list
43965897|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965898|NCT05553366|Analgesics|analgesics|mesh-ancestor
43965899|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
43965900|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965901|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965902|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
43965903|NCT05552196|Carbamazepine|carbamazepine|mesh-list
43965904|NCT05552196|Ponesimod|ponesimod|mesh-list
43965905|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
43965906|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
43965907|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241482|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241483|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241484|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241485|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
44241486|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564070|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
43965908|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965909|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965910|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43965911|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965912|NCT05552196|Analgesics|analgesics|mesh-ancestor
43965913|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
43965914|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965915|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43965916|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871143|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
43965917|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965918|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43965919|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43965920|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43965921|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965922|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
43704351|NCT05134688|Analgesics|analgesics|mesh-ancestor
43965924|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43965925|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965926|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
43965927|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965928|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
43965929|NCT05537766|Fludarabine|fludarabine|mesh-list
43965930|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965931|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
43965932|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965933|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965934|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43965935|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
43965936|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965937|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965938|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43965939|NCT05525273|Trametinib|trametinib|mesh-list
43965940|NCT05525273|Dabrafenib|dabrafenib|mesh-list
43965941|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965942|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43965952|NCT05498428|Carboplatin|carboplatin|mesh-list
43965953|NCT05498428|Pemetrexed|pemetrexed|mesh-list
43965954|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43965955|NCT05498428|Lazertinib|lazertinib|mesh-list
43965956|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965957|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965958|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965959|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43965960|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43965961|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43965962|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965963|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43965964|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965965|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965966|NCT05485805|Naproxen|naproxen|mesh-list
43965967|NCT05485805|Caffeine|caffeine|mesh-list
43965968|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43965969|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965970|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43965971|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965972|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965973|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43965974|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43965975|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
44006955|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
43965976|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241488|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241489|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241490|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
44241491|NCT00589927|Cilostazol|cilostazol|mesh-list
44241492|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43965977|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43965978|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965979|NCT05485805|Analgesics|analgesics|mesh-ancestor
43965980|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
43965981|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965982|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43965983|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43965984|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
43965985|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43965986|NCT05455684|Aticaprant|aticaprant|mesh-list
43965987|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43965988|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965989|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
43965990|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965991|NCT05401227|Ketamine|ketamine|mesh-list
43965992|NCT05401227|Analgesics|analgesics|mesh-ancestor
43965993|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
43965994|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965995|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965996|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43965997|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43965998|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
43965999|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
43966000|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966001|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43966002|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43966003|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966004|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966005|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43966006|NCT05388669|Lazertinib|lazertinib|mesh-list
43966015|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
43966016|NCT05379972|Olaparib|olaparib|mesh-list
43966017|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966018|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966019|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43966020|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966021|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966022|NCT05376722|Prednisone|prednisone|mesh-list
43966023|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966024|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
43966025|NCT05376722|Hormones|hormones|mesh-ancestor
43966026|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43966027|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966028|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966029|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966030|NCT05367687|Apatinib|apatinib|mesh-list
43966031|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966032|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966033|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966034|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966035|NCT05363111|Daratumumab|daratumumab|mesh-list
43966036|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966037|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43966038|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966039|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
43966040|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966041|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
43966042|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
43966043|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966044|NCT05342636|Paclitaxel|paclitaxel|mesh-list
43966045|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
43966046|NCT05342636|Irinotecan|irinotecan|mesh-list
43966047|NCT05342636|Lenvatinib|lenvatinib|mesh-list
43966048|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
44241494|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241495|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241496|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44241497|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44241498|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44241499|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966049|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43966050|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966051|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966052|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966053|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966054|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966055|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966056|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43966057|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43966058|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966059|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
43966060|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966061|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966062|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
43966063|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
43966064|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43966065|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43966066|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
43966067|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966068|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966069|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966071|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966084|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
43966085|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966086|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966087|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966088|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966089|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43966090|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966091|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966092|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43966093|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43966094|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966095|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
43966096|NCT05257460|Insulin|insulin|mesh-list
43966097|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43966098|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
43966099|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43966100|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966101|NCT05252533|Ustekinumab|ustekinumab|mesh-list
43966102|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966103|NCT05251909|Benralizumab|benralizumab|mesh-list
43966104|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43966105|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966106|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43966107|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43966108|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966109|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43966110|NCT05245292|Antibodies|antibodies|mesh-list
43966111|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
43966112|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966113|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
43966114|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
43966115|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966116|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966117|NCT05242458|Ustekinumab|ustekinumab|mesh-list
43966118|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966119|NCT05208983|Vaccines|vaccines|mesh-list
43966120|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
43966121|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241500|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241501|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44241502|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
44241503|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44241504|NCT00589927|Protective Agents|protective agents|mesh-ancestor
44007024|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241505|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44241506|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43966123|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43966124|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966125|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966126|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
43966127|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43966128|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966129|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966130|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966131|NCT05134363|Analgesics|analgesics|mesh-ancestor
43966132|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
43966133|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966134|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43966135|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43966150|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966152|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43966153|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
43966154|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
43966155|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966156|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966157|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44143017|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143018|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143019|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143020|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44143021|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143022|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143023|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
44143024|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44143025|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44143026|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44143027|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44143028|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143029|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44143030|NCT00188669|Tocopherols|tocopherols|mesh-list
44143031|NCT00188669|Vitamin E|vitamin e|mesh-list
44143032|NCT00188669|Tocotrienols|tocotrienols|mesh-list
44143033|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
44143034|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
44143035|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44143036|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143037|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143038|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44143039|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44143040|NCT00188669|Protective Agents|protective agents|mesh-ancestor
44143041|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143042|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
44143043|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44143044|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
44143045|NCT00188669|Vitamins|vitamins|mesh-ancestor
44143046|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
44143047|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
44143048|NCT00188773|Heparin|heparin|mesh-list
44143049|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44143050|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44143051|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
44143052|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44143053|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44143054|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241507|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241509|NCT00589953|Hematinics|hematinics|mesh-ancestor
44241510|NCT00589992|Ibutilide|ibutilide|mesh-list
44241511|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44241512|NCT00590070|Adenosine|adenosine|mesh-list
44241513|NCT00590070|Nitroprusside|nitroprusside|mesh-list
44241514|NCT00590070|Analgesics|analgesics|mesh-ancestor
44241515|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
44241516|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241517|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241518|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44241519|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
44241520|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44241521|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
44241522|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
44241523|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285637|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143055|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
44143073|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143074|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
44143075|NCT00188825|Basiliximab|basiliximab|mesh-list
44143076|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143077|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
44143078|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157526|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157527|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966158|NCT05092269|Ustekinumab|ustekinumab|mesh-list
43966159|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966160|NCT05083182|Ustekinumab|ustekinumab|mesh-list
43966161|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966162|NCT05074290|Taxane|taxane|mesh-list
43966163|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966164|NCT05073315|Adalimumab|adalimumab|mesh-list
43966165|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966166|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966167|NCT05045066|Vitamin D|vitamin d|mesh-list
43966168|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
43966169|NCT05045066|Vitamins|vitamins|mesh-ancestor
43966170|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
43966171|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966172|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43966173|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43966174|NCT05035888|Phenylephrine|phenylephrine|mesh-list
43966175|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
43966176|NCT05035888|Norepinephrine|norepinephrine|mesh-list
43966177|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43966178|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43966179|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
43966180|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
43966181|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966182|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966183|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
43966184|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
43966185|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966186|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43966187|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43966188|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43966189|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
43966190|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966191|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966192|NCT05035888|Protective Agents|protective agents|mesh-ancestor
44241524|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241525|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241526|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44241527|NCT00590122|Levodopa|levodopa|mesh-list
44241528|NCT00590122|Carbidopa|carbidopa|mesh-list
44459405|NCT01580488|Calcitriol|calcitriol|mesh-list
44241529|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44241530|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44241531|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44241532|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
44241533|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241534|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241535|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241536|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44241537|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241538|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44241539|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
44241540|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
44241541|NCT00590174|Aspirin|aspirin|mesh-list
44241542|NCT00590174|Clopidogrel|clopidogrel|mesh-list
44007135|NCT01685814|Growth Substances|growth substances|mesh-ancestor
44241543|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44241544|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241545|NCT00590174|Analgesics|analgesics|mesh-ancestor
43966207|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966208|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966209|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966210|NCT05014919|Vortioxetine|vortioxetine|mesh-list
43966211|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
43966212|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966213|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43966214|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966215|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966216|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966217|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43966218|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43966219|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43966220|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966221|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966222|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
43966223|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43966224|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43966225|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43966226|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43966227|NCT05011123|Vaccines|vaccines|mesh-list
43966228|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
43966229|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966230|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43966231|NCT04997811|Valproic Acid|valproic acid|mesh-list
43966232|NCT04997811|Bezafibrate|bezafibrate|mesh-list
43966233|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
43966234|NCT04997811|Danazol|danazol|mesh-list
43966235|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
43966236|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241546|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
44241547|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241548|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241549|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241550|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241551|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44241552|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44241553|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241554|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44241555|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44241556|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241557|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
44241558|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44241559|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44241560|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44241561|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
44241562|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241563|NCT00590213|Bicalutamide|bicalutamide|mesh-list
44241564|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
44241565|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
44241566|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241567|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241568|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241569|NCT00590278|Raltitrexed|raltitrexed|mesh-list
44241570|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241571|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
44241572|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241573|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241574|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44241575|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241576|NCT00590343|Vatalanib|vatalanib|mesh-list
44241577|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44241578|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241579|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007209|NCT02778113|Hormones|hormones|mesh-ancestor
43966237|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966238|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
43966239|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966240|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241581|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
43966241|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
43966242|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966243|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966244|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966245|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43966246|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43966247|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43966248|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
43966249|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43966250|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43966251|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43966252|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43966253|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966264|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43966265|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966266|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
43966267|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966268|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
43966269|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966270|NCT04940039|Risperidone|risperidone|mesh-list
43966271|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43966272|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43966273|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
43966274|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966275|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966276|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966277|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43966278|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966279|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966280|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966281|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43966282|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
43966283|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43966284|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43966285|NCT04887792|Acetazolamide|acetazolamide|mesh-list
43966286|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
43966287|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43966288|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966289|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966290|NCT04887792|Diuretics|diuretics|mesh-ancestor
43966291|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
43966292|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966293|NCT04882072|Ustekinumab|ustekinumab|mesh-list
43966294|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966295|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
43966296|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966297|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966298|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
43966299|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43966300|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966301|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
43966302|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966303|NCT04840199|Letermovir|letermovir|mesh-list
43966304|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43966305|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966306|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966307|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966308|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
43966309|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966310|NCT04829318|Esketamine|esketamine|mesh-list
43966311|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
43966312|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966313|NCT04814433|Lidocaine|lidocaine|mesh-list
43966314|NCT04814433|Epinephrine|epinephrine|mesh-list
43966315|NCT04814433|Racepinephrine|racepinephrine|mesh-list
43966316|NCT04814433|Bupivacaine|bupivacaine|mesh-list
43966317|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
43966318|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
43966319|NCT04814433|Thrombin|thrombin|mesh-list
43966320|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
43966321|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43966330|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43966331|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241582|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
44241583|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966332|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43966333|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966334|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
43966335|NCT04814433|Coagulants|coagulants|mesh-ancestor
43966336|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43966337|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43966338|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43966339|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966340|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43966341|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43966342|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
43966343|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43966344|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966345|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
43966346|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
43966347|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43966349|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966350|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
43966351|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966352|NCT04731363|Erythritol|erythritol|mesh-list
43966353|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
43966354|NCT04725188|Docetaxel|docetaxel|mesh-list
43966355|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
43966356|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966357|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966358|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966359|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966360|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966361|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966362|NCT04707625|Aflibercept|aflibercept|mesh-list
43966363|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43966364|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43966365|NCT04707625|Growth Substances|growth substances|mesh-ancestor
43966366|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966367|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
43966368|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966369|NCT04683939|Gemcitabine|gemcitabine|mesh-list
43966370|NCT04683939|Paclitaxel|paclitaxel|mesh-list
43966371|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43966372|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966373|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966374|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966375|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966376|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966377|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43966378|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
43966379|NCT04683939|Antiviral Agents|antiviral agents|mesh-ancestor
43966380|NCT04683939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966381|NCT04683939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966382|NCT04683939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43966383|NCT04683939|Immunologic Factors|immunologic factors|mesh-ancestor
43966384|NCT04683939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966385|NCT04677972|Ebselen|ebselen|mesh-list
43966386|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43966387|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966388|NCT04677972|Analgesics|analgesics|mesh-ancestor
43966398|NCT04677972|Protective Agents|protective agents|mesh-ancestor
43966399|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43966400|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966401|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43966402|NCT04673357|Ustekinumab|ustekinumab|mesh-list
43966403|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966404|NCT04667780|Colchicine|colchicine|mesh-list
43966405|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
43966406|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966407|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966408|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966409|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966410|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966411|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966412|NCT04630028|Ustekinumab|ustekinumab|mesh-list
43966413|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966414|NCT04606381|Lazertinib|lazertinib|mesh-list
44241586|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241587|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241588|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
44241589|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241590|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241591|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
44241593|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
44241594|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966415|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966416|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966417|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966418|NCT04599855|Esketamine|esketamine|mesh-list
43966419|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
43966420|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966421|NCT04569032|Prednisone|prednisone|mesh-list
43966422|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
43966423|NCT04569032|Doxorubicin|doxorubicin|mesh-list
43966424|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43966425|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43966426|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
43966427|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966428|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966429|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43966430|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
43966431|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966432|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966433|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43966434|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43966435|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43966436|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43966437|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966438|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966439|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
43966440|NCT04569032|Hormones|hormones|mesh-ancestor
43966441|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43966442|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966443|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966444|NCT04538664|Carboplatin|carboplatin|mesh-list
43966445|NCT04538664|Pemetrexed|pemetrexed|mesh-list
43966446|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43966447|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966448|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966449|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966450|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43966451|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43966452|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966453|NCT04526951|Aspirin|aspirin|mesh-list
43966454|NCT04526951|Tenecteplase|tenecteplase|mesh-list
43966462|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966463|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43966464|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966465|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966466|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43966467|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43966468|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966469|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
43966470|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
43966471|NCT04523480|Testosterone|testosterone|mesh-list
43966472|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
43966473|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
43966474|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43966475|NCT04523480|Androgens|androgens|mesh-ancestor
43966476|NCT04523480|Hormones|hormones|mesh-ancestor
43966477|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241595|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
44241596|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241597|NCT00590603|Protective Agents|protective agents|mesh-ancestor
44241598|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241599|NCT00590603|Vitamins|vitamins|mesh-ancestor
43966478|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966479|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966480|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966481|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
43966482|NCT04518228|Ritonavir|ritonavir|mesh-list
43966483|NCT04518228|Lopinavir|lopinavir|mesh-list
43966484|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43966485|NCT04518228|Darunavir|darunavir|mesh-list
43966486|NCT04518228|Tenofovir|tenofovir|mesh-list
43966487|NCT04518228|Dolutegravir|dolutegravir|mesh-list
43966488|NCT04518228|Cobicistat|cobicistat|mesh-list
43966489|NCT04518228|Cabotegravir|cabotegravir|mesh-list
43966490|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43966491|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43966492|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
43966493|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966494|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966495|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43966496|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43966497|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
43966498|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966499|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43966500|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43966501|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43966502|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43966503|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43966504|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43966505|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43966506|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
43966507|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966508|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43966509|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966510|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966511|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143079|NCT00188864|Dexamethasone|dexamethasone|mesh-list
44143080|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143081|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
44143082|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
44143083|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143084|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143085|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143086|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
44143087|NCT00188864|Hormones|hormones|mesh-ancestor
44143088|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143089|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44143101|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143102|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
44143103|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143104|NCT00188942|Olanzapine|olanzapine|mesh-list
44143105|NCT00188942|Fluoxetine|fluoxetine|mesh-list
44143106|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
44143107|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
44143108|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966512|NCT04487080|Osimertinib|osimertinib|mesh-list
43966513|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43966514|NCT04487080|Lazertinib|lazertinib|mesh-list
43966515|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966516|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966517|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966518|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966519|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966520|NCT04483466|Methotrexate|methotrexate|mesh-list
43966521|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43966522|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
43966523|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43966524|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241600|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
44241601|NCT00590629|Niacin|niacin|mesh-list
44241602|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
44241603|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44241604|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
44241605|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241606|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44147168|NCT00200174|Exemestane|exemestane|mesh-list
44241607|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
43966525|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43966526|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
43966527|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966528|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966529|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966530|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966531|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43966532|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43966533|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
43966534|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966535|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43966536|NCT04476446|Esketamine|esketamine|mesh-list
43966537|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
43966538|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966539|NCT04466618|Heparin|heparin|mesh-list
43966540|NCT04466618|Calcium heparin|calcium heparin|mesh-list
43966541|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43966542|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
43966543|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43966544|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43966545|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966546|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43966547|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43966548|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43966549|NCT04451863|Caryophyllene|caryophyllene|mesh-list
43966550|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966551|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966552|NCT04451863|Analgesics|analgesics|mesh-ancestor
43966553|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
43966554|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966555|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43966556|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966557|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966558|NCT04451187|Zopiclone|zopiclone|mesh-list
43966561|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966563|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43966564|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
43966565|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966566|NCT04386811|Calcitriol|calcitriol|mesh-list
43966567|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43966568|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966569|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43966570|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43966571|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966572|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43966573|NCT04386811|Vitamins|vitamins|mesh-ancestor
43966574|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
43966575|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43966576|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
43966577|NCT04357873|Vorinostat|vorinostat|mesh-list
43966578|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966579|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966580|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43966581|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966582|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966583|NCT04339101|Sirolimus|sirolimus|mesh-list
43966584|NCT04339101|Fludarabine|fludarabine|mesh-list
43966585|NCT04339101|Melphalan|melphalan|mesh-list
43966586|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
43966587|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44241608|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
43966588|NCT04339101|Tacrolimus|tacrolimus|mesh-list
43966589|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966590|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966591|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43966592|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
43966593|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966594|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43966595|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966596|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43966597|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966598|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43966599|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
43966600|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43966601|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
43966602|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43966603|NCT04327310|Meplazumab|meplazumab|mesh-list
43966604|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
43966605|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966606|NCT04312659|Infliximab|infliximab|mesh-list
43966607|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966608|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966609|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966610|NCT04283669|Crizotinib|crizotinib|mesh-list
43966611|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966612|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966613|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966614|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966615|NCT04252742|Erenumab|erenumab|mesh-list
43966616|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43966617|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966618|NCT04252742|Analgesics|analgesics|mesh-ancestor
43966619|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
43966620|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966621|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966622|NCT04220125|Midazolam|midazolam|mesh-list
43966623|NCT04220125|Ketamine|ketamine|mesh-list
43966624|NCT04220125|Analgesics|analgesics|mesh-ancestor
43966625|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
43966626|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966627|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966628|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43966629|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43966630|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
43966631|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
43966640|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966641|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966642|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
43966643|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
43966644|NCT04214691|Acetaminophen|acetaminophen|mesh-list
43966645|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966646|NCT04214691|Analgesics|analgesics|mesh-ancestor
43966647|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
43966648|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966649|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966650|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
43966651|NCT04200443|Temozolomide|temozolomide|mesh-list
43966652|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43966653|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
43966654|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966656|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43966657|NCT04197687|Trastuzumab|trastuzumab|mesh-list
43966658|NCT04197687|Pertuzumab|pertuzumab|mesh-list
43966659|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43966660|NCT04197687|Maytansine|maytansine|mesh-list
43966661|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43966662|NCT04197687|Vaccines|vaccines|mesh-list
43966663|NCT04197687|Antibodies|antibodies|mesh-list
43966664|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
43966665|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966666|NCT04197687|Sargramostim|sargramostim|mesh-list
43966667|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
43966668|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
43966669|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966670|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966671|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44241609|NCT00590629|Vitamins|vitamins|mesh-ancestor
44241610|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
44241611|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966672|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43966673|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43966674|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43966675|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966676|NCT04192981|GDC-0084|gdc-0084|mesh-list
43966677|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966678|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966679|NCT04191304|Benralizumab|benralizumab|mesh-list
43966680|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43966681|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966682|NCT04143061|Vaccines|vaccines|mesh-list
43966683|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
43966684|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966685|NCT04101357|Carboplatin|carboplatin|mesh-list
43966686|NCT04101357|Etoposide|etoposide|mesh-list
43966687|NCT04101357|Atezolizumab|atezolizumab|mesh-list
43966688|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966689|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43966690|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43966691|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43966692|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966693|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966694|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
43966695|NCT04083755|Hematinics|hematinics|mesh-ancestor
43966696|NCT04077463|Carboplatin|carboplatin|mesh-list
43966697|NCT04077463|Pemetrexed|pemetrexed|mesh-list
43966698|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43966699|NCT04077463|Lazertinib|lazertinib|mesh-list
43966703|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43966704|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43966705|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966706|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966707|NCT04075396|Lazertinib|lazertinib|mesh-list
43966708|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966709|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966710|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966711|NCT04073056|Bupivacaine|bupivacaine|mesh-list
43966712|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
43966713|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
43966714|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966715|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966716|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
43966717|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966718|NCT04015700|Coal Tar|coal tar|mesh-list
43966719|NCT04015700|Vaccines|vaccines|mesh-list
43966720|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
43966721|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966722|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
43966723|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966724|NCT03983993|Panitumumab|panitumumab|mesh-list
43966725|NCT03983993|Niraparib|niraparib|mesh-list
43966726|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966727|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966728|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43966729|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966730|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966732|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
43966733|NCT03977233|Irinotecan|irinotecan|mesh-list
43966734|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966735|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43966736|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43966737|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966738|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966739|NCT03977233|Antidotes|antidotes|mesh-ancestor
43966740|NCT03977233|Protective Agents|protective agents|mesh-ancestor
43966741|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966742|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
43966743|NCT03977233|Vitamins|vitamins|mesh-ancestor
43966744|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
43966745|NCT03951649|Acetaminophen|acetaminophen|mesh-list
43966746|NCT03951649|Caffeine|caffeine|mesh-list
43966747|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44241612|NCT00590694|Ranibizumab|ranibizumab|mesh-list
44241613|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44241614|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44241615|NCT00590694|Growth Substances|growth substances|mesh-ancestor
44241616|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241617|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44241618|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241619|NCT00590785|Tamoxifen|tamoxifen|mesh-list
43966748|NCT03951649|Analgesics|analgesics|mesh-ancestor
43966749|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
43966750|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966751|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966752|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
43966753|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43966754|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43966755|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966756|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966757|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43966758|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43966759|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
43966760|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966761|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43966762|NCT03933813|Hematinics|hematinics|mesh-ancestor
43966763|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966764|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
43966765|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966766|NCT03889912|Cemiplimab|cemiplimab|mesh-list
43966767|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966768|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966769|NCT03875287|Decitabine|decitabine|mesh-list
43966770|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43966771|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
44165289|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966783|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43966784|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43966785|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966786|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966787|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43966788|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43966789|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43966790|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43966791|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
43966793|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
43966794|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
43966795|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966796|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966797|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43966798|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43966799|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
43966800|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43966801|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43966802|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966803|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43966804|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43966805|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43966806|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43966807|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43966808|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966809|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43966810|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43966811|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43966812|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43966813|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43966814|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
43966815|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43966816|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
44241620|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
44241621|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
44241622|NCT00590785|Doxorubicin|doxorubicin|mesh-list
44241623|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241624|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
44285638|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966817|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43966818|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43966819|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43966820|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
43966821|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43966822|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43966823|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43966824|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43966825|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43966826|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
43966827|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966828|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43966829|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43966830|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
43966831|NCT03843541|Ambroxol|ambroxol|mesh-list
43966832|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43966833|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
43966834|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966835|NCT03843541|Expectorants|expectorants|mesh-ancestor
43966836|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
43966841|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966843|NCT03782376|Ustekinumab|ustekinumab|mesh-list
43966844|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966845|NCT03729258|Amantadine|amantadine|mesh-list
43966846|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43966847|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43966848|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
43966849|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966850|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
43966851|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966852|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966853|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966854|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966855|NCT03729258|Analgesics|analgesics|mesh-ancestor
43966856|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
43966857|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966858|NCT03702725|Dexamethasone|dexamethasone|mesh-list
43966859|NCT03702725|Lenalidomide|lenalidomide|mesh-list
43966860|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966861|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
43966862|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
43966863|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966864|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966865|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966866|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
43966867|NCT03702725|Hormones|hormones|mesh-ancestor
43966868|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43966869|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966870|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966871|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
43966872|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43966873|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43966874|NCT03702725|Growth Substances|growth substances|mesh-ancestor
43966875|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
43966876|NCT03691610|Vaccines|vaccines|mesh-list
43966877|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
43966878|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143109|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143110|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143111|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44143112|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44143113|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143114|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143115|NCT00188942|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43808572|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241625|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241626|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241627|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241628|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
44241629|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241630|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241631|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44143116|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44007799|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44143117|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143118|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143119|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143120|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
43966879|NCT03606499|Ustekinumab|ustekinumab|mesh-list
43966880|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966881|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
43966882|NCT03573700|Fludarabine|fludarabine|mesh-list
43966883|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43966884|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
43966885|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966886|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966887|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43966888|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
43966889|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966890|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966891|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43966892|NCT03466411|Ustekinumab|ustekinumab|mesh-list
43966893|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43966894|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966895|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
43966904|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
43966905|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966906|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966907|NCT03399539|Dexamethasone|dexamethasone|mesh-list
43966908|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
43966909|NCT03399539|Venetoclax|venetoclax|mesh-list
43966910|NCT03399539|Ixazomib|ixazomib|mesh-list
43966911|NCT03399539|Ichthammol|ichthammol|mesh-list
43966912|NCT03399539|BB 1101|bb 1101|mesh-list
43966913|NCT03399539|Glycine|glycine|mesh-list
43966914|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966915|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
43966916|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
43966917|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966918|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966919|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966920|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
43966921|NCT03399539|Hormones|hormones|mesh-ancestor
43966922|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43966923|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43966924|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966925|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966926|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
43966927|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966928|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966929|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
43966930|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966931|NCT03385655|Carboplatin|carboplatin|mesh-list
43966932|NCT03385655|Durvalumab|durvalumab|mesh-list
43966933|NCT03385655|Tremelimumab|tremelimumab|mesh-list
43966934|NCT03385655|Adavosertib|adavosertib|mesh-list
43966935|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966936|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966937|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966938|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966939|NCT03377361|Nivolumab|nivolumab|mesh-list
43966940|NCT03377361|Ipilimumab|ipilimumab|mesh-list
43966941|NCT03377361|Trametinib|trametinib|mesh-list
43966942|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966943|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241632|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241633|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44241634|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44241635|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241636|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44241637|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
44241638|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241639|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44241640|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43669717|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
43966944|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43966945|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966946|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966948|NCT03355170|Domperidone|domperidone|mesh-list
43966949|NCT03355170|Lansoprazole|lansoprazole|mesh-list
43966950|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
43966951|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43966952|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966953|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43705136|NCT03322280|Hormones|hormones|mesh-ancestor
43966954|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966955|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966956|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
43966957|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
43966958|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966959|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966960|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43966961|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
43966962|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966963|NCT03334617|Trastuzumab|trastuzumab|mesh-list
43966964|NCT03334617|Durvalumab|durvalumab|mesh-list
43966965|NCT03334617|Olaparib|olaparib|mesh-list
43966966|NCT03334617|Cediranib|cediranib|mesh-list
43966974|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966975|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966976|NCT03297710|Trifluridine|trifluridine|mesh-list
43966977|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
43966978|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966979|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
43966980|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966981|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43966982|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43966983|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966984|NCT03218488|Ustekinumab|ustekinumab|mesh-list
43966985|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966987|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43966988|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966989|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966990|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966991|NCT03203525|Leucovorin|leucovorin|mesh-list
43966992|NCT03203525|Sirolimus|sirolimus|mesh-list
43966993|NCT03203525|Bevacizumab|bevacizumab|mesh-list
43966994|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43966995|NCT03203525|Doxorubicin|doxorubicin|mesh-list
43966996|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43966997|NCT03203525|Fluorouracil|fluorouracil|mesh-list
43966998|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
43966999|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
43967000|NCT03203525|Antibodies|antibodies|mesh-list
43967001|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
43967002|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43967003|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
43967004|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967005|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43967006|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43967007|NCT03203525|Growth Substances|growth substances|mesh-ancestor
44241641|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44241642|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43669751|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967008|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967009|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
43967010|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
43967011|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967012|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43967013|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43967014|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967015|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967016|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
43967017|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967018|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967019|NCT03203525|Antidotes|antidotes|mesh-ancestor
43967020|NCT03203525|Protective Agents|protective agents|mesh-ancestor
43967021|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
43967022|NCT03203525|Vitamins|vitamins|mesh-ancestor
43967023|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
44007947|NCT02850601|Dexamethasone|dexamethasone|mesh-list
43967024|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967025|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967026|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
43967027|NCT03185819|Midazolam|midazolam|mesh-list
43967028|NCT03185819|Esketamine|esketamine|mesh-list
43967029|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43967030|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43705224|NCT05344027|Mitotane|mitotane|mesh-list
43967031|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967032|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967033|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43967034|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43967042|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967043|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
43967044|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
43967045|NCT03150329|Vorinostat|vorinostat|mesh-list
43967046|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967047|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967048|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43967049|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967050|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967051|NCT03138603|Metoprolol|metoprolol|mesh-list
43967052|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43967053|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43967054|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
43967055|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
43967056|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967057|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967058|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43967059|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43967060|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43967061|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967062|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967063|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967064|NCT03102125|Regadenoson|regadenoson|mesh-list
43967065|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43967066|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43967067|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
43967068|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
43967069|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967070|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967071|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967072|NCT03009240|Decitabine|decitabine|mesh-list
43967073|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43967074|NCT03009240|Pevonedistat|pevonedistat|mesh-list
43967075|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967076|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
43967077|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967078|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967079|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
43967080|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967081|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808573|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
43967082|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43967083|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967084|NCT02760498|Cemiplimab|cemiplimab|mesh-list
43967085|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967086|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967087|NCT02759588|Bevacizumab|bevacizumab|mesh-list
43967088|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967089|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967090|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43967091|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43967092|NCT02759588|Growth Substances|growth substances|mesh-ancestor
43967093|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967094|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
43967095|NCT02741128|Vaccines|vaccines|mesh-list
43967096|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
43967097|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967098|NCT02697344|Acetic Acid|acetic acid|mesh-list
43967099|NCT02697344|Dexamethasone|dexamethasone|mesh-list
43967100|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
43967101|NCT02697344|Lenalidomide|lenalidomide|mesh-list
43967102|NCT02697344|Retinol acetate|retinol acetate|mesh-list
43967103|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
44157528|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967110|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967111|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967112|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
43967113|NCT02697344|Hormones|hormones|mesh-ancestor
43967114|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967115|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43967116|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967117|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
43967118|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43967119|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43967120|NCT02697344|Growth Substances|growth substances|mesh-ancestor
43967121|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
43967122|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
43967123|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967124|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967125|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967126|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967127|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43967128|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43967129|NCT02697344|Protective Agents|protective agents|mesh-ancestor
43967130|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43967131|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
43967132|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43967133|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43967134|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43967135|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43967136|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43967137|NCT02609776|Carboplatin|carboplatin|mesh-list
43967138|NCT02609776|Pemetrexed|pemetrexed|mesh-list
43967139|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43967140|NCT02609776|Lazertinib|lazertinib|mesh-list
43967141|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43967142|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967143|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967144|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967145|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43967146|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43967147|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43967148|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967149|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
43967150|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967151|NCT02538666|Nivolumab|nivolumab|mesh-list
43967152|NCT02538666|Ipilimumab|ipilimumab|mesh-list
43967153|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967154|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967155|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43967156|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967157|NCT02509546|Adenosine|adenosine|mesh-list
43967158|NCT02509546|Analgesics|analgesics|mesh-ancestor
43967159|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
43967160|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241644|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669904|NCT02900729|Diuretics|diuretics|mesh-ancestor
43967161|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967162|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43967163|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
43967164|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43967165|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
43967166|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
43967167|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967168|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967169|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
43967170|NCT02476058|Promethazine|promethazine|mesh-list
43967171|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43967172|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43967174|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967176|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
43967177|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
43967178|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967179|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
43967180|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
43967181|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705332|NCT05278351|Irinotecan|irinotecan|mesh-list
43967182|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43967183|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
43967184|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
43967185|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967186|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967187|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43967188|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
43967189|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967190|NCT02440581|Alendronate|alendronate|mesh-list
43967191|NCT02440581|Teriparatide|teriparatide|mesh-list
43967192|NCT02440581|Cinacalcet|cinacalcet|mesh-list
43967193|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43967194|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967195|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43967196|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43967197|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
43967198|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967199|NCT02407236|Ustekinumab|ustekinumab|mesh-list
43967200|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967201|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
43967202|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967203|NCT02308241|Ribavirin|ribavirin|mesh-list
43967204|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
43967205|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967206|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
43967207|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967208|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
43967209|NCT02269267|Dasatinib|dasatinib|mesh-list
43967210|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
43967211|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967212|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43967213|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967214|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967215|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
43967216|NCT02269267|Protective Agents|protective agents|mesh-ancestor
43967217|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967218|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
43967219|NCT02159495|Fludarabine|fludarabine|mesh-list
43967220|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
43967221|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967222|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
43967223|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967224|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967225|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967226|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
43967227|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967228|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967229|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967230|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967231|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
43967232|NCT02143466|Durvalumab|durvalumab|mesh-list
43967233|NCT02143466|Osimertinib|osimertinib|mesh-list
43967234|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44241645|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44241646|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43826946|NCT05493228|Analgesics|analgesics|mesh-ancestor
43967235|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967236|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967237|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
43967238|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967239|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43967240|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967241|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967242|NCT02087111|Interferons|interferons|mesh-list
43967243|NCT02087111|Ribavirin|ribavirin|mesh-list
43967244|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
43967245|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
43967246|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43967251|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967253|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143121|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44143122|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143123|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44143124|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44143125|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143126|NCT00188955|Sirolimus|sirolimus|mesh-list
43967254|NCT02071394|Xenon|xenon|mesh-list
43967255|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43967256|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
43967257|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
43967258|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967259|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967260|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
43967261|NCT01850108|Sirolimus|sirolimus|mesh-list
43967262|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
43967263|NCT01850108|Fludarabine|fludarabine|mesh-list
43967264|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
43967265|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967266|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
43967267|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967268|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967269|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967270|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
43967271|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967272|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967273|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967274|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967275|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43967276|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
43967277|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967278|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967279|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967280|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
43967281|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
43967282|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
43967283|NCT01822652|Fludarabine|fludarabine|mesh-list
43967284|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
43967285|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967286|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
43967287|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967288|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967289|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967290|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
43967291|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967292|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967293|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967294|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967295|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967296|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
43967297|NCT01716806|Nivolumab|nivolumab|mesh-list
43967298|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43967299|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43967300|NCT01716806|Dacarbazine|dacarbazine|mesh-list
43808574|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
44241648|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241649|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
44241650|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241651|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967301|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967302|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967303|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43967304|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967305|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967306|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
43967307|NCT01338740|Adalimumab|adalimumab|mesh-list
43967308|NCT01338740|Infliximab|infliximab|mesh-list
43967309|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967310|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967311|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967317|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
43967318|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
43967319|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967321|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
43967322|NCT01229878|Vitamins|vitamins|mesh-ancestor
43967323|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
43967324|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967325|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43967326|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43967327|NCT01151605|Insulin|insulin|mesh-list
43967328|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43967329|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967330|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967331|NCT00995059|Sirolimus|sirolimus|mesh-list
43967332|NCT00995059|Bortezomib|bortezomib|mesh-list
43967333|NCT00995059|Melphalan|melphalan|mesh-list
43967334|NCT00995059|Tacrolimus|tacrolimus|mesh-list
43967335|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
43967336|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43967337|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
43967338|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967339|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
43967340|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967341|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43967342|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967343|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967344|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967345|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967346|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967347|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967348|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
43967349|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967350|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
43967351|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967352|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
43967353|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
43967354|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
43967355|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967356|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967357|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
43967358|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967359|NCT00606346|Infliximab|infliximab|mesh-list
43967360|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967361|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967362|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967363|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43967364|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43967365|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43967366|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
43967367|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
43967368|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43967369|NCT00003927|Paclitaxel|paclitaxel|mesh-list
43967370|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
43967371|NCT00003927|Doxorubicin|doxorubicin|mesh-list
43967372|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43967373|NCT00003927|Amifostine|amifostine|mesh-list
43967374|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43967375|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241652|NCT00590915|Asparaginase|asparaginase|mesh-list
44241653|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241654|NCT00590928|Esomeprazole|esomeprazole|mesh-list
44241655|NCT00590928|Ranitidine|ranitidine|mesh-list
44241656|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44241657|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44241658|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967376|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
43967377|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
43967378|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
43967379|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967380|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967381|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
44008283|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
43967382|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967383|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967384|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967385|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
43967386|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967387|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967388|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43967389|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43967390|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967391|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43967392|NCT00003927|Protective Agents|protective agents|mesh-ancestor
43967393|NCT05120076|Dexamethasone|dexamethasone|mesh-list
43967394|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
43967395|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967396|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
43967397|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
43967398|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967399|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967401|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
43967402|NCT05120076|Hormones|hormones|mesh-ancestor
43967403|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967404|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43967405|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967406|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43967407|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43967408|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43967409|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43967410|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967411|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967412|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967413|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967415|NCT05094804|Cemiplimab|cemiplimab|mesh-list
43967416|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967417|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
43967418|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
43967419|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
43967420|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967421|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967422|NCT05032807|Cannabidiol|cannabidiol|mesh-list
43967423|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
43967424|NCT05030272|Nicotine|nicotine|mesh-list
43967425|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43967426|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
43967427|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967428|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967429|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43967430|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43967431|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
43967432|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967433|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967434|NCT04992312|Glucagon|glucagon|mesh-list
43967435|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967436|NCT04992312|Hormones|hormones|mesh-ancestor
43967437|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967438|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967439|NCT04974580|Nicotine|nicotine|mesh-list
44241659|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44241660|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241661|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826957|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
43967440|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43967441|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
43967442|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967443|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967444|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43967445|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43967446|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
43967447|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967448|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967449|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
43967450|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43967451|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
43967452|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967453|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967454|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43967455|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
43967456|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43967457|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
43967458|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967459|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967460|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43967461|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
43967464|NCT04873596|Midazolam|midazolam|mesh-list
43967465|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
43967466|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43967467|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967468|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967469|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43967470|NCT04873596|Analgesics|analgesics|mesh-ancestor
43967471|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
43967472|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967473|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43967474|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43967475|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43967476|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967477|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967478|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967479|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43967480|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43967481|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43967482|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43967483|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43967484|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
43967485|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
43967486|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
43967487|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
43967488|NCT04868760|Ipilimumab|ipilimumab|mesh-list
43967489|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967490|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967491|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43967492|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967493|NCT04861948|Bevacizumab|bevacizumab|mesh-list
43967494|NCT04861948|Cisplatin|cisplatin|mesh-list
43967495|NCT04861948|Carboplatin|carboplatin|mesh-list
43967496|NCT04861948|Pemetrexed|pemetrexed|mesh-list
43967497|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967498|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967499|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43967500|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43967501|NCT04861948|Growth Substances|growth substances|mesh-ancestor
43967502|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967503|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
43967504|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967505|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967506|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43967507|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44241662|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44241663|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
44241664|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
44241665|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670080|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
43967508|NCT04850846|Metformin|metformin|mesh-list
43967509|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967510|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967511|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43967512|NCT04826354|Ezetimibe|ezetimibe|mesh-list
43967513|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43967514|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43967515|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
43967516|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967517|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43967518|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43967519|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143127|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44143128|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143129|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44143130|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143131|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
44143132|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143133|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
44143134|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143135|NCT00188994|Insulin|insulin|mesh-list
44143136|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44143137|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143138|NCT00189007|Allopurinol|allopurinol|mesh-list
44143139|NCT00189007|Mannitol|mannitol|mesh-list
44143140|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
44143141|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143142|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143151|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
44143152|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44143153|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
44143154|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143156|NCT00189033|Cathartics|cathartics|mesh-ancestor
44143157|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143158|NCT00189059|Amitriptyline|amitriptyline|mesh-list
44143159|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44143160|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143161|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143162|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44143163|NCT00189059|Analgesics|analgesics|mesh-ancestor
44143164|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
44143165|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143166|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967520|NCT04718116|Tramadol|tramadol|mesh-list
43967521|NCT04718116|Tapentadol|tapentadol|mesh-list
43967522|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43967523|NCT04718116|Narcotics|narcotics|mesh-ancestor
43967524|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967525|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967526|NCT04718116|Analgesics|analgesics|mesh-ancestor
43967527|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
43967528|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967529|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43967530|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43967531|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43967532|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967533|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967534|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967535|NCT04716335|Harmine|harmine|mesh-list
43967536|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
43967537|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967538|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43967539|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43967540|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967541|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967542|NCT04707794|Sevoflurane|sevoflurane|mesh-list
44241666|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241668|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44241669|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241670|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43967543|NCT04707794|Desflurane|desflurane|mesh-list
43967544|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43967545|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43967546|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
43967547|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
43967548|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967549|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967550|NCT04667312|Durvalumab|durvalumab|mesh-list
44008461|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967551|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967552|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967553|NCT04666272|Trametinib|trametinib|mesh-list
43967554|NCT04666272|Dabrafenib|dabrafenib|mesh-list
43967555|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967556|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43967557|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967558|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967559|NCT04652518|Pirfenidone|pirfenidone|mesh-list
43967560|NCT04652518|Analgesics|analgesics|mesh-ancestor
43967561|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
43967562|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967563|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967564|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43967570|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967571|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967572|NCT04592913|Durvalumab|durvalumab|mesh-list
43967573|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967574|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967575|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
43967576|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
43967577|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43967578|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967579|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967580|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43967581|NCT04508166|Analgesics|analgesics|mesh-ancestor
43967582|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
43967583|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967584|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43967585|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43967586|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43967587|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967588|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967589|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967590|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43967591|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43967592|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
43967594|NCT04488601|Sirolimus|sirolimus|mesh-list
43967595|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967596|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967597|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967598|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967599|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
43967600|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967601|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
43967602|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967603|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
43967604|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967605|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967606|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43967607|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43967608|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967609|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967610|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967611|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43967612|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43967613|NCT04414540|Metformin|metformin|mesh-list
44241671|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241672|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241673|NCT00591188|Interferons|interferons|mesh-list
44241674|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
44241675|NCT00591188|Capecitabine|capecitabine|mesh-list
43670176|NCT02897557|Pancrelipase|pancrelipase|mesh-list
43967614|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
43967615|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967616|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967617|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967618|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967619|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
43967620|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
43967621|NCT04387201|Dulaglutide|dulaglutide|mesh-list
43967622|NCT04387201|Vitamins|vitamins|mesh-ancestor
43967623|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
43967624|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967625|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
43967626|NCT04387201|Hematinics|hematinics|mesh-ancestor
43967627|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967628|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
43967629|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967630|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967631|NCT04277663|Interferons|interferons|mesh-list
43967632|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967633|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
43967634|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967635|NCT04236609|Sirolimus|sirolimus|mesh-list
43967636|NCT04236609|Everolimus|everolimus|mesh-list
43967637|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967643|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43967644|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
43967646|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
43967647|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967648|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
43967649|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
43967650|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
43967651|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967652|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967653|NCT04178005|Cladribine|cladribine|mesh-list
43967654|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967655|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967656|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
43967657|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967658|NCT04175964|Metformin|metformin|mesh-list
43967659|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967660|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967661|NCT04134845|Dantrolene|dantrolene|mesh-list
43967662|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43967663|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967664|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43967665|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967666|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43967667|NCT04113382|Laxatives|laxatives|mesh-ancestor
43967668|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967669|NCT04004845|Misoprostol|misoprostol|mesh-list
43967670|NCT04004845|Oxytocin|oxytocin|mesh-list
43967671|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
43967672|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43967673|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967674|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43967675|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
43967676|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43967677|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967678|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
43967679|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967680|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967681|NCT03864068|Inositol|inositol|mesh-list
43967682|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
43967683|NCT03864068|Vitamins|vitamins|mesh-ancestor
43967684|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
43967685|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967686|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
43967687|NCT03849651|Melphalan|melphalan|mesh-list
43967688|NCT03849651|Thiotepa|thiotepa|mesh-list
44241676|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241677|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
44241678|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670205|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
43967689|NCT03849651|Fludarabine|fludarabine|mesh-list
43967690|NCT03849651|Blinatumomab|blinatumomab|mesh-list
43967691|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
43967692|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967693|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
43967694|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967695|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967696|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967697|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
43967698|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967699|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967700|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44143167|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143168|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143169|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143170|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143171|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143172|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143173|NCT00189072|Gabapentin|gabapentin|mesh-list
44143174|NCT00189072|Analgesics|analgesics|mesh-ancestor
44143175|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
44143181|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143182|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143183|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44143184|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44143185|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143186|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143188|NCT00189085|Simvastatin|simvastatin|mesh-list
44143189|NCT00189085|Ezetimibe|ezetimibe|mesh-list
44143190|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44143191|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44143192|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44143193|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
44143194|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143195|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44143196|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44143197|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143198|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44143199|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44143200|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
44143201|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143202|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
44143203|NCT00189150|Valganciclovir|valganciclovir|mesh-list
44143204|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44143205|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143206|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44143207|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
44143208|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44143209|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143210|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143211|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143212|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
44143213|NCT00189163|Pioglitazone|pioglitazone|mesh-list
44143214|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44157529|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967702|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43967703|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43967704|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43967705|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967706|NCT03693807|Gemcitabine|gemcitabine|mesh-list
43967707|NCT03693807|Fluorouracil|fluorouracil|mesh-list
43967708|NCT03693807|Floxuridine|floxuridine|mesh-list
43967709|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
43967710|NCT03693807|Irinotecan|irinotecan|mesh-list
43967711|NCT03693807|Cetuximab|cetuximab|mesh-list
43967712|NCT03693807|Panitumumab|panitumumab|mesh-list
44241679|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241681|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241682|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
44241683|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241685|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44241686|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241687|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241688|NCT00591357|Loperamide|loperamide|mesh-list
43670276|NCT02896582|Cytarabine|cytarabine|mesh-list
43967713|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967714|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
43967715|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967716|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967717|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
43967718|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967719|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967720|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967721|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
43967722|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967723|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43967724|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43967725|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967726|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43967727|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43967728|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967729|NCT03692403|Quinagolide|quinagolide|mesh-list
43967730|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
43967733|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967735|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
43967736|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
43967737|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
43967738|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967739|NCT03624270|Protective Agents|protective agents|mesh-ancestor
43967740|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967741|NCT03624270|Vitamins|vitamins|mesh-ancestor
43967742|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
43967743|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967744|NCT03561259|Vorinostat|vorinostat|mesh-list
43967745|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43967746|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967747|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43967748|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967749|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967750|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43967751|NCT03556384|Temozolomide|temozolomide|mesh-list
43967752|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967753|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
43967754|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967755|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967756|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43967757|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43967758|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967759|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967760|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967761|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967762|NCT03455088|Fluoxetine|fluoxetine|mesh-list
43967763|NCT03455088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43967764|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43967765|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43967766|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967768|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
43967769|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967770|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43967771|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
44241689|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
44241690|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241691|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43967772|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43967773|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43967774|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43967775|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967776|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43967777|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967778|NCT03386721|Gemcitabine|gemcitabine|mesh-list
43967779|NCT03386721|Atezolizumab|atezolizumab|mesh-list
43967780|NCT03386721|Vinorelbine|vinorelbine|mesh-list
43967782|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
43967783|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967784|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967785|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
43967786|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967787|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967788|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
44008746|NCT02912364|Analgesics|analgesics|mesh-ancestor
43967789|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967790|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967791|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967792|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43967793|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
43967794|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
43967795|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
43967796|NCT03367871|Paclitaxel|paclitaxel|mesh-list
43967797|NCT03367871|Bevacizumab|bevacizumab|mesh-list
43967798|NCT03367871|Cisplatin|cisplatin|mesh-list
43967799|NCT03367871|Carboplatin|carboplatin|mesh-list
43967800|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
43967801|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43967802|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967803|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
43967807|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967808|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43967809|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43967810|NCT03367871|Growth Substances|growth substances|mesh-ancestor
43967811|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967812|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
43967814|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967815|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967816|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43967817|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967818|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
43967819|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43967820|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43967821|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43967822|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43967823|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967824|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
43967825|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967826|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967827|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43967828|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967829|NCT03283007|Nintedanib|nintedanib|mesh-list
43967830|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967831|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43967832|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967833|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967834|NCT03270020|Denosumab|denosumab|mesh-list
43967835|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43967836|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967837|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43967838|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967839|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967841|NCT03146962|Vitamins|vitamins|mesh-ancestor
43967842|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
43967843|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967844|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
43967845|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241692|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241693|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43670385|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
43967846|NCT03146962|Protective Agents|protective agents|mesh-ancestor
43967847|NCT03127631|Atorvastatin|atorvastatin|mesh-list
43967848|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43967849|NCT03127631|Simvastatin|simvastatin|mesh-list
43967850|NCT03127631|Pravastatin|pravastatin|mesh-list
43967851|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43967852|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43967853|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43967854|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
43967855|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967856|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43967857|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43967858|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967859|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
43967860|NCT03122197|Letrozole|letrozole|mesh-list
43967861|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967862|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43967863|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43967864|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967865|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967866|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43967867|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
43967868|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967869|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967870|NCT03083431|Propranolol|propranolol|mesh-list
43967871|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43967872|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43967873|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
43967881|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
43967882|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43967883|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967884|NCT03076112|Incretins|incretins|mesh-ancestor
43967885|NCT03076112|Hormones|hormones|mesh-ancestor
43967886|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967887|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43967888|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
43967889|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967890|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967891|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43967892|NCT03060083|Nicotine|nicotine|mesh-list
43967893|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43967894|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
43967895|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967896|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967897|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43967898|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43967899|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
43967900|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967901|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967902|NCT02989636|Nivolumab|nivolumab|mesh-list
43967903|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967904|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967905|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43967906|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967907|NCT02985190|Azacitidine|azacitidine|mesh-list
43967908|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967909|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
43967910|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967911|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967912|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967913|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
43967914|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967915|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967916|NCT02365766|Gemcitabine|gemcitabine|mesh-list
43967917|NCT02365766|Cisplatin|cisplatin|mesh-list
43967918|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
43967919|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967920|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241694|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241695|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459407|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44459408|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
44459409|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44459410|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967921|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
43967922|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967924|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967925|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967926|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967927|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
43967928|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967929|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43967930|NCT02219581|Dexamethasone|dexamethasone|mesh-list
43967931|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
43967932|NCT02219581|BB 1101|bb 1101|mesh-list
43967933|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967934|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
43967935|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
44008890|NCT02919111|Edetic Acid|edetic acid|mesh-list
43967936|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967937|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967938|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967939|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
43967940|NCT02219581|Hormones|hormones|mesh-ancestor
44165290|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
44143218|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
44143219|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143220|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143221|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44143222|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44143223|NCT00189176|Growth Substances|growth substances|mesh-ancestor
44143224|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143225|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44143226|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143227|NCT00189345|Catumaxomab|catumaxomab|mesh-list
44143228|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
44143229|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
44143230|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143231|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143232|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143233|NCT00189358|Tamoxifen|tamoxifen|mesh-list
44143234|NCT00189358|Gefitinib|gefitinib|mesh-list
44143235|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44143236|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
44143237|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143238|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143239|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44143240|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143241|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44143242|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44143243|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44143244|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44143245|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143246|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143247|NCT00189371|Paclitaxel|paclitaxel|mesh-list
44143248|NCT00189371|Carboplatin|carboplatin|mesh-list
44143249|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
44143250|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44143251|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143252|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
44143253|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
44143254|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
44143255|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143256|NCT00189371|Hematinics|hematinics|mesh-ancestor
44459411|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44459412|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459413|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459414|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44459415|NCT01580488|Vitamins|vitamins|mesh-ancestor
44459416|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
44459417|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44459418|NCT01580293|Factor VIII|factor viii|mesh-list
44459419|NCT01580293|Coagulants|coagulants|mesh-ancestor
44459420|NCT01580020|Dexamethasone|dexamethasone|mesh-list
44459421|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459422|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
44143257|NCT00189384|Gentamicins|gentamicins|mesh-list
44143258|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
44143259|NCT00189384|Penicillins|penicillins|mesh-list
44143260|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44143261|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
44143262|NCT00189384|Penicillin G|penicillin g|mesh-list
44143263|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44143264|NCT00189384|Procaine|procaine|mesh-list
44143265|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967947|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
43967948|NCT01946373|Fludarabine|fludarabine|mesh-list
43967949|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
43967950|NCT01946373|Interleukin-2|interleukin-2|mesh-list
43967951|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967952|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
43967953|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967954|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967962|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43967963|NCT01946373|Analgesics|analgesics|mesh-ancestor
43967964|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
43967965|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967966|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
43967967|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43967968|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43967969|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967970|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
43967971|NCT01869413|Coagulants|coagulants|mesh-ancestor
43967972|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43967973|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43967974|NCT01647932|Diuretics|diuretics|mesh-ancestor
43967975|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
43967976|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967977|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43967978|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43967979|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967980|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
43967981|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43967982|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967983|NCT01555697|Memantine|memantine|mesh-list
43967984|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43967985|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43967986|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
43967987|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967988|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967989|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967990|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43967991|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43967992|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43967993|NCT01437709|Ofatumumab|ofatumumab|mesh-list
43967994|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43967995|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967996|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
43967997|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459423|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
44459424|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459425|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459426|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967998|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967999|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
43968000|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968001|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43968002|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
43968003|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968004|NCT00695279|Vaccines|vaccines|mesh-list
43968005|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
43968006|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968007|NCT00588523|Temozolomide|temozolomide|mesh-list
43968008|NCT00588523|Busulfan|busulfan|mesh-list
43968009|NCT00588523|Thiotepa|thiotepa|mesh-list
43968010|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43968012|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968013|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968014|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968015|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
43968016|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968017|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43968018|NCT01598207|Dronabinol|dronabinol|mesh-list
43968019|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
43706088|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
43968020|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968021|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968028|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968029|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968030|NCT01598207|Hormones|hormones|mesh-ancestor
44009021|NCT02929667|Fluoxetine|fluoxetine|mesh-list
43968031|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968032|NCT01598545|Hydromorphone|hydromorphone|mesh-list
43968033|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43968034|NCT01598545|Narcotics|narcotics|mesh-ancestor
43968035|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968036|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968037|NCT01598545|Analgesics|analgesics|mesh-ancestor
43968038|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
43968039|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968040|NCT01598701|Acetaminophen|acetaminophen|mesh-list
43968041|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968042|NCT01598701|Analgesics|analgesics|mesh-ancestor
43968043|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
43968044|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968045|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968046|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
43968047|NCT01598740|Spironolactone|spironolactone|mesh-list
43968048|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43968049|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
43968050|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968051|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968052|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43968053|NCT01598740|Diuretics|diuretics|mesh-ancestor
43968054|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
43968055|NCT01600170|Atorvastatin|atorvastatin|mesh-list
43968056|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43968057|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43968058|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
43968059|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968060|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43968061|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43968062|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968063|NCT01600287|Propofol|propofol|mesh-list
43968064|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43968065|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968066|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968067|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43968068|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
43968069|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
44459427|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
44459429|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459430|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459431|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968070|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43968071|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968072|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968073|NCT01600703|Incretins|incretins|mesh-ancestor
43968074|NCT01600703|Hormones|hormones|mesh-ancestor
43968075|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968076|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43968077|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
43968078|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968079|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968080|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
43968081|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968082|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968083|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43968084|NCT01601236|Hormones|hormones|mesh-ancestor
43968085|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968086|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968087|NCT01602068|Dexamethasone|dexamethasone|mesh-list
43968088|NCT01602068|Citric Acid|citric acid|mesh-list
43968093|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
43968094|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968095|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968096|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968098|NCT01602068|Hormones|hormones|mesh-ancestor
43968099|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968100|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43968101|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968102|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
43968103|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43968104|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
43968105|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
43968106|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968107|NCT01602679|Progesterone|progesterone|mesh-list
43968108|NCT01602679|Progestins|progestins|mesh-ancestor
43968109|NCT01602679|Hormones|hormones|mesh-ancestor
43968110|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968111|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968112|NCT01602692|Lidocaine|lidocaine|mesh-list
43968113|NCT01602692|Epinephrine|epinephrine|mesh-list
43968114|NCT01602692|Racepinephrine|racepinephrine|mesh-list
43968115|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43968116|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
43968117|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
43968118|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
43968119|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968120|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968121|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
43968122|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968123|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968124|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43968125|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43968126|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968127|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968128|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43968129|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43968130|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968131|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968132|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43968133|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43968134|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
43968135|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43968136|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968137|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
44459432|NCT01579812|Metformin|metformin|mesh-list
44459433|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459434|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968138|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
43968139|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43968140|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
43968141|NCT01603420|Docetaxel|docetaxel|mesh-list
43968142|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
43968143|NCT01603420|Hormones|hormones|mesh-list
43968144|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43968145|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43968146|NCT01603420|Androgens|androgens|mesh-list
43968147|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968148|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43968149|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43968150|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43968151|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968152|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968153|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968154|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
43968155|NCT01603420|Protective Agents|protective agents|mesh-ancestor
43968156|NCT01603420|Vitamins|vitamins|mesh-ancestor
43968157|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
43968158|NCT01603420|Estrogens|estrogens|mesh-ancestor
43968159|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43968161|NCT01603940|Losartan|losartan|mesh-list
43968162|NCT01603940|Benazepril|benazepril|mesh-list
43968163|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968172|NCT01604109|Caseins|caseins|mesh-list
43968173|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43968174|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
43968175|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968176|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968177|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968178|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
43968179|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
43968180|NCT01605032|Bortezomib|bortezomib|mesh-list
43968181|NCT01605032|Melphalan|melphalan|mesh-list
43968182|NCT01605032|Busulfan|busulfan|mesh-list
43968183|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968184|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43968185|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
43968186|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968187|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43968188|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968189|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
43968190|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968191|NCT01605539|Cannabidiol|cannabidiol|mesh-list
43968192|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
43968193|NCT01605890|Tenofovir|tenofovir|mesh-list
43968194|NCT01605890|Emtricitabine|emtricitabine|mesh-list
43968195|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
43968196|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43968197|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
43968198|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968199|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43968200|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43968201|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968202|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968203|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43968204|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43968205|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43968206|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43968207|NCT01605903|Acetaminophen|acetaminophen|mesh-list
43968208|NCT01605903|Ibuprofen|ibuprofen|mesh-list
43968209|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968210|NCT01605903|Analgesics|analgesics|mesh-ancestor
43968211|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
43968212|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968213|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968214|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
43968215|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43968216|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968217|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43968218|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44459435|NCT01579578|Paclitaxel|paclitaxel|mesh-list
44459436|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44459437|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968219|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968220|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968221|NCT01605942|Dexamethasone|dexamethasone|mesh-list
43968222|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968223|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
43968224|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
43968225|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968226|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968227|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968228|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
43968235|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968236|NCT01606124|Protective Agents|protective agents|mesh-ancestor
43968237|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968238|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43968239|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43968240|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968241|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43968242|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
44009230|NCT02946489|Ketamine|ketamine|mesh-list
43968243|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43968244|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968245|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968246|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968247|NCT01606852|Analgesics|analgesics|mesh-ancestor
43968248|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
43968249|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968250|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43968251|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43968252|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43968253|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968254|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968255|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968256|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43968257|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43968258|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
43968259|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43968260|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
43968261|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43968262|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968263|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43968264|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43968265|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968267|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
43968268|NCT01607411|Protective Agents|protective agents|mesh-ancestor
43968269|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968270|NCT01607450|Glucagon|glucagon|mesh-list
43968271|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43968272|NCT01607450|Incretins|incretins|mesh-ancestor
43968273|NCT01607450|Hormones|hormones|mesh-ancestor
43968274|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968275|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968276|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968277|NCT01607645|Cytarabine|cytarabine|mesh-list
43968278|NCT01607645|Decitabine|decitabine|mesh-list
43968279|NCT01607645|Azacitidine|azacitidine|mesh-list
43968280|NCT01607645|Idarubicin|idarubicin|mesh-list
43968281|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968282|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
43968283|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968284|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968285|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
43968286|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968287|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968288|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
43968289|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968290|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968291|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43968292|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43968293|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43968294|NCT01607853|Calcitriol|calcitriol|mesh-list
44459438|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44459439|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459440|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44459441|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968295|NCT01607853|Betamethasone|betamethasone|mesh-list
43968296|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968297|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
43968298|NCT01607853|Hormones|hormones|mesh-ancestor
43968301|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43968302|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968303|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43968304|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43968305|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968306|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968307|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43968310|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43968311|NCT01608295|Paroxetine|paroxetine|mesh-list
43968312|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
43968313|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43968314|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43968315|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43968316|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968317|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968318|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968320|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968321|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43968322|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968323|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43968324|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43968325|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968326|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43968327|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43968328|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
43968329|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43968330|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43968331|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43968332|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968333|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968334|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
43968335|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968336|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968337|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43968338|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968339|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
43968340|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43968341|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43968342|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43968343|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968344|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968345|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
43968346|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968347|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968348|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43968349|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968350|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43968351|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43968352|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43968353|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968354|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968355|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968356|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968357|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43968358|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
43968359|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968360|NCT01610011|Glycine|glycine|mesh-list
43968361|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
44459442|NCT01579318|Interleukin-12|interleukin-12|mesh-list
44459443|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44459444|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
43968362|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968363|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968364|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968365|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43968366|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968373|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968374|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968375|NCT01610570|Plicamycin|plicamycin|mesh-list
43968376|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43968377|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968378|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44009320|NCT02951884|Bupivacaine|bupivacaine|mesh-list
43968379|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968380|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43968381|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968382|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968383|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143266|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143267|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44143268|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143269|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968384|NCT01611571|Teriparatide|teriparatide|mesh-list
43968385|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
43968386|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
43968387|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
43968388|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43968389|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968390|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43968391|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43968392|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968393|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968394|NCT01611662|Gemcitabine|gemcitabine|mesh-list
43968396|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968397|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968398|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
43968399|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968400|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
43968401|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968402|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968403|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968404|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
43968405|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968406|NCT01611948|Aprepitant|aprepitant|mesh-list
43968407|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
43968408|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
43968409|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968410|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968411|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968412|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43968413|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968414|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968415|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
43968416|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43968417|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
43968418|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968419|NCT01612221|Expectorants|expectorants|mesh-ancestor
43968420|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968421|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43968422|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
43968423|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968424|NCT01612221|Protective Agents|protective agents|mesh-ancestor
43968425|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968426|NCT01612221|Antidotes|antidotes|mesh-ancestor
43968427|NCT01612546|Camptothecin|camptothecin|mesh-list
43968428|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43968429|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968435|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44459445|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459446|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459447|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459448|NCT01579318|Growth Substances|growth substances|mesh-ancestor
43968436|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43968437|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43968438|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43968439|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43968440|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
43968441|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968442|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968443|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968444|NCT01614210|Tamoxifen|tamoxifen|mesh-list
43968445|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43968446|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
43968447|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968448|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968449|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43968450|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968451|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43968452|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43968453|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43968455|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43968456|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43968457|NCT01614509|Bevacizumab|bevacizumab|mesh-list
43968458|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43968459|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43968460|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968461|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968462|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968463|NCT01614509|Growth Substances|growth substances|mesh-ancestor
43968464|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968465|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968466|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968467|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
43968468|NCT01614509|Hormones|hormones|mesh-ancestor
43968469|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968470|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968471|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
43968472|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968473|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968474|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43968475|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43968476|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968477|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968478|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43968479|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968480|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968481|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
43968482|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968483|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
43968484|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43968485|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43968486|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43968487|NCT01615731|Digoxin|digoxin|mesh-list
43968488|NCT01615731|Misoprostol|misoprostol|mesh-list
43968489|NCT01615731|Mifepristone|mifepristone|mesh-list
43968490|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43968491|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
43968492|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43968493|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968494|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43968495|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968496|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
43968497|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968501|NCT01615731|Protective Agents|protective agents|mesh-ancestor
43968502|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43968503|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44459449|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459450|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459451|NCT01578850|Etanercept|etanercept|mesh-list
43968504|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43968505|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43968506|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
43968507|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43968508|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43968509|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
43968510|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968511|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
43968512|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43968513|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43968514|NCT01615809|Amphotericin B|amphotericin b|mesh-list
43968515|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43968516|NCT01615809|Amebicides|amebicides|mesh-ancestor
43968517|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43968518|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43968519|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968520|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968521|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
43968522|NCT01616082|Phentermine|phentermine|mesh-list
43968523|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43968524|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968525|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
43968526|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43968527|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
43968528|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
43968529|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968530|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968531|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968532|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968533|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
43968534|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968535|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
43968536|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43968537|NCT01617083|Azithromycin|azithromycin|mesh-list
43968538|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968539|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968540|NCT01617148|Aflibercept|aflibercept|mesh-list
43968541|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968542|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968543|NCT01617148|Growth Substances|growth substances|mesh-ancestor
43968544|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968545|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968546|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968547|NCT01617577|Lenograstim|lenograstim|mesh-list
43968548|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43968549|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
43968550|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968552|NCT01619774|Dabrafenib|dabrafenib|mesh-list
43968553|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968554|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43968555|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968556|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968557|NCT01619982|Vancomycin|vancomycin|mesh-list
43968558|NCT01619982|Cefazolin|cefazolin|mesh-list
43968559|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968560|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968561|NCT01620047|Fentanyl|fentanyl|mesh-list
43968562|NCT01620047|Ropivacaine|ropivacaine|mesh-list
43968563|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
43968564|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
43968565|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968566|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968567|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
43968568|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968569|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43968570|NCT01620047|Narcotics|narcotics|mesh-ancestor
43968571|NCT01620047|Analgesics|analgesics|mesh-ancestor
43968581|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
43968582|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968584|NCT01620216|Sunitinib|sunitinib|mesh-list
43968585|NCT01620216|Dasatinib|dasatinib|mesh-list
43968586|NCT01620216|Ponatinib|ponatinib|mesh-list
44459452|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43968587|NCT01620216|Idelalisib|idelalisib|mesh-list
43968588|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
43968589|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43968590|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43968591|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968592|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968593|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968594|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968595|NCT01620216|Growth Substances|growth substances|mesh-ancestor
43968596|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968597|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968598|NCT01620593|Metformin|metformin|mesh-list
43968599|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968600|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968601|NCT01621009|Bupropion|bupropion|mesh-list
43968602|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43706605|NCT02706015|Caffeine|caffeine|mesh-list
43968603|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
43968604|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968605|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43968606|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43968608|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968609|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
43968610|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968611|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968612|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43968613|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43968614|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968615|NCT01621230|Fentanyl|fentanyl|mesh-list
43968616|NCT01621230|Bupivacaine|bupivacaine|mesh-list
43968617|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
43968618|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
43968619|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968620|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968621|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
43968622|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968623|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43968624|NCT01621230|Narcotics|narcotics|mesh-ancestor
43968625|NCT01621230|Analgesics|analgesics|mesh-ancestor
43968626|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43968627|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43968628|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
43968629|NCT01621477|Cytarabine|cytarabine|mesh-list
43968630|NCT01621477|Plerixafor|plerixafor|mesh-list
43968631|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
43968632|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
43968633|NCT01621477|Busulfan|busulfan|mesh-list
43968634|NCT01621477|Clofarabine|clofarabine|mesh-list
43968635|NCT01621477|Tacrolimus|tacrolimus|mesh-list
43968636|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
43968637|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43968638|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968639|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
43968640|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968644|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968645|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968646|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43968647|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968648|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
43968649|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
43968650|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968651|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43968652|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968653|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43968654|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43968655|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
43968656|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968657|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43968658|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43968659|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43968660|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43968661|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968662|NCT01621672|Lenalidomide|lenalidomide|mesh-list
43968663|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
44459453|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459455|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
44459456|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009605|NCT02967354|Tryptophan|tryptophan|mesh-list
44459457|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459458|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459459|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459460|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459461|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968664|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968665|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968666|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968667|NCT01621672|Growth Substances|growth substances|mesh-ancestor
43968668|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968669|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968670|NCT01621776|Insulin|insulin|mesh-list
43968671|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43968672|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
43968673|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
43968674|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
43968675|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968676|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968677|NCT01622257|Metformin|metformin|mesh-list
43968678|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968679|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968680|NCT01622296|Lidocaine|lidocaine|mesh-list
43968681|NCT01622296|Epinephrine|epinephrine|mesh-list
43968682|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
43968683|NCT01622296|Anesthetics|anesthetics|mesh-list
43968684|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968685|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968686|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
43968687|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968688|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968689|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43968690|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43968691|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968692|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968693|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43968694|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43968695|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968696|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968697|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43968698|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43968699|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
43968700|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43968701|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968703|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
43968704|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43968705|NCT01622543|Leucovorin|leucovorin|mesh-list
43968706|NCT01622543|Bevacizumab|bevacizumab|mesh-list
43968707|NCT01622543|Fluorouracil|fluorouracil|mesh-list
43968708|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
43968709|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43968710|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968711|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968712|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968713|NCT01622543|Growth Substances|growth substances|mesh-ancestor
43968718|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968719|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968720|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
43968721|NCT01622543|Antidotes|antidotes|mesh-ancestor
43968722|NCT01622543|Protective Agents|protective agents|mesh-ancestor
43968723|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
43968724|NCT01622543|Vitamins|vitamins|mesh-ancestor
43968725|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
43968726|NCT01623323|Fluticasone|fluticasone|mesh-list
43968727|NCT01623323|Xhance|xhance|mesh-list
43968728|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459462|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
44459463|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
43968729|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43968730|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
43968731|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968732|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968733|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43968734|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968735|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
43968736|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43968737|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
43968738|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
43968739|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43968740|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968741|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43968742|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43968743|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43968744|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43968745|NCT01623479|Bimatoprost|bimatoprost|mesh-list
43968746|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968747|NCT01623869|Trebananib|trebananib|mesh-list
43968748|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43968749|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43968750|NCT01623869|Growth Substances|growth substances|mesh-ancestor
43968751|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968752|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968753|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968754|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
43968755|NCT01624948|Everolimus|everolimus|mesh-list
43968756|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968757|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968758|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
43968759|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968760|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43968761|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43968762|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
43968763|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968764|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968765|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968766|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968767|NCT01625013|Hylan|hylan|mesh-list
43968768|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
43968769|NCT01625013|Protective Agents|protective agents|mesh-ancestor
43968770|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968771|NCT01625169|Etravirine|etravirine|mesh-list
43968772|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43968773|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43968774|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968775|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968776|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
43968777|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968778|NCT01625455|Aprepitant|aprepitant|mesh-list
43968779|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
43968780|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
43968781|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968782|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968783|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968784|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43968785|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968793|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43968794|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43968795|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968796|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968797|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43968798|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43968799|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968800|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968801|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968802|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
43968804|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
43968805|NCT01626092|Melphalan|melphalan|mesh-list
43968806|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
43968807|NCT01626092|Clofarabine|clofarabine|mesh-list
43968808|NCT01626092|Cyclosporins|cyclosporins|mesh-list
44241696|NCT00591487|Lidocaine|lidocaine|mesh-list
44241697|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
44241698|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
44241699|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241700|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241701|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
44241702|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241703|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44241704|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44241705|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43968809|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968810|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968811|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968812|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
43968813|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968814|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
43968815|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968816|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
43968817|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43968818|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43968819|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43968820|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968821|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43968822|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
43968823|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43968824|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43968825|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
43968826|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43968827|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43968828|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968829|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
43968830|NCT01626664|Gemcitabine|gemcitabine|mesh-list
43968831|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
43968832|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
43968833|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43706788|NCT02704624|Vitamin D|vitamin d|mesh-list
43968834|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
43968835|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968836|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968837|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
43968838|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968839|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968840|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43968841|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
43968842|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968843|NCT01628588|Bimatoprost|bimatoprost|mesh-list
43968844|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968845|NCT01628601|Timolol|timolol|mesh-list
43968846|NCT01628601|Bimatoprost|bimatoprost|mesh-list
43968847|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43968848|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43968849|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968850|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968851|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968852|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968858|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968860|NCT01629134|Protective Agents|protective agents|mesh-ancestor
43968861|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
43968862|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
43968863|NCT01629290|Protective Agents|protective agents|mesh-ancestor
43968864|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808639|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
44241706|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44241707|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241708|NCT00591526|Cytarabine|cytarabine|mesh-list
44143270|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44143271|NCT00189384|Renal Agents|renal agents|mesh-ancestor
44143272|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
44143273|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44143274|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44143275|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
44143276|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
44143277|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143278|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143279|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
44143280|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143281|NCT00189397|Azathioprine|azathioprine|mesh-list
44143282|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
44143283|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143284|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143285|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143286|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143287|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
44143288|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143289|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143290|NCT00189410|Carboplatin|carboplatin|mesh-list
44143291|NCT00189410|Doxorubicin|doxorubicin|mesh-list
44143292|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44143293|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143294|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44143295|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44143296|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44143297|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143298|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143299|NCT00189501|Cinacalcet|cinacalcet|mesh-list
44143300|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44143301|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143302|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44143303|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
44143304|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143305|NCT00189514|Pramlintide|pramlintide|mesh-list
44143306|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44143307|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143308|NCT00189553|Paclitaxel|paclitaxel|mesh-list
44143309|NCT00189553|Carboplatin|carboplatin|mesh-list
44143310|NCT00189553|Doxorubicin|doxorubicin|mesh-list
44143311|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44143312|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44143313|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706862|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43968865|NCT01630109|Metoclopramide|metoclopramide|mesh-list
43968866|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
43968867|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
43968868|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968869|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968870|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968871|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43968872|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43968873|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
43968874|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968875|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968876|NCT01631110|Vaccines|vaccines|mesh-list
43968877|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
43968878|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968879|NCT01631149|Rocuronium|rocuronium|mesh-list
43968880|NCT01631149|Atracurium|atracurium|mesh-list
43968881|NCT01631149|Mivacurium|mivacurium|mesh-list
43968882|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43968883|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43968884|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43968885|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968886|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968887|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44009810|NCT02988050|Narcotics|narcotics|mesh-ancestor
43968888|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44241709|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43968889|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
43968890|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968891|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968892|NCT01631630|Pioglitazone|pioglitazone|mesh-list
43968893|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43968894|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968895|NCT01631656|Azelaic acid|azelaic acid|mesh-list
43968896|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968897|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
43968898|NCT01631682|Propranolol|propranolol|mesh-list
43968899|NCT01631682|Oxytocin|oxytocin|mesh-list
43968900|NCT01631682|Mifepristone|mifepristone|mesh-list
43968901|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
43968902|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43968903|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968904|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43968905|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43968906|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
43968907|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968908|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968909|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968910|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968911|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
43968912|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43968913|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
43968914|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43968915|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43968916|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43968917|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
43968918|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43968919|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43968920|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
43968921|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968922|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
43968923|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43968924|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43968925|NCT01632215|Gabapentin|gabapentin|mesh-list
43968926|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
43968927|NCT01632215|Analgesics|analgesics|mesh-ancestor
43968928|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
43968929|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968930|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968931|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43968932|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43968933|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968934|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43968935|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43968936|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43968937|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43968938|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706904|NCT02704507|Tretinoin|tretinoin|mesh-list
43968939|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
43968940|NCT01632423|Bimatoprost|bimatoprost|mesh-list
43968941|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968942|NCT01632709|Bupivacaine|bupivacaine|mesh-list
43968943|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
43968944|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
43968945|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968946|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968947|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
43968948|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968949|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43968950|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43968957|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43968958|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43968959|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43968960|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968961|NCT01633853|Vitamin D|vitamin d|mesh-list
44241711|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241712|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968962|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
43968963|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
43968964|NCT01633853|Vitamins|vitamins|mesh-list
43968965|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
43968966|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968967|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43968968|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43968969|NCT01634191|Apremilast|apremilast|mesh-list
43968970|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43968971|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968972|NCT01634191|Analgesics|analgesics|mesh-ancestor
43968973|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
43968974|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968975|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968976|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968977|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43968978|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43968979|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43968980|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968981|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968982|NCT01635062|Calcitriol|calcitriol|mesh-list
43968983|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43968984|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43968985|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968986|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43968987|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43968988|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968989|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43968990|NCT01635062|Vitamins|vitamins|mesh-ancestor
43968991|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
43968992|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43968993|NCT01635101|Acetaminophen|acetaminophen|mesh-list
43968994|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968995|NCT01635101|Analgesics|analgesics|mesh-ancestor
43968996|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
43968997|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968998|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968999|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
43969000|NCT01635439|Dinoprostone|dinoprostone|mesh-list
43969001|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
43969002|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43969003|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969004|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
43969005|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43969006|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43969007|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43969008|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969009|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969010|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969011|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969012|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969013|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43969014|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969015|NCT01636063|Misoprostol|misoprostol|mesh-list
43969016|NCT01636063|Mifepristone|mifepristone|mesh-list
43969017|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43969018|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
43969020|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969022|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969023|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
43969024|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43969025|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43969026|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43969027|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43969028|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
43969029|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43969030|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43969031|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
43969032|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241713|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
44241714|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241715|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241716|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
43969033|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
43969034|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43969035|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43969036|NCT01636206|Lifitegrast|lifitegrast|mesh-list
43969037|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43969038|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43969040|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969041|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969042|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
43969043|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969044|NCT01637935|Pioglitazone|pioglitazone|mesh-list
43969045|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43969046|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969047|NCT01638052|Clonidine|clonidine|mesh-list
43969048|NCT01638052|Bupivacaine|bupivacaine|mesh-list
43969049|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
43969050|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
43969051|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969052|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969053|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
43969054|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969055|NCT01638052|Analgesics|analgesics|mesh-ancestor
43969056|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969057|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
43969058|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
43969059|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43969060|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43969061|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43969062|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969063|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969064|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969065|NCT01639157|Buspirone|buspirone|mesh-list
43969066|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969067|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969068|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969069|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969070|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969071|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43969072|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
43969073|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969074|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969075|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
43969076|NCT01639222|Vitamin D|vitamin d|mesh-list
43969077|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
43969078|NCT01639222|Calcium|calcium|mesh-list
43969079|NCT01639222|Vitamins|vitamins|mesh-ancestor
43969080|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
43969081|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969082|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969083|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43969085|NCT01639352|Hormones|hormones|mesh-ancestor
43969086|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969087|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969088|NCT01639599|Dexamethasone|dexamethasone|mesh-list
43969089|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
43969090|NCT01639599|Haloperidol|haloperidol|mesh-list
44010016|NCT03001843|Ketamine|ketamine|mesh-list
43969091|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
43969092|NCT01639599|BB 1101|bb 1101|mesh-list
43969093|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969094|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
43969098|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969100|NCT01639599|Hormones|hormones|mesh-ancestor
43969101|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969102|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969103|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969104|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
43969105|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241718|NCT00591604|Vitamin D|vitamin d|mesh-list
44241719|NCT00591604|Vitamins|vitamins|mesh-ancestor
44241720|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
44241721|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241722|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43969106|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969107|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43969108|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969109|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969110|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969111|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43969112|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
43969113|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969114|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43969115|NCT01639872|Risperidone|risperidone|mesh-list
43969116|NCT01639872|Clozapine|clozapine|mesh-list
43969117|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43969118|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
43969119|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969120|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969121|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969122|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43969123|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969124|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969125|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969126|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43969127|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
43969128|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
43969129|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
43969130|NCT01640171|Ketorolac|ketorolac|mesh-list
43969131|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43969132|NCT01640171|Lidocaine|lidocaine|mesh-list
43969133|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
43969134|NCT01640171|Anesthetics|anesthetics|mesh-list
43969135|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
43969136|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969137|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969138|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
43969139|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969140|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43969141|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43969142|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43969143|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969144|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969145|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43969146|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969147|NCT01640171|Analgesics|analgesics|mesh-ancestor
43969148|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969149|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43969150|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969151|NCT01640197|Resveratrol|resveratrol|mesh-list
43969152|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
43969153|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969154|NCT01640197|Protective Agents|protective agents|mesh-ancestor
43969155|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969156|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969157|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43969159|NCT01640340|Ondansetron|ondansetron|mesh-list
43969160|NCT01640340|Aprepitant|aprepitant|mesh-list
43969161|NCT01640340|Palonosetron|palonosetron|mesh-list
43969162|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969163|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
43969164|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
43969165|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969166|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969176|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
43969177|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241723|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44241724|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44241725|NCT00591617|Narcotics|narcotics|mesh-ancestor
43969178|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969179|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43969180|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969181|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969182|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969183|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969184|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43969185|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43969186|NCT01640834|Glucagon|glucagon|mesh-list
43969187|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969188|NCT01640834|Hormones|hormones|mesh-ancestor
43969189|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969190|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969191|NCT01641120|Interferons|interferons|mesh-list
43969192|NCT01641120|Interferon-beta|interferon-beta|mesh-list
43969193|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
43969194|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969195|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
43969196|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969197|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
43969198|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969199|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43969200|NCT01641445|Topiramate|topiramate|mesh-list
43969201|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
43969202|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43969203|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969204|NCT01641653|Midazolam|midazolam|mesh-list
43969205|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43969206|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43969207|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969208|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969209|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969210|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969211|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969212|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43969213|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
43969214|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
43969215|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
43969216|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
43969217|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969218|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969219|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43969220|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
43969221|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969222|NCT01642147|Anesthetics|anesthetics|mesh-list
43969223|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969224|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969225|NCT01642238|Aspirin|aspirin|mesh-list
43969226|NCT01642238|Hirudins|hirudins|mesh-list
43969227|NCT01642238|Bivalirudin|bivalirudin|mesh-list
43969228|NCT01642238|Clopidogrel|clopidogrel|mesh-list
43969229|NCT01642238|Ticagrelor|ticagrelor|mesh-list
43969230|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43969231|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969232|NCT01642238|Analgesics|analgesics|mesh-ancestor
43969233|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
43969234|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969235|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969236|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969237|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969238|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43969239|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43969240|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969241|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43969242|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43969243|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969245|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43969246|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43969247|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44241726|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241727|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241728|NCT00591617|Analgesics|analgesics|mesh-ancestor
44241729|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
43969248|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
43969249|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969250|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
43969251|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43969252|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
43969253|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
43969254|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
43969255|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43969256|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969257|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43969258|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969259|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43969260|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43969261|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969262|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969263|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969264|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43969265|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
43969266|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43969267|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43969268|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43969269|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43969270|NCT01643382|Insulin|insulin|mesh-list
43969271|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43969272|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43969273|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969274|NCT01643616|Midazolam|midazolam|mesh-list
43969275|NCT01643616|Ropivacaine|ropivacaine|mesh-list
43969276|NCT01643616|Prilocaine|prilocaine|mesh-list
43969277|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
43969278|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
43969279|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969280|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969281|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
43969282|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969283|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43969284|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43969285|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969286|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969287|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969288|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43969289|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
43969290|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
43969291|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
43969292|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969293|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969294|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43969295|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43969296|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43969297|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969298|NCT01644331|Tolvaptan|tolvaptan|mesh-list
43969299|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43969300|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969301|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
43969302|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969303|NCT01644396|Adalimumab|adalimumab|mesh-list
43969304|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969305|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969306|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
43969307|NCT01645098|Ketamine|ketamine|mesh-list
43969308|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43969309|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969316|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43969317|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43969318|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969319|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241730|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241731|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43969320|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969321|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43969322|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43969323|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
43969324|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
43969325|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43969326|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43969327|NCT01646151|Bimatoprost|bimatoprost|mesh-list
43969328|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969329|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43969330|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43969331|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969332|NCT01646762|Paclitaxel|paclitaxel|mesh-list
43969333|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43969334|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43969335|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969336|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
43969337|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
43969338|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
43969339|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143314|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
44143315|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
44143316|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
44143317|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143318|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44143319|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44143320|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44143321|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143322|NCT00189566|Paclitaxel|paclitaxel|mesh-list
44143323|NCT00189566|Carboplatin|carboplatin|mesh-list
44143324|NCT00189566|Topotecan|topotecan|mesh-list
44143325|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44143326|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143327|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44143328|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44143329|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44143330|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143331|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44143332|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44143333|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143334|NCT00189579|Trastuzumab|trastuzumab|mesh-list
44143335|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44143336|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143337|NCT00189618|Aspirin|aspirin|mesh-list
44143338|NCT00189618|Clopidogrel|clopidogrel|mesh-list
44143339|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44143340|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44143341|NCT00189618|Analgesics|analgesics|mesh-ancestor
44143342|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
44143343|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143344|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143345|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143346|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143347|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44143348|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44143349|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143350|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44143355|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44143356|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44143357|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
44143358|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143359|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
44143360|NCT00189644|Fluorouracil|fluorouracil|mesh-list
44143361|NCT00189644|Epirubicin|epirubicin|mesh-list
43969340|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43969341|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43969343|NCT01647581|Hormones|hormones|mesh-ancestor
43969344|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969345|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241732|NCT00591643|Epinephrine|epinephrine|mesh-list
44241733|NCT00591643|Racepinephrine|racepinephrine|mesh-list
44241734|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
43969346|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969347|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969348|NCT01647945|Tacrolimus|tacrolimus|mesh-list
43969349|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969350|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
43969351|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969352|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43969353|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969354|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969355|NCT01649180|Axitinib|axitinib|mesh-list
43969356|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969357|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43969358|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969359|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969360|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
43969361|NCT01649609|Sirolimus|sirolimus|mesh-list
43969362|NCT01649609|Tacrolimus|tacrolimus|mesh-list
43969363|NCT01649609|Antimetabolites|antimetabolites|mesh-list
43969364|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969365|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
43969366|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969367|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43969368|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969369|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969370|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43969371|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969372|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43969373|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
43969374|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43969375|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969376|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
43969377|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
43969378|NCT01650298|Thrombin|thrombin|mesh-list
43969379|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
43969380|NCT01650298|Coagulants|coagulants|mesh-ancestor
43969381|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
43969382|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43969383|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
43969384|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969385|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969386|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
43969387|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
43969388|NCT01650545|Cyclosporine|cyclosporine|mesh-list
43969389|NCT01650545|Sirolimus|sirolimus|mesh-list
43969390|NCT01650545|Tacrolimus|tacrolimus|mesh-list
43969391|NCT01650545|Cyclosporins|cyclosporins|mesh-list
43969392|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969393|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
43969394|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969395|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43969396|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969397|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969398|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
43969399|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969400|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
43969401|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969405|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
43969406|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43969407|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969408|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969409|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43969410|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43969412|NCT01651442|Trazodone|trazodone|mesh-list
43969413|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43969414|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707350|NCT02701309|Iron|iron|mesh-list
43969415|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969416|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969417|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43969418|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
44241735|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44241736|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44241737|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
44241738|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241739|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241740|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969419|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
43969420|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969421|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969422|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969423|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969424|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969425|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43969426|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43969427|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969428|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
43969429|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43969430|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
43969431|NCT01651793|Caffeine|caffeine|mesh-list
43969432|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43969433|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969434|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43969435|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969436|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969437|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43969438|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43969439|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
43969440|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969441|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
43969442|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43969443|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43969444|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969445|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
43969446|NCT01651806|Coagulants|coagulants|mesh-ancestor
43969447|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
43969448|NCT01652040|Testosterone|testosterone|mesh-list
43969449|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
43969450|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
43969451|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43969452|NCT01652040|Androgens|androgens|mesh-ancestor
43969453|NCT01652040|Hormones|hormones|mesh-ancestor
43969454|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969455|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969456|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969457|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969458|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
43969459|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
43969460|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43969461|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43969462|NCT01652495|Prednisolone|prednisolone|mesh-list
43969463|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
43969464|NCT01652495|Triamcinolone|triamcinolone|mesh-list
43969465|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43969466|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43969467|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43969468|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
43969469|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43969470|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969471|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
43969472|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
43969475|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969476|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
43969477|NCT01652495|Hormones|hormones|mesh-ancestor
43969478|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969479|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43969480|NCT01652495|Protective Agents|protective agents|mesh-ancestor
43969481|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969482|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241741|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44241742|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43969483|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969484|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
43969485|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969486|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707434|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
43969487|NCT01652976|Leucovorin|leucovorin|mesh-list
43969488|NCT01652976|Fluorouracil|fluorouracil|mesh-list
43969490|NCT01652976|Dasatinib|dasatinib|mesh-list
43969491|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
43969492|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969493|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969494|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969495|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969496|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
43969497|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969498|NCT01652976|Antidotes|antidotes|mesh-ancestor
43969499|NCT01652976|Protective Agents|protective agents|mesh-ancestor
43969500|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
43969501|NCT01652976|Vitamins|vitamins|mesh-ancestor
43969502|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
43969503|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43969504|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969505|NCT01653418|Cytarabine|cytarabine|mesh-list
43969506|NCT01653418|Etoposide|etoposide|mesh-list
43969507|NCT01653418|Bortezomib|bortezomib|mesh-list
43969508|NCT01653418|Melphalan|melphalan|mesh-list
43969509|NCT01653418|Carmustine|carmustine|mesh-list
43969510|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43969511|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969512|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43969513|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43969514|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969515|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969516|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969517|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
43969518|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
43969519|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969520|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969521|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
43969522|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969523|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43969524|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
43969525|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43969526|NCT01653509|Acyclovir|acyclovir|mesh-list
43969527|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
43969528|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969529|NCT01654107|Nicotine|nicotine|mesh-list
43969530|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43969531|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
43969532|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969533|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969534|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43969535|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43969536|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969537|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969538|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969539|NCT01654445|Tenecteplase|tenecteplase|mesh-list
43969540|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43969541|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43969542|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969543|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
43969544|NCT01654861|Gemcitabine|gemcitabine|mesh-list
43969545|NCT01654861|Vitamins|vitamins|mesh-ancestor
43969546|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
43969547|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969554|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969555|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969556|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
43969557|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
43969558|NCT01654861|Protective Agents|protective agents|mesh-ancestor
43969559|NCT01655043|Regadenoson|regadenoson|mesh-list
44241744|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241745|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44241746|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
44241747|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
44241748|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
44241749|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43969560|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43969561|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43969562|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
43969563|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
43969564|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969565|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969566|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969568|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969569|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
43969570|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969571|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43969572|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969573|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969574|NCT01655719|Pioglitazone|pioglitazone|mesh-list
43969575|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43969576|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969577|NCT01656031|Cytarabine|cytarabine|mesh-list
43969578|NCT01656031|Clofarabine|clofarabine|mesh-list
43969579|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969580|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
43969581|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010497|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
43969582|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969583|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
43969584|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969585|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969586|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
43969587|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969588|NCT01656187|Memantine|memantine|mesh-list
43969589|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43969590|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43969591|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
43969592|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969593|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969594|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969595|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43969596|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43969597|NCT01656252|Cytarabine|cytarabine|mesh-list
43969598|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969599|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
43969600|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969601|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969602|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
43969603|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969604|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969605|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
43969606|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969607|NCT01656629|Vitamin D|vitamin d|mesh-list
43969608|NCT01656629|Alendronate|alendronate|mesh-list
43969609|NCT01656629|Teriparatide|teriparatide|mesh-list
43969610|NCT01656629|Calcium|calcium|mesh-list
43969611|NCT01656629|Vitamins|vitamins|mesh-ancestor
43969612|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
43969613|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969614|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969615|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43969616|NCT01658228|Donepezil|donepezil|mesh-list
43969617|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43969621|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969622|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969623|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969624|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241750|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
44241751|NCT00591708|Citric Acid|citric acid|mesh-list
44241752|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
44241753|NCT00591708|Calcium|calcium|mesh-list
44241754|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
44241755|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969625|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
43969626|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43969627|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43969628|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969629|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43969630|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
43969631|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969632|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43969633|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
43969634|NCT01658657|Metoprolol|metoprolol|mesh-list
43969635|NCT01658657|Amlodipine|amlodipine|mesh-list
43969636|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43969637|NCT01658657|Lisinopril|lisinopril|mesh-list
43969638|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
43969639|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969640|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43969641|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969642|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969643|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969644|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969645|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
43969646|NCT01658657|Diuretics|diuretics|mesh-ancestor
43969647|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
43969648|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43969649|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43969650|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
43969651|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
43969652|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969653|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43969654|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43969655|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43969656|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969657|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969658|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43969659|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
43969660|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969661|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43969662|NCT01658657|Protective Agents|protective agents|mesh-ancestor
43969663|NCT01658839|Travoprost|travoprost|mesh-list
43969664|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43969665|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43969666|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969667|NCT01658995|Doxycycline|doxycycline|mesh-list
43969668|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43969669|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969670|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
43969671|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43969672|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43969673|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
43969674|NCT01659866|Gentamicins|gentamicins|mesh-list
43969675|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
43969676|NCT01659866|Imipenem|imipenem|mesh-list
43969677|NCT01659866|Amikacin|amikacin|mesh-list
43969678|NCT01659866|Cefuroxime|cefuroxime|mesh-list
43969679|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43969680|NCT01659866|Aztreonam|aztreonam|mesh-list
43969681|NCT01659866|Trimethoprim|trimethoprim|mesh-list
43969682|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
43969683|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43969684|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969685|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43969686|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43969687|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241756|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241757|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44241758|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
44241759|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43969688|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969689|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969690|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43969691|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43969692|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43969693|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43969694|NCT01659866|Renal Agents|renal agents|mesh-ancestor
43969695|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
43969696|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43969697|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43969698|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43969699|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43969700|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43969701|NCT01660191|Atorvastatin|atorvastatin|mesh-list
43969702|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43969703|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43969704|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43969705|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
43969706|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969707|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43871144|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43969708|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43969709|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969710|NCT01660672|Levetiracetam|levetiracetam|mesh-list
43969711|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
43969712|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
43969713|NCT01660802|Dexamethasone|dexamethasone|mesh-list
43969714|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969715|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
43969716|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
43969717|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969718|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969719|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969720|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
43969721|NCT01660802|Hormones|hormones|mesh-ancestor
43969722|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969723|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969724|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969725|NCT01660893|Phenylephrine|phenylephrine|mesh-list
43969726|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
43969727|NCT01660893|Tetracaine|tetracaine|mesh-list
43969728|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
43969729|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
43969730|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969731|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969732|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
43969733|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969734|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43969735|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43969736|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969737|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969738|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969739|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
43969740|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
43969741|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
43969742|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43969743|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
43969744|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43969745|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
43969746|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43969747|NCT01660893|Protective Agents|protective agents|mesh-ancestor
43969748|NCT01661088|Folfirinox|folfirinox|mesh-list
43969749|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969750|NCT01661114|Gemcitabine|gemcitabine|mesh-list
43969751|NCT01661114|Cisplatin|cisplatin|mesh-list
43969752|NCT01661114|Fluorouracil|fluorouracil|mesh-list
43969753|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969754|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241760|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
44241761|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
44241762|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241764|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
43969755|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
43969756|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969757|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
43969758|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969759|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969760|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969761|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
43969762|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969763|NCT01661270|Aflibercept|aflibercept|mesh-list
43969764|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43969765|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43969766|NCT01661270|Growth Substances|growth substances|mesh-ancestor
43969769|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969770|NCT01661283|Bevacizumab|bevacizumab|mesh-list
43969771|NCT01661283|Everolimus|everolimus|mesh-list
43969772|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43969773|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969774|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43969775|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43969776|NCT01661283|Growth Substances|growth substances|mesh-ancestor
43969777|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969778|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
43969779|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969780|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
43969781|NCT01661621|Doxazosin|doxazosin|mesh-list
43969782|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43969783|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969784|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43969785|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43969786|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43969787|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969788|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969789|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969790|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969791|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43969792|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43969793|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969795|NCT01661946|Bevacizumab|bevacizumab|mesh-list
43969796|NCT01661946|Ranibizumab|ranibizumab|mesh-list
43969797|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43969798|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969799|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43969800|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43969801|NCT01661946|Growth Substances|growth substances|mesh-ancestor
43969802|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969803|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
43969804|NCT01662115|Nicotine|nicotine|mesh-list
43969805|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43969806|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
43969807|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969808|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969809|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43969810|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43969811|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969812|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969813|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969814|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43969815|NCT01662297|Trazodone|trazodone|mesh-list
43969816|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
43969817|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43969818|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43969819|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43969820|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43969821|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969822|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43969823|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44241765|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
44241766|NCT00591916|Coagulants|coagulants|mesh-ancestor
44241767|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44241768|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
44241769|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241770|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
44241771|NCT00591916|Protective Agents|protective agents|mesh-ancestor
44241772|NCT00591994|Piribedil|piribedil|mesh-list
44241773|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44241774|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44241775|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
44241776|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
44241777|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969824|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43969825|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969826|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969827|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969828|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
43969829|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43969830|NCT01662791|Rifaximin|rifaximin|mesh-list
43969831|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43969832|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969833|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969834|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43969835|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
43969836|NCT01662856|Coagulants|coagulants|mesh-ancestor
43969837|NCT01662908|Heparin|heparin|mesh-list
43969838|NCT01662908|Enoxaparin|enoxaparin|mesh-list
43969839|NCT01662908|Calcium heparin|calcium heparin|mesh-list
43969840|NCT01662908|Warfarin|warfarin|mesh-list
43969841|NCT01662908|Edoxaban|edoxaban|mesh-list
43969847|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
43969848|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43969849|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
43969850|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969851|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
43969852|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969853|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43969854|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43969855|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969856|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969857|NCT01663259|Cetuximab|cetuximab|mesh-list
43969858|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43969859|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969860|NCT01663272|Gemcitabine|gemcitabine|mesh-list
43969861|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969862|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
43969863|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969864|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969865|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
43969866|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969867|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969868|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969869|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
43969870|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143362|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143363|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
44143364|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143365|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143366|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44143367|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
44143368|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143369|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143370|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44143371|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
44241778|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241779|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241780|NCT00592111|Prednisone|prednisone|mesh-list
44241781|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
44143372|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143373|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44143374|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44143375|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44143376|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143377|NCT00189657|Irinotecan|irinotecan|mesh-list
44143378|NCT00189657|Fluorouracil|fluorouracil|mesh-list
44143379|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44143380|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44143381|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143382|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143383|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143384|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
44143385|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143386|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143387|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
44143388|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143389|NCT00189683|Capecitabine|capecitabine|mesh-list
44143390|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143391|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
44143392|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143393|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143394|NCT00189709|Fluconazole|fluconazole|mesh-list
44143395|NCT00189709|Micafungin|micafungin|mesh-list
44143396|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
44143397|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143398|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44143399|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44143400|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143401|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143407|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44143409|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143410|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
44143411|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143412|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143413|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143414|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143415|NCT00189748|Tacrolimus|tacrolimus|mesh-list
44143416|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143417|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
44143418|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143419|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143420|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143421|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143422|NCT00189761|Tacrolimus|tacrolimus|mesh-list
44143423|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143424|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
44143425|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143426|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143427|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143428|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143429|NCT00189774|Nateglinide|nateglinide|mesh-list
44143430|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44143431|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143432|NCT00189787|Tacrolimus|tacrolimus|mesh-list
44143433|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43969872|NCT01663935|Carbidopa|carbidopa|mesh-list
43969873|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43969874|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43969875|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
43969876|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969877|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969878|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969879|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43969880|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969881|NCT01664559|Ketorolac|ketorolac|mesh-list
44241783|NCT00592111|Vincristine|vincristine|mesh-list
44241784|NCT00592111|Doxorubicin|doxorubicin|mesh-list
44241785|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43969882|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43969883|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969884|NCT01664559|Analgesics|analgesics|mesh-ancestor
43969885|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
43969886|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969887|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969888|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969889|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969890|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43969891|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969892|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969893|NCT01664741|Nicotine|nicotine|mesh-list
43969894|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43969895|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
43969896|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969897|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969898|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43969899|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43969900|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
43969901|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969902|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969903|NCT01664858|Calcium|calcium|mesh-list
43969904|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969905|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969910|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969912|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43969913|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
43969914|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43969915|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43969916|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43969917|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
43969918|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969919|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969920|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969921|NCT01665950|Simvastatin|simvastatin|mesh-list
43969922|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43969923|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43969924|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
43969925|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969926|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43969927|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43969928|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969929|NCT01666197|Diclofenac|diclofenac|mesh-list
43969930|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43969931|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969932|NCT01666197|Analgesics|analgesics|mesh-ancestor
43969933|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
43969934|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969935|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969936|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969937|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969938|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43969939|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969940|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969942|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969943|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
43969944|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
43969945|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969946|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969947|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969948|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
43969949|NCT01666210|Hormones|hormones|mesh-ancestor
43969950|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969951|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969952|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969953|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
44241787|NCT00592111|Vinblastine|vinblastine|mesh-list
44241788|NCT00592111|Procarbazine|procarbazine|mesh-list
43969954|NCT01666912|Etonogestrel|etonogestrel|mesh-list
43969955|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43969956|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969957|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43969958|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43969959|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
43969960|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969961|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43969962|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969963|NCT01667029|Analgesics|analgesics|mesh-ancestor
43969964|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
43969965|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969966|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969967|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43969968|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43969969|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969970|NCT01667796|Vitamin D|vitamin d|mesh-list
43969971|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
43969972|NCT01667796|Vitamins|vitamins|mesh-ancestor
43969973|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
43969974|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969975|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43969983|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43969984|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969985|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969986|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43969987|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43969988|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
43969989|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969990|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43969991|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43969992|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43969993|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43969994|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43969995|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
43969996|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43969997|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969998|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43969999|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43970000|NCT01668017|Niacinamide|niacinamide|mesh-list
43970001|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
43970002|NCT01668017|Vitamins|vitamins|mesh-ancestor
43970003|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
43970004|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970005|NCT01668030|Bacitracin|bacitracin|mesh-list
43970006|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43970007|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970008|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970009|NCT01668836|Resveratrol|resveratrol|mesh-list
43970010|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
43970011|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970012|NCT01668836|Protective Agents|protective agents|mesh-ancestor
43970013|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970014|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970015|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43970016|NCT01669434|Ramipril|ramipril|mesh-list
43970017|NCT01669434|Enalapril|enalapril|mesh-list
43970018|NCT01669434|Enalaprilat|enalaprilat|mesh-list
43707879|NCT02698267|Itraconazole|itraconazole|mesh-list
43970019|NCT01669434|Lisinopril|lisinopril|mesh-list
43970020|NCT01669434|Perindopril|perindopril|mesh-list
43970021|NCT01669434|Benazepril|benazepril|mesh-list
43970022|NCT01669434|Captopril|captopril|mesh-list
43970023|NCT01669434|Quinapril|quinapril|mesh-list
43970024|NCT01669434|Trandolapril|trandolapril|mesh-list
43970025|NCT01669434|Fosinopril|fosinopril|mesh-list
43970026|NCT01669434|Moexipril|moexipril|mesh-list
43970027|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43970028|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
43970029|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970030|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970031|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43970032|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43970034|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970035|NCT01669538|Galantamine|galantamine|mesh-list
43970036|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43970037|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970038|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970039|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
43970040|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970041|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970042|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43970043|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
43970044|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970045|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
43970050|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970051|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43970052|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43970053|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
43970054|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
43970055|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970056|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43970057|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43970058|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970059|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970060|NCT01669720|Aflibercept|aflibercept|mesh-list
43970061|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43970062|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43970063|NCT01669720|Growth Substances|growth substances|mesh-ancestor
43970064|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970065|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
43970066|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970067|NCT01669785|Listerine|listerine|mesh-list
43970068|NCT01669785|Fluorides|fluorides|mesh-list
43970069|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
43970070|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
43970071|NCT01669785|Protective Agents|protective agents|mesh-ancestor
43970072|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970073|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43970074|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970075|NCT01670110|Pasireotide|pasireotide|mesh-list
43970076|NCT01670110|Hormones|hormones|mesh-ancestor
43970077|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970078|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970079|NCT01671423|Prednisone|prednisone|mesh-list
43970080|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970081|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
43970082|NCT01671423|Hormones|hormones|mesh-ancestor
43970083|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970084|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970085|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970086|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970087|NCT01672827|Flutemetamol|flutemetamol|mesh-list
43970088|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43970089|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970090|NCT01672983|Ritonavir|ritonavir|mesh-list
43970091|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43970092|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43970093|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
43970094|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143434|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
43970095|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970096|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43970097|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43970098|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
43970099|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970100|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43970101|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43970102|NCT01673191|Dexamethasone|dexamethasone|mesh-list
43970103|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
43970104|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43970105|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970106|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
43970107|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
43970108|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241790|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970109|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970110|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970111|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
43970112|NCT01673191|Hormones|hormones|mesh-ancestor
43970113|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970114|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970115|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970122|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
43970124|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
43970125|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
43970126|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970127|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970128|NCT01675297|Vitamins|vitamins|mesh-ancestor
43970129|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
43970130|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970131|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43970132|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970133|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970134|NCT01675635|Morphine|morphine|mesh-list
43970135|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970136|NCT01675635|Narcotics|narcotics|mesh-ancestor
43970137|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970138|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970139|NCT01675635|Analgesics|analgesics|mesh-ancestor
43970140|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
43970141|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970142|NCT01675778|Hydromorphone|hydromorphone|mesh-list
43970143|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970144|NCT01675778|Narcotics|narcotics|mesh-ancestor
43970145|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970146|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970147|NCT01675778|Analgesics|analgesics|mesh-ancestor
43970148|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
43970149|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970150|NCT01676311|Huperzine A|huperzine a|mesh-list
43970151|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43970152|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970153|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970154|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
43970155|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970156|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970157|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43970158|NCT01676311|Protective Agents|protective agents|mesh-ancestor
43970159|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
43970160|NCT01676415|Prednisone|prednisone|mesh-list
43970161|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
43970162|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970163|NCT01676415|Hormones|hormones|mesh-ancestor
43970164|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970165|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970166|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970167|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970168|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
43970169|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43970170|NCT01677286|Doxycycline|doxycycline|mesh-list
43970171|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970172|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970173|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
43970174|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43970175|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43970176|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43970177|NCT01678443|Antibodies|antibodies|mesh-list
43970178|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
43970179|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43970180|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
43970181|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970182|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970183|NCT01678794|Candesartan|candesartan|mesh-list
43970184|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43970185|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43970191|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43970192|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44241791|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
44241792|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241793|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44241794|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44241795|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
44285639|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970193|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970194|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970195|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43970196|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43970197|NCT01680172|Ketamine|ketamine|mesh-list
43970198|NCT01680172|Analgesics|analgesics|mesh-ancestor
43970199|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
43970200|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970201|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970202|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43970203|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43970204|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
43970205|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
43970206|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970207|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43970208|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43970209|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970210|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970211|NCT01680549|Gabapentin|gabapentin|mesh-list
43970212|NCT01680549|Analgesics|analgesics|mesh-ancestor
43970213|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
43970214|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970215|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970216|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
43970217|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43970218|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43970219|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970220|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970221|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43970222|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43970223|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970224|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970225|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
43970226|NCT01680653|Glucagon|glucagon|mesh-list
43970227|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43970228|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970229|NCT01680653|Hormones|hormones|mesh-ancestor
43970230|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970231|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970232|NCT01680653|Incretins|incretins|mesh-ancestor
43970233|NCT01680887|Varenicline|varenicline|mesh-list
43970234|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43970235|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43970236|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
43970237|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970238|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970239|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143435|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143436|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143437|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143438|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970240|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43970241|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
43970242|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970243|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43970244|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43970245|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970246|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970247|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843849|NCT04424654|Hormones|hormones|mesh-ancestor
44241796|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241797|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285640|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
43970250|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43970251|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43970252|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43970253|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
43970254|NCT01681030|Coagulants|coagulants|mesh-ancestor
43970256|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43970257|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
43970258|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970259|NCT01682135|Ramucirumab|ramucirumab|mesh-list
43970260|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970261|NCT01682538|Nitisinone|nitisinone|mesh-list
43970262|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970263|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970264|NCT01682642|Goserelin|goserelin|mesh-list
43970265|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970266|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970267|NCT01683331|Insulin|insulin|mesh-list
43970268|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43970269|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970270|NCT01683422|Gemcitabine|gemcitabine|mesh-list
43970271|NCT01683422|Capecitabine|capecitabine|mesh-list
43970272|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43970273|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43970274|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
43970275|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970276|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970277|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
43970278|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970279|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970280|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970281|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
43970282|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970283|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43970284|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43970285|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
43970286|NCT01684020|Coagulants|coagulants|mesh-ancestor
43970287|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
43970288|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43970289|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
43970290|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970291|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970292|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43970293|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43970294|NCT01684748|Olmesartan|olmesartan|mesh-list
43970295|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43970296|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43970297|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43970298|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43871145|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970299|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970300|NCT01685242|Cetirizine|cetirizine|mesh-list
43970301|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43970302|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43970303|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43970304|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
43970305|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
43970306|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970307|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970308|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970309|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
43970310|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
43970311|NCT01685411|Busulfan|busulfan|mesh-list
43970312|NCT01685411|Allopurinol|allopurinol|mesh-list
43970313|NCT01685411|Levetiracetam|levetiracetam|mesh-list
43970314|NCT01685411|Tacrolimus|tacrolimus|mesh-list
43970315|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43970316|NCT01685411|Lenograstim|lenograstim|mesh-list
43970317|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970318|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
43970319|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241798|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44241799|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241800|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
44241801|NCT00592111|Hormones|hormones|mesh-ancestor
44241802|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241803|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285641|NCT00755859|Hormones|hormones|mesh-ancestor
43970320|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970321|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43970329|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43970330|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43970331|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
43970332|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970333|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970334|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
43970335|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
43970336|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
43970337|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
43970338|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43970339|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
43970340|NCT01685411|Protective Agents|protective agents|mesh-ancestor
43970341|NCT01685684|Oxycodone|oxycodone|mesh-list
43970342|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970343|NCT01685684|Narcotics|narcotics|mesh-ancestor
43970344|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970345|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970346|NCT01685684|Analgesics|analgesics|mesh-ancestor
43970347|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
43970348|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970349|NCT01685996|Zonisamide|zonisamide|mesh-list
43970350|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
43970351|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43970352|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970353|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970354|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970355|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970356|NCT01686165|Rituximab|rituximab|mesh-list
43970357|NCT01686165|Belinostat|belinostat|mesh-list
43970358|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43970359|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43970360|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970361|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
43970362|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970363|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970364|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43970365|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970366|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970367|NCT01686451|Simvastatin|simvastatin|mesh-list
43970368|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43970369|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43970370|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
43970371|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970372|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43871146|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43970373|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43970374|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970376|NCT01686646|Caffeine|caffeine|mesh-list
43970377|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970378|NCT01686646|Analgesics|analgesics|mesh-ancestor
43970379|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
43970380|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970381|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970382|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
43970383|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43970384|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43970385|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970386|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809202|NCT01495637|Sargramostim|sargramostim|mesh-list
44241804|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44241805|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44241806|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43970387|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43970388|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43970403|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43970404|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970405|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970406|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970407|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43970408|NCT01687400|Decitabine|decitabine|mesh-list
43970409|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43970410|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
43970411|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970412|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970413|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970414|NCT01688102|Vitamin D|vitamin d|mesh-list
43970415|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
43970416|NCT01688102|Vitamins|vitamins|mesh-ancestor
43970417|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
43970418|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970419|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970420|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970421|NCT01688336|Leucovorin|leucovorin|mesh-list
43970422|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
43970423|NCT01688336|Irinotecan|irinotecan|mesh-list
43970424|NCT01688336|Folfirinox|folfirinox|mesh-list
43970425|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970426|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43970427|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43970428|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970429|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970430|NCT01688336|Antidotes|antidotes|mesh-ancestor
43970431|NCT01688336|Protective Agents|protective agents|mesh-ancestor
43970432|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970433|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
43970434|NCT01688336|Vitamins|vitamins|mesh-ancestor
43970435|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
43970436|NCT01688596|Bupivacaine|bupivacaine|mesh-list
43970437|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970438|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
43970439|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970440|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970441|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
43970442|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970443|NCT01688609|Paclitaxel|paclitaxel|mesh-list
43970444|NCT01688609|Trastuzumab|trastuzumab|mesh-list
43970445|NCT01688609|Lapatinib|lapatinib|mesh-list
43970446|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43970447|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970448|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
43970449|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
43970450|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
43970451|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970452|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43970459|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970460|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970461|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43970462|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970463|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970464|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43970465|NCT01689441|Vitamins|vitamins|mesh-ancestor
43708219|NCT05300594|Vitamins|vitamins|mesh-list
43970466|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
44143439|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
43970467|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970469|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
43970470|NCT01689779|Vitamins|vitamins|mesh-ancestor
43970471|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
43970472|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241808|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
43970473|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970474|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970475|NCT01690000|Melatonin|melatonin|mesh-list
43970476|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
43970477|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970478|NCT01690000|Protective Agents|protective agents|mesh-ancestor
43970479|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970480|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970481|NCT01690546|Naltrexone|naltrexone|mesh-list
43970482|NCT01690546|Buprenorphine|buprenorphine|mesh-list
43970483|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43970484|NCT01690546|Naloxone|naloxone|mesh-list
43970485|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970486|NCT01690546|Narcotics|narcotics|mesh-ancestor
43970487|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970488|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970489|NCT01690546|Analgesics|analgesics|mesh-ancestor
43970490|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
43970491|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970492|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43970493|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43970494|NCT01690663|Dexamethasone|dexamethasone|mesh-list
43970495|NCT01690663|Bupivacaine|bupivacaine|mesh-list
43970496|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970497|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
43970498|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
43970499|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970500|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970501|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970502|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
43970503|NCT01690663|Hormones|hormones|mesh-ancestor
43970504|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970505|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970506|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970507|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970508|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
43970509|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970510|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
43970511|NCT01691313|Vanoxerine|vanoxerine|mesh-list
43970512|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43970513|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43970514|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970515|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970516|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
43970517|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970518|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970519|NCT01691326|Vaccines|vaccines|mesh-list
43970520|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
43970521|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970522|NCT01691339|Vaccines|vaccines|mesh-list
43970523|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
43970524|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970525|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
43970526|NCT01691534|Clofazimine|clofazimine|mesh-list
43970527|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
43970528|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970529|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970530|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970531|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
43970532|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
43970533|NCT01691560|Listerine|listerine|mesh-list
43970534|NCT01691560|Calcium|calcium|mesh-list
43970535|NCT01691560|Fluorides|fluorides|mesh-list
43970536|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
43970537|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
43970538|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970539|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970540|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970541|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
43970542|NCT01691560|Protective Agents|protective agents|mesh-ancestor
43708290|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
43970543|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43970544|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241809|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44241810|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44241811|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43970545|NCT01691690|Acetaminophen|acetaminophen|mesh-list
43970546|NCT01691690|Dexamethasone|dexamethasone|mesh-list
43970547|NCT01691690|Midazolam|midazolam|mesh-list
43970548|NCT01691690|Morphine|morphine|mesh-list
43970549|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
43970550|NCT01691690|Ondansetron|ondansetron|mesh-list
43970551|NCT01691690|Propofol|propofol|mesh-list
43970552|NCT01691690|Sevoflurane|sevoflurane|mesh-list
43970553|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970554|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
43970555|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
43970556|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970557|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970558|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970559|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
43970560|NCT01691690|Hormones|hormones|mesh-ancestor
43970561|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970562|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970563|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970564|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43970565|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970566|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43970567|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
43970568|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
43970569|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970570|NCT01691690|Narcotics|narcotics|mesh-ancestor
43970571|NCT01691690|Analgesics|analgesics|mesh-ancestor
43970572|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
43970573|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43970574|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43970575|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43970576|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970577|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
43970578|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
43970579|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970580|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970581|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970582|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
43970583|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43970584|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43970585|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
43970586|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
43970587|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43970588|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
43970589|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43970590|NCT01692340|Lycopene|lycopene|mesh-list
43970591|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970592|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
43970593|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970594|NCT01692340|Protective Agents|protective agents|mesh-ancestor
43970595|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970596|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43970597|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43970598|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970599|NCT01692756|Triamcinolone|triamcinolone|mesh-list
43970600|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43970608|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970609|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970610|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
43970611|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970612|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970614|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43970615|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
43970616|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970617|NCT01694966|Methylene Blue|methylene blue|mesh-list
43970618|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970619|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970620|NCT01695291|Minocycline|minocycline|mesh-list
43970621|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970622|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970623|NCT01695330|Bortezomib|bortezomib|mesh-list
44241814|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44241815|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241816|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44241817|NCT00592150|Fenoldopam|fenoldopam|mesh-list
44241818|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44241819|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
44241820|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
44241821|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
44241822|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241823|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241824|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241825|NCT00592215|Misoprostol|misoprostol|mesh-list
44241826|NCT00592215|Mifepristone|mifepristone|mesh-list
44241827|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44241828|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
44241829|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43970624|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970625|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43970626|NCT01695668|Cyclosporine|cyclosporine|mesh-list
43970627|NCT01695668|Cyclosporins|cyclosporins|mesh-list
43970628|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970629|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970630|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970631|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
43970632|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970633|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
43970634|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970635|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
43970636|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970637|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43970638|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43970639|NCT01696084|Cytarabine|cytarabine|mesh-list
43970640|NCT01696084|Daunorubicin|daunorubicin|mesh-list
43970641|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43970642|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
43970643|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970644|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970645|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
43970646|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970647|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970648|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
43970649|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970650|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43970651|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43970652|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43970653|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970654|NCT01696760|Aspirin|aspirin|mesh-list
43970655|NCT01696760|Enoxaparin|enoxaparin|mesh-list
43970656|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
43970657|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
43970658|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43970659|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43970660|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970661|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43970662|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970663|NCT01696760|Analgesics|analgesics|mesh-ancestor
43970664|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
43970665|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241830|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241831|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44241832|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241834|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44241835|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44241836|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44241837|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44241838|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
43970666|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970667|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970668|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970677|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43970678|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970679|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143440|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44143441|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44143442|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
44143443|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143444|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143445|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143446|NCT00189800|Urological Agents|urological agents|mesh-ancestor
44143447|NCT00189826|Tacrolimus|tacrolimus|mesh-list
44143448|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143449|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
44143450|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143451|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143452|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143453|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143454|NCT00189839|Tacrolimus|tacrolimus|mesh-list
44143455|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708394|NCT04909073|Afatinib|afatinib|mesh-list
43970680|NCT01698710|Paclitaxel|paclitaxel|mesh-list
43970681|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43970682|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43970683|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970684|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
43970685|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
43970686|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
43970687|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970688|NCT01699607|Amphetamine|amphetamine|mesh-list
43970689|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
43970690|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43970691|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970692|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
43970693|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
43970694|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970695|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
43970696|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970697|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970698|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
43970699|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43970700|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43970701|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970702|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43970703|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43970704|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
43970705|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43970706|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43970707|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
43970708|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970709|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970710|NCT01700517|Anesthetics|anesthetics|mesh-list
43970711|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970712|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241839|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43970713|NCT01700907|Sevoflurane|sevoflurane|mesh-list
43970714|NCT01700907|Desflurane|desflurane|mesh-list
43970715|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43970716|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43970717|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
43970718|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
43970727|NCT01701102|Fentanyl|fentanyl|mesh-list
43970728|NCT01701102|Mepivacaine|mepivacaine|mesh-list
43970729|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970730|NCT01701102|Narcotics|narcotics|mesh-ancestor
43970731|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970732|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970733|NCT01701102|Analgesics|analgesics|mesh-ancestor
43970734|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
43970735|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970736|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43970737|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43970738|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
43970739|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
43970740|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970741|NCT01701115|Bupivacaine|bupivacaine|mesh-list
43970742|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
43970743|NCT01701115|Mepivacaine|mepivacaine|mesh-list
43970744|NCT01701115|Anesthetics|anesthetics|mesh-list
43970745|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970746|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970747|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
43970748|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970749|NCT01701375|Palbociclib|palbociclib|mesh-list
43970750|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970751|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43970752|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970753|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970754|NCT01701414|Bupivacaine|bupivacaine|mesh-list
43970755|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970757|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970758|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970759|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
43970760|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970761|NCT01701505|Phenylephrine|phenylephrine|mesh-list
43970762|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
43970763|NCT01701505|Tetracaine|tetracaine|mesh-list
43970764|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970765|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
44011616|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970766|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970767|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970768|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
43970769|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970770|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43970771|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43970772|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
43970773|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970774|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970775|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
43970776|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
43970777|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
43970778|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43970779|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
43970780|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43970781|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
43970782|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43970783|NCT01701505|Protective Agents|protective agents|mesh-ancestor
43970784|NCT01702233|Dexamethasone|dexamethasone|mesh-list
43970785|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
43970786|NCT01702233|BB 1101|bb 1101|mesh-list
43970787|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970788|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
43970796|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970797|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970798|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
43970799|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970800|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970801|NCT01703039|Riluzole|riluzole|mesh-list
43970802|NCT01703039|Sertraline|sertraline|mesh-list
44241840|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44241841|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
43970803|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
43970804|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970805|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43970806|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43970807|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970808|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970809|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970810|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
43970811|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970813|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43970814|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43970815|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43970816|NCT01703039|Protective Agents|protective agents|mesh-ancestor
43970817|NCT01703507|Ipilimumab|ipilimumab|mesh-list
43970818|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43970819|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970820|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43970821|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970822|NCT01704521|Ribavirin|ribavirin|mesh-list
43970823|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
43970824|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970825|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
43970826|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970827|NCT01704781|Lenalidomide|lenalidomide|mesh-list
43970828|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
43970829|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708541|NCT04648540|Celecoxib|celecoxib|mesh-list
43970830|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43970831|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43970832|NCT01704781|Growth Substances|growth substances|mesh-ancestor
43970833|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
43970834|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970835|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43970836|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43970837|NCT01705288|Morphine|morphine|mesh-list
43970838|NCT01705288|Narcotics|narcotics|mesh-list
43970839|NCT01705288|Anesthetics|anesthetics|mesh-list
43970840|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970841|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970842|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43970843|NCT01705288|Analgesics|analgesics|mesh-ancestor
43970844|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
43970845|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970846|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970847|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970848|NCT01705496|Fialuridine|fialuridine|mesh-list
43970849|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
43970850|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970851|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43970852|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970853|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970854|NCT01705964|Epinephrine|epinephrine|mesh-list
43970855|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43970863|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
43970864|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970865|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43970866|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
43970867|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
43970868|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
43970869|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43970870|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
43970871|NCT01706263|Salicylates|salicylates|mesh-list
43970872|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970873|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
43970874|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
43970875|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
43970876|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43970877|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970878|NCT01706263|Analgesics|analgesics|mesh-ancestor
43970879|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
43970880|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241842|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970881|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970882|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970883|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970884|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43970885|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970886|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970887|NCT01706588|Diclofenac|diclofenac|mesh-list
43970888|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43970889|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43970890|NCT01706588|Analgesics|analgesics|mesh-ancestor
43970891|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
43970892|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970893|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970894|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970895|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970896|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43970897|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970898|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970899|NCT01706666|Dexamethasone|dexamethasone|mesh-list
43970900|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
43970901|NCT01706666|Lenalidomide|lenalidomide|mesh-list
43970902|NCT01706666|Bortezomib|bortezomib|mesh-list
43970903|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970904|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
43970905|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970906|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43970907|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43970908|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
43970909|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970910|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970911|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43970912|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970913|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
43970914|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
43970915|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970916|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970917|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
43970918|NCT01706666|Hormones|hormones|mesh-ancestor
43970919|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970920|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43970921|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43970928|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43970929|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
43970930|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43970931|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43970932|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
43970933|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970934|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970935|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970936|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43970937|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43970938|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
43970939|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970940|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43970941|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
43970942|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
43970943|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
43970944|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43970945|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
43970946|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
43970947|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970948|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
43970949|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43970950|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43970951|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970952|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
43970953|NCT01707043|Calcitriol|calcitriol|mesh-list
43970954|NCT01707043|Betamethasone|betamethasone|mesh-list
43970955|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
43970956|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44241843|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
44241844|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44241845|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43970958|NCT01707043|Calcipotriene|calcipotriene|mesh-list
43970959|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43970960|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970961|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
43970962|NCT01707043|Hormones|hormones|mesh-ancestor
43970963|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970964|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970965|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43970966|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
43970967|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
43970968|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43970969|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43970970|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43970971|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970972|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43970973|NCT01707043|Vitamins|vitamins|mesh-ancestor
43970974|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
43970975|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43970976|NCT01707225|Octreotide|octreotide|mesh-list
43970977|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970978|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708643|NCT04360681|Lofexidine|lofexidine|mesh-list
43970979|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970980|NCT01707381|Timolol|timolol|mesh-list
43970981|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43970982|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43970983|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
43970984|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970985|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970986|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970987|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43970988|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43970990|NCT01707420|Analgesics|analgesics|mesh-ancestor
43970991|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
43970992|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970999|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43971000|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43971001|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971002|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971004|NCT01708122|Fentanyl|fentanyl|mesh-list
43971005|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971006|NCT01708122|Narcotics|narcotics|mesh-ancestor
43971007|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971008|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971009|NCT01708122|Analgesics|analgesics|mesh-ancestor
43971010|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
43971011|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971012|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43971013|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43971014|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
43971015|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
43971016|NCT01708278|Folic Acid|folic acid|mesh-list
43971017|NCT01708278|Quercetin|quercetin|mesh-list
43971018|NCT01708278|Hematinics|hematinics|mesh-ancestor
43971019|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
43971020|NCT01708278|Vitamins|vitamins|mesh-ancestor
43971021|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
43971022|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971023|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
43971024|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971025|NCT01708278|Protective Agents|protective agents|mesh-ancestor
43971026|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
43971027|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971028|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43971029|NCT01708525|Protective Agents|protective agents|mesh-ancestor
43971030|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971032|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43971033|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971034|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
44241846|NCT00592241|Insulin|insulin|mesh-list
44241847|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44241848|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43971035|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971036|NCT01708603|Ustekinumab|ustekinumab|mesh-list
43971037|NCT01708603|Brodalumab|brodalumab|mesh-list
43971038|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43971039|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971040|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
43971041|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971042|NCT01708629|Ustekinumab|ustekinumab|mesh-list
43971043|NCT01708629|Brodalumab|brodalumab|mesh-list
43971044|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43971045|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971046|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
43971047|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971048|NCT01709032|Deferasirox|deferasirox|mesh-list
43971049|NCT01709032|Deferiprone|deferiprone|mesh-list
43971050|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43971051|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
43971052|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
43971053|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971054|NCT01709422|Midazolam|midazolam|mesh-list
43971055|NCT01709422|Meperidine|meperidine|mesh-list
43971056|NCT01709422|Propofol|propofol|mesh-list
43971057|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43971058|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971059|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971060|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43971061|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
43971062|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
43971063|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43971064|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43971065|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971076|NCT01709474|Vitamin D|vitamin d|mesh-list
43971077|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
43971078|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
43971079|NCT01709474|Vitamins|vitamins|mesh-list
43971080|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
43971081|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971082|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43971083|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43971084|NCT01709747|Hydromorphone|hydromorphone|mesh-list
43971085|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971086|NCT01709747|Narcotics|narcotics|mesh-ancestor
43971087|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971088|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971089|NCT01709747|Analgesics|analgesics|mesh-ancestor
44011849|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971090|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
43971091|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971092|NCT01710137|Varenicline|varenicline|mesh-list
43971093|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43971094|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43971095|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
43971096|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971097|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971098|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971099|NCT01710254|Regadenoson|regadenoson|mesh-list
43971100|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43971101|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43971102|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
43971103|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
43971104|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971105|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971106|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971107|NCT01710332|Aflibercept|aflibercept|mesh-list
43971108|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43971109|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43971110|NCT01710332|Growth Substances|growth substances|mesh-ancestor
43971111|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971112|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
43971113|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971114|NCT01710787|Phenylephrine|phenylephrine|mesh-list
43971115|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
44241849|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241850|NCT00592280|Pancrelipase|pancrelipase|mesh-list
44241851|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241852|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
44241853|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44241854|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
44241855|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241856|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241857|NCT00592332|Alprazolam|alprazolam|mesh-list
44241858|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44241859|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44241860|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241861|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44241862|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971116|NCT01710787|Tetracaine|tetracaine|mesh-list
43971117|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
43971118|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
43971119|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971120|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971121|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
43971122|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971123|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43971124|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43971125|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971126|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971127|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971128|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
43971129|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
43971130|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
43971131|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44143456|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
43971135|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43971136|NCT01710787|Protective Agents|protective agents|mesh-ancestor
43971138|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43971139|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43971140|NCT01710839|Growth Substances|growth substances|mesh-ancestor
43971141|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971142|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
43971143|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971144|NCT01711177|Travoprost|travoprost|mesh-list
43971145|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971146|NCT01711658|Cisplatin|cisplatin|mesh-list
43971147|NCT01711658|Lapatinib|lapatinib|mesh-list
43971148|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971149|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43971150|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971151|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971152|NCT01711918|Domperidone|domperidone|mesh-list
43971153|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
43971154|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
43971155|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971156|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971157|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971158|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43971159|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
43971160|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971161|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971162|NCT01712230|Leuprolide|leuprolide|mesh-list
43971163|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43971164|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
43971165|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43971166|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241863|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241864|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
44241865|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
44241866|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971167|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971168|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971169|NCT01712360|Naftifine|naftifine|mesh-list
43971170|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
43971171|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971172|NCT01713400|Sirolimus|sirolimus|mesh-list
43971173|NCT01713400|Ustekinumab|ustekinumab|mesh-list
43971174|NCT01713400|Tacrolimus|tacrolimus|mesh-list
43971175|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971176|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
43971177|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971178|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43971179|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971180|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971181|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43971182|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971183|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43971184|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971185|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
43971186|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971187|NCT01713608|Artefenomel|artefenomel|mesh-list
43971188|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
43971189|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43971190|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43971191|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971192|NCT01713621|Artefenomel|artefenomel|mesh-list
43971193|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
43971194|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43971195|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43971196|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143457|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143458|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44143459|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143460|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143461|NCT00189878|Methotrexate|methotrexate|mesh-list
44143462|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44143463|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
44143464|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43971202|NCT01714336|Coagulants|coagulants|mesh-ancestor
43971203|NCT01715207|Atenolol|atenolol|mesh-list
43971204|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43971205|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971206|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
43971207|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
43971208|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971209|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971210|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43971211|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43971212|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43971213|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971214|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971215|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971216|NCT01715233|Leucovorin|leucovorin|mesh-list
43971217|NCT01715233|Cisplatin|cisplatin|mesh-list
43971218|NCT01715233|Carboplatin|carboplatin|mesh-list
43971219|NCT01715233|Docetaxel|docetaxel|mesh-list
43971220|NCT01715233|Fluorouracil|fluorouracil|mesh-list
44011993|NCT03158116|Aztreonam|aztreonam|mesh-list
43971221|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971222|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971223|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971224|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
43971225|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971226|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
43971227|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43971228|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971229|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
43971230|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971231|NCT01715233|Antidotes|antidotes|mesh-ancestor
43971232|NCT01715233|Protective Agents|protective agents|mesh-ancestor
43971233|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
43971234|NCT01715233|Vitamins|vitamins|mesh-ancestor
43824283|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971235|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
43971237|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971238|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971239|NCT01716195|Paclitaxel|paclitaxel|mesh-list
43971240|NCT01716195|Carboplatin|carboplatin|mesh-list
43971241|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971242|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971243|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971244|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971245|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
43971246|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971247|NCT01716208|Ofatumumab|ofatumumab|mesh-list
43971248|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971249|NCT01716221|Dexetimide|dexetimide|mesh-list
43971250|NCT01716221|Bupropion|bupropion|mesh-list
43971251|NCT01716221|Citalopram|citalopram|mesh-list
43971252|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43971253|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
43971254|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971264|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971265|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43971266|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
43971267|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43971268|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43971269|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
43971270|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
43971271|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971272|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43971273|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43971274|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
43971275|NCT01717053|Prednisone|prednisone|mesh-list
43971276|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
43971277|NCT01717053|Androgens|androgens|mesh-list
43971278|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971279|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
43971280|NCT01717053|Hormones|hormones|mesh-ancestor
43971281|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971282|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971283|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971284|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971285|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43971286|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971287|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971288|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
43971289|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43971290|NCT01717209|Epoprostenol|epoprostenol|mesh-list
43971291|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
43971292|NCT01717209|Tezosentan|tezosentan|mesh-list
43971293|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43971294|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
43971295|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971296|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971297|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43971298|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
43971299|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43971300|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
43971301|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971302|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971303|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43971304|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
43971305|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
43971306|NCT01717209|Protective Agents|protective agents|mesh-ancestor
43971307|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971308|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43971309|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43971310|NCT01717742|Plasminogen|plasminogen|mesh-list
43971311|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43971312|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43971313|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971314|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
43971315|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
43971316|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971317|NCT01717898|Prednisone|prednisone|mesh-list
44241867|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241869|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43971318|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
43971326|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971327|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43971328|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971329|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971330|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
43971331|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43971332|NCT01718691|Rituximab|rituximab|mesh-list
43971333|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971334|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971335|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
43971336|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971337|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971338|NCT01719367|Atenolol|atenolol|mesh-list
43971339|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43971340|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971341|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
43971342|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
43971343|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971344|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971345|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43971346|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43971347|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43971348|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971349|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971350|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971351|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43971352|NCT01719653|Laxatives|laxatives|mesh-ancestor
43971353|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971354|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43971355|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
43971356|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971357|NCT01720277|Vaccines|vaccines|mesh-list
43971358|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
43971359|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971360|NCT01720316|Glycine|glycine|mesh-list
43971361|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
43971362|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971363|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971364|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971365|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
43971366|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971367|NCT01721226|Narcotics|narcotics|mesh-ancestor
43971368|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971369|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971370|NCT01721226|Analgesics|analgesics|mesh-ancestor
43971371|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
43971372|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971373|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
43971374|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43971375|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971376|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971377|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43971378|NCT01721460|Analgesics|analgesics|mesh-ancestor
43971379|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
43971380|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971381|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43971382|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43971383|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43971384|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971385|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971388|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971389|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43971390|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971392|NCT01721603|Dabrafenib|dabrafenib|mesh-list
43971393|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241870|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44241871|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241872|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
44241873|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44241874|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241875|NCT00592566|Dexamethasone|dexamethasone|mesh-list
43971394|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43971395|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971396|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971397|NCT01721967|Ranolazine|ranolazine|mesh-list
43971398|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43971399|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971400|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971401|NCT01722292|Carboplatin|carboplatin|mesh-list
43971402|NCT01722292|Etoposide|etoposide|mesh-list
43971403|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971404|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971405|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43971406|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43971407|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971408|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971409|NCT01722318|Plecanatide|plecanatide|mesh-list
43971410|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43971411|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
43971412|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971413|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971414|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
43971415|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971416|NCT01722435|Narcotics|narcotics|mesh-ancestor
43971417|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971418|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971419|NCT01722435|Analgesics|analgesics|mesh-ancestor
43971420|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
43971421|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971422|NCT01722487|Chlorambucil|chlorambucil|mesh-list
43971423|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43971424|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
43971425|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971426|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971427|NCT01722604|Brinzolamide|brinzolamide|mesh-list
43971428|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43971429|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971430|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971431|NCT01723384|Naltrexone|naltrexone|mesh-list
43971432|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43971433|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43971434|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971435|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
43971436|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971437|NCT01723514|Erenumab|erenumab|mesh-list
43971438|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43971439|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971440|NCT01723514|Analgesics|analgesics|mesh-ancestor
43971441|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
43971442|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971443|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971444|NCT01723696|Vitamins|vitamins|mesh-list
43971445|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
43971446|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
43971447|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971448|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
43971449|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971450|NCT01723696|Protective Agents|protective agents|mesh-ancestor
43971451|NCT01723722|Methadone|methadone|mesh-list
43971452|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971453|NCT01723722|Narcotics|narcotics|mesh-ancestor
43971454|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971455|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241876|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44241877|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44241878|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
44241879|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
43971456|NCT01723722|Analgesics|analgesics|mesh-ancestor
43971466|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971467|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43971468|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971469|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971470|NCT01727089|Bevacizumab|bevacizumab|mesh-list
43971471|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43971472|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
43971473|NCT01727089|Antibodies|antibodies|mesh-list
43971474|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
43971475|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43971476|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
43971477|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971478|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43971479|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43971480|NCT01727089|Growth Substances|growth substances|mesh-ancestor
43971481|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971482|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
43971483|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
43971484|NCT01727414|Methylphenidate|methylphenidate|mesh-list
43971485|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43971486|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971487|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43971488|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43971489|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971490|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971491|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
43971492|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971493|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43971494|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
43971495|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
43971496|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971497|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43971498|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971499|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971500|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971501|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
43971502|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971503|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971504|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
43971505|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
43971506|NCT01727791|Pregabalin|pregabalin|mesh-list
43971507|NCT01727791|Analgesics|analgesics|mesh-ancestor
43971508|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
44012217|NCT05358626|Antibodies|antibodies|mesh-list
43971509|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971510|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971511|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
43971512|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43971513|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971514|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971515|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43971516|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43971517|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971518|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971519|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971520|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
43971521|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43971522|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43971527|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971528|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971529|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43971530|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971531|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
43971532|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43971533|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43971534|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241880|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241881|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241882|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241883|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
44241884|NCT00592566|Hormones|hormones|mesh-ancestor
44241885|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44241886|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971535|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
43971537|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
43971538|NCT01729338|Lenalidomide|lenalidomide|mesh-list
43971539|NCT01729338|Bortezomib|bortezomib|mesh-list
43971540|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971541|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
43971542|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971543|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971544|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43971545|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
43971546|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971547|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971548|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43971549|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43971550|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43971551|NCT01729338|Growth Substances|growth substances|mesh-ancestor
43971552|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
43971553|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
43971554|NCT01729494|Prednisone|prednisone|mesh-list
43971555|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
43971556|NCT01729494|Abatacept|abatacept|mesh-list
43971557|NCT01729494|Tacrolimus|tacrolimus|mesh-list
43971558|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
43971559|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43971560|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971561|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
43971562|NCT01729494|Hormones|hormones|mesh-ancestor
43971563|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971564|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971565|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971566|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971567|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971568|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
43971569|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43971570|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971571|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971572|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43971573|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43971574|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
43971575|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43971576|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971577|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971578|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43971579|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971580|NCT01729598|Valproic Acid|valproic acid|mesh-list
43971581|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
43971582|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971583|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971584|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
43971585|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971586|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971587|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
43971588|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971589|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971590|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971591|NCT01729845|Cytarabine|cytarabine|mesh-list
43971592|NCT01729845|Etoposide|etoposide|mesh-list
43971593|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
43971594|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
43971602|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971603|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241887|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241888|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
44241889|NCT00592566|Coagulants|coagulants|mesh-ancestor
43971604|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
43971605|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
43971606|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971607|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971608|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
43971609|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971611|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
43971612|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971613|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
43971614|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971615|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971616|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971617|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
43971618|NCT01729923|Celecoxib|celecoxib|mesh-list
43971619|NCT01729923|Capecitabine|capecitabine|mesh-list
43971620|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
43971621|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43971622|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
43971623|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971624|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971625|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43971626|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43971627|NCT01729923|Analgesics|analgesics|mesh-ancestor
43971628|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
43971629|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971630|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971631|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971632|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971633|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43971634|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43971635|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971636|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43971637|NCT01730846|Doxazosin|doxazosin|mesh-list
43971638|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971639|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43971640|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43971641|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43971642|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971643|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971644|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971645|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971646|NCT01730872|Prednisolone|prednisolone|mesh-list
43971647|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43971648|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
43971649|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43971650|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
43971651|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43971652|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43971653|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43971654|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
43971655|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971656|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
43971658|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971659|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971660|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971661|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971662|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
43971670|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43971671|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43971673|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
43971674|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971675|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971676|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971677|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43971678|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43971679|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971680|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971681|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241891|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
44241892|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44241893|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241894|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44241895|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44241896|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44241897|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241898|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
44241899|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44241900|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
43971682|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971683|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43971684|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43971685|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43971686|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
43971687|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971688|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971689|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43971690|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43971691|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
43971692|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43971693|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43971694|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
43971695|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
43971696|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43971697|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971698|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971699|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43971700|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43971701|NCT01732445|Danazol|danazol|mesh-list
43971702|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43971703|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43971704|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
43971705|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971706|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971707|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43971708|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971709|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971710|NCT01732718|Atorvastatin|atorvastatin|mesh-list
43971711|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43971712|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43971713|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
43971714|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971715|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43971716|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43971717|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971718|NCT05317325|Vaccines|vaccines|mesh-list
43971719|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
43971720|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971721|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
43971722|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143472|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44143473|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143474|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
44143475|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143483|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
44143484|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143485|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143486|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143487|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44143488|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241901|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241903|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
44241904|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44241905|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
44143489|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143490|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143491|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44143492|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
44143493|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143494|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143495|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44143496|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44143497|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
44143498|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
44143499|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
44143500|NCT00190008|Piracetam|piracetam|mesh-list
44143501|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44143502|NCT00190008|Protective Agents|protective agents|mesh-ancestor
44143503|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143504|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
44143505|NCT00190021|Donepezil|donepezil|mesh-list
44143506|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44143507|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143508|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143509|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
44143510|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143511|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143512|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
44143513|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
44143514|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44143515|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
44143516|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143517|NCT00190034|Expectorants|expectorants|mesh-ancestor
44143518|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
44143519|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44143520|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
44143521|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143522|NCT00190034|Protective Agents|protective agents|mesh-ancestor
44143523|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143524|NCT00190034|Antidotes|antidotes|mesh-ancestor
44143525|NCT00190060|Testosterone|testosterone|mesh-list
44143526|NCT00190060|Androgens|androgens|mesh-ancestor
44143527|NCT00190060|Hormones|hormones|mesh-ancestor
44143528|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143529|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143530|NCT00190099|Dexamethasone|dexamethasone|mesh-list
44143531|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143532|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
44143533|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
44143534|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143535|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143536|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143537|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
44143538|NCT00190099|Hormones|hormones|mesh-ancestor
44143539|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143540|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44143541|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143542|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
44143543|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44143544|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143545|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44143546|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43971730|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971731|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971732|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43971733|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43971734|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971735|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241906|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971736|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
43971738|NCT05316857|Itraconazole|itraconazole|mesh-list
43971739|NCT05316857|Rifampin|rifampin|mesh-list
43971740|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
43971741|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971742|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43971743|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43971744|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971745|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971746|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43971747|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43971748|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971749|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971750|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43971751|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43971752|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
43971753|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43971754|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
43971755|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43971756|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43971757|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43971758|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43971759|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43971760|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43971761|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43971762|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43971763|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
43971764|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971766|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971767|NCT05316649|Chrysarobin|chrysarobin|mesh-list
43971768|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43971769|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43971770|NCT05316649|Analgesics|analgesics|mesh-ancestor
43971771|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
43971772|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971773|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971774|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971775|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971776|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
43971777|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971778|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971779|NCT05316376|Paclitaxel|paclitaxel|mesh-list
43971780|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43971781|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971782|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971783|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971784|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971785|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165291|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43971788|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971789|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971790|NCT05316168|Dexamethasone|dexamethasone|mesh-list
43971791|NCT05316168|Bupivacaine|bupivacaine|mesh-list
43971792|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971793|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
43971794|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
43971795|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971796|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971798|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
43971799|NCT05316168|Hormones|hormones|mesh-ancestor
43971800|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971801|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971802|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971803|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
43971804|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
43971805|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971806|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
43971807|NCT05315999|Palonosetron|palonosetron|mesh-list
43971808|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
43971809|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
43809203|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
44241908|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241909|NCT00592618|Antidotes|antidotes|mesh-ancestor
44241910|NCT00592670|Fluoxetine|fluoxetine|mesh-list
44241911|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44241912|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43971810|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971811|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971812|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971813|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43971814|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43971815|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
43971816|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971817|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971818|NCT05315830|Vaccines|vaccines|mesh-list
43971819|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
43971820|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971821|NCT05315557|Terlipressin|terlipressin|mesh-list
43971822|NCT05315557|Vasopressins|vasopressins|mesh-list
43971823|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
43971824|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
43971825|NCT05315557|Coagulants|coagulants|mesh-ancestor
43971826|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43971827|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43971828|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
43971829|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971830|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43971831|NCT05315388|Vitamins|vitamins|mesh-list
43971832|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
43971833|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971834|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43971835|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
43971836|NCT05315128|Methotrexate|methotrexate|mesh-list
43971837|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43971838|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
43971839|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43971840|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971841|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43971842|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
43971843|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971844|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971845|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
43971846|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971847|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43971848|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971849|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
43971850|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971851|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43971852|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
43971853|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43971854|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43971855|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43971856|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971857|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971858|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
43971859|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971860|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971861|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43971862|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971863|NCT05302011|Cisplatin|cisplatin|mesh-list
43971864|NCT05302011|Carboplatin|carboplatin|mesh-list
43971865|NCT05302011|Docetaxel|docetaxel|mesh-list
43971866|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
43971867|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971868|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971869|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971870|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709415|NCT02697058|Leucovorin|leucovorin|mesh-list
43971871|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971872|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241913|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143548|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143549|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143550|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44143551|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44143553|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143554|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
44143555|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143556|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143557|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44143558|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
44143559|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143560|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143561|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44143562|NCT00190268|Amifampridine|amifampridine|mesh-list
44143563|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44143564|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143565|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143566|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44143567|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143568|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143569|NCT00190294|Misoprostol|misoprostol|mesh-list
44143570|NCT00190294|Mifepristone|mifepristone|mesh-list
44143571|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44143572|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
44143573|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44143574|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143575|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44143576|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143577|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
44143578|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44143579|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44143580|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44143581|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44143582|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
44143583|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44143584|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44143585|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
44143586|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143587|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
44143588|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44143589|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44143590|NCT00190307|Aspirin|aspirin|mesh-list
44143591|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44143592|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44143593|NCT00190307|Analgesics|analgesics|mesh-ancestor
44143594|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
44143595|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147711|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
44143596|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143597|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143598|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143599|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44143600|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44143601|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143602|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44143603|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44143604|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143605|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
44143606|NCT00190333|Citalopram|citalopram|mesh-list
44143607|NCT00190333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43971873|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
43971874|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971875|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971876|NCT05213169|Apomorphine|apomorphine|mesh-list
43971877|NCT05213169|Emetics|emetics|mesh-ancestor
43971878|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971879|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
43971880|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971881|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971882|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
44241914|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241916|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
44241917|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241918|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44241919|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
44241920|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241921|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44241922|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44241923|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241924|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
44241925|NCT00592917|Vitamin D|vitamin d|mesh-list
44241926|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
44241927|NCT00592917|Calcium|calcium|mesh-list
44241928|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44241929|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241930|NCT00592917|Vitamins|vitamins|mesh-ancestor
44241931|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
43971883|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
43971884|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971885|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971886|NCT05192265|Artesunate|artesunate|mesh-list
43971887|NCT05192265|Lumefantrine|lumefantrine|mesh-list
43971888|NCT05192265|Artemether|artemether|mesh-list
43971889|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43971890|NCT05192265|Pyronaridine|pyronaridine|mesh-list
43971891|NCT05192265|Antimalarials|antimalarials|mesh-list
43971892|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43971893|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43971894|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971895|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971896|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
43971897|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
43971898|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43971899|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
43971900|NCT05167643|Anastrozole|anastrozole|mesh-list
43971901|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971902|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971903|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43971904|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43971905|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971906|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971907|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43971908|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
43971909|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971910|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971912|NCT05161338|Progesterone|progesterone|mesh-list
43971913|NCT05161338|Estrogens|estrogens|mesh-ancestor
43971914|NCT05161338|Hormones|hormones|mesh-ancestor
43971915|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012672|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971916|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971917|NCT05161338|Progestins|progestins|mesh-ancestor
43971918|NCT05127928|Vitamins|vitamins|mesh-list
43971919|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
43971920|NCT05127928|Vitamin E|vitamin e|mesh-list
43971921|NCT05127928|Tocopherols|tocopherols|mesh-list
43971922|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
43971923|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971924|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
44241932|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44241933|NCT00592917|Antacids|antacids|mesh-ancestor
44241934|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241935|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241936|NCT00592930|Olanzapine|olanzapine|mesh-list
44241937|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
44241938|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
44241939|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44241940|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241941|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241942|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44241943|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241944|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971925|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971926|NCT05127928|Protective Agents|protective agents|mesh-ancestor
43971927|NCT05115409|Rituximab|rituximab|mesh-list
43971928|NCT05115409|Antibodies|antibodies|mesh-list
43971929|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
43971930|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971931|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43971947|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971948|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43971949|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
43971950|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971951|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971952|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43971953|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971954|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
43971955|NCT05093140|Hormones|hormones|mesh-ancestor
43971956|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971957|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971958|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971959|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971960|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971961|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
43971962|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43971963|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43971964|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43971965|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971966|NCT04955236|Fentanyl|fentanyl|mesh-list
43971967|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971968|NCT04955236|Narcotics|narcotics|mesh-ancestor
43971969|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971970|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971971|NCT04955236|Analgesics|analgesics|mesh-ancestor
43971972|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
43971973|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971974|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43971975|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43971976|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
43971977|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
43971978|NCT04903652|Vinorelbine|vinorelbine|mesh-list
43971979|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971980|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971981|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
43971982|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
43971983|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
43971984|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971985|NCT04894188|Goserelin|goserelin|mesh-list
43971986|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971987|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971988|NCT04887285|Anesthetics|anesthetics|mesh-list
44241946|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44241947|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44241948|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44241949|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241950|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241951|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
44241952|NCT00592969|Metformin|metformin|mesh-list
44241953|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
44241954|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
44241955|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44241956|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241957|NCT00593008|Gemcitabine|gemcitabine|mesh-list
44241958|NCT00593008|Sirolimus|sirolimus|mesh-list
44241959|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44241960|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
44241961|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241962|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241963|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
44241964|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241965|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241966|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241967|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
44241968|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241969|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44241970|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241971|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
44241972|NCT00593060|Sirolimus|sirolimus|mesh-list
44241973|NCT00593060|Cetuximab|cetuximab|mesh-list
44241974|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44241975|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44241976|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43971989|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
43971990|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43971991|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971992|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
43972006|NCT04834557|Digoxin|digoxin|mesh-list
43972007|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43972008|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43972009|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43972010|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972011|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972012|NCT04834557|Protective Agents|protective agents|mesh-ancestor
43972013|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241977|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44241978|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44241979|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
44241980|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44241981|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
44241982|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241983|NCT00593099|Bupropion|bupropion|mesh-list
44241984|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44241985|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
44241986|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44241987|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44241988|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44241989|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44241990|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241991|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
44241992|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44241993|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241994|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44241995|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44241996|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44241997|NCT00593125|Levetiracetam|levetiracetam|mesh-list
44241998|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
44241999|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
44242000|NCT00593138|Methylphenidate|methylphenidate|mesh-list
44242001|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44242002|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44242003|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242004|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44242005|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44242006|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242010|NCT00593151|Interferons|interferons|mesh-list
44242019|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
44242020|NCT00593164|Analgesics|analgesics|mesh-ancestor
44242021|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
44242022|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972014|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43972015|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972017|NCT04826692|Biguanides|biguanides|mesh-list
43972018|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43972019|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972020|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
43972021|NCT04825990|Olaparib|olaparib|mesh-list
43972022|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972023|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972024|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43972025|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972026|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972027|NCT04812626|Triamcinolone|triamcinolone|mesh-list
43972028|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43972029|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43972030|NCT04812626|Fluorouracil|fluorouracil|mesh-list
43972031|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43972032|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
43972033|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972034|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972035|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972036|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972037|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
43972038|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972039|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972040|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
43972041|NCT04812626|Hormones|hormones|mesh-ancestor
43972042|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972043|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972044|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
43972045|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43972046|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972047|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972048|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
43972049|NCT04803747|Coagulants|coagulants|mesh-ancestor
43972050|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
43972051|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43972052|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43871147|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43972053|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972054|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
43972055|NCT04797156|Coagulants|coagulants|mesh-ancestor
44143619|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157530|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44157531|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157532|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
44157533|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157534|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157535|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157536|NCT00234858|Losartan|losartan|mesh-list
44157537|NCT00234858|Verapamil|verapamil|mesh-list
44157538|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44157539|NCT00234858|Trandolapril|trandolapril|mesh-list
44157540|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44157541|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157542|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44157543|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44157544|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157545|NCT00234858|Diuretics|diuretics|mesh-ancestor
44157546|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
44157547|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157548|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44157549|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157550|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157551|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157552|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
44242023|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242024|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
44242025|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157553|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44157554|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157555|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157557|NCT00234871|Amlodipine|amlodipine|mesh-list
44157558|NCT00234871|Benazepril|benazepril|mesh-list
44157559|NCT00234871|Trandolapril|trandolapril|mesh-list
44157560|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157561|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157562|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157563|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157564|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157565|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709607|NCT05271721|Dexamethasone|dexamethasone|mesh-list
43972061|NCT04771481|Metoclopramide|metoclopramide|mesh-list
43972062|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
43972063|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
43972064|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972065|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972066|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972067|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43972068|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43972069|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
43972070|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972071|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972072|NCT04728217|Factor VIII|factor viii|mesh-list
43972073|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
43972074|NCT04728217|Coagulants|coagulants|mesh-ancestor
43972075|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
43972076|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972077|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
43972078|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43972079|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972090|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972091|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972092|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972093|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
43972094|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972095|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972096|NCT04642287|Emollients|emollients|mesh-ancestor
43972097|NCT04639960|Risperidone|risperidone|mesh-list
43972098|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43972099|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
43972100|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972101|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972102|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972103|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43972104|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972105|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972106|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972107|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43972108|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
43972109|NCT04581343|Gemcitabine|gemcitabine|mesh-list
43972110|NCT04581343|Paclitaxel|paclitaxel|mesh-list
43972111|NCT04581343|Spartalizumab|spartalizumab|mesh-list
43972112|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43972113|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972114|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
43972115|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
43972116|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
43972117|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972118|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972119|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
43972120|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
43972121|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972122|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972123|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972124|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
43809890|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
44012899|NCT03717155|Cisplatin|cisplatin|mesh-list
44242026|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242028|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44242029|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972125|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972126|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43972127|NCT04580771|Cisplatin|cisplatin|mesh-list
43972128|NCT04580771|Vaccines|vaccines|mesh-list
43972129|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
43972130|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972131|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972132|NCT04579120|Corticosterone|corticosterone|mesh-list
43972133|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972134|NCT04566016|Anesthetics|anesthetics|mesh-list
43972135|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972136|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972137|NCT04552795|Lamivudine|lamivudine|mesh-list
43972138|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43972139|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43972140|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972141|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972142|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
43972143|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972144|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43972145|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43972146|NCT04514653|Ranibizumab|ranibizumab|mesh-list
43972147|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43972156|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
43972157|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972158|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972159|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972160|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
43972161|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972162|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972163|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972164|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972165|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43972166|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972167|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
43972168|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972169|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43972170|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43972171|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
43972172|NCT04507711|Palonosetron|palonosetron|mesh-list
43972173|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
43972174|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
43972175|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972176|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972177|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972178|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43972179|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43972180|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
43972181|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972182|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972183|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43972184|NCT04504123|Doxycycline|doxycycline|mesh-list
43972185|NCT04504123|Tetracycline|tetracycline|mesh-list
43972186|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972187|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
43972188|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43972189|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43972190|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43972191|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972192|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972193|NCT04499274|Ondansetron|ondansetron|mesh-list
43972194|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
43972195|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
44012967|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
43972196|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972197|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242030|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242031|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44242032|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
43972198|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972199|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
43972200|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972201|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43972202|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
43972203|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972204|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972205|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43972206|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972207|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972208|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972209|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43972210|NCT04471714|Baclofen|baclofen|mesh-list
43972211|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43972212|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972213|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44165292|NCT00259766|Budesonide|budesonide|mesh-list
43972221|NCT04428866|Glucagon|glucagon|mesh-list
43972222|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972223|NCT04428866|Hormones|hormones|mesh-ancestor
43972224|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972225|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972226|NCT04425239|Leucovorin|leucovorin|mesh-list
43972227|NCT04425239|Folic Acid|folic acid|mesh-list
43972228|NCT04425239|Fluorouracil|fluorouracil|mesh-list
43972229|NCT04425239|Irinotecan|irinotecan|mesh-list
43972230|NCT04425239|Panitumumab|panitumumab|mesh-list
43972231|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
43972232|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
43972233|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972234|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972235|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972236|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972237|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
43972238|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972239|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43972240|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43972241|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972243|NCT04425239|Protective Agents|protective agents|mesh-ancestor
43972244|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
43972245|NCT04425239|Vitamins|vitamins|mesh-ancestor
43972246|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
43972247|NCT04425239|Hematinics|hematinics|mesh-ancestor
43972248|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972249|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
43972250|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972251|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972252|NCT04413344|Bromocriptine|bromocriptine|mesh-list
43972253|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43972254|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43972255|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
43972256|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972257|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972258|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
43972259|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
43972260|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972261|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972262|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
43972263|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
43972264|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43972265|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43972266|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972267|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972268|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972269|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972270|NCT04379999|Aspirin|aspirin|mesh-list
43972271|NCT04379999|Atorvastatin|atorvastatin|mesh-list
44013032|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
43972272|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43972273|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43972274|NCT04379999|Analgesics|analgesics|mesh-ancestor
44242033|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972275|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
43972276|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972277|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972278|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972279|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972280|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43972281|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972282|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972283|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43972284|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43972294|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972295|NCT04329221|Calcitriol|calcitriol|mesh-list
43972296|NCT04329221|Fluorouracil|fluorouracil|mesh-list
43972297|NCT04329221|Calcipotriene|calcipotriene|mesh-list
43972298|NCT04329221|Petrolatum|petrolatum|mesh-list
43972299|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
43972300|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972301|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972302|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972303|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972304|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
43972305|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972306|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972307|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43972308|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43972309|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972310|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43972311|NCT04329221|Vitamins|vitamins|mesh-ancestor
43972312|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
43972313|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43972314|NCT04329221|Emollients|emollients|mesh-ancestor
43972315|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
43972316|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43972317|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
43972318|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972319|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972320|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43972321|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
43972322|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43972323|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
43972324|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972325|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972326|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43972327|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
43972328|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
43972329|NCT04292483|Protective Agents|protective agents|mesh-ancestor
44143620|NCT00190411|Celiprolol|celiprolol|mesh-list
44143621|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44143622|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44143623|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
44143624|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
44143625|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143626|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143627|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
44143628|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44143629|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44143630|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44143631|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143632|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143633|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143634|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
44143635|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44143636|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
44143637|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143638|NCT00190437|Amoxicillin|amoxicillin|mesh-list
44143639|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44143640|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143641|NCT00190463|Amphotericin B|amphotericin b|mesh-list
44143642|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44242035|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44242036|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143644|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44143645|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44143646|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143647|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44143648|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
44143649|NCT00190476|Cisplatin|cisplatin|mesh-list
44143650|NCT00190476|Docetaxel|docetaxel|mesh-list
44143651|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143652|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
44143653|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
44143654|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
44143655|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143656|NCT00190489|Docetaxel|docetaxel|mesh-list
43972330|NCT04268771|Rituximab|rituximab|mesh-list
43972331|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972332|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972333|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
43972334|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972335|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972336|NCT04246619|Pregabalin|pregabalin|mesh-list
43972337|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43972338|NCT04246619|Analgesics|analgesics|mesh-ancestor
43972339|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
43972340|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972341|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972342|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
43972343|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43972344|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972345|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972346|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43972347|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43972348|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972349|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972350|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972351|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43972352|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43972353|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972354|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
43972355|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
43972356|NCT04246359|Interferons|interferons|mesh-list
43972357|NCT04246359|Rituximab|rituximab|mesh-list
43972358|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972359|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972360|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
43972361|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972362|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972363|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
43972364|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972365|NCT04196868|Metformin|metformin|mesh-list
43972366|NCT04196868|Methotrexate|methotrexate|mesh-list
43972367|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43972368|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972369|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43972370|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
43972371|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972372|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972373|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
43972374|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972375|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972376|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972377|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972378|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43972379|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972380|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
43972381|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972382|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43972383|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
43972384|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43972385|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242037|NCT00593255|Insulin|insulin|mesh-list
44242038|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44242039|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
44242040|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
44242041|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
44242042|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
44242043|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242044|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242045|NCT00593294|Drospirenone|drospirenone|mesh-list
44242046|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44242047|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242048|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44242049|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
44242050|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242051|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43972386|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972387|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972388|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43972389|NCT04107051|Nalmefene|nalmefene|mesh-list
43972390|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43972398|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972400|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972401|NCT04062097|Vitamin K|vitamin k|mesh-list
43972402|NCT04062097|Dabigatran|dabigatran|mesh-list
43972403|NCT04062097|Vitamins|vitamins|mesh-ancestor
43972404|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
43972405|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972406|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
43972407|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43972408|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
43972409|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972410|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972411|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
43972412|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43972413|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972414|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
43972415|NCT04062097|Coagulants|coagulants|mesh-ancestor
43972416|NCT04007874|Vitamin E|vitamin e|mesh-list
43972417|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
43972418|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43972419|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43972420|NCT04007874|Vitamins|vitamins|mesh-ancestor
43972421|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
43972422|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972423|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
43972424|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972425|NCT04007874|Protective Agents|protective agents|mesh-ancestor
43972426|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43972427|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
43972428|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972429|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43972430|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43972431|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43972432|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43972434|NCT04007874|Hormones|hormones|mesh-ancestor
43972435|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972436|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43972437|NCT04005079|Ofloxacin|ofloxacin|mesh-list
43972438|NCT04005079|Prednisolone|prednisolone|mesh-list
43972439|NCT04005079|Pilocarpine|pilocarpine|mesh-list
43972440|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242056|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44242057|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
44242058|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44242059|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44242060|NCT00593294|Estrogens|estrogens|mesh-ancestor
44242061|NCT00593294|Hormones|hormones|mesh-ancestor
44459465|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44459466|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
44459467|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459468|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459469|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459470|NCT01578551|Metformin|metformin|mesh-list
44459471|NCT01578551|Biguanides|biguanides|mesh-list
44459472|NCT01578551|Paclitaxel|paclitaxel|mesh-list
44459473|NCT01578551|Bevacizumab|bevacizumab|mesh-list
44459474|NCT01578551|Carboplatin|carboplatin|mesh-list
43972441|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
43972442|NCT04005079|Hormones|hormones|mesh-ancestor
43972443|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972444|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972445|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43972446|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972447|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
43972448|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972449|NCT04005079|Miotics|miotics|mesh-ancestor
43972450|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43972451|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43972452|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
43972453|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972454|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972455|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43972456|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972457|NCT04005079|Renal Agents|renal agents|mesh-ancestor
43972458|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972459|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43972473|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43972474|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43972475|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
43972476|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972477|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972478|NCT03924791|Dexamethasone|dexamethasone|mesh-list
43972479|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
43972480|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43972481|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43972482|NCT03924791|Prednisolone|prednisolone|mesh-list
43972483|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
43972484|NCT03924791|Lidocaine|lidocaine|mesh-list
44459475|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44459477|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
43972485|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43972486|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
43972487|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972488|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
43972489|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
43972490|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972491|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972492|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972493|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
43972494|NCT03924791|Hormones|hormones|mesh-ancestor
43972495|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972496|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43972497|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972498|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
43972499|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
43972500|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972501|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
43972502|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43972503|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43972504|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43972505|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972506|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972507|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43972508|NCT03924791|Protective Agents|protective agents|mesh-ancestor
43972509|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
43972510|NCT03899103|Rituximab|rituximab|mesh-list
43972511|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972512|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972513|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
43972514|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972515|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972516|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43972517|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43972518|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
43972519|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972522|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013296|NCT04535713|Docetaxel|docetaxel|mesh-list
43972523|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
43972524|NCT03878472|Apatinib|apatinib|mesh-list
43972525|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972526|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972527|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972528|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972529|NCT03813199|Methotrexate|methotrexate|mesh-list
43972530|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43972531|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
43972532|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972533|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972534|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972535|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
43972536|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972537|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972538|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972539|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972540|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43972541|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972542|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
43972543|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972544|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43972545|NCT03809234|Ondansetron|ondansetron|mesh-list
43972546|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
43972547|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
43972548|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972549|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972550|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972551|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
43972552|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
43972553|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43972554|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
44459478|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
43972555|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972556|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972557|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43972558|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972559|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972560|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972561|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43972562|NCT03804580|Osimertinib|osimertinib|mesh-list
43972563|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972564|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972565|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972566|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972567|NCT03781765|Methylphenidate|methylphenidate|mesh-list
43972568|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43972569|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43972570|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972571|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43972572|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43972573|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972574|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972575|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
43972576|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972577|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43972578|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
43972580|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43972581|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972582|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43972583|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43972584|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972585|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972586|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
43972587|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972588|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
43972589|NCT03718065|Lofexidine|lofexidine|mesh-list
43972590|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43972591|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43972600|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972601|NCT03711188|Nivolumab|nivolumab|mesh-list
43972602|NCT03711188|Ipilimumab|ipilimumab|mesh-list
43972603|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972604|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972605|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43972606|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972607|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
43972608|NCT03684785|Cemiplimab|cemiplimab|mesh-list
43972609|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972610|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972611|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
43972612|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972613|NCT03654833|Bevacizumab|bevacizumab|mesh-list
43972614|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
43972615|NCT03654833|Atezolizumab|atezolizumab|mesh-list
43972616|NCT03654833|Niraparib|niraparib|mesh-list
43972617|NCT03654833|Rucaparib|rucaparib|mesh-list
43972618|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972619|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972620|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43972621|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43972622|NCT03654833|Growth Substances|growth substances|mesh-ancestor
43972623|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972624|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
43972625|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43972626|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972627|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972628|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43972629|NCT03527108|Nivolumab|nivolumab|mesh-list
43972630|NCT03527108|Ramucirumab|ramucirumab|mesh-list
43972631|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972632|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972633|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44242063|NCT00593463|Verapamil|verapamil|mesh-list
44242064|NCT00593463|Diltiazem|diltiazem|mesh-list
44242065|NCT00593463|Isradipine|isradipine|mesh-list
44242066|NCT00593463|Nifedipine|nifedipine|mesh-list
44242067|NCT00593463|Gabapentin|gabapentin|mesh-list
44242068|NCT00593463|Naloxone|naloxone|mesh-list
43972634|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972635|NCT03516305|Alprazolam|alprazolam|mesh-list
43972636|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43972637|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972638|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972639|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43972640|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972641|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972642|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
43972643|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
43972644|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972645|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143657|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143658|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44143659|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44143660|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871148|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
44143661|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143662|NCT00190502|Antibodies|antibodies|mesh-list
44143663|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
44143664|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143665|NCT00190515|Leucovorin|leucovorin|mesh-list
44143666|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
44143667|NCT00190515|Antidotes|antidotes|mesh-ancestor
44143675|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143676|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
44143677|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143678|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143679|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143680|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
44143681|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143682|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143683|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143684|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143685|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143686|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143687|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143688|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143689|NCT00190567|Analgesics|analgesics|mesh-ancestor
44143690|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
44143691|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143692|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143693|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143694|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
44143695|NCT00190580|Valsartan|valsartan|mesh-list
44143696|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
44143697|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44143698|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44143699|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143700|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44143701|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44143702|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
44143703|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143704|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143705|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44143706|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44143707|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44143708|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143709|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143710|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143711|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972646|NCT03499483|Tenofovir|tenofovir|mesh-list
43972647|NCT03499483|Emtricitabine|emtricitabine|mesh-list
44242069|NCT00593463|Analgesics|analgesics|mesh-ancestor
44242070|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
44242071|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972648|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43972649|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
43972650|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972651|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43972652|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43972653|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972654|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972655|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43972656|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43972657|NCT03494530|Edoxaban|edoxaban|mesh-list
43972658|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43972659|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
43972660|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43972661|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
43972662|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972663|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972664|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
43972665|NCT03453489|Tryptophan|tryptophan|mesh-list
43972666|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43972667|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
43972677|NCT03211286|Coagulants|coagulants|mesh-ancestor
43972678|NCT03162510|Paclitaxel|paclitaxel|mesh-list
43972679|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43972680|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
43972681|NCT03162510|Tegafur|tegafur|mesh-list
43972682|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43972683|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972684|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
43972685|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
43972686|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
43972687|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972688|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972689|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
43972690|NCT03162497|Azithromycin|azithromycin|mesh-list
43972691|NCT03162497|Doxycycline|doxycycline|mesh-list
43972692|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972693|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972694|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
43972695|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43972696|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43972697|NCT03161756|Denosumab|denosumab|mesh-list
43972698|NCT03161756|Nivolumab|nivolumab|mesh-list
43972699|NCT03161756|Ipilimumab|ipilimumab|mesh-list
43972700|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972701|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972702|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43972703|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972704|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43972705|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972714|NCT02996760|Mitogens|mitogens|mesh-list
43972715|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
43972716|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972717|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43972718|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972719|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972720|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972721|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972722|NCT02987946|Nadroparin|nadroparin|mesh-list
43972723|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
43972724|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43972725|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972726|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242072|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242073|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
43972727|NCT02969083|Gemcitabine|gemcitabine|mesh-list
43972728|NCT02969083|Cisplatin|cisplatin|mesh-list
43972729|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972730|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972731|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
43972732|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972733|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
43972734|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972742|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972743|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43972744|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972745|NCT02865473|Pilocarpine|pilocarpine|mesh-list
43972747|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
43972748|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972749|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972750|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43972751|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43972752|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
43972753|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972754|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972755|NCT02850419|Doxorubicin|doxorubicin|mesh-list
43972756|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43972757|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43972758|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972759|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43972760|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43972761|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972762|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972763|NCT02841371|Edetic Acid|edetic acid|mesh-list
43972764|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
43972765|NCT02841371|Antidotes|antidotes|mesh-ancestor
43972766|NCT02841371|Protective Agents|protective agents|mesh-ancestor
43972767|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972768|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
43972769|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
43972770|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972771|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43972772|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
43972773|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43972774|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43972775|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972776|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972777|NCT02783859|Amoxicillin|amoxicillin|mesh-list
43972778|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
43972779|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
43972780|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43972781|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972782|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972783|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972784|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972785|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43972786|NCT02652169|Amikacin|amikacin|mesh-list
43972787|NCT02652169|Teicoplanin|teicoplanin|mesh-list
43972788|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972789|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972790|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
43972791|NCT02620865|Leucovorin|leucovorin|mesh-list
43972792|NCT02620865|Folic Acid|folic acid|mesh-list
43972793|NCT02620865|Gemcitabine|gemcitabine|mesh-list
43972794|NCT02620865|Aldesleukin|aldesleukin|mesh-list
43972795|NCT02620865|Paclitaxel|paclitaxel|mesh-list
43972796|NCT02620865|Camptothecin|camptothecin|mesh-list
43972797|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43972798|NCT02620865|Fluorouracil|fluorouracil|mesh-list
43972799|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
43972800|NCT02620865|Irinotecan|irinotecan|mesh-list
43972801|NCT02620865|Interleukin-2|interleukin-2|mesh-list
43972802|NCT02620865|Antibodies|antibodies|mesh-list
43972803|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
43972804|NCT02620865|Sargramostim|sargramostim|mesh-list
43972805|NCT02620865|Calcium|calcium|mesh-list
43972806|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
43972808|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972809|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
43972810|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
44242074|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44242075|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242076|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242077|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242078|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44242079|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44242080|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242081|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242082|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
44242083|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44242084|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44242085|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242086|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44242087|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
43972811|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
43972812|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972813|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
43972814|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972815|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972817|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
43972818|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972819|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972820|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972821|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43972822|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43972823|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43972824|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43972826|NCT02620865|Protective Agents|protective agents|mesh-ancestor
43972827|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
43972829|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
43972830|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43972831|NCT02620865|Analgesics|analgesics|mesh-ancestor
43972832|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
43972833|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972834|NCT02620865|Hematinics|hematinics|mesh-ancestor
43972835|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43972836|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43972837|NCT02585375|Latanoprost|latanoprost|mesh-list
43972838|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43972839|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43972840|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
43972841|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972842|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
43972843|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972844|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972845|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43972846|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
43972847|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972848|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972849|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43972850|NCT02516813|Cisplatin|cisplatin|mesh-list
43972851|NCT02516813|Peposertib|peposertib|mesh-list
43972852|NCT02516813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972853|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972854|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972855|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972856|NCT02478775|Cetrorelix|cetrorelix|mesh-list
43972857|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44242088|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
44242089|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44242090|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43972858|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
43972859|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43972860|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972861|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
43972862|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972863|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
43972864|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972865|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972866|NCT02394132|Imiquimod|imiquimod|mesh-list
43972867|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43972868|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
43972869|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972870|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972871|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
43972872|NCT02392871|Trametinib|trametinib|mesh-list
43972873|NCT02392871|Dabrafenib|dabrafenib|mesh-list
43972874|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972875|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43972876|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157566|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
43972877|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972879|NCT02382575|Tacrolimus|tacrolimus|mesh-list
43972880|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43972881|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972886|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972888|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972889|NCT02239874|Vitamin D|vitamin d|mesh-list
43972890|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
43972891|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
43972892|NCT02239874|Vitamins|vitamins|mesh-list
43972893|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
43972894|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972895|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43972896|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43972897|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43972898|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43972899|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972901|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
43972902|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43972903|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43972904|NCT02115997|Prednisolone|prednisolone|mesh-list
44013689|NCT02849457|Vigabatrin|vigabatrin|mesh-list
43972905|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
43972906|NCT02115997|Rituximab|rituximab|mesh-list
43972907|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43972908|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
43972909|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972910|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972911|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
43972912|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972913|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972914|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43972915|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
43972916|NCT02115997|Hormones|hormones|mesh-ancestor
43972917|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43972918|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43972919|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
43972920|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
43972921|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972922|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43972923|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43972924|NCT02115997|Protective Agents|protective agents|mesh-ancestor
44143712|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143713|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143714|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143715|NCT00190606|Analgesics|analgesics|mesh-ancestor
44143716|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
44143717|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143718|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143719|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242091|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242092|NCT00593463|Renal Agents|renal agents|mesh-ancestor
44242093|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44242094|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
44242095|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242096|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
44242097|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44143720|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
44143721|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143722|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143723|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143724|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143725|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143726|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143727|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143728|NCT00190619|Analgesics|analgesics|mesh-ancestor
44143729|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
44143730|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143731|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143732|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143733|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
44143734|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143735|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143736|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43972925|NCT01746238|Bevacizumab|bevacizumab|mesh-list
43972926|NCT01746238|Doxorubicin|doxorubicin|mesh-list
43972934|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43972935|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43972936|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43972937|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972938|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972939|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
43972940|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43972941|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972943|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
43972944|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
43972945|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972946|NCT01420874|Leucovorin|leucovorin|mesh-list
43972947|NCT01420874|Fluorouracil|fluorouracil|mesh-list
43972948|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
43972949|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
43972950|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972951|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43972952|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972953|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972954|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
43972955|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972956|NCT01420874|Antidotes|antidotes|mesh-ancestor
43972957|NCT01420874|Protective Agents|protective agents|mesh-ancestor
43972958|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
43972959|NCT01420874|Vitamins|vitamins|mesh-ancestor
43972960|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
43972961|NCT01312922|Dexetimide|dexetimide|mesh-list
43972962|NCT01312922|Pipamperone|pipamperone|mesh-list
43972963|NCT01312922|Citalopram|citalopram|mesh-list
43972964|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43972965|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43972966|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43972967|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972968|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972969|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
43972970|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972971|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43972972|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
43972973|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242098|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44242099|NCT00593502|Oseltamivir|oseltamivir|mesh-list
44242100|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
44242101|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242102|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972974|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43972975|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43972976|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
43972977|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
43972978|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972979|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43972980|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43972981|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
43972982|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43972983|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43972984|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43972985|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972986|NCT01091831|Dexamethasone|dexamethasone|mesh-list
43972987|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
43972988|NCT01091831|Melphalan|melphalan|mesh-list
43972989|NCT01091831|Lenalidomide|lenalidomide|mesh-list
43972990|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972991|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
43972992|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972993|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972994|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43973002|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973003|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973004|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
43973006|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973007|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43973008|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43973009|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43973010|NCT01091831|Growth Substances|growth substances|mesh-ancestor
43973011|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
43973012|NCT00700596|Salvinorin A|salvinorin a|mesh-list
43973013|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
43973014|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973015|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973016|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43973017|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43973018|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43973019|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973020|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973021|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43973022|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973023|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973024|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013794|NCT03181009|Omalizumab|omalizumab|mesh-list
43973025|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973026|NCT01733472|Remifentanil|remifentanil|mesh-list
43973027|NCT01733472|Propofol|propofol|mesh-list
43973028|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43973029|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973030|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973031|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43973032|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
43973033|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
43973034|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43973035|NCT01733472|Narcotics|narcotics|mesh-ancestor
43973036|NCT01733472|Analgesics|analgesics|mesh-ancestor
43973037|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
43973038|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973039|NCT01733745|Vitamins|vitamins|mesh-list
43973040|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43973041|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
43973042|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973043|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43973044|NCT01733953|Atorvastatin|atorvastatin|mesh-list
43973045|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43973046|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43973047|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
43973048|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242103|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242104|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
43973049|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43973050|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43973051|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973052|NCT01734161|Dexamethasone|dexamethasone|mesh-list
43973053|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973054|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
43973055|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
43973056|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973057|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973058|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973059|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
43973061|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165293|NCT00259766|Terbutaline|terbutaline|mesh-list
43973068|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
43973069|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973070|NCT01734551|Clonidine|clonidine|mesh-list
43973071|NCT01734551|Morphine|morphine|mesh-list
43973072|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43973073|NCT01734551|Narcotics|narcotics|mesh-ancestor
43973074|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973075|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710475|NCT02696694|Progesterone|progesterone|mesh-list
43973077|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
43973078|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973079|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973080|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
43973081|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
43973082|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43973083|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43973084|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43973085|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973086|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973087|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973088|NCT01734889|Nitisinone|nitisinone|mesh-list
43973089|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973090|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973091|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
43973092|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973093|NCT01736085|Nicotine|nicotine|mesh-list
43973094|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43973095|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
43973096|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973097|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973098|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43973099|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43973100|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973101|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973102|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973103|NCT01736358|Ketorolac|ketorolac|mesh-list
43973104|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43973105|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973106|NCT01736358|Analgesics|analgesics|mesh-ancestor
43973107|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
43973108|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973109|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973110|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973111|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973112|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43973113|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973114|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973115|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43973116|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43973117|NCT01736852|Oxytocin|oxytocin|mesh-list
43973118|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
43973119|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973120|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973121|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
43973122|NCT01736865|Vitamin D|vitamin d|mesh-list
43973123|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43973124|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242105|NCT00593580|Vitamin D|vitamin d|mesh-list
44242106|NCT00593580|Alendronate|alendronate|mesh-list
43973125|NCT01736865|Vitamins|vitamins|mesh-ancestor
43973126|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
43973127|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43973128|NCT01736943|Doxorubicin|doxorubicin|mesh-list
43973129|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43973130|NCT01736943|Bortezomib|bortezomib|mesh-list
43973131|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43973138|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973139|NCT01737593|Analgesics|analgesics|mesh-ancestor
43973140|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
43973141|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973142|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973143|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
43973144|NCT01737944|Methotrexate|methotrexate|mesh-list
43973145|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43973146|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
43973147|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973148|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973149|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973150|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
43973151|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973152|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973153|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973154|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973155|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43973156|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973157|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
43973158|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973159|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43973160|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
43973161|NCT01738672|Entonox|entonox|mesh-list
43973162|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43973163|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
43973164|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
43973165|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973166|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973167|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973168|NCT01738672|Analgesics|analgesics|mesh-ancestor
43973169|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
43973170|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973171|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43973172|NCT01739361|Acetaminophen|acetaminophen|mesh-list
43973173|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973174|NCT01739361|Analgesics|analgesics|mesh-ancestor
43973175|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
43973176|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973177|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973178|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
43973179|NCT01739699|Acetaminophen|acetaminophen|mesh-list
43973180|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973181|NCT01739699|Analgesics|analgesics|mesh-ancestor
43973182|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
43973183|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973184|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973185|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
43973186|NCT01740206|Methylphenidate|methylphenidate|mesh-list
43973187|NCT01740206|Amphetamine|amphetamine|mesh-list
43973188|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43973189|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973190|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43973191|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43973192|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973193|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973194|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
43973195|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973196|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
43973197|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
43973198|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973199|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973200|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43973201|NCT01740258|Bevacizumab|bevacizumab|mesh-list
43973202|NCT01740258|Temozolomide|temozolomide|mesh-list
44242107|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44242108|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973203|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43973204|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973205|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43973206|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43973207|NCT01740258|Growth Substances|growth substances|mesh-ancestor
43973208|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973209|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
43973210|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43973211|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
43973212|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973213|NCT01740362|Tofacitinib|tofacitinib|mesh-list
43973214|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43973215|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973216|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973217|NCT01740414|Ibudilast|ibudilast|mesh-list
43973218|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43973219|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
43973220|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973221|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973222|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43973223|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
43973224|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43973225|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973226|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973227|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43973228|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
43973229|NCT01740713|Deferiprone|deferiprone|mesh-list
43973230|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43973231|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
43973232|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
43973233|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973234|NCT01740726|Fluoxetine|fluoxetine|mesh-list
43973235|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43973236|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43973237|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973238|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973239|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973240|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
43973241|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973242|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43973243|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
43973244|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973245|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43973246|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43973247|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973248|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43973249|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43973250|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43973251|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43973252|NCT01741454|Tamsulosin|tamsulosin|mesh-list
43973253|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43973254|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43973255|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43973256|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43973257|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973258|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973259|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973260|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973261|NCT01741454|Urological Agents|urological agents|mesh-ancestor
43973262|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43973263|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43973264|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973265|NCT01742117|Clopidogrel|clopidogrel|mesh-list
43973266|NCT01742117|Ticagrelor|ticagrelor|mesh-list
43973267|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43973268|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44242109|NCT00593580|Vitamins|vitamins|mesh-ancestor
44242110|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
43973269|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43973270|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43973271|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
43973272|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973283|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43973284|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973285|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973286|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973287|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
43973288|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973289|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43973290|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
43973291|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973292|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43973293|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43973294|NCT01743131|Abatacept|abatacept|mesh-list
43973295|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43973296|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973297|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973298|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973299|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
43973300|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973301|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973302|NCT01743521|Ribavirin|ribavirin|mesh-list
43973303|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
43973304|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973305|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
43973306|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973307|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
43973308|NCT01743677|Tofacitinib|tofacitinib|mesh-list
43973309|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973310|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973311|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43973312|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43973313|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973314|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973315|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973316|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43973317|NCT01743729|Lifitegrast|lifitegrast|mesh-list
43973318|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43973319|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43973320|NCT01743859|Lenalidomide|lenalidomide|mesh-list
43973321|NCT01743859|Azacitidine|azacitidine|mesh-list
43973322|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
43973323|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973324|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43973325|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43973326|NCT01743859|Growth Substances|growth substances|mesh-ancestor
43973327|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
43973328|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973329|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973330|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
44165294|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
43973336|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973337|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973338|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973339|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973340|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
43973341|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
43973342|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43973343|NCT01744353|Paclitaxel|paclitaxel|mesh-list
43973344|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973345|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973346|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43973347|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
43973348|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
43973349|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242111|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44242112|NCT00593619|Iron|iron|mesh-list
44242113|NCT00593619|Dextrans|dextrans|mesh-list
44242114|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44242115|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
44242116|NCT00593619|Trace Elements|trace elements|mesh-ancestor
44242117|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
44242118|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242119|NCT00593619|Hematinics|hematinics|mesh-ancestor
44242120|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
44242121|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
44242122|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
44242123|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
43973350|NCT01744574|Progesterone|progesterone|mesh-list
43973351|NCT01744574|Progestins|progestins|mesh-ancestor
43973352|NCT01744574|Hormones|hormones|mesh-ancestor
43973353|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973354|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973355|NCT01744704|Mitogens|mitogens|mesh-list
43973356|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
43973357|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973358|NCT01744730|Clindamycin|clindamycin|mesh-list
43973359|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
43973360|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
43973361|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973362|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973363|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43973364|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973365|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973366|NCT01744821|Vitamin D|vitamin d|mesh-list
43973367|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
43973368|NCT01744821|Vitamins|vitamins|mesh-ancestor
43973369|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
43973370|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973371|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43973372|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44143737|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143738|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143739|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143740|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143741|NCT00190632|Analgesics|analgesics|mesh-ancestor
44143742|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
44143743|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143744|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143745|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143746|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
44143747|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143748|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143749|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143750|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143751|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143752|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143753|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143754|NCT00190645|Analgesics|analgesics|mesh-ancestor
44143755|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
44143756|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143757|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143758|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143759|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
44143760|NCT00190710|Gemcitabine|gemcitabine|mesh-list
44143761|NCT00190710|Carboplatin|carboplatin|mesh-list
44143762|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143771|NCT00190710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143772|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44242124|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44242125|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242126|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713655|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
44143773|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143774|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143775|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143776|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143777|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143778|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143779|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143780|NCT00190762|Pemetrexed|pemetrexed|mesh-list
44143781|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143782|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143783|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143784|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44143785|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143786|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44143787|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143788|NCT00190801|Cisplatin|cisplatin|mesh-list
44143789|NCT00190801|Pemetrexed|pemetrexed|mesh-list
44143790|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143791|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143792|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143793|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44143794|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143795|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143796|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143797|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143798|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143799|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143800|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143801|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143802|NCT00190814|Analgesics|analgesics|mesh-ancestor
43973373|NCT01745055|Methotrexate|methotrexate|mesh-list
43973374|NCT01745055|Tofacitinib|tofacitinib|mesh-list
43973375|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43973376|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
43973377|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973378|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973379|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973380|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
43973381|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973382|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973383|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973384|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973385|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43973386|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973387|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
43973388|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973389|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43973390|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43973391|NCT01745133|Calcitriol|calcitriol|mesh-list
43973392|NCT01745133|Clobetasol|clobetasol|mesh-list
43973393|NCT01745133|Calcipotriene|calcipotriene|mesh-list
43973394|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973395|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
43973396|NCT01745133|Hormones|hormones|mesh-ancestor
43973398|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973399|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973400|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43973401|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43973402|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973403|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973404|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43973405|NCT01745133|Vitamins|vitamins|mesh-ancestor
43973406|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
43973407|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44242127|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44242128|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43973408|NCT01745822|Tenofovir|tenofovir|mesh-list
43973409|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
43973410|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973411|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43973412|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43973413|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973414|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973415|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43973416|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43973417|NCT01746043|Minocycline|minocycline|mesh-list
43973418|NCT01746043|Modafinil|modafinil|mesh-list
43973419|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973420|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973421|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43973422|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973423|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43973424|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43973425|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43973426|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973427|NCT01746095|Vancomycin|vancomycin|mesh-list
43973428|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973429|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973430|NCT01746264|Vitamin D|vitamin d|mesh-list
43973431|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
43973432|NCT01746264|Vitamins|vitamins|mesh-ancestor
43973433|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
43973434|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973435|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43973436|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43973437|NCT01746420|Becaplermin|becaplermin|mesh-list
43973438|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
43973439|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
43973440|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43973441|NCT01746420|Growth Substances|growth substances|mesh-ancestor
43973442|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973443|NCT01746511|Glycerol|glycerol|mesh-list
43973444|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43973445|NCT01746511|Protective Agents|protective agents|mesh-ancestor
43973446|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973447|NCT01746940|Cocaine|cocaine|mesh-list
43973448|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43973450|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
43973451|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973452|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973453|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
43973454|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973455|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43973456|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43973457|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43973458|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973459|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973460|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
43973461|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973462|NCT01746979|Gemcitabine|gemcitabine|mesh-list
43973463|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973464|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
43973465|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973466|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973467|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
43973468|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973469|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973472|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973474|NCT01747330|Pancrelipase|pancrelipase|mesh-list
43973475|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973476|NCT01747850|Ethanol|ethanol|mesh-list
43973477|NCT01747850|Nabiximols|nabiximols|mesh-list
43973478|NCT01747850|Dronabinol|dronabinol|mesh-list
43973479|NCT01747850|Cannabidiol|cannabidiol|mesh-list
43973480|NCT01747850|Peppermint oil|peppermint oil|mesh-list
43973481|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43973482|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242129|NCT00593658|Protective Agents|protective agents|mesh-ancestor
43713845|NCT02673463|Spironolactone|spironolactone|mesh-list
43973483|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973484|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973485|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
43973486|NCT01747850|Analgesics|analgesics|mesh-ancestor
43973487|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
43973488|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973489|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
43973490|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973491|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973492|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43973493|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43973494|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973495|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973496|NCT01747850|Hormones|hormones|mesh-ancestor
43973497|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973498|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
43973499|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
43973500|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973501|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
43973502|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
43973503|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43973504|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
43973505|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973506|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973507|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43973508|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
43973509|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43973510|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
43973511|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973512|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973513|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43973514|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
43973515|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
43973516|NCT01748045|Protective Agents|protective agents|mesh-ancestor
43973517|NCT01748240|Azacitidine|azacitidine|mesh-list
43973518|NCT01748240|Vorinostat|vorinostat|mesh-list
43973519|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973520|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
43973521|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710816|NCT02694809|Hormones|hormones|mesh-ancestor
43973522|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973523|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973524|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43973525|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
43973526|NCT01748643|Rocuronium|rocuronium|mesh-list
43973527|NCT01748643|Neostigmine|neostigmine|mesh-list
43973528|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43973529|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43973530|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43973531|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973532|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973533|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43973534|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973535|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973536|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973537|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973538|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43973539|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
43973540|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43973541|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43973542|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43973550|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973551|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973552|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
43973553|NCT01748799|Analgesics|analgesics|mesh-ancestor
43973554|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
43973555|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973556|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
43973557|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973558|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973559|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44242130|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242131|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
44242132|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44242133|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
44242134|NCT00593697|Docetaxel|docetaxel|mesh-list
44242135|NCT00593697|Trastuzumab|trastuzumab|mesh-list
44242136|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242137|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44242138|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44242139|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242140|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242141|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242142|NCT00593710|Losartan|losartan|mesh-list
44242143|NCT00593710|Atenolol|atenolol|mesh-list
44242144|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242145|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973560|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43973561|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973562|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973563|NCT01748799|Hormones|hormones|mesh-ancestor
43973564|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973565|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
43973566|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
43973567|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973568|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
43973569|NCT01748942|Dexamethasone|dexamethasone|mesh-list
43973570|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
43973571|NCT01748942|Ichthammol|ichthammol|mesh-list
43973572|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43973573|NCT01748942|BB 1101|bb 1101|mesh-list
43973574|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973575|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
43973576|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
43973577|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973578|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973579|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973580|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
43973581|NCT01748942|Hormones|hormones|mesh-ancestor
43973582|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973583|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43973584|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973585|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
43973586|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973587|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973588|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973589|NCT01748955|Bupropion|bupropion|mesh-list
43973590|NCT01748955|Paroxetine|paroxetine|mesh-list
43973591|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43973592|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
43973593|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973594|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43973595|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43973596|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973597|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973598|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
43973599|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973600|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973601|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43973602|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44242146|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44242147|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43973603|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973604|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43973605|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
43973606|NCT01749215|Topiramate|topiramate|mesh-list
43973607|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
43973608|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43973609|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973610|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
43973611|NCT01749293|Busulfan|busulfan|mesh-list
43973612|NCT01749293|Fludarabine|fludarabine|mesh-list
43973613|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973614|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
43973620|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973621|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43973622|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
43973623|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43973624|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43973625|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43973626|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973627|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973628|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973629|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973630|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973631|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43973632|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973634|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43973635|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43973636|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43973637|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973638|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973639|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
43973640|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
43973641|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973642|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973643|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43973644|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43973645|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973646|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973647|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973648|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43973649|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43973650|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43973651|NCT01749605|Renal Agents|renal agents|mesh-ancestor
43973652|NCT01749904|Timolol|timolol|mesh-list
43973653|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43973654|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44014483|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
43973655|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973656|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973657|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973658|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973659|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43973660|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973661|NCT01749930|Timolol|timolol|mesh-list
43973662|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43973663|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43973664|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973665|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973666|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973667|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973668|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43973669|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973670|NCT01749956|Leucovorin|leucovorin|mesh-list
43973671|NCT01749956|Fluorouracil|fluorouracil|mesh-list
43973672|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
43973673|NCT01749956|Aflibercept|aflibercept|mesh-list
43973674|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
43973675|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973676|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973677|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973678|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242148|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242149|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
44242150|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
43973679|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
43973680|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973681|NCT01749956|Antidotes|antidotes|mesh-ancestor
43973682|NCT01749956|Protective Agents|protective agents|mesh-ancestor
43973683|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
43973684|NCT01749956|Vitamins|vitamins|mesh-ancestor
43973685|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
43973686|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43973687|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43973688|NCT01749956|Growth Substances|growth substances|mesh-ancestor
43973689|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
43973690|NCT01750086|Denosumab|denosumab|mesh-list
43973691|NCT01750086|Alendronate|alendronate|mesh-list
43973692|NCT01750086|Teriparatide|teriparatide|mesh-list
43973693|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43973694|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973695|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43973696|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
43973697|NCT01750398|Leuprolide|leuprolide|mesh-list
43973698|NCT01750398|Goserelin|goserelin|mesh-list
43973699|NCT01750398|Testosterone|testosterone|mesh-list
43973700|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
43973701|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
43973702|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43973703|NCT01750398|Androgens|androgens|mesh-ancestor
43973704|NCT01750398|Hormones|hormones|mesh-ancestor
43973705|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973706|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973707|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43973708|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973709|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
43973710|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43973711|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
43973712|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973713|NCT01750931|Meloxicam|meloxicam|mesh-list
43973714|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43973715|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973716|NCT01750931|Analgesics|analgesics|mesh-ancestor
43973717|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
43973718|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973719|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973720|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973721|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973722|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43973723|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43973724|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973725|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973726|NCT01751386|Baclofen|baclofen|mesh-list
43973727|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43973728|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973729|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43973730|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973731|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43973732|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
43973733|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
43973734|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973735|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973736|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
43973737|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973738|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43973739|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973740|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973741|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
43973742|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973743|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973744|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43711000|NCT02692599|Vaccines|vaccines|mesh-list
44242151|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242152|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973745|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
43973746|NCT01752413|Hematinics|hematinics|mesh-ancestor
43973747|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
43973748|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973749|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43973750|NCT01752426|Protective Agents|protective agents|mesh-ancestor
43973751|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973753|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
43973754|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973755|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973756|NCT01753362|Liraglutide|liraglutide|mesh-list
43973757|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43973766|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973767|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
43973768|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43973769|NCT01754389|Sirolimus|sirolimus|mesh-list
43973770|NCT01754389|Methotrexate|methotrexate|mesh-list
43973771|NCT01754389|Bortezomib|bortezomib|mesh-list
43973772|NCT01754389|Tacrolimus|tacrolimus|mesh-list
43973773|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43973774|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
43973775|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43973776|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973777|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973778|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
43973779|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973780|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973781|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973782|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973783|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43973784|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973785|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
43973786|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014618|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
43973787|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43973788|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43973789|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43973790|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973791|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43973792|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
43973793|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43973794|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
43973795|NCT01754480|Coagulants|coagulants|mesh-ancestor
43973796|NCT01754623|Gemcitabine|gemcitabine|mesh-list
43973797|NCT01754623|Fluorouracil|fluorouracil|mesh-list
43973798|NCT01754623|Capecitabine|capecitabine|mesh-list
43973799|NCT01754623|Docetaxel|docetaxel|mesh-list
43973800|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43973801|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
43973802|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973803|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973804|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
43973805|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973806|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973807|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973808|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
43973809|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973810|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
43973811|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
43973812|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
43973813|NCT01754909|Enalapril|enalapril|mesh-list
43973814|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43973815|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
43973816|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973817|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973818|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973819|NCT01755169|Ketamine|ketamine|mesh-list
43973820|NCT01755169|Analgesics|analgesics|mesh-ancestor
43973821|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
43973822|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973823|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973824|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43973825|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43973826|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
43973832|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973833|NCT01755949|Colchicine|colchicine|mesh-list
43973834|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
43973835|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973836|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
43973837|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
43973838|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
43973839|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973840|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973841|NCT01756209|Acetaminophen|acetaminophen|mesh-list
43973842|NCT01756209|Ibuprofen|ibuprofen|mesh-list
43973843|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973844|NCT01756209|Analgesics|analgesics|mesh-ancestor
43973845|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
43973846|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973847|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973848|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
43973849|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43973850|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973851|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973852|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43973853|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973854|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973855|NCT01756885|Varenicline|varenicline|mesh-list
43973856|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43973857|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43973858|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
43973859|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973860|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973861|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973863|NCT01757561|Sevoflurane|sevoflurane|mesh-list
43973864|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43973865|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973866|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973867|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43973868|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
43973869|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
43973870|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43973871|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43973872|NCT01758432|Apixaban|apixaban|mesh-list
43973873|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43973874|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
43973875|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43973876|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
43973877|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973878|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973879|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
43973880|NCT01758588|Interferons|interferons|mesh-list
43973881|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
43973882|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43973883|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973884|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
43973885|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973886|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
43973887|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973888|NCT01759277|Anesthetics|anesthetics|mesh-list
43973889|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
43973890|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973891|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973892|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
43973893|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973894|NCT01759602|Complement C1s|complement c1s|mesh-list
43973895|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43973896|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43973897|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
43973898|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973904|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43973905|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
43973906|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973907|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973908|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43973909|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43973910|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
43973911|NCT01760304|Hormones|hormones|mesh-ancestor
44242153|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44242154|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43714219|NCT02670434|Pitavastatin|pitavastatin|mesh-list
43973912|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973913|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43973914|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43973915|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43973916|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
43973917|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973918|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973919|NCT01760785|Valproic Acid|valproic acid|mesh-list
43973920|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
43973922|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973923|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
43973924|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973925|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973926|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
43973927|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43973928|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973929|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43973930|NCT01761747|Ponatinib|ponatinib|mesh-list
43973931|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973932|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43973933|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973934|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973935|NCT01762059|Pancrelipase|pancrelipase|mesh-list
43973936|NCT01762059|Pancreatin|pancreatin|mesh-list
43973937|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43973938|NCT01762501|Amlodipine|amlodipine|mesh-list
43973939|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43973940|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43973941|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43973942|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43973943|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973944|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43973945|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973946|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
43973947|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43973948|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44143803|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
44143804|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143805|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143806|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143807|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
44143808|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143809|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143810|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143811|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143812|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143813|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143814|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143815|NCT00190827|Analgesics|analgesics|mesh-ancestor
44143816|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
44143817|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143818|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143819|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143820|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
44143821|NCT00190840|Pemetrexed|pemetrexed|mesh-list
43973951|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43973953|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43973954|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973955|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973956|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973957|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
43973958|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
43973959|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43973960|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43973961|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
43973962|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242156|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
44242157|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973963|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43973964|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43973965|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43973966|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973967|NCT01763346|Metformin|metformin|mesh-list
43973968|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43973969|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973970|NCT01763606|Aspirin|aspirin|mesh-list
43973971|NCT01763606|Enoxaparin|enoxaparin|mesh-list
43973972|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43973973|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43973974|NCT01763606|Analgesics|analgesics|mesh-ancestor
43973975|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
43973976|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43973977|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973978|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973979|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973980|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43973981|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43973982|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973983|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43973984|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43973985|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973986|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
43973987|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
43973989|NCT01763645|Bevacizumab|bevacizumab|mesh-list
43973990|NCT01763645|Carboplatin|carboplatin|mesh-list
43973991|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43973992|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973993|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
43973994|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
43973995|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
43973996|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973997|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43973998|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43973999|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974000|NCT01763645|Growth Substances|growth substances|mesh-ancestor
43974001|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974002|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974003|NCT01763931|Digoxin|digoxin|mesh-list
43974004|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43974005|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43974006|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974007|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974008|NCT01763931|Protective Agents|protective agents|mesh-ancestor
43974009|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974010|NCT01764607|Sirolimus|sirolimus|mesh-list
43974011|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974012|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974013|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43974014|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974015|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
43974016|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974017|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
43974023|NCT01765803|Thioridazine|thioridazine|mesh-list
43974024|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43974025|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43974026|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974027|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974028|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974029|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43974030|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
43974031|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974032|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974034|NCT01766024|Interferon-beta|interferon-beta|mesh-list
43974035|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
43974036|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974037|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
43974038|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974039|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
44242159|NCT00593801|Hematinics|hematinics|mesh-ancestor
43974040|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974041|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43974042|NCT01766076|Atorvastatin|atorvastatin|mesh-list
43974043|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43974044|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43974045|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
43974046|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974047|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43974048|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43974050|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
43974051|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
43974052|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974053|NCT01766219|Protective Agents|protective agents|mesh-ancestor
43974054|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974055|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
43974056|NCT01766219|Vitamins|vitamins|mesh-ancestor
43974057|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
43974058|NCT01766440|Calcitriol|calcitriol|mesh-list
43974059|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43974060|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974061|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43974062|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974063|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974064|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43974065|NCT01766440|Vitamins|vitamins|mesh-ancestor
43974066|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
43974067|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43974068|NCT01766466|Ticagrelor|ticagrelor|mesh-list
43974069|NCT01766466|Cangrelor|cangrelor|mesh-list
43974070|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44014856|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
43974071|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43974072|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43974073|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43974074|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
43974075|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974076|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974077|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974078|NCT01766713|Ezetimibe|ezetimibe|mesh-list
43974079|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43974080|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43974081|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
43974082|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974083|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43974084|NCT01767103|Deferiprone|deferiprone|mesh-list
43974085|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43974086|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
43974087|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
43974088|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974089|NCT01767155|Doxorubicin|doxorubicin|mesh-list
43974094|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43974095|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974096|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974097|NCT01767285|Etonogestrel|etonogestrel|mesh-list
43974098|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43974099|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
43974100|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974101|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974102|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43974103|NCT01767506|Azithromycin|azithromycin|mesh-list
43974104|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974105|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974106|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
43974107|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43974108|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43974109|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
43974110|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974111|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43974112|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43974113|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974114|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974115|NCT01767792|Bevacizumab|bevacizumab|mesh-list
44242160|NCT00593853|Methylphenidate|methylphenidate|mesh-list
44242161|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43974116|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
43974117|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43974118|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974119|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974120|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974121|NCT01767792|Growth Substances|growth substances|mesh-ancestor
43974122|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974123|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974124|NCT01768520|Celecoxib|celecoxib|mesh-list
43974125|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974126|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974127|NCT01768520|Analgesics|analgesics|mesh-ancestor
43974128|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
43974129|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974130|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974131|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974132|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974133|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43974134|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974135|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974136|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974137|NCT01769170|Cidofovir|cidofovir|mesh-list
43974138|NCT01769170|Brincidofovir|brincidofovir|mesh-list
43974139|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
43974140|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974141|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974142|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974143|NCT01769209|Cytarabine|cytarabine|mesh-list
43974144|NCT01769209|Dexamethasone|dexamethasone|mesh-list
43974145|NCT01769209|Doxorubicin|doxorubicin|mesh-list
43974146|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43974147|NCT01769209|Methotrexate|methotrexate|mesh-list
43974148|NCT01769209|Vincristine|vincristine|mesh-list
43974149|NCT01769209|Bortezomib|bortezomib|mesh-list
43974150|NCT01769209|Asparaginase|asparaginase|mesh-list
43974151|NCT01769209|Pegaspargase|pegaspargase|mesh-list
43974152|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974153|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
43974154|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
43974155|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974156|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974157|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974158|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
43974159|NCT01769209|Hormones|hormones|mesh-ancestor
43974160|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974161|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974164|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43974165|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43974166|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974167|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974168|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43974169|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
43974170|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974171|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974172|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
43974173|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974174|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43974175|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974176|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
43974177|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974178|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43974179|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
43974180|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974181|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43974182|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
43974183|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
43974184|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
43974185|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43974186|NCT01769222|Ipilimumab|ipilimumab|mesh-list
43974187|NCT01769222|Antibodies|antibodies|mesh-list
43974188|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
44242162|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242163|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43974190|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
43974191|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974192|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974193|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43974194|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974195|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
43974196|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974197|NCT01769365|Amoxicillin|amoxicillin|mesh-list
43974198|NCT01769365|Metronidazole|metronidazole|mesh-list
43974199|NCT01769365|Clarithromycin|clarithromycin|mesh-list
43974200|NCT01769365|Pantoprazole|pantoprazole|mesh-list
43974201|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974202|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974203|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43974204|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43974205|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43974206|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974207|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974208|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43974209|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43974210|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43974211|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974212|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43974213|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
43974214|NCT01769586|Promethazine|promethazine|mesh-list
43974216|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43974217|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43974218|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974219|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974220|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43974221|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43974222|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974223|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43974224|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
43974225|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
43974226|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
43974227|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
43974228|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974229|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974230|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43974231|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
43974232|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
43974233|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974234|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
43974235|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
43974238|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
43974239|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
43974240|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43974241|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
43974242|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974244|NCT01770483|Ribavirin|ribavirin|mesh-list
43974245|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
43974246|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
43974247|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974248|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
43974249|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974250|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
43974251|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974252|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
43974253|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974254|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43974255|NCT01770652|Deferiprone|deferiprone|mesh-list
43974256|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43974257|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
43974258|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
43974259|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974260|NCT01771627|Nicotine|nicotine|mesh-list
43974261|NCT01771627|Varenicline|varenicline|mesh-list
43974262|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43974263|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
44242164|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44242165|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974264|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974265|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974266|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43974267|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43974268|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
43974269|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974270|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974271|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
43974272|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43974273|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974274|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
43974275|NCT01771952|Hylan|hylan|mesh-list
43974276|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43974277|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
43974278|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974279|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
43974280|NCT01771952|Protective Agents|protective agents|mesh-ancestor
43974281|NCT01772758|Antioxidants|antioxidants|mesh-list
43974282|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974283|NCT01772758|Protective Agents|protective agents|mesh-ancestor
43974284|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974285|NCT01773954|Aflibercept|aflibercept|mesh-list
43974286|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974287|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974288|NCT01773954|Growth Substances|growth substances|mesh-ancestor
43974289|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974290|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974291|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974292|NCT01774149|Diazepam|diazepam|mesh-list
43974293|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43974294|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
43974295|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
43974296|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
43974297|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974298|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974299|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974300|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43974301|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974302|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43974303|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43974304|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43974305|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43974306|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974307|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43974308|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
43974309|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
43974310|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
43974311|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
43974312|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974313|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974314|NCT01774604|Indomethacin|indomethacin|mesh-list
43974315|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974316|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974317|NCT01774604|Analgesics|analgesics|mesh-ancestor
43974318|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
43974319|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974320|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974321|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974322|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974323|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
43974324|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
43974325|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974326|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974327|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974328|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974329|NCT01774851|Paclitaxel|paclitaxel|mesh-list
43974330|NCT01774851|Trastuzumab|trastuzumab|mesh-list
43974331|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43974332|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974333|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
43974334|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
44242166|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974335|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
43974336|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974337|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43974338|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43974339|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
43974340|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974341|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974342|NCT01775865|Analgesics|analgesics|mesh-ancestor
43974343|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
43974344|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974345|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974346|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974347|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974348|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974349|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974350|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974351|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
43974352|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43974353|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43974354|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
43974355|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974356|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974357|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974358|NCT01777217|Urological Agents|urological agents|mesh-ancestor
43974359|NCT01777412|Bevacizumab|bevacizumab|mesh-list
43974360|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43974361|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974362|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974363|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974364|NCT01777412|Growth Substances|growth substances|mesh-ancestor
43974365|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974366|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974367|NCT01777945|Docetaxel|docetaxel|mesh-list
43974368|NCT01777945|Capecitabine|capecitabine|mesh-list
43974369|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974370|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
43974371|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
43974372|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
43974373|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974374|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974375|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
43974376|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
43974377|NCT01778465|Salicylates|salicylates|mesh-list
43974378|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974379|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974380|NCT01778465|Analgesics|analgesics|mesh-ancestor
43974381|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
43974382|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974383|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974384|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974386|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974387|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974388|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974389|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974390|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
43974391|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
43974392|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974393|NCT01778634|Azithromycin|azithromycin|mesh-list
43974394|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974395|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143824|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143825|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44143826|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143827|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43974396|NCT01779167|Thalidomide|thalidomide|mesh-list
43974397|NCT01779167|Rituximab|rituximab|mesh-list
43974398|NCT01779167|Lenalidomide|lenalidomide|mesh-list
43974399|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242168|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242169|NCT00593879|Mecamylamine|mecamylamine|mesh-list
44242170|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44242171|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44242172|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
44242173|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242174|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242175|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43974400|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974401|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
43974402|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974403|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974404|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974405|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974406|NCT01779167|Growth Substances|growth substances|mesh-ancestor
43974407|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974408|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974409|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
43974410|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974411|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974412|NCT01779375|Metformin|metformin|mesh-list
43974413|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
43974414|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43974415|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974416|NCT01780324|Lidocaine|lidocaine|mesh-list
43974417|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
43974418|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
43974419|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974420|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974421|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
43974422|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974423|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43974424|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43974425|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43974426|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974427|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974428|NCT01780337|Oxytocin|oxytocin|mesh-list
43974429|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
43974430|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974431|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974432|NCT01780454|Rituximab|rituximab|mesh-list
43974433|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43974434|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974435|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
43974436|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974437|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974438|NCT01781169|Vitamin D|vitamin d|mesh-list
43974439|NCT01781169|Vitamins|vitamins|mesh-ancestor
43974440|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
43974441|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974442|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43974443|NCT01781403|Capecitabine|capecitabine|mesh-list
43974444|NCT01781403|Temozolomide|temozolomide|mesh-list
43974445|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974446|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
43974447|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974448|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974449|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43974450|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
43974451|NCT01781806|Tenofovir|tenofovir|mesh-list
43974452|NCT01781806|Emtricitabine|emtricitabine|mesh-list
43974453|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
43974454|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974458|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974460|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43974461|NCT01782898|Esmolol|esmolol|mesh-list
43974462|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43974463|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44242176|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44242177|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
44242178|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974464|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43974465|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
43974466|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974467|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974468|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974469|NCT01782963|Dexamethasone|dexamethasone|mesh-list
43974470|NCT01782963|Lenalidomide|lenalidomide|mesh-list
43974471|NCT01782963|Bortezomib|bortezomib|mesh-list
43974472|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974474|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
43974475|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974476|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974477|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974478|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
43974479|NCT01782963|Hormones|hormones|mesh-ancestor
44015207|NCT03354598|Renal Agents|renal agents|mesh-ancestor
43974480|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974481|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974482|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974483|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
43974484|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974485|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974486|NCT01782963|Growth Substances|growth substances|mesh-ancestor
43974487|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974488|NCT01783054|Gemcitabine|gemcitabine|mesh-list
43974489|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974490|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
43974491|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974492|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974493|NCT01783054|Antiviral Agents|antiviral agents|mesh-ancestor
43974494|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974495|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974496|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974497|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
43974498|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974499|NCT01783236|Acetaminophen|acetaminophen|mesh-list
43974500|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974501|NCT01783236|Analgesics|analgesics|mesh-ancestor
43974502|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
43974503|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974504|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974505|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
43974506|NCT01783470|Mirabegron|mirabegron|mesh-list
43974507|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
43974508|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
43974509|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43974510|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43974511|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974512|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974513|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974514|NCT01783470|Urological Agents|urological agents|mesh-ancestor
43974515|NCT01783561|Caffeine|caffeine|mesh-list
43974516|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
43974517|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974518|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43974519|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974520|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43974521|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974522|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43974523|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43974524|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
43974525|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974528|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
43974529|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
43974530|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43974531|NCT01783574|Androgens|androgens|mesh-ancestor
43974532|NCT01783574|Hormones|hormones|mesh-ancestor
43974533|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242179|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242180|NCT00593996|Vitamin D|vitamin d|mesh-list
44242181|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
44242182|NCT00593996|Vitamins|vitamins|mesh-ancestor
44242183|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
44242184|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242185|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44242186|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44242187|NCT00594087|Eszopiclone|eszopiclone|mesh-list
44242188|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44242189|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242190|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242191|NCT00594126|Imetelstat|imetelstat|mesh-list
44242192|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
43974534|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974535|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974536|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974537|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
43974538|NCT01783847|Prednisolone|prednisolone|mesh-list
43974539|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43974540|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
43974541|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43974542|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
43974543|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
43974544|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43974545|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
43974546|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974547|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
43974548|NCT01783847|Hormones|hormones|mesh-ancestor
43974549|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974550|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974551|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974552|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974553|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
43974554|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
43974555|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974556|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974557|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43974558|NCT01783847|Protective Agents|protective agents|mesh-ancestor
43974559|NCT01783847|Hematinics|hematinics|mesh-ancestor
43974560|NCT01783860|Azithromycin|azithromycin|mesh-list
43974561|NCT01783860|Doxycycline|doxycycline|mesh-list
43974562|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974563|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974564|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
43974565|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43974566|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43974567|NCT01783912|Nicotine|nicotine|mesh-list
43974568|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43974569|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
43974570|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974571|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974572|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43974573|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43974574|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
43974576|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974577|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
43974578|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974579|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
43974580|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974581|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974582|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44242193|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242194|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242195|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43974583|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43974584|NCT01784666|Isradipine|isradipine|mesh-list
43974585|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43974586|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43974587|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974588|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974589|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43974590|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974591|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
43974592|NCT01784770|Azithromycin|azithromycin|mesh-list
43974593|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974594|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974595|NCT01785095|Hormones|hormones|mesh-list
43974596|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43974597|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974598|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974599|NCT01785186|Pyridoxine|pyridoxine|mesh-list
43974600|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
43974604|NCT01785186|Ethambutol|ethambutol|mesh-list
43974605|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974606|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974607|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43974608|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43974609|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974610|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974611|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974612|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974613|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43974614|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
43974615|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
43974616|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43974617|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43974618|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43974619|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43974620|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43974621|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43974622|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43974623|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43974624|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43974625|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
43974626|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43974627|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
43974628|NCT01785186|Vitamins|vitamins|mesh-ancestor
43974629|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
43974630|NCT01785810|Maraviroc|maraviroc|mesh-list
43974631|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43974632|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43974633|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974634|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43974635|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43974636|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
43974637|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974638|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43974639|NCT01786161|Vancomycin|vancomycin|mesh-list
43974640|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974641|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974642|NCT01786239|Risperidone|risperidone|mesh-list
43974643|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43974644|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
43974645|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974646|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974647|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974648|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43974649|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43974650|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974651|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974652|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44242197|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44242198|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44242199|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
44242200|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242201|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44242202|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44242203|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242204|NCT00594217|Progesterone|progesterone|mesh-list
44242205|NCT00594217|Progestins|progestins|mesh-ancestor
44242206|NCT00594217|Hormones|hormones|mesh-ancestor
44242207|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242208|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242209|NCT00594269|Risperidone|risperidone|mesh-list
44242210|NCT00594269|Citalopram|citalopram|mesh-list
44242211|NCT00594269|Sertraline|sertraline|mesh-list
44242212|NCT00594269|Paroxetine|paroxetine|mesh-list
44242213|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44242214|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
43974653|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
43974654|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43974655|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974656|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974657|NCT01786343|Decitabine|decitabine|mesh-list
43974658|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974659|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
44015430|NCT03380026|Hormones|hormones|mesh-ancestor
43974660|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974661|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974662|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974663|NCT01786902|Hormones|hormones|mesh-list
43974664|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974665|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974666|NCT01786967|Fesoterodine|fesoterodine|mesh-list
43974667|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43974668|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43974669|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
43974670|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974671|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974672|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974679|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974680|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974681|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974682|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
43974683|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974684|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43974685|NCT01787240|Citalopram|citalopram|mesh-list
43974686|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43974687|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43974688|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974689|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974690|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974691|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
43974692|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242215|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974693|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43974694|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
43974695|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974697|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43974698|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974699|NCT01787916|Incretins|incretins|mesh-ancestor
43974700|NCT01787916|Hormones|hormones|mesh-ancestor
43974701|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974702|NCT01788631|Regadenoson|regadenoson|mesh-list
43974703|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43974704|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43974705|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
43974706|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
43974707|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974708|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974709|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974710|NCT01789255|Cyclosporine|cyclosporine|mesh-list
43974711|NCT01789255|Methotrexate|methotrexate|mesh-list
43974712|NCT01789255|Vorinostat|vorinostat|mesh-list
43974713|NCT01789255|Tacrolimus|tacrolimus|mesh-list
43974714|NCT01789255|Cyclosporins|cyclosporins|mesh-list
43974715|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43974716|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
43974717|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974718|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974719|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974720|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
43974721|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974722|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974723|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974724|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974725|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43974726|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974727|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
43974728|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974729|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43974730|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43974731|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
43974732|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974733|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43974735|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43974736|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43974737|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43974738|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43974739|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43974740|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
43974741|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974742|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974744|NCT01789905|Tigecycline|tigecycline|mesh-list
43974745|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974746|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974747|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43974748|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974749|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974750|NCT01790490|Ketamine|ketamine|mesh-list
43974751|NCT01790490|Lorazepam|lorazepam|mesh-list
43974752|NCT01790490|Analgesics|analgesics|mesh-ancestor
43974753|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
43974754|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974755|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974756|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43974757|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43974758|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
43974759|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
43974760|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43974761|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43974762|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43974763|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974764|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242216|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242217|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974765|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
43974767|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
43974768|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974769|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43974770|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43974771|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43974772|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974773|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
43974775|NCT01790659|Gentamicins|gentamicins|mesh-list
43974776|NCT01790659|Paromomycin|paromomycin|mesh-list
43974777|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974778|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974779|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43974780|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974781|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974782|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43974783|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43974784|NCT01790685|Dexamethasone|dexamethasone|mesh-list
43974785|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974786|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
43974787|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
43974788|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974789|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974790|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974791|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
43974792|NCT01790685|Hormones|hormones|mesh-ancestor
43974793|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974794|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974795|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974796|NCT01791465|Exenatide|exenatide|mesh-list
43974797|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43974798|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974799|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43974800|NCT01791465|Incretins|incretins|mesh-ancestor
43974801|NCT01791465|Hormones|hormones|mesh-ancestor
43974802|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974803|NCT01791491|Abatacept|abatacept|mesh-list
43974804|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43974805|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974806|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974807|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974808|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
43974809|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974810|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974811|NCT01791972|Albuterol|albuterol|mesh-list
43974812|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43974813|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
43974814|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974815|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974816|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43974817|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
43974818|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
43974819|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43974820|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43974821|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43974822|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43974823|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
43974824|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974825|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974826|NCT01793285|Etanercept|etanercept|mesh-list
43974827|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974828|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974829|NCT01793285|Analgesics|analgesics|mesh-ancestor
43974830|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
43974831|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974832|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974833|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974834|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974835|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242218|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44242219|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242220|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242221|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242222|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43974836|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974837|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
43974838|NCT01794039|Dexamethasone|dexamethasone|mesh-list
43974839|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
43974840|NCT01794039|Lenalidomide|lenalidomide|mesh-list
43974841|NCT01794039|Pomalidomide|pomalidomide|mesh-list
43974842|NCT01794039|Ichthammol|ichthammol|mesh-list
43974843|NCT01794039|BB 1101|bb 1101|mesh-list
43974844|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974845|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
43974846|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
43974847|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974848|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974849|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974850|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
43974851|NCT01794039|Hormones|hormones|mesh-ancestor
43974852|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974853|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974854|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974855|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
43974856|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43974857|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43974858|NCT01794039|Growth Substances|growth substances|mesh-ancestor
43974859|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
43974860|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
43974861|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974862|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974863|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974864|NCT01794455|Candesartan|candesartan|mesh-list
43974865|NCT01794455|Sertraline|sertraline|mesh-list
43974866|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
43974867|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974868|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43974869|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43974870|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974871|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974872|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974873|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
43974874|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974875|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43974876|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43974877|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43974878|NCT01794702|Cytarabine|cytarabine|mesh-list
43974879|NCT01794702|Decitabine|decitabine|mesh-list
43974880|NCT01794702|Clofarabine|clofarabine|mesh-list
43974881|NCT01794702|Idarubicin|idarubicin|mesh-list
43974882|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43974883|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
43974884|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974885|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974886|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
43974887|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974888|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43974889|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
43974890|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974891|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974892|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43974893|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43974894|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43974906|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
43974907|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974908|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43974909|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974910|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974911|NCT01796665|Clindamycin|clindamycin|mesh-list
43974912|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
44242223|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
44242224|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44242225|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43974913|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
43974914|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43974915|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974916|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974917|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43974918|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974919|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711943|NCT02686385|Hormones|hormones|mesh-ancestor
43974920|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
44143828|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143829|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143830|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143831|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143832|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143833|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143834|NCT00190853|Analgesics|analgesics|mesh-ancestor
44143835|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
44143836|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143837|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143838|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143839|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
44143840|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143841|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143842|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143843|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143844|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143845|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143846|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143847|NCT00190866|Analgesics|analgesics|mesh-ancestor
44143848|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
44143849|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143850|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143851|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143852|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
44143853|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44143854|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143855|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143856|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143857|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143858|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143859|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143860|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143861|NCT00190892|Carbamazepine|carbamazepine|mesh-list
44143862|NCT00190892|Olanzapine|olanzapine|mesh-list
44143863|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
44143867|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143868|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44143869|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44143870|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44143871|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143872|NCT00190892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44143873|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143874|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143875|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143876|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143877|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
44143878|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
44143879|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
44143880|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44143881|NCT00190892|Analgesics|analgesics|mesh-ancestor
44143882|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
44143883|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44143884|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44143885|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44242226|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242227|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44143886|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143887|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143888|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143889|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143890|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143891|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143892|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143893|NCT00190905|Analgesics|analgesics|mesh-ancestor
44143894|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
44143895|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143896|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143897|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43974921|NCT01797484|Ranolazine|ranolazine|mesh-list
43974922|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43974923|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43974924|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974925|NCT01797575|Aspirin|aspirin|mesh-list
43974926|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
43974927|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43974928|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974929|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974930|NCT01797575|Analgesics|analgesics|mesh-ancestor
43974931|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
43974932|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974933|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974934|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974935|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974936|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43974937|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43974938|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974939|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43974940|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974941|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974942|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
43974943|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
43974944|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974945|NCT01797575|Expectorants|expectorants|mesh-ancestor
43974946|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
43974947|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43974949|NCT01797575|Protective Agents|protective agents|mesh-ancestor
43974950|NCT01797575|Antidotes|antidotes|mesh-ancestor
43974951|NCT01797822|Dexamethasone|dexamethasone|mesh-list
43974952|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
43974953|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974954|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
43974955|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
43974956|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974957|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974958|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974962|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43974963|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974964|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43974965|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43974966|NCT01798225|Doxycycline|doxycycline|mesh-list
43974967|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43974968|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43974969|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
43974970|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43974971|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43974972|NCT01798264|Exenatide|exenatide|mesh-list
43974973|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43974974|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974975|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43974976|NCT01798264|Incretins|incretins|mesh-ancestor
43974977|NCT01798264|Hormones|hormones|mesh-ancestor
43974978|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974979|NCT01798316|Acetaminophen|acetaminophen|mesh-list
43974980|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43974981|NCT01798316|Analgesics|analgesics|mesh-ancestor
43974982|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
43810026|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44242228|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
43974983|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974984|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974985|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
43974986|NCT01798394|Progesterone|progesterone|mesh-list
43974987|NCT01798394|Progestins|progestins|mesh-ancestor
43974988|NCT01798394|Hormones|hormones|mesh-ancestor
43974989|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43974990|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974991|NCT01798550|Enoxaparin|enoxaparin|mesh-list
43974992|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
43974993|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43974994|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43974995|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43974996|NCT01799213|Meloxicam|meloxicam|mesh-list
43974997|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43974998|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975000|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
43975001|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975002|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975003|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975004|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975005|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43975006|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43975007|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975008|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975009|NCT01800838|Silicon|silicon|mesh-list
43975010|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
43975011|NCT01800838|Trace Elements|trace elements|mesh-ancestor
43975012|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
43975013|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975014|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
43975015|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43975016|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43975017|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975018|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
43975019|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43975020|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
43975021|NCT01800877|Phenylephrine|phenylephrine|mesh-list
43975022|NCT01800877|Dopamine|dopamine|mesh-list
43975023|NCT01800877|Vasopressins|vasopressins|mesh-list
43975024|NCT01800877|Epinephrine|epinephrine|mesh-list
43975025|NCT01800877|Norepinephrine|norepinephrine|mesh-list
43975026|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43975027|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43975028|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43975029|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975030|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975031|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975032|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975033|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44015856|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975043|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43975044|NCT01800877|Protective Agents|protective agents|mesh-ancestor
43975045|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
43975046|NCT01800877|Coagulants|coagulants|mesh-ancestor
43975047|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43975048|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
43975049|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
43975050|NCT01801124|Bupivacaine|bupivacaine|mesh-list
43975051|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
43975052|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
43975053|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975054|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975055|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
43975056|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975057|NCT01801449|Rilonacept|rilonacept|mesh-list
43975058|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975059|NCT01803074|Ritonavir|ritonavir|mesh-list
43975060|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43975061|NCT01803074|Tenofovir|tenofovir|mesh-list
43975062|NCT01803074|Emtricitabine|emtricitabine|mesh-list
43975063|NCT01803074|BMS-955176|bms-955176|mesh-list
43975064|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43975065|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43975066|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
43975067|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975068|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242229|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44242230|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44242231|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975069|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43975070|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43975071|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
43975072|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975073|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43975074|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43975075|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43975076|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43975077|NCT01804036|Zolpidem|zolpidem|mesh-list
43975078|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43975079|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43975080|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975081|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975082|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43975083|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
43975084|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
43975085|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975086|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975087|NCT01804075|Morphine|morphine|mesh-list
43975088|NCT01804075|Methadone|methadone|mesh-list
43975089|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43975090|NCT01804075|Narcotics|narcotics|mesh-ancestor
43975091|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975092|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975093|NCT01804075|Analgesics|analgesics|mesh-ancestor
43975094|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
43975095|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975096|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
43975097|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975098|NCT01804101|Cytarabine|cytarabine|mesh-list
43975099|NCT01804101|Daunorubicin|daunorubicin|mesh-list
43975100|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975101|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
44165295|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975105|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975106|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975108|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975109|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43975110|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43975111|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43975112|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975113|NCT01804465|Ipilimumab|ipilimumab|mesh-list
43975114|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44015925|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44015955|NCT03460990|VX-659|vx-659|mesh-list
43975115|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975116|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44173548|NCT00293475|Diuretics|diuretics|mesh-ancestor
43975117|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975118|NCT01805089|Melatonin|melatonin|mesh-list
43975119|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
43975120|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975121|NCT01805089|Protective Agents|protective agents|mesh-ancestor
43975122|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975123|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975124|NCT01805297|Aflibercept|aflibercept|mesh-list
43975125|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43975126|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43975127|NCT01805297|Growth Substances|growth substances|mesh-ancestor
43975128|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975129|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
43975130|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975131|NCT01805323|Dexamethasone|dexamethasone|mesh-list
43975132|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975133|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
43975134|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
43975135|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975136|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975137|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43975138|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
43975139|NCT01805323|Hormones|hormones|mesh-ancestor
43810396|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242232|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44242233|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
44242234|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975140|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43975141|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43975142|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975143|NCT01807624|Phenylephrine|phenylephrine|mesh-list
43975144|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
43975145|NCT01807624|Tetracaine|tetracaine|mesh-list
43975146|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
43975147|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
43975148|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975149|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975150|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
44143898|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
43975151|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975152|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43975153|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43975154|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975155|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975156|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975157|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
43975158|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
43975159|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
43975160|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43975161|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975162|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43975163|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
43975164|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43975165|NCT01807624|Protective Agents|protective agents|mesh-ancestor
43975166|NCT01807871|Nicotine|nicotine|mesh-list
43975167|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43975168|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
43975169|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975170|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975171|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43975172|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43975173|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
43975187|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975188|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975189|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975190|NCT01808755|Trimethoprim|trimethoprim|mesh-list
43975191|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
43975192|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43975193|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975194|NCT01808755|Renal Agents|renal agents|mesh-ancestor
43975195|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
43975196|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43975197|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43975198|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43975199|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975200|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975201|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43975202|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43975203|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43975205|NCT01809054|Fondaparinux|fondaparinux|mesh-list
43975206|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43975207|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975208|NCT01809054|Analgesics|analgesics|mesh-ancestor
43975209|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
43975210|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975211|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975212|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975213|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975214|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43975215|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43975216|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975217|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43975218|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242236|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
44242237|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975219|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975220|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
43975221|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43975222|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
43975223|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43975224|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
43975225|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
43975226|NCT01809106|Fentanyl|fentanyl|mesh-list
43975227|NCT01809106|Morphine|morphine|mesh-list
43975228|NCT01809106|Oxycodone|oxycodone|mesh-list
43975229|NCT01809106|Buprenorphine|buprenorphine|mesh-list
43975230|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43975231|NCT01809106|Narcotics|narcotics|mesh-ancestor
43975232|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975233|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975234|NCT01809106|Analgesics|analgesics|mesh-ancestor
43975235|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
43975236|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975240|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
43975241|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43975242|NCT01809639|Progesterone|progesterone|mesh-list
43975243|NCT01809639|Progestins|progestins|mesh-ancestor
43975244|NCT01809639|Hormones|hormones|mesh-ancestor
44016009|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
43975245|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43975246|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975247|NCT01810666|Factor VIII|factor viii|mesh-list
43975248|NCT01810666|Coagulants|coagulants|mesh-ancestor
43975249|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
44173680|NCT00293839|Oxybutynin|oxybutynin|mesh-list
44016057|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44173759|NCT00294255|Risperidone|risperidone|mesh-list
43975250|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43975251|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
43975252|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975253|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975254|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43975255|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975256|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
43975257|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43975258|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
43975259|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975260|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975261|NCT01810952|Insulin|insulin|mesh-list
43975262|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43975263|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
43975264|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
43975265|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
43975266|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
43975267|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
43975268|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43975269|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975270|NCT01811147|Norepinephrine|norepinephrine|mesh-list
43975271|NCT01811147|Serotonin|serotonin|mesh-list
43975272|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43975273|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43975274|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43975275|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975276|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016058|NCT03473184|Diacetylrhein|diacetylrhein|mesh-list
43975277|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975278|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975279|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
43975280|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
43975281|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975282|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43975283|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44016086|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016088|NCT03478982|Alprazolam|alprazolam|mesh-list
43975284|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
43975285|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44173938|NCT00294918|Hormones|hormones|mesh-list
43975286|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975287|NCT01811355|Mexiletine|mexiletine|mesh-list
43975288|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43975289|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43975290|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43975291|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975292|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975293|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
44016093|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43975294|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43975295|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
44242238|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44242239|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44242240|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975296|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975298|NCT01811654|Protective Agents|protective agents|mesh-ancestor
43712308|NCT02684409|Sumatriptan|sumatriptan|mesh-list
43975299|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
43975300|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43975301|NCT01811940|Topiramate|topiramate|mesh-list
43975302|NCT01811940|Adderall|adderall|mesh-list
43975304|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43975305|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975306|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43975307|NCT01812005|Rituximab|rituximab|mesh-list
43975308|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43975309|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975310|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
43975322|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43975323|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43975324|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975325|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975326|NCT01812668|Fluorides|fluorides|mesh-list
43975327|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
43975328|NCT01812668|Protective Agents|protective agents|mesh-ancestor
43975329|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975331|NCT01813149|Phenylephrine|phenylephrine|mesh-list
43975332|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
43975333|NCT01813149|Anesthetics|anesthetics|mesh-list
43975334|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
43975335|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975336|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975337|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
43975338|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975339|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43975340|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
43975341|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
43975342|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
43975343|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43975344|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
43975345|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975346|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43975347|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43975348|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43975349|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975350|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975351|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975352|NCT01813149|Protective Agents|protective agents|mesh-ancestor
43975353|NCT01813149|Analgesics|analgesics|mesh-ancestor
43975354|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43975355|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
43975356|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44016146|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016147|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
44016150|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
43975357|NCT01813214|Vemurafenib|vemurafenib|mesh-list
43975358|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975359|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975360|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975361|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975362|NCT01813734|Ponatinib|ponatinib|mesh-list
43975363|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975364|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975365|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975366|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975367|NCT01814813|Bevacizumab|bevacizumab|mesh-list
43975368|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43975369|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975370|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43975371|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43975372|NCT01814813|Growth Substances|growth substances|mesh-ancestor
44016154|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016155|NCT03496324|Analgesics|analgesics|mesh-ancestor
44016170|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975373|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975374|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
43975375|NCT01815008|Aspirin|aspirin|mesh-list
44242241|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242242|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44242243|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44242244|NCT00594542|Lidocaine|lidocaine|mesh-list
44242245|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44242246|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
44242247|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242248|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242249|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
44242250|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242251|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44174490|NCT00296465|Clomiphene|clomiphene|mesh-list
43975383|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975384|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975385|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43975386|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43975387|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975388|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43975389|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43975390|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975391|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
43975392|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43975393|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43975394|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43975395|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
43975396|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975397|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43975398|NCT01815333|Hematinics|hematinics|mesh-ancestor
43975399|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43975400|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44143900|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143901|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143902|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143903|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44143904|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143905|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44016185|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
44143906|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143907|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143908|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143909|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143910|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143911|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143912|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143913|NCT00190944|Teriparatide|teriparatide|mesh-list
44143914|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44143915|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143916|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44143917|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44143918|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143919|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143920|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143921|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143922|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143923|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143924|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143925|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
44143926|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143927|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143928|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143929|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44242252|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44242253|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44242254|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242255|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242257|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
44242258|NCT00594555|Cladribine|cladribine|mesh-list
44242259|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44242260|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
44242261|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242262|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242263|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
44242264|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242265|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242266|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
44016217|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44242267|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242268|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242269|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242270|NCT00594633|Donepezil|donepezil|mesh-list
44242271|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44242272|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242273|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242274|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
44242275|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242276|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143930|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143931|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143932|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143933|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143934|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143935|NCT00190996|Analgesics|analgesics|mesh-ancestor
44143936|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
44143944|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975402|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975403|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975404|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975405|NCT01817907|Trazodone|trazodone|mesh-list
44016268|NCT03503578|Ketamine|ketamine|mesh-list
43975406|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43975407|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43975408|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174911|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43975409|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975410|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43975411|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43975412|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43975413|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975414|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242277|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
44242278|NCT00594737|Memantine|memantine|mesh-list
44242279|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44242280|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44242281|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
44242282|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242283|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242284|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242285|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44242286|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44242287|NCT00594867|Aspirin|aspirin|mesh-list
43975415|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975416|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
43975417|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43975418|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
43975419|NCT01818063|Paclitaxel|paclitaxel|mesh-list
43975420|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
43975421|NCT01818063|Carboplatin|carboplatin|mesh-list
43975422|NCT01818063|Doxorubicin|doxorubicin|mesh-list
43975423|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43975424|NCT01818063|Veliparib|veliparib|mesh-list
44175354|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
43975425|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43975426|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975427|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43975428|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43975430|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975431|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975432|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
43975433|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975434|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975435|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43975436|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
43975437|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43975438|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43975439|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43975440|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43975441|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975442|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43975443|NCT01818414|Vitamins|vitamins|mesh-list
43975444|NCT01818414|Folic Acid|folic acid|mesh-list
43975445|NCT01818414|Misoprostol|misoprostol|mesh-list
43975446|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
43975447|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975448|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43975449|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
43975450|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43975451|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43975452|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43975453|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
43975454|NCT01818414|Hematinics|hematinics|mesh-ancestor
43975455|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
43975456|NCT01819935|Vancomycin|vancomycin|mesh-list
43975457|NCT01819935|Linezolid|linezolid|mesh-list
43975458|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43975459|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975460|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43975461|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975472|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975473|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43975474|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43975475|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43975476|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43975477|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975478|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43975479|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44242289|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44242290|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44242291|NCT00594867|Analgesics|analgesics|mesh-ancestor
44242292|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
44242293|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242294|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242295|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242296|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242297|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44242298|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43975480|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43975481|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975482|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975483|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43975484|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43975485|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43975486|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43975487|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975488|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975489|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975490|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43975491|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43975492|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
44175477|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44175556|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975493|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43975494|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43975495|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
43975496|NCT01822548|Metformin|metformin|mesh-list
43975497|NCT01822548|Vildagliptin|vildagliptin|mesh-list
43975498|NCT01822548|Glyburide|glyburide|mesh-list
43975499|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43975500|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975501|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43975502|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
43975503|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975504|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975505|NCT01822886|Gemcitabine|gemcitabine|mesh-list
44016318|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
43975506|NCT01822886|Romidepsin|romidepsin|mesh-list
43975507|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975508|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
43975509|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975510|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975511|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
43975512|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975513|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975514|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975515|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
43975516|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975517|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43975518|NCT01823497|Morphine|morphine|mesh-list
44016331|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
44016336|NCT03513757|Lidocaine|lidocaine|mesh-list
43975519|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43975520|NCT01823497|Narcotics|narcotics|mesh-ancestor
43975521|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975522|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975523|NCT01823497|Analgesics|analgesics|mesh-ancestor
43975524|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
43975525|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975526|NCT01823510|Aspirin|aspirin|mesh-list
43975544|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43975545|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43975547|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
43975548|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975549|NCT01824901|Docetaxel|docetaxel|mesh-list
43975550|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016345|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016346|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
44016347|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016348|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44016349|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44016350|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623076|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623077|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
43623078|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623079|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623080|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
43623081|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623082|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44016358|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44242299|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242301|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242302|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242303|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
44242304|NCT00595049|Bosentan|bosentan|mesh-list
44242305|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44242306|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44242307|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242308|NCT00595140|Octreotide|octreotide|mesh-list
44242309|NCT00595140|Dopamine|dopamine|mesh-list
44242310|NCT00595140|Cabergoline|cabergoline|mesh-list
44016359|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44242311|NCT00595140|Somatostatin|somatostatin|mesh-list
44242312|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
44242313|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43975551|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
43975552|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
43975553|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
43975554|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975555|NCT01825122|Nadolol|nadolol|mesh-list
43975556|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43975557|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43975558|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975559|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975560|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975561|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975562|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43975563|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43975564|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
43975565|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
43975566|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975567|NCT01825408|Azithromycin|azithromycin|mesh-list
43975568|NCT01825408|Doxycycline|doxycycline|mesh-list
43975569|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43975570|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43975571|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975572|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
43975573|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43975574|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44016367|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43975575|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43975576|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975577|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975578|NCT01825512|Deferasirox|deferasirox|mesh-list
43975579|NCT01825512|Deferiprone|deferiprone|mesh-list
43975580|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43975581|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
43975582|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
43975585|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43975586|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43975587|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44016398|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975588|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
43975589|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
43975590|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975591|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975592|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975594|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43975595|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43975596|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
43844103|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
44242314|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44242315|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242316|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44242317|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
44016405|NCT03522441|Clindamycin|clindamycin|mesh-list
44242318|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
44242319|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242320|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242321|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
44242322|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242323|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975597|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975598|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43975599|NCT01826851|Bupivacaine|bupivacaine|mesh-list
43975600|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
43975601|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
43975602|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975603|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975604|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
43975605|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975606|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
43975607|NCT01827358|Mupirocin|mupirocin|mesh-list
43975608|NCT01827358|Calcium|calcium|mesh-list
43975609|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43975610|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975611|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43975612|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43975613|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975614|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43975615|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975616|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975617|NCT01827462|Vaccines|vaccines|mesh-list
43975618|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
43975619|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975620|NCT01827475|Acetaminophen|acetaminophen|mesh-list
43975621|NCT01827475|Ibuprofen|ibuprofen|mesh-list
43975622|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975623|NCT01827475|Analgesics|analgesics|mesh-ancestor
43975624|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
43975625|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975626|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975627|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
43975628|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43975629|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975630|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975631|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43975632|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975633|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975634|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
43975635|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975636|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975637|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975638|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975639|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
43975640|NCT01828476|Navitoclax|navitoclax|mesh-list
43975641|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
43975642|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43975643|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43975644|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975645|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975646|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975647|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975648|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975649|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
43975650|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44242324|NCT00595140|Protective Agents|protective agents|mesh-ancestor
44242325|NCT00595140|Hormones|hormones|mesh-ancestor
44242326|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242327|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44242328|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44242329|NCT00595322|Bevacizumab|bevacizumab|mesh-list
44242330|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242331|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242332|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44242333|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44242334|NCT00595322|Growth Substances|growth substances|mesh-ancestor
44242335|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242336|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242337|NCT00595374|Insulin|insulin|mesh-list
44242338|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44242339|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
43975651|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975652|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
43975653|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43975654|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43975660|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975661|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43975662|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43975663|NCT01828554|Capecitabine|capecitabine|mesh-list
43975664|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975665|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
43975666|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975667|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975668|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
43975669|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43975670|NCT01828593|Antibodies|antibodies|mesh-list
43975671|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
43975672|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975673|NCT01829217|Sunitinib|sunitinib|mesh-list
43975674|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975675|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43975676|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43975677|NCT01829217|Growth Substances|growth substances|mesh-ancestor
43975678|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975679|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
43975680|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975681|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975682|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975683|NCT01829399|Epinephrine|epinephrine|mesh-list
43975684|NCT01829399|Bupivacaine|bupivacaine|mesh-list
43975685|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
43975686|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
43975687|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975688|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975689|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
43975690|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975691|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43975692|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43975693|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975694|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975695|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975696|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43975697|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44242341|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
44242342|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
44242343|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
44242344|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242345|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242346|NCT00595543|Diclofenac|diclofenac|mesh-list
44242347|NCT00595543|Ketorolac|ketorolac|mesh-list
44242348|NCT00595543|Bromfenac|bromfenac|mesh-list
44242349|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44242350|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44242351|NCT00595543|Analgesics|analgesics|mesh-ancestor
44242352|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
44242353|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016540|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
44242354|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242355|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242356|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242357|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242358|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242359|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975698|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
43975699|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43975700|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975701|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
43975702|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
43975703|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43975704|NCT01829503|Cytarabine|cytarabine|mesh-list
43975705|NCT01829503|Decitabine|decitabine|mesh-list
43975706|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975707|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
44016541|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43975708|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975709|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975710|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
43975711|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975712|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975713|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
43975714|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975715|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975716|NCT01829516|Oxytocin|oxytocin|mesh-list
43975717|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
43975718|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43975719|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975720|NCT01829919|Paroxetine|paroxetine|mesh-list
43975721|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43975722|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43975723|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975727|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016567|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
44016568|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016569|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43640502|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640503|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43640504|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640505|NCT02320435|Trastuzumab|trastuzumab|mesh-list
43640506|NCT02320435|Pertuzumab|pertuzumab|mesh-list
43640507|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640508|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640509|NCT02268448|Clonidine|clonidine|mesh-list
43640510|NCT02268448|Naltrexone|naltrexone|mesh-list
43640511|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43640512|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43640513|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640514|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
43640515|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640516|NCT02268448|Analgesics|analgesics|mesh-ancestor
43640578|NCT02170090|Gemcitabine|gemcitabine|mesh-list
43975728|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43975729|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
43975730|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43975731|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43975732|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43975733|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975734|NCT01830140|Bimatoprost|bimatoprost|mesh-list
43975735|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43975736|NCT01830699|Triamcinolone|triamcinolone|mesh-list
44242361|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242362|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459479|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44459480|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242363|NCT00595972|Endostar protein|endostar protein|mesh-list
44242364|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44242365|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44242366|NCT00595972|Growth Substances|growth substances|mesh-ancestor
44242367|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242368|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242369|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242370|NCT00595985|Sorafenib|sorafenib|mesh-list
44242371|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242372|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242373|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242374|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242375|NCT00596037|Hormones|hormones|mesh-list
44242376|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242377|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242378|NCT00596050|Lidocaine|lidocaine|mesh-list
44242379|NCT00596050|Fentanyl|fentanyl|mesh-list
44242380|NCT00596050|Midazolam|midazolam|mesh-list
44242381|NCT00596050|Ketamine|ketamine|mesh-list
44242382|NCT00596050|Etomidate|etomidate|mesh-list
44242383|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
44242384|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
44242385|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242386|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975737|NCT01830699|Rilonacept|rilonacept|mesh-list
43975738|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975739|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
43975740|NCT01830699|Hormones|hormones|mesh-ancestor
43975741|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43975742|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975743|NCT01830842|Nicotine|nicotine|mesh-list
43975744|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43975745|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
43975746|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975747|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975748|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43975749|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43975750|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016572|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
43975751|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975752|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242387|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
44242388|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242389|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242390|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43975753|NCT01831232|Cytarabine|cytarabine|mesh-list
43975754|NCT01831232|Idarubicin|idarubicin|mesh-list
43975755|NCT01831232|Pravastatin|pravastatin|mesh-list
43975756|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44016598|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016599|NCT03562988|Protective Agents|protective agents|mesh-ancestor
44016601|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44016602|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
44016603|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
44016604|NCT03565666|Pancrelipase|pancrelipase|mesh-list
44016605|NCT03565666|Pancreatin|pancreatin|mesh-list
44016606|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44016607|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016608|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016609|NCT03570476|Olaparib|olaparib|mesh-list
44016610|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43851985|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851986|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851987|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
43975757|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
43975758|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975759|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975760|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
43975761|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975762|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975763|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
43975764|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975765|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43975766|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43975767|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43975768|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975769|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43975770|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43975771|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43975772|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43712721|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
43975773|NCT01831934|Vaccines|vaccines|mesh-list
44016611|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016612|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016613|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016614|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44016615|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
44016616|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016617|NCT03571724|Menthol|menthol|mesh-list
44016618|NCT03571724|Nicotine|nicotine|mesh-list
44016619|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44016620|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
44016621|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016622|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016623|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44016624|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44016625|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016626|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016627|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016628|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
44016629|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
43975774|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
43975775|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975776|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
43975777|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
43975778|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975779|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975780|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43975781|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44016630|NCT03572478|Nivolumab|nivolumab|mesh-list
44016631|NCT03572478|Rucaparib|rucaparib|mesh-list
44016632|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016633|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016634|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44016635|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016636|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43834334|NCT05148000|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43975782|NCT01833026|Albuterol|albuterol|mesh-list
43975783|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43975784|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
43975785|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975786|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975787|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43975788|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975789|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
43975790|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43975791|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43975792|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43975793|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44143946|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143947|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143948|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143949|NCT00191022|Paroxetine|paroxetine|mesh-list
44143950|NCT00191022|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44143951|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143952|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143953|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143954|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143955|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
44143956|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143957|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44143958|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143959|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143960|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44143961|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44016637|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016638|NCT03572972|Warfarin|warfarin|mesh-list
44016639|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
44016640|NCT03572972|Dabigatran|dabigatran|mesh-list
44016641|NCT03572972|Apixaban|apixaban|mesh-list
44016642|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
44016643|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44016644|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
44016645|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44016646|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
44016647|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016648|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016649|NCT03574818|Gemcitabine|gemcitabine|mesh-list
44016650|NCT03574818|Cisplatin|cisplatin|mesh-list
44016651|NCT03574818|Necitumumab|necitumumab|mesh-list
44143962|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143963|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44143964|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143965|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143966|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143967|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242392|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242393|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242394|NCT00596050|Analgesics|analgesics|mesh-ancestor
44242395|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44242396|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44242397|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
44242398|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44143968|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143969|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143970|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143971|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44016670|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43536685|NCT04484922|Analgesics|analgesics|mesh-ancestor
43536872|NCT03705845|Vitamins|vitamins|mesh-ancestor
43536944|NCT03437421|Vitamins|vitamins|mesh-ancestor
43537375|NCT05691517|Camptothecin|camptothecin|mesh-list
43537452|NCT05659563|Tamoxifen|tamoxifen|mesh-list
43537453|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43537454|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
43537455|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537600|NCT05501548|Olaparib|olaparib|mesh-list
43537752|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537753|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537754|NCT05351229|Analgesics|analgesics|mesh-ancestor
43537755|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
43537756|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537757|NCT05346354|Ravulizumab|ravulizumab|mesh-list
43537758|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43537760|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
44143972|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143973|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143974|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143975|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143976|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44143977|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143978|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143979|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143980|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143981|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44016671|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016672|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016673|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016674|NCT03580343|Tofacitinib|tofacitinib|mesh-list
44016675|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44016676|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016677|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016678|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
44016679|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44016680|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
44016681|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016682|NCT03581084|Expectorants|expectorants|mesh-ancestor
44016683|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
43538103|NCT05057247|Docetaxel|docetaxel|mesh-list
43538179|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538180|NCT04995029|Buprenorphine|buprenorphine|mesh-list
43538181|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43538182|NCT04995029|Narcotics|narcotics|mesh-ancestor
43538183|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538784|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
43539012|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43539013|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539014|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43539015|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
43539016|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143982|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975809|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975810|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
43975813|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
43975814|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975815|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975816|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975817|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
43975818|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975819|NCT01833741|Bimatoprost|bimatoprost|mesh-list
43975820|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43975821|NCT01833845|Ribavirin|ribavirin|mesh-list
43975822|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
43975823|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
43975824|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975825|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
43975826|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975827|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
43975828|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43975829|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43975830|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975831|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975832|NCT01833988|Pancrelipase|pancrelipase|mesh-list
43975833|NCT01833988|Pancreatin|pancreatin|mesh-list
43975834|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43975835|NCT01834261|Oxytocin|oxytocin|mesh-list
43975836|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
43975837|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43975838|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975839|NCT01834404|Topiramate|topiramate|mesh-list
43975840|NCT01834404|Phentermine|phentermine|mesh-list
43975841|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
43975842|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43975843|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975844|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43975845|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
43975846|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43975847|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
43975848|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
43975849|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975850|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975851|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975852|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975853|NCT01835262|Ketamine|ketamine|mesh-list
43975854|NCT01835262|Morphine|morphine|mesh-list
44242399|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44242400|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242401|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44242402|NCT00596050|Narcotics|narcotics|mesh-ancestor
44242403|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44242404|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44242405|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44242406|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242407|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242408|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
44242409|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
44242410|NCT00596063|Insulin|insulin|mesh-list
44242411|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242412|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242413|NCT00596115|Pramipexole|pramipexole|mesh-list
44242414|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
43975855|NCT01835262|Analgesics|analgesics|mesh-ancestor
43975856|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
43975857|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975858|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975859|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43975860|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43975861|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
43975862|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
43975863|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975864|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43975865|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43975866|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975867|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975868|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43975869|NCT01835262|Narcotics|narcotics|mesh-ancestor
43975870|NCT01835496|Deferiprone|deferiprone|mesh-list
43975871|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43975872|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
44016755|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016756|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
44016757|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539207|NCT03589768|Antacids|antacids|mesh-ancestor
43539322|NCT03283761|Leucovorin|leucovorin|mesh-list
43539781|NCT01227187|Protein C|protein c|mesh-list
43540406|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540480|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43540629|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
43540630|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540631|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43540632|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43540633|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43540634|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540635|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540636|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43540637|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43540638|NCT04987372|Analgesics|analgesics|mesh-ancestor
43540639|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43540848|NCT03623373|Cytarabine|cytarabine|mesh-list
43541000|NCT02027935|Analgesics|analgesics|mesh-ancestor
43543404|NCT03694873|Narcotics|narcotics|mesh-ancestor
43543546|NCT03693183|Ketorolac|ketorolac|mesh-list
43543631|NCT03692416|Analgesics|analgesics|mesh-ancestor
43544150|NCT03687073|Silybin|silybin|mesh-list
43544305|NCT03684772|Digoxin|digoxin|mesh-list
43544520|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
43544591|NCT03680495|Hormones|hormones|mesh-ancestor
43544900|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
43544971|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016758|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975873|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
43975874|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975875|NCT01835912|Citric Acid|citric acid|mesh-list
43975876|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
43975877|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
43975878|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43975879|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
43975880|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
43975881|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975882|NCT01836029|Cisplatin|cisplatin|mesh-list
43975883|NCT01836029|Carboplatin|carboplatin|mesh-list
43975884|NCT01836029|Fluorouracil|fluorouracil|mesh-list
43975885|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975886|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
44016759|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44016760|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
44016761|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016762|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016763|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44016764|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016765|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016766|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
44016767|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
44016768|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016769|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548386|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548767|NCT03639415|Oxycodone|oxycodone|mesh-list
43549117|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
43549321|NCT03633994|Heparin|heparin|mesh-list
43549829|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
43975888|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975889|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975890|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
43975891|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975892|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43975893|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975894|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43975895|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975896|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975897|NCT01836185|Evacetrapib|evacetrapib|mesh-list
43975898|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43975899|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43975900|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
43975901|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242415|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242416|NCT00596115|Protective Agents|protective agents|mesh-ancestor
44242417|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242418|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44242419|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44242420|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
44242421|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
44242422|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242423|NCT00596128|Insulin|insulin|mesh-list
44242424|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242425|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975902|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43975903|NCT01837069|Metoprolol|metoprolol|mesh-list
43975904|NCT01837069|Lisinopril|lisinopril|mesh-list
43975905|NCT01837069|Atorvastatin|atorvastatin|mesh-list
43975906|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43975907|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43975908|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43975909|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
43975910|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975911|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43975912|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43975913|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016770|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
43975914|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43975915|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43975916|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
43975917|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
43975918|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975919|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975920|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43975921|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43975922|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43975923|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975924|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975925|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
43975926|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43975927|NCT01837069|Protective Agents|protective agents|mesh-ancestor
43975928|NCT01838317|Pioglitazone|pioglitazone|mesh-list
43975929|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43975930|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975931|NCT01838655|Nitisinone|nitisinone|mesh-list
43975932|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975933|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975934|NCT01839110|Ranolazine|ranolazine|mesh-list
43975935|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43975936|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975937|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975938|NCT01839799|Gemcitabine|gemcitabine|mesh-list
43975939|NCT01839799|Paclitaxel|paclitaxel|mesh-list
43975940|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43975941|NCT01839799|Folfirinox|folfirinox|mesh-list
43975942|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43975943|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975944|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
43975945|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
43975946|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
43975947|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975948|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43975949|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
43975950|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
43975951|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975952|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975953|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43975954|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
43975955|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975956|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
43975957|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
43975958|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43975959|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
43975969|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43975970|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
44016852|NCT03605914|Narcotics|narcotics|mesh-ancestor
43585906|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43586728|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
43586806|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43586878|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43586954|NCT03398837|Hormones|hormones|mesh-ancestor
43587105|NCT03397537|Letrozole|letrozole|mesh-list
43587331|NCT03395665|Estradiol|estradiol|mesh-list
43587409|NCT03395002|Fluticasone|fluticasone|mesh-list
43587710|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
43588534|NCT03387163|Valsartan|valsartan|mesh-list
43588778|NCT03385382|Hormones|hormones|mesh-ancestor
43588990|NCT03383328|Prednisolone|prednisolone|mesh-list
43589439|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
43826776|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826777|NCT05494567|Urological Agents|urological agents|mesh-ancestor
43826778|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43826779|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43826780|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43826781|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826782|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975971|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43975972|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975973|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
43975974|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975975|NCT01841606|Ondansetron|ondansetron|mesh-list
43975976|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
43975977|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
43975978|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975979|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975980|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43975981|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
44016855|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
43669121|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43669122|NCT02907710|Endostar protein|endostar protein|mesh-list
43669123|NCT02907710|Endostatins|endostatins|mesh-list
43669124|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43669125|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43669126|NCT02907710|Growth Substances|growth substances|mesh-ancestor
43669127|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669128|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
43669129|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669130|NCT02907554|Cyclosporine|cyclosporine|mesh-list
43669132|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669133|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669134|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669135|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
43669136|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669137|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
43669138|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669139|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
43669140|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669141|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43669142|NCT02907632|Metoclopramide|metoclopramide|mesh-list
43975982|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
43975983|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43975984|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
43975985|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975986|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975987|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43975988|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44016856|NCT03608488|Vitamin D|vitamin d|mesh-list
43975989|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975990|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43975991|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43975992|NCT01842594|Sirolimus|sirolimus|mesh-list
43975993|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
43975994|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43975995|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975996|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43975997|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975998|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
43975999|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976000|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
43976001|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976002|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
43976003|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43976004|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43976005|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976006|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976007|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976008|NCT01843621|Vaccines|vaccines|mesh-list
43976009|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
44242458|NCT00596206|Leflunomide|leflunomide|mesh-list
44242459|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242460|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242461|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242462|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
44242463|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242464|NCT00596219|Celecoxib|celecoxib|mesh-list
44242465|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44242466|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44242467|NCT00596219|Analgesics|analgesics|mesh-ancestor
44242468|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
44242469|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242470|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242471|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242472|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976010|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976011|NCT01843751|Buprenorphine|buprenorphine|mesh-list
44016861|NCT03608839|Dexamethasone|dexamethasone|mesh-list
43976012|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43976013|NCT01843751|Naloxone|naloxone|mesh-list
43976014|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976015|NCT01843751|Narcotics|narcotics|mesh-ancestor
43976016|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976017|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976018|NCT01843751|Analgesics|analgesics|mesh-ancestor
43976019|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
43976020|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976021|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976022|NCT01843920|Trimethoprim|trimethoprim|mesh-list
43976023|NCT01843920|Polymyxins|polymyxins|mesh-list
43976024|NCT01843920|Polymyxin B|polymyxin b|mesh-list
43976025|NCT01843920|Prednisolone|prednisolone|mesh-list
43976026|NCT01843920|Timolol|timolol|mesh-list
43976027|NCT01843920|Dorzolamide|dorzolamide|mesh-list
44016900|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44016901|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148182|NCT00203528|Risperidone|risperidone|mesh-list
44148184|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
43976028|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976029|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
43976030|NCT01843920|Hormones|hormones|mesh-ancestor
43976032|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976033|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43976034|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976035|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43976036|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43976037|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976038|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976039|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976040|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976041|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976042|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43976043|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976045|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
43976046|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43976047|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43976048|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43976049|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976050|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43976051|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43976052|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43976053|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43976054|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242474|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242475|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242476|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242477|NCT00596297|Bevacizumab|bevacizumab|mesh-list
44242478|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242479|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242480|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44242481|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44242482|NCT00596297|Growth Substances|growth substances|mesh-ancestor
44242483|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242484|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242485|NCT00596336|Imiquimod|imiquimod|mesh-list
43976055|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43976056|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43976057|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43976058|NCT01844388|Laxatives|laxatives|mesh-ancestor
43976059|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976060|NCT01845636|Atropine|atropine|mesh-list
43976061|NCT01845636|Donepezil|donepezil|mesh-list
43976062|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43976063|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43976064|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43976065|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976066|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976067|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
43976068|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976069|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976070|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
43976071|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43976072|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976073|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43976074|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
44148238|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
44148239|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148241|NCT00203658|Tinzaparin|tinzaparin|mesh-list
43976075|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976076|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43976077|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
43976078|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
43976079|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
43976080|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43976081|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43976082|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
43976083|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976084|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43976085|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976086|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016912|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016913|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44016914|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016915|NCT03620890|Protamines|protamines|mesh-list
44016916|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
44016917|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016918|NCT03620890|Coagulants|coagulants|mesh-ancestor
44016919|NCT03621085|Ketamine|ketamine|mesh-list
44016920|NCT03621085|Analgesics|analgesics|mesh-ancestor
44016921|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
44016922|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016923|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669321|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669322|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
43669323|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669327|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
43669328|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
43669329|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669330|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669331|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669332|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
43669333|NCT02905305|Hormones|hormones|mesh-ancestor
43669334|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669335|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43669336|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846781|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
43846782|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846783|NCT04172844|Azacitidine|azacitidine|mesh-list
43846784|NCT04172844|Venetoclax|venetoclax|mesh-list
43846785|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43976087|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
43976088|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976089|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976090|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43976091|NCT01846455|Promethazine|promethazine|mesh-list
43976092|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
43976093|NCT01846455|Buprenorphine|buprenorphine|mesh-list
43976094|NCT01846455|Naloxone|naloxone|mesh-list
43976095|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976096|NCT01846455|Narcotics|narcotics|mesh-ancestor
43976097|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976098|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976099|NCT01846455|Analgesics|analgesics|mesh-ancestor
43976100|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
43976101|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242487|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
44242488|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242489|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242490|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
44242491|NCT00596375|Lidocaine|lidocaine|mesh-list
44242492|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
44242493|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
44242494|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242495|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976102|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976110|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43976111|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43976112|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43976113|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976114|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
43976115|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
43976116|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
43976117|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976118|NCT01846728|Estrogens|estrogens|mesh-list
43976119|NCT01846728|Hormones|hormones|mesh-ancestor
43976120|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016924|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44016927|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
43976121|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976122|NCT01847001|Paclitaxel|paclitaxel|mesh-list
43976123|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43976124|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
43976125|NCT01847001|Doxorubicin|doxorubicin|mesh-list
43976126|NCT01847001|Trastuzumab|trastuzumab|mesh-list
43976127|NCT01847001|Pertuzumab|pertuzumab|mesh-list
43976128|NCT01847001|Propranolol|propranolol|mesh-list
43976129|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43976130|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976131|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
43976132|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
43976133|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
43976134|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976135|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976136|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
43976137|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976138|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976139|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43976140|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
43976141|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43976142|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43976143|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43976144|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43976145|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976146|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43976147|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43976148|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43976149|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976150|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976151|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976152|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976153|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
43976154|NCT01847014|Macitentan|macitentan|mesh-list
44016962|NCT03631433|Ibuprofen|ibuprofen|mesh-list
43976155|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43976156|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43976157|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976158|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43976159|NCT01847131|Phenylephrine|phenylephrine|mesh-list
43976160|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
43976161|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43976162|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976163|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016994|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43669483|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
43669484|NCT02904031|Vitamins|vitamins|mesh-ancestor
43669485|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
43669486|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669487|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
43669488|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43669489|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
43669490|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669491|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669492|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43669493|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43669494|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43669495|NCT02904109|Mannitol|mannitol|mesh-list
43669496|NCT02904109|Triflusal|triflusal|mesh-list
43669497|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43669498|NCT02904109|Diuretics|diuretics|mesh-ancestor
43669499|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669500|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669501|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43669503|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
43669504|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669505|NCT02903901|Protective Agents|protective agents|mesh-ancestor
43669506|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669507|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669508|NCT02903498|Tegafur|tegafur|mesh-list
43669509|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669510|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
43826857|NCT05493735|Lidocaine|lidocaine|mesh-list
43669511|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669512|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669513|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
43669514|NCT02903524|Doxorubicin|doxorubicin|mesh-list
43669515|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43669516|NCT02903524|Pirarubicin|pirarubicin|mesh-list
43669517|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669518|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
43669519|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669520|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669521|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43669522|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
43669523|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669524|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669525|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43669526|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669527|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43669553|NCT02903251|Oxytocin|oxytocin|mesh-list
44242496|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
44242497|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242498|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242499|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44242500|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44242501|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242502|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976164|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976165|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976166|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976167|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
43976168|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
43976169|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976170|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
43976172|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
43976173|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43976174|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
44016998|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016999|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017000|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
44017001|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44017002|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
44017003|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
44017004|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017005|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
44017006|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44017007|NCT03633487|Guaifenesin|guaifenesin|mesh-list
44017008|NCT03633487|Expectorants|expectorants|mesh-ancestor
44017009|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017010|NCT03633526|Ivacaftor|ivacaftor|mesh-list
44017011|NCT03633526|VX-659|vx-659|mesh-list
44017012|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43669657|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43669658|NCT02902640|Expectorants|expectorants|mesh-ancestor
43669659|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
43669660|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43669661|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43669725|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
43669726|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669727|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43669728|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43669729|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43669730|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669731|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669732|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669733|NCT02902289|Ibuprofen|ibuprofen|mesh-list
43669735|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976175|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43976176|NCT01847131|Protective Agents|protective agents|mesh-ancestor
43976177|NCT01847469|Zonisamide|zonisamide|mesh-list
43976178|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
43976179|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43976180|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976181|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976182|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43976183|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976184|NCT01847638|Nepafenac|nepafenac|mesh-list
43976185|NCT01847638|Bromfenac|bromfenac|mesh-list
43976186|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43976187|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43713112|NCT02678520|Goserelin|goserelin|mesh-list
43976188|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017013|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976189|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976190|NCT01847638|Analgesics|analgesics|mesh-ancestor
43976191|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
43976192|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976193|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976194|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976195|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976196|NCT01848041|Phenylephrine|phenylephrine|mesh-list
43976197|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
43976198|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43976199|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43976200|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43976201|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976202|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976203|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976204|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976205|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976206|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
43976207|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
43976208|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976209|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
43976210|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43976211|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
43976212|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43976213|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
43976214|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43976215|NCT01848041|Protective Agents|protective agents|mesh-ancestor
43976216|NCT01848054|Buprenorphine|buprenorphine|mesh-list
43976217|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43976218|NCT01848054|Naloxone|naloxone|mesh-list
43976219|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976220|NCT01848054|Narcotics|narcotics|mesh-ancestor
43976221|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976222|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242504|NCT00596414|Meperidine|meperidine|mesh-list
44242505|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44242506|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44242507|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242508|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242509|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44242510|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242511|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242512|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44242513|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
44242514|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
44242515|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
44242516|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
44242517|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242518|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242519|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976223|NCT01848054|Analgesics|analgesics|mesh-ancestor
43976224|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
43976225|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976226|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976227|NCT01848067|Prednisone|prednisone|mesh-list
43976228|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
43976229|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976230|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
43976231|NCT01848067|Hormones|hormones|mesh-ancestor
43976232|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976233|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976234|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43976235|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976236|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43976237|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976238|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976239|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
43976240|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43976241|NCT01848899|Bivalirudin|bivalirudin|mesh-list
43976242|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
43976243|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43976244|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
43976261|NCT01849692|Growth Substances|growth substances|mesh-ancestor
43976262|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976263|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
43976264|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976265|NCT01849770|Mexiletine|mexiletine|mesh-list
43976266|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976267|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976268|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43669851|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976269|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976270|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976271|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
43976272|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43976282|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43976283|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
43976284|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976285|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976286|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976287|NCT01852175|Ticagrelor|ticagrelor|mesh-list
43976288|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44242521|NCT00596414|Analgesics|analgesics|mesh-ancestor
44242522|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
43976289|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43976290|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43976291|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43976292|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43976293|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
43976294|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017102|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017103|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
43976295|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976296|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976297|NCT01852344|Methylphenidate|methylphenidate|mesh-list
43976298|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43976299|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976300|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43976301|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43976302|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976303|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976304|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
43976305|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976306|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43976307|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43976308|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43976309|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976310|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976311|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976312|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976313|NCT01852383|Analgesics|analgesics|mesh-ancestor
43976314|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
43976315|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976316|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
44017106|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017107|NCT03655301|Metformin|metformin|mesh-list
44017108|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44017109|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017110|NCT03655444|Nivolumab|nivolumab|mesh-list
44017111|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44017112|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017113|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44017114|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017115|NCT03657407|Glycerol|glycerol|mesh-list
44017116|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44017117|NCT03657407|Protective Agents|protective agents|mesh-ancestor
44017118|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017119|NCT03661346|Labetalol|labetalol|mesh-list
44017120|NCT03661346|Esmolol|esmolol|mesh-list
44017121|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44017122|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44017123|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44017124|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
43748604|NCT02516631|Misoprostol|misoprostol|mesh-list
44017125|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017126|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017127|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669930|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669932|NCT02900417|Hormones|hormones|mesh-ancestor
43669933|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669934|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43669935|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
43669936|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669937|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669939|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669940|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669941|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
43669942|NCT02900430|Clotrimazole|clotrimazole|mesh-list
43669943|NCT02900430|Miconazole|miconazole|mesh-list
43976317|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43976318|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
43976319|NCT01852669|Furosemide|furosemide|mesh-list
43976320|NCT01852669|Diuretics|diuretics|mesh-ancestor
43976321|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
43976322|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976323|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44017130|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
44017131|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017133|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43976324|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976325|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976326|NCT01852955|Acetaminophen|acetaminophen|mesh-list
43976327|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976328|NCT01852955|Analgesics|analgesics|mesh-ancestor
43976329|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
43976330|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976331|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976332|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
43976333|NCT01853085|Bimatoprost|bimatoprost|mesh-list
43976334|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43976342|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43976343|NCT01853553|Diuretics|diuretics|mesh-ancestor
43976344|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
43976346|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
43976347|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
43976348|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
43976349|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976350|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976351|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976352|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43976353|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976354|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976355|NCT01854359|Idebenone|idebenone|mesh-list
43976356|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
43976357|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976358|NCT01854359|Protective Agents|protective agents|mesh-ancestor
43976359|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976360|NCT01854593|Bevacizumab|bevacizumab|mesh-list
43976361|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43976362|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976363|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44242523|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242524|NCT00596479|Lenograstim|lenograstim|mesh-list
43976364|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43976365|NCT01854593|Growth Substances|growth substances|mesh-ancestor
43976366|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976367|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
43976368|NCT01855360|Doxycycline|doxycycline|mesh-list
43976369|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43976370|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43976371|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976372|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
43976373|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43976374|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43976375|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
43976376|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43976377|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976378|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43976379|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
43976380|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
43976381|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976382|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976383|NCT01856530|Oxytocin|oxytocin|mesh-list
43976384|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
43976385|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43976386|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976387|NCT01856712|Naltrexone|naltrexone|mesh-list
43976388|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43976389|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976390|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976391|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
43976392|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976393|NCT01857232|Dexamethasone|dexamethasone|mesh-list
43976394|NCT01857232|Ondansetron|ondansetron|mesh-list
43976395|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
43976396|NCT01857232|Aprepitant|aprepitant|mesh-list
44148283|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44148284|NCT00203736|Renal Agents|renal agents|mesh-ancestor
44148285|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43976397|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976398|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
43976399|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
43976400|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976401|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976402|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976403|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
43976404|NCT01857232|Hormones|hormones|mesh-ancestor
43976406|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44017140|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43670115|NCT02898012|Temozolomide|temozolomide|mesh-list
43670116|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670117|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670118|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670119|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43670120|NCT02898012|Growth Substances|growth substances|mesh-ancestor
43670121|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670122|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670123|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43670124|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
43670125|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670126|NCT02897869|Amikacin|amikacin|mesh-list
43670127|NCT02897869|Murepavadin|murepavadin|mesh-list
43670128|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670129|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670130|NCT02897856|Midazolam|midazolam|mesh-list
43670131|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43670132|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43670133|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670134|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670135|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43670136|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43670137|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43670138|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43670139|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
43670140|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
43670141|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
43670142|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
43670143|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976408|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
43976409|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
43976410|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43976411|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
43976412|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976413|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976414|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43976415|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43976416|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976417|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43976418|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43976419|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43976420|NCT01857297|Vaccines|vaccines|mesh-list
43976421|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
43976422|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976423|NCT01857362|Nitisinone|nitisinone|mesh-list
43976424|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976425|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976426|NCT01858428|Paclitaxel|paclitaxel|mesh-list
43976427|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43976428|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976429|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
43976430|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
43976431|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
43976432|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976433|NCT01859013|Topiramate|topiramate|mesh-list
43976434|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
44017153|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44017154|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017155|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976435|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43976436|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976437|NCT01859078|Digoxin|digoxin|mesh-list
43976438|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976439|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43976440|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242525|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44242526|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
44242527|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242529|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44242530|NCT00596557|Everolimus|everolimus|mesh-list
44242531|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242532|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242533|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
44017167|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017168|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44017169|NCT03664544|Protective Agents|protective agents|mesh-ancestor
44017170|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017171|NCT03665155|Daratumumab|daratumumab|mesh-list
44017172|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017173|NCT03666663|Lidocaine|lidocaine|mesh-list
44017174|NCT03666663|Bupivacaine|bupivacaine|mesh-list
44017175|NCT03666663|Ropivacaine|ropivacaine|mesh-list
44017176|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017177|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
44017178|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017179|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017180|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
43670243|NCT02897011|Methotrexate|methotrexate|mesh-list
43670252|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
43976441|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976442|NCT01859078|Protective Agents|protective agents|mesh-ancestor
43976443|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976444|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
43976445|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43976446|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976447|NCT01859637|Lenograstim|lenograstim|mesh-list
43976448|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43976449|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
43976450|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976451|NCT01860287|Buprenorphine|buprenorphine|mesh-list
43976452|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976453|NCT01860287|Narcotics|narcotics|mesh-ancestor
43976454|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976455|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976456|NCT01860287|Analgesics|analgesics|mesh-ancestor
43976457|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
43976458|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976459|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976460|NCT01860521|Sufentanil|sufentanil|mesh-list
43976461|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
43976462|NCT01860521|Gemeprost|gemeprost|mesh-list
43976463|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976464|NCT01860521|Narcotics|narcotics|mesh-ancestor
43976465|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976466|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976467|NCT01860521|Analgesics|analgesics|mesh-ancestor
43976468|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
43976469|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976470|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43976471|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43976472|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
43976473|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
43976474|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976475|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43976476|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
43976477|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43976478|NCT01860586|Bevacizumab|bevacizumab|mesh-list
43976481|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43976482|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43976483|NCT01860586|Growth Substances|growth substances|mesh-ancestor
43976484|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976485|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
43976487|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43976488|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
43976489|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976490|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976491|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43976492|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
43976493|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43976494|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976495|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976496|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43976497|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
43976499|NCT01861002|Methotrexate|methotrexate|mesh-list
43976500|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
43976501|NCT01861002|Azacitidine|azacitidine|mesh-list
44242534|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242535|NCT00596596|Prucalopride|prucalopride|mesh-list
44242536|NCT00596596|Laxatives|laxatives|mesh-ancestor
44242537|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242538|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44242539|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44242540|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
44242541|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242542|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242543|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976502|NCT01861002|Fludarabine|fludarabine|mesh-list
43976503|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43976504|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
43976505|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43976506|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976507|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43976508|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
43976509|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976510|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976511|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
43976512|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976513|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43976514|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976515|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
43976516|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976517|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43976518|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
43976519|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976520|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43976521|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976522|NCT01861665|Bupivacaine|bupivacaine|mesh-list
43976523|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976524|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
43976525|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976526|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976527|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
43976528|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017254|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44017255|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44017256|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44017257|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44017258|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44017260|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43976529|NCT01862536|Tadalafil|tadalafil|mesh-list
43976530|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
43976531|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43976532|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43976533|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976534|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976535|NCT01862536|Urological Agents|urological agents|mesh-ancestor
43976536|NCT01862614|Epinephrine|epinephrine|mesh-list
43976537|NCT01862614|Racepinephrine|racepinephrine|mesh-list
43976538|NCT01862614|Carticaine|carticaine|mesh-list
43976539|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
43976540|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43976541|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976542|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976543|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976544|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976545|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976546|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43976547|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43976548|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
43976549|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976550|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43976551|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
43976557|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976558|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
43976559|NCT01863134|Eptifibatide|eptifibatide|mesh-list
43623570|NCT04221880|Lidocaine|lidocaine|mesh-list
44242544|NCT00596609|Morphine|morphine|mesh-list
44242545|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44242546|NCT00596609|Narcotics|narcotics|mesh-ancestor
44242547|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242548|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242549|NCT00596609|Analgesics|analgesics|mesh-ancestor
44242550|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
44242551|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242552|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44242553|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242554|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242555|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976560|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43976562|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43976563|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976564|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976565|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017293|NCT03696758|Urological Agents|urological agents|mesh-ancestor
44017294|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017296|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
44143996|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143997|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143998|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143999|NCT00191087|Analgesics|analgesics|mesh-ancestor
44144000|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
44144001|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144002|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144003|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144004|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
44144005|NCT00191126|Gemcitabine|gemcitabine|mesh-list
44144007|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144008|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144009|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
44144010|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144011|NCT00191126|Antiviral Agents|antiviral agents|mesh-ancestor
44144012|NCT00191126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144013|NCT00191126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144014|NCT00191126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144015|NCT00191126|Immunologic Factors|immunologic factors|mesh-ancestor
44017317|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44144016|NCT00191126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144017|NCT00191178|Insulin|insulin|mesh-list
44144018|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44144019|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
44144020|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
44144021|NCT00191178|Protamines|protamines|mesh-list
44144022|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44144023|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144024|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
44144025|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144026|NCT00191178|Coagulants|coagulants|mesh-ancestor
44144027|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44144028|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44144029|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144030|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144031|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144032|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144033|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144034|NCT00191204|Analgesics|analgesics|mesh-ancestor
44144035|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
44017337|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017339|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
44144036|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144037|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144038|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144039|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
44144040|NCT00191230|Gemcitabine|gemcitabine|mesh-list
44144041|NCT00191230|Cisplatin|cisplatin|mesh-list
44144042|NCT00191230|Carboplatin|carboplatin|mesh-list
44242556|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242558|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242559|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44242560|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44242561|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44242562|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242563|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242564|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242565|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242566|NCT00596986|Analgesics|analgesics|mesh-ancestor
44242567|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
44242568|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242569|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
44242570|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242571|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
44242572|NCT00597064|Prednisone|prednisone|mesh-list
44242573|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242574|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
44144043|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144044|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144045|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
44144046|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144047|NCT00191230|Antiviral Agents|antiviral agents|mesh-ancestor
44144048|NCT00191230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144049|NCT00191230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144050|NCT00191230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144051|NCT00191230|Immunologic Factors|immunologic factors|mesh-ancestor
44144052|NCT00191230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713510|NCT02676011|Atropine|atropine|mesh-list
43976566|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43976589|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976590|NCT01868425|Analgesics|analgesics|mesh-ancestor
43976591|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43976592|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43976593|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
43976594|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43976595|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43976596|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976597|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976598|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976599|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
43976600|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
43976601|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43976602|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43976603|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43976604|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
43976605|NCT01868633|Dexamethasone|dexamethasone|mesh-list
43976606|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976607|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
43976608|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
43976609|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976610|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976611|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976612|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
44242575|NCT00597064|Hormones|hormones|mesh-ancestor
44242576|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242577|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242578|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44242579|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242580|NCT00597181|Mitomycins|mitomycins|mesh-list
44242581|NCT00597181|Mitomycin|mitomycin|mesh-list
44242582|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44242583|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976613|NCT01868633|Hormones|hormones|mesh-ancestor
43976614|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976615|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43976616|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976617|NCT01868776|Lidocaine|lidocaine|mesh-list
43976618|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976619|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
43976620|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976621|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976625|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976626|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43976627|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976628|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976629|NCT01869634|Ritonavir|ritonavir|mesh-list
43976630|NCT01869634|Darunavir|darunavir|mesh-list
43976631|NCT01869634|Emtricitabine|emtricitabine|mesh-list
43976632|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43976633|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43976634|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
43976635|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976636|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976637|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43976638|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43976639|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
43976640|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976641|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43976642|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43976643|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43976644|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43976646|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43976647|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976648|NCT01870596|Cytarabine|cytarabine|mesh-list
43976649|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43976650|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
43976651|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976652|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976653|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
43976654|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976655|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976656|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
43976657|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976658|NCT01871077|Ketorolac|ketorolac|mesh-list
43976659|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43976660|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976661|NCT01871077|Analgesics|analgesics|mesh-ancestor
43976662|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
43976663|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976664|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976665|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976666|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976667|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43976668|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976669|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976670|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
43976671|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
44242584|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
44242585|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242586|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670409|NCT02895191|Urinastatin|urinastatin|mesh-list
43670410|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
43670411|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43670412|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670413|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670414|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670415|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
43670416|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43670417|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43670418|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670419|NCT02895061|Vitamins|vitamins|mesh-ancestor
43670420|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
43670421|NCT02895113|Aspirin|aspirin|mesh-list
43670422|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43670423|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670424|NCT02895113|Analgesics|analgesics|mesh-ancestor
43670425|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
43670426|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670427|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670428|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670429|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670430|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43670431|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43670432|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670433|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43670450|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670451|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
43670456|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43670457|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44242587|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242588|NCT00597233|Insulin|insulin|mesh-list
43976672|NCT01871441|Tacrolimus|tacrolimus|mesh-list
43976673|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976674|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
43976675|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976676|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976677|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43976678|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
43976679|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976680|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976681|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43976682|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43976683|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976684|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43976685|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43976686|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
43976687|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43976688|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976689|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
43976690|NCT01873989|Testosterone|testosterone|mesh-list
43976691|NCT01873989|Androgens|androgens|mesh-ancestor
43976692|NCT01873989|Hormones|hormones|mesh-ancestor
44165296|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43976700|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976701|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976702|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43976703|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976704|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976705|NCT01874392|Insulin|insulin|mesh-list
43976706|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43976707|NCT01874392|Pancrelipase|pancrelipase|mesh-list
43976708|NCT01874392|Pancreatin|pancreatin|mesh-list
43976709|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43976710|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976711|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976712|NCT01874951|Naltrexone|naltrexone|mesh-list
43976713|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43976714|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43976715|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713634|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
43976716|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
43976717|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976718|NCT01875159|Caffeine|caffeine|mesh-list
43976719|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
43976720|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976721|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43976722|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976723|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43976724|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976725|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43976726|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43976727|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
43976728|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976729|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43976730|NCT01875510|SMOFlipid|smoflipid|mesh-list
43976731|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43976732|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43976733|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43976734|NCT01876212|Dasatinib|dasatinib|mesh-list
43976735|NCT01876212|Vaccines|vaccines|mesh-list
43976736|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
43976737|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976738|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976739|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43976740|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871149|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242590|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
44242591|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
44017521|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
44242592|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
44242593|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
44242594|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242595|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242596|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44242597|NCT00597259|Entecavir|entecavir|mesh-list
44242598|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
44242599|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242600|NCT00597389|Propranolol|propranolol|mesh-list
44242601|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44242602|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44242603|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44242604|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242605|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242606|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242607|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242608|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976741|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976742|NCT01876992|Metformin|metformin|mesh-list
43976743|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43976744|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976745|NCT01877538|Donepezil|donepezil|mesh-list
43976746|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43976747|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976748|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976749|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
43976750|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976751|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976752|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
43976753|NCT01877642|Lorazepam|lorazepam|mesh-list
43976754|NCT01877642|Loxapine|loxapine|mesh-list
43976755|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
43976756|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
43976757|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
43976758|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976759|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976768|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976769|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976770|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43976771|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43976773|NCT01878006|Morphine|morphine|mesh-list
43976774|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976775|NCT01878006|Narcotics|narcotics|mesh-ancestor
43976776|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976777|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976778|NCT01878006|Analgesics|analgesics|mesh-ancestor
43976779|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
43976780|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976781|NCT01878526|Domperidone|domperidone|mesh-list
43976782|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
43976783|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
43976784|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844328|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
44242609|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
44242611|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44242612|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44242613|NCT00597415|Analgesics|analgesics|mesh-ancestor
44242614|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
44242615|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017576|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43827080|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43827081|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43846831|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846832|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846833|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846834|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670649|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670650|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
43670651|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670652|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670653|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
43670654|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670655|NCT05427383|Paclitaxel|paclitaxel|mesh-list
43670656|NCT05427383|Docetaxel|docetaxel|mesh-list
43670657|NCT05427383|Irinotecan|irinotecan|mesh-list
43670660|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44017577|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
44242616|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242617|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242618|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242619|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43976785|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976786|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976787|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43976788|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
43976789|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976790|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976791|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43976792|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
43976793|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976794|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43976795|NCT01878656|Sevoflurane|sevoflurane|mesh-list
43976796|NCT01878656|Desflurane|desflurane|mesh-list
43976797|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43976798|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43976799|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
43976800|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
43976801|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976802|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976803|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
43976804|NCT01878799|Ledipasvir|ledipasvir|mesh-list
43976805|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
43976806|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976807|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43976808|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
43976809|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976810|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43976811|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976812|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976813|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43976814|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
43976815|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976816|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43976817|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976818|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976819|NCT01879371|Ibuprofen|ibuprofen|mesh-list
43976820|NCT01879371|Caffeine|caffeine|mesh-list
43976821|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43976822|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976823|NCT01879371|Analgesics|analgesics|mesh-ancestor
43976824|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
44017612|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976825|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976826|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976827|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976828|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976829|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43976830|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976831|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976832|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43976833|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43976834|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44242620|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242621|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242622|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242623|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44242624|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017622|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44017623|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017624|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44017625|NCT04256603|Gabapentin|gabapentin|mesh-list
44017626|NCT04256603|Analgesics|analgesics|mesh-ancestor
44017627|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
44017628|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670785|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
44017638|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242625|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242626|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242627|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459481|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459482|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459483|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459484|NCT01578551|Growth Substances|growth substances|mesh-ancestor
44459485|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459486|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
44017639|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
44017640|NCT04290494|Plasminogen|plasminogen|mesh-list
44017641|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44017642|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44017643|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017644|NCT04303156|Islatravir|islatravir|mesh-list
44017645|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
44017646|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017647|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459487|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459488|NCT01578499|Methotrexate|methotrexate|mesh-list
43976835|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43976836|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
43976837|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976838|NCT05329090|Rituximab|rituximab|mesh-list
43976839|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43976840|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976841|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
43976842|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976843|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017648|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017649|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44017650|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44017651|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44017652|NCT04323852|Vitamin D|vitamin d|mesh-list
44017653|NCT04323852|Vitamins|vitamins|mesh-ancestor
44017654|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
44017655|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017656|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44017657|NCT04327843|Haloperidol|haloperidol|mesh-list
43670809|NCT05424692|Vitamins|vitamins|mesh-ancestor
43976844|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
43976845|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43976846|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43976847|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43976848|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
43976849|NCT05328674|Mitogens|mitogens|mesh-list
43976850|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
43976851|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976852|NCT05328635|Candesartan|candesartan|mesh-list
43976853|NCT05328635|Gabapentin|gabapentin|mesh-list
43976854|NCT05328635|Analgesics|analgesics|mesh-ancestor
43976855|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
44017658|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
44017659|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
44017660|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
44017661|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017662|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017663|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44017664|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44017665|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44017666|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017667|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44017668|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43644793|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976856|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976857|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976858|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
43976859|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43976860|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43976861|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976862|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43976863|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43976864|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43976865|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976866|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976867|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
43976868|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017669|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
44017670|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017671|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670810|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
43976869|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43976870|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43976871|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
43976872|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
43976873|NCT05328427|Protective Agents|protective agents|mesh-ancestor
43976874|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976875|NCT05328310|Nebivolol|nebivolol|mesh-list
44459489|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44459490|NCT01578499|Bexarotene|bexarotene|mesh-list
44459491|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44459492|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
44459493|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44459494|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459495|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44459496|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
44459497|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459498|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459499|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44459500|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976876|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976877|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
43976878|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43976879|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44017672|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44017673|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
44017674|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44017675|NCT04373421|Benzydamine|benzydamine|mesh-list
44017676|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44017677|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017678|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
44017679|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
44017680|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017681|NCT04420572|Betamethasone|betamethasone|mesh-list
44017682|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017683|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
44017684|NCT04420572|Hormones|hormones|mesh-ancestor
44017685|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44017686|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017687|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017688|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017689|NCT04501640|Mirabegron|mirabegron|mesh-list
44017690|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44017691|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44017692|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44017693|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017694|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017695|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976880|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976881|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976882|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976883|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976884|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144053|NCT00191243|Gemcitabine|gemcitabine|mesh-list
44144054|NCT00191243|Docetaxel|docetaxel|mesh-list
44144055|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144056|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
44144057|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017696|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017697|NCT04501640|Urological Agents|urological agents|mesh-ancestor
44017698|NCT04926233|Bromides|bromides|mesh-list
43827083|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
44144058|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144060|NCT00191243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144061|NCT00191243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144062|NCT00191243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144063|NCT00191243|Immunologic Factors|immunologic factors|mesh-ancestor
44144064|NCT00191243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144065|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144066|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144067|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144068|NCT00191256|Gemcitabine|gemcitabine|mesh-list
44144069|NCT00191256|Paclitaxel|paclitaxel|mesh-list
44144070|NCT00191256|Carboplatin|carboplatin|mesh-list
44144077|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144078|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
44144079|NCT00191256|Antiviral Agents|antiviral agents|mesh-ancestor
44144080|NCT00191256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144081|NCT00191256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144082|NCT00191256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144083|NCT00191256|Immunologic Factors|immunologic factors|mesh-ancestor
44144084|NCT00191256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144085|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44017699|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
44017700|NCT04926233|Olodaterol|olodaterol|mesh-list
44017701|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44017702|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
44017703|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017704|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017705|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017706|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017707|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
44017708|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44017709|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017710|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017711|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017712|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
44017713|NCT04943159|Afamelanotide|afamelanotide|mesh-list
44017714|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44017715|NCT04525157|Afamelanotide|afamelanotide|mesh-list
44017716|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
44017717|NCT04511520|Trimetazidine|trimetazidine|mesh-list
44017718|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44017719|NCT04495712|Spironolactone|spironolactone|mesh-list
44144086|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144087|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144088|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144089|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144090|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144091|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017720|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44017721|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
44017722|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44017723|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017724|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44144092|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144093|NCT00191321|Teriparatide|teriparatide|mesh-list
44144094|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44144095|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144096|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144097|NCT00191347|Gemcitabine|gemcitabine|mesh-list
44144098|NCT00191347|Pemetrexed|pemetrexed|mesh-list
44144099|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144100|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
44459501|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44459502|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459503|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
44459504|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459505|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44459506|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459507|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44459508|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44459509|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459511|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
44459512|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459513|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144101|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144102|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144103|NCT00191347|Antiviral Agents|antiviral agents|mesh-ancestor
44144104|NCT00191347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144105|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144106|NCT00191347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43976885|NCT05328102|Lenalidomide|lenalidomide|mesh-list
43976886|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
43976887|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976888|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43976889|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43976890|NCT05328102|Growth Substances|growth substances|mesh-ancestor
43976891|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
43976892|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976893|NCT05327894|Blinatumomab|blinatumomab|mesh-list
43976894|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43976895|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976896|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
43976897|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976898|NCT05327777|Oxycodone|oxycodone|mesh-list
43976899|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976900|NCT05327777|Narcotics|narcotics|mesh-ancestor
43976901|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976902|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976903|NCT05327777|Analgesics|analgesics|mesh-ancestor
43976904|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
43976905|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976906|NCT05327751|Celecoxib|celecoxib|mesh-list
43976907|NCT05327751|Capecitabine|capecitabine|mesh-list
43976908|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43976909|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
43976910|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976911|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976912|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017764|NCT04456634|Lumefantrine|lumefantrine|mesh-list
44017765|NCT04456634|Artemether|artemether|mesh-list
44017766|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44017767|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
44017768|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43976913|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976914|NCT05327751|Analgesics|analgesics|mesh-ancestor
43976915|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
43976916|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976918|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976919|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976920|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43976921|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43976922|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976923|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
43976924|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
43976925|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976926|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
43976927|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459514|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459515|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459516|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44242629|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017769|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017770|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017771|NCT04428359|Vitamin D|vitamin d|mesh-list
44017772|NCT04428359|Vitamins|vitamins|mesh-ancestor
44017773|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
44017774|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017775|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44017776|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
44017777|NCT04410159|Listerine|listerine|mesh-list
44017778|NCT04410159|Povidone|povidone|mesh-list
44017779|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
44017780|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
44017781|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44017782|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017783|NCT04425850|Ivermectin|ivermectin|mesh-list
44017784|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017785|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017786|NCT04425746|Afamelanotide|afamelanotide|mesh-list
44017787|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44017788|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
44242630|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242631|NCT00597662|Icodextrin|icodextrin|mesh-list
44242632|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
44242633|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44242634|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
44242635|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44242636|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242637|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
44242638|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
44242639|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242640|NCT00598013|Pioglitazone|pioglitazone|mesh-list
43976928|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976929|NCT05327582|Paclitaxel|paclitaxel|mesh-list
43976930|NCT05327582|Durvalumab|durvalumab|mesh-list
43976931|NCT05327582|Lenvatinib|lenvatinib|mesh-list
43976932|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43976933|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976934|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
43976935|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
43976936|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
43976937|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976938|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43976939|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43976940|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976941|NCT05327309|Bleomycin|bleomycin|mesh-list
43976942|NCT05327309|Propranolol|propranolol|mesh-list
43976943|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43976944|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43976945|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976946|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976947|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976948|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976949|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976950|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976951|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
43976952|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43976953|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976954|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
43976955|NCT05327088|Nalbuphine|nalbuphine|mesh-list
43976956|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43976957|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976958|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976959|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43976960|NCT05327088|Analgesics|analgesics|mesh-ancestor
43976961|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
43976962|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976963|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43976964|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43976965|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976966|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976967|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976968|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976969|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43976970|NCT05327088|Narcotics|narcotics|mesh-ancestor
43976971|NCT05326984|Metformin|metformin|mesh-list
43976972|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43976973|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242641|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242642|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242643|NCT00598052|Citalopram|citalopram|mesh-list
43722173|NCT02618603|Hormones|hormones|mesh-ancestor
43976974|NCT05326867|Lidocaine|lidocaine|mesh-list
43976975|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976976|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
43976977|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976978|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976979|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
43976980|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976981|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017851|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44017852|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017853|NCT04343222|Bromfenac|bromfenac|mesh-list
44017854|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
44017855|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44017856|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44017857|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017858|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017859|NCT04343222|Analgesics|analgesics|mesh-ancestor
43976982|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43976983|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43976984|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43976985|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976986|NCT05326841|Vitamin D|vitamin d|mesh-list
43976987|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
43976988|NCT05326841|Vitamins|vitamins|mesh-ancestor
43976989|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
43976990|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017860|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
44017861|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017862|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017863|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976992|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43976993|NCT05324995|Celecoxib|celecoxib|mesh-list
43976994|NCT05324995|Epinephrine|epinephrine|mesh-list
43976995|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43976996|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43976997|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
43976998|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976999|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977000|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977001|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43977002|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43977003|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
43977004|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977005|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43977006|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977007|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
43977008|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
44017864|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017865|NCT04343092|Ivermectin|ivermectin|mesh-list
44017866|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017867|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017868|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
44017869|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44017870|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44017871|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017872|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017873|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44017874|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44017875|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44017876|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017877|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017878|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017879|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
44017880|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43834336|NCT05148000|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43977009|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43977010|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977011|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977012|NCT05324995|Analgesics|analgesics|mesh-ancestor
43977013|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
43977014|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977015|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977016|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43977017|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43977018|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977019|NCT05318521|Ibuprofen|ibuprofen|mesh-list
43977020|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977021|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977022|NCT05318521|Analgesics|analgesics|mesh-ancestor
43977023|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
43977024|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977025|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017881|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
44017882|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43644796|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644797|NCT04418401|Antibodies|antibodies|mesh-list
43644798|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
43644799|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644800|NCT04404140|Docetaxel|docetaxel|mesh-list
43977026|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977027|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977028|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43977029|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977030|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977031|NCT05304364|Naltrexone|naltrexone|mesh-list
43977032|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43977033|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44017883|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44017884|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017885|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43644801|NCT04404140|Atezolizumab|atezolizumab|mesh-list
43977034|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144107|NCT00191347|Immunologic Factors|immunologic factors|mesh-ancestor
43977035|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
43977036|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977037|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
43977038|NCT05302336|Docetaxel|docetaxel|mesh-list
43977039|NCT05302336|Doxorubicin|doxorubicin|mesh-list
43977040|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44017888|NCT04342130|Narcotics|narcotics|mesh-ancestor
44017889|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644802|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977041|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977042|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
44242644|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44242645|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44242646|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242647|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242648|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242649|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
44242650|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242651|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44242652|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
44242653|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44242654|NCT00598091|Gemcitabine|gemcitabine|mesh-list
44242655|NCT00598091|Dasatinib|dasatinib|mesh-list
44242656|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44242657|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
43977043|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977044|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977045|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44017890|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017891|NCT04342130|Analgesics|analgesics|mesh-ancestor
44017892|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
44017893|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017894|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44017895|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
44017896|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017897|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017898|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
44017899|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44017900|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44017901|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017902|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
43977046|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
43977047|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977048|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977049|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43977050|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977051|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977052|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977053|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977054|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977055|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977056|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977057|NCT05301712|Naloxone|naloxone|mesh-list
43977058|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43977059|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977060|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
43977061|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977062|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43850373|NCT05626439|Alprazolam|alprazolam|mesh-list
43977072|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
44017903|NCT04338074|Coagulants|coagulants|mesh-ancestor
44017904|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
44017905|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977073|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43977074|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43977075|NCT05300841|Progestins|progestins|mesh-ancestor
43977076|NCT05290194|Capecitabine|capecitabine|mesh-list
43977077|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43977078|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977079|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
43977080|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977081|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977082|NCT05244226|Fentanyl|fentanyl|mesh-list
43977083|NCT05244226|Methadone|methadone|mesh-list
43977084|NCT05244226|Hydromorphone|hydromorphone|mesh-list
43977085|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44017906|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977086|NCT05244226|Narcotics|narcotics|mesh-ancestor
43977087|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977088|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977089|NCT05244226|Analgesics|analgesics|mesh-ancestor
43977090|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
43977091|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977092|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44017907|NCT04335552|Azithromycin|azithromycin|mesh-list
44017908|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
44017909|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44017910|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017911|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
44017912|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44017913|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017914|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977093|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977094|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
43977095|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
43977096|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
44242658|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242659|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242660|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
44242661|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242662|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242663|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242664|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
43977097|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977098|NCT05228574|Amiloride|amiloride|mesh-list
43977099|NCT05228574|Diuretics|diuretics|mesh-ancestor
43977100|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
43977101|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977102|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43977103|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43977104|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43977105|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977106|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43977107|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43977108|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
43977109|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43977110|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43977111|NCT05058287|Prednisolone|prednisolone|mesh-list
43977112|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
43977113|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43977114|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
43977115|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977116|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
43977117|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
43977118|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977119|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977120|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977121|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
43977122|NCT05058287|Hormones|hormones|mesh-ancestor
43977123|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977124|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43977125|NCT05058287|Protective Agents|protective agents|mesh-ancestor
43977126|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977127|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144108|NCT00191347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144109|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44165297|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
44144114|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
44144115|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144116|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144117|NCT00191373|Antiviral Agents|antiviral agents|mesh-ancestor
44144118|NCT00191373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144119|NCT00191373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144120|NCT00191373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144121|NCT00191373|Immunologic Factors|immunologic factors|mesh-ancestor
44144122|NCT00191373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144123|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144124|NCT00191399|Olanzapine|olanzapine|mesh-list
44144125|NCT00191399|Fluoxetine|fluoxetine|mesh-list
44144126|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
44144127|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
44144128|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144129|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144130|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44144131|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44144132|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44017917|NCT04334876|Antibodies|antibodies|mesh-list
44017981|NCT04310085|Artemether|artemether|mesh-list
43834337|NCT05148000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644804|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144133|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144134|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144135|NCT00191399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44144136|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144137|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144138|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242665|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242666|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242667|NCT00598156|Bevacizumab|bevacizumab|mesh-list
44242668|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44242669|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144139|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144140|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
44144141|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44144142|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144143|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44144144|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44144145|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144146|NCT00191412|Pemetrexed|pemetrexed|mesh-list
44144147|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144148|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144149|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144150|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44144151|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144152|NCT00191425|Teriparatide|teriparatide|mesh-list
44144153|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44144154|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44144155|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144156|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144157|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44017982|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44017983|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
44017984|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44017985|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017986|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017987|NCT04297631|Tobramycin|tobramycin|mesh-list
44017988|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44144158|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
44144159|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44144160|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44144161|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44144162|NCT00191438|Gemcitabine|gemcitabine|mesh-list
44144163|NCT00191438|Capecitabine|capecitabine|mesh-list
43977128|NCT04986072|Nitroprusside|nitroprusside|mesh-list
43977129|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43977130|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
43977131|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43977132|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977133|NCT04969627|Metformin|metformin|mesh-list
43977134|NCT04969627|Exenatide|exenatide|mesh-list
43977135|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977136|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977137|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43977138|NCT04969627|Incretins|incretins|mesh-ancestor
43977139|NCT04969627|Hormones|hormones|mesh-ancestor
43977140|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977141|NCT04953325|Vaccines|vaccines|mesh-list
43977142|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43977143|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
43977153|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977155|NCT04885712|Pioglitazone|pioglitazone|mesh-list
43977156|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
43977157|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977158|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977159|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43977160|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977161|NCT04871061|Fentanyl|fentanyl|mesh-list
43977162|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43977163|NCT04871061|Narcotics|narcotics|mesh-ancestor
43977164|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977165|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977166|NCT04871061|Analgesics|analgesics|mesh-ancestor
43977167|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
43977168|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977169|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43977170|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977171|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
43977172|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
43977173|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
43977174|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
43977175|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
43977176|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242670|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242671|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44242672|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44242673|NCT00598156|Growth Substances|growth substances|mesh-ancestor
44242674|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242675|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242676|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44242677|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242678|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242679|NCT00598169|Dexamethasone|dexamethasone|mesh-list
44242680|NCT00598169|Rituximab|rituximab|mesh-list
43977177|NCT04837066|Imidacloprid|imidacloprid|mesh-list
43977178|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
43977179|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977180|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977181|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977182|NCT04827537|Metronidazole|metronidazole|mesh-list
43977183|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977184|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43977185|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43977186|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43977187|NCT04814927|Copper|copper|mesh-list
43977188|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43977189|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
43977190|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
43977191|NCT04814927|Etonogestrel|etonogestrel|mesh-list
43977192|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43977193|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
43977194|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43977195|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977196|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43977197|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43977198|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43977199|NCT04814927|Trace Elements|trace elements|mesh-ancestor
43977200|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
43977201|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43977202|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43977203|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714043|NCT02671318|Sirolimus|sirolimus|mesh-list
44148363|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644806|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644807|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
43977204|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977205|NCT04810949|Vitamin D|vitamin d|mesh-list
43977206|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
43977207|NCT04810949|Vitamins|vitamins|mesh-ancestor
43977208|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
43977209|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977210|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43977215|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977216|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148364|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148365|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
44148366|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
44148367|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977218|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977219|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
43977220|NCT04795583|Hormones|hormones|mesh-ancestor
43977221|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977222|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977223|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977224|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977225|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43977226|NCT04774068|Romidepsin|romidepsin|mesh-list
43977227|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977228|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977229|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977230|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43977232|NCT04728087|Coagulants|coagulants|mesh-ancestor
43977233|NCT04654507|Dexamethasone|dexamethasone|mesh-list
43977234|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977235|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
44242681|NCT00598169|Carboplatin|carboplatin|mesh-list
44242682|NCT00598169|Etoposide|etoposide|mesh-list
44242683|NCT00598169|Bortezomib|bortezomib|mesh-list
44242684|NCT00598169|Ifosfamide|ifosfamide|mesh-list
44242685|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44242686|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977236|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
43977237|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977238|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977239|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977240|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
43977241|NCT04654507|Hormones|hormones|mesh-ancestor
43977242|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977243|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977244|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977245|NCT04630834|Acetaminophen|acetaminophen|mesh-list
43977246|NCT04630834|Ibuprofen|ibuprofen|mesh-list
43977247|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977248|NCT04630834|Analgesics|analgesics|mesh-ancestor
43977249|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
43977250|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977251|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977252|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
43977253|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977254|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977255|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977256|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43977257|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977258|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977259|NCT04630769|Interleukin-2|interleukin-2|mesh-list
43977260|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977261|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977262|NCT04630769|Analgesics|analgesics|mesh-ancestor
43977263|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
43977264|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977265|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977266|NCT04550377|Cannabidiol|cannabidiol|mesh-list
43977267|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
43977268|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43977269|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977270|NCT04457219|Hemostatics|hemostatics|mesh-list
43977271|NCT04457219|Coagulants|coagulants|mesh-ancestor
43977272|NCT04443010|Temozolomide|temozolomide|mesh-list
43977273|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43977274|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
43977275|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977276|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977277|NCT04272333|Nivolumab|nivolumab|mesh-list
43977278|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977279|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977280|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43977281|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144165|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144176|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144177|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144178|NCT00191464|Insulin|insulin|mesh-list
44144179|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44144180|NCT00191464|Metformin|metformin|mesh-list
44144181|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
44144182|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
44144183|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44144184|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144185|NCT00191490|Gemcitabine|gemcitabine|mesh-list
44144186|NCT00191490|Cisplatin|cisplatin|mesh-list
44144187|NCT00191490|Docetaxel|docetaxel|mesh-list
44144188|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144189|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144190|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
44144191|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144192|NCT00191490|Antiviral Agents|antiviral agents|mesh-ancestor
44144193|NCT00191490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144194|NCT00191490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242688|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242689|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242690|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44144195|NCT00191490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144196|NCT00191490|Immunologic Factors|immunologic factors|mesh-ancestor
44144197|NCT00191490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144198|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144199|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144200|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144201|NCT00191503|Gemcitabine|gemcitabine|mesh-list
44144203|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144204|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
44144205|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144206|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144207|NCT00191503|Antiviral Agents|antiviral agents|mesh-ancestor
44144208|NCT00191503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144209|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144210|NCT00191503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144211|NCT00191503|Immunologic Factors|immunologic factors|mesh-ancestor
44144212|NCT00191503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144213|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44144214|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018108|NCT04184999|Prednisolone|prednisolone|mesh-list
44018109|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44018110|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
44018116|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
44144215|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44144216|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144217|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144218|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144219|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144220|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144221|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144222|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144223|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44144224|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44018145|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44018146|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44018147|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018148|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144225|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144226|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144227|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144228|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144229|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144230|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144231|NCT00191555|Haloperidol|haloperidol|mesh-list
44144233|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
44144234|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
44144235|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
44144236|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018149|NCT04173429|Nadroparin|nadroparin|mesh-list
44018150|NCT04173429|Warfarin|warfarin|mesh-list
44018151|NCT04173429|Calcium|calcium|mesh-list
44144237|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977282|NCT04226495|Sufentanil|sufentanil|mesh-list
43977283|NCT04226495|Dsuvia|dsuvia|mesh-list
43977284|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43977285|NCT04226495|Narcotics|narcotics|mesh-ancestor
43977286|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977287|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977288|NCT04226495|Analgesics|analgesics|mesh-ancestor
43977289|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
43977290|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977291|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43977292|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977293|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
43977294|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
43977295|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43977296|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
43977297|NCT04103034|Coagulants|coagulants|mesh-ancestor
43977298|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43977299|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
43977300|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977301|NCT04060108|Methamphetamine|methamphetamine|mesh-list
43977302|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43977303|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977304|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
43977305|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
43977306|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977307|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
44242693|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242694|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242695|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
44242696|NCT00598169|Hormones|hormones|mesh-ancestor
44242697|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242698|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977308|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977309|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977310|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
43977311|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43977312|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43977313|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43977314|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43977315|NCT04058470|Prednisone|prednisone|mesh-list
43977316|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
43977317|NCT04058470|Rituximab|rituximab|mesh-list
43977318|NCT04058470|Doxorubicin|doxorubicin|mesh-list
43977319|NCT04058470|Vincristine|vincristine|mesh-list
43977320|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977321|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
43977322|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977323|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977324|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43977325|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
43977326|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977327|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977328|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43977329|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977330|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977331|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977332|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977333|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977334|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977335|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
43977336|NCT04058470|Hormones|hormones|mesh-ancestor
43977337|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977338|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977339|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977340|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977341|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977342|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977343|NCT03921060|Denosumab|denosumab|mesh-list
43977344|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43977345|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977346|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
43977347|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43977348|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977349|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977350|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977351|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977357|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977358|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43977359|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
43977360|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
43977362|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
43977363|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018219|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44018220|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44018221|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44018222|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44018223|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43646268|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
43646269|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646270|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43646419|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43646420|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43646421|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
43646422|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646457|NCT03064867|Etoposide|etoposide|mesh-list
43646458|NCT03064867|Venetoclax|venetoclax|mesh-list
43646459|NCT03064867|Ifosfamide|ifosfamide|mesh-list
43646460|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647173|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43977364|NCT03858231|Acetaminophen|acetaminophen|mesh-list
43977365|NCT03858231|Ibuprofen|ibuprofen|mesh-list
43977366|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977367|NCT03858231|Analgesics|analgesics|mesh-ancestor
43977368|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
43648933|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648967|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648968|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
43648969|NCT03033316|Hormones|hormones|mesh-ancestor
43648970|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648971|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648972|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648973|NCT03032848|Estrogens|estrogens|mesh-list
43648974|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43648975|NCT03032848|Hormones|hormones|mesh-ancestor
43648976|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648977|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824284|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43824285|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649015|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649718|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43649719|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649720|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649721|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43649722|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43649723|NCT03018665|Metformin|metformin|mesh-list
43649724|NCT03018665|Exenatide|exenatide|mesh-list
43649725|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977369|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977370|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242699|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44242701|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44242702|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242703|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242704|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44242705|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
44242706|NCT00598195|Ketamine|ketamine|mesh-list
43977371|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
43977372|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977373|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977374|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977375|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43977376|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977377|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977378|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43977379|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43977380|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44018224|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44018225|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44018226|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44018227|NCT04121078|Rifampin|rifampin|mesh-list
43977381|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43977382|NCT03799731|Trifluridine|trifluridine|mesh-list
43977384|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977385|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
43977386|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977387|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
43977388|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
43977389|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977390|NCT03605342|Buprenorphine|buprenorphine|mesh-list
43977391|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43977392|NCT03605342|Narcotics|narcotics|mesh-ancestor
43977393|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977394|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977395|NCT03605342|Analgesics|analgesics|mesh-ancestor
43977396|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
43977397|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977398|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43977399|NCT03550391|Memantine|memantine|mesh-list
43977400|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43977401|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43977402|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
43977403|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977404|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977405|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977406|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43977407|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43977408|NCT03471364|Ketoconazole|ketoconazole|mesh-list
43977409|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
43977410|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977411|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43977412|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43977413|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977414|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977415|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43977416|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
43977417|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977418|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977419|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43977420|NCT03440450|Gemcitabine|gemcitabine|mesh-list
43977421|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977422|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
43977423|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977430|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977431|NCT03420014|Doxorubicin|doxorubicin|mesh-list
43977432|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43977433|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44242707|NCT00598195|Analgesics|analgesics|mesh-ancestor
44242708|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
44242709|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242710|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242711|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44242712|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44242713|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
44242714|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
44242715|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242716|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44242717|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44242718|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242719|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242720|NCT00598234|Celecoxib|celecoxib|mesh-list
44242721|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977434|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977435|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977436|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977437|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977438|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977439|NCT03360890|Docetaxel|docetaxel|mesh-list
43977440|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
43977441|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977442|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977443|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977444|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977445|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977446|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977447|NCT03222570|Serotonin|serotonin|mesh-list
43977448|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43977449|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43977450|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
43977451|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977452|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977453|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977454|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43977455|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43977456|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
44018320|NCT04069221|Artefenomel|artefenomel|mesh-list
44018321|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43653083|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43846537|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
43653084|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43653085|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
43653086|NCT02986451|Clarithromycin|clarithromycin|mesh-list
43977457|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977458|NCT03169361|Ixazomib|ixazomib|mesh-list
43977459|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977460|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
43977461|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977462|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977463|NCT03062059|Gemcitabine|gemcitabine|mesh-list
43977464|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977465|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
43977466|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977467|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977468|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
43977469|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977470|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977471|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977472|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
44018327|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018328|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977473|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977474|NCT03054038|Afatinib|afatinib|mesh-list
43977475|NCT03054038|Necitumumab|necitumumab|mesh-list
43977476|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242723|NCT00598234|Analgesics|analgesics|mesh-ancestor
44242724|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
44242725|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242726|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242727|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242728|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44242729|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43977477|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44018329|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
44018330|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43977478|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977479|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977480|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144238|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44144239|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44144240|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44144241|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144242|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144243|NCT00191555|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43657193|NCT02955641|Nepafenac|nepafenac|mesh-list
43657449|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43657450|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657451|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43657452|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43657453|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43657454|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43657455|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
43657456|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43657912|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657914|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43657915|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
43657916|NCT02949466|Protective Agents|protective agents|mesh-ancestor
43657917|NCT02949310|Nefopam|nefopam|mesh-list
43657918|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657919|NCT02949310|Analgesics|analgesics|mesh-ancestor
43657920|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
43657921|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657922|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657923|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
43657933|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657934|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657935|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
43657936|NCT02949349|Hormones|hormones|mesh-ancestor
43657937|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657938|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659121|NCT02940756|Artemether|artemether|mesh-list
43659122|NCT02940756|Piperaquine|piperaquine|mesh-list
43659123|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43659124|NCT02940756|Amodiaquine|amodiaquine|mesh-list
43659125|NCT02940756|Artenimol|artenimol|mesh-list
43659126|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
43659127|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43659128|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43659334|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
43659335|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44144244|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144245|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144246|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144247|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144248|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
44144259|NCT00191568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144260|NCT00191568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144261|NCT00191568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144262|NCT00191568|Immunologic Factors|immunologic factors|mesh-ancestor
43977482|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43977483|NCT03021083|Narcotics|narcotics|mesh-ancestor
43977484|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977485|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977486|NCT03021083|Analgesics|analgesics|mesh-ancestor
43977487|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
43977488|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977489|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43977490|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977491|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
43977492|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
43977493|NCT03000257|Venetoclax|venetoclax|mesh-list
43977494|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977495|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
43977496|NCT02990533|Testosterone|testosterone|mesh-list
43977497|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
43977498|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
43977499|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43977500|NCT02990533|Androgens|androgens|mesh-ancestor
43977501|NCT02990533|Hormones|hormones|mesh-ancestor
43977502|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977503|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977504|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977505|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977506|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
43977508|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43977509|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977510|NCT02945813|Metformin|metformin|mesh-list
43977511|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977512|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977513|NCT02891447|Cisplatin|cisplatin|mesh-list
43977514|NCT02891447|Mitomycins|mitomycins|mesh-list
43977515|NCT02891447|Mitomycin|mitomycin|mesh-list
43977516|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977517|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977518|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
43977519|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977520|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44242730|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44242731|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242732|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242733|NCT00598247|Paclitaxel|paclitaxel|mesh-list
43977521|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977522|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
43977523|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977524|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977525|NCT02815033|Choline|choline|mesh-list
43977526|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
43977527|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43977528|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
43977529|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977530|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977531|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43977532|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
43977533|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43977534|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43977537|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977538|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977539|NCT02766582|Paclitaxel|paclitaxel|mesh-list
43977540|NCT02766582|Carboplatin|carboplatin|mesh-list
43977541|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
43977542|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977543|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977544|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977545|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977546|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977547|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977548|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977549|NCT02734602|Ketamine|ketamine|mesh-list
43977550|NCT02734602|Analgesics|analgesics|mesh-ancestor
43977551|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
43977552|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977553|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977554|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43977555|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977556|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
43977557|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
43977558|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977559|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43977560|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43977561|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977562|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977563|NCT02647099|Aspirin|aspirin|mesh-list
43977564|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43977565|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977566|NCT02647099|Analgesics|analgesics|mesh-ancestor
43977567|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
43977568|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977569|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977570|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977571|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977572|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43977573|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43977574|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977575|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43977576|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43977577|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977578|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
43977579|NCT02506192|Prednisone|prednisone|mesh-list
43977580|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977581|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
43977582|NCT02506192|Hormones|hormones|mesh-ancestor
43977583|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977584|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977585|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977586|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977587|NCT02281838|Enalapril|enalapril|mesh-list
43977588|NCT02281838|Labetalol|labetalol|mesh-list
43977589|NCT02281838|Hydralazine|hydralazine|mesh-list
44242735|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44018413|NCT04039867|Gemcitabine|gemcitabine|mesh-list
44018453|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
43825785|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43825786|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43825787|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43661640|NCT02921269|Bevacizumab|bevacizumab|mesh-list
43661641|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43661642|NCT02921269|Atezolizumab|atezolizumab|mesh-list
43661643|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
43661644|NCT02921269|Antibodies|antibodies|mesh-list
43661645|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
43977590|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43977591|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
43977592|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977593|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977594|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43977595|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43977596|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43977597|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
44018454|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826088|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43977598|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977599|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977600|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
43977601|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
43977602|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977603|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43977604|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43977605|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
43977606|NCT02270632|Methotrexate|methotrexate|mesh-list
43977611|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43663999|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664000|NCT05459792|Lidocaine|lidocaine|mesh-list
43664001|NCT05459792|Bupivacaine|bupivacaine|mesh-list
43664002|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664003|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
43664004|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664005|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664006|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
43664007|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664008|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664009|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43664010|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43664011|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664012|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664031|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664032|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43664033|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43664034|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664035|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977613|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977614|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977615|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
43977616|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977617|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43977618|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977619|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
43977620|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977621|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43977622|NCT02261883|Treprostinil|treprostinil|mesh-list
43977623|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43977624|NCT02076646|Interleukin-2|interleukin-2|mesh-list
43977625|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977626|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43977627|NCT02076646|Analgesics|analgesics|mesh-ancestor
43977628|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
44018455|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43664085|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43664086|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664088|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
43826201|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826203|NCT01665274|Capecitabine|capecitabine|mesh-list
43826204|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
43664415|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43664416|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43664417|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43664418|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
43664419|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664420|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
43664421|NCT04893148|Dulaglutide|dulaglutide|mesh-list
43664422|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664423|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664424|NCT04885686|Formaldehyde|formaldehyde|mesh-list
43664425|NCT04885686|Thymol|thymol|mesh-list
43664426|NCT04885686|Dexamethasone|dexamethasone|mesh-list
43664427|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
43664428|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664429|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
43664435|NCT04885686|Hormones|hormones|mesh-ancestor
43977629|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977630|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977631|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43977632|NCT02007122|Cephalosporins|cephalosporins|mesh-list
43977633|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43977634|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977635|NCT01919086|Dexamethasone|dexamethasone|mesh-list
43977636|NCT01919086|Lenalidomide|lenalidomide|mesh-list
43977637|NCT01919086|Bortezomib|bortezomib|mesh-list
43977638|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977639|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
43977640|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
43977641|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977642|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977643|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977644|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
43977645|NCT01919086|Hormones|hormones|mesh-ancestor
43977646|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977647|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977648|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977649|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
43977650|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43977651|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43977652|NCT01919086|Growth Substances|growth substances|mesh-ancestor
43977653|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
43977654|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43977655|NCT01794143|Liraglutide|liraglutide|mesh-list
43977656|NCT01794143|Glimepiride|glimepiride|mesh-list
43977657|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43977658|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977659|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977660|NCT01794143|Incretins|incretins|mesh-ancestor
43977662|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977663|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
43977664|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977665|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977666|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44242736|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242737|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
44242738|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
44242739|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242740|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242741|NCT00598338|Prucalopride|prucalopride|mesh-list
44242742|NCT00598338|Laxatives|laxatives|mesh-ancestor
44242743|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977667|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977668|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
43977669|NCT01766128|Zonisamide|zonisamide|mesh-list
43977670|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
43977671|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43977672|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43977673|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977674|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43977675|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977676|NCT01727193|Azathioprine|azathioprine|mesh-list
43977677|NCT01727193|Leflunomide|leflunomide|mesh-list
43977681|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977682|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977683|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
43977684|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977685|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977686|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018495|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665638|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665640|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43977687|NCT01643460|Ethanol|ethanol|mesh-list
43977688|NCT01643460|Paclitaxel|paclitaxel|mesh-list
43977689|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43977690|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977691|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977692|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977693|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977694|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977695|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977696|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43977697|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977698|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977699|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977700|NCT01547741|Paclitaxel|paclitaxel|mesh-list
43977701|NCT01547741|Docetaxel|docetaxel|mesh-list
43977702|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
43977703|NCT01547741|Doxorubicin|doxorubicin|mesh-list
43977704|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977705|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977706|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977707|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977708|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977709|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977710|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977711|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
43977712|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977713|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977714|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43977715|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
43977716|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43977717|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977718|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977719|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977720|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977721|NCT00954876|Capecitabine|capecitabine|mesh-list
43977722|NCT00954876|Cetuximab|cetuximab|mesh-list
43977723|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977724|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
43977725|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977726|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977727|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977728|NCT00181701|Paclitaxel|paclitaxel|mesh-list
43977729|NCT00181701|Carboplatin|carboplatin|mesh-list
44242744|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44242746|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
44242747|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242748|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242749|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242750|NCT00598377|Cosyntropin|cosyntropin|mesh-list
44242751|NCT00598377|Hormones|hormones|mesh-ancestor
44242752|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242753|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242754|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
43977730|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977731|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977732|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977733|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977734|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977735|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977736|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
43977737|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977738|NCT01880099|Galantamine|galantamine|mesh-list
43977739|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
43977740|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977741|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977742|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
43977743|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977744|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977745|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43977746|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
43977747|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977748|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
43977749|NCT01880723|Albuterol|albuterol|mesh-list
43977753|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977754|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43977755|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977757|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43977758|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43977759|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43977760|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43977761|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
43977762|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977763|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977764|NCT01880840|Azelastine|azelastine|mesh-list
43977765|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43977766|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
43977767|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977768|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977769|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43977770|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977771|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43977772|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977773|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977774|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43977775|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43977776|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43977777|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
43977778|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
43977779|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977780|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
43977781|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
43977782|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
44242755|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
44242756|NCT00598403|Cefditoren|cefditoren|mesh-list
44242757|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242758|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242759|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977783|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977784|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977785|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
43831810|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831811|NCT05296304|Bexarotene|bexarotene|mesh-list
43831812|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712064|NCT02685657|Docetaxel|docetaxel|mesh-list
43977786|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977787|NCT01881113|Cetirizine|cetirizine|mesh-list
43977788|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43977789|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43977790|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43977791|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
43977792|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
43977793|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977794|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977795|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977796|NCT01881412|Fluticasone|fluticasone|mesh-list
43977797|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977798|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43977799|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
43977800|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977801|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018610|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43977802|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43977803|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977804|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
43977805|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43977806|NCT01881828|Metformin|metformin|mesh-list
43977807|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977808|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977809|NCT01882868|Leucovorin|leucovorin|mesh-list
44018611|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44018612|NCT03976752|Elvitegravir|elvitegravir|mesh-list
43712379|NCT02684084|Hormones|hormones|mesh-ancestor
43977810|NCT01882868|Irinotecan|irinotecan|mesh-list
43977811|NCT01882868|Aflibercept|aflibercept|mesh-list
43977812|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
43977813|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43977814|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977815|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977816|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977817|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977818|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43977819|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43977820|NCT01882868|Growth Substances|growth substances|mesh-ancestor
43977825|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
43977826|NCT01882868|Vitamins|vitamins|mesh-ancestor
43977827|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
44144263|NCT00191568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144264|NCT00191581|Insulin|insulin|mesh-list
44144265|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
44144266|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44144267|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44144268|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44144269|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144270|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44144271|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44144272|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144273|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144274|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144275|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144276|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144277|NCT00191594|Analgesics|analgesics|mesh-ancestor
44144278|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
44144279|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144280|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144281|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144282|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
44144283|NCT00191607|Gemcitabine|gemcitabine|mesh-list
44144284|NCT00191607|Doxorubicin|doxorubicin|mesh-list
44144285|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44144286|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44242761|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242762|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242763|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242764|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44242765|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44242766|NCT00598429|Alprostadil|alprostadil|mesh-list
44242767|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44242768|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
44144287|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
44144288|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144289|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977828|NCT01884844|Vitamin D|vitamin d|mesh-list
43977829|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
43977830|NCT01884844|Vitamins|vitamins|mesh-ancestor
43977831|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
43977832|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977833|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43977834|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43977835|NCT01885910|Doxycycline|doxycycline|mesh-list
43977836|NCT01885910|Dapsone|dapsone|mesh-list
43977837|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43977838|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977839|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
43977840|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43977841|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43977842|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43977843|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977844|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977845|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
43977846|NCT01886937|Phentermine|phentermine|mesh-list
43977847|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43977848|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977849|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
43977850|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43977851|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
43977852|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
43977853|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977854|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43977855|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977856|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977857|NCT01887132|Donepezil|donepezil|mesh-list
43977858|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43977859|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977860|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977861|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
43977862|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977863|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977864|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
43977865|NCT01887171|Tacrolimus|tacrolimus|mesh-list
43977871|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977873|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977874|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977875|NCT01887587|Dexamethasone|dexamethasone|mesh-list
43977876|NCT01887587|Doxorubicin|doxorubicin|mesh-list
43977877|NCT01887587|Vincristine|vincristine|mesh-list
43977878|NCT01887587|Ixazomib|ixazomib|mesh-list
43977879|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977880|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
43977881|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
43977882|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977883|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148417|NCT00204191|Tacrolimus|tacrolimus|mesh-list
43712584|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43712585|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
43712586|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712587|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43712588|NCT02682758|Xenon|xenon|mesh-list
43712589|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43712590|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
43712591|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
43712592|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977884|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43977885|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
44242769|NCT00598429|Urological Agents|urological agents|mesh-ancestor
44242770|NCT00598533|Sirolimus|sirolimus|mesh-list
44242771|NCT00598533|Probucol|probucol|mesh-list
44242772|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43977886|NCT01887587|Hormones|hormones|mesh-ancestor
43977887|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977888|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977889|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977890|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43977891|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977892|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977893|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713070|NCT02678949|Xhance|xhance|mesh-list
43977894|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977895|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977896|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977897|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977898|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977899|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
43977900|NCT01887990|Ketamine|ketamine|mesh-list
43977901|NCT01887990|Analgesics|analgesics|mesh-ancestor
43977902|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
43977903|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018676|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44018677|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713081|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
43713082|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713107|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831885|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
43831886|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43713165|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713166|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713167|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
43713168|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713169|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43713170|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43713171|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43713172|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713173|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713174|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43713175|NCT02678585|Narcotics|narcotics|mesh-ancestor
43713176|NCT02678585|Analgesics|analgesics|mesh-ancestor
43713177|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
43713178|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43713423|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713424|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
43713425|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43713426|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
43713427|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713428|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713429|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43713430|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
43977904|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977905|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43977906|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43977907|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
43977908|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
43977909|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977910|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43977911|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43977912|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977913|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977914|NCT01888952|Prednisone|prednisone|mesh-list
43977915|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43977916|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
43977917|NCT01888952|Hormones|hormones|mesh-ancestor
43977918|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977919|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977920|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43977921|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977922|NCT01889667|Insulin|insulin|mesh-list
43977923|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43977924|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977925|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977926|NCT01889797|Rituximab|rituximab|mesh-list
43977927|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
43977928|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43977929|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977930|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
43977931|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977932|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43977933|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43977934|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43977941|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
43977942|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977943|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43977944|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43977945|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43977946|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43977947|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977949|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
43977950|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977951|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43977952|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43977953|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977954|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977955|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43977956|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
44242773|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242774|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44242775|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242776|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
44242777|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242778|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
44242779|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242780|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44242781|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44242782|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
44242783|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242784|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44242786|NCT00598533|Protective Agents|protective agents|mesh-ancestor
44242787|NCT00598572|Deferoxamine|deferoxamine|mesh-list
44242788|NCT00598572|Siderophores|siderophores|mesh-ancestor
44242789|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44242790|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
44242791|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
44242792|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242793|NCT00598611|Loratadine|loratadine|mesh-list
44242794|NCT00598611|Desloratadine|desloratadine|mesh-list
44242795|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44242796|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44242797|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242798|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242799|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242800|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44242801|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44242802|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
44242803|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
44242804|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
44242805|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
44242807|NCT00598624|Treosulfan|treosulfan|mesh-list
44242816|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242817|NCT00598676|Sirolimus|sirolimus|mesh-list
44242818|NCT00598676|Everolimus|everolimus|mesh-list
44242819|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242820|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242821|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
44242822|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242823|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242824|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242825|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44242826|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
44242827|NCT00598715|Sirolimus|sirolimus|mesh-list
44242828|NCT00598715|Paclitaxel|paclitaxel|mesh-list
44242829|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44242830|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242831|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44242832|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44018753|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018754|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44018755|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44018756|NCT03930264|Azathioprine|azathioprine|mesh-list
44018757|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
44018758|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018759|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44018760|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018761|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018762|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
44018763|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018764|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018765|NCT03929367|Oxytocin|oxytocin|mesh-list
44018766|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
44242833|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242834|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242835|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242836|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242837|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44242838|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
43832018|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832019|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832020|NCT05284812|Vaccines|vaccines|mesh-list
43832021|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
43832022|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832023|NCT05284591|Daratumumab|daratumumab|mesh-list
43832024|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242839|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242840|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
44242841|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242842|NCT00598793|Insulin|insulin|mesh-list
44242843|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44242844|NCT00598793|Metformin|metformin|mesh-list
44242845|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
44242846|NCT00598793|Pioglitazone|pioglitazone|mesh-list
44242847|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
44018770|NCT03928522|Vancomycin|vancomycin|mesh-list
44242848|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
44242849|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242850|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242851|NCT00598858|Prednisone|prednisone|mesh-list
44242852|NCT00598858|Cortisone|cortisone|mesh-list
44242853|NCT00598858|Docetaxel|docetaxel|mesh-list
44242858|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242859|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242861|NCT00598858|Hormones|hormones|mesh-ancestor
44018776|NCT03927781|Pregabalin|pregabalin|mesh-list
44018777|NCT03927781|Analgesics|analgesics|mesh-ancestor
44018778|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
44242862|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242863|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242864|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44242865|NCT00598897|Clarithromycin|clarithromycin|mesh-list
44242866|NCT00598897|Rifabutin|rifabutin|mesh-list
43977957|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977958|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977959|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43977960|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43977961|NCT01891968|Bortezomib|bortezomib|mesh-list
43977962|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977963|NCT01892709|Hydromorphone|hydromorphone|mesh-list
43977964|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43977965|NCT01892709|Narcotics|narcotics|mesh-ancestor
43977966|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977967|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977968|NCT01892709|Analgesics|analgesics|mesh-ancestor
43977969|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
43977970|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977971|NCT01893632|Gabapentin|gabapentin|mesh-list
43977972|NCT01893632|Analgesics|analgesics|mesh-ancestor
43977973|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
43977974|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977975|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977976|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
43977977|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43977978|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43977979|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977980|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43977981|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43977982|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43977983|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43977984|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977986|NCT01893801|Gemcitabine|gemcitabine|mesh-list
43977987|NCT01893801|Paclitaxel|paclitaxel|mesh-list
43977988|NCT01893801|Cisplatin|cisplatin|mesh-list
43977989|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977990|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977991|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
43977992|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
43977993|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
43977994|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977995|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977996|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
43977997|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
43977998|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977999|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978000|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978001|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
43978012|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43978013|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978014|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978015|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
43978016|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978017|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978018|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43978019|NCT01894555|Aspirin|aspirin|mesh-list
43978020|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43978021|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44242867|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242868|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242869|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44242870|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242871|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242872|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44242873|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44242874|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44242875|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
44242877|NCT00598923|Phenytoin|phenytoin|mesh-list
43978022|NCT01894555|Analgesics|analgesics|mesh-ancestor
43978023|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
43978024|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978025|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714104|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714105|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714106|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714107|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43714108|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714109|NCT02670564|Busulfan|busulfan|mesh-list
43978026|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978027|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978028|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43978029|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43978030|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978031|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43978032|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43978033|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978034|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
43714334|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
43714335|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714336|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714337|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714338|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
43714339|NCT02669303|Hormones|hormones|mesh-ancestor
43714340|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714341|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43714342|NCT02669303|Protective Agents|protective agents|mesh-ancestor
43714343|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714344|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978035|NCT01895036|Naltrexone|naltrexone|mesh-list
43978036|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43978037|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43978038|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978039|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
43978040|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978041|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
43978042|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43978043|NCT01895127|Antibodies|antibodies|mesh-list
43978044|NCT01895127|Eculizumab|eculizumab|mesh-list
43978045|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
43978046|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978047|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43978048|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978049|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
43978050|NCT01896544|Vitamin D|vitamin d|mesh-list
43978051|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43978052|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978053|NCT01896544|Vitamins|vitamins|mesh-ancestor
43978054|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
43978055|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43978056|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
43978057|NCT01896921|Maraviroc|maraviroc|mesh-list
43978058|NCT01896921|Dolutegravir|dolutegravir|mesh-list
43978059|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43978060|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43978061|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
43978062|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978063|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43978064|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43978065|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978066|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978067|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43978068|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43978069|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43978072|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978073|NCT01897402|Vaccines|vaccines|mesh-list
43978074|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
43978075|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978076|NCT01897792|Vitamins|vitamins|mesh-list
43978077|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
44242878|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
44242879|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44242880|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242881|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44242882|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44242883|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242884|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242885|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44242886|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44242887|NCT00598962|Azithromycin|azithromycin|mesh-list
44242888|NCT00598962|Rifampin|rifampin|mesh-list
44242889|NCT00598962|Rifabutin|rifabutin|mesh-list
44242890|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242891|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242892|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44242893|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
44242894|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
44242895|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44242896|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242897|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242898|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44242899|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44242900|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44242901|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43978078|NCT01897792|Vitamin E|vitamin e|mesh-list
43978079|NCT01897792|Tocopherols|tocopherols|mesh-list
44018920|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43714693|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714694|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714727|NCT02666417|Trace Elements|trace elements|mesh-ancestor
43714728|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
43714729|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714731|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
43714732|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714733|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
43714734|NCT02666157|Apixaban|apixaban|mesh-list
43714735|NCT02666157|Dabigatran|dabigatran|mesh-list
43714736|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43714737|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
43714738|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43714739|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714740|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714741|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714742|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
43714743|NCT02666053|Fostemsavir|fostemsavir|mesh-list
43714744|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43714745|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43714746|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
43714747|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714766|NCT02665806|Hormones|hormones|mesh-ancestor
43978080|NCT01897792|Tocotrienols|tocotrienols|mesh-list
43978081|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
43978082|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
43978083|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978084|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
43978085|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978086|NCT01897792|Protective Agents|protective agents|mesh-ancestor
43978087|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43978088|NCT01898689|Ropivacaine|ropivacaine|mesh-list
43978089|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
43978090|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
43978091|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978092|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978093|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
43978094|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978095|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43978096|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43978097|NCT01901250|Fluorides|fluorides|mesh-list
43978098|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
43978099|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
43978100|NCT01901250|Protective Agents|protective agents|mesh-ancestor
43978101|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978102|NCT01901575|Remifentanil|remifentanil|mesh-list
44018921|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44018922|NCT03855059|Dexamethasone|dexamethasone|mesh-list
44018923|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
44018924|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44018925|NCT03855059|BB 1101|bb 1101|mesh-list
44018926|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018927|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
44018928|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
44018929|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018930|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018931|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018932|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
44018933|NCT03855059|Hormones|hormones|mesh-ancestor
44018934|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018935|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018936|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018937|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
44018938|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018939|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242902|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44242903|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44242904|NCT00599079|Azithromycin|azithromycin|mesh-list
44242905|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44242906|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242907|NCT00599222|Ranibizumab|ranibizumab|mesh-list
44242908|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978103|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978104|NCT01901575|Narcotics|narcotics|mesh-ancestor
43978105|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978106|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978107|NCT01901575|Analgesics|analgesics|mesh-ancestor
43978108|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
43978109|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978110|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
43978111|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43978112|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978113|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978114|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978115|NCT01901588|Analgesics|analgesics|mesh-ancestor
43978116|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
43978117|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978118|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43978119|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43978120|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43978121|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978122|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978123|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978124|NCT01901809|Dopamine|dopamine|mesh-list
43978125|NCT01901809|Furosemide|furosemide|mesh-list
43978126|NCT01901809|Diuretics|diuretics|mesh-ancestor
43978127|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
43978128|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978129|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43978130|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978131|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978132|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43978133|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
43978134|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
43978135|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978136|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
43978137|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978138|NCT01901809|Protective Agents|protective agents|mesh-ancestor
43978139|NCT01902004|Memantine|memantine|mesh-list
43978140|NCT01902004|Citalopram|citalopram|mesh-list
43978141|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43978142|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43978143|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978144|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978151|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43978152|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43978154|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43978155|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44148450|NCT00204269|Hormones|hormones|mesh-ancestor
43714791|NCT02665936|BB 1101|bb 1101|mesh-list
43978156|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43978157|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
43978158|NCT01902459|Coagulants|coagulants|mesh-ancestor
43978159|NCT01902758|Ambrisentan|ambrisentan|mesh-list
43978160|NCT01902758|Theophylline|theophylline|mesh-list
43978161|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43978162|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
43978163|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978164|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978165|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978166|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43978167|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43715711|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43715732|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43715733|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715735|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
43715736|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715737|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715738|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715739|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715740|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43715741|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715742|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978168|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978169|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242909|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44242910|NCT00599222|Growth Substances|growth substances|mesh-ancestor
44242911|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242912|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44242913|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242914|NCT00599235|Hydralazine|hydralazine|mesh-list
44242915|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
44242916|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
44242917|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44242918|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44242919|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242920|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242921|NCT00599235|Urological Agents|urological agents|mesh-ancestor
44242922|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44242923|NCT00599274|Interferons|interferons|mesh-list
44242924|NCT00599274|Interferon-beta|interferon-beta|mesh-list
44242925|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
44242926|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242927|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
44242928|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242929|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
44242930|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978170|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
43978171|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43978172|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43978173|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
43978174|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978175|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978176|NCT01903005|Buprenorphine|buprenorphine|mesh-list
43978177|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43978178|NCT01903005|Naloxone|naloxone|mesh-list
43978179|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978180|NCT01903005|Narcotics|narcotics|mesh-ancestor
43978181|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978182|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978183|NCT01903005|Analgesics|analgesics|mesh-ancestor
43978184|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
43978185|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978186|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43978187|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
43978188|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43978189|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
43978190|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978191|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43978192|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978193|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43978194|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978195|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978196|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978197|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
43978198|NCT01903798|Prednisolone|prednisolone|mesh-list
43978199|NCT01903798|Rilonacept|rilonacept|mesh-list
43978200|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43978201|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242933|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
44242934|NCT00599287|Methylphenidate|methylphenidate|mesh-list
44242935|NCT00599287|Rivastigmine|rivastigmine|mesh-list
44242936|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44242937|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242938|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44242939|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44242940|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978202|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44018987|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018988|NCT03857750|Rocuronium|rocuronium|mesh-list
44018989|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43716055|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716056|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716057|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
43716086|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716087|NCT02656082|Etanercept|etanercept|mesh-list
43716088|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43716089|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716090|NCT02656082|Analgesics|analgesics|mesh-ancestor
43716091|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
43716092|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716093|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018990|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43716318|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716319|NCT02654665|Liraglutide|liraglutide|mesh-list
43716320|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43716321|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716359|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
43716360|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716361|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716362|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
43978203|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
43978204|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978205|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978206|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978207|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978208|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978209|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
43978210|NCT01903798|Hormones|hormones|mesh-ancestor
43978211|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43978212|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978214|NCT01904071|Morphine|morphine|mesh-list
43978215|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978216|NCT01904071|Narcotics|narcotics|mesh-ancestor
43978217|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978218|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978219|NCT01904071|Analgesics|analgesics|mesh-ancestor
43978220|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
43978221|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144290|NCT00191607|Antiviral Agents|antiviral agents|mesh-ancestor
44144291|NCT00191607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144292|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144293|NCT00191607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018991|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44018992|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018993|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018994|NCT03860753|Pioglitazone|pioglitazone|mesh-list
44144294|NCT00191607|Immunologic Factors|immunologic factors|mesh-ancestor
44144295|NCT00191607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144296|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44144297|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44144298|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144299|NCT00191620|Gemcitabine|gemcitabine|mesh-list
44144300|NCT00191620|Cisplatin|cisplatin|mesh-list
44144301|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144302|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144303|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
44019014|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019015|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
44019016|NCT03825939|Coagulants|coagulants|mesh-ancestor
44019017|NCT03840278|Pancrelipase|pancrelipase|mesh-list
44144304|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144305|NCT00191620|Antiviral Agents|antiviral agents|mesh-ancestor
44144306|NCT00191620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144307|NCT00191620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144308|NCT00191620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144309|NCT00191620|Immunologic Factors|immunologic factors|mesh-ancestor
44144310|NCT00191620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144311|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44019025|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019026|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
44019027|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019028|NCT03822078|Denosumab|denosumab|mesh-list
44019029|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44165307|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832297|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832298|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144312|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144313|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144314|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144315|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144316|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144317|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144318|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144319|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44019030|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019031|NCT03811951|Insulin|insulin|mesh-list
43717768|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144320|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144321|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144322|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44242941|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242942|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
44242943|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242944|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
44019032|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44019033|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019034|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
43832380|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832381|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832382|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43832389|NCT05268120|Renal Agents|renal agents|mesh-ancestor
44242945|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
44242946|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44242947|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242948|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44242949|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44242950|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242951|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144323|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144324|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019035|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44019036|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019037|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718032|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718344|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43718345|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
43718346|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718347|NCT02643433|Vaccines|vaccines|mesh-list
43718348|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
43718349|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718350|NCT02643407|Cisplatin|cisplatin|mesh-list
43718351|NCT02643407|Docetaxel|docetaxel|mesh-list
43718352|NCT02643407|Nedaplatin|nedaplatin|mesh-list
43718353|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718354|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718355|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144325|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144326|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144327|NCT00191672|Gemcitabine|gemcitabine|mesh-list
44144329|NCT00191672|Docetaxel|docetaxel|mesh-list
44144330|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144331|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144332|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144333|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144334|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144335|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019038|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
44019039|NCT03806556|Coagulants|coagulants|mesh-ancestor
43718468|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43718469|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718470|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718471|NCT02642523|Insulin|insulin|mesh-list
43718472|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43718473|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43718474|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718475|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718476|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
43718477|NCT02642497|Ketamine|ketamine|mesh-list
44144336|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144337|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
44144338|NCT00191672|Antiviral Agents|antiviral agents|mesh-ancestor
44144339|NCT00191672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144340|NCT00191672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144341|NCT00191672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144342|NCT00191672|Immunologic Factors|immunologic factors|mesh-ancestor
44144343|NCT00191672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144344|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44144345|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43978223|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978224|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44019040|NCT03831854|Lamotrigine|lamotrigine|mesh-list
44019041|NCT03831854|Ketamine|ketamine|mesh-list
43718557|NCT02642601|Indomethacin|indomethacin|mesh-list
43978225|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43978226|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43978227|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978228|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978229|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978233|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978234|NCT01904864|Trace Elements|trace elements|mesh-ancestor
43978235|NCT01905423|Albendazole|albendazole|mesh-list
44019042|NCT03831854|Analgesics|analgesics|mesh-ancestor
44019043|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
43718626|NCT02641847|Epirubicin|epirubicin|mesh-list
43718627|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43718628|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
43718629|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718630|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718631|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43718632|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
43718633|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718634|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718644|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43718645|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43718646|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43718647|NCT02641899|Acetaminophen|acetaminophen|mesh-list
43718648|NCT02641899|Exenatide|exenatide|mesh-list
43718649|NCT02641899|Digoxin|digoxin|mesh-list
43978236|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
43978237|NCT01905423|Piperazine|piperazine|mesh-list
43978238|NCT01905423|Mebendazole|mebendazole|mesh-list
43978239|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
43978240|NCT01905423|Citric Acid|citric acid|mesh-list
43978241|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
43978242|NCT01905423|DMP 777|dmp 777|mesh-list
43978243|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
43978244|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44019044|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019045|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718686|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718687|NCT02641652|Sertraline|sertraline|mesh-list
43718688|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
43718689|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718731|NCT02641301|Morphine|morphine|mesh-list
43718732|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43718733|NCT02641301|Narcotics|narcotics|mesh-ancestor
43718734|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718735|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718736|NCT02641301|Analgesics|analgesics|mesh-ancestor
43718737|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
43718738|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832459|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43832460|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
43832461|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
43832465|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
43718765|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718766|NCT02641093|Cisplatin|cisplatin|mesh-list
43718767|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
43718768|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718769|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43718770|NCT02640989|Vaccines|vaccines|mesh-list
43718771|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
43718772|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718773|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43718774|NCT02640976|Cetrorelix|cetrorelix|mesh-list
43718775|NCT02640976|Menotropins|menotropins|mesh-list
43718776|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718777|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718778|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43718779|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
43718780|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
43718781|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718782|NCT02640846|Simendan|simendan|mesh-list
43718783|NCT02640846|Milrinone|milrinone|mesh-list
43718784|NCT02640846|Norepinephrine|norepinephrine|mesh-list
43718804|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718805|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718806|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718807|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718808|NCT02641054|Levodopa|levodopa|mesh-list
43978245|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
43978246|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
43978247|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978248|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
43978249|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43978250|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978251|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
43978252|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43978253|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43978254|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
43978255|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
43978256|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44242952|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44242953|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44242954|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44242955|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242956|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
44242957|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44242958|NCT00599287|Protective Agents|protective agents|mesh-ancestor
44242959|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
44242960|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44242961|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
44242962|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242963|NCT00599534|Montelukast|montelukast|mesh-list
44242964|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978257|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978258|NCT01905423|Filaricides|filaricides|mesh-ancestor
43978259|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
43978260|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43978261|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978262|NCT01906515|Chrysarobin|chrysarobin|mesh-list
43978263|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43978264|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978265|NCT01906515|Analgesics|analgesics|mesh-ancestor
43978266|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
43978267|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978268|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978269|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978270|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978271|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43978273|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43978274|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978275|NCT01906866|Melatonin|melatonin|mesh-list
43978276|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
43978277|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978278|NCT01906866|Protective Agents|protective agents|mesh-ancestor
43978279|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978280|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978281|NCT01907113|Empagliflozin|empagliflozin|mesh-list
43978282|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43978283|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978284|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43978285|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978286|NCT01907321|Capsaicin|capsaicin|mesh-list
43978287|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
43978288|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978289|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
43978290|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978291|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978292|NCT01907334|Fluticasone|fluticasone|mesh-list
43978293|NCT01907334|Xhance|xhance|mesh-list
43978294|NCT01907334|Albuterol|albuterol|mesh-list
43978295|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43978296|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43978297|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
43978298|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978299|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43978300|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
43978301|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978302|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978303|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978304|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
43978312|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242965|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44242966|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43718867|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
43718887|NCT02640365|Vitamins|vitamins|mesh-ancestor
43718888|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
43718889|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43718890|NCT02640313|Choline|choline|mesh-list
43718891|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
43718892|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43718893|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
43718895|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44242967|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
44242968|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44242969|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242970|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44242971|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44242972|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019121|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019122|NCT03809182|Analgesics|analgesics|mesh-ancestor
43719022|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719023|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719024|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43719032|NCT02638922|Estrogens|estrogens|mesh-ancestor
43719033|NCT02638922|Hormones|hormones|mesh-ancestor
43719034|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719035|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719036|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43719037|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
43719038|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719039|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43719040|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43719041|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43719042|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43719043|NCT02638909|Ceritinib|ceritinib|mesh-list
43719044|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719045|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43719046|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719047|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719048|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
43719049|NCT02638896|Celecoxib|celecoxib|mesh-list
43719050|NCT02638896|Etanercept|etanercept|mesh-list
43719051|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44242973|NCT00599560|Vasopressins|vasopressins|mesh-list
44242974|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
44242975|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
43978314|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978315|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
43978316|NCT01907334|Hormones|hormones|mesh-ancestor
43978317|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43978318|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
43978319|NCT01907334|Miotics|miotics|mesh-ancestor
43978320|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43978321|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44019123|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
44019124|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644808|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719108|NCT02638831|Ketorolac|ketorolac|mesh-list
43719109|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43719110|NCT02638831|Ketoprofen|ketoprofen|mesh-list
43719111|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43719112|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719113|NCT02638831|Analgesics|analgesics|mesh-ancestor
43719161|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719162|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43719163|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
43719164|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719165|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719166|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
43719167|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719168|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43719169|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43719170|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719171|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719172|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
43719173|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719174|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43719175|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43719176|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
43719177|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
43978322|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43978323|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43978325|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
43978326|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43978327|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
43978328|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978329|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978330|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
43978331|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978332|NCT01907607|Palbociclib|palbociclib|mesh-list
43978333|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978334|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43978335|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978336|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978337|NCT01908062|Naltrexone|naltrexone|mesh-list
43978338|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44019125|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44019126|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43719190|NCT02638584|Rabeprazole|rabeprazole|mesh-list
43719191|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43719192|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719193|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43719194|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719195|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719196|NCT02638415|Carvedilol|carvedilol|mesh-list
43719197|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43719285|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43719286|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719287|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719288|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
43719289|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43719290|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43719291|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43978339|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43978340|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978341|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
43978342|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978343|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
43978344|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978345|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
43978346|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
43978347|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978348|NCT01908751|Vitamin D|vitamin d|mesh-list
43978349|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
43978350|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
43978351|NCT01908751|Vitamins|vitamins|mesh-list
43978352|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
43978353|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978354|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43978355|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43978356|NCT01908842|Buprenorphine|buprenorphine|mesh-list
43978357|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978358|NCT01908842|Narcotics|narcotics|mesh-ancestor
43978359|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978360|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978361|NCT01908842|Analgesics|analgesics|mesh-ancestor
43978362|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
43978363|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978364|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43978365|NCT01908972|Prednisolone|prednisolone|mesh-list
43978366|NCT01908972|Propranolol|propranolol|mesh-list
43978367|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44242976|NCT00599560|Coagulants|coagulants|mesh-ancestor
44242977|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44242978|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44242979|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
44242980|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242981|NCT00599573|Ondansetron|ondansetron|mesh-list
44242982|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
44242983|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
44242984|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978368|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
43978369|NCT01908972|Hormones|hormones|mesh-ancestor
43978370|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43978371|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978372|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43978373|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715106|NCT02663596|Vancomycin|vancomycin|mesh-list
43978381|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
43978383|NCT01909141|Pioglitazone|pioglitazone|mesh-list
43978384|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
43978385|NCT01909141|Letrozole|letrozole|mesh-list
43978386|NCT01909141|Clomiphene|clomiphene|mesh-list
43978387|NCT01909141|Enclomiphene|enclomiphene|mesh-list
43978388|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
43978389|NCT01909141|Hormones|hormones|mesh-list
43978390|NCT01909141|Estradiol|estradiol|mesh-list
43978391|NCT01909141|Testosterone|testosterone|mesh-list
43978392|NCT01909141|Progesterone|progesterone|mesh-list
43978393|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43978394|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43978395|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978396|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978397|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43978398|NCT01909141|Estrogens|estrogens|mesh-ancestor
43978399|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978400|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978401|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43978402|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43978403|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978404|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43978405|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
43978406|NCT01909141|Androgens|androgens|mesh-ancestor
43978407|NCT01909141|Progestins|progestins|mesh-ancestor
43978408|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43978409|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978410|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43978411|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
43978412|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43978413|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43978414|NCT01910064|Adapalene|adapalene|mesh-list
43978415|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43978416|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978417|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43978418|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978419|NCT01910064|Analgesics|analgesics|mesh-ancestor
43719499|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43719525|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719526|NCT02635893|Renal Agents|renal agents|mesh-ancestor
43719527|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43719528|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
43719529|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719530|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
43719531|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832576|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43832579|NCT05256264|Ketamine|ketamine|mesh-list
43722174|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722175|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43722176|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
43722177|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722178|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43722179|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722180|NCT02618356|Raltitrexed|raltitrexed|mesh-list
44019202|NCT03797872|Methotrexate|methotrexate|mesh-list
43723097|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43723098|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43723099|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723100|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723101|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723102|NCT02612259|Tryptophan|tryptophan|mesh-list
43723103|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43723104|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
43723649|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43723650|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723651|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
43723652|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
43723928|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723929|NCT02607072|Analgesics|analgesics|mesh-ancestor
43723930|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
43723931|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723932|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723933|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723934|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723935|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723936|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724109|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43724110|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724214|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43724215|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724216|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
43724217|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724218|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724219|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724220|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
43724221|NCT02605694|Hormones|hormones|mesh-ancestor
43978420|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
43978421|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978422|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978423|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978424|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978425|NCT01910311|Rifampin|rifampin|mesh-list
43978426|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43978427|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
43978428|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978429|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978430|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
43833224|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
43724461|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
43724462|NCT02604134|Protective Agents|protective agents|mesh-ancestor
43724463|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724464|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43724465|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724466|NCT02604095|Melatonin|melatonin|mesh-list
43724467|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
43724468|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724469|NCT02604095|Protective Agents|protective agents|mesh-ancestor
43724524|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724525|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724526|NCT02603770|Lovastatin|lovastatin|mesh-list
43724527|NCT02603770|L 647318|l 647318|mesh-list
43724528|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
43724529|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43724530|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43724654|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724703|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43724704|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
43724706|NCT02602743|Analgesics|analgesics|mesh-ancestor
43724707|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
43724708|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978431|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43978432|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978433|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978434|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44242985|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242987|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
44242988|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
44242989|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44242990|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
44242991|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242992|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242993|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44242994|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978435|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43978436|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43978437|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43978438|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43978439|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43978440|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
43978441|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
43978442|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978445|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978446|NCT01911169|Vitamin D|vitamin d|mesh-list
43978447|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
43978448|NCT01911169|Vitamins|vitamins|mesh-list
43978449|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
43978450|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978451|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43978452|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43978453|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
43978454|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43978455|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
43978456|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
43978457|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978458|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978459|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978460|NCT01911351|Analgesics|analgesics|mesh-ancestor
43978461|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
43978462|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978463|NCT01912274|Azacitidine|azacitidine|mesh-list
43978464|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43978465|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
43978466|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978467|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978468|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978469|NCT01912352|Methylphenidate|methylphenidate|mesh-list
43978470|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43978471|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978472|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43978473|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43978474|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871150|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978475|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978476|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
43978477|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978478|NCT01912716|Indomethacin|indomethacin|mesh-list
44019204|NCT03797872|Leflunomide|leflunomide|mesh-list
44019263|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978479|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43978480|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978481|NCT01912716|Analgesics|analgesics|mesh-ancestor
43978482|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
43978483|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978484|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978485|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978486|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978487|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
44242995|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44242997|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44459517|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44459518|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459519|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459520|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
44459521|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242998|NCT00599625|Pravastatin|pravastatin|mesh-list
44242999|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44243000|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44243001|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
44243002|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978488|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
43978489|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978490|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43978491|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978492|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978493|NCT01913535|Aticaprant|aticaprant|mesh-list
44019265|NCT03796182|Metformin|metformin|mesh-list
43978494|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43978495|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978496|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
43978497|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978498|NCT01914159|Ranibizumab|ranibizumab|mesh-list
43978499|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978500|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978501|NCT01914159|Growth Substances|growth substances|mesh-ancestor
44019290|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44019291|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44019292|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43724871|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724872|NCT02601924|Anesthetics|anesthetics|mesh-list
43724873|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
43724874|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644810|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724882|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724884|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
43724885|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724886|NCT02601898|Protective Agents|protective agents|mesh-ancestor
43724887|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
43724922|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724924|NCT02601508|Atracurium|atracurium|mesh-list
43833269|NCT05220358|Fostemsavir|fostemsavir|mesh-list
43833270|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43833271|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43833272|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
43833273|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833274|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43833275|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43833276|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833277|NCT05220293|Betamethasone|betamethasone|mesh-list
43833278|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
43833279|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43724997|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43724998|NCT02601235|Protective Agents|protective agents|mesh-ancestor
43724999|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43725000|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43725001|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725002|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43725003|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
43725004|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
43978502|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978503|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
43978504|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978505|NCT01915108|Remifentanil|remifentanil|mesh-list
43978506|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978507|NCT01915108|Narcotics|narcotics|mesh-ancestor
43978508|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978509|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978510|NCT01915108|Analgesics|analgesics|mesh-ancestor
44019293|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019294|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43644811|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725377|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725379|NCT02598427|Trastuzumab|trastuzumab|mesh-list
43725380|NCT02598427|Pertuzumab|pertuzumab|mesh-list
43725381|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725382|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725383|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
43725384|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
43725385|NCT02598414|Protective Agents|protective agents|mesh-ancestor
43725386|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725387|NCT02598440|Alendronate|alendronate|mesh-list
43725388|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
43725389|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725390|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725391|NCT02598310|Paclitaxel|paclitaxel|mesh-list
43725392|NCT02598310|Trastuzumab|trastuzumab|mesh-list
43725393|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43725394|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725395|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725396|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725397|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725398|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725481|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725482|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725483|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725484|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725485|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833315|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833316|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43833321|NCT05216770|Bupivacaine|bupivacaine|mesh-list
43978511|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
43978512|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978513|NCT01915823|Fluticasone|fluticasone|mesh-list
43978514|NCT01915823|Xhance|xhance|mesh-list
43978515|NCT01915823|Azelastine|azelastine|mesh-list
43978518|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
43978519|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978520|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019295|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44019296|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43725590|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
43725591|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833358|NCT05216055|Analgesics|analgesics|mesh-ancestor
43833359|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43833360|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43833361|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43833362|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833363|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833365|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
43978521|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978522|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
43978523|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978524|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43978525|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43978526|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978527|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978528|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43978529|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43978530|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
43978531|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
43978532|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978533|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
43978534|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43978535|NCT01916629|Protective Agents|protective agents|mesh-ancestor
44243003|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44243004|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44243005|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243006|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44243007|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44243008|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
44243009|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44243010|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
44243011|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243012|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
44243013|NCT00599716|Protective Agents|protective agents|mesh-ancestor
44243015|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
44243016|NCT00599807|Vitamins|vitamins|mesh-ancestor
43978536|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978537|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978538|NCT01916681|Misoprostol|misoprostol|mesh-list
43978539|NCT01916681|Oxytocin|oxytocin|mesh-list
43978540|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
43978541|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978542|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019299|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019300|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726000|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726001|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
43726002|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726003|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43726004|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
43726174|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726175|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
43726176|NCT02593227|Vaccines|vaccines|mesh-list
43726177|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
43726178|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726179|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726180|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726181|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43726182|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
43726183|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726316|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43726317|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726318|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833428|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833429|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833430|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833431|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43833432|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833433|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726319|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
43726384|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726385|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726386|NCT02591849|Incretins|incretins|mesh-ancestor
43726444|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726445|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43726446|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726447|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
43726448|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
43726449|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726450|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43726451|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43978543|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43978544|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
43978545|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43978546|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978547|NCT01916941|Prazosin|prazosin|mesh-list
43978548|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978549|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43978550|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43978551|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43978552|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978553|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978554|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978555|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978556|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43978557|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44019301|NCT03792191|Fentanyl|fentanyl|mesh-list
44019302|NCT03792191|Bupivacaine|bupivacaine|mesh-list
44019303|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019304|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
44019305|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019306|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019307|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
44019308|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848974|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848975|NCT03976310|Benralizumab|benralizumab|mesh-list
43848976|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726552|NCT02590133|Fluorouracil|fluorouracil|mesh-list
43726553|NCT02590133|Endostar protein|endostar protein|mesh-list
43726554|NCT02590133|Endostatins|endostatins|mesh-list
43726555|NCT02590133|Nedaplatin|nedaplatin|mesh-list
43726556|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
43726557|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726558|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43726970|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726971|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726972|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726973|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726974|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
43726975|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
43726976|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726977|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726978|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
43833510|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978558|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978559|NCT01917214|Sunitinib|sunitinib|mesh-list
43978560|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978561|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978562|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978563|NCT01917214|Growth Substances|growth substances|mesh-ancestor
43978564|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978565|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
43978566|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43978567|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978568|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978569|NCT01917773|Octreotide|octreotide|mesh-list
43978570|NCT01917773|Bisacodyl|bisacodyl|mesh-list
43978571|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019320|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
43728601|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728699|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728701|NCT02575768|Analgesics|analgesics|mesh-ancestor
43728702|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
43729411|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43729413|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
43729414|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
43729415|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729416|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729610|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729612|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729613|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43834343|NCT05148000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730403|NCT02565693|Analgesics|analgesics|mesh-ancestor
43730404|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
43730405|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730406|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43730407|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43730408|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43730409|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43730410|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730411|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43730487|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43730515|NCT02564003|Analgesics|analgesics|mesh-ancestor
43978572|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43978573|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978574|NCT01917773|Cathartics|cathartics|mesh-ancestor
43978575|NCT01917773|Laxatives|laxatives|mesh-ancestor
43978576|NCT01918761|Pemetrexed|pemetrexed|mesh-list
43978577|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978578|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978579|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978580|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44019321|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019322|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44019323|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
44019324|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019325|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44019326|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44019327|NCT03781479|Amifampridine|amifampridine|mesh-list
44019328|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019329|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834345|NCT05144854|Tegafur|tegafur|mesh-list
43732044|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732158|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
43732160|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732161|NCT02551796|Levofloxacin|levofloxacin|mesh-list
43732163|NCT02551796|Tobramycin|tobramycin|mesh-list
43732164|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43732165|NCT02551796|Dexamethasone|dexamethasone|mesh-list
43732166|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
43732167|NCT02551796|BB 1101|bb 1101|mesh-list
43732168|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
43732169|NCT02551796|Dipivefrin|dipivefrin|mesh-list
43732171|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
43978581|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43978582|NCT01919216|Citalopram|citalopram|mesh-list
43978583|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44243017|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
44243018|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243019|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44243020|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44243021|NCT00599820|Bevacizumab|bevacizumab|mesh-list
44019330|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165308|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732449|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732450|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
43732451|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732453|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43732454|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732455|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43834197|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834198|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43834199|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
43834200|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732841|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43732843|NCT02547597|Protective Agents|protective agents|mesh-ancestor
43732844|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43847621|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43847622|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
43847623|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847624|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847625|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847626|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734475|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
43734476|NCT02539706|Rocuronium|rocuronium|mesh-list
43734479|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44243022|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243023|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243024|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243025|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243026|NCT00599820|Growth Substances|growth substances|mesh-ancestor
44243027|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978584|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43978585|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978586|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019331|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44019332|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735101|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43735102|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735103|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735104|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43735105|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735106|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735108|NCT05299164|Rituximab|rituximab|mesh-list
43735109|NCT05299164|Vinorelbine|vinorelbine|mesh-list
43735110|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
43735111|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735112|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735113|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
43735114|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735115|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834466|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735116|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43735118|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735119|NCT05299164|Antiviral Agents|antiviral agents|mesh-ancestor
43735120|NCT05299164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735149|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
43735150|NCT05298683|Promethazine|promethazine|mesh-list
43735151|NCT05298683|Dexamethasone|dexamethasone|mesh-list
43978587|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978590|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43978592|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978593|NCT01919450|Regadenoson|regadenoson|mesh-list
43978594|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43978595|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43978596|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
43978597|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
44019333|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019334|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44019335|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
44019336|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44019337|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
44019338|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019339|NCT03783130|Antacids|antacids|mesh-ancestor
43735573|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735574|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
43735575|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43735576|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43735577|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43735578|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735588|NCT03259165|Diuretics|diuretics|mesh-list
43978598|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144346|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43978599|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978600|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978601|NCT01919606|Bupivacaine|bupivacaine|mesh-list
43978602|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
43978603|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
43978604|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978605|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978606|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
43978607|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978608|NCT01919697|Plecanatide|plecanatide|mesh-list
43978609|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43978610|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
43978611|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978612|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978613|NCT01919996|Azithromycin|azithromycin|mesh-list
43978614|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978615|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978616|NCT01920282|Nebivolol|nebivolol|mesh-list
43978617|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978618|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
43978619|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43978620|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43978621|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43978622|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978623|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978624|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978625|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978626|NCT01920802|Olanzapine|olanzapine|mesh-list
43978627|NCT01920802|Iloperidone|iloperidone|mesh-list
43978628|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
43978629|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
43978630|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978631|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978632|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978633|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43978634|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978635|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243028|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44243029|NCT00599833|Cetuximab|cetuximab|mesh-list
44243030|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243031|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243032|NCT00599885|Valsartan|valsartan|mesh-list
44243033|NCT00599885|Telmisartan|telmisartan|mesh-list
44243034|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019368|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43834567|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
43736751|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736752|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736753|NCT05357196|Gemcitabine|gemcitabine|mesh-list
43736754|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43736755|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
43736756|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736847|NCT05355337|Pramipexole|pramipexole|mesh-list
44243035|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44243036|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44243037|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978636|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978637|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43978638|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43978639|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978640|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978641|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978642|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
44019369|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43737765|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737766|NCT04471246|Cephalexin|cephalexin|mesh-list
43737767|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43737768|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737769|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
43737770|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
43737771|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737772|NCT04460326|Insulin|insulin|mesh-list
43737773|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43737774|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
43737791|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737792|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834758|NCT05098366|Furosemide|furosemide|mesh-list
43834759|NCT05098366|Diuretics|diuretics|mesh-ancestor
43834760|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
43834761|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834762|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43834763|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834764|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834765|NCT05098210|Poly I-C|poly i-c|mesh-list
43737951|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737952|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737953|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
43737954|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43737981|NCT04250064|Bevacizumab|bevacizumab|mesh-list
43737982|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737983|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978643|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
43978644|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43978645|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
43978646|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978647|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43978648|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978649|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43978650|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978651|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978652|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978653|NCT01921751|Gemcitabine|gemcitabine|mesh-list
43978654|NCT01921751|Paclitaxel|paclitaxel|mesh-list
43978655|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43978656|NCT01921751|Capecitabine|capecitabine|mesh-list
43978657|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43978658|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978659|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43978660|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43978661|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43978662|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978663|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43978664|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
43978665|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
43978666|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978667|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978668|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978669|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
43978670|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978672|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
43978673|NCT01921894|Vitamins|vitamins|mesh-ancestor
43978674|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
44019372|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44019373|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44019374|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
44019375|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
44019376|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44019377|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44019378|NCT03771560|Leucovorin|leucovorin|mesh-list
43978675|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978676|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43978677|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43978678|NCT01922115|Trospium chloride|trospium chloride|mesh-list
43978679|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
43978680|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
43978681|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978682|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978683|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43978684|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43978685|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
44019403|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019404|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019405|NCT03765502|Incretins|incretins|mesh-ancestor
44019407|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
43978686|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978687|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978688|NCT01922115|Urological Agents|urological agents|mesh-ancestor
43978689|NCT01922336|Infliximab|infliximab|mesh-list
43978690|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44243038|NCT00599898|Nifedipine|nifedipine|mesh-list
44243039|NCT00599898|Atosiban|atosiban|mesh-list
44243040|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44019414|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43738433|NCT03513406|Neostigmine|neostigmine|mesh-list
43738434|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43738435|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243041|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243042|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243043|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44243044|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978691|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978692|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978693|NCT01923129|Prazosin|prazosin|mesh-list
43978694|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978695|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43978696|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43978697|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43978698|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978699|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978700|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978701|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978703|NCT01924169|Vaccines|vaccines|mesh-list
43978704|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
43978705|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019423|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
44019424|NCT03758365|Clobetasol|clobetasol|mesh-list
44019425|NCT03758365|Desonide|desonide|mesh-list
44019426|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44019427|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43750551|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
43739799|NCT02533323|Antiviral Agents|antiviral agents|mesh-ancestor
43739800|NCT02533323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739801|NCT02533323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739802|NCT02533323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739803|NCT02533323|Immunologic Factors|immunologic factors|mesh-ancestor
43739804|NCT02533323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739805|NCT02533336|Abamectin|abamectin|mesh-list
43739806|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
43739807|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43739808|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739809|NCT02533349|Pantoprazole|pantoprazole|mesh-list
43739810|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43739838|NCT02533011|Heparin|heparin|mesh-list
43978706|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978707|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978708|NCT01924169|Growth Substances|growth substances|mesh-ancestor
43978709|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
43978710|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978711|NCT01924871|Remifentanil|remifentanil|mesh-list
43978712|NCT01924871|Desflurane|desflurane|mesh-list
43978713|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978714|NCT01924871|Narcotics|narcotics|mesh-ancestor
43978715|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978716|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978717|NCT01924871|Analgesics|analgesics|mesh-ancestor
43978718|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
43978719|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978720|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43978721|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
43978722|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
43978723|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
43978724|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43978725|NCT01924949|Ledipasvir|ledipasvir|mesh-list
43978726|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
43978727|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978728|NCT01925144|Omeprazole|omeprazole|mesh-list
43978729|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43978730|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43978731|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43978732|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978733|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144347|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144361|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978735|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
43978736|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
43978737|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978738|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978739|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
43978740|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978742|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43978743|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
43978744|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978745|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978746|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43978747|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43978748|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
43978749|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978750|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978751|NCT01926496|Imiquimod|imiquimod|mesh-list
44243045|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
44243046|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
44243047|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44243048|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44019471|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
44019472|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019473|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019474|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019475|NCT03740659|Levofloxacin|levofloxacin|mesh-list
44019476|NCT03740659|Ofloxacin|ofloxacin|mesh-list
44019477|NCT03740659|Dexamethasone|dexamethasone|mesh-list
44019478|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
44019479|NCT03740659|BB 1101|bb 1101|mesh-list
44019480|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739913|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739914|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739915|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
43739916|NCT02532634|Hormones|hormones|mesh-ancestor
43739917|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740101|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
43740102|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243049|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243050|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44243051|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44243052|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44243053|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243054|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243055|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243056|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243058|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
43978752|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43978753|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
43978754|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978755|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978756|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
43978757|NCT01926977|Ranibizumab|ranibizumab|mesh-list
43978758|NCT01926977|Aflibercept|aflibercept|mesh-list
43978759|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978760|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978761|NCT01926977|Growth Substances|growth substances|mesh-ancestor
43978762|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978763|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
43978764|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978765|NCT01927120|Sirolimus|sirolimus|mesh-list
43978766|NCT01927120|Aldesleukin|aldesleukin|mesh-list
43978767|NCT01927120|Tacrolimus|tacrolimus|mesh-list
43978768|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978769|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
43978770|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978771|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43978772|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978773|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978774|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978775|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978776|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43978777|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978778|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
43978788|NCT01927718|Growth Substances|growth substances|mesh-ancestor
43978789|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
43978790|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978791|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978792|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
43978793|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019481|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
43978794|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978795|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43978796|NCT01927887|Hematinics|hematinics|mesh-ancestor
43978797|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43978798|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43978799|NCT01928186|Alovudine|alovudine|mesh-list
43978800|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
43978801|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740833|NCT02527772|Antiviral Agents|antiviral agents|mesh-ancestor
43740834|NCT02527772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740835|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740836|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740837|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
43740838|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740839|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43740840|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740979|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43740980|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740981|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
43740982|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
43740983|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
43741167|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741168|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
43741169|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741170|NCT02525172|Rituximab|rituximab|mesh-list
43741171|NCT02525172|Methotrexate|methotrexate|mesh-list
43741172|NCT02525172|Bortezomib|bortezomib|mesh-list
43741173|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
43741174|NCT02525172|Antibodies|antibodies|mesh-list
43741175|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
43978802|NCT01928290|Leucovorin|leucovorin|mesh-list
43978803|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43978804|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
43978805|NCT01928290|Fluorouracil|fluorouracil|mesh-list
44243059|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243060|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243061|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243062|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
44243063|NCT00599937|Tretinoin|tretinoin|mesh-list
44019524|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44019525|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44019526|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43741278|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
43741279|NCT02524821|Metformin|metformin|mesh-list
43741280|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741281|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741282|NCT02524743|Acetaminophen|acetaminophen|mesh-list
43741283|NCT02524743|Lidocaine|lidocaine|mesh-list
43741284|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741285|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
43741286|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741287|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741288|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
43741289|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741290|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44243064|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243065|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
44243066|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44243067|NCT00599950|Mitomycins|mitomycins|mesh-list
44243068|NCT00599950|Mitomycin|mitomycin|mesh-list
44243069|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44243070|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243071|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
44243072|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019527|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019528|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741678|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
43741679|NCT05667805|Coagulants|coagulants|mesh-ancestor
43741680|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43741681|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
43741682|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741704|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741706|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741707|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
43741708|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243073|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44243074|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243075|NCT00600041|Pantoprazole|pantoprazole|mesh-list
44243076|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43978806|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
43978807|NCT01928290|Trastuzumab|trastuzumab|mesh-list
43978808|NCT01928290|Irinotecan|irinotecan|mesh-list
43715490|NCT02660684|Tacrolimus|tacrolimus|mesh-list
43978809|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
43978810|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
44019529|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019530|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44019531|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
43835409|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
43835410|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
43847751|NCT04080908|Hematinics|hematinics|mesh-ancestor
43978811|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978812|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43978813|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978814|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978815|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
43978816|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978817|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43978818|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44019532|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019533|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
44019534|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44019535|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019536|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019537|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978819|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43978820|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978821|NCT01928290|Antidotes|antidotes|mesh-ancestor
43978822|NCT01928290|Protective Agents|protective agents|mesh-ancestor
43978823|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
43978824|NCT01928290|Vitamins|vitamins|mesh-ancestor
43978825|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
43978826|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
43978827|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
43978828|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019538|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44019539|NCT03723980|Propolis|propolis|mesh-list
44019540|NCT03723980|Calcium|calcium|mesh-list
44019541|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44019542|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019543|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019544|NCT03723447|Dexamethasone|dexamethasone|mesh-list
43742628|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742629|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742630|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742631|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742632|NCT05064085|Capecitabine|capecitabine|mesh-list
43742633|NCT05064085|Cemiplimab|cemiplimab|mesh-list
43978829|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978830|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978831|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
43978832|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978833|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978834|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978835|NCT01928680|Cisplatin|cisplatin|mesh-list
43978836|NCT01928680|Capecitabine|capecitabine|mesh-list
43978837|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978838|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43978839|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
43978840|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978841|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
43978842|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
43978843|NCT01928693|Besifloxacin|besifloxacin|mesh-list
43978844|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43978845|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43978846|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44243077|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44243078|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44243079|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243080|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243081|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
44243083|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44243084|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
44243085|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019545|NCT03723447|Epinephrine|epinephrine|mesh-list
44019546|NCT03723447|Bupivacaine|bupivacaine|mesh-list
44019547|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019548|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
44019549|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
44019550|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019551|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019552|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019553|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
44019554|NCT03723447|Hormones|hormones|mesh-ancestor
44019572|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
43743198|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743199|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
43743200|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743201|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743202|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43743981|NCT04128956|Aspirin|aspirin|mesh-list
43744042|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744043|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744044|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
43744045|NCT04068103|Leucovorin|leucovorin|mesh-list
43744047|NCT04068103|Fluorouracil|fluorouracil|mesh-list
43744048|NCT04068103|Capecitabine|capecitabine|mesh-list
43744049|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
43744050|NCT04068103|Calcium|calcium|mesh-list
43744051|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
43744052|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43744053|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744054|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43744055|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
43744056|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744057|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744060|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
44243086|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243087|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243088|NCT00600093|Amantadine|amantadine|mesh-list
44243089|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44243090|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44243091|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
43726439|NCT02591017|Morphine|morphine|mesh-list
43978847|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978854|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43978855|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
43978856|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978857|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019573|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44019574|NCT03701295|Azacitidine|azacitidine|mesh-list
43744699|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
43744700|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744701|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744702|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
43744703|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43744704|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43744705|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744706|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744707|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744708|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978858|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43978859|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43978860|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43978861|NCT01928849|Valproic Acid|valproic acid|mesh-list
43978862|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
43978863|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978864|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978865|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
43978866|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978867|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978868|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
43978869|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978870|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019575|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44019576|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
43745450|NCT02408549|Lacosamide|lacosamide|mesh-list
43745451|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
43745524|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
43745525|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745526|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835750|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
43745618|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745619|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43745783|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
43745784|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745785|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43745786|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
43745787|NCT01979536|Hormones|hormones|mesh-ancestor
43745788|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43745789|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745790|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
43745791|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745799|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
43978871|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978872|NCT01929291|Vaccines|vaccines|mesh-list
43978873|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
43978874|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978875|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
43978876|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978877|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978878|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43978879|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43978880|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978881|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978882|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978883|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43978884|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43978885|NCT01929642|Sirolimus|sirolimus|mesh-list
43978886|NCT01929642|Everolimus|everolimus|mesh-list
43978887|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978888|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978889|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
43978890|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978891|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43978892|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978893|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43978894|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
43978895|NCT01929759|Tenofovir|tenofovir|mesh-list
43978896|NCT01929759|Emtricitabine|emtricitabine|mesh-list
43978897|NCT01929759|Cobicistat|cobicistat|mesh-list
44106634|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243093|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
44243094|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243095|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019577|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243096|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243097|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243098|NCT00600093|Analgesics|analgesics|mesh-ancestor
44243099|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
44243100|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243101|NCT00600145|Mirtazapine|mirtazapine|mesh-list
44243102|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243103|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243104|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44243105|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
44243106|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
44243107|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243108|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243109|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243110|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44243111|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44243112|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978898|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43978899|NCT01929759|Elvitegravir|elvitegravir|mesh-list
43978900|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
43978901|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978902|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43978903|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43978904|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978905|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978906|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43978907|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43978908|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43978909|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43978910|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43978911|NCT01929889|Iloperidone|iloperidone|mesh-list
43978912|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43978913|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43978914|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978926|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
43978927|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
43978928|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43978929|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978930|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43978931|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43978932|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43978933|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978934|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43978935|NCT01930747|Narcotics|narcotics|mesh-ancestor
43978936|NCT01930747|Analgesics|analgesics|mesh-ancestor
43978937|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
44019610|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019662|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835754|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835755|NCT05025605|Analgesics|analgesics|mesh-ancestor
43746193|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746194|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746195|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
43746196|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243113|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44243114|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44243115|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44243116|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44243117|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44243118|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44243119|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
44243120|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44243121|NCT00600158|Lidocaine|lidocaine|mesh-list
44243122|NCT00600158|Hydromorphone|hydromorphone|mesh-list
44243123|NCT00600158|Bupivacaine|bupivacaine|mesh-list
44243124|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
44243125|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
44019663|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43746659|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746660|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746661|NCT02522897|Growth Substances|growth substances|mesh-ancestor
43746679|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43746680|NCT02522858|Analgesics|analgesics|mesh-ancestor
43746681|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
43746682|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43746683|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43746684|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43746685|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43746686|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
43746687|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746688|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747487|NCT05583214|Hormones|hormones|mesh-ancestor
44243126|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243127|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243128|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
44243129|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243130|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44243131|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44243132|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44243133|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978939|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978940|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43978941|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
43978942|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978943|NCT01931527|Rasburicase|rasburicase|mesh-list
43978944|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
43978945|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978946|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43978947|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43978948|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978949|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978950|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43978951|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978952|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978953|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
43978954|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978955|NCT01932060|Oxytocin|oxytocin|mesh-list
43978956|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
43978957|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43978958|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978959|NCT01932112|Adenosine|adenosine|mesh-list
43978960|NCT01932112|Analgesics|analgesics|mesh-ancestor
44019664|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019665|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019666|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44019667|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44019668|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019669|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019670|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
43978961|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
43978962|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978963|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978964|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43978965|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
43978966|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43978967|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
43978968|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
43978969|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243134|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243135|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44243136|NCT00600158|Narcotics|narcotics|mesh-ancestor
44243137|NCT00600158|Analgesics|analgesics|mesh-ancestor
44243138|NCT00600210|Bevacizumab|bevacizumab|mesh-list
44243139|NCT00600210|Carboplatin|carboplatin|mesh-list
44243140|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243141|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243142|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243143|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978970|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978971|NCT01933425|Rocuronium|rocuronium|mesh-list
43978972|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43978973|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43978974|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43978975|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978976|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978977|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
43978980|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978981|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978982|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978983|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
43978985|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
43978986|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978988|NCT01933984|Fenoterol|fenoterol|mesh-list
43978989|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43978990|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
43978991|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978992|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
43978993|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978994|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978995|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43978996|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
43978997|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978998|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43978999|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43979000|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43979001|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43979002|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979003|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979004|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979005|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
43979006|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
43979007|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979008|NCT01934231|Amoxicillin|amoxicillin|mesh-list
43979009|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
43979010|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
43979011|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43979012|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979013|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979014|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43979015|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979016|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979017|NCT01934582|Treprostinil|treprostinil|mesh-list
43979018|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43979019|NCT01935622|Doxycycline|doxycycline|mesh-list
43979020|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979021|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979022|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
43979023|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43979024|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43979025|NCT01935791|Glucagon|glucagon|mesh-list
43979026|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43979027|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979028|NCT01935791|Hormones|hormones|mesh-ancestor
44243144|NCT00600210|Growth Substances|growth substances|mesh-ancestor
44019724|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243145|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243146|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
44243147|NCT00600249|Docetaxel|docetaxel|mesh-list
44243148|NCT00600249|Cetuximab|cetuximab|mesh-list
44243149|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979029|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979030|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979031|NCT01935791|Incretins|incretins|mesh-ancestor
43979032|NCT01936363|Niacinamide|niacinamide|mesh-list
43979033|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
43979034|NCT01936363|Vitamins|vitamins|mesh-ancestor
43979035|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
43979036|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979037|NCT01936519|Cyclosporine|cyclosporine|mesh-list
44019725|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44019726|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019727|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019728|NCT03189433|Dantrolene|dantrolene|mesh-list
44019729|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44019730|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019731|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019732|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019733|NCT03161964|Propranolol|propranolol|mesh-list
44019734|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44019735|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44019736|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550916|NCT03619408|Antacids|antacids|mesh-list
43747737|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43747738|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748231|NCT03218137|Verapamil|verapamil|mesh-list
43748232|NCT03218137|Analgesics|analgesics|mesh-ancestor
43748233|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
43748234|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979038|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
43979039|NCT01936519|Everolimus|everolimus|mesh-list
43979040|NCT01936519|Tacrolimus|tacrolimus|mesh-list
43979041|NCT01936519|Cyclosporins|cyclosporins|mesh-list
43979042|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43979043|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979044|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
43979045|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979046|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979047|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979048|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
44019737|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748279|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
43748280|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748281|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748282|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748283|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
43748284|NCT03030261|Hormones|hormones|mesh-ancestor
43748285|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748286|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748313|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748333|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748335|NCT02437370|Docetaxel|docetaxel|mesh-list
43836021|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748445|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43748446|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748447|NCT00198718|Vitamin A|vitamin a|mesh-list
43748448|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
43748449|NCT00198718|Vitamins|vitamins|mesh-ancestor
43748486|NCT02517684|Hormones|hormones|mesh-ancestor
43748487|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748488|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748489|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748490|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836046|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
43836047|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
43836048|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
43836049|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43836050|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43836051|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
43836052|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43836053|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43836054|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
43979049|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979050|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979051|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979052|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979053|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43979056|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979057|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43979058|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979059|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43979060|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
43979061|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43979062|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43979063|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
43979064|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979065|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979066|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43979067|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979069|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
43979070|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
43979071|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979073|NCT01937260|Brodalumab|brodalumab|mesh-list
43979074|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979075|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43979076|NCT01937598|Liraglutide|liraglutide|mesh-list
43979077|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979078|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019738|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019739|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019740|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44019741|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019742|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
44019743|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44019744|NCT03150160|Travoprost|travoprost|mesh-list
44019745|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43979079|NCT01937598|Incretins|incretins|mesh-ancestor
43979080|NCT01937598|Hormones|hormones|mesh-ancestor
43979081|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979082|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43979083|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
43979084|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979085|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979086|NCT01937975|Grazoprevir|grazoprevir|mesh-list
43979087|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
43979088|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979089|NCT01938040|Ibuprofen|ibuprofen|mesh-list
43979090|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43979091|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43979092|NCT01938040|Analgesics|analgesics|mesh-ancestor
43979093|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
43979094|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979095|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979096|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979097|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243150|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
44243151|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
44243152|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
44243153|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243154|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243155|NCT00600262|Bevacizumab|bevacizumab|mesh-list
44243156|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243157|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243158|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243159|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243160|NCT00600262|Growth Substances|growth substances|mesh-ancestor
43979098|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43979099|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979100|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979101|NCT01938079|Ketamine|ketamine|mesh-list
43979102|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43979103|NCT01938079|Analgesics|analgesics|mesh-ancestor
43979104|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
43979105|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979106|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979107|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43979108|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43979109|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
43979110|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
43979111|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979112|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43979113|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43979114|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979115|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979116|NCT01938664|Candesartan|candesartan|mesh-list
43979117|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019801|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44019802|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44019803|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019804|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019805|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019806|NCT03007719|Fluorides|fluorides|mesh-list
44019807|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
44019808|NCT03007719|Protective Agents|protective agents|mesh-ancestor
44019809|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019810|NCT02985801|Pancrelipase|pancrelipase|mesh-list
44019811|NCT02985801|Pancreatin|pancreatin|mesh-list
43836216|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836217|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
43836218|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836219|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
43836220|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43836221|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
43836222|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836223|NCT04987775|Expectorants|expectorants|mesh-ancestor
43836224|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
43836225|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43836226|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
43836227|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749812|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
43979118|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43979119|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43979120|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979121|NCT01938989|Methamphetamine|methamphetamine|mesh-list
43979122|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
43979123|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43979124|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44019816|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43836261|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836262|NCT04985136|Sorafenib|sorafenib|mesh-list
43836263|NCT04985136|Apatinib|apatinib|mesh-list
43836264|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836265|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43553857|NCT03576963|Nivolumab|nivolumab|mesh-list
43836266|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836267|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836268|NCT04984993|Tadalafil|tadalafil|mesh-list
43750476|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
43750477|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750478|NCT02505087|Expectorants|expectorants|mesh-ancestor
43750479|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750481|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
43979125|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43979128|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
43979129|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979130|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
43979131|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979132|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979133|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979134|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43979135|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43979136|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43979137|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43979138|NCT01938989|Hormones|hormones|mesh-ancestor
44019817|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019818|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019819|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
43836369|NCT04978649|Amlodipine|amlodipine|mesh-list
43751573|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751574|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751576|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751577|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43751578|NCT02497157|Leucovorin|leucovorin|mesh-list
43751579|NCT02497157|Bevacizumab|bevacizumab|mesh-list
43751695|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43751696|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43751697|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43751698|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
43751728|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751729|NCT02496455|Tramadol|tramadol|mesh-list
43751730|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43751731|NCT02496455|Narcotics|narcotics|mesh-ancestor
43751732|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751733|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751734|NCT02496455|Analgesics|analgesics|mesh-ancestor
43751735|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
43847838|NCT04074746|Antibodies|antibodies|mesh-list
43847839|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43979139|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979140|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
43979141|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43979142|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
43979143|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979144|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979145|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43979146|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
43979147|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43979148|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
44243161|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243162|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44243163|NCT00600301|Triamcinolone|triamcinolone|mesh-list
44243164|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44243165|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44243166|NCT00600301|Bevacizumab|bevacizumab|mesh-list
44243167|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44243168|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243169|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019824|NCT02994251|Gemcitabine|gemcitabine|mesh-list
44019825|NCT02994251|Cisplatin|cisplatin|mesh-list
44019826|NCT02994251|Doxorubicin|doxorubicin|mesh-list
44019827|NCT02994251|Mitomycins|mitomycins|mesh-list
44019828|NCT02994251|Mitomycin|mitomycin|mesh-list
44019829|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019830|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44019832|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019834|NCT02994251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019835|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019836|NCT02994251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019837|NCT02994251|Immunologic Factors|immunologic factors|mesh-ancestor
44019838|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019839|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43752115|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
43752116|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752117|NCT02493335|Budesonide|budesonide|mesh-list
43752118|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752120|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
43979149|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979150|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979151|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43979152|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
43979153|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
43979154|NCT01939301|Protective Agents|protective agents|mesh-ancestor
43979155|NCT01940276|Prednisone|prednisone|mesh-list
43979156|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
43979157|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979158|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
43979159|NCT01940276|Hormones|hormones|mesh-ancestor
43979160|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979161|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979162|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43979163|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979164|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43979165|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979166|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979167|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
43979168|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43979169|NCT01940510|Rifampin|rifampin|mesh-list
43979170|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43979171|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
43979172|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979173|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979174|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
43979175|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43979176|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979177|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979178|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43979179|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43979180|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43836474|NCT04970108|Telmisartan|telmisartan|mesh-list
43836477|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979181|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43979182|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43979183|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43979184|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
43979185|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43979186|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43979187|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979188|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
43979189|NCT01940523|Coagulants|coagulants|mesh-ancestor
44019874|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019875|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43979191|NCT01941628|Succinylcholine|succinylcholine|mesh-list
43979192|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43979193|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43979194|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43979195|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979196|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979207|NCT01942668|Progesterone|progesterone|mesh-list
43979208|NCT01942668|Estrogens|estrogens|mesh-ancestor
43979209|NCT01942668|Hormones|hormones|mesh-ancestor
43979210|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753246|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43753247|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753248|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43753281|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43753282|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
43753283|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43754413|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43754414|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754415|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43754416|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754449|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754450|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43754451|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
43754580|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43754592|NCT02477514|Tedizolid|tedizolid|mesh-list
44019876|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979211|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979212|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43979213|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
44243170|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243171|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243172|NCT00600301|Growth Substances|growth substances|mesh-ancestor
44243173|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243174|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
44243175|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243176|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
44243177|NCT00600301|Hormones|hormones|mesh-ancestor
44243178|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979214|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979215|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43979216|NCT01942668|Progestins|progestins|mesh-ancestor
43979217|NCT01943461|Avelumab|avelumab|mesh-list
43979218|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43979219|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43979220|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979221|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
43979222|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979223|NCT01943565|Hydromorphone|hydromorphone|mesh-list
43979224|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979225|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979226|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43979227|NCT01943565|Narcotics|narcotics|mesh-ancestor
43979228|NCT01943565|Analgesics|analgesics|mesh-ancestor
43979229|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
43979230|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979231|NCT01943864|Trametinib|trametinib|mesh-list
43979232|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979233|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43979234|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979235|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144362|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144363|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144364|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144365|NCT00191711|Gemcitabine|gemcitabine|mesh-list
44144366|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144367|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
44144368|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144369|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144370|NCT00191711|Antiviral Agents|antiviral agents|mesh-ancestor
44019879|NCT02974686|Everolimus|everolimus|mesh-list
44144371|NCT00191711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144372|NCT00191711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144373|NCT00191711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144374|NCT00191711|Immunologic Factors|immunologic factors|mesh-ancestor
44144375|NCT00191711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144376|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44144377|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144378|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144379|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144380|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144381|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144382|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144383|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144384|NCT00191750|Pemetrexed|pemetrexed|mesh-list
43979236|NCT01944293|Midazolam|midazolam|mesh-list
43979237|NCT01944293|Ketamine|ketamine|mesh-list
43979238|NCT01944293|Analgesics|analgesics|mesh-ancestor
43979241|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979242|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43979243|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43979244|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
43979245|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
43979246|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979247|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43979248|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44243179|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243180|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
44243181|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243182|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243183|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
44243184|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
44243185|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44243186|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979249|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979250|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979251|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43979252|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43979253|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43979254|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43979255|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43979256|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
43979257|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
43979258|NCT01944319|Meropenem|meropenem|mesh-list
43979259|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979260|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979261|NCT01944371|Disulfiram|disulfiram|mesh-list
43979262|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43979263|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43979264|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836893|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836894|NCT04943198|Vemurafenib|vemurafenib|mesh-list
43836895|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836896|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836897|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836898|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755914|NCT02470117|Antacids|antacids|mesh-list
43755915|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756078|NCT02468232|Enalapril|enalapril|mesh-list
43756447|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
43756448|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
43979265|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979266|NCT01944423|Cycloserine|cycloserine|mesh-list
43979267|NCT01944423|Nicotine|nicotine|mesh-list
43979268|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43979269|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
43979270|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979271|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979272|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44019968|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837020|NCT04937699|Aspirin|aspirin|mesh-list
43837021|NCT04937699|Clopidogrel|clopidogrel|mesh-list
43837022|NCT04937699|Ticagrelor|ticagrelor|mesh-list
43837023|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43837024|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756771|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43979273|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44019969|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979274|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
43979275|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979276|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979277|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43979278|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979279|NCT01944423|Renal Agents|renal agents|mesh-ancestor
43979280|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43979281|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
43979282|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979283|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
44019970|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44019971|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019972|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019973|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019974|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44019975|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
44019976|NCT02744352|Ropivacaine|ropivacaine|mesh-list
44019977|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019978|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
44019979|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757352|NCT02460692|Analgesics|analgesics|mesh-ancestor
43757353|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
43757354|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757355|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43757356|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43757357|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757358|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757359|NCT02460692|Hormones|hormones|mesh-ancestor
43757360|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757361|NCT02460640|Morphine|morphine|mesh-list
43757362|NCT02460640|Ropivacaine|ropivacaine|mesh-list
43757363|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43757364|NCT02460640|Narcotics|narcotics|mesh-ancestor
43979284|NCT01945138|Insulin|insulin|mesh-list
43979285|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43979286|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979287|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979288|NCT01945294|Interferons|interferons|mesh-list
43979289|NCT01945294|Ribavirin|ribavirin|mesh-list
43979290|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
43979291|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
43979292|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43979293|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979294|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
43979295|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019980|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757462|NCT02460146|CXA-10|cxa-10|mesh-list
43979296|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
43979297|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979298|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
43979299|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979300|NCT01947153|Metformin|metformin|mesh-list
43979301|NCT01947153|Linagliptin|linagliptin|mesh-list
43979302|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979303|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979304|NCT01947153|Incretins|incretins|mesh-ancestor
43979305|NCT01947153|Hormones|hormones|mesh-ancestor
43979306|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979307|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44243187|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243188|NCT00600405|Ibuprofen|ibuprofen|mesh-list
44243189|NCT00600405|Oxycodone|oxycodone|mesh-list
44243190|NCT00600405|Tamsulosin|tamsulosin|mesh-list
44243191|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44243192|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243193|NCT00600405|Analgesics|analgesics|mesh-ancestor
44019984|NCT02758132|Prednisone|prednisone|mesh-list
44019985|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019986|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
43757687|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757688|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757689|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43757690|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43757691|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43757692|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
43757694|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
43757699|NCT02458729|Coagulants|coagulants|mesh-ancestor
44243194|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
44243195|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243196|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243197|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243198|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243199|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243200|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243201|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243202|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44243203|NCT00600405|Narcotics|narcotics|mesh-ancestor
44243204|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979308|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
43979309|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715902|NCT02658214|Vitamins|vitamins|mesh-ancestor
43979310|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979311|NCT01947907|Hormones|hormones|mesh-list
43979315|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43979316|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
43979318|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979319|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43979320|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979321|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979322|NCT01948310|Ranolazine|ranolazine|mesh-list
43979323|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43979324|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43979325|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979326|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43979327|NCT01948388|Hormones|hormones|mesh-ancestor
43979328|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979329|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979330|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
43979331|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
43979332|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43979333|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43758297|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43758298|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837170|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43837171|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837172|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837173|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
43758308|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
43758309|NCT02455609|Ketamine|ketamine|mesh-list
43758310|NCT02455609|Bupivacaine|bupivacaine|mesh-list
43758311|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758312|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
43758421|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758425|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979334|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979335|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979336|NCT01948518|Urological Agents|urological agents|mesh-ancestor
43979337|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
43979338|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43979339|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979340|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979341|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979342|NCT01949844|Regadenoson|regadenoson|mesh-list
43979343|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43979344|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43979345|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
43979346|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
43979347|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243205|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44020024|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
44020025|NCT02749617|Apixaban|apixaban|mesh-list
44020027|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
44243206|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44243207|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44243208|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44243209|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243210|NCT00600405|Urological Agents|urological agents|mesh-ancestor
44243211|NCT00600509|Levetiracetam|levetiracetam|mesh-list
44243212|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
44243213|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
44243214|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
43979348|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979349|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979350|NCT01950039|Betaine|betaine|mesh-list
43979351|NCT01950039|Glycine|glycine|mesh-list
43979352|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
43979353|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979354|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979355|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979356|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979357|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
43979358|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43979359|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
43979360|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43979361|NCT01950260|Hormones|hormones|mesh-list
43979362|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979363|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979364|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43979365|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979366|NCT01951066|Dexamethasone|dexamethasone|mesh-list
43979367|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979368|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
43979369|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
43979370|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979371|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979372|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979373|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
43979374|NCT01951066|Hormones|hormones|mesh-ancestor
43979375|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979376|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43979377|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979378|NCT01951118|Donepezil|donepezil|mesh-list
43979379|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43979387|NCT01951339|Glimepiride|glimepiride|mesh-list
43979388|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020048|NCT02721277|SMOFlipid|smoflipid|mesh-list
43979389|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979390|NCT01951339|Incretins|incretins|mesh-ancestor
43979391|NCT01951339|Hormones|hormones|mesh-ancestor
43979392|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979393|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43979394|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
43979395|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979396|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979397|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43979398|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979399|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
43979400|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43979401|NCT01951391|Triclocarban|triclocarban|mesh-list
43979402|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43979403|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979404|NCT01951651|Exenatide|exenatide|mesh-list
43979405|NCT01951651|Glipizide|glipizide|mesh-list
43979406|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979407|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979408|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43979409|NCT01951651|Incretins|incretins|mesh-ancestor
43979410|NCT01951651|Hormones|hormones|mesh-ancestor
44020086|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43759442|NCT02449369|Oxycodone|oxycodone|mesh-list
43759443|NCT02449369|Hydromorphone|hydromorphone|mesh-list
43759444|NCT02449369|Orphenadrine|orphenadrine|mesh-list
44020087|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44243215|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
44243216|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243217|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44243218|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243219|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243220|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
44243221|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243222|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020088|NCT02687165|Cycloserine|cycloserine|mesh-list
44020089|NCT02687165|Milnacipran|milnacipran|mesh-list
44020090|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
44020091|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44020092|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020093|NCT02687165|Renal Agents|renal agents|mesh-ancestor
44020094|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44020095|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
43760506|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760629|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
43760630|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760631|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
43760632|NCT02444169|Protective Agents|protective agents|mesh-ancestor
43760633|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43760634|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760635|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760636|NCT02444364|Incretins|incretins|mesh-ancestor
43760637|NCT02444364|Hormones|hormones|mesh-ancestor
43760639|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44243223|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44243224|NCT00600535|Hormones|hormones|mesh-ancestor
44243225|NCT00600548|Miltefosine|miltefosine|mesh-list
44243226|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44243227|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
44243228|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243229|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243230|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44020096|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44020097|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
43671128|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671129|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
43671130|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
43671131|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
43671132|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671133|NCT05153525|Cisatracurium|cisatracurium|mesh-list
43671134|NCT05153525|Atracurium|atracurium|mesh-list
43671135|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43671166|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43671167|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43671168|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43671169|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671170|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671171|NCT05125796|Analgesics|analgesics|mesh-ancestor
44243231|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44243232|NCT00600587|Gemcitabine|gemcitabine|mesh-list
44243233|NCT00600587|Carboplatin|carboplatin|mesh-list
44243234|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44243235|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243236|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44243237|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
44243238|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243239|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
44020098|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020099|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43671343|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827168|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43827176|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43827177|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43671359|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43671360|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671362|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671363|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
44243240|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243241|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243242|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243243|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
44243244|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979411|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979412|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43979413|NCT01951768|Gentamicins|gentamicins|mesh-list
43979414|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979415|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43979416|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020100|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43671552|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
43671553|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
43671554|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671555|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671556|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
43671557|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671558|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43671559|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43671560|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43671578|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
43671579|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
43671580|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43671581|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43979417|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979418|NCT01951820|Lidocaine|lidocaine|mesh-list
43979419|NCT01951820|Tetracaine|tetracaine|mesh-list
43979420|NCT01951820|Carticaine|carticaine|mesh-list
43979421|NCT01951820|Benzocaine|benzocaine|mesh-list
43979422|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
43979423|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
43979424|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979425|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243245|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44243246|NCT00600600|Tigecycline|tigecycline|mesh-list
44243247|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243248|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243249|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44243250|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243251|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243252|NCT00600626|Insulin|insulin|mesh-list
44243253|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43979426|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
43979427|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979428|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43979429|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43979430|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43979431|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020101|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020102|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020103|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020104|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020105|NCT02687165|Analgesics|analgesics|mesh-ancestor
44020106|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
44020107|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979432|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979433|NCT01951950|Nicardipine|nicardipine|mesh-list
43979434|NCT01951950|Esmolol|esmolol|mesh-list
43979435|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43979436|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43979437|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43979438|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979439|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020126|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020127|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671967|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671968|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671969|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
43671970|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671971|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672099|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43672100|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672101|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
43672102|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43672103|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672104|NCT02830360|Amiodarone|amiodarone|mesh-list
43672105|NCT02830360|Sotalol|sotalol|mesh-list
43672106|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43672107|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
43672108|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43672109|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43672110|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672111|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43672112|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43849883|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
43672287|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672288|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43672289|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43672290|NCT02434744|Metformin|metformin|mesh-list
43672291|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43672331|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672332|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43672340|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43979440|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979441|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979442|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43979443|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43979444|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715958|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
43979457|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979458|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43979459|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43979460|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979461|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979462|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43979463|NCT01951963|Narcotics|narcotics|mesh-ancestor
43979464|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
44020128|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672778|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43827395|NCT05488925|Vitamins|vitamins|mesh-ancestor
43827396|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
43827397|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827398|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43827399|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43827400|NCT05488925|Analgesics|analgesics|mesh-ancestor
43673080|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43673081|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43673082|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43673084|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
43673085|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673086|NCT02046395|Urological Agents|urological agents|mesh-ancestor
43673087|NCT02044341|Benzocaine|benzocaine|mesh-list
43673088|NCT02044341|Glycerol|glycerol|mesh-list
43673089|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43673090|NCT02044341|Protective Agents|protective agents|mesh-ancestor
43673098|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43979465|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43979466|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979467|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43979468|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43979469|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979470|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979471|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979472|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44020129|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44020130|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43673446|NCT01893190|Nimodipine|nimodipine|mesh-list
43673447|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43673448|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43673449|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673450|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673451|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43673452|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673453|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
43673454|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43673455|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979473|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43979474|NCT01953081|Metoclopramide|metoclopramide|mesh-list
43979475|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
43979476|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
43979477|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979478|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979479|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979480|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43979481|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43979482|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
44020131|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673995|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673996|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
43673998|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43673999|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43674000|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43674001|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43674002|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
43674003|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979483|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979484|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979485|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
43979486|NCT01953211|Norinyl|norinyl|mesh-list
43979487|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
43979488|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43979489|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979490|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243254|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
44243255|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
44243256|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44243257|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
44243258|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
44243259|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
44243260|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
44243261|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44243262|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243263|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44243264|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44243265|NCT00600639|Prednisolone|prednisolone|mesh-list
44243266|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44243267|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
44243268|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44243269|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
44243270|NCT00600639|Albuterol|albuterol|mesh-list
44243271|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43979491|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43979492|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43979493|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43979494|NCT01953432|Doxazosin|doxazosin|mesh-list
43979495|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43979496|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43979497|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43979498|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43979499|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979500|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979501|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979502|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979503|NCT01955382|Artesunate|artesunate|mesh-list
43979504|NCT01955382|Amodiaquine|amodiaquine|mesh-list
43979505|NCT01955382|Charcoal|charcoal|mesh-list
43979506|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
43979523|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43979524|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
43979525|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979526|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979527|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43979528|NCT01955629|Capecitabine|capecitabine|mesh-list
43979529|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
43979530|NCT01955629|Aflibercept|aflibercept|mesh-list
43979531|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43979532|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
43979533|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979534|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979535|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43979536|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43979537|NCT01955629|Growth Substances|growth substances|mesh-ancestor
43979538|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979539|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
43979540|NCT01957410|Ketamine|ketamine|mesh-list
43979541|NCT01957410|Analgesics|analgesics|mesh-ancestor
43979542|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
43979543|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979544|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979545|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43979546|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44243272|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
44243273|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243274|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
44243275|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243276|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
44243277|NCT00600639|Hormones|hormones|mesh-ancestor
44243278|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243279|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243280|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43979547|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
43979548|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
43979549|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979550|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43979551|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43979552|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979553|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979554|NCT01957930|Insulin|insulin|mesh-list
43979555|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43979556|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979557|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979558|NCT01958073|Estradiol|estradiol|mesh-list
43979559|NCT01958073|Estrogens|estrogens|mesh-list
43979560|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43979561|NCT01958073|Hormones|hormones|mesh-ancestor
44020214|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44020215|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44020216|NCT02589145|Growth Substances|growth substances|mesh-ancestor
44256165|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063430|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
44063431|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063432|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063433|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063434|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063435|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827545|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827546|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827547|NCT05487755|Urological Agents|urological agents|mesh-ancestor
43827548|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43827549|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43827550|NCT05487755|Protective Agents|protective agents|mesh-ancestor
43675191|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675192|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675193|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675194|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675195|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43675196|NCT02886299|Simvastatin|simvastatin|mesh-list
43675197|NCT02886299|Fenofibrate|fenofibrate|mesh-list
43675198|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43675199|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43675200|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
43675201|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675202|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43675277|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43675278|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43675279|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
43979562|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979563|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979564|NCT01958112|Trametinib|trametinib|mesh-list
43979565|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979566|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43979581|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
43979582|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
43979583|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979584|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979585|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
43979586|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979587|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979588|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43979589|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
43979590|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44020217|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
44020218|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44020219|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
44020220|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44020221|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
44020222|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44020223|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44020224|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44020225|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
44020227|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
44020228|NCT02593682|Suvorexant|suvorexant|mesh-list
44020229|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44020230|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44020231|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020232|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020233|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44020234|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827573|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43675383|NCT02884713|Doxycycline|doxycycline|mesh-list
43675384|NCT02884713|Levofloxacin|levofloxacin|mesh-list
43675385|NCT02884713|Ofloxacin|ofloxacin|mesh-list
43979591|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43979592|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43979593|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43979594|NCT01959490|Growth Substances|growth substances|mesh-ancestor
43979595|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
43979596|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43979597|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43979598|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43979599|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979600|NCT01959685|Enclomiphene|enclomiphene|mesh-list
43979601|NCT01959685|Clomiphene|clomiphene|mesh-list
43979602|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
43979603|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43979604|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
43979605|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979606|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716103|NCT02655757|Hormones|hormones|mesh-ancestor
43979607|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43979608|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
43979609|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979610|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43979611|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43979612|NCT01959945|Vaccines|vaccines|mesh-list
43979613|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
43979614|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
43979615|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243281|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243282|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
44243283|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
44243284|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243285|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44243286|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44243287|NCT00600639|Protective Agents|protective agents|mesh-ancestor
44243288|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44243289|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44243290|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
44243291|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
44243292|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44243293|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44243294|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44243295|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44243296|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979616|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
43979617|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
43979618|NCT01960075|Levetiracetam|levetiracetam|mesh-list
43979619|NCT01960075|Valproic Acid|valproic acid|mesh-list
43979620|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
43979621|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
43979622|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979623|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979624|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
44020236|NCT02587650|Ceritinib|ceritinib|mesh-list
43979625|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979626|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979627|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
43979628|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43979629|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979630|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43979631|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43979632|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020266|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43827644|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
43827645|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675802|NCT02881619|Etodolac|etodolac|mesh-list
43675803|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43675804|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43675805|NCT02881619|Analgesics|analgesics|mesh-ancestor
43675806|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
43675807|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675808|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675809|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43675810|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979634|NCT01960387|Clofarabine|clofarabine|mesh-list
43979635|NCT01960387|Antimetabolites|antimetabolites|mesh-list
43979636|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43979637|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979638|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979639|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
43979640|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979641|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979642|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
44020267|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44020268|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676067|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
43676068|NCT02878785|Decitabine|decitabine|mesh-list
43676069|NCT02878785|Talazoparib|talazoparib|mesh-list
43676070|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43676071|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
43676108|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43676109|NCT02878772|Protective Agents|protective agents|mesh-ancestor
43676156|NCT02878200|Artenimol|artenimol|mesh-list
43676157|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
43676158|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43676159|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676160|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676161|NCT02878291|Vaccines|vaccines|mesh-list
43676162|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
43676163|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676164|NCT02878083|Adalimumab|adalimumab|mesh-list
43676165|NCT02878083|Vedolizumab|vedolizumab|mesh-list
43676166|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676167|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676168|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676281|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676282|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43979643|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144385|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144386|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144387|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144388|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44144389|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144390|NCT00191763|Gemcitabine|gemcitabine|mesh-list
44144392|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020269|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020270|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020271|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44020272|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43676414|NCT02876250|Cyclosporins|cyclosporins|mesh-list
43676415|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847631|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676487|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676488|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43676489|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846947|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43846948|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846949|NCT04157036|Analgesics|analgesics|mesh-ancestor
44144393|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144394|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
44144395|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144396|NCT00191763|Antiviral Agents|antiviral agents|mesh-ancestor
44144397|NCT00191763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144398|NCT00191763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144399|NCT00191763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144400|NCT00191763|Immunologic Factors|immunologic factors|mesh-ancestor
44144401|NCT00191763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243297|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243298|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243299|NCT00600691|Finasteride|finasteride|mesh-list
44243300|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44243301|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44243302|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243303|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243304|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
44144402|NCT00191802|Teriparatide|teriparatide|mesh-list
44144403|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44144404|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144405|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144407|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
44144408|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
44144409|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144410|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144411|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44144412|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44144413|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44144414|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144415|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144416|NCT00191828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44144417|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144418|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144419|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144420|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144421|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
44144422|NCT00191841|Gemcitabine|gemcitabine|mesh-list
44144423|NCT00191841|Cisplatin|cisplatin|mesh-list
43979644|NCT01961271|Buprenorphine|buprenorphine|mesh-list
43979645|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43979646|NCT01961271|Narcotics|narcotics|mesh-ancestor
43979647|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020273|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
43979648|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979649|NCT01961271|Analgesics|analgesics|mesh-ancestor
43979650|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
43979651|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979652|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43979653|NCT01962428|Ticagrelor|ticagrelor|mesh-list
43979654|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43979655|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43979656|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43979657|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43979658|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
43979659|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020319|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827719|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827721|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43827722|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43827723|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43827724|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827725|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827726|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
43827727|NCT05485896|Lenvatinib|lenvatinib|mesh-list
43827728|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827729|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677379|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43677380|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
43677381|NCT02867930|Ketamine|ketamine|mesh-list
43677382|NCT02867930|Propofol|propofol|mesh-list
43677383|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43677384|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677385|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677386|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43677450|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43979660|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979661|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979662|NCT01962688|Diuretics|diuretics|mesh-list
43979663|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
43979664|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979665|NCT01962870|Vasopressins|vasopressins|mesh-list
43979676|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979677|NCT01962961|Expectorants|expectorants|mesh-ancestor
43979678|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
43979679|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43979680|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
43979681|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020320|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44020321|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
44020322|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677547|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43677548|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43677549|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677550|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677551|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43677552|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43677553|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677554|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677907|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677908|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
43677909|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677911|NCT02865174|Enoxaparin|enoxaparin|mesh-list
43677912|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43677913|NCT02865174|Tinzaparin|tinzaparin|mesh-list
43677914|NCT02865174|Dalteparin|dalteparin|mesh-list
43677915|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
43677916|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
43677917|NCT02865174|Thrombin|thrombin|mesh-list
43677918|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
43677919|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43677920|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43677921|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677922|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43979682|NCT01962961|Protective Agents|protective agents|mesh-ancestor
43979683|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979684|NCT01962961|Antidotes|antidotes|mesh-ancestor
43979686|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
43979687|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979688|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979689|NCT01963091|Oxytocin|oxytocin|mesh-list
43979690|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
44243305|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243306|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243307|NCT00600691|Urological Agents|urological agents|mesh-ancestor
44243308|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44243309|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243310|NCT00600769|Clarithromycin|clarithromycin|mesh-list
44243311|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243312|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243313|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44243314|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243315|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243316|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44243317|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44243318|NCT00600847|Loratadine|loratadine|mesh-list
44243319|NCT00600847|Desloratadine|desloratadine|mesh-list
44243320|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44243321|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
44243322|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243323|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243324|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243325|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44243326|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44243327|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
44243328|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
43979691|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979692|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979693|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
43979694|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43979695|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43979696|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
43979697|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979698|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
43979699|NCT01963481|Exemestane|exemestane|mesh-list
43979700|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979701|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
43979702|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979703|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979704|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43979705|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
43979706|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979707|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979708|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43979709|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43979710|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43979711|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979712|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43979713|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
44243330|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44243331|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44243332|NCT00600873|Pramipexole|pramipexole|mesh-list
44243333|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
44243334|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243335|NCT00600873|Protective Agents|protective agents|mesh-ancestor
44243336|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243337|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44243338|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44243339|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
43979714|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979715|NCT01963793|Aprepitant|aprepitant|mesh-list
43979716|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
43979717|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
43979718|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
43979719|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979720|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979721|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751298|NCT02499237|Denosumab|denosumab|mesh-list
43979722|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43979723|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979724|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979725|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43979726|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979727|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979728|NCT01963845|Incretins|incretins|mesh-ancestor
43979729|NCT01963845|Hormones|hormones|mesh-ancestor
43979730|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979731|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43979732|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
43979756|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
43979757|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979758|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979759|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979760|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
43979761|NCT01965366|Hormones|hormones|mesh-ancestor
43979762|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979763|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43979764|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979765|NCT01965756|Metformin|metformin|mesh-list
43979766|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979767|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979768|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
43979769|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43979770|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
43979771|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979772|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979773|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43979774|NCT01966718|Hormones|hormones|mesh-ancestor
43979775|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979776|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979777|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43979778|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979779|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979780|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43979781|NCT01966978|Insulin|insulin|mesh-list
43979782|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43979783|NCT01966978|Metformin|metformin|mesh-list
43979784|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
43979788|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
43979789|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979790|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243341|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243342|NCT00600912|SMOFlipid|smoflipid|mesh-list
44243343|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44243344|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43846966|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846967|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846968|NCT04156581|Dexamethasone|dexamethasone|mesh-list
43846969|NCT04156581|Bupivacaine|bupivacaine|mesh-list
43679023|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
43644822|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43679365|NCT02854241|Liver Extracts|liver extracts|mesh-list
43679366|NCT02854241|Hematinics|hematinics|mesh-ancestor
43679367|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
43679368|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43679369|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679370|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
43679372|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43679511|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679512|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43679513|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
43679514|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243345|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44243346|NCT00600964|Obatoclax|obatoclax|mesh-list
44243347|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243348|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243349|NCT00600977|Doxorubicin|doxorubicin|mesh-list
44243350|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44243351|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43979791|NCT01966978|Incretins|incretins|mesh-ancestor
43979792|NCT01966978|Hormones|hormones|mesh-ancestor
43979793|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979794|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
43979795|NCT01967433|Promethazine|promethazine|mesh-list
43979796|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43979797|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43979798|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979799|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979800|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43979801|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
43979802|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
43979803|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979804|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
43979805|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
44020450|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020451|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44020452|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679933|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43679934|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43679935|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679936|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679937|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
43679938|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43679939|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43679941|NCT05380245|Voriconazole|voriconazole|mesh-list
43979806|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43979807|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43979808|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
43979809|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
43979810|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979811|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979812|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43979813|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
43979814|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979815|NCT01967641|Buprenorphine|buprenorphine|mesh-list
43979816|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43680484|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680666|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
43680667|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43680668|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
43680669|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680670|NCT04762082|Tadalafil|tadalafil|mesh-list
43680671|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
43680672|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43680673|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43680674|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979817|NCT01967641|Naloxone|naloxone|mesh-list
43979818|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43979819|NCT01967641|Narcotics|narcotics|mesh-ancestor
43979820|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43979821|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979822|NCT01967641|Analgesics|analgesics|mesh-ancestor
43979823|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
43979824|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979825|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43979826|NCT01967862|Listerine|listerine|mesh-list
43979827|NCT01967862|Fluorides|fluorides|mesh-list
43979828|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
43979829|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
43979830|NCT01967862|Protective Agents|protective agents|mesh-ancestor
43979831|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979832|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43979833|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979834|NCT01968057|Cyclosporine|cyclosporine|mesh-list
43979835|NCT01968057|Cyclosporins|cyclosporins|mesh-list
43979836|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979837|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979838|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979839|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
43979840|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020453|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020454|NCT02434146|Phenylephrine|phenylephrine|mesh-list
44020455|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
44020456|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44020457|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
44020458|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
44020472|NCT02436265|Dexamethasone|dexamethasone|mesh-list
43979841|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
44243353|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44243354|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44243355|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243356|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243357|NCT00600990|Vestipitant|vestipitant|mesh-list
44243358|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44243359|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243360|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243361|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243362|NCT00601016|Imiquimod|imiquimod|mesh-list
44243363|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44243364|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
44243365|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243366|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243367|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
44243368|NCT00601042|Lobeline|lobeline|mesh-list
44459522|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43896396|NCT05269030|Ivermectin|ivermectin|mesh-list
44020482|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020483|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020484|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020485|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
44020486|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
44020487|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020488|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
44020491|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020492|NCT02417870|Aldesleukin|aldesleukin|mesh-list
44020493|NCT02417870|Interleukin-2|interleukin-2|mesh-list
44020494|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020495|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020496|NCT02417870|Analgesics|analgesics|mesh-ancestor
44020497|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
43682070|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682071|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43682072|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43682248|NCT02850211|Analgesics|analgesics|mesh-ancestor
43682249|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
43682250|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682251|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682713|NCT02846428|Capecitabine|capecitabine|mesh-list
43682714|NCT02846428|Epirubicin|epirubicin|mesh-list
43682715|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43682716|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
43682717|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682852|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682853|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682868|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
43682869|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
43682870|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43682906|NCT02845388|Urological Agents|urological agents|mesh-ancestor
43682907|NCT02845466|Becaplermin|becaplermin|mesh-list
43683091|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683459|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43683460|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43683461|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43683462|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43683463|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
43683465|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
43683466|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
43683467|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683470|NCT03896880|Clotrimazole|clotrimazole|mesh-list
44243369|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43979842|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979843|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979844|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979845|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43979846|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
43979847|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
43979848|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43979849|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979850|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979851|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43979852|NCT01968317|Metformin|metformin|mesh-list
43979853|NCT01968317|Megestrol|megestrol|mesh-list
44020498|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020499|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020500|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44020501|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44020502|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
44020503|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020504|NCT02413047|Methotrexate|methotrexate|mesh-list
43979854|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
43979855|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979856|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979857|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43979858|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43979862|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43979863|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43979864|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43979865|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979866|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
43828578|NCT05476081|Ticagrelor|ticagrelor|mesh-list
43828579|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43684004|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
43684005|NCT00212784|Olanzapine|olanzapine|mesh-list
43684006|NCT00212784|Asenapine|asenapine|mesh-list
43684007|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
43684008|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
43684009|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684010|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684011|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684012|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43684013|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43684014|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684015|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43684016|NCT00212784|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43684017|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43684018|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684386|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43684387|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43684388|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43684389|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684390|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684391|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684402|NCT02842983|Esmolol|esmolol|mesh-list
43979867|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43979869|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
43979870|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43716350|NCT02654405|Butyric Acid|butyric acid|mesh-list
43979871|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43979872|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979873|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020511|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020512|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
44020513|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020514|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020515|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020516|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979874|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979875|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
43979876|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
43979877|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
43979878|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43979879|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
44243371|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243372|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243373|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43979880|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979881|NCT01969201|Hormones|hormones|mesh-list
43979882|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979883|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979884|NCT01969435|Cytarabine|cytarabine|mesh-list
43979885|NCT01969435|Etoposide|etoposide|mesh-list
43979886|NCT01969435|Melphalan|melphalan|mesh-list
43979887|NCT01969435|Carmustine|carmustine|mesh-list
43979888|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
43979889|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43979890|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979891|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43979892|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43979893|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979894|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979895|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43979896|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
43979897|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
43979898|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979899|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979900|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
43979901|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979902|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43979903|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
43979904|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43979905|NCT01969708|Bevacizumab|bevacizumab|mesh-list
43979906|NCT01969708|Aflibercept|aflibercept|mesh-list
43979907|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43979908|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979909|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43979910|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43979911|NCT01969708|Growth Substances|growth substances|mesh-ancestor
43979912|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979913|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
43979914|NCT01969747|Empagliflozin|empagliflozin|mesh-list
43979915|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43979916|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979917|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43979918|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979919|NCT01969916|Regadenoson|regadenoson|mesh-list
43979920|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43979921|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43979922|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
43979923|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
43979924|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020560|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44020561|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979925|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979926|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979927|NCT01970176|Tadalafil|tadalafil|mesh-list
43979928|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
43979934|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43979935|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
43979936|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43979937|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
43979938|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979940|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43979941|NCT01971593|Eplerenone|eplerenone|mesh-list
43979942|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43979943|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
43979944|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979945|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979946|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43979947|NCT01971593|Diuretics|diuretics|mesh-ancestor
43979948|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
43979949|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43979950|NCT01973036|Oxytocin|oxytocin|mesh-list
43979951|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
44243374|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44243375|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
44243376|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243377|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979952|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979953|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979955|NCT01973205|Acetaminophen|acetaminophen|mesh-list
43979956|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43979957|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43979958|NCT01973205|Analgesics|analgesics|mesh-ancestor
43979959|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
43979960|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979961|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979962|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979963|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979964|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43979965|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43979966|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979967|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43979968|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43979969|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979970|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
43979971|NCT01973335|Spironolactone|spironolactone|mesh-list
43979972|NCT01973335|Acetazolamide|acetazolamide|mesh-list
43979974|NCT01973335|Diuretics|diuretics|mesh-list
43979975|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44020573|NCT02379585|Paclitaxel|paclitaxel|mesh-list
43685275|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685276|NCT02837198|Renal Agents|renal agents|mesh-ancestor
43685277|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685278|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685279|NCT02837094|Insulin|insulin|mesh-list
43685280|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43685281|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685445|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685446|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685447|NCT02836353|Hormones|hormones|mesh-ancestor
43685448|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685449|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685466|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685467|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
43685468|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685469|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685470|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685471|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020621|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43685657|NCT02834052|Poly ICLC|poly iclc|mesh-list
43685658|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685659|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685660|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
43685705|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
43685706|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
43685707|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43685708|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
43685709|NCT02833480|Hormones|hormones|mesh-ancestor
43979976|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43979977|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
43979978|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979979|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979980|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43979981|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
43979982|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
43979983|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43979984|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020622|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020623|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
43685842|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43686250|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686251|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43686252|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686253|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
43686254|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686441|NCT02827877|Antibodies|antibodies|mesh-list
43686442|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
43686443|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43686444|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
43979985|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979986|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43979987|NCT01973348|Methamphetamine|methamphetamine|mesh-list
43979988|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43979989|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979990|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
43979991|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
43979992|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979993|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
43979994|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979995|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979996|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980007|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980009|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
43980010|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43980011|NCT01974687|Itraconazole|itraconazole|mesh-list
43980012|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
43980013|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
43980014|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980015|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43980016|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43980017|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980018|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980019|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43980020|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
44020626|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980021|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980022|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980023|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43980024|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
43980025|NCT01974700|Levetiracetam|levetiracetam|mesh-list
44243378|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
44243379|NCT00601198|Leucovorin|leucovorin|mesh-list
44243380|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
44243381|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
44243382|NCT00601198|Amifostine|amifostine|mesh-list
44020650|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44020652|NCT02345772|Trastuzumab|trastuzumab|mesh-list
44020653|NCT02345772|Fulvestrant|fulvestrant|mesh-list
43828878|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686585|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
43686586|NCT02826746|Analgesics|analgesics|mesh-ancestor
43686587|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
43686588|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686589|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686590|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
43686591|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686592|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43686608|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
43686610|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43686611|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686612|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43686613|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686614|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686616|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43686617|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43686618|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
43686619|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
43686620|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644823|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644824|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644825|NCT04349267|Nivolumab|nivolumab|mesh-list
43644826|NCT04349267|Cetuximab|cetuximab|mesh-list
43644827|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644828|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644829|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644831|NCT04349124|Nifedipine|nifedipine|mesh-list
44243383|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243384|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243385|NCT00601198|Antidotes|antidotes|mesh-ancestor
44243386|NCT00601198|Protective Agents|protective agents|mesh-ancestor
44243387|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
44243388|NCT00601198|Vitamins|vitamins|mesh-ancestor
44243389|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
44243390|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44243391|NCT00601211|Pilocarpine|pilocarpine|mesh-list
44243392|NCT00601211|Miotics|miotics|mesh-ancestor
44243393|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
44020654|NCT02345772|Pertuzumab|pertuzumab|mesh-list
44020655|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686676|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
43686677|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
43686678|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686679|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
43686733|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43686734|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43686735|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43686736|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43686737|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
44243394|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243395|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980026|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
43980027|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
43980028|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43980029|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
43980030|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980031|NCT01975935|Amlexanox|amlexanox|mesh-list
44020656|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020657|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020658|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43687444|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687445|NCT02819869|Metformin|metformin|mesh-list
43687446|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43687447|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687448|NCT02819648|Prednisolone|prednisolone|mesh-list
43687449|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
43687450|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43687451|NCT02819648|Hormones|hormones|mesh-ancestor
43828955|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43687452|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687453|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687454|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43687455|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687456|NCT02819414|Acetaminophen|acetaminophen|mesh-list
43687457|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43687559|NCT02818725|Cisplatin|cisplatin|mesh-list
43687560|NCT02818725|Doxorubicin|doxorubicin|mesh-list
43687561|NCT02818725|Methotrexate|methotrexate|mesh-list
43687562|NCT02818725|Panitumumab|panitumumab|mesh-list
43687563|NCT02818725|Vinblastine|vinblastine|mesh-list
43687564|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687565|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43687566|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43687567|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43687568|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687571|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
43980032|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44144424|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144425|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144426|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
44144427|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144428|NCT00191841|Antiviral Agents|antiviral agents|mesh-ancestor
44144429|NCT00191841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687785|NCT02817503|Folic Acid|folic acid|mesh-list
44144431|NCT00191841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144432|NCT00191841|Immunologic Factors|immunologic factors|mesh-ancestor
44144433|NCT00191841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144434|NCT00191867|Teriparatide|teriparatide|mesh-list
44144435|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44144436|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144437|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144438|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44144439|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144440|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144441|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144442|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020659|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020660|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020661|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43688102|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688103|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43688104|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43688105|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43688106|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688107|NCT02815111|Analgesics|analgesics|mesh-ancestor
43829048|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44144443|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
44144444|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144445|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144446|NCT00191893|Teriparatide|teriparatide|mesh-list
44144447|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44144448|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144449|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44144460|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144461|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144462|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
44144463|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44144464|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44144465|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144466|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144467|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243396|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44243397|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44243398|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
44243399|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243400|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243401|NCT00601276|Leuprolide|leuprolide|mesh-list
44243402|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
44020662|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44020663|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44020664|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
44020665|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020666|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020667|NCT02341495|Vitamin D|vitamin d|mesh-list
44020668|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
44020669|NCT02341495|Azacitidine|azacitidine|mesh-list
44020670|NCT02341495|Deferasirox|deferasirox|mesh-list
44020671|NCT02341495|Vitamins|vitamins|mesh-ancestor
44020672|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
44020673|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020674|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44020676|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
44243403|NCT00601276|Cyproterone|cyproterone|mesh-list
44243404|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44144468|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144469|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144470|NCT00191932|Analgesics|analgesics|mesh-ancestor
44144471|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
44144472|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144473|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144474|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144475|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
44144476|NCT00191971|Gemcitabine|gemcitabine|mesh-list
44144477|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144478|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
44144479|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144480|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980033|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
43980034|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980035|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
43980036|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980037|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980038|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43980039|NCT01976572|Candesartan|candesartan|mesh-list
43980040|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980041|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43980042|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43980043|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980044|NCT01976650|Dexamethasone|dexamethasone|mesh-list
43980045|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980046|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
43980047|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
43980048|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980049|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980050|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980051|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
43980052|NCT01976650|Hormones|hormones|mesh-ancestor
43980053|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980054|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43980055|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980056|NCT01976871|Rotigotine|rotigotine|mesh-list
43980057|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
43980058|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
43980059|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980060|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980064|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43980065|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43980066|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980067|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
43980068|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43980069|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43980070|NCT01977781|Prednisolone|prednisolone|mesh-list
43980071|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
43980072|NCT01977781|Tacrolimus|tacrolimus|mesh-list
43980073|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43980074|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
43980075|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43980076|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
43980077|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980078|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43980079|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243405|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
44243406|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44243407|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243408|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44243409|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243410|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
44243411|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44243412|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243413|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44243414|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
44243415|NCT00601289|Temozolomide|temozolomide|mesh-list
44020732|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020733|NCT02280252|Paclitaxel|paclitaxel|mesh-list
44020734|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020735|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020736|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020737|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020738|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020739|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020740|NCT02266797|Dexamethasone|dexamethasone|mesh-list
44020741|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020755|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
43688779|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688780|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
43688781|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
43688782|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688783|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43688784|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43688790|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
43847143|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689475|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
43689476|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43689477|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689478|NCT02803385|Narcotics|narcotics|mesh-ancestor
43689479|NCT02803385|Analgesics|analgesics|mesh-ancestor
43689480|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
43689481|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689482|NCT02803216|Amoxicillin|amoxicillin|mesh-list
43689483|NCT02803216|Clarithromycin|clarithromycin|mesh-list
43689484|NCT02803216|Omeprazole|omeprazole|mesh-list
44243416|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44243417|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
44243418|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243419|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243420|NCT00601302|Amlodipine|amlodipine|mesh-list
44243421|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44243422|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44243423|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980080|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020756|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020757|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689927|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
43689928|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
43689929|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689930|NCT02799927|Calcium|calcium|mesh-list
43689931|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43689968|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689970|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689971|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689972|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43690184|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690185|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690187|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
43690188|NCT02798068|Hormones|hormones|mesh-ancestor
43690189|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690190|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43690191|NCT02798068|Protective Agents|protective agents|mesh-ancestor
43690356|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690357|NCT02796859|Siltuximab|siltuximab|mesh-list
43980081|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980082|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
43980083|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
43980084|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980085|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980086|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
43980087|NCT01977781|Hormones|hormones|mesh-ancestor
43980088|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980089|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43980090|NCT01977781|Protective Agents|protective agents|mesh-ancestor
43980091|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020758|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43690358|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690359|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
43690360|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
43690361|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
43690362|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43690363|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690364|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
43690365|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691161|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691162|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691195|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691197|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43691277|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691278|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
43691279|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980092|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980093|NCT01978600|Timolol|timolol|mesh-list
43980094|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43980095|NCT01978600|Brinzolamide|brinzolamide|mesh-list
43980096|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43980097|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43980098|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980099|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980100|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980101|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980102|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980103|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980104|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980105|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43980106|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980107|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980108|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43980109|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
43980110|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43980111|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43980112|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
43980113|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020759|NCT02253394|Diuretics|diuretics|mesh-ancestor
44020760|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
44020761|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44020762|NCT02239627|Clonidine|clonidine|mesh-list
44020763|NCT02239627|Analgesics|analgesics|mesh-ancestor
44020776|NCT02234011|Ketamine|ketamine|mesh-list
44243424|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243425|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44243426|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243427|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44243428|NCT00601315|Clarithromycin|clarithromycin|mesh-list
44243429|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243430|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243431|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43729600|NCT02571140|Teriparatide|teriparatide|mesh-list
43980114|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43980115|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43980116|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980117|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980118|NCT01979276|Dexamethasone|dexamethasone|mesh-list
43980119|NCT01979276|Pomalidomide|pomalidomide|mesh-list
43980120|NCT01979276|Romidepsin|romidepsin|mesh-list
43980121|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980122|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
43980123|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
44020783|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
44020784|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
44020785|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020786|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44020787|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44020788|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148566|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020789|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020790|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
44020791|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44020792|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44020793|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020794|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
44020795|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
44020796|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020797|NCT02200328|Metronidazole|metronidazole|mesh-list
44020798|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020799|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44020800|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43980124|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980125|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980126|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980127|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
43980128|NCT01979276|Hormones|hormones|mesh-ancestor
43980129|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980130|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43980131|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980132|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
43980133|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43980140|NCT01979445|Cangrelor|cangrelor|mesh-list
43980141|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43980142|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43980143|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43980144|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43980145|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
43980146|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980147|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980148|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980149|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
43980150|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
43980151|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980152|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
43980153|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980154|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980155|NCT01980524|Acipimox|acipimox|mesh-list
43980156|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43980157|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
43980158|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980159|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43980160|NCT01980589|Dexamethasone|dexamethasone|mesh-list
44020801|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44020803|NCT02177773|Edotreotide|edotreotide|mesh-list
44020816|NCT02152670|Raclopride|raclopride|mesh-list
43980161|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
43980162|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43980163|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
43980164|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980165|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980166|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43980167|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
43980168|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980169|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020834|NCT02137096|Etoposide|etoposide|mesh-list
44020835|NCT02137096|Ifosfamide|ifosfamide|mesh-list
44020836|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
44020837|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691769|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
43691770|NCT02784860|Lidocaine|lidocaine|mesh-list
43691771|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691772|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
43644832|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43691773|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691774|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691775|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
43691776|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691777|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43691778|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43691779|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43691780|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691781|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980170|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43980171|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980172|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
43980173|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
43980174|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243432|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243433|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243434|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44243435|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44243436|NCT00601328|Calcitriol|calcitriol|mesh-list
44243437|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44243438|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020838|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692189|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44243439|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44243440|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243441|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243442|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44243443|NCT00601328|Vitamins|vitamins|mesh-ancestor
44243444|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
43980175|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980176|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
43980177|NCT01980589|Hormones|hormones|mesh-ancestor
43980178|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980179|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020839|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44020840|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44020841|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692506|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
43692507|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
43692508|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
43692509|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547783|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692510|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692511|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692512|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43692589|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692590|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43692591|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43692592|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43692593|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692594|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43692595|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43692596|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43980180|NCT01980654|Rituximab|rituximab|mesh-list
43716678|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
43980181|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43980182|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980183|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
43980184|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980185|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980186|NCT01981759|Cycloserine|cycloserine|mesh-list
44020842|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020843|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693221|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693222|NCT02775474|Analgesics|analgesics|mesh-ancestor
43693223|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
43693224|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693225|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43693316|NCT02775006|Docetaxel|docetaxel|mesh-list
43693317|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43693318|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693319|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
43693320|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
43693321|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
43693333|NCT02774837|Tenofovir|tenofovir|mesh-list
43693551|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693552|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
43693553|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693554|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43693555|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693556|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
43693557|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43693558|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
43693559|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43693560|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
43693561|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693564|NCT02773251|Laxatives|laxatives|mesh-ancestor
43980187|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43980188|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980189|NCT01981759|Renal Agents|renal agents|mesh-ancestor
43980190|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43980191|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
43980192|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43980193|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
44020844|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
44020845|NCT02147834|Ranolazine|ranolazine|mesh-list
44020846|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44020847|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020849|NCT02144155|Oxytocin|oxytocin|mesh-list
43980194|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980195|NCT01981772|Lidocaine|lidocaine|mesh-list
43980196|NCT01981772|Epinephrine|epinephrine|mesh-list
43980197|NCT01981772|Racepinephrine|racepinephrine|mesh-list
43980198|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
43980199|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980200|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
43980201|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020852|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020853|NCT02140788|Metformin|metformin|mesh-list
44020854|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020855|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020856|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
44020857|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43693858|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693859|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43980213|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980214|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43980215|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43980217|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43980218|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
43980219|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
43980220|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
43980221|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43980222|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
43980223|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43980224|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43980225|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980226|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
43980227|NCT01981863|Coagulants|coagulants|mesh-ancestor
43980228|NCT01981967|Vaccines|vaccines|mesh-list
43980229|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
43980230|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980231|NCT01982123|Edetic Acid|edetic acid|mesh-list
43980232|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
44020858|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
44020859|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
44020860|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020861|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020862|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020863|NCT02145169|Analgesics|analgesics|mesh-ancestor
43980233|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
44243445|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44459523|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44459524|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44459525|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459526|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459527|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459528|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44459529|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44459530|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
44459531|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459532|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459533|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44459534|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44459535|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
44020881|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
43694689|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694690|NCT02767102|Protective Agents|protective agents|mesh-ancestor
43694691|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694692|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694693|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43694694|NCT02767232|Plasminogen|plasminogen|mesh-list
43694695|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43694696|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43694697|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694698|NCT02767479|Esomeprazole|esomeprazole|mesh-list
43694869|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829760|NCT05408026|Pomalidomide|pomalidomide|mesh-list
43829761|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829762|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
43829763|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
43829764|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829765|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459536|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44459537|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44459538|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43980234|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
43980235|NCT01982123|Antidotes|antidotes|mesh-ancestor
43980236|NCT01982123|Protective Agents|protective agents|mesh-ancestor
43980237|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980238|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
44020882|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
43980239|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
43980240|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980241|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43980242|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
43980243|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43980244|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43980245|NCT01982240|Bisacodyl|bisacodyl|mesh-list
43980246|NCT01982240|Plecanatide|plecanatide|mesh-list
43980247|NCT01982240|Cathartics|cathartics|mesh-ancestor
43980248|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980249|NCT01982240|Laxatives|laxatives|mesh-ancestor
43980250|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43980251|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
43980252|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980253|NCT01982539|Diclofenac|diclofenac|mesh-list
43980254|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980255|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716772|NCT02651870|Amlodipine|amlodipine|mesh-list
43980256|NCT01982539|Analgesics|analgesics|mesh-ancestor
43980257|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
43980258|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980259|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980260|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980261|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980262|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43980272|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43980273|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
43980274|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980275|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43980276|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43980277|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020887|NCT02133534|Atorvastatin|atorvastatin|mesh-list
44020888|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44020889|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44020890|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
43980278|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980279|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
43980280|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459539|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459540|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459542|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44459543|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44020918|NCT02094352|Ketamine|ketamine|mesh-list
44020919|NCT02094352|Analgesics|analgesics|mesh-ancestor
43695432|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
44459544|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
44459545|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459546|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459547|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44459548|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44459549|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
44459550|NCT01576718|Fluticasone|fluticasone|mesh-list
44459551|NCT01576718|Xhance|xhance|mesh-list
43980281|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44020921|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829908|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
43829909|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43696182|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696183|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
43696184|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829912|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43829913|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696375|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696376|NCT02755909|Anesthetics|anesthetics|mesh-list
43696377|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696378|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644935|NCT04329325|Dasatinib|dasatinib|mesh-list
43980282|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43980283|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980284|NCT01982695|Losartan|losartan|mesh-list
43980285|NCT01982695|Lisinopril|lisinopril|mesh-list
43980286|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980287|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980288|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43980289|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43980290|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980291|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43980292|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
43980293|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020922|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020923|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44020924|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020925|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
44020926|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
43847260|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847261|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43847262|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43847263|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
43644948|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43644949|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
43644950|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644962|NCT04326920|Sargramostim|sargramostim|mesh-list
43980294|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43980295|NCT01982695|Protective Agents|protective agents|mesh-ancestor
43980296|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980297|NCT01983020|Lidocaine|lidocaine|mesh-list
43980298|NCT01983020|Ketamine|ketamine|mesh-list
43980299|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980300|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
43980301|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020927|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020928|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44020929|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44020930|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020931|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020932|NCT02075411|Bupivacaine|bupivacaine|mesh-list
43697019|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697020|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697021|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43644965|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
43644966|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43644967|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43644968|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644969|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
43697022|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43697028|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697031|NCT02752412|Metformin|metformin|mesh-list
43980302|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980303|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
43980304|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980305|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980306|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43980307|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43980308|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980309|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980310|NCT01983020|Analgesics|analgesics|mesh-ancestor
43980311|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43980312|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43980313|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
43980314|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43980315|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43980316|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980317|NCT01983566|Omeprazole|omeprazole|mesh-list
43980318|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43980319|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980320|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43980321|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980322|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980323|NCT01983878|Ramucirumab|ramucirumab|mesh-list
43980324|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980325|NCT01984398|Citric Acid|citric acid|mesh-list
43980326|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
43980327|NCT01984398|Enclomiphene|enclomiphene|mesh-list
43980328|NCT01984398|Clomiphene|clomiphene|mesh-list
44459553|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
44459554|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459555|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44459556|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
44459557|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459558|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459559|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459560|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459561|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44459562|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44459563|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
44459564|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43980329|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
43980330|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
43980331|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43980332|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
43980333|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
43980334|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980335|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43980336|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
43980337|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020933|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980338|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980339|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43980340|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
43980341|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43980342|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43980343|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43980344|NCT01985425|Colchicine|colchicine|mesh-list
43980345|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
43980346|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980347|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
43980348|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
43980349|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44148568|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
44148569|NCT00204581|Aldesleukin|aldesleukin|mesh-list
44148570|NCT00204581|Interleukin-2|interleukin-2|mesh-list
43697061|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697062|NCT02751619|Lidocaine|lidocaine|mesh-list
43980350|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980351|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980352|NCT01985581|Guanfacine|guanfacine|mesh-list
43980353|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980354|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43980355|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980356|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980357|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980358|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980359|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980360|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980361|NCT01985685|Thiamine|thiamine|mesh-list
43980362|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
43980363|NCT01985685|Vitamins|vitamins|mesh-ancestor
43980364|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
43697390|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43697391|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
43697392|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697393|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697394|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697395|NCT04359979|Urological Agents|urological agents|mesh-ancestor
43697396|NCT04335292|Pemetrexed|pemetrexed|mesh-list
43697397|NCT04335292|Osimertinib|osimertinib|mesh-list
43697398|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697399|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697400|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980365|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980366|NCT01985763|Genistein|genistein|mesh-list
43980367|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43980368|NCT01985763|Protective Agents|protective agents|mesh-ancestor
43980369|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980370|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980371|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43980372|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980373|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980374|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
43980375|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43980376|NCT01985763|Estrogens|estrogens|mesh-ancestor
43980377|NCT01985763|Hormones|hormones|mesh-ancestor
43844329|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44459565|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44459566|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44459567|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459568|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459569|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459570|NCT01576705|Leucovorin|leucovorin|mesh-list
44459571|NCT01576705|Folic Acid|folic acid|mesh-list
44459572|NCT01576705|Hormones|hormones|mesh-list
44459573|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
44459574|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459575|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459576|NCT01576705|Antidotes|antidotes|mesh-ancestor
44459577|NCT01576705|Protective Agents|protective agents|mesh-ancestor
44148573|NCT00204581|Analgesics|analgesics|mesh-ancestor
44148574|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
44148575|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148576|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148577|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44148578|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44148579|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
44148580|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148581|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44148586|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
44459578|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
43980378|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980379|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
43980380|NCT01986361|Analgesics|analgesics|mesh-ancestor
43980381|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
43980382|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980383|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980384|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980385|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980386|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980387|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980388|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44020981|NCT02017379|Erythromycin|erythromycin|mesh-list
43697669|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
43697670|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697671|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697672|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697673|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980389|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980390|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980391|NCT01986946|Hydromorphone|hydromorphone|mesh-list
43980392|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43980393|NCT01986946|Narcotics|narcotics|mesh-ancestor
43980394|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980395|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980396|NCT01986946|Analgesics|analgesics|mesh-ancestor
44020982|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
44020983|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44020984|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
43697767|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
43980397|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
43980398|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980399|NCT01987219|Bromides|bromides|mesh-list
43980400|NCT01987219|Albuterol|albuterol|mesh-list
43980401|NCT01987219|Ipratropium|ipratropium|mesh-list
43980402|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
43980403|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43980406|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980407|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43980408|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
43980409|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
43980410|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43980411|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43980412|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43980413|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980414|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980415|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980416|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980417|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43980418|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
43980420|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43980421|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43980422|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
43980423|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43980424|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43980425|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43980426|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459580|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
44459581|NCT01576705|Hematinics|hematinics|mesh-ancestor
44459582|NCT01576575|Rifampin|rifampin|mesh-list
44459583|NCT01576575|Ketoconazole|ketoconazole|mesh-list
44459584|NCT01576575|Buprenorphine|buprenorphine|mesh-list
44459585|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44459586|NCT01576575|Narcotics|narcotics|mesh-ancestor
44459587|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459588|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459589|NCT01576575|Analgesics|analgesics|mesh-ancestor
44459590|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
44459591|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980427|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980428|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980429|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980430|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980431|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980432|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43980433|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980434|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980435|NCT01988246|Aflibercept|aflibercept|mesh-list
43980436|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43980437|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43980438|NCT01988246|Growth Substances|growth substances|mesh-ancestor
43980439|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980440|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
43980441|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980442|NCT01988922|Ketamine|ketamine|mesh-list
43980443|NCT01988922|Analgesics|analgesics|mesh-ancestor
43980444|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
43980445|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980446|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980447|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43980448|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43980449|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
43980450|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
43980451|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980452|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43980453|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43980454|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980455|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980456|NCT01989195|Manganese|manganese|mesh-list
43980457|NCT01989195|Trace Elements|trace elements|mesh-ancestor
43980458|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
43980459|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980460|NCT01989221|Granisetron|granisetron|mesh-list
43980461|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
43980462|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
43980463|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980464|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980465|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980466|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43980467|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
43980468|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980469|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980470|NCT01989793|Losartan|losartan|mesh-list
43980471|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980472|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980473|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43980474|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43980478|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44459592|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44021055|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021056|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44021057|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44021066|NCT01938833|Romidepsin|romidepsin|mesh-list
44021070|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459593|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44459594|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
43896545|NCT04287790|Disulfiram|disulfiram|mesh-list
44459595|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243446|NCT00601432|Levofloxacin|levofloxacin|mesh-list
44243447|NCT00601432|Ofloxacin|ofloxacin|mesh-list
44243448|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43980479|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43980481|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980482|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
43980483|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980484|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43980485|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43980486|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43980487|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43980488|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43980489|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43980490|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43980491|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43980492|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43980493|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43980494|NCT01990677|Eplerenone|eplerenone|mesh-list
44021071|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
44021072|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021073|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021074|NCT01916590|Bupivacaine|bupivacaine|mesh-list
44021075|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021076|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
44021077|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021078|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021079|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
44021080|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021081|NCT01901679|Celecoxib|celecoxib|mesh-list
44021082|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44021083|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021084|NCT01901679|Analgesics|analgesics|mesh-ancestor
44021085|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
44021086|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021087|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980495|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43980496|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
43980497|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980498|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980499|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43980500|NCT01990677|Diuretics|diuretics|mesh-ancestor
43980501|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
43980502|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980503|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
43980504|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43980505|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
43980506|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43980507|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980508|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43980509|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44021096|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021097|NCT01890694|Tolvaptan|tolvaptan|mesh-list
44021098|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44021099|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021100|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
44021101|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699010|NCT02741232|Racepinephrine|racepinephrine|mesh-list
43699011|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
43699012|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
43699013|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
43699014|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980510|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43980511|NCT01990898|Cyclosporine|cyclosporine|mesh-list
43980512|NCT01990898|Cyclosporins|cyclosporins|mesh-list
43980513|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980514|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980515|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43980516|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
43980517|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980518|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
43980519|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980520|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
43980521|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980522|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43980523|NCT01991548|Insulin|insulin|mesh-list
43980524|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43980525|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980526|NCT01991860|Amisulpride|amisulpride|mesh-list
43980527|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43980528|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43980529|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980530|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980531|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980532|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43980533|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
43980534|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980535|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980536|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43980537|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243449|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243450|NCT00601432|Renal Agents|renal agents|mesh-ancestor
44243451|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243452|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44243453|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44243454|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243455|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243456|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243457|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44243458|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44243459|NCT00601510|Cisplatin|cisplatin|mesh-list
44243460|NCT00601510|Capecitabine|capecitabine|mesh-list
44243461|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
44243462|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243463|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44243464|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
44243465|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980538|NCT01992016|Ranolazine|ranolazine|mesh-list
43980539|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43980540|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980541|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980542|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
43980543|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43980551|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
43980552|NCT01992523|Ticagrelor|ticagrelor|mesh-list
43980553|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43980554|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43980555|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43980556|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43980557|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
44021165|NCT01851174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645065|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699598|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43699599|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43699601|NCT02737254|Oxytocin|oxytocin|mesh-list
43699602|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
43699603|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699604|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699605|NCT02737202|Saracatinib|saracatinib|mesh-list
43699607|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980558|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980559|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980560|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980561|NCT01992874|Niacinamide|niacinamide|mesh-list
43980562|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
43980563|NCT01992874|Vitamins|vitamins|mesh-ancestor
43980564|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
43980565|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980566|NCT01993108|Naltrexone|naltrexone|mesh-list
44021166|NCT01851174|Immunologic Factors|immunologic factors|mesh-ancestor
44021167|NCT01851174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021168|NCT01846182|Pregabalin|pregabalin|mesh-list
44021169|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44021170|NCT01846182|Analgesics|analgesics|mesh-ancestor
43699950|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43699951|NCT02734524|Carboplatin|carboplatin|mesh-list
43699952|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699953|NCT02734511|Propofol|propofol|mesh-list
43699954|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700006|NCT02733640|Pantoprazole|pantoprazole|mesh-list
43700118|NCT02733458|Immunologic Factors|immunologic factors|mesh-ancestor
43700119|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700120|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43700121|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43700122|NCT02733445|Dasatinib|dasatinib|mesh-list
43645075|NCT04255277|Protective Agents|protective agents|mesh-ancestor
43645076|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43645077|NCT04255277|Estrogens|estrogens|mesh-ancestor
43980567|NCT01993108|Methylphenidate|methylphenidate|mesh-list
43980568|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43980569|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43871151|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
43980570|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980571|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
43980572|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980573|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43980574|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43980575|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43980576|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021171|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
44021172|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021173|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021174|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
44021175|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44021176|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021177|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021178|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44021179|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43980577|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980579|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144481|NCT00191971|Antiviral Agents|antiviral agents|mesh-ancestor
44144482|NCT00191971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144483|NCT00191971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144484|NCT00191971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243466|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44243467|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243468|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
44243469|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243470|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243471|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243472|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243473|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
44243474|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44243475|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243476|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144485|NCT00191971|Immunologic Factors|immunologic factors|mesh-ancestor
44144486|NCT00191971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144487|NCT00191997|Olanzapine|olanzapine|mesh-list
44144488|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
44144489|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
44144490|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144491|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144492|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44144493|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44144494|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44144495|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144496|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144497|NCT00191997|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44144498|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144499|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144500|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144501|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144502|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
44144503|NCT00192049|Gemcitabine|gemcitabine|mesh-list
44144504|NCT00192049|Mitomycins|mitomycins|mesh-list
44144505|NCT00192049|Mitomycin|mitomycin|mesh-list
44144506|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144507|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
44144508|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144509|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144510|NCT00192049|Antiviral Agents|antiviral agents|mesh-ancestor
44144511|NCT00192049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144518|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144519|NCT00192062|Gemcitabine|gemcitabine|mesh-list
44144520|NCT00192062|Vinorelbine|vinorelbine|mesh-list
44144521|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144522|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
44144523|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144524|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144525|NCT00192062|Antiviral Agents|antiviral agents|mesh-ancestor
44144526|NCT00192062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980580|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
43980581|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43980582|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
43980583|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980584|NCT01993849|Expectorants|expectorants|mesh-ancestor
43980585|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
43980586|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43980587|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
43980588|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980589|NCT01993849|Protective Agents|protective agents|mesh-ancestor
43980590|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980591|NCT01993849|Antidotes|antidotes|mesh-ancestor
43980592|NCT01993875|Lubiprostone|lubiprostone|mesh-list
43980593|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43980594|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243479|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243480|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44243481|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44243482|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243483|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
44243484|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243485|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44243486|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44243487|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
44243488|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243489|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243490|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243491|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243492|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
43980595|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980596|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43980597|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
43980598|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43980599|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980600|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980601|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
43980602|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980603|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980604|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43980606|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
43980607|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980608|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
43980609|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980610|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980611|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980612|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980613|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980614|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980615|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
43980616|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
43980617|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980618|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
43980619|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43980620|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
43980621|NCT01994746|Glucagon|glucagon|mesh-list
43980622|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43980623|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980624|NCT01994746|Hormones|hormones|mesh-ancestor
43980625|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980626|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980627|NCT01994746|Incretins|incretins|mesh-ancestor
43980628|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43980629|NCT01994993|Metronidazole|metronidazole|mesh-list
43980630|NCT01994993|Clindamycin|clindamycin|mesh-list
43980631|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
44021258|NCT01797380|Citalopram|citalopram|mesh-list
43980632|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
43980633|NCT01994993|Gentamicins|gentamicins|mesh-list
43980634|NCT01994993|Tazobactam|tazobactam|mesh-list
43980635|NCT01994993|Piperacillin|piperacillin|mesh-list
43980644|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43980646|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43980647|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44243493|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44243494|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243495|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243496|NCT00601588|Sertraline|sertraline|mesh-list
44243497|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44243498|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243499|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44243500|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43980648|NCT01995045|Bupivacaine|bupivacaine|mesh-list
43980649|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44021301|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701426|NCT02724332|Sirolimus|sirolimus|mesh-list
43980650|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980651|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
43980652|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980653|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980654|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
43980655|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980656|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980657|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
43980658|NCT01995045|Hormones|hormones|mesh-ancestor
43980659|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980660|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021306|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021307|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44021308|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44021309|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021310|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021311|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
44021312|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021313|NCT01756586|Dexamethasone|dexamethasone|mesh-list
44021314|NCT01756586|Bupivacaine|bupivacaine|mesh-list
44021315|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021316|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
44021317|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
43701471|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701472|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701473|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701474|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701475|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
43701601|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43701602|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
43701603|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701604|NCT02723669|Protective Agents|protective agents|mesh-ancestor
43701605|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980661|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
43980662|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980663|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980664|NCT01996657|Warfarin|warfarin|mesh-list
43980665|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
43980666|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43980667|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43980668|NCT01996943|Ethanol|ethanol|mesh-list
43980669|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44021318|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021319|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021320|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021321|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
44021322|NCT01756586|Hormones|hormones|mesh-ancestor
44021323|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021324|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645124|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
43645125|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645126|NCT04208997|Amiodarone|amiodarone|mesh-list
43645127|NCT04208997|Sotalol|sotalol|mesh-list
43645128|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43702065|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43702066|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702067|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702068|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702069|NCT02720471|Anesthetics|anesthetics|mesh-list
43702070|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
43645129|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
43645130|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43645131|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645132|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645133|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43645134|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43980670|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980671|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980672|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980673|NCT01997229|Eculizumab|eculizumab|mesh-list
43980674|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43980675|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43980676|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
43980677|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021325|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021326|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021327|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
44021328|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021329|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
44021330|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
43830702|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
43830703|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
43830704|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
43830705|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
43830706|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830707|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830708|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43830709|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830710|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43830711|NCT05348824|Eusol|eusol|mesh-list
43830712|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
43830713|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847349|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702362|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
43702363|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43980678|NCT01997411|Glucagon|glucagon|mesh-list
43980679|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43980680|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980681|NCT01997411|Hormones|hormones|mesh-ancestor
43980682|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980683|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980684|NCT01997411|Incretins|incretins|mesh-ancestor
43980685|NCT01997515|Ketamine|ketamine|mesh-list
43980686|NCT01997515|Analgesics|analgesics|mesh-ancestor
43980687|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
43980688|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980689|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980690|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43980691|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43980692|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
43980693|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
43980694|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980695|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43980696|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43980697|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980698|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021331|NCT01754987|Sorafenib|sorafenib|mesh-list
44021332|NCT01754987|Vitamins|vitamins|mesh-ancestor
44021333|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
44021334|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980699|NCT01997905|Protein S|protein s|mesh-list
43980700|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
43980701|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
43980703|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43980704|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980705|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
43980706|NCT01998438|Coagulants|coagulants|mesh-ancestor
43980707|NCT01999348|Timolol|timolol|mesh-list
44243502|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243503|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021353|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
44021354|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021355|NCT01745913|Fludarabine|fludarabine|mesh-list
44021356|NCT01745913|Melphalan|melphalan|mesh-list
44021357|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
44021358|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021359|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021360|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021361|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
44021362|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702735|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43702736|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702737|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702738|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243504|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
44243505|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243506|NCT00601614|Temozolomide|temozolomide|mesh-list
44243507|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44243508|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
43980708|NCT01999348|Bimatoprost|bimatoprost|mesh-list
43980709|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43980710|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43980711|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44021363|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44021364|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
44021365|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44021366|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44021367|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44021368|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021369|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44021370|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43703181|NCT02712125|Isosorbide|isosorbide|mesh-list
43703182|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43980712|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980713|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980714|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980715|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980716|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980717|NCT01999400|Mesalamine|mesalamine|mesh-list
43980718|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980719|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980720|NCT01999400|Analgesics|analgesics|mesh-ancestor
43980721|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
43980722|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021371|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021372|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021373|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
43703295|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
43980723|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980724|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980725|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980726|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
43980727|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
43980728|NCT01999530|Prazosin|prazosin|mesh-list
43980729|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43980730|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43980731|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43980732|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43980733|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980734|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980735|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980736|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980737|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43980738|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
43980739|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980740|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43980741|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43980742|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980743|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980744|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980745|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
43980746|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980747|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43980748|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43980749|NCT01999985|Dasatinib|dasatinib|mesh-list
43980750|NCT01999985|Afatinib|afatinib|mesh-list
43980751|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980752|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43980753|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980754|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980755|NCT02000973|Lidocaine|lidocaine|mesh-list
43980756|NCT02000973|Bupivacaine|bupivacaine|mesh-list
43980757|NCT02000973|Ropivacaine|ropivacaine|mesh-list
43980758|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980759|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
43980760|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980761|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980762|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
43980763|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243509|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243510|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243512|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44243513|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44243514|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980764|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980765|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43980766|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43980767|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980768|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980769|NCT02002650|Indomethacin|indomethacin|mesh-list
43980770|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980771|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980772|NCT02002650|Analgesics|analgesics|mesh-ancestor
43980773|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
43980782|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980783|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980785|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
43980786|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980787|NCT02002832|Risperidone|risperidone|mesh-list
43980788|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43980789|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43980790|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
43980791|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980792|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021376|NCT01718444|Clomiphene|clomiphene|mesh-list
44021445|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980793|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980794|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43980795|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43980796|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980797|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980798|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43980799|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
43980800|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43980801|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43980802|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43980803|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980804|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43980805|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44021446|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021448|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
44021449|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021450|NCT01692691|Dacarbazine|dacarbazine|mesh-list
44021451|NCT01692691|Carmustine|carmustine|mesh-list
44021452|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44021453|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
44021456|NCT01691079|Bromides|bromides|mesh-list
43704431|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
43704432|NCT04942067|Lenalidomide|lenalidomide|mesh-list
43704433|NCT04942067|Daratumumab|daratumumab|mesh-list
43704434|NCT04942067|Pomalidomide|pomalidomide|mesh-list
43704435|NCT04942067|BB 1101|bb 1101|mesh-list
43704436|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704437|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
43704438|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
43704464|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645217|NCT04155008|Mirtazapine|mirtazapine|mesh-list
43645225|NCT04155008|Hormones|hormones|mesh-ancestor
43980806|NCT02003625|Meloxicam|meloxicam|mesh-list
43980807|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980808|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980809|NCT02003625|Analgesics|analgesics|mesh-ancestor
43980810|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
43980811|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980812|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980813|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021459|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44021460|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
43831007|NCT05332717|Protective Agents|protective agents|mesh-ancestor
43831008|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831009|NCT05332561|Trastuzumab|trastuzumab|mesh-list
43831010|NCT05332561|Pertuzumab|pertuzumab|mesh-list
43831011|NCT05332561|Atezolizumab|atezolizumab|mesh-list
43704663|NCT04511039|Trifluridine|trifluridine|mesh-list
43704664|NCT04511039|Talazoparib|talazoparib|mesh-list
43704665|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43704666|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704667|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980814|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980815|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43980816|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43980817|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980818|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980819|NCT02003911|Azithromycin|azithromycin|mesh-list
43980820|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43980821|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980822|NCT02004132|Testosterone|testosterone|mesh-list
43980823|NCT02004132|Androgens|androgens|mesh-ancestor
43980824|NCT02004132|Hormones|hormones|mesh-ancestor
43980825|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980826|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980827|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
43980828|NCT02004366|Linagliptin|linagliptin|mesh-list
43980829|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43980830|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980831|NCT02004366|Incretins|incretins|mesh-ancestor
44243515|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243516|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44243517|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
44243518|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
44243519|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243520|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243522|NCT00601692|Docetaxel|docetaxel|mesh-list
44243523|NCT00601692|Irinotecan|irinotecan|mesh-list
44243524|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980832|NCT02004366|Hormones|hormones|mesh-ancestor
43980833|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980834|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43980835|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44021462|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021463|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44021464|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44021465|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43980836|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980837|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980838|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
43980841|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980842|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980843|NCT02004613|Analgesics|analgesics|mesh-ancestor
43980844|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
44021487|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
44021488|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021489|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021490|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
44021491|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980845|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980846|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43980847|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980848|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980849|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980850|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980851|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980852|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
43980854|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
43980855|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
44021493|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44021494|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44021495|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021496|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705870|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705871|NCT03492099|Buprenorphine|buprenorphine|mesh-list
43705872|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43645267|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43645268|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43645269|NCT04151082|Prednisolone|prednisolone|mesh-list
43645271|NCT04151082|Cortisone|cortisone|mesh-list
43980856|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43980857|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980858|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
43980859|NCT02005354|Anesthetics|anesthetics|mesh-list
43980860|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
43706441|NCT01029717|Minocycline|minocycline|mesh-list
43980861|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980862|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980863|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
43980864|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980865|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43980866|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
43980867|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980868|NCT02005354|Analgesics|analgesics|mesh-ancestor
43980869|NCT02005549|Bevacizumab|bevacizumab|mesh-list
43980870|NCT02005549|Docetaxel|docetaxel|mesh-list
43980871|NCT02005549|Capecitabine|capecitabine|mesh-list
43980872|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43980873|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980874|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43980875|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43980876|NCT02005549|Growth Substances|growth substances|mesh-ancestor
44021502|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44021504|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44021505|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44021506|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
44021507|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
44021508|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44021509|NCT01675960|Gabapentin|gabapentin|mesh-list
44021510|NCT01675960|Analgesics|analgesics|mesh-ancestor
44021511|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
44021512|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021513|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707086|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707087|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707088|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
43707089|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
43707090|NCT02702960|Prednisone|prednisone|mesh-list
43707091|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
43707092|NCT02702960|Fludarabine|fludarabine|mesh-list
43707093|NCT02702960|Tacrolimus|tacrolimus|mesh-list
43707094|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43707095|NCT02702960|Mesna|mesna|mesh-list
43707096|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707097|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
43707098|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707099|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707100|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43707101|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
43707102|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645305|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
43980877|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980878|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
43980879|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
43980880|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
43980881|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
43980882|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980883|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43980884|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
43980885|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43980886|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44021514|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
43707460|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43707461|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707462|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43707463|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43707466|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
44021518|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980887|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43980888|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980889|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980890|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243525|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
44243526|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
44243527|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
44243528|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980891|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980893|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
43980894|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980895|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
44021519|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44021520|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44021521|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021522|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021523|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
44021524|NCT01645709|Verapamil|verapamil|mesh-list
44021525|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44021526|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44021527|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021528|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021529|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43707618|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43707619|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707620|NCT02699658|Renal Agents|renal agents|mesh-ancestor
43707621|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707622|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43707623|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43707624|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707629|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
43980896|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43980897|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
43980898|NCT02005666|Clindamycin|clindamycin|mesh-list
43980899|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
43980900|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
43980901|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43980902|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43980903|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980904|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43980905|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980906|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980907|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
43980908|NCT02006056|Ondansetron|ondansetron|mesh-list
43980909|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
43980910|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
43980911|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021530|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021531|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
44021532|NCT01633814|Estradiol|estradiol|mesh-list
44021533|NCT01633814|Estrogens|estrogens|mesh-ancestor
44021534|NCT01633814|Hormones|hormones|mesh-ancestor
44021535|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021536|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021537|NCT01636466|Everolimus|everolimus|mesh-list
44021538|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021539|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021540|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
44021541|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021542|NCT01629329|Aspirin|aspirin|mesh-list
44021543|NCT01629329|Acetaminophen|acetaminophen|mesh-list
44021544|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
43707947|NCT02698228|Analgesics|analgesics|mesh-ancestor
43707948|NCT02697955|Epinephrine|epinephrine|mesh-list
43707949|NCT02697955|Bupivacaine|bupivacaine|mesh-list
43707950|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707951|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
43707952|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708133|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43708134|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43708135|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
43708167|NCT05322681|Pregabalin|pregabalin|mesh-list
43980916|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43980917|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
43980918|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43980919|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980920|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43980921|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43980922|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980923|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44021545|NCT01629329|Caffeine|caffeine|mesh-list
44021546|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44021547|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021548|NCT01629329|Analgesics|analgesics|mesh-ancestor
44021549|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
43708176|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43708177|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708178|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708179|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708180|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708181|NCT05322603|Diclofenac|diclofenac|mesh-list
43708182|NCT05322603|Morphine|morphine|mesh-list
43980924|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43980925|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43980927|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43980928|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43980929|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
43980930|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43980931|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980932|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980933|NCT02006342|Insulin|insulin|mesh-list
43980934|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43980935|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
43980936|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44021550|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021551|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021552|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980937|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980938|NCT02006836|Insulin|insulin|mesh-list
43980939|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43980940|NCT02006836|Metformin|metformin|mesh-list
43980941|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
43980942|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43980943|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980944|NCT02007863|Fludarabine|fludarabine|mesh-list
43980945|NCT02007863|Melphalan|melphalan|mesh-list
44021562|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44021563|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44021564|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44021565|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
44021566|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021567|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
43708331|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708332|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708333|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831421|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831422|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708502|NCT04733144|Hormones|hormones|mesh-ancestor
43708503|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708504|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708505|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708506|NCT04724720|Famotidine|famotidine|mesh-list
43708507|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43708508|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708509|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43708573|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
43708574|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43708707|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708708|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708801|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708802|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708803|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
43708805|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980946|NCT02007863|Busulfan|busulfan|mesh-list
43980947|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980948|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980949|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43980950|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
43980951|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980952|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43980953|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
43980954|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43980955|NCT02008617|Bupivacaine|bupivacaine|mesh-list
43980956|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
43980957|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
43980958|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980959|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980960|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
43980961|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980962|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43980963|NCT02008682|Liraglutide|liraglutide|mesh-list
43980964|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44243529|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44243530|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44243531|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243532|NCT00601874|Pilocarpine|pilocarpine|mesh-list
44243533|NCT00601874|Miotics|miotics|mesh-ancestor
44243534|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
44243535|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243536|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243537|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44243538|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44243539|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
44243540|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243541|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243542|NCT00601887|Meloxicam|meloxicam|mesh-list
44243543|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44243544|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243545|NCT00601887|Analgesics|analgesics|mesh-ancestor
43980965|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980966|NCT02008682|Incretins|incretins|mesh-ancestor
43980967|NCT02008682|Hormones|hormones|mesh-ancestor
43980968|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980969|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43980970|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
43980971|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871152|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43980972|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980974|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43980975|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43980976|NCT02008942|Analgesics|analgesics|mesh-ancestor
43980977|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
43980978|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980979|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980980|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980981|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980982|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43980987|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980988|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
43980989|NCT02010021|Letrozole|letrozole|mesh-list
43980990|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43980991|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44021617|NCT01602198|Protective Agents|protective agents|mesh-ancestor
44021618|NCT01606150|Lidocaine|lidocaine|mesh-list
43980992|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43980993|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980994|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980995|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43980996|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
43980997|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43980998|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980999|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
43981000|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44021625|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44021626|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43709060|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43709061|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43831500|NCT05309525|Coagulants|coagulants|mesh-ancestor
43831501|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
43831503|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831504|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831505|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831506|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831507|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709165|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709166|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709167|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43709168|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43709169|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
43709170|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43709171|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43709172|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
43709173|NCT01972035|Valacyclovir|valacyclovir|mesh-list
43709174|NCT01972035|Valganciclovir|valganciclovir|mesh-list
43709175|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
43709176|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981001|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
43981002|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981003|NCT02010645|Decitabine|decitabine|mesh-list
43981004|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981005|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
43981006|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981007|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981008|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243546|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
44243547|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021627|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43709248|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709249|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709250|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43709251|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43709252|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709253|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709254|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709255|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709256|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43645346|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645347|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
43831554|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709674|NCT05160493|Pregabalin|pregabalin|mesh-list
43709740|NCT05086874|Protective Agents|protective agents|mesh-ancestor
43709823|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709824|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709825|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43709826|NCT04988256|Protective Agents|protective agents|mesh-ancestor
43709827|NCT04962841|Metformin|metformin|mesh-list
43709828|NCT04962841|Amlodipine|amlodipine|mesh-list
43709829|NCT04962841|Ramipril|ramipril|mesh-list
43709830|NCT04962841|Nebivolol|nebivolol|mesh-list
43709831|NCT04962841|Rivastigmine|rivastigmine|mesh-list
43709832|NCT04962841|Sertraline|sertraline|mesh-list
43709833|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709834|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709835|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43709836|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43709837|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709838|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021628|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243548|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243549|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243550|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243551|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44243552|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243553|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981009|NCT02011464|Bupivacaine|bupivacaine|mesh-list
43981010|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981011|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
43981012|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981013|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981014|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
43981015|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144527|NCT00192062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144528|NCT00192062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144529|NCT00192062|Immunologic Factors|immunologic factors|mesh-ancestor
44144530|NCT00192062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144531|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144532|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144533|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144534|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144535|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
44144536|NCT00192088|Pemetrexed|pemetrexed|mesh-list
44144537|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144538|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981016|NCT02011516|Baclofen|baclofen|mesh-list
43981017|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43981018|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981019|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44021629|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021630|NCT01606709|Leuprolide|leuprolide|mesh-list
44021631|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44021632|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
43981020|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981021|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43981022|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
43981023|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
43981024|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981025|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981026|NCT02012192|Paclitaxel|paclitaxel|mesh-list
43981027|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43981028|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981029|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
43981030|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
43981031|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
43981032|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981033|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43981034|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43981035|NCT02012348|Triclocarban|triclocarban|mesh-list
43981036|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981037|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43981038|NCT02013245|Vaccines|vaccines|mesh-list
43981039|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
44021664|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021665|NCT01587963|Protective Agents|protective agents|mesh-ancestor
44021666|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021667|NCT01587963|Vitamins|vitamins|mesh-ancestor
44021668|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
43710315|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710316|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710317|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
43710318|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
43710319|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645352|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645353|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
43645354|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645355|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710320|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710321|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
43710322|NCT02436707|Hormones|hormones|mesh-ancestor
43710323|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710324|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710325|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710326|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
43710327|NCT02436707|Antiviral Agents|antiviral agents|mesh-ancestor
43710333|NCT02200978|Cytarabine|cytarabine|mesh-list
43981040|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981048|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981049|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981050|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43981051|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43981052|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021669|NCT01583647|Niacin|niacin|mesh-list
43981053|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981054|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
43981055|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981056|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
43981057|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43981058|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
43981059|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43981060|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44021675|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44021678|NCT01583647|Vitamins|vitamins|mesh-ancestor
44021685|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43981061|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243554|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243555|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44243556|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243557|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44243558|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243559|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243560|NCT00601978|Levodopa|levodopa|mesh-list
44243561|NCT00601978|Carbidopa|carbidopa|mesh-list
44021686|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243562|NCT00601978|Entacapone|entacapone|mesh-list
44243563|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44243564|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43981062|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43981063|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021696|NCT01555489|Vitamins|vitamins|mesh-ancestor
43981064|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43981065|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981066|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
43981067|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43981068|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43981069|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43981070|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981071|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981072|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981073|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981074|NCT02017327|Bimatoprost|bimatoprost|mesh-list
43981075|NCT02017327|Latanoprost|latanoprost|mesh-list
43981076|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43981077|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43981078|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43981079|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43981080|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43981081|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981082|NCT02018627|Glucagon|glucagon|mesh-list
43981083|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43981084|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981085|NCT02018627|Hormones|hormones|mesh-ancestor
43981086|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981087|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717448|NCT02647671|Calcium|calcium|mesh-list
43981088|NCT02018627|Incretins|incretins|mesh-ancestor
43981089|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
43981090|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
43981091|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
43981092|NCT02018653|Calcium|calcium|mesh-list
43981093|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43981094|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981095|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43981096|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981097|NCT02019069|Cytarabine|cytarabine|mesh-list
43981098|NCT02019069|Daunorubicin|daunorubicin|mesh-list
43981099|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981100|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
43981101|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981102|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981103|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
43981104|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981105|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981106|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
43981107|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981110|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43981111|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981112|NCT02019758|Fluticasone|fluticasone|mesh-list
43981113|NCT02019758|Budesonide|budesonide|mesh-list
43981114|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981115|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44243565|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44243566|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
44243567|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243568|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243569|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243570|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44243571|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981116|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
43981117|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981118|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981119|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43981120|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43981121|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981122|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43981123|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
43981124|NCT02019758|Hormones|hormones|mesh-ancestor
43981125|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981126|NCT02019940|Riluzole|riluzole|mesh-list
43981127|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
43981128|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43981129|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43981130|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981131|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981132|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981133|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43981134|NCT02019940|Protective Agents|protective agents|mesh-ancestor
43981135|NCT02020278|Tolvaptan|tolvaptan|mesh-list
43981136|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43981137|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981138|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
43981139|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981140|NCT02020408|Raclopride|raclopride|mesh-list
43981141|NCT02020408|Amphetamine|amphetamine|mesh-list
43981142|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
43981143|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43981144|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981145|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
43981146|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
43981147|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981148|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
43981149|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981150|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981151|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
43981152|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43981153|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43981154|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43981155|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43981156|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43981157|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021783|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44021784|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021785|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44021786|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021787|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021788|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
44021789|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
44021790|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44021791|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44021792|NCT01530880|Acetaminophen|acetaminophen|mesh-list
44021793|NCT01530880|Ibuprofen|ibuprofen|mesh-list
44021794|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021795|NCT01530880|Analgesics|analgesics|mesh-ancestor
44021796|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
44021797|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871178|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021798|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644583|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644584|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644585|NCT04543071|Gemcitabine|gemcitabine|mesh-list
43644586|NCT04543071|Paclitaxel|paclitaxel|mesh-list
43644587|NCT04543071|Cemiplimab|cemiplimab|mesh-list
43644588|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644589|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644590|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644591|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644592|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
43981158|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981159|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43981160|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43981161|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43981162|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
43981163|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43981164|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43981165|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43981166|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981167|NCT02021929|Sorafenib|sorafenib|mesh-list
43981168|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981169|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44021800|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44021801|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021802|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645384|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644595|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
43981170|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981171|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981172|NCT02021942|Pasireotide|pasireotide|mesh-list
44243572|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44243573|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44243574|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
44243575|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
44243576|NCT00601991|Aflibercept|aflibercept|mesh-list
44243577|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
44243578|NCT00601991|Growth Substances|growth substances|mesh-ancestor
44243579|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021803|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44021804|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021805|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021806|NCT01527942|Acetaminophen|acetaminophen|mesh-list
44021807|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021808|NCT01527942|Analgesics|analgesics|mesh-ancestor
44021809|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
44021810|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021811|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021812|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
44021813|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
43645385|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645386|NCT04090190|Urological Agents|urological agents|mesh-ancestor
43645387|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
44243580|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243581|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243582|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
44243583|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981174|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981175|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981176|NCT02023125|Esomeprazole|esomeprazole|mesh-list
44021814|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
44021815|NCT01532635|Tacrolimus|tacrolimus|mesh-list
44021816|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021817|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
44021818|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021819|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021820|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44021821|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
43645389|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645390|NCT04088409|Adalimumab|adalimumab|mesh-list
43645391|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645392|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981177|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43981178|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981188|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43981189|NCT02024204|Fluticasone|fluticasone|mesh-list
43981190|NCT02024204|Xhance|xhance|mesh-list
43981191|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43981192|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43981193|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981194|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43981195|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
43645393|NCT04085887|Panitumumab|panitumumab|mesh-list
43645394|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645395|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645396|NCT04085237|Ropivacaine|ropivacaine|mesh-list
43644597|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644598|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644599|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644600|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
43644601|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644602|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645397|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981196|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981197|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981198|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43981199|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
43981200|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981201|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43981202|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43981203|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43981204|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43981205|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
43981206|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981207|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981208|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
43981209|NCT02024204|Hormones|hormones|mesh-ancestor
43981210|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981211|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
43981212|NCT02024386|Riociguat|riociguat|mesh-list
43981213|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
44021822|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021823|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021824|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44021825|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44021826|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021827|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021828|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44021829|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
44021830|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44021831|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021832|NCT01526408|Famciclovir|famciclovir|mesh-list
44021833|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
44021834|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021835|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44021836|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021837|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021838|NCT01525927|Cisplatin|cisplatin|mesh-list
44021839|NCT01525927|Carboplatin|carboplatin|mesh-list
44021840|NCT01525927|Etoposide|etoposide|mesh-list
43645403|NCT04080895|Lumefantrine|lumefantrine|mesh-list
43645404|NCT04080895|Artemether|artemether|mesh-list
43645405|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43645406|NCT04080895|Amodiaquine|amodiaquine|mesh-list
43645407|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
43645408|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43645409|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43645410|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645411|NCT04080869|Vitamin A|vitamin a|mesh-list
43645412|NCT04080869|Tretinoin|tretinoin|mesh-list
43645413|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
43645414|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644603|NCT04542733|Everolimus|everolimus|mesh-list
43981214|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981215|NCT02024477|Saxagliptin|saxagliptin|mesh-list
43981216|NCT02024477|Incretins|incretins|mesh-ancestor
43981217|NCT02024477|Hormones|hormones|mesh-ancestor
43981218|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981219|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981220|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43981221|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981222|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981223|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981224|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43981225|NCT02024646|Brodalumab|brodalumab|mesh-list
43981226|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43981227|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021841|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021842|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44021843|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44021844|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44021845|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645415|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
43645416|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645417|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
43645418|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645419|NCT04080869|Protective Agents|protective agents|mesh-ancestor
43645420|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645421|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43645422|NCT04080869|Vitamins|vitamins|mesh-ancestor
43645423|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
43645424|NCT04038437|Venetoclax|venetoclax|mesh-list
43645425|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645426|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
43645427|NCT04017442|Morphine|morphine|mesh-list
43645428|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43645429|NCT04017442|Narcotics|narcotics|mesh-ancestor
43645430|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645431|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981228|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
43981229|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981230|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
43981231|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44243585|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44243586|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44243587|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44243588|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44243589|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243590|NCT00601159|Gemcitabine|gemcitabine|mesh-list
44243591|NCT00601159|Cisplatin|cisplatin|mesh-list
44243592|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981232|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
43981233|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981234|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
43981235|NCT02024711|Protective Agents|protective agents|mesh-ancestor
43981236|NCT02024724|Dexamethasone|dexamethasone|mesh-list
43981237|NCT02024724|Triamcinolone|triamcinolone|mesh-list
43981238|NCT02024724|Bupivacaine|bupivacaine|mesh-list
43981239|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981240|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
44021846|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021847|NCT01507233|Morphine|morphine|mesh-list
44021848|NCT01507233|Bupivacaine|bupivacaine|mesh-list
44021849|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021850|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
44021851|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021852|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021853|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
44021854|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021855|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44021856|NCT01507233|Narcotics|narcotics|mesh-ancestor
44021857|NCT01507233|Analgesics|analgesics|mesh-ancestor
44021858|NCT01500772|Ribavirin|ribavirin|mesh-list
44021859|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44021860|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
44021861|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021862|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
44021863|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021864|NCT01507584|Bimatoprost|bimatoprost|mesh-list
44021865|NCT01507584|Brinzolamide|brinzolamide|mesh-list
44021866|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44021867|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43645432|NCT04017442|Analgesics|analgesics|mesh-ancestor
43645433|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
43645434|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645435|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43645436|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44021868|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981247|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981249|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981250|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981251|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
43981252|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981253|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
43981254|NCT02025075|Rocuronium|rocuronium|mesh-list
43981255|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43981256|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43981257|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43981258|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981259|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981260|NCT02025426|Phenylephrine|phenylephrine|mesh-list
43981261|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
43981262|NCT02025426|Ephedrine|ephedrine|mesh-list
43981263|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43981264|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
43981265|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
43981266|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981267|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981268|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
43981269|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43981270|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
43981271|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
43981272|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43981273|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43981274|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43981275|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
43981276|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981277|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981278|NCT02025426|Protective Agents|protective agents|mesh-ancestor
43981279|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43981280|NCT02025439|Amantadine|amantadine|mesh-list
43981281|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43981282|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43981283|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
43981284|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981285|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
43981286|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981287|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981288|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981289|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981290|NCT02025439|Analgesics|analgesics|mesh-ancestor
43981291|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
43981292|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981293|NCT02025634|Acetaminophen|acetaminophen|mesh-list
43981294|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981295|NCT02025634|Analgesics|analgesics|mesh-ancestor
44243593|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44243595|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243596|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
44243597|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243598|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243599|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243600|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
44243601|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243602|NCT00602017|Amlodipine|amlodipine|mesh-list
43981296|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
43981297|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981298|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981299|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
43981300|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
43981301|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43981302|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44021913|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44021914|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021915|NCT01472692|Febuxostat|febuxostat|mesh-list
44021916|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
44021917|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021918|NCT01446250|Ribavirin|ribavirin|mesh-list
44021919|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44021920|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
44021921|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021922|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
44021923|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021924|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
44021925|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44021926|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021927|NCT01434745|Simvastatin|simvastatin|mesh-list
44021928|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44021929|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44021930|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
44021931|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021932|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43645437|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645438|NCT04003649|Nivolumab|nivolumab|mesh-list
43645439|NCT04003649|Ipilimumab|ipilimumab|mesh-list
43645440|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645441|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645442|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43981303|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981304|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
43981305|NCT02026297|Coagulants|coagulants|mesh-ancestor
43981306|NCT02028676|Lamivudine|lamivudine|mesh-list
43981307|NCT02028676|Zidovudine|zidovudine|mesh-list
43981308|NCT02028676|Efavirenz|efavirenz|mesh-list
43981309|NCT02028676|Nevirapine|nevirapine|mesh-list
43981310|NCT02028676|Abacavir|abacavir|mesh-list
43981315|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43645443|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645444|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43645445|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43645446|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645447|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645448|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43645449|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644605|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645450|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645451|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
43645452|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645453|NCT03990571|Avelumab|avelumab|mesh-list
43645454|NCT03990571|Axitinib|axitinib|mesh-list
43645455|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645456|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645457|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645458|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645459|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645460|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645461|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
43645462|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645463|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
43981316|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43981317|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43981318|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981319|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981320|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
43981321|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981322|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43981323|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43981324|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
43981325|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43981326|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43981327|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43981328|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43981329|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43981330|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43981331|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43981332|NCT02028676|Renal Agents|renal agents|mesh-ancestor
43981333|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
43981334|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43981335|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43981336|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43981337|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43981338|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43981339|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43981340|NCT02028754|Levofloxacin|levofloxacin|mesh-list
43981341|NCT02028754|Ofloxacin|ofloxacin|mesh-list
43981342|NCT02028754|Prednisolone|prednisolone|mesh-list
43981343|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
43981344|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43981345|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981346|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
43981347|NCT02028754|Hormones|hormones|mesh-ancestor
44021933|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44021934|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021935|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
44021936|NCT01406860|Promethazine|promethazine|mesh-list
44021937|NCT01406860|Droperidol|droperidol|mesh-list
44021938|NCT01406860|Metoclopramide|metoclopramide|mesh-list
44021939|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44021940|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44021941|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981348|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981349|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981350|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981351|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981352|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981353|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43981354|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981355|NCT02028754|Renal Agents|renal agents|mesh-ancestor
43981356|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243603|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44243604|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44243605|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243606|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981357|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43981358|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43981359|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981360|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981361|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43981362|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43981363|NCT02028754|Laxatives|laxatives|mesh-ancestor
43981364|NCT02028780|Dabigatran|dabigatran|mesh-list
43981365|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
43981366|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43981367|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981368|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981369|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981370|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
43981371|NCT02029495|Brodalumab|brodalumab|mesh-list
43981372|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43981373|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981374|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
43981375|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981376|NCT02029703|Hylan|hylan|mesh-list
43981377|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
43981378|NCT02029703|Protective Agents|protective agents|mesh-ancestor
43981379|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981380|NCT02029755|Anesthetics|anesthetics|mesh-list
43981381|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
43981390|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43981391|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981392|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43981393|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981394|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
43981395|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981396|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43981397|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43981398|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981399|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981402|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981403|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981404|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
43981405|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981406|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
43981407|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022021|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
43981408|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981409|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981410|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
43981411|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981412|NCT02032212|Nicotine|nicotine|mesh-list
43981413|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43981414|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
43981415|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981416|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981417|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43981418|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43981419|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981420|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981421|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144539|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144540|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44144541|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144542|NCT00192101|Gemcitabine|gemcitabine|mesh-list
44144543|NCT00192101|Cisplatin|cisplatin|mesh-list
44144544|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144545|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144546|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
44243607|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44243608|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144547|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144548|NCT00192101|Antiviral Agents|antiviral agents|mesh-ancestor
44144549|NCT00192101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144550|NCT00192101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144551|NCT00192101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144552|NCT00192101|Immunologic Factors|immunologic factors|mesh-ancestor
44144553|NCT00192101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157568|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44157569|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
44022022|NCT01383447|Entinostat|entinostat|mesh-list
44022023|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44022024|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022025|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44022026|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022028|NCT01385280|Exemestane|exemestane|mesh-list
44022031|NCT01385280|Estradiol|estradiol|mesh-list
43644606|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
43644607|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644608|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43644609|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644610|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644611|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644612|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
43644613|NCT04539379|Analgesics|analgesics|mesh-ancestor
43644614|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
43644615|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644616|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644617|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
43644618|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644619|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43644620|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
43644621|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157570|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157572|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157573|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157574|NCT00234910|Ritonavir|ritonavir|mesh-list
44157575|NCT00234910|Lopinavir|lopinavir|mesh-list
44157576|NCT00234910|Tenofovir|tenofovir|mesh-list
44157577|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44157578|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44157579|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157580|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644627|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
44157594|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44157595|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43981422|NCT02032433|Naltrexone|naltrexone|mesh-list
43981423|NCT02032433|Buprenorphine|buprenorphine|mesh-list
43981424|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43981425|NCT02032433|Naloxone|naloxone|mesh-list
43981426|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43981427|NCT02032433|Narcotics|narcotics|mesh-ancestor
43981428|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981429|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981430|NCT02032433|Analgesics|analgesics|mesh-ancestor
43981431|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
43981432|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981433|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44022054|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44022055|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022056|NCT01379469|Analgesics|analgesics|mesh-ancestor
44022057|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
44022058|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022059|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44022060|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022061|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022062|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44022063|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44022064|NCT01347632|Metronidazole|metronidazole|mesh-list
44022065|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022066|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022067|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43981434|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43981435|NCT02032758|Propranolol|propranolol|mesh-list
43981436|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43981437|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43981438|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
43981439|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871154|NCT02661035|Protective Agents|protective agents|mesh-ancestor
43981440|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981441|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022068|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43846369|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43644628|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644629|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644630|NCT04506554|Nivolumab|nivolumab|mesh-list
43644631|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43981442|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43981443|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43981444|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
43981445|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43981446|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43981447|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981449|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43981450|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43981451|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981452|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43981453|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43981454|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43981455|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981456|NCT02034019|Dexamethasone|dexamethasone|mesh-list
44022069|NCT01350232|Cytarabine|cytarabine|mesh-list
44022070|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
44022071|NCT01350232|Rituximab|rituximab|mesh-list
44022072|NCT01350232|Fludarabine|fludarabine|mesh-list
44022073|NCT01350232|Bortezomib|bortezomib|mesh-list
44022074|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022075|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
44022076|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022077|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022078|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44022079|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
44022080|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022081|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022082|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44022083|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43981457|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981458|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
43981459|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
43981460|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981461|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981462|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981463|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
43981464|NCT02034019|Hormones|hormones|mesh-ancestor
43981465|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981466|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981467|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981468|NCT02034578|Apixaban|apixaban|mesh-list
43981483|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43981484|NCT02036424|Growth Substances|growth substances|mesh-ancestor
44243609|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
44243610|NCT00602082|Cisplatin|cisplatin|mesh-list
44243611|NCT00602082|Capecitabine|capecitabine|mesh-list
44022084|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022085|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
44022086|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
44022087|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022088|NCT01350258|Fludarabine|fludarabine|mesh-list
44243612|NCT00602082|Streptozocin|streptozocin|mesh-list
44243613|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243614|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44243615|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
44243616|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243617|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44243618|NCT00602095|Misoprostol|misoprostol|mesh-list
44243619|NCT00602095|Dinoprostone|dinoprostone|mesh-list
44243620|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44243621|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
44243622|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44243623|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243624|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44243625|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44243626|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
44243627|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
44243628|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
44243629|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243630|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981485|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981486|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
43981487|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981488|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
43981489|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
44022089|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
44022090|NCT01350258|Melphalan|melphalan|mesh-list
44022091|NCT01350258|Thiotepa|thiotepa|mesh-list
44022092|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022093|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022094|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
44022095|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022096|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022097|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
44022098|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022099|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44022100|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
44022101|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44022103|NCT01340573|Ribavirin|ribavirin|mesh-list
44022104|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44022105|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022106|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
44022107|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022108|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
44022109|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022110|NCT01340885|Rivastigmine|rivastigmine|mesh-list
44022111|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44022112|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44022113|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43981490|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981491|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981492|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
43981493|NCT02036424|Hormones|hormones|mesh-ancestor
43981494|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981495|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981496|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44022115|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644632|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644633|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644634|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644635|NCT04487444|Thymalfasin|thymalfasin|mesh-list
43981497|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981498|NCT02037061|Bupivacaine|bupivacaine|mesh-list
43981499|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981500|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
43981501|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981502|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981503|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
43981504|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981505|NCT02037230|Gemcitabine|gemcitabine|mesh-list
43981506|NCT02037230|Adavosertib|adavosertib|mesh-list
43981507|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981508|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
43981509|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022116|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022117|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022118|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022119|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44022120|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022121|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
44022122|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44022123|NCT01340885|Protective Agents|protective agents|mesh-ancestor
44022124|NCT01326923|Cetuximab|cetuximab|mesh-list
44022125|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44022126|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022127|NCT01309581|Ketamine|ketamine|mesh-list
44022128|NCT01309581|Methohexital|methohexital|mesh-list
44022129|NCT01309581|Analgesics|analgesics|mesh-ancestor
44022130|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
43981510|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981511|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
43981512|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981513|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981514|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981516|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243631|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243632|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243633|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
44243634|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243635|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44022131|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022132|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022133|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44022134|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44022135|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
44022136|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
44022137|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44022138|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44022139|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43644636|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43644637|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
43644638|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644639|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
43644640|NCT04483544|Olaparib|olaparib|mesh-list
43644641|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644642|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243636|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243637|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44243638|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44243639|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243640|NCT05645432|Pregnanolone|pregnanolone|mesh-list
44243641|NCT05645432|Brexanolone|brexanolone|mesh-list
44243642|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
44243643|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243644|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022140|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644643|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43644644|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644645|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022141|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243645|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
43981517|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43981518|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43981519|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43981520|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981521|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981522|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43981523|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43981524|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981525|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981526|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981527|NCT02037555|Antithrombins|antithrombins|mesh-list
43981528|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
43981529|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43850656|NCT05353062|Coagulants|coagulants|mesh-ancestor
43981532|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981534|NCT02037893|Antipyrine|antipyrine|mesh-list
43981535|NCT02037893|Benzocaine|benzocaine|mesh-list
43981536|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43981537|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981538|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
43981539|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981540|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981541|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
43981542|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981543|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43981544|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981545|NCT02037893|Analgesics|analgesics|mesh-ancestor
43981546|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022142|NCT01315873|Bortezomib|bortezomib|mesh-list
44022143|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44022144|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022145|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44022146|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
44022147|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022148|NCT01313416|Gemcitabine|gemcitabine|mesh-list
44022149|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022150|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
44022151|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022152|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022153|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
44022154|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022155|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981547|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981548|NCT02038023|Iron|iron|mesh-list
43981549|NCT02038023|Dextrans|dextrans|mesh-list
43981550|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
43981551|NCT02038023|Trace Elements|trace elements|mesh-ancestor
43981552|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
43981553|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981554|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
43981555|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
43981556|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
43981557|NCT02038023|Hematinics|hematinics|mesh-ancestor
43981558|NCT02038179|Allopurinol|allopurinol|mesh-list
43981559|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
43981560|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981561|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981562|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
43981563|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981564|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44243647|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243648|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
44243649|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
44243650|NCT05645406|Estradiol|estradiol|mesh-list
43981565|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
43981566|NCT02038179|Protective Agents|protective agents|mesh-ancestor
44022169|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022170|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022171|NCT01302444|Tadalafil|tadalafil|mesh-list
44022172|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
44022173|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44022174|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44022175|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022176|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022177|NCT01302444|Urological Agents|urological agents|mesh-ancestor
44022178|NCT01301963|Plerixafor|plerixafor|mesh-list
44022179|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44022180|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44022181|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
44022182|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022183|NCT01292070|Histamine|histamine|mesh-list
44022184|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
44022185|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
44022186|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022187|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022188|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022189|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
44022190|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981567|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981568|NCT02038894|Propofol|propofol|mesh-list
43981569|NCT02038894|Sevoflurane|sevoflurane|mesh-list
43981570|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43981571|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981572|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981573|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43981574|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
43981575|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
43981576|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43981577|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43981578|NCT02039115|Prednisone|prednisone|mesh-list
43981579|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981580|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
43981581|NCT02039115|Hormones|hormones|mesh-ancestor
43981582|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981583|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981584|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981585|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981586|NCT02039947|Trametinib|trametinib|mesh-list
43981587|NCT02039947|Dabrafenib|dabrafenib|mesh-list
43981588|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981589|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43981590|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871155|NCT02641782|Aldesleukin|aldesleukin|mesh-list
43981591|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981592|NCT02040116|Rituximab|rituximab|mesh-list
43981593|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43981594|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981595|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
43981596|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981597|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981598|NCT02040298|Clemastine|clemastine|mesh-list
43981599|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
43981600|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981601|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43981602|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
43981603|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
43981604|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981605|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981607|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43981608|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43981609|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43981610|NCT02041325|Lenalidomide|lenalidomide|mesh-list
43981611|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
43981612|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981613|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43981614|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43981615|NCT02041325|Growth Substances|growth substances|mesh-ancestor
43981616|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
43981617|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981618|NCT02042534|Warfarin|warfarin|mesh-list
43981619|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
43981620|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
43981621|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43981622|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
43981623|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43981624|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
44148607|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148608|NCT00204698|Rabeprazole|rabeprazole|mesh-list
44148609|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44148610|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148611|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44148612|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148613|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148614|NCT00204737|Prednisone|prednisone|mesh-list
44148615|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148616|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
43645464|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645465|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645467|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
43645468|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644650|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
43644651|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43981625|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981626|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981627|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
43981628|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43981629|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981630|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
43981631|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43981632|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44243651|NCT05645406|Estrogens|estrogens|mesh-ancestor
44243652|NCT05645406|Hormones|hormones|mesh-ancestor
44243653|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243654|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243655|NCT05645393|Estrogens|estrogens|mesh-list
44243656|NCT05645393|Hormones|hormones|mesh-ancestor
44243657|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243658|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981633|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43981634|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645469|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43645470|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43645471|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981635|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981636|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981637|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981638|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981639|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43981640|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981641|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43981642|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
43981643|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981644|NCT02043652|Chloroquine|chloroquine|mesh-list
43981645|NCT02043652|Primaquine|primaquine|mesh-list
43981646|NCT02043652|Amebicides|amebicides|mesh-ancestor
43981647|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43717947|NCT02645058|Analgesics|analgesics|mesh-list
43981648|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43981649|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981650|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
43981651|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981652|NCT02043704|Acetaminophen|acetaminophen|mesh-list
43981653|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981654|NCT02043704|Analgesics|analgesics|mesh-ancestor
43981655|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
43981656|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981657|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148618|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148619|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148620|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44148621|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148622|NCT00204776|Capecitabine|capecitabine|mesh-list
44148623|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
44148624|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022235|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44022236|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022237|NCT01284504|Analgesics|analgesics|mesh-ancestor
44022238|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
44022239|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022240|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022241|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022242|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022243|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44022244|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44022245|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022246|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022247|NCT01269034|Insulin|insulin|mesh-list
44022248|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44022249|NCT01269034|Exenatide|exenatide|mesh-list
44022250|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
43645472|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
43981658|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
43981659|NCT02044367|Dabigatran|dabigatran|mesh-list
43981660|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
43981661|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43981662|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981663|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981664|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981665|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
43981666|NCT02044380|Afatinib|afatinib|mesh-list
43981667|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981668|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43981669|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981670|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022251|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
44022252|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
44022253|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44022254|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645476|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645477|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
43981671|NCT02044393|Itraconazole|itraconazole|mesh-list
43981672|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
43981673|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981674|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43981675|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43981676|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981677|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981678|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43981685|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
43981687|NCT02044796|Lenograstim|lenograstim|mesh-list
43981688|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981689|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
43981690|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981691|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981692|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
43981693|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981694|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981695|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
43981696|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981697|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43981698|NCT02044796|Analgesics|analgesics|mesh-ancestor
43981699|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
43981700|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981701|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43981702|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43981703|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981704|NCT02045264|Icatibant|icatibant|mesh-list
43981705|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43981706|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981707|NCT02045264|Analgesics|analgesics|mesh-ancestor
43981708|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
43981709|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981710|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981711|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981712|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981713|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43981714|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43981715|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981716|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43981717|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981718|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
43981719|NCT02046200|Ethanol|ethanol|mesh-list
43981720|NCT02046200|Ivermectin|ivermectin|mesh-list
43981721|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43981722|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981723|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144554|NCT00192413|Vaccines|vaccines|mesh-list
43717951|NCT02645032|Vaccines|vaccines|mesh-list
43981724|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981725|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43981726|NCT02046382|Acetaminophen|acetaminophen|mesh-list
43981727|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981728|NCT02046382|Analgesics|analgesics|mesh-ancestor
43981729|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
43981730|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981731|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981732|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
43981733|NCT02046772|Morphine|morphine|mesh-list
43981734|NCT02046772|Bupivacaine|bupivacaine|mesh-list
43981735|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981736|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
43981737|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981738|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981739|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
44022308|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022309|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44022310|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44022311|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644652|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644653|NCT04469764|Letrozole|letrozole|mesh-list
43644654|NCT04469764|Anastrozole|anastrozole|mesh-list
43644655|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644656|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43644657|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43644665|NCT04468230|Nicotine|nicotine|mesh-list
43644666|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43644667|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
43644668|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645478|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645480|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43981740|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981741|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43981742|NCT02046772|Narcotics|narcotics|mesh-ancestor
43981743|NCT02046772|Analgesics|analgesics|mesh-ancestor
43981744|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
43981745|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43981747|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981748|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981749|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981750|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981751|NCT02047032|Urological Agents|urological agents|mesh-ancestor
43981752|NCT02047500|Gemcitabine|gemcitabine|mesh-list
43981753|NCT02047500|Paclitaxel|paclitaxel|mesh-list
43981754|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43981755|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981756|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
44243681|NCT05645302|Lidocaine|lidocaine|mesh-list
44243682|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
44243683|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
44022312|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022313|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022314|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44022315|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44022316|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44022317|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44022318|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44022319|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44022320|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44022321|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022322|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022323|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022324|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022325|NCT01223001|Analgesics|analgesics|mesh-ancestor
44022326|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
44022327|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022328|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
43645481|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
43644669|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644670|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43644672|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
43644673|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243684|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243685|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243686|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
43981757|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
43981758|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
43981759|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981760|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981761|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
43981762|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
43981763|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981764|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981765|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981766|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
43981767|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981768|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43981769|NCT02048891|Progesterone|progesterone|mesh-list
43981770|NCT02048891|Progestins|progestins|mesh-ancestor
43981771|NCT02048891|Hormones|hormones|mesh-ancestor
43981772|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981773|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981774|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
43981775|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43981776|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
44022329|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44022330|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
44022331|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
44022332|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44022333|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44022334|NCT01216631|Prednisolone|prednisolone|mesh-list
44022335|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
44022336|NCT01216631|Infliximab|infliximab|mesh-list
44022337|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44022338|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
44022339|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022340|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
44022341|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
44022342|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022343|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022344|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022345|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
44022346|NCT01216631|Hormones|hormones|mesh-ancestor
44022347|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022348|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44022349|NCT01216631|Protective Agents|protective agents|mesh-ancestor
44022350|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022351|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022352|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022353|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981777|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43981778|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43981779|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981780|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981781|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
43981782|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981783|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
43981784|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981785|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43981786|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43981787|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
43981788|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981789|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981790|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43981791|NCT02049307|Losartan|losartan|mesh-list
43981792|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43981793|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43981794|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43981795|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43981796|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981797|NCT02049385|Diazoxide|diazoxide|mesh-list
43981798|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43981799|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
43981800|NCT02049476|Dexamethasone|dexamethasone|mesh-list
43981801|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981802|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
43981803|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
43981804|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981805|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981806|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981807|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
43981808|NCT02049476|Hormones|hormones|mesh-ancestor
43981809|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981810|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981811|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981812|NCT02050334|Caffeic acid|caffeic acid|mesh-list
43981813|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
44243687|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243689|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44243690|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44243691|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645482|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645483|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645484|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43645485|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43644674|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644675|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
43644676|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243692|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243693|NCT05645289|Alendronate|alendronate|mesh-list
44243694|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44243695|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243696|NCT05645146|Nicotine|nicotine|mesh-list
44243697|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44243698|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
43871156|NCT02641782|Interleukin-2|interleukin-2|mesh-list
44022397|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022398|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44022399|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43645492|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43645493|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644683|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644684|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645494|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43645495|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43981814|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981815|NCT02050334|Protective Agents|protective agents|mesh-ancestor
43981816|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144555|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
44144557|NCT00192569|Interferons|interferons|mesh-list
44144558|NCT00192569|Ribavirin|ribavirin|mesh-list
44144559|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
44144560|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
44144561|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44144562|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144563|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
44144564|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144565|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
44144566|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144567|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
44144568|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144569|NCT00192595|Tenofovir|tenofovir|mesh-list
44144570|NCT00192595|Lamivudine|lamivudine|mesh-list
44144571|NCT00192595|Zidovudine|zidovudine|mesh-list
44144572|NCT00192595|Efavirenz|efavirenz|mesh-list
44144573|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
44144574|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144575|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44144576|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144577|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144578|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144579|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44144580|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44144581|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
44144582|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44144583|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44144584|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44144585|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44144586|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44144587|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44144588|NCT00192608|Saquinavir|saquinavir|mesh-list
44144589|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44144590|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44144591|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
44144592|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144593|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144594|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44144595|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44144596|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
44144597|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144598|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44144599|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44144600|NCT00192621|Lamivudine|lamivudine|mesh-list
44144601|NCT00192621|Zidovudine|zidovudine|mesh-list
44243699|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243700|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243701|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44243702|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44243703|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
44243704|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243705|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243706|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
44243707|NCT05645029|Methamphetamine|methamphetamine|mesh-list
44243708|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
44243709|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44243710|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144602|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44144603|NCT00192621|Lopinavir|lopinavir|mesh-list
44144604|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44144605|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144606|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144607|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144608|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
44144609|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144610|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43718091|NCT02644551|Ciclopirox|ciclopirox|mesh-list
44144611|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43981817|NCT02051335|Scopolamine|scopolamine|mesh-list
43981818|NCT02051335|Donepezil|donepezil|mesh-list
43981819|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43981820|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43981821|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981822|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981823|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
43981824|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981825|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981826|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
43981827|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43981828|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
43981829|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
43981830|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981831|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981832|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
43981833|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43981834|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43981837|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43981839|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43981840|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43981841|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43981842|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981843|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
43981844|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981845|NCT02051595|Vancomycin|vancomycin|mesh-list
43981846|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43981847|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981848|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
43981849|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43981850|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43981851|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981852|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
43981853|NCT02051686|Coagulants|coagulants|mesh-ancestor
43981854|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43981855|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43981856|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981857|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
43981858|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243712|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022496|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022497|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44022498|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44022499|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44022500|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022501|NCT01169610|Varenicline|varenicline|mesh-list
44022502|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44022503|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44022504|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
44022505|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022506|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022507|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022508|NCT01163084|Leuprolide|leuprolide|mesh-list
44022509|NCT01163084|Goserelin|goserelin|mesh-list
44022510|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44022511|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
44022512|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44243713|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44243714|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243715|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
44243716|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
44243717|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243718|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
44243719|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243720|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243721|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44243722|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44243723|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44243724|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44243725|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44243726|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
44243727|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44243728|NCT05645029|Protective Agents|protective agents|mesh-ancestor
43981859|NCT02052557|Bupivacaine|bupivacaine|mesh-list
43981860|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981861|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
43981862|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981863|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981864|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
43981865|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981866|NCT02052635|Clopidogrel|clopidogrel|mesh-list
43981867|NCT02052635|Ticagrelor|ticagrelor|mesh-list
43981868|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43981869|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43981870|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43981871|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43981872|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
43981873|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981874|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981875|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981876|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43981877|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
43981878|NCT02054156|Azithromycin|azithromycin|mesh-list
43981879|NCT02054156|Tobramycin|tobramycin|mesh-list
43981880|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43981881|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981882|NCT02054338|Gemcitabine|gemcitabine|mesh-list
43981883|NCT02054338|Paclitaxel|paclitaxel|mesh-list
43981884|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43981885|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981886|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
43981887|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
43981888|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
43981889|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981890|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718171|NCT02644252|Vitamin E|vitamin e|mesh-list
43981891|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
43981892|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
43981893|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981894|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243729|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44243730|NCT05644769|Lisinopril|lisinopril|mesh-list
44243731|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44243732|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
44243733|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243734|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243735|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44243736|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44243737|NCT05644769|Protective Agents|protective agents|mesh-ancestor
44243738|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243739|NCT05644743|Gemcitabine|gemcitabine|mesh-list
44243740|NCT05644743|Cisplatin|cisplatin|mesh-list
44243741|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896797|NCT02215265|Cisplatin|cisplatin|mesh-list
43981895|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43981896|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
43981897|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981898|NCT02054754|HU 211|hu 211|mesh-list
43981899|NCT02054754|Dronabinol|dronabinol|mesh-list
43981900|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43981901|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
43981902|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
43981903|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981904|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022558|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44022559|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44022560|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44022561|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
44022562|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022563|NCT01147042|Interferons|interferons|mesh-list
44022564|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
44022565|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022566|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
44022568|NCT01139996|Clonidine|clonidine|mesh-list
43981905|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981906|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43981910|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43981911|NCT02054754|Protective Agents|protective agents|mesh-ancestor
43981912|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
43981913|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43981914|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981915|NCT02054754|Analgesics|analgesics|mesh-ancestor
43981916|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
43981917|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43981918|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43981919|NCT02054754|Hormones|hormones|mesh-ancestor
43981920|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981922|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43981923|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981924|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
43981925|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981926|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43981927|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
43981928|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44022591|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022592|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022593|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022594|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44022595|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022596|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022597|NCT01126801|Estradiol|estradiol|mesh-list
44022598|NCT01126801|Estrogens|estrogens|mesh-ancestor
44022599|NCT01126801|Hormones|hormones|mesh-ancestor
44022600|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022601|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022602|NCT01126957|Fentanyl|fentanyl|mesh-list
44022603|NCT01126957|Ketamine|ketamine|mesh-list
44022604|NCT01126957|Propofol|propofol|mesh-list
43753043|NCT02487212|Clobetasol|clobetasol|mesh-list
44022605|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44022606|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44022607|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022608|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44022609|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
44022610|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
44022611|NCT01126957|Analgesics|analgesics|mesh-ancestor
43645496|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43645497|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
43645498|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645499|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981929|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43981930|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43981931|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981932|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981933|NCT02057640|Dexamethasone|dexamethasone|mesh-list
43981934|NCT02057640|Ixazomib|ixazomib|mesh-list
43981935|NCT02057640|Panobinostat|panobinostat|mesh-list
43981936|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43981937|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
43981938|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
43981939|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981940|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981941|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981942|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
43981943|NCT02057640|Hormones|hormones|mesh-ancestor
43981944|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981945|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981946|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243742|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44243743|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
44243744|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243745|NCT05644743|Antiviral Agents|antiviral agents|mesh-ancestor
44243746|NCT05644743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43981947|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981948|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981949|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981950|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43981951|NCT02057939|Leuprolide|leuprolide|mesh-list
43981952|NCT02057939|Androgens|androgens|mesh-list
43981953|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43981954|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
43981955|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43981956|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981957|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981958|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981959|NCT02057939|Hormones|hormones|mesh-ancestor
43981960|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981961|NCT02058251|Oxytocin|oxytocin|mesh-list
43981962|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
43981963|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43981964|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981965|NCT02058511|Anesthetics|anesthetics|mesh-list
44144612|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
43981966|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981967|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981968|NCT02059070|Bupivacaine|bupivacaine|mesh-list
43981969|NCT02059070|Ropivacaine|ropivacaine|mesh-list
43981970|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981971|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
43981972|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981973|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981974|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
43981975|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981976|NCT02059213|Palbociclib|palbociclib|mesh-list
43981977|NCT02059213|Leuprolide|leuprolide|mesh-list
43981978|NCT02059213|Goserelin|goserelin|mesh-list
43981979|NCT02059213|Bicalutamide|bicalutamide|mesh-list
43981993|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43981994|NCT02059902|Lidocaine|lidocaine|mesh-list
43981995|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
43981996|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
43981997|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981998|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981999|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
43982000|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982001|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44022651|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44022652|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022653|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022654|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
44022655|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022656|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022657|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022658|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022659|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44022660|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022661|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
44022662|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022663|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44022664|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44022665|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44022666|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44022667|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
44022668|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982002|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43982003|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43982004|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982005|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982006|NCT02061384|Calcitriol|calcitriol|mesh-list
43982007|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43982008|NCT02061384|Tretinoin|tretinoin|mesh-list
43982009|NCT02061384|Isotretinoin|isotretinoin|mesh-list
43982010|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982011|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
43982012|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982013|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43982014|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982015|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43982016|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982017|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982018|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43982019|NCT02061384|Vitamins|vitamins|mesh-ancestor
43982020|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
43982021|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43982022|NCT02061397|Sirolimus|sirolimus|mesh-list
43982023|NCT02061397|Everolimus|everolimus|mesh-list
43982024|NCT02061397|Simvastatin|simvastatin|mesh-list
44243747|NCT05644743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243748|NCT05644743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243749|NCT05644743|Immunologic Factors|immunologic factors|mesh-ancestor
44243750|NCT05644743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243751|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
44243752|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44243753|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243754|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44243755|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243756|NCT05644691|Emollients|emollients|mesh-list
44243757|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44243758|NCT05644600|Nintedanib|nintedanib|mesh-list
44243759|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243760|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44243761|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243762|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982025|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982026|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982027|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
43982028|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982029|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982030|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982031|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43982032|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
43982033|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43982034|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43982035|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
43982036|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982037|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43982038|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43982039|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982056|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43982057|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
43982058|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982059|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982060|NCT02062177|Midazolam|midazolam|mesh-list
43982061|NCT02062177|Propofol|propofol|mesh-list
43982062|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43982063|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982064|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982065|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43982066|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
43982067|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
43982068|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43982069|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44022724|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44022725|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022726|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022727|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022728|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44022729|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44022730|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
44022731|NCT01072526|Cyclosporine|cyclosporine|mesh-list
44022732|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
44022733|NCT01072526|Cyclosporins|cyclosporins|mesh-list
44022734|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022735|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022736|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022737|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
44022738|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022739|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
44022740|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022741|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022742|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022743|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44022744|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44022745|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44022747|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43645501|NCT03958045|Rucaparib|rucaparib|mesh-list
43645502|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43982070|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43982071|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982072|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
43982073|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
43982074|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982075|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982076|NCT02062359|Aldesleukin|aldesleukin|mesh-list
43982077|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
43982078|NCT02062359|Fludarabine|fludarabine|mesh-list
43982079|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982080|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
43982081|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982082|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243764|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44243765|NCT05644587|Naloxone|naloxone|mesh-list
44243766|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44243767|NCT05644587|Narcotics|narcotics|mesh-ancestor
44243768|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243769|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243770|NCT05644587|Analgesics|analgesics|mesh-ancestor
44243771|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
44243772|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243773|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43982083|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43982084|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
43982085|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982086|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982087|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43982088|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43982089|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43982090|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
43982091|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982092|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
43982093|NCT02062710|Promethazine|promethazine|mesh-list
43982094|NCT02062710|Phenylephrine|phenylephrine|mesh-list
43982095|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
43982096|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
43982097|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43982098|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
43982099|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
43982100|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982101|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982107|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43982108|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982109|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982110|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982111|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982112|NCT02062710|Protective Agents|protective agents|mesh-ancestor
43982113|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43982114|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43982115|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982116|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
43982117|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
43982118|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
43982119|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
43982120|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982121|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43982122|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
43982123|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
43982124|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43982125|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
43982126|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982127|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
43982128|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43982129|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43982130|NCT02062801|Ephedrine|ephedrine|mesh-list
43982131|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43982132|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982133|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
43982134|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
43982135|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982136|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43982137|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982138|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982139|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982140|NCT02062905|Dexamethasone|dexamethasone|mesh-list
44459597|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
44459598|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44459599|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459600|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459601|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44459602|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44459603|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43982141|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982142|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
43982143|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
43982144|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982145|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982146|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982147|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
43982148|NCT02062905|Hormones|hormones|mesh-ancestor
43982149|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982150|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43718436|NCT02642874|Antacids|antacids|mesh-ancestor
43982151|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982152|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
43982153|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43982154|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982155|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982156|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
43982157|NCT02063035|Coagulants|coagulants|mesh-ancestor
43982158|NCT02064582|Leuprolide|leuprolide|mesh-list
43982159|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43982160|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
43982161|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645503|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645504|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645505|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982162|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982163|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43982164|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982165|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
43982166|NCT02064907|Lansoprazole|lansoprazole|mesh-list
43982167|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43982168|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982169|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43982170|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982171|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982172|NCT02064985|Ticagrelor|ticagrelor|mesh-list
43982173|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43982174|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43982175|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43982176|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43982177|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
43982178|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982179|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982180|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982181|NCT02065479|Ticagrelor|ticagrelor|mesh-list
43982182|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43982183|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43982184|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43982185|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43982186|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43982187|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
43982188|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982189|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022844|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022845|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022846|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44022847|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44022848|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022849|NCT01009931|Dexamethasone|dexamethasone|mesh-list
44022850|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
44022851|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
44022852|NCT01009931|Choline|choline|mesh-list
44022853|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44022854|NCT01009931|BB 1101|bb 1101|mesh-list
44022855|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022856|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
44022857|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
43982190|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982191|NCT02065687|Metformin|metformin|mesh-list
43982192|NCT02065687|Paclitaxel|paclitaxel|mesh-list
43982193|NCT02065687|Carboplatin|carboplatin|mesh-list
44459604|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44459605|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44459606|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43982194|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43982195|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43982196|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982197|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
43982198|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43982199|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
43982200|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982201|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43982202|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982203|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
43982204|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43982205|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982206|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982207|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022873|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
44022874|NCT01009931|Analgesics|analgesics|mesh-ancestor
44022875|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
44022876|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44022877|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022878|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022879|NCT01006018|Pioglitazone|pioglitazone|mesh-list
44022880|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44022881|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44022882|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022883|NCT01006018|Incretins|incretins|mesh-ancestor
44022884|NCT01006018|Hormones|hormones|mesh-ancestor
44022885|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022886|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44022887|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
44022888|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022889|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022890|NCT00996502|Prednisone|prednisone|mesh-list
44022891|NCT00996502|Bevacizumab|bevacizumab|mesh-list
44022892|NCT00996502|Docetaxel|docetaxel|mesh-list
44022893|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44022894|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44022895|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982209|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
43982210|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982211|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43982212|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43982213|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982214|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982215|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022896|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43645506|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43645507|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645508|NCT03954990|Metronidazole|metronidazole|mesh-list
43645509|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982216|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982217|NCT02066792|Cycloserine|cycloserine|mesh-list
43982218|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43982219|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982220|NCT02066792|Renal Agents|renal agents|mesh-ancestor
43982221|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43982222|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
43982223|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982224|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
43982225|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022897|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43645510|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645511|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43645512|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43645513|NCT03949478|Ibuprofen|ibuprofen|mesh-list
43645514|NCT03949478|Nifedipine|nifedipine|mesh-list
43645515|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982226|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
43982227|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
43982228|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
43982229|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982230|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982231|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
43982232|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982233|NCT02068027|Clonidine|clonidine|mesh-list
43982234|NCT02068027|Analgesics|analgesics|mesh-ancestor
43982235|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
43982236|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982237|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982238|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43982239|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
43982240|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
43982241|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43982242|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43982243|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982244|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982248|NCT02068157|Trioxsalen|trioxsalen|mesh-list
43982249|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982250|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982251|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43982252|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
43982253|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
43982254|NCT02068820|Protective Agents|protective agents|mesh-ancestor
44022899|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022900|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
44022901|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
44022902|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
44022903|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
44022904|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022905|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022906|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
44022907|NCT00996502|Hormones|hormones|mesh-ancestor
44022908|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022909|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022910|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44022911|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022912|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44022913|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44022914|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022915|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
44022916|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982255|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982256|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
43982257|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982258|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982259|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43982260|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43982261|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022923|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022924|NCT00986947|Rituximab|rituximab|mesh-list
44022925|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44022926|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645516|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43645517|NCT03949478|Analgesics|analgesics|mesh-ancestor
43645518|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
43644698|NCT04446039|Fluoxetine|fluoxetine|mesh-list
43644699|NCT04446039|Paroxetine|paroxetine|mesh-list
43645519|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645520|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645521|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645522|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645523|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43645524|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645525|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022927|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
43982262|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982263|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982264|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44459607|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
44459608|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44459609|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44022928|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022929|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022930|NCT00982995|Palonosetron|palonosetron|mesh-list
44022931|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
44022932|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
44022933|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645528|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43645529|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
44459610|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44459611|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
43982265|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43982266|NCT02069041|Leucovorin|leucovorin|mesh-list
43982267|NCT02069041|Fluorouracil|fluorouracil|mesh-list
43982268|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
43982269|NCT02069041|Ramucirumab|ramucirumab|mesh-list
43982270|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
43982271|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982272|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43982273|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982274|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982275|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
43982276|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982277|NCT02069041|Antidotes|antidotes|mesh-ancestor
43982278|NCT02069041|Protective Agents|protective agents|mesh-ancestor
43982279|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
43982280|NCT02069041|Vitamins|vitamins|mesh-ancestor
43982281|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
44144613|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44144614|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44144615|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44144616|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44144617|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44144618|NCT00192634|Tenofovir|tenofovir|mesh-list
44144619|NCT00192634|Lamivudine|lamivudine|mesh-list
44144620|NCT00192634|Emtricitabine|emtricitabine|mesh-list
44144621|NCT00192634|Abacavir|abacavir|mesh-list
44144622|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
44144623|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144624|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44144625|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144626|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144627|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144628|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44144629|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44144630|NCT00192660|Ritonavir|ritonavir|mesh-list
44144631|NCT00192660|Nelfinavir|nelfinavir|mesh-list
44144632|NCT00192660|Indinavir|indinavir|mesh-list
44144633|NCT00192660|Saquinavir|saquinavir|mesh-list
44144634|NCT00192660|Amprenavir|amprenavir|mesh-list
44144635|NCT00192660|Tenofovir|tenofovir|mesh-list
44144636|NCT00192660|Lamivudine|lamivudine|mesh-list
44144637|NCT00192660|Zidovudine|zidovudine|mesh-list
44144638|NCT00192660|Nevirapine|nevirapine|mesh-list
44144639|NCT00192660|Abacavir|abacavir|mesh-list
44144640|NCT00192660|Didanosine|didanosine|mesh-list
44144641|NCT00192660|Stavudine|stavudine|mesh-list
44144642|NCT00192660|Tipranavir|tipranavir|mesh-list
44144643|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
44144644|NCT00192660|Efavirenz|efavirenz|mesh-list
44144645|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44144646|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44144647|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
44144648|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144649|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144650|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44144651|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44144652|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
44144665|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
44148629|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144666|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44144667|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44144668|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44144669|NCT00192673|Asparaginase|asparaginase|mesh-list
44144670|NCT00192673|Pegaspargase|pegaspargase|mesh-list
44144671|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144672|NCT00192712|Gemcitabine|gemcitabine|mesh-list
44144673|NCT00192712|Irinotecan|irinotecan|mesh-list
44144674|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144675|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
44144676|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459612|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148630|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44148631|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44148632|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44148633|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645530|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
44459614|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44459615|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
44459616|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459617|NCT01576406|Crizotinib|crizotinib|mesh-list
44459618|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459619|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459620|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459621|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459622|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
44459623|NCT01576341|Hematinics|hematinics|mesh-ancestor
43645531|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823972|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823973|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43823974|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44459624|NCT01576172|Prednisone|prednisone|mesh-list
44459625|NCT01576172|Cortisone|cortisone|mesh-list
44459626|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
44459627|NCT01576172|Veliparib|veliparib|mesh-list
44459628|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459629|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
44459630|NCT01576172|Hormones|hormones|mesh-ancestor
44459631|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982282|NCT02069184|Acetaminophen|acetaminophen|mesh-list
43982283|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982284|NCT02069184|Analgesics|analgesics|mesh-ancestor
44148634|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44148635|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148636|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148637|NCT00204893|Calcium|calcium|mesh-list
44148638|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44148639|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148640|NCT00204906|Vitamin D|vitamin d|mesh-list
44148641|NCT00204906|Vitamins|vitamins|mesh-ancestor
44148642|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
44148643|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823975|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823976|NCT05517174|Vaccines|vaccines|mesh-list
43982285|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
43982286|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982287|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982288|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
43982289|NCT02069704|Leucovorin|leucovorin|mesh-list
43982290|NCT02069704|Folic Acid|folic acid|mesh-list
43982291|NCT02069704|Bevacizumab|bevacizumab|mesh-list
43982292|NCT02069704|Fluorouracil|fluorouracil|mesh-list
43982293|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
43982294|NCT02069704|Irinotecan|irinotecan|mesh-list
43982295|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
43982296|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871157|NCT02641782|Tretinoin|tretinoin|mesh-list
43982298|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43982299|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43982300|NCT02069704|Growth Substances|growth substances|mesh-ancestor
44148644|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44148645|NCT00204919|Vitamin D|vitamin d|mesh-list
44148646|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
44148647|NCT00204919|Vitamins|vitamins|mesh-ancestor
44148648|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
44148649|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148650|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44148651|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157813|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44157814|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44157815|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
44157816|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157817|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
44157818|NCT00235261|Dexamethasone|dexamethasone|mesh-list
44157819|NCT00235261|Pregabalin|pregabalin|mesh-list
43823977|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
43823978|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823979|NCT05517122|Niacinamide|niacinamide|mesh-list
44157820|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982301|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982302|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
43982303|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
43982304|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982305|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43982306|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982307|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
43982308|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43982309|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43982310|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982311|NCT02069704|Antidotes|antidotes|mesh-ancestor
43982312|NCT02069704|Protective Agents|protective agents|mesh-ancestor
43982313|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
43982314|NCT02069704|Vitamins|vitamins|mesh-ancestor
43982315|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
43982316|NCT02069704|Hematinics|hematinics|mesh-ancestor
43982317|NCT02069847|Budesonide|budesonide|mesh-list
43982318|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459632|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157821|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
44157822|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
43753385|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157823|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157824|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157825|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44157826|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
44157827|NCT00235261|Hormones|hormones|mesh-ancestor
44157828|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157829|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44157830|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157831|NCT00235261|Analgesics|analgesics|mesh-ancestor
44157832|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
44157833|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
44157834|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157835|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157836|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459633|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459634|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982319|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43982320|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
43982323|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43982324|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
43982326|NCT02069847|Hormones|hormones|mesh-ancestor
43982327|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982328|NCT02070237|Enoxaparin|enoxaparin|mesh-list
43982329|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
43982330|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43982331|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982332|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982333|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
43982334|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43982335|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43982336|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43982337|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982338|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982339|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
43982340|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982341|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982342|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43982343|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982344|NCT02070692|Tamoxifen|tamoxifen|mesh-list
43982345|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43982346|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
43982347|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982348|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982349|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43982350|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982351|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43982352|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43982353|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43982354|NCT02071095|Poly I-C|poly i-c|mesh-list
43982355|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43982356|NCT02071095|Poly ICLC|poly iclc|mesh-list
43982357|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
43982358|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
43982359|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982360|NCT02071095|Laxatives|laxatives|mesh-ancestor
43982361|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982362|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
43982363|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982364|NCT02071810|Opicapone|opicapone|mesh-list
43982365|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43982366|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982367|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982368|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43982369|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43982370|NCT02071823|Opicapone|opicapone|mesh-list
43982371|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43982372|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982373|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982374|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43982375|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43982376|NCT02072200|Prednisone|prednisone|mesh-list
43982377|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982378|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
43982379|NCT02072200|Hormones|hormones|mesh-ancestor
43982380|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982381|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982382|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43982383|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982384|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
43982385|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43982386|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43982387|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43982388|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459635|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44459636|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243774|NCT05644561|Ravulizumab|ravulizumab|mesh-list
44243775|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43982389|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982390|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
43982399|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982400|NCT02073448|Analgesics|analgesics|mesh-ancestor
43982401|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
43982402|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982403|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023040|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
44023041|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43823981|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
43823982|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
43823983|NCT05517122|Vitamins|vitamins|mesh-ancestor
43823984|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
43823985|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645532|NCT03943888|Atropine|atropine|mesh-list
43645533|NCT03943888|Neostigmine|neostigmine|mesh-list
43982404|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982405|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982406|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43982407|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982408|NCT02073487|Paclitaxel|paclitaxel|mesh-list
43982409|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43982410|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43982411|NCT02073487|Trastuzumab|trastuzumab|mesh-list
43982412|NCT02073487|Lapatinib|lapatinib|mesh-list
43982413|NCT02073487|Pertuzumab|pertuzumab|mesh-list
43982414|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43982415|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982416|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
43982417|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
43982418|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
43982419|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982420|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43982421|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43982422|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982423|NCT02073747|Albuterol|albuterol|mesh-list
43982424|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43982425|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
43982426|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982427|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982428|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43982429|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
43982430|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
43982431|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43982432|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43982433|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43982434|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982435|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982436|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982437|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982438|NCT02074358|Apixaban|apixaban|mesh-list
43982439|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43982440|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
43982441|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43982442|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
43982443|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871158|NCT02641782|Dinutuximab|dinutuximab|mesh-list
43982444|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982445|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
43982446|NCT02074709|Bupivacaine|bupivacaine|mesh-list
43982447|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
43982448|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
43982449|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982450|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982451|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
43982452|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982453|NCT02074735|Choline|choline|mesh-list
43982454|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43982455|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
43982456|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43982457|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
43982460|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43982461|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
43982462|NCT02075125|Ticagrelor|ticagrelor|mesh-list
43982463|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43982464|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43982465|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44243776|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44243777|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
44243778|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243779|NCT05644496|Meloxicam|meloxicam|mesh-list
44243780|NCT05644496|Bupivacaine|bupivacaine|mesh-list
44243781|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
44243782|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
44023096|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44023097|NCT00932152|Bevacizumab|bevacizumab|mesh-list
44023098|NCT00932152|Fulvestrant|fulvestrant|mesh-list
44023099|NCT00932152|Anastrozole|anastrozole|mesh-list
44023100|NCT00932152|Analgesics|analgesics|mesh-list
44023101|NCT00932152|Antiemetics|antiemetics|mesh-list
44023102|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023103|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023104|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023105|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023106|NCT00932152|Growth Substances|growth substances|mesh-ancestor
44023107|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023108|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
43645534|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43645535|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43645536|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44243783|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982466|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43982467|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43982468|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
43982469|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982470|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982471|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982472|NCT02076100|Ruzasvir|ruzasvir|mesh-list
44023109|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645537|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
43645538|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982473|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
43982474|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982475|NCT02076152|Bevacizumab|bevacizumab|mesh-list
43982476|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43982477|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982478|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43982479|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43982480|NCT02076152|Growth Substances|growth substances|mesh-ancestor
44023110|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645539|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645540|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43645541|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
43645542|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
43645543|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
43645544|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43645545|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43645546|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
43645547|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645548|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645549|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43645550|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645551|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43645552|NCT03939897|Fulvestrant|fulvestrant|mesh-list
43645553|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645554|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645555|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43645556|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43645557|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
43645558|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645559|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645560|NCT03934372|Ponatinib|ponatinib|mesh-list
43645561|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645562|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645563|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645567|NCT03932136|Protective Agents|protective agents|mesh-ancestor
43645568|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982481|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982482|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
43982483|NCT02076243|Paclitaxel|paclitaxel|mesh-list
43982484|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43982485|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982486|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
43982487|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
43982488|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
43982489|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982490|NCT02076321|Acetaminophen|acetaminophen|mesh-list
43982491|NCT02076321|Ibuprofen|ibuprofen|mesh-list
43982492|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982493|NCT02076321|Analgesics|analgesics|mesh-ancestor
43982494|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
43982495|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982496|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982497|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
43982498|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982499|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982500|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982501|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43982502|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982503|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982504|NCT02076919|Acrizanib|acrizanib|mesh-list
43982505|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43982506|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43982507|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43982508|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982509|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982510|NCT02076997|Methotrexate|methotrexate|mesh-list
43982511|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43982512|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
43982513|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44023111|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44023112|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44023113|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
44023114|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023124|NCT00924807|Leuprolide|leuprolide|mesh-list
43982514|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982515|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43982516|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
43982517|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982518|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982519|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982520|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982521|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43982522|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982523|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
43982524|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243784|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243785|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
44243786|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243787|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44243788|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243790|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243791|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243792|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44243793|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243794|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982525|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43982526|NCT02078180|Bupropion|bupropion|mesh-list
43982527|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43982528|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
43982531|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43982532|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982533|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982534|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
43982535|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023146|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44023147|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023148|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023149|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023150|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023151|NCT00904423|Vitamin D|vitamin d|mesh-list
44023152|NCT00904423|Vitamins|vitamins|mesh-ancestor
44023153|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
44023156|NCT00903396|Palonosetron|palonosetron|mesh-list
43982536|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982537|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43982538|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43982539|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982540|NCT02078193|Abatacept|abatacept|mesh-list
43982541|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43982542|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982543|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982544|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982545|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
43982546|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982547|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982548|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43982549|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43982550|NCT02078284|Protective Agents|protective agents|mesh-ancestor
43982551|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982552|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43982553|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
43982554|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982555|NCT02078492|Ketorolac|ketorolac|mesh-list
43982556|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43982557|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982558|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982559|NCT02078492|Analgesics|analgesics|mesh-ancestor
43982560|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
43982561|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023179|NCT00875394|Metformin|metformin|mesh-list
44023180|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44023181|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44023182|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023183|NCT00875394|Incretins|incretins|mesh-ancestor
44023184|NCT00875394|Hormones|hormones|mesh-ancestor
44023185|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023186|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44023187|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44023188|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023189|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023190|NCT00879619|Prednisone|prednisone|mesh-list
44023191|NCT00879619|Cortisone|cortisone|mesh-list
44023192|NCT00879619|Docetaxel|docetaxel|mesh-list
44023193|NCT00879619|Sunitinib|sunitinib|mesh-list
44023194|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023195|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
44023196|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
44023197|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
44023198|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023199|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982562|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982563|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982564|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982565|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43982566|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982567|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982568|NCT02078726|Glucagon|glucagon|mesh-list
43982569|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982570|NCT02078726|Hormones|hormones|mesh-ancestor
43982571|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982572|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982573|NCT02078882|Abatacept|abatacept|mesh-list
43982574|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44023206|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023207|NCT00879619|Growth Substances|growth substances|mesh-ancestor
44023208|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023209|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44023210|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023211|NCT00869414|Insulin|insulin|mesh-list
44023212|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44023213|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
44023214|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44023215|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023216|NCT00843986|Conivaptan|conivaptan|mesh-list
44023217|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44023218|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023219|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
44023220|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982575|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982576|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243795|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243796|NCT05644483|Propofol|propofol|mesh-list
44243797|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44243798|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44243799|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243800|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44243801|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
44243802|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
44243803|NCT05644301|Minocycline|minocycline|mesh-list
44243804|NCT05644301|Celecoxib|celecoxib|mesh-list
44243805|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44243806|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243807|NCT05644301|Analgesics|analgesics|mesh-ancestor
44243808|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
44243809|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982577|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982578|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
43982579|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982580|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982581|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
43982582|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
43982583|NCT02080195|Fludarabine|fludarabine|mesh-list
43982584|NCT02080195|Tacrolimus|tacrolimus|mesh-list
43982585|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
43982586|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43982587|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982588|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
43982589|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982590|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982591|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43982592|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
43982593|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982594|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982595|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43982596|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43982597|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982598|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43982599|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43982607|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982608|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43982609|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982610|NCT02080455|Atorvastatin|atorvastatin|mesh-list
43982611|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43982612|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43982613|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
43982614|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982615|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43982616|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43982617|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982618|NCT02080468|Norgestimate|norgestimate|mesh-list
44023267|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023268|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44023269|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
43982619|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43982620|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
43982621|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43982622|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982623|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43982624|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43982625|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43982626|NCT02080637|Ambrisentan|ambrisentan|mesh-list
43982627|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43982628|NCT02080780|Clarithromycin|clarithromycin|mesh-list
43982629|NCT02080780|Diltiazem|diltiazem|mesh-list
44243810|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243811|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243812|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023270|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
44023271|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645569|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645570|NCT03929029|Nivolumab|nivolumab|mesh-list
43645571|NCT03929029|Ipilimumab|ipilimumab|mesh-list
43645572|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43645573|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644703|NCT04446039|Tianeptine|tianeptine|mesh-list
44243813|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44243814|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243815|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243816|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243817|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243818|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243819|NCT05644210|Aspirin|aspirin|mesh-list
44023272|NCT00832520|Mirtazapine|mirtazapine|mesh-list
44023273|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023274|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023275|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44023276|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
44023277|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
44023278|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645574|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645575|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645576|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645577|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43645578|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
43645581|NCT03924323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44243820|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
44243821|NCT05644210|Prednisone|prednisone|mesh-list
44243822|NCT05644210|Rituximab|rituximab|mesh-list
44243823|NCT05644210|Warfarin|warfarin|mesh-list
44243824|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243825|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982630|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982631|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982632|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43982633|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982634|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982635|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43982636|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43982637|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43982638|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43982639|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982640|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43982641|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982642|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
43982643|NCT02080819|Levodopa|levodopa|mesh-list
43982644|NCT02080819|Carbidopa|carbidopa|mesh-list
43982645|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43982646|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43982647|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
43982648|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982649|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982650|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982651|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43982652|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982653|NCT02081014|Glucagon|glucagon|mesh-list
43982654|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43982655|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982657|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982658|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982659|NCT02081014|Incretins|incretins|mesh-ancestor
43982660|NCT02081443|Ticagrelor|ticagrelor|mesh-list
43982661|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43982662|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43982663|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43982664|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43982665|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
43982666|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982667|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982668|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982675|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023281|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43982676|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982677|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243826|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
44243827|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243828|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243829|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243830|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
44243831|NCT05644210|Hormones|hormones|mesh-ancestor
44243832|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44243833|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43982678|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982679|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43982680|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982681|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982682|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43982683|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43982684|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982685|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
43982686|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43982687|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43982688|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
43982689|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43982690|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43982691|NCT02081950|Enoxaparin|enoxaparin|mesh-list
43982692|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
43982693|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
43982694|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43982695|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982696|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982697|NCT02081963|Amikacin|amikacin|mesh-list
43982698|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982699|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023328|NCT00836355|Enoxaparin|enoxaparin|mesh-list
44023329|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
44023330|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44023331|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44023332|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023333|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44023334|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023335|NCT00816777|Irinotecan|irinotecan|mesh-list
43982700|NCT02082392|Citalopram|citalopram|mesh-list
43982701|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43982702|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43982703|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982704|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982705|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982706|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
43982707|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982708|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43982709|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
43982710|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982711|NCT02082678|Ondansetron|ondansetron|mesh-list
43982712|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
43982713|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
43982714|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982715|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982716|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982717|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
43982718|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982719|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43982720|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
44023362|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023364|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44023365|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023366|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023367|NCT00809458|Vitamin E|vitamin e|mesh-list
44023368|NCT00809458|Tocopherols|tocopherols|mesh-list
44023369|NCT00809458|Tocotrienols|tocotrienols|mesh-list
44023370|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
44023371|NCT00809458|Vitamins|vitamins|mesh-ancestor
44023372|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
44023373|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023374|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
44023375|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023376|NCT00809458|Protective Agents|protective agents|mesh-ancestor
44023377|NCT00803283|Morphine|morphine|mesh-list
44023378|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44023379|NCT00803283|Narcotics|narcotics|mesh-ancestor
44023380|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023381|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023382|NCT00803283|Analgesics|analgesics|mesh-ancestor
44023383|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
44023384|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645582|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43982721|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982722|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982723|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43982724|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43982725|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982726|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982727|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43982728|NCT02082769|Allopurinol|allopurinol|mesh-list
43982729|NCT02082769|Febuxostat|febuxostat|mesh-list
43982731|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982732|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982733|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
43982734|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023385|NCT00811590|Everolimus|everolimus|mesh-list
44023386|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023387|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645583|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645584|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645585|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645586|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
43645587|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645588|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43982735|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43982736|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
43982737|NCT02082769|Protective Agents|protective agents|mesh-ancestor
44243835|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243836|NCT05644210|Analgesics|analgesics|mesh-ancestor
44243837|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
44243838|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243839|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44243840|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982738|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982739|NCT02083107|Misoprostol|misoprostol|mesh-list
43982754|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43982755|NCT02083679|Cisplatin|cisplatin|mesh-list
43982756|NCT02083679|Carboplatin|carboplatin|mesh-list
43982757|NCT02083679|Pemetrexed|pemetrexed|mesh-list
43982758|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43982759|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43982760|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982761|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
43982762|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
43982763|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
43982764|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982765|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43982766|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
43982767|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
43982768|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982769|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982770|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982771|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
43982772|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982773|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43982774|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43982775|NCT02083809|Oxytocin|oxytocin|mesh-list
43982776|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
43982777|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43982778|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982779|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
43982780|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43982781|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982782|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982783|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982784|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982785|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982786|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
43982787|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
43982788|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982789|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
43982790|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43982791|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
43982792|NCT02084069|Atorvastatin|atorvastatin|mesh-list
43982793|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43982794|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43982795|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
43982796|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982797|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43982798|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43982799|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982800|NCT02084511|Celecoxib|celecoxib|mesh-list
43982801|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982802|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982803|NCT02084511|Analgesics|analgesics|mesh-ancestor
43982804|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
43982811|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982812|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982813|NCT02084706|Triamcinolone|triamcinolone|mesh-list
43982814|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43982815|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43982816|NCT02084706|Lidocaine|lidocaine|mesh-list
44243841|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243842|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44243843|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243844|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243845|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
44243846|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
44243847|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
44243848|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44243849|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43982817|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43982818|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
43982819|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
43982820|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982821|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645589|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
43645590|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43645592|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43645593|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645594|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
43645595|NCT03918850|Buprenorphine|buprenorphine|mesh-list
43645596|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43645597|NCT03918850|Narcotics|narcotics|mesh-ancestor
43645598|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645599|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645600|NCT03918850|Analgesics|analgesics|mesh-ancestor
43645601|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
43645602|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645603|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43645604|NCT03911739|Buprenorphine|buprenorphine|mesh-list
43645605|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43702660|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43982822|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
43982823|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982824|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43982825|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43982826|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43982827|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43982828|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982829|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982830|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
43982831|NCT02084706|Hormones|hormones|mesh-ancestor
43982832|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982833|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43982834|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
43982835|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982836|NCT02084797|Tolvaptan|tolvaptan|mesh-list
43982837|NCT02084797|Vasopressins|vasopressins|mesh-list
43982838|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
43982839|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43982840|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982841|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
43982842|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982843|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
43982844|NCT02084797|Coagulants|coagulants|mesh-ancestor
43982845|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43982846|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43982847|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
43982848|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43982849|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982850|NCT02085447|Haloperidol|haloperidol|mesh-list
43982851|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43982852|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
43982853|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
43982854|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43982855|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982856|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023461|NCT00790478|Melatonin|melatonin|mesh-list
43645607|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645608|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645609|NCT03911739|Analgesics|analgesics|mesh-ancestor
43645610|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
43645611|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645612|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43645613|NCT03911557|Durvalumab|durvalumab|mesh-list
43645614|NCT03911557|Tremelimumab|tremelimumab|mesh-list
43982857|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982858|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43982859|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43982860|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
43982861|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982862|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982863|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43982864|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43982865|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
44023491|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44023492|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645627|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645628|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645629|NCT03887936|Testosterone|testosterone|mesh-list
43645630|NCT03887936|Androgens|androgens|mesh-ancestor
43645631|NCT03887936|Hormones|hormones|mesh-ancestor
43645632|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645633|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645635|NCT03880019|Olaparib|olaparib|mesh-list
43645636|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43645637|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645638|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
43645641|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982866|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
43982867|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
43982868|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982869|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982870|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43982871|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
43982872|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44243851|NCT05644184|Vaccines|vaccines|mesh-list
44023493|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023494|NCT00771602|Rituximab|rituximab|mesh-list
44023495|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
44023496|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645656|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
43645657|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645658|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645659|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645660|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645661|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43645662|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43645663|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43645664|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645665|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
43645666|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43645667|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645668|NCT03842085|Antibodies|antibodies|mesh-list
43645669|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645670|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43645671|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
43645672|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645673|NCT03835533|Nivolumab|nivolumab|mesh-list
43645674|NCT03835533|Poly ICLC|poly iclc|mesh-list
43645675|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645676|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645677|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645678|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645679|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
43645680|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
44243852|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
44243853|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243854|NCT05643820|Ivermectin|ivermectin|mesh-list
44243855|NCT05643820|Permethrin|permethrin|mesh-list
44243856|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44243857|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243858|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982878|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43982880|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982881|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982882|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982883|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43982884|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023497|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023498|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
44023499|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023500|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023502|NCT00780455|Interferon-beta|interferon-beta|mesh-list
44023503|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
44023504|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023505|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
44023506|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023507|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
44023508|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023509|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44023510|NCT00780481|Bradykinin|bradykinin|mesh-list
44023511|NCT00780481|Kininogens|kininogens|mesh-list
44023512|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
43645681|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645682|NCT03829410|Bevacizumab|bevacizumab|mesh-list
43645683|NCT03829410|Onvansertib|onvansertib|mesh-list
43645684|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645685|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645686|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43645687|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43645688|NCT03829410|Growth Substances|growth substances|mesh-ancestor
43645689|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645690|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
43645691|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645692|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982885|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982886|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982887|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43982888|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
43982889|NCT02087306|Brincidofovir|brincidofovir|mesh-list
43982890|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
43982891|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982892|NCT02087748|Diclofenac|diclofenac|mesh-list
43982893|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982894|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982895|NCT02087748|Analgesics|analgesics|mesh-ancestor
43982896|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
43982897|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982898|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982899|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982900|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023513|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44023514|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44023515|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645702|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645703|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645704|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645705|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
43645706|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645707|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645708|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645709|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645710|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43982901|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43982902|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982903|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982904|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
43982905|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43982906|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
43982907|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982908|NCT02088216|Expectorants|expectorants|mesh-ancestor
44023516|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023517|NCT00755261|Bevacizumab|bevacizumab|mesh-list
44023518|NCT00755261|Doxorubicin|doxorubicin|mesh-list
44023519|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023520|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645743|NCT03789604|Antibodies|antibodies|mesh-list
43645744|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645745|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
43645746|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645747|NCT03787264|Venetoclax|venetoclax|mesh-list
43645748|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43645749|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
43645750|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
43645751|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645752|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645753|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
43645754|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645755|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645756|NCT03784599|Trastuzumab|trastuzumab|mesh-list
43645757|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43645758|NCT03784599|Osimertinib|osimertinib|mesh-list
43645759|NCT03784599|Maytansine|maytansine|mesh-list
43645760|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645761|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645762|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645763|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645764|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645765|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43645766|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
43645767|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645768|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645769|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
43645770|NCT03781934|Lenvatinib|lenvatinib|mesh-list
43645771|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645772|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645773|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645774|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645775|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645776|NCT03781700|Prednisolone|prednisolone|mesh-list
43645777|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645778|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
43645780|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982909|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
43982910|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43982911|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
43982912|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982913|NCT02088216|Protective Agents|protective agents|mesh-ancestor
43982914|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982915|NCT02088216|Antidotes|antidotes|mesh-ancestor
43982916|NCT02089113|Dexamethasone|dexamethasone|mesh-list
43982917|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982918|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
43982919|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
43982920|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982921|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982922|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982923|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
43982924|NCT02089113|Hormones|hormones|mesh-ancestor
43982925|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982926|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43982927|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982928|NCT02090075|Warfarin|warfarin|mesh-list
43982929|NCT02090075|Apixaban|apixaban|mesh-list
44023521|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023522|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023523|NCT00755261|Growth Substances|growth substances|mesh-ancestor
44023524|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023525|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023526|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44023527|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44023528|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44023529|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023530|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023531|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
44023532|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
44023533|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44023534|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44023535|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023536|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023537|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023538|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023539|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
44023540|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44023541|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43645781|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645782|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645783|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645784|NCT03780127|Fenfluramine|fenfluramine|mesh-list
43645785|NCT03780127|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43982930|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
43982931|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43982932|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
43982933|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43982934|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
43982935|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982936|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982937|NCT02090374|Vitamin D|vitamin d|mesh-list
44243860|NCT05643677|Irinotecan|irinotecan|mesh-list
44023542|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023543|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023544|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023545|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023546|NCT00759577|Urological Agents|urological agents|mesh-ancestor
44023547|NCT00760461|Domperidone|domperidone|mesh-list
44023548|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
44023549|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
44023550|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645786|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43645787|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645788|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645789|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645790|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
43645791|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243861|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44243862|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44243863|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243864|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243865|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243866|NCT05643651|Aspirin|aspirin|mesh-list
44243867|NCT05643651|Vitamin K|vitamin k|mesh-list
44243868|NCT05643651|Warfarin|warfarin|mesh-list
44243869|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
44243870|NCT05643651|Clopidogrel|clopidogrel|mesh-list
44243871|NCT05643651|Vitamins|vitamins|mesh-ancestor
44243872|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
43982943|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
43982944|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
43982945|NCT02091882|Aripiprazole|aripiprazole|mesh-list
43982946|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
43982947|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982948|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43982949|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43982950|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43982951|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982952|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
43982953|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
43982954|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982955|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982956|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43982957|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43982958|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
44023551|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023552|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44023553|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44023554|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
44023555|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023556|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023557|NCT00749658|Bupropion|bupropion|mesh-list
44023558|NCT00749658|Varenicline|varenicline|mesh-list
44023559|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44023560|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023561|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023562|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44023563|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023564|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023565|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982959|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43982960|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43982961|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43982962|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43982964|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43982965|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982966|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982967|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43982968|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43982969|NCT02092181|Mirabegron|mirabegron|mesh-list
44023577|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44023578|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023579|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023580|NCT00746239|Dexetimide|dexetimide|mesh-list
44023581|NCT00746239|Citalopram|citalopram|mesh-list
44023582|NCT00746239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44023583|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023584|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023585|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023586|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023587|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
43645796|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645797|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
43645798|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645799|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645800|NCT03758781|Nivolumab|nivolumab|mesh-list
43645801|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645802|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645803|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43982970|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43982971|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43982972|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43982973|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
43982974|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982975|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982976|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982977|NCT02092181|Urological Agents|urological agents|mesh-ancestor
43982978|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
43982979|NCT02092298|Cisplatin|cisplatin|mesh-list
43982980|NCT02092298|Mitomycins|mitomycins|mesh-list
43982981|NCT02092298|Mitomycin|mitomycin|mesh-list
43982982|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982983|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43982984|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
43982985|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982986|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43982987|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982988|NCT02092298|Antidotes|antidotes|mesh-ancestor
43982989|NCT02092298|Protective Agents|protective agents|mesh-ancestor
43844330|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
44243873|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243874|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44023588|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645804|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645805|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
43645806|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645807|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645809|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43645810|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
43645811|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243875|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44243876|NCT05643651|Analgesics|analgesics|mesh-ancestor
44243877|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
44243878|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243879|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44243880|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44243881|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44243882|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44243883|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982990|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982991|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
43982992|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
43982993|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982994|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982995|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
43982996|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
43982997|NCT02093962|Pemetrexed|pemetrexed|mesh-list
43982998|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43982999|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983000|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983001|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43983002|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43983003|NCT02094443|Ribavirin|ribavirin|mesh-list
43983004|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
43983005|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983006|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
44023589|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44023590|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023591|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023592|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44023593|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44023594|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
44023595|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
44023596|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023597|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44023598|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44023599|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023600|NCT00746603|Simvastatin|simvastatin|mesh-list
44023601|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44023602|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44023603|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
44023604|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023605|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44023606|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44023607|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023608|NCT00738972|Valsartan|valsartan|mesh-list
43983007|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983008|NCT02094534|Insulin|insulin|mesh-list
43983009|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983012|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43983014|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983015|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983016|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43983017|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44023617|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44023618|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023619|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44023620|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44023621|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44023622|NCT00731770|Fluticasone|fluticasone|mesh-list
44023624|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43645812|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645813|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43645814|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
43645815|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43645816|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
43645817|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645818|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645819|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43983018|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983019|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983020|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983021|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
43983022|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43983023|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43983024|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43983025|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43983026|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983027|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983028|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983029|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983030|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983031|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43983032|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983033|NCT02096107|Everolimus|everolimus|mesh-list
43983034|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983035|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983036|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
43983037|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983038|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
43983039|NCT02096458|Lansoprazole|lansoprazole|mesh-list
43983040|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43983041|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983042|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43983043|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023625|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44023626|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023627|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44023628|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
44023629|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023630|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023631|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44023632|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023633|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44023634|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44023635|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44023636|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44023637|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44023638|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
44023639|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023640|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023641|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
44023642|NCT00731770|Hormones|hormones|mesh-ancestor
44023643|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023644|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
43811575|NCT04842383|Peppermint oil|peppermint oil|mesh-list
44243884|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44243885|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44243887|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
43983044|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983045|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
43983046|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43983047|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
43983048|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
43983049|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983050|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983051|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983052|NCT02096575|Analgesics|analgesics|mesh-ancestor
43983053|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
43983054|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983055|NCT02096679|Osimertinib|osimertinib|mesh-list
43983056|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983057|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43983058|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983059|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983060|NCT02096718|Afatinib|afatinib|mesh-list
44023650|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023651|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023652|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023653|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023654|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44023655|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023657|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023658|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023659|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
44023661|NCT00728845|Bevacizumab|bevacizumab|mesh-list
44023662|NCT00728845|Carboplatin|carboplatin|mesh-list
44023663|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44023664|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023665|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44023666|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44023667|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44023668|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023669|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023670|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023671|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43645821|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
43645822|NCT03748082|Protective Agents|protective agents|mesh-ancestor
43645823|NCT03742986|Paclitaxel|paclitaxel|mesh-list
43645824|NCT03742986|Docetaxel|docetaxel|mesh-list
43645825|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43983061|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983062|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43983063|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983064|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983065|NCT02096861|Infliximab|infliximab|mesh-list
43983066|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983067|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983068|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983069|NCT02097303|Prednisone|prednisone|mesh-list
43983070|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
43983071|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43983072|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983073|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
43983074|NCT02097303|Hormones|hormones|mesh-ancestor
43983075|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43983076|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983077|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43983078|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983079|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43983080|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983081|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983084|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
43983085|NCT02097537|Miotics|miotics|mesh-ancestor
43983086|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
43983087|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983088|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983089|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43983090|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43983091|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
43983092|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43983093|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43983094|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983095|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983096|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983097|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
43983098|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43983099|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43983100|NCT02097732|Ipilimumab|ipilimumab|mesh-list
43983101|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983102|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983103|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43983104|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983105|NCT02097849|Interferons|interferons|mesh-list
43983106|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43983107|NCT02097849|Vaccines|vaccines|mesh-list
43983108|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43983109|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
43983110|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983111|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983112|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
44243888|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44243889|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44243890|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44243891|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
44243892|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243893|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
44243894|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44243895|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
44243896|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44243897|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
44243898|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44243899|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
44243900|NCT05643651|Coagulants|coagulants|mesh-ancestor
44243902|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44243903|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44243904|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44243905|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44243906|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44243907|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
44243908|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243909|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243910|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243911|NCT05643417|Bevacizumab|bevacizumab|mesh-list
44243912|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44243913|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243914|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44243915|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44243916|NCT05643417|Growth Substances|growth substances|mesh-ancestor
44243917|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983113|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983114|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983115|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983116|NCT02098993|Heparin|heparin|mesh-list
43983117|NCT02098993|Calcium heparin|calcium heparin|mesh-list
43983118|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
43983119|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43983120|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43983121|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983122|NCT02099006|Ketoprofen|ketoprofen|mesh-list
43983123|NCT02099006|Ketamine|ketamine|mesh-list
43983124|NCT02099006|Gabapentin|gabapentin|mesh-list
43983125|NCT02099006|Amitriptyline|amitriptyline|mesh-list
43983126|NCT02099006|Baclofen|baclofen|mesh-list
43983127|NCT02099006|Loperamide|loperamide|mesh-list
44243919|NCT05643170|Xanomeline|xanomeline|mesh-list
44243920|NCT05643170|Trospium chloride|trospium chloride|mesh-list
44243921|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
44243922|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
44243923|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243924|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243925|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44243926|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44243927|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983128|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
43983129|NCT02099006|Analgesics|analgesics|mesh-ancestor
43983130|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
43983131|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983132|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983133|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43983134|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43983135|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
43983136|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
43983137|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983138|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43983139|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43983140|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983141|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983142|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
43983143|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43983144|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43983145|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43983146|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
43983147|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43983148|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43983149|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43983150|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
43983151|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
43983152|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43983153|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983154|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983155|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983156|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43983160|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43983161|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43983162|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983163|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983164|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983165|NCT02099084|Teduglutide|teduglutide|mesh-list
43983166|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983167|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43983168|NCT02099084|Protective Agents|protective agents|mesh-ancestor
43983169|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983170|NCT02099461|Denosumab|denosumab|mesh-list
43983171|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43983172|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983173|NCT02100007|Topotecan|topotecan|mesh-list
43983174|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43983175|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43983176|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983177|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983178|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719243|NCT02637830|Fluorides|fluorides|mesh-list
43983180|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983181|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
43983182|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983183|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983184|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
44243929|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243930|NCT05643170|Urological Agents|urological agents|mesh-ancestor
44243931|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44243932|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44243933|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44243934|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44243935|NCT05642962|Pancrelipase|pancrelipase|mesh-list
44243936|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44243937|NCT05642923|Thiamine|thiamine|mesh-list
44243938|NCT05642923|Vitamins|vitamins|mesh-ancestor
44243939|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
43983185|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983186|NCT02100748|Morphine|morphine|mesh-list
43983187|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43983188|NCT02100748|Narcotics|narcotics|mesh-ancestor
43983189|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983190|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983191|NCT02100748|Analgesics|analgesics|mesh-ancestor
43983192|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
43983193|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983195|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43983196|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983197|NCT02100930|Molgramostim|molgramostim|mesh-list
43983198|NCT02100930|Isotretinoin|isotretinoin|mesh-list
43983199|NCT02100930|Antibodies|antibodies|mesh-list
43983200|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43983201|NCT02100930|Sargramostim|sargramostim|mesh-list
43983202|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
43983203|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983204|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983205|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983206|NCT02101008|Disulfiram|disulfiram|mesh-list
43983207|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43983208|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43983209|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983210|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983211|NCT02101190|Opicapone|opicapone|mesh-list
43983212|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44023766|NCT00676026|Progestins|progestins|mesh-ancestor
43983213|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983214|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983215|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43983216|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43983217|NCT02101918|Aflibercept|aflibercept|mesh-list
43983218|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
43983219|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43983220|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43983221|NCT02101918|Growth Substances|growth substances|mesh-ancestor
43983222|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983223|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
43983224|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983225|NCT02102100|Menthol|menthol|mesh-list
43983226|NCT02102100|Nicotine|nicotine|mesh-list
43983227|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43983228|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
43983229|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983230|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983237|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983238|NCT02102932|Metformin|metformin|mesh-list
43983239|NCT02102932|Empagliflozin|empagliflozin|mesh-list
43983240|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983241|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983242|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44106635|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44243940|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243941|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
44459637|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459638|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44459639|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459640|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44459641|NCT01576042|Amiodarone|amiodarone|mesh-list
44459642|NCT01576042|Sotalol|sotalol|mesh-list
44459643|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44459644|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
44459645|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44459646|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459647|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459648|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44459649|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44459650|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459651|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459652|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44459653|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44459654|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44459655|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44459656|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43983243|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983244|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
43983245|NCT02103114|Antithrombins|antithrombins|mesh-list
43983246|NCT02103114|Thrombin|thrombin|mesh-list
43983247|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
43983248|NCT02103114|Coagulants|coagulants|mesh-ancestor
43983249|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43983250|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
43983251|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983252|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983253|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
44144681|NCT00192712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144682|NCT00192712|Immunologic Factors|immunologic factors|mesh-ancestor
43983254|NCT02103855|Abatacept|abatacept|mesh-list
43983255|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43983256|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983257|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983258|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983259|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
43983260|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983261|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983262|NCT02104414|Epinephrine|epinephrine|mesh-list
43983263|NCT02104414|Bupivacaine|bupivacaine|mesh-list
43983264|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983265|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
43983266|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983267|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459658|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459659|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459660|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
44459661|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
44459662|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459663|NCT01575899|Amoxicillin|amoxicillin|mesh-list
44459664|NCT01575899|Clarithromycin|clarithromycin|mesh-list
44459665|NCT01575899|Levofloxacin|levofloxacin|mesh-list
44459666|NCT01575899|Ofloxacin|ofloxacin|mesh-list
44459667|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
44459668|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44459669|NCT01575899|Rabeprazole|rabeprazole|mesh-list
44459670|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43983268|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
43983269|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983270|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43983271|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43983272|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983273|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983274|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983275|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43983276|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43983277|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
43983278|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43983279|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
43983280|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
43983281|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
43983282|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43983283|NCT02104739|Exenatide|exenatide|mesh-list
43983284|NCT02104739|Saxagliptin|saxagliptin|mesh-list
43983285|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983286|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983287|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43983288|NCT02104739|Incretins|incretins|mesh-ancestor
43983289|NCT02104739|Hormones|hormones|mesh-ancestor
43983290|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43983291|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43983292|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
43983293|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983294|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983295|NCT02104830|Lenograstim|lenograstim|mesh-list
43983296|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43983297|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
43983298|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983300|NCT02105324|Pancreatin|pancreatin|mesh-list
43983301|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983302|NCT02105415|Ketamine|ketamine|mesh-list
43983303|NCT02105415|Propofol|propofol|mesh-list
43983304|NCT02105415|Etomidate|etomidate|mesh-list
43983305|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43983306|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983307|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983308|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43983309|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
43983310|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
43983311|NCT02105415|Analgesics|analgesics|mesh-ancestor
43983312|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
43983313|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983314|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43983315|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43983316|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43983317|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106636|NCT00076635|Interferons|interferons|mesh-list
44459671|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983318|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983319|NCT02105558|Anesthetics|anesthetics|mesh-list
43983320|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983321|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983322|NCT02106494|Dexamethasone|dexamethasone|mesh-list
43983323|NCT02106494|Ondansetron|ondansetron|mesh-list
43983324|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
43983325|NCT02106494|Aprepitant|aprepitant|mesh-list
43983326|NCT02106494|Granisetron|granisetron|mesh-list
43983327|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983328|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
43983329|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
43983330|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983331|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983332|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983333|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
43983334|NCT02106494|Hormones|hormones|mesh-ancestor
43983335|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43983336|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43983337|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983338|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
43983339|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983340|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43983341|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
43983342|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983343|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983344|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43983345|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43983346|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983347|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43983348|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43983349|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43983350|NCT02106962|Bacitracin|bacitracin|mesh-list
43983351|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
43983352|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43983353|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43983354|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983355|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
43983356|NCT02106962|Coagulants|coagulants|mesh-ancestor
43983357|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43983358|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983359|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43983360|NCT02107339|Methadone|methadone|mesh-list
43983361|NCT02107339|Hydromorphone|hydromorphone|mesh-list
43983362|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43983363|NCT02107339|Narcotics|narcotics|mesh-ancestor
43983364|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983365|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983366|NCT02107339|Analgesics|analgesics|mesh-ancestor
43983367|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
43983368|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983369|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
43983370|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
43983371|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
43983372|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43983373|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983374|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983377|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
43983378|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983379|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43983380|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43983381|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43983382|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983383|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983384|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983385|NCT02108288|Carteolol|carteolol|mesh-list
43983386|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43983387|NCT02108288|Latanoprost|latanoprost|mesh-list
43983388|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43983389|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44024029|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
44024030|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44024031|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44024032|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024033|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024034|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024035|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024036|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44024037|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44024038|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
44024039|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024040|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44024041|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
43645836|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645838|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
43645839|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983390|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43983391|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983392|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106637|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
44459672|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44459673|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459674|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459675|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44459676|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459677|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43983393|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983394|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983395|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43983396|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43983397|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
43983398|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
43983399|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983400|NCT02109640|Oxycodone|oxycodone|mesh-list
43983401|NCT02109640|Naloxone|naloxone|mesh-list
43983402|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43983403|NCT02109640|Narcotics|narcotics|mesh-ancestor
43983404|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983405|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983406|NCT02109640|Analgesics|analgesics|mesh-ancestor
43983407|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
43983408|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983409|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43983410|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
43983411|NCT02110264|Naltrexone|naltrexone|mesh-list
43983412|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43983413|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43983414|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983415|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
43983416|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983417|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
43983418|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43983419|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983420|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
43983421|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983422|NCT02111447|Propofol|propofol|mesh-list
43983423|NCT02111447|Sevoflurane|sevoflurane|mesh-list
43983424|NCT02111447|Isoflurane|isoflurane|mesh-list
43983425|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43983426|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983427|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983428|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43983429|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
44024056|NCT00625703|Linezolid|linezolid|mesh-list
43983430|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
43983431|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43983432|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43983433|NCT02111746|Bupivacaine|bupivacaine|mesh-list
43983434|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983435|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
43983436|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983437|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983438|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
43983439|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983440|NCT02111798|Bupropion|bupropion|mesh-list
43983441|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43983442|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
43983443|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43983444|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43983445|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43983446|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983447|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983448|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
43983451|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43983452|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43983453|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983454|NCT02111863|Aldesleukin|aldesleukin|mesh-list
43983455|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
43983456|NCT02111863|Fludarabine|fludarabine|mesh-list
44459679|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44459680|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43983457|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983458|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
43983459|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983460|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983461|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43983462|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
43983463|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983464|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983465|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43983466|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43983467|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43983468|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
43983469|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983470|NCT02112370|Epinephrine|epinephrine|mesh-list
43983471|NCT02112370|Racepinephrine|racepinephrine|mesh-list
43983472|NCT02112370|Ropivacaine|ropivacaine|mesh-list
43983473|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
43983474|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983475|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
43983476|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983477|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983478|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
43983479|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983480|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43983481|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44024093|NCT00610532|Renal Agents|renal agents|mesh-ancestor
43983482|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983483|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983484|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983485|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43983486|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43983487|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
43983488|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43983489|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
43983490|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
43983491|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
43983492|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43983493|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
43983494|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43983495|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983496|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983497|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983498|NCT02115048|Letrozole|letrozole|mesh-list
43983499|NCT02115048|Afatinib|afatinib|mesh-list
43983500|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983501|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43983502|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43983503|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983504|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983505|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43983506|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
43983507|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43983508|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983509|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43983510|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
43983511|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43983512|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983513|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983514|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983515|NCT02115581|Ubiquinone|ubiquinone|mesh-list
43983516|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
43983517|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
43983518|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983519|NCT02115581|Vitamins|vitamins|mesh-ancestor
43983520|NCT02115750|Etanercept|etanercept|mesh-list
43983524|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
43983525|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983526|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983527|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459681|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459682|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44459683|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44459684|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983528|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983529|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983530|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983531|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
43983532|NCT02117934|Vaccines|vaccines|mesh-list
43983533|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
44024147|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983534|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983535|NCT02118831|Bevacizumab|bevacizumab|mesh-list
43983536|NCT02118831|Ranibizumab|ranibizumab|mesh-list
43983537|NCT02118831|Aflibercept|aflibercept|mesh-list
43983538|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983539|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983540|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43983541|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43983542|NCT02118831|Growth Substances|growth substances|mesh-ancestor
43983543|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983544|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
43983545|NCT02120261|Triamcinolone|triamcinolone|mesh-list
43983546|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43983547|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43983548|NCT02120261|Lidocaine|lidocaine|mesh-list
43983549|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43983550|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983551|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
43983552|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983553|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983554|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
43983555|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983556|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43983557|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43983558|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43983559|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983560|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983561|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983562|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
43983563|NCT02120261|Hormones|hormones|mesh-ancestor
43983564|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024199|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024200|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
44024201|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024202|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44024203|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44024204|NCT00570258|Fulvestrant|fulvestrant|mesh-list
44024205|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024206|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024207|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024208|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024215|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
43983565|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983566|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
43983567|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983568|NCT02120287|Bevacizumab|bevacizumab|mesh-list
43983569|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983570|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983571|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43983572|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43983573|NCT02120287|Growth Substances|growth substances|mesh-ancestor
43983574|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983575|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
43983576|NCT02121041|Losartan|losartan|mesh-list
43983577|NCT02121041|Amlodipine|amlodipine|mesh-list
43983578|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
43983579|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43983580|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43983581|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983582|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983583|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43983584|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983585|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
43983586|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43983587|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43983588|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43983589|NCT02121041|Diuretics|diuretics|mesh-ancestor
43983590|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
43983591|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43983594|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
43983595|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44459685|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44459686|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44459688|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43739484|NCT00762554|Fentanyl|fentanyl|mesh-list
43983596|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983597|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43983598|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43983599|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43983600|NCT02121418|Cytarabine|cytarabine|mesh-list
43983601|NCT02121418|Decitabine|decitabine|mesh-list
43983602|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43983603|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
43983604|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983605|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983606|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
43983607|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983608|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983609|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
43983610|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983611|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983612|NCT02121483|Empagliflozin|empagliflozin|mesh-list
43983613|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43983614|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983615|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983616|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983617|NCT02122471|Plecanatide|plecanatide|mesh-list
43983618|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43983619|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
44024271|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024272|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024273|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
44024274|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024275|NCT05600673|Bimatoprost|bimatoprost|mesh-list
44024276|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024277|NCT05600517|Fluorides|fluorides|mesh-list
44024278|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
44024279|NCT05600517|Protective Agents|protective agents|mesh-ancestor
44024280|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024281|NCT05600491|Temozolomide|temozolomide|mesh-list
44024282|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44024283|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
44024284|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024285|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024286|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44024287|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44024288|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44148688|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148689|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43645840|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702661|NCT02715531|Growth Substances|growth substances|mesh-ancestor
43983620|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983621|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44144683|NCT00192712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144684|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144685|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144686|NCT00192725|Tryptophan|tryptophan|mesh-list
44144687|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44144688|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144689|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144690|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
44144691|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983622|NCT02123017|Lactulose|lactulose|mesh-list
43983623|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983624|NCT02123849|Aspirin|aspirin|mesh-list
43983625|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43983626|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983627|NCT02123849|Analgesics|analgesics|mesh-ancestor
43983628|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
43983629|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983630|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983631|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983632|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983633|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44148690|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44148691|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
44148692|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148693|NCT00205322|Leucovorin|leucovorin|mesh-list
44148694|NCT00205322|Capecitabine|capecitabine|mesh-list
44024289|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
44024290|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024291|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024292|NCT05600231|Listerine|listerine|mesh-list
44024293|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44024294|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
44024295|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
44024296|NCT05600231|Protective Agents|protective agents|mesh-ancestor
44024297|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024298|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024299|NCT05600127|Avelumab|avelumab|mesh-list
44024300|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024301|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024302|NCT05600075|Insulin|insulin|mesh-list
44024303|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44024304|NCT05600075|Glycolic acid|glycolic acid|mesh-list
44024305|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44024306|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024307|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
44024308|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983634|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43983635|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983636|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43983637|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43983638|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983640|NCT02124044|Asunaprevir|asunaprevir|mesh-list
43983641|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
43983642|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983643|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983644|NCT02124083|Vorinostat|vorinostat|mesh-list
43983645|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983646|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43983647|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983648|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983649|NCT02124512|Rifaximin|rifaximin|mesh-list
43983650|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43983651|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983652|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459689|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459690|NCT01575860|Lenalidomide|lenalidomide|mesh-list
43983653|NCT02125292|Mesalamine|mesalamine|mesh-list
43983654|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43983655|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983658|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983659|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983660|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983661|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983662|NCT02125721|Penicillamine|penicillamine|mesh-list
43983663|NCT02125721|Antidotes|antidotes|mesh-ancestor
43983664|NCT02125721|Protective Agents|protective agents|mesh-ancestor
43983665|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983666|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
43983667|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
43983668|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983669|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983670|NCT02128230|Thalidomide|thalidomide|mesh-list
43983671|NCT02128230|Dexamethasone|dexamethasone|mesh-list
43983672|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
43983673|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
43983674|NCT02128230|Melphalan|melphalan|mesh-list
43983675|NCT02128230|Cisplatin|cisplatin|mesh-list
43983676|NCT02128230|Doxorubicin|doxorubicin|mesh-list
43983677|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43983678|NCT02128230|Etoposide|etoposide|mesh-list
43983679|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
43983680|NCT02128230|Lenalidomide|lenalidomide|mesh-list
44024315|NCT05599971|Digoxin|digoxin|mesh-list
43983681|NCT02128230|Lenograstim|lenograstim|mesh-list
43983682|NCT02128230|BB 1101|bb 1101|mesh-list
43983683|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983684|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
43983685|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983686|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983687|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43983688|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
43983689|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983690|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983691|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43983692|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983693|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
43983694|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
43983695|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983696|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983697|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
43983698|NCT02128230|Hormones|hormones|mesh-ancestor
43983699|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43983700|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43983701|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
43983702|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983703|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43983704|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43983705|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43983706|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43983707|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43983708|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43983709|NCT02128230|Growth Substances|growth substances|mesh-ancestor
43983710|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
44024354|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024355|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44024356|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
44024357|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
44024358|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024359|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024360|NCT05599789|Docetaxel|docetaxel|mesh-list
44024361|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
44024362|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024363|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024364|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754490|NCT02478047|Dexamethasone|dexamethasone|mesh-list
43983711|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
43983712|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43983713|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983714|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43983715|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
43983716|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43983717|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983718|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43983719|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43983720|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
43983721|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983722|NCT02129075|Poly I-C|poly i-c|mesh-list
43983723|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43983724|NCT02129075|Poly ICLC|poly iclc|mesh-list
43983725|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
43983726|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
43983727|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
44024384|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024385|NCT05599230|Ivacaftor|ivacaftor|mesh-list
44024386|NCT05599230|Elexacaftor|elexacaftor|mesh-list
44024387|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44024388|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024389|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024390|NCT05599126|Lorazepam|lorazepam|mesh-list
44024391|NCT05599126|Mianserin|mianserin|mesh-list
44024392|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
44024393|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
44024394|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
44024395|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024396|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024397|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44024398|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44024399|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024400|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43645841|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645842|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
43645843|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43645844|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43983728|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459692|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459693|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459694|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459695|NCT01575860|Growth Substances|growth substances|mesh-ancestor
44243942|NCT05642845|Atorvastatin|atorvastatin|mesh-list
44243943|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44243944|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44243945|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
44243946|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44243947|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44243948|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44243949|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243950|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44243951|NCT05642767|Cetrimonium|cetrimonium|mesh-list
44243952|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243953|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44243954|NCT05642689|Iron|iron|mesh-list
44243955|NCT05642689|Trace Elements|trace elements|mesh-ancestor
44243956|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
44243957|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243958|NCT05642624|Amphotericin B|amphotericin b|mesh-list
44243959|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44243960|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
44243961|NCT05642624|Amebicides|amebicides|mesh-ancestor
44243962|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44243963|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44243964|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243965|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44243966|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
44243967|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44243968|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44243969|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44243970|NCT05642572|Osimertinib|osimertinib|mesh-list
43983729|NCT02129075|Laxatives|laxatives|mesh-ancestor
43983730|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983731|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
43983737|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
43983738|NCT02129426|Ketamine|ketamine|mesh-list
43983739|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43983740|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983741|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243971|NCT05642572|Ramucirumab|ramucirumab|mesh-list
44243972|NCT05642572|Antibodies|antibodies|mesh-list
44243973|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
44243974|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43740627|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
43983742|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983743|NCT02129426|Analgesics|analgesics|mesh-ancestor
43983744|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
44024403|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
43983745|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983746|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43983747|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43983748|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43983749|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983750|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983751|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983752|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43983753|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43983754|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
43983755|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
43983756|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43983757|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43983758|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43983759|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43983760|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43983761|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44024450|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024451|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44024452|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44024453|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024454|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024455|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44024456|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44024457|NCT05546047|Tacrolimus|tacrolimus|mesh-list
44024458|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024459|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
44024460|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024461|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44024462|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024463|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024464|NCT05526430|Harmine|harmine|mesh-list
44024465|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
44024466|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024467|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43645845|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43645846|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43645847|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983762|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
43983763|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
43983764|NCT02129478|Olanzapine|olanzapine|mesh-list
43983765|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
43983766|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
43983767|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983768|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983769|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983770|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43983771|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43983772|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983773|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719684|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
43983774|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44144692|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
43983775|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43983776|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024468|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44024469|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024470|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024471|NCT05525416|Propranolol|propranolol|mesh-list
44024472|NCT05525416|Nitroprusside|nitroprusside|mesh-list
44024473|NCT05525416|Phentolamine|phentolamine|mesh-list
44024474|NCT05525416|Phenylephrine|phenylephrine|mesh-list
44024475|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
44024476|NCT05525416|Norepinephrine|norepinephrine|mesh-list
44024477|NCT05525416|Synephrine|synephrine|mesh-list
44024478|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44024479|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44024480|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024481|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024482|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024483|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024484|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43645848|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645849|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43823986|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43823987|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
43823988|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823989|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43983777|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983778|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983779|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
43983780|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
43983781|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983782|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983783|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
43983784|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43983785|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43983786|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43983787|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
43871159|NCT02641782|Isotretinoin|isotretinoin|mesh-list
43983788|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983789|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983790|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983791|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
43983792|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983793|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
43983794|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43983795|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43983796|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024485|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024486|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024487|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44024488|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
44024489|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
44024490|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024491|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
44024492|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44024493|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
44024494|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
44024495|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44024496|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44024497|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44024498|NCT05525416|Protective Agents|protective agents|mesh-ancestor
44024499|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44024500|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44024501|NCT05524584|Fulvestrant|fulvestrant|mesh-list
44024502|NCT05524584|Anastrozole|anastrozole|mesh-list
44024503|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024504|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024505|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44024506|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43983797|NCT02129725|Urological Agents|urological agents|mesh-ancestor
43983799|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43983806|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43983807|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983808|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983810|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43983811|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43983812|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44243975|NCT05642572|Lexatumumab|lexatumumab|mesh-list
44243976|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
44243977|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243978|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740668|NCT02528201|Celecoxib|celecoxib|mesh-list
43983813|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
43983814|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
43983815|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983816|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983817|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983818|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
43983819|NCT02132468|Combretastatin|combretastatin|mesh-list
43983820|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43983821|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983822|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
43983823|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
43983824|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
43983825|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983826|NCT02132533|Nifedipine|nifedipine|mesh-list
43983827|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43983828|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983829|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983830|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43983831|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983832|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
43983833|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
43983834|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43983835|NCT02132832|Buspirone|buspirone|mesh-list
43983836|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43983837|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43983838|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983839|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983840|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43983841|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43983842|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
43983843|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983844|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983845|NCT02132936|Calcipotriene|calcipotriene|mesh-list
43983846|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983847|NCT02133781|Vaccines|vaccines|mesh-list
43719760|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43983848|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
43983849|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983850|NCT02134184|Vaccines|vaccines|mesh-list
43983851|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
43983852|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983853|NCT02134210|Etanercept|etanercept|mesh-list
43983854|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43983855|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983856|NCT02134210|Analgesics|analgesics|mesh-ancestor
43983857|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
43983858|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983859|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983860|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43983861|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983862|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983863|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983864|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
43983865|NCT02134314|Complement C1s|complement c1s|mesh-list
43983866|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43983867|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43983875|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983876|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983877|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43983878|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43983880|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
43983881|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983882|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43983883|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43983884|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44243980|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44243981|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148718|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43983885|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983886|NCT02135016|Lidocaine|lidocaine|mesh-list
43983887|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983888|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
43983889|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983890|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983891|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
43983892|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983893|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43983894|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43983895|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43983896|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983897|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983898|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
43983899|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43983900|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43983901|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
43983902|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983903|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983904|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983905|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
43983906|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
43983907|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983908|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
43983909|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43983910|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
43983911|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
43983912|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43983913|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43983914|NCT02135432|Ivacaftor|ivacaftor|mesh-list
43983915|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43983916|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43983917|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983918|NCT02136420|Promethazine|promethazine|mesh-list
43983919|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
43983920|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
43983921|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
43983922|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43983923|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
43983924|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
43983925|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983926|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983927|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983928|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43983929|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43983930|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43983931|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983932|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
43983933|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
43983942|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983943|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983944|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983945|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983946|NCT02137382|Pancrelipase|pancrelipase|mesh-list
43983947|NCT02137382|Pancreatin|pancreatin|mesh-list
43983948|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983949|NCT02137538|Letrozole|letrozole|mesh-list
43983950|NCT02137538|Anastrozole|anastrozole|mesh-list
43983951|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983952|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43983953|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43983954|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983955|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983956|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43983957|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
43983958|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811576|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
44243982|NCT05642416|Ropivacaine|ropivacaine|mesh-list
44243983|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44243984|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
44243985|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43983959|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983960|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024573|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
44024612|NCT05164614|Teriparatide|teriparatide|mesh-list
44024613|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43983962|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43983963|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43983964|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983965|NCT02139007|Alendronate|alendronate|mesh-list
43983966|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43983967|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983968|NCT02139358|Gemcitabine|gemcitabine|mesh-list
43983969|NCT02139358|Trastuzumab|trastuzumab|mesh-list
43983970|NCT02139358|Pertuzumab|pertuzumab|mesh-list
43983971|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43983972|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
43983973|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983974|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983975|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
43983976|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983977|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983978|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983979|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
43983980|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983981|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983982|NCT02140372|Colchicine|colchicine|mesh-list
44024614|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024615|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44024616|NCT05117489|Cortisone|cortisone|mesh-list
44024617|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44024618|NCT05091203|Vitamin D|vitamin d|mesh-list
44024619|NCT05091203|Vitamins|vitamins|mesh-ancestor
44024620|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
44024621|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024622|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44024623|NCT05080556|Carboplatin|carboplatin|mesh-list
44024624|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024625|NCT05048719|Dulaglutide|dulaglutide|mesh-list
44024626|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44024627|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024628|NCT05001048|Phenylephrine|phenylephrine|mesh-list
44024629|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
44024630|NCT05001048|Synephrine|synephrine|mesh-list
44024631|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44024632|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
44024633|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
43983983|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
43983984|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43983985|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
43983986|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
43983987|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
43983988|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983989|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983990|NCT02140593|Rocuronium|rocuronium|mesh-list
43983991|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43983992|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43983993|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43719834|NCT02633852|Aflibercept|aflibercept|mesh-list
43983994|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983995|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983996|NCT02141451|Rituximab|rituximab|mesh-list
43983997|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43983998|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43983999|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
43984000|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144702|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
44144703|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144704|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144705|NCT00192803|Candesartan|candesartan|mesh-list
44144706|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44144707|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44144708|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44144709|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144710|NCT00192842|Gemcitabine|gemcitabine|mesh-list
44144712|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144713|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
44144714|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144715|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144716|NCT00192842|Antiviral Agents|antiviral agents|mesh-ancestor
44144717|NCT00192842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144718|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144719|NCT00192842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144720|NCT00192842|Immunologic Factors|immunologic factors|mesh-ancestor
44144721|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144722|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44144723|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44144724|NCT00192842|Analgesics|analgesics|mesh-ancestor
44144725|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
44144726|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243986|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243987|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
44243988|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44243989|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44243991|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
44243992|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44243993|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44144727|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44144728|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144729|NCT00192855|Entacapone|entacapone|mesh-list
44024668|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024669|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44024670|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44024671|NCT04941833|Progestins|progestins|mesh-ancestor
44024672|NCT04941833|Hormones|hormones|mesh-ancestor
44024673|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024674|NCT04916886|Vaccines|vaccines|mesh-list
44024675|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
44024676|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024677|NCT04915612|Cytarabine|cytarabine|mesh-list
44024678|NCT04915612|Daunorubicin|daunorubicin|mesh-list
44024679|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
44024680|NCT04915612|Calicheamicins|calicheamicins|mesh-list
44024681|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024682|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
44024683|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024684|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024685|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
44024686|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024687|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024688|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
43645855|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645856|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43645857|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43645858|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
43645859|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144730|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44144731|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44144732|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44144733|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144734|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144735|NCT00192959|Propofol|propofol|mesh-list
44144736|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44144737|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44144738|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144739|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44144740|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
44144741|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
44144742|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
44144743|NCT00193011|Docetaxel|docetaxel|mesh-list
44144744|NCT00193011|Fluorouracil|fluorouracil|mesh-list
44144745|NCT00193011|Methotrexate|methotrexate|mesh-list
44144746|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144747|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
44024689|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024690|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44024691|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44024692|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44024693|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024694|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44148751|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148752|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148753|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148754|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148755|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148756|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148757|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148758|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148759|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
44148760|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
44148761|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
44148762|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645861|NCT03735628|Nivolumab|nivolumab|mesh-list
43645862|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645863|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645864|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43702663|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
44144748|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144749|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144750|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144751|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
44144752|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144753|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144754|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43984009|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
43984010|NCT02141581|Vaccines|vaccines|mesh-list
43984011|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
44148763|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148764|NCT00205738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44148765|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44148766|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148767|NCT00205751|Thalidomide|thalidomide|mesh-list
44148768|NCT00205751|Dexamethasone|dexamethasone|mesh-list
44148769|NCT00205751|Prednisone|prednisone|mesh-list
44148770|NCT00205751|Melphalan|melphalan|mesh-list
44148771|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148772|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
44148773|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
44148774|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644704|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43984012|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984013|NCT02142049|Lenalidomide|lenalidomide|mesh-list
43984014|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
43984015|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984016|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43984017|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43984018|NCT02142049|Growth Substances|growth substances|mesh-ancestor
43984019|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
43984020|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984021|NCT02142153|Olorofim|olorofim|mesh-list
43984022|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
43984023|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984024|NCT02143648|Nalbuphine|nalbuphine|mesh-list
43984025|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984026|NCT02143648|Narcotics|narcotics|mesh-ancestor
43984027|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984028|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984029|NCT02143648|Analgesics|analgesics|mesh-ancestor
43984030|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
43984031|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984032|NCT02143973|Nalbuphine|nalbuphine|mesh-list
43984033|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984034|NCT02143973|Narcotics|narcotics|mesh-ancestor
43984035|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984036|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984037|NCT02143973|Analgesics|analgesics|mesh-ancestor
43984038|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
43984039|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984040|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
43984041|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44243994|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44243996|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
44243997|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
44243998|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984042|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
43984043|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
43984044|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984045|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43984046|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
43984047|NCT02144259|Etonogestrel|etonogestrel|mesh-list
43984048|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43984049|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43984050|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43984051|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
43984052|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984053|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984054|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43984055|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43984056|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43984057|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984058|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984065|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984067|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
43984068|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984069|NCT02144675|Cytarabine|cytarabine|mesh-list
43984070|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
43984071|NCT02144675|Salicylates|salicylates|mesh-list
43984072|NCT02144675|Idarubicin|idarubicin|mesh-list
43984073|NCT02144675|Choline|choline|mesh-list
43984074|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43984075|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
43984076|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984077|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984078|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
43984079|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984080|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984081|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
43984082|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984083|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43984084|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43984085|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43984086|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984087|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
43984088|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43984089|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984090|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43984091|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
43984092|NCT02144675|Analgesics|analgesics|mesh-ancestor
43984093|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
43984094|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984095|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43984096|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984097|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984098|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984099|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43984100|NCT02144714|Adalimumab|adalimumab|mesh-list
43984101|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984102|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984103|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
43984104|NCT02145039|Fludarabine|fludarabine|mesh-list
43984105|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984106|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
43984107|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984108|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984109|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43984110|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
43984111|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984112|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984113|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44243999|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244000|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
44244001|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244002|NCT05642026|Analgesics|analgesics|mesh-ancestor
44244003|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44244004|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244005|NCT05641909|Fentanyl|fentanyl|mesh-list
43984114|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43984115|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984116|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984117|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
43984118|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43984119|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43984120|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43984121|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984122|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984123|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984124|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984125|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984126|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43984127|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984136|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984138|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984139|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43984140|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984141|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984142|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984143|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984144|NCT02148874|Vaccines|vaccines|mesh-list
43984145|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
43984146|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984147|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
43984148|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43984149|NCT02149173|Fluorides|fluorides|mesh-list
43984150|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43984151|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984152|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
43984153|NCT02149173|Protective Agents|protective agents|mesh-ancestor
43984154|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984156|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
43984157|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984158|NCT02149303|Dabigatran|dabigatran|mesh-list
43984159|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
43984160|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43984161|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
43984162|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984163|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984164|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
43984165|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43984166|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43984167|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43984168|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984169|NCT02149524|Trastuzumab|trastuzumab|mesh-list
43984170|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43984171|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984172|NCT02150499|Albuterol|albuterol|mesh-list
43984173|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43984174|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
43984175|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984176|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984177|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43984178|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
43984179|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
43984180|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984181|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43984182|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43984183|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984184|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44244007|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44244008|NCT05641909|Narcotics|narcotics|mesh-ancestor
44244009|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244010|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984185|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984186|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984187|NCT02150759|Fentanyl|fentanyl|mesh-list
43984188|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
44024801|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
44024802|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
44024803|NCT04375631|Cladribine|cladribine|mesh-list
44024804|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43645868|NCT03732677|Durvalumab|durvalumab|mesh-list
43984189|NCT02150759|Ketamine|ketamine|mesh-list
43984190|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43984191|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984192|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984193|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984194|NCT02150759|Analgesics|analgesics|mesh-ancestor
43984195|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
43984196|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024834|NCT04317807|Levetiracetam|levetiracetam|mesh-list
44024835|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
44024836|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
44024837|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
44024838|NCT04311632|Tacrolimus|tacrolimus|mesh-list
43645872|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645873|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
43645874|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645875|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645876|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645877|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
43645878|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645879|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645880|NCT03719690|Tipifarnib|tipifarnib|mesh-list
43645881|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645882|NCT03704363|Infliximab|infliximab|mesh-list
43645883|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645884|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43645885|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645886|NCT03703375|Gemcitabine|gemcitabine|mesh-list
43645887|NCT03703375|Azacitidine|azacitidine|mesh-list
43645888|NCT03703375|Romidepsin|romidepsin|mesh-list
43645889|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645890|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
43645891|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645892|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645893|NCT03703375|Antiviral Agents|antiviral agents|mesh-ancestor
43645894|NCT03703375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645895|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645896|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984197|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43984198|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984199|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984200|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984201|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984202|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984203|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44024839|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024840|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
44024841|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024842|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44024843|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645897|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
43645898|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645899|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43645900|NCT03701763|Apremilast|apremilast|mesh-list
43645901|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43645902|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43645903|NCT03701763|Analgesics|analgesics|mesh-ancestor
43645904|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
43984204|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43984205|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
43984206|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
43984207|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43984208|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43984209|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984210|NCT02150759|Narcotics|narcotics|mesh-ancestor
43984211|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43984212|NCT02151253|Modafinil|modafinil|mesh-list
43984213|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43984214|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984215|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43984216|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43984217|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43984218|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984219|NCT02151448|Interferons|interferons|mesh-list
43984220|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
43984221|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
43984222|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43984223|NCT02151448|Celecoxib|celecoxib|mesh-list
43984224|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984225|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
43984226|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984227|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
43984228|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984229|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43984230|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984231|NCT02151448|Analgesics|analgesics|mesh-ancestor
43984232|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
43984233|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984234|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984235|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984236|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43984237|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43984238|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984239|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984240|NCT02151487|Dexamethasone|dexamethasone|mesh-list
43984241|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
43984243|NCT02151487|Ropivacaine|ropivacaine|mesh-list
43984244|NCT02151487|BB 1101|bb 1101|mesh-list
43984245|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984246|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
43984247|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
43984248|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984249|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984250|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244011|NCT05641909|Analgesics|analgesics|mesh-ancestor
44244012|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
43984251|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
43984252|NCT02151487|Hormones|hormones|mesh-ancestor
43984253|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984254|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984255|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984256|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
43984257|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984258|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984259|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984260|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
43984261|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984262|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
43984263|NCT02151487|Analgesics|analgesics|mesh-ancestor
43984264|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024887|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44024888|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
44024889|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024890|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44024891|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44024892|NCT04225611|Dexamethasone|dexamethasone|mesh-list
44024893|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44024894|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
44024895|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
44024896|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024897|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024898|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44024899|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
44024900|NCT04225611|Hormones|hormones|mesh-ancestor
44024901|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024902|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024903|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024904|NCT04209855|Paclitaxel|paclitaxel|mesh-list
43645905|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645906|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645907|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645908|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645909|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43645910|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43645911|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645912|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645913|NCT03698162|Bevacizumab|bevacizumab|mesh-list
43645914|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645916|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43645917|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43984265|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
43984266|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43984267|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984268|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984269|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984270|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984271|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
43984280|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984281|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984282|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43984283|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
43984284|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
43984285|NCT02151877|Protective Agents|protective agents|mesh-ancestor
43984286|NCT02151994|Zamicastat|zamicastat|mesh-list
43984287|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984288|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984289|NCT02152696|Methotrexate|methotrexate|mesh-list
43984290|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43984291|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
43984292|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984293|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984294|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43984295|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
43984296|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984297|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984298|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984299|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984300|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43984301|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984302|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
43984303|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984304|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43984306|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
43984307|NCT02153671|Vaccines|vaccines|mesh-list
43984308|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
43984309|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984310|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
43984311|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
43984312|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44024947|NCT04038515|Menthol|menthol|mesh-list
43984313|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
43984314|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984315|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984316|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984317|NCT02153983|Colchicine|colchicine|mesh-list
43984319|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984320|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
43984321|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
43984322|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
43984323|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984324|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984325|NCT02154048|Dexamethasone|dexamethasone|mesh-list
43984326|NCT02154048|Ropivacaine|ropivacaine|mesh-list
43984327|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984328|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
44024948|NCT04038515|Nicotine|nicotine|mesh-list
44024949|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44024950|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
44024951|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024952|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024953|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44024954|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44024955|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
44024956|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024957|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024958|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
44024959|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024960|NCT04030559|Niraparib|niraparib|mesh-list
43984329|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
43984330|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984331|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984332|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244013|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244014|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244015|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43545307|NCT03673735|Cisplatin|cisplatin|mesh-list
43984333|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
43984334|NCT02154048|Hormones|hormones|mesh-ancestor
43984335|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984336|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984337|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984338|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984339|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
43984345|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984346|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984347|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44024961|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44024962|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024963|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024964|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024965|NCT04022785|Azacitidine|azacitidine|mesh-list
44024966|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024967|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
44024968|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024969|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024970|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148814|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148815|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148816|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44148817|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44148818|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148819|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148820|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
43645918|NCT03698162|Growth Substances|growth substances|mesh-ancestor
43645919|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645920|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
43645921|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43645922|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
43984348|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43984349|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984350|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984351|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984352|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984353|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984354|NCT02154477|Insulin|insulin|mesh-list
43984355|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43984356|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984357|NCT02154763|Ropivacaine|ropivacaine|mesh-list
43984358|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984359|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
43984360|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984361|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984362|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
43984363|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984364|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
43984365|NCT02155010|Bupivacaine|bupivacaine|mesh-list
43984366|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984367|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
43984368|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984369|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984370|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
43984371|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984372|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43984373|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984374|NCT02155010|Analgesics|analgesics|mesh-ancestor
43984375|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44148821|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148822|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148823|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44148824|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44148825|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148826|NCT00206024|Esomeprazole|esomeprazole|mesh-list
44148827|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44148828|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148829|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44148830|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148831|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148832|NCT00206050|Esomeprazole|esomeprazole|mesh-list
44148833|NCT00206050|Pantoprazole|pantoprazole|mesh-list
44148834|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44148835|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148836|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44148837|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984376|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984377|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984378|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984379|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984380|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984382|NCT02155101|Lopinavir|lopinavir|mesh-list
43984383|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43984384|NCT02155101|Darunavir|darunavir|mesh-list
43984385|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43984386|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43984387|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
43984388|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984389|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984390|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43984391|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43984392|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
43984393|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024977|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44024978|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
44024979|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024980|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024981|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44024982|NCT03866499|Gefitinib|gefitinib|mesh-list
44024983|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024984|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024985|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024986|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024987|NCT03835065|Calpastatin|calpastatin|mesh-list
44024988|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44024989|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
44024990|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024991|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024992|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
44024993|NCT03713593|Lenvatinib|lenvatinib|mesh-list
43645923|NCT03696121|Coagulants|coagulants|mesh-ancestor
43645924|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43645925|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
43645926|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645927|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43645928|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43645929|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645930|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43645931|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43645932|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43984394|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43984395|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43984396|NCT02155257|Gabapentin|gabapentin|mesh-list
43984397|NCT02155257|Modafinil|modafinil|mesh-list
43984398|NCT02155257|Analgesics|analgesics|mesh-ancestor
43984399|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
43984400|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984401|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984402|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
43984403|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43984404|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43984405|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024994|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024995|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024996|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024997|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024998|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024999|NCT03617705|Ethanol|ethanol|mesh-list
44025000|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44025001|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025002|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025003|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025004|NCT03582930|Calfactant|calfactant|mesh-list
43645935|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645936|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244016|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
43897133|NCT04263090|Nivolumab|nivolumab|mesh-list
44244017|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
43984406|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43984407|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43984408|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43984409|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984410|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984420|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43984421|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
43984422|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025005|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44025006|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
43645937|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645938|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
43645939|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645940|NCT03686488|Ramucirumab|ramucirumab|mesh-list
43645941|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645942|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
43645943|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
43645944|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43645945|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43645946|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702664|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025007|NCT03579472|Halichondrin B|halichondrin b|mesh-list
43645947|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645948|NCT03686306|Urological Agents|urological agents|mesh-ancestor
43645949|NCT03683069|Amlodipine|amlodipine|mesh-list
43645950|NCT03683069|Eplerenone|eplerenone|mesh-list
43645951|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43645952|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43645953|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984423|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43984424|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984425|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43984426|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984427|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984428|NCT02156154|Acetaminophen|acetaminophen|mesh-list
43984429|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984430|NCT02156154|Analgesics|analgesics|mesh-ancestor
43984431|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
43984432|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984433|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984434|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
43984435|NCT02157103|Bevacizumab|bevacizumab|mesh-list
43984436|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43984437|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984438|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43984439|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43984440|NCT02157103|Growth Substances|growth substances|mesh-ancestor
43984441|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984442|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
43984443|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43984444|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43984445|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984446|NCT02158273|Fenofibrate|fenofibrate|mesh-list
43984447|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44025008|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025009|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025010|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025011|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025012|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025013|NCT03493685|Irbesartan|irbesartan|mesh-list
44025014|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44025015|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44025016|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44025017|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025018|NCT03472872|Acetaminophen|acetaminophen|mesh-list
44025019|NCT03472872|Ketorolac|ketorolac|mesh-list
44025020|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025021|NCT03472872|Analgesics|analgesics|mesh-ancestor
44025022|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
44025023|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025024|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025025|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
44025026|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025027|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025028|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025029|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025032|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43984448|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
43984449|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984450|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43984451|NCT02158520|Paclitaxel|paclitaxel|mesh-list
43984452|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43984453|NCT02158520|Bevacizumab|bevacizumab|mesh-list
43984454|NCT02158520|Ipilimumab|ipilimumab|mesh-list
43984455|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43984456|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
43984457|NCT02158520|Antibodies|antibodies|mesh-list
43984458|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
43984459|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43984460|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
43984461|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43984462|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984463|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
43984464|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
43984465|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
43984466|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984467|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43984468|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43984470|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984471|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
43984472|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
44025033|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
44025034|NCT03461406|Coagulants|coagulants|mesh-ancestor
44025035|NCT03332797|Palbociclib|palbociclib|mesh-list
44025036|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025037|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025038|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025039|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025040|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
44025041|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44025042|NCT03301038|Rifampin|rifampin|mesh-list
44025043|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43984473|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43984474|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
43984475|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984476|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984479|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984480|NCT02159547|Analgesics|analgesics|mesh-ancestor
43984481|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
43984482|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984483|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984484|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984485|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43984486|NCT02159859|Ertapenem|ertapenem|mesh-list
43984487|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44244018|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44244019|NCT05641753|Atorvastatin|atorvastatin|mesh-list
44244021|NCT05641753|Evolocumab|evolocumab|mesh-list
44244022|NCT05641753|Calcium|calcium|mesh-list
44244023|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44244024|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244025|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43984488|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144762|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44144763|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
44144764|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144765|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44144766|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144767|NCT00193024|Docetaxel|docetaxel|mesh-list
44144768|NCT00193024|Epirubicin|epirubicin|mesh-list
44144769|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144770|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144771|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144772|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144773|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144774|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44144775|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44144776|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144777|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144778|NCT00193076|Gemcitabine|gemcitabine|mesh-list
44144779|NCT00193076|Carboplatin|carboplatin|mesh-list
44144780|NCT00193076|Trastuzumab|trastuzumab|mesh-list
44144781|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144782|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144783|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
44144784|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144785|NCT00193076|Antiviral Agents|antiviral agents|mesh-ancestor
44144786|NCT00193076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144787|NCT00193076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144788|NCT00193076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144789|NCT00193076|Immunologic Factors|immunologic factors|mesh-ancestor
44144790|NCT00193076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144791|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144792|NCT00193089|Docetaxel|docetaxel|mesh-list
44144793|NCT00193089|Trastuzumab|trastuzumab|mesh-list
44144794|NCT00193089|Vinorelbine|vinorelbine|mesh-list
44144795|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144796|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144797|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144798|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144799|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144800|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144801|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144802|NCT00193102|Thalidomide|thalidomide|mesh-list
44144803|NCT00193102|Capecitabine|capecitabine|mesh-list
43984489|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
43984490|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43984491|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984492|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43984493|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984494|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984495|NCT02159976|Amoxicillin|amoxicillin|mesh-list
43984496|NCT02159976|Metronidazole|metronidazole|mesh-list
43984497|NCT02159976|Clarithromycin|clarithromycin|mesh-list
43984498|NCT02159976|Tetracycline|tetracycline|mesh-list
43984499|NCT02159976|Pantoprazole|pantoprazole|mesh-list
43984500|NCT02159976|Bismuth|bismuth|mesh-list
43984501|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43984502|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984503|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43984504|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43984505|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43984506|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984507|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984508|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44244026|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44244028|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244029|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44244030|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44244031|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984519|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984520|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984521|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984522|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984523|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43984524|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984525|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43984526|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43984527|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44025113|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
43984528|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984529|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984530|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43984531|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984532|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984533|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984534|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984535|NCT02160730|Roscovitine|roscovitine|mesh-list
43984536|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984537|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
43984538|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984539|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43984540|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984541|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984542|NCT02160808|Secretin|secretin|mesh-list
43984543|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984544|NCT02160808|Hormones|hormones|mesh-ancestor
43984545|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984546|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984547|NCT02160990|Exenatide|exenatide|mesh-list
43984548|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43984549|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984550|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43984551|NCT02160990|Incretins|incretins|mesh-ancestor
43984552|NCT02160990|Hormones|hormones|mesh-ancestor
43984553|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984554|NCT02161484|Bupivacaine|bupivacaine|mesh-list
43984555|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984556|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
43984557|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984558|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984559|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
43984560|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984561|NCT02161705|Ropivacaine|ropivacaine|mesh-list
43984562|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984563|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
43984564|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984565|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984566|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
43984567|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984568|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
43984569|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43984570|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984571|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984580|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984581|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984583|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984584|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
43984585|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984586|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984587|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
44244033|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
44244034|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984588|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984589|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43984590|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984591|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984592|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984593|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984594|NCT02163421|Vedolizumab|vedolizumab|mesh-list
43984595|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984596|NCT02163434|Gabapentin|gabapentin|mesh-list
43984597|NCT02163434|Metoclopramide|metoclopramide|mesh-list
43984598|NCT02163434|Analgesics|analgesics|mesh-ancestor
43984599|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
43984600|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984601|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984602|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
43984603|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43984604|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43984605|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984606|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43984607|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43984608|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43984609|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984610|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984611|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
43984612|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
43984613|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
43984614|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984615|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43984616|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43984617|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
43984618|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43984619|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43984620|NCT02163837|Rifaximin|rifaximin|mesh-list
43984621|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43984622|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984623|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984624|NCT02164240|Sunitinib|sunitinib|mesh-list
43984625|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984626|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43984627|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43984628|NCT02164240|Growth Substances|growth substances|mesh-ancestor
43984629|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984630|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
43984631|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43984632|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984633|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984634|NCT02164422|Guanfacine|guanfacine|mesh-list
43984635|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43984637|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984639|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984640|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984641|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984642|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984643|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
43984644|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43984645|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43984646|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43984647|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871161|NCT02641782|Sargramostim|sargramostim|mesh-list
43984648|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984649|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984650|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984651|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984652|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43984653|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984654|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
43984655|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43984656|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106638|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244035|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244036|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
44244037|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244038|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244039|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
44244040|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244041|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244042|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43984657|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984658|NCT02167204|Alovudine|alovudine|mesh-list
43984659|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
43984660|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984661|NCT02167217|Prednisolone|prednisolone|mesh-list
43984662|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43984663|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
43984664|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43984665|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
43984666|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43984667|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
43984668|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984669|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
43984670|NCT02167217|Hormones|hormones|mesh-ancestor
43984671|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984672|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984673|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984674|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984675|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
43984676|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
43984677|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984678|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984679|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43984680|NCT02167217|Protective Agents|protective agents|mesh-ancestor
43984681|NCT02168062|Leuprolide|leuprolide|mesh-list
43984682|NCT02168062|Goserelin|goserelin|mesh-list
43984683|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43984684|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43984685|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
43984686|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984687|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984688|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984689|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984690|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
43984691|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43984692|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
43984693|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43984694|NCT02168309|Labetalol|labetalol|mesh-list
43984695|NCT02168309|Nifedipine|nifedipine|mesh-list
43984696|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43984697|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984698|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984699|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43984700|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984701|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
43984702|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
43984703|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984704|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43984705|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43984706|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984707|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244057|NCT05640830|Trastuzumab|trastuzumab|mesh-list
44244058|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43984708|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43984719|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43984721|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984722|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
43984723|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984724|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
43984725|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984726|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
43984727|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984728|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
43984729|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984731|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
43984732|NCT02168660|Vitamins|vitamins|mesh-ancestor
43984733|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
43984734|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984735|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43984736|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43984737|NCT02168855|Nicotine|nicotine|mesh-list
43984738|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43984739|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
43984740|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984741|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984742|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43984743|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43984744|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984745|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984746|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984747|NCT02169115|Omalizumab|omalizumab|mesh-list
43984748|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43984749|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43984750|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43984751|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
43984752|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
44025297|NCT00652574|Dasatinib|dasatinib|mesh-list
43984753|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984754|NCT02169427|Opicapone|opicapone|mesh-list
43984755|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984756|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984757|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984758|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984759|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984760|NCT02169440|Opicapone|opicapone|mesh-list
43984761|NCT02169440|Warfarin|warfarin|mesh-list
43984762|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
43984763|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984764|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984765|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984766|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984767|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984768|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43984769|NCT02169453|Opicapone|opicapone|mesh-list
43984770|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43984771|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
43984772|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984773|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984774|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984775|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
43984776|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
43984779|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984780|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984781|NCT02169466|Opicapone|opicapone|mesh-list
43984782|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
44244059|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244060|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
44244061|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
44244062|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
44244063|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244064|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244065|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44244066|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44244067|NCT05640830|Growth Substances|growth substances|mesh-ancestor
44244068|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984783|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984784|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984785|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984786|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984787|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984789|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984790|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984791|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43984792|NCT02169479|Opicapone|opicapone|mesh-list
43984793|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43984794|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
43984795|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984796|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984797|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984798|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
43984799|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
43984800|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984801|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984802|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984803|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984804|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
43984805|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43984806|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
43984807|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984808|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984809|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43984810|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43984811|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43984812|NCT02169895|Opicapone|opicapone|mesh-list
43984813|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
43984814|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984815|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984816|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984817|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984818|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984819|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
43984820|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984821|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984822|NCT02170220|Vortioxetine|vortioxetine|mesh-list
43984823|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
43984824|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43984825|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43984826|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43984827|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984828|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984829|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43984830|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43984831|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984832|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984833|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984834|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
44244071|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244072|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44244073|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244074|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244075|NCT05637645|Bupivacaine|bupivacaine|mesh-list
44244076|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
44244077|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
44244078|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984835|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43984836|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43984837|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43984838|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43984839|NCT02170376|Levodopa|levodopa|mesh-list
43984840|NCT02170376|Carbidopa|carbidopa|mesh-list
43984841|NCT02170376|Opicapone|opicapone|mesh-list
43984842|NCT02170376|Entacapone|entacapone|mesh-list
43984843|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43984844|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43984845|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
43984846|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984847|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984854|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
43984855|NCT02170532|Albuterol|albuterol|mesh-list
43984856|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43984857|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
43984858|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984859|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984860|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43984861|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
43984862|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
43984863|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984864|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43984865|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43984866|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984867|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984868|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984869|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984870|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43984871|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
43984872|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984873|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984874|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984875|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984876|NCT02170662|Bimatoprost|bimatoprost|mesh-list
43984877|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43984878|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43984879|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
43984880|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984881|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984882|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984883|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984884|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43984885|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
43984886|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984887|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984888|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984889|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984890|NCT02171611|Dabigatran|dabigatran|mesh-list
43984891|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
43984892|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44244079|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244080|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
44244081|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459696|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459697|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459698|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44459699|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44459700|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44459701|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984893|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
43984894|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984895|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984896|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
43984897|NCT02172742|Digoxin|digoxin|mesh-list
43984898|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43984899|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43984900|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43984901|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984902|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984903|NCT02172742|Protective Agents|protective agents|mesh-ancestor
43984904|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984905|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
43984906|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984907|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984908|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984909|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43984910|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
43984911|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43984912|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43984916|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
43984917|NCT02174419|Nalbuphine|nalbuphine|mesh-list
43984918|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984919|NCT02174419|Narcotics|narcotics|mesh-ancestor
43984920|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984921|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984922|NCT02174419|Analgesics|analgesics|mesh-ancestor
43984923|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
43984924|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984925|NCT02174432|Nalbuphine|nalbuphine|mesh-list
43984926|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984927|NCT02174432|Narcotics|narcotics|mesh-ancestor
43984928|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984929|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984930|NCT02174432|Analgesics|analgesics|mesh-ancestor
43984931|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
43984932|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720674|NCT02628522|Lidocaine|lidocaine|mesh-list
43984933|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43984934|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43984935|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43984936|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984937|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984938|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43984939|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43984940|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43984941|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43984942|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984943|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984944|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984945|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43984946|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43984948|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43984949|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43984950|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
43984951|NCT02174913|Fentanyl|fentanyl|mesh-list
44459702|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459703|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459704|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44459705|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43897204|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244082|NCT05617820|Estradiol|estradiol|mesh-list
44244083|NCT05617820|Estrogens|estrogens|mesh-ancestor
44244084|NCT05617820|Hormones|hormones|mesh-ancestor
43984952|NCT02174913|Propofol|propofol|mesh-list
43984953|NCT02174913|Atracurium|atracurium|mesh-list
43984954|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43984955|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984956|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984957|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43984958|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
43984959|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
43984960|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43984961|NCT02174913|Narcotics|narcotics|mesh-ancestor
43984962|NCT02174913|Analgesics|analgesics|mesh-ancestor
43984963|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
43984964|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984965|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43984966|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43984967|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43984968|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43984969|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43984970|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43984971|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
43984972|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984973|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984974|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
43984975|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
43984976|NCT02175212|Androgens|androgens|mesh-list
43984977|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43984978|NCT02175212|Hormones|hormones|mesh-ancestor
43984979|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43984980|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984981|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
43984982|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984983|NCT02175212|Protective Agents|protective agents|mesh-ancestor
43984984|NCT02175212|Vitamins|vitamins|mesh-ancestor
43984999|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43985000|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43985001|NCT02176031|Prednisolone|prednisolone|mesh-list
43985002|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
43985003|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43985004|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
43985005|NCT02176031|Natalizumab|natalizumab|mesh-list
43985006|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985007|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
43985008|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
43985009|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985010|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985011|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985012|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
43985013|NCT02176031|Hormones|hormones|mesh-ancestor
43985014|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985015|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43985016|NCT02176031|Protective Agents|protective agents|mesh-ancestor
43871162|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
43985017|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43985018|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985019|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
43985020|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
43985021|NCT02176382|Denosumab|denosumab|mesh-list
43985022|NCT02176382|Teriparatide|teriparatide|mesh-list
43985023|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43985024|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985025|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44244085|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244086|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244087|NCT05605535|Paclitaxel|paclitaxel|mesh-list
44244088|NCT05605535|Carboplatin|carboplatin|mesh-list
44244089|NCT05605535|Oregovomab|oregovomab|mesh-list
44244090|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44244091|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244092|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
43985026|NCT02176486|Ixazomib|ixazomib|mesh-list
43985027|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985028|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
43985029|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985030|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985031|NCT02178241|Gemcitabine|gemcitabine|mesh-list
43985032|NCT02178241|Halichondrin B|halichondrin b|mesh-list
43985033|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43985034|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
43985035|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985036|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985037|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
43985038|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985039|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985040|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985041|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
43985042|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985043|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
43985044|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
43985045|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
43985049|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
43985050|NCT02178696|Citalopram|citalopram|mesh-list
43985051|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985052|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43985053|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43985054|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985055|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985056|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985057|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
43985058|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985059|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44144804|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144805|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
44144806|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144807|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144808|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144809|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
44144810|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144811|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
44144812|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44144813|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144814|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44144815|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44144816|NCT00193102|Growth Substances|growth substances|mesh-ancestor
44144817|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44144818|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
44144819|NCT00193115|Docetaxel|docetaxel|mesh-list
44144820|NCT00193115|Doxorubicin|doxorubicin|mesh-list
44144821|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144822|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
44144823|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144824|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144825|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144826|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
43720782|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
43985060|NCT02178800|Cabotegravir|cabotegravir|mesh-list
43985061|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43985062|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43985063|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244093|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
44244094|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
44244095|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244096|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244097|NCT05600179|Dexamethasone|dexamethasone|mesh-list
44244098|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244099|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
44244100|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
44244101|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985064|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985065|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43985066|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43985067|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
43985068|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985070|NCT02179671|Gefitinib|gefitinib|mesh-list
43985071|NCT02179671|Tremelimumab|tremelimumab|mesh-list
43985072|NCT02179671|Osimertinib|osimertinib|mesh-list
43985073|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985074|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
43985075|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
43985076|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
43985077|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985078|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43985079|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985080|NCT02179788|Metformin|metformin|mesh-list
43985081|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43985082|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985083|NCT02179892|Acetaminophen|acetaminophen|mesh-list
43985084|NCT02179892|Dexamethasone|dexamethasone|mesh-list
43985085|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
43985086|NCT02179892|Bupivacaine|bupivacaine|mesh-list
43985087|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985088|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
43985089|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
43985090|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985091|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985092|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985093|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
43985094|NCT02179892|Hormones|hormones|mesh-ancestor
43985095|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985106|NCT02180100|Terconazole|terconazole|mesh-list
43985107|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
43985108|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985109|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43985110|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43985111|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985112|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985113|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43985114|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
43985115|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985116|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985117|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43985118|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43985119|NCT02180828|Fluconazole|fluconazole|mesh-list
43985120|NCT02180828|Clotrimazole|clotrimazole|mesh-list
43985121|NCT02180828|Miconazole|miconazole|mesh-list
43985122|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
43985123|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985124|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43985125|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43985126|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985127|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985128|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43985129|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
44106639|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
44244102|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244103|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244104|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
44244105|NCT05600179|Hormones|hormones|mesh-ancestor
44244106|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244107|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44244108|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244109|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
44244110|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
44244111|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
44244112|NCT05590936|Ondansetron|ondansetron|mesh-list
44244113|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
43985130|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985131|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985132|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43985133|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43985134|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43985135|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43985136|NCT02181075|Doxorubicin|doxorubicin|mesh-list
43985137|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43985138|NCT02181075|Liver Extracts|liver extracts|mesh-list
43985139|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43985140|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985141|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43985142|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43985143|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985144|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985146|NCT02181127|Glucagon|glucagon|mesh-list
43985147|NCT02181127|Pancrelipase|pancrelipase|mesh-list
43985148|NCT02181127|Pancreatin|pancreatin|mesh-list
43985149|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985150|NCT02181127|Hormones|hormones|mesh-ancestor
43985151|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985152|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985153|NCT02181231|Buprenorphine|buprenorphine|mesh-list
43985154|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43985155|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43985156|NCT02181231|Narcotics|narcotics|mesh-ancestor
43985157|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985158|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985159|NCT02181231|Analgesics|analgesics|mesh-ancestor
43985160|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
43985170|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985171|NCT02181387|Acetaminophen|acetaminophen|mesh-list
43985172|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985173|NCT02181387|Analgesics|analgesics|mesh-ancestor
43985174|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
43985175|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985176|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985177|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
43985178|NCT02181426|Ketorolac|ketorolac|mesh-list
43985179|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43985180|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985181|NCT02181426|Analgesics|analgesics|mesh-ancestor
43985182|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
43985183|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985184|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985185|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985186|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985187|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43985188|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985189|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985190|NCT02181517|Ranibizumab|ranibizumab|mesh-list
44244114|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
44244115|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
44244116|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244117|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244118|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244119|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
44244120|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
44244121|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44244122|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
43985191|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43985192|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43985193|NCT02181517|Growth Substances|growth substances|mesh-ancestor
43985194|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985195|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
43985196|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985197|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43985198|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985199|NCT02182492|Clarithromycin|clarithromycin|mesh-list
43985200|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
43985201|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985202|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985203|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43985204|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985205|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985206|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43985207|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43832829|NCT05249972|Vitamins|vitamins|mesh-ancestor
43985208|NCT02182492|Hormones|hormones|mesh-ancestor
43985209|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985210|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985211|NCT02183792|Furosemide|furosemide|mesh-list
43985212|NCT02183792|Tolvaptan|tolvaptan|mesh-list
43985213|NCT02183792|Diuretics|diuretics|mesh-ancestor
43985214|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
43985215|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985216|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43985217|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985218|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985219|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43985220|NCT02185131|Mirtazapine|mirtazapine|mesh-list
43985221|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
43985232|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43985234|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43985235|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985236|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43985237|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43985238|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
43985239|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43985240|NCT02185339|Rocuronium|rocuronium|mesh-list
43985241|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43985242|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43985243|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43985244|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985245|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985246|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43985247|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43985248|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43985249|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43985250|NCT02186665|Calcitriol|calcitriol|mesh-list
43985251|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43985252|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985253|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43985254|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106640|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244123|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244124|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244125|NCT05590936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44244126|NCT05590936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244127|NCT05590936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244128|NCT05590936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244129|NCT05590936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44244130|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44244131|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
44244132|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
44244133|NCT05582096|Tirzepatide|tirzepatide|mesh-list
44025831|NCT00281879|Busulfan|busulfan|mesh-list
43985255|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985256|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43985257|NCT02186665|Vitamins|vitamins|mesh-ancestor
43985258|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
43985259|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43985260|NCT02187016|Listerine|listerine|mesh-list
43985261|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43985262|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985263|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
43985264|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43985265|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43985266|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985267|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
43985268|NCT02188576|Coagulants|coagulants|mesh-ancestor
43985269|NCT02189122|Aspirin|aspirin|mesh-list
43985270|NCT02189122|Bradykinin|bradykinin|mesh-list
43985271|NCT02189122|Kininogens|kininogens|mesh-list
43985272|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43985273|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985274|NCT02189122|Analgesics|analgesics|mesh-ancestor
43985275|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
43985276|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985277|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985278|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985279|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985280|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43985282|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985283|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43985284|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43985293|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43985294|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43985295|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985296|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985297|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985298|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
43985299|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985300|NCT02189317|Bupivacaine|bupivacaine|mesh-list
43985301|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985302|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
43985303|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985304|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985305|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
43985306|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985307|NCT02189629|Trifarotene|trifarotene|mesh-list
43985308|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43985309|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43985310|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43985311|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985312|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43985313|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985314|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985315|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44244134|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244135|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244136|NCT05582096|Incretins|incretins|mesh-ancestor
44244137|NCT05582096|Hormones|hormones|mesh-ancestor
44244138|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244139|NCT05572203|Caseins|caseins|mesh-list
44244140|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
44244141|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
44244142|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244143|NCT05569382|Verapamil|verapamil|mesh-list
44244144|NCT05569382|Bisoprolol|bisoprolol|mesh-list
44244145|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244146|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44244147|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44244148|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985316|NCT02189889|Hematinics|hematinics|mesh-ancestor
43985317|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43985318|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43985319|NCT02190903|Anesthetics|anesthetics|mesh-list
43985320|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985321|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985322|NCT02191033|Nicotine|nicotine|mesh-list
43985323|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43985324|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
43985325|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985326|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985327|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43985328|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43985329|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
43985330|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985331|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985332|NCT02191865|Nintedanib|nintedanib|mesh-list
43985333|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985334|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43985335|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985336|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985337|NCT02192541|Aflibercept|aflibercept|mesh-list
43985338|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43985339|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43985340|NCT02192541|Growth Substances|growth substances|mesh-ancestor
43985341|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985342|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
43985343|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985344|NCT02192684|Pioglitazone|pioglitazone|mesh-list
43985345|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43985346|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985347|NCT02192814|Lacosamide|lacosamide|mesh-list
43985348|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
43985349|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43985350|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43985351|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985372|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43985373|NCT02194088|Diclofenac|diclofenac|mesh-list
43985374|NCT02194088|Atropine|atropine|mesh-list
43985375|NCT02194088|Analgesics|analgesics|mesh-list
43985376|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43985377|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985378|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
43985379|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985380|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244149|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44244150|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244151|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244152|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44244153|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
44244154|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
44244155|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897207|NCT03830918|Temozolomide|temozolomide|mesh-list
43985381|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985382|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985383|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43985384|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985385|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985386|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43985387|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43985388|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43985389|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
43985390|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43985391|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
43985392|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
43985393|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
43985394|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43985395|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43985396|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
43985397|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985398|NCT02195232|Quercetin|quercetin|mesh-list
43985399|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
43985400|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985401|NCT02195232|Protective Agents|protective agents|mesh-ancestor
43985402|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985403|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
43985404|NCT02195895|Vitamin D|vitamin d|mesh-list
43985405|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
43985406|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
43985407|NCT02195895|Alendronate|alendronate|mesh-list
43985408|NCT02195895|Vitamins|vitamins|mesh-list
43985424|NCT02196168|Adavosertib|adavosertib|mesh-list
43985425|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985426|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985427|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985428|NCT02196831|Tesamorelin|tesamorelin|mesh-list
43985429|NCT02196831|Growth Substances|growth substances|mesh-ancestor
43985430|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985431|NCT02196857|Azacitidine|azacitidine|mesh-list
43985432|NCT02196857|Sorafenib|sorafenib|mesh-list
43985433|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43985434|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
43985435|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985436|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985437|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985438|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43985439|NCT02197065|Atorvastatin|atorvastatin|mesh-list
43985440|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43985441|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43985442|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
43985443|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985444|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43985445|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43985446|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985447|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43985448|NCT02197273|Epinephrine|epinephrine|mesh-list
43985449|NCT02197273|Fentanyl|fentanyl|mesh-list
43985450|NCT02197273|Morphine|morphine|mesh-list
43985451|NCT02197273|Bupivacaine|bupivacaine|mesh-list
43985452|NCT02197273|Ropivacaine|ropivacaine|mesh-list
43985453|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985454|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
43985455|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985456|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244156|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44244157|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44244158|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44244159|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
44244160|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244161|NCT05568797|Vaccines|vaccines|mesh-list
44244162|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
44244163|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985457|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
43985458|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985459|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43985460|NCT02197273|Narcotics|narcotics|mesh-ancestor
43985461|NCT02197273|Analgesics|analgesics|mesh-ancestor
43985462|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43985463|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43985464|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
43985465|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43985466|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43985467|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985468|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985469|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985479|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
43985480|NCT02197273|Hormones|hormones|mesh-ancestor
43985481|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985482|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43985483|NCT02197273|Protective Agents|protective agents|mesh-ancestor
43985484|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43985485|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985486|NCT02197455|Tofacitinib|tofacitinib|mesh-list
43985487|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43985488|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985489|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985490|NCT02197767|Rituximab|rituximab|mesh-list
43985491|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43985492|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985493|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
43985494|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985495|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985496|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
43985497|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
43985498|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43985499|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43985500|NCT02199041|Prednisolone|prednisolone|mesh-list
43985501|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
43985502|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
43985503|NCT02199041|Melphalan|melphalan|mesh-list
43985504|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
43985505|NCT02199041|Thiotepa|thiotepa|mesh-list
43985506|NCT02199041|Fludarabine|fludarabine|mesh-list
43985507|NCT02199041|Tacrolimus|tacrolimus|mesh-list
43985508|NCT02199041|Lenograstim|lenograstim|mesh-list
43985509|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43985510|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
43985511|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985512|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
43985513|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985514|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985515|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43985516|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
43985517|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985518|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985519|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43985520|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43985521|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985522|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43985523|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43985524|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
43985525|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44244164|NCT05568095|Leucovorin|leucovorin|mesh-list
44244165|NCT05568095|Fluorouracil|fluorouracil|mesh-list
44244166|NCT05568095|Capecitabine|capecitabine|mesh-list
44244167|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
44244168|NCT05568095|Nivolumab|nivolumab|mesh-list
44244169|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
44244170|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244171|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44244172|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244173|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244174|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
44244175|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244176|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244177|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43985526|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985527|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985528|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
43985529|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
43985530|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985531|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985532|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
43985533|NCT02199041|Hormones|hormones|mesh-ancestor
43985534|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985535|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43985536|NCT02199041|Protective Agents|protective agents|mesh-ancestor
43985537|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43985544|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985545|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
43985546|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985547|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985548|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
43985549|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985550|NCT02199652|Prazosin|prazosin|mesh-list
43985551|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43985552|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43985553|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43985554|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43985555|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985556|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985557|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985558|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144827|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144828|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144829|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44144830|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144831|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144832|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144833|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44144834|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44144835|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144836|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144837|NCT00193141|Paclitaxel|paclitaxel|mesh-list
44144838|NCT00193141|Carboplatin|carboplatin|mesh-list
44144839|NCT00193141|Fluorouracil|fluorouracil|mesh-list
44144840|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144841|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144842|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144843|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144844|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144845|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144846|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
44244178|NCT05568095|Antidotes|antidotes|mesh-ancestor
44244179|NCT05568095|Protective Agents|protective agents|mesh-ancestor
44244180|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
44244181|NCT05568095|Vitamins|vitamins|mesh-ancestor
44244182|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
44244183|NCT05566223|Aldesleukin|aldesleukin|mesh-list
44244184|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
44244185|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
44244186|NCT05566223|Fludarabine|fludarabine|mesh-list
44244187|NCT05566223|Interleukin-2|interleukin-2|mesh-list
44244188|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244189|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
44244190|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244191|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144847|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144848|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144849|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
43721208|NCT02624505|Albuterol|albuterol|mesh-list
43985559|NCT02199743|Haloperidol|haloperidol|mesh-list
43985560|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
43985561|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43985562|NCT02199743|Perphenazine|perphenazine|mesh-list
43985563|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
43985564|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
43985565|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985566|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985567|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985568|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43985569|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985570|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985571|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985572|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43985573|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
43985574|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985575|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985576|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43985577|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43985578|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43985579|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43985580|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985581|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43985582|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43985583|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
43985596|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985597|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43985598|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43985599|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43985601|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985602|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985603|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
44026188|NCT00003726|Lepirudin|lepirudin|mesh-list
43985604|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985605|NCT02201394|Aspirin|aspirin|mesh-list
43985606|NCT02201394|Ticagrelor|ticagrelor|mesh-list
43985607|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43985608|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985609|NCT02201394|Analgesics|analgesics|mesh-ancestor
43985610|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
43985611|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985612|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985613|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985614|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985615|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43985616|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43985617|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985618|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44244193|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
44244194|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244195|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244196|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44244197|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244198|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44244199|NCT05566223|Analgesics|analgesics|mesh-ancestor
44244200|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
44244201|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244202|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44244203|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44244204|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
44244205|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985619|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43985620|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985621|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
43985622|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43985623|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43985624|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43985625|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
43985626|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985627|NCT02202135|Vancomycin|vancomycin|mesh-list
43985628|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43985629|NCT02202135|Aztreonam|aztreonam|mesh-list
43985630|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985631|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985632|NCT02203019|Fentanyl|fentanyl|mesh-list
43985633|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
43985634|NCT02203019|Propofol|propofol|mesh-list
43985635|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43985636|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985637|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985638|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43985639|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
43985640|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
43985641|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985642|NCT02203019|Analgesics|analgesics|mesh-ancestor
43985643|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
43985644|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985645|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43985646|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43985647|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43985648|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985651|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43985652|NCT02203019|Narcotics|narcotics|mesh-ancestor
43985653|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43985654|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43985655|NCT02203565|Eusol|eusol|mesh-list
43985656|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43985657|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
43985658|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985659|NCT02203578|Romidepsin|romidepsin|mesh-list
43985660|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43985661|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985662|NCT02203630|Phenylephrine|phenylephrine|mesh-list
43985663|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
43985664|NCT02203630|Norepinephrine|norepinephrine|mesh-list
43985665|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43985666|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
43985667|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
43985668|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985669|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244206|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
44244208|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
44244209|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244210|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244211|NCT05555615|Pimavanserin|pimavanserin|mesh-list
44244212|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44244213|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44244214|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44244215|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244216|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244217|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244218|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244219|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43985670|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
43985671|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43985672|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
43985673|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43985674|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43985675|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43985676|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43985677|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985678|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985679|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985680|NCT02203630|Protective Agents|protective agents|mesh-ancestor
43985681|NCT02203786|Haloperidol|haloperidol|mesh-list
43985682|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
43985683|NCT02203786|Fluphenazine|fluphenazine|mesh-list
43985684|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
43985685|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
43985686|NCT02203786|Amphetamine|amphetamine|mesh-list
43985687|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
43985688|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
43985689|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
43985690|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985691|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985692|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985693|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43985694|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985695|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985696|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985697|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43985698|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
43985699|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985700|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985701|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43985702|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43985703|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
43985704|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
43985705|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43985706|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43985707|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985708|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43985709|NCT02205801|Bupivacaine|bupivacaine|mesh-list
43985710|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985711|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
43985712|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244220|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44244221|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
44244222|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244223|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985713|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985714|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
43985715|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985716|NCT02205983|Acetaminophen|acetaminophen|mesh-list
43985717|NCT02205983|Hydromorphone|hydromorphone|mesh-list
43985718|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985719|NCT02205983|Analgesics|analgesics|mesh-ancestor
43985720|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
43985721|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985722|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985723|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
43985733|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43985734|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43985735|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
43985737|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985738|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43985739|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43985740|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985741|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985742|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43985743|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43985744|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43985745|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985746|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985747|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
43985748|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
43985749|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
43985750|NCT02208037|Maraviroc|maraviroc|mesh-list
43985751|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
43985752|NCT02208037|Methotrexate|methotrexate|mesh-list
43985753|NCT02208037|Bortezomib|bortezomib|mesh-list
43985754|NCT02208037|Tacrolimus|tacrolimus|mesh-list
43985755|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985756|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
43985757|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985758|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43985759|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43985760|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
43985761|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985762|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985763|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43985764|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43985765|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
43985766|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43985767|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43985768|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
43985769|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
43985770|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985771|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43985772|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43985773|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43985774|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43985775|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43985776|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
43985777|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985778|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985779|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43985780|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43985781|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43985782|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44244237|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44244238|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
44244239|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
44244240|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244241|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244242|NCT05548660|Analgesics|analgesics|mesh-list
43985783|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
43985784|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43985785|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43985786|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43985787|NCT02208310|Vitamin D|vitamin d|mesh-list
43985788|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
43985789|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
43985790|NCT02208310|Vitamins|vitamins|mesh-list
43985791|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
43985798|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985799|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985800|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985801|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
43985802|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985803|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43985804|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
43985805|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985806|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43985807|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43985808|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985810|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
43985811|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985812|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
43985813|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985814|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985815|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
43985816|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985817|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43985818|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43985819|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43985820|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985821|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985822|NCT02209519|Metronidazole|metronidazole|mesh-list
43985823|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985824|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985825|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43985826|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43985827|NCT02209610|Fentanyl|fentanyl|mesh-list
43985828|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43985829|NCT02209610|Narcotics|narcotics|mesh-ancestor
43985830|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985831|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985832|NCT02209610|Analgesics|analgesics|mesh-ancestor
43985833|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
43985834|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985835|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43985836|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43985837|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
43985838|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
43985839|NCT02209948|Temozolomide|temozolomide|mesh-list
43985840|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43985841|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
43985842|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985843|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985844|NCT02210195|Aprepitant|aprepitant|mesh-list
43985845|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
43985846|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
43985847|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244243|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
44244244|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244245|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244246|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44244247|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244248|NCT05542667|Fluorides|fluorides|mesh-list
44244249|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
44244250|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
43985848|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985849|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985850|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43985851|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985852|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985853|NCT02210247|Bupivacaine|bupivacaine|mesh-list
43985854|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985855|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
43985856|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985857|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985869|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43985870|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985871|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43985872|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985873|NCT02213900|Haloperidol|haloperidol|mesh-list
43985874|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
43985875|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
43985876|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
43985877|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985878|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985879|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985880|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43985881|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985882|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985883|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985884|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43985885|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
43985886|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985887|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985888|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43985889|NCT02214290|Caffeine|caffeine|mesh-list
43985890|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43985891|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985892|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43985893|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985894|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985895|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43985896|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43985897|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
43985898|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985900|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
43985901|NCT02214420|Simeprevir|simeprevir|mesh-list
43985902|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
43985903|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985904|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
43985905|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985906|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
43985907|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985908|NCT02214615|Carbamazepine|carbamazepine|mesh-list
43985909|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
43985910|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
43985911|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985912|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985913|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985914|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985915|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985916|NCT02214615|Analgesics|analgesics|mesh-ancestor
43985917|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
44244251|NCT05542667|Protective Agents|protective agents|mesh-ancestor
44244252|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244253|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
44244254|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44244255|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244256|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244257|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244258|NCT05534087|Irinotecan|irinotecan|mesh-list
44244259|NCT05534087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44244260|NCT05534087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44244261|NCT05534087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244262|NCT05534087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244263|NCT05534087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244264|NCT05529251|Carboplatin|carboplatin|mesh-list
43985918|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985919|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43985920|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985921|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985925|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
43985926|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
43985927|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43985928|NCT02214628|Growth Substances|growth substances|mesh-ancestor
43985929|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985930|NCT02215070|Pasireotide|pasireotide|mesh-list
43985932|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43985933|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721511|NCT02622854|Insulin|insulin|mesh-list
43985934|NCT02215200|Lenograstim|lenograstim|mesh-list
43985935|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
43985936|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43985937|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43985938|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
43985939|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985940|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985941|NCT02216422|Ritonavir|ritonavir|mesh-list
43985942|NCT02216422|Ribavirin|ribavirin|mesh-list
43985943|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43985944|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43985945|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
43985946|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985947|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985948|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43985949|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43985950|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
43985951|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985952|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43985953|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43985954|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
43985955|NCT02217800|Octreotide|octreotide|mesh-list
43985956|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985957|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43985958|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985959|NCT02217904|Islatravir|islatravir|mesh-list
43985960|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
43985961|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985962|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985963|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985964|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43985965|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44244265|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459706|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44459707|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459708|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459709|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459710|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44459711|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44459712|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
44459713|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44459714|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44459715|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
43985966|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43985967|NCT02218190|Alvimopan|alvimopan|mesh-list
43985968|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985969|NCT02218203|Lidocaine|lidocaine|mesh-list
43985970|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
43985971|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985972|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
43850315|NCT05688332|Metformin|metformin|mesh-list
43985973|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985974|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985975|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
43985976|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985977|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43985978|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43985979|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43985980|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985981|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985982|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
43985983|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
43985984|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43985985|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43985986|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985987|NCT02218307|Mupirocin|mupirocin|mesh-list
43985988|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985989|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985990|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43985991|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985999|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43986000|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43986001|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986002|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986003|NCT02218463|Estradiol|estradiol|mesh-list
43986004|NCT02218463|Estrogens|estrogens|mesh-ancestor
43986005|NCT02218463|Hormones|hormones|mesh-ancestor
43986006|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986007|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986008|NCT02219321|Lidocaine|lidocaine|mesh-list
43986009|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
43986010|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
43986011|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986012|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986013|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
43986014|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986015|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43986016|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43986017|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43986018|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986019|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986020|NCT02219503|Ritonavir|ritonavir|mesh-list
43986021|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43986022|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44459716|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
44459717|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44459718|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44459719|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44459720|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459721|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459722|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986023|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986024|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986025|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986026|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43986027|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43986028|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
43986029|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986030|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43986031|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43986032|NCT02219516|Verinurad|verinurad|mesh-list
43986033|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
43986034|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144850|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144851|NCT00193154|Bevacizumab|bevacizumab|mesh-list
44144852|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44144853|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144854|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144855|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44144856|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44144857|NCT00193154|Growth Substances|growth substances|mesh-ancestor
44144858|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144859|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44144860|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44144861|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144862|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144863|NCT00193167|Topotecan|topotecan|mesh-list
44144864|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144865|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144866|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144867|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144868|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144869|NCT00193193|Paclitaxel|paclitaxel|mesh-list
44144870|NCT00193193|Carboplatin|carboplatin|mesh-list
44144871|NCT00193193|Estramustine|estramustine|mesh-list
44144872|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144873|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144877|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144878|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144880|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44144881|NCT00193232|Docetaxel|docetaxel|mesh-list
44144882|NCT00193232|Bortezomib|bortezomib|mesh-list
44144883|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144884|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144885|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144886|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144887|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144888|NCT00193245|Docetaxel|docetaxel|mesh-list
44144889|NCT00193245|Topotecan|topotecan|mesh-list
44144890|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144891|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144892|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144893|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144894|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144895|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144896|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144897|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144898|NCT00193271|Docetaxel|docetaxel|mesh-list
44144899|NCT00193271|Estramustine|estramustine|mesh-list
44144900|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144901|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44459723|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459724|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459725|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44459726|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459727|NCT01575028|Bupivacaine|bupivacaine|mesh-list
44459728|NCT01575028|Ropivacaine|ropivacaine|mesh-list
44459729|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
44144902|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
43986035|NCT02219997|Methamphetamine|methamphetamine|mesh-list
43986036|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
43986037|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43986038|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43986039|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43986040|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986041|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
43986042|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
43986043|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986044|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
43986045|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986046|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986047|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43986048|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43986049|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43986050|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986051|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43986053|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986054|NCT02221219|Indomethacin|indomethacin|mesh-list
43986055|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986056|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986057|NCT02221219|Analgesics|analgesics|mesh-ancestor
43986058|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
43986059|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986060|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986061|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986062|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986063|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
43986064|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
43986065|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986066|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43986067|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986068|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986069|NCT02221349|Listerine|listerine|mesh-list
43986070|NCT02221349|Fluorides|fluorides|mesh-list
43986071|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
43986072|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
43986073|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
43986074|NCT02221349|Protective Agents|protective agents|mesh-ancestor
43986075|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986076|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43986077|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986078|NCT02221739|Ipilimumab|ipilimumab|mesh-list
43986084|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43986085|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
43986086|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986087|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986088|NCT02222129|Bupivacaine|bupivacaine|mesh-list
43986089|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
43986090|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
43986091|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986092|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986093|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
43986094|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986095|NCT02222610|Ranibizumab|ranibizumab|mesh-list
43986096|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43986097|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43986098|NCT02222610|Growth Substances|growth substances|mesh-ancestor
43986099|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986100|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459732|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459733|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
44459734|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459735|NCT01574716|Gemcitabine|gemcitabine|mesh-list
44459736|NCT01574716|Docetaxel|docetaxel|mesh-list
44459737|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44459738|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
44459739|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459740|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986101|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986102|NCT02222870|Vaccines|vaccines|mesh-list
43986103|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
43986104|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986105|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
43986106|NCT02223065|Saxagliptin|saxagliptin|mesh-list
43986107|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43986108|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986109|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43986110|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986111|NCT02223065|Incretins|incretins|mesh-ancestor
43986112|NCT02223065|Hormones|hormones|mesh-ancestor
43986113|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986114|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43986115|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986116|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986117|NCT02223260|Dabigatran|dabigatran|mesh-list
43986118|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
43986119|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43986120|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986121|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986122|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986123|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
43986124|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
43986125|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43986126|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986127|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43986128|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43986129|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986130|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986131|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986132|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43986133|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43986134|NCT02223351|Ritonavir|ritonavir|mesh-list
43986135|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43986136|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43986137|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986138|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986139|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986140|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43986141|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43986142|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
43986143|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986144|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43986145|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43986156|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
43986157|NCT02223702|Amoxicillin|amoxicillin|mesh-list
43986158|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
43986159|NCT02223702|Metronidazole|metronidazole|mesh-list
43986160|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43986161|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459742|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459743|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459744|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459745|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
44459746|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244267|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244268|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43986162|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43986163|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43986164|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986165|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986166|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986167|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43986168|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43986169|NCT02223871|Lumefantrine|lumefantrine|mesh-list
43986170|NCT02223871|Artemether|artemether|mesh-list
43986171|NCT02223871|Primaquine|primaquine|mesh-list
43986172|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
43986173|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43986174|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43986175|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986176|NCT02224313|Estradiol|estradiol|mesh-list
43986177|NCT02224313|Progesterone|progesterone|mesh-list
43986178|NCT02224313|Estrogens|estrogens|mesh-ancestor
43986179|NCT02224313|Hormones|hormones|mesh-ancestor
43986180|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986181|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986182|NCT02224313|Progestins|progestins|mesh-ancestor
43986183|NCT02224729|Dexamethasone|dexamethasone|mesh-list
43986184|NCT02224729|Bortezomib|bortezomib|mesh-list
43986185|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43986186|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986187|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
43986188|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
43986189|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986190|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986191|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43986192|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
43986193|NCT02224729|Hormones|hormones|mesh-ancestor
43986194|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986195|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986196|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986197|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43986198|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
43986199|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986200|NCT02225106|Methylphenidate|methylphenidate|mesh-list
43986201|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43986202|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986203|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43986204|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43986205|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986206|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986207|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
43986208|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986209|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
43986210|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986211|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
43986212|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986213|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986214|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43986225|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986226|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43986227|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986228|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244269|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244270|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244271|NCT05523895|Pimavanserin|pimavanserin|mesh-list
44244272|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44244273|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44244274|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44244275|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244276|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244277|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244278|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244279|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44244280|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44244281|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
44244282|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244283|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244284|NCT05518149|Aticaprant|aticaprant|mesh-list
44244285|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44244286|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244287|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
44244288|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244289|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
44244290|NCT05513560|Ibudilast|ibudilast|mesh-list
44244291|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44244292|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244293|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986229|NCT02227329|Ethanol|ethanol|mesh-list
43986230|NCT02227329|Heparin|heparin|mesh-list
43986231|NCT02227329|Calcium heparin|calcium heparin|mesh-list
43986232|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
43986233|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43986234|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43986235|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986236|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43986237|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986238|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986239|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986240|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
43986241|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43986242|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986243|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
43986244|NCT02227667|Durvalumab|durvalumab|mesh-list
43986245|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43986246|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986247|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43986248|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
43986249|NCT02227706|Coagulants|coagulants|mesh-ancestor
43986250|NCT02228408|Hydralazine|hydralazine|mesh-list
43986251|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43986252|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244294|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44244295|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44244296|NCT05513560|Protective Agents|protective agents|mesh-ancestor
44244297|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244298|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244299|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44244300|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
44244301|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44244302|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
44244303|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244304|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43986253|NCT02228681|Tamoxifen|tamoxifen|mesh-list
43986254|NCT02228681|Everolimus|everolimus|mesh-list
43986255|NCT02228681|Letrozole|letrozole|mesh-list
43986256|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43986257|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
43986258|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986259|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986260|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
43986261|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986262|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43986263|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43986264|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986265|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986266|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43986267|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
43986268|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986269|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986270|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43986271|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43986272|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43986273|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43986274|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43986275|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43986276|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
43986277|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986278|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43986285|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986287|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43986288|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986289|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986290|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986291|NCT02229461|Aspirin|aspirin|mesh-list
43986292|NCT02229461|Naproxen|naproxen|mesh-list
43986293|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986294|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986296|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
43986297|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986298|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986299|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986300|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986301|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43986302|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43986303|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986304|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43986305|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43986306|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986307|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
43986308|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
43986309|NCT02230696|Fluticasone|fluticasone|mesh-list
43986310|NCT02230696|Xhance|xhance|mesh-list
43986311|NCT02230696|Azelastine|azelastine|mesh-list
43986312|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244305|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244306|NCT05507775|Digoxin|digoxin|mesh-list
44244307|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244308|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44244309|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244310|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244311|NCT05507775|Protective Agents|protective agents|mesh-ancestor
44244312|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244313|NCT05506982|Psilocybin|psilocybin|mesh-list
43986313|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43986314|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
43986315|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986316|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986317|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43986318|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
43986319|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
43986320|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43986321|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43986322|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986323|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986324|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43986325|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43986326|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
43986327|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
43986328|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986329|NCT02230995|Metformin|metformin|mesh-list
43986330|NCT02230995|Empagliflozin|empagliflozin|mesh-list
43986331|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43986332|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986333|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43721887|NCT02620293|Emollients|emollients|mesh-list
44144903|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
43986334|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986335|NCT02231086|Leucovorin|leucovorin|mesh-list
43986336|NCT02231086|Fluorouracil|fluorouracil|mesh-list
43986337|NCT02231086|Capecitabine|capecitabine|mesh-list
43986338|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
43986339|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
43986340|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986341|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43986342|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986343|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986344|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
43986345|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986346|NCT02231086|Antidotes|antidotes|mesh-ancestor
43986356|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986357|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43986358|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
43986359|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
43986360|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43986361|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986362|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986363|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986364|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
43986365|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43986366|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43986367|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986368|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
43986369|NCT02233101|Coagulants|coagulants|mesh-ancestor
43986371|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43986372|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
43986373|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986374|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986375|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986376|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
43986377|NCT02233751|Testosterone|testosterone|mesh-list
44244314|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
44244315|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244316|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244317|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
44244318|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44244319|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
44244320|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244321|NCT05494398|Expectorants|expectorants|mesh-ancestor
44244322|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244323|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44244324|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
44244325|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244326|NCT05494398|Protective Agents|protective agents|mesh-ancestor
44244327|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244328|NCT05494398|Antidotes|antidotes|mesh-ancestor
43986378|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
43986379|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
43986380|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43986381|NCT02233751|Androgens|androgens|mesh-ancestor
43986382|NCT02233751|Hormones|hormones|mesh-ancestor
43986383|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986384|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986385|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986386|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986387|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
43986388|NCT02233998|Listerine|listerine|mesh-list
43986389|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
43986390|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43986391|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986392|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
43986393|NCT02233998|Protective Agents|protective agents|mesh-ancestor
43986394|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986395|NCT02234115|Leuprolide|leuprolide|mesh-list
43986396|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43986397|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
43986398|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986399|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986400|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986401|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986402|NCT02234427|Aspirin|aspirin|mesh-list
43986403|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986404|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986405|NCT02234427|Analgesics|analgesics|mesh-ancestor
43986406|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
43721957|NCT02619513|Ropivacaine|ropivacaine|mesh-list
43986407|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986408|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986409|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986410|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986411|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43986412|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43986413|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986435|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986436|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43986438|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986439|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
43986440|NCT02235064|Sertraline|sertraline|mesh-list
43986441|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
43986442|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027134|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986443|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43986444|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44244329|NCT05491356|Plasminogen|plasminogen|mesh-list
44244330|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44244331|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44244332|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44244333|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244334|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
44244335|NCT05478837|Fludarabine|fludarabine|mesh-list
44244336|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244337|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
44244338|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244339|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244340|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44244341|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
43986445|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986446|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986447|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986448|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
43986449|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986450|NCT02235987|Octreotide|octreotide|mesh-list
43986451|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43986452|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986453|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986454|NCT02237417|Aripiprazole|aripiprazole|mesh-list
43986455|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
43986456|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
43986457|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43986458|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43986459|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986460|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986461|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
43986462|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
43986463|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986464|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986465|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43986466|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43986467|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
43986482|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43722007|NCT02619526|Carvedilol|carvedilol|mesh-list
43986483|NCT02237989|Acetaminophen|acetaminophen|mesh-list
43986484|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986485|NCT02237989|Analgesics|analgesics|mesh-ancestor
43986486|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
43986487|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986488|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986489|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
44144904|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144905|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144906|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
44144907|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44144908|NCT00193284|Carboplatin|carboplatin|mesh-list
44144909|NCT00193284|Docetaxel|docetaxel|mesh-list
44144910|NCT00193284|Fluorouracil|fluorouracil|mesh-list
44144911|NCT00193284|Gefitinib|gefitinib|mesh-list
44144912|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144913|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144914|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144915|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144916|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144917|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
44144918|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106642|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44244342|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244344|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44244345|NCT05476432|Leucovorin|leucovorin|mesh-list
44244346|NCT05476432|Fluorouracil|fluorouracil|mesh-list
44244347|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
44244348|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
44244349|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244350|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44244351|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244352|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144919|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144920|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
44144921|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144922|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44144923|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144924|NCT00193297|Paclitaxel|paclitaxel|mesh-list
44144925|NCT00193297|Carboplatin|carboplatin|mesh-list
44144926|NCT00193297|Topotecan|topotecan|mesh-list
44144927|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144928|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144929|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144930|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144931|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144932|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144933|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144934|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144935|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144936|NCT00193310|Paclitaxel|paclitaxel|mesh-list
44144937|NCT00193310|Carboplatin|carboplatin|mesh-list
44144938|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144939|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144940|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144941|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144942|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144950|NCT00193323|Antiviral Agents|antiviral agents|mesh-ancestor
44144951|NCT00193323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144952|NCT00193323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144953|NCT00193323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144954|NCT00193323|Immunologic Factors|immunologic factors|mesh-ancestor
44144955|NCT00193323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144956|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144957|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144958|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144959|NCT00193336|Gefitinib|gefitinib|mesh-list
44144960|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144961|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44144962|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144963|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144964|NCT00193349|Carboplatin|carboplatin|mesh-list
44144965|NCT00193349|Irinotecan|irinotecan|mesh-list
44144966|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
44144967|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144968|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144969|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144970|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144971|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144972|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44144973|NCT00193362|Gemcitabine|gemcitabine|mesh-list
44144974|NCT00193362|Paclitaxel|paclitaxel|mesh-list
43986490|NCT02238977|Bupropion|bupropion|mesh-list
43986491|NCT02238977|Fluoxetine|fluoxetine|mesh-list
43986492|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43986493|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
43986494|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811577|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
44244353|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
44244354|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244355|NCT05476432|Antidotes|antidotes|mesh-ancestor
44244356|NCT05476432|Protective Agents|protective agents|mesh-ancestor
44244357|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
44244358|NCT05476432|Vitamins|vitamins|mesh-ancestor
44244359|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
44244360|NCT05469685|Amoxicillin|amoxicillin|mesh-list
44244361|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44244362|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244363|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44244364|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
44244365|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244366|NCT05455658|Vaccines|vaccines|mesh-list
44244367|NCT05455658|Sargramostim|sargramostim|mesh-list
44244368|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
44244369|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244370|NCT05449522|Vitamin D|vitamin d|mesh-list
44244371|NCT05449522|Vitamins|vitamins|mesh-ancestor
44244372|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
43986495|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43986496|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43986497|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986498|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986499|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
43986500|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986501|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986502|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43986503|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43986504|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986505|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43986506|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
43986507|NCT02239380|Lorazepam|lorazepam|mesh-list
43986508|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
43986509|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
43986510|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
43986511|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986512|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986513|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43986514|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43986515|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986516|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43986517|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43986518|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43986519|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
43986520|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
43986521|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871163|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986522|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986523|NCT02239770|Nicotine|nicotine|mesh-list
43986530|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986531|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986532|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986533|NCT02240030|Levodopa|levodopa|mesh-list
43986534|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43986535|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43986536|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
43986537|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244374|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44244375|NCT05430152|Naltrexone|naltrexone|mesh-list
44244376|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44244377|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44244378|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244379|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
44244380|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986538|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986539|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986540|NCT02240329|Capsaicin|capsaicin|mesh-list
43986541|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
43986542|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
43986543|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
43986544|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986545|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986546|NCT02240589|Memantine|memantine|mesh-list
43986547|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43986548|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43986549|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
43986550|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986551|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986552|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986553|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43986554|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43986555|NCT02240667|Vitamin K|vitamin k|mesh-list
43986556|NCT02240667|Dabigatran|dabigatran|mesh-list
43986557|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
43986558|NCT02240667|Vitamins|vitamins|mesh-ancestor
43986559|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
44027345|NCT00000301|Analgesics|analgesics|mesh-ancestor
43986560|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986561|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
43986562|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43986563|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986564|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722102|NCT02619032|Remifentanil|remifentanil|mesh-list
43986565|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986566|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
43986567|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43986568|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43986569|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
43986570|NCT02240667|Coagulants|coagulants|mesh-ancestor
43986571|NCT02241486|Fentanyl|fentanyl|mesh-list
43986572|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43986573|NCT02241486|Narcotics|narcotics|mesh-ancestor
43986574|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986575|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986576|NCT02241486|Analgesics|analgesics|mesh-ancestor
43986577|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
43986578|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986579|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43986580|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43986581|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
43986582|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
43986583|NCT02241655|Anesthetics|anesthetics|mesh-list
43986584|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986585|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986586|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
43986587|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43986588|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43986589|NCT02242630|Prednisolone|prednisolone|mesh-list
43986590|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
43986591|NCT02242630|Triamcinolone|triamcinolone|mesh-list
43986592|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43986593|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43986608|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986609|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244381|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
44244382|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
44244383|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
44244384|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244385|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
44244386|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44244387|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244388|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244389|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244390|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
44244391|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244392|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244393|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244394|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43986610|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986611|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
43986612|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986613|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986614|NCT02243007|Gemcitabine|gemcitabine|mesh-list
43986615|NCT02243007|Paclitaxel|paclitaxel|mesh-list
43986616|NCT02243007|Capecitabine|capecitabine|mesh-list
43986617|NCT02243007|Folfirinox|folfirinox|mesh-list
43986618|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43986619|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986620|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
43986621|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
43986622|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
43986623|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986624|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43986625|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
43986626|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
43986627|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986628|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986629|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986630|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
43986631|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986632|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
43986633|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43986634|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986635|NCT02243943|Neostigmine|neostigmine|mesh-list
43986636|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43986637|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986638|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986639|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986640|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144975|NCT00193362|Vinorelbine|vinorelbine|mesh-list
43986641|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986642|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43986643|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
43986644|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986645|NCT02244918|Nicotine|nicotine|mesh-list
43986646|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43986647|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
43986648|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986649|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986650|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43986651|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43986652|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986653|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986675|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244395|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44244396|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
44244397|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244398|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244400|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244401|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244402|NCT05410223|Amoxicillin|amoxicillin|mesh-list
44244403|NCT05410223|Clarithromycin|clarithromycin|mesh-list
44244404|NCT05410223|Doxycycline|doxycycline|mesh-list
44244405|NCT05410223|Furazolidone|furazolidone|mesh-list
44244406|NCT05410223|Bismuth|bismuth|mesh-list
44244407|NCT05410223|Antibodies|antibodies|mesh-list
43986676|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986677|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986678|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986680|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43986681|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986682|NCT02249585|Trace Elements|trace elements|mesh-ancestor
43986683|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
43986684|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986685|NCT02250612|Timolol|timolol|mesh-list
43986686|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43986687|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43986688|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
43986689|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986690|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986691|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986692|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43986693|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43986694|NCT02250703|Midazolam|midazolam|mesh-list
43986695|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
43986696|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43986697|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986698|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986699|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986700|NCT02250703|Analgesics|analgesics|mesh-ancestor
43986701|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
43986702|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986703|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43986704|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43986711|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43986712|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43986713|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43986714|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
43986715|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
43986716|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
43986717|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
43986718|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
43986719|NCT02250807|Simeprevir|simeprevir|mesh-list
43986720|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
43986721|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986722|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986723|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986724|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986725|NCT02251236|Tenofovir|tenofovir|mesh-list
43986726|NCT02251236|Emtricitabine|emtricitabine|mesh-list
43986727|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43986728|NCT02251236|Cobicistat|cobicistat|mesh-list
43986729|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43986730|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43986731|NCT02251236|Elvitegravir|elvitegravir|mesh-list
43986732|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
43986733|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986734|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44244408|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
44244409|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
44244410|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244411|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44244412|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244413|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44244414|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244415|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244416|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43897460|NCT02772588|Leuprolide|leuprolide|mesh-list
44244417|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44244418|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
44244419|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43986735|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43986736|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986737|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986738|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43986739|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43986740|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43986741|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43986742|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43986743|NCT02251379|Fluticasone|fluticasone|mesh-list
43986744|NCT02251379|Xhance|xhance|mesh-list
43986745|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43986746|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43986747|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
43986748|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986749|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986750|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43986751|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
43986752|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
43986753|NCT02251379|Hormones|hormones|mesh-ancestor
43986754|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986755|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
43986756|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986757|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
43986758|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43986759|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43986760|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43986761|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43986762|NCT02251613|Epinastine|epinastine|mesh-list
43986763|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986764|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986765|NCT02251613|Analgesics|analgesics|mesh-ancestor
43986766|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
43986767|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986768|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986769|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986770|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986771|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43986772|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43986781|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43986782|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986783|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
43986784|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986785|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
43986786|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986787|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43986788|NCT02252354|Relugolix|relugolix|mesh-list
43986789|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
43986790|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
44244420|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44244421|NCT05410223|Antacids|antacids|mesh-ancestor
44244422|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244423|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44244424|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44244425|NCT05410223|Renal Agents|renal agents|mesh-ancestor
44244426|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43986791|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986792|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986793|NCT02252445|Propofol|propofol|mesh-list
43986794|NCT02252445|Sevoflurane|sevoflurane|mesh-list
43986795|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43986796|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986797|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986798|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43986799|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
43986800|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
43986801|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43986802|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43986803|NCT02253160|Lenograstim|lenograstim|mesh-list
43986804|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43986805|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
43986806|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986807|NCT02253173|Estradiol|estradiol|mesh-list
43986808|NCT02253173|Estrogens|estrogens|mesh-ancestor
43986809|NCT02253173|Hormones|hormones|mesh-ancestor
43986810|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986811|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986812|NCT02254252|Nicorandil|nicorandil|mesh-list
43986813|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
43986814|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
43986815|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43986816|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43986817|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
43986818|NCT02254252|Vitamins|vitamins|mesh-ancestor
43986819|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
43986820|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986822|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43986823|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986824|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43986825|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43986826|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986827|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986828|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43986829|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43986830|NCT02255175|Estradiol|estradiol|mesh-list
43986831|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43986832|NCT02255175|Progesterone|progesterone|mesh-list
43986833|NCT02255175|Estrogens|estrogens|mesh-ancestor
43986834|NCT02255175|Hormones|hormones|mesh-ancestor
43986835|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986836|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986837|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43986838|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
43986839|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986840|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43986841|NCT02255175|Progestins|progestins|mesh-ancestor
43986842|NCT02255357|Oxytocin|oxytocin|mesh-list
43986843|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
43986844|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986845|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986846|NCT02255513|Methylphenidate|methylphenidate|mesh-list
43986847|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43986848|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986849|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43986850|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43986851|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986852|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244427|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44459748|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459749|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44459750|NCT01574703|Bupropion|bupropion|mesh-list
44459751|NCT01574703|Nicotine|nicotine|mesh-list
44459752|NCT01574703|Varenicline|varenicline|mesh-list
44459753|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44459754|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
44459755|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459756|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459757|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44459758|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44459759|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459760|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986853|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
43986854|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986855|NCT02256111|Androgens|androgens|mesh-list
43986856|NCT02256111|Hormones|hormones|mesh-ancestor
43986857|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986858|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986859|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43986860|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43986861|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986862|NCT02256189|Incretins|incretins|mesh-ancestor
43986863|NCT02256189|Hormones|hormones|mesh-ancestor
43986864|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986865|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43986866|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986867|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986868|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986869|NCT02256358|Midazolam|midazolam|mesh-list
43986870|NCT02256358|Ketamine|ketamine|mesh-list
43986871|NCT02256358|Analgesics|analgesics|mesh-ancestor
43986872|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
43986873|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986874|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986875|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43986876|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43986877|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
43986878|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
43986879|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986880|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43986881|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43986882|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986883|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986884|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43986885|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43986886|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43986887|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43986888|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43986889|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
43986890|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
43986891|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
43986892|NCT02257541|Infigratinib|infigratinib|mesh-list
43986893|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986894|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43986895|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986896|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459761|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459762|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44459763|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
43986897|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43986898|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
43986899|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43986900|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43986901|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
43986902|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986903|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
43986904|NCT02257957|Protective Agents|protective agents|mesh-ancestor
43986905|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43986906|NCT02258217|Hormones|hormones|mesh-ancestor
43986907|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986908|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144976|NCT00193362|Carboplatin|carboplatin|mesh-list
44144977|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144978|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144979|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144980|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144981|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144982|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144993|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44144994|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144995|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144996|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144997|NCT00193401|Topotecan|topotecan|mesh-list
44144998|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44144999|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145000|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145001|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145002|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145003|NCT00193440|Rituximab|rituximab|mesh-list
44145004|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44145005|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145006|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
43986910|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43986911|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
43986912|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986913|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43986914|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986915|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
43986916|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
43986917|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43986918|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
43986919|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986920|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
43986921|NCT02260440|Azacitidine|azacitidine|mesh-list
43986922|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43986923|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986924|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43986925|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
43986926|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986927|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986928|NCT02260531|Trastuzumab|trastuzumab|mesh-list
43986929|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43986930|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986931|NCT02260622|Aspirin|aspirin|mesh-list
43986932|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
43986933|NCT02260622|Clopidogrel|clopidogrel|mesh-list
43986934|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986935|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986936|NCT02260622|Analgesics|analgesics|mesh-ancestor
43986937|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
43986938|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986939|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986940|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986941|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43986942|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43986943|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44459764|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459765|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44459766|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44459767|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459768|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
44459769|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44027705|NCT00000345|Lofexidine|lofexidine|mesh-list
44459770|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459771|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459772|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
44459773|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
44459774|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
43752359|NCT02491970|Xhance|xhance|mesh-list
43986944|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986945|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43986946|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43986947|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986948|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
43986949|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43986955|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
43986956|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43986957|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
43986958|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
43986959|NCT02261727|Prednisone|prednisone|mesh-list
43986960|NCT02261727|Cortisone|cortisone|mesh-list
43986961|NCT02261727|Theophylline|theophylline|mesh-list
43986962|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986963|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
43986964|NCT02261727|Hormones|hormones|mesh-ancestor
43986965|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986966|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986967|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43986968|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986969|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43986970|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
43986971|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986972|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43986973|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
43986974|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43986975|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986976|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986977|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
43986978|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43986979|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43986980|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
43986981|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986982|NCT02261805|Doxorubicin|doxorubicin|mesh-list
43986983|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43986984|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986985|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43986986|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43986987|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986988|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986989|NCT02261948|Simendan|simendan|mesh-list
43986990|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43986991|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
43986992|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43986993|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43986994|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986995|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986996|NCT02261948|Protective Agents|protective agents|mesh-ancestor
43986997|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986998|NCT02262130|Omalizumab|omalizumab|mesh-list
44459775|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44459776|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
44459777|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459778|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459779|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459780|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
43986999|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43987000|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43987001|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987002|NCT02264353|Donepezil|donepezil|mesh-list
43987003|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43987004|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987005|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987006|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
43987007|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987008|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987009|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
43987010|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
43987011|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43987012|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
43987013|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987014|NCT02265224|Expectorants|expectorants|mesh-ancestor
43987015|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987016|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43987017|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
43987018|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987019|NCT02265224|Protective Agents|protective agents|mesh-ancestor
43987029|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987031|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
43987032|NCT02266472|Metformin|metformin|mesh-list
43987033|NCT02266472|Empagliflozin|empagliflozin|mesh-list
43987034|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43987035|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987036|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43987037|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987038|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
43987039|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987040|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
43987041|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43987042|NCT02267083|Doxorubicin|doxorubicin|mesh-list
43987043|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43987044|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987045|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43987046|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43987047|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987048|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987049|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
43987050|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43987051|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987052|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987053|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987054|NCT02267538|Analgesics|analgesics|mesh-ancestor
43987055|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
43987056|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987057|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43987058|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43987060|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987061|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987062|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987063|NCT02267772|Acetaminophen|acetaminophen|mesh-list
43987064|NCT02267772|Morphine|morphine|mesh-list
43987065|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43987066|NCT02267772|Narcotics|narcotics|mesh-ancestor
43987067|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987068|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987069|NCT02267772|Analgesics|analgesics|mesh-ancestor
43987070|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
44459781|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44459782|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44459783|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44459784|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459785|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459786|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459787|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
44459788|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44459789|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
44459790|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44459791|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44459793|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
44459794|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459795|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
43987071|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987072|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987073|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
43987074|NCT02268955|Ibuprofen|ibuprofen|mesh-list
43987075|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987076|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987077|NCT02268955|Analgesics|analgesics|mesh-ancestor
43987078|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
43987079|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987080|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987081|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987082|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987083|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987084|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987085|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987086|NCT02270255|Lidocaine|lidocaine|mesh-list
43987099|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
43987100|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43987101|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987102|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987103|NCT02271425|Evacetrapib|evacetrapib|mesh-list
43987104|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43987105|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43987106|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
43987107|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987108|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43987109|NCT02271698|Dexamethasone|dexamethasone|mesh-list
43987110|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
43987111|NCT02271698|BB 1101|bb 1101|mesh-list
43987112|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987113|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
43987114|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
43987115|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987116|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987117|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987118|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
43987119|NCT02271698|Hormones|hormones|mesh-ancestor
43987120|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987121|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987122|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987123|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
43987124|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987125|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987126|NCT02271906|Afatinib|afatinib|mesh-list
44459796|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459797|NCT01574326|Sevelamer|sevelamer|mesh-list
44459798|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
44459799|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
44459800|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459801|NCT01574274|Pegaspargase|pegaspargase|mesh-list
44459802|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459803|NCT01574248|Icatibant|icatibant|mesh-list
43987127|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987128|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43987129|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987130|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987131|NCT02273115|Oxytocin|oxytocin|mesh-list
43987132|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
43987133|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43987134|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987135|NCT02274870|Bupivacaine|bupivacaine|mesh-list
43987136|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987137|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
44027945|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027946|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027947|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027948|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027949|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44027950|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027951|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027952|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027953|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645970|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
43645972|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43645973|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43645974|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645975|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645976|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43645977|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645978|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645979|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
43987138|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987139|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987140|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
43987141|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987142|NCT02276274|Alogliptin|alogliptin|mesh-list
43987143|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43987144|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987145|NCT02276274|Incretins|incretins|mesh-ancestor
43987146|NCT02276274|Hormones|hormones|mesh-ancestor
44165298|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027955|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027956|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027957|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44027958|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44027959|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027960|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43645980|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645981|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645982|NCT03632642|Floxacillin|floxacillin|mesh-list
43645983|NCT03632642|Penicillin G|penicillin g|mesh-list
43987156|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987157|NCT02277249|Protective Agents|protective agents|mesh-ancestor
43987158|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987160|NCT02277548|Analgesics|analgesics|mesh-ancestor
43987161|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
43987162|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987163|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987164|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
43987165|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43987166|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027961|NCT00000390|Imipramine|imipramine|mesh-list
44027962|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43645985|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
43645986|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645987|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645988|NCT03618134|Durvalumab|durvalumab|mesh-list
43987167|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987168|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43987169|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43987170|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43987171|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987172|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43987173|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44027963|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
43645989|NCT03618134|Ipilimumab|ipilimumab|mesh-list
43645990|NCT03618134|Tremelimumab|tremelimumab|mesh-list
43645991|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
43645992|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645993|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
43645994|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645995|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645996|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
43987174|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145007|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145008|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145009|NCT00193466|Rituximab|rituximab|mesh-list
44145010|NCT00193466|Fludarabine|fludarabine|mesh-list
44145011|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44145012|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145013|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
44145014|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145015|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44027964|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027965|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027966|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027967|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027968|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027969|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027970|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027971|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027972|NCT00000399|Hormones|hormones|mesh-list
43645997|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645998|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645999|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646001|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646002|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43646003|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
43646004|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145016|NCT00193505|Rituximab|rituximab|mesh-list
44145017|NCT00193505|Carboplatin|carboplatin|mesh-list
44145018|NCT00193505|Etoposide|etoposide|mesh-list
44145019|NCT00193505|Ifosfamide|ifosfamide|mesh-list
44145020|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44145021|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145022|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
44145023|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027973|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44027974|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027975|NCT00000400|Alendronate|alendronate|mesh-list
44027976|NCT00000400|Teriparatide|teriparatide|mesh-list
44027977|NCT00000400|Hormones|hormones|mesh-list
44027978|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
43646005|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646006|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43646007|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
43646008|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
43646009|NCT03615742|Hormones|hormones|mesh-ancestor
43646010|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145024|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145025|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145026|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44145027|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44459804|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44459805|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459806|NCT01574248|Analgesics|analgesics|mesh-ancestor
44459807|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
44459808|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459809|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459810|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459811|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459812|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44145028|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145029|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027979|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44027980|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027981|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44027982|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44027983|NCT00000402|Calcium|calcium|mesh-list
44027984|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44027985|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757698|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
44027986|NCT00000403|Doxycycline|doxycycline|mesh-list
44027987|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44027988|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44027989|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
44027990|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44027991|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44027992|NCT00000412|Alendronate|alendronate|mesh-list
44027994|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43646012|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
43646013|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43646014|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
43646015|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646016|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646017|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43646018|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44145030|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44145031|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
44145032|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
44145033|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145034|NCT00193531|Paclitaxel|paclitaxel|mesh-list
44145035|NCT00193531|Etoposide|etoposide|mesh-list
44145036|NCT00193531|Carboplatin|carboplatin|mesh-list
44145037|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145038|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145039|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
43987175|NCT02279641|Allopurinol|allopurinol|mesh-list
43987176|NCT02279641|Verinurad|verinurad|mesh-list
43987177|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
43987186|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987187|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
43987188|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44027995|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027996|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44027997|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44027998|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027999|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028000|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44028001|NCT00000412|Vitamins|vitamins|mesh-ancestor
44028002|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
44028003|NCT00000415|Calcium|calcium|mesh-list
44028004|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44028005|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028006|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
44028007|NCT00000429|Calcium|calcium|mesh-list
44028008|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44028009|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646019|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43646020|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987189|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987190|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987191|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987192|NCT02280811|Aldesleukin|aldesleukin|mesh-list
43987193|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
43987194|NCT02280811|Fludarabine|fludarabine|mesh-list
43987195|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987196|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
43987197|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987198|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987199|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43987200|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
44028010|NCT00000429|Antacids|antacids|mesh-ancestor
44028011|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028012|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44028013|NCT00000430|Alendronate|alendronate|mesh-list
44028014|NCT00000430|Estrogens|estrogens|mesh-list
44028015|NCT00000430|Progestins|progestins|mesh-list
44028016|NCT00000430|Hormones|hormones|mesh-ancestor
44028017|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028018|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028019|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44028020|NCT00000437|Naltrexone|naltrexone|mesh-list
44028021|NCT00000437|Nicotine|nicotine|mesh-list
44028022|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44028023|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
43646022|NCT03614494|Analgesics|analgesics|mesh-ancestor
43646023|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
43646024|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646025|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646026|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646027|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43646028|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987201|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987202|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987203|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43987204|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43987205|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43987206|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
43987207|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987208|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43987209|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43987210|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
43987211|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
43987212|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987213|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987214|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
43987215|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987216|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987217|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987218|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987219|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987220|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
43987221|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
43987222|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43987223|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43987224|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987225|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
44106643|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44244428|NCT05398484|Psilocybin|psilocybin|mesh-list
44244429|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
44244430|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244431|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244432|NCT05392608|Fulvestrant|fulvestrant|mesh-list
44244433|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44244434|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244435|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44244436|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44244437|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
43987226|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987227|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987228|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987229|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987230|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44028026|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43987231|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987232|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
43987233|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987234|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987235|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987236|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987237|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987238|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
43987239|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987240|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987247|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
43987248|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987249|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
43987250|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987251|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987252|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43987253|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
43987254|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987255|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987256|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43987257|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43987258|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987259|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
44028067|NCT00000441|Lorazepam|lorazepam|mesh-list
44028068|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
44028069|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
44028070|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
44028071|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028072|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028073|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44028074|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44028075|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028076|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44028077|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44028078|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028079|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
44028080|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
44028081|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028082|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028083|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
44028084|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44028085|NCT00000441|Analgesics|analgesics|mesh-ancestor
44028086|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
44028087|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44028088|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028089|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44028090|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44028091|NCT00000442|Naltrexone|naltrexone|mesh-list
43987260|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
43987261|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987262|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987263|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
43987265|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987266|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43987267|NCT02282514|Protective Agents|protective agents|mesh-ancestor
43987268|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987269|NCT02282904|Sirolimus|sirolimus|mesh-list
43987270|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
43987271|NCT02282904|Busulfan|busulfan|mesh-list
43987272|NCT02282904|Fludarabine|fludarabine|mesh-list
43987273|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987274|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
43987275|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987276|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028092|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028093|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028094|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028095|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
44028096|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028097|NCT00000443|Ondansetron|ondansetron|mesh-list
44028098|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
44028099|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
44028100|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028101|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028102|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44028103|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
44028104|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44028105|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44028107|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028108|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028109|NCT00000443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43987277|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43987278|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
43987279|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987280|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987281|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43987282|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987283|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987284|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43987285|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
44244438|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244439|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244440|NCT05392452|Insulin|insulin|mesh-list
44244441|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244442|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244443|NCT05382728|Osimertinib|osimertinib|mesh-list
44244444|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244445|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44244446|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987286|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43987287|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987288|NCT02283814|Topiramate|topiramate|mesh-list
43987289|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987290|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
43987291|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43987292|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987293|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987294|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987295|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987296|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028110|NCT00000443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44028111|NCT00000443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028112|NCT00000443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028113|NCT00000443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44028114|NCT00000444|Nicotine|nicotine|mesh-list
44028115|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44028116|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
44028117|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028118|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028119|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44028120|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44028121|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
44028124|NCT00000445|Naltrexone|naltrexone|mesh-list
43987297|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987298|NCT02283827|Phenytoin|phenytoin|mesh-list
43987299|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
43987300|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987301|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987302|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987303|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987304|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43987305|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43987306|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987307|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
43987319|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722768|NCT02614833|Paclitaxel|paclitaxel|mesh-list
43987320|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
43987321|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987322|NCT02284464|Prednisone|prednisone|mesh-list
43987323|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987324|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
43987325|NCT02284464|Hormones|hormones|mesh-ancestor
43987326|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987327|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987328|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987329|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987330|NCT02284516|Lifitegrast|lifitegrast|mesh-list
43987331|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43987332|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43987333|NCT02284555|Mupirocin|mupirocin|mesh-list
43987334|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987335|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987336|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43987337|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987338|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987339|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987340|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
43987341|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987342|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987343|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987344|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987345|NCT02284854|Carbamazepine|carbamazepine|mesh-list
43987346|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987347|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
43987348|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
43987349|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43987350|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244447|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244448|NCT05382091|Naltrexone|naltrexone|mesh-list
44244449|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44244450|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44244451|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244452|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
43987351|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987352|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028182|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44028183|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43646029|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646030|NCT03604978|Nivolumab|nivolumab|mesh-list
43646031|NCT03604978|Ipilimumab|ipilimumab|mesh-list
43646032|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646033|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646034|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646035|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987353|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987354|NCT02284854|Analgesics|analgesics|mesh-ancestor
43987355|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
43987356|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987357|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987358|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987359|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987360|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43987361|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43987362|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987363|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987364|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
43987365|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987366|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987367|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028184|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028185|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028186|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
44028187|NCT00000452|Naltrexone|naltrexone|mesh-list
44028188|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028189|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028190|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028191|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
44028192|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028193|NCT00000454|Nicotine|nicotine|mesh-list
44028194|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44028195|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
44028196|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028197|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028198|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44028199|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44028200|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43987374|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987375|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987376|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43987377|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
43987378|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987379|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987380|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43987382|NCT02285634|Phenylephrine|phenylephrine|mesh-list
43987383|NCT02285634|Epinephrine|epinephrine|mesh-list
43987384|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
43987385|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987386|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
43987387|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987388|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987389|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
43987390|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987391|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43987392|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987393|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987394|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987395|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987396|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44028201|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028202|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028203|NCT00000455|Naltrexone|naltrexone|mesh-list
44028204|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028205|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028206|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028207|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
44028208|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028209|NCT00000458|Sertraline|sertraline|mesh-list
44028210|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
44028211|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028212|NCT00000458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44028213|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44028214|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028215|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028216|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028217|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
44028218|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028219|NCT00000469|Aspirin|aspirin|mesh-list
44028220|NCT00000469|Lovastatin|lovastatin|mesh-list
44028221|NCT00000469|L 647318|l 647318|mesh-list
44028222|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
44028223|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44028224|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987397|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43987398|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987399|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987400|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43987401|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43987402|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
43987403|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43987404|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987405|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
43987406|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
43987407|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43987408|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43987409|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
43987410|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43987411|NCT02285634|Protective Agents|protective agents|mesh-ancestor
43987412|NCT02286726|Cytarabine|cytarabine|mesh-list
43987413|NCT02286726|Daunorubicin|daunorubicin|mesh-list
43987414|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44028225|NCT00000469|Analgesics|analgesics|mesh-ancestor
43646036|NCT03602157|Fludarabine|fludarabine|mesh-list
43646037|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43646038|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646039|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646040|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646041|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
43646042|NCT03568838|Enoxaparin|enoxaparin|mesh-list
43646043|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
43646044|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43646045|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43646046|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646047|NCT03564678|Folic Acid|folic acid|mesh-list
43987415|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
43987416|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244453|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244454|NCT05378269|Tamoxifen|tamoxifen|mesh-list
44244455|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44244456|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
44244457|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244458|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244459|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44244460|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028226|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
44028227|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028228|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028229|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44028230|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028231|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44028232|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44028233|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028234|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44028235|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43646049|NCT03564678|Vitamins|vitamins|mesh-ancestor
44028236|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244461|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44244462|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43987417|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987418|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
43987419|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987420|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987421|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
43987422|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987423|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43987424|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43987425|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43987426|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028237|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
44028238|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44028239|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028240|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
44028241|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44028242|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44028243|NCT00000477|Lovastatin|lovastatin|mesh-list
44028244|NCT00000477|L 647318|l 647318|mesh-list
44028245|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
44028246|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44028247|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028248|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
44028249|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987427|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
43987428|NCT02286921|Testosterone|testosterone|mesh-list
43987429|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
43987430|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
43987431|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43987432|NCT02286921|Androgens|androgens|mesh-ancestor
43987433|NCT02286921|Hormones|hormones|mesh-ancestor
43987434|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987440|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987442|NCT02287350|Analgesics|analgesics|mesh-ancestor
43987443|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
43987444|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028250|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44028251|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44028252|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028253|NCT00000483|Niacin|niacin|mesh-list
44028255|NCT00000483|Estrogens|estrogens|mesh-list
44028256|NCT00000483|Hormones|hormones|mesh-ancestor
44028257|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028258|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028259|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028260|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
43646050|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
43646051|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646052|NCT03564678|Hematinics|hematinics|mesh-ancestor
43646054|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43646055|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987445|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987446|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987447|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987448|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987449|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987450|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987451|NCT02287376|Diclofenac|diclofenac|mesh-list
43987452|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987453|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987454|NCT02287376|Analgesics|analgesics|mesh-ancestor
43987455|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
44028261|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028262|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44028263|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028264|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
44028265|NCT00000483|Vitamins|vitamins|mesh-ancestor
43646056|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43646057|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
43646058|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
44028266|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
43987456|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987457|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987458|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722913|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43987459|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987460|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987461|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028267|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44028268|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
44028269|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44028270|NCT00000484|Diuretics|diuretics|mesh-ancestor
44028271|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
44028272|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028273|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43646059|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646060|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646061|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646062|NCT03543189|Nivolumab|nivolumab|mesh-list
43646063|NCT03543189|Androgens|androgens|mesh-list
43987462|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987463|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43987464|NCT02287415|Warfarin|warfarin|mesh-list
43987465|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
43987466|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
43987467|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987468|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987469|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987470|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987472|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43987473|NCT02287909|Clopidogrel|clopidogrel|mesh-list
43987474|NCT02287909|Ticagrelor|ticagrelor|mesh-list
44244463|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44244465|NCT05378100|Ketamine|ketamine|mesh-list
44244466|NCT05378100|Analgesics|analgesics|mesh-ancestor
43987475|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43987476|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43987477|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43987478|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43987479|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
43987480|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028274|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028275|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028276|NCT00000496|Aspirin|aspirin|mesh-list
44028277|NCT00000496|Dipyridamole|dipyridamole|mesh-list
44028278|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44028279|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44028280|NCT00000496|Analgesics|analgesics|mesh-ancestor
44028281|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
44028282|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028283|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028284|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44028285|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028286|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44028287|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43757937|NCT02456961|Riboflavin|riboflavin|mesh-list
44028288|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028289|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44028290|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44028291|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028292|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
44028293|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44028294|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
43987481|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987482|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987483|NCT02288156|Capsaicin|capsaicin|mesh-list
43987484|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
43987485|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
43987486|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
43987487|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987488|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987489|NCT02288273|Exenatide|exenatide|mesh-list
43987490|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43987491|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987492|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43987493|NCT02288273|Incretins|incretins|mesh-ancestor
43987494|NCT02288273|Hormones|hormones|mesh-ancestor
43987495|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987496|NCT02288364|Lidocaine|lidocaine|mesh-list
43987497|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987498|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
43987499|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987500|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987501|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
43987502|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987508|NCT02288819|Diuretics|diuretics|mesh-list
43987509|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43987510|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
43987511|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987512|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987513|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987514|NCT02289222|Dexamethasone|dexamethasone|mesh-list
43987515|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
43987516|NCT02289222|Pomalidomide|pomalidomide|mesh-list
43987517|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987518|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
43987519|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
43987520|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987521|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148981|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44148982|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987522|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987523|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
43987524|NCT02289222|Hormones|hormones|mesh-ancestor
43987525|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987526|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987527|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987528|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43987529|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
43987530|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43987531|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43987532|NCT02289222|Growth Substances|growth substances|mesh-ancestor
43987533|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
43987534|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
43987535|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987536|NCT02290106|Pitavastatin|pitavastatin|mesh-list
43987537|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43987538|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43987539|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43987540|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
43987541|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987542|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987543|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43987545|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44149016|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149017|NCT00206466|Docetaxel|docetaxel|mesh-list
44149018|NCT00206466|Doxorubicin|doxorubicin|mesh-list
44149019|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
44149020|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44149021|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149022|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149023|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149024|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149025|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149026|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44149027|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44149028|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44149029|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149030|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149031|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
44149032|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149033|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149034|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44149035|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
44149036|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44149040|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106644|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
44244467|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
44244468|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244469|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244470|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44244471|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44244472|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
43987546|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43987547|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
43987548|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987549|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149041|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149042|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149043|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149044|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44149045|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43758020|NCT02456844|Vitamins|vitamins|mesh-ancestor
44028295|NCT00000505|Plasminogen|plasminogen|mesh-list
44028296|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44028297|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44028298|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43646068|NCT03543189|Hormones|hormones|mesh-ancestor
43646069|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646070|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646071|NCT03535363|Osimertinib|osimertinib|mesh-list
43987550|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987551|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987552|NCT02290613|Ambrisentan|ambrisentan|mesh-list
43987553|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43987554|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
43987555|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43987556|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
43987557|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987558|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987559|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43987560|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44028299|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028300|NCT00000506|Phentermine|phentermine|mesh-list
44028301|NCT00000506|Fenfluramine|fenfluramine|mesh-list
44028302|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43646072|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646073|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43646074|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646075|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646076|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
43646077|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44028303|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987561|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43987562|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43987563|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43987564|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987565|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987566|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987567|NCT02291133|Bleomycin|bleomycin|mesh-list
43987568|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43987569|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028304|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
44028305|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44028306|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
44028307|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
44028308|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028309|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
44028310|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028311|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646078|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646080|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646081|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43987578|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
43987579|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
43987580|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987581|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987582|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987583|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
43987584|NCT02292082|Hormones|hormones|mesh-ancestor
44028312|NCT00000506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44028313|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44028314|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43646082|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646083|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824019|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43824020|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43824021|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43824022|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
43824023|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824024|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824025|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824026|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
43824027|NCT05516589|Paclitaxel|paclitaxel|mesh-list
43824028|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43824029|NCT05516589|Cisplatin|cisplatin|mesh-list
43824030|NCT05516589|Afatinib|afatinib|mesh-list
43824031|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824032|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824033|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
43824034|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
43824035|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
43987585|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987586|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987587|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987588|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987589|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
43987590|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987591|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
43987592|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43987593|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43987594|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
43987595|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43987596|NCT02292082|Narcotics|narcotics|mesh-ancestor
43987597|NCT02292082|Analgesics|analgesics|mesh-ancestor
43987598|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43987599|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43987600|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43987601|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43987602|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
43987603|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
43987604|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987605|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987606|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44028315|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
44028316|NCT00000507|Streptokinase|streptokinase|mesh-list
44028317|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44028318|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44028319|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028320|NCT00000510|Aspirin|aspirin|mesh-list
44028321|NCT00000510|Dipyridamole|dipyridamole|mesh-list
44028322|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44028323|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44028324|NCT00000510|Analgesics|analgesics|mesh-ancestor
44028325|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
44028326|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028327|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028328|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44028329|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028330|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44028331|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44028332|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028333|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44028334|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44028335|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028336|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
43987607|NCT02292082|Protective Agents|protective agents|mesh-ancestor
43987608|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987609|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987610|NCT02293096|Metoprolol|metoprolol|mesh-list
43723055|NCT02612272|Ketorolac|ketorolac|mesh-list
43987611|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
43987612|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43987613|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43987614|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
43824036|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824037|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43824038|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824040|NCT05516446|Paclitaxel|paclitaxel|mesh-list
43824041|NCT05516446|Everolimus|everolimus|mesh-list
43824042|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824043|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824044|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
43987615|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
44244473|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
44244474|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987616|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987617|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987618|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43987619|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43987620|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43987621|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987622|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028337|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44028338|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028339|NCT00000512|Niacin|niacin|mesh-list
44028340|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
44028341|NCT00000512|Lovastatin|lovastatin|mesh-list
43824045|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646084|NCT03485729|TIC10 compound|tic10 compound|mesh-list
43646085|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646086|NCT03474744|Rituximab|rituximab|mesh-list
43987623|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987624|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
43987625|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987626|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43987627|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43987628|NCT02294253|Buprenorphine|buprenorphine|mesh-list
43987629|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43987630|NCT02294253|Naloxone|naloxone|mesh-list
44028342|NCT00000512|L 647318|l 647318|mesh-list
44028343|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
44028344|NCT00000512|Colestipol|colestipol|mesh-list
44028345|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43646087|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646088|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646089|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
43987631|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43987632|NCT02294253|Narcotics|narcotics|mesh-ancestor
43987633|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987634|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987635|NCT02294253|Analgesics|analgesics|mesh-ancestor
43987636|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
43987637|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987638|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43987639|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43987645|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987646|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43987647|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
43987648|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
43987649|NCT02295553|Analgesics|analgesics|mesh-ancestor
43987650|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
43987651|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987652|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43987653|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43987654|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43987655|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987656|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987657|NCT02296099|Bupivacaine|bupivacaine|mesh-list
43987658|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987659|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
43987660|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987661|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987662|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
43987663|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987664|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
43987665|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
44028346|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
44028347|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028348|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44028349|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028350|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
44028351|NCT00000512|Vitamins|vitamins|mesh-ancestor
44028352|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
44028353|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028354|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44028355|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44028356|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028357|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
44028358|NCT00000513|Atenolol|atenolol|mesh-list
43987666|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987667|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43987668|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987669|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43987670|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43987671|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
43987672|NCT02296346|Prednisolone|prednisolone|mesh-list
43987673|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
43987674|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43987675|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
43987676|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987677|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
43987678|NCT02296346|Hormones|hormones|mesh-ancestor
43987679|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987680|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987681|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43987682|NCT02296346|Protective Agents|protective agents|mesh-ancestor
43987683|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987684|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987685|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
43987686|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
43987687|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244475|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43987688|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987689|NCT02296775|Rituximab|rituximab|mesh-list
43987690|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43987691|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028376|NCT00000541|Vitamins|vitamins|mesh-list
44028377|NCT00000541|Folic Acid|folic acid|mesh-list
44028378|NCT00000541|Vitamin E|vitamin e|mesh-list
44028379|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
44028380|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
44028381|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
44028382|NCT00000541|Pyridoxal|pyridoxal|mesh-list
44028383|NCT00000541|Pyridoxine|pyridoxine|mesh-list
44028384|NCT00000541|Beta Carotene|beta carotene|mesh-list
44028385|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
44028386|NCT00000541|Carotenoids|carotenoids|mesh-list
44028387|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
44028388|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028389|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
44028390|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028391|NCT00000541|Protective Agents|protective agents|mesh-ancestor
44028392|NCT00000541|Hematinics|hematinics|mesh-ancestor
44028393|NCT00000541|Provitamins|provitamins|mesh-ancestor
44028394|NCT00000542|Amlodipine|amlodipine|mesh-list
44028395|NCT00000542|Lisinopril|lisinopril|mesh-list
44028396|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
44028397|NCT00000542|Doxazosin|doxazosin|mesh-list
43987692|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
43987693|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987694|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987695|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43987696|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43987697|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43987698|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987699|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987700|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44028407|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44028408|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028409|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
44028410|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646090|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646091|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646092|NCT03456063|Gemcitabine|gemcitabine|mesh-list
43646093|NCT03456063|Paclitaxel|paclitaxel|mesh-list
43646094|NCT03456063|Cisplatin|cisplatin|mesh-list
43646095|NCT03456063|Carboplatin|carboplatin|mesh-list
43646096|NCT03456063|Pemetrexed|pemetrexed|mesh-list
44028411|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43987701|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987702|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987703|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
43987704|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145040|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145041|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145042|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145043|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44028412|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028413|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
44028414|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44028415|NCT00000542|Protective Agents|protective agents|mesh-ancestor
44028416|NCT00000542|Diuretics|diuretics|mesh-ancestor
44028417|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
44028418|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43646097|NCT03456063|Atezolizumab|atezolizumab|mesh-list
43646098|NCT03456063|Antibodies|antibodies|mesh-list
43646099|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646100|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646101|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646102|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646103|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646104|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646105|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
44145044|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145045|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145047|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
44145048|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145049|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
44145050|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145051|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
44145052|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145053|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028419|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44028420|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44028421|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44028422|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44028423|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028424|NCT00000543|Calcium|calcium|mesh-list
44028425|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44028426|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028427|NCT00000547|Enalapril|enalapril|mesh-list
43646106|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646107|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43646108|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
43646109|NCT03456063|Antiviral Agents|antiviral agents|mesh-ancestor
43646110|NCT03456063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646111|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646112|NCT03456063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145054|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44145055|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44145056|NCT00193544|Growth Substances|growth substances|mesh-ancestor
44145057|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
44145058|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145059|NCT00193557|Bortezomib|bortezomib|mesh-list
44145060|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145061|NCT00193570|Docetaxel|docetaxel|mesh-list
44145062|NCT00193570|Topotecan|topotecan|mesh-list
44145063|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145064|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
44028428|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44028429|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44028430|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028431|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028432|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44028433|NCT00000549|Hormones|hormones|mesh-list
44028434|NCT00000549|Estrogens|estrogens|mesh-list
44028435|NCT00000549|Progestins|progestins|mesh-list
44028436|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028437|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646113|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43646114|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43646115|NCT03439345|Fenofibrate|fenofibrate|mesh-list
43646116|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43646117|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
43646118|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646119|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646120|NCT03439046|Letrozole|letrozole|mesh-list
43646121|NCT03439046|Fulvestrant|fulvestrant|mesh-list
43646122|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646123|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43646124|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43646125|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028438|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44145065|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145066|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145067|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145068|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44145069|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145070|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145071|NCT00193583|Carboplatin|carboplatin|mesh-list
44145072|NCT00193583|Topotecan|topotecan|mesh-list
44145073|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028439|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
44028440|NCT00000574|Ibuprofen|ibuprofen|mesh-list
44028441|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44028442|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44028443|NCT00000574|Analgesics|analgesics|mesh-ancestor
44028444|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
44028445|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028446|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646126|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646128|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646129|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646130|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646131|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43646132|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43646133|NCT03430661|Clopidogrel|clopidogrel|mesh-list
44028447|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145074|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44145075|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145076|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145077|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145078|NCT00193622|Bevacizumab|bevacizumab|mesh-list
44145079|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44145080|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44145081|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145082|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44145083|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44145084|NCT00193622|Growth Substances|growth substances|mesh-ancestor
44145085|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145086|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
44145087|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44145088|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145089|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145090|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
44145091|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145092|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145093|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44145094|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
44244476|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44244477|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244478|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145095|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145096|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145097|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987706|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43987707|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987708|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
43987709|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987710|NCT02299050|Bromocriptine|bromocriptine|mesh-list
44028448|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028449|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987711|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43987712|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987713|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
43987714|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987715|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987716|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
43987717|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
43987718|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987719|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723277|NCT02611336|Urological Agents|urological agents|mesh-ancestor
43987720|NCT02299089|Octreotide|octreotide|mesh-list
43987721|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987722|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987723|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987724|NCT02299297|Tofacitinib|tofacitinib|mesh-list
43987737|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
43987738|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987739|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43987740|NCT02299349|Narcotics|narcotics|mesh-ancestor
44028481|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028482|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028483|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43646138|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43646140|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
43646141|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646142|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646143|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646144|NCT03430219|Calcium|calcium|mesh-list
43646145|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43646146|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646147|NCT03424005|Gemcitabine|gemcitabine|mesh-list
43646148|NCT03424005|Paclitaxel|paclitaxel|mesh-list
43987741|NCT02299349|Analgesics|analgesics|mesh-ancestor
43987742|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43987743|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43987744|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987745|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987746|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987747|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43987748|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43987749|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
44028484|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
44028485|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44028486|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
44028487|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028488|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43646149|NCT03424005|Bevacizumab|bevacizumab|mesh-list
43646150|NCT03424005|Carboplatin|carboplatin|mesh-list
43646151|NCT03424005|Capecitabine|capecitabine|mesh-list
43646152|NCT03424005|Atezolizumab|atezolizumab|mesh-list
43646153|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646154|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646155|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646156|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644706|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987750|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43987751|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987752|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
43987753|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
43987754|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43987755|NCT02300077|Fentanyl|fentanyl|mesh-list
43987756|NCT02300077|Morphine|morphine|mesh-list
43987757|NCT02300077|Methadone|methadone|mesh-list
43987758|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43987759|NCT02300077|Narcotics|narcotics|mesh-ancestor
43987760|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987761|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987762|NCT02300077|Analgesics|analgesics|mesh-ancestor
43987763|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
43987764|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987765|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43987766|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43987767|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
43987768|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
43987769|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
43987770|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987771|NCT02300727|Curcumin|curcumin|mesh-list
43987772|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987773|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987774|NCT02300727|Analgesics|analgesics|mesh-ancestor
43987775|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
43987776|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987777|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987778|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987779|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987780|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987781|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244479|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244480|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44244481|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44244482|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244483|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244484|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
44244485|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
44244486|NCT05377333|Dulaglutide|dulaglutide|mesh-list
43987782|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987783|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
43987784|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43987785|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987786|NCT02301416|Topiramate|topiramate|mesh-list
43987787|NCT02301416|Phentermine|phentermine|mesh-list
43987788|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
43987789|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43987790|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987796|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987797|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
43987798|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987799|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987800|NCT02302092|Cefepime|cefepime|mesh-list
43987801|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987802|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987803|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
43987804|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43987805|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43987806|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
43987807|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987808|NCT02303184|Aflibercept|aflibercept|mesh-list
43987809|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43987810|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43987811|NCT02303184|Growth Substances|growth substances|mesh-ancestor
43987812|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987813|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
43987814|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987815|NCT02303977|Gemcitabine|gemcitabine|mesh-list
43987816|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43987817|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43987818|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
43987819|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987820|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987821|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
43987822|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987823|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987824|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43987825|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
43987826|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987827|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
43987828|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43987829|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987830|NCT02304159|Ribavirin|ribavirin|mesh-list
43987831|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
43987832|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
43987833|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987834|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
43987835|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028564|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028565|NCT00000614|Warfarin|warfarin|mesh-list
44028566|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
44028567|NCT00000617|Azithromycin|azithromycin|mesh-list
43646157|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646158|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987836|NCT02304432|Cycloserine|cycloserine|mesh-list
43987837|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43987838|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987839|NCT02304432|Renal Agents|renal agents|mesh-ancestor
43987840|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43987841|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
43987842|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987843|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
43987844|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987845|NCT02304757|Alendronate|alendronate|mesh-list
43987846|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
43987847|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44244487|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244488|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987848|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987849|NCT02305017|Acetaminophen|acetaminophen|mesh-list
43987850|NCT02305017|Opicapone|opicapone|mesh-list
43987851|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987852|NCT02305017|Analgesics|analgesics|mesh-ancestor
43987853|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
43987854|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987855|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987856|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
43723300|NCT02610920|Iron|iron|mesh-list
43987857|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43987858|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987859|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987860|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43987866|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43987867|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987868|NCT02305316|Opicapone|opicapone|mesh-list
43987869|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43987870|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987871|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987872|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43987873|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987874|NCT02305329|Opicapone|opicapone|mesh-list
43987875|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43987876|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987877|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987878|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43987879|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987880|NCT02306759|Ketamine|ketamine|mesh-list
43987881|NCT02306759|Analgesics|analgesics|mesh-ancestor
43987882|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
43987883|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987884|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987885|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43987886|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43987887|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
43987888|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
44028611|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028612|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44028613|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44028614|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028615|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028616|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44028617|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
44028618|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028619|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646159|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646160|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43646161|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43646162|NCT03424005|Growth Substances|growth substances|mesh-ancestor
43646163|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646164|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
43646165|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43987889|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987890|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43987891|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43987892|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987893|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987894|NCT02307318|Hemostatics|hemostatics|mesh-list
43987895|NCT02307318|Coagulants|coagulants|mesh-ancestor
43987896|NCT02307526|Bromides|bromides|mesh-list
44028620|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44028621|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44028622|NCT00000628|Zidovudine|zidovudine|mesh-list
44028623|NCT00000628|L-697661|l-697661|mesh-list
44028624|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
43646166|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
43646167|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
43646168|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646169|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646170|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43646171|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
43646172|NCT03423342|Niacinamide|niacinamide|mesh-list
43646174|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
43646175|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
43987897|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43987898|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
43987899|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43987900|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987901|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987902|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
43987903|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987904|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987905|NCT02307916|Mitogens|mitogens|mesh-list
43987906|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
44028625|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028626|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028627|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028628|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028629|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
44028630|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028631|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028632|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028633|NCT00000629|Zidovudine|zidovudine|mesh-list
44028634|NCT00000629|Valproic Acid|valproic acid|mesh-list
43547788|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646176|NCT03423342|Vitamins|vitamins|mesh-ancestor
43646177|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
43646178|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646179|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43646180|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
43646181|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987907|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987908|NCT02308501|Alcaftadine|alcaftadine|mesh-list
43987909|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43987910|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
43987911|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
43987912|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987913|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987914|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987915|NCT02311907|Paclitaxel|paclitaxel|mesh-list
43987916|NCT02311907|Carboplatin|carboplatin|mesh-list
43987917|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43987918|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43987919|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987920|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44244490|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44244491|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
44244492|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244493|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244494|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987921|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
43987922|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
43987923|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987925|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43987926|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
43987927|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987928|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987931|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43987932|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43987933|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43987934|NCT02312622|Irinotecan|irinotecan|mesh-list
43987935|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
43987936|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43987937|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43987938|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987939|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987940|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987941|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43987942|NCT02312739|Ketorolac|ketorolac|mesh-list
43987943|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43987944|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
43987945|NCT02312739|Analgesics|analgesics|mesh-list
43987946|NCT02312739|Lorazepam|lorazepam|mesh-list
43987947|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987948|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987949|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
43987950|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987951|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987952|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987953|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987954|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987955|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987956|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987957|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43987958|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
43987959|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
43987960|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987961|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
43987962|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
43987963|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
43987964|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43987965|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43987966|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43987967|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43987968|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43987969|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
43987970|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
43987971|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43987972|NCT02312882|Tofacitinib|tofacitinib|mesh-list
43987973|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43987974|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987975|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987976|NCT02313675|Acetaminophen|acetaminophen|mesh-list
43987977|NCT02313675|Ketorolac|ketorolac|mesh-list
43987978|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43987979|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987980|NCT02313675|Analgesics|analgesics|mesh-ancestor
43987981|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
43987982|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987983|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987984|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
43987985|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43987986|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987987|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244496|NCT05373901|Dinutuximab|dinutuximab|mesh-list
44244497|NCT05373901|Isotretinoin|isotretinoin|mesh-list
44244498|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244499|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
44244500|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44244502|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244503|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44244504|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244505|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244506|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43987988|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43987989|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987990|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987991|NCT02314104|Ropivacaine|ropivacaine|mesh-list
43987992|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987993|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
43987994|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987995|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987996|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
43987997|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987998|NCT02314403|Rituximab|rituximab|mesh-list
43987999|NCT02314403|Abatacept|abatacept|mesh-list
44028722|NCT00000647|Zidovudine|zidovudine|mesh-list
44028723|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44028724|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028725|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
44028726|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028727|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
44028728|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028729|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
44028730|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028731|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028732|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028733|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028734|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028735|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028736|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
44028737|NCT00000648|Penicillins|penicillins|mesh-list
44028738|NCT00000648|Penicillin G|penicillin g|mesh-list
44028739|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44028740|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
44028741|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028742|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646182|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646183|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
43646184|NCT03422731|Alovudine|alovudine|mesh-list
43646185|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
43646186|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646187|NCT03416530|TIC10 compound|tic10 compound|mesh-list
43646188|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646189|NCT03393741|Paclitaxel|paclitaxel|mesh-list
43646190|NCT03393741|Vinorelbine|vinorelbine|mesh-list
43988000|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43988001|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988002|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
43988011|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43988012|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988013|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988014|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43988015|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43988016|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988017|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43988018|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
43988020|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
43988021|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
43988022|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988023|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988024|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
43988025|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
43988026|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988027|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43988028|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43988029|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43988030|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988031|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43988032|NCT02315872|Hormones|hormones|mesh-ancestor
43988033|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988034|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988035|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
43988036|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43988037|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43988038|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988039|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
43988040|NCT02317549|Coagulants|coagulants|mesh-ancestor
43988041|NCT02317744|Naltrexone|naltrexone|mesh-list
43988042|NCT02317744|Bupropion|bupropion|mesh-list
43988043|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43988044|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43988045|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988046|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
43988047|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244508|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244509|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44244510|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
44244511|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
44244512|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
44244513|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
44244514|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244515|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244516|NCT05362292|Mirabegron|mirabegron|mesh-list
43988048|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43988049|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
43988050|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988051|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43988052|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43988053|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988054|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988055|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
43988056|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028801|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988057|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43988058|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43988059|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988060|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
43988061|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43988062|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988063|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988064|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43988065|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43988066|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988067|NCT02318303|Analgesics|analgesics|mesh-ancestor
43988073|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43988074|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
43988075|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
43988076|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988077|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157596|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43988078|NCT02319304|Leucovorin|leucovorin|mesh-list
43988079|NCT02319304|Fluorouracil|fluorouracil|mesh-list
43988080|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
43988081|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
43988082|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988083|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988084|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988085|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988086|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
43988087|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988088|NCT02319304|Antidotes|antidotes|mesh-ancestor
43988089|NCT02319304|Protective Agents|protective agents|mesh-ancestor
43988090|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
43988091|NCT02319304|Vitamins|vitamins|mesh-ancestor
43988092|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
43988093|NCT02319369|Azacitidine|azacitidine|mesh-list
43988094|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988095|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
44028802|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028803|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028804|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988096|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988097|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988098|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988100|NCT02319486|Etoposide|etoposide|mesh-list
43988101|NCT02319486|Vincristine|vincristine|mesh-list
43988102|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988103|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43988104|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43988105|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43988106|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988107|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244518|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44244519|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44244520|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44244521|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
44244522|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244523|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244524|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244525|NCT05362292|Urological Agents|urological agents|mesh-ancestor
44244526|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44244527|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44244528|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988108|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
43988109|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
43988110|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
43988111|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44028838|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028839|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028840|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44028841|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44028842|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
44028843|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
44028844|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028845|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44028846|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
44028848|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028850|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44028866|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
43988112|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
43988113|NCT02320695|Bacitracin|bacitracin|mesh-list
43988114|NCT02320695|Neomycin|neomycin|mesh-list
43988115|NCT02320695|Polymyxin B|polymyxin b|mesh-list
43988116|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43988117|NCT02320695|Ethanol|ethanol|mesh-list
43988118|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988119|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
43988120|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43988121|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988122|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988123|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43988124|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988125|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988126|NCT02321748|Montelukast|montelukast|mesh-list
43988127|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43988128|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44028868|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
44028869|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44028870|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
44028871|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
44028872|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
44028873|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
44028874|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44028875|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
44028876|NCT00000659|Zidovudine|zidovudine|mesh-list
44028877|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
44028878|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028879|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028880|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028881|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028882|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
44028883|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988129|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43988130|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
43988131|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988132|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988133|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43988134|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43988135|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988136|NCT02322242|Dexamethasone|dexamethasone|mesh-list
43988137|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
43988138|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43988139|NCT02322242|BB 1101|bb 1101|mesh-list
43988140|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988141|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
43988142|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
43988143|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988144|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988145|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988146|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
43988147|NCT02322242|Hormones|hormones|mesh-ancestor
43988148|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988149|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43988150|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988151|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
43723536|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
43988152|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988153|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988154|NCT02322320|Lenalidomide|lenalidomide|mesh-list
43988155|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
44244529|NCT05361447|Diazepam|diazepam|mesh-list
44244530|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244531|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
44244532|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
44244533|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
44244534|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244535|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244536|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244537|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44244538|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244539|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44244540|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44244541|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44244542|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43988156|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988157|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43988158|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43988159|NCT02322320|Growth Substances|growth substances|mesh-ancestor
43988160|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
43988161|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988162|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43988163|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44028935|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988164|NCT02322788|Terbutaline|terbutaline|mesh-list
43988165|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43988166|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
43988167|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988168|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988169|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43988170|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
43988171|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
43988172|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
43988173|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43988174|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43988175|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43988176|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43988177|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988178|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988179|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988180|NCT02323048|Methamphetamine|methamphetamine|mesh-list
43988181|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43988182|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988183|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
43988184|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
44028936|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028937|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028938|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028939|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
44028940|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028941|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028942|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028944|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44028945|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
44028946|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028947|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028948|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028949|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028950|NCT00000669|Didanosine|didanosine|mesh-list
44028951|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
44028952|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028953|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028954|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43646204|NCT03390010|Oxytocin|oxytocin|mesh-list
43646205|NCT03390010|Methylergonovine|methylergonovine|mesh-list
43646206|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
43646207|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43646208|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
43988185|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988186|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
43988187|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988188|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988189|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988190|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43988191|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43988192|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988193|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43988194|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
43988195|NCT02323217|Idazoxan|idazoxan|mesh-list
43988196|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43988197|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43988198|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43988199|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988200|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988201|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244543|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244544|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43756340|NCT02467010|Bortezomib|bortezomib|mesh-list
43988202|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988203|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
43988204|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988205|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43988206|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988207|NCT02324543|Gemcitabine|gemcitabine|mesh-list
43988208|NCT02324543|Cisplatin|cisplatin|mesh-list
43988209|NCT02324543|Docetaxel|docetaxel|mesh-list
43988215|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988216|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
43988217|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988218|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988219|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988220|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
44028955|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028956|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
44028957|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028958|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028959|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028960|NCT00000670|Zidovudine|zidovudine|mesh-list
43988221|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988222|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
43988223|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
43988224|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
43988225|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43988226|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43988227|NCT02324673|Cannabidiol|cannabidiol|mesh-list
43988228|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
43988229|NCT02326844|Talazoparib|talazoparib|mesh-list
43988230|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43988231|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988232|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988233|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988234|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
44028990|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028991|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028992|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028993|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028994|NCT00000685|Zidovudine|zidovudine|mesh-list
44028995|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
44028996|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028997|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028998|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028999|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029000|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
44029001|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029002|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029003|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029004|NCT00000691|Foscarnet|foscarnet|mesh-list
43846372|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988235|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43988236|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43988237|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988238|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
43988239|NCT02327117|Coagulants|coagulants|mesh-ancestor
43988240|NCT02327741|Clopidogrel|clopidogrel|mesh-list
43988241|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43988242|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43988243|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43988244|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44029005|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44029006|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
43646217|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43646218|NCT03365622|Analgesics|analgesics|mesh-ancestor
43646219|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
43646220|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646221|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646222|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
43646223|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
43646224|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
43646225|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43646226|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
43646227|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646228|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646229|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44029007|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988245|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
43988246|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988247|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988248|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988249|NCT02328404|Vitamin D|vitamin d|mesh-list
43988250|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
43988251|NCT02328404|Vitamins|vitamins|mesh-ancestor
43988252|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
43988253|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988254|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43988255|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43988256|NCT02328755|Methotrexate|methotrexate|mesh-list
43988257|NCT02328755|Tacrolimus|tacrolimus|mesh-list
43988258|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44029008|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029009|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029010|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029011|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029012|NCT00000692|Miglustat|miglustat|mesh-list
44029013|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029014|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029015|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029017|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
44029018|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029019|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44029020|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43646230|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
43646232|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988259|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
43988260|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43988261|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988262|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988263|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
43988264|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988265|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988266|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988267|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988268|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43988269|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988270|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
43988271|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988272|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43988273|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43988274|NCT02329600|Triamcinolone|triamcinolone|mesh-list
43988275|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43988276|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43988277|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43988278|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988280|NCT02329600|Hormones|hormones|mesh-ancestor
43988285|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988286|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988287|NCT02329964|Neostigmine|neostigmine|mesh-list
43988288|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43988289|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43988290|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988291|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988292|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988293|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988294|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988295|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43988296|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
43988297|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988298|NCT02330094|Gabapentin|gabapentin|mesh-list
43988299|NCT02330094|Analgesics|analgesics|mesh-ancestor
43988300|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
43723654|NCT02608658|Antibodies|antibodies|mesh-list
43988301|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988302|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988303|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
43988304|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43988305|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43988306|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988307|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988308|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43988309|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43988310|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44029022|NCT00000693|Zidovudine|zidovudine|mesh-list
43988311|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988312|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
43988313|NCT02330172|Neostigmine|neostigmine|mesh-list
43988314|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43988315|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988316|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988317|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988318|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988319|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988320|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43988321|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
43988322|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988324|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
43988325|NCT02331095|Atorvastatin|atorvastatin|mesh-list
43988326|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43988327|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43988328|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
43988329|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988330|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43988331|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43988332|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988333|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
43988334|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43988335|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
43988336|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43988337|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
43988338|NCT02331108|Propofol|propofol|mesh-list
43988339|NCT02331108|Anesthetics|anesthetics|mesh-list
43988340|NCT02331108|Sevoflurane|sevoflurane|mesh-list
43988341|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43988342|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988343|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988344|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43988345|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
43988346|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43988347|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43988348|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
43988349|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43988350|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
43988351|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988352|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988353|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43988354|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
44029108|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029109|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029110|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029111|NCT00000702|Zidovudine|zidovudine|mesh-list
44029112|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
44029113|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029114|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029115|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029116|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029117|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
43646276|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
43646277|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43646278|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646279|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
43646280|NCT03283605|Durvalumab|durvalumab|mesh-list
43646281|NCT03283605|Tremelimumab|tremelimumab|mesh-list
43646282|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646283|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646284|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
43646285|NCT03267277|Antidotes|antidotes|mesh-ancestor
43988355|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
44244545|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
44244547|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
44244548|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
44244549|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244550|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244551|NCT05344248|Antibodies|antibodies|mesh-list
43988356|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43988357|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988358|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44029118|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029119|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029120|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029121|NCT00000703|Leucovorin|leucovorin|mesh-list
44029122|NCT00000703|Cytarabine|cytarabine|mesh-list
44029123|NCT00000703|Zidovudine|zidovudine|mesh-list
44029124|NCT00000703|Dexamethasone|dexamethasone|mesh-list
44029125|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
44029126|NCT00000703|Doxorubicin|doxorubicin|mesh-list
44029127|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44029128|NCT00000703|Methotrexate|methotrexate|mesh-list
44029129|NCT00000703|Vincristine|vincristine|mesh-list
43646286|NCT03267277|Protective Agents|protective agents|mesh-ancestor
43646287|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646288|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
43646289|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646290|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
43646291|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43646292|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646293|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
43646294|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
43646295|NCT03252938|Avelumab|avelumab|mesh-list
43646296|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43988359|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988361|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988362|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988363|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
43988364|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988365|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43988366|NCT02333045|Maraviroc|maraviroc|mesh-list
43988367|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43988368|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43988369|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988370|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988371|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
43988372|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988373|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43723664|NCT02608437|Ipilimumab|ipilimumab|mesh-list
43988374|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43988375|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43988376|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43988377|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43988378|NCT02334059|Ketamine|ketamine|mesh-list
43988379|NCT02334059|Analgesics|analgesics|mesh-ancestor
43988380|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
43988381|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029130|NCT00000703|Bleomycin|bleomycin|mesh-list
44029131|NCT00000703|Allopurinol|allopurinol|mesh-list
44029132|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
44029133|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029134|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
44029135|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029136|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44029137|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44029138|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
44029139|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029140|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029141|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44029142|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029143|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
44029144|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
44029145|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029146|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029147|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
44029148|NCT00000703|Hormones|hormones|mesh-ancestor
44029149|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029150|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029155|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43988382|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988383|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43988384|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43988385|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
43988386|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
43988387|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988388|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43988389|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43988390|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988391|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988392|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
43988393|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43988394|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43988395|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43988396|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988397|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988398|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988399|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988400|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988401|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43988402|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988403|NCT02334527|Palbociclib|palbociclib|mesh-list
43988404|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988405|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43988406|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029156|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
44029157|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44029158|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029159|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
44029160|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
44029161|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029162|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029163|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
44029164|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029165|NCT00000703|Antidotes|antidotes|mesh-ancestor
44029166|NCT00000703|Protective Agents|protective agents|mesh-ancestor
44029167|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029168|NCT00000703|Vitamins|vitamins|mesh-ancestor
44029169|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
44029170|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44029171|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44029172|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44029173|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44029174|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029175|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029176|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029177|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
43988407|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988408|NCT02334800|Palbociclib|palbociclib|mesh-list
43988409|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988410|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43988411|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988412|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988413|NCT02334813|Dexamethasone|dexamethasone|mesh-list
43988414|NCT02334813|Prednisone|prednisone|mesh-list
43988415|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244552|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44244553|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
44244554|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244555|NCT05343572|Plerixafor|plerixafor|mesh-list
44244556|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44244557|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43988416|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
43988417|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
43988418|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988419|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988420|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988421|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
43988422|NCT02334813|Hormones|hormones|mesh-ancestor
43988426|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
43988427|NCT02335294|Morphine|morphine|mesh-list
43988428|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43988429|NCT02335294|Narcotics|narcotics|mesh-ancestor
43988430|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988431|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988432|NCT02335294|Analgesics|analgesics|mesh-ancestor
43988433|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
43988434|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988435|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43988436|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43988437|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988438|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
43988439|NCT02336438|Cathartics|cathartics|mesh-ancestor
43988440|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988441|NCT02336594|Verinurad|verinurad|mesh-list
43988442|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
43988443|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988444|NCT02336958|Ropivacaine|ropivacaine|mesh-list
43988445|NCT02336958|Prilocaine|prilocaine|mesh-list
43988446|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
43723764|NCT02608073|Cisplatin|cisplatin|mesh-list
43988447|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
43988448|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988449|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029190|NCT00000706|Zidovudine|zidovudine|mesh-list
43988450|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
43988451|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988452|NCT02337530|Cisplatin|cisplatin|mesh-list
43988453|NCT02337530|Carboplatin|carboplatin|mesh-list
43988454|NCT02337530|Pemetrexed|pemetrexed|mesh-list
43988455|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988456|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988457|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029228|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029229|NCT00000714|Leucovorin|leucovorin|mesh-list
44029230|NCT00000714|Trimetrexate|trimetrexate|mesh-list
43646308|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646310|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
43646311|NCT03238248|Azacitidine|azacitidine|mesh-list
43646312|NCT03238248|Pevonedistat|pevonedistat|mesh-list
43646313|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43646314|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
43646315|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646316|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988458|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43988459|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43988460|NCT02337933|Ursolic acid|ursolic acid|mesh-list
43988461|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988462|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988463|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43988464|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988465|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43988466|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988467|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43988468|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988470|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
43988471|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988472|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988473|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029231|NCT00000714|Calcium|calcium|mesh-list
44029232|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
44029233|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43547789|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646317|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646318|NCT03237377|Durvalumab|durvalumab|mesh-list
43646319|NCT03237377|Tremelimumab|tremelimumab|mesh-list
43646320|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646321|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646322|NCT03236545|Estradiol|estradiol|mesh-list
43646323|NCT03236545|Estrogens|estrogens|mesh-list
43646324|NCT03236545|Hormones|hormones|mesh-ancestor
43646325|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646326|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646327|NCT03201939|Lisinopril|lisinopril|mesh-list
43646328|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43646329|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
43646330|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646331|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988474|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988475|NCT02338076|Petrolatum|petrolatum|mesh-list
43988476|NCT02338076|Emollients|emollients|mesh-ancestor
43988477|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988478|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
43988479|NCT02338713|Antacids|antacids|mesh-ancestor
43988480|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988481|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988482|NCT02338973|Interferons|interferons|mesh-list
44029234|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547790|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646332|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43646333|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43646334|NCT03201939|Protective Agents|protective agents|mesh-ancestor
43646335|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646336|NCT03200808|Methylene Blue|methylene blue|mesh-list
43646337|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646338|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646339|NCT03198078|Aripiprazole|aripiprazole|mesh-list
43646340|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
43646341|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
43646342|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43646343|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43646344|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43646345|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43646346|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646347|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
43646348|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
43646349|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646350|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646351|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43646352|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43646353|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
43646354|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43646355|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43646356|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43988483|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
43988484|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988485|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
44244558|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
44244559|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244561|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44244562|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244563|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244564|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244565|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
44244566|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244567|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988486|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145098|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145099|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
44145100|NCT00193648|Adalimumab|adalimumab|mesh-list
44145101|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145102|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145103|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44145104|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145105|NCT00193661|Testosterone|testosterone|mesh-list
44145106|NCT00193661|Androgens|androgens|mesh-ancestor
44145111|NCT00193674|Progestins|progestins|mesh-ancestor
44145112|NCT00193674|Hormones|hormones|mesh-ancestor
44029235|NCT00000714|Antidotes|antidotes|mesh-ancestor
44029236|NCT00000714|Protective Agents|protective agents|mesh-ancestor
44029237|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029238|NCT00000714|Vitamins|vitamins|mesh-ancestor
44029239|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
44029240|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
44029241|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029242|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029243|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
44029244|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029245|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029246|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029247|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029248|NCT00000723|Leucovorin|leucovorin|mesh-list
44029249|NCT00000723|Zidovudine|zidovudine|mesh-list
44029250|NCT00000723|Dexamethasone|dexamethasone|mesh-list
44029251|NCT00000723|Methotrexate|methotrexate|mesh-list
44029252|NCT00000723|Calcium|calcium|mesh-list
44029253|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
44029254|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029255|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
44029256|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
44029257|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029258|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029259|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029260|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
44145113|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145114|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157597|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157598|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157599|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157600|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157601|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157602|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
44157603|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157604|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44157605|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157606|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44157607|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157608|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
44157609|NCT00234936|Adalimumab|adalimumab|mesh-list
44157610|NCT00234936|Methotrexate|methotrexate|mesh-list
44157611|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44157612|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
44029261|NCT00000723|Hormones|hormones|mesh-ancestor
44029262|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029263|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029264|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029265|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44029266|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44029267|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
44029268|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44029269|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029270|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
44029271|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029272|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
44029273|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029274|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029275|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029276|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
44029277|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44029278|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43547791|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
43824049|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
43824050|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824051|NCT05516446|Trace Elements|trace elements|mesh-ancestor
43824052|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
43824053|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44157613|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44157614|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157615|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157616|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
43988487|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
43988488|NCT02339038|Ledipasvir|ledipasvir|mesh-list
43988489|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
43988490|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988491|NCT02339246|Tacrolimus|tacrolimus|mesh-list
43988492|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988493|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
43988494|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988495|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43988496|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029279|NCT00000723|Antidotes|antidotes|mesh-ancestor
44029280|NCT00000723|Protective Agents|protective agents|mesh-ancestor
44029281|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029282|NCT00000723|Vitamins|vitamins|mesh-ancestor
44029283|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
44029284|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029285|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
44029286|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646373|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646374|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
43646375|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43646376|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43988497|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988498|NCT02339415|Edoxaban|edoxaban|mesh-list
43988499|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43988500|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
43988501|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43988502|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
43988503|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988504|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988505|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
43988506|NCT02339558|Nivolumab|nivolumab|mesh-list
43988507|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244569|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44244570|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
44244571|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244572|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244573|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44244574|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44244575|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244576|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988508|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988509|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43988510|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988511|NCT02340156|Temozolomide|temozolomide|mesh-list
43988512|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43988513|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
43988514|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988515|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988516|NCT02341144|Ropivacaine|ropivacaine|mesh-list
43988517|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
43988518|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
43988519|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988520|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988521|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
43988522|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988523|NCT02342015|Atorvastatin|atorvastatin|mesh-list
43988524|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43988525|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43988526|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
43988527|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988528|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43988531|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43988532|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
43988533|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43988534|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
43988535|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44029329|NCT00000727|Pentamidine|pentamidine|mesh-list
44029330|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44029331|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
44029332|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029333|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029334|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029335|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029336|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
43988536|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988537|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43988538|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43988539|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988541|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
43988542|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988543|NCT02342379|Bevacizumab|bevacizumab|mesh-list
43988544|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43988545|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988546|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43988547|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43988548|NCT02342379|Growth Substances|growth substances|mesh-ancestor
43988549|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988550|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
43988551|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
43988552|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43988553|NCT02343081|Temozolomide|temozolomide|mesh-list
43988554|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43988555|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
43988556|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988557|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988558|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
43988559|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
44029337|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029338|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029339|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029340|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
44029341|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029342|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029343|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029344|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029345|NCT00000727|Renal Agents|renal agents|mesh-ancestor
44029346|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44029347|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44029348|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029349|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
44029350|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44029351|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44149046|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149047|NCT00206505|Docetaxel|docetaxel|mesh-list
44149048|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149049|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149050|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149051|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157856|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
43988560|NCT02343575|Valproic Acid|valproic acid|mesh-list
43988561|NCT02343575|Haloperidol|haloperidol|mesh-list
43723905|NCT02607293|Hormones|hormones|mesh-ancestor
43988562|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
43988563|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
43988564|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
43988565|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244577|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244578|NCT05333289|Vaccines|vaccines|mesh-list
44244579|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
44244580|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244582|NCT05317000|Azacitidine|azacitidine|mesh-list
43988566|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988567|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988568|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43988569|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43988570|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988571|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988572|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43988573|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
43988574|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988575|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988576|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43988577|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
43988578|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988580|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
43988581|NCT02344225|Ibuprofen|ibuprofen|mesh-list
43988582|NCT02344225|Ketorolac|ketorolac|mesh-list
43988583|NCT02344225|Caffeine|caffeine|mesh-list
43988584|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
44157857|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157858|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
44157859|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44157860|NCT00235300|Basiliximab|basiliximab|mesh-list
44157861|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
44157862|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157863|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029352|NCT00000728|Zidovudine|zidovudine|mesh-list
44029353|NCT00000728|Aldesleukin|aldesleukin|mesh-list
44029354|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
44029355|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029356|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029357|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029358|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029359|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
44029360|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029364|NCT00000729|Foscarnet|foscarnet|mesh-list
44029374|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43988585|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988586|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43988587|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988588|NCT02344225|Analgesics|analgesics|mesh-ancestor
43988589|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
43988590|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988591|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988592|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988593|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988594|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43988595|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988596|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43988597|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43988598|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43988599|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43988600|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
43988601|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988603|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
43988605|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
43988606|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988607|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43988608|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988609|NCT02344316|Melatonin|melatonin|mesh-list
43988610|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
44029375|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
44029376|NCT00000730|Pentamidine|pentamidine|mesh-list
44029377|NCT00000730|Trimetrexate|trimetrexate|mesh-list
44029378|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
44029379|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
44029380|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029381|NCT00000730|Antidotes|antidotes|mesh-ancestor
44029382|NCT00000730|Protective Agents|protective agents|mesh-ancestor
44029383|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029384|NCT00000730|Vitamins|vitamins|mesh-ancestor
44029385|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
44029386|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029388|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
44029389|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029390|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029391|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
44029392|NCT00000730|Hormones|hormones|mesh-ancestor
44029393|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029394|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44029395|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029396|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029397|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988611|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988612|NCT02344316|Protective Agents|protective agents|mesh-ancestor
43988613|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988614|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988615|NCT02344628|Azithromycin|azithromycin|mesh-list
43988616|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43988617|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988618|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
43988619|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43988620|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43988621|NCT02346903|Capsaicin|capsaicin|mesh-list
43988622|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
43988623|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988624|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
43988625|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988626|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988627|NCT02346916|Capsaicin|capsaicin|mesh-list
43988628|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
43988629|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988630|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
43988631|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988632|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244583|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244585|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44029426|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
43988633|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
43988634|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43988635|NCT02347345|Ledipasvir|ledipasvir|mesh-list
43988636|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
43988637|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988638|NCT02347605|Nicotine|nicotine|mesh-list
43988639|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43988640|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
43988641|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988642|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988643|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43758959|NCT02451787|Vitamins|vitamins|mesh-ancestor
43988644|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43988645|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
43988646|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988647|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988648|NCT02348385|Amphetamine|amphetamine|mesh-list
43988649|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
43988650|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43988651|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988652|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
43988653|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
43988654|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029436|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029437|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029438|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029439|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
44029440|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029441|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029442|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029443|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029444|NCT00000732|Renal Agents|renal agents|mesh-ancestor
44029445|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
44029446|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029447|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43646480|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646481|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43646482|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646483|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646484|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646485|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43646486|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43646487|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43646488|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
43646489|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646490|NCT03054519|Metformin|metformin|mesh-list
43988655|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
43988656|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988657|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988658|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988659|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43988660|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43988661|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44029448|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029449|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44029450|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44029451|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029452|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029453|NCT00000733|Ribavirin|ribavirin|mesh-list
44029454|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
43646507|NCT03043924|Cyproterone|cyproterone|mesh-list
43646508|NCT03043924|Estrogens|estrogens|mesh-ancestor
43646509|NCT03043924|Hormones|hormones|mesh-ancestor
43646510|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646511|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646512|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43646513|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
43646514|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44029455|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029456|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
43988662|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43988663|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43988664|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43988665|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43988666|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988668|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43988669|NCT02348775|Glycine|glycine|mesh-list
43988670|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
43988671|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988672|NCT02348775|Expectorants|expectorants|mesh-ancestor
43988673|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
43988674|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43988675|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
43988676|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988677|NCT02348775|Protective Agents|protective agents|mesh-ancestor
43988683|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43988684|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988685|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43988686|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43988687|NCT02348918|Growth Substances|growth substances|mesh-ancestor
43988688|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988689|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
43988690|NCT02349152|Fentanyl|fentanyl|mesh-list
44029457|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029458|NCT00000734|Zidovudine|zidovudine|mesh-list
44029459|NCT00000734|Trimethoprim|trimethoprim|mesh-list
44029460|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
44029461|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44029462|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
44029463|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029464|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029465|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029466|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029467|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
44029468|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029469|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029470|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029471|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029472|NCT00000734|Renal Agents|renal agents|mesh-ancestor
44029473|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
44029474|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029475|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029476|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029477|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43988691|NCT02349152|Remifentanil|remifentanil|mesh-list
43988692|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43988693|NCT02349152|Narcotics|narcotics|mesh-ancestor
43988694|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988695|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988696|NCT02349152|Analgesics|analgesics|mesh-ancestor
43988697|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
43988698|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988699|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43988700|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44029478|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44029479|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029480|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029481|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44029482|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
44029483|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029484|NCT00000736|Zidovudine|zidovudine|mesh-list
44029485|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
44029486|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646515|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43646516|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43646517|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43646518|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43988701|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
43988702|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
43988703|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
43988704|NCT02349178|Etoposide|etoposide|mesh-list
43988705|NCT02349178|Clofarabine|clofarabine|mesh-list
43988706|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988707|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
44244586|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988708|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988709|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44029487|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029488|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029489|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646519|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
43646520|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646521|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646522|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43646524|NCT03043014|Mifepristone|mifepristone|mesh-list
43646525|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43646526|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
43646527|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646528|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646529|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43646530|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43646531|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
43646532|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43646533|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43646534|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43646535|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43646536|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
44029490|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
43988710|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43988711|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
43988712|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988713|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988714|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43988715|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43988716|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43988717|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43988718|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988719|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988721|NCT02349477|Gabapentin|gabapentin|mesh-list
43988722|NCT02349477|Analgesics|analgesics|mesh-ancestor
43988723|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
43988724|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988725|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988726|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
43988727|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43988728|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44029491|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029492|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029493|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029494|NCT00000737|Megestrol|megestrol|mesh-list
44029495|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
44029496|NCT00000737|Dronabinol|dronabinol|mesh-list
44029497|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
44029498|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029499|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44029500|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44029501|NCT00000737|Analgesics|analgesics|mesh-ancestor
44029502|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
44029503|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029504|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44029505|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44029506|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44029507|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029508|NCT00000737|Hormones|hormones|mesh-ancestor
43646538|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43646539|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646540|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646541|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
43646542|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43988729|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988730|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988731|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43988732|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43988733|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988734|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988735|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
43988736|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
43988737|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43988738|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
43988739|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43988740|NCT02350569|Ledipasvir|ledipasvir|mesh-list
43988741|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
43988742|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988743|NCT02351037|Azacitidine|azacitidine|mesh-list
43988744|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988745|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
43988746|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988747|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988748|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988749|NCT02351115|Alprazolam|alprazolam|mesh-list
43988754|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43988755|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988756|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
43988757|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
43988758|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44029509|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029510|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44029511|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44029512|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44029513|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
44029514|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44029515|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44029516|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44029517|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029518|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029519|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
44029520|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44029521|NCT00000738|Zidovudine|zidovudine|mesh-list
44029522|NCT00000738|Nimodipine|nimodipine|mesh-list
44029523|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
44029524|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029525|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029526|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029527|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029528|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
44029529|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029534|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988759|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988760|NCT02351700|Ibuprofen|ibuprofen|mesh-list
43988761|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43988762|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988763|NCT02351700|Analgesics|analgesics|mesh-ancestor
43988764|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
43988765|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988766|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029535|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44029536|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029537|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
44029538|NCT00000743|Zidovudine|zidovudine|mesh-list
44029539|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
44029540|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029541|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43646551|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646552|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646553|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646554|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646555|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43988767|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988768|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988769|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43988770|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988771|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988772|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
43988773|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
43988774|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44029542|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029543|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029544|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
43646556|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43646557|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848921|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988775|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988776|NCT02352259|Bleomycin|bleomycin|mesh-list
43988777|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43988778|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988779|NCT02352363|Levodopa|levodopa|mesh-list
43988780|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43988781|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43988782|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
43988783|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244587|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44244588|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
43988784|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029545|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029546|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029547|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029548|NCT00000750|Zidovudine|zidovudine|mesh-list
44029549|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
44029550|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029551|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029552|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029553|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029554|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
44029555|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029556|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029557|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646558|NCT03038100|Growth Substances|growth substances|mesh-ancestor
43646559|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646560|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43646561|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
43646563|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646564|NCT03014167|Albendazole|albendazole|mesh-list
43646565|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
43646566|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029558|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
43988785|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988786|NCT02352831|Capecitabine|capecitabine|mesh-list
43988787|NCT02352831|Tosedostat|tosedostat|mesh-list
43988788|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988789|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
44145115|NCT00193700|Testosterone|testosterone|mesh-list
43988790|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988791|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029559|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44029560|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029561|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44029562|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44029563|NCT00000763|Growth Substances|growth substances|mesh-ancestor
44029564|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646567|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646568|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
44029565|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
43988792|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988793|NCT02352844|Everolimus|everolimus|mesh-list
43988794|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988795|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988796|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
43988797|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988798|NCT02352922|Bupivacaine|bupivacaine|mesh-list
43988799|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
43988800|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
43988801|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988802|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988803|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
44029566|NCT00000764|Interferons|interferons|mesh-list
44029567|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
44029568|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
44029569|NCT00000764|Isotretinoin|isotretinoin|mesh-list
44029570|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029571|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
44029572|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029573|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
44029574|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029575|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
44029576|NCT00000765|Zidovudine|zidovudine|mesh-list
43759102|NCT02451033|Hormones|hormones|mesh-list
43646569|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43646570|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43646571|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646572|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646573|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646574|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988804|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988805|NCT02352974|Vitamin D|vitamin d|mesh-list
43988806|NCT02352974|Vitamins|vitamins|mesh-ancestor
43988807|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
43988808|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988809|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43988810|NCT02353299|Zolpidem|zolpidem|mesh-list
43988811|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43988812|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43988813|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988814|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988815|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43988816|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
43988817|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
43988818|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988819|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988822|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
43988823|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
43988824|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988825|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029577|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
44029578|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029579|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029580|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029581|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029582|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
44029583|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029584|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029585|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029586|NCT00000766|Ganciclovir|ganciclovir|mesh-list
44029587|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44029588|NCT00000766|Foscarnet|foscarnet|mesh-list
44029589|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44029590|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
44029591|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029592|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029593|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029594|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029595|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029596|NCT00000767|Vaccines|vaccines|mesh-list
44029597|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
43988826|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
43988827|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988828|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43988829|NCT02353754|Narcotics|narcotics|mesh-ancestor
43988830|NCT02353754|Analgesics|analgesics|mesh-ancestor
43988831|NCT02353780|Etanercept|etanercept|mesh-list
43988832|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43988833|NCT02353780|Abatacept|abatacept|mesh-list
43988834|NCT02353780|Infliximab|infliximab|mesh-list
43988835|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
43988836|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43988837|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988838|NCT02353780|Analgesics|analgesics|mesh-ancestor
43988839|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
43988840|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988841|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988842|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988843|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988844|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988845|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988846|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
43988847|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43988848|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988849|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988850|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
43988851|NCT02353806|Amlodipine|amlodipine|mesh-list
43988852|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43988853|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43988854|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43988855|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811859|NCT04837131|Ixazomib|ixazomib|mesh-list
44244590|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
44244591|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44244592|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44244593|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244594|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
43988856|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43988857|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988858|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
43988859|NCT02354092|Anesthetics|anesthetics|mesh-list
43988860|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
43988861|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988862|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029598|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988863|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
43988864|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988865|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
43988866|NCT02354339|Antacids|antacids|mesh-ancestor
43988867|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988868|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43988869|NCT02354352|Eplerenone|eplerenone|mesh-list
43988870|NCT02354352|Spironolactone|spironolactone|mesh-list
43988871|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43988872|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
43988873|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988874|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988875|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43988876|NCT02354352|Diuretics|diuretics|mesh-ancestor
43988877|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
43988878|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43988879|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
43988880|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43988881|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988882|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988883|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43988884|NCT02354378|Analgesics|analgesics|mesh-ancestor
43988885|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
43988886|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988887|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43988888|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43988889|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43988890|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
44029657|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029658|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
44029659|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029660|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44029661|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029662|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029663|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029664|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44029665|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
44029666|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44029667|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44029668|NCT00000776|Amebicides|amebicides|mesh-ancestor
44029669|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029670|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43646575|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646576|NCT02964078|Aldesleukin|aldesleukin|mesh-list
43646577|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
43646578|NCT02964078|Interleukin-2|interleukin-2|mesh-list
43988891|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988892|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988899|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
43988900|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
43988901|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43988902|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
43988903|NCT02354833|Phenylephrine|phenylephrine|mesh-list
43988904|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
43988905|NCT02354833|Norepinephrine|norepinephrine|mesh-list
43988906|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43988907|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
43988908|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
43988909|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988910|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988911|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
43988912|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43988913|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
43988914|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
43988915|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43988916|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43988917|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43988918|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988919|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988920|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988921|NCT02354833|Protective Agents|protective agents|mesh-ancestor
43988922|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
43988923|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43988924|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244596|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
44244597|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44244598|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244599|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
44029671|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029672|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
44029673|NCT00000778|Pyridoxine|pyridoxine|mesh-list
44029674|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
44029675|NCT00000778|Levofloxacin|levofloxacin|mesh-list
44029676|NCT00000778|Ofloxacin|ofloxacin|mesh-list
44029677|NCT00000778|Isoniazid|isoniazid|mesh-list
44029678|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029679|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029680|NCT00000778|Renal Agents|renal agents|mesh-ancestor
44029681|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029705|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44244600|NCT05309785|Canagliflozin|canagliflozin|mesh-list
44244601|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44244602|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244603|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244604|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244605|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
43988925|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145116|NCT00193700|Androgens|androgens|mesh-ancestor
44145117|NCT00193700|Hormones|hormones|mesh-ancestor
44145118|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029706|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029707|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
44029708|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029709|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029710|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029711|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44029712|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44029713|NCT00000782|Vaccines|vaccines|mesh-list
44029714|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
43646579|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646580|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646581|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145119|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145120|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44145121|NCT00193726|Estradiol|estradiol|mesh-list
44145122|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44145123|NCT00193726|Estrogens|estrogens|mesh-ancestor
44145124|NCT00193726|Hormones|hormones|mesh-ancestor
44145125|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145126|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145127|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44029715|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029716|NCT00000791|Zidovudine|zidovudine|mesh-list
44029717|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
44029718|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029719|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029720|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029721|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029722|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
44029723|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646582|NCT02964078|Analgesics|analgesics|mesh-ancestor
43646583|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
43646584|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145128|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
44145129|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145130|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43988926|NCT02355158|Clonidine|clonidine|mesh-list
43988927|NCT02355158|Analgesics|analgesics|mesh-ancestor
43988928|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
43988929|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988930|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988931|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43988932|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
43988933|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
43988934|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43988935|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43988936|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43988937|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988938|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988939|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988940|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
43988941|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988942|NCT02355821|Bisoprolol|bisoprolol|mesh-list
43988943|NCT02355821|Moxonidine|moxonidine|mesh-list
43988944|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43988945|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
43988946|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
43988947|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988948|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988951|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43988952|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
43988953|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988954|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988955|NCT02355886|Gabapentin|gabapentin|mesh-list
43988956|NCT02355886|Analgesics|analgesics|mesh-ancestor
43988957|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
43988958|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988959|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988960|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
43988961|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43988962|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43812106|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
44244607|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
44244608|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244609|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244610|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44244611|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244612|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44244613|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
43988963|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988964|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988965|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43988966|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43988967|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988968|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988969|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
43988970|NCT02355977|Minocycline|minocycline|mesh-list
43988971|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43988972|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988973|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44029772|NCT00000800|Methadone|methadone|mesh-list
43646585|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646586|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43646587|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646588|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
43646589|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646590|NCT02956785|Dinoprostone|dinoprostone|mesh-list
43646591|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
43646592|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646593|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646594|NCT02947581|Albendazole|albendazole|mesh-list
43646595|NCT02947581|Praziquantel|praziquantel|mesh-list
43646596|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
43646597|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43646598|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988974|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43988975|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
43988976|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43988977|NCT02356198|Hydromorphone|hydromorphone|mesh-list
43988978|NCT02356198|Bupivacaine|bupivacaine|mesh-list
43988979|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
43988980|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
43988981|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988982|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988983|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
43988984|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029773|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
44029774|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029775|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029776|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029777|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029778|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
44029779|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029780|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029781|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029782|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44029783|NCT00000800|Narcotics|narcotics|mesh-ancestor
43646599|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
43646600|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43646601|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43646602|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646603|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646604|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646605|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646606|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646607|NCT02943590|Atorvastatin|atorvastatin|mesh-list
43646608|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43646609|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43988985|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43988986|NCT02356198|Narcotics|narcotics|mesh-ancestor
43988987|NCT02356198|Analgesics|analgesics|mesh-ancestor
43988988|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
43988989|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43988990|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
43988991|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988992|NCT02357290|Expectorants|expectorants|mesh-ancestor
43988993|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
44029784|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44029785|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029786|NCT00000800|Analgesics|analgesics|mesh-ancestor
44029787|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
44029788|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029789|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
44029790|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
44029791|NCT00000801|Cytarabine|cytarabine|mesh-list
43646610|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
43646611|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646612|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646613|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43646614|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646615|NCT02939300|Nivolumab|nivolumab|mesh-list
43646616|NCT02939300|Ipilimumab|ipilimumab|mesh-list
43646617|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646618|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646619|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646620|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646621|NCT02934282|HBOC 201|hboc 201|mesh-list
43646622|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
43988994|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43988995|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
43988996|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988997|NCT02357290|Protective Agents|protective agents|mesh-ancestor
43988998|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988999|NCT02357290|Antidotes|antidotes|mesh-ancestor
43989000|NCT02357706|Acetaminophen|acetaminophen|mesh-list
43989001|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989002|NCT02357706|Analgesics|analgesics|mesh-ancestor
44029792|NCT00000801|Dexamethasone|dexamethasone|mesh-list
44029793|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
44029794|NCT00000801|Doxorubicin|doxorubicin|mesh-list
44029795|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44029796|NCT00000801|Vincristine|vincristine|mesh-list
44029797|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029798|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
43646623|NCT02921893|Dexamethasone|dexamethasone|mesh-list
43646624|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
43646625|NCT02921893|Lenalidomide|lenalidomide|mesh-list
43646626|NCT02921893|Ixazomib|ixazomib|mesh-list
43646627|NCT02921893|Ichthammol|ichthammol|mesh-list
43646628|NCT02921893|BB 1101|bb 1101|mesh-list
43646629|NCT02921893|Glycine|glycine|mesh-list
43646630|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989003|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
43989004|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989005|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989006|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
43989007|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43989008|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989009|NCT02357836|Itraconazole|itraconazole|mesh-list
43989010|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
43989011|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989012|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43989013|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43989014|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989015|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029799|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029800|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644709|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
43989016|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43989017|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
43989018|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989019|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989020|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44244614|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244615|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244616|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44244617|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244618|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
44244619|NCT05304039|Protective Agents|protective agents|mesh-ancestor
44244620|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44244621|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44244622|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244623|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
44244624|NCT05295589|Paclitaxel|paclitaxel|mesh-list
44244625|NCT05295589|Doxorubicin|doxorubicin|mesh-list
44244626|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43989027|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989028|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989029|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
43989030|NCT02359006|Minocycline|minocycline|mesh-list
43989031|NCT02359006|Tetracycline|tetracycline|mesh-list
43989032|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43989033|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989034|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43989035|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989036|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989037|NCT02359058|Cisplatin|cisplatin|mesh-list
43989038|NCT02359058|Capecitabine|capecitabine|mesh-list
43989039|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
43989040|NCT02359058|Ramucirumab|ramucirumab|mesh-list
43989041|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989042|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43989043|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
43989044|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029801|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44029807|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
43989045|NCT02359110|Gabapentin|gabapentin|mesh-list
43989046|NCT02359110|Analgesics|analgesics|mesh-ancestor
43989047|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
43989048|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989049|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989050|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
43989051|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43989052|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43989053|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989054|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989055|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43989056|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989057|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44029837|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029838|NCT00000803|Zidovudine|zidovudine|mesh-list
44029839|NCT00000803|Didanosine|didanosine|mesh-list
44029840|NCT00000803|Delavirdine|delavirdine|mesh-list
43848922|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989058|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989059|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
43989060|NCT02359305|Acetaminophen|acetaminophen|mesh-list
43989061|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989062|NCT02359305|Analgesics|analgesics|mesh-ancestor
43989063|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
43989064|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989065|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989066|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
43989067|NCT02360124|Fluorides|fluorides|mesh-list
43989068|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
44029841|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
44029842|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029843|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43989069|NCT02360124|Protective Agents|protective agents|mesh-ancestor
43989070|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989071|NCT02360215|Memantine|memantine|mesh-list
43989072|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43989073|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43989074|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
43989075|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989076|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244627|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44244628|NCT05295589|Topotecan|topotecan|mesh-list
44244629|NCT05295589|Olaparib|olaparib|mesh-list
44244630|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44244631|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44244632|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989077|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989078|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43989079|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989080|NCT02360319|Aripiprazole|aripiprazole|mesh-list
43989081|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
43989082|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
43989083|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989084|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43989085|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989086|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989087|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
43989088|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
43989089|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989090|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989094|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43989095|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43989096|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43989097|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43989098|NCT02360631|Varenicline|varenicline|mesh-list
43989099|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43989100|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43989101|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
43989102|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989103|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989104|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989105|NCT02360774|Canagliflozin|canagliflozin|mesh-list
43989106|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43989107|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989108|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43989109|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989110|NCT02361476|Clonidine|clonidine|mesh-list
43989111|NCT02361476|Analgesics|analgesics|mesh-ancestor
43989112|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
43989113|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989114|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989115|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43989116|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
43989117|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
43989118|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43989119|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43989120|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43989121|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989122|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989123|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989124|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
43989125|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
43989126|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989127|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989128|NCT02362321|Dexamethasone|dexamethasone|mesh-list
43989129|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989130|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
43989131|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
43989132|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989133|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989134|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989135|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
43989136|NCT02362321|Hormones|hormones|mesh-ancestor
43989137|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029897|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029898|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029899|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029900|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
44029901|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029902|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029903|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029904|NCT00000811|Azithromycin|azithromycin|mesh-list
44029905|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44029906|NCT00000811|Trimethoprim|trimethoprim|mesh-list
44029907|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
44029908|NCT00000811|Atovaquone|atovaquone|mesh-list
44029909|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029910|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029911|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029912|NCT00000811|Renal Agents|renal agents|mesh-ancestor
44029913|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
44029914|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029915|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029916|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029917|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989138|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43989139|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989140|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
43989141|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44244634|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44244635|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44244636|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244637|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44244638|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44244639|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44244640|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244641|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44244642|NCT05280704|Lidocaine|lidocaine|mesh-list
44244643|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
44244644|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
43989142|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
43989143|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43989144|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029918|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029919|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44029920|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44029921|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029922|NCT00000812|Thalidomide|thalidomide|mesh-list
44029923|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029924|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
44029925|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029926|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
44029927|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029928|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029929|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44029930|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44029931|NCT00000812|Growth Substances|growth substances|mesh-ancestor
44029932|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
44029933|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029934|NCT00000814|Zidovudine|zidovudine|mesh-list
44029935|NCT00000814|Nevirapine|nevirapine|mesh-list
44029936|NCT00000814|Didanosine|didanosine|mesh-list
43646631|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
43989145|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43989146|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43989147|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43989148|NCT02363270|Ketamine|ketamine|mesh-list
43989149|NCT02363270|Analgesics|analgesics|mesh-ancestor
43989150|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
43989151|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989152|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989153|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44029937|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
44029938|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029939|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029940|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029941|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029942|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
44029943|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029944|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43646633|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646634|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989154|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43989155|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
43989157|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989158|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43989159|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989160|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989161|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989167|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989168|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989169|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029945|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029946|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44029947|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44029948|NCT00000818|Zidovudine|zidovudine|mesh-list
44029949|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
44029950|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029951|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029952|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029953|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029954|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
44029955|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644710|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029956|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43989171|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
43989172|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
43989173|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989174|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989175|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
43989176|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989177|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44029957|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029958|NCT00000819|Prednisone|prednisone|mesh-list
44029959|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029960|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
44029962|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029963|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646635|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43646636|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
43646637|NCT02921893|Hormones|hormones|mesh-ancestor
43646638|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702667|NCT02715531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989178|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43989179|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43989180|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989181|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989182|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
43989183|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989184|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989185|NCT02365870|Rotigotine|rotigotine|mesh-list
43989186|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
43989187|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
43989188|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989189|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989190|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989191|NCT02365961|Clonidine|clonidine|mesh-list
43989192|NCT02365961|Epinephrine|epinephrine|mesh-list
44029964|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029965|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029966|NCT00000823|Zidovudine|zidovudine|mesh-list
44029967|NCT00000823|Didanosine|didanosine|mesh-list
44029968|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
44029969|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029970|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029971|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029972|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029973|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
44029974|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029975|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029976|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029977|NCT00000825|Aldesleukin|aldesleukin|mesh-list
44029978|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029979|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029980|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646639|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43646640|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646641|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
43646642|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646643|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702668|NCT02715531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989193|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43989194|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43989195|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989196|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244645|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244646|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244647|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
44029981|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
44029982|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029983|NCT00000829|Vaccines|vaccines|mesh-list
44029984|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44029985|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
44029986|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029987|NCT00000833|Ribavirin|ribavirin|mesh-list
44029988|NCT00000833|Didanosine|didanosine|mesh-list
44029989|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
43646644|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
43646645|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43646646|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43646647|NCT02921893|Growth Substances|growth substances|mesh-ancestor
44029990|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244648|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244649|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43989197|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989198|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989199|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43989200|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43989201|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
43989202|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989203|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43989204|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
43989205|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
43989206|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
43989207|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43989208|NCT02365961|Analgesics|analgesics|mesh-ancestor
43989209|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
43989210|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43989211|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
43989212|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43989213|NCT02366663|Cytarabine|cytarabine|mesh-list
43989214|NCT02366663|Rituximab|rituximab|mesh-list
43989215|NCT02366663|Etoposide|etoposide|mesh-list
43989216|NCT02366663|Melphalan|melphalan|mesh-list
43989217|NCT02366663|Carmustine|carmustine|mesh-list
43989218|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989219|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989220|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
43989221|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989222|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989223|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43989224|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43989225|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43724424|NCT02604459|Fentanyl|fentanyl|mesh-list
43989226|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989227|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029991|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
44029992|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029993|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029994|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029995|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029999|NCT00000834|Zidovudine|zidovudine|mesh-list
43989228|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43989229|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
43989230|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
43989231|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989233|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43989234|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
43989235|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43989237|NCT02366871|Apixaban|apixaban|mesh-list
43989238|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
43989239|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43989240|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43989241|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989242|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43989243|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
43989244|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43989245|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989246|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030025|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030026|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030027|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030028|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030029|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
44030030|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030031|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030032|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030033|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
44030034|NCT00000839|Didanosine|didanosine|mesh-list
44030035|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
44030036|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030037|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030038|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030039|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030040|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
44030041|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702669|NCT02715531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989247|NCT02367599|Vitamin D|vitamin d|mesh-list
43989248|NCT02367599|Vitamins|vitamins|mesh-ancestor
43989249|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
43989250|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989251|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43989252|NCT02367859|Trametinib|trametinib|mesh-list
43989253|NCT02367859|Dabrafenib|dabrafenib|mesh-list
43989254|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989255|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43989256|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030042|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030043|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646648|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
43646649|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
43646650|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
43646651|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646652|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
43702670|NCT02715531|Immunologic Factors|immunologic factors|mesh-ancestor
43646653|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646654|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646656|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646657|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43989257|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989258|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
43989259|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989260|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989261|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
44244650|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44244652|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44244653|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030044|NCT00000841|Lamivudine|lamivudine|mesh-list
44030045|NCT00000841|Zidovudine|zidovudine|mesh-list
44030046|NCT00000841|Stavudine|stavudine|mesh-list
43646658|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43646659|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43646660|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
43646661|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
43849040|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43646662|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646663|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646665|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43646666|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646667|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43646668|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646669|NCT02884908|Pregabalin|pregabalin|mesh-list
43646670|NCT02884908|Analgesics|analgesics|mesh-ancestor
44030047|NCT00000841|Indinavir|indinavir|mesh-list
44030048|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44459813|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44244655|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44244656|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44244657|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44244658|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244659|NCT05259566|Menthol|menthol|mesh-list
44244660|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
43989262|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
43989263|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
43989264|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43989265|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989266|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989267|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989268|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989269|NCT02368431|Zonisamide|zonisamide|mesh-list
43989270|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
43989271|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43989272|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989273|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989274|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43989275|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989276|NCT02368457|Tocopherols|tocopherols|mesh-list
44030049|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030050|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030051|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030052|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
44030053|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030054|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030055|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030056|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
44030057|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030058|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030059|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030060|NCT00000842|Mitogens|mitogens|mesh-list
44030061|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
44030062|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030063|NCT00000843|Adefovir|adefovir|mesh-list
44030064|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44030065|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
44030066|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030067|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030068|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43989277|NCT02368457|Vitamin E|vitamin e|mesh-list
43989278|NCT02368457|Tocotrienols|tocotrienols|mesh-list
43989279|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
43989280|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
43989281|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43989282|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989283|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989284|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43989285|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43989286|NCT02368457|Protective Agents|protective agents|mesh-ancestor
43989287|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989288|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
43989289|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43989290|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
43989291|NCT02368457|Vitamins|vitamins|mesh-ancestor
43989292|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
43989293|NCT02369068|Triamcinolone|triamcinolone|mesh-list
43989294|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43989295|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43989296|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43989297|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989298|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
43989299|NCT02369068|Hormones|hormones|mesh-ancestor
43989300|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44030070|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030071|NCT00000844|Interferons|interferons|mesh-list
44030072|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
44030073|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030074|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
44030075|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030076|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
44030077|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030078|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
44030079|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44030080|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
44030081|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030082|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44030083|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030084|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
44030085|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030086|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
44030087|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44030088|NCT00000847|Protective Agents|protective agents|mesh-ancestor
44030089|NCT00000848|Indinavir|indinavir|mesh-list
44030090|NCT00000848|Saquinavir|saquinavir|mesh-list
44030091|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030092|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030093|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030094|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989302|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989303|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
43989304|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989305|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43989306|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989310|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989311|NCT02369172|Bupropion|bupropion|mesh-list
43989312|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43989313|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
44244663|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44244664|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
44244665|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244666|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244667|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44244668|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244669|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
44244670|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44244671|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44244672|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44244673|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44244674|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989314|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989315|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43989316|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43989317|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989318|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989319|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
43989320|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989321|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989322|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43989323|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43989324|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989325|NCT02369211|Acetaminophen|acetaminophen|mesh-list
43989326|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989327|NCT02369211|Analgesics|analgesics|mesh-ancestor
43989328|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
43989329|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989330|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989331|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
43989332|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43989333|NCT02369835|Eusol|eusol|mesh-list
43989334|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43989335|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
43989336|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989337|NCT02369900|Esmolol|esmolol|mesh-list
43989338|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43989339|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43989340|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989341|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989342|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989343|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989344|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43989345|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
43989346|NCT02370693|Bortezomib|bortezomib|mesh-list
43989347|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43989348|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989349|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43989350|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
44030143|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030144|NCT00000862|Zidovudine|zidovudine|mesh-list
44030145|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
43646678|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43989351|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43989352|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989353|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989354|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989355|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
43989356|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43989357|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244676|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030146|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646679|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43646680|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43646681|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43646682|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43646683|NCT02883062|Paclitaxel|paclitaxel|mesh-list
44244677|NCT05199597|Atropine|atropine|mesh-list
44244678|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244679|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244680|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44244681|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
44244682|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244683|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244684|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44244685|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244686|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
44244687|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
44030147|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030148|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43646684|NCT02883062|Carboplatin|carboplatin|mesh-list
43646685|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43646686|NCT02883062|Atezolizumab|atezolizumab|mesh-list
43646687|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43646688|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646689|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646690|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646691|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646692|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43989358|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43989359|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989360|NCT02371252|Alendronate|alendronate|mesh-list
43989361|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43989362|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989363|NCT02371850|Nicotine|nicotine|mesh-list
43989364|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43989365|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
43989366|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989367|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030149|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030150|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
44030151|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030152|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030153|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646693|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646694|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
43646695|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646696|NCT02863991|TIC10 compound|tic10 compound|mesh-list
43646697|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646699|NCT02861898|Mannitol|mannitol|mesh-list
43702671|NCT02715531|Antidotes|antidotes|mesh-ancestor
43989368|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43989369|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43989370|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
43989371|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989372|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989373|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
43989374|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43989375|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989376|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989380|NCT02373137|Prednisolone|prednisolone|mesh-list
43989381|NCT02373137|Phenylephrine|phenylephrine|mesh-list
43989382|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
43989383|NCT02373137|Tropicamide|tropicamide|mesh-list
43989384|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989385|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
43989386|NCT02373137|Hormones|hormones|mesh-ancestor
43989387|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989388|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989389|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43989390|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989391|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
43989392|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989393|NCT02373137|Protective Agents|protective agents|mesh-ancestor
43989394|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43989395|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
43989396|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
43989397|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43989398|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
43989399|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
43989400|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43989401|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43989402|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43989403|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989404|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989405|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989406|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43989407|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43989408|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244688|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44244689|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44244690|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244691|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244692|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244693|NCT05194995|Cetuximab|cetuximab|mesh-list
44244694|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44244695|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244696|NCT05182112|Gemcitabine|gemcitabine|mesh-list
44244697|NCT05182112|Cisplatin|cisplatin|mesh-list
44244698|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244699|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44244700|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
44244701|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244702|NCT05182112|Antiviral Agents|antiviral agents|mesh-ancestor
44244703|NCT05182112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244704|NCT05182112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244705|NCT05182112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44030194|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030195|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030196|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
44030197|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646700|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646701|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646702|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43646703|NCT02861898|Diuretics|diuretics|mesh-ancestor
43646704|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
43646705|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646706|NCT02860091|Ropivacaine|ropivacaine|mesh-list
44244706|NCT05182112|Immunologic Factors|immunologic factors|mesh-ancestor
44244707|NCT05182112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989409|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43989410|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989411|NCT02373137|Renal Agents|renal agents|mesh-ancestor
43989412|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43989413|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43989414|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43989415|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989416|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43989417|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030198|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030199|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030200|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
43849041|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43644711|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43989418|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43989419|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43989420|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
43989421|NCT02374060|Dexamethasone|dexamethasone|mesh-list
43989422|NCT02374060|Triamcinolone|triamcinolone|mesh-list
43989423|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43989424|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43989425|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43989426|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989427|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
43989428|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
43989429|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989430|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989431|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989432|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
43989433|NCT02374060|Hormones|hormones|mesh-ancestor
43989434|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989435|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43989436|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989437|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989438|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
43989439|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989440|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989441|NCT02374164|Febuxostat|febuxostat|mesh-list
43989442|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
44244708|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44244709|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44244710|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244712|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244713|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44244714|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44244715|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44244716|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244717|NCT05154669|Nicotine|nicotine|mesh-list
44244718|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44244719|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
44244720|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244721|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244722|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44244723|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44244724|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244725|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244726|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244727|NCT05145413|Xanomeline|xanomeline|mesh-list
44244728|NCT05145413|Trospium chloride|trospium chloride|mesh-list
44244729|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
44244730|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
44244731|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244732|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244733|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44244734|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44244735|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244743|NCT05139225|Daratumumab|daratumumab|mesh-list
44244753|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244754|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030260|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44244755|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244756|NCT05125146|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44244757|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44244758|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44244759|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244760|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244761|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
44244762|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44244763|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
44244764|NCT05117554|Midazolam|midazolam|mesh-list
44244765|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43989443|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989444|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
43989445|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43989446|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44145131|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43989449|NCT02374398|Coagulants|coagulants|mesh-ancestor
43989450|NCT02376010|Warfarin|warfarin|mesh-list
43989451|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
43989452|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
43989453|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43989454|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
43989455|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43989456|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989457|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989458|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989459|NCT02376257|Cycloserine|cycloserine|mesh-list
43989460|NCT02376257|Modafinil|modafinil|mesh-list
43989461|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43989462|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989463|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43989464|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43989465|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43989466|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989467|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43989468|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989469|NCT02376257|Renal Agents|renal agents|mesh-ancestor
43989470|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43989471|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
43989472|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43989473|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
43989474|NCT02376283|Clopidogrel|clopidogrel|mesh-list
43989475|NCT02376283|Ticagrelor|ticagrelor|mesh-list
43989476|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43989477|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43989478|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43989479|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43989480|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43989481|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
43989482|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989483|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989484|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989485|NCT02377752|Doxorubicin|doxorubicin|mesh-list
43989486|NCT02377752|Olaratumab|olaratumab|mesh-list
43989487|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43989488|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989489|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43989490|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44244767|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244768|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244769|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44244770|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44244771|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244772|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44244773|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
44244774|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
44244775|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
44244776|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
44244777|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244778|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244779|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
44244780|NCT05114837|Fludarabine|fludarabine|mesh-list
44244781|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149069|NCT00206557|Hormones|hormones|mesh-ancestor
44244782|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
44244783|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244784|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244785|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44244786|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
44244787|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244788|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244789|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44244790|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
44244791|NCT05110742|Fludarabine|fludarabine|mesh-list
44244792|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
44244793|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244794|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
44244795|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149107|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149108|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44149109|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
43646709|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43646710|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646711|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
43646712|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702672|NCT02715531|Protective Agents|protective agents|mesh-ancestor
44244796|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244797|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44244798|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
43989491|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989492|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989493|NCT02378714|Varenicline|varenicline|mesh-list
43989494|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43989495|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43646714|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43646715|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43849043|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
44149110|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43989496|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
43989497|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244799|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244800|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897911|NCT00003910|Methotrexate|methotrexate|mesh-list
44244801|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44244802|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149111|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
44149112|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149113|NCT00206661|Molgramostim|molgramostim|mesh-list
44149114|NCT00206661|Sargramostim|sargramostim|mesh-list
43759765|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
44030284|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
44030285|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43646716|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43646717|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43646718|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646719|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
43646720|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459814|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459815|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44459816|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44459817|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
44459818|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
44459819|NCT01573910|Ofloxacin|ofloxacin|mesh-list
44459820|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44459821|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44459822|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44459823|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030286|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
44030287|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030288|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43646721|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646722|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44459824|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44459825|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44459826|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459830|NCT01573910|Renal Agents|renal agents|mesh-ancestor
44459865|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
44459866|NCT01572792|Bromides|bromides|mesh-list
44459867|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
44459868|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44459869|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
44459870|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459871|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459872|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459873|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459874|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44459875|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44459876|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44459877|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
44459878|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459879|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459880|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
44459881|NCT01572740|Liraglutide|liraglutide|mesh-list
44459882|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44459883|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137985|NCT00169572|Dexamethasone|dexamethasone|mesh-list
44459884|NCT01572740|Incretins|incretins|mesh-ancestor
44459885|NCT01572740|Hormones|hormones|mesh-ancestor
44244804|NCT05096481|Temozolomide|temozolomide|mesh-list
44244805|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44244806|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
43989498|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989499|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989500|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43989501|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
43989502|NCT02379195|Fludarabine|fludarabine|mesh-list
43989503|NCT02379195|Interleukin-2|interleukin-2|mesh-list
43989504|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989505|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
43989506|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989507|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989508|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43989509|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
44030289|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989510|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989511|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989512|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43989513|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989514|NCT02379195|Analgesics|analgesics|mesh-ancestor
43989515|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
43989516|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989517|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
43989518|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989519|NCT02379858|Alvimopan|alvimopan|mesh-list
43989520|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989521|NCT02382848|Prazosin|prazosin|mesh-list
43989527|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989528|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244807|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244808|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244809|NCT05094128|Upadacitinib|upadacitinib|mesh-list
44244810|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44244811|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44244812|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244813|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244814|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244815|NCT05092984|Spironolactone|spironolactone|mesh-list
44244816|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44244817|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
44244818|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244819|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244820|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44244821|NCT05092984|Diuretics|diuretics|mesh-ancestor
44244822|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
44030333|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030334|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
44030335|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030336|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030337|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030338|NCT00000889|Aldesleukin|aldesleukin|mesh-list
44030339|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030340|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030341|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030342|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
44030343|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244835|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
44244836|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44244837|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
44244838|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244840|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44244841|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244842|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244843|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44244844|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
44244849|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
44030368|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030369|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
43646723|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646724|NCT02856295|Enoxaparin|enoxaparin|mesh-list
43646725|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
43646726|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44244853|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244854|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244855|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244856|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44244857|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
44244858|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244859|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
44244860|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44244861|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44030370|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030371|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030372|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646727|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43646728|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646729|NCT02854670|Capsaicin|capsaicin|mesh-list
44244862|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244863|NCT05061368|Urological Agents|urological agents|mesh-ancestor
44244864|NCT05056142|Anesthetics|anesthetics|mesh-list
44244865|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244866|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244867|NCT05051007|Lidocaine|lidocaine|mesh-list
44244868|NCT05051007|Fentanyl|fentanyl|mesh-list
43989529|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989530|NCT02383043|Cocaine|cocaine|mesh-list
44030373|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
43646730|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
43646731|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
43646732|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
43646733|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646734|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646735|NCT02851056|Lenograstim|lenograstim|mesh-list
43989531|NCT02383043|Amphetamine|amphetamine|mesh-list
43989532|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
43989533|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43989534|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989535|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
43989536|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
43989537|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989538|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
43989539|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989540|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989541|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989542|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44030374|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
44030375|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030376|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646736|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43646737|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
43646738|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646739|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
43646740|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43646741|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
43646742|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644712|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
43644713|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989543|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43989544|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989545|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43989546|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
43989547|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
43989548|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989549|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
43989550|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43989551|NCT02384044|Listerine|listerine|mesh-list
43989552|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
43989553|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
43989554|NCT02384044|Protective Agents|protective agents|mesh-ancestor
43989555|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989556|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43989557|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989558|NCT02384070|Aspirin|aspirin|mesh-list
43989559|NCT02384070|Bivalirudin|bivalirudin|mesh-list
43989560|NCT02384070|Clopidogrel|clopidogrel|mesh-list
43989561|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43989562|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989563|NCT02384070|Analgesics|analgesics|mesh-ancestor
43989564|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
43989565|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989566|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989567|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244869|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44244870|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
44244871|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44244872|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244873|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
44030377|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030378|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030379|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030380|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030381|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030382|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44030383|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44030384|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44030385|NCT00000896|Growth Substances|growth substances|mesh-ancestor
44030386|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44030387|NCT00000897|Zidovudine|zidovudine|mesh-list
44030388|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
44030389|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030408|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
44244874|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244875|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44244876|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44244877|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44244878|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44244879|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244880|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44244881|NCT05051007|Narcotics|narcotics|mesh-ancestor
44244882|NCT05051007|Analgesics|analgesics|mesh-ancestor
44244883|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44244884|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44244885|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
44244887|NCT05046522|Analgesics|analgesics|mesh-ancestor
44244888|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
44244889|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244890|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989568|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989569|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43989570|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44030409|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030410|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030411|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030412|NCT00000902|Ritonavir|ritonavir|mesh-list
44030413|NCT00000902|Nelfinavir|nelfinavir|mesh-list
44030414|NCT00000902|Lamivudine|lamivudine|mesh-list
44030415|NCT00000902|Zidovudine|zidovudine|mesh-list
44030416|NCT00000902|Nevirapine|nevirapine|mesh-list
44030417|NCT00000902|Didanosine|didanosine|mesh-list
44030418|NCT00000902|Stavudine|stavudine|mesh-list
44030419|NCT00000902|Zalcitabine|zalcitabine|mesh-list
44030420|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030421|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030422|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030423|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030424|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030425|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030426|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030427|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
44030428|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646743|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43646744|NCT02839265|Protective Agents|protective agents|mesh-ancestor
43646745|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
43646746|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43646747|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
43646748|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646749|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646750|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43989571|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989572|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43989573|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43989574|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989575|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
43989576|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43989577|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43989578|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43989579|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
43989580|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989581|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
43989582|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43989583|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989584|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
43989585|NCT02384200|Vancomycin|vancomycin|mesh-list
43989586|NCT02384200|Gentamicins|gentamicins|mesh-list
43989587|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
43989588|NCT02384200|Ampicillin|ampicillin|mesh-list
43989589|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
43989590|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43989591|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989602|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989603|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
43989604|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989605|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43989606|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43989607|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44244891|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44244892|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44244893|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244894|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030429|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030430|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030431|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030432|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030433|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
44030434|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030435|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030436|NCT00000909|Aldesleukin|aldesleukin|mesh-list
44030437|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030438|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030439|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646751|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
43646752|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43646753|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
43646754|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646755|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646756|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43646757|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
43646758|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
43646759|NCT02836899|Protective Agents|protective agents|mesh-ancestor
43646760|NCT02832401|Caffeine|caffeine|mesh-list
43646761|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44244895|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
44244896|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44244897|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44244898|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44244899|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244900|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244902|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44244903|NCT05036278|Factor VIII|factor viii|mesh-list
43989608|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43989609|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44030461|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030462|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030463|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030464|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030465|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030466|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030467|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030468|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44030469|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
44030470|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030472|NCT00000913|Nelfinavir|nelfinavir|mesh-list
43646762|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646763|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43646764|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646765|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646766|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43646767|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43646768|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
43646769|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646770|NCT02823145|Fenfluramine|fenfluramine|mesh-list
43646771|NCT02823145|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43646772|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43646773|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644714|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989610|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989612|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989613|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989615|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
43989616|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989617|NCT02386319|Protective Agents|protective agents|mesh-ancestor
43989618|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989619|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989620|NCT02387359|Plecanatide|plecanatide|mesh-list
43989621|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43989622|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
43989623|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989624|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989625|NCT02387554|Losartan|losartan|mesh-list
43989626|NCT02387554|Amlodipine|amlodipine|mesh-list
43989627|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
43989628|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43989629|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43989630|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989631|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989632|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43989633|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989634|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
43989635|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43989636|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43989637|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43989638|NCT02387554|Diuretics|diuretics|mesh-ancestor
43989639|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
43989640|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43989641|NCT02387710|Tiagabine|tiagabine|mesh-list
43989642|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
43989643|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
43989644|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43989645|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989646|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989647|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
43989648|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989649|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989650|NCT02387801|Ixekizumab|ixekizumab|mesh-list
43989651|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
43989652|NCT02388321|Fentanyl|fentanyl|mesh-list
43989653|NCT02388321|Ketamine|ketamine|mesh-list
43989654|NCT02388321|Analgesics|analgesics|mesh-ancestor
44030518|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
43646774|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989655|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
44244906|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44244907|NCT05034952|Analgesics|analgesics|mesh-ancestor
44244908|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
44244909|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244910|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244911|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
44244912|NCT05032794|Bisacodyl|bisacodyl|mesh-list
44244913|NCT05032794|Cathartics|cathartics|mesh-ancestor
44244914|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44244915|NCT05032794|Laxatives|laxatives|mesh-ancestor
44244916|NCT05015686|Vaccines|vaccines|mesh-list
44244917|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
44244918|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244919|NCT05010122|Decitabine|decitabine|mesh-list
44244920|NCT05010122|Venetoclax|venetoclax|mesh-list
44244921|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43989663|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43989664|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43989665|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989666|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989667|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43989668|NCT02388321|Narcotics|narcotics|mesh-ancestor
43989669|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43989670|NCT02389088|Letrozole|letrozole|mesh-list
44030519|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030520|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030521|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030522|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
44030523|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030524|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
44030525|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030526|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030527|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030528|NCT00000918|Ritonavir|ritonavir|mesh-list
44030529|NCT00000918|Indinavir|indinavir|mesh-list
44030530|NCT00000918|Saquinavir|saquinavir|mesh-list
44030531|NCT00000918|Amprenavir|amprenavir|mesh-list
44030532|NCT00000918|Lamivudine|lamivudine|mesh-list
44030533|NCT00000918|Zidovudine|zidovudine|mesh-list
44030534|NCT00000918|Didanosine|didanosine|mesh-list
44030535|NCT00000918|Stavudine|stavudine|mesh-list
44030536|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44030537|NCT00000918|Efavirenz|efavirenz|mesh-list
44030538|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030539|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030540|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030541|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030542|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030543|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030544|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43989671|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989672|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43989673|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43989674|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989675|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989676|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43989677|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
43989678|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989679|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989680|NCT02389361|Acetaminophen|acetaminophen|mesh-list
43989681|NCT02389361|Tramadol|tramadol|mesh-list
43989682|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989683|NCT02389361|Analgesics|analgesics|mesh-ancestor
43989685|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989686|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989687|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
43989688|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43989689|NCT02389361|Narcotics|narcotics|mesh-ancestor
43989690|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989691|NCT02389738|Temozolomide|temozolomide|mesh-list
43989692|NCT02389738|Regadenoson|regadenoson|mesh-list
43989693|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43989694|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
43989695|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989696|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989697|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43989698|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43989699|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
43989700|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
43989701|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989702|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989703|NCT02389959|Bevacizumab|bevacizumab|mesh-list
43812646|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44030545|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
44030546|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030547|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030548|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030549|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030550|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030578|NCT00000921|Prednisone|prednisone|mesh-list
43702674|NCT02715531|Vitamins|vitamins|mesh-ancestor
44244923|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244924|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244925|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244926|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44244927|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44244928|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244929|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244930|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44244931|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44244932|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244933|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244934|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244935|NCT04999644|Nicotine|nicotine|mesh-list
44244936|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44244937|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
44244938|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244939|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244940|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44030579|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44030580|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
44030581|NCT00000921|Hormones|hormones|mesh-ancestor
44030582|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44030583|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030584|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44030585|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030586|NCT00000923|Lamivudine|lamivudine|mesh-list
44030587|NCT00000923|Zidovudine|zidovudine|mesh-list
44030588|NCT00000923|Didanosine|didanosine|mesh-list
44030589|NCT00000923|Stavudine|stavudine|mesh-list
44030590|NCT00000923|Aldesleukin|aldesleukin|mesh-list
44030591|NCT00000923|Indinavir|indinavir|mesh-list
44030592|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030593|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030594|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030595|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030596|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
44030597|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030598|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44244941|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43989704|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989705|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989706|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989707|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989708|NCT02389959|Growth Substances|growth substances|mesh-ancestor
43989709|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989710|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989711|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
43989712|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43989713|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030599|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030600|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
43989714|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
43989715|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
43989716|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
43989717|NCT02391714|Povidone|povidone|mesh-list
43989718|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43989719|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989720|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
43989721|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
43989722|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
43989723|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43989724|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
43989726|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989727|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989728|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989730|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
43989731|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989732|NCT02392208|Telavancin|telavancin|mesh-list
43989733|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030601|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030602|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43989734|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989735|NCT02392286|Prednisone|prednisone|mesh-list
43989736|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
43989737|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244942|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
44244943|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244944|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244945|NCT04999215|Choline|choline|mesh-list
44244946|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
44244947|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44244948|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
44244949|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244950|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898083|NCT00006170|Bupropion|bupropion|mesh-list
44244951|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44244952|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
44244954|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44244955|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44244956|NCT04989166|Analgesics|analgesics|mesh-ancestor
44244957|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
44244958|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244959|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244960|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44244961|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44244962|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244963|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030603|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030604|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030605|NCT00000924|Ritonavir|ritonavir|mesh-list
44030606|NCT00000924|Nelfinavir|nelfinavir|mesh-list
44030607|NCT00000924|Nevirapine|nevirapine|mesh-list
44030608|NCT00000924|Didanosine|didanosine|mesh-list
44030609|NCT00000924|Stavudine|stavudine|mesh-list
44030610|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030611|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030612|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030613|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030614|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030615|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030616|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030617|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
44030618|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030619|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030620|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030621|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030622|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030623|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030624|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44244964|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244965|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
44244966|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
43989738|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
43989739|NCT02392286|Hormones|hormones|mesh-ancestor
43989740|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989741|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989742|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43989743|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989744|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
43989745|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
43989746|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989747|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989748|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43989749|NCT02392286|Protective Agents|protective agents|mesh-ancestor
43989750|NCT02393339|Acetaminophen|acetaminophen|mesh-list
43989751|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989752|NCT02393339|Analgesics|analgesics|mesh-ancestor
43989753|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
43989754|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989755|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989756|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
44145132|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44145133|NCT00193739|Paclitaxel|paclitaxel|mesh-list
44145134|NCT00193739|Cisplatin|cisplatin|mesh-list
44145135|NCT00193739|Carboplatin|carboplatin|mesh-list
44030631|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
44030632|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44030633|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44030634|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
44030635|NCT00000935|Antibodies|antibodies|mesh-list
44030636|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
44030637|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44030638|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44030639|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
44030640|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030641|NCT00000936|Cyclosporine|cyclosporine|mesh-list
44030642|NCT00000936|Cyclosporins|cyclosporins|mesh-list
44030643|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030644|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030645|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44030646|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
44030647|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030648|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
44030649|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030650|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
44030651|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030652|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44030653|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44145136|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145137|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244967|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44244968|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44244969|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244970|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244971|NCT04985929|Urological Agents|urological agents|mesh-ancestor
44244972|NCT04982029|Cannabidiol|cannabidiol|mesh-list
44244973|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
44244974|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
44244975|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44244976|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44244977|NCT04975256|Adagrasib|adagrasib|mesh-list
44244978|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244979|NCT04972396|Metformin|metformin|mesh-list
44244980|NCT04972396|Digoxin|digoxin|mesh-list
44244981|NCT04972396|Warfarin|warfarin|mesh-list
44244982|NCT04972396|Atorvastatin|atorvastatin|mesh-list
44244983|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
44244984|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44244985|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44244986|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244987|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44244988|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44145138|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
44030658|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030659|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
44030660|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44030661|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44030662|NCT00000939|Efavirenz|efavirenz|mesh-list
44030663|NCT00000939|Didanosine|didanosine|mesh-list
44030664|NCT00000939|Stavudine|stavudine|mesh-list
44030665|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
44030666|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030667|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030668|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030669|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030670|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
44030671|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030672|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44030673|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030674|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44030675|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030676|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030677|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030678|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030679|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
44030680|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
44030681|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44145139|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145140|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145141|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145142|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
44145144|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44145145|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145146|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44145147|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
44145148|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44030682|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030683|NCT00000942|Nevirapine|nevirapine|mesh-list
44030684|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030685|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030686|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030687|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030688|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
44030689|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030690|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030691|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646775|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646776|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
43646777|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646778|NCT02810704|Aspirin|aspirin|mesh-list
43646779|NCT02810704|Warfarin|warfarin|mesh-list
43646780|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
43646781|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702675|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
44145149|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44145150|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145151|NCT00193869|Dexamethasone|dexamethasone|mesh-list
44145152|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145153|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
44145154|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
44145155|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145156|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145157|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145158|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
44145159|NCT00193869|Hormones|hormones|mesh-ancestor
43646782|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43646783|NCT02810704|Analgesics|analgesics|mesh-ancestor
43646784|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
43646785|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145160|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145161|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44145162|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145163|NCT00193882|Cisplatin|cisplatin|mesh-list
44145164|NCT00193882|Fluorouracil|fluorouracil|mesh-list
44145165|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145166|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
44145167|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145168|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145169|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145170|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
44145171|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145172|NCT00193895|Carboplatin|carboplatin|mesh-list
44244989|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
44244990|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244991|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44244992|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44244993|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244994|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
44244995|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44244996|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
44244997|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44244998|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44030692|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030693|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030694|NCT00000944|Lamivudine|lamivudine|mesh-list
43646786|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646787|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646788|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030695|NCT00000944|Zidovudine|zidovudine|mesh-list
44244999|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44245000|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44245001|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44245002|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44245003|NCT04972396|Protective Agents|protective agents|mesh-ancestor
44145173|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145174|NCT00193921|Gemcitabine|gemcitabine|mesh-list
44145175|NCT00193921|Cisplatin|cisplatin|mesh-list
44145176|NCT00193921|Vinorelbine|vinorelbine|mesh-list
44145185|NCT00193921|Immunologic Factors|immunologic factors|mesh-ancestor
44030696|NCT00000944|Indinavir|indinavir|mesh-list
44030697|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030698|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030699|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030700|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030701|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
44030702|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030703|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43646789|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43646790|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43646791|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646792|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43646793|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43646794|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646795|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
43646796|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
43646797|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43646798|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
44145186|NCT00193921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145187|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145188|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44145189|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145190|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145191|NCT00193973|Methotrexate|methotrexate|mesh-list
44145192|NCT00193973|Idarubicin|idarubicin|mesh-list
44145193|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44145194|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
44145195|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145196|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145197|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145198|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
44158432|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
43989758|NCT02393378|Adalimumab|adalimumab|mesh-list
44030704|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030705|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
44030706|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030707|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030708|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030709|NCT00000945|Cidofovir|cidofovir|mesh-list
44030710|NCT00000945|Probenecid|probenecid|mesh-list
44030711|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
44030712|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
44030713|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030714|NCT00000945|Renal Agents|renal agents|mesh-ancestor
44030715|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
44030716|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030717|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030718|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030719|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
44030720|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43989759|NCT02393378|Methotrexate|methotrexate|mesh-list
43989760|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43989761|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
43989762|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43989763|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989764|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43989765|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
43989766|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989767|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989768|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
43989769|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989770|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43989771|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989772|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
43989773|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989774|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43989775|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989777|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
43989778|NCT02393378|Vitamins|vitamins|mesh-ancestor
43989779|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
43989780|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
43989781|NCT02393677|Ropivacaine|ropivacaine|mesh-list
43989782|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43989783|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812647|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245005|NCT04972396|Estrogens|estrogens|mesh-ancestor
44245006|NCT04972396|Hormones|hormones|mesh-ancestor
44245007|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245008|NCT04964622|Ibuprofen|ibuprofen|mesh-list
44245009|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245010|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245011|NCT04964622|Analgesics|analgesics|mesh-ancestor
44245012|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
44245013|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245014|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245015|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245016|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245017|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44245018|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245019|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459886|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459887|NCT01572727|Paclitaxel|paclitaxel|mesh-list
43989784|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989785|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989786|NCT02393677|Analgesics|analgesics|mesh-ancestor
43989787|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
43989788|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989789|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43989790|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43989791|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43989792|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989793|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989794|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989795|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
43989796|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
43989797|NCT02394457|Cosyntropin|cosyntropin|mesh-list
43989798|NCT02394457|Hormones|hormones|mesh-ancestor
43989799|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989800|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989801|NCT02394951|Pregabalin|pregabalin|mesh-list
43989802|NCT02394951|Analgesics|analgesics|mesh-ancestor
43989807|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43989808|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989809|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989810|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43989811|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43989812|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43989813|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989814|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989815|NCT02395692|Temozolomide|temozolomide|mesh-list
43989816|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43989817|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
43989818|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989819|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989820|NCT02396147|Relugolix|relugolix|mesh-list
43989821|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
44459889|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459890|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
44459891|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459892|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245020|NCT04963725|Ustekinumab|ustekinumab|mesh-list
44245021|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245022|NCT04956302|Dexamethasone|dexamethasone|mesh-list
44245023|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
44245024|NCT04956302|Bortezomib|bortezomib|mesh-list
44245025|NCT04956302|Daratumumab|daratumumab|mesh-list
44245026|NCT04956302|Panobinostat|panobinostat|mesh-list
44245027|NCT04956302|Ichthammol|ichthammol|mesh-list
44245028|NCT04956302|BB 1101|bb 1101|mesh-list
44245029|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44245030|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989822|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
43989823|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989824|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989825|NCT02396511|Bevacizumab|bevacizumab|mesh-list
43989826|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989827|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989828|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989829|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989830|NCT02396511|Growth Substances|growth substances|mesh-ancestor
43989831|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989832|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989833|NCT02396732|Aspirin|aspirin|mesh-list
43989834|NCT02396732|Enoxaparin|enoxaparin|mesh-list
43989835|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43989836|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43989837|NCT02396732|Analgesics|analgesics|mesh-ancestor
43989838|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
43989839|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989840|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989841|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989843|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43989844|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43989845|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989846|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43989847|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43989848|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989849|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
43989850|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
43989851|NCT02397265|Insulin|insulin|mesh-list
43989852|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43989853|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989854|NCT02397291|Inositol|inositol|mesh-list
43989855|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
43989856|NCT02397291|Vitamins|vitamins|mesh-ancestor
43989857|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
43989858|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989859|NCT02397954|Ranibizumab|ranibizumab|mesh-list
43989860|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989861|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989862|NCT02397954|Growth Substances|growth substances|mesh-ancestor
43989863|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989864|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989865|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989866|NCT02399085|Lenalidomide|lenalidomide|mesh-list
43989867|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
43989868|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245033|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245034|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245035|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245036|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
44245037|NCT04956302|Hormones|hormones|mesh-ancestor
44245038|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245039|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245040|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245041|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
44245042|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245043|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245044|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
44245045|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43989869|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989870|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989871|NCT02399085|Growth Substances|growth substances|mesh-ancestor
43989872|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989873|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989874|NCT02399345|Ritonavir|ritonavir|mesh-list
43989882|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43989883|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43989884|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
43989885|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43989886|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43989887|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43989888|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
43989889|NCT02399917|Azacitidine|azacitidine|mesh-list
43989890|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43989891|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
43989892|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989893|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989894|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989895|NCT02400437|Dexamethasone|dexamethasone|mesh-list
43989896|NCT02400437|Rituximab|rituximab|mesh-list
43989897|NCT02400437|Ixazomib|ixazomib|mesh-list
43989898|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989899|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989900|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
43989901|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989902|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989903|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43989904|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
43989905|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
43989906|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989907|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43989908|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
43989909|NCT02400437|Hormones|hormones|mesh-ancestor
43989910|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44030903|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44030904|NCT00000981|Fiacitabine|fiacitabine|mesh-list
44030905|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030906|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
43646800|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
43646802|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
43646803|NCT02784171|Pemetrexed|pemetrexed|mesh-list
43646804|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644716|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
43644717|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43989911|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43989912|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989913|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989914|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989915|NCT02401048|Durvalumab|durvalumab|mesh-list
43989916|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43989917|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245048|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
44245049|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245050|NCT04949828|Pancrelipase|pancrelipase|mesh-list
44245051|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245052|NCT04933682|Rifampin|rifampin|mesh-list
44245053|NCT04933682|Fluconazole|fluconazole|mesh-list
44245054|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44245055|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
44245056|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44245057|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030907|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030909|NCT00000982|Didanosine|didanosine|mesh-list
44030910|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
43646805|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646806|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646807|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245058|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
44245059|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43989919|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43989920|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43989921|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989922|NCT02401542|Docetaxel|docetaxel|mesh-list
43989923|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989924|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
43989925|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
43989926|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
43989927|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989928|NCT02402062|Sunitinib|sunitinib|mesh-list
43989929|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989930|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44030911|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030912|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43646809|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43824054|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43824055|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824056|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824057|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
43644719|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824058|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824059|NCT05516251|Topiramate|topiramate|mesh-list
43989931|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989932|NCT02402062|Growth Substances|growth substances|mesh-ancestor
43989933|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989934|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
43989935|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43989936|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989937|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989938|NCT02403830|Morphine|morphine|mesh-list
43989939|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
43989940|NCT02403830|Ticagrelor|ticagrelor|mesh-list
43989941|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43989942|NCT02403830|Narcotics|narcotics|mesh-ancestor
43989943|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989947|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44030913|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030914|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030915|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
44030916|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030917|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030918|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030919|NCT00000983|Zidovudine|zidovudine|mesh-list
44030920|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
44030921|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030922|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030923|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030924|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030925|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
44030926|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030927|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030928|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43989948|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43989949|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43989950|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43989951|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43989952|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
43989953|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989954|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989955|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43989956|NCT02403895|Paclitaxel|paclitaxel|mesh-list
43989957|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43989958|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989959|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
43989960|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
43989961|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
43989962|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989963|NCT02404168|Lamotrigine|lamotrigine|mesh-list
44030929|NCT00000987|Zidovudine|zidovudine|mesh-list
44030930|NCT00000987|Doxorubicin|doxorubicin|mesh-list
44030931|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44030932|NCT00000987|Bleomycin|bleomycin|mesh-list
44030933|NCT00000987|Vincristine|vincristine|mesh-list
44030934|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44030935|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030936|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44030937|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44030938|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030939|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030940|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44030941|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
44030942|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
44030943|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
44030944|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
43824060|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
43824061|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824062|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824064|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824065|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824066|NCT05515939|Insulin|insulin|mesh-list
43824067|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824068|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824069|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43824070|NCT05515874|Hematinics|hematinics|mesh-ancestor
43824071|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43989964|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
43989965|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43989966|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813053|NCT04819438|Riluzole|riluzole|mesh-list
44245061|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245062|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44245063|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44245064|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44245065|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44245066|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44245067|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44245068|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
44245069|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44245070|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44245071|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44245072|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
44245073|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989967|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989968|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43989969|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989970|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43989971|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43989972|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989973|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43989974|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43989975|NCT02404610|Propofol|propofol|mesh-list
43989976|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43989977|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989978|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989979|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43989980|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
43989981|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
43989982|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43989983|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43989984|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989985|NCT02406443|Incretins|incretins|mesh-ancestor
43989987|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43989988|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43989989|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989990|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989991|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989993|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43989994|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
43989995|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43824072|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43824073|NCT05515822|Oxycodone|oxycodone|mesh-list
43824074|NCT05515822|Dezocine|dezocine|mesh-list
43824075|NCT05515822|Esketamine|esketamine|mesh-list
43824076|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43824077|NCT05515822|Narcotics|narcotics|mesh-ancestor
43824078|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824079|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824080|NCT05515822|Analgesics|analgesics|mesh-ancestor
43824081|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
43702676|NCT02715479|Dolutegravir|dolutegravir|mesh-list
44030994|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43989996|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989997|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989998|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989999|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
43990000|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
43990001|NCT02408445|Testosterone|testosterone|mesh-list
43990002|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
43990003|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
43990004|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44030995|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030996|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030997|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
44030998|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030999|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43824082|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824083|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
43824084|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846373|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846374|NCT04203901|Nivolumab|nivolumab|mesh-list
43846375|NCT04203901|Ipilimumab|ipilimumab|mesh-list
43846376|NCT04203901|Everolimus|everolimus|mesh-list
43846377|NCT04203901|Lenvatinib|lenvatinib|mesh-list
43990005|NCT02408445|Androgens|androgens|mesh-ancestor
43990006|NCT02408445|Hormones|hormones|mesh-ancestor
43990007|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245074|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245075|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44245076|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44245077|NCT04926571|Dexamethasone|dexamethasone|mesh-list
44245078|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245079|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
44245080|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
44245081|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245082|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245083|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245084|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
44245085|NCT04926571|Hormones|hormones|mesh-ancestor
43990008|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990009|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43990010|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990011|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
43990012|NCT02408965|Methylergonovine|methylergonovine|mesh-list
43990013|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
43990014|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43990015|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990025|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990026|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43990028|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
43990029|NCT02410707|Propofol|propofol|mesh-list
43990030|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43990031|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990032|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990033|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990034|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
43990035|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
43990036|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43990037|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43990038|NCT02410707|Analgesics|analgesics|mesh-ancestor
43990039|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
43990040|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990041|NCT02411916|Misoprostol|misoprostol|mesh-list
43990042|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43990043|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
43990044|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43990045|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990046|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43990047|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990048|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
43990049|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
43990050|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43990051|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990052|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43990053|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990054|NCT02412644|Apremilast|apremilast|mesh-list
43990055|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43990056|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44031043|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031044|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031045|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031046|NCT00000995|Zidovudine|zidovudine|mesh-list
44031047|NCT00000995|Ganciclovir|ganciclovir|mesh-list
44031048|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44031049|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
44031050|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031051|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031052|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031053|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846378|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846379|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846380|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43846381|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846382|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846383|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
43846384|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846385|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846386|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846387|NCT04201496|Empagliflozin|empagliflozin|mesh-list
43990057|NCT02412644|Analgesics|analgesics|mesh-ancestor
43990058|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
43990059|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990060|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990061|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990062|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990063|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43990064|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43990065|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990066|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245086|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245087|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245088|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245089|NCT04922723|Daratumumab|daratumumab|mesh-list
44245090|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245091|NCT04908865|Belimumab|belimumab|mesh-list
44245092|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245093|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
44245094|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245095|NCT04904978|Listerine|listerine|mesh-list
44245096|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
44245097|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
43990068|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
43990069|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
43990070|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43990071|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43990072|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990073|NCT02413034|Vancomycin|vancomycin|mesh-list
43990074|NCT02413034|Cefazolin|cefazolin|mesh-list
43990075|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990076|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990077|NCT02413203|Celecoxib|celecoxib|mesh-list
43990078|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43990079|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43990080|NCT02413203|Analgesics|analgesics|mesh-ancestor
43990081|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
43990082|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990083|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990085|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990086|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43990087|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43990088|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990089|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145199|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145200|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145201|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
44145202|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145203|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44145204|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145205|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
44145206|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145207|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44145208|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145209|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44145210|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145211|NCT00194038|Aripiprazole|aripiprazole|mesh-list
44145212|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
44145213|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145214|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44145215|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145216|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145217|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145218|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
44145219|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
44145220|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145221|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145222|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44145223|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44145224|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
44145225|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44145226|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44145227|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44245099|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245100|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44245101|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245102|NCT04882085|Ceftazidime|ceftazidime|mesh-list
44245103|NCT04882085|Avibactam|avibactam|mesh-list
44245104|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44245105|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44245106|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245107|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44245108|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245109|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145228|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44145229|NCT00194064|Olanzapine|olanzapine|mesh-list
44145230|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
44145231|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
44145232|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145233|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145234|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145235|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44145236|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145237|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145238|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145239|NCT00194064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43990090|NCT02413320|Paclitaxel|paclitaxel|mesh-list
43990091|NCT02413320|Docetaxel|docetaxel|mesh-list
43990092|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
43990093|NCT02413320|Carboplatin|carboplatin|mesh-list
43990094|NCT02413320|Doxorubicin|doxorubicin|mesh-list
43990095|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43990096|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990097|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
43990098|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
43990099|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
43990101|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990102|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
43990103|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990104|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990105|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43990106|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
43990107|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43990108|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031158|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43846388|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43846389|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846390|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43846391|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646810|NCT02781090|Nicotine|nicotine|mesh-list
43646811|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43646812|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
43646813|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646814|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646815|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43646816|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43646817|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
43646818|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646819|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646820|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
43646821|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
43646822|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43646823|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
43646824|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990109|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43990110|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43990111|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990112|NCT02413918|Iloperidone|iloperidone|mesh-list
43990113|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43990114|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43990115|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990116|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990123|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990124|NCT02414204|Urological Agents|urological agents|mesh-ancestor
44031159|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
44031161|NCT00001024|Didanosine|didanosine|mesh-list
44031162|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
43646825|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646826|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646827|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
43990125|NCT02415855|Dabigatran|dabigatran|mesh-list
43990126|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
43990127|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43990128|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
43990129|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990130|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990131|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
43990132|NCT02416102|Losartan|losartan|mesh-list
43813054|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
44245121|NCT04878432|Azacitidine|azacitidine|mesh-list
44245122|NCT04878432|Decitabine|decitabine|mesh-list
44245123|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43990133|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43990134|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43990135|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43990136|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44031163|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031164|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031165|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031166|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031167|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
44031168|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031169|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031170|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031171|NCT00001025|Zidovudine|zidovudine|mesh-list
44031172|NCT00001025|Didanosine|didanosine|mesh-list
44031173|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
44031174|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031175|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031176|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031177|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646828|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646829|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646830|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43646831|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646832|NCT02760667|Cisplatin|cisplatin|mesh-list
43646833|NCT02760667|Carboplatin|carboplatin|mesh-list
43646834|NCT02760667|Docetaxel|docetaxel|mesh-list
43646835|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646836|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646837|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
43990137|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990138|NCT02416193|Vitamin D|vitamin d|mesh-list
43990139|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
43990140|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
43990141|NCT02416193|Vitamins|vitamins|mesh-list
43990142|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
43990143|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990144|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43990145|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43990146|NCT02417129|Rituximab|rituximab|mesh-list
44031178|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
43646838|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646839|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646840|NCT02740985|Docetaxel|docetaxel|mesh-list
43646841|NCT02740985|Durvalumab|durvalumab|mesh-list
43646842|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
43646843|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646844|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646846|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646847|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646848|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646849|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43646850|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990147|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990148|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990149|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
43990150|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990151|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990152|NCT02417831|Tamsulosin|tamsulosin|mesh-list
43990153|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43990154|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43990155|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43990156|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990157|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990158|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990159|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031179|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031180|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031181|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031182|NCT00001027|Pentamidine|pentamidine|mesh-list
44031183|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
44031184|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031185|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031186|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031187|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44031188|NCT00001028|Dapsone|dapsone|mesh-list
44031189|NCT00001028|Pentamidine|pentamidine|mesh-list
44031190|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031191|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
44031192|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031193|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031194|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43646851|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646852|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990160|NCT02417831|Urological Agents|urological agents|mesh-ancestor
43990161|NCT02417844|Tamsulosin|tamsulosin|mesh-list
43990162|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43990163|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43990164|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43990165|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990166|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990167|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990168|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031195|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031196|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646853|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646854|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43646856|NCT02735902|Vitamin K|vitamin k|mesh-list
43646857|NCT02735902|Anticoagulants|anticoagulants|mesh-list
43646858|NCT02735902|Vitamins|vitamins|mesh-ancestor
43646859|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
43646860|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990169|NCT02417844|Urological Agents|urological agents|mesh-ancestor
43990170|NCT02418312|Famotidine|famotidine|mesh-list
43990171|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
43990172|NCT02418312|Histamine|histamine|mesh-list
43990173|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43990174|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990175|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
43990176|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
43990177|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990178|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990179|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990180|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
44031197|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
44031198|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43646861|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43646862|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43646863|NCT02735902|Analgesics|analgesics|mesh-ancestor
43646864|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
43646865|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646866|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646867|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646868|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43646869|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43646870|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646871|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43646872|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43646873|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646874|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
43990182|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43990183|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990184|NCT02419547|Fentanyl|fentanyl|mesh-list
43990185|NCT02419547|Midazolam|midazolam|mesh-list
43990186|NCT02419547|Propofol|propofol|mesh-list
43990194|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990195|NCT02419547|Narcotics|narcotics|mesh-ancestor
43990196|NCT02419547|Analgesics|analgesics|mesh-ancestor
43990197|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
43990198|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990199|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43990200|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44245125|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245126|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245127|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245128|NCT04876248|Lenalidomide|lenalidomide|mesh-list
44245129|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
44245130|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245131|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245132|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44245133|NCT04876248|Growth Substances|growth substances|mesh-ancestor
44245134|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245135|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245136|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44245137|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
44245138|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245139|NCT04872218|Abatacept|abatacept|mesh-list
44245140|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44245141|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245142|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245143|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245144|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
44245145|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245146|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245147|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
44245148|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245149|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245150|NCT04862234|Dulaglutide|dulaglutide|mesh-list
43990201|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43990202|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990203|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
43990204|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
43990205|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44031199|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
43646875|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43646876|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
43646877|NCT02735902|Coagulants|coagulants|mesh-ancestor
43646878|NCT02713945|Simvastatin|simvastatin|mesh-list
43646879|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43646880|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43646881|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
43646882|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990206|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990207|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43990208|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43990209|NCT02420015|Bupropion|bupropion|mesh-list
43990210|NCT02420015|Nicotine|nicotine|mesh-list
43990211|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43990212|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
43990213|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990214|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990215|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43990216|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43990217|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43990218|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245152|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245153|NCT04860635|Celecoxib|celecoxib|mesh-list
44245154|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245155|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245156|NCT04860635|Analgesics|analgesics|mesh-ancestor
44245157|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
44245158|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245159|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245160|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245161|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245162|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44031243|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031244|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44031245|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44031246|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031247|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
44031248|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031249|NCT00001044|Antacids|antacids|mesh-ancestor
44031250|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031251|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44031252|NCT00001049|Zidovudine|zidovudine|mesh-list
44031253|NCT00001049|Didanosine|didanosine|mesh-list
44031254|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
44031255|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031256|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031257|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031258|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031259|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
44031260|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031261|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031262|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031263|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44031264|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031265|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
44031266|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245163|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44245164|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245165|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245166|NCT04828005|Naloxone|naloxone|mesh-list
44245167|NCT04828005|Nalmefene|nalmefene|mesh-list
44245168|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44245169|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245170|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
43990219|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031268|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646883|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646884|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43646885|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646886|NCT02697383|Dexamethasone|dexamethasone|mesh-list
43646887|NCT02697383|Ixazomib|ixazomib|mesh-list
43646888|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43646889|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
43646890|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
43646891|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646892|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646893|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44031269|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43646897|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43646904|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990220|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43990221|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
43990222|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990223|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43990224|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43990225|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990226|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
43990227|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43990228|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43990229|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990230|NCT02420041|Triamcinolone|triamcinolone|mesh-list
43990231|NCT02420041|Lidocaine|lidocaine|mesh-list
43990232|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990233|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
44031270|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44031271|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031272|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
43646906|NCT02697253|Hormones|hormones|mesh-ancestor
43646910|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646911|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646912|NCT02677051|Sulforaphane|sulforaphane|mesh-list
43646913|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43646914|NCT02677051|Protective Agents|protective agents|mesh-ancestor
43646915|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646916|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646917|NCT02667886|Axitinib|axitinib|mesh-list
43646918|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646919|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43646920|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646921|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646922|NCT02660905|Tenofovir|tenofovir|mesh-list
43646923|NCT02660905|Emtricitabine|emtricitabine|mesh-list
43646924|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
43646925|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43646926|NCT02660905|Rilpivirine|rilpivirine|mesh-list
43646927|NCT02660905|Ledipasvir|ledipasvir|mesh-list
43646928|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
43646929|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990234|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990235|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990236|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
43990237|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990238|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43990239|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44031273|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031274|NCT00001053|Antacids|antacids|mesh-ancestor
44031275|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031276|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44031277|NCT00001054|Valacyclovir|valacyclovir|mesh-list
44031278|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
44031279|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031280|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
43990240|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43990241|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990242|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990243|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990244|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
43990245|NCT02420041|Hormones|hormones|mesh-ancestor
43990246|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990247|NCT02420210|Dexamethasone|dexamethasone|mesh-list
43990248|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43990249|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
43990250|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990251|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
43990252|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
44245171|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245173|NCT04823052|Gaboxadol|gaboxadol|mesh-list
44245174|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245175|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245176|NCT04823052|Analgesics|analgesics|mesh-ancestor
44245177|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
44245178|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245179|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245180|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245181|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245182|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245183|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43990253|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990254|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990257|NCT02420210|Hormones|hormones|mesh-ancestor
43990258|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990259|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44031281|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031282|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
44031283|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031284|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031285|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031286|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
44031287|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031288|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
44031289|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44031290|NCT00001055|Protective Agents|protective agents|mesh-ancestor
44149115|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
44149117|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990260|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990261|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43990262|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
43990263|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990264|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990265|NCT02420873|Maytansine|maytansine|mesh-list
43990266|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
43990267|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43990268|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990269|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
43990270|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
43990271|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
43990272|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990273|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990274|NCT02420951|Bupivacaine|bupivacaine|mesh-list
43990275|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990276|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
43990277|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990278|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990279|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
43990280|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990281|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
43990282|NCT02421211|Ledipasvir|ledipasvir|mesh-list
43990283|NCT02421211|Simeprevir|simeprevir|mesh-list
43990284|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
43990285|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990286|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
43990287|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990288|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990289|NCT02421354|Nivolumab|nivolumab|mesh-list
43990290|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990291|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990292|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44149137|NCT00206739|Renal Agents|renal agents|mesh-ancestor
44149138|NCT00206765|Risperidone|risperidone|mesh-list
44149139|NCT00206765|Paroxetine|paroxetine|mesh-list
44149140|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149141|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
44149142|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149143|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990293|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990294|NCT02422290|Ketamine|ketamine|mesh-list
43990295|NCT02422290|Analgesics|analgesics|mesh-ancestor
43990296|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
43990297|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990298|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990299|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43990300|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990301|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
43990302|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
43990303|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245184|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245185|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245186|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
44245187|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
44245188|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
44245189|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245190|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
44245191|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245192|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245193|NCT04801368|Anesthetics|anesthetics|mesh-list
44245194|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
44245195|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245196|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245197|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
44245198|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459893|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459894|NCT01572675|Celecoxib|celecoxib|mesh-list
44459895|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44459896|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44459897|NCT01572675|Analgesics|analgesics|mesh-ancestor
44459898|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
44459899|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990304|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43990305|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43990306|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990307|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990308|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
43990309|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43990310|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990311|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990312|NCT02423980|Glucagon|glucagon|mesh-list
43990313|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43990314|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990316|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990317|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990318|NCT02423980|Incretins|incretins|mesh-ancestor
43990319|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
43990320|NCT02424357|Povidone|povidone|mesh-list
43990321|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43990322|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43990323|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
43990324|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
43990325|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44149179|NCT00206934|Dexetimide|dexetimide|mesh-list
43990326|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990327|NCT02424799|GSK2646264|gsk2646264|mesh-list
43990330|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990332|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
43990333|NCT02424968|Cyclosporins|cyclosporins|mesh-list
43990334|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
43990335|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43990336|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459900|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459901|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459902|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44459903|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44459904|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44459905|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459906|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459907|NCT01572480|Dexamethasone|dexamethasone|mesh-list
44459908|NCT01572480|Lenalidomide|lenalidomide|mesh-list
44459909|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459910|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
44459911|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
44459912|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459913|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459914|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459915|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
44031338|NCT00001061|Foscarnet|foscarnet|mesh-list
44031339|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44031340|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
44031341|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031342|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031343|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031344|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031345|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031346|NCT00001062|Ganciclovir|ganciclovir|mesh-list
44031347|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44031348|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
44031349|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031350|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031351|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031352|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031353|NCT00001063|Zidovudine|zidovudine|mesh-list
44031354|NCT00001063|Didanosine|didanosine|mesh-list
44031355|NCT00001063|Stavudine|stavudine|mesh-list
44031356|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
44031357|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031358|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031359|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031360|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031361|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
43990337|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990338|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990339|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
43990340|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990341|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
43990342|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990343|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
43990344|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990345|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43990346|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43990347|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990348|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43990349|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
43990350|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990351|NCT02425449|Succinylcholine|succinylcholine|mesh-list
43990352|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43990353|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43990354|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43990355|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990356|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990357|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43990358|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990359|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990360|NCT02428478|Desipramine|desipramine|mesh-list
43990361|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43990362|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
43990363|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990364|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990365|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990366|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43990367|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43990368|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990369|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990370|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44031363|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43990371|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990372|NCT02429869|Everolimus|everolimus|mesh-list
43990373|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990374|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990375|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
43990376|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990377|NCT02430090|Fentanyl|fentanyl|mesh-list
43990378|NCT02430090|Sufentanil|sufentanil|mesh-list
44459916|NCT01572480|Hormones|hormones|mesh-ancestor
44459917|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459918|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459919|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459920|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
44459921|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459922|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459923|NCT01572480|Growth Substances|growth substances|mesh-ancestor
44459924|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459925|NCT01572038|Paclitaxel|paclitaxel|mesh-list
44459926|NCT01572038|Docetaxel|docetaxel|mesh-list
44459927|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44459928|NCT01572038|Trastuzumab|trastuzumab|mesh-list
44459929|NCT01572038|Pertuzumab|pertuzumab|mesh-list
44459930|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44459931|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459932|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44459933|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44459934|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44459935|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459936|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459937|NCT01571453|Vortioxetine|vortioxetine|mesh-list
44459938|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43990379|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
43990380|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990381|NCT02430090|Narcotics|narcotics|mesh-ancestor
43990382|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990383|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990384|NCT02430090|Analgesics|analgesics|mesh-ancestor
43990385|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
43990386|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990387|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43990388|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990390|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
43990391|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990392|NCT02430389|Remifentanil|remifentanil|mesh-list
43990393|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990394|NCT02430389|Narcotics|narcotics|mesh-ancestor
43990395|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990396|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990397|NCT02430389|Analgesics|analgesics|mesh-ancestor
43990398|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
43990399|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990401|NCT02430818|Morphine|morphine|mesh-list
43990402|NCT02430818|Analgesics|analgesics|mesh-ancestor
43990408|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
43990410|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990411|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43990412|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43990413|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990414|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990415|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990416|NCT02430818|Narcotics|narcotics|mesh-ancestor
43990417|NCT02431572|Vaccines|vaccines|mesh-list
44245199|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
44245200|NCT04778787|Digoxin|digoxin|mesh-list
44245201|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44245202|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
44245203|NCT04778787|Diuretics|diuretics|mesh-list
44245204|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44245205|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44245206|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245207|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44245208|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245209|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44245210|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44245211|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245212|NCT04778787|Protective Agents|protective agents|mesh-ancestor
44245213|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
44245214|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44245215|NCT04774159|Colchicine|colchicine|mesh-list
44245216|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
44245217|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990418|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
43990419|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031464|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
44031465|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031466|NCT00001090|Sargramostim|sargramostim|mesh-list
44031467|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
44031468|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031469|NCT00001091|Ritonavir|ritonavir|mesh-list
44031470|NCT00001091|Nelfinavir|nelfinavir|mesh-list
44031471|NCT00001091|Lamivudine|lamivudine|mesh-list
44031472|NCT00001091|Nevirapine|nevirapine|mesh-list
44031473|NCT00001091|Stavudine|stavudine|mesh-list
44031474|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031475|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031476|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031477|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031478|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031479|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031480|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031481|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
44031482|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031483|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031484|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43644723|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43990420|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43990421|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
43990422|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
43990423|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990424|NCT02431637|Piperaquine|piperaquine|mesh-list
43990425|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
43990426|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43990427|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43990428|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990429|NCT02431650|Primaquine|primaquine|mesh-list
43990430|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
44031485|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031486|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031487|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44031488|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44031489|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
44031490|NCT00001094|Lamivudine|lamivudine|mesh-list
44031491|NCT00001094|Zidovudine|zidovudine|mesh-list
44031492|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44031493|NCT00001094|Delavirdine|delavirdine|mesh-list
44031494|NCT00001094|Nelfinavir|nelfinavir|mesh-list
44031495|NCT00001094|Saquinavir|saquinavir|mesh-list
44031496|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43646930|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43646931|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43646932|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990431|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43990432|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43990433|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990434|NCT02431754|Tadalafil|tadalafil|mesh-list
43990435|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
43990436|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43990437|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43990438|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990439|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990440|NCT02431754|Urological Agents|urological agents|mesh-ancestor
43990441|NCT02432287|Metformin|metformin|mesh-list
43990442|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43990443|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990444|NCT02432456|Acetaminophen|acetaminophen|mesh-list
43990445|NCT02432456|Ibuprofen|ibuprofen|mesh-list
43990446|NCT02432456|Ketamine|ketamine|mesh-list
43990447|NCT02432456|Narcotics|narcotics|mesh-list
44031497|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031498|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031499|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031500|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
44031501|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031502|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031503|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031504|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
44031505|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031506|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031507|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031508|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031509|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031510|NCT00001095|Lamivudine|lamivudine|mesh-list
44031511|NCT00001095|Zidovudine|zidovudine|mesh-list
44031512|NCT00001095|Nevirapine|nevirapine|mesh-list
44031513|NCT00001095|Stavudine|stavudine|mesh-list
43646934|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43990448|NCT02432456|Methocarbamol|methocarbamol|mesh-list
43990449|NCT02432456|Pantoprazole|pantoprazole|mesh-list
43990450|NCT02432456|Analgesics|analgesics|mesh-ancestor
43990451|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
43990452|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990453|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990454|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43990455|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990456|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
43990457|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
44245219|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245220|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245221|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245222|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245223|NCT04767594|Palbociclib|palbociclib|mesh-list
44245224|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245225|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44245226|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245227|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245228|NCT04762069|Lomustine|lomustine|mesh-list
44031514|NCT00001095|Indinavir|indinavir|mesh-list
44031515|NCT00001095|Amprenavir|amprenavir|mesh-list
44031516|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031517|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43760924|NCT02442466|BQ 788|bq 788|mesh-list
44031518|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031519|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031520|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
44031521|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031522|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031523|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031524|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
44031525|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44031526|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44031527|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031528|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031529|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031530|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44031531|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
43646959|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646960|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245229|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44245230|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
44245232|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245277|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44245278|NCT04746235|Decitabine|decitabine|mesh-list
43990458|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990459|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43990460|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43990461|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725496|NCT02597400|Metformin|metformin|mesh-list
43990462|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990463|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43990464|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
43990465|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43990466|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990467|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990468|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43990469|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990470|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43990471|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990476|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43990477|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
43990478|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43990479|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990480|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43990481|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43990482|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43990483|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
43990484|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990485|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43990486|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43990487|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031532|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031533|NCT00001100|Ganciclovir|ganciclovir|mesh-list
44031534|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44031535|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
44031536|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031537|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031538|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031540|NCT00001101|Doxycycline|doxycycline|mesh-list
44031566|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43990488|NCT02434523|Amitriptyline|amitriptyline|mesh-list
43990489|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43990490|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
43990491|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990492|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43990493|NCT02434523|Analgesics|analgesics|mesh-ancestor
43990494|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
43990495|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031567|NCT00001107|Fluconazole|fluconazole|mesh-list
44031568|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44031569|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
44031570|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031571|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43644724|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43646961|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43646962|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646963|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646964|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43646965|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
43646966|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646967|NCT02635841|Deferiprone|deferiprone|mesh-list
43646968|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43646969|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
43646970|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
43990496|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990497|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43990498|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43990499|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990500|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990501|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990502|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145240|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44145241|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44031572|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031573|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646971|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646972|NCT02631733|Irinotecan|irinotecan|mesh-list
43646973|NCT02631733|Veliparib|veliparib|mesh-list
43646974|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43646975|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43646976|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43646977|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145242|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145243|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145244|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
44145245|NCT00194272|Methotrexate|methotrexate|mesh-list
44145246|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44145247|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
44145248|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145249|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145250|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145251|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
44145252|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145253|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031574|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031575|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44031576|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44031577|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031578|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031579|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44031580|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44031581|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031582|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031583|NCT00001108|Ritonavir|ritonavir|mesh-list
44031584|NCT00001108|Nelfinavir|nelfinavir|mesh-list
44031585|NCT00001108|Saquinavir|saquinavir|mesh-list
43646978|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646980|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43646981|NCT02631733|Hematinics|hematinics|mesh-ancestor
43646982|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43646983|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43646984|NCT02630121|Phenylephrine|phenylephrine|mesh-list
43646985|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
43646986|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43646987|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43646988|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44031586|NCT00001108|Lamivudine|lamivudine|mesh-list
44145254|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
44145255|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145256|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44145257|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145258|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
44145259|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145260|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44145261|NCT00194324|Miconazole|miconazole|mesh-list
44145262|NCT00194324|Clotrimazole|clotrimazole|mesh-list
44145263|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
44145264|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145265|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43813785|NCT04807569|Tamsulosin|tamsulosin|mesh-list
44245279|NCT04746235|Venetoclax|venetoclax|mesh-list
44245280|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245281|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
44145266|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145267|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145268|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145269|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44145270|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
44145271|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031587|NCT00001108|Nevirapine|nevirapine|mesh-list
44031588|NCT00001108|Didanosine|didanosine|mesh-list
44031589|NCT00001108|Stavudine|stavudine|mesh-list
44031590|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031591|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031592|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031593|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031594|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031595|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031596|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031597|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
44031598|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031599|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031600|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031601|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031602|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031603|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44031604|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44031605|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
44031606|NCT00001110|Dimercaprol|dimercaprol|mesh-list
44031607|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
44031608|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
44145272|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145273|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43990503|NCT02435901|Cyclosporine|cyclosporine|mesh-list
43990504|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
43990505|NCT02435901|Fludarabine|fludarabine|mesh-list
43990506|NCT02435901|Melphalan|melphalan|mesh-list
43990507|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
43990508|NCT02435901|Tacrolimus|tacrolimus|mesh-list
43990520|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990521|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43990522|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43990523|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
43990524|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990525|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43990526|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
43990527|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031609|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031610|NCT00001112|Interferons|interferons|mesh-list
44031611|NCT00001112|Zidovudine|zidovudine|mesh-list
44031612|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
43702677|NCT02715479|BMS-955176|bms-955176|mesh-list
43990528|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990529|NCT02436031|Desipramine|desipramine|mesh-list
43990530|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43990531|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
43990532|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990533|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990534|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031613|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031614|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
44031615|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031616|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
43646991|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646992|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
43646993|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
43646994|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646995|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
43646996|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43646997|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
43646998|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43646999|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
43647000|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43990535|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43990536|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43990537|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990538|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990539|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990540|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990541|NCT02436668|Gemcitabine|gemcitabine|mesh-list
43990542|NCT02436668|Paclitaxel|paclitaxel|mesh-list
43990543|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031617|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031618|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031619|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644726|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43990544|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990545|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
43990546|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
43990547|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
43990548|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990549|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43990550|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
43990551|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
44031620|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031621|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031622|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031624|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
44031625|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031626|NCT00001122|Efavirenz|efavirenz|mesh-list
43647003|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43647004|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647005|NCT02618577|Edoxaban|edoxaban|mesh-list
43647006|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43647007|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
43647008|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43647009|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
43647010|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647011|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647012|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
43647013|NCT02584933|Ceritinib|ceritinib|mesh-list
43647014|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647015|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43990552|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990553|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990554|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990555|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
43990556|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990557|NCT02437253|Adalimumab|adalimumab|mesh-list
43990558|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990559|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990560|NCT02437344|Naltrexone|naltrexone|mesh-list
44031627|NCT00001122|Didanosine|didanosine|mesh-list
44031628|NCT00001122|Stavudine|stavudine|mesh-list
43647016|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647017|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647018|NCT02568267|Entrectinib|entrectinib|mesh-list
43647019|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647021|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031629|NCT00001122|Nelfinavir|nelfinavir|mesh-list
43990561|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43990562|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43990563|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990564|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
43990565|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990566|NCT02437383|Propranolol|propranolol|mesh-list
43990567|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43990568|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43990569|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990570|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990571|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990572|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990573|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43725576|NCT02597322|Axitinib|axitinib|mesh-list
44245282|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990579|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990580|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990581|NCT02437669|Analgesics|analgesics|mesh-ancestor
43990582|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
43990583|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990584|NCT02438540|Metformin|metformin|mesh-list
43990585|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43990586|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990587|NCT02439164|Midazolam|midazolam|mesh-list
43990588|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43990589|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43990590|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990591|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990592|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44031630|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031631|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031632|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031633|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031634|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
44031635|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031636|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44031637|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031638|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44031639|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44031640|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44031641|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43990593|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43990594|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990595|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990596|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
43990597|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
43990598|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
43990599|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
43990600|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990601|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990603|NCT02439281|Ropivacaine|ropivacaine|mesh-list
43990604|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990605|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
43990606|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990607|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990608|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
43990609|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990610|NCT02439281|Analgesics|analgesics|mesh-ancestor
43990611|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43990612|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
43990613|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
43990614|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43990615|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43990616|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43990617|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990618|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990619|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990620|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
43990621|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
44031658|NCT00001128|Azithromycin|azithromycin|mesh-list
44031659|NCT00001128|Paromomycin|paromomycin|mesh-list
44031660|NCT00001128|Interleukin-12|interleukin-12|mesh-list
44031661|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031662|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031663|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031664|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
44031665|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031666|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44031667|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44031668|NCT00001128|Growth Substances|growth substances|mesh-ancestor
44031669|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
44031670|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031671|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031672|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031673|NCT00001131|Aldesleukin|aldesleukin|mesh-list
44031674|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031675|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031677|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
43990622|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990623|NCT02439879|Protective Agents|protective agents|mesh-ancestor
43990624|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990625|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
43990626|NCT02439879|Vitamins|vitamins|mesh-ancestor
43990627|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
43990628|NCT02440178|Micafungin|micafungin|mesh-list
43990629|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
43990630|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990631|NCT02440204|Remifentanil|remifentanil|mesh-list
43990632|NCT02440204|Sevoflurane|sevoflurane|mesh-list
43990633|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44031688|NCT00001133|Ritonavir|ritonavir|mesh-list
44031689|NCT00001133|Indinavir|indinavir|mesh-list
44031690|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031691|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031692|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031693|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647023|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647024|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
43647025|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647026|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43647027|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647028|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647031|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647032|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
43647033|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647034|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647035|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
43990634|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43990635|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
43990636|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
43990637|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990638|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990639|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990640|NCT02440204|Narcotics|narcotics|mesh-ancestor
43990641|NCT02440204|Analgesics|analgesics|mesh-ancestor
44031694|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031695|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031696|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031697|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
44031698|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031699|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43647036|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
43647037|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647038|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647039|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43647040|NCT02541955|Hormones|hormones|mesh-ancestor
43647041|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990642|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
43990643|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990644|NCT02440308|Bombesin|bombesin|mesh-list
43990645|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990646|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990650|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990652|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43990653|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43990654|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43990655|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
44245283|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990656|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990657|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031700|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031701|NCT00001135|Nevirapine|nevirapine|mesh-list
44031702|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031703|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031704|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647042|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647043|NCT02535312|Cisplatin|cisplatin|mesh-list
43647044|NCT02535312|Pemetrexed|pemetrexed|mesh-list
43647045|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647046|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990658|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43990659|NCT02444143|Tacrolimus|tacrolimus|mesh-list
43990660|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990661|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
43990662|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990663|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43990664|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990665|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990666|NCT02444234|Tedizolid|tedizolid|mesh-list
43990667|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
43990668|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990669|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990670|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43990671|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990672|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990673|NCT02444936|Vaccines|vaccines|mesh-list
43990674|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
43990675|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990676|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
43990677|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43990678|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43990679|NCT02445326|Dexamethasone|dexamethasone|mesh-list
43990680|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990681|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
43990682|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
43990683|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990684|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990685|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990686|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
43990687|NCT02445326|Hormones|hormones|mesh-ancestor
43990688|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990689|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43990690|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990691|NCT02445807|Clobetasol|clobetasol|mesh-list
43990692|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990693|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
43990694|NCT02445807|Hormones|hormones|mesh-ancestor
43990695|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990696|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990697|NCT02445859|Cefuroxime|cefuroxime|mesh-list
43990698|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
44031722|NCT00001193|Melphalan|melphalan|mesh-list
43990699|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990700|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990701|NCT02446483|Rabeprazole|rabeprazole|mesh-list
43990702|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43990703|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990704|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43990705|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990706|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990707|NCT02446496|Cefadroxil|cefadroxil|mesh-list
43990708|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43990709|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990710|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
43990711|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
43990712|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44031745|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647047|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647048|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43647049|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647050|NCT02508311|Albuterol|albuterol|mesh-list
43647051|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43990713|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990714|NCT02448368|Verinurad|verinurad|mesh-list
43990715|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
43990716|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990717|NCT02448654|Tolcapone|tolcapone|mesh-list
43990718|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43990719|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43990727|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990728|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990730|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990731|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43990732|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990733|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
43990734|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
43990735|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43990736|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44245285|NCT04745910|Rasburicase|rasburicase|mesh-list
44245286|NCT04745910|Uric Acid|uric acid|mesh-list
44245287|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
43681398|NCT03553004|Niraparib|niraparib|mesh-list
43990737|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
43990738|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990739|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43990740|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43990742|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
43990743|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990744|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990745|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43990746|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43990747|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43990748|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990749|NCT02451202|Rocuronium|rocuronium|mesh-list
43990750|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43990751|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43990752|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43990753|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990754|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990755|NCT02451488|Sargramostim|sargramostim|mesh-list
43990756|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
43990757|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990758|NCT02452060|Ketamine|ketamine|mesh-list
43990759|NCT02452060|Analgesics|analgesics|mesh-ancestor
43990760|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
43990761|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990762|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990763|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43990764|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990765|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
43990766|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
43990767|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990768|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44031785|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031786|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644727|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43647052|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
43647053|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647054|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647055|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43647056|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647057|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
43647058|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43647059|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43647060|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43647061|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43990769|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43990770|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990771|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990772|NCT02452346|Tosedostat|tosedostat|mesh-list
43990773|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990774|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990775|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
43990776|NCT02452528|Promethazine|promethazine|mesh-list
44031787|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031788|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44031789|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031790|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
44031791|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647062|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
43647063|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647064|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647065|NCT02498613|Misonidazole|misonidazole|mesh-list
43647066|NCT02498613|Olaparib|olaparib|mesh-list
43647067|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43647068|NCT02498613|Cediranib|cediranib|mesh-list
43647069|NCT02498613|Maleic acid|maleic acid|mesh-list
43647070|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990777|NCT02452528|Tenofovir|tenofovir|mesh-list
43990778|NCT02452528|Entecavir|entecavir|mesh-list
43990779|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
43990780|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990781|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43990782|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43990783|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990784|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990785|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43990786|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43990795|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
43990796|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
43990797|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990798|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43990799|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
43990800|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
43990801|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990802|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43990803|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
43990804|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
43990805|NCT02452866|Secnidazole|secnidazole|mesh-list
44031792|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031793|NCT00001282|Zidovudine|zidovudine|mesh-list
44031794|NCT00001282|Interleukin-2|interleukin-2|mesh-list
44031795|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031796|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44031797|NCT00001282|Analgesics|analgesics|mesh-ancestor
44031798|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
44031799|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031800|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031801|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
44031802|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031803|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031804|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031805|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031806|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
44031807|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031808|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031809|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44149182|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149183|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647071|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647072|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647073|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43990806|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43990807|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43990809|NCT02452931|Leuprolide|leuprolide|mesh-list
43990810|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43990811|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
43990812|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43990813|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990814|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43990815|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245288|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149184|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647075|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44245289|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
44245290|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245291|NCT04745910|Protective Agents|protective agents|mesh-ancestor
44245292|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245293|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
44245294|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43990816|NCT02453360|Bupivacaine|bupivacaine|mesh-list
43990817|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990818|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
43990819|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149185|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149186|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
44149187|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149188|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43647076|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990820|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990821|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
43990822|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990823|NCT02453581|Artefenomel|artefenomel|mesh-list
43990824|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
43990825|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43990826|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43990827|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990828|NCT02453672|Bevacizumab|bevacizumab|mesh-list
44149189|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149190|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149191|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44149192|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44031810|NCT00001296|Interferons|interferons|mesh-list
44031811|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
44031812|NCT00001296|Melphalan|melphalan|mesh-list
44031813|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990829|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990830|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990831|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43990832|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43990833|NCT02453672|Growth Substances|growth substances|mesh-ancestor
43990834|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990835|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
43990836|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
43990837|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
43990838|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990839|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990840|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43990841|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
43990842|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
43990843|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
44031814|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
44031815|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031816|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031817|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
44031818|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031819|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031820|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031821|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
44031822|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031823|NCT00001300|Doxorubicin|doxorubicin|mesh-list
44031824|NCT00001300|Ifosfamide|ifosfamide|mesh-list
44031825|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031826|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031827|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43644728|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44031828|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43990844|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43990845|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990847|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43990848|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43990849|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990850|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990851|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
43990852|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990853|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990854|NCT02454296|Lidocaine|lidocaine|mesh-list
43990855|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990860|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990861|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43990862|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43990863|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44031829|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031830|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990864|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990865|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990867|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
43990868|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
43990869|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990870|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
43990871|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990872|NCT02455453|Estradiol|estradiol|mesh-list
43990873|NCT02455453|Estrogens|estrogens|mesh-ancestor
43990874|NCT02455453|Hormones|hormones|mesh-ancestor
43990875|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43990876|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990877|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
43990878|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
43990879|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43990880|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43844768|NCT04340141|Vitamins|vitamins|mesh-ancestor
44245296|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031831|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031832|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
44031833|NCT00001307|Capsaicin|capsaicin|mesh-list
44031834|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
44031835|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44031836|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
44031837|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031838|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031840|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
44031841|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44031842|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44031843|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031844|NCT00001317|Interferons|interferons|mesh-list
44031845|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
44031846|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031847|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
44031848|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031849|NCT00001318|Interferons|interferons|mesh-list
44031850|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
44245297|NCT04732000|Expectorants|expectorants|mesh-ancestor
44245298|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
44245299|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44245300|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
44245301|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245302|NCT04732000|Protective Agents|protective agents|mesh-ancestor
43990881|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990882|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990883|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43990884|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44145274|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44145275|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44031851|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031852|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
44031853|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031854|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44031855|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44031856|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031857|NCT00001335|Topotecan|topotecan|mesh-list
44031858|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44031859|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031860|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031861|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031862|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031863|NCT00001339|Doxorubicin|doxorubicin|mesh-list
44031864|NCT00001339|Etoposide|etoposide|mesh-list
44145276|NCT00194402|Niacin|niacin|mesh-list
44145277|NCT00194402|Niacinamide|niacinamide|mesh-list
44145278|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
44145279|NCT00194402|Atorvastatin|atorvastatin|mesh-list
44145280|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44145281|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44145282|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
44145283|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145284|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44145285|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44145286|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145287|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
44145288|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
44145289|NCT00194402|Vitamins|vitamins|mesh-ancestor
44145290|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
44145291|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145292|NCT00194467|Valganciclovir|valganciclovir|mesh-list
44145293|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
44145294|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145295|NCT00194480|Interferons|interferons|mesh-list
44145296|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145297|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
44145298|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145299|NCT00194519|Acyclovir|acyclovir|mesh-list
44145300|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
44145301|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145302|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
44145303|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145304|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
44145305|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44145306|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44145307|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145308|NCT00194597|Urological Agents|urological agents|mesh-ancestor
44145309|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
44145310|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44145311|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44145312|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44145313|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44031865|NCT00001339|Vincristine|vincristine|mesh-list
44031902|NCT00001381|Suramin|suramin|mesh-list
44145314|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145321|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145322|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145323|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44145324|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44145325|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
44145326|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145327|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44145328|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44145329|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145330|NCT00194727|Capecitabine|capecitabine|mesh-list
44145331|NCT00194727|Vinorelbine|vinorelbine|mesh-list
44145332|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145333|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
44245303|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245304|NCT04732000|Antidotes|antidotes|mesh-ancestor
44245305|NCT04725656|Nicotine|nicotine|mesh-list
44145334|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031903|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
44031904|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
44031905|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031906|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031907|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031908|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44031909|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031910|NCT00001383|Paclitaxel|paclitaxel|mesh-list
44031911|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031912|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031913|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031914|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031915|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031916|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031917|NCT00001384|Paclitaxel|paclitaxel|mesh-list
44031918|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
44031919|NCT00001384|Doxorubicin|doxorubicin|mesh-list
44031920|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44145335|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145336|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145337|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
44145338|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145339|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145340|NCT00194740|Docetaxel|docetaxel|mesh-list
44145341|NCT00194740|Vinorelbine|vinorelbine|mesh-list
44145342|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145343|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44145344|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145345|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145346|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990885|NCT02458235|Azacitidine|azacitidine|mesh-list
43990886|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43990887|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
43990888|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990889|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990890|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990891|NCT02458690|Dopamine|dopamine|mesh-list
43990892|NCT02458690|Norepinephrine|norepinephrine|mesh-list
43990893|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
44031921|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031922|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031923|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031924|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031925|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031926|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031927|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031928|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
44031929|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031930|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44031931|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031932|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
44031933|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031934|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031935|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44031936|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031937|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031938|NCT00001407|Interferons|interferons|mesh-list
44031939|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
44031940|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031941|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
43644730|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44031942|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990895|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43990896|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
43990897|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43990898|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43990899|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990900|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990901|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990902|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990903|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
43990904|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
43990905|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990906|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43990907|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990908|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43990909|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
43990910|NCT02458690|Protective Agents|protective agents|mesh-ancestor
43990911|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43990912|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
43990913|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44031943|NCT00001409|Interleukin-2|interleukin-2|mesh-list
44031944|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031945|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44031946|NCT00001409|Analgesics|analgesics|mesh-ancestor
44031947|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
44031948|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031949|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031950|NCT00001422|Fludarabine|fludarabine|mesh-list
44031951|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031952|NCT00001426|Paclitaxel|paclitaxel|mesh-list
44031953|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
44031954|NCT00001426|Cisplatin|cisplatin|mesh-list
44031955|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031956|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031957|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031958|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031959|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031960|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031961|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031962|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
44031963|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990914|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43990915|NCT02458768|Menotropins|menotropins|mesh-list
43990916|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43990917|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
43990918|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43990919|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990920|NCT02459275|Metoclopramide|metoclopramide|mesh-list
43990921|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
44031964|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990922|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
43990923|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990932|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43990933|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990934|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43990936|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990937|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43990938|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43990939|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
43990940|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990941|NCT02462148|Dexamethasone|dexamethasone|mesh-list
43990942|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
43990943|NCT02462148|Epinephrine|epinephrine|mesh-list
44031965|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031966|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
43990944|NCT02462148|Bupivacaine|bupivacaine|mesh-list
43990945|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43990946|NCT02462148|BB 1101|bb 1101|mesh-list
43990947|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990948|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
43990949|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
43990950|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990951|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245307|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
44245308|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245309|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245310|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44245311|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44245312|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
43990952|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990953|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
43990954|NCT02462148|Hormones|hormones|mesh-ancestor
43990955|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031967|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031969|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
44031970|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031971|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44031972|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031973|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031974|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
44031975|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031976|NCT00001431|Gemcitabine|gemcitabine|mesh-list
44031977|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44031978|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
44031979|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031980|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031981|NCT00001431|Antiviral Agents|antiviral agents|mesh-ancestor
44031982|NCT00001431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031983|NCT00001431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031984|NCT00001431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647078|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43647079|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
43647080|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647081|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647082|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43647083|NCT02490904|Diuretics|diuretics|mesh-ancestor
44031985|NCT00001431|Immunologic Factors|immunologic factors|mesh-ancestor
43990956|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43990957|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990958|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
43725907|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
43990959|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990960|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990961|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990962|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
43990963|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990964|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
43990965|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43990966|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43990967|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
43990968|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990969|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43990970|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43990971|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43990972|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
44031986|NCT00001431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031987|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
44031988|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44031989|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031990|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031991|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44031992|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44031993|NCT00001437|Protective Agents|protective agents|mesh-ancestor
44031994|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031995|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
44031996|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44031997|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
44031998|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
44031999|NCT00001438|Tretinoin|tretinoin|mesh-list
44032000|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032001|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
44032002|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032003|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
43647084|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
43647085|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43647086|NCT02467621|Pantoprazole|pantoprazole|mesh-list
43647087|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43990973|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
43990974|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
43990975|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43990976|NCT02462382|Ropivacaine|ropivacaine|mesh-list
43990977|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990978|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
43990979|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990980|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990981|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
43990982|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990983|NCT02464033|Vitamin D|vitamin d|mesh-list
43990984|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
43990985|NCT02464033|Etanercept|etanercept|mesh-list
43990986|NCT02464033|Vitamins|vitamins|mesh-ancestor
43990987|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
43990988|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990989|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43990994|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
43990995|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990996|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990997|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43990998|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990999|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43991000|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
43991001|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
43991002|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
43991003|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
43991004|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991005|NCT02464176|Dexamethasone|dexamethasone|mesh-list
43991006|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
43991007|NCT02464176|Epinephrine|epinephrine|mesh-list
43991008|NCT02464176|Bupivacaine|bupivacaine|mesh-list
43991009|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43991010|NCT02464176|BB 1101|bb 1101|mesh-list
43991011|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991012|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
43991013|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
43991014|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991015|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991016|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991017|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
43991018|NCT02464176|Hormones|hormones|mesh-ancestor
44245313|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245314|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245315|NCT04716881|Naltrexone|naltrexone|mesh-list
44245316|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44245317|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43991019|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991020|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032052|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991021|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991022|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
43991023|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991024|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991025|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991026|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
43991027|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991028|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
43991029|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43991030|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43991031|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991032|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991033|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43991034|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43991035|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43991036|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43991037|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
43991038|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
44032053|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
44032054|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032055|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032056|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032057|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
44032058|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032059|NCT00001449|Antidotes|antidotes|mesh-ancestor
44032060|NCT00001449|Protective Agents|protective agents|mesh-ancestor
44032061|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
44032062|NCT00001449|Vitamins|vitamins|mesh-ancestor
44032063|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
44032064|NCT00001450|Paclitaxel|paclitaxel|mesh-list
44032065|NCT00001450|Cisplatin|cisplatin|mesh-list
44032066|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032067|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032068|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032069|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032070|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032071|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991039|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43991040|NCT02464657|Cytarabine|cytarabine|mesh-list
43991041|NCT02464657|Dexamethasone|dexamethasone|mesh-list
43991042|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
43991043|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43991044|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43991045|NCT02464657|Prednisolone|prednisolone|mesh-list
43991046|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
43991047|NCT02464657|Nivolumab|nivolumab|mesh-list
43991048|NCT02464657|Idarubicin|idarubicin|mesh-list
43991049|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43991050|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
43991051|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032072|NCT00001498|Leucovorin|leucovorin|mesh-list
44032073|NCT00001498|Paclitaxel|paclitaxel|mesh-list
44032074|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
44032075|NCT00001498|Doxorubicin|doxorubicin|mesh-list
44032076|NCT00001498|Fluorouracil|fluorouracil|mesh-list
44032077|NCT00001498|Methotrexate|methotrexate|mesh-list
44032078|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032079|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032080|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032081|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032082|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
43647088|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647089|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43647090|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991052|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
43991053|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
43991054|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991055|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991056|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991057|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
43991058|NCT02464657|Hormones|hormones|mesh-ancestor
43991059|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991060|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43991061|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991062|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991070|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
43991071|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43991072|NCT02464657|Protective Agents|protective agents|mesh-ancestor
43991073|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43991074|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43991075|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43991076|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991077|NCT02465450|Lenabasum|lenabasum|mesh-list
43991078|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43991079|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43991080|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991081|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991082|NCT02465450|Hormones|hormones|mesh-ancestor
43991083|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991084|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991085|NCT02465632|Clindamycin|clindamycin|mesh-list
43991086|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
43991087|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
43991088|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43991089|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44245318|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245319|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
44245320|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245321|NCT04695847|Antibodies|antibodies|mesh-list
44245322|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
44245323|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
44245324|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43991090|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991091|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43991092|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991093|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991094|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
43991095|NCT02466958|Milnacipran|milnacipran|mesh-list
43991096|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
43991097|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43991098|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43991099|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991100|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991101|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991102|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991103|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
43991104|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991105|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991106|NCT02466958|Analgesics|analgesics|mesh-ancestor
43991107|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
43991108|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991109|NCT02467504|Folic Acid|folic acid|mesh-list
43991110|NCT02467504|Loxoprofen|loxoprofen|mesh-list
43991111|NCT02467504|Hematinics|hematinics|mesh-ancestor
43991112|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
43991114|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
44032124|NCT00001520|Neostigmine|neostigmine|mesh-list
44032125|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44032126|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032127|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032128|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
44032129|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032130|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032131|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44032132|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
44032133|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032134|NCT00001526|Daclizumab|daclizumab|mesh-list
44032135|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032136|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
44032137|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032138|NCT00001534|Losartan|losartan|mesh-list
44032139|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44032140|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44032141|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44032142|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44032143|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032149|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991115|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991116|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43991117|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991118|NCT02467504|Analgesics|analgesics|mesh-ancestor
43991119|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
43991120|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991121|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991123|NCT02468700|Dexamethasone|dexamethasone|mesh-list
43991124|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991125|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
43991126|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
43991127|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032150|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032151|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
44032152|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44032153|NCT00001561|Antibodies|antibodies|mesh-list
44032154|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44032155|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
44032156|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032157|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44032158|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032159|NCT00001569|Paclitaxel|paclitaxel|mesh-list
44032160|NCT00001569|Cisplatin|cisplatin|mesh-list
43991128|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991129|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991130|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
43991131|NCT02468700|Hormones|hormones|mesh-ancestor
43991134|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991136|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43991137|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43991138|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43991139|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991140|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991141|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991142|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991143|NCT02468830|Urological Agents|urological agents|mesh-ancestor
43991144|NCT02469116|Carboplatin|carboplatin|mesh-list
43991145|NCT02469116|Docetaxel|docetaxel|mesh-list
43991146|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991147|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
43991148|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
43991149|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
43991150|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991151|NCT02469597|Furosemide|furosemide|mesh-list
43991152|NCT02469597|Diuretics|diuretics|mesh-ancestor
43991153|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
43991154|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991155|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43844769|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
44245325|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
44245326|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991156|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991157|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991158|NCT02469701|Nivolumab|nivolumab|mesh-list
43991159|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991160|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991161|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43991162|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991163|NCT02470234|Methylphenidate|methylphenidate|mesh-list
43991164|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43991165|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991166|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43991167|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43991168|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44032162|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991169|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991170|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
43991171|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991172|NCT02470390|Fentanyl|fentanyl|mesh-list
43991173|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991174|NCT02470390|Narcotics|narcotics|mesh-ancestor
43991175|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991176|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991177|NCT02470390|Analgesics|analgesics|mesh-ancestor
43991178|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
43991179|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991180|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991181|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991182|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
43991183|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
43726067|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
43991184|NCT02470741|Letrozole|letrozole|mesh-list
43991185|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991186|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43991187|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43991188|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991189|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991190|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43991191|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
43991192|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991193|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991195|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43991196|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43991197|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43991198|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991199|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991201|NCT02471651|Ranibizumab|ranibizumab|mesh-list
43991205|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43991207|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991208|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
43991209|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991210|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
43991211|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
43991212|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991213|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991214|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
43991215|NCT02471651|Hormones|hormones|mesh-ancestor
43991216|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991217|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43991218|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
43991219|NCT02472223|Povidone|povidone|mesh-list
43991220|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
43991221|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
43991222|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
43991223|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43991224|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991225|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43991226|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43991227|NCT02472314|Bupivacaine|bupivacaine|mesh-list
43991228|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991229|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
43991230|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991231|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991232|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
43991233|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991234|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
43991235|NCT02472522|Ropivacaine|ropivacaine|mesh-list
43991236|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
43991237|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991238|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991239|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991240|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991241|NCT02472522|Analgesics|analgesics|mesh-ancestor
43991242|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
43991243|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991244|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43991245|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43991246|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991247|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991248|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991249|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991250|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
43991251|NCT02473783|Sertraline|sertraline|mesh-list
43991252|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
43991253|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991254|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43991255|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43991256|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991257|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991258|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991259|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
43991260|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991261|NCT02474407|Diazepam|diazepam|mesh-list
43991262|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991263|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
43991264|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
43991265|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
43991266|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991267|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991268|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991269|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991270|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991271|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43991272|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43991273|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43991280|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
43991281|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991282|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991283|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
43991284|NCT02475070|Vildagliptin|vildagliptin|mesh-list
43991285|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43991286|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991287|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43991288|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991289|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43991290|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
43991291|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991292|NCT02475837|Vorapaxar|vorapaxar|mesh-list
43991293|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44145347|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44245336|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
44145348|NCT00194753|Paclitaxel|paclitaxel|mesh-list
44145349|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
44145350|NCT00194753|Doxorubicin|doxorubicin|mesh-list
44145351|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145352|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145353|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44145354|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44145355|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145356|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145357|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145358|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
44145359|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145360|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145361|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44145362|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
44145363|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44145364|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145365|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44145366|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145367|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145368|NCT00194766|Temozolomide|temozolomide|mesh-list
44145369|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44145370|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
44145371|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145372|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145373|NCT00194818|Mesalamine|mesalamine|mesh-list
44145374|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44145375|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145376|NCT00194818|Analgesics|analgesics|mesh-ancestor
44145377|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
44145378|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145379|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145380|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145381|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145382|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
44032316|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145383|NCT00194857|Hematinics|hematinics|mesh-ancestor
44145384|NCT00194883|Hormones|hormones|mesh-list
44145385|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145386|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145387|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
43991294|NCT02477423|Gentamicins|gentamicins|mesh-list
43991295|NCT02477423|Ampicillin|ampicillin|mesh-list
43991296|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991297|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991298|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43991299|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991300|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991301|NCT02478489|Naltrexone|naltrexone|mesh-list
43991302|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43991307|NCT02478580|Modafinil|modafinil|mesh-list
43991308|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43991309|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991310|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43991311|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43991312|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43991313|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991314|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43991315|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
43991316|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991317|NCT02480998|Vaccines|vaccines|mesh-list
43991318|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
43991319|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991320|NCT02481219|Erythromycin|erythromycin|mesh-list
43991321|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
44032317|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032318|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032319|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032320|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032321|NCT00001698|Ketorolac|ketorolac|mesh-list
44032322|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43991322|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43991323|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
44245337|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44245338|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44245339|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
44245340|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991324|NCT02481219|Metoclopramide|metoclopramide|mesh-list
43991325|NCT02481219|Bisacodyl|bisacodyl|mesh-list
43991326|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43991327|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
43991328|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
43991329|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991330|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991331|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991332|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43991333|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43991334|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
43991335|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991336|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991337|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991338|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991339|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43991340|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991341|NCT02481219|Cathartics|cathartics|mesh-ancestor
43991342|NCT02481219|Laxatives|laxatives|mesh-ancestor
43991343|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
43991344|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
43991345|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991346|NCT02481297|Rituximab|rituximab|mesh-list
43991347|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991348|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991349|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
43991350|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991351|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43991352|NCT02481375|Iron|iron|mesh-list
43991353|NCT02481375|Trace Elements|trace elements|mesh-list
43991354|NCT02481375|Micronutrients|micronutrients|mesh-list
43991355|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991356|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
43991357|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991358|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
43991359|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991360|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991361|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
43991362|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991363|NCT02482675|Caseins|caseins|mesh-list
43991364|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
43991365|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
43991366|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991367|NCT02483000|Biotin|biotin|mesh-list
43991368|NCT02483000|Cytarabine|cytarabine|mesh-list
43991369|NCT02483000|Etoposide|etoposide|mesh-list
43991371|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
43991372|NCT02483000|Melphalan|melphalan|mesh-list
43991373|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
43991374|NCT02483000|Carmustine|carmustine|mesh-list
43991375|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43991380|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43991381|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991382|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991383|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43991384|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
43991385|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
43991386|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991387|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43991388|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
43991389|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991390|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43991391|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
43991392|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43991393|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
43991394|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
43991395|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
43991396|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245341|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44245342|NCT04672460|Talazoparib|talazoparib|mesh-list
44245343|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44245344|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245345|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245346|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245347|NCT04667117|Ofatumumab|ofatumumab|mesh-list
44245348|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245349|NCT04661358|Fenofibrate|fenofibrate|mesh-list
43991397|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
43991398|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
43991399|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
43991400|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
43991402|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
43991403|NCT02484222|Fentanyl|fentanyl|mesh-list
43991404|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991405|NCT02484222|Narcotics|narcotics|mesh-ancestor
43991406|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991407|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991408|NCT02484222|Analgesics|analgesics|mesh-ancestor
43991409|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
43991410|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991411|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991412|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991413|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
43991414|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
43991415|NCT02484859|Metoprolol|metoprolol|mesh-list
43991416|NCT02484859|Remifentanil|remifentanil|mesh-list
43991417|NCT02484859|Tramadol|tramadol|mesh-list
43991418|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991419|NCT02484859|Narcotics|narcotics|mesh-ancestor
43991420|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991421|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991422|NCT02484859|Analgesics|analgesics|mesh-ancestor
43991423|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
43991424|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991425|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43991426|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43991427|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
43991428|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
43991429|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43991430|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43991431|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43991432|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991433|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991434|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991435|NCT02485834|Docetaxel|docetaxel|mesh-list
43991436|NCT02485834|Capecitabine|capecitabine|mesh-list
43991437|NCT02485834|Irinotecan|irinotecan|mesh-list
43991438|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991439|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
43991440|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
43991441|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
43991442|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991443|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43991444|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
43991445|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43991446|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43991451|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991452|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991454|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
43991455|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991456|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991457|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991458|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
43991459|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
43991460|NCT02486211|Amantadine|amantadine|mesh-list
43991461|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44245350|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44245351|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
44245352|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245353|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44245354|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
44245355|NCT04660539|Azathioprine|azathioprine|mesh-list
43991462|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43991463|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
43991464|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991465|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
43991466|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991467|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991468|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991469|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991470|NCT02486211|Analgesics|analgesics|mesh-ancestor
43991471|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
43991472|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991473|NCT02486328|Midazolam|midazolam|mesh-list
43991474|NCT02486328|Meperidine|meperidine|mesh-list
43991475|NCT02486328|Remifentanil|remifentanil|mesh-list
43991476|NCT02486328|Propofol|propofol|mesh-list
43991477|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991478|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991479|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991480|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991481|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
43991482|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
43991483|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991484|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43991485|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43991486|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991487|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
43991488|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
43991489|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991490|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991491|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991492|NCT02486328|Narcotics|narcotics|mesh-ancestor
43991493|NCT02486328|Analgesics|analgesics|mesh-ancestor
43991494|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
43991495|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991496|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
43991497|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43991498|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991499|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991500|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43991501|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43991502|NCT02487225|Protective Agents|protective agents|mesh-ancestor
43991503|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991504|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
43991505|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43991506|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
43991507|NCT02487303|Acetaminophen|acetaminophen|mesh-list
43991508|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991509|NCT02487303|Analgesics|analgesics|mesh-ancestor
43991510|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
43991511|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991512|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991513|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
43991514|NCT02487485|Sirolimus|sirolimus|mesh-list
43991515|NCT02487485|Ketamine|ketamine|mesh-list
43991516|NCT02487485|Analgesics|analgesics|mesh-ancestor
43991517|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
43991518|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991519|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991520|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43991524|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991525|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43991526|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43991527|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991528|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245356|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44245358|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44245359|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
44245360|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991529|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991530|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991531|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43991532|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991533|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
43991534|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43991535|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
43991537|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43991538|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
43991539|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991540|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991541|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991543|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43991544|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
43991545|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
43991546|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991547|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
43991548|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43991549|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43991550|NCT02489227|Adalimumab|adalimumab|mesh-list
43991551|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991552|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43991553|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
43991554|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991555|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991556|NCT02489734|Sevoflurane|sevoflurane|mesh-list
43991557|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43991558|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43991559|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
43991560|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
43991561|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991562|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991563|NCT02490293|Cephalosporins|cephalosporins|mesh-list
43991564|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991565|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991566|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
43991567|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43991568|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43991569|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991570|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
43991571|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
43991572|NCT02490670|Cephalexin|cephalexin|mesh-list
43991573|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991574|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991575|NCT02491437|Progesterone|progesterone|mesh-list
43991576|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
43991577|NCT02491437|Progestins|progestins|mesh-ancestor
43991578|NCT02491437|Hormones|hormones|mesh-ancestor
43991579|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991580|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991581|NCT02491788|Suvorexant|suvorexant|mesh-list
43991582|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43991583|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991584|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991585|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991586|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43991587|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991588|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991589|NCT02491944|Osimertinib|osimertinib|mesh-list
43991590|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991591|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43991592|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991593|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991598|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991599|NCT02492750|Dexamethasone|dexamethasone|mesh-list
44245361|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245362|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245363|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245364|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
44245365|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245366|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245367|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
44245368|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245369|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43991600|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
43991601|NCT02492750|Lenalidomide|lenalidomide|mesh-list
43991602|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43991603|NCT02492750|Ichthammol|ichthammol|mesh-list
44032570|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
43991604|NCT02492750|BB 1101|bb 1101|mesh-list
43991605|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991606|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
43991607|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
43991608|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991609|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991610|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991611|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
43991612|NCT02492750|Hormones|hormones|mesh-ancestor
43991613|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991614|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43991615|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991616|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
43991617|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43991618|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43991619|NCT02492750|Growth Substances|growth substances|mesh-ancestor
43991620|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
43991621|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
43991622|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991623|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991624|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43991625|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
43991626|NCT02492802|Posaconazole|posaconazole|mesh-list
43991627|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
43991628|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991629|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43991630|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43991631|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43991632|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43991633|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43991634|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991635|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991636|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43991637|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032571|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032572|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032573|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991638|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991639|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991640|NCT02493257|Ethanol|ethanol|mesh-list
43991641|NCT02493257|Capsaicin|capsaicin|mesh-list
43991642|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43991643|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991644|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991645|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991646|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
43991647|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
43991648|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
43991649|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991650|NCT02493452|Plecanatide|plecanatide|mesh-list
43991651|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43991652|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
43991653|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991654|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991655|NCT02494102|Modafinil|modafinil|mesh-list
44245371|NCT04655755|Venetoclax|venetoclax|mesh-list
44245372|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245373|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
44245374|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991656|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43991657|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991658|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43991659|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43991660|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43991661|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991662|NCT02494180|Fentanyl|fentanyl|mesh-list
43991663|NCT02494180|Midazolam|midazolam|mesh-list
43991664|NCT02494180|Diazepam|diazepam|mesh-list
43991668|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991669|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991670|NCT02494180|Analgesics|analgesics|mesh-ancestor
43991671|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
43991672|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991673|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991674|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991675|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
43991676|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
43991677|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991678|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43991679|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43991680|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991681|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
43991682|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
43991683|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991684|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991685|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
43991686|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
43991687|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
43991688|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991689|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43991690|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43991691|NCT02494336|Ropivacaine|ropivacaine|mesh-list
43991692|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991693|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
43991694|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991695|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991696|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
43991697|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991698|NCT02494713|Ketoconazole|ketoconazole|mesh-list
43991700|NCT02494713|Doxorubicin|doxorubicin|mesh-list
43991701|NCT02494713|Estramustine|estramustine|mesh-list
43991702|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991703|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
43991704|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032652|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032653|NCT00001937|Fluconazole|fluconazole|mesh-list
44032654|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
44032655|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032656|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032657|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032658|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032659|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032660|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032661|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032662|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032663|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032664|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44032665|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44032666|NCT00001940|Voriconazole|voriconazole|mesh-list
44032667|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
44032668|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032669|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032670|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032671|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991705|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
43991706|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991707|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43991708|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43991709|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43991710|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991711|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
43991712|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991713|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43991714|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43991715|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43991716|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
43991717|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991718|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991719|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43991720|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43991721|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
43991722|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032672|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032673|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032674|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032675|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032676|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032677|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44032678|NCT00001944|Vinorelbine|vinorelbine|mesh-list
44032679|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032680|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032681|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032682|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032683|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149301|NCT00207363|Interferons|interferons|mesh-list
44032684|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032685|NCT00001954|Etanercept|etanercept|mesh-list
44032686|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032687|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032688|NCT00001954|Analgesics|analgesics|mesh-ancestor
43647110|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647111|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
43647112|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647113|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991723|NCT02495038|Rocuronium|rocuronium|mesh-list
43991724|NCT02495038|Atracurium|atracurium|mesh-list
44245375|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245376|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245377|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
43991725|NCT02495038|Cisatracurium|cisatracurium|mesh-list
43991726|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43991727|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43991728|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43991729|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991730|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991731|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43991732|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43991733|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
43991734|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991735|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991736|NCT02495103|Metformin|metformin|mesh-list
43991737|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43991748|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43991749|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43991750|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145388|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
43991751|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991752|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43991753|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43991754|NCT02495831|Diclofenac|diclofenac|mesh-list
43991755|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43991756|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991757|NCT02495831|Analgesics|analgesics|mesh-ancestor
43991758|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
43991759|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991760|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991761|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991762|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43991763|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43991764|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991765|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991766|NCT02497040|Bupivacaine|bupivacaine|mesh-list
43991767|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
43991768|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991769|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
43991770|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991771|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991772|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
43991773|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991774|NCT02498483|Acetaminophen|acetaminophen|mesh-list
43991775|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991776|NCT02498483|Analgesics|analgesics|mesh-ancestor
43991777|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
43991778|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991779|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991780|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
43991781|NCT02498522|Metformin|metformin|mesh-list
43991782|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43991783|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991784|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
43991785|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43991786|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43991787|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43991788|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991789|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991790|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
43991791|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991792|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991793|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43991794|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991795|NCT02499081|Ixazomib|ixazomib|mesh-list
43991796|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991797|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
43991798|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991799|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991800|NCT02499497|Androgens|androgens|mesh-list
43991801|NCT02499497|Hormones|hormones|mesh-ancestor
44165299|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245379|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44245380|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245381|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245382|NCT04640896|Lidocaine|lidocaine|mesh-list
44245383|NCT04640896|Bupivacaine|bupivacaine|mesh-list
44245384|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
44245385|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
44145391|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145392|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145393|NCT00194909|Urological Agents|urological agents|mesh-ancestor
44145395|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44145396|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145397|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145398|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145399|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145400|NCT00194948|Citalopram|citalopram|mesh-list
44145401|NCT00194948|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44145402|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44145403|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44145404|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145405|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145406|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
44145407|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145408|NCT00194948|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43991804|NCT02500602|Doxazosin|doxazosin|mesh-list
43991805|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43991806|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43991807|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43991808|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43991809|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991810|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991811|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991812|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991813|NCT02500628|Metformin|metformin|mesh-list
43991814|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43991815|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991816|NCT02500836|Cocaine|cocaine|mesh-list
43991817|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43991818|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991819|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
43991820|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991821|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991822|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
43991823|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991824|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43991825|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43991826|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43991827|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991828|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991829|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
43991830|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991831|NCT02501135|Bupivacaine|bupivacaine|mesh-list
43991832|NCT02501135|Ropivacaine|ropivacaine|mesh-list
43991833|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991834|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
43991835|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991836|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991837|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
43991838|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991839|NCT02501265|Nicotine|nicotine|mesh-list
43991840|NCT02501265|Varenicline|varenicline|mesh-list
43991841|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43991842|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
44245386|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245387|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245388|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
44245389|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245390|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44245391|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43991843|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991844|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991845|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43991846|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43991847|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
43991848|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991853|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
43991854|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991855|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991856|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
43991857|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991858|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
43991859|NCT02503735|Ledipasvir|ledipasvir|mesh-list
43991860|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
43991861|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991862|NCT02503982|Valganciclovir|valganciclovir|mesh-list
43991863|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
43991864|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991865|NCT02504554|Vancomycin|vancomycin|mesh-list
43991866|NCT02504554|Omeprazole|omeprazole|mesh-list
43991867|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43991868|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991869|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43991870|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991871|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43991872|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991873|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991874|NCT02504723|Carvedilol|carvedilol|mesh-list
43991875|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43991876|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43991877|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991878|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991879|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991880|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991881|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43991883|NCT02504723|Protective Agents|protective agents|mesh-ancestor
43991884|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43991885|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991886|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43991887|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
43991888|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43991889|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43991890|NCT02504775|Acetaminophen|acetaminophen|mesh-list
43991891|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991892|NCT02504775|Analgesics|analgesics|mesh-ancestor
44032847|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032853|NCT00001997|Zidovudine|zidovudine|mesh-list
43991893|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
43991894|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991895|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991896|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
43991897|NCT02504931|Sertraline|sertraline|mesh-list
43991898|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
43991899|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991900|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43991901|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43991902|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991903|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991904|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991905|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
43991906|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991907|NCT02505269|Doxorubicin|doxorubicin|mesh-list
43991908|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43991909|NCT02505269|Dacarbazine|dacarbazine|mesh-list
44245392|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44245393|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44245394|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245395|NCT04640779|Salicylates|salicylates|mesh-list
44245396|NCT04640779|Choline|choline|mesh-list
44245397|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
44245398|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44245399|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
44245400|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991910|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43991911|NCT02505269|Imidazole|imidazole|mesh-list
43991912|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44032886|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032887|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
44032888|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032889|NCT00002000|Valacyclovir|valacyclovir|mesh-list
44032890|NCT00002000|Acyclovir|acyclovir|mesh-list
44032891|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
44032892|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032893|NCT00002001|Zidovudine|zidovudine|mesh-list
44032894|NCT00002001|Didanosine|didanosine|mesh-list
44032895|NCT00002001|Zalcitabine|zalcitabine|mesh-list
44032896|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
44032897|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032898|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032899|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43991913|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991914|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43991915|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43991916|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991917|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991918|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43991919|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
43991920|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991921|NCT02506114|Ipilimumab|ipilimumab|mesh-list
43991931|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991932|NCT02506660|Dexamethasone|dexamethasone|mesh-list
43991933|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
43991934|NCT02506660|Bupivacaine|bupivacaine|mesh-list
43991935|NCT02506660|BB 1101|bb 1101|mesh-list
43991936|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43991937|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
43991938|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
43991939|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991940|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991941|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991942|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
43991943|NCT02506660|Hormones|hormones|mesh-ancestor
43991944|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991945|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43991946|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991947|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
43991948|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991949|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991950|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991951|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
43991952|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726730|NCT02588716|Terlipressin|terlipressin|mesh-list
43991953|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
43991954|NCT02506673|Midazolam|midazolam|mesh-list
43991955|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43991956|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43991957|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43991958|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991959|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43991960|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43991962|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991963|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
43991964|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
43991965|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
43991966|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
43991967|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43991968|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991969|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
43991970|NCT02506868|Hematinics|hematinics|mesh-ancestor
43991971|NCT02507011|Carvedilol|carvedilol|mesh-list
43991972|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43991973|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44032919|NCT00002002|Renal Agents|renal agents|mesh-ancestor
43991974|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
43991975|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245401|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245402|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44245403|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
44245404|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245405|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245406|NCT04640779|Analgesics|analgesics|mesh-ancestor
44245407|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
44245408|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245409|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245410|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245411|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245412|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44245413|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245414|NCT04639986|Gemcitabine|gemcitabine|mesh-list
44245415|NCT04639986|Capecitabine|capecitabine|mesh-list
44245416|NCT04639986|Vinorelbine|vinorelbine|mesh-list
44245417|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245418|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
44245419|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245420|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991976|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991977|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991978|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43991979|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
43991980|NCT02507011|Protective Agents|protective agents|mesh-ancestor
43991981|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43991982|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44032971|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
44032972|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149302|NCT00207363|Ribavirin|ribavirin|mesh-list
44149303|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
44149304|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
44149305|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44149306|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149307|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
44149308|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149309|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
44149310|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149311|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
44149312|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149313|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
44149314|NCT00207402|Interferons|interferons|mesh-list
43991983|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43991984|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
43991985|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43991988|NCT02508077|Leucovorin|leucovorin|mesh-list
43991989|NCT02508077|Folic Acid|folic acid|mesh-list
43991990|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43991991|NCT02508077|Panitumumab|panitumumab|mesh-list
43991992|NCT02508077|Fluorouracil|fluorouracil|mesh-list
43991993|NCT02508077|Irinotecan|irinotecan|mesh-list
43991994|NCT02508077|Camptothecin|camptothecin|mesh-list
43991995|NCT02508077|Antibodies|antibodies|mesh-list
43991996|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
43991997|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43991998|NCT02508077|Calcium|calcium|mesh-list
43991999|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
43992000|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
43992001|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992002|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992003|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43992004|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43992005|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
43992006|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992007|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43992008|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992009|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43992010|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43992011|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992012|NCT02508077|Antidotes|antidotes|mesh-ancestor
44245421|NCT04639986|Antiviral Agents|antiviral agents|mesh-ancestor
44245422|NCT04639986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245423|NCT04639986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245424|NCT04639986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245425|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
44245426|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245427|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44245428|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
44245429|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245430|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245431|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43992013|NCT02508077|Protective Agents|protective agents|mesh-ancestor
43992014|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
43992016|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
43992017|NCT02508077|Hematinics|hematinics|mesh-ancestor
43992018|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43992019|NCT02508103|Oxytocin|oxytocin|mesh-list
43992020|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
43992021|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992022|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992023|NCT02508207|Ivacaftor|ivacaftor|mesh-list
43992024|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43992025|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992026|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992027|NCT02508259|Suramin|suramin|mesh-list
43992028|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
43992029|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
43992030|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43992031|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992032|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992033|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43992034|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43992035|NCT02508389|Cisplatin|cisplatin|mesh-list
43992036|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
43992037|NCT02508389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992038|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
43992039|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992040|NCT02508389|Protective Agents|protective agents|mesh-ancestor
43992041|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992042|NCT02508636|Leuprolide|leuprolide|mesh-list
43992043|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43992044|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
43992045|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992046|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992047|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992048|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992049|NCT02509065|Pancrelipase|pancrelipase|mesh-list
43992050|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992051|NCT02509481|Ivermectin|ivermectin|mesh-list
43992052|NCT02509481|Albendazole|albendazole|mesh-list
43992053|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43992054|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992055|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
44033031|NCT00002018|Interferons|interferons|mesh-list
43992056|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
43992057|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43992058|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43992059|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
43992060|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
43992061|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
43992062|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992063|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992065|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43992066|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992067|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992068|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44245432|NCT04631601|Androgens|androgens|mesh-list
44245433|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
44245434|NCT04631601|Hormones|hormones|mesh-ancestor
44245435|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245436|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245437|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245438|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245439|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
44245440|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
44245441|NCT04614545|Phentermine|phentermine|mesh-list
44245442|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44245443|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245444|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
44245445|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44245446|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
44245447|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
44245448|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245449|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992069|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
43992070|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43992071|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44033068|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033069|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033070|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033071|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992072|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43992073|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
43992074|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992075|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992076|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43992077|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43992078|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43992079|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992080|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992081|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
43992082|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43992083|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992084|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992085|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
43992086|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992087|NCT02511236|Nicotine|nicotine|mesh-list
43992088|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43992089|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
43992090|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992091|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992092|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43992093|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43992094|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
43992095|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992096|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992097|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43992098|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43992099|NCT02511535|Vaccines|vaccines|mesh-list
43992100|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
44033103|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033104|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
44033105|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033106|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033107|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033108|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44033109|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44033110|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44033111|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44033112|NCT00002030|Pentamidine|pentamidine|mesh-list
44033113|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
44033114|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033115|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43992101|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992102|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
43992103|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43992104|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992105|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43992106|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44245450|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245451|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245452|NCT04603001|Azacitidine|azacitidine|mesh-list
44245453|NCT04603001|Venetoclax|venetoclax|mesh-list
43992108|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992109|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992110|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43992111|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43992112|NCT02512575|Prednisolone|prednisolone|mesh-list
43992113|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992114|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
43992116|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992117|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992118|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992119|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992120|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
43992121|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992122|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
43992123|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992124|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992125|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43992126|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
43992127|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992128|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992129|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43992130|NCT02512783|Lidocaine|lidocaine|mesh-list
43992131|NCT02512783|Propofol|propofol|mesh-list
43992132|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992133|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
43992134|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992135|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992136|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
43992137|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992145|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
43992146|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
43992147|NCT02512809|Isoflurane|isoflurane|mesh-list
43992148|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43992149|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992150|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992151|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43992152|NCT02512809|Analgesics|analgesics|mesh-ancestor
43992153|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
43992154|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992155|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43992156|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992157|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992158|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992159|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992160|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992161|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43992162|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
43992163|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
43992164|NCT02513095|Dantrolene|dantrolene|mesh-list
43992165|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43992166|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992167|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43992168|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992169|NCT02513212|Fluorides|fluorides|mesh-list
43992170|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
43992171|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
43992172|NCT02513212|Protective Agents|protective agents|mesh-ancestor
43992173|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992174|NCT02513446|Itraconazole|itraconazole|mesh-list
43992175|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
43992176|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992177|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43992178|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43992179|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992180|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844770|NCT04339036|Capecitabine|capecitabine|mesh-list
44245454|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245455|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
44033185|NCT00002040|Fluconazole|fluconazole|mesh-list
44033186|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
44033187|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033188|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033189|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033190|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033191|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033192|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033193|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033194|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033195|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033196|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033197|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033198|NCT00002041|Amphotericin B|amphotericin b|mesh-list
44033199|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44033200|NCT00002041|Amebicides|amebicides|mesh-ancestor
44033201|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033202|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033213|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44245456|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992181|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43992182|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
43992183|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992184|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992185|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43992186|NCT02513498|Ixazomib|ixazomib|mesh-list
43992187|NCT02513498|Glycine|glycine|mesh-list
43992188|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992189|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992190|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
43992191|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992192|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
43992193|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992194|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992195|NCT02513719|Everolimus|everolimus|mesh-list
43992196|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992197|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992198|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
43992199|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992200|NCT02513940|Ibutilide|ibutilide|mesh-list
43992201|NCT02513940|Testosterone|testosterone|mesh-list
43992202|NCT02513940|Progesterone|progesterone|mesh-list
43992203|NCT02513940|Androgens|androgens|mesh-ancestor
43992204|NCT02513940|Hormones|hormones|mesh-ancestor
43992208|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43992209|NCT02514044|Adderall|adderall|mesh-list
43992210|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
43992211|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43992212|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992213|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43992214|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43992215|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992216|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992217|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
43992218|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992219|NCT02515305|Clindamycin|clindamycin|mesh-list
43992220|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
43992221|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
43992222|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43992223|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43992224|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992225|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43992226|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992227|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992228|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992229|NCT02515890|Midazolam|midazolam|mesh-list
43992230|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
43992231|NCT02515890|Ketamine|ketamine|mesh-list
43992232|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43992233|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992234|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992235|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43992236|NCT02515890|Analgesics|analgesics|mesh-ancestor
44033218|NCT00002044|Zidovudine|zidovudine|mesh-list
43992237|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
43992238|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992239|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43992240|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992241|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992242|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992243|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992244|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992245|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43992246|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43992247|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
43992248|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
43992249|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43992250|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44245457|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245458|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245460|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245461|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44245462|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245463|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245464|NCT04594811|Nivolumab|nivolumab|mesh-list
44245465|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245466|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992251|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43992252|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43992253|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43726958|NCT02586753|Cisplatin|cisplatin|mesh-list
43992254|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43992255|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
43992256|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
43992257|NCT02516150|Ethanol|ethanol|mesh-list
43992258|NCT02516150|Glucagon|glucagon|mesh-list
43992259|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992260|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992261|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992262|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992263|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992264|NCT02516150|Hormones|hormones|mesh-ancestor
43992265|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992266|NCT02517021|Dexamethasone|dexamethasone|mesh-list
43992267|NCT02517021|Palonosetron|palonosetron|mesh-list
43992268|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992269|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
43992270|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
43992271|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992272|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992273|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992274|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
43992275|NCT02517021|Hormones|hormones|mesh-ancestor
43992278|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992279|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43992280|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43992281|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
43992282|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992283|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992284|NCT02517580|Vitamin K|vitamin k|mesh-list
43992285|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
43992286|NCT02517580|Vitamins|vitamins|mesh-ancestor
43992287|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
43992288|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992289|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43992290|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43992291|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992292|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
43992293|NCT02517580|Coagulants|coagulants|mesh-ancestor
43992294|NCT02517996|Lidocaine|lidocaine|mesh-list
43992295|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992296|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
43992297|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992298|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992299|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
43992300|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992301|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43992302|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43992303|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43992304|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992305|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245467|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44245468|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245470|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245471|NCT04586023|Teriflunomide|teriflunomide|mesh-list
44245472|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245473|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245474|NCT04586023|Analgesics|analgesics|mesh-ancestor
44245475|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
44245476|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245477|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033323|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
44033324|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033325|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
44033326|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033327|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
44245478|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245479|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992306|NCT02518191|Goserelin|goserelin|mesh-list
43992307|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992308|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992309|NCT02519023|Acetaminophen|acetaminophen|mesh-list
43992310|NCT02519023|Ibuprofen|ibuprofen|mesh-list
43992311|NCT02519023|Epinephrine|epinephrine|mesh-list
43992312|NCT02519023|Oxycodone|oxycodone|mesh-list
43992313|NCT02519023|Bupivacaine|bupivacaine|mesh-list
43992314|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992315|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
43992316|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992317|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992318|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
43992319|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992320|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43992321|NCT02519023|Analgesics|analgesics|mesh-ancestor
43992322|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
43992323|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43992324|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992325|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992326|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43992327|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992328|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992329|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992330|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992331|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992332|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992333|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43992334|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43992335|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
43992336|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43992337|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
43992338|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
43992339|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
43992340|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43992341|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43992342|NCT02519023|Narcotics|narcotics|mesh-ancestor
43992343|NCT02519387|Buprenorphine|buprenorphine|mesh-list
43992344|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43992345|NCT02519387|Narcotics|narcotics|mesh-ancestor
43992346|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992347|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992348|NCT02519387|Analgesics|analgesics|mesh-ancestor
44145410|NCT00194948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145411|NCT00194961|Hormones|hormones|mesh-list
44145412|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145413|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145414|NCT00194974|Clonidine|clonidine|mesh-list
44145415|NCT00194974|Labetalol|labetalol|mesh-list
44145416|NCT00194974|Methyldopa|methyldopa|mesh-list
44145417|NCT00194974|Nifedipine|nifedipine|mesh-list
44145418|NCT00194974|Analgesics|analgesics|mesh-ancestor
44245480|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245481|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
44245482|NCT04586010|Teriflunomide|teriflunomide|mesh-list
44245483|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245484|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245485|NCT04586010|Analgesics|analgesics|mesh-ancestor
44245486|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
44245487|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245488|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145419|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
44145420|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145421|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145422|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44145423|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
44145424|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
44145425|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44145426|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44145427|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44145428|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
44145429|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145430|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145431|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44145432|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44145433|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44145434|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
44145435|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
44145436|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145437|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44145438|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44145439|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
44145440|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44145441|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44145442|NCT00195000|Cytarabine|cytarabine|mesh-list
44145443|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
44145444|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145445|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
44145446|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145447|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145448|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
44145449|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145450|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145451|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
44145452|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145453|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44145454|NCT00195078|Cisplatin|cisplatin|mesh-list
44145455|NCT00195078|Gefitinib|gefitinib|mesh-list
44145456|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145457|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44145458|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145459|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145460|NCT00195104|Cytarabine|cytarabine|mesh-list
44145461|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
44145462|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145463|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
43992352|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
43992353|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43992354|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992355|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43992356|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992357|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
43992358|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992359|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
43992360|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992361|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245490|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245491|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245492|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
44459939|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44459940|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44459941|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44459942|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245495|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245496|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245497|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
43992362|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43992364|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992365|NCT02523235|Ropivacaine|ropivacaine|mesh-list
43992368|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992369|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992370|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
43992371|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992372|NCT02524054|Furosemide|furosemide|mesh-list
43992373|NCT02524054|Diuretics|diuretics|mesh-ancestor
43992374|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
43992375|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992376|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43992377|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992378|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992379|NCT02524106|Bococizumab|bococizumab|mesh-list
43992380|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43992381|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43992382|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
43992383|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992384|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43992385|NCT02524561|Estradiol|estradiol|mesh-list
43992386|NCT02524561|Progesterone|progesterone|mesh-list
43992387|NCT02524561|Estrogens|estrogens|mesh-ancestor
43992388|NCT02524561|Hormones|hormones|mesh-ancestor
43992389|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992390|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992391|NCT02524561|Progestins|progestins|mesh-ancestor
44033478|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43992392|NCT02524769|Estrogens|estrogens|mesh-list
43992393|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43992394|NCT02524769|Hormones|hormones|mesh-ancestor
43992395|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992396|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992397|NCT02525523|Alicaforsen|alicaforsen|mesh-list
43992398|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992399|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992400|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
43992401|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992402|NCT02525536|Trebananib|trebananib|mesh-list
43992403|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43992404|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43992405|NCT02525536|Growth Substances|growth substances|mesh-ancestor
43992406|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992407|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
43992408|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992409|NCT02525549|Adapalene|adapalene|mesh-list
43992410|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43992411|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245498|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245499|NCT04570410|Antiviral Agents|antiviral agents|mesh-ancestor
44245500|NCT04570410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245501|NCT04570410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245502|NCT04570410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245503|NCT04570410|Immunologic Factors|immunologic factors|mesh-ancestor
44245504|NCT04570410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992412|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43992413|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43992415|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
43992416|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992417|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992418|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992419|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992420|NCT02525653|Gemcitabine|gemcitabine|mesh-list
43992421|NCT02525653|Paclitaxel|paclitaxel|mesh-list
43992422|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43992423|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43992424|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992425|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
43992426|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
43992427|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
43992428|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992429|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43992430|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
43992431|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
43992432|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992434|NCT02525653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992435|NCT02525653|Immunologic Factors|immunologic factors|mesh-ancestor
43992436|NCT02525653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992437|NCT02525718|Dexamethasone|dexamethasone|mesh-list
43992438|NCT02525718|Epinephrine|epinephrine|mesh-list
43992439|NCT02525718|Bupivacaine|bupivacaine|mesh-list
43992440|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992445|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992446|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
43992447|NCT02525718|Hormones|hormones|mesh-ancestor
43992448|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992449|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992450|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992451|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992452|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
43992453|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992454|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
43992455|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992456|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992457|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992458|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992459|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992460|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43992461|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43992462|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43992463|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
43992464|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
43992465|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
43992466|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43992467|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
43992468|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43992469|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992470|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992471|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
43992472|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992473|NCT02527265|Insulin|insulin|mesh-list
43992474|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43992475|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992476|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
43992477|NCT02527512|Povidone|povidone|mesh-list
43992478|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
44245506|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
44245507|NCT04566328|Lenalidomide|lenalidomide|mesh-list
44245508|NCT04566328|Bortezomib|bortezomib|mesh-list
44245509|NCT04566328|Daratumumab|daratumumab|mesh-list
44245510|NCT04566328|Ichthammol|ichthammol|mesh-list
44245511|NCT04566328|BB 1101|bb 1101|mesh-list
44245512|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44245513|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245514|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
44245515|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
44245516|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245517|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245518|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245519|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
44245520|NCT04566328|Hormones|hormones|mesh-ancestor
44245521|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245522|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245523|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245524|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
43992479|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
43992480|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992481|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992482|NCT02528409|Vortioxetine|vortioxetine|mesh-list
43992483|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
43992484|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43992485|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43992486|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43992487|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992488|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992489|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43992490|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43992491|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992492|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992493|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992494|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
43992495|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43992496|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43992497|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43992498|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43992499|NCT02529072|Nivolumab|nivolumab|mesh-list
43992500|NCT02529072|Vaccines|vaccines|mesh-list
43992501|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
43992502|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992503|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43992504|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992505|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43992506|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992507|NCT02530151|Clonidine|clonidine|mesh-list
43992509|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43992510|NCT02530151|Narcotics|narcotics|mesh-ancestor
43992511|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992512|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992516|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43992517|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
43992518|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
43992519|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44245525|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245526|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992520|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992521|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992522|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992523|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992524|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992525|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
43992526|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43992527|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44033635|NCT00002097|Nystatin|nystatin|mesh-list
43992528|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43992529|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
43992530|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992531|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992532|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992533|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
43992534|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43992535|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43992536|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43992537|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
43992538|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992539|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992540|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992541|NCT02530476|Sorafenib|sorafenib|mesh-list
43992542|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992543|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43992544|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992545|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992546|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
43992547|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43992548|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992549|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992550|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
43992551|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992552|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
43992553|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43992554|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992555|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992556|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
43992557|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992558|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
43992559|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43992560|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992561|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992562|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
43992563|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992564|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
43992565|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43992566|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43992567|NCT02531321|Estradiol|estradiol|mesh-list
43992568|NCT02531321|Estrogens|estrogens|mesh-ancestor
43992569|NCT02531321|Hormones|hormones|mesh-ancestor
43992570|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992571|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992572|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43992573|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
43992574|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992575|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43992576|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43992577|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43992578|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43992579|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43992580|NCT02531971|Fentanyl|fentanyl|mesh-list
43992581|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43992582|NCT02531971|Narcotics|narcotics|mesh-ancestor
43992583|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992584|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992588|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43992589|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43992590|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
43992591|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
43992592|NCT02532010|Cytarabine|cytarabine|mesh-list
43992593|NCT02532010|Decitabine|decitabine|mesh-list
44245528|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245529|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44245530|NCT04566328|Growth Substances|growth substances|mesh-ancestor
44245531|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245532|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245534|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43992594|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43992595|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
43992596|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992597|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992598|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
43992599|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992600|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992601|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
43992602|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992603|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992604|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
43992605|NCT02532998|Eplerenone|eplerenone|mesh-list
43992606|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43992607|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
43992608|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992609|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992610|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43992611|NCT02532998|Diuretics|diuretics|mesh-ancestor
43992612|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
43992613|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43992614|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992615|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43992616|NCT02533427|Norgestimate|norgestimate|mesh-list
43992617|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43992618|NCT02533427|Estradiol|estradiol|mesh-list
43992619|NCT02533427|Estrogens|estrogens|mesh-ancestor
43992620|NCT02533427|Hormones|hormones|mesh-ancestor
43992621|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992622|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033725|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992623|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43992624|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
43992625|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992626|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43992627|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43992628|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43992629|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43992630|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43992631|NCT02533466|Listerine|listerine|mesh-list
43992632|NCT02533466|Fluorides|fluorides|mesh-list
43992633|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
43992634|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
43992635|NCT02533466|Protective Agents|protective agents|mesh-ancestor
43992636|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992637|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992638|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992639|NCT02533505|Budesonide|budesonide|mesh-list
43992640|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
43992641|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992642|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43992643|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
43992644|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992645|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992646|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43992647|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
43992648|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
43992649|NCT02533505|Hormones|hormones|mesh-ancestor
43844771|NCT04339036|Temozolomide|temozolomide|mesh-list
44245535|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245537|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245538|NCT04562129|Aldesleukin|aldesleukin|mesh-list
44245539|NCT04562129|Nivolumab|nivolumab|mesh-list
44245540|NCT04562129|Ipilimumab|ipilimumab|mesh-list
44245541|NCT04562129|Interleukin-2|interleukin-2|mesh-list
44245542|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245543|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245544|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43691358|NCT02787928|Hydromorphone|hydromorphone|mesh-list
43992650|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833564|NCT05204147|Antibodies|antibodies|mesh-list
43992651|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43992652|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43992653|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992654|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992655|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992656|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992664|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43992665|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43992666|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
43992667|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992668|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992669|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992670|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43992671|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43992672|NCT02535806|Cytarabine|cytarabine|mesh-list
43992673|NCT02535806|Dexamethasone|dexamethasone|mesh-list
43992674|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
43992675|NCT02535806|Methotrexate|methotrexate|mesh-list
43992676|NCT02535806|Vincristine|vincristine|mesh-list
43992677|NCT02535806|Bortezomib|bortezomib|mesh-list
43992678|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
43992679|NCT02535806|Pegaspargase|pegaspargase|mesh-list
43992680|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992681|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
43992682|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
43992683|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992684|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992685|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992686|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
43992687|NCT02535806|Hormones|hormones|mesh-ancestor
43992688|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992689|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992690|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992691|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43992692|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
43992693|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992694|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43992695|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
44033829|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033830|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033831|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033832|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033833|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033834|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033835|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033836|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033837|NCT00002112|Ionophores|ionophores|mesh-ancestor
44033838|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44033839|NCT00002113|Fluconazole|fluconazole|mesh-list
44033840|NCT00002113|Flucytosine|flucytosine|mesh-list
44033841|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
44033842|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033843|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033844|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43647116|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43647117|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647118|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992696|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992697|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992698|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992699|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43992700|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992701|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
43992702|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992703|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43992704|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
43992705|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992706|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43992707|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
43992708|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245545|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245546|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245547|NCT04562129|Analgesics|analgesics|mesh-ancestor
44245548|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
44245549|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245550|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245551|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44245552|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44245553|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
44245554|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245555|NCT04559412|Etanercept|etanercept|mesh-list
43992709|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
43992710|NCT02535806|Analgesics|analgesics|mesh-ancestor
43992711|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
43992712|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43992713|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43992714|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
43992715|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43992716|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43992717|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992718|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
43992719|NCT02535949|Coagulants|coagulants|mesh-ancestor
43992720|NCT02536040|Fluorides|fluorides|mesh-list
43992721|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
43992722|NCT02536040|Protective Agents|protective agents|mesh-ancestor
43992723|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992724|NCT02536105|Methylphenidate|methylphenidate|mesh-list
43992725|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43992726|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992727|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43992728|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43992729|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992732|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992733|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43992734|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43992735|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992736|NCT02536248|Incretins|incretins|mesh-ancestor
43992737|NCT02536248|Hormones|hormones|mesh-ancestor
43992738|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992739|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43992740|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
43992741|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033845|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992742|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992743|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
43992744|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
43992745|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43992746|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992747|NCT02537873|Cocaine|cocaine|mesh-list
43992748|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992749|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
43992750|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992751|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992752|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
43992753|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992754|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43992755|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43992756|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43992757|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992758|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992759|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
43992760|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992761|NCT02537951|Lidocaine|lidocaine|mesh-list
43992762|NCT02537951|Prilocaine|prilocaine|mesh-list
43844800|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245556|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245557|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245558|NCT04559412|Analgesics|analgesics|mesh-ancestor
44245559|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
44245560|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245561|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245562|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245563|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245564|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245565|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245566|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
44245567|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
43992763|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43992764|NCT02537951|Capsaicin|capsaicin|mesh-list
43992765|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992766|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
43992767|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992768|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992769|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
43992770|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992771|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43992772|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43992773|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43992774|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992775|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992776|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
43992777|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992778|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43992779|NCT02538016|Tolvaptan|tolvaptan|mesh-list
43992780|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43992781|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992782|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
43992783|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992784|NCT02538042|Nicotine|nicotine|mesh-list
43992785|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43992786|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
43992787|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992788|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992789|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43992790|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43992791|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
43992792|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992793|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992794|NCT02538354|Riboflavin|riboflavin|mesh-list
43992795|NCT02538354|Vitamins|vitamins|mesh-ancestor
43992796|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
43992797|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992798|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
43992799|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43992800|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992801|NCT02538679|Epinephrine|epinephrine|mesh-list
43992808|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992810|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992811|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43992812|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43992813|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
43992814|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992815|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992816|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43992817|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43992818|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
43992819|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44245568|NCT04558359|Giapreza|giapreza|mesh-list
44245569|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
44245570|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44245571|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44245572|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
44245573|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245574|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245575|NCT04550481|Lisinopril|lisinopril|mesh-list
44245576|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44245577|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44245578|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245579|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245580|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44245581|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43992820|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
43992821|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
43992822|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
43992823|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43992824|NCT02539108|Vaccines|vaccines|mesh-list
43992825|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
43992826|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992827|NCT02539342|Calcium|calcium|mesh-list
43992828|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43992829|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992830|NCT02539511|Ketamine|ketamine|mesh-list
43992831|NCT02539511|Analgesics|analgesics|mesh-ancestor
43992832|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
43992833|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992834|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992835|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43992836|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43992837|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
43992838|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
43992839|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992840|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43992841|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43992842|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992843|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992844|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43992845|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
43992846|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992847|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
43992848|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43992849|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43992850|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992851|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
43992852|NCT02540226|Coagulants|coagulants|mesh-ancestor
44145464|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145465|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145466|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
44145467|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145468|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145469|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
44145470|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145471|NCT00195156|Valproic Acid|valproic acid|mesh-list
44145472|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
44145473|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145474|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145475|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
44145476|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245582|NCT04550481|Protective Agents|protective agents|mesh-ancestor
44245583|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245584|NCT04545554|Vitamin D|vitamin d|mesh-list
44145477|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145478|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
44145479|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145480|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145481|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43992857|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43992859|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992860|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
43992861|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992862|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
43992863|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992864|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
43992865|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992866|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
43992867|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43992868|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
43992869|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992870|NCT02541422|Expectorants|expectorants|mesh-ancestor
43992871|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
43992872|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43992873|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
43992874|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992875|NCT02541422|Protective Agents|protective agents|mesh-ancestor
43992876|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992877|NCT02541422|Antidotes|antidotes|mesh-ancestor
43992878|NCT02541565|Prednisone|prednisone|mesh-list
43992879|NCT02541565|Cortisone|cortisone|mesh-list
43992880|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
43992881|NCT02541565|Rituximab|rituximab|mesh-list
43992882|NCT02541565|Doxorubicin|doxorubicin|mesh-list
43992883|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43992884|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
43992885|NCT02541565|Vincristine|vincristine|mesh-list
43992886|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43992887|NCT02541565|Antibodies|antibodies|mesh-list
43992888|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
43992889|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43992890|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992891|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
43992892|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992893|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43992894|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43992895|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
43992896|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992897|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992898|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43992899|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43992900|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43992901|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43992902|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992903|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992904|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
43992905|NCT02541565|Hormones|hormones|mesh-ancestor
43992906|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992907|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992908|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43992909|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
43992910|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
43992911|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
43992912|NCT02541864|Amoxicillin|amoxicillin|mesh-list
43992913|NCT02541864|Metronidazole|metronidazole|mesh-list
43992917|NCT02541864|Pantoprazole|pantoprazole|mesh-list
43992918|NCT02541864|Bismuth|bismuth|mesh-list
43992919|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43992920|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992921|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43992922|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43992923|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43992924|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992925|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992926|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44245585|NCT04545554|Calcium|calcium|mesh-list
44245586|NCT04545554|Vitamins|vitamins|mesh-ancestor
44245587|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
44245588|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245589|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44245590|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43992927|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43992928|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43992929|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992930|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43992931|NCT02541864|Antacids|antacids|mesh-ancestor
43992932|NCT02542150|Ethanol|ethanol|mesh-list
43992933|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992934|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992935|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992936|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992937|NCT02542410|Cabergoline|cabergoline|mesh-list
43992938|NCT02542410|Norethindrone|norethindrone|mesh-list
43992939|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
43992940|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43992941|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43992942|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43992943|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
43992944|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43992945|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992946|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43992947|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43992948|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43992949|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43992950|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
43992951|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
43992952|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992953|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992954|NCT02542462|Vaccines|vaccines|mesh-list
43992955|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
43992956|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992957|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
43992958|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43992959|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992960|NCT02544607|Ketamine|ketamine|mesh-list
43992961|NCT02544607|Analgesics|analgesics|mesh-ancestor
43992962|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
43992963|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992964|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992965|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43992966|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43992967|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
43992968|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
43992969|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992970|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43992971|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43992972|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43992973|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992974|NCT02544984|Azithromycin|azithromycin|mesh-list
43992975|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43992976|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992977|NCT02545907|Thalidomide|thalidomide|mesh-list
43992978|NCT02545907|Dexamethasone|dexamethasone|mesh-list
43992979|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43992980|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
43992981|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
43992982|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992983|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992984|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992985|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
43992986|NCT02545907|Hormones|hormones|mesh-ancestor
44165300|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43992989|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43992990|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992991|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
44245592|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44245593|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
44245594|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
44245595|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44245596|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245597|NCT04528680|Paclitaxel|paclitaxel|mesh-list
44245598|NCT04528680|Carboplatin|carboplatin|mesh-list
44245599|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44245600|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43992992|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
43992993|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43992994|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992995|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43992996|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43992997|NCT02545907|Growth Substances|growth substances|mesh-ancestor
43992998|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
43992999|NCT02546570|Oxytocin|oxytocin|mesh-list
43993000|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
43993001|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43993002|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993003|NCT02547012|Amoxicillin|amoxicillin|mesh-list
43993004|NCT02547012|Levofloxacin|levofloxacin|mesh-list
43993005|NCT02547012|Ofloxacin|ofloxacin|mesh-list
43727540|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43993007|NCT02547012|Esomeprazole|esomeprazole|mesh-list
43993008|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43993009|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993010|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43993011|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993012|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43993013|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993014|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993015|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43993016|NCT02547012|Renal Agents|renal agents|mesh-ancestor
43993017|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43993018|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43993019|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993020|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43993021|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43993022|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43993023|NCT02547623|Dexamethasone|dexamethasone|mesh-list
43993024|NCT02547623|Prednisolone|prednisolone|mesh-list
43993025|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993026|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
43993027|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
43993028|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993029|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993030|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993031|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
43993032|NCT02547623|Hormones|hormones|mesh-ancestor
43993033|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993034|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993035|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993036|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
43993037|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43993038|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43993039|NCT02548728|Oxytocin|oxytocin|mesh-list
43993040|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
43993041|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43993042|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993043|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
43993044|NCT02548910|Citric Acid|citric acid|mesh-list
43993045|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
43993046|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43993047|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
43993048|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
43844801|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245601|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245602|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
44245603|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245604|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245605|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245607|NCT04527991|Docetaxel|docetaxel|mesh-list
44245608|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44245609|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245610|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44245611|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245612|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993049|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993050|NCT02550743|Capecitabine|capecitabine|mesh-list
43993051|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43993052|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
43993053|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993054|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993055|NCT02551094|Colchicine|colchicine|mesh-list
43993056|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
44034247|NCT00002159|Amebicides|amebicides|mesh-ancestor
43993057|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993058|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993059|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993060|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993064|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
43993065|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43993066|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993067|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993068|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993069|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993070|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993071|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43993072|NCT02551744|Pantoprazole|pantoprazole|mesh-list
43993074|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43993075|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
43993076|NCT02551744|Histamine|histamine|mesh-list
43993077|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43993078|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993079|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993080|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993081|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
43993082|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
43993083|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993084|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993085|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
43993086|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
43993087|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993088|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993089|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
43993090|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43993091|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43993092|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43993093|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
43993094|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993095|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993096|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993097|NCT02555228|Simethicone|simethicone|mesh-list
43993098|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
43993099|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993100|NCT02555228|Emollients|emollients|mesh-ancestor
43993101|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245613|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245615|NCT04505774|Empagliflozin|empagliflozin|mesh-list
44245616|NCT04505774|Canagliflozin|canagliflozin|mesh-list
44245617|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
44245618|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44245619|NCT04505774|Heparin|heparin|mesh-list
44245620|NCT04505774|Calcium heparin|calcium heparin|mesh-list
44245621|NCT04505774|Enoxaparin|enoxaparin|mesh-list
44245622|NCT04505774|Dalteparin|dalteparin|mesh-list
44245623|NCT04505774|Tinzaparin|tinzaparin|mesh-list
44245624|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43993102|NCT02556333|Tenofovir|tenofovir|mesh-list
43993103|NCT02556333|Emtricitabine|emtricitabine|mesh-list
43993104|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
43993105|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993106|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034271|NCT00002162|Lamivudine|lamivudine|mesh-list
43993107|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43993108|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993109|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993110|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43993111|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43993112|NCT02556788|Trifarotene|trifarotene|mesh-list
43993113|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993114|NCT02557035|Dexamethasone|dexamethasone|mesh-list
43993115|NCT02557035|Palonosetron|palonosetron|mesh-list
43993116|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993117|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
43993118|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
43993119|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993120|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993121|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993122|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
43993123|NCT02557035|Hormones|hormones|mesh-ancestor
43993124|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993125|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993126|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993127|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43993128|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43993129|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
43993130|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993131|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993136|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43993137|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
43993138|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993139|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993140|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993141|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993142|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43993144|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43993145|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993146|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993147|NCT02560038|Gemcitabine|gemcitabine|mesh-list
43993148|NCT02560038|Paclitaxel|paclitaxel|mesh-list
43993149|NCT02560038|Cisplatin|cisplatin|mesh-list
43993150|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43993151|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993152|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993153|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993154|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993155|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993156|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43993157|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
43993158|NCT02560038|Antiviral Agents|antiviral agents|mesh-ancestor
43993159|NCT02560038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993160|NCT02560038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245625|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
44245626|NCT04505774|Clopidogrel|clopidogrel|mesh-list
44034381|NCT00002174|Thalidomide|thalidomide|mesh-list
44245627|NCT04505774|Ticagrelor|ticagrelor|mesh-list
44245628|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44245629|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44245630|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44245631|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44245632|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
44245633|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245634|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245635|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245636|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
44245637|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44245638|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44245639|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44245640|NCT04503551|Ranibizumab|ranibizumab|mesh-list
44245641|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245642|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44245643|NCT04503551|Growth Substances|growth substances|mesh-ancestor
44245644|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245645|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245646|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993161|NCT02560038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993162|NCT02560038|Immunologic Factors|immunologic factors|mesh-ancestor
43993163|NCT02560038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993164|NCT02560051|Ketoconazole|ketoconazole|mesh-list
43993165|NCT02560051|Docetaxel|docetaxel|mesh-list
43993166|NCT02560051|Doxorubicin|doxorubicin|mesh-list
43993167|NCT02560051|Estramustine|estramustine|mesh-list
43993168|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993169|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993170|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993171|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993172|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993173|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43993174|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44034418|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034422|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
43993175|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43993176|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993177|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
43993178|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993179|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43993180|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43993181|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43993182|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
43993183|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993184|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993185|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43993186|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43993187|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
43993188|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993189|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44245647|NCT04502693|Vaccines|vaccines|mesh-list
44245648|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
44245649|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245650|NCT04493138|Azacitidine|azacitidine|mesh-list
44245651|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245652|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
44245653|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993190|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43993191|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993192|NCT02560779|Sorafenib|sorafenib|mesh-list
43993193|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993194|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43993195|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993196|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993197|NCT02561130|Metformin|metformin|mesh-list
43993198|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
43993199|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
43993200|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993201|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993202|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43993205|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43993206|NCT02561481|Protective Agents|protective agents|mesh-ancestor
43993207|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993208|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993209|NCT02561702|Mexiletine|mexiletine|mesh-list
43993210|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993211|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43993212|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43993213|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993214|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993215|NCT02561897|Warfarin|warfarin|mesh-list
43993216|NCT02561897|Edoxaban|edoxaban|mesh-list
43993217|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
43993218|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43993219|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
43993220|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43993221|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
43993222|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993223|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993224|NCT02562066|Amifampridine|amifampridine|mesh-list
43993225|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43993226|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993227|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993228|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43993229|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993230|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993232|NCT02562521|Varenicline|varenicline|mesh-list
43993233|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43993234|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
43993235|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993236|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993237|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43993238|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43993239|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
43993240|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993241|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993242|NCT02562755|Sorafenib|sorafenib|mesh-list
43993243|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993244|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43993245|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993246|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993247|NCT02562898|Gemcitabine|gemcitabine|mesh-list
43993248|NCT02562898|Paclitaxel|paclitaxel|mesh-list
43993249|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44034461|NCT00002180|Tenofovir|tenofovir|mesh-list
43993250|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993251|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993252|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245654|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245655|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245656|NCT04480086|Navitoclax|navitoclax|mesh-list
44245657|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245658|NCT04478942|Misoprostol|misoprostol|mesh-list
44245659|NCT04478942|Oxytocin|oxytocin|mesh-list
44245660|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
44245661|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44245662|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245663|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44245664|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
43644851|NCT04341467|Olanzapine|olanzapine|mesh-list
43993253|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993254|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993255|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43993256|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
43993257|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
43993258|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993259|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993260|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993261|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
43993262|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993263|NCT02562924|Prednisone|prednisone|mesh-list
43993264|NCT02562924|Budesonide|budesonide|mesh-list
43993265|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993266|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
43993267|NCT02562924|Hormones|hormones|mesh-ancestor
43993268|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993269|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993270|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993271|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993272|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43993273|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
43993274|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993275|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44145490|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145492|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44145493|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145494|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44145495|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145496|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145497|NCT00195286|Tazobactam|tazobactam|mesh-list
44145498|NCT00195286|Piperacillin|piperacillin|mesh-list
44145499|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44145500|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145501|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145502|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44145503|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145504|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145505|NCT00195299|Sirolimus|sirolimus|mesh-list
44145506|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145507|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145508|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145509|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145510|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
44145511|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145512|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
44145513|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145514|NCT00195312|Bupivacaine|bupivacaine|mesh-list
44145515|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
44145516|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
44145517|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145518|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145519|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
43993277|NCT02563093|Vaccines|vaccines|mesh-list
44245665|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44245666|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245667|NCT04471987|Interleukin-12|interleukin-12|mesh-list
44245668|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44245669|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
44245670|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245671|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245672|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43644867|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
43993278|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
43993279|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993280|NCT02563496|Chloroquine|chloroquine|mesh-list
43993281|NCT02563496|Tafenoquine|tafenoquine|mesh-list
43993282|NCT02563496|Amebicides|amebicides|mesh-ancestor
43993283|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43993284|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43993285|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993286|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
43993287|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993288|NCT02563834|Insulin|insulin|mesh-list
43993289|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993290|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993291|NCT02563860|Lovastatin|lovastatin|mesh-list
43993292|NCT02563860|L 647318|l 647318|mesh-list
43993293|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
43993294|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43993295|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43993296|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
43993297|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993298|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43993299|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43993300|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993301|NCT02564029|Lorazepam|lorazepam|mesh-list
43993302|NCT02564029|PF-06372865|pf-06372865|mesh-list
43993303|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
43993304|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
43993305|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
43993306|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993307|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993308|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993309|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43993310|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993311|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43993312|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43993313|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43993314|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
43993315|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
43993316|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993317|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993318|NCT02564497|Abatacept|abatacept|mesh-list
43993319|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43993322|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993323|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
43993324|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993325|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993326|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
43993327|NCT02564926|Glimepiride|glimepiride|mesh-list
43993328|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43993329|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993330|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993331|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993332|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993333|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993334|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
43993335|NCT02565628|PF-06669571|pf-06669571|mesh-list
43993336|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
43993337|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
43993338|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106645|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245673|NCT04471987|Growth Substances|growth substances|mesh-ancestor
44245674|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245675|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245676|NCT04462328|Durvalumab|durvalumab|mesh-list
44245677|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
44245678|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245679|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245680|NCT04460937|Adavosertib|adavosertib|mesh-list
43993339|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993340|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993341|NCT02565901|Sirolimus|sirolimus|mesh-list
43993342|NCT02565901|Carboplatin|carboplatin|mesh-list
43993343|NCT02565901|Docetaxel|docetaxel|mesh-list
43993344|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993345|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993346|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993347|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993348|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993349|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43993350|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727853|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
43993351|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43993352|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
43993353|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993354|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
43993355|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993356|NCT02566369|Trifarotene|trifarotene|mesh-list
43993357|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993359|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
43993360|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993361|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43993362|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993363|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43993364|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993365|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43993366|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43993367|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
43993368|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993369|NCT02568644|Ketoprofen|ketoprofen|mesh-list
43993370|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43993371|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43993372|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43993373|NCT02568644|Analgesics|analgesics|mesh-ancestor
43993374|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
43993375|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993376|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993377|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993378|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43993379|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993380|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993381|NCT02568852|Anesthetics|anesthetics|mesh-list
43993382|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993383|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993384|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
43993385|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43993386|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993387|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43993388|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993389|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993390|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
43993407|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993408|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43993409|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43993410|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
43993411|NCT02571153|Ketamine|ketamine|mesh-list
43993412|NCT02571153|Analgesics|analgesics|mesh-ancestor
43993413|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
44245681|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245682|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245684|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
44245685|NCT04443348|Carboplatin|carboplatin|mesh-list
44245686|NCT04443348|Doxorubicin|doxorubicin|mesh-list
44245687|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
44245688|NCT04443348|Capecitabine|capecitabine|mesh-list
44245689|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44245690|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245691|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
44245692|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245693|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245694|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245695|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644881|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
43993414|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993415|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993416|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43993417|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43993418|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
43993419|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
43993420|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993421|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43993422|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43993423|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993424|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993426|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
43993427|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
43993428|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993429|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993430|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
43993431|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993432|NCT02571634|Fentanyl|fentanyl|mesh-list
43993433|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43993434|NCT02571634|Narcotics|narcotics|mesh-ancestor
43993435|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993436|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993437|NCT02571634|Analgesics|analgesics|mesh-ancestor
43993438|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
43993439|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993440|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43993441|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43993442|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
43993443|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
43993444|NCT02572609|Ambroxol|ambroxol|mesh-list
43993445|NCT02572609|Expectorants|expectorants|mesh-ancestor
43993446|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
43993447|NCT02572752|Nintedanib|nintedanib|mesh-list
43993448|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993449|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43993450|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165301|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
43993454|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993456|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
43993457|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43993458|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43993459|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993460|NCT02574598|Docetaxel|docetaxel|mesh-list
43993461|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
43993462|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245696|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
44245697|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245698|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245699|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44245700|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
44245701|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44245702|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44245703|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44245704|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44245705|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245706|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245707|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245708|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
44245709|NCT04433767|Nicotine|nicotine|mesh-list
43993463|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993464|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993465|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993466|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993467|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43993468|NCT02574832|Lidocaine|lidocaine|mesh-list
43993469|NCT02574832|Fentanyl|fentanyl|mesh-list
43993470|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
43993471|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
43993472|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993473|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993474|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
43993475|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993476|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993477|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43993478|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43993479|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993480|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993481|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43993482|NCT02574832|Narcotics|narcotics|mesh-ancestor
43993483|NCT02574832|Analgesics|analgesics|mesh-ancestor
43993484|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43993485|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43993486|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
43993487|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
43993488|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43993489|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43993490|NCT02576249|Prednisolone|prednisolone|mesh-list
43993491|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
43993492|NCT02576249|Ropivacaine|ropivacaine|mesh-list
43993493|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43993494|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
43993495|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
43993496|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
43993497|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993498|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993499|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
43993500|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993501|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993502|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
43993503|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
43993504|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993505|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
43993506|NCT02576249|Hormones|hormones|mesh-ancestor
43993507|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993508|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43993509|NCT02576249|Protective Agents|protective agents|mesh-ancestor
44245710|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44245711|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
44245712|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245713|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245714|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44245715|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44245716|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
44245717|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245718|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245719|NCT04433494|Tamoxifen|tamoxifen|mesh-list
44245720|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44245721|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
44245722|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245723|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245724|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245725|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993510|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993511|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993512|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
43993513|NCT02577042|Atorvastatin|atorvastatin|mesh-list
43993514|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43993515|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43993516|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
43993517|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993518|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43993519|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43993520|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993521|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43993524|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993525|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43993526|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43993527|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
43993528|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43993529|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
43993530|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
43993531|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43993532|NCT02577601|Estradiol|estradiol|mesh-list
43993533|NCT02577601|Estrogens|estrogens|mesh-ancestor
43993534|NCT02577601|Hormones|hormones|mesh-ancestor
43993535|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993536|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993537|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43993538|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
43993539|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43993540|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43993541|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43993542|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43993543|NCT02577991|Triamcinolone|triamcinolone|mesh-list
43993544|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993545|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993546|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
43993547|NCT02577991|Hormones|hormones|mesh-ancestor
43993548|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993549|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
43993550|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43993551|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43814295|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44245726|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44245727|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44245728|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44245730|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
44245731|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
44245732|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245733|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245734|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
43644928|NCT04336241|Nivolumab|nivolumab|mesh-list
43993552|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993553|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
43993554|NCT02578901|Coagulants|coagulants|mesh-ancestor
43993555|NCT02579057|Furosemide|furosemide|mesh-list
43993556|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43993557|NCT02579057|Diuretics|diuretics|mesh-ancestor
43993558|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
43993559|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993560|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43993561|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993562|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993563|NCT02579343|Dexetimide|dexetimide|mesh-list
43993564|NCT02579343|Citalopram|citalopram|mesh-list
43993565|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43993566|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43993567|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993568|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993569|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993570|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
43993571|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993572|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43993573|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
43993574|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43993575|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43993576|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43993577|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
43728050|NCT02579707|Ivosidenib|ivosidenib|mesh-list
43993579|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993580|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43993581|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43993582|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
43993583|NCT02579421|Progesterone|progesterone|mesh-list
43993584|NCT02579421|Progestins|progestins|mesh-ancestor
43993585|NCT02579421|Hormones|hormones|mesh-ancestor
43993586|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993587|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993588|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
43993589|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993590|NCT02581111|Naloxone|naloxone|mesh-list
43993591|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43993592|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993593|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
43993594|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993600|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
43993601|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
43993602|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993603|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034815|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43993604|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993605|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
43993606|NCT02581839|Hormones|hormones|mesh-ancestor
43993607|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993608|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993609|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993610|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
43993611|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245735|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245736|NCT04420195|Tacrolimus|tacrolimus|mesh-list
44245737|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245738|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
44245739|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245740|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44245741|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245742|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245743|NCT04406857|Capecitabine|capecitabine|mesh-list
44245744|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
44245745|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245746|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
44245747|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644934|NCT04329325|Methotrexate|methotrexate|mesh-list
43993612|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993613|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
43993614|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993615|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43993616|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
43993617|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993618|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43993619|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43993620|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993621|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43993622|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43993623|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
43993624|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43993625|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993626|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993627|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993628|NCT02582970|Bevacizumab|bevacizumab|mesh-list
43993629|NCT02582970|Fluorouracil|fluorouracil|mesh-list
43993630|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
43993631|NCT02582970|Irinotecan|irinotecan|mesh-list
43993632|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43993633|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993634|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43993635|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43993636|NCT02582970|Growth Substances|growth substances|mesh-ancestor
43993637|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993638|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
43993639|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
43993640|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993641|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43993642|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993643|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
43993644|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43993645|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43993646|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993647|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
43993648|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
43993649|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993650|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
43993651|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43993652|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43993653|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43993654|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993655|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993656|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
43993657|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245748|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245749|NCT04401774|Nivolumab|nivolumab|mesh-list
44245750|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245751|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245752|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44245753|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245754|NCT04401748|Azacitidine|azacitidine|mesh-list
44245755|NCT04401748|Venetoclax|venetoclax|mesh-list
44245756|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245757|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
44245758|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245759|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245760|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245761|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
44245762|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
44245763|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245764|NCT04373317|Pimavanserin|pimavanserin|mesh-list
44245765|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43993658|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993659|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43993660|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993661|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
43993662|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43993663|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43993664|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993665|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
44034921|NCT00002222|Valganciclovir|valganciclovir|mesh-list
44157617|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157618|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157620|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157621|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44157622|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157623|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
44157624|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157625|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157626|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157627|NCT00234949|Cephalexin|cephalexin|mesh-list
44157628|NCT00234949|Cefdinir|cefdinir|mesh-list
44157629|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157630|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157631|NCT00234962|Ritonavir|ritonavir|mesh-list
44157632|NCT00234962|Lopinavir|lopinavir|mesh-list
44157633|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44157634|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44157635|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157636|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157637|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157638|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157639|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157640|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
44157641|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157642|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44157643|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157644|NCT00234975|Ritonavir|ritonavir|mesh-list
44157645|NCT00234975|Lopinavir|lopinavir|mesh-list
44157646|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44157647|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44157648|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
44245766|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
44245767|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44245768|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44245769|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44245770|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245771|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245772|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44245773|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44245774|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44157649|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157650|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157651|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157652|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157653|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
44157654|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157655|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44157656|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157657|NCT00234988|Sibutramine|sibutramine|mesh-list
44157658|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
44157659|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44157660|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
44157661|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44157662|NCT00235001|Verapamil|verapamil|mesh-list
44157663|NCT00235001|Trandolapril|trandolapril|mesh-list
44157664|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44157665|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157666|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157667|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157668|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157669|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157670|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
44157671|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44157672|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157673|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034991|NCT00002229|Saquinavir|saquinavir|mesh-list
44157674|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43993670|NCT02585843|Spironolactone|spironolactone|mesh-list
43993671|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43993672|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
43993673|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993674|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993675|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43993683|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993684|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993685|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993686|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993687|NCT02587117|Protective Agents|protective agents|mesh-ancestor
43993688|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
43993689|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993690|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43993691|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43993692|NCT02587351|Metoprolol|metoprolol|mesh-list
43993693|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993694|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43993695|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
43993696|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
43993697|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993698|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993699|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43993700|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43993701|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43993702|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43993703|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245775|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44245776|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
44245777|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245778|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245779|NCT04370548|Clindamycin|clindamycin|mesh-list
44245780|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
44245781|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
44245782|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44245783|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245784|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44245785|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245786|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245787|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
44245788|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
44245789|NCT04370301|Melphalan|melphalan|mesh-list
44245790|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
44245791|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43993704|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993705|NCT05249556|Ganaxolone|ganaxolone|mesh-list
43993706|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
43993707|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993708|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993709|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993710|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
43993711|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
43993712|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
43993713|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993714|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
43993715|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993716|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993717|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43993718|NCT05249231|Fluorides|fluorides|mesh-list
43993719|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
43993720|NCT05249231|Protective Agents|protective agents|mesh-ancestor
43993721|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993722|NCT05249153|Sufentanil|sufentanil|mesh-list
43993723|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
43993725|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43993726|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993727|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993728|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43993729|NCT05249153|Analgesics|analgesics|mesh-ancestor
43993730|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
43993731|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993732|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43993733|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43993734|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43993735|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
43993736|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993737|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993738|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43993739|NCT05249153|Narcotics|narcotics|mesh-ancestor
43993740|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43993741|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43993742|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
43993743|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
43993744|NCT05249023|Butyric Acid|butyric acid|mesh-list
43993745|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
44245792|NCT04370301|Fludarabine|fludarabine|mesh-list
44245793|NCT04370301|Tacrolimus|tacrolimus|mesh-list
44245794|NCT04370301|Lenograstim|lenograstim|mesh-list
44245795|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44245796|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245797|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
44245798|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245799|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993757|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993758|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993760|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993761|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43993762|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993763|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993764|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
43993765|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43993766|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993767|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43993768|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43993769|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43993770|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993771|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43993772|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
43993773|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43993774|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993775|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993776|NCT05247788|Ethanol|ethanol|mesh-list
43993777|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43993778|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993779|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993780|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993781|NCT05247684|Paclitaxel|paclitaxel|mesh-list
43993782|NCT05247684|Cisplatin|cisplatin|mesh-list
43993783|NCT05247684|Carboplatin|carboplatin|mesh-list
43993784|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43993785|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993786|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993787|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993788|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993789|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993790|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
44035173|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993791|NCT05247554|Prednisone|prednisone|mesh-list
43993792|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993793|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
43993794|NCT05247554|Hormones|hormones|mesh-ancestor
43993795|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43993796|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993797|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993798|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993799|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
43993800|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43993801|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43993802|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993803|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993804|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993805|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993806|NCT05220813|Lidocaine|lidocaine|mesh-list
43993807|NCT05220813|Bupivacaine|bupivacaine|mesh-list
43993808|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
43993809|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
43993810|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993816|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43993817|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993818|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993819|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
43993821|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993822|NCT05184348|Acitretin|acitretin|mesh-list
44245800|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44245801|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
44245802|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245803|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245804|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44245805|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44035174|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035175|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035176|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44035177|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
44035178|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035179|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035180|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44245806|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245807|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44245808|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44245809|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
44245810|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43993823|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
43993824|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993825|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
43993826|NCT05159193|Carboplatin|carboplatin|mesh-list
43993827|NCT05159193|Docetaxel|docetaxel|mesh-list
43993828|NCT05159193|Doxorubicin|doxorubicin|mesh-list
43993829|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43993830|NCT05159193|Trastuzumab|trastuzumab|mesh-list
43993831|NCT05159193|Pertuzumab|pertuzumab|mesh-list
43993832|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993833|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
43993834|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993835|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993836|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43993837|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
43993838|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993839|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993840|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43993841|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993842|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993843|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993844|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43993845|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43993846|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43993847|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993848|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43993849|NCT05143424|Morphine|morphine|mesh-list
43993850|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43993851|NCT05143424|Narcotics|narcotics|mesh-ancestor
43993852|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993853|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993854|NCT05143424|Analgesics|analgesics|mesh-ancestor
43993855|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
43993856|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993857|NCT05132166|Sirolimus|sirolimus|mesh-list
43993858|NCT05132166|Everolimus|everolimus|mesh-list
43993859|NCT05132166|Vedolizumab|vedolizumab|mesh-list
43993860|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43993861|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993862|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43993863|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
43993864|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993865|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43993866|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993867|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43993868|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
43993869|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43993870|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43993871|NCT05078606|Anesthetics|anesthetics|mesh-list
43993872|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993873|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145521|NCT00195364|Etanercept|etanercept|mesh-list
44145522|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245811|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245812|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44245813|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44245814|NCT04369664|Atorvastatin|atorvastatin|mesh-list
44245815|NCT04369664|Ezetimibe|ezetimibe|mesh-list
44245816|NCT04369664|Evolocumab|evolocumab|mesh-list
44245817|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44245818|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44245819|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
44245820|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245821|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44145523|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145524|NCT00195364|Analgesics|analgesics|mesh-ancestor
44145525|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
44145526|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165302|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
44145530|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145531|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145532|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
44145533|NCT00195377|Etanercept|etanercept|mesh-list
44145534|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44145535|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145536|NCT00195377|Analgesics|analgesics|mesh-ancestor
44145537|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
44145538|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145539|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145540|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145541|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43993874|NCT04932915|Niclosamide|niclosamide|mesh-list
43993875|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
43993876|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43993877|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
43993878|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43993879|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993880|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
43993881|NCT04845490|Mitomycins|mitomycins|mesh-list
43993882|NCT04845490|Mitomycin|mitomycin|mesh-list
43993883|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43993884|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993885|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
43993886|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993887|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43993888|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993889|NCT04830397|Timolol|timolol|mesh-list
43993890|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43993891|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43993892|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
43993893|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993894|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993895|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993896|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993897|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43993898|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
43993899|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43993900|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43993901|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993902|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993903|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43993904|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43993905|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993906|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
43993907|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993908|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43993909|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43993910|NCT04819360|Urological Agents|urological agents|mesh-ancestor
44245823|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245824|NCT04351555|Cisplatin|cisplatin|mesh-list
44245825|NCT04351555|Carboplatin|carboplatin|mesh-list
44245826|NCT04351555|Pemetrexed|pemetrexed|mesh-list
44245827|NCT04351555|Osimertinib|osimertinib|mesh-list
44245828|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245829|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43993911|NCT04808466|Paclitaxel|paclitaxel|mesh-list
43993912|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43993913|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993914|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
43993915|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
43993916|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
43993917|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993918|NCT04787354|Capecitabine|capecitabine|mesh-list
43993919|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
43993920|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43993921|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
43993922|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993923|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993924|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
43993925|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43993926|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993927|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43993928|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145542|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145547|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145549|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44145550|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145551|NCT00195416|Analgesics|analgesics|mesh-ancestor
44145552|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
44145553|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145554|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145555|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145556|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145557|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44145558|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145559|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
43993929|NCT04631510|Gabapentin|gabapentin|mesh-list
43993930|NCT04631510|Analgesics|analgesics|mesh-ancestor
43993931|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
43993932|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993933|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993934|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
43993935|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43993936|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43993937|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993938|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43993939|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43993940|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43993941|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993942|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993943|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
43993944|NCT04590664|Verteporfin|verteporfin|mesh-list
43993945|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43993946|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993947|NCT04563923|Avdoralimab|avdoralimab|mesh-list
43993948|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993949|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
43993950|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993951|NCT04542434|Niclosamide|niclosamide|mesh-list
43993952|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
43993953|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43993954|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
43993955|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43993956|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44245830|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245832|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44245833|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459943|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44459944|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459945|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44459946|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
44459947|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44459948|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43993957|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
43993958|NCT04477733|Butorphanol|butorphanol|mesh-list
43993959|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43993960|NCT04477733|Narcotics|narcotics|mesh-ancestor
43993961|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993962|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993963|NCT04477733|Analgesics|analgesics|mesh-ancestor
43993964|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
43993965|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993966|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
43993967|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
43993968|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43993969|NCT04436731|Phentolamine|phentolamine|mesh-list
43993970|NCT04436731|Phenylephrine|phenylephrine|mesh-list
43993971|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
43993972|NCT04436731|Norepinephrine|norepinephrine|mesh-list
43993973|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
43993974|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43993975|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993976|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993977|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43993978|NCT04436731|Analgesics|analgesics|mesh-ancestor
43993979|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
43993980|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993981|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43993982|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43993983|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43993987|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43993988|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
43993989|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
43993990|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
43993991|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43993992|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
43993993|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
43993994|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43993995|NCT04436731|Protective Agents|protective agents|mesh-ancestor
43993996|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43993997|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43993998|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43993999|NCT04436458|Niclosamide|niclosamide|mesh-list
43994000|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
43994001|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43994002|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
43994003|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43994004|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994005|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
43994006|NCT04250805|Lidocaine|lidocaine|mesh-list
43994007|NCT04250805|Ropivacaine|ropivacaine|mesh-list
43994008|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
43994009|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
43994010|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994011|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994012|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
43994013|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994014|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44459949|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44459950|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459951|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44459952|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
44459953|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44459954|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44459955|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44459956|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44459958|NCT01571362|Oxycodone|oxycodone|mesh-list
44459959|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44459960|NCT01571362|Narcotics|narcotics|mesh-ancestor
44459961|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44459962|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459963|NCT01571362|Analgesics|analgesics|mesh-ancestor
44459964|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
44459965|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459966|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43823944|NCT05517330|Afatinib|afatinib|mesh-list
43994015|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43994016|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43994017|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994018|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994019|NCT04218773|Phenylephrine|phenylephrine|mesh-list
43994020|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
43994021|NCT04218773|Norepinephrine|norepinephrine|mesh-list
43994022|NCT04218773|Synephrine|synephrine|mesh-list
43994023|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43994024|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
43994025|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
43994026|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994027|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994028|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
43994029|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43994030|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
43994031|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
43994032|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43994033|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43994034|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43994035|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994036|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994037|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994038|NCT04218773|Protective Agents|protective agents|mesh-ancestor
43994039|NCT04186286|Propranolol|propranolol|mesh-list
43994040|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43994041|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43994042|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994043|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994044|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994045|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994046|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43994047|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43994048|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
43994049|NCT04044560|Blinatumomab|blinatumomab|mesh-list
43994050|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994051|NCT03952130|Insulin|insulin|mesh-list
43994052|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44459967|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44459968|NCT01571284|Aflibercept|aflibercept|mesh-list
44459969|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459970|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459971|NCT01571284|Growth Substances|growth substances|mesh-ancestor
44459972|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459973|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44459974|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459975|NCT01571232|Dexamethasone|dexamethasone|mesh-list
44459976|NCT01571232|Bevacizumab|bevacizumab|mesh-list
44459977|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44459978|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459979|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44459980|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44459981|NCT01571232|Growth Substances|growth substances|mesh-ancestor
44459982|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245834|NCT04325659|Lofexidine|lofexidine|mesh-list
44245835|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44245836|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44245837|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994053|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
43994054|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
43994055|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43994056|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994061|NCT03907176|Acetaminophen|acetaminophen|mesh-list
43994062|NCT03907176|Ibuprofen|ibuprofen|mesh-list
43994063|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43994064|NCT03907176|Analgesics|analgesics|mesh-ancestor
43994065|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
43994066|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994067|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994068|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
43994069|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43994070|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994071|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994072|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43994073|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994074|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994075|NCT03807440|Empagliflozin|empagliflozin|mesh-list
43994076|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43994077|NCT03807440|Linagliptin|linagliptin|mesh-list
43994079|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43994080|NCT03807440|Glucagon|glucagon|mesh-list
44035508|NCT00002287|Zidovudine|zidovudine|mesh-list
43994081|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43994082|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994083|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43994084|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994085|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994086|NCT03807440|Hormones|hormones|mesh-ancestor
43994087|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994088|NCT03807440|Incretins|incretins|mesh-ancestor
43994089|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
43994090|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994091|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
43994092|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245838|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
44245839|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245840|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44245841|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44245842|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44245843|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
44245844|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245845|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245846|NCT04318548|Vaccines|vaccines|mesh-list
44245847|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
44245848|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994093|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994094|NCT03675672|Misoprostol|misoprostol|mesh-list
43994095|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43994096|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
43994097|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43994098|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994099|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43994100|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994101|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
43994102|NCT03664830|Plerixafor|plerixafor|mesh-list
43994103|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43994104|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43994105|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
43994106|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994107|NCT03619707|Progesterone|progesterone|mesh-list
43994108|NCT03619707|Progestins|progestins|mesh-ancestor
43994109|NCT03619707|Hormones|hormones|mesh-ancestor
43994110|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994111|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145561|NCT00195455|Estrogens|estrogens|mesh-ancestor
44145562|NCT00195455|Hormones|hormones|mesh-ancestor
44145563|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145564|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145565|NCT00195468|Cyclosporine|cyclosporine|mesh-list
44145566|NCT00195468|Cyclosporins|cyclosporins|mesh-list
44145567|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145568|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145569|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145570|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
44145571|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145572|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
44145573|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145574|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
44145575|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145576|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44145577|NCT00195481|Sirolimus|sirolimus|mesh-list
44145578|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145582|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
44145583|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145584|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
44145585|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145586|NCT00195533|Tazobactam|tazobactam|mesh-list
44145587|NCT00195533|Piperacillin|piperacillin|mesh-list
44145588|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44145589|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145590|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145591|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44145592|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145593|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145594|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
44145595|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44145596|NCT00195559|Estradiol|estradiol|mesh-list
44145597|NCT00195559|Estrogens|estrogens|mesh-ancestor
44145598|NCT00195559|Hormones|hormones|mesh-ancestor
44245849|NCT04313881|Azacitidine|azacitidine|mesh-list
44245850|NCT04313881|Magrolimab|magrolimab|mesh-list
44245851|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245852|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
44245853|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245854|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245855|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245856|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245857|NCT04304144|Dexamethasone|dexamethasone|mesh-list
43645022|NCT04281108|Xhance|xhance|mesh-list
44145599|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145600|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145601|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44145603|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145604|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44145605|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44145606|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44145607|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43994112|NCT03500380|Capecitabine|capecitabine|mesh-list
43994113|NCT03500380|Lapatinib|lapatinib|mesh-list
43994114|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994115|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
43994116|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994117|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994118|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43994119|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994120|NCT03494569|Fludarabine|fludarabine|mesh-list
43994121|NCT03494569|Melphalan|melphalan|mesh-list
43994122|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
43994123|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43994124|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994125|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994126|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994127|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
43994128|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994129|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43994130|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
43994131|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43994132|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
43994133|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994134|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994135|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
43994136|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994137|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994138|NCT03389620|Dexamethasone|dexamethasone|mesh-list
43994139|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994140|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
43994141|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
43994142|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994143|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994144|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994145|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
43994146|NCT03389620|Hormones|hormones|mesh-ancestor
43994147|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994148|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994149|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994150|NCT03256916|Nelfinavir|nelfinavir|mesh-list
43994151|NCT03256916|Cisplatin|cisplatin|mesh-list
43994152|NCT03256916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994153|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43994154|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43994155|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
43994159|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43994160|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
43994161|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994162|NCT03241771|Naloxone|naloxone|mesh-list
44245858|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
44245859|NCT04304144|Bortezomib|bortezomib|mesh-list
44245860|NCT04304144|Daratumumab|daratumumab|mesh-list
44245861|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44245862|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
44245863|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245864|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245865|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44245866|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
44245867|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245868|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245869|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44245870|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245871|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
44245872|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
44245873|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245874|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245875|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
44245876|NCT04304144|Hormones|hormones|mesh-ancestor
44245877|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245878|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245879|NCT04268277|Rituximab|rituximab|mesh-list
44245880|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
44245881|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44245882|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245883|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
44245884|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645033|NCT04260477|Rifampin|rifampin|mesh-list
43994163|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43994164|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994165|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
43994166|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994167|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43994168|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
43994169|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43994170|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
43994171|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43994172|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994173|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43994174|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994175|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994176|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
43994177|NCT03113487|Vaccines|vaccines|mesh-list
43994178|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
43994179|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994180|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994181|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245885|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245886|NCT04238819|Irinotecan|irinotecan|mesh-list
44245887|NCT04238819|Temozolomide|temozolomide|mesh-list
44245888|NCT04238819|Dinutuximab|dinutuximab|mesh-list
44245889|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44245890|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44245891|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245892|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245893|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245894|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44245895|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
44245896|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
44245897|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44245898|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
44245899|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245900|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645061|NCT04255277|Charcoal|charcoal|mesh-list
43994182|NCT02865135|Vaccines|vaccines|mesh-list
43994183|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
43994184|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994185|NCT02632045|Fulvestrant|fulvestrant|mesh-list
43994186|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994187|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994188|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43994189|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43994190|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
43994191|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994192|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994193|NCT02205762|Cytarabine|cytarabine|mesh-list
43994194|NCT02205762|Prednisone|prednisone|mesh-list
43994195|NCT02205762|Indomethacin|indomethacin|mesh-list
43994196|NCT02205762|Methotrexate|methotrexate|mesh-list
43994197|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
43994198|NCT02205762|Vinblastine|vinblastine|mesh-list
43994199|NCT02205762|Cladribine|cladribine|mesh-list
43994200|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
43994201|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43994202|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
43994203|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43994204|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994205|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
43994206|NCT02205762|Hormones|hormones|mesh-ancestor
43994207|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994208|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994209|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994210|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994211|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43994212|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
43994213|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43994214|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994215|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
43994216|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994217|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
43994218|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994219|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43994220|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994221|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
43994222|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994223|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43994224|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
44245901|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44245902|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
44245903|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44245904|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
44245905|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245906|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245907|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43899037|NCT04306900|Gemcitabine|gemcitabine|mesh-list
44245908|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
44245909|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
43994225|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994226|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994227|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994232|NCT02205762|Analgesics|analgesics|mesh-ancestor
43994233|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
43994234|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994235|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
43994236|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
43994237|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43994238|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
43994239|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43994240|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
43994241|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994242|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
43994243|NCT02136901|Protective Agents|protective agents|mesh-ancestor
43994244|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
43994245|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43994246|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
43994247|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994248|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
43994249|NCT02108496|Protective Agents|protective agents|mesh-ancestor
43994250|NCT02056236|Midazolam|midazolam|mesh-list
43994251|NCT02056236|Levetiracetam|levetiracetam|mesh-list
43994252|NCT02056236|Valproic Acid|valproic acid|mesh-list
43994253|NCT02056236|Lorazepam|lorazepam|mesh-list
43994254|NCT02056236|Thiopental|thiopental|mesh-list
43994255|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
43994256|NCT02056236|Propofol|propofol|mesh-list
43994257|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43994258|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994259|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994260|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43994261|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
43728647|NCT02576015|Ropivacaine|ropivacaine|mesh-list
43994262|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
43994263|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43994264|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43994265|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43994266|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43994267|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
43994268|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
43994269|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994270|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994271|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
43994272|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994273|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
43994274|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
43994275|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
43994276|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994277|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994278|NCT01962246|Capecitabine|capecitabine|mesh-list
43994279|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
43994280|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994281|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
43994282|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994283|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994284|NCT01810705|Asparaginase|asparaginase|mesh-list
43994285|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245910|NCT04231760|Protective Agents|protective agents|mesh-ancestor
44245912|NCT04223661|Lenalidomide|lenalidomide|mesh-list
44245913|NCT04223661|Daratumumab|daratumumab|mesh-list
44245914|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245915|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
44245916|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
44245917|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245918|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245919|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245920|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
43994286|NCT01568918|Tamsulosin|tamsulosin|mesh-list
43994287|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43994288|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43994289|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43994290|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994291|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994292|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994293|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994294|NCT01568918|Urological Agents|urological agents|mesh-ancestor
43994295|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
43994296|NCT00641381|Carmustine|carmustine|mesh-list
43994297|NCT00641381|Etoposide|etoposide|mesh-list
43994298|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994299|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
43994300|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994301|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994311|NCT00544414|Leucovorin|leucovorin|mesh-list
43994312|NCT00544414|Gemcitabine|gemcitabine|mesh-list
43994313|NCT00544414|Cisplatin|cisplatin|mesh-list
43994314|NCT00544414|Docetaxel|docetaxel|mesh-list
43994315|NCT00544414|Fluorouracil|fluorouracil|mesh-list
43994316|NCT00544414|Calcium|calcium|mesh-list
43994317|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
43994318|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994319|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994320|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
43994321|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994322|NCT00544414|Antiviral Agents|antiviral agents|mesh-ancestor
43994323|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994324|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994325|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994326|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
43994327|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994328|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994329|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994330|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994331|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43994332|NCT00544414|Antidotes|antidotes|mesh-ancestor
43994333|NCT00544414|Protective Agents|protective agents|mesh-ancestor
43994334|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
43994336|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
43994337|NCT00534469|Cytarabine|cytarabine|mesh-list
43994338|NCT00534469|Aldesleukin|aldesleukin|mesh-list
43994339|NCT00534469|Etoposide|etoposide|mesh-list
43994340|NCT00534469|Idarubicin|idarubicin|mesh-list
43994341|NCT00534469|Busulfan|busulfan|mesh-list
43994342|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994343|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994344|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43994345|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994346|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994347|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994348|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994349|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
43994350|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
43994351|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994352|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994353|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
43994354|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994355|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
44245921|NCT04223661|Hormones|hormones|mesh-ancestor
44245922|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44245923|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44245924|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245925|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
44245926|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245927|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44245928|NCT04223661|Growth Substances|growth substances|mesh-ancestor
44245929|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245930|NCT04220489|Ketamine|ketamine|mesh-list
44245931|NCT04220489|Analgesics|analgesics|mesh-ancestor
44245932|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
44245933|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245934|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994356|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43994357|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43994358|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43994359|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43994360|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43994361|NCT00534430|Cyclosporine|cyclosporine|mesh-list
43994362|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
43994363|NCT00534430|Etoposide|etoposide|mesh-list
43994364|NCT00534430|Busulfan|busulfan|mesh-list
43994365|NCT00534430|Cyclosporins|cyclosporins|mesh-list
43994366|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994367|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994368|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43994369|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994370|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994373|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
43994374|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994375|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
43994376|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994377|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
43994378|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994379|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43994380|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43994381|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43994382|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
43994383|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43994384|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
43994385|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43994386|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43994387|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43994388|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
43994389|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994390|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
43994391|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43994392|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43994393|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994394|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
43994395|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
43994396|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43994397|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43994398|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994399|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
43994400|NCT02589977|Regadenoson|regadenoson|mesh-list
43994401|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43994402|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43994403|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
43994404|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
43994405|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245936|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44245937|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
44245938|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
44245939|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245940|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44245941|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44245942|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245943|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245944|NCT04218240|Lofexidine|lofexidine|mesh-list
44245945|NCT04218240|Pregabalin|pregabalin|mesh-list
44245946|NCT04218240|Analgesics|analgesics|mesh-ancestor
44245947|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
44245948|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645103|NCT04212026|Nivolumab|nivolumab|mesh-list
43994406|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994407|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994408|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
43994409|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43871164|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994410|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994411|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43994412|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994413|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43994414|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
43994415|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994417|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43994420|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
43994421|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
43994422|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994423|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994424|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
43994425|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994426|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43994427|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43994428|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43994429|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994430|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994431|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994432|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
43994433|NCT02592629|Hormones|hormones|mesh-ancestor
43994434|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994435|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994436|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
43994437|NCT02593396|Bupropion|bupropion|mesh-list
43994438|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43994439|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
43994440|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43994441|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43994445|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
43994446|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994447|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994448|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43994449|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43994450|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994451|NCT05372536|Cytarabine|cytarabine|mesh-list
43994452|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44245949|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245951|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44245952|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44245953|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245954|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44245955|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44245956|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43994453|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
43994454|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994455|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994456|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
43994457|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994458|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994459|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
43994460|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994461|NCT05372133|Morphine|morphine|mesh-list
43994462|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43994463|NCT05372133|Narcotics|narcotics|mesh-ancestor
43994464|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994465|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994466|NCT05372133|Analgesics|analgesics|mesh-ancestor
43994467|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
43994468|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145608|NCT00195572|Leucovorin|leucovorin|mesh-list
44145609|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
44145610|NCT00195572|Antidotes|antidotes|mesh-ancestor
44145611|NCT00195572|Protective Agents|protective agents|mesh-ancestor
44145612|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145613|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
44145614|NCT00195572|Vitamins|vitamins|mesh-ancestor
44145615|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
44145616|NCT00195585|Leucovorin|leucovorin|mesh-list
44145617|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
44145618|NCT00195585|Antidotes|antidotes|mesh-ancestor
44145619|NCT00195585|Protective Agents|protective agents|mesh-ancestor
44145620|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145621|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
44145622|NCT00195585|Vitamins|vitamins|mesh-ancestor
44145623|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
44145624|NCT00195598|Paroxetine|paroxetine|mesh-list
44145625|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44145626|NCT00195598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44145627|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44145628|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44145629|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145630|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145631|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
43994469|NCT05371574|Clonidine|clonidine|mesh-list
43994470|NCT05371574|Analgesics|analgesics|mesh-ancestor
43994471|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
43994472|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44036056|NCT00002349|Stavudine|stavudine|mesh-list
43994473|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994474|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43994475|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
43994476|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
43994477|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43994478|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43994479|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43994480|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994481|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994482|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994483|NCT05371340|Quercetin|quercetin|mesh-list
43994484|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
43994485|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994486|NCT05371340|Protective Agents|protective agents|mesh-ancestor
43994487|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994488|NCT05371301|Paclitaxel|paclitaxel|mesh-list
44245957|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245958|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44245959|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44245960|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44245961|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44245962|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44245963|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44245964|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44245965|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245967|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
44245968|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245969|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245970|NCT04194203|Paclitaxel|paclitaxel|mesh-list
44245971|NCT04194203|Bevacizumab|bevacizumab|mesh-list
44245972|NCT04194203|Carboplatin|carboplatin|mesh-list
44245973|NCT04194203|Pemetrexed|pemetrexed|mesh-list
44245974|NCT04194203|Atezolizumab|atezolizumab|mesh-list
44245975|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44245976|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44245977|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44036090|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245978|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245979|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
44245980|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245981|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899112|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
44245982|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44245983|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44245984|NCT04194203|Growth Substances|growth substances|mesh-ancestor
44245985|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245986|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44245987|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245988|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44245989|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44245990|NCT04191616|Dexamethasone|dexamethasone|mesh-list
44245991|NCT04191616|Pomalidomide|pomalidomide|mesh-list
44245992|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994489|NCT05371301|Carboplatin|carboplatin|mesh-list
44165303|NCT00259766|Hormones|hormones|mesh-ancestor
43994492|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994493|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
44245993|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
44245994|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
44245995|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245996|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245997|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245998|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
44245999|NCT04191616|Hormones|hormones|mesh-ancestor
44246000|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246001|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246002|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246003|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
44246004|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44246005|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44246006|NCT04191616|Growth Substances|growth substances|mesh-ancestor
44246007|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246008|NCT04187196|Propofol|propofol|mesh-list
44246009|NCT04187196|Methohexital|methohexital|mesh-list
43994494|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994495|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994496|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
43994497|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
43994498|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43994499|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
43994500|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994501|NCT05371288|Protective Agents|protective agents|mesh-ancestor
43994502|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994503|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
43994504|NCT05371288|Vitamins|vitamins|mesh-ancestor
43994505|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
43994506|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
43994507|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994508|NCT05371288|Expectorants|expectorants|mesh-ancestor
43994509|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
43994510|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43994511|NCT05371288|Antidotes|antidotes|mesh-ancestor
43994512|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43994513|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994514|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994515|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
43994516|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43994517|NCT05365880|Lidocaine|lidocaine|mesh-list
43994518|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
43994519|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
43994520|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994521|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994522|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
43994523|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994524|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43994525|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43994526|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43994527|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994528|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994529|NCT05365802|FAPI-46|fapi-46|mesh-list
43994530|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43994531|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994532|NCT05363007|Leucovorin|leucovorin|mesh-list
43994533|NCT05363007|Irinotecan|irinotecan|mesh-list
43994534|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43816054|NCT00988364|Ezetimibe|ezetimibe|mesh-list
44246010|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44246011|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246012|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246013|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44246014|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
44246016|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
44246017|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44246018|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
44246019|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994535|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994536|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994537|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994538|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994540|NCT05363007|Protective Agents|protective agents|mesh-ancestor
43994541|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994542|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
43994543|NCT05363007|Vitamins|vitamins|mesh-ancestor
43994544|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
43994546|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43994547|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994548|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43994549|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994550|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
43994551|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994552|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
43994553|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994554|NCT05343429|Aspirin|aspirin|mesh-list
43994555|NCT05343429|Benzydamine|benzydamine|mesh-list
43994556|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43994557|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43994558|NCT05343429|Analgesics|analgesics|mesh-ancestor
44036204|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036205|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
44036206|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036207|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036208|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036211|NCT00002369|Lamivudine|lamivudine|mesh-list
43994559|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
43994560|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994561|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994562|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994563|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994564|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43994567|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43994568|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43994570|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
43994571|NCT05323396|Metronidazole|metronidazole|mesh-list
43994572|NCT05323396|Albendazole|albendazole|mesh-list
43994573|NCT05323396|Praziquantel|praziquantel|mesh-list
43994574|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
43994575|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994576|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43994577|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43994578|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
43994579|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
43994580|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43994581|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994582|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994583|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994584|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994585|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994586|NCT05319873|Carboplatin|carboplatin|mesh-list
43994587|NCT05319873|Docetaxel|docetaxel|mesh-list
43994588|NCT05319873|Trastuzumab|trastuzumab|mesh-list
43994589|NCT05319873|Fulvestrant|fulvestrant|mesh-list
43994590|NCT05319873|Pertuzumab|pertuzumab|mesh-list
43994591|NCT05319873|Tucatinib|tucatinib|mesh-list
43994592|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43994593|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43994594|NCT05319873|Antibodies|antibodies|mesh-list
43994595|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
43994596|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43994597|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
44246020|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246021|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44246022|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44246023|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44246025|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246026|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246027|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44246028|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
44246029|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
44246030|NCT04181359|Protective Agents|protective agents|mesh-ancestor
44246031|NCT04161755|Atezolizumab|atezolizumab|mesh-list
44246032|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246033|NCT04160052|Azacitidine|azacitidine|mesh-list
44246034|NCT04160052|Venetoclax|venetoclax|mesh-list
44246035|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246036|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
44246037|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994598|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994599|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994600|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994601|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994602|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994603|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994604|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994605|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43994606|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43994607|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
43994608|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994609|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43994610|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994611|NCT05315271|Ketamine|ketamine|mesh-list
43994612|NCT05315271|Bupivacaine|bupivacaine|mesh-list
43994613|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
43994614|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
43994615|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994616|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994617|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
43994618|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994619|NCT05315271|Analgesics|analgesics|mesh-ancestor
43994620|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43994621|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43994622|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
43994623|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43994624|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43994625|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994626|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994627|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
43994628|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43994629|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994630|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
43994631|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
43994632|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43994633|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994634|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
43994635|NCT05193591|Autoantibodies|autoantibodies|mesh-list
44246038|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246039|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246040|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
44246041|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246042|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246043|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
44246044|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44246045|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
44246046|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246047|NCT04155632|Expectorants|expectorants|mesh-ancestor
44246048|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
44246049|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43994636|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
43994637|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994638|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
43994642|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994643|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43994644|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43994645|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43994646|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994647|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994648|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43994649|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994650|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994651|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
43994652|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994653|NCT05105074|Morphine|morphine|mesh-list
43994654|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43994655|NCT05105074|Narcotics|narcotics|mesh-ancestor
43994656|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994657|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994658|NCT05105074|Analgesics|analgesics|mesh-ancestor
43994659|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
43994660|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994661|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
43994662|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43994663|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994664|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994665|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43994666|NCT05099055|Analgesics|analgesics|mesh-ancestor
43994667|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
43994668|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994669|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43994670|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43994671|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43994672|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994673|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994674|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994675|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
43994676|NCT05081193|Testosterone|testosterone|mesh-list
43994677|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
43994678|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
43994679|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43994680|NCT05081193|Androgens|androgens|mesh-ancestor
43994681|NCT05081193|Hormones|hormones|mesh-ancestor
43994682|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994683|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994684|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994685|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994686|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
43994687|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
43994688|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43994689|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44246050|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
44246051|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246052|NCT04155632|Protective Agents|protective agents|mesh-ancestor
44246053|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246054|NCT04155632|Antidotes|antidotes|mesh-ancestor
44246055|NCT04150042|Vitamins|vitamins|mesh-list
44246056|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
44246057|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
44246058|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
43899187|NCT03815929|Estradiol|estradiol|mesh-list
44246059|NCT04150042|Ethanol|ethanol|mesh-list
44246060|NCT04150042|Melphalan|melphalan|mesh-list
44246061|NCT04150042|Carmustine|carmustine|mesh-list
44246062|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
44246063|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645177|NCT04174170|Sertraline|sertraline|mesh-list
43994690|NCT05068349|Protective Agents|protective agents|mesh-ancestor
43994691|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145632|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145633|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44145634|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
43994692|NCT04945122|Atorvastatin|atorvastatin|mesh-list
43994693|NCT04945122|Pitavastatin|pitavastatin|mesh-list
43994694|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43994695|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43994696|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
43994697|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994698|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43994699|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43994700|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994701|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43994702|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43994703|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994704|NCT04932382|Misoprostol|misoprostol|mesh-list
43994707|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43994708|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994709|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43994710|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994711|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
43994712|NCT04882774|Treprostinil|treprostinil|mesh-list
43994713|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43994714|NCT04870034|Palbociclib|palbociclib|mesh-list
43994715|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994716|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43994717|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994718|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994719|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43994720|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994721|NCT04804735|Anesthetics|anesthetics|mesh-list
43994722|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994723|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994724|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
43994725|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994726|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
43994727|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994728|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994729|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43994730|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43994731|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43994732|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994733|NCT04395196|Choline|choline|mesh-list
43994734|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
44246064|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246065|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
44246066|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246067|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246068|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44246069|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246070|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
44246072|NCT04150042|Protective Agents|protective agents|mesh-ancestor
44246073|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
44036407|NCT00002384|Cidofovir|cidofovir|mesh-list
44246074|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44246075|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994735|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43994736|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
43994737|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994738|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994739|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43994740|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
43994741|NCT04375527|Nivolumab|nivolumab|mesh-list
43994742|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994743|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994744|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43994745|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994746|NCT04276363|Nicotine|nicotine|mesh-list
43994747|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43994748|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
43994749|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994750|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994751|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43994752|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43994753|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
43994754|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994755|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994756|NCT04267809|Vitamin D|vitamin d|mesh-list
43994757|NCT04267809|Metformin|metformin|mesh-list
43994758|NCT04267809|Calcium|calcium|mesh-list
43994759|NCT04267809|Vitamins|vitamins|mesh-ancestor
43994761|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994762|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43994763|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43994764|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43994765|NCT04227366|Methotrexate|methotrexate|mesh-list
43994766|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43994767|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
43994768|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43994769|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994770|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994771|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
43994772|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994773|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994774|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
43994775|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994776|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43994777|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994782|NCT04158362|Capecitabine|capecitabine|mesh-list
43994783|NCT04158362|Letrozole|letrozole|mesh-list
43994784|NCT04158362|Fulvestrant|fulvestrant|mesh-list
43994785|NCT04158362|Anastrozole|anastrozole|mesh-list
43994786|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994787|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994788|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994789|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994790|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246076|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246077|NCT04150042|Hematinics|hematinics|mesh-ancestor
44246078|NCT04131829|Fluoxetine|fluoxetine|mesh-list
44036479|NCT00002391|Lamivudine|lamivudine|mesh-list
44246079|NCT04131829|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44246080|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44246081|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246082|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246083|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246084|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
43994791|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994792|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994793|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
43994794|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43994795|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43994796|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994797|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43994798|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
43994799|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994800|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994801|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994802|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43994803|NCT04143607|Gefitinib|gefitinib|mesh-list
43994804|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994805|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43994806|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994807|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994808|NCT04082806|Trazodone|trazodone|mesh-list
43994809|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43994810|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43994811|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994812|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994813|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43994814|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43994815|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43994816|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994817|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994818|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994819|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
43994820|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43994821|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
43994822|NCT04055649|Paclitaxel|paclitaxel|mesh-list
43994823|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43994824|NCT04055649|TIC10 compound|tic10 compound|mesh-list
43994825|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994826|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994827|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994828|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994829|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994830|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994831|NCT04025060|Caffeine|caffeine|mesh-list
43994832|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43994833|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994834|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43994835|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994836|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994837|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43994838|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43994839|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
43994840|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43994841|NCT04001881|Anesthetics|anesthetics|mesh-list
43994842|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994843|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246085|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246086|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44246087|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
44246088|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44246089|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44246090|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44246091|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246092|NCT04128748|Cytarabine|cytarabine|mesh-list
44246093|NCT04128748|Daunorubicin|daunorubicin|mesh-list
43645208|NCT04157075|Bupivacaine|bupivacaine|mesh-list
43994844|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
43994845|NCT03970252|Leucovorin|leucovorin|mesh-list
43994846|NCT03970252|Folic Acid|folic acid|mesh-list
43994847|NCT03970252|Fluorouracil|fluorouracil|mesh-list
43994848|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
43994853|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
43994854|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43994855|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994856|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43994857|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
43994858|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994859|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994860|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994861|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994862|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
43994863|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994864|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43994865|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43994866|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994867|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994868|NCT03970252|Antidotes|antidotes|mesh-ancestor
43994869|NCT03970252|Protective Agents|protective agents|mesh-ancestor
43994870|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
43994871|NCT03970252|Vitamins|vitamins|mesh-ancestor
43994872|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
43994873|NCT03970252|Hematinics|hematinics|mesh-ancestor
43994874|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994875|NCT03947385|Crizotinib|crizotinib|mesh-list
43994876|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994877|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43994878|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994879|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994880|NCT03904251|Cytarabine|cytarabine|mesh-list
43994881|NCT03904251|Daunorubicin|daunorubicin|mesh-list
43994882|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
43994883|NCT03904251|Calicheamicins|calicheamicins|mesh-list
43994884|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43994885|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
43994886|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994887|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994888|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
43994889|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994890|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994891|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
43994892|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994893|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43994894|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43994895|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994896|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994897|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994898|NCT03874936|Dexamethasone|dexamethasone|mesh-list
43994899|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43994900|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994901|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
43994902|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
44036669|NCT00002409|Lamivudine|lamivudine|mesh-list
43994903|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246096|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246098|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
44246099|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246100|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246101|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
44246102|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246103|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246104|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44246105|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43645216|NCT04155008|Dronabinol|dronabinol|mesh-list
43994904|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994905|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994906|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
43994907|NCT03874936|Hormones|hormones|mesh-ancestor
43994908|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994909|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994910|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145635|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145636|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44145637|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145638|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145639|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44157676|NCT00235014|Trandolapril|trandolapril|mesh-list
43994911|NCT03801304|Atezolizumab|atezolizumab|mesh-list
43994912|NCT03801304|Vinorelbine|vinorelbine|mesh-list
43994913|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994914|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994915|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994920|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43994921|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994925|NCT03708627|Bimatoprost|bimatoprost|mesh-list
43994926|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43994927|NCT03630705|Vaccines|vaccines|mesh-list
43994928|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
43994929|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994930|NCT03560466|Prednisone|prednisone|mesh-list
43994931|NCT03560466|Prednisolone|prednisolone|mesh-list
43994932|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994933|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
43994934|NCT03560466|Hormones|hormones|mesh-ancestor
43994935|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994936|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994937|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994938|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994939|NCT03545035|Rituximab|rituximab|mesh-list
43994940|NCT03545035|Idelalisib|idelalisib|mesh-list
43994941|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43994942|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994943|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
43994944|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994945|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994946|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994947|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994948|NCT03528941|Lamivudine|lamivudine|mesh-list
43994949|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44246106|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246107|NCT04119037|Morphine|morphine|mesh-list
44246108|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44246109|NCT04119037|Narcotics|narcotics|mesh-ancestor
44246110|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246111|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246112|NCT04119037|Analgesics|analgesics|mesh-ancestor
44246113|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
44246114|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246115|NCT04116502|Interferons|interferons|mesh-list
44246116|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
43994950|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43994951|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994952|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994953|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
43994954|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43994955|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43994956|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43994957|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43994958|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43994959|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994960|NCT03422861|Nabilone|nabilone|mesh-list
43994961|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
43994962|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
43994963|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994964|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994965|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994966|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43994967|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43994968|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43994969|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43994970|NCT03376698|Colchicine|colchicine|mesh-list
43994971|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
43994972|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994973|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
43994974|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994975|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994976|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994977|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994978|NCT03295734|Losartan|losartan|mesh-list
43994979|NCT03295734|Perindopril|perindopril|mesh-list
43994980|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43994981|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43994982|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43994983|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43994984|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994985|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43994986|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
43994992|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43994993|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43994994|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43994995|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
43994996|NCT03275285|Hormones|hormones|mesh-ancestor
43994997|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43994998|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43994999|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995000|NCT03246750|Cisplatin|cisplatin|mesh-list
43995001|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995002|NCT03192345|Cemiplimab|cemiplimab|mesh-list
43995003|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43995004|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995005|NCT03119012|Aspirin|aspirin|mesh-list
43995006|NCT03119012|Clopidogrel|clopidogrel|mesh-list
43995007|NCT03119012|Ticagrelor|ticagrelor|mesh-list
43995008|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44246117|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
44246119|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246120|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
44246121|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246122|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
44246123|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157900|NCT00235729|Lofexidine|lofexidine|mesh-list
44246124|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
44246125|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246126|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246127|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44246128|NCT04104672|Gemcitabine|gemcitabine|mesh-list
43995009|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995010|NCT03119012|Analgesics|analgesics|mesh-ancestor
43995011|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
43995012|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995013|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995014|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995015|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995016|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43995017|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43995018|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995019|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43995020|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43995021|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995022|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
43995023|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43995024|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43995025|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43995026|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
43995027|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995028|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
43995029|NCT03069963|Antacids|antacids|mesh-ancestor
43995030|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995031|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995032|NCT02961257|Prednisone|prednisone|mesh-list
43995033|NCT02961257|Lenograstim|lenograstim|mesh-list
43995034|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995035|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
43995036|NCT02961257|Hormones|hormones|mesh-ancestor
43995037|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995038|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995039|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43995040|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995041|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43995042|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
43995043|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43995044|NCT02791568|Hematinics|hematinics|mesh-ancestor
43995045|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43995046|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43995047|NCT02454543|Androgens|androgens|mesh-list
43995048|NCT02454543|Hormones|hormones|mesh-ancestor
43995049|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995050|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995051|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43995052|NCT02429375|Mocetinostat|mocetinostat|mesh-list
43995053|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43995054|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995055|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43995056|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995059|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
44246130|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246131|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246132|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246133|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246134|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
44459983|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246135|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645250|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
43995060|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
43995061|NCT02377492|Coagulants|coagulants|mesh-ancestor
43995062|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43995063|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43995064|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
43995065|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995066|NCT02377479|Letrozole|letrozole|mesh-list
43995067|NCT02377479|Clomiphene|clomiphene|mesh-list
43995068|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995069|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43995070|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43995071|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995072|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995073|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43995074|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
43995075|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995076|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995077|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43995078|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
43995079|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43995080|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43995081|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43995082|NCT01750567|Metformin|metformin|mesh-list
43995083|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43995084|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995085|NCT02593903|Trimethoprim|trimethoprim|mesh-list
43995086|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43995087|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
43995088|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43995089|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995090|NCT02593903|Renal Agents|renal agents|mesh-ancestor
43995091|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
43995092|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43995093|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43995094|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43995095|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995096|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995097|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43995098|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43995099|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43995100|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995101|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43995102|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43995103|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995104|NCT02595684|Tadalafil|tadalafil|mesh-list
43995105|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
43995106|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43995107|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43995108|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995109|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995110|NCT02595684|Urological Agents|urological agents|mesh-ancestor
43995111|NCT02596022|Ketamine|ketamine|mesh-list
43995112|NCT02596022|Analgesics|analgesics|mesh-ancestor
43995113|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
43995114|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995115|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246136|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246137|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
44246138|NCT04104672|Antiviral Agents|antiviral agents|mesh-ancestor
44246139|NCT04104672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246140|NCT04104672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246141|NCT04104672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246142|NCT04104672|Immunologic Factors|immunologic factors|mesh-ancestor
44246143|NCT04104672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459984|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995116|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43995117|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995118|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
43995119|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
43995120|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995121|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43995122|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43995123|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995124|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995125|NCT02596451|Diclofenac|diclofenac|mesh-list
43995126|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43995127|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995128|NCT02596451|Analgesics|analgesics|mesh-ancestor
43995132|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995133|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995134|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43995135|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995136|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145640|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44145641|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
44145642|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145643|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
44145645|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
44145646|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44145647|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44145648|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
44145649|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145651|NCT00195689|Antibodies|antibodies|mesh-list
44145652|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44145653|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
44145654|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145655|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145656|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145657|NCT00195728|Acetaminophen|acetaminophen|mesh-list
44145658|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44145659|NCT00195728|Hydrocodone|hydrocodone|mesh-list
44145660|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145661|NCT00195728|Analgesics|analgesics|mesh-ancestor
44145662|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
44145663|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145664|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145665|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
44145666|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44145667|NCT00195728|Narcotics|narcotics|mesh-ancestor
44145668|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145669|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
44145670|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
44145671|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44145672|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145673|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145674|NCT00195741|Valproic Acid|valproic acid|mesh-list
44145675|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
44145676|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145677|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145678|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
44145679|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145680|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459986|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
44459987|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459988|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44459989|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
44459990|NCT01571232|Hormones|hormones|mesh-ancestor
44459991|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459992|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44459993|NCT01570868|Ponatinib|ponatinib|mesh-list
44459994|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145681|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
44145682|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145683|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145684|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145685|NCT00195754|Valproic Acid|valproic acid|mesh-list
44145686|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
44145687|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145688|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145689|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
44145690|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145691|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145692|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
44145693|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145694|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145695|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145696|NCT00195767|Valproic Acid|valproic acid|mesh-list
44145697|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
44036883|NCT00002430|Nelfinavir|nelfinavir|mesh-list
44145698|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145699|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145700|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
44145701|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145702|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145703|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
44145704|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145710|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145711|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
44145712|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995137|NCT02596867|Propranolol|propranolol|mesh-list
43995138|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43995139|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43995140|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
43995141|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995142|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995143|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995144|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995145|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43995146|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
43995148|NCT02597101|Saxagliptin|saxagliptin|mesh-list
43995149|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43995150|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995151|NCT02597101|Incretins|incretins|mesh-ancestor
43995152|NCT02597101|Hormones|hormones|mesh-ancestor
43995153|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995154|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43995155|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995156|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995157|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995158|NCT02597543|Regadenoson|regadenoson|mesh-list
43995159|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43995160|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43995161|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
43995162|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
43995163|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995164|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459995|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44459996|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44459997|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459998|NCT01570751|Insulin|insulin|mesh-list
44459999|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44460000|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
44460001|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460002|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460003|NCT01570491|Anesthetics|anesthetics|mesh-list
43995165|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995166|NCT02597907|Aprepitant|aprepitant|mesh-list
43995167|NCT02597907|Palonosetron|palonosetron|mesh-list
43995168|NCT02597907|Ramosetron|ramosetron|mesh-list
43995169|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
43995170|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
43995171|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995172|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995173|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995174|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43995175|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995176|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036943|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43995177|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43995178|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43995179|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
43995180|NCT02599649|Nivolumab|nivolumab|mesh-list
43995181|NCT02599649|Azacitidine|azacitidine|mesh-list
43995182|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43995183|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995184|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43995185|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995186|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43995187|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
43995188|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995189|NCT02600325|Grazoprevir|grazoprevir|mesh-list
43995190|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43995191|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
43995192|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995193|NCT02600611|Vancomycin|vancomycin|mesh-list
43995194|NCT02600611|Iclaprim|iclaprim|mesh-list
43995195|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995196|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995197|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43995198|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995201|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43995202|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43995203|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43995204|NCT02600715|Narcotics|narcotics|mesh-ancestor
43995205|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995206|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995207|NCT02600715|Analgesics|analgesics|mesh-ancestor
43995208|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
43995209|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995210|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43995211|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43995212|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995213|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995214|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
43995215|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995216|NCT02600767|Lumefantrine|lumefantrine|mesh-list
43995217|NCT02600767|Artemether|artemether|mesh-list
44037004|NCT00002442|Lamivudine|lamivudine|mesh-list
43995218|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43995219|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
43995220|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43995221|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43995222|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995223|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
43995224|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44460004|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460005|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460007|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
44460008|NCT01570387|Pomalidomide|pomalidomide|mesh-list
44460009|NCT01570387|BB 1101|bb 1101|mesh-list
44460010|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460011|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
44460012|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
43645288|NCT04150640|Nivolumab|nivolumab|mesh-list
43995225|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
43995226|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995227|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
43995228|NCT02601170|Protective Agents|protective agents|mesh-ancestor
43995229|NCT02601833|Fluorides|fluorides|mesh-list
43995230|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
43995231|NCT02601833|Protective Agents|protective agents|mesh-ancestor
43995232|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995233|NCT02601976|Ribavirin|ribavirin|mesh-list
43995234|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43995235|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
43995236|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995237|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
43995238|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995239|NCT02603926|Pregnanolone|pregnanolone|mesh-list
43995240|NCT02603926|Brexanolone|brexanolone|mesh-list
43995241|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
43995242|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995243|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995244|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
43995245|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995246|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995247|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
43995248|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
43995249|NCT02604173|Budesonide|budesonide|mesh-list
43995250|NCT02604173|Acetazolamide|acetazolamide|mesh-list
43995251|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995252|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43995253|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
43995254|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995255|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995256|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43995257|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
43995258|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
43995259|NCT02604173|Hormones|hormones|mesh-ancestor
43995260|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995261|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
43995262|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43995263|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995264|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995265|NCT02604173|Diuretics|diuretics|mesh-ancestor
43995266|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
43995267|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
43995268|NCT02604810|Antibodies|antibodies|mesh-list
43995269|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
43995270|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43995271|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43995272|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
43995273|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
43995280|NCT02605187|Narcotics|narcotics|mesh-ancestor
43995281|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995282|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995283|NCT02605187|Analgesics|analgesics|mesh-ancestor
43995284|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
43995285|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995286|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995287|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
43995288|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43995289|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460013|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460014|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460015|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460016|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
44460017|NCT01570387|Hormones|hormones|mesh-ancestor
44460018|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460019|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44460020|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995290|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995291|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43995292|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995293|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995294|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
43995295|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995296|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995297|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995298|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43995299|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43995300|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995301|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
43995303|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
43995304|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43995305|NCT02605304|Ledipasvir|ledipasvir|mesh-list
43995306|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
43995307|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995308|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
43995309|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995310|NCT02605395|Rabeprazole|rabeprazole|mesh-list
43995311|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43995312|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995313|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43995314|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995315|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995316|NCT02607254|Pregabalin|pregabalin|mesh-list
43995317|NCT02607254|Analgesics|analgesics|mesh-ancestor
43995318|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
43995319|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995320|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995321|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
43995322|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43995323|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995324|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995325|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43995326|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995327|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995328|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995329|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995330|NCT02607618|Vancomycin|vancomycin|mesh-list
43995331|NCT02607618|Iclaprim|iclaprim|mesh-list
43995332|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995333|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995334|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43995335|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995336|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995337|NCT02608177|Linagliptin|linagliptin|mesh-list
43995338|NCT02608177|Glipizide|glipizide|mesh-list
43995339|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43995340|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995341|NCT02608177|Incretins|incretins|mesh-ancestor
43995342|NCT02608177|Hormones|hormones|mesh-ancestor
43995343|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995344|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44037111|NCT00002451|Ritonavir|ritonavir|mesh-list
43995345|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995351|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43995352|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460021|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460022|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460023|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460024|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
44460025|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460026|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44460027|NCT01570387|Growth Substances|growth substances|mesh-ancestor
44460028|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
44460029|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44460030|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
44460031|NCT01570309|Vitamin D|vitamin d|mesh-list
44460032|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43645303|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43995353|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
43995354|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
43995355|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
43995356|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995357|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43995358|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
43995359|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
43995360|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995361|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995362|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43995363|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
43995364|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995365|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
43995366|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43995367|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
43995368|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995369|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
43995370|NCT02608489|Protective Agents|protective agents|mesh-ancestor
43995371|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43995372|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
43995373|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43995374|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995375|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995376|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
43995377|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995378|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995379|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43995380|NCT02611154|Testosterone|testosterone|mesh-list
43995381|NCT02611154|Androgens|androgens|mesh-ancestor
43995382|NCT02611154|Hormones|hormones|mesh-ancestor
43995383|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995384|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995385|NCT02611765|Penicillins|penicillins|mesh-list
43995386|NCT02611765|Penicillin G|penicillin g|mesh-list
43995387|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43995388|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
43995389|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995390|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995391|NCT02613117|Fluorides|fluorides|mesh-list
43995392|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
43995393|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
43995394|NCT02613117|Protective Agents|protective agents|mesh-ancestor
43995395|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995396|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
43995397|NCT02613897|Saxagliptin|saxagliptin|mesh-list
43995398|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43995399|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995400|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43995401|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460033|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460034|NCT01570309|Vitamins|vitamins|mesh-ancestor
44460035|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
43995402|NCT02613897|Incretins|incretins|mesh-ancestor
43995403|NCT02613897|Hormones|hormones|mesh-ancestor
43995404|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995405|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43995406|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995407|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995408|NCT02615535|Alprostadil|alprostadil|mesh-list
43995409|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43995410|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
43995411|NCT02615535|Urological Agents|urological agents|mesh-ancestor
43995412|NCT02616250|Ivermectin|ivermectin|mesh-list
43995413|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43995414|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43995415|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995416|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43995424|NCT02616523|Lidocaine|lidocaine|mesh-list
43995425|NCT02616523|Fentanyl|fentanyl|mesh-list
43995426|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
43995427|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995428|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
43995429|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995430|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995431|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
43995432|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995433|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995434|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43995435|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43995436|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995437|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995438|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995439|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995441|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43995442|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43995443|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43995444|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
43995445|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995446|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43995447|NCT02616523|Narcotics|narcotics|mesh-ancestor
43995448|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43995449|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995450|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
43995451|NCT02617667|Cyclosporine|cyclosporine|mesh-list
43995452|NCT02617667|Cyclosporins|cyclosporins|mesh-list
43995453|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995454|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995455|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43995456|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
43995457|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995458|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
43995459|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995460|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995461|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995462|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43995463|NCT02617784|Oseltamivir|oseltamivir|mesh-list
43995464|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
43995465|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995466|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995467|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995468|NCT02617888|Bismuth|bismuth|mesh-list
43995469|NCT02617888|Antacids|antacids|mesh-ancestor
43995470|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995471|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995472|NCT02618187|Vancomycin|vancomycin|mesh-list
43995473|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995474|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995475|NCT02618343|Ondansetron|ondansetron|mesh-list
43995476|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
43995477|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
43995478|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995479|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995480|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460036|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44460038|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44460039|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44460040|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
44460041|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44460042|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460043|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44460044|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44460045|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44460046|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44460047|NCT01570244|Estrogens|estrogens|mesh-ancestor
44460048|NCT01570244|Hormones|hormones|mesh-ancestor
44460049|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995481|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
43995482|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995483|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43995484|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
43995485|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995494|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995495|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995496|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995498|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995499|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995500|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995501|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
43995502|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
43995503|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
43995504|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
43995505|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995506|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995507|NCT02619409|Bupivacaine|bupivacaine|mesh-list
43995509|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
43995510|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995511|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995512|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
43995513|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995514|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
43995515|NCT02619799|Midazolam|midazolam|mesh-list
43995516|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43995517|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995518|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995519|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995520|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995521|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995522|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995523|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995524|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
43995525|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
43995526|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
43995527|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
43995528|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995529|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995530|NCT02619799|Analgesics|analgesics|mesh-ancestor
43995531|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
43995532|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995533|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995534|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
43995535|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43995536|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43816144|NCT05474690|Pertuzumab|pertuzumab|mesh-list
44460050|NCT01570192|Vancomycin|vancomycin|mesh-list
44246144|NCT04095715|Hemostatics|hemostatics|mesh-list
44246145|NCT04095715|Coagulants|coagulants|mesh-ancestor
44246146|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
44246147|NCT04094701|Narcotics|narcotics|mesh-ancestor
44037320|NCT00002471|Leucovorin|leucovorin|mesh-list
44246148|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246149|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246150|NCT04094701|Analgesics|analgesics|mesh-ancestor
44246151|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
44246152|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246153|NCT04084210|Nicotine|nicotine|mesh-list
44246154|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44246155|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
43995537|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43995538|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
43995539|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43995540|NCT02620683|Lidocaine|lidocaine|mesh-list
43995541|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995542|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
43995543|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995544|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995545|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
43995546|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995547|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995548|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43995549|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43995550|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995551|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995552|NCT02620774|Tazobactam|tazobactam|mesh-list
43995557|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43995558|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995559|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995560|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43995562|NCT02620878|Pancrelipase|pancrelipase|mesh-list
43995563|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995564|NCT02620904|Mifepristone|mifepristone|mesh-list
43995565|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43995566|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
43995567|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43995568|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995569|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43995570|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43995571|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43995572|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
43995573|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43995574|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43995575|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
43995576|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995577|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
43995578|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43995579|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43995580|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
43995582|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995583|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995584|NCT02621619|Acetaminophen|acetaminophen|mesh-list
43995585|NCT02621619|Hydromorphone|hydromorphone|mesh-list
43995586|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995587|NCT02621619|Analgesics|analgesics|mesh-ancestor
43995588|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
43995589|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995590|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995591|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
44246156|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246157|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246158|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44246159|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44246160|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
43995592|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43995593|NCT02621619|Narcotics|narcotics|mesh-ancestor
43995594|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145713|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145714|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
44145715|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145716|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145717|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145718|NCT00195793|Atorvastatin|atorvastatin|mesh-list
44145719|NCT00195793|Ezetimibe|ezetimibe|mesh-list
44145720|NCT00195793|Fenofibrate|fenofibrate|mesh-list
44145721|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44145722|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44145723|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
44145724|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145725|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44145726|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44145727|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145728|NCT00195806|Valproic Acid|valproic acid|mesh-list
44145729|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
44145730|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145731|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145732|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
44145733|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145734|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145735|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
44145736|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44145737|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145738|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145739|NCT00195845|Galantamine|galantamine|mesh-list
44145740|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44145741|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145744|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145745|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145746|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44145747|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
44145748|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145749|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
44145750|NCT00195871|Cytarabine|cytarabine|mesh-list
44145751|NCT00195871|Prednisone|prednisone|mesh-list
44145752|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
44145753|NCT00195871|Methotrexate|methotrexate|mesh-list
44145754|NCT00195871|Etoposide|etoposide|mesh-list
44145755|NCT00195871|Vincristine|vincristine|mesh-list
44145756|NCT00195871|Daunorubicin|daunorubicin|mesh-list
44145757|NCT00195871|Asparaginase|asparaginase|mesh-list
44145758|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145759|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
44145760|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145761|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145762|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44145763|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
44145764|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145765|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145766|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44145767|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145768|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
44145769|NCT00195871|Hormones|hormones|mesh-ancestor
44145770|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145771|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44145772|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44145773|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
44145774|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145775|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145776|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
44145777|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
44246161|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246162|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246164|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44246165|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44246166|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
44246167|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246168|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44246169|NCT04075474|Listerine|listerine|mesh-list
44246170|NCT04075474|Fluorides|fluorides|mesh-list
44246171|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
44246172|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
44246173|NCT04075474|Protective Agents|protective agents|mesh-ancestor
43823961|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
44145778|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145779|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44145780|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44145781|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44145782|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44145783|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145784|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
43995595|NCT02623803|Lidocaine|lidocaine|mesh-list
43995596|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995597|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
43995598|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995599|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995600|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
43995601|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995602|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995603|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43995604|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43995605|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995606|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995607|NCT02624180|Colchicine|colchicine|mesh-list
43995608|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
43995609|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995610|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
43995611|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
43995612|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
43995613|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995614|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995615|NCT02624700|Pemetrexed|pemetrexed|mesh-list
43995616|NCT02624700|Sorafenib|sorafenib|mesh-list
43995617|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995618|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995619|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995620|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43995621|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43995622|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43995623|NCT02624843|Ethanol|ethanol|mesh-list
43995624|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
43995627|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995628|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995629|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995630|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
43995631|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
43995632|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995633|NCT02625181|Promethazine|promethazine|mesh-list
43995634|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
43995635|NCT02625181|Meclizine|meclizine|mesh-list
43995636|NCT02625181|Dexamethasone|dexamethasone|mesh-list
43995637|NCT02625181|Fentanyl|fentanyl|mesh-list
43995638|NCT02625181|Sufentanil|sufentanil|mesh-list
44246174|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246175|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44246176|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246178|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246179|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246180|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
43645315|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43995639|NCT02625181|Scopolamine|scopolamine|mesh-list
43995640|NCT02625181|Oxymorphone|oxymorphone|mesh-list
43995641|NCT02625181|Meperidine|meperidine|mesh-list
43995642|NCT02625181|Droperidol|droperidol|mesh-list
43995643|NCT02625181|Ketamine|ketamine|mesh-list
43995644|NCT02625181|Morphine|morphine|mesh-list
43995645|NCT02625181|Remifentanil|remifentanil|mesh-list
43995646|NCT02625181|Oxycodone|oxycodone|mesh-list
43995647|NCT02625181|Methadone|methadone|mesh-list
43995648|NCT02625181|Hydromorphone|hydromorphone|mesh-list
43995649|NCT02625181|Hydrocodone|hydrocodone|mesh-list
43995650|NCT02625181|Alfentanil|alfentanil|mesh-list
43995651|NCT02625181|Haloperidol|haloperidol|mesh-list
43995652|NCT02625181|Ondansetron|ondansetron|mesh-list
43995653|NCT02625181|Aprepitant|aprepitant|mesh-list
43995654|NCT02625181|Palonosetron|palonosetron|mesh-list
43995655|NCT02625181|Metoclopramide|metoclopramide|mesh-list
43995656|NCT02625181|Granisetron|granisetron|mesh-list
43995657|NCT02625181|Ramosetron|ramosetron|mesh-list
43995658|NCT02625181|Tropisetron|tropisetron|mesh-list
43995659|NCT02625181|Dolasetron|dolasetron|mesh-list
43995660|NCT02625181|Anesthetics|anesthetics|mesh-list
43995661|NCT02625181|Propofol|propofol|mesh-list
43995662|NCT02625181|Sevoflurane|sevoflurane|mesh-list
43995663|NCT02625181|Desflurane|desflurane|mesh-list
43995664|NCT02625181|Isoflurane|isoflurane|mesh-list
43995665|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43995666|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995667|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
43995668|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
43995669|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995670|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995671|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995672|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
43995673|NCT02625181|Hormones|hormones|mesh-ancestor
43995674|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995675|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43995676|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145785|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
43995677|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995678|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995679|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995680|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
43995681|NCT02625181|Analgesics|analgesics|mesh-ancestor
43995682|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
43995683|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43995684|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43995685|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43995686|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995687|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995688|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43995689|NCT02625181|Narcotics|narcotics|mesh-ancestor
43995690|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43995691|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43995692|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43995693|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
43995694|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995695|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43995696|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
43995697|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43995698|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995699|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995700|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995701|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
43995702|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816231|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
44246181|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246182|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246183|NCT04068194|Avelumab|avelumab|mesh-list
44246184|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44246185|NCT04068194|Peposertib|peposertib|mesh-list
44246186|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645323|NCT04108481|Durvalumab|durvalumab|mesh-list
43995703|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43995704|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43995713|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
43995714|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43995715|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
43995716|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
43995717|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43995718|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43995719|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995720|NCT02625207|Maraviroc|maraviroc|mesh-list
43995721|NCT02625207|Darunavir|darunavir|mesh-list
43995722|NCT02625207|Cobicistat|cobicistat|mesh-list
43995723|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43995724|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43995725|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43995726|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995727|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43995728|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43995729|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
43995730|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995731|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43995732|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43995733|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43995734|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995735|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995736|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43995737|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43995738|NCT02625298|Pemetrexed|pemetrexed|mesh-list
43995739|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995740|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995741|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995742|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43995743|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43995744|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
43995745|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995746|NCT02626611|Omalizumab|omalizumab|mesh-list
43995747|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43995748|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43995749|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
43995750|NCT02628106|Alprostadil|alprostadil|mesh-list
43729998|NCT02568111|Interferon-beta|interferon-beta|mesh-list
43995751|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43995752|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
43995753|NCT02628106|Urological Agents|urological agents|mesh-ancestor
43995754|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43995755|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43995756|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995757|NCT02629094|Eplerenone|eplerenone|mesh-list
43995758|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43995759|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
43995760|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995761|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995762|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43995763|NCT02629094|Diuretics|diuretics|mesh-ancestor
43995764|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
43995765|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43995766|NCT02629354|Ibuprofen|ibuprofen|mesh-list
43995767|NCT02629354|Caffeine|caffeine|mesh-list
43995768|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43995769|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995770|NCT02629354|Analgesics|analgesics|mesh-ancestor
43995771|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
43995775|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037665|NCT00002494|Hormones|hormones|mesh-ancestor
44246187|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246188|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
44246189|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995776|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43995777|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995778|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995779|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43995780|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43995781|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43995782|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43995783|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
43995784|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995785|NCT02629991|Oxytocin|oxytocin|mesh-list
43995786|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
43995787|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43995788|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995789|NCT02630017|Methylphenidate|methylphenidate|mesh-list
43995790|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43995791|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995792|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43995793|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43995794|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995795|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995796|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
43995797|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995798|NCT02630030|Ixazomib|ixazomib|mesh-list
43995799|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995800|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995801|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995802|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995803|NCT02630719|Timolol|timolol|mesh-list
43995804|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43995805|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
43995806|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43995807|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43995808|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43995809|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
43995810|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995811|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995812|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995813|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43995814|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43995815|NCT02630992|Amoxicillin|amoxicillin|mesh-list
43995816|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
43995817|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
43995818|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43995819|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995820|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995821|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43995822|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995823|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995824|NCT02631057|Warfarin|warfarin|mesh-list
43995825|NCT02631057|Dabigatran|dabigatran|mesh-list
43995826|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
43995827|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
43995828|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43995829|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
43995830|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995831|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995832|NCT02631525|Propofol|propofol|mesh-list
43995833|NCT02631525|Desflurane|desflurane|mesh-list
43995834|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995835|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995836|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995837|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43995838|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
43995839|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
43995840|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43995841|NCT02631590|Gemcitabine|gemcitabine|mesh-list
43995842|NCT02631590|Cisplatin|cisplatin|mesh-list
43995846|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246190|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246191|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246192|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246193|NCT04067115|Alovudine|alovudine|mesh-list
44246194|NCT04067115|Irinotecan|irinotecan|mesh-list
44246195|NCT04067115|Trabectedin|trabectedin|mesh-list
44246196|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44246197|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44246198|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246199|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246200|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995847|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
43995848|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995849|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995850|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43995851|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
43995852|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995854|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
43995855|NCT02631772|Ledipasvir|ledipasvir|mesh-list
43995856|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
43995857|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995858|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
43995859|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995860|NCT02631954|Voriconazole|voriconazole|mesh-list
43995861|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
43995862|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995863|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43995864|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43995865|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995866|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995867|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43995868|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
43995869|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995870|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995871|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43995872|NCT02632812|Naproxen|naproxen|mesh-list
43995873|NCT02632812|Rebamipide|rebamipide|mesh-list
43995874|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43995875|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43995876|NCT02632812|Analgesics|analgesics|mesh-ancestor
43995877|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
43995878|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995879|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995880|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995881|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43995882|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
43995883|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43995884|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995885|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995886|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43995887|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995888|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
43995889|NCT02632812|Protective Agents|protective agents|mesh-ancestor
43995890|NCT02633371|Oxybutynin|oxybutynin|mesh-list
43995891|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
43995892|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
43995893|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995894|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730148|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730149|NCT02567331|Capecitabine|capecitabine|mesh-list
43730150|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43730151|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
43730152|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246201|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246202|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
44246204|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246205|NCT04066491|Gemcitabine|gemcitabine|mesh-list
44246206|NCT04066491|Cisplatin|cisplatin|mesh-list
44246207|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037794|NCT00002502|Cytarabine|cytarabine|mesh-list
44246208|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246209|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
43833906|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
43995895|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43995896|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43995897|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
43995898|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995899|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995900|NCT02633371|Urological Agents|urological agents|mesh-ancestor
43995901|NCT02633488|Metformin|metformin|mesh-list
43995902|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43995903|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995904|NCT02633956|Atorvastatin|atorvastatin|mesh-list
43995905|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43995906|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43995907|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
43995909|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43995910|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43995911|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995913|NCT02634073|Sorbitol|sorbitol|mesh-list
43995914|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43995915|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43995916|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995917|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995918|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
43995919|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995920|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43995921|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43995922|NCT02634073|Cathartics|cathartics|mesh-ancestor
43995923|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995924|NCT02634684|Amphetamine|amphetamine|mesh-list
43995925|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
43995926|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43995927|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995928|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
43995929|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
43995930|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995931|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
43995932|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995933|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995934|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
43995935|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43995936|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43995937|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995938|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43995939|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43995940|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43995941|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995942|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43995943|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43995944|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995945|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995946|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
43995947|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995948|NCT02635542|Cisatracurium|cisatracurium|mesh-list
43995949|NCT02635542|Succinylcholine|succinylcholine|mesh-list
43995950|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43995951|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43995952|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246210|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246211|NCT04066491|Antiviral Agents|antiviral agents|mesh-ancestor
44246212|NCT04066491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246213|NCT04066491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246214|NCT04066491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246215|NCT04066491|Immunologic Factors|immunologic factors|mesh-ancestor
44246216|NCT04066491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246217|NCT04064359|Antibodies|antibodies|mesh-list
44246218|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
44246219|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
44246220|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246221|NCT04052568|Psilocybin|psilocybin|mesh-list
44246222|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
44246223|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246224|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44246225|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
44246226|NCT04049669|Temozolomide|temozolomide|mesh-list
43995953|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995954|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43995955|NCT02635828|Promethazine|promethazine|mesh-list
43995956|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
43995958|NCT02635828|Palonosetron|palonosetron|mesh-list
43995959|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995960|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
43995961|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
43995962|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995963|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995964|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43995965|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
43995966|NCT02635828|Hormones|hormones|mesh-ancestor
43995967|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43995968|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43995969|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995970|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43995971|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43995972|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
43995973|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995974|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995975|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
43995976|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
43995977|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43995978|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
43995979|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
43995983|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995985|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
43995986|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
43995987|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43995988|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
43995989|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
43995990|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995991|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995992|NCT02638168|Methylphenidate|methylphenidate|mesh-list
43995993|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43995994|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995995|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43995996|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43995997|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43995998|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995999|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
44246227|NCT04049669|Lomustine|lomustine|mesh-list
44246228|NCT04049669|Etoposide|etoposide|mesh-list
44246229|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246230|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
43996000|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996001|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
43996002|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43996003|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
43996004|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996005|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43996006|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43996007|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996008|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996009|NCT02639429|Misoprostol|misoprostol|mesh-list
43996010|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43996011|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
43996012|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43996013|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996014|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43996015|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996016|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
43996017|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43996018|NCT02639637|Valsartan|valsartan|mesh-list
43996019|NCT02639637|Enalaprilat|enalaprilat|mesh-list
43996020|NCT02639637|Enalapril|enalapril|mesh-list
43996021|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43996022|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996023|NCT02639637|Incretins|incretins|mesh-ancestor
43996024|NCT02639637|Hormones|hormones|mesh-ancestor
43996025|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996026|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43996027|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
43996028|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996029|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996030|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43996031|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43996032|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43996033|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43996034|NCT02641353|Thalidomide|thalidomide|mesh-list
43996035|NCT02641353|Apremilast|apremilast|mesh-list
43996036|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43996037|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996038|NCT02641353|Analgesics|analgesics|mesh-ancestor
43996039|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
43996040|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996041|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996042|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996043|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996044|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43996045|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43996046|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996047|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996048|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996049|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
43996054|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43996056|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996057|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996058|NCT02641522|Siltuximab|siltuximab|mesh-list
43996059|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996060|NCT02641561|Indomethacin|indomethacin|mesh-list
43996061|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43996062|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996063|NCT02641561|Analgesics|analgesics|mesh-ancestor
43996064|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
43996065|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996066|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996067|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996068|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996069|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
43996070|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
43996071|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44246231|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246232|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246233|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246234|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
43996072|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43996073|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996074|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996075|NCT02641691|Leucovorin|leucovorin|mesh-list
43996076|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43996077|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
43996078|NCT02641691|Fluorouracil|fluorouracil|mesh-list
43996079|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
43996080|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
43996081|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
43996082|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996083|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43996084|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996085|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996086|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
43996087|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996088|NCT02641691|Antidotes|antidotes|mesh-ancestor
43996089|NCT02641691|Protective Agents|protective agents|mesh-ancestor
43996090|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
43996091|NCT02641691|Vitamins|vitamins|mesh-ancestor
43996092|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
43996093|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
43996094|NCT05588999|Salicylates|salicylates|mesh-list
43996095|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996096|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
43996097|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
43996098|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
43996099|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43996100|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996101|NCT05588999|Analgesics|analgesics|mesh-ancestor
43996102|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
43996103|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996104|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996105|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996106|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996107|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43996108|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996109|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996110|NCT05588908|Betamethasone|betamethasone|mesh-list
43996111|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43996112|NCT05588908|Antibodies|antibodies|mesh-list
43996113|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
43996114|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43996115|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
43996116|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996117|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996118|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996119|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
43996120|NCT05588908|Hormones|hormones|mesh-ancestor
43996121|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996126|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996127|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996128|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996129|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
43996130|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996131|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
43996132|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996133|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
43996134|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996135|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43996136|NCT05588830|Belimumab|belimumab|mesh-list
43996137|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996138|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
43996139|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145786|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
44145787|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
44145788|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145789|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246235|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246236|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246237|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44246238|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246239|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44246240|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44145791|NCT00195910|Hydromorphone|hydromorphone|mesh-list
44145792|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44145793|NCT00195910|Narcotics|narcotics|mesh-ancestor
44145794|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145795|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145796|NCT00195910|Analgesics|analgesics|mesh-ancestor
44145797|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
44145798|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145799|NCT00195923|Clindamycin|clindamycin|mesh-list
44145800|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
44145801|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
44145802|NCT00195923|Gentamicins|gentamicins|mesh-list
44145803|NCT00195923|Ceftazidime|ceftazidime|mesh-list
44145804|NCT00195923|Ampicillin|ampicillin|mesh-list
44145805|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145806|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145807|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44145808|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145809|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145810|NCT00195936|Cinacalcet|cinacalcet|mesh-list
44145811|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44145812|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145813|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44145814|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
44145815|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145816|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
44145817|NCT00195988|Tacrolimus|tacrolimus|mesh-list
44145818|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145819|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
44145820|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145821|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44145822|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145823|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145824|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145825|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145826|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44145827|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
44145828|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145829|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145830|NCT00196131|Morphine|morphine|mesh-list
44145831|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44145832|NCT00196131|Narcotics|narcotics|mesh-ancestor
44145833|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145834|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145835|NCT00196131|Analgesics|analgesics|mesh-ancestor
44145836|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
44145837|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145838|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
44145839|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44145840|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
43996144|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996145|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
43996146|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996149|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996150|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996151|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43996152|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038153|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43996153|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996154|NCT05588518|Propolis|propolis|mesh-list
43996155|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996156|NCT05588492|Rifamycins|rifamycins|mesh-list
44246241|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246242|NCT04047641|Cytarabine|cytarabine|mesh-list
44246243|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44246244|NCT04047641|Idarubicin|idarubicin|mesh-list
44246245|NCT04047641|Cladribine|cladribine|mesh-list
43996157|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
43996158|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996159|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996160|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996161|NCT05588388|Bevacizumab|bevacizumab|mesh-list
43996162|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996163|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996164|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43996165|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43996166|NCT05588388|Growth Substances|growth substances|mesh-ancestor
43996167|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996168|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996169|NCT05588336|Morphine|morphine|mesh-list
43996170|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43996171|NCT05588336|Narcotics|narcotics|mesh-ancestor
43996172|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996173|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996174|NCT05588336|Analgesics|analgesics|mesh-ancestor
43996175|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
43996176|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996177|NCT05588297|Bevacizumab|bevacizumab|mesh-list
43996178|NCT05588297|Nivolumab|nivolumab|mesh-list
43996179|NCT05588297|Capecitabine|capecitabine|mesh-list
43996180|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
43996181|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996182|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996183|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43996184|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43996185|NCT05588297|Growth Substances|growth substances|mesh-ancestor
43996186|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996187|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996188|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43996189|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
43996190|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996191|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43996192|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
43996193|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43996194|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
43996195|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43996196|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
43996197|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996198|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996199|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
43996200|NCT05588219|Cisplatin|cisplatin|mesh-list
43996201|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43996202|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996203|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996204|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
43996205|NCT05588102|Citalopram|citalopram|mesh-list
43996206|NCT05588102|Fluoxetine|fluoxetine|mesh-list
43996207|NCT05588102|Paroxetine|paroxetine|mesh-list
43996208|NCT05588102|Sertraline|sertraline|mesh-list
43996209|NCT05588102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43996210|NCT05588102|Serotonin|serotonin|mesh-list
43996211|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43996214|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996215|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
43996216|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996217|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43996218|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
43996219|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43996220|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43996221|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996222|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996223|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43996224|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43996225|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43996226|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246246|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246247|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
44246248|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246249|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246250|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
44246251|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644314|NCT04655170|Ipratropium|ipratropium|mesh-list
43996227|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43996228|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43996229|NCT05588037|Dexamethasone|dexamethasone|mesh-list
43996230|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
43996231|NCT05588037|BB 1101|bb 1101|mesh-list
43996232|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996233|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
43996234|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
43996235|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996236|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996237|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996238|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
43996239|NCT05588037|Hormones|hormones|mesh-ancestor
43996240|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996241|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43996242|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996243|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
43996244|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996245|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996246|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
43996247|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
43996248|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996249|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996250|NCT05587894|Ritonavir|ritonavir|mesh-list
43996251|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43996252|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43996253|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
43996254|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996255|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996256|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43996257|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43996258|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
43996259|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996260|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43996261|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996262|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43996263|NCT05587621|Ezetimibe|ezetimibe|mesh-list
43996264|NCT05587621|Evolocumab|evolocumab|mesh-list
43996265|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43996266|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43996267|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
43996268|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996269|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43996270|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996271|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43996272|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996273|NCT05587426|Iproplatin|iproplatin|mesh-list
43996274|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996275|NCT05587400|Dobutamine|dobutamine|mesh-list
43996276|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
43996277|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43996278|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
43996279|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996280|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996281|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43996282|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
43996285|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996286|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996287|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43996288|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
44246252|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246253|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
44246254|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246255|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246256|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44246257|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43996289|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
43996290|NCT05587400|Protective Agents|protective agents|mesh-ancestor
43996291|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43996292|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
43996293|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43996294|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43996295|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43996296|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996297|NCT05587361|Propranolol|propranolol|mesh-list
43996298|NCT05587361|Nicotine|nicotine|mesh-list
43996299|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43996300|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
43996301|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996302|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996303|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43996304|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43996305|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
43996306|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996307|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996308|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43996309|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43996310|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996311|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43996312|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43996313|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
43996314|NCT05587257|Minoxidil|minoxidil|mesh-list
43996315|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43996316|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
43996317|NCT05587231|Fluorometholone|fluorometholone|mesh-list
43996318|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996319|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996320|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
43996321|NCT05587231|Hormones|hormones|mesh-ancestor
43996322|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996323|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43996324|NCT05586971|Allopurinol|allopurinol|mesh-list
43996325|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
43996326|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996327|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996328|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
43996329|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996330|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43996331|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
43996332|NCT05586971|Protective Agents|protective agents|mesh-ancestor
43996333|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996334|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
43996335|NCT05585658|Hematinics|hematinics|mesh-ancestor
43996336|NCT05580549|Ethanol|ethanol|mesh-list
43996337|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43996338|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996339|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996340|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996341|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
43996342|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43996343|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996344|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43996345|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996346|NCT05559437|Bupivacaine|bupivacaine|mesh-list
43996347|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
43996348|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996349|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
44038348|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996350|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996351|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996352|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
44246258|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246260|NCT04047576|Prednisone|prednisone|mesh-list
44246261|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246262|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
44246263|NCT04047576|Hormones|hormones|mesh-ancestor
44246264|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996353|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996355|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43996356|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43996357|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996362|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
43996363|NCT05553314|Protective Agents|protective agents|mesh-ancestor
43996364|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43996365|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730492|NCT02564315|Nicotine|nicotine|mesh-list
43996366|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43996367|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
43996368|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43996369|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44145842|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145843|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44145844|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44145845|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44145846|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
44145847|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44145848|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
44145849|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44145850|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145851|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44145852|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44145853|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44145855|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44145856|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
44145857|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
44145858|NCT00196378|Hormones|hormones|mesh-ancestor
44145859|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145860|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145861|NCT00196391|Progesterone|progesterone|mesh-list
44145862|NCT00196391|Progestins|progestins|mesh-ancestor
44145863|NCT00196391|Hormones|hormones|mesh-ancestor
44145864|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145865|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145866|NCT00196417|Heparin|heparin|mesh-list
44145867|NCT00196417|Certoparin|certoparin|mesh-list
44145868|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
44145869|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44145870|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44145871|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145872|NCT00196469|Heparin|heparin|mesh-list
44145873|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
44145874|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44145875|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44145876|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145877|NCT00196534|Thrombin|thrombin|mesh-list
44145878|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
44145879|NCT00196534|Coagulants|coagulants|mesh-ancestor
44145880|NCT00196547|Montelukast|montelukast|mesh-list
44145881|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44145882|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44145883|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44145884|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
44145885|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145886|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145887|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44145888|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44145889|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246265|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246266|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644562|NCT04567615|Nivolumab|nivolumab|mesh-list
44145890|NCT00196586|Interferons|interferons|mesh-list
44145891|NCT00196586|Ribavirin|ribavirin|mesh-list
44145892|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
44145893|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
44145894|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44145895|NCT00196586|Interleukin-2|interleukin-2|mesh-list
44145896|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145897|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
44145898|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145899|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
44145902|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145903|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44145905|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
44145906|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145907|NCT00196599|Emtricitabine|emtricitabine|mesh-list
44145908|NCT00196599|Efavirenz|efavirenz|mesh-list
44145909|NCT00196599|Didanosine|didanosine|mesh-list
44145910|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
44145911|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145912|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43996370|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
43996371|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
43996372|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996373|NCT05510856|Lacosamide|lacosamide|mesh-list
43996374|NCT05510856|Gabapentin|gabapentin|mesh-list
43996375|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43996376|NCT05510856|Analgesics|analgesics|mesh-ancestor
43996377|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
43996378|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996379|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996380|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
43996381|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43996382|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43996383|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996384|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43996385|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43996386|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43996387|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996388|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996389|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
43996390|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43996391|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43996392|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996393|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
43996394|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
43996395|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43996396|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43996397|NCT05502211|Lidocaine|lidocaine|mesh-list
43996398|NCT05502211|Fentanyl|fentanyl|mesh-list
43996399|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996400|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
43996401|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996402|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996403|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
43996404|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996405|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43996406|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43996407|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43996408|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996409|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996410|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43996411|NCT05502211|Narcotics|narcotics|mesh-ancestor
43996412|NCT05502211|Analgesics|analgesics|mesh-ancestor
43996413|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43996414|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43996415|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
43996416|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
43996417|NCT05501665|Paclitaxel|paclitaxel|mesh-list
43996418|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43996419|NCT05501665|Carboplatin|carboplatin|mesh-list
43996420|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
44246267|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246268|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996421|NCT05501665|Pemetrexed|pemetrexed|mesh-list
43996422|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43996423|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43996424|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996425|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
43996426|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
43996427|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
43996428|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996429|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996430|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996458|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996459|NCT05437575|Fentanyl|fentanyl|mesh-list
43996460|NCT05437575|Ketamine|ketamine|mesh-list
43996461|NCT05437575|Analgesics|analgesics|mesh-ancestor
43996462|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
43996463|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996464|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996465|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43996466|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43996467|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
43996468|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
43996469|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996470|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43996471|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43996472|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996473|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996474|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43996475|NCT05437575|Narcotics|narcotics|mesh-ancestor
43996476|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43996477|NCT05416320|Calcipotriene|calcipotriene|mesh-list
43996481|NCT05403138|Daratumumab|daratumumab|mesh-list
43996482|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996484|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43996485|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43996486|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43996487|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996488|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996489|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996490|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996491|NCT05369351|Urological Agents|urological agents|mesh-ancestor
43996492|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
43996493|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996494|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996495|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43996496|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43996497|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996498|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996499|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996500|NCT05345210|Amoxicillin|amoxicillin|mesh-list
43996501|NCT05345210|Clarithromycin|clarithromycin|mesh-list
43996502|NCT05345210|Tetracycline|tetracycline|mesh-list
43996503|NCT05345210|Furazolidone|furazolidone|mesh-list
43996504|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996505|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996506|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43996507|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996508|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996509|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43996510|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996511|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43996512|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43996513|NCT05345210|Renal Agents|renal agents|mesh-ancestor
43996514|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43996515|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43996516|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43996517|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43996519|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996520|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996521|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43996522|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246269|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246270|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246271|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
43996523|NCT05342818|Ondansetron|ondansetron|mesh-list
43996524|NCT05342818|Metoclopramide|metoclopramide|mesh-list
43996525|NCT05342818|Neostigmine|neostigmine|mesh-list
43996526|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
43996527|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
43996528|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996529|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996530|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996531|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
43996532|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
43996533|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43996534|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
43996535|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996536|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996537|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43996538|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43996539|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996540|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43996541|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43996542|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43996543|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996544|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
43996545|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43996546|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43996547|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43996548|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
43996549|NCT05335148|Colchicine|colchicine|mesh-list
43996550|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
43996551|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996558|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
43996559|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43996560|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
43996561|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996562|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996563|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
43996564|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996565|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996566|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996567|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
43996568|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996569|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996570|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
43996571|NCT05303987|Propofol|propofol|mesh-list
43996572|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43996573|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996574|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996575|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43996576|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
43996577|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
43996578|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996579|NCT05303987|Analgesics|analgesics|mesh-ancestor
43996580|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
43996581|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996582|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43996583|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43996584|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43996585|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996586|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996587|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996588|NCT05281770|Erenumab|erenumab|mesh-list
43996589|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43996590|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996591|NCT05281770|Analgesics|analgesics|mesh-ancestor
43996592|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
43996593|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996594|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996597|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
43996598|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996599|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
43996600|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44246272|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246273|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
44246274|NCT04046107|Cemiplimab|cemiplimab|mesh-list
44246275|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44038601|NCT00002551|Levamisole|levamisole|mesh-list
44246276|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246277|NCT04019288|Durvalumab|durvalumab|mesh-list
43996601|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996602|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996603|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996604|NCT05225610|Analgesics|analgesics|mesh-ancestor
43996605|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
43996606|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996607|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43996608|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43996609|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43996610|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996611|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996612|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996613|NCT05219266|Midostaurin|midostaurin|mesh-list
43996614|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996615|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43996616|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996617|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996618|NCT05197270|Aflibercept|aflibercept|mesh-list
43996619|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43996620|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43996622|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996623|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996624|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996625|NCT05167487|Cisplatin|cisplatin|mesh-list
43996626|NCT05167487|Carboplatin|carboplatin|mesh-list
43996627|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996628|NCT05150652|Tamoxifen|tamoxifen|mesh-list
43996629|NCT05150652|Letrozole|letrozole|mesh-list
43996630|NCT05150652|Anastrozole|anastrozole|mesh-list
43996631|NCT05150652|Exemestane|exemestane|mesh-list
43996632|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996633|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43996634|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43996635|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996636|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996637|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43996638|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
43996639|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996640|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996641|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43996642|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43996643|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43996644|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43996645|NCT05144542|Nicotine|nicotine|mesh-list
43996646|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43996647|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
43996648|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996649|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996650|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43996651|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43996652|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
43996653|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996654|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996655|NCT05084859|Prednisone|prednisone|mesh-list
43996656|NCT05084859|Docetaxel|docetaxel|mesh-list
43996657|NCT05084859|Panitumumab|panitumumab|mesh-list
43996658|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996659|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
43996660|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
43996661|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
43996662|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996663|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996664|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
44246278|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
44038679|NCT00002554|Busulfan|busulfan|mesh-list
44246279|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44246280|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
44246281|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996666|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996667|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996668|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43996669|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996670|NCT05073692|Liraglutide|liraglutide|mesh-list
43996671|NCT05073692|Empagliflozin|empagliflozin|mesh-list
43996672|NCT05073692|Exenatide|exenatide|mesh-list
43996673|NCT05073692|Glimepiride|glimepiride|mesh-list
43996674|NCT05073692|Linagliptin|linagliptin|mesh-list
43996675|NCT05073692|Saxagliptin|saxagliptin|mesh-list
43996676|NCT05073692|Alogliptin|alogliptin|mesh-list
43996677|NCT05073692|Glipizide|glipizide|mesh-list
43996678|NCT05073692|Glucagon|glucagon|mesh-list
43996679|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43996680|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43996681|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996682|NCT05073692|Incretins|incretins|mesh-ancestor
43996683|NCT05073692|Hormones|hormones|mesh-ancestor
43996684|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996685|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43996686|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996687|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43996688|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43996689|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996690|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
43996691|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43996692|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
43996693|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996694|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996695|NCT05044871|Paclitaxel|paclitaxel|mesh-list
43996696|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43996697|NCT05044871|Bevacizumab|bevacizumab|mesh-list
43996700|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
43996701|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
43996702|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
43996703|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996704|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996705|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43996706|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43996707|NCT05044871|Growth Substances|growth substances|mesh-ancestor
43996708|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996709|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996710|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
43996711|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
43996712|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996713|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145913|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44145914|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145915|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145916|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44145917|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44145918|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44145919|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145920|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44145921|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44145922|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44145923|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44145924|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
44145925|NCT00196612|Emtricitabine|emtricitabine|mesh-list
44145926|NCT00196612|Efavirenz|efavirenz|mesh-list
44145927|NCT00196612|Didanosine|didanosine|mesh-list
44145928|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
44145929|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145930|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44145931|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44145932|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701046|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246282|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246283|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
44038749|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
44246284|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246285|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44246286|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44246287|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145933|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145934|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44145935|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44145936|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44145937|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145938|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44145939|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44145940|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44145941|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44145942|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
44145943|NCT00196625|Ritonavir|ritonavir|mesh-list
43996714|NCT04950621|Propofol|propofol|mesh-list
43996715|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43996716|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996717|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996718|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43996719|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
43996720|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
43996721|NCT04947085|Ketamine|ketamine|mesh-list
43996722|NCT04947085|Analgesics|analgesics|mesh-ancestor
43996723|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
43996724|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996725|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996726|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43996727|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43996728|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
43996729|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
43996730|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996731|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43996732|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43996733|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996734|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996735|NCT04931693|Acetaminophen|acetaminophen|mesh-list
43996736|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996737|NCT04931693|Analgesics|analgesics|mesh-ancestor
43996743|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996744|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996745|NCT04817969|Cimetidine|cimetidine|mesh-list
43996746|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43996747|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996748|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43996749|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
43996750|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
43996751|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996752|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996753|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996754|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43996755|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996756|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996757|NCT04805125|Vaccines|vaccines|mesh-list
43996758|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
43996759|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996760|NCT04797767|Cytarabine|cytarabine|mesh-list
44038832|NCT00002565|Hormones|hormones|mesh-ancestor
43996761|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43996762|NCT04797767|Venetoclax|venetoclax|mesh-list
43996763|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
43996764|NCT04797767|Cladribine|cladribine|mesh-list
43996765|NCT04797767|Lenograstim|lenograstim|mesh-list
43996766|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43996767|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
43996768|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996769|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246288|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246290|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246291|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
44246292|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246293|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246294|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
44246295|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43996770|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
43996771|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996772|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996773|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
43996774|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996775|NCT04797767|Analgesics|analgesics|mesh-ancestor
43996776|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
43996777|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996778|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43996779|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43996780|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996781|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43996782|NCT04778267|Dexamethasone|dexamethasone|mesh-list
43996783|NCT04778267|Bupivacaine|bupivacaine|mesh-list
43996784|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43996785|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996786|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
43996787|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
43996788|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996789|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730954|NCT02561013|Ionophores|ionophores|mesh-ancestor
43996790|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43996791|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
43996792|NCT04778267|Hormones|hormones|mesh-ancestor
43996793|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996794|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43996795|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996796|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996797|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
43996798|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996799|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
43996800|NCT04771000|Ambrisentan|ambrisentan|mesh-list
43996801|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43996802|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
43996803|NCT04735471|Fludarabine|fludarabine|mesh-list
43996804|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996805|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
43996806|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996807|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996808|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43996812|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43996813|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43996815|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43996816|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43996817|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43996818|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43996819|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
43996820|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996821|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996822|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996823|NCT04651595|Morphine|morphine|mesh-list
43996824|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43996825|NCT04651595|Narcotics|narcotics|mesh-ancestor
44038881|NCT00002568|Cisplatin|cisplatin|mesh-list
43996826|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996827|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996828|NCT04651595|Analgesics|analgesics|mesh-ancestor
43996829|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
43996830|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996831|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44246296|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
44246297|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246298|NCT05664789|Expectorants|expectorants|mesh-ancestor
44246299|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
43996832|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
43996833|NCT04520607|Lorecivivint|lorecivivint|mesh-list
43996834|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996835|NCT04511052|Carotenoids|carotenoids|mesh-list
43996836|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
43996837|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996838|NCT04511052|Protective Agents|protective agents|mesh-ancestor
43996839|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996841|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43996842|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996843|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996844|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996845|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43996846|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43996847|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996848|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43996849|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43996850|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996851|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996852|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
43996853|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996854|NCT04317430|Niclosamide|niclosamide|mesh-list
43996855|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
43996856|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43996857|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
43996858|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43996859|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996860|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
43996861|NCT04277884|Firibastat|firibastat|mesh-list
43996862|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43996863|NCT04237623|Sargramostim|sargramostim|mesh-list
43996864|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
43996865|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996866|NCT04235036|Rituximab|rituximab|mesh-list
43996867|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996868|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996869|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
43996870|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996871|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145947|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
44145948|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145949|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145950|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44145951|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44145952|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
44145953|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145954|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44145955|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145956|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44145957|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
44145958|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145959|NCT00196638|Interferons|interferons|mesh-list
44145960|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
44145961|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44145962|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145963|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
44145964|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145965|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
44038953|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
44145966|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145967|NCT00196664|Paroxetine|paroxetine|mesh-list
44246300|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44246302|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246303|NCT05664789|Protective Agents|protective agents|mesh-ancestor
44246304|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246305|NCT05664789|Antidotes|antidotes|mesh-ancestor
44246306|NCT03965117|Norepinephrine|norepinephrine|mesh-list
44246307|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44246308|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44246309|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
44246310|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246311|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246312|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246313|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
44246314|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
44246315|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44145968|NCT00196664|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44145969|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44145970|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44145971|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145972|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145973|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
44145974|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145975|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44145976|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
44145977|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145978|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44145979|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44145980|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145981|NCT00196677|Vitamins|vitamins|mesh-list
44145982|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
44145983|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145984|NCT00196690|Donepezil|donepezil|mesh-list
44145985|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44145986|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145987|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145988|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
44145989|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145990|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145991|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
44145992|NCT00196703|Memantine|memantine|mesh-list
44145993|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44145994|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44145995|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
44145996|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145997|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145998|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145999|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44146000|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44146001|NCT00196755|Calcium|calcium|mesh-list
44146002|NCT00196755|Sevelamer|sevelamer|mesh-list
44146003|NCT00196755|Calcium acetate|calcium acetate|mesh-list
43996879|NCT04219280|Methylphenidate|methylphenidate|mesh-list
43996880|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43996881|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996882|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43996883|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43996884|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246316|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44246317|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44246318|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246319|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246321|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
44246322|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246323|NCT03945019|Infliximab|infliximab|mesh-list
44039027|NCT00002576|Analgesics|analgesics|mesh-ancestor
44246324|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
44246325|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246326|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246327|NCT03937986|Cocaine|cocaine|mesh-list
43996885|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996886|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
43996887|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996888|NCT04214288|Fulvestrant|fulvestrant|mesh-list
43996889|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43996895|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996896|NCT04172961|Cyclosporine|cyclosporine|mesh-list
43996897|NCT04172961|Lifitegrast|lifitegrast|mesh-list
43996898|NCT04172961|Cyclosporins|cyclosporins|mesh-list
43996899|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996900|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996901|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996902|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
43996903|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996904|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
43996905|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996906|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
43996907|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996908|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43996909|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43996910|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43996911|NCT04146571|Ensartinib|ensartinib|mesh-list
43996912|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996913|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43996914|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996915|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996916|NCT04074265|Ketorolac|ketorolac|mesh-list
43996917|NCT04074265|Epinephrine|epinephrine|mesh-list
43996918|NCT04074265|Ropivacaine|ropivacaine|mesh-list
43996919|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996920|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
43996921|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996922|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996923|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
43996924|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996925|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43996926|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43996927|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
43996928|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996929|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996930|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43996931|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43996932|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
43996933|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43996934|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
43996935|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
43996936|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
43996937|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43996938|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43996939|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43996940|NCT04074265|Analgesics|analgesics|mesh-ancestor
43996941|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43996942|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43996943|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44246328|NCT03937986|Suvorexant|suvorexant|mesh-list
44246329|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
44246330|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
44246331|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246332|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246333|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
44246334|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246335|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43996944|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996945|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
43996946|NCT04049799|Narcotics|narcotics|mesh-ancestor
43996947|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996948|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996949|NCT04049799|Analgesics|analgesics|mesh-ancestor
43996950|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
43996951|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996952|NCT04047251|Topotecan|topotecan|mesh-list
43996953|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43996954|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43996955|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996956|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996957|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996958|NCT04045613|Atezolizumab|atezolizumab|mesh-list
43996959|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43996964|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996965|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996966|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43996967|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996968|NCT03926624|Cytarabine|cytarabine|mesh-list
43996969|NCT03926624|Fludarabine|fludarabine|mesh-list
43996970|NCT03926624|Etoposide|etoposide|mesh-list
43996971|NCT03926624|Azacitidine|azacitidine|mesh-list
43996972|NCT03926624|Decitabine|decitabine|mesh-list
43996973|NCT03926624|Venetoclax|venetoclax|mesh-list
43996974|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
43996975|NCT03926624|Idarubicin|idarubicin|mesh-list
43996976|NCT03926624|Cladribine|cladribine|mesh-list
43996977|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996978|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43996979|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
43996980|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996981|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43996982|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
43996983|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996984|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43996985|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43996986|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43996987|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43996988|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
43996989|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996990|NCT03926624|Analgesics|analgesics|mesh-ancestor
43996991|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
43996992|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996993|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43996994|NCT03899155|Nivolumab|nivolumab|mesh-list
43996995|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43996996|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996997|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43996998|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996999|NCT03867851|Heparin|heparin|mesh-list
43997000|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
43997001|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43997002|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997003|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997004|NCT03821272|Vaccines|vaccines|mesh-list
43997005|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
43997006|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997007|NCT03750071|Avelumab|avelumab|mesh-list
43701047|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246336|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44246337|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44246338|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246339|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246340|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
44246341|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246342|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44246343|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44246344|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44246345|NCT03937635|Dexamethasone|dexamethasone|mesh-list
43997008|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997009|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997010|NCT03693846|Nivolumab|nivolumab|mesh-list
43997011|NCT03693846|Ipilimumab|ipilimumab|mesh-list
43997012|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997013|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997014|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43997015|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997016|NCT03635567|Paclitaxel|paclitaxel|mesh-list
43997017|NCT03635567|Bevacizumab|bevacizumab|mesh-list
43997018|NCT03635567|Cisplatin|cisplatin|mesh-list
43997019|NCT03635567|Carboplatin|carboplatin|mesh-list
43997020|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
43997021|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43997022|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997023|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
43997024|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
43997025|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
43997026|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997027|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997028|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43997029|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43997030|NCT03635567|Growth Substances|growth substances|mesh-ancestor
43997031|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997032|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
43997035|NCT03575013|Docetaxel|docetaxel|mesh-list
43997036|NCT03575013|Avelumab|avelumab|mesh-list
43997037|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997038|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
43997039|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
43997040|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
43997041|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997042|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997043|NCT03529890|Nivolumab|nivolumab|mesh-list
43997044|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997045|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997046|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43997047|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997048|NCT03471624|Tenofovir|tenofovir|mesh-list
43997049|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
43997050|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997051|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43997052|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43997053|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997054|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997055|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43997056|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43997057|NCT03441048|Cytarabine|cytarabine|mesh-list
43997058|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
43997059|NCT03441048|Cladribine|cladribine|mesh-list
43997060|NCT03441048|Lintuzumab|lintuzumab|mesh-list
43997061|NCT03441048|Lenograstim|lenograstim|mesh-list
43997062|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43997063|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
44246346|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
44246347|NCT03937635|Lenalidomide|lenalidomide|mesh-list
44246348|NCT03937635|Daratumumab|daratumumab|mesh-list
44246349|NCT03937635|Ichthammol|ichthammol|mesh-list
44246350|NCT03937635|BB 1101|bb 1101|mesh-list
44246351|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246352|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
44246353|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
44246354|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246355|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997064|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997065|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997066|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
43997067|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997068|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997069|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
43997070|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997071|NCT03441048|Analgesics|analgesics|mesh-ancestor
43997072|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
43997073|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997074|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43997075|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43997076|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997077|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997078|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43997079|NCT03402945|Vancomycin|vancomycin|mesh-list
43997080|NCT03402945|Cefazolin|cefazolin|mesh-list
43997081|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43997082|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997083|NCT03349281|Cytarabine|cytarabine|mesh-list
43997084|NCT03349281|Dexamethasone|dexamethasone|mesh-list
43997085|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
43997086|NCT03349281|Doxorubicin|doxorubicin|mesh-list
43997087|NCT03349281|Methotrexate|methotrexate|mesh-list
43997088|NCT03349281|Vincristine|vincristine|mesh-list
43997089|NCT03349281|Asparaginase|asparaginase|mesh-list
43997090|NCT03349281|Pegaspargase|pegaspargase|mesh-list
43997091|NCT03349281|Pevonedistat|pevonedistat|mesh-list
43997092|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997093|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
43997094|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
43997095|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997096|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997097|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997098|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
43997099|NCT03349281|Hormones|hormones|mesh-ancestor
43997100|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997101|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43997102|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997103|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43997104|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43997105|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43997106|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997107|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997111|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43997113|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
43997114|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43997115|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997116|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
43997117|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997118|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43997119|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
43997120|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997121|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43997122|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
43997123|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
43997124|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
43997125|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
43997126|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246356|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246357|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
44246358|NCT03937635|Hormones|hormones|mesh-ancestor
44246359|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246360|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246361|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246362|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
44246363|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44246364|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43997127|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997128|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
43997129|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43997130|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43997131|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43997132|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997133|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997134|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
43997135|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997136|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997137|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43997138|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997139|NCT03206151|Leucovorin|leucovorin|mesh-list
43997140|NCT03206151|Folic Acid|folic acid|mesh-list
43997141|NCT03206151|Fluorouracil|fluorouracil|mesh-list
43997142|NCT03206151|Irinotecan|irinotecan|mesh-list
43997143|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
43997144|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
43997145|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997146|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43997147|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997148|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997149|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
43997150|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997151|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43997152|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43997153|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997154|NCT03206151|Antidotes|antidotes|mesh-ancestor
43997155|NCT03206151|Protective Agents|protective agents|mesh-ancestor
43997156|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
43997157|NCT03206151|Vitamins|vitamins|mesh-ancestor
43997158|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
43997159|NCT03206151|Hematinics|hematinics|mesh-ancestor
43997160|NCT03206047|Poly I-C|poly i-c|mesh-list
43997161|NCT03206047|Atezolizumab|atezolizumab|mesh-list
43997162|NCT03206047|Guadecitabine|guadecitabine|mesh-list
43997163|NCT03206047|Azacitidine|azacitidine|mesh-list
43997164|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43997165|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43997166|NCT03206047|Poly ICLC|poly iclc|mesh-list
43997167|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997168|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
43997169|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997170|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
43997171|NCT03206047|Laxatives|laxatives|mesh-ancestor
43997173|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
43997174|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997175|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43997176|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
43997177|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997178|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997179|NCT03189706|Irinotecan|irinotecan|mesh-list
43997180|NCT03189706|Temozolomide|temozolomide|mesh-list
43997181|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43997182|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43997194|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43997195|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997196|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
43997197|NCT02828592|Fludarabine|fludarabine|mesh-list
43997198|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
43997212|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
43997213|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997214|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
43997215|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997216|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997217|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997218|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
43997219|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997220|NCT02540018|Paclitaxel|paclitaxel|mesh-list
43997221|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43997222|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997223|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
43997224|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
43997225|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
43997226|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246375|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246377|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44246378|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
44246379|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997263|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43997264|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43997265|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997266|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997267|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
43997268|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997269|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43997270|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43997271|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
43997272|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43997273|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43997274|NCT02303405|Pioglitazone|pioglitazone|mesh-list
43997275|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
43997276|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43997277|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997278|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
43997279|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43997280|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43997281|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997282|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997283|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997284|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997285|NCT02164955|Pomalidomide|pomalidomide|mesh-list
43997286|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
43997287|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997288|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43997289|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43997290|NCT02164955|Growth Substances|growth substances|mesh-ancestor
43997291|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
43997292|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146004|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44146005|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146006|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
44146007|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
44146008|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146009|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
44146010|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146011|NCT00196820|Capecitabine|capecitabine|mesh-list
44146012|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146013|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
44146014|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146015|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146016|NCT00196846|Goserelin|goserelin|mesh-list
44146017|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146018|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146019|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
44146020|NCT00196859|Capecitabine|capecitabine|mesh-list
44146021|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146022|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
44146023|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146024|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146025|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44146026|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146027|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
44146028|NCT00196872|Epirubicin|epirubicin|mesh-list
44146029|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146030|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
44146031|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146032|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246380|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44246381|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246382|NCT03909152|Anastrozole|anastrozole|mesh-list
44246383|NCT03909152|Onapristone|onapristone|mesh-list
44246384|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246385|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246386|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44246387|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44246388|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039442|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246389|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246390|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44146033|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146034|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
44146035|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146036|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146037|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146038|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146039|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146040|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43997311|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997312|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43997313|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43997314|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
43997315|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997317|NCT02643615|Desflurane|desflurane|mesh-list
43997318|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997319|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997320|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997321|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43997322|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
43997323|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
43997324|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43997325|NCT02643862|Omalizumab|omalizumab|mesh-list
43997326|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43997327|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43997328|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
43997329|NCT02643979|Ketamine|ketamine|mesh-list
43997330|NCT02643979|Propofol|propofol|mesh-list
43997331|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997332|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997333|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997334|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43997335|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
43997336|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
43997337|NCT02643979|Analgesics|analgesics|mesh-ancestor
43997338|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
43997339|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997340|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43997341|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43997342|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43997343|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997344|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997345|NCT02645617|Imidacloprid|imidacloprid|mesh-list
43997346|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
43997347|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997348|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997349|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997350|NCT02646449|Mirtazapine|mirtazapine|mesh-list
43997351|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
43997352|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997353|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43997354|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
43997355|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
44246392|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246393|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246394|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44246395|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
44246396|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44246397|NCT03887702|Tenofovir|tenofovir|mesh-list
44246398|NCT03887702|Entecavir|entecavir|mesh-list
44246399|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
44246400|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997356|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997359|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43997360|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43997361|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997362|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43997363|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43997364|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43997365|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997366|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43997367|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43997368|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
43997369|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43997370|NCT02649192|Vitamin D|vitamin d|mesh-list
43997371|NCT02649192|Vitamin A|vitamin a|mesh-list
43997372|NCT02649192|Vitamins|vitamins|mesh-ancestor
43997373|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
43997374|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997375|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43997376|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
43997377|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43997378|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997379|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997380|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
43997381|NCT02650856|Coagulants|coagulants|mesh-ancestor
43997382|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
43997383|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997384|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997385|NCT02651259|Vitamins|vitamins|mesh-list
43997386|NCT02651259|Pyridoxine|pyridoxine|mesh-list
43997387|NCT02651259|Pyridoxal|pyridoxal|mesh-list
43997388|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
43997389|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
43997390|NCT02651259|Isoniazid|isoniazid|mesh-list
43997391|NCT02651259|Rifapentine|rifapentine|mesh-list
43997392|NCT02651259|Rifamycins|rifamycins|mesh-list
43997393|NCT02651259|Hydrazine|hydrazine|mesh-list
43997394|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
43997395|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997396|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
43997397|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43997398|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997399|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43997400|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43997401|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
43997402|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997403|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43997404|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43997405|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
43997406|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997407|NCT02651272|Macitentan|macitentan|mesh-list
43997408|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43997409|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43997410|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997411|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43997412|NCT02651415|Perindopril|perindopril|mesh-list
43997413|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43997414|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44246401|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44246402|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44246404|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997415|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997416|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997417|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43997418|NCT02651428|Taurolidine|taurolidine|mesh-list
43997419|NCT02651428|Heparin|heparin|mesh-list
43997420|NCT02651428|Calcium heparin|calcium heparin|mesh-list
43997421|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
43997422|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997423|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43997424|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997425|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997426|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43997427|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997428|NCT02651584|Buprenorphine|buprenorphine|mesh-list
43997429|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997430|NCT02651584|Narcotics|narcotics|mesh-ancestor
43997432|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997434|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
43997435|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997436|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43997437|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
43997438|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43997439|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43997440|NCT02652390|Prednisolone|prednisolone|mesh-list
43997441|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
43997442|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43997443|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
43997444|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997445|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
43997446|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
43997447|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997448|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997449|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997450|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
43997451|NCT02652390|Hormones|hormones|mesh-ancestor
43997452|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997453|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43997454|NCT02652390|Protective Agents|protective agents|mesh-ancestor
43997455|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43997456|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997457|NCT02653144|Dexamethasone|dexamethasone|mesh-list
43997458|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
43997459|NCT02653144|Ropivacaine|ropivacaine|mesh-list
43997460|NCT02653144|Anesthetics|anesthetics|mesh-list
43997461|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997462|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
43997463|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
43997464|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997465|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997466|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997467|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
43997468|NCT02653144|Hormones|hormones|mesh-ancestor
43997469|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997470|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43997471|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997472|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997473|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997474|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43997475|NCT02653144|Analgesics|analgesics|mesh-ancestor
43997476|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
43997477|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43997478|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43997479|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43997480|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997481|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997482|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246405|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44246406|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43997483|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997484|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43997485|NCT02653183|Laxatives|laxatives|mesh-ancestor
43997486|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997487|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43997488|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43997489|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
43997490|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
43997491|NCT02653560|Citric Acid|citric acid|mesh-list
43997492|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
43997493|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
43997494|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43997495|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
43997496|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
43997497|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997498|NCT02653560|Diuretics|diuretics|mesh-ancestor
43997499|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
43997500|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997501|NCT02653560|Expectorants|expectorants|mesh-ancestor
43997502|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
43997503|NCT02653560|Cathartics|cathartics|mesh-ancestor
43997504|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997505|NCT02653872|Itraconazole|itraconazole|mesh-list
43997510|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43997511|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43997513|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997514|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43997515|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
43997516|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997517|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731591|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43997518|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43997519|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43997520|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43997521|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997522|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43997523|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
43997524|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43997525|NCT02654483|Serlopitant|serlopitant|mesh-list
43997526|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43997527|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997528|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997529|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997530|NCT02654860|Acetaminophen|acetaminophen|mesh-list
43997531|NCT02654860|Bupivacaine|bupivacaine|mesh-list
43997532|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997533|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
43997534|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997535|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997536|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
43997537|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997538|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43997539|NCT02654860|Analgesics|analgesics|mesh-ancestor
43997540|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
43997541|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
43997542|NCT02655354|Promethazine|promethazine|mesh-list
43997543|NCT02655354|Prazosin|prazosin|mesh-list
43997544|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43997545|NCT02655354|Mirtazapine|mirtazapine|mesh-list
43997546|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
43997547|NCT02655354|Trazodone|trazodone|mesh-list
43997548|NCT02655354|Sertraline|sertraline|mesh-list
43997549|NCT02655354|Fluoxetine|fluoxetine|mesh-list
43997550|NCT02655354|Paroxetine|paroxetine|mesh-list
43997551|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43997552|NCT02655354|Citalopram|citalopram|mesh-list
43997553|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43997554|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43997555|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997556|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246407|NCT03872388|Capecitabine|capecitabine|mesh-list
44246408|NCT03872388|Atorvastatin|atorvastatin|mesh-list
44246409|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246410|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
43997557|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997558|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997559|NCT02655354|Analgesics|analgesics|mesh-ancestor
43997560|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
43997561|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997562|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
43997563|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997564|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
43997565|NCT02655354|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43997566|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
43997567|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43997568|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43997569|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43997570|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997571|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
43997572|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43997573|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997574|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997575|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997577|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
43997578|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997579|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43997580|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
43997581|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
43997582|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43997583|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
43997584|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
43997585|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43997586|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43997587|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43997588|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43997589|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43997590|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997591|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43997592|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43997593|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43731595|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
43997594|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43997595|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43997596|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43997597|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44146050|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146051|NCT00196885|Protective Agents|protective agents|mesh-ancestor
44146052|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146053|NCT00196885|Antidotes|antidotes|mesh-ancestor
44157677|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44157678|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157679|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157680|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157681|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157682|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157683|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
44157684|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44157685|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157686|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157687|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157688|NCT00235053|Fluticasone|fluticasone|mesh-list
44157689|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44157690|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44157691|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157692|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44157693|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
44157694|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157695|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157696|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44246411|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246412|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246413|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44246414|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44157697|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
44157698|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157699|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44157700|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44157701|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44157702|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44157703|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
44157704|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157705|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157706|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
44157707|NCT00235053|Hormones|hormones|mesh-ancestor
44157708|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157709|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
44157710|NCT00235079|Colchicine|colchicine|mesh-list
44157711|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
44157712|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157713|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
44157714|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
44157715|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157716|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157717|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157718|NCT00235092|Sirolimus|sirolimus|mesh-list
44157719|NCT00235092|Paclitaxel|paclitaxel|mesh-list
44157720|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44157726|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157727|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157728|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157729|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
44157730|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157731|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
44157732|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157733|NCT00235105|Adalimumab|adalimumab|mesh-list
44157734|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157735|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157736|NCT00235144|Sirolimus|sirolimus|mesh-list
44157737|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157738|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157739|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157740|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157741|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
43731670|NCT02556437|Antibodies|antibodies|mesh-list
43997598|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
43997599|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
43997600|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43997601|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997602|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997603|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
43997604|NCT02655653|Coagulants|coagulants|mesh-ancestor
43997605|NCT02656069|Glucagon|glucagon|mesh-list
43997606|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43997607|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997608|NCT02656069|Hormones|hormones|mesh-ancestor
43997609|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997610|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997611|NCT02656069|Incretins|incretins|mesh-ancestor
43997612|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
43997613|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43997614|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997615|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997616|NCT02657252|Polidocanol|polidocanol|mesh-list
43997617|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43997618|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43997619|NCT02657928|Letrozole|letrozole|mesh-list
43997620|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997621|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43997622|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43997623|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830595|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246415|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44246416|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44246417|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997624|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997625|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43997626|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
43997627|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997628|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997630|NCT02658240|Ropivacaine|ropivacaine|mesh-list
43997631|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997632|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
43997633|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997634|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997635|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
43997636|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997637|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43997638|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43997639|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997640|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997641|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997642|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43997643|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43997644|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
43997645|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43997654|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43997656|NCT02659501|Diazepam|diazepam|mesh-list
43997657|NCT02659501|Morphine|morphine|mesh-list
43997658|NCT02659501|Hydrocodone|hydrocodone|mesh-list
43997660|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997661|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
43997662|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997663|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997664|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
43997665|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997666|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997667|NCT02659501|Narcotics|narcotics|mesh-ancestor
43997668|NCT02659501|Analgesics|analgesics|mesh-ancestor
43997669|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43997670|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
43997671|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43997672|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43997673|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997674|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997675|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997676|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43997677|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43997678|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
43997679|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43997680|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
43997681|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
43997682|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
43997683|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43997684|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
43997685|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43997686|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
43997687|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
43997688|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997689|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997690|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43997691|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43997692|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43997693|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43997694|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997695|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43997696|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
43997697|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
43997698|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
43997699|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43997700|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997701|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997702|NCT02659787|Buprenorphine|buprenorphine|mesh-list
44246418|NCT03870438|Lamivudine|lamivudine|mesh-list
44246419|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44246420|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44246421|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246422|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645466|NCT03970304|Vaccines|vaccines|mesh-list
43997703|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997704|NCT02659787|Narcotics|narcotics|mesh-ancestor
43997705|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997706|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997707|NCT02659787|Analgesics|analgesics|mesh-ancestor
43997708|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
43997709|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997710|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43997711|NCT02660918|Bupivacaine|bupivacaine|mesh-list
43997712|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997713|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
43997714|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997715|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997716|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
43997750|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
43997752|NCT02664922|Analgesics|analgesics|mesh-ancestor
43997753|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
43997754|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997755|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43997756|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43997757|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43997758|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997759|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997766|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997767|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43997768|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43997769|NCT02664961|Growth Substances|growth substances|mesh-ancestor
43997770|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997771|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
43997772|NCT02665260|Cantharidin|cantharidin|mesh-list
43997773|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997774|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997775|NCT02665273|Bupivacaine|bupivacaine|mesh-list
43997776|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997777|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
43997778|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997779|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997780|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
43997781|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997783|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997784|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
43997786|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
43997787|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997788|NCT02666846|Ibuprofen|ibuprofen|mesh-list
43997789|NCT02666846|Diclofenac|diclofenac|mesh-list
43997790|NCT02666846|Salicylates|salicylates|mesh-list
43997791|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
43997792|NCT02666846|Menthol|menthol|mesh-list
43997793|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43997794|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43997795|NCT02666846|Analgesics|analgesics|mesh-ancestor
43997796|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
43997797|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997798|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997799|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997800|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997801|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43997802|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997803|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997804|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
43997805|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
43997806|NCT02666950|Cytarabine|cytarabine|mesh-list
43997807|NCT02666950|Adavosertib|adavosertib|mesh-list
43830596|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
44246423|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
44246424|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246425|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43997808|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43997809|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
43997810|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997811|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997812|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
43997813|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997815|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
43997816|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997817|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997818|NCT02667704|Nintedanib|nintedanib|mesh-list
43997819|NCT02667704|Bosentan|bosentan|mesh-list
43997820|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997821|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43997822|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997823|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997824|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43997825|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43997826|NCT02668432|Amiodarone|amiodarone|mesh-list
43997827|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43997828|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
43997829|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43997830|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997831|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997834|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43997835|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997836|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43997837|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43997838|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43997840|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43997841|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
43997842|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997843|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997844|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43997845|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997846|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
43997847|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997849|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997850|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997851|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
43997852|NCT02670343|Testosterone|testosterone|mesh-list
43997853|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
43997854|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
43997855|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43997856|NCT02670343|Androgens|androgens|mesh-ancestor
43997857|NCT02670343|Hormones|hormones|mesh-ancestor
43997858|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997859|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997860|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43997861|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997862|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
43997863|NCT02672111|Buprenorphine|buprenorphine|mesh-list
43997864|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997865|NCT02672111|Narcotics|narcotics|mesh-ancestor
43997866|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997867|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997868|NCT02672111|Analgesics|analgesics|mesh-ancestor
43997869|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
43997870|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997871|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43997872|NCT02673138|Canagliflozin|canagliflozin|mesh-list
43997873|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43997874|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997875|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43997876|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997877|NCT02673372|Ketamine|ketamine|mesh-list
43997878|NCT02673372|Morphine|morphine|mesh-list
43997879|NCT02673372|Analgesics|analgesics|mesh-ancestor
43997880|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
44246426|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44246427|NCT03867357|Goserelin|goserelin|mesh-list
44246428|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43997881|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997882|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997883|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43997884|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43997885|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
43997886|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
43997887|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997888|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43997890|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997891|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997892|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997893|NCT02673372|Narcotics|narcotics|mesh-ancestor
43997894|NCT02674412|Buspirone|buspirone|mesh-list
43997895|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43997896|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43997897|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997898|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997899|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997900|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43997901|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
43997902|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997903|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997904|NCT02676375|Bupropion|bupropion|mesh-list
43997908|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43997909|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43997910|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43997911|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997912|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
43997913|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997914|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997915|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43997916|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43997917|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997919|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
43997920|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997921|NCT02677623|Mannitol|mannitol|mesh-list
43997922|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43997923|NCT02677623|Diuretics|diuretics|mesh-ancestor
43997924|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
43997925|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997926|NCT02677701|Azithromycin|azithromycin|mesh-list
43997927|NCT02677701|Tobramycin|tobramycin|mesh-list
43997928|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43997929|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997930|NCT02679469|Nalmefene|nalmefene|mesh-list
43997931|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43997932|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997933|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
43997934|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146054|NCT00196989|Pioglitazone|pioglitazone|mesh-list
44146055|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44146056|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146057|NCT00197080|Ropinirole|ropinirole|mesh-list
44146058|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44146059|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44146060|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
44146061|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
44146062|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146063|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146064|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146065|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
44146066|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44146067|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146068|NCT00197197|Aplaviroc|aplaviroc|mesh-list
44146069|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44146070|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44146071|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146072|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44146073|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44246430|NCT03866200|Resveratrol|resveratrol|mesh-list
44246431|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
43645475|NCT03959241|Tacrolimus|tacrolimus|mesh-list
44146074|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
44146075|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146076|NCT00197249|Vaccines|vaccines|mesh-list
44146077|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
44146078|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146079|NCT00197327|Bupivacaine|bupivacaine|mesh-list
44146080|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
44146081|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
44146082|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146083|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146084|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
44146085|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146087|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
44146088|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
44146089|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146090|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146091|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
44146092|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146093|NCT00197353|Bupivacaine|bupivacaine|mesh-list
44146094|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
44146095|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
44146096|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997937|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
43997938|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997939|NCT02680054|Insulin|insulin|mesh-list
43997940|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
43997941|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43997942|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997943|NCT02680301|Triamcinolone|triamcinolone|mesh-list
43997944|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43997945|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43997946|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43997947|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43997948|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
43997949|NCT02680301|Hormones|hormones|mesh-ancestor
43997950|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43997951|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997952|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997953|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
43997954|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997955|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997956|NCT02680457|Insulin|insulin|mesh-list
43997957|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43997958|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
43997959|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43997960|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997961|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43997962|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997963|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
43997964|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43997965|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997966|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997967|NCT02682381|Teduglutide|teduglutide|mesh-list
43997968|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997969|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43997970|NCT02682381|Protective Agents|protective agents|mesh-ancestor
43997971|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997972|NCT02682498|Bupivacaine|bupivacaine|mesh-list
43997973|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997974|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
43997975|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997976|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997977|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
43997978|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997979|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
43997980|NCT02682563|Gliclazide|gliclazide|mesh-list
43997981|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43997982|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997983|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44246432|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246433|NCT03866200|Protective Agents|protective agents|mesh-ancestor
44246434|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246435|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645479|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997984|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997985|NCT02683161|Varenicline|varenicline|mesh-list
43997986|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43997987|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44040220|NCT00002678|Prednisone|prednisone|mesh-list
43997988|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43997989|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43997990|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997991|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997992|NCT02683707|Lidocaine|lidocaine|mesh-list
43997993|NCT02683707|Fentanyl|fentanyl|mesh-list
43997994|NCT02683707|Midazolam|midazolam|mesh-list
43997995|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997996|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
43997997|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997998|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997999|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
43998000|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998001|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43998002|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43998003|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43998004|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998005|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998006|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998010|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998011|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
43998012|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998013|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43998014|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43998015|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43998016|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
43998017|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
43998018|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998019|NCT02684136|Suvorexant|suvorexant|mesh-list
43998020|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43998021|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998022|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998023|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998024|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43998025|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998026|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998027|NCT02684942|Fentanyl|fentanyl|mesh-list
43998028|NCT02684942|Meperidine|meperidine|mesh-list
43998029|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998030|NCT02684942|Narcotics|narcotics|mesh-ancestor
43998031|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998032|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998033|NCT02684942|Analgesics|analgesics|mesh-ancestor
43998034|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
43998035|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998036|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998037|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998038|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
43998039|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
43998040|NCT02685267|Prednisone|prednisone|mesh-list
43998041|NCT02685267|Docetaxel|docetaxel|mesh-list
43998042|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998043|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
43998044|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
43998045|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
43998046|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998047|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998048|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
43998049|NCT02685267|Hormones|hormones|mesh-ancestor
43998050|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998051|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246436|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44246437|NCT03859427|Dexamethasone|dexamethasone|mesh-list
44246438|NCT03859427|Lenalidomide|lenalidomide|mesh-list
44246439|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246440|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
44040268|NCT00002680|Tamoxifen|tamoxifen|mesh-list
44246441|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
43998052|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998053|NCT02685436|Domperidone|domperidone|mesh-list
43998054|NCT02685436|Omeprazole|omeprazole|mesh-list
43998055|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43998056|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998057|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43998058|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998059|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998060|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
43998061|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
43998062|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998063|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998064|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43998065|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
43998066|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998067|NCT02688829|Sirolimus|sirolimus|mesh-list
43998068|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998069|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998070|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43998071|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998072|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
43998073|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998074|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
43998075|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998076|NCT02688842|Sirolimus|sirolimus|mesh-list
43998077|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998078|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998079|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43998080|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998081|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
43998090|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998091|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998093|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43998094|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998095|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43998096|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43998097|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998098|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998099|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
43998100|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998101|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998102|NCT02691416|Propofol|propofol|mesh-list
43998103|NCT02691416|Sevoflurane|sevoflurane|mesh-list
43998104|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998105|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998106|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998107|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998108|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
43998109|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
43998110|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43998111|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43998112|NCT02692391|Indomethacin|indomethacin|mesh-list
43998113|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43998114|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43998115|NCT02692391|Analgesics|analgesics|mesh-ancestor
43998116|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
43998117|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998118|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998119|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998120|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43998121|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
43998122|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
43998123|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44246443|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246444|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246445|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
44246446|NCT03859427|Hormones|hormones|mesh-ancestor
44246447|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460051|NCT01570192|Gentamicins|gentamicins|mesh-list
44246448|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998124|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43998125|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998126|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998127|NCT02692755|Letrozole|letrozole|mesh-list
43998128|NCT02692755|Fulvestrant|fulvestrant|mesh-list
43998129|NCT02692755|Palbociclib|palbociclib|mesh-list
43998130|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998131|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43998132|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43998133|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998134|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998135|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43998136|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43998137|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998138|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998139|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998140|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43998141|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43998142|NCT02694601|Caffeine|caffeine|mesh-list
43998143|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43998144|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998145|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43998149|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43998151|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998152|NCT02695290|Afatinib|afatinib|mesh-list
43998153|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998154|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43998155|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998156|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998157|NCT02695446|Minocycline|minocycline|mesh-list
43998158|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998159|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998160|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43998161|NCT02697071|Ketamine|ketamine|mesh-list
43998162|NCT02697071|Analgesics|analgesics|mesh-ancestor
43998163|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
43998164|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998165|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998166|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43998167|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998168|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
43998169|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
43998170|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998171|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43998172|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43998173|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998174|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998175|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
43998176|NCT02697188|Testosterone|testosterone|mesh-list
43998177|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
43998178|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
43998179|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43998180|NCT02697188|Androgens|androgens|mesh-ancestor
43998181|NCT02697188|Hormones|hormones|mesh-ancestor
43998182|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998183|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246449|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246450|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
43998184|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998185|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998186|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
43998187|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
44040415|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
43998188|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43998189|NCT02697292|Antibodies|antibodies|mesh-list
43998190|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
43998191|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43998192|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
43998193|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998194|NCT02698215|Naltrexone|naltrexone|mesh-list
43998195|NCT02698215|Varenicline|varenicline|mesh-list
43998196|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43998197|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43998198|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998199|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
43998200|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998201|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43998202|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43998203|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
43998204|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998205|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998206|NCT02698566|Ranibizumab|ranibizumab|mesh-list
43998207|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43998208|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43998209|NCT02698566|Growth Substances|growth substances|mesh-ancestor
43998210|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998211|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
43998212|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998213|NCT02698735|Gentamicins|gentamicins|mesh-list
43998214|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998215|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998216|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43998218|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998219|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
43998220|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43998221|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998222|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43998223|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146098|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
44146099|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146100|NCT00197379|Roxithromycin|roxithromycin|mesh-list
44146101|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146102|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146103|NCT00197418|Amoxicillin|amoxicillin|mesh-list
44146104|NCT00197418|Metronidazole|metronidazole|mesh-list
44146105|NCT00197418|Clarithromycin|clarithromycin|mesh-list
44146106|NCT00197418|Rabeprazole|rabeprazole|mesh-list
44146107|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146108|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146109|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43732143|NCT02551536|Fexofenadine|fexofenadine|mesh-list
44146110|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43998225|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
43998226|NCT02701062|Dabigatran|dabigatran|mesh-list
43998227|NCT02701062|Apixaban|apixaban|mesh-list
43998228|NCT02701062|Anticoagulants|anticoagulants|mesh-list
43998229|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43998230|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
43998231|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43998232|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
43998233|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998234|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998235|NCT02701257|Glucagon|glucagon|mesh-list
43998236|NCT02701257|Pancrelipase|pancrelipase|mesh-list
43998237|NCT02701257|Pancreatin|pancreatin|mesh-list
43998238|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43998239|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998240|NCT02701257|Hormones|hormones|mesh-ancestor
44040475|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43998241|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998242|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998243|NCT02701257|Incretins|incretins|mesh-ancestor
43998244|NCT02701400|Durvalumab|durvalumab|mesh-list
44246451|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44246452|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44246453|NCT03859427|Growth Substances|growth substances|mesh-ancestor
44246454|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246456|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645500|NCT03958045|Nivolumab|nivolumab|mesh-list
43998245|NCT02701400|Ipilimumab|ipilimumab|mesh-list
43998246|NCT02701400|Tremelimumab|tremelimumab|mesh-list
43998247|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998248|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998249|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43998250|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998251|NCT02701582|Phenylephrine|phenylephrine|mesh-list
43998252|NCT02701582|Epinephrine|epinephrine|mesh-list
43998253|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
43998254|NCT02701582|Synephrine|synephrine|mesh-list
43998255|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43998256|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43998257|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
43998258|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998259|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998260|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998261|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43998262|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998263|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
43998264|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998265|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43998266|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998267|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
43998268|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
43998269|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43998270|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43998271|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
43998272|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43998273|NCT02701582|Protective Agents|protective agents|mesh-ancestor
43998274|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
43998275|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43998276|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998277|NCT02703779|Plerixafor|plerixafor|mesh-list
43998278|NCT02703779|Bortezomib|bortezomib|mesh-list
43998279|NCT02703779|Lenograstim|lenograstim|mesh-list
43998280|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43998281|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
43998284|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43998285|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43998286|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
43998287|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998288|NCT02703909|Rocuronium|rocuronium|mesh-list
43998289|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43998290|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43998291|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43998292|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998293|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998294|NCT02704104|Hemostatics|hemostatics|mesh-list
43998295|NCT02704104|Coagulants|coagulants|mesh-ancestor
43998296|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43998297|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43998298|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732201|NCT02551276|Albuterol|albuterol|mesh-list
43998299|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
43998300|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998301|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43998302|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43998303|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998304|NCT02705352|Fluorouracil|fluorouracil|mesh-list
43998305|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
43998306|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998307|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43998308|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998309|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998310|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
44246457|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246458|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246459|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
44246460|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246461|NCT03849443|Ascorbic Acid|ascorbic acid|mesh-list
43998311|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998312|NCT02705807|Epoprostenol|epoprostenol|mesh-list
43998313|NCT02705807|Tezosentan|tezosentan|mesh-list
43998314|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43998315|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43998316|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998317|NCT02706249|Enoxaparin|enoxaparin|mesh-list
43998318|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
43998319|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43998320|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43998321|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998322|NCT02707523|Azithromycin|azithromycin|mesh-list
43998323|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998324|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998325|NCT02708238|Simethicone|simethicone|mesh-list
43998326|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
43998327|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998328|NCT02708238|Emollients|emollients|mesh-ancestor
43998329|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
43998330|NCT02708433|Lidocaine|lidocaine|mesh-list
43998331|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43998332|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
43998333|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998334|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998335|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
43998336|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998337|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43998338|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43998339|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43998340|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998341|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998342|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
43998343|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998344|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998345|NCT02709018|Losartan|losartan|mesh-list
43998346|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43998347|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43998348|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43998349|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43998350|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998351|NCT02710526|Buprenorphine|buprenorphine|mesh-list
43998352|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998353|NCT02710526|Narcotics|narcotics|mesh-ancestor
43998356|NCT02710526|Analgesics|analgesics|mesh-ancestor
43998357|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
43998358|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998359|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43998360|NCT02710630|Dabigatran|dabigatran|mesh-list
43998361|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
43998362|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43998363|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
43998364|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998365|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998366|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
43998367|NCT02710890|Lacosamide|lacosamide|mesh-list
43998368|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
43998369|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43998370|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43998371|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998372|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998373|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
43998374|NCT02710981|Clomiphene|clomiphene|mesh-list
43998375|NCT02710981|Enclomiphene|enclomiphene|mesh-list
43998376|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
43998377|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246462|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
44246463|NCT03849443|Vitamins|vitamins|mesh-ancestor
44246464|NCT03849443|Micronutrients|micronutrients|mesh-ancestor
44246465|NCT03849443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998378|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998379|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43998380|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43998381|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998382|NCT02710981|Urological Agents|urological agents|mesh-ancestor
43998383|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43998384|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
43998385|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998386|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998387|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43998388|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
43998389|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43998390|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43998391|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43998392|NCT02712047|Fluticasone|fluticasone|mesh-list
43998394|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998395|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998396|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
43998397|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998398|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998399|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43998400|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998401|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
43998402|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43998403|NCT02713178|Bupivacaine|bupivacaine|mesh-list
43998404|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
43998405|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
43998406|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998407|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998408|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
43998409|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998410|NCT02713230|Bupivacaine|bupivacaine|mesh-list
43998411|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
43998412|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
43998413|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998414|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998415|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
43998416|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998417|NCT02713698|Propofol|propofol|mesh-list
43998418|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998419|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998420|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998421|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998422|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
43998423|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
43998424|NCT02714283|Azithromycin|azithromycin|mesh-list
43998425|NCT02714283|Erythromycin|erythromycin|mesh-list
43998426|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998427|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998430|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998431|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998432|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43998433|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43998434|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43998435|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998436|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998437|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998438|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998439|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43998440|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
43998441|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43998442|NCT02714504|Voriconazole|voriconazole|mesh-list
43998443|NCT02714504|Posaconazole|posaconazole|mesh-list
43998444|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
43998445|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998446|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44246466|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44246467|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44246468|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246469|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
44246470|NCT03849443|Coagulants|coagulants|mesh-ancestor
43998447|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43998448|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732352|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
43998449|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998450|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43998451|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
43998452|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998453|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998454|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43998455|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43998456|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43998457|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43998458|NCT02715700|Methadone|methadone|mesh-list
43998459|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998460|NCT02715700|Narcotics|narcotics|mesh-ancestor
43998461|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998462|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998463|NCT02715700|Analgesics|analgesics|mesh-ancestor
43998464|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
43998465|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998466|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
43998467|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998468|NCT02716818|Dexamethasone|dexamethasone|mesh-list
43998469|NCT02716818|Prednisone|prednisone|mesh-list
43998470|NCT02716818|Prednisolone|prednisolone|mesh-list
43998471|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
43998472|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43998473|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43998474|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43998475|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
43998476|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998477|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
43998478|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
43998479|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998480|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998481|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998482|NCT02716818|Hormones|hormones|mesh-ancestor
43998483|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998484|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998485|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998486|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43998487|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43998488|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998489|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
43998490|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
43998491|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998492|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998493|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43998494|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43998495|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998496|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998497|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998499|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43998500|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43998501|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43998502|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998503|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998504|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
43998505|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998507|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998508|NCT02721017|Narcotics|narcotics|mesh-ancestor
43998509|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998510|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246471|NCT03849443|Antioxidants|antioxidants|mesh-ancestor
44246472|NCT03849443|Protective Agents|protective agents|mesh-ancestor
44246473|NCT03846505|Oxytocin|oxytocin|mesh-list
44246474|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
44246475|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43998511|NCT02721017|Analgesics|analgesics|mesh-ancestor
43998512|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
44040773|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998513|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998514|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998515|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998516|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
43998517|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
43998518|NCT02721641|Trastuzumab|trastuzumab|mesh-list
43998519|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998520|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998521|NCT02722239|Metformin|metformin|mesh-list
43732420|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
43998523|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43998524|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998525|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43998526|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998527|NCT02722564|Ethanol|ethanol|mesh-list
43998528|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43998529|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998530|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998531|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998532|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
43998533|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43998534|NCT02722837|Velpatasvir|velpatasvir|mesh-list
43998535|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
43998536|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998537|NCT02724033|Dexamethasone|dexamethasone|mesh-list
43998538|NCT02724033|Ondansetron|ondansetron|mesh-list
43998539|NCT02724033|Antiemetics|antiemetics|mesh-list
43998540|NCT02724033|Bupivacaine|bupivacaine|mesh-list
43998541|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998542|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
43998543|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998544|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998545|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998546|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
43998547|NCT02724033|Hormones|hormones|mesh-ancestor
43998548|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998549|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998550|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998551|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998552|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
43998553|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
43998554|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998555|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
43998556|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
43998557|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
43998558|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43998559|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
43998560|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998561|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43998562|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43998563|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43998564|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43998565|NCT02724423|Diazepam|diazepam|mesh-list
43998566|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998567|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
43998568|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
43998569|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
43998570|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998571|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998574|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998575|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43998576|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43998577|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43998578|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43998579|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43998580|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44246476|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246477|NCT03846310|Carboplatin|carboplatin|mesh-list
44246478|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
44246479|NCT03846310|Pemetrexed|pemetrexed|mesh-list
43998581|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
43998582|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
43998583|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
43998584|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
43998585|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998586|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998587|NCT02726178|Ibuprofen|ibuprofen|mesh-list
43998588|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43998589|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43998590|NCT02726178|Analgesics|analgesics|mesh-ancestor
43998591|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
43998592|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998593|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998594|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998595|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732469|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
43998596|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43998598|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998599|NCT02726620|Lidocaine|lidocaine|mesh-list
43998600|NCT02726620|Atropine|atropine|mesh-list
43998601|NCT02726620|Terlipressin|terlipressin|mesh-list
43998602|NCT02726620|Phenylephrine|phenylephrine|mesh-list
43998603|NCT02726620|Dobutamine|dobutamine|mesh-list
43998604|NCT02726620|Dopamine|dopamine|mesh-list
43998605|NCT02726620|Milrinone|milrinone|mesh-list
43998606|NCT02726620|Isoproterenol|isoproterenol|mesh-list
43998607|NCT02726620|Vasopressins|vasopressins|mesh-list
43998608|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
43998609|NCT02726620|Epinephrine|epinephrine|mesh-list
43998610|NCT02726620|Norepinephrine|norepinephrine|mesh-list
43998611|NCT02726620|Ephedrine|ephedrine|mesh-list
43998612|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
43998613|NCT02726620|Bupivacaine|bupivacaine|mesh-list
43998614|NCT02726620|Ropivacaine|ropivacaine|mesh-list
43998615|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
43998616|NCT02726620|Tetracaine|tetracaine|mesh-list
43998617|NCT02726620|Prilocaine|prilocaine|mesh-list
43998618|NCT02726620|Mepivacaine|mepivacaine|mesh-list
43998619|NCT02726620|Benzocaine|benzocaine|mesh-list
43998620|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
43998621|NCT02726620|Procaine|procaine|mesh-list
43998622|NCT02726620|Anesthetics|anesthetics|mesh-list
43998623|NCT02726620|Propofol|propofol|mesh-list
43998624|NCT02726620|Sevoflurane|sevoflurane|mesh-list
43998625|NCT02726620|Desflurane|desflurane|mesh-list
43998626|NCT02726620|Isoflurane|isoflurane|mesh-list
43998627|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43998628|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
43998629|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
43998630|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998631|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998632|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
43998633|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998634|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43998635|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43998636|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43998637|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998638|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998639|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998640|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998641|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
43998642|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43998643|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43998644|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43998645|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43998646|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
43998647|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998648|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43998649|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998650|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
43998652|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998654|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
43998655|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43998656|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44246480|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246481|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246482|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998657|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
43998658|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43998659|NCT02726620|Protective Agents|protective agents|mesh-ancestor
43998660|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998661|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
43998662|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43998663|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43998664|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
43998665|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
43998666|NCT02726620|Coagulants|coagulants|mesh-ancestor
43998667|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43998668|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
43998669|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43998670|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43998671|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43998672|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
43998673|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998674|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43998675|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43998676|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998677|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43998679|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
43998680|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
43998681|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43998682|NCT02726789|Entecavir|entecavir|mesh-list
43998683|NCT02726789|REP 2139|rep 2139|mesh-list
43998684|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998685|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
43998686|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998687|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
43998688|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998689|NCT02730247|Paclitaxel|paclitaxel|mesh-list
43998690|NCT02730247|Ramucirumab|ramucirumab|mesh-list
43998691|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43998692|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998693|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
43998694|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
43998695|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
43998696|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998697|NCT02730884|ON 01910|on 01910|mesh-list
43998698|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998699|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43998700|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998701|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998702|NCT02730962|Vancomycin|vancomycin|mesh-list
43998703|NCT02730962|Clindamycin|clindamycin|mesh-list
43998704|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
43998705|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
43998706|NCT02730962|Neomycin|neomycin|mesh-list
43998707|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998708|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998709|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43998710|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998711|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998712|NCT02731313|Trastuzumab|trastuzumab|mesh-list
43998713|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998714|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998715|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
43998716|NCT02731469|Hematinics|hematinics|mesh-ancestor
43998717|NCT02731820|Vitamin D|vitamin d|mesh-list
43998718|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
43998719|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
43998720|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
43998721|NCT02731820|Calcium|calcium|mesh-list
43998722|NCT02731820|Vitamins|vitamins|mesh-ancestor
43998723|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
43998724|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998725|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43998726|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43998727|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998728|NCT02731820|Antacids|antacids|mesh-ancestor
43998732|NCT02731820|Expectorants|expectorants|mesh-ancestor
44246483|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246484|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44246485|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44460052|NCT01570192|Meropenem|meropenem|mesh-list
44460053|NCT01570192|Linezolid|linezolid|mesh-list
44460054|NCT01570192|Tobramycin|tobramycin|mesh-list
44460055|NCT01570192|Amikacin|amikacin|mesh-list
44460056|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44460057|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460058|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43998733|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998734|NCT02731833|Fluorides|fluorides|mesh-list
43998735|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
43998736|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
43998737|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
43998738|NCT02731833|Protective Agents|protective agents|mesh-ancestor
43998739|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998740|NCT02732587|Saracatinib|saracatinib|mesh-list
43998741|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998742|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998743|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998744|NCT02732899|Sirolimus|sirolimus|mesh-list
43998745|NCT02732899|Aflibercept|aflibercept|mesh-list
43998746|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998747|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998748|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43998749|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998750|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
43998751|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998752|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
43998753|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998754|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43998755|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43998756|NCT02732899|Growth Substances|growth substances|mesh-ancestor
43998757|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
43998759|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43998760|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998761|NCT02733588|Hormones|hormones|mesh-ancestor
43998762|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998763|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998764|NCT02733588|Incretins|incretins|mesh-ancestor
43998765|NCT02733757|Clonidine|clonidine|mesh-list
43998766|NCT02733757|Analgesics|analgesics|mesh-ancestor
43998767|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
43998768|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998769|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998770|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43998771|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
43998772|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
43998773|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43998774|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43998775|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43998776|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
43998777|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998778|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998779|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
43998780|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
43998781|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998782|NCT02734147|Protective Agents|protective agents|mesh-ancestor
43998783|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998784|NCT02734147|Vitamins|vitamins|mesh-ancestor
43998785|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
43998786|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
43998787|NCT02734238|Testosterone|testosterone|mesh-list
43998788|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
43998789|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
44041057|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
43998790|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43998791|NCT02734238|Androgens|androgens|mesh-ancestor
44460059|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460060|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998792|NCT02734238|Hormones|hormones|mesh-ancestor
43998793|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998794|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998795|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998796|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998797|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
43998798|NCT02734355|Amlodipine|amlodipine|mesh-list
43998799|NCT02734355|Telmisartan|telmisartan|mesh-list
43998800|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43998801|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43998802|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43998803|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998815|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43998816|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998817|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43998818|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
43998819|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998820|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998821|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43998822|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998823|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
43998824|NCT02734953|Protective Agents|protective agents|mesh-ancestor
43998826|NCT02735187|Vitamins|vitamins|mesh-ancestor
43998827|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
43998828|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998829|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43732608|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43998830|NCT02736175|Dexamethasone|dexamethasone|mesh-list
43998831|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998832|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
43998833|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
43998834|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998835|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998836|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998837|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
43998838|NCT02736175|Hormones|hormones|mesh-ancestor
43998839|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998840|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998841|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998842|NCT02737072|Durvalumab|durvalumab|mesh-list
43998843|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43998844|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998845|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
43998846|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998847|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43998848|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998849|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998850|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
43998851|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998852|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998853|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43998854|NCT05446493|Tadalafil|tadalafil|mesh-list
43998855|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998856|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43998857|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43998858|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998859|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998860|NCT05446493|Urological Agents|urological agents|mesh-ancestor
43998861|NCT05446480|Desloratadine|desloratadine|mesh-list
43998862|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43998867|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44041129|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
43998869|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
43998870|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
43998871|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
43998872|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998873|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
43998874|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998875|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998876|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44460061|NCT01569841|Insulin|insulin|mesh-list
44460062|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44460063|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
43998877|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998878|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43998879|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
43998880|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998881|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998882|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43998883|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998884|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
43998885|NCT05446090|Protective Agents|protective agents|mesh-ancestor
43998886|NCT05445661|Mannitol|mannitol|mesh-list
43998887|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43998888|NCT05445661|Diuretics|diuretics|mesh-ancestor
43998889|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
43998890|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998891|NCT05445479|Doxycycline|doxycycline|mesh-list
43998892|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43998893|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998894|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
43998895|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43998896|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43998897|NCT05445297|Amiodarone|amiodarone|mesh-list
43998898|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43998899|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998900|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43998901|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43998902|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998903|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43732687|NCT02548806|Clonidine|clonidine|mesh-list
43998904|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43998905|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43998906|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998907|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43998908|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43998909|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43998910|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43998911|NCT05445076|Antibodies|antibodies|mesh-list
43998912|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
43998913|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43998914|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
43998915|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998916|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146111|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44146112|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146113|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146114|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44146115|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44146116|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44146117|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146118|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44146119|NCT00197444|Nedaplatin|nedaplatin|mesh-list
44146120|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146121|NCT00197483|Pergolide|pergolide|mesh-list
44146122|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
44146123|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
44146124|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146131|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146132|NCT00197548|Hematinics|hematinics|mesh-ancestor
44146133|NCT00197561|Selenium|selenium|mesh-list
44146134|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
44146135|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146136|NCT00197561|Protective Agents|protective agents|mesh-ancestor
44146137|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146138|NCT00197561|Trace Elements|trace elements|mesh-ancestor
44146139|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
44146140|NCT00197587|Nevirapine|nevirapine|mesh-list
44146141|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44146142|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146143|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830597|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44460064|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460065|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460067|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
44460068|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
44146144|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146145|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
44146146|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146147|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44146148|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44146149|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44146150|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44146151|NCT00197613|Lamivudine|lamivudine|mesh-list
44146152|NCT00197613|Zidovudine|zidovudine|mesh-list
44146153|NCT00197613|Efavirenz|efavirenz|mesh-list
44146154|NCT00197613|Nevirapine|nevirapine|mesh-list
44146155|NCT00197613|Didanosine|didanosine|mesh-list
44146156|NCT00197613|Stavudine|stavudine|mesh-list
44146157|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44146158|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146159|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146160|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146161|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
44146162|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146163|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44146164|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44146165|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
44146166|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44146167|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44146168|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44146169|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44146170|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44146171|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43998917|NCT05445024|Sufentanil|sufentanil|mesh-list
43998918|NCT05445024|Nalbuphine|nalbuphine|mesh-list
43998919|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43998920|NCT05445024|Narcotics|narcotics|mesh-ancestor
43998921|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998922|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998923|NCT05445024|Analgesics|analgesics|mesh-ancestor
43998924|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
43998925|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998926|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998927|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43998928|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
43998929|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
43998930|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
43998931|NCT05445011|Fludarabine|fludarabine|mesh-list
43998932|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
43998933|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998934|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
43998935|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998936|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43998937|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43998938|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
43998941|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43998942|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43998943|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
43998944|NCT05444998|Paclitaxel|paclitaxel|mesh-list
43998945|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43998946|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998947|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
43998948|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
43998949|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
43998950|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998951|NCT05444946|Itraconazole|itraconazole|mesh-list
43998952|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43998953|NCT05444946|Prednisone|prednisone|mesh-list
43998954|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998955|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
43998956|NCT05444946|Hormones|hormones|mesh-ancestor
43816885|NCT03660488|Penicillin G|penicillin g|mesh-list
44460069|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460070|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460071|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998957|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998958|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998959|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43998960|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998961|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
43998962|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43998963|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43998964|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43998965|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998966|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998967|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43998968|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
43998969|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43998970|NCT05444842|Insulin|insulin|mesh-list
43998971|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43998972|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43998973|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998974|NCT05444751|Anesthetics|anesthetics|mesh-list
43998975|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
43998976|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998977|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998978|NCT05444738|Oxytocin|oxytocin|mesh-list
43998979|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
43998980|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43998981|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998982|NCT05444673|Cisplatin|cisplatin|mesh-list
43998983|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998984|NCT05444543|Fluticasone|fluticasone|mesh-list
43998985|NCT05444543|Xhance|xhance|mesh-list
43998986|NCT05444543|Budesonide|budesonide|mesh-list
43998987|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43998988|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998989|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
43998990|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998991|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998992|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44146172|NCT00197639|Ritonavir|ritonavir|mesh-list
43998993|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
43998994|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
43998995|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43998996|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
43998997|NCT05444543|Hormones|hormones|mesh-ancestor
43998998|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43998999|NCT05444452|Sirolimus|sirolimus|mesh-list
43999000|NCT05444452|Everolimus|everolimus|mesh-list
43999001|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999002|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999003|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
43999004|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999005|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999006|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999007|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999008|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
43999009|NCT05444374|Bevacizumab|bevacizumab|mesh-list
43999010|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999011|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999019|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999020|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999021|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43999022|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43999023|NCT05444088|Bevacizumab|bevacizumab|mesh-list
43999024|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999025|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999026|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43999027|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43999028|NCT05444088|Growth Substances|growth substances|mesh-ancestor
43999029|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999030|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
43999031|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
44460072|NCT01569295|Rituximab|rituximab|mesh-list
44460073|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44460074|NCT01569295|Idelalisib|idelalisib|mesh-list
44460075|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999032|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43999033|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43999034|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999035|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43999036|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999037|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43999038|NCT05443932|Diuretics|diuretics|mesh-ancestor
43999039|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
43999040|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43999041|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999042|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43999043|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999044|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999045|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
43999046|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
43999047|NCT05443360|Calcium|calcium|mesh-list
43999048|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43999049|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999050|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43999051|NCT05443360|Antacids|antacids|mesh-ancestor
43999052|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999053|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999054|NCT05443308|Acetazolamide|acetazolamide|mesh-list
43999055|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
43999056|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43999057|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999058|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999059|NCT05443308|Diuretics|diuretics|mesh-ancestor
43999060|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
43999061|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999062|NCT05443282|Hormones|hormones|mesh-list
43999063|NCT05443282|Estradiol|estradiol|mesh-list
43999064|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43999065|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732858|NCT02547870|Rilpivirine|rilpivirine|mesh-list
43999066|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999067|NCT05443282|Estrogens|estrogens|mesh-ancestor
43999068|NCT05443178|Isoniazid|isoniazid|mesh-list
43999069|NCT05443178|Ethambutol|ethambutol|mesh-list
43999070|NCT05443178|Chloroquine|chloroquine|mesh-list
43999071|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
43999072|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999073|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999074|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999075|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43999076|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43999077|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
43999078|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43999083|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999084|NCT05442996|Antibodies|antibodies|mesh-list
43999085|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
43999086|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43999087|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
43999088|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999089|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
43999090|NCT05442931|Pregabalin|pregabalin|mesh-list
43999091|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
43999092|NCT05442931|Analgesics|analgesics|mesh-ancestor
43999093|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
43999094|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999095|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999096|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
43999097|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43999098|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999099|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999100|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43999101|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43999102|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460076|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460077|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
44460078|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460079|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460080|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44460081|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
43999103|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999104|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43999105|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
43999106|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43999107|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
43999108|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43999109|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
43999110|NCT05442801|Tropicamide|tropicamide|mesh-list
43999111|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
43999112|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
43999113|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
43999114|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999115|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999116|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43999117|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43999118|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
43999119|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999120|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999121|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
43999122|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
43999123|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999124|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999125|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43999126|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999127|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999128|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999129|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999130|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43999131|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43999132|NCT05442411|Parecoxib|parecoxib|mesh-list
43999133|NCT05442411|Ropivacaine|ropivacaine|mesh-list
43999134|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
43999135|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
43999136|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999137|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999138|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
43999139|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999140|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43999141|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43999142|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146173|NCT00197639|Indinavir|indinavir|mesh-list
43999143|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999144|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43999145|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999147|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999148|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999149|NCT05441150|Ketamine|ketamine|mesh-list
43999150|NCT05441150|Analgesics|analgesics|mesh-ancestor
43999151|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
43999154|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43999156|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
43999157|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
43999158|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999159|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43999160|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43999161|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999162|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146174|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44146175|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44146176|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
44146177|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146178|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460082|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460083|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460084|NCT01569152|Methotrexate|methotrexate|mesh-list
44146179|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44146180|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44146181|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
44146182|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146183|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44146184|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44146185|NCT00197730|Folic Acid|folic acid|mesh-list
44146186|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
44146187|NCT00197730|Vitamins|vitamins|mesh-ancestor
44146188|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
44146189|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146190|NCT00197730|Hematinics|hematinics|mesh-ancestor
44146191|NCT00197743|Vitamin A|vitamin a|mesh-list
44146192|NCT00197743|Beta Carotene|beta carotene|mesh-list
44146193|NCT00197743|Carotenoids|carotenoids|mesh-list
44146194|NCT00197743|Vitamins|vitamins|mesh-ancestor
44146195|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
44146196|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146197|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
44146198|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146199|NCT00197743|Protective Agents|protective agents|mesh-ancestor
44146200|NCT00197743|Provitamins|provitamins|mesh-ancestor
44146201|NCT00197756|Vitamins|vitamins|mesh-list
44146202|NCT00197756|Vitamin A|vitamin a|mesh-list
44146203|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
44146204|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
44146205|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146206|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
44146207|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146208|NCT00197756|Protective Agents|protective agents|mesh-ancestor
44146209|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44146210|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146211|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44146212|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
44146213|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146214|NCT00197834|Valproic Acid|valproic acid|mesh-list
44146215|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
44146216|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146217|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146218|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
44146219|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146220|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146221|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
44146222|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146223|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146224|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146225|NCT00197886|Norepinephrine|norepinephrine|mesh-list
44146226|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44146227|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44146228|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44146229|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999163|NCT05439993|Paclitaxel|paclitaxel|mesh-list
43999164|NCT05439993|Tepotinib|tepotinib|mesh-list
43999165|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43999166|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999167|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
43999168|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999169|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999176|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999178|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
43999179|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999180|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43999181|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43999182|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43999183|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
43999184|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999185|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999186|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43999187|NCT05439564|Narcotics|narcotics|mesh-ancestor
43999188|NCT05439499|Letrozole|letrozole|mesh-list
43999189|NCT05439499|Anastrozole|anastrozole|mesh-list
43999190|NCT05439499|Goserelin|goserelin|mesh-list
44460085|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44460086|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
43999191|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999192|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43999193|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43999194|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999195|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999196|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43999197|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
43999198|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999199|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999200|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999201|NCT05438810|Fulvestrant|fulvestrant|mesh-list
43999202|NCT05438810|Goserelin|goserelin|mesh-list
43999203|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999204|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999205|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43999206|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43999207|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
43999208|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999209|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999210|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
43999211|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43999212|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43999213|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999214|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
43999215|NCT05437822|Coagulants|coagulants|mesh-ancestor
43999216|NCT05437601|Carotenoids|carotenoids|mesh-list
43999217|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
43999218|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999219|NCT05437601|Protective Agents|protective agents|mesh-ancestor
43999220|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999221|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
44041607|NCT00002785|Cobalt|cobalt|mesh-list
43999222|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43999223|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43999224|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999225|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
43999226|NCT05434533|Coagulants|coagulants|mesh-ancestor
43999227|NCT05434065|Celecoxib|celecoxib|mesh-list
43999228|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43999229|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999230|NCT05434065|Analgesics|analgesics|mesh-ancestor
43999231|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
43999232|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999233|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999234|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999235|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999236|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43999239|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999240|NCT05432843|Pregabalin|pregabalin|mesh-list
43999241|NCT05432843|Analgesics|analgesics|mesh-ancestor
43999242|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
43999243|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999244|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999245|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
43999246|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43999247|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999248|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999249|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43999250|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43999251|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43999252|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999253|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43999254|NCT05432089|Oxytocin|oxytocin|mesh-list
43999255|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
43999256|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43999257|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999258|NCT05429866|Nivolumab|nivolumab|mesh-list
43999259|NCT05429866|Durvalumab|durvalumab|mesh-list
43999260|NCT05429866|Avelumab|avelumab|mesh-list
43999261|NCT05429866|Cemiplimab|cemiplimab|mesh-list
43999262|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44460087|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44460088|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138205|NCT00170664|Paclitaxel|paclitaxel|mesh-list
44460089|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246487|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44246488|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44246489|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246490|NCT03832998|Analgesics|analgesics|mesh-ancestor
44246491|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
44246492|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246493|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246494|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
44246495|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
44246496|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246497|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246498|NCT03823534|Acetaminophen|acetaminophen|mesh-list
44246499|NCT03823534|Ketorolac|ketorolac|mesh-list
44246500|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44246501|NCT03823534|Morphine|morphine|mesh-list
44246502|NCT03823534|Oxycodone|oxycodone|mesh-list
44246503|NCT03823534|Hydrocodone|hydrocodone|mesh-list
44246504|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44246505|NCT03823534|Narcotics|narcotics|mesh-ancestor
44246506|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44246507|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246508|NCT03823534|Analgesics|analgesics|mesh-ancestor
43999263|NCT05429866|Atezolizumab|atezolizumab|mesh-list
43999264|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999265|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999266|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999267|NCT05429814|Menthol|menthol|mesh-list
43999268|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
43999269|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
43999270|NCT05428969|Azacitidine|azacitidine|mesh-list
43999271|NCT05428969|Venetoclax|venetoclax|mesh-list
43999272|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43999273|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
43999274|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999275|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999276|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999277|NCT05424523|Omalizumab|omalizumab|mesh-list
43999278|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43999279|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43999280|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
43999281|NCT05423340|Nicotine|nicotine|mesh-list
43999282|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43999283|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
43999284|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999285|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246509|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
44246510|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246511|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44246512|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
44246513|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44246514|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246515|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246516|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44246517|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246518|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246519|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
43999286|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43999287|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43999288|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
43999289|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999290|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999292|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
43999293|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999294|NCT05407961|Dulaglutide|dulaglutide|mesh-list
43999295|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43999296|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999297|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
43999298|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43999299|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999300|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999301|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
43999302|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999303|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999304|NCT05401097|Azacitidine|azacitidine|mesh-list
43999305|NCT05401097|Venetoclax|venetoclax|mesh-list
43999306|NCT05401097|Ivosidenib|ivosidenib|mesh-list
43999307|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43999308|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
43999309|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999310|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999311|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999315|NCT05387811|Diuretics|diuretics|mesh-list
43999316|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
43999317|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999318|NCT05351762|Paclitaxel|paclitaxel|mesh-list
43999319|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
43999320|NCT05351762|Nedaplatin|nedaplatin|mesh-list
43999321|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43999322|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999323|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
43999324|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999325|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999326|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041751|NCT00002790|Sirolimus|sirolimus|mesh-list
43999327|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999328|NCT05340673|Petrolatum|petrolatum|mesh-list
43999329|NCT05340673|Mineral Oil|mineral oil|mesh-list
43999330|NCT05340673|Emollients|emollients|mesh-ancestor
43999331|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
43999332|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43999333|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999334|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999335|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
43999336|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43999337|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43999338|NCT05339542|Prednisolone|prednisolone|mesh-list
43999339|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
43999340|NCT05339542|Lidocaine|lidocaine|mesh-list
43999341|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43999342|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
44246520|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44246522|NCT03814005|Docetaxel|docetaxel|mesh-list
44246523|NCT03814005|Carboplatin|carboplatin|mesh-list
44246524|NCT03814005|Azacitidine|azacitidine|mesh-list
44246525|NCT03814005|Pevonedistat|pevonedistat|mesh-list
44246526|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246527|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246528|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246529|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999343|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
43999344|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
43999345|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999346|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999347|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
43999348|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999349|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43999350|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43999351|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43999352|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999353|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999354|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999355|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
43999356|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
43999357|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999358|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
43999359|NCT05339542|Hormones|hormones|mesh-ancestor
43999360|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999361|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43999362|NCT05339542|Protective Agents|protective agents|mesh-ancestor
43999363|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999364|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999365|NCT05339373|Aceclofenac|aceclofenac|mesh-list
43999366|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43999367|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999368|NCT05339373|Analgesics|analgesics|mesh-ancestor
43999369|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
43999370|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999371|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999372|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999373|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999374|NCT05335252|Dronabinol|dronabinol|mesh-list
43999375|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
43999376|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999377|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43999378|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999379|NCT05335252|Analgesics|analgesics|mesh-ancestor
43999380|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
43999381|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999382|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43999383|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44157742|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999389|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43999390|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
43999391|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999392|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999393|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43999394|NCT05303636|Diuretics|diuretics|mesh-ancestor
43999395|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
43999396|NCT05278715|Carboplatin|carboplatin|mesh-list
43999397|NCT05278715|Vincristine|vincristine|mesh-list
43999398|NCT05278715|Endostatins|endostatins|mesh-list
43999399|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999400|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246530|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246531|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246532|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246533|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
43999401|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
43999402|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999403|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999404|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999405|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43999406|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43999407|NCT05278715|Growth Substances|growth substances|mesh-ancestor
43999408|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999409|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
43999410|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43999411|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
43999412|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43999413|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999414|NCT05266404|Incretins|incretins|mesh-ancestor
43999415|NCT05266404|Hormones|hormones|mesh-ancestor
43999416|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999417|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43999418|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
43999419|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999420|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999421|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43999422|NCT05266027|Nalbuphine|nalbuphine|mesh-list
43999423|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43999424|NCT05266027|Narcotics|narcotics|mesh-ancestor
43999425|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999426|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999427|NCT05266027|Analgesics|analgesics|mesh-ancestor
43999428|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
43999429|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999430|NCT05261672|Midazolam|midazolam|mesh-list
43999431|NCT05261672|Bupivacaine|bupivacaine|mesh-list
43999432|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
43999433|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
43999434|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999435|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999436|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
43999437|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999438|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43999439|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43999440|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43999441|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43999442|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43999443|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43999444|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
43999445|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
43999446|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
43999447|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999448|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999449|NCT05257018|Doxorubicin|doxorubicin|mesh-list
43999450|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999451|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999455|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999456|NCT05248984|Ketorolac|ketorolac|mesh-list
43999457|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43999458|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999459|NCT05248984|Analgesics|analgesics|mesh-ancestor
43999460|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
43999461|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733226|NCT02545231|Pitavastatin|pitavastatin|mesh-list
43999462|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999463|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999464|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999465|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43999466|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246534|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246535|NCT03809481|Danaparoid|danaparoid|mesh-list
44246536|NCT03809481|Argatroban|argatroban|mesh-list
44246537|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
44246538|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44246539|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
44246540|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999467|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999469|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
43999470|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
43999471|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999472|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999473|NCT05215925|Carboplatin|carboplatin|mesh-list
43999474|NCT05215925|Docetaxel|docetaxel|mesh-list
43999475|NCT05215925|Pemetrexed|pemetrexed|mesh-list
43999476|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999477|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
43999478|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999479|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999480|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999481|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999482|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43999483|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43999484|NCT05175235|Nivolumab|nivolumab|mesh-list
43999485|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999486|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999487|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43999488|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999489|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43999490|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43999491|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43999492|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999493|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999494|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
43999495|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999496|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999497|NCT05145400|Dexamethasone|dexamethasone|mesh-list
43999498|NCT05145400|Lenalidomide|lenalidomide|mesh-list
43999499|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999500|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
43999501|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
43999502|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999503|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999504|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999505|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
43999506|NCT05145400|Hormones|hormones|mesh-ancestor
43999507|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999508|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999509|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999510|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
43999511|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43999512|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44041940|NCT00002801|Leucovorin|leucovorin|mesh-list
43999513|NCT05145400|Growth Substances|growth substances|mesh-ancestor
43999514|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
43999515|NCT05122494|Capecitabine|capecitabine|mesh-list
43999516|NCT05122494|Lapatinib|lapatinib|mesh-list
43999517|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43999518|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
43999519|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999520|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999521|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43999522|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999525|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999526|NCT05109143|Analgesics|analgesics|mesh-ancestor
43999527|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
43999528|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999529|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246541|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246542|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
44246543|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44246544|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44246545|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44246546|NCT03792841|Etanercept|etanercept|mesh-list
44246547|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
44246548|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43645580|NCT03924323|Citalopram|citalopram|mesh-list
43999530|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999531|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999532|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
43999533|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
43999534|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43999535|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43999536|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999537|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999538|NCT05107427|Avelumab|avelumab|mesh-list
43999539|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999540|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146230|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146231|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146232|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
44146233|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
44146234|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146235|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44146236|NCT00197912|Celecoxib|celecoxib|mesh-list
44146237|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
44146238|NCT00197912|Interleukin-2|interleukin-2|mesh-list
44146239|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
44146240|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146241|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146242|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146243|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146244|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
44146245|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146246|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146247|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146248|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44146249|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44146250|NCT00197912|Analgesics|analgesics|mesh-ancestor
44146251|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
44146252|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146253|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146254|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44146255|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44146256|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146257|NCT00198055|Aripiprazole|aripiprazole|mesh-list
44146258|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
44146259|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146260|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44146261|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146262|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146263|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146264|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
44146265|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
44146266|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146267|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146268|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44146269|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44146270|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
44146271|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44146272|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44146273|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44146274|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44246549|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246550|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246551|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44246552|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44246553|NCT03792841|Analgesics|analgesics|mesh-ancestor
44246554|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
44146276|NCT00198094|Sertraline|sertraline|mesh-list
44146277|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
44146278|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146279|NCT00198094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44146280|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44146281|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44146282|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146283|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146293|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44146294|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146295|NCT00198120|Renal Agents|renal agents|mesh-ancestor
44146296|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44146297|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
44146298|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999541|NCT05063604|Citalopram|citalopram|mesh-list
43999542|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43999543|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43999544|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999545|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999546|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999547|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
43999548|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999549|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43999550|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
43999551|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43999552|NCT05052957|Temozolomide|temozolomide|mesh-list
43999553|NCT05052957|Carmustine|carmustine|mesh-list
43999554|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
43999555|NCT05052957|Lenograstim|lenograstim|mesh-list
43999556|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43999557|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
43999558|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999559|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43999560|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
43999561|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999562|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999563|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999564|NCT05049226|Vaccines|vaccines|mesh-list
43999565|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
43999566|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999567|NCT05044936|Cannabidiol|cannabidiol|mesh-list
43999568|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
43999569|NCT05023993|Niacinamide|niacinamide|mesh-list
43999571|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
43999572|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
43999573|NCT05023993|Vitamins|vitamins|mesh-ancestor
43999574|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
43999575|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042080|NCT00002809|Tacrolimus|tacrolimus|mesh-list
43999576|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43999577|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
43999578|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999579|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43999580|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
43999581|NCT05020145|Vaccines|vaccines|mesh-list
43999582|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
43999583|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999584|NCT05005000|Triamcinolone|triamcinolone|mesh-list
43999585|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43999586|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43999587|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43999588|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999589|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
43999590|NCT05005000|Hormones|hormones|mesh-ancestor
44246555|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246556|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246557|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246558|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246559|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43645591|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
43999591|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999592|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999593|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999594|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
43999597|NCT05002114|Cannabidiol|cannabidiol|mesh-list
43999598|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
43999599|NCT04978428|Cannabidiol|cannabidiol|mesh-list
43999600|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
43999601|NCT04976595|Testosterone|testosterone|mesh-list
43999602|NCT04976595|Androgens|androgens|mesh-ancestor
43999603|NCT04976595|Hormones|hormones|mesh-ancestor
43999604|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999605|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999606|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
43999607|NCT04973566|Etanercept|etanercept|mesh-list
43999608|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
43999609|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43999610|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43999611|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999612|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999613|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999614|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999615|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43733403|NCT02544282|Tramadol|tramadol|mesh-list
43999616|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999617|NCT04973566|Analgesics|analgesics|mesh-ancestor
43999618|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
43999619|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999620|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999621|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999622|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999623|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999624|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
43999625|NCT04968054|Propofol|propofol|mesh-list
43999626|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43999627|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999628|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999629|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43999630|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
43999631|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
43999632|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
43999633|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43999634|NCT04947020|Metformin|metformin|mesh-list
43999635|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43999636|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999637|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
43999638|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43999639|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
43999640|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999641|NCT04915508|Hormones|hormones|mesh-list
43999642|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042143|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999643|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999644|NCT04898920|Dexamethasone|dexamethasone|mesh-list
43999645|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999646|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
43999647|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
43999648|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999649|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999650|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999651|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
43999652|NCT04898920|Hormones|hormones|mesh-ancestor
43999653|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999654|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999655|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246560|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246561|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
44246562|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246564|NCT03762564|Ramucirumab|ramucirumab|mesh-list
44246565|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246566|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246567|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246568|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246569|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246570|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246571|NCT03749187|Temozolomide|temozolomide|mesh-list
43999656|NCT04880395|Lamivudine|lamivudine|mesh-list
43999657|NCT04880395|Emtricitabine|emtricitabine|mesh-list
43999658|NCT04880395|Dolutegravir|dolutegravir|mesh-list
43999659|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43999660|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43999661|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999662|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999663|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
43999664|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999665|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43999666|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43999667|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43999674|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999675|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999676|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43999677|NCT04821817|Rocuronium|rocuronium|mesh-list
43999678|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43999679|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43999680|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43999681|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999682|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999683|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
43999684|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43999685|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999686|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43999687|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999688|NCT04780464|Prednisone|prednisone|mesh-list
43999689|NCT04780464|Prednisolone|prednisolone|mesh-list
43999690|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
43999691|NCT04780464|Doxorubicin|doxorubicin|mesh-list
43999692|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43999693|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999694|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
43999695|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999696|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999697|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43999698|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
43999699|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999700|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999701|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43999702|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999703|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43999704|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999705|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999706|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999707|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
43999708|NCT04780464|Hormones|hormones|mesh-ancestor
43999709|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999710|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999711|NCT04772235|Osimertinib|osimertinib|mesh-list
44246572|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44246573|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246574|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
44246575|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246576|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246577|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246578|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
44246579|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44246580|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
44246581|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44246582|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
44246583|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246584|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246585|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
44246586|NCT03733132|Metformin|metformin|mesh-list
44246587|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44246588|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246589|NCT03711279|Apatinib|apatinib|mesh-list
44246590|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246591|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246592|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645606|NCT03911739|Narcotics|narcotics|mesh-ancestor
43999712|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999713|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43999714|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999715|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999716|NCT04770155|Bosentan|bosentan|mesh-list
43999717|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
43999718|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
43999719|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43999720|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43999721|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999722|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999723|NCT04770155|Urological Agents|urological agents|mesh-ancestor
43999724|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43999725|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43999726|NCT04766463|Morphine|morphine|mesh-list
43999727|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43999728|NCT04766463|Narcotics|narcotics|mesh-ancestor
43999729|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999730|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999731|NCT04766463|Analgesics|analgesics|mesh-ancestor
43999732|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
43999733|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999734|NCT04744181|Folic Acid|folic acid|mesh-list
43999735|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
43999736|NCT04744181|Vitamins|vitamins|mesh-ancestor
43999737|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
43999745|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999746|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999747|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43999748|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
43999749|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44246593|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246594|NCT03709017|Ponatinib|ponatinib|mesh-list
44246595|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246596|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246597|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999750|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999751|NCT04704453|Analgesics|analgesics|mesh-ancestor
43999752|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43999753|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43999754|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999755|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999756|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
43999757|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999758|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
43999759|NCT04700761|Anesthetics|anesthetics|mesh-list
43999760|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44042292|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
43999761|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999762|NCT04700761|Narcotics|narcotics|mesh-ancestor
43999763|NCT04700761|Analgesics|analgesics|mesh-ancestor
43999764|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
43999765|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146299|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
44146300|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999766|NCT04670432|Troxerutin|troxerutin|mesh-list
43999767|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
43999768|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
43999769|NCT04661852|Topotecan|topotecan|mesh-list
43999770|NCT04661852|Mitogens|mitogens|mesh-list
43999771|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999772|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
43999773|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999774|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999775|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43999776|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
43999777|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999778|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999779|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43999780|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43999781|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999782|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999783|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999784|NCT04652193|Anesthetics|anesthetics|mesh-list
43999785|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999786|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999787|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
43999788|NCT04651088|Diuretics|diuretics|mesh-ancestor
43999789|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
43999790|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999791|NCT04651088|Expectorants|expectorants|mesh-ancestor
43999792|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
43999793|NCT04635839|Heparin|heparin|mesh-list
43999794|NCT04635839|Calcium heparin|calcium heparin|mesh-list
43999795|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
43999796|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43999797|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43999798|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999799|NCT04635826|Adderall|adderall|mesh-list
43999800|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43999801|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999802|NCT04595617|Antibodies|antibodies|mesh-list
43999803|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
43999804|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999805|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
43999812|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999813|NCT04562792|Daunorubicin|daunorubicin|mesh-list
43999814|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999815|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999816|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43999817|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999818|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999821|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999822|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999840|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43999841|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44146301|NCT00198146|Daclizumab|daclizumab|mesh-list
43999842|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999843|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999844|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43999845|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999846|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
43999847|NCT04537793|Ivacaftor|ivacaftor|mesh-list
43999848|NCT04537793|Elexacaftor|elexacaftor|mesh-list
43999849|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43999850|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44042371|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
43999851|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999852|NCT04523701|SMOFlipid|smoflipid|mesh-list
43999853|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43999854|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43999855|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43999856|NCT04521348|Antibodies|antibodies|mesh-list
43999857|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
43999858|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
43999859|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999860|NCT04495608|Fluconazole|fluconazole|mesh-list
43999861|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
43999862|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999863|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43999864|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43999865|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999866|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246609|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
44246610|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
44246611|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246612|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44246614|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44246615|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
44246616|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44246617|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
44246618|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246619|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246620|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
44246621|NCT03691090|Paclitaxel|paclitaxel|mesh-list
44246622|NCT03691090|Cisplatin|cisplatin|mesh-list
44246623|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246624|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246625|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246626|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999867|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43999868|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
43999869|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999870|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999871|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43999874|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43999875|NCT04458545|Narcotics|narcotics|mesh-ancestor
43999876|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999877|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999878|NCT04458545|Analgesics|analgesics|mesh-ancestor
43999879|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
43999880|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999882|NCT04408625|Prednisone|prednisone|mesh-list
43999883|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
43999885|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999886|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999887|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
43999888|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999889|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999890|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999891|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
43999892|NCT04408625|Hormones|hormones|mesh-ancestor
43999893|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999894|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999895|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999896|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999897|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999898|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
43999899|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999900|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
43999901|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
43999902|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999903|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43999904|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43999905|NCT04408625|Protective Agents|protective agents|mesh-ancestor
43999906|NCT04395508|Trastuzumab|trastuzumab|mesh-list
43999907|NCT04395508|Pertuzumab|pertuzumab|mesh-list
43999908|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43999909|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999910|NCT04375605|Leucovorin|leucovorin|mesh-list
43999911|NCT04375605|Docetaxel|docetaxel|mesh-list
44246627|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246628|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246629|NCT03683433|Azacitidine|azacitidine|mesh-list
44246630|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246631|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
44246632|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246633|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246634|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246635|NCT03679546|Infliximab|infliximab|mesh-list
44246636|NCT03679546|Vedolizumab|vedolizumab|mesh-list
44246637|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
44246638|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246639|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246640|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
44246641|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44246642|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
44246643|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246644|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246645|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44246646|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44246647|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43999912|NCT04375605|Fluorouracil|fluorouracil|mesh-list
43999913|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
43999914|NCT04375605|Calcium|calcium|mesh-list
43999915|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
43999916|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999917|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
43999918|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
43999919|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
43999920|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999921|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43999922|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999923|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
43999924|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43999925|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43999926|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
43999927|NCT04375605|Antidotes|antidotes|mesh-ancestor
43999928|NCT04375605|Protective Agents|protective agents|mesh-ancestor
43999929|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
43999930|NCT04375605|Vitamins|vitamins|mesh-ancestor
43999931|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
43999932|NCT04356690|Etoposide|etoposide|mesh-list
43999933|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43999934|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999935|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43999936|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999937|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999938|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999939|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
43999940|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43999941|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43999942|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999943|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
43999944|NCT04344860|Coagulants|coagulants|mesh-ancestor
43999945|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
44246648|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
44246649|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246650|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246651|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44246652|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
44246653|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
44246654|NCT03679312|Protective Agents|protective agents|mesh-ancestor
44246655|NCT03678883|Gemcitabine|gemcitabine|mesh-list
44246656|NCT03678883|Paclitaxel|paclitaxel|mesh-list
44246657|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44246658|NCT03678883|Carboplatin|carboplatin|mesh-list
44246659|NCT03678883|Doxorubicin|doxorubicin|mesh-list
44246660|NCT03678883|Irinotecan|irinotecan|mesh-list
44246661|NCT03678883|Lomustine|lomustine|mesh-list
44042512|NCT00002835|Methotrexate|methotrexate|mesh-list
44246662|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246663|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246664|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246665|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246666|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246667|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246668|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246669|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
44246670|NCT03678883|Antiviral Agents|antiviral agents|mesh-ancestor
44246671|NCT03678883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246672|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246673|NCT03678883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246674|NCT03678883|Immunologic Factors|immunologic factors|mesh-ancestor
44246675|NCT03678883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246676|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43999946|NCT04344184|Vitamins|vitamins|mesh-ancestor
43999947|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
43999948|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999953|NCT04315948|Ritonavir|ritonavir|mesh-list
43999954|NCT04315948|Lopinavir|lopinavir|mesh-list
43999955|NCT04315948|Interferon-beta|interferon-beta|mesh-list
43999956|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
43999957|NCT04315948|Remdesivir|remdesivir|mesh-list
43999958|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
43999959|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999960|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
43999961|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999962|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43999963|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43999964|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
43999965|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999966|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999967|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43999968|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43845431|NCT04279054|Analgesics|analgesics|mesh-ancestor
44246678|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44246679|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44246680|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246681|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
44246682|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44246683|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246684|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246685|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246686|NCT03667313|Sirolimus|sirolimus|mesh-list
44246687|NCT03667313|Paclitaxel|paclitaxel|mesh-list
44246688|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44246689|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246690|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246691|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246692|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246693|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246694|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44246695|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246696|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44246697|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
44246698|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246699|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
44246700|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246701|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
44246702|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042588|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246703|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246704|NCT03661723|Bevacizumab|bevacizumab|mesh-list
44246705|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
44246706|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246707|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246708|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44246709|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43999969|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43999970|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43999971|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
43999972|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43999973|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43999974|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999975|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
44246710|NCT03661723|Growth Substances|growth substances|mesh-ancestor
44246711|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246712|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44246714|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44246715|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44246716|NCT03643133|Mifamurtide|mifamurtide|mesh-list
44246717|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44246718|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
44246719|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246720|NCT03639935|Nivolumab|nivolumab|mesh-list
44246721|NCT03639935|Rucaparib|rucaparib|mesh-list
44246722|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246723|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246724|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44246725|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246726|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44246727|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246728|NCT03637543|Nivolumab|nivolumab|mesh-list
44246729|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246730|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246731|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43999976|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999977|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43999978|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
43999979|NCT04306965|Apremilast|apremilast|mesh-list
43999980|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43999981|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43999982|NCT04306965|Analgesics|analgesics|mesh-ancestor
43999983|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
43999984|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999985|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999986|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43999987|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43999988|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43999989|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43999990|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733741|NCT04292470|Amitriptyline|amitriptyline|mesh-list
43999991|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999992|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43999993|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43999994|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43999995|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999996|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
43999997|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999998|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999999|NCT04265053|Ketorolac|ketorolac|mesh-list
44000000|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44000001|NCT04265053|Estradiol|estradiol|mesh-list
44000002|NCT04265053|Testosterone|testosterone|mesh-list
44000003|NCT04265053|Ganirelix|ganirelix|mesh-list
44000004|NCT04265053|Estrogens|estrogens|mesh-ancestor
44000005|NCT04265053|Hormones|hormones|mesh-ancestor
44042646|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000006|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246732|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246733|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
44246734|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44246735|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44246736|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
44246737|NCT03624036|Fludarabine|fludarabine|mesh-list
44246738|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246739|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
44246740|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246741|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246742|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000007|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000008|NCT04265053|Androgens|androgens|mesh-ancestor
44000009|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44000010|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000011|NCT04265053|Analgesics|analgesics|mesh-ancestor
44000012|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
44000013|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000014|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000015|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000016|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44000017|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000018|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000019|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000021|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44000022|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
44000023|NCT04238624|Trametinib|trametinib|mesh-list
44000024|NCT04238624|Dabrafenib|dabrafenib|mesh-list
44000025|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000026|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000027|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000028|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146302|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146303|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
44146304|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146305|NCT00198159|Gefitinib|gefitinib|mesh-list
44146306|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146307|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146308|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146309|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146310|NCT00198172|Cisplatin|cisplatin|mesh-list
44146311|NCT00198172|Epirubicin|epirubicin|mesh-list
44146312|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146313|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146314|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146315|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146316|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146317|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146318|NCT00198198|Aripiprazole|aripiprazole|mesh-list
44146319|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
44146320|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146321|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44146322|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146323|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146324|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146325|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
44146326|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
44146327|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146328|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146329|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44146330|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44146331|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
44146332|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44246744|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246745|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246746|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44246747|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
44246748|NCT03602235|Melphalan|melphalan|mesh-list
44246749|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246750|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
44042715|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44246751|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246752|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645779|NCT03781700|Hormones|hormones|mesh-ancestor
44146333|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44146334|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44146335|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44146336|NCT00198237|Docetaxel|docetaxel|mesh-list
44146337|NCT00198237|Capecitabine|capecitabine|mesh-list
44146338|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146339|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146340|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146341|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000029|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
44000030|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44000031|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000032|NCT04134442|Bupivacaine|bupivacaine|mesh-list
44000033|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
44000034|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
44000035|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000036|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000037|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
44000038|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000039|NCT04130438|Nebivolol|nebivolol|mesh-list
44000040|NCT04130438|Diltiazem|diltiazem|mesh-list
44000041|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000042|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000043|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44000044|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44000045|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000046|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000047|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000048|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000049|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000050|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44000051|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000052|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44000053|NCT04127578|Sirolimus|sirolimus|mesh-list
44000057|NCT04127578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000058|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000059|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
44000060|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000061|NCT04127578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000062|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000063|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
44000065|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000066|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000067|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000068|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000069|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44000070|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
44000071|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000072|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
44000073|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
44000074|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000075|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246753|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44246754|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246756|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246757|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
44246758|NCT03602235|Protective Agents|protective agents|mesh-ancestor
44246759|NCT03602235|Vitamins|vitamins|mesh-ancestor
44246760|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
44246761|NCT03596645|Golimumab|golimumab|mesh-list
44246762|NCT03596645|Infliximab|infliximab|mesh-list
44000076|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44000077|NCT04127578|Protective Agents|protective agents|mesh-ancestor
44000078|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
44000079|NCT04103476|Estrogens|estrogens|mesh-list
44000080|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44000081|NCT04103476|Hormones|hormones|mesh-ancestor
44000082|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000083|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000084|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44000085|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44000086|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000087|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44000088|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44000089|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000090|NCT04063124|Dasatinib|dasatinib|mesh-list
44000091|NCT04063124|Quercetin|quercetin|mesh-list
44000092|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000093|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000094|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000095|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000096|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
44000097|NCT04063124|Protective Agents|protective agents|mesh-ancestor
44000098|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000099|NCT04048850|Grazoprevir|grazoprevir|mesh-list
44000100|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44000101|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
43733813|NCT03955861|Adalimumab|adalimumab|mesh-list
44000102|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000103|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
44000104|NCT04048161|Tacrolimus|tacrolimus|mesh-list
44000105|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000106|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
44000107|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000108|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44000109|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000110|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000111|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44000112|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000113|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44000114|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
44000115|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000116|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000117|NCT04036435|BMS-986165|bms-986165|mesh-list
44000118|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44000119|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000120|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000121|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000122|NCT04023331|Copper|copper|mesh-list
44000123|NCT04023331|Trace Elements|trace elements|mesh-ancestor
44000124|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
44000125|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000126|NCT04017468|Vancomycin|vancomycin|mesh-list
44000133|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000134|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
44000135|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000136|NCT03974217|Talazoparib|talazoparib|mesh-list
44000137|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44000138|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246763|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
44246764|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246765|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246766|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44246767|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246768|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246769|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
44246770|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000139|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000140|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000141|NCT03965091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44000142|NCT03965091|Immunologic Factors|immunologic factors|mesh-ancestor
44000143|NCT03965091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000145|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44000146|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000147|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000148|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
44000149|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000150|NCT03889106|Ribavirin|ribavirin|mesh-list
44000151|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
44000152|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000153|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
44000154|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000155|NCT03833921|Prednisone|prednisone|mesh-list
44000156|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
44000157|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000158|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
44000159|NCT03833921|Hormones|hormones|mesh-ancestor
44000160|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000161|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000162|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000163|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000164|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44000165|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000166|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000167|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000168|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44000169|NCT03816982|Bupivacaine|bupivacaine|mesh-list
44000170|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
44000171|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
44000172|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000173|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000174|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
44000175|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000176|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
44157743|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
43733854|NCT02543710|Taxane|taxane|mesh-list
44000177|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44000178|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000179|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000180|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000182|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
44000183|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000184|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44000185|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44000186|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000187|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000188|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000189|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000190|NCT03697850|Atezolizumab|atezolizumab|mesh-list
44000191|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000192|NCT03668340|Adavosertib|adavosertib|mesh-list
44000193|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000202|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246772|NCT03588884|Vitamin D|vitamin d|mesh-list
44246773|NCT03588884|Calcifediol|calcifediol|mesh-list
44246774|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44246775|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246776|NCT03588884|Vitamins|vitamins|mesh-ancestor
44246777|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
44246778|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44246779|NCT03558152|Vedolizumab|vedolizumab|mesh-list
44246780|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000203|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000204|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000205|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000206|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000207|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
44000208|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000209|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000210|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
44000211|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000212|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000213|NCT03615547|Clomiphene|clomiphene|mesh-list
44000214|NCT03615547|Enclomiphene|enclomiphene|mesh-list
44000215|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
44000216|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44000217|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000218|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000219|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000220|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44000221|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
44000222|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44000223|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44000224|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44146342|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146343|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146344|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
44146345|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44146346|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44146347|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44146348|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44146349|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146350|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146351|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146352|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44146353|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
44146354|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146355|NCT00198354|Gemcitabine|gemcitabine|mesh-list
44146356|NCT00198354|Paclitaxel|paclitaxel|mesh-list
44146357|NCT00198354|Carboplatin|carboplatin|mesh-list
44146358|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146359|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146360|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146361|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146362|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146363|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146364|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146365|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
44000225|NCT03614663|Cannabidiol|cannabidiol|mesh-list
44000226|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
44000227|NCT03613532|Fludarabine|fludarabine|mesh-list
44000228|NCT03613532|Azacitidine|azacitidine|mesh-list
44000229|NCT03613532|Busulfan|busulfan|mesh-list
44000230|NCT03613532|Decitabine|decitabine|mesh-list
44000231|NCT03613532|Venetoclax|venetoclax|mesh-list
44000232|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000233|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000234|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
44246782|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246783|NCT03554317|Nivolumab|nivolumab|mesh-list
44246784|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
44246785|NCT03554317|Testosterone|testosterone|mesh-list
44246786|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
44246787|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
44246788|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44246789|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000235|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000245|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44000246|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
44000247|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000248|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000249|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44000250|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44000251|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
44000252|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000253|NCT03593317|Spironolactone|spironolactone|mesh-list
44000254|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44000255|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000256|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000257|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000258|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44000259|NCT03593317|Diuretics|diuretics|mesh-ancestor
44000260|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
44000261|NCT03586284|Valganciclovir|valganciclovir|mesh-list
44000262|NCT03586284|Ganciclovir|ganciclovir|mesh-list
44000263|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44000264|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
44000265|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000266|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44000267|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000268|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000269|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44000270|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
44000271|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
44000272|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000273|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000274|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
44000275|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000276|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44000277|NCT03567642|Etoposide|etoposide|mesh-list
44000278|NCT03567642|Osimertinib|osimertinib|mesh-list
44000279|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000280|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000281|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44000282|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44000283|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000284|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000285|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000286|NCT03538457|Acetaminophen|acetaminophen|mesh-list
44000287|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000288|NCT03538457|Analgesics|analgesics|mesh-ancestor
44000289|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
44000290|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000291|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000292|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
44000293|NCT03535376|Valsartan|valsartan|mesh-list
44000294|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000295|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44000296|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44000297|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146366|NCT00198354|Antiviral Agents|antiviral agents|mesh-ancestor
44000304|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44246790|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246791|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44246792|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246793|NCT03554317|Androgens|androgens|mesh-ancestor
44246795|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246796|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246797|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246798|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
44000305|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44000307|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000308|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44000309|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000311|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000312|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000313|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000314|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000315|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44000316|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44000317|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000318|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
44000319|NCT03357224|Atezolizumab|atezolizumab|mesh-list
44000320|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000322|NCT03333616|Ipilimumab|ipilimumab|mesh-list
44000323|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000324|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000325|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44000326|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000327|NCT03310541|Fulvestrant|fulvestrant|mesh-list
44000328|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000329|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000330|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44000331|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44000332|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
44000333|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000334|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000335|NCT03190668|Cefazolin|cefazolin|mesh-list
44000336|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
44000337|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000338|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000339|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44000340|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
44000341|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000342|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000343|NCT03166228|Glycine|glycine|mesh-list
44000344|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
44000345|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000346|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000347|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000348|NCT03154996|Topotecan|topotecan|mesh-list
44000349|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44000350|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44000351|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000352|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000353|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000354|NCT03134118|Nivolumab|nivolumab|mesh-list
44000355|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000356|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000357|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44000358|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000359|NCT03122509|Durvalumab|durvalumab|mesh-list
44000360|NCT03122509|Tremelimumab|tremelimumab|mesh-list
44000361|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000362|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246799|NCT03545464|Prednisone|prednisone|mesh-list
44246800|NCT03545464|Levocetirizine|levocetirizine|mesh-list
44246801|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246802|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
44246803|NCT03545464|Hormones|hormones|mesh-ancestor
44246804|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246805|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246806|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000363|NCT03113695|Lenalidomide|lenalidomide|mesh-list
44000364|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
44000365|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
44000366|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000367|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44000368|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44000369|NCT03113695|Growth Substances|growth substances|mesh-ancestor
44000370|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44000371|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043134|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000372|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000373|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44000374|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
44000375|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000376|NCT03080883|Apixaban|apixaban|mesh-list
44000377|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44000378|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
44000379|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44000420|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
44000421|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000422|NCT02904291|Amlodipine|amlodipine|mesh-list
44000423|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000424|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44000425|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000426|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000427|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44000428|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000429|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000439|NCT02867865|Gemcitabine|gemcitabine|mesh-list
44000440|NCT02867865|Cisplatin|cisplatin|mesh-list
44000441|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000442|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000443|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
44000444|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000445|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
44000446|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000447|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000448|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000449|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
44000454|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000455|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000456|NCT02833233|Nivolumab|nivolumab|mesh-list
44000457|NCT02833233|Ipilimumab|ipilimumab|mesh-list
44000458|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000459|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000460|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44000461|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000462|NCT02757313|Dronabinol|dronabinol|mesh-list
44000463|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
44000464|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000465|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000466|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000467|NCT02757313|Analgesics|analgesics|mesh-ancestor
44000468|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
44000469|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000470|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44000471|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44000472|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000473|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000474|NCT02757313|Hormones|hormones|mesh-ancestor
44246807|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246808|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44246809|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44246810|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
44246811|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
44246812|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246813|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246814|NCT03537690|Paclitaxel|paclitaxel|mesh-list
44246815|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44246816|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000475|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000476|NCT02711735|Vaccines|vaccines|mesh-list
44000477|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
44000478|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146367|NCT00198354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146368|NCT00198354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146369|NCT00198354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146370|NCT00198354|Immunologic Factors|immunologic factors|mesh-ancestor
44146371|NCT00198354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146373|NCT00198367|Carboplatin|carboplatin|mesh-list
44146374|NCT00198367|Vinorelbine|vinorelbine|mesh-list
44146375|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146376|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146377|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146378|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146379|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146380|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146381|NCT00198380|Gefitinib|gefitinib|mesh-list
44146382|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146383|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146384|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146385|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146386|NCT00198393|Gemcitabine|gemcitabine|mesh-list
44146387|NCT00198393|Docetaxel|docetaxel|mesh-list
44146388|NCT00198393|Gefitinib|gefitinib|mesh-list
44146389|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146390|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
44146391|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146392|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146393|NCT00198393|Antiviral Agents|antiviral agents|mesh-ancestor
44146394|NCT00198393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146395|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146396|NCT00198393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146397|NCT00198393|Immunologic Factors|immunologic factors|mesh-ancestor
44146398|NCT00198393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146399|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146400|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146401|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146402|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146403|NCT00198432|Paclitaxel|paclitaxel|mesh-list
44146404|NCT00198432|Vinorelbine|vinorelbine|mesh-list
44146405|NCT00198432|Cisplatin|cisplatin|mesh-list
44146406|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146407|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146408|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146409|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146410|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000499|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000500|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000501|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44000502|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
44000503|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000504|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000505|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
44000506|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000507|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000508|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44000509|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44000510|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000511|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000512|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
44000513|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44000514|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000515|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000516|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000517|NCT02409810|Analgesics|analgesics|mesh-ancestor
44000518|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
44000519|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000520|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44000521|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44000522|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000523|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000524|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000525|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000526|NCT02379806|Enoxaparin|enoxaparin|mesh-list
44000527|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
44000528|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44000529|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44000530|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000531|NCT02358356|Capecitabine|capecitabine|mesh-list
44000532|NCT02358356|Temozolomide|temozolomide|mesh-list
44000533|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000534|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
44000535|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000536|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000537|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000538|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
44000539|NCT02345265|Olaparib|olaparib|mesh-list
44000540|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44000541|NCT02345265|Cediranib|cediranib|mesh-list
44000542|NCT02345265|Maleic acid|maleic acid|mesh-list
44000543|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000544|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000545|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000549|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000551|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
44000552|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000553|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000554|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
44000555|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000556|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000557|NCT02162810|Prednisolone|prednisolone|mesh-list
44000558|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000559|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
44000560|NCT02162810|Hormones|hormones|mesh-ancestor
44000561|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000562|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000563|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000564|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000565|NCT02101905|Lapatinib|lapatinib|mesh-list
44000566|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000567|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000568|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000569|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000570|NCT01970345|Mecasermin|mecasermin|mesh-list
44000571|NCT01970345|Growth Substances|growth substances|mesh-ancestor
44000572|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000573|NCT01954966|Progesterone|progesterone|mesh-list
44000574|NCT01954966|Progestins|progestins|mesh-ancestor
44000575|NCT01954966|Hormones|hormones|mesh-ancestor
44000576|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000577|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000578|NCT01937468|Interleukin-2|interleukin-2|mesh-list
44000579|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000580|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000581|NCT01937468|Analgesics|analgesics|mesh-ancestor
44000582|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
44246818|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246819|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246820|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246821|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000583|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000584|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000585|NCT01871766|Dactinomycin|dactinomycin|mesh-list
44000586|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
44000587|NCT01871766|Ifosfamide|ifosfamide|mesh-list
44000588|NCT01871766|Bevacizumab|bevacizumab|mesh-list
44000589|NCT01871766|Doxorubicin|doxorubicin|mesh-list
44000590|NCT01871766|Irinotecan|irinotecan|mesh-list
44000591|NCT01871766|Etoposide|etoposide|mesh-list
44000592|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
44000593|NCT01871766|Vincristine|vincristine|mesh-list
44000594|NCT01871766|Sorafenib|sorafenib|mesh-list
44000595|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
44000596|NCT01871766|Razoxane|razoxane|mesh-list
44000597|NCT01871766|Mitogens|mitogens|mesh-list
44000598|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000599|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
44000600|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000601|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000602|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000603|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
44000604|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000605|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000606|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44000607|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000608|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44000609|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44000610|NCT01871766|Growth Substances|growth substances|mesh-ancestor
44000611|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
44000612|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44000613|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44000614|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44000615|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000616|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44000617|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000618|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000619|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000633|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000634|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000635|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44000636|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44000637|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000639|NCT01141309|Everolimus|everolimus|mesh-list
44000640|NCT01141309|Sorafenib|sorafenib|mesh-list
44000641|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000642|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000643|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
44000644|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000645|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000646|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000647|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000648|NCT00961142|Fludarabine|fludarabine|mesh-list
44000649|NCT00961142|Melphalan|melphalan|mesh-list
44000650|NCT00961142|Thiotepa|thiotepa|mesh-list
44000651|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
44000652|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000653|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000654|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000655|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
44000656|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000657|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000658|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
44000659|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44000660|NCT00914823|Hormones|hormones|mesh-list
44000661|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000662|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000663|NCT00823563|Adenosine|adenosine|mesh-list
44000664|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
44246822|NCT03531645|Fulvestrant|fulvestrant|mesh-list
44246823|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246824|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246825|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44246826|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44246827|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
44246828|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246829|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000665|NCT00823563|Analgesics|analgesics|mesh-ancestor
44000666|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
44000667|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000668|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000669|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44000670|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000671|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44000672|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
44000673|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
44000674|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000675|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000677|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44000678|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44000679|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
44000680|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000682|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000683|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44000684|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
44000685|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000686|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000687|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
44000688|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000689|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000690|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44000691|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44000692|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000693|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000694|NCT00251433|Docetaxel|docetaxel|mesh-list
44000695|NCT00251433|Trastuzumab|trastuzumab|mesh-list
44000696|NCT00251433|Lapatinib|lapatinib|mesh-list
44000697|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000698|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000699|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000700|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000701|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000702|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43734381|NCT02540395|Tacrolimus|tacrolimus|mesh-list
44000703|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000704|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000705|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44000706|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
44000707|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000708|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000709|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
44000710|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000711|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000712|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44000713|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44000714|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44000715|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000716|NCT00059930|Leucovorin|leucovorin|mesh-list
44000717|NCT00059930|Dexamethasone|dexamethasone|mesh-list
44000718|NCT00059930|Fluorouracil|fluorouracil|mesh-list
44000719|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
44000720|NCT00059930|Floxuridine|floxuridine|mesh-list
44000721|NCT00059930|Calcium|calcium|mesh-list
44000722|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
43818557|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
44246831|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44246832|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
44246833|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246834|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460090|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
44460091|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460092|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460093|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460094|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460095|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44460096|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460097|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
44460098|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460099|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44460100|NCT01568892|Dolutegravir|dolutegravir|mesh-list
44460101|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44460102|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44460103|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460104|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460105|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44460106|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44460107|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
44460108|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460109|NCT01568866|Dexamethasone|dexamethasone|mesh-list
44460110|NCT01568866|Bortezomib|bortezomib|mesh-list
44460111|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460112|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
44460113|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
44000723|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44000724|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
44000725|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
44000726|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000727|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000728|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000729|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
44000730|NCT00059930|Hormones|hormones|mesh-ancestor
44000731|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000732|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44000733|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000734|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44000735|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
44000736|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000737|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000738|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460114|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460115|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460116|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899954|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44246835|NCT03500484|Liraglutide|liraglutide|mesh-list
44246836|NCT03500484|Glucagon|glucagon|mesh-list
44246837|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44246838|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44246839|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246840|NCT03500484|Incretins|incretins|mesh-ancestor
44246841|NCT03500484|Hormones|hormones|mesh-ancestor
44000739|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
44000740|NCT00059930|Antidotes|antidotes|mesh-ancestor
44000741|NCT00059930|Protective Agents|protective agents|mesh-ancestor
44000742|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
44000744|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
44000745|NCT05452785|Minocycline|minocycline|mesh-list
44000746|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000747|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000748|NCT05452577|Estazolam|estazolam|mesh-list
44000749|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
44000750|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44000751|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44000752|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000753|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000754|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000758|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000759|NCT05452512|Vitamin D|vitamin d|mesh-list
44000760|NCT05452512|Vitamins|vitamins|mesh-list
44000761|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
44000762|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000763|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44000764|NCT05452434|Mirabegron|mirabegron|mesh-list
44000765|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44000766|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44000767|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000768|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000769|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000770|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000771|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000772|NCT05452434|Urological Agents|urological agents|mesh-ancestor
44000773|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44000774|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
44000775|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146414|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44146415|NCT00198445|Analgesics|analgesics|mesh-ancestor
44146416|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
43734407|NCT02540369|Aflibercept|aflibercept|mesh-list
44000777|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
44000778|NCT05451472|Hormones|hormones|mesh-list
44000779|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44000780|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000781|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000782|NCT05451290|Gemcitabine|gemcitabine|mesh-list
44000783|NCT05451290|Tegafur|tegafur|mesh-list
44000784|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
44000785|NCT05451290|Apatinib|apatinib|mesh-list
44000786|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000787|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
44000788|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000789|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000790|NCT05451290|Antiviral Agents|antiviral agents|mesh-ancestor
44000791|NCT05451290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000792|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000793|NCT05451290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000794|NCT05451290|Immunologic Factors|immunologic factors|mesh-ancestor
44000795|NCT05451290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246842|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44246843|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246845|NCT03493425|Carboplatin|carboplatin|mesh-list
44246846|NCT03493425|Docetaxel|docetaxel|mesh-list
44000796|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000797|NCT05451173|Durvalumab|durvalumab|mesh-list
44000798|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000799|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000800|NCT05451147|Metformin|metformin|mesh-list
44000801|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44000802|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000803|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
44000804|NCT05451121|Propofol|propofol|mesh-list
44000805|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44000806|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000807|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000808|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44000809|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
44000810|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
44000811|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000812|NCT05451121|Analgesics|analgesics|mesh-ancestor
44000813|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
44000814|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000815|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44000816|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44000817|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000818|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000819|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000820|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000821|NCT05451043|Gemcitabine|gemcitabine|mesh-list
44000822|NCT05451043|Paclitaxel|paclitaxel|mesh-list
44000823|NCT05451043|Cisplatin|cisplatin|mesh-list
44000824|NCT05451043|Durvalumab|durvalumab|mesh-list
44000825|NCT05451043|Tremelimumab|tremelimumab|mesh-list
44000826|NCT05451043|Propranolol|propranolol|mesh-list
44000827|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000828|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000829|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000830|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000831|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000832|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000833|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000835|NCT05451043|Antiviral Agents|antiviral agents|mesh-ancestor
44000836|NCT05451043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000837|NCT05451043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000838|NCT05451043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000839|NCT05451043|Immunologic Factors|immunologic factors|mesh-ancestor
44000840|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000841|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000842|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44000843|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44000844|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000845|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000846|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44000847|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000848|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000849|NCT05450900|Biotin|biotin|mesh-list
44000850|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44000851|NCT05450900|Vitamins|vitamins|mesh-ancestor
44000852|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
44000853|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000854|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
44000855|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44000856|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
44000857|NCT05450497|Propofol|propofol|mesh-list
44000858|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44000859|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000860|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000861|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44000862|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
44000863|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
44000864|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44246847|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246848|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246849|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246850|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246851|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246852|NCT03451331|Gemcitabine|gemcitabine|mesh-list
44246853|NCT03451331|Carboplatin|carboplatin|mesh-list
44246854|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
44246855|NCT03451331|Nivolumab|nivolumab|mesh-list
44246856|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645867|NCT03732677|Cisplatin|cisplatin|mesh-list
44000865|NCT05450497|Analgesics|analgesics|mesh-ancestor
44000866|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
44000867|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000868|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44000869|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44000870|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44000871|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000872|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000873|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000874|NCT05450484|Durvalumab|durvalumab|mesh-list
44000875|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000876|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000877|NCT05450458|Sorbitol|sorbitol|mesh-list
44000878|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
44000879|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44000880|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
44000881|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000882|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
44000883|NCT05450458|Protective Agents|protective agents|mesh-ancestor
44000884|NCT05450458|Cathartics|cathartics|mesh-ancestor
44000885|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000886|NCT05450328|Epoprostenol|epoprostenol|mesh-list
44000887|NCT05450328|Milrinone|milrinone|mesh-list
44000888|NCT05450328|Tezosentan|tezosentan|mesh-list
44000889|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44000890|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44000891|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
44000892|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44000893|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44000894|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000895|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000896|NCT05450328|Protective Agents|protective agents|mesh-ancestor
44043613|NCT00002955|Trimetrexate|trimetrexate|mesh-list
44000897|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000898|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000899|NCT05450042|Paclitaxel|paclitaxel|mesh-list
44000900|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000901|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000902|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000905|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000906|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
44000907|NCT05449899|Busulfan|busulfan|mesh-list
44000908|NCT05449899|Fludarabine|fludarabine|mesh-list
44000909|NCT05449899|Decitabine|decitabine|mesh-list
44000910|NCT05449899|Lenograstim|lenograstim|mesh-list
44000911|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000912|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
44000913|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000914|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44000915|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000916|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
44000917|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000918|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000919|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44000920|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000921|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
44000922|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246857|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246858|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
44246859|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246860|NCT03451331|Antiviral Agents|antiviral agents|mesh-ancestor
44246861|NCT03451331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246862|NCT03451331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246863|NCT03451331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246864|NCT03451331|Immunologic Factors|immunologic factors|mesh-ancestor
44246865|NCT03451331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246866|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246867|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44246868|NCT03449901|Gemcitabine|gemcitabine|mesh-list
44246869|NCT03449901|Docetaxel|docetaxel|mesh-list
44246870|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44246871|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
44246872|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246873|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246874|NCT03449901|Antiviral Agents|antiviral agents|mesh-ancestor
44246875|NCT03449901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246876|NCT03449901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246877|NCT03449901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000923|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44000924|NCT05449548|Lenalidomide|lenalidomide|mesh-list
44000925|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
44000926|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000927|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44000928|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43734563|NCT02538926|Hormones|hormones|mesh-ancestor
44000929|NCT05449548|Growth Substances|growth substances|mesh-ancestor
44000930|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
44000931|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000932|NCT05449483|Paclitaxel|paclitaxel|mesh-list
44000933|NCT05449483|Cisplatin|cisplatin|mesh-list
44000934|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000935|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000936|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000937|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000938|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000939|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000940|NCT05449366|Paclitaxel|paclitaxel|mesh-list
44000941|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44000942|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000943|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000944|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000945|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000946|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000947|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000948|NCT05449145|Vitamin D|vitamin d|mesh-list
44000949|NCT05449145|Vitamins|vitamins|mesh-ancestor
44000950|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
44000951|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000952|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44000953|NCT05449028|Bismuth|bismuth|mesh-list
44000954|NCT05449028|Antacids|antacids|mesh-ancestor
44246878|NCT03449901|Immunologic Factors|immunologic factors|mesh-ancestor
44246879|NCT03449901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246880|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44246881|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44246882|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44246883|NCT03447574|Ethanol|ethanol|mesh-list
44246884|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44246885|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246886|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000955|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000956|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44000957|NCT05448937|Eugenol|eugenol|mesh-list
44000958|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
44000959|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44000960|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
44000961|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44000962|NCT05448937|Protective Agents|protective agents|mesh-ancestor
44000963|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000964|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000965|NCT05448924|Hormones|hormones|mesh-list
44000966|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44000967|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000968|NCT05448885|Gemcitabine|gemcitabine|mesh-list
44000969|NCT05448885|Cisplatin|cisplatin|mesh-list
44000970|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000971|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000972|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
44000973|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000974|NCT05448885|Antiviral Agents|antiviral agents|mesh-ancestor
44000975|NCT05448885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000976|NCT05448885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000979|NCT05448885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000981|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44000982|NCT05448781|Carboplatin|carboplatin|mesh-list
44000983|NCT05448781|Pemetrexed|pemetrexed|mesh-list
44000984|NCT05448781|Endostatins|endostatins|mesh-list
44000985|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44000986|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000987|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44000988|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000989|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000990|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000991|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000992|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44000993|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44000994|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44000995|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44000996|NCT05448781|Growth Substances|growth substances|mesh-ancestor
44000997|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000998|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
44146417|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146418|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146419|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146420|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146421|NCT00198523|Tobramycin|tobramycin|mesh-list
44146422|NCT00198523|Prednisolone|prednisolone|mesh-list
44146423|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44000999|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
44001000|NCT05448586|Narcotics|narcotics|mesh-ancestor
44001001|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001002|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001003|NCT05448586|Analgesics|analgesics|mesh-ancestor
44001004|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
44001005|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001006|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44001007|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43818558|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246887|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246888|NCT03433469|Osimertinib|osimertinib|mesh-list
44246889|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246890|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246891|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246892|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246893|NCT03412773|Sorafenib|sorafenib|mesh-list
44246894|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246895|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44246896|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001008|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001009|NCT05448365|Vitamin D|vitamin d|mesh-list
44001010|NCT05448365|Vitamins|vitamins|mesh-list
44001011|NCT05448365|Inositol|inositol|mesh-list
44001012|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
44001013|NCT05448365|Pyridoxal|pyridoxal|mesh-list
44001014|NCT05448365|Pyridoxine|pyridoxine|mesh-list
44001015|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44001016|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
44001017|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001018|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44001019|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
44001020|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
44001021|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001022|NCT05448365|Protective Agents|protective agents|mesh-ancestor
44001023|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44001024|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44001025|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001026|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44001027|NCT05448183|Gemcitabine|gemcitabine|mesh-list
44001028|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
44001029|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44001030|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
44001031|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001032|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001033|NCT05448183|Antiviral Agents|antiviral agents|mesh-ancestor
44001034|NCT05448183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001035|NCT05448183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001036|NCT05448183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001037|NCT05448183|Immunologic Factors|immunologic factors|mesh-ancestor
44001038|NCT05448183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001039|NCT05448001|Lansoprazole|lansoprazole|mesh-list
44001040|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
44001041|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44001042|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44001043|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44001044|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001049|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001050|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001051|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
44001052|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001053|NCT05447936|Vitamin D|vitamin d|mesh-list
44001054|NCT05447936|Vitamins|vitamins|mesh-ancestor
44001055|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
44001056|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001057|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44001058|NCT05447871|Bupivacaine|bupivacaine|mesh-list
44001059|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001060|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
44001061|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001062|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001063|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
44001064|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001065|NCT05447780|Anesthetics|anesthetics|mesh-list
44001066|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001067|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001068|NCT05447702|Paclitaxel|paclitaxel|mesh-list
44246897|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246899|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44246900|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44001069|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
44001070|NCT05447702|Apatinib|apatinib|mesh-list
44001071|NCT05447702|Epirubicin|epirubicin|mesh-list
44001072|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44001073|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001074|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44001075|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44001076|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44001077|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001078|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001079|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
44001080|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001081|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001082|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44001083|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
44001084|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44001085|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44001086|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001087|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44001088|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44001089|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44001090|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
44001091|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44001092|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001093|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001094|NCT05447559|Cefazolin|cefazolin|mesh-list
44001095|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44001096|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001097|NCT05447520|Montelukast|montelukast|mesh-list
44001098|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44001099|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
44001100|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44001101|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44001102|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001103|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001104|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44001105|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44001106|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001107|NCT05447455|Anesthetics|anesthetics|mesh-list
44001108|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
44001109|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001110|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001111|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
44001112|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001113|NCT05447364|Pregabalin|pregabalin|mesh-list
44001114|NCT05447364|Analgesics|analgesics|mesh-ancestor
44001121|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001122|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44001124|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44001125|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001126|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001127|NCT05447169|Antibodies|antibodies|mesh-list
44001128|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
44001129|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001130|NCT05447039|Montelukast|montelukast|mesh-list
44001131|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44001132|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44001133|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44001134|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
44001135|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001136|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001137|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44246901|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44246902|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246903|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44246904|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
44246905|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246906|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
44001138|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44001139|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001140|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
44001141|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44001142|NCT05446805|Corticosterone|corticosterone|mesh-list
44001143|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001144|NCT05446727|Ropivacaine|ropivacaine|mesh-list
44001145|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001146|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
44001147|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001148|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001149|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
44001150|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001151|NCT05446623|Sufentanil|sufentanil|mesh-list
44001152|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
44001153|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44001154|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001155|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001156|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001157|NCT05446623|Analgesics|analgesics|mesh-ancestor
44001158|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
44001159|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001160|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44001161|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44001162|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44001163|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001164|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001165|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001166|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44001167|NCT05446623|Narcotics|narcotics|mesh-ancestor
44001168|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44001169|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44001170|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
44001171|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
44001172|NCT05446415|Glucagon|glucagon|mesh-list
44001173|NCT05446415|Incretins|incretins|mesh-list
44001174|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44001175|NCT05446415|Hormones|hormones|mesh-ancestor
44001176|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001177|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001178|NCT05444777|Ketamine|ketamine|mesh-list
44001179|NCT05444777|Analgesics|analgesics|mesh-ancestor
44001180|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
44001181|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001185|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
44001186|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
44001187|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001188|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44001189|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44001190|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001191|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146424|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
44146425|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44146426|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
44146427|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44146428|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
44146429|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146430|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
44146431|NCT00198523|Hormones|hormones|mesh-ancestor
44063436|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146432|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146433|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146434|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146435|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246907|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246908|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246909|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
44246910|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44246911|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44246912|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44246913|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246914|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246915|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
44246916|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246917|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146436|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
44146437|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
44146438|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146439|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146440|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44146441|NCT00198523|Protective Agents|protective agents|mesh-ancestor
44146442|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146443|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146445|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146446|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44146447|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146448|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
44146449|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146450|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146451|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44146452|NCT00198536|Protective Agents|protective agents|mesh-ancestor
44146453|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146454|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146455|NCT00198562|Losartan|losartan|mesh-list
44001192|NCT05442905|Anesthetics|anesthetics|mesh-list
44001193|NCT05442905|Propofol|propofol|mesh-list
44001194|NCT05442905|Sevoflurane|sevoflurane|mesh-list
44001195|NCT05442905|Atracurium|atracurium|mesh-list
44001196|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001197|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001198|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44001199|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44001200|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
44001201|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44001202|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44001203|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44001204|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44001205|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44001206|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001207|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44001208|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44001209|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44001210|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001211|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001212|NCT05442684|Vaccines|vaccines|mesh-list
44001213|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
44001214|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001215|NCT05441254|Paclitaxel|paclitaxel|mesh-list
44001216|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44001217|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001218|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
44001219|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
44001220|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
44001221|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001226|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
44246918|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44246919|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246920|NCT03372941|Dalbavancin|dalbavancin|mesh-list
44246921|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44246922|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001227|NCT05436288|Protective Agents|protective agents|mesh-ancestor
44001229|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44001230|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
44001231|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
44001232|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001233|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001234|NCT05431673|Doxycycline|doxycycline|mesh-list
44001235|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
44001236|NCT05431673|Rifampin|rifampin|mesh-list
44001237|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44001238|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001239|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
44001240|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44001241|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44001242|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44001243|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44001244|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001245|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001246|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001247|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44001248|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44001249|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44001250|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
44001251|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
44001252|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44001253|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44001254|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44001255|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44001256|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44001257|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44001258|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44001259|NCT05430867|Memantine|memantine|mesh-list
44001260|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44001261|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44001262|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
44001263|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001264|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001265|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146456|NCT00198562|Amlodipine|amlodipine|mesh-list
44001266|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44001267|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44001268|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
44001269|NCT05430750|Sevoflurane|sevoflurane|mesh-list
44001270|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44001271|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44001272|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
44001273|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
44001274|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001275|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001276|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001277|NCT05430750|Analgesics|analgesics|mesh-ancestor
44001278|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
44001279|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001280|NCT05418036|Sotalol|sotalol|mesh-list
44001281|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44001282|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44001283|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001284|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001285|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001286|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001287|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44001288|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
44001289|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
43734882|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
44001290|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246924|NCT03365609|Antacids|antacids|mesh-ancestor
44246925|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246926|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44246927|NCT03328026|Interferons|interferons|mesh-list
44246928|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
44246929|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44246930|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
44246931|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246932|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44246933|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44001291|NCT05394142|Metformin|metformin|mesh-list
44001296|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44001298|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001299|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44001300|NCT05394142|Diuretics|diuretics|mesh-ancestor
44001301|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
44001302|NCT05393050|Methotrexate|methotrexate|mesh-list
44001303|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44001304|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
44001305|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44001306|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001307|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44001308|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
44001309|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001310|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001311|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44001312|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001313|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44001314|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001315|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
44001316|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001317|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44001318|NCT05383495|Midazolam|midazolam|mesh-list
44001319|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
44001320|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
44001321|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44001322|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001323|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001324|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001325|NCT05383495|Analgesics|analgesics|mesh-ancestor
44001326|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
44001327|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001328|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44001329|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44001330|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44001331|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001332|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001333|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001334|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44001335|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44001336|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44001337|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001338|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44001339|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
44001341|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
44001342|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
44001343|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44001344|NCT05377424|Istradefylline|istradefylline|mesh-list
44001345|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44001346|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44001347|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44001348|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
44001349|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44246934|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
44246935|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246936|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246937|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44246938|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
44246939|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44246940|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
44246941|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001350|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001351|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001352|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
44001353|NCT05365893|Losartan|losartan|mesh-list
44001354|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
44001355|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44001356|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44001357|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001358|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001359|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001360|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001361|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44001362|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44001367|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
44001369|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001370|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001371|NCT05358873|Antibodies|antibodies|mesh-list
44001372|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
44001373|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001374|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
44001375|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44001376|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
44001377|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001378|NCT05340504|Expectorants|expectorants|mesh-ancestor
44001379|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
44001380|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44001381|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
44001382|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001383|NCT05340504|Protective Agents|protective agents|mesh-ancestor
44001384|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001385|NCT05340504|Antidotes|antidotes|mesh-ancestor
44001386|NCT05338801|Menthol|menthol|mesh-list
44001387|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
44001388|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146457|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
44146458|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44146459|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44146460|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146461|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44146462|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146463|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44146464|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44146465|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44146466|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44146467|NCT00198588|Argatroban|argatroban|mesh-list
44146468|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
44146469|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44146470|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
44146471|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146472|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146473|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
44146474|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44146475|NCT00198601|Gentamicins|gentamicins|mesh-list
44146476|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146477|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146478|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44146479|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830598|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246942|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246943|NCT03312257|Atropine|atropine|mesh-list
44246944|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44246945|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44246946|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44246947|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
44246948|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44246949|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246950|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44246951|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44246952|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
44246953|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
44246954|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44246955|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44246956|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
44246957|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146480|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146481|NCT00198614|Metoprolol|metoprolol|mesh-list
44146482|NCT00198614|Carvedilol|carvedilol|mesh-list
44001389|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
44001390|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44001391|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
44001392|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001393|NCT05321251|Insulin|insulin|mesh-list
44001394|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44001395|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001396|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44001397|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44001398|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44001399|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001400|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001401|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44001402|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001403|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001404|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
44001405|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001406|NCT05315947|Brivaracetam|brivaracetam|mesh-list
44001407|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
44001408|NCT05274048|Trastuzumab|trastuzumab|mesh-list
44001412|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44001413|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44001414|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
44001415|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001416|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001417|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44001418|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
44001420|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
44001421|NCT05243654|Metformin|metformin|mesh-list
44001422|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44001423|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001424|NCT05242315|Tacrolimus|tacrolimus|mesh-list
44001425|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001426|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
44001427|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001428|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44001429|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001430|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001431|NCT05227131|Capecitabine|capecitabine|mesh-list
44001432|NCT05227131|Tucatinib|tucatinib|mesh-list
44001433|NCT05227131|Margetuximab|margetuximab|mesh-list
43830599|NCT05354102|Nivolumab|nivolumab|mesh-list
44246958|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246959|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
44246960|NCT03311334|Nivolumab|nivolumab|mesh-list
44246961|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44246962|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246963|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44246964|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246965|NCT03391869|Nivolumab|nivolumab|mesh-list
44246966|NCT03391869|Ipilimumab|ipilimumab|mesh-list
44246967|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645971|NCT03642028|Suvorexant|suvorexant|mesh-list
44001434|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44001435|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
44001436|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001437|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001438|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44001439|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001440|NCT05225961|Aspirin|aspirin|mesh-list
44001441|NCT05225961|Tirofiban|tirofiban|mesh-list
44001442|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44001443|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001444|NCT05225961|Analgesics|analgesics|mesh-ancestor
44001445|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
44001446|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001447|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001448|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001449|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001450|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44001451|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44001452|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001453|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44001454|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44001455|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001456|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
44001457|NCT05208944|Cemiplimab|cemiplimab|mesh-list
44001458|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001459|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001460|NCT05202158|Gentamicins|gentamicins|mesh-list
44001461|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44001462|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001463|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44001464|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001465|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001466|NCT05193071|Aspirin|aspirin|mesh-list
44001467|NCT05193071|Clopidogrel|clopidogrel|mesh-list
44001468|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44001469|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001470|NCT05193071|Analgesics|analgesics|mesh-ancestor
44001471|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
44001472|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001473|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001474|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001475|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001476|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44001477|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44001478|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001479|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44001480|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44001481|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001484|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44001485|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44001487|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001488|NCT05180825|Trametinib|trametinib|mesh-list
44246978|NCT03288675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44246979|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44246980|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
44246981|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001489|NCT05180825|Vinblastine|vinblastine|mesh-list
44001491|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44001492|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001493|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001494|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44001495|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44001496|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44001497|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44001498|NCT05177848|Nicotine|nicotine|mesh-list
44001499|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44001500|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
44001501|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001502|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001503|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44001504|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44001505|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
44001506|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001507|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001508|NCT05174884|Etonogestrel|etonogestrel|mesh-list
44001509|NCT05174884|Desogestrel|desogestrel|mesh-list
44001510|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44001511|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
44001512|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44001513|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001514|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44001515|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44001516|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44001517|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44001518|NCT05174884|Progestins|progestins|mesh-ancestor
44001519|NCT05174884|Hormones|hormones|mesh-ancestor
44001520|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001521|NCT05172817|Adalimumab|adalimumab|mesh-list
44001522|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001523|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001533|NCT05161637|Bupivacaine|bupivacaine|mesh-list
44001534|NCT05161637|Ropivacaine|ropivacaine|mesh-list
44001535|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
44246982|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44246983|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246984|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43645984|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44001537|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001538|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001539|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
44001540|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001541|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
44001542|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001543|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001545|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001546|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44001547|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001548|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001549|NCT05124171|Vaccines|vaccines|mesh-list
44001550|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
44001551|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146483|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44146484|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44146485|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
44146486|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
44146488|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146489|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44146490|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44146491|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44146492|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44146493|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146494|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146495|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
44146496|NCT00198614|Protective Agents|protective agents|mesh-ancestor
44146497|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44146498|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44146499|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44146500|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
44146501|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44146502|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44146503|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44146504|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44149608|NCT00208312|Adenosine|adenosine|mesh-list
44146505|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146506|NCT00198627|Renal Agents|renal agents|mesh-ancestor
44146507|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146508|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
44146509|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44146510|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44146511|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44146512|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157744|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157746|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157747|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157748|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157749|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157750|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
44157751|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157752|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
44157753|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157754|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
44157755|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44157756|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
44157757|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44157759|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
44157760|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157761|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44157762|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157763|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157764|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
43845572|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
44246985|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44246987|NCT03263650|Carboplatin|carboplatin|mesh-list
44246988|NCT03263650|Olaparib|olaparib|mesh-list
44246989|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44246990|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44246991|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
44246992|NCT03263650|Hormones|hormones|mesh-ancestor
44246993|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157765|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157766|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157767|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157768|NCT00235235|Gemcitabine|gemcitabine|mesh-list
44157769|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
44157770|NCT00235235|Doxorubicin|doxorubicin|mesh-list
44157771|NCT00235235|Capecitabine|capecitabine|mesh-list
44157772|NCT00235235|Vinorelbine|vinorelbine|mesh-list
44157773|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157774|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
44157775|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001552|NCT05084586|Epirubicin|epirubicin|mesh-list
44001553|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44001554|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44001555|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001556|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44001557|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44001558|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001559|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001560|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44001561|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44001562|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001563|NCT05064319|Gabapentin|gabapentin|mesh-list
44001564|NCT05064319|Analgesics|analgesics|mesh-ancestor
44001565|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
44001566|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001567|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001572|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001573|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44001574|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44001575|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001576|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001577|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
44001579|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44001580|NCT05062577|ASP8062|asp8062|mesh-list
44001581|NCT05062577|Naloxone|naloxone|mesh-list
44001582|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44001583|NCT05062577|Narcotics|narcotics|mesh-ancestor
44001584|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001585|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001586|NCT05062577|Analgesics|analgesics|mesh-ancestor
44001587|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
44001588|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001589|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44001590|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
44001591|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
44001592|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001593|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001594|NCT05061901|Lisinopril|lisinopril|mesh-list
44001595|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44001596|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
44001597|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001598|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001599|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44001600|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44001601|NCT05061901|Protective Agents|protective agents|mesh-ancestor
44001602|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001603|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44246994|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44246995|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44246996|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44246997|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44246998|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247000|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44247001|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
44247002|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
43646000|NCT03615742|Budesonide|budesonide|mesh-list
44001604|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44001605|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001606|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001607|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44001608|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001609|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001610|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
44001611|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001612|NCT05031520|Metoprolol|metoprolol|mesh-list
44001613|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
44001614|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44001615|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44001616|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
44001617|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
44001618|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001619|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001620|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44001621|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44001622|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44001623|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001624|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735117|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
44001625|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001626|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44001627|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44001628|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44001629|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44001630|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001631|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001632|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001633|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001634|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44001640|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001641|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001643|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
44001644|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001645|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44001646|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44001647|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44001648|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001649|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001650|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001652|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44001653|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44001654|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001655|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001656|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001657|NCT04967443|Prazosin|prazosin|mesh-list
44001658|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44001659|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44001660|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44001662|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44001663|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001664|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001665|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001667|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
44001668|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44001669|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44001670|NCT04964466|Growth Substances|growth substances|mesh-ancestor
44001671|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001672|NCT04956484|Belimumab|belimumab|mesh-list
44001673|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001674|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
44001675|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001676|NCT04947527|Fluorides|fluorides|mesh-list
44001677|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
44001678|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
44001679|NCT04947527|Protective Agents|protective agents|mesh-ancestor
44001680|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001681|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
44001682|NCT04938765|Analgesics|analgesics|mesh-ancestor
44001683|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
44001684|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001685|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001686|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
44001687|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001688|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44001689|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
44001690|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44001691|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001692|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001693|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44001694|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
44001695|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44001696|NCT04937452|Rotigotine|rotigotine|mesh-list
44001697|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
44001698|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
44001699|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001700|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001701|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001702|NCT04921007|Bupivacaine|bupivacaine|mesh-list
44001703|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001704|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
44001705|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001709|NCT04920994|Bupivacaine|bupivacaine|mesh-list
44001710|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001711|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
44001712|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001713|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001714|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
44001715|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001772|NCT04895410|Daratumumab|daratumumab|mesh-list
44001773|NCT04895410|Pomalidomide|pomalidomide|mesh-list
44001774|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001775|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
44001776|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
44247022|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
44247023|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247024|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247025|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44247026|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44247027|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
44247028|NCT03245840|Hormones|hormones|mesh-ancestor
43646021|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001777|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001780|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
44001782|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001783|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44001784|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001785|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
44001786|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44001787|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44001788|NCT04895410|Growth Substances|growth substances|mesh-ancestor
44001789|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44001790|NCT04891718|Nivolumab|nivolumab|mesh-list
44001791|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001792|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001793|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44001794|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001795|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
44001796|NCT04880889|Thiamine|thiamine|mesh-list
44001797|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
44001798|NCT04880889|Vitamins|vitamins|mesh-ancestor
44001799|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
44001800|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146513|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
44146514|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44146515|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146516|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
44146517|NCT00198848|Folic Acid|folic acid|mesh-list
44146518|NCT00198848|Hematinics|hematinics|mesh-ancestor
44146519|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
44146520|NCT00198848|Vitamins|vitamins|mesh-ancestor
44146521|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
44146522|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146523|NCT00198978|Cytarabine|cytarabine|mesh-list
44146524|NCT00198978|Dexamethasone|dexamethasone|mesh-list
44146525|NCT00198978|Prednisolone|prednisolone|mesh-list
44146526|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
44146527|NCT00198978|Rituximab|rituximab|mesh-list
44146528|NCT00198978|Methotrexate|methotrexate|mesh-list
44146529|NCT00198978|Vincristine|vincristine|mesh-list
44146530|NCT00198978|Asparaginase|asparaginase|mesh-list
44146531|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
44146532|NCT00198978|Idarubicin|idarubicin|mesh-list
44146533|NCT00198978|Lenograstim|lenograstim|mesh-list
44146534|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146535|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
44146536|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146537|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146538|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146539|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
44146540|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146541|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146542|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146543|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146544|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146545|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
44146546|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
44146547|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146548|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146549|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
44146550|NCT00198978|Hormones|hormones|mesh-ancestor
44146551|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247029|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146552|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146553|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146554|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
44146555|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146556|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146557|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
44146558|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146559|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146560|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146561|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146562|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
44001801|NCT04850638|Furosemide|furosemide|mesh-list
44001802|NCT04850638|Diuretics|diuretics|mesh-ancestor
44001803|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
44001806|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001807|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001809|NCT04849377|Carboplatin|carboplatin|mesh-list
44001810|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001811|NCT04845139|Nivolumab|nivolumab|mesh-list
44001812|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001813|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001814|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44001815|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001816|NCT04835623|Cyclosporine|cyclosporine|mesh-list
44001817|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44001818|NCT04835623|Cyclosporins|cyclosporins|mesh-list
44001819|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001820|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001822|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
44001823|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001824|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
44001825|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001826|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
44001827|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44001828|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44001829|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44001830|NCT04806919|Progesterone|progesterone|mesh-list
44001831|NCT04806919|Progestins|progestins|mesh-ancestor
44001832|NCT04806919|Hormones|hormones|mesh-ancestor
44001833|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001834|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001835|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44001836|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
44001837|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001838|NCT04793659|Fasudil|fasudil|mesh-list
44001839|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
44001840|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44001841|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001842|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001843|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44001844|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001845|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
44001846|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44001847|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001848|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
44001849|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001850|NCT04766762|Flunarizine|flunarizine|mesh-list
44001851|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
44001852|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44001853|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001854|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001855|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44001856|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001857|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44001858|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
44001859|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
44001860|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001861|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
44001862|NCT04747496|Edoxaban|edoxaban|mesh-list
44001863|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44001864|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
44247030|NCT03241186|Nivolumab|nivolumab|mesh-list
44247031|NCT03241186|Ipilimumab|ipilimumab|mesh-list
44247032|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247033|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247034|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247035|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247036|NCT03237702|Carotenoids|carotenoids|mesh-list
44247037|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
44247038|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247039|NCT03237702|Protective Agents|protective agents|mesh-ancestor
44001865|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44001866|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
44001867|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001868|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001869|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
44001870|NCT04739384|Ticagrelor|ticagrelor|mesh-list
44001871|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44001872|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44001873|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44001874|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44001877|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001879|NCT04732455|Lidocaine|lidocaine|mesh-list
44001880|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44001881|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001882|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
44001883|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001884|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001885|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
44001886|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001887|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44001888|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44001889|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44001890|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001891|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871165|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44001892|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44001893|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44001895|NCT04732455|Analgesics|analgesics|mesh-ancestor
44001896|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44001897|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001898|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
44001899|NCT04727424|Budesonide|budesonide|mesh-list
44001900|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
44001901|NCT04727424|Fluoxetine|fluoxetine|mesh-list
44001902|NCT04727424|Maleic acid|maleic acid|mesh-list
44001903|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001904|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44001905|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
44001906|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001907|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001908|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44001909|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44001910|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
44001911|NCT04727424|Hormones|hormones|mesh-ancestor
44001912|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001913|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001914|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001915|NCT04727424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44001916|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44001917|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001918|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001919|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
43845573|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247040|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247041|NCT03237286|Ketamine|ketamine|mesh-list
44247042|NCT03237286|Analgesics|analgesics|mesh-ancestor
44247043|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
44001920|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44001921|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
44001922|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001923|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44001924|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44001925|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44001926|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44001927|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001928|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44001929|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44001930|NCT04719273|Anastrozole|anastrozole|mesh-list
44001931|NCT04719273|Onapristone|onapristone|mesh-list
44001932|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44001933|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001934|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44001935|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44001936|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001937|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001938|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44001939|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44001940|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001941|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001942|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44001943|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
44001948|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001949|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001951|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001952|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
44001953|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
44001954|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44001955|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
44001956|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001957|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001958|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44001959|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
44001960|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001961|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44001962|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44001963|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001964|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001966|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44001967|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44001968|NCT04657068|Gemcitabine|gemcitabine|mesh-list
44001969|NCT04657068|Irinotecan|irinotecan|mesh-list
44001970|NCT04657068|Camptothecin|camptothecin|mesh-list
44001971|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44001972|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
44001973|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001974|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001975|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
44001976|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44001977|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001978|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001979|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
44001980|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001981|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44001982|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44001983|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44001984|NCT04635189|Dexamethasone|dexamethasone|mesh-list
44001985|NCT04635189|Lenalidomide|lenalidomide|mesh-list
44001986|NCT04635189|Daratumumab|daratumumab|mesh-list
44001987|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001988|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
44001989|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
44001990|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001991|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247045|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247046|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44247047|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44247048|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
44247049|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
44247050|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247051|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44247052|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44247053|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247054|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247055|NCT03223155|Nivolumab|nivolumab|mesh-list
44247056|NCT03223155|Ipilimumab|ipilimumab|mesh-list
44247057|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247058|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247059|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44460117|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
44247060|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247061|NCT03217565|Tedizolid|tedizolid|mesh-list
44247062|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
44247063|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
44247064|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44001992|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44001993|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
44001994|NCT04635189|Hormones|hormones|mesh-ancestor
44001995|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44001996|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44001997|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001998|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
44001999|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44002000|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44002001|NCT04635189|Growth Substances|growth substances|mesh-ancestor
44002002|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44002003|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
44002004|NCT04627012|Lenvatinib|lenvatinib|mesh-list
44002005|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002006|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002007|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002008|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002009|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002010|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44002011|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44002012|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146563|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146564|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146565|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146568|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44146569|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146570|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247065|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247066|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44247067|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247068|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247069|NCT03212742|Temozolomide|temozolomide|mesh-list
44247070|NCT03212742|Olaparib|olaparib|mesh-list
44247071|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247072|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
44247073|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146571|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44002015|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44002016|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44002017|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002018|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
44002019|NCT04560010|Coagulants|coagulants|mesh-ancestor
44002020|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44002021|NCT04539626|Estradiol|estradiol|mesh-list
44002022|NCT04539626|Estrogens|estrogens|mesh-list
44002023|NCT04539626|Hormones|hormones|mesh-ancestor
44002024|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002025|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002026|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44002027|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
44002028|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44002029|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44002030|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44002031|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44002032|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44002033|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002034|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44002036|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44002037|NCT04522206|Narcotics|narcotics|mesh-ancestor
44002038|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002039|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002040|NCT04522206|Analgesics|analgesics|mesh-ancestor
44002041|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
44002042|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002043|NCT04519944|Edoxaban|edoxaban|mesh-list
44002044|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44002045|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
44002046|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44002047|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44002048|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002049|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002050|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
44002051|NCT04505592|Tenecteplase|tenecteplase|mesh-list
44002052|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44002053|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44002054|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002055|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
44002056|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44002057|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002058|NCT04502407|Cisplatin|cisplatin|mesh-list
44002059|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002060|NCT04483583|Clopidogrel|clopidogrel|mesh-list
44002061|NCT04483583|Ticagrelor|ticagrelor|mesh-list
44002062|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44002063|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44002064|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44002065|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44002066|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
44002067|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002068|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002069|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002070|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
44247074|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247075|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43646048|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
44002071|NCT04477200|Temozolomide|temozolomide|mesh-list
44002072|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44002073|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002074|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44002075|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
44002076|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002077|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002078|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002079|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002080|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44002083|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002084|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002085|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
44002086|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735517|NCT04038086|Insulin|insulin|mesh-list
44002087|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002088|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002089|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002090|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
44002091|NCT04476628|Hormones|hormones|mesh-ancestor
44002092|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002093|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44002094|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44002095|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
44002096|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44002097|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
44002098|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002099|NCT04450316|Naltrexone|naltrexone|mesh-list
44002100|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44002101|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44002102|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002103|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
44002104|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002105|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
44002107|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
44002108|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
44002109|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44002110|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002111|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
44002112|NCT04415892|Capsaicin|capsaicin|mesh-list
44002113|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
44002114|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002115|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
44002116|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002117|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002118|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002119|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002120|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44002121|NCT04415892|Protective Agents|protective agents|mesh-ancestor
44002122|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
44002123|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44002124|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44002125|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002126|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
44002127|NCT04387305|Coagulants|coagulants|mesh-ancestor
44002128|NCT04359953|Azithromycin|azithromycin|mesh-list
44002129|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
44002130|NCT04359953|Telmisartan|telmisartan|mesh-list
44002131|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002132|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002133|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
44002134|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44002135|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44002136|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002137|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002138|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002139|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44002140|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44002141|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44002142|NCT04316676|Regadenoson|regadenoson|mesh-list
44247076|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247077|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
44247078|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247079|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247080|NCT03202849|Vitamin D|vitamin d|mesh-list
43646053|NCT03554291|Famotidine|famotidine|mesh-list
44002143|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44002144|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44002145|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
44002146|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
44002147|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002148|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002149|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002150|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44002151|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
44002152|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002153|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
44002154|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002155|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002161|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
44002162|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
44002164|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44002165|NCT04267887|Androgens|androgens|mesh-list
44002166|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
44002167|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002168|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
44002169|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002170|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002171|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44002172|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002173|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44002174|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002175|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002176|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
44002177|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44002178|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
44002179|NCT04267887|Protective Agents|protective agents|mesh-ancestor
44002180|NCT04267887|Vitamins|vitamins|mesh-ancestor
44002181|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
44002182|NCT04267887|Estrogens|estrogens|mesh-ancestor
44002183|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
44002184|NCT04262206|Atorvastatin|atorvastatin|mesh-list
44002185|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44002186|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44002187|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
44002188|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002189|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44002190|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44002191|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002192|NCT04196530|Atezolizumab|atezolizumab|mesh-list
44002193|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002194|NCT04189783|Bupivacaine|bupivacaine|mesh-list
44002195|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
44002196|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
44002197|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002198|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002199|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
44002200|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002201|NCT04176354|Letrozole|letrozole|mesh-list
44002202|NCT04176354|Palbociclib|palbociclib|mesh-list
44002203|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44002204|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002205|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44002206|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002207|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002208|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44002209|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
44002210|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247081|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
44247082|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
44247083|NCT03202849|Vitamins|vitamins|mesh-list
44247084|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
44002211|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002212|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002213|NCT04173780|Atropine|atropine|mesh-list
44002214|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44002215|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44002216|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002217|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
44002218|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002222|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
44002223|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
44002224|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44002225|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44002226|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
44002227|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002228|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002229|NCT04168203|Apixaban|apixaban|mesh-list
44002230|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44002231|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
44002232|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44002233|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
44002234|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002235|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002236|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
44002237|NCT04135989|Everolimus|everolimus|mesh-list
44002238|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002239|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002240|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
44002241|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002242|NCT04129554|Tenofovir|tenofovir|mesh-list
44002243|NCT04129554|Entecavir|entecavir|mesh-list
44002244|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
44002245|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
44002246|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002247|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44002248|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44002249|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002250|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002251|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44002252|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44002253|NCT04128540|Fentanyl|fentanyl|mesh-list
44002254|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44002255|NCT04128540|Narcotics|narcotics|mesh-ancestor
44002256|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002257|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002258|NCT04128540|Analgesics|analgesics|mesh-ancestor
44002259|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
44002260|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002261|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44002262|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44002263|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
44002264|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
44002265|NCT04104438|Everolimus|everolimus|mesh-list
44002266|NCT04104438|Basiliximab|basiliximab|mesh-list
44002267|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002268|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002269|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
44002270|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002271|NCT04093531|Ustekinumab|ustekinumab|mesh-list
44002272|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002273|NCT04065841|Licogliflozin|licogliflozin|mesh-list
44002274|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44002275|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002276|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44002277|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002278|NCT04052698|Factor VIII|factor viii|mesh-list
44002279|NCT04052698|Coagulants|coagulants|mesh-ancestor
44002280|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44002281|NCT04048304|Vancomycin|vancomycin|mesh-list
44002282|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002283|NCT04046575|Paclitaxel|paclitaxel|mesh-list
44002284|NCT04046575|Carboplatin|carboplatin|mesh-list
43845574|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
44247085|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247086|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44247087|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44247088|NCT03188796|Vitamin D|vitamin d|mesh-list
44002285|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002286|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002287|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002288|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
44002289|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002290|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002291|NCT04027322|Dexamethasone|dexamethasone|mesh-list
44002292|NCT04027322|Budesonide|budesonide|mesh-list
44002293|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002298|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002299|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
44002300|NCT04027322|Hormones|hormones|mesh-ancestor
44002301|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002302|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44045253|NCT00003133|Cisplatin|cisplatin|mesh-list
44002303|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002304|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002305|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002306|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002307|NCT04021121|Linezolid|linezolid|mesh-list
44002308|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002309|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002310|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44002311|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002312|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002313|NCT03999268|Insulin|insulin|mesh-list
44002314|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44002315|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002316|NCT03996057|Methenamine|methenamine|mesh-list
44002317|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
44002318|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
44002319|NCT03996057|Estrogens|estrogens|mesh-list
44002320|NCT03996057|Hormones|hormones|mesh-ancestor
44002321|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002322|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002323|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44002324|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002325|NCT03996057|Renal Agents|renal agents|mesh-ancestor
44002326|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002327|NCT03970655|Dexamethasone|dexamethasone|mesh-list
44002328|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
44002329|NCT03970655|Epinephrine|epinephrine|mesh-list
44002330|NCT03970655|Racepinephrine|racepinephrine|mesh-list
44002332|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
44002333|NCT03970655|BB 1101|bb 1101|mesh-list
44002334|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002335|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
44002336|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
44002337|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002338|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002339|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002340|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
44002341|NCT03970655|Hormones|hormones|mesh-ancestor
44002342|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002343|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44002344|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002345|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
44002346|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002347|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002348|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
44002349|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
44002350|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002351|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
44002352|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44002353|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44002354|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
44002355|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002356|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44247090|NCT03188796|Vitamins|vitamins|mesh-ancestor
44247091|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
44247092|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247093|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44002357|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002358|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002359|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002360|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
44002361|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
44002362|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44002363|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44002364|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002365|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44002366|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44002368|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002369|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
44002370|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002372|NCT03929068|Carbidopa|carbidopa|mesh-list
44002373|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44002374|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44002375|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44002376|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
44002377|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002378|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002379|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002380|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44002381|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002382|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44002383|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
44002384|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
44002385|NCT03924518|Granisetron|granisetron|mesh-list
44002386|NCT03924518|Serotonin|serotonin|mesh-list
44002387|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
44002388|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
44002389|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002390|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002391|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002392|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44002393|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
44002394|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002395|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002396|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44002397|NCT03913104|Mifepristone|mifepristone|mesh-list
44002398|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44002399|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
44002400|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44002401|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002402|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44002403|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44002404|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44002405|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
44002406|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44002407|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44002408|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
44002409|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002410|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
44002411|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44002412|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44002413|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44002415|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
44002416|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002417|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44002418|NCT03910972|Antacids|antacids|mesh-ancestor
44002419|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002420|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002421|NCT03908593|Pantoprazole|pantoprazole|mesh-list
44002422|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44002423|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247094|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44247095|NCT03186209|Benralizumab|benralizumab|mesh-list
44247096|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44247097|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
44247098|NCT03164928|Denosumab|denosumab|mesh-list
44002424|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44002425|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002426|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002427|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44002428|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002429|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002430|NCT03886922|Cromakalim|cromakalim|mesh-list
44002431|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44002432|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002433|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
44002434|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002435|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002436|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002437|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002438|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
44002443|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002444|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002445|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002446|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
44002447|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002448|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002449|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146578|NCT00199004|Vincristine|vincristine|mesh-list
44146579|NCT00199004|Doxorubicin|doxorubicin|mesh-list
44146580|NCT00199004|Daunorubicin|daunorubicin|mesh-list
44146581|NCT00199004|Asparaginase|asparaginase|mesh-list
44146582|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
44146583|NCT00199004|Thioguanine|thioguanine|mesh-list
44146584|NCT00199004|Vindesine|vindesine|mesh-list
44146585|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146586|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
44146587|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146588|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146589|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146590|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
44002450|NCT03845257|Dimercaprol|dimercaprol|mesh-list
44002451|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
44002452|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
44002453|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002454|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
44002455|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002456|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002457|NCT03821857|Corticosterone|corticosterone|mesh-list
44002458|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002460|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002461|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002462|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
44002463|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44002464|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002465|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
44002466|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
44002467|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002468|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002469|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002470|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
44002471|NCT03818737|Hormones|hormones|mesh-ancestor
44002472|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002473|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44002474|NCT03818737|Protective Agents|protective agents|mesh-ancestor
44002475|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
44002476|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44002477|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44002478|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002479|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
44002480|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002481|NCT03776487|Fluorouracil|fluorouracil|mesh-list
44247099|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44247100|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247101|NCT03150511|Tesamorelin|tesamorelin|mesh-list
44247102|NCT03150511|Growth Substances|growth substances|mesh-ancestor
44247103|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247104|NCT03122002|Clopidogrel|clopidogrel|mesh-list
44002482|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
44002483|NCT03776487|Nivolumab|nivolumab|mesh-list
44002484|NCT03776487|Ipilimumab|ipilimumab|mesh-list
44002485|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
44002486|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002487|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002488|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002489|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002490|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
44002491|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002492|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002493|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44002494|NCT03770689|Capecitabine|capecitabine|mesh-list
44002495|NCT03770689|Peposertib|peposertib|mesh-list
44002496|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002497|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
44002498|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002499|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002500|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002501|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002509|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002510|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002511|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002512|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
44002513|NCT03754049|Hormones|hormones|mesh-ancestor
44002514|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002515|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44002516|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002517|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44002518|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002519|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002520|NCT03746080|Plerixafor|plerixafor|mesh-list
44002521|NCT03746080|Temozolomide|temozolomide|mesh-list
44002522|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44002523|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
44002524|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002525|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002526|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44002527|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44002528|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
44002529|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002530|NCT03745950|Olaparib|olaparib|mesh-list
44002531|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44002532|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002533|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002534|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002535|NCT03737604|Bupivacaine|bupivacaine|mesh-list
44002536|NCT03737604|Ropivacaine|ropivacaine|mesh-list
44002537|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
44002538|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
44002539|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002540|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002541|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
44002542|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002543|NCT03737461|Lidocaine|lidocaine|mesh-list
44002545|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
44002546|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002547|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002548|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
44002549|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002550|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44002551|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44247105|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247106|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247107|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44247108|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44247109|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44247110|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44247111|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
44247112|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247114|NCT03082209|Venetoclax|venetoclax|mesh-list
44247115|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247116|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247117|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247118|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247119|NCT03082209|Growth Substances|growth substances|mesh-ancestor
44045554|NCT00003160|Paclitaxel|paclitaxel|mesh-list
44247120|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247121|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247122|NCT03074513|Bevacizumab|bevacizumab|mesh-list
44247123|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43646079|NCT03506048|Lenvatinib|lenvatinib|mesh-list
44002552|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44002553|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44002554|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002555|NCT03716349|Anesthetics|anesthetics|mesh-list
44002556|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
44002557|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002558|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002559|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
44002560|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002561|NCT03710642|Prazosin|prazosin|mesh-list
44002562|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44002563|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44002564|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44002565|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44002566|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44002567|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002568|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002569|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002575|NCT03703206|Anesthetics|anesthetics|mesh-list
44002579|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
44002580|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002581|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44002582|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
44002583|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002584|NCT03698461|Leucovorin|leucovorin|mesh-list
44002585|NCT03698461|Bevacizumab|bevacizumab|mesh-list
44002586|NCT03698461|Fluorouracil|fluorouracil|mesh-list
44002587|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
44002588|NCT03698461|Atezolizumab|atezolizumab|mesh-list
44002589|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
44002590|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002591|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002592|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247124|NCT03074513|Atezolizumab|atezolizumab|mesh-list
44247125|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
44247126|NCT03074513|Antibodies|antibodies|mesh-list
44247127|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
44002593|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44002594|NCT03698461|Growth Substances|growth substances|mesh-ancestor
44002595|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002596|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
44002597|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
44002598|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002599|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002600|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002601|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
44002602|NCT03698461|Antidotes|antidotes|mesh-ancestor
44002603|NCT03698461|Protective Agents|protective agents|mesh-ancestor
44002604|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
44002605|NCT03698461|Vitamins|vitamins|mesh-ancestor
44002606|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
44002607|NCT03689244|Selexipag|selexipag|mesh-list
44002608|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44002609|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
44002610|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
44063437|NCT00006048|Gemcitabine|gemcitabine|mesh-list
44002611|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002612|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002613|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002614|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
44002615|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
44002616|NCT03558087|Gemcitabine|gemcitabine|mesh-list
44002617|NCT03558087|Cisplatin|cisplatin|mesh-list
44002618|NCT03558087|Nivolumab|nivolumab|mesh-list
44002619|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002620|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002621|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
44002622|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002623|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
44002624|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002625|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002626|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002627|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
44002628|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002629|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002630|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44002631|NCT03490344|Lenalidomide|lenalidomide|mesh-list
44002632|NCT03490344|Daratumumab|daratumumab|mesh-list
44002633|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
44002634|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002635|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44002636|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44002637|NCT03490344|Growth Substances|growth substances|mesh-ancestor
44002638|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44002639|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002640|NCT03448718|Olaparib|olaparib|mesh-list
44002641|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44002642|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002643|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002644|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002645|NCT03443856|Nivolumab|nivolumab|mesh-list
44002646|NCT03443856|Ipilimumab|ipilimumab|mesh-list
44002647|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002648|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002649|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44002656|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002657|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44002658|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44002659|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002660|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
44002661|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
44002662|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44002663|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44002664|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002665|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002666|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002667|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247128|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247129|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
44247130|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247131|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247132|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44146591|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146592|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146593|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146594|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146595|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146596|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
44146597|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
44146598|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002669|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44002670|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44002671|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44002672|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
44002673|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002674|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002675|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002676|NCT03326245|Methylphenidate|methylphenidate|mesh-list
44002677|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44002678|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002679|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44002680|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44002681|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44002682|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002683|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
44002684|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002685|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44002686|NCT03325959|Analgesics|analgesics|mesh-ancestor
44002687|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
44002688|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002689|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002690|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44002691|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002692|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44002693|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44002694|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44002695|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002696|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
44002697|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
44002698|NCT03323398|Durvalumab|durvalumab|mesh-list
44002699|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002700|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002701|NCT03298451|Sorafenib|sorafenib|mesh-list
44002702|NCT03298451|Durvalumab|durvalumab|mesh-list
44002703|NCT03298451|Tremelimumab|tremelimumab|mesh-list
44002704|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44002705|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002706|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002707|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002708|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002711|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002712|NCT03273023|Chromium|chromium|mesh-list
44002713|NCT03273023|Everolimus|everolimus|mesh-list
44002714|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002715|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002716|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
44002717|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002718|NCT03273023|Trace Elements|trace elements|mesh-ancestor
44002719|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
44002720|NCT03269136|Thalidomide|thalidomide|mesh-list
44002721|NCT03269136|Dexamethasone|dexamethasone|mesh-list
44002722|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
44002723|NCT03269136|Lenalidomide|lenalidomide|mesh-list
44002724|NCT03269136|Pomalidomide|pomalidomide|mesh-list
44002725|NCT03269136|Antibodies|antibodies|mesh-list
44002726|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
44002727|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44247133|NCT03074513|Growth Substances|growth substances|mesh-ancestor
44247134|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247135|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247136|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
44247137|NCT03070223|Pitavastatin|pitavastatin|mesh-list
43824039|NCT05516446|Chromium|chromium|mesh-list
44002728|NCT03269136|BB 1101|bb 1101|mesh-list
44002729|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
44002730|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002731|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002732|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
44002733|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
44002734|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002735|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002736|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
44002737|NCT03269136|Hormones|hormones|mesh-ancestor
44002738|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002739|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44002740|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002741|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
44002742|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002743|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002744|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44002745|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44002746|NCT03269136|Growth Substances|growth substances|mesh-ancestor
44002747|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
44002748|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002749|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
44002750|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002751|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002752|NCT03260712|Gemcitabine|gemcitabine|mesh-list
44002753|NCT03260712|Cisplatin|cisplatin|mesh-list
44002754|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
44002755|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002756|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002757|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
44002758|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002759|NCT03260712|Antiviral Agents|antiviral agents|mesh-ancestor
44002760|NCT03260712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002761|NCT03260712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002762|NCT03260712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002763|NCT03260712|Immunologic Factors|immunologic factors|mesh-ancestor
44002764|NCT03260712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002765|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002766|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44002767|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002768|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002769|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
44002770|NCT03251651|Propofol|propofol|mesh-list
44002771|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44002772|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002773|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002774|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44002775|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
44002776|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
44002777|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44002778|NCT03251651|Analgesics|analgesics|mesh-ancestor
44002779|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
44002780|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002781|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44002782|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44002783|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44002786|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002787|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
44002788|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
44002789|NCT03249831|Pentostatin|pentostatin|mesh-list
44002790|NCT03249831|Tacrolimus|tacrolimus|mesh-list
44002791|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
44002792|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44002793|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002794|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
44247138|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44247139|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44247140|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44063438|NCT00006048|Cisplatin|cisplatin|mesh-list
44002795|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002796|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002797|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44002798|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
44002799|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002800|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002801|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44002802|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44002803|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002804|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44002805|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44002806|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
44002807|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44002808|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002809|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44002810|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44002812|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44002813|NCT03233347|Doxorubicin|doxorubicin|mesh-list
44002814|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44002815|NCT03233347|Daunorubicin|daunorubicin|mesh-list
44002816|NCT03233347|Dacarbazine|dacarbazine|mesh-list
44002817|NCT03233347|Vinblastine|vinblastine|mesh-list
44002818|NCT03233347|Antibodies|antibodies|mesh-list
44002819|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
44002820|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44002821|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
44002822|NCT03233347|Imidazole|imidazole|mesh-list
44002823|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
44002824|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002825|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002826|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44002827|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44002828|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44002829|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002830|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002831|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44002832|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44002833|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
44002834|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002835|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002836|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44002837|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002838|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
44002839|NCT03225664|Trametinib|trametinib|mesh-list
44002840|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002841|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002842|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002843|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002844|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002845|NCT03215719|Cisplatin|cisplatin|mesh-list
44002846|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002847|NCT03182426|Liraglutide|liraglutide|mesh-list
44002848|NCT03182426|Plerixafor|plerixafor|mesh-list
44002849|NCT03182426|Etanercept|etanercept|mesh-list
44002850|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
44002851|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44002852|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44002853|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002854|NCT03182426|Incretins|incretins|mesh-ancestor
44002855|NCT03182426|Hormones|hormones|mesh-ancestor
44002856|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44002857|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44002858|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44002863|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002864|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44002865|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002866|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
44045862|NCT00003200|Docetaxel|docetaxel|mesh-list
44002867|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247141|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
44247142|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002868|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002869|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44002870|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44002871|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
44002872|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002873|NCT03160911|Hemostatics|hemostatics|mesh-list
44002874|NCT03160911|Coagulants|coagulants|mesh-ancestor
44002875|NCT03137771|Gemcitabine|gemcitabine|mesh-list
44002876|NCT03137771|Docetaxel|docetaxel|mesh-list
44002877|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
44002878|NCT03137771|Pemetrexed|pemetrexed|mesh-list
44002879|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44002880|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002881|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
44002882|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002883|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002884|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
44002885|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44002886|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002887|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002888|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
44002889|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002890|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002891|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44002892|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002893|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002894|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44002895|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157776|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002896|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002898|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002899|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002900|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44002901|NCT03125928|Paclitaxel|paclitaxel|mesh-list
44002902|NCT03125928|Trastuzumab|trastuzumab|mesh-list
44002903|NCT03125928|Atezolizumab|atezolizumab|mesh-list
44002904|NCT03125928|Pertuzumab|pertuzumab|mesh-list
44002905|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002906|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002907|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002908|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44002909|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002910|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002911|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002912|NCT03086616|Irinotecan|irinotecan|mesh-list
44002913|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44002914|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44002915|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002916|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002917|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002918|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
44002919|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002920|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44002921|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002922|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002923|NCT03041883|Riboflavin|riboflavin|mesh-list
44002924|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
44002925|NCT03041883|Vitamins|vitamins|mesh-ancestor
44002926|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
44002927|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002928|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44002929|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002930|NCT03040596|Fluticasone|fluticasone|mesh-list
44002931|NCT03040596|Xhance|xhance|mesh-list
44002932|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002945|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
44002946|NCT03036488|Epirubicin|epirubicin|mesh-list
44002947|NCT03036488|Lenograstim|lenograstim|mesh-list
44002948|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44002949|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002950|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
44002951|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247143|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247144|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44247145|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
44247146|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247147|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247148|NCT03048578|Liraglutide|liraglutide|mesh-list
44002952|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002953|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002954|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44002955|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
44002956|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002957|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002958|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44002959|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
44002960|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44002961|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44002962|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44002963|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44002964|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002965|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002966|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44002967|NCT02966756|Venetoclax|venetoclax|mesh-list
44002968|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002969|NCT02955940|Capecitabine|capecitabine|mesh-list
44002970|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44002971|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
44002972|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002973|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002974|NCT02952924|Midazolam|midazolam|mesh-list
44002975|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44002976|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44002977|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002978|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002979|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44002980|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44002981|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44002982|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44002983|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
44002984|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
44002985|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
44002986|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
44002987|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871166|NCT02641782|Analgesics|analgesics|mesh-ancestor
44002988|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002989|NCT02939872|Aspirin|aspirin|mesh-list
44002990|NCT02939872|Clopidogrel|clopidogrel|mesh-list
44002991|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44002992|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44002993|NCT02939872|Analgesics|analgesics|mesh-ancestor
44002994|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
44002995|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002996|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003002|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44003003|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44003004|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003005|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
44003006|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44003007|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44003008|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44003009|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
44003010|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003011|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
44003012|NCT02905578|Gemcitabine|gemcitabine|mesh-list
44003013|NCT02905578|Paclitaxel|paclitaxel|mesh-list
44003014|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44003015|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003016|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44003017|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003018|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063439|NCT00006048|Gefitinib|gefitinib|mesh-list
43830600|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247150|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247151|NCT03048578|Incretins|incretins|mesh-ancestor
44247152|NCT03048578|Hormones|hormones|mesh-ancestor
44247153|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247154|NCT03043807|Docetaxel|docetaxel|mesh-list
44247155|NCT03043807|Leuprolide|leuprolide|mesh-list
44247156|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
44247157|NCT03043807|Bicalutamide|bicalutamide|mesh-list
44003019|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003020|NCT02905578|Vitamins|vitamins|mesh-ancestor
44003021|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
44003022|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003023|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003024|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
44003025|NCT02905578|Antiviral Agents|antiviral agents|mesh-ancestor
44003026|NCT02905578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003027|NCT02905578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003028|NCT02905578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003029|NCT02905578|Immunologic Factors|immunologic factors|mesh-ancestor
44003030|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
44003031|NCT02905578|Protective Agents|protective agents|mesh-ancestor
44003032|NCT02859064|Lanreotide|lanreotide|mesh-list
44003033|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003034|NCT02768727|Xenon|xenon|mesh-list
44003035|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44003036|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
44003037|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
44003038|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003039|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003040|NCT02688309|Dexamethasone|dexamethasone|mesh-list
44003041|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003042|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
44003043|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
44003044|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003045|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003046|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003047|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
44003048|NCT02688309|Hormones|hormones|mesh-ancestor
44146599|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736275|NCT04573673|Emodin|emodin|mesh-list
44003049|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003050|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003051|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146601|NCT00199004|Hormones|hormones|mesh-ancestor
44146602|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146603|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146604|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146605|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
44146606|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146607|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146608|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
44146609|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146610|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146611|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146612|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146613|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
44146614|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146618|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146619|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146620|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146621|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146622|NCT00199017|Cytarabine|cytarabine|mesh-list
44146623|NCT00199017|Dexamethasone|dexamethasone|mesh-list
44146624|NCT00199017|Prednisolone|prednisolone|mesh-list
44146625|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
44146626|NCT00199017|Methotrexate|methotrexate|mesh-list
44146627|NCT00199017|Vincristine|vincristine|mesh-list
44146628|NCT00199017|Doxorubicin|doxorubicin|mesh-list
44146629|NCT00199017|Daunorubicin|daunorubicin|mesh-list
44247158|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247159|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247160|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046072|NCT00003215|Melphalan|melphalan|mesh-list
44247161|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247162|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247163|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44146630|NCT00199017|Asparaginase|asparaginase|mesh-list
44146631|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
44146632|NCT00199017|Thioguanine|thioguanine|mesh-list
44146633|NCT00199017|Cladribine|cladribine|mesh-list
44146634|NCT00199017|Vindesine|vindesine|mesh-list
44146635|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146636|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
44146637|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146638|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146639|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146640|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
44146641|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146642|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146643|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146644|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146645|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
44146646|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
44146647|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146648|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146649|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
44146650|NCT00199017|Hormones|hormones|mesh-ancestor
44146651|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146652|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146653|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146654|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
44146655|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146656|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146657|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
44146658|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146659|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146660|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146661|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146662|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
44146663|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146664|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146665|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146666|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146667|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146668|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146669|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146670|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146671|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
44146672|NCT00199030|Cladribine|cladribine|mesh-list
44003052|NCT02661971|Leucovorin|leucovorin|mesh-list
44003053|NCT02661971|Docetaxel|docetaxel|mesh-list
44003054|NCT02661971|Fluorouracil|fluorouracil|mesh-list
44003055|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
44003056|NCT02661971|Ramucirumab|ramucirumab|mesh-list
44003057|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003058|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44003059|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003060|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44003061|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003062|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
44003063|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003064|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003065|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
44003066|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003067|NCT02661971|Antidotes|antidotes|mesh-ancestor
44003068|NCT02661971|Protective Agents|protective agents|mesh-ancestor
44003069|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
44003073|NCT02656511|Emtricitabine|emtricitabine|mesh-list
44003074|NCT02656511|Dolutegravir|dolutegravir|mesh-list
44003075|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
44003076|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247164|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
44247165|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44247166|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247167|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247168|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44247169|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247170|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
44247171|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247172|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44247173|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
44247174|NCT03040999|Cisplatin|cisplatin|mesh-list
44247175|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
44247176|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003077|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44003078|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44003079|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003080|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003081|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44003082|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44003083|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44003084|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44003085|NCT02626130|Tremelimumab|tremelimumab|mesh-list
44003086|NCT02626130|Ipilimumab|ipilimumab|mesh-list
44003087|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003088|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003089|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003090|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003091|NCT02618720|Ornidazole|ornidazole|mesh-list
44003092|NCT02618720|Amebicides|amebicides|mesh-ancestor
44003093|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44003094|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44003095|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003096|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44003097|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44003098|NCT02616965|Romidepsin|romidepsin|mesh-list
44003099|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003100|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003101|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003102|NCT02588027|Ibuprofen|ibuprofen|mesh-list
44003103|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44003104|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003105|NCT02588027|Analgesics|analgesics|mesh-ancestor
44003106|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
44003107|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003108|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003109|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003110|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003111|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44003112|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003113|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003114|NCT02572323|Tesamorelin|tesamorelin|mesh-list
44003115|NCT02572323|Growth Substances|growth substances|mesh-ancestor
44003116|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003117|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
44003118|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003119|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003120|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44003121|NCT02520141|Ramucirumab|ramucirumab|mesh-list
44003122|NCT02520141|Antibodies|antibodies|mesh-list
44003123|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
44003124|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247177|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247178|NCT03002103|Gemcitabine|gemcitabine|mesh-list
44247179|NCT03002103|Paclitaxel|paclitaxel|mesh-list
44247180|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247181|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247182|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247183|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247184|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247185|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247186|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247187|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
44247188|NCT03002103|Antiviral Agents|antiviral agents|mesh-ancestor
44247189|NCT03002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247190|NCT03002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646127|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44003125|NCT02520141|Lexatumumab|lexatumumab|mesh-list
44003126|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
44003127|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003128|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003129|NCT02475772|Cisplatin|cisplatin|mesh-list
44003130|NCT02475772|Doxorubicin|doxorubicin|mesh-list
44003131|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44003132|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003133|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003134|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003135|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003136|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003137|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003138|NCT02471430|Interferons|interferons|mesh-list
44003139|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
44003140|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
44003141|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44003142|NCT02471430|Panobinostat|panobinostat|mesh-list
44003143|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003144|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
44003145|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003146|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
44003150|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003151|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
44003152|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
44003153|NCT02466581|Prednisolone|prednisolone|mesh-list
44003154|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44003155|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
44003156|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44003157|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
44003158|NCT02466581|Abatacept|abatacept|mesh-list
44003159|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
44003160|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44003161|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
44003162|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003163|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
44003164|NCT02466581|Hormones|hormones|mesh-ancestor
44003165|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003166|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003167|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003168|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003169|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
44003170|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
44003171|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003172|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003173|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44003174|NCT02466581|Protective Agents|protective agents|mesh-ancestor
44247191|NCT03002103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247192|NCT03002103|Immunologic Factors|immunologic factors|mesh-ancestor
44247193|NCT03002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247194|NCT02994069|Cisplatin|cisplatin|mesh-list
44247195|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247196|NCT02966782|Azacitidine|azacitidine|mesh-list
44247197|NCT02966782|Venetoclax|venetoclax|mesh-list
44247198|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247199|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
44247200|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247201|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003175|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
44003176|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44003177|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44003178|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003179|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046268|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003180|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003181|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003182|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003183|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003184|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
44003185|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44003186|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003187|NCT02466581|Analgesics|analgesics|mesh-ancestor
44003188|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
44003189|NCT02419040|Lidocaine|lidocaine|mesh-list
44003190|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44003191|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
44003192|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003193|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003194|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
44003195|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003196|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44003197|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44003198|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44003199|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003200|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003201|NCT02377271|Bosentan|bosentan|mesh-list
44003202|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44003203|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44003204|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003205|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
44003206|NCT02344355|Temozolomide|temozolomide|mesh-list
44003207|NCT02344355|Vitamins|vitamins|mesh-ancestor
44003208|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
44003209|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003210|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44003211|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
44003212|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003213|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003214|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
44003215|NCT02344355|Protective Agents|protective agents|mesh-ancestor
44003216|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
44003217|NCT02278887|Fludarabine|fludarabine|mesh-list
44003218|NCT02278887|Ipilimumab|ipilimumab|mesh-list
44003226|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003228|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44003229|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003230|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003231|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003232|NCT02278887|Analgesics|analgesics|mesh-ancestor
44003233|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
44003234|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003235|NCT02229578|Lidocaine|lidocaine|mesh-list
44247202|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247203|NCT02965963|Dopamine|dopamine|mesh-list
44247204|NCT02965963|Metoclopramide|metoclopramide|mesh-list
44247205|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
44247206|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
44247207|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247208|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247209|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247210|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44003236|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
44003237|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
44003238|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003239|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003240|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
44003241|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003242|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44046343|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003243|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44003244|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44003245|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003246|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003247|NCT02042989|Vorinostat|vorinostat|mesh-list
44003248|NCT02042989|Ixazomib|ixazomib|mesh-list
44003249|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003250|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44003251|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003252|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003253|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
44003254|NCT02028221|Metformin|metformin|mesh-list
44003255|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44003256|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003257|NCT02011971|Vinpocetine|vinpocetine|mesh-list
44003258|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44003259|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003260|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003261|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
44003262|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44003263|NCT02011971|Protective Agents|protective agents|mesh-ancestor
44003264|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003265|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
44003266|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44003267|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
44003268|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003269|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44003270|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
44003271|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003272|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003273|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44003274|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44003275|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003276|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003277|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
44003278|NCT01854814|Losartan|losartan|mesh-list
44003279|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43736492|NCT05361278|Eusol|eusol|mesh-list
44003280|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003281|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44003282|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
44003283|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44003294|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003295|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003296|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003297|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003299|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003300|NCT01809379|Cisplatin|cisplatin|mesh-list
44003301|NCT01809379|Doxorubicin|doxorubicin|mesh-list
44003302|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247211|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44247212|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
44247213|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003303|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003304|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003305|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003306|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003307|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003308|NCT01743742|Vitamins|vitamins|mesh-list
44003309|NCT01743742|Ascorbic Acid|ascorbic acid|mesh-list
44003310|NCT01743742|Vitamin E|vitamin e|mesh-list
44003311|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
44003312|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003313|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
44003314|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003315|NCT01743742|Protective Agents|protective agents|mesh-ancestor
44003316|NCT01555281|Nelfinavir|nelfinavir|mesh-list
44003317|NCT01555281|Dexamethasone|dexamethasone|mesh-list
44003318|NCT01555281|Lenalidomide|lenalidomide|mesh-list
44003319|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003320|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
44003321|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
44003322|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003323|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003324|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003325|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
44003326|NCT01555281|Hormones|hormones|mesh-ancestor
44003327|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003328|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003329|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003330|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
44003331|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44003332|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44003333|NCT01555281|Growth Substances|growth substances|mesh-ancestor
44003334|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44003335|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44003336|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44003337|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44003338|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003339|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003340|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44003341|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44003342|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
44003343|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003344|NCT01491815|Abatacept|abatacept|mesh-list
44003345|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003346|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003347|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003348|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003349|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
44003358|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003359|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003360|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
44003361|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003362|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
44003363|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003364|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44003365|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
44003366|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003367|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44003369|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003370|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003371|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44003372|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44003373|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003374|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003375|NCT00783510|Adalimumab|adalimumab|mesh-list
44003376|NCT00783510|Methotrexate|methotrexate|mesh-list
44003377|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44003378|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
44003379|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44003380|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247214|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247215|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44247217|NCT02965963|Protective Agents|protective agents|mesh-ancestor
44247218|NCT02964585|Canagliflozin|canagliflozin|mesh-list
44046474|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
44247219|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44247220|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247221|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44247222|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460118|NCT01568866|Hormones|hormones|mesh-ancestor
44460119|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003381|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003382|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
44003383|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003384|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003385|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
44003386|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003387|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44003388|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003389|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
44003390|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003391|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44003392|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003393|NCT00677586|Liver Extracts|liver extracts|mesh-list
44003394|NCT00677586|Hematinics|hematinics|mesh-ancestor
44003395|NCT00673335|Letrozole|letrozole|mesh-list
44003396|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003397|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44003398|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44003399|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003400|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003401|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44003402|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44003403|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003404|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003405|NCT00481091|Navitoclax|navitoclax|mesh-list
44003406|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003407|NCT00392756|Hormones|hormones|mesh-list
44003408|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003409|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003410|NCT00212134|Dipivefrin|dipivefrin|mesh-list
44003411|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003412|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003413|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003414|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003415|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146674|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146675|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146676|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
44146677|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146678|NCT00199043|Allopurinol|allopurinol|mesh-list
44146679|NCT00199043|Rasburicase|rasburicase|mesh-list
43736593|NCT05360030|Ketamine|ketamine|mesh-list
44003421|NCT05454683|Melatonin|melatonin|mesh-list
44003422|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
44003423|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003424|NCT05454683|Protective Agents|protective agents|mesh-ancestor
44003425|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003426|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003427|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
44003428|NCT05454345|Rifampin|rifampin|mesh-list
44003429|NCT05454345|Isoniazid|isoniazid|mesh-list
44460120|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44460121|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460122|NCT01568112|Aspirin|aspirin|mesh-list
44460123|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43646173|NCT03423342|Niacin|niacin|mesh-list
44003430|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
44003431|NCT05454345|Ethambutol|ethambutol|mesh-list
44003432|NCT05454345|Rifapentine|rifapentine|mesh-list
44003433|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
44003434|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44003435|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003436|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003437|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003438|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003439|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003440|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003441|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44003442|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
44003443|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
44003444|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44003445|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44003446|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44003447|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44003448|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44003449|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44003450|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44003451|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44003452|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44003453|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
44003454|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44003456|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44003457|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003458|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44003459|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003460|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003461|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44003462|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44003463|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
44003464|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003465|NCT05454085|Bisphenol A|bisphenol a|mesh-list
44003466|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44003467|NCT05454085|Estrogens|estrogens|mesh-ancestor
44003468|NCT05454085|Hormones|hormones|mesh-ancestor
44003469|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003470|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003471|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44003472|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
44003473|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003474|NCT05454085|Protective Agents|protective agents|mesh-ancestor
44003475|NCT05453929|Rocuronium|rocuronium|mesh-list
44003476|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44003485|NCT05453552|Busulfan|busulfan|mesh-list
44003486|NCT05453552|Fludarabine|fludarabine|mesh-list
44003487|NCT05453552|Decitabine|decitabine|mesh-list
44003488|NCT05453552|Lenograstim|lenograstim|mesh-list
44003489|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003490|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
44003491|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003492|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003493|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44003494|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
44146680|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
44003495|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003496|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003497|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44003498|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003499|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
44003500|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003501|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44003502|NCT05453448|Tenofovir|tenofovir|mesh-list
44003503|NCT05453448|Entecavir|entecavir|mesh-list
44460124|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44460125|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44460126|NCT01568112|Analgesics|analgesics|mesh-ancestor
44460127|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
44460128|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460129|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003504|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
44003505|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003506|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44003507|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44003508|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003509|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003510|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44003511|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44003513|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
44003514|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003515|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
44003516|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44003517|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44003518|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44003519|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003520|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
44003521|NCT05453266|Coagulants|coagulants|mesh-ancestor
44003522|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
44003523|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003524|NCT05452928|Valacyclovir|valacyclovir|mesh-list
44003525|NCT05452928|Acyclovir|acyclovir|mesh-list
44003526|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
44003527|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003528|NCT05451719|Capecitabine|capecitabine|mesh-list
44003529|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003530|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
44003531|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003532|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003533|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
44003534|NCT05451381|Propofol|propofol|mesh-list
44003535|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44003536|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003537|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003538|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44003539|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
44003540|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
44003541|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003542|NCT05451381|Analgesics|analgesics|mesh-ancestor
44003543|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
44003551|NCT05450913|Lidocaine|lidocaine|mesh-list
44003552|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
44003553|NCT05450913|Anesthetics|anesthetics|mesh-list
44003554|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003555|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003556|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
44003557|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003558|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44003559|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44003560|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44003561|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003562|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003563|NCT05450419|Vitamin D|vitamin d|mesh-list
44003564|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
44003565|NCT05450419|Vitamins|vitamins|mesh-ancestor
44003566|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
44003567|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003568|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44003569|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43736733|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
44003570|NCT05448989|Atropine|atropine|mesh-list
44003571|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44003572|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44460130|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460131|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460132|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44460133|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44460134|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460135|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44460136|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44460137|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460138|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
44460139|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460140|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460141|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
44003573|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44003574|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
44003575|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003576|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003577|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44003578|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
44003579|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
44003580|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
44003581|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44003582|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44003583|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
44003584|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003585|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003586|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
44003587|NCT05446779|Epinephrine|epinephrine|mesh-list
44003588|NCT05446779|Racepinephrine|racepinephrine|mesh-list
44003589|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
44003590|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003591|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44003592|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003593|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003594|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003595|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003596|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003597|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44003598|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44003599|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
44003600|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003601|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44003602|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44003603|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
44003604|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
44003605|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44003606|NCT05444478|Lenvatinib|lenvatinib|mesh-list
44003607|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003608|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44003609|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003622|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44003623|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003624|NCT05413369|Metformin|metformin|mesh-list
44003625|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
44003626|NCT05413369|Lixisenatide|lixisenatide|mesh-list
44003627|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44003628|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44003629|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003630|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146681|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146682|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146683|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
44146684|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460142|NCT01568047|Levodopa|levodopa|mesh-list
44460143|NCT01568047|Carbidopa|carbidopa|mesh-list
44460144|NCT01568047|Opicapone|opicapone|mesh-list
44460145|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44460146|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44460147|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
44460148|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460149|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460150|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146685|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44146686|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
44146687|NCT00199043|Protective Agents|protective agents|mesh-ancestor
44146688|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146689|NCT00199056|Cytarabine|cytarabine|mesh-list
44146690|NCT00199056|Dexamethasone|dexamethasone|mesh-list
44146691|NCT00199056|Prednisolone|prednisolone|mesh-list
44146692|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
44146693|NCT00199056|Ifosfamide|ifosfamide|mesh-list
44146694|NCT00199056|Methotrexate|methotrexate|mesh-list
43736785|NCT05356169|Venetoclax|venetoclax|mesh-list
44146695|NCT00199056|Fludarabine|fludarabine|mesh-list
44003631|NCT05378971|Pomalidomide|pomalidomide|mesh-list
44003632|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
44003633|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003634|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44003635|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44003636|NCT05378971|Growth Substances|growth substances|mesh-ancestor
44003637|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44003638|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003639|NCT05354466|Neostigmine|neostigmine|mesh-list
44003640|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44003641|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003642|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003643|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
44003644|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003645|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003646|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44003647|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
44003648|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003649|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44003650|NCT05283837|Pertuzumab|pertuzumab|mesh-list
44003651|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003652|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003653|NCT05277727|Fucoidan|fucoidan|mesh-list
44003654|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44003655|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003656|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
44003667|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44003668|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44003669|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003670|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003671|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44003672|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
44003673|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003674|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003676|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44003677|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003678|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
44003679|NCT05114421|Lenvatinib|lenvatinib|mesh-list
44003680|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003681|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003682|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44003683|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003684|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003685|NCT05100160|Gabapentin|gabapentin|mesh-list
44003686|NCT05100160|Analgesics|analgesics|mesh-ancestor
44003687|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
44003688|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003689|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460151|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44460152|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460153|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44460154|NCT01568034|Levodopa|levodopa|mesh-list
44460155|NCT01568034|Carbidopa|carbidopa|mesh-list
44460156|NCT01568034|Opicapone|opicapone|mesh-list
44460157|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44460158|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44460159|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
44460160|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460161|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460162|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460163|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44460164|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046794|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44460165|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44460166|NCT01567865|Vaccines|vaccines|mesh-list
44460167|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
44460168|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460169|NCT01567852|Ketamine|ketamine|mesh-list
44460170|NCT01567852|Methohexital|methohexital|mesh-list
44460171|NCT01567852|Analgesics|analgesics|mesh-ancestor
44003690|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
44003691|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44003692|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44003693|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003694|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44003695|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44003696|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44003697|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003698|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003699|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
44003700|NCT05083845|Anesthetics|anesthetics|mesh-list
44003701|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
44003702|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003703|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003704|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
44003705|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003706|NCT05071833|Peppermint oil|peppermint oil|mesh-list
44003707|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
44003708|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
44003709|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003710|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003711|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003712|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
44003713|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
44003714|NCT05064280|Lenvatinib|lenvatinib|mesh-list
44003715|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003716|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003717|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44003718|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003719|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003720|NCT05057689|Fentanyl|fentanyl|mesh-list
44003723|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44003724|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460173|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460174|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460175|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44460176|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44460177|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
44460178|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
44460179|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247223|NCT02953509|Gemcitabine|gemcitabine|mesh-list
44003725|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003726|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003728|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
44003729|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003730|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44003731|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44003732|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003733|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003734|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003735|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003736|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44003737|NCT05057689|Narcotics|narcotics|mesh-ancestor
44003738|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44003739|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44003740|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
44003741|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
44003742|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44003743|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44003744|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44003745|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
44003746|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
44003747|NCT05055050|Imiquimod|imiquimod|mesh-list
44003748|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44003749|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
44003750|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003751|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003752|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
44003753|NCT05039736|Nivolumab|nivolumab|mesh-list
44003754|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003755|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003756|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003757|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003758|NCT05032183|Leucovorin|leucovorin|mesh-list
44003759|NCT05032183|Cytarabine|cytarabine|mesh-list
44003760|NCT05032183|Dexamethasone|dexamethasone|mesh-list
44003761|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
44003762|NCT05032183|Prednisone|prednisone|mesh-list
44003763|NCT05032183|Cortisone|cortisone|mesh-list
44003764|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
44003765|NCT05032183|Rituximab|rituximab|mesh-list
44003766|NCT05032183|Methotrexate|methotrexate|mesh-list
44003767|NCT05032183|Vincristine|vincristine|mesh-list
44003768|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
44003769|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44003770|NCT05032183|Antibodies|antibodies|mesh-list
44003771|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
44003772|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44003773|NCT05032183|Lenograstim|lenograstim|mesh-list
44003774|NCT05032183|BB 1101|bb 1101|mesh-list
44003775|NCT05032183|Mesna|mesna|mesh-list
44003776|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003777|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
44003778|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003779|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003780|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44003781|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
44003782|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003783|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003784|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146696|NCT00199056|Vincristine|vincristine|mesh-list
44247224|NCT02953509|Rituximab|rituximab|mesh-list
44247225|NCT02953509|Magrolimab|magrolimab|mesh-list
44247226|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
44247227|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247228|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247229|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
44247230|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247231|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247232|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247233|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
44247234|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247235|NCT02953509|Antiviral Agents|antiviral agents|mesh-ancestor
44247236|NCT02953509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003785|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003786|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
44003787|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
44003788|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003789|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003790|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
44003791|NCT05032183|Hormones|hormones|mesh-ancestor
44003792|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003793|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003794|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
44003795|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003796|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44003805|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003806|NCT05032183|Antidotes|antidotes|mesh-ancestor
44003807|NCT05032183|Protective Agents|protective agents|mesh-ancestor
44003808|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
44003809|NCT05032183|Vitamins|vitamins|mesh-ancestor
44003810|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
44003811|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44003812|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44003813|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44003814|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003815|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44003816|NCT05006677|Vitamin K|vitamin k|mesh-list
44003817|NCT05006677|Anticoagulants|anticoagulants|mesh-list
44003818|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44003819|NCT05006677|Vitamins|vitamins|mesh-ancestor
44003820|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
44003821|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003822|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44003823|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44003824|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003825|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
44003826|NCT05006677|Coagulants|coagulants|mesh-ancestor
44003827|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
44003828|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003829|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003830|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
44003831|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44003832|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
44003833|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003834|NCT04978584|Prednisone|prednisone|mesh-list
44003835|NCT04978584|Cortisone|cortisone|mesh-list
44003836|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
44003837|NCT04978584|Rituximab|rituximab|mesh-list
44003838|NCT04978584|Doxorubicin|doxorubicin|mesh-list
44003839|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44003840|NCT04978584|Vincristine|vincristine|mesh-list
44003841|NCT04978584|Lenalidomide|lenalidomide|mesh-list
44003842|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
44003843|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44003844|NCT04978584|Antibodies|antibodies|mesh-list
44003845|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
44247237|NCT02953509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247238|NCT02953509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247239|NCT02951767|Atezolizumab|atezolizumab|mesh-list
44247240|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247242|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44247243|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247244|NCT02939183|Dexamethasone|dexamethasone|mesh-list
44247245|NCT02939183|Pomalidomide|pomalidomide|mesh-list
44247246|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247247|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
44247248|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
44247249|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247250|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247251|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247252|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
44247253|NCT02939183|Hormones|hormones|mesh-ancestor
44247254|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247255|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247256|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247257|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
44247258|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247259|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247260|NCT02939183|Growth Substances|growth substances|mesh-ancestor
44247261|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247262|NCT02899299|Cisplatin|cisplatin|mesh-list
44247263|NCT02899299|Carboplatin|carboplatin|mesh-list
44247264|NCT02899299|Nivolumab|nivolumab|mesh-list
44247265|NCT02899299|Pemetrexed|pemetrexed|mesh-list
44247266|NCT02899299|Ipilimumab|ipilimumab|mesh-list
44247267|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247268|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247269|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247271|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247281|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44247282|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
44247283|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44247284|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44247285|NCT02899000|Analgesics|analgesics|mesh-ancestor
44247286|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
44247287|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247288|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247289|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247290|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247291|NCT02869009|Aspirin|aspirin|mesh-list
44247292|NCT02869009|Clopidogrel|clopidogrel|mesh-list
44247293|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44247294|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003846|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44003847|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003848|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
44003849|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003850|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003851|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44003852|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
44003853|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003854|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003855|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44003856|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003857|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003858|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003859|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003860|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003861|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
44003862|NCT04978584|Hormones|hormones|mesh-ancestor
44146697|NCT00199056|Doxorubicin|doxorubicin|mesh-list
44003863|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003864|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003865|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44003875|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003876|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44003877|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003878|NCT04906096|GDC-0084|gdc-0084|mesh-list
44003879|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003880|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003881|NCT04852484|Ketamine|ketamine|mesh-list
44003882|NCT04852484|Morphine|morphine|mesh-list
44003883|NCT04852484|Anesthetics|anesthetics|mesh-list
44003884|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
44003885|NCT04852484|Analgesics|analgesics|mesh-ancestor
44003886|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
44003887|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003888|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003889|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44003890|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44003891|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
44003892|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003893|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44003894|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44003895|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003896|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003897|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44003898|NCT04852484|Narcotics|narcotics|mesh-ancestor
44003899|NCT04809662|Imiquimod|imiquimod|mesh-list
44247295|NCT02869009|Analgesics|analgesics|mesh-ancestor
44247296|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
44247297|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247298|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247299|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247300|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247301|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44247302|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44247303|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247304|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44247305|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44247306|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003900|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44003901|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
44003902|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003903|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003904|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
44003905|NCT04790474|Dexamethasone|dexamethasone|mesh-list
44003906|NCT04790474|Pomalidomide|pomalidomide|mesh-list
44003907|NCT04790474|Ixazomib|ixazomib|mesh-list
44003908|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003909|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
44003910|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
44003911|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003912|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003913|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003914|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
44003915|NCT04790474|Hormones|hormones|mesh-ancestor
44003916|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003917|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44003918|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003919|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
44003920|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44003921|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44003922|NCT04790474|Growth Substances|growth substances|mesh-ancestor
44003923|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
44003924|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
44003925|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003926|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146698|NCT00199056|Daunorubicin|daunorubicin|mesh-list
44146699|NCT00199056|Asparaginase|asparaginase|mesh-list
44146700|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
44146701|NCT00199056|Idarubicin|idarubicin|mesh-list
44146702|NCT00199056|Thioguanine|thioguanine|mesh-list
44146703|NCT00199056|Vindesine|vindesine|mesh-list
44146704|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146705|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
44146707|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146708|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146709|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
44003927|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44003928|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44003929|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003930|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003931|NCT04717193|Epinephrine|epinephrine|mesh-list
44003932|NCT04717193|Racepinephrine|racepinephrine|mesh-list
44003933|NCT04717193|Bupivacaine|bupivacaine|mesh-list
44003934|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
44003935|NCT04717193|Anesthetics|anesthetics|mesh-list
44003936|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
44003937|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003938|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003939|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
44003940|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247307|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
44247308|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44247309|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44247310|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44247311|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
44003941|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44003942|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003943|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003944|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003945|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003946|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44003947|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44003948|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
44003949|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44003950|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44003951|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
44003952|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
44003953|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44003954|NCT04679831|Praziquantel|praziquantel|mesh-list
44003955|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
44003956|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44003957|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003959|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
44003960|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003961|NCT04659616|Cytarabine|cytarabine|mesh-list
44003962|NCT04659616|Daunorubicin|daunorubicin|mesh-list
44003963|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003964|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
44003965|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003966|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003967|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
44003968|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003969|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003970|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
44003971|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003972|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44003973|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44003974|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44003975|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003976|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
44003977|NCT04587973|Ropivacaine|ropivacaine|mesh-list
44003978|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44003979|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003980|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003981|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44003982|NCT04587973|Analgesics|analgesics|mesh-ancestor
44003983|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
44003984|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003985|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44003986|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44003987|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003988|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003989|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003990|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003991|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
44003992|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
44003993|NCT04527887|Dexamethasone|dexamethasone|mesh-list
44003994|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44003995|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
44003996|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
44003997|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004008|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004009|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004010|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
44004011|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44004012|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
44004013|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44004014|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44004015|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830601|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247312|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247313|NCT02829723|Spartalizumab|spartalizumab|mesh-list
44247314|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247315|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247316|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247317|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
44247318|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247319|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247320|NCT02819856|Ebselen|ebselen|mesh-list
43646309|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
44004016|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004017|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
44004018|NCT04480138|Interferons|interferons|mesh-list
44004019|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004020|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
44004021|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004023|NCT04459611|Carboplatin|carboplatin|mesh-list
44004024|NCT04459611|Pemetrexed|pemetrexed|mesh-list
44004025|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44004026|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004027|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004028|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004029|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004030|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004031|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004032|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004033|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44004034|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44004035|NCT04458610|Rituximab|rituximab|mesh-list
44004036|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44004037|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
44004038|NCT04458610|Antibodies|antibodies|mesh-list
44004039|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
44004040|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44004041|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
44004042|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004043|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004044|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004045|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004046|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004047|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004048|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44004049|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004050|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004051|NCT04404959|Ropivacaine|ropivacaine|mesh-list
44004052|NCT04404959|Anesthetics|anesthetics|mesh-list
44004053|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
44004054|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004055|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004056|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
44004057|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004058|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
44004059|NCT04403711|Anesthetics|anesthetics|mesh-list
44004060|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
44004061|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44004062|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004068|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44004069|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44004071|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
44004072|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004073|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004074|NCT04403087|Trimebutine|trimebutine|mesh-list
44004075|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004076|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
44004077|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
44247322|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44247323|NCT02819856|Analgesics|analgesics|mesh-ancestor
44247324|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
44247325|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247326|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247327|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247328|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247329|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44247330|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247331|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
44247332|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247333|NCT02819856|Protective Agents|protective agents|mesh-ancestor
44247334|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44004078|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004079|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004081|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004083|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004084|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
44004085|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004086|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004087|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004088|NCT04330040|Olaparib|olaparib|mesh-list
44004089|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44004090|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004091|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004092|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004093|NCT04303702|Oxytocin|oxytocin|mesh-list
44004094|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
44004095|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004096|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004097|NCT04293393|Paclitaxel|paclitaxel|mesh-list
44004098|NCT04293393|Docetaxel|docetaxel|mesh-list
44004099|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
44004100|NCT04293393|Doxorubicin|doxorubicin|mesh-list
44004101|NCT04293393|Letrozole|letrozole|mesh-list
44004102|NCT04293393|Leuprolide|leuprolide|mesh-list
44004103|NCT04293393|Goserelin|goserelin|mesh-list
44004104|NCT04293393|Taxane|taxane|mesh-list
44004105|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004106|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004107|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004108|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004109|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004110|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004111|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004112|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
44004113|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004114|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004115|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44004116|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
44004117|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004118|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004119|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44004120|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004121|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004122|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44004123|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44004124|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44004125|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
44247335|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247336|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44247337|NCT02815995|Durvalumab|durvalumab|mesh-list
44247338|NCT02815995|Tremelimumab|tremelimumab|mesh-list
44247339|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247340|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247341|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44247342|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44247343|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44247344|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
44247345|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247346|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247347|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
44247348|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
44247349|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44247350|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44247351|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
44247352|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247353|NCT02725567|Ivacaftor|ivacaftor|mesh-list
44247354|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44247355|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44247356|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247357|NCT02701088|Mitomycins|mitomycins|mesh-list
44247358|NCT02701088|Mitomycin|mitomycin|mesh-list
44247359|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44247360|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247361|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
44247362|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247363|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44247364|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247365|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
44247366|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646358|NCT03195478|Nivolumab|nivolumab|mesh-list
44004126|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004127|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44004128|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
44004129|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004130|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004131|NCT04260022|Blinatumomab|blinatumomab|mesh-list
44004132|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004133|NCT04241562|Mitogens|mitogens|mesh-list
44247367|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247368|NCT02581215|Ramucirumab|ramucirumab|mesh-list
44247369|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004134|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004144|NCT04184609|Albuterol|albuterol|mesh-list
44004145|NCT04184609|Ipratropium|ipratropium|mesh-list
44004146|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
44004147|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44004148|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
44004149|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004150|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004151|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004152|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004153|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
44004154|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004155|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44004156|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44004157|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44004158|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44004159|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004160|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004161|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44004162|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
44004163|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44004164|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
44004165|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44004166|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
44004167|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004168|NCT04177355|Antacids|antacids|mesh-ancestor
44004169|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004170|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004171|NCT04105114|Buspirone|buspirone|mesh-list
44004172|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44004173|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44004174|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004175|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004176|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44004177|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44004178|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
44004179|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004180|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004181|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
44004182|NCT04095624|Narcotics|narcotics|mesh-ancestor
44004183|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004184|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004185|NCT04095624|Analgesics|analgesics|mesh-ancestor
44004186|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
44004187|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004188|NCT04092452|PF-06700841|pf-06700841|mesh-list
44004189|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004190|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004191|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004192|NCT04077424|Vaccines|vaccines|mesh-list
44004193|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
44004194|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
44004195|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004196|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
44004197|NCT04015622|Docetaxel|docetaxel|mesh-list
44004198|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004199|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004225|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004226|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
44004227|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004228|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004229|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44004230|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
44004231|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004232|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004233|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004234|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004235|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004236|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247370|NCT02567253|Cisplatin|cisplatin|mesh-list
44247371|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247372|NCT02554812|Avelumab|avelumab|mesh-list
44247373|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247374|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900574|NCT00049036|Hormones|hormones|mesh-ancestor
44247375|NCT02537314|Benzocaine|benzocaine|mesh-list
44247376|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44247377|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
44247378|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247379|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247380|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
44247381|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247382|NCT02530489|Paclitaxel|paclitaxel|mesh-list
43646369|NCT03190915|Trametinib|trametinib|mesh-list
44004237|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004238|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004239|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004240|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
44004242|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004243|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004244|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004245|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004246|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004247|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004248|NCT03745716|Azacitidine|azacitidine|mesh-list
44004249|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004250|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
44004251|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004252|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004253|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004254|NCT03708237|Gabapentin|gabapentin|mesh-list
44004255|NCT03708237|Ropinirole|ropinirole|mesh-list
44004256|NCT03708237|Analgesics|analgesics|mesh-ancestor
44004264|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44004265|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44004266|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44004267|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004268|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004269|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
44004270|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44004271|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44004272|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
44004273|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
44004274|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
44004275|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004276|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146710|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146711|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146712|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146713|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146714|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
44146715|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
44146716|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146717|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146718|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
44146719|NCT00199056|Hormones|hormones|mesh-ancestor
44146720|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146721|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146722|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146723|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
43819589|NCT04677855|Prednisone|prednisone|mesh-list
44247383|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44247384|NCT02530489|Atezolizumab|atezolizumab|mesh-list
44247385|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247386|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146724|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146725|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146726|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
44146727|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146728|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146729|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146730|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146731|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
44146732|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146733|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146734|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146735|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146736|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146737|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004277|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
44004278|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004279|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004280|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
44004281|NCT03576001|Testosterone|testosterone|mesh-list
44004282|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
44004283|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
44004284|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44004285|NCT03576001|Androgens|androgens|mesh-ancestor
44004286|NCT03576001|Hormones|hormones|mesh-ancestor
44004287|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004288|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004289|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004290|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004291|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
44004292|NCT03559868|Digoxin|digoxin|mesh-list
44004293|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44004294|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44004295|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004301|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004302|NCT03540485|Protective Agents|protective agents|mesh-ancestor
44004303|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004304|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004305|NCT03465111|Hormones|hormones|mesh-list
44004306|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44004307|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44004308|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
44004309|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004310|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004311|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004312|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004313|NCT03341676|Dexamethasone|dexamethasone|mesh-list
44004314|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004315|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
44004316|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
44004317|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004318|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004319|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004320|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
44004321|NCT03341676|Hormones|hormones|mesh-ancestor
44004322|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004323|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004324|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004325|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
44004326|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004327|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004328|NCT03289299|Dexamethasone|dexamethasone|mesh-list
44004329|NCT03289299|Lenalidomide|lenalidomide|mesh-list
44004330|NCT03289299|Daratumumab|daratumumab|mesh-list
44004331|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004332|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
44004333|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
44004334|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247387|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247388|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247389|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247390|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247391|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247392|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
44247393|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247394|NCT02523469|Nivolumab|nivolumab|mesh-list
44004335|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004336|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004337|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
44004338|NCT03289299|Hormones|hormones|mesh-ancestor
44004339|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004340|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004341|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004342|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
44004343|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44004344|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44004345|NCT03289299|Growth Substances|growth substances|mesh-ancestor
44004346|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
44004347|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
44004348|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44004349|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004350|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004351|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004352|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004353|NCT03121716|Gemcitabine|gemcitabine|mesh-list
44004354|NCT03121716|Cisplatin|cisplatin|mesh-list
44004355|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004356|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
44004357|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004358|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004359|NCT03121716|Antiviral Agents|antiviral agents|mesh-ancestor
44004360|NCT03121716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004361|NCT03121716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004362|NCT03121716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004363|NCT03121716|Immunologic Factors|immunologic factors|mesh-ancestor
44004364|NCT03121716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004367|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
44004368|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004369|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004370|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44004371|NCT03031821|Metformin|metformin|mesh-list
44004372|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44004373|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004374|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
44004375|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004376|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004377|NCT02876302|Paclitaxel|paclitaxel|mesh-list
44004378|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
44004379|NCT02876302|Doxorubicin|doxorubicin|mesh-list
44004380|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004381|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004382|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004383|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004384|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004385|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004386|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004387|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
44004388|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004389|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004390|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44004391|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
44004392|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004393|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047642|NCT00003399|Hormones|hormones|mesh-ancestor
44004394|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247395|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247396|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247397|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247398|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247399|NCT02445391|Cisplatin|cisplatin|mesh-list
44247400|NCT02445391|Carboplatin|carboplatin|mesh-list
44247401|NCT02445391|Capecitabine|capecitabine|mesh-list
44247402|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247403|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247404|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
44247405|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247406|NCT02420574|Albendazole|albendazole|mesh-list
44247407|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
44247408|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44247409|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247410|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
44247411|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44247412|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44247413|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247414|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247415|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247416|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247417|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247418|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
44247419|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247420|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247421|NCT02350764|Nivolumab|nivolumab|mesh-list
44247422|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247423|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247424|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247425|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247426|NCT02338609|Everolimus|everolimus|mesh-list
44247427|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247428|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247435|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247436|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247437|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
44247438|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247439|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247440|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
44247441|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247442|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44247443|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247444|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44247445|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247446|NCT02232737|Nicotine|nicotine|mesh-list
44247447|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44247448|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
44247449|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900639|NCT00052910|Leucovorin|leucovorin|mesh-list
44247450|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247451|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44247452|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44247453|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
44247454|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247455|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247456|NCT02199184|Prednisone|prednisone|mesh-list
44247457|NCT02199184|Cortisone|cortisone|mesh-list
44247458|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
44247459|NCT02199184|Rituximab|rituximab|mesh-list
44247460|NCT02199184|Doxorubicin|doxorubicin|mesh-list
44247461|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44247462|NCT02199184|Etoposide|etoposide|mesh-list
44247463|NCT02199184|Vincristine|vincristine|mesh-list
44247464|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
44247465|NCT02199184|Ofatumumab|ofatumumab|mesh-list
44247466|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
44247467|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44247468|NCT02199184|Antibodies|antibodies|mesh-list
44247469|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
44247470|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247474|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247475|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247476|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
44247477|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247478|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247479|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44247480|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44247481|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247482|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44247483|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247484|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247485|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
44247486|NCT02199184|Hormones|hormones|mesh-ancestor
44247487|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247488|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247489|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247490|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247491|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247492|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247493|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
44247494|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
44247495|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44247496|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44247497|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247498|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
44247499|NCT02191566|Tegafur|tegafur|mesh-list
44247500|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247501|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43646472|NCT03056755|Letrozole|letrozole|mesh-list
44004395|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004396|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004397|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
44004398|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
44004399|NCT02833805|Fludarabine|fludarabine|mesh-list
44004400|NCT02833805|Tacrolimus|tacrolimus|mesh-list
44004401|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
44004402|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44004403|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004404|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
44004405|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004406|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004407|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44004408|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
44004409|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004410|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247503|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247504|NCT02188264|Cyclosporine|cyclosporine|mesh-list
44247505|NCT02188264|Cyclosporins|cyclosporins|mesh-list
44247506|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247507|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247508|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247509|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
44247510|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247511|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
44247512|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247513|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44247514|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247515|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44247516|NCT02157051|Vaccines|vaccines|mesh-list
44247517|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
44247518|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247519|NCT02140255|Ritonavir|ritonavir|mesh-list
44004411|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004412|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44004413|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004414|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004415|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44004416|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
44004417|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44004418|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004419|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
44004420|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
44004421|NCT02714634|Methotrexate|methotrexate|mesh-list
44004422|NCT02714634|Leflunomide|leflunomide|mesh-list
44004423|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44004424|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
44004425|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004426|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004427|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004428|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
44004429|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004430|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004431|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004432|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004433|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44004434|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004435|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
44004436|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004437|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44004438|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
44004443|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44004445|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
44004446|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004447|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004448|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004449|NCT02708394|Olanzapine|olanzapine|mesh-list
44004450|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
44004451|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
44004452|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004453|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004454|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004455|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44247520|NCT02140255|Lopinavir|lopinavir|mesh-list
44247521|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
44247522|NCT02140255|Nevirapine|nevirapine|mesh-list
44247523|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44247524|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44247525|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44247526|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
44247527|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247528|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247529|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44004456|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44004457|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004458|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44004459|NCT02708394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44004460|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44004461|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44004462|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004463|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004464|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
44004465|NCT02582905|Choline|choline|mesh-list
44004466|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44004467|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
44004468|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44004469|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
44004470|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004471|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004472|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44004473|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
44004474|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
44004475|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44004476|NCT02425306|Poly ICLC|poly iclc|mesh-list
44004477|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
44004478|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004479|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004480|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004481|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44004482|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
44004483|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004484|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004485|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004486|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44004487|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
44004488|NCT02327195|Methylphenidate|methylphenidate|mesh-list
44004489|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44004490|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004491|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44004492|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44004493|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44004494|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004495|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
44004496|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004497|NCT01682616|Rituximab|rituximab|mesh-list
44004498|NCT01682616|Venetoclax|venetoclax|mesh-list
44004499|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004500|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004501|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
44004502|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004503|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004504|NCT01614665|Tacrolimus|tacrolimus|mesh-list
44004505|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004506|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
44004507|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004508|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44004509|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004514|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
44247530|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44247531|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
44247532|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247533|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44004515|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004516|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44004517|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004518|NCT00553800|Bevacizumab|bevacizumab|mesh-list
44004519|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44004520|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004521|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004522|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44004523|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44004524|NCT00553800|Growth Substances|growth substances|mesh-ancestor
44004525|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004526|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
44004527|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004528|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004529|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004530|NCT02737891|Metoprolol|metoprolol|mesh-list
44004531|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44004532|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44004533|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
44004534|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
44004535|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004536|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004537|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44004538|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44004539|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44004540|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44004541|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004542|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004543|NCT02739698|Paclitaxel|paclitaxel|mesh-list
44004544|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004545|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004546|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004547|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004548|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004549|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004550|NCT02740114|Oxycodone|oxycodone|mesh-list
44004551|NCT02740114|Bupivacaine|bupivacaine|mesh-list
44004552|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
44004553|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
44004554|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004555|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004556|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
44004557|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004558|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44004559|NCT02740114|Narcotics|narcotics|mesh-ancestor
44004560|NCT02740114|Analgesics|analgesics|mesh-ancestor
44004561|NCT02740543|Fluticasone|fluticasone|mesh-list
44004562|NCT02740543|Xhance|xhance|mesh-list
44004563|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004564|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44004565|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
44004566|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004567|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004568|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004569|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004570|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004571|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44004572|NCT02740582|Tolcapone|tolcapone|mesh-list
44004573|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44004574|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44004575|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44004576|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004577|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004580|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44004581|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004582|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44247534|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44247535|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44247536|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44247537|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44247538|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44247539|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44247540|NCT02108652|Atezolizumab|atezolizumab|mesh-list
44247541|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247542|NCT02100956|Oxytocin|oxytocin|mesh-list
44247543|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
44247544|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44247545|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247546|NCT02090998|Lidocaine|lidocaine|mesh-list
44247547|NCT02090998|Amitriptyline|amitriptyline|mesh-list
44247548|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
44247549|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
44247550|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247551|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004591|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004592|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004593|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004595|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004596|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44004597|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44004598|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44004599|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
44004601|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004602|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004603|NCT02741687|Insulin|insulin|mesh-list
44004604|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44004605|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
44004606|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44004607|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
44004608|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
44004609|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
44004610|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44004611|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004612|NCT02741687|Incretins|incretins|mesh-ancestor
44004613|NCT02741687|Hormones|hormones|mesh-ancestor
44004614|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004615|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44004616|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
44004617|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004618|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004619|NCT02742532|Oxytocin|oxytocin|mesh-list
44004620|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
44004621|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004622|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004623|NCT02742987|Clopidogrel|clopidogrel|mesh-list
44004624|NCT02742987|Ticagrelor|ticagrelor|mesh-list
44004625|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44004626|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44004627|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44004628|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44004629|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
44004630|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004631|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247552|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
44247553|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247554|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44247555|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44247556|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44247557|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44247558|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247559|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44247560|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
44247561|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44247562|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44247563|NCT02090998|Analgesics|analgesics|mesh-ancestor
44247564|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44004632|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004633|NCT02743078|Bevacizumab|bevacizumab|mesh-list
44004634|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004635|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004636|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44004637|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44004638|NCT02743078|Growth Substances|growth substances|mesh-ancestor
44004639|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004640|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44004641|NCT02743377|Rolipram|rolipram|mesh-list
44048023|NCT00003425|Melphalan|melphalan|mesh-list
44004642|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44004643|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44004644|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44004645|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44004646|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004647|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146738|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43737660|NCT04553133|Letrozole|letrozole|mesh-list
44004648|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44004649|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004651|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44004652|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004653|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
44004654|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004655|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44004656|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004657|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
44004658|NCT02746991|Hormones|hormones|mesh-ancestor
44004659|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004660|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004661|NCT02747186|Lidocaine|lidocaine|mesh-list
44004662|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
44004663|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
44004664|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004665|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004666|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
44004667|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004668|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44004669|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44004670|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44004671|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44004672|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004673|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
44004674|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44004675|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44247565|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44247566|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44247567|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247568|NCT02073968|Paclitaxel|paclitaxel|mesh-list
44247569|NCT02073968|Carboplatin|carboplatin|mesh-list
44247570|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44247571|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004676|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004677|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
44004678|NCT02747615|Coagulants|coagulants|mesh-ancestor
44004679|NCT02747628|Melatonin|melatonin|mesh-list
44004680|NCT02747628|Nicotine|nicotine|mesh-list
44004681|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44004682|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
44004683|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004684|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004685|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44004686|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44004687|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
44004688|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004689|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004690|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
44004691|NCT02747628|Protective Agents|protective agents|mesh-ancestor
44004692|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004693|NCT02748070|Fluticasone|fluticasone|mesh-list
44004694|NCT02748070|Prednisone|prednisone|mesh-list
44004695|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004696|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
44004697|NCT02748070|Hormones|hormones|mesh-ancestor
44004698|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004699|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004700|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004701|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004702|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44004703|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
44004704|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004705|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004706|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004707|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004708|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44004709|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
44004710|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44004711|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004712|NCT02748785|Methotrexate|methotrexate|mesh-list
44004713|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44004714|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
44004715|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004716|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004717|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004720|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004721|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004722|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004723|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44004724|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004725|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
44004726|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004727|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44004728|NCT02748889|Carboplatin|carboplatin|mesh-list
44004729|NCT02748889|Etoposide|etoposide|mesh-list
44004730|NCT02748889|Atezolizumab|atezolizumab|mesh-list
44004731|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004732|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004733|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44004734|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004735|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004736|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004737|NCT02751385|Nintedanib|nintedanib|mesh-list
44004738|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43819590|NCT04677855|Dutasteride|dutasteride|mesh-list
44247572|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247573|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247574|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247575|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247576|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247577|NCT02023996|Trastuzumab|trastuzumab|mesh-list
44247578|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247579|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247580|NCT02020707|Paclitaxel|paclitaxel|mesh-list
44247581|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44247582|NCT02020707|Bevacizumab|bevacizumab|mesh-list
44247583|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44247584|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
44247585|NCT02020707|Antibodies|antibodies|mesh-list
44247586|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
44247587|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247588|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
44247589|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247590|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004739|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44004740|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004741|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004742|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004743|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004744|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44004745|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
44004746|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004747|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004748|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44004749|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44004750|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44004751|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44004752|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44004753|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44004754|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44004755|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44004756|NCT02752256|Plasminogen|plasminogen|mesh-list
44004757|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44004758|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44004759|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44004760|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004761|NCT02754518|Valsartan|valsartan|mesh-list
44004762|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44004763|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44004764|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44004765|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44004766|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004767|NCT02754570|Pilocarpine|pilocarpine|mesh-list
44004768|NCT02754570|Miotics|miotics|mesh-ancestor
44004769|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
44004770|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004771|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004772|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44247591|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247592|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247593|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247594|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247595|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247596|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247597|NCT02020707|Growth Substances|growth substances|mesh-ancestor
43646562|NCT03037385|Pralsetinib|pralsetinib|mesh-list
44004773|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44004774|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
44004775|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004776|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004777|NCT02756572|Cytarabine|cytarabine|mesh-list
44004778|NCT02756572|Cyclosporine|cyclosporine|mesh-list
44004779|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
44004780|NCT02756572|Sirolimus|sirolimus|mesh-list
44004781|NCT02756572|Fludarabine|fludarabine|mesh-list
44004782|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
44004783|NCT02756572|Melphalan|melphalan|mesh-list
44004784|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
44004785|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
44004786|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44004787|NCT02756572|Cladribine|cladribine|mesh-list
44004788|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44004790|NCT02756572|Lenograstim|lenograstim|mesh-list
44004792|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44004793|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
44004794|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004795|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44004796|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
44004797|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004798|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
44004799|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004800|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44004801|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004802|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
44004803|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004804|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44004805|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44004806|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004807|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44004808|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
44004809|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44004810|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048217|NCT00003446|Vitamins|vitamins|mesh-ancestor
44004811|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
44004812|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44004813|NCT02756572|Analgesics|analgesics|mesh-ancestor
44004814|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
44004815|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004816|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44004817|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004818|NCT02756624|Cetirizine|cetirizine|mesh-list
44004819|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44004820|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44004821|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44004822|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
44004823|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
44004824|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004825|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004826|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004827|NCT02757105|Ondansetron|ondansetron|mesh-list
44004828|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
44004829|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
44004830|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004831|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004832|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004833|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
44004834|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004835|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44247598|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247599|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44004836|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
44004837|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004838|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004839|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44004840|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44004841|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004842|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44004843|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44004844|NCT02753881|Doxorubicin|doxorubicin|mesh-list
44004845|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44004846|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44004847|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004848|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44004849|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004850|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004851|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004852|NCT02759575|Cisplatin|cisplatin|mesh-list
44004853|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
44004854|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004855|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004856|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
44004857|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44004858|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44004859|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44004860|NCT02760862|Mannitol|mannitol|mesh-list
44004861|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004862|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44004863|NCT02760862|Diuretics|diuretics|mesh-ancestor
44004864|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
43851628|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
44004873|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44004874|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44004875|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004876|NCT02762071|Bupivacaine|bupivacaine|mesh-list
44004877|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
44004878|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
44004879|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004880|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004881|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
44004882|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004883|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
44004885|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
44004886|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004887|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
44004888|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004889|NCT02762331|Protective Agents|protective agents|mesh-ancestor
44004890|NCT02762513|Axitinib|axitinib|mesh-list
44004891|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004892|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004893|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004894|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004895|NCT02762799|Lenograstim|lenograstim|mesh-list
44004896|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44004897|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
44004898|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004899|NCT02765256|Promethazine|promethazine|mesh-list
44004900|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
44004901|NCT02765256|Vancomycin|vancomycin|mesh-list
44004902|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
44004903|NCT02765256|Neomycin|neomycin|mesh-list
44004904|NCT02765256|Fluconazole|fluconazole|mesh-list
44004905|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44004906|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44004907|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004908|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44004909|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44004910|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004911|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004912|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004913|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44004914|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44004915|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
44247600|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
44247601|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44247602|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
44247603|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247604|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247605|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004916|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44004917|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44004918|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
44004919|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004920|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004921|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44004922|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44004923|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
44004924|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004925|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44004926|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
44004927|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
44004928|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004939|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004940|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44004941|NCT02765256|Laxatives|laxatives|mesh-ancestor
44004942|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44004943|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004944|NCT02766517|Capsaicin|capsaicin|mesh-list
44004945|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
44004946|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004947|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
44004948|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004949|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004950|NCT02766673|Albuterol|albuterol|mesh-list
44004951|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44004952|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
44004953|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004954|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004955|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004956|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004957|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
44004958|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44004959|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44004960|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44004961|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44004962|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
44004963|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004964|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004965|NCT02767128|Citric Acid|citric acid|mesh-list
44004966|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
44004967|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
44004968|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44004969|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
44004970|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
44004971|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004972|NCT02767271|Luliconazole|luliconazole|mesh-list
44004973|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
44004974|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004975|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
44004976|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44004977|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44004978|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004979|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
44004980|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004981|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44004982|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44004983|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
44004984|NCT02767492|Hormones|hormones|mesh-ancestor
44004985|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004986|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004987|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247607|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44247609|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
44247610|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44004988|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
44004989|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
44004990|NCT02767869|Antacids|antacids|mesh-ancestor
44004991|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004992|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004993|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
44004994|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44004995|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004996|NCT02767947|Luliconazole|luliconazole|mesh-list
44004997|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
44005005|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005006|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44005007|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44005008|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44005009|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005010|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44005012|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005013|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005014|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44005015|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005016|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44005017|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005018|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005019|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44005020|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44005021|NCT02770365|Estradiol|estradiol|mesh-list
44005022|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44005023|NCT02770365|Estrogens|estrogens|mesh-ancestor
44005024|NCT02770365|Hormones|hormones|mesh-ancestor
44005025|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005026|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005027|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44005028|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
44005029|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44005030|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44005031|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
44005032|NCT02770521|Treprostinil|treprostinil|mesh-list
44005033|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005034|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005035|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44146742|NCT00199069|Prednisolone|prednisolone|mesh-list
44146743|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
44146744|NCT00199069|Ifosfamide|ifosfamide|mesh-list
44146745|NCT00199069|Methotrexate|methotrexate|mesh-list
44146746|NCT00199069|Vincristine|vincristine|mesh-list
44146747|NCT00199069|Doxorubicin|doxorubicin|mesh-list
44146748|NCT00199069|Daunorubicin|daunorubicin|mesh-list
44146749|NCT00199069|Asparaginase|asparaginase|mesh-list
44146750|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
44146751|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
44146752|NCT00199069|Thioguanine|thioguanine|mesh-list
44146753|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146754|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
44146755|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146756|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146757|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146758|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
44146759|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146760|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146761|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146762|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146763|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
44146764|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
44146765|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146766|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146767|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
44146768|NCT00199069|Hormones|hormones|mesh-ancestor
44146769|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247611|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
44247612|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247613|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247614|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146770|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146771|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146772|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
44146782|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146783|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146784|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146785|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146786|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146787|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146788|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146789|NCT00199069|Analgesics|analgesics|mesh-ancestor
44146790|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
44146791|NCT00199095|Cytarabine|cytarabine|mesh-list
44146792|NCT00199095|Dexamethasone|dexamethasone|mesh-list
44146793|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
44146794|NCT00199095|Ifosfamide|ifosfamide|mesh-list
44146796|NCT00199095|Vincristine|vincristine|mesh-list
44146797|NCT00199095|Doxorubicin|doxorubicin|mesh-list
44146798|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
44146799|NCT00199095|Idarubicin|idarubicin|mesh-list
44146800|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146801|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
44146802|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146803|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44146804|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44146805|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
44005037|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005038|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005039|NCT02771093|Incretins|incretins|mesh-ancestor
44005040|NCT02771093|Hormones|hormones|mesh-ancestor
44005041|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005042|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44005043|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44005044|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005045|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005046|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
44005047|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
44005048|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005049|NCT02772783|Insulin|insulin|mesh-list
44005050|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44005051|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005052|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005053|NCT02773758|Fluorides|fluorides|mesh-list
44005054|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
44005055|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
44005056|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
44005057|NCT02773758|Protective Agents|protective agents|mesh-ancestor
44005058|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005059|NCT02774226|Vitamins|vitamins|mesh-list
44005060|NCT02774226|Vitamin E|vitamin e|mesh-list
44005061|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
44005062|NCT02774226|Antioxidants|antioxidants|mesh-list
44005063|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
44005064|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005065|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005066|NCT02774226|Protective Agents|protective agents|mesh-ancestor
44005067|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
44005068|NCT02774343|Pioglitazone|pioglitazone|mesh-list
44005069|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005070|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005071|NCT02775240|Maribavir|maribavir|mesh-list
44005072|NCT02775240|Digoxin|digoxin|mesh-list
44005073|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
44005078|NCT02775240|Protective Agents|protective agents|mesh-ancestor
44005079|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005080|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
44005081|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005082|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44005083|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44005084|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247615|NCT01996605|Oxytocin|oxytocin|mesh-list
44247616|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
44247617|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44247618|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005085|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
44005086|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005087|NCT02775617|Azithromycin|azithromycin|mesh-list
44005088|NCT02775617|Ivermectin|ivermectin|mesh-list
44005089|NCT02775617|Permethrin|permethrin|mesh-list
44005090|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44005091|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005092|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44005093|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005094|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005095|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
44005096|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005097|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
44005098|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44005099|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44005100|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44005101|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005102|NCT05349929|Ibuprofen|ibuprofen|mesh-list
44005103|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44005104|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44005105|NCT05349929|Analgesics|analgesics|mesh-ancestor
44005106|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
44005107|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005108|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005109|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005110|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005111|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44005112|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005113|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005114|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44005115|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
44005116|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005117|NCT05349903|Protective Agents|protective agents|mesh-ancestor
44005118|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005119|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44005120|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44005121|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005122|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44005123|NCT05349825|Losartan|losartan|mesh-list
44005124|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44005125|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44005126|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44005127|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44005128|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005129|NCT05349474|Metformin|metformin|mesh-list
44005130|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005131|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005132|NCT05349396|Eszopiclone|eszopiclone|mesh-list
44005133|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44005134|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005135|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005136|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
44005137|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44005138|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44005139|NCT05349071|Prednisolone|prednisolone|mesh-list
44005140|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
44005141|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44005142|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
44005143|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005157|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005159|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44005160|NCT05349045|Antibodies|antibodies|mesh-list
44005161|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
44005162|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005163|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44005164|NCT05349045|Growth Substances|growth substances|mesh-ancestor
44005165|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247619|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44247620|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44247621|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44247622|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
44247623|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247624|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247625|NCT01964430|Gemcitabine|gemcitabine|mesh-list
44247626|NCT01964430|Paclitaxel|paclitaxel|mesh-list
44247627|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247628|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247629|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247630|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247631|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247632|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005166|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005167|NCT05349032|Curcumin|curcumin|mesh-list
44005168|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44005169|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44005170|NCT05349032|Analgesics|analgesics|mesh-ancestor
44005171|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
44005172|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005173|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005174|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005175|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005176|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005177|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005178|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005179|NCT05348980|Phenylephrine|phenylephrine|mesh-list
44005180|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
44005181|NCT05348980|Synephrine|synephrine|mesh-list
44005182|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44005183|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
44005184|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
44005185|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005186|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005187|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
44005188|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005189|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
44005190|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005191|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44005192|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44005193|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44005194|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
44005195|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005196|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005197|NCT05348980|Protective Agents|protective agents|mesh-ancestor
44005198|NCT05348434|Ether|ether|mesh-list
44005199|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44005200|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
44005201|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
44005202|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005203|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005204|NCT05348239|Copper|copper|mesh-list
44005219|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44005220|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44005221|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
44005223|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005224|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005225|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005226|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44247633|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247634|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
44247635|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
44247636|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247637|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247638|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247639|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
44247640|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247641|NCT01962415|Fludarabine|fludarabine|mesh-list
44247643|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
44247644|NCT01962415|Thiotepa|thiotepa|mesh-list
44005227|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44005228|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44005229|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
44005230|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
44005231|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005232|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
44005233|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005234|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005235|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44005236|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
44005237|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44005238|NCT05348148|Protective Agents|protective agents|mesh-ancestor
44005239|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
44005240|NCT05339581|Lenvatinib|lenvatinib|mesh-list
44005241|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005242|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005243|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44005244|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005245|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146806|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146807|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146808|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146809|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146810|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
44146811|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
44146812|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146813|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146814|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
44146815|NCT00199095|Hormones|hormones|mesh-ancestor
44146816|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146817|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146818|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146819|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048670|NCT00003565|Docetaxel|docetaxel|mesh-list
44146820|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146821|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146822|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
43738220|NCT03875391|Oxytocin|oxytocin|mesh-list
44005246|NCT05337436|Calcium|calcium|mesh-list
44005247|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44005248|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005249|NCT05334017|Cocaine|cocaine|mesh-list
44005251|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
44005252|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
44005253|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005254|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005255|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
44005256|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005257|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005258|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44005259|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44005260|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005261|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247645|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
44247646|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247647|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247648|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247649|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
44247650|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247651|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247652|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
44247653|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44247654|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247655|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
44247656|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247657|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44247658|NCT01914367|Vaccines|vaccines|mesh-list
44247659|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
44005262|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
44005263|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005264|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
44005265|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005266|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44005267|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44005268|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
44005269|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005270|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005271|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005272|NCT05320718|Ropivacaine|ropivacaine|mesh-list
44005273|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
44005274|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
44005275|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005276|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005277|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
44005278|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005279|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44005280|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44005281|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
44005282|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005283|NCT05257590|Nivolumab|nivolumab|mesh-list
44005284|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005285|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005286|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44005287|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005288|NCT05223231|Antibodies|antibodies|mesh-list
44005289|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
44005290|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
44005291|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005292|NCT05215535|Liver Extracts|liver extracts|mesh-list
44005293|NCT05215535|Hematinics|hematinics|mesh-ancestor
44005294|NCT05201183|Fludarabine|fludarabine|mesh-list
44005295|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005296|NCT05180318|Ketamine|ketamine|mesh-list
44005297|NCT05180318|Esketamine|esketamine|mesh-list
44005298|NCT05180318|Analgesics|analgesics|mesh-ancestor
44005299|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
44005300|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005301|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005302|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44005303|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44005304|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
44005305|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
43820000|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247660|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247661|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
44247662|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44247663|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
44247664|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247665|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247666|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
44005306|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005307|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44005308|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44005309|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005310|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005311|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
44005312|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44005313|NCT05177991|Bupivacaine|bupivacaine|mesh-list
44005314|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
44005315|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
44005316|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005317|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005318|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
44005319|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005320|NCT05158153|Furosemide|furosemide|mesh-list
44005321|NCT05158153|Diuretics|diuretics|mesh-ancestor
44005322|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
44005323|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005326|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005327|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
44005328|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44005329|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44005331|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
44005332|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44005333|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
44005334|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005335|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
44005336|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
44005337|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005338|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005339|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005340|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
44005341|NCT05113901|Hormones|hormones|mesh-ancestor
44005342|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005343|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44005344|NCT05113901|Protective Agents|protective agents|mesh-ancestor
44005345|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005346|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005347|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
44005348|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005349|NCT05456763|Butyric Acid|butyric acid|mesh-list
44005350|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
44005351|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
44005352|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005353|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005354|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005355|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44005356|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005357|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005358|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44005359|NCT05456542|Dexamethasone|dexamethasone|mesh-list
44005360|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005361|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
44005362|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
44005363|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005364|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005365|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005366|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
44005367|NCT05456542|Hormones|hormones|mesh-ancestor
44005368|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247667|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247668|NCT01880567|Rituximab|rituximab|mesh-list
44247669|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44005369|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005370|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005371|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
44005372|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44005373|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146823|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146824|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146825|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146826|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146827|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
44146828|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146829|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146830|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146831|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146832|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146833|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146834|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146835|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146836|NCT00199121|Zidovudine|zidovudine|mesh-list
44146837|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
44146838|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146839|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44146840|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146841|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146842|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
44146843|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005383|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44005384|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44005385|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005386|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005387|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
44005388|NCT05456022|Protective Agents|protective agents|mesh-ancestor
44005389|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005391|NCT05455918|Cisplatin|cisplatin|mesh-list
44005392|NCT05455918|Ifosfamide|ifosfamide|mesh-list
44005393|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44005394|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005395|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44005396|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44005397|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44005398|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005399|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44005400|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
44005401|NCT05455359|Famotidine|famotidine|mesh-list
44005402|NCT05455359|Prucalopride|prucalopride|mesh-list
44005403|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44005404|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005405|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44005406|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
44005407|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
44005408|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005409|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005410|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005411|NCT05455359|Laxatives|laxatives|mesh-ancestor
44005412|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44005413|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44005414|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
44005415|NCT05455073|Folic Acid|folic acid|mesh-list
44005416|NCT05455073|Hematinics|hematinics|mesh-ancestor
44005417|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
44005418|NCT05455073|Vitamins|vitamins|mesh-ancestor
44005419|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
44005420|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005421|NCT05453916|Rifaximin|rifaximin|mesh-list
44005422|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
44005423|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44005424|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005425|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005426|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44005427|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44005428|NCT05453500|Prednisone|prednisone|mesh-list
44247670|NCT01880567|Antibodies|antibodies|mesh-list
44247671|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
44005429|NCT05453500|Cortisone|cortisone|mesh-list
44005430|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
44005431|NCT05453500|Rituximab|rituximab|mesh-list
44005432|NCT05453500|Doxorubicin|doxorubicin|mesh-list
44005433|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44005434|NCT05453500|Etoposide|etoposide|mesh-list
44005435|NCT05453500|Vincristine|vincristine|mesh-list
44005436|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
44005437|NCT05453500|Daunorubicin|daunorubicin|mesh-list
44005438|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
44005439|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44005441|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
44005442|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44005443|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44005444|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
44005445|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146844|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44005453|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44005454|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44005455|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005456|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005457|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
44005458|NCT05453500|Hormones|hormones|mesh-ancestor
44005459|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005460|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005461|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44005462|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
44005463|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
44005464|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
44005465|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
44005466|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
44005467|NCT05450055|Lidocaine|lidocaine|mesh-list
44005468|NCT05450055|Analgesics|analgesics|mesh-list
44005469|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
44005470|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
44005471|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005472|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005473|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
44005474|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005475|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44005476|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44005477|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44005478|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005479|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005480|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44005481|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005482|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005483|NCT05443984|Esomeprazole|esomeprazole|mesh-list
44005484|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44005485|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005486|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44005487|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005488|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005489|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
44005490|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44005491|NCT05437965|Hormones|hormones|mesh-ancestor
44005492|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005493|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005494|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
44005495|NCT05437094|Itraconazole|itraconazole|mesh-list
44005496|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
44005497|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005498|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44048951|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44005499|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44005500|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005501|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005502|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44005503|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44005504|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005505|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005506|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44247672|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247673|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
44247674|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247675|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005507|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44005508|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
44005515|NCT05323721|Artenimol|artenimol|mesh-list
44005516|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
44005517|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44005518|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44005519|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005520|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44005521|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005522|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005523|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44005524|NCT05323721|Renal Agents|renal agents|mesh-ancestor
44005525|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
44005526|NCT05288075|Charcoal|charcoal|mesh-list
44005527|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44005528|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44005529|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44005530|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
44005531|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005532|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005533|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005534|NCT05288075|Antidotes|antidotes|mesh-ancestor
44005535|NCT05288075|Protective Agents|protective agents|mesh-ancestor
44005536|NCT05273814|Bevacizumab|bevacizumab|mesh-list
44005538|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44005539|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005540|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005541|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44005542|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44005543|NCT05273814|Growth Substances|growth substances|mesh-ancestor
44005544|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005545|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44005546|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005547|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005548|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44005549|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44005550|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
44005551|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44005552|NCT05272787|Protective Agents|protective agents|mesh-ancestor
44005553|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005554|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146845|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44146846|NCT00199134|Letrozole|letrozole|mesh-list
44146847|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146848|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44146849|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44146850|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146851|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146852|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44146853|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
44146854|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146855|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146856|NCT00199147|Cytarabine|cytarabine|mesh-list
44146857|NCT00199147|Fludarabine|fludarabine|mesh-list
44146858|NCT00199147|Etoposide|etoposide|mesh-list
44146859|NCT00199147|Idarubicin|idarubicin|mesh-list
44146860|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146861|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146862|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
44146863|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146864|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146865|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
44146866|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146867|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146868|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146869|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146870|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247676|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460180|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44460181|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44247677|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
44146877|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146878|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146880|NCT00199186|Dexamethasone|dexamethasone|mesh-list
44146881|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
44146882|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
44146883|NCT00199186|Methotrexate|methotrexate|mesh-list
44146884|NCT00199186|Vincristine|vincristine|mesh-list
44146885|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
44146886|NCT00199186|Idarubicin|idarubicin|mesh-list
44146887|NCT00199186|BB 1101|bb 1101|mesh-list
43738447|NCT03469713|Nivolumab|nivolumab|mesh-list
44146888|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44146889|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
44146890|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146891|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005555|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
44005556|NCT05199493|Giapreza|giapreza|mesh-list
44005557|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
44005558|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005559|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44005560|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
44005561|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005562|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005563|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44005564|NCT05145569|Paclitaxel|paclitaxel|mesh-list
44005565|NCT05145569|Carboplatin|carboplatin|mesh-list
44005566|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44005567|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005568|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44005569|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44005570|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44005571|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005572|NCT05125237|Amiloride|amiloride|mesh-list
44005573|NCT05125237|Triamterene|triamterene|mesh-list
44005574|NCT05125237|Diuretics|diuretics|mesh-ancestor
44005575|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
44005576|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005577|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44005578|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44005579|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005580|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005581|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44005582|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44005583|NCT05100628|Doxorubicin|doxorubicin|mesh-list
44005584|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44005585|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005586|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44005587|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44005588|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005589|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005592|NCT05013255|Pioglitazone|pioglitazone|mesh-list
44005593|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005594|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005600|NCT04869449|Ketoconazole|ketoconazole|mesh-list
44005601|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
44005602|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005603|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44005607|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44005608|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
44005609|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005610|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247678|NCT01809691|Bicalutamide|bicalutamide|mesh-list
44247679|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
44247680|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
44005611|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44005613|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44005614|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44005615|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005617|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005618|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005619|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005620|NCT04826133|Vitamins|vitamins|mesh-ancestor
44005621|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
44005622|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44005623|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
44005624|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44005625|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005626|NCT04784208|Hormones|hormones|mesh-list
44005627|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005628|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005629|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
44005630|NCT04767074|Guaifenesin|guaifenesin|mesh-list
44005631|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44005632|NCT04767074|Expectorants|expectorants|mesh-ancestor
44005633|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005634|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44005635|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44005636|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44005637|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005638|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005639|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005640|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
44005641|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44005642|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
44005643|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
44005644|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005645|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
44005646|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44005647|NCT04762381|Dexamethasone|dexamethasone|mesh-list
44005648|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
44005649|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44005650|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005651|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
44005652|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
44005653|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005654|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005655|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005656|NCT04762381|Hormones|hormones|mesh-ancestor
44005657|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005658|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005659|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005660|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
44005661|NCT04741620|Capsaicin|capsaicin|mesh-list
44005662|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
44005663|NCT04741620|Citric Acid|citric acid|mesh-list
44005664|NCT04741620|Piperine|piperine|mesh-list
44005665|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
44005666|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
44005667|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
44005668|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005669|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005670|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
44005671|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44005672|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
44005673|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
44005674|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005684|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005685|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44005686|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005687|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005688|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44247681|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247682|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247683|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247684|NCT01786265|Prednisone|prednisone|mesh-list
44247685|NCT01786265|Cortisone|cortisone|mesh-list
44005689|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005690|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005691|NCT04647110|Crizotinib|crizotinib|mesh-list
44005692|NCT04647110|Ceritinib|ceritinib|mesh-list
44005693|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005694|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44005695|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005696|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005697|NCT04564339|Ravulizumab|ravulizumab|mesh-list
44005698|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44005699|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44005700|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
44005701|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146892|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44005702|NCT04405349|Atezolizumab|atezolizumab|mesh-list
44005703|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005704|NCT04282954|Esomeprazole|esomeprazole|mesh-list
44005705|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44005706|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005707|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44005708|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005709|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005710|NCT04233229|Insulin|insulin|mesh-list
44005711|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005712|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005713|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
44005714|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
44005715|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44005716|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005717|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005718|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
44005719|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44005720|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005721|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005722|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
44005723|NCT04208347|Apatinib|apatinib|mesh-list
44005724|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005725|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44005726|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005727|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005728|NCT04120415|Vedolizumab|vedolizumab|mesh-list
44005729|NCT04120415|Vaccines|vaccines|mesh-list
44005730|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
44005731|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005732|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005733|NCT04098874|Bupropion|bupropion|mesh-list
44005734|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44005735|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
44005736|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44005737|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44005738|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44005745|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44005746|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005747|NCT04080843|Capecitabine|capecitabine|mesh-list
44005748|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
44005749|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44005750|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
44005751|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005752|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005754|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44005755|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44005756|NCT04066348|Analgesics|analgesics|mesh-ancestor
44005757|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
44005758|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247686|NCT01786265|Leuprolide|leuprolide|mesh-list
44247687|NCT01786265|Goserelin|goserelin|mesh-list
44247688|NCT01786265|Flutamide|flutamide|mesh-list
44247689|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
44247690|NCT01786265|Bicalutamide|bicalutamide|mesh-list
44247691|NCT01786265|Nilutamide|nilutamide|mesh-list
44247692|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005759|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005760|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005761|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005762|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005763|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44005764|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
44005765|NCT04064684|Budesonide|budesonide|mesh-list
44005766|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005767|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44005768|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
44005769|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005770|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005771|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44005772|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005773|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
44005774|NCT04064684|Hormones|hormones|mesh-ancestor
44005775|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005776|NCT04024878|Nivolumab|nivolumab|mesh-list
44005777|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005778|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005779|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44005780|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005781|NCT03875235|Durvalumab|durvalumab|mesh-list
44005782|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005783|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005784|NCT03860207|Antibodies|antibodies|mesh-list
44005785|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
44005786|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44005787|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
44005788|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005789|NCT03845010|Verapamil|verapamil|mesh-list
44005790|NCT03845010|Sotalol|sotalol|mesh-list
44005791|NCT03845010|Flecainide|flecainide|mesh-list
44005792|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44005793|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44005794|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005795|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005796|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44005797|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005798|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44005799|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44005800|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44005801|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
44005802|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005803|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
44005804|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
44005805|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005813|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005814|NCT03829046|Evolocumab|evolocumab|mesh-list
44005815|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44005816|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44005817|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
44005818|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005819|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44005820|NCT03808077|Rocuronium|rocuronium|mesh-list
44005821|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44005822|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44005823|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44005824|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005825|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005826|NCT03763175|Lovastatin|lovastatin|mesh-list
44005827|NCT03763175|L 647318|l 647318|mesh-list
44005828|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
44247693|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
44247694|NCT01786265|Hormones|hormones|mesh-ancestor
44247695|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247696|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005829|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44005830|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44005831|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
44005832|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005833|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44005834|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44005836|NCT03762395|CXA-10|cxa-10|mesh-list
44005837|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005838|NCT03713437|Insulin|insulin|mesh-list
44005839|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005840|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005841|NCT03568890|Aspirin|aspirin|mesh-list
44005842|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
44005843|NCT03568890|Apixaban|apixaban|mesh-list
44005844|NCT03568890|Edoxaban|edoxaban|mesh-list
44005845|NCT03568890|Dabigatran|dabigatran|mesh-list
44005846|NCT03568890|Clopidogrel|clopidogrel|mesh-list
44005847|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44005848|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44005849|NCT03568890|Analgesics|analgesics|mesh-ancestor
44005850|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
44005851|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005852|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005853|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005854|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005855|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44005856|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44005857|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005858|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44005859|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44005860|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005861|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
44005862|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44005863|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44005864|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44005865|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
44005866|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005867|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44005868|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
44005869|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44005870|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
44005871|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
44005872|NCT03439670|Prednisone|prednisone|mesh-list
44005873|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005874|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
44005875|NCT03439670|Hormones|hormones|mesh-ancestor
44005876|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005890|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005891|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005892|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
44005902|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
44005903|NCT03277729|Fludarabine|fludarabine|mesh-list
44005904|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
44005905|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44005906|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
44005907|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005908|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005909|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44005910|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
44005911|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005912|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005913|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44005914|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44005915|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
44005916|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
44005917|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44005918|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44005919|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
44247697|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247698|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247699|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44247700|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
44247701|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44247702|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44005920|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005921|NCT03241732|Expectorants|expectorants|mesh-ancestor
44005922|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
44005923|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44005924|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
44005925|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005926|NCT03241732|Protective Agents|protective agents|mesh-ancestor
44005927|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005928|NCT03241732|Antidotes|antidotes|mesh-ancestor
44005929|NCT03229057|Metformin|metformin|mesh-list
44005930|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44005931|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146893|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
44146894|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146895|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146896|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44146897|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44146898|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
44146899|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
44146900|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146901|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146902|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
44146903|NCT00199186|Hormones|hormones|mesh-ancestor
44146904|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44146905|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44146906|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44146907|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146908|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44146914|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146915|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146916|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146917|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44146918|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146919|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44146920|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
44146921|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146922|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146923|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146924|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146925|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146926|NCT00199212|Trastuzumab|trastuzumab|mesh-list
44146928|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146929|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146930|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
44146931|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44146932|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146933|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44146934|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146935|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146936|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146937|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146938|NCT00199264|Albaconazole|albaconazole|mesh-list
44146939|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
44146940|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146941|NCT00199277|Iron|iron|mesh-list
44146942|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44146943|NCT00199277|Trace Elements|trace elements|mesh-ancestor
44146944|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
44146945|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146946|NCT00199277|Hematinics|hematinics|mesh-ancestor
44146947|NCT00199316|Morphine|morphine|mesh-list
44146948|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44146949|NCT00199316|Narcotics|narcotics|mesh-ancestor
43634163|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44247703|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247704|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247705|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
44247706|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43646655|NCT02908750|Fexofenadine|fexofenadine|mesh-list
44146950|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146951|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146952|NCT00199316|Analgesics|analgesics|mesh-ancestor
44146953|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
44146954|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146955|NCT00199329|Ondansetron|ondansetron|mesh-list
44146956|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
44146957|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
44146958|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146959|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146960|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44146961|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
44146962|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146963|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44146964|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
44146965|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146966|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005932|NCT03069131|Rifaximin|rifaximin|mesh-list
44005933|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44005934|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005935|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005936|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
44005937|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44005938|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44005939|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44005940|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005941|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005942|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
44005943|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005944|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005949|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005950|NCT02581527|Rifampin|rifampin|mesh-list
44005951|NCT02581527|Isoniazid|isoniazid|mesh-list
44005952|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
44005953|NCT02581527|Ethambutol|ethambutol|mesh-list
44005954|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44005955|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
44005956|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44005957|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005958|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
44005959|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44005960|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005961|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005962|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44005963|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44005964|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44005965|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44005966|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44005967|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44005968|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44005969|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44005970|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
44005971|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44005972|NCT02529930|Vaccines|vaccines|mesh-list
44005973|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
44005974|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005975|NCT02522715|Prednisone|prednisone|mesh-list
44005976|NCT02522715|Cortisone|cortisone|mesh-list
44005977|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005978|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
44005979|NCT02522715|Hormones|hormones|mesh-ancestor
44005980|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005981|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005982|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247707|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
44247709|NCT01740427|Palbociclib|palbociclib|mesh-list
44247710|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247711|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44247712|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44005983|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005984|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
44005985|NCT02453373|Plasminogen|plasminogen|mesh-list
44005986|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44005987|NCT02453373|Propofol|propofol|mesh-list
44005988|NCT02453373|Etomidate|etomidate|mesh-list
44005989|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44005990|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44005991|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005992|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44005993|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
44005994|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
44005995|NCT02453373|Analgesics|analgesics|mesh-ancestor
44005996|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
44005997|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005998|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44005999|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
44006000|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44006001|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006002|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006003|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44006004|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
44006005|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006006|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44006007|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44006009|NCT02415712|Antidotes|antidotes|mesh-ancestor
44006010|NCT02415712|Protective Agents|protective agents|mesh-ancestor
44006011|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006012|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006013|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006014|NCT02374242|Nivolumab|nivolumab|mesh-list
44006015|NCT02374242|Ipilimumab|ipilimumab|mesh-list
44006016|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006017|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006024|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006025|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006027|NCT01674140|Everolimus|everolimus|mesh-list
44006028|NCT01674140|Letrozole|letrozole|mesh-list
44006029|NCT01674140|Anastrozole|anastrozole|mesh-list
44006030|NCT01674140|Leuprolide|leuprolide|mesh-list
44006031|NCT01674140|Exemestane|exemestane|mesh-list
44006032|NCT01674140|Goserelin|goserelin|mesh-list
44006033|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006034|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006035|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44006036|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
44006037|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006038|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44006039|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44006040|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006041|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44006042|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
44006043|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006044|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44006045|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44006046|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44006047|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44006048|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44006049|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
44006050|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006051|NCT01163383|Iodine|iodine|mesh-list
44006052|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
44006053|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44006054|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44006055|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247713|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247714|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247715|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44247716|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
44247717|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247718|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247719|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247720|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44247722|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44247723|NCT01735825|Everolimus|everolimus|mesh-list
44247724|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247725|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247726|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646664|NCT02891954|Canagliflozin|canagliflozin|mesh-list
44006056|NCT01163383|Trace Elements|trace elements|mesh-ancestor
44006057|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
44006058|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006059|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006060|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006061|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006062|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44006064|NCT00966914|Docetaxel|docetaxel|mesh-list
44006065|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44006066|NCT00966914|Cisplatin|cisplatin|mesh-list
44006067|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
44006068|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44006069|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006070|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44006071|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006072|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006073|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006074|NCT00966914|Protective Agents|protective agents|mesh-ancestor
44006075|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006076|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
44006077|NCT00039780|Protective Agents|protective agents|mesh-ancestor
44006078|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006079|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
44006080|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44006081|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
44006082|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006083|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006084|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006085|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006086|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44006087|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
44006092|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
44006093|NCT05101746|Protective Agents|protective agents|mesh-ancestor
44006094|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
44006095|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44006096|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44006097|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
44006098|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006099|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049663|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006100|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006101|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006102|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44006103|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
44006104|NCT05088369|Protective Agents|protective agents|mesh-ancestor
44247727|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247728|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247729|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006105|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
44006106|NCT05063396|Anesthetics|anesthetics|mesh-list
44006107|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006108|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006109|NCT05063396|Narcotics|narcotics|mesh-ancestor
44006110|NCT05063396|Analgesics|analgesics|mesh-ancestor
44006111|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
44006112|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006113|NCT05062317|Leucovorin|leucovorin|mesh-list
44006114|NCT05062317|Bevacizumab|bevacizumab|mesh-list
44006115|NCT05062317|Fluorouracil|fluorouracil|mesh-list
44006116|NCT05062317|Capecitabine|capecitabine|mesh-list
44006117|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
44006118|NCT05062317|Irinotecan|irinotecan|mesh-list
44006119|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006120|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006121|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44006122|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44006123|NCT05062317|Growth Substances|growth substances|mesh-ancestor
44006124|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006125|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
44006126|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
44006127|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006128|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44006129|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44006130|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
44006131|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44006132|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44006133|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006134|NCT05062317|Antidotes|antidotes|mesh-ancestor
44006135|NCT05062317|Protective Agents|protective agents|mesh-ancestor
44006136|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
44006137|NCT05062317|Vitamins|vitamins|mesh-ancestor
44006138|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
44006139|NCT05055752|Aspirin|aspirin|mesh-list
44006140|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006141|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006142|NCT05055752|Analgesics|analgesics|mesh-ancestor
44006143|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
44006144|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006145|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006146|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006147|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006148|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44006149|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44006150|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006151|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44006152|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44006153|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006154|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
44006155|NCT05051527|Silymarin|silymarin|mesh-list
44006156|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
44006157|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006158|NCT05051527|Protective Agents|protective agents|mesh-ancestor
44146967|NCT00199329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44006163|NCT05045937|Remdesivir|remdesivir|mesh-list
44006164|NCT05045937|Ibuprofen|ibuprofen|mesh-list
44006165|NCT05045937|Budesonide|budesonide|mesh-list
44006166|NCT05045937|Melatonin|melatonin|mesh-list
44006167|NCT05045937|Albuterol|albuterol|mesh-list
44006168|NCT05045937|Quercetin|quercetin|mesh-list
44049743|NCT00003671|Leucovorin|leucovorin|mesh-list
44006169|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006170|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
44006171|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44006172|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006173|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006174|NCT05045937|Analgesics|analgesics|mesh-ancestor
44006175|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
44006176|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006177|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006178|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830602|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44247730|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247731|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
44006179|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006180|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44006181|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006182|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44006183|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
44006184|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006185|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006186|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
44006187|NCT05045937|Hormones|hormones|mesh-ancestor
44006188|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006189|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
44006190|NCT05045937|Protective Agents|protective agents|mesh-ancestor
44006191|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006192|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
44006193|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006194|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44006195|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44006196|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44006197|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006198|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006199|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44006200|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006201|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
44006202|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
44006203|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44006204|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006205|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006206|NCT05037032|Naltrexone|naltrexone|mesh-list
44006207|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44006208|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44006209|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006210|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
44006211|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006212|NCT05029726|Clonidine|clonidine|mesh-list
44006213|NCT05029726|Epinephrine|epinephrine|mesh-list
44006214|NCT05029726|Bupivacaine|bupivacaine|mesh-list
44006215|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
44006216|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
44006217|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006218|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006219|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
44006220|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006221|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44006222|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44006223|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006224|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006225|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006226|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44006227|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44006228|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
44006229|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006230|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006231|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
44006232|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
44006239|NCT04982237|Bevacizumab|bevacizumab|mesh-list
44006240|NCT04982237|Cisplatin|cisplatin|mesh-list
44006241|NCT04982237|Carboplatin|carboplatin|mesh-list
44006242|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44006243|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006244|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44006245|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006246|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006247|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006248|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006249|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44006250|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44006251|NCT04982237|Growth Substances|growth substances|mesh-ancestor
44006252|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006253|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
44006254|NCT04958811|Bevacizumab|bevacizumab|mesh-list
44006255|NCT04958811|Atezolizumab|atezolizumab|mesh-list
44006256|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247732|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247733|NCT01734928|Thalidomide|thalidomide|mesh-list
44247734|NCT01734928|Dexamethasone|dexamethasone|mesh-list
44247735|NCT01734928|Bortezomib|bortezomib|mesh-list
44247736|NCT01734928|Pomalidomide|pomalidomide|mesh-list
44006257|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006258|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44006259|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44006260|NCT04958811|Growth Substances|growth substances|mesh-ancestor
44006261|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006262|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
44006263|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
44006264|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44006265|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44006266|NCT04900220|Prednisolone|prednisolone|mesh-list
44006267|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
44006268|NCT04900220|Betamethasone|betamethasone|mesh-list
44006269|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44006270|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
44006271|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006272|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
44006273|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
44006274|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006275|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006276|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44006277|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
44006278|NCT04900220|Hormones|hormones|mesh-ancestor
44006279|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006280|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44006281|NCT04900220|Protective Agents|protective agents|mesh-ancestor
44006282|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44006283|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006284|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006285|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006323|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
44006324|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006325|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44006326|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820600|NCT05405387|Budesonide|budesonide|mesh-list
44247737|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247738|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
44247739|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
44247740|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247741|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247742|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44247743|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
44247744|NCT01734928|Hormones|hormones|mesh-ancestor
44006327|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006328|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
44006329|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006330|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006331|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44006332|NCT04825522|Vancomycin|vancomycin|mesh-list
44006333|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006334|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146968|NCT00199329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146969|NCT00199329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146970|NCT00199329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146971|NCT00199329|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44146972|NCT00199342|Ecromeximab|ecromeximab|mesh-list
44146973|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146974|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146975|NCT00199355|Istradefylline|istradefylline|mesh-list
44146976|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44146977|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44146978|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44146979|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
44146980|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146981|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146982|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146983|NCT00199368|Istradefylline|istradefylline|mesh-list
44146984|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44146985|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44146986|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44146987|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
44146988|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146989|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146990|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146991|NCT00199394|Istradefylline|istradefylline|mesh-list
44146992|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44146993|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44146994|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44146995|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
44146996|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44146997|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146998|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146999|NCT00199407|Istradefylline|istradefylline|mesh-list
44147000|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44147001|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44147002|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44147003|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
44147004|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147005|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147006|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147007|NCT00199420|Istradefylline|istradefylline|mesh-list
44147013|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147014|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147015|NCT00199433|Istradefylline|istradefylline|mesh-list
44147016|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44006335|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44006336|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006337|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
44247745|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247746|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247747|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247748|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
44247749|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247750|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247751|NCT01734928|Growth Substances|growth substances|mesh-ancestor
44006338|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44006339|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
44006340|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006341|NCT04792021|Expectorants|expectorants|mesh-ancestor
44006342|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
44049944|NCT00003686|Pilocarpine|pilocarpine|mesh-list
44006343|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44006344|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
44006345|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006346|NCT04792021|Protective Agents|protective agents|mesh-ancestor
44006347|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006348|NCT04792021|Antidotes|antidotes|mesh-ancestor
44006349|NCT04771299|Cariprazine|cariprazine|mesh-list
44006350|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44006351|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44006352|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006353|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006354|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44006355|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
44006356|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44006357|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
44006358|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006359|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
44006360|NCT04766918|Protective Agents|protective agents|mesh-ancestor
44006361|NCT04763226|Furosemide|furosemide|mesh-list
44006362|NCT04763226|Diuretics|diuretics|mesh-ancestor
44006363|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
44006364|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006365|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44006366|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006367|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006368|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
44006369|NCT04757675|Ketamine|ketamine|mesh-list
44006370|NCT04757675|Esketamine|esketamine|mesh-list
44006371|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44006372|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006373|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006374|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006375|NCT04757675|Analgesics|analgesics|mesh-ancestor
44006376|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
44006377|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006378|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44006379|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44006380|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44006381|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006382|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006383|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006384|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44006385|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006386|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
44006387|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
44006388|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44006389|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44006390|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
44006391|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44006392|NCT04755712|Sufentanil|sufentanil|mesh-list
44006393|NCT04755712|Morphine|morphine|mesh-list
44006394|NCT04755712|Bupivacaine|bupivacaine|mesh-list
44006395|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
43821679|NCT03571633|Trastuzumab|trastuzumab|mesh-list
44247753|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247754|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
44247755|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44247756|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247757|NCT01723774|Anastrozole|anastrozole|mesh-list
44247758|NCT01723774|Goserelin|goserelin|mesh-list
44006409|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006410|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006411|NCT04751812|Analgesics|analgesics|mesh-ancestor
44006412|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
44006413|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006414|NCT04665089|Erythromycin|erythromycin|mesh-list
44006415|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
44006416|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44006417|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
44006418|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006419|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006420|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44006421|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44006422|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006423|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006424|NCT04654988|Prednisone|prednisone|mesh-list
44006425|NCT04654988|Azathioprine|azathioprine|mesh-list
44006426|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006427|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
44006428|NCT04654988|Hormones|hormones|mesh-ancestor
44006429|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006430|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006431|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44006432|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006433|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
44006434|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006435|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44006436|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44006437|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
44006438|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006439|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
44006440|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44006441|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006442|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006443|NCT04645823|Lidocaine|lidocaine|mesh-list
44006444|NCT04645823|Fentanyl|fentanyl|mesh-list
44006445|NCT04645823|Citric Acid|citric acid|mesh-list
44006446|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
44006447|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
44006448|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
44006449|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006450|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006451|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
44006452|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006453|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44006454|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44006455|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44006456|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006457|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006459|NCT04645823|Narcotics|narcotics|mesh-ancestor
44006460|NCT04645823|Analgesics|analgesics|mesh-ancestor
44006461|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44006462|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006463|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
44006464|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
44006465|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44006466|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
44006467|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
44006468|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
44006469|NCT04606901|Neostigmine|neostigmine|mesh-list
44006470|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44006471|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247760|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247761|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247762|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44247763|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44247764|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247765|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006472|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006473|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
44006474|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006475|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006476|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44006477|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
44006478|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006479|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44006480|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44006481|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44006482|NCT04549428|Atezolizumab|atezolizumab|mesh-list
44006483|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006484|NCT04527900|Paclitaxel|paclitaxel|mesh-list
44006485|NCT04527900|Carboplatin|carboplatin|mesh-list
44006486|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739317|NCT03218085|Tenofovir|tenofovir|mesh-list
44006487|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006488|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44006489|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006490|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006491|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006492|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44006493|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44006494|NCT04507022|Estradiol|estradiol|mesh-list
44006495|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44006496|NCT04507022|Progesterone|progesterone|mesh-list
44006497|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44006498|NCT04507022|Estrogens|estrogens|mesh-ancestor
44006499|NCT04507022|Hormones|hormones|mesh-ancestor
44006500|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006501|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006502|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44006503|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
44006504|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006505|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44006506|NCT04507022|Progestins|progestins|mesh-ancestor
44006507|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44006508|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006509|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006510|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44006511|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44006512|NCT04504175|Ketamine|ketamine|mesh-list
44006513|NCT04504175|Analgesics|analgesics|mesh-ancestor
44006514|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
44006515|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006516|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006517|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44006518|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006519|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
44006520|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
44006521|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006522|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44006523|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44006524|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006525|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006526|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
44006527|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44006528|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006529|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006530|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
44247766|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44247767|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646708|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
44006531|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006540|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006541|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44006542|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006543|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006544|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006545|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44147017|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44147018|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44147019|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
44147020|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147021|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147022|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147023|NCT00199446|Istradefylline|istradefylline|mesh-list
44147024|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44147025|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44147026|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44147027|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
44147028|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147029|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006546|NCT04340856|Bisacodyl|bisacodyl|mesh-list
44006547|NCT04340856|Laxatives|laxatives|mesh-list
44006548|NCT04340856|Cathartics|cathartics|mesh-ancestor
44006549|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44006550|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
44006551|NCT04336189|Piperaquine|piperaquine|mesh-list
44006552|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
44006553|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44006554|NCT04336189|Artenimol|artenimol|mesh-list
44006555|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
44006556|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44006557|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44006558|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006559|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44006560|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006561|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006562|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44006563|NCT04336189|Renal Agents|renal agents|mesh-ancestor
44006564|NCT04332497|Ibuprofen|ibuprofen|mesh-list
44006565|NCT04332497|Fentanyl|fentanyl|mesh-list
44006566|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44006567|NCT04332497|Narcotics|narcotics|mesh-ancestor
44006568|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006569|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006570|NCT04332497|Analgesics|analgesics|mesh-ancestor
44006571|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
44006572|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006573|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44006574|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006575|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
44006576|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
44006577|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006578|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006579|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006580|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006581|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44006582|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006583|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006584|NCT04311567|Methotrexate|methotrexate|mesh-list
44006585|NCT04311567|Tofacitinib|tofacitinib|mesh-list
44006588|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006589|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006590|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44006591|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
44006592|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006593|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006594|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
44006595|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006596|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44006597|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247768|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247769|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247770|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247771|NCT01667744|Citalopram|citalopram|mesh-list
44006598|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
44006599|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006600|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44006601|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44006603|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
44006604|NCT04260659|Fentanyl|fentanyl|mesh-list
44006605|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
44006606|NCT04260659|Ketamine|ketamine|mesh-list
44006607|NCT04260659|Remifentanil|remifentanil|mesh-list
44006608|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
44006609|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
44006610|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006611|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006612|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
44006613|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006614|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44006615|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44006616|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44006617|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006618|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006619|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44006620|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006621|NCT04260659|Analgesics|analgesics|mesh-ancestor
43739408|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44006622|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44006623|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44006624|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44006625|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006626|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006627|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44006628|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006629|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
44006630|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44006631|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44006632|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44006634|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44006635|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
44006636|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44006637|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44006638|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
44006639|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006640|NCT04259775|Insulin|insulin|mesh-list
44006641|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44006642|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006643|NCT04258397|Pirfenidone|pirfenidone|mesh-list
44006644|NCT04258397|Analgesics|analgesics|mesh-ancestor
44006645|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
44006646|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006647|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006648|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006649|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006650|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006651|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006652|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006653|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
44006654|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006655|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006656|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
44006657|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006662|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
44006663|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006664|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006665|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44006666|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44006667|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44247772|NCT01667744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44247773|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43646713|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
44006668|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006669|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006670|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006671|NCT04231708|Urological Agents|urological agents|mesh-ancestor
44006672|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
44006673|NCT04225078|Loperamide|loperamide|mesh-list
44006674|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
44006675|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006676|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006677|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050289|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
44006678|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44006679|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006680|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006681|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006682|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44006683|NCT04188665|Lectins|lectins|mesh-list
44006684|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
44006685|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
44006686|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006687|NCT04188665|Coagulants|coagulants|mesh-ancestor
44006688|NCT04186247|Azithromycin|azithromycin|mesh-list
44006689|NCT04186247|Metronidazole|metronidazole|mesh-list
44006690|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006691|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006692|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44006693|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44006694|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
44006695|NCT04181515|Yohimbine|yohimbine|mesh-list
44006696|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006697|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
44006698|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
44006699|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006700|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006701|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44006702|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44006703|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44006704|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006705|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006706|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006707|NCT04181515|Urological Agents|urological agents|mesh-ancestor
44006708|NCT04181255|Poractant alfa|poractant alfa|mesh-list
44006709|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44006710|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006711|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
44006712|NCT04180969|Yohimbine|yohimbine|mesh-list
44006713|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006714|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
44006715|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
44006716|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006717|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006718|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44006719|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44006720|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44006721|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006722|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006723|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006724|NCT04180969|Urological Agents|urological agents|mesh-ancestor
44006725|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
44006726|NCT04164069|Leucovorin|leucovorin|mesh-list
44006727|NCT04164069|Folic Acid|folic acid|mesh-list
44006728|NCT04164069|Bevacizumab|bevacizumab|mesh-list
44006729|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44006730|NCT04164069|Fluorouracil|fluorouracil|mesh-list
44006731|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
44006732|NCT04164069|Dasatinib|dasatinib|mesh-list
44006740|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006741|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44006742|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44006743|NCT04164069|Growth Substances|growth substances|mesh-ancestor
44006744|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006745|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247774|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44247775|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247776|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247777|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
44247778|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006746|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
44006747|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44050351|NCT00003728|Antidotes|antidotes|mesh-ancestor
44006748|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44006749|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
44006750|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006751|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44006752|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44006753|NCT04164069|Antidotes|antidotes|mesh-ancestor
44006754|NCT04164069|Protective Agents|protective agents|mesh-ancestor
44006755|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
44006756|NCT04164069|Vitamins|vitamins|mesh-ancestor
44006757|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
44006758|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44006759|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006760|NCT04164069|Hematinics|hematinics|mesh-ancestor
44006761|NCT04101877|Bevacizumab|bevacizumab|mesh-list
44006762|NCT04101877|Aflibercept|aflibercept|mesh-list
44006763|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006764|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006765|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44006766|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44006767|NCT04101877|Growth Substances|growth substances|mesh-ancestor
44006768|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006769|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
44006770|NCT04061330|Ketamine|ketamine|mesh-list
44006771|NCT04061330|Morphine|morphine|mesh-list
44006772|NCT04061330|Analgesics|analgesics|mesh-ancestor
44006773|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
44006774|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006775|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006776|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44006777|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006778|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
44006780|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006781|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44006782|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44006783|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006784|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006785|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44006786|NCT04061330|Narcotics|narcotics|mesh-ancestor
44006787|NCT04040790|Phenylephrine|phenylephrine|mesh-list
44006788|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
44006789|NCT04040790|Tropicamide|tropicamide|mesh-list
44006790|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44006791|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
44006792|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
44006793|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006794|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006795|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
44006796|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44006797|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
44006798|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006799|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44006800|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44006801|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44006802|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006803|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006804|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006809|NCT04033354|Paclitaxel|paclitaxel|mesh-list
44006810|NCT04033354|Carboplatin|carboplatin|mesh-list
44006811|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44006812|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006813|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247779|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44247780|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
44006814|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006815|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006816|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006817|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44006818|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44006819|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44006820|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006821|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006822|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44006823|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006824|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006825|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
44006826|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006827|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
44006828|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44006829|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006830|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006831|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44006832|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006833|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006835|NCT03797196|Everolimus|everolimus|mesh-list
44006836|NCT03797196|Tacrolimus|tacrolimus|mesh-list
44006837|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44006838|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
44006839|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006840|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44006841|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006842|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006843|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006844|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44006845|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44006846|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
44006847|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006848|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006849|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44006850|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44006851|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006852|NCT03743766|Nivolumab|nivolumab|mesh-list
44006853|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006854|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006855|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44006856|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147030|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147031|NCT00199472|Diuretics|diuretics|mesh-list
44147032|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
44147033|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147034|NCT00199511|Mannitol|mannitol|mesh-list
44147035|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44147036|NCT00199511|Diuretics|diuretics|mesh-ancestor
44147037|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
44147038|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147039|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
44147040|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147041|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44147042|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44147043|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147044|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147045|NCT00199563|Urological Agents|urological agents|mesh-ancestor
44147046|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
44147047|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44147048|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44147051|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44147052|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
44147053|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44147054|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
44147055|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
44147056|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247782|NCT01664910|Rituximab|rituximab|mesh-list
44147057|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147058|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147059|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
44147061|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147062|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44147063|NCT00199576|Protective Agents|protective agents|mesh-ancestor
44147064|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44147065|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147066|NCT00199602|Heparin|heparin|mesh-list
44147067|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
44147068|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44147069|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44147070|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147071|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
44147072|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147073|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147074|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44147075|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
44147076|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44147077|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147078|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147079|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147080|NCT00199719|Ribavirin|ribavirin|mesh-list
44147081|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
44147082|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147083|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
44147084|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147085|NCT00199745|Atorvastatin|atorvastatin|mesh-list
44147086|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44147087|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44147088|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
44147089|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147090|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44147091|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44147092|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147093|NCT00199758|Gemcitabine|gemcitabine|mesh-list
44147094|NCT00199758|Cisplatin|cisplatin|mesh-list
44147095|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147096|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147097|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
43739687|NCT02534623|Narcotics|narcotics|mesh-ancestor
44006857|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
44006858|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44006859|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006860|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44006861|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006862|NCT03581409|Aspirin|aspirin|mesh-list
44006863|NCT03581409|Cilostazol|cilostazol|mesh-list
44006864|NCT03581409|Clopidogrel|clopidogrel|mesh-list
44006865|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44006866|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006867|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006868|NCT03581409|Analgesics|analgesics|mesh-ancestor
44006869|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
44006870|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006871|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006872|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006873|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006874|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44006875|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44006876|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006877|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44006878|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44006879|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006882|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44006883|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44006884|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
44006885|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006886|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44006888|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44006889|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44247783|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44247784|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44247785|NCT01664910|Methotrexate|methotrexate|mesh-list
44247786|NCT01664910|Fludarabine|fludarabine|mesh-list
44006890|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44006891|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44006892|NCT03581409|Protective Agents|protective agents|mesh-ancestor
44006893|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44006894|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44006895|NCT03566667|Metoprolol|metoprolol|mesh-list
44006896|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44006897|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44006898|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
44006899|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
44006900|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006901|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006902|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44006903|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44006904|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44006905|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
44006906|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006907|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006908|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44006909|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44006910|NCT03556800|Estradiol|estradiol|mesh-list
44006911|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44006912|NCT03556800|Estrogens|estrogens|mesh-ancestor
44006913|NCT03556800|Hormones|hormones|mesh-ancestor
44006914|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44006915|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006916|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44006917|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
44006918|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44006919|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44006920|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
44006921|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
44006922|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44006923|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
44006924|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006925|NCT03510741|Expectorants|expectorants|mesh-ancestor
44006926|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006927|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44006928|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
44006929|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006930|NCT03510741|Protective Agents|protective agents|mesh-ancestor
43739775|NCT02533544|Tenofovir|tenofovir|mesh-list
44006931|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006932|NCT03510741|Antidotes|antidotes|mesh-ancestor
44006933|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
44006934|NCT03503513|Gentamicins|gentamicins|mesh-list
44006935|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44006936|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44006937|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44006938|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006939|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006940|NCT03472495|Diltiazem|diltiazem|mesh-list
44006941|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44006942|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44006943|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44006944|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006945|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44006946|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006947|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
44006956|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44006957|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006958|NCT03197194|Aspirin|aspirin|mesh-list
44006959|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44247787|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
44247788|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44247789|NCT01664910|Antibodies|antibodies|mesh-list
44247790|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
44247791|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44006960|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44006961|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44006962|NCT03197194|Analgesics|analgesics|mesh-ancestor
44006963|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
44006964|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006965|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006966|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006967|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44006968|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44006969|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44006970|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006971|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44006972|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44006973|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006974|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
44006975|NCT03168880|Paclitaxel|paclitaxel|mesh-list
44006976|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44006977|NCT03168880|Carboplatin|carboplatin|mesh-list
44006978|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44006979|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006981|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
44006982|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
44006983|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006984|NCT03092895|Apatinib|apatinib|mesh-list
44006985|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006986|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44006987|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006988|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006989|NCT02977299|Aripiprazole|aripiprazole|mesh-list
44006990|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44006991|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
44006992|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44006993|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44006994|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44006995|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006996|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006997|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
44006998|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
44006999|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007000|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007001|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44007002|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44007003|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
44007004|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44007005|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44007006|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44007007|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44007008|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44007009|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44007010|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007011|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44007012|NCT02923466|Interferon-beta|interferon-beta|mesh-list
44007013|NCT02923466|Avelumab|avelumab|mesh-list
44007014|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007015|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007016|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
44007017|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007018|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
44007019|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007020|NCT02850874|Gemcitabine|gemcitabine|mesh-list
44007021|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44007022|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
44007027|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007028|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247792|NCT01664910|Tacrolimus|tacrolimus|mesh-list
44247793|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
44247794|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44247795|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
44247796|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247797|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007029|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
44007030|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007031|NCT02827838|Durvalumab|durvalumab|mesh-list
44007032|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
44007033|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44007034|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
44007035|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007036|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007037|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
44007038|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007039|NCT02794337|Sorafenib|sorafenib|mesh-list
44007040|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007041|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44007042|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007043|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007044|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
44007045|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007046|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007047|NCT02638701|Infliximab|infliximab|mesh-list
44007048|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007049|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007050|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007051|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
44007052|NCT02590523|Vancomycin|vancomycin|mesh-list
44007054|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007055|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44007056|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44007057|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007058|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007059|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007060|NCT02582125|Nivolumab|nivolumab|mesh-list
44007061|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007062|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007063|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44007064|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007065|NCT02344498|Tenofovir|tenofovir|mesh-list
44007066|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
44007067|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007068|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44007069|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44007070|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007071|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007072|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44007073|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44007074|NCT02278185|Leuprolide|leuprolide|mesh-list
44007075|NCT02278185|Goserelin|goserelin|mesh-list
44007076|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44007077|NCT02278185|Tryptophan|tryptophan|mesh-list
44007078|NCT02278185|Androgens|androgens|mesh-list
44007079|NCT02278185|Hormones|hormones|mesh-ancestor
43739850|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
44007080|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007081|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007082|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44007083|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
44007084|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44007085|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007086|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007087|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
44007088|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44007089|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
44007090|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44007091|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44007092|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
44007093|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44247798|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247799|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44247800|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
44247801|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44247802|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247803|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
44247804|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247805|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007100|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007101|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007102|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007103|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007104|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007105|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44007106|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44007107|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44007109|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44007110|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44007111|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007112|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44007113|NCT01821781|Fludarabine|fludarabine|mesh-list
44007114|NCT01821781|Melphalan|melphalan|mesh-list
44007115|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
44007116|NCT01821781|Thiotepa|thiotepa|mesh-list
44007117|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007118|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007119|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44007120|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
44007121|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007122|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44007123|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
44007124|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44007125|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44147098|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147099|NCT00199758|Antiviral Agents|antiviral agents|mesh-ancestor
44147100|NCT00199758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147101|NCT00199758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147102|NCT00199758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147103|NCT00199758|Immunologic Factors|immunologic factors|mesh-ancestor
44147104|NCT00199758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147105|NCT00199771|Dextrans|dextrans|mesh-list
44147106|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
44147107|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
44147108|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
44147109|NCT00199784|Phenylephrine|phenylephrine|mesh-list
44147110|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
44147111|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44147112|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
44147113|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
44147114|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147115|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147116|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
44147117|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44147118|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
44147119|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44147120|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44147121|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44147122|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44147123|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147124|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739927|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
44007126|NCT01785420|Trastuzumab|trastuzumab|mesh-list
44007127|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007128|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007129|NCT01685814|Lenalidomide|lenalidomide|mesh-list
44247806|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247807|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44247808|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247809|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44247810|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44247811|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247812|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
44247813|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44007131|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
44007132|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007133|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44007134|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44007140|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007141|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007142|NCT01547468|Analgesics|analgesics|mesh-ancestor
44007143|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
44007144|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007145|NCT01387763|Interferons|interferons|mesh-list
44007146|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
44007147|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
44007148|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44007149|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44007150|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
44007151|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007152|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
44007153|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007154|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
44007155|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007156|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
44007157|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007158|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007159|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44007160|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
44007161|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
44007162|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007163|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
44007164|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007165|NCT00800514|Amantadine|amantadine|mesh-list
44007166|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44007167|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44007168|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
44007169|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007170|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
44007171|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007172|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007173|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007174|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007175|NCT00800514|Analgesics|analgesics|mesh-ancestor
44007176|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
44007177|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007178|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
44007179|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
44007180|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007181|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
44007182|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007183|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
44007184|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
44007185|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007186|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
44007187|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007188|NCT00200200|Bevacizumab|bevacizumab|mesh-list
44007189|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007190|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007191|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44007192|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44007193|NCT00200200|Growth Substances|growth substances|mesh-ancestor
44247814|NCT01661881|Cytarabine|cytarabine|mesh-list
44247815|NCT01661881|Rituximab|rituximab|mesh-list
44247816|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44247817|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050848|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
44247818|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247819|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
44247820|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247821|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247822|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247823|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
44247824|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247825|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
44007194|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007195|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44007196|NCT00199862|Antibodies|antibodies|mesh-list
44007197|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
44007198|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007199|NCT02777749|Bupivacaine|bupivacaine|mesh-list
44007200|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
44007201|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
44007202|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007203|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007204|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
44007205|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007206|NCT02778113|Glucagon|glucagon|mesh-list
44007213|NCT02778880|Fentanyl|fentanyl|mesh-list
44007214|NCT02778880|Ketamine|ketamine|mesh-list
44007215|NCT02778880|Analgesics|analgesics|mesh-ancestor
44007216|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
44007217|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007218|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007219|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44007220|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44007221|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
44007222|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
44007223|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007224|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44007225|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44007226|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007227|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007228|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44007229|NCT02778880|Narcotics|narcotics|mesh-ancestor
44007230|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44007231|NCT02779166|Celecoxib|celecoxib|mesh-list
44007232|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007233|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007234|NCT02779166|Analgesics|analgesics|mesh-ancestor
44007235|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
44007236|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007237|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007238|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007239|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007240|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44007241|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44007242|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007243|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007244|NCT02780622|Oseltamivir|oseltamivir|mesh-list
44007245|NCT02780622|Warfarin|warfarin|mesh-list
44007246|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
44007247|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
44007248|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007249|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007250|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007251|NCT02780869|Thrombin|thrombin|mesh-list
44247826|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247827|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247828|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247829|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
44247831|NCT01610557|Ranibizumab|ranibizumab|mesh-list
44247832|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44247833|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247834|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44247835|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247836|NCT01610557|Growth Substances|growth substances|mesh-ancestor
44247837|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247838|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247839|NCT01489813|Genistein|genistein|mesh-list
44007252|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44007253|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
44007254|NCT02780869|Coagulants|coagulants|mesh-ancestor
44007255|NCT02781454|Mexiletine|mexiletine|mesh-list
44007256|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44007257|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44007258|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44007259|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007260|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007261|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
44007262|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44007263|NCT02781571|Velpatasvir|velpatasvir|mesh-list
44007264|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
44007265|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007266|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44007267|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007268|NCT02781649|Ribavirin|ribavirin|mesh-list
44007269|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
44007270|NCT02781649|Grazoprevir|grazoprevir|mesh-list
44007271|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44007272|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
44007273|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007274|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
44007275|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007276|NCT02783443|Anesthetics|anesthetics|mesh-list
44007278|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007279|NCT02785159|Tazarotene|tazarotene|mesh-list
44007280|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007281|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
44007282|NCT02785172|Clobetasol|clobetasol|mesh-list
44007283|NCT02785172|Halobetasol|halobetasol|mesh-list
44007284|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44007285|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007286|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
44007287|NCT02785172|Hormones|hormones|mesh-ancestor
44007288|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007289|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007290|NCT02785185|Clobetasol|clobetasol|mesh-list
44007291|NCT02785185|Halobetasol|halobetasol|mesh-list
44007292|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44007293|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007294|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
44007295|NCT02785185|Hormones|hormones|mesh-ancestor
44007296|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007297|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007298|NCT02785406|Suvorexant|suvorexant|mesh-list
44007299|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44007300|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44007301|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007302|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247840|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44247841|NCT01489813|Protective Agents|protective agents|mesh-ancestor
44247842|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247843|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247844|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247845|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247846|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007303|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44007304|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007305|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007306|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
44007307|NCT02786719|Cisplatin|cisplatin|mesh-list
44007308|NCT02786719|Doxorubicin|doxorubicin|mesh-list
44007309|NCT02786719|Etoposide|etoposide|mesh-list
44007310|NCT02786719|Vincristine|vincristine|mesh-list
44007311|NCT02786719|Topotecan|topotecan|mesh-list
44007312|NCT02786719|Sargramostim|sargramostim|mesh-list
44007313|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44007314|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
44007315|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007316|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007317|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44007318|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
44007319|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007320|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007321|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44007322|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44007323|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44007324|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44007325|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007326|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44007327|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
44007328|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
44007329|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
44007330|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44007331|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
44007332|NCT02787057|Vancomycin|vancomycin|mesh-list
44007333|NCT02787057|Ceftazidime|ceftazidime|mesh-list
44007334|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44007335|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007336|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44007337|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44007338|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007339|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007340|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007341|NCT02788019|Ropivacaine|ropivacaine|mesh-list
44007342|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
44007343|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
44007344|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007345|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007346|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
44007347|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007348|NCT02788097|Progesterone|progesterone|mesh-list
44007349|NCT02788097|Progestins|progestins|mesh-ancestor
44007350|NCT02788097|Hormones|hormones|mesh-ancestor
44007351|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007355|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44007357|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44007358|NCT02789033|Diuretics|diuretics|mesh-ancestor
44007359|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
44007360|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007361|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
44007362|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44007363|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007364|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44007365|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44007366|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
44007367|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44247847|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
44247848|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44247849|NCT01489813|Estrogens|estrogens|mesh-ancestor
44247850|NCT01489813|Hormones|hormones|mesh-ancestor
44247851|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247852|NCT01473628|Rituximab|rituximab|mesh-list
44247853|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44247854|NCT01473628|Antibodies|antibodies|mesh-list
44247855|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
44247856|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44247857|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
44247858|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247859|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247860|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247861|NCT01471106|Dasatinib|dasatinib|mesh-list
44247862|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247863|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247864|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007368|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
44007369|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
44007370|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
44007371|NCT02789033|Coagulants|coagulants|mesh-ancestor
44007372|NCT02789410|Morphine|morphine|mesh-list
44007373|NCT02789410|Hydromorphone|hydromorphone|mesh-list
44007374|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44007375|NCT02789410|Narcotics|narcotics|mesh-ancestor
44007376|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007377|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007378|NCT02789410|Analgesics|analgesics|mesh-ancestor
44007379|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
44007380|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007381|NCT02790736|Propranolol|propranolol|mesh-list
44007382|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44007383|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44007384|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
44007385|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007386|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007387|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007388|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44007389|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44007390|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44007391|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
44007392|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44007393|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44007394|NCT02790788|Prednisolone|prednisolone|mesh-list
44007395|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
44007396|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
44007397|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44007398|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44007399|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
44007400|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007402|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
44007403|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007404|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007405|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007406|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
44007407|NCT02790788|Hormones|hormones|mesh-ancestor
44007408|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007409|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44007410|NCT02790788|Protective Agents|protective agents|mesh-ancestor
44247865|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247867|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
44247868|NCT01410344|Melphalan|melphalan|mesh-list
44247869|NCT01410344|Busulfan|busulfan|mesh-list
44247870|NCT01410344|Fludarabine|fludarabine|mesh-list
44247871|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
44007411|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007412|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007413|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
44007414|NCT02791308|Tacrolimus|tacrolimus|mesh-list
44007415|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007416|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007417|NCT02791308|Analgesics|analgesics|mesh-ancestor
44007418|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
44007419|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007420|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007421|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007422|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007423|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007424|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44007425|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
44007426|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43740202|NCT02531412|Diuretics|diuretics|mesh-ancestor
44007431|NCT02791906|Micronutrients|micronutrients|mesh-ancestor
44051122|NCT00003834|Antidotes|antidotes|mesh-ancestor
44007432|NCT02791906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007434|NCT02791906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007435|NCT02791906|Protective Agents|protective agents|mesh-ancestor
44007436|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
44007437|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44007438|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
44007439|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007440|NCT02791945|Expectorants|expectorants|mesh-ancestor
44007441|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007442|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44007443|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
44007444|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007445|NCT02791945|Protective Agents|protective agents|mesh-ancestor
44007446|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007447|NCT02791945|Antidotes|antidotes|mesh-ancestor
44007448|NCT02793154|Exenatide|exenatide|mesh-list
44007449|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
44007450|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007451|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007452|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44007453|NCT02793154|Incretins|incretins|mesh-ancestor
44007454|NCT02793154|Hormones|hormones|mesh-ancestor
44007455|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007456|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44007457|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44147125|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147126|NCT00199784|Protective Agents|protective agents|mesh-ancestor
44147127|NCT00199940|Ziprasidone|ziprasidone|mesh-list
44147128|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44147129|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
44147130|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147131|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147132|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147133|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44147134|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147135|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147136|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147137|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44147138|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
44147139|NCT00199953|Rabeprazole|rabeprazole|mesh-list
44147140|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44147141|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147142|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44147143|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147144|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147145|NCT00199966|Valproic Acid|valproic acid|mesh-list
44247873|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
44247874|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247875|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247876|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247877|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
44247878|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247879|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247880|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44147146|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
44147147|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147148|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147149|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
44147150|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147151|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147152|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
44147153|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147154|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147155|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147157|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44147158|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44147159|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147160|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147161|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
44147162|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147163|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44147164|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44147165|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44147169|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147170|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44147171|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44147172|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147173|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147174|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44007458|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
44007459|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44007460|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
44007461|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007462|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007463|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44007464|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
44007465|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007466|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007467|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44007468|NCT02794441|Dexamethasone|dexamethasone|mesh-list
44007469|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007470|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
44007471|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
44007472|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007473|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007474|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007475|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
44007477|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007478|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007479|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007480|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44007481|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007482|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007483|NCT02795117|Ivermectin|ivermectin|mesh-list
44007484|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44007485|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247882|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
44247883|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
44247884|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007486|NCT02796144|Metformin|metformin|mesh-list
44007487|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007488|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007489|NCT02796352|Interleukin-2|interleukin-2|mesh-list
44007490|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007491|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007492|NCT02796352|Analgesics|analgesics|mesh-ancestor
44007493|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
44007494|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007495|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007496|NCT02800148|Azelaic acid|azelaic acid|mesh-list
44007497|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007498|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007499|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
44007500|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44007501|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007502|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44007503|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44007504|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007505|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007506|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007507|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44007508|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44007510|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44007511|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
44007512|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007513|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007514|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44007515|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007516|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
44007517|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44007518|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44007519|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44007520|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44007521|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
44007529|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007530|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
44007531|NCT02802449|Vitamin D|vitamin d|mesh-list
44007532|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
44007533|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
44007534|NCT02802449|Calcifediol|calcifediol|mesh-list
44007535|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44007536|NCT02802449|Vitamins|vitamins|mesh-list
44007537|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
44007538|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007539|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44007540|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44007541|NCT02802501|Piperaquine|piperaquine|mesh-list
44007542|NCT02802501|Primaquine|primaquine|mesh-list
44007543|NCT02802501|Artenimol|artenimol|mesh-list
44007544|NCT02802501|Tafenoquine|tafenoquine|mesh-list
44007545|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
44007546|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44007547|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44007548|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007549|NCT02802514|Exenatide|exenatide|mesh-list
44007550|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
44007551|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44007552|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007553|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007554|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44007555|NCT02802514|Incretins|incretins|mesh-ancestor
44007556|NCT02802514|Hormones|hormones|mesh-ancestor
44007557|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007558|NCT02803229|Amphetamine|amphetamine|mesh-list
44007559|NCT02803229|Adderall|adderall|mesh-list
44007560|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44007561|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007562|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
44247885|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
44247886|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
44247887|NCT01409200|Axitinib|axitinib|mesh-list
44247888|NCT01409200|Hormones|hormones|mesh-list
44247889|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44247890|NCT01409200|Androgens|androgens|mesh-list
44247891|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
44007563|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
44007564|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007565|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
44007566|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007567|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007568|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
44007569|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44007570|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44007571|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007572|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44007573|NCT02803749|Buspirone|buspirone|mesh-list
44007574|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44007575|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44007576|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007577|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007579|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44007580|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
44007581|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007582|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007583|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
44007584|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44007585|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
44007586|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007587|NCT02804594|Expectorants|expectorants|mesh-ancestor
44051411|NCT00003877|Thiotepa|thiotepa|mesh-list
44007588|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007589|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44007590|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
44007591|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007592|NCT02804594|Protective Agents|protective agents|mesh-ancestor
44007598|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007599|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007600|NCT02806544|Tamoxifen|tamoxifen|mesh-list
44007601|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44007602|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007603|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007604|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007605|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007606|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007607|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44007608|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44007609|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44007610|NCT02806869|Ibuprofen|ibuprofen|mesh-list
44007611|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007612|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007613|NCT02806869|Analgesics|analgesics|mesh-ancestor
44007614|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
44007615|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007616|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007617|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007618|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007619|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44007620|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007621|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007622|NCT02808052|Minocycline|minocycline|mesh-list
44007623|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44007624|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007625|NCT02810873|Copper|copper|mesh-list
44007626|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
44007627|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44007628|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44007629|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007630|NCT02810873|Trace Elements|trace elements|mesh-ancestor
44247892|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247893|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247894|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
44247895|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247896|NCT01409200|Protective Agents|protective agents|mesh-ancestor
44247897|NCT01409200|Vitamins|vitamins|mesh-ancestor
44247898|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
44247899|NCT01409200|Estrogens|estrogens|mesh-ancestor
44247900|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247901|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247902|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
44247903|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247904|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247905|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
44247906|NCT01254864|Prednisone|prednisone|mesh-list
44247907|NCT01254864|Sunitinib|sunitinib|mesh-list
44247908|NCT01254864|Dasatinib|dasatinib|mesh-list
44007631|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
44007632|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007633|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
44007634|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
44007635|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007636|NCT02812238|Niacinamide|niacinamide|mesh-list
44007638|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
44007639|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
44007640|NCT02812238|Vitamins|vitamins|mesh-ancestor
44007641|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
44007642|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007643|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44007644|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
44007645|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007646|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44007647|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
44007648|NCT02812342|Tofacitinib|tofacitinib|mesh-list
44007649|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44007650|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007651|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007653|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
44007654|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007655|NCT02813070|Flutemetamol|flutemetamol|mesh-list
44007656|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44007657|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007658|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44007659|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44007660|NCT02813551|Torsemide|torsemide|mesh-list
44007661|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44007662|NCT02813551|Diuretics|diuretics|mesh-ancestor
44007663|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
44007664|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007667|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007668|NCT02814279|Dipyrone|dipyrone|mesh-list
44007669|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
44007670|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44007671|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007672|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
44007673|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007674|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007675|NCT02814279|Analgesics|analgesics|mesh-ancestor
44247910|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247911|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
44247913|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44247914|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247915|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44247916|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247917|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44007676|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
44007677|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007678|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007679|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007680|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007681|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
44007682|NCT02815644|Empagliflozin|empagliflozin|mesh-list
44007683|NCT02815644|Linagliptin|linagliptin|mesh-list
44007684|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44147175|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007685|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007686|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007687|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007689|NCT02815644|Hormones|hormones|mesh-ancestor
44007690|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007691|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44007692|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
44007693|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007694|NCT02815709|Morphine|morphine|mesh-list
44007695|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44007696|NCT02815709|Narcotics|narcotics|mesh-ancestor
44007697|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007698|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007699|NCT02815709|Analgesics|analgesics|mesh-ancestor
44007700|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
44007701|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007702|NCT02817763|Dipyrone|dipyrone|mesh-list
44007703|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007704|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007705|NCT02817763|Analgesics|analgesics|mesh-ancestor
44007706|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
44007707|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007708|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007709|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007710|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007711|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
44007712|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
44007713|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44007714|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007715|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007716|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44007717|NCT02818569|Analgesics|analgesics|mesh-ancestor
44007718|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
44007719|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007720|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44007721|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44007722|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44007723|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44007724|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007725|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007726|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44007727|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44007728|NCT02820324|Morphine|morphine|mesh-list
44007729|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44247918|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44247919|NCT01254864|Growth Substances|growth substances|mesh-ancestor
44247920|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
44247921|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44247922|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007730|NCT02820324|Narcotics|narcotics|mesh-ancestor
44007731|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007732|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007733|NCT02820324|Analgesics|analgesics|mesh-ancestor
44007734|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
44007735|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007736|NCT02821338|Lamotrigine|lamotrigine|mesh-list
44007738|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44007739|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007740|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007741|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44007742|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007743|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44007744|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44007745|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007746|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44007747|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44147176|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147177|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147178|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44147179|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44147180|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44157777|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44157778|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
44157779|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740535|NCT02529059|Tenofovir|tenofovir|mesh-list
44007748|NCT02822950|Ceftazidime|ceftazidime|mesh-list
44007750|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44007751|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44007752|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007753|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44007754|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007755|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007756|NCT02823080|Cetrorelix|cetrorelix|mesh-list
44007757|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44007758|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
44007759|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44007760|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007761|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007762|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007763|NCT02823431|Lidocaine|lidocaine|mesh-list
44007764|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
44007765|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
44007766|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007767|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007768|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
44007769|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007770|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44007771|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44007772|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44007773|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007774|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007775|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44007776|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44007777|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
44007778|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44007779|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44007780|NCT02825212|Ledipasvir|ledipasvir|mesh-list
44007781|NCT02825212|Velpatasvir|velpatasvir|mesh-list
44007782|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
44007783|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007784|NCT02829034|Ranolazine|ranolazine|mesh-list
44247923|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247924|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44247925|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007785|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44007786|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871167|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
44007787|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007789|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44007790|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007791|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44007792|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007793|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007794|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44007795|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44007796|NCT02831569|Loxoprofen|loxoprofen|mesh-list
44007797|NCT02831569|Methocarbamol|methocarbamol|mesh-list
44007798|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44007805|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44007806|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44007807|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44007808|NCT02831816|Ethanol|ethanol|mesh-list
44007809|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
44007810|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44007811|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44007812|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007813|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007814|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007815|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
44007816|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007817|NCT02831998|Ethanol|ethanol|mesh-list
44007818|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
44007819|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44007820|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44007821|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007822|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007823|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007824|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
44007825|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007826|NCT02832115|Lidocaine|lidocaine|mesh-list
44007827|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
44007828|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
44007829|NCT02832115|Anesthetics|anesthetics|mesh-list
44007830|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007831|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007832|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
44007833|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007834|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44007835|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44007836|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44007837|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007838|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007839|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44007840|NCT02833415|Empagliflozin|empagliflozin|mesh-list
44007841|NCT02833415|Glycerol|glycerol|mesh-list
44007842|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44007843|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007844|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007845|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007846|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44007847|NCT02833415|Protective Agents|protective agents|mesh-ancestor
44007848|NCT02834624|Poractant alfa|poractant alfa|mesh-list
44007849|NCT02834624|Calfactant|calfactant|mesh-list
44007850|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44007851|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007852|NCT02834663|Ranibizumab|ranibizumab|mesh-list
44007853|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44007854|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44007855|NCT02834663|Growth Substances|growth substances|mesh-ancestor
44007856|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007857|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44007858|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247926|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44247928|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247929|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247930|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
44247931|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247932|NCT01098955|Varenicline|varenicline|mesh-list
44247933|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44247934|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44247935|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
44247936|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007859|NCT02835846|Estrogens|estrogens|mesh-list
44007860|NCT02835846|Hormones|hormones|mesh-ancestor
44007861|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007862|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007864|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44007865|NCT02837237|Hormones|hormones|mesh-ancestor
44007866|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007867|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007868|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
44007871|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
44007872|NCT02837744|Hemostatics|hemostatics|mesh-list
44007873|NCT02837744|Coagulants|coagulants|mesh-ancestor
44007874|NCT02839772|Glycerol|glycerol|mesh-list
44007875|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44007876|NCT02839772|Protective Agents|protective agents|mesh-ancestor
44007877|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007878|NCT02839889|Naloxegol|naloxegol|mesh-list
44007879|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44007880|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007881|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
44007882|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007883|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
44007884|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44007885|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44007886|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007887|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
44007888|NCT02840097|Coagulants|coagulants|mesh-ancestor
44007889|NCT02841033|Daratumumab|daratumumab|mesh-list
44007890|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007891|NCT02841241|Esmolol|esmolol|mesh-list
44007892|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44007893|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44007894|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44007895|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
44007896|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147181|NCT00200187|Anesthetics|anesthetics|mesh-list
44007897|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007898|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007900|NCT02844582|Cortisone|cortisone|mesh-list
44007901|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007902|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
44007903|NCT02844582|Hormones|hormones|mesh-ancestor
44007904|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007905|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007906|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007907|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007908|NCT02845752|Bromides|bromides|mesh-list
44007909|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
44007910|NCT02845752|Olodaterol|olodaterol|mesh-list
44007911|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44007912|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
44007913|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007914|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007915|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44247937|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247938|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247940|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
44247941|NCT01082393|Tacrolimus|tacrolimus|mesh-list
44007916|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007917|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
44007918|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44007919|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
44007920|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007921|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007922|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
44007923|NCT02846233|Metformin|metformin|mesh-list
44007924|NCT02846233|Empagliflozin|empagliflozin|mesh-list
44007925|NCT02846233|Dulaglutide|dulaglutide|mesh-list
44007926|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44007927|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
44007928|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44007929|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007930|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007931|NCT02846233|Incretins|incretins|mesh-ancestor
44007932|NCT02846233|Hormones|hormones|mesh-ancestor
44007933|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007934|NCT02846792|Nivolumab|nivolumab|mesh-list
44007935|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44007936|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007937|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44007938|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007939|NCT02849184|Suvorexant|suvorexant|mesh-list
44007940|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44007941|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44007942|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007948|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007950|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
44007951|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007952|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007953|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007954|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
44007955|NCT02850601|Hormones|hormones|mesh-ancestor
44007956|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007957|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44007958|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007959|NCT02851108|Primaquine|primaquine|mesh-list
44007960|NCT02851108|Phenothiazine|phenothiazine|mesh-list
44007961|NCT02851108|Methylene Blue|methylene blue|mesh-list
44007962|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
44007963|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44007964|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44007965|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007966|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007967|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007968|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44007969|NCT02855086|Cetuximab|cetuximab|mesh-list
44007970|NCT02855086|Antibodies|antibodies|mesh-list
44007971|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
44007972|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44007973|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
44007974|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007975|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007976|NCT02858713|Betamethasone|betamethasone|mesh-list
44007977|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
44007978|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44007979|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
44007980|NCT02858713|Calcipotriene|calcipotriene|mesh-list
44007981|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44007982|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007983|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
44007984|NCT02858713|Hormones|hormones|mesh-ancestor
44007985|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821875|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44247942|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247943|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
44247944|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007986|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007987|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44007988|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44007989|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
44007990|NCT02859441|Ranibizumab|ranibizumab|mesh-list
44007991|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44007992|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44007993|NCT02859441|Growth Substances|growth substances|mesh-ancestor
44007994|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007995|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
44007996|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007997|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
44007998|NCT02860507|Neostigmine|neostigmine|mesh-list
44007999|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008000|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008001|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008002|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008003|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008004|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008005|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44008006|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
44008007|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008008|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44008009|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44008010|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44008011|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44008015|NCT02860845|Clotrimazole|clotrimazole|mesh-list
44008017|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
44008018|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008019|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44008020|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008021|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008022|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44008023|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44008024|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44008025|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44008026|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
44008027|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008028|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008029|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44008030|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44147182|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147183|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147184|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
44147185|NCT00200226|Pyridoxal|pyridoxal|mesh-list
44147186|NCT00200226|Pyridoxine|pyridoxine|mesh-list
44147187|NCT00200226|Misoprostol|misoprostol|mesh-list
44147188|NCT00200226|Vitamins|vitamins|mesh-ancestor
44147189|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
44147190|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147191|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44147192|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
44147193|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44147194|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44147195|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147196|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
44147197|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
44008031|NCT02861131|Neostigmine|neostigmine|mesh-list
44008032|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008033|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008034|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008035|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008036|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008037|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008038|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44008039|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
43846108|NCT04216693|Protective Agents|protective agents|mesh-ancestor
44247945|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44247946|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247947|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247948|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44247949|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44247950|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43646808|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44008040|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008041|NCT02862912|Fentanyl|fentanyl|mesh-list
44008042|NCT02862912|Bupivacaine|bupivacaine|mesh-list
44008043|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
44008044|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008045|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
44008046|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008047|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008048|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
44008049|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008050|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44008051|NCT02862912|Narcotics|narcotics|mesh-ancestor
44008052|NCT02862912|Analgesics|analgesics|mesh-ancestor
44008053|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44008054|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44008055|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
44008056|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
44008057|NCT02863263|Povidone|povidone|mesh-list
44008058|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
44008059|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
44008060|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44008061|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008062|NCT02864706|Cyclosporine|cyclosporine|mesh-list
44008063|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
44008064|NCT02864706|Everolimus|everolimus|mesh-list
44008065|NCT02864706|Cyclosporins|cyclosporins|mesh-list
44008066|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008067|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008068|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008070|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008071|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
44008076|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008077|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44008078|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44008079|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
44008080|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44008081|NCT02865590|Cimetidine|cimetidine|mesh-list
44008082|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44008083|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44008084|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44008085|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
44008086|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
44008087|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008088|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008089|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008090|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44008091|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44008092|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008093|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44008094|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44008095|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008096|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
44008097|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008098|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
44008099|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44008100|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44008101|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008102|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
44008103|NCT02867163|Coagulants|coagulants|mesh-ancestor
44008104|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
44008105|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44147198|NCT00200252|Oxytocin|oxytocin|mesh-list
44247951|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44247952|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740845|NCT02527772|Vitamins|vitamins|mesh-ancestor
44008106|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008107|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
44008108|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44008109|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
44008110|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008111|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
44008112|NCT02867605|Protective Agents|protective agents|mesh-ancestor
44008113|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
44008114|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44008115|NCT02868242|Ledipasvir|ledipasvir|mesh-list
44008116|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
44008117|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008118|NCT02869451|Bupropion|bupropion|mesh-list
44008119|NCT02869451|Nicotine|nicotine|mesh-list
44008120|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44008121|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
44008122|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008123|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008124|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44008125|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44008126|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008127|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008128|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008129|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44008130|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
44008131|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008132|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44008133|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44008134|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008135|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
44008136|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44008137|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44008138|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008139|NCT02870283|Carbamazepine|carbamazepine|mesh-list
44008140|NCT02870283|Valproic Acid|valproic acid|mesh-list
44008141|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008148|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
44008150|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008151|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008152|NCT02870283|Analgesics|analgesics|mesh-ancestor
44008153|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
44008154|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008155|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008156|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008157|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44008158|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44008159|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44008160|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44008161|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44008162|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
44008163|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008164|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008165|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
44008166|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44008167|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
44008168|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008169|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008170|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44008171|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
44008172|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44008173|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
44008174|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008175|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008176|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44008177|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44008178|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
44008179|NCT02871011|Protective Agents|protective agents|mesh-ancestor
44008180|NCT02872857|Galantamine|galantamine|mesh-list
44008181|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008182|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247953|NCT01082393|Analgesics|analgesics|mesh-ancestor
44247954|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
44247955|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247956|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44247957|NCT01081912|Hydrocodone|hydrocodone|mesh-list
44247958|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44247959|NCT01081912|Narcotics|narcotics|mesh-ancestor
44247960|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44247961|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247962|NCT01081912|Analgesics|analgesics|mesh-ancestor
44247963|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
44247964|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824063|NCT05515978|Metformin|metformin|mesh-list
44008183|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008184|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008185|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008186|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008187|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44008189|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008190|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
44008191|NCT02874092|Ticagrelor|ticagrelor|mesh-list
44008192|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44008193|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44008194|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44008195|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44008196|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
44008197|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008198|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008199|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008200|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44008201|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44008202|NCT02876900|Asenapine|asenapine|mesh-list
44008203|NCT02876900|Maleic acid|maleic acid|mesh-list
44008204|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008205|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008206|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44008207|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008208|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008209|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008210|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008215|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44008217|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008218|NCT02877485|Triamcinolone|triamcinolone|mesh-list
44008219|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44008220|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44008221|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44052015|NCT00003956|Antidotes|antidotes|mesh-ancestor
44008222|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008223|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
44008224|NCT02877485|Hormones|hormones|mesh-ancestor
44008225|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008226|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008227|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008228|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
44008229|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008230|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008231|NCT02878057|Apatinib|apatinib|mesh-list
44008232|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008233|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44008234|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008235|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247965|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
44247966|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
44247967|NCT00936936|Gemcitabine|gemcitabine|mesh-list
44247968|NCT00936936|Carboplatin|carboplatin|mesh-list
44247969|NCT00936936|Docetaxel|docetaxel|mesh-list
44247970|NCT00936936|Etoposide|etoposide|mesh-list
44247971|NCT00936936|Melphalan|melphalan|mesh-list
44247972|NCT00936936|Ifosfamide|ifosfamide|mesh-list
44247973|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44247974|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44247975|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
44008236|NCT02878382|Calcipotriene|calcipotriene|mesh-list
44008237|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008238|NCT02880228|Dexamethasone|dexamethasone|mesh-list
44008239|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
44008240|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
44008241|NCT02880228|Lenalidomide|lenalidomide|mesh-list
44008242|NCT02880228|Ichthammol|ichthammol|mesh-list
44008243|NCT02880228|BB 1101|bb 1101|mesh-list
44008244|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008245|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
44008246|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
44008247|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008248|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008249|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44008250|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
44008251|NCT02880228|Hormones|hormones|mesh-ancestor
44008252|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008253|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44008254|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008255|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44008256|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
44008257|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44008258|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44008259|NCT02880228|Growth Substances|growth substances|mesh-ancestor
44008260|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44008261|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44008262|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008263|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008264|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008265|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
44008266|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008267|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008268|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44008269|NCT02880852|Belimumab|belimumab|mesh-list
44008270|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008271|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
44008272|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008273|NCT02881008|Entecavir|entecavir|mesh-list
44008274|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
44008275|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008276|NCT02881996|Acetaminophen|acetaminophen|mesh-list
44008277|NCT02881996|Ketorolac|ketorolac|mesh-list
44008278|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008279|NCT02881996|Analgesics|analgesics|mesh-ancestor
44008280|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
44008281|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008282|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008286|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008287|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008288|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008289|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008291|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008293|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008294|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008295|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
44008296|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008297|NCT02882711|Ketamine|ketamine|mesh-list
44008298|NCT02882711|Analgesics|analgesics|mesh-ancestor
43822479|NCT05534685|Budesonide|budesonide|mesh-list
44247976|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247977|NCT00936936|Antiviral Agents|antiviral agents|mesh-ancestor
44247978|NCT00936936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247979|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44247980|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247981|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
44247982|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008299|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
44008300|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008301|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008302|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44008303|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44008304|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
44008305|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
44008306|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008307|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44008308|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44008309|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008310|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008311|NCT02885012|Ambrisentan|ambrisentan|mesh-list
44008312|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44008313|NCT02885025|Fluticasone|fluticasone|mesh-list
44008314|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008315|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44008316|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
44008317|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008318|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008319|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44008320|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44008321|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008322|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44008323|NCT02885636|Albuterol|albuterol|mesh-list
44008324|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44008325|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
44008326|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008327|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008328|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44008329|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
44008330|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
44008331|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44008332|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44008333|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44008334|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44008335|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008336|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008337|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008339|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
44008340|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008341|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008342|NCT02888665|Doxorubicin|doxorubicin|mesh-list
44008343|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44008344|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
44008345|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44008346|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008347|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44008348|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44008349|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008350|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008351|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44008352|NCT02889393|Teduglutide|teduglutide|mesh-list
44008353|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44008354|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44008364|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44008365|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44008366|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008367|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44247983|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
44247984|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
44247985|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44247986|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44247987|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44247988|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44247989|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44247990|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
44247991|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44247993|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44247994|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44008368|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008369|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147200|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44147201|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147202|NCT00200382|Bortezomib|bortezomib|mesh-list
44147203|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147204|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44147205|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147206|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44147207|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147208|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147209|NCT00200421|Atenolol|atenolol|mesh-list
44147210|NCT00200421|Nebivolol|nebivolol|mesh-list
44147211|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44147212|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147213|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
44147214|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
44147215|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147216|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147217|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44147218|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44147219|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44147220|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147221|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147222|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147223|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147224|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44147225|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44147226|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44147227|NCT00200434|Nebivolol|nebivolol|mesh-list
44147228|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147229|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147230|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44147231|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44147232|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43741040|NCT02526745|Vaccines|vaccines|mesh-list
44008370|NCT02895035|Ketorolac|ketorolac|mesh-list
44008371|NCT02895035|Phenylephrine|phenylephrine|mesh-list
44008372|NCT02895035|Epinephrine|epinephrine|mesh-list
44008373|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
44008374|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44008375|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44008376|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008377|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008378|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008379|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008380|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44008381|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44008382|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
44008383|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44247995|NCT00879931|Prednisolone|prednisolone|mesh-list
44247996|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
44247997|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44247998|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
44247999|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248000|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
44248001|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
44248002|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248003|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248004|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248005|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
44248006|NCT00879931|Hormones|hormones|mesh-ancestor
44248007|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248008|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44248009|NCT00879931|Protective Agents|protective agents|mesh-ancestor
44248010|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44248011|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248012|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
44248013|NCT00739141|Thiotepa|thiotepa|mesh-list
44248014|NCT00739141|Fludarabine|fludarabine|mesh-list
44248015|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008384|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44008385|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
44008388|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44008389|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008390|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008392|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
44008393|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008394|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008395|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008396|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008397|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44008398|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
44008399|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44008400|NCT02895035|Protective Agents|protective agents|mesh-ancestor
44008401|NCT02896595|Anesthetics|anesthetics|mesh-list
44008402|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008403|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008404|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
44008406|NCT02896907|Leucovorin|leucovorin|mesh-list
44008407|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
44008408|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44008409|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
44008410|NCT02896907|Fluorouracil|fluorouracil|mesh-list
44008411|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
44008412|NCT02896907|Irinotecan|irinotecan|mesh-list
44008413|NCT02896907|Camptothecin|camptothecin|mesh-list
44008414|NCT02896907|Calcium|calcium|mesh-list
44008415|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
44008416|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
44008417|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008418|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44008419|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44008420|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
44008421|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008422|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44248016|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
44248017|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248018|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248019|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44008423|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008424|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008425|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
44008426|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44008427|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44008428|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008430|NCT02896907|Protective Agents|protective agents|mesh-ancestor
44008431|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
44008432|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
44008433|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44008434|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
44008435|NCT02901249|Sertraline|sertraline|mesh-list
44008436|NCT02901249|Nortriptyline|nortriptyline|mesh-list
44008437|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
44008438|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008439|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44008440|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44008441|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008442|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008443|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008444|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
43741104|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008445|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008446|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008447|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
44008448|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008449|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008450|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44008451|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44008452|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008453|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
44008454|NCT02901899|Guadecitabine|guadecitabine|mesh-list
44008455|NCT02901899|Azacitidine|azacitidine|mesh-list
44008456|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44008457|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008458|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44008459|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
44008460|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008463|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
44008464|NCT02902172|Acetaminophen|acetaminophen|mesh-list
44008466|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008467|NCT02902172|Analgesics|analgesics|mesh-ancestor
44008468|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
44008469|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008470|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008471|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
44008472|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008473|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008474|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008475|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008476|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008477|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008478|NCT02902237|Thromboplastin|thromboplastin|mesh-list
44008479|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
44008480|NCT02902237|Coagulants|coagulants|mesh-ancestor
44008481|NCT02902770|Ketorolac|ketorolac|mesh-list
44008482|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44008484|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008485|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
44008486|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008487|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008488|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
44008489|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008490|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44008491|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44248020|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
44248021|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248022|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248023|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44248024|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
44248025|NCT00580047|Vitamin D|vitamin d|mesh-list
44248026|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
44248027|NCT00580047|Alendronate|alendronate|mesh-list
44248028|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
44248029|NCT00580047|Calcium|calcium|mesh-list
44248030|NCT00580047|Vitamins|vitamins|mesh-ancestor
44008492|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008493|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008494|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008495|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008496|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008497|NCT02902770|Analgesics|analgesics|mesh-ancestor
44008498|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008499|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008500|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008501|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008502|NCT02902913|Ibuprofen|ibuprofen|mesh-list
44008503|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008504|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008505|NCT02902913|Analgesics|analgesics|mesh-ancestor
44008506|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
44008507|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008508|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008509|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008510|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008511|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008512|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008513|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008514|NCT02903121|Tamoxifen|tamoxifen|mesh-list
44008515|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44008516|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
44008517|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008518|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008519|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44008520|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741120|NCT02525848|Dexamethasone|dexamethasone|mesh-list
44008521|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44008522|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44008523|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44008524|NCT02903407|Midazolam|midazolam|mesh-list
44008525|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
44008526|NCT02903407|Propofol|propofol|mesh-list
44008527|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44008528|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008529|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008530|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44008531|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
44008532|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
44008533|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008538|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44008539|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44008540|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008541|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008542|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008543|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44008544|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44008545|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008546|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008547|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
44008548|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
44008549|NCT02903446|Denosumab|denosumab|mesh-list
44248031|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
44248032|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248033|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44248034|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44248035|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248036|NCT00580047|Antacids|antacids|mesh-ancestor
44248037|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248038|NCT00494728|Nicotine|nicotine|mesh-list
44248039|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44248040|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
44248041|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248042|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248043|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44008550|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44008551|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008552|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
44008553|NCT02903836|Nafithromycin|nafithromycin|mesh-list
44008554|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44008555|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008556|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44008557|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44008558|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008559|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008560|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008561|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44008562|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
44008563|NCT02904226|Nivolumab|nivolumab|mesh-list
44008564|NCT02904226|Ipilimumab|ipilimumab|mesh-list
44008565|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44008566|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008567|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44008568|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008569|NCT02904915|Lidocaine|lidocaine|mesh-list
44008570|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008571|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
44008572|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741196|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008573|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008574|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
44008575|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008576|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44008577|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44008578|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008579|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008580|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008581|NCT02905981|Citric Acid|citric acid|mesh-list
44008582|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
44008583|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
44008584|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44008585|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
44008586|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
44008587|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008588|NCT02906566|Vitamin A|vitamin a|mesh-list
44008589|NCT02906566|Vitamins|vitamins|mesh-ancestor
44008590|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
44008591|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008592|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44008593|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44008594|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44147233|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008595|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248044|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44248045|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
44248046|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008596|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008597|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44008598|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008599|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008600|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
44052492|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44008601|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008608|NCT02907918|Goserelin|goserelin|mesh-list
44008609|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44008610|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008611|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44008612|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44008613|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008614|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008615|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44008616|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
44008617|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008618|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008619|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44008620|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44008621|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
44008622|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
44008623|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44008624|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44008625|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008626|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008627|NCT02908490|Urological Agents|urological agents|mesh-ancestor
44008628|NCT02908620|Anesthetics|anesthetics|mesh-list
44008629|NCT02908620|Tetracaine|tetracaine|mesh-list
44008630|NCT02908620|Benzocaine|benzocaine|mesh-list
44008631|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008632|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008633|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008634|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
44008635|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008636|NCT02909140|Lidocaine|lidocaine|mesh-list
44008637|NCT02909140|Phenylephrine|phenylephrine|mesh-list
44008638|NCT02909140|Epinephrine|epinephrine|mesh-list
44008639|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
44008640|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
44008641|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008642|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
44008643|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008644|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008645|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
44008646|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008647|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44008648|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44008649|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008650|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008651|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008652|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44008653|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44008654|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008655|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008656|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44008657|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44008658|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
44008659|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44008660|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
44008661|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
44008662|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
44008663|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44008664|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44008665|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
44008666|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44008667|NCT02909140|Protective Agents|protective agents|mesh-ancestor
44008668|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
44008669|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44248047|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248048|NCT00492050|Valacyclovir|valacyclovir|mesh-list
44248049|NCT00492050|Rituximab|rituximab|mesh-list
44248050|NCT00492050|Bortezomib|bortezomib|mesh-list
44248051|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44248052|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248053|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
43646855|NCT02735902|Aspirin|aspirin|mesh-list
44008670|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44008671|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008672|NCT02909439|Neostigmine|neostigmine|mesh-list
44008677|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008678|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008679|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44008680|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
44008681|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008682|NCT02909959|Sulforaphane|sulforaphane|mesh-list
44008683|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44008684|NCT02909959|Protective Agents|protective agents|mesh-ancestor
44008685|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008686|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008687|NCT02911324|Nabilone|nabilone|mesh-list
44008688|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
44008689|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
44008690|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008691|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008692|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44008693|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44008694|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008695|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008696|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008697|NCT02911818|Liraglutide|liraglutide|mesh-list
44008698|NCT02911818|Phentermine|phentermine|mesh-list
44008699|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44008700|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008702|NCT02911818|Hormones|hormones|mesh-ancestor
44008703|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008704|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44008705|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
44008706|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44008707|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
44008708|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
44008709|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008710|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008711|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008712|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008713|NCT02911844|Fulvestrant|fulvestrant|mesh-list
44008714|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44008715|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008716|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44008717|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44008718|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
44008719|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008720|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008721|NCT02912195|Lidocaine|lidocaine|mesh-list
44008722|NCT02912195|Morphine|morphine|mesh-list
44008723|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
44008724|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
44008725|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008726|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008727|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
44008728|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008729|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44008730|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44008731|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008732|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008733|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248054|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248055|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248056|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
44248057|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248058|NCT00489307|Dexamethasone|dexamethasone|mesh-list
44248059|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248060|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
44248061|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
44248062|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248063|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248064|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248065|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
44248066|NCT00489307|Hormones|hormones|mesh-ancestor
44248067|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248068|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44248069|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248070|NCT00422565|Sirolimus|sirolimus|mesh-list
44248071|NCT00422565|Paclitaxel|paclitaxel|mesh-list
44248072|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44008734|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44008735|NCT02912195|Narcotics|narcotics|mesh-ancestor
44008736|NCT02912195|Analgesics|analgesics|mesh-ancestor
44008737|NCT02912364|Carbamazepine|carbamazepine|mesh-list
44008738|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44008739|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
44008740|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
44008741|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008742|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008743|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008747|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
44008748|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008749|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44008750|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008751|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008752|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44008753|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44008754|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44008755|NCT02913521|Diclofenac|diclofenac|mesh-list
44008756|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008757|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008758|NCT02913521|Analgesics|analgesics|mesh-ancestor
44008759|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
44008760|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008761|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008762|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008763|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008764|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44008765|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008766|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008767|NCT02913924|Clonazepam|clonazepam|mesh-list
44008768|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
44008769|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
44008770|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
44008771|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008772|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008773|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248073|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248074|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248075|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248076|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44248077|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248078|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248079|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248080|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44248081|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
44008774|NCT02914119|Rocuronium|rocuronium|mesh-list
44008775|NCT02914119|Mivacurium|mivacurium|mesh-list
44008776|NCT02914119|Cisatracurium|cisatracurium|mesh-list
44008777|NCT02914119|Succinylcholine|succinylcholine|mesh-list
44008778|NCT02914119|Neostigmine|neostigmine|mesh-list
44008779|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44008780|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44008781|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44008782|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008783|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008784|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008785|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008786|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008787|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008788|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008789|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44008790|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
44008791|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44008792|NCT02914509|Travoprost|travoprost|mesh-list
44008793|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44008794|NCT02915705|Vitamin D|vitamin d|mesh-list
44008795|NCT02915705|Vitamins|vitamins|mesh-ancestor
44008796|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
44008797|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008798|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44008799|NCT02915744|Gemcitabine|gemcitabine|mesh-list
44008800|NCT02915744|Paclitaxel|paclitaxel|mesh-list
44008801|NCT02915744|Vinorelbine|vinorelbine|mesh-list
44008802|NCT02915744|Docetaxel|docetaxel|mesh-list
44008803|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44008804|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
44008805|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44008806|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008807|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44008808|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44008809|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44008810|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008811|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44008812|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
44008813|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
44008814|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008815|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008816|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008820|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44008821|NCT02916407|Sevoflurane|sevoflurane|mesh-list
44008822|NCT02916407|Desflurane|desflurane|mesh-list
44008823|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44008824|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44008825|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
44008826|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
44008827|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008828|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008829|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44008830|NCT02916745|Trioxsalen|trioxsalen|mesh-list
44008831|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008832|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008833|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44008834|NCT02917122|Sertraline|sertraline|mesh-list
44008835|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
44248082|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248083|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
44248084|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248086|NCT00329043|Leuprolide|leuprolide|mesh-list
44008836|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008837|NCT02917122|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44008838|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44008839|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008840|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008841|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008842|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
44008843|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008844|NCT02918097|Risperidone|risperidone|mesh-list
44008845|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
44008846|NCT02918097|Sertraline|sertraline|mesh-list
44008847|NCT02918097|Nortriptyline|nortriptyline|mesh-list
44008848|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44008849|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
44008850|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008851|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008852|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008853|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44008854|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008855|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008856|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008857|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44008858|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
44008859|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
44008860|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44008861|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44008862|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008863|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008864|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
44008865|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44008866|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44008867|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
44008868|NCT02918357|Edetic Acid|edetic acid|mesh-list
44008869|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44008870|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
44008871|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
44008872|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008873|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
44008874|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44008875|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44008876|NCT02918617|Fluorides|fluorides|mesh-list
44008877|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
44008878|NCT02918617|Protective Agents|protective agents|mesh-ancestor
44008879|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008880|NCT02918630|Nicotine|nicotine|mesh-list
44008881|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44008882|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
44008883|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008884|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008885|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44008886|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44008887|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008888|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008889|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008892|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
44008893|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
44008894|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008895|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
44008896|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44008897|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44008898|NCT02920749|Anesthetics|anesthetics|mesh-list
44008899|NCT02920749|Propofol|propofol|mesh-list
44008900|NCT02920749|Sevoflurane|sevoflurane|mesh-list
44008901|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008902|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008903|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44248087|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248088|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44248089|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44248090|NCT00329043|Growth Substances|growth substances|mesh-ancestor
44248091|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248092|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44248093|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248094|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248095|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248096|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44008904|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44008905|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
44008906|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44008907|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44008908|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44008909|NCT02920918|Canagliflozin|canagliflozin|mesh-list
44008910|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44008911|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008912|NCT02920918|Incretins|incretins|mesh-ancestor
44008913|NCT02920918|Hormones|hormones|mesh-ancestor
44008914|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008915|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44008916|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44008917|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008918|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008919|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44008920|NCT02921061|Cytarabine|cytarabine|mesh-list
44008921|NCT02921061|Decitabine|decitabine|mesh-list
44008922|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44008923|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
44008924|NCT02921061|Cladribine|cladribine|mesh-list
44008926|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44008927|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
44008928|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008929|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008930|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
44008931|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008932|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44008933|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
44008934|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008935|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44008936|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008937|NCT02921061|Analgesics|analgesics|mesh-ancestor
44008938|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
44008939|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008940|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44008941|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44008942|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
44008943|NCT02921386|Testosterone|testosterone|mesh-list
44008944|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
44008945|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
44008946|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44008947|NCT02921386|Androgens|androgens|mesh-ancestor
44008948|NCT02921386|Hormones|hormones|mesh-ancestor
44008949|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008950|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008951|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44008952|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44008953|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
44147234|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147235|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147236|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147237|NCT00200447|Carbidopa|carbidopa|mesh-list
44147238|NCT00200447|Levodopa|levodopa|mesh-list
44248097|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
44248098|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44248099|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44248100|NCT00286013|Gemcitabine|gemcitabine|mesh-list
44248101|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
44147239|NCT00200447|Entacapone|entacapone|mesh-list
44147240|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44147241|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44147242|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44147243|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
44147244|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147245|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147249|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44147251|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147252|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741478|NCT05670509|Midazolam|midazolam|mesh-list
44008955|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44008956|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44008957|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008958|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
44008959|NCT02922582|Coagulants|coagulants|mesh-ancestor
44008960|NCT02922959|Naloxone|naloxone|mesh-list
44008961|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008962|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
44008963|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008964|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44008965|NCT02923895|Fluorides|fluorides|mesh-list
44008966|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
44008967|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
44008968|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
44008969|NCT02923895|Protective Agents|protective agents|mesh-ancestor
44008970|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008971|NCT02924350|Fluorides|fluorides|mesh-list
44008972|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
44008973|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
44008974|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
44008975|NCT02924350|Protective Agents|protective agents|mesh-ancestor
44008976|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008977|NCT02925611|Desflurane|desflurane|mesh-list
44008978|NCT02925611|Isoflurane|isoflurane|mesh-list
44008979|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44008980|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
44008981|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
44008982|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008983|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008984|NCT02925858|Ketamine|ketamine|mesh-list
44008985|NCT02925858|Analgesics|analgesics|mesh-ancestor
44008986|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
44008987|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008988|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008989|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44008990|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44008991|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
44008992|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
44008993|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008994|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44008995|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44008996|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44008997|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008998|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44008999|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44009000|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44009001|NCT02927223|Atropine|atropine|mesh-list
44009002|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44009003|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44009004|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44009005|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
44009006|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009007|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009008|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44009009|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009010|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
44009011|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
44248102|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44248103|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
44248104|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248105|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248106|NCT00286013|Antiviral Agents|antiviral agents|mesh-ancestor
44248107|NCT00286013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248108|NCT00286013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248109|NCT00286013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44009012|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44009013|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44009014|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009015|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009016|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009017|NCT02927457|GSK2646264|gsk2646264|mesh-list
44052907|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44009018|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44009024|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009025|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009027|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
44009028|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009029|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44009030|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
44009031|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009032|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44009033|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44009034|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009035|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44009036|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44009038|NCT02931045|Ticagrelor|ticagrelor|mesh-list
44009039|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44009040|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44009041|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44009042|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44009043|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
44009044|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009045|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009046|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009047|NCT02931253|Metformin|metformin|mesh-list
44009048|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009049|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009050|NCT02933034|Manganese|manganese|mesh-list
44009051|NCT02933034|Trace Elements|trace elements|mesh-ancestor
44009052|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
44009053|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009054|NCT02933320|Rituximab|rituximab|mesh-list
44009055|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44009056|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009057|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
44009058|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009059|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44009060|NCT02933372|Varenicline|varenicline|mesh-list
44009061|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44009062|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44009063|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009064|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009065|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009066|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009067|NCT02934191|Acetaminophen|acetaminophen|mesh-list
44009068|NCT02934191|Celecoxib|celecoxib|mesh-list
44009069|NCT02934191|Oxycodone|oxycodone|mesh-list
44009070|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
44009071|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009072|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009073|NCT02934191|Analgesics|analgesics|mesh-ancestor
44009074|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
44009075|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009076|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
44248110|NCT00286013|Immunologic Factors|immunologic factors|mesh-ancestor
44248111|NCT00286013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248112|NCT00254423|Dasatinib|dasatinib|mesh-list
44248113|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248114|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248115|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248116|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248117|NCT00134303|Metformin|metformin|mesh-list
44248118|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248119|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248120|NCT00061282|Clotrimazole|clotrimazole|mesh-list
44248121|NCT00061282|Miconazole|miconazole|mesh-list
44248122|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44248123|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248124|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
44248125|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44248126|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44248127|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248128|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248129|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44248130|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44248131|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248132|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248133|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44248134|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44248136|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248137|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
43646905|NCT02697253|Incretins|incretins|mesh-ancestor
44009077|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44009078|NCT02934191|Narcotics|narcotics|mesh-ancestor
44009079|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009080|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44009081|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009082|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44009083|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44009084|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44009085|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009086|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009087|NCT02934191|Antacids|antacids|mesh-ancestor
44009096|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44009097|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009098|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009099|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
44248138|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009100|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
44009101|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
44009102|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009103|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
44009104|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
44009105|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009106|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44009107|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
44009108|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
44009109|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009110|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009111|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44009112|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
44009113|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44009114|NCT02935738|Prednisolone|prednisolone|mesh-list
44009115|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009116|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
44009117|NCT02935738|Hormones|hormones|mesh-ancestor
44009118|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009119|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009120|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009121|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009122|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44009123|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44009124|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44009125|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44009126|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
44009127|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009128|NCT02937168|Reslizumab|reslizumab|mesh-list
44009129|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44009130|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44009131|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009132|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44009133|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009134|NCT02937506|Fentanyl|fentanyl|mesh-list
44009135|NCT02937506|Midazolam|midazolam|mesh-list
44009136|NCT02937506|Propofol|propofol|mesh-list
44009137|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44009138|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009139|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009140|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44009141|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
44009142|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
44009143|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44009144|NCT02937506|Narcotics|narcotics|mesh-ancestor
44009145|NCT02937506|Analgesics|analgesics|mesh-ancestor
44009146|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
44009147|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009148|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44009149|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44009150|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009151|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009152|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
44009153|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
44009154|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009161|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009162|NCT02937558|Incretins|incretins|mesh-ancestor
44009163|NCT02937623|Calcium|calcium|mesh-list
44009164|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44009165|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009166|NCT02938494|Tazarotene|tazarotene|mesh-list
44009167|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44009168|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
44009169|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
44009170|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44009171|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009172|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44009173|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44009174|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
44009175|NCT02941640|Hormones|hormones|mesh-ancestor
44009176|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009177|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009178|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248139|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147253|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44009179|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009180|NCT02941692|Oxytocin|oxytocin|mesh-list
44009181|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
44009182|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44009183|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009184|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
44009185|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009186|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009187|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
44009188|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
44009189|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
44009190|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009191|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009192|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009193|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44009194|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009195|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009196|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009197|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44009198|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
44009199|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009200|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009201|NCT02944461|Dapsone|dapsone|mesh-list
44009202|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009203|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
44009204|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44009205|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44009206|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44009207|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009208|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009209|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
44009210|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44009211|NCT02944565|Daratumumab|daratumumab|mesh-list
44009212|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009213|NCT02945150|Grazoprevir|grazoprevir|mesh-list
44009214|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
44009215|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009216|NCT02946034|Ribavirin|ribavirin|mesh-list
44009217|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
44009218|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009219|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
44009220|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009221|NCT02946073|Buprenorphine|buprenorphine|mesh-list
44009222|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44009231|NCT02946489|Analgesics|analgesics|mesh-ancestor
44009232|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
44009233|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009234|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009235|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44009236|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44009237|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
44009238|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
44009239|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009240|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44009241|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44009242|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009243|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009244|NCT02946892|Carvedilol|carvedilol|mesh-list
44009245|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44009246|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44009247|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009248|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009249|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009250|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009251|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44009252|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
44009253|NCT02946892|Protective Agents|protective agents|mesh-ancestor
44009254|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44009255|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009256|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44248140|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248141|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248143|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44248144|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248145|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44248146|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
44009257|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
44009258|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44009259|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44009260|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
44009261|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
44009262|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009263|NCT02949674|Bupivacaine|bupivacaine|mesh-list
44009264|NCT02949674|Ropivacaine|ropivacaine|mesh-list
44009265|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009266|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
44009267|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009268|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009269|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
44009270|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009271|NCT02949921|Lidocaine|lidocaine|mesh-list
44009272|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009273|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
44009274|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009275|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009276|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
44009277|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009278|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44009279|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44009280|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44009281|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009282|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009283|NCT02950467|Psilocybin|psilocybin|mesh-list
44009284|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44009285|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
44009286|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009287|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009288|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44147258|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147259|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147260|NCT00200473|Nebivolol|nebivolol|mesh-list
44147261|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147262|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147263|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44147264|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44147265|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44147266|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147267|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147268|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147269|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147270|NCT00200499|Nebivolol|nebivolol|mesh-list
44147271|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147272|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147273|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44147274|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44147275|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44147276|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147277|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147278|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147279|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147280|NCT00200512|Apomorphine|apomorphine|mesh-list
44147281|NCT00200512|Emetics|emetics|mesh-ancestor
44147282|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248147|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44248148|NCT00602173|Protective Agents|protective agents|mesh-ancestor
44248149|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44248150|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44248151|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248152|NCT00602186|Prazosin|prazosin|mesh-list
44248153|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44248154|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44248155|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44248156|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44248157|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248158|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248159|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248160|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248161|NCT00602251|Terbinafine|terbinafine|mesh-list
44248162|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
44248163|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248164|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248165|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248166|NCT00602303|Torsemide|torsemide|mesh-list
44248167|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44248168|NCT00602303|Diuretics|diuretics|mesh-ancestor
44248169|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
44248170|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248171|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44147283|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
44147284|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147285|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147286|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
44147287|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
44147288|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157780|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009293|NCT02951182|Ivacaftor|ivacaftor|mesh-list
44009294|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44009295|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009296|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009297|NCT02951195|Ivacaftor|ivacaftor|mesh-list
44009298|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44009299|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009300|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009301|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
44009302|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44009303|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44009304|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44009305|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44009306|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009307|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248172|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248173|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009308|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009309|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009311|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009312|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
44009313|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009314|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009315|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
44009316|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009318|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44009324|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009325|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
44009326|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009327|NCT02953561|Azacitidine|azacitidine|mesh-list
44009328|NCT02953561|Avelumab|avelumab|mesh-list
44009329|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44009330|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44009331|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
44009332|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009333|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009334|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009335|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44009336|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
44009337|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009338|NCT02953860|Fulvestrant|fulvestrant|mesh-list
44009339|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009340|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009341|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44009342|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44009343|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009344|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009345|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009346|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
44009347|NCT02953873|Prednisone|prednisone|mesh-list
44009348|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
44009349|NCT02953873|Tacrolimus|tacrolimus|mesh-list
44009350|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009351|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
44009352|NCT02953873|Hormones|hormones|mesh-ancestor
44009353|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009354|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009355|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009356|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009357|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44009358|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
44009359|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44009360|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009361|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009362|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44009363|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44053328|NCT00004139|Gemcitabine|gemcitabine|mesh-list
44009364|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
44009365|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44009366|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009367|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
44009368|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
44009369|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009370|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009371|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44009372|NCT02953873|Protective Agents|protective agents|mesh-ancestor
44009374|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
44009375|NCT02953886|Protective Agents|protective agents|mesh-ancestor
44009376|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009377|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
44009378|NCT02954198|Prednisone|prednisone|mesh-list
44009379|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
44009380|NCT02954198|Everolimus|everolimus|mesh-list
44009381|NCT02954198|Tacrolimus|tacrolimus|mesh-list
44009382|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009383|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
44009384|NCT02954198|Hormones|hormones|mesh-ancestor
44248174|NCT00602316|Chelating Agents|chelating agents|mesh-list
44248175|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
44248176|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248177|NCT00602342|Terbinafine|terbinafine|mesh-list
44248178|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
44248179|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248180|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248181|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248182|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
44248183|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
44248184|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009385|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009386|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009387|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009388|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009389|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44009390|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
44009400|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
44009401|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009402|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009403|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44009404|NCT02954198|Protective Agents|protective agents|mesh-ancestor
44009405|NCT02955147|Prednisone|prednisone|mesh-list
44009406|NCT02955147|Ustekinumab|ustekinumab|mesh-list
44009407|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009408|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
44009409|NCT02955147|Hormones|hormones|mesh-ancestor
44009410|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009411|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009412|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009413|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009414|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
44009415|NCT02955329|Nicotine|nicotine|mesh-list
44009416|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44009417|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
44009418|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009419|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009420|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44009421|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44009422|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009423|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009424|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009425|NCT02956044|Metformin|metformin|mesh-list
44009426|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44009427|NCT02956044|Glimepiride|glimepiride|mesh-list
44009428|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
44009429|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009430|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009431|NCT02956044|Incretins|incretins|mesh-ancestor
44009432|NCT02956044|Hormones|hormones|mesh-ancestor
44009433|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009434|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44009435|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
44009436|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009437|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009438|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44009439|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44009440|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
44009441|NCT02956070|Dexamethasone|dexamethasone|mesh-list
44009442|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
44009443|NCT02956070|BB 1101|bb 1101|mesh-list
44009444|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009445|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
44009446|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
44248185|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248186|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248187|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
44248188|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44248189|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248190|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248191|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
44009447|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009448|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009449|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009450|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
44009451|NCT02956070|Hormones|hormones|mesh-ancestor
44009452|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009453|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009454|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009455|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44009456|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009459|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44009460|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44009461|NCT02956122|Prednisolone|prednisolone|mesh-list
44009462|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
44009463|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44009464|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
44009465|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
44009466|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44009467|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009468|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
44009469|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
44009470|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009471|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009472|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009473|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
44009474|NCT02956122|Hormones|hormones|mesh-ancestor
44009475|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009476|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44009477|NCT02956122|Protective Agents|protective agents|mesh-ancestor
44009478|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009479|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009480|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009481|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009482|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44009483|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44009484|NCT02956616|Ketorolac|ketorolac|mesh-list
44009485|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44009486|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009487|NCT02956616|Analgesics|analgesics|mesh-ancestor
44009488|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
44009489|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009490|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009491|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009492|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053470|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44009493|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44009494|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009495|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009496|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
44009497|NCT02956746|Antibodies|antibodies|mesh-list
44009498|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
44009499|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44009500|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44009501|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
44009502|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009503|NCT02957305|Misoprostol|misoprostol|mesh-list
44009504|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44009505|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
44009506|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44009507|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009508|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44248193|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248194|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248195|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248196|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
44248197|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44248198|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248199|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248200|NCT00602407|Cilostazol|cilostazol|mesh-list
44248201|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248202|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
43646979|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009509|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009510|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
44009511|NCT02958345|Vaccines|vaccines|mesh-list
44009512|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
44009513|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009514|NCT02958956|Pioglitazone|pioglitazone|mesh-list
44009515|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009516|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009517|NCT02958969|Apixaban|apixaban|mesh-list
44009518|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44009519|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
44009520|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44009521|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
44009522|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009523|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009524|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
44009526|NCT02959840|Metoclopramide|metoclopramide|mesh-list
44009527|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
44009528|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
44009529|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009530|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009535|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
44009536|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009537|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009538|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44009539|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009540|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009541|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009543|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44009544|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44009545|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
44009546|NCT02959853|Anastrozole|anastrozole|mesh-list
44009547|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009548|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009549|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44009550|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44009551|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009552|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009553|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44009554|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009555|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009556|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009557|NCT02959996|Bupivacaine|bupivacaine|mesh-list
44009558|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009559|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
44009560|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009561|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009562|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
44009563|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009564|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
44248203|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901377|NCT00072514|Rituximab|rituximab|mesh-list
44248204|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009565|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
44009566|NCT02964416|Tramadol|tramadol|mesh-list
44009567|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44009568|NCT02964416|Narcotics|narcotics|mesh-ancestor
44009569|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009570|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009571|NCT02964416|Analgesics|analgesics|mesh-ancestor
44009572|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
44009573|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009574|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
44009575|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44009576|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
44009577|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009578|NCT02965924|Phenylephrine|phenylephrine|mesh-list
44009579|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
44009580|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44009581|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
44009582|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
44009583|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009584|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009585|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
44009586|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44009587|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
44009588|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009589|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44009590|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44009591|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44009592|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009593|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009594|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009596|NCT02966275|Glucagon|glucagon|mesh-list
44009597|NCT02966275|Pancrelipase|pancrelipase|mesh-list
44009598|NCT02966275|Pancreatin|pancreatin|mesh-list
44009599|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44009600|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009601|NCT02966275|Hormones|hormones|mesh-ancestor
44009602|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009603|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009604|NCT02966275|Incretins|incretins|mesh-ancestor
44009612|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009613|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44009614|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44009615|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44009616|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44009617|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44009619|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009620|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44009621|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009622|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053600|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009623|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009624|NCT02968368|Ferric maltol|ferric maltol|mesh-list
44009625|NCT02968368|Hematinics|hematinics|mesh-ancestor
44009626|NCT02968914|Benralizumab|benralizumab|mesh-list
44009627|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44009628|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009629|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
44009630|NCT02969317|Olodaterol|olodaterol|mesh-list
44009631|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44009632|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
44009633|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009634|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009635|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44009636|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009637|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
44009638|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44009639|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009640|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009641|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009642|NCT02969876|Vortioxetine|vortioxetine|mesh-list
43822480|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44248205|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248206|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248207|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44248208|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44248209|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248210|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44248211|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
44248212|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44248213|NCT00602407|Protective Agents|protective agents|mesh-ancestor
44009643|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44009644|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009645|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44009646|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009647|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009648|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009649|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44009650|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44009651|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009652|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009653|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009654|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
44009655|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44009656|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44009657|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44009658|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44009659|NCT02970032|Heparin|heparin|mesh-list
44009660|NCT02970032|Calcium heparin|calcium heparin|mesh-list
44009661|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
44009662|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44009663|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44009664|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009665|NCT02970162|Amifampridine|amifampridine|mesh-list
44009666|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44009667|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009668|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009669|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44009670|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009671|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009672|NCT02970552|Progesterone|progesterone|mesh-list
44009679|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44009680|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009681|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009682|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009683|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009684|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44009685|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44009686|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44009687|NCT02973503|Grazoprevir|grazoprevir|mesh-list
44009688|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44009689|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
44009690|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009692|NCT02975297|Nicotine|nicotine|mesh-list
44009693|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44009694|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
44009695|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009696|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009697|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44009698|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44009699|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009700|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009701|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009702|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009703|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44248214|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44248215|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44248216|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009704|NCT02975297|Incretins|incretins|mesh-ancestor
44009705|NCT02975297|Hormones|hormones|mesh-ancestor
44009706|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009707|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44009708|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
44009709|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44009710|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44009711|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44009712|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44009713|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009714|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009715|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009716|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009717|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44009718|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44009719|NCT02978157|Amoxicillin|amoxicillin|mesh-list
44009720|NCT02978157|Levofloxacin|levofloxacin|mesh-list
44009721|NCT02978157|Ofloxacin|ofloxacin|mesh-list
44009722|NCT02978157|Tetracycline|tetracycline|mesh-list
44009723|NCT02978157|Esomeprazole|esomeprazole|mesh-list
44009724|NCT02978157|Bismuth|bismuth|mesh-list
44009725|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44009726|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009727|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44009728|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009729|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44009730|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009731|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009732|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44009733|NCT02978157|Renal Agents|renal agents|mesh-ancestor
44009734|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44009735|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44009736|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009737|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44009738|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44009739|NCT02978157|Antacids|antacids|mesh-ancestor
44009740|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44009741|NCT02978339|Curcumin|curcumin|mesh-list
44009742|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44009752|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147289|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147290|NCT00200525|Apomorphine|apomorphine|mesh-list
44147292|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147293|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
44147294|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147295|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147296|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
44147297|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
44147298|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147299|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147300|NCT00200538|Memantine|memantine|mesh-list
44147301|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44147302|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44147303|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
44147304|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147305|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147306|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147307|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44147308|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44147309|NCT00200551|Cyclosporine|cyclosporine|mesh-list
44147310|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
44147311|NCT00200551|Cyclosporins|cyclosporins|mesh-list
44147312|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44147313|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147314|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147315|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147316|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
44147317|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248218|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248219|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248220|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44248221|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248222|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248223|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44248224|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44147318|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
44147319|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147320|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
44147321|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147322|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44147323|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147324|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147325|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44147326|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
44147327|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44147329|NCT00200564|Analgesics|analgesics|mesh-ancestor
44147330|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
44147331|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147332|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147333|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44147334|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44147335|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
44147336|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
44147337|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147338|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44147339|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44147340|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147341|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147342|NCT00200590|Acetaminophen|acetaminophen|mesh-list
44147343|NCT00200590|Morphine|morphine|mesh-list
44147344|NCT00200590|Nalbuphine|nalbuphine|mesh-list
44009754|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009755|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009756|NCT02979301|Tamoxifen|tamoxifen|mesh-list
44009757|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44009758|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009759|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009760|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009761|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009762|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009763|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44009764|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44009765|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44009766|NCT02983981|Desoximetasone|desoximetasone|mesh-list
44009767|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009768|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
44009769|NCT02983981|Hormones|hormones|mesh-ancestor
44009770|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009771|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009773|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44009774|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009775|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44009776|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009777|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
44009778|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
44009779|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009780|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009781|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009782|NCT02988050|Lidocaine|lidocaine|mesh-list
44009783|NCT02988050|Epinephrine|epinephrine|mesh-list
44009784|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
44460182|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460183|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460184|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44460186|NCT01567826|Simvastatin|simvastatin|mesh-list
44460187|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44460188|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44460189|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
44460190|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460191|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44460192|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44460193|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460194|NCT01567527|Aripiprazole|aripiprazole|mesh-list
44460195|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
44460196|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460197|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44460198|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460199|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009785|NCT02988050|Remifentanil|remifentanil|mesh-list
44009786|NCT02988050|Bupivacaine|bupivacaine|mesh-list
44009787|NCT02988050|Propofol|propofol|mesh-list
44009788|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009789|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
44009790|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009791|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009792|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
44009793|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009794|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44009795|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44009796|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44009797|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009798|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009799|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44009800|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44009801|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
44009802|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009803|NCT02988050|Analgesics|analgesics|mesh-ancestor
44009804|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44009805|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44009806|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44009814|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44009815|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44009816|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
44009817|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
44009818|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44009819|NCT02988349|Listerine|listerine|mesh-list
44009820|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
44009821|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
44009822|NCT02988349|Protective Agents|protective agents|mesh-ancestor
44009823|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009824|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44009825|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009826|NCT02988843|Bevacizumab|bevacizumab|mesh-list
44009827|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44009828|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44009829|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823330|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
44460200|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460201|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
44460202|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
44460203|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647022|NCT02555787|Tacrolimus|tacrolimus|mesh-list
44009830|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44009831|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44009832|NCT02988843|Growth Substances|growth substances|mesh-ancestor
44009833|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009834|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
44009835|NCT02988882|Dexamethasone|dexamethasone|mesh-list
44009836|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009837|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
44009838|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
44009839|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009840|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009841|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009842|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
44009843|NCT02988882|Hormones|hormones|mesh-ancestor
44009844|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009845|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009846|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009848|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44009849|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
44009850|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009851|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009852|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009853|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009854|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44009855|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44009856|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44009857|NCT02989493|Doxazosin|doxazosin|mesh-list
44009858|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44009859|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44009860|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44009861|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44009862|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009863|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009864|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009865|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009866|NCT02989714|Nivolumab|nivolumab|mesh-list
44009867|NCT02989714|Interleukin-2|interleukin-2|mesh-list
44009868|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44009869|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009870|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44009871|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009872|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009873|NCT02989714|Analgesics|analgesics|mesh-ancestor
44009874|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
44009875|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009883|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009884|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44009885|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009886|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009887|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009888|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44009889|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
44009890|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44009891|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44009892|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009893|NCT02993302|Vitamins|vitamins|mesh-ancestor
44009894|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
44009895|NCT02995915|Bupropion|bupropion|mesh-list
44009896|NCT02995915|Nicotine|nicotine|mesh-list
44009897|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44009898|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
44009899|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009900|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009902|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44009903|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460204|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460205|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44460206|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44460208|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44460209|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44460210|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44009904|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009905|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009906|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44009907|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
44009908|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009909|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44009910|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44009911|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009912|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
44009913|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44009914|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44009915|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009916|NCT02996591|Dexamethasone|dexamethasone|mesh-list
44009917|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
44009919|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
44009920|NCT02996591|Ketamine|ketamine|mesh-list
44009921|NCT02996591|Bupivacaine|bupivacaine|mesh-list
44009922|NCT02996591|Mepivacaine|mepivacaine|mesh-list
44009923|NCT02996591|Anesthetics|anesthetics|mesh-list
44009924|NCT02996591|Propofol|propofol|mesh-list
44009925|NCT02996591|Sevoflurane|sevoflurane|mesh-list
44009926|NCT02996591|BB 1101|bb 1101|mesh-list
44009927|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009928|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
44009929|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
44009930|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009931|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009932|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009933|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
44009934|NCT02996591|Hormones|hormones|mesh-ancestor
44009935|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009936|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44009937|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009938|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44009939|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009940|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009941|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009942|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009943|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
44009944|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44009952|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44009953|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44009954|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44009955|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009956|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
44009957|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
44009958|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44009959|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44009960|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44009961|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44009962|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
44009963|NCT02997722|Ketamine|ketamine|mesh-list
44009964|NCT02997722|Analgesics|analgesics|mesh-ancestor
44009965|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
44009966|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009967|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009968|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44009969|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44009970|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
44009971|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
44460211|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44460212|NCT01567163|Docetaxel|docetaxel|mesh-list
44460213|NCT01567163|Ramucirumab|ramucirumab|mesh-list
44460214|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460215|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44460216|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460217|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460218|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460219|NCT01567085|Eculizumab|eculizumab|mesh-list
44460220|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44460221|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460222|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
44009972|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009973|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44009974|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44009975|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742216|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
44009976|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009977|NCT03000283|Conivaptan|conivaptan|mesh-list
44009978|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44009979|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009980|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
44009981|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009982|NCT03000309|Apremilast|apremilast|mesh-list
44009983|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44009984|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009985|NCT03000309|Analgesics|analgesics|mesh-ancestor
44009986|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
44009987|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009988|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009989|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009990|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44009991|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44009992|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44009993|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009994|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009995|NCT03001453|Epinephrine|epinephrine|mesh-list
44009996|NCT03001453|Bupivacaine|bupivacaine|mesh-list
44009997|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009998|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
44009999|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010000|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010001|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
44010002|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010003|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44010004|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44010005|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010006|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010007|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010008|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44010009|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44010010|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
44010019|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
44010020|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010021|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010022|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44010023|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010024|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
44010025|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
44010026|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010027|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44010029|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010030|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010031|NCT03002012|Fluconazole|fluconazole|mesh-list
44010032|NCT03002012|Sertraline|sertraline|mesh-list
44010033|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
44010034|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44010035|NCT03002012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44010036|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44010037|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010038|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010039|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010040|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
44010041|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010042|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
44010043|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010044|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44010045|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010046|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010047|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43742259|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
44010048|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
44010049|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010050|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44010051|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44010052|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
44010053|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44010054|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44010055|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010056|NCT03002506|Tazobactam|tazobactam|mesh-list
44010057|NCT03002506|Ceftolozane|ceftolozane|mesh-list
44010058|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44010059|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010060|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010061|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44010063|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010064|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44010065|NCT03002506|Renal Agents|renal agents|mesh-ancestor
44010066|NCT03002974|Triamcinolone|triamcinolone|mesh-list
44010067|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44010068|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44010069|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44010070|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44010071|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010072|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
44010073|NCT03002974|Hormones|hormones|mesh-ancestor
44010074|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010075|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010076|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44010084|NCT03003949|Hormones|hormones|mesh-ancestor
44010085|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010086|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010087|NCT03003949|Progestins|progestins|mesh-ancestor
44010088|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
44010089|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44010090|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010091|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44010092|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010093|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
44010094|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44010095|NCT03007225|Estrogens|estrogens|mesh-ancestor
44010096|NCT03007225|Hormones|hormones|mesh-ancestor
44010097|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010098|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010099|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010100|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010101|NCT03008213|Palonosetron|palonosetron|mesh-list
44010102|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
44010103|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
44010104|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460223|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460224|NCT01566773|Bromides|bromides|mesh-list
44460225|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
44460226|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44460227|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
44460228|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010105|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010106|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010107|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44010108|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44010109|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
44010110|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010111|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010112|NCT03008590|Naltrexone|naltrexone|mesh-list
44010113|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44010114|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44010115|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010116|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
44010117|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010118|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
44010119|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44010120|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
44010121|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010122|NCT03008889|Expectorants|expectorants|mesh-ancestor
44010123|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
44010124|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44010125|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
44010126|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010127|NCT03008889|Protective Agents|protective agents|mesh-ancestor
44010128|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010129|NCT03008889|Antidotes|antidotes|mesh-ancestor
44010130|NCT03009162|Lasmiditan|lasmiditan|mesh-list
44010131|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44010132|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
44010133|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010134|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010135|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010136|NCT03009396|Clarithromycin|clarithromycin|mesh-list
44010137|NCT03009396|Rifabutin|rifabutin|mesh-list
44010138|NCT03009396|Clofazimine|clofazimine|mesh-list
44010139|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010140|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010141|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44010142|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010143|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010144|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010148|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010149|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
44147355|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44147356|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147357|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
44147358|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44147360|NCT00200629|Analgesics|analgesics|mesh-ancestor
44147361|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
44147362|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147363|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147364|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44147365|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147366|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44147367|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
44147368|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
44147369|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147370|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147371|NCT00200655|Pravastatin|pravastatin|mesh-list
44147372|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44147373|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44147374|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
44147375|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147376|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44460229|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460230|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44460231|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460232|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
44460233|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44248225|NCT00602511|Thalidomide|thalidomide|mesh-list
44147377|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44147378|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147379|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44147380|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44147381|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147382|NCT00200681|Bortezomib|bortezomib|mesh-list
44147383|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147384|NCT00200694|Valsartan|valsartan|mesh-list
44147385|NCT00200694|Ramipril|ramipril|mesh-list
44147386|NCT00200694|Furosemide|furosemide|mesh-list
44147387|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147388|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44147389|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44147390|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147391|NCT00200694|Diuretics|diuretics|mesh-ancestor
44147392|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
44147393|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147394|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44147395|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44147396|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44147397|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
44147398|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147399|NCT00200941|Topiramate|topiramate|mesh-list
44010150|NCT03010631|Lubiprostone|lubiprostone|mesh-list
44010151|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44010152|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010153|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010154|NCT03010683|Metformin|metformin|mesh-list
44010155|NCT03010683|Liraglutide|liraglutide|mesh-list
44010156|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44010157|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010158|NCT03010683|Incretins|incretins|mesh-ancestor
44010159|NCT03010683|Hormones|hormones|mesh-ancestor
44010160|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010161|NCT03012191|Gentamicins|gentamicins|mesh-list
44010162|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010163|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010164|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44010165|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010166|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010168|NCT03012477|Adavosertib|adavosertib|mesh-list
44010169|NCT03012477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010170|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010177|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010178|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010179|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
44010180|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010181|NCT03017508|Riluzole|riluzole|mesh-list
44010182|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
44010183|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44010184|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44010185|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010186|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010187|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010188|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44010189|NCT03017508|Protective Agents|protective agents|mesh-ancestor
44010190|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
44010191|NCT03018223|Sirolimus|sirolimus|mesh-list
44010192|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
44010193|NCT03018223|Busulfan|busulfan|mesh-list
44010194|NCT03018223|Fludarabine|fludarabine|mesh-list
44010195|NCT03018223|Lenograstim|lenograstim|mesh-list
44010196|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248227|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248228|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248229|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
44248230|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248231|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
44248232|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248233|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248234|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44248235|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44248236|NCT00602511|Growth Substances|growth substances|mesh-ancestor
44010197|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
44010198|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010199|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010200|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44010201|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
44010202|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010203|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010204|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44010205|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44010206|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44010207|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
44010208|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010209|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010210|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010211|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
44010212|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44010213|NCT03018925|Golimumab|golimumab|mesh-list
44010214|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44010215|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010216|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44010217|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
44010218|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010219|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44010220|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44010221|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44010222|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010223|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010224|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010225|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010226|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010227|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
44010228|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010229|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
44010230|NCT03019887|Haloperidol|haloperidol|mesh-list
44010231|NCT03019887|Olanzapine|olanzapine|mesh-list
44010232|NCT03019887|Risperidone|risperidone|mesh-list
44010233|NCT03019887|Aripiprazole|aripiprazole|mesh-list
44010234|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44010235|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44010236|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
44010237|NCT03019887|Perphenazine|perphenazine|mesh-list
44010238|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44010240|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010241|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010242|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010245|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010247|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44010248|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
44010249|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
44010250|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
44010251|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010252|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010253|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44010254|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44010255|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248237|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
44248238|NCT00602524|Pilocarpine|pilocarpine|mesh-list
44248239|NCT00602524|Miotics|miotics|mesh-ancestor
44248240|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
44248241|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248242|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248243|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44248244|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44248245|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
44010256|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
44010257|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
44010258|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44010259|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44010260|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44010261|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44010262|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44010263|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010264|NCT03019887|Analgesics|analgesics|mesh-ancestor
44010265|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
44010266|NCT03019939|Isavuconazole|isavuconazole|mesh-list
44010267|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
44010268|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010269|NCT03020004|Ritonavir|ritonavir|mesh-list
44010270|NCT03020004|Ribavirin|ribavirin|mesh-list
44010271|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44010272|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44010273|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44010274|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010275|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010276|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010277|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010278|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010279|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
44010280|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010281|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010282|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010283|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
44010284|NCT03020082|Ritonavir|ritonavir|mesh-list
44010285|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44010286|NCT03020082|Ribavirin|ribavirin|mesh-list
44010287|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44010288|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44010289|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010290|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010291|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010292|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010293|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010294|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
44010295|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010296|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010297|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010298|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
44010299|NCT03020095|Ritonavir|ritonavir|mesh-list
44010300|NCT03020095|Ribavirin|ribavirin|mesh-list
44010301|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44010302|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44010303|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010304|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010305|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010306|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010307|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010308|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
44010309|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010310|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010311|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010312|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
44010313|NCT03021343|Colchicine|colchicine|mesh-list
44010315|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248246|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248247|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248248|NCT00602550|Zidovudine|zidovudine|mesh-list
44010316|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
44010317|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
44010335|NCT03022916|Efinaconazole|efinaconazole|mesh-list
44010336|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44010337|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
44010338|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010339|NCT03023891|Prednisone|prednisone|mesh-list
44010340|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010341|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
44010342|NCT03023891|Hormones|hormones|mesh-ancestor
44010343|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010344|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010345|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010346|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010347|NCT03025945|Nepafenac|nepafenac|mesh-list
44010348|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44010349|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010350|NCT03025945|Analgesics|analgesics|mesh-ancestor
44010351|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
44010352|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010353|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010354|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010355|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010356|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
44010357|NCT03026556|Apixaban|apixaban|mesh-list
44010358|NCT03026556|Dabigatran|dabigatran|mesh-list
44010359|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44010360|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
44010361|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44010362|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010363|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010364|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010365|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
44010366|NCT03026803|Capecitabine|capecitabine|mesh-list
44010367|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
44010368|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44010369|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
44010370|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010371|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010372|NCT03027661|Bupivacaine|bupivacaine|mesh-list
44010373|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010374|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
44010375|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010376|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010377|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
44010383|NCT03028103|Omeprazole|omeprazole|mesh-list
44010384|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44010385|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010386|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44010387|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010388|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010389|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
44010390|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010391|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44010392|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010393|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44010394|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
44010395|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010396|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010397|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44010398|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44010399|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44010400|NCT03028467|Folic Acid|folic acid|mesh-list
44010401|NCT03028467|Methotrexate|methotrexate|mesh-list
44054474|NCT00004300|Sertraline|sertraline|mesh-list
44010402|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44010403|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
44010404|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44010405|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010406|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44248249|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
43647074|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44010407|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
44010408|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010409|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010410|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44010411|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010412|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44010413|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44010414|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
44010415|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010416|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44010417|NCT03028467|Hematinics|hematinics|mesh-ancestor
44010418|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
44010419|NCT03028467|Vitamins|vitamins|mesh-ancestor
44010420|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
44010421|NCT03029091|Losartan|losartan|mesh-list
44010422|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44010423|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44010424|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44010425|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44010426|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010427|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
44010428|NCT03029715|Remifentanil|remifentanil|mesh-list
44010429|NCT03029715|Propofol|propofol|mesh-list
44010430|NCT03029715|Desflurane|desflurane|mesh-list
44010431|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010432|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010433|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010434|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010435|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
44010436|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
44010437|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010438|NCT03029715|Analgesics|analgesics|mesh-ancestor
44010439|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
44010440|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010441|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44010442|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44010443|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44010444|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010445|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010446|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010447|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44010448|NCT03029715|Narcotics|narcotics|mesh-ancestor
44010476|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
44010477|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44010478|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
44010479|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
44010480|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010481|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010482|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44010483|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44010484|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010485|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44010486|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
44010487|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44010488|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44010489|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44010490|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
44010491|NCT03032965|Protective Agents|protective agents|mesh-ancestor
44010492|NCT03033511|Dexamethasone|dexamethasone|mesh-list
44010493|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
44010494|NCT03033511|BB 1101|bb 1101|mesh-list
44010495|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
44010500|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010501|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010502|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
44010503|NCT03033511|Hormones|hormones|mesh-ancestor
44010504|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010505|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010506|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010507|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010508|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010509|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248250|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248251|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44248252|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44248253|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248254|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
44248255|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248256|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44248257|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44248258|NCT00602589|Levofloxacin|levofloxacin|mesh-list
44248259|NCT00602589|Ofloxacin|ofloxacin|mesh-list
44248260|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44248261|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248262|NCT00602589|Renal Agents|renal agents|mesh-ancestor
44248263|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248264|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44248265|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44248266|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248267|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010510|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
44010511|NCT03035708|Varenicline|varenicline|mesh-list
44010512|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44010513|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44010514|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
44010515|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010516|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010517|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010518|NCT03035760|Oxfendazole|oxfendazole|mesh-list
44010519|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
44010520|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44010521|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010522|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
44010523|NCT03035929|Dexamethasone|dexamethasone|mesh-list
44010524|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
44010525|NCT03035929|BB 1101|bb 1101|mesh-list
44010526|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010527|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
44010528|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
44010529|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010530|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010531|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010532|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
44010533|NCT03035929|Hormones|hormones|mesh-ancestor
43851547|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010534|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010535|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010536|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010537|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010538|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010539|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010541|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010542|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44010544|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
44010545|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010546|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010547|NCT03036384|Sufentanil|sufentanil|mesh-list
44010548|NCT03036384|Morphine|morphine|mesh-list
44010549|NCT03036384|Prilocaine|prilocaine|mesh-list
44010550|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44248268|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248269|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44248270|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44248272|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44248273|NCT00602615|Diuretics|diuretics|mesh-ancestor
44248274|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
44248275|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010551|NCT03036384|Narcotics|narcotics|mesh-ancestor
44010552|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010553|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010554|NCT03036384|Analgesics|analgesics|mesh-ancestor
44010555|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
44010556|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010557|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010558|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010559|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
44010560|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
44010561|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010562|NCT03038308|Ropinirole|ropinirole|mesh-list
44010563|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44010564|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44010565|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
44010566|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
44010567|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010568|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010569|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010575|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010576|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010578|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
44010579|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010580|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
44010581|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44010582|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
44010583|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44010584|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44010585|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010586|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010587|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010588|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010589|NCT03039543|Rocuronium|rocuronium|mesh-list
44010590|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44010591|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44010592|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44010593|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010594|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010595|NCT03040011|Dexamethasone|dexamethasone|mesh-list
44010596|NCT03040011|Bupivacaine|bupivacaine|mesh-list
44010597|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010598|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
44010599|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
44010600|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010601|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010602|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010603|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
44010604|NCT03040011|Hormones|hormones|mesh-ancestor
44010605|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010606|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43742704|NCT05027295|Vitamins|vitamins|mesh-ancestor
44010607|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010608|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010609|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
44010610|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010611|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
44010612|NCT03040362|Lasmiditan|lasmiditan|mesh-list
43823331|NCT05525351|Alfentanil|alfentanil|mesh-list
44248276|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44248277|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248278|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248279|NCT00602680|Donepezil|donepezil|mesh-list
44010613|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44010614|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
44010615|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010616|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010617|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147400|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
44147401|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44147402|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147403|NCT00201253|Dimercaprol|dimercaprol|mesh-list
44147404|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
44147405|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
44147406|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147407|NCT00201305|Leucovorin|leucovorin|mesh-list
44147408|NCT00201305|Gemcitabine|gemcitabine|mesh-list
44147409|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147410|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
44147411|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147412|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147413|NCT00201305|Antiviral Agents|antiviral agents|mesh-ancestor
44147414|NCT00201305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147415|NCT00201305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147416|NCT00201305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147417|NCT00201305|Immunologic Factors|immunologic factors|mesh-ancestor
44147422|NCT00201305|Vitamins|vitamins|mesh-ancestor
44147423|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
44147424|NCT00201318|Lamivudine|lamivudine|mesh-list
44147425|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
44147426|NCT00201318|Doxorubicin|doxorubicin|mesh-list
44147427|NCT00201318|Vincristine|vincristine|mesh-list
44147428|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147429|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
44147430|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147431|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147432|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44147433|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
44147434|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147435|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147436|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44147437|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147438|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44147439|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44147440|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147441|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44147442|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147443|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44147444|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44147445|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44147446|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44147447|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
44147448|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147449|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44147450|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44147451|NCT00201331|Leucovorin|leucovorin|mesh-list
44147452|NCT00201331|Antidotes|antidotes|mesh-ancestor
44147453|NCT00201331|Protective Agents|protective agents|mesh-ancestor
44147454|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147455|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147456|NCT00201331|Vitamins|vitamins|mesh-ancestor
44147457|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
44147458|NCT00201344|Leucovorin|leucovorin|mesh-list
44147459|NCT00201344|Cisplatin|cisplatin|mesh-list
44147460|NCT00201344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147461|NCT00201344|Antidotes|antidotes|mesh-ancestor
44147462|NCT00201344|Protective Agents|protective agents|mesh-ancestor
44147463|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147464|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147465|NCT00201344|Vitamins|vitamins|mesh-ancestor
44054665|NCT00004357|Hormones|hormones|mesh-ancestor
44248280|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44147466|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
44147467|NCT00201357|Thalidomide|thalidomide|mesh-list
44010618|NCT03040479|Lasmiditan|lasmiditan|mesh-list
44010619|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44010620|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
44010621|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010622|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010623|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010624|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44010625|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
44010626|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
44010627|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010628|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44010629|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44010630|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010631|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010632|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44010633|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44010634|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44010635|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010636|NCT03043105|Thalidomide|thalidomide|mesh-list
44010637|NCT03043105|Prednisone|prednisone|mesh-list
44010638|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
44010639|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44010640|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
44010665|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
44010666|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010667|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010668|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010669|NCT03044418|Propofol|propofol|mesh-list
44010670|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
44010671|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010672|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010673|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010674|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010675|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
44010676|NCT03045861|Cobicistat|cobicistat|mesh-list
44010677|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
44010678|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010679|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010680|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
44010681|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010682|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010683|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010684|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010685|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010686|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44010687|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
44010695|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44010696|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010697|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010698|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
44010699|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010700|NCT03050294|Desoximetasone|desoximetasone|mesh-list
44010701|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010702|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
44010703|NCT03050294|Hormones|hormones|mesh-ancestor
44010704|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010705|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010706|NCT03050619|Empagliflozin|empagliflozin|mesh-list
44010707|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44010708|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010709|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44010710|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010711|NCT03051256|Methadone|methadone|mesh-list
44010712|NCT03051256|D-methadone|d-methadone|mesh-list
44010713|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44010714|NCT03051256|Narcotics|narcotics|mesh-ancestor
44010715|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010716|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248281|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248282|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248283|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
44248284|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248285|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248286|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
44010717|NCT03051256|Analgesics|analgesics|mesh-ancestor
44010718|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
44010719|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010720|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
44010721|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44010722|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010723|NCT03051646|Aspirin|aspirin|mesh-list
44010724|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44010725|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010726|NCT03051646|Analgesics|analgesics|mesh-ancestor
44010727|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
44010728|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010729|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010730|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010731|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010732|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44010733|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44010734|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010735|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44010736|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44010737|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010738|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
44010739|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
44010740|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44010741|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010742|NCT03053401|Anesthetics|anesthetics|mesh-list
44010743|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
44010744|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010745|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010746|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
44010747|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010748|NCT03054103|Midazolam|midazolam|mesh-list
44010749|NCT03054103|Ketamine|ketamine|mesh-list
44010750|NCT03054103|Analgesics|analgesics|mesh-ancestor
44010751|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
44010752|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010760|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44010761|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742850|NCT04949516|Aspirin|aspirin|mesh-list
44010762|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010763|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010764|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010765|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44010766|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44010767|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44010768|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
44010769|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
44010770|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44010771|NCT03054506|Laxatives|laxatives|mesh-ancestor
44010772|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010773|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
44010774|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010775|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
44010776|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010777|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010778|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
44010779|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010780|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
44010782|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010783|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010784|NCT03054844|Lidocaine|lidocaine|mesh-list
44010785|NCT03054844|Midazolam|midazolam|mesh-list
44010786|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010787|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
44248287|NCT00602693|Sirolimus|sirolimus|mesh-list
44248288|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
44248289|NCT00602693|Fludarabine|fludarabine|mesh-list
44010788|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010789|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010790|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
44010791|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010792|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44010793|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44010794|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44010795|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010796|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010797|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010798|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010799|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44010800|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44010801|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44010802|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010803|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
44010804|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
44010805|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
44010806|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010807|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
44010808|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010809|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010810|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010811|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010812|NCT03054857|Analgesics|analgesics|mesh-ancestor
44010813|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
44010814|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010815|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44010816|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44010817|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44010818|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44010819|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010824|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
44010825|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44010826|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010827|NCT03057132|Protective Agents|protective agents|mesh-list
44010828|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010829|NCT03057366|Paclitaxel|paclitaxel|mesh-list
44010830|NCT03057366|Docetaxel|docetaxel|mesh-list
44010831|NCT03057366|Carboplatin|carboplatin|mesh-list
44010832|NCT03057366|Pevonedistat|pevonedistat|mesh-list
44010833|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44010834|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010835|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
44010836|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
44010837|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
44010838|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010839|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010840|NCT03057704|Lidocaine|lidocaine|mesh-list
44010841|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010842|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
44010843|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010844|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010845|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
44010846|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010847|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44010848|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44010849|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44010850|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010851|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010852|NCT03060486|Hybenx|hybenx|mesh-list
44010853|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
44010854|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
44010855|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010856|NCT03061812|Dexamethasone|dexamethasone|mesh-list
44010857|NCT03061812|Topotecan|topotecan|mesh-list
44010858|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010859|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
44010860|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
44010861|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823332|NCT05525351|Propofol|propofol|mesh-list
44248290|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
44248291|NCT00602693|Allopurinol|allopurinol|mesh-list
44248292|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248293|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
44248294|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248295|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248296|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44010862|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010863|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44010864|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
44010865|NCT03061812|Hormones|hormones|mesh-ancestor
44010866|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010867|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010868|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010869|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44010870|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44010871|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010872|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010873|NCT03062488|Acetaminophen|acetaminophen|mesh-list
44010874|NCT03062488|Fentanyl|fentanyl|mesh-list
44010875|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44010876|NCT03062488|Narcotics|narcotics|mesh-ancestor
44010877|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010878|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010879|NCT03062488|Analgesics|analgesics|mesh-ancestor
44010880|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
44010881|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010882|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010883|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010884|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
44010885|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
44010886|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010887|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
44010888|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
44010889|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44010890|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010891|NCT03063255|Anesthetics|anesthetics|mesh-list
44010892|NCT03063255|Mepivacaine|mepivacaine|mesh-list
44010896|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44010897|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44010898|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44010899|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010900|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010901|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
44010902|NCT03065179|Nivolumab|nivolumab|mesh-list
44010903|NCT03065179|Ipilimumab|ipilimumab|mesh-list
44010904|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44010905|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010906|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44010907|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010908|NCT03066947|Interferons|interferons|mesh-list
44010909|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
44010910|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
44010911|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
44010912|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44010913|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
44010914|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010916|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44010917|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
44010918|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010919|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010920|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44010921|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
44010922|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010923|NCT03068312|Ivacaftor|ivacaftor|mesh-list
44010924|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44010925|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010926|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248297|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
44248298|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248299|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010927|NCT03068897|Ibuprofen|ibuprofen|mesh-list
44010928|NCT03068897|Tizanidine|tizanidine|mesh-list
44010929|NCT03068897|Baclofen|baclofen|mesh-list
44010930|NCT03068897|Metaxalone|metaxalone|mesh-list
44010931|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44010932|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010933|NCT03068897|Analgesics|analgesics|mesh-ancestor
44010934|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
44010935|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010936|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010937|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010938|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010939|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44010940|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010941|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010942|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44010943|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44010944|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44010945|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
44010946|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
44010947|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010948|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
44010949|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
44010950|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
44010951|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44010952|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44010953|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44010954|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147468|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147469|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
44147470|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147471|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
44147472|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44147473|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147474|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44147475|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44147476|NCT00201357|Growth Substances|growth substances|mesh-ancestor
44147477|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
44147478|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147480|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147481|NCT00201396|Leucovorin|leucovorin|mesh-list
44147482|NCT00201396|Cisplatin|cisplatin|mesh-list
44147483|NCT00201396|Fluorouracil|fluorouracil|mesh-list
44147484|NCT00201396|Epirubicin|epirubicin|mesh-list
44147485|NCT00201396|Mitomycins|mitomycins|mesh-list
44147486|NCT00201396|Mitomycin|mitomycin|mesh-list
44147487|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147488|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
44147489|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147490|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147491|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147492|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
44147493|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147494|NCT00201396|Antidotes|antidotes|mesh-ancestor
44147495|NCT00201396|Protective Agents|protective agents|mesh-ancestor
44147496|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147497|NCT00201396|Vitamins|vitamins|mesh-ancestor
44147498|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
44147499|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147500|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44147501|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44147502|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147503|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
44010955|NCT03069677|Midazolam|midazolam|mesh-list
44010956|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010957|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44010958|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010959|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010960|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44010961|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44010962|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248300|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44248301|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44248302|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
44248303|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248304|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010963|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010964|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
44010965|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
44010966|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
44010967|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
44010968|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010969|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010970|NCT03070470|Ritonavir|ritonavir|mesh-list
44010971|NCT03070470|Lopinavir|lopinavir|mesh-list
44010972|NCT03070470|Chloroquine|chloroquine|mesh-list
44010973|NCT03070470|Verapamil|verapamil|mesh-list
44010974|NCT03070470|Dofetilide|dofetilide|mesh-list
44010975|NCT03070470|Diltiazem|diltiazem|mesh-list
44010976|NCT03070470|Ranolazine|ranolazine|mesh-list
44010977|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44010978|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44010979|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44010980|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010981|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010982|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44010983|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44010984|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
44010985|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010986|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44010987|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010988|NCT03070470|Amebicides|amebicides|mesh-ancestor
44010989|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44010990|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44010991|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
44010992|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010993|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010994|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44010995|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44010996|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010997|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44010998|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44010999|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44011000|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011001|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44011002|NCT03070548|Talazoparib|talazoparib|mesh-list
44011003|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44011004|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011005|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011006|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011007|NCT03070730|Atenolol|atenolol|mesh-list
44011008|NCT03070730|Droxidopa|droxidopa|mesh-list
44011014|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011015|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44011016|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44011017|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44011018|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011019|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011020|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011021|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44011022|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44011023|NCT03071744|Fentanyl|fentanyl|mesh-list
44011024|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011025|NCT03071744|Narcotics|narcotics|mesh-ancestor
44011026|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011027|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011028|NCT03071744|Analgesics|analgesics|mesh-ancestor
44011029|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
43743070|NCT04777539|Natalizumab|natalizumab|mesh-list
44011030|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011031|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44011032|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011033|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
44248305|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44248306|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
44248307|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248308|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
44011034|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
44011035|NCT03073876|Donepezil|donepezil|mesh-list
44011036|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44011037|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011038|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011039|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
44011040|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011041|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011042|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
44011043|NCT03074409|Oxytocin|oxytocin|mesh-list
44011044|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
44011045|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44011046|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011047|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
44011048|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44011049|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44011050|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44011051|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
44011052|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011053|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44011054|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44011055|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011056|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44011057|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011058|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011059|NCT03075553|Nivolumab|nivolumab|mesh-list
44011060|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44011061|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011062|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44011063|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011064|NCT03078075|Naltrexone|naltrexone|mesh-list
44011065|NCT03078075|Bupropion|bupropion|mesh-list
44011066|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44011067|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44011068|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011069|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
44011070|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011071|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44011072|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
44011073|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011074|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44011075|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011076|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011080|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44011081|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44011082|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011083|NCT03078946|Midazolam|midazolam|mesh-list
44011084|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
44011085|NCT03078946|Morphine|morphine|mesh-list
44011086|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44011087|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011088|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011089|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011090|NCT03078946|Analgesics|analgesics|mesh-ancestor
44011091|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
44011092|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011093|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44011094|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011095|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44011096|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011097|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011098|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011099|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011100|NCT03078946|Narcotics|narcotics|mesh-ancestor
44011101|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44011102|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44248309|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44248310|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
44248311|NCT00602693|Protective Agents|protective agents|mesh-ancestor
44248312|NCT00602706|Melphalan|melphalan|mesh-list
44011103|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44011104|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011105|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011106|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
44011107|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
44011108|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
44011109|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
44011110|NCT03080142|Bupivacaine|bupivacaine|mesh-list
44011111|NCT03080142|Ropivacaine|ropivacaine|mesh-list
44011112|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011113|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
44011114|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011115|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011116|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
44011117|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011118|NCT03081117|Insulin|insulin|mesh-list
44011119|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011120|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011121|NCT03082196|Fluorides|fluorides|mesh-list
44011122|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
44011123|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
44011124|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
44011125|NCT03082196|Protective Agents|protective agents|mesh-ancestor
44011126|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011127|NCT03086213|Lidocaine|lidocaine|mesh-list
44011128|NCT03086213|Sufentanil|sufentanil|mesh-list
44011129|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
44011130|NCT03086213|Dsuvia|dsuvia|mesh-list
44011131|NCT03086213|Ropivacaine|ropivacaine|mesh-list
44011132|NCT03086213|Propofol|propofol|mesh-list
44011133|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011134|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
44011135|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011136|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011137|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
44011138|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011139|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011140|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011141|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011142|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011143|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011144|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44011145|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011146|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
44011147|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011148|NCT03086213|Analgesics|analgesics|mesh-ancestor
44011149|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44011150|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011155|NCT03086213|Narcotics|narcotics|mesh-ancestor
44011156|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44011157|NCT03086356|Dabigatran|dabigatran|mesh-list
44011158|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
44011159|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44011160|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
44011161|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011162|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011163|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
44011164|NCT03087604|Lidocaine|lidocaine|mesh-list
44011165|NCT03087604|Epinephrine|epinephrine|mesh-list
44011166|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011167|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
44011168|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011169|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011170|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
44011171|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011172|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011173|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011174|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011175|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011176|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846293|NCT04205968|Folic Acid|folic acid|mesh-list
44248314|NCT00602706|Sargramostim|sargramostim|mesh-list
44248315|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44248316|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
44248317|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248318|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248319|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44011177|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011179|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011180|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011181|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44011182|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44011184|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44011185|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011186|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
44011187|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
44011188|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44011189|NCT03088267|Amphetamine|amphetamine|mesh-list
44011190|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44011191|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011192|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
44011193|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
44011194|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011195|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
44011196|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011197|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011198|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011199|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44011200|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011201|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011202|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44011203|NCT03088345|Vasopressins|vasopressins|mesh-list
44011204|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
44011205|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
44011206|NCT03088345|Coagulants|coagulants|mesh-ancestor
44011207|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44011208|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44011209|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
44011210|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011211|NCT03088800|Ibuprofen|ibuprofen|mesh-list
44011212|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011213|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011214|NCT03088800|Analgesics|analgesics|mesh-ancestor
44011215|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
44011216|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011217|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011218|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011219|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011220|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011221|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011222|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011223|NCT03090620|Lorazepam|lorazepam|mesh-list
44011224|NCT03090620|Physostigmine|physostigmine|mesh-list
44011229|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011230|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44011231|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44011232|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011233|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44011234|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44011235|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011236|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
44011237|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
44011238|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011239|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011240|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44011241|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248320|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248321|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
44248322|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248323|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248325|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
44248326|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248327|NCT00602719|Zolpidem|zolpidem|mesh-list
44248328|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44248329|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44248330|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011242|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
44011243|NCT03090620|Miotics|miotics|mesh-ancestor
44011244|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
44011245|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44011246|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011247|NCT03091673|Glucagon|glucagon|mesh-list
44011248|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44011249|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44011250|NCT03091673|Hormones|hormones|mesh-ancestor
44011251|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011252|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011253|NCT03091673|Incretins|incretins|mesh-ancestor
44011254|NCT03093207|Aspirin|aspirin|mesh-list
44011255|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011256|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011257|NCT03093207|Analgesics|analgesics|mesh-ancestor
44011258|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
44011259|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011260|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011261|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011262|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011263|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44011264|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44011265|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011266|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44011267|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011268|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011269|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
44011270|NCT03093272|Prednisone|prednisone|mesh-list
44011271|NCT03093272|Docetaxel|docetaxel|mesh-list
44011272|NCT03093272|Leuprolide|leuprolide|mesh-list
44011273|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011274|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
44011275|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
44011276|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
44011277|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011278|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011279|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
44011280|NCT03093272|Hormones|hormones|mesh-ancestor
44011281|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011282|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011283|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44011284|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44011285|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
44011286|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44011287|NCT03095638|Dolutegravir|dolutegravir|mesh-list
44011288|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44011289|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44011290|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011291|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011292|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44011293|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44248331|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248332|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44248333|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
44248334|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
44011294|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
44011295|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011296|NCT03096353|Naloxone|naloxone|mesh-list
44011297|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44011300|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011301|NCT03096444|Lidocaine|lidocaine|mesh-list
44011302|NCT03096444|Ketamine|ketamine|mesh-list
44011303|NCT03096444|Amitriptyline|amitriptyline|mesh-list
44011304|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011305|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
44011306|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011307|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011308|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
44011309|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011310|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44055338|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
44011311|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011312|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011313|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011314|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011315|NCT03096444|Analgesics|analgesics|mesh-ancestor
44011316|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44011317|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011318|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
44011319|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44011320|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44011321|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011322|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44011323|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
44011324|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011325|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011326|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44011327|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011328|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011330|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
44011331|NCT03096730|Remifentanil|remifentanil|mesh-list
44011333|NCT03096730|Nalmefene|nalmefene|mesh-list
44011334|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44011335|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011336|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011337|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011338|NCT03096730|Analgesics|analgesics|mesh-ancestor
44011339|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
44011340|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011341|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44011342|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011343|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44011344|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011345|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011346|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011347|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011348|NCT03096730|Narcotics|narcotics|mesh-ancestor
44011349|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44011350|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011351|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
44011352|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
44011353|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44011354|NCT03098420|Dexamethasone|dexamethasone|mesh-list
44011355|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
44011356|NCT03098420|Morphine|morphine|mesh-list
44011357|NCT03098420|Bupivacaine|bupivacaine|mesh-list
44011358|NCT03098420|Ropivacaine|ropivacaine|mesh-list
44011359|NCT03098420|BB 1101|bb 1101|mesh-list
44011360|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011361|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
44011362|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
44011363|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011364|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011365|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44011366|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
44248335|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248336|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011367|NCT03098420|Hormones|hormones|mesh-ancestor
44011368|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011369|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44011370|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011371|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
44011372|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011375|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
44011376|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011377|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
44011378|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011379|NCT03098420|Narcotics|narcotics|mesh-ancestor
44011380|NCT03098420|Analgesics|analgesics|mesh-ancestor
44011381|NCT03098615|Efinaconazole|efinaconazole|mesh-list
44011382|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
44011383|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011384|NCT03100123|Aspirin|aspirin|mesh-list
44011385|NCT03100123|Heparin|heparin|mesh-list
44011386|NCT03100123|Enoxaparin|enoxaparin|mesh-list
44011387|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44011388|NCT03100123|Tinzaparin|tinzaparin|mesh-list
44011389|NCT03100123|Dalteparin|dalteparin|mesh-list
44011390|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011391|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011392|NCT03100123|Analgesics|analgesics|mesh-ancestor
44011393|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
44011394|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011395|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011396|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011397|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011398|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44011399|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44011400|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011401|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44011402|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011403|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011404|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
44011405|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
44011406|NCT03101033|Betamethasone|betamethasone|mesh-list
44011407|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
44011408|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44011409|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
44011410|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44011411|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011412|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
44011413|NCT03101033|Hormones|hormones|mesh-ancestor
44011414|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011415|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011416|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44011417|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011418|NCT03101111|Vaccines|vaccines|mesh-list
44011419|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
44011420|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011421|NCT03102190|Verapamil|verapamil|mesh-list
44011422|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011423|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44011424|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011425|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011426|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44011427|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011428|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
44011429|NCT03102645|Imipramine|imipramine|mesh-list
44011430|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44011431|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44011432|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011433|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43780405|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44011434|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011435|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011436|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011437|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248338|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44248339|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248340|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44248341|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44248342|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011438|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011439|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147504|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44147505|NCT00201422|Amoxicillin|amoxicillin|mesh-list
44147506|NCT00201422|Clarithromycin|clarithromycin|mesh-list
44147507|NCT00201422|Omeprazole|omeprazole|mesh-list
44147508|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44147509|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147513|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147514|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147515|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44147516|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44147517|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44147518|NCT00201435|Paclitaxel|paclitaxel|mesh-list
44147519|NCT00201435|Docetaxel|docetaxel|mesh-list
44147520|NCT00201435|Capecitabine|capecitabine|mesh-list
44147521|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44147522|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147523|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147524|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44147525|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44147526|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147527|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147528|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
44147529|NCT00201539|Morphine|morphine|mesh-list
44147530|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44147531|NCT00201539|Narcotics|narcotics|mesh-ancestor
44147532|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147533|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147534|NCT00201539|Analgesics|analgesics|mesh-ancestor
44147535|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
44147536|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147537|NCT00201630|Alfuzosin|alfuzosin|mesh-list
44147538|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44147539|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44147540|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44147541|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147542|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147543|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147544|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147545|NCT00201630|Urological Agents|urological agents|mesh-ancestor
44147546|NCT00201669|Clofarabine|clofarabine|mesh-list
44147547|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147548|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
43743460|NCT04491877|Vaccines|vaccines|mesh-list
44011440|NCT03102736|Nitroprusside|nitroprusside|mesh-list
44011441|NCT03102736|Ketamine|ketamine|mesh-list
44011442|NCT03102736|Analgesics|analgesics|mesh-ancestor
44011443|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
44011444|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011445|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011446|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43743536|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
44011447|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011448|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
44011449|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
44011450|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011451|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44011452|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44011453|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011454|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011455|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44011456|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44248343|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248344|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248345|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
44248346|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248347|NCT00602862|Bevacizumab|bevacizumab|mesh-list
44248349|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44248350|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248351|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44248352|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44248353|NCT00602862|Growth Substances|growth substances|mesh-ancestor
44011457|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44011458|NCT03103061|Regadenoson|regadenoson|mesh-list
44011459|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44011460|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44011461|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
44011462|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
44011463|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011464|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011465|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011466|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
44011467|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44011468|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
44011469|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011470|NCT03104725|Expectorants|expectorants|mesh-ancestor
44011475|NCT03104725|Protective Agents|protective agents|mesh-ancestor
44011476|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011477|NCT03104725|Antidotes|antidotes|mesh-ancestor
44011478|NCT03104738|Insulin|insulin|mesh-list
44011479|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011480|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011481|NCT03105479|Vancomycin|vancomycin|mesh-list
44011482|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44011483|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011484|NCT03106870|Insulin|insulin|mesh-list
44011485|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44011486|NCT03106870|Metformin|metformin|mesh-list
44011487|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
44011488|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011489|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011490|NCT03107754|Lidocaine|lidocaine|mesh-list
44011491|NCT03107754|Anesthetics|anesthetics|mesh-list
44011492|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011493|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011494|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011495|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
44011496|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011497|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011498|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011499|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011500|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011501|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011502|NCT03108482|Celecoxib|celecoxib|mesh-list
44011503|NCT03108482|Tramadol|tramadol|mesh-list
44011504|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011505|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011506|NCT03108482|Analgesics|analgesics|mesh-ancestor
44011507|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
44011508|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011509|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011510|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011511|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248354|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248356|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248357|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647109|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44011512|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44011513|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011514|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011515|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011516|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011517|NCT03108482|Narcotics|narcotics|mesh-ancestor
44011518|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011519|NCT03109015|Sunitinib|sunitinib|mesh-list
44011520|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011521|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44011522|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44011523|NCT03109015|Growth Substances|growth substances|mesh-ancestor
44011524|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011525|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
44011526|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44011527|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011528|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011529|NCT03110003|Bupivacaine|bupivacaine|mesh-list
44011530|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011531|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
44011532|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011533|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011534|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
44011535|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011536|NCT03111316|Dinoprostone|dinoprostone|mesh-list
44011537|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
44011538|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44011539|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011540|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44011543|NCT03111381|Analgesics|analgesics|mesh-ancestor
44011544|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
44011545|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011546|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011547|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011548|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011549|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011550|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011551|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011552|NCT03111628|Omalizumab|omalizumab|mesh-list
44011553|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44011554|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44011555|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011556|NCT03112863|Vitamin A|vitamin a|mesh-list
44011557|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
44011558|NCT03112863|Vitamins|vitamins|mesh-ancestor
44011559|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
44011560|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011561|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
44011562|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011563|NCT03112863|Protective Agents|protective agents|mesh-ancestor
44011564|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44011565|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011566|NCT03114995|Tirofiban|tirofiban|mesh-list
44011567|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44011568|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44011569|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011570|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44011571|NCT03115177|Doxycycline|doxycycline|mesh-list
44011572|NCT03115177|Cefazolin|cefazolin|mesh-list
44011573|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44011574|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011575|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
44011576|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44011577|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44011578|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
44011579|NCT03115801|Nivolumab|nivolumab|mesh-list
44248358|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248359|NCT00602901|Naproxen|naproxen|mesh-list
44248360|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011581|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
44011582|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44011583|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011584|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44011585|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011586|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011587|NCT03115827|Carbidopa|carbidopa|mesh-list
44011588|NCT03115827|Droxidopa|droxidopa|mesh-list
44011589|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44011590|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44011591|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
44011592|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011593|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011594|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011595|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44011596|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011597|NCT03117140|Dexamethasone|dexamethasone|mesh-list
44011598|NCT03117140|Clonidine|clonidine|mesh-list
44011599|NCT03117140|Buprenorphine|buprenorphine|mesh-list
44011600|NCT03117140|Ropivacaine|ropivacaine|mesh-list
44011601|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011602|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
44011603|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
44011604|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011605|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011606|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44011607|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
44011608|NCT03117140|Hormones|hormones|mesh-ancestor
44011609|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011610|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44011611|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011612|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011613|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
44011614|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011615|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
44011620|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44011621|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
44011622|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44011623|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011624|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44011625|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011626|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011627|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011628|NCT03117517|Metformin|metformin|mesh-list
44011629|NCT03117517|Pioglitazone|pioglitazone|mesh-list
44011630|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011631|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011632|NCT03117634|Aflibercept|aflibercept|mesh-list
44011633|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44011634|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44011635|NCT03117634|Growth Substances|growth substances|mesh-ancestor
44011636|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011637|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
44011638|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011639|NCT03118466|Cytarabine|cytarabine|mesh-list
44011640|NCT03118466|Etoposide|etoposide|mesh-list
44011641|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
44011642|NCT03118466|Lenalidomide|lenalidomide|mesh-list
44011643|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44011644|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055706|NCT00004727|Aspirin|aspirin|mesh-list
44011645|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44011646|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44011647|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011648|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011649|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44011650|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
44011651|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
44011652|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011653|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248361|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248362|NCT00602901|Analgesics|analgesics|mesh-ancestor
44248363|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
44248364|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248365|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248366|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248367|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248368|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
44248369|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44248370|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248371|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248372|NCT00603031|Glucagon|glucagon|mesh-list
44460234|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
43901617|NCT00078286|Sertraline|sertraline|mesh-list
44248373|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44248374|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248375|NCT00603031|Hormones|hormones|mesh-ancestor
44248376|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248377|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248378|NCT00603031|Incretins|incretins|mesh-ancestor
44248379|NCT00603083|Ketorolac|ketorolac|mesh-list
44248380|NCT00603083|Ropivacaine|ropivacaine|mesh-list
44248381|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
44248382|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
44248383|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248384|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248385|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
44248386|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248387|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44248388|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248389|NCT00603083|Analgesics|analgesics|mesh-ancestor
44248390|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248391|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011654|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
44011655|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011656|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44011657|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44011658|NCT03118466|Growth Substances|growth substances|mesh-ancestor
44011659|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
44011660|NCT03118466|Analgesics|analgesics|mesh-ancestor
44011661|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
44011662|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248392|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011663|NCT03118843|Velpatasvir|velpatasvir|mesh-list
44011664|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
44011665|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011666|NCT03119168|Simethicone|simethicone|mesh-list
44011667|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
44011668|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011669|NCT03119168|Emollients|emollients|mesh-ancestor
44011670|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44011671|NCT03119181|Lidocaine|lidocaine|mesh-list
44011672|NCT03119181|Epinephrine|epinephrine|mesh-list
44011673|NCT03119181|Racepinephrine|racepinephrine|mesh-list
44055771|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
44011674|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44011675|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
44011676|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011677|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
44011678|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011679|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011680|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
44011681|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011682|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011683|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011684|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011685|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011686|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011687|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44011688|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44011690|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011691|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44011692|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44011693|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
44011694|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44011695|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011696|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
44011697|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
44011698|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44011699|NCT03119831|Ethanol|ethanol|mesh-list
44011700|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
44011701|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44011702|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44011703|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011704|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011705|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011706|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
44011707|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
44011708|NCT03121820|Memantine|memantine|mesh-list
44011709|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44011710|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44011711|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
44011712|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011713|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011714|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011715|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44011716|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44011717|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
44011718|NCT03122587|Vitamins|vitamins|mesh-ancestor
44011719|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
44011720|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011721|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44011722|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
44011723|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44011724|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011725|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44011726|NCT03123614|Prednisolone|prednisolone|mesh-list
44011727|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44011728|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
44011729|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44011730|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
44011731|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44011732|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
44011733|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011734|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
44011735|NCT03123614|Hormones|hormones|mesh-ancestor
43701385|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248394|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248395|NCT00603109|Rimonabant|rimonabant|mesh-list
44248396|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44248397|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44248398|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44248399|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011736|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011737|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011738|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44011739|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011740|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
44011741|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
44011742|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011743|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44011744|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44011745|NCT03123614|Protective Agents|protective agents|mesh-ancestor
44011746|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44011748|NCT03123848|Cobicistat|cobicistat|mesh-list
44011749|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44011750|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44011751|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44011752|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
44011753|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011754|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011755|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44011756|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44011757|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
44011758|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011759|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44011760|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44011761|NCT03124121|Golimumab|golimumab|mesh-list
44011762|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44011763|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011764|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44011766|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011767|NCT03124758|Chrysarobin|chrysarobin|mesh-list
44011768|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011769|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011770|NCT03124758|Analgesics|analgesics|mesh-ancestor
44011771|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
44011772|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011773|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011774|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011775|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011776|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44011777|NCT03126370|Emtricitabine|emtricitabine|mesh-list
44011778|NCT03126370|Tenofovir|tenofovir|mesh-list
44011779|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44011780|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
44011781|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44011782|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44011783|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011784|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011785|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
44011786|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011787|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44011788|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44011789|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44011790|NCT03126682|Bupropion|bupropion|mesh-list
44011791|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44011792|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
44011793|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44011794|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44011795|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011796|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011797|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011798|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
44248400|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248401|NCT00603109|Hormones|hormones|mesh-ancestor
44248402|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248403|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011799|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011800|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055902|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011801|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44011802|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44011803|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011804|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44011805|NCT03126760|Hormones|hormones|mesh-ancestor
44011806|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011807|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011809|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011810|NCT03127943|Lidocaine|lidocaine|mesh-list
44011811|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011812|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
44011813|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011814|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743692|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
44011815|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
44011816|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011817|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011818|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44011819|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44011820|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011821|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011822|NCT03128008|Paclitaxel|paclitaxel|mesh-list
44011823|NCT03128008|Carboplatin|carboplatin|mesh-list
44011824|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44011825|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011826|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44011827|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44011828|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44011829|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147549|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147550|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147551|NCT00201682|Etanercept|etanercept|mesh-list
44147552|NCT00201682|Rituximab|rituximab|mesh-list
44147553|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44147554|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147555|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
44147560|NCT00201682|Analgesics|analgesics|mesh-ancestor
44147561|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
44147562|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147563|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44147564|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147565|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147566|NCT00201695|Dexamethasone|dexamethasone|mesh-list
44147567|NCT00201695|Doxorubicin|doxorubicin|mesh-list
44147568|NCT00201695|Vincristine|vincristine|mesh-list
44147569|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
44147570|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44147571|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
44147572|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
44147573|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147574|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147575|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147576|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
44147577|NCT00201695|Hormones|hormones|mesh-ancestor
44147578|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147579|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44147580|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147581|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147582|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44147583|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44147584|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147585|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248404|NCT00603135|Levetiracetam|levetiracetam|mesh-list
44248405|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
44248406|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
44248407|NCT00603317|Amoxicillin|amoxicillin|mesh-list
44248408|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
44248409|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
44147586|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44147587|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147588|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44147589|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44147590|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
44147591|NCT00201708|Docetaxel|docetaxel|mesh-list
44147592|NCT00201708|Doxorubicin|doxorubicin|mesh-list
44147593|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147594|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
44147595|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147596|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147597|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44147598|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
44147599|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147600|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147601|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44147602|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147603|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44147604|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44147605|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147606|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44147607|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44011830|NCT03129945|Indomethacin|indomethacin|mesh-list
44011831|NCT03129945|Nifedipine|nifedipine|mesh-list
44011832|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44011833|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011834|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011835|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44011836|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011837|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
44011838|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
44011839|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44011840|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011841|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011842|NCT03129945|Analgesics|analgesics|mesh-ancestor
44011843|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
44011844|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011845|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011846|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011847|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
44011852|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
44011853|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011854|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44011855|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44011856|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011857|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011858|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44011859|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
44011860|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44011861|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011862|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44011863|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44011864|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44011865|NCT03132571|Naltrexone|naltrexone|mesh-list
44011866|NCT03132571|Bupropion|bupropion|mesh-list
44011867|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44011868|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44011869|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011870|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
44011871|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011872|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44011873|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44011874|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248410|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44248411|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248412|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248413|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248414|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248415|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44248416|NCT00603343|Propiverine|propiverine|mesh-list
44248417|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
44248418|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
44248419|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248420|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248421|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44248422|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44248423|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
44248424|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248425|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248426|NCT00603343|Urological Agents|urological agents|mesh-ancestor
44248427|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44248428|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248429|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248430|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248431|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248441|NCT00603759|Celecoxib|celecoxib|mesh-list
44248458|NCT00603785|Omalizumab|omalizumab|mesh-list
44248459|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44248460|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44011875|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44011876|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44011877|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44011878|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011879|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
44011880|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011881|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44011882|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44011883|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011884|NCT03134703|Morphine|morphine|mesh-list
44011885|NCT03134703|Methadone|methadone|mesh-list
44011886|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011887|NCT03134703|Narcotics|narcotics|mesh-ancestor
44011888|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011889|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011890|NCT03134703|Analgesics|analgesics|mesh-ancestor
44011891|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
44011892|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011893|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
44011894|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011896|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44011897|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011898|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
44011899|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44011900|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44011901|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743867|NCT04273945|Macitentan|macitentan|mesh-list
44011902|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
44011903|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
44011904|NCT03140631|Protamines|protamines|mesh-list
44011905|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
44011906|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011907|NCT03140631|Coagulants|coagulants|mesh-ancestor
44011908|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
44011909|NCT03140722|Hematinics|hematinics|mesh-ancestor
44011910|NCT03143569|Heparin|heparin|mesh-list
44011911|NCT03143569|Calcium heparin|calcium heparin|mesh-list
44011912|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
44011913|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44011914|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44011915|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011916|NCT03144635|Grazoprevir|grazoprevir|mesh-list
44011917|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
44011918|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011919|NCT03145259|Diclofenac|diclofenac|mesh-list
44011922|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011923|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011924|NCT03145259|Analgesics|analgesics|mesh-ancestor
44011925|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
44011926|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011927|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011928|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011929|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44011930|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011931|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44011932|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011933|NCT03146806|Ketamine|ketamine|mesh-list
44011934|NCT03146806|Analgesics|analgesics|mesh-ancestor
44011935|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
44011936|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011937|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011938|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44011939|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011940|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
44011941|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
44011942|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011943|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44011944|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44011945|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248461|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248463|NCT00603824|Lepirudin|lepirudin|mesh-list
44248464|NCT00603824|Fondaparinux|fondaparinux|mesh-list
44248465|NCT00603824|Argatroban|argatroban|mesh-list
44248466|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44248467|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
44248468|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44248469|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44248470|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248471|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248472|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
44011946|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011947|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
44011948|NCT03148236|Vitamins|vitamins|mesh-ancestor
44011949|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
44011950|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011951|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
44011952|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011953|NCT03148236|Protective Agents|protective agents|mesh-ancestor
44011954|NCT03149887|Bupivacaine|bupivacaine|mesh-list
44011955|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011956|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
44011957|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011958|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011959|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
44011960|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011961|NCT03149991|Ketamine|ketamine|mesh-list
44011962|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
44011963|NCT03149991|Analgesics|analgesics|mesh-ancestor
44011964|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
44011965|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011966|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011967|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44011968|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44011969|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
44011971|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011972|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44011973|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44011974|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743938|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
44011975|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011976|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
44011977|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
44011978|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
44011979|NCT03152591|Licogliflozin|licogliflozin|mesh-list
44011980|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44011981|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011982|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44011983|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011984|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
44011985|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44011986|NCT03154658|Ropivacaine|ropivacaine|mesh-list
44011987|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
44011988|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
44011989|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44011990|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011991|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
44011994|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44011995|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44011997|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
44011998|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44011999|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
44012000|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248473|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44248474|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44248475|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44012001|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
44012002|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012003|NCT03161158|Diuretics|diuretics|mesh-list
44012004|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
44012005|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012006|NCT03161938|Dexamethasone|dexamethasone|mesh-list
44012007|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012008|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
44012009|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
44012010|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012011|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012012|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44012013|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
44012014|NCT03161938|Hormones|hormones|mesh-ancestor
44012015|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012016|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44012017|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012018|NCT03163303|Nicotine|nicotine|mesh-list
44012019|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44012020|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
44012021|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012022|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012023|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44012024|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44012025|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
44012026|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012027|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012028|NCT03163472|Anesthetics|anesthetics|mesh-list
44012029|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
44012030|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012031|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012032|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
44012033|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012034|NCT03165981|Vaccines|vaccines|mesh-list
44012035|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44012036|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
44012037|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012038|NCT03168022|Amitriptyline|amitriptyline|mesh-list
44012039|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
44012040|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44012041|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44012042|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012043|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44012044|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012045|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44012046|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012047|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44012048|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012049|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44012050|NCT03168022|Analgesics|analgesics|mesh-ancestor
44012051|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
44012052|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44012053|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44012054|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44012055|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012056|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
44012057|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012058|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
44012059|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44012060|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012061|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44012062|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012063|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
44012073|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012075|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44248477|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44248478|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
44248479|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248480|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248481|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44012076|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44147608|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147609|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
44147610|NCT00201721|Rituximab|rituximab|mesh-list
44147611|NCT00201721|Pentostatin|pentostatin|mesh-list
44147612|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147613|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
44147614|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147615|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147616|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44147617|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
44147618|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147619|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147620|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44147621|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44147622|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44147623|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147624|NCT00201747|Mitomycins|mitomycins|mesh-list
44147625|NCT00201747|Mitomycin|mitomycin|mesh-list
44147626|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44147627|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147628|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
44147629|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147630|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44147631|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147632|NCT00201786|Pentostatin|pentostatin|mesh-list
44147633|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147634|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44147635|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147636|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147637|NCT00201799|Infliximab|infliximab|mesh-list
44147638|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44147639|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147640|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147641|NCT00201812|Dexamethasone|dexamethasone|mesh-list
44147642|NCT00201812|Etanercept|etanercept|mesh-list
44147643|NCT00201812|Docetaxel|docetaxel|mesh-list
44147644|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
44147645|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44147646|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
44147647|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
44147648|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147649|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147650|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147652|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147653|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44147654|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147655|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147656|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44147657|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
43744046|NCT04068103|Folic Acid|folic acid|mesh-list
44012077|NCT03168841|Efinaconazole|efinaconazole|mesh-list
44012078|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
44012079|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012093|NCT03173170|Itraconazole|itraconazole|mesh-list
44012094|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
44012095|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012096|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44012097|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44012098|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012099|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012100|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44012101|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701386|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248482|NCT00604006|Diuretics|diuretics|mesh-ancestor
44248483|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
44248484|NCT00604032|Tretinoin|tretinoin|mesh-list
44248485|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248486|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
44248487|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
44248488|NCT00604058|Vaccines|vaccines|mesh-list
44248489|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
44248490|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248491|NCT00604084|Ivermectin|ivermectin|mesh-list
44248492|NCT00604084|Permethrin|permethrin|mesh-list
44248493|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44248494|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012102|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012103|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012104|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44012105|NCT03174158|Nicotine|nicotine|mesh-list
44012106|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44012107|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
44012108|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012109|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012110|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44012111|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44012112|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44012113|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012114|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012115|NCT03174366|Denosumab|denosumab|mesh-list
44012116|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44012117|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012118|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44012119|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012120|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012121|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
44012122|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44012123|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
44012124|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012125|NCT03177395|Expectorants|expectorants|mesh-ancestor
44012126|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
44012127|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44012128|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
44012129|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012130|NCT03177395|Protective Agents|protective agents|mesh-ancestor
44012131|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012132|NCT03177395|Antidotes|antidotes|mesh-ancestor
44012133|NCT03177798|Icatibant|icatibant|mesh-list
44012134|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44012135|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44012136|NCT03177798|Analgesics|analgesics|mesh-ancestor
44012137|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
44012138|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012140|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012141|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012142|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44012143|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44012144|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012145|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44012146|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012147|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
44012149|NCT03179345|Gabapentin|gabapentin|mesh-list
44012151|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
44012152|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012153|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012154|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
43701387|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
44248495|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248496|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248497|NCT00604253|Insulin|insulin|mesh-list
44248498|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44248499|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
44248500|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
44248501|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
44248502|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
44012155|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44012156|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44012157|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012158|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44012159|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44012160|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44012161|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012162|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012163|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44012164|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44012165|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012166|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
44012167|NCT03179410|Avelumab|avelumab|mesh-list
44012168|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012169|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012170|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
44012171|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44012172|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012173|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44012174|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012175|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44012176|NCT05364567|Vitamin D|vitamin d|mesh-list
44012177|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
44012178|NCT05364567|Vitamins|vitamins|mesh-ancestor
44012179|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
44012180|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012181|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44012182|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44012183|NCT05363917|Folic Acid|folic acid|mesh-list
44012184|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
44012185|NCT05363917|Hematinics|hematinics|mesh-ancestor
44012186|NCT05363917|Vitamins|vitamins|mesh-ancestor
44012187|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
44012188|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012189|NCT05363722|Bevacizumab|bevacizumab|mesh-list
44012190|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012191|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012192|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012193|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44012194|NCT05363722|Growth Substances|growth substances|mesh-ancestor
44012195|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056450|NCT00004872|Endostatins|endostatins|mesh-list
44012196|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44012197|NCT05363501|Naloxone|naloxone|mesh-list
44012198|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44012199|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012200|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
44012201|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012202|NCT05360628|Allopurinol|allopurinol|mesh-list
44012203|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
44012204|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012205|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012206|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
44012207|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012208|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44012209|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
44012210|NCT05360628|Protective Agents|protective agents|mesh-ancestor
44012211|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012213|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44012214|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43846294|NCT04205968|Paclitaxel|paclitaxel|mesh-list
44248503|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248504|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248505|NCT00604344|Insulin|insulin|mesh-list
44248506|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44012215|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44012216|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012218|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
44012219|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
44012220|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012221|NCT05357911|Digoxin|digoxin|mesh-list
44012222|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44012223|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44012224|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012225|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012226|NCT05357911|Protective Agents|protective agents|mesh-ancestor
44012227|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012228|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
44012229|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44012230|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44012231|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012232|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
44012233|NCT05357079|Coagulants|coagulants|mesh-ancestor
44012234|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
44012235|NCT05347082|Vitamin D|vitamin d|mesh-list
44012236|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44012237|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012238|NCT05347082|Vitamins|vitamins|mesh-ancestor
44012239|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
44012240|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44012241|NCT05341375|Anesthetics|anesthetics|mesh-list
44012242|NCT05341375|Esketamine|esketamine|mesh-list
44012243|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012244|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012245|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
44012246|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012247|NCT05325099|Azacitidine|azacitidine|mesh-list
44012248|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44012249|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
44012250|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012251|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012252|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012253|NCT05324384|Sirolimus|sirolimus|mesh-list
44012254|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012255|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012256|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012257|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012258|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
44012259|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012260|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
44012261|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012262|NCT05312268|Rasburicase|rasburicase|mesh-list
44012263|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
44012264|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012265|NCT05304455|Heparin|heparin|mesh-list
44012266|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44012267|NCT05304455|Tinzaparin|tinzaparin|mesh-list
44012268|NCT05304455|Dalteparin|dalteparin|mesh-list
44012269|NCT05304455|Dipyridamole|dipyridamole|mesh-list
44012270|NCT05304455|Apixaban|apixaban|mesh-list
44012271|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
44012272|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44012273|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44012274|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012275|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44012276|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
44012277|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44012278|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
44012279|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012280|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44012281|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44012282|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147658|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147659|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44248508|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
44248509|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
44248510|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
44248511|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248512|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248513|NCT00604357|Sirolimus|sirolimus|mesh-list
44248514|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248515|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248516|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44248517|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248518|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
44248519|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248520|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
44248521|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248522|NCT00604396|Insulin|insulin|mesh-list
44248523|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44248524|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
44248525|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
44248526|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
44248527|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
44248528|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248529|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248530|NCT00604409|Capecitabine|capecitabine|mesh-list
44248531|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44248532|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
44248533|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248534|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248535|NCT00604435|Docetaxel|docetaxel|mesh-list
44248536|NCT00604435|Epirubicin|epirubicin|mesh-list
44248537|NCT00604435|Endostatins|endostatins|mesh-list
44248538|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248539|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248540|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248541|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44248543|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44248548|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44056582|NCT00004887|Paclitaxel|paclitaxel|mesh-list
44248549|NCT00604435|Growth Substances|growth substances|mesh-ancestor
44248550|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248551|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
44248552|NCT00604578|Pioglitazone|pioglitazone|mesh-list
44147660|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44147661|NCT00201812|Analgesics|analgesics|mesh-ancestor
44147662|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
44147663|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147664|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157784|NCT00235235|Antiviral Agents|antiviral agents|mesh-ancestor
44157785|NCT00235235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157786|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157787|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157788|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744271|NCT03875690|Hormones|hormones|mesh-ancestor
44157789|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44157790|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44012283|NCT05293509|Cyclosporine|cyclosporine|mesh-list
44012284|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
44012285|NCT05293509|Dexamethasone|dexamethasone|mesh-list
44012286|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
44012287|NCT05293509|Busulfan|busulfan|mesh-list
44012288|NCT05293509|Rituximab|rituximab|mesh-list
44012289|NCT05293509|Fludarabine|fludarabine|mesh-list
44012290|NCT05293509|Bortezomib|bortezomib|mesh-list
44012291|NCT05293509|Tacrolimus|tacrolimus|mesh-list
44012292|NCT05293509|Cyclosporins|cyclosporins|mesh-list
44012293|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
44012294|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012295|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
44012296|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012297|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012298|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44012299|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
44012300|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012301|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012302|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44012303|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012304|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012305|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
44012306|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
44012307|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012308|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44012309|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
44012310|NCT05293509|Hormones|hormones|mesh-ancestor
44012311|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012312|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44012313|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44012314|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012315|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
44012316|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012317|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44012318|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012319|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44012320|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
44012321|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012322|NCT05267054|Rituximab|rituximab|mesh-list
44012323|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012324|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012325|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
44012326|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012327|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012328|NCT05201859|Capecitabine|capecitabine|mesh-list
44012329|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44012330|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
44012331|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012332|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012333|NCT05185583|Methylphenidate|methylphenidate|mesh-list
44012334|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44012335|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012336|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44248553|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248554|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248555|NCT00604591|Tolcapone|tolcapone|mesh-list
44248556|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44248557|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44012337|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44012338|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44012339|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012340|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
44012341|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012342|NCT05178043|Nivolumab|nivolumab|mesh-list
44012343|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012348|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
44012349|NCT05113004|Leflunomide|leflunomide|mesh-list
44012350|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012351|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012352|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44012353|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
44012354|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012355|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012356|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012357|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012358|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
44012359|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44012360|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44012361|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012362|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012363|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
44012364|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012365|NCT05093790|Aspirin|aspirin|mesh-list
44012366|NCT05093790|Ticagrelor|ticagrelor|mesh-list
44012367|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44012368|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44012369|NCT05093790|Analgesics|analgesics|mesh-ancestor
44012370|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
44012371|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012372|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012373|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012374|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012375|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44012376|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44012377|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012378|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44012379|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44012380|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012381|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
44012382|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44012383|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44012384|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44012385|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
44012386|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012387|NCT05066061|Analgesics|analgesics|mesh-list
44012388|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
44012389|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
44012390|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012391|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012392|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44012393|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012394|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012395|NCT05048238|Tofacitinib|tofacitinib|mesh-list
44012396|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44012397|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012398|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012399|NCT05010954|Lansoprazole|lansoprazole|mesh-list
44012400|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
44012401|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44012402|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44012403|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44012404|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056688|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248558|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44248560|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248561|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
44248562|NCT00604630|Hematinics|hematinics|mesh-ancestor
44012405|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012406|NCT04960215|Ubiquinone|ubiquinone|mesh-list
44012407|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
44012408|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
44012409|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012410|NCT04960215|Vitamins|vitamins|mesh-ancestor
44012411|NCT04949477|Acetaminophen|acetaminophen|mesh-list
44012412|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
44012413|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44012414|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012428|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
44012429|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
44012430|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012431|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012432|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
44012433|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012434|NCT04933344|Daptomycin|daptomycin|mesh-list
44012435|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012436|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012437|NCT04874545|Propofol|propofol|mesh-list
44012438|NCT04874545|Sevoflurane|sevoflurane|mesh-list
44012439|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44012440|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012441|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012442|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44012443|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
44012444|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
44012445|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44012446|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44012447|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
44012448|NCT04873895|Axitinib|axitinib|mesh-list
44012449|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
44012450|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44012451|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44012452|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012453|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012454|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012455|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012456|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012457|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44012458|NCT04830813|Chiauranib|chiauranib|mesh-list
44012459|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012460|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44012461|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012462|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012463|NCT04823156|Calcium|calcium|mesh-list
44012464|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44012465|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012466|NCT05406674|Cisplatin|cisplatin|mesh-list
44012467|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012468|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
44012469|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44012470|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012471|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44012472|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012473|NCT05406388|Fentanyl|fentanyl|mesh-list
44012474|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44012475|NCT05406388|Narcotics|narcotics|mesh-ancestor
44012476|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012477|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012478|NCT05406388|Analgesics|analgesics|mesh-ancestor
44012482|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44012483|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
44012484|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
44012485|NCT05406180|Vaccines|vaccines|mesh-list
44012486|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
44248563|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
44248564|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248565|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248567|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44248568|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248569|NCT00604682|Analgesics|analgesics|mesh-ancestor
44248570|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
44248571|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248572|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248573|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248574|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248575|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44248576|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44248577|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248578|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460235|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460236|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824111|NCT05515315|Paclitaxel|paclitaxel|mesh-list
44012487|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147666|NCT00201955|Rebamipide|rebamipide|mesh-list
44147667|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44147668|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147669|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
44147670|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147671|NCT00201955|Protective Agents|protective agents|mesh-ancestor
44147672|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147673|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147674|NCT00201981|Rebamipide|rebamipide|mesh-list
44147675|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44147676|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147677|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
44147678|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147679|NCT00201981|Protective Agents|protective agents|mesh-ancestor
44147680|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147681|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147682|NCT00201994|Tolvaptan|tolvaptan|mesh-list
44147683|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44147684|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147685|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
44147686|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147687|NCT00202007|Risperidone|risperidone|mesh-list
44147688|NCT00202007|Aripiprazole|aripiprazole|mesh-list
44012488|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
44012489|NCT05406050|Vitamin D|vitamin d|mesh-list
44012490|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44012491|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012492|NCT05406050|Vitamins|vitamins|mesh-ancestor
44012493|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
44012494|NCT05405907|Hemostatics|hemostatics|mesh-list
44012495|NCT05405907|Coagulants|coagulants|mesh-ancestor
44012496|NCT05405751|Tenofovir|tenofovir|mesh-list
44012497|NCT05405751|Emtricitabine|emtricitabine|mesh-list
44012498|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44012499|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
44012500|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460237|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
44460238|NCT01566721|Trastuzumab|trastuzumab|mesh-list
43647264|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44012501|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44012502|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44012503|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012504|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012505|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44012506|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44012507|NCT05405608|Ondansetron|ondansetron|mesh-list
44012508|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
44012509|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
44012510|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012511|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012512|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44012513|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
44012514|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44012515|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44012516|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
44012517|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012518|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012519|NCT05405608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44012520|NCT05405608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44012521|NCT05405608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012522|NCT05405608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012523|NCT05405608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44012524|NCT05405478|Omalizumab|omalizumab|mesh-list
44012525|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44012526|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44012527|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44012528|NCT05405465|Golimumab|golimumab|mesh-list
44012529|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44012539|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
44012540|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012542|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
44012543|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012544|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
44012546|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012547|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012548|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44012549|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012550|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44012551|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012552|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012553|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
44012554|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44012555|NCT05405270|Imiquimod|imiquimod|mesh-list
44012556|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44012557|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
44012558|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012559|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012560|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
44012561|NCT05405257|Oxytocin|oxytocin|mesh-list
44012562|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
44012563|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012564|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012565|NCT05404334|Androgens|androgens|mesh-list
44012566|NCT05404334|Hormones|hormones|mesh-ancestor
44012567|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012568|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012569|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
44012570|NCT05400993|Docetaxel|docetaxel|mesh-list
44012571|NCT05400993|Epirubicin|epirubicin|mesh-list
44012572|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012573|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
44012574|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012575|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012576|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44012577|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
44012578|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012579|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012580|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44460239|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460240|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460241|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
44460242|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44012581|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44012582|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44012583|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44012584|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012585|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44012586|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44012587|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012588|NCT05361499|Amoxicillin|amoxicillin|mesh-list
44012589|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012590|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012591|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44012592|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
44012593|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012594|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
44012595|NCT05282069|DA-8010|da-8010|mesh-list
44012598|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44012599|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012600|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012601|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012602|NCT05282069|Urological Agents|urological agents|mesh-ancestor
44012603|NCT05262738|Misoprostol|misoprostol|mesh-list
44012604|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44012605|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
44012606|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012607|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012608|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44012609|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44012610|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
44012611|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44012612|NCT05236738|Cobicistat|cobicistat|mesh-list
44012613|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44012614|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44012615|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
44012616|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012617|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012618|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44012619|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44012620|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
44012621|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012622|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44012623|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44012624|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
44012625|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44012626|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44012627|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44012628|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012629|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012630|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
44012631|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012632|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44012633|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44012634|NCT05011188|Antibodies|antibodies|mesh-list
44012635|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
44012636|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
44012637|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
44012638|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012639|NCT04964089|Aflibercept|aflibercept|mesh-list
44012640|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012641|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44012642|NCT04964089|Growth Substances|growth substances|mesh-ancestor
44012643|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012644|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44012645|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147689|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44147690|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
44147691|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147692|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460243|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44460244|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460245|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460246|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460247|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460248|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460250|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44460251|NCT01566435|Cisplatin|cisplatin|mesh-list
44460252|NCT01566435|Fluorouracil|fluorouracil|mesh-list
44460253|NCT01566435|Cetuximab|cetuximab|mesh-list
44460254|NCT01566435|Antibodies|antibodies|mesh-list
44460255|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44460256|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44147693|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147694|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44147695|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147696|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147697|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147698|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44147699|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
44147700|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
44147701|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
44147702|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44147703|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44147704|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44056987|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44147705|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44147706|NCT00202020|Aspirin|aspirin|mesh-list
44147707|NCT00202020|Cilostazol|cilostazol|mesh-list
44147708|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44147709|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44147710|NCT00202020|Analgesics|analgesics|mesh-ancestor
44147715|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147716|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44147717|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44147718|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147719|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44147720|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44147721|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147722|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
44147723|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44147724|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
44147725|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44147726|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
44147727|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147728|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44147729|NCT00202020|Protective Agents|protective agents|mesh-ancestor
44147730|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44147731|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44147732|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
44147733|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44147734|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147735|NCT00202124|Tryptophan|tryptophan|mesh-list
44147736|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44147737|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
44147738|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147739|NCT00202163|Testosterone|testosterone|mesh-list
44147740|NCT00202163|Androgens|androgens|mesh-ancestor
44147741|NCT00202163|Hormones|hormones|mesh-ancestor
44147742|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147743|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147744|NCT00202176|Bromides|bromides|mesh-list
44248579|NCT00604864|Infliximab|infliximab|mesh-list
44248580|NCT00604864|Antibodies|antibodies|mesh-list
44248581|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44248582|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
44248583|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248584|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
44248585|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248586|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248587|NCT00604942|Domperidone|domperidone|mesh-list
44248588|NCT00604942|Esomeprazole|esomeprazole|mesh-list
44147745|NCT00202176|Ipratropium|ipratropium|mesh-list
44147746|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
44147747|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44147748|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
44147749|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147750|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147751|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44147752|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
44147753|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44147754|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
44147755|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147756|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012646|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44012647|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44012648|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012649|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
44012650|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012651|NCT04807504|Ropivacaine|ropivacaine|mesh-list
44012652|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
44012653|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
44012654|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012655|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012656|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
44012657|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012658|NCT04791943|Melatonin|melatonin|mesh-list
44012659|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
44012660|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012661|NCT04791943|Protective Agents|protective agents|mesh-ancestor
44012662|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012663|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012664|NCT04771156|Ketorolac|ketorolac|mesh-list
44012665|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44012666|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44012667|NCT04771156|Analgesics|analgesics|mesh-ancestor
44012668|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
44012669|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012674|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012675|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012676|NCT04709276|Carboplatin|carboplatin|mesh-list
44012677|NCT04709276|Nivolumab|nivolumab|mesh-list
44012678|NCT04709276|Ipilimumab|ipilimumab|mesh-list
44012679|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012680|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012681|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44012682|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012683|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
44012684|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
44012685|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012686|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
44012687|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012688|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012689|NCT04611152|Aflibercept|aflibercept|mesh-list
44012690|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012691|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44012692|NCT04611152|Growth Substances|growth substances|mesh-ancestor
44012693|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248589|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44248590|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248591|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44248592|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012694|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44012695|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012696|NCT04603937|Aflibercept|aflibercept|mesh-list
44012697|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012698|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44012699|NCT04603937|Growth Substances|growth substances|mesh-ancestor
44012700|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012701|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
44012702|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012704|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44012705|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012706|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012707|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44012708|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44012709|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
44012710|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44012711|NCT04586153|Meplazumab|meplazumab|mesh-list
44012712|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
44012713|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012714|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44012715|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
44012716|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012717|NCT04468568|Terbutaline|terbutaline|mesh-list
44012718|NCT04468568|Atosiban|atosiban|mesh-list
44012719|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44012720|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
44012721|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012722|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012723|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44012724|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
44012725|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
44012726|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
44012727|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012728|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44012729|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44012730|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44012731|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44012732|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012733|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012734|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
44012735|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012736|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
44012737|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
44012738|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012739|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
44012740|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44012741|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
44012743|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012745|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
44012746|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44012747|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
44012748|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012749|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012750|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44012751|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
44012752|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
44012753|NCT04450108|Protective Agents|protective agents|mesh-ancestor
44012754|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
44012755|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012756|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012757|NCT04393454|Sirolimus|sirolimus|mesh-list
44012758|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44012759|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012760|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012761|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012762|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
44012763|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012764|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
44248602|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248603|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248604|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44248605|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44248606|NCT00605020|Insulin|insulin|mesh-list
44248607|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44248608|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
44248609|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
44248610|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44248611|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
44248612|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
44248613|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248614|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012765|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012766|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
44012767|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44012768|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44012769|NCT04348695|Simvastatin|simvastatin|mesh-list
44012770|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44012771|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44012772|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
44012773|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012774|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44057190|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
44012775|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44012776|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012777|NCT04316871|Morphine|morphine|mesh-list
44012778|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44012779|NCT04316871|Narcotics|narcotics|mesh-ancestor
44012780|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012781|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012782|NCT04316871|Analgesics|analgesics|mesh-ancestor
44012783|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
44012784|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012794|NCT04263792|Trimethoprim|trimethoprim|mesh-list
44012795|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44012796|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248616|NCT00605098|Lopinavir|lopinavir|mesh-list
44248617|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44248618|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44248619|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
44012797|NCT04263792|Renal Agents|renal agents|mesh-ancestor
44012798|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
44012799|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44012800|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44012801|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44012802|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012803|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012804|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44012805|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44012806|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44012808|NCT04122170|Ticagrelor|ticagrelor|mesh-list
44012809|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44012810|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44012811|NCT04122170|Analgesics|analgesics|mesh-ancestor
44012812|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
44012813|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012814|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012815|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012819|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012820|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44012821|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44012823|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
44012824|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44012825|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44012826|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44012827|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
44012828|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012829|NCT04120805|Hemostatics|hemostatics|mesh-list
44012830|NCT04120805|Coagulants|coagulants|mesh-ancestor
44012831|NCT04049266|Aflibercept|aflibercept|mesh-list
44012832|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012833|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44012834|NCT04049266|Growth Substances|growth substances|mesh-ancestor
44012835|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012836|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
44012837|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012838|NCT03944915|Paclitaxel|paclitaxel|mesh-list
44012839|NCT03944915|Cisplatin|cisplatin|mesh-list
44012840|NCT03944915|Carboplatin|carboplatin|mesh-list
44012841|NCT03944915|Fluorouracil|fluorouracil|mesh-list
44012842|NCT03944915|Nivolumab|nivolumab|mesh-list
44012843|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
44012844|NCT03944915|Lenograstim|lenograstim|mesh-list
44012845|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44012846|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012847|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44012848|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44012849|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44012850|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012851|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
44012853|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012854|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
44012855|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012856|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012857|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44012858|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44012859|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
44012860|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012861|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44012862|NCT03872700|Fentanyl|fentanyl|mesh-list
44012863|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44012864|NCT03872700|Narcotics|narcotics|mesh-ancestor
44012865|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012866|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012867|NCT03872700|Analgesics|analgesics|mesh-ancestor
44012868|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
44012869|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248620|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248621|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248622|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44248623|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44248624|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
44248625|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248626|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44248627|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44248628|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
44248629|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
44248630|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248631|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248632|NCT00605137|Insulin|insulin|mesh-list
44248633|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44248634|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
44248635|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
44248636|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
44248637|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
44248638|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248639|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248640|NCT00605371|Lamotrigine|lamotrigine|mesh-list
44248641|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
44248642|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44248643|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248644|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647324|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44012870|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44012871|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44012872|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
44012873|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
44012874|NCT03865615|Oxytocin|oxytocin|mesh-list
44012875|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
44012876|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012877|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147757|NCT00202189|Budesonide|budesonide|mesh-list
44147758|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44147759|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44147760|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
44147761|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147762|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147763|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44147764|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44147765|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
44147766|NCT00202189|Hormones|hormones|mesh-ancestor
44147767|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147768|NCT00202228|Riboflavin|riboflavin|mesh-list
44147769|NCT00202228|Thiamine|thiamine|mesh-list
44147773|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147774|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44147775|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44248645|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44248646|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248647|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44248648|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147776|NCT00202241|Testosterone|testosterone|mesh-list
44147777|NCT00202241|Androgens|androgens|mesh-ancestor
44147778|NCT00202241|Hormones|hormones|mesh-ancestor
44147779|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147780|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147781|NCT00202280|Folic Acid|folic acid|mesh-list
44147782|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
44147783|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
44147784|NCT00202280|Vitamins|vitamins|mesh-ancestor
44147785|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
44147786|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147787|NCT00202280|Hematinics|hematinics|mesh-ancestor
44147788|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147789|NCT00202293|Olanzapine|olanzapine|mesh-list
44147790|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
44147791|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
44147792|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
44147793|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147794|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147795|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147796|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44147797|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147798|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147799|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147800|NCT00202293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44147801|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44147802|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44147803|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147804|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147805|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
44147806|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44147807|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
44147809|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44147810|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147811|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147812|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147813|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
44147814|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147815|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147816|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147817|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44147818|NCT00202345|Hematinics|hematinics|mesh-ancestor
44147819|NCT00202358|Atenolol|atenolol|mesh-list
44147820|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44147821|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147822|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
44147823|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
44147824|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147825|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147826|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44147827|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44147828|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44147829|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44012878|NCT03792490|Fasudil|fasudil|mesh-list
44012879|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44012880|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44012881|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012882|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44012883|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012884|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
44012885|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44012886|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012887|NCT03744663|Buprenorphine|buprenorphine|mesh-list
44012888|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44012889|NCT03744663|Naloxone|naloxone|mesh-list
44012890|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44012891|NCT03744663|Narcotics|narcotics|mesh-ancestor
43846295|NCT04205968|Camptothecin|camptothecin|mesh-list
44248649|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248650|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248651|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44248652|NCT00605397|Trastuzumab|trastuzumab|mesh-list
43647355|NCT01957956|Temozolomide|temozolomide|mesh-list
44012892|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012900|NCT03717155|Carboplatin|carboplatin|mesh-list
44012901|NCT03717155|Cetuximab|cetuximab|mesh-list
44012902|NCT03717155|Avelumab|avelumab|mesh-list
44012903|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012904|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44012905|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
44012906|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012907|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
44012908|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44012909|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012910|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012911|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
44012912|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012913|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44012914|NCT03606889|Bupivacaine|bupivacaine|mesh-list
44012915|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44012916|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
44012917|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012918|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012919|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
44012920|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012921|NCT03261193|Bupivacaine|bupivacaine|mesh-list
44012922|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
44012923|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
44012924|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012925|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012926|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
44012927|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012928|NCT03243461|Temozolomide|temozolomide|mesh-list
44012929|NCT03243461|Valproic Acid|valproic acid|mesh-list
44012930|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44012931|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
44012932|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012933|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012934|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
44012935|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012936|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
44012937|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012938|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012939|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
44012940|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44012941|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012942|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44012943|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
44012944|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012945|NCT03137160|Ixekizumab|ixekizumab|mesh-list
44012946|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
44012947|NCT03113500|Prednisone|prednisone|mesh-list
44012948|NCT03113500|Cortisone|cortisone|mesh-list
44012949|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
44012950|NCT03113500|Doxorubicin|doxorubicin|mesh-list
44012951|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44012952|NCT03113500|Etoposide|etoposide|mesh-list
44012953|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
44012954|NCT03113500|Daunorubicin|daunorubicin|mesh-list
44012955|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44012956|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
44012957|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44012959|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
44012960|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44012961|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
44012962|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012963|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
44012964|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012965|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012974|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012975|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012976|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
44248653|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44248655|NCT00605410|Bromides|bromides|mesh-list
43901888|NCT00083720|Cetuximab|cetuximab|mesh-list
44248657|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
44248658|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248659|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
44248660|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248661|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248662|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248663|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248664|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44248665|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
44248666|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012977|NCT03113500|Hormones|hormones|mesh-ancestor
44012978|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44012979|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44012980|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44012981|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
44012982|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
44012983|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
44012984|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
44012985|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
44012986|NCT03085147|Olaparib|olaparib|mesh-list
44012987|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44012988|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012989|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012990|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012991|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44012992|NCT02997761|Blinatumomab|blinatumomab|mesh-list
44012993|NCT02997761|Antibodies|antibodies|mesh-list
44012994|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
44012995|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44012996|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
44012997|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44012998|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
44012999|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013000|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013001|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013002|NCT02971033|Ezetimibe|ezetimibe|mesh-list
44013003|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44013004|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44013005|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
44013006|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013007|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44013008|NCT02856126|Sorafenib|sorafenib|mesh-list
44013009|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013010|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013011|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013012|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013013|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
44013014|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013015|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013016|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
44013017|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
44013018|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
44013019|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013020|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013021|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013022|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44248668|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
44248669|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
44248670|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248671|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44248672|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44248673|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248674|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248675|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248676|NCT00605683|Cabergoline|cabergoline|mesh-list
44248677|NCT00605683|Pramipexole|pramipexole|mesh-list
44248678|NCT00605683|Ropinirole|ropinirole|mesh-list
44248679|NCT00605683|Bromocriptine|bromocriptine|mesh-list
44248680|NCT00605683|Lisuride|lisuride|mesh-list
44248681|NCT00605683|Apomorphine|apomorphine|mesh-list
44248682|NCT00605683|Pergolide|pergolide|mesh-list
44248683|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44013023|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
44013024|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013025|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013026|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44013027|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013028|NCT02582008|Bupropion|bupropion|mesh-list
44013029|NCT02582008|Nicotine|nicotine|mesh-list
44013030|NCT02582008|Varenicline|varenicline|mesh-list
44013034|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013035|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44013036|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44013037|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013038|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013039|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013040|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44013041|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
44013042|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44013043|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44057504|NCT00005061|Bevacizumab|bevacizumab|mesh-list
44013044|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44013045|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013046|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
44013047|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44013048|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44013049|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013050|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
44013051|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013052|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013054|NCT02366819|Fluorouracil|fluorouracil|mesh-list
44013055|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
44013056|NCT02366819|Irinotecan|irinotecan|mesh-list
44013057|NCT02366819|Calcium|calcium|mesh-list
44013058|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
44013059|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44013060|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013061|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
44013062|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013063|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013064|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013065|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013066|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
43642232|NCT05476770|Cytarabine|cytarabine|mesh-list
44248684|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44248685|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
44248686|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
44248687|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248688|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248689|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248690|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
44248691|NCT00605683|Protective Agents|protective agents|mesh-ancestor
44248692|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44248693|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248694|NCT00605683|Emetics|emetics|mesh-ancestor
44248695|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
44248696|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248697|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44248698|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44248699|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
44248700|NCT00605774|Epinephrine|epinephrine|mesh-list
44248701|NCT00605774|Racepinephrine|racepinephrine|mesh-list
44248702|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
44248703|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44248704|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44248705|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248706|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248707|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248708|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248709|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44248710|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248711|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
44248712|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647394|NCT01661647|Anesthetics|anesthetics|mesh-list
44013067|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44013068|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013069|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013070|NCT02366819|Antidotes|antidotes|mesh-ancestor
44013071|NCT02366819|Protective Agents|protective agents|mesh-ancestor
44013072|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
44013073|NCT02366819|Vitamins|vitamins|mesh-ancestor
44013074|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
44013075|NCT02192021|Doxorubicin|doxorubicin|mesh-list
44013076|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44013077|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44013078|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013079|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44013080|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013081|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248713|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248714|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248716|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
44013082|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013083|NCT01801189|Pregabalin|pregabalin|mesh-list
44013084|NCT01801189|Analgesics|analgesics|mesh-ancestor
44013085|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
44013086|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013087|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013088|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
44013089|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44013090|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013091|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013092|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44013093|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44013094|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44013095|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013096|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44013097|NCT01461915|Gemcitabine|gemcitabine|mesh-list
44013098|NCT01461915|Paclitaxel|paclitaxel|mesh-list
44013099|NCT01461915|Heparin|heparin|mesh-list
44013100|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44013101|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013102|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44147830|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013105|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013106|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013107|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
44013108|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
44013109|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013110|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013111|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013112|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
44013113|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013114|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
44013115|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44013116|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44013117|NCT01306994|Adenosine|adenosine|mesh-list
44013118|NCT01306994|Analgesics|analgesics|mesh-ancestor
44013119|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
44013120|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013121|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013122|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44013123|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
44013124|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44013125|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
44013126|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
44013127|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013128|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013129|NCT00754312|Entinostat|entinostat|mesh-list
44013130|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013131|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44013132|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013133|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013134|NCT00716755|Olanzapine|olanzapine|mesh-list
44013135|NCT00716755|Risperidone|risperidone|mesh-list
44013136|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44013137|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
44013138|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013139|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013140|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013141|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44013142|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44013143|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013144|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44013145|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44013146|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
44013147|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
44013148|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
44013149|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248717|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44248718|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
44248719|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
44248720|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013150|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013151|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44013152|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44013153|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013154|NCT00392821|Everolimus|everolimus|mesh-list
44013155|NCT00392821|Sorafenib|sorafenib|mesh-list
44013156|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013157|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013158|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
44013159|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013160|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013161|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013162|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013163|NCT04781673|Lidocaine|lidocaine|mesh-list
44013164|NCT04781673|Ketamine|ketamine|mesh-list
44013165|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
44013166|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
44013167|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013168|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013169|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
44013170|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013171|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44013172|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44013173|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44013174|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013178|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44013179|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
44013180|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44013181|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44013182|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013183|NCT04776395|Dexamethasone|dexamethasone|mesh-list
44013184|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
44013185|NCT04776395|Ichthammol|ichthammol|mesh-list
44013186|NCT04776395|BB 1101|bb 1101|mesh-list
44013187|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44013188|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
44013189|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
44013190|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013191|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013192|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013193|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
44013194|NCT04776395|Hormones|hormones|mesh-ancestor
44013195|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013196|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013197|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013198|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
44013199|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013200|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013201|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
44013202|NCT04735926|Calcifediol|calcifediol|mesh-list
44013203|NCT04735926|Vitamins|vitamins|mesh-ancestor
44013204|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
44013205|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013206|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44147831|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147832|NCT00202397|Riluzole|riluzole|mesh-list
44147833|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
44147834|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44147835|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44147836|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147837|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147838|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147839|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44147840|NCT00202397|Protective Agents|protective agents|mesh-ancestor
44147841|NCT00202423|Nabiximols|nabiximols|mesh-list
44147842|NCT00202423|Analgesics|analgesics|mesh-ancestor
44248722|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147843|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
44147844|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147845|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147846|NCT00202462|Testosterone|testosterone|mesh-list
44147847|NCT00202462|Androgens|androgens|mesh-ancestor
44147848|NCT00202462|Hormones|hormones|mesh-ancestor
44147849|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147850|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147852|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
44147853|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147854|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147855|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
44147856|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147857|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147858|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
44147859|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44147860|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147861|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44147862|NCT00202553|Perindopril|perindopril|mesh-list
44147863|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44147864|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
44147865|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147866|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147867|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147868|NCT00202592|Perindopril|perindopril|mesh-list
44147869|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44147870|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
44147872|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147873|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147874|NCT00202605|Amphetamine|amphetamine|mesh-list
44147875|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
44147876|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44147877|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147878|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
44013208|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44013209|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44013210|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
44013211|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013212|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44013213|NCT04708171|Anesthetics|anesthetics|mesh-list
44013214|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013215|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013216|NCT04704921|Ranibizumab|ranibizumab|mesh-list
44013217|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44013218|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44013219|NCT04704921|Growth Substances|growth substances|mesh-ancestor
44013220|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013221|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
44013222|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013223|NCT04682574|Ascorbic Acid|ascorbic acid|mesh-list
44013225|NCT04682574|Micronutrients|micronutrients|mesh-ancestor
44013226|NCT04682574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013227|NCT04682574|Antioxidants|antioxidants|mesh-ancestor
44013228|NCT04682574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013229|NCT04682574|Protective Agents|protective agents|mesh-ancestor
44013230|NCT04652440|Antibodies|antibodies|mesh-list
44013231|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44013232|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
44013233|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013234|NCT04624295|Aspirin|aspirin|mesh-list
44013235|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44013236|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013237|NCT04624295|Analgesics|analgesics|mesh-ancestor
44057791|NCT00005110|Albuterol|albuterol|mesh-list
44013238|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
44013239|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013240|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013241|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44013242|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248723|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44248724|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44248725|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248726|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
44248727|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248728|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248729|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248730|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248731|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44248732|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44248733|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44248734|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248735|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248736|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248737|NCT00605930|Niacinamide|niacinamide|mesh-list
44248739|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
44248740|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
44248741|NCT00605930|Vitamins|vitamins|mesh-ancestor
44248742|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
44248743|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248744|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44248745|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
44248746|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248747|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44248748|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
44248749|NCT00605995|Simvastatin|simvastatin|mesh-list
44248750|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44248751|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44248752|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
44248768|NCT00606125|Sorafenib|sorafenib|mesh-list
44248769|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248770|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248771|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248772|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248773|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
44248774|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44013243|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44013244|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44013245|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013246|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44013247|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44013248|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013249|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
44013250|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
44013251|NCT04598074|Narcotics|narcotics|mesh-ancestor
44013252|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013253|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013254|NCT04598074|Analgesics|analgesics|mesh-ancestor
43745272|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
44013255|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
44013256|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013257|NCT04593940|Remdesivir|remdesivir|mesh-list
44013258|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
44013259|NCT04593940|Abatacept|abatacept|mesh-list
44013260|NCT04593940|Infliximab|infliximab|mesh-list
44013261|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
44013262|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013263|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013264|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013265|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013266|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013267|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013268|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
44013269|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013270|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
44013271|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
44013272|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013273|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44013278|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44013279|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44013280|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013281|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013282|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013283|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013284|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013285|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44013286|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013287|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44013288|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44013289|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44013290|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013291|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013292|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
44013293|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013294|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013295|NCT04535713|Gemcitabine|gemcitabine|mesh-list
44013297|NCT04535713|Doxorubicin|doxorubicin|mesh-list
44013298|NCT04535713|Nivolumab|nivolumab|mesh-list
44013299|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013300|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
44013301|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013302|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013303|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
44013304|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013305|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013306|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013307|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
44248775|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
44248776|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248777|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248778|NCT00606203|Milnacipran|milnacipran|mesh-list
44248779|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
44013308|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013309|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013310|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013311|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013312|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44013313|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44013314|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013315|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013316|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013317|NCT04524351|Phenserine|phenserine|mesh-list
44013318|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44013319|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013320|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013321|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013322|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013323|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013324|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
44013325|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44013326|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013327|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44013328|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
44013329|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44013330|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013332|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013333|NCT04450355|Nefopam|nefopam|mesh-list
44013334|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013335|NCT04450355|Analgesics|analgesics|mesh-ancestor
44013336|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
44013337|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013338|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013339|NCT04436133|Vaccines|vaccines|mesh-list
44013340|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
44013341|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013342|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44013343|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44013344|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44013361|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44013362|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44013363|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013364|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013365|NCT04356716|Urological Agents|urological agents|mesh-ancestor
44013366|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44013367|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44013368|NCT04275362|Cimetidine|cimetidine|mesh-list
44013369|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44013370|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013371|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44013372|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
44013373|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
44013374|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013375|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013376|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013377|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44013378|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44013379|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013380|NCT04165330|Nivolumab|nivolumab|mesh-list
44013381|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013382|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013383|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013384|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013385|NCT04131192|Gemcitabine|gemcitabine|mesh-list
44013386|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013387|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
43701388|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44248780|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44248781|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44248782|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013388|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013389|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013390|NCT04131192|Antiviral Agents|antiviral agents|mesh-ancestor
44013391|NCT04131192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013392|NCT04131192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013393|NCT04131192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013394|NCT04131192|Immunologic Factors|immunologic factors|mesh-ancestor
44013395|NCT04131192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013396|NCT04121403|Rituximab|rituximab|mesh-list
44013397|NCT04121403|Cladribine|cladribine|mesh-list
44013398|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013399|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013400|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
44013401|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013404|NCT04088786|Irinotecan|irinotecan|mesh-list
44013405|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44013406|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013407|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013408|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013409|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013410|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
44013411|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44013412|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013413|NCT03906071|Docetaxel|docetaxel|mesh-list
44013414|NCT03906071|Nivolumab|nivolumab|mesh-list
44013415|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013416|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013417|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013418|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013419|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013420|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013421|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44147879|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
44147880|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147881|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
44147882|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44147883|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147884|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147885|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44157791|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013422|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
44013423|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
44013424|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44013425|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
44013426|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013427|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
44013428|NCT03883074|Protective Agents|protective agents|mesh-ancestor
44013429|NCT03883074|Antacids|antacids|mesh-ancestor
44013430|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013431|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013432|NCT03837509|Daratumumab|daratumumab|mesh-list
44013433|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013434|NCT03795350|Beclomethasone|beclomethasone|mesh-list
44013435|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
44013436|NCT03795350|Bromides|bromides|mesh-list
44013437|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
44013438|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44013439|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
44013440|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013441|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013442|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44013443|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
44013444|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44013445|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44013446|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44013447|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
44013448|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701389|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248783|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248784|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248785|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248786|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248787|NCT00606203|Analgesics|analgesics|mesh-ancestor
43647488|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44013449|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013450|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
44013451|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44013452|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44013453|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44013454|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013455|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44013456|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
44013457|NCT03795350|Hormones|hormones|mesh-ancestor
44013458|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013459|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
44013460|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44013461|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
44013462|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44013463|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
44013464|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013465|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013466|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
44013467|NCT03670836|Misoprostol|misoprostol|mesh-list
44013469|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
44013470|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44013471|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013472|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44013473|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013474|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
44013475|NCT03655613|Nivolumab|nivolumab|mesh-list
44013476|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013477|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013478|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013479|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013480|NCT03653338|Rituximab|rituximab|mesh-list
44013481|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
44013482|NCT03653338|Fludarabine|fludarabine|mesh-list
44013483|NCT03653338|Thiotepa|thiotepa|mesh-list
44013484|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
44013485|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013486|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013487|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
44013488|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013489|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013490|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013491|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013492|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44013493|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
44013494|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44013495|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
44013496|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013497|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44013498|NCT03624062|Insulin|insulin|mesh-list
44013499|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44013500|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013501|NCT03607656|Docetaxel|docetaxel|mesh-list
44013502|NCT03607656|Capecitabine|capecitabine|mesh-list
44013503|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
44013504|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013505|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013506|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013507|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013508|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013509|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013510|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
44013511|NCT03598842|Metronidazole|metronidazole|mesh-list
44013512|NCT03598842|Ivermectin|ivermectin|mesh-list
44013513|NCT03598842|Albendazole|albendazole|mesh-list
44248788|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
44248789|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248790|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44248791|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248792|NCT00606242|Fluticasone|fluticasone|mesh-list
44013514|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
44013515|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013516|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44013517|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44013518|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
44013519|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
44013520|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44013521|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013522|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013523|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013524|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013525|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013526|NCT03525028|Metformin|metformin|mesh-list
44013527|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44013528|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013529|NCT03523312|Capecitabine|capecitabine|mesh-list
44013530|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013531|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
44013532|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013533|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013534|NCT03505762|Prednisone|prednisone|mesh-list
44013535|NCT03505762|Cortisone|cortisone|mesh-list
44013536|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
44013537|NCT03505762|Rituximab|rituximab|mesh-list
44013538|NCT03505762|Doxorubicin|doxorubicin|mesh-list
44013539|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44013540|NCT03505762|Vincristine|vincristine|mesh-list
44013541|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44013542|NCT03505762|Antibodies|antibodies|mesh-list
44013543|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
44013544|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44013549|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44013550|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
44013551|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013552|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013553|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44013554|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44013555|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44013556|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013557|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013558|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44013559|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
44013560|NCT03505762|Hormones|hormones|mesh-ancestor
44013561|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013562|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013563|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44013564|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013565|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013566|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013567|NCT03503942|Metformin|metformin|mesh-list
44013568|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44013569|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013570|NCT03471663|Palbociclib|palbociclib|mesh-list
44013571|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013572|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013573|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745535|NCT02275533|Nivolumab|nivolumab|mesh-list
44013574|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013575|NCT03458429|Lenograstim|lenograstim|mesh-list
44013576|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44013577|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
44013578|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013579|NCT03447782|Naltrexone|naltrexone|mesh-list
44013580|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44013581|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44013582|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013583|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
44248793|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248794|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248795|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
44248796|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647499|NCT01158417|Resveratrol|resveratrol|mesh-list
44013584|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013585|NCT03410446|Ketamine|ketamine|mesh-list
44013586|NCT03410446|Analgesics|analgesics|mesh-ancestor
44013587|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
44013588|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013589|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013590|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44013591|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44013592|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
44013593|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
44013594|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013595|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44013596|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44013597|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013598|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013599|NCT03409614|Cemiplimab|cemiplimab|mesh-list
44013600|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013601|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013602|NCT03374839|Nivolumab|nivolumab|mesh-list
44013603|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013604|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013605|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013606|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013607|NCT03347929|Naproxen|naproxen|mesh-list
44013608|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44013609|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013610|NCT03347929|Analgesics|analgesics|mesh-ancestor
44013611|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
44013612|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013613|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058201|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
44013619|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013620|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
44013621|NCT03325647|Testosterone|testosterone|mesh-list
44013622|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
44013623|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
44013624|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44013625|NCT03325647|Androgens|androgens|mesh-ancestor
44013626|NCT03325647|Hormones|hormones|mesh-ancestor
44013627|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013628|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013629|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013630|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013631|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
44013632|NCT03324373|Everolimus|everolimus|mesh-list
44013633|NCT03324373|Lenvatinib|lenvatinib|mesh-list
44013634|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013635|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013636|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
44013637|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013638|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013639|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013640|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013641|NCT03282669|Morphine|morphine|mesh-list
44013642|NCT03282669|Hydromorphone|hydromorphone|mesh-list
44013643|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44013644|NCT03282669|Narcotics|narcotics|mesh-ancestor
44013645|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013646|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013647|NCT03282669|Analgesics|analgesics|mesh-ancestor
44013648|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
44013649|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013650|NCT03247569|Edoxaban|edoxaban|mesh-list
44013651|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44013652|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
44013653|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44248798|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248799|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248800|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44248801|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44248802|NCT00606268|Micafungin|micafungin|mesh-list
44248803|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
44248804|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248805|NCT00606333|Sirolimus|sirolimus|mesh-list
44248806|NCT00606333|Paclitaxel|paclitaxel|mesh-list
44248807|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44248808|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44248809|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248810|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248811|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248812|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013654|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44013655|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013656|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013657|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
44013658|NCT03200587|Avelumab|avelumab|mesh-list
44013659|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013660|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013661|NCT03138161|Nivolumab|nivolumab|mesh-list
44013662|NCT03138161|Ipilimumab|ipilimumab|mesh-list
44013663|NCT03138161|Trabectedin|trabectedin|mesh-list
44013664|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013665|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013666|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013667|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013668|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44013669|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
44013670|NCT03087578|Mirabegron|mirabegron|mesh-list
44013671|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44013672|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44013673|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44013674|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
44013675|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013676|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013677|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013678|NCT03087578|Urological Agents|urological agents|mesh-ancestor
44013679|NCT03001726|Docetaxel|docetaxel|mesh-list
44013680|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
44013681|NCT03001726|Tegafur|tegafur|mesh-list
44013682|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013683|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
44013684|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013685|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013691|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013692|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013693|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
44013694|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013695|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013696|NCT02807558|Azacitidine|azacitidine|mesh-list
44013697|NCT02807558|Daratumumab|daratumumab|mesh-list
44013698|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013699|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
44013700|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248813|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248814|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248815|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013701|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013702|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013703|NCT02792465|Fulvestrant|fulvestrant|mesh-list
44013704|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013705|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013706|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44013707|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44013708|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44013709|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013710|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013711|NCT02751255|Tretinoin|tretinoin|mesh-list
44013712|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013713|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
44013714|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
44013715|NCT02651844|Mifepristone|mifepristone|mesh-list
44013716|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44013717|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
44013718|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44013719|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013720|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44013721|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44013722|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44013723|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
44157792|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745678|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
44013724|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44013725|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44013726|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
44013727|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44013728|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
44013729|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44013730|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44013731|NCT02108860|Abatacept|abatacept|mesh-list
44013732|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013733|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013734|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013735|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013736|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
44013737|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013738|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013739|NCT02076217|Copper|copper|mesh-list
44013740|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44013741|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
44013742|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
44013743|NCT02076217|Etonogestrel|etonogestrel|mesh-list
44013744|NCT02076217|Desogestrel|desogestrel|mesh-list
44013745|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44013746|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013747|NCT02076217|Trace Elements|trace elements|mesh-ancestor
44013748|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
44013749|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44013750|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44013751|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44013752|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44013756|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013757|NCT02076217|Progestins|progestins|mesh-ancestor
44013758|NCT02076217|Hormones|hormones|mesh-ancestor
44013759|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44147886|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44147887|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44147888|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44147889|NCT00202618|Amlodipine|amlodipine|mesh-list
44147890|NCT00202618|Valsartan|valsartan|mesh-list
44147891|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44147892|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44147893|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44147894|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248816|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44248817|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
44248818|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248819|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
44248820|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248821|NCT00606411|Topiramate|topiramate|mesh-list
44248822|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
44248823|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44248824|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248825|NCT00606437|Fludarabine|fludarabine|mesh-list
44248826|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248827|NCT00606450|Thalidomide|thalidomide|mesh-list
44248828|NCT00606450|Apremilast|apremilast|mesh-list
44248829|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44248830|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248831|NCT00606450|Analgesics|analgesics|mesh-ancestor
44248832|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
44248833|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248834|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248835|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248836|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248837|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44248838|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44248839|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147895|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44147896|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147897|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
44147898|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44147899|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44147900|NCT00202696|Nalmefene|nalmefene|mesh-list
44147901|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44147902|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147903|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
44147904|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147905|NCT00202774|Fluorouracil|fluorouracil|mesh-list
44147906|NCT00202774|Capecitabine|capecitabine|mesh-list
44147907|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
44147908|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
44147909|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147910|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147911|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147912|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147913|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
44147914|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147915|NCT00202787|Leucovorin|leucovorin|mesh-list
44147916|NCT00202787|Cetuximab|cetuximab|mesh-list
44147917|NCT00202787|Fluorouracil|fluorouracil|mesh-list
44147918|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
44147919|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44147920|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147921|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
43701496|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44248840|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248841|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44248842|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
44248843|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
44248844|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44248845|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248846|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44248847|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44248848|NCT00606450|Growth Substances|growth substances|mesh-ancestor
44248849|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44248850|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248851|NCT00606515|Paclitaxel|paclitaxel|mesh-list
44248852|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44248853|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44248854|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248855|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248856|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248857|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
44248858|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248859|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44248860|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
44248861|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44248862|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44248863|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44248864|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248865|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248866|NCT00606775|Carvedilol|carvedilol|mesh-list
44248867|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43647549|NCT00856947|Vitamin D|vitamin d|mesh-list
44147922|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745758|NCT01979536|Doxorubicin|doxorubicin|mesh-list
44013760|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
44013761|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44013762|NCT02002130|Butyric Acid|butyric acid|mesh-list
44013763|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44013764|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
44013765|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013766|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
44013767|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013768|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013769|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
44013770|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
44013771|NCT01658241|Panobinostat|panobinostat|mesh-list
44013772|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013773|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44248868|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44248869|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248870|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248871|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248872|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248873|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44248874|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
44248875|NCT00606775|Protective Agents|protective agents|mesh-ancestor
44013774|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013775|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013776|NCT01463670|Lenalidomide|lenalidomide|mesh-list
44013777|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
44013778|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013779|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44013780|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44013781|NCT01463670|Growth Substances|growth substances|mesh-ancestor
44013782|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
44013783|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013784|NCT01455051|Ofatumumab|ofatumumab|mesh-list
44013785|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013786|NCT00151398|Donepezil|donepezil|mesh-list
44013790|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013791|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013792|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013793|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
44013795|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44013796|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44013797|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44013798|NCT03181308|Nivolumab|nivolumab|mesh-list
44013799|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013800|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013801|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44013802|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013804|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44013805|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
44013806|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013807|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013808|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013809|NCT03185065|Amantadine|amantadine|mesh-list
44013810|NCT03185065|Methylphenidate|methylphenidate|mesh-list
44013811|NCT03185065|Modafinil|modafinil|mesh-list
44013812|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44013813|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013814|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44013815|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44013816|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44013817|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013818|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
44013819|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013820|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44013821|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44013822|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44013823|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44013824|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44013825|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
44013826|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013827|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013828|NCT03185065|Analgesics|analgesics|mesh-ancestor
44013829|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
44013830|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013831|NCT03185546|Nicotine|nicotine|mesh-list
44013832|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44013833|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
44013834|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013835|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013836|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44248876|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44248877|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248878|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44248879|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
44013837|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44013838|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013839|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013840|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013841|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
44013842|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44013843|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44013844|NCT03186261|Fluorides|fluorides|mesh-list
44013845|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
44013846|NCT03186261|Protective Agents|protective agents|mesh-ancestor
44013847|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013848|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44013849|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013850|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
44013851|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
44013852|NCT03187678|Selexipag|selexipag|mesh-list
44013853|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44013854|NCT03187730|Nicotine|nicotine|mesh-list
44013855|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44013856|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
44013857|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851962|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013863|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013865|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013866|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013867|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013868|NCT03190005|Clopidogrel|clopidogrel|mesh-list
44013869|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44013870|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44013871|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44013872|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44013873|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
44013874|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013875|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013876|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013877|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
44013878|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013879|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013880|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44013881|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
44013883|NCT03192826|Brinzolamide|brinzolamide|mesh-list
44013884|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44013885|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44013886|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44013887|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44013888|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44013889|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013890|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013891|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013892|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44013893|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44013894|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44013895|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013896|NCT03194373|Carboplatin|carboplatin|mesh-list
44013897|NCT03194373|Palbociclib|palbociclib|mesh-list
44013898|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013899|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44013900|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013901|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013902|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
44013903|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013904|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013905|NCT03197025|Aldesleukin|aldesleukin|mesh-list
44013906|NCT03197025|Interleukin-2|interleukin-2|mesh-list
44248880|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44248881|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44248883|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248884|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248885|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248886|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
44248887|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013907|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013908|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013909|NCT03197025|Analgesics|analgesics|mesh-ancestor
44013910|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
44013911|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013912|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013913|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44013914|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44013915|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
44013916|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013917|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
44013918|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44013919|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013920|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44013921|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44013922|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
44013923|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
44013924|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44013925|NCT03198221|Citric Acid|citric acid|mesh-list
44013926|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
44013927|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44013948|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44013949|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44013950|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
44013951|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013952|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44013953|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44013954|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
44013955|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
44013956|NCT03202134|Anesthetics|anesthetics|mesh-list
44013957|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013958|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013959|NCT03202134|Narcotics|narcotics|mesh-ancestor
44013960|NCT03202134|Analgesics|analgesics|mesh-ancestor
44013961|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
44013962|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013963|NCT03202550|Oxycodone|oxycodone|mesh-list
44013964|NCT03202550|Lorazepam|lorazepam|mesh-list
44013965|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44013966|NCT03202550|Narcotics|narcotics|mesh-ancestor
44013967|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013968|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013969|NCT03202550|Analgesics|analgesics|mesh-ancestor
44013970|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
44013971|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013972|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
44013973|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
44013974|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
44013975|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013976|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44013977|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44013978|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44013979|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44013980|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
44013981|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
44013982|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013983|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013984|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
44013985|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44013986|NCT03203681|Testosterone|testosterone|mesh-list
44013993|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44248889|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248890|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248891|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248892|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460257|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013994|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013995|NCT03203681|Androgens|androgens|mesh-ancestor
44013996|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44013997|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
44013998|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44013999|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44014000|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
44014001|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44014002|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44014003|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44014004|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014005|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014006|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014007|NCT03210376|Neostigmine|neostigmine|mesh-list
44014008|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014009|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44014010|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014011|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014012|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014013|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014014|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44014015|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
44014016|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014017|NCT03211117|Docetaxel|docetaxel|mesh-list
44014018|NCT03211117|Doxorubicin|doxorubicin|mesh-list
44014019|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44014020|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
44014021|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014022|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
44014023|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
44014024|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
44014025|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014026|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44014027|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44014028|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44014030|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44014031|NCT03211234|Ranibizumab|ranibizumab|mesh-list
44014032|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014033|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44014034|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44014035|NCT03211234|Growth Substances|growth substances|mesh-ancestor
44014036|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014037|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
44014038|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014039|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014040|NCT03216902|Latanoprost|latanoprost|mesh-list
44014041|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44014042|NCT03218592|Tenofovir|tenofovir|mesh-list
44014043|NCT03218592|Emtricitabine|emtricitabine|mesh-list
44014044|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44014045|NCT03218592|Maraviroc|maraviroc|mesh-list
44014046|NCT03218592|Dolutegravir|dolutegravir|mesh-list
44014047|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
44014048|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014049|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44014050|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44014051|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014052|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014053|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44014054|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44014055|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44014056|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44014059|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44460258|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44460259|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460260|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460261|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460262|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
44460263|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147923|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147924|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147925|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
44147926|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014060|NCT03219294|Bromides|bromides|mesh-list
44014061|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
44014062|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
44014063|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44014064|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44014065|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44014066|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014067|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014068|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44014069|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44014070|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014071|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014072|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014073|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
44014074|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44014075|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014076|NCT03219866|Budesonide|budesonide|mesh-list
44014077|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
44014078|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44014079|NCT03219866|Ipratropium|ipratropium|mesh-list
44014080|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014081|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44014082|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
44014083|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014084|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014085|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44014086|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44014087|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
44014088|NCT03219866|Hormones|hormones|mesh-ancestor
44014089|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014090|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
44014091|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44014092|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014093|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014094|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014095|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
44014096|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
44014097|NCT03220958|Promethazine|promethazine|mesh-list
44014098|NCT03220958|Metoclopramide|metoclopramide|mesh-list
44014099|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44014100|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44014101|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014102|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014103|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014104|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
44014105|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
44014106|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014107|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
44014108|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
44014109|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014110|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44014111|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
44014112|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
44014113|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014114|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014115|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44014116|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
44460264|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
44460265|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44460266|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460267|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460268|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
44460269|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
44460270|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
44460271|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44460272|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
44460273|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647606|NCT00420667|Enoxaparin|enoxaparin|mesh-list
44014117|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014118|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44014119|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44014120|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
44014121|NCT03221764|Amiodarone|amiodarone|mesh-list
44014122|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44014123|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
44014124|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44014125|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014131|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44014132|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44014133|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44014134|NCT03223272|Reserpine|reserpine|mesh-list
44014135|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44014136|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44014137|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44014138|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014139|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014140|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44014141|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44014142|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44014143|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014144|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014145|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014146|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014147|NCT03224351|Ivacaftor|ivacaftor|mesh-list
44014148|NCT03224351|VX-659|vx-659|mesh-list
44014149|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44014150|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014151|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014152|NCT03224403|Acetaminophen|acetaminophen|mesh-list
44014153|NCT03224403|Ibuprofen|ibuprofen|mesh-list
44014154|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44014155|NCT03224403|Analgesics|analgesics|mesh-ancestor
44014156|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
44014157|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014158|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014160|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44014161|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014162|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014163|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44014164|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014165|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014166|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44014167|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014168|NCT03225313|Bupivacaine|bupivacaine|mesh-list
44014169|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014170|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014171|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
44014172|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014173|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460274|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460275|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44460276|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460277|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44460278|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44460279|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44460280|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44460281|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824126|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
44014174|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
44014175|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014176|NCT03226223|Methamphetamine|methamphetamine|mesh-list
44014177|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44014178|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014179|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
44014180|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
44014181|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014182|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
44014183|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014184|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014185|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014186|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44014187|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44014188|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014189|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44014190|NCT03226457|Empagliflozin|empagliflozin|mesh-list
44014192|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44014194|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44014195|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014196|NCT03226457|Diuretics|diuretics|mesh-ancestor
44014197|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
44014198|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44014199|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014200|NCT03226691|Plerixafor|plerixafor|mesh-list
44014201|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44014202|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44014203|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
44014204|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014205|NCT03226899|Colchicine|colchicine|mesh-list
44014206|NCT03226899|Allopurinol|allopurinol|mesh-list
44014207|NCT03226899|Febuxostat|febuxostat|mesh-list
44014208|NCT03226899|Lesinurad|lesinurad|mesh-list
44014209|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
44014210|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014211|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44014212|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44014213|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44014214|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014215|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014216|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
44014217|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014218|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44014219|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
44014220|NCT03226899|Protective Agents|protective agents|mesh-ancestor
44014221|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014222|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
44014223|NCT03226899|Renal Agents|renal agents|mesh-ancestor
44014224|NCT03228017|Aspirin|aspirin|mesh-list
44014225|NCT03228017|Atorvastatin|atorvastatin|mesh-list
44014226|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44014227|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44014228|NCT03228017|Analgesics|analgesics|mesh-ancestor
44014229|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
44014230|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014231|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014232|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460282|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460283|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460284|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014233|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014234|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44014235|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44014236|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014237|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44014238|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44014239|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014241|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44014242|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44014243|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
44014244|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44014245|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44014246|NCT03228914|Phenylephrine|phenylephrine|mesh-list
44014247|NCT03228914|Epinephrine|epinephrine|mesh-list
44014248|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
44014249|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44014250|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44014251|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014252|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014253|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014254|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014255|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44014256|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44014257|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
44014258|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014259|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44014260|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
44014261|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
44014262|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
44014263|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44014264|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
44014265|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44014266|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44014267|NCT03228914|Protective Agents|protective agents|mesh-ancestor
44014268|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44014271|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44014272|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014274|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
44014275|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014276|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014277|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014278|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
44014279|NCT03232749|Hormones|hormones|mesh-ancestor
44014280|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014281|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44014282|NCT03232749|Protective Agents|protective agents|mesh-ancestor
44014283|NCT03233737|Anesthetics|anesthetics|mesh-list
44014284|NCT03233737|Tetracaine|tetracaine|mesh-list
44014285|NCT03233737|Benzocaine|benzocaine|mesh-list
44014286|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014287|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014288|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014289|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
44014290|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014291|NCT03234374|Bupivacaine|bupivacaine|mesh-list
44014292|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014293|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
44014294|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014295|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014296|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
44014297|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014298|NCT03236168|Ivermectin|ivermectin|mesh-list
44014299|NCT03236168|Permethrin|permethrin|mesh-list
44014300|NCT03236168|Malathion|malathion|mesh-list
44014301|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44014302|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014303|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014304|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460285|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44248893|NCT00606957|Vitamin D|vitamin d|mesh-list
44248894|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
44248895|NCT00606957|Vitamins|vitamins|mesh-ancestor
44014305|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44014306|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014307|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014308|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014309|NCT03239106|Apremilast|apremilast|mesh-list
44014310|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44014311|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44014312|NCT03239106|Analgesics|analgesics|mesh-ancestor
44014313|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
44014314|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014315|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014316|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014317|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014318|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44014319|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44014320|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014321|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014322|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014323|NCT03239522|Glycine|glycine|mesh-list
44014324|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
44014325|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014326|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014327|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014328|NCT03241030|Acetaminophen|acetaminophen|mesh-list
44014329|NCT03241030|Ibuprofen|ibuprofen|mesh-list
44014330|NCT03241030|Sucralfate|sucralfate|mesh-list
44014331|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44014332|NCT03241030|Analgesics|analgesics|mesh-ancestor
44014333|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
44014334|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014335|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014336|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
44014337|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44014338|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014339|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014340|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44014341|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014345|NCT03241485|Morphine|morphine|mesh-list
44014346|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44014347|NCT03241485|Narcotics|narcotics|mesh-ancestor
44014348|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014349|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014350|NCT03241485|Analgesics|analgesics|mesh-ancestor
44014351|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
44014352|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014353|NCT03241810|Fulvestrant|fulvestrant|mesh-list
44014354|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44014355|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014356|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44014357|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44014358|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
44147927|NCT00202787|Antidotes|antidotes|mesh-ancestor
43746199|NCT00602459|Rituximab|rituximab|mesh-list
44014359|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014360|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014361|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
44014362|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44014363|NCT03242408|Testosterone|testosterone|mesh-list
44014364|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
44014365|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
44014366|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44014367|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014368|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
44014369|NCT03242408|Hormones|hormones|mesh-ancestor
44014370|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014371|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014372|NCT03242408|Androgens|androgens|mesh-ancestor
44248896|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
44248897|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248898|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44248899|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44248900|NCT00606983|Tamsulosin|tamsulosin|mesh-list
44248901|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44248902|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44248903|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44248904|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
44248905|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248906|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248907|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248908|NCT00606983|Urological Agents|urological agents|mesh-ancestor
44248909|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44248910|NCT00607035|Olmesartan|olmesartan|mesh-list
44248911|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44248912|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44248913|NCT00607035|Diuretics|diuretics|mesh-ancestor
44248914|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
44248915|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248916|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44248917|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248918|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248919|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44248920|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44248921|NCT00607074|Albendazole|albendazole|mesh-list
44248922|NCT00607074|Anthelmintics|anthelmintics|mesh-list
44248923|NCT00607074|Secnidazole|secnidazole|mesh-list
44248924|NCT00607074|Metronidazole|metronidazole|mesh-list
44248925|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44248926|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248927|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
44248928|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44248929|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44248930|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248931|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248933|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248934|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248935|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44014373|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
44014374|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44014375|NCT03242590|Testosterone|testosterone|mesh-list
44014376|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
44014377|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
44014378|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44014379|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014380|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
43871168|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014382|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014383|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014384|NCT03242590|Androgens|androgens|mesh-ancestor
44014385|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
44014386|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44014387|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
44014388|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014389|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
44014390|NCT03245463|Protective Agents|protective agents|mesh-ancestor
44014391|NCT03245762|Oxytocin|oxytocin|mesh-list
44014392|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
44014393|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44014394|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014395|NCT03247738|Cangrelor|cangrelor|mesh-list
44014396|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44059081|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014397|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44014398|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44014399|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44014400|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
44014401|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014402|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014403|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014404|NCT03247790|Lasmiditan|lasmiditan|mesh-list
44014405|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44014406|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
44014407|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014408|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014409|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014415|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014416|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014418|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
44014419|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014420|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44014421|NCT03249272|Adenosine|adenosine|mesh-list
44014422|NCT03249272|Regadenoson|regadenoson|mesh-list
44014423|NCT03249272|Analgesics|analgesics|mesh-ancestor
44014424|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
44014425|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014426|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014427|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44014428|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
44014429|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44014430|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
44014431|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
44014432|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014433|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014434|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44014435|NCT03252353|Octreotide|octreotide|mesh-list
44014436|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014437|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44014438|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014439|NCT03254147|Warfarin|warfarin|mesh-list
44014440|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
44014441|NCT03254147|Dabigatran|dabigatran|mesh-list
44014442|NCT03254147|Apixaban|apixaban|mesh-list
44014443|NCT03254147|Edoxaban|edoxaban|mesh-list
44014444|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
44014445|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44014446|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
44248936|NCT00607152|Allopurinol|allopurinol|mesh-list
44248937|NCT00607152|Rasburicase|rasburicase|mesh-list
44248938|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
44248939|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014447|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44014448|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44014449|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014450|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014451|NCT03256136|Carboplatin|carboplatin|mesh-list
44014452|NCT03256136|Nivolumab|nivolumab|mesh-list
44014453|NCT03256136|Pemetrexed|pemetrexed|mesh-list
44014454|NCT03256136|Ipilimumab|ipilimumab|mesh-list
44014455|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014456|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44014457|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43871169|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
44014458|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014459|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014460|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44014461|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44014462|NCT03256162|Midazolam|midazolam|mesh-list
44014463|NCT03256162|Ketamine|ketamine|mesh-list
44014464|NCT03256162|Analgesics|analgesics|mesh-ancestor
44014465|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
44014466|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014467|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014468|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44014469|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44014470|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
44014471|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
44014472|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014473|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44014474|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44014475|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014476|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014477|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44014478|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44014479|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44014480|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44014484|NCT03256253|Pregabalin|pregabalin|mesh-list
44014485|NCT03256253|Analgesics|analgesics|mesh-ancestor
44014486|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
44014487|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014488|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014489|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
44014490|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44014491|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014492|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014493|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44014494|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44014495|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44014496|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014497|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44014498|NCT03256799|Ivacaftor|ivacaftor|mesh-list
44014499|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44014500|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014501|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147928|NCT00202787|Protective Agents|protective agents|mesh-ancestor
44147929|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147930|NCT00202787|Vitamins|vitamins|mesh-ancestor
44147931|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
44147932|NCT00202800|Gemcitabine|gemcitabine|mesh-list
44147933|NCT00202800|Etoposide|etoposide|mesh-list
44147934|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147935|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
44147936|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014502|NCT03257202|Clindamycin|clindamycin|mesh-list
44014503|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
44014504|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
44014505|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44014506|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642233|NCT05476770|Dexamethasone|dexamethasone|mesh-list
44248941|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
44248942|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248943|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44248944|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
44248945|NCT00607152|Protective Agents|protective agents|mesh-ancestor
44014507|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014508|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44014509|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014510|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014511|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014512|NCT03258645|Dabigatran|dabigatran|mesh-list
44014513|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
44014514|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44014515|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
44014516|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014517|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014518|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
44014519|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44014520|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
44014521|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014522|NCT03261999|Leuprolide|leuprolide|mesh-list
44014523|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44014525|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44014526|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014527|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44014528|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014529|NCT03264157|Vaccines|vaccines|mesh-list
44014530|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
44014531|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014532|NCT03266419|Rocuronium|rocuronium|mesh-list
44014533|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44014534|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44014535|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44014536|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014537|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014538|NCT03269435|Metoclopramide|metoclopramide|mesh-list
44014539|NCT03269435|Bupivacaine|bupivacaine|mesh-list
44014540|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014541|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
44014542|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014543|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014544|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
44014545|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014553|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014554|NCT03270332|Albuterol|albuterol|mesh-list
44014555|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44014556|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
44014557|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014558|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014559|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44014560|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
44014561|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
44014562|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44014563|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44014564|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44014565|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44014566|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014567|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014568|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014569|NCT03270514|Bupivacaine|bupivacaine|mesh-list
44014570|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014571|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
44014572|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014573|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014574|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
44014575|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014576|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44014577|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248946|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248947|NCT00607178|Vaccines|vaccines|mesh-list
44248948|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
44248949|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248950|NCT00607217|Vaccines|vaccines|mesh-list
44248951|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
44248952|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248953|NCT00607282|Udenafil|udenafil|mesh-list
44248954|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44248955|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44248956|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248957|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248958|NCT00607438|Paclitaxel|paclitaxel|mesh-list
44248959|NCT00607438|Sorafenib|sorafenib|mesh-list
44248960|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44248961|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44248962|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248963|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
44248964|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
44248965|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
44248966|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248967|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44248968|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248969|NCT00607503|Terbutaline|terbutaline|mesh-list
44248970|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44248971|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
44248972|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248973|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248974|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44248975|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
44248976|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
44248977|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
44248978|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44248979|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44248980|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44248981|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44248982|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014578|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
44248983|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248984|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248985|NCT00607542|Baclofen|baclofen|mesh-list
44248986|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43647620|NCT05620940|Naltrexone|naltrexone|mesh-list
44014579|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
44014580|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44014581|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44014582|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014583|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014584|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014585|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014586|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44014588|NCT03278886|Nalmefene|nalmefene|mesh-list
44014589|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44014590|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44014591|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014592|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
44014593|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014594|NCT03279237|Leucovorin|leucovorin|mesh-list
44014595|NCT03279237|Paclitaxel|paclitaxel|mesh-list
44014596|NCT03279237|Carboplatin|carboplatin|mesh-list
44014597|NCT03279237|Fluorouracil|fluorouracil|mesh-list
44014598|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
44014599|NCT03279237|Irinotecan|irinotecan|mesh-list
44014600|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44014601|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014602|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44014603|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44014604|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44014605|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014606|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
44014607|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44014608|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44014609|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
44014610|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014611|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44014612|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44014613|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014614|NCT03279237|Antidotes|antidotes|mesh-ancestor
44014615|NCT03279237|Protective Agents|protective agents|mesh-ancestor
44014616|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
44014633|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014634|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014635|NCT03283436|Bupivacaine|bupivacaine|mesh-list
44014636|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014637|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
44014638|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014639|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014640|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
44014641|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014642|NCT03285984|Listerine|listerine|mesh-list
44014643|NCT03285984|Fluorides|fluorides|mesh-list
44014644|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
44014645|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
44014646|NCT03285984|Protective Agents|protective agents|mesh-ancestor
44014647|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014648|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44014649|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014650|NCT03286829|Metoprolol|metoprolol|mesh-list
44014651|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44014652|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44014653|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
44014654|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
44014655|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014656|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014657|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44014658|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44014659|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44014660|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014661|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701497|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44248987|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248988|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44248989|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248990|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44248991|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
44248992|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
44014662|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014663|NCT03287310|Albuterol|albuterol|mesh-list
44014664|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44014665|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
44014666|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014667|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014668|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44014669|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
44014670|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
44014671|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44014672|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44014673|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44014674|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44014675|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
44014676|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014677|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014678|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
44014680|NCT03287674|Fludarabine|fludarabine|mesh-list
44014681|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
44014682|NCT03287674|Ipilimumab|ipilimumab|mesh-list
44014683|NCT03287674|Interleukin-2|interleukin-2|mesh-list
44014684|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44014685|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
44014686|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014687|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014688|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44014689|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
44014690|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014691|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014692|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44014693|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44014694|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44014695|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44014696|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
44014697|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44014698|NCT03287674|Analgesics|analgesics|mesh-ancestor
44014699|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
44014700|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014701|NCT03289234|Edaravone|edaravone|mesh-list
44014702|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44014703|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
44014704|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014705|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44014706|NCT03289234|Protective Agents|protective agents|mesh-ancestor
44014707|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014708|NCT03289858|Bupivacaine|bupivacaine|mesh-list
44014709|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014710|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
44014711|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014712|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014713|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
44014714|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014715|NCT03290027|Tazarotene|tazarotene|mesh-list
44014716|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014717|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
44014718|NCT03290378|Tramadol|tramadol|mesh-list
44014719|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44014720|NCT03290378|Narcotics|narcotics|mesh-ancestor
44014721|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014722|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014723|NCT03290378|Analgesics|analgesics|mesh-ancestor
44014724|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
44014725|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014726|NCT03291080|Tretinoin|tretinoin|mesh-list
44248993|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248994|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248995|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44248996|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44248997|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44248998|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647628|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
44014727|NCT03291080|Isotretinoin|isotretinoin|mesh-list
44014728|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014729|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
44014730|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014731|NCT03291197|Bupivacaine|bupivacaine|mesh-list
44014732|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014733|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
44014734|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014735|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014736|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
44014737|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014738|NCT03294850|Cholic Acids|cholic acids|mesh-list
44014739|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014741|NCT03296072|Fluorides|fluorides|mesh-list
44014742|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
44014743|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
44014744|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
44014745|NCT03296072|Protective Agents|protective agents|mesh-ancestor
44014746|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014747|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44014748|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014749|NCT03296163|Paclitaxel|paclitaxel|mesh-list
44014750|NCT03296163|Bevacizumab|bevacizumab|mesh-list
44014751|NCT03296163|Carboplatin|carboplatin|mesh-list
44014752|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44014753|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44014754|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44014755|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44014757|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014758|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44014759|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44014760|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44014761|NCT03296163|Growth Substances|growth substances|mesh-ancestor
44014762|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014763|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44014764|NCT03296345|Ketamine|ketamine|mesh-list
44014765|NCT03296345|Analgesics|analgesics|mesh-ancestor
44014766|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
44014767|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014768|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014769|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44014770|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44014771|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
44014772|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
44014773|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014774|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44014775|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44014776|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014777|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014778|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
44014779|NCT03296800|Rifampin|rifampin|mesh-list
44014780|NCT03296800|Probenecid|probenecid|mesh-list
44014781|NCT03296800|Verapamil|verapamil|mesh-list
44014782|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44014783|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
44014784|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44014785|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014786|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
44014787|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44014788|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248999|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249000|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44249001|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249002|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249003|NCT00607581|Dexamethasone|dexamethasone|mesh-list
44249004|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
44014789|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014790|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44014791|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44014792|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44014793|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44014794|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44014795|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44014796|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44014797|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44014798|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014799|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44014800|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014801|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
44014802|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
44014803|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
44014804|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44014805|NCT03296800|Renal Agents|renal agents|mesh-ancestor
44014806|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44014808|NCT03297944|Alprazolam|alprazolam|mesh-list
44014809|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44014810|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44014811|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014812|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014813|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44014814|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
44014815|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
44014816|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014817|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014818|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44014819|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44014820|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44014821|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
44014822|NCT03298113|Protective Agents|protective agents|mesh-list
44014823|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014824|NCT03300674|Lidocaine|lidocaine|mesh-list
44014825|NCT03300674|Hydromorphone|hydromorphone|mesh-list
44014826|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014827|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
44014828|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014829|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014836|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014838|NCT03300674|Narcotics|narcotics|mesh-ancestor
44014839|NCT03300674|Analgesics|analgesics|mesh-ancestor
44147937|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147938|NCT00202800|Antiviral Agents|antiviral agents|mesh-ancestor
44147939|NCT00202800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147940|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147941|NCT00202800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147942|NCT00202800|Immunologic Factors|immunologic factors|mesh-ancestor
44147943|NCT00202800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147944|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44147945|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44147946|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44147947|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
44147948|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44147949|NCT00202852|Infliximab|infliximab|mesh-list
44147950|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44147951|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147952|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147953|NCT00202865|Infliximab|infliximab|mesh-list
44147954|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
44147955|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147956|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249005|NCT00607581|Lenalidomide|lenalidomide|mesh-list
44249006|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249007|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
44249008|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249009|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249010|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249011|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
44249012|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249013|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249014|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44249015|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249016|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
44249017|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
44249018|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249019|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249020|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
44249021|NCT00607581|Hormones|hormones|mesh-ancestor
44249022|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249023|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249024|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44249025|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44249026|NCT00607581|Growth Substances|growth substances|mesh-ancestor
44249027|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44249028|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44249029|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44249030|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
44249031|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249032|NCT00607685|Fluorouracil|fluorouracil|mesh-list
44249033|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
44249048|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249049|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249050|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
44249051|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249052|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147957|NCT00202891|Sisomicin|sisomicin|mesh-list
44147958|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44147959|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44147960|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44147961|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059699|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147962|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147963|NCT00202917|Fludarabine|fludarabine|mesh-list
44147964|NCT00202917|Melphalan|melphalan|mesh-list
44147965|NCT00202917|Thiotepa|thiotepa|mesh-list
44147966|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147967|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147968|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147969|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
44147970|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147971|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44147972|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
44147973|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44147974|NCT00202969|Cisplatin|cisplatin|mesh-list
44147975|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147976|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
44147977|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
44147978|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44147979|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
44014840|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44014841|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44014842|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44014843|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014844|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014845|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44014846|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014847|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014848|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014849|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014850|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
44014851|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44014852|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
44014853|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44014854|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014860|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014861|NCT03303794|Bupivacaine|bupivacaine|mesh-list
44014862|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014863|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
44014864|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014865|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014866|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
44014867|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014868|NCT03304054|Amifampridine|amifampridine|mesh-list
44014869|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44014870|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014871|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014872|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44014873|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014874|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014875|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
44014876|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44014877|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
44014878|NCT03305159|Povidone|povidone|mesh-list
44014879|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44014880|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014881|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
44014882|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44014883|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
44014884|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
44014885|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
44014886|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249054|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44014887|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014888|NCT03306589|Molgramostim|molgramostim|mesh-list
44014889|NCT03306589|Sargramostim|sargramostim|mesh-list
44014890|NCT03306589|Cantharidin|cantharidin|mesh-list
44014891|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
44014892|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014893|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059762|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44014894|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014895|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014896|NCT03307005|Zolpidem|zolpidem|mesh-list
44014897|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44014898|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44014899|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014900|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014901|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44014902|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
44014903|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
44014904|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014905|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014906|NCT03308669|Topiramate|topiramate|mesh-list
44014907|NCT03308669|Lasmiditan|lasmiditan|mesh-list
44014908|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
44014909|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44014910|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014911|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44014912|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
44014913|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014914|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014916|NCT03309657|Ceftolozane|ceftolozane|mesh-list
44014917|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44014918|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44014919|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014920|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44014921|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014922|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014923|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44014924|NCT03309657|Renal Agents|renal agents|mesh-ancestor
44014925|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
44014930|NCT03312517|Suvorexant|suvorexant|mesh-list
44014931|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44014932|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44014933|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014934|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014935|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44014936|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014937|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014938|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
44014939|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44014940|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
44014941|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44014942|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
44014943|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014944|NCT03315559|Nemiralisib|nemiralisib|mesh-list
44014945|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44014946|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014947|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014948|NCT03315780|Dulaglutide|dulaglutide|mesh-list
44014949|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44014950|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014951|NCT03316378|Ropivacaine|ropivacaine|mesh-list
44014952|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
44014953|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
44014954|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014955|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014956|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
44014957|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014958|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
44014959|NCT03316976|Lansoprazole|lansoprazole|mesh-list
44014960|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44014961|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014962|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44249055|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44249057|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249058|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249059|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44249060|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44249061|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249062|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249063|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249064|NCT00607763|Micafungin|micafungin|mesh-list
44014963|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014964|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014965|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
44014966|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44014967|NCT03319277|Narcotics|narcotics|mesh-ancestor
44014968|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44014969|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014970|NCT03319277|Analgesics|analgesics|mesh-ancestor
44014971|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
44014972|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014973|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
44014974|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44014975|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44014976|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
44014977|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014978|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
44014979|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44014980|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014981|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014982|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014983|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014984|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014985|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
44014986|NCT03322657|Neostigmine|neostigmine|mesh-list
44014987|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43746748|NCT02522078|Misoprostol|misoprostol|mesh-list
44014988|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014989|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014990|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
44014991|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014992|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014993|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44014994|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
44014995|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015005|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44015006|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015007|NCT03325816|Nivolumab|nivolumab|mesh-list
44015008|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44015009|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44015010|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015011|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44015012|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015013|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44015014|NCT03326999|Bupivacaine|bupivacaine|mesh-list
44015015|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015016|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
44015017|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015018|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015019|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
44015020|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015021|NCT03327051|Omeprazole|omeprazole|mesh-list
44015022|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44015023|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015024|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44249065|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
44249066|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249067|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
44249068|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44249069|NCT00607932|Protective Agents|protective agents|mesh-ancestor
44249070|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249071|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249072|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
44249073|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249074|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249075|NCT00607958|Ritonavir|ritonavir|mesh-list
44249076|NCT00607958|Tipranavir|tipranavir|mesh-list
44249077|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44249078|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44249079|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
44249080|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249081|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249082|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44249083|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44249084|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
43647708|NCT05620589|Antacids|antacids|mesh-ancestor
44015025|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015026|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015027|NCT03329209|Vedolizumab|vedolizumab|mesh-list
44015028|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015029|NCT03329911|Paclitaxel|paclitaxel|mesh-list
44015030|NCT03329911|Carboplatin|carboplatin|mesh-list
44015031|NCT03329911|Bevacizumab|bevacizumab|mesh-list
44015032|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44015033|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015034|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44015035|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44015036|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44015037|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015038|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44015039|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44015040|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44015041|NCT03329911|Growth Substances|growth substances|mesh-ancestor
44015042|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015043|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44015044|NCT03329937|Niraparib|niraparib|mesh-list
44015045|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44015046|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015047|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015048|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015049|NCT03330457|Betrixaban|betrixaban|mesh-list
44015050|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44015051|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
44015052|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44015053|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015054|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015055|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015056|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
44015057|NCT03331835|Brodalumab|brodalumab|mesh-list
44015058|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015059|NCT03331965|Metoclopramide|metoclopramide|mesh-list
44249085|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249086|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44249087|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44249088|NCT00607971|Renzapride|renzapride|mesh-list
44249089|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44249090|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
44015060|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
44015061|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
44015062|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015063|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147980|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147981|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147982|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147983|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
44147985|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
44147986|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44147987|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
44147988|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147989|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44147990|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147991|NCT00203034|Rasagiline|rasagiline|mesh-list
44147992|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44147993|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147994|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44147995|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44147996|NCT00203034|Protective Agents|protective agents|mesh-ancestor
44147997|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147998|NCT00203060|Rasagiline|rasagiline|mesh-list
44147999|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44148000|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148001|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148002|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44148003|NCT00203060|Protective Agents|protective agents|mesh-ancestor
44148004|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148005|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
44148006|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
44148007|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
44148008|NCT00203073|Analgesics|analgesics|mesh-ancestor
44148009|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
44148010|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148011|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148012|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148013|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44148014|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44148015|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148016|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148017|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44148018|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
44148019|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148020|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148021|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
44148025|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
44148026|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148027|NCT00203099|Expectorants|expectorants|mesh-ancestor
44148028|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148029|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44148030|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
44148031|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148032|NCT00203099|Protective Agents|protective agents|mesh-ancestor
44148033|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148034|NCT00203099|Antidotes|antidotes|mesh-ancestor
44148035|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44148036|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
44148037|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148038|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148039|NCT00203112|Minocycline|minocycline|mesh-list
44148040|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
44015081|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44015082|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015083|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249091|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249092|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249093|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015084|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015085|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44015086|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44015087|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015088|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44015089|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
44015090|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
44059910|NCT00005928|Ramipril|ramipril|mesh-list
44015091|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
44015092|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
44015093|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015094|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015095|NCT03336645|Midazolam|midazolam|mesh-list
44015096|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44015097|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015098|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871170|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015099|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015100|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44015101|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44015102|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015103|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44015104|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
44015105|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
44015106|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
44015107|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
44015108|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015109|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015110|NCT03336853|Hybenx|hybenx|mesh-list
44015111|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
44015112|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
44015113|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015114|NCT03338803|Linagliptin|linagliptin|mesh-list
44015115|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44015116|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015117|NCT03338803|Incretins|incretins|mesh-ancestor
44015118|NCT03338803|Hormones|hormones|mesh-ancestor
44015119|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015120|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44015121|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015122|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015123|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015124|NCT03340350|Minocycline|minocycline|mesh-list
44015125|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015126|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015127|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
44015128|NCT03341910|Tazarotene|tazarotene|mesh-list
44015129|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015130|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
44015131|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
44015132|NCT03341910|Vitamins|vitamins|mesh-ancestor
44015133|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
44015134|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015135|NCT03343080|Lidocaine|lidocaine|mesh-list
44015139|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015140|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
44015141|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015142|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44015143|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44015144|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44015145|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44015146|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015148|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015149|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015150|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44015151|NCT03344861|Trioxsalen|trioxsalen|mesh-list
44015152|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015153|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015154|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44249095|NCT00607984|Thiotepa|thiotepa|mesh-list
44249096|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249097|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
44249098|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249099|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249100|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44015155|NCT03348683|Propranolol|propranolol|mesh-list
43746927|NCT02521155|Fenbendazole|fenbendazole|mesh-list
44015156|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44015157|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44015158|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015159|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015160|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015161|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015162|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44015163|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44015164|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44015165|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44015166|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
44015167|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
44015168|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
44015169|NCT03351933|Antibodies|antibodies|mesh-list
44015170|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
44015171|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44015172|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44015173|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
44015174|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015176|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
44015177|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44015178|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44015179|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015180|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015181|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015182|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015183|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
44015184|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
44015185|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015186|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
44015187|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44015188|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015189|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44015190|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
44015191|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44015192|NCT03352323|Protective Agents|protective agents|mesh-ancestor
44015193|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
44015194|NCT03354598|Probenecid|probenecid|mesh-list
44015195|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015196|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015197|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44015198|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44015199|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015200|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015201|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015202|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44015203|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44015204|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
44015205|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
44015206|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015209|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
44015210|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015211|NCT03357393|Midazolam|midazolam|mesh-list
44015212|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
44015213|NCT03357393|Scopolamine|scopolamine|mesh-list
44015214|NCT03357393|Morphine|morphine|mesh-list
44015215|NCT03357393|Propofol|propofol|mesh-list
44015216|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44015217|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015218|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015219|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249101|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249102|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
44249103|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249104|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
44249105|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249106|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249107|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249108|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249109|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
44249110|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44249111|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249112|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249113|NCT00608101|Dexamethasone|dexamethasone|mesh-list
44249114|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
44249115|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249116|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
44249117|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
44249118|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249119|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249120|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249121|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
44249123|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249124|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249125|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249126|NCT00608179|Glimepiride|glimepiride|mesh-list
44249127|NCT00608179|Glyburide|glyburide|mesh-list
43647744|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
44015220|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44015221|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
44015222|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
44015223|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015224|NCT03357393|Narcotics|narcotics|mesh-ancestor
44015225|NCT03357393|Analgesics|analgesics|mesh-ancestor
44015226|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
44015227|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015228|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44015229|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44015230|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44015231|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015232|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
44015233|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
44015234|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015235|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015236|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44015237|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44015238|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
44015239|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
44015240|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
44015241|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249128|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44249130|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249131|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249132|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
44249133|NCT00608218|Ciclesonide|ciclesonide|mesh-list
44249134|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
44249135|NCT00608218|Hormones|hormones|mesh-ancestor
43647771|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015242|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
44015243|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
44015244|NCT03357614|Amoxicillin|amoxicillin|mesh-list
44015245|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
44015246|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
44015247|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
44015248|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44015249|NCT03357614|Ertapenem|ertapenem|mesh-list
44015250|NCT03357614|Lactams|lactams|mesh-list
44015251|NCT03357614|Probenecid|probenecid|mesh-list
44015252|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015253|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015255|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44015256|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015257|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015258|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015259|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44015260|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44015261|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44015262|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
44015263|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
44015264|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015265|NCT03357614|Renal Agents|renal agents|mesh-ancestor
44015266|NCT03358576|Amoxicillin|amoxicillin|mesh-list
44015267|NCT03358576|Metronidazole|metronidazole|mesh-list
44015268|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
44015269|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
44015270|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
44015271|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44015272|NCT03358576|Ertapenem|ertapenem|mesh-list
44015273|NCT03358576|Lactams|lactams|mesh-list
44015274|NCT03358576|Probenecid|probenecid|mesh-list
44015275|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015276|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015277|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44015278|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44015279|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44015280|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44015281|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015282|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015283|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015284|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44015285|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44015290|NCT03358576|Renal Agents|renal agents|mesh-ancestor
44015291|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
44015292|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015293|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015294|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44015295|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44015296|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015297|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015298|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015299|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44015300|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44015301|NCT03368235|Prednisolone|prednisolone|mesh-list
44015302|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015303|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
44015304|NCT03368235|Hormones|hormones|mesh-ancestor
44015305|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249136|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249137|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249138|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44249139|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
44015306|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015307|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44015308|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015309|NCT03371836|Clobazam|clobazam|mesh-list
44015310|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
44015311|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44015312|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44015313|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015314|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015315|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015316|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44015318|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
44015319|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015320|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015321|NCT03372382|Acetaminophen|acetaminophen|mesh-list
44015322|NCT03372382|Ibuprofen|ibuprofen|mesh-list
44015323|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015324|NCT03372382|Analgesics|analgesics|mesh-ancestor
44015325|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
44015326|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015327|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015328|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
43871171|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44015329|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44015330|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015331|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015332|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44015333|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015334|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015335|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44015336|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44015337|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44015338|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015339|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015340|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44015341|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44015342|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015343|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
44015344|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015345|NCT03373591|Bupivacaine|bupivacaine|mesh-list
44015346|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015347|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
44015348|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015349|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015350|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
44015351|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015352|NCT03374176|Amoxicillin|amoxicillin|mesh-list
44015353|NCT03374176|Metronidazole|metronidazole|mesh-list
44015354|NCT03374176|Clindamycin|clindamycin|mesh-list
44015355|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
44015356|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
44015362|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015363|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015364|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
44015365|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44015366|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
44015367|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
44015368|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015369|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015370|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015371|NCT03375294|Analgesics|analgesics|mesh-ancestor
44015372|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
44015373|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015374|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
44015375|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44015376|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44249140|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44249141|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249142|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249143|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249144|NCT00608231|Analgesics|analgesics|mesh-ancestor
44249145|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
44249146|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015377|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015378|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
44015379|NCT03376061|Coagulants|coagulants|mesh-ancestor
44015380|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
44015381|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44015382|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
44015383|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747141|NCT02519660|Lidocaine|lidocaine|mesh-list
44015384|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015385|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44015386|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015387|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
44015388|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44015389|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
44015390|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015391|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015392|NCT03378076|Triamcinolone|triamcinolone|mesh-list
44015393|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44015394|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44015395|NCT03378076|FX006|fx006|mesh-list
44015396|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44015397|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015398|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
44015399|NCT03378076|Hormones|hormones|mesh-ancestor
44015400|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015401|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015402|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44015403|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
44015404|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015405|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015406|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
44015407|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015408|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015409|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015410|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015411|NCT03378973|Analgesics|analgesics|mesh-ancestor
44015412|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
44015413|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015414|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44015415|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44015416|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44015417|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015418|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015419|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015420|NCT03379506|Grazoprevir|grazoprevir|mesh-list
44015421|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
44015422|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015423|NCT03380026|Triamcinolone|triamcinolone|mesh-list
44015424|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44015425|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44015431|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015433|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44015434|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
44015435|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015436|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015437|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
44015438|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44015439|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015440|NCT03381742|Clopidogrel|clopidogrel|mesh-list
44249147|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44249148|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44249149|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44249150|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
44249151|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015441|NCT03381742|Ticagrelor|ticagrelor|mesh-list
44015442|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44015443|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44015444|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44015445|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44015446|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
44015447|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015448|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015449|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148041|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
44148042|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148043|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148044|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44148045|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
44148046|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148047|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148048|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148049|NCT00203125|Rasagiline|rasagiline|mesh-list
44015450|NCT03383523|Praziquantel|praziquantel|mesh-list
44015451|NCT03383523|Emodepside|emodepside|mesh-list
44015452|NCT03383523|Toltrazuril|toltrazuril|mesh-list
44015453|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
44015454|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44015455|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015456|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
44015457|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44015458|NCT03383588|Epinephrine|epinephrine|mesh-list
44015459|NCT03383588|Fentanyl|fentanyl|mesh-list
44015460|NCT03383588|Morphine|morphine|mesh-list
44015461|NCT03383588|Bupivacaine|bupivacaine|mesh-list
44015462|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015463|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
44015464|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015465|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015466|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
44015467|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015468|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015469|NCT03383588|Narcotics|narcotics|mesh-ancestor
44015470|NCT03383588|Analgesics|analgesics|mesh-ancestor
44015471|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44015472|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44015473|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
44015474|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44015475|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44015476|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015477|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015478|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015479|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44015480|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44015481|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
44015482|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44015483|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015484|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
44015485|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
44015486|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44015487|NCT03384329|Resveratrol|resveratrol|mesh-list
44015488|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
44015496|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015497|NCT03393208|Metformin|metformin|mesh-list
44015498|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44015499|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015500|NCT03393494|Adapalene|adapalene|mesh-list
44015501|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44015502|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015503|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44015504|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015505|NCT03393494|Analgesics|analgesics|mesh-ancestor
44015506|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
44249152|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249154|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
44249155|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249156|NCT00608361|Dasatinib|dasatinib|mesh-list
44249157|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249158|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249159|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249160|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249161|NCT00608374|Fludarabine|fludarabine|mesh-list
44249162|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
44249163|NCT00608374|Chlorambucil|chlorambucil|mesh-list
44249164|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015507|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015508|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015509|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015510|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015511|NCT03395808|Tramadol|tramadol|mesh-list
44015512|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015513|NCT03395808|Narcotics|narcotics|mesh-ancestor
44015514|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015515|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015516|NCT03395808|Analgesics|analgesics|mesh-ancestor
44015517|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
44015518|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015519|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
44015520|NCT03395886|Remifentanil|remifentanil|mesh-list
44015521|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015522|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015523|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015524|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015525|NCT03395886|Analgesics|analgesics|mesh-ancestor
44015526|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
44015527|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015528|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44015529|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44015530|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44015531|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015532|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015533|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015534|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015536|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
44015537|NCT03395990|Procaine|procaine|mesh-list
44015538|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015539|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
44015540|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015541|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015542|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
44015543|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015544|NCT03397394|Rucaparib|rucaparib|mesh-list
44015545|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44015546|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015547|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015548|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015550|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015551|NCT03398278|Narcotics|narcotics|mesh-ancestor
44015552|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015553|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015554|NCT03398278|Analgesics|analgesics|mesh-ancestor
44015555|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
44015556|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015557|NCT03398330|Oxycodone|oxycodone|mesh-list
44249165|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44249166|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
44249167|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249168|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249169|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
44249170|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015558|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015562|NCT03398330|Analgesics|analgesics|mesh-ancestor
44015563|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
44015564|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015565|NCT03398421|Itraconazole|itraconazole|mesh-list
44015566|NCT03398421|Nemiralisib|nemiralisib|mesh-list
44015567|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
44015568|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015569|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44015570|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44015571|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015572|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015573|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44015574|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44015575|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015576|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015577|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44015578|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44015579|NCT03400475|Simvastatin|simvastatin|mesh-list
44015580|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44015581|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44015582|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
44015583|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015584|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44015585|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44015586|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015587|NCT03402243|Menthol|menthol|mesh-list
44015588|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
44015589|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015590|NCT03403504|Oxycodone|oxycodone|mesh-list
44015591|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015592|NCT03403504|Narcotics|narcotics|mesh-ancestor
44015593|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015594|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015595|NCT03403504|Analgesics|analgesics|mesh-ancestor
44015596|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
44015597|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015598|NCT03403517|Dexamethasone|dexamethasone|mesh-list
44015599|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
44015600|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44015601|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44015602|NCT03403517|Prednisolone|prednisolone|mesh-list
44015603|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
44015604|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44015605|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
44015606|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015607|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
44015608|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
44015609|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015610|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015611|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015612|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
44015613|NCT03403517|Hormones|hormones|mesh-ancestor
44015614|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015615|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44015616|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015617|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44015618|NCT03403517|Protective Agents|protective agents|mesh-ancestor
44015619|NCT03403712|Dexamethasone|dexamethasone|mesh-list
44015620|NCT03403712|Palonosetron|palonosetron|mesh-list
44015621|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249171|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249172|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
44249173|NCT00608595|Celecoxib|celecoxib|mesh-list
44249174|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44015622|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
44015623|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
44015624|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015625|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015626|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015627|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
44015628|NCT03403712|Hormones|hormones|mesh-ancestor
44015629|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015630|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44015636|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015638|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
44015639|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44015640|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
44015641|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015642|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015643|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44015644|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
44015645|NCT03383198|Bupivacaine|bupivacaine|mesh-list
44015646|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015647|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
44015648|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015649|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015650|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
44015651|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015652|NCT03405259|Fluorides|fluorides|mesh-list
44015653|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
44015654|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
44015655|NCT03405259|Protective Agents|protective agents|mesh-ancestor
44015656|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015657|NCT03407625|Misoprostol|misoprostol|mesh-list
44015658|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44015659|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
44015660|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44015661|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015662|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44015663|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015664|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
44015665|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
44015666|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44015667|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
44015668|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44015669|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015670|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015671|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015672|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
44015673|NCT03415243|Acetaminophen|acetaminophen|mesh-list
44015674|NCT03415243|Phenylephrine|phenylephrine|mesh-list
44015675|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
44015676|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
44015677|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015678|NCT03415243|Analgesics|analgesics|mesh-ancestor
44015679|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
44015680|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015681|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015682|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
44015683|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44015684|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
44015685|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
44015686|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
44015687|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44015688|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
44015689|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015690|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44015691|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44015692|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44015693|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44015694|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015695|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249175|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249176|NCT00608595|Analgesics|analgesics|mesh-ancestor
44249177|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
43824168|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
44015696|NCT03415243|Protective Agents|protective agents|mesh-ancestor
44015697|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
44015698|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44015699|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44015701|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015702|NCT03415581|Narcotics|narcotics|mesh-ancestor
44015706|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
44015707|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148050|NCT00203125|Tyramine|tyramine|mesh-list
44148051|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44148052|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148053|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148054|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44148055|NCT00203125|Protective Agents|protective agents|mesh-ancestor
44148056|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148057|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
44148058|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
44148059|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148060|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44148061|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44148062|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148063|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44148064|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148065|NCT00203138|Rasagiline|rasagiline|mesh-list
44148066|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44148067|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148068|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148069|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44148070|NCT00203138|Protective Agents|protective agents|mesh-ancestor
44148071|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148072|NCT00203164|Rasagiline|rasagiline|mesh-list
44148073|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44148074|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148075|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148076|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44148077|NCT00203164|Protective Agents|protective agents|mesh-ancestor
44148078|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148079|NCT00203177|Rasagiline|rasagiline|mesh-list
44148080|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44148081|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148082|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148083|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44148084|NCT00203177|Protective Agents|protective agents|mesh-ancestor
44148085|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148086|NCT00203190|Topiramate|topiramate|mesh-list
44148087|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
44148088|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148089|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148090|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
44148091|NCT00203281|Tacrolimus|tacrolimus|mesh-list
44148092|NCT00203281|Daclizumab|daclizumab|mesh-list
44148093|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
43747393|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
44148094|NCT00203281|Antibodies|antibodies|mesh-list
44148095|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
44148096|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44148097|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44015708|NCT03418714|Salvinorin A|salvinorin a|mesh-list
44015709|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
44015710|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015711|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015712|NCT03421210|Nicotine|nicotine|mesh-list
44015713|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44015714|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
44015715|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015716|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015717|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44015718|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44015719|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249178|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249179|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249181|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249182|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44249183|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44249184|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249185|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015720|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015721|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015722|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
44015723|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015724|NCT03424681|Modafinil|modafinil|mesh-list
44015725|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44015726|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015738|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015739|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015740|NCT03426228|Progesterone|progesterone|mesh-list
44015741|NCT03426228|Estrogens|estrogens|mesh-list
44015742|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015743|NCT03426228|Hormones|hormones|mesh-ancestor
44015744|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015745|NCT03426228|Progestins|progestins|mesh-ancestor
44015746|NCT03428230|Acetaminophen|acetaminophen|mesh-list
44015747|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
44015748|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44015749|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015750|NCT03428230|Analgesics|analgesics|mesh-ancestor
44015751|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
44015752|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015753|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015754|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
44015755|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015756|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
44015757|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015758|NCT03430050|Progesterone|progesterone|mesh-list
44015759|NCT03430050|Progestins|progestins|mesh-ancestor
44015760|NCT03430050|Hormones|hormones|mesh-ancestor
44015761|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060685|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44015762|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015763|NCT03435614|Analgesics|analgesics|mesh-list
44015764|NCT03435614|Narcotics|narcotics|mesh-list
44015765|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015766|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015767|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
44015768|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015769|NCT03437044|Clopidogrel|clopidogrel|mesh-list
44015770|NCT03437044|Ticagrelor|ticagrelor|mesh-list
44015771|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44015772|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44015773|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44015774|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44015775|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
44015776|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015777|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015778|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015779|NCT03437564|Vortioxetine|vortioxetine|mesh-list
44015780|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
44015781|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44015782|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44015783|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44015784|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015785|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015786|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44015787|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249187|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
44249188|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44249189|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
44249190|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
44015788|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44015796|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
44015797|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44015799|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015800|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
44015801|NCT03438266|Protective Agents|protective agents|mesh-ancestor
44015802|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44015803|NCT03440229|Laxatives|laxatives|mesh-ancestor
44015804|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015805|NCT03440424|Lemborexant|lemborexant|mesh-list
44015806|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44015807|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015808|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015809|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44015810|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015811|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015812|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015814|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44015815|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44015816|NCT03441269|Analgesics|analgesics|mesh-ancestor
44015817|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
44015818|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015819|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015820|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015821|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015822|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44015823|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015824|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015825|NCT03441581|Eluxadoline|eluxadoline|mesh-list
44015826|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015827|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
44015828|NCT03441633|Apixaban|apixaban|mesh-list
44015829|NCT03441633|Dabigatran|dabigatran|mesh-list
44015830|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44015831|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
44015832|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44015833|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015834|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015835|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015836|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
44015837|NCT03443063|Lemborexant|lemborexant|mesh-list
44015838|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44015839|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015840|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015841|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44015842|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015843|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015844|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015845|NCT03445195|Imipenem|imipenem|mesh-list
44015846|NCT03445195|Sulbactam|sulbactam|mesh-list
44015847|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44015848|NCT03445195|Cilastatin|cilastatin|mesh-list
44015849|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015850|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015851|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015852|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015853|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015854|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44015855|NCT03445390|Acetaminophen|acetaminophen|mesh-list
44015970|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015971|NCT03463915|Triamcinolone|triamcinolone|mesh-list
44015972|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44015973|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44015974|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44015975|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249191|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44249192|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249193|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
44249194|NCT00608673|Hormones|hormones|mesh-ancestor
44249195|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249196|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249197|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44249198|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
44249199|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249200|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249201|NCT00608673|Analgesics|analgesics|mesh-ancestor
44249202|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
44249203|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249204|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249205|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249206|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249207|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
44249208|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44249209|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249210|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249211|NCT00608699|Niacin|niacin|mesh-list
44249212|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249213|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
44249214|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249215|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249216|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
44249217|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
44249218|NCT00608699|Vitamins|vitamins|mesh-ancestor
44249219|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
44249220|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015976|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
44015977|NCT03463915|Hormones|hormones|mesh-ancestor
44015978|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44015979|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015980|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44015981|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
44015982|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015983|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148098|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148099|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
44148100|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148101|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44148102|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249221|NCT00608712|Esomeprazole|esomeprazole|mesh-list
44249222|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44249223|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249224|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44148103|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148104|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148105|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148106|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44148107|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
44148108|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148109|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148110|NCT00203320|Etanercept|etanercept|mesh-list
44148111|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44148112|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44148113|NCT00203320|Analgesics|analgesics|mesh-ancestor
44148114|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
44148115|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148116|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148117|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148118|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148119|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148120|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148121|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
44015984|NCT03467685|Anesthetics|anesthetics|mesh-list
44015985|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015986|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015987|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
44015988|NCT03468075|Gemcitabine|gemcitabine|mesh-list
44015989|NCT03468075|Vitamins|vitamins|mesh-ancestor
44015990|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
44015991|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015992|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44015993|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
44015994|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015995|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015996|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
44015997|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015998|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015999|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016000|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
44016001|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
44016002|NCT03468075|Protective Agents|protective agents|mesh-ancestor
44016003|NCT03468920|Acetaminophen|acetaminophen|mesh-list
44016004|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016005|NCT03468920|Analgesics|analgesics|mesh-ancestor
44016006|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
44016007|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016008|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016044|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016045|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44016046|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44016047|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016048|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
44016049|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44016050|NCT03472469|Narcotics|narcotics|mesh-ancestor
44016051|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44148160|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
44148161|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148162|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148163|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
44148164|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148165|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148166|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
44148167|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148168|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148169|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148171|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
44148172|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44148173|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44063440|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148174|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148175|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44249225|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249226|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249227|NCT00608790|Albuterol|albuterol|mesh-list
44249228|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44249229|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
44249230|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249231|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249232|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44249233|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44249234|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
44249235|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44148176|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148177|NCT00203463|Topiramate|topiramate|mesh-list
44016309|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
44016310|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
44016311|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016312|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016313|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016314|NCT03509883|Apixaban|apixaban|mesh-list
44016315|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44016316|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
44016411|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016412|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016413|NCT03523988|Acetaminophen|acetaminophen|mesh-list
44016414|NCT03523988|Ibuprofen|ibuprofen|mesh-list
44016415|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016416|NCT03523988|Analgesics|analgesics|mesh-ancestor
44016417|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
44016418|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016419|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016420|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
44016421|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016422|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016423|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016424|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016425|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016426|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016427|NCT03524339|Tamsulosin|tamsulosin|mesh-list
44016428|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44016429|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44016430|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44016431|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016432|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016433|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016434|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016435|NCT03524339|Urological Agents|urological agents|mesh-ancestor
44016436|NCT03525548|Ivacaftor|ivacaftor|mesh-list
44016437|NCT03525548|Elexacaftor|elexacaftor|mesh-list
44016438|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44016439|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016440|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016441|NCT03528512|Fentanyl|fentanyl|mesh-list
44016442|NCT03528512|Midazolam|midazolam|mesh-list
44016443|NCT03528512|Ketamine|ketamine|mesh-list
44016444|NCT03528512|Analgesics|analgesics|mesh-ancestor
44016445|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
44016446|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016447|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016448|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44016449|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44016450|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
44016451|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
44016452|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249236|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44249237|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44249238|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44249239|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016453|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44016454|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44016455|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016456|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016457|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44016458|NCT03528512|Narcotics|narcotics|mesh-ancestor
43747969|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44016459|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44016460|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44016461|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44016462|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44016463|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016464|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
44016465|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
44016466|NCT03530631|Adderall|adderall|mesh-list
44016467|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44016468|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016469|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
44016470|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44016471|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016472|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
44016473|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44016474|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
44016475|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
44016476|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
44016477|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016478|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44016479|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44016481|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
44016482|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
44016483|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44016484|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016485|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
44016486|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016509|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44016510|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016511|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016512|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016513|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016514|NCT03541356|Carbidopa|carbidopa|mesh-list
44016515|NCT03541356|Levodopa|levodopa|mesh-list
44016516|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44016517|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44016518|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44016519|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
44016520|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016521|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016522|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016523|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44016524|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016525|NCT03541941|Bupivacaine|bupivacaine|mesh-list
44016526|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016527|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
44016528|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016529|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016530|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
44016531|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016532|NCT03541980|Acetaminophen|acetaminophen|mesh-list
44016533|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748037|NCT04197986|Infigratinib|infigratinib|mesh-list
44016534|NCT03541980|Analgesics|analgesics|mesh-ancestor
44016535|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
44016536|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061028|NCT00006029|Gemcitabine|gemcitabine|mesh-list
44016537|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016538|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
44016539|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44157797|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701498|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249240|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249241|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249242|NCT00608803|Doxorubicin|doxorubicin|mesh-list
44249243|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44249244|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249245|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44249246|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44157798|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44157800|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
44157801|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157802|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157803|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157804|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157805|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44157806|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44157807|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157808|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44157809|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44157810|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157811|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
44157812|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43748104|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
44016586|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
44016587|NCT03559179|Narcotics|narcotics|mesh-ancestor
44016588|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016589|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016590|NCT03559179|Analgesics|analgesics|mesh-ancestor
44016591|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
44016592|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016593|NCT03562988|Vitamins|vitamins|mesh-list
44016594|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
44016595|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
44016596|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016597|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
44016691|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44016692|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016693|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44016694|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44016695|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016696|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016697|NCT03587207|Vaccines|vaccines|mesh-list
44016698|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
44016699|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016700|NCT03587428|Zinc|zinc|mesh-list
44016701|NCT03587428|Trace Elements|trace elements|mesh-ancestor
44016702|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
44016703|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016704|NCT03588806|Oxycodone|oxycodone|mesh-list
44016705|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44016706|NCT03588806|Narcotics|narcotics|mesh-ancestor
44016707|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016708|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016709|NCT03588806|Analgesics|analgesics|mesh-ancestor
44016710|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
44016711|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016712|NCT03591068|Fluticasone|fluticasone|mesh-list
44016713|NCT03591068|Xhance|xhance|mesh-list
44016714|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016715|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44016716|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
44016717|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016718|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016719|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44016720|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
44016721|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44016722|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44016723|NCT03592121|Phenylephrine|phenylephrine|mesh-list
44016724|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44016725|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
44249247|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249248|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249249|NCT00608816|Epinephrine|epinephrine|mesh-list
44249250|NCT00608816|Racepinephrine|racepinephrine|mesh-list
44249251|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
44016726|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
44016727|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016728|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016729|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
44016730|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44016731|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
44016732|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
44016733|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44016734|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44016735|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44016736|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016737|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016738|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016739|NCT03592121|Protective Agents|protective agents|mesh-ancestor
43748252|NCT03143985|Pomalidomide|pomalidomide|mesh-list
44016741|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44016742|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016743|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
44016744|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44016745|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44016746|NCT03593902|Prednisolone|prednisolone|mesh-list
44016747|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
44016748|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
44016749|NCT03593902|Rituximab|rituximab|mesh-list
44016750|NCT03593902|Fludarabine|fludarabine|mesh-list
44016751|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
44016752|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44016753|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44016754|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
44016804|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
44016805|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016806|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016839|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016841|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
44016842|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016843|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016844|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
44016845|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016846|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016847|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016848|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016849|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016895|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44016897|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44016898|NCT03610633|Oxytocin|oxytocin|mesh-list
44016899|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
44148228|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
44148229|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
44148230|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44148231|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148232|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
44148233|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148234|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
44148235|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148236|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
44148237|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017028|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017029|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017030|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017031|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
44017032|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017033|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44017034|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
44017035|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44017036|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44249252|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44249253|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44249254|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
44249255|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249256|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249257|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249258|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44249259|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44249260|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
44249261|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017037|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44017038|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017039|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44017040|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44017041|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44017042|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017043|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017044|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017045|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017046|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017047|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44017048|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017049|NCT03642457|Bupivacaine|bupivacaine|mesh-list
44017050|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017051|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
44017052|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017053|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017054|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
44017055|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017056|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
44017057|NCT03644095|Guaifenesin|guaifenesin|mesh-list
43871172|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44017058|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44017059|NCT03644095|Expectorants|expectorants|mesh-ancestor
44017060|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017061|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44017062|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44017063|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017064|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017065|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017066|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017067|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
44017068|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44017069|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
44017070|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
44017071|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017072|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
44017073|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44017074|NCT03644108|Guaifenesin|guaifenesin|mesh-list
44017075|NCT03644108|Expectorants|expectorants|mesh-ancestor
44017076|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017077|NCT03644212|Vitamin D|vitamin d|mesh-list
44017078|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
44017079|NCT03644212|Vitamins|vitamins|mesh-list
44017080|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
44017081|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017082|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44017083|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44017084|NCT03649750|Guaifenesin|guaifenesin|mesh-list
44017085|NCT03649750|Expectorants|expectorants|mesh-ancestor
44017086|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017087|NCT03654417|Lidocaine|lidocaine|mesh-list
44017088|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017089|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
44249262|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44249263|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
44249264|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
44249265|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
44249266|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44249268|NCT00608946|Trace Elements|trace elements|mesh-ancestor
44249269|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
43647849|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44017090|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017091|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017092|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
44017093|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017094|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017095|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017096|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017097|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017098|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017099|NCT03655080|Paclitaxel|paclitaxel|mesh-list
44017100|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44148281|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148282|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849660|NCT03904446|Methylergonovine|methylergonovine|mesh-list
44017181|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017182|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017183|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017184|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017185|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017186|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017187|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
44017188|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44017189|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44017190|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
44017191|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017192|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44017193|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44017194|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017195|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017196|NCT03670030|Sirolimus|sirolimus|mesh-list
44017197|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44017198|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017199|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44017200|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017201|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
44017202|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44017203|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
44017204|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017205|NCT03670160|Clonidine|clonidine|mesh-list
44017206|NCT03670160|Phenobarbital|phenobarbital|mesh-list
44017207|NCT03670160|Analgesics|analgesics|mesh-ancestor
44017208|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
44017209|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017210|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017211|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017212|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
44017213|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
44017214|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44017215|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44017216|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44017217|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017218|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017219|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017220|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
44017221|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44017222|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017223|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017224|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44249270|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249271|NCT00608972|Bevacizumab|bevacizumab|mesh-list
44150277|NCT00209885|Lidocaine|lidocaine|mesh-list
44249272|NCT00608972|Carboplatin|carboplatin|mesh-list
44249273|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249274|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249275|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44017225|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
44017226|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
44017227|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44017228|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44017229|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44017230|NCT03674970|Nicotine|nicotine|mesh-list
44017231|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44017232|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
44017233|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017234|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017235|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44017236|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44017237|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017238|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017239|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017240|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44017241|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44017242|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017243|NCT03675581|Nintedanib|nintedanib|mesh-list
44017244|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44017245|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44017246|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017247|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44017248|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017249|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017250|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44017251|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
44017252|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44017253|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017377|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44017378|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44017379|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
44017380|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
44017381|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017382|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017383|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
44017384|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
44017385|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017386|NCT03716076|Carbetocin|carbetocin|mesh-list
44017387|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
44017388|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44017389|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017390|NCT03717051|Nicotine|nicotine|mesh-list
44017391|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44017392|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
44017393|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017394|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017395|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44017396|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44017397|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017398|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017399|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017400|NCT03717506|Clindamycin|clindamycin|mesh-list
44017401|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
44017402|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
44017403|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44017404|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017405|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44017406|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017407|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017408|NCT03720119|Lidocaine|lidocaine|mesh-list
44017409|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
44249276|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44249277|NCT00608972|Growth Substances|growth substances|mesh-ancestor
44249278|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017423|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
44017424|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017425|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44017426|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017427|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017428|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017429|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44148308|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148309|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148310|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43748890|NCT02514941|Talinolol|talinolol|mesh-list
44017430|NCT03828422|Calcium|calcium|mesh-list
44017431|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44017432|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017433|NCT03829618|Lidocaine|lidocaine|mesh-list
44017434|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017435|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
44017436|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017437|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017438|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
44017439|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017440|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017441|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017442|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017443|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017444|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017445|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
44017446|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
44017447|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017448|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
44017449|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44017450|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017451|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
44017452|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017453|NCT03862755|Heparin|heparin|mesh-list
44017454|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44017455|NCT03862755|Tinzaparin|tinzaparin|mesh-list
44017456|NCT03862755|Dalteparin|dalteparin|mesh-list
44017457|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
44017458|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44017459|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44017460|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017461|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
44017462|NCT03889158|Vaccines|vaccines|mesh-list
44017463|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
44017464|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017465|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
44017489|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017490|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017491|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
44017492|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44017493|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44017494|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
44017495|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017496|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017497|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017499|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
44017500|NCT03979807|Olodaterol|olodaterol|mesh-list
44017501|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44017502|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
44017503|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017504|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748961|NCT02514629|Metformin|metformin|mesh-list
44017505|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017506|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017507|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
44017508|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44017509|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249279|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
44249280|NCT00609011|Temozolomide|temozolomide|mesh-list
44017510|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017511|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017512|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
44017514|NCT04011592|Analgesics|analgesics|mesh-ancestor
44017515|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
44017516|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017566|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44017567|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017568|NCT04138758|Bromides|bromides|mesh-list
44017569|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
44017570|NCT04138758|Olodaterol|olodaterol|mesh-list
44017571|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44017572|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
44017573|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017574|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017575|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017758|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
44017759|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44017760|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44017761|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017762|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017763|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
44017804|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017805|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44017806|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44017807|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44017808|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017809|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017811|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017812|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017814|NCT04374500|Nitroprusside|nitroprusside|mesh-list
44017815|NCT04374500|Acetylcholine|acetylcholine|mesh-list
44017816|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
44017817|NCT04374500|Bradykinin|bradykinin|mesh-list
44017818|NCT04374500|Substance P|substance p|mesh-list
44017819|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017820|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44017821|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017822|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017823|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44017824|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017825|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017826|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44017827|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44017828|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017829|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017830|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
44017831|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
44017832|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
44017833|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017834|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44017835|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
44017836|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017837|NCT04358991|Ceftazidime|ceftazidime|mesh-list
44017838|NCT04358991|Avibactam|avibactam|mesh-list
44017839|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44017840|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44017841|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017842|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44017843|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017844|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017845|NCT04352660|Mitomycins|mitomycins|mesh-list
44017846|NCT04352660|Mitomycin|mitomycin|mesh-list
44017847|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44017848|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017849|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
44017850|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017926|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017927|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017928|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017929|NCT04322968|Ketorolac|ketorolac|mesh-list
44017930|NCT04322968|Ketamine|ketamine|mesh-list
44249281|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249282|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
44249283|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249284|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460286|NCT01565941|Insulin|insulin|mesh-list
44460287|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44017931|NCT04322968|Analgesics|analgesics|mesh-ancestor
44017932|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
44017933|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017934|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017935|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44017936|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44017937|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
44017938|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
44017939|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017940|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017941|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017942|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017943|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017944|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017945|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017946|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017947|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017948|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44017949|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017950|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
44017951|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44017952|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44017953|NCT04323592|Prednisolone|prednisolone|mesh-list
44017954|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
44017955|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44017956|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
44017957|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017958|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
44017959|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
44017960|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017961|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017963|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
44017964|NCT04323592|Hormones|hormones|mesh-ancestor
44017965|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44017966|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44017967|NCT04323592|Protective Agents|protective agents|mesh-ancestor
44017968|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44017969|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017970|NCT04322396|Azithromycin|azithromycin|mesh-list
44017971|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
44017972|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44017973|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017974|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
44017975|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44017976|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017977|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017978|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017979|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017980|NCT04310085|Lumefantrine|lumefantrine|mesh-list
44018018|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
44018019|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
44018020|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44018021|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44018022|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
44018023|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018024|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018025|NCT04284930|Bupivacaine|bupivacaine|mesh-list
44018026|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018027|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
44018028|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018029|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018030|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
44460288|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460289|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460290|NCT01565889|Ritonavir|ritonavir|mesh-list
44460291|NCT01565889|Ribavirin|ribavirin|mesh-list
44460292|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44460293|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44460294|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460295|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460296|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460297|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44460298|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44460299|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
44460300|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460301|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44460302|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460303|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
44460304|NCT01565850|Darunavir|darunavir|mesh-list
44460305|NCT01565850|Cobicistat|cobicistat|mesh-list
44460306|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460307|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460308|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
44460309|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460310|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44460311|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44460312|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44460313|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44460314|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460315|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44460316|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43647871|NCT05179421|Oxytocin|oxytocin|mesh-list
44018031|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018032|NCT04283773|Antibodies|antibodies|mesh-list
44018033|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
44018034|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44018035|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
44018036|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018037|NCT04277936|Levetiracetam|levetiracetam|mesh-list
44018038|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
44018039|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
44018040|NCT04267770|Insulin|insulin|mesh-list
44018041|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44018042|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018043|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148313|NCT00203801|Lumefantrine|lumefantrine|mesh-list
44148314|NCT00203801|Artemether|artemether|mesh-list
44148315|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
44148316|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
44460317|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
44460318|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44460319|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460320|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460321|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148317|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44148318|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44148319|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
44148320|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44148321|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44148322|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148323|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148324|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
44148325|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
44148326|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44148327|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
44148328|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44148329|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148330|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148331|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44148332|NCT00203801|Renal Agents|renal agents|mesh-ancestor
44148333|NCT00203814|Artesunate|artesunate|mesh-list
44148334|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
44148335|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
44148336|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44148337|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
44148338|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44148339|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44148340|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148341|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148342|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
44148343|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
44148344|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44148345|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
44148346|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44148347|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148348|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148349|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44148350|NCT00203814|Renal Agents|renal agents|mesh-ancestor
44148351|NCT00203905|Bevacizumab|bevacizumab|mesh-list
44148352|NCT00203905|Fluorouracil|fluorouracil|mesh-list
44148353|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
44148354|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44148355|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148356|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44148357|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44148358|NCT00203905|Growth Substances|growth substances|mesh-ancestor
44148359|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148360|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
44148361|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
44148362|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148369|NCT00203957|Istradefylline|istradefylline|mesh-list
44148370|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44148371|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44148372|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44148373|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
44148374|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148375|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148376|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148377|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
44148378|NCT00204022|Azathioprine|azathioprine|mesh-list
44018044|NCT04203225|Lidocaine|lidocaine|mesh-list
44018045|NCT04203225|Epinephrine|epinephrine|mesh-list
44018046|NCT04203225|Tetracaine|tetracaine|mesh-list
44018047|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018049|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018050|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018051|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
44018052|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642234|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
44460322|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460323|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460324|NCT01565707|Urological Agents|urological agents|mesh-ancestor
44460325|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
44460326|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44018053|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44018054|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44018055|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44018056|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44018057|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018058|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44018059|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44018060|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
44018061|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018062|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44018063|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44018064|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
44018065|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44018066|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018067|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
44018068|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
44018069|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44018070|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
44018071|NCT04218799|Mupirocin|mupirocin|mesh-list
44018072|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44018073|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018074|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
44018075|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018076|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44018077|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018078|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018079|NCT04204057|Tenalisib|tenalisib|mesh-list
44018080|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
44018081|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018082|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018083|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
44018084|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
44018085|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44018086|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44018087|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018088|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018089|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018090|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018091|NCT04198948|Gliclazide|gliclazide|mesh-list
44018092|NCT04198948|Omeprazole|omeprazole|mesh-list
44018093|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44018094|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018095|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44018096|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018097|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018098|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018099|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018100|NCT04204200|Vitamins|vitamins|mesh-list
44018101|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
44018102|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
44018103|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018104|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
44018105|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018106|NCT04204200|Protective Agents|protective agents|mesh-ancestor
44018107|NCT04184999|Dexamethasone|dexamethasone|mesh-list
44018156|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44018157|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018158|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
44018159|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44018160|NCT04169113|Narcotics|narcotics|mesh-ancestor
44018161|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018162|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018163|NCT04169113|Analgesics|analgesics|mesh-ancestor
44460328|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460329|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460330|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018164|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
44018165|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018166|NCT04167189|Lidocaine|lidocaine|mesh-list
44018167|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018168|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
44018169|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018170|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018171|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
44018172|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018173|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44018174|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44018175|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44018176|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44018177|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018178|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44018179|NCT04150861|Hormones|hormones|mesh-ancestor
44018180|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018181|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018182|NCT04150224|Macozinone|macozinone|mesh-list
44018183|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
44018184|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018185|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018186|NCT04149405|Diphosphonates|diphosphonates|mesh-list
44018187|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44018188|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018189|NCT04141930|Baloxavir|baloxavir|mesh-list
44018190|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
44018191|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018192|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018193|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018194|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44018195|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44018196|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018197|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44018198|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44018199|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44018200|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018201|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
44018202|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018203|NCT04137627|Melatonin|melatonin|mesh-list
44018204|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
44018205|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018206|NCT04137627|Protective Agents|protective agents|mesh-ancestor
44018207|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018208|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018209|NCT04136145|Belimumab|belimumab|mesh-list
44018210|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018211|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
44018212|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018213|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44018214|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44018215|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44018216|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
44018217|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018218|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018244|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
44018245|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018246|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018247|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
44018248|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018249|NCT04112160|Ketorolac|ketorolac|mesh-list
44460331|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460333|NCT01565499|Paclitaxel|paclitaxel|mesh-list
44460334|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44460335|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460336|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44460337|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460338|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460339|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460340|NCT01565148|Ranibizumab|ranibizumab|mesh-list
44460341|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460342|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44249285|NCT00609063|Atorvastatin|atorvastatin|mesh-list
44249286|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44249287|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249288|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
44018250|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44018251|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44018252|NCT04112160|Analgesics|analgesics|mesh-ancestor
44018253|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
44018254|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018255|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018256|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018257|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018258|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44018259|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018260|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018261|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
44018262|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
44018263|NCT04112069|Pancrelipase|pancrelipase|mesh-list
44018264|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018265|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018266|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018267|NCT04102956|Kallikreins|kallikreins|mesh-list
44018268|NCT04102956|Coagulants|coagulants|mesh-ancestor
44018269|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44018270|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
44018271|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018272|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018273|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44018274|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44018275|NCT04089982|Varenicline|varenicline|mesh-list
44018276|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44018277|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44018278|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
44018279|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018280|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018281|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018282|NCT04098575|Empagliflozin|empagliflozin|mesh-list
44018283|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44018284|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018285|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018286|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018287|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
44018288|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44018289|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
44018290|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249289|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249290|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249291|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44018292|NCT04081610|Protective Agents|protective agents|mesh-ancestor
44018294|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44018295|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
44018296|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018297|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018298|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018299|NCT04076787|Sunitinib|sunitinib|mesh-list
44018300|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018301|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44018302|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44018303|NCT04076787|Growth Substances|growth substances|mesh-ancestor
44018304|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018305|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
44018306|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44018307|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018308|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018309|NCT04042324|Heparin|heparin|mesh-list
44018310|NCT04042324|Calcium heparin|calcium heparin|mesh-list
44018311|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
44018312|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018313|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44018314|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44018315|NCT04070287|Antibodies|antibodies|mesh-list
44018316|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
44018317|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
44018318|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018319|NCT04069221|Cobicistat|cobicistat|mesh-list
44148386|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018332|NCT04066647|Dexamethasone|dexamethasone|mesh-list
44018333|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018334|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
44018335|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
44018336|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018337|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018338|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018339|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
44018340|NCT04066647|Hormones|hormones|mesh-ancestor
44018341|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018342|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018343|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018344|NCT04066426|Acetaminophen|acetaminophen|mesh-list
44018345|NCT04066426|Dexamethasone|dexamethasone|mesh-list
44018346|NCT04066426|Naproxen|naproxen|mesh-list
44018347|NCT04066426|Codeine|codeine|mesh-list
44018348|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018349|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
44018350|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
44018351|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018352|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018353|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018354|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
44018355|NCT04066426|Hormones|hormones|mesh-ancestor
44018356|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018357|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018358|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018359|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44018360|NCT04066426|Analgesics|analgesics|mesh-ancestor
44018361|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
44018362|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
44018363|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44018364|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018365|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
44018366|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44018367|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018368|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018369|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44018370|NCT04066426|Narcotics|narcotics|mesh-ancestor
44249293|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44249294|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
44249295|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249296|NCT00609154|Glucagon|glucagon|mesh-list
44018371|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018372|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
44018373|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018374|NCT04051684|Ropivacaine|ropivacaine|mesh-list
44018375|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018376|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
44018377|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018378|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018379|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
44018380|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018381|NCT04045964|Nicotine|nicotine|mesh-list
44018382|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44018383|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
44018384|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018385|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018386|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44018387|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44018388|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
44018389|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018390|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018391|NCT04053270|Afamelanotide|afamelanotide|mesh-list
44018392|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
44018393|NCT04041453|Ivermectin|ivermectin|mesh-list
44018394|NCT04041453|Albendazole|albendazole|mesh-list
44018395|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44018396|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018397|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
44018398|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
44018399|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44018400|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44018401|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
44018402|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
44018403|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
44018404|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018405|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018406|NCT04041219|Tacrolimus|tacrolimus|mesh-list
44018407|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018437|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44018439|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
44018440|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018441|NCT04031885|Paclitaxel|paclitaxel|mesh-list
44018442|NCT04031885|Docetaxel|docetaxel|mesh-list
44018443|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44018444|NCT04031885|Capecitabine|capecitabine|mesh-list
44018445|NCT04031885|Fulvestrant|fulvestrant|mesh-list
44018446|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44018447|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018448|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44018449|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44018450|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44018451|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018452|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44018488|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44018489|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44061873|NCT05247970|Midazolam|midazolam|mesh-list
44018490|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44018491|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018492|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44018493|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44018514|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44018515|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018516|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
44018517|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018518|NCT03995680|Mebendazole|mebendazole|mesh-list
44018519|NCT03995680|Piperazine|piperazine|mesh-list
44018520|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
44249297|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44249298|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249299|NCT00609154|Hormones|hormones|mesh-ancestor
44249300|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249301|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249302|NCT00609154|Incretins|incretins|mesh-ancestor
44249303|NCT00609180|Antioxidants|antioxidants|mesh-list
43647920|NCT05099848|Leucovorin|leucovorin|mesh-list
44018521|NCT03995680|DMP 777|dmp 777|mesh-list
44018522|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
44018523|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
44018524|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44018525|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018526|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
44018527|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
44018528|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
44018529|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018530|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018531|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018532|NCT04005404|Ropivacaine|ropivacaine|mesh-list
44018533|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018534|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
44018535|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018536|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018537|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
44018538|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018539|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
44018540|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44018541|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018542|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44018543|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
44018544|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
44018545|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
44018546|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018547|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018548|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44018549|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44018550|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44018551|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44018552|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44018553|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44018554|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018555|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018581|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
44018582|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44018583|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44018584|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
44018585|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018586|NCT03993119|Anticoagulants|anticoagulants|mesh-list
44018587|NCT03984838|Dolutegravir|dolutegravir|mesh-list
44018588|NCT03984838|Rilpivirine|rilpivirine|mesh-list
44018589|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
44018590|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44018591|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44018592|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018593|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018594|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44018595|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44018596|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
44018597|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018598|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44018599|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018600|NCT03983941|Ropivacaine|ropivacaine|mesh-list
44018601|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018602|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
44018603|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018604|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018605|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
44249304|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249305|NCT00609180|Protective Agents|protective agents|mesh-ancestor
44249306|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249307|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44249308|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249309|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249310|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44018606|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018607|NCT03976752|Tenofovir|tenofovir|mesh-list
44018608|NCT03976752|Emtricitabine|emtricitabine|mesh-list
44018609|NCT03976752|Cobicistat|cobicistat|mesh-list
44018613|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
44018614|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018615|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44018616|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018617|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018618|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018619|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44018620|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44018621|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44018622|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44018623|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44018624|NCT03979066|Atezolizumab|atezolizumab|mesh-list
44018625|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018626|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
44018627|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018628|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
44018629|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44018630|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
44018631|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018632|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018633|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44018634|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018635|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
44018636|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44018637|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
44018638|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018639|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018640|NCT03965039|Fluorides|fluorides|mesh-list
44018641|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
44018642|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
44018643|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
44018644|NCT03965039|Protective Agents|protective agents|mesh-ancestor
44018645|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018646|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
44018647|NCT03962634|Tetracaine|tetracaine|mesh-list
44018648|NCT03962634|Carticaine|carticaine|mesh-list
44018649|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018650|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
44018651|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018652|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018653|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
44018654|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018655|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44018656|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44018657|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44018658|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018659|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018660|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
44018661|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
44018662|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
44018663|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44018664|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148388|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44148389|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148390|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
44148391|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148392|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249311|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44249312|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249313|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249314|NCT00609284|Carboplatin|carboplatin|mesh-list
44249315|NCT00609284|Cetuximab|cetuximab|mesh-list
44249316|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148393|NCT00204061|Amisulpride|amisulpride|mesh-list
44148394|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148395|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148396|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148397|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148398|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148399|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148400|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
44148401|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148402|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148403|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44148404|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148405|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44148406|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44148407|NCT00204074|Estradiol|estradiol|mesh-list
44148408|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44148409|NCT00204074|Estrogens|estrogens|mesh-ancestor
44148410|NCT00204074|Hormones|hormones|mesh-ancestor
44165305|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44018680|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018681|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44018682|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44018683|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018684|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018685|NCT03949621|Vedolizumab|vedolizumab|mesh-list
44018686|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018687|NCT03949244|Latanoprost|latanoprost|mesh-list
44018688|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44018689|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44018690|NCT03948386|Bupivacaine|bupivacaine|mesh-list
44018691|NCT03948386|Mepivacaine|mepivacaine|mesh-list
44018692|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018693|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
44018694|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018695|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018696|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
44018697|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018698|NCT03936387|Ropivacaine|ropivacaine|mesh-list
44018699|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018700|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
44018701|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018702|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018703|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
44018704|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018705|NCT03935399|Oxytocin|oxytocin|mesh-list
44018706|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
44018707|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018708|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018709|NCT03928327|Itraconazole|itraconazole|mesh-list
44018710|NCT03928327|Rifampin|rifampin|mesh-list
44018711|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
44018712|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018713|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44018714|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44018715|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018716|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018717|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44018718|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
44018719|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018720|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018721|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44018722|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44249317|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249319|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44249320|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018723|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
44018724|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018725|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
44018726|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018727|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44018728|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44018729|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44018730|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44018731|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44018732|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44018733|NCT03933774|Tretinoin|tretinoin|mesh-list
44018734|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018735|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
44018736|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
44018738|NCT03933618|Clomiphene|clomiphene|mesh-list
44018739|NCT03933618|Enclomiphene|enclomiphene|mesh-list
44018740|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
44018741|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018742|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018743|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018744|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44018745|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44018746|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018747|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44018748|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
44018749|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018750|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018751|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44018752|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
44018784|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018785|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44018787|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44018788|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018789|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44018790|NCT03895307|Anesthetics|anesthetics|mesh-list
44018791|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
44018792|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018793|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018794|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
44018795|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018796|NCT03921190|Anesthetics|anesthetics|mesh-list
44018797|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018798|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018799|NCT03920865|Risdiplam|risdiplam|mesh-list
44018800|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44018801|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018802|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018803|NCT03896633|Brinzolamide|brinzolamide|mesh-list
44018804|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44018805|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018806|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018807|NCT03906448|Temozolomide|temozolomide|mesh-list
44018808|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44018809|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
44018810|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018811|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018812|NCT03909763|Danazol|danazol|mesh-list
44018813|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44018814|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
44018815|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018816|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018817|NCT03889444|Dexamethasone|dexamethasone|mesh-list
44018818|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018819|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
44018820|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
44249322|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249323|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
44249324|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249325|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44249326|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647942|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
44018821|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018822|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018823|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018824|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
44018826|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018827|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018828|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018829|NCT03888755|Icatibant|icatibant|mesh-list
44018830|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44018831|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44018832|NCT03888755|Analgesics|analgesics|mesh-ancestor
44018833|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
44018834|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018835|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018836|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018837|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44018838|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44018839|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44018840|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018841|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44018842|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018843|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
44018844|NCT03888365|Treprostinil|treprostinil|mesh-list
44018845|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44018846|NCT03887299|Disinfectants|disinfectants|mesh-list
44018847|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018848|NCT03886701|Isoniazid|isoniazid|mesh-list
44018849|NCT03886701|Rifapentine|rifapentine|mesh-list
44018850|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
44018851|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018852|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018853|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44018854|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44018855|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
44018856|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018975|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148432|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148433|NCT00204243|Naltrexone|naltrexone|mesh-list
44148434|NCT00204243|Methadone|methadone|mesh-list
44148435|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44148436|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44148437|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148438|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
44148439|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148440|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44062189|NCT04743661|Irinotecan|irinotecan|mesh-list
44148441|NCT00204243|Narcotics|narcotics|mesh-ancestor
44148442|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148443|NCT00204243|Analgesics|analgesics|mesh-ancestor
44148444|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
44148445|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148446|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44148447|NCT00204256|Hematinics|hematinics|mesh-ancestor
44148448|NCT00204269|Testosterone|testosterone|mesh-list
44148449|NCT00204269|Androgens|androgens|mesh-ancestor
44148488|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44148489|NCT00204438|Desogestrel|desogestrel|mesh-list
44148490|NCT00204438|Estradiol|estradiol|mesh-list
44148491|NCT00204438|Estrogens|estrogens|mesh-ancestor
44148492|NCT00204438|Hormones|hormones|mesh-ancestor
44148493|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148494|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148495|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44249327|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249328|NCT00609401|Sorafenib|sorafenib|mesh-list
44249329|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249330|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249331|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249332|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249333|NCT00609531|Citalopram|citalopram|mesh-list
44249334|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44249335|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249336|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44249337|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249338|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249339|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
44249340|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249341|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44249342|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249343|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249344|NCT00609544|Rilonacept|rilonacept|mesh-list
44249345|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249346|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44249347|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44249348|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249349|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44249350|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249351|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249352|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249353|NCT00609557|Analgesics|analgesics|mesh-ancestor
44249354|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
44249355|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249356|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249357|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249359|NCT00609570|Calcium|calcium|mesh-list
44249360|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44249364|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44249365|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249366|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249367|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
43824225|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750190|NCT02506439|Vitamin D|vitamin d|mesh-list
44018976|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44018977|NCT03857230|Hormones|hormones|mesh-ancestor
44018978|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018979|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018980|NCT03847389|Clobetasol|clobetasol|mesh-list
44018981|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018982|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
44018983|NCT03847389|Hormones|hormones|mesh-ancestor
44018984|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018985|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018986|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44019046|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44019047|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019048|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
44019049|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
44019050|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019051|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44019052|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44019053|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019054|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019055|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
44019056|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44019057|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019058|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44019059|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44019060|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019061|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019062|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44019063|NCT03806270|Midazolam|midazolam|mesh-list
44019064|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
44019065|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44019066|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019067|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019068|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019069|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44019070|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019071|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019072|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019073|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
44019074|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
44019075|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
44019076|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
44019077|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019078|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019079|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
44019080|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
44019081|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44019082|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
44019083|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
44019084|NCT03818815|Amoxicillin|amoxicillin|mesh-list
44019085|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
44019086|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
44019087|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44019088|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019089|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019090|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44019091|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019092|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019093|NCT03812328|Enoxaparin|enoxaparin|mesh-list
44019094|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
44019095|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44019096|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019097|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249368|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249369|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249370|NCT00609752|Prednisolone|prednisolone|mesh-list
44249371|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249372|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
44249373|NCT00609752|Hormones|hormones|mesh-ancestor
44249374|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249375|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249376|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249377|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249378|NCT00609817|Dexamethasone|dexamethasone|mesh-list
44249379|NCT00609817|Bortezomib|bortezomib|mesh-list
44249380|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249381|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
44249382|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
44249383|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249384|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249385|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249386|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
44249387|NCT00609817|Hormones|hormones|mesh-ancestor
44249388|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249389|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249390|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249391|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
44249392|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249393|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
44019098|NCT03822377|Ticagrelor|ticagrelor|mesh-list
44019099|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44019100|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44019101|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44019102|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44019103|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
44019104|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019105|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019106|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019107|NCT03820388|Propofol|propofol|mesh-list
44019108|NCT03820388|Etomidate|etomidate|mesh-list
44019109|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019110|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019111|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019112|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019113|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
44019114|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
44019115|NCT03809182|Fentanyl|fentanyl|mesh-list
44019116|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
44019117|NCT03809182|Morphine|morphine|mesh-list
44019118|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019119|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019120|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249394|NCT00609856|Pioglitazone|pioglitazone|mesh-list
44249395|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249396|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249397|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
44019163|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
44019164|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019165|NCT03802864|Bupivacaine|bupivacaine|mesh-list
44019166|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019167|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
44019168|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019169|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019220|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44019221|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44019222|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019223|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
44019224|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
44019225|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019226|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019227|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
44019228|NCT03797872|Hormones|hormones|mesh-ancestor
44019229|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019230|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44019231|NCT03797872|Protective Agents|protective agents|mesh-ancestor
44019232|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019233|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019234|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44019235|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019236|NCT03797872|Analgesics|analgesics|mesh-ancestor
44019237|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
44019238|NCT03799484|Lidocaine|lidocaine|mesh-list
44019239|NCT03799484|Prilocaine|prilocaine|mesh-list
44019240|NCT03799484|Petrolatum|petrolatum|mesh-list
44019241|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
44019242|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44019243|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44019244|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019245|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
44019246|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019247|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019248|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
44019249|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019250|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44019251|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44019252|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44019253|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019254|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019255|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44019256|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
44019257|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019258|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019259|NCT03799484|Emollients|emollients|mesh-ancestor
44019260|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44019261|NCT03796260|Entrectinib|entrectinib|mesh-list
44019262|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44019462|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44019463|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44019464|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44019465|NCT03753113|Minoxidil|minoxidil|mesh-list
44019466|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019467|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
44019468|NCT03742154|Varenicline|varenicline|mesh-list
44019469|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44019470|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44019510|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019512|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019513|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44019514|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
44019515|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019516|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019517|NCT03730116|Bisoprolol|bisoprolol|mesh-list
44019518|NCT03730116|Perindopril|perindopril|mesh-list
44019519|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019520|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
44249398|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249399|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249400|NCT00609934|Sorafenib|sorafenib|mesh-list
44249401|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249402|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44019521|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
44019522|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019523|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019635|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
44019636|NCT03465735|Dabigatran|dabigatran|mesh-list
44019637|NCT03465735|Apixaban|apixaban|mesh-list
44019638|NCT03465735|Edoxaban|edoxaban|mesh-list
44019639|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
44019640|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44019641|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019642|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019643|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44019644|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
44019645|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44019646|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
44019647|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019648|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
44019649|NCT03447639|Povidone|povidone|mesh-list
44019650|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
44019651|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
44019652|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44019653|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019655|NCT03426137|Oxycodone|oxycodone|mesh-list
44019656|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44019657|NCT03426137|Narcotics|narcotics|mesh-ancestor
44019658|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019659|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019660|NCT03426137|Analgesics|analgesics|mesh-ancestor
44019661|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
44148513|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44148514|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44148515|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44148516|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44148517|NCT00204503|Valproic Acid|valproic acid|mesh-list
44148518|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
44148519|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148520|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148521|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
44148522|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148523|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148524|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
44148525|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148526|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148527|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148528|NCT00204529|Interferons|interferons|mesh-list
44148529|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
44148530|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
44148531|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44148532|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148533|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
44148534|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148535|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
44148536|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148537|NCT00204542|Diclofenac|diclofenac|mesh-list
44148538|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44148539|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44148540|NCT00204542|Analgesics|analgesics|mesh-ancestor
44148541|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
44148542|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148543|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148544|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148545|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44019681|NCT03360903|Caffeine|caffeine|mesh-list
44019682|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44019683|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019684|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44019685|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642235|NCT05476770|Methotrexate|methotrexate|mesh-list
44249403|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249404|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249405|NCT00609960|Midazolam|midazolam|mesh-list
44249406|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44249407|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44249408|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249409|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249410|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44249411|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44249412|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249413|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44249414|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
44249415|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
44249416|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
44249417|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
44249418|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249419|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249420|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44249421|NCT00609999|Dasatinib|dasatinib|mesh-list
44249422|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249423|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249424|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019686|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019687|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44019688|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44019689|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
44019690|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019691|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44019692|NCT03342157|Sennosides|sennosides|mesh-list
44062519|NCT04221477|Analgesics|analgesics|mesh-ancestor
44019693|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
44019694|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019695|NCT03342157|Laxatives|laxatives|mesh-ancestor
44019696|NCT03333746|Nivolumab|nivolumab|mesh-list
44019697|NCT03333746|Lenalidomide|lenalidomide|mesh-list
44019698|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44019699|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019700|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44019701|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019702|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
44019703|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019704|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44019705|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44019706|NCT03333746|Growth Substances|growth substances|mesh-ancestor
44019707|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
44019708|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
44019709|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019710|NCT03325114|Diuretics|diuretics|mesh-ancestor
44019711|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
44019712|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019713|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44019714|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019715|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019716|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
44249425|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249426|NCT00610038|Glyburide|glyburide|mesh-list
44249427|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249428|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249429|NCT00610077|Letrozole|letrozole|mesh-list
44249430|NCT00610077|Clomiphene|clomiphene|mesh-list
44019717|NCT03277183|Hematinics|hematinics|mesh-ancestor
44019718|NCT03248141|Factor VIII|factor viii|mesh-list
44019719|NCT03248141|Coagulants|coagulants|mesh-ancestor
44019720|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44019721|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44019722|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019723|NCT03232892|Trametinib|trametinib|mesh-list
44019800|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019905|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019906|NCT02936999|Vitamin D|vitamin d|mesh-list
44019907|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
44019908|NCT02936999|Vitamins|vitamins|mesh-ancestor
44019909|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
44019910|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019911|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44019912|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44019913|NCT02936206|Tamoxifen|tamoxifen|mesh-list
44019914|NCT02936206|Fulvestrant|fulvestrant|mesh-list
44019915|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44019916|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
44019917|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019918|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019943|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019944|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019945|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
44019947|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019948|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44019949|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44019950|NCT02826551|Bupivacaine|bupivacaine|mesh-list
44019951|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019952|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
44019953|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019954|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019955|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
44019956|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019957|NCT02774148|Acetaminophen|acetaminophen|mesh-list
44019958|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019959|NCT02774148|Analgesics|analgesics|mesh-ancestor
44019960|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
44019961|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019962|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019963|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
44019964|NCT02773576|Risperidone|risperidone|mesh-list
44019965|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44019966|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
44019967|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020073|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020074|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
44020075|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44020076|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020077|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44020078|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44020079|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44020080|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020081|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44020082|NCT02693717|Pemetrexed|pemetrexed|mesh-list
44020083|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020084|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020166|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020167|NCT02614586|Ondansetron|ondansetron|mesh-list
44020168|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
44020169|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
44020170|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249432|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
43902740|NCT00112827|Melphalan|melphalan|mesh-list
44249433|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249434|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249435|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44020171|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020172|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020173|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
44020213|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020259|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020260|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148546|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44148547|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148548|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148549|NCT00204555|Imiquimod|imiquimod|mesh-list
44148550|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44148551|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
44148552|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148553|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148554|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
44148555|NCT00204568|Doxorubicin|doxorubicin|mesh-list
44148556|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44148557|NCT00204568|Trofosfamide|trofosfamide|mesh-list
44148558|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148559|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148560|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44148561|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44148562|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148563|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148564|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148565|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
44020262|NCT02534038|Quinidine|quinidine|mesh-list
44020263|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
44020264|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
44020265|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
44020306|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44020307|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
44020308|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020309|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020310|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44020311|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020312|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
44020313|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
44020314|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020315|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020316|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
44020317|NCT02518750|Hormones|hormones|mesh-ancestor
44020318|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020323|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020324|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
44020325|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020326|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020327|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44020328|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44020329|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020330|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44020331|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44020332|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
44020333|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020334|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020335|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020336|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020337|NCT02518750|Analgesics|analgesics|mesh-ancestor
44020338|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
44020339|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44020340|NCT02515851|Bupivacaine|bupivacaine|mesh-list
44020341|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
44020342|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
44249436|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44249437|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249438|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44249439|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44249440|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249441|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249442|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44249443|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
44249444|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44249445|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44249446|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44249447|NCT00610103|Apomorphine|apomorphine|mesh-list
44249448|NCT00610103|Emetics|emetics|mesh-ancestor
44249449|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249450|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
43648008|NCT04941703|Cathartics|cathartics|mesh-ancestor
44020343|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020344|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020345|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
44020346|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020347|NCT02506985|Warfarin|warfarin|mesh-list
44020348|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
44020349|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
44020350|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44020351|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
44020352|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44020353|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020354|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020355|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020356|NCT02514252|Fentanyl|fentanyl|mesh-list
44020357|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44020358|NCT02514252|Narcotics|narcotics|mesh-ancestor
44020359|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020360|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020361|NCT02514252|Analgesics|analgesics|mesh-ancestor
44020362|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
44020363|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020364|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44020365|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020366|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
44020367|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
44020368|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
44020369|NCT02501759|Antidotes|antidotes|mesh-ancestor
44020370|NCT02501759|Protective Agents|protective agents|mesh-ancestor
44020371|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020372|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
44020373|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
44020374|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020375|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44020376|NCT02487277|Gemcitabine|gemcitabine|mesh-list
44020377|NCT02487277|Paclitaxel|paclitaxel|mesh-list
44020378|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020379|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020380|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020381|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020382|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020383|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020384|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020385|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
44249451|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249452|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249453|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
44249454|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
44249455|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249456|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249457|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
44249458|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
44249459|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249460|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249461|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020386|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
44020387|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020388|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020389|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020390|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
44020391|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020392|NCT02499887|Prednisone|prednisone|mesh-list
44020393|NCT02499887|Albuterol|albuterol|mesh-list
44020394|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020395|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
44020396|NCT02499887|Hormones|hormones|mesh-ancestor
44020397|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020398|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020425|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44020426|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44020427|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
44020428|NCT02492295|Propofol|propofol|mesh-list
44020429|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44020430|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020431|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020432|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020433|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
44020434|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
44020435|NCT02468583|Triamcinolone|triamcinolone|mesh-list
44020436|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44020437|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44020439|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44020440|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020441|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
44020442|NCT02468583|Hormones|hormones|mesh-ancestor
44020443|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020444|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020445|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020446|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
44020548|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020549|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44020550|NCT02373865|Glimepiride|glimepiride|mesh-list
44020551|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020552|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020553|NCT02373865|Incretins|incretins|mesh-ancestor
44020554|NCT02373865|Hormones|hormones|mesh-ancestor
44020555|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020556|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44020557|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020558|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020559|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020598|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44020599|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44020600|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020601|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020602|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44020603|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44249463|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
44249464|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249465|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249466|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249467|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249468|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249469|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
44249470|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44249471|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249472|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249474|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249475|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44249476|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249477|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249478|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
44020604|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020605|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020606|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
44020607|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
44020608|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
44020609|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
44020610|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020611|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020612|NCT02360059|Metformin|metformin|mesh-list
44020613|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020614|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020615|NCT02345460|Leucovorin|leucovorin|mesh-list
44020616|NCT02345460|Fluorouracil|fluorouracil|mesh-list
44020617|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
44020618|NCT02345460|Irinotecan|irinotecan|mesh-list
44020619|NCT02345460|Calcium|calcium|mesh-list
44020620|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
44020712|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020713|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020714|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020715|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020716|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062843|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
43871174|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020717|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020718|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020719|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
44020720|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020721|NCT02282332|Ticagrelor|ticagrelor|mesh-list
44020722|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44020723|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44020724|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44020725|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44020726|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
44020727|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020728|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020729|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020730|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44020731|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44020958|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020959|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249479|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44249480|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44249481|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249482|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
43648053|NCT04765111|Rituximab|rituximab|mesh-list
44020960|NCT02043860|Melphalan|melphalan|mesh-list
44020961|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
44020962|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020963|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44020964|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
44020965|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020966|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020967|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44020968|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020969|NCT02027272|Dexamethasone|dexamethasone|mesh-list
44020970|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
44020971|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020972|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
44020973|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
44020974|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020975|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020976|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020977|NCT02027272|Hormones|hormones|mesh-ancestor
44020978|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020979|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020980|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148567|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44020985|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44020986|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020987|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020988|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44020990|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020991|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44020992|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020993|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020994|NCT02015910|Incretins|incretins|mesh-ancestor
44020995|NCT02015910|Hormones|hormones|mesh-ancestor
44020996|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020997|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44020998|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020999|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021000|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021001|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
44021002|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021003|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
44021004|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44021005|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44021006|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021007|NCT01996852|Urological Agents|urological agents|mesh-ancestor
44021008|NCT01997567|Ropivacaine|ropivacaine|mesh-list
44021009|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021010|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
44021011|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021012|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021013|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
44021014|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021015|NCT01973062|Rituximab|rituximab|mesh-list
44021016|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44021017|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021018|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021019|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
44021020|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021021|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021022|NCT01974284|Ethanol|ethanol|mesh-list
44021023|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44021024|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021025|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021026|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021027|NCT01971853|Analgesics|analgesics|mesh-list
44249483|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249484|NCT00610350|Simendan|simendan|mesh-list
44249485|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44249486|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
44249487|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44021028|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
44021029|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021030|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021031|NCT01980342|Efavirenz|efavirenz|mesh-list
44021032|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44021033|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44021034|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021035|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021036|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
44021037|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021038|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44021039|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44021040|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44021041|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44021042|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44021043|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44021044|NCT01978535|Iron|iron|mesh-list
44021045|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44021046|NCT01978535|Trace Elements|trace elements|mesh-ancestor
44021047|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
44021048|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021049|NCT01978535|Hematinics|hematinics|mesh-ancestor
44021050|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43871176|NCT02641314|Propranolol|propranolol|mesh-list
44021051|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44021052|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44021053|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
44021054|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021162|NCT01851174|Antiviral Agents|antiviral agents|mesh-ancestor
44021163|NCT01851174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021164|NCT01851174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021183|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44021184|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44021186|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
44021187|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
44021188|NCT01844206|Morphine|morphine|mesh-list
44021189|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44021190|NCT01844206|Narcotics|narcotics|mesh-ancestor
44021191|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021192|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021193|NCT01844206|Analgesics|analgesics|mesh-ancestor
44021194|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
44150472|NCT00210392|Bortezomib|bortezomib|mesh-list
44021195|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021196|NCT01856361|Ramipril|ramipril|mesh-list
44021197|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44021198|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
44021199|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021200|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021201|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44021202|NCT01841931|Buprenorphine|buprenorphine|mesh-list
44021203|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44021204|NCT01841931|Naloxone|naloxone|mesh-list
44021205|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44021206|NCT01841931|Narcotics|narcotics|mesh-ancestor
44021207|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021208|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021209|NCT01841931|Analgesics|analgesics|mesh-ancestor
44021210|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
44021211|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021212|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44021213|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44021214|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
44021215|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249488|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44249489|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249490|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249491|NCT00610350|Protective Agents|protective agents|mesh-ancestor
44249492|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249493|NCT00610454|Levetiracetam|levetiracetam|mesh-list
44249494|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
44249495|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
44249496|NCT00610493|Sirolimus|sirolimus|mesh-list
44249497|NCT00610493|Bevacizumab|bevacizumab|mesh-list
44249498|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249499|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249500|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44249501|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44249502|NCT00610493|Growth Substances|growth substances|mesh-ancestor
44249503|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249504|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
44249505|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44249506|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249507|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44249508|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
44249509|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249510|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
44249511|NCT00610506|Dexetimide|dexetimide|mesh-list
44021216|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
44021217|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021218|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44021219|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44021220|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44021221|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021222|NCT01830790|Urological Agents|urological agents|mesh-ancestor
44021223|NCT01821859|Bevacizumab|bevacizumab|mesh-list
44021224|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44021225|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021226|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021227|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021228|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44021229|NCT01821859|Growth Substances|growth substances|mesh-ancestor
44021230|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021231|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
44021232|NCT01804166|Golimumab|golimumab|mesh-list
44021233|NCT01804166|Infliximab|infliximab|mesh-list
44062993|NCT03297606|Nivolumab|nivolumab|mesh-list
44021234|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021235|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021236|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021237|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44021238|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021239|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021240|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
44021241|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021242|NCT01800162|Methotrexate|methotrexate|mesh-list
43642236|NCT05476770|Fludarabine|fludarabine|mesh-list
44249513|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44249514|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43648084|NCT04661007|Lenalidomide|lenalidomide|mesh-list
44021243|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44021244|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
44021245|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021246|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021247|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021248|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
44021249|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021250|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021251|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021252|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021253|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44021254|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021255|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
44021256|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021285|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021286|NCT01784991|Morphine|morphine|mesh-list
44021287|NCT01784991|Hydromorphone|hydromorphone|mesh-list
44021288|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44021289|NCT01784991|Narcotics|narcotics|mesh-ancestor
44021290|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021291|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021292|NCT01784991|Analgesics|analgesics|mesh-ancestor
44021293|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
44021294|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021295|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44021296|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44021297|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021298|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44021299|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44021300|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021381|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44021382|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
44021383|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021384|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021385|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44021386|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
44021387|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021388|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44021389|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44021390|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44021391|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44021392|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44021393|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
44021394|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44021395|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44021396|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44021397|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44021398|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021399|NCT01718444|Hormones|hormones|mesh-ancestor
44021400|NCT01717482|Metformin|metformin|mesh-list
44021401|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44063056|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
44021402|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021403|NCT01702896|Interleukin-2|interleukin-2|mesh-list
44021404|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021405|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021406|NCT01702896|Analgesics|analgesics|mesh-ancestor
44021407|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
44021408|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021409|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021410|NCT01709136|Sirolimus|sirolimus|mesh-list
44021411|NCT01709136|Tacrolimus|tacrolimus|mesh-list
44021412|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021413|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
44021414|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021415|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44021416|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249515|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648087|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021417|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021418|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44021419|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021420|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021421|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021423|NCT01705106|Celecoxib|celecoxib|mesh-list
44021424|NCT01705106|Capecitabine|capecitabine|mesh-list
44021425|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021426|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
44021427|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021428|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021429|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44021430|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021431|NCT01705106|Analgesics|analgesics|mesh-ancestor
44021432|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
44021433|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021434|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021435|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021436|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021437|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44021438|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44021439|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021440|NCT01702909|Interleukin-2|interleukin-2|mesh-list
44021441|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021442|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021443|NCT01702909|Analgesics|analgesics|mesh-ancestor
44021444|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
44021591|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
44021592|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021593|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021594|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44021595|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
44021596|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021597|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44021598|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44021599|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44021600|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44021601|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
44021602|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44021603|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44021604|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44021605|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021606|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44021607|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44021608|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44021609|NCT01602198|Rivastigmine|rivastigmine|mesh-list
44021610|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44021611|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021612|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021613|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
44021614|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021615|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021616|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44021898|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44021899|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021900|NCT01487499|Cisplatin|cisplatin|mesh-list
44021901|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021902|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
44021903|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44021904|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44021905|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44021906|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021907|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021908|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
44021909|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021910|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021911|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44249516|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249517|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249518|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
44249519|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249520|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44249521|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
44021912|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021985|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021986|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44021987|NCT01402531|Growth Substances|growth substances|mesh-ancestor
44021988|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021989|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
44021991|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021992|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021993|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021994|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44021995|NCT01397695|Growth Substances|growth substances|mesh-ancestor
44021996|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021997|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44021998|NCT01394211|Anastrozole|anastrozole|mesh-list
44021999|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022000|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022001|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44022002|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44022003|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022004|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022005|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44022006|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022007|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022008|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022009|NCT01377441|Ibuprofen|ibuprofen|mesh-list
44022010|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44022011|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44022012|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022013|NCT01377441|Analgesics|analgesics|mesh-ancestor
44022014|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
44022015|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022016|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022017|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022018|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44022019|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022020|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022221|NCT01280643|Protective Agents|protective agents|mesh-ancestor
44022222|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
44022223|NCT01280643|Vitamins|vitamins|mesh-ancestor
44022224|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
44022225|NCT01272141|Everolimus|everolimus|mesh-list
44022226|NCT01272141|Lapatinib|lapatinib|mesh-list
44022227|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022228|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022229|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
44022230|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022231|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44022232|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022233|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148600|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148601|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
44148602|NCT00204659|Rituximab|rituximab|mesh-list
44148603|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44148604|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148605|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
44148606|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022276|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022277|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022278|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
44249522|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249523|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43648097|NCT04641104|Thiamine|thiamine|mesh-list
44022279|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022280|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022281|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022282|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
44022283|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022284|NCT01231750|Capsaicin|capsaicin|mesh-list
44022285|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
44022286|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022287|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
44022288|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022289|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022290|NCT01222871|Triamcinolone|triamcinolone|mesh-list
44022291|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022292|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
44022293|NCT01222871|Hormones|hormones|mesh-ancestor
44022294|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022295|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022296|NCT01219673|Minocycline|minocycline|mesh-list
44022297|NCT01219673|Modafinil|modafinil|mesh-list
44022298|NCT01219673|Bupropion|bupropion|mesh-list
44022299|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44022300|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
44022302|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44022303|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44022304|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022305|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752853|NCT02488616|Insulin|insulin|mesh-list
44022306|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
44022307|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022386|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022387|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44022388|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44022389|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
44022390|NCT01200602|Megestrol|megestrol|mesh-list
44022391|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
44022392|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44022393|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44022394|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44022395|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
44022396|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44022419|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44022420|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44022422|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44022423|NCT01194856|Efavirenz|efavirenz|mesh-list
44022424|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44063262|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44022425|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44022426|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
44022427|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022428|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022429|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44022430|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44022431|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
44022432|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022433|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44022434|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44022435|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44022436|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44022437|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44022438|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44022439|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44022440|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44022441|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44022442|NCT01194427|Tamoxifen|tamoxifen|mesh-list
44022443|NCT01194427|Vorinostat|vorinostat|mesh-list
44022444|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44022445|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022446|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022447|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022448|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249524|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44249525|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
44249526|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
44249527|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249528|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44249529|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44022449|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022450|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44022451|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44022484|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
44022485|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022486|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022487|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
44022488|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022490|NCT01183429|Isotretinoin|isotretinoin|mesh-list
44022491|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022492|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
44022493|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022494|NCT01169753|Modafinil|modafinil|mesh-list
44022495|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44022543|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44022544|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44022545|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44022546|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44022547|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44022548|NCT01155518|Clomiphene|clomiphene|mesh-list
44022549|NCT01155518|Testosterone|testosterone|mesh-list
44022550|NCT01155518|Androgens|androgens|mesh-ancestor
44022551|NCT01155518|Hormones|hormones|mesh-ancestor
44022552|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022553|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022554|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44022555|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022556|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44022557|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
44022649|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44022650|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
44022706|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022707|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022708|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44022709|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44022711|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44022712|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022713|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022714|NCT01074437|Prednisolone|prednisolone|mesh-list
44022715|NCT01074437|Propranolol|propranolol|mesh-list
44022716|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022717|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
44022718|NCT01074437|Hormones|hormones|mesh-ancestor
44022719|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022720|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022721|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022722|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022723|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44022781|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022783|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022784|NCT01035944|Chitosan|chitosan|mesh-list
44022785|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44022786|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022787|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
44022805|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44022807|NCT01031550|Propofol|propofol|mesh-list
44022808|NCT01031550|Isoflurane|isoflurane|mesh-list
44022809|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44022810|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44022811|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022812|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44022813|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
44022814|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
44249530|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249531|NCT00610545|Atorvastatin|atorvastatin|mesh-list
44249532|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44249533|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249534|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
44249535|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249536|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249537|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44249538|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249539|NCT00610571|Temozolomide|temozolomide|mesh-list
44022815|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44022816|NCT01025271|Daptomycin|daptomycin|mesh-list
44022817|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022818|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022819|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
44022820|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44022821|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022822|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
44022823|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022824|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022825|NCT01020903|Aprepitant|aprepitant|mesh-list
44022826|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
44022827|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
44022828|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022829|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022830|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022831|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44022832|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022833|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022834|NCT01023620|Pioglitazone|pioglitazone|mesh-list
44022835|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44022836|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022837|NCT01016561|Cisplatin|cisplatin|mesh-list
44022838|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022839|NCT01016847|Montelukast|montelukast|mesh-list
44022840|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44022841|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
44022842|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44022843|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022952|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44022954|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44022955|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44022956|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44022957|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022958|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44022959|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44022960|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022961|NCT00983645|Cyclosporine|cyclosporine|mesh-list
44022962|NCT00983645|Tacrolimus|tacrolimus|mesh-list
44022963|NCT00983645|Cyclosporins|cyclosporins|mesh-list
44022964|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022965|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
44022966|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022967|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44022968|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150505|NCT00210509|Almotriptan|almotriptan|mesh-list
44022969|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022970|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
44022971|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022972|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
44022973|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022974|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44022975|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44022976|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022977|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
43753313|NCT02485613|Dexamethasone|dexamethasone|mesh-list
44249540|NCT00610571|Topotecan|topotecan|mesh-list
44249541|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249542|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
44022978|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022979|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022980|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44022981|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148625|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
44148626|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148627|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148628|NCT00204789|Eflornithine|eflornithine|mesh-list
44157837|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157838|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44157839|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44157840|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157841|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44157842|NCT00235274|Secretin|secretin|mesh-list
44157843|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44157844|NCT00235274|Hormones|hormones|mesh-ancestor
44157845|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157846|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157847|NCT00235287|Candesartan|candesartan|mesh-list
44157848|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
44157849|NCT00235287|Enalapril|enalapril|mesh-list
44157850|NCT00235287|Enalaprilat|enalaprilat|mesh-list
44157851|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157852|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44157853|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44157854|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022982|NCT00979550|Imiquimod|imiquimod|mesh-list
44022983|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44022984|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
44022985|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022986|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022987|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
44022988|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
44022989|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44022990|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022991|NCT00981370|Deferasirox|deferasirox|mesh-list
44022992|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44022993|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
44022994|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
44022995|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022996|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44022997|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44022998|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022999|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
44023000|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023001|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44023002|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44023003|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023004|NCT00979810|Alovudine|alovudine|mesh-list
44023005|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
44023006|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023007|NCT00976339|Vitamin D|vitamin d|mesh-list
44023008|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
44023009|NCT00976339|Vitamins|vitamins|mesh-ancestor
44023010|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
44023011|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023012|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44023013|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44023014|NCT00957827|Cephalexin|cephalexin|mesh-list
44023015|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44023016|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023017|NCT00965055|Atorvastatin|atorvastatin|mesh-list
44023018|NCT00965055|Ezetimibe|ezetimibe|mesh-list
44023019|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44023020|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44023021|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
44023022|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023023|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249543|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249544|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249545|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44249546|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44249547|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249549|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44249550|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44249551|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44249552|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
44249553|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
44023024|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44023025|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023026|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
44023027|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
44023028|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023029|NCT00962429|Protective Agents|protective agents|mesh-ancestor
44023030|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023031|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
44023032|NCT00962429|Vitamins|vitamins|mesh-ancestor
44023033|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
44023034|NCT00954187|Pregabalin|pregabalin|mesh-list
44023035|NCT00954187|Gabapentin|gabapentin|mesh-list
44023036|NCT00954187|Analgesics|analgesics|mesh-ancestor
44023037|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
44023038|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023039|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023061|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023062|NCT00947284|Analgesics|analgesics|mesh-ancestor
44023063|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44023064|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023066|NCT00947791|Ketamine|ketamine|mesh-list
44023067|NCT00947791|Analgesics|analgesics|mesh-ancestor
44023068|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
44023069|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023070|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023071|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44023072|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44023073|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
44023074|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
44023075|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023076|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44023077|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44023078|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023079|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023080|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44023081|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44023082|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44023083|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023084|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023085|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
44023086|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
44023087|NCT00920309|Sirolimus|sirolimus|mesh-list
44023088|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44023089|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023090|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44023091|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023092|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
44023093|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023094|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
44023095|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023251|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023252|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44023253|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
44249554|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249555|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023255|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023256|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44023257|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023258|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
44023259|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023260|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023261|NCT00843310|Growth Substances|growth substances|mesh-ancestor
44023262|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023263|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44023264|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
44023265|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023266|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44023305|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44023306|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44023307|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44023308|NCT00832572|Ranolazine|ranolazine|mesh-list
44023309|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44023310|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023311|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023312|NCT00832299|Leucovorin|leucovorin|mesh-list
44023313|NCT00832299|Fluorouracil|fluorouracil|mesh-list
44023314|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
44023315|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
44023316|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023317|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44023318|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023319|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023320|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
44023321|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023322|NCT00832299|Antidotes|antidotes|mesh-ancestor
44023323|NCT00832299|Protective Agents|protective agents|mesh-ancestor
44023324|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
44023325|NCT00832299|Vitamins|vitamins|mesh-ancestor
44023326|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
44023327|NCT00836355|Minocycline|minocycline|mesh-list
44023399|NCT00801931|Busulfan|busulfan|mesh-list
44023400|NCT00801931|Thiotepa|thiotepa|mesh-list
44023401|NCT00801931|Fludarabine|fludarabine|mesh-list
44023402|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
44023403|NCT00801931|Phenytoin|phenytoin|mesh-list
44023404|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
44023405|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
44023406|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44023407|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023408|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
44023409|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023410|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023411|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44023412|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
44023413|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023414|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023415|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44023416|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023417|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
44023418|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44023419|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44023420|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023421|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44023422|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44023423|NCT00793520|Milnacipran|milnacipran|mesh-list
44023424|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
44023425|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44023426|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023427|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023428|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023429|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023430|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023431|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44023432|NCT00793520|Analgesics|analgesics|mesh-ancestor
44249556|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249557|NCT00610610|Paroxetine|paroxetine|mesh-list
44249558|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44249559|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249560|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023433|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
44023434|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023435|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023437|NCT00795236|Melatonin|melatonin|mesh-list
44023438|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
44023439|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023440|NCT00795236|Protective Agents|protective agents|mesh-ancestor
44023441|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023442|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023443|NCT00799773|Rituximab|rituximab|mesh-list
44023444|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023445|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023446|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
44023447|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023448|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023449|NCT00795665|Bevacizumab|bevacizumab|mesh-list
44023450|NCT00795665|Carmustine|carmustine|mesh-list
44023451|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023452|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023686|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023687|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023689|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
44023690|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023691|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
44023692|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023693|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
44023694|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148652|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44148653|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
44148654|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148655|NCT00204984|Hydralazine|hydralazine|mesh-list
44148656|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44148657|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
44148658|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148659|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44148660|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
44148661|NCT00205166|Caffeine|caffeine|mesh-list
44148662|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44148663|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148664|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44148665|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148666|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148667|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44148668|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44148669|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
44148670|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148671|NCT00205231|Etanercept|etanercept|mesh-list
44148672|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44148673|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44148674|NCT00205231|Analgesics|analgesics|mesh-ancestor
44148675|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
44148676|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148677|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148678|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148679|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148680|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148681|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148682|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
44148683|NCT00205283|Nelfinavir|nelfinavir|mesh-list
43753953|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44148684|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44148685|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44148686|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
44148687|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249561|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249562|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249563|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
44249564|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249565|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44249566|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249567|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249568|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44249569|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44023695|NCT00716807|Nalbuphine|nalbuphine|mesh-list
44023696|NCT00716807|Naloxone|naloxone|mesh-list
44023697|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44023706|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44023707|NCT00703885|Alprazolam|alprazolam|mesh-list
44023708|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44023709|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023710|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023711|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44023712|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023713|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023714|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
44023715|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
44023716|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023717|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023718|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
44023719|NCT00704496|Ephedrine|ephedrine|mesh-list
44023720|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44023721|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
44023722|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023723|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023724|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44023725|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023726|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
44023727|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44023728|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44023729|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
44023730|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
44023731|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023732|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023733|NCT00703339|Treprostinil|treprostinil|mesh-list
44023734|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44023735|NCT00691444|Melatonin|melatonin|mesh-list
44023736|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
44023737|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023738|NCT00691444|Protective Agents|protective agents|mesh-ancestor
44023739|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023740|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023741|NCT00691652|Rituximab|rituximab|mesh-list
44023742|NCT00691652|Clofarabine|clofarabine|mesh-list
44023743|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063687|NCT00006082|Rubitecan|rubitecan|mesh-list
44023744|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023745|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
44023746|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023747|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023748|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44023749|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
44023750|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023751|NCT00691574|Melatonin|melatonin|mesh-list
44023752|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
44023753|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023754|NCT00691574|Protective Agents|protective agents|mesh-ancestor
44023755|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023756|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023757|NCT00692094|Melatonin|melatonin|mesh-list
44249570|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249571|NCT00610623|Azithromycin|azithromycin|mesh-list
44249572|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44249573|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249574|NCT00610792|Doxorubicin|doxorubicin|mesh-list
44023758|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
44023759|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023760|NCT00692094|Protective Agents|protective agents|mesh-ancestor
44023761|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023762|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023763|NCT00676026|Zolpidem|zolpidem|mesh-list
44023764|NCT00676026|Fluoxetine|fluoxetine|mesh-list
44023765|NCT00676026|Progesterone|progesterone|mesh-list
44023776|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44023777|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023778|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023779|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44023780|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44023781|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023782|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44023783|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44023784|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023785|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44023786|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
44023787|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
44023788|NCT00678574|Fluoxetine|fluoxetine|mesh-list
44023789|NCT00678574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44023790|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023791|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023792|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023793|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023794|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
44023795|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023796|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44023797|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023798|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023799|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44023800|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44023801|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023802|NCT00688935|Melatonin|melatonin|mesh-list
44023803|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
44023804|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023805|NCT00688935|Protective Agents|protective agents|mesh-ancestor
44023806|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023807|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023808|NCT00685880|Betamethasone|betamethasone|mesh-list
44023809|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
44023810|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023811|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
44023812|NCT00685880|Hormones|hormones|mesh-ancestor
44023813|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023814|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023815|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44023816|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023817|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44023818|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
44023819|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023820|NCT00681044|Melphalan|melphalan|mesh-list
44023821|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
44023822|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023823|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44023824|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
44023825|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023826|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023845|NCT00673309|Insulin|insulin|mesh-list
44023846|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44023847|NCT00673309|Itraconazole|itraconazole|mesh-list
44023848|NCT00673309|Propranolol|propranolol|mesh-list
44023849|NCT00673309|Hormones|hormones|mesh-list
44023850|NCT00673309|Oxandrolone|oxandrolone|mesh-list
44249575|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44249576|NCT00610792|Bortezomib|bortezomib|mesh-list
44249577|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44249578|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023851|NCT00673309|Nandrolone|nandrolone|mesh-list
44023852|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44023853|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023854|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023855|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023856|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
44023857|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023858|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44023859|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44023860|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023861|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44023862|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
44023863|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44023864|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44023865|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44023866|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
44023867|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023868|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44023869|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44023870|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
44023871|NCT00673309|Androgens|androgens|mesh-ancestor
44023872|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
44023873|NCT00673595|Varenicline|varenicline|mesh-list
44023874|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44023875|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44023876|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023877|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023878|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023879|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023880|NCT00668785|Ranibizumab|ranibizumab|mesh-list
44023881|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023882|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023883|NCT00668785|Growth Substances|growth substances|mesh-ancestor
44023884|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023909|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023910|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
44023911|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023912|NCT00655057|Citalopram|citalopram|mesh-list
44023913|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44023914|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023915|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023916|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023917|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023919|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023920|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44023921|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023922|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023923|NCT00652457|Memantine|memantine|mesh-list
44023924|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44023925|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44023926|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
44023927|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023928|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023929|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023930|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44023931|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44023932|NCT00642603|Bevacizumab|bevacizumab|mesh-list
44023933|NCT00642603|Capecitabine|capecitabine|mesh-list
44023934|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
44023935|NCT00642603|Irinotecan|irinotecan|mesh-list
44023936|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023937|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023971|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
44023972|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44023973|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44023975|NCT00634322|Antidotes|antidotes|mesh-ancestor
44249579|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44249580|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44249581|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023976|NCT00634322|Protective Agents|protective agents|mesh-ancestor
44023977|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024010|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44024011|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024012|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44024013|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44024014|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024015|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024016|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44024017|NCT00623974|Vitamins|vitamins|mesh-ancestor
44024018|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
44024019|NCT00624650|Phenylephrine|phenylephrine|mesh-list
44024020|NCT00624650|Dobutamine|dobutamine|mesh-list
44024021|NCT00624650|Furosemide|furosemide|mesh-list
44024022|NCT00624650|Vasopressins|vasopressins|mesh-list
44024023|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
44024024|NCT00624650|Epinephrine|epinephrine|mesh-list
44024025|NCT00624650|Racepinephrine|racepinephrine|mesh-list
44024026|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
44024027|NCT00624650|Norepinephrine|norepinephrine|mesh-list
44024028|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44024070|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024071|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024072|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
44024073|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024074|NCT00616343|Zonisamide|zonisamide|mesh-list
44024075|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
44024076|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44024077|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024078|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024079|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44024080|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024081|NCT00610532|Probenecid|probenecid|mesh-list
44024082|NCT00610532|Phenytoin|phenytoin|mesh-list
44024083|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
44024084|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44024085|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44024086|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024087|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024088|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44024110|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44024112|NCT00608777|Hormones|hormones|mesh-ancestor
44024113|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024114|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024115|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44024116|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
44024117|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024118|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44024119|NCT00601848|Trioxsalen|trioxsalen|mesh-list
44024120|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024121|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024122|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44024123|NCT00607477|Minoxidil|minoxidil|mesh-list
44024124|NCT00607477|Hydralazine|hydralazine|mesh-list
44024125|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024126|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024127|NCT00599131|Cisplatin|cisplatin|mesh-list
44024128|NCT00599131|Docetaxel|docetaxel|mesh-list
44024129|NCT00599131|Fluorouracil|fluorouracil|mesh-list
44024130|NCT00599131|Cetuximab|cetuximab|mesh-list
44024131|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024132|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024133|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024134|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024135|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024137|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024138|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024139|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
44024140|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024141|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249582|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249583|NCT00610818|Mitogens|mitogens|mesh-list
44249584|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
44249585|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024142|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
44024143|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
44024166|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44024167|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44024168|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
44024169|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024170|NCT00588471|Simvastatin|simvastatin|mesh-list
44024171|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024172|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024173|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
44024174|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024175|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024176|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024177|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024178|NCT00585611|Atorvastatin|atorvastatin|mesh-list
44024179|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024180|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024181|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
44024182|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024183|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024184|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024185|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024186|NCT00572260|Daptomycin|daptomycin|mesh-list
44024187|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024188|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024189|NCT00571194|Pravastatin|pravastatin|mesh-list
44024190|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024191|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024192|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
44024193|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024194|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024195|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024196|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024197|NCT00584935|Rituximab|rituximab|mesh-list
44024198|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024266|NCT05600686|Hormones|hormones|mesh-ancestor
44024267|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024268|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024269|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44024270|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024339|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44024340|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
44024341|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024342|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024343|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44024344|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024345|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
44024346|NCT05599919|Protective Agents|protective agents|mesh-ancestor
44024347|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44024348|NCT05599828|Omeprazole|omeprazole|mesh-list
44024349|NCT05599828|Famotidine|famotidine|mesh-list
44024350|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44024351|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44024352|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44024353|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024428|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44024429|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44024430|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024431|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024432|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44024433|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44024434|NCT05594407|Analgesics|analgesics|mesh-ancestor
44024435|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44249586|NCT00610870|Atorvastatin|atorvastatin|mesh-list
44249587|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44249588|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024436|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44024437|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44024438|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024439|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148695|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
44024440|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44024441|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44024442|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
44024443|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44024444|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44024445|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44024446|NCT05594407|Narcotics|narcotics|mesh-ancestor
44024447|NCT05550519|Tenofovir|tenofovir|mesh-list
44024448|NCT05550519|Entecavir|entecavir|mesh-list
44024449|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
44148698|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148699|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148700|NCT00205322|Antidotes|antidotes|mesh-ancestor
44148701|NCT00205322|Protective Agents|protective agents|mesh-ancestor
44148702|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148703|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
44148704|NCT00205322|Vitamins|vitamins|mesh-ancestor
44148705|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
44148706|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44148707|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
44148708|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148709|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44148710|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44148711|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44148746|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
44148747|NCT00205738|Olanzapine|olanzapine|mesh-list
44148748|NCT00205738|Risperidone|risperidone|mesh-list
44148749|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44024535|NCT05494125|Ropivacaine|ropivacaine|mesh-list
44024601|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024602|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024603|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024604|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754758|NCT02477072|Heparin|heparin|mesh-list
44148799|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148800|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44148801|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148802|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
44148803|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148804|NCT00205816|Tigecycline|tigecycline|mesh-list
44148805|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148806|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148807|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44148808|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148809|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148810|NCT00205842|Alvimopan|alvimopan|mesh-list
44148811|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148812|NCT00205946|Bupropion|bupropion|mesh-list
44148813|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43754851|NCT02476708|Analgesics|analgesics|mesh-ancestor
44024695|NCT04841369|Vaccines|vaccines|mesh-list
44024696|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
44024697|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024698|NCT04840992|Vaccines|vaccines|mesh-list
44024699|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
44024700|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024701|NCT04828057|Timolol|timolol|mesh-list
44024702|NCT04828057|Bimatoprost|bimatoprost|mesh-list
44024703|NCT04828057|Travoprost|travoprost|mesh-list
44024704|NCT04828057|Latanoprost|latanoprost|mesh-list
44024738|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44024739|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
44024740|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249589|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
44249590|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249591|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249592|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44249593|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249594|NCT00610909|Paroxetine|paroxetine|mesh-list
44249595|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44249596|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44249597|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44249598|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249599|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249600|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
44249601|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249602|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44249603|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249604|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249605|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44249606|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44249607|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249608|NCT00610948|Leucovorin|leucovorin|mesh-list
44249609|NCT00610948|Fluorouracil|fluorouracil|mesh-list
44249610|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
44249611|NCT00610948|Everolimus|everolimus|mesh-list
44249612|NCT00610948|Panitumumab|panitumumab|mesh-list
44249613|NCT00610948|Calcium|calcium|mesh-list
44249614|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
43648161|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
44024741|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024742|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44024743|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024744|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
44024745|NCT04755647|Protective Agents|protective agents|mesh-ancestor
44024769|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024770|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
44024771|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024772|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024773|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024774|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024775|NCT04566770|Vaccines|vaccines|mesh-list
44024776|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
44024777|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024778|NCT04499924|Paclitaxel|paclitaxel|mesh-list
44024779|NCT04499924|Trastuzumab|trastuzumab|mesh-list
44024780|NCT04499924|Ramucirumab|ramucirumab|mesh-list
44024781|NCT04499924|Tucatinib|tucatinib|mesh-list
44024782|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44024783|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024784|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
44249615|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44249616|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249617|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
44024785|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024786|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024787|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024788|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024789|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024790|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024791|NCT04429880|Oxytocin|oxytocin|mesh-list
44024792|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
44024793|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44024794|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024795|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
44024796|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44024797|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024798|NCT04375631|Cytarabine|cytarabine|mesh-list
44024799|NCT04375631|Cyclosporine|cyclosporine|mesh-list
44024800|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
44024874|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44024876|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063441|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024877|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024878|NCT04266197|Urological Agents|urological agents|mesh-ancestor
44024879|NCT04246723|Ritonavir|ritonavir|mesh-list
44024880|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
44024881|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44024882|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44024883|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
44024884|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024885|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024886|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44024942|NCT04043520|Estrogens|estrogens|mesh-list
44024943|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44024944|NCT04043520|Hormones|hormones|mesh-ancestor
44024945|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024946|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025076|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025077|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
44025078|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025079|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025080|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025081|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
44025082|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025083|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025084|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025085|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44025086|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44025087|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
44025088|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44025089|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025090|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025091|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
44025093|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025094|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025095|NCT03055247|Analgesics|analgesics|mesh-ancestor
44025096|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
44025097|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025098|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025099|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025100|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025101|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025102|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025103|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025104|NCT02953665|Liraglutide|liraglutide|mesh-list
44025105|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44025106|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025107|NCT02953665|Incretins|incretins|mesh-ancestor
44025108|NCT02953665|Hormones|hormones|mesh-ancestor
44025109|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44025110|NCT02921906|Acetaminophen|acetaminophen|mesh-list
44249618|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648185|NCT04341779|Tenofovir|tenofovir|mesh-list
44025111|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025112|NCT02921906|Analgesics|analgesics|mesh-ancestor
44025146|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025147|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44025148|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44025149|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
44025150|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
44025151|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44025152|NCT02598778|Listerine|listerine|mesh-list
44025153|NCT02598778|Fluorides|fluorides|mesh-list
44025154|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
44025155|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
44025179|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025180|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025181|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025182|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
44025183|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025185|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
44025186|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025187|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44025188|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44025189|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
44025190|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025191|NCT02411526|Risperidone|risperidone|mesh-list
44025192|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44025193|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
44025194|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025195|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025196|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025197|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44025198|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44025199|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025200|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025201|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44025202|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
44025203|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
44025204|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44025205|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
44025206|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
44025208|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
44025209|NCT01807611|Thiotepa|thiotepa|mesh-list
44025210|NCT01807611|Fludarabine|fludarabine|mesh-list
44025211|NCT01807611|Lenograstim|lenograstim|mesh-list
44025220|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025221|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44025222|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44025223|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
44025224|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44025225|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025226|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025227|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44148844|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148845|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
44148846|NCT00206089|Ximelagatran|ximelagatran|mesh-list
44148847|NCT00206089|Melagatran|melagatran|mesh-list
44148848|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
44148849|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44148850|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
44148851|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148852|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148853|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
44148854|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44148855|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148856|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148857|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148858|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148859|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148860|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148861|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44148862|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148863|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148864|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148865|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44249619|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44249620|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249621|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249622|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
44249624|NCT00610948|Protective Agents|protective agents|mesh-ancestor
44148866|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148867|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148868|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44148869|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148870|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148871|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148872|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148873|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148874|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148876|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
44063442|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
44148877|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148878|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44148879|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
44148880|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148881|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148882|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44148883|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148884|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
44148885|NCT00206154|Hormones|hormones|mesh-ancestor
44148886|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148887|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44148888|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44148889|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44025228|NCT01795586|Carboplatin|carboplatin|mesh-list
44025229|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025230|NCT01692717|Losartan|losartan|mesh-list
44025231|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44025232|NCT01692717|Atorvastatin|atorvastatin|mesh-list
44025245|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
44025246|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025247|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44025248|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44025250|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44025251|NCT01692171|Tinzaparin|tinzaparin|mesh-list
44025252|NCT01692171|Dalteparin|dalteparin|mesh-list
44025253|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
44025254|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44025255|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44025256|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025257|NCT01692158|Heparin|heparin|mesh-list
44025258|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44025259|NCT01692158|Tinzaparin|tinzaparin|mesh-list
44025260|NCT01692158|Dalteparin|dalteparin|mesh-list
44025261|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
44025262|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44025263|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44025264|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025265|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
44025266|NCT01685333|Hematinics|hematinics|mesh-ancestor
44025267|NCT01475500|Dimercaprol|dimercaprol|mesh-list
44025268|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
44025269|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
44025270|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025271|NCT01376505|Vaccines|vaccines|mesh-list
44025272|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
44025273|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025274|NCT01055756|Loratadine|loratadine|mesh-list
44025275|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
44025276|NCT01055756|Ephedrine|ephedrine|mesh-list
44025277|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
44025278|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025279|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44025280|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44025281|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44249625|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
44249626|NCT00610948|Vitamins|vitamins|mesh-ancestor
44249627|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
44025282|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
44025283|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
44025284|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025285|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025286|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025287|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44025288|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
44025289|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025290|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44025291|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
44025292|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
44025293|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44025294|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44025331|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025332|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025333|NCT00558870|Analgesics|analgesics|mesh-ancestor
44025339|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
44025340|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44025341|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44025342|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025343|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44025344|NCT00521924|Cyclosporine|cyclosporine|mesh-list
44025345|NCT00521924|Chloroquine|chloroquine|mesh-list
44025346|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
44025347|NCT00521924|Methotrexate|methotrexate|mesh-list
44025348|NCT00521924|Infliximab|infliximab|mesh-list
44025349|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
44025350|NCT00521924|Cyclosporins|cyclosporins|mesh-list
44025351|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44025352|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
44025353|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44025354|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025355|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025356|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
44025357|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025358|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025359|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025360|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025361|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44025362|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025363|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
44025364|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44025365|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
44025366|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025367|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44025368|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44025370|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44025371|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44025372|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
44025373|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025374|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025375|NCT00521924|Analgesics|analgesics|mesh-ancestor
44025376|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
44025377|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025378|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025379|NCT00548886|Epinephrine|epinephrine|mesh-list
44025380|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44025381|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44025382|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44025383|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025384|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025385|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025386|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44025387|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44025388|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
44025389|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025390|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44025391|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
44249628|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249630|NCT00611000|Hematinics|hematinics|mesh-ancestor
44249631|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
44249632|NCT00611000|Vitamins|vitamins|mesh-ancestor
44249633|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
44025392|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
44025393|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
44025394|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44025395|NCT00542542|Fentanyl|fentanyl|mesh-list
44025396|NCT00542542|Midazolam|midazolam|mesh-list
44025397|NCT00542542|Propofol|propofol|mesh-list
44025398|NCT00542542|Ropivacaine|ropivacaine|mesh-list
44025399|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44025400|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025401|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025402|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44025403|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
44025404|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
44025405|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44025425|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025426|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025427|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025428|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
44064381|NCT00006208|Emtricitabine|emtricitabine|mesh-list
44025429|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025430|NCT00539617|Antidotes|antidotes|mesh-ancestor
44025431|NCT00539617|Protective Agents|protective agents|mesh-ancestor
44025432|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
44025434|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
44025435|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025436|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025437|NCT00546455|Fenretinide|fenretinide|mesh-list
44025439|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44025440|NCT00546455|Protective Agents|protective agents|mesh-ancestor
44025441|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025442|NCT00538980|Dasatinib|dasatinib|mesh-list
44025443|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025444|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025445|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025446|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025447|NCT00529282|Vancomycin|vancomycin|mesh-list
44025448|NCT00529282|Cefepime|cefepime|mesh-list
44025449|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
44025450|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44025451|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44025452|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025453|NCT00528437|Carboplatin|carboplatin|mesh-list
44025454|NCT00528437|Temozolomide|temozolomide|mesh-list
44025455|NCT00528437|Thiotepa|thiotepa|mesh-list
44025456|NCT00528437|Tretinoin|tretinoin|mesh-list
44025457|NCT00528437|Isotretinoin|isotretinoin|mesh-list
44025458|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025459|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025460|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
44148890|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
44025461|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025462|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025463|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025464|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
44025465|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025480|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025481|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025482|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025483|NCT00523809|Bevacizumab|bevacizumab|mesh-list
44025484|NCT00523809|Fludarabine|fludarabine|mesh-list
44025485|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
44025487|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
44025488|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44025489|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025490|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025491|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44025492|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44025493|NCT00523809|Growth Substances|growth substances|mesh-ancestor
43642237|NCT05476770|Vincristine|vincristine|mesh-list
44249634|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460343|NCT01565148|Growth Substances|growth substances|mesh-ancestor
44460344|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460345|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
44460346|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460347|NCT01565083|Trastuzumab|trastuzumab|mesh-list
44460348|NCT01565083|Pertuzumab|pertuzumab|mesh-list
44025494|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025495|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
44025496|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025497|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
44025498|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025499|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025500|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
44025501|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025502|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
44025503|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025504|NCT00506064|Melatonin|melatonin|mesh-list
44025505|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
44064452|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44025506|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025507|NCT00506064|Protective Agents|protective agents|mesh-ancestor
44025508|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025509|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025510|NCT00503880|Cytarabine|cytarabine|mesh-list
44025511|NCT00503880|Clofarabine|clofarabine|mesh-list
44025512|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025513|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
44025514|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025515|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025516|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
44025517|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025518|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025519|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
44025520|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025521|NCT00506909|Oxytocin|oxytocin|mesh-list
44025522|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
44025523|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44025524|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025525|NCT00500045|Niacin|niacin|mesh-list
44025526|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
44025527|NCT00500045|Niacinamide|niacinamide|mesh-list
44025528|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44025529|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
44025530|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025531|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44025532|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
44025533|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
44025534|NCT00500045|Vitamins|vitamins|mesh-ancestor
44025535|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
43755601|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
44025536|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025537|NCT00501345|Aspirin|aspirin|mesh-list
44025538|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025539|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025540|NCT00501345|Analgesics|analgesics|mesh-ancestor
44025541|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
44025542|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025543|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025544|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025545|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025546|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44025547|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44025548|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025549|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44025550|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025551|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025552|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
44025553|NCT00496756|Sorafenib|sorafenib|mesh-list
44025554|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460349|NCT01565083|Vinorelbine|vinorelbine|mesh-list
44460350|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460351|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460352|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44460353|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44460354|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025555|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025556|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025557|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025558|NCT00495716|Acyclovir|acyclovir|mesh-list
44025559|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
44025560|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025561|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
44025562|NCT00500890|Carboplatin|carboplatin|mesh-list
44025563|NCT00500890|Etoposide|etoposide|mesh-list
44025564|NCT00500890|Vincristine|vincristine|mesh-list
44025565|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025566|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
44025567|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025568|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025569|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025570|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
44025571|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025572|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025573|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025574|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025575|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44025576|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44025577|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025578|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025579|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025580|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025581|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
44025582|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025583|NCT00487461|Simvastatin|simvastatin|mesh-list
44025584|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44025585|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44025586|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
44025587|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025588|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44025589|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44025590|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025591|NCT00484718|Celecoxib|celecoxib|mesh-list
44025592|NCT00484718|Oxycodone|oxycodone|mesh-list
44025593|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44025594|NCT00484718|Narcotics|narcotics|mesh-ancestor
44025595|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025596|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025597|NCT00484718|Analgesics|analgesics|mesh-ancestor
44025598|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
44025599|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025600|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025601|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025602|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025603|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025604|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44025605|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025606|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025607|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025608|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44025609|NCT00476827|Gemcitabine|gemcitabine|mesh-list
44025610|NCT00476827|Paclitaxel|paclitaxel|mesh-list
44025611|NCT00476827|Vinorelbine|vinorelbine|mesh-list
44025613|NCT00476827|Bevacizumab|bevacizumab|mesh-list
44025614|NCT00476827|Irinotecan|irinotecan|mesh-list
44025615|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025616|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025617|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025618|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025619|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460355|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460356|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460357|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44460358|NCT01564862|Vortioxetine|vortioxetine|mesh-list
44460359|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44460360|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44460361|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460362|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460363|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249635|NCT00611039|Ritonavir|ritonavir|mesh-list
44249636|NCT00611039|Darunavir|darunavir|mesh-list
44249637|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44249638|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44249639|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
44249640|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249641|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249642|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44249643|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44249644|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
44249645|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025620|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025621|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025622|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44025623|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44025624|NCT00476827|Growth Substances|growth substances|mesh-ancestor
44025625|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025626|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
44025627|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025628|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
44025629|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
44025630|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025631|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025632|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025633|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
44025634|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44025635|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44025636|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44025637|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44025638|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
44025639|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025640|NCT00459121|Paclitaxel|paclitaxel|mesh-list
44025641|NCT00459121|Carboplatin|carboplatin|mesh-list
44025642|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025643|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025644|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025645|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025646|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025647|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025648|NCT00456989|Docetaxel|docetaxel|mesh-list
44025649|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025650|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025651|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
44249646|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44249647|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44249649|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43648232|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
44025652|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025653|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025654|NCT00448682|Leucovorin|leucovorin|mesh-list
44025655|NCT00448682|Docetaxel|docetaxel|mesh-list
44025656|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
44025657|NCT00448682|Floxuridine|floxuridine|mesh-list
44025658|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
44025659|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025660|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025661|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025662|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025663|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025664|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025665|NCT00448682|Antidotes|antidotes|mesh-ancestor
44025666|NCT00448682|Protective Agents|protective agents|mesh-ancestor
44025667|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
44025668|NCT00448682|Vitamins|vitamins|mesh-ancestor
44025669|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
44025670|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025671|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
44025672|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44025673|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025674|NCT00428207|Insulin|insulin|mesh-list
44025675|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44025676|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
44025677|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
44025678|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44025679|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
44025680|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44025681|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025683|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44025684|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
44025685|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025686|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025687|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025688|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44025689|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44025690|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025691|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025692|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44025693|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
44025694|NCT00374543|Ziprasidone|ziprasidone|mesh-list
44025695|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44025696|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
44025697|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025698|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025699|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025700|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44025701|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44025702|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025703|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025704|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44025705|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
44025706|NCT00368654|Methotrexate|methotrexate|mesh-list
44025707|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44025708|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
44025709|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44025710|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025711|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025712|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
44025713|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025714|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025715|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025716|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025717|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44025718|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249650|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249651|NCT05331053|Atorvastatin|atorvastatin|mesh-list
44249652|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44025719|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
44025720|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025721|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44025722|NCT00356187|Propranolol|propranolol|mesh-list
44025723|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44025724|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44025725|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44025726|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025727|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025728|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025729|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44025730|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44025731|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44025732|NCT00325572|Ascorbic Acid|ascorbic acid|mesh-list
44025733|NCT00325572|Vitamins|vitamins|mesh-ancestor
44025734|NCT00325572|Micronutrients|micronutrients|mesh-ancestor
44025735|NCT00325572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025736|NCT00325572|Antioxidants|antioxidants|mesh-ancestor
44025737|NCT00325572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025738|NCT00325572|Protective Agents|protective agents|mesh-ancestor
44025739|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44025740|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44025741|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44025742|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
44025743|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025744|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025745|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025746|NCT00323635|Urological Agents|urological agents|mesh-ancestor
44025747|NCT00329732|Lidocaine|lidocaine|mesh-list
44025748|NCT00329732|Bupivacaine|bupivacaine|mesh-list
44025749|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
44025750|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
44025751|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025752|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025753|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
44025754|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025755|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44025756|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44025757|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44025758|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44025759|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025760|NCT00314353|Bevacizumab|bevacizumab|mesh-list
44025761|NCT00314353|Capecitabine|capecitabine|mesh-list
44025762|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
44025763|NCT00314353|Irinotecan|irinotecan|mesh-list
44025764|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025765|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025766|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44025767|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44025768|NCT00314353|Growth Substances|growth substances|mesh-ancestor
44025769|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025770|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
44025771|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025772|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
44025773|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025774|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44025775|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44025776|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025778|NCT00305643|Capecitabine|capecitabine|mesh-list
44025779|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025780|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
44025781|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025782|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025783|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025784|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025785|NCT00305643|Analgesics|analgesics|mesh-ancestor
44025786|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
44025787|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249653|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249654|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
44249655|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249656|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44025788|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025789|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025790|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025791|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44025792|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025793|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025794|NCT00299195|Sulindac|sulindac|mesh-list
44025795|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025796|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025797|NCT00299195|Analgesics|analgesics|mesh-ancestor
44025798|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
44025799|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025800|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025801|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025802|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025803|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025804|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025805|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025806|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025807|NCT00279409|Aripiprazole|aripiprazole|mesh-list
44025808|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
44025809|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025810|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44025811|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44025812|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025813|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025814|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
44025815|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
44025816|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025817|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025818|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44025819|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44025820|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
44025821|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44025822|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44025823|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44025824|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44025825|NCT00281879|Cytarabine|cytarabine|mesh-list
44025826|NCT00281879|Cyclosporine|cyclosporine|mesh-list
44025827|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
44025828|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
44025829|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
44025830|NCT00281879|Melphalan|melphalan|mesh-list
44025832|NCT00281879|Carmustine|carmustine|mesh-list
44025833|NCT00281879|Methotrexate|methotrexate|mesh-list
44025834|NCT00281879|Fludarabine|fludarabine|mesh-list
44025835|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
44025836|NCT00281879|Etoposide|etoposide|mesh-list
44025837|NCT00281879|Tacrolimus|tacrolimus|mesh-list
44025838|NCT00281879|Cyclosporins|cyclosporins|mesh-list
44025839|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44025840|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025841|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
44025842|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025843|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025844|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025845|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
44025846|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025847|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025848|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44025849|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44025850|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
44025851|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44025852|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025853|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
44025854|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249657|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44249658|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249659|NCT05330390|Levetiracetam|levetiracetam|mesh-list
44025855|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025856|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44025857|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44025858|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025859|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44025860|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44025861|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
44025862|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025863|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44025864|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
44025865|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44025866|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44025867|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
44025868|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44025869|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025870|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
44025871|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
44025872|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025873|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44025874|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
44025875|NCT00281879|Hormones|hormones|mesh-ancestor
44025876|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44025877|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44025878|NCT00281879|Protective Agents|protective agents|mesh-ancestor
44025879|NCT00271011|Irinotecan|irinotecan|mesh-list
44025880|NCT00271011|Cetuximab|cetuximab|mesh-list
44025881|NCT00271011|Mitomycins|mitomycins|mesh-list
44025882|NCT00271011|Mitomycin|mitomycin|mesh-list
44025883|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44025884|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44025885|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025886|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025887|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025888|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025889|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44025890|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
44025891|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44025892|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
44025893|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025894|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025895|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025896|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025897|NCT00268450|Gemcitabine|gemcitabine|mesh-list
44025899|NCT00268450|Bevacizumab|bevacizumab|mesh-list
44025900|NCT00268450|Cisplatin|cisplatin|mesh-list
44025901|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025902|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025903|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025904|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025905|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025906|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025907|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025924|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44025925|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44025926|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025927|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025929|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025930|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44025931|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
44025932|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025933|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44025934|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44025935|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
44025936|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
44025937|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025938|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44025939|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44025940|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249660|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
44249661|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
44249662|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
44249663|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44249664|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44025941|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44025942|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44025943|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44025944|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44025945|NCT00240227|Prazosin|prazosin|mesh-list
44025946|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44025947|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44025948|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44025949|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44025950|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
44025951|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025952|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025953|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025954|NCT00233090|Modafinil|modafinil|mesh-list
44025955|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44025956|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025957|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44025958|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44025959|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44025960|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025961|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
44025962|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44025963|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025964|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025965|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44025966|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44025967|NCT00205049|Protective Agents|protective agents|mesh-ancestor
44025968|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025969|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
44025970|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44148891|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148892|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148893|NCT00206167|Budesonide|budesonide|mesh-list
44148894|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
44148895|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148896|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44148897|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
44148898|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148899|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148900|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44148901|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148902|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
44148903|NCT00206167|Hormones|hormones|mesh-ancestor
44148904|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148905|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44025972|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
44025973|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44025974|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025975|NCT00183963|Tamoxifen|tamoxifen|mesh-list
44025976|NCT00183963|Fulvestrant|fulvestrant|mesh-list
44025977|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44025978|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
44025979|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44025980|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025981|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44025982|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025983|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44025984|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44025985|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44025986|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44025987|NCT00176631|Docetaxel|docetaxel|mesh-list
44025988|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025989|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
44249665|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43648242|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44025990|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025991|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025992|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025993|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
44025994|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44025995|NCT00177970|Antibodies|antibodies|mesh-list
44025996|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
44025997|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
44025998|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44025999|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
44026000|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026001|NCT00177866|Celecoxib|celecoxib|mesh-list
44026002|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44026003|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026004|NCT00177866|Analgesics|analgesics|mesh-ancestor
44026005|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
44026006|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026007|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026008|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026009|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44026010|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44026011|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44026012|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026013|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026014|NCT00145704|Vitamin D|vitamin d|mesh-list
44026015|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
44026016|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
44026017|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
44026018|NCT00145704|Diphosphonates|diphosphonates|mesh-list
44026019|NCT00145704|Vitamins|vitamins|mesh-list
44026020|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
44026021|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026022|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44026023|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44026024|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44026025|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026026|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026028|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
44026029|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44026030|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44026031|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026032|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026033|NCT00133679|Urological Agents|urological agents|mesh-ancestor
44026035|NCT00118053|Docetaxel|docetaxel|mesh-list
44026036|NCT00118053|Trastuzumab|trastuzumab|mesh-list
44026037|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026038|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44026039|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44026040|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44026041|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026042|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44026043|NCT00108342|Nicotine|nicotine|mesh-list
44026044|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44026045|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
44026046|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026047|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026048|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44026049|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44026050|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
44026051|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026052|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026053|NCT00089414|Drospirenone|drospirenone|mesh-list
44026054|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44026055|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44026056|NCT00089414|Estradiol|estradiol|mesh-list
44026057|NCT00089414|Progesterone|progesterone|mesh-list
44026058|NCT00089414|Estrogens|estrogens|mesh-ancestor
44026059|NCT00089414|Hormones|hormones|mesh-ancestor
44026060|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44026061|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249666|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44249667|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249668|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
44249669|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249670|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249671|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44249672|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249674|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44026062|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44026063|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
44026064|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44026065|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44026066|NCT00089414|Progestins|progestins|mesh-ancestor
44026067|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44026068|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44026069|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44026070|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
44026071|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44026072|NCT00089414|Diuretics|diuretics|mesh-ancestor
44026073|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
44026074|NCT00090870|Interferons|interferons|mesh-list
44026075|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
44026076|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
44026077|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44026078|NCT00090870|Thalidomide|thalidomide|mesh-list
44026079|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026080|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
44026081|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026082|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
44026083|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026084|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026085|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
44026086|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44026087|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44026088|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44026089|NCT00090870|Growth Substances|growth substances|mesh-ancestor
44026090|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
44026091|NCT00088972|Celecoxib|celecoxib|mesh-list
44026092|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44026093|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026094|NCT00088972|Analgesics|analgesics|mesh-ancestor
44026095|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
44026096|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026097|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026098|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026099|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44026100|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44026101|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44026102|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026103|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026106|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44026107|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
44026108|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026109|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026110|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
44026111|NCT00089128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026112|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026113|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026114|NCT00089128|Immunologic Factors|immunologic factors|mesh-ancestor
44026115|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026116|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44026117|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44026118|NCT00075608|Melphalan|melphalan|mesh-list
43756069|NCT02468375|Mirabegron|mirabegron|mesh-list
44249675|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249676|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44026119|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
44026120|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026121|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44026122|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
44026123|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026124|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026125|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44026126|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026128|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44026129|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
44026130|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
44026131|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026132|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026133|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44026134|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44026135|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44026136|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026137|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026138|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026139|NCT00074724|Protective Agents|protective agents|mesh-ancestor
44026140|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
44026141|NCT00058188|Vitamin D|vitamin d|mesh-list
44026142|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
44026143|NCT00058188|Calcium|calcium|mesh-list
44026144|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44026145|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026146|NCT00058188|Vitamins|vitamins|mesh-ancestor
44026147|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
44026148|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44026149|NCT00014560|Antibodies|antibodies|mesh-list
44026150|NCT00014560|Sargramostim|sargramostim|mesh-list
44026151|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44026152|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
44026153|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026154|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
44026155|NCT00020722|Ifosfamide|ifosfamide|mesh-list
44026156|NCT00020722|Thiotepa|thiotepa|mesh-list
44026157|NCT00020722|Carboplatin|carboplatin|mesh-list
44026158|NCT00020722|Etoposide|etoposide|mesh-list
44026159|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
44026160|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026161|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
44026162|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026163|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44026164|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44026165|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
44026166|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026167|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026168|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44026169|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44026170|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44026171|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44026172|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026173|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44026174|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44065176|NCT00006361|Semaxinib|semaxinib|mesh-list
44026175|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
44026177|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026178|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
44026179|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026180|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
44026181|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44026182|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026183|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44026184|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44026185|NCT00019747|Growth Substances|growth substances|mesh-ancestor
44026186|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44026187|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026189|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
44026190|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44026191|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
44026192|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642238|NCT05476770|Azacitidine|azacitidine|mesh-list
44249677|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44249678|NCT05330065|Growth Substances|growth substances|mesh-ancestor
44249679|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249680|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
44026193|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026194|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
44026195|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44026196|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44026198|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44026199|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
44026200|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026201|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026202|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026203|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44026204|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026205|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
44026206|NCT02126878|Hormones|hormones|mesh-ancestor
44026207|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44026208|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026209|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026210|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
44026211|NCT02595996|Propranolol|propranolol|mesh-list
44026212|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44026213|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44026214|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026215|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026216|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026217|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026218|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44026219|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44026220|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
44026221|NCT00521885|Enoxaparin|enoxaparin|mesh-list
44026222|NCT00521885|Fondaparinux|fondaparinux|mesh-list
44026223|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
44026224|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44026225|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44026226|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026227|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44026228|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
44026229|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44026230|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
44026231|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026232|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
44026233|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44026234|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026235|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026236|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
44026237|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026238|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026239|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
44026240|NCT02212574|Lomustine|lomustine|mesh-list
44026241|NCT02212574|Cisplatin|cisplatin|mesh-list
44026242|NCT02212574|Vincristine|vincristine|mesh-list
44026243|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44026244|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
44026245|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026246|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44026247|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44026248|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
44026249|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026250|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026255|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
44026257|NCT04422210|Etoposide|etoposide|mesh-list
44026258|NCT04422210|Atezolizumab|atezolizumab|mesh-list
44026259|NCT04422210|Venetoclax|venetoclax|mesh-list
44026260|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026261|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44026262|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44026263|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44026264|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249681|NCT05330000|Voriconazole|voriconazole|mesh-list
44249682|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
44249683|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026265|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026266|NCT04298918|Trastuzumab|trastuzumab|mesh-list
44026267|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44026268|NCT04298918|Venetoclax|venetoclax|mesh-list
44026269|NCT04298918|Maytansine|maytansine|mesh-list
44026270|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44026271|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026272|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44026273|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44026274|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44026275|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44026276|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026277|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
44026278|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44026279|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026280|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
44026281|NCT00955929|Alprostadil|alprostadil|mesh-list
44026282|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44026283|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44026284|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44026285|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026286|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026287|NCT00955929|Urological Agents|urological agents|mesh-ancestor
44026288|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44026289|NCT00402883|Folic Acid|folic acid|mesh-list
44026290|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
44026291|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
44026292|NCT00402883|Bevacizumab|bevacizumab|mesh-list
44026293|NCT00402883|Carboplatin|carboplatin|mesh-list
44026294|NCT00402883|Pemetrexed|pemetrexed|mesh-list
44026295|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44026296|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026297|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44026298|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44026299|NCT00402883|Growth Substances|growth substances|mesh-ancestor
44026300|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026301|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
44026302|NCT00402883|Vitamins|vitamins|mesh-ancestor
44026303|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
44026304|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026305|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026306|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44026307|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44026308|NCT00402883|Hematinics|hematinics|mesh-ancestor
44026309|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
44026310|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44026311|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
44026312|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44026313|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
44026314|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026315|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
44026316|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44026317|NCT00000117|Antibodies|antibodies|mesh-list
44026318|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
44026319|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026320|NCT00000119|Heparin|heparin|mesh-list
44026321|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
44026322|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44026323|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44026324|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026325|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44026326|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
44026327|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44026328|NCT00000123|Protective Agents|protective agents|mesh-ancestor
44026329|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026330|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44026331|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026332|NCT00000132|Betaxolol|betaxolol|mesh-list
44026333|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44026334|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
44026335|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
44026336|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249684|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44249685|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44249686|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249687|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249688|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44249689|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44249690|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249691|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249692|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44249693|NCT05329857|Metformin|metformin|mesh-list
44249694|NCT05329857|Vildagliptin|vildagliptin|mesh-list
44249695|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249696|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249697|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44249698|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
44249699|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249700|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249701|NCT05329844|Vildagliptin|vildagliptin|mesh-list
44249702|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44249703|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249704|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44249705|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
44249706|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249707|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249708|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
44249709|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44249710|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44249711|NCT05329740|Prednisolone|prednisolone|mesh-list
44026337|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026338|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44026339|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44026340|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44026341|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026342|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026343|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026344|NCT00000138|Acyclovir|acyclovir|mesh-list
44026345|NCT00000138|Prednisolone|prednisolone|mesh-list
44026346|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44026347|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
44026348|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43756234|NCT02467400|Atenolol|atenolol|mesh-list
44026349|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
44249712|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
44249713|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44249714|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
44249715|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249716|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
44249717|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
44249718|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026350|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44026351|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
44026352|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026353|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
44026354|NCT00000138|Hormones|hormones|mesh-ancestor
44026355|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44026356|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026357|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44026358|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026359|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
44026360|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
44026361|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026362|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44026363|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026364|NCT00000138|Protective Agents|protective agents|mesh-ancestor
44026365|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
44026366|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026368|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026369|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
44026370|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
44026371|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026372|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026373|NCT00000161|Aspirin|aspirin|mesh-list
44026374|NCT00000161|Vitamins|vitamins|mesh-list
44026375|NCT00000161|Ascorbic Acid|ascorbic acid|mesh-list
44026376|NCT00000161|Vitamin E|vitamin e|mesh-list
44026377|NCT00000161|Beta Carotene|beta carotene|mesh-list
44026378|NCT00000161|Carotenoids|carotenoids|mesh-list
44026379|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
44026380|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026381|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44026382|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026383|NCT00000161|Analgesics|analgesics|mesh-ancestor
44026384|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
44026385|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026386|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026387|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44026388|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44026389|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44026390|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026391|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44026392|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44026393|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026394|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
44026395|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
44026396|NCT00000161|Protective Agents|protective agents|mesh-ancestor
44026397|NCT00000161|Provitamins|provitamins|mesh-ancestor
44026398|NCT00000174|Rivastigmine|rivastigmine|mesh-list
44026399|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44026400|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026401|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026402|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44026403|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026405|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026406|NCT00000174|Protective Agents|protective agents|mesh-ancestor
44026407|NCT00000178|Prednisone|prednisone|mesh-list
44026408|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44026409|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
44026410|NCT00000178|Hormones|hormones|mesh-ancestor
44026411|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44026412|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026413|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44026414|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026415|NCT00000188|Selegiline|selegiline|mesh-list
44249719|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249720|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249721|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
44249722|NCT05329740|Hormones|hormones|mesh-ancestor
44026416|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026417|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026418|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44026419|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44026420|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44026421|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026422|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026423|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026424|NCT00000188|Protective Agents|protective agents|mesh-ancestor
44026425|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026426|NCT00000189|Gepirone|gepirone|mesh-list
43756303|NCT02467023|Narcotics|narcotics|mesh-ancestor
44026427|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026428|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026429|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44026430|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026431|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026432|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026433|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44026434|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
44026435|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026436|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026437|NCT00000192|Lamotrigine|lamotrigine|mesh-list
44026438|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
44026439|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44026440|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026441|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026442|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44026443|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026444|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44026445|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026446|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026447|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026448|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44026449|NCT00000194|Cycloserine|cycloserine|mesh-list
44026450|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44026451|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026452|NCT00000194|Renal Agents|renal agents|mesh-ancestor
44026453|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44026454|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
44026455|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44026456|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
44026457|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026459|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44026460|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026461|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026462|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
44026463|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026464|NCT00000196|Naltrexone|naltrexone|mesh-list
44026465|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44026466|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026467|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026468|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
44026469|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026470|NCT00000197|Propranolol|propranolol|mesh-list
44026471|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44026472|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44026473|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026474|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026475|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026476|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026488|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026489|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
44026490|NCT00000200|Methadone|methadone|mesh-list
44026491|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026492|NCT00000200|Narcotics|narcotics|mesh-ancestor
43642444|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44150655|NCT00210899|Ceftazidime|ceftazidime|mesh-list
44249723|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249724|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43648302|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
44026493|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026494|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026495|NCT00000200|Analgesics|analgesics|mesh-ancestor
44026496|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
44026497|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026498|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
44026499|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44026501|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026502|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026503|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44026504|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44026505|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44026506|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026507|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026508|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026509|NCT00000201|Protective Agents|protective agents|mesh-ancestor
44026510|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026511|NCT00000202|Buprenorphine|buprenorphine|mesh-list
44026512|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026513|NCT00000202|Narcotics|narcotics|mesh-ancestor
44026514|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026515|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026516|NCT00000202|Analgesics|analgesics|mesh-ancestor
44026517|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
44026518|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026519|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026520|NCT00000203|Buprenorphine|buprenorphine|mesh-list
44026521|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026522|NCT00000203|Narcotics|narcotics|mesh-ancestor
44026523|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026524|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026525|NCT00000203|Analgesics|analgesics|mesh-ancestor
44026526|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
44026527|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026528|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026529|NCT00000204|Buprenorphine|buprenorphine|mesh-list
44026530|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026531|NCT00000204|Narcotics|narcotics|mesh-ancestor
44026532|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026533|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026534|NCT00000204|Analgesics|analgesics|mesh-ancestor
44026535|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
44026536|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026537|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026538|NCT00000206|Buprenorphine|buprenorphine|mesh-list
44026539|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026540|NCT00000206|Narcotics|narcotics|mesh-ancestor
44026541|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026542|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026543|NCT00000206|Analgesics|analgesics|mesh-ancestor
44026544|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
44026545|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026546|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026548|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026549|NCT00000207|Narcotics|narcotics|mesh-ancestor
44026550|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026551|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026552|NCT00000207|Analgesics|analgesics|mesh-ancestor
44026553|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
44026554|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026555|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026556|NCT00000208|Buprenorphine|buprenorphine|mesh-list
44026557|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026558|NCT00000208|Narcotics|narcotics|mesh-ancestor
44026559|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026560|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026561|NCT00000208|Analgesics|analgesics|mesh-ancestor
44026562|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
44249725|NCT05329740|Protective Agents|protective agents|mesh-ancestor
44249726|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44249727|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44026563|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026564|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44148906|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44148907|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44148908|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
44148909|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148910|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148911|NCT00206180|Esomeprazole|esomeprazole|mesh-list
44148912|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44148913|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148914|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44148915|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148916|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148917|NCT00206193|Misoprostol|misoprostol|mesh-list
44148918|NCT00206193|Sulprostone|sulprostone|mesh-list
44148919|NCT00206193|Mifepristone|mifepristone|mesh-list
44026565|NCT00000209|Buprenorphine|buprenorphine|mesh-list
44026566|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026567|NCT00000209|Narcotics|narcotics|mesh-ancestor
44026568|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026569|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026570|NCT00000209|Analgesics|analgesics|mesh-ancestor
44026571|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
44026572|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026573|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026574|NCT00000210|Buprenorphine|buprenorphine|mesh-list
44026575|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026576|NCT00000210|Narcotics|narcotics|mesh-ancestor
44026577|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026578|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026579|NCT00000210|Analgesics|analgesics|mesh-ancestor
44026580|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
44026581|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026582|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026583|NCT00000211|Buprenorphine|buprenorphine|mesh-list
44026584|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026585|NCT00000211|Narcotics|narcotics|mesh-ancestor
44026586|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026587|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026588|NCT00000211|Analgesics|analgesics|mesh-ancestor
44026589|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
44026590|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026591|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026592|NCT00000212|Desipramine|desipramine|mesh-list
44026593|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44026594|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026595|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026596|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026597|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026598|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44026599|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44026600|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026601|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026602|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026603|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026604|NCT00000213|Fluoxetine|fluoxetine|mesh-list
44026605|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44026606|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44026607|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026608|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026609|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026610|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
44026611|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026612|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44026613|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026614|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026615|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44249729|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249731|NCT05329454|Analgesics|analgesics|mesh-ancestor
44249732|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
44249733|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249734|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249735|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249736|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249737|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44249738|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249739|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249740|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
44249741|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44249742|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44249743|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249744|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
44249745|NCT05321199|Coagulants|coagulants|mesh-ancestor
44249746|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
44249747|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249748|NCT05291403|Erythromycin|erythromycin|mesh-list
44249749|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
44249750|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44249751|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
44249752|NCT05291403|Cisplatin|cisplatin|mesh-list
44249753|NCT05291403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249754|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44249755|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249756|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44249757|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44249758|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249759|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460364|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460365|NCT01564862|Analgesics|analgesics|mesh-ancestor
44460366|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
44460367|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026616|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460368|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
44460369|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460370|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
44460371|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44460372|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460373|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460374|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44460375|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
44460376|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44460377|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44460378|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44460379|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44460380|NCT01564784|Cytarabine|cytarabine|mesh-list
44460381|NCT01564784|Fludarabine|fludarabine|mesh-list
44460382|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
44460383|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44460384|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460385|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44460386|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
44249761|NCT05214807|Hylan|hylan|mesh-list
44249762|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43648349|NCT03656536|Cisplatin|cisplatin|mesh-list
44026617|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026619|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
44026620|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
44026621|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026622|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026623|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026625|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
44026626|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
44026627|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026628|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026629|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026630|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026631|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026632|NCT00000217|Analgesics|analgesics|mesh-ancestor
44026633|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
44026634|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026635|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44026636|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026637|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026638|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44026639|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44026640|NCT00000218|Carbamazepine|carbamazepine|mesh-list
44026641|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
44026642|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
44026643|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026644|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026645|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026646|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026647|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026648|NCT00000218|Analgesics|analgesics|mesh-ancestor
44026649|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
44026650|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026651|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44249763|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249764|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
44249765|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249766|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44026652|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026653|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026654|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44026655|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44026656|NCT00000219|Buprenorphine|buprenorphine|mesh-list
44026657|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026658|NCT00000219|Narcotics|narcotics|mesh-ancestor
44026659|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026660|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026661|NCT00000219|Analgesics|analgesics|mesh-ancestor
44026662|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
44026663|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026664|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026665|NCT00000222|Buprenorphine|buprenorphine|mesh-list
44026666|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026667|NCT00000222|Narcotics|narcotics|mesh-ancestor
44026668|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026669|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026670|NCT00000222|Analgesics|analgesics|mesh-ancestor
44026671|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
44026672|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026673|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026674|NCT00000223|Buprenorphine|buprenorphine|mesh-list
44026675|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026676|NCT00000223|Narcotics|narcotics|mesh-ancestor
44026677|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026678|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026679|NCT00000223|Analgesics|analgesics|mesh-ancestor
44026680|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
44026681|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026682|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026683|NCT00000224|Buprenorphine|buprenorphine|mesh-list
44026684|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026685|NCT00000224|Narcotics|narcotics|mesh-ancestor
44026686|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026687|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026688|NCT00000224|Analgesics|analgesics|mesh-ancestor
44026689|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
44026690|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026691|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026692|NCT00000225|Buprenorphine|buprenorphine|mesh-list
44026693|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026694|NCT00000225|Narcotics|narcotics|mesh-ancestor
44026695|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026696|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026697|NCT00000225|Analgesics|analgesics|mesh-ancestor
44026698|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
44026699|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026700|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026701|NCT00000226|Buprenorphine|buprenorphine|mesh-list
44026702|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026703|NCT00000226|Narcotics|narcotics|mesh-ancestor
44026704|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026705|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026706|NCT00000226|Analgesics|analgesics|mesh-ancestor
44026707|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
44026708|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026709|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026710|NCT00000227|Buprenorphine|buprenorphine|mesh-list
44026711|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026712|NCT00000227|Narcotics|narcotics|mesh-ancestor
44026713|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026714|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026715|NCT00000227|Analgesics|analgesics|mesh-ancestor
44026716|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
44026717|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026718|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44249767|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
44249768|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
44249769|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
44249770|NCT05214807|Coagulants|coagulants|mesh-ancestor
43648363|NCT03609047|Doxorubicin|doxorubicin|mesh-list
44026719|NCT00000228|Buprenorphine|buprenorphine|mesh-list
44026720|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026721|NCT00000228|Narcotics|narcotics|mesh-ancestor
44026722|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026723|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026724|NCT00000228|Analgesics|analgesics|mesh-ancestor
44026725|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
44026726|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026727|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026728|NCT00000229|Buprenorphine|buprenorphine|mesh-list
44026729|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026730|NCT00000229|Narcotics|narcotics|mesh-ancestor
44026731|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026732|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026733|NCT00000229|Analgesics|analgesics|mesh-ancestor
44026734|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
44026735|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026736|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026737|NCT00000230|Buprenorphine|buprenorphine|mesh-list
44026738|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026739|NCT00000230|Narcotics|narcotics|mesh-ancestor
44026740|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026741|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026742|NCT00000230|Analgesics|analgesics|mesh-ancestor
44026743|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
44026744|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026745|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026746|NCT00000231|Buprenorphine|buprenorphine|mesh-list
44026747|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026748|NCT00000231|Narcotics|narcotics|mesh-ancestor
44026749|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026750|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026751|NCT00000231|Analgesics|analgesics|mesh-ancestor
44026752|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
44026753|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026754|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026755|NCT00000232|Buprenorphine|buprenorphine|mesh-list
44026756|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026758|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026759|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026760|NCT00000232|Analgesics|analgesics|mesh-ancestor
44026761|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
44026762|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026763|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026764|NCT00000233|Buprenorphine|buprenorphine|mesh-list
44026765|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026766|NCT00000233|Narcotics|narcotics|mesh-ancestor
44026767|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026768|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026769|NCT00000233|Analgesics|analgesics|mesh-ancestor
44026770|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
44026771|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026772|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026773|NCT00000234|Buprenorphine|buprenorphine|mesh-list
44026774|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026775|NCT00000234|Narcotics|narcotics|mesh-ancestor
44026776|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026777|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026778|NCT00000234|Analgesics|analgesics|mesh-ancestor
44026779|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
44026780|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026781|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026782|NCT00000235|Buprenorphine|buprenorphine|mesh-list
44026783|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026784|NCT00000235|Narcotics|narcotics|mesh-ancestor
44026785|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026786|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026787|NCT00000235|Analgesics|analgesics|mesh-ancestor
44026788|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
44249772|NCT05214807|Protective Agents|protective agents|mesh-ancestor
44249773|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249774|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
44249775|NCT05188508|Temozolomide|temozolomide|mesh-list
44026789|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026790|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026791|NCT00000236|Buprenorphine|buprenorphine|mesh-list
44026792|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44026793|NCT00000236|Naloxone|naloxone|mesh-list
44026794|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026796|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026797|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026798|NCT00000236|Analgesics|analgesics|mesh-ancestor
44026799|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
44026800|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026801|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026802|NCT00000237|Buprenorphine|buprenorphine|mesh-list
44026803|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026804|NCT00000237|Narcotics|narcotics|mesh-ancestor
44026805|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026806|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026807|NCT00000237|Analgesics|analgesics|mesh-ancestor
44026808|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
44026809|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026810|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026811|NCT00000238|Buprenorphine|buprenorphine|mesh-list
44026812|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026813|NCT00000238|Narcotics|narcotics|mesh-ancestor
44026814|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026815|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026816|NCT00000238|Analgesics|analgesics|mesh-ancestor
44026817|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
44026818|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026819|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026820|NCT00000239|Buprenorphine|buprenorphine|mesh-list
44026821|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026822|NCT00000239|Narcotics|narcotics|mesh-ancestor
44026823|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026824|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026825|NCT00000239|Analgesics|analgesics|mesh-ancestor
44026826|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
44026827|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026828|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026829|NCT00000240|Buprenorphine|buprenorphine|mesh-list
44026830|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026831|NCT00000240|Narcotics|narcotics|mesh-ancestor
44026832|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026833|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026834|NCT00000240|Analgesics|analgesics|mesh-ancestor
44026837|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026839|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44026840|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44026841|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026842|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026843|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026844|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026845|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44026846|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
44026847|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026848|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026849|NCT00000242|Carbamazepine|carbamazepine|mesh-list
44026850|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
44026851|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
44026852|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44026853|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026854|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026855|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026856|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026857|NCT00000242|Analgesics|analgesics|mesh-ancestor
44026858|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
44026859|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249777|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249778|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249779|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249780|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
44249781|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249782|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44249783|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249784|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44249785|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44249786|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44249787|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
44249788|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249789|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44249790|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44249791|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249792|NCT05132595|Ketorolac|ketorolac|mesh-list
44249793|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44249794|NCT05132595|Esketamine|esketamine|mesh-list
44249795|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249796|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249797|NCT05132595|Analgesics|analgesics|mesh-ancestor
44249798|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
44249799|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249800|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249801|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249802|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249803|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44249804|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249805|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249806|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249807|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44249808|NCT05082909|Probenecid|probenecid|mesh-list
44026860|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44026861|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026862|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026863|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44249809|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
44249810|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
44249811|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249812|NCT05082909|Renal Agents|renal agents|mesh-ancestor
44249813|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
44026864|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44026865|NCT00000243|Buprenorphine|buprenorphine|mesh-list
44026866|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44026867|NCT00000243|Narcotics|narcotics|mesh-ancestor
44026868|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756729|NCT02464501|Paclitaxel|paclitaxel|mesh-list
44026869|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026870|NCT00000243|Analgesics|analgesics|mesh-ancestor
44026871|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
44026872|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026873|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44026875|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026876|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026877|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026878|NCT00000245|Desipramine|desipramine|mesh-list
44026879|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44026880|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
44026881|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44026882|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44026883|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026884|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44026885|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44026886|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44026887|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
44026888|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026889|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026890|NCT00000246|Flumazenil|flumazenil|mesh-list
44026891|NCT00000246|Antidotes|antidotes|mesh-ancestor
44026892|NCT00000246|Protective Agents|protective agents|mesh-ancestor
44026893|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026894|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
44026895|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
44026896|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44026897|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44026898|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
44026899|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026900|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
44026901|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
44026902|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026903|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026904|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026905|NCT00000249|Analgesics|analgesics|mesh-ancestor
44026906|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
44026907|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026908|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
44026909|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026910|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
44026911|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
44026912|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026913|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026914|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026915|NCT00000250|Analgesics|analgesics|mesh-ancestor
44026916|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
44026917|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026918|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
44026919|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026920|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
44026922|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026923|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026924|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026925|NCT00000253|Analgesics|analgesics|mesh-ancestor
44026926|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
44026927|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026928|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
44026929|NCT00000254|Isoflurane|isoflurane|mesh-list
44026930|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44249814|NCT05069935|Fludarabine|fludarabine|mesh-list
44249815|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44249816|NCT05069935|Antibodies|antibodies|mesh-list
44249817|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
44026931|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
44026932|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
44026933|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026934|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026935|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026936|NCT00000254|Analgesics|analgesics|mesh-ancestor
44026937|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
44026938|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026939|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
44026940|NCT00000259|Sevoflurane|sevoflurane|mesh-list
44026941|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44026942|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026943|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
44026944|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
44026945|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026946|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026947|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026948|NCT00000259|Analgesics|analgesics|mesh-ancestor
44026949|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
44026950|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026951|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
44026952|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026953|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
44026954|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
44026955|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026956|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026957|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026958|NCT00000260|Analgesics|analgesics|mesh-ancestor
44026959|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
44026960|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026961|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
44026962|NCT00000261|Sevoflurane|sevoflurane|mesh-list
44026963|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44026964|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026965|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
44026966|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
44026967|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026968|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026969|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026970|NCT00000261|Analgesics|analgesics|mesh-ancestor
44026971|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
44026972|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026973|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
44026974|NCT00000262|Sevoflurane|sevoflurane|mesh-list
44026975|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44026976|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026977|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
44026978|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
44026979|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026980|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026981|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026982|NCT00000262|Analgesics|analgesics|mesh-ancestor
44026983|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
44026984|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026986|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
44026987|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44026988|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44026989|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44026990|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026991|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44026992|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
44026993|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
44026994|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026995|NCT00000263|Analgesics|analgesics|mesh-ancestor
44026996|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
44026997|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026998|NCT00000264|Ethanol|ethanol|mesh-list
44026999|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
44027000|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44027001|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249818|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44249819|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44027002|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027003|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027004|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44027005|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
44027007|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44027008|NCT00000264|Analgesics|analgesics|mesh-ancestor
44027009|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
44027010|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027011|NCT00000266|Flupenthixol|flupenthixol|mesh-list
44027012|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44027013|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027014|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027015|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027016|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027017|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756816|NCT02463552|Naproxen|naproxen|mesh-list
44027018|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027019|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
44027020|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027021|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027022|NCT00000267|Risperidone|risperidone|mesh-list
44027023|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027024|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
44027025|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027026|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027027|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027028|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027029|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027030|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027031|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027032|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027033|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
44027034|NCT00000268|Bupropion|bupropion|mesh-list
44027035|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027036|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027037|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027038|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027039|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027040|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027041|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027042|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
44027043|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027044|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027045|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44027046|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44027047|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027048|NCT00000269|Pergolide|pergolide|mesh-list
44027049|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
44027050|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
44027051|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027052|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027053|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027054|NCT00000270|Cocaine|cocaine|mesh-list
44027055|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
44027056|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
44027057|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027058|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027059|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
44027060|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027061|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44027062|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027063|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027064|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027065|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027067|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027068|NCT00000271|Desipramine|desipramine|mesh-list
44027069|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44027070|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
44249820|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
44249821|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249822|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648398|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
44027071|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027072|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027073|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027074|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027075|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027076|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027077|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027078|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027079|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027081|NCT00000273|Morphine|morphine|mesh-list
44027082|NCT00000273|Oxycodone|oxycodone|mesh-list
44027083|NCT00000273|Buprenorphine|buprenorphine|mesh-list
44027084|NCT00000273|Methadone|methadone|mesh-list
44027085|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027086|NCT00000273|Narcotics|narcotics|mesh-ancestor
44027087|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027088|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027089|NCT00000273|Analgesics|analgesics|mesh-ancestor
44027090|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
44027091|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027092|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44027093|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44027094|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
44027095|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
44027096|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027097|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
44027098|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
44027099|NCT00000274|Flupenthixol|flupenthixol|mesh-list
44027100|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44027101|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027102|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027103|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027104|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027105|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027106|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027107|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
44027108|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027109|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027110|NCT00000275|Flupenthixol|flupenthixol|mesh-list
44027111|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44027112|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027113|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027114|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027115|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027116|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027117|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027118|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
44027119|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027120|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027122|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027123|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027124|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027125|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027126|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027127|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027128|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027129|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
44027130|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027131|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027132|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44027141|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027143|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027144|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027145|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
44027147|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44027148|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44249823|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249824|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
44249825|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249826|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249827|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44249828|NCT04981041|Clopidogrel|clopidogrel|mesh-list
44249829|NCT04981041|Ticagrelor|ticagrelor|mesh-list
44249830|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44249831|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44249832|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44249833|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44249834|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44249835|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
44249836|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249837|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027149|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027150|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027151|NCT00000279|Clonidine|clonidine|mesh-list
44027152|NCT00000279|Analgesics|analgesics|mesh-ancestor
44027153|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
44027154|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027155|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027156|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027157|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
44027158|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
44027159|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44027160|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44027161|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44027162|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027163|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027164|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027165|NCT00000280|Nimodipine|nimodipine|mesh-list
44027166|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027167|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44027168|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027169|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027170|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44027171|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027172|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
44027173|NCT00000281|Amantadine|amantadine|mesh-list
44027174|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027175|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027176|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
44027177|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44027178|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
44027179|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027180|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027181|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027182|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44027183|NCT00000281|Analgesics|analgesics|mesh-ancestor
44027184|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
44027185|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027186|NCT00000282|Pemoline|pemoline|mesh-list
44027187|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027188|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027189|NCT00000285|Phenytoin|phenytoin|mesh-list
44027190|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
44249838|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249839|NCT04963036|Anesthetics|anesthetics|mesh-list
44249840|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027191|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44027192|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44027193|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027194|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027195|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44027196|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44027197|NCT00000286|Nefazodone|nefazodone|mesh-list
44027198|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44027199|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44066230|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44027200|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027201|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027202|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027203|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027204|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027205|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027206|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027207|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44027208|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027209|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
44027210|NCT00000289|Ondansetron|ondansetron|mesh-list
44027211|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
44027212|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
44027213|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027214|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027215|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44027216|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
44027217|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
44027218|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027219|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
44027220|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027221|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027222|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027223|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027224|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027225|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027226|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44027228|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
44027229|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
44027230|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027231|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027232|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
44027233|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027234|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44027235|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027236|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027237|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027238|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027239|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
44027240|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027241|NCT00000291|Labetalol|labetalol|mesh-list
44027242|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44027243|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44027244|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027245|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027246|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027247|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027248|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027249|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
44027250|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
44027251|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027252|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44027253|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44027254|NCT00000292|Cocaine|cocaine|mesh-list
44027255|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
44249841|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249843|NCT04939467|Nintedanib|nintedanib|mesh-list
44027256|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
44027257|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027258|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027259|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
44027260|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027261|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44027262|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027263|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027264|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027265|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027266|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
44027267|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027269|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44027270|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027271|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027272|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027273|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027274|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027275|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027276|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027277|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027278|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44027279|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027280|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
44027281|NCT00000294|Carvedilol|carvedilol|mesh-list
44027282|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44027283|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44027284|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027285|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027286|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027287|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027288|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027289|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
44027290|NCT00000294|Protective Agents|protective agents|mesh-ancestor
44027291|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44027292|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027293|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44027294|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
44027295|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44027296|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44027297|NCT00000295|Progesterone|progesterone|mesh-list
44027298|NCT00000295|Progestins|progestins|mesh-ancestor
44027299|NCT00000295|Hormones|hormones|mesh-ancestor
44027300|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44027301|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027302|NCT00000297|Labetalol|labetalol|mesh-list
44027303|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44027304|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44027305|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027306|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027307|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027308|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027309|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027310|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
44027311|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
44027313|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44027314|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44027315|NCT00000298|Buprenorphine|buprenorphine|mesh-list
44027316|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44027317|NCT00000298|Naloxone|naloxone|mesh-list
44027318|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027319|NCT00000298|Narcotics|narcotics|mesh-ancestor
44027320|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027321|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027322|NCT00000298|Analgesics|analgesics|mesh-ancestor
43642445|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
44249844|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249845|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44027323|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
44027324|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027325|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027326|NCT00000299|Buprenorphine|buprenorphine|mesh-list
44027327|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027328|NCT00000299|Narcotics|narcotics|mesh-ancestor
44027329|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027330|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027331|NCT00000299|Analgesics|analgesics|mesh-ancestor
44027332|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
44027333|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027334|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027335|NCT00000301|Amantadine|amantadine|mesh-list
44027336|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027337|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027338|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
44027339|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44027340|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
44027341|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027355|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027356|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027357|NCT00000303|Baclofen|baclofen|mesh-list
44027358|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44027359|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027360|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44027361|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027362|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44027363|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
44027364|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
44027365|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027366|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027367|NCT00000304|Amphetamine|amphetamine|mesh-list
44027368|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
44027369|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027370|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027371|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
44027372|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
44027373|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027374|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
44027375|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027376|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027377|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027378|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027379|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027380|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027381|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027382|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
44027383|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027384|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027385|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027386|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027387|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027388|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027389|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
44027390|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027391|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
44027392|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027393|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027394|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027395|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027396|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027397|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027398|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
44027399|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027400|NCT00000307|Naltrexone|naltrexone|mesh-list
44027401|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44027402|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027403|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027404|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
43642446|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
44249846|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249847|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249848|NCT04939467|Analgesics|analgesics|mesh-ancestor
44249849|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
44249850|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249851|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249852|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249853|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249854|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249855|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44027405|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027406|NCT00000308|Amphetamine|amphetamine|mesh-list
44027407|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
44027408|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027409|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027410|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
44027411|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
44027412|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027413|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
44027414|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027415|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027416|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027417|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027418|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027419|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027420|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027421|NCT00000309|Risperidone|risperidone|mesh-list
44027422|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027423|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
44027424|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027425|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027426|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027427|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027428|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027429|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027430|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027431|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027432|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
44027433|NCT00000310|Risperidone|risperidone|mesh-list
44027434|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027435|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
44027436|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027437|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027438|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027439|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027440|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027441|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027442|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027443|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027444|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
44027445|NCT00000311|Buprenorphine|buprenorphine|mesh-list
44027447|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027448|NCT00000311|Narcotics|narcotics|mesh-ancestor
44027449|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027450|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027451|NCT00000311|Analgesics|analgesics|mesh-ancestor
44027452|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
44027453|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027454|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027455|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
44027456|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
44027457|NCT00000313|Fenfluramine|fenfluramine|mesh-list
44027458|NCT00000313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44249857|NCT04938232|Ipilimumab|ipilimumab|mesh-list
44249858|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44249859|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249860|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44249861|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249862|NCT04908605|Melatonin|melatonin|mesh-list
44249863|NCT04908605|Mirtazapine|mirtazapine|mesh-list
44249864|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
44249865|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249866|NCT04908605|Protective Agents|protective agents|mesh-ancestor
43757214|NCT02461914|Warfarin|warfarin|mesh-list
44027459|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027460|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027461|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027462|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027463|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
44027464|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027465|NCT00000315|Cocaine|cocaine|mesh-list
44027466|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
44027467|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
44027468|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027469|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027470|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
44027471|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027472|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44027473|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027474|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027475|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027476|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027477|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
44027478|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027479|NCT00000316|Cocaine|cocaine|mesh-list
44027480|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
44027481|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
44027482|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027483|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027484|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
44027485|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027486|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44027487|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027488|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027489|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027490|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027491|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
44027492|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027493|NCT00000317|Risperidone|risperidone|mesh-list
44027494|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027495|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
44027496|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027497|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027498|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027499|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027500|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027501|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027502|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027503|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027504|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
44027505|NCT00000318|Buprenorphine|buprenorphine|mesh-list
44027506|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027507|NCT00000318|Narcotics|narcotics|mesh-ancestor
44027508|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643181|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
44249867|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249868|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249869|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027509|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027510|NCT00000318|Analgesics|analgesics|mesh-ancestor
44027511|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
44027512|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027513|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027514|NCT00000319|Buprenorphine|buprenorphine|mesh-list
44027515|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027516|NCT00000319|Narcotics|narcotics|mesh-ancestor
44027517|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027518|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027519|NCT00000319|Analgesics|analgesics|mesh-ancestor
44027520|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
44027521|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027522|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027523|NCT00000320|Buprenorphine|buprenorphine|mesh-list
44027524|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027525|NCT00000320|Narcotics|narcotics|mesh-ancestor
44027526|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027527|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027528|NCT00000320|Analgesics|analgesics|mesh-ancestor
44027529|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
44027530|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027531|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027532|NCT00000321|Desipramine|desipramine|mesh-list
44027533|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44027534|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027535|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027536|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027537|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027538|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027539|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027540|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027541|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027542|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027543|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148920|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44148921|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
44148922|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44148923|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148924|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44148933|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44148934|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44148935|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148936|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
44148937|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44148938|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44148939|NCT00206219|Methotrexate|methotrexate|mesh-list
44148940|NCT00206219|Gefitinib|gefitinib|mesh-list
44148941|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44148942|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
44148943|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44148944|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148945|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44148946|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
44148947|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148948|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148949|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44148950|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148951|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44148952|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148953|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
44148954|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148955|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44148956|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44148957|NCT00206232|Spironolactone|spironolactone|mesh-list
44249871|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44148958|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44148959|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
44148960|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148961|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148962|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44148963|NCT00206232|Diuretics|diuretics|mesh-ancestor
44148964|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
44148965|NCT00206258|Pramlintide|pramlintide|mesh-list
44148966|NCT00206258|Glucagon|glucagon|mesh-list
44148967|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148968|NCT00206258|Hormones|hormones|mesh-ancestor
44148969|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148970|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148971|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148972|NCT00206297|Pramlintide|pramlintide|mesh-list
44148973|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148974|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148975|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44148976|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44148977|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44148978|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
44148979|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148980|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44027544|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44027545|NCT00000325|Hormones|hormones|mesh-ancestor
44027546|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44027547|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027548|NCT00000326|Heroin|heroin|mesh-list
44027549|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027550|NCT00000326|Narcotics|narcotics|mesh-ancestor
44027551|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027552|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027554|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
44027555|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027556|NCT00000327|Heroin|heroin|mesh-list
44027557|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027558|NCT00000327|Narcotics|narcotics|mesh-ancestor
44027559|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027560|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027561|NCT00000327|Analgesics|analgesics|mesh-ancestor
44027562|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
44027563|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027564|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
44027565|NCT00000328|Narcotics|narcotics|mesh-ancestor
44027566|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027567|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027568|NCT00000328|Analgesics|analgesics|mesh-ancestor
44027569|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
44027570|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027571|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
44027572|NCT00000329|Narcotics|narcotics|mesh-ancestor
44027573|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027574|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027575|NCT00000329|Analgesics|analgesics|mesh-ancestor
44027576|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
44027577|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027578|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
44027579|NCT00000330|Narcotics|narcotics|mesh-ancestor
44027580|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027581|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027582|NCT00000330|Analgesics|analgesics|mesh-ancestor
44027583|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
44027584|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027585|NCT00000332|Nimodipine|nimodipine|mesh-list
44027586|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027587|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44027588|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027589|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027590|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44249872|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
44249873|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
44249874|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249875|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44249876|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43824249|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44027591|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027592|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
44027593|NCT00000333|Benztropine|benztropine|mesh-list
44027594|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027595|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027596|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
44027597|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
44027598|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027599|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027600|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44027601|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44027602|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
44027603|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027604|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027605|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44027606|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027607|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027608|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
44027609|NCT00000334|Buprenorphine|buprenorphine|mesh-list
44027610|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027611|NCT00000334|Narcotics|narcotics|mesh-ancestor
44027612|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027613|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027614|NCT00000334|Analgesics|analgesics|mesh-ancestor
44027615|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
44027616|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027617|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027619|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027620|NCT00000335|Narcotics|narcotics|mesh-ancestor
44027621|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027622|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027623|NCT00000335|Analgesics|analgesics|mesh-ancestor
44027624|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
44027625|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027626|NCT00000336|Selegiline|selegiline|mesh-list
44027628|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027629|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027630|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027631|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44027632|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027633|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027634|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44027635|NCT00000336|Protective Agents|protective agents|mesh-ancestor
44027636|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027637|NCT00000337|Selegiline|selegiline|mesh-list
44027638|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027639|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027640|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027641|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027642|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44027643|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027644|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027645|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44027646|NCT00000337|Protective Agents|protective agents|mesh-ancestor
44027647|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027648|NCT00000338|Lisuride|lisuride|mesh-list
44027649|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44027650|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44027651|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44027652|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
44027653|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027654|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643268|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44249877|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44249878|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44249879|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44249880|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44249881|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44249882|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027655|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027656|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
44027657|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
44027658|NCT00000339|Risperidone|risperidone|mesh-list
44027659|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027660|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
44027661|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027662|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027663|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027664|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027665|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027666|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027667|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027668|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027669|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
44027670|NCT00000340|Pemoline|pemoline|mesh-list
44027671|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027672|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027673|NCT00000341|Buprenorphine|buprenorphine|mesh-list
44027674|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027675|NCT00000341|Narcotics|narcotics|mesh-ancestor
44027676|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027677|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027678|NCT00000341|Analgesics|analgesics|mesh-ancestor
44027679|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
44027680|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027681|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027682|NCT00000342|Risperidone|risperidone|mesh-list
44027683|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027684|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
44027685|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027686|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027687|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027688|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027689|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027690|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027691|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027692|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027693|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
44027694|NCT00000344|Buprenorphine|buprenorphine|mesh-list
44027695|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44027697|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027698|NCT00000344|Narcotics|narcotics|mesh-ancestor
44027699|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027700|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027701|NCT00000344|Analgesics|analgesics|mesh-ancestor
44027719|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
44027720|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027721|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027722|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027723|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027724|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027725|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027726|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027727|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027728|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
44027729|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
44027730|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
44027731|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
44027732|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027733|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027734|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249883|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
44249884|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44249886|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44249887|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44249888|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249889|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44249890|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44249891|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
44249892|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249893|NCT04901676|Leronlimab|leronlimab|mesh-list
44249894|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44249895|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44249896|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249897|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44249898|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44249899|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
44249900|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44027735|NCT00000349|Flupenthixol|flupenthixol|mesh-list
44027736|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44027737|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027738|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027739|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027740|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027741|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027742|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027743|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
44027744|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027745|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027746|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
44027747|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
44027748|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
44027749|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44027750|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44027751|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027752|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027753|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027754|NCT00000353|Buprenorphine|buprenorphine|mesh-list
44027755|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44027757|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027758|NCT00000353|Narcotics|narcotics|mesh-ancestor
44027770|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027771|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44027772|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44027773|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44027774|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027775|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027776|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027777|NCT00000355|Buprenorphine|buprenorphine|mesh-list
44027778|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027779|NCT00000355|Narcotics|narcotics|mesh-ancestor
44027780|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027781|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027782|NCT00000355|Analgesics|analgesics|mesh-ancestor
44027783|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
44249901|NCT04871412|Vitamin D|vitamin d|mesh-list
44249902|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
44249903|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
44249904|NCT04871412|Vitamins|vitamins|mesh-list
44249905|NCT04871412|Curcumin|curcumin|mesh-list
44027784|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027785|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027786|NCT00000357|Buprenorphine|buprenorphine|mesh-list
44027787|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027788|NCT00000357|Narcotics|narcotics|mesh-ancestor
44027789|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027790|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027791|NCT00000357|Analgesics|analgesics|mesh-ancestor
44027792|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
44027793|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027794|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027795|NCT00000358|Lofexidine|lofexidine|mesh-list
44027796|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027797|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027798|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027799|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
44027800|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027801|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44027802|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44027803|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44027804|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027805|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027806|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027807|NCT00000361|Methotrexate|methotrexate|mesh-list
44027808|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44027809|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
44027810|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44027811|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027812|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44027813|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
44027814|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027815|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44027816|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44027817|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027818|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44027819|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44027820|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
44027821|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44027836|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027837|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027839|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027840|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027841|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027842|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
44027843|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
44027844|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
44027845|NCT00000373|Olanzapine|olanzapine|mesh-list
44027846|NCT00000373|Fluoxetine|fluoxetine|mesh-list
44027847|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
44027848|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
44027849|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027850|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027851|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44027852|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027853|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027854|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027855|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027856|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44027857|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027858|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027859|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027860|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027861|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
44027862|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027863|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027864|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43643269|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
44249906|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
44249907|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249908|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44249909|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43903276|NCT00124579|Thalidomide|thalidomide|mesh-list
44249910|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44249911|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249912|NCT04871412|Analgesics|analgesics|mesh-ancestor
44249913|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
44027865|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44027866|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027867|NCT00000374|Olanzapine|olanzapine|mesh-list
44027868|NCT00000374|Risperidone|risperidone|mesh-list
44027869|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027870|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
44027871|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027872|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027873|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027874|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027875|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027876|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027877|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027878|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44027879|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
44027880|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
44027881|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
44027882|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027883|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44027884|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44027895|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027897|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027898|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027899|NCT00000377|Nortriptyline|nortriptyline|mesh-list
44027900|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44027901|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027902|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027903|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027904|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027905|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027906|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027907|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027908|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027909|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027910|NCT00000379|Fluoxetine|fluoxetine|mesh-list
44027911|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44027912|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027913|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027914|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027915|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027916|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
44027917|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027918|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44027919|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027920|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027921|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44027922|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44027923|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027925|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027926|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027927|NCT00000384|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44027928|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027929|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43643368|NCT05073172|Petrolatum|petrolatum|mesh-list
44249914|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249915|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44249916|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44027930|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027931|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027932|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
44027933|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027934|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
44027935|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027936|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027937|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027938|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027939|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
44027940|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44027941|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027942|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027943|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
44027944|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44028056|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
44028057|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028058|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
44028059|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028060|NCT00000440|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44028061|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44028062|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028063|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028064|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028065|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
44028173|NCT00000451|Sertraline|sertraline|mesh-list
44028174|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028175|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028176|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028177|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
44028178|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028179|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
44028180|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028181|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44028490|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028491|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028492|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44028493|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44028494|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
44028495|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028496|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
44028497|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44028498|NCT00000580|Antibodies|antibodies|mesh-list
44028499|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
44028500|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44028501|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
44028502|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028503|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
44028504|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44028505|NCT00000584|Antibodies|antibodies|mesh-list
44028506|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
44028507|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028508|NCT00000585|Penicillins|penicillins|mesh-list
44028509|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028510|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028511|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
44028512|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44028513|NCT00000590|Antibodies|antibodies|mesh-list
44028514|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
44028515|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028516|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44028517|NCT00000597|Nandrolone|nandrolone|mesh-list
44028518|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44028519|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44028520|NCT00000597|Androgens|androgens|mesh-ancestor
44028521|NCT00000597|Hormones|hormones|mesh-ancestor
44028522|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643369|NCT05073172|Mineral Oil|mineral oil|mesh-list
44249918|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249919|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249920|NCT04833140|Estradiol|estradiol|mesh-list
44249921|NCT04833140|Estrogens|estrogens|mesh-ancestor
44249922|NCT04833140|Hormones|hormones|mesh-ancestor
44249923|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44249924|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249925|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
44249926|NCT04808934|Apixaban|apixaban|mesh-list
44249927|NCT04808934|Dabigatran|dabigatran|mesh-list
43648483|NCT02867813|Evolocumab|evolocumab|mesh-list
44028523|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028524|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
44028525|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44028526|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
44028527|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44028528|NCT00000600|Vitamins|vitamins|mesh-list
44028529|NCT00000600|Ascorbic Acid|ascorbic acid|mesh-list
44028530|NCT00000600|Vitamin E|vitamin e|mesh-list
44028531|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
44028532|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028533|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
44028534|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028535|NCT00000600|Protective Agents|protective agents|mesh-ancestor
44028536|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44028537|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
44028538|NCT00000605|Hormones|hormones|mesh-list
44028539|NCT00000605|Estrogens|estrogens|mesh-list
44028540|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028541|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028542|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44028543|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44028544|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44028545|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
44028546|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44028547|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44028548|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44028549|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44028550|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44028551|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028552|NCT00000613|Genistein|genistein|mesh-list
44028553|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44028554|NCT00000613|Protective Agents|protective agents|mesh-ancestor
44028555|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028556|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028557|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44028558|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028559|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028560|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
44028561|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44028562|NCT00000613|Estrogens|estrogens|mesh-ancestor
44028563|NCT00000613|Hormones|hormones|mesh-ancestor
44067118|NCT00008424|Irinotecan|irinotecan|mesh-list
44028603|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44028604|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
44028605|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44028606|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44028607|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44028608|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44028609|NCT00000627|Fluconazole|fluconazole|mesh-list
44028610|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
44028664|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44028665|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44028666|NCT00000636|Pyridoxine|pyridoxine|mesh-list
44249928|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44249930|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43648495|NCT02777372|Sertraline|sertraline|mesh-list
44028667|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
44028668|NCT00000636|Rifampin|rifampin|mesh-list
44028669|NCT00000636|Isoniazid|isoniazid|mesh-list
44028670|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
44028671|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44028672|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
44028673|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028674|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028675|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
44028676|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028677|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028678|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028679|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44028680|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44028681|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44028716|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
44028717|NCT00000638|Vitamins|vitamins|mesh-ancestor
44028718|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
44028719|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028720|NCT00000647|Interferons|interferons|mesh-list
44028721|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
44028760|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
44028761|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028762|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
44028763|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
44028764|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028765|NCT00000653|Zalcitabine|zalcitabine|mesh-list
44028766|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
44028767|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028768|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028769|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028770|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028771|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
44028772|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028773|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028774|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028775|NCT00000654|Fialuridine|fialuridine|mesh-list
44028776|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
44028777|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028778|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028779|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028780|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028781|NCT00000655|Trimethoprim|trimethoprim|mesh-list
44028782|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44028783|NCT00000655|Atovaquone|atovaquone|mesh-list
44028784|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
44028785|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44028786|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028787|NCT00000655|Renal Agents|renal agents|mesh-ancestor
44028788|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
44028789|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44028790|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44028791|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44028792|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028793|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028794|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44028795|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44028796|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44028797|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028798|NCT00000656|Zidovudine|zidovudine|mesh-list
44028799|NCT00000656|Didanosine|didanosine|mesh-list
44028800|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
44028908|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44028909|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028910|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
44028911|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
44028912|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028913|NCT00000662|Zidovudine|zidovudine|mesh-list
44249931|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
44249932|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44249933|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249935|NCT04786275|Fentanyl|fentanyl|mesh-list
44028914|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
44028915|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028916|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028917|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028918|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028919|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
44028920|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028921|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028922|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028923|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44028924|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
44028925|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028926|NCT00000664|Zidovudine|zidovudine|mesh-list
44028927|NCT00000664|Interleukin-2|interleukin-2|mesh-list
44028928|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028929|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44028930|NCT00000664|Analgesics|analgesics|mesh-ancestor
44028931|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
44028932|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028933|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028934|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
44029047|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029048|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029049|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029050|NCT00000695|Interferons|interferons|mesh-list
44029051|NCT00000695|Zidovudine|zidovudine|mesh-list
44029052|NCT00000695|Interferon-beta|interferon-beta|mesh-list
44029053|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
44029054|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029055|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
44029056|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029057|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
44029058|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029059|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029060|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029061|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029063|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029064|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
44029065|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029066|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44029067|NCT00000697|Foscarnet|foscarnet|mesh-list
44029068|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44029069|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
44029070|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029071|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029072|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029211|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
44029212|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
44029213|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
44029214|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44029215|NCT00000706|Renal Agents|renal agents|mesh-ancestor
44029216|NCT00000709|Zidovudine|zidovudine|mesh-list
44029217|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
44029218|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029219|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029220|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029221|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029222|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
44029223|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029224|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029225|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029226|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44029227|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
44029325|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
44029326|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
44029327|NCT00000727|Trimethoprim|trimethoprim|mesh-list
44029328|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
44249936|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44249937|NCT04786275|Narcotics|narcotics|mesh-ancestor
44249938|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249939|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249940|NCT04786275|Analgesics|analgesics|mesh-ancestor
44249941|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
44249942|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44249943|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44249944|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44249945|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
44249946|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
44249947|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
44249948|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44249949|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44249950|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249951|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
44249952|NCT04785651|Coagulants|coagulants|mesh-ancestor
44249953|NCT04675866|Paclitaxel|paclitaxel|mesh-list
44249954|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44249955|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43648503|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
44029614|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029615|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029616|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029617|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44029618|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44029620|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029621|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029622|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029623|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029624|NCT00000772|Ribavirin|ribavirin|mesh-list
44029625|NCT00000772|Didanosine|didanosine|mesh-list
44029626|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
44029627|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029628|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
44029629|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029630|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029631|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029632|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029633|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029634|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029635|NCT00000773|Atovaquone|atovaquone|mesh-list
44029636|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029637|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
44029638|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029639|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029640|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029641|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029642|NCT00000776|Fluconazole|fluconazole|mesh-list
44029643|NCT00000776|Amphotericin B|amphotericin b|mesh-list
44029644|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44029645|NCT00000776|Flucytosine|flucytosine|mesh-list
44029646|NCT00000776|Dexamethasone|dexamethasone|mesh-list
44029647|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029648|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
44029649|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
43643370|NCT05073172|Emollients|emollients|mesh-ancestor
44249956|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249957|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44249958|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44249959|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44249960|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249961|NCT04623944|Cytarabine|cytarabine|mesh-list
44029650|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029651|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029652|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029653|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
44029654|NCT00000776|Hormones|hormones|mesh-ancestor
44029655|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029656|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029756|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44029757|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44029758|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44029759|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44029760|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44029761|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44029762|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44029763|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
44029764|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44029765|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029766|NCT00000796|Vitamins|vitamins|mesh-ancestor
44029767|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
44029768|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029769|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029770|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44029771|NCT00000800|Zidovudine|zidovudine|mesh-list
44029864|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029866|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029867|NCT00000807|Etoposide|etoposide|mesh-list
44029868|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44029869|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029870|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44029871|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44029872|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029873|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029874|NCT00000808|Nevirapine|nevirapine|mesh-list
44029875|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029876|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029877|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029878|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029879|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
44029880|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029881|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029882|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44149053|NCT00206544|Tamoxifen|tamoxifen|mesh-list
43759362|NCT02450058|Paclitaxel|paclitaxel|mesh-list
44029883|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44029884|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44029885|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44029886|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44029887|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
44029888|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029889|NCT00000809|Antacids|antacids|mesh-ancestor
44029890|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029891|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029892|NCT00000810|Zidovudine|zidovudine|mesh-list
44029893|NCT00000810|Didanosine|didanosine|mesh-list
44029894|NCT00000810|Delavirdine|delavirdine|mesh-list
44029895|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
44029896|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030121|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030122|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
44030123|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44030124|NCT00000856|Ganciclovir|ganciclovir|mesh-list
43643371|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249962|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
44249963|NCT04623944|Fludarabine|fludarabine|mesh-list
44249964|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44030125|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44030126|NCT00000856|Foscarnet|foscarnet|mesh-list
44030127|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44030128|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
44030129|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030130|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030131|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030132|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030133|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030134|NCT00000861|Indinavir|indinavir|mesh-list
44030135|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030136|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030137|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030138|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030139|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030140|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030141|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030142|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
44030193|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030221|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030222|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030223|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
44030224|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030225|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030226|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030227|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
44030228|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030229|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44030230|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44030231|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44030232|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
44030233|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
44030234|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
44030235|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
44030236|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44030237|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44030238|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
44030239|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
44030240|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44030241|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44030242|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
44030243|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44030244|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030245|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030246|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030247|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44030248|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
44030249|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030251|NCT00000878|Zidovudine|zidovudine|mesh-list
44030252|NCT00000878|Stavudine|stavudine|mesh-list
44030253|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030254|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030255|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030256|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030257|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
44030258|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030259|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44149067|NCT00206557|Estradiol|estradiol|mesh-list
44149068|NCT00206557|Estrogens|estrogens|mesh-ancestor
44149106|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
44030324|NCT00000887|Zidovudine|zidovudine|mesh-list
44030325|NCT00000887|Nelfinavir|nelfinavir|mesh-list
44030326|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030327|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030328|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030329|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030330|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
44030331|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030332|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030503|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43643548|NCT04981509|Atezolizumab|atezolizumab|mesh-list
44249965|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
44249966|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249967|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44249968|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249969|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
44249970|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249971|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249972|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44030504|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030505|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030506|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030508|NCT00000916|Zidovudine|zidovudine|mesh-list
44030509|NCT00000916|Didanosine|didanosine|mesh-list
44030510|NCT00000916|Stavudine|stavudine|mesh-list
44030511|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44030512|NCT00000916|Indinavir|indinavir|mesh-list
44030513|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
44030514|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030515|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030516|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030517|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030759|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030760|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030766|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44030767|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
44030768|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44030769|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
44030770|NCT00000950|Vitamins|vitamins|mesh-ancestor
44030771|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
44030772|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030773|NCT00000953|Acyclovir|acyclovir|mesh-list
44030774|NCT00000953|Sorivudine|sorivudine|mesh-list
44030775|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
44030776|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030777|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030778|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030779|NCT00000954|Didanosine|didanosine|mesh-list
44030780|NCT00000954|Zalcitabine|zalcitabine|mesh-list
44030781|NCT00000954|Doxorubicin|doxorubicin|mesh-list
44030782|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44030783|NCT00000954|Bleomycin|bleomycin|mesh-list
44030784|NCT00000954|Vincristine|vincristine|mesh-list
44030785|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44030786|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030787|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44030788|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44030789|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030790|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030791|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44030792|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44030793|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44030794|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
44030795|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
44030796|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030797|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030798|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
44030799|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030800|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030801|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030802|NCT00000960|Zidovudine|zidovudine|mesh-list
44030803|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
44030804|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030805|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030806|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030807|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030808|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
44249973|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44249974|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
44249975|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
44249976|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44249978|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
44249979|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44249980|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44249981|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
44249982|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
44249983|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903338|NCT00125593|Simvastatin|simvastatin|mesh-list
44249984|NCT04562090|Mirabegron|mirabegron|mesh-list
44249985|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44249986|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44249988|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
44249989|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44249990|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249991|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249992|NCT04562090|Urological Agents|urological agents|mesh-ancestor
44249993|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
44249994|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
44249995|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
44249996|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44249997|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249998|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
44249999|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460387|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460388|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460389|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
44460390|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460391|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
44460392|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460393|NCT01564784|Analgesics|analgesics|mesh-ancestor
44030809|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030810|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030811|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030812|NCT00000961|Zidovudine|zidovudine|mesh-list
44460394|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
44460395|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460396|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44460397|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44030813|NCT00000961|Immune Sera|immune sera|mesh-list
44030814|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
44030815|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030816|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030817|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030818|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030819|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
44030820|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030821|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030822|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030823|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
44030824|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030825|NCT00000963|Didanosine|didanosine|mesh-list
44030826|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
44030827|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030828|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030829|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030830|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030837|NCT00000964|Ranitidine|ranitidine|mesh-list
44030838|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44030839|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44030840|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44030841|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44030842|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
44030843|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
44030844|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44030845|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030846|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030847|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
44030848|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030849|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030850|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030851|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030852|NCT00000967|Interferons|interferons|mesh-list
44030854|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
44030855|NCT00000967|Zidovudine|zidovudine|mesh-list
44030856|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030857|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
44030858|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030859|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
44030860|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030861|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
44030862|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030863|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030864|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030865|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030866|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030867|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030868|NCT00000974|Pentamidine|pentamidine|mesh-list
44030869|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
44030870|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030871|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44030872|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44030873|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44030874|NCT00000976|Zidovudine|zidovudine|mesh-list
44030875|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44030876|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
44030877|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030878|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030879|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030880|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030881|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
44030882|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030883|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030884|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030885|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
44030886|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460399|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460400|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44460401|NCT01564758|Linezolid|linezolid|mesh-list
44460402|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44460403|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460404|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43648528|NCT02427451|Venetoclax|venetoclax|mesh-list
44030887|NCT00000979|Zidovudine|zidovudine|mesh-list
44030888|NCT00000979|Didanosine|didanosine|mesh-list
44030889|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
44030890|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030891|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030892|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030893|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030894|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
44030895|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030896|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030897|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030898|NCT00000980|Spiramycin|spiramycin|mesh-list
44030899|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030900|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030901|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
43760287|NCT03808025|Narcotics|narcotics|mesh-ancestor
44030902|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44030972|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030973|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030974|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
44030975|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030976|NCT00000990|Zidovudine|zidovudine|mesh-list
44030977|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
44030978|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030979|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030980|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030981|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030982|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
44030983|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030984|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030985|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030986|NCT00000991|Zidovudine|zidovudine|mesh-list
44030987|NCT00000991|Trimethoprim|trimethoprim|mesh-list
44030988|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
44030989|NCT00000991|Dapsone|dapsone|mesh-list
44030990|NCT00000991|Pentamidine|pentamidine|mesh-list
44030991|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44030992|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
44030993|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031029|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031030|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031032|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
44031033|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031034|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031035|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031036|NCT00000994|Zidovudine|zidovudine|mesh-list
44031037|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
44031038|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031039|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031040|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031041|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031042|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
44031079|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031080|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031081|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44031082|NCT00001006|Protective Agents|protective agents|mesh-ancestor
44031083|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031084|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031085|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031086|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460405|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460406|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460408|NCT01564277|Rasburicase|rasburicase|mesh-list
44460409|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
44460410|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031087|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
44031088|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031090|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
44031091|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
44031092|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
44031093|NCT00001015|Ribavirin|ribavirin|mesh-list
44031094|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
44031095|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031096|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
44031097|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031098|NCT00001016|Leucovorin|leucovorin|mesh-list
44031099|NCT00001016|Trimetrexate|trimetrexate|mesh-list
44031100|NCT00001016|Calcium|calcium|mesh-list
44031101|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
44031102|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44031124|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031125|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031126|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44031127|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
44031128|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031129|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760457|NCT01194622|Xhance|xhance|mesh-list
44031130|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44031131|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44031133|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031134|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031135|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031136|NCT00001022|Zidovudine|zidovudine|mesh-list
44031137|NCT00001022|Didanosine|didanosine|mesh-list
44031138|NCT00001022|Zalcitabine|zalcitabine|mesh-list
44031139|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
44031140|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031141|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031142|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031143|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031144|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
44031145|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031146|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031147|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031148|NCT00001023|Azithromycin|azithromycin|mesh-list
44031149|NCT00001023|Clarithromycin|clarithromycin|mesh-list
44031150|NCT00001023|Rifabutin|rifabutin|mesh-list
44031151|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031152|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031153|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44031154|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031155|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031156|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031157|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031232|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031233|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031234|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031235|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
44031237|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44031238|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
44031239|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031240|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
44031241|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031242|NCT00001042|Antacids|antacids|mesh-ancestor
44031298|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
44031299|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031300|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44460412|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
44460413|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460414|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44460415|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
44460416|NCT01564277|Protective Agents|protective agents|mesh-ancestor
44460417|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460418|NCT01563536|Ritonavir|ritonavir|mesh-list
44460419|NCT01563536|Ribavirin|ribavirin|mesh-list
44460420|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44460421|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44460422|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031301|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031303|NCT00001058|Indinavir|indinavir|mesh-list
44031304|NCT00001058|Clarithromycin|clarithromycin|mesh-list
44031305|NCT00001058|Ethambutol|ethambutol|mesh-list
44031306|NCT00001058|Rifabutin|rifabutin|mesh-list
44031307|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031308|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031309|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031310|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031311|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031312|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031313|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031314|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
44031315|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031316|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031317|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031318|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031319|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44031320|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
44031321|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44031322|NCT00001059|Doxorubicin|doxorubicin|mesh-list
44031323|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44031324|NCT00001059|Bleomycin|bleomycin|mesh-list
44031325|NCT00001059|Vincristine|vincristine|mesh-list
44031326|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031327|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031328|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44031329|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031330|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031331|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031332|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031333|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031334|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031335|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031336|NCT00001061|Ganciclovir|ganciclovir|mesh-list
44031337|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44031401|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
44031416|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
44031417|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
44031418|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44031419|NCT00001079|Androgens|androgens|mesh-ancestor
44031420|NCT00001079|Hormones|hormones|mesh-ancestor
44067700|NCT00000151|Analgesics|analgesics|mesh-ancestor
44031421|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031422|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031423|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44031424|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031425|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
44031426|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44031427|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44031428|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44031429|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
44031430|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44031431|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44460423|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460424|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460425|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44460426|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44460427|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
44460428|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460429|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44460430|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460431|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
44460433|NCT01563354|Pasireotide|pasireotide|mesh-list
44460434|NCT01563354|Somatostatin|somatostatin|mesh-list
44460435|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460436|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460437|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
44031432|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44031433|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
44031434|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44031435|NCT00001080|Lamivudine|lamivudine|mesh-list
44031436|NCT00001080|Vaccines|vaccines|mesh-list
44031437|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44031438|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
44031439|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031440|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031441|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031442|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031443|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031444|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
44031445|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031446|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031447|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031448|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
44031449|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031450|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031451|NCT00001082|Adefovir|adefovir|mesh-list
44031452|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44031453|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
44031454|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031455|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031456|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031457|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031458|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031459|NCT00001088|Bupivacaine|bupivacaine|mesh-list
44031460|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
44031461|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
44031462|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44031463|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031737|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
44031738|NCT00001209|Ifosfamide|ifosfamide|mesh-list
44031739|NCT00001209|Vincristine|vincristine|mesh-list
44031740|NCT00001209|Doxorubicin|doxorubicin|mesh-list
44150928|NCT00211744|Topiramate|topiramate|mesh-list
44031741|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44031742|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031743|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
44031744|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031782|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44031783|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44031784|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
44032032|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032033|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460438|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460439|NCT01563354|Hormones|hormones|mesh-ancestor
44460440|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032034|NCT00001446|Thalidomide|thalidomide|mesh-list
44032035|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032036|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
44032037|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032038|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
44032039|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032040|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032041|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032042|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44032043|NCT00001446|Growth Substances|growth substances|mesh-ancestor
44032044|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032045|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032046|NCT00001449|Leucovorin|leucovorin|mesh-list
44032047|NCT00001449|Gemcitabine|gemcitabine|mesh-list
44032048|NCT00001449|Floxuridine|floxuridine|mesh-list
44032049|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44032050|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
44032051|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032118|NCT00001504|Tretinoin|tretinoin|mesh-list
44032119|NCT00001504|Alitretinoin|alitretinoin|mesh-list
44032120|NCT00001504|Isotretinoin|isotretinoin|mesh-list
44032121|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032122|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
44032123|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032191|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032192|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44032193|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032194|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032196|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032198|NCT00001579|Protective Agents|protective agents|mesh-ancestor
44032199|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
44032200|NCT00001579|Vitamins|vitamins|mesh-ancestor
44032201|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
44032202|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032203|NCT00001587|Melphalan|melphalan|mesh-list
44032204|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44032205|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
44149211|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149212|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149213|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149214|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149231|NCT00206973|Diuretics|diuretics|mesh-ancestor
44149232|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
44149233|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149234|NCT00206986|Clonidine|clonidine|mesh-list
44149235|NCT00206986|Analgesics|analgesics|mesh-ancestor
44149236|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
44149237|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149238|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032224|NCT00001626|Cyclosporine|cyclosporine|mesh-list
44032225|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
44032226|NCT00001626|Cyclosporins|cyclosporins|mesh-list
44032227|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44032228|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032229|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
44032230|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032231|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032232|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44032233|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
44032234|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032235|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032236|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44032237|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032238|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
44032239|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032240|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032241|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44032242|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
44032243|NCT00001628|Giapreza|giapreza|mesh-list
44032244|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
44460441|NCT01563185|Ibuprofen|ibuprofen|mesh-list
44460442|NCT01563185|Famotidine|famotidine|mesh-list
44460443|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44460444|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44460445|NCT01563185|Analgesics|analgesics|mesh-ancestor
44460446|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
44250000|NCT04524130|Lidocaine|lidocaine|mesh-list
44250001|NCT04524130|Ketamine|ketamine|mesh-list
44250002|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
44250003|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
44250004|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250005|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250006|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
44250007|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250008|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44250009|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44250010|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44250011|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250012|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250013|NCT04524130|Analgesics|analgesics|mesh-ancestor
44250014|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44250015|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44250016|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
44250017|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44250018|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44250019|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250023|NCT04472637|Atorvastatin|atorvastatin|mesh-list
44250024|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44032245|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
44032246|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44032247|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44032248|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
44032249|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032250|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032251|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44032252|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
44032253|NCT00001629|Giapreza|giapreza|mesh-list
44032254|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
44032255|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
44032256|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44032257|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44032258|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
44032259|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250025|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44250026|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
44250027|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250028|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43648605|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032260|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032280|NCT00001658|Amoxicillin|amoxicillin|mesh-list
44032281|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032282|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032283|NCT00001676|Fludarabine|fludarabine|mesh-list
44032284|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032285|NCT00001677|Methotrexate|methotrexate|mesh-list
44032286|NCT00001677|Fludarabine|fludarabine|mesh-list
44032287|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44032288|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
44032289|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44032290|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032291|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44032292|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
44032293|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032294|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032295|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032296|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032297|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44032298|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032299|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
44032300|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032301|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032302|NCT00001680|Thalidomide|thalidomide|mesh-list
44032303|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032304|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
44032305|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032306|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
44032307|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032308|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032309|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032310|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44032311|NCT00001680|Growth Substances|growth substances|mesh-ancestor
44032312|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032313|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032314|NCT00001689|Vincristine|vincristine|mesh-list
44032315|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032380|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032381|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032382|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032383|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44032384|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
44032418|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
44032419|NCT00001812|Ionophores|ionophores|mesh-ancestor
44032420|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44032421|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032422|NCT00001827|Aldesleukin|aldesleukin|mesh-list
44032423|NCT00001827|Sargramostim|sargramostim|mesh-list
44032424|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
44032425|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
44032426|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032427|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032428|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032429|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032430|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
44032431|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032432|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032434|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032435|NCT00001839|Cyclosporine|cyclosporine|mesh-list
44032436|NCT00001839|Cyclosporins|cyclosporins|mesh-list
44032437|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44032438|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032439|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250029|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44250030|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250031|NCT04450329|Aflibercept|aflibercept|mesh-list
44250032|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032440|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032441|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
44032442|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032443|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
44032444|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032445|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032446|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761727|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032447|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44032448|NCT00001842|Dexamethasone|dexamethasone|mesh-list
44032449|NCT00001842|Lenograstim|lenograstim|mesh-list
44032450|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032451|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
44032452|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
44032453|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032454|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032455|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032456|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
44032457|NCT00001842|Hormones|hormones|mesh-ancestor
44032458|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032459|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032460|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032461|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032462|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
44032463|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44032464|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44032465|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032466|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032467|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032468|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44032469|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44032470|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44032471|NCT00001854|Ribavirin|ribavirin|mesh-list
44032472|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
44032473|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032474|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
44032475|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032476|NCT00001860|Octreotide|octreotide|mesh-list
44032477|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032478|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44032479|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032480|NCT00001862|Etanercept|etanercept|mesh-list
44032481|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032482|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032483|NCT00001862|Analgesics|analgesics|mesh-ancestor
44032484|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
44032485|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032486|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032487|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032488|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032489|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032490|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032491|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
44032492|NCT00001863|Leflunomide|leflunomide|mesh-list
44032493|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032494|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032495|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032496|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
44032497|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032498|NCT00001864|Atropine|atropine|mesh-list
44032499|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44032517|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032518|NCT00001870|Acetylcholine|acetylcholine|mesh-list
44032519|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44032520|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44250033|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44250034|NCT04450329|Growth Substances|growth substances|mesh-ancestor
44250035|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250036|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032521|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
44032522|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149239|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44032523|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032524|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032525|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
44032526|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44032527|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032528|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032529|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44032530|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44032531|NCT00001877|Protective Agents|protective agents|mesh-ancestor
44032532|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032533|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
44032534|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44032535|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
44149240|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
44149241|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
44149242|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44149243|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44149244|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44149245|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
44149246|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149247|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149248|NCT00206999|Imipramine|imipramine|mesh-list
44149249|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44149250|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149251|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149252|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44149253|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149254|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149255|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149256|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
44149257|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149258|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149259|NCT00207051|Cetuximab|cetuximab|mesh-list
44149260|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149261|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149262|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44149263|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149264|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149265|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149266|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149267|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149268|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149269|NCT00207077|Cetuximab|cetuximab|mesh-list
44149270|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44149271|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149272|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149273|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44149274|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068018|NCT00000378|Sertraline|sertraline|mesh-list
44149275|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149276|NCT00207116|Cetuximab|cetuximab|mesh-list
44149277|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149278|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149279|NCT00207129|Capecitabine|capecitabine|mesh-list
44149280|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149281|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
44149282|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149283|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149284|NCT00207155|Cetuximab|cetuximab|mesh-list
44149285|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149286|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149287|NCT00207311|Interferons|interferons|mesh-list
44149288|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
44250037|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250038|NCT04432623|Benserazide|benserazide|mesh-list
44250039|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44250040|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44250041|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250042|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250043|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
44250044|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250045|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250046|NCT04431778|Ethosuximide|ethosuximide|mesh-list
44250047|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
44250048|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
44250049|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44250050|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250051|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250052|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44250053|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44250054|NCT04417049|Protective Agents|protective agents|mesh-ancestor
44250055|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250056|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
44250057|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44250058|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
44250059|NCT04246437|Carbidopa|carbidopa|mesh-list
44250060|NCT04246437|Entacapone|entacapone|mesh-list
44250061|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43648635|NCT00467987|Hormones|hormones|mesh-ancestor
44149289|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
44149290|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44149291|NCT00207311|Orlistat|orlistat|mesh-list
44149292|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149293|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
44149294|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149295|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
44149296|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149297|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149298|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149299|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44149300|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44032536|NCT00001889|Dobutamine|dobutamine|mesh-list
44032537|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44032538|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
44032539|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
44032540|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032541|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032542|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44032543|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44068137|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44032544|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44032545|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44032546|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032547|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250062|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44250063|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
44250064|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032548|NCT00001889|Protective Agents|protective agents|mesh-ancestor
44032549|NCT00001890|Estrogens|estrogens|mesh-list
44032550|NCT00001890|Hormones|hormones|mesh-ancestor
44032551|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032552|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032553|NCT00001891|Dobutamine|dobutamine|mesh-list
44032554|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44032555|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
44032556|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
44032557|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032558|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032559|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44032560|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44032561|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44032562|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44032563|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032564|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032565|NCT00001891|Protective Agents|protective agents|mesh-ancestor
44032566|NCT00001893|Etanercept|etanercept|mesh-list
44032567|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032568|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032569|NCT00001893|Analgesics|analgesics|mesh-ancestor
44032634|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032635|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
44032636|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032637|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032638|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032639|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032640|NCT00001930|Analgesics|analgesics|mesh-ancestor
44032641|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
44032642|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032643|NCT00001933|Nefiracetam|nefiracetam|mesh-list
44032644|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44032645|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44032646|NCT00001933|Protective Agents|protective agents|mesh-ancestor
44032647|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032648|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
44032649|NCT00001934|Daclizumab|daclizumab|mesh-list
44032650|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032651|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
44032708|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44032709|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032710|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032711|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032712|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032713|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
44032715|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032716|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
44032717|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032718|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032719|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032720|NCT00001963|Chrysarobin|chrysarobin|mesh-list
44032721|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
44032722|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44032723|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
44032724|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032725|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032726|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44032727|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
44032728|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44032729|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
44032730|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032731|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032732|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44032733|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
44032734|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
44032735|NCT00001963|Protective Agents|protective agents|mesh-ancestor
44250067|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44250068|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250069|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44250070|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
44250071|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44032736|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032737|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032738|NCT00001963|Analgesics|analgesics|mesh-ancestor
44032739|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
44032740|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032741|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032742|NCT00001964|Cyclosporine|cyclosporine|mesh-list
44032743|NCT00001964|Cyclosporins|cyclosporins|mesh-list
44032774|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032775|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032776|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032777|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
44032778|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032779|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44032780|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032781|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032782|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032783|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44032784|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
44032785|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032787|NCT00001989|Trichosanthin|trichosanthin|mesh-list
44032788|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
44032789|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032809|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032811|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032812|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
44032813|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032814|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032815|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032816|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032818|NCT00001993|Zidovudine|zidovudine|mesh-list
44032819|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
44032820|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032821|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032822|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032823|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032824|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
44032825|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032826|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032827|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032828|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44032829|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44032830|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032831|NCT00001994|Atovaquone|atovaquone|mesh-list
44032832|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032833|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
44032834|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032835|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032836|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032837|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032839|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032840|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032841|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44032842|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
44032843|NCT00001996|Atovaquone|atovaquone|mesh-list
44250072|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250073|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
44250074|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44250075|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44032844|NCT00001996|Pentamidine|pentamidine|mesh-list
44032845|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032846|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
44032941|NCT00002006|Zidovudine|zidovudine|mesh-list
44032942|NCT00002006|Sargramostim|sargramostim|mesh-list
44032943|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
44032944|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032945|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032946|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032947|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032948|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
44032949|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032950|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032951|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032952|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
44032953|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032954|NCT00002007|Zidovudine|zidovudine|mesh-list
44032955|NCT00002007|Sargramostim|sargramostim|mesh-list
44032956|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
44032957|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032958|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032959|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032960|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032961|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
44032962|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032963|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032964|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032965|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
44032966|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032967|NCT00002008|Sargramostim|sargramostim|mesh-list
44032968|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
44032969|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032970|NCT00002009|Sargramostim|sargramostim|mesh-list
44033018|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033019|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
44033020|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033021|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033022|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033023|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033024|NCT00002017|Interleukin-2|interleukin-2|mesh-list
44033025|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033026|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44033027|NCT00002017|Analgesics|analgesics|mesh-ancestor
44033066|NCT00002023|Zidovudine|zidovudine|mesh-list
44033067|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
44033155|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033157|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
44033158|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033159|NCT00002037|Trifluridine|trifluridine|mesh-list
44033160|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
44033161|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033162|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
44033163|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033164|NCT00002038|Fluconazole|fluconazole|mesh-list
44033165|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
44033166|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033167|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033168|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033169|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033170|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033171|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033172|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
44063443|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033173|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033174|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033175|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033176|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44250076|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44250077|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250078|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250079|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
44250080|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250081|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250082|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44250083|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250084|NCT04177953|Cisplatin|cisplatin|mesh-list
44250085|NCT04177953|Carboplatin|carboplatin|mesh-list
44033177|NCT00002039|Foscarnet|foscarnet|mesh-list
44033178|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44033179|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
44033180|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033181|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033182|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033183|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033184|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033232|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033233|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033234|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
44033235|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033236|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033237|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033238|NCT00002046|Zidovudine|zidovudine|mesh-list
44033239|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
44033240|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033241|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033242|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033243|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033244|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
44033245|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033246|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033247|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033248|NCT00002047|Zidovudine|zidovudine|mesh-list
44033249|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
44033250|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033251|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033252|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033253|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033254|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
44033255|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033256|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033257|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033258|NCT00002048|Zidovudine|zidovudine|mesh-list
44033259|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
44033260|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033261|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033262|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033263|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033264|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
44033265|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033289|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033290|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44033291|NCT00002054|Pentamidine|pentamidine|mesh-list
44033292|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
44033293|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033294|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033295|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033296|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44033297|NCT00002055|Pentamidine|pentamidine|mesh-list
44033298|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
44033299|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033300|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033301|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44250086|NCT04177953|Nivolumab|nivolumab|mesh-list
44250087|NCT04177953|Pemetrexed|pemetrexed|mesh-list
44250088|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250089|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250090|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44033302|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44033303|NCT00002056|Pentamidine|pentamidine|mesh-list
44033304|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
44033305|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033306|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033307|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033308|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44033309|NCT00002057|Nystatin|nystatin|mesh-list
44033310|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033311|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033312|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
44033313|NCT00002057|Ionophores|ionophores|mesh-ancestor
44033314|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44033315|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033316|NCT00002058|Clofazimine|clofazimine|mesh-list
44033317|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44033318|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
44033319|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033320|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033321|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
44033322|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033384|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033385|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44033386|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44033387|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44033388|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033389|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
44033390|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44033391|NCT00002068|Fluconazole|fluconazole|mesh-list
44033392|NCT00002068|Amphotericin B|amphotericin b|mesh-list
44033393|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44033394|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
44033395|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033396|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033397|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033398|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033399|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033400|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033401|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033402|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033403|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033404|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033405|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033406|NCT00002068|Amebicides|amebicides|mesh-ancestor
44033413|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033414|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
44033415|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033416|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
44033417|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
44033418|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033419|NCT00002070|Ganciclovir|ganciclovir|mesh-list
44033420|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033421|NCT00002070|Sargramostim|sargramostim|mesh-list
44033422|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
44033423|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033424|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
44033425|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033426|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033427|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033428|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033429|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
44033430|NCT00002071|Hematinics|hematinics|mesh-ancestor
44033431|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
44033432|NCT00002072|Hematinics|hematinics|mesh-ancestor
44033433|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
44250091|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250093|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44250094|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44250095|NCT04145076|Citalopram|citalopram|mesh-list
44250096|NCT04145076|Tianeptine|tianeptine|mesh-list
44250097|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44250098|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44250099|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648673|NCT03035578|Morphine|morphine|mesh-list
44033434|NCT00002073|Hematinics|hematinics|mesh-ancestor
44033435|NCT00002074|Fluconazole|fluconazole|mesh-list
44033436|NCT00002074|Amphotericin B|amphotericin b|mesh-list
44033437|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44033438|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
44033439|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033440|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033441|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033442|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033443|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033444|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033446|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033447|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033448|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033449|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033450|NCT00002074|Amebicides|amebicides|mesh-ancestor
44033451|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033452|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033453|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033454|NCT00002075|Fluconazole|fluconazole|mesh-list
44033455|NCT00002075|Amphotericin B|amphotericin b|mesh-list
44033456|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44033457|NCT00002075|Flucytosine|flucytosine|mesh-list
44033458|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
44033459|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033460|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033461|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033462|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033463|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033464|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033465|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033466|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033467|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033468|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033469|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033470|NCT00002075|Amebicides|amebicides|mesh-ancestor
44033471|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033472|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033473|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033474|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
44033475|NCT00002076|Fluconazole|fluconazole|mesh-list
44033476|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
44033477|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033525|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44033526|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
44033527|NCT00002081|Zidovudine|zidovudine|mesh-list
44033528|NCT00002081|Zalcitabine|zalcitabine|mesh-list
44033529|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
44033530|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033531|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033532|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033533|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250100|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250101|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250102|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
44250103|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250104|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44250105|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
44250106|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44250107|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44250108|NCT04133948|Nivolumab|nivolumab|mesh-list
44250109|NCT04133948|Ipilimumab|ipilimumab|mesh-list
44250110|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250111|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250112|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250113|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250114|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
44250115|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
44250116|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250117|NCT04094961|Dexamethasone|dexamethasone|mesh-list
44250118|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
44250119|NCT04094961|Pomalidomide|pomalidomide|mesh-list
44250120|NCT04094961|Ixazomib|ixazomib|mesh-list
44250121|NCT04094961|BB 1101|bb 1101|mesh-list
44250122|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250123|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
44250124|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
44250125|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250126|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033534|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
44033535|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033536|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033537|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033538|NCT00002082|Azithromycin|azithromycin|mesh-list
44033539|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033540|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033541|NCT00002084|Valacyclovir|valacyclovir|mesh-list
44033542|NCT00002084|Acyclovir|acyclovir|mesh-list
44033543|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
44033544|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033545|NCT00002085|Azithromycin|azithromycin|mesh-list
44033546|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033547|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033548|NCT00002086|Interferons|interferons|mesh-list
44033549|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
44033550|NCT00002086|Zidovudine|zidovudine|mesh-list
44033551|NCT00002086|Zalcitabine|zalcitabine|mesh-list
44033552|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033553|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
44033554|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033555|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
44033556|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033557|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
44063444|NCT00006048|Antiviral Agents|antiviral agents|mesh-ancestor
44250127|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250128|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
44250129|NCT04094961|Hormones|hormones|mesh-ancestor
44033558|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033559|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033560|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033561|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033562|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033563|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033564|NCT00002089|Azithromycin|azithromycin|mesh-list
44033565|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033566|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033567|NCT00002090|Azithromycin|azithromycin|mesh-list
44033568|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033569|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033570|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
44033571|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44033572|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033573|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033574|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44033575|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44033576|NCT00002091|Protective Agents|protective agents|mesh-ancestor
44033577|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033607|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44033608|NCT00002094|Atevirdine|atevirdine|mesh-list
44033609|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033610|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033611|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033612|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033613|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
44033614|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033615|NCT00002095|Ganciclovir|ganciclovir|mesh-list
44033616|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033617|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
44033618|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033619|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033620|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033621|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033622|NCT00002096|Zidovudine|zidovudine|mesh-list
44033623|NCT00002096|Didanosine|didanosine|mesh-list
44033624|NCT00002096|Ganciclovir|ganciclovir|mesh-list
44033654|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
44033655|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033656|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033657|NCT00002099|Didanosine|didanosine|mesh-list
44033658|NCT00002099|Lentinan|lentinan|mesh-list
44033659|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
44033660|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033661|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033662|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033664|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
44033665|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033666|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033667|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033668|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033669|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
44033670|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033696|NCT00002102|Antidotes|antidotes|mesh-ancestor
44033697|NCT00002102|Protective Agents|protective agents|mesh-ancestor
44033698|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44033699|NCT00002102|Vitamins|vitamins|mesh-ancestor
44033700|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
44033701|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
44033702|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033703|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44033704|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
44033705|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033706|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033707|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44033708|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033709|NCT00002103|Leucovorin|leucovorin|mesh-list
44033710|NCT00002103|Trimetrexate|trimetrexate|mesh-list
44250130|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250131|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250132|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250133|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
44033711|NCT00002103|Calcium|calcium|mesh-list
44033712|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
44033713|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44033714|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033715|NCT00002103|Antidotes|antidotes|mesh-ancestor
44033716|NCT00002103|Protective Agents|protective agents|mesh-ancestor
44033717|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
44033718|NCT00002103|Vitamins|vitamins|mesh-ancestor
44033719|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
44033720|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
44033721|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033722|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44033723|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
44033724|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033751|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44033752|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44033753|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44033754|NCT00002106|Ranitidine|ranitidine|mesh-list
44033755|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44033756|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44033757|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44033758|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44033759|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
44033760|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
44033761|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44033762|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033763|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033764|NCT00002107|Aldesleukin|aldesleukin|mesh-list
44033765|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033766|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033767|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033768|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
44033769|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033770|NCT00002108|Lamivudine|lamivudine|mesh-list
44033771|NCT00002108|Zidovudine|zidovudine|mesh-list
44033772|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033773|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033774|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033790|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033791|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
44033792|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033793|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033794|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033795|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033796|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
44033797|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149321|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149322|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44149323|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149324|NCT00207428|Carbamazepine|carbamazepine|mesh-list
44149325|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
44149326|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
44149327|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149328|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149329|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033798|NCT00002110|Zidovudine|zidovudine|mesh-list
44033799|NCT00002110|Cysteamine|cysteamine|mesh-list
44033800|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
44033801|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033802|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033803|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033804|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033805|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
44033806|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033807|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033808|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44250135|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250137|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44250138|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44250139|NCT04094961|Growth Substances|growth substances|mesh-ancestor
44250140|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
44033809|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44033811|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44033812|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44033813|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
44033814|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033815|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033816|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033817|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033818|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
44033819|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033820|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44033821|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033822|NCT00002112|Fluconazole|fluconazole|mesh-list
44033823|NCT00002112|Nystatin|nystatin|mesh-list
44033824|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
44033825|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033826|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033827|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033828|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033862|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
44033863|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033864|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033865|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033866|NCT00002117|Zidovudine|zidovudine|mesh-list
44033867|NCT00002117|Zalcitabine|zalcitabine|mesh-list
44033868|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
44033869|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033870|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033871|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033872|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033873|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
44033874|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033875|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033876|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033877|NCT00002118|Zalcitabine|zalcitabine|mesh-list
44033878|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
44033879|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033880|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033881|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033882|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033883|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
44033884|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033885|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033886|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033887|NCT00002120|Leucovorin|leucovorin|mesh-list
44033888|NCT00002120|Trimethoprim|trimethoprim|mesh-list
44033889|NCT00002120|Dapsone|dapsone|mesh-list
44033890|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
44033891|NCT00002120|Trimetrexate|trimetrexate|mesh-list
44033892|NCT00002120|Calcium|calcium|mesh-list
44033893|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
44033894|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44033895|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033896|NCT00002120|Antidotes|antidotes|mesh-ancestor
44033897|NCT00002120|Protective Agents|protective agents|mesh-ancestor
44033898|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
44033899|NCT00002120|Vitamins|vitamins|mesh-ancestor
44033900|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
44033934|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033935|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44250142|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44250143|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
44250144|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250145|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
44250146|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
44250147|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903542|NCT00137969|Prednisone|prednisone|mesh-list
44033936|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
44033937|NCT00002123|Didanosine|didanosine|mesh-list
44033938|NCT00002123|Delavirdine|delavirdine|mesh-list
44033939|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
44033940|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033969|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033970|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
44033971|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033972|NCT00002127|Thalidomide|thalidomide|mesh-list
44033973|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44033974|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
44033975|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033976|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
44033977|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033978|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033979|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44033980|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44033981|NCT00002127|Growth Substances|growth substances|mesh-ancestor
44033982|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
44033983|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033985|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44033986|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
44033987|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033988|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033989|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033990|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034027|NCT00002131|Protective Agents|protective agents|mesh-ancestor
44034057|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
44034058|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034059|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034060|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034061|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034062|NCT00002135|Ganciclovir|ganciclovir|mesh-list
44034063|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44034064|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
44034065|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034066|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034067|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034101|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034102|NCT00002143|Acitretin|acitretin|mesh-list
44034103|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
44034104|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44034105|NCT00002144|Foscarnet|foscarnet|mesh-list
44034106|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44034107|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
44034108|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034109|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034122|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44034123|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
44034124|NCT00002146|Analgesics|analgesics|mesh-ancestor
44034125|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
44034126|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44034127|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034128|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
44034129|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44034130|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44034131|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
44034132|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44034133|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43643650|NCT04940871|Favipiravir|favipiravir|mesh-list
44250148|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
44250149|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250150|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
44250151|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
44034134|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034135|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44034136|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
44034137|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44034138|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
44034139|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034140|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034141|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034142|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034143|NCT00002147|Doxorubicin|doxorubicin|mesh-list
44034144|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44034145|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44034146|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034147|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44034148|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44034149|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034150|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034151|NCT00002148|OPC 14117|opc 14117|mesh-list
44034152|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44034153|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
44034154|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034155|NCT00002148|Protective Agents|protective agents|mesh-ancestor
44034156|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034157|NCT00002149|Amoxicillin|amoxicillin|mesh-list
44034158|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
44034159|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
44034160|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
44034161|NCT00002149|Ephedrine|ephedrine|mesh-list
44034162|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034163|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034164|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44034165|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034166|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034167|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44034168|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
44034169|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44034170|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034173|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
44034174|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44034175|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44034176|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
44034177|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44034178|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44034180|NCT00002154|Selegiline|selegiline|mesh-list
44034181|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
44034182|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44034183|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44034184|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44034185|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44034186|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034187|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034188|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44034189|NCT00002154|Protective Agents|protective agents|mesh-ancestor
44034190|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034191|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
44034192|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
44034193|NCT00002154|Vitamins|vitamins|mesh-ancestor
44034194|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
44034195|NCT00002155|Lamivudine|lamivudine|mesh-list
44034196|NCT00002155|Zidovudine|zidovudine|mesh-list
44034197|NCT00002155|Indinavir|indinavir|mesh-list
44034198|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034199|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034200|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034201|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034202|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
44034203|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034204|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44250152|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
44250154|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44250155|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44250156|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250157|NCT03960554|Denosumab|denosumab|mesh-list
44250158|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44250159|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250160|NCT03929601|Rituximab|rituximab|mesh-list
44250161|NCT03929601|Abatacept|abatacept|mesh-list
44250162|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250163|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250164|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
44250165|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250166|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250167|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250168|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250169|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250170|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
44250171|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250172|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250173|NCT03889756|Midazolam|midazolam|mesh-list
44250174|NCT03889756|Ketamine|ketamine|mesh-list
44250175|NCT03889756|Analgesics|analgesics|mesh-ancestor
44250176|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
44250177|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250178|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250179|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44250180|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44250181|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
44250182|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
44250183|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44034205|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034206|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
44034207|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034208|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034209|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034210|NCT00002156|Ganciclovir|ganciclovir|mesh-list
44034211|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44034212|NCT00002156|Fomivirsen|fomivirsen|mesh-list
44034213|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
44034214|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034215|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034216|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701499|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44250184|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44250185|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43648712|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
44034217|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034218|NCT00002157|Thalidomide|thalidomide|mesh-list
44034219|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44034220|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
44034221|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034222|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
44034223|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034224|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034225|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44034226|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44034227|NCT00002157|Growth Substances|growth substances|mesh-ancestor
44034228|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
44034229|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034230|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
44034231|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44034232|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034233|NCT00002159|Itraconazole|itraconazole|mesh-list
44034234|NCT00002159|Amphotericin B|amphotericin b|mesh-list
44034235|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44034236|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
44034237|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034238|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44034239|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034240|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034241|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034242|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44034243|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149330|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43763339|NCT02426723|Hormones|hormones|mesh-ancestor
44034289|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034290|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034291|NCT00002163|Abacavir|abacavir|mesh-list
44034292|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034293|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034294|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034295|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034296|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
44034297|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034298|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034299|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034300|NCT00002164|Nelfinavir|nelfinavir|mesh-list
44034301|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034302|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034303|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034304|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034305|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034306|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034307|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034308|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
44034309|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034310|NCT00002165|Nelfinavir|nelfinavir|mesh-list
44034311|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034312|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034313|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034314|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034315|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763417|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034316|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034317|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034318|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
44034319|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034320|NCT00002166|Nevirapine|nevirapine|mesh-list
44034321|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034322|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034323|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034324|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034325|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
44034326|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701500|NCT02724163|Cytarabine|cytarabine|mesh-list
44250186|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250187|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250188|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44250189|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44034352|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034353|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034354|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034355|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034356|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034357|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034358|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034359|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
44034360|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034361|NCT00002170|Nelfinavir|nelfinavir|mesh-list
44034362|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034363|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034364|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034365|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034366|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034367|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034368|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034369|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
44034370|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034371|NCT00002171|Nelfinavir|nelfinavir|mesh-list
44034372|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034373|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034374|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034375|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034376|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034377|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034378|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034379|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
44034380|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034480|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
44034481|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44034482|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034483|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44034484|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44034485|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44034486|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034487|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
44034488|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44034489|NCT00002183|Lamivudine|lamivudine|mesh-list
44034490|NCT00002183|Zidovudine|zidovudine|mesh-list
44034491|NCT00002183|Abacavir|abacavir|mesh-list
44034492|NCT00002183|Amprenavir|amprenavir|mesh-list
44034493|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034494|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034495|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034496|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034497|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
44034498|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034499|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034515|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034516|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034517|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034518|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034519|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
44069000|NCT00000612|Estrogens|estrogens|mesh-list
44034520|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034521|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034522|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034523|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
44034524|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034525|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034526|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034527|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034528|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034529|NCT00002185|Nelfinavir|nelfinavir|mesh-list
44250191|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44250192|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44250194|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
44250195|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
44250196|NCT03851627|Testosterone|testosterone|mesh-list
44034530|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034531|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034532|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034533|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034534|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034535|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034536|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034537|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
44034538|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034539|NCT00002186|Acyclovir|acyclovir|mesh-list
44034540|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
44034541|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034542|NCT00002187|Fomivirsen|fomivirsen|mesh-list
44034543|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
44034544|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763583|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
44034545|NCT00002188|Alitretinoin|alitretinoin|mesh-list
44034546|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034547|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44034548|NCT00002189|Paclitaxel|paclitaxel|mesh-list
44034549|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44034550|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034551|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
44034552|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
44034553|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
44034554|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034556|NCT00002190|Zidovudine|zidovudine|mesh-list
44034557|NCT00002190|Saquinavir|saquinavir|mesh-list
44034558|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034559|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034560|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034561|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034562|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
44034563|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034564|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034582|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034584|NCT00002192|Azithromycin|azithromycin|mesh-list
44034585|NCT00002192|Clarithromycin|clarithromycin|mesh-list
44034586|NCT00002192|Ethambutol|ethambutol|mesh-list
44034587|NCT00002192|Rifapentine|rifapentine|mesh-list
44034588|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034589|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034590|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44034591|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034592|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034593|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034594|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034595|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034596|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034597|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
44034598|NCT00002193|Amprenavir|amprenavir|mesh-list
44069067|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44034599|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034600|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034601|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034602|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034603|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034604|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034605|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034606|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034607|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034608|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034609|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034610|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
44034611|NCT00002194|Clarithromycin|clarithromycin|mesh-list
44034612|NCT00002194|Erythromycin|erythromycin|mesh-list
44034613|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
44250197|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
44250198|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
44250199|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44250200|NCT03851627|Androgens|androgens|mesh-ancestor
44250201|NCT03851627|Hormones|hormones|mesh-ancestor
43648726|NCT03035084|Vitamins|vitamins|mesh-list
44034614|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44034615|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
44034616|NCT00002194|Nevirapine|nevirapine|mesh-list
44034617|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034618|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034619|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44034620|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034621|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034622|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034647|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034648|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034649|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034651|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034652|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034653|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034654|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034655|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
44034656|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034657|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034658|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034659|NCT00002198|Abacavir|abacavir|mesh-list
44034660|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034661|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034662|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034663|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034664|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
44034665|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034666|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034667|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034668|NCT00002199|Lamivudine|lamivudine|mesh-list
44034669|NCT00002199|Zidovudine|zidovudine|mesh-list
44034670|NCT00002199|Abacavir|abacavir|mesh-list
44034671|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44034672|NCT00002199|Indinavir|indinavir|mesh-list
44034673|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034706|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034707|NCT00002202|Indinavir|indinavir|mesh-list
44034709|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034710|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034711|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034712|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034713|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034714|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034715|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034716|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
44034717|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034718|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034719|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034734|NCT00002205|Amprenavir|amprenavir|mesh-list
44034735|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034736|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034737|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034738|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034739|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
44034740|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034741|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034742|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034743|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034744|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034745|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034746|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034747|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034748|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034749|NCT00002206|Adefovir|adefovir|mesh-list
44250202|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250203|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250204|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250205|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250206|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
44250207|NCT03773445|Golimumab|golimumab|mesh-list
44250208|NCT03773445|Antibodies|antibodies|mesh-list
44250209|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44250210|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
44250211|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034750|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44034751|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
44034752|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034753|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034754|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034755|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034756|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034757|NCT00002208|Lamivudine|lamivudine|mesh-list
44034758|NCT00002208|Zidovudine|zidovudine|mesh-list
44034759|NCT00002208|Stavudine|stavudine|mesh-list
44034760|NCT00002208|Indinavir|indinavir|mesh-list
44034761|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034762|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034763|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034764|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034765|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
44034766|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034767|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034768|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034769|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
44034770|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034771|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034772|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034773|NCT00002210|Delavirdine|delavirdine|mesh-list
44034774|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43763831|NCT02424045|Hormones|hormones|mesh-ancestor
44034775|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034777|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034778|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
44034779|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034780|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034781|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44149349|NCT00207558|Vitamins|vitamins|mesh-ancestor
44149350|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
44149351|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149352|NCT00207584|Doxycycline|doxycycline|mesh-list
44149353|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44149354|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149355|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
44149356|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44149357|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44149358|NCT00207662|Infliximab|infliximab|mesh-list
44149359|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149360|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149361|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149362|NCT00207675|Infliximab|infliximab|mesh-list
44149363|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149364|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149365|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149366|NCT00207688|Infliximab|infliximab|mesh-list
44149367|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149368|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149369|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149370|NCT00207701|Infliximab|infliximab|mesh-list
44149371|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149372|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149373|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149374|NCT00207753|Ivermectin|ivermectin|mesh-list
44250212|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44250213|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250214|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250215|NCT03690089|Atropine|atropine|mesh-list
44250216|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44250217|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44250218|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44250219|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
44250220|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250221|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250222|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44250223|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44250224|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
44250225|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
44250226|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44250227|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44250228|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
44250229|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250230|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250231|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
44250232|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44250233|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44250234|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250236|NCT03690037|Coagulants|coagulants|mesh-ancestor
44250237|NCT03686332|Atezolizumab|atezolizumab|mesh-list
44250238|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44250239|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250240|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
44250241|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250242|NCT03539952|Penicillamine|penicillamine|mesh-list
44250243|NCT03539952|Trientine|trientine|mesh-list
44250244|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
44250245|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
44069255|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
44250246|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250247|NCT03539952|Antidotes|antidotes|mesh-ancestor
44149375|NCT00207753|Albendazole|albendazole|mesh-list
44149376|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44149377|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149378|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
44149379|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
44250249|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250250|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250251|NCT03513562|Venetoclax|venetoclax|mesh-list
44250252|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250253|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
44250254|NCT03441893|Mesalamine|mesalamine|mesh-list
44250255|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44250256|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250257|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44149380|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44149381|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44149382|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149383|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149384|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149385|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149386|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149387|NCT00207766|Infliximab|infliximab|mesh-list
44149388|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149389|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149390|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149391|NCT00207779|Heparin|heparin|mesh-list
44149392|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
44149393|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44034809|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44034810|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034818|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034819|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034820|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034821|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034822|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034823|NCT00002214|Capravirine|capravirine|mesh-list
44034824|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034825|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034826|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034827|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034828|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
44034829|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034830|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034831|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034832|NCT00002215|Nelfinavir|nelfinavir|mesh-list
44034833|NCT00002215|Emivirine|emivirine|mesh-list
44034834|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034835|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034836|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034837|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034838|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034839|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034840|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034841|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
44034842|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034843|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034844|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034845|NCT00002216|Lamivudine|lamivudine|mesh-list
44034846|NCT00002216|Zidovudine|zidovudine|mesh-list
44034847|NCT00002216|Abacavir|abacavir|mesh-list
44034848|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44034849|NCT00002216|Nelfinavir|nelfinavir|mesh-list
44034850|NCT00002216|Amprenavir|amprenavir|mesh-list
44034851|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034852|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034853|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069316|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
44034854|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034855|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
44034856|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034857|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44250259|NCT03441893|Analgesics|analgesics|mesh-ancestor
44250260|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
44250261|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250262|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034858|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034859|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
44034860|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034861|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034862|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034863|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034864|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034865|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034867|NCT00002217|Zidovudine|zidovudine|mesh-list
44034868|NCT00002217|Abacavir|abacavir|mesh-list
44034869|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44034870|NCT00002217|Amprenavir|amprenavir|mesh-list
44034871|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034872|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034873|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034874|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034875|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
44034876|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034877|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034878|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034879|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
44034914|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034915|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034916|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034917|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034918|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034919|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034940|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034941|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034942|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034943|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034944|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
44034945|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034946|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44034947|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034948|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44034949|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44034950|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034951|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034952|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
44034953|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034954|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034955|NCT00002226|Semaxinib|semaxinib|mesh-list
44034956|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44034957|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44034958|NCT00002226|Growth Substances|growth substances|mesh-ancestor
44034959|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034960|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
44034961|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034962|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44034963|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034964|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034965|NCT00002227|Lamivudine|lamivudine|mesh-list
44034966|NCT00002227|Efavirenz|efavirenz|mesh-list
44034967|NCT00002227|Stavudine|stavudine|mesh-list
44034968|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034969|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034970|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034971|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034972|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
44034973|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034974|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034975|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44250264|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44034984|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44034985|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44034986|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034987|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034988|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034989|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
44034990|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034992|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034993|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034994|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034995|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034996|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034997|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034998|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034999|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
44035000|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035001|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035002|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035003|NCT00002230|Efavirenz|efavirenz|mesh-list
44035004|NCT00002230|Didanosine|didanosine|mesh-list
44035005|NCT00002230|Stavudine|stavudine|mesh-list
44035006|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
44035007|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035008|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035009|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035010|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035011|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
44035012|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035013|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035014|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035015|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035016|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44035017|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035018|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035019|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035020|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
44035022|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035023|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035024|NCT00002233|Lamivudine|lamivudine|mesh-list
44035025|NCT00002233|Abacavir|abacavir|mesh-list
44035026|NCT00002233|Indinavir|indinavir|mesh-list
44035027|NCT00002233|Amprenavir|amprenavir|mesh-list
44035028|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035029|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035030|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035031|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035032|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
44035033|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035034|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035035|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035036|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035037|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035038|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035039|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44035040|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
44035041|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035042|NCT00002234|Lamivudine|lamivudine|mesh-list
44035043|NCT00002234|Efavirenz|efavirenz|mesh-list
44035044|NCT00002234|Didanosine|didanosine|mesh-list
44035045|NCT00002234|Adefovir|adefovir|mesh-list
44035046|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44035047|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035048|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035049|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035050|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035051|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
44035052|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035053|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035054|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035055|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035056|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44250265|NCT03432949|Dexamethasone|dexamethasone|mesh-list
44250266|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
44250267|NCT03432949|BB 1101|bb 1101|mesh-list
44035057|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035058|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44035059|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035060|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035061|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
44035062|NCT00002235|Efavirenz|efavirenz|mesh-list
44035063|NCT00002235|Nelfinavir|nelfinavir|mesh-list
44035064|NCT00002235|Indinavir|indinavir|mesh-list
44035065|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035066|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035067|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035068|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035069|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
44035070|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035071|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035072|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035073|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035074|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44035075|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035076|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035077|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035078|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035079|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035080|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035081|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035082|NCT00002236|Zidovudine|zidovudine|mesh-list
44035083|NCT00002236|Delavirdine|delavirdine|mesh-list
44035084|NCT00002236|Indinavir|indinavir|mesh-list
44035085|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
44035086|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035087|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035088|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035089|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035090|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
44035091|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035092|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035093|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035094|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44069493|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
44035095|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035096|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035097|NCT00002238|Interferons|interferons|mesh-list
44035098|NCT00002238|Zidovudine|zidovudine|mesh-list
44035099|NCT00002238|Interferon-beta|interferon-beta|mesh-list
44035100|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
44035101|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035102|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
44035103|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035104|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
44035105|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035106|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035107|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035108|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035109|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035110|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035111|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
44035112|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035113|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035114|NCT00002239|Ritonavir|ritonavir|mesh-list
44035115|NCT00002239|Amprenavir|amprenavir|mesh-list
44035116|NCT00002239|Abacavir|abacavir|mesh-list
44035117|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
44035118|NCT00002239|Efavirenz|efavirenz|mesh-list
44035138|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
44035139|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035140|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44035141|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44035142|NCT00002241|Ritonavir|ritonavir|mesh-list
44035143|NCT00002241|Indinavir|indinavir|mesh-list
44035144|NCT00002241|Lamivudine|lamivudine|mesh-list
44035145|NCT00002241|Stavudine|stavudine|mesh-list
44035146|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035147|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44250268|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250269|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
44250270|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
44250271|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250272|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250273|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250274|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
44250275|NCT03432949|Hormones|hormones|mesh-ancestor
44250276|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250277|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250278|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250279|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035148|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035149|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035150|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035151|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035152|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035153|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
44035154|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035155|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035156|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035157|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035158|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035159|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
44035160|NCT00002243|Calanolide A|calanolide a|mesh-list
44035161|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035162|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035163|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
44035164|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035165|NCT00002245|Lamivudine|lamivudine|mesh-list
44035166|NCT00002245|Abacavir|abacavir|mesh-list
44035167|NCT00002245|Amprenavir|amprenavir|mesh-list
44035168|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035169|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035170|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063445|NCT00006048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035171|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035172|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
44035226|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035228|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035229|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035230|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
44035231|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035232|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035233|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035234|NCT00002255|Hematinics|hematinics|mesh-ancestor
44035235|NCT00002256|Zalcitabine|zalcitabine|mesh-list
44035236|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
44035237|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035238|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035239|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035240|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035241|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
44035242|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035243|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035244|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035245|NCT00002257|Ganciclovir|ganciclovir|mesh-list
44035246|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035247|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
44035248|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035249|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035250|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035251|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250280|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250281|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250282|NCT03421288|Leucovorin|leucovorin|mesh-list
44250283|NCT03421288|Docetaxel|docetaxel|mesh-list
44035252|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
44035253|NCT00002259|Analgesics|analgesics|mesh-ancestor
44035254|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
44035255|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44035256|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035257|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035258|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44035259|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44035260|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035285|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035287|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
44035288|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035289|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035290|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035291|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44035292|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035293|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
44035294|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035295|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035296|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44035297|NCT00002266|Protective Agents|protective agents|mesh-ancestor
44035298|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035299|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035300|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035301|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035302|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
44035303|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035304|NCT00002267|Rifabutin|rifabutin|mesh-list
44035305|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035306|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035307|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44035309|NCT00002269|Zidovudine|zidovudine|mesh-list
44035310|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44035311|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
44035320|NCT00002270|Interferons|interferons|mesh-list
44035321|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
44035322|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
44035323|NCT00002270|Zidovudine|zidovudine|mesh-list
44035324|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035325|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
44035326|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035327|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
44035328|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035329|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
44035330|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035331|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035332|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035333|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035334|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035335|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035336|NCT00002271|Alovudine|alovudine|mesh-list
44035337|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
44035338|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035339|NCT00002272|Foscarnet|foscarnet|mesh-list
44035340|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44035341|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
44035342|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035343|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035344|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035345|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035346|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035347|NCT00002273|Ganciclovir|ganciclovir|mesh-list
44035348|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035349|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
44035350|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035351|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035352|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250285|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
44250286|NCT03421288|Atezolizumab|atezolizumab|mesh-list
44250287|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250288|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
44250289|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250290|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648785|NCT03034408|Nalmefene|nalmefene|mesh-list
44035353|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035354|NCT00002274|Didanosine|didanosine|mesh-list
44035355|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
44035356|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035357|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035358|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035359|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035360|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
44035361|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035362|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035363|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035364|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44035365|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44035366|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44035367|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44035368|NCT00002276|Zidovudine|zidovudine|mesh-list
44035369|NCT00002276|Ibuprofen|ibuprofen|mesh-list
44035370|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44035371|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44035372|NCT00002276|Analgesics|analgesics|mesh-ancestor
44035373|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
44035374|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44035375|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035376|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44035377|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44035378|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44035394|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035395|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035396|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035397|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035398|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035399|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035400|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035401|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035402|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035403|NCT00002277|Amebicides|amebicides|mesh-ancestor
44035404|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035405|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035406|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035407|NCT00002278|Diclazuril|diclazuril|mesh-list
44035408|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
44035409|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035410|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035411|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035412|NCT00002279|Zalcitabine|zalcitabine|mesh-list
44035413|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
44035414|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035415|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035416|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035417|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035418|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
44035419|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035420|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035421|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035422|NCT00002280|Didanosine|didanosine|mesh-list
44035423|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
44035424|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035425|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035426|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44250291|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250292|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
44250293|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44035427|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035428|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
44035429|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035430|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035431|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035432|NCT00002281|Zidovudine|zidovudine|mesh-list
44035433|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
44035434|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
44035435|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035436|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035437|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035438|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035453|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035454|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035455|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035456|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035457|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035458|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035459|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44035460|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035461|NCT00002283|Trimethoprim|trimethoprim|mesh-list
44035462|NCT00002283|Dapsone|dapsone|mesh-list
44035463|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
44035464|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44035465|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035466|NCT00002283|Renal Agents|renal agents|mesh-ancestor
44035467|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
44035468|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035469|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035470|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44035471|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035472|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035473|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44035474|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44035475|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035476|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
44035477|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035478|NCT00002284|Zidovudine|zidovudine|mesh-list
44035479|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
44035480|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035481|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035482|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035483|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035484|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
44035485|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035486|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035487|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035488|NCT00002285|Zidovudine|zidovudine|mesh-list
44035489|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
44035490|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035491|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035492|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035493|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035494|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
44035495|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035496|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035497|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035498|NCT00002286|Zidovudine|zidovudine|mesh-list
44035499|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
44035519|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
44035520|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035521|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035522|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035523|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035524|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
44035525|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250294|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250295|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
44250296|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250298|NCT03421288|Protective Agents|protective agents|mesh-ancestor
44250299|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
44250300|NCT03421288|Vitamins|vitamins|mesh-ancestor
44250301|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
44250302|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
44250303|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44250304|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44250305|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44250306|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250307|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250308|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
44250309|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250310|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035526|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035527|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035528|NCT00002289|Thymopentin|thymopentin|mesh-list
44035529|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035530|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
44035531|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035533|NCT00002290|Acyclovir|acyclovir|mesh-list
44035534|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
44035535|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035536|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035537|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035538|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035539|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
44035540|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035541|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035542|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035543|NCT00002291|Pentamidine|pentamidine|mesh-list
44035544|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
44035545|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035546|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035547|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035548|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44035549|NCT00002292|Pentamidine|pentamidine|mesh-list
44035550|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
44035551|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035552|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035553|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035554|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44035555|NCT00002293|Nystatin|nystatin|mesh-list
44035556|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035567|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035568|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035569|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035570|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035571|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035572|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035573|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035574|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035575|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
44035576|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44250311|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44250312|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44035577|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
44035578|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035579|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
44035580|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035581|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
44035582|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035583|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
44035584|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035585|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
44035586|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035587|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
44035588|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035589|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
44035590|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035591|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
44035592|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035593|NCT00002298|Ribavirin|ribavirin|mesh-list
44035594|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
44035595|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035596|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
44035597|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035598|NCT00002299|Interferons|interferons|mesh-list
44035599|NCT00002299|Interferon-beta|interferon-beta|mesh-list
44035600|NCT00002299|Ganciclovir|ganciclovir|mesh-list
44035601|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035602|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
44035603|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035604|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
44035605|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035606|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
44035607|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035608|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035609|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035610|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035611|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035613|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
44035614|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44035615|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44035616|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44035617|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
44035618|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44035619|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035620|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44035621|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44035622|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44035623|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035624|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
44035625|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44035626|NCT00002301|Foscarnet|foscarnet|mesh-list
44035627|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44035628|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
44035629|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035630|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035631|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035632|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035633|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035634|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
44035635|NCT00002302|Hematinics|hematinics|mesh-ancestor
44035636|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
44035637|NCT00002303|Hematinics|hematinics|mesh-ancestor
44035638|NCT00002304|Fluconazole|fluconazole|mesh-list
44035639|NCT00002304|Ketoconazole|ketoconazole|mesh-list
44035640|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
44035641|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035642|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035643|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035644|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035645|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035646|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035647|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035648|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250314|NCT03245892|Carboplatin|carboplatin|mesh-list
44250316|NCT03245892|Ipilimumab|ipilimumab|mesh-list
44250317|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44250318|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250319|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
44250320|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
44035649|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035650|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035651|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035652|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035653|NCT00002305|Fluconazole|fluconazole|mesh-list
44035654|NCT00002305|Amphotericin B|amphotericin b|mesh-list
44035655|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44035656|NCT00002305|Flucytosine|flucytosine|mesh-list
44035657|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
44035658|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035659|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035660|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035661|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035662|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035663|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035664|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035665|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035666|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035667|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035668|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035669|NCT00002305|Amebicides|amebicides|mesh-ancestor
44035670|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035671|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035672|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035673|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
44035674|NCT00002306|Fluconazole|fluconazole|mesh-list
44035675|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
44035676|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035677|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43764598|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44035678|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035679|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035680|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035681|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035682|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035683|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035684|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035685|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035686|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035688|NCT00002307|Stavudine|stavudine|mesh-list
44035689|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
44035690|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035691|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035707|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035708|NCT00002309|Azithromycin|azithromycin|mesh-list
44035709|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035710|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035711|NCT00002311|Wobenzym|wobenzym|mesh-list
44035712|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035713|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
44035714|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035715|NCT00002312|Zidovudine|zidovudine|mesh-list
44035716|NCT00002312|Delavirdine|delavirdine|mesh-list
44035717|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
44035718|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035719|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035720|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035721|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035722|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
44250321|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250322|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250323|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250324|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44460447|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460448|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460449|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460450|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460451|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44035723|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035724|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035725|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035726|NCT00002313|Didanosine|didanosine|mesh-list
44035727|NCT00002313|Nystatin|nystatin|mesh-list
44035728|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
44035729|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035730|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035731|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035732|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035733|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
44035734|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035735|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035736|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035737|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035738|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
44035739|NCT00002313|Ionophores|ionophores|mesh-ancestor
44035740|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149404|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149405|NCT00207844|Selenium|selenium|mesh-list
44149406|NCT00207844|Selenious Acid|selenious acid|mesh-list
44149407|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
44149408|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
44149409|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149410|NCT00207844|Protective Agents|protective agents|mesh-ancestor
44149411|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149412|NCT00207844|Trace Elements|trace elements|mesh-ancestor
44149413|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
44149414|NCT00207948|Ritonavir|ritonavir|mesh-list
44149415|NCT00207948|Lopinavir|lopinavir|mesh-list
44149416|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035742|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
44035778|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44035779|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44035780|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035781|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035782|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44035783|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44035784|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44035785|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44035786|NCT00002319|Doxorubicin|doxorubicin|mesh-list
44035796|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035797|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035798|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035799|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035800|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
44035801|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035802|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035803|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035804|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
44035805|NCT00002321|Aldesleukin|aldesleukin|mesh-list
44035806|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035807|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035808|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035809|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
44035810|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035811|NCT00002322|Zidovudine|zidovudine|mesh-list
44460452|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460453|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460454|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44460455|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44035812|NCT00002322|Atevirdine|atevirdine|mesh-list
44035813|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
44035814|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035815|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035816|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035817|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035818|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
44035819|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035820|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035821|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035822|NCT00002323|Zidovudine|zidovudine|mesh-list
44035823|NCT00002323|Nevirapine|nevirapine|mesh-list
44035824|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
44035825|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035826|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035827|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035828|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035829|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
44035830|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035831|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035832|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035833|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035834|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035835|NCT00002324|Zidovudine|zidovudine|mesh-list
44035836|NCT00002324|Nevirapine|nevirapine|mesh-list
44035837|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
44035838|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035839|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035840|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035841|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035842|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
44035843|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035844|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035845|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035846|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035847|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035848|NCT00002325|Fluconazole|fluconazole|mesh-list
44035849|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
44035850|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035851|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035852|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035872|NCT00002327|Cidofovir|cidofovir|mesh-list
44035873|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
44035874|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035875|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035876|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035877|NCT00002328|Azithromycin|azithromycin|mesh-list
44035878|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035879|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035880|NCT00002330|Ganciclovir|ganciclovir|mesh-list
44035881|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035882|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
44035883|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035884|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035885|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035886|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035887|NCT00002331|Clarithromycin|clarithromycin|mesh-list
44035888|NCT00002331|Ethambutol|ethambutol|mesh-list
44035889|NCT00002331|Clofazimine|clofazimine|mesh-list
44035890|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035891|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035892|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44035893|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035894|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035895|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035896|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460456|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44460457|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
44460458|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
44460459|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460460|NCT01563172|Listerine|listerine|mesh-list
44460461|NCT01563172|Fluorides|fluorides|mesh-list
44460462|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
44460463|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
44460464|NCT01563172|Protective Agents|protective agents|mesh-ancestor
43648832|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44035897|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
44035898|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44035899|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
44035900|NCT00002332|Thymopentin|thymopentin|mesh-list
44035901|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035902|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
44035903|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035904|NCT00002333|Saquinavir|saquinavir|mesh-list
44035906|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035907|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035913|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
44035914|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035915|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035916|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035917|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
44035918|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035919|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035920|NCT00002334|Zidovudine|zidovudine|mesh-list
44035921|NCT00002334|Zalcitabine|zalcitabine|mesh-list
44035922|NCT00002334|Saquinavir|saquinavir|mesh-list
44035923|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
44035924|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035925|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035926|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035927|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035928|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
44035929|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035930|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035931|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035932|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035933|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035934|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035935|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035936|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035937|NCT00002335|Emtricitabine|emtricitabine|mesh-list
44035938|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
44035939|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035940|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035941|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035942|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035943|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035944|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035945|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035946|NCT00002336|Clarithromycin|clarithromycin|mesh-list
44035947|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035948|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035949|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44035950|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035951|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035952|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035953|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035954|NCT00002337|Vesnarinone|vesnarinone|mesh-list
44035955|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44035956|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
44035957|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035958|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460465|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460466|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44460467|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460468|NCT01563029|Fluticasone|fluticasone|mesh-list
44460469|NCT01563029|Xhance|xhance|mesh-list
44460470|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460471|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44460472|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
44460473|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460474|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460475|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44460476|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460477|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460478|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44460479|NCT01562743|Rotigotine|rotigotine|mesh-list
44460480|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
44460481|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
44460482|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460483|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460484|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460485|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
44460486|NCT01562548|Guaifenesin|guaifenesin|mesh-list
44460487|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44460488|NCT01562548|Expectorants|expectorants|mesh-ancestor
44460489|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460490|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44460491|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44460492|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44460493|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460496|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
44250336|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250337|NCT02977052|Nivolumab|nivolumab|mesh-list
44250338|NCT02977052|Ipilimumab|ipilimumab|mesh-list
44035959|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
44035960|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035961|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44035962|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44035963|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035964|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035965|NCT00002337|Protective Agents|protective agents|mesh-ancestor
44035966|NCT00002339|Fluconazole|fluconazole|mesh-list
44035967|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
44035968|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035969|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035970|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035971|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035972|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035973|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035974|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035983|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035984|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035985|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035986|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035987|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
44035988|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44035989|NCT00002341|Itraconazole|itraconazole|mesh-list
44035990|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
44035991|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035992|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035993|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035994|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035995|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035996|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035997|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035998|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035999|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036000|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036001|NCT00002343|Ethambutol|ethambutol|mesh-list
44036002|NCT00002343|Rifabutin|rifabutin|mesh-list
44036003|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036004|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036005|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036006|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44036007|NCT00002344|Azithromycin|azithromycin|mesh-list
44036008|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036009|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036010|NCT00002345|Megestrol|megestrol|mesh-list
44036011|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
44036012|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44036013|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44036014|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44036015|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
44036016|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44036017|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036018|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44036019|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44036020|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44036021|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036022|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
44036023|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44036024|NCT00002346|Adefovir|adefovir|mesh-list
44036025|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44036026|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
44036027|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036028|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036029|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036030|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701501|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
44250340|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250341|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250342|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250344|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
44250345|NCT02973386|Cisplatin|cisplatin|mesh-list
44250346|NCT02973386|Capecitabine|capecitabine|mesh-list
44036031|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036032|NCT00002347|Zidovudine|zidovudine|mesh-list
44036033|NCT00002347|Nevirapine|nevirapine|mesh-list
44036034|NCT00002347|Zalcitabine|zalcitabine|mesh-list
44036035|NCT00002347|Saquinavir|saquinavir|mesh-list
44036036|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
44036037|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036038|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036039|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036067|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036068|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036069|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036070|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036071|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036072|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036073|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036074|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
44036075|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036076|NCT00002352|Lobucavir|lobucavir|mesh-list
44036077|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036078|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036079|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036080|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036081|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
44036082|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036083|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036084|NCT00002354|Stavudine|stavudine|mesh-list
44036085|NCT00002354|Indinavir|indinavir|mesh-list
44036086|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
44036087|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036088|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036089|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036128|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036130|NCT00002361|Indinavir|indinavir|mesh-list
44036131|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036132|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036133|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036134|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036135|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036136|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036137|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036138|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
44036139|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036140|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036141|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036142|NCT00002362|Emtricitabine|emtricitabine|mesh-list
44036143|NCT00002362|Efavirenz|efavirenz|mesh-list
44036144|NCT00002362|Abacavir|abacavir|mesh-list
44036145|NCT00002362|Stavudine|stavudine|mesh-list
44036146|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
44036147|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036148|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036149|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036150|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036151|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036152|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036153|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44250347|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250348|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250349|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
44250350|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036154|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44036155|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036156|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44036157|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44036158|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036159|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036160|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
44036161|NCT00002364|Abacavir|abacavir|mesh-list
44036162|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036163|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036164|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036165|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036166|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
44036167|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036168|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036169|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036170|NCT00002366|Ritonavir|ritonavir|mesh-list
44036171|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036172|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036173|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036174|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036175|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036176|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036177|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036178|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
44036179|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036180|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036181|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036182|NCT00002367|Lamivudine|lamivudine|mesh-list
44036183|NCT00002367|Zidovudine|zidovudine|mesh-list
44036184|NCT00002367|Saquinavir|saquinavir|mesh-list
44036185|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036186|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036187|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036188|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036189|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
44036190|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036191|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036192|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036194|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036195|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036196|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036197|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036198|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036199|NCT00002368|Lamivudine|lamivudine|mesh-list
44036200|NCT00002368|Nevirapine|nevirapine|mesh-list
44036201|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036202|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036203|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036256|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036257|NCT00002373|Maribavir|maribavir|mesh-list
44036258|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
44036259|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036260|NCT00002374|Ritonavir|ritonavir|mesh-list
44036261|NCT00002374|Nelfinavir|nelfinavir|mesh-list
44036262|NCT00002374|Saquinavir|saquinavir|mesh-list
44036263|NCT00002374|Stavudine|stavudine|mesh-list
44036264|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036265|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036266|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036267|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036268|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036269|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036270|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036271|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
44036272|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250351|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44250352|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250353|NCT02543255|Prednisone|prednisone|mesh-list
44250354|NCT02543255|Leuprolide|leuprolide|mesh-list
44250355|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
44250356|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250357|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
44250358|NCT02543255|Hormones|hormones|mesh-ancestor
44036273|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036274|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036275|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
44036276|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036277|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036279|NCT00002375|Indinavir|indinavir|mesh-list
44036280|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036281|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036282|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036283|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036284|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036285|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036286|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036287|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
44036288|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036289|NCT00002376|Lamivudine|lamivudine|mesh-list
44036290|NCT00002376|Zidovudine|zidovudine|mesh-list
44036291|NCT00002376|Didanosine|didanosine|mesh-list
44036292|NCT00002376|Stavudine|stavudine|mesh-list
44036293|NCT00002376|Indinavir|indinavir|mesh-list
44036294|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036295|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036296|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036297|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036298|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
44036324|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036325|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036326|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036327|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036328|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
44036329|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036330|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036331|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036332|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036333|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036334|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
44036335|NCT00002379|Lamivudine|lamivudine|mesh-list
44036336|NCT00002379|Zidovudine|zidovudine|mesh-list
44036337|NCT00002379|Stavudine|stavudine|mesh-list
44036338|NCT00002379|Adefovir|adefovir|mesh-list
44036339|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44036340|NCT00002379|Indinavir|indinavir|mesh-list
44036341|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036342|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036343|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765176|NCT02415023|Paclitaxel|paclitaxel|mesh-list
44036344|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036345|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
44036346|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036347|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036348|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036349|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
44036350|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036351|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036352|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036353|NCT00002380|Nelfinavir|nelfinavir|mesh-list
44036377|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036378|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036379|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036380|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036381|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036382|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
44036383|NCT00002382|Saquinavir|saquinavir|mesh-list
44250359|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44036384|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036385|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036386|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036387|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036388|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036389|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036390|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036391|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
44036392|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036393|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036394|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036395|NCT00002383|Saquinavir|saquinavir|mesh-list
44036396|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036397|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036398|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036399|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036400|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036401|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036402|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036403|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
44036404|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036405|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036406|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036421|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036422|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
44036423|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036424|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036425|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036426|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
44036427|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036428|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036429|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036430|NCT00002387|Efavirenz|efavirenz|mesh-list
44036431|NCT00002387|Indinavir|indinavir|mesh-list
44036432|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036433|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036434|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036435|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036436|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
44036437|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036438|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44036439|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036440|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44036441|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44036442|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036443|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036444|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036445|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036446|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036447|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036448|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036450|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036451|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036452|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036453|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036454|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
44036455|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036456|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036457|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036458|NCT00002389|Lamivudine|lamivudine|mesh-list
44036459|NCT00002389|Zidovudine|zidovudine|mesh-list
44036460|NCT00002389|Abacavir|abacavir|mesh-list
44036461|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036462|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036463|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036464|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036465|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
44036466|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250363|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44250364|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
44250365|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44250366|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44250367|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250368|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250369|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
44036467|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036468|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036469|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
44036470|NCT00002390|Abacavir|abacavir|mesh-list
44036490|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
44036491|NCT00002392|Thalidomide|thalidomide|mesh-list
44036492|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44036493|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
44036494|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036495|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
44036496|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036497|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036498|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44036499|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44036501|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
44036502|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036503|NCT00002393|Efavirenz|efavirenz|mesh-list
44036504|NCT00002393|Indinavir|indinavir|mesh-list
44036505|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036506|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036507|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036508|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036509|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
44036510|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036511|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44036512|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036513|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44036514|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44036515|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036516|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036517|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036518|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036519|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036520|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036521|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036522|NCT00002394|Terbinafine|terbinafine|mesh-list
44036523|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
44036524|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036525|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036526|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036527|NCT00002395|Topotecan|topotecan|mesh-list
44036528|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44036529|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44036530|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036531|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036532|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036533|NCT00002396|Tenofovir|tenofovir|mesh-list
44036534|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
44036535|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036536|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036537|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036538|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036539|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036540|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44250370|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44250372|NCT02437279|Ipilimumab|ipilimumab|mesh-list
44250373|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250374|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648908|NCT03033121|Hormones|hormones|mesh-list
44036541|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036542|NCT00002397|Lamivudine|lamivudine|mesh-list
44036543|NCT00002397|Stavudine|stavudine|mesh-list
44036544|NCT00002397|Nelfinavir|nelfinavir|mesh-list
44036545|NCT00002397|Saquinavir|saquinavir|mesh-list
44036546|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036547|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036548|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036549|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036550|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
44036551|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036552|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036553|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036554|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036555|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036556|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036557|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
44036558|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036559|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036560|NCT00002398|Adefovir|adefovir|mesh-list
44036561|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44036562|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
44036563|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036564|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036565|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036566|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036567|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036568|NCT00002399|Fluconazole|fluconazole|mesh-list
44036569|NCT00002399|Posaconazole|posaconazole|mesh-list
44036570|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
44036571|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036572|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44070623|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
44036573|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036574|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036575|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036576|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44036577|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44036578|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44036579|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036580|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44036581|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44036582|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44036583|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44036584|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44036585|NCT00002400|Lamivudine|lamivudine|mesh-list
44036586|NCT00002400|Zidovudine|zidovudine|mesh-list
44036587|NCT00002400|Delavirdine|delavirdine|mesh-list
44036588|NCT00002400|Indinavir|indinavir|mesh-list
44036589|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036590|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036591|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036592|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036593|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
44036594|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036595|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036596|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036597|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
44036598|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036599|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036600|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036601|NCT00002401|Lamivudine|lamivudine|mesh-list
44036626|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036627|NCT00002405|Amprenavir|amprenavir|mesh-list
44036628|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44250375|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250376|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250377|NCT02224144|Vitamin D|vitamin d|mesh-list
44250378|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
44250379|NCT02224144|Calcitriol|calcitriol|mesh-list
44250380|NCT02224144|Vitamins|vitamins|mesh-ancestor
44250381|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
44250382|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250383|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44250384|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44250385|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44250386|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250387|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250388|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44250389|NCT02030990|Fluorometholone|fluorometholone|mesh-list
44250390|NCT02030990|Mitomycins|mitomycins|mesh-list
44250391|NCT02030990|Mitomycin|mitomycin|mesh-list
44250392|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44250393|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250394|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
44250395|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250396|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44250397|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250398|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903825|NCT00153166|Pioglitazone|pioglitazone|mesh-list
44250399|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
44250400|NCT02030990|Hormones|hormones|mesh-ancestor
44250401|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250420|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
44250421|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250422|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598391|NCT03300440|Biotin|biotin|mesh-list
44036629|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036630|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036631|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036632|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036633|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036634|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036635|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036636|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036637|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036638|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036639|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
44036640|NCT00002406|Indinavir|indinavir|mesh-list
44036641|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036642|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036643|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036644|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036645|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036646|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036647|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036648|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
44036649|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036650|NCT00002407|Lamivudine|lamivudine|mesh-list
44036651|NCT00002407|Nevirapine|nevirapine|mesh-list
44036652|NCT00002407|Didanosine|didanosine|mesh-list
44036653|NCT00002407|Stavudine|stavudine|mesh-list
44036654|NCT00002407|Indinavir|indinavir|mesh-list
44036655|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036672|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44036674|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036675|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036676|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036677|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
44036678|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036679|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036680|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036681|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
44036682|NCT00002410|Lamivudine|lamivudine|mesh-list
44036683|NCT00002410|Zidovudine|zidovudine|mesh-list
44036684|NCT00002410|Indinavir|indinavir|mesh-list
44036685|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036686|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036687|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036688|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036689|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
44036690|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036691|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036692|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036693|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
44036694|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036695|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036696|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036697|NCT00002412|Didanosine|didanosine|mesh-list
44036698|NCT00002412|Stavudine|stavudine|mesh-list
44036699|NCT00002412|Emivirine|emivirine|mesh-list
44036700|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
44036701|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036702|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
44036703|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036704|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036705|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036706|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
44036707|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036708|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
44036709|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036710|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036711|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036712|NCT00002413|Emivirine|emivirine|mesh-list
44036713|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036714|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036715|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036724|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250423|NCT01898793|Analgesics|analgesics|mesh-ancestor
44250424|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
44250425|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250426|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44250427|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036725|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036726|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036727|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036728|NCT00002416|Lamivudine|lamivudine|mesh-list
44036729|NCT00002416|Emtricitabine|emtricitabine|mesh-list
44036730|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036731|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036732|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036733|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036734|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
44036735|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036736|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036737|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44149417|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44149418|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
44149419|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149420|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149421|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44149422|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44149423|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
44149424|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149425|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44149426|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157865|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44157866|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
44157867|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157868|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157869|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44157870|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44157871|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
44157872|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157873|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157874|NCT00235508|Eszopiclone|eszopiclone|mesh-list
44157875|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44157876|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157877|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157879|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44157880|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
44157881|NCT00235560|Sirolimus|sirolimus|mesh-list
44157882|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157883|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157884|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157885|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157886|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
44157887|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157888|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
44157889|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157890|NCT00235651|Amphotericin B|amphotericin b|mesh-list
44157891|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44157892|NCT00235651|Amebicides|amebicides|mesh-ancestor
44157893|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44157894|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44157895|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157896|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157897|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
44157898|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
44157899|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44036752|NCT00002418|Didanosine|didanosine|mesh-list
44036753|NCT00002418|Stavudine|stavudine|mesh-list
44036754|NCT00002418|Emivirine|emivirine|mesh-list
44036755|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
44070829|NCT00001005|Zidovudine|zidovudine|mesh-list
44036756|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036757|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036758|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036759|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250428|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
44250429|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44250430|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44250431|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44036760|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
44036761|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036762|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036771|NCT00002419|Adefovir|adefovir|mesh-list
44036772|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44036773|NCT00002419|Amprenavir|amprenavir|mesh-list
44036774|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036775|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036776|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036777|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036778|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
44036779|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036780|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44036781|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036782|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44036783|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44036784|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036785|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036786|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036787|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036788|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44036789|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036790|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036791|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036792|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036793|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036794|NCT00002420|Didanosine|didanosine|mesh-list
44036795|NCT00002420|Stavudine|stavudine|mesh-list
44036796|NCT00002420|Delavirdine|delavirdine|mesh-list
44036797|NCT00002420|Emivirine|emivirine|mesh-list
44036798|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
44036799|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036800|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
44036801|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036802|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036803|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036804|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
44036805|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036806|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
44036807|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036808|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036809|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036810|NCT00002423|Lamivudine|lamivudine|mesh-list
44036811|NCT00002423|Abacavir|abacavir|mesh-list
44036812|NCT00002423|Nelfinavir|nelfinavir|mesh-list
44036813|NCT00002423|Indinavir|indinavir|mesh-list
44036814|NCT00002423|Amprenavir|amprenavir|mesh-list
44036815|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036816|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036817|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036818|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036819|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
44036820|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036821|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036822|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036823|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036824|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036825|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036826|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44036827|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036828|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036829|NCT00002424|Lamivudine|lamivudine|mesh-list
44036830|NCT00002424|Stavudine|stavudine|mesh-list
44036831|NCT00002424|Indinavir|indinavir|mesh-list
44036832|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036859|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036860|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036861|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44250433|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250434|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
44250435|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250436|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250437|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44250438|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250439|NCT01773707|Abatacept|abatacept|mesh-list
44250440|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250441|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250442|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250443|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250444|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
44250445|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250446|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250447|NCT01711021|Amphetamine|amphetamine|mesh-list
44250448|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
44250449|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44250450|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250451|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
44250452|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
44250453|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250454|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
44250455|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250456|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250457|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
44250458|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44250459|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44250460|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250461|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44250462|NCT01518556|Idarubicin|idarubicin|mesh-list
44250463|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44250464|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250465|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44036862|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701502|NCT02724163|Busulfan|busulfan|mesh-list
44250466|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44250468|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250469|NCT01208662|Dexamethasone|dexamethasone|mesh-list
44250470|NCT01208662|Lenalidomide|lenalidomide|mesh-list
44250471|NCT01208662|Bortezomib|bortezomib|mesh-list
44250472|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44036863|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036864|NCT00002427|Didanosine|didanosine|mesh-list
44036865|NCT00002427|Stavudine|stavudine|mesh-list
44036866|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
44036867|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036868|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
44036869|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036870|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036871|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036872|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
44036873|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036874|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
44036875|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036876|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036877|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036878|NCT00002428|Vaccines|vaccines|mesh-list
44036879|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
44036880|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036881|NCT00002430|Lamivudine|lamivudine|mesh-list
44036882|NCT00002430|Stavudine|stavudine|mesh-list
44036900|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036901|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
44036902|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
44036904|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44036905|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
44036906|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036907|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036908|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036909|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036910|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036911|NCT00002433|Interferons|interferons|mesh-list
44036912|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
44036913|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036914|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
44036915|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036916|NCT00002434|Leucovorin|leucovorin|mesh-list
44036917|NCT00002434|Trimetrexate|trimetrexate|mesh-list
44036918|NCT00002434|Calcium|calcium|mesh-list
44036919|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
44036920|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44036921|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036922|NCT00002434|Antidotes|antidotes|mesh-ancestor
44036923|NCT00002434|Protective Agents|protective agents|mesh-ancestor
44036924|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
44036925|NCT00002434|Vitamins|vitamins|mesh-ancestor
44036926|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
44036927|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
44036928|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036929|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44036930|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
44036931|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036932|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036933|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44036934|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036935|NCT00002435|Zidovudine|zidovudine|mesh-list
44036936|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
44036937|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036938|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036939|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036940|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036941|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
44036942|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036959|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
44036960|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
44250475|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250476|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036961|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44036962|NCT00002437|Renal Agents|renal agents|mesh-ancestor
44036963|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
44036964|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036965|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036966|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036967|NCT00002438|Itraconazole|itraconazole|mesh-list
44036968|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
44036969|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036970|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44149427|NCT00208039|Calfactant|calfactant|mesh-list
44036971|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036972|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036973|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036974|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44036975|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
44036976|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44036977|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036978|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036979|NCT00002439|Alitretinoin|alitretinoin|mesh-list
44036980|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036981|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44036982|NCT00002440|Ritonavir|ritonavir|mesh-list
44036983|NCT00002440|Nelfinavir|nelfinavir|mesh-list
44036984|NCT00002440|Indinavir|indinavir|mesh-list
44036985|NCT00002440|Saquinavir|saquinavir|mesh-list
44036986|NCT00002440|Amprenavir|amprenavir|mesh-list
44036987|NCT00002440|Abacavir|abacavir|mesh-list
44036988|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036989|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036990|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036991|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036992|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036993|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036994|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036995|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
44036996|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036997|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036998|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036999|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037000|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037001|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44037002|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
44037003|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44037041|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44037042|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44037043|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037044|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037052|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44037053|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44037054|NCT00002447|Ritonavir|ritonavir|mesh-list
44037055|NCT00002447|Saquinavir|saquinavir|mesh-list
44037056|NCT00002447|Efavirenz|efavirenz|mesh-list
44037057|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037058|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037059|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037060|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037061|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037062|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037063|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037064|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
44037065|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037066|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44037067|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44037068|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037069|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037070|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43701503|NCT02724163|Fludarabine|fludarabine|mesh-list
44250477|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250478|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
44250479|NCT01208662|Hormones|hormones|mesh-ancestor
43648945|NCT03033342|Omeprazole|omeprazole|mesh-list
44037071|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44037072|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44037073|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44037074|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44037075|NCT00002448|Ritonavir|ritonavir|mesh-list
44037076|NCT00002448|Saquinavir|saquinavir|mesh-list
44037077|NCT00002448|Efavirenz|efavirenz|mesh-list
44037078|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037079|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037080|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037081|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037082|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037083|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037084|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037085|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
44037086|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037087|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44037088|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44037089|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037090|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037091|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44037092|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44037093|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44037094|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44037095|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44037096|NCT00002449|Aldesleukin|aldesleukin|mesh-list
44037097|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037098|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037099|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037100|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
44037101|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037102|NCT00002450|Tenofovir|tenofovir|mesh-list
44037103|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
44037104|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037105|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037106|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037107|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037108|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037116|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037118|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037119|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037120|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037121|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037122|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
44037123|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037124|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44037125|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44037126|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037127|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037128|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
44037129|NCT00002452|Indinavir|indinavir|mesh-list
44037130|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037131|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037132|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037133|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037134|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037135|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037136|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037137|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
44037138|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037139|NCT00002453|Tenofovir|tenofovir|mesh-list
44037140|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
44037141|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037142|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037143|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037144|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701504|NCT02724163|Daunorubicin|daunorubicin|mesh-list
44250480|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250481|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250482|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250483|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
44250484|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44250485|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44250486|NCT01208662|Growth Substances|growth substances|mesh-ancestor
44250487|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44250488|NCT01198522|Gemcitabine|gemcitabine|mesh-list
44250489|NCT01198522|Antibodies|antibodies|mesh-list
44250490|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44250491|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
44250492|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250493|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250494|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
44250495|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250496|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250497|NCT01198522|Antiviral Agents|antiviral agents|mesh-ancestor
44250498|NCT01198522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250499|NCT01198522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250500|NCT01198522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250501|NCT01134250|Paclitaxel|paclitaxel|mesh-list
44250502|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44250503|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250504|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
44250505|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250506|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250507|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250508|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
44250525|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250527|NCT05333159|Empagliflozin|empagliflozin|mesh-list
44250528|NCT05333159|Canagliflozin|canagliflozin|mesh-list
44250529|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44250530|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250531|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44250532|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250533|NCT05332470|Lamivudine|lamivudine|mesh-list
44250534|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037145|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037146|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037147|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037148|NCT00002456|Cyclosporine|cyclosporine|mesh-list
44037149|NCT00002456|Methotrexate|methotrexate|mesh-list
44037150|NCT00002456|Cyclosporins|cyclosporins|mesh-list
44037151|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037152|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037153|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037154|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037155|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037156|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
44037157|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037158|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037159|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037160|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037161|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037162|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037163|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
44037164|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037165|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037166|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
44037167|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037168|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44037169|NCT00002458|Antibodies|antibodies|mesh-list
44037170|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44037171|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
44037172|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037173|NCT00002460|Tamoxifen|tamoxifen|mesh-list
44037174|NCT00002460|Goserelin|goserelin|mesh-list
44037175|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44037176|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
44037177|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037188|NCT00002461|Sargramostim|sargramostim|mesh-list
44037189|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037190|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
44037191|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037192|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037193|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037194|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
44037195|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037196|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037197|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037198|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037199|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037200|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037201|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037203|NCT00002462|Prednisone|prednisone|mesh-list
44037204|NCT00002462|Doxorubicin|doxorubicin|mesh-list
44037205|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037206|NCT00002462|Bleomycin|bleomycin|mesh-list
44250535|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44250536|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250537|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250538|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
44250539|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250540|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037208|NCT00002462|Vinblastine|vinblastine|mesh-list
44037209|NCT00002462|Procarbazine|procarbazine|mesh-list
44037210|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
44037211|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037212|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037213|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037214|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037215|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037216|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037217|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037218|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
44037219|NCT00002462|Hormones|hormones|mesh-ancestor
44037220|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037221|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037222|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037223|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037224|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037225|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037226|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037227|NCT00002462|Trace Elements|trace elements|mesh-ancestor
44037228|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
44037229|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
44037230|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037231|NCT00002463|Leucovorin|leucovorin|mesh-list
44037232|NCT00002463|Prednisone|prednisone|mesh-list
44037233|NCT00002463|Methotrexate|methotrexate|mesh-list
44037234|NCT00002463|Vincristine|vincristine|mesh-list
44037235|NCT00002463|Procarbazine|procarbazine|mesh-list
44037236|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
44037237|NCT00002463|Calcium|calcium|mesh-list
44037238|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
44037239|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44037240|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037241|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037242|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
44037243|NCT00002463|Hormones|hormones|mesh-ancestor
44037244|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037248|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037249|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037250|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037251|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
44037252|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037253|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037254|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037255|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037256|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037257|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
44037258|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037259|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037260|NCT00002463|Antidotes|antidotes|mesh-ancestor
44037261|NCT00002463|Protective Agents|protective agents|mesh-ancestor
44037262|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037263|NCT00002463|Vitamins|vitamins|mesh-ancestor
44037264|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
44037265|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037266|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037267|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037268|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037269|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
44037270|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037271|NCT00002465|Megestrol|megestrol|mesh-list
44037272|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
44037273|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44250541|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44250542|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
44250543|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44250544|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
44250545|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903973|NCT00166036|Atorvastatin|atorvastatin|mesh-list
44250547|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44250548|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44250549|NCT05332314|Analgesics|analgesics|mesh-ancestor
44250550|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
44250551|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250552|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250553|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250554|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250555|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44250556|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250557|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250558|NCT05332106|Dienogest|dienogest|mesh-list
44250559|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44250560|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44250561|NCT05332106|Estradiol|estradiol|mesh-list
44250562|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44250563|NCT05332106|Nandrolone|nandrolone|mesh-list
44250564|NCT05332106|Estrogens|estrogens|mesh-ancestor
44250565|NCT05332106|Hormones|hormones|mesh-ancestor
44250566|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250567|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250588|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250589|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44250590|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44250591|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
44250592|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44037274|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44037275|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44037276|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
44037277|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037278|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037279|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44037280|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44037281|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037282|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037283|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
44037284|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44037285|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
44037286|NCT00002466|Ifosfamide|ifosfamide|mesh-list
44037287|NCT00002466|Doxorubicin|doxorubicin|mesh-list
44037288|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037289|NCT00002466|Etoposide|etoposide|mesh-list
44037290|NCT00002466|Vincristine|vincristine|mesh-list
44037291|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037292|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
44037293|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037294|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037295|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037296|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
44037297|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037298|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037299|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037300|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037301|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037302|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037303|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037304|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037305|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037306|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037307|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037308|NCT00002470|Interferons|interferons|mesh-list
44037309|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
44037310|NCT00002470|Fluorouracil|fluorouracil|mesh-list
44037311|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
44037312|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037313|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037314|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037315|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037316|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
44037328|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
44037329|NCT00002471|Thiotepa|thiotepa|mesh-list
44037330|NCT00002471|Methotrexate|methotrexate|mesh-list
44037331|NCT00002471|Etoposide|etoposide|mesh-list
44037332|NCT00002471|Vincristine|vincristine|mesh-list
44037333|NCT00002471|Daunorubicin|daunorubicin|mesh-list
44037334|NCT00002471|Asparaginase|asparaginase|mesh-list
44037335|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
44037336|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037337|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
44037338|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037339|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037340|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037341|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
44037342|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037343|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037344|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037345|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037346|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
44037347|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
44037348|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037349|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44037350|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
44037351|NCT00002471|Hormones|hormones|mesh-ancestor
44250594|NCT05332028|Analgesics|analgesics|mesh-ancestor
44250595|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44250596|NCT05331781|Morphine|morphine|mesh-list
44250597|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44037352|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037353|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037354|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037355|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037356|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037357|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037359|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037360|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037361|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037362|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037363|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037364|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037365|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037366|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
44037367|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037368|NCT00002471|Antidotes|antidotes|mesh-ancestor
44037369|NCT00002471|Protective Agents|protective agents|mesh-ancestor
44037370|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037371|NCT00002471|Vitamins|vitamins|mesh-ancestor
44037372|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
44037373|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44071444|NCT00001212|Hormones|hormones|mesh-ancestor
44037374|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037375|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037376|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44037377|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037378|NCT00002472|Cisplatin|cisplatin|mesh-list
44037379|NCT00002472|Etoposide|etoposide|mesh-list
44037380|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037381|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037382|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037383|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037384|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037387|NCT00002474|Carboplatin|carboplatin|mesh-list
44037388|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
44037389|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037390|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
44037391|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037392|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037393|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037394|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
44037395|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037396|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037397|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037398|NCT00002474|Analgesics|analgesics|mesh-ancestor
44037399|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
44037400|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037401|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037402|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037403|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037404|NCT00002475|Interferons|interferons|mesh-list
44037405|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
44037406|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
44037407|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
44037408|NCT00002475|Vaccines|vaccines|mesh-list
44037409|NCT00002475|Sargramostim|sargramostim|mesh-list
44037410|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
44037411|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037412|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037413|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037414|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037415|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
44037416|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037417|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037418|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037419|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
44037420|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037421|NCT00002476|Leucovorin|leucovorin|mesh-list
44250598|NCT05331781|Narcotics|narcotics|mesh-ancestor
44250599|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250600|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250601|NCT05331781|Analgesics|analgesics|mesh-ancestor
44250602|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
44250603|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250604|NCT05331768|Terlipressin|terlipressin|mesh-list
44037422|NCT00002476|Cobalt|cobalt|mesh-list
44037423|NCT00002476|Fluorouracil|fluorouracil|mesh-list
44037424|NCT00002476|Methotrexate|methotrexate|mesh-list
43766091|NCT02409563|Hormones|hormones|mesh-ancestor
44037425|NCT00002476|Vincristine|vincristine|mesh-list
44037426|NCT00002476|Bleomycin|bleomycin|mesh-list
44037427|NCT00002476|Calcium|calcium|mesh-list
44037428|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
44037429|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44037430|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037432|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037433|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037434|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037435|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037436|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
44037437|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037438|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037439|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037440|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037441|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037442|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037443|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037444|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037446|NCT00002476|Protective Agents|protective agents|mesh-ancestor
44037447|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037448|NCT00002476|Vitamins|vitamins|mesh-ancestor
44037449|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
44037450|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037451|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037452|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037453|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037454|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037455|NCT00002476|Trace Elements|trace elements|mesh-ancestor
44037456|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
44037457|NCT00002477|Cisplatin|cisplatin|mesh-list
44037458|NCT00002477|Carboplatin|carboplatin|mesh-list
44037459|NCT00002477|Doxorubicin|doxorubicin|mesh-list
44037460|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037461|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037470|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037471|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037472|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037473|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037474|NCT00002478|Etoposide|etoposide|mesh-list
44037475|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037476|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037477|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037478|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037479|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037480|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037481|NCT00002481|Cytarabine|cytarabine|mesh-list
44037482|NCT00002481|Dexamethasone|dexamethasone|mesh-list
44037483|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
44037484|NCT00002481|Cisplatin|cisplatin|mesh-list
44037485|NCT00002481|Etoposide|etoposide|mesh-list
44037486|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037487|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
44037488|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037489|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037490|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037491|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
44037492|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037493|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037494|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44250605|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44250606|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44460500|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460502|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44460503|NCT01562314|Cannabidiol|cannabidiol|mesh-list
43648983|NCT03032536|Tenofovir|tenofovir|mesh-list
44037495|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037496|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
44037497|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
44037498|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037499|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44037500|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
44037501|NCT00002481|Hormones|hormones|mesh-ancestor
44037502|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037503|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037504|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037505|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037506|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037507|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037508|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037509|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
44037510|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
44037511|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037512|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
44037514|NCT00002482|Antibodies|antibodies|mesh-list
44037515|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037516|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
44037517|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037518|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037519|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037520|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
44037521|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037522|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037523|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037524|NCT00002487|Methotrexate|methotrexate|mesh-list
44037525|NCT00002487|Dipyridamole|dipyridamole|mesh-list
44037526|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037527|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037528|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037539|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037540|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037541|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44037542|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44037543|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44037544|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
44037545|NCT00002488|Cisplatin|cisplatin|mesh-list
44037546|NCT00002488|Etoposide|etoposide|mesh-list
44037547|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037548|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
44037549|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037550|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037551|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037552|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
44037553|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037554|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037555|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037556|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037557|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037558|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037559|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037560|NCT00002489|Leucovorin|leucovorin|mesh-list
44037561|NCT00002489|Dactinomycin|dactinomycin|mesh-list
44037562|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
44037563|NCT00002489|Carboplatin|carboplatin|mesh-list
44037564|NCT00002489|Doxorubicin|doxorubicin|mesh-list
44037565|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037566|NCT00002489|Methotrexate|methotrexate|mesh-list
44037567|NCT00002489|Etoposide|etoposide|mesh-list
44037568|NCT00002489|Vincristine|vincristine|mesh-list
44037569|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
44460505|NCT01562028|Bevacizumab|bevacizumab|mesh-list
44460506|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44460507|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44460508|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460509|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460510|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44460511|NCT01562028|Growth Substances|growth substances|mesh-ancestor
44460512|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037570|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037571|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
44037572|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037573|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037574|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037575|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
44037576|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037577|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037578|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037579|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037580|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037581|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037582|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037583|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037584|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037585|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037586|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037587|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
44037588|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037589|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037590|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037591|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037593|NCT00002489|Protective Agents|protective agents|mesh-ancestor
44037611|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037612|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44037613|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
44037614|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037616|NCT00002492|Doxorubicin|doxorubicin|mesh-list
44037617|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037618|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037619|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037620|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037621|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037622|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037623|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037624|NCT00002493|Cisplatin|cisplatin|mesh-list
44037625|NCT00002493|Doxorubicin|doxorubicin|mesh-list
44037626|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037627|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037628|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037629|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037630|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037631|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037632|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037633|NCT00002494|Leucovorin|leucovorin|mesh-list
44037634|NCT00002494|Cobalt|cobalt|mesh-list
44037635|NCT00002494|Cytarabine|cytarabine|mesh-list
44037636|NCT00002494|Dexamethasone|dexamethasone|mesh-list
44037637|NCT00002494|Prednisone|prednisone|mesh-list
44037638|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
44037639|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44037640|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44037641|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44037642|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
44037643|NCT00002494|Ifosfamide|ifosfamide|mesh-list
44037644|NCT00002494|Doxorubicin|doxorubicin|mesh-list
44037645|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44460513|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
43904015|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
44460514|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44460515|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250607|NCT05324215|Fentanyl|fentanyl|mesh-list
44250608|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44250609|NCT05324215|Narcotics|narcotics|mesh-ancestor
44250610|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250611|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250612|NCT05324215|Analgesics|analgesics|mesh-ancestor
44250613|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
44250614|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250615|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44250616|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44250617|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
44250618|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
44250619|NCT05320991|Ketamine|ketamine|mesh-list
44250620|NCT05320991|Analgesics|analgesics|mesh-ancestor
44250621|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
44250622|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250623|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250624|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44250625|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44250626|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
44250627|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
44250628|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250633|NCT05315024|Imiquimod|imiquimod|mesh-list
44250653|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250654|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44250655|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250656|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037646|NCT00002494|Methotrexate|methotrexate|mesh-list
44037647|NCT00002494|Etoposide|etoposide|mesh-list
44037648|NCT00002494|Vincristine|vincristine|mesh-list
44037649|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
44037650|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037651|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
44037652|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037653|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037654|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037655|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
44037656|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037670|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037671|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037672|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037673|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037674|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037675|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037676|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
44037677|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037678|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037679|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037680|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037681|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
44037682|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037683|NCT00002494|Antidotes|antidotes|mesh-ancestor
44037684|NCT00002494|Protective Agents|protective agents|mesh-ancestor
44037685|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037686|NCT00002494|Vitamins|vitamins|mesh-ancestor
44037687|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
44037688|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037689|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037690|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037691|NCT00002494|Trace Elements|trace elements|mesh-ancestor
44037692|NCT00002495|Doxorubicin|doxorubicin|mesh-list
44037693|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037694|NCT00002495|Vinblastine|vinblastine|mesh-list
44037695|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037696|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037697|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037698|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037699|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037700|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037701|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037702|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037703|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037704|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037706|NCT00002496|Cisplatin|cisplatin|mesh-list
44037707|NCT00002496|Fluorouracil|fluorouracil|mesh-list
44037708|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037709|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
44037710|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037711|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037712|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037713|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
44037714|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037715|NCT00002496|Trace Elements|trace elements|mesh-ancestor
44037716|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
44037717|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
44037718|NCT00002498|Fluorouracil|fluorouracil|mesh-list
44037719|NCT00002498|Methotrexate|methotrexate|mesh-list
44037720|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
44037721|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037722|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
44037729|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037730|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
44037731|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037732|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037733|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
44250657|NCT05242874|Dexamethasone|dexamethasone|mesh-list
44250658|NCT05242874|Olanzapine|olanzapine|mesh-list
44250659|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
44250660|NCT05242874|Aprepitant|aprepitant|mesh-list
44250661|NCT05242874|Antiemetics|antiemetics|mesh-list
44250662|NCT05242874|Tropisetron|tropisetron|mesh-list
44250663|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250664|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
44037734|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037735|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037736|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037737|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037738|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037739|NCT00002498|Analgesics|analgesics|mesh-ancestor
44037740|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
44037741|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037742|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037743|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037744|NCT00002499|Cytarabine|cytarabine|mesh-list
44037745|NCT00002499|Dexamethasone|dexamethasone|mesh-list
44037746|NCT00002499|Prednisone|prednisone|mesh-list
44037747|NCT00002499|Methotrexate|methotrexate|mesh-list
44037748|NCT00002499|Vincristine|vincristine|mesh-list
44037749|NCT00002499|Daunorubicin|daunorubicin|mesh-list
44037750|NCT00002499|Asparaginase|asparaginase|mesh-list
44037751|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037752|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
44037753|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
44037754|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037755|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037756|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44037757|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
44037758|NCT00002499|Hormones|hormones|mesh-ancestor
44037759|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037760|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037761|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037762|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037763|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037764|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037765|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037766|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
44037767|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037768|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037769|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037770|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037771|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037772|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
44037773|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037774|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037775|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
44037776|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037777|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037778|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037779|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037780|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037781|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037782|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037783|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037784|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
44037785|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037786|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
44037787|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037788|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037789|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037790|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
44037791|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037792|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037793|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037795|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
44037796|NCT00002502|Busulfan|busulfan|mesh-list
44037797|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250665|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250666|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250667|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250668|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
44250670|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037798|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
44037799|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037800|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037801|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037802|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
44037803|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037804|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037805|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037806|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037807|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
44037808|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
43766433|NCT02407340|Oxytocin|oxytocin|mesh-list
44037809|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037810|NCT00002504|Interferons|interferons|mesh-list
44037811|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
44037812|NCT00002504|Aldesleukin|aldesleukin|mesh-list
44037813|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037814|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
44037815|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037816|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
44037817|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037818|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037819|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037820|NCT00002505|Interferons|interferons|mesh-list
44037821|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
44037822|NCT00002505|Vaccines|vaccines|mesh-list
44037823|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037824|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
44037825|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037826|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
44037827|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037828|NCT00002506|Interferons|interferons|mesh-list
44037829|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
44037830|NCT00002506|Isotretinoin|isotretinoin|mesh-list
44037831|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037832|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
44037833|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037834|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
44037835|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037836|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037837|NCT00002507|Mitomycins|mitomycins|mesh-list
44037838|NCT00002507|Mitomycin|mitomycin|mesh-list
44037839|NCT00002507|Porfiromycin|porfiromycin|mesh-list
44037840|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037841|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037842|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
44037843|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037844|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037845|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037846|NCT00002508|Carboplatin|carboplatin|mesh-list
44037847|NCT00002508|Etoposide|etoposide|mesh-list
44037848|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037849|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037850|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037851|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44071806|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
44037852|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037853|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037854|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
44037855|NCT00002509|Carboplatin|carboplatin|mesh-list
44037856|NCT00002509|Etoposide|etoposide|mesh-list
44037857|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037858|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
44037859|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037860|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037861|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44250671|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250672|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250673|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250674|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44250675|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44250676|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250677|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44250678|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44250679|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904092|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250680|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250681|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250682|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
44250683|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44250684|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44250685|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44250686|NCT05177614|Micronutrients|micronutrients|mesh-list
44250687|NCT05177614|Trace Elements|trace elements|mesh-list
44250688|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250689|NCT05159934|Nicotine|nicotine|mesh-list
44250690|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44250691|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
44250692|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250693|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250694|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44250695|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44250696|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
44250697|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250698|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250699|NCT05091866|Progesterone|progesterone|mesh-list
44250700|NCT05091866|Progestins|progestins|mesh-list
44250701|NCT05091866|Hormones|hormones|mesh-ancestor
44250702|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250703|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250704|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
44037862|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
44037863|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250705|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250706|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
44250707|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
44250708|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44250710|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44250711|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
44250712|NCT04923620|Cetuximab|cetuximab|mesh-list
44250713|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250714|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250715|NCT04907370|Gemcitabine|gemcitabine|mesh-list
44250716|NCT04907370|Cisplatin|cisplatin|mesh-list
44250717|NCT04907370|Antibodies|antibodies|mesh-list
44250718|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
44250719|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
44250720|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250721|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250722|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250723|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
44250724|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250725|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
44250726|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250727|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250728|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250729|NCT04500665|Colchicine|colchicine|mesh-list
44250730|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
44250731|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250732|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037864|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037865|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037866|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037867|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037869|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037870|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
44037871|NCT00002510|Etoposide|etoposide|mesh-list
44037872|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037873|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
44037874|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037875|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037876|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037877|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
44037878|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037879|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037880|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037881|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037882|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037883|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037884|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250733|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250734|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250735|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250736|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250737|NCT04413279|Dexamethasone|dexamethasone|mesh-list
44250738|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250739|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
44250740|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
44250741|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250742|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250743|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250744|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
44037885|NCT00002514|Leucovorin|leucovorin|mesh-list
44037886|NCT00002514|Cytarabine|cytarabine|mesh-list
44037887|NCT00002514|Dexamethasone|dexamethasone|mesh-list
44037888|NCT00002514|Prednisone|prednisone|mesh-list
44037889|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
44037891|NCT00002514|Etoposide|etoposide|mesh-list
44037892|NCT00002514|Vincristine|vincristine|mesh-list
44037893|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
44037894|NCT00002514|Daunorubicin|daunorubicin|mesh-list
44037895|NCT00002514|Asparaginase|asparaginase|mesh-list
44037896|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
44037897|NCT00002514|Thioguanine|thioguanine|mesh-list
44037898|NCT00002514|Sargramostim|sargramostim|mesh-list
44037899|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
44037900|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037901|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
44037902|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037903|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037904|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037905|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
44037906|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037907|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037908|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037909|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037910|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
44037911|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
44037912|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037913|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44037914|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
44037915|NCT00002514|Hormones|hormones|mesh-ancestor
44037916|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037917|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037918|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037919|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
44037920|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44037921|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037922|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
44037923|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037924|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037925|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037926|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037927|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037928|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037929|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037930|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
44037931|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037932|NCT00002514|Antidotes|antidotes|mesh-ancestor
44037933|NCT00002514|Protective Agents|protective agents|mesh-ancestor
44037934|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037935|NCT00002514|Vitamins|vitamins|mesh-ancestor
44037936|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
44037937|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037938|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037939|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250745|NCT04413279|Hormones|hormones|mesh-ancestor
44250746|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649108|NCT03031405|Oxytocin|oxytocin|mesh-list
44037940|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44037941|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037942|NCT00002515|Carboplatin|carboplatin|mesh-list
44037943|NCT00002515|Topotecan|topotecan|mesh-list
44037944|NCT00002515|Thiotepa|thiotepa|mesh-list
44037945|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037951|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037952|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037953|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
44037954|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037955|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037956|NCT00002516|Cobalt|cobalt|mesh-list
44037957|NCT00002516|Dactinomycin|dactinomycin|mesh-list
44037958|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
44037959|NCT00002516|Ifosfamide|ifosfamide|mesh-list
44037960|NCT00002516|Doxorubicin|doxorubicin|mesh-list
44037961|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44037962|NCT00002516|Etoposide|etoposide|mesh-list
44037963|NCT00002516|Vincristine|vincristine|mesh-list
44037964|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037965|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
44037966|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037967|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037968|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037969|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
44063446|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037970|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037971|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037972|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037973|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037974|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037975|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037976|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037977|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44037978|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037979|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037980|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037981|NCT00002516|Trace Elements|trace elements|mesh-ancestor
44037982|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
44037983|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44037984|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037985|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44037986|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037988|NCT00002517|Dexamethasone|dexamethasone|mesh-list
44037989|NCT00002517|Etoposide|etoposide|mesh-list
44037990|NCT00002517|Daunorubicin|daunorubicin|mesh-list
44037991|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
44037992|NCT00002517|Idarubicin|idarubicin|mesh-list
44037993|NCT00002517|Thioguanine|thioguanine|mesh-list
44037994|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037995|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
44037996|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
44037997|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037998|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037999|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038000|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
44038001|NCT00002517|Hormones|hormones|mesh-ancestor
44038002|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038003|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038004|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038005|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038006|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038007|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038008|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038009|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038010|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038011|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
44038012|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
44038013|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038014|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038015|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
44038016|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44250747|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250749|NCT04413253|Dexamethasone|dexamethasone|mesh-list
44250750|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44250751|NCT04413253|Lifitegrast|lifitegrast|mesh-list
44250752|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44250753|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250754|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
44250755|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
44250756|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250757|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250758|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44250759|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
44250760|NCT04413253|Hormones|hormones|mesh-ancestor
44250761|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038017|NCT00002517|Analgesics|analgesics|mesh-ancestor
44038019|NCT00002519|Paclitaxel|paclitaxel|mesh-list
44038020|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038021|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038022|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038023|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038024|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038025|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038026|NCT00002520|Nicotine|nicotine|mesh-list
44038027|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44038028|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
44038029|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038030|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038031|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44038032|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44038033|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
44038034|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44038035|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038036|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
44038037|NCT00002521|Cisplatin|cisplatin|mesh-list
44038038|NCT00002521|Etoposide|etoposide|mesh-list
44038039|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038040|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
44038041|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038042|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038043|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038045|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038046|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038047|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038048|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038049|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038050|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038051|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038052|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
44038053|NCT00002522|Cisplatin|cisplatin|mesh-list
44038054|NCT00002522|Etoposide|etoposide|mesh-list
44038055|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038056|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
44038057|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038058|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038059|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038060|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
44038061|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038062|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250762|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038063|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038064|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038065|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038066|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038067|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038068|NCT00002523|Leucovorin|leucovorin|mesh-list
44038069|NCT00002523|Fluorouracil|fluorouracil|mesh-list
44038070|NCT00002523|Calcium|calcium|mesh-list
44038071|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
44038072|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44038073|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038074|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
44038075|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038076|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038077|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038078|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038079|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
44038080|NCT00002523|Antidotes|antidotes|mesh-ancestor
44038081|NCT00002523|Protective Agents|protective agents|mesh-ancestor
44038082|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038083|NCT00002523|Vitamins|vitamins|mesh-ancestor
44038084|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
44038085|NCT00002524|Leucovorin|leucovorin|mesh-list
44038086|NCT00002524|Cytarabine|cytarabine|mesh-list
44038087|NCT00002524|Zidovudine|zidovudine|mesh-list
44038088|NCT00002524|Trimethoprim|trimethoprim|mesh-list
44038089|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
44038090|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44038091|NCT00002524|Pentamidine|pentamidine|mesh-list
44038092|NCT00002524|Prednisone|prednisone|mesh-list
44038093|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
44038094|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44038116|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038118|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038119|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038120|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038121|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038122|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038123|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038125|NCT00002524|Hormones|hormones|mesh-ancestor
44038126|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038127|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038128|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
44038129|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038130|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038131|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038132|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038133|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038134|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038135|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038136|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038137|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
44038138|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038139|NCT00002524|Antidotes|antidotes|mesh-ancestor
44038140|NCT00002524|Protective Agents|protective agents|mesh-ancestor
44038141|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038142|NCT00002524|Vitamins|vitamins|mesh-ancestor
44038143|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
44038144|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038145|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038146|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038147|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
44038148|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
44038149|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038150|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038151|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44038152|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44038175|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038176|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
44038177|NCT00002527|Aspirin|aspirin|mesh-list
44038178|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44038179|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44038180|NCT00002527|Analgesics|analgesics|mesh-ancestor
44038181|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
44038182|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250763|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649125|NCT03031444|Protective Agents|protective agents|mesh-ancestor
44038183|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038184|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038185|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038186|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44038187|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44038188|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038189|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44038190|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44038191|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038192|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
44038193|NCT00002528|Tamoxifen|tamoxifen|mesh-list
44038194|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44038195|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149428|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44038196|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038197|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038198|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038199|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038200|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44038201|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44038202|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44038203|NCT00002529|Tamoxifen|tamoxifen|mesh-list
44038207|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038208|NCT00002529|Epirubicin|epirubicin|mesh-list
44038209|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038210|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
44038211|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038212|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038213|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038214|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
44038215|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038216|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038217|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038218|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038219|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038220|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038221|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038222|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44038223|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
44038224|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038225|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038226|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44038227|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44038228|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44038229|NCT00002531|Leucovorin|leucovorin|mesh-list
44038230|NCT00002531|Cytarabine|cytarabine|mesh-list
44038231|NCT00002531|Dexamethasone|dexamethasone|mesh-list
44038232|NCT00002531|Prednisolone|prednisolone|mesh-list
44038233|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
44038234|NCT00002531|Ifosfamide|ifosfamide|mesh-list
44038235|NCT00002531|Doxorubicin|doxorubicin|mesh-list
44038236|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038237|NCT00002531|Methotrexate|methotrexate|mesh-list
44038238|NCT00002531|Etoposide|etoposide|mesh-list
44038239|NCT00002531|Vincristine|vincristine|mesh-list
44038240|NCT00002531|Daunorubicin|daunorubicin|mesh-list
44038241|NCT00002531|Asparaginase|asparaginase|mesh-list
44038242|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
44038243|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
44038244|NCT00002531|Thioguanine|thioguanine|mesh-list
44038245|NCT00002531|Vindesine|vindesine|mesh-list
44038246|NCT00002531|Teniposide|teniposide|mesh-list
44038247|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
44038248|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038249|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
44038250|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038251|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038252|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038253|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
44038254|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038255|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250765|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44250766|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250767|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44250768|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250769|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250770|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44250771|NCT04286529|Vitamins|vitamins|mesh-ancestor
44038256|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038257|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038258|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
44038259|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
44038260|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038261|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038262|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
44038263|NCT00002531|Hormones|hormones|mesh-ancestor
44038264|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038265|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038266|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038267|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038268|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038269|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038270|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038271|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038272|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038273|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038274|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
44038275|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038276|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038277|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038278|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038292|NCT00002532|Cytarabine|cytarabine|mesh-list
44038293|NCT00002532|Dexamethasone|dexamethasone|mesh-list
44038294|NCT00002532|Prednisolone|prednisolone|mesh-list
44038295|NCT00002532|Methotrexate|methotrexate|mesh-list
44038296|NCT00002532|Etoposide|etoposide|mesh-list
44038297|NCT00002532|Daunorubicin|daunorubicin|mesh-list
44038298|NCT00002532|Asparaginase|asparaginase|mesh-list
44038299|NCT00002532|Ifosfamide|ifosfamide|mesh-list
44038300|NCT00002532|Idarubicin|idarubicin|mesh-list
44038301|NCT00002532|Vindesine|vindesine|mesh-list
44038302|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
44038303|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038304|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
44038305|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
44038306|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038307|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038308|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038309|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
44038310|NCT00002532|Hormones|hormones|mesh-ancestor
44038311|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038312|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038313|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038314|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038315|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038316|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038317|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038318|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
44038319|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038320|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038321|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038322|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038323|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038324|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
44038325|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038326|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038327|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038328|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43701505|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
44250772|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
44250773|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44460516|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038329|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038330|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
44038331|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038332|NCT00002532|Antidotes|antidotes|mesh-ancestor
44038333|NCT00002532|Protective Agents|protective agents|mesh-ancestor
44038334|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038335|NCT00002532|Vitamins|vitamins|mesh-ancestor
44038336|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
44038337|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038338|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038339|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
44038340|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038341|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038342|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038343|NCT00002533|Fluconazole|fluconazole|mesh-list
44038344|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
44038345|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038346|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44038349|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038350|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44038351|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
44038352|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038353|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038354|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44038355|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44038357|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
44038358|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
44038359|NCT00002534|Thiotepa|thiotepa|mesh-list
44038360|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44038361|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038362|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
44038363|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038364|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038365|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038366|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
44038367|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038368|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038369|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038370|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038371|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
44038372|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
44038373|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038374|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038375|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
44038376|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
44038377|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038378|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038379|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
44038380|NCT00002534|Hormones|hormones|mesh-ancestor
44038381|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038382|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44038383|NCT00002534|Protective Agents|protective agents|mesh-ancestor
44149429|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44149430|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
44149431|NCT00208065|Ephedrine|ephedrine|mesh-list
44149432|NCT00208065|Almotriptan|almotriptan|mesh-list
44149433|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44149434|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
44149435|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149436|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149437|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44149438|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
44149439|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
44149440|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44149441|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44149442|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
44149443|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44460518|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
44460519|NCT01561989|Vaccines|vaccines|mesh-list
44460520|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
44460521|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460522|NCT01561989|Vitamins|vitamins|mesh-ancestor
44460523|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
44460524|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44460525|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44460526|NCT01561976|Metformin|metformin|mesh-list
44460527|NCT01561976|Glimepiride|glimepiride|mesh-list
44460528|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460529|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460530|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44460531|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460532|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
44460533|NCT01561963|Rifampin|rifampin|mesh-list
44460534|NCT01561963|Apremilast|apremilast|mesh-list
44460535|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44149444|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149445|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149446|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44149447|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
44149448|NCT00208117|Sertraline|sertraline|mesh-list
44149449|NCT00208117|Simvastatin|simvastatin|mesh-list
44149450|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44149451|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44149452|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
44149453|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149454|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44149455|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44149456|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149457|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149458|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149459|NCT00208117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149460|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149461|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149462|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149466|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
44149467|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44149468|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149470|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44149471|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44038384|NCT00002535|Aldesleukin|aldesleukin|mesh-list
44038385|NCT00002535|Indomethacin|indomethacin|mesh-list
44038386|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
44038387|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038388|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
44038389|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038390|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038391|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038392|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
44038393|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038394|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038395|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038396|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44038397|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44038398|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
44038399|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460537|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44460538|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460539|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
44460540|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44460541|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460542|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649158|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44038400|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44038401|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44038402|NCT00002535|Analgesics|analgesics|mesh-ancestor
44038403|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
44038404|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038405|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038406|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
44038407|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
44038408|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038409|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44038410|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038412|NCT00002536|Vincristine|vincristine|mesh-list
44038413|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038414|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038415|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038416|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038417|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038418|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038419|NCT00002537|Topotecan|topotecan|mesh-list
44038420|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44038421|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038422|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038423|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038424|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038425|NCT00002539|Cisplatin|cisplatin|mesh-list
44038426|NCT00002539|Doxorubicin|doxorubicin|mesh-list
44038427|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038428|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038429|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038430|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038431|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038432|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038433|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038434|NCT00002542|Tamoxifen|tamoxifen|mesh-list
44038435|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
44038436|NCT00002542|Doxorubicin|doxorubicin|mesh-list
44038437|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038438|NCT00002542|Fluorouracil|fluorouracil|mesh-list
44038439|NCT00002542|Methotrexate|methotrexate|mesh-list
44038440|NCT00002542|Epirubicin|epirubicin|mesh-list
44038441|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038442|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
44038443|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038444|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038445|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038446|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
44038447|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038448|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038451|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038452|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038454|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
44038455|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038456|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038457|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038458|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038459|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038460|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43701506|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
44460543|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44460544|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44038461|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038462|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44038463|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
44038464|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038465|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038466|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44038467|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44038468|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44038469|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
44038470|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44038471|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038472|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038474|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
44038475|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038476|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038477|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038478|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038479|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038480|NCT00002544|Analgesics|analgesics|mesh-ancestor
44038481|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
44038482|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038483|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038484|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038485|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038486|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038487|NCT00002545|Carmustine|carmustine|mesh-list
44038488|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072471|NCT05638893|Metformin|metformin|mesh-list
44038489|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
44038490|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038491|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038492|NCT00002546|Cisplatin|cisplatin|mesh-list
44038493|NCT00002546|Ifosfamide|ifosfamide|mesh-list
44038494|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038495|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038496|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
44038497|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038498|NCT00002547|Cytarabine|cytarabine|mesh-list
44038499|NCT00002547|Cyclosporine|cyclosporine|mesh-list
44038500|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
44038501|NCT00002547|Busulfan|busulfan|mesh-list
44038502|NCT00002547|Methotrexate|methotrexate|mesh-list
44038503|NCT00002547|Cyclosporins|cyclosporins|mesh-list
44038504|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038505|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
44038506|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038507|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038508|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038509|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
44038510|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038511|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038512|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038513|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038514|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038515|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038516|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038517|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
44038518|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038519|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038520|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038521|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038522|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
44038523|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038524|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
44038525|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44038526|NCT00002548|Interferons|interferons|mesh-list
44038527|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
44038528|NCT00002548|Dexamethasone|dexamethasone|mesh-list
44038529|NCT00002548|Prednisone|prednisone|mesh-list
44038530|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
44038531|NCT00002548|Melphalan|melphalan|mesh-list
44038533|NCT00002548|Doxorubicin|doxorubicin|mesh-list
44460545|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44460546|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44460547|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44460548|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44460549|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44038534|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038535|NCT00002548|Vincristine|vincristine|mesh-list
44038536|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038537|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
44038538|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038539|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038540|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038541|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
44038542|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038543|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038544|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038545|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038547|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
44038548|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038549|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038550|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
44038551|NCT00002548|Hormones|hormones|mesh-ancestor
44038552|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038553|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038554|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038555|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038556|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038557|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038558|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
44038559|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038560|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038561|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038562|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038563|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038564|NCT00002549|Cytarabine|cytarabine|mesh-list
44038565|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
44038566|NCT00002549|Busulfan|busulfan|mesh-list
44038567|NCT00002549|Etoposide|etoposide|mesh-list
44038568|NCT00002549|Daunorubicin|daunorubicin|mesh-list
44038569|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
44038570|NCT00002549|Idarubicin|idarubicin|mesh-list
44038571|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038572|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
44038573|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038574|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038575|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038576|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
44038577|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038578|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038579|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038580|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038581|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038582|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038583|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038584|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038585|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
44038586|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
44038587|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038588|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038589|NCT00002549|Analgesics|analgesics|mesh-ancestor
44038590|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
44038591|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038592|NCT00002550|Cisplatin|cisplatin|mesh-list
44038593|NCT00002550|Etoposide|etoposide|mesh-list
44038594|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038595|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038596|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038597|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038598|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460550|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44460551|NCT01561963|Analgesics|analgesics|mesh-ancestor
44460552|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
44460553|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460554|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038599|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038600|NCT00002551|Leucovorin|leucovorin|mesh-list
44038602|NCT00002551|Fluorouracil|fluorouracil|mesh-list
44038603|NCT00002551|Calcium|calcium|mesh-list
44038604|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
44038605|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44038606|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038607|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
44038608|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038609|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038610|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038611|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038612|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
44038613|NCT00002551|Antidotes|antidotes|mesh-ancestor
44038614|NCT00002551|Protective Agents|protective agents|mesh-ancestor
44038615|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038616|NCT00002551|Vitamins|vitamins|mesh-ancestor
44038617|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
44038618|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44038619|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
44038620|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
44038621|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44038622|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038623|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038624|NCT00002552|Leucovorin|leucovorin|mesh-list
44038625|NCT00002552|Cytarabine|cytarabine|mesh-list
44038626|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
44038627|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44038628|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44038629|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44038630|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
44038631|NCT00002552|Carmustine|carmustine|mesh-list
44038632|NCT00002552|Methotrexate|methotrexate|mesh-list
44038633|NCT00002552|Etoposide|etoposide|mesh-list
44038634|NCT00002552|Sargramostim|sargramostim|mesh-list
44038635|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
44038636|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038637|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
44038638|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038639|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038640|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038641|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
44038642|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038643|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038644|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038645|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038646|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038647|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038648|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038649|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
44038650|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038651|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038652|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038653|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038654|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038655|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038656|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038657|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
44038658|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038659|NCT00002552|Antidotes|antidotes|mesh-ancestor
44038660|NCT00002552|Protective Agents|protective agents|mesh-ancestor
44038661|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038662|NCT00002552|Vitamins|vitamins|mesh-ancestor
44038663|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
44038664|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038665|NCT00002553|Cobalt|cobalt|mesh-list
44038666|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
44038667|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460556|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460557|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44460558|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44460559|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44460560|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44460561|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460562|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460563|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460564|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460565|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44460566|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44460567|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
44460568|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460569|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460570|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44460571|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44460572|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
44460573|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
44460574|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44250774|NCT04235062|Furosemide|furosemide|mesh-list
44250775|NCT04235062|Calcium|calcium|mesh-list
44250776|NCT04235062|Diuretics|diuretics|mesh-list
44250777|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43649176|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44038668|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
44038669|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038670|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038671|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038672|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
44038673|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038674|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038675|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038676|NCT00002553|Trace Elements|trace elements|mesh-ancestor
44038677|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
44038687|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767185|NCT02403284|Hormones|hormones|mesh-ancestor
44038688|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038689|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038690|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038691|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038692|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038693|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038694|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
44038695|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038696|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038697|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038698|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038699|NCT00002555|Cobalt|cobalt|mesh-list
44250778|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43649201|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44038701|NCT00002555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038702|NCT00002555|Trace Elements|trace elements|mesh-ancestor
44038703|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
44038704|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038705|NCT00002556|Interferons|interferons|mesh-list
44038706|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
44038707|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
44038708|NCT00002556|Prednisone|prednisone|mesh-list
44038709|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
44038710|NCT00002556|Melphalan|melphalan|mesh-list
44038711|NCT00002556|Carmustine|carmustine|mesh-list
44038712|NCT00002556|Vincristine|vincristine|mesh-list
44038713|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038714|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
44038715|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038716|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038717|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038718|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
44038719|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038720|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038721|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038722|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038723|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
44038724|NCT00002556|Hormones|hormones|mesh-ancestor
44038725|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038726|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038727|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
44038728|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038729|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038730|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038731|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038732|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038733|NCT00002557|Leucovorin|leucovorin|mesh-list
44038734|NCT00002557|Doxorubicin|doxorubicin|mesh-list
44038735|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038736|NCT00002557|Etoposide|etoposide|mesh-list
44038737|NCT00002557|Methotrexate|methotrexate|mesh-list
44038738|NCT00002557|Calcium|calcium|mesh-list
44038739|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
44038740|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038741|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038742|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038743|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038744|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038745|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038747|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038748|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038750|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038751|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038752|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
44038753|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44038754|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038755|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038756|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
44038757|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038758|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038759|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038760|NCT00002557|Antidotes|antidotes|mesh-ancestor
43767244|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
44038761|NCT00002557|Protective Agents|protective agents|mesh-ancestor
44038762|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038763|NCT00002557|Vitamins|vitamins|mesh-ancestor
44038764|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
44038765|NCT00002559|Paclitaxel|paclitaxel|mesh-list
44038766|NCT00002559|Cisplatin|cisplatin|mesh-list
44038767|NCT00002559|Ifosfamide|ifosfamide|mesh-list
44038768|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038769|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038770|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038771|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038772|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038773|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250779|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250780|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
44250781|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250782|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250783|NCT04029116|Fluconazole|fluconazole|mesh-list
44250784|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
43602380|NCT03255473|Prednisone|prednisone|mesh-list
44038774|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038775|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
44038776|NCT00002560|Antibodies|antibodies|mesh-list
44038777|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44038778|NCT00002560|Sargramostim|sargramostim|mesh-list
44038779|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
44038780|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038781|NCT00002561|Doxorubicin|doxorubicin|mesh-list
44038782|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038783|NCT00002561|Bleomycin|bleomycin|mesh-list
44038784|NCT00002561|Dacarbazine|dacarbazine|mesh-list
44038785|NCT00002561|Vinblastine|vinblastine|mesh-list
44038786|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038787|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038788|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038789|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038790|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038791|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072773|NCT05551858|Proglumide|proglumide|mesh-list
44038792|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038793|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
44038794|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038795|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038796|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038797|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038798|NCT00002562|Paclitaxel|paclitaxel|mesh-list
44038799|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038800|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038801|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038802|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038803|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038804|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038805|NCT00002565|Cytarabine|cytarabine|mesh-list
44038806|NCT00002565|Prednisone|prednisone|mesh-list
44038807|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
44038808|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
44038809|NCT00002565|Ifosfamide|ifosfamide|mesh-list
44038810|NCT00002565|Doxorubicin|doxorubicin|mesh-list
44038811|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038812|NCT00002565|Etoposide|etoposide|mesh-list
44038813|NCT00002565|Vincristine|vincristine|mesh-list
44038814|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
44038815|NCT00002565|Idarubicin|idarubicin|mesh-list
44038816|NCT00002565|Bleomycin|bleomycin|mesh-list
44038817|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038818|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
44038819|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038820|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038821|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038837|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
44038838|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
44038839|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038840|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038841|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038842|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038843|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
44038844|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
44038845|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44038846|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038847|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44038848|NCT00002565|Protective Agents|protective agents|mesh-ancestor
44038849|NCT00002565|Analgesics|analgesics|mesh-ancestor
44038850|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
44038851|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
44038852|NCT00002566|Ifosfamide|ifosfamide|mesh-list
44038853|NCT00002566|Cisplatin|cisplatin|mesh-list
44038854|NCT00002566|Carboplatin|carboplatin|mesh-list
44038855|NCT00002566|Etoposide|etoposide|mesh-list
44250785|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
44250786|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250787|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44250788|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44250789|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649209|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44038856|NCT00002566|Vinblastine|vinblastine|mesh-list
44038857|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038858|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
44038859|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038860|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038861|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038862|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
44038863|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038864|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038865|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072826|NCT05490940|Coagulants|coagulants|mesh-ancestor
44038866|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038867|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038868|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038869|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038870|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038871|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038872|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038873|NCT00002567|Etoposide|etoposide|mesh-list
44038874|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038875|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038876|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038877|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038878|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038879|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038880|NCT00002568|Paclitaxel|paclitaxel|mesh-list
44038887|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038889|NCT00002569|Lomustine|lomustine|mesh-list
44038890|NCT00002569|Procarbazine|procarbazine|mesh-list
44038891|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038892|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038893|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038894|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038895|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038896|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038897|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038898|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
44038899|NCT00002570|Leucovorin|leucovorin|mesh-list
44038900|NCT00002570|Fluorouracil|fluorouracil|mesh-list
44038901|NCT00002570|Calcium|calcium|mesh-list
44038902|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
44038903|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44038904|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038905|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
44038906|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038907|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038908|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038909|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038910|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
44038911|NCT00002570|Antidotes|antidotes|mesh-ancestor
44038912|NCT00002570|Protective Agents|protective agents|mesh-ancestor
44038913|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038914|NCT00002570|Vitamins|vitamins|mesh-ancestor
44038915|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
44038916|NCT00002571|Leucovorin|leucovorin|mesh-list
44038917|NCT00002571|Cytarabine|cytarabine|mesh-list
44038918|NCT00002571|Trimethoprim|trimethoprim|mesh-list
44038919|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
44038920|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44038921|NCT00002571|Prednisone|prednisone|mesh-list
44038922|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
44038923|NCT00002571|Doxorubicin|doxorubicin|mesh-list
44038924|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038925|NCT00002571|Methotrexate|methotrexate|mesh-list
44038927|NCT00002571|Vincristine|vincristine|mesh-list
44038928|NCT00002571|Bleomycin|bleomycin|mesh-list
44250790|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250791|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44250792|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
44250793|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250794|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250795|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44250796|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44250797|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44038929|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
44038930|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038931|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
44072888|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44038932|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038933|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038934|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038935|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
44038936|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038937|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038938|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038939|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038940|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038941|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038942|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038943|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038944|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
44038946|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038947|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038948|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44038949|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
44038950|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44038951|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038952|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
44038958|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038959|NCT00002571|Antidotes|antidotes|mesh-ancestor
44038960|NCT00002571|Protective Agents|protective agents|mesh-ancestor
44038961|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038963|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
44038964|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038965|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038966|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038967|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44038968|NCT00002571|Renal Agents|renal agents|mesh-ancestor
44038969|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
44038970|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44038971|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44038972|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44038973|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44038974|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44038975|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44038976|NCT00002572|Aldesleukin|aldesleukin|mesh-list
44038977|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
44038978|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038979|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44038980|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44038981|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
44038982|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038983|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
44038984|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038985|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038986|NCT00002574|Interferons|interferons|mesh-list
44038987|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
44038988|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
44038989|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038990|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
43643651|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
44250798|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250800|NCT04019964|Nivolumab|nivolumab|mesh-list
44250801|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250802|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250803|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44250804|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250805|NCT04019015|Thrombin|thrombin|mesh-list
44250806|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
44250807|NCT04019015|Coagulants|coagulants|mesh-ancestor
44038991|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038992|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
44038993|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038994|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038995|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44038996|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038997|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038998|NCT00002576|Prednisolone|prednisolone|mesh-list
44038999|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
44039000|NCT00002576|Doxorubicin|doxorubicin|mesh-list
44039001|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039002|NCT00002576|Vincristine|vincristine|mesh-list
44039003|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
44039004|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039005|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
44039006|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039007|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039008|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039009|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
44039010|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039011|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039012|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039013|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039014|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039015|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039016|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039017|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039018|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039019|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039020|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039021|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44039022|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
44039023|NCT00002576|Hormones|hormones|mesh-ancestor
44039031|NCT00002578|Methotrexate|methotrexate|mesh-list
44039032|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
44039033|NCT00002578|Calcium|calcium|mesh-list
44039034|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
44039035|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44039036|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250826|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44250827|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44250828|NCT03936192|Analgesics|analgesics|mesh-ancestor
43824343|NCT05513365|Goserelin|goserelin|mesh-list
44039037|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039038|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039039|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039040|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039041|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
44039042|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039043|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039044|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039045|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039046|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039047|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039048|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
44039049|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039050|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039051|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
44039052|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039053|NCT00002578|Antidotes|antidotes|mesh-ancestor
44039054|NCT00002578|Protective Agents|protective agents|mesh-ancestor
44039055|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
44039056|NCT00002578|Vitamins|vitamins|mesh-ancestor
44039057|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
44039058|NCT00002579|Tamoxifen|tamoxifen|mesh-list
44039059|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
44039060|NCT00002579|Fluorouracil|fluorouracil|mesh-list
44039061|NCT00002579|Methotrexate|methotrexate|mesh-list
44039062|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039063|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
44039064|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073016|NCT05321160|Sevoflurane|sevoflurane|mesh-list
44039065|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039066|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039067|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
44039068|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039069|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039070|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039071|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
44039072|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767545|NCT02400931|Rocuronium|rocuronium|mesh-list
44039073|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039074|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039075|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039076|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039077|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039078|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039079|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039080|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039081|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039082|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039083|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039084|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039085|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039086|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039087|NCT00002580|Tamoxifen|tamoxifen|mesh-list
44039088|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
44039089|NCT00002580|Fluorouracil|fluorouracil|mesh-list
44039090|NCT00002580|Methotrexate|methotrexate|mesh-list
44039091|NCT00002580|Leuprolide|leuprolide|mesh-list
44039096|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039097|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039098|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
44039099|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039100|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039101|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039102|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
44039103|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039104|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44250829|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
44250830|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250831|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250832|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824344|NCT05513365|Bicalutamide|bicalutamide|mesh-list
44039105|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039106|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039107|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039108|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039109|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039110|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039111|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039112|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039113|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039114|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039115|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039116|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039117|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039118|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44039119|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
44039120|NCT00002581|Tamoxifen|tamoxifen|mesh-list
44039121|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
44039122|NCT00002581|Fluorouracil|fluorouracil|mesh-list
44039123|NCT00002581|Methotrexate|methotrexate|mesh-list
44039124|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039125|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
44073072|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039126|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039127|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039128|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039129|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
44039130|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039131|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039132|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039133|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
44039134|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039135|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039136|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039137|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039138|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039139|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039140|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039141|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039142|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039143|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039144|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039145|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039146|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039147|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039148|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039150|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
44039151|NCT00002582|Doxorubicin|doxorubicin|mesh-list
44039152|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039153|NCT00002582|Fluorouracil|fluorouracil|mesh-list
44039154|NCT00002582|Methotrexate|methotrexate|mesh-list
44039155|NCT00002582|Leuprolide|leuprolide|mesh-list
44039156|NCT00002582|Goserelin|goserelin|mesh-list
44039157|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039158|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
44039159|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039160|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039161|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039166|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039167|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039168|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039169|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039170|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
44039171|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039172|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44250834|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44250835|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44250836|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250837|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250838|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
44250839|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250840|NCT03901729|Furosemide|furosemide|mesh-list
44250841|NCT03901729|Diuretics|diuretics|mesh-ancestor
44250842|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
44250843|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250844|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44250845|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43824349|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039173|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039174|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039175|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039176|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039177|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039178|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039179|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039180|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151252|NCT00213252|Prednisolone|prednisolone|mesh-list
44039181|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039182|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039183|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039184|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039185|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44039186|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
44039188|NCT00002583|Vinorelbine|vinorelbine|mesh-list
44039189|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039190|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039191|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039192|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039193|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039194|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039195|NCT00002585|NSC 366140|nsc 366140|mesh-list
44039196|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039197|NCT00002586|Vitamin E|vitamin e|mesh-list
44039198|NCT00002586|Tocopherols|tocopherols|mesh-list
44039199|NCT00002586|Tocotrienols|tocotrienols|mesh-list
44039200|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
44039201|NCT00002586|Tretinoin|tretinoin|mesh-list
44039202|NCT00002586|Isotretinoin|isotretinoin|mesh-list
44039203|NCT00002586|Vitamins|vitamins|mesh-ancestor
44039204|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
44039205|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039206|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
44039207|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039208|NCT00002586|Protective Agents|protective agents|mesh-ancestor
44039209|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039210|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
44039211|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039212|NCT00002587|Paclitaxel|paclitaxel|mesh-list
44039213|NCT00002587|Topotecan|topotecan|mesh-list
44039214|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039215|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039216|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039217|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039218|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039219|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250846|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250847|NCT03897335|Aminophylline|aminophylline|mesh-list
44250848|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44250849|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
44250850|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250851|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250852|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44250853|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
44250854|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44250855|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44250856|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250857|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250858|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44250859|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44250860|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
44250861|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250862|NCT03897335|Protective Agents|protective agents|mesh-ancestor
44250863|NCT03879577|Tamoxifen|tamoxifen|mesh-list
44250864|NCT03879577|Docetaxel|docetaxel|mesh-list
44250865|NCT03879577|Trastuzumab|trastuzumab|mesh-list
44250866|NCT03879577|Letrozole|letrozole|mesh-list
44250867|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250868|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603319|NCT03247218|Memantine|memantine|mesh-list
44039220|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44039222|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039223|NCT00002588|Etoposide|etoposide|mesh-list
44039224|NCT00002588|Topotecan|topotecan|mesh-list
44039225|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039226|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039227|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039228|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039229|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039230|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039231|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44039232|NCT00002589|Aldesleukin|aldesleukin|mesh-list
44039252|NCT00002590|Asparaginase|asparaginase|mesh-list
44039253|NCT00002590|Pegaspargase|pegaspargase|mesh-list
44039254|NCT00002590|Thioguanine|thioguanine|mesh-list
44039255|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
44039256|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039257|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
44039258|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039259|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039260|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039261|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
44039262|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039263|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039264|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039265|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039266|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039267|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44250870|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250871|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250872|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250873|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44250874|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44250875|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250876|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44250877|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039268|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039269|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44039270|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
44039271|NCT00002590|Hormones|hormones|mesh-ancestor
44039272|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039273|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039274|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039275|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039276|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039277|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039278|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
44039279|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039280|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039281|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039282|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039283|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
44039284|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039285|NCT00002590|Antidotes|antidotes|mesh-ancestor
44039286|NCT00002590|Protective Agents|protective agents|mesh-ancestor
44039287|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
44039288|NCT00002590|Vitamins|vitamins|mesh-ancestor
44039289|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
44039290|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039291|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039292|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039293|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
44039294|NCT00002592|Busulfan|busulfan|mesh-list
44039296|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
44039297|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039298|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767731|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
44039299|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039300|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
44039301|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039302|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039303|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039304|NCT00002593|Leucovorin|leucovorin|mesh-list
44039305|NCT00002593|Levamisole|levamisole|mesh-list
44039306|NCT00002593|Fluorouracil|fluorouracil|mesh-list
44039307|NCT00002593|Calcium|calcium|mesh-list
44039308|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
44039309|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44039310|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039311|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
44039312|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039313|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039314|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039315|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039316|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
44039317|NCT00002593|Antidotes|antidotes|mesh-ancestor
44039318|NCT00002593|Protective Agents|protective agents|mesh-ancestor
44039319|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
44039320|NCT00002593|Vitamins|vitamins|mesh-ancestor
44039321|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
44039322|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44039323|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
44250878|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250879|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250880|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250881|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44250882|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44250883|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44250884|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44250885|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44250886|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039324|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
44039325|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44039326|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039327|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039328|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
44039329|NCT00002594|Melphalan|melphalan|mesh-list
44039330|NCT00002594|Molgramostim|molgramostim|mesh-list
44039331|NCT00002594|Sargramostim|sargramostim|mesh-list
44039332|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039333|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
44039334|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039335|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039336|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039337|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
44039338|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039339|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039340|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039341|NCT00002595|Toremifene|toremifene|mesh-list
44039342|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039343|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039344|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039345|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039346|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039347|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039348|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039349|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039350|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
44039351|NCT00002596|Cisplatin|cisplatin|mesh-list
44039352|NCT00002596|Carboplatin|carboplatin|mesh-list
44039353|NCT00002596|Etoposide|etoposide|mesh-list
44039354|NCT00002596|Bleomycin|bleomycin|mesh-list
44039355|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039356|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
44039357|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039358|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039359|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039360|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
44039361|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039362|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039363|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039364|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039365|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039366|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039367|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039368|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039377|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039378|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
44039379|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039381|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44250892|NCT03711305|Carboplatin|carboplatin|mesh-list
44250893|NCT03711305|Etoposide|etoposide|mesh-list
44250894|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250895|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039382|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
44039383|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039384|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039385|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039386|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039387|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039388|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039389|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039390|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
44039391|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039392|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039393|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039394|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039395|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039396|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039397|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039398|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
44039399|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039400|NCT00002598|Analgesics|analgesics|mesh-ancestor
44039401|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
44039402|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44039403|NCT00002599|Cobalt|cobalt|mesh-list
44039404|NCT00002599|Interferons|interferons|mesh-list
44039405|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
44039406|NCT00002599|Prednisone|prednisone|mesh-list
44039407|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
44039408|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
44039409|NCT00002599|Melphalan|melphalan|mesh-list
44039410|NCT00002599|Carmustine|carmustine|mesh-list
44039411|NCT00002599|Doxorubicin|doxorubicin|mesh-list
44039412|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039413|NCT00002599|Vincristine|vincristine|mesh-list
44039414|NCT00002599|Sargramostim|sargramostim|mesh-list
44039415|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039416|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
44039417|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039418|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039419|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039420|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
44039421|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039422|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039423|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039424|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039425|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039426|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039427|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039428|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44039429|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
44039430|NCT00002599|Hormones|hormones|mesh-ancestor
44039431|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039432|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039433|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
44039434|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039435|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039436|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039437|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039438|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039439|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
44039440|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
44039441|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073332|NCT04908371|Epinephrine|epinephrine|mesh-list
44039451|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039453|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039454|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
44039455|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039456|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039457|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039459|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44250896|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44250897|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44250898|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250899|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250900|NCT03608657|Apremilast|apremilast|mesh-list
44250901|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44250902|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44250903|NCT03608657|Analgesics|analgesics|mesh-ancestor
44250904|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
44250905|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250906|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039460|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039461|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
44039462|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039463|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039464|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039466|NCT00002608|Cisplatin|cisplatin|mesh-list
44039467|NCT00002608|Doxorubicin|doxorubicin|mesh-list
44039468|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039469|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039470|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039471|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039472|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039473|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039474|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039475|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039476|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039477|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039478|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039479|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039480|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039481|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039482|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039483|NCT00002609|Cytarabine|cytarabine|mesh-list
44039484|NCT00002609|Idarubicin|idarubicin|mesh-list
44039485|NCT00002609|Lintuzumab|lintuzumab|mesh-list
44039486|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039487|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
44039488|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039489|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039490|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
44039491|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039492|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039493|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
44039494|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039495|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039496|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039497|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039498|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039499|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44039500|NCT00002610|Dactinomycin|dactinomycin|mesh-list
44073399|NCT04870957|Analgesics|analgesics|mesh-ancestor
44039501|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
44039502|NCT00002610|Carboplatin|carboplatin|mesh-list
44039503|NCT00002610|Doxorubicin|doxorubicin|mesh-list
44039504|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039505|NCT00002610|Etoposide|etoposide|mesh-list
44039506|NCT00002610|Vincristine|vincristine|mesh-list
44039507|NCT00002610|Lenograstim|lenograstim|mesh-list
44039508|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039509|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
44039510|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039520|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039521|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44250908|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250909|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44250910|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44250911|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250912|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250913|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
44250914|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44250915|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
44250916|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44039522|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44039523|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039524|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039525|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039526|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44039527|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039528|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44039529|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039530|NCT00002611|Dactinomycin|dactinomycin|mesh-list
44039531|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
44039532|NCT00002611|Doxorubicin|doxorubicin|mesh-list
44039533|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039534|NCT00002611|Etoposide|etoposide|mesh-list
44039535|NCT00002611|Vincristine|vincristine|mesh-list
44039536|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039537|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
44039538|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039539|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039540|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039541|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
44039542|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039543|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039544|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039545|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039546|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039547|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039548|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039549|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039550|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039551|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039552|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039553|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44039554|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039555|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44039556|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039557|NCT00002615|Cisplatin|cisplatin|mesh-list
44039558|NCT00002615|Fluorouracil|fluorouracil|mesh-list
44039559|NCT00002615|Epirubicin|epirubicin|mesh-list
44039560|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039561|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
44039562|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039563|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039564|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039565|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
44039566|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039567|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039568|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039569|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039570|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039571|NCT00002616|Aldesleukin|aldesleukin|mesh-list
44039572|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
44039573|NCT00002616|Thiotepa|thiotepa|mesh-list
44039574|NCT00002616|Carboplatin|carboplatin|mesh-list
44039575|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039585|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44250917|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250919|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
44250920|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44250921|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
44250922|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250923|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250924|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44250925|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44250926|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
44250927|NCT03576885|Protective Agents|protective agents|mesh-ancestor
44250928|NCT03573648|Palbociclib|palbociclib|mesh-list
44250930|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250931|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44250932|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250933|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649231|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
44039586|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
44039587|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039589|NCT00002618|Cobalt|cobalt|mesh-list
44039590|NCT00002618|Cytarabine|cytarabine|mesh-list
44039591|NCT00002618|Prednisone|prednisone|mesh-list
44039592|NCT00002618|Doxorubicin|doxorubicin|mesh-list
44039593|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039594|NCT00002618|Methotrexate|methotrexate|mesh-list
44039595|NCT00002618|Vincristine|vincristine|mesh-list
44039596|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
44039597|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
44039598|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039599|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039600|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039601|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039602|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039603|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039604|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039605|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44039606|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
44039607|NCT00002618|Hormones|hormones|mesh-ancestor
44039608|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039609|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039610|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039611|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039612|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039613|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039614|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
44039615|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039616|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039617|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039618|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
44039619|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039620|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039621|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
44039622|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039623|NCT00002618|Antidotes|antidotes|mesh-ancestor
44039624|NCT00002618|Protective Agents|protective agents|mesh-ancestor
44039625|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
44039626|NCT00002618|Vitamins|vitamins|mesh-ancestor
44039627|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
43823817|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
44250934|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44250936|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
44250937|NCT03561376|Emollients|emollients|mesh-ancestor
44250938|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
44250939|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
44250940|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44250941|NCT03561376|Protective Agents|protective agents|mesh-ancestor
44039628|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039629|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039630|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039631|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039632|NCT00002618|Trace Elements|trace elements|mesh-ancestor
44039633|NCT00002619|Carboplatin|carboplatin|mesh-list
44039634|NCT00002619|Thiotepa|thiotepa|mesh-list
44039635|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039636|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
44039637|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039638|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039639|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
44039640|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039641|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039642|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039646|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039647|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
44039648|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039649|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039650|NCT00002620|Trace Elements|trace elements|mesh-ancestor
44039651|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
44039652|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039653|NCT00002621|Interferons|interferons|mesh-list
44039654|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
44039655|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
44039656|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039657|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
44039658|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039659|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
44039660|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039661|NCT00002623|Cisplatin|cisplatin|mesh-list
44039662|NCT00002623|Carboplatin|carboplatin|mesh-list
44039663|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039664|NCT00002625|Topotecan|topotecan|mesh-list
44039665|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44039666|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039667|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039668|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039669|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039670|NCT00002627|Paclitaxel|paclitaxel|mesh-list
44039671|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
44039672|NCT00002627|Carboplatin|carboplatin|mesh-list
44039673|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039674|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039675|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039676|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039677|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039678|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039679|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039680|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
44039681|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039682|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039683|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039684|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
44039685|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039686|NCT00002628|Paclitaxel|paclitaxel|mesh-list
44039687|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
44039688|NCT00002628|Carboplatin|carboplatin|mesh-list
44039689|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039690|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039691|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039692|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250942|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250943|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44250944|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44250945|NCT03425812|Analgesics|analgesics|mesh-ancestor
44250946|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
44250947|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250948|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250949|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44250950|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250951|NCT03377387|Capecitabine|capecitabine|mesh-list
44039693|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039694|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039695|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039696|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
44039697|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039698|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039699|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039700|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
44039701|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039702|NCT00002630|Cobalt|cobalt|mesh-list
44039703|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
44039704|NCT00002630|Melphalan|melphalan|mesh-list
44039705|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039706|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
44039707|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039708|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039709|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039710|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
44039711|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039712|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039713|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039714|NCT00002630|Trace Elements|trace elements|mesh-ancestor
44039715|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
44039716|NCT00002631|Cisplatin|cisplatin|mesh-list
44039717|NCT00002631|Fluorouracil|fluorouracil|mesh-list
44039718|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039719|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
44039720|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039721|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039722|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039723|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
44039724|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039725|NCT00002632|Paclitaxel|paclitaxel|mesh-list
44039726|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039727|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039728|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039729|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039730|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039731|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039732|NCT00002633|Leuprolide|leuprolide|mesh-list
44039733|NCT00002633|Goserelin|goserelin|mesh-list
44039734|NCT00002633|Flutamide|flutamide|mesh-list
44039735|NCT00002633|Bicalutamide|bicalutamide|mesh-list
44039736|NCT00002633|Nilutamide|nilutamide|mesh-list
44039737|NCT00002633|Buserelin|buserelin|mesh-list
44039738|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44039739|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
44039740|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039741|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039742|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039743|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039744|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
44039745|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039746|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039747|NCT00002634|Cobalt|cobalt|mesh-list
44039748|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
44250952|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250953|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
44250954|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250955|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250956|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44250957|NCT03335488|Glycerol|glycerol|mesh-list
44250958|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44250959|NCT03335488|Protective Agents|protective agents|mesh-ancestor
44250960|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250961|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250962|NCT03085004|Gemcitabine|gemcitabine|mesh-list
44250963|NCT03085004|Ethanol|ethanol|mesh-list
44250964|NCT03085004|Paclitaxel|paclitaxel|mesh-list
44250965|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44250966|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250967|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44250968|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44250969|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44250970|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250971|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250972|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
44250973|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
44250974|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250975|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250976|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250977|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
44250978|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250979|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44039749|NCT00002634|Cisplatin|cisplatin|mesh-list
44039750|NCT00002634|Doxorubicin|doxorubicin|mesh-list
44039751|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039752|NCT00002634|Etoposide|etoposide|mesh-list
44039753|NCT00002634|Vincristine|vincristine|mesh-list
44039754|NCT00002634|Antibodies|antibodies|mesh-list
44039755|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44039756|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039757|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
44039758|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768082|NCT02397512|Lactulose|lactulose|mesh-list
44039759|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039760|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039761|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
44039762|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039763|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039764|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039765|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039766|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039767|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44250980|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250981|NCT02993198|Carvedilol|carvedilol|mesh-list
44250982|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44250983|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44250984|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
44250985|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250986|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250987|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250988|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44250989|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
44039769|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039770|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039771|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039772|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039773|NCT00002634|Trace Elements|trace elements|mesh-ancestor
44039774|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
44039775|NCT00002635|Lenograstim|lenograstim|mesh-list
44039776|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44039777|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
44039778|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039779|NCT00002637|Interferons|interferons|mesh-list
44039780|NCT00002637|Aldesleukin|aldesleukin|mesh-list
44039781|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
44039782|NCT00002637|Vaccines|vaccines|mesh-list
44039783|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039784|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
44039785|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039786|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44039787|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44039788|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
44039789|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039790|NCT00002638|Cytarabine|cytarabine|mesh-list
44039791|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
44039792|NCT00002638|Carmustine|carmustine|mesh-list
44039793|NCT00002638|Etoposide|etoposide|mesh-list
44039794|NCT00002638|Sargramostim|sargramostim|mesh-list
44039795|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039796|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
44039797|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039798|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039799|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039801|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039802|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039803|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039804|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039805|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039806|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039807|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039808|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039809|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
44039810|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
44039811|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039812|NCT00002639|Suramin|suramin|mesh-list
44039813|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
44039814|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
44039815|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44039816|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039817|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039818|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44039819|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44039820|NCT00002641|Doxorubicin|doxorubicin|mesh-list
44039821|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039822|NCT00002641|Ifosfamide|ifosfamide|mesh-list
44039823|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039824|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039825|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039826|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039827|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250990|NCT02993198|Protective Agents|protective agents|mesh-ancestor
44250991|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44250992|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44250993|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44250994|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
44250995|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44250996|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44250997|NCT02795858|Octreotide|octreotide|mesh-list
44250998|NCT02795858|Ramucirumab|ramucirumab|mesh-list
44250999|NCT02795858|Lanreotide|lanreotide|mesh-list
44251000|NCT02795858|Somatostatin|somatostatin|mesh-list
44251001|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251002|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251003|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251004|NCT02795858|Hormones|hormones|mesh-ancestor
43649289|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039828|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039829|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039830|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
44039832|NCT00002642|Cisplatin|cisplatin|mesh-list
44039833|NCT00002642|Etoposide|etoposide|mesh-list
44039834|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039835|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039836|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039837|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039838|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039839|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039841|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
44039842|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039843|NCT00002643|Cobalt|cobalt|mesh-list
44039844|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
44039845|NCT00002643|Ifosfamide|ifosfamide|mesh-list
44039846|NCT00002643|Doxorubicin|doxorubicin|mesh-list
44039847|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039848|NCT00002643|Etoposide|etoposide|mesh-list
44039849|NCT00002643|Vincristine|vincristine|mesh-list
44039850|NCT00002643|Topotecan|topotecan|mesh-list
44039851|NCT00002643|Amifostine|amifostine|mesh-list
44039852|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039853|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
44039854|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039855|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039856|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039857|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
44039858|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039859|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039860|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039861|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039862|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039863|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039864|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039865|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44039866|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44039867|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44039868|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44039869|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44039870|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44039871|NCT00002643|Protective Agents|protective agents|mesh-ancestor
44039872|NCT00002643|Trace Elements|trace elements|mesh-ancestor
44039873|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
44039874|NCT00002646|Tamoxifen|tamoxifen|mesh-list
44251005|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251006|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251007|NCT02771249|Pyridoxine|pyridoxine|mesh-list
44251008|NCT02771249|Isoniazid|isoniazid|mesh-list
44251009|NCT02771249|Darunavir|darunavir|mesh-list
44251010|NCT02771249|Cobicistat|cobicistat|mesh-list
44251011|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44251012|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
44251013|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44251014|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649305|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
44039875|NCT00002646|Fenretinide|fenretinide|mesh-list
44039876|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44039877|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44039883|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44039884|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44039885|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44039886|NCT00002646|Protective Agents|protective agents|mesh-ancestor
44039887|NCT00002647|Verteporfin|verteporfin|mesh-list
44039888|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44039889|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039890|NCT00002649|Aldesleukin|aldesleukin|mesh-list
44039891|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
44039892|NCT00002649|Etoposide|etoposide|mesh-list
44039893|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
44039894|NCT00002649|Interleukin-2|interleukin-2|mesh-list
44039895|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039896|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
44039897|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039898|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039899|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039900|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
44039901|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039902|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039903|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039904|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073855|NCT04340076|Ixekizumab|ixekizumab|mesh-list
44039905|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039906|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039907|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039908|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44039909|NCT00002649|Analgesics|analgesics|mesh-ancestor
44039910|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
44039911|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44039912|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44039913|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44039914|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
43768220|NCT02396303|Carbetocin|carbetocin|mesh-list
44039915|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039916|NCT00002650|Folic Acid|folic acid|mesh-list
44039917|NCT00002650|Hematinics|hematinics|mesh-ancestor
44039918|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
44039919|NCT00002650|Vitamins|vitamins|mesh-ancestor
44039920|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
44039921|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039922|NCT00002652|Suramin|suramin|mesh-list
44039923|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
44039924|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
44039925|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44039926|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039927|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039928|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44039929|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44039930|NCT00002653|Prednisone|prednisone|mesh-list
44039931|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
44039932|NCT00002653|Melphalan|melphalan|mesh-list
44039933|NCT00002653|Carmustine|carmustine|mesh-list
44039934|NCT00002653|Doxorubicin|doxorubicin|mesh-list
44039935|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039936|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251015|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44251016|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44251017|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
44251018|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251019|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44251020|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44251021|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44251022|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251023|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251024|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44251025|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44251026|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
44251027|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44251028|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44251029|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
44251030|NCT02771249|Vitamins|vitamins|mesh-ancestor
44251031|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
44251032|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251033|NCT02419287|Crizotinib|crizotinib|mesh-list
44251034|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251035|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44251036|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251037|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251038|NCT02342444|Enoxaparin|enoxaparin|mesh-list
44251039|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
44251067|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251068|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251069|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
44251070|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251071|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251072|NCT01497509|Narcotics|narcotics|mesh-ancestor
44251073|NCT01497509|Analgesics|analgesics|mesh-ancestor
44251074|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44251075|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251076|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
44251077|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44073868|NCT04300192|Vaccines|vaccines|mesh-list
44251078|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251079|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251080|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251081|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039937|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
44039938|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039939|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039940|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039941|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
44039942|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039943|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039944|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039945|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039946|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039947|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039950|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
44039951|NCT00002653|Hormones|hormones|mesh-ancestor
44039952|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039953|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039955|NCT00002654|Cisplatin|cisplatin|mesh-list
44039956|NCT00002654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039957|NCT00002654|Trace Elements|trace elements|mesh-ancestor
44039958|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
44039959|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039960|NCT00002656|NSC 366140|nsc 366140|mesh-list
44039961|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039962|NCT00002657|Interferons|interferons|mesh-list
44039963|NCT00002657|Cytarabine|cytarabine|mesh-list
44039964|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
44039965|NCT00002657|Prednisone|prednisone|mesh-list
44039966|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
44039967|NCT00002657|Doxorubicin|doxorubicin|mesh-list
44039968|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039969|NCT00002657|Methotrexate|methotrexate|mesh-list
44039970|NCT00002657|Etoposide|etoposide|mesh-list
44039971|NCT00002657|Vincristine|vincristine|mesh-list
44039972|NCT00002657|Bleomycin|bleomycin|mesh-list
44039973|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039974|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
44039975|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039976|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039977|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039978|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
44039979|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039980|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039981|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039982|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039983|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039984|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039985|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251082|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44251083|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44251084|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
44039986|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44039987|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
44039988|NCT00002657|Hormones|hormones|mesh-ancestor
44039989|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039990|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039991|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44039992|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
44039993|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44039994|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44039995|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
44039996|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44039997|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44039998|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44039999|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040001|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040002|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040003|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040004|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040006|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
44040007|NCT00002658|Etoposide|etoposide|mesh-list
44040008|NCT00002658|Daunorubicin|daunorubicin|mesh-list
44040009|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
44040010|NCT00002658|Idarubicin|idarubicin|mesh-list
44040011|NCT00002658|Tretinoin|tretinoin|mesh-list
44040012|NCT00002658|Thioguanine|thioguanine|mesh-list
44040013|NCT00002658|Amsacrine|amsacrine|mesh-list
44040014|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040015|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
44040016|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040017|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040018|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040019|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
44040020|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040021|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040022|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040023|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040024|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040025|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040026|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149473|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149474|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149475|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149476|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149477|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149478|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149479|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149480|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149481|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
44149482|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149483|NCT00208156|Mifepristone|mifepristone|mesh-list
44149484|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44149485|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
44149486|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44149487|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149488|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44149489|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44149490|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44149491|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
44149492|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44149493|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44149494|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149495|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149496|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
44149497|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44149498|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44149499|NCT00208169|Aripiprazole|aripiprazole|mesh-list
44149500|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149501|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149502|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44251085|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44251086|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
44251087|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
44251088|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
44251089|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44251090|NCT05337969|Metformin|metformin|mesh-list
44251091|NCT05337969|Vildagliptin|vildagliptin|mesh-list
44251092|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44251093|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251094|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44149503|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149504|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149505|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149506|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
44149507|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
44149508|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44040038|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040039|NCT00002662|Paclitaxel|paclitaxel|mesh-list
44040040|NCT00002662|Docetaxel|docetaxel|mesh-list
44040041|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040042|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040043|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040044|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040045|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040046|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040047|NCT00002664|Sargramostim|sargramostim|mesh-list
44040048|NCT00002664|Edrecolomab|edrecolomab|mesh-list
44040049|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
44040050|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040051|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44040052|NCT00002665|Leucovorin|leucovorin|mesh-list
44040053|NCT00002665|Cytarabine|cytarabine|mesh-list
44040054|NCT00002665|Dexamethasone|dexamethasone|mesh-list
44040055|NCT00002665|Prednisone|prednisone|mesh-list
44040056|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
44040057|NCT00002665|Doxorubicin|doxorubicin|mesh-list
44040061|NCT00002665|Vincristine|vincristine|mesh-list
44040062|NCT00002665|Daunorubicin|daunorubicin|mesh-list
44040063|NCT00002665|Asparaginase|asparaginase|mesh-list
44040064|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
44040065|NCT00002665|Thioguanine|thioguanine|mesh-list
44040066|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
44040067|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040068|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
44040069|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040070|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040071|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040072|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
44040073|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040074|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040075|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040076|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040077|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
44040078|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
44040079|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040080|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040081|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
44040082|NCT00002665|Hormones|hormones|mesh-ancestor
44040083|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040084|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074039|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
44040085|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040086|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040087|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040088|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040089|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040090|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040091|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040092|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251095|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251096|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251097|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251098|NCT05337657|Letrozole|letrozole|mesh-list
44251099|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251100|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44251101|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44251102|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251103|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251104|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44251105|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
44251106|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251107|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460575|NCT01561755|Antibodies|antibodies|mesh-list
44460576|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
44460577|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44460578|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
44460579|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460580|NCT01561313|Adalimumab|adalimumab|mesh-list
44460581|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460582|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460583|NCT01561079|Buprenorphine|buprenorphine|mesh-list
44460584|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44460585|NCT01561079|Narcotics|narcotics|mesh-ancestor
44460586|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460587|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460588|NCT01561079|Analgesics|analgesics|mesh-ancestor
44460589|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
44460590|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460591|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44460592|NCT01560949|Gemcitabine|gemcitabine|mesh-list
44040093|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
44040094|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040095|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040096|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040097|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040098|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
44040099|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040100|NCT00002665|Antidotes|antidotes|mesh-ancestor
44040101|NCT00002665|Protective Agents|protective agents|mesh-ancestor
44040102|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040103|NCT00002665|Vitamins|vitamins|mesh-ancestor
44040104|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
44040105|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040106|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460593|NCT01560949|Fluorouracil|fluorouracil|mesh-list
44460594|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
44460595|NCT01560949|Irinotecan|irinotecan|mesh-list
44460596|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44460597|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
44460598|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460599|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460600|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
44460601|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460602|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040107|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040108|NCT00002669|Interferons|interferons|mesh-list
44040109|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
44040110|NCT00002669|Aldesleukin|aldesleukin|mesh-list
44040111|NCT00002669|Cisplatin|cisplatin|mesh-list
44040112|NCT00002669|Dacarbazine|dacarbazine|mesh-list
44040113|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074105|NCT03991884|Hormones|hormones|mesh-ancestor
44040114|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
44040115|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040116|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
44040117|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040118|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44040119|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44040120|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040121|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
44040122|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040123|NCT00002670|Cobalt|cobalt|mesh-list
44040124|NCT00002670|Cisplatin|cisplatin|mesh-list
44040125|NCT00002670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040126|NCT00002670|Trace Elements|trace elements|mesh-ancestor
44040127|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
44040128|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040129|NCT00002674|Cytarabine|cytarabine|mesh-list
44040130|NCT00002674|Etoposide|etoposide|mesh-list
44040131|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
44040132|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
44040133|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040134|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040144|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
44040145|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040146|NCT00002674|Analgesics|analgesics|mesh-ancestor
44040147|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
44040148|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040149|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
44040150|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040151|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
44040152|NCT00002675|Cisplatin|cisplatin|mesh-list
44040153|NCT00002675|Carboplatin|carboplatin|mesh-list
44040154|NCT00002675|Etoposide|etoposide|mesh-list
44040155|NCT00002675|Vincristine|vincristine|mesh-list
44040156|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040157|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
44040158|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040159|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040160|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040161|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
44040162|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040163|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040164|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040165|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040166|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040167|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040168|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040169|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040170|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040171|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040172|NCT00002676|Cobalt|cobalt|mesh-list
44040173|NCT00002676|Cytarabine|cytarabine|mesh-list
44040174|NCT00002676|Dexamethasone|dexamethasone|mesh-list
44040175|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
44460604|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
44460605|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460606|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44040176|NCT00002676|Carmustine|carmustine|mesh-list
44040177|NCT00002676|Doxorubicin|doxorubicin|mesh-list
44040178|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040179|NCT00002676|Methotrexate|methotrexate|mesh-list
44040180|NCT00002676|Vincristine|vincristine|mesh-list
44040181|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040182|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
44040183|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040184|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040185|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040186|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
44040187|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040188|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040189|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040190|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040191|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
44040192|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
44040193|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040194|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040195|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
44040196|NCT00002676|Hormones|hormones|mesh-ancestor
44040197|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040198|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040199|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040200|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040201|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040209|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040210|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040211|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
44040212|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040213|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040214|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040215|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040216|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040217|NCT00002676|Trace Elements|trace elements|mesh-ancestor
44040218|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
44040219|NCT00002678|Dexamethasone|dexamethasone|mesh-list
44040221|NCT00002678|Melphalan|melphalan|mesh-list
44040222|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040223|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
44040224|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
44040225|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040226|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040227|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040228|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
44040229|NCT00002678|Hormones|hormones|mesh-ancestor
44040230|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040231|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040232|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040233|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040234|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
44040235|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040236|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040237|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040238|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
44040239|NCT00002679|Tamoxifen|tamoxifen|mesh-list
44040240|NCT00002679|Paclitaxel|paclitaxel|mesh-list
44040241|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
44040242|NCT00002679|Doxorubicin|doxorubicin|mesh-list
44040243|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040244|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040245|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074209|NCT03877549|Hormones|hormones|mesh-ancestor
44040246|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040247|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040248|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040249|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040250|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040251|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
44460607|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44460608|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44460609|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44460610|NCT01560507|Bupropion|bupropion|mesh-list
44040252|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040253|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040254|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040255|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
44040256|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040257|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040258|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040259|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040260|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040261|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44040262|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
44040263|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040264|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040265|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44040266|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44040267|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43768490|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040278|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040279|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
44040280|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040281|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040282|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040283|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44040284|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44040285|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040286|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040287|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44040288|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44040289|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44040290|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44040291|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44040292|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44040293|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
44040294|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040295|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44040296|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44040297|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
44040298|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44040300|NCT00002681|Daclizumab|daclizumab|mesh-list
44040301|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040302|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44040303|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44040304|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
44040305|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040306|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040307|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
44040308|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040309|NCT00002682|Amoxicillin|amoxicillin|mesh-list
44040310|NCT00002682|Metronidazole|metronidazole|mesh-list
44040311|NCT00002682|Clarithromycin|clarithromycin|mesh-list
44040312|NCT00002682|Tetracycline|tetracycline|mesh-list
44040313|NCT00002682|Omeprazole|omeprazole|mesh-list
44040314|NCT00002682|Bismuth|bismuth|mesh-list
44040315|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44040316|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44040317|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074342|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074343|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074344|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44074345|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44074346|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44040318|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44040319|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44040320|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44040321|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040322|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44040323|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040324|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040325|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44040326|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44460611|NCT01560507|Nicotine|nicotine|mesh-list
44460612|NCT01560507|Varenicline|varenicline|mesh-list
44460613|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44460614|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
44460615|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460616|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460617|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44251108|NCT05337332|Triamcinolone|triamcinolone|mesh-list
44251109|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44251110|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44251111|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44251112|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251113|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
44251114|NCT05337332|Hormones|hormones|mesh-ancestor
44251115|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251116|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040327|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44040328|NCT00002682|Antacids|antacids|mesh-ancestor
44040329|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
44040330|NCT00002684|Paclitaxel|paclitaxel|mesh-list
44040331|NCT00002684|Cisplatin|cisplatin|mesh-list
44040332|NCT00002684|Ifosfamide|ifosfamide|mesh-list
44040333|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040334|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040335|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040338|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040340|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
44040341|NCT00002687|Aldesleukin|aldesleukin|mesh-list
44040342|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040343|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44040344|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44040345|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
44040346|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040348|NCT00002688|Etoposide|etoposide|mesh-list
44040349|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
44040350|NCT00002688|Cyclosporins|cyclosporins|mesh-list
44040351|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040352|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040353|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040354|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040355|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040356|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040357|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040358|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
44040359|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040360|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
44040361|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040362|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040363|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040364|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44040365|NCT00002688|Analgesics|analgesics|mesh-ancestor
44040366|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
44040367|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040368|NCT00002689|Dexamethasone|dexamethasone|mesh-list
44040369|NCT00002689|Fluorouracil|fluorouracil|mesh-list
44040370|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040371|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
44040372|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
44040373|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040374|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040375|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040376|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
44251117|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251118|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
44251119|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251120|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251121|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
44251122|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44251123|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
44251124|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
44251125|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251126|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251127|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251128|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251129|NCT05337254|Analgesics|analgesics|mesh-ancestor
44251130|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
44040377|NCT00002689|Hormones|hormones|mesh-ancestor
44040378|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040379|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040380|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040381|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
44040382|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040383|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040384|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040385|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
44040386|NCT00002691|Leucovorin|leucovorin|mesh-list
44040387|NCT00002691|Cytarabine|cytarabine|mesh-list
44040388|NCT00002691|Dexamethasone|dexamethasone|mesh-list
44040389|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
44040390|NCT00002691|Methotrexate|methotrexate|mesh-list
44040391|NCT00002691|Etoposide|etoposide|mesh-list
44040392|NCT00002691|Vincristine|vincristine|mesh-list
44040393|NCT00002691|Daunorubicin|daunorubicin|mesh-list
44040394|NCT00002691|Asparaginase|asparaginase|mesh-list
44040395|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
44040396|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040397|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
44040398|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040399|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040400|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040401|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
44040402|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040403|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040404|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040405|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040406|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
44040407|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
44040408|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040409|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040410|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
44040411|NCT00002691|Hormones|hormones|mesh-ancestor
44040423|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040424|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040425|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040426|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
44040427|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040428|NCT00002691|Antidotes|antidotes|mesh-ancestor
44040429|NCT00002691|Protective Agents|protective agents|mesh-ancestor
44040430|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040431|NCT00002691|Vitamins|vitamins|mesh-ancestor
44040432|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
44040433|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040434|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040435|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040436|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44251131|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251132|NCT05337085|Midazolam|midazolam|mesh-list
44251133|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
44251134|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44040437|NCT00002692|Leucovorin|leucovorin|mesh-list
44040438|NCT00002692|Fluorouracil|fluorouracil|mesh-list
44040439|NCT00002692|Calcium|calcium|mesh-list
44040440|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
44040441|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44040442|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040443|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
44040444|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040445|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040446|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040447|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040448|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
44040449|NCT00002692|Antidotes|antidotes|mesh-ancestor
44040450|NCT00002692|Protective Agents|protective agents|mesh-ancestor
44040451|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040452|NCT00002692|Vitamins|vitamins|mesh-ancestor
44040453|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
44040454|NCT00002693|Carboplatin|carboplatin|mesh-list
44040455|NCT00002693|Topotecan|topotecan|mesh-list
44040456|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040457|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44040458|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040459|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040460|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040461|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
44040462|NCT00002696|Doxorubicin|doxorubicin|mesh-list
44040463|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040464|NCT00002696|Fluorouracil|fluorouracil|mesh-list
44040465|NCT00002696|Methotrexate|methotrexate|mesh-list
44040466|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040467|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
44040468|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040469|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040470|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040471|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
44040472|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040473|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040474|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43537131|NCT02432209|Orlistat|orlistat|mesh-list
44040486|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040488|NCT00002697|Etoposide|etoposide|mesh-list
44040489|NCT00002697|Ifosfamide|ifosfamide|mesh-list
44040490|NCT00002697|Sargramostim|sargramostim|mesh-list
44040491|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040492|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040493|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040494|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040495|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040496|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040497|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
44040498|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040499|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040502|NCT00002700|Cytarabine|cytarabine|mesh-list
44040503|NCT00002700|Dexamethasone|dexamethasone|mesh-list
44040504|NCT00002700|Prednisone|prednisone|mesh-list
44040505|NCT00002700|Prednisolone|prednisolone|mesh-list
44040506|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
44040507|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44040508|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44040509|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44040510|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
44040511|NCT00002700|Doxorubicin|doxorubicin|mesh-list
44040512|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040513|NCT00002700|Methotrexate|methotrexate|mesh-list
44040514|NCT00002700|Vincristine|vincristine|mesh-list
44040515|NCT00002700|Daunorubicin|daunorubicin|mesh-list
44040516|NCT00002700|Asparaginase|asparaginase|mesh-list
44040517|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
44040518|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
44040519|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
44040520|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040521|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
44251135|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251136|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251137|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251138|NCT05337085|Analgesics|analgesics|mesh-ancestor
44251139|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
44251140|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251141|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44040522|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040523|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040524|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040525|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
44040526|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040527|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040528|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040529|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040530|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
44040531|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
44040532|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040533|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040534|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
44040536|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040537|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040538|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040539|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040540|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040541|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040544|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040545|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040546|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
44040547|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040548|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040549|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040550|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
44040551|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040552|NCT00002700|Antidotes|antidotes|mesh-ancestor
44040553|NCT00002700|Protective Agents|protective agents|mesh-ancestor
44040554|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040555|NCT00002700|Vitamins|vitamins|mesh-ancestor
44040556|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
44040557|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040558|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040559|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040560|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040561|NCT00002700|Analgesics|analgesics|mesh-ancestor
44040562|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
44040563|NCT00002701|Cytarabine|cytarabine|mesh-list
44040564|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
44040565|NCT00002701|Busulfan|busulfan|mesh-list
44040566|NCT00002701|Methotrexate|methotrexate|mesh-list
44040567|NCT00002701|Etoposide|etoposide|mesh-list
44040568|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
44040569|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
44040570|NCT00002701|Idarubicin|idarubicin|mesh-list
44040571|NCT00002701|Tretinoin|tretinoin|mesh-list
44040572|NCT00002701|Thioguanine|thioguanine|mesh-list
44040573|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040575|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040576|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040577|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040578|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
44040579|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040580|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040581|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040582|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040583|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040584|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040585|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040586|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
44251142|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44251143|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251144|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251145|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251146|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251147|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44251148|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44251149|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44251150|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44251151|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251152|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
44251154|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
44251155|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
44251156|NCT05336825|Lidocaine|lidocaine|mesh-list
44251157|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251158|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
44251159|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251160|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251161|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
44251162|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251163|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44251164|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44251165|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44251166|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251167|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251168|NCT05336721|Capecitabine|capecitabine|mesh-list
44251169|NCT05336721|Chiauranib|chiauranib|mesh-list
44251170|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251171|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
44040587|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040588|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040589|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040590|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040591|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040592|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040593|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040594|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
44040595|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040596|NCT00002701|Analgesics|analgesics|mesh-ancestor
44040597|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
44040598|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040599|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040600|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
44040601|NCT00002702|Aldesleukin|aldesleukin|mesh-list
44251172|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251173|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040602|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040603|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44040604|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44040605|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
44040606|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040607|NCT00002704|Leucovorin|leucovorin|mesh-list
44040608|NCT00002704|Cytarabine|cytarabine|mesh-list
44040609|NCT00002704|Dexamethasone|dexamethasone|mesh-list
44040610|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
44040611|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44040612|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44040613|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44040614|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
44040615|NCT00002704|Thiotepa|thiotepa|mesh-list
44040616|NCT00002704|Methotrexate|methotrexate|mesh-list
44040617|NCT00002704|Etoposide|etoposide|mesh-list
44040618|NCT00002704|Vincristine|vincristine|mesh-list
44040619|NCT00002704|Daunorubicin|daunorubicin|mesh-list
44040620|NCT00002704|Asparaginase|asparaginase|mesh-list
44040622|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
44040623|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040624|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
44040625|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040626|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040627|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040628|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
44040629|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040630|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040631|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040632|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040633|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
44040634|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
44040635|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040636|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040637|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
44040638|NCT00002704|Hormones|hormones|mesh-ancestor
44040639|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040640|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040641|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040642|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040643|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040644|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040645|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
44040646|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040647|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040648|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040649|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040650|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040651|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040652|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040653|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
44040654|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040655|NCT00002704|Antidotes|antidotes|mesh-ancestor
44040656|NCT00002704|Protective Agents|protective agents|mesh-ancestor
44040657|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040659|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
44040660|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040661|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040662|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040663|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040664|NCT00002705|Topotecan|topotecan|mesh-list
44040665|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44040666|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040667|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040668|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040669|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040670|NCT00002707|Tamoxifen|tamoxifen|mesh-list
44040671|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
44040672|NCT00002707|Docetaxel|docetaxel|mesh-list
44040673|NCT00002707|Doxorubicin|doxorubicin|mesh-list
44040674|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040675|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
44251174|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44251175|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251176|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44251177|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43649458|NCT03023514|Vitamins|vitamins|mesh-ancestor
44040676|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040677|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040678|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040679|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
44040680|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040681|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074660|NCT03317392|Olaparib|olaparib|mesh-list
44040682|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040683|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040684|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040685|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040686|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040687|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040688|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040689|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040690|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44040691|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
44040692|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040693|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040694|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44040695|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44040697|NCT00002711|Paclitaxel|paclitaxel|mesh-list
44040698|NCT00002711|Cisplatin|cisplatin|mesh-list
44040699|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040700|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040701|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040702|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040703|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040704|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040705|NCT00002714|Prednisone|prednisone|mesh-list
44040706|NCT00002714|Doxorubicin|doxorubicin|mesh-list
44040707|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040708|NCT00002714|Bleomycin|bleomycin|mesh-list
44040709|NCT00002714|Etoposide|etoposide|mesh-list
44040710|NCT00002714|Vincristine|vincristine|mesh-list
44040711|NCT00002714|Vinblastine|vinblastine|mesh-list
44040712|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
44040713|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040714|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040715|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040716|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040717|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040718|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040719|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040720|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
44040721|NCT00002714|Hormones|hormones|mesh-ancestor
44040722|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040723|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040724|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040725|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040726|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040727|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040728|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040729|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
44040730|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040731|NCT00002715|Prednisone|prednisone|mesh-list
44040732|NCT00002715|Doxorubicin|doxorubicin|mesh-list
44040733|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040734|NCT00002715|Bleomycin|bleomycin|mesh-list
44040735|NCT00002715|Etoposide|etoposide|mesh-list
44040736|NCT00002715|Vincristine|vincristine|mesh-list
44040737|NCT00002715|Vinblastine|vinblastine|mesh-list
44040738|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
44040739|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040740|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040741|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040742|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040743|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251178|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44251179|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44251180|NCT05335837|Anesthetics|anesthetics|mesh-list
44251181|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460618|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44251182|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251184|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
44074729|NCT03096782|Melphalan|melphalan|mesh-list
44251185|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251186|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
44251187|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251188|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251189|NCT05335278|Nintedanib|nintedanib|mesh-list
44251190|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251191|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44040744|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040745|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040746|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
44040747|NCT00002715|Hormones|hormones|mesh-ancestor
44040748|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040749|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040750|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040751|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040752|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040753|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040754|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040755|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
44040756|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040757|NCT00002716|Leucovorin|leucovorin|mesh-list
44040758|NCT00002716|Dexamethasone|dexamethasone|mesh-list
44040759|NCT00002716|Fluorouracil|fluorouracil|mesh-list
44040760|NCT00002716|Floxuridine|floxuridine|mesh-list
44040761|NCT00002716|Calcium|calcium|mesh-list
44040762|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
44040763|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040764|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
44040765|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
44040766|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040767|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040768|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040769|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
44040770|NCT00002716|Hormones|hormones|mesh-ancestor
44040771|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040772|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040778|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040779|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
44040780|NCT00002716|Antidotes|antidotes|mesh-ancestor
44040781|NCT00002716|Protective Agents|protective agents|mesh-ancestor
44040782|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040783|NCT00002716|Vitamins|vitamins|mesh-ancestor
44040784|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
44040785|NCT00002717|Paclitaxel|paclitaxel|mesh-list
44040786|NCT00002717|Cisplatin|cisplatin|mesh-list
44040787|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040788|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040789|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040790|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040791|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040792|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040793|NCT00002718|Cytarabine|cytarabine|mesh-list
44040794|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
44040795|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
44040796|NCT00002718|Thiotepa|thiotepa|mesh-list
44040797|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44251192|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251193|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251194|NCT05335122|Bimatoprost|bimatoprost|mesh-list
44251195|NCT05335122|Travoprost|travoprost|mesh-list
44251196|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44251197|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
44251198|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44251199|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
44251200|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251201|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
44251202|NCT05334745|Protective Agents|protective agents|mesh-ancestor
44460619|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460620|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460621|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460622|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44460623|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
44460624|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460625|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44460626|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44460627|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460628|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
44460629|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44460630|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460631|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460632|NCT01560416|Fulvestrant|fulvestrant|mesh-list
44460633|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040798|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040799|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
44040800|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040801|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040802|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040803|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
44040804|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040805|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040806|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040807|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040808|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
44040809|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
44040810|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040811|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040812|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
44040813|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
44040814|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040815|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040816|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
44040817|NCT00002718|Hormones|hormones|mesh-ancestor
43701507|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460634|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460635|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44460636|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44460637|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
44460638|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460639|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460640|NCT01560403|Teduglutide|teduglutide|mesh-list
44040818|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040819|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44040820|NCT00002718|Protective Agents|protective agents|mesh-ancestor
44040821|NCT00002719|Cytarabine|cytarabine|mesh-list
44040822|NCT00002719|Etoposide|etoposide|mesh-list
44040823|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
44040824|NCT00002719|Idarubicin|idarubicin|mesh-list
44040825|NCT00002719|Carmustine|carmustine|mesh-list
44040826|NCT00002719|Amsacrine|amsacrine|mesh-list
44040827|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040828|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040829|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040830|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040831|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074862|NCT02985866|Pancrelipase|pancrelipase|mesh-list
44040832|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040833|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040834|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
44040835|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
44040836|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040837|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040838|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
44040839|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040840|NCT00002719|Analgesics|analgesics|mesh-ancestor
44040841|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
44040842|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040843|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43537477|NCT05627466|Magrolimab|magrolimab|mesh-list
44040849|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040850|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040851|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040852|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040853|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44040854|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44040855|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44040856|NCT00002721|Doxorubicin|doxorubicin|mesh-list
44040857|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040858|NCT00002721|Estramustine|estramustine|mesh-list
44040859|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040860|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040861|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040862|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040863|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040864|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040865|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040866|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
44040867|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040868|NCT00002722|Leucovorin|leucovorin|mesh-list
44040869|NCT00002722|Cisplatin|cisplatin|mesh-list
44040870|NCT00002722|Fluorouracil|fluorouracil|mesh-list
44040871|NCT00002722|Calcium|calcium|mesh-list
44040872|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
44040873|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040874|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44040875|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040876|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
44040877|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040878|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040879|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040880|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
44040882|NCT00002722|Protective Agents|protective agents|mesh-ancestor
44460641|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460642|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44460643|NCT01560403|Protective Agents|protective agents|mesh-ancestor
44460644|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460646|NCT01559935|Dexamethasone|dexamethasone|mesh-list
44460647|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
44040883|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040884|NCT00002722|Vitamins|vitamins|mesh-ancestor
44040885|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
44040886|NCT00002723|Suramin|suramin|mesh-list
44040887|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
44040889|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44040890|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040891|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040892|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44040893|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44040894|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
44040895|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44040896|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
44040897|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040898|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040899|NCT00002730|Melphalan|melphalan|mesh-list
44040900|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
44040901|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040902|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
44063447|NCT00006048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040903|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040904|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040905|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44040906|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040907|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
44040908|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040909|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
44040910|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040911|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040912|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44040913|NCT00002730|Protective Agents|protective agents|mesh-ancestor
44040914|NCT00002733|Interferons|interferons|mesh-list
44040915|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
44040916|NCT00002733|Aldesleukin|aldesleukin|mesh-list
44040927|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44040928|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
44040930|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44040931|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040932|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44040933|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44040934|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040935|NCT00002734|Interferons|interferons|mesh-list
44040936|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
44040937|NCT00002734|Paclitaxel|paclitaxel|mesh-list
44040938|NCT00002734|Topotecan|topotecan|mesh-list
44040939|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44040940|NCT00002734|Antibodies|antibodies|mesh-list
44040941|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
44040942|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44040943|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44040944|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040945|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44040946|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040947|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040948|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040949|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
44040950|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040951|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
44040952|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040953|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44040954|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040955|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040956|NCT00002735|Cobalt|cobalt|mesh-list
44040957|NCT00002735|Cisplatin|cisplatin|mesh-list
44040958|NCT00002735|Fluorouracil|fluorouracil|mesh-list
43701508|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
44460649|NCT01559935|BB 1101|bb 1101|mesh-list
44460650|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460651|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
44460652|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
44460653|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460654|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460655|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460656|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
44460657|NCT01559935|Hormones|hormones|mesh-ancestor
44040959|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040961|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040962|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040963|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040964|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
44040965|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040966|NCT00002735|Trace Elements|trace elements|mesh-ancestor
44040967|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
44040968|NCT00002737|Interferons|interferons|mesh-list
44040969|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
44040970|NCT00002737|Isotretinoin|isotretinoin|mesh-list
44040971|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040972|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
44040973|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040974|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
44040975|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040976|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040977|NCT00002738|Leucovorin|leucovorin|mesh-list
44040978|NCT00002738|Trimetrexate|trimetrexate|mesh-list
44040979|NCT00002738|Calcium|calcium|mesh-list
44040980|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
44040981|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44040982|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040983|NCT00002738|Antidotes|antidotes|mesh-ancestor
44040984|NCT00002738|Protective Agents|protective agents|mesh-ancestor
44040985|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44040995|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040996|NCT00002740|Cobalt|cobalt|mesh-list
44040997|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
44040998|NCT00002740|Carboplatin|carboplatin|mesh-list
44040999|NCT00002740|Doxorubicin|doxorubicin|mesh-list
44041000|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041001|NCT00002740|Etoposide|etoposide|mesh-list
44041002|NCT00002740|Vincristine|vincristine|mesh-list
44041003|NCT00002740|Lenograstim|lenograstim|mesh-list
44041004|NCT00002740|Mesna|mesna|mesh-list
44041005|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041006|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
44041007|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041008|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041009|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041010|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
44041011|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041012|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041013|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041014|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041015|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041016|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041017|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041018|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041019|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44041020|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041021|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041022|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041023|NCT00002740|Protective Agents|protective agents|mesh-ancestor
44041024|NCT00002740|Trace Elements|trace elements|mesh-ancestor
44041025|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
44041026|NCT00002742|Amphotericin B|amphotericin b|mesh-list
44041027|NCT00002742|Nystatin|nystatin|mesh-list
43644049|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460658|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460659|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44460660|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460661|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460662|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460663|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460664|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
44460665|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460666|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44460667|NCT01559935|Growth Substances|growth substances|mesh-ancestor
44460668|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
44460669|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44460670|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904770|NCT00187655|Cefotaxime|cefotaxime|mesh-list
44251203|NCT05334316|Dexamethasone|dexamethasone|mesh-list
44251204|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251205|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
44251206|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
44251209|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251243|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44251244|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251245|NCT05333640|Sirolimus|sirolimus|mesh-list
44251246|NCT05333640|Paclitaxel|paclitaxel|mesh-list
44251247|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251248|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041028|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44041029|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44041030|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
44041031|NCT00002742|Amebicides|amebicides|mesh-ancestor
44041032|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44041033|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44041034|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041035|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44041036|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
44041037|NCT00002742|Ionophores|ionophores|mesh-ancestor
44041038|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44041039|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041040|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44041041|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041042|NCT00002744|Cobalt|cobalt|mesh-list
44041043|NCT00002744|Cytarabine|cytarabine|mesh-list
44041044|NCT00002744|Dexamethasone|dexamethasone|mesh-list
44041045|NCT00002744|Prednisone|prednisone|mesh-list
44041046|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
44041047|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041048|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041049|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44041050|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
44041051|NCT00002744|Doxorubicin|doxorubicin|mesh-list
44041052|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041053|NCT00002744|Methotrexate|methotrexate|mesh-list
44041054|NCT00002744|Vincristine|vincristine|mesh-list
44041055|NCT00002744|Daunorubicin|daunorubicin|mesh-list
44041056|NCT00002744|Asparaginase|asparaginase|mesh-list
44041061|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
44041062|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041063|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041064|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041065|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
44041066|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041067|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041068|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041069|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041070|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
44041071|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
44041072|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041073|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041074|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
44041075|NCT00002744|Hormones|hormones|mesh-ancestor
44041076|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041077|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041078|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041079|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041080|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041081|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041082|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041083|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
44075071|NCT02693821|Gabapentin|gabapentin|mesh-list
44041084|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041085|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041086|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
44041087|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041088|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041089|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041090|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
44041091|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041092|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041093|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041094|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251249|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251250|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251251|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251252|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041095|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041096|NCT00002744|Trace Elements|trace elements|mesh-ancestor
44041097|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
44041098|NCT00002746|Aldesleukin|aldesleukin|mesh-list
44041099|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041100|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44041101|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041102|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
44041103|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041105|NCT00002747|Cisplatin|cisplatin|mesh-list
44041106|NCT00002747|Fluorouracil|fluorouracil|mesh-list
44041107|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041108|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
44041109|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041110|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041111|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041112|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
44041113|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041114|NCT00002747|Trace Elements|trace elements|mesh-ancestor
44041115|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
44041116|NCT00002748|Interleukin-2|interleukin-2|mesh-list
43769076|NCT02390440|Bupivacaine|bupivacaine|mesh-list
44041117|NCT00002748|Vaccines|vaccines|mesh-list
44041118|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041119|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44041120|NCT00002748|Analgesics|analgesics|mesh-ancestor
44041121|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
44041122|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041123|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041124|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
44041125|NCT00002749|Carboplatin|carboplatin|mesh-list
44041126|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041127|NCT00002750|Melphalan|melphalan|mesh-list
44041128|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537762|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
44041136|NCT00002751|Antibodies|antibodies|mesh-list
44041137|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44041138|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
44041139|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041140|NCT00002752|Antibodies|antibodies|mesh-list
44041141|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44041142|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
44041143|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041144|NCT00002753|Antibodies|antibodies|mesh-list
44041145|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44041146|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
44041147|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041148|NCT00002754|Antibodies|antibodies|mesh-list
44041149|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44041150|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
44041151|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041152|NCT00002755|Tamoxifen|tamoxifen|mesh-list
44041154|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
44041155|NCT00002755|Thiotepa|thiotepa|mesh-list
44041156|NCT00002755|Doxorubicin|doxorubicin|mesh-list
44041157|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041158|NCT00002755|Fluorouracil|fluorouracil|mesh-list
44041159|NCT00002755|Methotrexate|methotrexate|mesh-list
44041160|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041161|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
44041162|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041163|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041164|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041165|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
44041166|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041167|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041168|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041169|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041170|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041171|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041172|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251253|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44251254|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44251255|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44251256|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
44251257|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251258|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
44251259|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251260|NCT05333419|Latanoprost|latanoprost|mesh-list
44251261|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44251262|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44251263|NCT05327647|Bicalutamide|bicalutamide|mesh-list
44251264|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
44251265|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
44251266|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
44251267|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251268|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251269|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251270|NCT05326425|Lazertinib|lazertinib|mesh-list
44251271|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44251272|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251273|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251274|NCT05326360|Ramosetron|ramosetron|mesh-list
44251275|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
44251276|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
44251277|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041173|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
44041174|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041175|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041176|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041177|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041178|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041179|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041180|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041181|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44041182|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44041183|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041184|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041185|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44063448|NCT00006048|Immunologic Factors|immunologic factors|mesh-ancestor
44041186|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44041187|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44041188|NCT00002755|Trace Elements|trace elements|mesh-ancestor
44041189|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
44041190|NCT00002756|Leucovorin|leucovorin|mesh-list
44041191|NCT00002756|Cytarabine|cytarabine|mesh-list
44041192|NCT00002756|Prednisone|prednisone|mesh-list
44041193|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
44041194|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041195|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041196|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44251278|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251280|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44251281|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
44251282|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649522|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041197|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
44041198|NCT00002756|Methotrexate|methotrexate|mesh-list
44041203|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
44041204|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
44041205|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041206|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
44041207|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041208|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041209|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041210|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
44041211|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041212|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041213|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041214|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041215|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
44041216|NCT00002756|Hormones|hormones|mesh-ancestor
44041217|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041218|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041219|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041220|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041221|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041222|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041223|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
44041224|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041225|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041226|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041227|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041228|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041229|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041230|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041231|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
44041232|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041233|NCT00002756|Antidotes|antidotes|mesh-ancestor
44041234|NCT00002756|Protective Agents|protective agents|mesh-ancestor
44041235|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
44041236|NCT00002756|Vitamins|vitamins|mesh-ancestor
44041237|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
44041238|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041239|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041240|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041241|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041242|NCT00002757|Cytarabine|cytarabine|mesh-list
44041243|NCT00002757|Prednisone|prednisone|mesh-list
44041244|NCT00002757|Prednisolone|prednisolone|mesh-list
44041245|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
44041246|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041247|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041248|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44041249|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
44041250|NCT00002757|Doxorubicin|doxorubicin|mesh-list
44041251|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041252|NCT00002757|Methotrexate|methotrexate|mesh-list
44041253|NCT00002757|Etoposide|etoposide|mesh-list
44041254|NCT00002757|Vincristine|vincristine|mesh-list
44041255|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041256|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
44041257|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041258|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041259|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041260|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
44041261|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041262|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041263|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041264|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041265|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041266|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041267|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251283|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251284|NCT05324059|Pregabalin|pregabalin|mesh-list
44251285|NCT05324059|Tramadol|tramadol|mesh-list
44251286|NCT05324059|Analgesics|analgesics|mesh-ancestor
44251287|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
44251288|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041268|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041269|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
44041270|NCT00002757|Hormones|hormones|mesh-ancestor
44041271|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041272|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041287|NCT00002759|Cyclosporine|cyclosporine|mesh-list
44041288|NCT00002759|Irinotecan|irinotecan|mesh-list
44041289|NCT00002759|Phenobarbital|phenobarbital|mesh-list
44041290|NCT00002759|Cyclosporins|cyclosporins|mesh-list
44041291|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44041292|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041293|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041294|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041295|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041296|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041297|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
44041298|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041299|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
44041300|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041301|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041302|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041303|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041304|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
44041305|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44041306|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44041307|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44041308|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44041309|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44041310|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
44041311|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
44041312|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44041313|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44041314|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44041315|NCT00002760|Ketoconazole|ketoconazole|mesh-list
44041316|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
44041317|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041318|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041319|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44041320|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
44041321|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041322|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
44041323|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041324|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44041325|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44041326|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041327|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041328|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44041329|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
44041330|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44075322|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
44041331|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041332|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44041344|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041345|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041346|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
44041347|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041348|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041349|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041350|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
44041351|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041352|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041353|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
44251289|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251290|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
44251291|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44251292|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251293|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041354|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041355|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
44041356|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041357|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041358|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041359|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041360|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041362|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
44041363|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041364|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
44041365|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041366|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
44041367|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041368|NCT00002764|Doxorubicin|doxorubicin|mesh-list
44041369|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041371|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041372|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041373|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041374|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041375|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041376|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041377|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041378|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
44041379|NCT00002765|Immunotoxins|immunotoxins|mesh-list
44041380|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
44041381|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041382|NCT00002767|Interferons|interferons|mesh-list
44041383|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
44041384|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
44041385|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041386|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
44041387|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041388|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
44041389|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041390|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44041391|NCT00002768|Cytarabine|cytarabine|mesh-list
44041392|NCT00002768|Methotrexate|methotrexate|mesh-list
44041393|NCT00002768|Etoposide|etoposide|mesh-list
44041394|NCT00002768|Busulfan|busulfan|mesh-list
44041395|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041396|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041397|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041398|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041399|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041400|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
44041401|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041415|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
44041416|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041417|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041419|NCT00002771|Cytarabine|cytarabine|mesh-list
44041420|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
44041421|NCT00002771|Busulfan|busulfan|mesh-list
44041422|NCT00002771|Idarubicin|idarubicin|mesh-list
44041423|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
44041424|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041425|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
44041426|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041427|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041428|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
44041429|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041430|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041431|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
44041432|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041433|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
44041434|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44251294|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44251295|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44251296|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44251297|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251298|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44251299|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251300|NCT05324059|Narcotics|narcotics|mesh-ancestor
44251302|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44251303|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251304|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
44251305|NCT05322733|Fludarabine|fludarabine|mesh-list
44251306|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
44251307|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251308|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
44251309|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251310|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251311|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44251312|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
44251313|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251314|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251315|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44251316|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251344|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44251345|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649556|NCT03020680|Vitamins|vitamins|mesh-ancestor
44041435|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041436|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041437|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041438|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075439|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
44041439|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041440|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
44041441|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041442|NCT00002772|Tamoxifen|tamoxifen|mesh-list
44041443|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
44041444|NCT00002772|Carboplatin|carboplatin|mesh-list
44041445|NCT00002772|Doxorubicin|doxorubicin|mesh-list
44041446|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041447|NCT00002772|Thiotepa|thiotepa|mesh-list
44041448|NCT00002772|Carmustine|carmustine|mesh-list
44041449|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041450|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041451|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041452|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
44041453|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041454|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041455|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041456|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
44041457|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041458|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041459|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041460|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041461|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041462|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44041463|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
44041472|NCT00002773|Sargramostim|sargramostim|mesh-list
44041473|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041474|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
44041475|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041476|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041477|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041478|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
44041479|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041480|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041481|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041482|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
44041483|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041484|NCT00002774|Cisplatin|cisplatin|mesh-list
44041485|NCT00002774|Fluorouracil|fluorouracil|mesh-list
44041486|NCT00002774|Tirapazamine|tirapazamine|mesh-list
44041487|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041488|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
44041489|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041490|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041491|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041492|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
44041493|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041494|NCT00002775|Docetaxel|docetaxel|mesh-list
44041495|NCT00002775|Estramustine|estramustine|mesh-list
44041496|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041497|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041498|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041499|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041500|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041501|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041503|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041504|NCT00002777|Tamoxifen|tamoxifen|mesh-list
44041505|NCT00002777|Exemestane|exemestane|mesh-list
44041506|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041507|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44041508|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
44041509|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041510|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041511|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041512|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251346|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251347|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251349|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251350|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251351|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251352|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251353|NCT05246007|Analgesics|analgesics|mesh-ancestor
44251354|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
44251355|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041513|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44041514|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44041515|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44041516|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44041517|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44041518|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041519|NCT00002778|Sargramostim|sargramostim|mesh-list
44041520|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
44041521|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041522|NCT00002779|Fludarabine|fludarabine|mesh-list
44041523|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
44041524|NCT00002779|Octreotide|octreotide|mesh-list
44041525|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041526|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041527|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
44041528|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538172|NCT05007041|Vaccines|vaccines|mesh-list
44041532|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041533|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041534|NCT00002780|Aldesleukin|aldesleukin|mesh-list
44041535|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
44041536|NCT00002780|Thiotepa|thiotepa|mesh-list
44041537|NCT00002780|Carboplatin|carboplatin|mesh-list
44041538|NCT00002780|Sargramostim|sargramostim|mesh-list
44041539|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041540|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
44041541|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041542|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041543|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041544|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
44041545|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041546|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041547|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041548|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44041549|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041550|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
44041551|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041552|NCT00002783|Leucovorin|leucovorin|mesh-list
44041553|NCT00002783|Cisplatin|cisplatin|mesh-list
44041554|NCT00002783|Fluorouracil|fluorouracil|mesh-list
44041555|NCT00002783|Floxuridine|floxuridine|mesh-list
44041556|NCT00002783|Calcium|calcium|mesh-list
44041557|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
44041558|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041559|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44041560|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041561|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
44041562|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041563|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041564|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041565|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
44041566|NCT00002783|Antidotes|antidotes|mesh-ancestor
44041567|NCT00002783|Protective Agents|protective agents|mesh-ancestor
44041568|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
44041569|NCT00002783|Vitamins|vitamins|mesh-ancestor
44251356|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44251357|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44251358|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251359|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251360|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251361|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251363|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
44251364|NCT05243940|Ketamine|ketamine|mesh-list
44251365|NCT05243940|Remifentanil|remifentanil|mesh-list
44251366|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251367|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
44251368|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251369|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251370|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
44251371|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251372|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44251373|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44251374|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44251375|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251376|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251377|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43649570|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
44041570|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
44041571|NCT00002784|Tamoxifen|tamoxifen|mesh-list
44041572|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
44041573|NCT00002784|Doxorubicin|doxorubicin|mesh-list
44041574|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041575|NCT00002784|Fluorouracil|fluorouracil|mesh-list
44041576|NCT00002784|Methotrexate|methotrexate|mesh-list
44041577|NCT00002784|Epirubicin|epirubicin|mesh-list
44041578|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041579|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
44041580|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041581|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041582|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041583|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
44041584|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041585|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041586|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041587|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041588|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041589|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041590|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041591|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
44041592|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041593|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041594|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041595|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041596|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041597|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44251378|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251379|NCT05243940|Analgesics|analgesics|mesh-ancestor
44251380|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44251381|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44251382|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251383|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251384|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649594|NCT03019991|Ritonavir|ritonavir|mesh-list
44041598|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041599|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44041600|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
44041601|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041602|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041609|NCT00002785|Cyclosporine|cyclosporine|mesh-list
44041610|NCT00002785|Dexamethasone|dexamethasone|mesh-list
44041611|NCT00002785|Prednisone|prednisone|mesh-list
44041612|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
44041613|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
44041614|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041615|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041616|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44041617|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
44041618|NCT00002785|Methotrexate|methotrexate|mesh-list
44041619|NCT00002785|Etoposide|etoposide|mesh-list
44041620|NCT00002785|Vincristine|vincristine|mesh-list
44041621|NCT00002785|Daunorubicin|daunorubicin|mesh-list
44041622|NCT00002785|Asparaginase|asparaginase|mesh-list
44041623|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
44041624|NCT00002785|Pegaspargase|pegaspargase|mesh-list
44041625|NCT00002785|Cyclosporins|cyclosporins|mesh-list
44041626|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
44041627|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041628|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
44041629|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041630|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041631|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041632|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
44041633|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041634|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041635|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041636|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041637|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
44041638|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
44041639|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041640|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041641|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
44041642|NCT00002785|Hormones|hormones|mesh-ancestor
44041643|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041644|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041645|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041646|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041647|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041648|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041649|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
44041650|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041651|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041652|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041653|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041654|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041655|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041656|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041658|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041659|NCT00002785|Antidotes|antidotes|mesh-ancestor
44041660|NCT00002785|Protective Agents|protective agents|mesh-ancestor
44041661|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
44041662|NCT00002785|Vitamins|vitamins|mesh-ancestor
44041663|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
44041664|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041665|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041666|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251385|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44251386|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251387|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
44251388|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43649601|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041667|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
44041668|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041669|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44041670|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041671|NCT00002785|Trace Elements|trace elements|mesh-ancestor
44041673|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041674|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44041675|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041676|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
44041683|NCT00002787|Antibodies|antibodies|mesh-list
44041684|NCT00002787|Sargramostim|sargramostim|mesh-list
44041685|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44041686|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44041687|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
44041688|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041689|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041690|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44041691|NCT00002787|Analgesics|analgesics|mesh-ancestor
44041692|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
44041693|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041694|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44041695|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041696|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
44041697|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041698|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44041699|NCT00002788|Dexamethasone|dexamethasone|mesh-list
44041700|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
44041701|NCT00002788|Etoposide|etoposide|mesh-list
44041702|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041703|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
44041704|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041705|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041706|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041707|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
44041708|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041709|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041710|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041711|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041712|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
44041713|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
44041714|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041715|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041716|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
44041717|NCT00002788|Hormones|hormones|mesh-ancestor
44041718|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041719|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041720|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041721|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041722|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041723|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041724|NCT00002789|Cyclosporine|cyclosporine|mesh-list
44041725|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
44041726|NCT00002789|Busulfan|busulfan|mesh-list
44041727|NCT00002789|Methotrexate|methotrexate|mesh-list
44041728|NCT00002789|Cyclosporins|cyclosporins|mesh-list
44041729|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041730|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
44041731|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041732|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041734|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
44041735|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041736|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041737|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041738|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041739|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
44251389|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44251390|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251391|NCT05243940|Narcotics|narcotics|mesh-ancestor
44251392|NCT05237141|Etonogestrel|etonogestrel|mesh-list
44251393|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44251394|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
44251395|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44251396|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251397|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44041740|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041741|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041743|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041744|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041745|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041746|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041747|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
44041748|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041749|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041750|NCT00002790|Cyclosporine|cyclosporine|mesh-list
44041760|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041761|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041762|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041763|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041764|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041765|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041766|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
44041767|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041768|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041769|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
44041770|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041771|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041772|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44041773|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041774|NCT00002791|Doxorubicin|doxorubicin|mesh-list
44041775|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041776|NCT00002791|Ifosfamide|ifosfamide|mesh-list
44041777|NCT00002791|Dacarbazine|dacarbazine|mesh-list
44041778|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041779|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041780|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041781|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041782|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041783|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041784|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041785|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
44149509|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149510|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44149511|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44149512|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
44149513|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44149514|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149515|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44149516|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149517|NCT00208182|Risperidone|risperidone|mesh-list
44149518|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149519|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
44149520|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149521|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149522|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149523|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149524|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149525|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149526|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149527|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149528|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
44251398|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
44251399|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
44251400|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460671|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44460672|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44460673|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44460674|NCT01559844|Ribavirin|ribavirin|mesh-list
44460675|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
44460676|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
44460677|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460678|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
44460679|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460680|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
44460681|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44149529|NCT00208195|Valproic Acid|valproic acid|mesh-list
44149531|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041786|NCT00002792|Cyclosporine|cyclosporine|mesh-list
44041787|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
44041789|NCT00002792|Methotrexate|methotrexate|mesh-list
44041790|NCT00002792|Tacrolimus|tacrolimus|mesh-list
44041791|NCT00002792|Cyclosporins|cyclosporins|mesh-list
44041792|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041793|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
44041794|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041795|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041801|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041803|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041804|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041805|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
44041806|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041807|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041808|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041809|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041810|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44041811|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
44041812|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041813|NCT00002793|Leucovorin|leucovorin|mesh-list
44041814|NCT00002793|Fluorouracil|fluorouracil|mesh-list
44041815|NCT00002793|Calcium|calcium|mesh-list
44041816|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
44041817|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44041818|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041819|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
44041820|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041821|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041822|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041823|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041824|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
44041825|NCT00002793|Antidotes|antidotes|mesh-ancestor
44041826|NCT00002793|Protective Agents|protective agents|mesh-ancestor
44041827|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
44041828|NCT00002793|Vitamins|vitamins|mesh-ancestor
44041829|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
44041830|NCT00002794|Carboplatin|carboplatin|mesh-list
44041831|NCT00002794|Vincristine|vincristine|mesh-list
44041832|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041833|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041834|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041835|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041836|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041837|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041838|NCT00002796|Interferons|interferons|mesh-list
44041839|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
44041840|NCT00002796|Indomethacin|indomethacin|mesh-list
44460682|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44460683|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44460684|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44460685|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44460686|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
44460688|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
44460689|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44460690|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
44041841|NCT00002796|Fluorouracil|fluorouracil|mesh-list
44041842|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44041843|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
44041844|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041845|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041846|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041847|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041848|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
44041849|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041850|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
44041851|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041852|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44041853|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44041854|NCT00002796|Analgesics|analgesics|mesh-ancestor
44041855|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
44041856|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041857|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041858|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041859|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
44041860|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
44041861|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041862|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44041863|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041864|NCT00002798|Cytarabine|cytarabine|mesh-list
44041882|NCT00002798|Thioguanine|thioguanine|mesh-list
44041883|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041884|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
44041885|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041886|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041887|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041888|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
44041889|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041890|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041891|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041892|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44041893|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
44041894|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
44041895|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44041896|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44041897|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
44041898|NCT00002798|Hormones|hormones|mesh-ancestor
44041899|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041900|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041901|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041902|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041903|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041904|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041905|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
44041906|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041907|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041908|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041909|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041910|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041911|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041912|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041913|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
44460691|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138436|NCT00171093|Valsartan|valsartan|mesh-list
44460692|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
44460693|NCT01559675|Hormones|hormones|mesh-ancestor
44460694|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041914|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041915|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041916|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44041917|NCT00002798|Analgesics|analgesics|mesh-ancestor
44041918|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
44041919|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44041920|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44041921|NCT00002800|Cytarabine|cytarabine|mesh-list
44041922|NCT00002800|Etoposide|etoposide|mesh-list
44041923|NCT00002800|Idarubicin|idarubicin|mesh-list
44041924|NCT00002800|Lintuzumab|lintuzumab|mesh-list
44041925|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041926|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041927|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538594|NCT04586231|Lenvatinib|lenvatinib|mesh-list
44041931|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041932|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
44041933|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
44041934|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041935|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041936|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
44041937|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041938|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041939|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44041941|NCT00002801|Tegafur|tegafur|mesh-list
44041942|NCT00002801|Calcium|calcium|mesh-list
44041943|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
44041944|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44041945|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041946|NCT00002801|Antidotes|antidotes|mesh-ancestor
44041947|NCT00002801|Protective Agents|protective agents|mesh-ancestor
44041948|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
44041949|NCT00002801|Vitamins|vitamins|mesh-ancestor
44041950|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
44041951|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041952|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
44041953|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041954|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041955|NCT00002802|Cobalt|cobalt|mesh-list
44041956|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
44041957|NCT00002802|Melphalan|melphalan|mesh-list
44041958|NCT00002802|Ifosfamide|ifosfamide|mesh-list
44041959|NCT00002802|Dacarbazine|dacarbazine|mesh-list
44041960|NCT00002802|Carboplatin|carboplatin|mesh-list
44041961|NCT00002802|Doxorubicin|doxorubicin|mesh-list
44041962|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041963|NCT00002802|Etoposide|etoposide|mesh-list
44041964|NCT00002802|Vincristine|vincristine|mesh-list
44041965|NCT00002802|Vindesine|vindesine|mesh-list
44041966|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041967|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
44041968|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041969|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041970|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041971|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
44041972|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041973|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041974|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041975|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041976|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041977|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041978|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041979|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041980|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041981|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041982|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041983|NCT00002802|Trace Elements|trace elements|mesh-ancestor
44041984|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
44041985|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
44041986|NCT00002803|Doxorubicin|doxorubicin|mesh-list
44251401|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44251402|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44251403|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
44251405|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251406|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251407|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251408|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251409|NCT05210764|Ketamine|ketamine|mesh-list
44251410|NCT05210764|Anesthetics|anesthetics|mesh-list
44251411|NCT05210764|Propofol|propofol|mesh-list
44251412|NCT05210764|Sevoflurane|sevoflurane|mesh-list
44251413|NCT05210764|Esketamine|esketamine|mesh-list
44251414|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251415|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251416|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251417|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251418|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
44251419|NCT05210764|Analgesics|analgesics|mesh-ancestor
44251420|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
44251421|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251422|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44251423|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44041987|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44041988|NCT00002803|Vincristine|vincristine|mesh-list
44041989|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041990|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
44041991|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041992|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041993|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041994|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
44041995|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041996|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041997|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041998|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44041999|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042000|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042001|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042010|NCT00002804|Ifosfamide|ifosfamide|mesh-list
44042011|NCT00002804|Lenograstim|lenograstim|mesh-list
44042012|NCT00002804|Mesna|mesna|mesh-list
44042013|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042014|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042015|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042016|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042017|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042018|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042019|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44042020|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
44042021|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042022|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042023|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251424|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44251425|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44042024|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042025|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042026|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042027|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
44042028|NCT00002804|Protective Agents|protective agents|mesh-ancestor
44042029|NCT00002804|Trace Elements|trace elements|mesh-ancestor
44042030|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
44042033|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
44042034|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44042035|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44042036|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44042037|NCT00002805|Methotrexate|methotrexate|mesh-list
44042038|NCT00002805|Etoposide|etoposide|mesh-list
44042039|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
44042040|NCT00002805|Cladribine|cladribine|mesh-list
44042041|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042042|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042043|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042044|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042045|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042046|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
44042047|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042048|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042049|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042050|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042051|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042052|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042053|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
44042054|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042055|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042056|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042057|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042058|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042059|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
44042060|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042061|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042062|NCT00002805|Analgesics|analgesics|mesh-ancestor
44042063|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
44042064|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042065|NCT00002805|Trace Elements|trace elements|mesh-ancestor
44042066|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
44042067|NCT00002806|Vincristine|vincristine|mesh-list
44042068|NCT00002806|Lomustine|lomustine|mesh-list
44042069|NCT00002806|Procarbazine|procarbazine|mesh-list
44042070|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042071|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042072|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538727|NCT04339062|Sirolimus|sirolimus|mesh-list
44042081|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44042082|NCT00002809|Sargramostim|sargramostim|mesh-list
44042083|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
44042084|NCT00002809|Antibodies|antibodies|mesh-list
44042085|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
44042086|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44042087|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44042088|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042089|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
44042090|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042091|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042092|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042093|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
44042094|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042095|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042096|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042097|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042098|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042099|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042100|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042101|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
44042102|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042103|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042104|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44251426|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251427|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44251428|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44251429|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
44042105|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042106|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44042107|NCT00002810|Melphalan|melphalan|mesh-list
44042108|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
44042109|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042110|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042111|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
44042112|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042113|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042114|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042115|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042116|NCT00002812|Cytarabine|cytarabine|mesh-list
44042117|NCT00002812|Dexamethasone|dexamethasone|mesh-list
44042118|NCT00002812|Prednisone|prednisone|mesh-list
44042119|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
44042120|NCT00002812|Doxorubicin|doxorubicin|mesh-list
44042121|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042122|NCT00002812|Methotrexate|methotrexate|mesh-list
44042123|NCT00002812|Vincristine|vincristine|mesh-list
44042124|NCT00002812|Daunorubicin|daunorubicin|mesh-list
44042125|NCT00002812|Asparaginase|asparaginase|mesh-list
44042126|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
44042127|NCT00002812|Idarubicin|idarubicin|mesh-list
44042128|NCT00002812|Pegaspargase|pegaspargase|mesh-list
44042129|NCT00002812|Thioguanine|thioguanine|mesh-list
44042130|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042131|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
44042132|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042133|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042134|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042135|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
44042136|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042137|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042138|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042139|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042140|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
44042141|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
44042142|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042147|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042148|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042149|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042150|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042151|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042152|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042153|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042154|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042155|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042156|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
44042157|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042158|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042159|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042160|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
44042161|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042162|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042163|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042164|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042165|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042166|NCT00002813|Cisplatin|cisplatin|mesh-list
44042167|NCT00002813|Vinorelbine|vinorelbine|mesh-list
44042168|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042169|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042170|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042171|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042172|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042173|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042175|NCT00002814|Topotecan|topotecan|mesh-list
44042176|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042177|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251430|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44251432|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44251433|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
43649665|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44042178|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042179|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042180|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042181|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042182|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44042183|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042184|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042185|NCT00002816|Leucovorin|leucovorin|mesh-list
44042187|NCT00002816|Cytarabine|cytarabine|mesh-list
44042188|NCT00002816|Dexamethasone|dexamethasone|mesh-list
44042189|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
44042190|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44042191|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44042192|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44042193|NCT00002816|Methotrexate|methotrexate|mesh-list
44042194|NCT00002816|Etoposide|etoposide|mesh-list
44042195|NCT00002816|Vincristine|vincristine|mesh-list
44042196|NCT00002816|Asparaginase|asparaginase|mesh-list
44042197|NCT00002816|Ifosfamide|ifosfamide|mesh-list
44042198|NCT00002816|Idarubicin|idarubicin|mesh-list
44042199|NCT00002816|Pegaspargase|pegaspargase|mesh-list
44042200|NCT00002816|Thioguanine|thioguanine|mesh-list
44042201|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
44042202|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042203|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
44042204|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
44042205|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042206|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042207|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042208|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
44042209|NCT00002816|Hormones|hormones|mesh-ancestor
44042210|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042211|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042212|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042213|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042214|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042215|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042216|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042217|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
44042221|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042222|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042223|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
44042224|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042225|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042226|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042227|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042228|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042229|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
44042230|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042231|NCT00002816|Antidotes|antidotes|mesh-ancestor
44042232|NCT00002816|Protective Agents|protective agents|mesh-ancestor
44042233|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
44042234|NCT00002816|Vitamins|vitamins|mesh-ancestor
44042235|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
44042236|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042237|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042238|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042239|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042240|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
44042241|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042242|NCT00002816|Trace Elements|trace elements|mesh-ancestor
44042243|NCT00002817|Sargramostim|sargramostim|mesh-list
44042244|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
44042245|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042246|NCT00002818|Cytarabine|cytarabine|mesh-list
44042247|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042248|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
44042249|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042250|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251434|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44251435|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251436|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251437|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251438|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
44251439|NCT05208333|Albendazole|albendazole|mesh-list
44251440|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
44251441|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44251442|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44251443|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
44042251|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
44042252|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042253|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042254|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
44042255|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042256|NCT00002819|Paclitaxel|paclitaxel|mesh-list
44042257|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
44042258|NCT00002819|Carboplatin|carboplatin|mesh-list
44042259|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
44042260|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042261|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042262|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042263|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042264|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042265|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042266|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042267|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
44042268|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042269|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042270|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042271|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
44042272|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042273|NCT00002819|Analgesics|analgesics|mesh-ancestor
44042274|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
44042275|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042276|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042277|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042278|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042279|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
44042280|NCT00002822|Ifosfamide|ifosfamide|mesh-list
44042281|NCT00002822|Cisplatin|cisplatin|mesh-list
44042282|NCT00002822|Carboplatin|carboplatin|mesh-list
44042283|NCT00002822|Doxorubicin|doxorubicin|mesh-list
44042284|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042285|NCT00002822|Etoposide|etoposide|mesh-list
44042286|NCT00002822|Vincristine|vincristine|mesh-list
44042287|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042288|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
44042289|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042290|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042291|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042293|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042295|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042296|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042297|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042298|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042299|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042300|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042301|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042302|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042303|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042304|NCT00002823|Cisplatin|cisplatin|mesh-list
44042305|NCT00002823|Etoposide|etoposide|mesh-list
44042306|NCT00002823|Vinorelbine|vinorelbine|mesh-list
44042307|NCT00002823|Vinblastine|vinblastine|mesh-list
44042308|NCT00002823|Vindesine|vindesine|mesh-list
44042309|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042310|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251444|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44251445|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44251446|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251447|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251448|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251449|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251450|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251451|NCT05174832|Paclitaxel|paclitaxel|mesh-list
44251452|NCT05174832|Cisplatin|cisplatin|mesh-list
44251453|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
44251454|NCT05174832|Olaparib|olaparib|mesh-list
44251455|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251456|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251457|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251458|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251459|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251460|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251461|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251462|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44251463|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251464|NCT05122208|Famotidine|famotidine|mesh-list
44251465|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44251466|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251467|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44251468|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
44251469|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
44251470|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251471|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042311|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042312|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042313|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042314|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042315|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042316|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042317|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042318|NCT00002824|Ganciclovir|ganciclovir|mesh-list
44042319|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44042320|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
44042321|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042322|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042323|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042324|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042325|NCT00002825|Docetaxel|docetaxel|mesh-list
44042326|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042327|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042328|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251472|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251473|NCT05113368|Fulvestrant|fulvestrant|mesh-list
44251474|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251475|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251476|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44251477|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44076325|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
44251478|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
43769921|NCT02384512|Rasagiline|rasagiline|mesh-list
44042329|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042330|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042332|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042333|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042334|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042335|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042336|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042337|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042338|NCT00002827|Cobalt|cobalt|mesh-list
44042339|NCT00002827|Doxorubicin|doxorubicin|mesh-list
44042340|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042341|NCT00002827|Bleomycin|bleomycin|mesh-list
44042342|NCT00002827|Etoposide|etoposide|mesh-list
44042343|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
44042344|NCT00002827|Vincristine|vincristine|mesh-list
44042345|NCT00002827|Razoxane|razoxane|mesh-list
44042346|NCT00002827|Lenograstim|lenograstim|mesh-list
44042347|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042348|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042349|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042350|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042351|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042352|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042353|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042354|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44042355|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
44042356|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042357|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042358|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042359|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042360|NCT00002827|Trace Elements|trace elements|mesh-ancestor
44042361|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
44042362|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44042363|NCT00002827|Protective Agents|protective agents|mesh-ancestor
44042364|NCT00002828|Fluorouracil|fluorouracil|mesh-list
44042365|NCT00002828|Raltitrexed|raltitrexed|mesh-list
44042366|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
44042367|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042375|NCT00002829|Interferons|interferons|mesh-list
44042376|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
44042377|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
44042378|NCT00002829|Etoposide|etoposide|mesh-list
44042379|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042380|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
44042381|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042382|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042383|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042384|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
44042385|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042386|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042387|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042388|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042389|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042390|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042391|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042392|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
44042393|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042394|NCT00002831|Cyclosporine|cyclosporine|mesh-list
44042395|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
44042396|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44042397|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44042398|NCT00002831|Prednisolone|prednisolone|mesh-list
44251479|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251480|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251481|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
44251482|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44251483|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44251484|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44251485|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251486|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042399|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
44042400|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
44042401|NCT00002831|Busulfan|busulfan|mesh-list
44042402|NCT00002831|Methotrexate|methotrexate|mesh-list
44042403|NCT00002831|Decitabine|decitabine|mesh-list
44042404|NCT00002831|Tacrolimus|tacrolimus|mesh-list
43769993|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042405|NCT00002831|Cyclosporins|cyclosporins|mesh-list
44042406|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44042407|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
44042408|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042409|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
44042410|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042411|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042412|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042413|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
44042414|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042415|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042416|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042417|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042418|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042419|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042420|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042421|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
44042422|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042423|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042424|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042425|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042426|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44042427|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
44042428|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042429|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042430|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
44042431|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
44042432|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042433|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042434|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
44042435|NCT00002831|Hormones|hormones|mesh-ancestor
43539125|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
44042440|NCT00002832|Cyclosporine|cyclosporine|mesh-list
44042441|NCT00002832|Decitabine|decitabine|mesh-list
44042442|NCT00002832|Cyclosporins|cyclosporins|mesh-list
44042443|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
44042444|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042445|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042446|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042447|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042448|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
44042449|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042450|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042451|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042452|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44042453|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042454|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
44042455|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042456|NCT00002833|Cytarabine|cytarabine|mesh-list
44042457|NCT00002833|Cyclosporine|cyclosporine|mesh-list
44042458|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
44042459|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44251487|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44251488|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251489|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251490|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44251491|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042460|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44042461|NCT00002833|Prednisolone|prednisolone|mesh-list
44042462|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
44042463|NCT00002833|Fludarabine|fludarabine|mesh-list
44042464|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
44042465|NCT00002833|Idarubicin|idarubicin|mesh-list
44042466|NCT00002833|Cladribine|cladribine|mesh-list
44042467|NCT00002833|Cyclosporins|cyclosporins|mesh-list
44042468|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44042469|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
44042470|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042471|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042472|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
44042473|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042474|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042475|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
44042476|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042477|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
44042478|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042479|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042480|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
44042481|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042482|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042483|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44042484|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042485|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
44042487|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042488|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042489|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
44042491|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042492|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44042493|NCT00002833|Protective Agents|protective agents|mesh-ancestor
44042494|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042495|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042496|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042497|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042498|NCT00002835|Leucovorin|leucovorin|mesh-list
44042499|NCT00002835|Interferons|interferons|mesh-list
44042500|NCT00002835|Cytarabine|cytarabine|mesh-list
44042501|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
44042502|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
44042503|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44042504|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44042505|NCT00002835|Prednisolone|prednisolone|mesh-list
44042506|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
44042507|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
44042508|NCT00002835|Melphalan|melphalan|mesh-list
44042509|NCT00002835|Ifosfamide|ifosfamide|mesh-list
44042510|NCT00002835|Carmustine|carmustine|mesh-list
44042511|NCT00002835|Cisplatin|cisplatin|mesh-list
44042518|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
44042519|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44042520|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
44042521|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042522|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
44042523|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042524|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042525|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042526|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
44042527|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042528|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042529|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042530|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042531|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042532|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042533|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042534|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
44042535|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
44251493|NCT05104554|Micronutrients|micronutrients|mesh-list
44251494|NCT05104554|Trace Elements|trace elements|mesh-list
44251495|NCT05104554|Hematinics|hematinics|mesh-ancestor
44251496|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
44251497|NCT05104554|Vitamins|vitamins|mesh-ancestor
44251498|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251499|NCT05074355|Azacitidine|azacitidine|mesh-list
44251500|NCT05074355|Venetoclax|venetoclax|mesh-list
44251501|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251502|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
44251503|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251504|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251505|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251506|NCT05053334|Omalizumab|omalizumab|mesh-list
44251507|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44251508|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44251509|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
44251510|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44251511|NCT05037045|Incretins|incretins|mesh-ancestor
44251512|NCT05037045|Hormones|hormones|mesh-ancestor
44251513|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251514|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251515|NCT05018520|Prednisone|prednisone|mesh-list
44251516|NCT05018520|Rituximab|rituximab|mesh-list
44251517|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
44251518|NCT05018520|Vincristine|vincristine|mesh-list
44251519|NCT05018520|Doxorubicin|doxorubicin|mesh-list
44251520|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251541|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44251542|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251543|NCT04991493|Tramadol|tramadol|mesh-list
44251544|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251545|NCT04991493|Narcotics|narcotics|mesh-ancestor
44042536|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042537|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042538|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042539|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042540|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042541|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042542|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
44042543|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042544|NCT00002835|Antidotes|antidotes|mesh-ancestor
44042545|NCT00002835|Protective Agents|protective agents|mesh-ancestor
44042546|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
44042547|NCT00002835|Vitamins|vitamins|mesh-ancestor
44042548|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
44042549|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042550|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042551|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042552|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042553|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
44042554|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
44042555|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042556|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042557|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
44042558|NCT00002835|Hormones|hormones|mesh-ancestor
44042559|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042560|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44042561|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042562|NCT00002835|Analgesics|analgesics|mesh-ancestor
44042563|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
44042564|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042566|NCT00002836|Thiotepa|thiotepa|mesh-list
44042567|NCT00002836|Carmustine|carmustine|mesh-list
44042568|NCT00002836|Cisplatin|cisplatin|mesh-list
44042569|NCT00002836|Etoposide|etoposide|mesh-list
44042570|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042571|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
44042572|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042573|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042574|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042575|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
44042576|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042577|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042578|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042579|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042580|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042581|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042582|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042583|NCT00002837|Paclitaxel|paclitaxel|mesh-list
44042584|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
44042585|NCT00002837|Doxorubicin|doxorubicin|mesh-list
44042586|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042601|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042602|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042603|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042604|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
44042606|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
44042607|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042608|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
44042609|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042610|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042611|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042612|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
44042613|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042614|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042615|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042616|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042617|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
44042618|NCT00002839|Cisplatin|cisplatin|mesh-list
44042619|NCT00002839|Fluorouracil|fluorouracil|mesh-list
44042620|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251546|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251547|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251548|NCT04991493|Analgesics|analgesics|mesh-ancestor
44251549|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
44251550|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251551|NCT04958538|Methotrexate|methotrexate|mesh-list
44042621|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
44042622|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042623|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042624|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042625|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
44042626|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042627|NCT00002840|Vincristine|vincristine|mesh-list
44042628|NCT00002840|Lomustine|lomustine|mesh-list
44042629|NCT00002840|Procarbazine|procarbazine|mesh-list
44042630|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042631|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042632|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042633|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042634|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042635|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042636|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042637|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
44042638|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
44042639|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042640|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
44042641|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042642|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042643|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042644|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
43539351|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
44042654|NCT00002846|Aldesleukin|aldesleukin|mesh-list
44042655|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042656|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44042657|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44042658|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
44042659|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042660|NCT00002847|Interferons|interferons|mesh-list
44042661|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
44042662|NCT00002847|Aldesleukin|aldesleukin|mesh-list
44042663|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042664|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
44042665|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042666|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
44042667|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042668|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44042669|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44042670|NCT00002849|Interferons|interferons|mesh-list
44042671|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
44042672|NCT00002849|Dexamethasone|dexamethasone|mesh-list
44042673|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042674|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
44042675|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
44042676|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042677|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042678|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042679|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
44042680|NCT00002849|Hormones|hormones|mesh-ancestor
44042681|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042682|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042683|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042684|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
44042685|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042686|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
44042687|NCT00002852|Paclitaxel|paclitaxel|mesh-list
44042688|NCT00002852|Carboplatin|carboplatin|mesh-list
44042689|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042690|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042691|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042692|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042693|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251552|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44251553|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
44251554|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042694|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042695|NCT00002854|Paclitaxel|paclitaxel|mesh-list
44042696|NCT00002854|Etoposide|etoposide|mesh-list
44042697|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
44042698|NCT00002854|Cisplatin|cisplatin|mesh-list
44042699|NCT00002854|Carboplatin|carboplatin|mesh-list
44042700|NCT00002854|Ifosfamide|ifosfamide|mesh-list
44042701|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042702|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042703|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042704|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042705|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042706|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042707|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042708|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
44042709|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042710|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042711|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042712|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
44042713|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042714|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539411|NCT03182244|Cytarabine|cytarabine|mesh-list
44042718|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
44042719|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44042720|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44042721|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44042722|NCT00002855|Doxorubicin|doxorubicin|mesh-list
44042723|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042724|NCT00002855|Bicalutamide|bicalutamide|mesh-list
44042725|NCT00002855|Vinblastine|vinblastine|mesh-list
44042726|NCT00002855|Flutamide|flutamide|mesh-list
44042727|NCT00002855|Estramustine|estramustine|mesh-list
44042728|NCT00002855|Nilutamide|nilutamide|mesh-list
44042729|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042730|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042731|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042732|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042733|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042734|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042735|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042736|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
44042737|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042738|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44042739|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44042740|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44042741|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44042742|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042743|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042744|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44042745|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
44042746|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042747|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042748|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042749|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042750|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042751|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042752|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
44042753|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
44042754|NCT00002858|Cisplatin|cisplatin|mesh-list
44042755|NCT00002858|Doxorubicin|doxorubicin|mesh-list
44042756|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042757|NCT00002858|Etoposide|etoposide|mesh-list
44042758|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042759|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
44042760|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042761|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042762|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042763|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
44042764|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251555|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251556|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251557|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
44251558|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251559|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251560|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44251561|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251562|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44251563|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251564|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
44251565|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251566|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44251568|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44251569|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44251570|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251571|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251572|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251573|NCT04931602|Vitamin D|vitamin d|mesh-list
44251574|NCT04931602|Vitamins|vitamins|mesh-ancestor
44251575|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
44251576|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251577|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44460695|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460696|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44460697|NCT01559675|Protective Agents|protective agents|mesh-ancestor
44460698|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44460699|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460700|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
44460701|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
44460702|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460703|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460704|NCT01559454|Buprenorphine|buprenorphine|mesh-list
44460715|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44460716|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
44460717|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460718|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
44460719|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44042765|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042766|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042767|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042768|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042769|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042770|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042771|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042772|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
44042773|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042774|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042775|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042776|NCT00002864|Tamoxifen|tamoxifen|mesh-list
44042777|NCT00002864|Octreotide|octreotide|mesh-list
44042778|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44042779|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
44042780|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042781|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042782|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042783|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042784|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44042785|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44042786|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44042787|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042804|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042805|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
44042806|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042807|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042808|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042809|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
44042810|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042811|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042812|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042813|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042814|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
44042815|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
44042816|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042817|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042818|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
44042819|NCT00002865|Hormones|hormones|mesh-ancestor
44042820|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042821|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042822|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042823|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042824|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042825|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042826|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44042827|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
44042828|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44042829|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042830|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
44042831|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042832|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042833|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042834|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042835|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
44042836|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042837|NCT00002865|Antidotes|antidotes|mesh-ancestor
44042838|NCT00002865|Protective Agents|protective agents|mesh-ancestor
44042839|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
44042840|NCT00002865|Vitamins|vitamins|mesh-ancestor
44042841|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
44042842|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042843|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042844|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460720|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460722|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460723|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460724|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460725|NCT01559389|Urological Agents|urological agents|mesh-ancestor
44460726|NCT01559259|Acetaminophen|acetaminophen|mesh-list
44460727|NCT01559259|Ibuprofen|ibuprofen|mesh-list
44460728|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44460729|NCT01559259|Analgesics|analgesics|mesh-ancestor
43649768|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
44042845|NCT00002865|Trace Elements|trace elements|mesh-ancestor
44042846|NCT00002866|Docetaxel|docetaxel|mesh-list
44042847|NCT00002866|Epirubicin|epirubicin|mesh-list
44042848|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042849|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042850|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042851|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042852|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042853|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43539560|NCT02584478|Paclitaxel|paclitaxel|mesh-list
44042862|NCT00002868|Busulfan|busulfan|mesh-list
44042863|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
44042864|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042865|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042866|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042867|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042868|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042869|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042870|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
44042871|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042872|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042873|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
44042874|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042875|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
44042876|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042877|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
44042878|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042879|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042880|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042881|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
44042882|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042883|NCT00002869|Interferons|interferons|mesh-list
44042884|NCT00002869|Cytarabine|cytarabine|mesh-list
44042885|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
44042886|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
44042887|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042888|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
44042889|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042890|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042891|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
44042892|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042893|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042894|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
44042895|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042896|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
44042897|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042898|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44042899|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
44042900|NCT00002870|Thiotepa|thiotepa|mesh-list
44042901|NCT00002870|Fluorouracil|fluorouracil|mesh-list
44042902|NCT00002870|Epirubicin|epirubicin|mesh-list
44042903|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042904|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
44042905|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042906|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460730|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
44460731|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460732|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042907|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042908|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
44042909|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042910|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042911|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042912|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
44042913|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042914|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042915|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042916|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042917|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042918|NCT00002872|Doxycycline|doxycycline|mesh-list
44042919|NCT00002872|Bleomycin|bleomycin|mesh-list
44042920|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44042921|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042922|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
44042923|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44042924|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44042937|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042938|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042939|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042940|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042941|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042942|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042943|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042945|NCT00002876|Etoposide|etoposide|mesh-list
44042946|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042947|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042948|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042949|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076895|NCT00014144|Gefitinib|gefitinib|mesh-list
44042950|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042951|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042953|NCT00002878|Doxorubicin|doxorubicin|mesh-list
44042954|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042955|NCT00002878|Vincristine|vincristine|mesh-list
44042956|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042957|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
44042958|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
44042959|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44042960|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042961|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44042962|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
44042963|NCT00002878|Hormones|hormones|mesh-ancestor
44042964|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042965|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042966|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042967|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042968|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042969|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042970|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042971|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042972|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042973|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042974|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042975|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042976|NCT00002879|Cladribine|cladribine|mesh-list
44042977|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042978|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042979|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
44042980|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042981|NCT00002880|Etoposide|etoposide|mesh-list
44042982|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
44042983|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042984|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042985|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042986|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042987|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701509|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460733|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
44460734|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44460735|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460736|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460737|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44460738|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460739|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460740|NCT01559129|Pomalidomide|pomalidomide|mesh-list
44460741|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
44460742|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905139|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
44251578|NCT04919096|Aflibercept|aflibercept|mesh-list
44251579|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44251580|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44251581|NCT04919096|Growth Substances|growth substances|mesh-ancestor
44042988|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042991|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44042992|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44042993|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44042994|NCT00002881|Leuprolide|leuprolide|mesh-list
44042995|NCT00002881|Goserelin|goserelin|mesh-list
44042996|NCT00002881|Flutamide|flutamide|mesh-list
44042997|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44042998|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44042999|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
44043000|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043001|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043002|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043003|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043004|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
44043005|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
44043006|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043007|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
44043008|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
44043009|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44043010|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043011|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44043012|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44043013|NCT00002882|Interferons|interferons|mesh-list
44043014|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
44043015|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
44043016|NCT00002882|Aldesleukin|aldesleukin|mesh-list
44043017|NCT00002882|Cisplatin|cisplatin|mesh-list
44043018|NCT00002882|Interleukin-2|interleukin-2|mesh-list
44043019|NCT00002882|Dacarbazine|dacarbazine|mesh-list
44043020|NCT00002882|Vinblastine|vinblastine|mesh-list
44043021|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043022|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
44043023|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043024|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
44043025|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043026|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44043028|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
44043029|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44043030|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44043031|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44043032|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043033|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
44043034|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043035|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043036|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251582|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251583|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
44251584|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251585|NCT04909697|Sivelestat|sivelestat|mesh-list
44251586|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44251587|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251588|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251589|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251590|NCT04907279|Aripiprazole|aripiprazole|mesh-list
44251591|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
44251592|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44251593|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44251594|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44251595|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251596|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251597|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
44251598|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
44251599|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251600|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043037|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043038|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043039|NCT00002883|Cisplatin|cisplatin|mesh-list
44043040|NCT00002883|Fluorouracil|fluorouracil|mesh-list
44043041|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043042|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
44043043|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043044|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043045|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043046|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
44043047|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043048|NCT00002884|Cisplatin|cisplatin|mesh-list
44043049|NCT00002884|Fluorouracil|fluorouracil|mesh-list
44043050|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043051|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
44043052|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043053|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043054|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043055|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
44043056|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043057|NCT00002887|Cisplatin|cisplatin|mesh-list
44043058|NCT00002887|Etoposide|etoposide|mesh-list
44043059|NCT00002887|Vinorelbine|vinorelbine|mesh-list
44043060|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
44043061|NCT00002887|Vinblastine|vinblastine|mesh-list
44043062|NCT00002887|Vindesine|vindesine|mesh-list
44043063|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043064|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043065|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043066|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043079|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043080|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043081|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043082|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043083|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
44043084|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043085|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251601|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44251602|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44251603|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
44251604|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43610145|NCT03182413|Modafinil|modafinil|mesh-list
44043086|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
44043087|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043088|NCT00002889|Leuprolide|leuprolide|mesh-list
44043089|NCT00002889|Goserelin|goserelin|mesh-list
44043090|NCT00002889|Flutamide|flutamide|mesh-list
44043091|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44043092|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
44043093|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043094|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043095|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043096|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043097|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
44043098|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
44043099|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043100|NCT00002890|Lintuzumab|lintuzumab|mesh-list
44043101|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44043102|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043103|NCT00002892|Interferons|interferons|mesh-list
44043104|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
44043105|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043106|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
44043107|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043108|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
44043109|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043110|NCT00002893|Leucovorin|leucovorin|mesh-list
44043111|NCT00002893|Fluorouracil|fluorouracil|mesh-list
44043112|NCT00002893|Raltitrexed|raltitrexed|mesh-list
44043113|NCT00002893|Calcium|calcium|mesh-list
44043114|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
44043115|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44043116|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043117|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
44043118|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043119|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043120|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043121|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043122|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
44043123|NCT00002893|Antidotes|antidotes|mesh-ancestor
44043124|NCT00002893|Protective Agents|protective agents|mesh-ancestor
44043125|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
44043126|NCT00002893|Vitamins|vitamins|mesh-ancestor
44043127|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
44043128|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043129|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043130|NCT00002894|Paclitaxel|paclitaxel|mesh-list
44043131|NCT00002894|Cisplatin|cisplatin|mesh-list
44043132|NCT00002894|Carboplatin|carboplatin|mesh-list
44043139|NCT00002896|Leucovorin|leucovorin|mesh-list
44043141|NCT00002896|Fluorouracil|fluorouracil|mesh-list
44043142|NCT00002896|Calcium|calcium|mesh-list
44043143|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
44043144|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44043145|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043146|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
44043147|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043148|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043149|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043150|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043151|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
44043152|NCT00002896|Antidotes|antidotes|mesh-ancestor
44043153|NCT00002896|Protective Agents|protective agents|mesh-ancestor
44043154|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
44043155|NCT00002896|Vitamins|vitamins|mesh-ancestor
44043156|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
44043157|NCT00002896|Trace Elements|trace elements|mesh-ancestor
44043158|NCT00002897|Cisplatin|cisplatin|mesh-list
44043159|NCT00002897|Fluorouracil|fluorouracil|mesh-list
44043160|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043161|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
44251605|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44251606|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44251607|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44251608|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
44251609|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251610|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251611|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251612|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251613|NCT04876937|Analgesics|analgesics|mesh-ancestor
44251614|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
44251615|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251616|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44251617|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44251618|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251619|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251620|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251621|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251622|NCT04861181|Niraparib|niraparib|mesh-list
44251623|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44251624|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043162|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043163|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043164|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043165|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
44043166|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043167|NCT00002898|Dactinomycin|dactinomycin|mesh-list
44043168|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
44043169|NCT00002898|Ifosfamide|ifosfamide|mesh-list
44043170|NCT00002898|Carboplatin|carboplatin|mesh-list
44043171|NCT00002898|Etoposide|etoposide|mesh-list
44043172|NCT00002898|Vincristine|vincristine|mesh-list
44043173|NCT00002898|Epirubicin|epirubicin|mesh-list
44043174|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043175|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
44043176|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043177|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043178|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043179|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
44043180|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043181|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043182|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043183|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043184|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043185|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043186|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043187|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043188|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043189|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043190|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043191|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44043192|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043193|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44043194|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44251625|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251626|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251628|NCT04848597|Antibodies|antibodies|mesh-list
44251629|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44251630|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251631|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251632|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251633|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251634|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251635|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251636|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251637|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
44251638|NCT04769050|Docetaxel|docetaxel|mesh-list
44251639|NCT04769050|Capecitabine|capecitabine|mesh-list
44251640|NCT04769050|Trastuzumab|trastuzumab|mesh-list
44251641|NCT04769050|Pertuzumab|pertuzumab|mesh-list
44043195|NCT00002901|Docetaxel|docetaxel|mesh-list
44043196|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043197|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043198|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043199|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043200|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043201|NCT00002902|Irinotecan|irinotecan|mesh-list
44043202|NCT00002902|Raltitrexed|raltitrexed|mesh-list
44043203|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043209|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
44043210|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043211|NCT00002903|Docetaxel|docetaxel|mesh-list
44043212|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043213|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043214|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043215|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043216|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043217|NCT00002904|Trabectedin|trabectedin|mesh-list
44043218|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043219|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
44043220|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043221|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043222|NCT00002905|Zidovudine|zidovudine|mesh-list
44043223|NCT00002905|Didanosine|didanosine|mesh-list
44043224|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
44043225|NCT00002905|Prednimustine|prednimustine|mesh-list
44043226|NCT00002905|Doxorubicin|doxorubicin|mesh-list
44043227|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043228|NCT00002905|Etoposide|etoposide|mesh-list
44043229|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
44043230|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043231|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
44043232|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043233|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043234|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043235|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
44043236|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043237|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043238|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043239|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043240|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043241|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44251642|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251643|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251644|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251645|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251646|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251647|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043242|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043243|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043244|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
44043245|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44043246|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043247|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
44043248|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043249|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44043250|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44043251|NCT00002905|Analgesics|analgesics|mesh-ancestor
44043252|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
44043253|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44043254|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
44043255|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44043256|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
44043257|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043258|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043260|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
44043261|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043262|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043263|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043264|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043265|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043266|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043267|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44043268|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
44043269|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043270|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44043271|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043272|NCT00002911|Marimastat|marimastat|mesh-list
44043273|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539941|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
44043282|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043283|NCT00002912|Analgesics|analgesics|mesh-ancestor
44043284|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
44043285|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44043286|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043287|NCT00002913|Paclitaxel|paclitaxel|mesh-list
44043288|NCT00002913|Cisplatin|cisplatin|mesh-list
44043289|NCT00002913|Topotecan|topotecan|mesh-list
44043290|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043291|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043292|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043293|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043294|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043295|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043296|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043297|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043298|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043299|NCT00002914|Piritrexim|piritrexim|mesh-list
44043300|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043301|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043302|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043303|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043304|NCT00002915|Penclomedine|penclomedine|mesh-list
44043305|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043306|NCT00002917|Paclitaxel|paclitaxel|mesh-list
44043307|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043308|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043309|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043310|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043311|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043312|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251648|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
44251649|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251650|NCT04763135|Mirtazapine|mirtazapine|mesh-list
44251651|NCT04763135|Citalopram|citalopram|mesh-list
44251652|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44251653|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44251654|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251655|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251656|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44043313|NCT00002919|Cisplatin|cisplatin|mesh-list
44043314|NCT00002919|Doxorubicin|doxorubicin|mesh-list
44043315|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043316|NCT00002919|Methotrexate|methotrexate|mesh-list
44043317|NCT00002919|Vinblastine|vinblastine|mesh-list
44043318|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043319|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043320|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043321|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043322|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043323|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043324|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44043325|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
44043326|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043327|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043328|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043329|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
44043330|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
44043331|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043332|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043333|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
44043334|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043335|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043336|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043337|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043338|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043339|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
43540009|NCT00725374|Tibolone|tibolone|mesh-list
44149543|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149544|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149545|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149547|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149548|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149549|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149550|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149551|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
44149552|NCT00208221|Telmisartan|telmisartan|mesh-list
44149553|NCT00208221|Ramipril|ramipril|mesh-list
44149554|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44149555|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44149556|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44149557|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149558|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44149559|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
44149560|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149561|NCT00208234|Omalizumab|omalizumab|mesh-list
44149562|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44149563|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44149564|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44149565|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44149566|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
44149567|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149568|NCT00208260|Leucovorin|leucovorin|mesh-list
44149569|NCT00208260|Fluorouracil|fluorouracil|mesh-list
44149570|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
44149571|NCT00208260|Folfirinox|folfirinox|mesh-list
44149572|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
44251658|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251659|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44251660|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
44251661|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649864|NCT03018236|Ethanol|ethanol|mesh-list
44149573|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149574|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149575|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149576|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149577|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
44149578|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149579|NCT00208260|Antidotes|antidotes|mesh-ancestor
44149580|NCT00208260|Protective Agents|protective agents|mesh-ancestor
44149581|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
44149582|NCT00208260|Vitamins|vitamins|mesh-ancestor
44149583|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
44149584|NCT00208273|Letrozole|letrozole|mesh-list
44149585|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149586|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44149587|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44149588|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149589|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149590|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44149591|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149592|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149593|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149594|NCT00208299|Adenosine|adenosine|mesh-list
44149595|NCT00208299|Regadenoson|regadenoson|mesh-list
44043340|NCT00002920|Tamoxifen|tamoxifen|mesh-list
44043341|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44043342|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
44043343|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44043344|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
44043345|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043346|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043347|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043348|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043349|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44043350|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44043351|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44043352|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44043353|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44043354|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44043355|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
44043356|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043357|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44043358|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44043359|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44043360|NCT00002921|Suramin|suramin|mesh-list
44043361|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
44043362|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44043363|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44043364|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44043365|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44043366|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
44043367|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
44043368|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44043369|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043370|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043371|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44043372|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44043373|NCT00002922|Paclitaxel|paclitaxel|mesh-list
44043374|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043375|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043376|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043377|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043378|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
43701510|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251662|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44251663|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
44251664|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
44251665|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44251666|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44251667|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251668|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44251669|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44251670|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44251671|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
44251672|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44251673|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43649869|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043379|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043380|NCT00002923|KRN 5500|krn 5500|mesh-list
44043381|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043382|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44043383|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063449|NCT00006048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043384|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043385|NCT00002925|Aldesleukin|aldesleukin|mesh-list
44043386|NCT00002925|Etoposide|etoposide|mesh-list
44043387|NCT00002925|Daunorubicin|daunorubicin|mesh-list
44043388|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043389|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043390|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043391|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043392|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043393|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043394|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043395|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44043396|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44043397|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
44043398|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043399|NCT00002926|Cytarabine|cytarabine|mesh-list
44043400|NCT00002926|Etoposide|etoposide|mesh-list
44043401|NCT00002926|Idarubicin|idarubicin|mesh-list
44043402|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043410|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
44043411|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043412|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043413|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
44043414|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043415|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043416|NCT00002928|Paclitaxel|paclitaxel|mesh-list
44043417|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043418|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043419|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043420|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043421|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043422|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043423|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44043424|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44043425|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043426|NCT00002932|Cisplatin|cisplatin|mesh-list
44043427|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043428|NCT00002933|Irinotecan|irinotecan|mesh-list
44043429|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043430|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043431|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043432|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043433|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251674|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44251676|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44251677|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251678|NCT04745975|Gemcitabine|gemcitabine|mesh-list
44251679|NCT04745975|Paclitaxel|paclitaxel|mesh-list
44251680|NCT04745975|Vinorelbine|vinorelbine|mesh-list
44251681|NCT04745975|Capecitabine|capecitabine|mesh-list
44251682|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251683|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251684|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043434|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44043435|NCT00002935|Trioxsalen|trioxsalen|mesh-list
44043436|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043437|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44043438|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44043439|NCT00002936|Etoposide|etoposide|mesh-list
44043440|NCT00002936|Altretamine|altretamine|mesh-list
44043441|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043442|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043443|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043444|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043445|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043446|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043447|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043448|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
44043449|NCT00002937|Paclitaxel|paclitaxel|mesh-list
44043450|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043451|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043452|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043453|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043454|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043455|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043456|NCT00002939|Paclitaxel|paclitaxel|mesh-list
44043457|NCT00002939|Irinotecan|irinotecan|mesh-list
44043458|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043459|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043460|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043461|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043462|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043463|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043464|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043465|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043466|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043467|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
44043468|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043469|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
44043471|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043472|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043474|NCT00002941|Carmustine|carmustine|mesh-list
44043475|NCT00002941|Etoposide|etoposide|mesh-list
44043476|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043477|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
44043478|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043479|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043480|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043481|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
44043482|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043483|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043484|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043485|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043486|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043487|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043488|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251685|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251686|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251687|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251688|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251689|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
44251690|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
44043489|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
44043490|NCT00002943|Carboplatin|carboplatin|mesh-list
44043492|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043493|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
44043494|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043495|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043496|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043497|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
44043498|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043499|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043500|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043501|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043502|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043503|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043504|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043505|NCT00002944|Carboplatin|carboplatin|mesh-list
44043506|NCT00002944|Vincristine|vincristine|mesh-list
44043507|NCT00002944|Thioguanine|thioguanine|mesh-list
44043508|NCT00002944|Lomustine|lomustine|mesh-list
44043509|NCT00002944|Procarbazine|procarbazine|mesh-list
44043510|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043511|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043512|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043513|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043514|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043515|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043516|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043517|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
44043518|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043519|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
44043520|NCT00002945|Cytarabine|cytarabine|mesh-list
44043521|NCT00002945|Aldesleukin|aldesleukin|mesh-list
44043522|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
44043523|NCT00002945|Melphalan|melphalan|mesh-list
44043524|NCT00002945|Etoposide|etoposide|mesh-list
44043525|NCT00002945|Idarubicin|idarubicin|mesh-list
44043526|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043527|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
44043528|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043529|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043530|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043531|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
44043532|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043533|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043534|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043535|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043536|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043537|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043538|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043539|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043540|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
44043541|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
44043542|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043543|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44043544|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44043552|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043554|NCT00002949|Paclitaxel|paclitaxel|mesh-list
44043555|NCT00002949|Vinorelbine|vinorelbine|mesh-list
44043556|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043557|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043558|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043559|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043560|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043561|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251691|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44251693|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251694|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
44251695|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251696|NCT04745728|Prednisone|prednisone|mesh-list
44251697|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
44251698|NCT04745728|Rituximab|rituximab|mesh-list
44251699|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251700|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
44251701|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251702|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251703|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44251704|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
44251705|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251706|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043562|NCT00002950|Topotecan|topotecan|mesh-list
44043563|NCT00002950|Sargramostim|sargramostim|mesh-list
44043564|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043565|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043566|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043567|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043568|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043569|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
44043570|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043571|NCT00002951|Fluorouracil|fluorouracil|mesh-list
44043572|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
44043573|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
44043574|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043575|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043576|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043577|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043578|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
44043579|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043580|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
44043581|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043582|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043583|NCT00002952|Interleukin-12|interleukin-12|mesh-list
44043584|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44077666|NCT00015938|Docetaxel|docetaxel|mesh-list
44043585|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
44043586|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043587|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44043588|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44043589|NCT00002952|Growth Substances|growth substances|mesh-ancestor
44043590|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
44043591|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043592|NCT00002953|Paclitaxel|paclitaxel|mesh-list
44043593|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
44043594|NCT00002953|Epirubicin|epirubicin|mesh-list
44043595|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043596|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043597|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043598|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043599|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043600|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043601|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043602|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
44043603|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043604|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251707|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44251708|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251709|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251710|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
44251712|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251713|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043605|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043606|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
44043607|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043608|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043609|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043610|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043611|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043612|NCT00002955|Leucovorin|leucovorin|mesh-list
44043618|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043620|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043621|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043622|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043623|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043624|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
44043625|NCT00002955|Antidotes|antidotes|mesh-ancestor
44043626|NCT00002955|Protective Agents|protective agents|mesh-ancestor
44043627|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
44043628|NCT00002955|Vitamins|vitamins|mesh-ancestor
44043629|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
44043630|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
44043631|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043632|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043633|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043634|NCT00002961|Cyclosporine|cyclosporine|mesh-list
44043635|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
44043636|NCT00002961|Busulfan|busulfan|mesh-list
44043637|NCT00002961|Methotrexate|methotrexate|mesh-list
44043638|NCT00002961|Etoposide|etoposide|mesh-list
44043639|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
44043640|NCT00002961|Cyclosporins|cyclosporins|mesh-list
44043641|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043642|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
44043643|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043644|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043645|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043646|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
44043647|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043648|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043649|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043650|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44043651|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
44043652|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043653|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043654|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
44043655|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44043656|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043657|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043658|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043659|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043660|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043661|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043662|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
44043663|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043664|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44043665|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44043666|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44043667|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
44043668|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44043669|NCT00002964|Trioxsalen|trioxsalen|mesh-list
44043670|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043671|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
44251714|NCT04692467|Amlodipine|amlodipine|mesh-list
44251715|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44251716|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44251717|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44043672|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44043673|NCT00002965|Interferons|interferons|mesh-list
44043674|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
44043675|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
44043676|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44043677|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043678|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
44043679|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043680|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
44043681|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043682|NCT00002967|Tamoxifen|tamoxifen|mesh-list
44043683|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
44043684|NCT00002967|Doxorubicin|doxorubicin|mesh-list
44043685|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043686|NCT00002967|Octreotide|octreotide|mesh-list
44043691|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043692|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
44043693|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043694|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043695|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043696|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043697|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043698|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043699|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043700|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44043701|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
44043702|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043703|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043704|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44043705|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44043706|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44043707|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44043709|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44043710|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
44043711|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043712|NCT00002969|Paclitaxel|paclitaxel|mesh-list
44043713|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043714|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043715|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043716|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043717|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043718|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043719|NCT00002970|Cytarabine|cytarabine|mesh-list
44043720|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
44043721|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44043722|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44043723|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44043724|NCT00002970|Methotrexate|methotrexate|mesh-list
44043725|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44043726|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
44043727|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44043728|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043729|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043730|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
44043731|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043732|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043733|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44043734|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043735|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44043736|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043737|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
44043738|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043739|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043740|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
44043741|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043742|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44043743|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44251718|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043744|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043745|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043746|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043748|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043749|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043750|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043751|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043752|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043753|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043754|NCT00002973|Melphalan|melphalan|mesh-list
43540468|NCT05224336|Niacin|niacin|mesh-list
44043763|NCT00002974|Carboplatin|carboplatin|mesh-list
44043764|NCT00002974|Etoposide|etoposide|mesh-list
44043765|NCT00002974|Ifosfamide|ifosfamide|mesh-list
44043766|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043767|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043768|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043769|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043770|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043771|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043772|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043773|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
44043774|NCT00002976|Estrogens|estrogens|mesh-list
44043775|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44043776|NCT00002976|Hormones|hormones|mesh-ancestor
44043777|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043778|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043779|NCT00002977|Melphalan|melphalan|mesh-list
44043780|NCT00002977|Thiotepa|thiotepa|mesh-list
44043781|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
44043782|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043783|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043784|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
44043785|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043786|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043787|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043788|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043789|NCT00002980|Decitabine|decitabine|mesh-list
44043790|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043791|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
44043792|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771083|NCT02374736|Antibodies|antibodies|mesh-list
44043793|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043794|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043795|NCT00002982|Cytarabine|cytarabine|mesh-list
44043796|NCT00002982|Carboplatin|carboplatin|mesh-list
44043797|NCT00002982|Etoposide|etoposide|mesh-list
44043798|NCT00002982|Melphalan|melphalan|mesh-list
44043799|NCT00002982|Ifosfamide|ifosfamide|mesh-list
44043800|NCT00002982|Carmustine|carmustine|mesh-list
44043801|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043802|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043803|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043804|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043805|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043806|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043807|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043808|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
44043809|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
44043810|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043811|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043812|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
44043813|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043814|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043815|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
44043816|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043817|NCT00002984|Paclitaxel|paclitaxel|mesh-list
44043818|NCT00002984|Cisplatin|cisplatin|mesh-list
44043819|NCT00002984|Fluorouracil|fluorouracil|mesh-list
44043820|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043828|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043830|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043831|NCT00002985|Doxorubicin|doxorubicin|mesh-list
44251719|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44251720|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251721|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
44251723|NCT04690322|BAX 855|bax 855|mesh-list
44251724|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44251725|NCT04690322|Coagulants|coagulants|mesh-ancestor
43905287|NCT00205374|Cidofovir|cidofovir|mesh-list
44251726|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
44251727|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251728|NCT04661930|Fenofibrate|fenofibrate|mesh-list
44251729|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44251730|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
44251731|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251732|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44251733|NCT04657003|Tirzepatide|tirzepatide|mesh-list
44251734|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44251735|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251736|NCT04657003|Incretins|incretins|mesh-ancestor
44251737|NCT04657003|Hormones|hormones|mesh-ancestor
44251738|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251739|NCT04647435|Tramadol|tramadol|mesh-list
44251740|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251741|NCT04647435|Narcotics|narcotics|mesh-ancestor
44251742|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251743|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251744|NCT04647435|Analgesics|analgesics|mesh-ancestor
44251745|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
44251746|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251747|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
44251748|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251749|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251750|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251751|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251752|NCT04642651|Analgesics|analgesics|mesh-ancestor
44043832|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043833|NCT00002985|Daunorubicin|daunorubicin|mesh-list
44043834|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043835|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043836|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043837|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44251753|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
44251754|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251755|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44251756|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44251757|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44251758|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44043838|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043839|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043840|NCT00002986|Topotecan|topotecan|mesh-list
44043841|NCT00002986|Carmustine|carmustine|mesh-list
44043842|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043843|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043844|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043845|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043846|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043847|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043848|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
44043849|NCT00002987|Prednisolone|prednisolone|mesh-list
44043850|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
44043851|NCT00002987|Doxorubicin|doxorubicin|mesh-list
44043852|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043853|NCT00002987|Etoposide|etoposide|mesh-list
44043854|NCT00002987|Vincristine|vincristine|mesh-list
44043855|NCT00002987|Bleomycin|bleomycin|mesh-list
44043856|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043857|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
44043858|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043859|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043860|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043861|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
44043862|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043863|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043864|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043865|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043866|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043867|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043868|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043869|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043871|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043872|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043873|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44043874|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
44043875|NCT00002987|Hormones|hormones|mesh-ancestor
44043876|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44043877|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44043878|NCT00002988|Irinotecan|irinotecan|mesh-list
44043879|NCT00002988|Carmustine|carmustine|mesh-list
44043880|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043881|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043882|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043883|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043884|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043885|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043886|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
44043887|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
44043888|NCT00002989|Melphalan|melphalan|mesh-list
44043889|NCT00002989|Busulfan|busulfan|mesh-list
44043894|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043895|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043896|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
44043897|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043898|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043899|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043900|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043901|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043902|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043903|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043905|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44251759|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251760|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251761|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
44251762|NCT04637594|Nivolumab|nivolumab|mesh-list
44251763|NCT04637594|Durvalumab|durvalumab|mesh-list
44043906|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
44043907|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043908|NCT00002993|Cisplatin|cisplatin|mesh-list
44043909|NCT00002993|Doxorubicin|doxorubicin|mesh-list
44043910|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44043911|NCT00002993|Mitomycins|mitomycins|mesh-list
44043912|NCT00002993|Mitomycin|mitomycin|mesh-list
44043913|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043914|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043915|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043916|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043917|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043918|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043919|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
44043920|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043921|NCT00002994|Interleukin-2|interleukin-2|mesh-list
44043922|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043923|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44043924|NCT00002994|Analgesics|analgesics|mesh-ancestor
44043925|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
44043926|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44043927|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043928|NCT00002995|Dactinomycin|dactinomycin|mesh-list
44043929|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
44043930|NCT00002995|Vincristine|vincristine|mesh-list
44043931|NCT00002995|Sargramostim|sargramostim|mesh-list
44043932|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043933|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
44043934|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043935|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043936|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043937|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
44043938|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043939|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043940|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043941|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043942|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043943|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043944|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043945|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44043946|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043947|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043948|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44043949|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043950|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043951|NCT00002996|Flecainide|flecainide|mesh-list
44043952|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44043953|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44043954|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44043955|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44043956|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043957|NCT00002998|Gemcitabine|gemcitabine|mesh-list
44043958|NCT00002998|Cisplatin|cisplatin|mesh-list
44043959|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043960|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043969|NCT00002999|Cisplatin|cisplatin|mesh-list
44043970|NCT00002999|Fluorouracil|fluorouracil|mesh-list
44043971|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043972|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
44043973|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043974|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043975|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043976|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
44043977|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043978|NCT00003000|Fentanyl|fentanyl|mesh-list
44043979|NCT00003000|Morphine|morphine|mesh-list
44043980|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251765|NCT04637594|Atezolizumab|atezolizumab|mesh-list
44251766|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251767|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251768|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44251769|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251770|NCT04637529|Ibuprofen|ibuprofen|mesh-list
44251771|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44251772|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44078128|NCT00016432|Exemestane|exemestane|mesh-list
44251773|NCT04637529|Analgesics|analgesics|mesh-ancestor
44251774|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
44251775|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251776|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251777|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251778|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043981|NCT00003000|Narcotics|narcotics|mesh-ancestor
44043982|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44043983|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043984|NCT00003000|Analgesics|analgesics|mesh-ancestor
44043985|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
44043986|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44043987|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44043988|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44043989|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
44043990|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
44043991|NCT00003001|Leucovorin|leucovorin|mesh-list
44043992|NCT00003001|Gemcitabine|gemcitabine|mesh-list
44043993|NCT00003001|Fluorouracil|fluorouracil|mesh-list
44043994|NCT00003001|Calcium|calcium|mesh-list
44043995|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
44043996|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043997|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
44043998|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043999|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044000|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
44044001|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044002|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044003|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044004|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
44044005|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044006|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44044007|NCT00003001|Antidotes|antidotes|mesh-ancestor
44044008|NCT00003001|Protective Agents|protective agents|mesh-ancestor
44044009|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
44044010|NCT00003001|Vitamins|vitamins|mesh-ancestor
44044011|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
44044012|NCT00003002|Sargramostim|sargramostim|mesh-list
44044013|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
44044014|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044015|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
44044016|NCT00003003|Mitomycins|mitomycins|mesh-list
44044017|NCT00003003|Mitomycin|mitomycin|mesh-list
44044018|NCT00003003|Sargramostim|sargramostim|mesh-list
44044019|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
44044020|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044021|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044022|NCT00003003|Analgesics|analgesics|mesh-ancestor
44044023|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
44044024|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044025|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044026|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044027|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251779|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44251780|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251781|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251782|NCT04635605|Methylene Blue|methylene blue|mesh-list
44251783|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251784|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251785|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
44251786|NCT04629534|Vitamin D|vitamin d|mesh-list
44251787|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44251788|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251789|NCT04629534|Vitamins|vitamins|mesh-ancestor
44251790|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
44251791|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44251792|NCT04627142|Irinotecan|irinotecan|mesh-list
44251793|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44044028|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044029|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044030|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
44044039|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044040|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044041|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
44044042|NCT00003004|Growth Substances|growth substances|mesh-ancestor
44044043|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078152|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
44044044|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44044045|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044046|NCT00003005|Cordycepin|cordycepin|mesh-list
44044047|NCT00003005|Pentostatin|pentostatin|mesh-list
44044048|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044049|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44044050|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044051|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044052|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
44044053|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044054|NCT00003007|Interferons|interferons|mesh-list
44044055|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
44044056|NCT00003007|Dexamethasone|dexamethasone|mesh-list
44044057|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
44044058|NCT00003007|Melphalan|melphalan|mesh-list
44044059|NCT00003007|Sargramostim|sargramostim|mesh-list
44044060|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044061|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
44044062|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044063|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044064|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044065|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
44044066|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044067|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044068|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044069|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44044070|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
44044071|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
44044072|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044073|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44044074|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
44044075|NCT00003007|Hormones|hormones|mesh-ancestor
44044076|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044077|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044078|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
44044079|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044080|NCT00003008|Ritonavir|ritonavir|mesh-list
44251794|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44251795|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251796|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251797|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251799|NCT04622904|Ketamine|ketamine|mesh-list
44251800|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251801|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
44251802|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251803|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251804|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
43649908|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
44044081|NCT00003008|Nelfinavir|nelfinavir|mesh-list
44044082|NCT00003008|Indinavir|indinavir|mesh-list
44044084|NCT00003008|Paclitaxel|paclitaxel|mesh-list
44044085|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044086|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044087|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044088|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044089|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044090|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044091|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44044092|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44044093|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
44044094|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044095|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044096|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044097|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
44044098|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044099|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44044100|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44044106|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044108|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044109|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044110|NCT00003011|Marimastat|marimastat|mesh-list
44044111|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044112|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044113|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
44044114|NCT00003012|Fluorouracil|fluorouracil|mesh-list
44044115|NCT00003012|Methotrexate|methotrexate|mesh-list
44044116|NCT00003012|Epirubicin|epirubicin|mesh-list
44044117|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044118|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
44044119|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044120|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044121|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044122|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
44044123|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044124|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044125|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044126|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
44044127|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044128|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044129|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044130|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044131|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044132|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044133|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044134|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044135|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044136|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044137|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044138|NCT00003013|Tamoxifen|tamoxifen|mesh-list
44251805|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251806|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44251807|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44251808|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44251809|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251810|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251811|NCT04622904|Analgesics|analgesics|mesh-ancestor
44251812|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44044139|NCT00003013|Paclitaxel|paclitaxel|mesh-list
44044140|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
44044141|NCT00003013|Doxorubicin|doxorubicin|mesh-list
44044142|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044143|NCT00003013|Fluorouracil|fluorouracil|mesh-list
44044144|NCT00003013|Methotrexate|methotrexate|mesh-list
44044145|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044146|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044147|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044148|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044149|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044150|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044151|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044152|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
44044153|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044154|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044155|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044156|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
44044157|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044158|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044159|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044160|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044161|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044162|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
44044163|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044164|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044165|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044166|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044167|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044168|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044169|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044170|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044171|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044185|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044186|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044188|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044189|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044190|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044191|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044192|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044193|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044194|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044195|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044196|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044197|NCT00003017|Interleukin-12|interleukin-12|mesh-list
44044198|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044199|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
44044200|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044201|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44044202|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44044203|NCT00003017|Growth Substances|growth substances|mesh-ancestor
44044204|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
44044205|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044206|NCT00003018|Leucovorin|leucovorin|mesh-list
44044207|NCT00003018|Fluorouracil|fluorouracil|mesh-list
44044208|NCT00003018|Mitomycins|mitomycins|mesh-list
44044209|NCT00003018|Mitomycin|mitomycin|mesh-list
44251813|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251814|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
44251815|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44251816|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44251817|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251818|NCT04605861|Liraglutide|liraglutide|mesh-list
44251819|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44251820|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251821|NCT04605861|Incretins|incretins|mesh-ancestor
44251822|NCT04605861|Hormones|hormones|mesh-ancestor
44251823|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460743|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44460744|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44460745|NCT01559129|Growth Substances|growth substances|mesh-ancestor
44460746|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
44460747|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460748|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
44460749|NCT01559116|Olodaterol|olodaterol|mesh-list
44460750|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44460751|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
44460752|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460753|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460754|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44460755|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44460756|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
44460757|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460758|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460759|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460760|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460761|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44460762|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
44460763|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460764|NCT01559012|Clonidine|clonidine|mesh-list
44460765|NCT01559012|Analgesics|analgesics|mesh-ancestor
44460766|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
44460767|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460769|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44460770|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
44460771|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
44460772|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44460773|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44460774|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43649958|NCT03017222|Ondansetron|ondansetron|mesh-list
44044210|NCT00003018|Dipyridamole|dipyridamole|mesh-list
44044211|NCT00003018|Calcium|calcium|mesh-list
44044212|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
44044213|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44044214|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044215|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
44044216|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044217|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044218|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044219|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044220|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
44044221|NCT00003018|Antidotes|antidotes|mesh-ancestor
44044222|NCT00003018|Protective Agents|protective agents|mesh-ancestor
44044223|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
44044224|NCT00003018|Vitamins|vitamins|mesh-ancestor
44044225|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
44044226|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044227|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
44044228|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044229|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044230|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44044231|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44044232|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
44044236|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044237|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044238|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044239|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044240|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
44044241|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044242|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044243|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044244|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044245|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044246|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044247|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
44044248|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044249|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044250|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044251|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044252|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044253|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044254|NCT00003020|Immunotoxins|immunotoxins|mesh-list
44044255|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
44044256|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044257|NCT00003021|Bizelesin|bizelesin|mesh-list
44044258|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044259|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044260|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044261|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
44044262|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044263|NCT00003022|Antibodies|antibodies|mesh-list
44044264|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44044265|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
44044266|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044267|NCT00003023|Vaccines|vaccines|mesh-list
44044268|NCT00003023|Antibodies|antibodies|mesh-list
44044269|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44044270|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
44044271|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
44044272|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044273|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044274|NCT00003026|Bicalutamide|bicalutamide|mesh-list
44044275|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44460775|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
44460776|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460777|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460778|NCT01558674|Torsemide|torsemide|mesh-list
44460779|NCT01558674|Furosemide|furosemide|mesh-list
44460780|NCT01558674|Diuretics|diuretics|mesh-ancestor
44460781|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
44460782|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460783|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44044276|NCT00003026|Flutamide|flutamide|mesh-list
44044277|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
44044278|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044279|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044280|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044281|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044282|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
44044283|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44044284|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
44044285|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044286|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44044287|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044288|NCT00003027|Interferons|interferons|mesh-list
44044289|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
44044290|NCT00003027|Aldesleukin|aldesleukin|mesh-list
44044291|NCT00003027|Cisplatin|cisplatin|mesh-list
44044292|NCT00003027|Dacarbazine|dacarbazine|mesh-list
44044293|NCT00003027|Vinblastine|vinblastine|mesh-list
44044294|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044295|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
44044296|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044297|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
44044298|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044299|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044300|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044301|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044302|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
44044303|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044304|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044305|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
43771463|NCT02373280|Metronidazole|metronidazole|mesh-list
44044316|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044317|NCT00003031|Voriconazole|voriconazole|mesh-list
44044318|NCT00003031|Amphotericin B|amphotericin b|mesh-list
44044319|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44044320|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44044321|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
44044322|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
44044323|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044324|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44044325|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44044326|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044327|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044328|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44044329|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044330|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044331|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044332|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44044333|NCT00003031|Amebicides|amebicides|mesh-ancestor
44044334|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44044335|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44044336|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44044337|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44044338|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44044339|NCT00003032|Tamoxifen|tamoxifen|mesh-list
44044340|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
44044341|NCT00003032|Cisplatin|cisplatin|mesh-list
44460784|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460785|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460786|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44460787|NCT01558271|Liraglutide|liraglutide|mesh-list
44460788|NCT01558271|Dulaglutide|dulaglutide|mesh-list
44460789|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460790|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460791|NCT01558271|Incretins|incretins|mesh-ancestor
44460792|NCT01558271|Hormones|hormones|mesh-ancestor
44460793|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460794|NCT01558089|Etanercept|etanercept|mesh-list
44251824|NCT04597333|Dinoprostone|dinoprostone|mesh-list
44251825|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
44251826|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44251827|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251828|NCT04553536|Sufentanil|sufentanil|mesh-list
44251829|NCT04553536|Remifentanil|remifentanil|mesh-list
44251830|NCT04553536|Dsuvia|dsuvia|mesh-list
44044342|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
44044343|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044344|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
44044345|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044346|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044347|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044348|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
44044349|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044350|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044351|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044352|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044353|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044354|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044355|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044356|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044357|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044358|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044359|NCT00003032|Analgesics|analgesics|mesh-ancestor
44044360|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
44044361|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044362|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044363|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044364|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044365|NCT00003034|Doxorubicin|doxorubicin|mesh-list
44044366|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044367|NCT00003034|Ranpirnase|ranpirnase|mesh-list
44044368|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43541102|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
44044376|NCT00003035|Paclitaxel|paclitaxel|mesh-list
44044377|NCT00003035|Doxorubicin|doxorubicin|mesh-list
44044378|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044379|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044380|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044381|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044382|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044384|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044385|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044386|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044387|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044388|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251831|NCT04553536|Bromides|bromides|mesh-list
44251832|NCT04553536|Propofol|propofol|mesh-list
44251833|NCT04553536|Esketamine|esketamine|mesh-list
44251834|NCT04553536|Rocuronium|rocuronium|mesh-list
44251835|NCT04553536|Cisatracurium|cisatracurium|mesh-list
44251836|NCT04553536|Atracurium|atracurium|mesh-list
44251837|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251838|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44044389|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044390|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044391|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044392|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044393|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044394|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044395|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044396|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044397|NCT00003037|Gemcitabine|gemcitabine|mesh-list
44044398|NCT00003037|Cisplatin|cisplatin|mesh-list
44044400|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044401|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044402|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
44044403|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044404|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
44044405|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044406|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044407|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044408|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
44044409|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044410|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044411|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044412|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044413|NCT00003038|Suramin|suramin|mesh-list
44044414|NCT00003038|Doxorubicin|doxorubicin|mesh-list
44044415|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044416|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044417|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044418|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044419|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044420|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044421|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044422|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
44044423|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
44044424|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44044425|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044426|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44044427|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44044428|NCT00003039|Alvocidib|alvocidib|mesh-list
44044429|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044430|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44044431|NCT00003039|Growth Substances|growth substances|mesh-ancestor
44044432|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044433|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44044434|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044435|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149602|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44149603|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
44149607|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44149609|NCT00208312|Regadenoson|regadenoson|mesh-list
44149610|NCT00208312|Analgesics|analgesics|mesh-ancestor
44149611|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
44149612|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149613|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149614|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44149615|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
44149616|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44149617|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
44149618|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
44149619|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149620|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251839|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251840|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44251841|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
44251842|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
44251843|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44251844|NCT04553536|Narcotics|narcotics|mesh-ancestor
44251845|NCT04553536|Analgesics|analgesics|mesh-ancestor
44251846|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
44251847|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251848|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
44251849|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44251850|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44251851|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44251852|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
44251853|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44251854|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44251855|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44251856|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
44251857|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251858|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251859|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44251860|NCT04551547|Vaccines|vaccines|mesh-list
44251861|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
44251862|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251863|NCT04549792|Ustekinumab|ustekinumab|mesh-list
44251864|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44251865|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
44251866|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44251867|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251868|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251869|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44251870|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44251871|NCT04533997|Furosemide|furosemide|mesh-list
44149621|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44149622|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44149624|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44149625|NCT00208403|Protective Agents|protective agents|mesh-ancestor
44149626|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149627|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
44149628|NCT00208442|Diuretics|diuretics|mesh-ancestor
44149629|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
44149630|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251872|NCT04533997|Diuretics|diuretics|mesh-ancestor
44251873|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
44251874|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251875|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44251876|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251877|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251878|NCT04533451|Carboplatin|carboplatin|mesh-list
44251879|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
44251881|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251882|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251883|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251884|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251885|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44251886|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44149631|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44149632|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149633|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149634|NCT00208520|Lamotrigine|lamotrigine|mesh-list
44149635|NCT00208520|Carbamazepine|carbamazepine|mesh-list
44149636|NCT00208520|Levetiracetam|levetiracetam|mesh-list
44149637|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
44149638|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
44149639|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44044436|NCT00003041|NSC 366140|nsc 366140|mesh-list
44044437|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044438|NCT00003044|Cisplatin|cisplatin|mesh-list
44044439|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044440|NCT00003046|Interleukin-12|interleukin-12|mesh-list
44044441|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044442|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
44044443|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044444|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44044445|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44044446|NCT00003046|Growth Substances|growth substances|mesh-ancestor
44044447|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
44044448|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044449|NCT00003048|Amifostine|amifostine|mesh-list
44044450|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44044451|NCT00003048|Protective Agents|protective agents|mesh-ancestor
44044452|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044453|NCT00003049|Leucovorin|leucovorin|mesh-list
44044454|NCT00003049|Fluorouracil|fluorouracil|mesh-list
44044455|NCT00003049|Calcium|calcium|mesh-list
44044456|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
44044457|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44044458|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044459|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
44044460|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044461|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044462|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044463|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044464|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
44044465|NCT00003049|Antidotes|antidotes|mesh-ancestor
44044466|NCT00003049|Protective Agents|protective agents|mesh-ancestor
44044467|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44044468|NCT00003049|Vitamins|vitamins|mesh-ancestor
44044469|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
44044470|NCT00003050|Tamoxifen|tamoxifen|mesh-list
44044471|NCT00003050|Paclitaxel|paclitaxel|mesh-list
44251888|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44251889|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44251890|NCT04519476|Prednisolone|prednisolone|mesh-list
44251891|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
44251892|NCT04519476|Lenalidomide|lenalidomide|mesh-list
44251893|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44251894|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
44251895|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
44251896|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251897|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44251898|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44251899|NCT04519476|Growth Substances|growth substances|mesh-ancestor
44251900|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
44251901|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251902|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251903|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
44044472|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
44044473|NCT00003050|Doxorubicin|doxorubicin|mesh-list
44044474|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044483|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044484|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044485|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044486|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
44044487|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044488|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044489|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044490|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044491|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044492|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044493|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044494|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044495|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044496|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044497|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044498|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044500|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044501|NCT00003052|Etoposide|etoposide|mesh-list
44044502|NCT00003052|Ifosfamide|ifosfamide|mesh-list
44044503|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044504|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044505|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044506|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044507|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771620|NCT02372812|Hormones|hormones|mesh-ancestor
44044508|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044509|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044510|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044511|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
44044512|NCT00003053|Cisplatin|cisplatin|mesh-list
44044513|NCT00003053|Etoposide|etoposide|mesh-list
44044514|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044515|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044516|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044517|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044518|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044519|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251904|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
44251905|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251906|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251907|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
44251908|NCT04519476|Hormones|hormones|mesh-ancestor
44251909|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251910|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44251911|NCT04519476|Protective Agents|protective agents|mesh-ancestor
44251912|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251913|NCT04500158|Lidocaine|lidocaine|mesh-list
44251914|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251915|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
44251916|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251917|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251918|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
44251919|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251920|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44251921|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44251922|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44251923|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44251924|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251925|NCT04493203|Nivolumab|nivolumab|mesh-list
44251926|NCT04493203|Axitinib|axitinib|mesh-list
44251927|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251928|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044520|NCT00003054|Paclitaxel|paclitaxel|mesh-list
44044521|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044522|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044523|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044524|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044525|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044526|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044527|NCT00003055|Cisplatin|cisplatin|mesh-list
44044528|NCT00003055|Irinotecan|irinotecan|mesh-list
44044529|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044530|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44044531|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044532|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044533|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044534|NCT00003056|Cyclosporine|cyclosporine|mesh-list
44044535|NCT00003056|Methotrexate|methotrexate|mesh-list
44044536|NCT00003056|Cyclosporins|cyclosporins|mesh-list
44044537|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044539|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044540|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044541|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044542|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
44044543|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251929|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44251930|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251931|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44251932|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251933|NCT04480190|Gemcitabine|gemcitabine|mesh-list
44251934|NCT04480190|Cisplatin|cisplatin|mesh-list
44251935|NCT04480190|Fluorouracil|fluorouracil|mesh-list
44251936|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251937|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251938|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
44251939|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044544|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044545|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044546|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044547|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044548|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044549|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
44044550|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044551|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044552|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
44044553|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044554|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44044555|NCT00003057|Octreotide|octreotide|mesh-list
44044556|NCT00003057|Loperamide|loperamide|mesh-list
44044557|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
44044558|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44044559|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044560|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044561|NCT00003058|Troglitazone|troglitazone|mesh-list
44044562|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44044563|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044564|NCT00003060|Cyclosporine|cyclosporine|mesh-list
44044565|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
44044566|NCT00003060|Busulfan|busulfan|mesh-list
44044567|NCT00003060|Methotrexate|methotrexate|mesh-list
44044568|NCT00003060|Cyclosporins|cyclosporins|mesh-list
44044569|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044570|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
44044571|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044572|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044573|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044574|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
44044575|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044576|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044577|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044578|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044579|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044580|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044581|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044582|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
44044583|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044584|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044585|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044586|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044587|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
44044589|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44044591|NCT00003061|Methotrexate|methotrexate|mesh-list
44044592|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044593|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044594|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44044595|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044596|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044597|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
44044598|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251940|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
44251941|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44251942|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251943|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251944|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
44251945|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251946|NCT04480125|Azacitidine|azacitidine|mesh-list
44251947|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251948|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
44251949|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251950|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251951|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251952|NCT04472143|Granisetron|granisetron|mesh-list
44251953|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
44251954|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
44251955|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251999|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
44252000|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44252001|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
44252002|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252003|NCT04432935|Lactoferrin|lactoferrin|mesh-list
44252004|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252005|NCT04425538|Infliximab|infliximab|mesh-list
44252006|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44252007|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252008|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252009|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
44252010|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44252011|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
44252012|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252013|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252014|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44252015|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44252016|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44252017|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
44252018|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252019|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824446|NCT05512364|Tamoxifen|tamoxifen|mesh-list
44044599|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044600|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
44044601|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044602|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44044603|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044604|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
44044605|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044606|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044607|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
44044608|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044609|NCT00003062|Temozolomide|temozolomide|mesh-list
44044610|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044611|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
44063450|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44044612|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044613|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044624|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044625|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044626|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044627|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044628|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
44044629|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
44044630|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044631|NCT00003063|Antidotes|antidotes|mesh-ancestor
44044632|NCT00003063|Protective Agents|protective agents|mesh-ancestor
44044633|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
44044634|NCT00003063|Vitamins|vitamins|mesh-ancestor
44044635|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
44044636|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044637|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
44044638|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
44044639|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44044640|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044641|NCT00003064|Paclitaxel|paclitaxel|mesh-list
44044642|NCT00003064|Etoposide|etoposide|mesh-list
44252021|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44252022|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
44252023|NCT04388683|Protective Agents|protective agents|mesh-ancestor
44252024|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
44252025|NCT04377932|Fludarabine|fludarabine|mesh-list
44252026|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
44252027|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252028|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
44252029|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252030|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044643|NCT00003064|Carboplatin|carboplatin|mesh-list
44044644|NCT00003064|Topotecan|topotecan|mesh-list
44044645|NCT00003064|Thiotepa|thiotepa|mesh-list
44044646|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
44044647|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044648|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044649|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044650|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044651|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044652|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044653|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044654|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044655|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044656|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
44044657|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044658|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44044659|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044660|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
44044661|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044662|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044663|NCT00003065|Paclitaxel|paclitaxel|mesh-list
43771772|NCT02371408|Ribavirin|ribavirin|mesh-list
44044664|NCT00003065|Topotecan|topotecan|mesh-list
44044665|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044666|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044667|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044668|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044669|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044670|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044671|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44044672|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044673|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044674|NCT00003066|Docetaxel|docetaxel|mesh-list
44044675|NCT00003066|Estramustine|estramustine|mesh-list
44044676|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044677|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044678|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044679|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044680|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044681|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044682|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
44044690|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
44044691|NCT00003068|Thiotepa|thiotepa|mesh-list
44044692|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
44044693|NCT00003068|Amifostine|amifostine|mesh-list
44044694|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044695|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
44044696|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044697|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044698|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044699|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
44044700|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044701|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252031|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252032|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
44252033|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252034|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252035|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252036|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252037|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
44252039|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252040|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252041|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
44252042|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44044702|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044703|NCT00003068|Analgesics|analgesics|mesh-ancestor
44044704|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
44044705|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044706|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044707|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044708|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044709|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44044710|NCT00003068|Protective Agents|protective agents|mesh-ancestor
44044711|NCT00003070|Enalapril|enalapril|mesh-list
44044712|NCT00003070|Enalaprilat|enalaprilat|mesh-list
44044713|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044714|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044715|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44044716|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44044717|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44044718|NCT00003072|Paclitaxel|paclitaxel|mesh-list
44044719|NCT00003072|Carboplatin|carboplatin|mesh-list
44044720|NCT00003072|Amifostine|amifostine|mesh-list
44044721|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044722|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044723|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044724|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044725|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044726|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044727|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44044728|NCT00003072|Protective Agents|protective agents|mesh-ancestor
44044729|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044730|NCT00003073|Cytarabine|cytarabine|mesh-list
44044731|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044732|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
44044733|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044734|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044735|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
44044736|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044737|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044738|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
44044739|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044740|NCT00003075|Fenretinide|fenretinide|mesh-list
44044741|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044742|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44044743|NCT00003075|Protective Agents|protective agents|mesh-ancestor
44044744|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044745|NCT00003076|Eflornithine|eflornithine|mesh-list
44044746|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044747|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44044748|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44044749|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44044750|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044751|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44044752|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252043|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44044756|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044757|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
44044758|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044759|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044760|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044761|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
44044762|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044763|NCT00003079|Cytarabine|cytarabine|mesh-list
44044764|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
44044765|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044766|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
44044767|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044768|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044769|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
44044770|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044771|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044772|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
44044773|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044774|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044775|NCT00003080|Tamoxifen|tamoxifen|mesh-list
44044776|NCT00003080|Melphalan|melphalan|mesh-list
44044777|NCT00003080|Thiotepa|thiotepa|mesh-list
44044778|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
44044779|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044780|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044781|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
44044782|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044783|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044784|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044785|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
44044786|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044787|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44044788|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044789|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044790|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044791|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044792|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044793|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044794|NCT00003080|Analgesics|analgesics|mesh-ancestor
44044795|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
44044796|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044797|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044798|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044799|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044800|NCT00003081|Melphalan|melphalan|mesh-list
44044801|NCT00003081|Busulfan|busulfan|mesh-list
44044802|NCT00003081|Thiotepa|thiotepa|mesh-list
44044803|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
44044804|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044805|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044806|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
44044807|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044808|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044809|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044810|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044811|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44044812|NCT00003082|Antibodies|antibodies|mesh-list
44044813|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
44044814|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44044815|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
44044816|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044818|NCT00003084|Ketoconazole|ketoconazole|mesh-list
44044819|NCT00003084|Paclitaxel|paclitaxel|mesh-list
44044820|NCT00003084|Etoposide|etoposide|mesh-list
44044821|NCT00003084|Vinblastine|vinblastine|mesh-list
44044822|NCT00003084|Doxorubicin|doxorubicin|mesh-list
44044823|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044824|NCT00003084|Estramustine|estramustine|mesh-list
44044825|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044826|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044835|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
44044836|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044837|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44044838|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44044839|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44044840|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044841|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044842|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044843|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44044844|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044845|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
44044846|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044847|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
44044848|NCT00003086|Carboplatin|carboplatin|mesh-list
44044849|NCT00003086|Doxorubicin|doxorubicin|mesh-list
44044850|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044851|NCT00003086|Fluorouracil|fluorouracil|mesh-list
44044852|NCT00003086|Melphalan|melphalan|mesh-list
44044853|NCT00003086|Ifosfamide|ifosfamide|mesh-list
44044854|NCT00003086|Thiotepa|thiotepa|mesh-list
44044855|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44044856|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044857|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044858|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044859|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
44044860|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044861|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044862|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044863|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
44044864|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044865|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044866|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044867|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044868|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044869|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
44044870|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044871|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44044872|NCT00003086|Analgesics|analgesics|mesh-ancestor
44044873|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
44044874|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044875|NCT00003087|Paclitaxel|paclitaxel|mesh-list
44044877|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044878|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044879|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044880|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044881|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044882|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044883|NCT00003088|Paclitaxel|paclitaxel|mesh-list
44044884|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
44044885|NCT00003088|Doxorubicin|doxorubicin|mesh-list
44044886|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044887|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044888|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044889|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044890|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044891|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044892|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044893|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044901|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044902|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044903|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044905|NCT00003089|Carboplatin|carboplatin|mesh-list
44044906|NCT00003089|Amifostine|amifostine|mesh-list
44044907|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044908|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044909|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044910|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252058|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
44252059|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44252060|NCT04340882|Lexatumumab|lexatumumab|mesh-list
44252061|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
44252062|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252063|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252064|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252065|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252066|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044911|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044912|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044913|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44044914|NCT00003089|Protective Agents|protective agents|mesh-ancestor
44044915|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044916|NCT00003090|Aldesleukin|aldesleukin|mesh-list
44044917|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044918|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044919|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044920|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
44044921|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044922|NCT00003091|Interferons|interferons|mesh-list
44044923|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
44044924|NCT00003091|Aldesleukin|aldesleukin|mesh-list
44044925|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044926|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
44044927|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044928|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
44044929|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044930|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044931|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044932|NCT00003092|Paclitaxel|paclitaxel|mesh-list
44044933|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044934|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044935|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044936|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044937|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044938|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044939|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
44044940|NCT00003093|Carboplatin|carboplatin|mesh-list
44044941|NCT00003093|Doxorubicin|doxorubicin|mesh-list
44044942|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44044943|NCT00003093|Etoposide|etoposide|mesh-list
44044944|NCT00003093|Molgramostim|molgramostim|mesh-list
44044945|NCT00003093|Lenograstim|lenograstim|mesh-list
44044946|NCT00003093|Sargramostim|sargramostim|mesh-list
44044947|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044948|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
44044949|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044950|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044951|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044952|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
44044953|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044954|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252067|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252068|NCT04329832|Azithromycin|azithromycin|mesh-list
44252069|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
44252070|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252071|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252072|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
44252073|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44252074|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44252075|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252076|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252077|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252078|NCT04321395|Vigabatrin|vigabatrin|mesh-list
44252079|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
44252080|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252081|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252082|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
44252083|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252084|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252085|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
44252086|NCT04275661|Ketamine|ketamine|mesh-list
44252087|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
44252088|NCT04275661|Analgesics|analgesics|mesh-ancestor
44252089|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
44252090|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44044955|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044956|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044957|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044958|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044959|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044960|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044961|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44044962|NCT00003099|Tamoxifen|tamoxifen|mesh-list
44044963|NCT00003099|Fenretinide|fenretinide|mesh-list
44044964|NCT00003099|Retinamide|retinamide|mesh-list
44044969|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044970|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044971|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44044972|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44044973|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044974|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44044975|NCT00003099|Protective Agents|protective agents|mesh-ancestor
44044977|NCT00003101|Busulfan|busulfan|mesh-list
44044978|NCT00003101|Thiotepa|thiotepa|mesh-list
44044979|NCT00003101|Lomustine|lomustine|mesh-list
44044980|NCT00003101|Procarbazine|procarbazine|mesh-list
44044981|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
44044982|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044983|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044984|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044985|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044986|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044987|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
43701511|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252091|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252092|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44252093|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44252094|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
43650108|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
44044988|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044989|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
44044990|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044991|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044992|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044993|NCT00003103|Docetaxel|docetaxel|mesh-list
44044994|NCT00003103|Oblimersen|oblimersen|mesh-list
44044995|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044996|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044997|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044998|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044999|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045000|NCT00003105|Gemcitabine|gemcitabine|mesh-list
44045001|NCT00003105|Paclitaxel|paclitaxel|mesh-list
44045002|NCT00003105|Cisplatin|cisplatin|mesh-list
44045003|NCT00003105|Doxorubicin|doxorubicin|mesh-list
44045004|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045005|NCT00003105|Ifosfamide|ifosfamide|mesh-list
44045006|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045007|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045008|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045009|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045010|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045011|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045012|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045013|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
44045014|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
44045015|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045016|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045017|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045018|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
44045019|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045020|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045021|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045022|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045023|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045024|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
44045025|NCT00003107|Interleukin-12|interleukin-12|mesh-list
44045026|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045027|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
44045028|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045029|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44045030|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44045031|NCT00003107|Growth Substances|growth substances|mesh-ancestor
44045032|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
44045033|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045034|NCT00003108|Cisplatin|cisplatin|mesh-list
44045035|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
44045040|NCT00003109|Irinotecan|irinotecan|mesh-list
44045041|NCT00003109|Raltitrexed|raltitrexed|mesh-list
44045042|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045043|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045044|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045045|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045046|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045047|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045049|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44045050|NCT00003110|Bleomycin|bleomycin|mesh-list
44045051|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045052|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045053|NCT00003111|Paclitaxel|paclitaxel|mesh-list
44045054|NCT00003111|Cisplatin|cisplatin|mesh-list
44045055|NCT00003111|Carboplatin|carboplatin|mesh-list
44045056|NCT00003111|Irinotecan|irinotecan|mesh-list
44045057|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045058|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252096|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252097|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44252098|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44252099|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252100|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045059|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045060|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045061|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045062|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045063|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045064|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045065|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045066|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
44045067|NCT00003113|Lomustine|lomustine|mesh-list
44045068|NCT00003113|Etoposide|etoposide|mesh-list
44045069|NCT00003113|Procarbazine|procarbazine|mesh-list
44045070|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045071|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
44045072|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045073|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045074|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045075|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
44045076|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045077|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045078|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045079|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045080|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045081|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045082|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045083|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
44045084|NCT00003114|Lomustine|lomustine|mesh-list
44045085|NCT00003114|Etoposide|etoposide|mesh-list
44045086|NCT00003114|Procarbazine|procarbazine|mesh-list
44045087|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045088|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
44045089|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045090|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045091|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045092|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
44045093|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045094|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045095|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045096|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045097|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045098|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045099|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045100|NCT00003115|Hydromorphone|hydromorphone|mesh-list
44045101|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44045102|NCT00003115|Narcotics|narcotics|mesh-ancestor
44045103|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44045104|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045105|NCT00003115|Analgesics|analgesics|mesh-ancestor
44045106|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
44045107|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44045109|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
44045110|NCT00003116|Busulfan|busulfan|mesh-list
44045116|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045117|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
44045118|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045119|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045120|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045121|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045122|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
44045123|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045124|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44045125|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44045126|NCT00003117|Paclitaxel|paclitaxel|mesh-list
44252101|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44252102|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
44252103|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44252104|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252105|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44252106|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
44252107|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44252108|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
44252109|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
44252110|NCT04207177|Tacrolimus|tacrolimus|mesh-list
44252111|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252112|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
44252113|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252114|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44252115|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252116|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252117|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252118|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252119|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44252120|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
44252121|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079442|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44079443|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44079445|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44252122|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252123|NCT04205136|Spironolactone|spironolactone|mesh-list
44252124|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44252125|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
44252126|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252127|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252129|NCT04205136|Diuretics|diuretics|mesh-ancestor
44252130|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
44252131|NCT04192903|Cisplatin|cisplatin|mesh-list
44252132|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460795|NCT01558089|Methotrexate|methotrexate|mesh-list
44460796|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44460797|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
44460798|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44460801|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
44460802|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460803|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460804|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460805|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460806|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43650148|NCT03016650|Acetaminophen|acetaminophen|mesh-list
44045127|NCT00003117|Carboplatin|carboplatin|mesh-list
44045128|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045129|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045130|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045131|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045132|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045133|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045134|NCT00003118|Cisplatin|cisplatin|mesh-list
44045135|NCT00003118|Fluorouracil|fluorouracil|mesh-list
44045136|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045137|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
44045138|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045139|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045140|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045141|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
44045142|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045143|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
44045144|NCT00003119|Carboplatin|carboplatin|mesh-list
44045145|NCT00003119|Doxorubicin|doxorubicin|mesh-list
44045146|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045147|NCT00003119|Etoposide|etoposide|mesh-list
44045148|NCT00003119|Sargramostim|sargramostim|mesh-list
44045149|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045150|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
44045151|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045152|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045153|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045154|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
44045155|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045156|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045157|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045158|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045159|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045160|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045161|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045162|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045163|NCT00003120|Paclitaxel|paclitaxel|mesh-list
44045164|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045165|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045166|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045167|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045168|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045169|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045170|NCT00003123|Amifostine|amifostine|mesh-list
44045171|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045172|NCT00003123|Protective Agents|protective agents|mesh-ancestor
44045173|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045174|NCT00003124|Leuprolide|leuprolide|mesh-list
44045175|NCT00003124|Flutamide|flutamide|mesh-list
44045176|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44045177|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
44045178|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44045179|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045180|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541926|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
44045188|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
44045189|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045190|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045191|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44045192|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44045193|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
44045194|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460807|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460808|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
44460809|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460810|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44460811|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44460812|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44045195|NCT00003126|Aldesleukin|aldesleukin|mesh-list
44045196|NCT00003126|Interleukin-2|interleukin-2|mesh-list
44045197|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045198|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44045199|NCT00003126|Analgesics|analgesics|mesh-ancestor
44045200|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
44045201|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44045202|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045203|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44045204|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44045205|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
44045206|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045207|NCT00003127|Paclitaxel|paclitaxel|mesh-list
44045208|NCT00003127|Carboplatin|carboplatin|mesh-list
44045209|NCT00003127|Amifostine|amifostine|mesh-list
44045210|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045211|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045212|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045213|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045214|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045215|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045216|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045217|NCT00003127|Protective Agents|protective agents|mesh-ancestor
44045218|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045219|NCT00003128|Paclitaxel|paclitaxel|mesh-list
44045220|NCT00003128|Ifosfamide|ifosfamide|mesh-list
44045221|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045222|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045223|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045224|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045225|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045226|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045227|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045228|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
44045229|NCT00003129|Valrubicin|valrubicin|mesh-list
44045230|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045231|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045232|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045233|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045234|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045235|NCT00003130|Paclitaxel|paclitaxel|mesh-list
44045236|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045237|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045238|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045239|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045240|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045241|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045242|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
44045243|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44045244|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045245|NCT00003132|Cisplatin|cisplatin|mesh-list
44045246|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
44045247|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045248|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045249|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
44045250|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045251|NCT00003133|Gemcitabine|gemcitabine|mesh-list
44045252|NCT00003133|Paclitaxel|paclitaxel|mesh-list
44045256|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045257|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045258|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045259|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045260|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
44460813|NCT01558089|Analgesics|analgesics|mesh-ancestor
44460814|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
44460815|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460816|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460817|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460818|NCT01557946|Citalopram|citalopram|mesh-list
44460819|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44460820|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44460821|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460822|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650162|NCT03016611|Ticagrelor|ticagrelor|mesh-list
44045261|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045262|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045263|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
44045264|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
44045265|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045266|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045267|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045268|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
44045269|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045270|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045271|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045272|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045273|NCT00003134|Irinotecan|irinotecan|mesh-list
44045274|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045275|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045276|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045277|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045278|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045279|NCT00003135|Doxorubicin|doxorubicin|mesh-list
44045280|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045281|NCT00003135|Fluorouracil|fluorouracil|mesh-list
44045282|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045283|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045284|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045285|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045286|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045287|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045288|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
44045289|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045290|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045291|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
44045292|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045293|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
44045294|NCT00003136|Carboplatin|carboplatin|mesh-list
44045295|NCT00003136|Amifostine|amifostine|mesh-list
44045296|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045297|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
44045298|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045299|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045300|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045301|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
44045302|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045303|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045304|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045305|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045306|NCT00003136|Protective Agents|protective agents|mesh-ancestor
44045307|NCT00003137|Irinotecan|irinotecan|mesh-list
44045308|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045309|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045310|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045311|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045312|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460823|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460824|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
44460825|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460826|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44460827|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
44045313|NCT00003139|Pilocarpine|pilocarpine|mesh-list
44045314|NCT00003139|Miotics|miotics|mesh-ancestor
44045315|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
44045316|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063451|NCT00006049|Paclitaxel|paclitaxel|mesh-list
44045317|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045318|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44045319|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44045320|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
44045321|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44045322|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045323|NCT00003140|Letrozole|letrozole|mesh-list
44045324|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045329|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44045330|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
44045331|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045332|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045333|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
44045334|NCT00003141|Thiotepa|thiotepa|mesh-list
44045335|NCT00003141|Cisplatin|cisplatin|mesh-list
44045336|NCT00003141|Carboplatin|carboplatin|mesh-list
44045337|NCT00003141|Etoposide|etoposide|mesh-list
44045338|NCT00003141|Vincristine|vincristine|mesh-list
44045339|NCT00003141|Lenograstim|lenograstim|mesh-list
44045340|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045341|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
44045342|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045343|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045344|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045345|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
44045346|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045347|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045348|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045349|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045350|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045351|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045352|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045353|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045354|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045355|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045356|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045358|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045359|NCT00003143|Protective Agents|protective agents|mesh-ancestor
44045360|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045361|NCT00003144|Gemcitabine|gemcitabine|mesh-list
44045362|NCT00003144|Cisplatin|cisplatin|mesh-list
44045363|NCT00003144|Amifostine|amifostine|mesh-list
44045364|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045365|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045366|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
44045367|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045368|NCT00003144|Antiviral Agents|antiviral agents|mesh-ancestor
44045369|NCT00003144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045370|NCT00003144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045371|NCT00003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045372|NCT00003144|Immunologic Factors|immunologic factors|mesh-ancestor
44045373|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045374|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045375|NCT00003144|Protective Agents|protective agents|mesh-ancestor
44045376|NCT00003145|Cyclosporine|cyclosporine|mesh-list
44045377|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
44045378|NCT00003145|Fludarabine|fludarabine|mesh-list
44045379|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
44045380|NCT00003145|Cyclosporins|cyclosporins|mesh-list
44045381|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045382|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045383|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
43701512|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
44460828|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460829|NCT01557920|Propofol|propofol|mesh-list
44460830|NCT01557920|Sevoflurane|sevoflurane|mesh-list
44460831|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44045384|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045385|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045386|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
44045387|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045388|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045389|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
44045390|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045391|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44045392|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079699|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
44045393|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44045394|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045395|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44045396|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
43542141|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
44045401|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045402|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
44045403|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045404|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045405|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045406|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045407|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
44045408|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045409|NCT00003148|Aldesleukin|aldesleukin|mesh-list
44045410|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045411|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44045412|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44045413|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
44045414|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045415|NCT00003149|Interleukin-12|interleukin-12|mesh-list
44045416|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045417|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
44045418|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045419|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44045420|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44045421|NCT00003149|Growth Substances|growth substances|mesh-ancestor
44045422|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
44045423|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045424|NCT00003150|Prednisone|prednisone|mesh-list
44045425|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
44045426|NCT00003150|Rituximab|rituximab|mesh-list
44045427|NCT00003150|Doxorubicin|doxorubicin|mesh-list
44045428|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045429|NCT00003150|Vincristine|vincristine|mesh-list
44045430|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045431|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
44045432|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045433|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045434|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045435|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
44045436|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045437|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045438|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045439|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44045440|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045441|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045442|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045443|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045444|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44045445|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
44045446|NCT00003150|Hormones|hormones|mesh-ancestor
44045447|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045448|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44045449|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045450|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045451|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045452|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045453|NCT00003151|Amoxicillin|amoxicillin|mesh-list
44045454|NCT00003151|Metronidazole|metronidazole|mesh-list
44045455|NCT00003151|Clarithromycin|clarithromycin|mesh-list
44460832|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460833|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460834|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44460835|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
44460836|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
44460837|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44460838|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44460839|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44460840|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44460841|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44460842|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460843|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460844|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44460845|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460846|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460847|NCT01557517|Clobetasol|clobetasol|mesh-list
44460848|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460849|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
44460850|NCT01557517|Hormones|hormones|mesh-ancestor
44460851|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460852|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460853|NCT01557504|Metformin|metformin|mesh-list
44460854|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44460855|NCT01557504|Hormones|hormones|mesh-list
44460856|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460857|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045456|NCT00003151|Tetracycline|tetracycline|mesh-list
44045457|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44045458|NCT00003151|Omeprazole|omeprazole|mesh-list
44045459|NCT00003151|Bismuth|bismuth|mesh-list
44045460|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44045461|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045462|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44045463|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44045464|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44045465|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44045466|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44045467|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045468|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045469|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44045470|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44045474|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
44045476|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
44045477|NCT00003152|Vincristine|vincristine|mesh-list
44045478|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045479|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
44045480|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045481|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045482|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44460858|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460859|NCT01557504|Incretins|incretins|mesh-ancestor
44460860|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44460861|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460862|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252133|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
44252134|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44252135|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079762|NCT05156905|Docetaxel|docetaxel|mesh-list
44252136|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252137|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252138|NCT04111926|Analgesics|analgesics|mesh-ancestor
44252139|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
44252140|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252141|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44252142|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44252143|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44252144|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44252145|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252146|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252147|NCT04081831|Aspirin|aspirin|mesh-list
44252148|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44045483|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
44045484|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045485|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045486|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045487|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44045488|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
44045489|NCT00003152|Hormones|hormones|mesh-ancestor
44045490|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045491|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44045492|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
44045493|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045494|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045495|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772372|NCT02366585|Cyclosporine|cyclosporine|mesh-list
44045496|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045497|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149640|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149641|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149642|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44149643|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045498|NCT00003156|Topotecan|topotecan|mesh-list
44045499|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045500|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045501|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045502|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045503|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045504|NCT00003157|Gemcitabine|gemcitabine|mesh-list
44045505|NCT00003157|Cisplatin|cisplatin|mesh-list
44045506|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252149|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252151|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
44252152|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252153|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252154|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252155|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252156|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44252157|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44252158|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252159|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44252160|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44252161|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252162|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
44252163|NCT04032964|Doxorubicin|doxorubicin|mesh-list
44252164|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252165|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252166|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252167|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252168|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252169|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252170|NCT04020913|Hormones|hormones|mesh-list
44252171|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252172|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252173|NCT04017247|Oxytocin|oxytocin|mesh-list
44252174|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
44252175|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44252176|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252177|NCT04004819|Rituximab|rituximab|mesh-list
44252193|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
44063452|NCT00006049|Carboplatin|carboplatin|mesh-list
44252194|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252195|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252196|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44252197|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44252199|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252200|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252201|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252202|NCT03974594|Trifluridine|trifluridine|mesh-list
44252203|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
44252204|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252206|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252207|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
44045507|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045508|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
44045509|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045510|NCT00003157|Antiviral Agents|antiviral agents|mesh-ancestor
44045511|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045512|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045513|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045514|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
44045515|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045516|NCT00003158|Paclitaxel|paclitaxel|mesh-list
44045517|NCT00003158|Etoposide|etoposide|mesh-list
44045518|NCT00003158|Carboplatin|carboplatin|mesh-list
44045519|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045520|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045521|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045522|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045523|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045524|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045525|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045526|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045527|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045528|NCT00003159|Gemcitabine|gemcitabine|mesh-list
44045529|NCT00003159|Vinorelbine|vinorelbine|mesh-list
44045530|NCT00003159|Vinblastine|vinblastine|mesh-list
44045531|NCT00003159|Docetaxel|docetaxel|mesh-list
44045532|NCT00003159|Carboplatin|carboplatin|mesh-list
44045533|NCT00003159|Ifosfamide|ifosfamide|mesh-list
44045534|NCT00003159|Mitomycins|mitomycins|mesh-list
44045535|NCT00003159|Mitomycin|mitomycin|mesh-list
44045536|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045537|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045538|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045539|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045553|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44045555|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045556|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045557|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045558|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045559|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045560|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045561|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
44045562|NCT00003163|Melphalan|melphalan|mesh-list
44045563|NCT00003163|Sargramostim|sargramostim|mesh-list
44045564|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045565|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
44045566|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252208|NCT03964688|Vitamins|vitamins|mesh-ancestor
44252209|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
44252210|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252211|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
43650251|NCT03015857|Fentanyl|fentanyl|mesh-list
44045567|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045568|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045569|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
44045570|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045571|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045572|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045573|NCT00003165|Doxorubicin|doxorubicin|mesh-list
44045574|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045575|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045576|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045577|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045578|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045579|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045580|NCT00003166|Vincristine|vincristine|mesh-list
44045581|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
44045582|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045583|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045584|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045585|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045586|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045587|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045588|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045589|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
44045590|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045591|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
44045592|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045593|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
44045594|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045595|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045596|NCT00003172|Interferons|interferons|mesh-list
44045597|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
44045598|NCT00003172|Docetaxel|docetaxel|mesh-list
44045599|NCT00003172|Doxorubicin|doxorubicin|mesh-list
43542356|NCT03703063|Vitamins|vitamins|mesh-ancestor
44045616|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045617|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
44045618|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045619|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
44045620|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44045621|NCT00003173|Thiotepa|thiotepa|mesh-list
44045622|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
44045623|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045624|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045625|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
44045626|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045627|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045628|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045629|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045630|NCT00003174|Cladribine|cladribine|mesh-list
44045631|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
44045632|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045633|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045634|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
44045635|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045636|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045637|NCT00003175|Fluorouracil|fluorouracil|mesh-list
44045638|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
44045639|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045640|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045641|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045642|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045643|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
44045644|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045645|NCT00003176|Temozolomide|temozolomide|mesh-list
44045646|NCT00003176|Carmustine|carmustine|mesh-list
44045647|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045648|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
44252212|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252213|NCT03964688|Protective Agents|protective agents|mesh-ancestor
44252214|NCT03940196|Paclitaxel|paclitaxel|mesh-list
44252215|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44252216|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252217|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252218|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045649|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045650|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045652|NCT00003178|Cladribine|cladribine|mesh-list
44045653|NCT00003178|Lenograstim|lenograstim|mesh-list
44045654|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045655|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
44045656|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045657|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045658|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045659|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045667|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44045668|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44045669|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
44045670|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44045671|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045672|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44045673|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44045674|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44045675|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44045676|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838585|NCT04834310|Cefazolin|cefazolin|mesh-list
44045677|NCT00003181|Aldesleukin|aldesleukin|mesh-list
44045678|NCT00003181|Vinblastine|vinblastine|mesh-list
44045679|NCT00003181|Sargramostim|sargramostim|mesh-list
44045680|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
44045681|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045682|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045683|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44045684|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44045685|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
44045686|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045687|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045688|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045689|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045690|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045691|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045692|NCT00003182|Gemcitabine|gemcitabine|mesh-list
44045693|NCT00003182|Cisplatin|cisplatin|mesh-list
44045694|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045695|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045696|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
44045697|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045698|NCT00003182|Antiviral Agents|antiviral agents|mesh-ancestor
44045699|NCT00003182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045700|NCT00003182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045701|NCT00003182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045702|NCT00003182|Immunologic Factors|immunologic factors|mesh-ancestor
44045703|NCT00003182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045704|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
44045705|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045706|NCT00003183|Analgesics|analgesics|mesh-ancestor
44045707|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
44045708|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44045709|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045710|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045711|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045712|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045713|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045714|NCT00003184|Vaccines|vaccines|mesh-list
44045715|NCT00003184|Sargramostim|sargramostim|mesh-list
44045716|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
44252219|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252220|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252221|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252222|NCT03927378|Ketamine|ketamine|mesh-list
44252223|NCT03927378|Esketamine|esketamine|mesh-list
44252224|NCT03927378|Analgesics|analgesics|mesh-ancestor
44045717|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
44045718|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045719|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045720|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
44045721|NCT00003185|Sargramostim|sargramostim|mesh-list
44045722|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045723|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
44045724|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045725|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045726|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045736|NCT00003187|Cyclosporins|cyclosporins|mesh-list
44045737|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045738|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
44045739|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045740|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045741|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045742|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
44045743|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045744|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045745|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045746|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44045747|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
44045748|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44045749|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045750|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
44045751|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
44045752|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045753|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44045754|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44045755|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
44045756|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045757|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
44045758|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44045759|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44045760|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
44045761|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
44045762|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44045763|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44045764|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
44045765|NCT00003187|Hormones|hormones|mesh-ancestor
44045766|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045767|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44045768|NCT00003187|Protective Agents|protective agents|mesh-ancestor
44045769|NCT00003190|Cytarabine|cytarabine|mesh-list
44045770|NCT00003190|Etoposide|etoposide|mesh-list
44045771|NCT00003190|Daunorubicin|daunorubicin|mesh-list
44045772|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
44045773|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045774|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045775|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045776|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045777|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045778|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045779|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045780|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
44045781|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
44045782|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045783|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045784|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
44045785|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045786|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045787|NCT00003191|Fenretinide|fenretinide|mesh-list
44045788|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045789|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44252225|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
44252226|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252227|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252228|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44252229|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44252230|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
44252231|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
44045790|NCT00003191|Protective Agents|protective agents|mesh-ancestor
44045791|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045792|NCT00003193|Paclitaxel|paclitaxel|mesh-list
44045793|NCT00003193|Amifostine|amifostine|mesh-list
44045794|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045810|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045811|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045812|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045813|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
44045814|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045815|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045816|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045817|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045818|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045819|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045820|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045821|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045822|NCT00003195|Interferons|interferons|mesh-list
44045823|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
44045824|NCT00003195|Busulfan|busulfan|mesh-list
44045825|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045826|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
44045827|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045828|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
44045829|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045830|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
44045831|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045832|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045833|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045834|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045835|NCT00003196|Cyclosporine|cyclosporine|mesh-list
44045836|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
44045837|NCT00003196|Cyclosporins|cyclosporins|mesh-list
44045838|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045839|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045840|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045841|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
44045842|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045843|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
44045844|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045845|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
44045846|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045847|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44045848|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045849|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045850|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44045851|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
44045852|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44045853|NCT00003198|Topotecan|topotecan|mesh-list
44045854|NCT00003198|Ifosfamide|ifosfamide|mesh-list
44045855|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44045856|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045857|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045866|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045867|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045868|NCT00003202|Gemcitabine|gemcitabine|mesh-list
44045870|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045871|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045872|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
44045873|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252232|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252233|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44252234|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44252235|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252236|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252237|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44252238|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44252239|NCT03925402|Ertapenem|ertapenem|mesh-list
44045874|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
43772674|NCT02364479|Analgesics|analgesics|mesh-ancestor
44045875|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045876|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045877|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045878|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
44045879|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045880|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
44045881|NCT00003203|Cisplatin|cisplatin|mesh-list
44045882|NCT00003203|Carboplatin|carboplatin|mesh-list
44045883|NCT00003203|Vincristine|vincristine|mesh-list
44045884|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045885|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
44045886|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045887|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045888|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045889|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
44045890|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045891|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045892|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045893|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045894|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045895|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045896|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045897|NCT00003204|Prednisone|prednisone|mesh-list
44045898|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
44045899|NCT00003204|Rituximab|rituximab|mesh-list
44045900|NCT00003204|Fludarabine|fludarabine|mesh-list
44045901|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
44045902|NCT00003204|Vincristine|vincristine|mesh-list
44045903|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045904|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
44045905|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045906|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045907|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045908|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
44045909|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045910|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045911|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045912|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44045913|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44045914|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
44045915|NCT00003204|Hormones|hormones|mesh-ancestor
44045916|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045917|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44045918|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045919|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
44045920|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045921|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045922|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045923|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045924|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
44045931|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045932|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045933|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045934|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045935|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045936|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252240|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252241|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252242|NCT03893175|Acetaminophen|acetaminophen|mesh-list
44252243|NCT03893175|Ibuprofen|ibuprofen|mesh-list
44252244|NCT03893175|Oxycodone|oxycodone|mesh-list
44252245|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252246|NCT03893175|Analgesics|analgesics|mesh-ancestor
44252247|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
44252248|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252249|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252250|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
44252251|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44252252|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252253|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252254|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44252255|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252256|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252257|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44252258|NCT03893175|Narcotics|narcotics|mesh-ancestor
44252259|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252260|NCT03853044|Prednisone|prednisone|mesh-list
44252261|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
44252262|NCT03853044|Doxorubicin|doxorubicin|mesh-list
44252263|NCT03853044|Vincristine|vincristine|mesh-list
44252264|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252265|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
44045937|NCT00003207|Doxorubicin|doxorubicin|mesh-list
44045938|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045939|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045940|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045941|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045942|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045943|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045944|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045945|NCT00003209|Cisplatin|cisplatin|mesh-list
44045946|NCT00003209|Fluorouracil|fluorouracil|mesh-list
44045947|NCT00003209|Methotrexate|methotrexate|mesh-list
44045948|NCT00003209|Ifosfamide|ifosfamide|mesh-list
44045949|NCT00003209|Mitomycins|mitomycins|mesh-list
44045950|NCT00003209|Mitomycin|mitomycin|mesh-list
44045951|NCT00003209|Bleomycin|bleomycin|mesh-list
43772749|NCT02363764|Dimercaprol|dimercaprol|mesh-list
44045952|NCT00003209|Vinblastine|vinblastine|mesh-list
44045953|NCT00003209|Vindesine|vindesine|mesh-list
44045954|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045955|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
44045956|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045957|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045958|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045959|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
44045960|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045961|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44045962|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
44252266|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252267|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252268|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252269|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
44252270|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252271|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252272|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43650306|NCT03015701|Mifepristone|mifepristone|mesh-list
44045963|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44045964|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
44045965|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045966|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44045967|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045968|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44045969|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045970|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
44045971|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045972|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045973|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045974|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045975|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045976|NCT00003210|Interleukin-12|interleukin-12|mesh-list
44045977|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045978|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
44045979|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045980|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44045981|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44045982|NCT00003210|Growth Substances|growth substances|mesh-ancestor
44045983|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
44045984|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045985|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
44045986|NCT00003211|Cisplatin|cisplatin|mesh-list
44045987|NCT00003211|Vincristine|vincristine|mesh-list
44045988|NCT00003211|Amifostine|amifostine|mesh-list
44045989|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045990|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
44045991|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045992|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045993|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045994|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
43542743|NCT03700359|Etoposide|etoposide|mesh-list
44045998|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44045999|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046000|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046001|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046002|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046003|NCT00003211|Protective Agents|protective agents|mesh-ancestor
44046004|NCT00003212|Doxorubicin|doxorubicin|mesh-list
44046005|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046006|NCT00003212|Ifosfamide|ifosfamide|mesh-list
44046007|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046008|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046009|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046010|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046011|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046012|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046013|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046014|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
44046015|NCT00003213|Dexamethasone|dexamethasone|mesh-list
44046016|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
44046017|NCT00003213|Metoclopramide|metoclopramide|mesh-list
44046018|NCT00003213|Granisetron|granisetron|mesh-list
44046019|NCT00003213|BB 1101|bb 1101|mesh-list
44046020|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046021|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
44046022|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
44046023|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046024|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252273|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252274|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252275|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252276|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252277|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252278|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
43905959|NCT00233103|Sertraline|sertraline|mesh-list
44046025|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44046026|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
44046027|NCT00003213|Hormones|hormones|mesh-ancestor
44046028|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772805|NCT02363400|Cisplatin|cisplatin|mesh-list
44046029|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046030|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046031|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
44046032|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046033|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046034|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44046035|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44046036|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
44046037|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44046038|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44046039|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
44046040|NCT00003214|Paclitaxel|paclitaxel|mesh-list
44046041|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
44046042|NCT00003214|Cisplatin|cisplatin|mesh-list
44046043|NCT00003214|Carboplatin|carboplatin|mesh-list
44046044|NCT00003214|Doxorubicin|doxorubicin|mesh-list
44046045|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046046|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046047|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046048|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046049|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046050|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046051|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046052|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046053|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
44046054|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046055|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046056|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046057|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
44046058|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046059|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046060|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046061|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046062|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046063|NCT00003215|Leucovorin|leucovorin|mesh-list
44046064|NCT00003215|Cytarabine|cytarabine|mesh-list
44046065|NCT00003215|Prednisone|prednisone|mesh-list
44046066|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
44046067|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
44046073|NCT00003215|Doxorubicin|doxorubicin|mesh-list
44046074|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046075|NCT00003215|Methotrexate|methotrexate|mesh-list
44046076|NCT00003215|Etoposide|etoposide|mesh-list
44046077|NCT00003215|Vincristine|vincristine|mesh-list
44046078|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
44046079|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
44046080|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046081|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
44046082|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046083|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046084|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046085|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
44046086|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046087|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046088|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046089|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046090|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046091|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252280|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252281|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252282|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252283|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252284|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252285|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252286|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44252289|NCT03843645|Anesthetics|anesthetics|mesh-list
44252290|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650323|NCT03015675|Vitamins|vitamins|mesh-ancestor
44046092|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046093|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046094|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
44046095|NCT00003215|Hormones|hormones|mesh-ancestor
44046096|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046097|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046098|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44046099|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046100|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44046101|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046102|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
44046103|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
44046104|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44149644|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43772870|NCT02362945|Oxytocin|oxytocin|mesh-list
44046105|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046106|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046107|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
44046108|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046109|NCT00003215|Antidotes|antidotes|mesh-ancestor
44046110|NCT00003215|Protective Agents|protective agents|mesh-ancestor
44046111|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046112|NCT00003215|Vitamins|vitamins|mesh-ancestor
44046113|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
44046114|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046115|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046116|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046117|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
44046118|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
44046119|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046120|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44046121|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44046122|NCT00003215|Analgesics|analgesics|mesh-ancestor
44046123|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
44046124|NCT00003216|Gemcitabine|gemcitabine|mesh-list
44046125|NCT00003216|Fluorouracil|fluorouracil|mesh-list
44046126|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046127|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
44046128|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046129|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046130|NCT00003216|Antiviral Agents|antiviral agents|mesh-ancestor
44046131|NCT00003216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046132|NCT00003216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046133|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046134|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
44046135|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046136|NCT00003217|Cytarabine|cytarabine|mesh-list
44046137|NCT00003217|Dexamethasone|dexamethasone|mesh-list
44046138|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
44046152|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046153|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046154|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
44046155|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
44046156|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046157|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252291|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252292|NCT03826303|Ethanol|ethanol|mesh-list
44252293|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44252294|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252295|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44046158|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
44046159|NCT00003217|Hormones|hormones|mesh-ancestor
44046160|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046161|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046162|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046163|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046164|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046165|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046166|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44046167|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046168|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44046169|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046170|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
44046171|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
44046172|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44046173|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046174|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
44046175|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046176|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046177|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046178|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046179|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046180|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772943|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44046182|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046183|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046184|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046185|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
44046186|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046187|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
44046188|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046189|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046190|NCT00003223|Fenretinide|fenretinide|mesh-list
44046191|NCT00003223|Retinamide|retinamide|mesh-list
44046192|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046193|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44046194|NCT00003223|Protective Agents|protective agents|mesh-ancestor
44046195|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046196|NCT00003225|Irinotecan|irinotecan|mesh-list
44046197|NCT00003225|Amifostine|amifostine|mesh-list
44046198|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046199|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046200|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542953|NCT03698682|Levofloxacin|levofloxacin|mesh-list
44046208|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44046209|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44046210|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
44046211|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046212|NCT00003230|Paclitaxel|paclitaxel|mesh-list
44046213|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046214|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046215|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046216|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046217|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046218|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046219|NCT00003231|Cisplatin|cisplatin|mesh-list
44046220|NCT00003231|Docetaxel|docetaxel|mesh-list
44046221|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046222|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046223|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046224|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046225|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046226|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
44046227|NCT00003232|Prednisone|prednisone|mesh-list
44046228|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
44046229|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046230|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
44252296|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252297|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
44252298|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
44252299|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252300|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252301|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44252302|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252303|NCT03803761|Fulvestrant|fulvestrant|mesh-list
44046231|NCT00003232|Hormones|hormones|mesh-ancestor
44063453|NCT00006049|Gefitinib|gefitinib|mesh-list
44046232|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046233|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046234|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046235|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046236|NCT00003232|Analgesics|analgesics|mesh-ancestor
44046237|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
44046238|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046239|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046240|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046241|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046242|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046243|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44046244|NCT00003234|Vinorelbine|vinorelbine|mesh-list
44046245|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046246|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046247|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046248|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046249|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046250|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046251|NCT00003235|Paclitaxel|paclitaxel|mesh-list
44046252|NCT00003235|Carboplatin|carboplatin|mesh-list
44046253|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046254|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046255|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773021|NCT02361567|Oxycodone|oxycodone|mesh-list
44046256|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046257|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046258|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046259|NCT00003236|ISIS 5132|isis 5132|mesh-list
44046260|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046261|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046262|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046263|NCT00003237|Paclitaxel|paclitaxel|mesh-list
44046264|NCT00003237|Cisplatin|cisplatin|mesh-list
44046265|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046266|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046267|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046269|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046270|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046272|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046273|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046274|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046275|NCT00003239|Interferons|interferons|mesh-list
44046276|NCT00003239|Cytarabine|cytarabine|mesh-list
44046277|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
44046278|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
44046279|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
44046280|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046281|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
44046282|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046283|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046284|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
44046285|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046286|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046287|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
44046288|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046289|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252304|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252305|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252306|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44080563|NCT03958799|Vaccines|vaccines|mesh-list
44252307|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44252308|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44252309|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252310|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252311|NCT03787251|Apatinib|apatinib|mesh-list
44252312|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252313|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44046290|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44046291|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046292|NCT00003240|Cisplatin|cisplatin|mesh-list
44046293|NCT00003240|Vinorelbine|vinorelbine|mesh-list
44046294|NCT00003240|Ifosfamide|ifosfamide|mesh-list
44046295|NCT00003240|Mitomycins|mitomycins|mesh-list
44046296|NCT00003240|Mitomycin|mitomycin|mesh-list
44046297|NCT00003240|Vinblastine|vinblastine|mesh-list
44046298|NCT00003240|Vindesine|vindesine|mesh-list
44046299|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046300|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046301|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046302|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046303|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046304|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046305|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046306|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
44046307|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046308|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046309|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046310|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
44046311|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046312|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
44046313|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046314|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046315|NCT00003242|Paclitaxel|paclitaxel|mesh-list
44046316|NCT00003242|Cisplatin|cisplatin|mesh-list
44046317|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
44046318|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046319|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046320|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046321|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046322|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046323|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046324|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046325|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
44046326|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046327|NCT00003243|Aldesleukin|aldesleukin|mesh-list
44046328|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
44046329|NCT00003243|Doxorubicin|doxorubicin|mesh-list
44046330|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046331|NCT00003243|Etoposide|etoposide|mesh-list
44046332|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046333|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
44046334|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046335|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046336|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046337|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
44046338|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046339|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046340|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046341|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046342|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046353|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046354|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252314|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252315|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252316|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
44252317|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252318|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460863|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460864|NCT01557283|Etanercept|etanercept|mesh-list
44046355|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046356|NCT00003248|Rituximab|rituximab|mesh-list
44046357|NCT00003248|Fludarabine|fludarabine|mesh-list
44046358|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
44046359|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44046360|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046361|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
44046362|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046363|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046364|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046365|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
44046366|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046367|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046368|NCT00003249|Ketoconazole|ketoconazole|mesh-list
44046369|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44046370|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
44046371|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046372|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44046373|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44046374|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046375|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046376|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44046377|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
44046378|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046379|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046380|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44046381|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046382|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44046383|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44046384|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44046385|NCT00003250|Fenretinide|fenretinide|mesh-list
44046386|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046387|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44046388|NCT00003250|Protective Agents|protective agents|mesh-ancestor
44046389|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046390|NCT00003251|Paclitaxel|paclitaxel|mesh-list
44046391|NCT00003251|Cisplatin|cisplatin|mesh-list
44046392|NCT00003251|Amifostine|amifostine|mesh-list
44046393|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046394|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046395|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046396|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046397|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046398|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046399|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046400|NCT00003251|Protective Agents|protective agents|mesh-ancestor
44046401|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046402|NCT00003252|Amifostine|amifostine|mesh-list
44046403|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046404|NCT00003252|Protective Agents|protective agents|mesh-ancestor
44046405|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046407|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
44046420|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
44046421|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046422|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046423|NCT00003255|Carboplatin|carboplatin|mesh-list
44046424|NCT00003255|Topotecan|topotecan|mesh-list
44046425|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046426|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44460865|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44460866|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44460867|NCT01557283|Analgesics|analgesics|mesh-ancestor
44460868|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
44460869|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460870|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046427|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046428|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046429|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046430|NCT00003256|Alvocidib|alvocidib|mesh-list
44046431|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046432|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
44046433|NCT00003256|Growth Substances|growth substances|mesh-ancestor
44046434|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046435|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44046436|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046437|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046438|NCT00003259|Vinorelbine|vinorelbine|mesh-list
44046439|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046440|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046441|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046442|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046443|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046444|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046445|NCT00003260|Leucovorin|leucovorin|mesh-list
44046446|NCT00003260|Fluorouracil|fluorouracil|mesh-list
44046447|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
44046448|NCT00003260|Irinotecan|irinotecan|mesh-list
44046449|NCT00003260|Calcium|calcium|mesh-list
44046450|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
44046451|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44046452|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046453|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
44046454|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046455|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046456|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046457|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046458|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
44046459|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046460|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046461|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046462|NCT00003260|Antidotes|antidotes|mesh-ancestor
44046463|NCT00003260|Protective Agents|protective agents|mesh-ancestor
44046464|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046465|NCT00003260|Vitamins|vitamins|mesh-ancestor
44046466|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
44046467|NCT00003261|Zidovudine|zidovudine|mesh-list
44046468|NCT00003261|Methotrexate|methotrexate|mesh-list
44046469|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44046470|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046471|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44046481|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
44046482|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046483|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046484|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44046485|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
44046486|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046487|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44046488|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44046489|NCT00003262|Prednisone|prednisone|mesh-list
44046490|NCT00003262|Doxorubicin|doxorubicin|mesh-list
44046491|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046492|NCT00003262|Epirubicin|epirubicin|mesh-list
44046493|NCT00003262|Bleomycin|bleomycin|mesh-list
44046494|NCT00003262|Etoposide|etoposide|mesh-list
44046495|NCT00003262|Vincristine|vincristine|mesh-list
44046496|NCT00003262|Vinblastine|vinblastine|mesh-list
44046497|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
44046498|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046499|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046500|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44460871|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460872|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460873|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460874|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44460875|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
44460876|NCT01557244|Fesoterodine|fesoterodine|mesh-list
44046501|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046502|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046503|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046504|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046505|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
44046506|NCT00003262|Hormones|hormones|mesh-ancestor
44046507|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046508|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046509|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046510|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046511|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046512|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046513|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046514|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
44046515|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046516|NCT00003263|Interferons|interferons|mesh-list
44046517|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
44046518|NCT00003263|Cisplatin|cisplatin|mesh-list
44046519|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046520|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
44046521|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046522|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
44046523|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046524|NCT00003264|Gemcitabine|gemcitabine|mesh-list
44046525|NCT00003264|Cisplatin|cisplatin|mesh-list
44046526|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046527|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046528|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
44046529|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046530|NCT00003264|Antiviral Agents|antiviral agents|mesh-ancestor
44046531|NCT00003264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046532|NCT00003264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046533|NCT00003264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046534|NCT00003264|Immunologic Factors|immunologic factors|mesh-ancestor
44046535|NCT00003264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046536|NCT00003266|Methylphenidate|methylphenidate|mesh-list
44046537|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44046538|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046548|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046549|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
44046550|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046551|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046552|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
44046553|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046554|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046555|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
44046556|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046557|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44149645|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44046558|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046559|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046560|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046561|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046562|NCT00003268|Protective Agents|protective agents|mesh-ancestor
44046563|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
44046566|NCT00003269|Sargramostim|sargramostim|mesh-list
44046567|NCT00003269|Amifostine|amifostine|mesh-list
44046568|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046569|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
44046570|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046571|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046572|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046573|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
43701619|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
44460877|NCT01557244|Oxybutynin|oxybutynin|mesh-list
44460878|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44460879|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44460880|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
44460881|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44046574|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046575|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046576|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046577|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046578|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046579|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046580|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046581|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046582|NCT00003269|Protective Agents|protective agents|mesh-ancestor
44046583|NCT00003273|Leucovorin|leucovorin|mesh-list
44046584|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
44046585|NCT00003273|Temozolomide|temozolomide|mesh-list
44046586|NCT00003273|Thiotepa|thiotepa|mesh-list
44046587|NCT00003273|Carboplatin|carboplatin|mesh-list
44046588|NCT00003273|Methotrexate|methotrexate|mesh-list
44046589|NCT00003273|Etoposide|etoposide|mesh-list
44046590|NCT00003273|Vincristine|vincristine|mesh-list
44046591|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
44046592|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046593|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
44046594|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046595|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046596|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046597|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
44046598|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046599|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046600|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046601|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44046602|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046603|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44046604|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046605|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
44046620|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046622|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
44046623|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
44046624|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046625|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046626|NCT00003276|Irinotecan|irinotecan|mesh-list
44046627|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046628|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046629|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046630|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046631|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046632|NCT00003278|Dexamethasone|dexamethasone|mesh-list
44046633|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046634|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
44046635|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
44046636|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046637|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046638|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44046639|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
44046640|NCT00003278|Hormones|hormones|mesh-ancestor
44046641|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046642|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046643|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046644|NCT00003279|Antibodies|antibodies|mesh-list
44046645|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44046646|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
44046647|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
44046648|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046649|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046650|NCT00003280|Rituximab|rituximab|mesh-list
44046651|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44046652|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046653|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
44046654|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046655|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44460882|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460883|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460884|NCT01557244|Urological Agents|urological agents|mesh-ancestor
44460885|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
44460886|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
44046656|NCT00003281|Paclitaxel|paclitaxel|mesh-list
44046657|NCT00003281|Topotecan|topotecan|mesh-list
44046658|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046659|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046660|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046661|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046662|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046663|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046664|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046665|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046666|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046667|NCT00003283|Prednisone|prednisone|mesh-list
44046668|NCT00003283|Octreotide|octreotide|mesh-list
44046673|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046674|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046675|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046676|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44046677|NCT00003284|Paclitaxel|paclitaxel|mesh-list
44046678|NCT00003284|Etoposide|etoposide|mesh-list
44046679|NCT00003284|Carboplatin|carboplatin|mesh-list
44046680|NCT00003284|Ifosfamide|ifosfamide|mesh-list
44046681|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046682|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046683|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046684|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046685|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046686|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046687|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046688|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046689|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046690|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046691|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
44149646|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149647|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149648|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44149649|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
44149650|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44149651|NCT00208520|Analgesics|analgesics|mesh-ancestor
44149652|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
44149653|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149654|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44149655|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44149657|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149658|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149659|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149660|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149661|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149662|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149663|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
44149664|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
44149665|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44046692|NCT00003287|Leucovorin|leucovorin|mesh-list
44046693|NCT00003287|Fluorouracil|fluorouracil|mesh-list
44046694|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
44046695|NCT00003287|Calcium|calcium|mesh-list
44046696|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
44046697|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44046698|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046699|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
44046700|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046701|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046702|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046703|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046704|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
44046705|NCT00003287|Antidotes|antidotes|mesh-ancestor
44046706|NCT00003287|Protective Agents|protective agents|mesh-ancestor
44460887|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460888|NCT01557166|Liraglutide|liraglutide|mesh-list
44460889|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460890|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460891|NCT01557166|Incretins|incretins|mesh-ancestor
44460892|NCT01557166|Hormones|hormones|mesh-ancestor
44046707|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046708|NCT00003287|Vitamins|vitamins|mesh-ancestor
44046709|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
44046710|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
44046711|NCT00003288|Tirapazamine|tirapazamine|mesh-list
44046712|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046713|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
44046714|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046715|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046716|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046717|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
44046718|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046719|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046720|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046721|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44046724|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046725|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046726|NCT00003290|Hormones|hormones|mesh-list
44046727|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046728|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046729|NCT00003292|Ifosfamide|ifosfamide|mesh-list
44046730|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046731|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
44046732|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046733|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046734|NCT00003293|Procarbazine|procarbazine|mesh-list
44046735|NCT00003293|Leflunomide|leflunomide|mesh-list
44046736|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046737|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046738|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046739|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
44046740|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046741|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046742|NCT00003294|Paclitaxel|paclitaxel|mesh-list
44046743|NCT00003294|Carboplatin|carboplatin|mesh-list
44046744|NCT00003294|Amifostine|amifostine|mesh-list
44046745|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046746|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046747|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046748|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046749|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046750|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046751|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046752|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046753|NCT00003294|Protective Agents|protective agents|mesh-ancestor
44046754|NCT00003296|Doxorubicin|doxorubicin|mesh-list
44046755|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046756|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046757|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046758|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046759|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046760|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046761|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046763|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
44046764|NCT00003297|Thiotepa|thiotepa|mesh-list
44046765|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046766|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773469|NCT02358993|Renal Agents|renal agents|mesh-ancestor
44046767|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046768|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046769|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046770|NCT00003297|Analgesics|analgesics|mesh-ancestor
44046771|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
44460893|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460895|NCT01556997|Perindopril|perindopril|mesh-list
44460896|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43906051|NCT00238615|Docetaxel|docetaxel|mesh-list
44046772|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046773|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046774|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046775|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046776|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
44046777|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046778|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046779|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
44046780|NCT00003299|Paclitaxel|paclitaxel|mesh-list
44046781|NCT00003299|Etoposide|etoposide|mesh-list
44046782|NCT00003299|Cisplatin|cisplatin|mesh-list
44046783|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046784|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046785|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046786|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046787|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046788|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046789|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046790|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046791|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046792|NCT00003301|Irinotecan|irinotecan|mesh-list
44046793|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046798|NCT00003304|Temozolomide|temozolomide|mesh-list
44046799|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046800|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
44046801|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046802|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046803|NCT00003305|Leucovorin|leucovorin|mesh-list
44046804|NCT00003305|Calcium|calcium|mesh-list
44046805|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
44046806|NCT00003305|Aminopterin|aminopterin|mesh-list
44046807|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44046808|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046809|NCT00003305|Antidotes|antidotes|mesh-ancestor
44046810|NCT00003305|Protective Agents|protective agents|mesh-ancestor
44046811|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046812|NCT00003305|Vitamins|vitamins|mesh-ancestor
44046813|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
44046814|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44046815|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046816|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046817|NCT00003307|Amifostine|amifostine|mesh-list
44046818|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046819|NCT00003307|Protective Agents|protective agents|mesh-ancestor
44046820|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046821|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
44046822|NCT00003309|Cisplatin|cisplatin|mesh-list
44046823|NCT00003309|Etoposide|etoposide|mesh-list
44046824|NCT00003309|Vincristine|vincristine|mesh-list
44046825|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046826|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
44046827|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046828|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046829|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046830|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
44046831|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046832|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046833|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046834|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046835|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046836|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046837|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046838|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046839|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046840|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046841|NCT00003311|Cytarabine|cytarabine|mesh-list
44046842|NCT00003311|Dexamethasone|dexamethasone|mesh-list
43773504|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
44252319|NCT03747419|Avelumab|avelumab|mesh-list
44252320|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44046843|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
44046844|NCT00003311|Doxorubicin|doxorubicin|mesh-list
44046845|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046846|NCT00003311|Methotrexate|methotrexate|mesh-list
44046847|NCT00003311|Vincristine|vincristine|mesh-list
44046848|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046849|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
44046850|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046851|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046852|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046853|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
44046854|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046855|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046856|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046857|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046858|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
44046859|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
44046860|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44046861|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44046862|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
44046863|NCT00003311|Hormones|hormones|mesh-ancestor
44046864|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43543617|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046871|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
44046872|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44046873|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046874|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
44046875|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44046876|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44046877|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046878|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
44046879|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046880|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046881|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046882|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046883|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046884|NCT00003313|Paclitaxel|paclitaxel|mesh-list
44046885|NCT00003313|Carboplatin|carboplatin|mesh-list
44046886|NCT00003313|Amifostine|amifostine|mesh-list
44046887|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046888|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046889|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046890|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046891|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046892|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046893|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046894|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046895|NCT00003313|Protective Agents|protective agents|mesh-ancestor
44046896|NCT00003315|Amphotericin B|amphotericin b|mesh-list
44046897|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44046898|NCT00003315|Sargramostim|sargramostim|mesh-list
44046899|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
44046900|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046901|NCT00003315|Amebicides|amebicides|mesh-ancestor
44046902|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44046903|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44046904|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046905|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44046906|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
44046907|NCT00003316|Gemcitabine|gemcitabine|mesh-list
44046908|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046909|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
44046910|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046911|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046912|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
44046913|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046914|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046915|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046916|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
44046917|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046918|NCT00003317|Paclitaxel|paclitaxel|mesh-list
44046919|NCT00003317|Carboplatin|carboplatin|mesh-list
44046920|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824463|NCT05512351|Bevacizumab|bevacizumab|mesh-list
44046921|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046922|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046923|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046924|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046925|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046926|NCT00003322|Paclitaxel|paclitaxel|mesh-list
44046927|NCT00003322|Cisplatin|cisplatin|mesh-list
44046928|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046929|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046930|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046931|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046932|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046933|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046940|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
44046941|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046942|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046943|NCT00003323|Urological Agents|urological agents|mesh-ancestor
44046944|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
44046945|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046946|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046947|NCT00003326|Paclitaxel|paclitaxel|mesh-list
44046948|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046949|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046950|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046951|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046952|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046953|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046954|NCT00003327|Paclitaxel|paclitaxel|mesh-list
44046955|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046956|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046957|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046958|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046959|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046960|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046961|NCT00003328|Porfiromycin|porfiromycin|mesh-list
44046962|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046963|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046964|NCT00003330|Interleukin-12|interleukin-12|mesh-list
44046965|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44046966|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
44046967|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046968|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44046969|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44046970|NCT00003330|Growth Substances|growth substances|mesh-ancestor
44046971|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44046972|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046973|NCT00003331|Leucovorin|leucovorin|mesh-list
44046974|NCT00003331|Fluorouracil|fluorouracil|mesh-list
44046975|NCT00003331|Topotecan|topotecan|mesh-list
44046976|NCT00003331|Calcium|calcium|mesh-list
44046977|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
44046978|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44046979|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046980|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
44046981|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046982|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046983|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046984|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046985|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
44046986|NCT00003331|Antidotes|antidotes|mesh-ancestor
44046987|NCT00003331|Protective Agents|protective agents|mesh-ancestor
44046988|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046989|NCT00003331|Vitamins|vitamins|mesh-ancestor
44046990|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
44046991|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046992|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046993|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046994|NCT00003332|Gemcitabine|gemcitabine|mesh-list
44046995|NCT00003332|Cisplatin|cisplatin|mesh-list
44046996|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046997|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046999|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047000|NCT00003332|Antiviral Agents|antiviral agents|mesh-ancestor
44047001|NCT00003332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252321|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252322|NCT03669614|Gallium citrate|gallium citrate|mesh-list
44252323|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252324|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44047002|NCT00003332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047003|NCT00003332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43543755|NCT03691636|Lifitegrast|lifitegrast|mesh-list
44047012|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047013|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047014|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047015|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047016|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047017|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047018|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047019|NCT00003335|Cyclosporine|cyclosporine|mesh-list
44047020|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
44047022|NCT00003335|Busulfan|busulfan|mesh-list
44047023|NCT00003335|Cyclosporins|cyclosporins|mesh-list
44047024|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44047025|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047026|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047027|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047028|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
44047029|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047030|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
44047031|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047032|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047033|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047034|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44047035|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047036|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
44047037|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
44047038|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047039|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047040|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
44047041|NCT00003335|Hormones|hormones|mesh-ancestor
44047042|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047043|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44047044|NCT00003335|Protective Agents|protective agents|mesh-ancestor
44047045|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047046|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047047|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
44047048|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047049|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
44047050|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
44047051|NCT00003336|Melphalan|melphalan|mesh-list
44047052|NCT00003336|Busulfan|busulfan|mesh-list
44047053|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44047054|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047055|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
44047056|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047057|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047058|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047059|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
44047060|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047061|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047062|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047063|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047064|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
44047065|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
44047066|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047067|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047068|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
44047069|NCT00003336|Hormones|hormones|mesh-ancestor
44047070|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047071|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44047072|NCT00003336|Protective Agents|protective agents|mesh-ancestor
44047082|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
44047083|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047084|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44047085|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252326|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252327|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252328|NCT03651011|Growth Substances|growth substances|mesh-ancestor
44252329|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252330|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
44252331|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252332|NCT03641326|Sunitinib|sunitinib|mesh-list
44252333|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047086|NCT00003339|Growth Substances|growth substances|mesh-ancestor
44047087|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
44047088|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047089|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
44047091|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047092|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
44047093|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047094|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047095|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047096|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
44047097|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047098|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047099|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047100|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047101|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047102|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047103|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
44047104|NCT00003341|Hematinics|hematinics|mesh-ancestor
44047105|NCT00003342|Gemcitabine|gemcitabine|mesh-list
44047106|NCT00003342|Paclitaxel|paclitaxel|mesh-list
44047107|NCT00003342|Carboplatin|carboplatin|mesh-list
44047108|NCT00003342|Doxorubicin|doxorubicin|mesh-list
44047109|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047110|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047111|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047112|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047113|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047114|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047115|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047116|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047117|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
44047118|NCT00003342|Antiviral Agents|antiviral agents|mesh-ancestor
44047119|NCT00003342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047120|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047121|NCT00003342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047122|NCT00003342|Immunologic Factors|immunologic factors|mesh-ancestor
44047123|NCT00003342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047124|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047125|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047126|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047127|NCT00003343|Prednisone|prednisone|mesh-list
44047128|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
44047129|NCT00003343|Prinomastat|prinomastat|mesh-list
44047130|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047131|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
44047132|NCT00003343|Hormones|hormones|mesh-ancestor
44047133|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047134|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047135|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047136|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047137|NCT00003343|Analgesics|analgesics|mesh-ancestor
44047138|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
44047139|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047140|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047141|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047157|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047158|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047159|NCT00003346|Acetaminophen|acetaminophen|mesh-list
44047160|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
44252334|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252335|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252336|NCT03641326|Growth Substances|growth substances|mesh-ancestor
44252337|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252338|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44047161|NCT00003346|Carmustine|carmustine|mesh-list
44047162|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44047163|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44047164|NCT00003346|Analgesics|analgesics|mesh-ancestor
44047165|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
44047166|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047167|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047168|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
44047169|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
44047170|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047171|NCT00003346|Expectorants|expectorants|mesh-ancestor
44047172|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
44047173|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44047174|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
44047175|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047176|NCT00003346|Protective Agents|protective agents|mesh-ancestor
44047177|NCT00003346|Antidotes|antidotes|mesh-ancestor
44047178|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047179|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
44047180|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047181|NCT00003348|Carmustine|carmustine|mesh-list
44047182|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44047183|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047184|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
44081355|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
44047185|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047186|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047187|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047188|NCT00003350|Paclitaxel|paclitaxel|mesh-list
44047189|NCT00003350|Doxorubicin|doxorubicin|mesh-list
44047190|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047191|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047192|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047193|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047194|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047195|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047196|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047197|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047198|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047199|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047200|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047201|NCT00003351|Irinotecan|irinotecan|mesh-list
44047202|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43543973|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
44047206|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047208|NCT00003352|Docetaxel|docetaxel|mesh-list
44047209|NCT00003352|Doxorubicin|doxorubicin|mesh-list
44047210|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047211|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047212|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
44047213|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047214|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047215|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047216|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
44047217|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047218|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047219|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047220|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047221|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047222|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047223|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047224|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047225|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047226|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047228|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
44047229|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047230|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252339|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252341|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252342|NCT03637062|Progesterone|progesterone|mesh-list
44252343|NCT03637062|Progestins|progestins|mesh-ancestor
44252344|NCT03637062|Hormones|hormones|mesh-ancestor
44252345|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047231|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
44047232|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047233|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047234|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047235|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047236|NCT00003356|Aldesleukin|aldesleukin|mesh-list
44047237|NCT00003356|Rituximab|rituximab|mesh-list
44047238|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44047239|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047240|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
44047241|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047242|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047243|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44047244|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44047245|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
44047246|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047247|NCT00003358|Gemcitabine|gemcitabine|mesh-list
44047248|NCT00003358|Cisplatin|cisplatin|mesh-list
44047249|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047250|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047251|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
44047252|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047253|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
44047254|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047255|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047256|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047257|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
44047258|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047259|NCT00003360|Antibodies|antibodies|mesh-list
44047260|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44047261|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
44047262|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047263|NCT00003361|Decitabine|decitabine|mesh-list
44047264|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047265|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
44047266|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047267|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047268|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047269|NCT00003362|Sargramostim|sargramostim|mesh-list
44047270|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
44047271|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
44047272|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047273|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44047274|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
44047275|NCT00003364|Cisplatin|cisplatin|mesh-list
44047276|NCT00003364|Doxorubicin|doxorubicin|mesh-list
44047277|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047281|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
44047282|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047283|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047284|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047285|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
44047286|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047287|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047288|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047289|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047290|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047291|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047292|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047293|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047294|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252346|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252348|NCT03633110|Nivolumab|nivolumab|mesh-list
44047295|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047296|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047297|NCT00003365|Curcumin|curcumin|mesh-list
44047298|NCT00003365|Sulindac|sulindac|mesh-list
44047299|NCT00003365|Quercetin|quercetin|mesh-list
44047300|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44047301|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44047302|NCT00003365|Analgesics|analgesics|mesh-ancestor
44047303|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
44047304|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047305|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047306|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047307|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047308|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047309|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047310|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047311|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
44047312|NCT00003365|Protective Agents|protective agents|mesh-ancestor
44047313|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44047315|NCT00003367|Vitamins|vitamins|mesh-ancestor
44047316|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
44047317|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047318|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
44047319|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047320|NCT00003367|Protective Agents|protective agents|mesh-ancestor
44047321|NCT00003368|Irinotecan|irinotecan|mesh-list
44047322|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047323|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047324|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047325|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047326|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047327|NCT00003369|Cisplatin|cisplatin|mesh-list
44047328|NCT00003369|Tirapazamine|tirapazamine|mesh-list
44047329|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047330|NCT00003370|Irofulven|irofulven|mesh-list
44047331|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047332|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
44047333|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047334|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047335|NCT00003372|Topotecan|topotecan|mesh-list
44047336|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047337|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047338|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047339|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047340|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047341|NCT00003375|Vincristine|vincristine|mesh-list
44047342|NCT00003375|Lomustine|lomustine|mesh-list
44047343|NCT00003375|Procarbazine|procarbazine|mesh-list
44047344|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047345|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047346|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047347|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047348|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047349|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047350|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047351|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
44047361|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047362|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047363|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047364|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047365|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047366|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047367|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047368|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047369|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44047370|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
44047371|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44047372|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047373|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047374|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
44252349|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252350|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252351|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44252352|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047375|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047376|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44047377|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047378|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
44047379|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047380|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44047382|NCT00003378|Paclitaxel|paclitaxel|mesh-list
44047383|NCT00003378|Carboplatin|carboplatin|mesh-list
44047384|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047385|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047386|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047387|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047388|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047389|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047390|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047391|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
44047392|NCT00003378|Antiviral Agents|antiviral agents|mesh-ancestor
44047393|NCT00003378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047394|NCT00003378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047395|NCT00003378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047396|NCT00003378|Immunologic Factors|immunologic factors|mesh-ancestor
44047397|NCT00003378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047398|NCT00003379|Paclitaxel|paclitaxel|mesh-list
44047399|NCT00003379|Cisplatin|cisplatin|mesh-list
44047400|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047401|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047402|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047403|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047404|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047405|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047406|NCT00003380|Doxorubicin|doxorubicin|mesh-list
44047407|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047408|NCT00003380|Etoposide|etoposide|mesh-list
44047409|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047410|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047411|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047412|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047413|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047414|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047415|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047416|NCT00003382|Gemcitabine|gemcitabine|mesh-list
44047417|NCT00003382|Topotecan|topotecan|mesh-list
44047418|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047419|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
44047420|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047422|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
44047423|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047424|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047425|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047426|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
44047427|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047428|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047429|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047430|NCT00003385|Paclitaxel|paclitaxel|mesh-list
44047431|NCT00003385|Carboplatin|carboplatin|mesh-list
44047432|NCT00003385|Doxorubicin|doxorubicin|mesh-list
44047433|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047434|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047435|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047436|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047437|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047438|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047439|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047440|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047441|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047442|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252353|NCT03628066|Letrozole|letrozole|mesh-list
44252354|NCT03628066|Palbociclib|palbociclib|mesh-list
44252355|NCT03628066|Goserelin|goserelin|mesh-list
44252356|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047443|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047444|NCT00003386|Paclitaxel|paclitaxel|mesh-list
44047445|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
44047446|NCT00003386|Cisplatin|cisplatin|mesh-list
44047447|NCT00003386|Carboplatin|carboplatin|mesh-list
44047448|NCT00003386|Vaccines|vaccines|mesh-list
44047449|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
44047450|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
44047451|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773877|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
44047452|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047453|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047454|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047455|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047456|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047457|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047458|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047459|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047460|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047461|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
44047462|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047463|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44047465|NCT00003387|Carboplatin|carboplatin|mesh-list
44047466|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047467|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047468|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047469|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047470|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047471|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047472|NCT00003388|Cytarabine|cytarabine|mesh-list
44047473|NCT00003388|Prednisone|prednisone|mesh-list
44047474|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
44047475|NCT00003388|Doxorubicin|doxorubicin|mesh-list
44047476|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047477|NCT00003388|Methotrexate|methotrexate|mesh-list
44047478|NCT00003388|Vincristine|vincristine|mesh-list
44047479|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047480|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
44047481|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047482|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047483|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047484|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
44047485|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047486|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047487|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047488|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047489|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047490|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047491|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047492|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047493|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
44047494|NCT00003388|Hormones|hormones|mesh-ancestor
44047495|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047496|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047499|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44047500|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047501|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
44047502|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047503|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44047504|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44047505|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
44047506|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047507|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047508|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047509|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047510|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047511|NCT00003390|Irofulven|irofulven|mesh-list
44047512|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047513|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
44047514|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252357|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44252358|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44252359|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252360|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252361|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44252362|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
44252363|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047515|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047517|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44047518|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
44047519|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047520|NCT00003392|Paclitaxel|paclitaxel|mesh-list
44047521|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
44047522|NCT00003392|Carboplatin|carboplatin|mesh-list
44047523|NCT00003392|Melphalan|melphalan|mesh-list
44047524|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047525|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047526|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047527|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773930|NCT02355938|Vancomycin|vancomycin|mesh-list
44047528|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047529|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047530|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047531|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
44047532|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047533|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047534|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047535|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
44047536|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047538|NCT00003394|Carboplatin|carboplatin|mesh-list
44047539|NCT00003394|Leuprolide|leuprolide|mesh-list
44047540|NCT00003394|Goserelin|goserelin|mesh-list
44047541|NCT00003394|Estramustine|estramustine|mesh-list
44047542|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047543|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047544|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047545|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047546|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047547|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047548|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44047549|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
44047550|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44047551|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047552|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047553|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047554|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
44047555|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
44047556|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047557|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
44047558|NCT00003396|Melphalan|melphalan|mesh-list
44047559|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44047560|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047561|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
44047562|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047563|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047564|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047565|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
44047566|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047567|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047568|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047569|NCT00003397|Gemcitabine|gemcitabine|mesh-list
44047570|NCT00003397|Dexamethasone|dexamethasone|mesh-list
44047571|NCT00003397|Etoposide|etoposide|mesh-list
44047581|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
44047582|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047583|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047584|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047585|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
44252364|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252365|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252366|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047587|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44047588|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047589|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
44047590|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
44047591|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047592|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047593|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
44047595|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047596|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047597|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047598|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
44047599|NCT00003397|Antiviral Agents|antiviral agents|mesh-ancestor
44047600|NCT00003397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047601|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047602|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047603|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047604|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
44047606|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44047607|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047608|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
44047609|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047610|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047611|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047612|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
44047613|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047614|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047615|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047616|NCT00003399|Dexamethasone|dexamethasone|mesh-list
44047617|NCT00003399|Paclitaxel|paclitaxel|mesh-list
44047618|NCT00003399|Etoposide|etoposide|mesh-list
44047619|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
44047620|NCT00003399|Cisplatin|cisplatin|mesh-list
44047621|NCT00003399|Melphalan|melphalan|mesh-list
44047622|NCT00003399|Carmustine|carmustine|mesh-list
44047623|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047624|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047625|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047626|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047627|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047628|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047629|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047630|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
44047631|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047632|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047633|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047634|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
44047635|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047636|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047637|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
44047638|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
44047639|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047640|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047641|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
44047649|NCT00003400|Melphalan|melphalan|mesh-list
44047650|NCT00003400|Vinorelbine|vinorelbine|mesh-list
44047651|NCT00003400|Carmustine|carmustine|mesh-list
44047652|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047653|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
44047654|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047655|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047656|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
44047657|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047658|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047659|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047660|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047661|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047662|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047663|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252367|NCT03568097|Avelumab|avelumab|mesh-list
44252368|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252369|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252370|NCT03567720|Paclitaxel|paclitaxel|mesh-list
44047664|NCT00003401|Gemcitabine|gemcitabine|mesh-list
44047665|NCT00003401|Dexamethasone|dexamethasone|mesh-list
44047666|NCT00003401|Paclitaxel|paclitaxel|mesh-list
44047667|NCT00003401|Etoposide|etoposide|mesh-list
44047668|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
44047669|NCT00003401|Cisplatin|cisplatin|mesh-list
44047670|NCT00003401|Melphalan|melphalan|mesh-list
44047671|NCT00003401|Carmustine|carmustine|mesh-list
44047672|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047673|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047674|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047675|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047676|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047677|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047678|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047679|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
44047680|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047681|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047682|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047683|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
44047684|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047685|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047686|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
44047687|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
44047688|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047689|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047690|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
44047692|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047693|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047694|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047695|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
44047696|NCT00003401|Antiviral Agents|antiviral agents|mesh-ancestor
44047697|NCT00003401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047698|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047699|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047700|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047701|NCT00003402|Dexamethasone|dexamethasone|mesh-list
44047702|NCT00003402|Paclitaxel|paclitaxel|mesh-list
44047703|NCT00003402|Etoposide|etoposide|mesh-list
44047704|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
44047705|NCT00003402|Cisplatin|cisplatin|mesh-list
44047706|NCT00003402|Melphalan|melphalan|mesh-list
44047707|NCT00003402|Carmustine|carmustine|mesh-list
44047708|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047709|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047710|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047711|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047712|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
43544457|NCT03682198|Protective Agents|protective agents|mesh-ancestor
44047732|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047733|NCT00003405|Interferons|interferons|mesh-list
44047734|NCT00003405|Cytarabine|cytarabine|mesh-list
44047735|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
44081839|NCT01807000|Laxatives|laxatives|mesh-ancestor
44047736|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
44047737|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
44047738|NCT00003405|Idoxuridine|idoxuridine|mesh-list
44047739|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
44047740|NCT00003405|Idarubicin|idarubicin|mesh-list
44047741|NCT00003405|Isotretinoin|isotretinoin|mesh-list
44047742|NCT00003405|Amifostine|amifostine|mesh-list
44047743|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047744|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
44047745|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047746|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047747|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
44047748|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047749|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047750|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
44047751|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047753|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
44047754|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047755|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047756|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252371|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
44252372|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252373|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252374|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252375|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252376|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252377|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047757|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047758|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047759|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047760|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44047761|NCT00003405|Protective Agents|protective agents|mesh-ancestor
44047762|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44047763|NCT00003406|Carboplatin|carboplatin|mesh-list
44047764|NCT00003406|Docetaxel|docetaxel|mesh-list
44047765|NCT00003406|Ifosfamide|ifosfamide|mesh-list
44047766|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047767|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047768|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047769|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
43544538|NCT03680638|Tempol|tempol|mesh-list
44047773|NCT00003407|Cytarabine|cytarabine|mesh-list
44047774|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
44047775|NCT00003407|Amifostine|amifostine|mesh-list
44047776|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047777|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
44047778|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047779|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047780|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
44047781|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047782|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047783|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
44047784|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047785|NCT00003407|Analgesics|analgesics|mesh-ancestor
44047786|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
44047787|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047788|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047789|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047790|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047791|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44047792|NCT00003407|Protective Agents|protective agents|mesh-ancestor
44047793|NCT00003408|Interferons|interferons|mesh-list
44047794|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
44047795|NCT00003408|Aldesleukin|aldesleukin|mesh-list
44047796|NCT00003408|Sargramostim|sargramostim|mesh-list
44047797|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047798|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
44047799|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047800|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
44047801|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047802|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44047803|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44047804|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
44047805|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047806|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44047807|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44149666|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149667|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44149668|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44149669|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
44149670|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44149671|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149672|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44149673|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149674|NCT00208546|Bevacizumab|bevacizumab|mesh-list
44149675|NCT00208546|Cetuximab|cetuximab|mesh-list
44149676|NCT00208546|Capecitabine|capecitabine|mesh-list
44149677|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
44149678|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149679|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252378|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252379|NCT03557788|Rifaximin|rifaximin|mesh-list
44252380|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252381|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252382|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252383|NCT03491059|Nicotine|nicotine|mesh-list
44252384|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44252385|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
44252386|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252387|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252388|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44252389|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44252390|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
44252391|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650379|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
44149680|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44149681|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44149682|NCT00208546|Growth Substances|growth substances|mesh-ancestor
44149683|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149684|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
44149685|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149686|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
44149687|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149688|NCT00208559|Ziprasidone|ziprasidone|mesh-list
44149689|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149690|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
44149691|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149692|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149693|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047808|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
44047809|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047810|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44047811|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047812|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
44047813|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047817|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44047818|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
44047819|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047820|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44047821|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44047822|NCT00003412|Growth Substances|growth substances|mesh-ancestor
44047823|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
44047824|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047825|NCT00003413|Paclitaxel|paclitaxel|mesh-list
44047826|NCT00003413|Cisplatin|cisplatin|mesh-list
44047827|NCT00003413|Melphalan|melphalan|mesh-list
44047828|NCT00003413|Carmustine|carmustine|mesh-list
44047829|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047830|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047831|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047832|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047833|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047834|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047835|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
44047836|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047837|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047838|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
44047839|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047840|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047841|NCT00003414|Interferons|interferons|mesh-list
44047842|NCT00003414|Aldesleukin|aldesleukin|mesh-list
44252392|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252393|NCT03421756|Sirolimus|sirolimus|mesh-list
44252395|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252396|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252397|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252398|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252399|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
44252400|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252401|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
44252402|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252403|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252404|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
44252405|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252406|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047843|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
44047844|NCT00003414|Cyclosporine|cyclosporine|mesh-list
44047845|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
44047846|NCT00003414|Busulfan|busulfan|mesh-list
44047847|NCT00003414|Cyclosporins|cyclosporins|mesh-list
44047848|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047849|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
44047850|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047851|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047852|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047853|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
44047854|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047855|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047856|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047857|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
44047858|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047859|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047860|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
44047861|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047862|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44047863|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44047864|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44047865|NCT00003415|Topotecan|topotecan|mesh-list
44047866|NCT00003415|Amifostine|amifostine|mesh-list
44047867|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047868|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047869|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047870|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047871|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047872|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44047873|NCT00003415|Protective Agents|protective agents|mesh-ancestor
44047874|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047875|NCT00003416|Interferons|interferons|mesh-list
44047876|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
44047877|NCT00003416|Dexamethasone|dexamethasone|mesh-list
44047878|NCT00003416|Melphalan|melphalan|mesh-list
44047879|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047880|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
44047881|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
44047882|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047883|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047884|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047885|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
44047886|NCT00003416|Hormones|hormones|mesh-ancestor
44047887|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047888|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047899|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252407|NCT03412266|Cytarabine|cytarabine|mesh-list
44252408|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
44252409|NCT03412266|Busulfan|busulfan|mesh-list
44252410|NCT03412266|Semustine|semustine|mesh-list
44252411|NCT03412266|Fludarabine|fludarabine|mesh-list
44252412|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44252413|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252414|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
44252415|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252416|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650408|NCT03014687|Cefdinir|cefdinir|mesh-list
44047901|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047902|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047903|NCT00003418|Tamoxifen|tamoxifen|mesh-list
44047904|NCT00003418|Exemestane|exemestane|mesh-list
44047905|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047906|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44047907|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
44047908|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047909|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047910|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047911|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047912|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44047913|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44047914|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44047915|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44047916|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44047917|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047918|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
44047919|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047920|NCT00003421|Prednisolone|prednisolone|mesh-list
44047921|NCT00003421|Doxorubicin|doxorubicin|mesh-list
44047922|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047923|NCT00003421|Bleomycin|bleomycin|mesh-list
44047924|NCT00003421|Etoposide|etoposide|mesh-list
44047925|NCT00003421|Vincristine|vincristine|mesh-list
44047926|NCT00003421|Dacarbazine|dacarbazine|mesh-list
44047927|NCT00003421|Vinblastine|vinblastine|mesh-list
44047928|NCT00003421|Procarbazine|procarbazine|mesh-list
44047929|NCT00003421|Chlorambucil|chlorambucil|mesh-list
44047930|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44047931|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047932|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047933|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047934|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047935|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047936|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047937|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047938|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
44047939|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
44047940|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047941|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
44047942|NCT00003421|Hormones|hormones|mesh-ancestor
44047943|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047944|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047945|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047946|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047947|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
44047948|NCT00003422|Leucovorin|leucovorin|mesh-list
44047949|NCT00003422|Fluorouracil|fluorouracil|mesh-list
44047950|NCT00003422|Calcium|calcium|mesh-list
44047951|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
44047952|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44047953|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047954|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
44047964|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
44047965|NCT00003423|Cytarabine|cytarabine|mesh-list
44047966|NCT00003423|Dexamethasone|dexamethasone|mesh-list
44252417|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252418|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
44252419|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252420|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252421|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252422|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252423|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
44252424|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
44252425|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252426|NCT03365752|Anesthetics|anesthetics|mesh-list
44252427|NCT03365752|Mepivacaine|mepivacaine|mesh-list
44252428|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
44047967|NCT00003423|Prednisolone|prednisolone|mesh-list
44047968|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
44047969|NCT00003423|Methotrexate|methotrexate|mesh-list
44047970|NCT00003423|Etoposide|etoposide|mesh-list
44047971|NCT00003423|Vincristine|vincristine|mesh-list
44047972|NCT00003423|Daunorubicin|daunorubicin|mesh-list
44047973|NCT00003423|Asparaginase|asparaginase|mesh-list
44047974|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
44047975|NCT00003423|Thioguanine|thioguanine|mesh-list
44047976|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047977|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
44047978|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047979|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047980|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047981|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
44047982|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047983|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047984|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047985|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047986|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
44047987|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
44047988|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047989|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047990|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
44047991|NCT00003423|Hormones|hormones|mesh-ancestor
44047992|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047993|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047994|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44047995|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
44047996|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44047997|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047998|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
44047999|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048000|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048001|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048002|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048003|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048004|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048005|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048006|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
44048007|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048008|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048009|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048010|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048011|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048012|NCT00003424|Tamoxifen|tamoxifen|mesh-list
44048013|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44048014|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
44048015|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048016|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048017|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048018|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252429|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
44252430|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252431|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252432|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
44252433|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
44252434|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252436|NCT03254654|Vinorelbine|vinorelbine|mesh-list
44252437|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252438|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44048019|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44048020|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43544796|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44048037|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048039|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048040|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048041|NCT00003426|Antiviral Agents|antiviral agents|mesh-ancestor
44048042|NCT00003426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082147|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
44048043|NCT00003426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048044|NCT00003426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048045|NCT00003426|Immunologic Factors|immunologic factors|mesh-ancestor
44048046|NCT00003426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048047|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
44048048|NCT00003427|Irinotecan|irinotecan|mesh-list
44048049|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048050|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44048051|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048052|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048053|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048054|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44048055|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44048056|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048057|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
44048058|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048059|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
44048060|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048061|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048062|NCT00003431|Protective Agents|protective agents|mesh-ancestor
44048063|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
44048064|NCT00003435|Melphalan|melphalan|mesh-list
44048065|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44048066|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048067|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
44048068|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048069|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048070|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048071|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048072|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
44048073|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048074|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048075|NCT00003436|Cytarabine|cytarabine|mesh-list
44048076|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
44048077|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44048078|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44048089|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048090|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048091|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
44048092|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048093|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048094|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048095|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048096|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048097|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048098|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
44252439|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252440|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252441|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252442|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252443|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252444|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252445|NCT03127592|Etodolac|etodolac|mesh-list
44252446|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
44252447|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44048099|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048100|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048101|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048102|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048103|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048104|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
44048105|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048106|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048107|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048108|NCT00003436|Analgesics|analgesics|mesh-ancestor
44048109|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
44048110|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44048112|NCT00003437|Dexamethasone|dexamethasone|mesh-list
44048113|NCT00003437|Prednisolone|prednisolone|mesh-list
44048114|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
44048115|NCT00003437|Doxorubicin|doxorubicin|mesh-list
44048116|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44048117|NCT00003437|Methotrexate|methotrexate|mesh-list
44048118|NCT00003437|Vincristine|vincristine|mesh-list
44048119|NCT00003437|Daunorubicin|daunorubicin|mesh-list
44048120|NCT00003437|Asparaginase|asparaginase|mesh-list
44048121|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
44048122|NCT00003437|Pegaspargase|pegaspargase|mesh-list
44048123|NCT00003437|Thioguanine|thioguanine|mesh-list
44048124|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048125|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
44048126|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048127|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048128|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048129|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
44048130|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048131|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048132|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048133|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048134|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
44048135|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
44048136|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44048137|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44048138|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
44048140|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048141|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048142|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048143|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048144|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048145|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048146|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43544926|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
44048155|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048156|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048157|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048158|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048159|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048160|NCT00003439|Interleukin-12|interleukin-12|mesh-list
44048161|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048162|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
44048163|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048164|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44048165|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252449|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44252450|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44252451|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252452|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44252453|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252454|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44252455|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252456|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44252457|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252458|NCT03127592|Analgesics|analgesics|mesh-ancestor
43650452|NCT03014297|Everolimus|everolimus|mesh-list
44048166|NCT00003439|Growth Substances|growth substances|mesh-ancestor
44048167|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
44048168|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048169|NCT00003440|Paclitaxel|paclitaxel|mesh-list
44048170|NCT00003440|Trastuzumab|trastuzumab|mesh-list
44048171|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048172|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048173|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048174|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048175|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048176|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048177|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44048178|NCT00003441|Irofulven|irofulven|mesh-list
44048179|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048180|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
44048181|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048182|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048183|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
44048184|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048185|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
44048186|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048187|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774494|NCT02351895|Copper|copper|mesh-list
44048188|NCT00003444|Interferons|interferons|mesh-list
44048189|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
44048190|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048191|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
44048192|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048193|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
44048194|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048195|NCT00003445|Docetaxel|docetaxel|mesh-list
44048196|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048197|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048198|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048199|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048200|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048201|NCT00003446|Leucovorin|leucovorin|mesh-list
44048202|NCT00003446|Trimetrexate|trimetrexate|mesh-list
44048203|NCT00003446|Fluorouracil|fluorouracil|mesh-list
44048204|NCT00003446|Calcium|calcium|mesh-list
44048205|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
44048206|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44048207|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048208|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
44048209|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048210|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048211|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048212|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048213|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
44048219|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
44048220|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048221|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44252459|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
44252460|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252461|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252462|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44252463|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44252464|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252465|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252466|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
44252467|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
44252468|NCT03116425|Vitamins|vitamins|mesh-ancestor
44252469|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
44252470|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252471|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
44252472|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44048222|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048223|NCT00003447|Gemcitabine|gemcitabine|mesh-list
44048224|NCT00003447|Vinorelbine|vinorelbine|mesh-list
44048225|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048226|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
44048227|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048228|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048229|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
44048230|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048231|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048232|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048233|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
44048234|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048235|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048236|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048237|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048238|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048239|NCT00003449|Gemcitabine|gemcitabine|mesh-list
44048240|NCT00003449|Dexamethasone|dexamethasone|mesh-list
44048241|NCT00003449|Paclitaxel|paclitaxel|mesh-list
44048242|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048243|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048244|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048245|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048246|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048247|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048248|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048249|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
44048250|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
44048251|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44048252|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048253|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44048254|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
44048255|NCT00003449|Hormones|hormones|mesh-ancestor
44048256|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048257|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048258|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048259|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
44048260|NCT00003449|Antiviral Agents|antiviral agents|mesh-ancestor
44048261|NCT00003449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048262|NCT00003449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048263|NCT00003449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048264|NCT00003449|Immunologic Factors|immunologic factors|mesh-ancestor
44048265|NCT00003451|Interferons|interferons|mesh-list
44048266|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
44048267|NCT00003451|Interleukin-12|interleukin-12|mesh-list
44048268|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048269|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
44252475|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
44252476|NCT03110822|Lenalidomide|lenalidomide|mesh-list
44252477|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44252478|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
44252479|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
44252480|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252481|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252482|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252483|NCT03110822|Growth Substances|growth substances|mesh-ancestor
44252484|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
44048270|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048271|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
44048272|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048273|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048274|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44048275|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44048276|NCT00003451|Growth Substances|growth substances|mesh-ancestor
44048277|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
44048279|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44048280|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
44048281|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048282|NCT00003462|Busulfan|busulfan|mesh-list
44048283|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
44048284|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048285|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048286|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
44048287|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048296|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048297|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048298|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048299|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
44048300|NCT00003464|Temozolomide|temozolomide|mesh-list
44048301|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048302|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
44048303|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048304|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048305|NCT00003465|Temozolomide|temozolomide|mesh-list
44048306|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048307|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
44048308|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048309|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048310|NCT00003466|Temozolomide|temozolomide|mesh-list
44048311|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048312|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
44048313|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048314|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048316|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048317|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
44048318|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048319|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048320|NCT00003478|Antibodies|antibodies|mesh-list
44048321|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44048322|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
44048323|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048324|NCT00003484|Irinotecan|irinotecan|mesh-list
44048325|NCT00003484|Carmustine|carmustine|mesh-list
44048326|NCT00003484|Antibodies|antibodies|mesh-list
44048327|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44048328|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
44252485|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252486|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252487|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
44252488|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
44252489|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252490|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252491|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
44252492|NCT03110822|Hormones|hormones|mesh-ancestor
44252493|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252494|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44048329|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048330|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44048331|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048332|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048333|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048334|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048335|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048336|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
44048337|NCT00003490|Prednisone|prednisone|mesh-list
44048338|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
44048339|NCT00003490|Vincristine|vincristine|mesh-list
44048340|NCT00003490|Sargramostim|sargramostim|mesh-list
44048341|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048342|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
44048343|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048344|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048345|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048346|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
44048347|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048348|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048349|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048350|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048351|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
44048352|NCT00003490|Hormones|hormones|mesh-ancestor
44048353|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43545134|NCT03675191|Orlistat|orlistat|mesh-list
44048363|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048364|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
44048365|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
44048366|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44048367|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048368|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44048369|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
44048370|NCT00003493|Hormones|hormones|mesh-ancestor
44048371|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048372|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048373|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048374|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048375|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048376|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048377|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048378|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048379|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048380|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048381|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048382|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048383|NCT00003517|Leuprolide|leuprolide|mesh-list
44048384|NCT00003517|Flutamide|flutamide|mesh-list
44048385|NCT00003517|Bicalutamide|bicalutamide|mesh-list
44048386|NCT00003517|Hormones|hormones|mesh-list
44048387|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
44048388|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048389|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048390|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44252495|NCT03110822|Protective Agents|protective agents|mesh-ancestor
44252496|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252497|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
44252498|NCT03105843|Miotics|miotics|mesh-ancestor
44252499|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
44252500|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252501|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252502|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44252503|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44252504|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44252505|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44252506|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44252507|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620936|NCT03120221|Iodine|iodine|mesh-list
44048391|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
44048392|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048393|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048394|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048395|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
44048396|NCT00003518|Gemcitabine|gemcitabine|mesh-list
44048397|NCT00003518|Paclitaxel|paclitaxel|mesh-list
44048398|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048399|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048400|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048401|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048402|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048403|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048404|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048405|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
44048406|NCT00003518|Antiviral Agents|antiviral agents|mesh-ancestor
44048407|NCT00003518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048408|NCT00003518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048409|NCT00003518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048410|NCT00003518|Immunologic Factors|immunologic factors|mesh-ancestor
44048411|NCT00003518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048412|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
44048413|NCT00003519|Docetaxel|docetaxel|mesh-list
44048414|NCT00003519|Doxorubicin|doxorubicin|mesh-list
44048415|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43774634|NCT02351297|Caseins|caseins|mesh-list
44048416|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048417|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
44048418|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048419|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048420|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048424|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048425|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048426|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048427|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048428|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048429|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048430|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048431|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048432|NCT00003528|Raltitrexed|raltitrexed|mesh-list
44048433|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048434|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
44048435|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048436|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048437|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048438|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048439|NCT00003536|Methotrexate|methotrexate|mesh-list
44048440|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048441|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
44252508|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252509|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252510|NCT03103750|Calcitriol|calcitriol|mesh-list
44252511|NCT03103750|Amphetamine|amphetamine|mesh-list
44252512|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
44252513|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44252514|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252515|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43824489|NCT05512013|Analgesics|analgesics|mesh-ancestor
44048442|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048443|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048444|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048445|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
44048446|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048447|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048448|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048449|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048450|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048451|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048452|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
44048453|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048454|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048455|NCT00003539|Paclitaxel|paclitaxel|mesh-list
44048456|NCT00003539|Trastuzumab|trastuzumab|mesh-list
44048457|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048458|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048459|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048460|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048461|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048462|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048463|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44048464|NCT00003540|Gemcitabine|gemcitabine|mesh-list
44048465|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048466|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
44048467|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048468|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048469|NCT00003540|Antiviral Agents|antiviral agents|mesh-ancestor
44048470|NCT00003540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048471|NCT00003540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048472|NCT00003540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048473|NCT00003540|Immunologic Factors|immunologic factors|mesh-ancestor
44048474|NCT00003540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048475|NCT00003541|Prednisone|prednisone|mesh-list
44048476|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
44048477|NCT00003541|Ifosfamide|ifosfamide|mesh-list
44048478|NCT00003541|Carboplatin|carboplatin|mesh-list
44048479|NCT00003541|Doxorubicin|doxorubicin|mesh-list
44048480|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44048481|NCT00003541|Etoposide|etoposide|mesh-list
44048482|NCT00003541|Vincristine|vincristine|mesh-list
44048483|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048484|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
44048485|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048486|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048487|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048488|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
44048489|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048490|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048491|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048492|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048494|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048495|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048496|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048498|NCT00003541|Hormones|hormones|mesh-ancestor
44048499|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048500|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252516|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252517|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252518|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44252520|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
44252521|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44252522|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44252523|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
44252524|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
44252525|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252526|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
44252527|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252528|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
44048501|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048502|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048503|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048504|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048505|NCT00003542|Interferons|interferons|mesh-list
44048506|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
44048507|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048508|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
44048509|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048510|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
44048511|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048512|NCT00003543|Fluorouracil|fluorouracil|mesh-list
44048513|NCT00003543|Vincristine|vincristine|mesh-list
44048514|NCT00003543|Carmustine|carmustine|mesh-list
44048515|NCT00003543|Streptozocin|streptozocin|mesh-list
44048516|NCT00003543|Antibodies|antibodies|mesh-list
44048517|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44048518|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
44048519|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048520|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
44048521|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048522|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048523|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048524|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048525|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048526|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048527|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048528|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048529|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048530|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
44048531|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048532|NCT00003544|Irinotecan|irinotecan|mesh-list
44048533|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44048534|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048535|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048536|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048537|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048538|NCT00003546|Gemcitabine|gemcitabine|mesh-list
44048539|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048540|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
44048541|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048542|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048543|NCT00003546|Antiviral Agents|antiviral agents|mesh-ancestor
44048544|NCT00003546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048545|NCT00003546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048546|NCT00003546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048547|NCT00003546|Immunologic Factors|immunologic factors|mesh-ancestor
44048548|NCT00003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048549|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
44048550|NCT00003549|Fluorouracil|fluorouracil|mesh-list
44252529|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44252530|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44252531|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44252533|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252534|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252535|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
44252536|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
44252537|NCT03083678|Afatinib|afatinib|mesh-list
44252538|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048551|NCT00003549|Methotrexate|methotrexate|mesh-list
44048552|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048553|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
44048554|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048555|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048556|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048557|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
44048558|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048559|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048560|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048561|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
44048562|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048563|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048564|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048565|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048566|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048572|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44048573|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048574|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
44048575|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048576|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048577|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048578|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
44048579|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048580|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048581|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048582|NCT00003554|Prednisone|prednisone|mesh-list
44048583|NCT00003554|Rituximab|rituximab|mesh-list
44048584|NCT00003554|Melphalan|melphalan|mesh-list
44048585|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44048586|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048587|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
44048588|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048589|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048590|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048591|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
44048592|NCT00003554|Hormones|hormones|mesh-ancestor
44048593|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048594|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048595|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048596|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
44048597|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048598|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048599|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149694|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149695|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149696|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149697|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149698|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149699|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
44149700|NCT00208572|Citalopram|citalopram|mesh-list
44149701|NCT00208572|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149702|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44252539|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252540|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252541|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252542|NCT03071926|Doxorubicin|doxorubicin|mesh-list
44252543|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44252544|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252545|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252546|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252547|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252548|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846429|NCT04199572|Acetaminophen|acetaminophen|mesh-list
44149703|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149704|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149705|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149707|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149708|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44149709|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149710|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149711|NCT00208585|Sertraline|sertraline|mesh-list
44149712|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149713|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149714|NCT00208585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149715|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149716|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149717|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149718|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149719|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
44149720|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149721|NCT00208611|Vitamins|vitamins|mesh-list
44149722|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
44149723|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
44149724|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
44149725|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
44149726|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149727|NCT00208611|Hematinics|hematinics|mesh-ancestor
44149728|NCT00208702|Sertraline|sertraline|mesh-list
44149729|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149730|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149731|NCT00208702|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44048603|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048604|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048605|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048606|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048607|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048608|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048609|NCT00003555|Protective Agents|protective agents|mesh-ancestor
44048610|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048611|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
44048612|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048613|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048614|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048615|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048616|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048617|NCT00003558|Leucovorin|leucovorin|mesh-list
44048618|NCT00003558|Paclitaxel|paclitaxel|mesh-list
44048619|NCT00003558|Etoposide|etoposide|mesh-list
44048620|NCT00003558|Carboplatin|carboplatin|mesh-list
44048621|NCT00003558|Fluorouracil|fluorouracil|mesh-list
44048622|NCT00003558|Calcium|calcium|mesh-list
44048623|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
44048624|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048625|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048626|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048627|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048628|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252549|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460897|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44460898|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460899|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460900|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44460901|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460902|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44460903|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44460904|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
44460905|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44460906|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
44048629|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048630|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44048631|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048632|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
44048633|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048634|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048635|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
44048636|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048637|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048638|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048639|NCT00003558|Antidotes|antidotes|mesh-ancestor
44048640|NCT00003558|Protective Agents|protective agents|mesh-ancestor
44048641|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44048642|NCT00003558|Vitamins|vitamins|mesh-ancestor
44048643|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
44048644|NCT00003560|Carboplatin|carboplatin|mesh-list
44048645|NCT00003560|Docetaxel|docetaxel|mesh-list
44048646|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048647|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048648|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048649|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048650|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048651|NCT00003561|Interferons|interferons|mesh-list
44048652|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
44048653|NCT00003561|Sargramostim|sargramostim|mesh-list
44048654|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048655|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
44048656|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048657|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
44048658|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048659|NCT00003562|Carboplatin|carboplatin|mesh-list
44048660|NCT00003562|Docetaxel|docetaxel|mesh-list
44048661|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048662|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048663|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048664|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048673|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048674|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048675|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048676|NCT00003567|Temozolomide|temozolomide|mesh-list
44048677|NCT00003567|Carmustine|carmustine|mesh-list
44048678|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44048679|NCT00003567|Sargramostim|sargramostim|mesh-list
44048680|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
44048681|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048682|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048683|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
44048684|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048685|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048686|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048687|NCT00003568|Aldesleukin|aldesleukin|mesh-list
44048688|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
44460907|NCT01556932|Promethazine|promethazine|mesh-list
44460908|NCT01556932|Lorazepam|lorazepam|mesh-list
44460909|NCT01556932|Haloperidol|haloperidol|mesh-list
44460910|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44460911|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44460912|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460913|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460914|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
44460915|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
44460916|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
44460917|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460918|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
44048689|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048690|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44048691|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44048692|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
44048693|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048694|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048695|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
44048696|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048697|NCT00003569|Paclitaxel|paclitaxel|mesh-list
44048698|NCT00003569|Cisplatin|cisplatin|mesh-list
44048699|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048700|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048701|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048702|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048703|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048704|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048705|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
44048706|NCT00003572|Tacrolimus|tacrolimus|mesh-list
44048707|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048708|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
44048709|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048710|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44048711|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048712|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048713|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048714|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048715|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44048716|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
44048717|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44048718|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048719|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
44048720|NCT00003573|Cisplatin|cisplatin|mesh-list
44048721|NCT00003573|Etoposide|etoposide|mesh-list
44048722|NCT00003573|Vincristine|vincristine|mesh-list
44048723|NCT00003573|Lenograstim|lenograstim|mesh-list
44048724|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048725|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
44048726|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048727|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048728|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048729|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
44048730|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048731|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048732|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048737|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048739|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048740|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048741|NCT00003575|Etoposide|etoposide|mesh-list
44048742|NCT00003575|Ifosfamide|ifosfamide|mesh-list
44048743|NCT00003575|Interleukin-12|interleukin-12|mesh-list
44048744|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048745|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048746|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048747|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44460920|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460921|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44460922|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
44460923|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
44460924|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44460925|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460926|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44460927|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
44460928|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460929|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44460930|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460931|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44048748|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048749|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048750|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44048751|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
44048752|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048753|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048754|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
44048755|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44048756|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44048757|NCT00003575|Growth Substances|growth substances|mesh-ancestor
44048758|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
44048759|NCT00003576|Cisplatin|cisplatin|mesh-list
44048760|NCT00003576|Fluorouracil|fluorouracil|mesh-list
44048761|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048762|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
44048763|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048764|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048765|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048766|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
44048767|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048768|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
44048769|NCT00003577|Fluorouracil|fluorouracil|mesh-list
44048770|NCT00003577|Methotrexate|methotrexate|mesh-list
44048771|NCT00003577|Epirubicin|epirubicin|mesh-list
44048772|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048773|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
44048774|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048775|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048776|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048777|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
44048778|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048779|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048780|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048781|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
44048782|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048783|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048784|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048785|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048786|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048787|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048788|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048789|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048790|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048791|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048792|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048793|NCT00003578|Cytarabine|cytarabine|mesh-list
44048794|NCT00003578|Prednisone|prednisone|mesh-list
44048795|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
44048796|NCT00003578|Melphalan|melphalan|mesh-list
44048797|NCT00003578|Carmustine|carmustine|mesh-list
44460932|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44460933|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
44460934|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44460935|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
44460936|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44460937|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
44460938|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
44460939|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
43621502|NCT03115775|Vitamin D|vitamin d|mesh-list
44048798|NCT00003578|Doxorubicin|doxorubicin|mesh-list
44048799|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44048800|NCT00003578|Etoposide|etoposide|mesh-list
44048801|NCT00003578|Vincristine|vincristine|mesh-list
44048802|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048803|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
44048804|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048808|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048810|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048811|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048812|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048813|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048814|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048815|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048816|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
44048817|NCT00003578|Hormones|hormones|mesh-ancestor
44048818|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048819|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048820|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048821|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048822|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
44048823|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
44048824|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048825|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048826|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048827|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048828|NCT00003580|Cisplatin|cisplatin|mesh-list
44048829|NCT00003580|Amifostine|amifostine|mesh-list
44048830|NCT00003580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048831|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048833|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048834|NCT00003582|Paclitaxel|paclitaxel|mesh-list
44048835|NCT00003582|Cisplatin|cisplatin|mesh-list
44048836|NCT00003582|Fluorouracil|fluorouracil|mesh-list
44048837|NCT00003582|Amifostine|amifostine|mesh-list
44048838|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048839|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048840|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048841|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048842|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048843|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048844|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
44048845|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048846|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048847|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
44048848|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048849|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048850|NCT00003582|Protective Agents|protective agents|mesh-ancestor
44048851|NCT00003583|Cisplatin|cisplatin|mesh-list
44048852|NCT00003583|Etoposide|etoposide|mesh-list
44048853|NCT00003583|Amifostine|amifostine|mesh-list
44048854|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048855|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048856|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048857|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048858|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048859|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048860|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048861|NCT00003583|Protective Agents|protective agents|mesh-ancestor
44048862|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048863|NCT00003584|Prednisone|prednisone|mesh-list
44460940|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44460941|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460942|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460943|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44460945|NCT01556438|Bortezomib|bortezomib|mesh-list
44460946|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460947|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
44460948|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
44460949|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44048864|NCT00003584|Estramustine|estramustine|mesh-list
44048865|NCT00003584|Vinorelbine|vinorelbine|mesh-list
44048866|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048867|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
44048868|NCT00003584|Hormones|hormones|mesh-ancestor
44048869|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44048870|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048871|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048872|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048873|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048874|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048875|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048876|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545689|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
44048879|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
44048880|NCT00003585|Interferons|interferons|mesh-list
44048881|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
44048882|NCT00003585|Aldesleukin|aldesleukin|mesh-list
44048883|NCT00003585|Fluorouracil|fluorouracil|mesh-list
44048884|NCT00003585|Isotretinoin|isotretinoin|mesh-list
44048885|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
44048886|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048887|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048888|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048889|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048890|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
44048891|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048892|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
44048893|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048894|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44048895|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44048896|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048897|NCT00003587|Gemcitabine|gemcitabine|mesh-list
44048898|NCT00003587|Paclitaxel|paclitaxel|mesh-list
44048899|NCT00003587|Vinorelbine|vinorelbine|mesh-list
44048900|NCT00003587|Docetaxel|docetaxel|mesh-list
44048901|NCT00003587|Cisplatin|cisplatin|mesh-list
44048902|NCT00003587|Carboplatin|carboplatin|mesh-list
44048903|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048904|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048905|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048906|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048907|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048908|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048909|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048910|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
44048911|NCT00003587|Antiviral Agents|antiviral agents|mesh-ancestor
44048912|NCT00003587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048913|NCT00003587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048914|NCT00003587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048915|NCT00003587|Immunologic Factors|immunologic factors|mesh-ancestor
44048916|NCT00003587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048917|NCT00003589|Gemcitabine|gemcitabine|mesh-list
44048918|NCT00003589|Paclitaxel|paclitaxel|mesh-list
44048919|NCT00003589|Cisplatin|cisplatin|mesh-list
44048920|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048921|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048922|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048923|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44460950|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460951|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44460952|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
44460954|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44460955|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44460956|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460957|NCT01556165|Rasagiline|rasagiline|mesh-list
44460958|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44460959|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048924|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048925|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048926|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048927|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
44048928|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
44048929|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048930|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048931|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048932|NCT00003589|Immunologic Factors|immunologic factors|mesh-ancestor
44048933|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048934|NCT00003591|Paclitaxel|paclitaxel|mesh-list
44048935|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048936|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048937|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048938|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048939|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048940|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048941|NCT00003592|Paclitaxel|paclitaxel|mesh-list
44048942|NCT00003592|Methotrexate|methotrexate|mesh-list
44048943|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048944|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048945|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048946|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048947|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048948|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048949|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048950|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048955|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048956|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048957|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048958|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048959|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
44048960|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048961|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048962|NCT00003593|Cytarabine|cytarabine|mesh-list
44048963|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
44048964|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44048965|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44048966|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44048967|NCT00003593|Methotrexate|methotrexate|mesh-list
44048968|NCT00003593|Thioguanine|thioguanine|mesh-list
44048969|NCT00003593|Daunorubicin|daunorubicin|mesh-list
44048970|NCT00003593|Asparaginase|asparaginase|mesh-list
44048971|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048972|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048973|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048974|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048975|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048976|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
44048977|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048978|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048979|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048980|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048981|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44460960|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460961|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44460962|NCT01556165|Protective Agents|protective agents|mesh-ancestor
44460963|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460964|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
44460965|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44460966|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
44460967|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048982|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048983|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
44048984|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048985|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048986|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
44048987|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44048988|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44048989|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048990|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048991|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44048992|NCT00003594|Leucovorin|leucovorin|mesh-list
44048993|NCT00003594|Fluorouracil|fluorouracil|mesh-list
44048994|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
44048995|NCT00003594|Irinotecan|irinotecan|mesh-list
44048996|NCT00003594|Calcium|calcium|mesh-list
44048997|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
44048998|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44048999|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049000|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
44049001|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049002|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049003|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049004|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049005|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
44049006|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44049007|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049008|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049009|NCT00003594|Antidotes|antidotes|mesh-ancestor
44049010|NCT00003594|Protective Agents|protective agents|mesh-ancestor
44049011|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
44049012|NCT00003594|Vitamins|vitamins|mesh-ancestor
44049013|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
44049014|NCT00003595|Prednisone|prednisone|mesh-list
44049015|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
44049016|NCT00003595|Rituximab|rituximab|mesh-list
44049017|NCT00003595|Doxorubicin|doxorubicin|mesh-list
44049018|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049019|NCT00003595|Vincristine|vincristine|mesh-list
44049020|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049021|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
44049022|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049023|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545843|NCT03668054|Bevacizumab|bevacizumab|mesh-list
44049029|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049030|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049031|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049033|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049034|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049035|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
44049036|NCT00003595|Hormones|hormones|mesh-ancestor
44049037|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049038|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049039|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049040|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049041|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049042|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049043|NCT00003596|Cisplatin|cisplatin|mesh-list
44049044|NCT00003596|Fluorouracil|fluorouracil|mesh-list
44049045|NCT00003596|Mitomycins|mitomycins|mesh-list
44049046|NCT00003596|Mitomycin|mitomycin|mesh-list
44049047|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049048|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
44252550|NCT03044613|Paclitaxel|paclitaxel|mesh-list
44252551|NCT03044613|Carboplatin|carboplatin|mesh-list
44252552|NCT03044613|Nivolumab|nivolumab|mesh-list
44252553|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252554|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252555|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252556|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049049|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049050|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049051|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049052|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
44049053|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049054|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049055|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
44049056|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049057|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049058|NCT00003597|Carboplatin|carboplatin|mesh-list
44049059|NCT00003597|Etoposide|etoposide|mesh-list
44049060|NCT00003597|Ifosfamide|ifosfamide|mesh-list
44049061|NCT00003597|Lenograstim|lenograstim|mesh-list
44049062|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049063|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049064|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049065|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049066|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049067|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049068|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049069|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
44049070|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44049071|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
44049072|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049073|NCT00003598|Tretinoin|tretinoin|mesh-list
44049074|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049075|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
44049076|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049077|NCT00003599|Vitamin E|vitamin e|mesh-list
44049078|NCT00003599|Tocopherols|tocopherols|mesh-list
44049079|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
44049080|NCT00003599|Isotretinoin|isotretinoin|mesh-list
44049081|NCT00003599|Vitamins|vitamins|mesh-ancestor
44049082|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
44049083|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049084|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
44049085|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049086|NCT00003599|Protective Agents|protective agents|mesh-ancestor
44049087|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049088|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
44049089|NCT00003600|Hematinics|hematinics|mesh-ancestor
44049090|NCT00003601|Tretinoin|tretinoin|mesh-list
44049091|NCT00003601|Fenretinide|fenretinide|mesh-list
44049092|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049093|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
44049094|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049095|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44049096|NCT00003601|Protective Agents|protective agents|mesh-ancestor
44049099|NCT00003602|Etoposide|etoposide|mesh-list
44049100|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
44049101|NCT00003602|Idarubicin|idarubicin|mesh-list
44049102|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049103|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049104|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049105|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049106|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049107|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049108|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049109|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
44049110|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
44049111|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049112|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049113|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
44049114|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049115|NCT00003602|Analgesics|analgesics|mesh-ancestor
44252557|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252558|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252559|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252560|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44252562|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
44252563|NCT03028519|Vitamins|vitamins|mesh-ancestor
44252564|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
44252565|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650517|NCT03013205|Triamcinolone|triamcinolone|mesh-list
44049116|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
44049117|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049118|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049119|NCT00003603|Dexamethasone|dexamethasone|mesh-list
44049120|NCT00003603|Prednisolone|prednisolone|mesh-list
44049121|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
44049122|NCT00003603|Melphalan|melphalan|mesh-list
44049123|NCT00003603|Lomustine|lomustine|mesh-list
44049124|NCT00003603|Idarubicin|idarubicin|mesh-list
44049125|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049126|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
44049127|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049128|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049129|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049130|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
44049131|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049132|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049133|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049134|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049135|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
44049136|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
44049137|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049138|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049139|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
44049140|NCT00003603|Hormones|hormones|mesh-ancestor
44149737|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049141|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049142|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049143|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049144|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049145|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049146|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049147|NCT00003604|Aldesleukin|aldesleukin|mesh-list
44049148|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049149|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44049150|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44049151|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
44049152|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049153|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
44049154|NCT00003605|Rituximab|rituximab|mesh-list
44049155|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049156|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
44049157|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049158|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049159|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049160|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
44049161|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049162|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049163|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049164|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049165|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
44049166|NCT00003606|Cisplatin|cisplatin|mesh-list
44049167|NCT00003606|Etoposide|etoposide|mesh-list
44049168|NCT00003606|Epirubicin|epirubicin|mesh-list
44049169|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049170|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
43545976|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
44252566|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44252567|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44252568|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
44252569|NCT03012971|Morphine|morphine|mesh-list
44252570|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44252571|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252572|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650532|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
44049175|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049177|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049178|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049179|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049180|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049181|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049182|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049183|NCT00003610|Capsaicin|capsaicin|mesh-list
44049184|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
44049185|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049187|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049188|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049189|NCT00003611|Acitretin|acitretin|mesh-list
44049190|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
44049191|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049192|NCT00003612|Paclitaxel|paclitaxel|mesh-list
44049193|NCT00003612|Carboplatin|carboplatin|mesh-list
44049194|NCT00003612|Trastuzumab|trastuzumab|mesh-list
44049195|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049196|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049197|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049198|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049199|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049200|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049201|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049202|NCT00003613|Carmustine|carmustine|mesh-list
44049203|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44049204|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049205|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
44049206|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049207|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049208|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049209|NCT00003614|Paclitaxel|paclitaxel|mesh-list
44049210|NCT00003614|Estramustine|estramustine|mesh-list
44049211|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049212|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049213|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049214|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049215|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149738|NCT00208715|Modafinil|modafinil|mesh-list
44049216|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049217|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049218|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
44049219|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049220|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
44049221|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049222|NCT00003616|Irinotecan|irinotecan|mesh-list
44049223|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44049224|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049225|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049226|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049227|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049228|NCT00003617|Clarithromycin|clarithromycin|mesh-list
44049229|NCT00003617|Tinidazole|tinidazole|mesh-list
44049230|NCT00003617|Chlorambucil|chlorambucil|mesh-list
44049231|NCT00003617|Omeprazole|omeprazole|mesh-list
44049232|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44049233|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049234|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44049235|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252573|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252574|NCT03012971|Analgesics|analgesics|mesh-ancestor
44252575|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
44252576|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252577|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44252578|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44252579|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44252580|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
44252581|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252582|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252583|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44252584|NCT03012971|Narcotics|narcotics|mesh-ancestor
44049236|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049237|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44049238|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049239|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44049240|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44049246|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44049247|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44049249|NCT00003619|Cytarabine|cytarabine|mesh-list
44049250|NCT00003619|Fludarabine|fludarabine|mesh-list
44049251|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
44049252|NCT00003619|Etoposide|etoposide|mesh-list
44049253|NCT00003619|Busulfan|busulfan|mesh-list
44049254|NCT00003619|Topotecan|topotecan|mesh-list
44049255|NCT00003619|Isotretinoin|isotretinoin|mesh-list
44049256|NCT00003619|Vitamins|vitamins|mesh-ancestor
44049257|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
44049258|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049259|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049260|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049261|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
44049262|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049263|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049264|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
44049265|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049266|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049267|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049268|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049269|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
44049270|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049271|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
44049272|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049273|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049274|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44049275|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
44049276|NCT00003619|Protective Agents|protective agents|mesh-ancestor
44049277|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049278|NCT00003620|Alvocidib|alvocidib|mesh-list
44049279|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049280|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
44049281|NCT00003620|Growth Substances|growth substances|mesh-ancestor
44049282|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049283|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44049284|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049285|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049286|NCT00003622|Paclitaxel|paclitaxel|mesh-list
44049287|NCT00003622|Vinorelbine|vinorelbine|mesh-list
44049288|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049289|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083339|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
44049290|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049291|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
43775397|NCT02345993|Hormones|hormones|mesh-ancestor
44049292|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252585|NCT02992522|Lenalidomide|lenalidomide|mesh-list
44252586|NCT02992522|Venetoclax|venetoclax|mesh-list
44252587|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
44252588|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
44252589|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252590|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252591|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252592|NCT02992522|Growth Substances|growth substances|mesh-ancestor
44252593|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
44252594|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252595|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252596|NCT02978612|Capecitabine|capecitabine|mesh-list
44252597|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252598|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
44252599|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252600|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252601|NCT02957032|Cytarabine|cytarabine|mesh-list
44252602|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252603|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
44049293|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049295|NCT00003624|Cisplatin|cisplatin|mesh-list
44049296|NCT00003624|Amifostine|amifostine|mesh-list
44049297|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049298|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049299|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049300|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049301|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049302|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049303|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44049304|NCT00003624|Protective Agents|protective agents|mesh-ancestor
44049305|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049306|NCT00003625|Cyclosporine|cyclosporine|mesh-list
44049307|NCT00003625|Etoposide|etoposide|mesh-list
44049308|NCT00003625|Vincristine|vincristine|mesh-list
44049309|NCT00003625|Cyclosporins|cyclosporins|mesh-list
44049310|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049311|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049312|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049319|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049320|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
44049321|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049322|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
44049323|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049324|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049325|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049326|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44049327|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
44049328|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049329|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049330|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049331|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049332|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049333|NCT00003627|Cisplatin|cisplatin|mesh-list
44049334|NCT00003627|Fluorouracil|fluorouracil|mesh-list
44049335|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049336|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
44049337|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252604|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252605|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252606|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
44252607|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252608|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252609|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
44252610|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252611|NCT02947516|Liver Extracts|liver extracts|mesh-list
44252612|NCT02947516|Hematinics|hematinics|mesh-ancestor
44252613|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
44252614|NCT02932956|Fludarabine|fludarabine|mesh-list
44252615|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
44252616|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252617|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
44252618|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049338|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049339|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049340|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
44049341|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049342|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
44049343|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049344|NCT00003632|Cytarabine|cytarabine|mesh-list
44049345|NCT00003632|Methotrexate|methotrexate|mesh-list
44049346|NCT00003632|Etoposide|etoposide|mesh-list
44049347|NCT00003632|Melphalan|melphalan|mesh-list
44049348|NCT00003632|Carmustine|carmustine|mesh-list
44049349|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44049350|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
44049351|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049352|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049353|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049354|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
44049355|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049356|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049357|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049358|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049359|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44049360|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049361|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
44049362|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049363|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049364|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049365|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049366|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049367|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
44049368|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049369|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049370|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
44049371|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049372|NCT00003633|Prednisone|prednisone|mesh-list
44049373|NCT00003633|Docetaxel|docetaxel|mesh-list
44049374|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
44049375|NCT00003633|Estramustine|estramustine|mesh-list
44049376|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049377|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049378|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049379|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049380|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049381|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049382|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
44049383|NCT00003633|Hormones|hormones|mesh-ancestor
44049385|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252619|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252620|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252621|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
44252622|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252623|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252624|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252625|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252626|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
44252627|NCT02909361|Fulvestrant|fulvestrant|mesh-list
44252628|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252629|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252630|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44252631|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44252632|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
44252633|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252634|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252635|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44252636|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44252637|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252638|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
44252639|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
44252640|NCT02897050|Docetaxel|docetaxel|mesh-list
44252641|NCT02897050|Fluorouracil|fluorouracil|mesh-list
44049386|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049387|NCT00003633|Analgesics|analgesics|mesh-ancestor
44049388|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
44049389|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049390|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049391|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049392|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049393|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049394|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
44049395|NCT00003634|Oregovomab|oregovomab|mesh-list
44049396|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049397|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049398|NCT00003636|Cisplatin|cisplatin|mesh-list
44049399|NCT00003636|Carboplatin|carboplatin|mesh-list
44049400|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049401|NCT00003637|Cisplatin|cisplatin|mesh-list
44049402|NCT00003637|Fluorouracil|fluorouracil|mesh-list
44049403|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049404|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
44049405|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049406|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049407|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049408|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
44049409|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049410|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
44049411|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44049412|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
44049413|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252643|NCT02897050|Epirubicin|epirubicin|mesh-list
44252644|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252645|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
44252646|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252647|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252648|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252649|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
44252650|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252651|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049414|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
44049415|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049416|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049417|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049418|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
44049419|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049420|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049421|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049422|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44049423|NCT00003639|Interferons|interferons|mesh-list
44049424|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
44049425|NCT00003639|Dexamethasone|dexamethasone|mesh-list
44049426|NCT00003639|Idarubicin|idarubicin|mesh-list
44049427|NCT00003639|Chlorambucil|chlorambucil|mesh-list
44049428|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049429|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
44049430|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
44049431|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049432|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049433|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049434|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
44049435|NCT00003639|Hormones|hormones|mesh-ancestor
44049436|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049437|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049438|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049439|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
44049440|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049441|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
44049442|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049443|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049444|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049446|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049447|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049448|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
44049449|NCT00003640|Cisplatin|cisplatin|mesh-list
44049450|NCT00003640|Doxorubicin|doxorubicin|mesh-list
44049451|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049452|NCT00003640|Methotrexate|methotrexate|mesh-list
44049453|NCT00003640|Vinblastine|vinblastine|mesh-list
44049454|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049455|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049456|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049457|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049458|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049463|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049464|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049465|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
44049466|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049467|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44049468|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049469|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
44049470|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049471|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049472|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049473|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252652|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252653|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252654|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252655|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252656|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
44252657|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252658|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252659|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252660|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252661|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252662|NCT02864953|Glyburide|glyburide|mesh-list
44252663|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44252664|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252665|NCT02821507|Sirolimus|sirolimus|mesh-list
44049474|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049475|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049476|NCT00003642|Cisplatin|cisplatin|mesh-list
44049477|NCT00003642|Fluorouracil|fluorouracil|mesh-list
44049478|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049479|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
44049480|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049481|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049482|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049483|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
44049484|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049485|NCT00003643|Paclitaxel|paclitaxel|mesh-list
44049486|NCT00003643|Etoposide|etoposide|mesh-list
44049487|NCT00003643|Cisplatin|cisplatin|mesh-list
44049488|NCT00003643|Bleomycin|bleomycin|mesh-list
44049489|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049490|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049491|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049492|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049493|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049494|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049495|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049496|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049497|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049498|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049499|NCT00003647|Dacarbazine|dacarbazine|mesh-list
44049500|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049501|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
44049502|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049503|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049504|NCT00003650|Cytarabine|cytarabine|mesh-list
44049505|NCT00003650|Dexamethasone|dexamethasone|mesh-list
44049506|NCT00003650|Prednisone|prednisone|mesh-list
44049507|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
44049508|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
44049509|NCT00003650|Methotrexate|methotrexate|mesh-list
44049510|NCT00003650|Etoposide|etoposide|mesh-list
44049511|NCT00003650|Vincristine|vincristine|mesh-list
44049512|NCT00003650|Daunorubicin|daunorubicin|mesh-list
44049513|NCT00003650|Asparaginase|asparaginase|mesh-list
44049514|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
44049515|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
44049516|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049517|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
44049518|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049519|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049520|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049521|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
44049522|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049523|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049524|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252666|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
44252667|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252668|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
44252669|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252670|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252671|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252672|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
44252673|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252674|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252675|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252676|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252677|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252678|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049525|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049526|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
44049527|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
44049528|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049529|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049530|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
44049531|NCT00003650|Hormones|hormones|mesh-ancestor
44049533|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049534|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44049535|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
44049536|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049537|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049538|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
44049539|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049540|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049541|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44049542|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049543|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049544|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049545|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049546|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
44049547|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049548|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049549|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049550|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049551|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44049552|NCT00003650|Protective Agents|protective agents|mesh-ancestor
44049553|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049555|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
44049556|NCT00003652|Cisplatin|cisplatin|mesh-list
44049557|NCT00003652|Fluorouracil|fluorouracil|mesh-list
44049558|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049559|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
44049560|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049561|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049562|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049563|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
44049564|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049565|NCT00003653|Leuprolide|leuprolide|mesh-list
44049566|NCT00003653|Goserelin|goserelin|mesh-list
44049567|NCT00003653|Flutamide|flutamide|mesh-list
44049568|NCT00003653|Bicalutamide|bicalutamide|mesh-list
44049569|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
44049570|NCT00003653|Nilutamide|nilutamide|mesh-list
44049571|NCT00003653|Buserelin|buserelin|mesh-list
44049572|NCT00003653|Cyproterone|cyproterone|mesh-list
44049573|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44049574|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
44049575|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049576|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252679|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
44252680|NCT02607215|Vinorelbine|vinorelbine|mesh-list
44252681|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252682|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252683|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252684|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252685|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252686|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252687|NCT02589353|Acarbose|acarbose|mesh-list
44252688|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44252689|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252690|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252691|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44252692|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252693|NCT02584309|Doxorubicin|doxorubicin|mesh-list
44252694|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44252695|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
44252696|NCT02584309|Razoxane|razoxane|mesh-list
44252697|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049577|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049578|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049579|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
44049580|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
44049581|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049582|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44049583|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
44049584|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44049585|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44049586|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049587|NCT00003657|Carboplatin|carboplatin|mesh-list
44049588|NCT00003657|Etoposide|etoposide|mesh-list
44049589|NCT00003657|Ifosfamide|ifosfamide|mesh-list
44049590|NCT00003657|Amifostine|amifostine|mesh-list
44049591|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049592|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049593|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049594|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049595|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049596|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049597|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049598|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049599|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
44049600|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44049601|NCT00003657|Protective Agents|protective agents|mesh-ancestor
44049602|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
44049603|NCT00003658|Rituximab|rituximab|mesh-list
44049604|NCT00003658|Pentostatin|pentostatin|mesh-list
44049605|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049629|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049630|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049631|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049632|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44049633|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049634|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
44049635|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
44049636|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252699|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252700|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252701|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252702|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252703|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44252704|NCT02584309|Protective Agents|protective agents|mesh-ancestor
44252705|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252706|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252707|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252708|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
44252709|NCT02512926|Etoposide|etoposide|mesh-list
44252710|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252711|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
44252712|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252713|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252714|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252715|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
44049637|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049638|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
44049639|NCT00003661|Hormones|hormones|mesh-ancestor
44049640|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049641|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44049642|NCT00003661|Protective Agents|protective agents|mesh-ancestor
44049643|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049644|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049645|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
44049647|NCT00003662|Cyclosporine|cyclosporine|mesh-list
44049648|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
44049649|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
44049650|NCT00003662|Melphalan|melphalan|mesh-list
44049651|NCT00003662|Busulfan|busulfan|mesh-list
44049652|NCT00003662|Cyclosporins|cyclosporins|mesh-list
44049653|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44049654|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049655|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
44049656|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049657|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049658|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049659|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
44049666|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049667|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44049668|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049669|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
44049670|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
44049671|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049672|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049673|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
43775701|NCT02344095|Paclitaxel|paclitaxel|mesh-list
44049674|NCT00003662|Hormones|hormones|mesh-ancestor
44049675|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049676|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44049677|NCT00003662|Protective Agents|protective agents|mesh-ancestor
44049678|NCT00003663|Dexamethasone|dexamethasone|mesh-list
44049679|NCT00003663|Rituximab|rituximab|mesh-list
44049680|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049681|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049682|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
44252716|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252717|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252718|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252719|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252720|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252721|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252723|NCT02512497|Fludarabine|fludarabine|mesh-list
44252724|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
44252725|NCT02512497|Busulfan|busulfan|mesh-list
44252726|NCT02512497|Romidepsin|romidepsin|mesh-list
44252727|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
44252728|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44252729|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252730|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252731|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
44252732|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252733|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252734|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
44252735|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252736|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
44252737|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252738|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252739|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252740|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44049683|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049684|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049685|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049686|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
44049687|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
44049688|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049689|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049690|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
44049691|NCT00003663|Hormones|hormones|mesh-ancestor
44049692|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049693|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049694|NCT00003664|Gemcitabine|gemcitabine|mesh-list
44049695|NCT00003664|Interferons|interferons|mesh-list
44049696|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
44049697|NCT00003664|Aldesleukin|aldesleukin|mesh-list
44049698|NCT00003664|Fluorouracil|fluorouracil|mesh-list
44049699|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049700|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
44049701|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049702|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049703|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
44049704|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049705|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049706|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049707|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
44252741|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
44252742|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
44252743|NCT02389036|Tobramycin|tobramycin|mesh-list
44252744|NCT02389036|Colistin|colistin|mesh-list
44252745|NCT02389036|Nystatin|nystatin|mesh-list
44252746|NCT02389036|Cefotaxime|cefotaxime|mesh-list
44252747|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252748|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252749|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252750|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252751|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623044|NCT05375305|Analgesics|analgesics|mesh-ancestor
44049708|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049709|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44049710|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44049711|NCT00003666|Irofulven|irofulven|mesh-list
44049712|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049713|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
44049714|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049715|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049716|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
44049717|NCT00003667|Doxorubicin|doxorubicin|mesh-list
44049718|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049719|NCT00003667|Vincristine|vincristine|mesh-list
44049720|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
44049721|NCT00003667|Razoxane|razoxane|mesh-list
44049722|NCT00003667|Glycerol|glycerol|mesh-list
44049723|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049724|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
44049725|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049726|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049727|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049728|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
44049729|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049738|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049739|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049740|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44049741|NCT00003667|Protective Agents|protective agents|mesh-ancestor
44049742|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44049744|NCT00003671|Cytarabine|cytarabine|mesh-list
44049745|NCT00003671|Dexamethasone|dexamethasone|mesh-list
44049746|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
44049747|NCT00003671|Methotrexate|methotrexate|mesh-list
44049748|NCT00003671|Vincristine|vincristine|mesh-list
44049749|NCT00003671|Daunorubicin|daunorubicin|mesh-list
44049750|NCT00003671|Asparaginase|asparaginase|mesh-list
44049751|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
44049752|NCT00003671|Thioguanine|thioguanine|mesh-list
44049753|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
44049754|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049755|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
44049756|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049757|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049758|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049759|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
44049760|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049761|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049762|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049763|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049764|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
44049765|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
44049766|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049767|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049768|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
44049769|NCT00003671|Hormones|hormones|mesh-ancestor
44049770|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049771|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049772|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44252752|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252753|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44252754|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44252755|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
44252756|NCT02389036|Ionophores|ionophores|mesh-ancestor
44252757|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252758|NCT02349906|Treosulfan|treosulfan|mesh-list
44252759|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252760|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
44252761|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049773|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
44049774|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049775|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049776|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
44049777|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049778|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049779|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44049780|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049781|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
44049782|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049783|NCT00003671|Antidotes|antidotes|mesh-ancestor
44049784|NCT00003671|Protective Agents|protective agents|mesh-ancestor
44049785|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
44049786|NCT00003671|Vitamins|vitamins|mesh-ancestor
44049787|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
44049788|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049789|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049790|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049791|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049792|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049793|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049794|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049795|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
44049796|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049797|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049798|NCT00003674|Dalteparin|dalteparin|mesh-list
44049808|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049809|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049810|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049811|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
44049812|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049813|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049814|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049815|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049816|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049817|NCT00003678|Tamoxifen|tamoxifen|mesh-list
44049818|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44049819|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
44049820|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049821|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049822|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049823|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049824|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44049825|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44049826|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149739|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44049827|NCT00003679|Tamoxifen|tamoxifen|mesh-list
44049828|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
44049829|NCT00003679|Docetaxel|docetaxel|mesh-list
44049830|NCT00003679|Doxorubicin|doxorubicin|mesh-list
44049831|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049832|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049833|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
44049834|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252762|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252763|NCT02341911|Gemcitabine|gemcitabine|mesh-list
44252764|NCT02341911|Cisplatin|cisplatin|mesh-list
44252765|NCT02341911|Carboplatin|carboplatin|mesh-list
44252766|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252767|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252768|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
44252769|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252770|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
43650727|NCT03011905|Hormones|hormones|mesh-ancestor
44049835|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049836|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049837|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
44049838|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049839|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049840|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049841|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049842|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049843|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049844|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049845|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049846|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049847|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049848|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44049849|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
44049850|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049851|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049852|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44049853|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44049854|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44049855|NCT00003680|Tamoxifen|tamoxifen|mesh-list
44049856|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
44049857|NCT00003680|Thiotepa|thiotepa|mesh-list
44049858|NCT00003680|Fluorouracil|fluorouracil|mesh-list
44049859|NCT00003680|Methotrexate|methotrexate|mesh-list
44049860|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049861|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
44049862|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049863|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43546651|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44049865|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
44049866|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049867|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049868|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049869|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
44049870|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44049871|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44049872|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44049873|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049874|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44049875|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049876|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44049877|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049878|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44049879|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44049880|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049881|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049882|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44049883|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44049884|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44049886|NCT00003681|Amifostine|amifostine|mesh-list
44049887|NCT00003681|Hematinics|hematinics|mesh-ancestor
44049888|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44049889|NCT00003681|Protective Agents|protective agents|mesh-ancestor
44049890|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252773|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252774|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
44252775|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252776|NCT02336750|Aprepitant|aprepitant|mesh-list
44252777|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
44252778|NCT02336750|Mirtazapine|mirtazapine|mesh-list
44252779|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
44252780|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
44252781|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252782|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252783|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252784|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44252785|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252786|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252787|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
44252788|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44252789|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44252790|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
44049891|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
44049892|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44049893|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44049894|NCT00003682|Prednisolone|prednisolone|mesh-list
44049895|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
44049896|NCT00003682|Doxorubicin|doxorubicin|mesh-list
44049897|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049898|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44049899|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
44049900|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049901|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049902|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049903|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049904|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049905|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049906|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44049907|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
44049908|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
44049909|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049910|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049911|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44049912|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
44049913|NCT00003682|Hormones|hormones|mesh-ancestor
44049914|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049915|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44049916|NCT00003682|Protective Agents|protective agents|mesh-ancestor
44049917|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44049918|NCT00003683|Doxorubicin|doxorubicin|mesh-list
44049919|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049920|NCT00003683|Ifosfamide|ifosfamide|mesh-list
44049921|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049922|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049923|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049924|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049925|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252791|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
44252792|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44252793|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44252794|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44252795|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44252796|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44252797|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44252798|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
44252799|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44252800|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44252801|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
44252802|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44252803|NCT02268175|Prednisone|prednisone|mesh-list
44252804|NCT02268175|Leuprolide|leuprolide|mesh-list
44252805|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
44252806|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252807|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
44252808|NCT02268175|Hormones|hormones|mesh-ancestor
44252809|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44252810|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252811|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44252812|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252813|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44252814|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
44252815|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44252816|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44252817|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252818|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252819|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
44252820|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44252821|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
44252822|NCT02066220|Lomustine|lomustine|mesh-list
44252823|NCT02066220|Cisplatin|cisplatin|mesh-list
44252824|NCT02066220|Carboplatin|carboplatin|mesh-list
44049926|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049927|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049928|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
44049929|NCT00003684|Theophylline|theophylline|mesh-list
44049930|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44049931|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
44252837|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252838|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252839|NCT01855867|Tenofovir|tenofovir|mesh-list
44252840|NCT01855867|Emtricitabine|emtricitabine|mesh-list
44252841|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
44252842|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252843|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44252844|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44252845|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252846|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252847|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44252848|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44049960|NCT00003687|Analgesics|analgesics|mesh-ancestor
44049961|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
44049962|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049963|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
44049964|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44049965|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44049966|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44049967|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44252888|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252889|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252890|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44252891|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252892|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252893|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44252894|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44252895|NCT01293682|Calcitriol|calcitriol|mesh-list
44252896|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44252897|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252898|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44252899|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44252900|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252901|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44252902|NCT01293682|Vitamins|vitamins|mesh-ancestor
44252903|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
44252904|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44252905|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
44252906|NCT00887536|Bevacizumab|bevacizumab|mesh-list
44252907|NCT00887536|Docetaxel|docetaxel|mesh-list
44252908|NCT00887536|Doxorubicin|doxorubicin|mesh-list
44252909|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44252910|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
43650811|NCT03011476|Donepezil|donepezil|mesh-list
44049968|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049969|NCT00003688|Dactinomycin|dactinomycin|mesh-list
44049970|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44049971|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049972|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049973|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049974|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44049975|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049976|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049977|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44049978|NCT00003690|Cisplatin|cisplatin|mesh-list
44049979|NCT00003690|Carboplatin|carboplatin|mesh-list
44049980|NCT00003690|Alvocidib|alvocidib|mesh-list
44049981|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049982|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44049983|NCT00003690|Growth Substances|growth substances|mesh-ancestor
44049984|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049985|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44049986|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049987|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049988|NCT00003691|Paclitaxel|paclitaxel|mesh-list
44049989|NCT00003691|Cisplatin|cisplatin|mesh-list
44049990|NCT00003691|Doxorubicin|doxorubicin|mesh-list
44049991|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44049992|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44252911|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252912|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252913|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44252914|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
44252915|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252916|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252917|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44252918|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252919|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252920|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252921|NCT00887536|Growth Substances|growth substances|mesh-ancestor
44252922|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
44252923|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
44252924|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
44252925|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
44252926|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44252927|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44252928|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44252929|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252932|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252933|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252934|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44252935|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44252936|NCT00867321|Growth Substances|growth substances|mesh-ancestor
44252937|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252938|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
44252939|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252940|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049993|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049994|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049995|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049996|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049997|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050001|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050002|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
44050003|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050004|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050005|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050006|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050007|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050008|NCT00003694|Cytarabine|cytarabine|mesh-list
44050009|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
44050010|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44252941|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460969|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44460970|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44460971|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44252942|NCT05342597|Edaravone|edaravone|mesh-list
44252943|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44252944|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
44252945|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252946|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44252947|NCT05342597|Protective Agents|protective agents|mesh-ancestor
44252948|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252949|NCT05342558|Fluticasone|fluticasone|mesh-list
44252951|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252952|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44252953|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
44252954|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44252955|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252956|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44252957|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
44252958|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44252959|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44252960|NCT05342532|Amoxicillin|amoxicillin|mesh-list
44252961|NCT05342532|Clarithromycin|clarithromycin|mesh-list
44252962|NCT05342532|Omeprazole|omeprazole|mesh-list
44252963|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44252964|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252965|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44252966|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252967|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44050011|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
44050012|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050013|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050014|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
44050015|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050016|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050017|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
44050018|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050019|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084284|NCT00130455|Citalopram|citalopram|mesh-list
44050020|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44050022|NCT00003696|Paclitaxel|paclitaxel|mesh-list
44050023|NCT00003696|Etoposide|etoposide|mesh-list
44050024|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
44050025|NCT00003696|Carboplatin|carboplatin|mesh-list
44252968|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252969|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252970|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44252971|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44252972|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44252973|NCT05342389|Apatinib|apatinib|mesh-list
44252974|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252975|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44252976|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252977|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252978|NCT05342272|Lactoferrin|lactoferrin|mesh-list
44252979|NCT05342272|Muramidase|muramidase|mesh-list
44252980|NCT05342272|Betaine|betaine|mesh-list
44252981|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252982|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44252983|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
44252984|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44252985|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
44252986|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252987|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44252988|NCT05341999|Ibuprofen|ibuprofen|mesh-list
44252989|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44252990|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44252991|NCT05341999|Analgesics|analgesics|mesh-ancestor
44252992|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
44252993|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650885|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
44050026|NCT00003696|Doxorubicin|doxorubicin|mesh-list
44050027|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050028|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050029|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050030|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050031|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050032|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050033|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050034|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050035|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
44050036|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050037|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050038|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050039|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
44050040|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050041|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050042|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050043|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050044|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050045|NCT00003697|Vadimezan|vadimezan|mesh-list
44252994|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252995|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44252996|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252997|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44252998|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252999|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253000|NCT05341856|Isosorbide|isosorbide|mesh-list
44253001|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44253002|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44253003|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44253004|NCT05341856|Diuretics|diuretics|mesh-ancestor
44253005|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
44253006|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253007|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253008|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44253009|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253010|NCT05341817|Letrozole|letrozole|mesh-list
44253011|NCT05341817|Mifepristone|mifepristone|mesh-list
44253012|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253013|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44253014|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253015|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063454|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44253016|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253017|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44253018|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
44253019|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253020|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253021|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44253022|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
44253023|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253024|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44253025|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44253026|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44253027|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
43650909|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
44050046|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050047|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
44253028|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44253029|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44253030|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
44253031|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44253032|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44253033|NCT05341583|Ensartinib|ensartinib|mesh-list
44253034|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253035|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44253036|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253037|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253038|NCT05341401|Prednisolone|prednisolone|mesh-list
44253039|NCT05341401|Budesonide|budesonide|mesh-list
44253040|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253041|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
44253042|NCT05341401|Hormones|hormones|mesh-ancestor
44253043|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253044|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253045|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44253046|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050048|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050049|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050050|NCT00003700|Leucovorin|leucovorin|mesh-list
44050051|NCT00003700|Cytarabine|cytarabine|mesh-list
44050052|NCT00003700|Prednisone|prednisone|mesh-list
44050053|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
44050054|NCT00003700|Methotrexate|methotrexate|mesh-list
44050055|NCT00003700|Vincristine|vincristine|mesh-list
44050056|NCT00003700|Daunorubicin|daunorubicin|mesh-list
44050057|NCT00003700|Asparaginase|asparaginase|mesh-list
44050058|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
44050059|NCT00003700|Allopurinol|allopurinol|mesh-list
44050060|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
44050061|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050062|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
44050063|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050064|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050065|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050066|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
44050067|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050068|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050069|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050070|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050071|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
44050072|NCT00003700|Hormones|hormones|mesh-ancestor
44050073|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050074|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050075|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44050076|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
44050077|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050078|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050079|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
44050080|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050081|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050082|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050083|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050084|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
44253048|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253049|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44253050|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44253051|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
44253052|NCT05341193|Gemcitabine|gemcitabine|mesh-list
44253053|NCT05341193|Bevacizumab|bevacizumab|mesh-list
44253054|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253055|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253056|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44253057|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44253058|NCT05341193|Growth Substances|growth substances|mesh-ancestor
44253059|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253060|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44253061|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44253062|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
44050085|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050086|NCT00003700|Antidotes|antidotes|mesh-ancestor
44050087|NCT00003700|Protective Agents|protective agents|mesh-ancestor
44050088|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050089|NCT00003700|Vitamins|vitamins|mesh-ancestor
44050090|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
44050091|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050092|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050093|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050094|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050095|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050096|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050097|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050098|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
44050099|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44050100|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
44050101|NCT00003701|Paclitaxel|paclitaxel|mesh-list
44050102|NCT00003701|Vinblastine|vinblastine|mesh-list
44050103|NCT00003701|Cisplatin|cisplatin|mesh-list
44050104|NCT00003701|Carboplatin|carboplatin|mesh-list
44050105|NCT00003701|Doxorubicin|doxorubicin|mesh-list
44050106|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050107|NCT00003701|Methotrexate|methotrexate|mesh-list
44050108|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050109|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050110|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050111|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050112|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050113|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050114|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050115|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050116|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050117|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050118|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44050119|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
44050120|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050121|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050122|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050123|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
44050124|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050125|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050126|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776086|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
44050127|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
44253063|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253064|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
44253065|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253066|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253067|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253068|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
44253069|NCT05341076|Oxytocin|oxytocin|mesh-list
44253070|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
44253071|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253072|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253073|NCT05340985|Vitamin D|vitamin d|mesh-list
44253074|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
44253075|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
44253076|NCT05340985|Calcifediol|calcifediol|mesh-list
44253077|NCT05340985|Vitamins|vitamins|mesh-list
44253078|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
44050128|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050129|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050130|NCT00003704|Capecitabine|capecitabine|mesh-list
44050131|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050132|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
44050133|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050134|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050135|NCT00003706|Pemetrexed|pemetrexed|mesh-list
44050136|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050137|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050138|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050139|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050140|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050141|NCT00003707|Gemcitabine|gemcitabine|mesh-list
44050142|NCT00003707|Tipifarnib|tipifarnib|mesh-list
44050143|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050144|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
44050145|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050146|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050156|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050157|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050158|NCT00003709|Carbendazim|carbendazim|mesh-list
44050159|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
44050160|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
44050161|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44050162|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050163|NCT00003710|Irinotecan|irinotecan|mesh-list
44050164|NCT00003710|Mitomycins|mitomycins|mesh-list
44050165|NCT00003710|Mitomycin|mitomycin|mesh-list
44050166|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050167|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050168|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050169|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050170|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050171|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050172|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
44050173|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050174|NCT00003711|Irinotecan|irinotecan|mesh-list
44050175|NCT00003711|Pemetrexed|pemetrexed|mesh-list
44050176|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050177|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050178|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050179|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050180|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050181|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44253079|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
44253081|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253082|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44253083|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253084|NCT05340985|Provitamins|provitamins|mesh-ancestor
44253085|NCT05340946|Anesthetics|anesthetics|mesh-list
44253086|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253087|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253088|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
44253089|NCT05340803|Midazolam|midazolam|mesh-list
44253090|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
44253091|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44253092|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253093|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253094|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253095|NCT05340803|Analgesics|analgesics|mesh-ancestor
44253096|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
44253097|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253098|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44253099|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44050182|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050183|NCT00003712|Sirolimus|sirolimus|mesh-list
44050184|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44050185|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050186|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050187|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050188|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
44050189|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050190|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
44050191|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050192|NCT00003621|Cisplatin|cisplatin|mesh-list
44050193|NCT00003621|Etoposide|etoposide|mesh-list
44050194|NCT00003621|Carmustine|carmustine|mesh-list
44050195|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050196|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050197|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050198|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050199|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050200|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050201|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050202|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
44050203|NCT00003714|NSC 366140|nsc 366140|mesh-list
44050204|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050205|NCT00003715|Interferons|interferons|mesh-list
44050207|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
44050208|NCT00003715|Vaccines|vaccines|mesh-list
44050209|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
44050210|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
44050211|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050212|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050213|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050214|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050215|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
44253100|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44253101|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
44253102|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253103|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253104|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44253105|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44253106|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44253107|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253108|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44253109|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
44253110|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
44253111|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
44253112|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
44253113|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44253114|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
44253115|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44253116|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44253117|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253118|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
44253119|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050218|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050219|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
44050220|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050221|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44050222|NCT00003717|Paclitaxel|paclitaxel|mesh-list
44050223|NCT00003717|Estramustine|estramustine|mesh-list
44050224|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050225|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050226|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050227|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050228|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050229|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050230|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050231|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
44050232|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050233|NCT00003718|Temozolomide|temozolomide|mesh-list
44050234|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050235|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
44050236|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050237|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050238|NCT00003719|Irinotecan|irinotecan|mesh-list
44050239|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050240|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050241|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050242|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050243|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050244|NCT00003720|Semaxinib|semaxinib|mesh-list
44050245|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44050246|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44050247|NCT00003720|Growth Substances|growth substances|mesh-ancestor
44050248|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050249|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
44084643|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
44050250|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050251|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44050252|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253120|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
44253121|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44253122|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253123|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253124|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253125|NCT05340725|Analgesics|analgesics|mesh-ancestor
44253126|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
44253127|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253128|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44253129|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44253130|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44253131|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
44253132|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44050253|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050254|NCT00003723|Gemcitabine|gemcitabine|mesh-list
44050255|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050256|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
44050257|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050258|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050259|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
44050260|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050261|NCT00003723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050262|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050263|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
44050264|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050265|NCT00003725|Valrubicin|valrubicin|mesh-list
44050266|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050267|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050268|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050269|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050270|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050271|NCT00003727|Gemcitabine|gemcitabine|mesh-list
44050272|NCT00003727|Interferons|interferons|mesh-list
44050273|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
44050274|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
44050275|NCT00003727|Melphalan|melphalan|mesh-list
44050276|NCT00003727|Carmustine|carmustine|mesh-list
44050277|NCT00003727|Etoposide|etoposide|mesh-list
44050278|NCT00003727|Sargramostim|sargramostim|mesh-list
44050279|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050280|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
43776219|NCT02340481|Simethicone|simethicone|mesh-list
44050281|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050282|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050283|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050284|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
44050285|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050286|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050287|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050304|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44050306|NCT00003728|Doxorubicin|doxorubicin|mesh-list
44050307|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050308|NCT00003728|Methotrexate|methotrexate|mesh-list
44050309|NCT00003728|Etoposide|etoposide|mesh-list
44050310|NCT00003728|Vincristine|vincristine|mesh-list
44050311|NCT00003728|Daunorubicin|daunorubicin|mesh-list
44050312|NCT00003728|Asparaginase|asparaginase|mesh-list
44050313|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
44050314|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
44050315|NCT00003728|Thioguanine|thioguanine|mesh-list
44050316|NCT00003728|Vindesine|vindesine|mesh-list
44050317|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
44050318|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050319|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
44050320|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253133|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253135|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
44253136|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253137|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253138|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44253139|NCT05340530|Meropenem|meropenem|mesh-list
44253140|NCT05340530|Avibactam|avibactam|mesh-list
44253141|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253142|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253143|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44253144|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253145|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253146|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44253147|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44253148|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253149|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253150|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44253151|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43650975|NCT03010436|Benralizumab|benralizumab|mesh-list
44050321|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050322|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050323|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
44050324|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050325|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050326|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050327|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050328|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
44050329|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
44050330|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44050331|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44050332|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
44050333|NCT00003728|Hormones|hormones|mesh-ancestor
44050334|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050335|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050336|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050337|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050338|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050339|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050340|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44050341|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
44050342|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050343|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050344|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
44050345|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050346|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050347|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050348|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43547152|NCT03656094|Docetaxel|docetaxel|mesh-list
44050358|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050359|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44050360|NCT00003728|Analgesics|analgesics|mesh-ancestor
44253152|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253153|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44253154|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253155|NCT05340413|Olaparib|olaparib|mesh-list
44253156|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44253157|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650996|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050361|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
44050362|NCT00003729|Cytarabine|cytarabine|mesh-list
44050363|NCT00003729|Fludarabine|fludarabine|mesh-list
44050364|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
44050365|NCT00003729|Idarubicin|idarubicin|mesh-list
44050366|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050367|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050368|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
44050369|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050370|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050371|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
44050372|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050373|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
44050374|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050375|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050376|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050377|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050378|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050379|NCT00003730|Fluorouracil|fluorouracil|mesh-list
44050380|NCT00003730|Vinorelbine|vinorelbine|mesh-list
44050381|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
44050382|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050383|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050384|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050385|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050386|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
44050387|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050388|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050389|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050390|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050391|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050392|NCT00003731|Temozolomide|temozolomide|mesh-list
44050393|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050394|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
44050395|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050396|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050397|NCT00003732|Paclitaxel|paclitaxel|mesh-list
44050398|NCT00003732|Carboplatin|carboplatin|mesh-list
44050399|NCT00003732|Topotecan|topotecan|mesh-list
44050400|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050401|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050402|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050403|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050404|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050405|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050406|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050407|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050408|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050409|NCT00003733|Paclitaxel|paclitaxel|mesh-list
44050410|NCT00003733|Carboplatin|carboplatin|mesh-list
44050411|NCT00003733|Topotecan|topotecan|mesh-list
44050412|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050413|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050414|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050415|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050416|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050417|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050426|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050427|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050428|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44253158|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253159|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253160|NCT05340192|Octreotide|octreotide|mesh-list
44253161|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624688|NCT03337087|Vitamins|vitamins|mesh-ancestor
44050429|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050430|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050431|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
44050432|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
44050433|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050434|NCT00003735|Topotecan|topotecan|mesh-list
44050435|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
44050436|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050437|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050438|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050439|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050440|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050441|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050442|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
44050443|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050444|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44050445|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050446|NCT00003739|Lenograstim|lenograstim|mesh-list
44050447|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44050448|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
44050449|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050450|NCT00003740|Trastuzumab|trastuzumab|mesh-list
44050451|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050452|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050454|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44050455|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
44050456|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050457|NCT00003742|Paclitaxel|paclitaxel|mesh-list
44050458|NCT00003742|Cisplatin|cisplatin|mesh-list
44050459|NCT00003742|Irinotecan|irinotecan|mesh-list
44050460|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050461|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050462|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050463|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050464|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050465|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050466|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050467|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050468|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050469|NCT00003743|Aldesleukin|aldesleukin|mesh-list
44050470|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050471|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44050472|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44050473|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
44050474|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050475|NCT00003744|Gemcitabine|gemcitabine|mesh-list
44050476|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050477|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
44050478|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050479|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050480|NCT00003744|Antiviral Agents|antiviral agents|mesh-ancestor
44050481|NCT00003744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050482|NCT00003744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050483|NCT00003744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050484|NCT00003744|Immunologic Factors|immunologic factors|mesh-ancestor
44050485|NCT00003744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547271|NCT03654170|BI 425809|bi 425809|mesh-list
44050490|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050491|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050492|NCT00003746|Cladribine|cladribine|mesh-list
44050493|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050494|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050495|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
44050496|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050497|NCT00003747|Carboplatin|carboplatin|mesh-list
44050498|NCT00003747|Temozolomide|temozolomide|mesh-list
44253162|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44253163|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253164|NCT05340153|Lumefantrine|lumefantrine|mesh-list
44253165|NCT05340153|Artemether|artemether|mesh-list
44050499|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050500|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050501|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
44050502|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050503|NCT00003748|Irinotecan|irinotecan|mesh-list
44050504|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050505|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050506|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050507|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050508|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050509|NCT00003751|Penicillamine|penicillamine|mesh-list
44050510|NCT00003751|Antidotes|antidotes|mesh-ancestor
44050511|NCT00003751|Protective Agents|protective agents|mesh-ancestor
44050512|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050513|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
44050514|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
44050515|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050516|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050517|NCT00003752|Bexarotene|bexarotene|mesh-list
44050518|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050519|NCT00003753|Dexamethasone|dexamethasone|mesh-list
44050520|NCT00003753|Irinotecan|irinotecan|mesh-list
44050521|NCT00003753|Floxuridine|floxuridine|mesh-list
44050522|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050523|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
44050524|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
44050525|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44050526|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050527|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44050528|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
44050529|NCT00003753|Hormones|hormones|mesh-ancestor
44050530|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050531|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050532|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050533|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050534|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050535|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050536|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050537|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050538|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
44050539|NCT00003754|Thalidomide|thalidomide|mesh-list
44050540|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
44050541|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050542|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
44050543|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050544|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050545|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050546|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
44050547|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050548|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050549|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050550|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
44050551|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44050552|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050553|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44050554|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44050555|NCT00003754|Growth Substances|growth substances|mesh-ancestor
44050556|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
44050558|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050559|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050562|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050563|NCT00003758|Cytarabine|cytarabine|mesh-list
44050564|NCT00003758|Idarubicin|idarubicin|mesh-list
44050565|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050566|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
44050567|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050568|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050569|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
44253166|NCT05340153|Piperaquine|piperaquine|mesh-list
44253167|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44253169|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
44050570|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050571|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050572|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
44050573|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050574|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050575|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050576|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050577|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050578|NCT00003759|Valrubicin|valrubicin|mesh-list
44050579|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
44050580|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44050581|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
44050582|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776440|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
44050583|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050584|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050585|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050586|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050587|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050588|NCT00003760|Irofulven|irofulven|mesh-list
44050589|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050590|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
44050591|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050592|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050593|NCT00003762|Gemcitabine|gemcitabine|mesh-list
44050594|NCT00003762|Docetaxel|docetaxel|mesh-list
44050595|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050596|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
44050597|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050598|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050599|NCT00003762|Antiviral Agents|antiviral agents|mesh-ancestor
44050600|NCT00003762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050601|NCT00003762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050602|NCT00003762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050603|NCT00003762|Immunologic Factors|immunologic factors|mesh-ancestor
44050604|NCT00003762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050605|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050606|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050607|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050608|NCT00003763|Folic Acid|folic acid|mesh-list
44050609|NCT00003763|Hematinics|hematinics|mesh-ancestor
44050610|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050611|NCT00003763|Vitamins|vitamins|mesh-ancestor
44050612|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
44050613|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050614|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
44050615|NCT00003764|Fludarabine|fludarabine|mesh-list
44050616|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
44050617|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050618|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
44050619|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050620|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050621|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050622|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
44050623|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050624|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050625|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050626|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050627|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
44050628|NCT00003765|Carmustine|carmustine|mesh-list
44050629|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44050630|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050631|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
44050632|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050640|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050641|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050642|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
44050643|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050644|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050645|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253170|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44253171|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44253172|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253173|NCT05339802|Linezolid|linezolid|mesh-list
44253174|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253175|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253176|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44253177|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050646|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44050647|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44050648|NCT00003771|Norethindrone|norethindrone|mesh-list
44050649|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
44050650|NCT00003771|Estradiol|estradiol|mesh-list
44050651|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44050652|NCT00003771|Estrogens|estrogens|mesh-ancestor
44050653|NCT00003771|Hormones|hormones|mesh-ancestor
44050654|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050655|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050656|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44050657|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
44050658|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050659|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44050660|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44050661|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44050662|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44050663|NCT00003775|Leflunomide|leflunomide|mesh-list
44050664|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050665|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050666|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050667|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
44050668|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050669|NCT00003776|Leucovorin|leucovorin|mesh-list
44050670|NCT00003776|Trimetrexate|trimetrexate|mesh-list
44050671|NCT00003776|Doxorubicin|doxorubicin|mesh-list
44050672|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050673|NCT00003776|Methotrexate|methotrexate|mesh-list
44050674|NCT00003776|Ifosfamide|ifosfamide|mesh-list
44050675|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
44050676|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050677|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050678|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050679|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050680|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050681|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050682|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050683|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44050684|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
44050685|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050686|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050687|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
44050688|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050689|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050690|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050691|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
44050692|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050693|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050694|NCT00003776|Antidotes|antidotes|mesh-ancestor
44050695|NCT00003776|Protective Agents|protective agents|mesh-ancestor
44050696|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050697|NCT00003776|Vitamins|vitamins|mesh-ancestor
44050698|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
44050699|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050700|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
44050701|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
44050711|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
44050712|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050713|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050714|NCT00003780|Antiviral Agents|antiviral agents|mesh-ancestor
44050715|NCT00003780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253178|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460973|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44460974|NCT01555671|Narcotics|narcotics|mesh-ancestor
44460975|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460976|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460977|NCT01555671|Analgesics|analgesics|mesh-ancestor
44460978|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
44460979|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460980|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44460981|NCT01555463|Azelaic acid|azelaic acid|mesh-list
44050716|NCT00003780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050717|NCT00003780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050718|NCT00003780|Immunologic Factors|immunologic factors|mesh-ancestor
44050719|NCT00003780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050720|NCT00003781|Docetaxel|docetaxel|mesh-list
44050721|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050722|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050723|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050724|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050725|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050726|NCT00003783|Leucovorin|leucovorin|mesh-list
44050727|NCT00003783|Cytarabine|cytarabine|mesh-list
44050728|NCT00003783|Dexamethasone|dexamethasone|mesh-list
44050729|NCT00003783|Prednisone|prednisone|mesh-list
44050730|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
44050731|NCT00003783|Methotrexate|methotrexate|mesh-list
44050732|NCT00003783|Etoposide|etoposide|mesh-list
44050733|NCT00003783|Vincristine|vincristine|mesh-list
44050734|NCT00003783|Daunorubicin|daunorubicin|mesh-list
44050735|NCT00003783|Asparaginase|asparaginase|mesh-list
44050736|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
44050737|NCT00003783|Idarubicin|idarubicin|mesh-list
44050738|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
44050739|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050740|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
44050741|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050742|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050743|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050744|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
44050745|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050746|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050747|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050748|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050749|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
44050750|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
44050751|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44050752|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44050753|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
44050754|NCT00003783|Hormones|hormones|mesh-ancestor
44050755|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050756|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050757|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44050758|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
44050759|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44050760|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050761|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
44050762|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050763|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050764|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44050765|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050766|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050767|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050768|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050769|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
44050770|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44460982|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44460983|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460984|NCT01555164|Metformin|metformin|mesh-list
44460985|NCT01555164|Ranolazine|ranolazine|mesh-list
44460986|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44460987|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460988|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44460989|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44460990|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460991|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
44460992|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44460993|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44460994|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44460995|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44460996|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44460997|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
44460998|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460999|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461000|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44461001|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
44461002|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44461003|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44461004|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44461005|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44461006|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461007|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461008|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44461009|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
44461010|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461011|NCT01555073|Celecoxib|celecoxib|mesh-list
44461012|NCT01555073|Pregabalin|pregabalin|mesh-list
44461013|NCT01555073|Analgesics|analgesics|mesh-ancestor
44461014|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
44461015|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44050771|NCT00003783|Antidotes|antidotes|mesh-ancestor
44050786|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050787|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
44050788|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050789|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050790|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461016|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461018|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44461019|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461020|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461021|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44461022|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44050791|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
44050792|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050793|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050794|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050795|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050796|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050797|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050798|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050799|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44050800|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
44050801|NCT00003784|Hormones|hormones|mesh-ancestor
44050802|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44050803|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44050804|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050805|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050806|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050807|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050808|NCT00003786|Irofulven|irofulven|mesh-list
44050809|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050810|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
44050811|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050812|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050813|NCT00003788|Carmustine|carmustine|mesh-list
44050814|NCT00003788|Lomustine|lomustine|mesh-list
44050815|NCT00003788|Procarbazine|procarbazine|mesh-list
44050816|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44050817|NCT00003788|Trioxsalen|trioxsalen|mesh-list
44050818|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050819|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
44050820|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050821|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050822|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050823|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44050824|NCT00003789|Melphalan|melphalan|mesh-list
44050825|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050826|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
44050827|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050828|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050829|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44050830|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050831|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
44050832|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050833|NCT00003792|Lenograstim|lenograstim|mesh-list
44050834|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44050835|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
44149746|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
44149747|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44149748|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149749|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149750|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149751|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
44149752|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149753|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149754|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
44149755|NCT00208793|Vitamin D|vitamin d|mesh-list
44149756|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
44149757|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
44149758|NCT00208793|Vitamins|vitamins|mesh-list
44149759|NCT00208793|Calcium|calcium|mesh-list
44149760|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
44461023|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461024|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461025|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461026|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461027|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461028|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461029|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461030|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44149761|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149762|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44149763|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149765|NCT00208819|Olanzapine|olanzapine|mesh-list
44149766|NCT00208819|Risperidone|risperidone|mesh-list
44149767|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44149768|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149769|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
44149770|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149771|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149772|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149773|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149774|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149775|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149776|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149777|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149778|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
44149779|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
44149780|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
44149781|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149782|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149783|NCT00208819|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149784|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149785|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149786|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149787|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
44149788|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149789|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
44149790|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
44149791|NCT00208858|Topiramate|topiramate|mesh-list
44149792|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
43776702|NCT02337036|Tacrolimus|tacrolimus|mesh-list
44149793|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44149794|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050838|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050839|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
44050840|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050841|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050842|NCT00003797|Gemcitabine|gemcitabine|mesh-list
44050843|NCT00003797|Trastuzumab|trastuzumab|mesh-list
44050844|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050845|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
44050846|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050847|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547684|NCT03649945|Nedaplatin|nedaplatin|mesh-list
44050853|NCT00003797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050854|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050855|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
44050856|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050857|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44050858|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44050859|NCT00003799|Leucovorin|leucovorin|mesh-list
44050860|NCT00003799|Fluorouracil|fluorouracil|mesh-list
44050861|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
44050862|NCT00003799|Calcium|calcium|mesh-list
44050863|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
44050864|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44050865|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050866|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
44461031|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44461032|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461033|NCT01554618|Exenatide|exenatide|mesh-list
44461034|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44050867|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050868|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050869|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050870|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050871|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
44050872|NCT00003799|Antidotes|antidotes|mesh-ancestor
44050873|NCT00003799|Protective Agents|protective agents|mesh-ancestor
44050874|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050875|NCT00003799|Vitamins|vitamins|mesh-ancestor
44050876|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
44050877|NCT00003802|NSC 366140|nsc 366140|mesh-list
44050878|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050880|NCT00003803|Cisplatin|cisplatin|mesh-list
44050881|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050882|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050883|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
44050884|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050885|NCT00003803|Antiviral Agents|antiviral agents|mesh-ancestor
44050886|NCT00003803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050887|NCT00003803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050888|NCT00003803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050889|NCT00003803|Immunologic Factors|immunologic factors|mesh-ancestor
44050890|NCT00003803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050891|NCT00003804|Dactinomycin|dactinomycin|mesh-list
44050892|NCT00003804|Vincristine|vincristine|mesh-list
44050893|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050894|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050895|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050896|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050897|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050898|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050899|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44050900|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050901|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050902|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44050903|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050904|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44050905|NCT00003805|Vancomycin|vancomycin|mesh-list
44050906|NCT00003805|Tazobactam|tazobactam|mesh-list
44050907|NCT00003805|Piperacillin|piperacillin|mesh-list
44050908|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44050909|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44050910|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050911|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44050912|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149795|NCT00208897|Fluoxetine|fluoxetine|mesh-list
44050913|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050914|NCT00003808|Theophylline|theophylline|mesh-list
44050915|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44050916|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
44050917|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44050918|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050919|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44050937|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050938|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050939|NCT00003810|Antiviral Agents|antiviral agents|mesh-ancestor
44050940|NCT00003810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050941|NCT00003810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050942|NCT00003810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050943|NCT00003810|Immunologic Factors|immunologic factors|mesh-ancestor
44050944|NCT00003810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050945|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050946|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050947|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050949|NCT00003811|Etoposide|etoposide|mesh-list
44050950|NCT00003811|Bleomycin|bleomycin|mesh-list
44050951|NCT00003811|Amifostine|amifostine|mesh-list
44050952|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050953|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44253179|NCT05339646|Ritonavir|ritonavir|mesh-list
44253180|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44253181|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44253182|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
44253183|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253184|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253185|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44253186|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44253187|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
44253188|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253189|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44253190|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44253191|NCT05339217|Aldesleukin|aldesleukin|mesh-list
44253192|NCT05339217|Interleukin-2|interleukin-2|mesh-list
44253193|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253194|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253195|NCT05339217|Analgesics|analgesics|mesh-ancestor
44253196|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
44253197|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253198|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253199|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44253200|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44253201|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
44253202|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253203|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44253204|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44253205|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44253206|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
44253207|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253208|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44253209|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44253210|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253211|NCT05338671|Anesthetics|anesthetics|mesh-list
44253212|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
44253213|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253214|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253216|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253217|NCT05338606|Bimatoprost|bimatoprost|mesh-list
44253218|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44253219|NCT05338489|Itraconazole|itraconazole|mesh-list
44253220|NCT05338489|Rifampin|rifampin|mesh-list
44253221|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
44253222|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253223|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44253224|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44253225|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253226|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253227|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253228|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
44253229|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253230|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085401|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44253231|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44253232|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44253233|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
44253234|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253235|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
44253236|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44253237|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44253238|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44050954|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050955|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050956|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050957|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050958|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050959|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44050960|NCT00003811|Protective Agents|protective agents|mesh-ancestor
44050961|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050962|NCT00003812|Paclitaxel|paclitaxel|mesh-list
44050963|NCT00003812|Etoposide|etoposide|mesh-list
44050964|NCT00003812|Carboplatin|carboplatin|mesh-list
44050965|NCT00003812|Topotecan|topotecan|mesh-list
44050966|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050967|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050968|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050969|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050970|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050971|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050972|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050973|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050974|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050975|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050976|NCT00003814|Eflornithine|eflornithine|mesh-list
44050977|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050978|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44253239|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44253240|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44253241|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44253242|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44253243|NCT05338476|Midazolam|midazolam|mesh-list
44253244|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44253245|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44253246|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253247|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253248|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44253249|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44253250|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253251|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44253252|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
44253253|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
44253254|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
44253255|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
44253256|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253257|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253258|NCT05338320|Fentanyl|fentanyl|mesh-list
44253259|NCT05338320|Morphine|morphine|mesh-list
44253260|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
44253261|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253262|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253263|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44253264|NCT05338320|Narcotics|narcotics|mesh-ancestor
44050982|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44050984|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050985|NCT00003815|Cytarabine|cytarabine|mesh-list
44050986|NCT00003815|Prednisolone|prednisolone|mesh-list
44050987|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
44050988|NCT00003815|Melphalan|melphalan|mesh-list
44050989|NCT00003815|Carmustine|carmustine|mesh-list
44050990|NCT00003815|Doxorubicin|doxorubicin|mesh-list
44050991|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050992|NCT00003815|Etoposide|etoposide|mesh-list
44050993|NCT00003815|Vincristine|vincristine|mesh-list
44050994|NCT00003815|Bleomycin|bleomycin|mesh-list
44050995|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050996|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
44050997|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050998|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44050999|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051000|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
44051001|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051002|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051003|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051004|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051005|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051006|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44253265|NCT05338320|Analgesics|analgesics|mesh-ancestor
44253266|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
44253267|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253268|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44253269|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44253270|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
44253272|NCT05338190|Belimumab|belimumab|mesh-list
44253273|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253274|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253275|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
44253276|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253277|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253278|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253279|NCT05331859|Insulin|insulin|mesh-list
43651090|NCT03009500|Lidocaine|lidocaine|mesh-list
44051007|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051008|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051009|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051010|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
44051011|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
44051012|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051013|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051014|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051015|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051016|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44051017|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
44051018|NCT00003815|Hormones|hormones|mesh-ancestor
44051019|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051020|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44051021|NCT00003817|Ondansetron|ondansetron|mesh-list
44051022|NCT00003817|Granisetron|granisetron|mesh-list
44051023|NCT00003817|Tropisetron|tropisetron|mesh-list
44051024|NCT00003817|Dolasetron|dolasetron|mesh-list
44051025|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
44051026|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
44051027|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44051028|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051029|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44051030|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
44051031|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051032|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44051033|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
44051034|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44051035|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051036|NCT00003817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44051037|NCT00003817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44051038|NCT00003817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44051039|NCT00003817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44051040|NCT00003817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44051041|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44051042|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44051043|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44051044|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
44051045|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051046|NCT00003821|Aminopterin|aminopterin|mesh-list
44051047|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051048|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051049|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051050|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44051051|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
44051052|NCT00003824|Cephalexin|cephalexin|mesh-list
44253280|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253281|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253282|NCT05326490|Metformin|metformin|mesh-list
44253283|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253284|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253285|NCT05325489|Budesonide|budesonide|mesh-list
44253286|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253287|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44051057|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051059|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44051060|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44051061|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
44051062|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
44051063|NCT00003827|Cytarabine|cytarabine|mesh-list
44051064|NCT00003827|Topotecan|topotecan|mesh-list
43776858|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
44051065|NCT00003827|Amifostine|amifostine|mesh-list
44051066|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051068|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051069|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051070|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
44051071|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051072|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051073|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
44051074|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051075|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051076|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051077|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051078|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44051079|NCT00003827|Protective Agents|protective agents|mesh-ancestor
44051080|NCT00003828|Vinorelbine|vinorelbine|mesh-list
44051081|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051082|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051083|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051084|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051085|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051086|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051087|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
44051088|NCT00003829|Fludarabine|fludarabine|mesh-list
44051089|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
44051090|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051091|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
44051092|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051093|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051094|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051095|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
43776944|NCT02334904|Risperidone|risperidone|mesh-list
44051096|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051097|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051098|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051099|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051100|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
44051101|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
44051102|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
44051103|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
44085597|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
44051104|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051105|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051106|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051107|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
44051108|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051109|NCT00003834|Leucovorin|leucovorin|mesh-list
44051110|NCT00003834|Fluorouracil|fluorouracil|mesh-list
44051111|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
44051112|NCT00003834|Calcium|calcium|mesh-list
44051113|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
44051114|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44051115|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051116|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
44253288|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
44253289|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253290|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253291|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44253292|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44253293|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
44253294|NCT05325489|Hormones|hormones|mesh-ancestor
44253295|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253296|NCT05322031|Aripiprazole|aripiprazole|mesh-list
44253297|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
44051117|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051118|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051119|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051120|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051121|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
44051126|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
44051128|NCT00003835|Fluorouracil|fluorouracil|mesh-list
44051129|NCT00003835|Irinotecan|irinotecan|mesh-list
44051130|NCT00003835|Calcium|calcium|mesh-list
44051131|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
44051132|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44051133|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051134|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
44051135|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051136|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051137|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051138|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051139|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
44051140|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051141|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051142|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051143|NCT00003835|Antidotes|antidotes|mesh-ancestor
44051144|NCT00003835|Protective Agents|protective agents|mesh-ancestor
44051145|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
44051146|NCT00003835|Vitamins|vitamins|mesh-ancestor
44051147|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
44051148|NCT00003842|Interleukin-4|interleukin-4|mesh-list
44051149|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44051150|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
44051151|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051152|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051153|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051154|NCT00003843|Irinotecan|irinotecan|mesh-list
44051155|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051156|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051157|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051158|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051159|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051160|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
44051161|NCT00003846|Thiotepa|thiotepa|mesh-list
44051162|NCT00003846|Carboplatin|carboplatin|mesh-list
44051163|NCT00003846|Vincristine|vincristine|mesh-list
44051164|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051165|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
44051166|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051167|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051168|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051169|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
44051170|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051171|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051172|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051173|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051174|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051175|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051176|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051177|NCT00003847|Doxorubicin|doxorubicin|mesh-list
44253298|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253299|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44253300|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44253301|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253302|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253303|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
44253304|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
44253305|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253306|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253307|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44253308|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44253309|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
44253310|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44253311|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44253312|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44253313|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44253314|NCT05319093|Ozanimod|ozanimod|mesh-list
44253315|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44253316|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253317|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253318|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
44253319|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253320|NCT05314660|Fluorides|fluorides|mesh-list
44253321|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
44253322|NCT05314660|Protective Agents|protective agents|mesh-ancestor
44253323|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253324|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44253325|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253326|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
44253327|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
44051178|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44051179|NCT00003847|Vincristine|vincristine|mesh-list
44051180|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051181|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051182|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051183|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051184|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051185|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051186|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051187|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051188|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051189|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253329|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44253330|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44253331|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
44253332|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253334|NCT05279833|Dronedarone|dronedarone|mesh-list
44253335|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44253336|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44253337|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
44253338|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253339|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253340|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253341|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44253342|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
44253343|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
44253344|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253345|NCT05266417|Insulin|insulin|mesh-list
44253346|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253347|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461035|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461036|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44461037|NCT01554618|Incretins|incretins|mesh-ancestor
44461038|NCT01554618|Hormones|hormones|mesh-ancestor
44461039|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461040|NCT01554514|Rituximab|rituximab|mesh-list
44461041|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44461042|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461043|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
44461044|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461045|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461046|NCT01554241|Vitamin D|vitamin d|mesh-list
44461047|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
44461048|NCT01554241|Vitamins|vitamins|mesh-ancestor
44461049|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
44461050|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051191|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44051192|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051193|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
44051194|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051195|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051196|NCT00003850|Thalidomide|thalidomide|mesh-list
44461051|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44461052|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44461053|NCT01554163|Celecoxib|celecoxib|mesh-list
44461054|NCT01554163|Etoricoxib|etoricoxib|mesh-list
44461055|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461056|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461057|NCT01554163|Analgesics|analgesics|mesh-ancestor
44461058|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
44461059|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461060|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461061|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461062|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461063|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44461064|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44461065|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461066|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461067|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
44461068|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
44461069|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461070|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461071|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461072|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
44461073|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461074|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461075|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461076|NCT01553851|Trametinib|trametinib|mesh-list
44461077|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461078|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44085812|NCT00020202|Romidepsin|romidepsin|mesh-list
44461079|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461080|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461081|NCT01553747|Eluxadoline|eluxadoline|mesh-list
44461082|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461083|NCT01553591|Eluxadoline|eluxadoline|mesh-list
44461084|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44051205|NCT00003850|Growth Substances|growth substances|mesh-ancestor
44051206|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
44051207|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051208|NCT00003851|Gemcitabine|gemcitabine|mesh-list
44051209|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44461085|NCT01553318|Ketotifen|ketotifen|mesh-list
44461086|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
44461087|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461088|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44461089|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
44461090|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
44253348|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44253349|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
44253350|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44253351|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
44253352|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253353|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44253354|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43651221|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
44051210|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
44051211|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051212|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051213|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
44051214|NCT00003851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051215|NCT00003851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051216|NCT00003851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051217|NCT00003851|Immunologic Factors|immunologic factors|mesh-ancestor
44051218|NCT00003851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051219|NCT00003852|Paclitaxel|paclitaxel|mesh-list
44051220|NCT00003852|Etoposide|etoposide|mesh-list
44051221|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
44051222|NCT00003852|Carboplatin|carboplatin|mesh-list
44051223|NCT00003852|Epirubicin|epirubicin|mesh-list
44051224|NCT00003852|Ifosfamide|ifosfamide|mesh-list
44051225|NCT00003852|Thiotepa|thiotepa|mesh-list
44051226|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051227|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051228|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051229|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051230|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051231|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051232|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051233|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
44051234|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051235|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051236|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051237|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
44051238|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051239|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051240|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051241|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051242|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051243|NCT00003853|Esorubicin|esorubicin|mesh-list
44051244|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051245|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051246|NCT00003856|Temoporfin|temoporfin|mesh-list
44051247|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051248|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44051249|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051250|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
44051251|NCT00003858|Analgesics|analgesics|mesh-ancestor
44051252|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
44051253|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44051254|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051255|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051256|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051257|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051258|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701620|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253355|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44253356|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253357|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253358|NCT05236985|Oxytocin|oxytocin|mesh-list
44253359|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
44253360|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253361|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253362|NCT05232032|Nociceptin|nociceptin|mesh-list
44253363|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253364|NCT05227391|Letrozole|letrozole|mesh-list
44253365|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44253366|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44253367|NCT05227391|Estradiol|estradiol|mesh-list
44051259|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051261|NCT00003859|Carboplatin|carboplatin|mesh-list
44051262|NCT00003859|Etoposide|etoposide|mesh-list
44051263|NCT00003859|Vincristine|vincristine|mesh-list
44051264|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051265|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
44051266|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051270|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051271|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051272|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051273|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051274|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051275|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051276|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051277|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051278|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051279|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051281|NCT00003860|Etoposide|etoposide|mesh-list
44051282|NCT00003860|Ifosfamide|ifosfamide|mesh-list
44051283|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051284|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051285|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051286|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051287|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051288|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051289|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051290|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
44051291|NCT00003862|Leucovorin|leucovorin|mesh-list
44051292|NCT00003862|Paclitaxel|paclitaxel|mesh-list
44051293|NCT00003862|Cisplatin|cisplatin|mesh-list
44051294|NCT00003862|Fluorouracil|fluorouracil|mesh-list
44051295|NCT00003862|Calcium|calcium|mesh-list
44051296|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
44051297|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051298|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051299|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051300|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051301|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051302|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051303|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44051304|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051305|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
44051306|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051307|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051308|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
44051309|NCT00003862|Antidotes|antidotes|mesh-ancestor
44051310|NCT00003862|Protective Agents|protective agents|mesh-ancestor
44051311|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
44051312|NCT00003862|Vitamins|vitamins|mesh-ancestor
44051313|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
44051314|NCT00003864|Carboplatin|carboplatin|mesh-list
44051315|NCT00003864|Docetaxel|docetaxel|mesh-list
44051316|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253369|NCT05227391|Estrogens|estrogens|mesh-ancestor
44253370|NCT05227391|Hormones|hormones|mesh-ancestor
44253371|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253372|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253373|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44253374|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
44253375|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253376|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44253377|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253378|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44253379|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253380|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063455|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253381|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253382|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44253383|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
44253384|NCT05206110|Ketorolac|ketorolac|mesh-list
43651244|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
44051317|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051318|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051319|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051320|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051321|NCT00003865|Toremifene|toremifene|mesh-list
44051322|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44051323|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051324|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44051325|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44051326|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
44051327|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051328|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051329|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44051330|NCT00003867|Capecitabine|capecitabine|mesh-list
44051331|NCT00003867|Irinotecan|irinotecan|mesh-list
44051332|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051333|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
44051334|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051335|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051336|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051337|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051338|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051346|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051347|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051348|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
44051349|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051350|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051351|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051352|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051353|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051354|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44051355|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051356|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
44051357|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051358|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051359|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44253385|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44253386|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253387|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253388|NCT05206110|Analgesics|analgesics|mesh-ancestor
44253389|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
44253390|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253391|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253392|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253393|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253394|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44253395|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253396|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253397|NCT05200988|Nivolumab|nivolumab|mesh-list
44253398|NCT05200988|Ipilimumab|ipilimumab|mesh-list
44253399|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253400|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051360|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051361|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
44051362|NCT00003870|Methotrexate|methotrexate|mesh-list
44051363|NCT00003870|Antibodies|antibodies|mesh-list
44051364|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44051365|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051366|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
44051367|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051368|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051369|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051370|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
44051371|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051373|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051374|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051375|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051376|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44051377|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051378|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
44051379|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051380|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051381|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051382|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051383|NCT00003871|Vaccines|vaccines|mesh-list
44051384|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
44051385|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051386|NCT00003873|Fluorouracil|fluorouracil|mesh-list
44051387|NCT00003873|Eniluracil|eniluracil|mesh-list
44051388|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
44051389|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051390|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051391|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051392|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051393|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
44051394|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051395|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051396|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44051397|NCT00003874|Antibodies|antibodies|mesh-list
44051398|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
44051399|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44051400|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
44051401|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051402|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253401|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253402|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253404|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253405|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253406|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253407|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253408|NCT05158686|Paclitaxel|paclitaxel|mesh-list
44253409|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44253410|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253411|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
44253412|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
44253413|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253414|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253415|NCT05157997|Antibodies|antibodies|mesh-list
44253416|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
44253417|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253418|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
44253419|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253420|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253421|NCT05128071|Progesterone|progesterone|mesh-list
43907280|NCT00287053|Valproic Acid|valproic acid|mesh-list
44253422|NCT05128071|Progestins|progestins|mesh-ancestor
44253423|NCT05128071|Hormones|hormones|mesh-ancestor
44253424|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253425|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253426|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
44253427|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253428|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253429|NCT05109416|Bupivacaine|bupivacaine|mesh-list
44253430|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44253431|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
44051403|NCT00003876|Carmustine|carmustine|mesh-list
44051404|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051405|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
44051406|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051407|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051408|NCT00003877|Paclitaxel|paclitaxel|mesh-list
44051409|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
44253432|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253433|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253434|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
44253435|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253436|NCT05091905|Ropivacaine|ropivacaine|mesh-list
44253437|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
44253438|NCT05091905|Anesthetics|anesthetics|mesh-list
44253439|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253440|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253441|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
44253442|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253443|NCT05074823|Ketamine|ketamine|mesh-list
44253444|NCT05074823|Analgesics|analgesics|mesh-ancestor
44253445|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
44253446|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253447|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253448|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44253449|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44253450|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
44253451|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
44253452|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253453|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44253454|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44253455|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253456|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253457|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
44253458|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44253459|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
44253460|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253461|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253462|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44253463|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
44051410|NCT00003877|Carboplatin|carboplatin|mesh-list
44051428|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051429|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051430|NCT00003880|Paclitaxel|paclitaxel|mesh-list
44051431|NCT00003880|Carboplatin|carboplatin|mesh-list
44051432|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051433|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051434|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
44253464|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44253465|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
44253466|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253467|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253468|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44253469|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253470|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
44253471|NCT05052229|Protective Agents|protective agents|mesh-ancestor
44253472|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
44253473|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44253474|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253475|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253476|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253477|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
44253478|NCT04977453|Lenvatinib|lenvatinib|mesh-list
44253479|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253480|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253481|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44253482|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253483|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253484|NCT04973891|Metformin|metformin|mesh-list
44253485|NCT04973891|Canagliflozin|canagliflozin|mesh-list
44253486|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253487|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253488|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44051435|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051436|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051437|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051438|NCT00003881|Paclitaxel|paclitaxel|mesh-list
44051439|NCT00003881|Carboplatin|carboplatin|mesh-list
44051440|NCT00003881|Trastuzumab|trastuzumab|mesh-list
44051441|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051442|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051443|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051444|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051445|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051446|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051447|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44051448|NCT00003883|Itraconazole|itraconazole|mesh-list
44051449|NCT00003883|Fluconazole|fluconazole|mesh-list
44051450|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
44051451|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051452|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44051453|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44051454|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051455|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051456|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253489|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253491|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
44253492|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253493|NCT04951362|Ivermectin|ivermectin|mesh-list
44253494|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44253495|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253496|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44461091|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461092|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461093|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461094|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44461095|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44461096|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
44461097|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051457|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
44051458|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051459|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051460|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44051461|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44051462|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44051463|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
44051464|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44051466|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
44051467|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051468|NCT00003888|Cisplatin|cisplatin|mesh-list
44051469|NCT00003888|Docetaxel|docetaxel|mesh-list
44051470|NCT00003888|Fluorouracil|fluorouracil|mesh-list
44051471|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051472|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051473|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051474|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051475|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051476|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
44051477|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051478|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051479|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
44051480|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051481|NCT00003891|Lurtotecan|lurtotecan|mesh-list
44051482|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051483|NCT00003892|ISIS 5132|isis 5132|mesh-list
43804575|NCT04944173|Durvalumab|durvalumab|mesh-list
44051484|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051485|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051486|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051487|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
44051488|NCT00003893|Doxorubicin|doxorubicin|mesh-list
44051489|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44051490|NCT00003893|Fluorouracil|fluorouracil|mesh-list
44051491|NCT00003893|Methotrexate|methotrexate|mesh-list
44051493|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
44051494|NCT00003893|Mitomycins|mitomycins|mesh-list
44051495|NCT00003893|Mitomycin|mitomycin|mesh-list
44051496|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051497|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
44051498|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051499|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051500|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051501|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
44461098|NCT01553188|Prednisone|prednisone|mesh-list
44461099|NCT01553188|Trebananib|trebananib|mesh-list
44461100|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461101|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
44461102|NCT01553188|Hormones|hormones|mesh-ancestor
44461103|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461104|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461105|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461106|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461107|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461108|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461109|NCT01553188|Growth Substances|growth substances|mesh-ancestor
44461110|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44461111|NCT01553136|Varenicline|varenicline|mesh-list
44461112|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44461113|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44461114|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461115|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461116|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461117|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461118|NCT01553084|Nicotine|nicotine|mesh-list
44461119|NCT01553084|Varenicline|varenicline|mesh-list
44461120|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44461121|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
43651314|NCT03008057|Vitamin D|vitamin d|mesh-list
44051502|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051503|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051504|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051505|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051506|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051507|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051508|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051509|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
44051510|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051511|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051512|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051513|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44051514|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051515|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051516|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051517|NCT00003893|Analgesics|analgesics|mesh-ancestor
44051518|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
43777275|NCT02332980|Idelalisib|idelalisib|mesh-list
44051519|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44051520|NCT00003894|Thalidomide|thalidomide|mesh-list
44051521|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051522|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
44051523|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051524|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
44152278|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
44051525|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44051526|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461122|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461123|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461124|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44461125|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44461126|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461127|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461128|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461130|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44461131|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
44461132|NCT01552928|Anagrelide|anagrelide|mesh-list
44461133|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461134|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461135|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461136|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44461137|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651336|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051527|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44051528|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44051529|NCT00003894|Growth Substances|growth substances|mesh-ancestor
44051530|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44051531|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051532|NCT00003897|Sargramostim|sargramostim|mesh-list
44051533|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
44051534|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051535|NCT00003899|Paclitaxel|paclitaxel|mesh-list
44051536|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
44051537|NCT00003899|Melphalan|melphalan|mesh-list
44051538|NCT00003899|Thiotepa|thiotepa|mesh-list
44051539|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051540|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051541|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051549|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051551|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051552|NCT00003900|Docetaxel|docetaxel|mesh-list
44051553|NCT00003900|Irinotecan|irinotecan|mesh-list
44051554|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051555|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051556|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051557|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051558|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051559|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051560|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051561|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051563|NCT00003902|Vinorelbine|vinorelbine|mesh-list
44051564|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051565|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
44051566|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051567|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051568|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051569|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051570|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051571|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051572|NCT00003906|Tamoxifen|tamoxifen|mesh-list
44051573|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44051574|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44051575|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
44051576|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051577|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461138|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461139|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461140|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44461141|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44461142|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44461144|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44461145|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44461146|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461147|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44461148|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461149|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461150|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461151|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
44051578|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44051579|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051580|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44051581|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44051582|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44051583|NCT00003908|Carboplatin|carboplatin|mesh-list
44051584|NCT00003908|Docetaxel|docetaxel|mesh-list
44051585|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051586|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051587|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051588|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051589|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051590|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
44051591|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051592|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44051593|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051594|NCT00003912|Cisplatin|cisplatin|mesh-list
44051595|NCT00003912|Carboplatin|carboplatin|mesh-list
44051596|NCT00003912|Doxorubicin|doxorubicin|mesh-list
44051597|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44051598|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051599|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051600|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051601|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051602|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051603|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051604|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
44051605|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
44051607|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44051608|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051609|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
43548403|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
44051631|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051632|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051633|NCT00003917|Topotecan|topotecan|mesh-list
44051634|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051635|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051636|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051637|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051639|NCT00003920|Cyclosporine|cyclosporine|mesh-list
44051640|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44051641|NCT00003920|Antibodies|antibodies|mesh-list
44051642|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
44461152|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461154|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44461155|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44461156|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461157|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44461158|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461159|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461160|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461161|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
44253497|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
44253498|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44253499|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253500|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253501|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44253502|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44253503|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253504|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253505|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253506|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44253507|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
44253508|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253509|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253510|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44253511|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44253512|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44253513|NCT04807348|Metformin|metformin|mesh-list
44253514|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44253515|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253516|NCT04771741|Acetaminophen|acetaminophen|mesh-list
44253517|NCT04771741|Ketorolac|ketorolac|mesh-list
44051643|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44051644|NCT00003920|Cyclosporins|cyclosporins|mesh-list
44051645|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
44051646|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051647|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051648|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051649|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051650|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051651|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
44253518|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44253519|NCT04771741|Meloxicam|meloxicam|mesh-list
44253520|NCT04771741|Pregabalin|pregabalin|mesh-list
44253521|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
44253522|NCT04771741|Analgesics|analgesics|mesh-ancestor
44253523|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
44253524|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253525|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253526|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
44253527|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44253528|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44253529|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253530|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253531|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44253532|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44253533|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44051652|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051653|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051654|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051655|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44051656|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44051657|NCT00003923|Trioxsalen|trioxsalen|mesh-list
44051658|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051659|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051660|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44051661|NCT00003924|Interferons|interferons|mesh-list
44051662|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
43548476|NCT03641404|Ergothioneine|ergothioneine|mesh-list
44051700|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051701|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051702|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051703|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44051704|NCT00003926|Protective Agents|protective agents|mesh-ancestor
44051713|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051714|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051716|NCT00003928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051718|NCT00003929|Procarbazine|procarbazine|mesh-list
44051719|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051720|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
44051721|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051722|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149796|NCT00208897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149797|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44063456|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149798|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149799|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149800|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149801|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
44149802|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149803|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44149804|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149805|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149806|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44149807|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44149808|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149809|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
44149810|NCT00208923|Busulfan|busulfan|mesh-list
44149811|NCT00208923|Fludarabine|fludarabine|mesh-list
44149812|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253534|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253535|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253536|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253537|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253538|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253539|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44253540|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253541|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
44253542|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44253543|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44253544|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
44253545|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44253546|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44253547|NCT04739592|Vitamin D|vitamin d|mesh-list
44253548|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
44253549|NCT04739592|Alendronate|alendronate|mesh-list
44253550|NCT04739592|Vitamins|vitamins|mesh-ancestor
44253551|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
44253552|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253553|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44253554|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44253555|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
44253556|NCT04710277|Narcotics|narcotics|mesh-ancestor
44253557|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253558|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253559|NCT04710277|Analgesics|analgesics|mesh-ancestor
44253560|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
44253561|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253562|NCT04703075|Rifapentine|rifapentine|mesh-list
44149813|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
44149814|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149815|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149816|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44149817|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
44149818|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149819|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149820|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44149821|NCT00208936|Cisplatin|cisplatin|mesh-list
44149822|NCT00208936|Fluorouracil|fluorouracil|mesh-list
44051723|NCT00003930|Gemcitabine|gemcitabine|mesh-list
44051724|NCT00003930|Paclitaxel|paclitaxel|mesh-list
44051725|NCT00003930|Cisplatin|cisplatin|mesh-list
44051726|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051727|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051728|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051729|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051730|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253563|NCT04703075|Rifampin|rifampin|mesh-list
44253564|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44253565|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
44253566|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253567|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253568|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
44253569|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44253570|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253571|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253572|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44253573|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44253574|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44253575|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44253576|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44253577|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44253578|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
44253579|NCT04701476|Tirapazamine|tirapazamine|mesh-list
44253580|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253581|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253583|NCT04688658|Axitinib|axitinib|mesh-list
44253584|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253585|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253586|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253587|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253588|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44253589|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253590|NCT04666961|Tamoxifen|tamoxifen|mesh-list
44253591|NCT04666961|Anastrozole|anastrozole|mesh-list
44253592|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44253593|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
44253594|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253595|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253596|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651445|NCT03007121|Sufentanil|sufentanil|mesh-list
44051731|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051732|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44253598|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44253599|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44253600|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44253601|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44253602|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253603|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253604|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253605|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
44253606|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44253607|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253608|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253609|NCT04657562|Tacrolimus|tacrolimus|mesh-list
44253610|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051733|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
44051734|NCT00003930|Antiviral Agents|antiviral agents|mesh-ancestor
44051735|NCT00003930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051736|NCT00003930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051737|NCT00003930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051738|NCT00003930|Immunologic Factors|immunologic factors|mesh-ancestor
44051739|NCT00003930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051740|NCT00003934|Cytarabine|cytarabine|mesh-list
44051741|NCT00003934|Methotrexate|methotrexate|mesh-list
44051742|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
44051743|NCT00003934|Daunorubicin|daunorubicin|mesh-list
44051744|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
44051745|NCT00003934|Tretinoin|tretinoin|mesh-list
43548544|NCT03640403|Artesunate|artesunate|mesh-list
44051758|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
44051759|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051760|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051761|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
44051762|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051763|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051764|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051765|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051766|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
44051767|NCT00003935|Etoposide|etoposide|mesh-list
44051768|NCT00003935|Vincristine|vincristine|mesh-list
44051769|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051770|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051771|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051772|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051773|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063457|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051774|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051775|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051776|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051777|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051778|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
44051779|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44051780|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
44051781|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051782|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051783|NCT00003937|Cisplatin|cisplatin|mesh-list
44051784|NCT00003937|Doxorubicin|doxorubicin|mesh-list
44051785|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44051786|NCT00003937|Methotrexate|methotrexate|mesh-list
44051787|NCT00003937|Etoposide|etoposide|mesh-list
44051788|NCT00003937|Ifosfamide|ifosfamide|mesh-list
44051789|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
44051790|NCT00003937|Razoxane|razoxane|mesh-list
44051791|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253612|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253613|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44253614|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253615|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253616|NCT04646837|Paclitaxel|paclitaxel|mesh-list
44253617|NCT04646837|Cisplatin|cisplatin|mesh-list
44253618|NCT04646837|Carboplatin|carboplatin|mesh-list
44253619|NCT04646837|Durvalumab|durvalumab|mesh-list
44253620|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44253621|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253622|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
44253623|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
44253624|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253625|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051792|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051793|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051794|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051795|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051796|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051797|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051798|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051799|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777454|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
44051800|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051801|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051803|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051804|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051805|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051806|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
43548621|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
44051820|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44051821|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051822|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44051823|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
44051824|NCT00003939|Trabectedin|trabectedin|mesh-list
44051825|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051826|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
44051827|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051828|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051829|NCT00003941|Cisplatin|cisplatin|mesh-list
44051830|NCT00003941|Etoposide|etoposide|mesh-list
44051831|NCT00003941|Ifosfamide|ifosfamide|mesh-list
44051832|NCT00003941|Bleomycin|bleomycin|mesh-list
44051833|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051834|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051835|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051836|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051837|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051838|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051839|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051840|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
44051841|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051842|NCT00003943|Paclitaxel|paclitaxel|mesh-list
44051843|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
44051844|NCT00003943|Carboplatin|carboplatin|mesh-list
44051845|NCT00003943|Topotecan|topotecan|mesh-list
44051846|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051847|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253627|NCT04572451|Nivolumab|nivolumab|mesh-list
44253628|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253629|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253630|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253631|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253632|NCT04549207|Denosumab|denosumab|mesh-list
44253633|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
44253634|NCT04549207|Pamidronate|pamidronate|mesh-list
44253635|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44253636|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253637|NCT04532463|Fluconazole|fluconazole|mesh-list
44253638|NCT04532463|Amphotericin B|amphotericin b|mesh-list
44253639|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44253640|NCT04532463|Flucytosine|flucytosine|mesh-list
44253641|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
44253642|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44253643|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44253644|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44253645|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253646|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253647|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253648|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
44253649|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253650|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253651|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44253652|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44253653|NCT04532463|Amebicides|amebicides|mesh-ancestor
44253654|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44253655|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44253656|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253657|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
44253658|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44253659|NCT04504734|Bucillamine|bucillamine|mesh-list
44051848|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051849|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051850|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253660|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253661|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253663|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
44253664|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253665|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253666|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253667|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253668|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
44253669|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253670|NCT04504734|Protective Agents|protective agents|mesh-ancestor
44051851|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051852|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051853|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
44051854|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051855|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051856|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051857|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
44051858|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051859|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051860|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051861|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051862|NCT00003944|Paclitaxel|paclitaxel|mesh-list
44051863|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
44051864|NCT00003944|Carboplatin|carboplatin|mesh-list
44051865|NCT00003944|Topotecan|topotecan|mesh-list
44051866|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051867|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051868|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051869|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051870|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051880|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051883|NCT00003945|Topotecan|topotecan|mesh-list
44051884|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051885|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051886|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051887|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063458|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051888|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051889|NCT00003946|Danazol|danazol|mesh-list
44051890|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44051891|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
44051892|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051893|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051894|NCT00003950|Cyclosporine|cyclosporine|mesh-list
44051895|NCT00003950|Irinotecan|irinotecan|mesh-list
44051896|NCT00003950|Cyclosporins|cyclosporins|mesh-list
44051897|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051898|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051899|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051900|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051901|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051902|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051903|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
44051904|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051905|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
44051906|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051907|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051908|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051909|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44051910|NCT00003951|Exatecan|exatecan|mesh-list
44051911|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051912|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051913|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253672|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253673|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253675|NCT04480918|Esketamine|esketamine|mesh-list
44253676|NCT04480918|Analgesics|analgesics|mesh-ancestor
44253677|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
44253678|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253679|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253680|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44253681|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44253682|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
44253683|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
44253684|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253685|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44253686|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44253687|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253688|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253689|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
44253690|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253691|NCT04479579|Apixaban|apixaban|mesh-list
44253692|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44253693|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
44253694|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44253695|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
44253696|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253697|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253698|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
44253699|NCT04477772|Antibodies|antibodies|mesh-list
44051914|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051915|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051916|NCT00003953|Tamoxifen|tamoxifen|mesh-list
44051917|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
44051918|NCT00003953|Docetaxel|docetaxel|mesh-list
44051919|NCT00003953|Doxorubicin|doxorubicin|mesh-list
44051920|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44051921|NCT00003953|Fluorouracil|fluorouracil|mesh-list
44051922|NCT00003953|Methotrexate|methotrexate|mesh-list
44051923|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051924|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
44051925|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051926|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051927|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051928|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
44051929|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051930|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051931|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44253700|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44253701|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
44253702|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253704|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44253705|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253706|NCT04377204|Lidocaine|lidocaine|mesh-list
44253707|NCT04377204|Bupivacaine|bupivacaine|mesh-list
44253708|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
44253709|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
44253710|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253711|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253712|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
44253713|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253714|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44253715|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44253716|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43907653|NCT00298155|Dutasteride|dutasteride|mesh-list
44253717|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44253718|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253719|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
44253720|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44253721|NCT04329039|Somatostatin|somatostatin|mesh-list
44253722|NCT04329039|Hormones|hormones|mesh-ancestor
44253723|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051932|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051933|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051934|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051935|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43548737|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
44051938|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051939|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
44051940|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051941|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051942|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051943|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44051944|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051945|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051946|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051947|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44051948|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
44051949|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051950|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44051951|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44051952|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44051953|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44051954|NCT00003954|Cyclosporine|cyclosporine|mesh-list
44253724|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253725|NCT04321668|Hylan|hylan|mesh-list
44253726|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
44253727|NCT04321668|Protective Agents|protective agents|mesh-ancestor
44253728|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461162|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461163|NCT01552772|Aripiprazole|aripiprazole|mesh-list
44461164|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
44461165|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461166|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44461167|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461168|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846477|NCT04197089|Vitamins|vitamins|mesh-ancestor
44051955|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
44051956|NCT00003954|Melphalan|melphalan|mesh-list
44051957|NCT00003954|Cyclosporins|cyclosporins|mesh-list
44051958|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051959|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051960|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051961|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
44051962|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051963|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
44086869|NCT00022230|Paclitaxel|paclitaxel|mesh-list
44051964|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051965|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051966|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051967|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44051968|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44051969|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051970|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44051971|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
44051972|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44051973|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051974|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
44051975|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051976|NCT00003955|Dactinomycin|dactinomycin|mesh-list
44051977|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
44051978|NCT00003955|Irinotecan|irinotecan|mesh-list
44051979|NCT00003955|Vincristine|vincristine|mesh-list
44051980|NCT00003955|Sargramostim|sargramostim|mesh-list
44051981|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051982|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
44051983|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051984|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051985|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051986|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
44051987|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051988|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051989|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051990|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051991|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051993|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051994|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051995|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051996|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051997|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44051998|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051999|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052000|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44052001|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44052002|NCT00003956|Leucovorin|leucovorin|mesh-list
44052003|NCT00003956|Fluorouracil|fluorouracil|mesh-list
44052004|NCT00003956|Calcium|calcium|mesh-list
44052005|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
44052006|NCT00003956|Lonafarnib|lonafarnib|mesh-list
44052007|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44461170|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
44461171|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
44461172|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461173|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461174|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44461175|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44461176|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
44461177|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44461178|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44461179|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44461180|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43846500|NCT04195945|Analgesics|analgesics|mesh-ancestor
44052008|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052009|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
44052011|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052012|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052013|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052014|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
44052016|NCT00003956|Protective Agents|protective agents|mesh-ancestor
44052017|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
44052018|NCT00003956|Vitamins|vitamins|mesh-ancestor
44052019|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
44052020|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052021|NCT00003957|Cytarabine|cytarabine|mesh-list
44052022|NCT00003957|Paclitaxel|paclitaxel|mesh-list
44052023|NCT00003957|Etoposide|etoposide|mesh-list
44052024|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
44052025|NCT00003957|Melphalan|melphalan|mesh-list
44052026|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
44052027|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052028|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052029|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052030|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052031|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052032|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052033|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052034|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
44052035|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052036|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052037|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052038|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
44052039|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052040|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052041|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052042|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052043|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052044|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
44052045|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
44052046|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052047|NCT00003957|Analgesics|analgesics|mesh-ancestor
44052048|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
44052049|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052050|NCT00003958|Dactinomycin|dactinomycin|mesh-list
44052051|NCT00003958|Cactinomycin|cactinomycin|mesh-list
44052052|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
44052053|NCT00003958|Vincristine|vincristine|mesh-list
44052054|NCT00003958|Topotecan|topotecan|mesh-list
44052055|NCT00003958|Sargramostim|sargramostim|mesh-list
44052056|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052057|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
44052058|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052059|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461183|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461184|NCT01552694|Incretins|incretins|mesh-ancestor
44461185|NCT01552694|Hormones|hormones|mesh-ancestor
44461186|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461187|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44461188|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461189|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461190|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461191|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
44461192|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
44461193|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461194|NCT01552603|Pancrelipase|pancrelipase|mesh-list
44461195|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461196|NCT01552408|Ranibizumab|ranibizumab|mesh-list
44461197|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461198|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461199|NCT01552408|Growth Substances|growth substances|mesh-ancestor
44461200|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461201|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44461202|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846504|NCT04195750|Everolimus|everolimus|mesh-list
44052060|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052061|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
44052062|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052063|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052064|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052065|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052066|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052067|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052068|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052069|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052070|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052071|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052072|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44052073|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052074|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052075|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44052076|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44052077|NCT00003959|Sargramostim|sargramostim|mesh-list
44052078|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
44052079|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052080|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
44052081|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44052082|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44052083|NCT00003960|Prednisolone|prednisolone|mesh-list
44052084|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
44052103|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
44052104|NCT00003960|Hormones|hormones|mesh-ancestor
44461204|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
44461205|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461206|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44461207|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44461208|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461209|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461210|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461211|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461212|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461213|NCT01552057|Analgesics|analgesics|mesh-ancestor
44461214|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
44461215|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461216|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
44461217|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461218|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
44461219|NCT01551745|Bevacizumab|bevacizumab|mesh-list
44461220|NCT01551745|Vaccines|vaccines|mesh-list
44461221|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
44461222|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461223|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44461224|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253729|NCT04318691|Dimercaprol|dimercaprol|mesh-list
44253730|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
44253731|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
44253732|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253733|NCT04276259|Naltrexone|naltrexone|mesh-list
44253734|NCT04276259|Buprenorphine|buprenorphine|mesh-list
44253735|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44253736|NCT04276259|Narcotics|narcotics|mesh-ancestor
44253737|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253738|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253739|NCT04276259|Analgesics|analgesics|mesh-ancestor
44253740|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
43651528|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
44052105|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052106|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44052108|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052109|NCT00003961|Sargramostim|sargramostim|mesh-list
44253741|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253742|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44253743|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44253744|NCT04267926|Ubiquinone|ubiquinone|mesh-list
44253745|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
44253746|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253747|NCT04243278|Aspirin|aspirin|mesh-list
44253748|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253749|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253750|NCT04243278|Analgesics|analgesics|mesh-ancestor
44253751|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
44253752|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253753|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253754|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253755|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253756|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44253757|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44253758|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253759|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44253760|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44253761|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253762|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
44253763|NCT04243122|Aspirin|aspirin|mesh-list
44253764|NCT04243122|Apixaban|apixaban|mesh-list
44253765|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253766|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253767|NCT04243122|Analgesics|analgesics|mesh-ancestor
44253768|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
44253769|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253770|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253771|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253772|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253773|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44253774|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44253775|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253776|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44052110|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
44253777|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44253778|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253779|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
44253780|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44253781|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
44253782|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44253783|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
44253784|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
44253785|NCT04234217|Niacin|niacin|mesh-list
44253786|NCT04234217|Niacinamide|niacinamide|mesh-list
44253787|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
44253788|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44253789|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
44253790|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253791|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44253792|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253793|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
44253794|NCT04234217|Vitamins|vitamins|mesh-ancestor
44253795|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
44253796|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253797|NCT04230252|Acetaminophen|acetaminophen|mesh-list
44253798|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253799|NCT04230252|Analgesics|analgesics|mesh-ancestor
44253800|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
44253801|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253802|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253803|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
44253804|NCT04230031|Daratumumab|daratumumab|mesh-list
44253805|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253806|NCT04213404|Spartalizumab|spartalizumab|mesh-list
44253807|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253808|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253809|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253822|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253824|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44253825|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
44253826|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
44253827|NCT04176783|Narcotics|narcotics|mesh-ancestor
44253828|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253829|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253830|NCT04176783|Analgesics|analgesics|mesh-ancestor
44253831|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
44253832|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253833|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
44253834|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44253835|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44253836|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44253837|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44253838|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253839|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
44253840|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253841|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253842|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44253843|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253844|NCT04141644|Ipilimumab|ipilimumab|mesh-list
44253845|NCT04141644|Osimertinib|osimertinib|mesh-list
43651644|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44052111|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052112|NCT00003962|Aldesleukin|aldesleukin|mesh-list
44052113|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052114|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44052115|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052116|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
44052117|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052118|NCT00003963|Rituximab|rituximab|mesh-list
44052119|NCT00003963|Vinorelbine|vinorelbine|mesh-list
44052120|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052121|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052122|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
44087120|NCT00022906|Antibodies|antibodies|mesh-list
44052123|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052124|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052125|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052126|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052127|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052128|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052129|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052130|NCT00003966|Defibrotide|defibrotide|mesh-list
44052131|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44052132|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44052133|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052134|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44052135|NCT00003967|Etoposide|etoposide|mesh-list
44253846|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253848|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253849|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253850|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44253851|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253852|NCT04115644|Triamcinolone|triamcinolone|mesh-list
44253853|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44253854|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44253855|NCT04115644|Ketorolac|ketorolac|mesh-list
44253856|NCT04115644|Bupivacaine|bupivacaine|mesh-list
44253857|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44253858|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
44253859|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
44253860|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253861|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253862|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
44253863|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052136|NCT00003967|Topotecan|topotecan|mesh-list
44052137|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052138|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052139|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052140|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052141|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052144|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
44052145|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052146|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
44052147|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052148|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052150|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052151|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052152|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052153|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052154|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052155|NCT00003972|Tamoxifen|tamoxifen|mesh-list
44052156|NCT00003972|Paclitaxel|paclitaxel|mesh-list
44052157|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
44052158|NCT00003972|Carboplatin|carboplatin|mesh-list
44052159|NCT00003972|Melphalan|melphalan|mesh-list
44052160|NCT00003972|Busulfan|busulfan|mesh-list
44052161|NCT00003972|Thiotepa|thiotepa|mesh-list
44052162|NCT00003972|Sargramostim|sargramostim|mesh-list
44052163|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052164|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052165|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052166|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052167|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052168|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052169|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052170|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
44052171|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052172|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052173|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052174|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
44052175|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052176|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44253864|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44253865|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
44063459|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253867|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253868|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253869|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
44253870|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253871|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253872|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44253873|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44253874|NCT04115644|Analgesics|analgesics|mesh-ancestor
44253875|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44253876|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44253877|NCT04109729|Nivolumab|nivolumab|mesh-list
44253878|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253879|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253880|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44253881|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253882|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
44253883|NCT04036929|Estrogens|estrogens|mesh-list
44253884|NCT04036929|Hormones|hormones|mesh-ancestor
44253885|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052177|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
44052178|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052179|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052180|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44052181|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44052182|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44052183|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
44052184|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052185|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
44052186|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052187|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052188|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052189|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
44052190|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052191|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052192|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052193|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44052194|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052195|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44052196|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052197|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052198|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44052199|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052200|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44052201|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253886|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253887|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44253888|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44253890|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44052202|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052203|NCT00003984|Lintuzumab|lintuzumab|mesh-list
44052204|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052205|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052206|NCT00003985|KRN 7000|krn 7000|mesh-list
44052207|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052208|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
44052209|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052210|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052211|NCT00003991|Aldesleukin|aldesleukin|mesh-list
44052212|NCT00003991|Histamine|histamine|mesh-list
44052213|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
44052224|NCT00003992|Tamoxifen|tamoxifen|mesh-list
44052225|NCT00003992|Paclitaxel|paclitaxel|mesh-list
44052226|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
44052227|NCT00003992|Doxorubicin|doxorubicin|mesh-list
44052228|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052229|NCT00003992|Trastuzumab|trastuzumab|mesh-list
44052230|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052231|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052232|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052233|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052234|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052235|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052236|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052237|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
44052238|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052239|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052240|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052241|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
44052242|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052243|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052244|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052245|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052246|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052247|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052248|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44052249|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
44052250|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052251|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052252|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44052253|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44052254|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44052255|NCT00003993|Aldesleukin|aldesleukin|mesh-list
44052256|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
44052257|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052258|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44052259|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052260|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
44052261|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052262|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052263|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
44052264|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052265|NCT00003994|Cisplatin|cisplatin|mesh-list
44052266|NCT00003994|Carboplatin|carboplatin|mesh-list
44052267|NCT00003994|Fluorouracil|fluorouracil|mesh-list
44052268|NCT00003994|Vincristine|vincristine|mesh-list
44052269|NCT00003994|Amifostine|amifostine|mesh-list
44052270|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052271|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
44052272|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052273|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052274|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052275|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
44052276|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253891|NCT04032626|Lenalidomide|lenalidomide|mesh-list
44253892|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
44253893|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253894|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44253895|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44253896|NCT04032626|Growth Substances|growth substances|mesh-ancestor
44253897|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
44253898|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253899|NCT04001829|Paclitaxel|paclitaxel|mesh-list
44253900|NCT04001829|Docetaxel|docetaxel|mesh-list
44052277|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052288|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052290|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052291|NCT00003996|Cisplatin|cisplatin|mesh-list
44052292|NCT00003996|Etoposide|etoposide|mesh-list
44052293|NCT00003996|Carmustine|carmustine|mesh-list
44052294|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052295|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052296|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052297|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052298|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052299|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052300|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052301|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
43777914|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
44052302|NCT00003997|Irofulven|irofulven|mesh-list
44052303|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052304|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
44052305|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052306|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052307|NCT00003998|Paclitaxel|paclitaxel|mesh-list
44052308|NCT00003998|Docetaxel|docetaxel|mesh-list
44052309|NCT00003998|Carboplatin|carboplatin|mesh-list
44052310|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052311|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052312|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052313|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052314|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052315|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052316|NCT00004001|Prednisone|prednisone|mesh-list
44052317|NCT00004001|Docetaxel|docetaxel|mesh-list
44052318|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
44052319|NCT00004001|Estramustine|estramustine|mesh-list
44052320|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052321|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052322|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052323|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052324|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052325|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44052326|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
44052327|NCT00004001|Hormones|hormones|mesh-ancestor
44052328|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052329|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052330|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052331|NCT00004001|Analgesics|analgesics|mesh-ancestor
44052332|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
44052333|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052334|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052335|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052336|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052337|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052338|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
44052340|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052341|NCT00004003|Gemcitabine|gemcitabine|mesh-list
44052342|NCT00004003|Cisplatin|cisplatin|mesh-list
44052350|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253901|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44253902|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44253903|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253904|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44253905|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44253906|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44253907|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253908|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
44253909|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44253910|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052351|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052352|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
44052353|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052354|NCT00004004|Procarbazine|procarbazine|mesh-list
44052355|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052356|NCT00004005|Leucovorin|leucovorin|mesh-list
44052357|NCT00004005|Fluorouracil|fluorouracil|mesh-list
44052358|NCT00004005|Irinotecan|irinotecan|mesh-list
44052359|NCT00004005|Calcium|calcium|mesh-list
44052360|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
44052361|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44052362|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052363|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
44052364|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052365|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052366|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052367|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052368|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
44052369|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052370|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052371|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052373|NCT00004005|Protective Agents|protective agents|mesh-ancestor
44052374|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
44052375|NCT00004005|Vitamins|vitamins|mesh-ancestor
44052376|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
44052377|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
44052378|NCT00004006|Carboplatin|carboplatin|mesh-list
44052379|NCT00004006|Doxorubicin|doxorubicin|mesh-list
44052380|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052381|NCT00004006|Etoposide|etoposide|mesh-list
44052382|NCT00004006|Topotecan|topotecan|mesh-list
44052383|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052384|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
44052385|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052386|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052387|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052388|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
44052389|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052390|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052391|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052392|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052393|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052394|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052395|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052396|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052397|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052398|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
44052399|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052400|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
44052401|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052402|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052403|NCT00004009|Tipifarnib|tipifarnib|mesh-list
44052404|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052405|NCT00004010|Prednisone|prednisone|mesh-list
44052406|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
44052407|NCT00004010|Dacarbazine|dacarbazine|mesh-list
44052408|NCT00004010|Doxorubicin|doxorubicin|mesh-list
44253911|NCT03974152|Nicotine|nicotine|mesh-list
44253912|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44253913|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
44253914|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253915|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253916|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44253917|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44253918|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
44253919|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253920|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253921|NCT03927989|Nicotine|nicotine|mesh-list
44253922|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44253923|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
44253924|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253925|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253926|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44052409|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052410|NCT00004010|Etoposide|etoposide|mesh-list
44052411|NCT00004010|Vincristine|vincristine|mesh-list
44052412|NCT00004010|Bleomycin|bleomycin|mesh-list
44052413|NCT00004010|Vinblastine|vinblastine|mesh-list
44052414|NCT00004010|Procarbazine|procarbazine|mesh-list
44052415|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052418|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052419|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052420|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
44052421|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052422|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052423|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052424|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052425|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052426|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052427|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052428|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44052430|NCT00004010|Hormones|hormones|mesh-ancestor
44052431|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052432|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052433|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052434|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052435|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052436|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052437|NCT00004011|Paclitaxel|paclitaxel|mesh-list
44052438|NCT00004011|Carboplatin|carboplatin|mesh-list
44052439|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052440|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052441|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052442|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052443|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052444|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052445|NCT00004012|Capecitabine|capecitabine|mesh-list
44052446|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052447|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
44052448|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052450|NCT00004013|Paclitaxel|paclitaxel|mesh-list
44052451|NCT00004013|Trastuzumab|trastuzumab|mesh-list
44052452|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052453|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052454|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052455|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44253927|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44253928|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
44253929|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253930|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253931|NCT03893617|Propranolol|propranolol|mesh-list
44253932|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44253933|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44253934|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
44253935|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253936|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052456|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052457|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052458|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052459|NCT00004014|Doxorubicin|doxorubicin|mesh-list
44052460|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052461|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052462|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052463|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052464|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052465|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052466|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052467|NCT00004016|Interferons|interferons|mesh-list
44052468|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
44052469|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052470|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
44052471|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052472|NCT00004017|Antibodies|antibodies|mesh-list
44052473|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44052474|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
44052475|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052476|NCT00004022|Aldesleukin|aldesleukin|mesh-list
44052477|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
44052478|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052479|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44052480|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052481|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
44052482|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052483|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
44052484|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052485|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052487|NCT00004024|Sargramostim|sargramostim|mesh-list
44052488|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
44052489|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
44052490|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052495|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052496|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052497|NCT00004025|Aldesleukin|aldesleukin|mesh-list
44052498|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052499|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44052500|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052501|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
44052502|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052503|NCT00004028|Carmustine|carmustine|mesh-list
44052504|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052505|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
44052506|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052507|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052508|NCT00004029|Sargramostim|sargramostim|mesh-list
44052509|NCT00004029|Vaccines|vaccines|mesh-list
43778082|NCT02327676|Emtricitabine|emtricitabine|mesh-list
44052510|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
44052511|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052512|NCT00004030|Doxorubicin|doxorubicin|mesh-list
44052513|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052514|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052515|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253937|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253938|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44253939|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44253940|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
44253942|NCT03879135|Coagulants|coagulants|mesh-ancestor
44253943|NCT03874715|Insulin|insulin|mesh-list
44253944|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44253945|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
44253946|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
44253947|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
44253948|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44253949|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44052516|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052517|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052518|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052519|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052520|NCT00004032|Interferons|interferons|mesh-list
44052521|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
44052522|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052523|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
44052524|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052525|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
44052526|NCT00004036|Carboplatin|carboplatin|mesh-list
44052527|NCT00004036|Sargramostim|sargramostim|mesh-list
44052528|NCT00004036|Amifostine|amifostine|mesh-list
44052529|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052530|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
44052531|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052532|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052533|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052534|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
44052535|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052536|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052537|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052538|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44052539|NCT00004036|Protective Agents|protective agents|mesh-ancestor
44052540|NCT00004037|Docetaxel|docetaxel|mesh-list
44052541|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052542|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052543|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052544|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052545|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052546|NCT00004039|Interferons|interferons|mesh-list
44052547|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
44052548|NCT00004039|Prednisone|prednisone|mesh-list
44052549|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
44052550|NCT00004039|Rituximab|rituximab|mesh-list
44052551|NCT00004039|Doxorubicin|doxorubicin|mesh-list
44052552|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052553|NCT00004039|Vincristine|vincristine|mesh-list
44052554|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052555|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
44052556|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052557|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052558|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052559|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
44052560|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052561|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052562|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052563|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052578|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052579|NCT00004040|Interferons|interferons|mesh-list
44052580|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
44052581|NCT00004040|Rituximab|rituximab|mesh-list
44253950|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253951|NCT03854929|Azithromycin|azithromycin|mesh-list
44253952|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
44253953|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44253954|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907924|NCT00304746|Testosterone|testosterone|mesh-list
44253955|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44253956|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44253957|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253958|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253959|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253960|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44253961|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44253963|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44253964|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
44253965|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253966|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44253967|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253968|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253969|NCT03812588|Citalopram|citalopram|mesh-list
44052582|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052583|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052584|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
44052585|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052586|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052587|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
44052588|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052589|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44052590|NCT00004042|Antibodies|antibodies|mesh-list
44052591|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
44052592|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44052593|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
44052594|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052595|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052596|NCT00004043|Calcitriol|calcitriol|mesh-list
44052597|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44052598|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052599|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44052600|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44052601|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052602|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44052603|NCT00004043|Vitamins|vitamins|mesh-ancestor
44052604|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
44052605|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44052606|NCT00004045|Exatecan|exatecan|mesh-list
44052607|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052608|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052609|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052610|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052611|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052612|NCT00004046|Exatecan|exatecan|mesh-list
44052613|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052614|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052615|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253970|NCT03812588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44253971|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44253972|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44253973|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253974|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253975|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
44253976|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253977|NCT03812588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44253978|NCT03812588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44253979|NCT03812588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44253980|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
44253981|NCT03760718|Procaine|procaine|mesh-list
44253982|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
44253983|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
44253984|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44253985|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253986|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
44052616|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052617|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052618|NCT00004047|Exatecan|exatecan|mesh-list
44052619|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052620|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052621|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052622|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052623|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052634|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052635|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052636|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052637|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052638|NCT00004050|Interleukin-2|interleukin-2|mesh-list
44052639|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052640|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44052641|NCT00004050|Analgesics|analgesics|mesh-ancestor
44052642|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
44052643|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052644|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052645|NCT00004051|Irinotecan|irinotecan|mesh-list
44052646|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052647|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052648|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052649|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052650|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052651|NCT00004055|Paclitaxel|paclitaxel|mesh-list
44052652|NCT00004055|Topotecan|topotecan|mesh-list
44052653|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052654|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052655|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052656|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052657|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052658|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052659|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052660|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052661|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052662|NCT00004056|Cytarabine|cytarabine|mesh-list
44052663|NCT00004056|Thioguanine|thioguanine|mesh-list
44052664|NCT00004056|Melphalan|melphalan|mesh-list
44253987|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44253988|NCT03737253|Menotropins|menotropins|mesh-list
44253989|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44253990|NCT03737253|Hormones|hormones|mesh-ancestor
44253991|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44253992|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44253993|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44253994|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
44253995|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44253996|NCT03724994|Gemcitabine|gemcitabine|mesh-list
44253997|NCT03724994|Paclitaxel|paclitaxel|mesh-list
44253998|NCT03724994|Fluorouracil|fluorouracil|mesh-list
44253999|NCT03724994|Folfirinox|folfirinox|mesh-list
44254000|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44254001|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651769|NCT03005678|Denosumab|denosumab|mesh-list
44052665|NCT00004056|Daunorubicin|daunorubicin|mesh-list
44052666|NCT00004056|Asparaginase|asparaginase|mesh-list
44052667|NCT00004056|Lenograstim|lenograstim|mesh-list
44052668|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052669|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
44052670|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052671|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052672|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
44052673|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052674|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052675|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
44052676|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052677|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052678|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052679|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
44052680|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052681|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052682|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052683|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052684|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052685|NCT00004057|Paclitaxel|paclitaxel|mesh-list
44052686|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052687|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052688|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052689|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052690|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052693|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44052694|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
44052695|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052696|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052697|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052698|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052699|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
44052700|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052701|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44052702|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052703|NCT00004060|Exatecan|exatecan|mesh-list
44052704|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052705|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052706|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052707|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052708|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052709|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
43778181|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44254003|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254004|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254005|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254006|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254007|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
44254008|NCT03724994|Antiviral Agents|antiviral agents|mesh-ancestor
44254009|NCT03724994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254010|NCT03724994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254011|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254012|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
44254013|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052710|NCT00004061|Ifosfamide|ifosfamide|mesh-list
44052711|NCT00004061|Etoposide|etoposide|mesh-list
44052712|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052713|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
44052714|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052715|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052716|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052717|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
44052718|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052719|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052720|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052721|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052722|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052723|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052724|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149823|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149824|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
44149825|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149826|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149827|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149828|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
44149829|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149830|NCT00209014|Thalidomide|thalidomide|mesh-list
44149831|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149832|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
44149833|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149834|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
44149835|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44149836|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149837|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44149838|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44149839|NCT00209014|Growth Substances|growth substances|mesh-ancestor
44149840|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
44149841|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149842|NCT00209079|Docetaxel|docetaxel|mesh-list
44149843|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
44149844|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149845|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149846|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149847|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149848|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149849|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44149850|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149852|NCT00209118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149853|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149854|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149855|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149856|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149857|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
44254014|NCT03709758|Cytarabine|cytarabine|mesh-list
44254015|NCT03709758|Daunorubicin|daunorubicin|mesh-list
44254016|NCT03709758|Venetoclax|venetoclax|mesh-list
44254017|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254018|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
44254019|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254020|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149858|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549495|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149865|NCT00209144|Insulin|insulin|mesh-list
44149866|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44149867|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149868|NCT00209209|Interferons|interferons|mesh-list
44149869|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
44149870|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
44149871|NCT00209209|Prednisone|prednisone|mesh-list
44149872|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
44149873|NCT00209209|Rituximab|rituximab|mesh-list
44149874|NCT00209209|Doxorubicin|doxorubicin|mesh-list
44149875|NCT00209209|Fludarabine|fludarabine|mesh-list
44149876|NCT00209209|Vincristine|vincristine|mesh-list
44149877|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149878|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
44149879|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149880|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149881|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44149882|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
44149883|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052726|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052727|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
44052728|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052729|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052730|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052731|NCT00004063|Gemcitabine|gemcitabine|mesh-list
44052732|NCT00004063|Interferons|interferons|mesh-list
44052733|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
44052734|NCT00004063|Cisplatin|cisplatin|mesh-list
44052735|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052736|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052737|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
44052738|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052739|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
44052740|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052741|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052742|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052743|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
44052744|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052745|NCT00004064|Oregovomab|oregovomab|mesh-list
44052746|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052747|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052748|NCT00004066|Gemcitabine|gemcitabine|mesh-list
44052749|NCT00004066|Docetaxel|docetaxel|mesh-list
44052750|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052751|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
44052752|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052753|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052754|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
44052755|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052756|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052757|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052758|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
44052759|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052760|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052761|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052762|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052763|NCT00004067|Paclitaxel|paclitaxel|mesh-list
44052764|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
44052765|NCT00004067|Doxorubicin|doxorubicin|mesh-list
44052766|NCT00004067|Trastuzumab|trastuzumab|mesh-list
44052767|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052768|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052769|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254021|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
44254022|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254023|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254024|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
44254025|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254026|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254027|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44254028|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44254029|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052770|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052771|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052780|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052781|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052782|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052783|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052784|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052785|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052787|NCT00004068|Temozolomide|temozolomide|mesh-list
44052788|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052789|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052790|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052791|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052792|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052793|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052794|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
44052795|NCT00004070|Interleukin-12|interleukin-12|mesh-list
43778299|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
44052796|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052797|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
44052798|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052799|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44052800|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44052801|NCT00004070|Growth Substances|growth substances|mesh-ancestor
44052802|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
44052803|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052804|NCT00004071|Prednisone|prednisone|mesh-list
44052805|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
44052806|NCT00004071|Leflunomide|leflunomide|mesh-list
44052807|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44052808|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
44052809|NCT00004071|Hormones|hormones|mesh-ancestor
44052810|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052811|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052812|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052813|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052814|NCT00004071|Analgesics|analgesics|mesh-ancestor
44052815|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
44052816|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052817|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052818|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052819|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052820|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052821|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052822|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
44052823|NCT00004072|Carmustine|carmustine|mesh-list
44052824|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44052825|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052826|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
44052827|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052828|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052829|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052830|NCT00004073|Suramin|suramin|mesh-list
44052831|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
44052832|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
44052833|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44052834|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461225|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461226|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461227|NCT01551745|Growth Substances|growth substances|mesh-ancestor
44461228|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
44461229|NCT01551303|Oxytocin|oxytocin|mesh-list
44461230|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
44461231|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44461232|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052835|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052836|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44052846|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052847|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44052848|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44052849|NCT00004074|Growth Substances|growth substances|mesh-ancestor
44052850|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
44052851|NCT00004077|Paclitaxel|paclitaxel|mesh-list
44052852|NCT00004077|Cisplatin|cisplatin|mesh-list
44052853|NCT00004077|Ifosfamide|ifosfamide|mesh-list
44052854|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052855|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052856|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052857|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052858|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052859|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052860|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052861|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
44052862|NCT00004078|Irinotecan|irinotecan|mesh-list
44052863|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052864|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052865|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052866|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052867|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052868|NCT00004081|Docetaxel|docetaxel|mesh-list
44052869|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052870|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052871|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052872|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052873|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052874|NCT00004082|Gemcitabine|gemcitabine|mesh-list
43778380|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
44052875|NCT00004082|Carboplatin|carboplatin|mesh-list
44052876|NCT00004082|Docetaxel|docetaxel|mesh-list
44052877|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052878|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052879|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
44052880|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052881|NCT00004082|Antiviral Agents|antiviral agents|mesh-ancestor
44052882|NCT00004082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052883|NCT00004082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052884|NCT00004082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052885|NCT00004082|Immunologic Factors|immunologic factors|mesh-ancestor
44052886|NCT00004082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052887|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052888|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052889|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052890|NCT00004083|Cisplatin|cisplatin|mesh-list
44052891|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052892|NCT00004084|Epratuzumab|epratuzumab|mesh-list
44052893|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052894|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052895|NCT00004085|Antibodies|antibodies|mesh-list
44052896|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44052897|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
44052898|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052899|NCT00004086|Cytarabine|cytarabine|mesh-list
44052900|NCT00004086|Cisplatin|cisplatin|mesh-list
44052901|NCT00004086|Etoposide|etoposide|mesh-list
44052902|NCT00004086|Ifosfamide|ifosfamide|mesh-list
44052903|NCT00004086|Epratuzumab|epratuzumab|mesh-list
44052904|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461234|NCT01551212|Tacrolimus|tacrolimus|mesh-list
44461235|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461236|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
44461237|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461238|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44052905|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052908|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052909|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052910|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052911|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
44052912|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
44052913|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052914|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052915|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
44052916|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052917|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052918|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
44052919|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052920|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44052921|NCT00004087|Antibodies|antibodies|mesh-list
44052922|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
44052923|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44052924|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
44052925|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052926|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052927|NCT00004089|Paclitaxel|paclitaxel|mesh-list
44052928|NCT00004089|Fluorouracil|fluorouracil|mesh-list
44052929|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
44052930|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052931|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052932|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052933|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052934|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052935|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052936|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
44052937|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052938|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052939|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
44052940|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052941|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
44052942|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052943|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44052944|NCT00004090|Gemcitabine|gemcitabine|mesh-list
44052945|NCT00004090|Cisplatin|cisplatin|mesh-list
44052946|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052947|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052948|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
44052949|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052950|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
44052951|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052952|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052953|NCT00004090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052954|NCT00004090|Immunologic Factors|immunologic factors|mesh-ancestor
44052955|NCT00004090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052956|NCT00004091|Antibodies|antibodies|mesh-list
44052957|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
44052958|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052959|NCT00004094|Paclitaxel|paclitaxel|mesh-list
44052960|NCT00004094|Carboplatin|carboplatin|mesh-list
44052961|NCT00004094|Fluorouracil|fluorouracil|mesh-list
44052962|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
44052963|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052964|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052965|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052966|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052967|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052968|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052969|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
44052970|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052971|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461239|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461240|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461241|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461242|NCT01550965|Adalimumab|adalimumab|mesh-list
44461243|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461244|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461245|NCT01550744|Ustekinumab|ustekinumab|mesh-list
44461246|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461247|NCT01550289|Vaccines|vaccines|mesh-list
43651814|NCT03005015|Doxorubicin|doxorubicin|mesh-list
44052972|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
44052973|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052974|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
44052975|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052976|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44052977|NCT00004095|Gemcitabine|gemcitabine|mesh-list
44052978|NCT00004095|Irinotecan|irinotecan|mesh-list
44052979|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44052981|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052983|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
44052984|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052985|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052986|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052987|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
44052988|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052989|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052990|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052991|NCT00004097|Gemcitabine|gemcitabine|mesh-list
44052992|NCT00004097|Paclitaxel|paclitaxel|mesh-list
44052993|NCT00004097|Fluorouracil|fluorouracil|mesh-list
44052994|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052995|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052996|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052997|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052998|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052999|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053000|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053001|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
44053002|NCT00004097|Antiviral Agents|antiviral agents|mesh-ancestor
44053003|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053004|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053005|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053006|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
44053007|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053008|NCT00004099|Leucovorin|leucovorin|mesh-list
44053009|NCT00004099|Cisplatin|cisplatin|mesh-list
44053010|NCT00004099|Fluorouracil|fluorouracil|mesh-list
44053011|NCT00004099|Calcium|calcium|mesh-list
44053012|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
44053013|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053014|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053015|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053016|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
44053017|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053018|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053019|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053020|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
44053021|NCT00004099|Antidotes|antidotes|mesh-ancestor
44053022|NCT00004099|Protective Agents|protective agents|mesh-ancestor
44053023|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053024|NCT00004099|Vitamins|vitamins|mesh-ancestor
44053025|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
44053026|NCT00004100|Gemcitabine|gemcitabine|mesh-list
44053027|NCT00004100|Cisplatin|cisplatin|mesh-list
44053028|NCT00004100|Vinorelbine|vinorelbine|mesh-list
44053029|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053030|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053031|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
44053032|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461248|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
44461249|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461250|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44461251|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44461252|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461253|NCT01549964|Incretins|incretins|mesh-ancestor
44461254|NCT01549964|Hormones|hormones|mesh-ancestor
44461255|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461256|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44461257|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461258|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461259|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461260|NCT01549951|Prednisone|prednisone|mesh-list
44461261|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461262|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
44461263|NCT01549951|Hormones|hormones|mesh-ancestor
44461264|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053033|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
44053034|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053035|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053036|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053037|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
44053038|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053039|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053040|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053041|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053042|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053043|NCT00004102|Leucovorin|leucovorin|mesh-list
44053044|NCT00004102|Fluorouracil|fluorouracil|mesh-list
44053045|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
44053046|NCT00004102|Calcium|calcium|mesh-list
44053047|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
44053048|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053049|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053050|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
44053051|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053052|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053053|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053054|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053055|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
44053061|NCT00004103|Cisplatin|cisplatin|mesh-list
44053062|NCT00004103|Irinotecan|irinotecan|mesh-list
44053063|NCT00004103|Floxuridine|floxuridine|mesh-list
44053064|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053065|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053066|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053067|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053068|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053069|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053070|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
44053071|NCT00004104|Interferons|interferons|mesh-list
44053072|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
44053073|NCT00004104|Interleukin-2|interleukin-2|mesh-list
44053074|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053075|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
44053076|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053077|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
44053078|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053079|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461265|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461266|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461267|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461269|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44461270|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461271|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
44053080|NCT00004104|Analgesics|analgesics|mesh-ancestor
44053081|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
44053082|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44053083|NCT00004105|Paclitaxel|paclitaxel|mesh-list
44053084|NCT00004105|Vinorelbine|vinorelbine|mesh-list
44053085|NCT00004105|Estramustine|estramustine|mesh-list
44053086|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053087|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053088|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053089|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053090|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053091|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053092|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053093|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
44053094|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053095|NCT00004107|Epratuzumab|epratuzumab|mesh-list
44053096|NCT00004107|Antibodies|antibodies|mesh-list
44053097|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44053098|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
44053099|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053100|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44053101|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053102|NCT00004108|Exatecan|exatecan|mesh-list
44053103|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053104|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053105|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053106|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053107|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053108|NCT00004109|Doxorubicin|doxorubicin|mesh-list
44053109|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053110|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053111|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053112|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053113|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053114|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053115|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053117|NCT00004110|Isotretinoin|isotretinoin|mesh-list
44053118|NCT00004110|Antibodies|antibodies|mesh-list
44053119|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44053120|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
44053121|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053122|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053123|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053124|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053125|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053126|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053127|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053128|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44053129|NCT00004112|Prednisone|prednisone|mesh-list
44053143|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053144|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44053145|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053146|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053147|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053148|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053149|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053150|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
44053152|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053153|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053154|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44461272|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461273|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461274|NCT01549873|Propofol|propofol|mesh-list
44461275|NCT01549873|Desflurane|desflurane|mesh-list
43651833|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
44053155|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053156|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053157|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053158|NCT00004113|Temozolomide|temozolomide|mesh-list
44053159|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053160|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
44053161|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053162|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053163|NCT00004114|Cytarabine|cytarabine|mesh-list
44053164|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
44053165|NCT00004114|Fludarabine|fludarabine|mesh-list
44053166|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
44053167|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053168|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
44053169|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053170|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053171|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053172|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
44053173|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053174|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053175|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053176|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053177|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
44053178|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
44053179|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053180|NCT00004115|Antibodies|antibodies|mesh-list
44053181|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44053182|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
44053183|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053184|NCT00004122|Interferons|interferons|mesh-list
44053185|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
44053186|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
44053187|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053188|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
44053189|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053190|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
44053191|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053192|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44053193|NCT00004123|Doxorubicin|doxorubicin|mesh-list
44053208|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053210|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053211|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053212|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053213|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053214|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
44053215|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053216|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053217|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053218|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
44053219|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053220|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053221|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053222|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053223|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053224|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44053225|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44053226|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053227|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053228|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44053229|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44053230|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44053231|NCT00004126|Paclitaxel|paclitaxel|mesh-list
44053232|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
44053233|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053234|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053235|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
44461276|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44461277|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461278|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461279|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44461280|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
44461281|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
44461282|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44461283|NCT01549652|Morphine|morphine|mesh-list
44461284|NCT01549652|Ondansetron|ondansetron|mesh-list
44461285|NCT01549652|Naloxone|naloxone|mesh-list
44053236|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053237|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053238|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053239|NCT00004127|Leucovorin|leucovorin|mesh-list
44053240|NCT00004127|Fluorouracil|fluorouracil|mesh-list
44053241|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
44053242|NCT00004127|Calcium|calcium|mesh-list
44053243|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
44053244|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053245|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053246|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
44053247|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053248|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053249|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053250|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053251|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
44053252|NCT00004127|Antidotes|antidotes|mesh-ancestor
44053253|NCT00004127|Protective Agents|protective agents|mesh-ancestor
43550049|NCT03626298|Analgesics|analgesics|mesh-ancestor
44053258|NCT00004128|Aldesleukin|aldesleukin|mesh-list
44053259|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
43778679|NCT04407988|Letrozole|letrozole|mesh-list
44053260|NCT00004128|Busulfan|busulfan|mesh-list
44053262|NCT00004128|Daunorubicin|daunorubicin|mesh-list
44053263|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053264|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
44053265|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053266|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053267|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053268|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
44053269|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053270|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053271|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053272|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053273|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053274|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053275|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053276|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053277|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
44053278|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
44053279|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053280|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053281|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44053282|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44053283|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
44053284|NCT00004132|Ifosfamide|ifosfamide|mesh-list
44053285|NCT00004132|Etoposide|etoposide|mesh-list
44053286|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053287|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
44053288|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053289|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053290|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053291|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
44053292|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053293|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053294|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053295|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053296|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461286|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44461287|NCT01549652|Narcotics|narcotics|mesh-ancestor
44461288|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461289|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461290|NCT01549652|Analgesics|analgesics|mesh-ancestor
44461291|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
44053297|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053298|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053299|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
44053300|NCT00004135|Fludarabine|fludarabine|mesh-list
44053301|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
44053302|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053303|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
44053304|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053305|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053306|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053307|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
44053308|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053309|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053310|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053311|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053312|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
44053313|NCT00004137|Paclitaxel|paclitaxel|mesh-list
44053314|NCT00004137|Carboplatin|carboplatin|mesh-list
44053315|NCT00004137|Topotecan|topotecan|mesh-list
44053316|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053317|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053318|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053319|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053320|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053321|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053322|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053323|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053324|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053325|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44053326|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43550112|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053333|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053334|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053335|NCT00004139|Antiviral Agents|antiviral agents|mesh-ancestor
44053336|NCT00004139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053337|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053338|NCT00004139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053339|NCT00004139|Immunologic Factors|immunologic factors|mesh-ancestor
44053340|NCT00004139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053341|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053342|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053343|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053344|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053345|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053346|NCT00004141|Cisplatin|cisplatin|mesh-list
44053347|NCT00004141|Dacarbazine|dacarbazine|mesh-list
44053348|NCT00004141|Molgramostim|molgramostim|mesh-list
44053349|NCT00004141|Sargramostim|sargramostim|mesh-list
44053350|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053351|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053352|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
44053353|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053354|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
44053355|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053356|NCT00004142|Fluorouracil|fluorouracil|mesh-list
44053357|NCT00004142|Floxuridine|floxuridine|mesh-list
44053358|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
44053359|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053360|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053361|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053362|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053363|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
44053364|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053365|NCT00004144|Gemcitabine|gemcitabine|mesh-list
44461292|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461293|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
44461294|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
44461295|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461296|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
44461297|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461298|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44461299|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
44461300|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461301|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254030|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
44053366|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
44053367|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053368|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
44053369|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053370|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053371|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
44053372|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053373|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053374|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053375|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
44053376|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053377|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44053378|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
44053379|NCT00004145|Fludarabine|fludarabine|mesh-list
44053380|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
44053381|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44053382|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053383|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
44053384|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053385|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053386|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053387|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
44053388|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053389|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053390|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053391|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053392|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
44053393|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
44053394|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053395|NCT00004150|Leucovorin|leucovorin|mesh-list
44053396|NCT00004150|Fluorouracil|fluorouracil|mesh-list
44053397|NCT00004150|Calcium|calcium|mesh-list
44053402|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053403|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053404|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053405|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053406|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
44053407|NCT00004150|Antidotes|antidotes|mesh-ancestor
44053408|NCT00004150|Protective Agents|protective agents|mesh-ancestor
44053409|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053410|NCT00004150|Vitamins|vitamins|mesh-ancestor
44053411|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
44053412|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44053413|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44053414|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053415|NCT00004154|Fenretinide|fenretinide|mesh-list
44053416|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053417|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44053418|NCT00004154|Protective Agents|protective agents|mesh-ancestor
44053419|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053420|NCT00004157|Oprelvekin|oprelvekin|mesh-list
44053421|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053422|NCT00004158|Melphalan|melphalan|mesh-list
44053423|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053424|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
44254031|NCT03695510|Afatinib|afatinib|mesh-list
44254032|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254033|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254034|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44254035|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254036|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053425|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053426|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053427|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053428|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053429|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
44053430|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053431|NCT00004159|Gemcitabine|gemcitabine|mesh-list
44053432|NCT00004159|Paclitaxel|paclitaxel|mesh-list
44053433|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053434|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053435|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053436|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053437|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053438|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053439|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053440|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
44053441|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
44053442|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053443|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053444|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053445|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
44053446|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053447|NCT00004160|Gemcitabine|gemcitabine|mesh-list
44053448|NCT00004160|Paclitaxel|paclitaxel|mesh-list
44053449|NCT00004160|Cisplatin|cisplatin|mesh-list
44053450|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053451|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053452|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053453|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053454|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053455|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053456|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053457|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
44053458|NCT00004160|Antiviral Agents|antiviral agents|mesh-ancestor
44053459|NCT00004160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053460|NCT00004160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053461|NCT00004160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053462|NCT00004160|Immunologic Factors|immunologic factors|mesh-ancestor
44053463|NCT00004160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053464|NCT00004161|Fenretinide|fenretinide|mesh-list
44053465|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053466|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44053467|NCT00004161|Protective Agents|protective agents|mesh-ancestor
44053468|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053469|NCT00004162|Doxorubicin|doxorubicin|mesh-list
44053482|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44053483|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053484|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053485|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
44053486|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44053487|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44053488|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053489|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
44053490|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053491|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44053492|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053493|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053494|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053495|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053496|NCT00004163|Trastuzumab|trastuzumab|mesh-list
44053497|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44053498|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053499|NCT00004164|Leucovorin|leucovorin|mesh-list
44254037|NCT03673527|Tacrolimus|tacrolimus|mesh-list
44254038|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254039|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
44254040|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254041|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44254042|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053500|NCT00004164|Cisplatin|cisplatin|mesh-list
44053501|NCT00004164|Docetaxel|docetaxel|mesh-list
44053502|NCT00004164|Fluorouracil|fluorouracil|mesh-list
44053503|NCT00004164|Calcium|calcium|mesh-list
44053504|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
44053505|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053506|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053507|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053508|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053509|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053510|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053511|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053512|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
44053513|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053514|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053515|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
44053516|NCT00004164|Antidotes|antidotes|mesh-ancestor
44053517|NCT00004164|Protective Agents|protective agents|mesh-ancestor
44053518|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053519|NCT00004164|Vitamins|vitamins|mesh-ancestor
44053520|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
44053521|NCT00004173|Paclitaxel|paclitaxel|mesh-list
44053522|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
44053523|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053524|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053525|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053526|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053527|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053528|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053529|NCT00004174|Paclitaxel|paclitaxel|mesh-list
44053530|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
44053532|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053533|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053534|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
43550325|NCT03624231|Durvalumab|durvalumab|mesh-list
44053543|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
44053544|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053545|NCT00004176|Cisplatin|cisplatin|mesh-list
44053546|NCT00004176|Etoposide|etoposide|mesh-list
44053547|NCT00004176|Amifostine|amifostine|mesh-list
44053548|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053549|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053550|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053551|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053552|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053553|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053554|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44053555|NCT00004176|Protective Agents|protective agents|mesh-ancestor
44053556|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053557|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44053558|NCT00004177|Antibodies|antibodies|mesh-list
44053559|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
44053560|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44053561|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
44053562|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053563|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053564|NCT00004179|Prednisone|prednisone|mesh-list
44053565|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
44053566|NCT00004179|Rituximab|rituximab|mesh-list
44053567|NCT00004179|Doxorubicin|doxorubicin|mesh-list
44053568|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053569|NCT00004179|Vincristine|vincristine|mesh-list
44053570|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053571|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
44053572|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053573|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053574|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254043|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254045|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44254046|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254047|NCT03663504|Metronidazole|metronidazole|mesh-list
44254048|NCT03663504|Neomycin|neomycin|mesh-list
44053575|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
44053576|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053577|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053578|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43778996|NCT05077111|Anesthetics|anesthetics|mesh-list
44053579|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44053580|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053581|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053582|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053583|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053584|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053585|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
44053586|NCT00004179|Hormones|hormones|mesh-ancestor
44053587|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053588|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053589|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053590|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053591|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053592|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053593|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
44053594|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44053595|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053596|NCT00004183|Capecitabine|capecitabine|mesh-list
44053597|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053598|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
44053599|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550382|NCT03623711|Citalopram|citalopram|mesh-list
44053613|NCT00004186|Etoposide|etoposide|mesh-list
44053614|NCT00004186|Topotecan|topotecan|mesh-list
44053615|NCT00004186|Ifosfamide|ifosfamide|mesh-list
44053616|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053617|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053618|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053619|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053620|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053621|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053622|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053623|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053624|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
44053625|NCT00004187|Capecitabine|capecitabine|mesh-list
44053626|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
44053627|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053628|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
44053629|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053630|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053631|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
44053632|NCT00004188|Melphalan|melphalan|mesh-list
44053633|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
44053634|NCT00004188|Cisplatin|cisplatin|mesh-list
44053635|NCT00004188|Carboplatin|carboplatin|mesh-list
44053636|NCT00004188|Doxorubicin|doxorubicin|mesh-list
44053637|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053638|NCT00004188|Etoposide|etoposide|mesh-list
44053639|NCT00004188|Vincristine|vincristine|mesh-list
44053640|NCT00004188|Topotecan|topotecan|mesh-list
44053641|NCT00004188|Isotretinoin|isotretinoin|mesh-list
44053642|NCT00004188|Lenograstim|lenograstim|mesh-list
44053643|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053645|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053646|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053647|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053648|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
44053649|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053650|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254049|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254050|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254052|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44254053|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44254054|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254055|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254056|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
44254057|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254058|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254059|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44254060|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254061|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254062|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254063|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44254064|NCT03633058|Ketamine|ketamine|mesh-list
44254065|NCT03633058|Analgesics|analgesics|mesh-ancestor
44254066|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
44254067|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254068|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651872|NCT03005002|Durvalumab|durvalumab|mesh-list
44053651|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053652|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053653|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053654|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053655|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053656|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053657|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44053658|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053659|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053660|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053661|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053662|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44053663|NCT00004189|Cisplatin|cisplatin|mesh-list
44053664|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053665|NCT00004190|Gemcitabine|gemcitabine|mesh-list
44053666|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
44053667|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053668|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
44053671|NCT00004190|Antiviral Agents|antiviral agents|mesh-ancestor
44053672|NCT00004190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053673|NCT00004190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053674|NCT00004190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053675|NCT00004190|Immunologic Factors|immunologic factors|mesh-ancestor
44053676|NCT00004190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053677|NCT00004192|Cytarabine|cytarabine|mesh-list
44053678|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
44053679|NCT00004192|Etoposide|etoposide|mesh-list
44053680|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053681|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053682|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053683|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053684|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053685|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254069|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44254070|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44254071|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
44254072|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
44254073|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254074|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44254075|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44254076|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254077|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254078|NCT03593655|Tenofovir|tenofovir|mesh-list
44254079|NCT03593655|Emtricitabine|emtricitabine|mesh-list
44254080|NCT03593655|Dapivirine|dapivirine|mesh-list
44254081|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
44254082|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053686|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053687|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
44053688|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
44053689|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053690|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053691|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
44053692|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053693|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053694|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
44053695|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
44053696|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44053697|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44053698|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
44053699|NCT00004192|Hormones|hormones|mesh-ancestor
44053700|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053701|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44053702|NCT00004192|Protective Agents|protective agents|mesh-ancestor
44053703|NCT00004194|Fludarabine|fludarabine|mesh-list
44053704|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
44053705|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053706|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053707|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
44053708|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053709|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053710|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
44053711|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053712|NCT00004195|Eniluracil|eniluracil|mesh-list
44053713|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053714|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053715|NCT00004196|Interferons|interferons|mesh-list
44053716|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
44053717|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053718|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
44053719|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053720|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
44053721|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053723|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
44053724|NCT00004197|Doxorubicin|doxorubicin|mesh-list
44053725|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053726|NCT00004197|Vincristine|vincristine|mesh-list
44053727|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
44053728|NCT00004197|Sargramostim|sargramostim|mesh-list
44053729|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44053730|NCT00004197|Vaccines|vaccines|mesh-list
44053731|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053732|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
44053733|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053734|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053735|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254083|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44254084|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44254086|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254087|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44053736|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
44053737|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053738|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053739|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053740|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053741|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053742|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053746|NCT00004197|Hormones|hormones|mesh-ancestor
44053747|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053748|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053749|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053750|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053751|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053752|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053753|NCT00004197|Analgesics|analgesics|mesh-ancestor
44053754|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
44053755|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44053756|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44149884|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149885|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44149886|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149887|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44149888|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44149889|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44149890|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149891|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44149892|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
44149893|NCT00209209|Hormones|hormones|mesh-ancestor
44149894|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149895|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149896|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
44149897|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149898|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44149899|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149900|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149901|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149902|NCT00209222|Cytarabine|cytarabine|mesh-list
44149903|NCT00209222|Dexamethasone|dexamethasone|mesh-list
44149904|NCT00209222|Prednisone|prednisone|mesh-list
44149905|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
44149906|NCT00209222|Melphalan|melphalan|mesh-list
44149907|NCT00209222|Rituximab|rituximab|mesh-list
44149908|NCT00209222|Doxorubicin|doxorubicin|mesh-list
44149909|NCT00209222|Etoposide|etoposide|mesh-list
44149910|NCT00209222|Vincristine|vincristine|mesh-list
44149911|NCT00209222|Cisplatin|cisplatin|mesh-list
44149912|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44149913|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
44149914|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149915|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149916|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44149917|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
44149918|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149919|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149920|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44149921|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44149922|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053757|NCT00004198|Sargramostim|sargramostim|mesh-list
44053758|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44053759|NCT00004198|Vaccines|vaccines|mesh-list
44053760|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
44053761|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053762|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44254088|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44254089|NCT03562871|Carboplatin|carboplatin|mesh-list
44254090|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
44254091|NCT03562871|Pemetrexed|pemetrexed|mesh-list
44254092|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254093|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254094|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053763|NCT00004199|Gemcitabine|gemcitabine|mesh-list
44053764|NCT00004199|Cisplatin|cisplatin|mesh-list
44053765|NCT00004199|Prinomastat|prinomastat|mesh-list
44053766|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053767|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053768|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
44053769|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053770|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
44053771|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053772|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053773|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053774|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
44053775|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053776|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44053777|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
44053781|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
44053782|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053783|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053784|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44053785|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
44053786|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053787|NCT00004201|Gemcitabine|gemcitabine|mesh-list
44053788|NCT00004201|Cisplatin|cisplatin|mesh-list
44053789|NCT00004201|Carboplatin|carboplatin|mesh-list
44053790|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053791|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053792|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
44053793|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053794|NCT00004201|Antiviral Agents|antiviral agents|mesh-ancestor
44053795|NCT00004201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053796|NCT00004201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053797|NCT00004201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053798|NCT00004201|Immunologic Factors|immunologic factors|mesh-ancestor
44053799|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053800|NCT00004202|Paclitaxel|paclitaxel|mesh-list
44053801|NCT00004202|Carboplatin|carboplatin|mesh-list
44053802|NCT00004202|Efaproxiral|efaproxiral|mesh-list
44053803|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053804|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053805|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053806|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053807|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053808|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053809|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
44053810|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
44053811|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053812|NCT00004204|Temozolomide|temozolomide|mesh-list
44053813|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053814|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
44053815|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053816|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053817|NCT00004205|Tamoxifen|tamoxifen|mesh-list
44053818|NCT00004205|Letrozole|letrozole|mesh-list
44053819|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053820|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053821|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44053822|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44053823|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053824|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44053825|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
44053826|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053827|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254095|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254096|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44254097|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44254099|NCT03521102|Hydromorphone|hydromorphone|mesh-list
44053828|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053829|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44053830|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44053831|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44053832|NCT00004206|Leucovorin|leucovorin|mesh-list
44053833|NCT00004206|Fluorouracil|fluorouracil|mesh-list
44053834|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
44053835|NCT00004206|Calcium|calcium|mesh-list
44053836|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
44053837|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053838|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053839|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
44053840|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053841|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053842|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053843|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053844|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
44053845|NCT00004206|Antidotes|antidotes|mesh-ancestor
44053846|NCT00004206|Protective Agents|protective agents|mesh-ancestor
44053847|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053848|NCT00004206|Vitamins|vitamins|mesh-ancestor
44053849|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
44053850|NCT00004207|Daunorubicin|daunorubicin|mesh-list
44053861|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053862|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053863|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
44053864|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053865|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44053866|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053867|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053868|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053869|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053870|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053871|NCT00004212|Exatecan|exatecan|mesh-list
44053872|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44053873|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053874|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053875|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053876|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053877|NCT00004215|Cytarabine|cytarabine|mesh-list
44053878|NCT00004215|Daunorubicin|daunorubicin|mesh-list
44053879|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053880|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
44053881|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053882|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053883|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
44053884|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053885|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053886|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
44053887|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053888|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053889|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053890|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053891|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053892|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
44053893|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
44053894|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44053895|NCT00004216|Cefixime|cefixime|mesh-list
44053896|NCT00004216|Trimethoprim|trimethoprim|mesh-list
44053897|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
44053898|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44053899|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053900|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053901|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053902|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254101|NCT03521102|Analgesics|analgesics|mesh-ancestor
44254102|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
44254103|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254104|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254105|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
44254106|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44254107|NCT03521102|Narcotics|narcotics|mesh-ancestor
44254108|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254109|NCT03405090|Fentanyl|fentanyl|mesh-list
44053903|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053904|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053905|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44053906|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44053907|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44053908|NCT00004216|Renal Agents|renal agents|mesh-ancestor
44053909|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
44053910|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44053911|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44053912|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44053913|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44053914|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44053915|NCT00004217|Cytarabine|cytarabine|mesh-list
44053916|NCT00004217|Daunorubicin|daunorubicin|mesh-list
44053926|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053927|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053928|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053929|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053930|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053931|NCT00004218|Prednisolone|prednisolone|mesh-list
44053932|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
44053933|NCT00004218|Chlorambucil|chlorambucil|mesh-list
44053934|NCT00004218|Doxorubicin|doxorubicin|mesh-list
44053935|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053936|NCT00004218|Fludarabine|fludarabine|mesh-list
44053937|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
44053938|NCT00004218|Vincristine|vincristine|mesh-list
44053939|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053940|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
44053941|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053942|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053943|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053944|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
44053945|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053946|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053947|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44053948|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053949|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053950|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053951|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053952|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053953|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
44053954|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053955|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053956|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053957|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053958|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053959|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
44053960|NCT00004218|Hormones|hormones|mesh-ancestor
44053961|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44053962|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44053963|NCT00004219|Granisetron|granisetron|mesh-list
44053964|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
44053965|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
44053966|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254110|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
44254111|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44254112|NCT03405090|Narcotics|narcotics|mesh-ancestor
44254113|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254114|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254115|NCT03405090|Analgesics|analgesics|mesh-ancestor
44254116|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
44254117|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254118|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44053967|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053968|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44053969|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44053970|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
44053971|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44053972|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053973|NCT00004220|Gemcitabine|gemcitabine|mesh-list
44053974|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
44053975|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053976|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
44053977|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053978|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053979|NCT00004220|Antiviral Agents|antiviral agents|mesh-ancestor
44053980|NCT00004220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053981|NCT00004220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053982|NCT00004220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053990|NCT00004221|Lenograstim|lenograstim|mesh-list
44053991|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053992|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053993|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053994|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053995|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053996|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053997|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053998|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
44053999|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054000|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054001|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44054002|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
44054003|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054004|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44054005|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44054006|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054007|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054008|NCT00004223|Gemcitabine|gemcitabine|mesh-list
44054009|NCT00004223|Docetaxel|docetaxel|mesh-list
44054010|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054011|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
44054012|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054013|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054014|NCT00004223|Antiviral Agents|antiviral agents|mesh-ancestor
44054015|NCT00004223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054016|NCT00004223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054017|NCT00004223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054018|NCT00004223|Immunologic Factors|immunologic factors|mesh-ancestor
44054019|NCT00004223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054020|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054021|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054022|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054023|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
44054024|NCT00004224|Etoposide|etoposide|mesh-list
44054025|NCT00004224|Vincristine|vincristine|mesh-list
44054026|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054027|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
44054028|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054029|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054030|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254119|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44254120|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
44254121|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
44054031|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
44054032|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054033|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054034|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054035|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44054036|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44054037|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054038|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054039|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054040|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054041|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054042|NCT00004227|Cetuximab|cetuximab|mesh-list
44054043|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44054044|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054045|NCT00004229|Endostatins|endostatins|mesh-list
44054046|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054047|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44054048|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44054049|NCT00004229|Growth Substances|growth substances|mesh-ancestor
44054050|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054051|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44054052|NCT00004232|Cyclosporine|cyclosporine|mesh-list
44054056|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054057|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
44054058|NCT00004232|Hormones|hormones|mesh-ancestor
44054059|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054060|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054061|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054062|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054063|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
44054064|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054065|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054066|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054067|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
44054068|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054069|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
44054070|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054071|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44054072|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
44054073|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
44054074|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054075|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054076|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44054077|NCT00004232|Protective Agents|protective agents|mesh-ancestor
44054078|NCT00004233|Leucovorin|leucovorin|mesh-list
44054079|NCT00004233|Fluorouracil|fluorouracil|mesh-list
44054080|NCT00004233|Calcium|calcium|mesh-list
44054081|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
44054082|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054083|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054084|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
44054085|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054086|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054087|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054088|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054089|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
44054090|NCT00004233|Antidotes|antidotes|mesh-ancestor
44054091|NCT00004233|Protective Agents|protective agents|mesh-ancestor
44054092|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
44054093|NCT00004233|Vitamins|vitamins|mesh-ancestor
44054094|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
44054095|NCT00004235|Docetaxel|docetaxel|mesh-list
44054096|NCT00004235|Irinotecan|irinotecan|mesh-list
44054097|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054098|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054099|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054100|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054101|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054102|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44054104|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054105|NCT00004236|Doxorubicin|doxorubicin|mesh-list
44254122|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
44254123|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44254124|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
44254126|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44254127|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254128|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
44254129|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44254130|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44254131|NCT03333408|Clindamycin|clindamycin|mesh-list
44254132|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
44254133|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
44054106|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44054107|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44054108|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054109|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44054110|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054111|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054112|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054113|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
44054114|NCT00004237|Doxorubicin|doxorubicin|mesh-list
44054115|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44054116|NCT00004237|Vinorelbine|vinorelbine|mesh-list
44054117|NCT00004237|Epirubicin|epirubicin|mesh-list
44054118|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
44054119|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054120|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
44054121|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054122|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054123|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44054124|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
44054125|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054126|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054127|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054128|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44054143|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
44054144|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054145|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054146|NCT00004242|Antiviral Agents|antiviral agents|mesh-ancestor
44054147|NCT00004242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089349|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
44054148|NCT00004242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054149|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054150|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
44054151|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054152|NCT00004243|Docetaxel|docetaxel|mesh-list
44054153|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
44054154|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054155|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054156|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054157|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054158|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054159|NCT00004244|Interferons|interferons|mesh-list
44054160|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
44054161|NCT00004244|Interleukin-12|interleukin-12|mesh-list
44054162|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054163|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
44054164|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054165|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
44054166|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054167|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44054168|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44054169|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44054170|NCT00004244|Growth Substances|growth substances|mesh-ancestor
44054171|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
44054172|NCT00004245|Salicylates|salicylates|mesh-list
44054173|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
44254134|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44254135|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651912|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
44054174|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44054175|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44054176|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44054177|NCT00004245|Analgesics|analgesics|mesh-ancestor
44054178|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
44054179|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054180|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054181|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054182|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054183|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44054184|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054185|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054186|NCT00004246|Fludarabine|fludarabine|mesh-list
44054187|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
44054188|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054189|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054190|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
43551002|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054194|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054195|NCT00004248|Aldesleukin|aldesleukin|mesh-list
44054196|NCT00004248|Doxorubicin|doxorubicin|mesh-list
44054197|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44054198|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44054199|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054200|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44054201|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054202|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054203|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054204|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44054205|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44054206|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
44054207|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054208|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44054209|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44054210|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
44054211|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054212|NCT00004250|Dactinomycin|dactinomycin|mesh-list
44054213|NCT00004250|Melphalan|melphalan|mesh-list
44054214|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44054215|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
44054216|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054217|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054218|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054219|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054220|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
44054221|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054222|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44054223|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054224|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44054225|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44054226|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054227|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44054229|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054230|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44054231|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44054232|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054233|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054234|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44054235|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
44054236|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054237|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054238|NCT00004252|Leucovorin|leucovorin|mesh-list
44054239|NCT00004252|Fluorouracil|fluorouracil|mesh-list
44054240|NCT00004252|Calcium|calcium|mesh-list
44054241|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
44054242|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054243|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254136|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44254137|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254138|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254139|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44254140|NCT03326791|Aspirin|aspirin|mesh-list
44254141|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44254142|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44254143|NCT03326791|Analgesics|analgesics|mesh-ancestor
44254144|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
44254145|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254146|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254147|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254148|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254149|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44254150|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44254151|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254152|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254153|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44254154|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054244|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
44054245|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054246|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054247|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054248|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054249|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
44054250|NCT00004252|Antidotes|antidotes|mesh-ancestor
44054251|NCT00004252|Protective Agents|protective agents|mesh-ancestor
44054252|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
44054253|NCT00004252|Vitamins|vitamins|mesh-ancestor
44054254|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
44054255|NCT00004253|Paclitaxel|paclitaxel|mesh-list
44054256|NCT00004253|Carboplatin|carboplatin|mesh-list
44054257|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44054258|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054259|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054260|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054261|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054262|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054277|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
44054278|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054279|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054280|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44054281|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
44054282|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054283|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054284|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054285|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054286|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
44054287|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44054288|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054289|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054290|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
44054291|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
44054292|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254155|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
44254156|NCT03289741|Octreotide|octreotide|mesh-list
44254157|NCT03289741|Lanreotide|lanreotide|mesh-list
44254158|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254159|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254160|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254161|NCT03259867|Nivolumab|nivolumab|mesh-list
44254162|NCT03259867|Tirapazamine|tirapazamine|mesh-list
44254163|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254164|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254165|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44254166|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254167|NCT03255915|Tenofovir|tenofovir|mesh-list
44254168|NCT03255915|Emtricitabine|emtricitabine|mesh-list
44254169|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
44254170|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254171|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44254172|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44254173|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254174|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254175|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44054293|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054294|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
44054295|NCT00004255|Hormones|hormones|mesh-ancestor
44054296|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054297|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44054298|NCT00004255|Protective Agents|protective agents|mesh-ancestor
44054299|NCT00004256|Sargramostim|sargramostim|mesh-list
44054300|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
44054301|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054302|NCT00004257|Fluorouracil|fluorouracil|mesh-list
44054303|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
44054304|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
44054305|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054306|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054307|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054308|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054309|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
44054310|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054311|NCT00004260|Rituximab|rituximab|mesh-list
44054312|NCT00004260|Interleukin-12|interleukin-12|mesh-list
44054313|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44054314|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054315|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
44054316|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054317|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054318|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44054319|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44054320|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44054321|NCT00004260|Growth Substances|growth substances|mesh-ancestor
44054322|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
44054323|NCT00004261|Antibodies|antibodies|mesh-list
44054324|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
44054325|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054337|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254177|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44254178|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
44254179|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254180|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
44254181|NCT03195374|Narcotics|narcotics|mesh-ancestor
44254182|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254183|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254184|NCT03195374|Analgesics|analgesics|mesh-ancestor
44054338|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054339|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
44054340|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054341|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44054342|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054343|NCT00004264|Cisplatin|cisplatin|mesh-list
44054344|NCT00004264|Docetaxel|docetaxel|mesh-list
44054345|NCT00004264|Amifostine|amifostine|mesh-list
44054346|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054347|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054348|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054349|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054350|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054351|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44054352|NCT00004264|Protective Agents|protective agents|mesh-ancestor
44054353|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054354|NCT00004265|Paclitaxel|paclitaxel|mesh-list
44054355|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44054356|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054357|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054358|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054359|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054360|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054361|NCT00004266|Lisinopril|lisinopril|mesh-list
44054362|NCT00004266|Nifedipine|nifedipine|mesh-list
44054363|NCT00004266|Simvastatin|simvastatin|mesh-list
44054364|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44054365|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44054366|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
44054367|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054368|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44054369|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44054370|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054371|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44054372|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054373|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054374|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054375|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
44054377|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054378|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44054379|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
44054380|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44054381|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44054382|NCT00004266|Protective Agents|protective agents|mesh-ancestor
44054383|NCT00004268|Midodrine|midodrine|mesh-list
44054384|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
44054385|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
44054386|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054387|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054388|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44054389|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44054390|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44054392|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
44054393|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054394|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054395|NCT00004274|Estrogens|estrogens|mesh-list
44054396|NCT00004274|Hormones|hormones|mesh-ancestor
44254185|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
44254186|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254187|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
44254188|NCT03193216|Antacids|antacids|mesh-ancestor
44254189|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254190|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254191|NCT03188068|Sirolimus|sirolimus|mesh-list
44254192|NCT03188068|Prednisolone|prednisolone|mesh-list
44254193|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254194|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651964|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054397|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054398|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054399|NCT00004275|Hormones|hormones|mesh-list
44054400|NCT00004275|Oxandrolone|oxandrolone|mesh-list
44054401|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054402|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054403|NCT00004275|Androgens|androgens|mesh-ancestor
44054404|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
44054406|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054407|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
44054408|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054409|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
44054410|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44054411|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054412|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44054413|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44054414|NCT00004276|Growth Substances|growth substances|mesh-ancestor
44054415|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
44054416|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054417|NCT00004278|Ganciclovir|ganciclovir|mesh-list
44054418|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44054419|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
44054420|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054421|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44054422|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054423|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054424|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
44054425|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
44054426|NCT00004284|Diuretics|diuretics|mesh-ancestor
44054427|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
44054428|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054429|NCT00004284|Expectorants|expectorants|mesh-ancestor
44054430|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
44054431|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
44054432|NCT00004284|Protective Agents|protective agents|mesh-ancestor
44054433|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
44054434|NCT00004286|Antibodies|antibodies|mesh-list
44054435|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
44054436|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44054437|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44054438|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
44054439|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054440|NCT00004288|Olsalazine|olsalazine|mesh-list
44054441|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779576|NCT02896712|Modafinil|modafinil|mesh-list
44054442|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44054443|NCT00004288|Analgesics|analgesics|mesh-ancestor
44054444|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
44054445|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054446|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054447|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054448|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254195|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254196|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254197|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
44254198|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254199|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
44054449|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054450|NCT00004297|Diazepam|diazepam|mesh-list
44054451|NCT00004297|Lorazepam|lorazepam|mesh-list
44054452|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
44054453|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
44054454|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
44054455|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054456|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054457|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054458|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44054459|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054460|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44054461|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44054462|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054463|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
44054464|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
44054465|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054466|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054478|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44054479|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054480|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054481|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054482|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
44054483|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054484|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44054485|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44054486|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
44054487|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054488|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
44054489|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
44054491|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44054492|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
44054493|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054494|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44054495|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44054496|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054497|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054498|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054499|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
44054500|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054502|NCT00004311|Spironolactone|spironolactone|mesh-list
44054503|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44054504|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
44054505|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054506|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054507|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054508|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054509|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44054510|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44054511|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054512|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44054513|NCT00004311|Diuretics|diuretics|mesh-ancestor
44054514|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
44054515|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44054516|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44054517|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
44054518|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054519|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44054520|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44054521|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054522|NCT00004316|Capsaicin|capsaicin|mesh-list
44054523|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
44054524|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
44254201|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254202|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
44254203|NCT03188068|Hormones|hormones|mesh-ancestor
44254204|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254205|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254206|NCT03133221|Idelalisib|idelalisib|mesh-list
44254207|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054525|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
44054526|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054527|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054528|NCT00004317|Leucovorin|leucovorin|mesh-list
44054529|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
44054530|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
44054531|NCT00004317|Spiramycin|spiramycin|mesh-list
44054541|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
44054542|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44054543|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44054544|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089762|NCT00028327|Zidovudine|zidovudine|mesh-list
44054545|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44054546|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054547|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054548|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44054549|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
44054550|NCT00004323|Cyclosporine|cyclosporine|mesh-list
44054551|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
44054552|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
44054553|NCT00004323|Methotrexate|methotrexate|mesh-list
44054554|NCT00004323|Cyclosporins|cyclosporins|mesh-list
44054555|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44054556|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054557|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
44054558|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054559|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054560|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44054561|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
44054562|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054563|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054564|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054565|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44054566|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
44054567|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054568|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054569|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
44054570|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44054571|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054572|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44054573|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44054574|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
44054575|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054576|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44054577|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054578|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
44054579|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
44054580|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054581|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054582|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
44054583|NCT00004323|Hormones|hormones|mesh-ancestor
44054584|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054585|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44054586|NCT00004323|Protective Agents|protective agents|mesh-ancestor
44054587|NCT00004327|Octreotide|octreotide|mesh-list
44054588|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054589|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054590|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779696|NCT04997174|Celecoxib|celecoxib|mesh-list
44054591|NCT00004328|Enalapril|enalapril|mesh-list
44054592|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44254208|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254209|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254211|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44254212|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44254213|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44254214|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254215|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254216|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
44254217|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254218|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254219|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43651994|NCT03003728|Melphalan|melphalan|mesh-list
44054593|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44054594|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
44054595|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054596|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054597|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44054598|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
44149932|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44149934|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149935|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44149936|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149937|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149938|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149939|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149940|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
44149941|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
44149942|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149943|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44149944|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
44149945|NCT00209261|Coagulants|coagulants|mesh-ancestor
44149946|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44149947|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
44149948|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149949|NCT00209300|Mesalamine|mesalamine|mesh-list
44149950|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44149951|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44149952|NCT00209300|Analgesics|analgesics|mesh-ancestor
44149953|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
44149954|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149955|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149956|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44149957|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44149958|NCT00209313|Acyclovir|acyclovir|mesh-list
44149959|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
44149960|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149961|NCT00209352|Acyclovir|acyclovir|mesh-list
44149962|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
44149963|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149964|NCT00209469|Alendronate|alendronate|mesh-list
44149965|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149966|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149967|NCT00209482|Metformin|metformin|mesh-list
44149968|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44149969|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149970|NCT00209495|Dexamethasone|dexamethasone|mesh-list
44149971|NCT00209495|Pregabalin|pregabalin|mesh-list
44149972|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44149973|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
44149974|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
44149975|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254220|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254221|NCT03100786|Dexamethasone|dexamethasone|mesh-list
44254222|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254223|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
44254224|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
44254225|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254226|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254227|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254228|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
44254229|NCT03100786|Hormones|hormones|mesh-ancestor
44254230|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254231|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254232|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254233|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
44149976|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149977|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149978|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
44149979|NCT00209495|Hormones|hormones|mesh-ancestor
44149980|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149986|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44149987|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149988|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149989|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054603|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44054604|NCT00004339|Trientine|trientine|mesh-list
44054605|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
44054606|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
44054607|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054608|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054609|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44054610|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089904|NCT00028600|Fludarabine|fludarabine|mesh-list
44054611|NCT00004339|Growth Substances|growth substances|mesh-ancestor
44054612|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054613|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
44054614|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054615|NCT00004340|Calcitriol|calcitriol|mesh-list
44054616|NCT00004340|Hormones|hormones|mesh-list
44054617|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054618|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054619|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054620|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44054621|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054622|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054623|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44054624|NCT00004340|Vitamins|vitamins|mesh-ancestor
44054625|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
44054626|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44054627|NCT00004344|Leuprolide|leuprolide|mesh-list
44054628|NCT00004344|Testosterone|testosterone|mesh-list
44054629|NCT00004344|Androgens|androgens|mesh-ancestor
44054630|NCT00004344|Hormones|hormones|mesh-ancestor
44054631|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054632|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054633|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054634|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054635|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44054636|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
44054637|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054638|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44254234|NCT03015974|Prednisone|prednisone|mesh-list
44254235|NCT03015974|Prednisolone|prednisolone|mesh-list
44254236|NCT03015974|Deflazacort|deflazacort|mesh-list
44254237|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
44254238|NCT03015974|Dipyridamole|dipyridamole|mesh-list
44254239|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44254240|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44254241|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254242|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
44254243|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254244|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254245|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254246|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
44254247|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254248|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254249|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44254250|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652016|NCT03003273|Ofloxacin|ofloxacin|mesh-list
44054639|NCT00004346|Lovastatin|lovastatin|mesh-list
44054640|NCT00004346|L 647318|l 647318|mesh-list
44054641|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
44054642|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44054643|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44054644|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
44054645|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054646|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44054647|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44054648|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054649|NCT00004346|Cathartics|cathartics|mesh-ancestor
44054650|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054651|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
44054652|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44054653|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44054654|NCT00004357|Prednisolone|prednisolone|mesh-list
44054655|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
44054656|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44054657|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
44054658|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054659|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
44054660|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
44054661|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054662|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054663|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054667|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44054668|NCT00004357|Protective Agents|protective agents|mesh-ancestor
44054669|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054670|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054671|NCT00004358|Calcitonin|calcitonin|mesh-list
44054672|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
44054673|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44054674|NCT00004358|Katacalcin|katacalcin|mesh-list
44054675|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054676|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054677|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44054678|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
44054679|NCT00004359|Methoxsalen|methoxsalen|mesh-list
44054680|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44054681|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44054682|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
44254251|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
44254252|NCT03015974|Hormones|hormones|mesh-ancestor
44254253|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254254|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254255|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254256|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44254257|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
44054683|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44054684|NCT00004360|Diuretics|diuretics|mesh-ancestor
44054685|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
44054686|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054687|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44054688|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054689|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054690|NCT00004361|Citric Acid|citric acid|mesh-list
44054691|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
44054692|NCT00004361|Calcium|calcium|mesh-list
44054693|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054694|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054695|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
44054696|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44054697|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
44054698|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
44054699|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054700|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
44054701|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44054702|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
44054703|NCT00004363|Coagulants|coagulants|mesh-ancestor
44054704|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44054705|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
44054706|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054707|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44054708|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44054709|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
44054710|NCT00004364|Coagulants|coagulants|mesh-ancestor
44054711|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44054712|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
44054713|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054714|NCT00004368|Colchicine|colchicine|mesh-list
44054715|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
44054716|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054717|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054718|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054719|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054720|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054721|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054722|NCT00004373|Alprazolam|alprazolam|mesh-list
44054723|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44054724|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054725|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054726|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44054727|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44054728|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054729|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
44054730|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
44054731|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054732|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054733|NCT00004376|Guanfacine|guanfacine|mesh-list
44054734|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44054735|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44054736|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44054745|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44054746|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054747|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44054748|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054749|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054750|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44054751|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254258|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254259|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254260|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254261|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
44254262|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44254263|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254264|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
44254265|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
44254268|NCT03013504|Epirubicin|epirubicin|mesh-list
44254269|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054752|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054753|NCT00004390|Morphine|morphine|mesh-list
44054754|NCT00004390|Methadone|methadone|mesh-list
44054755|NCT00004390|Nortriptyline|nortriptyline|mesh-list
44054756|NCT00004390|Desipramine|desipramine|mesh-list
44054757|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44054758|NCT00004390|Narcotics|narcotics|mesh-ancestor
44054759|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054760|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054761|NCT00004390|Analgesics|analgesics|mesh-ancestor
44054762|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
44054763|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054764|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
44054765|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44054766|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44054767|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
44054768|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054769|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44054770|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44054771|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054772|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054773|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
44054774|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054775|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054776|NCT00004393|Risperidone|risperidone|mesh-list
44054777|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44054778|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
44054779|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054780|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054781|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054782|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44054783|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44054784|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054785|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054786|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44054787|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
44054788|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44054789|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054790|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054791|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44054792|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054793|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054794|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44054795|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054796|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054797|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
44054798|NCT00004399|Nimodipine|nimodipine|mesh-list
44054799|NCT00004399|Analgesics|analgesics|mesh-ancestor
44054800|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
44054801|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551670|NCT03611426|Thrombin|thrombin|mesh-list
44054804|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054805|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44054807|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44254270|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
44254271|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254272|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254273|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254274|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
44054808|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054809|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054810|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054811|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
44054812|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054813|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44054814|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
44054815|NCT00004400|Testosterone|testosterone|mesh-list
44054816|NCT00004400|Androgens|androgens|mesh-ancestor
44054817|NCT00004400|Hormones|hormones|mesh-ancestor
44054818|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054819|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054820|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
44054821|NCT00004401|Antibodies|antibodies|mesh-list
44054822|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
44054823|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44054824|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44054825|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
44054826|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054827|NCT00004402|Calcitriol|calcitriol|mesh-list
44054828|NCT00004402|Interferons|interferons|mesh-list
44054829|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
44054830|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054831|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
44054832|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054833|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054834|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054835|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44054836|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054837|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054838|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44054839|NCT00004402|Vitamins|vitamins|mesh-ancestor
44054840|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
44054841|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44054842|NCT00004403|Albendazole|albendazole|mesh-list
44054843|NCT00004403|Dexamethasone|dexamethasone|mesh-list
44054844|NCT00004403|Phenytoin|phenytoin|mesh-list
44054845|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054846|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
44054847|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
44054848|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054849|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054850|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054851|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
44054852|NCT00004403|Hormones|hormones|mesh-ancestor
44054853|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054854|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054855|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054856|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
44054857|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44054858|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054859|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
44054860|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44054861|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44054862|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054863|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054864|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054865|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054866|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
44054867|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44054868|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44054869|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054870|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44054871|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44054873|NCT00004404|Miconazole|miconazole|mesh-list
44254275|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254276|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254277|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44054874|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
44054875|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054887|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054888|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054889|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44054890|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44054891|NCT00004406|Hormones|hormones|mesh-list
44054892|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
44054893|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054894|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054895|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054896|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
44054897|NCT00004407|Antibodies|antibodies|mesh-list
44054898|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
44054899|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44054900|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44054901|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
44054902|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054903|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44054904|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
44054905|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054906|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44054907|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44054908|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
44054909|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44054910|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44054911|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44054912|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44054913|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054914|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
44054915|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054916|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054917|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44054918|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054920|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054921|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054922|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
44054923|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44054924|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44054925|NCT00004420|Analgesics|analgesics|mesh-ancestor
44054926|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
44054927|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054928|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054929|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054930|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44054931|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44054932|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
44054933|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054934|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44054935|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
44054936|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
44054954|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
44054955|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
44054956|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44054957|NCT00004424|Narcotics|narcotics|mesh-ancestor
44054958|NCT00004424|Analgesics|analgesics|mesh-ancestor
44054959|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
44054960|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054961|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44054962|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44054963|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44054964|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054965|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
44054966|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
44054967|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054968|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054969|NCT00004426|Leuprolide|leuprolide|mesh-list
44254278|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254279|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254280|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254281|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254282|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254283|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44254284|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44254285|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254286|NCT02974049|Ivermectin|ivermectin|mesh-list
44254287|NCT02974049|Albendazole|albendazole|mesh-list
44254288|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
44254289|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44054970|NCT00004426|Hormones|hormones|mesh-list
44054971|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054972|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054973|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44054974|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
44054975|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44054976|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054977|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054978|NCT00004429|Hormones|hormones|mesh-list
44054979|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054980|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054982|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44054983|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
44054984|NCT00004430|Hormones|hormones|mesh-ancestor
44054985|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054986|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054987|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44054988|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054989|NCT00004431|Baclofen|baclofen|mesh-list
44054990|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44054991|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054992|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44054993|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054994|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44054995|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
44054996|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
44054997|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055007|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055009|NCT00004436|Hormones|hormones|mesh-ancestor
44055010|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055011|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055012|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055013|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055014|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44055015|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
44055016|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055018|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44055019|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
44055020|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055021|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055022|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055023|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055024|NCT00004440|Ibuprofen|ibuprofen|mesh-list
44055025|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44055026|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44055027|NCT00004440|Analgesics|analgesics|mesh-ancestor
44055028|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
44055029|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055030|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055031|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254290|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254291|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
44254292|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
44254293|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44254294|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44254295|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254296|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44055032|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055033|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44055034|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055035|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055036|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44055037|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44055038|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44055039|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055040|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
44055041|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055042|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44055043|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44055044|NCT00004442|Cholic Acids|cholic acids|mesh-list
44055045|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44055046|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055047|NCT00004442|Cathartics|cathartics|mesh-ancestor
44055048|NCT00004444|Paromomycin|paromomycin|mesh-list
44055049|NCT00004444|Streptomycin|streptomycin|mesh-list
44055050|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055051|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055052|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44055053|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44055054|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44055055|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055056|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055058|NCT00004446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44055059|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44055060|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055061|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055062|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055063|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
44055073|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
44055074|NCT00004448|Hormones|hormones|mesh-ancestor
44055075|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055076|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090378|NCT00029627|Yohimbine|yohimbine|mesh-list
44055077|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055078|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055079|NCT00004450|Interferons|interferons|mesh-list
44055080|NCT00004450|Interferon-beta|interferon-beta|mesh-list
44055081|NCT00004450|Thalidomide|thalidomide|mesh-list
44055082|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055083|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
44055084|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055085|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055086|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
44055087|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055088|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
44055089|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055091|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44055092|NCT00004450|Growth Substances|growth substances|mesh-ancestor
44055093|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44055094|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
44055095|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055096|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
44055097|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055098|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055099|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44055100|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
44055101|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055102|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254297|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254298|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254299|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254300|NCT02974049|Filaricides|filaricides|mesh-ancestor
44254301|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
44254302|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43770583|NCT02378740|Ketamine|ketamine|mesh-list
44055103|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44055104|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
44055105|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44055106|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055107|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055108|NCT00004466|Atorvastatin|atorvastatin|mesh-list
44055109|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44055110|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44055111|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
44055112|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055113|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44055114|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44055115|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055116|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
44055117|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44055118|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
44055119|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055120|NCT00004467|Expectorants|expectorants|mesh-ancestor
44055121|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
44055122|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44055123|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
44055124|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055125|NCT00004467|Protective Agents|protective agents|mesh-ancestor
44055126|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780055|NCT05083026|Antibodies|antibodies|mesh-list
44055127|NCT00004467|Antidotes|antidotes|mesh-ancestor
44055128|NCT00004468|Calcitriol|calcitriol|mesh-list
44055137|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44055138|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
44055139|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44055140|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055141|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
44055142|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055143|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055144|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44055145|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
44055146|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055147|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055148|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44055149|NCT00004478|Droxidopa|droxidopa|mesh-list
44055150|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44055151|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44055152|NCT00004479|Midodrine|midodrine|mesh-list
44055153|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
44055154|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
44055155|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055156|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055157|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44055158|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44055159|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44055160|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44055161|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
44055162|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055163|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055164|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
44055165|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44055166|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44055167|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44055168|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055169|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055170|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
44254303|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254304|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44254305|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44254306|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44254307|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
44254308|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254309|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254310|NCT02937766|Progestins|progestins|mesh-ancestor
44055171|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055172|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055173|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44055174|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055175|NCT00004482|Cyclosporine|cyclosporine|mesh-list
44055176|NCT00004482|Prednisone|prednisone|mesh-list
44055177|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
44055178|NCT00004482|Cyclosporins|cyclosporins|mesh-list
44055179|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
44055180|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055181|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
44055182|NCT00004482|Hormones|hormones|mesh-ancestor
44055183|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055184|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055185|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055186|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055187|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055188|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055189|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055190|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
44055191|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
44055192|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552039|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
43780134|NCT05048069|Rebamipide|rebamipide|mesh-list
44055201|NCT00004482|Protective Agents|protective agents|mesh-ancestor
44055202|NCT00004485|Cyclosporine|cyclosporine|mesh-list
44055203|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
44055204|NCT00004485|Fludarabine|fludarabine|mesh-list
44055205|NCT00004485|Cyclosporins|cyclosporins|mesh-list
44055206|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055207|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055208|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055209|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
44055210|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055211|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055212|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
44055213|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055214|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44055215|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055216|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44055217|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44055218|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44055219|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
44055220|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44149990|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44149991|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149992|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149993|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149994|NCT00209521|Propofol|propofol|mesh-list
44149995|NCT00209521|Fospropofol|fospropofol|mesh-list
44149996|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44149997|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149998|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149999|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44150000|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
44150001|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
44150002|NCT00209534|Fospropofol|fospropofol|mesh-list
44150003|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44150004|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150005|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254311|NCT02937766|Hormones|hormones|mesh-ancestor
44254312|NCT02883400|Spironolactone|spironolactone|mesh-list
44254313|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44254314|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
44150006|NCT00209547|Fospropofol|fospropofol|mesh-list
44150007|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44150008|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150009|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150010|NCT00209573|Fospropofol|fospropofol|mesh-list
44150011|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44150012|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150013|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157919|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157920|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157921|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
44157922|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157923|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
44157924|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157925|NCT00235820|Adalimumab|adalimumab|mesh-list
44157926|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157927|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157928|NCT00235859|Adalimumab|adalimumab|mesh-list
44157929|NCT00235859|Methotrexate|methotrexate|mesh-list
44157930|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44157931|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
44157932|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44157933|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157934|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157944|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157945|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157946|NCT00235885|Adalimumab|adalimumab|mesh-list
44157947|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157948|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157949|NCT00235898|Leucovorin|leucovorin|mesh-list
44157950|NCT00235898|Fluorouracil|fluorouracil|mesh-list
44157951|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
44055221|NCT00004486|Fluoxetine|fluoxetine|mesh-list
44055222|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44055223|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44055224|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055225|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090568|NCT00030407|Analgesics|analgesics|mesh-ancestor
44055226|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055227|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
44055228|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055229|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44055230|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
44055231|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44055232|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44055233|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055234|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055235|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
44055236|NCT00004488|Vitamin D|vitamin d|mesh-list
44055237|NCT00004488|Alendronate|alendronate|mesh-list
44055238|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
44055239|NCT00004488|Calcium|calcium|mesh-list
44055240|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44055241|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055242|NCT00004488|Vitamins|vitamins|mesh-ancestor
44055243|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
44055244|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44055245|NCT00004488|Antacids|antacids|mesh-ancestor
44055246|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055247|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055248|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
44055249|NCT00004489|Vitamin D|vitamin d|mesh-list
44055250|NCT00004489|Alendronate|alendronate|mesh-list
44055251|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
44055252|NCT00004489|Calcium|calcium|mesh-list
44055253|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44055254|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055255|NCT00004489|Vitamins|vitamins|mesh-ancestor
44254315|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254316|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254317|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44254318|NCT02883400|Diuretics|diuretics|mesh-ancestor
44254319|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
44461302|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44461303|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461304|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461305|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44055257|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44055259|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055260|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055261|NCT00004492|Clotrimazole|clotrimazole|mesh-list
44055262|NCT00004492|Miconazole|miconazole|mesh-list
44055263|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
44055264|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055265|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
44055266|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055267|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055268|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055269|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44055270|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055271|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
44055281|NCT00004495|Pyridoxine|pyridoxine|mesh-list
44055282|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
44055283|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
44055284|NCT00004495|Hematinics|hematinics|mesh-ancestor
44055285|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
44055286|NCT00004495|Vitamins|vitamins|mesh-ancestor
44055287|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
44055288|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055289|NCT00004496|Hormones|hormones|mesh-list
44055290|NCT00004496|alpha-MSH|alpha-msh|mesh-list
44055291|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44055292|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44055293|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
43780247|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44055294|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055295|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055296|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090634|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44055297|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055298|NCT00004551|Nicotine|nicotine|mesh-list
44055299|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44055300|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
44055301|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055302|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055303|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44055304|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44055305|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44055306|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055307|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055308|NCT00004552|Acamprosate|acamprosate|mesh-list
44055309|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44055310|NCT00004554|Naltrexone|naltrexone|mesh-list
44055311|NCT00004554|Sertraline|sertraline|mesh-list
44055312|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44055313|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44055314|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055315|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
44055316|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055317|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
44055318|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44055319|NCT00004554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44055320|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44055321|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461306|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44461307|NCT01549613|Vancomycin|vancomycin|mesh-list
44461308|NCT01549613|Daptomycin|daptomycin|mesh-list
44461309|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461310|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461311|NCT01549041|Asenapine|asenapine|mesh-list
43908321|NCT04207944|Sulindac|sulindac|mesh-list
44055322|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055323|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055324|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
44055325|NCT00004564|Clopidogrel|clopidogrel|mesh-list
44055326|NCT00004564|Atorvastatin|atorvastatin|mesh-list
44055327|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44055328|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44055329|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
44055330|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055331|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44055332|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44055333|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552211|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
44055349|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055351|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44055352|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
44055353|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055354|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055355|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055356|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055358|NCT00004575|Bradykinin|bradykinin|mesh-list
44055359|NCT00004575|Kininogens|kininogens|mesh-list
44055360|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055361|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055362|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
44055363|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055364|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44055365|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055366|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44055367|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
44055368|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055369|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055370|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44055371|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055372|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
44055373|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44055374|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055375|NCT00004578|Ritonavir|ritonavir|mesh-list
44055376|NCT00004578|Lopinavir|lopinavir|mesh-list
44055377|NCT00004578|Lamivudine|lamivudine|mesh-list
44055378|NCT00004578|Stavudine|stavudine|mesh-list
44055379|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055380|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055381|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055382|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055383|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055384|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055385|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055386|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
44055387|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055388|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055389|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055390|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055408|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055409|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055410|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055412|NCT00004581|Lopinavir|lopinavir|mesh-list
44055413|NCT00004581|Nevirapine|nevirapine|mesh-list
44055414|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055415|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055416|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055417|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461312|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44254320|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
44254321|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44254322|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254323|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254324|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44254325|NCT02856594|Analgesics|analgesics|mesh-ancestor
44254326|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
44254327|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254328|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44055418|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055419|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055420|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055421|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
44055422|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055423|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055424|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055425|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055426|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055427|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055428|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055429|NCT00004582|Ritonavir|ritonavir|mesh-list
44055430|NCT00004582|Lopinavir|lopinavir|mesh-list
44055431|NCT00004582|Efavirenz|efavirenz|mesh-list
44055432|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055433|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055434|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055435|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055436|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055437|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055438|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055439|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
44055440|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055441|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055442|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055443|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055444|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055445|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44055446|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44055447|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44055463|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055464|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055465|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055466|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055467|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055468|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
44055469|NCT00004585|Lamivudine|lamivudine|mesh-list
44055470|NCT00004585|Zidovudine|zidovudine|mesh-list
44055471|NCT00004585|Efavirenz|efavirenz|mesh-list
44055472|NCT00004585|Abacavir|abacavir|mesh-list
44055473|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
44055474|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44055475|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055476|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055478|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055479|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
44055480|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055481|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055482|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055483|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
44055484|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44055485|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44254329|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44254330|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44254331|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44254332|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254333|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254334|NCT02799134|Ascorbic Acid|ascorbic acid|mesh-list
44254335|NCT02799134|Dexamethasone|dexamethasone|mesh-list
44254336|NCT02799134|Vitamins|vitamins|mesh-ancestor
44254337|NCT02799134|Micronutrients|micronutrients|mesh-ancestor
44254338|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254339|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254340|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
44254341|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
44254342|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824655|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055486|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44055487|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44055488|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055489|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055490|NCT00004637|Vitamin E|vitamin e|mesh-list
44055491|NCT00004637|Vitamins|vitamins|mesh-ancestor
44055492|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
44055493|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055494|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
44055495|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055496|NCT00004637|Protective Agents|protective agents|mesh-ancestor
44055497|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
44055498|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44055499|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055500|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
44055501|NCT00004643|Cytarabine|cytarabine|mesh-list
44055502|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44055503|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
44055504|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055505|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055506|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
44055507|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055508|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055509|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
44055510|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780404|NCT05325502|Caffeine|caffeine|mesh-list
44055518|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055520|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055521|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055522|NCT00004647|Mexiletine|mexiletine|mesh-list
44055523|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44055524|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44055525|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44055526|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44063460|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44055527|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055528|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44055529|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
44055530|NCT00004650|Estrogens|estrogens|mesh-list
44055531|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44055532|NCT00004650|Hormones|hormones|mesh-ancestor
44055533|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055534|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055535|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44055536|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44055537|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44254343|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254344|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
44254345|NCT02799134|Hormones|hormones|mesh-ancestor
44254346|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254347|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254348|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254349|NCT02799134|Antioxidants|antioxidants|mesh-ancestor
44254350|NCT02799134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254351|NCT02799134|Protective Agents|protective agents|mesh-ancestor
44254352|NCT02792413|Denosumab|denosumab|mesh-list
44254353|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44254354|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254355|NCT02773212|Amphetamine|amphetamine|mesh-list
44254356|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
44254357|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43652084|NCT03002961|Narcotics|narcotics|mesh-ancestor
44055538|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
44055539|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055540|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44055541|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44055542|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44055543|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055544|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055546|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44055547|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44055548|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44055549|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055550|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44055551|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44055552|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
44055553|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055554|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055555|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44055556|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44055557|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44055558|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
44055559|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055560|NCT00004664|Megestrol|megestrol|mesh-list
44055561|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44055562|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44055563|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44055564|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
44055565|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055566|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055567|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44055576|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055577|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
44055578|NCT00004682|Antibodies|antibodies|mesh-list
44055579|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
44055580|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44055581|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44055582|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
44055583|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055584|NCT00004685|Albuterol|albuterol|mesh-list
44055585|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43780415|NCT05325502|Diuretics|diuretics|mesh-ancestor
44055586|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
44063461|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055587|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055588|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254358|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254359|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
44254360|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
44254361|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254362|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
44254363|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254364|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254365|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44254366|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44254367|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44254368|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254369|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44254371|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
44254372|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
44254373|NCT02757872|Vitamins|vitamins|mesh-list
44254374|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
44254375|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652090|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44055589|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44055590|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
44055591|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
44055592|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055593|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44055594|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44055595|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44055596|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44055597|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055598|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055600|NCT00004686|Methotrexate|methotrexate|mesh-list
44055601|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055602|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
44055603|NCT00004686|Hormones|hormones|mesh-ancestor
44055604|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055605|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055606|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055607|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055608|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44055609|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
44055610|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055611|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44055612|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
44055613|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055614|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44055615|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055616|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44055618|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
44055619|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055620|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055621|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
44055622|NCT00004688|Carmustine|carmustine|mesh-list
44055623|NCT00004688|Streptozocin|streptozocin|mesh-list
44055624|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
44055625|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055626|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254376|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44254377|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44254378|NCT02746796|Capecitabine|capecitabine|mesh-list
44254379|NCT02746796|Tegafur|tegafur|mesh-list
44254380|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
44254381|NCT02746796|Nivolumab|nivolumab|mesh-list
44254382|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254383|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
44254384|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254385|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254386|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771990|NCT02369146|UB-421|ub-421|mesh-list
44055627|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055628|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055629|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
44055630|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055631|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055632|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055633|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44055634|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
44055644|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055645|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055646|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055647|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055648|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44055649|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
44055650|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
44055651|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055652|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44055653|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055654|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44055655|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44055656|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44055657|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055659|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
44055660|NCT00004690|Protective Agents|protective agents|mesh-ancestor
44055661|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055662|NCT00004694|Heparin|heparin|mesh-list
44055663|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
44055664|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44055665|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44055666|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055667|NCT00004695|Interleukin-2|interleukin-2|mesh-list
44055668|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055669|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44055670|NCT00004695|Analgesics|analgesics|mesh-ancestor
44055671|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
44055672|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055673|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055674|NCT00004696|Morphine|morphine|mesh-list
44055675|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44055676|NCT00004696|Narcotics|narcotics|mesh-ancestor
44055677|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44055678|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055679|NCT00004696|Analgesics|analgesics|mesh-ancestor
44055680|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
44055681|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055682|NCT00004697|Choline|choline|mesh-list
44055683|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
44055684|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44055685|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
43701621|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254387|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44254388|NCT02744976|Metformin|metformin|mesh-list
44254389|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652112|NCT03002493|Rifampin|rifampin|mesh-list
44055686|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055687|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055688|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44055689|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
44055690|NCT00004699|Mitogens|mitogens|mesh-list
44055691|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44055692|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055693|NCT00004700|Mitogens|mitogens|mesh-list
44055694|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44055695|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055696|NCT00004705|Amiloride|amiloride|mesh-list
44055697|NCT00004705|Diuretics|diuretics|mesh-ancestor
44055698|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
44055699|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055700|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44055701|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44055705|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44055707|NCT00004727|Ticlopidine|ticlopidine|mesh-list
44055708|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44055709|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44055710|NCT00004727|Analgesics|analgesics|mesh-ancestor
44055711|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
44055712|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055713|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055714|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055715|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055716|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44055717|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44055718|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055719|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44055720|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44055721|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055722|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
44055723|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44055724|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44055725|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44055726|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
44055727|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055728|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44055729|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055730|NCT00004728|Aspirin|aspirin|mesh-list
44055731|NCT00004728|Warfarin|warfarin|mesh-list
44055732|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44055733|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44055734|NCT00004728|Analgesics|analgesics|mesh-ancestor
44055735|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
44055736|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055737|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055738|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055739|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055740|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44055741|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44055742|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055743|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44055744|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44055745|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055746|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
44055747|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
44055748|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
44055749|NCT00004730|Analgesics|analgesics|mesh-ancestor
44055750|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
44055751|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055752|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055753|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
44055754|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44055755|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44254390|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254392|NCT02719392|Minocycline|minocycline|mesh-list
44254393|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44254394|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
44254395|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254396|NCT02719392|Expectorants|expectorants|mesh-ancestor
44254397|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
44055756|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
44055757|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44055758|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055759|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055760|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44055761|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
44055762|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055763|NCT00004731|Ubiquinone|ubiquinone|mesh-list
44055764|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
44055765|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
44055766|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055767|NCT00004731|Vitamins|vitamins|mesh-ancestor
44055768|NCT00004733|Levodopa|levodopa|mesh-list
44055769|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43552643|NCT03602638|Acarbose|acarbose|mesh-list
44055783|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055785|NCT00004736|Zidovudine|zidovudine|mesh-list
44055786|NCT00004736|Stavudine|stavudine|mesh-list
44055787|NCT00004736|Nelfinavir|nelfinavir|mesh-list
44055788|NCT00004736|Isoniazid|isoniazid|mesh-list
44055789|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
44055790|NCT00004736|Ethambutol|ethambutol|mesh-list
44055791|NCT00004736|Rifabutin|rifabutin|mesh-list
44055792|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055793|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055794|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055795|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055796|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
44055797|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055798|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055799|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055800|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
44055801|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
44055802|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055803|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44055804|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44055805|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44055806|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055807|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055808|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055809|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44055810|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44055811|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
44055812|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055814|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
44055815|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055816|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055817|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44055818|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44055819|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
44055820|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055821|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44055822|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
44055823|NCT00004744|Antibodies|antibodies|mesh-list
44055824|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
44055825|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44055826|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44055827|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
44055828|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055829|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
44055830|NCT00004747|Antibodies|antibodies|mesh-list
44055831|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
44254398|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44254399|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
44254400|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254401|NCT02719392|Protective Agents|protective agents|mesh-ancestor
44254402|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254403|NCT02719392|Antidotes|antidotes|mesh-ancestor
44254404|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254406|NCT02697448|Sevoflurane|sevoflurane|mesh-list
44055832|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44055833|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44055834|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
44055835|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055836|NCT00004748|Methotrexate|methotrexate|mesh-list
44055837|NCT00004748|Colchicine|colchicine|mesh-list
44055841|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055842|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055843|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44055844|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
44055845|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055846|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055847|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
44055848|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055849|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44055850|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055851|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
44055852|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055853|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055854|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
44055855|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44055856|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44055857|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44055858|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44055859|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055860|NCT00004754|Epoprostenol|epoprostenol|mesh-list
44055861|NCT00004754|Tezosentan|tezosentan|mesh-list
44055862|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44055863|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44055864|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
44055865|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44055866|NCT00004755|Allopurinol|allopurinol|mesh-list
44055867|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
44055868|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055869|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055870|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
44055871|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055872|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44055873|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
44055874|NCT00004755|Protective Agents|protective agents|mesh-ancestor
44055875|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055876|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44055877|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44055878|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150014|NCT00209586|Fospropofol|fospropofol|mesh-list
44150015|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44150016|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150017|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150018|NCT00209599|Fospropofol|fospropofol|mesh-list
44150019|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44150020|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150021|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150022|NCT00209612|Paclitaxel|paclitaxel|mesh-list
44150023|NCT00209612|Irinotecan|irinotecan|mesh-list
44055879|NCT00004757|Acyclovir|acyclovir|mesh-list
44055880|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
44055881|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055882|NCT00004758|Pyridoxine|pyridoxine|mesh-list
44055883|NCT00004758|Carbamazepine|carbamazepine|mesh-list
44055884|NCT00004758|Valproic Acid|valproic acid|mesh-list
44055885|NCT00004758|Nitrazepam|nitrazepam|mesh-list
44055886|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44254407|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44254408|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254409|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254410|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44254411|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
44254412|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
44254413|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254414|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44254415|NCT02685709|Octreotide|octreotide|mesh-list
44254416|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254417|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254418|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254419|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44254420|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
44254421|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44254422|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44254423|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254424|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
44254425|NCT02684851|Coagulants|coagulants|mesh-ancestor
44254426|NCT02546934|Gemcitabine|gemcitabine|mesh-list
44254427|NCT02546934|Cisplatin|cisplatin|mesh-list
44055887|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
44055888|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055889|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055890|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
44055891|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055892|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055893|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
44055894|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44055895|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44055896|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44055897|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44055898|NCT00004758|Analgesics|analgesics|mesh-ancestor
44055899|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
44055900|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055901|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44055910|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44055911|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44055912|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
44055913|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
44055914|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44055915|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44055916|NCT00004759|Prednisolone|prednisolone|mesh-list
44055917|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
44055918|NCT00004759|Tirilazad|tirilazad|mesh-list
44055919|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44055920|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
44055921|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055922|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
44055923|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
44055924|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055925|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055926|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055927|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
44055928|NCT00004759|Hormones|hormones|mesh-ancestor
44055929|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254428|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254429|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254430|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
44254431|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091298|NCT00031876|Capecitabine|capecitabine|mesh-list
44091299|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091300|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091301|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091302|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254432|NCT02546934|Antiviral Agents|antiviral agents|mesh-ancestor
44254433|NCT02546934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254434|NCT02546934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254435|NCT02546934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254436|NCT02546934|Immunologic Factors|immunologic factors|mesh-ancestor
44254437|NCT02546934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254438|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
44254439|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254440|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
44254441|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254442|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254443|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254444|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
44254445|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254446|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254447|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44254448|NCT02329847|Nivolumab|nivolumab|mesh-list
44254449|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254450|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254451|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44254452|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254453|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
44254454|NCT02326311|Dasatinib|dasatinib|mesh-list
44055930|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44055931|NCT00004759|Protective Agents|protective agents|mesh-ancestor
44055932|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055933|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055934|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
44055935|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055936|NCT00004762|Cladribine|cladribine|mesh-list
44055937|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055938|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055939|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
44055940|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055941|NCT00004763|Leuprolide|leuprolide|mesh-list
44055942|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44055943|NCT00004763|Norethindrone|norethindrone|mesh-list
44055944|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
44055945|NCT00004763|Norinyl|norinyl|mesh-list
44055946|NCT00004763|Estradiol|estradiol|mesh-list
44055947|NCT00004763|Estrogens|estrogens|mesh-ancestor
44055948|NCT00004763|Hormones|hormones|mesh-ancestor
44055949|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254455|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254456|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44254458|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254459|NCT02265367|Milnacipran|milnacipran|mesh-list
44254460|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
44254461|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44254462|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44254463|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254464|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254465|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254466|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254467|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
44254468|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44254469|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44254471|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
44254472|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254473|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
44055950|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055951|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44055952|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
44055953|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055954|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44055955|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44055956|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
44055957|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055958|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055959|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44055960|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44055961|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44055962|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44055963|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
44055964|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44055965|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
44055966|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055967|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44055968|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
44055969|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055975|NCT00004770|Protective Agents|protective agents|mesh-ancestor
44055976|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055977|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
44055978|NCT00004770|Vitamins|vitamins|mesh-ancestor
44055979|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
44055980|NCT00004771|Leuprolide|leuprolide|mesh-list
44055981|NCT00004771|Testosterone|testosterone|mesh-list
44055982|NCT00004771|Androgens|androgens|mesh-ancestor
44055983|NCT00004771|Hormones|hormones|mesh-ancestor
44055984|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055985|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055986|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055987|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055988|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44055989|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
44254474|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44254475|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44254476|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254477|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254478|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
44254479|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44254480|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254481|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254482|NCT01999569|Letrozole|letrozole|mesh-list
44254483|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254484|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44254485|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44254486|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254487|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254488|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44254489|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
44254490|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254491|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254492|NCT01959464|Progesterone|progesterone|mesh-list
44254493|NCT01959464|Progestins|progestins|mesh-ancestor
44254494|NCT01959464|Hormones|hormones|mesh-ancestor
44254495|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254496|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254497|NCT01921166|Leuprolide|leuprolide|mesh-list
44055990|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44055992|NCT00004772|Antibodies|antibodies|mesh-list
44055993|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
44055994|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44055995|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44055996|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
44055997|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055998|NCT00004776|Topiramate|topiramate|mesh-list
44055999|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
44056000|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44056001|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056002|NCT00004778|Dexamethasone|dexamethasone|mesh-list
44056003|NCT00004778|Betamethasone|betamethasone|mesh-list
44056004|NCT00004778|Hormones|hormones|mesh-list
44056005|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
44056006|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44056007|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
44056008|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
44056009|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056010|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056011|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056012|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
44056013|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056014|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44056015|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056016|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44254498|NCT01921166|Clomiphene|clomiphene|mesh-list
44254499|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44254500|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
44254501|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44254502|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254503|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44254504|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254505|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44254506|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
44254507|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254508|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44254509|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44254510|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44254511|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44254512|NCT01227616|Hematinics|hematinics|mesh-ancestor
44254513|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44254514|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44254515|NCT01192698|Interferons|interferons|mesh-list
44254516|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254517|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
44254518|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056017|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
44056018|NCT00004784|Methotrexate|methotrexate|mesh-list
44056019|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44056020|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44056021|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
44056022|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44056023|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056024|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056025|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
44056026|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056027|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056028|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
44056029|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056030|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44056031|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056032|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
44056033|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056034|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056035|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44056036|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056037|NCT00004785|Dexamethasone|dexamethasone|mesh-list
44056038|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
44056039|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44056040|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44056041|NCT00004785|Prednisolone|prednisolone|mesh-list
44056042|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
44056053|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056054|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44056055|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056056|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44056057|NCT00004785|Protective Agents|protective agents|mesh-ancestor
44254520|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
44254521|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
44254522|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254523|NCT00782288|Digitoxin|digitoxin|mesh-list
44254524|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44091479|NCT00032136|Tamoxifen|tamoxifen|mesh-list
44254525|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44254526|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254527|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254528|NCT00782288|Protective Agents|protective agents|mesh-ancestor
44254529|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254530|NCT00771654|Phentermine|phentermine|mesh-list
44254531|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44254532|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254533|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
44254534|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44254535|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
44254536|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
44254537|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254538|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44254539|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254540|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254541|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
43824677|NCT05509374|Hormones|hormones|mesh-ancestor
44056058|NCT00004786|Iloprost|iloprost|mesh-list
44056059|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44056060|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
44056061|NCT00004787|Lenograstim|lenograstim|mesh-list
44056062|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056063|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
44056064|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056065|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44056066|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056067|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056069|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
44056070|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056071|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056072|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056073|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44056074|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056075|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
44056076|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056077|NCT00004796|Lactulose|lactulose|mesh-list
44056078|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056079|NCT00004799|Vaccines|vaccines|mesh-list
44056080|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
44056081|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056082|NCT00004800|Vaccines|vaccines|mesh-list
44056083|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
44056084|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056085|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
44056086|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44254542|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
44254543|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254544|NCT00765310|Protective Agents|protective agents|mesh-ancestor
44254545|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254546|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
44254548|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
44254549|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
44254550|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
44254551|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254552|NCT00764270|Protective Agents|protective agents|mesh-ancestor
44254553|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254554|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
44254555|NCT00764270|Vitamins|vitamins|mesh-ancestor
44254556|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
44254557|NCT00302744|Niacin|niacin|mesh-list
44254558|NCT00302744|Psilocybin|psilocybin|mesh-list
44254559|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44056087|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056088|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056089|NCT00004804|Interferons|interferons|mesh-list
44056090|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
44056091|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056092|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
44056093|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056094|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
44063462|NCT00006050|Leucovorin|leucovorin|mesh-list
44056095|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056096|NCT00004807|Topiramate|topiramate|mesh-list
44056097|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
44056098|NCT00004807|Donepezil|donepezil|mesh-list
44056099|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44056100|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056101|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056102|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44056103|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44056104|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056105|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
44056106|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
44056107|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44056108|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
44056109|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
43552982|NCT03600727|Propofol|propofol|mesh-list
44056114|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056115|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44056116|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44056117|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056118|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056119|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44056120|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
44056121|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056122|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056123|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44056124|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44056125|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44056126|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
44056127|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44056128|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056129|NCT00004811|Itraconazole|itraconazole|mesh-list
44056130|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
44056131|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254560|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
44254561|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254562|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44254563|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
44254564|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
44056132|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44056133|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44056134|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056135|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056136|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44056137|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
44056138|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056139|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056140|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44056141|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
44056142|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
44056143|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056144|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
44056145|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056146|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056147|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056148|NCT00004815|Hormones|hormones|mesh-list
44056149|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091589|NCT00032773|Pentostatin|pentostatin|mesh-list
44056150|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056151|NCT00004816|Antibodies|antibodies|mesh-list
44056152|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44056153|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
44056154|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056155|NCT00004817|Phenytoin|phenytoin|mesh-list
44056156|NCT00004817|Valproic Acid|valproic acid|mesh-list
44056157|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
44056158|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056159|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056160|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
44056161|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44056162|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056163|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
44056164|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44056165|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44056166|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44056167|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44056168|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44056169|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44056170|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44056171|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44056172|NCT00004825|Insulin|insulin|mesh-list
44056173|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44056174|NCT00004825|Mitogens|mitogens|mesh-list
44056175|NCT00004825|Mecasermin|mecasermin|mesh-list
44056176|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44056177|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056178|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056190|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44056191|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
44056192|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
44056193|NCT00004829|Tobramycin|tobramycin|mesh-list
44056194|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44056195|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056196|NCT00004832|Amifampridine|amifampridine|mesh-list
44056197|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44056198|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056199|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056200|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44056201|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44056202|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056203|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
44056204|NCT00004833|Antibodies|antibodies|mesh-list
44056205|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
44056206|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44056207|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44254567|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254568|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
44254569|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44254570|NCT00255216|Policosanol|policosanol|mesh-list
44254571|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44254572|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44254573|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
44254574|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254575|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44254576|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254577|NCT00248703|Docetaxel|docetaxel|mesh-list
44254578|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254579|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254580|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091652|NCT00032929|Selegiline|selegiline|mesh-list
44254581|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254582|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254583|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44254584|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
44254585|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
44254586|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254587|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254588|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44254589|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44254590|NCT00195091|Growth Substances|growth substances|mesh-ancestor
44254591|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254592|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
44254593|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056208|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
44056209|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056210|NCT00004834|Imipramine|imipramine|mesh-list
44056211|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44056212|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
44056213|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44056214|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44056215|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44056216|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44056217|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056218|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44056219|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44056220|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056221|NCT00004838|Succimer|succimer|mesh-list
44254600|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
44254601|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254602|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44254603|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44254604|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254605|NCT00611169|Tirofiban|tirofiban|mesh-list
44254606|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44254607|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44056222|NCT00004838|Antidotes|antidotes|mesh-ancestor
44056223|NCT00004838|Protective Agents|protective agents|mesh-ancestor
44056224|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056225|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
44056226|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
44056227|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056228|NCT00004840|Hormones|hormones|mesh-list
44056229|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
44056230|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056231|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056232|NCT00004842|Budesonide|budesonide|mesh-list
44056233|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44056234|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44056235|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
44056236|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056237|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056238|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44056239|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
44056240|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
44056241|NCT00004842|Hormones|hormones|mesh-ancestor
44056250|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056251|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44056252|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056253|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
44056254|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44056255|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056256|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056259|NCT00004852|Zidovudine|zidovudine|mesh-list
44056260|NCT00004852|Efavirenz|efavirenz|mesh-list
44056261|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44056262|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056263|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056264|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056265|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
44056266|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056267|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44056268|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44056269|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
44056270|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44056271|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44056272|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44056273|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44056274|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44056275|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44056276|NCT00004853|Lenograstim|lenograstim|mesh-list
44056277|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056278|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
44254608|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254609|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254610|NCT00611195|Remifentanil|remifentanil|mesh-list
44254612|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44254613|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254614|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254615|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44254616|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
44254617|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
44254618|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652250|NCT03000660|Hormones|hormones|mesh-ancestor
44056279|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056280|NCT00004854|Carvedilol|carvedilol|mesh-list
44056281|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44056282|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44056283|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
44056284|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44056285|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056286|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056287|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44056288|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
44056289|NCT00004854|Protective Agents|protective agents|mesh-ancestor
44056290|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44056291|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44056292|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056293|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
44056294|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44056295|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44056296|NCT00004855|Ritonavir|ritonavir|mesh-list
44056297|NCT00004855|Lopinavir|lopinavir|mesh-list
44056298|NCT00004855|Lamivudine|lamivudine|mesh-list
44056299|NCT00004855|Nevirapine|nevirapine|mesh-list
44056300|NCT00004855|Abacavir|abacavir|mesh-list
44056301|NCT00004855|Stavudine|stavudine|mesh-list
44056302|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44056303|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44056304|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44056305|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056306|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056307|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44056308|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44056318|NCT00004856|Trastuzumab|trastuzumab|mesh-list
44056319|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056320|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056321|NCT00004857|Fludarabine|fludarabine|mesh-list
44056322|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
44056323|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
44091774|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
44056324|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056325|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056326|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
44056327|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056328|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056329|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
44056330|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056331|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056332|NCT00004858|Genistein|genistein|mesh-list
44056333|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
44056334|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44056335|NCT00004858|Protective Agents|protective agents|mesh-ancestor
44056336|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056337|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056338|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44056339|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254619|NCT00611195|Narcotics|narcotics|mesh-ancestor
44254620|NCT00611195|Analgesics|analgesics|mesh-ancestor
44254621|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
44254622|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461313|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461314|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461315|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461316|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461317|NCT01549002|Fentanyl|fentanyl|mesh-list
44056340|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056341|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
44056342|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44056343|NCT00004858|Estrogens|estrogens|mesh-ancestor
44056344|NCT00004858|Hormones|hormones|mesh-ancestor
44056345|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056346|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
44056347|NCT00004860|Leucovorin|leucovorin|mesh-list
44056348|NCT00004860|Tegafur|tegafur|mesh-list
44056349|NCT00004860|Calcium|calcium|mesh-list
44056350|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
44056351|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056352|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056353|NCT00004860|Antidotes|antidotes|mesh-ancestor
44056354|NCT00004860|Protective Agents|protective agents|mesh-ancestor
44056355|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
44056356|NCT00004860|Vitamins|vitamins|mesh-ancestor
44056357|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
44056358|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056359|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
44056360|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056361|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056362|NCT00004861|Gemcitabine|gemcitabine|mesh-list
44056363|NCT00004861|Tacedinaline|tacedinaline|mesh-list
44056364|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056365|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
44056366|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056367|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056368|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
44056369|NCT00004861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056370|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056371|NCT00004861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056372|NCT00004861|Immunologic Factors|immunologic factors|mesh-ancestor
44056373|NCT00004861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056374|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44056376|NCT00004862|Fludarabine|fludarabine|mesh-list
44056377|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
44056378|NCT00004862|Oblimersen|oblimersen|mesh-list
44056379|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056380|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056381|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
44056382|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056383|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056384|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
44056385|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056386|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
44056387|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056388|NCT00004863|Paclitaxel|paclitaxel|mesh-list
44056389|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056390|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056391|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056392|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056393|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056394|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056395|NCT00004864|Docetaxel|docetaxel|mesh-list
44056396|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056397|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056398|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056399|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44461318|NCT01549002|Morphine|morphine|mesh-list
44461319|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44461320|NCT01549002|Narcotics|narcotics|mesh-ancestor
44461321|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461322|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461323|NCT01549002|Analgesics|analgesics|mesh-ancestor
44461324|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
44461325|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461326|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44461327|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44056400|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056401|NCT00004865|Paclitaxel|paclitaxel|mesh-list
44056402|NCT00004865|Cisplatin|cisplatin|mesh-list
44056403|NCT00004865|Fluorouracil|fluorouracil|mesh-list
44056404|NCT00004865|Cetuximab|cetuximab|mesh-list
43780951|NCT01828697|Nadroparin|nadroparin|mesh-list
44056405|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056406|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056407|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056408|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056409|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056410|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056411|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
44056412|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056413|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056414|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
44056415|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056416|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056417|NCT00004866|Exatecan|exatecan|mesh-list
44056418|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056419|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056420|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056421|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056422|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056423|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44056424|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44056425|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056426|NCT00004868|Semaxinib|semaxinib|mesh-list
44056427|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44056428|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44056429|NCT00004868|Growth Substances|growth substances|mesh-ancestor
44056430|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056431|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
44056432|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056433|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44056434|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056435|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056436|NCT00004870|Irinotecan|irinotecan|mesh-list
44056437|NCT00004870|Oblimersen|oblimersen|mesh-list
44056438|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056439|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056440|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056441|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056442|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056444|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44056445|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056446|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
44056447|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553319|NCT03586934|Acetaminophen|acetaminophen|mesh-list
44056456|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44056457|NCT00004873|Cisplatin|cisplatin|mesh-list
44056458|NCT00004873|Docetaxel|docetaxel|mesh-list
44056459|NCT00004873|Fluorouracil|fluorouracil|mesh-list
44056460|NCT00004873|Epirubicin|epirubicin|mesh-list
44056461|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056462|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
44461329|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
44461330|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44461331|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
44461332|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461333|NCT01548638|Galantamine|galantamine|mesh-list
44461334|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44461335|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461336|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461337|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461338|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461339|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461340|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44461341|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
44461342|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056463|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056464|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056465|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056466|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
44056467|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056468|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056469|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
44056470|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056471|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056472|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056473|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056474|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056475|NCT00004874|Iodine|iodine|mesh-list
44056476|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
44056477|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44056478|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056479|NCT00004874|Trace Elements|trace elements|mesh-ancestor
44056480|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
44056481|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056482|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056483|NCT00004875|Heparin|heparin|mesh-list
44056485|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
44056486|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44056487|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44056488|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056489|NCT00004876|Thalidomide|thalidomide|mesh-list
44056490|NCT00004876|Carboplatin|carboplatin|mesh-list
44056491|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056492|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056493|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
44056494|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056495|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
44056496|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44056497|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056498|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44056499|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44056500|NCT00004876|Growth Substances|growth substances|mesh-ancestor
44056501|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
44056502|NCT00004878|Cytarabine|cytarabine|mesh-list
44056503|NCT00004878|Methotrexate|methotrexate|mesh-list
44056504|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
44056505|NCT00004878|Fludarabine|fludarabine|mesh-list
44056506|NCT00004878|Idarubicin|idarubicin|mesh-list
44056507|NCT00004878|Tacrolimus|tacrolimus|mesh-list
44056508|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44056509|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
44461343|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
44461344|NCT01548573|Thalidomide|thalidomide|mesh-list
44461345|NCT01548573|Dexamethasone|dexamethasone|mesh-list
44461346|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
44461347|NCT01548573|Melphalan|melphalan|mesh-list
44461348|NCT01548573|Doxorubicin|doxorubicin|mesh-list
44461349|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44461350|NCT01548573|Etoposide|etoposide|mesh-list
44461351|NCT01548573|Bortezomib|bortezomib|mesh-list
44461352|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
44461353|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461354|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
44461355|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652299|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
44056510|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44056511|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056512|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056513|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
44056514|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056515|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056516|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
44056517|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056518|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44056534|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056536|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056537|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056538|NCT00004884|Gemcitabine|gemcitabine|mesh-list
44056539|NCT00004884|Cisplatin|cisplatin|mesh-list
44056540|NCT00004884|Docetaxel|docetaxel|mesh-list
44056541|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056542|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056543|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
44056544|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056545|NCT00004884|Antiviral Agents|antiviral agents|mesh-ancestor
44056546|NCT00004884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056547|NCT00004884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056548|NCT00004884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056549|NCT00004884|Immunologic Factors|immunologic factors|mesh-ancestor
44056550|NCT00004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056551|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056552|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056553|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056554|NCT00004885|Leucovorin|leucovorin|mesh-list
44056555|NCT00004885|Fluorouracil|fluorouracil|mesh-list
44056556|NCT00004885|Irinotecan|irinotecan|mesh-list
44056557|NCT00004885|Calcium|calcium|mesh-list
44056558|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
44056559|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056560|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056561|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
44056562|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056563|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056564|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056565|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056567|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056568|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056569|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056570|NCT00004885|Antidotes|antidotes|mesh-ancestor
44056571|NCT00004885|Protective Agents|protective agents|mesh-ancestor
44056572|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
44056573|NCT00004885|Vitamins|vitamins|mesh-ancestor
44056574|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
44056575|NCT00004886|Docetaxel|docetaxel|mesh-list
44056576|NCT00004886|Dofequidar|dofequidar|mesh-list
44056577|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056578|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056579|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44461356|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461357|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461358|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
44461359|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461360|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461361|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44461362|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461363|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
44461364|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
44461365|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461366|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461367|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
44461368|NCT01548573|Hormones|hormones|mesh-ancestor
44461369|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461370|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461371|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44461372|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461373|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44461374|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461375|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44461376|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
44461377|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461378|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461379|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461380|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461381|NCT01548573|Growth Substances|growth substances|mesh-ancestor
44461382|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
44056580|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056581|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056593|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056594|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056595|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056596|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
44056597|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056598|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056599|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056600|NCT00004889|Rituximab|rituximab|mesh-list
44056601|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056602|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056603|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
44056604|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056605|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056606|NCT00004890|Aldesleukin|aldesleukin|mesh-list
44056607|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056608|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44461383|NCT01548417|Mifepristone|mifepristone|mesh-list
44461384|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44461385|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
44461386|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44254623|NCT00611286|Sirolimus|sirolimus|mesh-list
44254624|NCT00611286|Paclitaxel|paclitaxel|mesh-list
43773338|NCT02359643|Analgesics|analgesics|mesh-ancestor
44056609|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44056610|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
44056611|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150024|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44150025|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150026|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44150027|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44150028|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150029|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150030|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44150031|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150032|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150033|NCT00209625|Leucovorin|leucovorin|mesh-list
44150034|NCT00209625|Fluorouracil|fluorouracil|mesh-list
44150035|NCT00209625|Irinotecan|irinotecan|mesh-list
44150036|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
44150037|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150038|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150039|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150040|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150041|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
44150042|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150043|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44150044|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150045|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150046|NCT00209625|Antidotes|antidotes|mesh-ancestor
44150047|NCT00209625|Protective Agents|protective agents|mesh-ancestor
44150048|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
44150049|NCT00209625|Vitamins|vitamins|mesh-ancestor
44150050|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
44150051|NCT00209638|Irinotecan|irinotecan|mesh-list
44056612|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44056613|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44056614|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056615|NCT00004892|Carmustine|carmustine|mesh-list
44056616|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44056617|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056618|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
44056619|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056620|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056621|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056633|NCT00004900|Cisplatin|cisplatin|mesh-list
44056634|NCT00004900|Carboplatin|carboplatin|mesh-list
44056635|NCT00004900|Etoposide|etoposide|mesh-list
44056636|NCT00004900|Anastrozole|anastrozole|mesh-list
44056637|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056638|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
44056639|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056640|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056641|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056642|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
44056643|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056644|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056645|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056646|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056647|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056648|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056649|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056650|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44056651|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44056652|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44056653|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44056654|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701622|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
44254625|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44254627|NCT00611286|Clopidogrel|clopidogrel|mesh-list
44254628|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
44254629|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44254630|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254631|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254632|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254633|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254634|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254635|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254636|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
44254637|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254638|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44254639|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44254640|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44254641|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
44254642|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254643|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254644|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254645|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254646|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
44254647|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44254648|NCT00611416|Caffeine|caffeine|mesh-list
44254649|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44254650|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254651|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44254652|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254653|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652341|NCT02999815|Antibodies|antibodies|mesh-list
44056655|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056656|NCT00004901|Fluorouracil|fluorouracil|mesh-list
44056657|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
44056658|NCT00004901|Eniluracil|eniluracil|mesh-list
44056659|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
44056660|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056661|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056662|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056663|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056664|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
44056665|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056666|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
44254654|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44254655|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44254656|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
44254657|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254658|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
44254659|NCT00611416|Protective Agents|protective agents|mesh-ancestor
44254660|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44254661|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44254662|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254663|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44254664|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
44254665|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254666|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254667|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44254668|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
44254669|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254670|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254671|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254672|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254673|NCT00611507|Fluorouracil|fluorouracil|mesh-list
44254674|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
44254675|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
44056667|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056668|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056669|NCT00004903|Interferons|interferons|mesh-list
44056670|NCT00004903|Cytarabine|cytarabine|mesh-list
44056671|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
44056672|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
44056673|NCT00004903|Melphalan|melphalan|mesh-list
44056674|NCT00004903|Cisplatin|cisplatin|mesh-list
44056675|NCT00004903|Etoposide|etoposide|mesh-list
44056676|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056677|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
44056678|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056679|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056680|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056681|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
44056682|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056683|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056684|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056685|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056686|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056687|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056689|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
44056690|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056691|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056692|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
44056693|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
44056694|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
44056695|NCT00004904|Etoposide|etoposide|mesh-list
44056696|NCT00004904|Cladribine|cladribine|mesh-list
44056697|NCT00004904|Tacrolimus|tacrolimus|mesh-list
44056698|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44056699|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056700|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
43781465|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
44254676|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254677|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254678|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254679|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254680|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
44056701|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056702|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056703|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056704|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
44056705|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056706|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056707|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056708|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056709|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056710|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056711|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056712|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44056713|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44056714|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
44056715|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
44056716|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056717|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056718|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
44056719|NCT00004904|Hormones|hormones|mesh-ancestor
44056720|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056721|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44056722|NCT00004904|Protective Agents|protective agents|mesh-ancestor
44056723|NCT00004905|Interferons|interferons|mesh-list
44056724|NCT00004905|Cytarabine|cytarabine|mesh-list
44056725|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
44056726|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
44056727|NCT00004905|Etoposide|etoposide|mesh-list
44056728|NCT00004905|Idarubicin|idarubicin|mesh-list
44056729|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056730|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
44056731|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056732|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056733|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056734|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
44056735|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056736|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056737|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056738|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056739|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056740|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056741|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056742|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
44056743|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056744|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056745|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
44056746|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056747|NCT00004906|Pamidronate|pamidronate|mesh-list
44056748|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
44056749|NCT00004906|Thiotepa|thiotepa|mesh-list
44056750|NCT00004906|Carboplatin|carboplatin|mesh-list
44056751|NCT00004906|Docetaxel|docetaxel|mesh-list
44056752|NCT00004906|Doxorubicin|doxorubicin|mesh-list
44056753|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44056754|NCT00004906|Etoposide|etoposide|mesh-list
44056755|NCT00004906|Anastrozole|anastrozole|mesh-list
44056756|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056757|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
44056758|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056759|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056760|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056761|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
44056762|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056763|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056764|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056766|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254681|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254682|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44254683|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
44254684|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254685|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44254686|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
44254687|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254688|NCT00611650|Protective Agents|protective agents|mesh-ancestor
44254689|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254690|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43652381|NCT02998918|Curcumin|curcumin|mesh-list
44056767|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056768|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056769|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056770|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056771|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056772|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056773|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44056774|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44056775|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44056776|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44056777|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
44056778|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056779|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44056780|NCT00004913|Leucovorin|leucovorin|mesh-list
44056781|NCT00004913|Cisplatin|cisplatin|mesh-list
44056782|NCT00004913|Docetaxel|docetaxel|mesh-list
44056783|NCT00004913|Fluorouracil|fluorouracil|mesh-list
44056784|NCT00004913|Calcium|calcium|mesh-list
44056785|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
44056786|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056787|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056788|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056789|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056790|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056791|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056792|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056793|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
44056794|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056795|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056796|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
44056797|NCT00004913|Antidotes|antidotes|mesh-ancestor
44056798|NCT00004913|Protective Agents|protective agents|mesh-ancestor
44056799|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
44056800|NCT00004913|Vitamins|vitamins|mesh-ancestor
44056801|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
44056802|NCT00004917|Cisplatin|cisplatin|mesh-list
44056803|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
44056804|NCT00004917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056805|NCT00004917|Hematinics|hematinics|mesh-ancestor
44056806|NCT00004918|Sargramostim|sargramostim|mesh-list
44056807|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44056808|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
44056809|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056810|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056811|NCT00004919|Cisplatin|cisplatin|mesh-list
44056812|NCT00004919|Irinotecan|irinotecan|mesh-list
44056813|NCT00004919|Amifostine|amifostine|mesh-list
44056814|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056815|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056816|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056817|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056818|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056819|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44056820|NCT00004919|Protective Agents|protective agents|mesh-ancestor
44254691|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44254692|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254693|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44254694|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44254695|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
44254696|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254697|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44254698|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44254699|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44254700|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254701|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254702|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254703|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254704|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44254705|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
44254706|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44254707|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
44254708|NCT00611689|Vatalanib|vatalanib|mesh-list
44254709|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254710|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44254711|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254712|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254713|NCT00611728|Irinotecan|irinotecan|mesh-list
44254714|NCT00611728|Sunitinib|sunitinib|mesh-list
44254715|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44254716|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44254717|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652393|NCT02998606|Naloxegol|naloxegol|mesh-list
44056821|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056822|NCT00004920|Cisplatin|cisplatin|mesh-list
44056823|NCT00004920|Raltitrexed|raltitrexed|mesh-list
44056824|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056825|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056826|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
44056827|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056828|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44056829|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056830|NCT00004921|Paclitaxel|paclitaxel|mesh-list
44056831|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
44056832|NCT00004921|Carboplatin|carboplatin|mesh-list
44056833|NCT00004921|Melphalan|melphalan|mesh-list
44056834|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056835|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056836|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056837|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254718|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254719|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254720|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44254721|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44254722|NCT00611728|Growth Substances|growth substances|mesh-ancestor
44254723|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254724|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
44254725|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44254726|NCT00611741|Furosemide|furosemide|mesh-list
44254727|NCT00611741|Diuretics|diuretics|mesh-ancestor
44254728|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
44254729|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254730|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44254731|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44254732|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254733|NCT00611754|Fluorouracil|fluorouracil|mesh-list
44254734|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
44254735|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
44254736|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254737|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254738|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254739|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056838|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056839|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056840|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056841|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
43553724|NCT03578354|Atenolol|atenolol|mesh-list
44056844|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44056845|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
44056846|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44056848|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056849|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056850|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056851|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056852|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056853|NCT00004923|Docetaxel|docetaxel|mesh-list
44056854|NCT00004923|Irinotecan|irinotecan|mesh-list
44056855|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056856|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056857|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056858|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056859|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056860|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056861|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056862|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056863|NCT00004924|Paclitaxel|paclitaxel|mesh-list
44056864|NCT00004924|Irinotecan|irinotecan|mesh-list
44056865|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056866|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056867|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254740|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
44254741|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254742|NCT00611793|Bevacizumab|bevacizumab|mesh-list
44254743|NCT00611793|Vatalanib|vatalanib|mesh-list
44254744|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254745|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254746|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44254747|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44254748|NCT00611793|Growth Substances|growth substances|mesh-ancestor
44254749|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254750|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
44254751|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44254752|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254753|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254754|NCT00611819|Interferons|interferons|mesh-list
44254755|NCT00611819|Ribavirin|ribavirin|mesh-list
44254756|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44254757|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
44254758|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254759|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
44254760|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254761|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
44254762|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254763|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
44254764|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254765|NCT00611845|Aprotinin|aprotinin|mesh-list
44254766|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
44254767|NCT00611845|Coagulants|coagulants|mesh-ancestor
44254768|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44254769|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44254770|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44254771|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254772|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254773|NCT00611871|Propranolol|propranolol|mesh-list
44056868|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056869|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056870|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056871|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056872|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056873|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056874|NCT00004925|Doxorubicin|doxorubicin|mesh-list
44056875|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44254774|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44254775|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44254776|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44254777|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254778|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254779|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254780|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44254781|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44254782|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44254783|NCT00611910|Sirolimus|sirolimus|mesh-list
44254784|NCT00611910|Paclitaxel|paclitaxel|mesh-list
44254785|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44254786|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254787|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254788|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254789|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254790|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254791|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254792|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254793|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254794|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
44254795|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254796|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
44254797|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254798|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44254799|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44254800|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44254801|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43824686|NCT05509244|Acetaminophen|acetaminophen|mesh-list
44056876|NCT00004925|Trastuzumab|trastuzumab|mesh-list
44056877|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056878|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056879|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056880|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056881|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056882|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056883|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056884|NCT00004926|Vitamin D|vitamin d|mesh-list
44056885|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
44056886|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
44056887|NCT00004926|Vitamins|vitamins|mesh-ancestor
44056888|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
44056889|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056890|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44254802|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254804|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254805|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254806|NCT00611962|Paclitaxel|paclitaxel|mesh-list
44254807|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
44254808|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44254809|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254810|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
44254811|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
44254812|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
44254813|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254814|NCT00612079|Sertindole|sertindole|mesh-list
44254815|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44254816|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44254817|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254818|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254819|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44254820|NCT00612144|Metformin|metformin|mesh-list
44254821|NCT00612144|Glimepiride|glimepiride|mesh-list
44254822|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44254823|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254824|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44254825|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254826|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
44254827|NCT00612157|Eszopiclone|eszopiclone|mesh-list
44254828|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44056891|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056892|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056893|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
44056894|NCT00004928|Calcitriol|calcitriol|mesh-list
44056895|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44056896|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056897|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056898|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44056899|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44056900|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056901|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44056902|NCT00004928|Vitamins|vitamins|mesh-ancestor
44056903|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
44056904|NCT00004930|Doxorubicin|doxorubicin|mesh-list
44056905|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44056906|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056907|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056908|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056909|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056910|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781466|NCT04726098|BB 1101|bb 1101|mesh-list
44254829|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254830|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254831|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44254832|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254833|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
44254834|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254835|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254836|NCT00612261|Triamcinolone|triamcinolone|mesh-list
44254837|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44254838|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44254839|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44254840|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44254841|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
44254842|NCT00612261|Hormones|hormones|mesh-ancestor
44254843|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254844|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652488|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44056911|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056912|NCT00004931|Leucovorin|leucovorin|mesh-list
44056913|NCT00004931|Fluorouracil|fluorouracil|mesh-list
44056914|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
44056915|NCT00004931|Calcium|calcium|mesh-list
44056916|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
44056919|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
44056920|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056921|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44056922|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056923|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056924|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
44056925|NCT00004931|Antidotes|antidotes|mesh-ancestor
44056926|NCT00004931|Protective Agents|protective agents|mesh-ancestor
44056927|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
44056928|NCT00004931|Vitamins|vitamins|mesh-ancestor
44056929|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
44056930|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
44056931|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056932|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44056933|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056934|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056935|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
44056936|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
44056937|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056938|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
44056939|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056940|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063463|NCT00006050|Fluorouracil|fluorouracil|mesh-list
44056941|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056942|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056943|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44056944|NCT00004934|Paclitaxel|paclitaxel|mesh-list
44056945|NCT00004934|Carboplatin|carboplatin|mesh-list
44056946|NCT00004934|Epirubicin|epirubicin|mesh-list
44056947|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056948|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056949|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056950|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056951|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056952|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254845|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254846|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
44254847|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254848|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254850|NCT00612274|Methotrexate|methotrexate|mesh-list
44254851|NCT00612274|Tacrolimus|tacrolimus|mesh-list
44254852|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44254853|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
44254854|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44254855|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254856|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254857|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
44254858|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254859|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254860|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44254861|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254862|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44254863|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254864|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
44254865|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254866|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44254867|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44254868|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254869|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254870|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44254871|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
44254872|NCT00612287|Buprenorphine|buprenorphine|mesh-list
44254894|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44254895|NCT00612495|Fluorouracil|fluorouracil|mesh-list
44254896|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
44254897|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
44254898|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254899|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254900|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254901|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254902|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
44254903|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254904|NCT00612521|Adenosine|adenosine|mesh-list
44254905|NCT00612521|Analgesics|analgesics|mesh-ancestor
44254906|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
44254907|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254908|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254909|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44056953|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056954|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056955|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056956|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056957|NCT00004938|Fluconazole|fluconazole|mesh-list
44056958|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
44056959|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056960|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44056961|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44056962|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056963|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056964|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44056965|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
44056966|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056967|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056968|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44056969|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44056970|NCT00004941|Infliximab|infliximab|mesh-list
44056971|NCT00004941|Antibodies|antibodies|mesh-list
44056972|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44056973|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
44056974|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056975|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44056976|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056977|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056978|NCT00004979|Paclitaxel|paclitaxel|mesh-list
44056979|NCT00004979|Topotecan|topotecan|mesh-list
44056980|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056981|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056982|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056983|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056984|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44056985|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056986|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44056990|NCT00004981|Zidovudine|zidovudine|mesh-list
44056991|NCT00004981|Abacavir|abacavir|mesh-list
44056992|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
44056993|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44056994|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44056995|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056996|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056997|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254910|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
44254911|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44254912|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
44254913|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
44254914|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44254915|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254916|NCT00612547|Artesunate|artesunate|mesh-list
44254917|NCT00612547|Amodiaquine|amodiaquine|mesh-list
44254918|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
44254919|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44254920|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44254921|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254922|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254923|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
44254924|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
44254925|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44254926|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
44254927|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
44254928|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
44254929|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44254930|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254931|NCT00612612|Rituximab|rituximab|mesh-list
44254932|NCT00612612|Fludarabine|fludarabine|mesh-list
43652570|NCT02990468|Cisplatin|cisplatin|mesh-list
44056998|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
44056999|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057000|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057001|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057002|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
44057003|NCT00004984|Insulin|insulin|mesh-list
44057004|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44057005|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44057006|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057007|NCT00004985|Nelfinavir|nelfinavir|mesh-list
44057008|NCT00004985|Capravirine|capravirine|mesh-list
44057009|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057010|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057011|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057012|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057013|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057014|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057015|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057016|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
44057017|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057018|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057019|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057020|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
44057021|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44057022|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057023|NCT00004990|Dexamethasone|dexamethasone|mesh-list
44057024|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44057025|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
44057026|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
44057027|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057028|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057029|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254933|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
44254934|NCT00612612|Obatoclax|obatoclax|mesh-list
44254935|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44254936|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254937|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
44254938|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254939|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44254940|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44254941|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
43652589|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057030|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
44057031|NCT00004990|Hormones|hormones|mesh-ancestor
44057032|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057033|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44057034|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057035|NCT00004992|Metformin|metformin|mesh-list
44057036|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44057037|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057038|NCT00004993|Hormones|hormones|mesh-list
44057039|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
44057040|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057041|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057042|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057043|NCT00004997|Leucovorin|leucovorin|mesh-list
44057044|NCT00004997|Antidotes|antidotes|mesh-ancestor
44057045|NCT00004997|Protective Agents|protective agents|mesh-ancestor
44057046|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057047|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
44057048|NCT00004997|Vitamins|vitamins|mesh-ancestor
44057049|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
44057050|NCT00004998|Lamivudine|lamivudine|mesh-list
44057051|NCT00004998|Zidovudine|zidovudine|mesh-list
44057052|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44057053|NCT00004998|Capravirine|capravirine|mesh-list
44057054|NCT00004998|Nelfinavir|nelfinavir|mesh-list
44057055|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44063464|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
44057056|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057057|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057058|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057059|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
44057060|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057061|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057074|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057075|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057076|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
44057077|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057078|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057079|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057080|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
44057081|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057082|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057083|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057084|NCT00005000|Lamivudine|lamivudine|mesh-list
44057085|NCT00005000|Zidovudine|zidovudine|mesh-list
44057086|NCT00005000|Efavirenz|efavirenz|mesh-list
44057087|NCT00005000|Didanosine|didanosine|mesh-list
44057088|NCT00005000|Stavudine|stavudine|mesh-list
44057089|NCT00005000|Nelfinavir|nelfinavir|mesh-list
44057090|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44057091|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057092|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057093|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057094|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057095|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
44057096|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057097|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057098|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44254942|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254943|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44254944|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254945|NCT00612625|Glucagon|glucagon|mesh-list
44254946|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44254947|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44254948|NCT00612625|Hormones|hormones|mesh-ancestor
44254949|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254950|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254951|NCT00612625|Incretins|incretins|mesh-ancestor
44254952|NCT00612638|Irinotecan|irinotecan|mesh-list
44254953|NCT00612638|Temozolomide|temozolomide|mesh-list
44254954|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44254955|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44254956|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44254957|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254958|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254959|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254960|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254961|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
44254962|NCT00612651|Temozolomide|temozolomide|mesh-list
44254963|NCT00612651|Lonafarnib|lonafarnib|mesh-list
44254964|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44254965|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
44254966|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254967|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44254968|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254969|NCT00612755|Ribavirin|ribavirin|mesh-list
44254970|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44254988|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44254989|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254990|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
44254991|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254992|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44254993|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44254994|NCT00612950|Glucagon|glucagon|mesh-list
44254995|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44254996|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44254997|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43908942|NCT00314106|Aldesleukin|aldesleukin|mesh-list
44254998|NCT00612950|Hormones|hormones|mesh-ancestor
44254999|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255000|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255002|NCT00612989|Temozolomide|temozolomide|mesh-list
44255003|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44255004|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255005|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
44255006|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255007|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255008|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255009|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
44255010|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
44255011|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255012|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255013|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255014|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255015|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
44255016|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057099|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
44057100|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44057101|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44057102|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44057103|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44057104|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44057105|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44057106|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057107|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057108|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057109|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44057110|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
44057111|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057112|NCT00005002|Lamivudine|lamivudine|mesh-list
44057113|NCT00005002|Zidovudine|zidovudine|mesh-list
44255017|NCT00613067|Citalopram|citalopram|mesh-list
44255018|NCT00613067|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44255019|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43652663|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44057114|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44057115|NCT00005002|Nelfinavir|nelfinavir|mesh-list
44057116|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057117|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057118|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057119|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057120|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
44057121|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057122|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057123|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057124|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
44057125|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43554022|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
44057139|NCT00005007|Etanercept|etanercept|mesh-list
44057140|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44057141|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44057142|NCT00005007|Analgesics|analgesics|mesh-ancestor
44057143|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
44057144|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057145|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057146|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44057147|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057148|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44057149|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057150|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
44057151|NCT00005009|Vaccines|vaccines|mesh-list
44057152|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
44057153|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057154|NCT00005010|Irbesartan|irbesartan|mesh-list
44057155|NCT00005010|Pravastatin|pravastatin|mesh-list
44057156|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44057157|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44057158|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
44057159|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057160|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44057161|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44057162|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057163|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44057164|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44057165|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44057166|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44057167|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
44057168|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057169|NCT00005013|Sertraline|sertraline|mesh-list
44057170|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
44057171|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44057172|NCT00005013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44057173|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44057174|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44057175|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057176|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057177|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
44057178|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057179|NCT00005014|Risperidone|risperidone|mesh-list
44057180|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44057181|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
44057183|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057184|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057185|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44057186|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44057191|NCT00005015|Fluoxetine|fluoxetine|mesh-list
44057192|NCT00005015|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44057193|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44057194|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44057195|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057196|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255020|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255021|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255022|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255023|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
44255024|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255025|NCT00613067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44255026|NCT00613067|Antidepressive Agents|antidepressive agents|mesh-ancestor
44255027|NCT00613067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255028|NCT00613093|Temozolomide|temozolomide|mesh-list
44255029|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44255030|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255031|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
44255032|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255033|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255034|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255035|NCT00613132|Everolimus|everolimus|mesh-list
44255036|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
44255037|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
44057197|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
44057198|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057199|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44057200|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
44057201|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44057202|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44057203|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44057204|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057205|NCT00005017|Ritonavir|ritonavir|mesh-list
44057206|NCT00005017|Amprenavir|amprenavir|mesh-list
44057207|NCT00005017|Lamivudine|lamivudine|mesh-list
44057208|NCT00005017|Abacavir|abacavir|mesh-list
44057209|NCT00005017|Stavudine|stavudine|mesh-list
44057210|NCT00005017|Efavirenz|efavirenz|mesh-list
44057211|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057212|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057213|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057214|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057215|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057216|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057217|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43781494|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
44057218|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
44057219|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057220|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44057221|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44057222|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057223|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057224|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44057225|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44057226|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44057227|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44057228|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44057229|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
44057230|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44057231|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
44057232|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44057233|NCT00005018|Efavirenz|efavirenz|mesh-list
44255038|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255039|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255040|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
44255041|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255042|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255043|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057234|NCT00005018|Abacavir|abacavir|mesh-list
44057235|NCT00005018|Didanosine|didanosine|mesh-list
44057236|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
44057237|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057238|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057239|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057240|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057241|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
44057242|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057243|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44057244|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44057245|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44057246|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44057247|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44057248|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44057249|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057250|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
44057251|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057252|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057253|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
44057255|NCT00005021|Carboplatin|carboplatin|mesh-list
44057256|NCT00005021|Topotecan|topotecan|mesh-list
43554144|NCT03574649|Paclitaxel|paclitaxel|mesh-list
44057260|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057261|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057262|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057263|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057264|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057265|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057266|NCT00005022|Cisplatin|cisplatin|mesh-list
44057267|NCT00005022|Etoposide|etoposide|mesh-list
44057268|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057269|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057270|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44057271|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057272|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057273|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057274|NCT00005023|Sargramostim|sargramostim|mesh-list
44057275|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
44057276|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057277|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
44057278|NCT00005024|Carboplatin|carboplatin|mesh-list
44057279|NCT00005024|Doxorubicin|doxorubicin|mesh-list
44057280|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44057281|NCT00005024|Granisetron|granisetron|mesh-list
44057282|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057283|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
44057284|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057285|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057286|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057287|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
44057288|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057289|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057290|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057291|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057292|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44057293|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057294|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057296|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
44057297|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057298|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44057299|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44057300|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
44255044|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255045|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
44255046|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255048|NCT00613145|Sorafenib|sorafenib|mesh-list
44057301|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057302|NCT00005025|Ganciclovir|ganciclovir|mesh-list
44057303|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44057304|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
44057305|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057306|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057307|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057308|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057309|NCT00005026|Paclitaxel|paclitaxel|mesh-list
44057310|NCT00005026|Carboplatin|carboplatin|mesh-list
44057311|NCT00005026|Topotecan|topotecan|mesh-list
44057312|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057313|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057314|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057315|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057316|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057317|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057318|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057319|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057320|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057321|NCT00005028|Paclitaxel|paclitaxel|mesh-list
44057322|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
44057323|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057324|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057325|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057326|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057327|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057328|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057329|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44057335|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057336|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057337|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057339|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057340|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057341|NCT00005031|Irofulven|irofulven|mesh-list
44057342|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057343|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
44057344|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057345|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057346|NCT00005032|Paclitaxel|paclitaxel|mesh-list
44057347|NCT00005032|Oblimersen|oblimersen|mesh-list
44057348|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057349|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057350|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057351|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057352|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057353|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057354|NCT00005033|Trastuzumab|trastuzumab|mesh-list
44057355|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44057356|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057357|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
44057358|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057359|NCT00005036|Leucovorin|leucovorin|mesh-list
44057360|NCT00005036|Fluorouracil|fluorouracil|mesh-list
44057361|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
44057362|NCT00005036|Irinotecan|irinotecan|mesh-list
44057363|NCT00005036|Calcium|calcium|mesh-list
44057364|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
44057365|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057366|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057367|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
44057368|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057369|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43781748|NCT02864004|Emetics|emetics|mesh-ancestor
44255049|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255050|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
44255051|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255052|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255053|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255054|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255055|NCT00613223|Etoposide|etoposide|mesh-list
44255056|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
44255057|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255058|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255059|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255060|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255061|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057370|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057371|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057372|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
44057373|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057374|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057375|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057376|NCT00005036|Antidotes|antidotes|mesh-ancestor
44057377|NCT00005036|Protective Agents|protective agents|mesh-ancestor
44057378|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
44057379|NCT00005036|Vitamins|vitamins|mesh-ancestor
44057380|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
44057381|NCT00005037|Temozolomide|temozolomide|mesh-list
44057382|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057383|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
44057384|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057385|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057386|NCT00005038|Aldesleukin|aldesleukin|mesh-list
44057387|NCT00005038|Histamine|histamine|mesh-list
44057388|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
44057389|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057390|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057391|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057392|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
44057393|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057394|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
44057395|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
44057396|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057397|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057398|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057399|NCT00005039|Vaccines|vaccines|mesh-list
44057400|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
44057401|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057402|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
44057405|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057406|NCT00005042|Semaxinib|semaxinib|mesh-list
44057407|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44057408|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44057409|NCT00005042|Growth Substances|growth substances|mesh-ancestor
44057410|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057411|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
44057412|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057413|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44057414|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057415|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057416|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44057417|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057418|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44057419|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44057420|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255062|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255063|NCT00613249|Dapivirine|dapivirine|mesh-list
44255064|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255065|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255066|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
44255067|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461387|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461388|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44461389|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44461390|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44255068|NCT00613288|Testosterone|testosterone|mesh-list
44255069|NCT00613288|Androgens|androgens|mesh-ancestor
43824743|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057421|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057422|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057423|NCT00005046|Paclitaxel|paclitaxel|mesh-list
44057424|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057425|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057426|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057427|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057428|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057429|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057430|NCT00005048|Paclitaxel|paclitaxel|mesh-list
44057431|NCT00005048|Estramustine|estramustine|mesh-list
44057432|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057433|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057434|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057435|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057436|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057437|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057438|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057439|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
44057440|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44057441|NCT00005049|Cisplatin|cisplatin|mesh-list
44057442|NCT00005049|Carboplatin|carboplatin|mesh-list
44057443|NCT00005049|Floxuridine|floxuridine|mesh-list
44057444|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057445|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057446|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
44057447|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057448|NCT00005050|Fluorouracil|fluorouracil|mesh-list
44057449|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
44057450|NCT00005050|Eniluracil|eniluracil|mesh-list
44057451|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
44057452|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057453|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057454|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057455|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057456|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
44057457|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057458|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057459|NCT00005051|Paclitaxel|paclitaxel|mesh-list
44057460|NCT00005051|Cisplatin|cisplatin|mesh-list
44057461|NCT00005051|Carboplatin|carboplatin|mesh-list
44057462|NCT00005051|Topotecan|topotecan|mesh-list
44057463|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057464|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057465|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057466|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057467|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057468|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057469|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057470|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255071|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255072|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255073|NCT00613392|Antioxidants|antioxidants|mesh-list
44255074|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255075|NCT00613392|Protective Agents|protective agents|mesh-ancestor
43824757|NCT05508516|Analgesics|analgesics|mesh-ancestor
44057471|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150052|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44150053|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150054|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150055|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150056|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150057|NCT00209651|Irinotecan|irinotecan|mesh-list
44150058|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44150059|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150060|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150061|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150062|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150063|NCT00209664|Irinotecan|irinotecan|mesh-list
44150064|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44150065|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150066|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150067|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150068|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150069|NCT00209677|Gemcitabine|gemcitabine|mesh-list
44150070|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150071|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
44150072|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150073|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150074|NCT00209677|Antiviral Agents|antiviral agents|mesh-ancestor
44150075|NCT00209677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150076|NCT00209677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150077|NCT00209677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150078|NCT00209677|Immunologic Factors|immunologic factors|mesh-ancestor
44150079|NCT00209677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150080|NCT00209690|Cisplatin|cisplatin|mesh-list
44150081|NCT00209690|Docetaxel|docetaxel|mesh-list
44150082|NCT00209690|Fluorouracil|fluorouracil|mesh-list
44150083|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150084|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44150085|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44150086|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150087|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150088|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
44150089|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150090|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150091|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
44150092|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150093|NCT00209703|Leucovorin|leucovorin|mesh-list
44150094|NCT00209703|Fluorouracil|fluorouracil|mesh-list
44150095|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
44150096|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
44150097|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
44150098|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150099|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150100|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057473|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057474|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
44063465|NCT00006050|Calcium|calcium|mesh-list
44057475|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057476|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057477|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
44057478|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44057479|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
44057480|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057481|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057482|NCT00005057|Ganciclovir|ganciclovir|mesh-list
44057483|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44057484|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
44255076|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255078|NCT00613457|Dexamethasone|dexamethasone|mesh-list
44255079|NCT00613457|Prednisone|prednisone|mesh-list
44255080|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
44255081|NCT00613457|Ifosfamide|ifosfamide|mesh-list
44255082|NCT00613457|Doxorubicin|doxorubicin|mesh-list
44255083|NCT00613457|Methotrexate|methotrexate|mesh-list
44255084|NCT00613457|Etoposide|etoposide|mesh-list
44255085|NCT00613457|Vincristine|vincristine|mesh-list
44255086|NCT00613457|Daunorubicin|daunorubicin|mesh-list
44057485|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057486|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057487|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057488|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057489|NCT00005059|Paclitaxel|paclitaxel|mesh-list
44057490|NCT00005059|Carboplatin|carboplatin|mesh-list
44057491|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057492|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057493|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057494|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057495|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057496|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057497|NCT00005060|Cisplatin|cisplatin|mesh-list
44057498|NCT00005060|Docetaxel|docetaxel|mesh-list
44057499|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057500|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057501|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057502|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057503|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057505|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44057506|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057507|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44057508|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44057509|NCT00005061|Growth Substances|growth substances|mesh-ancestor
44057510|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057512|NCT00005064|Bortezomib|bortezomib|mesh-list
44057513|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057514|NCT00005065|Paclitaxel|paclitaxel|mesh-list
44057515|NCT00005065|Carboplatin|carboplatin|mesh-list
44057516|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
44057517|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057518|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057519|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057520|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057521|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057522|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057523|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44057524|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057525|NCT00005066|Carmustine|carmustine|mesh-list
44057526|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44057527|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057528|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
44057529|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057530|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057531|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057532|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
44057533|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44057534|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057535|NCT00005068|Leucovorin|leucovorin|mesh-list
44057536|NCT00005068|Fluorouracil|fluorouracil|mesh-list
44057537|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
44057538|NCT00005068|Irinotecan|irinotecan|mesh-list
44057539|NCT00005068|Calcium|calcium|mesh-list
44057540|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
44057541|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057542|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057543|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
44057544|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255087|NCT00613457|Asparaginase|asparaginase|mesh-list
44255088|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
44255089|NCT00613457|Thioguanine|thioguanine|mesh-list
44255091|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255092|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
44255093|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255094|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255095|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255096|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
44255097|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255098|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255099|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824768|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
44057545|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057546|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057547|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057548|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
44057549|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057550|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057551|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057552|NCT00005068|Antidotes|antidotes|mesh-ancestor
44057553|NCT00005068|Protective Agents|protective agents|mesh-ancestor
44057554|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
44057555|NCT00005068|Vitamins|vitamins|mesh-ancestor
44057556|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
44057557|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
44057558|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057559|NCT00005070|Irofulven|irofulven|mesh-list
44057560|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057561|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
44057562|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057563|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057564|NCT00005072|Interleukin-2|interleukin-2|mesh-list
44057565|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057566|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44057567|NCT00005072|Analgesics|analgesics|mesh-ancestor
44057568|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
44057569|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057570|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057571|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
44057572|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44057573|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057574|NCT00005074|Alvocidib|alvocidib|mesh-list
44057575|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057576|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
44057577|NCT00005074|Growth Substances|growth substances|mesh-ancestor
44057578|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057579|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44057580|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554511|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
44057589|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44057590|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
44057591|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057592|NCT00005078|Paclitaxel|paclitaxel|mesh-list
44057593|NCT00005078|Carboplatin|carboplatin|mesh-list
44057594|NCT00005078|Tirapazamine|tirapazamine|mesh-list
44057595|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057596|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057597|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057598|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057599|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063466|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
44057600|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255100|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255101|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
44255102|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
44255103|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255104|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255105|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
44255106|NCT00613457|Hormones|hormones|mesh-ancestor
44255107|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255108|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44255109|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44255110|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255111|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255112|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255113|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44255114|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
44255115|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44057601|NCT00005081|Carmustine|carmustine|mesh-list
44057602|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44057603|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057604|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
44057605|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057606|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057607|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057608|NCT00005086|Gemcitabine|gemcitabine|mesh-list
44057609|NCT00005086|Cisplatin|cisplatin|mesh-list
44057610|NCT00005086|Docetaxel|docetaxel|mesh-list
44057611|NCT00005086|Methotrexate|methotrexate|mesh-list
44057612|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057613|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057614|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
44057615|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057616|NCT00005086|Antiviral Agents|antiviral agents|mesh-ancestor
44057617|NCT00005086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057618|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057619|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057620|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
44057621|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057622|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057623|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057624|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057625|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44057626|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
44057627|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44057628|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057629|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44057630|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057631|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057632|NCT00005087|Paclitaxel|paclitaxel|mesh-list
44057633|NCT00005087|Cisplatin|cisplatin|mesh-list
44057634|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057635|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057636|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057637|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057638|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057639|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057640|NCT00005088|Cisplatin|cisplatin|mesh-list
44057641|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057642|NCT00005089|Prednisone|prednisone|mesh-list
44057643|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
44057644|NCT00005089|Rituximab|rituximab|mesh-list
44255116|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255117|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
44093519|NCT00037609|Analgesics|analgesics|mesh-ancestor
44255118|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44255119|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44255120|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255121|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255122|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
44255123|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255124|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44255125|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255126|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255127|NCT00613470|Citalopram|citalopram|mesh-list
44255128|NCT00613470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44255129|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44255130|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255131|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255132|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255133|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
44057645|NCT00005089|Doxorubicin|doxorubicin|mesh-list
44057646|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44057647|NCT00005089|Vincristine|vincristine|mesh-list
44057648|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057649|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
44057650|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057651|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057665|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057666|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44057667|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057668|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057669|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057670|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057671|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
44057672|NCT00005090|Dacarbazine|dacarbazine|mesh-list
44057673|NCT00005090|Carmustine|carmustine|mesh-list
44057674|NCT00005090|Doxorubicin|doxorubicin|mesh-list
44057675|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44057676|NCT00005090|Etoposide|etoposide|mesh-list
44057677|NCT00005090|Bleomycin|bleomycin|mesh-list
44057678|NCT00005090|Vinblastine|vinblastine|mesh-list
44057679|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057680|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
44057681|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057682|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057683|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057684|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
44057685|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057686|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057687|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057688|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057689|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44057690|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057691|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057692|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057693|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057694|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057695|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057696|NCT00005091|Exatecan|exatecan|mesh-list
44255134|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255135|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44255136|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
44255137|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255138|NCT00613496|Irbesartan|irbesartan|mesh-list
44255139|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44255140|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44057697|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057698|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057699|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057700|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781907|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
44057701|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057702|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
44057703|NCT00005092|Thiotepa|thiotepa|mesh-list
44057704|NCT00005092|Methoxsalen|methoxsalen|mesh-list
44057705|NCT00005092|Furocoumarins|furocoumarins|mesh-list
44057706|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057707|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
44057708|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057709|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057710|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057711|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
44057712|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057713|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057716|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057717|NCT00005093|Gemcitabine|gemcitabine|mesh-list
44057718|NCT00005093|Tacedinaline|tacedinaline|mesh-list
44057719|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057720|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
44057721|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057722|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057723|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
44057724|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057725|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057726|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057727|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
44057728|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057729|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44057730|NCT00005094|Celecoxib|celecoxib|mesh-list
44057731|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44057732|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44057733|NCT00005094|Analgesics|analgesics|mesh-ancestor
44057734|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
44057735|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057736|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057738|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057739|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44057740|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44057741|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057742|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057743|NCT00005096|Docetaxel|docetaxel|mesh-list
44057744|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057745|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057746|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057747|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057748|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057749|NCT00005104|Metformin|metformin|mesh-list
44057750|NCT00005104|Clomiphene|clomiphene|mesh-list
44057751|NCT00005104|Enclomiphene|enclomiphene|mesh-list
44057752|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
44057753|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44057754|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057755|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44057756|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
44057757|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057758|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44255141|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44255142|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909094|NCT00318812|Iron|iron|mesh-list
44255143|NCT00613561|Fludarabine|fludarabine|mesh-list
44255144|NCT00613561|Busulfan|busulfan|mesh-list
44255145|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43652720|NCT02988908|Donepezil|donepezil|mesh-list
44057759|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
44057760|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44057761|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44057762|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44057763|NCT00005106|Lamivudine|lamivudine|mesh-list
44057764|NCT00005106|Zidovudine|zidovudine|mesh-list
44057765|NCT00005106|Abacavir|abacavir|mesh-list
44057766|NCT00005106|Stavudine|stavudine|mesh-list
44057767|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44057768|NCT00005106|Nelfinavir|nelfinavir|mesh-list
44057769|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057770|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057771|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057772|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057773|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
44057774|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057775|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057776|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057777|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
44057778|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057779|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057780|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057781|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44057782|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057783|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057784|NCT00005108|Estradiol|estradiol|mesh-list
44057785|NCT00005108|Progesterone|progesterone|mesh-list
44057786|NCT00005108|Estrogens|estrogens|mesh-ancestor
44057787|NCT00005108|Hormones|hormones|mesh-ancestor
44057788|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057794|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
44057795|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057796|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057797|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44057798|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44057799|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44057800|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44057801|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44057802|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
44057803|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057804|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057805|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
44057806|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44057807|NCT00005113|Cyclosporine|cyclosporine|mesh-list
44057809|NCT00005113|Tacrolimus|tacrolimus|mesh-list
44057810|NCT00005113|Cyclosporins|cyclosporins|mesh-list
44057811|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057812|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
44057813|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057814|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44057815|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057816|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057817|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
44057818|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057819|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057820|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057821|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44057822|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057823|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057824|NCT00005117|Pravastatin|pravastatin|mesh-list
44057825|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44057826|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44057827|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
44255146|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255147|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255148|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255149|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
44255150|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652727|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
44057828|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057829|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44057830|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44057831|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057832|NCT00005118|Ritonavir|ritonavir|mesh-list
44057833|NCT00005118|Indinavir|indinavir|mesh-list
44057834|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057835|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057836|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057837|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057838|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057839|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057840|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057841|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
44057842|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057843|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44057844|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44057845|NCT00005119|Calcium|calcium|mesh-list
44057846|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057847|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057848|NCT00005120|Calanolide A|calanolide a|mesh-list
44057849|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057850|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057851|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
44057852|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057853|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44057854|NCT00005520|Candesartan|candesartan|mesh-list
44057855|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44057856|NCT00005520|Diuretics|diuretics|mesh-ancestor
44057857|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
44057858|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057859|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44057860|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44057861|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057862|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44057863|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44057864|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44057866|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
44057867|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057868|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057869|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057870|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057871|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057872|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
44057873|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057874|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44057875|NCT00005571|Eculizumab|eculizumab|mesh-list
44093751|NCT00038259|Aldesleukin|aldesleukin|mesh-list
44057876|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44057877|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057878|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
44057879|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057880|NCT00005574|Gentamicins|gentamicins|mesh-list
44057881|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44057882|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057883|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44057884|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057885|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057887|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44057888|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
44057889|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255151|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
44255152|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255153|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44255154|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44255155|NCT00613600|Cathartics|cathartics|mesh-ancestor
44255156|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255157|NCT00613613|Fenofibrate|fenofibrate|mesh-list
44255158|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44255159|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
44255160|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255161|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44255162|NCT00613665|Vaccines|vaccines|mesh-list
43652730|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
44057890|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44057891|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44057892|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44057893|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057894|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44057895|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057896|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150101|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150102|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
44150103|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150104|NCT00209703|Antidotes|antidotes|mesh-ancestor
44150105|NCT00209703|Protective Agents|protective agents|mesh-ancestor
44150106|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
44150107|NCT00209703|Vitamins|vitamins|mesh-ancestor
44150108|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
44150109|NCT00209716|Cisplatin|cisplatin|mesh-list
44150110|NCT00209716|Docetaxel|docetaxel|mesh-list
44150111|NCT00209716|Fluorouracil|fluorouracil|mesh-list
44150112|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150113|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44150114|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44150115|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150116|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150117|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
44150118|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150119|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150120|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
44150121|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150122|NCT00209729|Docetaxel|docetaxel|mesh-list
44150123|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150124|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
44150125|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
44150126|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150127|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150128|NCT00209742|Leucovorin|leucovorin|mesh-list
44150129|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
44150130|NCT00209742|Tegafur|tegafur|mesh-list
44150131|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
44150132|NCT00209742|Antidotes|antidotes|mesh-ancestor
44057897|NCT00005576|Aldesleukin|aldesleukin|mesh-list
44057898|NCT00005576|Interleukin-2|interleukin-2|mesh-list
44057899|NCT00005576|Dinutuximab|dinutuximab|mesh-list
44057900|NCT00005576|Isotretinoin|isotretinoin|mesh-list
44057901|NCT00005576|Antibodies|antibodies|mesh-list
44057902|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44057903|NCT00005576|Sargramostim|sargramostim|mesh-list
44057904|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
44057916|NCT00005577|Gemcitabine|gemcitabine|mesh-list
44057917|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057918|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
44057919|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057920|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057921|NCT00005577|Antiviral Agents|antiviral agents|mesh-ancestor
44255163|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
44255164|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255165|NCT00613717|Vitamin D|vitamin d|mesh-list
44255166|NCT00613717|Vitamins|vitamins|mesh-list
44255167|NCT00613717|Folic Acid|folic acid|mesh-list
44255168|NCT00613717|Vitamin A|vitamin a|mesh-list
44255169|NCT00613717|Iron|iron|mesh-list
44255170|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
44255171|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
44255172|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
44255173|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057922|NCT00005577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057923|NCT00005577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057924|NCT00005577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057925|NCT00005577|Immunologic Factors|immunologic factors|mesh-ancestor
44057926|NCT00005577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057927|NCT00005578|Prednisone|prednisone|mesh-list
44057928|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
44057929|NCT00005578|Doxorubicin|doxorubicin|mesh-list
44057930|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44057931|NCT00005578|Etoposide|etoposide|mesh-list
44057932|NCT00005578|Vincristine|vincristine|mesh-list
44057933|NCT00005578|Bleomycin|bleomycin|mesh-list
44057934|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
44057935|NCT00005578|Razoxane|razoxane|mesh-list
44057936|NCT00005578|Lenograstim|lenograstim|mesh-list
44057937|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057938|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
44057939|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057940|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057941|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057942|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
44057943|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057944|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057945|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057946|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057947|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44057948|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057949|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057950|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44057951|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
44057952|NCT00005578|Hormones|hormones|mesh-ancestor
44057953|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057954|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44057955|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057956|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44057957|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057958|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057959|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057960|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44057961|NCT00005578|Protective Agents|protective agents|mesh-ancestor
44057962|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
44057963|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057964|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057965|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057966|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057967|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057968|NCT00005580|Fludarabine|fludarabine|mesh-list
44057969|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
44057970|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
43554939|NCT03566576|Docetaxel|docetaxel|mesh-list
44057972|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057973|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
44057974|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150133|NCT00209742|Protective Agents|protective agents|mesh-ancestor
44057975|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057976|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
44057977|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057978|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44057979|NCT00005581|Paclitaxel|paclitaxel|mesh-list
44255174|NCT00613717|Trace Elements|trace elements|mesh-ancestor
44255175|NCT00613717|Hematinics|hematinics|mesh-ancestor
44255176|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
44255177|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255178|NCT00613717|Protective Agents|protective agents|mesh-ancestor
44255179|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44255180|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255181|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44255182|NCT00613743|Morphine|morphine|mesh-list
43775921|NCT02342509|Sevoflurane|sevoflurane|mesh-list
44057980|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
44057981|NCT00005581|Fluorouracil|fluorouracil|mesh-list
44057982|NCT00005581|Epirubicin|epirubicin|mesh-list
44057983|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057984|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057985|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057986|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
44057987|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
44057988|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057989|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44057990|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
44057991|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057992|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44057993|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057994|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
44057995|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057996|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
44057997|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44057998|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057999|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058000|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058001|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058002|NCT00005583|Cisplatin|cisplatin|mesh-list
44058003|NCT00005583|Doxorubicin|doxorubicin|mesh-list
44058004|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44058005|NCT00005583|Epirubicin|epirubicin|mesh-list
44058006|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058007|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058008|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058009|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058010|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058011|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058013|NCT00005584|Epirubicin|epirubicin|mesh-list
44058014|NCT00005584|Bleomycin|bleomycin|mesh-list
44058015|NCT00005584|Vinblastine|vinblastine|mesh-list
44058016|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058017|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
44058018|NCT00005584|Hormones|hormones|mesh-ancestor
44058019|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058020|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058021|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058022|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058023|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058024|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058025|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058026|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058027|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058028|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058029|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058030|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058031|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058032|NCT00005585|Leucovorin|leucovorin|mesh-list
44058033|NCT00005585|Cytarabine|cytarabine|mesh-list
44058034|NCT00005585|Dexamethasone|dexamethasone|mesh-list
44058035|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
44058036|NCT00005585|Methotrexate|methotrexate|mesh-list
44058037|NCT00005585|Vincristine|vincristine|mesh-list
44058038|NCT00005585|Daunorubicin|daunorubicin|mesh-list
44255183|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44255185|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255186|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255187|NCT00613743|Analgesics|analgesics|mesh-ancestor
44255188|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
44255189|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255190|NCT00613769|Metronidazole|metronidazole|mesh-list
44255191|NCT00613769|Trimethoprim|trimethoprim|mesh-list
44058039|NCT00005585|Asparaginase|asparaginase|mesh-list
44058040|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
44058041|NCT00005585|Pegaspargase|pegaspargase|mesh-list
44058042|NCT00005585|Thioguanine|thioguanine|mesh-list
44058043|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
44058044|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058045|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
44058046|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555002|NCT03566303|Vitamin K|vitamin k|mesh-list
44058048|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058050|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058051|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058052|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058053|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058054|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
44058055|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
44058056|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058057|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058058|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
44058059|NCT00005585|Hormones|hormones|mesh-ancestor
44058060|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058061|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058062|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44058063|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
44058064|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058065|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058066|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
44058067|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058068|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058069|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44058070|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058071|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
44058072|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058073|NCT00005585|Antidotes|antidotes|mesh-ancestor
44058074|NCT00005585|Protective Agents|protective agents|mesh-ancestor
44058075|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
44058076|NCT00005585|Vitamins|vitamins|mesh-ancestor
44058077|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
44058078|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058079|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058080|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058081|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058082|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058083|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058084|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058085|NCT00005586|Leucovorin|leucovorin|mesh-list
44058086|NCT00005586|Fluorouracil|fluorouracil|mesh-list
44058087|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
44058088|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
44058089|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058090|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058091|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058092|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058093|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
44058094|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058095|NCT00005586|Antidotes|antidotes|mesh-ancestor
44058096|NCT00005586|Protective Agents|protective agents|mesh-ancestor
44058097|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
44058098|NCT00005586|Vitamins|vitamins|mesh-ancestor
44058099|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
44255192|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
44255193|NCT00613769|Cefuroxime|cefuroxime|mesh-list
44255194|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
44255195|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44255196|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255197|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44255198|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44255199|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44255200|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43776089|NCT02341586|Iron|iron|mesh-list
44058100|NCT00005589|Cytarabine|cytarabine|mesh-list
44058101|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
44058102|NCT00005589|Melphalan|melphalan|mesh-list
44058103|NCT00005589|Carmustine|carmustine|mesh-list
44058104|NCT00005589|Rituximab|rituximab|mesh-list
44058105|NCT00005589|Etoposide|etoposide|mesh-list
44058106|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058107|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
44058108|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058109|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058110|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058111|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
44058112|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058113|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058114|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058115|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058116|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058117|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058118|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058119|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058120|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058121|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
44058122|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
44058123|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058124|NCT00005590|Levofloxacin|levofloxacin|mesh-list
44058125|NCT00005590|Ofloxacin|ofloxacin|mesh-list
44058126|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44058127|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058128|NCT00005590|Renal Agents|renal agents|mesh-ancestor
44058129|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44058130|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058131|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058132|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058133|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058134|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058135|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44058136|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44058137|NCT00005591|Gemcitabine|gemcitabine|mesh-list
44058138|NCT00005591|Cetuximab|cetuximab|mesh-list
44058139|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058140|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
44058141|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058142|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058143|NCT00005591|Antiviral Agents|antiviral agents|mesh-ancestor
44058144|NCT00005591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058145|NCT00005591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058146|NCT00005591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058147|NCT00005591|Immunologic Factors|immunologic factors|mesh-ancestor
44058148|NCT00005591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058149|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058150|NCT00005592|Rituximab|rituximab|mesh-list
44058151|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44058152|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058153|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058154|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
44058155|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255201|NCT00613769|Renal Agents|renal agents|mesh-ancestor
44255202|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
44255203|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44255204|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255205|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255206|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44255207|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43652775|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44058156|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058157|NCT00005593|Carboplatin|carboplatin|mesh-list
44058158|NCT00005593|Fludarabine|fludarabine|mesh-list
44058159|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
44058160|NCT00005593|Topotecan|topotecan|mesh-list
44058161|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058162|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058163|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
44058164|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058165|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058166|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
44058167|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058168|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058169|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058170|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058171|NCT00005596|Leucovorin|leucovorin|mesh-list
44058172|NCT00005596|Cytarabine|cytarabine|mesh-list
44058173|NCT00005596|Dexamethasone|dexamethasone|mesh-list
44058174|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
44058175|NCT00005596|Methotrexate|methotrexate|mesh-list
44058176|NCT00005596|Vincristine|vincristine|mesh-list
44058177|NCT00005596|Daunorubicin|daunorubicin|mesh-list
44058178|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
44058179|NCT00005596|Pegaspargase|pegaspargase|mesh-list
44058180|NCT00005596|Thioguanine|thioguanine|mesh-list
44058181|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
44058182|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058183|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
44058184|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058185|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058186|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058187|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
44058188|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058189|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058190|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058191|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058192|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
43782300|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
44058193|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
44058194|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058195|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058196|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
44058197|NCT00005596|Hormones|hormones|mesh-ancestor
44058198|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058215|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
44058216|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058217|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058218|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058219|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058220|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058221|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058222|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058223|NCT00005597|Temozolomide|temozolomide|mesh-list
44058224|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058225|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
44058226|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058227|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058228|NCT00005598|Azacitidine|azacitidine|mesh-list
44058229|NCT00005598|Amifostine|amifostine|mesh-list
44058230|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058231|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
43782149|NCT02339766|Narcotics|narcotics|mesh-ancestor
44255208|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44152558|NCT00217386|Analgesics|analgesics|mesh-ancestor
44255209|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
44255210|NCT00613782|Testosterone|testosterone|mesh-list
44255211|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
44255212|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
44255213|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44255214|NCT00613782|Androgens|androgens|mesh-ancestor
44058232|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058233|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058234|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058235|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44058236|NCT00005598|Protective Agents|protective agents|mesh-ancestor
44058237|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058238|NCT00005599|Paclitaxel|paclitaxel|mesh-list
44058239|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
44058240|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058241|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058242|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058243|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058244|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058245|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058246|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058247|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
44058248|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058249|NCT00005601|Cytarabine|cytarabine|mesh-list
44058250|NCT00005601|Dexamethasone|dexamethasone|mesh-list
44058251|NCT00005601|Rituximab|rituximab|mesh-list
44058252|NCT00005601|Cisplatin|cisplatin|mesh-list
44058253|NCT00005601|Sargramostim|sargramostim|mesh-list
44058254|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058255|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058256|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
44058257|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058258|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058266|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058268|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058269|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
44058270|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058271|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
44058272|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058273|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058274|NCT00005602|Carboplatin|carboplatin|mesh-list
44058275|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058276|NCT00005603|Cytarabine|cytarabine|mesh-list
44058277|NCT00005603|Dexamethasone|dexamethasone|mesh-list
44058278|NCT00005603|Prednisone|prednisone|mesh-list
44058279|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
43782345|NCT04543643|Carvedilol|carvedilol|mesh-list
44058280|NCT00005603|Doxorubicin|doxorubicin|mesh-list
44058281|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44058282|NCT00005603|Methotrexate|methotrexate|mesh-list
44058283|NCT00005603|Vincristine|vincristine|mesh-list
44058284|NCT00005603|Daunorubicin|daunorubicin|mesh-list
44058285|NCT00005603|Asparaginase|asparaginase|mesh-list
44058286|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
44058287|NCT00005603|Thioguanine|thioguanine|mesh-list
44058288|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058289|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
44058290|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058291|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058292|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058293|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
44058294|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058295|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058296|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058297|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058298|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
44058299|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
44058300|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058301|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058302|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
44058303|NCT00005603|Hormones|hormones|mesh-ancestor
44255215|NCT00613782|Hormones|hormones|mesh-ancestor
44255216|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255217|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255218|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44255219|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255220|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
44255221|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
44255222|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44255223|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
44255224|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255225|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255226|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44255227|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44255228|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44255229|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
44255230|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255231|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255232|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44255233|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44255234|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
44058304|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058305|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058306|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058307|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058308|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058309|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058310|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44058311|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
44058312|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058313|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058314|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
44058315|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058316|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44058317|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058318|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
44058319|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058320|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058321|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058322|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058323|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058324|NCT00005604|Aldesleukin|aldesleukin|mesh-list
44058325|NCT00005604|Interleukin-2|interleukin-2|mesh-list
44058326|NCT00005604|Interleukin-12|interleukin-12|mesh-list
44058327|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058333|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44058334|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44058335|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
44058336|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058337|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058338|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
44058339|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44058340|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44094205|NCT03336333|Rituximab|rituximab|mesh-list
44058341|NCT00005604|Growth Substances|growth substances|mesh-ancestor
44255235|NCT00613808|Protective Agents|protective agents|mesh-ancestor
44255237|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44255238|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44255239|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255240|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255241|NCT00613964|Diuretics|diuretics|mesh-list
44255242|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44255243|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
44255244|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255245|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255246|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255247|NCT00614159|Ketamine|ketamine|mesh-list
44255248|NCT00614159|Propofol|propofol|mesh-list
44255249|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44255250|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255251|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255252|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44255253|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
44255254|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
44255255|NCT00614159|Analgesics|analgesics|mesh-ancestor
44255256|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
44255257|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255258|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44255259|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44255260|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44255261|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652782|NCT02988089|Renal Agents|renal agents|mesh-ancestor
44058342|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44058343|NCT00005607|Leucovorin|leucovorin|mesh-list
44058344|NCT00005607|Fluorouracil|fluorouracil|mesh-list
44058345|NCT00005607|Irinotecan|irinotecan|mesh-list
44058346|NCT00005607|Calcium|calcium|mesh-list
44058347|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
44058348|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44058349|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058350|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
44058351|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058352|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058353|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058354|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058355|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
44058356|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058357|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058358|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058359|NCT00005607|Antidotes|antidotes|mesh-ancestor
44255262|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255263|NCT00614328|Naltrexone|naltrexone|mesh-list
44255264|NCT00614328|Baclofen|baclofen|mesh-list
44255265|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44255266|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44255267|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255268|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
44058360|NCT00005607|Protective Agents|protective agents|mesh-ancestor
44058361|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
44058363|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
44058364|NCT00005609|Rituximab|rituximab|mesh-list
44058365|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058366|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058367|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
44058368|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058369|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058370|NCT00005610|Sargramostim|sargramostim|mesh-list
44058371|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
44058372|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058373|NCT00005612|Paclitaxel|paclitaxel|mesh-list
44058374|NCT00005612|Etoposide|etoposide|mesh-list
44058375|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
44058376|NCT00005612|Carboplatin|carboplatin|mesh-list
44058377|NCT00005612|Topotecan|topotecan|mesh-list
44058378|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058379|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058380|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058381|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058382|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058383|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058384|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058385|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
44058386|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058387|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058388|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058389|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
44058390|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058391|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058392|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058394|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058395|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
44058396|NCT00005613|Carmustine|carmustine|mesh-list
44058397|NCT00005613|Etoposide|etoposide|mesh-list
44058398|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058399|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
44058400|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058401|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43555358|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
44058403|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
44058404|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058405|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058406|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058407|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058408|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058409|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058410|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058411|NCT00005614|Gemcitabine|gemcitabine|mesh-list
44058412|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058413|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
44058414|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058415|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058416|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
44058417|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058418|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058419|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058420|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
44058421|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058422|NCT00005615|Interferons|interferons|mesh-list
44058423|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
44058424|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255269|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255270|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44255271|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44255272|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44255273|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
44255274|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
44255275|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44058425|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
44058426|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058427|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
44058428|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058429|NCT00005616|Antibodies|antibodies|mesh-list
44058430|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44058431|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
44058432|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058433|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
44058434|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058435|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
44058436|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058437|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
44058438|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058439|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058440|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058441|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
44058442|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058443|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058444|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058445|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
44058446|NCT00005623|Cyproterone|cyproterone|mesh-list
44058447|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
44058448|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44058449|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058450|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058451|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058452|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44058453|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
44058454|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058455|NCT00005624|Tacedinaline|tacedinaline|mesh-list
44058456|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44058457|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058458|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058459|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058460|NCT00005625|Trabectedin|trabectedin|mesh-list
44058461|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058462|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
44058463|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058464|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058465|NCT00005626|Irinotecan|irinotecan|mesh-list
44058466|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058467|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058468|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058469|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058470|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058472|NCT00005627|Docetaxel|docetaxel|mesh-list
44058473|NCT00005627|Estramustine|estramustine|mesh-list
44058474|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058475|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058477|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058478|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058479|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058480|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
44058481|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058482|NCT00005630|Sargramostim|sargramostim|mesh-list
44058483|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
44058484|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058485|NCT00005631|Rituximab|rituximab|mesh-list
44058486|NCT00005631|Carboplatin|carboplatin|mesh-list
44058487|NCT00005631|Etoposide|etoposide|mesh-list
44255276|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255277|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44255278|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
44255279|NCT00614471|Entecavir|entecavir|mesh-list
44255280|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
44255281|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255282|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
44255283|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255284|NCT00614536|Rabeprazole|rabeprazole|mesh-list
44255285|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44255286|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255287|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44255288|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255289|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058488|NCT00005631|Ifosfamide|ifosfamide|mesh-list
44058489|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058490|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058491|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
44058492|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058493|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058494|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058495|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058496|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058497|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058498|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058499|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058500|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
44058501|NCT00005634|Vorinostat|vorinostat|mesh-list
44058502|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058503|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44058504|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058505|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058506|NCT00005635|Paclitaxel|paclitaxel|mesh-list
44058507|NCT00005635|Trastuzumab|trastuzumab|mesh-list
44058508|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058509|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058510|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058511|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058512|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058513|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058514|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058515|NCT00005636|Cisplatin|cisplatin|mesh-list
44058516|NCT00005636|Pemetrexed|pemetrexed|mesh-list
44058517|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058518|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058519|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058520|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44058521|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058522|NCT00005637|Temozolomide|temozolomide|mesh-list
44058523|NCT00005637|Carmustine|carmustine|mesh-list
44058524|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058525|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
44058526|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058527|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058528|NCT00005638|Cisplatin|cisplatin|mesh-list
44058529|NCT00005638|Irinotecan|irinotecan|mesh-list
44058530|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058531|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058532|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058533|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255290|NCT00614588|Anesthetics|anesthetics|mesh-list
44255291|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255292|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255293|NCT00614653|Bevacizumab|bevacizumab|mesh-list
44255294|NCT00614653|Capecitabine|capecitabine|mesh-list
44255295|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44255296|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44255297|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255298|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44255299|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44255300|NCT00614653|Growth Substances|growth substances|mesh-ancestor
44255301|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255302|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
44255303|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255304|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
44058534|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058535|NCT00005639|Azacitidine|azacitidine|mesh-list
44058536|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44058537|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058538|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
44058539|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058540|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058541|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058542|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44058543|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44058544|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058545|NCT00005641|Leucovorin|leucovorin|mesh-list
44058546|NCT00005641|Cyclosporine|cyclosporine|mesh-list
44058547|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
44058548|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
44058552|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44058553|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
44058554|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058555|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
44058556|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058557|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058558|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058559|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
44058560|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058561|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058562|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058563|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44058564|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
44058565|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058566|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058567|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
44058568|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058569|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058570|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44058571|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058572|NCT00005641|Antidotes|antidotes|mesh-ancestor
44058573|NCT00005641|Protective Agents|protective agents|mesh-ancestor
44058574|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
44058575|NCT00005641|Vitamins|vitamins|mesh-ancestor
44058576|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
44058577|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
44058578|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058579|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44058580|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058581|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
44255305|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255306|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255307|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255308|NCT00614666|Nikkomycin|nikkomycin|mesh-list
44058582|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
44058583|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058584|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058585|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
44058586|NCT00005641|Hormones|hormones|mesh-ancestor
44058587|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058588|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44058590|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44058591|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44058592|NCT00005642|Growth Substances|growth substances|mesh-ancestor
44058593|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058594|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
44058595|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058596|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44058597|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058598|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058599|NCT00005643|Doxorubicin|doxorubicin|mesh-list
44058600|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44058601|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058602|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058603|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058604|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058605|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058606|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058607|NCT00005644|Gemcitabine|gemcitabine|mesh-list
44058608|NCT00005644|Paclitaxel|paclitaxel|mesh-list
44058609|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058610|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058611|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058612|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058613|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058614|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058615|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058616|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
44058617|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
44058618|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058619|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058620|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058621|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
44058622|NCT00005644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058623|NCT00005646|Paclitaxel|paclitaxel|mesh-list
44058624|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058626|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058627|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058628|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058629|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058630|NCT00005647|Paclitaxel|paclitaxel|mesh-list
44058631|NCT00005647|Semaxinib|semaxinib|mesh-list
44058632|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058633|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058634|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058635|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058636|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058637|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058638|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44058639|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44058640|NCT00005647|Growth Substances|growth substances|mesh-ancestor
44058641|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058642|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
44058643|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44058644|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058645|NCT00005648|Gemcitabine|gemcitabine|mesh-list
44058646|NCT00005648|Tipifarnib|tipifarnib|mesh-list
44058647|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058648|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
44058649|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255309|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
44255310|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058650|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058651|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
44058652|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058653|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058654|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058655|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
44058656|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058657|NCT00005649|Paclitaxel|paclitaxel|mesh-list
44058658|NCT00005649|Capecitabine|capecitabine|mesh-list
44058659|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058660|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058661|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058662|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058663|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058664|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058665|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058666|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
44058668|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44058669|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058670|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
44058671|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058672|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058673|NCT00005654|Metformin|metformin|mesh-list
44058674|NCT00005654|Clomiphene|clomiphene|mesh-list
44058675|NCT00005654|Enclomiphene|enclomiphene|mesh-list
44058676|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
44058677|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44058678|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058679|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44058680|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44058681|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058682|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44058683|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
44058684|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058685|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44058686|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44058687|NCT00005658|Glycine|glycine|mesh-list
44058688|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
44058689|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44058690|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058691|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058692|NCT00005663|Valacyclovir|valacyclovir|mesh-list
44058693|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
44058694|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058695|NCT00005665|Interferons|interferons|mesh-list
44058696|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
44058697|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058698|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
44058699|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058700|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
44058701|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058702|NCT00005668|Itraconazole|itraconazole|mesh-list
44058703|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
44058704|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058705|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44058706|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44058707|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058708|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058709|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44058710|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44058711|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058712|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058713|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44058714|NCT00005673|Capravirine|capravirine|mesh-list
44058715|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44058716|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058717|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058718|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058719|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
44255311|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255312|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255313|NCT00614679|Tigecycline|tigecycline|mesh-list
44255314|NCT00614679|Heparin|heparin|mesh-list
44255315|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
44255316|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44255317|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44255318|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255319|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43652854|NCT02987920|Acetaminophen|acetaminophen|mesh-list
44058720|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058721|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44058722|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44058723|NCT00005684|Heparin|heparin|mesh-list
44058724|NCT00005684|Warfarin|warfarin|mesh-list
44058725|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
44058726|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44058727|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44058728|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150134|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150135|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
44150136|NCT00209742|Vitamins|vitamins|mesh-ancestor
44150137|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
44150138|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150139|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
44150140|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150141|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150142|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058729|NCT00005762|Ritonavir|ritonavir|mesh-list
44058730|NCT00005762|Nelfinavir|nelfinavir|mesh-list
44058731|NCT00005762|Indinavir|indinavir|mesh-list
44058732|NCT00005762|Saquinavir|saquinavir|mesh-list
44058733|NCT00005762|Amprenavir|amprenavir|mesh-list
44058734|NCT00005762|Efavirenz|efavirenz|mesh-list
44058735|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44058736|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44058737|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
44058738|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058739|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058740|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44058741|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44058742|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
44058743|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058744|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44058745|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44058746|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44058747|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058748|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44058749|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44058750|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44058751|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44058752|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44058753|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44058754|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
44058755|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44058756|NCT00005764|Lamivudine|lamivudine|mesh-list
44058757|NCT00005764|Zidovudine|zidovudine|mesh-list
44058758|NCT00005764|Abacavir|abacavir|mesh-list
44058759|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44058760|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44058761|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058762|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058763|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058764|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
44058767|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255320|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255321|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44255322|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255323|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
44255324|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44255325|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
44058768|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
44058770|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44058771|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
44058772|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058773|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058774|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44058775|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44058776|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
44058777|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44058778|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058779|NCT00005768|Estrogens|estrogens|mesh-list
44058780|NCT00005768|Hormones|hormones|mesh-ancestor
44058781|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058782|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058783|NCT00005769|Hormones|hormones|mesh-list
44058784|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058785|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058786|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
44058787|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44058788|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
44058789|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058790|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058791|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44058792|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44058793|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44058794|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
44058795|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058796|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44058797|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44058798|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
44058799|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
44058800|NCT00005773|Protective Agents|protective agents|mesh-ancestor
44058801|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44058802|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
44150143|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
44058803|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44058804|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44058806|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
44058807|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44058808|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
44058809|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058810|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058811|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44058812|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
44058813|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44058814|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
44058815|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058816|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44058817|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44058818|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44058819|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
44058820|NCT00005776|Protective Agents|protective agents|mesh-ancestor
44058821|NCT00005777|Dexamethasone|dexamethasone|mesh-list
44058822|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058823|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
44058824|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
44058825|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058826|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058827|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058828|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
44058829|NCT00005777|Hormones|hormones|mesh-ancestor
44106646|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255326|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255327|NCT00614757|Expectorants|expectorants|mesh-ancestor
44255328|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44255329|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44255330|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
44255331|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058830|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44058831|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058832|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058833|NCT00005779|Interleukin-12|interleukin-12|mesh-list
44058834|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058835|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
44058836|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058846|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
44058847|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058848|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
44058849|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
44058850|NCT00005787|Sargramostim|sargramostim|mesh-list
44058851|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058852|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
44058853|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058854|NCT00005787|Hematinics|hematinics|mesh-ancestor
44058855|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44058856|NCT00005787|Protective Agents|protective agents|mesh-ancestor
44058857|NCT00005791|Cisplatin|cisplatin|mesh-list
44058858|NCT00005791|Fluorouracil|fluorouracil|mesh-list
44058859|NCT00005791|Irinotecan|irinotecan|mesh-list
44058860|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058861|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
44058862|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058863|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058864|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058865|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
44058866|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058867|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058868|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058869|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058870|NCT00005792|Etoposide|etoposide|mesh-list
44058871|NCT00005792|Melphalan|melphalan|mesh-list
44058872|NCT00005792|Topotecan|topotecan|mesh-list
44058873|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
44058874|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058875|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058876|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058877|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058878|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058879|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058880|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058881|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
44058882|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058883|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058884|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
44058885|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058886|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058887|NCT00005793|Cytarabine|cytarabine|mesh-list
44058888|NCT00005793|Etoposide|etoposide|mesh-list
44058889|NCT00005793|Daunorubicin|daunorubicin|mesh-list
44058890|NCT00005793|Topotecan|topotecan|mesh-list
44058891|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058892|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058893|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058894|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058895|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058896|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058897|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058898|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
44058899|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
44058900|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058901|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058902|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
44255332|NCT00614757|Protective Agents|protective agents|mesh-ancestor
44255333|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255334|NCT00614757|Antidotes|antidotes|mesh-ancestor
44255335|NCT00614809|Gefitinib|gefitinib|mesh-list
44255336|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255337|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255338|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255339|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255340|NCT00614835|Gemcitabine|gemcitabine|mesh-list
44255341|NCT00614835|Docetaxel|docetaxel|mesh-list
44255342|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255343|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
44255344|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058903|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058904|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058909|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058911|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058912|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058913|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44058914|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058915|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058916|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
44150144|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44150145|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
44150146|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150147|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
44150148|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44150149|NCT00209755|Ribavirin|ribavirin|mesh-list
44150150|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
44150151|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150152|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
44150153|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150154|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
44150155|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
44150156|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44094833|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094834|NCT00039390|Capecitabine|capecitabine|mesh-list
44150157|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
44150158|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44150159|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44150160|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150161|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44150162|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150163|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150164|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44150165|NCT00209781|Renal Agents|renal agents|mesh-ancestor
44150166|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
44150167|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
44150168|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44150169|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
44150170|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44150171|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44150172|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150173|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44150174|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150175|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150176|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44150177|NCT00209794|Renal Agents|renal agents|mesh-ancestor
44150178|NCT00209807|Citalopram|citalopram|mesh-list
44150179|NCT00209807|Reboxetine|reboxetine|mesh-list
44150180|NCT00209807|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44150181|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44058917|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
44058918|NCT00005797|Busulfan|busulfan|mesh-list
44058919|NCT00005797|Etoposide|etoposide|mesh-list
44255345|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255346|NCT00614835|Antiviral Agents|antiviral agents|mesh-ancestor
44255347|NCT00614835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255348|NCT00614835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255349|NCT00614835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255350|NCT00614835|Immunologic Factors|immunologic factors|mesh-ancestor
44255351|NCT00614835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255352|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058920|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058921|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
44058922|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058923|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058924|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058925|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
44058926|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058927|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058928|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058929|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44058930|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058931|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058932|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058933|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
44058934|NCT00005798|Thiotepa|thiotepa|mesh-list
44058935|NCT00005798|Carboplatin|carboplatin|mesh-list
44058936|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058937|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
44058938|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058939|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058940|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058948|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
44058949|NCT00005799|Cyclosporins|cyclosporins|mesh-list
44058950|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058951|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058952|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
44058953|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058954|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44058955|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
44058956|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058957|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058958|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
44058959|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058960|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058961|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058962|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44058963|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058964|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44058965|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
44058966|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44058968|NCT00005800|Doxorubicin|doxorubicin|mesh-list
44058969|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44058970|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058971|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44058972|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44058973|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094917|NCT00039481|Protective Agents|protective agents|mesh-ancestor
44094918|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094919|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094920|NCT00039494|Temozolomide|temozolomide|mesh-list
44094921|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44094922|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094923|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
44094924|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094925|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094926|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094927|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094928|NCT00039520|Sulindac|sulindac|mesh-list
44094929|NCT00039520|Docetaxel|docetaxel|mesh-list
44058974|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058975|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44058976|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44058977|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44058978|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058979|NCT00005802|Cytarabine|cytarabine|mesh-list
44058980|NCT00005802|Aldesleukin|aldesleukin|mesh-list
44058981|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
44058982|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44058983|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44058984|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44058985|NCT00005802|Methotrexate|methotrexate|mesh-list
44058986|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
44058987|NCT00005802|Fludarabine|fludarabine|mesh-list
44255353|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255354|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255355|NCT00614965|Cisplatin|cisplatin|mesh-list
44255356|NCT00614965|Irinotecan|irinotecan|mesh-list
44255357|NCT00614965|Pemetrexed|pemetrexed|mesh-list
44255358|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058988|NCT00005802|Etoposide|etoposide|mesh-list
44058989|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
44058990|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44058991|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
44058992|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058993|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058994|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058995|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
44058996|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058997|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058998|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058999|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059000|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44059001|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059002|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
44059003|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059004|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059005|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059006|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059007|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059008|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
44059009|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556016|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
44059015|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059016|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
44059017|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059019|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059020|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059021|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094948|NCT00039546|Epirubicin|epirubicin|mesh-list
44059022|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
44059023|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059024|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059025|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059026|NCT00005806|Paclitaxel|paclitaxel|mesh-list
44059027|NCT00005806|Carboplatin|carboplatin|mesh-list
44059028|NCT00005806|Gefitinib|gefitinib|mesh-list
44059029|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059030|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059031|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059032|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059033|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059034|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059035|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44059036|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059037|NCT00005807|Epothilones|epothilones|mesh-list
44059038|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059039|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059040|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059041|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059042|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059043|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
44059044|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44059045|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059046|NCT00005810|Carboplatin|carboplatin|mesh-list
44059047|NCT00005810|Docetaxel|docetaxel|mesh-list
44059048|NCT00005810|Estramustine|estramustine|mesh-list
44059049|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059050|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059051|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059052|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059053|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059054|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059055|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
44059056|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059057|NCT00005811|Topotecan|topotecan|mesh-list
44255359|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44255360|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255361|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255362|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255363|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44255364|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255365|NCT00614978|Temozolomide|temozolomide|mesh-list
44255366|NCT00614978|Lapatinib|lapatinib|mesh-list
44255367|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255368|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
44255369|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255370|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909320|NCT00325078|Infliximab|infliximab|mesh-list
44255371|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255372|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255373|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
44255374|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44255375|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44255376|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255377|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255378|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255379|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
44255380|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255381|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
43652899|NCT02987907|Hormones|hormones|mesh-ancestor
44059058|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059059|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059060|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059061|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059062|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059063|NCT00005812|Temozolomide|temozolomide|mesh-list
44059064|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059065|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
44059066|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059067|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095070|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
43782913|NCT05095571|Vitamins|vitamins|mesh-ancestor
44059068|NCT00005813|Antibodies|antibodies|mesh-list
44059069|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44059070|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
44059071|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059072|NCT00005814|Cisplatin|cisplatin|mesh-list
44059073|NCT00005814|Cetuximab|cetuximab|mesh-list
44059074|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059075|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44059076|NCT00005815|Thalidomide|thalidomide|mesh-list
44059077|NCT00005815|Temozolomide|temozolomide|mesh-list
44059078|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059079|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
44059080|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059084|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255382|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44255383|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44059085|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
44059086|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44059087|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059088|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44059089|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44059090|NCT00005815|Growth Substances|growth substances|mesh-ancestor
44059091|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44059092|NCT00005818|Irinotecan|irinotecan|mesh-list
44059093|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059094|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095071|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44095072|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44095073|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44095074|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44095075|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44095076|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095077|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095078|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44095080|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095081|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095082|NCT00040014|Exemestane|exemestane|mesh-list
44095083|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095084|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44095085|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44095086|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095087|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095088|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44095089|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
44095090|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095091|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059095|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059096|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059097|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059098|NCT00005819|Paclitaxel|paclitaxel|mesh-list
44059099|NCT00005819|Cisplatin|cisplatin|mesh-list
44059100|NCT00005819|Fenretinide|fenretinide|mesh-list
44059101|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059102|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059103|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059104|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059105|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059106|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059107|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44059108|NCT00005819|Protective Agents|protective agents|mesh-ancestor
44059109|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059110|NCT00005822|Tamoxifen|tamoxifen|mesh-list
44059111|NCT00005822|Doxorubicin|doxorubicin|mesh-list
44059112|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44059113|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059114|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059115|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059116|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059117|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059118|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059119|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44059120|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
44059121|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059122|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059123|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059124|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44059125|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44059126|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44059127|NCT00005823|Cytarabine|cytarabine|mesh-list
44059128|NCT00005823|Etoposide|etoposide|mesh-list
44059129|NCT00005823|Daunorubicin|daunorubicin|mesh-list
44059130|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
44059131|NCT00005823|Idarubicin|idarubicin|mesh-list
44059132|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
44059133|NCT00005823|Tretinoin|tretinoin|mesh-list
44059134|NCT00005823|Thioguanine|thioguanine|mesh-list
44059135|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059136|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059137|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059138|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059139|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059140|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059141|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059142|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
44059143|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
44059144|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059145|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059146|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
44059147|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059148|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059149|NCT00005823|Analgesics|analgesics|mesh-ancestor
44059150|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
44059151|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059152|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
43556159|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
44059159|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
44255384|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255385|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
44255386|NCT00615147|Coagulants|coagulants|mesh-ancestor
43778262|NCT02327416|Entecavir|entecavir|mesh-list
44059160|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059161|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059162|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059163|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
44059164|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059165|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059166|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059167|NCT00005825|Cisplatin|cisplatin|mesh-list
44059168|NCT00005825|Vinorelbine|vinorelbine|mesh-list
44059169|NCT00005825|Mitomycins|mitomycins|mesh-list
44059170|NCT00005825|Mitomycin|mitomycin|mesh-list
44059171|NCT00005825|Tretinoin|tretinoin|mesh-list
44059172|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059173|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059174|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059175|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059176|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059177|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059178|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059179|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
44059180|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059181|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059182|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
44059183|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059184|NCT00005826|Rubitecan|rubitecan|mesh-list
44059185|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059186|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059187|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059188|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059189|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059190|NCT00005827|Genistein|genistein|mesh-list
44059191|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44059192|NCT00005827|Protective Agents|protective agents|mesh-ancestor
44059193|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059194|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059195|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44059196|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059197|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059198|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
44059199|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44059200|NCT00005827|Estrogens|estrogens|mesh-ancestor
44059201|NCT00005827|Hormones|hormones|mesh-ancestor
44059202|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059203|NCT00005829|Gemcitabine|gemcitabine|mesh-list
44059204|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059205|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
44059206|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059207|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059208|NCT00005829|Antiviral Agents|antiviral agents|mesh-ancestor
44059209|NCT00005829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059210|NCT00005829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059211|NCT00005829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059212|NCT00005829|Immunologic Factors|immunologic factors|mesh-ancestor
44059213|NCT00005829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059214|NCT00005830|Cisplatin|cisplatin|mesh-list
44059215|NCT00005830|Doxorubicin|doxorubicin|mesh-list
44059216|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44059217|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059218|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059219|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059220|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059221|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059222|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059233|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059234|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
44059235|NCT00005831|Antiviral Agents|antiviral agents|mesh-ancestor
44059236|NCT00005831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059237|NCT00005831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255388|NCT00615160|Vatalanib|vatalanib|mesh-list
44255389|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255390|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
44255391|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255392|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255393|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255394|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255395|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
44255396|NCT00615173|Azathioprine|azathioprine|mesh-list
44255397|NCT00615173|Tacrolimus|tacrolimus|mesh-list
43652928|NCT02987556|Insulin|insulin|mesh-list
44059238|NCT00005831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059239|NCT00005831|Immunologic Factors|immunologic factors|mesh-ancestor
44059240|NCT00005831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059241|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44059243|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059244|NCT00005833|Tipifarnib|tipifarnib|mesh-list
44059245|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059246|NCT00005834|Thalidomide|thalidomide|mesh-list
44059247|NCT00005834|Dexamethasone|dexamethasone|mesh-list
44059248|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
44059249|NCT00005834|Cisplatin|cisplatin|mesh-list
44059250|NCT00005834|Etoposide|etoposide|mesh-list
44059251|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059252|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
44059253|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059254|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059255|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059256|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
44059257|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059258|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059259|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059260|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059261|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
44059262|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
44059263|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059264|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44059265|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
44059266|NCT00005834|Hormones|hormones|mesh-ancestor
44059267|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059268|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059269|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059270|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059271|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059272|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059273|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
44059274|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44059275|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059276|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44059277|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44059278|NCT00005834|Growth Substances|growth substances|mesh-ancestor
44059279|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
44059280|NCT00005835|Melphalan|melphalan|mesh-list
44059281|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
44059282|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
44059283|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059284|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059285|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
44059286|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059287|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059288|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059298|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059299|NCT00005838|Paclitaxel|paclitaxel|mesh-list
44059300|NCT00005838|Vinorelbine|vinorelbine|mesh-list
44255398|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255399|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
44255400|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255401|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255402|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255403|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
44255404|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255405|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255406|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44255407|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44255408|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255409|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
44255410|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255411|NCT00615186|Temozolomide|temozolomide|mesh-list
44255412|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255413|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
44255414|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255415|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255416|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
43652948|NCT02987400|Venetoclax|venetoclax|mesh-list
44059301|NCT00005838|Cisplatin|cisplatin|mesh-list
44059302|NCT00005838|Carboplatin|carboplatin|mesh-list
44059303|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059304|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059305|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059306|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059307|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059308|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059309|NCT00005839|Capecitabine|capecitabine|mesh-list
44059310|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
44059311|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059312|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
44059313|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059314|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059315|NCT00005840|Paclitaxel|paclitaxel|mesh-list
44059316|NCT00005840|Cisplatin|cisplatin|mesh-list
44059317|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059318|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059320|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059321|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059322|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059323|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
44059324|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44059325|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
44059326|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059327|NCT00005842|Trastuzumab|trastuzumab|mesh-list
44059328|NCT00005842|Tipifarnib|tipifarnib|mesh-list
44059329|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44059330|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059331|NCT00005843|Tipifarnib|tipifarnib|mesh-list
44059332|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059333|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
44059334|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059335|NCT00005845|Tipifarnib|tipifarnib|mesh-list
44059336|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255418|NCT00615212|Midazolam|midazolam|mesh-list
44255419|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44255420|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44255421|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255422|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255423|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44255424|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44255425|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255426|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44255427|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
44255428|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
44255429|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
44255430|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
44255431|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255432|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255433|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44255434|NCT00615212|Analgesics|analgesics|mesh-ancestor
44255435|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
44255436|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255437|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44255438|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44255439|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255440|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255441|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44255442|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255443|NCT00615303|Simethicone|simethicone|mesh-list
44059337|NCT00005847|Interferons|interferons|mesh-list
44059338|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
44059339|NCT00005847|Paclitaxel|paclitaxel|mesh-list
44059340|NCT00005847|Vinorelbine|vinorelbine|mesh-list
44059341|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
44059342|NCT00005847|Estramustine|estramustine|mesh-list
44059343|NCT00005847|Isotretinoin|isotretinoin|mesh-list
44059344|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059345|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059346|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059347|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059348|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059349|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059350|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
44059351|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059352|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
44059353|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059354|NCT00005847|Analgesics|analgesics|mesh-ancestor
44059355|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
44059356|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059357|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059368|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059369|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255445|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255446|NCT00615303|Emollients|emollients|mesh-ancestor
44255447|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461391|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
44461392|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44461393|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44461394|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
44461395|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461396|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
44461397|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44461398|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44461399|NCT01547728|Antithrombins|antithrombins|mesh-list
44461400|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
44461401|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44059370|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059371|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059372|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059373|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059374|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44059375|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
44059376|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059377|NCT00005850|Gemcitabine|gemcitabine|mesh-list
44059378|NCT00005850|Cisplatin|cisplatin|mesh-list
44059379|NCT00005850|Fluoxetine|fluoxetine|mesh-list
44059380|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059381|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059382|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
44059383|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059384|NCT00005850|Antiviral Agents|antiviral agents|mesh-ancestor
44059385|NCT00005850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059386|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059387|NCT00005850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059388|NCT00005850|Immunologic Factors|immunologic factors|mesh-ancestor
44059389|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059390|NCT00005850|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44059391|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44059392|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44059393|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44059394|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
44059395|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44059396|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
44059397|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44059398|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44059399|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44059400|NCT00005851|Cyclosporine|cyclosporine|mesh-list
44059401|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
44059402|NCT00005851|Fludarabine|fludarabine|mesh-list
44059403|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
44059404|NCT00005851|Cyclosporins|cyclosporins|mesh-list
44059405|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059406|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059407|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
44059408|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059409|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059410|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
44059411|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461402|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461403|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461404|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461405|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
44461406|NCT01547598|Timolol|timolol|mesh-list
44461407|NCT01547598|Bimatoprost|bimatoprost|mesh-list
44461408|NCT01547598|Travoprost|travoprost|mesh-list
44461409|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44461410|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44461411|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44461412|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44461413|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
44461414|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461415|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461416|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461417|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44461418|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44461419|NCT01547390|Aspirin|aspirin|mesh-list
44461420|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461421|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461422|NCT01547390|Analgesics|analgesics|mesh-ancestor
44461423|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
44461424|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461425|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461426|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461427|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461428|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44461429|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44461430|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461431|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44461432|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44461433|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461434|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
44461435|NCT01547299|Leuprolide|leuprolide|mesh-list
44461436|NCT01547299|Dutasteride|dutasteride|mesh-list
44461437|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44461438|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
44059412|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461439|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44461440|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461441|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461442|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461443|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44461444|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44461446|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461447|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44461448|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461449|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
44461450|NCT01547286|Miotics|miotics|mesh-ancestor
44461451|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
44461452|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461453|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461454|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44461455|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44461456|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
44461457|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44461458|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44461459|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461460|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461461|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461462|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
44461463|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255448|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
44255449|NCT00615368|Hematinics|hematinics|mesh-ancestor
44255450|NCT00615381|Insulin|insulin|mesh-list
44255451|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44255452|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44255453|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255454|NCT00615446|Gemcitabine|gemcitabine|mesh-list
44255455|NCT00615446|Sunitinib|sunitinib|mesh-list
44255456|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255457|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
44255460|NCT00615446|Antiviral Agents|antiviral agents|mesh-ancestor
44255461|NCT00615446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255462|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255463|NCT00615446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255464|NCT00615446|Immunologic Factors|immunologic factors|mesh-ancestor
44255465|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255466|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44255467|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44255468|NCT00615446|Growth Substances|growth substances|mesh-ancestor
44255469|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44255470|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255472|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255473|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44255474|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44255475|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095436|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255476|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255477|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44255478|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
44255479|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255480|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255481|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
44255482|NCT00615602|Docetaxel|docetaxel|mesh-list
44255483|NCT00615602|Trastuzumab|trastuzumab|mesh-list
44255484|NCT00615602|Epirubicin|epirubicin|mesh-list
44255485|NCT00615602|Fluorouracil|fluorouracil|mesh-list
44255486|NCT00615602|Lenograstim|lenograstim|mesh-list
44255487|NCT00615602|Mitogens|mitogens|mesh-list
44255488|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255489|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
44255490|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255491|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653057|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
44255504|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255505|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
44255506|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255507|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44255508|NCT00615615|Levetiracetam|levetiracetam|mesh-list
44255509|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
44255510|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
44255511|NCT00615667|Tacrolimus|tacrolimus|mesh-list
44255512|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255513|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
44255514|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255515|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44255516|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255517|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653096|NCT02986451|Hormones|hormones|mesh-ancestor
44059413|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
44059414|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059415|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059416|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059417|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059418|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059419|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44059420|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
44059421|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44059422|NCT00005852|Cyclosporine|cyclosporine|mesh-list
44059432|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059433|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
44059434|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059435|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059436|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059437|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059438|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
44059439|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059440|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059441|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059442|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059443|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
44059444|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
44059445|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059446|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44059447|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
44059448|NCT00005852|Hormones|hormones|mesh-ancestor
44059449|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059450|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44059451|NCT00005852|Protective Agents|protective agents|mesh-ancestor
44059452|NCT00005853|Etanercept|etanercept|mesh-list
44059453|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44059454|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44059455|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44059456|NCT00005853|Analgesics|analgesics|mesh-ancestor
44059457|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
44059458|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059459|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059460|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059461|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059462|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44059463|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059464|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
44059465|NCT00005854|Cyclosporine|cyclosporine|mesh-list
44059466|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
44059467|NCT00005854|Methotrexate|methotrexate|mesh-list
44059468|NCT00005854|Cyclosporins|cyclosporins|mesh-list
44255518|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44255519|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44255520|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255522|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255523|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
44255524|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255525|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255526|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44059469|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059470|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
44059471|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059472|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059473|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059474|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
44059475|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059476|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059477|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059478|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44059479|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
44059480|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44059481|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059482|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
44059483|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059484|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059485|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44059486|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059487|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
44059488|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059489|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059490|NCT00005855|Carmustine|carmustine|mesh-list
44059500|NCT00005857|Trastuzumab|trastuzumab|mesh-list
44059501|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059502|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059503|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059504|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059505|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059506|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44059507|NCT00005858|Immunotoxins|immunotoxins|mesh-list
44059508|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
44059509|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059510|NCT00005859|Tipifarnib|tipifarnib|mesh-list
44059511|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059512|NCT00005860|Leucovorin|leucovorin|mesh-list
44059513|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
44059514|NCT00005860|Floxuridine|floxuridine|mesh-list
44059515|NCT00005860|Calcium|calcium|mesh-list
44059516|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
44059517|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44059518|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059519|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059520|NCT00005860|Antidotes|antidotes|mesh-ancestor
44059521|NCT00005860|Protective Agents|protective agents|mesh-ancestor
44059522|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
44059523|NCT00005860|Vitamins|vitamins|mesh-ancestor
44059524|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
44059525|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059526|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
44150182|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44059527|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059529|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44059530|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059531|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059532|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255527|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44255528|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255529|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255530|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255531|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255532|NCT00615797|Penicillins|penicillins|mesh-list
44255533|NCT00615797|Penicillin V|penicillin v|mesh-list
44255534|NCT00615797|Haloperidol|haloperidol|mesh-list
44255535|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
44255536|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
44255537|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44255538|NCT00615797|Antibodies|antibodies|mesh-list
44255539|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
44255540|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44255541|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
44255542|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255543|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
44255544|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
44255545|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255546|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255547|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44255548|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653115|NCT02986321|Budesonide|budesonide|mesh-list
44059533|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059534|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059535|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059536|NCT00005862|Semaxinib|semaxinib|mesh-list
44059537|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44059538|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44059539|NCT00005862|Growth Substances|growth substances|mesh-ancestor
44059540|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059541|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
44059542|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059543|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44059544|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059545|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059546|NCT00005863|Cytarabine|cytarabine|mesh-list
44059547|NCT00005863|Fludarabine|fludarabine|mesh-list
44059548|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
44059549|NCT00005863|Etoposide|etoposide|mesh-list
44059550|NCT00005863|Daunorubicin|daunorubicin|mesh-list
44059551|NCT00005863|Tretinoin|tretinoin|mesh-list
44059552|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059553|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059554|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
44059555|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059556|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059557|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
44059558|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059564|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059565|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059566|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
44059567|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059568|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
44059569|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255549|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255550|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255551|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44255552|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
44255553|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255554|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255555|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44255556|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44255557|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255558|NCT00615810|Efavirenz|efavirenz|mesh-list
44095619|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44255559|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44255560|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44255561|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255562|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255563|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255564|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
44255565|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255566|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44255567|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44255568|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44255569|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44255570|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44255571|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44255572|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255573|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255574|NCT00615823|Atorvastatin|atorvastatin|mesh-list
44255575|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44255576|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44255577|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
44059570|NCT00005865|Vinorelbine|vinorelbine|mesh-list
44059571|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059572|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059573|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059574|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059575|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059576|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059577|NCT00005866|Cyclosporine|cyclosporine|mesh-list
44059578|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
44059579|NCT00005866|Busulfan|busulfan|mesh-list
44059580|NCT00005866|Methotrexate|methotrexate|mesh-list
44059581|NCT00005866|Cyclosporins|cyclosporins|mesh-list
44059582|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255578|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255579|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44255580|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44255581|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255582|NCT00615875|Naproxen|naproxen|mesh-list
44255583|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44255584|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44059583|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
44059584|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059585|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059586|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059587|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
44059588|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059589|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059590|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059591|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44059592|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
44059593|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44059594|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059595|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
44059596|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059597|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059598|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44059599|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095693|NCT00041431|Hormones|hormones|mesh-list
44059600|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
44059601|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059602|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059603|NCT00005867|Prednisolone|prednisolone|mesh-list
44059604|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
44059605|NCT00005867|Doxorubicin|doxorubicin|mesh-list
44059606|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44059607|NCT00005867|Etoposide|etoposide|mesh-list
44059608|NCT00005867|Vincristine|vincristine|mesh-list
44059609|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
44059610|NCT00005867|Bleomycin|bleomycin|mesh-list
44059611|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059612|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
44059613|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059614|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059615|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059616|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
44059617|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059618|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059619|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059620|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059621|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059622|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059623|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059624|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059626|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059627|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059628|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059629|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
44059630|NCT00005867|Hormones|hormones|mesh-ancestor
43556635|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
44059638|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059639|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059640|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059641|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059642|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059643|NCT00005869|Gemcitabine|gemcitabine|mesh-list
44059644|NCT00005869|Rubitecan|rubitecan|mesh-list
44059645|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059646|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
44059647|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059648|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059649|NCT00005869|Antiviral Agents|antiviral agents|mesh-ancestor
44255585|NCT00615875|Analgesics|analgesics|mesh-ancestor
44255586|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
44255587|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255588|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255589|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059650|NCT00005869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059651|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059652|NCT00005869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059653|NCT00005869|Immunologic Factors|immunologic factors|mesh-ancestor
44059654|NCT00005869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059655|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059656|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059657|NCT00005870|Gemcitabine|gemcitabine|mesh-list
44059658|NCT00005870|Fluorouracil|fluorouracil|mesh-list
44059659|NCT00005870|Mitomycins|mitomycins|mesh-list
44059660|NCT00005870|Mitomycin|mitomycin|mesh-list
44059661|NCT00005870|Rubitecan|rubitecan|mesh-list
44059662|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059663|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
44059664|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059665|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059666|NCT00005870|Antiviral Agents|antiviral agents|mesh-ancestor
44059667|NCT00005870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059668|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059669|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059670|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
44059671|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059672|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059673|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
44059674|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059675|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059676|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059677|NCT00005871|Fluorouracil|fluorouracil|mesh-list
44059678|NCT00005871|Rubitecan|rubitecan|mesh-list
44059679|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
44059680|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059681|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059682|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059683|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059684|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
44059685|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059686|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059687|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059688|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059689|NCT00005872|Rubitecan|rubitecan|mesh-list
44059690|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059691|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059692|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059693|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059694|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059695|NCT00005873|Rubitecan|rubitecan|mesh-list
44059696|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059697|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059698|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556703|NCT03549923|Esmolol|esmolol|mesh-list
44059706|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059707|NCT00005875|Rubitecan|rubitecan|mesh-list
44059708|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059709|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059710|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059711|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059712|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059713|NCT00005876|Rubitecan|rubitecan|mesh-list
44059714|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059715|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059716|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059717|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059718|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059719|NCT00005877|Rubitecan|rubitecan|mesh-list
44059720|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782444|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
44255590|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255591|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
44255592|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44255593|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059721|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059722|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059723|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059724|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059725|NCT00005878|Celecoxib|celecoxib|mesh-list
44059726|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44059727|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44059728|NCT00005878|Analgesics|analgesics|mesh-ancestor
44059729|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
44059730|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059731|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059732|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059733|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059734|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44059735|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44059736|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059737|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059738|NCT00005880|Budesonide|budesonide|mesh-list
44152721|NCT00217711|Capecitabine|capecitabine|mesh-list
44059739|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059740|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44059741|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
44059742|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059743|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059744|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44059745|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
44059746|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
44059747|NCT00005880|Hormones|hormones|mesh-ancestor
44059748|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059749|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
44059750|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059751|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783419|NCT04796636|Vitamins|vitamins|mesh-ancestor
44059752|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44059753|NCT00005883|Protective Agents|protective agents|mesh-ancestor
44059754|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059755|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059756|NCT00005884|Eflornithine|eflornithine|mesh-list
44059757|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059758|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44059759|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44059760|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44059761|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556768|NCT03549702|Povidone|povidone|mesh-list
44059770|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059772|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44059773|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44059774|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44059775|NCT00005887|Efaproxiral|efaproxiral|mesh-list
44059776|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
44059778|NCT00005889|Glycerol|glycerol|mesh-list
44059779|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059780|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44059781|NCT00005889|Hormones|hormones|mesh-ancestor
44059782|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059783|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44059784|NCT00005889|Protective Agents|protective agents|mesh-ancestor
44095850|NCT00042146|Zolpidem|zolpidem|mesh-list
44059785|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44059786|NCT00005890|Hormones|hormones|mesh-ancestor
44059787|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059788|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059789|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
44059790|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059791|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
44059792|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255594|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255595|NCT00616005|Irinotecan|irinotecan|mesh-list
43909598|NCT00334074|Cytarabine|cytarabine|mesh-list
44255596|NCT00616005|Temozolomide|temozolomide|mesh-list
44255597|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059793|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059794|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059795|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
44059796|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059797|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059798|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059799|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
44059800|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059801|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
44059802|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059803|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059804|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059805|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
44059806|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059807|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059808|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059809|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
44059810|NCT00005893|Busulfan|busulfan|mesh-list
44059811|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44059812|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059813|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
44059814|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059815|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059816|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059817|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
44059818|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059819|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059820|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059821|NCT00005896|Lenograstim|lenograstim|mesh-list
44059822|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44059823|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
44059833|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059835|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059836|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
44059837|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059838|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059839|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44059840|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059841|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
44059842|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059843|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059844|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059845|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059846|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
44059847|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
44059848|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059849|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44059850|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
44059851|NCT00005898|Hormones|hormones|mesh-ancestor
44059852|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059853|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44059854|NCT00005898|Protective Agents|protective agents|mesh-ancestor
44150183|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150184|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150185|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
44150186|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150187|NCT00209807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44150188|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
44150189|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150190|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44150191|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
44150192|NCT00209833|Cytarabine|cytarabine|mesh-list
44150193|NCT00209833|Fludarabine|fludarabine|mesh-list
44150194|NCT00209833|Etoposide|etoposide|mesh-list
44255598|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255599|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255600|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255601|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255602|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255603|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
44255604|NCT00616031|Paclitaxel|paclitaxel|mesh-list
44255605|NCT00616031|Carboplatin|carboplatin|mesh-list
44255606|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
44255607|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255608|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150195|NCT00209833|Idarubicin|idarubicin|mesh-list
44150196|NCT00209833|Daunorubicin|daunorubicin|mesh-list
44150197|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150198|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150199|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
44150200|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150201|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150202|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
44150203|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150204|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44150205|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44150206|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150207|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150208|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
44150209|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150210|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44150211|NCT00209846|Gaboxadol|gaboxadol|mesh-list
44150212|NCT00209846|Analgesics|analgesics|mesh-ancestor
44150213|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
44150214|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150215|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150216|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
44150217|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
44150218|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
44150226|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
44150227|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44150228|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150229|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059855|NCT00005912|Voriconazole|voriconazole|mesh-list
44059856|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
44059857|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059858|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44059859|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44059860|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059861|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059862|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44059863|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
44059864|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059865|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059866|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44059867|NCT00005920|Caspofungin|caspofungin|mesh-list
44059868|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
44059869|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059870|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059871|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059872|NCT00005921|Caspofungin|caspofungin|mesh-list
44059873|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
44059874|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059875|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059876|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059877|NCT00005922|Triamcinolone|triamcinolone|mesh-list
44059878|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44255610|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255611|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255612|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255613|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
44255614|NCT00616044|Anesthetics|anesthetics|mesh-list
44255615|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255616|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255617|NCT00616070|Difluprednate|difluprednate|mesh-list
44255618|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
44255619|NCT00616070|Hormones|hormones|mesh-ancestor
44255620|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255621|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255622|NCT00616187|Interferons|interferons|mesh-list
44255623|NCT00616187|Interferon-beta|interferon-beta|mesh-list
44255624|NCT00616187|Atorvastatin|atorvastatin|mesh-list
44255625|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255626|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
44255627|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255628|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44255629|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44255630|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
44255631|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255632|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44255633|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44255634|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255635|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
44255636|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255637|NCT00616213|Lenograstim|lenograstim|mesh-list
44255638|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44255639|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
44255640|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255641|NCT00616382|Indomethacin|indomethacin|mesh-list
44255642|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
44255643|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44059879|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44059880|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44059881|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255645|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255646|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44255647|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44255648|NCT00616382|Protective Agents|protective agents|mesh-ancestor
44255649|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255650|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
44255651|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44255652|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
44255653|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653162|NCT02985697|Analgesics|analgesics|mesh-ancestor
44059882|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
44059884|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059885|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059886|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059887|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
44059888|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059889|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059891|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44059892|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
44059893|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
44059894|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44059895|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059896|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059897|NCT00005926|Gemcitabine|gemcitabine|mesh-list
44059898|NCT00005926|Trastuzumab|trastuzumab|mesh-list
44059899|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059900|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
44059901|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059902|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096015|NCT00042731|Lycopene|lycopene|mesh-list
44059903|NCT00005926|Antiviral Agents|antiviral agents|mesh-ancestor
44059904|NCT00005926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059905|NCT00005926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059906|NCT00005926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059907|NCT00005926|Immunologic Factors|immunologic factors|mesh-ancestor
44059908|NCT00005926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059909|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44059919|NCT00005931|Growth Substances|growth substances|mesh-ancestor
44059920|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059921|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44059922|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059923|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44059924|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059925|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059926|NCT00005934|Azacitidine|azacitidine|mesh-list
44059927|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059928|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
44059929|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059930|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059931|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059932|NCT00005935|Cyclosporine|cyclosporine|mesh-list
44059933|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
44059934|NCT00005935|Cyclosporins|cyclosporins|mesh-list
44059935|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059936|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059937|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059938|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
44059939|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059940|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
44059941|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255654|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44255655|NCT00616382|Analgesics|analgesics|mesh-ancestor
44255656|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
44255657|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059942|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059943|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059944|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059945|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44059946|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059947|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44059948|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
44059949|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44059950|NCT00005938|Exatecan|exatecan|mesh-list
44059951|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059952|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059953|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059954|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059955|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059957|NCT00005940|Cyclosporine|cyclosporine|mesh-list
44059958|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
44059959|NCT00005940|Busulfan|busulfan|mesh-list
44059960|NCT00005940|Methotrexate|methotrexate|mesh-list
44059961|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44059962|NCT00005940|Cyclosporins|cyclosporins|mesh-list
44059963|NCT00005940|Antibodies|antibodies|mesh-list
44059964|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
44059965|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44059966|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059967|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
44059968|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059969|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059970|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059971|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
44059972|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059973|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059974|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43557040|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060000|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
44060001|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060002|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060003|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
44060004|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060005|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060006|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060007|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44060008|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060009|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44060010|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
44060011|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44060013|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060014|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060015|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060016|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060017|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060018|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060019|NCT00005943|Aldesleukin|aldesleukin|mesh-list
44060020|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060021|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44060022|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44060023|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
44060024|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060025|NCT00005944|Leucovorin|leucovorin|mesh-list
44060026|NCT00005944|Fluorouracil|fluorouracil|mesh-list
44060031|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44060032|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060034|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060035|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060036|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060037|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060038|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
44060039|NCT00005944|Antidotes|antidotes|mesh-ancestor
44060040|NCT00005944|Protective Agents|protective agents|mesh-ancestor
44255658|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255659|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255660|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
44255661|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
44255662|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44255663|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44255665|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255666|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44255667|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255668|NCT00616460|Bivalirudin|bivalirudin|mesh-list
44255669|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
44255670|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44255671|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
44255672|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255673|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255674|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
44255675|NCT00616499|Gefitinib|gefitinib|mesh-list
44255676|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255677|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255678|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255679|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255680|NCT00616538|Fluticasone|fluticasone|mesh-list
44255681|NCT00616538|Xhance|xhance|mesh-list
44255682|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255683|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44255684|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
44255685|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255686|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255687|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44255688|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
44255689|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060041|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
44060042|NCT00005944|Vitamins|vitamins|mesh-ancestor
44060043|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
44060044|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060045|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
44060046|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44060047|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060048|NCT00005945|Cytarabine|cytarabine|mesh-list
44060049|NCT00005945|Dexamethasone|dexamethasone|mesh-list
44060050|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
44060051|NCT00005945|Doxorubicin|doxorubicin|mesh-list
44060052|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060053|NCT00005945|Methotrexate|methotrexate|mesh-list
44255690|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44255691|NCT00616551|Octreotide|octreotide|mesh-list
44255692|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255693|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44255694|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255695|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
44255696|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
44255697|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44255698|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44255699|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255700|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060054|NCT00005945|Vincristine|vincristine|mesh-list
44060055|NCT00005945|Daunorubicin|daunorubicin|mesh-list
44060056|NCT00005945|Asparaginase|asparaginase|mesh-list
44060057|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
44060058|NCT00005945|Pegaspargase|pegaspargase|mesh-list
44060059|NCT00005945|Thioguanine|thioguanine|mesh-list
44060060|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060061|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
44060062|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060063|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060064|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060065|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
44060066|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060067|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060068|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060069|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060070|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
44060071|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
44060072|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060073|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060074|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
44060075|NCT00005945|Hormones|hormones|mesh-ancestor
44060076|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060077|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060078|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060079|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060080|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060081|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060082|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44060083|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
44060084|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44060086|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
44060087|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060088|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44060089|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44060090|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
44060091|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060092|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060093|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060094|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060095|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060096|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
44060097|NCT00005946|Etoposide|etoposide|mesh-list
44060098|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060099|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
44060100|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060101|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557149|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
44060127|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44060128|NCT00005949|Aldesleukin|aldesleukin|mesh-list
44060129|NCT00005949|Interleukin-2|interleukin-2|mesh-list
44060130|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060131|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44060132|NCT00005949|Analgesics|analgesics|mesh-ancestor
44255701|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44060133|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
44060134|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060135|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060136|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44060137|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44060138|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
44060139|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060140|NCT00005951|Irinotecan|irinotecan|mesh-list
44060141|NCT00005951|Temozolomide|temozolomide|mesh-list
44060142|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060143|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060144|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060145|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060146|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060147|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060148|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
44060149|NCT00005952|Temozolomide|temozolomide|mesh-list
44060150|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060151|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
44060185|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060186|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
44060187|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060188|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060189|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060190|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
44060191|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060198|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060199|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060200|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
44060201|NCT00005959|Hormones|hormones|mesh-ancestor
44060202|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060203|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060204|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060205|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060206|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060207|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060208|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
44060209|NCT00005960|Docetaxel|docetaxel|mesh-list
44060210|NCT00005960|Doxorubicin|doxorubicin|mesh-list
44060211|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060212|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060213|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
44060214|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060215|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060216|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060217|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
44060218|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060219|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060220|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060221|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060222|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060223|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060224|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060225|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060226|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060227|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060228|NCT00005961|Carmustine|carmustine|mesh-list
44060229|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44060230|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060231|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
44060232|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783809|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
44060233|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060235|NCT00005962|Cytarabine|cytarabine|mesh-list
44060236|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
44060237|NCT00005962|Daunorubicin|daunorubicin|mesh-list
44060238|NCT00005962|Topotecan|topotecan|mesh-list
44060239|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
44060240|NCT00005962|Sargramostim|sargramostim|mesh-list
44060241|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060242|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
44060243|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060244|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782567|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
44255702|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44255703|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
44255704|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44255705|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255706|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255707|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44255708|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779542|NCT03199755|Artemether|artemether|mesh-list
44060245|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060246|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
44060247|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060248|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060249|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060250|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060251|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
44060252|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
44060253|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060254|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060255|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060256|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060257|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060258|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060259|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44060260|NCT00005963|Carboplatin|carboplatin|mesh-list
44060270|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060272|NCT00005964|Vincristine|vincristine|mesh-list
44060273|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060274|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
44060275|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060276|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060277|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060278|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
44060279|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060280|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060281|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060282|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060283|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060284|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060285|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060286|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060287|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
44060288|NCT00005964|Hormones|hormones|mesh-ancestor
44060289|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060290|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060291|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060292|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060293|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060294|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060295|NCT00005965|Cisplatin|cisplatin|mesh-list
44060296|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
44060297|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060298|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44060299|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
44060300|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060301|NCT00005966|Interferons|interferons|mesh-list
44060302|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
44060303|NCT00005966|Thalidomide|thalidomide|mesh-list
44060304|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060305|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
44060306|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060307|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
43783886|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44060308|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060309|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060310|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
44255709|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44255710|NCT00616720|Interferons|interferons|mesh-list
44255711|NCT00616720|Aldesleukin|aldesleukin|mesh-list
44255712|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
44060311|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44060312|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060313|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060314|NCT00005966|Growth Substances|growth substances|mesh-ancestor
44060315|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060316|NCT00005967|Tipifarnib|tipifarnib|mesh-list
44060317|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060318|NCT00005968|Irofulven|irofulven|mesh-list
44060319|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060320|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
44060321|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060322|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060323|NCT00005969|Tretinoin|tretinoin|mesh-list
44060324|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060325|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
44060326|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060327|NCT00005970|Tamoxifen|tamoxifen|mesh-list
44060328|NCT00005970|Paclitaxel|paclitaxel|mesh-list
44060338|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44060339|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44060340|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060341|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060342|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060343|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060344|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060345|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060346|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060347|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
44060348|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060349|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060350|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060351|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
44060352|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060353|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060354|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060355|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060356|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060357|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44060358|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
44060359|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060360|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060361|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44060362|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44060363|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44060364|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44060366|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060367|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060368|NCT00005971|Growth Substances|growth substances|mesh-ancestor
44060369|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060370|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060371|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060372|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060373|NCT00005972|Gemcitabine|gemcitabine|mesh-list
44060374|NCT00005972|Irinotecan|irinotecan|mesh-list
44060375|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060376|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
44060377|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060378|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060379|NCT00005972|Antiviral Agents|antiviral agents|mesh-ancestor
44060380|NCT00005972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060381|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060382|NCT00005972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060383|NCT00005972|Immunologic Factors|immunologic factors|mesh-ancestor
44060384|NCT00005972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150230|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
44060385|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060386|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255713|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255714|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
44255715|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255716|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255717|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255718|NCT00616746|Ethanol|ethanol|mesh-list
44255719|NCT00616746|Nicotine|nicotine|mesh-list
44255720|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44060387|NCT00005974|Alvocidib|alvocidib|mesh-list
44060388|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060389|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060390|NCT00005974|Growth Substances|growth substances|mesh-ancestor
44060391|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060392|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060393|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060402|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060403|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44060404|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44060405|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060406|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060407|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
44060408|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44060409|NCT00005976|Carboplatin|carboplatin|mesh-list
44060410|NCT00005976|NSC 366140|nsc 366140|mesh-list
44060411|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060412|NCT00005977|Leucovorin|leucovorin|mesh-list
44060413|NCT00005977|Cytarabine|cytarabine|mesh-list
44060414|NCT00005977|Dexamethasone|dexamethasone|mesh-list
44060415|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
44060416|NCT00005977|Ifosfamide|ifosfamide|mesh-list
44060417|NCT00005977|Doxorubicin|doxorubicin|mesh-list
44060418|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060419|NCT00005977|Methotrexate|methotrexate|mesh-list
44060420|NCT00005977|Etoposide|etoposide|mesh-list
44060421|NCT00005977|Vincristine|vincristine|mesh-list
44060422|NCT00005977|Lenograstim|lenograstim|mesh-list
44060423|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
44060424|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060425|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
44060426|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060427|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060428|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060429|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
44060430|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060431|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060432|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060433|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060434|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
44060435|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
44060436|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060437|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060438|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
44060439|NCT00005977|Hormones|hormones|mesh-ancestor
44060440|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060441|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060442|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060443|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060444|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060445|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060446|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44060447|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
44060448|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44060449|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060450|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
44060451|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060452|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44060453|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44060454|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060455|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
44060456|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060457|NCT00005977|Antidotes|antidotes|mesh-ancestor
44255722|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255723|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255724|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44255725|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44255726|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
44255727|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44060458|NCT00005977|Protective Agents|protective agents|mesh-ancestor
44060459|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
44060460|NCT00005977|Vitamins|vitamins|mesh-ancestor
44060461|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
43783969|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
44060466|NCT00005978|Carboplatin|carboplatin|mesh-list
44060467|NCT00005978|Etoposide|etoposide|mesh-list
44060468|NCT00005978|Melphalan|melphalan|mesh-list
44060469|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44060470|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060471|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060472|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060473|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060474|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060475|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060476|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
44060477|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060478|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060479|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
44060480|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060481|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060482|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44060483|NCT00005979|Leucovorin|leucovorin|mesh-list
44060484|NCT00005979|Fluorouracil|fluorouracil|mesh-list
44060485|NCT00005979|Irinotecan|irinotecan|mesh-list
44060486|NCT00005979|Calcium|calcium|mesh-list
44060487|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
44060488|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44060489|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060490|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
44060491|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060492|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060493|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060494|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060495|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
44060496|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060497|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060498|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060499|NCT00005979|Antidotes|antidotes|mesh-ancestor
44060500|NCT00005979|Protective Agents|protective agents|mesh-ancestor
44060501|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
44060502|NCT00005979|Vitamins|vitamins|mesh-ancestor
44060503|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
44060504|NCT00005980|Doxorubicin|doxorubicin|mesh-list
44060505|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060506|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060507|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060508|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060509|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060510|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060511|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060512|NCT00005981|Carmustine|carmustine|mesh-list
44060513|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44060514|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060515|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
44060516|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060517|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060518|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060519|NCT00005984|Interferons|interferons|mesh-list
44060520|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
44060521|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
44060522|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096509|NCT00043901|Lamotrigine|lamotrigine|mesh-list
44255728|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255729|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44255730|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653240|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44060523|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
44060524|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060525|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060526|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060527|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
44060528|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060529|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060530|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060531|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
44060532|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060533|NCT00005985|Cytarabine|cytarabine|mesh-list
44060534|NCT00005985|Dexamethasone|dexamethasone|mesh-list
44060539|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060540|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
44060541|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060542|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060543|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060544|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
44060545|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060546|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060547|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060548|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060549|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
44060550|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
44060551|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060552|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060553|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
44060554|NCT00005985|Hormones|hormones|mesh-ancestor
44060555|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060556|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060557|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060558|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060559|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060560|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060561|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060562|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
44060563|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
44060564|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060565|NCT00005985|Analgesics|analgesics|mesh-ancestor
44060566|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
44060567|NCT00005986|Interferons|interferons|mesh-list
44060568|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
44060569|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
44060570|NCT00005986|Busulfan|busulfan|mesh-list
44060571|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060572|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
44060573|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060574|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060575|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060576|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
44060577|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060578|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060579|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060580|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
44060581|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060582|NCT00005987|Interferons|interferons|mesh-list
44060583|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
44060584|NCT00005987|Dexamethasone|dexamethasone|mesh-list
44060585|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
44060586|NCT00005987|Carmustine|carmustine|mesh-list
44060587|NCT00005987|Etoposide|etoposide|mesh-list
44060588|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
44060589|NCT00005987|Sargramostim|sargramostim|mesh-list
44060590|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060591|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
44060592|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060593|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060594|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255731|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255732|NCT00616785|Cisplatin|cisplatin|mesh-list
44255733|NCT00616785|Irinotecan|irinotecan|mesh-list
44060595|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
44060596|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060597|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060598|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060599|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060600|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
44060601|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
44060602|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060603|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060604|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
44060605|NCT00005987|Hormones|hormones|mesh-ancestor
44060606|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060607|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060608|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060611|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060613|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060615|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
44060616|NCT00005988|Leucovorin|leucovorin|mesh-list
44060617|NCT00005988|Cyclosporine|cyclosporine|mesh-list
44060618|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
44060619|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
44060620|NCT00005988|Methotrexate|methotrexate|mesh-list
44060621|NCT00005988|Cyclosporins|cyclosporins|mesh-list
44060622|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
44060623|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060624|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
44060625|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060626|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060627|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060628|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
44060629|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060630|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060631|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060632|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44060633|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
44060634|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44060635|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060636|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
44060637|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060638|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060639|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44060640|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44060641|NCT00005988|Antidotes|antidotes|mesh-ancestor
44060642|NCT00005988|Protective Agents|protective agents|mesh-ancestor
44060643|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
44060644|NCT00005988|Vitamins|vitamins|mesh-ancestor
44060645|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
44060646|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
44060647|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060648|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44060649|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060650|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
44060651|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
44060652|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060653|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060654|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
44060655|NCT00005988|Hormones|hormones|mesh-ancestor
44060656|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060657|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44060658|NCT00005989|Tipifarnib|tipifarnib|mesh-list
44060659|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060660|NCT00005990|Topotecan|topotecan|mesh-list
44060661|NCT00005990|Tipifarnib|tipifarnib|mesh-list
44060662|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060663|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060664|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060665|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060666|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060667|NCT00005991|Gemcitabine|gemcitabine|mesh-list
44060668|NCT00005991|Doxorubicin|doxorubicin|mesh-list
44060669|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43782842|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
44255734|NCT00616785|Etoposide|etoposide|mesh-list
44255735|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255736|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44255737|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255738|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255739|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255740|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255741|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255742|NCT00616850|Lidocaine|lidocaine|mesh-list
44255743|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
44255744|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
44255745|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909747|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
44255746|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255747|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
44255748|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255749|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44255750|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44255751|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44255752|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255753|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255754|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
44255755|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
44060670|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060671|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
44060672|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060673|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060674|NCT00005991|Antiviral Agents|antiviral agents|mesh-ancestor
44060675|NCT00005991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060676|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060677|NCT00005991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060678|NCT00005991|Immunologic Factors|immunologic factors|mesh-ancestor
44060679|NCT00005991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060680|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060681|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060682|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060683|NCT00005993|Aldesleukin|aldesleukin|mesh-list
44060684|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060696|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44060697|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44060698|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
44060699|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44060700|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060701|NCT00005994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44060702|NCT00005994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44060703|NCT00005994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44060704|NCT00005994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44060705|NCT00005994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44060706|NCT00005996|Gemcitabine|gemcitabine|mesh-list
44060708|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255756|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44255757|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44255758|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255759|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255760|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44255761|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44255763|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255764|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44255765|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
44255766|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255767|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44255768|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44255769|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44255770|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255771|NCT00616915|Bupropion|bupropion|mesh-list
44255772|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44255773|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
44255774|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255775|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44060709|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060710|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
44060711|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060712|NCT00005996|Antiviral Agents|antiviral agents|mesh-ancestor
44060713|NCT00005996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060714|NCT00005996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060715|NCT00005996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060716|NCT00005996|Immunologic Factors|immunologic factors|mesh-ancestor
44060717|NCT00005996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060718|NCT00005998|Cytarabine|cytarabine|mesh-list
44060719|NCT00005998|Dexamethasone|dexamethasone|mesh-list
44060720|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
44060721|NCT00005998|Carmustine|carmustine|mesh-list
44060722|NCT00005998|Etoposide|etoposide|mesh-list
44060723|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
44060724|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060725|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
44060726|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060727|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44060728|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060729|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
44060730|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060731|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060732|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060733|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060734|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
44060735|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
44060736|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060737|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060738|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
44060739|NCT00005998|Hormones|hormones|mesh-ancestor
44060740|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060741|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060742|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255776|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44255777|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255778|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255780|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255781|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255782|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44255783|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44255784|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255785|NCT00616993|Difluprednate|difluprednate|mesh-list
44255786|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
44255787|NCT00616993|Hormones|hormones|mesh-ancestor
44255788|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255789|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255790|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44255791|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44255792|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44255793|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653291|NCT02985333|Paclitaxel|paclitaxel|mesh-list
44060743|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060744|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060745|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060746|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060747|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
44060748|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
44060749|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060750|NCT00005998|Analgesics|analgesics|mesh-ancestor
44060760|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060761|NCT00006001|Semaxinib|semaxinib|mesh-list
44060762|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060763|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060764|NCT00006001|Growth Substances|growth substances|mesh-ancestor
44060765|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060766|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060767|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060768|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060769|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060770|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060771|NCT00006002|Dexamethasone|dexamethasone|mesh-list
44060772|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44060773|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
44060774|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
44060775|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060776|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060777|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060778|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
44060779|NCT00006002|Hormones|hormones|mesh-ancestor
44060780|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44060781|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44060782|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060783|NCT00006003|Semaxinib|semaxinib|mesh-list
44255794|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255795|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255796|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255798|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
44255799|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255800|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
44255801|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255802|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
44255803|NCT00617253|Sunitinib|sunitinib|mesh-list
44060784|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060785|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060786|NCT00006003|Growth Substances|growth substances|mesh-ancestor
44060787|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060788|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060789|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060790|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060791|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060792|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060793|NCT00006004|Gemcitabine|gemcitabine|mesh-list
44060794|NCT00006004|Paclitaxel|paclitaxel|mesh-list
44060795|NCT00006004|Cisplatin|cisplatin|mesh-list
44060796|NCT00006004|Carboplatin|carboplatin|mesh-list
44060797|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060798|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060799|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060800|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060801|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060802|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060803|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060804|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
44060805|NCT00006004|Antiviral Agents|antiviral agents|mesh-ancestor
44060806|NCT00006004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060807|NCT00006004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060808|NCT00006004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060809|NCT00006004|Immunologic Factors|immunologic factors|mesh-ancestor
44060810|NCT00006004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060811|NCT00006005|Thalidomide|thalidomide|mesh-list
44060812|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060813|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
44060814|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060815|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
44060816|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43557866|NCT03537612|Clonidine|clonidine|mesh-list
44060820|NCT00006005|Growth Substances|growth substances|mesh-ancestor
44060821|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060822|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060824|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
44060825|NCT00006006|Thalidomide|thalidomide|mesh-list
44060826|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060827|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
44060828|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060829|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
44060830|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060831|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060832|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
44060833|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44060834|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060835|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060836|NCT00006006|Growth Substances|growth substances|mesh-ancestor
44060837|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060838|NCT00006007|Gemcitabine|gemcitabine|mesh-list
44060839|NCT00006007|Pemetrexed|pemetrexed|mesh-list
44060840|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060841|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
44060842|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255804|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255805|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44255806|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44255807|NCT00617253|Growth Substances|growth substances|mesh-ancestor
44255808|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255809|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
44255810|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060843|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060844|NCT00006007|Antiviral Agents|antiviral agents|mesh-ancestor
44060845|NCT00006007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060846|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060847|NCT00006007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060848|NCT00006007|Immunologic Factors|immunologic factors|mesh-ancestor
44060849|NCT00006007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060850|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44060851|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44060852|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
44060853|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060854|NCT00006009|Visilizumab|visilizumab|mesh-list
44060855|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
44060856|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060857|NCT00006010|Gemcitabine|gemcitabine|mesh-list
44060858|NCT00006010|Docetaxel|docetaxel|mesh-list
44060859|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060860|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
44060861|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060862|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060863|NCT00006010|Antiviral Agents|antiviral agents|mesh-ancestor
44060864|NCT00006010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060865|NCT00006010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060866|NCT00006010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060867|NCT00006010|Immunologic Factors|immunologic factors|mesh-ancestor
44060868|NCT00006010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060869|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060870|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060871|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060872|NCT00006012|Paclitaxel|paclitaxel|mesh-list
44060873|NCT00006012|Etoposide|etoposide|mesh-list
44060874|NCT00006012|Cisplatin|cisplatin|mesh-list
44060875|NCT00006012|Topotecan|topotecan|mesh-list
44060876|NCT00006012|Amifostine|amifostine|mesh-list
44060877|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060878|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060879|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060880|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060881|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060882|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060883|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060884|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060885|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060886|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060887|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060888|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44060889|NCT00006012|Protective Agents|protective agents|mesh-ancestor
44060890|NCT00006013|Semaxinib|semaxinib|mesh-list
44060894|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060895|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060896|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060897|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060898|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060899|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060901|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060902|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060903|NCT00006014|Growth Substances|growth substances|mesh-ancestor
44060904|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060905|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060906|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060907|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44060908|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255811|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060909|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060911|NCT00006015|Fluorouracil|fluorouracil|mesh-list
44060912|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
44060913|NCT00006015|Trastuzumab|trastuzumab|mesh-list
44060914|NCT00006015|Calcium|calcium|mesh-list
44060915|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
44060916|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44060917|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060918|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
44060919|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060920|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060921|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060922|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060923|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
44152812|NCT00218140|Nicotine|nicotine|mesh-list
44060924|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44060925|NCT00006015|Antidotes|antidotes|mesh-ancestor
44060926|NCT00006015|Protective Agents|protective agents|mesh-ancestor
44060927|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
44060928|NCT00006015|Vitamins|vitamins|mesh-ancestor
44060929|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
44060930|NCT00006016|Thalidomide|thalidomide|mesh-list
44060931|NCT00006016|Doxorubicin|doxorubicin|mesh-list
44060932|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060933|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060934|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060935|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060936|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060937|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060938|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060939|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060940|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
44060941|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060942|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
44060943|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44060944|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060945|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060946|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060947|NCT00006016|Growth Substances|growth substances|mesh-ancestor
44060948|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
44060949|NCT00006018|Paclitaxel|paclitaxel|mesh-list
44060950|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060951|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060952|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060953|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060954|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060955|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060956|NCT00006019|Azacitidine|azacitidine|mesh-list
44060957|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44060958|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060959|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
44060960|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060961|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558010|NCT03536611|Warfarin|warfarin|mesh-list
44060966|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060968|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060969|NCT00006021|Vitamins|vitamins|mesh-ancestor
44060970|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
44060971|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060972|NCT00006022|Aldesleukin|aldesleukin|mesh-list
44060973|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
44060974|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060975|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44060976|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44060977|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
44060978|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060979|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44060980|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
44060981|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060982|NCT00006023|Capecitabine|capecitabine|mesh-list
44060983|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060984|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
44060985|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255812|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255813|NCT00617370|Paclitaxel|paclitaxel|mesh-list
44255814|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
44255815|NCT00617370|Epirubicin|epirubicin|mesh-list
44255816|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44255817|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255818|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
44255819|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255820|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255821|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255822|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255823|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
44255824|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255825|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255826|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255827|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
44255828|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060986|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150231|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150232|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150233|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
44150234|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150235|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44150236|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150237|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
44150238|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44150239|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44150240|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
44150241|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150242|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44150243|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44150244|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
44060987|NCT00006024|Temozolomide|temozolomide|mesh-list
44060988|NCT00006024|Lomustine|lomustine|mesh-list
44060989|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060990|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
44060991|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060992|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060993|NCT00006025|Irinotecan|irinotecan|mesh-list
44060994|NCT00006025|Temozolomide|temozolomide|mesh-list
44060995|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060996|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060997|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060998|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060999|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061000|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061001|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
44061002|NCT00006026|Rubitecan|rubitecan|mesh-list
44061003|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061004|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44061005|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061006|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061007|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061008|NCT00006027|Paclitaxel|paclitaxel|mesh-list
44061009|NCT00006027|Cisplatin|cisplatin|mesh-list
44061010|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061011|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255829|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44255830|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255831|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44255832|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061012|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061013|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061014|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061015|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061016|NCT00006028|Gemcitabine|gemcitabine|mesh-list
44061017|NCT00006028|Cisplatin|cisplatin|mesh-list
44061018|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061019|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061033|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
44061034|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061035|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061036|NCT00006029|Antiviral Agents|antiviral agents|mesh-ancestor
44061037|NCT00006029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061038|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061039|NCT00006029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061040|NCT00006029|Immunologic Factors|immunologic factors|mesh-ancestor
44061041|NCT00006029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061042|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44061043|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44061044|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061045|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061046|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061047|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061048|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061050|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44061051|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061052|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061053|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061054|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44061055|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061056|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44061057|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44061058|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44061059|NCT00006032|Etoposide|etoposide|mesh-list
44061060|NCT00006032|Topotecan|topotecan|mesh-list
44061061|NCT00006032|Ifosfamide|ifosfamide|mesh-list
44150245|NCT00209859|Hormones|hormones|mesh-ancestor
44061062|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061063|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061064|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44061065|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061066|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061067|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061068|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44061069|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061070|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
44061071|NCT00006033|Methotrexate|methotrexate|mesh-list
44061072|NCT00006033|Interleukin-2|interleukin-2|mesh-list
44061073|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44061074|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
44061075|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44061076|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061077|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061078|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
44061079|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061082|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061083|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44061084|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061085|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
44061086|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061087|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44061088|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44061089|NCT00006033|Analgesics|analgesics|mesh-ancestor
44061090|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
44461465|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
44461466|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44461467|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461468|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061091|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061092|NCT00006034|Doxorubicin|doxorubicin|mesh-list
44061093|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44061094|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44061095|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44061096|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061097|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44061098|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061099|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061100|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061101|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44061102|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
44061103|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061104|NCT00006035|Bleomycin|bleomycin|mesh-list
44061105|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44061106|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061107|NCT00006036|Cisplatin|cisplatin|mesh-list
44061108|NCT00006036|Lurtotecan|lurtotecan|mesh-list
44061109|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061110|NCT00006037|Fluorouracil|fluorouracil|mesh-list
44061111|NCT00006037|Irinotecan|irinotecan|mesh-list
44061112|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
44061113|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061114|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061115|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061116|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061117|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
44061118|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061119|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44061120|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061121|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061122|NCT00006038|Leucovorin|leucovorin|mesh-list
44061123|NCT00006038|Cisplatin|cisplatin|mesh-list
44061124|NCT00006038|Docetaxel|docetaxel|mesh-list
44061125|NCT00006038|Fluorouracil|fluorouracil|mesh-list
44061126|NCT00006038|Floxuridine|floxuridine|mesh-list
44061127|NCT00006038|Calcium|calcium|mesh-list
44061128|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
44061129|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061130|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061131|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061132|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061133|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061134|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44061135|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061136|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
44061137|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061138|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061140|NCT00006038|Antidotes|antidotes|mesh-ancestor
44061141|NCT00006038|Protective Agents|protective agents|mesh-ancestor
44061142|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
44061143|NCT00006038|Vitamins|vitamins|mesh-ancestor
44061144|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
44061145|NCT00006039|Interferons|interferons|mesh-list
44061146|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
44061147|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061148|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
44061149|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061150|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
44061151|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061152|NCT00006040|Etoposide|etoposide|mesh-list
44061153|NCT00006040|Antibodies|antibodies|mesh-list
44061154|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44061155|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
44061156|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558200|NCT03535233|Triamcinolone|triamcinolone|mesh-list
44061160|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061161|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061162|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061163|NCT00006041|Vaccines|vaccines|mesh-list
44461469|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461471|NCT01546857|Gabapentin|gabapentin|mesh-list
44461472|NCT01546857|Analgesics|analgesics|mesh-ancestor
44461473|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
44461474|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461475|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461476|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
44461477|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44461478|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461479|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461480|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461481|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44461482|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44461483|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097180|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461484|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461485|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
44461486|NCT01546688|Zonisamide|zonisamide|mesh-list
44461487|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
44461488|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44461489|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461490|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461491|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44061164|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
44061165|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
44061166|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061167|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44061168|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
44061169|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
44061170|NCT00006042|Fludarabine|fludarabine|mesh-list
44061171|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
44061172|NCT00006042|Tacrolimus|tacrolimus|mesh-list
44061173|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061174|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
44061175|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061176|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061177|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061178|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
44061179|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061180|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061181|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44061182|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061183|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
44061184|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44061185|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061186|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44061187|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44061188|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
44461492|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461493|NCT01546649|Leuprolide|leuprolide|mesh-list
44461494|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44461495|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
44461496|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653330|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061189|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44061190|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061191|NCT05680974|Antibodies|antibodies|mesh-list
44061192|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
44061193|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061194|NCT05680870|Omeprazole|omeprazole|mesh-list
44061195|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44061196|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44061197|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44061198|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061199|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061201|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
44061202|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
44061203|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061204|NCT05680857|Vitamins|vitamins|mesh-ancestor
44061205|NCT05680818|Vitamin D|vitamin d|mesh-list
44061206|NCT05680818|Calcitriol|calcitriol|mesh-list
44061207|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
44061208|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44061209|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
44061210|NCT05680818|Calcium|calcium|mesh-list
44061211|NCT05680818|Vitamins|vitamins|mesh-ancestor
44061212|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
44061213|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061214|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44061215|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44061216|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44061217|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44061218|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061219|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44061221|NCT05680805|Metformin|metformin|mesh-list
44061222|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061223|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061224|NCT05680792|Ritonavir|ritonavir|mesh-list
44061225|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44061226|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
44061227|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44061228|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44061229|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061230|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061231|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061239|NCT05680662|Metformin|metformin|mesh-list
44061240|NCT05680662|Quercetin|quercetin|mesh-list
44061241|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061242|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061243|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
44061244|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061245|NCT05680662|Protective Agents|protective agents|mesh-ancestor
44061246|NCT05680584|Melatonin|melatonin|mesh-list
44061247|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
44061248|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
44061249|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061250|NCT05680584|Protective Agents|protective agents|mesh-ancestor
44061251|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061252|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061253|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
44061254|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
44061255|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44061256|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
44061257|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
44061258|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061259|NCT05680558|Methoxsalen|methoxsalen|mesh-list
44061260|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44061261|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44061262|NCT05680545|Sevoflurane|sevoflurane|mesh-list
44061263|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44461497|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461498|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461499|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461500|NCT01546623|Leuprolide|leuprolide|mesh-list
44461501|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44461502|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
44461503|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653339|NCT02985242|Empagliflozin|empagliflozin|mesh-list
44061264|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44061265|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
44061266|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
44061267|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061268|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061269|NCT05680389|Minocycline|minocycline|mesh-list
44061270|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44061271|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061272|NCT05680194|Diphosphonates|diphosphonates|mesh-list
44061273|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44061274|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061275|NCT05680142|Tramadol|tramadol|mesh-list
44061276|NCT05680142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44061277|NCT05680142|Narcotics|narcotics|mesh-ancestor
44061278|NCT05680142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061279|NCT05680142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061280|NCT05680142|Analgesics|analgesics|mesh-ancestor
44061281|NCT05680142|Sensory System Agents|sensory system agents|mesh-ancestor
44061282|NCT05680142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061283|NCT05680129|Metformin|metformin|mesh-list
44061284|NCT05680129|Dulaglutide|dulaglutide|mesh-list
44061285|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061286|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061287|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
44061288|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061289|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061290|NCT05679908|Oxytocin|oxytocin|mesh-list
44061291|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
44061292|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44061293|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061294|NCT05679830|Cannabidiol|cannabidiol|mesh-list
44061295|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
44150246|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44150247|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44150248|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
44150249|NCT00209872|Lidocaine|lidocaine|mesh-list
44150250|NCT00209872|Ketamine|ketamine|mesh-list
44150251|NCT00209872|Gabapentin|gabapentin|mesh-list
44150252|NCT00209872|Esketamine|esketamine|mesh-list
44150263|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150264|NCT00209872|Analgesics|analgesics|mesh-ancestor
44150265|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44150266|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44150267|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
44150268|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44150269|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44150270|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150271|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
44150272|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44150273|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150274|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150275|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
44150276|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
44150278|NCT00209885|Droperidol|droperidol|mesh-list
44150279|NCT00209885|Ketamine|ketamine|mesh-list
44150280|NCT00209885|Gabapentin|gabapentin|mesh-list
44150281|NCT00209885|Esketamine|esketamine|mesh-list
44150282|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
44150283|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
44150284|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150285|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150286|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
43783225|NCT02758431|Anastrozole|anastrozole|mesh-list
44461504|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461505|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461507|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
44461508|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44150287|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150288|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44150289|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44150290|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44150291|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150292|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150293|NCT00209885|Analgesics|analgesics|mesh-ancestor
44150294|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44150295|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44150296|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
44150297|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44150298|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44150299|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150300|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
44150301|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44150302|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150303|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150305|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
44150306|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44150307|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
44150308|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
44150309|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44150310|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150311|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150312|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150313|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
44150314|NCT00209924|Gaboxadol|gaboxadol|mesh-list
44150315|NCT00209924|Analgesics|analgesics|mesh-ancestor
44150316|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
44097376|NCT00046176|Lamivudine|lamivudine|mesh-list
44150317|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558414|NCT03533556|Caffeine|caffeine|mesh-list
44061306|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061307|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061308|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44061309|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061310|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44061311|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44061312|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061313|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061314|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
44061315|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
44061316|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061317|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
44061318|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061319|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061320|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061321|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
44061322|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061323|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061324|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44061325|NCT05679401|Hormones|hormones|mesh-ancestor
44061326|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061327|NCT05679388|Ritonavir|ritonavir|mesh-list
44061328|NCT05679388|Itraconazole|itraconazole|mesh-list
44061329|NCT05679388|Relugolix|relugolix|mesh-list
44061330|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44061331|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44061332|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061333|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061334|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061335|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44061336|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44061337|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
44061338|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461509|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461510|NCT01546038|Cytarabine|cytarabine|mesh-list
44461511|NCT01546038|Decitabine|decitabine|mesh-list
44461512|NCT01546038|Daunorubicin|daunorubicin|mesh-list
44461513|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44461514|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
44461515|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461516|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461517|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
44461518|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461519|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061339|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44061340|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44061341|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
44061342|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44061343|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44061344|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061345|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061346|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061347|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
44061348|NCT05679375|Ketamine|ketamine|mesh-list
44061349|NCT05679375|Analgesics|analgesics|mesh-ancestor
44061350|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
44061351|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061352|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061353|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44061355|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
44061356|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
44061357|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061364|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061365|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
44061366|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061367|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061368|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784686|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
44061369|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
44061370|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061371|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061372|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44061373|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061374|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44061376|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061377|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
44061378|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061379|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061380|NCT05677919|Venetoclax|venetoclax|mesh-list
44061381|NCT05677919|Pyrazole|pyrazole|mesh-list
44061382|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061383|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061384|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061385|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
44061386|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44061387|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061388|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
44061389|NCT05675943|Antibodies|antibodies|mesh-list
44061390|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
44061391|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061392|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44061393|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061394|NCT05675163|Vitamin K|vitamin k|mesh-list
44061395|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
44061396|NCT05675163|Vitamins|vitamins|mesh-ancestor
44061397|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
44061398|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461520|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
44461521|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461522|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44255833|NCT00617448|Anesthetics|anesthetics|mesh-list
44255834|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061399|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44061400|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44061401|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061402|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
44061403|NCT05675163|Coagulants|coagulants|mesh-ancestor
44061404|NCT05673629|Docetaxel|docetaxel|mesh-list
44061405|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061406|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061407|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061408|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061409|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061410|NCT05669664|Leuprolide|leuprolide|mesh-list
44061411|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
44061412|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44061413|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
44061414|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44061415|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061416|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44097502|NCT00046735|Lenalidomide|lenalidomide|mesh-list
44061417|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061418|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061419|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061420|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
44061421|NCT05664217|Antithrombins|antithrombins|mesh-list
44061422|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44061423|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061424|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558539|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
44061444|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150320|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
44061445|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061446|NCT05656027|Miotics|miotics|mesh-ancestor
44061447|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
44061448|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061449|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44061453|NCT05645536|Tamoxifen|tamoxifen|mesh-list
44061454|NCT05645536|Letrozole|letrozole|mesh-list
44061455|NCT05645536|Anastrozole|anastrozole|mesh-list
44061456|NCT05645536|Exemestane|exemestane|mesh-list
44061457|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061458|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44061459|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44061460|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061461|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061462|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44061463|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061464|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061465|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061466|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44061467|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44061468|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44061469|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44061470|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
44061471|NCT05633602|Ramucirumab|ramucirumab|mesh-list
44061472|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061473|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061474|NCT05626725|Insulin|insulin|mesh-list
44061475|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061476|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061477|NCT05625412|Docetaxel|docetaxel|mesh-list
44061478|NCT05625412|Capecitabine|capecitabine|mesh-list
44061479|NCT05625412|Nivolumab|nivolumab|mesh-list
44061480|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061481|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061485|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061487|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44255835|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255836|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
44255837|NCT00617474|Hematinics|hematinics|mesh-ancestor
43824815|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061488|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44061489|NCT05620628|Durvalumab|durvalumab|mesh-list
44061490|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061491|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061492|NCT05617625|Fludarabine|fludarabine|mesh-list
44061493|NCT05617625|Melphalan|melphalan|mesh-list
44061494|NCT05617625|Busulfan|busulfan|mesh-list
44061495|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061496|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061497|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061498|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
44061499|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061500|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061501|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
44061502|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44061503|NCT05605509|Gemcitabine|gemcitabine|mesh-list
44061504|NCT05605509|Trastuzumab|trastuzumab|mesh-list
44061505|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061506|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
44061507|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061508|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061509|NCT05605509|Antiviral Agents|antiviral agents|mesh-ancestor
44061510|NCT05605509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061511|NCT05605509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061512|NCT05605509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061513|NCT05605509|Immunologic Factors|immunologic factors|mesh-ancestor
44061514|NCT05605509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061515|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44150321|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
44150322|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150323|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150324|NCT00209937|Gaboxadol|gaboxadol|mesh-list
44150325|NCT00209937|Analgesics|analgesics|mesh-ancestor
44061517|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44061518|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44061519|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44061520|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
44061521|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061522|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061523|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44061524|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
44061525|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
44061526|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
44061527|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44061528|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44061529|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
44061530|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061531|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061532|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
44061533|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44061534|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
44061535|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061536|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
44061537|NCT05591651|Protective Agents|protective agents|mesh-ancestor
44061538|NCT05581589|Camptothecin|camptothecin|mesh-list
44061539|NCT05581589|Irinotecan|irinotecan|mesh-list
44061540|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
44061541|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
44061542|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061543|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061544|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061545|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44061546|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44061547|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061548|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061559|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
44255839|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44255840|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255841|NCT00617513|Prucalopride|prucalopride|mesh-list
44255842|NCT00617513|Laxatives|laxatives|mesh-ancestor
44255843|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255844|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44255845|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44255846|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
44255847|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255848|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255849|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255850|NCT00617565|Insulin|insulin|mesh-list
44255851|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44255852|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
44255853|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
44255854|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44255855|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255856|NCT00617643|Nevirapine|nevirapine|mesh-list
44255857|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44255858|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255859|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255860|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255861|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
44255862|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255863|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255864|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255865|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44255866|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44255867|NCT00617656|Gemcitabine|gemcitabine|mesh-list
44255868|NCT00617656|Cisplatin|cisplatin|mesh-list
44255869|NCT00617656|Docetaxel|docetaxel|mesh-list
44255870|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061560|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061561|NCT05555888|Capecitabine|capecitabine|mesh-list
43784884|NCT05104788|Carboplatin|carboplatin|mesh-list
44061562|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
44061563|NCT05555888|Antibodies|antibodies|mesh-list
44061564|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
44061565|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061566|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061567|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
44061568|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255871|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255872|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
44255873|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061569|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061570|NCT05553522|Capecitabine|capecitabine|mesh-list
44061571|NCT05553522|Trastuzumab|trastuzumab|mesh-list
44061572|NCT05553522|Tucatinib|tucatinib|mesh-list
44061573|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061574|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
44061575|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061576|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061577|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061578|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44061579|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061580|NCT05552404|Aminophylline|aminophylline|mesh-list
44061581|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44061582|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
44061583|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061584|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061585|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44061586|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
44061587|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44061588|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44061589|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061590|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061591|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44061592|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44061593|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
44061594|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061595|NCT05552404|Protective Agents|protective agents|mesh-ancestor
44061597|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061598|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061599|NCT05546320|Aspirin|aspirin|mesh-list
44061600|NCT05546320|Metoprolol|metoprolol|mesh-list
44061601|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
44061602|NCT05546320|Clopidogrel|clopidogrel|mesh-list
44061603|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44061604|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44061605|NCT05546320|Analgesics|analgesics|mesh-ancestor
44061606|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
44061607|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061608|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097662|NCT00047099|Goserelin|goserelin|mesh-list
44061609|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44061610|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061611|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44061612|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44061613|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061624|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
44061625|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44061626|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061627|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
44061628|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44061629|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44061630|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
44061631|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
44061632|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44061633|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44061634|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44061635|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061636|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44061637|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061638|NCT05536791|Dabigatran|dabigatran|mesh-list
44061639|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
44061640|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44061641|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061642|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061643|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061644|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
44061645|NCT05535595|Perindopril|perindopril|mesh-list
44061646|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44061647|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
44255875|NCT00617656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255876|NCT00617656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255877|NCT00617656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44255878|NCT00617656|Immunologic Factors|immunologic factors|mesh-ancestor
44255879|NCT00617656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061648|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061649|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061650|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44061651|NCT05533775|Rituximab|rituximab|mesh-list
44061652|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
44061653|NCT05533775|Carboplatin|carboplatin|mesh-list
44061654|NCT05533775|Etoposide|etoposide|mesh-list
44061655|NCT05533775|Ifosfamide|ifosfamide|mesh-list
44061656|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061657|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061658|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
44061659|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061660|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061661|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061662|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44061663|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43840204|NCT04725994|Irinotecan|irinotecan|mesh-list
44061664|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061665|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061666|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061668|NCT05506943|Paclitaxel|paclitaxel|mesh-list
44061669|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061670|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061671|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061672|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061673|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061674|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061675|NCT05495204|Ibalizumab|ibalizumab|mesh-list
44061676|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44061677|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44061678|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44061690|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44061691|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061693|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
44061694|NCT05459571|Fludarabine|fludarabine|mesh-list
44061695|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061696|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
44061697|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061698|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061699|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061700|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
44061701|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061702|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061703|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44061704|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44061705|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
44061706|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
44061707|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061708|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44061709|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
44061710|NCT05459571|Hormones|hormones|mesh-ancestor
44061711|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061712|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44061713|NCT05457257|Prednisone|prednisone|mesh-list
44061714|NCT05457257|Olaparib|olaparib|mesh-list
44061715|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
44061716|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44061717|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
44061718|NCT05457257|Hormones|hormones|mesh-ancestor
44061719|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061720|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061721|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44061722|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783226|NCT02758431|Testosterone|testosterone|mesh-list
44255880|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
44255881|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255882|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061723|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44061724|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061725|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061726|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44061727|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061728|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44061729|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
44061730|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061731|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061732|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
44061733|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44061734|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061735|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061736|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44061737|NCT05439005|Analgesics|analgesics|mesh-ancestor
44061738|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
44061739|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061740|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44061741|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44061754|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061755|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061756|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061757|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061759|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
44061760|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061761|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44061762|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
44061763|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
44061764|NCT05423535|Coagulants|coagulants|mesh-ancestor
44061765|NCT05413018|Azacitidine|azacitidine|mesh-list
44061766|NCT05413018|Cc-486|cc-486|mesh-list
44061767|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061768|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
44061769|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061770|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061771|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061772|NCT05411861|Analgesics|analgesics|mesh-list
44061773|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
44061774|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
44061775|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061776|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061777|NCT05401786|Ipilimumab|ipilimumab|mesh-list
44061778|NCT05401786|Cemiplimab|cemiplimab|mesh-list
44061779|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061780|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061781|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44061782|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061783|NCT05388474|Ibalizumab|ibalizumab|mesh-list
44061784|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44061785|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44061786|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44061787|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
44061788|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061789|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
44061790|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061791|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
44061792|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061793|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44061794|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061795|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061796|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
44061797|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061798|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061799|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44255892|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44255893|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
44255894|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255895|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150326|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
44150327|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150328|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150329|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
44150330|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
44150331|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
44150332|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150333|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150334|NCT00209950|Gaboxadol|gaboxadol|mesh-list
44150335|NCT00209950|Analgesics|analgesics|mesh-ancestor
44150336|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
44150337|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150338|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150339|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
44150340|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
44150341|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
44150342|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150343|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150344|NCT00209963|Gaboxadol|gaboxadol|mesh-list
44150345|NCT00209963|Analgesics|analgesics|mesh-ancestor
44150346|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
44150347|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150348|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150349|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
44150350|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
44150351|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
44150352|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150353|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150354|NCT00209989|Tipifarnib|tipifarnib|mesh-list
44150355|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150356|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
44150357|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44150358|NCT00210002|Hematinics|hematinics|mesh-ancestor
44150359|NCT00210028|Tamoxifen|tamoxifen|mesh-list
44150360|NCT00210028|Tipifarnib|tipifarnib|mesh-list
44150361|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44150362|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
44150363|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44150364|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150365|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44150366|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255896|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255898|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44255899|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
43653355|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150367|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44150368|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44150369|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44150370|NCT00210041|Gemcitabine|gemcitabine|mesh-list
44150371|NCT00210041|Cisplatin|cisplatin|mesh-list
44150381|NCT00210041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150383|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
44150384|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
44150385|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150386|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150387|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
44150388|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150389|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
44150390|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44150391|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
44061826|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061827|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061828|NCT05298670|Metformin|metformin|mesh-list
44061829|NCT05298670|Interferons|interferons|mesh-list
44061830|NCT05298670|Interferon-beta|interferon-beta|mesh-list
44061831|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
44061832|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061833|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061834|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061835|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
44061836|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061837|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
44061838|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44061839|NCT05285683|Levodopa|levodopa|mesh-list
44061840|NCT05285683|Carbidopa|carbidopa|mesh-list
44061841|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44061842|NCT05285683|Methylphenidate|methylphenidate|mesh-list
44061843|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44061844|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061845|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44061846|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44061847|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44061848|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061849|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
44061850|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061851|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44061852|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44061853|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44061854|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061855|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44061856|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
44061857|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
44061858|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
44061859|NCT05281562|Vitamins|vitamins|mesh-ancestor
44061860|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
44061861|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061862|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
44061863|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061864|NCT05281562|Protective Agents|protective agents|mesh-ancestor
44061865|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
44061866|NCT05255666|Irinotecan|irinotecan|mesh-list
44061867|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061868|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061869|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44061870|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43559067|NCT04333160|Hylan|hylan|mesh-list
44061876|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44061877|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061878|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44061879|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44061880|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44255900|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255901|NCT00617799|Aldesleukin|aldesleukin|mesh-list
44255902|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255903|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255904|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44255905|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
44255906|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909978|NCT00345371|Topiramate|topiramate|mesh-list
44255907|NCT00617877|Losartan|losartan|mesh-list
44061881|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44061882|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
44061883|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
44061884|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
44061885|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
44061886|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061887|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061888|NCT05245071|Maytansine|maytansine|mesh-list
44061889|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061890|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061891|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061892|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061893|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061894|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061895|NCT05236673|Empagliflozin|empagliflozin|mesh-list
44061896|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44061897|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061898|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44061899|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061900|NCT05206175|Methamphetamine|methamphetamine|mesh-list
44061901|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44061902|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061903|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
44061904|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
44061905|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061906|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
44061907|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061908|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061909|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061910|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44061911|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44061912|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44061913|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44061915|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44061916|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
44061917|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
44061918|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061919|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
44061920|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44061921|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44061922|NCT05156710|Rituximab|rituximab|mesh-list
44061923|NCT05156710|Tacrolimus|tacrolimus|mesh-list
44061924|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
44061925|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44061926|NCT05156710|Antibodies|antibodies|mesh-list
44061927|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44061928|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
44061929|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44061930|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061931|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061932|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
44061933|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061934|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061935|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061936|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44061937|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061938|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061939|NCT05147233|Dexamethasone|dexamethasone|mesh-list
44061940|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255908|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44255909|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44255910|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44255911|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44255912|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43653368|NCT02984930|Mosapride|mosapride|mesh-list
44061941|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
44061949|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44061950|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061951|NCT05111262|Budesonide|budesonide|mesh-list
44061952|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
44061953|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44061954|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44061955|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
44061956|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061957|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061958|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44061959|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44061960|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
44061961|NCT05111262|Hormones|hormones|mesh-ancestor
44061962|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44061963|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44061964|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44061965|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44061966|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061967|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061968|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061969|NCT05056727|Valsartan|valsartan|mesh-list
44061970|NCT05056727|Lisinopril|lisinopril|mesh-list
44061971|NCT05056727|Irbesartan|irbesartan|mesh-list
44061972|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44061973|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44061974|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44061975|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061976|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44061977|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44061978|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061979|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44061980|NCT05056727|Protective Agents|protective agents|mesh-ancestor
44061981|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061982|NCT05023980|Rituximab|rituximab|mesh-list
44061983|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44061984|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061985|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061986|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
44061987|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061988|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44061989|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44061990|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
44061991|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061992|NCT05006794|Gemcitabine|gemcitabine|mesh-list
44061993|NCT05006794|Docetaxel|docetaxel|mesh-list
44061994|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061995|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
44061996|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061997|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061998|NCT05006794|Antiviral Agents|antiviral agents|mesh-ancestor
44061999|NCT05006794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062000|NCT05006794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062001|NCT05006794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062002|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
44062003|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062004|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062005|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062006|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062007|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
44062018|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062019|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44255913|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255914|NCT00617877|Diuretics|diuretics|mesh-ancestor
44255915|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
44255916|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255917|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44255918|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255919|NCT00617955|Aprotinin|aprotinin|mesh-list
44255920|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255921|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
44255922|NCT00617955|Coagulants|coagulants|mesh-ancestor
44255923|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44255924|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44255925|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
44255926|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255927|NCT00617968|Docetaxel|docetaxel|mesh-list
44255928|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255929|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44255930|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255931|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255932|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255933|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
44255934|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
44255935|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44255936|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44255937|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44255938|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255939|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44255940|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44255941|NCT00618059|Pilocarpine|pilocarpine|mesh-list
44255942|NCT00618059|Miotics|miotics|mesh-ancestor
44255943|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
44255944|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255945|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255946|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44062020|NCT04963296|Acetaminophen|acetaminophen|mesh-list
44062021|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
44062022|NCT04963296|Promethazine|promethazine|mesh-list
44062023|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
44062024|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
44062025|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44255947|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44255948|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
44255949|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255950|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062026|NCT04963296|Analgesics|analgesics|mesh-ancestor
44062027|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
44062028|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062029|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062030|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
44062031|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062032|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
44062033|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
44062034|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062035|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
44062036|NCT04963296|Hormones|hormones|mesh-ancestor
44062037|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062038|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44062039|NCT04963296|Protective Agents|protective agents|mesh-ancestor
44062040|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062041|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062042|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44062043|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44062044|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062045|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44062046|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
44062047|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44062048|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
44062049|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
44062050|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150392|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
44062051|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062053|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
44062054|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
44062055|NCT04959981|Osimertinib|osimertinib|mesh-list
44062056|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062057|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062058|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062059|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062060|NCT04958226|Midazolam|midazolam|mesh-list
44062061|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44062062|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44062063|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062064|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062065|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44062066|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44062067|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44062068|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44062069|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
44062070|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
44062071|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
44062072|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
44062073|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062074|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062075|NCT04941716|Venetoclax|venetoclax|mesh-list
44062084|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062085|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
44062086|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062087|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44062088|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44062089|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
44062090|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062091|NCT04915768|Antacids|antacids|mesh-ancestor
44062092|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062093|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44150393|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150394|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150395|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44150396|NCT00210158|Analgesics|analgesics|mesh-ancestor
44150397|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
44255952|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
44255953|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
44255954|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255955|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255956|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44255957|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44255958|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
44255959|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44255960|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255961|NCT00618124|Capecitabine|capecitabine|mesh-list
44255962|NCT00618124|Sunitinib|sunitinib|mesh-list
44255963|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44255964|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
44255965|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255966|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255967|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44255968|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44255969|NCT00618124|Growth Substances|growth substances|mesh-ancestor
44255970|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255971|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
44255972|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44255973|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255974|NCT00618163|Meloxicam|meloxicam|mesh-list
44255975|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653415|NCT02984852|Cobicistat|cobicistat|mesh-list
44150398|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150399|NCT00210210|Ketamine|ketamine|mesh-list
44150400|NCT00210210|Analgesics|analgesics|mesh-ancestor
44150401|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
44150402|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150403|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150404|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44150405|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44150406|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
44150407|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
44150408|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150409|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44150410|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44150411|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150412|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150413|NCT00210301|Modafinil|modafinil|mesh-list
44150414|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44150415|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150416|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44150417|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44150418|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44150419|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150420|NCT00210314|Cytarabine|cytarabine|mesh-list
44255976|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44255977|NCT00618163|Analgesics|analgesics|mesh-ancestor
44255978|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
44150421|NCT00210314|Methotrexate|methotrexate|mesh-list
44150422|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44150423|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
44062095|NCT04910568|Daratumumab|daratumumab|mesh-list
44062096|NCT04910568|Pomalidomide|pomalidomide|mesh-list
44062097|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062098|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
44062099|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
44062100|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062101|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062102|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062103|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
44062104|NCT04910568|Hormones|hormones|mesh-ancestor
44062105|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062106|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062107|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062108|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
44062109|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062110|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062111|NCT04910568|Growth Substances|growth substances|mesh-ancestor
44062112|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062120|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062121|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062122|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44062123|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44062124|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
44062125|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062127|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44062128|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062129|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062130|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062131|NCT04873362|Trastuzumab|trastuzumab|mesh-list
44062132|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44062133|NCT04873362|Atezolizumab|atezolizumab|mesh-list
44062134|NCT04873362|Maytansine|maytansine|mesh-list
44062135|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062136|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062137|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062138|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062139|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062140|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062141|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062142|NCT04857138|Atezolizumab|atezolizumab|mesh-list
44062143|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062144|NCT04833387|Antibodies|antibodies|mesh-list
44062145|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
44062146|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062148|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
44062149|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062150|NCT04803084|Protective Agents|protective agents|mesh-ancestor
44062151|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062152|NCT04793685|Prazosin|prazosin|mesh-list
44062153|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44062154|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44062155|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44062156|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44062157|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44062158|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062159|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062160|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062161|NCT04787991|Gemcitabine|gemcitabine|mesh-list
44062162|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
44062163|NCT04787991|Paclitaxel|paclitaxel|mesh-list
44062164|NCT04787991|Nivolumab|nivolumab|mesh-list
44062165|NCT04787991|Ipilimumab|ipilimumab|mesh-list
44062166|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062167|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785333|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
44255979|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44255980|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44255981|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44255983|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44255984|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44062168|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062169|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062170|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062171|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062172|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062173|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
44062174|NCT04787991|Antiviral Agents|antiviral agents|mesh-ancestor
44062175|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062176|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062177|NCT04787991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062178|NCT04787991|Immunologic Factors|immunologic factors|mesh-ancestor
43559390|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062183|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44062184|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44062185|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062187|NCT04743661|Dexamethasone|dexamethasone|mesh-list
44062188|NCT04743661|Bevacizumab|bevacizumab|mesh-list
44062190|NCT04743661|Temozolomide|temozolomide|mesh-list
44062191|NCT04743661|Antiemetics|antiemetics|mesh-list
44062192|NCT04743661|Emetics|emetics|mesh-list
44062193|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
44062194|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44062195|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062196|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062197|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062198|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062199|NCT04743661|Growth Substances|growth substances|mesh-ancestor
44062200|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062201|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062202|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062203|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
44098276|NCT00049023|Octreotide|octreotide|mesh-list
44062204|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062205|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062206|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
44062207|NCT04743661|Hormones|hormones|mesh-ancestor
44062208|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062209|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062210|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44062211|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44062212|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062213|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062214|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062215|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
44062216|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
44062217|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062218|NCT04742023|Insulin|insulin|mesh-list
44062219|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062220|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062222|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44062223|NCT04740918|Atezolizumab|atezolizumab|mesh-list
44062224|NCT04740918|Maytansine|maytansine|mesh-list
44062225|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062226|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062227|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062228|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062229|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062230|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062231|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062232|NCT04708886|Alendronate|alendronate|mesh-list
44098348|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
44098349|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098350|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098351|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098352|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
44098353|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098354|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098355|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44098356|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44098357|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44098358|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098359|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098361|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44098362|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062233|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44062234|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062235|NCT04686305|Cisplatin|cisplatin|mesh-list
44062236|NCT04686305|Carboplatin|carboplatin|mesh-list
44062237|NCT04686305|Trastuzumab|trastuzumab|mesh-list
44062238|NCT04686305|Pemetrexed|pemetrexed|mesh-list
44255985|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255986|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255988|NCT00618176|Zidovudine|zidovudine|mesh-list
44255989|NCT00618176|Nevirapine|nevirapine|mesh-list
44255990|NCT00618176|Didanosine|didanosine|mesh-list
44255991|NCT00618176|Stavudine|stavudine|mesh-list
44255992|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44255993|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255994|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44255995|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255996|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
44255997|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44255998|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44255999|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256000|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
44256001|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44256002|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44256003|NCT00618202|Balsalazide|balsalazide|mesh-list
44256004|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44256005|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256006|NCT00618202|Analgesics|analgesics|mesh-ancestor
44256007|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
44256008|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256010|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256035|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256036|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44256037|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062239|NCT04686305|Durvalumab|durvalumab|mesh-list
44062240|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062241|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062242|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062243|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062244|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44062245|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44062246|NCT04666038|Rituximab|rituximab|mesh-list
44062247|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44062248|NCT04666038|Idelalisib|idelalisib|mesh-list
44062249|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062250|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062251|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
44062255|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
44062256|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062257|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062258|NCT04659603|Gemcitabine|gemcitabine|mesh-list
44062259|NCT04659603|Maytansine|maytansine|mesh-list
44098378|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
44062260|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062261|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
44062262|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062263|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062264|NCT04659603|Antiviral Agents|antiviral agents|mesh-ancestor
44062265|NCT04659603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062266|NCT04659603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062267|NCT04659603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062268|NCT04659603|Immunologic Factors|immunologic factors|mesh-ancestor
44062269|NCT04659603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062270|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062271|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062272|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062273|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062274|NCT04650581|Fulvestrant|fulvestrant|mesh-list
44062275|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062276|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062277|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44062278|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44062279|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
44062280|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062281|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062282|NCT04643002|Dexamethasone|dexamethasone|mesh-list
44062283|NCT04643002|Pomalidomide|pomalidomide|mesh-list
44062284|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062285|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
44062286|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
44062287|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062288|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062289|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062290|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
44062291|NCT04643002|Hormones|hormones|mesh-ancestor
44062292|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062293|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062294|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062295|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
44062296|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062297|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062298|NCT04643002|Growth Substances|growth substances|mesh-ancestor
44062299|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062300|NCT04642365|Atezolizumab|atezolizumab|mesh-list
44062301|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062302|NCT04640545|Axitinib|axitinib|mesh-list
44062303|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062304|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062305|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062306|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062307|NCT04629248|Acetaminophen|acetaminophen|mesh-list
44062308|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
44062309|NCT04629248|Promethazine|promethazine|mesh-list
44256038|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44256039|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256040|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256041|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256042|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44256043|NCT00618254|Granisetron|granisetron|mesh-list
44256044|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
44256045|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
44256046|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256047|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062310|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
44062311|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
44062312|NCT04629248|Tacrolimus|tacrolimus|mesh-list
44062313|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062314|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
44062315|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062316|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44062317|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062318|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062319|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785419|NCT05110118|Bevacizumab|bevacizumab|mesh-list
44062320|NCT04629248|Analgesics|analgesics|mesh-ancestor
44062321|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
44062322|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062327|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062328|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
44062329|NCT04629248|Hormones|hormones|mesh-ancestor
44062330|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062331|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44062332|NCT04629248|Protective Agents|protective agents|mesh-ancestor
44062333|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062334|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062335|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44062336|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44062337|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062338|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
44062339|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
44062340|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44062341|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
44062342|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
44062343|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062344|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44062345|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
44062346|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44062347|NCT04590248|Adavosertib|adavosertib|mesh-list
44062348|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062349|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062350|NCT04575181|Insulin|insulin|mesh-list
44062351|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44062352|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
44062353|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062354|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062355|NCT04552080|Amoxicillin|amoxicillin|mesh-list
44062356|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44062357|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062358|NCT04551131|Dexamethasone|dexamethasone|mesh-list
44062359|NCT04551131|Etoposide|etoposide|mesh-list
44062360|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
44062361|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062362|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
44062363|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
44062364|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062365|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062366|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062367|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
44062368|NCT04551131|Hormones|hormones|mesh-ancestor
44062369|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256048|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256049|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44256050|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
44256051|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256052|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256053|NCT00618280|Nicotine|nicotine|mesh-list
44256054|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44256055|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
44256056|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062370|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062371|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062372|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062373|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44062374|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44062375|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062376|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062377|NCT04527107|Aflibercept|aflibercept|mesh-list
44062378|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062379|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062380|NCT04527107|Growth Substances|growth substances|mesh-ancestor
44062381|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062382|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062383|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062384|NCT04513522|Nivolumab|nivolumab|mesh-list
44062385|NCT04513522|Ipilimumab|ipilimumab|mesh-list
44062386|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062387|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062388|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062389|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062390|NCT04477343|Nivolumab|nivolumab|mesh-list
44062391|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062392|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062393|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062394|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062408|NCT04466475|Melphalan|melphalan|mesh-list
44062409|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
44062410|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44062411|NCT04466475|Daratumumab|daratumumab|mesh-list
44062412|NCT04466475|Antibodies|antibodies|mesh-list
44062413|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
44062414|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44062415|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
44062416|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062417|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062418|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062419|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
44062420|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062421|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44062422|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062423|NCT04449874|Bevacizumab|bevacizumab|mesh-list
44062424|NCT04449874|Cetuximab|cetuximab|mesh-list
44062425|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44062426|NCT04449874|Atezolizumab|atezolizumab|mesh-list
44062427|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062428|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062429|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062430|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062431|NCT04449874|Growth Substances|growth substances|mesh-ancestor
44062432|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062433|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062434|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062435|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062436|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062437|NCT04401995|Nivolumab|nivolumab|mesh-list
44062438|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256057|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256058|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44256059|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44256060|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44256061|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062439|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062440|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062441|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062442|NCT04390763|Gemcitabine|gemcitabine|mesh-list
44062443|NCT04390763|Paclitaxel|paclitaxel|mesh-list
44062444|NCT04390763|Spartalizumab|spartalizumab|mesh-list
44062445|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062446|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062447|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062448|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062449|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062450|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062451|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062452|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
44062453|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
44062454|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062459|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44150424|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44150425|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150426|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150427|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
44150428|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150429|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150430|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
44150431|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150432|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44150433|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062460|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
44062462|NCT04360473|Anesthetics|anesthetics|mesh-list
44062463|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098619|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
44062464|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062465|NCT04360473|Analgesics|analgesics|mesh-ancestor
44062466|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
44062467|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062468|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44062469|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44062470|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
44062471|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44062472|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44062473|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062474|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062475|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44062476|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
44062477|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44062478|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44062479|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44062480|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
44062481|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44062483|NCT04355572|Vitamins|vitamins|mesh-ancestor
44062484|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
44062485|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062486|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44062487|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44062488|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
44062489|NCT04329975|Coagulants|coagulants|mesh-ancestor
44062490|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44062491|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
44062492|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062493|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
44062494|NCT04305795|Cemiplimab|cemiplimab|mesh-list
44062495|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062496|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062497|NCT04246086|Lenalidomide|lenalidomide|mesh-list
44256062|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256064|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256065|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256066|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
44256067|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062498|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
44062499|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062500|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062501|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062502|NCT04246086|Growth Substances|growth substances|mesh-ancestor
44062503|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062504|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062505|NCT04221477|Acetaminophen|acetaminophen|mesh-list
44062506|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
44062507|NCT04221477|Promethazine|promethazine|mesh-list
44062508|NCT04221477|Prednisone|prednisone|mesh-list
44062509|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
44062510|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
44062511|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062512|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
44062513|NCT04221477|Hormones|hormones|mesh-ancestor
44062514|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062515|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062516|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062517|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062527|NCT04221477|Protective Agents|protective agents|mesh-ancestor
44062528|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062529|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44062530|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44062531|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062532|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
44062533|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
44062534|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44062535|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
44062536|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
44062537|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062538|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062539|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44062540|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
44062541|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
44062542|NCT04201834|Risperidone|risperidone|mesh-list
44062543|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44062544|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
44062545|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062546|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062547|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062548|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44062549|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44062550|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062551|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44062552|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44062553|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
44062554|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
44062555|NCT04201457|Trametinib|trametinib|mesh-list
44062556|NCT04201457|Dabrafenib|dabrafenib|mesh-list
44062557|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44062558|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
44062559|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44062560|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44062561|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062562|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062563|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062564|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062565|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062566|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062567|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44062568|NCT04201457|Protective Agents|protective agents|mesh-ancestor
44062569|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062570|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44256068|NCT00618358|Thrombin|thrombin|mesh-list
44256069|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44256070|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
44256071|NCT00618358|Coagulants|coagulants|mesh-ancestor
44256072|NCT00618384|Sorafenib|sorafenib|mesh-list
44256073|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653490|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
44062571|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
44062572|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
44062573|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44062574|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44062575|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062576|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
44062577|NCT04192435|Coagulants|coagulants|mesh-ancestor
44062578|NCT04191499|Fulvestrant|fulvestrant|mesh-list
44062579|NCT04191499|Palbociclib|palbociclib|mesh-list
44062580|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062581|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062582|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44062583|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44062584|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
44062585|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062601|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44062602|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062603|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062604|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062605|NCT04175613|Apremilast|apremilast|mesh-list
44062606|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44062607|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062608|NCT04175613|Analgesics|analgesics|mesh-ancestor
44062609|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
44062610|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150434|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
44062611|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062612|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062613|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062614|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44062615|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44062616|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062617|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062618|NCT04164199|Capecitabine|capecitabine|mesh-list
44062619|NCT04164199|Pemetrexed|pemetrexed|mesh-list
44062620|NCT04164199|Temozolomide|temozolomide|mesh-list
44062621|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062622|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
44062623|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062624|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062625|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062626|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44062627|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44062628|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062629|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
44062630|NCT04159519|Budesonide|budesonide|mesh-list
44062631|NCT04159519|Albuterol|albuterol|mesh-list
44062632|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
44062633|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44062634|NCT04159519|Benralizumab|benralizumab|mesh-list
44062635|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062636|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44062637|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
44062638|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062639|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062640|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44062641|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
44062642|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
44062660|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
44062661|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062662|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062663|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062664|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44256074|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256075|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256076|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256078|NCT00618397|Analgesics|analgesics|mesh-ancestor
44256079|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
44256080|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256081|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256082|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44256083|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44256084|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
44062665|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44062666|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062667|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44062668|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44062669|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062671|NCT04078568|Aspirin|aspirin|mesh-list
44062672|NCT04078568|Prednisolone|prednisolone|mesh-list
44062673|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
44062674|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44062675|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
44062676|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44062677|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44062678|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062679|NCT04078568|Analgesics|analgesics|mesh-ancestor
44062680|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
44062681|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062682|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062683|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062684|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785679|NCT03579693|Niacin|niacin|mesh-list
44062685|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44062686|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44062687|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062688|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44062689|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44062690|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062691|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
44062692|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
44062694|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062695|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062696|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062697|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
44062698|NCT04034927|Olaparib|olaparib|mesh-list
44062699|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44062700|NCT04034927|Tremelimumab|tremelimumab|mesh-list
44062708|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062709|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062710|NCT04009343|Lumefantrine|lumefantrine|mesh-list
44062711|NCT04009343|Artemether|artemether|mesh-list
44062712|NCT04009343|Piperaquine|piperaquine|mesh-list
44062713|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44062714|NCT04009343|Artenimol|artenimol|mesh-list
44062715|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
44062716|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44062717|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44062718|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062719|NCT03988257|Ascorbic Acid|ascorbic acid|mesh-list
44062720|NCT03988257|Vitamins|vitamins|mesh-ancestor
44062721|NCT03988257|Micronutrients|micronutrients|mesh-ancestor
44062722|NCT03988257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062723|NCT03988257|Antioxidants|antioxidants|mesh-ancestor
44062724|NCT03988257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062725|NCT03988257|Protective Agents|protective agents|mesh-ancestor
44256086|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256087|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44256088|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44256089|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256090|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256091|NCT00618423|Ketamine|ketamine|mesh-list
44256092|NCT00618423|Analgesics|analgesics|mesh-ancestor
44256093|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
44256094|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256095|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256096|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44062726|NCT03970837|Tofacitinib|tofacitinib|mesh-list
44062727|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062728|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062729|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062730|NCT03969641|Vaccines|vaccines|mesh-list
44062731|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
44062732|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062733|NCT03945357|Gemcitabine|gemcitabine|mesh-list
44062734|NCT03945357|Clindamycin|clindamycin|mesh-list
44062735|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
44062736|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
44062737|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062738|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
44062739|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062740|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062741|NCT03945357|Antiviral Agents|antiviral agents|mesh-ancestor
44062742|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062743|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062744|NCT03945357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062745|NCT03945357|Immunologic Factors|immunologic factors|mesh-ancestor
44062746|NCT03945357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062747|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44062748|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44062749|NCT03940586|Letermovir|letermovir|mesh-list
44062750|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44062751|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062752|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062753|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062754|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
44062755|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062756|NCT03913221|Caffeine|caffeine|mesh-list
44062757|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
44062758|NCT03913221|Citric Acid|citric acid|mesh-list
43785753|NCT02944799|Calcium|calcium|mesh-list
44062759|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
44062760|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
44062761|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44062762|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
44062763|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
44062764|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062765|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44062766|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062767|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44062768|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559990|NCT05411094|Durvalumab|durvalumab|mesh-list
44062776|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062778|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062779|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
44062780|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44062781|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
44062782|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
44062783|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062784|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062785|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062786|NCT03869736|Analgesics|analgesics|mesh-ancestor
44062787|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
44062788|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062789|NCT03801902|Durvalumab|durvalumab|mesh-list
44062790|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
44062791|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44062792|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
44062793|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062794|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062795|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
44062796|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062797|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
44062798|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062799|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062800|NCT03798626|Leucovorin|leucovorin|mesh-list
44062801|NCT03798626|Paclitaxel|paclitaxel|mesh-list
44062802|NCT03798626|Bevacizumab|bevacizumab|mesh-list
44062803|NCT03798626|Fluorouracil|fluorouracil|mesh-list
44062804|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
44062805|NCT03798626|Irinotecan|irinotecan|mesh-list
44062806|NCT03798626|Ramucirumab|ramucirumab|mesh-list
44062807|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
44062808|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44062809|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062810|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44062811|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44062812|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44062813|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062814|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062815|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44062816|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062817|NCT03798626|Growth Substances|growth substances|mesh-ancestor
44062818|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062819|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062820|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
44062821|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062822|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062823|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
44062824|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44062825|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44062826|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062827|NCT03798626|Antidotes|antidotes|mesh-ancestor
44062828|NCT03798626|Protective Agents|protective agents|mesh-ancestor
44062829|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
44062830|NCT03798626|Vitamins|vitamins|mesh-ancestor
44062831|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
44062832|NCT03786081|Bevacizumab|bevacizumab|mesh-list
44062833|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
44062834|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
44062835|NCT03786081|Carboplatin|carboplatin|mesh-list
44062836|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062837|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062838|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43560061|NCT05292339|Ketorolac|ketorolac|mesh-list
44062847|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062848|NCT03772964|Metformin|metformin|mesh-list
44062849|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062850|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062851|NCT03771157|Vaccines|vaccines|mesh-list
44062852|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
44062853|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062854|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
44062855|NCT03765229|Entinostat|entinostat|mesh-list
44062856|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062857|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062858|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44062859|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062860|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062861|NCT03741933|Apremilast|apremilast|mesh-list
44062862|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44062863|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062864|NCT03741933|Analgesics|analgesics|mesh-ancestor
44062865|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
44062866|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256097|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44256098|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
44256099|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
44098946|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
44062867|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062868|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062869|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062870|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44062871|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44062872|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062873|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062874|NCT03721172|Apremilast|apremilast|mesh-list
44062875|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44062876|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062877|NCT03721172|Analgesics|analgesics|mesh-ancestor
44062878|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
44062879|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062880|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062881|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062882|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062883|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44062884|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44062885|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062886|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062887|NCT03695380|Atezolizumab|atezolizumab|mesh-list
44062888|NCT03695380|Niraparib|niraparib|mesh-list
44062889|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062890|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44062891|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062892|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062893|NCT03678753|Cenobamate|cenobamate|mesh-list
44062894|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
44062895|NCT03662659|Nivolumab|nivolumab|mesh-list
44062896|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062897|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062898|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062899|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062900|NCT03628209|Nivolumab|nivolumab|mesh-list
44062901|NCT03628209|Azacitidine|azacitidine|mesh-list
44062902|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062903|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062907|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
44062908|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062910|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44150435|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062911|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062912|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062913|NCT03620942|Phenylephrine|phenylephrine|mesh-list
44062914|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
44062915|NCT03620942|Ephedrine|ephedrine|mesh-list
44062916|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44062917|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44062918|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
44062919|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
44062920|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062921|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062922|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
44062923|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
44062924|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44062925|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44062926|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44062927|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44062928|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
44062929|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062930|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062931|NCT03620942|Protective Agents|protective agents|mesh-ancestor
44062932|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44062933|NCT03601923|Niraparib|niraparib|mesh-list
44062934|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44062935|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099007|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
44062936|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062937|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256100|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256101|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44150436|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44150437|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
44150438|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150439|NCT00210327|Bortezomib|bortezomib|mesh-list
44150440|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150441|NCT00210340|Rituximab|rituximab|mesh-list
44150442|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44150443|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150444|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
44150445|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150446|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44150447|NCT00210366|Idarubicin|idarubicin|mesh-list
44150448|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44150449|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150450|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44150451|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150452|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150453|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150454|NCT00210379|Rituximab|rituximab|mesh-list
44150455|NCT00210379|Methotrexate|methotrexate|mesh-list
44150456|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44150457|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150458|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
44150459|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150460|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44150461|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44150462|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
44150463|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44150464|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150465|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
44150466|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150467|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
44150468|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150469|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44150470|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150479|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44150480|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44150481|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150482|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785933|NCT04685772|Hormones|hormones|mesh-ancestor
44062939|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44062940|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44062941|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44062942|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062943|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44062944|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44062945|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44062946|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44062947|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
44062948|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
44062949|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
44062950|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
44099067|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44062951|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062952|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062953|NCT03568656|Atezolizumab|atezolizumab|mesh-list
44062954|NCT03568656|Olaparib|olaparib|mesh-list
44062955|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
44062956|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062957|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44062958|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062959|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062960|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44062961|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
44062962|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062963|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062964|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44062965|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
44062966|NCT03565445|Nivolumab|nivolumab|mesh-list
44062967|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256102|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44256103|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256104|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256105|NCT00618501|Leucovorin|leucovorin|mesh-list
44062968|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062969|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062970|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062971|NCT03530124|Vaccines|vaccines|mesh-list
44062972|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44062973|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
44062974|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062975|NCT03521570|Nivolumab|nivolumab|mesh-list
44062976|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062977|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062978|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062979|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062980|NCT03352765|Rituximab|rituximab|mesh-list
44062981|NCT03352765|Melphalan|melphalan|mesh-list
44062982|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44062983|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062984|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062985|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
44062986|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062987|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062988|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062989|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
44062990|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560274|NCT05039177|Cetuximab|cetuximab|mesh-list
44063005|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063007|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063008|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063009|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063010|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099136|NCT00051285|Enoximone|enoximone|mesh-list
44063011|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43785980|NCT04335058|Iron|iron|mesh-list
44063012|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44063013|NCT03297606|Growth Substances|growth substances|mesh-ancestor
44063014|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063015|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
44063016|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44063017|NCT03265405|Prednisolone|prednisolone|mesh-list
44063018|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44063019|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
44063020|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44063021|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
44063022|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44063023|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
44063024|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063025|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
44063026|NCT03265405|Hormones|hormones|mesh-ancestor
44063027|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063028|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063029|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063030|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063031|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
44063032|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
44063033|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063034|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063035|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44063036|NCT03265405|Protective Agents|protective agents|mesh-ancestor
44063037|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
44063038|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063039|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
44063040|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063041|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063042|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44063043|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
44063044|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063045|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256107|NCT00618501|Prednisolone|prednisolone|mesh-list
44256108|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
44256109|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44256110|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44256111|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44063046|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44063047|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
44063048|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063049|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063050|NCT03084939|Capecitabine|capecitabine|mesh-list
44063051|NCT03084939|Trastuzumab|trastuzumab|mesh-list
44063052|NCT03084939|Lapatinib|lapatinib|mesh-list
44063053|NCT03084939|Maytansine|maytansine|mesh-list
44063054|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44063055|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063063|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063064|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063065|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063067|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44063068|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44063069|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
44063070|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063071|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44063072|NCT03006172|Metformin|metformin|mesh-list
44063073|NCT03006172|Trastuzumab|trastuzumab|mesh-list
44063074|NCT03006172|Pertuzumab|pertuzumab|mesh-list
44063075|NCT03006172|Letrozole|letrozole|mesh-list
44063076|NCT03006172|Fulvestrant|fulvestrant|mesh-list
44063077|NCT03006172|Palbociclib|palbociclib|mesh-list
44063078|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44063079|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063080|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063081|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063082|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44063083|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44063084|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063085|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063086|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44063087|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
44063088|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063089|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063090|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44063091|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063093|NCT03003325|Interferons|interferons|mesh-list
44063094|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063095|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
44063096|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063097|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44063098|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44063099|NCT03003325|Analgesics|analgesics|mesh-ancestor
44063100|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
44063101|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063102|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063103|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063104|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063105|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44063106|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44063107|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063108|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44063109|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44063110|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063111|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
44063112|NCT03002259|Dexamethasone|dexamethasone|mesh-list
44063113|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063114|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
44063115|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
44063116|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063117|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063118|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063119|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
44063120|NCT03002259|Hormones|hormones|mesh-ancestor
44256113|NCT00618501|Etoposide|etoposide|mesh-list
44256114|NCT00618501|Vincristine|vincristine|mesh-list
44256115|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
44256116|NCT00618501|Daunorubicin|daunorubicin|mesh-list
44256117|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
44256118|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256119|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44256120|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
44063121|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063122|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063133|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063134|NCT02979977|Cetuximab|cetuximab|mesh-list
44063135|NCT02979977|Afatinib|afatinib|mesh-list
44063136|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063137|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063138|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063139|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063140|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063141|NCT02966548|Nivolumab|nivolumab|mesh-list
44063142|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063143|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063144|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063145|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063146|NCT02936505|Cyclosporine|cyclosporine|mesh-list
44063147|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
44063148|NCT02936505|Tacrolimus|tacrolimus|mesh-list
44063149|NCT02936505|Cyclosporins|cyclosporins|mesh-list
44063150|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
44063151|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44063152|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063153|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
44063154|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063155|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44063156|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063157|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063158|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
44063159|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063160|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786114|NCT03512262|Abaloparatide|abaloparatide|mesh-list
44063161|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063162|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44063163|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063164|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44063165|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
44063166|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44063167|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
44063168|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
44063169|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44063170|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063171|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063172|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
44063173|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44063174|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44063175|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063176|NCT02921555|Prednisone|prednisone|mesh-list
44063177|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
44063178|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44063179|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44063180|NCT02921555|Prednisolone|prednisolone|mesh-list
44063181|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
44063182|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44063183|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
44063184|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063185|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
44063186|NCT02921555|Hormones|hormones|mesh-ancestor
44063187|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256121|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44256122|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256123|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
44256124|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256125|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256126|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256127|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256128|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43910191|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256129|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256130|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
44256131|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653536|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44063188|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063189|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063195|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44063196|NCT02921555|Protective Agents|protective agents|mesh-ancestor
44063197|NCT02890069|Everolimus|everolimus|mesh-list
44063198|NCT02890069|Panobinostat|panobinostat|mesh-list
44063199|NCT02890069|Spartalizumab|spartalizumab|mesh-list
44063200|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063201|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063202|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
44063203|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063204|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44063205|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063206|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063207|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063208|NCT02773030|Dexamethasone|dexamethasone|mesh-list
44063209|NCT02773030|Bortezomib|bortezomib|mesh-list
44063210|NCT02773030|Daratumumab|daratumumab|mesh-list
44063211|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063212|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
44063213|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
44063214|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063215|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063216|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063217|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
44063218|NCT02773030|Hormones|hormones|mesh-ancestor
44063219|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063220|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063221|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063222|NCT02712151|Ropivacaine|ropivacaine|mesh-list
44063223|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
44063224|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
44063225|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44063226|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063227|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
44063228|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063229|NCT02687906|Meropenem|meropenem|mesh-list
44063230|NCT02687906|Vaborbactam|vaborbactam|mesh-list
44063231|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44063232|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44063233|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063234|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063235|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063236|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
44063237|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063238|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063239|NCT02672917|Gemcitabine|gemcitabine|mesh-list
44063240|NCT02672917|Paclitaxel|paclitaxel|mesh-list
44063241|NCT02672917|Folfirinox|folfirinox|mesh-list
44063242|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256132|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44256133|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256134|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44256135|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44256137|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256138|NCT00618501|Antidotes|antidotes|mesh-ancestor
44256139|NCT00618501|Protective Agents|protective agents|mesh-ancestor
44256140|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44256141|NCT00618501|Vitamins|vitamins|mesh-ancestor
44256142|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
44256143|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256144|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256145|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256146|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256147|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
44256148|NCT00618501|Hormones|hormones|mesh-ancestor
44063243|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063244|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063245|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063246|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063247|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063248|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063249|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
44063250|NCT02672917|Antiviral Agents|antiviral agents|mesh-ancestor
44063251|NCT02672917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063252|NCT02672917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063253|NCT02672917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063254|NCT02672917|Immunologic Factors|immunologic factors|mesh-ancestor
44063255|NCT02672917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063256|NCT02648997|Nivolumab|nivolumab|mesh-list
44063257|NCT02648997|Ipilimumab|ipilimumab|mesh-list
44063258|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063259|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063260|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063261|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063272|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063273|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44063274|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063275|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
44063276|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
44063277|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063279|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44063280|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44063281|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44063282|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063283|NCT02478099|Atezolizumab|atezolizumab|mesh-list
44063284|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063285|NCT02453984|Atezolizumab|atezolizumab|mesh-list
44063286|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063287|NCT02425501|Aflibercept|aflibercept|mesh-list
44063288|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44063289|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44063290|NCT02425501|Growth Substances|growth substances|mesh-ancestor
44063291|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063292|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
44063293|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063294|NCT02409238|Metformin|metformin|mesh-list
44063295|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44063296|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063297|NCT02373813|Folic Acid|folic acid|mesh-list
44063298|NCT02373813|Etanercept|etanercept|mesh-list
44256149|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256150|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44256151|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256152|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44256153|NCT00618527|Interferons|interferons|mesh-list
44256154|NCT00618527|Interferon-beta|interferon-beta|mesh-list
44256155|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
44256156|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
44256157|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256158|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
44256159|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256160|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43824884|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
44063299|NCT02373813|Methotrexate|methotrexate|mesh-list
44063300|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44063301|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
44063302|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44063303|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063304|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063305|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
44063306|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063307|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063308|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
44063309|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063310|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44063311|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063312|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
44063313|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063314|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063315|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44063316|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44063318|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
44063319|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063320|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063321|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063322|NCT02373813|Hematinics|hematinics|mesh-ancestor
44063323|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
44063324|NCT02373813|Vitamins|vitamins|mesh-ancestor
44063325|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
44063326|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
44063327|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560602|NCT04106414|Nivolumab|nivolumab|mesh-list
44063363|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
44063364|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063365|NCT01853748|Paclitaxel|paclitaxel|mesh-list
44063366|NCT01853748|Maytansine|maytansine|mesh-list
44063367|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44063395|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063396|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44150483|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
44150484|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150485|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150486|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44150487|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150488|NCT00210457|Lanreotide|lanreotide|mesh-list
44150489|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150490|NCT00210483|Almotriptan|almotriptan|mesh-list
44150491|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44150492|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
44150493|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150494|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256161|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44256162|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
44256163|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782680|NCT04356534|Antibodies|antibodies|mesh-list
44150495|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150496|NCT00210496|Topiramate|topiramate|mesh-list
44150497|NCT00210496|Almotriptan|almotriptan|mesh-list
44150498|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
44150499|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150500|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150501|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44150502|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
44150503|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150516|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150517|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150518|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150519|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150520|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150521|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44150522|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44150523|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
44150524|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150525|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150526|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150527|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150528|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
44150530|NCT00210561|Tramadol|tramadol|mesh-list
44150531|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44150532|NCT00210561|Analgesics|analgesics|mesh-ancestor
44150533|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
44150534|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150535|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150536|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
44150537|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44150538|NCT00210561|Narcotics|narcotics|mesh-ancestor
44150539|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150540|NCT00210574|Topiramate|topiramate|mesh-list
44150541|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
44150542|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150543|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150544|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
44150545|NCT00210587|Hematinics|hematinics|mesh-ancestor
44150546|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
44150547|NCT00210600|Hematinics|hematinics|mesh-ancestor
44150548|NCT00210665|Trabectedin|trabectedin|mesh-list
44150549|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44150550|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
44150551|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150552|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150553|NCT00210691|Risperidone|risperidone|mesh-list
44063397|NCT00006043|Temozolomide|temozolomide|mesh-list
44063398|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44063399|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
44063400|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063401|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063402|NCT00006044|Testosterone|testosterone|mesh-list
44063403|NCT00006044|Androgens|androgens|mesh-ancestor
44063405|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063406|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063407|NCT00006045|Cytarabine|cytarabine|mesh-list
44063408|NCT00006045|Etoposide|etoposide|mesh-list
44063409|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
44063410|NCT00006045|Lintuzumab|lintuzumab|mesh-list
44063411|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063412|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063420|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063421|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063423|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063424|NCT00006045|Analgesics|analgesics|mesh-ancestor
44063425|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
44099549|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099550|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
44099551|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
44099552|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099553|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667718|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667719|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667720|NCT01235325|Vitamin K|vitamin k|mesh-list
44667721|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
44667722|NCT01235325|Vitamins|vitamins|mesh-ancestor
44667723|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
44667724|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667725|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44667726|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44667727|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667728|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
44667729|NCT01235325|Coagulants|coagulants|mesh-ancestor
44667730|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
44667731|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44667732|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667733|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667734|NCT01235455|Interferons|interferons|mesh-list
44667735|NCT01235455|Interferon-beta|interferon-beta|mesh-list
44667736|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
44667737|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667738|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
44667739|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667740|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
44667741|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667742|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44667743|NCT01235637|Sufentanil|sufentanil|mesh-list
44667744|NCT01235637|Alfentanil|alfentanil|mesh-list
44667745|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667746|NCT01235637|Narcotics|narcotics|mesh-ancestor
44667747|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667748|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667749|NCT01235637|Analgesics|analgesics|mesh-ancestor
44667750|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
44667751|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667752|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44667753|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44667754|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
44667755|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
44667756|NCT01235819|Insulin|insulin|mesh-list
44667757|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44667758|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44667759|NCT01235819|Exenatide|exenatide|mesh-list
44667760|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44667761|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667762|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667763|NCT01235819|Incretins|incretins|mesh-ancestor
44667764|NCT01235819|Hormones|hormones|mesh-ancestor
44062221|NCT04740918|Trastuzumab|trastuzumab|mesh-list
44667765|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667766|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
44667767|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667768|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667769|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44667770|NCT01236040|Vaccines|vaccines|mesh-list
44667771|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
44667772|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667773|NCT01236144|Plerixafor|plerixafor|mesh-list
44667774|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667775|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667776|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
44667777|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667778|NCT01236482|Oxytocin|oxytocin|mesh-list
44667779|NCT01236482|Ergonovine|ergonovine|mesh-list
44667780|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
44667781|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44667782|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667783|NCT01236495|Morphine|morphine|mesh-list
44667784|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667785|NCT01236495|Narcotics|narcotics|mesh-ancestor
44667786|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667787|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667788|NCT01236495|Analgesics|analgesics|mesh-ancestor
44667789|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
44667790|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667791|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44667792|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44667793|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667794|NCT01236586|Dexamethasone|dexamethasone|mesh-list
44667795|NCT01236586|R04929097|r04929097|mesh-list
44667796|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667797|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
44667798|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
44667799|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667800|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667801|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667802|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
44667803|NCT01236586|Hormones|hormones|mesh-ancestor
44099628|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667804|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667805|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44667806|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667807|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667808|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667809|NCT01236612|Chloroquine|chloroquine|mesh-list
44667810|NCT01236612|Proguanil|proguanil|mesh-list
44667811|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44667812|NCT01236612|Amebicides|amebicides|mesh-ancestor
44667813|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44667814|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44667815|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667816|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
44667817|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667818|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
44667819|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667820|NCT01236651|Drotaverin|drotaverin|mesh-list
44667821|NCT01236651|Meperidine|meperidine|mesh-list
44667822|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44667823|NCT01236651|Narcotics|narcotics|mesh-ancestor
44667824|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667825|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667826|NCT01236651|Analgesics|analgesics|mesh-ancestor
44667827|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
44667828|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667829|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44667830|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
44667831|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
44667832|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
44667833|NCT01236716|Gemcitabine|gemcitabine|mesh-list
44667834|NCT01236716|Paclitaxel|paclitaxel|mesh-list
44667835|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44667836|NCT01236716|Carboplatin|carboplatin|mesh-list
44667837|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44667838|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667839|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44667840|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44667841|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700456|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44667842|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667843|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44667844|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
44667845|NCT01236716|Antiviral Agents|antiviral agents|mesh-ancestor
44667846|NCT01236716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667847|NCT01236716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667848|NCT01236716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667849|NCT01236716|Immunologic Factors|immunologic factors|mesh-ancestor
44667850|NCT01236716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667851|NCT01236859|Gabapentin|gabapentin|mesh-list
44667852|NCT01236859|Analgesics|analgesics|mesh-ancestor
44667853|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
44667854|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667855|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667856|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
44667857|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44667858|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44667859|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44667860|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44667861|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44667862|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44667863|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667864|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667865|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
44667866|NCT01236911|Calcium|calcium|mesh-list
44667867|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44667868|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667869|NCT01236950|Listerine|listerine|mesh-list
44667870|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44667871|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667872|NCT01236963|Listerine|listerine|mesh-list
44667873|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44667874|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667875|NCT01236989|Liver Extracts|liver extracts|mesh-list
44667876|NCT01236989|Hematinics|hematinics|mesh-ancestor
44667877|NCT01237028|Calcitriol|calcitriol|mesh-list
44667878|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44667879|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667880|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44667881|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667882|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667883|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44667884|NCT01237028|Vitamins|vitamins|mesh-ancestor
44667885|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
44667886|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44667887|NCT01237067|Carboplatin|carboplatin|mesh-list
44667888|NCT01237067|Olaparib|olaparib|mesh-list
44667889|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667890|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44667891|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667892|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667893|NCT01237119|Liraglutide|liraglutide|mesh-list
44667894|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44667895|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667896|NCT01237119|Incretins|incretins|mesh-ancestor
44667897|NCT01237119|Hormones|hormones|mesh-ancestor
44667898|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667899|NCT01237249|Dexamethasone|dexamethasone|mesh-list
44667900|NCT01237249|Prednisone|prednisone|mesh-list
44667901|NCT01237249|Melphalan|melphalan|mesh-list
44667902|NCT01237249|Lenalidomide|lenalidomide|mesh-list
44667903|NCT01237249|Bortezomib|bortezomib|mesh-list
44667904|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667905|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
44667906|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
44667907|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667908|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667909|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667910|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
44667911|NCT01237249|Hormones|hormones|mesh-ancestor
44667912|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667913|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44667914|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667915|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44667916|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
44667917|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667918|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44667919|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667920|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
44667921|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099721|NCT00053001|Thalidomide|thalidomide|mesh-list
44667922|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44667923|NCT01237249|Growth Substances|growth substances|mesh-ancestor
44667924|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
44667925|NCT01237262|Adalimumab|adalimumab|mesh-list
44667926|NCT01237262|Etanercept|etanercept|mesh-list
44667927|NCT01237262|Infliximab|infliximab|mesh-list
44667928|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44667929|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44667930|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
44667931|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44667932|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44667933|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44667934|NCT01237262|Analgesics|analgesics|mesh-ancestor
44667935|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
44667936|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44667937|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667938|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44667939|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
44667940|NCT01237275|Sertraline|sertraline|mesh-list
44667941|NCT01237275|Fluoxetine|fluoxetine|mesh-list
44667942|NCT01237275|Paroxetine|paroxetine|mesh-list
44667943|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
44667944|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44667945|NCT01237275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44667946|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44667947|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44667948|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667949|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44667950|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
44667951|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667952|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44667953|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44667954|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44667955|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667956|NCT01237444|Ritonavir|ritonavir|mesh-list
44667957|NCT01237444|Lopinavir|lopinavir|mesh-list
44667958|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44667959|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44667960|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
44667961|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44667962|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667963|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44667964|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44667965|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
44667966|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667967|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44667968|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44667969|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44667970|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44667971|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44667972|NCT01237483|Cetuximab|cetuximab|mesh-list
44667973|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44667974|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44667975|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44667976|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
44667977|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667978|NCT01237522|Metformin|metformin|mesh-list
44667979|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235959|NCT00556634|Efavirenz|efavirenz|mesh-list
44667980|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667982|NCT01237535|Estrogens|estrogens|mesh-list
44667983|NCT01237535|Progestins|progestins|mesh-ancestor
44667984|NCT01237535|Hormones|hormones|mesh-ancestor
44667985|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44667986|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667987|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44667988|NCT01237730|Cefuroxime|cefuroxime|mesh-list
44667989|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
44667990|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44667991|NCT01237769|Vitamin D|vitamin d|mesh-list
44667992|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
44667993|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
44667994|NCT01237769|Vitamins|vitamins|mesh-list
44667995|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
44667996|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44667997|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44667998|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44667999|NCT01237782|Propolis|propolis|mesh-list
44668000|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44668001|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668002|NCT01237808|Cytarabine|cytarabine|mesh-list
44668003|NCT01237808|Etoposide|etoposide|mesh-list
44668004|NCT01237808|Tretinoin|tretinoin|mesh-list
44668005|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668006|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668007|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44668008|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44668009|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668010|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668011|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668012|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
44668013|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
44668014|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668015|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668016|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
44668017|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668018|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
44668019|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
44668020|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
44668021|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44668022|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44668023|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
44668024|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
44668025|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668026|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668027|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668028|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
44668029|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44668030|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44668031|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
44668032|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44668033|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44668034|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44668035|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668036|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668037|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
44668038|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668039|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668040|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44668041|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668042|NCT01238029|Capecitabine|capecitabine|mesh-list
44668043|NCT01238029|Vinorelbine|vinorelbine|mesh-list
44668044|NCT01238029|Lapatinib|lapatinib|mesh-list
44668045|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668046|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
44668047|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668048|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668049|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668050|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668051|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668052|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668053|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44668054|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668055|NCT01238055|Docetaxel|docetaxel|mesh-list
44668056|NCT01238055|Sunitinib|sunitinib|mesh-list
44668057|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668058|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668059|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668060|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668061|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668062|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668063|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668064|NCT01238055|Growth Substances|growth substances|mesh-ancestor
44668065|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668066|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668067|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44668068|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668069|NCT01238094|Simvastatin|simvastatin|mesh-list
44668070|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44668071|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44668072|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
44668073|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668074|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44668075|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44668076|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668077|NCT01238133|Paclitaxel|paclitaxel|mesh-list
44668078|NCT01238133|Carboplatin|carboplatin|mesh-list
44218508|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
44668079|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44668080|NCT01238133|R04929097|r04929097|mesh-list
44668081|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668082|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668083|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668084|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668085|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668086|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668087|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668088|NCT01238146|Rituximab|rituximab|mesh-list
44668089|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44668090|NCT01238146|Obatoclax|obatoclax|mesh-list
44668091|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099907|NCT00053300|Thalidomide|thalidomide|mesh-list
44668092|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668093|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
44668094|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668095|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668096|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44668097|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
44668098|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668099|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668100|NCT01238185|Aspirin|aspirin|mesh-list
44668101|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44668102|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44668103|NCT01238185|Analgesics|analgesics|mesh-ancestor
44668104|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
44668105|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668106|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668107|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668108|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668109|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44668110|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44668111|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668112|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44668113|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44668114|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668115|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
44668116|NCT01238224|Tadalafil|tadalafil|mesh-list
44668117|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
44668118|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44668119|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44668120|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668121|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668122|NCT01238224|Urological Agents|urological agents|mesh-ancestor
44668123|NCT01238237|Cetuximab|cetuximab|mesh-list
44668124|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44668125|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668126|NCT01238276|Cefazolin|cefazolin|mesh-list
44668127|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44668128|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668129|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
44668130|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44668131|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668132|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
44668133|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668135|NCT01238367|Coagulants|coagulants|mesh-ancestor
44668136|NCT01238393|Ranibizumab|ranibizumab|mesh-list
44668137|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668138|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668139|NCT01238393|Growth Substances|growth substances|mesh-ancestor
44668140|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668141|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668142|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668143|NCT01238406|Pancrelipase|pancrelipase|mesh-list
44668144|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218582|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668145|NCT01238523|Calpastatin|calpastatin|mesh-list
44668146|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44668147|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
44668148|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063426|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668149|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668150|NCT01238562|Lenograstim|lenograstim|mesh-list
44668151|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44668152|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
44668153|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668154|NCT01238627|Nicotine|nicotine|mesh-list
44668155|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44668156|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
44668157|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668158|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668159|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44668160|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44668161|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
44668162|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668163|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668164|NCT01238692|Rituximab|rituximab|mesh-list
44668165|NCT01238692|Panobinostat|panobinostat|mesh-list
44668166|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44668167|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668168|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
44668169|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668170|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668171|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44668172|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668173|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668174|NCT01238705|Metoprolol|metoprolol|mesh-list
44668175|NCT01238705|Felodipine|felodipine|mesh-list
44668176|NCT01238705|Irbesartan|irbesartan|mesh-list
44668177|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44668178|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44668179|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
44668180|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
44668181|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668182|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668183|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44668184|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44668185|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44668186|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44668187|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668188|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668189|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44668190|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44668191|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44668192|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668193|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44668194|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
44668195|NCT01238718|Lidocaine|lidocaine|mesh-list
44668196|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
44668197|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
44668198|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668199|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668200|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
44668201|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668202|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44668204|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44668205|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668206|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668207|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
44668208|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668209|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
44668210|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668211|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668212|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44668213|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
44668214|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668215|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668216|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44668217|NCT01238796|Telavancin|telavancin|mesh-list
44668218|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44668219|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668220|NCT01238926|Vitamins|vitamins|mesh-list
44668221|NCT01238926|Folic Acid|folic acid|mesh-list
44668222|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
44668223|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
44668224|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
44668225|NCT01238926|Pyridoxal|pyridoxal|mesh-list
44668226|NCT01238926|Pyridoxine|pyridoxine|mesh-list
44668227|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
44668228|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
44668229|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668230|NCT01238926|Hematinics|hematinics|mesh-ancestor
44668231|NCT01238952|Carboplatin|carboplatin|mesh-list
44668232|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668233|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
44668234|NCT01238965|Leucovorin|leucovorin|mesh-list
44668235|NCT01238965|Fluorouracil|fluorouracil|mesh-list
44668236|NCT01238965|Panobinostat|panobinostat|mesh-list
44668237|NCT01238965|Calcium|calcium|mesh-list
44668238|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
44668239|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44668240|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44668241|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668242|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44668243|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
44668244|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668245|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668246|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668247|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668248|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
44668249|NCT01238965|Antidotes|antidotes|mesh-ancestor
44668250|NCT01238965|Protective Agents|protective agents|mesh-ancestor
44668251|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
44668252|NCT01238965|Vitamins|vitamins|mesh-ancestor
44668253|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
44668254|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668255|NCT01238978|Vildagliptin|vildagliptin|mesh-list
44668256|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44668257|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668258|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44668259|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44668260|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668261|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668262|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44668263|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44668264|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44668265|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
44668266|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668267|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44668268|NCT01239017|Fasinumab|fasinumab|mesh-list
44668269|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44668270|NCT01239017|Analgesics|analgesics|mesh-ancestor
44668271|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
44668272|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668273|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668274|NCT01239030|Methylphenidate|methylphenidate|mesh-list
44668275|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44668276|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668277|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43778074|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
44668278|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44668279|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668280|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668281|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
44668282|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668283|NCT01239173|Propranolol|propranolol|mesh-list
44668284|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44668285|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44668286|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44668287|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668288|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668289|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668290|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44668291|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44668292|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
44668293|NCT01239368|Sirolimus|sirolimus|mesh-list
44668294|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44668295|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668296|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44668297|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668298|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
44668299|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668300|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
44668301|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668302|NCT01239459|Teriflunomide|teriflunomide|mesh-list
44668303|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
44668304|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44668305|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44668306|NCT01239459|Analgesics|analgesics|mesh-ancestor
44668307|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
44668308|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668309|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668310|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668311|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668312|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668313|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
44668314|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44668315|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44668316|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
44668317|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668318|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44668319|NCT01239485|Irinotecan|irinotecan|mesh-list
44668320|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44668321|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44668322|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668323|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668324|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668325|NCT01239498|Lidocaine|lidocaine|mesh-list
44668326|NCT01239498|Epinephrine|epinephrine|mesh-list
44668327|NCT01239498|Racepinephrine|racepinephrine|mesh-list
44668328|NCT01239498|Anesthetics|anesthetics|mesh-list
44668329|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
44668330|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
44668331|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668332|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668333|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
44668334|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668335|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44668336|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44668337|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44668338|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668339|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668340|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44668341|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44668342|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
44668343|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668344|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44668345|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44668346|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
44668347|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44668348|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
44668349|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
44668350|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
44668351|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44668352|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
44668353|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44668354|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668355|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
44668356|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44668357|NCT01239563|Basiliximab|basiliximab|mesh-list
44668358|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
44668359|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668360|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668361|NCT01239719|Clemastine|clemastine|mesh-list
44668362|NCT01239719|Dexamethasone|dexamethasone|mesh-list
44668363|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
44668364|NCT01239719|BB 1101|bb 1101|mesh-list
44668365|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668366|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
44668367|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
44668368|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668369|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218778|NCT00480272|Prednisone|prednisone|mesh-list
44668370|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44668371|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
44668372|NCT01239719|Hormones|hormones|mesh-ancestor
44668373|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668374|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668375|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668376|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44668377|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668378|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668379|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
44668380|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44668381|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44668382|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
44668383|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
44668384|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668385|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44668386|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
44668387|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44668388|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
44668389|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668390|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
44668391|NCT01239810|Protective Agents|protective agents|mesh-ancestor
44668392|NCT01239849|Atorvastatin|atorvastatin|mesh-list
44668393|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44668394|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44668395|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
44668396|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668397|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44668398|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44668399|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668400|NCT01239875|Vaccines|vaccines|mesh-list
44668401|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44668402|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
44668403|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668404|NCT01239888|Tibolone|tibolone|mesh-list
44668405|NCT01239888|Oxytocin|oxytocin|mesh-list
44668406|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
44668407|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44668408|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668409|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
44668410|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
44668411|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668412|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44668413|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668414|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668415|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44668416|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
44668417|NCT01239888|Hormones|hormones|mesh-ancestor
44668418|NCT01239940|Paclitaxel|paclitaxel|mesh-list
44668419|NCT01239940|Everolimus|everolimus|mesh-list
44668420|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668421|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668422|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668423|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668424|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668425|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668426|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668427|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
44668428|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668429|NCT01239953|Paclitaxel|paclitaxel|mesh-list
44668430|NCT01239953|Everolimus|everolimus|mesh-list
44668431|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668432|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668433|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668434|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668435|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668436|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668437|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668438|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
44668439|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668440|NCT01240213|Vitamin D|vitamin d|mesh-list
44668441|NCT01240213|Vitamins|vitamins|mesh-ancestor
44668442|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
44668443|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668444|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44668445|NCT01240265|Vitamin D|vitamin d|mesh-list
44668446|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
44218910|NCT00480649|Xhance|xhance|mesh-list
44668447|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
44668448|NCT01240265|Vitamins|vitamins|mesh-list
44668449|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
44668450|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668451|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44668452|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44668453|NCT01240850|Prednisone|prednisone|mesh-list
44668454|NCT01240850|Methotrexate|methotrexate|mesh-list
44668455|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668456|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
44668457|NCT01240850|Hormones|hormones|mesh-ancestor
44668458|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668459|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668460|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668461|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668462|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44668463|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
44668464|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44668465|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668466|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
44668467|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668468|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44668469|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668470|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44668471|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668472|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
44668473|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668474|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44668475|NCT01242410|Silicon|silicon|mesh-list
44668476|NCT01242410|Trace Elements|trace elements|mesh-ancestor
44668477|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
44668478|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668479|NCT01242605|Gemcitabine|gemcitabine|mesh-list
44668480|NCT01242605|Cisplatin|cisplatin|mesh-list
44668481|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668482|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668483|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
44668484|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668485|NCT01242605|Antiviral Agents|antiviral agents|mesh-ancestor
44668486|NCT01242605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668487|NCT01242605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668488|NCT01242605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668489|NCT01242605|Immunologic Factors|immunologic factors|mesh-ancestor
44668490|NCT01242605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668491|NCT01242774|Panobinostat|panobinostat|mesh-list
44668492|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668493|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44668494|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668495|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668496|NCT01242787|Entecavir|entecavir|mesh-list
44668497|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
44668498|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668499|NCT01243086|Dexamethasone|dexamethasone|mesh-list
44668500|NCT01243086|Ranibizumab|ranibizumab|mesh-list
44668501|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668502|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
44668503|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
44668504|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778116|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
44668505|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668506|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44668507|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
44668508|NCT01243086|Hormones|hormones|mesh-ancestor
44668509|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668510|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668511|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668512|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668513|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668514|NCT01243086|Growth Substances|growth substances|mesh-ancestor
44668515|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668516|NCT01243385|Metformin|metformin|mesh-list
44668517|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44668518|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668519|NCT01243476|Lenalidomide|lenalidomide|mesh-list
44668520|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
44668521|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668522|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668523|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668524|NCT01243476|Growth Substances|growth substances|mesh-ancestor
44668525|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668526|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668527|NCT01243697|Desogestrel|desogestrel|mesh-list
44668528|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44668529|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44668530|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44668531|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
44668532|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44668533|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668534|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44668535|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44668536|NCT01243697|Progestins|progestins|mesh-ancestor
44668537|NCT01243697|Hormones|hormones|mesh-ancestor
44668538|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668539|NCT01244347|Folic Acid|folic acid|mesh-list
44668540|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
44668541|NCT01244347|Hematinics|hematinics|mesh-ancestor
44668542|NCT01244347|Vitamins|vitamins|mesh-ancestor
44668543|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
44668544|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668545|NCT01244399|Inositol|inositol|mesh-list
44668546|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
44668547|NCT01244399|Vitamins|vitamins|mesh-ancestor
44668548|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
44668549|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668550|NCT01244880|Ketamine|ketamine|mesh-list
44668551|NCT01244880|Analgesics|analgesics|mesh-ancestor
44668552|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
44668553|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668554|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668555|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44668556|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44668557|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
44668558|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
44668559|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668560|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44668561|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44668562|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668563|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668564|NCT01244958|Rituximab|rituximab|mesh-list
44668565|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44668566|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668567|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
44668568|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668569|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668570|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44668571|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44668572|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
44668573|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668574|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668575|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44668576|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
44668578|NCT01245569|Hormones|hormones|mesh-ancestor
44668579|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668580|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
44668581|NCT01245660|Lapatinib|lapatinib|mesh-list
44668582|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668583|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44668584|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668585|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668586|NCT01245725|Tirofiban|tirofiban|mesh-list
44668587|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44668588|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44668589|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668590|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44668591|NCT01245959|Cisplatin|cisplatin|mesh-list
44668592|NCT01245959|Docetaxel|docetaxel|mesh-list
44668593|NCT01245959|Fluorouracil|fluorouracil|mesh-list
44668594|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668595|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668596|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668597|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668598|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668599|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
44668600|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668601|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668602|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
44668603|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668604|NCT01246323|Fentanyl|fentanyl|mesh-list
44668605|NCT01246323|Morphine|morphine|mesh-list
44668606|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
44668607|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668608|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668609|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44668610|NCT01246323|Narcotics|narcotics|mesh-ancestor
44668611|NCT01246323|Analgesics|analgesics|mesh-ancestor
44668612|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
44668613|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668614|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44668615|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44668616|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
44668617|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44668618|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44668619|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44668620|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668621|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
44668622|NCT01247805|Citric Acid|citric acid|mesh-list
44668623|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
44668624|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
44668625|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44668626|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
44668627|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
44668628|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668629|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44668630|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44668631|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44668632|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668633|NCT01247805|Urological Agents|urological agents|mesh-ancestor
44668634|NCT01247870|Metformin|metformin|mesh-list
44668635|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44668636|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668637|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44668638|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668639|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668640|NCT01248195|Olanzapine|olanzapine|mesh-list
44668641|NCT01248195|Clozapine|clozapine|mesh-list
44668642|NCT01248195|Amisulpride|amisulpride|mesh-list
44668643|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
44668644|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
44668645|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668646|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668647|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44668648|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44668649|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44668650|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668651|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44668652|NCT01248195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44668653|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44668654|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668655|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668656|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668657|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
44668658|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44668659|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
44668660|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
44668661|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44668662|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
44668663|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44668664|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
44668666|NCT01248299|Docetaxel|docetaxel|mesh-list
44668667|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
44668668|NCT01248299|Fluorouracil|fluorouracil|mesh-list
44668669|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668670|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668671|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668672|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668673|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668674|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
44668675|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668676|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668677|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
44668678|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668679|NCT01248871|Sufentanil|sufentanil|mesh-list
44668680|NCT01248871|Remifentanil|remifentanil|mesh-list
44668681|NCT01248871|Dsuvia|dsuvia|mesh-list
44668682|NCT01248871|Propofol|propofol|mesh-list
44668683|NCT01248871|Sevoflurane|sevoflurane|mesh-list
44668684|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44668685|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668686|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668687|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44668688|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
44668689|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
44668690|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44668691|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44668692|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44668693|NCT01248871|Narcotics|narcotics|mesh-ancestor
44668694|NCT01248871|Analgesics|analgesics|mesh-ancestor
44668695|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
44668696|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668697|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44668698|NCT01249352|Cisplatin|cisplatin|mesh-list
44668699|NCT01249352|Fluorouracil|fluorouracil|mesh-list
44668700|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
44668701|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668702|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
44668703|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668704|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668705|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668706|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
44668707|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668708|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44668709|NCT01249638|Bevacizumab|bevacizumab|mesh-list
44668710|NCT01249638|Capecitabine|capecitabine|mesh-list
44668711|NCT01249638|Irinotecan|irinotecan|mesh-list
44668712|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44668713|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668714|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668715|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668716|NCT01249638|Growth Substances|growth substances|mesh-ancestor
44668717|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668718|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668719|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44668720|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
44668721|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668722|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44668723|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44668724|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668725|NCT01249937|Triamcinolone|triamcinolone|mesh-list
44668726|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44100562|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668727|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44668728|NCT01249937|Ranibizumab|ranibizumab|mesh-list
44668729|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44668730|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44668731|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44668732|NCT01249937|Growth Substances|growth substances|mesh-ancestor
44668733|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668734|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
44668735|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668736|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100563|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100564|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100565|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100566|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100567|NCT00055159|Plasminogen|plasminogen|mesh-list
44100568|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44100569|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44100570|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43702678|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44668737|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
44668738|NCT01249937|Hormones|hormones|mesh-ancestor
44668739|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668740|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668741|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
44668742|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668743|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668744|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44668745|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44668746|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44668747|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44668748|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44668749|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
44668750|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668751|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668752|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668753|NCT01250249|Vaccines|vaccines|mesh-list
44668754|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
44668755|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
44668756|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668757|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44668758|NCT01250340|Aspirin|aspirin|mesh-list
44668759|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44668760|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44668761|NCT01250340|Analgesics|analgesics|mesh-ancestor
44668762|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
44668763|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668764|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668765|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668766|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668767|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44668768|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44668769|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668770|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44668771|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44668772|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668773|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
44668774|NCT01250366|Ribavirin|ribavirin|mesh-list
44668775|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
44668776|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668777|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
44668778|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668779|NCT01250405|Cinacalcet|cinacalcet|mesh-list
44668780|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44668781|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668782|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44668783|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
44668784|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668785|NCT01250457|Timolol|timolol|mesh-list
44668786|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44668787|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44668788|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
44668789|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668790|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668791|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668792|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44668793|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44668794|NCT01250470|Sargramostim|sargramostim|mesh-list
44668795|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44668796|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
44668797|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668798|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44668799|NCT01250496|Aminophylline|aminophylline|mesh-list
44668800|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44668802|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668803|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668804|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44668805|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
44668806|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44668807|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44668808|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668809|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668810|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44668811|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44668812|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
44668813|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668814|NCT01250496|Protective Agents|protective agents|mesh-ancestor
44668816|NCT01250535|Lovastatin|lovastatin|mesh-list
44668817|NCT01250535|L 647318|l 647318|mesh-list
44668818|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
44668819|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
44668820|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44668821|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44668822|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
44668823|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668824|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44668825|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44668826|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668827|NCT01250548|Apremilast|apremilast|mesh-list
44668828|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44668829|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44668830|NCT01250548|Analgesics|analgesics|mesh-ancestor
44668831|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
44668832|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668833|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668834|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668835|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668836|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44668837|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44668838|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668839|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668840|NCT01250561|Valacyclovir|valacyclovir|mesh-list
44668841|NCT01250561|Gabapentin|gabapentin|mesh-list
44668842|NCT01250561|Analgesics|analgesics|mesh-ancestor
44668843|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
44668844|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668845|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668846|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
44668847|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44668848|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44668849|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668850|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44668851|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44668852|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44668853|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668854|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668855|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
44668856|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
44668857|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668858|NCT01250652|Cetirizine|cetirizine|mesh-list
44668859|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
44668860|NCT01250652|Levocetirizine|levocetirizine|mesh-list
44668861|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44668862|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44668863|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
44668864|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
44668865|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668866|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668867|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668868|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44668869|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
44668870|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
44668871|NCT01250743|Vitamins|vitamins|mesh-list
44668872|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
44668873|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
44668874|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668875|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
44668876|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668877|NCT01250743|Protective Agents|protective agents|mesh-ancestor
44668878|NCT01250808|Dexamethasone|dexamethasone|mesh-list
44668879|NCT01250808|Bortezomib|bortezomib|mesh-list
44668880|NCT01250808|Melphalan|melphalan|mesh-list
44668881|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668882|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
44668883|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
44668884|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668885|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668886|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44668887|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
44668888|NCT01250808|Hormones|hormones|mesh-ancestor
44668889|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668890|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668891|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668892|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44668893|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
44668894|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668895|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44668896|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668897|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
44668898|NCT01250821|Menotropins|menotropins|mesh-list
44668899|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44668900|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
44668901|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44668902|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668903|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44668904|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
44668905|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44668906|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44668907|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44668908|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44668909|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668910|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44668911|NCT01250951|Deferasirox|deferasirox|mesh-list
44668912|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44668913|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
44668914|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
44668915|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668916|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
44668917|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44668918|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
44668919|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44668920|NCT01251029|Expectorants|expectorants|mesh-ancestor
44668921|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
44668922|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44668923|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
44668924|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668925|NCT01251029|Protective Agents|protective agents|mesh-ancestor
44668926|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668927|NCT01251029|Antidotes|antidotes|mesh-ancestor
44668928|NCT01251107|Prednisone|prednisone|mesh-list
44668929|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
44668930|NCT01251107|Dacarbazine|dacarbazine|mesh-list
44668931|NCT01251107|Doxorubicin|doxorubicin|mesh-list
44668932|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44668933|NCT01251107|Etoposide|etoposide|mesh-list
44668934|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
44668935|NCT01251107|Vincristine|vincristine|mesh-list
44668936|NCT01251107|Bleomycin|bleomycin|mesh-list
44668937|NCT01251107|Vinblastine|vinblastine|mesh-list
44668938|NCT01251107|Procarbazine|procarbazine|mesh-list
44668939|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668940|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
44668941|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668942|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44668943|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44668944|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
44668945|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668946|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668947|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44668948|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44668949|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44668950|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44668951|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668952|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44668953|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
44668954|NCT01251107|Hormones|hormones|mesh-ancestor
44668955|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668956|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44668957|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44668958|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44668959|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44668960|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44668961|NCT01251133|Vaccines|vaccines|mesh-list
44668962|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
44668963|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668964|NCT01251172|Melphalan|melphalan|mesh-list
44668965|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
44668966|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44668967|NCT01251172|R04929097|r04929097|mesh-list
44668968|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44668969|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
44668970|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668971|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44668972|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44668973|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44668974|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
44668975|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668976|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44668977|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
44668978|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44668979|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44668980|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44668981|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44668982|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44668983|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
44668984|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44668985|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668986|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44668987|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44668988|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44668989|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44668990|NCT01251263|Estradiol|estradiol|mesh-list
44668991|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44668992|NCT01251263|Estrogens|estrogens|mesh-ancestor
44668993|NCT01251263|Hormones|hormones|mesh-ancestor
44668994|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44668995|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44668996|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44668997|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
44668998|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44668999|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44669000|NCT01251328|Anesthetics|anesthetics|mesh-list
44669001|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669002|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669003|NCT01251458|Sirolimus|sirolimus|mesh-list
44669004|NCT01251458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44669005|NCT01251458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669006|NCT01251458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44669007|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669008|NCT01251458|Antifungal Agents|antifungal agents|mesh-ancestor
44669009|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44669010|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
44669011|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669012|NCT01251471|Citalopram|citalopram|mesh-list
44669013|NCT01251471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44669014|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44669015|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669016|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669017|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669018|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
44669019|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669020|NCT01251471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44669021|NCT01251471|Antidepressive Agents|antidepressive agents|mesh-ancestor
44669022|NCT01251471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669023|NCT01251484|Nintedanib|nintedanib|mesh-list
44669024|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669025|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44669026|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669027|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669028|NCT01251627|Decitabine|decitabine|mesh-list
44669029|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44669030|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
44669031|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669032|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669033|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669034|NCT01251640|Gemcitabine|gemcitabine|mesh-list
44669035|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44669036|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
44669037|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669038|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669039|NCT01251640|Antiviral Agents|antiviral agents|mesh-ancestor
44669040|NCT01251640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669041|NCT01251640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669042|NCT01251640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44669043|NCT01251640|Immunologic Factors|immunologic factors|mesh-ancestor
44669044|NCT01251640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669045|NCT01251718|Donepezil|donepezil|mesh-list
44669046|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44669047|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669048|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669049|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
44669050|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669051|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669052|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
44669053|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44669054|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669055|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44669056|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669057|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669058|NCT01251809|Pegaspargase|pegaspargase|mesh-list
44669059|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669060|NCT01251822|Prucalopride|prucalopride|mesh-list
44669061|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44669062|NCT01251822|Laxatives|laxatives|mesh-ancestor
44669063|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669064|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44669065|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44669066|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
44669067|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669068|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669069|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669070|NCT01251835|Rifampin|rifampin|mesh-list
44669071|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
44669072|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44669073|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
44669074|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44669075|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669076|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
44669077|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44669078|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063427|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669079|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669080|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44669081|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44669082|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44219490|NCT00482989|Sifalimumab|sifalimumab|mesh-list
44669083|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44669084|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44669085|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44669086|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44669087|NCT01251848|Ritonavir|ritonavir|mesh-list
44669088|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
44669089|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44669090|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44669091|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669092|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669093|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669094|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44669095|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44669096|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
44669097|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669098|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44669099|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44669100|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44669101|NCT01251874|Alovudine|alovudine|mesh-list
44669102|NCT01251874|Carboplatin|carboplatin|mesh-list
44669103|NCT01251874|Veliparib|veliparib|mesh-list
44669104|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669105|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44669106|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669107|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669108|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
44669109|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669110|NCT01251926|Bevacizumab|bevacizumab|mesh-list
44669111|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669112|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669113|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669114|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669115|NCT01251926|Growth Substances|growth substances|mesh-ancestor
44669116|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669117|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669118|NCT01251991|Psyllium|psyllium|mesh-list
44669119|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
44669120|NCT01251991|Cathartics|cathartics|mesh-ancestor
44669121|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669122|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
44669123|NCT01252056|Cilostazol|cilostazol|mesh-list
44669124|NCT01252056|Probucol|probucol|mesh-list
44669125|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669126|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
44669127|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669128|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669129|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669130|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669131|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44669132|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44669133|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669134|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44669135|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
44669136|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44669137|NCT01252056|Protective Agents|protective agents|mesh-ancestor
44669138|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44669139|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44669140|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669141|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44669142|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44669143|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
44669144|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44669145|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
44669146|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
44669147|NCT01252069|Progestins|progestins|mesh-list
44669148|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44669149|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
44669150|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44669151|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669152|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44669153|NCT01252069|Hormones|hormones|mesh-ancestor
44669154|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669155|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44669156|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
44669157|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44669158|NCT01252160|Capsaicin|capsaicin|mesh-list
44669159|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
44669160|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669161|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
44669162|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669163|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669164|NCT01252225|Lidocaine|lidocaine|mesh-list
44669165|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
44669166|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
44669167|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669168|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669169|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
44669170|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669171|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44669172|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44669173|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44669174|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669175|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669176|NCT01252342|Oxytocin|oxytocin|mesh-list
44669177|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
44669178|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44669179|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669180|NCT01252420|Enoxaparin|enoxaparin|mesh-list
44669181|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
44669182|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44669183|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44669184|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669185|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
44669186|NCT01252524|Psyllium|psyllium|mesh-list
44669187|NCT01252524|Calcium|calcium|mesh-list
44669188|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44669189|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669190|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
44669191|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669192|NCT01252524|Cathartics|cathartics|mesh-ancestor
44669193|NCT01252680|Vaccines|vaccines|mesh-list
44669194|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
44669195|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669196|NCT01252758|Albuterol|albuterol|mesh-list
44669197|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669198|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
44669199|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669200|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669201|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669202|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669203|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
44669204|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44669205|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44669206|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44669207|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669208|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669209|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669210|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669211|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44669212|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44669213|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669214|NCT01253382|Ecallantide|ecallantide|mesh-list
44669215|NCT01253382|Analgesics|analgesics|mesh-ancestor
44669216|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
44669217|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669218|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669219|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669220|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669221|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669222|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669223|NCT01253473|Budesonide|budesonide|mesh-list
44669224|NCT01253473|Albuterol|albuterol|mesh-list
44669225|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
44669226|NCT01253473|Ipratropium|ipratropium|mesh-list
44669227|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669228|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669229|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
44669230|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669231|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669232|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669233|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669234|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
44669235|NCT01253473|Hormones|hormones|mesh-ancestor
44669236|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669237|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44669238|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44669239|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669240|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669241|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669242|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669243|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
44669244|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44669245|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44669246|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44669247|NCT01253681|Paclitaxel|paclitaxel|mesh-list
44669248|NCT01253681|Carboplatin|carboplatin|mesh-list
44669249|NCT01253681|Trebananib|trebananib|mesh-list
44669250|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669251|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669252|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669253|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669254|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669255|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669256|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669257|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669258|NCT01253681|Growth Substances|growth substances|mesh-ancestor
44669259|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669260|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669262|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669263|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669264|NCT01253694|Growth Substances|growth substances|mesh-ancestor
44669265|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669266|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669267|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669268|NCT01253928|Pioglitazone|pioglitazone|mesh-list
44669269|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669270|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669271|NCT01254006|Thiamine|thiamine|mesh-list
44669272|NCT01254006|Vitamins|vitamins|mesh-ancestor
44669273|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
44669274|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669275|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
44669276|NCT01254071|Tamsulosin|tamsulosin|mesh-list
44669277|NCT01254071|Dutasteride|dutasteride|mesh-list
44669278|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44669279|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44669280|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44669281|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669282|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669283|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669284|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669285|NCT01254071|Urological Agents|urological agents|mesh-ancestor
44669286|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44669287|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44669288|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669289|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
44669290|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669291|NCT01254123|Exenatide|exenatide|mesh-list
44669292|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669293|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669294|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44669295|NCT01254123|Incretins|incretins|mesh-ancestor
44669296|NCT01254123|Hormones|hormones|mesh-ancestor
44669297|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669298|NCT01254175|Vaccines|vaccines|mesh-list
44669299|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
44669300|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669301|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
44669302|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
44669303|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44669304|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44669305|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669306|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669307|NCT01254383|Urological Agents|urological agents|mesh-ancestor
44669308|NCT01254461|Pravastatin|pravastatin|mesh-list
44669309|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44669310|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44669311|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
44669312|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669313|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44669314|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44669315|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669316|NCT01254513|Prednisone|prednisone|mesh-list
44669317|NCT01254513|Docetaxel|docetaxel|mesh-list
44669318|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669319|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669320|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669321|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669322|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669323|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669324|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
44669325|NCT01254513|Hormones|hormones|mesh-ancestor
44669326|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669327|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063666|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44669328|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44669329|NCT01254526|Paclitaxel|paclitaxel|mesh-list
44669330|NCT01254526|Bevacizumab|bevacizumab|mesh-list
44669331|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669332|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669333|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669334|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669335|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
44219780|NCT00484133|Dobutamine|dobutamine|mesh-list
44669336|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669337|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669338|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669339|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669340|NCT01254526|Growth Substances|growth substances|mesh-ancestor
44669341|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669342|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669343|NCT01254578|Lenalidomide|lenalidomide|mesh-list
44669344|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
44669345|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669346|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669347|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669348|NCT01254578|Growth Substances|growth substances|mesh-ancestor
44669349|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669350|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669351|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44669352|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44669353|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669354|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44669355|NCT01254617|Cetuximab|cetuximab|mesh-list
44669356|NCT01254617|Lenalidomide|lenalidomide|mesh-list
44669357|NCT01254617|Antibodies|antibodies|mesh-list
44669358|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
44669359|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44669360|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
44669361|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669362|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669363|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669364|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669365|NCT01254617|Growth Substances|growth substances|mesh-ancestor
44669366|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669367|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44669368|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
44669369|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669370|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44669371|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44669372|NCT01254799|Doxycycline|doxycycline|mesh-list
44669373|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44669374|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669375|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
44669376|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44669377|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44669378|NCT01254825|Ropivacaine|ropivacaine|mesh-list
44669379|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
44669380|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
44669381|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669382|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669383|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
44669384|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669385|NCT00660218|Paclitaxel|paclitaxel|mesh-list
44669386|NCT00660218|Cetuximab|cetuximab|mesh-list
44669387|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44669388|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669389|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669390|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669391|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669392|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669393|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669394|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669395|NCT01254929|Frovatriptan|frovatriptan|mesh-list
44669396|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44669397|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
44669398|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669399|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669400|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669401|NCT01254994|Entecavir|entecavir|mesh-list
44669402|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
43778250|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669403|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669405|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44669406|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669407|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669408|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
44669409|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669410|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669411|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
44669412|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
44669413|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669414|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
44669415|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669416|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669417|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669418|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669419|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44669420|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
44669421|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669422|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669423|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44669424|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
44669425|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
44669426|NCT01255215|Protective Agents|protective agents|mesh-ancestor
44669427|NCT01255358|Dexamethasone|dexamethasone|mesh-list
44669428|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
44669429|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44669430|NCT01255358|BB 1101|bb 1101|mesh-list
44669431|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669432|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
44669433|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
44669434|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669435|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669436|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669437|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
44669438|NCT01255358|Hormones|hormones|mesh-ancestor
44063428|NCT00006047|Etoposide|etoposide|mesh-list
44669439|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669440|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44669441|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669442|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669443|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669444|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669445|NCT01255371|Lopinavir|lopinavir|mesh-list
44669446|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44669447|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44669448|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44669449|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669450|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669451|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669452|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44669453|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44669454|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
44669455|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669456|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44669457|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44669458|NCT01255410|Vaccines|vaccines|mesh-list
44669459|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
44669460|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669461|NCT01255475|Amlodipine|amlodipine|mesh-list
44669462|NCT01255475|Hydralazine|hydralazine|mesh-list
44669463|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44669464|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44669465|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669466|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669467|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44669468|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669469|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
44669470|NCT01255527|Bortezomib|bortezomib|mesh-list
44669471|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669472|NCT01255579|Fluticasone|fluticasone|mesh-list
44669473|NCT01255579|Beclomethasone|beclomethasone|mesh-list
44669474|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
44669475|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44669476|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44669477|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669478|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669479|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
44669480|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669481|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669482|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669483|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669484|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669485|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44669486|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44669487|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44669488|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669489|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669490|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669491|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669492|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
44669493|NCT01255579|Hormones|hormones|mesh-ancestor
44669494|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669495|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
44669496|NCT01255644|Valganciclovir|valganciclovir|mesh-list
44669497|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
44669498|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669499|NCT01255774|Ranibizumab|ranibizumab|mesh-list
44669500|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669501|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669502|NCT01255774|Growth Substances|growth substances|mesh-ancestor
44669503|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669504|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669505|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669506|NCT01255800|Cetuximab|cetuximab|mesh-list
44669507|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669508|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669509|NCT01255852|Atorvastatin|atorvastatin|mesh-list
44669510|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44669511|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44669512|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
44669513|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669514|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44669515|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44669516|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669517|NCT01255878|Gabapentin|gabapentin|mesh-list
44669518|NCT01255878|Analgesics|analgesics|mesh-ancestor
44669519|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
44669520|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669521|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669522|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
44669523|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669524|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669525|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669526|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669527|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44669528|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44669529|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669530|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669531|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
44669532|NCT01255956|Sirolimus|sirolimus|mesh-list
44669533|NCT01255956|Paclitaxel|paclitaxel|mesh-list
44669534|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669535|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669536|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669537|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669538|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669539|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669540|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44669541|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669542|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44669543|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
44669544|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44669545|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
44669546|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669547|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
44669548|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44669549|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44669550|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44669551|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778691|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
44669552|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669553|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
44669554|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669555|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669556|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44669557|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669558|NCT01256151|Alprazolam|alprazolam|mesh-list
44669559|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44669560|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669561|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669562|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669563|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669564|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669565|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
44669566|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
44669567|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669568|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669569|NCT01256268|Paclitaxel|paclitaxel|mesh-list
44669570|NCT01256268|Carboplatin|carboplatin|mesh-list
44669571|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669572|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669573|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669574|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669575|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669576|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669577|NCT01256359|Docetaxel|docetaxel|mesh-list
44669578|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669579|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669580|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669581|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669582|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669584|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669585|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669586|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669587|NCT01256541|Lactulose|lactulose|mesh-list
44669588|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669589|NCT01256580|Dexamethasone|dexamethasone|mesh-list
44669590|NCT01256580|Bevacizumab|bevacizumab|mesh-list
44669591|NCT01256580|Verteporfin|verteporfin|mesh-list
44669592|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669593|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669594|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669595|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669596|NCT01256580|Growth Substances|growth substances|mesh-ancestor
44669597|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669598|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669599|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669600|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
44669601|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
44669602|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669603|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669604|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
44669605|NCT01256580|Hormones|hormones|mesh-ancestor
44669606|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669607|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44669608|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44669609|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669610|NCT01256619|Desogestrel|desogestrel|mesh-list
44669611|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44669612|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44669613|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44669614|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
44669615|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44669616|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669617|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44669618|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44669619|NCT01256619|Progestins|progestins|mesh-ancestor
44669620|NCT01256619|Hormones|hormones|mesh-ancestor
44669621|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669622|NCT01256632|Ranibizumab|ranibizumab|mesh-list
44669623|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669624|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669625|NCT01256632|Growth Substances|growth substances|mesh-ancestor
44669626|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669627|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669628|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669629|NCT01256775|Aspirin|aspirin|mesh-list
44669630|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
44669631|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669632|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669633|NCT01256775|Analgesics|analgesics|mesh-ancestor
44669634|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
44669635|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669636|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669637|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669638|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669639|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44669640|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44669641|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669642|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44669643|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44669644|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669645|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669646|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44669647|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
44669648|NCT01256801|Interleukin-2|interleukin-2|mesh-list
44669649|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669650|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669651|NCT01256801|Analgesics|analgesics|mesh-ancestor
44669652|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
44669653|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669654|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669655|NCT01256866|Midazolam|midazolam|mesh-list
44669656|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
44669657|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44669658|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669659|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669660|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669661|NCT01256866|Analgesics|analgesics|mesh-ancestor
44669662|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
44669663|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669664|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44669665|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44669666|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669667|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669668|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669669|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669670|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44669671|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669672|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669673|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669674|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44669675|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
44669676|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
44669677|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
44669678|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
44669679|NCT01256905|Modafinil|modafinil|mesh-list
44669680|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44669681|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669682|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44669683|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44669684|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44669685|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669686|NCT01257009|Atorvastatin|atorvastatin|mesh-list
44669687|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44669688|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44669689|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
44669690|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669691|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44669692|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44669693|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669694|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44669695|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44669696|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669697|NCT01257048|Budesonide|budesonide|mesh-list
44669698|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
44669699|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669700|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44669701|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
44669702|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669703|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669704|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44669705|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669706|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
44669707|NCT01257048|Hormones|hormones|mesh-ancestor
44669708|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669709|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44669710|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44669711|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669712|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669713|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669714|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669715|NCT01257074|Acyclovir|acyclovir|mesh-list
44669716|NCT01257074|Penciclovir|penciclovir|mesh-list
44669717|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
44669718|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669719|NCT01257126|Diclofenac|diclofenac|mesh-list
44669720|NCT01257126|Nimesulide|nimesulide|mesh-list
44669721|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669722|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669723|NCT01257126|Analgesics|analgesics|mesh-ancestor
44669724|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
44669725|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669726|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669727|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669728|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669729|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44669730|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669731|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669732|NCT01257139|Docetaxel|docetaxel|mesh-list
44669733|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669734|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669735|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669736|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669737|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669738|NCT01257165|Ethanol|ethanol|mesh-list
44669739|NCT01257165|Zopiclone|zopiclone|mesh-list
44669740|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44669741|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669742|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669743|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669744|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44669745|NCT01257243|Potassium iodate|potassium iodate|mesh-list
44669746|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
44669747|NCT01257243|Guaifenesin|guaifenesin|mesh-list
44669748|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44669749|NCT01257243|Expectorants|expectorants|mesh-ancestor
44669750|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44669751|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44669752|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44669753|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44669754|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669755|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669756|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669757|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
44669758|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44669759|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
44669760|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
44669761|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669762|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
44669763|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44669764|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
44669765|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669766|NCT01257334|Empagliflozin|empagliflozin|mesh-list
44669767|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44669768|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669769|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669770|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669771|NCT01257360|Panitumumab|panitumumab|mesh-list
44669772|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44669773|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669775|NCT01257373|Chromium|chromium|mesh-list
44669776|NCT01257373|Sirolimus|sirolimus|mesh-list
44669777|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44669778|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44669779|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44669780|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669781|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
44669782|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44669783|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
44669784|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669785|NCT01257373|Trace Elements|trace elements|mesh-ancestor
44669786|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
44669787|NCT01257386|Mesalamine|mesalamine|mesh-list
44669788|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669789|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669790|NCT01257386|Analgesics|analgesics|mesh-ancestor
44669791|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
44669792|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669793|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669794|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669795|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669796|NCT01257399|Mesalamine|mesalamine|mesh-list
44669797|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669798|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669799|NCT01257399|Analgesics|analgesics|mesh-ancestor
44669800|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
44669801|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669802|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669803|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669804|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669805|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
44669806|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44669807|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669808|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669809|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669810|NCT01257451|Vildagliptin|vildagliptin|mesh-list
44669811|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669812|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669813|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44669814|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669815|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669816|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669817|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44669818|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44669819|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44669820|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669821|NCT01257464|Incretins|incretins|mesh-ancestor
44669822|NCT01257464|Hormones|hormones|mesh-ancestor
44669823|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669824|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
44669825|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669826|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669827|NCT01257490|Bupropion|bupropion|mesh-list
44669828|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44669829|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
44669830|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669831|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44669832|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44669833|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669834|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669835|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
44669836|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669837|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669838|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44669839|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44669840|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669841|NCT01257516|Pregabalin|pregabalin|mesh-list
44669842|NCT01257516|Analgesics|analgesics|mesh-ancestor
44669843|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
44669844|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669845|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669846|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
44669847|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44063429|NCT00006047|Rubitecan|rubitecan|mesh-list
44669848|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669849|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778943|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
44669850|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44669851|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669852|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669853|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669854|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669855|NCT01257529|Pregabalin|pregabalin|mesh-list
44669856|NCT01257529|Analgesics|analgesics|mesh-ancestor
44669857|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
44669858|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669859|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669860|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
44669861|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44669862|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44669863|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669864|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44669865|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669866|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669867|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669868|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669869|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44669870|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669871|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44669872|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669873|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669874|NCT01257672|Ondansetron|ondansetron|mesh-list
44669875|NCT01257672|Domperidone|domperidone|mesh-list
44669876|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
44669877|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
44669878|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669879|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669880|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44669881|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
44669882|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669883|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44669884|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
44669885|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669886|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669887|NCT01257672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44669888|NCT01257672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669889|NCT01257672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669890|NCT01257672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669891|NCT01257672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44669892|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44669893|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
44669894|NCT01257815|Ranibizumab|ranibizumab|mesh-list
44669895|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44669896|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44669897|NCT01257815|Growth Substances|growth substances|mesh-ancestor
44669898|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669899|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44669900|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669901|NCT01257828|Riluzole|riluzole|mesh-list
44669902|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
44669903|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44669904|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44669905|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669906|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669907|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669908|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44669909|NCT01257828|Protective Agents|protective agents|mesh-ancestor
44669910|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
44669911|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
44669912|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44669913|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669914|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669915|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
44669916|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44669917|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669918|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669919|NCT01257893|Aspirin|aspirin|mesh-list
44669920|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669921|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669922|NCT01257893|Analgesics|analgesics|mesh-ancestor
44064242|NCT00006190|Efavirenz|efavirenz|mesh-list
44669923|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
44669924|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669925|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669926|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669927|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669928|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44669929|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44669930|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669931|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44669932|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44669933|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669934|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
44669935|NCT01257906|Tretinoin|tretinoin|mesh-list
44669936|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669937|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
44669938|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669939|NCT01257919|Azelaic acid|azelaic acid|mesh-list
44669940|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669941|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
44669942|NCT01257958|Vitamin D|vitamin d|mesh-list
44669943|NCT01257958|Vitamins|vitamins|mesh-ancestor
44669944|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
44669945|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669946|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44669947|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
44669948|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44669949|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44669950|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669951|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
44669952|NCT01258010|Coagulants|coagulants|mesh-ancestor
44669953|NCT01258036|Hormones|hormones|mesh-list
44669954|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44669955|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669956|NCT01258192|Paclitaxel|paclitaxel|mesh-list
44669957|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44669958|NCT01258192|Cisplatin|cisplatin|mesh-list
44220503|NCT00486772|Calcium|calcium|mesh-list
44669959|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44669960|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44669961|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
44669962|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
44669963|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
44669964|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220562|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
44669966|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44669967|NCT01258296|Narcotics|narcotics|mesh-ancestor
44669968|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44669969|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669970|NCT01258296|Analgesics|analgesics|mesh-ancestor
44669971|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
44669972|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669973|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44669974|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44669975|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
44669976|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
44669977|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44669978|NCT01258309|Ketorolac|ketorolac|mesh-list
44669979|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44669980|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44669981|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44669982|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44669983|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44669984|NCT01258309|Analgesics|analgesics|mesh-ancestor
44669985|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
44669986|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44669987|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44669988|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44669989|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44669990|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44669991|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44669992|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44669993|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44669994|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44669995|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44669996|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
44669997|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
44669998|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44669999|NCT01258322|Pioglitazone|pioglitazone|mesh-list
44670000|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44670001|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670002|NCT01258439|Ritonavir|ritonavir|mesh-list
44670003|NCT01258439|Darunavir|darunavir|mesh-list
44670004|NCT01258439|Tenofovir|tenofovir|mesh-list
44670005|NCT01258439|Emtricitabine|emtricitabine|mesh-list
44670006|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
44670007|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44670008|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44670009|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44670010|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
44670011|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670012|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670013|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44670014|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44670015|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
44670016|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670017|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44670018|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44670019|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44670020|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670021|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44670022|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44670023|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
44670025|NCT01258491|Niacinamide|niacinamide|mesh-list
44670026|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
44670027|NCT01258491|Vitamins|vitamins|mesh-ancestor
44670028|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
44670029|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670030|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44670031|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
44670032|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670033|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44670034|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670035|NCT01258530|Oseltamivir|oseltamivir|mesh-list
44670036|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
44670037|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670038|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670039|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670040|NCT01258569|Alvimopan|alvimopan|mesh-list
44670041|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44670042|NCT01258634|Leucovorin|leucovorin|mesh-list
44670043|NCT01258634|Cisplatin|cisplatin|mesh-list
44670044|NCT01258634|Doxorubicin|doxorubicin|mesh-list
44670045|NCT01258634|Etoposide|etoposide|mesh-list
44670046|NCT01258634|Ifosfamide|ifosfamide|mesh-list
44670047|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
44670048|NCT01258634|Razoxane|razoxane|mesh-list
44670049|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670050|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44670051|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44670052|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44670053|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256164|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670054|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670055|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44670056|NCT01258634|Antidotes|antidotes|mesh-ancestor
44670057|NCT01258634|Protective Agents|protective agents|mesh-ancestor
44670058|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670059|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
44670060|NCT01258634|Vitamins|vitamins|mesh-ancestor
44670061|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
44670062|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44670063|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
44670064|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44670065|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44670066|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44670067|NCT01258686|Silymarin|silymarin|mesh-list
44670068|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
44670069|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670070|NCT01258686|Protective Agents|protective agents|mesh-ancestor
44670071|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670072|NCT01258712|Methotrexate|methotrexate|mesh-list
44670073|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44670074|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
44670075|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44670076|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670077|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44670078|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
44670079|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670080|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670081|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
44670082|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670083|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44670084|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670085|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
44670086|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670087|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670088|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44670089|NCT01258764|Lisinopril|lisinopril|mesh-list
44670090|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44670091|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44670092|NCT01258764|Diuretics|diuretics|mesh-ancestor
44670093|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
44670094|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670095|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44670096|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670097|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670098|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
44670099|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670100|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44670101|NCT01258764|Protective Agents|protective agents|mesh-ancestor
44670102|NCT01258777|Golimumab|golimumab|mesh-list
44670103|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44670104|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44670105|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670106|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670107|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
44670108|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670109|NCT01258868|Celecoxib|celecoxib|mesh-list
44670110|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670111|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670112|NCT01258868|Analgesics|analgesics|mesh-ancestor
44670113|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
44670114|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670115|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220654|NCT00487591|Simvastatin|simvastatin|mesh-list
44670116|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670118|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44670119|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670120|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670121|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670122|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44670123|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44670124|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44670125|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670126|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670127|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44670128|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44670129|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44670130|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
44670131|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670132|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670133|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44670134|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44670135|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
44670136|NCT01258959|Anesthetics|anesthetics|mesh-list
44670137|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
44670138|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670139|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670140|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
44670141|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670142|NCT01259050|Copper|copper|mesh-list
44670143|NCT01259050|Trace Elements|trace elements|mesh-ancestor
44670144|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
44670145|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670146|NCT01259141|Azithromycin|azithromycin|mesh-list
44670147|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
44670148|NCT01259141|Cephalosporins|cephalosporins|mesh-list
44670149|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44670150|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670151|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44670152|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44670153|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670154|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670155|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670156|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
44670157|NCT01259193|Sorafenib|sorafenib|mesh-list
44670158|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670159|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670160|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670161|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670162|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44670163|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670164|NCT01259219|Rifabutin|rifabutin|mesh-list
44670165|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44670166|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670167|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44670168|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
44670169|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44670170|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
44670171|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670172|NCT01259336|Itraconazole|itraconazole|mesh-list
44670173|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
44670174|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670175|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44670176|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44670177|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670178|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670179|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44670180|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44670181|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670182|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670183|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44670184|NCT01259362|Cocaine|cocaine|mesh-list
44670185|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
44670186|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
44670187|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670188|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670189|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
44670190|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670191|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44670192|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44670193|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44670194|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670195|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670196|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
44670197|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670198|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
44670199|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670200|NCT01259479|Satraplatin|satraplatin|mesh-list
44670201|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670203|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44670204|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44670205|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44670206|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670207|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670208|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670209|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670210|NCT01259531|Urological Agents|urological agents|mesh-ancestor
44670211|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
44670212|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44670213|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44670214|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44670215|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670216|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670217|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
44670218|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670219|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670220|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44670221|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670222|NCT01259817|Aspirin|aspirin|mesh-list
44670223|NCT01259817|Interferons|interferons|mesh-list
44670224|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
44670225|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
44670226|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44670227|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670228|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
44670229|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670230|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670231|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670232|NCT01259817|Analgesics|analgesics|mesh-ancestor
44670233|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
44670234|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670235|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670236|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670237|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670238|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44670239|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44670240|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670241|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44670242|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670243|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670244|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
44670245|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
44670246|NCT01259830|Etoricoxib|etoricoxib|mesh-list
44670247|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670248|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670249|NCT01259830|Analgesics|analgesics|mesh-ancestor
44670250|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
44670251|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670252|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670253|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670254|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670255|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44670256|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670257|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670258|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670259|NCT01259934|Interferons|interferons|mesh-list
44670260|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
44670261|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
44670262|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670263|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
44670264|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670265|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
44670266|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670267|NCT01259973|Haloperidol|haloperidol|mesh-list
44670268|NCT01259973|Risperidone|risperidone|mesh-list
44670269|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
44670270|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44670271|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
44670272|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670273|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670274|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670275|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44670276|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44670277|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670278|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44670279|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44670280|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
44670281|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
44670282|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
44670283|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670284|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44670285|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44670286|NCT01260012|Praziquantel|praziquantel|mesh-list
44670287|NCT01260012|Antioxidants|antioxidants|mesh-list
44670288|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670289|NCT01260012|Protective Agents|protective agents|mesh-ancestor
44670290|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670291|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
44670292|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44670293|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670294|NCT01260025|Endostatins|endostatins|mesh-list
44670295|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670296|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44670297|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44670298|NCT01260025|Growth Substances|growth substances|mesh-ancestor
44670299|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670300|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
44670301|NCT01260103|Temozolomide|temozolomide|mesh-list
44670302|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44670303|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
44670304|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670305|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670307|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44670308|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44670309|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44670310|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670311|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670312|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670313|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670314|NCT01260129|Urological Agents|urological agents|mesh-ancestor
44220863|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
44670339|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670340|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670341|NCT01260285|Urological Agents|urological agents|mesh-ancestor
44670342|NCT01260376|Acipimox|acipimox|mesh-list
44670343|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44670344|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
44670345|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670346|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44670347|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
44670348|NCT01260415|Panitumumab|panitumumab|mesh-list
44670349|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670350|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670351|NCT01260506|Bevacizumab|bevacizumab|mesh-list
44670352|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670353|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670354|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44670355|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44670356|NCT01260506|Growth Substances|growth substances|mesh-ancestor
44670357|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670358|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44670359|NCT01260519|Heparin|heparin|mesh-list
44670360|NCT01260519|Calcium heparin|calcium heparin|mesh-list
44670361|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
44670362|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44670363|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44670364|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670365|NCT01260558|Sirolimus|sirolimus|mesh-list
44670366|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44670367|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670368|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44670369|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670370|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
44670371|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670372|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
44670373|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670374|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44670375|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
44670376|NCT01260610|Tenofovir|tenofovir|mesh-list
44670377|NCT01260610|Telbivudine|telbivudine|mesh-list
44670378|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
44670379|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670380|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44670381|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670382|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670383|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670384|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44670385|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44670386|NCT01260623|Prednisone|prednisone|mesh-list
44670387|NCT01260623|Prednisolone|prednisolone|mesh-list
44670388|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670389|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
44670390|NCT01260623|Hormones|hormones|mesh-ancestor
44670391|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670392|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670393|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44670394|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670395|NCT01260675|Buprenorphine|buprenorphine|mesh-list
44670396|NCT01260675|Naloxone|naloxone|mesh-list
44670397|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44670398|NCT01260675|Narcotics|narcotics|mesh-ancestor
43779001|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44670399|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670400|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670402|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
44670403|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670404|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44670405|NCT01260714|Etoposide|etoposide|mesh-list
44670406|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
44670407|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
44670408|NCT01260714|Azacitidine|azacitidine|mesh-list
44670409|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
44670410|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44670411|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670412|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44670413|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44670414|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670415|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670416|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44670417|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
44670418|NCT01260714|Analgesics|analgesics|mesh-ancestor
44670419|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
44670420|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670421|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670422|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
44670423|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
44670424|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44670425|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44670426|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44670428|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
44670429|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670430|NCT01260753|Fluticasone|fluticasone|mesh-list
44670431|NCT01260753|Xhance|xhance|mesh-list
44670432|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670433|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44670434|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
44670435|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670436|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670437|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44670438|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
44670439|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
44670440|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44670441|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
44670442|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44670443|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44670444|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670445|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
44670446|NCT01260818|Coagulants|coagulants|mesh-ancestor
44670447|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44670448|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
44670449|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670450|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
44670451|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44670452|NCT01260857|Diuretics|diuretics|mesh-ancestor
44670453|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
44670454|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670455|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44670456|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670457|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670458|NCT01260974|Caspofungin|caspofungin|mesh-list
44670459|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
44670460|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670461|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670462|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670463|NCT01261065|Carvedilol|carvedilol|mesh-list
44670464|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44670465|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44670466|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670467|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670468|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670469|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670470|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44670471|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
44670472|NCT01261065|Protective Agents|protective agents|mesh-ancestor
44670473|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44670474|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670475|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670476|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670477|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44670478|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44670480|NCT01261078|Racepinephrine|racepinephrine|mesh-list
44670481|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
44670482|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44670483|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44670484|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670485|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670486|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670487|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670488|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44670489|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44670490|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
44670492|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44670493|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44670494|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
44670495|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
44670496|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44670497|NCT01261117|Ibuprofen|ibuprofen|mesh-list
44670498|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670499|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670500|NCT01261117|Analgesics|analgesics|mesh-ancestor
44670501|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
44670502|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670503|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670504|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670505|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670506|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670507|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670508|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670509|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44670510|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44670511|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
44670512|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670513|NCT01261130|Antacids|antacids|mesh-ancestor
44670514|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670515|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44670516|NCT01261156|Diltiazem|diltiazem|mesh-list
44670517|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44670518|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44670519|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670520|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670521|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670522|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670523|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670524|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
44670525|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44670526|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670527|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44670528|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
44670529|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44670530|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670531|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670532|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670533|NCT01261234|Cilostazol|cilostazol|mesh-list
44670534|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44670535|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
44670536|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670537|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670538|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44670539|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44670540|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44670541|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44670542|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670543|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44670544|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670545|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44670546|NCT01261234|Protective Agents|protective agents|mesh-ancestor
44670547|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44670548|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44670549|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670551|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44670552|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44670553|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670554|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670555|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670556|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670557|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670558|NCT01261299|Carboplatin|carboplatin|mesh-list
44670559|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670560|NCT01261416|Levetiracetam|levetiracetam|mesh-list
44670561|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
44670562|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
44670563|NCT01261481|Tolvaptan|tolvaptan|mesh-list
44670564|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44670565|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670566|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
44670567|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670568|NCT01261546|Dexamethasone|dexamethasone|mesh-list
44670569|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670570|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
44670571|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
44670572|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670573|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670574|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44670575|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
44670576|NCT01261546|Hormones|hormones|mesh-ancestor
44670577|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670578|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44670579|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670580|NCT01261637|Ropivacaine|ropivacaine|mesh-list
44670581|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
44670582|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
44670583|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670584|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670585|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
44670586|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670587|NCT01261689|Sufentanil|sufentanil|mesh-list
44670589|NCT01261689|Ropivacaine|ropivacaine|mesh-list
44670590|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
44670591|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
44670592|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670593|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670594|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
44670595|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670596|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44670597|NCT01261689|Narcotics|narcotics|mesh-ancestor
44670598|NCT01261689|Analgesics|analgesics|mesh-ancestor
44670599|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44670600|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44670601|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
44670602|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
44670603|NCT01261702|Analgesics|analgesics|mesh-ancestor
44670604|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
44670605|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670606|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670607|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
44670608|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670609|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44670610|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
44670611|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44670612|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670613|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670614|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670615|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
44670616|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44670617|NCT01261741|Memantine|memantine|mesh-list
44670618|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44670619|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44670620|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
44670621|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670622|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670624|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44670625|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44670626|NCT01261832|Cilostazol|cilostazol|mesh-list
44670627|NCT01261832|Clopidogrel|clopidogrel|mesh-list
44670628|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44670629|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44670630|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44670631|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44670632|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
44670633|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670634|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670635|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670636|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44221188|NCT00490113|Vitamins|vitamins|mesh-ancestor
44670637|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
44670638|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670639|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44670640|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
44670641|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44670642|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44670643|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
44670644|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44670645|NCT01261832|Protective Agents|protective agents|mesh-ancestor
44670646|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44670647|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44670648|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670649|NCT01261897|Ropivacaine|ropivacaine|mesh-list
44670650|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
44670651|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
44670652|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670653|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670654|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
44670655|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670656|NCT01261923|Alitretinoin|alitretinoin|mesh-list
44670657|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670658|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44670659|NCT01262183|Panitumumab|panitumumab|mesh-list
44670660|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670661|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670662|NCT01262196|Chrysarobin|chrysarobin|mesh-list
44670663|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670664|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670665|NCT01262196|Analgesics|analgesics|mesh-ancestor
44670666|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
44670667|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670668|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670669|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670670|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670671|NCT01262274|Anastrozole|anastrozole|mesh-list
44670672|NCT01262274|Tegafur|tegafur|mesh-list
44670673|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44670674|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670675|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44670676|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44670677|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670678|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670679|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44670680|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
44670681|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670682|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670683|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44670684|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
44670685|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
44670686|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44670687|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44670688|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
44670689|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670690|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670691|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670692|NCT01262391|Urological Agents|urological agents|mesh-ancestor
44670693|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
44670694|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44670695|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
44670696|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670697|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
44670698|NCT01262417|Protective Agents|protective agents|mesh-ancestor
44670699|NCT01262469|Capecitabine|capecitabine|mesh-list
44670700|NCT01262469|Lapatinib|lapatinib|mesh-list
44670701|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44670702|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
44670703|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670704|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670705|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670706|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670707|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
44670708|NCT01262482|Sorafenib|sorafenib|mesh-list
44670709|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670710|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670711|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670712|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670713|NCT01262586|Glimepiride|glimepiride|mesh-list
44670714|NCT01262586|Vildagliptin|vildagliptin|mesh-list
44670715|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44670716|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44670717|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670718|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670719|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
44670720|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44670721|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
44670722|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670723|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670724|NCT01262612|Cediranib|cediranib|mesh-list
44670725|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670726|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670727|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670728|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670729|NCT01262729|Xenon|xenon|mesh-list
44670730|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44102338|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
44670731|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
44670732|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
44670733|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670734|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670736|NCT01262742|Oxytocin|oxytocin|mesh-list
44670737|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
44670738|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44670739|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670740|NCT01262859|Bevacizumab|bevacizumab|mesh-list
44670741|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670742|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670743|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44670744|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44670745|NCT01262859|Growth Substances|growth substances|mesh-ancestor
44670746|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670747|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
44670748|NCT01262924|Vaccines|vaccines|mesh-list
44670749|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
44670750|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670751|NCT01262963|Dabrafenib|dabrafenib|mesh-list
44670752|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670753|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670754|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670755|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670756|NCT01263002|Adefovir|adefovir|mesh-list
44670757|NCT01263002|Clevudine|clevudine|mesh-list
44670758|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
44670759|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670760|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44670761|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670762|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670763|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670764|NCT01263080|Folic Acid|folic acid|mesh-list
44670765|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
44670766|NCT01263080|Mirtazapine|mirtazapine|mesh-list
44670767|NCT01263080|Vitamins|vitamins|mesh-ancestor
44670768|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
44670770|NCT01263080|Hematinics|hematinics|mesh-ancestor
44670771|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
44670772|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44670773|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44670774|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
44670775|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
44670776|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670777|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670778|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44670779|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44670780|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670781|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44670782|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44670783|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44670784|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670785|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44670786|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44670787|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
44670788|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44670789|NCT01263145|Paclitaxel|paclitaxel|mesh-list
44670790|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44670791|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670792|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
44670793|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
44670794|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
44670795|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670796|NCT01263158|Oxytocin|oxytocin|mesh-list
44670797|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
44670798|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44670799|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670800|NCT01263171|Leucovorin|leucovorin|mesh-list
44670801|NCT01263171|Fluorouracil|fluorouracil|mesh-list
44670802|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
44670803|NCT01263171|Calcium|calcium|mesh-list
44670804|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
44102403|NCT00061321|Nevirapine|nevirapine|mesh-list
44670805|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670806|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670807|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
44670808|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670809|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44670810|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670811|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670812|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
44670813|NCT01263171|Antidotes|antidotes|mesh-ancestor
44670814|NCT01263171|Protective Agents|protective agents|mesh-ancestor
44670815|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
44670816|NCT01263171|Vitamins|vitamins|mesh-ancestor
44670817|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
44670818|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44670819|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
44670820|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670821|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
44670822|NCT01263288|Vitamin D|vitamin d|mesh-list
44670823|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44670824|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670825|NCT01263288|Vitamins|vitamins|mesh-ancestor
44670826|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
44670827|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44670828|NCT01263353|Everolimus|everolimus|mesh-list
44670829|NCT01263353|Pasireotide|pasireotide|mesh-list
44670830|NCT01263353|Somatostatin|somatostatin|mesh-list
44670831|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670832|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670833|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
44670834|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670835|NCT01263353|Hormones|hormones|mesh-ancestor
44670836|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670837|NCT01263366|Norepinephrine|norepinephrine|mesh-list
44670838|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44670839|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44670840|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
44670841|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670842|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670843|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670844|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
44670845|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
44670846|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670847|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44670848|NCT01263418|Ofatumumab|ofatumumab|mesh-list
44670849|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670850|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44670851|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44670852|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670853|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44670854|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44670855|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44670856|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670857|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
44670858|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670859|NCT01263574|Ethanol|ethanol|mesh-list
44670860|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44670861|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670862|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670863|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670864|NCT01263652|Dipyrone|dipyrone|mesh-list
44670865|NCT01263652|Diclofenac|diclofenac|mesh-list
44670866|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44670867|NCT01263652|Tramadol|tramadol|mesh-list
44670868|NCT01263652|Orphenadrine|orphenadrine|mesh-list
44670869|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670870|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670871|NCT01263652|Analgesics|analgesics|mesh-ancestor
44670872|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
44670873|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670874|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670875|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670876|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670877|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670878|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670879|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670880|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44670881|NCT01263652|Narcotics|narcotics|mesh-ancestor
44670882|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44670883|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
44670884|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44670885|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44670886|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44670888|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
44670889|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
44670890|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44670891|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44670892|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
44670893|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44670894|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
44670895|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44670896|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
44670897|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44670898|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670899|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44670900|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44670901|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670902|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670903|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670904|NCT01263834|Bevacizumab|bevacizumab|mesh-list
44670905|NCT01263834|Mitomycins|mitomycins|mesh-list
44670906|NCT01263834|Mitomycin|mitomycin|mesh-list
44670907|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670908|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670909|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44670910|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44670911|NCT01263834|Growth Substances|growth substances|mesh-ancestor
44670912|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670913|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
44670914|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44670915|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
44670916|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235975|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
44670917|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670918|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670920|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44670921|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
44670922|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
44670923|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670924|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
44670925|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670926|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
44670927|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670928|NCT01263951|Everolimus|everolimus|mesh-list
44670929|NCT01263951|Sorafenib|sorafenib|mesh-list
44670930|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670931|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44670932|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
44670933|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670934|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44670935|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670936|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670937|NCT01264094|Clevudine|clevudine|mesh-list
44670938|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
44670939|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670940|NCT01264133|Adefovir|adefovir|mesh-list
44670941|NCT01264133|Clevudine|clevudine|mesh-list
44670942|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
44102537|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
44670943|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44670944|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44670945|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44670946|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670947|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670948|NCT01264211|Diacetylrhein|diacetylrhein|mesh-list
44670949|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670950|NCT01264237|Etoricoxib|etoricoxib|mesh-list
44670951|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44670952|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44670953|NCT01264237|Analgesics|analgesics|mesh-ancestor
44670954|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
44670955|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44670956|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670957|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44670958|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44670959|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44670960|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44670961|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670962|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670963|NCT01264289|Finasteride|finasteride|mesh-list
44670964|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44670965|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44670966|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670967|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670968|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
44670969|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670970|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670971|NCT01264289|Urological Agents|urological agents|mesh-ancestor
44670972|NCT01264302|Finasteride|finasteride|mesh-list
44670973|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44670974|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44670975|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44670976|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670977|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
44670978|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44670979|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670980|NCT01264302|Urological Agents|urological agents|mesh-ancestor
44670981|NCT01264315|Lenalidomide|lenalidomide|mesh-list
44670982|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
44670983|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44670984|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44670985|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44670986|NCT01264315|Growth Substances|growth substances|mesh-ancestor
44670987|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
44670988|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670989|NCT01264328|Paclitaxel|paclitaxel|mesh-list
44670990|NCT01264328|Panitumumab|panitumumab|mesh-list
44670991|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44670992|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44670993|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44670994|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44670995|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44670996|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44670997|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44670998|NCT01264341|Sirolimus|sirolimus|mesh-list
44670999|NCT01264341|Bevacizumab|bevacizumab|mesh-list
44671000|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671001|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671002|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44671003|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44671004|NCT01264341|Growth Substances|growth substances|mesh-ancestor
44671005|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671006|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
44671007|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671008|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671009|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44671010|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
44671011|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671012|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
44671014|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44671015|NCT01264354|Clevudine|clevudine|mesh-list
44671016|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
44671017|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671018|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44671019|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44671020|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671021|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671022|NCT01264367|Interferons|interferons|mesh-list
44671023|NCT01264367|Clevudine|clevudine|mesh-list
44671024|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671025|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
44671026|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671027|NCT01264432|Veliparib|veliparib|mesh-list
44671028|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44671029|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671030|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671031|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671032|NCT01264445|Vaccines|vaccines|mesh-list
44671033|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
44671034|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671035|NCT01264484|Imidacloprid|imidacloprid|mesh-list
44671036|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
44671037|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671038|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671039|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671040|NCT01264497|Tesamorelin|tesamorelin|mesh-list
44671041|NCT01264497|Growth Substances|growth substances|mesh-ancestor
44671042|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671043|NCT01264536|Lactoferrin|lactoferrin|mesh-list
44671044|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671045|NCT01264575|Epinephrine|epinephrine|mesh-list
44671046|NCT01264575|Racepinephrine|racepinephrine|mesh-list
44671047|NCT01264575|Bupivacaine|bupivacaine|mesh-list
44671048|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
44671049|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
44671050|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
44671051|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671052|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671053|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
44671054|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671055|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44671056|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44671057|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44671058|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671059|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671060|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44671061|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44671062|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
44671063|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671064|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671065|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
44671066|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
44671067|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44671069|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671070|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671071|NCT01264640|Aspirin|aspirin|mesh-list
44671072|NCT01264640|Clopidogrel|clopidogrel|mesh-list
44671073|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671074|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671075|NCT01264640|Analgesics|analgesics|mesh-ancestor
44671076|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
44671077|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671078|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671079|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671080|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671081|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44671082|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44671083|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671084|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44221680|NCT00492219|Cimetidine|cimetidine|mesh-list
44671085|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44671087|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
44671088|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44671089|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44671090|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44671091|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
44671092|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671093|NCT01264653|Epinephrine|epinephrine|mesh-list
44671094|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44671095|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44671096|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44671097|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671098|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671099|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671100|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44671101|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44671102|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
44671103|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671104|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671105|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671106|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
44671107|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
44671108|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44671109|NCT01264692|Amlodipine|amlodipine|mesh-list
44671110|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44671111|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44671112|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671113|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671114|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671115|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671116|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44671117|NCT01264731|Imiquimod|imiquimod|mesh-list
44671118|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44671119|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
44671120|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671121|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671122|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
44671123|NCT01264783|RNS60|rns60|mesh-list
44671124|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671125|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671126|NCT01264783|Analgesics|analgesics|mesh-ancestor
44671127|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
44671128|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671129|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671130|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671131|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671132|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44671133|NCT01264822|Rabeprazole|rabeprazole|mesh-list
44671134|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44671135|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44671136|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44671137|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671138|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671139|NCT01264874|Vitamin D|vitamin d|mesh-list
44671140|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
44671141|NCT01264874|Vitamins|vitamins|mesh-ancestor
44671142|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
44671143|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671144|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44671145|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671146|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44671147|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
44671148|NCT01265004|Coagulants|coagulants|mesh-ancestor
44671149|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
44671150|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44671151|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44671152|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44671153|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44671154|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44671155|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44671156|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
44671157|NCT01265017|Estradiol|estradiol|mesh-list
44671158|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44671159|NCT01265017|Hormones|hormones|mesh-ancestor
44671160|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671161|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671162|NCT01265017|Estrogens|estrogens|mesh-ancestor
44671163|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44671164|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
44671165|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44671166|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44671167|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671168|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44671169|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44671170|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44671171|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44671172|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44671173|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671174|NCT01265108|Iron|iron|mesh-list
44671175|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44671176|NCT01265108|Trace Elements|trace elements|mesh-ancestor
44671177|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
44671178|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671179|NCT01265108|Hematinics|hematinics|mesh-ancestor
44671180|NCT01265147|Cisplatin|cisplatin|mesh-list
44671181|NCT01265147|Nedaplatin|nedaplatin|mesh-list
44671182|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671183|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
44671184|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
44671185|NCT01265173|Cefotaxime|cefotaxime|mesh-list
44671186|NCT01265173|Cefoxitin|cefoxitin|mesh-list
44671187|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671188|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671189|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44671190|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44671191|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671192|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671193|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671194|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44671195|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44671196|NCT01265199|Cytarabine|cytarabine|mesh-list
44671197|NCT01265199|Daunorubicin|daunorubicin|mesh-list
44671198|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44671199|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
44671200|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671201|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671202|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
44671203|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671204|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671205|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
44671206|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671207|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44671208|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102811|NCT00062270|Gemcitabine|gemcitabine|mesh-list
44671209|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44671210|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671211|NCT01265342|Beclomethasone|beclomethasone|mesh-list
44671212|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671213|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
44671214|NCT01265342|Hormones|hormones|mesh-ancestor
44671215|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671216|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671217|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671218|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671219|NCT01265433|Molgramostim|molgramostim|mesh-list
44671220|NCT01265433|Sargramostim|sargramostim|mesh-list
44671221|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44671222|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
44671223|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671224|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671225|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44671226|NCT01265576|Etodolac|etodolac|mesh-list
44671227|NCT01265576|Sorafenib|sorafenib|mesh-list
44671228|NCT01265576|Propranolol|propranolol|mesh-list
44671229|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671230|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44671231|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671232|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671233|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44671234|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44671235|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
44671236|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221827|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
44671237|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671238|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44671239|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44671240|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
44671241|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671242|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671244|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
44671245|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671246|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671247|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671248|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44671249|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44671250|NCT01265589|Vitamin A|vitamin a|mesh-list
44671251|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44671252|NCT01265589|Vitamins|vitamins|mesh-ancestor
44671253|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
44671254|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671255|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671256|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
44671257|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671258|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671259|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44671260|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44671261|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671262|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671263|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671264|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
44671265|NCT01265680|Hematinics|hematinics|mesh-ancestor
44221861|NCT00492986|Sorafenib|sorafenib|mesh-list
44671266|NCT01265810|Calcium|calcium|mesh-list
44671267|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671268|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671269|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
44671270|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44671271|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
44671272|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671273|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671274|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671275|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671276|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44671277|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
44671278|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671279|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671280|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44671281|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
44671282|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
44671283|NCT01265888|Protective Agents|protective agents|mesh-ancestor
44671284|NCT01265927|Trastuzumab|trastuzumab|mesh-list
44671285|NCT01265927|Imetelstat|imetelstat|mesh-list
44671286|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671287|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671288|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671289|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671290|NCT01265940|Vinblastine|vinblastine|mesh-list
44671291|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44671292|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671293|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
44671294|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
44671295|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
44671296|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671297|NCT01266005|Entecavir|entecavir|mesh-list
44671298|NCT01266005|Clevudine|clevudine|mesh-list
44671299|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
44671300|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671301|NCT01266031|Bevacizumab|bevacizumab|mesh-list
44671302|NCT01266031|Vorinostat|vorinostat|mesh-list
44671303|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671304|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671305|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44671306|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44671307|NCT01266031|Growth Substances|growth substances|mesh-ancestor
44671308|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671309|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44671310|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44671311|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671312|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671313|NCT01266057|Sirolimus|sirolimus|mesh-list
44671314|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
44671315|NCT01266057|Vorinostat|vorinostat|mesh-list
44671316|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671317|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671318|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44671319|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671320|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
44671321|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671322|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
44671323|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671324|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
44671325|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44671326|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44671327|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671328|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671329|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671330|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44671331|NCT01266174|Eltoprazine|eltoprazine|mesh-list
44671332|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44671333|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
44671334|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671335|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671336|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671337|NCT01266187|Leucovorin|leucovorin|mesh-list
44671338|NCT01266187|Cetuximab|cetuximab|mesh-list
44671339|NCT01266187|Fluorouracil|fluorouracil|mesh-list
44671340|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
44671341|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671342|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671343|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
44671344|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671345|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44671346|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671347|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
44671348|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671349|NCT01266187|Antidotes|antidotes|mesh-ancestor
44671350|NCT01266187|Protective Agents|protective agents|mesh-ancestor
44671351|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
44671352|NCT01266187|Vitamins|vitamins|mesh-ancestor
44102896|NCT00062556|Vitamins|vitamins|mesh-ancestor
44671353|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
44671354|NCT01266213|Fulvestrant|fulvestrant|mesh-list
44671355|NCT01266213|Anastrozole|anastrozole|mesh-list
44671356|NCT01266213|Goserelin|goserelin|mesh-list
44671357|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44671358|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671359|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44671360|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44671361|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
44671362|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671363|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671364|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44671365|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44671366|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671367|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671368|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
44671369|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44671370|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671371|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671372|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671373|NCT01266252|Analgesics|analgesics|mesh-ancestor
44671374|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
44671375|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671376|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44671377|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44671378|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44671379|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
44671380|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671381|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671382|NCT01266434|Simvastatin|simvastatin|mesh-list
44671383|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44671384|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44671385|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
44671386|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671387|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44671388|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44671389|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671390|NCT01266486|Metformin|metformin|mesh-list
44671391|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44671392|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671393|NCT01266499|Colistin|colistin|mesh-list
44671394|NCT01266499|Polymyxins|polymyxins|mesh-list
44671395|NCT01266499|Gentamicins|gentamicins|mesh-list
44671396|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671397|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671398|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44671399|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671400|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671401|NCT01266512|Cisplatin|cisplatin|mesh-list
44671402|NCT01266512|Docetaxel|docetaxel|mesh-list
44671403|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671404|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
44671405|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
44671406|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
44671407|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671408|NCT01266655|Baclofen|baclofen|mesh-list
44671409|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44671410|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671411|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44671412|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671413|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44671414|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
44671415|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
44671416|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671417|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671418|NCT01266681|Amiodarone|amiodarone|mesh-list
44671419|NCT01266681|Dronedarone|dronedarone|mesh-list
44671420|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44671421|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
44671422|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44671423|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671424|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671425|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44671426|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44671427|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44671428|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671429|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44671430|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44671431|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44671432|NCT01266694|Colchicine|colchicine|mesh-list
44671433|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
44671434|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671435|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44671436|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44671437|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44671438|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671439|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671440|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44671441|NCT01266707|Vaccines|vaccines|mesh-list
44671442|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
44671443|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671444|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44671445|NCT01266707|Growth Substances|growth substances|mesh-ancestor
44671446|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44671447|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671448|NCT01266720|Gemcitabine|gemcitabine|mesh-list
44671449|NCT01266720|Immunologic Factors|immunologic factors|mesh-ancestor
44671450|NCT01266720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671451|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44671452|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
44671453|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671454|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671455|NCT01266720|Antiviral Agents|antiviral agents|mesh-ancestor
44671456|NCT01266720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671457|NCT01266720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671458|NCT01266720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671459|NCT01266759|NuvaRing|nuvaring|mesh-list
44671460|NCT01266759|Norethindrone|norethindrone|mesh-list
44671461|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
44671462|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44671463|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
44671464|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44671465|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671466|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44671467|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44671468|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44671469|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44671470|NCT01266772|Budesonide|budesonide|mesh-list
44671471|NCT01266772|Montelukast|montelukast|mesh-list
44671472|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671473|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44671474|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
44671475|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671476|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671477|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671478|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671479|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
44671480|NCT01266772|Hormones|hormones|mesh-ancestor
44671481|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671482|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44671483|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
44671484|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44671485|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44671486|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671487|NCT01266785|Infliximab|infliximab|mesh-list
44671488|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44671489|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44671490|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671492|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
44671493|NCT01266811|Bortezomib|bortezomib|mesh-list
44671494|NCT01266811|Siltuximab|siltuximab|mesh-list
44671495|NCT01266811|BB 1101|bb 1101|mesh-list
44671496|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671497|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
44671498|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
44671499|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671500|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671501|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44671502|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
44671503|NCT01266811|Hormones|hormones|mesh-ancestor
44671504|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671505|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44671506|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671507|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
44671508|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671509|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671510|NCT01266837|Everolimus|everolimus|mesh-list
44671511|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671512|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671513|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
44671514|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671515|NCT01266928|Ascorbic Acid|ascorbic acid|mesh-list
44671516|NCT01266928|Vitamins|vitamins|mesh-ancestor
44671517|NCT01266928|Micronutrients|micronutrients|mesh-ancestor
44671518|NCT01266928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671519|NCT01266928|Antioxidants|antioxidants|mesh-ancestor
44671520|NCT01266928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671521|NCT01266928|Protective Agents|protective agents|mesh-ancestor
44671522|NCT01267058|Vaccines|vaccines|mesh-list
44671523|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
44671524|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671525|NCT01267084|Ketoconazole|ketoconazole|mesh-list
44671526|NCT01267084|Dexamethasone|dexamethasone|mesh-list
44671527|NCT01267084|Trabectedin|trabectedin|mesh-list
44671528|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671529|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
44671530|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
44671531|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671532|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671533|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44671534|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
44671535|NCT01267084|Hormones|hormones|mesh-ancestor
44671536|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671537|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44671538|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671539|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
44671540|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671541|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44671542|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44671543|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671544|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671545|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44671546|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44671547|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44671548|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44671549|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
44671550|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
44671551|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44671552|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
44671553|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671554|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
44671555|NCT01267214|Protective Agents|protective agents|mesh-ancestor
44671556|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
44671557|NCT01267305|PENTA|penta|mesh-list
44671558|NCT01267305|Nadroparin|nadroparin|mesh-list
44671559|NCT01267305|Fondaparinux|fondaparinux|mesh-list
44671560|NCT01267305|Calcium|calcium|mesh-list
44671561|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671562|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671563|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44671564|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44671565|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
44671566|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44671567|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
44671569|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671570|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
44671571|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44671572|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44671573|NCT01267344|Gemcitabine|gemcitabine|mesh-list
44671574|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
44671575|NCT01267344|Cetuximab|cetuximab|mesh-list
44671576|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44671577|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
44671578|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671579|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671580|NCT01267344|Antiviral Agents|antiviral agents|mesh-ancestor
44671581|NCT01267344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671582|NCT01267344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671583|NCT01267344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671584|NCT01267344|Immunologic Factors|immunologic factors|mesh-ancestor
44671585|NCT01267344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671586|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671587|NCT01267383|Sertraline|sertraline|mesh-list
44671588|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
44671589|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671590|NCT01267383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44671591|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44671592|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671593|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671594|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671595|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
44671596|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671597|NCT01267396|Sertraline|sertraline|mesh-list
44671598|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
44671599|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671600|NCT01267396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44671601|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44671602|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671603|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671604|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671605|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
44671606|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671607|NCT01267448|Metformin|metformin|mesh-list
44671608|NCT01267448|Saxagliptin|saxagliptin|mesh-list
44671609|NCT01267448|Glipizide|glipizide|mesh-list
44671610|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44671611|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671612|NCT01267448|Incretins|incretins|mesh-ancestor
44671613|NCT01267448|Hormones|hormones|mesh-ancestor
44671614|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671615|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44671616|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44671617|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671618|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671619|NCT01267487|Heparin|heparin|mesh-list
44671620|NCT01267487|Calcium heparin|calcium heparin|mesh-list
44671621|NCT01267487|Protamines|protamines|mesh-list
44671622|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
44671623|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44671624|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44671625|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671626|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
44671627|NCT01267487|Coagulants|coagulants|mesh-ancestor
44671628|NCT01267604|Inositol|inositol|mesh-list
44671629|NCT01267604|Melatonin|melatonin|mesh-list
44671630|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
44671631|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671632|NCT01267604|Protective Agents|protective agents|mesh-ancestor
44671633|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671634|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671635|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
44671636|NCT01267604|Vitamins|vitamins|mesh-ancestor
44671637|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
44671638|NCT01267643|Alefacept|alefacept|mesh-list
44671639|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
44671640|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
44671641|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671642|NCT01267669|Somatostatin|somatostatin|mesh-list
44671643|NCT01267669|Hormones|hormones|mesh-ancestor
44671644|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671645|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671646|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
44671647|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671648|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44671649|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671650|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671651|NCT01267734|Everolimus|everolimus|mesh-list
44671652|NCT01267734|Clopidogrel|clopidogrel|mesh-list
44671653|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671654|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671655|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
44671656|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671657|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44671658|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44671659|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44671660|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44671661|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
44671662|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671663|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671664|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
44671665|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44671666|NCT01267903|Vaccines|vaccines|mesh-list
44671667|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
44671668|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671669|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44671670|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671671|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671672|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44671673|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671674|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671675|NCT01268033|Rituximab|rituximab|mesh-list
44671676|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44671677|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671678|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
44671679|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671680|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671681|NCT01268163|Docetaxel|docetaxel|mesh-list
44671682|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671683|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44671684|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44671685|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44671686|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671687|NCT01268176|Vitamin D|vitamin d|mesh-list
44671688|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
44671689|NCT01268176|Vitamins|vitamins|mesh-ancestor
44671690|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
44671691|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671692|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44671693|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671694|NCT01268202|Pravastatin|pravastatin|mesh-list
44671695|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44671696|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44671697|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
44671698|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671699|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44671700|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44671701|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671702|NCT01268215|Budesonide|budesonide|mesh-list
44671703|NCT01268215|Calfactant|calfactant|mesh-list
44671704|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671705|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44671706|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
44671707|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671708|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671709|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44671710|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
44671711|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
44671712|NCT01268215|Hormones|hormones|mesh-ancestor
44671713|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671714|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44671715|NCT01268371|Everolimus|everolimus|mesh-list
44671716|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671717|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671718|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
44671719|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671720|NCT01268384|Gemcitabine|gemcitabine|mesh-list
44671721|NCT01268384|Capecitabine|capecitabine|mesh-list
44671722|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44671723|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
44671724|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671725|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671726|NCT01268384|Antiviral Agents|antiviral agents|mesh-ancestor
44671727|NCT01268384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671728|NCT01268384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671729|NCT01268384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671730|NCT01268384|Immunologic Factors|immunologic factors|mesh-ancestor
44671731|NCT01268384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671732|NCT01268631|Pregabalin|pregabalin|mesh-list
44671733|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44671734|NCT01268631|Analgesics|analgesics|mesh-ancestor
44671735|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
44671736|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671737|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671738|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
44671739|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44671740|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43780130|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
44671741|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671742|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44671743|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44671744|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44671745|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671746|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671747|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44671748|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44671749|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671750|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
44671751|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
44671752|NCT01268670|Ibuprofen|ibuprofen|mesh-list
44671753|NCT01268670|Oxycodone|oxycodone|mesh-list
44671754|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671755|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671756|NCT01268670|Analgesics|analgesics|mesh-ancestor
44671757|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
44671758|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671759|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671760|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671761|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671762|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44671763|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671764|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671765|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44671766|NCT01268670|Narcotics|narcotics|mesh-ancestor
44671767|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671768|NCT01268709|Doxepin|doxepin|mesh-list
44671769|NCT01268709|Nortriptyline|nortriptyline|mesh-list
44671770|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44671771|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
44671772|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671773|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44671774|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44671775|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671776|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671777|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
44671778|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671779|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671780|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44671781|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44671782|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671783|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
44671784|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
44671785|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44671786|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
44671787|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44671788|NCT01268761|Cetrorelix|cetrorelix|mesh-list
44671789|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44671790|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
44671791|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44671792|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671793|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
44671794|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671797|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44671798|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44671799|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671800|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671801|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
44671802|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671803|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44671804|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44671805|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44671806|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44671807|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44671808|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44671809|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44671810|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44671811|NCT01268904|Valproic Acid|valproic acid|mesh-list
44671812|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
44671813|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700482|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
44671814|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671815|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
44671816|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671817|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671818|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
44671819|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44671820|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671821|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671822|NCT01268917|Aspirin|aspirin|mesh-list
44671823|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671824|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671825|NCT01268917|Analgesics|analgesics|mesh-ancestor
44671826|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
44671827|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671828|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671829|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671830|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671831|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44671832|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44671833|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671834|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44671835|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44671836|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671837|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
44671838|NCT01268930|Hemostatics|hemostatics|mesh-list
44671839|NCT01268930|Coagulants|coagulants|mesh-ancestor
44671840|NCT01268995|Cyclosporine|cyclosporine|mesh-list
44671841|NCT01268995|Tacrolimus|tacrolimus|mesh-list
44671842|NCT01268995|Cyclosporins|cyclosporins|mesh-list
44671843|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44671844|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
44671845|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671846|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44671847|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671848|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671849|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
44671850|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671851|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
44671852|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671853|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
44671854|NCT01269021|Prednisone|prednisone|mesh-list
44671855|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671856|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
44671857|NCT01269021|Hormones|hormones|mesh-ancestor
44671858|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44671859|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671860|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44671861|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671862|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44671863|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44671864|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
44671865|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671866|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671867|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671868|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671869|NCT01269099|Fentanyl|fentanyl|mesh-list
44671870|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44671871|NCT01269099|Narcotics|narcotics|mesh-ancestor
44671872|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671873|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671874|NCT01269099|Analgesics|analgesics|mesh-ancestor
44671875|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
44671876|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671877|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44671878|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44671879|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
44671880|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
44671881|NCT01269112|Citric Acid|citric acid|mesh-list
44671882|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
44671883|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
44671884|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44671885|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
44671886|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
44671887|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671888|NCT01269138|Thrombin|thrombin|mesh-list
44671889|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
44671890|NCT01269138|Coagulants|coagulants|mesh-ancestor
44671891|NCT01269151|Ranibizumab|ranibizumab|mesh-list
44671892|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44671893|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44671894|NCT01269151|Growth Substances|growth substances|mesh-ancestor
44671895|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671896|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
44671897|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671898|NCT01269203|Curcumin|curcumin|mesh-list
44671899|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44671900|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44671901|NCT01269203|Analgesics|analgesics|mesh-ancestor
44671902|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
44671903|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671904|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671905|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671906|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44671907|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671908|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671909|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671910|NCT01269216|Leucovorin|leucovorin|mesh-list
44671911|NCT01269216|Irinotecan|irinotecan|mesh-list
44671912|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44671913|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44671914|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671915|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671916|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671917|NCT01269216|Antidotes|antidotes|mesh-ancestor
44671918|NCT01269216|Protective Agents|protective agents|mesh-ancestor
44671919|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671920|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44671921|NCT01269216|Vitamins|vitamins|mesh-ancestor
44671922|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
44671923|NCT01269242|Bindarit|bindarit|mesh-list
44671924|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44671925|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44671926|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671927|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671928|NCT01269255|Cisplatin|cisplatin|mesh-list
44671929|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671930|NCT01269281|Sumatriptan|sumatriptan|mesh-list
44671931|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44671932|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44671933|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44671934|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
44671935|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671936|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671937|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671938|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
44671939|NCT01269294|Simeprevir|simeprevir|mesh-list
44671940|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44671941|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44671942|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44671943|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44671944|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44671945|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671946|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671947|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44671948|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44671949|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
44671950|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44671951|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671952|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44671953|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44671954|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44671955|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
44671956|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44671957|NCT01269307|Ketamine|ketamine|mesh-list
44671958|NCT01269307|Propofol|propofol|mesh-list
44671959|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44671960|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671961|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671962|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44671963|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
44671964|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
44671965|NCT01269307|Analgesics|analgesics|mesh-ancestor
44671966|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
44671967|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44671968|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44671969|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44671970|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44671971|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671972|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671973|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
44671974|NCT01269333|Omeprazole|omeprazole|mesh-list
44671975|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44671976|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44671977|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44671978|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671979|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671980|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44671981|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44671982|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44671983|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44671984|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44671985|NCT01269333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44671986|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44671987|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44671988|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44671989|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
44671990|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44671991|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
44671992|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44671993|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44671994|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44671995|NCT01269411|R04929097|r04929097|mesh-list
44671996|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44671997|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44671998|NCT01269437|Budesonide|budesonide|mesh-list
44671999|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672000|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44672001|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
44672002|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672003|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672004|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44672005|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44672006|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
44672007|NCT01269437|Hormones|hormones|mesh-ancestor
44672008|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222646|NCT00496444|Azacitidine|azacitidine|mesh-list
44672010|NCT01269450|Progestins|progestins|mesh-ancestor
44672011|NCT01269450|Hormones|hormones|mesh-ancestor
44672012|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672013|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672014|NCT01269476|Fluorides|fluorides|mesh-list
44672015|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
44672016|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
44672017|NCT01269476|Protective Agents|protective agents|mesh-ancestor
44672018|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672019|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44672020|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672021|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672022|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672023|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672024|NCT01269515|Etoricoxib|etoricoxib|mesh-list
44672025|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44672026|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44672027|NCT01269515|Analgesics|analgesics|mesh-ancestor
44672028|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
44672029|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672030|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672031|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672032|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672033|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44672034|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44672035|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672036|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672037|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
44672038|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
44672039|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44672040|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
44672041|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672042|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672043|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44672044|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
44672045|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44672046|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
44672047|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672048|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672049|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44672050|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
44672051|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
44672052|NCT01269528|Protective Agents|protective agents|mesh-ancestor
44672053|NCT01269528|Miotics|miotics|mesh-ancestor
44672054|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44672055|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44672056|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44672057|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44672058|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672059|NCT01269541|Rifampin|rifampin|mesh-list
44672060|NCT01269541|Mupirocin|mupirocin|mesh-list
44672061|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44672062|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
44672063|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672064|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672065|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
44672066|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44672067|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672068|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672069|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44672070|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44672071|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44672072|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44672073|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44672074|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44672075|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44672076|NCT01269606|Insulin|insulin|mesh-list
44672077|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44672078|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
44672079|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
44672080|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44672081|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222709|NCT00497003|Metoprolol|metoprolol|mesh-list
44672082|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672083|NCT01269671|Peppermint oil|peppermint oil|mesh-list
44672084|NCT01269671|Melatonin|melatonin|mesh-list
44672085|NCT01269671|Simethicone|simethicone|mesh-list
44672086|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
44672087|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672088|NCT01269671|Protective Agents|protective agents|mesh-ancestor
44672089|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672090|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672091|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
44672092|NCT01269671|Emollients|emollients|mesh-ancestor
44672093|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672094|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
44672095|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
44672096|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672097|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672098|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
44672099|NCT01269684|Everolimus|everolimus|mesh-list
44672100|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672101|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672102|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
44672103|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672104|NCT01269788|Fluoxetine|fluoxetine|mesh-list
44672105|NCT01269788|Omeprazole|omeprazole|mesh-list
44672106|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44672107|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672108|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44672109|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672110|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672111|NCT01269788|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44672112|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44672113|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672114|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672115|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
44672116|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672117|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44672118|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
44672119|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44672120|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44672121|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44672122|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
44672123|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44672124|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672125|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672126|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44672127|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44672128|NCT01269827|Protective Agents|protective agents|mesh-ancestor
44672129|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672130|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
44672131|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44672132|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
44672133|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44672134|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44672135|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44672136|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672137|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672138|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672139|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672140|NCT01269866|Analgesics|analgesics|mesh-ancestor
44672141|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
44672142|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672143|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44672144|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44672145|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
44672146|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44672147|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44672148|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672149|NCT01269996|Metformin|metformin|mesh-list
44672150|NCT01269996|Gliclazide|gliclazide|mesh-list
44672151|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672152|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672153|NCT01270373|Docetaxel|docetaxel|mesh-list
44672154|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672155|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672156|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672157|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672158|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672159|NCT01270737|Daidzein|daidzein|mesh-list
44672160|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
44672161|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44672162|NCT01270737|Estrogens|estrogens|mesh-ancestor
44672163|NCT01270737|Hormones|hormones|mesh-ancestor
44672164|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672165|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672166|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
44672167|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44672168|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44672169|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672170|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
44672171|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672172|NCT01270789|Liraglutide|liraglutide|mesh-list
44672173|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672174|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672175|NCT01270789|Incretins|incretins|mesh-ancestor
44672176|NCT01270789|Hormones|hormones|mesh-ancestor
44672177|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672178|NCT01270815|Pregabalin|pregabalin|mesh-list
44672179|NCT01270815|Analgesics|analgesics|mesh-ancestor
44672180|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
44672181|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672182|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672183|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
44672184|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44235984|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
44672185|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672186|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672187|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44672188|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44672189|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44672190|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672191|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44672192|NCT01271179|Insulin|insulin|mesh-list
44672193|NCT01271179|Allopurinol|allopurinol|mesh-list
44672194|NCT01271179|Adenosine|adenosine|mesh-list
44672195|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44672196|NCT01271179|Analgesics|analgesics|mesh-ancestor
44672197|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
44672198|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672199|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672200|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44672201|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
44672202|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44672203|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
44672204|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
44672205|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672206|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672207|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
44672208|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672209|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
44672210|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672211|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44672212|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
44672213|NCT01271179|Protective Agents|protective agents|mesh-ancestor
44672214|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672215|NCT01271231|Azithromycin|azithromycin|mesh-list
44672216|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672217|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672218|NCT01271361|Sirolimus|sirolimus|mesh-list
44672219|NCT01271361|Umirolimus|umirolimus|mesh-list
44672220|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672221|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672222|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
44672223|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672224|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672225|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672226|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672227|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672228|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
44672229|NCT01271478|Telmisartan|telmisartan|mesh-list
44672230|NCT01271478|Captopril|captopril|mesh-list
44672231|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44672232|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44672233|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44672234|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672235|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44672236|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
44672237|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672238|NCT01271881|Heparin|heparin|mesh-list
44672239|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
44672240|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44672241|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44672242|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672243|NCT01273402|Antibodies|antibodies|mesh-list
44672244|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
44672245|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44672246|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
44672247|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672248|NCT01273441|Amoxicillin|amoxicillin|mesh-list
44672249|NCT01273441|Metronidazole|metronidazole|mesh-list
44672250|NCT01273441|Clarithromycin|clarithromycin|mesh-list
44672251|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672252|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672253|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44672254|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44672255|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44672256|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672257|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672258|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44672259|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44672260|NCT01273584|Metformin|metformin|mesh-list
44672261|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672262|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672263|NCT01274273|Interferons|interferons|mesh-list
44672264|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
44672265|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
44672266|NCT01274273|Aldesleukin|aldesleukin|mesh-list
44672267|NCT01274273|Bevacizumab|bevacizumab|mesh-list
44672268|NCT01274273|Interleukin-2|interleukin-2|mesh-list
44672269|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44672270|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672271|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44672272|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44672273|NCT01274273|Growth Substances|growth substances|mesh-ancestor
44672274|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672275|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
44672276|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
44672277|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672278|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
44672279|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44672280|NCT01274273|Analgesics|analgesics|mesh-ancestor
44672281|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
44672282|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672283|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44672284|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44672285|NCT01274780|Ritonavir|ritonavir|mesh-list
44672286|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44672287|NCT01274780|Darunavir|darunavir|mesh-list
44672288|NCT01274780|Tenofovir|tenofovir|mesh-list
44672289|NCT01274780|Emtricitabine|emtricitabine|mesh-list
44672290|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44672291|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44672292|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
44672293|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672294|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672295|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44672296|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44672297|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
44672298|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672299|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44672300|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44672301|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44672302|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44672303|NCT01275508|Adalimumab|adalimumab|mesh-list
44672304|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672305|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672306|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44672307|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44672308|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672309|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672310|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44672311|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672312|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672313|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672314|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672315|NCT01275911|Remifentanil|remifentanil|mesh-list
44672316|NCT01275911|Esmolol|esmolol|mesh-list
44672317|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44672318|NCT01275911|Narcotics|narcotics|mesh-ancestor
44672319|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672320|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672321|NCT01275911|Analgesics|analgesics|mesh-ancestor
44672322|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
44672323|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672324|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44672325|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44672326|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44672327|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
44672328|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672329|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672330|NCT01276431|Buprenorphine|buprenorphine|mesh-list
44672331|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44672332|NCT01276431|Narcotics|narcotics|mesh-ancestor
44103854|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672333|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672334|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672335|NCT01276431|Analgesics|analgesics|mesh-ancestor
44672336|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
44672337|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672338|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44672339|NCT01277016|Melphalan|melphalan|mesh-list
44672340|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44672341|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
44672342|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672343|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672344|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44672345|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672346|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
44672347|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672348|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44672349|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672350|NCT01277484|Decitabine|decitabine|mesh-list
44672351|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44672352|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
44672353|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672354|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672355|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672356|NCT01277705|Vaccines|vaccines|mesh-list
44672357|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
44672358|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672360|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672361|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44672362|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
44672363|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672364|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672365|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44672366|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
44672367|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
44672368|NCT01278082|Hormones|hormones|mesh-ancestor
44672369|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672370|NCT01278186|Paclitaxel|paclitaxel|mesh-list
44672371|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44672372|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672373|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672374|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672375|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672376|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672377|NCT01278264|Ropivacaine|ropivacaine|mesh-list
44672378|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
44672379|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
44672380|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672381|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672382|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
44672383|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672384|NCT01279811|Dopamine|dopamine|mesh-list
44672385|NCT01279811|Norepinephrine|norepinephrine|mesh-list
44672386|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44672387|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44672388|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44672389|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
44672390|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672391|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672392|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672393|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
44672394|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
44672395|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672396|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44672397|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
44672398|NCT01279811|Protective Agents|protective agents|mesh-ancestor
44672399|NCT01280006|Celecoxib|celecoxib|mesh-list
44672400|NCT01280006|Indomethacin|indomethacin|mesh-list
44672401|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44672402|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44672403|NCT01280006|Analgesics|analgesics|mesh-ancestor
44672404|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
44672405|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672406|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672407|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672408|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672409|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44672410|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44672411|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700483|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672412|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672413|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
44672414|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
44672415|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44672416|NCT01280071|Aminophylline|aminophylline|mesh-list
44672417|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44672418|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
44672419|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672420|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672421|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44672422|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
44672423|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44672424|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44672425|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672426|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672427|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44672428|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44672429|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
44672430|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672431|NCT01280071|Protective Agents|protective agents|mesh-ancestor
44672432|NCT01280149|Substance P|substance p|mesh-list
44672433|NCT01280149|Neurokinin A|neurokinin a|mesh-list
44672434|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672435|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672436|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672437|NCT01280162|Piperaquine|piperaquine|mesh-list
44672438|NCT01280162|Artenimol|artenimol|mesh-list
44672439|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
44672440|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44672441|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44672442|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672443|NCT01280175|Charcoal|charcoal|mesh-list
44672444|NCT01280175|Antidotes|antidotes|mesh-ancestor
44672445|NCT01280175|Protective Agents|protective agents|mesh-ancestor
44672446|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672447|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44672448|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
44672449|NCT01280188|Coagulants|coagulants|mesh-ancestor
44672450|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44672451|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
44672452|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672453|NCT01280214|Triamcinolone|triamcinolone|mesh-list
44672454|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672455|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
44672456|NCT01280214|Hormones|hormones|mesh-ancestor
44672457|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672458|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672459|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44672460|NCT01280240|Hematinics|hematinics|mesh-ancestor
44672461|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44672462|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44672463|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
44672464|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672465|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672466|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44672467|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44672468|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44672469|NCT01280526|Romidepsin|romidepsin|mesh-list
44672470|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104016|NCT00067158|Nicotine|nicotine|mesh-list
44672471|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672472|NCT01280669|Sirolimus|sirolimus|mesh-list
44672473|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672474|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672475|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672476|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672477|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
44672478|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672479|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
44672480|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672481|NCT01280682|Rituximab|rituximab|mesh-list
44672482|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44672483|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672484|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
44672485|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672486|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672487|NCT01280734|Melatonin|melatonin|mesh-list
44672488|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
44672489|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672490|NCT01280734|Protective Agents|protective agents|mesh-ancestor
44672491|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672492|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672493|NCT01280929|Ranibizumab|ranibizumab|mesh-list
44672494|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44672495|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44672496|NCT01280929|Growth Substances|growth substances|mesh-ancestor
44672497|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672498|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
44672499|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672500|NCT01281111|Aspirin|aspirin|mesh-list
44672501|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44672502|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44672503|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44672504|NCT01281111|Analgesics|analgesics|mesh-ancestor
44672505|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
44672506|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672507|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672508|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672509|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672510|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44672511|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44672512|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672513|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44672514|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44672515|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672516|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
44672517|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672518|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672519|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
44672521|NCT01281150|Carboplatin|carboplatin|mesh-list
44672522|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44672523|NCT01281150|Veliparib|veliparib|mesh-list
44672524|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44672525|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672526|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672527|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672528|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672529|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672530|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44672531|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672532|NCT01281163|Lapatinib|lapatinib|mesh-list
44672533|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672534|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44672535|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672536|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672537|NCT01281228|Exenatide|exenatide|mesh-list
44672538|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672539|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672540|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44672541|NCT01281228|Incretins|incretins|mesh-ancestor
44672542|NCT01281228|Hormones|hormones|mesh-ancestor
44672543|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672544|NCT01281514|Carboplatin|carboplatin|mesh-list
44672545|NCT01281514|Doxorubicin|doxorubicin|mesh-list
44672546|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44672547|NCT01281514|Everolimus|everolimus|mesh-list
44672548|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672549|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672550|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44672551|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44672552|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672553|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672554|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672555|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
44672556|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672557|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44672558|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44672559|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44672560|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066684|NCT00007982|Thiotepa|thiotepa|mesh-list
44672561|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672562|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44672563|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44672564|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44672565|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
44672566|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672567|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672568|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44672569|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44672570|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
44672571|NCT01281540|Cisapride|cisapride|mesh-list
44672572|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44672573|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672574|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44672575|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
44672576|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672577|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672578|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672579|NCT01281553|Cisapride|cisapride|mesh-list
44672580|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44672581|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672582|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44672583|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
44672584|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672585|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672586|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672587|NCT01281566|Cisapride|cisapride|mesh-list
44672588|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44672589|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672590|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44672591|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
44672592|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672593|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672594|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672595|NCT01281579|Canagliflozin|canagliflozin|mesh-list
44672596|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44672597|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672598|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672599|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672601|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44672602|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
44672603|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44672604|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672605|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44672606|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44672607|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672608|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672609|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
44153299|NCT00219921|Morphine|morphine|mesh-list
44672610|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672611|NCT01281696|Bevacizumab|bevacizumab|mesh-list
44672612|NCT01281696|Cisplatin|cisplatin|mesh-list
44672613|NCT01281696|Methotrexate|methotrexate|mesh-list
44672614|NCT01281696|Etoposide|etoposide|mesh-list
44672615|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44672616|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672617|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44672618|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44672619|NCT01281696|Growth Substances|growth substances|mesh-ancestor
44672620|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672621|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
44672622|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44672623|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
44672624|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44672625|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44672626|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
44672627|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672628|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672629|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672630|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44672631|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672632|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
44672633|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672634|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44672635|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44672636|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44672637|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44672638|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
44672639|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44672640|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44672641|NCT01281748|Prednisolone|prednisolone|mesh-list
44672642|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
44672643|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44672644|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
44672645|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672646|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
44672647|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
44672648|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672649|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672650|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672651|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
44672652|NCT01281748|Hormones|hormones|mesh-ancestor
44672653|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672654|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44672655|NCT01281748|Protective Agents|protective agents|mesh-ancestor
44672656|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44672657|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672658|NCT01281761|Irinotecan|irinotecan|mesh-list
44672659|NCT01281761|Cetuximab|cetuximab|mesh-list
44672660|NCT01281761|Simvastatin|simvastatin|mesh-list
44672661|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44672662|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44672663|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672664|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672665|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672666|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44672667|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44672668|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44672669|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
44672670|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44672671|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44672672|NCT01281787|Losartan|losartan|mesh-list
44672673|NCT01281787|Metoprolol|metoprolol|mesh-list
44672674|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44672675|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44672676|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44672677|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44672678|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672679|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
44672680|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
44672681|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672682|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672683|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44672684|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44672685|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44672686|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44672687|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672688|NCT01281800|Gemcitabine|gemcitabine|mesh-list
44672689|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44672690|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
44672691|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672692|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672693|NCT01281800|Antiviral Agents|antiviral agents|mesh-ancestor
44672694|NCT01281800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672695|NCT01281800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672696|NCT01281800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672697|NCT01281800|Immunologic Factors|immunologic factors|mesh-ancestor
44672698|NCT01281800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672699|NCT01281852|Paclitaxel|paclitaxel|mesh-list
44672700|NCT01281852|Cisplatin|cisplatin|mesh-list
44672701|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44672702|NCT01281852|Veliparib|veliparib|mesh-list
44672703|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44672704|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672705|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672706|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672707|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672708|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700484|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672709|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44672710|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672711|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
44672712|NCT01281878|Pyridoxal|pyridoxal|mesh-list
44672713|NCT01281878|Pyridoxine|pyridoxine|mesh-list
44672714|NCT01281878|Vitamins|vitamins|mesh-ancestor
44672715|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
44672716|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672717|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
44672718|NCT01281891|Morphine|morphine|mesh-list
44672719|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44672720|NCT01281891|Narcotics|narcotics|mesh-ancestor
44672721|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672722|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672723|NCT01281891|Analgesics|analgesics|mesh-ancestor
44672724|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
44672725|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672726|NCT01281943|Sirolimus|sirolimus|mesh-list
44672727|NCT01281943|Doxorubicin|doxorubicin|mesh-list
44672728|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44672729|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672730|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672731|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44672732|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44672733|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672734|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672735|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672736|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672737|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
44672738|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672739|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
44672740|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672741|NCT01282047|Lenalidomide|lenalidomide|mesh-list
44672742|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
44672743|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672744|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44672745|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44672746|NCT01282047|Growth Substances|growth substances|mesh-ancestor
44672747|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
44672748|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672749|NCT01282073|Cyclosporine|cyclosporine|mesh-list
44672750|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
44672751|NCT01282073|Cyclosporins|cyclosporins|mesh-list
44672752|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672753|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672754|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672755|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
44672756|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672757|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
44672758|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672759|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672760|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672761|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44672762|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672763|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672764|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44672765|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
44672766|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672767|NCT01282151|Cisplatin|cisplatin|mesh-list
44672768|NCT01282151|Pemetrexed|pemetrexed|mesh-list
44672769|NCT01282151|Docetaxel|docetaxel|mesh-list
44672770|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672771|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672772|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672773|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44672774|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44672775|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672776|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672777|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672778|NCT01282333|Gemcitabine|gemcitabine|mesh-list
44672779|NCT01282333|Cisplatin|cisplatin|mesh-list
44672780|NCT01282333|Veliparib|veliparib|mesh-list
44672781|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672782|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44672783|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
44672784|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672785|NCT01282333|Antiviral Agents|antiviral agents|mesh-ancestor
44672786|NCT01282333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672787|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672788|NCT01282333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672789|NCT01282333|Immunologic Factors|immunologic factors|mesh-ancestor
44672790|NCT01282333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672791|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44672793|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44672794|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44672795|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
44672796|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672797|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44672798|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44672799|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672800|NCT01282398|Simvastatin|simvastatin|mesh-list
44672801|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44672802|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44672803|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
44672804|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672805|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44672806|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44672807|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672808|NCT01282502|Midostaurin|midostaurin|mesh-list
44672809|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672810|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44672811|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672812|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672813|NCT01282515|Clobetasol|clobetasol|mesh-list
44672814|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44672815|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
44672816|NCT01282515|Hormones|hormones|mesh-ancestor
44672817|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672818|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672819|NCT01282528|Infliximab|infliximab|mesh-list
44672820|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
44672821|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672822|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44672823|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
44672824|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44672825|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44672826|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44672827|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672828|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672829|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672830|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672831|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672832|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44672833|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672834|NCT01282619|Huperzine A|huperzine a|mesh-list
44672835|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44672836|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672837|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672838|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672839|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672840|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672841|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44672842|NCT01282619|Protective Agents|protective agents|mesh-ancestor
44672843|NCT01282632|Olanzapine|olanzapine|mesh-list
44672844|NCT01282632|Risperidone|risperidone|mesh-list
44672845|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44672846|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
44672847|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672848|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672849|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672850|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44672851|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44672852|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672853|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44672854|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44672855|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
44672856|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
44672857|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
44672858|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672859|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44672860|NCT01282632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44672861|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44672862|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672864|NCT01282697|Irinotecan|irinotecan|mesh-list
44672865|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44672866|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44672867|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672868|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672869|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672870|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44672871|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672872|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44672873|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
44672874|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44672875|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
44672876|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672877|NCT01282762|Vaccines|vaccines|mesh-list
44672878|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
44672879|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672880|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44672881|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44672882|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44672883|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
44672884|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672885|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672886|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672887|NCT01282840|Urological Agents|urological agents|mesh-ancestor
44672888|NCT01282879|Itraconazole|itraconazole|mesh-list
44672889|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
44672890|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672891|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44672892|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44672893|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672894|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672895|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44672896|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
44672897|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672898|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672899|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44672901|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44672902|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672903|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44672904|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44672905|NCT01283048|Growth Substances|growth substances|mesh-ancestor
44672906|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672907|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44672908|NCT01283061|Zafirlukast|zafirlukast|mesh-list
44672909|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44672910|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44672911|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44672912|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
44672913|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44672914|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672915|NCT01283100|Dolutegravir|dolutegravir|mesh-list
44672916|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44672917|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44672918|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672919|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672920|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44672921|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44672922|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
44672923|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672924|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44672925|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672926|NCT01283178|Cisplatin|cisplatin|mesh-list
44672927|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44672928|NCT01283178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672929|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44672930|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672931|NCT01283204|Leucovorin|leucovorin|mesh-list
44672932|NCT01283204|Paclitaxel|paclitaxel|mesh-list
44672933|NCT01283204|Docetaxel|docetaxel|mesh-list
44672934|NCT01283204|Cisplatin|cisplatin|mesh-list
44672935|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
44672936|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
44672937|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44672938|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672939|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672940|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672941|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672942|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672943|NCT01283204|Antidotes|antidotes|mesh-ancestor
44672944|NCT01283204|Protective Agents|protective agents|mesh-ancestor
44672945|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672946|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
44672947|NCT01283204|Vitamins|vitamins|mesh-ancestor
44672948|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
44672949|NCT01283217|Cisplatin|cisplatin|mesh-list
44672950|NCT01283217|Docetaxel|docetaxel|mesh-list
44672951|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44672952|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44672953|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44672954|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44672955|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672956|NCT01283256|Zonisamide|zonisamide|mesh-list
44672957|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
44672958|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44672959|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44672960|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672961|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44672962|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672963|NCT01283360|Tenofovir|tenofovir|mesh-list
44672964|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
44672965|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44672966|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44672967|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44672968|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44672969|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672970|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44672971|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44672972|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
44672973|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44223596|NCT00501410|Leucovorin|leucovorin|mesh-list
44672974|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44672975|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672976|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44672977|NCT01283412|Analgesics|analgesics|mesh-ancestor
44672978|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
44672979|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44672980|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44672981|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44672982|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44672983|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44672984|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44672985|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672986|NCT01283646|Vitamins|vitamins|mesh-list
44672987|NCT01283646|Ascorbic Acid|ascorbic acid|mesh-list
44672988|NCT01283646|Folic Acid|folic acid|mesh-list
44672989|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
44672990|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
44672991|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44672992|NCT01283646|Antioxidants|antioxidants|mesh-ancestor
44672993|NCT01283646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44672994|NCT01283646|Protective Agents|protective agents|mesh-ancestor
44672995|NCT01283646|Hematinics|hematinics|mesh-ancestor
44672996|NCT01283724|Dienogest|dienogest|mesh-list
44672997|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44672998|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
44672999|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44153338|NCT00220103|Epirubicin|epirubicin|mesh-list
44673000|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673001|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44673002|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44673003|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44673004|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44673005|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44673006|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673007|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44673008|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673009|NCT01283763|Imiquimod|imiquimod|mesh-list
44673010|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44673011|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
44673012|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673013|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673014|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
44673015|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
44673016|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673017|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
44673018|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673019|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673020|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673021|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
44673022|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673023|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673024|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44673025|NCT01283789|Everolimus|everolimus|mesh-list
44673026|NCT01283789|Lapatinib|lapatinib|mesh-list
44673027|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673028|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673029|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
44673030|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673031|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44673032|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673033|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673034|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
44673035|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673036|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673037|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44673038|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
44673039|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673040|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673041|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673042|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673043|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
44673044|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673045|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673046|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44673047|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
44673048|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673049|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673050|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673051|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673052|NCT01283919|Pantoprazole|pantoprazole|mesh-list
44673053|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673054|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673055|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44673056|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673057|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673058|NCT01283932|Pantoprazole|pantoprazole|mesh-list
44673059|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673060|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673061|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44673062|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104528|NCT00069927|Amphetamine|amphetamine|mesh-list
44673063|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673064|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44673065|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44673066|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44673067|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44673068|NCT01284166|Timolol|timolol|mesh-list
44673069|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44673070|NCT01284166|Dorzolamide|dorzolamide|mesh-list
44673071|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44673072|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44673073|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44673074|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44673075|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
44673076|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673077|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673078|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673079|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44673080|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44673081|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44673082|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44673083|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44673084|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44673085|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673086|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
44673087|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44673088|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
44673089|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673090|NCT01284309|Mirabegron|mirabegron|mesh-list
44673091|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44673092|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44673093|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44673094|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
44673095|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673096|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673097|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673098|NCT01284309|Urological Agents|urological agents|mesh-ancestor
44673099|NCT01284413|Gemcitabine|gemcitabine|mesh-list
44673100|NCT01284413|Cisplatin|cisplatin|mesh-list
44673101|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673102|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673103|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
44673104|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673105|NCT01284413|Antiviral Agents|antiviral agents|mesh-ancestor
44673106|NCT01284413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673107|NCT01284413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673108|NCT01284413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673109|NCT01284413|Immunologic Factors|immunologic factors|mesh-ancestor
44673110|NCT01284413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673111|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
44673112|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44673113|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
44673114|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673115|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
44673116|NCT01284439|Protective Agents|protective agents|mesh-ancestor
44673117|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
44673118|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673119|NCT01284478|Dexamethasone|dexamethasone|mesh-list
44673120|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673121|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
44673122|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
44673123|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673124|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673125|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673126|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
44673127|NCT01284478|Hormones|hormones|mesh-ancestor
44673128|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673129|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44673130|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673131|NCT01284556|Phenobarbital|phenobarbital|mesh-list
44673132|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
44673133|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44673134|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673135|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673136|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44673137|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44673138|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673139|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673140|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
44673141|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
44673142|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44673143|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44673144|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44673145|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
44673146|NCT01284647|Sucralfate|sucralfate|mesh-list
44673147|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673148|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673149|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673150|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
44673151|NCT01284725|Azathioprine|azathioprine|mesh-list
44673152|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44673153|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673154|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673155|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44673156|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
44673157|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673158|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673159|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673160|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673161|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
44673162|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673163|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
44673164|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673165|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673166|NCT01284764|Mosapride|mosapride|mesh-list
44673167|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673168|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44673169|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
44673170|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673171|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673172|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673173|NCT01284855|Antivenins|antivenins|mesh-list
44673174|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
44673175|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673176|NCT01284868|Propranolol|propranolol|mesh-list
44673177|NCT01284868|Bisoprolol|bisoprolol|mesh-list
44673178|NCT01284868|Mirabegron|mirabegron|mesh-list
44673179|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44673180|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44673181|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44673182|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673183|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673184|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673185|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44673186|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44673187|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44673188|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44673189|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44104664|NCT00070148|Hormones|hormones|mesh-ancestor
44673190|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44673191|NCT01284868|Urological Agents|urological agents|mesh-ancestor
44673192|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
44673193|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
44673194|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673195|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44673196|NCT01284907|Vitamin D|vitamin d|mesh-list
44673197|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
44673198|NCT01284907|Vitamins|vitamins|mesh-ancestor
44673199|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
44673200|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673201|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44673202|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44673203|NCT01284946|Deferasirox|deferasirox|mesh-list
44673204|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44673205|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
44673206|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
44673207|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673208|NCT01285037|Gemcitabine|gemcitabine|mesh-list
44673209|NCT01285037|Cisplatin|cisplatin|mesh-list
44673210|NCT01285037|Cetuximab|cetuximab|mesh-list
44673211|NCT01285037|Ramucirumab|ramucirumab|mesh-list
44673212|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673213|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673214|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
44673215|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673216|NCT01285037|Antiviral Agents|antiviral agents|mesh-ancestor
44673217|NCT01285037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673218|NCT01285037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673219|NCT01285037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673220|NCT01285037|Immunologic Factors|immunologic factors|mesh-ancestor
44673221|NCT01285037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673222|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673223|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
44673224|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44673225|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
44673226|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673227|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673228|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673229|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
44673230|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673232|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44673233|NCT01285141|Protective Agents|protective agents|mesh-ancestor
44673234|NCT01285219|Lenograstim|lenograstim|mesh-list
44673235|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44673236|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
44673237|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673238|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44673239|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673240|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44673241|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673242|NCT01285271|Sevoflurane|sevoflurane|mesh-list
44673243|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44673244|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44673245|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
44673246|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
44673247|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673248|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673249|NCT01285375|Curcumin|curcumin|mesh-list
44673250|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44673251|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44673252|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673253|NCT01285375|Analgesics|analgesics|mesh-ancestor
44673254|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
44673255|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673256|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673257|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673258|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673259|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673260|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673261|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673262|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
44673263|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673264|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44673265|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44673266|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673267|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673268|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
44673269|NCT01285414|Temozolomide|temozolomide|mesh-list
44673270|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673271|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
44673272|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673273|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673274|NCT01285453|Vadimezan|vadimezan|mesh-list
44673275|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673276|NCT01285466|Paclitaxel|paclitaxel|mesh-list
44673277|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44673278|NCT01285466|Trastuzumab|trastuzumab|mesh-list
44673279|NCT01285466|Dactolisib|dactolisib|mesh-list
44673280|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44673281|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673282|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673283|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673284|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673285|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673286|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673287|NCT01285505|Alprazolam|alprazolam|mesh-list
44673288|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44673289|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673290|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673291|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44673292|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44673293|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44673294|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
44673295|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
44673296|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673297|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673298|NCT01285544|Atorvastatin|atorvastatin|mesh-list
44673299|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44673300|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44673301|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
44673302|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673303|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44067362|NCT05638217|Listerine|listerine|mesh-list
44673304|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44673305|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673306|NCT01285596|Mirabegron|mirabegron|mesh-list
44673307|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44673308|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44673309|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44673310|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44673311|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673312|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673313|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673314|NCT01285596|Urological Agents|urological agents|mesh-ancestor
44673315|NCT01285661|Vitamin K|vitamin k|mesh-list
44673316|NCT01285661|Warfarin|warfarin|mesh-list
44673317|NCT01285661|Anticoagulants|anticoagulants|mesh-list
44673318|NCT01285661|Vitamins|vitamins|mesh-ancestor
44673319|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
44673320|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673321|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44104799|NCT00070213|Vitamins|vitamins|mesh-ancestor
44673322|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44673323|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673324|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
44673325|NCT01285661|Coagulants|coagulants|mesh-ancestor
44673326|NCT01285674|Cisplatin|cisplatin|mesh-list
44673327|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673328|NCT01285765|Rituximab|rituximab|mesh-list
44673329|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673330|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673331|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
44673332|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673333|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673334|NCT01285778|Panitumumab|panitumumab|mesh-list
44673335|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673336|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673337|NCT01285817|Celecoxib|celecoxib|mesh-list
44673338|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
44673339|NCT01285817|Methotrexate|methotrexate|mesh-list
44673340|NCT01285817|Vinblastine|vinblastine|mesh-list
44673341|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673342|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
44673343|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673344|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673345|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673346|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
44673347|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673348|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673349|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44673350|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44673351|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
44673352|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44673353|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673354|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
44673355|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
44673356|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673357|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44673358|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44673359|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44673360|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673361|NCT01285817|Analgesics|analgesics|mesh-ancestor
44673362|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
44673363|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673364|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673365|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44673366|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44673367|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44673368|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673369|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673370|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673371|NCT01285934|Insulin|insulin|mesh-list
44673372|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673373|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673374|NCT01286051|Ganirelix|ganirelix|mesh-list
44673375|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
44673376|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673377|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673378|NCT01286090|Cisapride|cisapride|mesh-list
44673379|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673381|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44673382|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
44673383|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673384|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673385|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673386|NCT01286103|Canagliflozin|canagliflozin|mesh-list
44673387|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44673388|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673389|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673390|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673391|NCT01286194|Rabeprazole|rabeprazole|mesh-list
44673392|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673393|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673394|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44673395|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673396|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673397|NCT01286233|Metformin|metformin|mesh-list
44673398|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673399|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673400|NCT01286246|Progesterone|progesterone|mesh-list
44673401|NCT01286246|Progestins|progestins|mesh-ancestor
44673402|NCT01286246|Hormones|hormones|mesh-ancestor
44673403|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673404|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673405|NCT01286584|Varenicline|varenicline|mesh-list
44673406|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44673407|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44673408|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
44673409|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673410|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673411|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673412|NCT01286688|Terbinafine|terbinafine|mesh-list
44673413|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
44673414|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673415|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673416|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673417|NCT01286701|Terbinafine|terbinafine|mesh-list
44673418|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
44673419|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673420|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673421|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673422|NCT01286766|Cisplatin|cisplatin|mesh-list
44673423|NCT01286766|Docetaxel|docetaxel|mesh-list
44673424|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673425|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673426|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673427|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673428|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673429|NCT01286857|Silicon|silicon|mesh-list
44673430|NCT01286857|Trace Elements|trace elements|mesh-ancestor
44673431|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
44673432|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673433|NCT01286896|Sunitinib|sunitinib|mesh-list
44673434|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673435|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44673436|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44673437|NCT01286896|Growth Substances|growth substances|mesh-ancestor
44673438|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673439|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44673440|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44673441|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673442|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673443|NCT01286909|Lycopene|lycopene|mesh-list
44673444|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673445|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
44673446|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673447|NCT01286909|Protective Agents|protective agents|mesh-ancestor
44673448|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673449|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44673450|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44673451|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673452|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
44235988|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44673453|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44673455|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44673456|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673457|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44673458|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44673459|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44673460|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
44673461|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44673462|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
44673463|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
44673464|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673465|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673466|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673467|NCT01287052|Analgesics|analgesics|mesh-ancestor
44673468|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
44673469|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224197|NCT00504062|Fluticasone|fluticasone|mesh-list
44673470|NCT01287130|Cetuximab|cetuximab|mesh-list
44673471|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673472|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673473|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
44673474|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44673475|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44673476|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44673477|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673478|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
44673479|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673480|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673481|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44673482|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673483|NCT01287260|Nifedipine|nifedipine|mesh-list
44673484|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44673485|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44673486|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673487|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44673488|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673489|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
44673490|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
44673491|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44673492|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44673493|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44673494|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673495|NCT01287338|Analgesics|analgesics|mesh-ancestor
44673496|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
44673497|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673498|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673499|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673500|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673501|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44673502|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44673503|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44673504|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
44673505|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
44673506|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673507|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673508|NCT01287351|Fluticasone|fluticasone|mesh-list
44673509|NCT01287351|Xhance|xhance|mesh-list
44673510|NCT01287351|Beclomethasone|beclomethasone|mesh-list
44673511|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673512|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44673513|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
44673514|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673515|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673516|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44673517|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
44673518|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
44673519|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44673520|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
44673521|NCT01287351|Hormones|hormones|mesh-ancestor
44673522|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673523|NCT01287455|Vitamin D|vitamin d|mesh-list
44673524|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
44673525|NCT01287455|Vitamins|vitamins|mesh-ancestor
44673526|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
44673527|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673528|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44673529|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44673530|NCT01287494|Sertraline|sertraline|mesh-list
44673531|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
44673532|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44673533|NCT01287494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44673534|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44673535|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44673536|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673537|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673538|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
44673539|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673540|NCT01287507|Lactoferrin|lactoferrin|mesh-list
44673541|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673542|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
44224279|NCT00504283|Morphine|morphine|mesh-list
44673543|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44673544|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673545|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44673546|NCT01287546|Trametinib|trametinib|mesh-list
44673547|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673548|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44673549|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673550|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673551|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
44673552|NCT01287598|Midazolam|midazolam|mesh-list
44673553|NCT01287598|Omeprazole|omeprazole|mesh-list
44673554|NCT01287598|Warfarin|warfarin|mesh-list
44673555|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44673556|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44673557|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673558|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673559|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44673560|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44673561|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44673562|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44673563|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
44673564|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
44673565|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
44673566|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
44673567|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673568|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673569|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
44673570|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44673571|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673572|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44673573|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673574|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673575|NCT01287624|Gemcitabine|gemcitabine|mesh-list
44673576|NCT01287624|Paclitaxel|paclitaxel|mesh-list
44673577|NCT01287624|Cisplatin|cisplatin|mesh-list
44673578|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44673579|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673580|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673581|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673582|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673583|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673584|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673585|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
44673586|NCT01287624|Antiviral Agents|antiviral agents|mesh-ancestor
44673587|NCT01287624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673588|NCT01287624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673589|NCT01287624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673590|NCT01287624|Immunologic Factors|immunologic factors|mesh-ancestor
44673591|NCT01287624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673592|NCT01287663|Permethrin|permethrin|mesh-list
44673593|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673594|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673595|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
44673596|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44673597|NCT01287689|Antibodies|antibodies|mesh-list
44673598|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
44673599|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
44673600|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673602|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44673603|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673604|NCT01287715|Analgesics|analgesics|mesh-ancestor
44673605|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
44673606|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673607|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673608|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673609|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673610|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673611|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673612|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
44673613|NCT01287741|Prednisone|prednisone|mesh-list
44673614|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
44673615|NCT01287741|Rituximab|rituximab|mesh-list
44673616|NCT01287741|Doxorubicin|doxorubicin|mesh-list
44673617|NCT01287741|Vincristine|vincristine|mesh-list
44673618|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
44673619|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673620|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
44673621|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673622|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673623|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673624|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
44673625|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673626|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673627|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44673628|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673629|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673630|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44673631|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44673632|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673633|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673634|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
44673636|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673637|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44673638|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44673639|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673640|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673641|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673642|NCT01287780|Gentamicins|gentamicins|mesh-list
44673643|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673644|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673645|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44673646|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673647|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673648|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
44673649|NCT01287793|Tigecycline|tigecycline|mesh-list
44673650|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673651|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673652|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44673653|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44673654|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673655|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673656|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673657|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44673658|NCT01287806|Urinastatin|urinastatin|mesh-list
44673659|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44673660|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44673661|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44673662|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673663|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673664|NCT01287962|Apatinib|apatinib|mesh-list
44673665|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673666|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44673667|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673668|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673669|NCT01288092|Dactolisib|dactolisib|mesh-list
44673670|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673671|NCT01288131|Cyclosporine|cyclosporine|mesh-list
44673672|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
44673673|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
44673674|NCT01288131|Cyclosporins|cyclosporins|mesh-list
44673675|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673676|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
44673677|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673678|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673679|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673680|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
44673681|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673682|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673683|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44673684|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673685|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
44673686|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673687|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
44673688|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44673689|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673690|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44673691|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
44673692|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673693|NCT01288157|Golimumab|golimumab|mesh-list
44673694|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44673695|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44673696|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673697|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673698|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
44673699|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673700|NCT01288170|Tobramycin|tobramycin|mesh-list
44673701|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673702|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673703|NCT01288261|Paclitaxel|paclitaxel|mesh-list
44673704|NCT01288261|Bavituximab|bavituximab|mesh-list
44673705|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44673706|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673707|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
44673708|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
44673709|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
44673710|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673711|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673712|NCT01288326|Liraglutide|liraglutide|mesh-list
44673713|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673714|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673715|NCT01288326|Incretins|incretins|mesh-ancestor
44673716|NCT01288326|Hormones|hormones|mesh-ancestor
44673717|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673718|NCT01288339|Leucovorin|leucovorin|mesh-list
44673719|NCT01288339|Fluorouracil|fluorouracil|mesh-list
44673720|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
44673721|NCT01288339|Panitumumab|panitumumab|mesh-list
44673722|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
44673723|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673724|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44673725|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673726|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673727|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
44673728|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673729|NCT01288339|Antidotes|antidotes|mesh-ancestor
44673730|NCT01288339|Protective Agents|protective agents|mesh-ancestor
44673731|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
44673732|NCT01288339|Vitamins|vitamins|mesh-ancestor
44673733|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
44673734|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673735|NCT01288378|Caspofungin|caspofungin|mesh-list
44673736|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
44673737|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673738|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673739|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673740|NCT01288404|Fluorometholone|fluorometholone|mesh-list
44673741|NCT01288404|Bevacizumab|bevacizumab|mesh-list
44673742|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44673743|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673744|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44673745|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44673746|NCT01288404|Growth Substances|growth substances|mesh-ancestor
44673747|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673748|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
44673749|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673750|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
44673751|NCT01288404|Hormones|hormones|mesh-ancestor
44673752|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44673753|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44673754|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
44673755|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44673756|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44673757|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
44673758|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673759|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44673760|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44673761|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673762|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673763|NCT01288495|Psyllium|psyllium|mesh-list
44673764|NCT01288495|Cathartics|cathartics|mesh-ancestor
44673765|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673766|NCT01288508|Psyllium|psyllium|mesh-list
44673767|NCT01288508|Cathartics|cathartics|mesh-ancestor
44673768|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44673769|NCT01288547|Theobromine|theobromine|mesh-list
44673770|NCT01288547|Caffeine|caffeine|mesh-list
44673771|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44673772|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673773|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44673774|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105225|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
44673775|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673776|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44673777|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44673778|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
44673779|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673780|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44673781|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
44673782|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673783|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44673784|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44673785|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
44673786|NCT01288573|Plerixafor|plerixafor|mesh-list
44673787|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44673788|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44673789|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
44673790|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673791|NCT01288664|Tacrolimus|tacrolimus|mesh-list
44673792|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673793|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
44673794|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673795|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44673796|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673797|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673798|NCT01288716|Baclofen|baclofen|mesh-list
44673799|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44673800|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673801|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44673802|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673803|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44673804|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
44673805|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
44673806|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673807|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673808|NCT01288742|Simeprevir|simeprevir|mesh-list
44673809|NCT01288742|Digoxin|digoxin|mesh-list
44673810|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44673811|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44673812|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44673813|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
44673814|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673815|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44673816|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44673817|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673818|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44673819|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44673820|NCT01288742|Protective Agents|protective agents|mesh-ancestor
44673821|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673822|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
44673823|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673824|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
44673825|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
44673826|NCT01288755|Rilpivirine|rilpivirine|mesh-list
44673827|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44673828|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44673829|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
44673830|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673831|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44673832|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44673833|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673834|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673835|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44673836|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44673837|NCT01288794|Furosemide|furosemide|mesh-list
44673838|NCT01288794|Diuretics|diuretics|mesh-list
44673839|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
44673840|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673841|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44673842|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44673843|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673844|NCT01288820|Artesunate|artesunate|mesh-list
44673845|NCT01288820|Piperaquine|piperaquine|mesh-list
44673846|NCT01288820|Primaquine|primaquine|mesh-list
44673847|NCT01288820|Amodiaquine|amodiaquine|mesh-list
44673848|NCT01288820|Artenimol|artenimol|mesh-list
44673849|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
44673850|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44673851|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44673852|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673853|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673854|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
44673855|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
44673856|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44673857|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
44673858|NCT01288872|Praziquantel|praziquantel|mesh-list
44673859|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
44673860|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44673861|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673862|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
44673863|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44673864|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673865|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673866|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673867|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
44673868|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44673869|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673870|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44673871|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673872|NCT01288924|Parecoxib|parecoxib|mesh-list
44673873|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44673874|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44673875|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673876|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673877|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44673878|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673879|NCT01288924|Analgesics|analgesics|mesh-ancestor
44673880|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
44673881|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673882|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673883|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44673884|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673885|NCT01288950|Vitamin D|vitamin d|mesh-list
44673886|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
44673887|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
44673888|NCT01288950|Vitamins|vitamins|mesh-list
44673889|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
44673890|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673891|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44673892|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44673893|NCT01288963|Aldesleukin|aldesleukin|mesh-list
44673894|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673895|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44673896|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44673897|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
44673898|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673899|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
44673900|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673901|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44673902|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673903|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673904|NCT01289132|Candesartan|candesartan|mesh-list
44673905|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
44673906|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44673907|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44673908|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44673909|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44673910|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673911|NCT01289171|Glycolic acid|glycolic acid|mesh-list
44673912|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
44673913|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
44673914|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44673915|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44673916|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
44673917|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673918|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673919|NCT01289236|Milnacipran|milnacipran|mesh-list
44673920|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
44673921|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44673922|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44673923|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44673924|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673925|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673926|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673927|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44673928|NCT01289236|Analgesics|analgesics|mesh-ancestor
44673929|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
44673930|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673931|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
44673932|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44673933|NCT01289301|Cyclosporine|cyclosporine|mesh-list
44673934|NCT01289301|Sirolimus|sirolimus|mesh-list
44673935|NCT01289301|Everolimus|everolimus|mesh-list
44673936|NCT01289301|Tacrolimus|tacrolimus|mesh-list
44673937|NCT01289301|Cyclosporins|cyclosporins|mesh-list
44673938|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44673939|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44673940|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
44673941|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673942|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44673943|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673944|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
44673945|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673946|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44673947|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44673948|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673949|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44673950|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44673951|NCT01289327|Midazolam|midazolam|mesh-list
44673952|NCT01289327|Alfentanil|alfentanil|mesh-list
44673953|NCT01289327|Propofol|propofol|mesh-list
44673954|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44673955|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673956|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673957|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44673958|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
44673959|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
44673960|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44673961|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44673962|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44673963|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44673964|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
44673965|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
44673966|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44673967|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673968|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44673969|NCT01289327|Narcotics|narcotics|mesh-ancestor
44673970|NCT01289327|Analgesics|analgesics|mesh-ancestor
44673971|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
44673972|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44673973|NCT01289483|Fospropofol|fospropofol|mesh-list
44673974|NCT01289483|Propofol|propofol|mesh-list
44673975|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44673976|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673977|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673978|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44673979|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
44673980|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
44673982|NCT01289496|Ribavirin|ribavirin|mesh-list
44673983|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
44673984|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
44673985|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44673986|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44673987|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
44673988|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673989|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
44673990|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44673991|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
44673992|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44673993|NCT01289561|Ethanol|ethanol|mesh-list
44673994|NCT01289561|Quinine|quinine|mesh-list
44673995|NCT01289561|Caffeine|caffeine|mesh-list
44673996|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44673997|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44673998|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44673999|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674000|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44674001|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674002|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674003|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674004|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44674005|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44674006|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
44674007|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674008|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
44674009|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44674010|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44674011|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44674012|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44674013|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674014|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674015|NCT01289561|Analgesics|analgesics|mesh-ancestor
44674016|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
44674017|NCT01289730|Etanercept|etanercept|mesh-list
44674018|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44674019|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674020|NCT01289730|Analgesics|analgesics|mesh-ancestor
44674021|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
44674022|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674023|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224777|NCT00507000|Vitamin D|vitamin d|mesh-list
44674024|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674025|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674026|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674027|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44674028|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
44674029|NCT01289743|Etanercept|etanercept|mesh-list
44674030|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44674031|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674032|NCT01289743|Analgesics|analgesics|mesh-ancestor
44674033|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
44674034|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674035|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674036|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674037|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674038|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674039|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44674040|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
44674041|NCT01289756|Clarithromycin|clarithromycin|mesh-list
44674042|NCT01289756|Paroxetine|paroxetine|mesh-list
44674043|NCT01289756|Clomiphene|clomiphene|mesh-list
44674044|NCT01289756|Enclomiphene|enclomiphene|mesh-list
44674045|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
44674046|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674047|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674048|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44674049|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674050|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674051|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44674052|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44674053|NCT01289756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44674054|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44674055|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674056|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674058|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674059|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44674060|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
44674061|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674062|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44674063|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44674064|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
44674065|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674066|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44674067|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
44674068|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44674069|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44674070|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44674071|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
44674072|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44674073|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674074|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674075|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674076|NCT01289769|Analgesics|analgesics|mesh-ancestor
44674077|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
44674078|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674079|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44674080|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44674081|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44674082|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
44674083|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674084|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674085|NCT01289925|Selenium|selenium|mesh-list
44674086|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
44674087|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674088|NCT01289925|Protective Agents|protective agents|mesh-ancestor
44674089|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674090|NCT01289925|Trace Elements|trace elements|mesh-ancestor
44674091|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
44674092|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
44674093|NCT01289938|Promethazine|promethazine|mesh-list
44674094|NCT01289938|Metoclopramide|metoclopramide|mesh-list
44674095|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44674096|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44674097|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674098|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674099|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
44674100|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
44674101|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
44674102|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674103|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
44674104|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
44674105|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674106|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44674107|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
44674108|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
44674109|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674110|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674111|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44674112|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
44674113|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
44674114|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44674115|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44674116|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
44674117|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
44674118|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44674119|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44674120|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
44674121|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674122|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44674123|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44674124|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674125|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674127|NCT01290003|Piperacillin|piperacillin|mesh-list
44674128|NCT01290003|Amikacin|amikacin|mesh-list
44674129|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44674130|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674131|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674132|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44674134|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674135|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44674136|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
44674137|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674138|NCT01290120|Rituximab|rituximab|mesh-list
44674139|NCT01290120|Doxorubicin|doxorubicin|mesh-list
44674140|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674141|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674142|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
44674143|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674144|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674145|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44674146|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44674147|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674148|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674149|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674150|NCT01290133|Vestipitant|vestipitant|mesh-list
44674151|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44674152|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674153|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674154|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674155|NCT01290146|Simendan|simendan|mesh-list
44674156|NCT01290146|Diuretics|diuretics|mesh-list
44674157|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
44674158|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674159|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44674160|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674161|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44674162|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674163|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674164|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674165|NCT01290146|Protective Agents|protective agents|mesh-ancestor
44674166|NCT01290172|Somatostatin|somatostatin|mesh-list
44674167|NCT01290172|Hormones|hormones|mesh-ancestor
44674168|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674169|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674170|NCT01290198|Fluconazole|fluconazole|mesh-list
44674171|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
44224932|NCT00507663|Atenolol|atenolol|mesh-list
44674172|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
44674173|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674174|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44674175|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44674176|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674177|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674178|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44674179|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
44674180|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674181|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674182|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44674183|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44674184|NCT01290211|Ritonavir|ritonavir|mesh-list
44674185|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
44674186|NCT01290211|Maraviroc|maraviroc|mesh-list
44674187|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44674188|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44674189|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44674190|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674191|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674192|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44674193|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44674194|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
44674195|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674196|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44674197|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44674198|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44068150|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
44674199|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44674200|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44674202|NCT01290276|Methylphenidate|methylphenidate|mesh-list
44674203|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44674204|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674205|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44674206|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44674207|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674208|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674209|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
44674210|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674211|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
44674212|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
44674213|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674214|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674215|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
44674216|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
44674217|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44674218|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
44674219|NCT01290276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44674220|NCT01290276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44674221|NCT01290276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674222|NCT01290276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674223|NCT01290276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44674224|NCT01290302|Azacitidine|azacitidine|mesh-list
44674225|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44674226|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
44674227|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674228|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674229|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674230|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
44674231|NCT01290328|Hematinics|hematinics|mesh-ancestor
44674232|NCT01290354|Lapatinib|lapatinib|mesh-list
44674233|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674234|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44674235|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674236|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674237|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
44674238|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44674239|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
44674240|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674241|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
44674242|NCT01290367|Protective Agents|protective agents|mesh-ancestor
44674243|NCT01290380|Vadimezan|vadimezan|mesh-list
44674244|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224981|NCT00507845|Felodipine|felodipine|mesh-list
44674245|NCT01290406|Dactolisib|dactolisib|mesh-list
44674246|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674247|NCT01290419|Vaccines|vaccines|mesh-list
44674248|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
44674249|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674250|NCT01290432|Folic Acid|folic acid|mesh-list
44674251|NCT01290432|Melatonin|melatonin|mesh-list
44674252|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
44674253|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674254|NCT01290432|Protective Agents|protective agents|mesh-ancestor
44674255|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674256|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674257|NCT01290432|Hematinics|hematinics|mesh-ancestor
44674258|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
44674259|NCT01290432|Vitamins|vitamins|mesh-ancestor
44674260|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
44674261|NCT01290458|Vitamins|vitamins|mesh-list
44674262|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
44674263|NCT01290458|Vitamin E|vitamin e|mesh-list
44674264|NCT01290458|Tocopherols|tocopherols|mesh-list
44674265|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
44674266|NCT01290458|Antioxidants|antioxidants|mesh-list
44674267|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
44674268|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674269|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674270|NCT01290458|Protective Agents|protective agents|mesh-ancestor
44674271|NCT01290471|U3-1565|u3-1565|mesh-list
44674272|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674273|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674274|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
44674275|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44674276|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
44674277|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674278|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
44674279|NCT01290497|Protective Agents|protective agents|mesh-ancestor
44674280|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
44674281|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44674282|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
44674283|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674284|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
44674285|NCT01290510|Protective Agents|protective agents|mesh-ancestor
44674286|NCT01290549|Rituximab|rituximab|mesh-list
44674287|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674288|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674289|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
44674290|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674291|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674292|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44674293|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
44674294|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674295|NCT01290744|Clofazimine|clofazimine|mesh-list
44674296|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674297|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
44674298|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674299|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674300|NCT01290783|Irinotecan|irinotecan|mesh-list
44674301|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44674302|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674303|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674304|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674305|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674306|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
44674307|NCT01290900|Ceftazidime|ceftazidime|mesh-list
44674308|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44674309|NCT01290900|Avibactam|avibactam|mesh-list
44674310|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674311|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674312|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44674313|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674314|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674315|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674316|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674317|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44674318|NCT01290926|Sorafenib|sorafenib|mesh-list
44674319|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674320|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44674321|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674322|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674323|NCT01290939|Bevacizumab|bevacizumab|mesh-list
44674324|NCT01290939|Lomustine|lomustine|mesh-list
44674325|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674326|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674327|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44674328|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44674329|NCT01290939|Growth Substances|growth substances|mesh-ancestor
44674330|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674331|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44674332|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44674333|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
44674334|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674335|NCT01291069|Tadalafil|tadalafil|mesh-list
44674336|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674337|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674338|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44674339|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674340|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674341|NCT01291069|Urological Agents|urological agents|mesh-ancestor
44674342|NCT01291095|Cisplatin|cisplatin|mesh-list
44674343|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674344|NCT01291121|Ranibizumab|ranibizumab|mesh-list
44674345|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44674346|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44674347|NCT01291121|Growth Substances|growth substances|mesh-ancestor
44674348|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674349|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
44674350|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674351|NCT01291186|Epinephrine|epinephrine|mesh-list
44674352|NCT01291186|Racepinephrine|racepinephrine|mesh-list
44674353|NCT01291186|Bupivacaine|bupivacaine|mesh-list
44674354|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
44674355|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
44674356|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
44674357|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674358|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674359|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
44674360|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674361|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44674362|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44674363|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44674364|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674365|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674366|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44674367|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44674368|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
44674369|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44674370|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
44674371|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
44674372|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
44674373|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44674374|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44674375|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674376|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44674377|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674378|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674379|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674380|NCT01291199|Urological Agents|urological agents|mesh-ancestor
44674381|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
44674382|NCT01291212|Testosterone|testosterone|mesh-list
44674383|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
44674384|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
44674385|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44674386|NCT01291212|Androgens|androgens|mesh-ancestor
44674387|NCT01291212|Hormones|hormones|mesh-ancestor
44674388|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674389|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674390|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44674391|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674392|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
44674393|NCT01291316|Clonazepam|clonazepam|mesh-list
44674394|NCT01291316|Clobazam|clobazam|mesh-list
44674395|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44674396|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44674397|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44674398|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
44674399|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674400|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674401|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674402|NCT01291316|Urological Agents|urological agents|mesh-ancestor
44674403|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
44674404|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
44674405|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
44674406|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44674407|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44674408|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674409|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674410|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44674411|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
44674412|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
44674413|NCT01291433|Tocopherols|tocopherols|mesh-list
44674414|NCT01291433|Vitamin E|vitamin e|mesh-list
44674415|NCT01291433|Tocotrienols|tocotrienols|mesh-list
44674416|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
44674417|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
44674418|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674419|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674420|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674421|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44674422|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44674423|NCT01291433|Protective Agents|protective agents|mesh-ancestor
44674424|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674425|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674426|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44674427|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
44674428|NCT01291433|Vitamins|vitamins|mesh-ancestor
44674429|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
44674430|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44674431|NCT01291459|Tenofovir|tenofovir|mesh-list
44674432|NCT01291459|Emtricitabine|emtricitabine|mesh-list
44674433|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
44674434|NCT01291459|Maraviroc|maraviroc|mesh-list
44674435|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
44674436|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674437|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44674438|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44674439|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674440|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674441|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44674442|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44674443|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44674444|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44674445|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44674446|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44674447|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44674448|NCT01291472|Ketorolac|ketorolac|mesh-list
44674449|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44674450|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44674451|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674452|NCT01291472|Analgesics|analgesics|mesh-ancestor
44674453|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
44674454|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674455|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674456|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674457|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674458|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44674459|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674460|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674461|NCT01291511|Iloperidone|iloperidone|mesh-list
44674462|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44674463|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44674464|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674465|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674466|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674467|NCT01291524|Pregabalin|pregabalin|mesh-list
44674468|NCT01291524|Analgesics|analgesics|mesh-ancestor
44674469|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
44674470|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674471|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674472|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
44674473|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44674474|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674475|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674476|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44674477|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44674478|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44674479|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674480|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674481|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44674482|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44674483|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
44674484|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674485|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44674486|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44674487|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
44674488|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
44674489|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674490|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674491|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
44674492|NCT01291563|Bedaquiline|bedaquiline|mesh-list
44674493|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
44674494|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44674495|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674496|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674497|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44674498|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674499|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674500|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674501|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674502|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44674503|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
44674504|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44674505|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674506|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44674507|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44674508|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44674509|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
44674510|NCT01291602|Avibactam|avibactam|mesh-list
44674511|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44674512|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674513|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674514|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674515|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674516|NCT01291615|Gemcitabine|gemcitabine|mesh-list
44674517|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44674518|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
44674519|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674520|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674521|NCT01291615|Antiviral Agents|antiviral agents|mesh-ancestor
44674522|NCT01291615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674523|NCT01291615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674524|NCT01291615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44674525|NCT01291615|Immunologic Factors|immunologic factors|mesh-ancestor
44674526|NCT01291615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674527|NCT01291628|Copper|copper|mesh-list
44674528|NCT01291628|Trace Elements|trace elements|mesh-ancestor
44674529|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
44674530|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674531|NCT01291641|Cilostazol|cilostazol|mesh-list
44674532|NCT01291641|Probucol|probucol|mesh-list
44674533|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44674534|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44674535|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
44674536|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674537|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674538|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44674539|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
44674540|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44674541|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44674542|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674543|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44674544|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674545|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44674546|NCT01291641|Protective Agents|protective agents|mesh-ancestor
44674547|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44674548|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674549|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674550|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44674551|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44674552|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
44674553|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44674554|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
44674555|NCT01291654|Acetaminophen|acetaminophen|mesh-list
44674556|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674557|NCT01291654|Analgesics|analgesics|mesh-ancestor
44674558|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
44674559|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674560|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674561|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
44225335|NCT00509860|Irinotecan|irinotecan|mesh-list
44674562|NCT01291719|Insulin|insulin|mesh-list
44674563|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44674564|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674565|NCT01291823|Gefitinib|gefitinib|mesh-list
44674566|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674567|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44674568|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674569|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674570|NCT01291927|Pancrelipase|pancrelipase|mesh-list
44674571|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674572|NCT01291940|Petrolatum|petrolatum|mesh-list
44674573|NCT01291940|Emollients|emollients|mesh-ancestor
44674574|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
44674575|NCT01291979|Lidocaine|lidocaine|mesh-list
44674576|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
44674577|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
44674578|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674579|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674581|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674582|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44674583|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44674584|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44674585|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674586|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674587|NCT01292031|Meropenem|meropenem|mesh-list
44674588|NCT01292031|Colistin|colistin|mesh-list
44674589|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674590|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674591|NCT01292083|Azacitidine|azacitidine|mesh-list
44674592|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44674593|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
44674594|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674595|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674596|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674597|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
44674598|NCT01292109|Cathartics|cathartics|mesh-ancestor
44674599|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674600|NCT01292161|Silymarin|silymarin|mesh-list
44674601|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
44674602|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674603|NCT01292161|Protective Agents|protective agents|mesh-ancestor
44674604|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674605|NCT01292174|Ibalizumab|ibalizumab|mesh-list
44674606|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44674607|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44674608|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44674609|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
44674610|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674611|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
44674612|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674613|NCT01292213|Dimercaprol|dimercaprol|mesh-list
44674614|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
44674615|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
44674616|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674617|NCT01292343|Listerine|listerine|mesh-list
44674618|NCT01292343|Triclosan|triclosan|mesh-list
44674619|NCT01292343|Fluorides|fluorides|mesh-list
44674620|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
44674621|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
44674622|NCT01292343|Protective Agents|protective agents|mesh-ancestor
44674623|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674624|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44674625|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674626|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44674627|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44674628|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
44674629|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674630|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44674631|NCT01292356|Cetuximab|cetuximab|mesh-list
44674632|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674633|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674634|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
44674635|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
44674636|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44674637|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44674638|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674639|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674640|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674641|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674642|NCT01292460|Timolol|timolol|mesh-list
44674643|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44674644|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44674645|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
44674646|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674647|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674648|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674649|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44674650|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44674651|NCT01292525|Tacrolimus|tacrolimus|mesh-list
44674652|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44674653|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
44235994|NCT00557011|Adderall|adderall|mesh-list
44674654|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674655|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44674656|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674657|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674658|NCT01292551|Bosentan|bosentan|mesh-list
44674659|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44674660|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44674661|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674662|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
44674663|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44674664|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44674665|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44674666|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44674667|NCT01292694|Losartan|losartan|mesh-list
44674668|NCT01292694|Captopril|captopril|mesh-list
44674669|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44674670|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44674671|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44674672|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44674673|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674674|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44674675|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
44674676|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674677|NCT01292720|Vitamin D|vitamin d|mesh-list
44674678|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
44674679|NCT01292720|Vitamins|vitamins|mesh-ancestor
44674680|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
44674681|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674682|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44674683|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44674684|NCT01292785|Hormones|hormones|mesh-list
44674685|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674686|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674687|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44674688|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
44674689|NCT01292993|Metformin|metformin|mesh-list
44674690|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44674691|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44674692|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674693|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44674694|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674695|NCT01293058|Naloxone|naloxone|mesh-list
44674696|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44674697|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674698|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
44674699|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674700|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44674701|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44674702|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674703|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
44674704|NCT01293097|Atorvastatin|atorvastatin|mesh-list
44674705|NCT01293097|Pravastatin|pravastatin|mesh-list
44674706|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44674707|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44674708|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
44674709|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674710|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44674711|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44674712|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674713|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
44674714|NCT01293136|Narcotics|narcotics|mesh-ancestor
44674715|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674716|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674717|NCT01293136|Analgesics|analgesics|mesh-ancestor
44674718|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
44674719|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674720|NCT01293149|Clonidine|clonidine|mesh-list
44674721|NCT01293149|Ropivacaine|ropivacaine|mesh-list
44674722|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
44674723|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
44674724|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674725|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674726|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
44674727|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674728|NCT01293149|Analgesics|analgesics|mesh-ancestor
44674729|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44674730|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
44674731|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
44674732|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44674733|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44674734|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44674735|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44674736|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674737|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674738|NCT01293162|Folic Acid|folic acid|mesh-list
44674739|NCT01293162|Policosanol|policosanol|mesh-list
44674740|NCT01293162|Hematinics|hematinics|mesh-ancestor
44674741|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
44674742|NCT01293162|Vitamins|vitamins|mesh-ancestor
44674743|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
44674744|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674745|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44674746|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44674747|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
44674748|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674749|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44674750|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44674752|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44674753|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44674754|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674755|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44674756|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
44674757|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
44674758|NCT01293292|Teriparatide|teriparatide|mesh-list
44674759|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44674760|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674761|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44674762|NCT01293422|Rifampin|rifampin|mesh-list
44674763|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44674764|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
44674765|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674766|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674767|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
44674768|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44674769|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674770|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674771|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44674772|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44674773|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44674774|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44674775|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44674776|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44674777|NCT01293630|Paclitaxel|paclitaxel|mesh-list
44674778|NCT01293630|Carboplatin|carboplatin|mesh-list
44674779|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44674780|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674781|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44674782|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44674783|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44674784|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674785|NCT01293643|Clindamycin|clindamycin|mesh-list
44674786|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
44674787|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
44674788|NCT01293643|Amphotericin B|amphotericin b|mesh-list
44674789|NCT01293643|Tetracycline|tetracycline|mesh-list
44674790|NCT01293643|Ketoconazole|ketoconazole|mesh-list
44674791|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44674792|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44674793|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674794|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44674795|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674796|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674797|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
44674798|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44674799|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44674800|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44674801|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
44674802|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674803|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674804|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44674805|NCT01293643|Amebicides|amebicides|mesh-ancestor
44674806|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44674807|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44674808|NCT01293734|Budesonide|budesonide|mesh-list
44674809|NCT01293734|Theophylline|theophylline|mesh-list
44674810|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674811|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44674812|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
44674813|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674814|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674815|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44674816|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44674817|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
44674818|NCT01293734|Hormones|hormones|mesh-ancestor
44674819|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674820|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44674821|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674822|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674823|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674824|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44674825|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44674826|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
44674827|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674828|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44674829|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44674830|NCT01293747|Estradiol|estradiol|mesh-list
44674831|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44674832|NCT01293747|Progesterone|progesterone|mesh-list
44674833|NCT01293747|Estrogens|estrogens|mesh-ancestor
44674834|NCT01293747|Hormones|hormones|mesh-ancestor
44674835|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44674836|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674837|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44674838|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
44674839|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44674840|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44674841|NCT01293747|Progestins|progestins|mesh-ancestor
44674842|NCT01293838|Citalopram|citalopram|mesh-list
44674843|NCT01293838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44674844|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44674845|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674846|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674847|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674848|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
44674849|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674850|NCT01293838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44674851|NCT01293838|Antidepressive Agents|antidepressive agents|mesh-ancestor
44674852|NCT01293838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674853|NCT01293942|Bevacizumab|bevacizumab|mesh-list
44674854|NCT01293942|Capecitabine|capecitabine|mesh-list
44674855|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
44674856|NCT01293942|Irinotecan|irinotecan|mesh-list
44674857|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674858|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674859|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44674860|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44674861|NCT01293942|Growth Substances|growth substances|mesh-ancestor
44674862|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674863|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
44674864|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44674865|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
44674866|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674867|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44674868|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674869|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674870|NCT01294059|Milnacipran|milnacipran|mesh-list
44674871|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
44674872|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44674873|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44674874|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674875|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674876|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44674877|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674878|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674879|NCT01294059|Analgesics|analgesics|mesh-ancestor
44674880|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
44674881|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674882|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44674883|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44674885|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44674886|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674887|NCT01294072|Analgesics|analgesics|mesh-ancestor
44674888|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
44674889|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674890|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674891|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674892|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674893|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674894|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674895|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674896|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
44225710|NCT00511771|Tegaserod|tegaserod|mesh-list
44674897|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
44674898|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674899|NCT01294176|Protective Agents|protective agents|mesh-ancestor
44674900|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674901|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
44674902|NCT01294176|Vitamins|vitamins|mesh-ancestor
44674903|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
44674904|NCT01294215|Nifedipine|nifedipine|mesh-list
44674905|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44674906|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44674907|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674908|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44674909|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674910|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
44674911|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
44674912|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44674913|NCT01294293|Paclitaxel|paclitaxel|mesh-list
44674914|NCT01294293|Doxorubicin|doxorubicin|mesh-list
44674915|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44674916|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44674917|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674918|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44674919|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44674920|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44674921|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674922|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44674923|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44674924|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44674925|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674926|NCT01294410|Antibodies|antibodies|mesh-list
44674927|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
44674928|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
44674929|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674930|NCT01294605|Edetic Acid|edetic acid|mesh-list
44674931|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
44674932|NCT01294605|Antidotes|antidotes|mesh-ancestor
44674933|NCT01294605|Protective Agents|protective agents|mesh-ancestor
44674934|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674935|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
44674936|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
44674937|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674938|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44674939|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
44674940|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44674941|NCT01294618|Interferons|interferons|mesh-list
44674942|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674943|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
44674944|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674946|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44674947|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674948|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44674949|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674950|NCT01294735|Temozolomide|temozolomide|mesh-list
44674951|NCT01294735|Niraparib|niraparib|mesh-list
44674952|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44674953|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
44674954|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674955|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674956|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44674957|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674958|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
44674959|NCT01294761|Darunavir|darunavir|mesh-list
44674960|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44674961|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44674962|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
44674963|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44674964|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44674965|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44674966|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44674967|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44674968|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44674969|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44674970|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44674971|NCT01294826|Cetuximab|cetuximab|mesh-list
44674972|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44674973|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44674974|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44674975|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
44674976|NCT01294878|Omalizumab|omalizumab|mesh-list
44674977|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44674978|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44674979|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
44674980|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44674981|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44674982|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
44674983|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44674984|NCT01294956|Laxatives|laxatives|mesh-ancestor
44674985|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44674986|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44674987|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44674988|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44674989|NCT01294969|Analgesics|analgesics|mesh-ancestor
44674990|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
44674991|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44674992|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44674993|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44674994|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44674995|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44674996|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44674997|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44674998|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
44674999|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
44675000|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675001|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675002|NCT01295047|Atenolol|atenolol|mesh-list
44675003|NCT01295047|Verapamil|verapamil|mesh-list
44675004|NCT01295047|Perindopril|perindopril|mesh-list
44675005|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44675006|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44675007|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
44675008|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
44675009|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675010|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675011|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44675012|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44675013|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44675014|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44675015|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675016|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675017|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44675018|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675019|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675020|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675021|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44675022|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44675023|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675024|NCT01295073|Trientine|trientine|mesh-list
44675025|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
44675026|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
44675027|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675028|NCT01295086|Docetaxel|docetaxel|mesh-list
44675029|NCT01295086|Capecitabine|capecitabine|mesh-list
44675030|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
44675031|NCT01295086|Trastuzumab|trastuzumab|mesh-list
44675032|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675033|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44675034|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44675035|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44675036|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675037|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675038|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
44675039|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675040|NCT01295099|Triamcinolone|triamcinolone|mesh-list
44675041|NCT01295099|Fluorouracil|fluorouracil|mesh-list
44675042|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
44675043|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675044|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675045|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675046|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675047|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
44675048|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675049|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675050|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
44675051|NCT01295099|Hormones|hormones|mesh-ancestor
44675052|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675053|NCT01295138|Lactulose|lactulose|mesh-list
44675054|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675055|NCT01295151|Adalimumab|adalimumab|mesh-list
44675056|NCT01295151|Etanercept|etanercept|mesh-list
44675057|NCT01295151|Golimumab|golimumab|mesh-list
44675058|NCT01295151|Rituximab|rituximab|mesh-list
44675059|NCT01295151|Abatacept|abatacept|mesh-list
44675060|NCT01295151|Infliximab|infliximab|mesh-list
44675061|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
44675062|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675063|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675064|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
44675065|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675066|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675067|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675068|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44675069|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675070|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44675071|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44675072|NCT01295151|Analgesics|analgesics|mesh-ancestor
44675073|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
44675074|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675075|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675076|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44675077|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675078|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44675079|NCT01295177|Insulin|insulin|mesh-list
44675080|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44675081|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675082|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675083|NCT01295268|Emu Oil|emu oil|mesh-list
44675084|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675085|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44675086|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
44675087|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
44675088|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
44675089|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44675090|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44675091|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675092|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
44225952|NCT00513058|Lapatinib|lapatinib|mesh-list
44675093|NCT01295294|Coagulants|coagulants|mesh-ancestor
44675094|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44675095|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
44675096|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44675097|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675098|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44675099|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44675100|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44675101|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44675102|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44675104|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
44675105|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675106|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675107|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675108|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44675109|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675110|NCT01295307|Clofarabine|clofarabine|mesh-list
44675111|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675112|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
44675113|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675114|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675115|NCT01295372|Risperidone|risperidone|mesh-list
44675116|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44675117|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
44675118|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675119|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675120|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675121|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44675122|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44675123|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675124|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675125|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44675126|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
44675127|NCT01295450|Vitamins|vitamins|mesh-list
44675128|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
44675129|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675130|NCT01295502|Paclitaxel|paclitaxel|mesh-list
44675131|NCT01295502|Cisplatin|cisplatin|mesh-list
44675132|NCT01295502|Carboplatin|carboplatin|mesh-list
44675133|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44675134|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44675135|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675136|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
44675137|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
44675138|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
44675139|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675140|NCT01295567|Dipyridamole|dipyridamole|mesh-list
44675141|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675142|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675143|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675144|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44675145|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675146|NCT01295593|Cladribine|cladribine|mesh-list
44675147|NCT01295593|Valproic Acid|valproic acid|mesh-list
44675148|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
44675149|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675150|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675151|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
44675152|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675153|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675154|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
44675155|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44675156|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675157|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675158|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675159|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675160|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
44675162|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44675163|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675164|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
44675165|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675166|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44675167|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675168|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675169|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675170|NCT01295736|Urological Agents|urological agents|mesh-ancestor
44675171|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44675172|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
44675173|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44675174|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
44675175|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675176|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44675177|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44675178|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44675179|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675180|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675181|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
44675182|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44675183|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
44675184|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675185|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675186|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44675187|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44675188|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44675189|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
44675190|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675191|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675192|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44675193|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675194|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
44675195|NCT01295866|Protective Agents|protective agents|mesh-ancestor
44675196|NCT01295892|Estrogens|estrogens|mesh-list
44675197|NCT01295892|Hormones|hormones|mesh-ancestor
44675198|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675199|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675200|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44675201|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675202|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44675203|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675204|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
44675205|NCT01296074|Hormones|hormones|mesh-ancestor
44675206|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675207|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675208|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44675209|NCT01296074|Protective Agents|protective agents|mesh-ancestor
44675210|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675211|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675212|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44675213|NCT01296139|Hematinics|hematinics|mesh-ancestor
44675214|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44675215|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44675216|NCT01296178|Idarubicin|idarubicin|mesh-list
44675217|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44675218|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675219|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44675220|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44675221|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675222|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675223|NCT01296204|Antibodies|antibodies|mesh-list
44675224|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
44675225|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675226|NCT01296230|Hormones|hormones|mesh-list
44675227|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675228|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675229|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44675230|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44675231|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
44675232|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675233|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675234|NCT01296269|Vasopressins|vasopressins|mesh-list
44675235|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
44675236|NCT01296269|Oxytocin|oxytocin|mesh-list
44675237|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
44675238|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44675239|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675240|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
44675241|NCT01296269|Coagulants|coagulants|mesh-ancestor
44675242|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44675243|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44675244|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
44675245|NCT01296334|Morphine|morphine|mesh-list
44675246|NCT01296334|Buprenorphine|buprenorphine|mesh-list
44675247|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44675248|NCT01296334|Narcotics|narcotics|mesh-ancestor
44675249|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675250|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675251|NCT01296334|Analgesics|analgesics|mesh-ancestor
44675252|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
44675253|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675254|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44675255|NCT01296438|Insulin|insulin|mesh-list
44675256|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44675257|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
44675258|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
44675259|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44675260|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675261|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675262|NCT01296464|Carbidopa|carbidopa|mesh-list
44675263|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44675264|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44675265|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
44675266|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675267|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675268|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675269|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44675270|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675271|NCT01296503|Thalidomide|thalidomide|mesh-list
44675272|NCT01296503|Dexamethasone|dexamethasone|mesh-list
44675273|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
44675274|NCT01296503|BB 1101|bb 1101|mesh-list
44675275|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675276|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
44675277|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
44675278|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675279|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675280|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675281|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
44675282|NCT01296503|Hormones|hormones|mesh-ancestor
44675283|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675284|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675285|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675286|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
44675287|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675288|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675289|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675290|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
44675291|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
44675292|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44675293|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675294|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44675295|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44675296|NCT01296503|Growth Substances|growth substances|mesh-ancestor
44675297|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44675298|NCT01296555|Letrozole|letrozole|mesh-list
44675299|NCT01296555|Fulvestrant|fulvestrant|mesh-list
44675300|NCT01296555|Midazolam|midazolam|mesh-list
44675301|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44675302|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44675303|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675304|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675306|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44675307|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675308|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44675309|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
44675310|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
44675311|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
44675312|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
44675313|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675314|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675315|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675316|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44675317|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44675318|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675319|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44675320|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
44675321|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675322|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675323|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44675324|NCT01296802|Fenfluramine|fenfluramine|mesh-list
44675325|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
44675326|NCT01296802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44675327|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44675328|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675329|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675330|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675331|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
44675332|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675333|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44675335|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
44675336|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44675337|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
44675338|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44675339|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675340|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
44675341|NCT01296971|Ribavirin|ribavirin|mesh-list
44675342|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44675343|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
44675344|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675345|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
44675346|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675347|NCT01296997|Calcium|calcium|mesh-list
44675348|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675349|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675350|NCT01297010|Dexamethasone|dexamethasone|mesh-list
44675351|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
44675352|NCT01297010|BB 1101|bb 1101|mesh-list
44675353|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675354|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
44675355|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
44675356|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675357|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675358|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675359|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
44675360|NCT01297010|Hormones|hormones|mesh-ancestor
44675361|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675362|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675363|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675364|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
44675365|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675366|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675367|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
44675368|NCT01297023|Vitamin D|vitamin d|mesh-list
44675369|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
44675370|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
44675371|NCT01297023|Vitamins|vitamins|mesh-list
44675372|NCT01297023|Calcium|calcium|mesh-list
44675373|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
44675374|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675375|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236021|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
44675376|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44675377|NCT01297036|Donepezil|donepezil|mesh-list
44675378|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44675379|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675380|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675381|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
44675382|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675383|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675384|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
44675385|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44675386|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675387|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44675388|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675389|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675390|NCT05601895|Sorafenib|sorafenib|mesh-list
44675391|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675392|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44675393|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675394|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675395|NCT05599802|Vaccines|vaccines|mesh-list
44675396|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
44675397|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675398|NCT05594680|Methotrexate|methotrexate|mesh-list
44675399|NCT05594680|Cilostazol|cilostazol|mesh-list
44675400|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44675401|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
44675402|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44675403|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675404|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675405|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
44675406|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675407|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675408|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44675409|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675410|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44675411|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675412|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
44675413|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675414|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44675415|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44675416|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
44675417|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675418|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44675419|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
44675420|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44675421|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44675422|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44675423|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675424|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44675425|NCT05594680|Protective Agents|protective agents|mesh-ancestor
44106756|NCT00077168|Tamoxifen|tamoxifen|mesh-list
44675426|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44675427|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675428|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
44675429|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675430|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675431|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675432|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44675433|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44675434|NCT05575505|Protective Agents|protective agents|mesh-ancestor
44675435|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675436|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675437|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44675438|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
44675439|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
44675440|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675441|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675442|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675443|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44675444|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44675445|NCT05558761|Protective Agents|protective agents|mesh-ancestor
44675446|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675447|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675448|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44675449|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
44675450|NCT05545891|Aripiprazole|aripiprazole|mesh-list
44675451|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
44675452|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675453|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44675454|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44675455|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675456|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675457|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
44675458|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
44675459|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675460|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675461|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44675462|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44675463|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
44675464|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44675465|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44675466|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44675467|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44675468|NCT05516966|Dulaglutide|dulaglutide|mesh-list
44675469|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675470|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675471|NCT05510063|Adalimumab|adalimumab|mesh-list
44675472|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675473|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675474|NCT05505552|Vitamin K|vitamin k|mesh-list
44675475|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
44675476|NCT05505552|Vitamins|vitamins|mesh-ancestor
44675477|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
44675478|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675479|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44675480|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44675481|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675482|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
44675483|NCT05505552|Coagulants|coagulants|mesh-ancestor
44675484|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44675485|NCT05499052|Hormones|hormones|mesh-ancestor
44675486|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675487|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675488|NCT05487833|Insulin|insulin|mesh-list
44675489|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675490|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675491|NCT05483465|Niacinamide|niacinamide|mesh-list
44675492|NCT05483465|Niacin|niacin|mesh-list
44675493|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
44675494|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
44675495|NCT05483465|Vitamins|vitamins|mesh-ancestor
44675496|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
44675497|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675498|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44675499|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
44675500|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675501|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44675502|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675503|NCT05479591|Xultophy|xultophy|mesh-list
44675504|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675505|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675506|NCT05479591|Incretins|incretins|mesh-ancestor
44675507|NCT05479591|Hormones|hormones|mesh-ancestor
44675508|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675509|NCT05440864|Durvalumab|durvalumab|mesh-list
44675510|NCT05440864|Tremelimumab|tremelimumab|mesh-list
44675511|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675512|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675513|NCT05431244|Gemcitabine|gemcitabine|mesh-list
44675514|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
44675515|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675516|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
44675517|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675518|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675519|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675520|NCT05431244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675521|NCT05431244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675522|NCT05431244|Immunologic Factors|immunologic factors|mesh-ancestor
44675523|NCT05431244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675524|NCT05412082|Leucovorin|leucovorin|mesh-list
44675525|NCT05412082|Fluorouracil|fluorouracil|mesh-list
44675527|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
44675528|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
44675529|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675530|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675531|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675532|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675533|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
44675534|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675535|NCT05412082|Antidotes|antidotes|mesh-ancestor
44675536|NCT05412082|Protective Agents|protective agents|mesh-ancestor
44675537|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
44675538|NCT05412082|Vitamins|vitamins|mesh-ancestor
44675539|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
44675540|NCT05406895|Lidocaine|lidocaine|mesh-list
44675541|NCT05406895|Epinephrine|epinephrine|mesh-list
44675542|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
44675543|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
44675544|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675545|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675546|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
44675547|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675548|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44675549|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44675550|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44675551|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675552|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675553|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44675554|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44675555|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
44675556|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675557|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44675558|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44675559|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
44226525|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675560|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44675561|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
44675562|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
44675563|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
44675564|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44675565|NCT05403229|Topiramate|topiramate|mesh-list
44675566|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
44675567|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675568|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675569|NCT05386914|Sirolimus|sirolimus|mesh-list
44675570|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44675571|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106906|NCT00077428|Bortezomib|bortezomib|mesh-list
44675572|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44675573|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675574|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
44675575|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675576|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
44675577|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675578|NCT05358535|Propofol|propofol|mesh-list
44675579|NCT05358535|Etomidate|etomidate|mesh-list
44675580|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44675581|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675582|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675583|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44675584|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
44675585|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
44675586|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
44675587|NCT05325580|Analgesics|analgesics|mesh-ancestor
44675588|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
44675589|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675590|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675591|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
44675592|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675593|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44675594|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
44675595|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44675596|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675597|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675598|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675599|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
44675600|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44675601|NCT05289648|Niraparib|niraparib|mesh-list
44675602|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44675603|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675604|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675605|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675606|NCT05258773|Azasetron|azasetron|mesh-list
44675607|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
44675608|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
44675609|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675610|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675611|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675612|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44675613|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
44675614|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675615|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226528|NCT00515554|Rituximab|rituximab|mesh-list
44675616|NCT05184816|Deferoxamine|deferoxamine|mesh-list
44675617|NCT05184816|Siderophores|siderophores|mesh-ancestor
44675618|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44675619|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
44675620|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
44675621|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675622|NCT05156437|Amoxicillin|amoxicillin|mesh-list
44675623|NCT05156437|Vancomycin|vancomycin|mesh-list
44675624|NCT05156437|Levofloxacin|levofloxacin|mesh-list
44675625|NCT05156437|Rifampin|rifampin|mesh-list
44675626|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
44675627|NCT05156437|Linezolid|linezolid|mesh-list
44675628|NCT05156437|Daptomycin|daptomycin|mesh-list
44675629|NCT05156437|Cephalexin|cephalexin|mesh-list
44675630|NCT05156437|Ampicillin|ampicillin|mesh-list
44675631|NCT05156437|Cefepime|cefepime|mesh-list
44675632|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44675633|NCT05156437|Oxacillin|oxacillin|mesh-list
44675634|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
44675635|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44675636|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675637|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44675638|NCT05156437|Renal Agents|renal agents|mesh-ancestor
44675639|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44675640|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44675641|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675642|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675643|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675644|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44675645|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44675646|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44675647|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
44675648|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
44675649|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44675650|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44675651|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44675652|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44675653|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44675654|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44675655|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44675656|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44675657|NCT05132920|Dexamethasone|dexamethasone|mesh-list
44675658|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675659|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
44675660|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
44675661|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675662|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675663|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675664|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
44675665|NCT05132920|Hormones|hormones|mesh-ancestor
44675666|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675667|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675668|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675669|NCT05111808|Methylene Blue|methylene blue|mesh-list
44675670|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675671|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675672|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
44675673|NCT05104567|Cetuximab|cetuximab|mesh-list
44675674|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675675|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675676|NCT05084248|Vitamin D|vitamin d|mesh-list
44675677|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
44675678|NCT05084248|Vitamins|vitamins|mesh-ancestor
44675679|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
44675680|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675681|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44675682|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675683|NCT05081219|Insulin|insulin|mesh-list
44675684|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44675685|NCT05081219|Empagliflozin|empagliflozin|mesh-list
44675686|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44675687|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675688|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44675689|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675690|NCT05064020|Tenofovir|tenofovir|mesh-list
44675691|NCT05064020|Emtricitabine|emtricitabine|mesh-list
44675692|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44675693|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
44675694|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675695|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44675696|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44675697|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675698|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675699|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44675700|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44675701|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
44675702|NCT05061420|Cetuximab|cetuximab|mesh-list
44675703|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675704|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675705|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44675706|NCT05030415|Ixekizumab|ixekizumab|mesh-list
44675707|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44675708|NCT05016947|Dexamethasone|dexamethasone|mesh-list
44675709|NCT05016947|Venetoclax|venetoclax|mesh-list
44675710|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44675711|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675712|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
44675713|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
44675714|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675715|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675716|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44107053|NCT00077987|Sunitinib|sunitinib|mesh-list
44675717|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
44675718|NCT05016947|Hormones|hormones|mesh-ancestor
44675719|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675720|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675721|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675722|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675723|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44675724|NCT05013801|Hydroquinone|hydroquinone|mesh-list
44675725|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
44675726|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675727|NCT05013801|Protective Agents|protective agents|mesh-ancestor
44675728|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675729|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44675730|NCT05004064|Rituximab|rituximab|mesh-list
44675731|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
44675732|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675733|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675734|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
44675735|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675736|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675737|NCT04989335|Fludarabine|fludarabine|mesh-list
44675738|NCT04989335|Clofarabine|clofarabine|mesh-list
44675739|NCT04989335|Bisantrene|bisantrene|mesh-list
44675740|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675741|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44675742|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
44675743|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675744|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44675745|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44675746|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44675747|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
44675748|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675749|NCT04961281|Triamcinolone|triamcinolone|mesh-list
44675750|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
44675751|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44675752|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675753|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675754|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44675756|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
44675757|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675758|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44675759|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44675760|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44675761|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
44675762|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675763|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675764|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675765|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
44675766|NCT04961281|Hormones|hormones|mesh-ancestor
44675767|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675768|NCT04942184|Complement Factor H|complement factor h|mesh-list
44675769|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44675770|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675771|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
44675772|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675776|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
44675777|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
44675778|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675779|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675780|NCT04897841|Bupivacaine|bupivacaine|mesh-list
44675781|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
44675782|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
44675783|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675784|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675785|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
44675786|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675787|NCT04885530|Fluticasone|fluticasone|mesh-list
44675788|NCT04885530|Xhance|xhance|mesh-list
44675789|NCT04885530|Ivermectin|ivermectin|mesh-list
44675790|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
44675791|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675792|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44675793|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
44675794|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675795|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675796|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44675797|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
44675798|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
44675799|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44675800|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675801|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675802|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44675803|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675804|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44675805|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44675806|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675807|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675808|NCT04885530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44675809|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44675810|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675811|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675812|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
44675813|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44675814|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
44675815|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44675816|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44675817|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44675818|NCT04883255|Dronabinol|dronabinol|mesh-list
44675819|NCT04883255|Cannabidiol|cannabidiol|mesh-list
44675820|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
44675821|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
44675822|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675823|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44675824|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44675825|NCT04883255|Analgesics|analgesics|mesh-ancestor
44675826|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
44675827|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675828|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44675829|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44675830|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675831|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675832|NCT04883255|Hormones|hormones|mesh-ancestor
44675833|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675835|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
44675836|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675837|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44675838|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675839|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44675840|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675841|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44675842|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44675843|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
44675844|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675845|NCT04862949|Bevacizumab|bevacizumab|mesh-list
44675846|NCT04862949|Atezolizumab|atezolizumab|mesh-list
44675847|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675848|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675849|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44675850|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44675851|NCT04862949|Growth Substances|growth substances|mesh-ancestor
44675852|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675853|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
44675854|NCT04831398|Melatonin|melatonin|mesh-list
44675855|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
44675856|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675857|NCT04831398|Protective Agents|protective agents|mesh-ancestor
44675858|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675859|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675860|NCT04667507|Dexamethasone|dexamethasone|mesh-list
44675861|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675862|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
44675863|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
44675864|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675865|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675866|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675867|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
44675868|NCT04667507|Hormones|hormones|mesh-ancestor
44675869|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675870|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675871|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675872|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
44675873|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44675874|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675875|NCT04642807|Calpastatin|calpastatin|mesh-list
44675876|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44675877|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
44675878|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675879|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675880|NCT04638790|Dexamethasone|dexamethasone|mesh-list
44675881|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
44675882|NCT04638790|Dacarbazine|dacarbazine|mesh-list
44675883|NCT04638790|Doxorubicin|doxorubicin|mesh-list
44675884|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44675885|NCT04638790|Etoposide|etoposide|mesh-list
44675886|NCT04638790|Vincristine|vincristine|mesh-list
44675887|NCT04638790|Bleomycin|bleomycin|mesh-list
44675888|NCT04638790|Vinblastine|vinblastine|mesh-list
44675889|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675890|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
44675891|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675892|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44675893|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44675894|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
44675895|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675896|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675897|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44675898|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675899|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
44675900|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
44675901|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675902|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675903|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
44675905|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675906|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675907|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44675908|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44675909|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44675910|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675911|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44675912|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44675913|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44675914|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44675916|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
44675917|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44675918|NCT04589819|Teriparatide|teriparatide|mesh-list
44675919|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675920|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675921|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44675922|NCT04573751|Verapamil|verapamil|mesh-list
44675923|NCT04573751|Epinephrine|epinephrine|mesh-list
44675924|NCT04573751|Racepinephrine|racepinephrine|mesh-list
44675925|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
44675926|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44675927|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44675928|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44675929|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44675930|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675931|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675932|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44675933|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44675934|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
44675935|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675936|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44675937|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
44675938|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
44675939|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
44675940|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44675941|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44675942|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44675943|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44675944|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44675945|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
44675946|NCT04530409|Dexamethasone|dexamethasone|mesh-list
44675947|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
44675948|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44675949|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
44675950|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
44675951|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675952|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675953|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44675954|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
44675955|NCT04530409|Hormones|hormones|mesh-ancestor
44675956|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44675957|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44675958|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675959|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44675960|NCT04530409|Protective Agents|protective agents|mesh-ancestor
44675961|NCT04497012|Iron|iron|mesh-list
44675962|NCT04497012|Trace Elements|trace elements|mesh-ancestor
44675963|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
44675964|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675965|NCT04485559|Everolimus|everolimus|mesh-list
44675966|NCT04485559|Trametinib|trametinib|mesh-list
44675967|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44675968|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44675969|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
44675970|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675971|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44675972|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44675973|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44675974|NCT04454411|Naltrexone|naltrexone|mesh-list
44675975|NCT04454411|Buprenorphine|buprenorphine|mesh-list
44675976|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44675977|NCT04454411|Narcotics|narcotics|mesh-ancestor
44675978|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675979|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675980|NCT04454411|Analgesics|analgesics|mesh-ancestor
44675981|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
44675982|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675983|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44675984|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44675986|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44675987|NCT04429516|Narcotics|narcotics|mesh-ancestor
44675988|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44675989|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44675990|NCT04429516|Analgesics|analgesics|mesh-ancestor
44675991|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
44675992|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44675993|NCT04427904|Lidocaine|lidocaine|mesh-list
44675994|NCT04427904|Epinephrine|epinephrine|mesh-list
44675995|NCT04427904|Racepinephrine|racepinephrine|mesh-list
44675996|NCT04427904|Bupivacaine|bupivacaine|mesh-list
44675997|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
44675998|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
44675999|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
44676000|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676001|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676002|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
44676003|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676004|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676005|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44676006|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44676007|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676008|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676009|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44676010|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44676011|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676012|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676013|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44676014|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44676015|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
44676016|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44676017|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
44676018|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
44676019|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
44676020|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44676021|NCT04311099|Ropivacaine|ropivacaine|mesh-list
44676022|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
44676023|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
44676024|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676025|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676026|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
44676027|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676028|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
44676029|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44676030|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
44676031|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676032|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676033|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44676034|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
44676035|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44676036|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
44676037|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676038|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676039|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44676040|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
44676041|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
44676042|NCT04305457|Protective Agents|protective agents|mesh-ancestor
44676043|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
44676044|NCT04300751|Narcotics|narcotics|mesh-ancestor
44676045|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676046|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676047|NCT04300751|Analgesics|analgesics|mesh-ancestor
44676048|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
44676049|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676050|NCT04256824|Triclosan|triclosan|mesh-list
44236025|NCT00557102|Antidotes|antidotes|mesh-ancestor
44676051|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44676052|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676053|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44676054|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44676055|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
44676056|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676057|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44676058|NCT04199767|Insulin|insulin|mesh-list
44676059|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44676060|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
44676061|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44676062|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676063|NCT04156555|Amoxicillin|amoxicillin|mesh-list
44676064|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
44676065|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
44676066|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44676067|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676068|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676069|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44676070|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676071|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676072|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
44676073|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44676074|NCT04133792|Simvastatin|simvastatin|mesh-list
44676075|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44676076|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44676077|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
44676078|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676079|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44676080|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44676081|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676082|NCT04091490|Nivolumab|nivolumab|mesh-list
44676083|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676084|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676085|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44676086|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676087|NCT04068948|Midazolam|midazolam|mesh-list
44676088|NCT04068948|Meperidine|meperidine|mesh-list
44676089|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
44676090|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44676091|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44676092|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676093|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676094|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44227030|NCT00517764|Citalopram|citalopram|mesh-list
44676095|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44676096|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44676097|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44676098|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
44676099|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
44676100|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
44676101|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
44676102|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676103|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676104|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44676105|NCT04068948|Narcotics|narcotics|mesh-ancestor
44676106|NCT04068948|Analgesics|analgesics|mesh-ancestor
44676107|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
44676108|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676109|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
44676110|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
44676111|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44676112|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
44676113|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
44676114|NCT04068610|Leucovorin|leucovorin|mesh-list
44676115|NCT04068610|Durvalumab|durvalumab|mesh-list
44676116|NCT04068610|Fluorouracil|fluorouracil|mesh-list
44676117|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
44676118|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676119|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676120|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676121|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
44676122|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676123|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676124|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676125|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
44676126|NCT04068610|Antidotes|antidotes|mesh-ancestor
44676127|NCT04068610|Protective Agents|protective agents|mesh-ancestor
44676128|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
44676129|NCT04068610|Vitamins|vitamins|mesh-ancestor
44676130|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
44676131|NCT04042753|Nivolumab|nivolumab|mesh-list
44676132|NCT04042753|Ipilimumab|ipilimumab|mesh-list
44676133|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676134|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676135|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44676136|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676137|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
44676138|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44676139|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
44676140|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
44676141|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676142|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676143|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44676144|NCT04008628|Analgesics|analgesics|mesh-ancestor
44676145|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
44676146|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676147|NCT03991091|Oxytocin|oxytocin|mesh-list
44676148|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
44676149|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44107477|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
44676150|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676151|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
44676152|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
44676153|NCT03979599|Analgesics|analgesics|mesh-ancestor
44676154|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
44676155|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676156|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676157|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
44676158|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676159|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676160|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
44676161|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44676162|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676163|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676164|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44676165|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
44676166|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676167|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
44676168|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44676169|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676170|NCT03930615|Letermovir|letermovir|mesh-list
44676171|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44676172|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676173|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676174|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676175|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
44676176|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676177|NCT03909737|Azithromycin|azithromycin|mesh-list
44676178|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676179|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676180|NCT03905941|Metformin|metformin|mesh-list
44676181|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
44676182|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44676183|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676184|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676185|NCT03902912|Prednisolone|prednisolone|mesh-list
44676186|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676187|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
44676188|NCT03902912|Hormones|hormones|mesh-ancestor
44676189|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676190|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676191|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676192|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676193|NCT03892018|Paclitaxel|paclitaxel|mesh-list
44676194|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676195|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676196|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676197|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676198|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676199|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676200|NCT03817970|Ondansetron|ondansetron|mesh-list
44676201|NCT03817970|Palonosetron|palonosetron|mesh-list
44676202|NCT03817970|Granisetron|granisetron|mesh-list
44676203|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
44676204|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
44676205|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676206|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676207|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676208|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
44676209|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44676210|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44676211|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
44676212|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676213|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676214|NCT03817970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44676215|NCT03817970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44676216|NCT03817970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676217|NCT03817970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44676218|NCT03817970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44107541|NCT00079365|Gemcitabine|gemcitabine|mesh-list
44676219|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44676220|NCT03810235|Lidocaine|lidocaine|mesh-list
44676221|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
44676222|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
44676223|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676224|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676225|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
44676226|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676227|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676228|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44676229|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44676230|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676231|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676232|NCT03792516|Artesunate|artesunate|mesh-list
44676233|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
44676234|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44676235|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44676236|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676237|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676238|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
44676239|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
44676240|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44676241|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
44676242|NCT03760575|Cisplatin|cisplatin|mesh-list
44676243|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
44676244|NCT03760575|Pemetrexed|pemetrexed|mesh-list
44676245|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676246|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676247|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676248|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676249|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44676250|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44676251|NCT03743428|Bevacizumab|bevacizumab|mesh-list
44676252|NCT03743428|Apatinib|apatinib|mesh-list
44676253|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676254|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676255|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676256|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676257|NCT03743428|Growth Substances|growth substances|mesh-ancestor
44676258|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676259|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676260|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676261|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676262|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676263|NCT03674112|Trastuzumab|trastuzumab|mesh-list
44676264|NCT03674112|Pertuzumab|pertuzumab|mesh-list
44676265|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676266|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676267|NCT03668808|Insulin|insulin|mesh-list
44676268|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44676269|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
44676270|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
44676271|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44676272|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676273|NCT03617666|Avelumab|avelumab|mesh-list
44676274|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676275|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676276|NCT03556904|Docetaxel|docetaxel|mesh-list
44676277|NCT03556904|Hormones|hormones|mesh-list
44676278|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676279|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676280|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676281|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676282|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676283|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676284|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676285|NCT03537651|Ivacaftor|ivacaftor|mesh-list
44676286|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44676287|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676288|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676289|NCT03530397|Paclitaxel|paclitaxel|mesh-list
44676290|NCT03530397|Carboplatin|carboplatin|mesh-list
44676291|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
44676292|NCT03530397|Pemetrexed|pemetrexed|mesh-list
44676293|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676294|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676295|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676296|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676297|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676298|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676299|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676300|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676301|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44676302|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44676303|NCT03514069|Temozolomide|temozolomide|mesh-list
44676304|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44676305|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
44676306|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676307|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676308|NCT03473639|Capecitabine|capecitabine|mesh-list
44676309|NCT03473639|Entinostat|entinostat|mesh-list
44676310|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676311|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
44676312|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676313|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676314|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44676315|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676316|NCT03461120|Anesthetics|anesthetics|mesh-list
44676317|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
44676318|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676319|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676320|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
44676321|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676322|NCT03423979|Paclitaxel|paclitaxel|mesh-list
44676323|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676324|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676325|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676326|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676327|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676328|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676329|NCT03420339|Adderall|adderall|mesh-list
44676330|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44676331|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676332|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
44676333|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676334|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676335|NCT03359005|Vincristine|vincristine|mesh-list
44676336|NCT03359005|Temozolomide|temozolomide|mesh-list
44676337|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676338|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676339|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676340|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676341|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676342|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676343|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44676344|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
44676345|NCT03272698|Ketamine|ketamine|mesh-list
44676346|NCT03272698|Analgesics|analgesics|mesh-ancestor
44676347|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
44676348|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676349|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676350|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44676351|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44676352|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
44676353|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
44676354|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676355|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44676356|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44676357|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676358|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676359|NCT03173092|Dexamethasone|dexamethasone|mesh-list
44676360|NCT03173092|Lenalidomide|lenalidomide|mesh-list
44676361|NCT03173092|Ixazomib|ixazomib|mesh-list
44676362|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676363|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
44676364|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
44676365|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676366|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676367|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676368|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
44676369|NCT03173092|Hormones|hormones|mesh-ancestor
44676370|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676371|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676372|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676373|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
44676374|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676375|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676376|NCT03173092|Growth Substances|growth substances|mesh-ancestor
44676377|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676378|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
44676379|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676380|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676381|NCT03164057|Cytarabine|cytarabine|mesh-list
44676382|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
44676383|NCT03164057|Methotrexate|methotrexate|mesh-list
44676384|NCT03164057|Azacitidine|azacitidine|mesh-list
44676385|NCT03164057|Decitabine|decitabine|mesh-list
44676386|NCT03164057|Fludarabine|fludarabine|mesh-list
44676387|NCT03164057|Etoposide|etoposide|mesh-list
44676388|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
44676389|NCT03164057|Sorafenib|sorafenib|mesh-list
44676390|NCT03164057|Daunorubicin|daunorubicin|mesh-list
44676391|NCT03164057|Asparaginase|asparaginase|mesh-list
44676392|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
44676393|NCT03164057|Idarubicin|idarubicin|mesh-list
44676394|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
44676395|NCT03164057|Razoxane|razoxane|mesh-list
44676396|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
44676397|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44676398|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
44676399|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676400|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676401|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676402|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
44676403|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676404|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676405|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44676406|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676407|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44676408|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676409|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
44676410|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44676411|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44676412|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676413|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44676414|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44676415|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
44676416|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676417|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676418|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44676419|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676420|NCT03164057|Analgesics|analgesics|mesh-ancestor
44676421|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
44676422|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676423|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44676424|NCT03164057|Protective Agents|protective agents|mesh-ancestor
44676425|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676426|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676427|NCT03090165|Bicalutamide|bicalutamide|mesh-list
44676428|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
44676429|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
44676430|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676431|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676432|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676433|NCT03019003|Durvalumab|durvalumab|mesh-list
44676434|NCT03019003|Decitabine|decitabine|mesh-list
44676435|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676436|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676437|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676438|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
44676439|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676440|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676441|NCT02982954|Nivolumab|nivolumab|mesh-list
44676442|NCT02982954|Ipilimumab|ipilimumab|mesh-list
44676443|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676444|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676445|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44676446|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676447|NCT02966314|Omalizumab|omalizumab|mesh-list
44676448|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44676449|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44676450|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
44676451|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
44676452|NCT02959905|Fludarabine|fludarabine|mesh-list
44676453|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
44676454|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676455|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
44676456|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676457|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44676458|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44676459|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
44676460|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676461|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676462|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44676463|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676464|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
44676465|NCT02927392|Leuprolide|leuprolide|mesh-list
44676466|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44676467|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
44676468|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676469|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676470|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676471|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676472|NCT02892123|Paclitaxel|paclitaxel|mesh-list
44676473|NCT02892123|Vinorelbine|vinorelbine|mesh-list
44676474|NCT02892123|Capecitabine|capecitabine|mesh-list
44676475|NCT02892123|Tucatinib|tucatinib|mesh-list
44676476|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676477|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676478|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676479|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676480|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676481|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676482|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676483|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
44676484|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676485|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676486|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
44676487|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44676488|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
44676489|NCT02866279|Etonogestrel|etonogestrel|mesh-list
44676490|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676491|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676492|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44676493|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44676494|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
44676495|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44676496|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676497|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44676498|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676499|NCT02735473|Choline|choline|mesh-list
44676500|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
44676501|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44676502|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
44676503|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676504|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676505|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44676506|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
44676507|NCT02722941|Panobinostat|panobinostat|mesh-list
44676508|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676509|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44676510|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676511|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676512|NCT02654132|Dexamethasone|dexamethasone|mesh-list
44676513|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
44676514|NCT02654132|Pomalidomide|pomalidomide|mesh-list
44676515|NCT02654132|Elotuzumab|elotuzumab|mesh-list
44676516|NCT02654132|BB 1101|bb 1101|mesh-list
44676517|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676518|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
44676519|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
44676520|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676521|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676522|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676523|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
44676524|NCT02654132|Hormones|hormones|mesh-ancestor
44676525|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676526|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676527|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676528|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
44676529|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676530|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676531|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
44676532|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676533|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676534|NCT02654132|Growth Substances|growth substances|mesh-ancestor
44676535|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676536|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
44676537|NCT02633241|Propofol|propofol|mesh-list
44676538|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44676539|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676540|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676541|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44676542|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
44676543|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
44676544|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44676545|NCT02633241|Analgesics|analgesics|mesh-ancestor
44676546|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
44676547|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676548|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44676549|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44676550|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44676551|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676552|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676553|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676554|NCT02605486|Palbociclib|palbociclib|mesh-list
44676555|NCT02605486|Bicalutamide|bicalutamide|mesh-list
44676556|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676557|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676558|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676559|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676560|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
44676561|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
44676562|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676563|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676564|NCT02563002|Bevacizumab|bevacizumab|mesh-list
44676565|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
44676566|NCT02563002|Cetuximab|cetuximab|mesh-list
44676567|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676568|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676569|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676570|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676571|NCT02563002|Growth Substances|growth substances|mesh-ancestor
44676572|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676573|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676574|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
44676575|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44676576|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
44676577|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44676578|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
44676580|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676582|NCT02428270|Trametinib|trametinib|mesh-list
44676583|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676584|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676585|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676586|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676587|NCT02410980|Tretinoin|tretinoin|mesh-list
44676588|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676589|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
44676590|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
44676591|NCT02387996|Nivolumab|nivolumab|mesh-list
44676592|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676593|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676594|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44676595|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676596|NCT02155920|Everolimus|everolimus|mesh-list
44676597|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676598|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676599|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
44676600|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676601|NCT02047474|Leucovorin|leucovorin|mesh-list
44676602|NCT02047474|Fluorouracil|fluorouracil|mesh-list
44676603|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
44676604|NCT02047474|Irinotecan|irinotecan|mesh-list
44676605|NCT02047474|Calcium|calcium|mesh-list
44676606|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
44676607|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44676608|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676609|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
44676610|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676611|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676612|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676613|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676614|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
44676615|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44676616|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44676617|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676618|NCT02047474|Antidotes|antidotes|mesh-ancestor
44676619|NCT02047474|Protective Agents|protective agents|mesh-ancestor
44676620|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
44676621|NCT02047474|Vitamins|vitamins|mesh-ancestor
44676622|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
44676623|NCT01779050|Paclitaxel|paclitaxel|mesh-list
44676624|NCT01779050|Docetaxel|docetaxel|mesh-list
44676625|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
44676626|NCT01779050|Carboplatin|carboplatin|mesh-list
44676627|NCT01779050|Doxorubicin|doxorubicin|mesh-list
44676628|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44676629|NCT01779050|Fluorouracil|fluorouracil|mesh-list
44676630|NCT01779050|Trastuzumab|trastuzumab|mesh-list
44676631|NCT01779050|Epirubicin|epirubicin|mesh-list
44676632|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676633|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676634|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676635|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676636|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676637|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676638|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676639|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
44676640|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676641|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44676642|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44676643|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
44676644|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44676645|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44676646|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44676647|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44676648|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676649|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
44676650|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676651|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676652|NCT01495598|Pomalidomide|pomalidomide|mesh-list
44676653|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
44676654|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676655|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676656|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676657|NCT01495598|Growth Substances|growth substances|mesh-ancestor
44676658|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676659|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676660|NCT00890617|Prednisone|prednisone|mesh-list
44676661|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676662|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
44676663|NCT00890617|Hormones|hormones|mesh-ancestor
44676664|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676665|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676666|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676667|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676668|NCT00843882|Lenalidomide|lenalidomide|mesh-list
44676669|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
44676670|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
44676671|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676672|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676673|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676674|NCT00843882|Growth Substances|growth substances|mesh-ancestor
44676675|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676676|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676677|NCT00843882|Hematinics|hematinics|mesh-ancestor
44676678|NCT00610051|Alprostadil|alprostadil|mesh-list
44676679|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44107940|NCT00080522|Ritonavir|ritonavir|mesh-list
44676680|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
44676681|NCT00610051|Urological Agents|urological agents|mesh-ancestor
44676682|NCT01297166|Calcitriol|calcitriol|mesh-list
44676683|NCT01297166|Calcipotriene|calcipotriene|mesh-list
44676684|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
44676685|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44676686|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676687|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44676688|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676689|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676690|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44676691|NCT01297166|Vitamins|vitamins|mesh-ancestor
44676692|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
44676693|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44676694|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
44676695|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44676696|NCT01297179|Mirabegron|mirabegron|mesh-list
44676697|NCT01297179|Estradiol|estradiol|mesh-list
44676698|NCT01297179|Estrogens|estrogens|mesh-ancestor
44676699|NCT01297179|Hormones|hormones|mesh-ancestor
44676700|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676701|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676702|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44676703|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
44676704|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44676705|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44676706|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44676707|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44676708|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44676709|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44676710|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44676711|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44676712|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676713|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676714|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676715|NCT01297179|Urological Agents|urological agents|mesh-ancestor
44676716|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
44676717|NCT01297192|Mirabegron|mirabegron|mesh-list
44676718|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44676719|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44676720|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
44676721|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676722|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676723|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676724|NCT01297192|Urological Agents|urological agents|mesh-ancestor
44676725|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44676726|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44676727|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44676728|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676729|NCT01297452|Paclitaxel|paclitaxel|mesh-list
44676730|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44676731|NCT01297452|Carboplatin|carboplatin|mesh-list
44676732|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676733|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676734|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676735|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676736|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676737|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676738|NCT01297569|Ranibizumab|ranibizumab|mesh-list
44676739|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676740|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676741|NCT01297569|Growth Substances|growth substances|mesh-ancestor
44676742|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676743|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676744|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676745|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
44676746|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44676747|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44676748|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44676749|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676750|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676751|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
44676752|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676753|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676754|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44676755|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676756|NCT01297686|Dexamethasone|dexamethasone|mesh-list
44676757|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676758|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
44676759|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
44676760|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676761|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676762|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676763|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
44676764|NCT01297686|Hormones|hormones|mesh-ancestor
44676765|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676766|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676767|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676768|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
44676769|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676770|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44676771|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676772|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676773|NCT01297803|Mitomycins|mitomycins|mesh-list
44676774|NCT01297803|Mitomycin|mitomycin|mesh-list
44676775|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44676776|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676777|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
44676778|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676779|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44676780|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676781|NCT01297816|Minocycline|minocycline|mesh-list
44676782|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676783|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676784|NCT01297829|Ibuprofen|ibuprofen|mesh-list
44676785|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44676786|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44676787|NCT01297829|Analgesics|analgesics|mesh-ancestor
44676788|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
44676789|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676790|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676791|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676792|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44676793|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44676794|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676795|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676796|NCT01297842|Meropenem|meropenem|mesh-list
44676797|NCT01297842|Imipenem|imipenem|mesh-list
44676798|NCT01297842|Ertapenem|ertapenem|mesh-list
44676799|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676800|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676801|NCT01297855|Rifampin|rifampin|mesh-list
44676802|NCT01297855|Colistin|colistin|mesh-list
44676803|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44676804|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
44676805|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676806|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676807|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
44676808|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44676809|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676810|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676811|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44676812|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44676813|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44676814|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44676815|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44676816|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44676817|NCT01297894|Colistin|colistin|mesh-list
44676818|NCT01297894|Fosfomycin|fosfomycin|mesh-list
44676819|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676820|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676821|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
44676822|NCT01297907|Miotics|miotics|mesh-ancestor
44676823|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
44676824|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676825|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676826|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44676827|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44676828|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
44676829|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44676830|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44676831|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
44676832|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676833|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676834|NCT01297946|Hormones|hormones|mesh-list
44676835|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676836|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676837|NCT01297998|Gemcitabine|gemcitabine|mesh-list
44676838|NCT01297998|Cisplatin|cisplatin|mesh-list
44676839|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676840|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676841|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
44676842|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676843|NCT01297998|Antiviral Agents|antiviral agents|mesh-ancestor
44676844|NCT01297998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676845|NCT01297998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676846|NCT01297998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676847|NCT01297998|Immunologic Factors|immunologic factors|mesh-ancestor
44676848|NCT01297998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676849|NCT01298011|Gemcitabine|gemcitabine|mesh-list
44676850|NCT01298011|Paclitaxel|paclitaxel|mesh-list
44676851|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44676852|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44676853|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676854|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44676855|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44676856|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44676857|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676858|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676859|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
44676860|NCT01298011|Antiviral Agents|antiviral agents|mesh-ancestor
44676861|NCT01298011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676862|NCT01298011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676863|NCT01298011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676864|NCT01298011|Immunologic Factors|immunologic factors|mesh-ancestor
44676865|NCT01298011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676866|NCT01298076|Dexamethasone|dexamethasone|mesh-list
44676867|NCT01298076|Bevacizumab|bevacizumab|mesh-list
44676868|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44676869|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676870|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44676871|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44676872|NCT01298076|Growth Substances|growth substances|mesh-ancestor
44676873|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676874|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
44676875|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676876|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
44676877|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
44676878|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676879|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44676880|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
44676881|NCT01298076|Hormones|hormones|mesh-ancestor
44676882|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676883|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676884|NCT01298180|Hormones|hormones|mesh-list
44676885|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676886|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676887|NCT01298271|Propranolol|propranolol|mesh-list
44676888|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44676889|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44676890|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676891|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676892|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676893|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676894|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676895|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44676896|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
44676897|NCT01298284|Propranolol|propranolol|mesh-list
44676898|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44676899|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44676900|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
44676901|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676902|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676903|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676904|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676905|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44676906|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
44676907|NCT01298297|Morphine|morphine|mesh-list
44676908|NCT01298297|Buprenorphine|buprenorphine|mesh-list
44676909|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44676910|NCT01298297|Narcotics|narcotics|mesh-ancestor
44676911|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676912|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676913|NCT01298297|Analgesics|analgesics|mesh-ancestor
44676914|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
44676915|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676916|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44676917|NCT01298310|Lidocaine|lidocaine|mesh-list
44676918|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
44676919|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
44676920|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676921|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676922|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
44676923|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676924|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44676925|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44676926|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44676927|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676928|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676929|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
44676930|NCT01298336|Clarithromycin|clarithromycin|mesh-list
44676931|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676932|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676933|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44676934|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44676935|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676936|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676937|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676938|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44676939|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44676940|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44676941|NCT01298401|Gemcitabine|gemcitabine|mesh-list
44676942|NCT01298401|Capecitabine|capecitabine|mesh-list
44676943|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44676944|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
44676945|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676946|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676947|NCT01298401|Antiviral Agents|antiviral agents|mesh-ancestor
44676948|NCT01298401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676949|NCT01298401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676950|NCT01298401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676951|NCT01298401|Immunologic Factors|immunologic factors|mesh-ancestor
44676952|NCT01298401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676953|NCT01298466|Pregabalin|pregabalin|mesh-list
44676954|NCT01298466|Analgesics|analgesics|mesh-ancestor
44676955|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
44676956|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44676957|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676958|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
44676959|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44676960|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44676961|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676962|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44676963|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44676964|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44676965|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44676966|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44676967|NCT01298505|Fexofenadine|fexofenadine|mesh-list
44676968|NCT01298505|Terfenadine|terfenadine|mesh-list
44676969|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44676970|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44676971|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44676972|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
44676973|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
44676974|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44676975|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44676976|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676977|NCT01298713|Tamoxifen|tamoxifen|mesh-list
44676978|NCT01298713|Everolimus|everolimus|mesh-list
44676979|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676980|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44676981|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
44676982|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44676983|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44676984|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
44676985|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44676986|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44676987|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44676988|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44676989|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44676990|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44676991|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44676992|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44676993|NCT01298882|Diacetylrhein|diacetylrhein|mesh-list
44676994|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44676995|NCT01298934|Panobinostat|panobinostat|mesh-list
44676996|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44676997|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44676998|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44676999|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677000|NCT01299012|Liraglutide|liraglutide|mesh-list
44677001|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677002|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677003|NCT01299012|Incretins|incretins|mesh-ancestor
44677004|NCT01299012|Hormones|hormones|mesh-ancestor
44677005|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677006|NCT01299181|Atorvastatin|atorvastatin|mesh-list
44677007|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44677008|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44677009|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
44677010|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677011|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44677012|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44677013|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677014|NCT01299194|Atorvastatin|atorvastatin|mesh-list
44677015|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44677016|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44677017|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
44677018|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677019|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44677020|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44677021|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677022|NCT01299220|Acitretin|acitretin|mesh-list
44677023|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
44677024|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
44677025|NCT01299298|Mipomersen|mipomersen|mesh-list
44677026|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44677027|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44677028|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
44677029|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677030|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44677031|NCT01299415|Vadimezan|vadimezan|mesh-list
44677032|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677033|NCT01299558|Fluticasone|fluticasone|mesh-list
44677035|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677036|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44677037|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
44677038|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677039|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677040|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44677041|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
44677042|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44677043|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44677044|NCT01299597|Atorvastatin|atorvastatin|mesh-list
44677045|NCT01299597|Simvastatin|simvastatin|mesh-list
44677046|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44677047|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44677048|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
44677049|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677050|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44677051|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44677052|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677053|NCT01299662|Poly ICLC|poly iclc|mesh-list
44677054|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
44677055|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
44677056|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677057|NCT01299701|Vadimezan|vadimezan|mesh-list
44677058|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677059|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44677060|NCT01299779|Laxatives|laxatives|mesh-ancestor
44677061|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677062|NCT01299831|Hormones|hormones|mesh-list
44677063|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677064|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677065|NCT01299857|Rituximab|rituximab|mesh-list
44677066|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677067|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677068|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
44677069|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677070|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677071|NCT01299922|Cyclosporine|cyclosporine|mesh-list
44677072|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
44677073|NCT01299922|Cyclosporins|cyclosporins|mesh-list
44677074|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677075|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677076|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677077|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
44677078|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677079|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
44677080|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677081|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
44677082|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677083|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44677084|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677085|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677086|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44677087|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
44677088|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677089|NCT01299948|Prednisolone|prednisolone|mesh-list
44677090|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677091|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
44677092|NCT01299948|Hormones|hormones|mesh-ancestor
44677093|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677094|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677095|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44677096|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677097|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
44677098|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677099|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677100|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
44677101|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677102|NCT01300312|Diclofenac|diclofenac|mesh-list
44677103|NCT01300312|Eperisone|eperisone|mesh-list
44677104|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44677105|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677106|NCT01300312|Analgesics|analgesics|mesh-ancestor
44677107|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
44677108|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677109|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677110|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677111|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677112|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44677113|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677114|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677115|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
44677116|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44677117|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677118|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44677119|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44677120|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44677121|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
44677122|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
44677123|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
44677124|NCT01300364|Citalopram|citalopram|mesh-list
44677125|NCT01300364|Reboxetine|reboxetine|mesh-list
44677126|NCT01300364|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44677127|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44677128|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677129|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677130|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677131|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
44677132|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677133|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44677134|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
44677135|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44677136|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44677137|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44677138|NCT01300377|Lidocaine|lidocaine|mesh-list
44677139|NCT01300377|Bupivacaine|bupivacaine|mesh-list
44108397|NCT00081822|Cytarabine|cytarabine|mesh-list
44677140|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677141|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
44677142|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677143|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677144|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
44677145|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677146|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44677147|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44677148|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44677149|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677150|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677151|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44677152|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44677153|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
44677154|NCT01300637|Metformin|metformin|mesh-list
44677155|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677156|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677157|NCT01300676|Estradiol|estradiol|mesh-list
44677158|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
44677159|NCT01300676|Estrogens|estrogens|mesh-ancestor
44677160|NCT01300676|Hormones|hormones|mesh-ancestor
44677161|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677162|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677163|NCT01300676|Progestins|progestins|mesh-ancestor
44677164|NCT01300754|Lidocaine|lidocaine|mesh-list
44677165|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677166|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
44677167|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677168|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677169|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
44677170|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677171|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44677172|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44677173|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44228076|NCT00523133|Naltrexone|naltrexone|mesh-list
44677174|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677175|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677177|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44677178|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677179|NCT01300780|Analgesics|analgesics|mesh-ancestor
44677180|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
44677181|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677182|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677183|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677184|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677185|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44677186|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44677187|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677188|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677189|NCT01300793|Rituximab|rituximab|mesh-list
44677190|NCT01300793|Carboplatin|carboplatin|mesh-list
44677191|NCT01300793|Etoposide|etoposide|mesh-list
44677192|NCT01300793|Bortezomib|bortezomib|mesh-list
44677193|NCT01300793|Ifosfamide|ifosfamide|mesh-list
44677194|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
44677195|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677196|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677197|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
44677198|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677199|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677200|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677201|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44677202|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677203|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108466|NCT00082082|Thymalfasin|thymalfasin|mesh-list
44677204|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677205|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677206|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
44677207|NCT01300962|Capecitabine|capecitabine|mesh-list
44677208|NCT01300962|Trastuzumab|trastuzumab|mesh-list
44677209|NCT01300962|Lapatinib|lapatinib|mesh-list
44677210|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677211|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
44677212|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677213|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677214|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677215|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44677216|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677217|NCT01300988|Aprepitant|aprepitant|mesh-list
44677218|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
44677219|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
44677220|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
44677221|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677222|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677223|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677224|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44677225|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677226|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677227|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
44677228|NCT01301040|Docetaxel|docetaxel|mesh-list
44677229|NCT01301040|Epirubicin|epirubicin|mesh-list
44677230|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677231|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
44677232|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677233|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677234|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677235|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
44677236|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677237|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677238|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44677239|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677240|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677241|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677242|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677243|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44677244|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677245|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677246|NCT01301053|Insulin|insulin|mesh-list
44677247|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44677248|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677249|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677250|NCT01301222|Octreotide|octreotide|mesh-list
44677251|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677252|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44677253|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677254|NCT01301248|Cisplatin|cisplatin|mesh-list
44677255|NCT01301248|Cetuximab|cetuximab|mesh-list
44677256|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677257|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677258|NCT01301313|Simendan|simendan|mesh-list
44677259|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44677260|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
44677261|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44677262|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44677263|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677264|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677265|NCT01301313|Protective Agents|protective agents|mesh-ancestor
44677266|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677267|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44677268|NCT01301586|Doxycycline|doxycycline|mesh-list
44677269|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677270|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677271|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
44677272|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44677273|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44677274|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44677275|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
44677276|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44677277|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
44677278|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677279|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677280|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677281|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44677282|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677283|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
44677284|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677285|NCT01301612|Cisplatin|cisplatin|mesh-list
44677286|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
44677287|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677288|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677289|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
44677290|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677291|NCT01301716|Paclitaxel|paclitaxel|mesh-list
44677292|NCT01301716|Bevacizumab|bevacizumab|mesh-list
44677293|NCT01301716|Cisplatin|cisplatin|mesh-list
44677294|NCT01301716|Carboplatin|carboplatin|mesh-list
44677295|NCT01301716|Pemetrexed|pemetrexed|mesh-list
44677296|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677297|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677298|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677299|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677300|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677301|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677302|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677303|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44677304|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44677305|NCT01301716|Growth Substances|growth substances|mesh-ancestor
44677306|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677307|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
44677308|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677309|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44677310|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44677311|NCT01301820|Lenalidomide|lenalidomide|mesh-list
44677312|NCT01301820|Azacitidine|azacitidine|mesh-list
44677313|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
44677314|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677315|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44677316|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44677317|NCT01301820|Growth Substances|growth substances|mesh-ancestor
44677318|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44677319|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677320|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677321|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
44677322|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677323|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677324|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44677325|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44677326|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44677327|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677328|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44677329|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44677330|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44677331|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677365|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44677366|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677367|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677368|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677369|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
44677370|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44108559|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
44677371|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677373|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44677374|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
44677375|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677376|NCT01302210|Mupirocin|mupirocin|mesh-list
44677377|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677378|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677379|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44677380|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677381|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677382|NCT01302236|Eplerenone|eplerenone|mesh-list
44677383|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44677384|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
44677385|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677386|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677387|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44677388|NCT01302236|Diuretics|diuretics|mesh-ancestor
44677389|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
44677390|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44677391|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
44677392|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
44677393|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44677394|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44677395|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677396|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677397|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44677398|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44677399|NCT01302340|Dronabinol|dronabinol|mesh-list
44677400|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
44677401|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677402|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44677403|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677404|NCT01302340|Analgesics|analgesics|mesh-ancestor
44677405|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
44677406|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677407|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44677408|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44677409|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677410|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677411|NCT01302340|Hormones|hormones|mesh-ancestor
44677412|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677413|NCT01302353|Isoflurane|isoflurane|mesh-list
44677414|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44677415|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
44677416|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
44677417|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677418|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677419|NCT01302496|Ipilimumab|ipilimumab|mesh-list
44677420|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677421|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677422|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44677423|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677424|NCT01302587|Albuterol|albuterol|mesh-list
44677425|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44677426|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
44677427|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677428|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677429|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44677430|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
44677431|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
44677432|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44677433|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44677434|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44677435|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44677436|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
44677437|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677438|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677439|NCT01302613|Leucovorin|leucovorin|mesh-list
44677440|NCT01302613|Capecitabine|capecitabine|mesh-list
44677441|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
44677442|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677443|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
44677444|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677445|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677446|NCT01302613|Antidotes|antidotes|mesh-ancestor
44677447|NCT01302613|Protective Agents|protective agents|mesh-ancestor
44677448|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677449|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
44677450|NCT01302613|Vitamins|vitamins|mesh-ancestor
44677451|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
44677452|NCT01302756|Folic Acid|folic acid|mesh-list
44677453|NCT01302756|Hematinics|hematinics|mesh-ancestor
44677454|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
44677455|NCT01302756|Vitamins|vitamins|mesh-ancestor
44677456|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
44677457|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677458|NCT01302821|Tryptophan|tryptophan|mesh-list
44677459|NCT01302821|Vaccines|vaccines|mesh-list
44677460|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
44677461|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677462|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44677463|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
44677464|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44677465|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
44677466|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677467|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677468|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44677469|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677470|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677471|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677472|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677473|NCT01303029|Gemcitabine|gemcitabine|mesh-list
44677474|NCT01303029|Capecitabine|capecitabine|mesh-list
44677475|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44677476|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677477|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
44677478|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677479|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677480|NCT01303029|Antiviral Agents|antiviral agents|mesh-ancestor
44677481|NCT01303029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677482|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677483|NCT01303029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677484|NCT01303029|Immunologic Factors|immunologic factors|mesh-ancestor
44677485|NCT01303029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677486|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44677487|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
44677488|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
44677489|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677490|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677491|NCT01303055|Metformin|metformin|mesh-list
44677492|NCT01303055|Alogliptin|alogliptin|mesh-list
44677493|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677494|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677495|NCT01303055|Incretins|incretins|mesh-ancestor
44677496|NCT01303055|Hormones|hormones|mesh-ancestor
44108695|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
44677497|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677498|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44677499|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
44677500|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677501|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677503|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677504|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
44677505|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677506|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677507|NCT01303107|Bupivacaine|bupivacaine|mesh-list
44677508|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677509|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
44677510|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677511|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677512|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
44677513|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677515|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677516|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677517|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44677518|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
44677519|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
44677520|NCT01303471|Remifentanil|remifentanil|mesh-list
44677521|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44677522|NCT01303471|Narcotics|narcotics|mesh-ancestor
44677523|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677524|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677525|NCT01303471|Analgesics|analgesics|mesh-ancestor
44677526|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
44677527|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677528|NCT01303497|Paclitaxel|paclitaxel|mesh-list
44677529|NCT01303497|Bevacizumab|bevacizumab|mesh-list
44677530|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677531|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677532|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677533|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677534|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677535|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677536|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677537|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44677538|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44677539|NCT01303497|Growth Substances|growth substances|mesh-ancestor
44677540|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677541|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
44677542|NCT01303536|Ondansetron|ondansetron|mesh-list
44677543|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
44677544|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
44677545|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677546|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677547|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677548|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
44677549|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44677550|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44677551|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
44677552|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677553|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677554|NCT01303536|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44677555|NCT01303536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44677556|NCT01303536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677557|NCT01303536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44677558|NCT01303536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44677559|NCT01303549|Amphotericin B|amphotericin b|mesh-list
44677560|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44677561|NCT01303549|Anidulafungin|anidulafungin|mesh-list
44677562|NCT01303549|Amebicides|amebicides|mesh-ancestor
44677563|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44677564|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44677565|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677566|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677567|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
44677568|NCT01303601|Olanzapine|olanzapine|mesh-list
44677569|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
44677570|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
44677571|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071405|NCT00001190|Deslorelin|deslorelin|mesh-list
44677572|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677573|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677574|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44677575|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44677576|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677577|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44677578|NCT01303601|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44677579|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44677580|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677581|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677582|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677583|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
44677584|NCT01303614|Lidocaine|lidocaine|mesh-list
44677585|NCT01303614|Prilocaine|prilocaine|mesh-list
44677586|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44677587|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677588|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
44677589|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677590|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677591|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
44677592|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677593|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44677594|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44677595|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44677596|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677597|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677598|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44677599|NCT01303640|Everolimus|everolimus|mesh-list
44677600|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677601|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677602|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
44677603|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677604|NCT01303679|Paclitaxel|paclitaxel|mesh-list
44677605|NCT01303679|Bevacizumab|bevacizumab|mesh-list
44677606|NCT01303679|Exemestane|exemestane|mesh-list
44677607|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677608|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677609|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677610|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677611|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677612|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677613|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677614|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44677615|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44677616|NCT01303679|Growth Substances|growth substances|mesh-ancestor
44677617|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677618|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
44677619|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44677620|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44677621|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677622|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44677623|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
44677624|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677625|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
44677626|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677627|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
44677628|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677629|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677630|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677631|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
44677632|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677633|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677634|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44677635|NCT01303731|Fentanyl|fentanyl|mesh-list
44677636|NCT01303731|Bupivacaine|bupivacaine|mesh-list
44677637|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677638|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
44677639|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677640|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677641|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
44677642|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677643|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44677644|NCT01303731|Narcotics|narcotics|mesh-ancestor
44677645|NCT01303731|Analgesics|analgesics|mesh-ancestor
44677646|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44677647|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44677648|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
44228617|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44677649|NCT01303874|Etanercept|etanercept|mesh-list
44677650|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44677651|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677652|NCT01303874|Analgesics|analgesics|mesh-ancestor
44677653|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
44677654|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677655|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677656|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677657|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677658|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677659|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677660|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
44677661|NCT01303887|Prednisolone|prednisolone|mesh-list
44677662|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
44677663|NCT01303887|Rituximab|rituximab|mesh-list
44677664|NCT01303887|Fludarabine|fludarabine|mesh-list
44677665|NCT01303887|Vincristine|vincristine|mesh-list
44677666|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677667|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
44677668|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677669|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677670|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677671|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
44677672|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677673|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677674|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44677675|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677676|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677677|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677678|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677679|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677680|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677681|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
44677682|NCT01303887|Hormones|hormones|mesh-ancestor
44677683|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677684|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44677685|NCT01303926|Paclitaxel|paclitaxel|mesh-list
44677686|NCT01303926|Bevacizumab|bevacizumab|mesh-list
44677687|NCT01303926|Cisplatin|cisplatin|mesh-list
44677688|NCT01303926|Carboplatin|carboplatin|mesh-list
44677689|NCT01303926|Pemetrexed|pemetrexed|mesh-list
44677690|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677691|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677692|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677693|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677694|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677695|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677696|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677697|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44677698|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44677699|NCT01303926|Growth Substances|growth substances|mesh-ancestor
44677700|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677701|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
44677702|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677703|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44677704|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44677705|NCT01303952|Eculizumab|eculizumab|mesh-list
44677706|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44677707|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677708|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
44677709|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677710|NCT01304069|Etoricoxib|etoricoxib|mesh-list
44677711|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44677712|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677713|NCT01304069|Analgesics|analgesics|mesh-ancestor
44677714|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
44677715|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677716|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677717|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677718|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677719|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44677720|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44677721|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677722|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677723|NCT01304095|Ranolazine|ranolazine|mesh-list
44228691|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
44677724|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44677725|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44677726|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677727|NCT01304134|Morphine|morphine|mesh-list
44677728|NCT01304134|Oxycodone|oxycodone|mesh-list
44677729|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44677730|NCT01304134|Narcotics|narcotics|mesh-ancestor
44677731|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677732|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677733|NCT01304134|Analgesics|analgesics|mesh-ancestor
44677734|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
44677735|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677736|NCT01304212|Ketorolac|ketorolac|mesh-list
44677737|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44677738|NCT01304212|Epinephrine|epinephrine|mesh-list
44677739|NCT01304212|Racepinephrine|racepinephrine|mesh-list
44677740|NCT01304212|Morphine|morphine|mesh-list
44677741|NCT01304212|Ropivacaine|ropivacaine|mesh-list
44677742|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
44677743|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44677744|NCT01304212|Narcotics|narcotics|mesh-ancestor
44677745|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677746|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677747|NCT01304212|Analgesics|analgesics|mesh-ancestor
44677748|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
44677749|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677750|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677751|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
44677752|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44677753|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44677754|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44677755|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677756|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677757|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44677758|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44677759|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
44677760|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44677761|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
44677762|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
44677763|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
44677764|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44677765|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44677766|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44677767|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677768|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677769|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44677770|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677771|NCT01304264|Maleic acid|maleic acid|mesh-list
44677772|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677773|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677774|NCT01304316|Phenylephrine|phenylephrine|mesh-list
44677775|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
44677776|NCT01304316|Tetracaine|tetracaine|mesh-list
44677777|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
44677778|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
44677779|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677780|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677781|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
44677782|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677783|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44677784|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44677785|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
44677786|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677787|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677788|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
44677789|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
44677790|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
44677791|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44677792|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
44677793|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44677794|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
44677795|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44677796|NCT01304316|Protective Agents|protective agents|mesh-ancestor
44677798|NCT01304342|Remifentanil|remifentanil|mesh-list
44677799|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44677800|NCT01304342|Narcotics|narcotics|mesh-ancestor
44677801|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677802|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677803|NCT01304342|Analgesics|analgesics|mesh-ancestor
44677804|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
44677805|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677806|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44677807|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44677808|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
44677809|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
44677810|NCT01304472|Clopidogrel|clopidogrel|mesh-list
44677811|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44677812|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44677813|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44677814|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44677815|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44677816|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
44677817|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44677818|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677819|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677820|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44677821|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
44677822|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44677823|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44677824|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
44677825|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677826|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677827|NCT01304563|Vaccines|vaccines|mesh-list
44677828|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
44677829|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677830|NCT01304602|Irinotecan|irinotecan|mesh-list
44109046|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
44677831|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44677832|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677833|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677834|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677835|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677836|NCT01304784|Paclitaxel|paclitaxel|mesh-list
44677837|NCT01304784|Docetaxel|docetaxel|mesh-list
44677838|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44677839|NCT01304784|Cisplatin|cisplatin|mesh-list
44677840|NCT01304784|Capecitabine|capecitabine|mesh-list
44677841|NCT01304784|Trastuzumab|trastuzumab|mesh-list
44677842|NCT01304784|Lapatinib|lapatinib|mesh-list
44677843|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44677844|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44677845|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677846|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44677847|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
44677848|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44677849|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677850|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677851|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
44677852|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677853|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44677854|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677855|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
44677856|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677857|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
44677858|NCT01304797|Trastuzumab|trastuzumab|mesh-list
44677859|NCT01304797|Doxorubicin|doxorubicin|mesh-list
44677860|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
44677861|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677862|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
44677863|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677864|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44677865|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44677866|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
44677867|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677868|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677870|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44677871|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677872|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44677873|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677874|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677875|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
44677876|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
44677877|NCT01304836|Prednisolone|prednisolone|mesh-list
44677878|NCT01304836|Tacrolimus|tacrolimus|mesh-list
44677879|NCT01304836|Basiliximab|basiliximab|mesh-list
44677880|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677881|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
44677882|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677883|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44677884|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677885|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677886|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677887|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677888|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44677889|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
44677890|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677891|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677892|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44677893|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
44677894|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
44677895|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677896|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44677897|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
44677898|NCT01304836|Hormones|hormones|mesh-ancestor
44677899|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677900|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44677901|NCT01304836|Protective Agents|protective agents|mesh-ancestor
44677902|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44677903|NCT01304901|Montelukast|montelukast|mesh-list
44677904|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44677905|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44677906|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44677907|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44677908|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677909|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677910|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44677911|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44677912|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677913|NCT01304927|Vitamin D|vitamin d|mesh-list
44677914|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
44677915|NCT01304927|Calcium|calcium|mesh-list
44677916|NCT01304927|Vitamins|vitamins|mesh-ancestor
44677917|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
44677918|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677919|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44677920|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44677921|NCT01305057|Pyridoxine|pyridoxine|mesh-list
44677922|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
44677923|NCT01305057|Vitamins|vitamins|mesh-ancestor
44677924|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
44677925|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677926|NCT01305083|Udenafil|udenafil|mesh-list
44677927|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44677928|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44677929|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677930|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677931|NCT01305135|Azacitidine|azacitidine|mesh-list
44677932|NCT01305135|Idarubicin|idarubicin|mesh-list
44677933|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44677934|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
44677935|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677936|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677937|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677938|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677939|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44677940|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44677941|NCT01305148|Warfarin|warfarin|mesh-list
44677942|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
44677943|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
44677944|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44677945|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
44677946|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677947|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
44677948|NCT01305187|Protective Agents|protective agents|mesh-ancestor
44677949|NCT01305226|Streptokinase|streptokinase|mesh-list
44677950|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44677951|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44677952|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677953|NCT01305317|Atorvastatin|atorvastatin|mesh-list
44677954|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44677955|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44677956|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
44677957|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677958|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44677959|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44677960|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677961|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44677962|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44677963|NCT01305395|Sirolimus|sirolimus|mesh-list
44677964|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44677965|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44677966|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44677967|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44677968|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
44677969|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44677970|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
44677971|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677972|NCT01305551|Metformin|metformin|mesh-list
44677973|NCT01305551|Saxagliptin|saxagliptin|mesh-list
44109136|NCT05567770|Androgens|androgens|mesh-list
44677974|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44677975|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677976|NCT01305551|Incretins|incretins|mesh-ancestor
44677977|NCT01305551|Hormones|hormones|mesh-ancestor
44677978|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44677979|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44677980|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
44677981|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44677982|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44677983|NCT01305603|Bupivacaine|bupivacaine|mesh-list
44677984|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
44677985|NCT01305603|Anesthetics|anesthetics|mesh-list
44677986|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44677987|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44677988|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
44677989|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44677990|NCT01305707|Diazepam|diazepam|mesh-list
44677991|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44677992|NCT01305707|Lorazepam|lorazepam|mesh-list
44677993|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
44677994|NCT01305707|Dexetimide|dexetimide|mesh-list
44677995|NCT01305707|Olanzapine|olanzapine|mesh-list
44677996|NCT01305707|Risperidone|risperidone|mesh-list
44677997|NCT01305707|Aripiprazole|aripiprazole|mesh-list
44677998|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44677999|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
44678000|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
44678001|NCT01305707|Mirtazapine|mirtazapine|mesh-list
44678002|NCT01305707|Citalopram|citalopram|mesh-list
44678003|NCT01305707|Sertraline|sertraline|mesh-list
44678004|NCT01305707|Fluoxetine|fluoxetine|mesh-list
44678005|NCT01305707|Paroxetine|paroxetine|mesh-list
44678006|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44678007|NCT01305707|Nortriptyline|nortriptyline|mesh-list
44678008|NCT01305707|Imipramine|imipramine|mesh-list
44678009|NCT01305707|Clomipramine|clomipramine|mesh-list
44678010|NCT01305707|Mianserin|mianserin|mesh-list
44678011|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
44678012|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44678013|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
44678014|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678015|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678016|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678017|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44678018|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678019|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678020|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44678021|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
44678022|NCT01305707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44678023|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678024|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678025|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44678026|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44678027|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44678028|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
44678029|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
44678030|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678031|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44678032|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44678033|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44678034|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
44678035|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678036|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
44678037|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44678038|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44678039|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44678040|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44678041|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44678042|NCT01305707|Analgesics|analgesics|mesh-ancestor
44678043|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
44678044|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44678045|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44678046|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678047|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
44678048|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
44678049|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44678050|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44678051|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
44678052|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
44678053|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44678054|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
44678055|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
44678056|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44678057|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44678058|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44678059|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678060|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44678061|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44678062|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44678063|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44678064|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678065|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
44678066|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
44678067|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44678068|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44678069|NCT01305733|Ketorolac|ketorolac|mesh-list
44678070|NCT01305733|Epinephrine|epinephrine|mesh-list
44678071|NCT01305733|Racepinephrine|racepinephrine|mesh-list
44678072|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
44678073|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
44678074|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44678075|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678076|NCT01305733|Analgesics|analgesics|mesh-ancestor
44678077|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
44678078|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678079|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678080|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678081|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678082|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44678083|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678084|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678085|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678086|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
44678087|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678088|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44678089|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44678090|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678091|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678092|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44678093|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678094|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
44678095|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678096|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678097|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
44678098|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
44678099|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44678100|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
44678101|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44678102|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44678103|NCT01305837|Prednisolone|prednisolone|mesh-list
44678104|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
44678105|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44678106|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
44678107|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678108|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
44678109|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
44678110|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678111|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678112|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678113|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
44678114|NCT01305837|Hormones|hormones|mesh-ancestor
44678115|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678116|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44678117|NCT01305837|Protective Agents|protective agents|mesh-ancestor
44678118|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44678119|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678120|NCT01305850|Losartan|losartan|mesh-list
44678121|NCT01305850|Enalapril|enalapril|mesh-list
44678122|NCT01305850|Enalaprilat|enalaprilat|mesh-list
44678123|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678124|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44678125|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44678126|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44678127|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678128|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44678129|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678130|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678131|NCT01306006|Vaccines|vaccines|mesh-list
44678132|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
44678133|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678134|NCT01306097|Zinc|zinc|mesh-list
44678135|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
44678136|NCT01306097|Trace Elements|trace elements|mesh-ancestor
44678137|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
44678138|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678139|NCT01306097|Astringents|astringents|mesh-ancestor
44678140|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889356|NCT04528277|Isoniazid|isoniazid|mesh-list
44678142|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
44678143|NCT01306123|Vitamins|vitamins|mesh-ancestor
44678144|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
44678145|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678146|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678147|NCT01306123|Hematinics|hematinics|mesh-ancestor
44678148|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44678149|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678150|NCT01306266|Rizatriptan|rizatriptan|mesh-list
44678151|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44678152|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
44678153|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678154|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678155|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678156|NCT01306318|Diclofenac|diclofenac|mesh-list
44678157|NCT01306318|Eperisone|eperisone|mesh-list
44678158|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44678159|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678160|NCT01306318|Analgesics|analgesics|mesh-ancestor
44678161|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
44678162|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678163|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678164|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678165|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678166|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44678167|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678168|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678169|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
44678170|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44678171|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678172|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44678173|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44678174|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44678175|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
44678176|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
44678177|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
44678178|NCT01306357|Hormones|hormones|mesh-list
44678179|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678180|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678181|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
44678182|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44678183|NCT01306370|Hemostatics|hemostatics|mesh-list
44678184|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44678185|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44678186|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678187|NCT01306370|Coagulants|coagulants|mesh-ancestor
44678188|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
44678189|NCT01306409|Hematinics|hematinics|mesh-ancestor
44678190|NCT01306461|Timolol|timolol|mesh-list
44678191|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44678192|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44678193|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678194|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678195|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678196|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678197|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678198|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44678199|NCT01306565|Atorvastatin|atorvastatin|mesh-list
44678200|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44678201|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44678202|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
44229190|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
44678203|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678204|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44678205|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44678206|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678207|NCT01306591|Bevacizumab|bevacizumab|mesh-list
44678208|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678209|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678210|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678211|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678212|NCT01306591|Growth Substances|growth substances|mesh-ancestor
44071956|NCT00001696|Hormones|hormones|mesh-ancestor
44678213|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678214|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
44678215|NCT01306630|Capecitabine|capecitabine|mesh-list
44678216|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44678217|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
44678218|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678219|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678220|NCT01306708|Amitriptyline|amitriptyline|mesh-list
44678221|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44678222|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
44678223|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678224|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678225|NCT01306708|Analgesics|analgesics|mesh-ancestor
44678226|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
44678227|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678228|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678229|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44678230|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678231|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678232|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678233|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678234|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678235|NCT01306721|Fexofenadine|fexofenadine|mesh-list
44678236|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
44678238|NCT01306721|Terfenadine|terfenadine|mesh-list
44678239|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678240|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
44678241|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678242|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678243|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678244|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678245|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
44678246|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44678247|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44678248|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
44678249|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678250|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678251|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678252|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44678253|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44678254|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44678255|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
44678256|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
44678257|NCT01306760|Ketamine|ketamine|mesh-list
44678258|NCT01306760|Propofol|propofol|mesh-list
44678259|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44678260|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678261|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678262|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678263|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
44678264|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
44678265|NCT01306760|Analgesics|analgesics|mesh-ancestor
44678266|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
44678267|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678268|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44678269|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44678270|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44678271|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678272|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678273|NCT01306773|Oseltamivir|oseltamivir|mesh-list
44678274|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
44678275|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229263|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678276|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678277|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678278|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44678279|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
44678280|NCT01306851|Coagulants|coagulants|mesh-ancestor
44678281|NCT01306864|Hemostatics|hemostatics|mesh-list
44678282|NCT01306864|Coagulants|coagulants|mesh-ancestor
44678283|NCT01306981|Ranibizumab|ranibizumab|mesh-list
44678284|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678285|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678286|NCT01306981|Growth Substances|growth substances|mesh-ancestor
44678287|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678288|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
44678289|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678290|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
44678291|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678292|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
44678293|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678294|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678295|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678296|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678297|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
44678298|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44678299|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
44678300|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678301|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678302|NCT01307202|Gabapentin|gabapentin|mesh-list
44678303|NCT01307202|Analgesics|analgesics|mesh-ancestor
44678304|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
44678305|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678306|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678307|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
44678308|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44678309|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44678310|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678311|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678312|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44678313|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44678314|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678315|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678316|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
44678317|NCT01307215|Ropivacaine|ropivacaine|mesh-list
44678318|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678319|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
44109441|NCT04556617|Prednisone|prednisone|mesh-list
44678320|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678321|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678322|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
44678323|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678324|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
44678325|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678326|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678327|NCT01307475|Adenosine|adenosine|mesh-list
44678328|NCT01307475|Analgesics|analgesics|mesh-ancestor
44678329|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
44678330|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678331|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678332|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678333|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
44678334|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44678335|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
44678336|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
44678337|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678338|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678339|NCT01307488|Ritonavir|ritonavir|mesh-list
44678340|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44678341|NCT01307488|Lamivudine|lamivudine|mesh-list
44678342|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44678343|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44678344|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678345|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678346|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678347|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44678348|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44678349|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
44678350|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678351|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44678352|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44678353|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44678354|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44678356|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678357|NCT01307527|Vitamins|vitamins|mesh-ancestor
44678358|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
44678359|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678360|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44678361|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
44678362|NCT01307592|Gemcitabine|gemcitabine|mesh-list
44678363|NCT01307592|Rituximab|rituximab|mesh-list
44678364|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
44678365|NCT01307592|Lenalidomide|lenalidomide|mesh-list
44678366|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109504|NCT04538378|Olaparib|olaparib|mesh-list
44678367|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678368|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
44678369|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678370|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678371|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44678372|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
44678373|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678374|NCT01307592|Antiviral Agents|antiviral agents|mesh-ancestor
44678375|NCT01307592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678376|NCT01307592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678377|NCT01307592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678378|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678379|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678380|NCT01307592|Growth Substances|growth substances|mesh-ancestor
44678381|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
44678382|NCT01307839|Lidocaine|lidocaine|mesh-list
44678383|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678384|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
44678385|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678386|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678387|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
44678388|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678389|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678390|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44678391|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44678392|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678393|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678394|NCT01307865|Mannitol|mannitol|mesh-list
44678395|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44678396|NCT01307865|Diuretics|diuretics|mesh-ancestor
44678397|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
44678398|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678399|NCT01307969|Lidocaine|lidocaine|mesh-list
44678400|NCT01307969|Epinephrine|epinephrine|mesh-list
44678401|NCT01307969|Racepinephrine|racepinephrine|mesh-list
44678402|NCT01307969|Ropivacaine|ropivacaine|mesh-list
44678403|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
44678404|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678405|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
44678406|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678407|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678408|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
44678409|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678410|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678411|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44678412|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44678413|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678414|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678415|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44678416|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44678417|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678418|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678419|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44678420|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678422|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678423|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678424|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
44678425|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
44678426|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44678427|NCT01308047|Bupivacaine|bupivacaine|mesh-list
44678428|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678429|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
44678430|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678431|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109550|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
44678432|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
44678433|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678434|NCT01308086|Leucovorin|leucovorin|mesh-list
44678435|NCT01308086|Fluorouracil|fluorouracil|mesh-list
44678436|NCT01308086|Capecitabine|capecitabine|mesh-list
44678437|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
44678438|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
44678439|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
44678440|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678441|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44678442|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678443|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678444|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
44678445|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678446|NCT01308086|Antidotes|antidotes|mesh-ancestor
44678447|NCT01308086|Protective Agents|protective agents|mesh-ancestor
44678448|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678449|NCT01308086|Vitamins|vitamins|mesh-ancestor
44678450|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
44678451|NCT01308177|Ecabet|ecabet|mesh-list
44678452|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678453|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44678454|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678455|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678456|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678457|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678458|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44678459|NCT01308177|Protective Agents|protective agents|mesh-ancestor
44678460|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678461|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678462|NCT01308203|Niacin|niacin|mesh-list
44678463|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44678464|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
44678465|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678466|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44678467|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
44678468|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678469|NCT01308203|Vitamins|vitamins|mesh-ancestor
44678470|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
44678471|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678472|NCT01308229|Paclitaxel|paclitaxel|mesh-list
44678473|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44678474|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678475|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
44678476|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
44678477|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
44678478|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678479|NCT01308242|Sevelamer|sevelamer|mesh-list
44678480|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
44678481|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
44678482|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678483|NCT01308255|Vitamins|vitamins|mesh-list
44678484|NCT01308255|Folic Acid|folic acid|mesh-list
44678485|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
44678486|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44678487|NCT01308255|Methotrexate|methotrexate|mesh-list
44678488|NCT01308255|Infliximab|infliximab|mesh-list
44678489|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
44678490|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678491|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44678492|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
44678493|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44678494|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44678495|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
44678496|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236100|NCT00557544|Ketoprofen|ketoprofen|mesh-list
44678497|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678498|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
44678499|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678500|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44678501|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678502|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
44678503|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678504|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44678505|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678506|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
44678507|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
44678508|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678509|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678510|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
44678511|NCT01308255|Hormones|hormones|mesh-ancestor
44678512|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678513|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44678514|NCT01308255|Protective Agents|protective agents|mesh-ancestor
44678515|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44678516|NCT01308255|Hematinics|hematinics|mesh-ancestor
44678517|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678518|NCT01308268|Ivermectin|ivermectin|mesh-list
44678519|NCT01308268|Albendazole|albendazole|mesh-list
44678520|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44678521|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678522|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
44678523|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
44678524|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44678525|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44678526|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44678527|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44678528|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44678529|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678530|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678531|NCT01308320|Fentanyl|fentanyl|mesh-list
44678532|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44678533|NCT01308320|Narcotics|narcotics|mesh-ancestor
44678534|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678535|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678536|NCT01308320|Analgesics|analgesics|mesh-ancestor
44678537|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
44678538|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678539|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44678540|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678541|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
44678542|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
44678543|NCT01308346|Everolimus|everolimus|mesh-list
44678544|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678545|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678546|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
44678547|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678548|NCT01308437|Insulin|insulin|mesh-list
44678549|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44678550|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
44678551|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44678552|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678553|NCT01308528|Enoxaparin|enoxaparin|mesh-list
44678554|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
44678555|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
44678556|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44678557|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44678558|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678560|NCT01308541|Fospropofol|fospropofol|mesh-list
44678561|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44678562|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678563|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678564|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678565|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
44678566|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
44678567|NCT01308554|Bupivacaine|bupivacaine|mesh-list
44678568|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678569|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
44678570|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678571|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678572|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
44678573|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678574|NCT01308606|Simeprevir|simeprevir|mesh-list
44678575|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
44678576|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678577|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678578|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678579|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678580|NCT01308632|Irinotecan|irinotecan|mesh-list
44678581|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44678582|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44678583|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678584|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678585|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678586|NCT01308658|Ritonavir|ritonavir|mesh-list
44678587|NCT01308658|Darunavir|darunavir|mesh-list
44678588|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44678589|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44678590|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678591|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678592|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678593|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44678594|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44678595|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
44678596|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678597|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44678598|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44678599|NCT01308671|Varenicline|varenicline|mesh-list
44678600|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44678601|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44678602|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
44678603|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678604|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678605|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678606|NCT01308684|Bevacizumab|bevacizumab|mesh-list
44678607|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678608|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678609|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678610|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678611|NCT01308684|Growth Substances|growth substances|mesh-ancestor
44678612|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678613|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44678614|NCT01308723|Sorafenib|sorafenib|mesh-list
44678615|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44678616|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678617|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44678618|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678619|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678620|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
44678621|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678622|NCT01308944|Propranolol|propranolol|mesh-list
44678623|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44678624|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44678625|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678626|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678627|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678628|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678629|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44678630|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44678631|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
44678632|NCT01308983|Amiloride|amiloride|mesh-list
44678633|NCT01308983|Diuretics|diuretics|mesh-ancestor
44229611|NCT00530595|Losartan|losartan|mesh-list
44678634|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
44678635|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678636|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44678637|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44678638|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678639|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678640|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44678641|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44678642|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44678644|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678645|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
44678646|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678647|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678648|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678649|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678650|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
44678651|NCT01309022|Sirolimus|sirolimus|mesh-list
44678652|NCT01309022|Tacrolimus|tacrolimus|mesh-list
44678653|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678654|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
44678655|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678656|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44678657|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678658|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678659|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44678660|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678661|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44678662|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
44678663|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44678664|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678665|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
44678666|NCT01309074|Pregabalin|pregabalin|mesh-list
44678667|NCT01309074|Sertraline|sertraline|mesh-list
44678668|NCT01309074|Analgesics|analgesics|mesh-ancestor
44678669|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
44678670|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678671|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678672|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
44678673|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44678674|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678675|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678676|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44678677|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44678678|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44678679|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678680|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678681|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
44678682|NCT01309074|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44678683|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678684|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678685|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
44678686|NCT01309126|Cetuximab|cetuximab|mesh-list
44678687|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678688|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678689|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
44678690|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678691|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
44678692|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678693|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678694|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678695|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678696|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
44678697|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44678698|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
44678699|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678700|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678701|NCT01309178|Mannitol|mannitol|mesh-list
44678702|NCT01309178|Amitriptyline|amitriptyline|mesh-list
44678703|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44678704|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
44678705|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678706|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678707|NCT01309178|Analgesics|analgesics|mesh-ancestor
44678708|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
44678709|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678710|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678711|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44678712|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678713|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678714|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678715|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678716|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678717|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44678718|NCT01309178|Diuretics|diuretics|mesh-ancestor
44678719|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
44678720|NCT01309399|Teriparatide|teriparatide|mesh-list
44678721|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44678722|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678723|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44678724|NCT01309412|Siltuximab|siltuximab|mesh-list
44678725|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678726|NCT01309425|Tapentadol|tapentadol|mesh-list
44678727|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44678728|NCT01309425|Narcotics|narcotics|mesh-ancestor
44678729|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678730|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678731|NCT01309425|Analgesics|analgesics|mesh-ancestor
44678732|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
44678733|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678734|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44678735|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678736|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678737|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678738|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678739|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678740|NCT01309438|Erythromycin|erythromycin|mesh-list
44678741|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
44678742|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44678743|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
44678744|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
44678745|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44678746|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
44678747|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44678748|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678749|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678750|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678751|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
44678752|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44678753|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678754|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44678755|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44678756|NCT01309477|Tacrolimus|tacrolimus|mesh-list
44678757|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678758|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
44678759|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678760|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44678761|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678762|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678763|NCT01309490|Ribavirin|ribavirin|mesh-list
44678764|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
44678765|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678766|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
44678767|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678768|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44678769|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44678770|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678771|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678772|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678773|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678774|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236120|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
44678775|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
44678776|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678778|NCT01309607|Carboplatin|carboplatin|mesh-list
44678779|NCT01309607|Lapatinib|lapatinib|mesh-list
44678780|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44678781|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678782|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
44678783|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
44678784|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
44678785|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678786|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44678787|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678788|NCT01309620|Zinc|zinc|mesh-list
44678789|NCT01309620|Trace Elements|trace elements|mesh-ancestor
44678790|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
44678791|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678792|NCT01309633|Gemcitabine|gemcitabine|mesh-list
44678793|NCT01309633|Bevacizumab|bevacizumab|mesh-list
44678794|NCT01309633|Sunitinib|sunitinib|mesh-list
44678795|NCT01309633|Cisplatin|cisplatin|mesh-list
44678796|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678797|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678798|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678799|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678800|NCT01309633|Growth Substances|growth substances|mesh-ancestor
44678801|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678802|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
44678803|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44678804|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
44678805|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678806|NCT01309633|Antiviral Agents|antiviral agents|mesh-ancestor
44678807|NCT01309633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678808|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678809|NCT01309633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678810|NCT01309633|Immunologic Factors|immunologic factors|mesh-ancestor
44678811|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44678812|NCT01309685|Varenicline|varenicline|mesh-list
44678813|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44678814|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44678815|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
44678816|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678817|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678818|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678819|NCT01309698|Inositol|inositol|mesh-list
44678820|NCT01309698|Vildagliptin|vildagliptin|mesh-list
44678821|NCT01309698|Voglibose|voglibose|mesh-list
44678822|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44678823|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678824|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44678825|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
44678826|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678827|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678828|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44678829|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
44678830|NCT01309698|Vitamins|vitamins|mesh-ancestor
44678831|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
44678832|NCT01309776|Citalopram|citalopram|mesh-list
44678833|NCT01309776|Tianeptine|tianeptine|mesh-list
44678834|NCT01309776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44678835|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44678836|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44678837|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678838|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678839|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
44678840|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678841|NCT01309776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44678842|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
44678843|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678844|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44678845|NCT01309789|Prednisone|prednisone|mesh-list
44678846|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
44678847|NCT01309789|Doxorubicin|doxorubicin|mesh-list
44678848|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44678849|NCT01309789|Vincristine|vincristine|mesh-list
44678850|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44678851|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44678852|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678853|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
44678854|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678855|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678856|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44678857|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
44678858|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678859|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678860|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44678861|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44678862|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44678863|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44678864|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678865|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678866|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
44678867|NCT01309789|Hormones|hormones|mesh-ancestor
44229843|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
44678868|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678869|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44678870|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44678871|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44678872|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
44678873|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44678874|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678875|NCT01309854|Pioglitazone|pioglitazone|mesh-list
44678876|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44678877|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678878|NCT01309984|Propofol|propofol|mesh-list
44678879|NCT01309984|Fospropofol|fospropofol|mesh-list
44678880|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44678881|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678882|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678883|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678884|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
44678885|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
44678886|NCT01310452|Insulin|insulin|mesh-list
44678887|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44678888|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
44678889|NCT01310452|Protamines|protamines|mesh-list
44678890|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44678891|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678892|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
44678893|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678894|NCT01310452|Coagulants|coagulants|mesh-ancestor
44678895|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
44678896|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44678897|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678898|NCT01310647|Estradiol|estradiol|mesh-list
44678899|NCT01310647|Testosterone|testosterone|mesh-list
44678900|NCT01310647|Estrogens|estrogens|mesh-ancestor
44678901|NCT01310647|Hormones|hormones|mesh-ancestor
44678902|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678903|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678904|NCT01310647|Androgens|androgens|mesh-ancestor
44678905|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44678906|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678907|NCT01312298|Bupivacaine|bupivacaine|mesh-list
44678908|NCT01312298|Anesthetics|anesthetics|mesh-list
44678909|NCT01312298|Propofol|propofol|mesh-list
44678910|NCT01312298|Succinylcholine|succinylcholine|mesh-list
44678911|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
44678912|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44678913|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678914|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
44678915|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678916|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44678917|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44678918|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
44678919|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44678920|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44678921|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44678922|NCT01312402|Brinzolamide|brinzolamide|mesh-list
44678923|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44678924|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678925|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678926|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
44678927|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44678928|NCT01313429|Celecoxib|celecoxib|mesh-list
44678929|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
44678930|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44678931|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
44678932|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678933|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678934|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44678935|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
44678936|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678937|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678938|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44678939|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44678940|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678941|NCT01313429|Analgesics|analgesics|mesh-ancestor
44678942|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
44678943|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678944|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678945|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44678946|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44678947|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44678948|NCT01313585|Beclomethasone|beclomethasone|mesh-list
44678949|NCT01313585|Albuterol|albuterol|mesh-list
44678950|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44678951|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
44678952|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678953|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110045|NCT00083902|Hormones|hormones|mesh-ancestor
44678954|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44678955|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
44678956|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
44678957|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44678958|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44678959|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44678960|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44678961|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
44678962|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678963|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678964|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44678965|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
44678966|NCT01313585|Hormones|hormones|mesh-ancestor
44678967|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44678968|NCT01313611|Rituximab|rituximab|mesh-list
44678969|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44678970|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678971|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678972|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
44678973|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678974|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44678975|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44678976|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
44678977|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678978|NCT01313689|Ofatumumab|ofatumumab|mesh-list
44678979|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678980|NCT01313819|Amantadine|amantadine|mesh-list
44678981|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44678982|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44678983|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
44678984|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44678985|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
44678986|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44678987|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44678988|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44678989|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44678990|NCT01313819|Analgesics|analgesics|mesh-ancestor
44678991|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
44678992|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44678993|NCT01314066|Bevacizumab|bevacizumab|mesh-list
44678994|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44678995|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44678996|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44678997|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44678998|NCT01314066|Growth Substances|growth substances|mesh-ancestor
44678999|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679000|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679001|NCT01314300|Lidocaine|lidocaine|mesh-list
44679002|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
44679003|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
44679004|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679005|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679006|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
44679007|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679008|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44679009|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44679010|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44679011|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679012|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679013|NCT01314859|Nifedipine|nifedipine|mesh-list
44679014|NCT01314859|Atosiban|atosiban|mesh-list
44679015|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44679016|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679017|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679018|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679019|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679020|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
44679021|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
44679022|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44679023|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
44679024|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679025|NCT01314898|Spironolactone|spironolactone|mesh-list
44679026|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44679027|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
44679028|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679029|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679030|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44679031|NCT01314898|Diuretics|diuretics|mesh-ancestor
44679032|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
44679033|NCT01315912|Letrozole|letrozole|mesh-list
44679034|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679035|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44679036|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44679037|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679038|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679039|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44679040|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
44679041|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679042|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679043|NCT01316445|Midazolam|midazolam|mesh-list
44679044|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44679045|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679046|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679047|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679048|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44679049|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44679050|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679051|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44679052|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
44679053|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
44679054|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
44679055|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
44679056|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679057|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230011|NCT05318794|Cisplatin|cisplatin|mesh-list
44679058|NCT01316861|Acarbose|acarbose|mesh-list
44679059|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44679060|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679061|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679062|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44679063|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679064|NCT01316874|Valrubicin|valrubicin|mesh-list
44679065|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679066|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44679067|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44679068|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679069|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679070|NCT01317784|Antibodies|antibodies|mesh-list
44679071|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
44679072|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44679073|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
44679074|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679075|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
44679077|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
44679078|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44679079|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679080|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44679081|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44679082|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44679083|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44679084|NCT01318928|Metronidazole|metronidazole|mesh-list
44679085|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679086|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44679087|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44679088|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44679089|NCT01318941|Ranibizumab|ranibizumab|mesh-list
44679090|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679091|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679092|NCT01318941|Growth Substances|growth substances|mesh-ancestor
44679093|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679094|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679095|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679096|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44679097|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44679098|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
44679099|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679100|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679101|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44679102|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44679103|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44679104|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44679105|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44679106|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44679107|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679108|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679109|NCT01320007|Furosemide|furosemide|mesh-list
44679110|NCT01320007|Diuretics|diuretics|mesh-ancestor
44679111|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
44679112|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679113|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44679114|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679115|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679116|NCT01320020|Catumaxomab|catumaxomab|mesh-list
44679117|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679118|NCT01320111|Paclitaxel|paclitaxel|mesh-list
44679119|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44679120|NCT01320111|Sorafenib|sorafenib|mesh-list
44679121|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44679122|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679123|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44679124|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44679125|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44679126|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679127|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44679128|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679129|NCT01320176|Vaccines|vaccines|mesh-list
44679130|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
44679131|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230099|NCT05302388|Hormones|hormones|mesh-ancestor
44679132|NCT01320254|Gemcitabine|gemcitabine|mesh-list
44679133|NCT01320254|Cisplatin|cisplatin|mesh-list
44679134|NCT01320254|Panitumumab|panitumumab|mesh-list
44679135|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44679136|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679137|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44679138|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
44679139|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679140|NCT01320254|Antiviral Agents|antiviral agents|mesh-ancestor
44679141|NCT01320254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679142|NCT01320254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679143|NCT01320254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679144|NCT01320254|Immunologic Factors|immunologic factors|mesh-ancestor
44679145|NCT01320254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679146|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679147|NCT01320397|Losartan|losartan|mesh-list
44679148|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44679149|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44679150|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44679151|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44679152|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679153|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44679154|NCT01320436|Curcumin|curcumin|mesh-list
44679155|NCT01320436|Mesalamine|mesalamine|mesh-list
44679156|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679157|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679158|NCT01320436|Analgesics|analgesics|mesh-ancestor
44679159|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
44679160|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679161|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679162|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679163|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679164|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679165|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679166|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679167|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
44679168|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44679169|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679170|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
44679171|NCT01320449|Hematinics|hematinics|mesh-ancestor
44679172|NCT01320475|Sufentanil|sufentanil|mesh-list
44679173|NCT01320475|Ketamine|ketamine|mesh-list
44679174|NCT01320475|Analgesics|analgesics|mesh-ancestor
44679175|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
44679176|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679177|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679178|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44679179|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44679180|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
44679181|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
44679182|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679183|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44679184|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44679185|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679186|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679187|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44679188|NCT01320475|Narcotics|narcotics|mesh-ancestor
44679189|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44679190|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44679191|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679192|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44679193|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679194|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679195|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44679196|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
44679197|NCT01320514|Coagulants|coagulants|mesh-ancestor
44679198|NCT01320579|Tacrolimus|tacrolimus|mesh-list
44679199|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679200|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
44679201|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679202|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44679203|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679204|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679205|NCT01320592|Paclitaxel|paclitaxel|mesh-list
44679206|NCT01320592|Palbociclib|palbociclib|mesh-list
44679207|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44679208|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679209|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
44679210|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
44679211|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
44679212|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679213|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44679214|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679215|NCT01320709|Piroxicam|piroxicam|mesh-list
44679216|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679217|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679218|NCT01320709|Analgesics|analgesics|mesh-ancestor
44679219|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
44679220|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679222|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679223|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679224|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44679225|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679226|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679228|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44679229|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679230|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
44679231|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
44679232|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44679233|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
44679234|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44679235|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679236|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44679237|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44679238|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44679239|NCT01320982|Aspirin|aspirin|mesh-list
44679240|NCT01320982|Minocycline|minocycline|mesh-list
44679241|NCT01320982|Pramipexole|pramipexole|mesh-list
44679242|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679243|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679244|NCT01320982|Analgesics|analgesics|mesh-ancestor
44679245|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
44679246|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679247|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679248|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679249|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679250|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44679251|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44679252|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679253|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679254|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44679255|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679256|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
44679257|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44679258|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679259|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
44679260|NCT01320982|Protective Agents|protective agents|mesh-ancestor
44679261|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44679262|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44679263|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
44679264|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
44679265|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679266|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
44679267|NCT01321021|Promethazine|promethazine|mesh-list
44679268|NCT01321021|Losartan|losartan|mesh-list
44679269|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44679270|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44679271|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44110332|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
44679272|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44679273|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679274|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44679275|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679276|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679277|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679278|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
44679279|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
44679280|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
44679281|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679282|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
44679283|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
44679284|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679285|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44679286|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
44679287|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
44679288|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679289|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44679290|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
44679291|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44679293|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44679294|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
44679295|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679297|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
44679298|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
44679299|NCT01321034|Vitamins|vitamins|mesh-ancestor
44679300|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
44679301|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679302|NCT01321047|Propofol|propofol|mesh-list
44679303|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679304|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679305|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679306|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44679307|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
44679308|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
44679309|NCT01321099|Ascorbic Acid|ascorbic acid|mesh-list
44679310|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44679311|NCT01321099|Vitamins|vitamins|mesh-ancestor
44679312|NCT01321099|Micronutrients|micronutrients|mesh-ancestor
44679313|NCT01321099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679314|NCT01321099|Antioxidants|antioxidants|mesh-ancestor
44679315|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679316|NCT01321099|Protective Agents|protective agents|mesh-ancestor
44679317|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44679318|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
44679319|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
44679320|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
44679321|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44679322|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
44679323|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44679324|NCT01321125|Povidone|povidone|mesh-list
44679325|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679326|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
44679327|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
44679328|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
44679329|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
44679330|NCT01321138|Morphine|morphine|mesh-list
44679331|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44679332|NCT01321138|Narcotics|narcotics|mesh-ancestor
44679333|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679334|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679335|NCT01321138|Analgesics|analgesics|mesh-ancestor
44679336|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
44679337|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230282|NCT04817033|Analgesics|analgesics|mesh-ancestor
44679338|NCT01321255|Aspirin|aspirin|mesh-list
44679339|NCT01321255|Ramipril|ramipril|mesh-list
44679340|NCT01321255|Simvastatin|simvastatin|mesh-list
44679341|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679342|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679343|NCT01321255|Analgesics|analgesics|mesh-ancestor
44679344|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
44679345|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679346|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679347|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679348|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679349|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44679350|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44679351|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679352|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679353|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44679354|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679355|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
44679356|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44679357|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44679358|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
44679359|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44679360|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44679361|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44679362|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
44679363|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44679364|NCT01321268|Beta Carotene|beta carotene|mesh-list
44679365|NCT01321268|Lycopene|lycopene|mesh-list
44679366|NCT01321268|Resveratrol|resveratrol|mesh-list
44679367|NCT01321268|Carotenoids|carotenoids|mesh-list
44679368|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
44679369|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679370|NCT01321268|Protective Agents|protective agents|mesh-ancestor
44679371|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679372|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679373|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679374|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679375|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44679376|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44679377|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679378|NCT01321268|Provitamins|provitamins|mesh-ancestor
44679379|NCT01321268|Vitamins|vitamins|mesh-ancestor
44679380|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
44679381|NCT01321346|Cytarabine|cytarabine|mesh-list
44679382|NCT01321346|Panobinostat|panobinostat|mesh-list
44679383|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44679384|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
44679385|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679386|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679387|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
44679388|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679389|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679390|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
44679391|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679392|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44679393|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679394|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
44679395|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679396|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
44679397|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44679398|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44679399|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679400|NCT01321489|Urological Agents|urological agents|mesh-ancestor
44679401|NCT01321502|Famciclovir|famciclovir|mesh-list
44679402|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
44679403|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679404|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44679405|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679406|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679407|NCT01321515|Famciclovir|famciclovir|mesh-list
44679408|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
44679409|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679410|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44679411|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230362|NCT04447040|Acetaminophen|acetaminophen|mesh-list
44679412|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679413|NCT01321567|Rabeprazole|rabeprazole|mesh-list
44679414|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44679415|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679416|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44679417|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679418|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679419|NCT01321671|Pregabalin|pregabalin|mesh-list
44679420|NCT01321671|Analgesics|analgesics|mesh-ancestor
44679421|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
44679422|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679423|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679424|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
44679425|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44679426|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679427|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679428|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679429|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44679430|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44679431|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679432|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679433|NCT01321775|Paclitaxel|paclitaxel|mesh-list
44679434|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
44679435|NCT01321775|Bevacizumab|bevacizumab|mesh-list
44679436|NCT01321775|Trastuzumab|trastuzumab|mesh-list
44679437|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44679438|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679439|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
44679440|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
44679441|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
44679442|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679443|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679444|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
44679445|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679446|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679447|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44679448|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
44679449|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44679450|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679451|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679452|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679453|NCT01321775|Growth Substances|growth substances|mesh-ancestor
44679454|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679455|NCT01321788|Tinzaparin|tinzaparin|mesh-list
44679456|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44679457|NCT01321788|Dalteparin|dalteparin|mesh-list
44679458|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
44679459|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44679460|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44679461|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679462|NCT01321801|Pregabalin|pregabalin|mesh-list
44679463|NCT01321801|Analgesics|analgesics|mesh-ancestor
44679464|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
44679465|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679466|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679467|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
44679468|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44679469|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679470|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679471|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679472|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44679473|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44679474|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679475|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679476|NCT01321827|Itraconazole|itraconazole|mesh-list
44679477|NCT01321827|Prednisolone|prednisolone|mesh-list
44679478|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
44679479|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679480|NCT01321827|Hormones|hormones|mesh-ancestor
44679481|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679482|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679483|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44679484|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679485|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
44679486|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230403|NCT04283578|Oxytocin|oxytocin|mesh-list
44679487|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44679488|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44679489|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679490|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679491|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44679492|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
44679493|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44679494|NCT01321905|Vitamin D|vitamin d|mesh-list
44679495|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
44679496|NCT01321905|Vitamins|vitamins|mesh-ancestor
44679497|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
44679498|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679499|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44679500|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679501|NCT01321931|Nicotine|nicotine|mesh-list
44679502|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44679503|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
44679504|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679505|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679506|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44679507|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44679508|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
44679509|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679510|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679511|NCT01321944|Nicotine|nicotine|mesh-list
44679512|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44679513|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
44679514|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679515|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679516|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44679517|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44679518|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44679519|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780800|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
44679520|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679521|NCT01321957|Bevacizumab|bevacizumab|mesh-list
44679522|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
44679523|NCT01321957|Irinotecan|irinotecan|mesh-list
44679524|NCT01321957|Fluorouracil|fluorouracil|mesh-list
44679525|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679526|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679527|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679528|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679529|NCT01321957|Growth Substances|growth substances|mesh-ancestor
44679530|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679531|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679532|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44679533|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44679534|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679535|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679536|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
44679537|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44679538|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679539|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
44679540|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
44679541|NCT01322061|Vitamins|vitamins|mesh-ancestor
44679542|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
44679543|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679544|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
44679545|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679546|NCT01322061|Protective Agents|protective agents|mesh-ancestor
44679547|NCT01322100|Bleomycin|bleomycin|mesh-list
44679548|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44679549|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679550|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
44679551|NCT01322139|Nabiximols|nabiximols|mesh-list
44679552|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44679553|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44679554|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679555|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44679556|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44679557|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679558|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679559|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679560|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44679561|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
44679562|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44679563|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679564|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44679565|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44679566|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44679567|NCT01322139|Analgesics|analgesics|mesh-ancestor
44679568|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
44679569|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679570|NCT01322152|Capecitabine|capecitabine|mesh-list
44679572|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44679573|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
44679574|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679575|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679576|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44679577|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44679578|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679579|NCT01322178|Cetuximab|cetuximab|mesh-list
44679580|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679581|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679582|NCT01322191|Morphine|morphine|mesh-list
44679583|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44679584|NCT01322191|Narcotics|narcotics|mesh-ancestor
44679585|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679586|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679587|NCT01322191|Analgesics|analgesics|mesh-ancestor
44679588|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
44679589|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679590|NCT01322204|Codeine|codeine|mesh-list
44679591|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44679592|NCT01322204|Narcotics|narcotics|mesh-ancestor
44679593|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679594|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679595|NCT01322204|Analgesics|analgesics|mesh-ancestor
44679596|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
44679597|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679598|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
44679599|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44679600|NCT01322282|Cetirizine|cetirizine|mesh-list
44679601|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44679602|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44679603|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44679604|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
44679605|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
44679606|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679607|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679608|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679609|NCT01322308|Pioglitazone|pioglitazone|mesh-list
44679610|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44679611|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679612|NCT01322438|Rifampin|rifampin|mesh-list
44679613|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44679614|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
44679615|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44679616|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679617|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
44679618|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44679619|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679620|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679621|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44679622|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44679623|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44679624|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44679625|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44679626|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44679627|NCT01322464|Nabiximols|nabiximols|mesh-list
44679628|NCT01322464|Analgesics|analgesics|mesh-ancestor
44679629|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
44679630|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679631|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679632|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44679633|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44679634|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679635|NCT01322711|Atorvastatin|atorvastatin|mesh-list
44679636|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44679637|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44679638|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
44679639|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679640|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44679641|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44679642|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679643|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
44679644|NCT01322776|Fludarabine|fludarabine|mesh-list
44679645|NCT01322776|Bortezomib|bortezomib|mesh-list
44679646|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679647|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
44679648|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679649|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679650|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44679651|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
44679652|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679653|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679654|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44679655|NCT01322867|Alprazolam|alprazolam|mesh-list
44679656|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679657|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679658|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679659|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44679660|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44679661|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679662|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
44679663|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
44679664|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679665|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230567|NCT03160638|Azithromycin|azithromycin|mesh-list
44679666|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
44679667|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44679668|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
44679669|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679670|NCT05460858|Expectorants|expectorants|mesh-ancestor
44679671|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
44679672|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44679673|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
44679674|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679675|NCT05460858|Protective Agents|protective agents|mesh-ancestor
44679676|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679677|NCT05460858|Antidotes|antidotes|mesh-ancestor
44679679|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679680|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679681|NCT05460416|Analgesics|analgesics|mesh-ancestor
44679682|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
44679683|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679684|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679685|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679686|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679687|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44679688|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44679689|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679690|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679691|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44679692|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679693|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
44679695|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
44679696|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679697|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
44679698|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679699|NCT05459974|Colchicine|colchicine|mesh-list
44679700|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
44679701|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679702|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
44679703|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
44679704|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
44679705|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679706|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679707|NCT05459857|Menthol|menthol|mesh-list
44679708|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
44679709|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
44679710|NCT05459649|Cyclosporine|cyclosporine|mesh-list
44679711|NCT05459649|Prednisone|prednisone|mesh-list
44679712|NCT05459649|Cyclosporins|cyclosporins|mesh-list
44679713|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679714|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
44679715|NCT05459649|Hormones|hormones|mesh-ancestor
44679716|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679717|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679718|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44679719|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679720|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679721|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679722|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679723|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
44679724|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
44679725|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679726|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
44679727|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679728|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44679729|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
44679730|NCT05459441|Pemetrexed|pemetrexed|mesh-list
44679731|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679732|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679733|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679734|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44679735|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44679736|NCT05384496|Nivolumab|nivolumab|mesh-list
44679737|NCT05384496|Ipilimumab|ipilimumab|mesh-list
44679738|NCT05384496|Axitinib|axitinib|mesh-list
44679739|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679740|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679741|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44230643|NCT02665143|Nintedanib|nintedanib|mesh-list
44679742|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679743|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44679744|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679745|NCT05359224|Clopidogrel|clopidogrel|mesh-list
44679746|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44679747|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44679748|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44679749|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44679750|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44679751|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
44679752|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679753|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679754|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679755|NCT05323214|Fentanyl|fentanyl|mesh-list
44679756|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
44679757|NCT05323214|Analgesics|analgesics|mesh-list
44679758|NCT05323214|Bupivacaine|bupivacaine|mesh-list
44679759|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
44679760|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
44679761|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679762|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679763|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
44679764|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679765|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679766|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679767|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44679768|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44679769|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44679770|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44679771|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679772|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679773|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44679774|NCT05323214|Narcotics|narcotics|mesh-ancestor
44679775|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44679776|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44679777|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
44679778|NCT05320107|Ketamine|ketamine|mesh-list
44679779|NCT05320107|Analgesics|analgesics|mesh-ancestor
44679780|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
44679781|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679782|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679783|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44679784|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44679785|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
44679786|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
44679787|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679788|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44679789|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44679790|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679791|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679792|NCT05275907|Amlodipine|amlodipine|mesh-list
44679793|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
44679794|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44679795|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44679796|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679797|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679798|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679799|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679800|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
44679801|NCT05275907|Diuretics|diuretics|mesh-ancestor
44679802|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
44679803|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44679804|NCT05274633|Ravulizumab|ravulizumab|mesh-list
44679805|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44679806|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679807|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
44679808|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679809|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
44679810|NCT05261516|Analgesics|analgesics|mesh-ancestor
44679811|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
44679812|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679813|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679814|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
44679815|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679816|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44679817|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
44679818|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44679819|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679820|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679821|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44679822|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
44679823|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44679825|NCT05200884|Carticaine|carticaine|mesh-list
44679826|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
44679827|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
44679828|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679829|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679830|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
44679831|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679832|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44679833|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44679834|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44679835|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44679836|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679837|NCT05163496|Psilocybin|psilocybin|mesh-list
44679838|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
44679839|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679840|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679841|NCT05070039|Antibodies|antibodies|mesh-list
44679842|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
44679843|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679844|NCT05069896|Mirikizumab|mirikizumab|mesh-list
44679845|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44679846|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679847|NCT05069896|Analgesics|analgesics|mesh-ancestor
44679848|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
44679849|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679850|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679851|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679852|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44679853|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44679854|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679855|NCT05050305|Dexamethasone|dexamethasone|mesh-list
44679856|NCT05050305|Pomalidomide|pomalidomide|mesh-list
44679857|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679858|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
44679859|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
44679860|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679861|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679862|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679863|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
44679864|NCT05050305|Hormones|hormones|mesh-ancestor
44679865|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679866|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44679867|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679868|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
44679869|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679870|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679871|NCT05050305|Growth Substances|growth substances|mesh-ancestor
44679872|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679873|NCT05010590|Denosumab|denosumab|mesh-list
44679874|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44679875|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679876|NCT04978259|Remdesivir|remdesivir|mesh-list
44679877|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
44679878|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679879|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
44679880|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44679881|NCT04948697|Bevacizumab|bevacizumab|mesh-list
44679882|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679883|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679884|NCT04948697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679885|NCT04948697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679886|NCT04948697|Growth Substances|growth substances|mesh-ancestor
44679887|NCT04948697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679888|NCT04948697|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679889|NCT04943341|Triamcinolone|triamcinolone|mesh-list
44679890|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44073444|NCT04843904|Rituximab|rituximab|mesh-list
44679891|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44679892|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44679893|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679894|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
44679895|NCT04943341|Hormones|hormones|mesh-ancestor
44679896|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679897|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679898|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44679899|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
44679900|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679901|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679902|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
44679903|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44679904|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
44679905|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679906|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
44679907|NCT04936763|Protective Agents|protective agents|mesh-ancestor
44679908|NCT04918147|Acetaminophen|acetaminophen|mesh-list
44679909|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
44679910|NCT04918147|Promethazine|promethazine|mesh-list
44679911|NCT04918147|Prednisone|prednisone|mesh-list
44679912|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
44679913|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44679914|NCT04918147|Elotuzumab|elotuzumab|mesh-list
44679915|NCT04918147|Famotidine|famotidine|mesh-list
44679916|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679917|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
44679918|NCT04918147|Hormones|hormones|mesh-ancestor
44679919|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679920|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679921|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44679922|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679923|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679924|NCT04918147|Analgesics|analgesics|mesh-ancestor
44679925|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
44679926|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679927|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
44679928|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
44679929|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
44679930|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679931|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44679932|NCT04918147|Protective Agents|protective agents|mesh-ancestor
44679933|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44679934|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44679935|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44679936|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
44679937|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
44679938|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44679939|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
44679940|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
44679941|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679942|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679943|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44679944|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
44679945|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
44679946|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44679947|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44679948|NCT04889547|Dexamethasone|dexamethasone|mesh-list
44679949|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
44679950|NCT04889547|BB 1101|bb 1101|mesh-list
44679951|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44679952|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
44679953|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
44679954|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679955|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679956|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44679957|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
44679958|NCT04889547|Hormones|hormones|mesh-ancestor
44679959|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679960|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44679961|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679962|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44679963|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44679964|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679965|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44073521|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
44679966|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679967|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679968|NCT04764630|Naloxone|naloxone|mesh-list
44679969|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44679970|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679971|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
44679972|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679973|NCT04734080|Dronabinol|dronabinol|mesh-list
44679974|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
44679975|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679976|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44679977|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44679978|NCT04734080|Analgesics|analgesics|mesh-ancestor
44679979|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
44679980|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44679981|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44679982|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44679983|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44679984|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44679985|NCT04734080|Hormones|hormones|mesh-ancestor
44679986|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44679987|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
44679988|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679989|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679990|NCT04681677|Bevacizumab|bevacizumab|mesh-list
44679991|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44679992|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44679993|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44679994|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44679995|NCT04681677|Growth Substances|growth substances|mesh-ancestor
44679996|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44679997|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44679998|NCT04650542|Paroxetine|paroxetine|mesh-list
44679999|NCT04650542|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44680000|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44680001|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680002|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680003|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680004|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
44680005|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680006|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44680007|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
44680008|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44680009|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44680010|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680011|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680012|NCT04621058|Vitamin D|vitamin d|mesh-list
44680013|NCT04621058|Vitamins|vitamins|mesh-list
44680014|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
44680015|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111080|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680016|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680017|NCT04609514|Nicotine|nicotine|mesh-list
44680018|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44680019|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
44680020|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680021|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680022|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44680023|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44680024|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
44680025|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680026|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680027|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
44680028|NCT04596033|Fludarabine|fludarabine|mesh-list
44680029|NCT04596033|Interleukin-2|interleukin-2|mesh-list
44680030|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680031|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
44680032|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680033|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680034|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44680035|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
44680036|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680037|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680038|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44680039|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680040|NCT04596033|Analgesics|analgesics|mesh-ancestor
44680041|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
44680042|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680043|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
44680044|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
44680045|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680046|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
44680047|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680048|NCT04543968|Protective Agents|protective agents|mesh-ancestor
44680049|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680050|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44680051|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44680052|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
44680053|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
44680054|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680055|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680056|NCT04330248|Carbamazepine|carbamazepine|mesh-list
44680057|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
44680058|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
44680059|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44680060|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680061|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680062|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44680063|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680064|NCT04330248|Analgesics|analgesics|mesh-ancestor
44680065|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
44680066|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680067|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44680068|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680069|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680070|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44680071|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44680072|NCT04296305|Hydromorphone|hydromorphone|mesh-list
44680073|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44680074|NCT04296305|Narcotics|narcotics|mesh-ancestor
44680075|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680076|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680077|NCT04296305|Analgesics|analgesics|mesh-ancestor
44680078|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
44680079|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680080|NCT04292457|Propofol|propofol|mesh-list
44680081|NCT04292457|Sevoflurane|sevoflurane|mesh-list
44680082|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44680083|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680084|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680085|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44680086|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
44680087|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
44680088|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44680089|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44231023|NCT00532727|Docetaxel|docetaxel|mesh-list
44680090|NCT04145258|Aspirin|aspirin|mesh-list
44680091|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44680092|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680093|NCT04145258|Analgesics|analgesics|mesh-ancestor
44680094|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
44680095|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680096|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680097|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680098|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680099|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44680100|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44680101|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680102|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44680103|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44680104|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680105|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
44680106|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
44680107|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
44680108|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44680109|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44680110|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680111|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680112|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680113|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680114|NCT04116112|Labetalol|labetalol|mesh-list
44680115|NCT04116112|Hydralazine|hydralazine|mesh-list
44680116|NCT04116112|Nicardipine|nicardipine|mesh-list
44680117|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44680118|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44680119|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
44680120|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680121|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680122|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680123|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44680124|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
44680125|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
44680126|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680127|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44680128|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44680129|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
44680130|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44680131|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680132|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44680133|NCT04003285|Pregnanolone|pregnanolone|mesh-list
44680134|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
44680135|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680136|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680137|NCT03919617|Volagidemab|volagidemab|mesh-list
44680138|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44680139|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680140|NCT03917446|Propofol|propofol|mesh-list
44680141|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44680142|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680143|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680144|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44680145|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
44680146|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
44680147|NCT03891524|Enoxaparin|enoxaparin|mesh-list
44680148|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
44680149|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44680150|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44680151|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680152|NCT03777982|Prednisone|prednisone|mesh-list
44680153|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
44680154|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680155|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
44680156|NCT03777982|Hormones|hormones|mesh-ancestor
44680157|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680158|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680159|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680160|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680161|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44680162|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680163|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680164|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
44680165|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680166|NCT03772314|Modafinil|modafinil|mesh-list
44680167|NCT03772314|Amphetamine|amphetamine|mesh-list
44680168|NCT03772314|Adderall|adderall|mesh-list
44680169|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
44680170|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44680171|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680172|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44680173|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44680174|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44680175|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680176|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
44680177|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
44680178|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680179|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
44680180|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680181|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
44680182|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44680183|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44680184|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680185|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44680186|NCT03691376|Aldesleukin|aldesleukin|mesh-list
44680187|NCT03691376|Melphalan|melphalan|mesh-list
44680188|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
44680189|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44680190|NCT03691376|Interleukin-2|interleukin-2|mesh-list
44680191|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44680192|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
44680193|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680194|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680195|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44680196|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680197|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
44680198|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680199|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680200|NCT03691376|Analgesics|analgesics|mesh-ancestor
44680201|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
44680202|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680203|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44680204|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44680205|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
44680206|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680207|NCT03613181|Paclitaxel|paclitaxel|mesh-list
44680208|NCT03613181|Capecitabine|capecitabine|mesh-list
44680209|NCT03613181|Methotrexate|methotrexate|mesh-list
44680210|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680211|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680212|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680213|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680214|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680215|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680216|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680217|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
44680218|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44680219|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
44680220|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44680221|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680222|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111253|NCT00087542|Pimavanserin|pimavanserin|mesh-list
44680223|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680224|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44680225|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680226|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
44680227|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680228|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44680229|NCT03611010|Atorvastatin|atorvastatin|mesh-list
44680230|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44680231|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44680232|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
44680233|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680234|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44680235|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44680236|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680237|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
44680238|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
44231238|NCT00533611|Niacin|niacin|mesh-list
44680239|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680240|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680241|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44680243|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680244|NCT03476798|Bevacizumab|bevacizumab|mesh-list
44680245|NCT03476798|Rucaparib|rucaparib|mesh-list
44680246|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680247|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680248|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44680249|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44680250|NCT03476798|Growth Substances|growth substances|mesh-ancestor
44680251|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680252|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
44680253|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44680254|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680255|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680256|NCT03414034|Prednisone|prednisone|mesh-list
44680257|NCT03414034|Onvansertib|onvansertib|mesh-list
44680258|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680259|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
44680260|NCT03414034|Hormones|hormones|mesh-ancestor
44073820|NCT04439188|GSK2636771|gsk2636771|mesh-list
44680261|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680262|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680263|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680264|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680265|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44680266|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680267|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680269|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680270|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680271|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680272|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680273|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680274|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680275|NCT03300947|Lorazepam|lorazepam|mesh-list
44680276|NCT03300947|Psilocybin|psilocybin|mesh-list
44680277|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
44680278|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680279|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44680280|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
44680281|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
44680282|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
44680283|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680284|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680285|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44680286|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680287|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44680288|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44680289|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
44680290|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
44680291|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680292|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680293|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
44680294|NCT03263767|Fludarabine|fludarabine|mesh-list
44680295|NCT03263767|Clofarabine|clofarabine|mesh-list
44680296|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
44680297|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680298|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
44680299|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680300|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680301|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44680302|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
44680303|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680304|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680305|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44680306|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680307|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
44680308|NCT03251326|Propranolol|propranolol|mesh-list
44680309|NCT03251326|Nabilone|nabilone|mesh-list
44680310|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44680311|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44680312|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44680313|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680314|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680315|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680316|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44680317|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44680318|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
44680319|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
44680320|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
44680321|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680322|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680323|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44680324|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44680325|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680326|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44680327|NCT03117049|Paclitaxel|paclitaxel|mesh-list
44680328|NCT03117049|Bevacizumab|bevacizumab|mesh-list
44680329|NCT03117049|Carboplatin|carboplatin|mesh-list
44680330|NCT03117049|Nivolumab|nivolumab|mesh-list
44680331|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680332|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680333|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680334|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680335|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073863|NCT04310709|Nivolumab|nivolumab|mesh-list
44680336|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680337|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680338|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44680339|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44680340|NCT03117049|Growth Substances|growth substances|mesh-ancestor
44680341|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680342|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44680343|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44680344|NCT02936622|Paclitaxel|paclitaxel|mesh-list
44680345|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44680346|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680347|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680348|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680349|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680350|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680351|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680352|NCT02663622|Methotrexate|methotrexate|mesh-list
44680353|NCT02663622|Tacrolimus|tacrolimus|mesh-list
44680354|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44680355|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
44680356|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44680357|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680358|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680359|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
44680360|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680361|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680362|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44680363|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680364|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44680365|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680366|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
44680367|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680368|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44680369|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44680370|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
44680371|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680372|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680373|NCT02567825|Amoxicillin|amoxicillin|mesh-list
44680374|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
44680375|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
44680376|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
44680377|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44680378|NCT02567825|Ofloxacin|ofloxacin|mesh-list
44680379|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680380|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680381|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44680382|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680383|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680384|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44680385|NCT02567825|Renal Agents|renal agents|mesh-ancestor
44680386|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680387|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231317|NCT00533936|Paclitaxel|paclitaxel|mesh-list
44680388|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680389|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44680390|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680392|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680393|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680394|NCT02201108|Teriflunomide|teriflunomide|mesh-list
44680395|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44680396|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680397|NCT02201108|Analgesics|analgesics|mesh-ancestor
44680398|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
44680399|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680400|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680401|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680402|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680403|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680404|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
44680405|NCT02150967|Infigratinib|infigratinib|mesh-list
44680406|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680407|NCT01759459|Lidocaine|lidocaine|mesh-list
44073902|NCT04236414|Olaparib|olaparib|mesh-list
44680409|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
44680410|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680411|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680412|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
44680413|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680414|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44680415|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44680416|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44680417|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680418|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680419|NCT01323062|Bavituximab|bavituximab|mesh-list
44680420|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680421|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680422|NCT01323101|Doxycycline|doxycycline|mesh-list
44680423|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680424|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680425|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
44680426|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44680427|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44680428|NCT01323218|Vitamin D|vitamin d|mesh-list
44680429|NCT01323218|Vitamins|vitamins|mesh-ancestor
44680430|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
44680431|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680432|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680433|NCT01323244|Simeprevir|simeprevir|mesh-list
44680434|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
44680435|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680436|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
44680437|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680438|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680439|NCT01323257|Ritonavir|ritonavir|mesh-list
44680440|NCT01323257|Darunavir|darunavir|mesh-list
44680441|NCT01323257|Erythromycin|erythromycin|mesh-list
44680442|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
44680443|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44680444|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
44680445|NCT01323257|Simeprevir|simeprevir|mesh-list
44680446|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44680447|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44680448|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
44680449|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680450|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680451|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44680452|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44680453|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
44680454|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680455|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44680456|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680457|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680458|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680459|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44680460|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44680461|NCT01323296|Hematinics|hematinics|mesh-ancestor
44680462|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44680463|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44680464|NCT01323335|Rasburicase|rasburicase|mesh-list
44680465|NCT01323335|Uric Acid|uric acid|mesh-list
44680466|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
44680467|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680468|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
44680469|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680470|NCT01323335|Protective Agents|protective agents|mesh-ancestor
44680471|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680472|NCT01323374|Carbidopa|carbidopa|mesh-list
44680473|NCT01323374|Droxidopa|droxidopa|mesh-list
44680474|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44680475|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44680476|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
44680477|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680478|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680479|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680480|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44680481|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680482|NCT01323452|Entecavir|entecavir|mesh-list
44680483|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
44680484|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680485|NCT01323465|Rifampin|rifampin|mesh-list
44680486|NCT01323465|Ketoconazole|ketoconazole|mesh-list
44680487|NCT01323465|Nabiximols|nabiximols|mesh-list
44680488|NCT01323465|Omeprazole|omeprazole|mesh-list
44680489|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44680490|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680491|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44680492|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680493|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680494|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44680495|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
44680496|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680497|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680498|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
44680499|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44680500|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44680501|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44680502|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44680503|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44680504|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44680505|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44680506|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
44680507|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44680508|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680509|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44680510|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44680511|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111526|NCT00088504|Ribavirin|ribavirin|mesh-list
44680512|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680513|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44680514|NCT01323465|Analgesics|analgesics|mesh-ancestor
44680515|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
44680516|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680517|NCT01323491|Nicotine|nicotine|mesh-list
44680518|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44680519|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
44680520|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680521|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680522|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44680523|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44680524|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
44680525|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680526|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680527|NCT01323569|Nabiximols|nabiximols|mesh-list
44680528|NCT01323569|Dronabinol|dronabinol|mesh-list
44680529|NCT01323569|Analgesics|analgesics|mesh-ancestor
44680530|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
44680531|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680532|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680533|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
44680534|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44680535|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44680536|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44680537|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44680538|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680539|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680540|NCT01323569|Hormones|hormones|mesh-ancestor
44680541|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680542|NCT01323608|Vitamin D|vitamin d|mesh-list
44680543|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
44680544|NCT01323608|Vitamins|vitamins|mesh-ancestor
44680545|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
44680546|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680547|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680548|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44680549|NCT01323712|Vitamin D|vitamin d|mesh-list
44680550|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
44680551|NCT01323712|Vitamins|vitamins|mesh-ancestor
44680552|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
44680553|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680554|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680555|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44680556|NCT01323751|Ricolinostat|ricolinostat|mesh-list
44680557|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680558|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44680559|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680560|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680561|NCT01324063|Cytarabine|cytarabine|mesh-list
44680562|NCT01324063|Daunorubicin|daunorubicin|mesh-list
44680563|NCT01324063|Amsacrine|amsacrine|mesh-list
44680564|NCT01324063|Sargramostim|sargramostim|mesh-list
44680565|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680566|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
44680567|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680568|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680569|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
44680570|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680571|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680572|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
44680573|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680574|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44680575|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680576|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44680577|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680578|NCT01324076|Doxorubicin|doxorubicin|mesh-list
44680579|NCT01324076|Sorafenib|sorafenib|mesh-list
44680580|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44680581|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680582|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680583|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44680584|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680585|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680586|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44680587|NCT01324089|Resveratrol|resveratrol|mesh-list
44680588|NCT01324089|Piperine|piperine|mesh-list
44680589|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
44680590|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680591|NCT01324089|Protective Agents|protective agents|mesh-ancestor
44680592|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680593|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680594|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44680595|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44680596|NCT01324115|Nitroarginine|nitroarginine|mesh-list
44680597|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680598|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680599|NCT01324180|Metformin|metformin|mesh-list
44680600|NCT01324180|Dexamethasone|dexamethasone|mesh-list
44680601|NCT01324180|Doxorubicin|doxorubicin|mesh-list
44680602|NCT01324180|Vincristine|vincristine|mesh-list
44680603|NCT01324180|Asparaginase|asparaginase|mesh-list
44680604|NCT01324180|Pegaspargase|pegaspargase|mesh-list
44680605|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680606|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
44680607|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
44680608|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680609|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680610|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680611|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
44680612|NCT01324180|Hormones|hormones|mesh-ancestor
44680613|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680614|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680615|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680616|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44680617|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44680618|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680619|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44680620|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680621|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680622|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680623|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680624|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680625|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680626|NCT01324245|Fenoldopam|fenoldopam|mesh-list
44680627|NCT01324245|Enalaprilat|enalaprilat|mesh-list
44680628|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44680629|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
44680630|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
44680631|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
44680632|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680633|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680634|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680635|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44680636|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
44680637|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680638|NCT01324258|Gemcitabine|gemcitabine|mesh-list
44680639|NCT01324258|Trametinib|trametinib|mesh-list
44680640|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680641|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
44680642|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680643|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680644|NCT01324258|Antiviral Agents|antiviral agents|mesh-ancestor
44231563|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680645|NCT01324258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680647|NCT01324258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680648|NCT01324258|Immunologic Factors|immunologic factors|mesh-ancestor
44680649|NCT01324258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680650|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44680651|NCT01324284|Lubiprostone|lubiprostone|mesh-list
44680652|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44680653|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44680654|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680655|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
44680656|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
44680657|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680658|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680659|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111679|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
44680660|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680661|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
44680662|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680663|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44680664|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680665|NCT01324492|Everolimus|everolimus|mesh-list
44680666|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680667|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680668|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
44680669|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680670|NCT01324544|Buprenorphine|buprenorphine|mesh-list
44680671|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44680672|NCT01324544|Narcotics|narcotics|mesh-ancestor
44680673|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680674|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680675|NCT01324544|Analgesics|analgesics|mesh-ancestor
44680676|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
44680677|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680678|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44680679|NCT01324583|Prednisolone|prednisolone|mesh-list
44680680|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680681|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
44680682|NCT01324583|Hormones|hormones|mesh-ancestor
44680683|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680684|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680685|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680686|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680687|NCT01324596|Prednisolone|prednisolone|mesh-list
44680688|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44680689|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
44680690|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44680691|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
44680692|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
44680693|NCT01324596|Rituximab|rituximab|mesh-list
44680694|NCT01324596|Doxorubicin|doxorubicin|mesh-list
44680695|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44680696|NCT01324596|Vincristine|vincristine|mesh-list
44680697|NCT01324596|Bortezomib|bortezomib|mesh-list
44680698|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44680699|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
44680700|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680701|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
44680702|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680703|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44680704|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44680705|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
44680706|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680707|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680708|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44680709|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680710|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44680711|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680712|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44680713|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680714|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44680715|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680716|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680717|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680718|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680719|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
44680720|NCT01324596|Hormones|hormones|mesh-ancestor
44680721|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680722|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680724|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
44680725|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680726|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680727|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44680728|NCT01324596|Protective Agents|protective agents|mesh-ancestor
44680729|NCT01324635|Panobinostat|panobinostat|mesh-list
44680730|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44680731|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680732|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680733|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680734|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44680735|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
44680736|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680737|NCT01324752|Losartan|losartan|mesh-list
44680738|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44680739|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44680740|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44680741|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44680742|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680743|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44680744|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44680745|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
44680746|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680747|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680748|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
44680749|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680750|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44680751|NCT01324960|Aldesleukin|aldesleukin|mesh-list
44680752|NCT01324960|Azacitidine|azacitidine|mesh-list
44680753|NCT01324960|Histamine|histamine|mesh-list
44680754|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680755|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
44680756|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680757|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680758|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680759|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680760|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44680761|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44680762|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
44680763|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680764|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
44680765|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
44680766|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680767|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
44680768|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44680769|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44680770|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
44680771|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680772|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44680773|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44680774|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680775|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680776|NCT01325168|Oxytocin|oxytocin|mesh-list
44680777|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
44680778|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44680779|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680780|NCT01325194|Cytarabine|cytarabine|mesh-list
44680781|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680782|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
44680783|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680784|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680785|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
44680786|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680787|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680788|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
44680789|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680790|NCT01325220|Baclofen|baclofen|mesh-list
44680791|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44680792|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680793|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44680794|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680795|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44680796|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
44680797|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
44680798|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111751|NCT00089193|Sargramostim|sargramostim|mesh-list
44680799|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680800|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44680801|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44680802|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680803|NCT01325298|Riboflavin|riboflavin|mesh-list
44680804|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
44680805|NCT01325298|Vitamins|vitamins|mesh-ancestor
44680806|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
44680807|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680808|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44680809|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
44680810|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
44680811|NCT01325415|Naloxegol|naloxegol|mesh-list
44680812|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680813|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680814|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44680815|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44680816|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680817|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680818|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680819|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680820|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44680821|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
44680822|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680823|NCT01325558|Gemcitabine|gemcitabine|mesh-list
44680824|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44680825|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
44680826|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680827|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680828|NCT01325558|Antiviral Agents|antiviral agents|mesh-ancestor
44680829|NCT01325558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680830|NCT01325558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680831|NCT01325558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680832|NCT01325558|Immunologic Factors|immunologic factors|mesh-ancestor
44680833|NCT01325558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680834|NCT01325571|Tacrolimus|tacrolimus|mesh-list
44680835|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680836|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
44680837|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680838|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44680839|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680840|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680841|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
44680842|NCT01325610|Vitamin D|vitamin d|mesh-list
44680843|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44680844|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680845|NCT01325610|Vitamins|vitamins|mesh-ancestor
44680846|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
44680847|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680848|NCT01325779|Heparin|heparin|mesh-list
44680849|NCT01325779|Enoxaparin|enoxaparin|mesh-list
44680850|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
44680851|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44680852|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44680853|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680854|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44680855|NCT01325818|Pravastatin|pravastatin|mesh-list
44680856|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44680857|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44680858|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
44680859|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680860|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44680861|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44680862|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680863|NCT01325844|Anesthetics|anesthetics|mesh-list
44680864|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680865|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680866|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44680867|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
44680868|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680869|NCT01325935|Clopidogrel|clopidogrel|mesh-list
44680870|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44111817|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
44680871|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44680872|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44680873|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44680874|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
44680875|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680876|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680877|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680878|NCT01325987|Vitamin D|vitamin d|mesh-list
44680879|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
44680880|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
44680881|NCT01325987|Vitamins|vitamins|mesh-list
44680882|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
44680883|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680884|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680885|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44680886|NCT01326039|Bupivacaine|bupivacaine|mesh-list
44680887|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
44680888|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
44680889|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680890|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680891|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
44680892|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680893|NCT01326078|Propofol|propofol|mesh-list
44680894|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44680895|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680896|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680897|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44680898|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
44680899|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
44680900|NCT01326117|Tadalafil|tadalafil|mesh-list
44680901|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
44680902|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44680903|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44680904|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680905|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680906|NCT01326117|Urological Agents|urological agents|mesh-ancestor
44680907|NCT01326221|Tenofovir|tenofovir|mesh-list
44680908|NCT01326221|Emtricitabine|emtricitabine|mesh-list
44680909|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
44680910|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680911|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44680912|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44680913|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680914|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680915|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44680916|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44680917|NCT01326312|Leuprolide|leuprolide|mesh-list
44680918|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44680919|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
44680920|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44680921|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680922|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680923|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680924|NCT01326325|Ketamine|ketamine|mesh-list
44680925|NCT01326325|Analgesics|analgesics|mesh-ancestor
44680926|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
44680927|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680928|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680929|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44680930|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44680931|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
44680932|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
44680933|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44680934|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44680935|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44680936|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44680937|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680938|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
44680939|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44680940|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680941|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
44680942|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44680943|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44680944|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680945|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
44680946|NCT01326403|Coagulants|coagulants|mesh-ancestor
44680947|NCT01326442|Vitamin D|vitamin d|mesh-list
44680948|NCT01326442|Vitamins|vitamins|mesh-ancestor
44680949|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
44680950|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680951|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44680952|NCT01326468|Sirolimus|sirolimus|mesh-list
44680953|NCT01326468|Cisplatin|cisplatin|mesh-list
44680954|NCT01326468|Cetuximab|cetuximab|mesh-list
44680955|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680956|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680957|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44680958|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44680959|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44680960|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
44680961|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44680962|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
44680963|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680964|NCT01326494|Prednisone|prednisone|mesh-list
44680965|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680966|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
44680967|NCT01326494|Hormones|hormones|mesh-ancestor
44680968|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680969|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680970|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680971|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680972|NCT01326559|Cisplatin|cisplatin|mesh-list
44680973|NCT01326559|Docetaxel|docetaxel|mesh-list
44680974|NCT01326559|Cetuximab|cetuximab|mesh-list
44680975|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231932|NCT00537602|Miglustat|miglustat|mesh-list
44680976|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
44680977|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
44680978|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
44680979|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680980|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44680982|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
44680983|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44680984|NCT01326585|BB 1101|bb 1101|mesh-list
44680985|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44680986|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
44680987|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
44680988|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44680989|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44680990|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44680991|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
44680992|NCT01326585|Hormones|hormones|mesh-ancestor
44680993|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44680994|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44680995|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44680996|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44680997|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44680998|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44680999|NCT01326611|Clarithromycin|clarithromycin|mesh-list
44681000|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681001|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681002|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44681003|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681004|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681005|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44681006|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44681007|NCT01326650|Vitamin D|vitamin d|mesh-list
44681008|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
44681009|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
44681010|NCT01326650|Vitamins|vitamins|mesh-list
44681011|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44681012|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
44681013|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681014|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44681015|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44681016|NCT01326754|Artesunate|artesunate|mesh-list
44681017|NCT01326754|Lumefantrine|lumefantrine|mesh-list
44681018|NCT01326754|Artemether|artemether|mesh-list
44681019|NCT01326754|Piperaquine|piperaquine|mesh-list
44681020|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44681021|NCT01326754|Amodiaquine|amodiaquine|mesh-list
44681022|NCT01326754|Artenimol|artenimol|mesh-list
44681023|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
44681024|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
44681025|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44681026|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681027|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681028|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681029|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
44681030|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
44681031|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44681032|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
44681033|NCT01326767|Paclitaxel|paclitaxel|mesh-list
44681034|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44681035|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44681036|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681037|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
44681038|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
44681039|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
44681040|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681041|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44681042|NCT01326858|Ketotifen|ketotifen|mesh-list
44681043|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44681044|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44681045|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44681046|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44681047|NCT01326858|Analgesics|analgesics|mesh-ancestor
44681048|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
44681049|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681050|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681051|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681052|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681053|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44681054|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44681055|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44681056|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
44681057|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
44681058|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681059|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681060|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
44681061|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
44681062|NCT01326871|Gemcitabine|gemcitabine|mesh-list
44681063|NCT01326871|Cisplatin|cisplatin|mesh-list
44681064|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681065|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44681066|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
44681067|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681068|NCT01326871|Antiviral Agents|antiviral agents|mesh-ancestor
44681069|NCT01326871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681070|NCT01326871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681071|NCT01326871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681072|NCT01326871|Immunologic Factors|immunologic factors|mesh-ancestor
44681073|NCT01326871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681074|NCT01326988|Anesthetics|anesthetics|mesh-list
44681075|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681076|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681077|NCT01327027|Vasopressins|vasopressins|mesh-list
44681078|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
44681079|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
44681080|NCT01327027|Coagulants|coagulants|mesh-ancestor
44681081|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44681082|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44681083|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
44681084|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681087|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681088|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681089|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44681090|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681091|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681092|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681093|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681094|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44681095|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44681096|NCT01327079|Methadone|methadone|mesh-list
44681097|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44681098|NCT01327079|Narcotics|narcotics|mesh-ancestor
44681099|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681100|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681101|NCT01327079|Analgesics|analgesics|mesh-ancestor
44681102|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
44681103|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681104|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
44681105|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681106|NCT01327118|Dinoprost|dinoprost|mesh-list
44681107|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
44681108|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44681109|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
44681110|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44681111|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681112|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
44681113|NCT01327144|Acyclovir|acyclovir|mesh-list
44681114|NCT01327144|Famciclovir|famciclovir|mesh-list
44681115|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
44681116|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681117|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44681118|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681119|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681120|NCT01327222|Bevacizumab|bevacizumab|mesh-list
44681121|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681122|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681123|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44681124|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44681125|NCT01327222|Growth Substances|growth substances|mesh-ancestor
44681126|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681127|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44681128|NCT01327235|Cisplatin|cisplatin|mesh-list
44681129|NCT01327235|Endostar protein|endostar protein|mesh-list
44681130|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681131|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44681132|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44681133|NCT01327235|Growth Substances|growth substances|mesh-ancestor
44681134|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681135|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44681136|NCT01327261|Levodopa|levodopa|mesh-list
44681137|NCT01327261|Benserazide|benserazide|mesh-list
44681138|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44681139|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44681140|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
44681141|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681142|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681143|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681144|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681145|NCT01327326|Naltrexone|naltrexone|mesh-list
44681146|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44681147|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44681148|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681149|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
44681150|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681151|NCT01327469|Albendazole|albendazole|mesh-list
44681152|NCT01327469|Mebendazole|mebendazole|mesh-list
44681153|NCT01327469|Piperazine|piperazine|mesh-list
44681154|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
44681155|NCT01327469|Pyrantel|pyrantel|mesh-list
44681156|NCT01327469|Oxantel|oxantel|mesh-list
44681157|NCT01327469|DMP 777|dmp 777|mesh-list
44681158|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
44681159|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681160|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681161|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
44681162|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44681163|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44681164|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
44681165|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
44681166|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
44681167|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681168|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681169|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
44681170|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681171|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44681172|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44681173|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44681174|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681175|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681176|NCT01327521|Gemcitabine|gemcitabine|mesh-list
44681177|NCT01327521|Cisplatin|cisplatin|mesh-list
44681178|NCT01327521|Doxorubicin|doxorubicin|mesh-list
44681179|NCT01327521|Fluorouracil|fluorouracil|mesh-list
44681180|NCT01327521|Epirubicin|epirubicin|mesh-list
44681181|NCT01327521|Mitomycins|mitomycins|mesh-list
44681182|NCT01327521|Mitomycin|mitomycin|mesh-list
44681183|NCT01327521|Maleic acid|maleic acid|mesh-list
44681184|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681185|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44681186|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
44681187|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681188|NCT01327521|Antiviral Agents|antiviral agents|mesh-ancestor
44681189|NCT01327521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681190|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681191|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681192|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
44681193|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681194|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681195|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44681196|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681197|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
44681198|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44681199|NCT01327534|Clopidogrel|clopidogrel|mesh-list
44681200|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44681201|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44681202|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44681203|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44681204|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44681205|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
44681206|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681207|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681208|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681209|NCT01327625|Azithromycin|azithromycin|mesh-list
44681210|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681211|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681212|NCT01327729|Interferons|interferons|mesh-list
44681213|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
44681214|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
44681215|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44681216|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681217|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
44681218|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681219|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
44681220|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681221|NCT01327755|Selenium|selenium|mesh-list
44681222|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
44681223|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681224|NCT01327755|Protective Agents|protective agents|mesh-ancestor
44681225|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681226|NCT01327755|Trace Elements|trace elements|mesh-ancestor
44681227|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
44681228|NCT01327859|Donepezil|donepezil|mesh-list
44681229|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44681230|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681231|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681232|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
44112191|NCT00091117|Bortezomib|bortezomib|mesh-list
44681233|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681234|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681235|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
44681236|NCT01328015|Oxybutynin|oxybutynin|mesh-list
44681237|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44681238|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
44681239|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
44681240|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681241|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681242|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44681243|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
44681244|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681245|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681246|NCT01328015|Urological Agents|urological agents|mesh-ancestor
44681247|NCT01328106|Trametinib|trametinib|mesh-list
44681248|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681249|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44681250|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681251|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681252|NCT01328145|Aspirin|aspirin|mesh-list
44681253|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44681254|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44681255|NCT01328145|Analgesics|analgesics|mesh-ancestor
44681256|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
44681257|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681258|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681259|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681260|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681261|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44681262|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44681263|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681264|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44681265|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44681266|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681267|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
44681268|NCT01328171|Folic Acid|folic acid|mesh-list
44681269|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
44681270|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
44681271|NCT01328171|Irinotecan|irinotecan|mesh-list
44681272|NCT01328171|Panitumumab|panitumumab|mesh-list
44681273|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681274|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44681275|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681276|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681277|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681278|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681279|NCT01328171|Hematinics|hematinics|mesh-ancestor
44681280|NCT01328171|Vitamins|vitamins|mesh-ancestor
44681281|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
44681282|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681283|NCT01328223|Sorafenib|sorafenib|mesh-list
44681284|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681285|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44681286|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681287|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681288|NCT01328236|Dexamethasone|dexamethasone|mesh-list
44681289|NCT01328236|Doxorubicin|doxorubicin|mesh-list
44681290|NCT01328236|Bortezomib|bortezomib|mesh-list
44681291|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681292|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
44681293|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
44681294|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681295|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681296|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681297|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
44681298|NCT01328236|Hormones|hormones|mesh-ancestor
44681299|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681300|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681301|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681302|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681303|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44681304|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681305|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681306|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681307|NCT01328301|Methamphetamine|methamphetamine|mesh-list
44681308|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44681309|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681310|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
44681311|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
44681312|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681313|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
44232297|NCT00539149|Amoxicillin|amoxicillin|mesh-list
44681314|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681315|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681316|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
44681317|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44681318|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44681319|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681320|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44681321|NCT01328340|Methamphetamine|methamphetamine|mesh-list
44681322|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44681323|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681324|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
44681325|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
44681326|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681327|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
44681328|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681329|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681330|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44681331|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44681332|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44681333|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681334|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44681335|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
44681336|NCT01328392|Lansoprazole|lansoprazole|mesh-list
44681337|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44681338|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681339|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44681340|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681341|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681342|NCT01328457|Paromomycin|paromomycin|mesh-list
44681344|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681345|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681346|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44681347|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681348|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44681349|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681350|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681351|NCT01328470|Cilostazol|cilostazol|mesh-list
44681352|NCT01328470|Clopidogrel|clopidogrel|mesh-list
44681353|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44681354|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44681355|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44681356|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44681357|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
44681358|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681359|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681360|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681361|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44681362|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
44681363|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681364|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44681365|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681366|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44681367|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44681368|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44681369|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44681370|NCT01328470|Protective Agents|protective agents|mesh-ancestor
44681371|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44681372|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44681373|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681374|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
44681375|NCT01328652|Lansoprazole|lansoprazole|mesh-list
44681376|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44681377|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681378|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681379|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44681380|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681381|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
44681382|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44681383|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681384|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681385|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44681386|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44681387|NCT01328821|Protective Agents|protective agents|mesh-ancestor
44681388|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681389|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
44681390|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44681391|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
44681393|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681394|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
44681395|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681396|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44681397|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681398|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681399|NCT01328886|Omalizumab|omalizumab|mesh-list
44681400|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44681401|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44681402|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681403|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
44681404|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681405|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681406|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
44681407|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
44681408|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44681409|NCT01328990|Amodiaquine|amodiaquine|mesh-list
44681410|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
44681411|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44681412|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681413|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681414|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44681415|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681416|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681417|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44681418|NCT01328990|Renal Agents|renal agents|mesh-ancestor
44681419|NCT01329016|Metformin|metformin|mesh-list
44681420|NCT01329016|Glyburide|glyburide|mesh-list
44681421|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44681422|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681423|NCT01329042|Citric Acid|citric acid|mesh-list
44681424|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
44681425|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
44681426|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44681427|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
44681428|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
44681429|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681430|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
44681431|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681432|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681433|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44681434|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681435|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681436|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112347|NCT00091715|Bosentan|bosentan|mesh-list
44681437|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681438|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44681439|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44681440|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681441|NCT01329289|Dexamethasone|dexamethasone|mesh-list
44681442|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
44681443|NCT01329289|Bortezomib|bortezomib|mesh-list
44681444|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44681445|NCT01329289|Pasireotide|pasireotide|mesh-list
44681446|NCT01329289|BB 1101|bb 1101|mesh-list
44681447|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681448|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
44681449|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
44681450|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681451|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681452|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681453|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
44681454|NCT01329289|Hormones|hormones|mesh-ancestor
44681455|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681456|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681457|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681458|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
44681459|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681460|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681461|NCT01329367|Antioxidants|antioxidants|mesh-list
44681462|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681463|NCT01329367|Protective Agents|protective agents|mesh-ancestor
44681464|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681465|NCT01329406|Milnacipran|milnacipran|mesh-list
44681466|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
44681467|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44681468|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44681469|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681470|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681471|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681472|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681473|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44681474|NCT01329406|Analgesics|analgesics|mesh-ancestor
44681475|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
44681476|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681477|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
44681478|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44681479|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44681480|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681481|NCT01329614|Nicotine|nicotine|mesh-list
44681482|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44681483|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
44681484|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681485|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681486|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44681487|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44681488|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
44681489|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681490|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681491|NCT01329627|Paclitaxel|paclitaxel|mesh-list
44681492|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44681493|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
44681494|NCT01329627|Doxorubicin|doxorubicin|mesh-list
44681495|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44681496|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44681497|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681498|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44681499|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44681500|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44681501|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681502|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681503|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
44681504|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681505|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681506|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44681507|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
44681508|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44681509|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681510|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44681511|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681512|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681513|NCT01329640|Paclitaxel|paclitaxel|mesh-list
44681514|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
44681515|NCT01329640|Trastuzumab|trastuzumab|mesh-list
44681516|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44681517|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681518|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44681519|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44681520|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44681521|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681522|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681523|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
44681524|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681525|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681526|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44681527|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
44681528|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44681529|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681530|NCT01329666|Vitamin D|vitamin d|mesh-list
44232552|NCT00540800|Docetaxel|docetaxel|mesh-list
44681531|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
44681532|NCT01329666|Vitamins|vitamins|mesh-ancestor
44681533|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
44681534|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681535|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44681536|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44681537|NCT01329731|Olaflur|olaflur|mesh-list
44681538|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
44681539|NCT01329731|Protective Agents|protective agents|mesh-ancestor
44681540|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681541|NCT01329744|Mecasermin|mecasermin|mesh-list
44681542|NCT01329744|Growth Substances|growth substances|mesh-ancestor
44681543|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681544|NCT01329770|Vitamins|vitamins|mesh-list
44681545|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
44681546|NCT01329770|Vitamin E|vitamin e|mesh-list
44681547|NCT01329770|Tocopherols|tocopherols|mesh-list
44681548|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
44681549|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
44681550|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681551|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
44681552|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681553|NCT01329770|Protective Agents|protective agents|mesh-ancestor
44681554|NCT01329783|Maraviroc|maraviroc|mesh-list
44681555|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44681556|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44681557|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681558|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44681559|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44681560|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
44681561|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681562|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44681563|NCT05667662|Itraconazole|itraconazole|mesh-list
44681564|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
44681565|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681566|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44681567|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44681568|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681569|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681570|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44681571|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
44681572|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681573|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681574|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44681575|NCT05667428|Leuprolide|leuprolide|mesh-list
44681576|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44681577|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
44681578|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44681579|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681580|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681581|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681582|NCT05667415|Cisplatin|cisplatin|mesh-list
44681583|NCT05667415|Disulfiram|disulfiram|mesh-list
44681584|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681585|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44681586|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44681587|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681588|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681589|NCT05667285|Sirolimus|sirolimus|mesh-list
44681590|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681591|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681592|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681593|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681594|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
44681595|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681596|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
44681597|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681598|NCT05667090|Vitamin D|vitamin d|mesh-list
44681599|NCT05667090|Vitamins|vitamins|mesh-ancestor
44681600|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
44681601|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681602|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44681603|NCT05667077|Amantadine|amantadine|mesh-list
44681604|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44681605|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44681606|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
44681607|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681608|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
44681609|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681610|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681611|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681612|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44681613|NCT05667077|Analgesics|analgesics|mesh-ancestor
44681614|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
44681615|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232674|NCT00541112|Leucovorin|leucovorin|mesh-list
44681616|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44681617|NCT05666999|Laxatives|laxatives|mesh-ancestor
44681618|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681619|NCT05666869|Esketamine|esketamine|mesh-list
44681620|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
44681621|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44681622|NCT05666765|Isotretinoin|isotretinoin|mesh-list
44681623|NCT05666765|Silymarin|silymarin|mesh-list
44681624|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44681625|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
44681626|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681627|NCT05666765|Protective Agents|protective agents|mesh-ancestor
44681628|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681629|NCT05668455|Dexamethasone|dexamethasone|mesh-list
44681630|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
44681631|NCT05668455|Povidone|povidone|mesh-list
44681632|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681633|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
44681634|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
44681635|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681636|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681637|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681638|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
44681639|NCT05668455|Hormones|hormones|mesh-ancestor
44681640|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681641|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681642|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681643|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
44681644|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
44681645|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
44681646|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
44681647|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681648|NCT05668286|Triamcinolone|triamcinolone|mesh-list
44681649|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44681650|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44681651|NCT05668286|Prilocaine|prilocaine|mesh-list
44681652|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44681653|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681654|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
44681655|NCT05668286|Hormones|hormones|mesh-ancestor
44681656|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681657|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681658|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681659|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
44681660|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681661|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681662|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
44681663|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
44681664|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681665|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
44681666|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681667|NCT05668091|Ritonavir|ritonavir|mesh-list
44681668|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44681669|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44681670|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44681671|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681672|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681673|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44681674|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44681675|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
44681676|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681677|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44681678|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44681679|NCT05667987|Lidocaine|lidocaine|mesh-list
44681680|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
44681681|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
44681682|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681683|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681684|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
44681685|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681686|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44681687|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44681688|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44681689|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681690|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681691|NCT05667922|Tacrolimus|tacrolimus|mesh-list
44681692|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681693|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
44681694|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681695|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44681696|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681697|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681698|NCT05667909|Rituximab|rituximab|mesh-list
44681699|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681700|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681701|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
44681702|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681703|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681704|NCT05667896|Tacrolimus|tacrolimus|mesh-list
44681705|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
44681706|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681707|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
44681708|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681709|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44681710|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681711|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681712|NCT05667896|Hormones|hormones|mesh-ancestor
44681713|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681714|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
44681715|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
44681716|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681717|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
44681718|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681719|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681720|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44681721|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
44681722|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681723|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681724|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44681725|NCT05667883|Hormones|hormones|mesh-ancestor
44681726|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681727|NCT05667727|Epinephrine|epinephrine|mesh-list
44681728|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44681729|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44681730|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
44681731|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681732|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681733|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681734|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44681735|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44681736|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
44681737|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681738|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44681739|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681740|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
44681741|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
44681742|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44681743|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
44681744|NCT05669417|Analgesics|analgesics|mesh-ancestor
44681745|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
44681746|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681747|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681748|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
44681749|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681750|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44681751|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
44681752|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44681753|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681754|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681755|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44681756|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
44681757|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44681758|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
44681759|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681760|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681761|NCT05669339|Irinotecan|irinotecan|mesh-list
44681762|NCT05669339|Sorafenib|sorafenib|mesh-list
44681763|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44681764|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681765|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681766|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681767|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681768|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44681769|NCT05669274|Caseins|caseins|mesh-list
44681770|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
44681771|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
44681772|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681773|NCT05669170|Methylphenidate|methylphenidate|mesh-list
44681774|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44681775|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681776|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44681777|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44681778|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681779|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681780|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
44681781|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681782|NCT05669092|Capecitabine|capecitabine|mesh-list
44681783|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
44681784|NCT05669092|Irinotecan|irinotecan|mesh-list
44681785|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44681786|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44681787|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
44681788|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681789|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681790|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44681791|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44681792|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681793|NCT05669079|Decitabine|decitabine|mesh-list
44681794|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
44681795|NCT05669079|Lenograstim|lenograstim|mesh-list
44681796|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44681797|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
44681798|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681799|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681800|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681801|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44681802|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
44681803|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681804|NCT05669079|Hematinics|hematinics|mesh-ancestor
44681805|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
44681806|NCT05669001|Abatacept|abatacept|mesh-list
44681807|NCT05669001|Tacrolimus|tacrolimus|mesh-list
44681808|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44681809|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681810|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
44681811|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681812|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44681813|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681814|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681815|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44681816|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681817|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681818|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681819|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44681820|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
44681821|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681822|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681823|NCT05668988|Carboplatin|carboplatin|mesh-list
44681824|NCT05668988|Pemetrexed|pemetrexed|mesh-list
44681825|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681826|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681827|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681828|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44681829|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44681830|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
44681832|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681833|NCT05668884|Gemcitabine|gemcitabine|mesh-list
44681834|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
44681835|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44681836|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
44681837|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681838|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681839|NCT05668884|Antiviral Agents|antiviral agents|mesh-ancestor
44681840|NCT05668884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681841|NCT05668884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681842|NCT05668884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681843|NCT05668884|Immunologic Factors|immunologic factors|mesh-ancestor
44681844|NCT05668884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681845|NCT05668676|Prednisone|prednisone|mesh-list
44681846|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681847|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
44681848|NCT05668676|Hormones|hormones|mesh-ancestor
44681849|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681850|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681851|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681852|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681853|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
44681854|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681855|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681856|NCT05668585|Trametinib|trametinib|mesh-list
44681857|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681858|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44681859|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681860|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681861|NCT01329796|Lidocaine|lidocaine|mesh-list
44681862|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
44681863|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
44681864|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681865|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681866|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
44681867|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681868|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44681869|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44681870|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44681871|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44681872|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681873|NCT05666349|Niraparib|niraparib|mesh-list
44681874|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44681875|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681876|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681877|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681878|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
44681879|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
44681880|NCT05666336|Prednisone|prednisone|mesh-list
44681881|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
44681882|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
44681883|NCT05666336|Tacrolimus|tacrolimus|mesh-list
44681884|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44681885|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
44681886|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681887|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44681888|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44681889|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
44681890|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681891|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681892|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44681893|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44681894|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
44681895|NCT05666336|Hormones|hormones|mesh-ancestor
44681896|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44681897|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44681898|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44681899|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681900|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44681901|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44681902|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
44681903|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44681904|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681905|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
44681906|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
44681907|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681908|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44681909|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44681910|NCT05666336|Protective Agents|protective agents|mesh-ancestor
44681911|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
44681912|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44681913|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44681914|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
44681915|NCT05666310|Denosumab|denosumab|mesh-list
44681916|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44681917|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681918|NCT05666219|Aminophylline|aminophylline|mesh-list
44681919|NCT05666219|Theophylline|theophylline|mesh-list
44681920|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44681921|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
44681922|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681923|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681924|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44681925|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681926|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44681927|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44681928|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681929|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44681930|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44681931|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44681932|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
44681933|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681934|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44681935|NCT05666219|Protective Agents|protective agents|mesh-ancestor
44681936|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44681937|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
44681938|NCT05666206|Coagulants|coagulants|mesh-ancestor
44681939|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
44681940|NCT05666089|Calcium|calcium|mesh-list
44681941|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44681942|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44681943|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681944|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
44681945|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44681946|NCT05666089|Expectorants|expectorants|mesh-ancestor
44681947|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681948|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44681949|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
44681950|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681951|NCT05666089|Protective Agents|protective agents|mesh-ancestor
44681952|NCT05666089|Antidotes|antidotes|mesh-ancestor
44681953|NCT05666076|Bupivacaine|bupivacaine|mesh-list
44681954|NCT05666076|Prilocaine|prilocaine|mesh-list
44681955|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
44681956|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
44681957|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44681958|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681959|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
44681960|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681961|NCT05665881|Phenylephrine|phenylephrine|mesh-list
44681962|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
44681963|NCT05665881|Norepinephrine|norepinephrine|mesh-list
44681964|NCT05665881|Ephedrine|ephedrine|mesh-list
44681965|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44681966|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
44681967|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
44681968|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681969|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681970|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
44681971|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44681972|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
44681973|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
44681974|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44681975|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44681976|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44681977|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
44681978|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681979|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681980|NCT05665881|Protective Agents|protective agents|mesh-ancestor
44681981|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44681982|NCT05665465|Nicotine|nicotine|mesh-list
44681983|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44681984|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
44681985|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44681986|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44681987|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44681988|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44681989|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
44681990|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44681991|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44681992|NCT05665348|Bevacizumab|bevacizumab|mesh-list
44681993|NCT05665348|Ipilimumab|ipilimumab|mesh-list
44681994|NCT05665348|Atezolizumab|atezolizumab|mesh-list
44681995|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44681996|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44681997|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44681998|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44681999|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682000|NCT05665348|Growth Substances|growth substances|mesh-ancestor
44682001|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682002|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682003|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44682004|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682005|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
44682006|NCT05665283|Ensartinib|ensartinib|mesh-list
44682007|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682008|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44682009|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682010|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682011|NCT05665140|Dexamethasone|dexamethasone|mesh-list
44682012|NCT05665140|Lenalidomide|lenalidomide|mesh-list
44682013|NCT05665140|Bortezomib|bortezomib|mesh-list
44682014|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682015|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
44682016|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
44682017|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682018|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682019|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682020|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
44682021|NCT05665140|Hormones|hormones|mesh-ancestor
44682022|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682023|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682024|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682025|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
44682026|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682027|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682028|NCT05665140|Growth Substances|growth substances|mesh-ancestor
44682029|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682030|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
44682031|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44682032|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682033|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682034|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682035|NCT05665088|Analgesics|analgesics|mesh-ancestor
44682036|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
44682037|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682038|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44682039|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44682040|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44682041|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
44682042|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682043|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682044|NCT05665023|Bevacizumab|bevacizumab|mesh-list
44682045|NCT05665023|Folfirinox|folfirinox|mesh-list
44682046|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682047|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682048|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682049|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682050|NCT05665023|Growth Substances|growth substances|mesh-ancestor
44682051|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682052|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682053|NCT05664971|Paclitaxel|paclitaxel|mesh-list
44682054|NCT05664971|Etoposide|etoposide|mesh-list
44682055|NCT05664971|Docetaxel|docetaxel|mesh-list
44682056|NCT05664971|Cisplatin|cisplatin|mesh-list
44682057|NCT05664971|Carboplatin|carboplatin|mesh-list
44682058|NCT05664971|Pemetrexed|pemetrexed|mesh-list
44682059|NCT05664971|Antibodies|antibodies|mesh-list
44682060|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44682061|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44682062|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682063|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682064|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682065|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682066|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682067|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
44682068|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682069|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44682070|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44682071|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682072|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44682073|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682074|NCT05664958|Bupivacaine|bupivacaine|mesh-list
44682075|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
44682076|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
44682077|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682078|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682079|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
44682080|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682081|NCT05664711|Bupivacaine|bupivacaine|mesh-list
44682082|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
44682083|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
44682084|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682085|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682086|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
44682087|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682088|NCT05664685|Bismuth|bismuth|mesh-list
44682089|NCT05664685|Antacids|antacids|mesh-ancestor
44682090|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682091|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682092|NCT05664139|Paclitaxel|paclitaxel|mesh-list
44682093|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44682094|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682095|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682096|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682097|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682098|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682099|NCT05663307|Aspirin|aspirin|mesh-list
44682100|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44682101|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682102|NCT05663307|Analgesics|analgesics|mesh-ancestor
44682103|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
44682104|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682105|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682106|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682107|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682108|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44682109|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44682110|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682111|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44682112|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44682113|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682114|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
44682115|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44682116|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682117|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44682118|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682119|NCT05659914|Durvalumab|durvalumab|mesh-list
44682120|NCT05659914|Olaparib|olaparib|mesh-list
44682121|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682122|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682123|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44682124|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682125|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682126|NCT05659810|Gabapentin|gabapentin|mesh-list
44682127|NCT05659810|Analgesics|analgesics|mesh-ancestor
44682128|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
44682129|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780801|NCT03114865|Hormones|hormones|mesh-ancestor
44682130|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682131|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
44682132|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44682133|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44682134|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682135|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682136|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44682137|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44682138|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682139|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682140|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
44682141|NCT05658380|Atropine|atropine|mesh-list
44682142|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44682143|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44682144|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44682145|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
44682146|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682147|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682148|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44682149|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682150|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
44682151|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
44682152|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44682153|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44682154|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
44682155|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682156|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682157|NCT05657652|Cytarabine|cytarabine|mesh-list
44682158|NCT05657652|Venetoclax|venetoclax|mesh-list
44682159|NCT05657652|Cladribine|cladribine|mesh-list
44682160|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682161|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
44682162|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682163|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682164|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
44682165|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682166|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682167|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
44682168|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682169|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
44682170|NCT05650840|Calcium|calcium|mesh-list
44682171|NCT05650840|Charcoal|charcoal|mesh-list
44682172|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233286|NCT00543842|Bevacizumab|bevacizumab|mesh-list
44682173|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682174|NCT05650840|Antacids|antacids|mesh-ancestor
44682175|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682176|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682177|NCT05650840|Antidotes|antidotes|mesh-ancestor
44682178|NCT05650840|Protective Agents|protective agents|mesh-ancestor
44682179|NCT05645718|Cytarabine|cytarabine|mesh-list
44682180|NCT05645718|Dexamethasone|dexamethasone|mesh-list
44682181|NCT05645718|Prednisone|prednisone|mesh-list
44682182|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
44682183|NCT05645718|Rituximab|rituximab|mesh-list
44682184|NCT05645718|Methotrexate|methotrexate|mesh-list
44682185|NCT05645718|Vincristine|vincristine|mesh-list
44682186|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
44682187|NCT05645718|Blinatumomab|blinatumomab|mesh-list
44682188|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44682189|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682190|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
44682191|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682192|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682193|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44682194|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
44682195|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682196|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682197|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44682198|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682199|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682200|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
44682201|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
44682202|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682203|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682204|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
44682205|NCT05645718|Hormones|hormones|mesh-ancestor
44682206|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682207|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682208|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44682209|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
44682210|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682211|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682212|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
44682213|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44682214|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682215|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44682216|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682217|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
44682218|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682219|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44682220|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682221|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682222|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682223|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44682224|NCT05644353|Mirikizumab|mirikizumab|mesh-list
44682225|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44682226|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682227|NCT05644353|Analgesics|analgesics|mesh-ancestor
44682228|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
44682229|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682230|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682231|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682232|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682233|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44682234|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682235|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
44682236|NCT05638399|Denosumab|denosumab|mesh-list
44682237|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44682238|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682239|NCT05630339|Vitamin D|vitamin d|mesh-list
44682240|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
44682241|NCT05630339|Vitamins|vitamins|mesh-ancestor
44682242|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
44682243|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682244|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44682245|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44682246|NCT05619120|Mexiletine|mexiletine|mesh-list
44682247|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44682248|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44682249|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44682250|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44682251|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682252|NCT05602675|Repaglinide|repaglinide|mesh-list
44682253|NCT05602675|Methotrexate|methotrexate|mesh-list
44682254|NCT05602675|Midazolam|midazolam|mesh-list
44682255|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
44682257|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44682258|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
44682259|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682260|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682261|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682262|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
44682263|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682264|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682265|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44682266|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682267|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44682268|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682269|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
44682270|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682271|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682272|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44682273|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44682274|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682275|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44682276|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44682277|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44682278|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44682279|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
44682280|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
44682281|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
44682282|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
44682283|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682284|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
44682285|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
44682286|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682287|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44682288|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44682289|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44682290|NCT05588453|Temozolomide|temozolomide|mesh-list
44682291|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44682292|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
44682293|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682294|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682295|NCT05572515|Dexamethasone|dexamethasone|mesh-list
44682296|NCT05572515|Bortezomib|bortezomib|mesh-list
44682297|NCT05572515|Pomalidomide|pomalidomide|mesh-list
44682298|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682299|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
44682300|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
44682301|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682302|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682303|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682304|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
44682305|NCT05572515|Hormones|hormones|mesh-ancestor
44682306|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682307|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682308|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682309|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
44682310|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682311|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682312|NCT05572515|Growth Substances|growth substances|mesh-ancestor
44682313|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682314|NCT05567354|Oxycodone|oxycodone|mesh-list
44682315|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44682316|NCT05567354|Narcotics|narcotics|mesh-ancestor
44682317|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682318|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682319|NCT05567354|Analgesics|analgesics|mesh-ancestor
44682320|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
44682321|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682322|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
44682323|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682324|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682325|NCT05564052|Rituximab|rituximab|mesh-list
44682326|NCT05564052|Lenalidomide|lenalidomide|mesh-list
44682327|NCT05564052|Bortezomib|bortezomib|mesh-list
44682328|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682329|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682330|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
44682331|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682332|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682333|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682334|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682335|NCT05564052|Growth Substances|growth substances|mesh-ancestor
44682336|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682338|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44682339|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682340|NCT05556512|Incretins|incretins|mesh-ancestor
44682341|NCT05556512|Hormones|hormones|mesh-ancestor
44682342|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682343|NCT05555121|Progesterone|progesterone|mesh-list
44682344|NCT05555121|Progestins|progestins|mesh-ancestor
44682345|NCT05555121|Hormones|hormones|mesh-ancestor
44682346|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682347|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682348|NCT05552222|Dexamethasone|dexamethasone|mesh-list
44682349|NCT05552222|Lenalidomide|lenalidomide|mesh-list
44682350|NCT05552222|Daratumumab|daratumumab|mesh-list
44682351|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682352|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
44682353|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
44682354|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682355|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682356|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682357|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
44682358|NCT05552222|Hormones|hormones|mesh-ancestor
44682359|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682360|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682361|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682362|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
44682363|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682364|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682365|NCT05552222|Growth Substances|growth substances|mesh-ancestor
44682366|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682367|NCT05545020|Chromium|chromium|mesh-list
44682368|NCT05545020|Trace Elements|trace elements|mesh-ancestor
44682369|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
44682370|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682371|NCT05542446|Colistin|colistin|mesh-list
44682372|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44682373|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682374|NCT05538312|Itraconazole|itraconazole|mesh-list
44682375|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
44682376|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682377|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44682378|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44682379|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682380|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682381|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44682382|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
44682383|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682384|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682385|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44682386|NCT05538247|Indomethacin|indomethacin|mesh-list
44682387|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44682388|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44682389|NCT05538247|Analgesics|analgesics|mesh-ancestor
44682390|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
44682391|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682392|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682393|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682394|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44682395|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
44682396|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
44682397|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44682398|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44682399|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682400|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682401|NCT05533281|Dexamethasone|dexamethasone|mesh-list
44682402|NCT05533281|Metoclopramide|metoclopramide|mesh-list
44682403|NCT05533281|Tropisetron|tropisetron|mesh-list
44682404|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682405|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
44682406|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
44682407|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682408|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682409|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682410|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
44682411|NCT05533281|Hormones|hormones|mesh-ancestor
44682412|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682413|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682414|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682415|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44682416|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44682417|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
44682418|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682419|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682420|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44682421|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44682422|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
44682423|NCT05521087|Cytarabine|cytarabine|mesh-list
44682424|NCT05521087|Dexamethasone|dexamethasone|mesh-list
44682425|NCT05521087|Fludarabine|fludarabine|mesh-list
44682426|NCT05521087|Vincristine|vincristine|mesh-list
44682427|NCT05521087|Pegaspargase|pegaspargase|mesh-list
44682428|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44682429|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
44682430|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
44682431|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682432|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682433|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682434|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
44682435|NCT05521087|Hormones|hormones|mesh-ancestor
44682436|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44682437|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682438|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682439|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682440|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
44682441|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682442|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682443|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
44682444|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
44682445|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682446|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44682447|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682448|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682449|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682451|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44682452|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
44682453|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44682454|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682455|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
44682456|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682457|NCT05500092|Gemcitabine|gemcitabine|mesh-list
44682458|NCT05500092|Cisplatin|cisplatin|mesh-list
44682459|NCT05500092|Docetaxel|docetaxel|mesh-list
44682460|NCT05500092|Nivolumab|nivolumab|mesh-list
44682461|NCT05500092|Pemetrexed|pemetrexed|mesh-list
44682462|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682463|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682464|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
44682465|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682466|NCT05500092|Antiviral Agents|antiviral agents|mesh-ancestor
44682467|NCT05500092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682468|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682469|NCT05500092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44682470|NCT05500092|Immunologic Factors|immunologic factors|mesh-ancestor
44682471|NCT05500092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682472|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
44682473|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44682474|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44682475|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682476|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44682477|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44682478|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682479|NCT05497726|Bevacizumab|bevacizumab|mesh-list
44682480|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682481|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682482|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682483|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682484|NCT05497726|Growth Substances|growth substances|mesh-ancestor
44682485|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682486|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682487|NCT05494528|Entecavir|entecavir|mesh-list
44682488|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
44682489|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682498|NCT05481489|Atropine|atropine|mesh-list
44682499|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44682500|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44682501|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44682502|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
44682503|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682504|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682505|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44682506|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682507|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
44682508|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
44682509|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44682513|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682514|NCT05472220|Carboplatin|carboplatin|mesh-list
44682515|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
44682516|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682517|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682518|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682520|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44682521|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44682522|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44682523|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
44682524|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44682525|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682526|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44682527|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682528|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
44682529|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
44682530|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44682531|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44682532|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
44682533|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682534|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682535|NCT05470868|Naphazoline|naphazoline|mesh-list
44682536|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44682537|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44682538|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
44682539|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44682540|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682541|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682542|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
44682543|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44682544|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
44682545|NCT05467553|Tenofovir|tenofovir|mesh-list
44682546|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44682547|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
44682548|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44682549|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44682550|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44682551|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682552|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682553|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44682554|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44682555|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44682556|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682557|NCT05459844|Octreotide|octreotide|mesh-list
44682558|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44682559|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44682560|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44682561|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682562|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44682563|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682564|NCT05453903|Azacitidine|azacitidine|mesh-list
44682565|NCT05453903|Venetoclax|venetoclax|mesh-list
44682566|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44682567|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
44682568|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44682569|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682570|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44682574|NCT05448677|Bevacizumab|bevacizumab|mesh-list
44682575|NCT05448677|Atezolizumab|atezolizumab|mesh-list
44682576|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44682577|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682578|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682579|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44682580|NCT05448677|Growth Substances|growth substances|mesh-ancestor
44682581|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44682582|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44682583|NCT05446467|Cisplatin|cisplatin|mesh-list
44682595|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44682596|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44682597|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233822|NCT00546039|Genistein|genistein|mesh-list
44233903|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44233904|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233905|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44233906|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44233907|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44233908|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233909|NCT00546442|Metformin|metformin|mesh-list
44233910|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233911|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233912|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44233913|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44233914|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44233915|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44233916|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233917|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233918|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233919|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44233920|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
44233921|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233922|NCT00546507|Celecoxib|celecoxib|mesh-list
44233923|NCT00546507|Diclofenac|diclofenac|mesh-list
44233924|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44233925|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233926|NCT00546507|Analgesics|analgesics|mesh-ancestor
44233927|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
44233928|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233929|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233930|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233931|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233932|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44233933|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44233934|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233935|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233936|NCT00546520|Ciclesonide|ciclesonide|mesh-list
44233937|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
44233938|NCT00546520|Hormones|hormones|mesh-ancestor
44153948|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233939|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233940|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233941|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44233942|NCT00546533|Etanercept|etanercept|mesh-list
44233943|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44233944|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233945|NCT00546533|Analgesics|analgesics|mesh-ancestor
44233946|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
44233947|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233948|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233949|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233950|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233951|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44233952|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233953|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
44233954|NCT00546546|Methotrexate|methotrexate|mesh-list
44233955|NCT00546546|Azathioprine|azathioprine|mesh-list
44233956|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44233957|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44233958|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
44233959|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44233960|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233961|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233962|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
44233963|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233964|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233965|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
44233966|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233967|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44233968|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
44233969|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233970|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44233971|NCT00546559|Simvastatin|simvastatin|mesh-list
44233972|NCT00546559|Pravastatin|pravastatin|mesh-list
44233973|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44233974|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44233975|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
44233976|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233977|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44233978|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44233979|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233980|NCT00546650|Sumatriptan|sumatriptan|mesh-list
44233981|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44233982|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44233983|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44233984|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
44233985|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233986|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233987|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233988|NCT00546676|Telithromycin|telithromycin|mesh-list
44233989|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44233990|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233991|NCT00546741|Metformin|metformin|mesh-list
44233992|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
44233993|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233994|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233995|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44233996|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233997|NCT00546832|Celecoxib|celecoxib|mesh-list
44233998|NCT00546832|Diclofenac|diclofenac|mesh-list
44233999|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44234000|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234001|NCT00546832|Analgesics|analgesics|mesh-ancestor
44234002|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
44234003|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234004|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234005|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234006|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234007|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44234008|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44234009|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234010|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234011|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44234012|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44458750|NCT01591096|Plasminogen|plasminogen|mesh-list
44234013|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44234014|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234015|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234016|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234017|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234018|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44234019|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
44234020|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44234021|NCT00546936|Ranibizumab|ranibizumab|mesh-list
44234022|NCT00546936|Verteporfin|verteporfin|mesh-list
44234023|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44234024|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44234025|NCT00546936|Growth Substances|growth substances|mesh-ancestor
44234026|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234027|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
44234028|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234029|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44234030|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234031|NCT00547001|Estradiol|estradiol|mesh-list
44234032|NCT00547001|Estrogens|estrogens|mesh-ancestor
44234033|NCT00547001|Hormones|hormones|mesh-ancestor
44234034|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234035|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234036|NCT00547053|Amiloride|amiloride|mesh-list
44234037|NCT00547053|Diuretics|diuretics|mesh-ancestor
44234038|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
44234039|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234040|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44234041|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44234042|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234043|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234044|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44234045|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44234046|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
44234047|NCT00547092|Tadalafil|tadalafil|mesh-list
44234048|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234049|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234050|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234052|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234053|NCT00547092|Urological Agents|urological agents|mesh-ancestor
44234054|NCT00547131|Temozolomide|temozolomide|mesh-list
44234055|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234056|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
44234057|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234058|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234059|NCT00547144|Gemcitabine|gemcitabine|mesh-list
44234060|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234061|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
44234062|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234063|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234064|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
44234065|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234066|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234067|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234068|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
44234069|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234070|NCT00547170|Doxycycline|doxycycline|mesh-list
44234071|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44234072|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234073|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
44234074|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44234075|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44234076|NCT00547183|Tadalafil|tadalafil|mesh-list
44234077|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234078|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234079|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234080|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234081|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234082|NCT00547183|Urological Agents|urological agents|mesh-ancestor
44234083|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
44234084|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44234085|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
43887575|NCT04550351|Vaccines|vaccines|mesh-list
44234086|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
44234087|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234088|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234089|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234090|NCT00547209|Analgesics|analgesics|mesh-ancestor
44234091|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
44234092|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234093|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
44234094|NCT00547287|Tadalafil|tadalafil|mesh-list
44234095|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234096|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234097|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234098|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234099|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234100|NCT00547287|Urological Agents|urological agents|mesh-ancestor
44234101|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
44234102|NCT00547352|Tadalafil|tadalafil|mesh-list
44234103|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234104|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234105|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234106|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234107|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234108|NCT00547352|Urological Agents|urological agents|mesh-ancestor
44234109|NCT00547417|Tadalafil|tadalafil|mesh-list
44234110|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234111|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234112|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234113|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234114|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234115|NCT00547417|Urological Agents|urological agents|mesh-ancestor
44234116|NCT00547443|Paclitaxel|paclitaxel|mesh-list
44234117|NCT00547443|Carboplatin|carboplatin|mesh-list
44234118|NCT00547443|Sorafenib|sorafenib|mesh-list
44234119|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234120|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234121|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234122|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234123|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234124|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234125|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44234126|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234127|NCT00547495|Tadalafil|tadalafil|mesh-list
44234128|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234129|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234130|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234131|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234132|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234133|NCT00547495|Urological Agents|urological agents|mesh-ancestor
44234134|NCT00547508|Tadalafil|tadalafil|mesh-list
44234135|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234136|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234137|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234138|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234139|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234140|NCT00547508|Urological Agents|urological agents|mesh-ancestor
44234141|NCT00547547|Selenium|selenium|mesh-list
44234142|NCT00547547|Capecitabine|capecitabine|mesh-list
44234143|NCT00547547|Irinotecan|irinotecan|mesh-list
44234144|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234145|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
44234146|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234147|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234148|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44234149|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234150|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234151|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
44234152|NCT00547547|Protective Agents|protective agents|mesh-ancestor
44234153|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234154|NCT00547547|Trace Elements|trace elements|mesh-ancestor
44234155|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
44234156|NCT00547573|Tadalafil|tadalafil|mesh-list
44234157|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234158|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234159|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234160|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234161|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234162|NCT00547573|Urological Agents|urological agents|mesh-ancestor
44234163|NCT00547599|Tadalafil|tadalafil|mesh-list
44234164|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234165|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234166|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234167|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234168|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234169|NCT00547599|Urological Agents|urological agents|mesh-ancestor
44234170|NCT00547612|Substance P|substance p|mesh-list
44234171|NCT00547612|Neurokinin A|neurokinin a|mesh-list
44234172|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234173|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234174|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234175|NCT00547625|Tadalafil|tadalafil|mesh-list
44234176|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234177|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44234178|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234179|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234180|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234181|NCT00547625|Urological Agents|urological agents|mesh-ancestor
44234182|NCT00547664|Morphine|morphine|mesh-list
44234183|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44234184|NCT00547664|Narcotics|narcotics|mesh-ancestor
44234185|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234186|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234187|NCT00547664|Analgesics|analgesics|mesh-ancestor
44234188|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
44234189|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234190|NCT00547768|Fexofenadine|fexofenadine|mesh-list
44234191|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44234192|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44234193|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44234194|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
44234195|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
44234196|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234197|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234198|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234199|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
44234200|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44234201|NCT00547885|Narcotics|narcotics|mesh-ancestor
44234202|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234203|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234204|NCT00547885|Analgesics|analgesics|mesh-ancestor
44234205|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
44234206|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234207|NCT00547989|Bupivacaine|bupivacaine|mesh-list
44234208|NCT00547989|Ropivacaine|ropivacaine|mesh-list
44234209|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
44234210|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
44234211|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234212|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234213|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
44234214|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234215|NCT00548002|Levofloxacin|levofloxacin|mesh-list
44234216|NCT00548002|Ofloxacin|ofloxacin|mesh-list
44234217|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
44234218|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44234219|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234220|NCT00548002|Renal Agents|renal agents|mesh-ancestor
44234221|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44234222|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234223|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234224|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234225|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234226|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234227|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44234228|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44234229|NCT00548067|Amlodipine|amlodipine|mesh-list
44234230|NCT00548067|Valsartan|valsartan|mesh-list
44234231|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44234232|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44234233|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44234234|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234235|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234236|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44234238|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234239|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44234240|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44234241|NCT00548067|Diuretics|diuretics|mesh-ancestor
44234242|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
44234243|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44234244|NCT00548080|Caspofungin|caspofungin|mesh-list
44234245|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
44234246|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234247|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234248|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234249|NCT00548288|Pamidronate|pamidronate|mesh-list
44234250|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234251|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234252|NCT00548301|Cyclosporine|cyclosporine|mesh-list
44234253|NCT00548301|Cyclosporins|cyclosporins|mesh-list
44234254|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234255|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234256|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234257|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
44234258|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234259|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
44234260|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234261|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234262|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234263|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44458630|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44458631|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44458632|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458633|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458634|NCT01592409|Hormones|hormones|mesh-ancestor
44458635|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458636|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44458637|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458638|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44458639|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236608|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44458640|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458642|NCT01592370|Nivolumab|nivolumab|mesh-list
44458643|NCT01592370|Ipilimumab|ipilimumab|mesh-list
44458644|NCT01592370|Daratumumab|daratumumab|mesh-list
44458645|NCT01592370|Pomalidomide|pomalidomide|mesh-list
44458646|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458647|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
44458648|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
44458649|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458650|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458651|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44458652|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
44458653|NCT01592370|Hormones|hormones|mesh-ancestor
44458654|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458655|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44458656|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458657|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458658|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44458659|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458660|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
44458661|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458662|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44458663|NCT01592370|Growth Substances|growth substances|mesh-ancestor
44458664|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44458665|NCT01592292|Adalimumab|adalimumab|mesh-list
44458666|NCT01592292|Etanercept|etanercept|mesh-list
44458667|NCT01592292|Rituximab|rituximab|mesh-list
44458668|NCT01592292|Infliximab|infliximab|mesh-list
44458669|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458670|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458671|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
44458672|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458673|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458674|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458675|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458676|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44234265|NCT00548379|Vitamins|vitamins|mesh-ancestor
44234266|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
44234267|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234268|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234269|NCT00548483|Dexamethasone|dexamethasone|mesh-list
44234270|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234271|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
44234272|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
44234273|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234274|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234275|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44234276|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
44234277|NCT00548483|Hormones|hormones|mesh-ancestor
44234278|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234279|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44234280|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234281|NCT00548509|Vitamin K|vitamin k|mesh-list
44234282|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
44234283|NCT00548509|Menatetrenone|menatetrenone|mesh-list
44234284|NCT00548509|Vitamins|vitamins|mesh-ancestor
44234285|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
44234286|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234287|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44234288|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44234289|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234290|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
44234291|NCT00548509|Coagulants|coagulants|mesh-ancestor
44234292|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
44234293|NCT00548561|Razoxane|razoxane|mesh-list
44234294|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234295|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44234296|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234297|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234298|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234299|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234300|NCT00548561|Protective Agents|protective agents|mesh-ancestor
44234301|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234302|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234303|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234304|NCT00548574|Mesalamine|mesalamine|mesh-list
44234305|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44234306|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234307|NCT00548574|Analgesics|analgesics|mesh-ancestor
44234308|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
44234309|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234310|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234311|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234312|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234313|NCT00548678|Aspirin|aspirin|mesh-list
44234314|NCT00548678|Diclofenac|diclofenac|mesh-list
44234315|NCT00548678|Ketorolac|ketorolac|mesh-list
44234316|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44234317|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234318|NCT00548678|Analgesics|analgesics|mesh-ancestor
44234319|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
44234320|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234321|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234322|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234323|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234324|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44234325|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44234326|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234327|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44234328|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44234329|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234330|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
44234331|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
44234332|NCT00548704|Razoxane|razoxane|mesh-list
44234333|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234334|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44234335|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234336|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234337|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234338|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234339|NCT00548704|Protective Agents|protective agents|mesh-ancestor
44234340|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234341|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234342|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234343|NCT00548821|Cisplatin|cisplatin|mesh-list
44234344|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234345|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
44234346|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234347|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
44234348|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234349|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234350|NCT00548899|Sorafenib|sorafenib|mesh-list
44234351|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234352|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44234353|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234354|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234355|NCT00548938|Temozolomide|temozolomide|mesh-list
44234356|NCT00548938|Carmustine|carmustine|mesh-list
44234357|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234358|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
44234359|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234360|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234361|NCT00548964|Ketamine|ketamine|mesh-list
44234362|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
44234363|NCT00548964|Analgesics|analgesics|mesh-ancestor
44234364|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
44234365|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234366|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234367|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44234368|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44234369|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
44234370|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
44234371|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234372|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44234373|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44234374|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234375|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234376|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
44234377|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44234378|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234379|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
44234380|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44234381|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
44234382|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44234383|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234384|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234385|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44234386|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234387|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234388|NCT00549107|Simendan|simendan|mesh-list
44234389|NCT00549107|Milrinone|milrinone|mesh-list
44234390|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44234391|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234392|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44234393|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44234394|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234395|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234396|NCT00549107|Protective Agents|protective agents|mesh-ancestor
44234397|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234398|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44234399|NCT00549120|Propranolol|propranolol|mesh-list
44234400|NCT00549120|Albuterol|albuterol|mesh-list
44234401|NCT00549120|Ipratropium|ipratropium|mesh-list
44234402|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44234403|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44234404|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44234405|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234406|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234407|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234408|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44234409|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44234410|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
44234411|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44234412|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
44234413|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234414|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44234415|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44234416|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
44234417|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44234418|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44234419|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44234420|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44234421|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44234422|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
44234423|NCT00549133|Irbesartan|irbesartan|mesh-list
44234424|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44234425|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44234426|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44234427|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234428|NCT00549146|Fluticasone|fluticasone|mesh-list
44234429|NCT00549146|Xhance|xhance|mesh-list
44234430|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44234431|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44234432|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234433|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44234434|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
44234435|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234436|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234437|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44234438|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
44234439|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234440|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44234441|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44234442|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44234443|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44234444|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44234445|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234446|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234447|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
44234448|NCT00549146|Hormones|hormones|mesh-ancestor
43700485|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234449|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234450|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
44234451|NCT00549289|Cyclosporine|cyclosporine|mesh-list
44234452|NCT00549289|Cyclosporins|cyclosporins|mesh-list
44234453|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234454|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234455|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234456|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
44234457|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234458|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
44234459|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234460|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234461|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234462|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44234463|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
44234464|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44234465|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234466|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234467|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
44234468|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234469|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234470|NCT00549419|Dobutamine|dobutamine|mesh-list
44234471|NCT00549419|Norepinephrine|norepinephrine|mesh-list
44234472|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44234473|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44234474|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
44234475|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234476|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234477|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234478|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
44234479|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
44234480|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234481|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44234482|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44234483|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44234484|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44234485|NCT00549419|Protective Agents|protective agents|mesh-ancestor
44234486|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
44234487|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44234488|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44234489|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44234490|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234491|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234492|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
44234493|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234494|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234495|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44234496|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234497|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
44234498|NCT00549536|Calcium|calcium|mesh-list
44234499|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44234500|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234501|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234502|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
44234503|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44234504|NCT00549588|Protective Agents|protective agents|mesh-ancestor
44234505|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234506|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234507|NCT00549614|Acipimox|acipimox|mesh-list
44234508|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44234509|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
44234510|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234511|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44234512|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
44234513|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44234514|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44234515|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44234516|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44234517|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234518|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234519|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236156|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
44234520|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44234521|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44234522|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44234523|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
44234524|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234525|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234526|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44234527|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44234528|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
44234529|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44234530|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44234531|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
44234532|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44234533|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
44234534|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44234535|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44234536|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44234537|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44234538|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44234539|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234540|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234541|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234542|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234543|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234544|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
44234545|NCT00549874|Glyburide|glyburide|mesh-list
44234546|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234547|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234548|NCT00549887|Insulin|insulin|mesh-list
44234549|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44234550|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234551|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234552|NCT00549926|Atorvastatin|atorvastatin|mesh-list
44234553|NCT00549926|Pravastatin|pravastatin|mesh-list
44234554|NCT00549926|Pitavastatin|pitavastatin|mesh-list
44234555|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44234556|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44234557|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
44234558|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234559|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44234560|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44234561|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234562|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
44234563|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44234564|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234565|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234566|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44234567|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234568|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234569|NCT00550004|Gemcitabine|gemcitabine|mesh-list
44234570|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234571|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
44234572|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234573|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234574|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
44234575|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234576|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234577|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234578|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
44234579|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234581|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44234582|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44234583|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44234584|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234585|NCT00550108|Ethanol|ethanol|mesh-list
44234586|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44114129|NCT00098033|Clofarabine|clofarabine|mesh-list
44234587|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234588|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44234589|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234590|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
44234591|NCT00550121|Vitamins|vitamins|mesh-ancestor
44234592|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
44234593|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234595|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234596|NCT00550121|Protective Agents|protective agents|mesh-ancestor
44234597|NCT00550160|Artesunate|artesunate|mesh-list
44234598|NCT00550160|Amodiaquine|amodiaquine|mesh-list
44234599|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
44234600|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44234601|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44234602|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234603|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234604|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
44234605|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
44234606|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44234607|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
44234608|NCT00550199|Gemcitabine|gemcitabine|mesh-list
44234609|NCT00550199|Panobinostat|panobinostat|mesh-list
44234610|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234611|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
44234612|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234613|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234614|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
44234615|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234616|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234617|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234618|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
44234619|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234620|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44234621|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
44234622|NCT00550303|Estrogens|estrogens|mesh-list
44234623|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44234624|NCT00550303|Hormones|hormones|mesh-ancestor
44234625|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234626|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234627|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44234628|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44234629|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
44234630|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44458677|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44458678|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44458679|NCT01592292|Analgesics|analgesics|mesh-ancestor
44458680|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
44458681|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458682|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458683|NCT01592240|Bococizumab|bococizumab|mesh-list
44234633|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234634|NCT00550342|Rituximab|rituximab|mesh-list
44234635|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44234636|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234637|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
44234638|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234639|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234640|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
44234641|NCT00550433|Estrogens|estrogens|mesh-list
44234642|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44234643|NCT00550433|Hormones|hormones|mesh-ancestor
44234644|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234645|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234646|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44234647|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44234648|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
44234649|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234650|NCT00550485|Citalopram|citalopram|mesh-list
44234651|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44234652|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44234653|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44234654|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234655|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44234656|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
44234657|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234658|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44234659|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
44079255|NCT05576675|Dsuvia|dsuvia|mesh-list
44234660|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44234661|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
44234662|NCT00550563|Vitamin D|vitamin d|mesh-list
44234663|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44234664|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234665|NCT00550563|Vitamins|vitamins|mesh-ancestor
44234666|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
44234667|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44234668|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44234669|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44234670|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234671|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
44234672|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44234673|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234674|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
43887505|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
44234675|NCT00550784|Paclitaxel|paclitaxel|mesh-list
44136425|NCT00164710|Renal Agents|renal agents|mesh-ancestor
44234676|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
44234677|NCT00550784|Cisplatin|cisplatin|mesh-list
44234678|NCT00550784|Melphalan|melphalan|mesh-list
43887927|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43888003|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888101|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
44136566|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234680|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234681|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234682|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234683|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
43889285|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
44136770|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889548|NCT04455139|Melphalan|melphalan|mesh-list
44236609|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44136938|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889925|NCT04187248|Asparaginase|asparaginase|mesh-list
44136983|NCT00166413|Thalidomide|thalidomide|mesh-list
44234685|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234686|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890276|NCT05277038|Clonidine|clonidine|mesh-list
43890267|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234688|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137185|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43890707|NCT04035382|Misoprostol|misoprostol|mesh-list
44234690|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234691|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
44234692|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44234693|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43891446|NCT03034018|Suvorexant|suvorexant|mesh-list
44234694|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234695|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234696|NCT00550810|Sunitinib|sunitinib|mesh-list
43891666|NCT05281081|Morphine|morphine|mesh-list
43891741|NCT05280626|Hormones|hormones|mesh-ancestor
43891889|NCT05279040|Ivacaftor|ivacaftor|mesh-list
43891967|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
43892044|NCT05147376|Curcumin|curcumin|mesh-list
43892388|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44234697|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892570|NCT04568200|Paclitaxel|paclitaxel|mesh-list
44234698|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44234699|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44234700|NCT00550810|Growth Substances|growth substances|mesh-ancestor
44234701|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234702|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
44234703|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44234704|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888099|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
44234705|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234706|NCT00550901|Cisplatin|cisplatin|mesh-list
44234707|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
44234708|NCT00550901|Razoxane|razoxane|mesh-list
44234709|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234710|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44234711|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234712|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234713|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137325|NCT00167765|Abciximab|abciximab|mesh-list
43893110|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43893196|NCT03668392|Asparaginase|asparaginase|mesh-list
43893480|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
44137366|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43893726|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893861|NCT05283954|Ascorbic Acid|ascorbic acid|mesh-list
43894172|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894377|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43894451|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43894494|NCT03797547|Growth Substances|growth substances|mesh-ancestor
43894599|NCT05089175|Aspirin|aspirin|mesh-list
43894640|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894687|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894837|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43894919|NCT02393794|Cisplatin|cisplatin|mesh-list
43894956|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895032|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43895394|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895810|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137631|NCT00168779|Valsartan|valsartan|mesh-list
43896129|NCT05184777|Progesterone|progesterone|mesh-list
43896228|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
43896892|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44234714|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234715|NCT00550901|Protective Agents|protective agents|mesh-ancestor
44137865|NCT00169182|Niacin|niacin|mesh-list
43897071|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
44234716|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234717|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234718|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234719|NCT00550927|Bevacizumab|bevacizumab|mesh-list
43897703|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897780|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
43897857|NCT00350701|Testosterone|testosterone|mesh-list
44234720|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898012|NCT00005803|Carmustine|carmustine|mesh-list
44234721|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898593|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
43898807|NCT05571644|Leucovorin|leucovorin|mesh-list
44234722|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898870|NCT05228314|Antacids|antacids|mesh-ancestor
43899057|NCT04301492|Vortioxetine|vortioxetine|mesh-list
44234723|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44234725|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899511|NCT01148849|Margetuximab|margetuximab|mesh-list
44234726|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
44234727|NCT00550992|Leucovorin|leucovorin|mesh-list
44234728|NCT00550992|Cytarabine|cytarabine|mesh-list
44234729|NCT00550992|Cyclosporine|cyclosporine|mesh-list
44234730|NCT00550992|Prednisone|prednisone|mesh-list
44234731|NCT00550992|Prednisolone|prednisolone|mesh-list
43900065|NCT00030992|Ranitidine|ranitidine|mesh-list
44234732|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
43900268|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900490|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
44234733|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44234734|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44234735|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44234736|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
43901226|NCT00066937|Benztropine|benztropine|mesh-list
43901453|NCT00074035|Pentostatin|pentostatin|mesh-list
44234737|NCT00550992|Melphalan|melphalan|mesh-list
44234738|NCT00550992|Busulfan|busulfan|mesh-list
44234740|NCT00550992|Etoposide|etoposide|mesh-list
44234741|NCT00550992|Vincristine|vincristine|mesh-list
44234742|NCT00550992|Daunorubicin|daunorubicin|mesh-list
44234743|NCT00550992|Asparaginase|asparaginase|mesh-list
44234744|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
44234745|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
44234746|NCT00550992|Pegaspargase|pegaspargase|mesh-list
44234747|NCT00550992|Thioguanine|thioguanine|mesh-list
44234748|NCT00550992|Cyclosporins|cyclosporins|mesh-list
44234749|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44234750|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
44234751|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234752|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
44234753|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234754|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234755|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234757|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234758|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234759|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44234760|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234761|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
44234762|NCT00550992|Hormones|hormones|mesh-ancestor
44234763|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234764|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44234765|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44234766|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
44234767|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44234768|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234770|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
44234771|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234772|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44234773|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44234774|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234775|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234776|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234777|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
44234778|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234780|NCT00550992|Protective Agents|protective agents|mesh-ancestor
44234781|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
44234782|NCT00550992|Vitamins|vitamins|mesh-ancestor
44234783|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
44234784|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234785|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234786|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234787|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
44234788|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44234789|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234790|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44234791|NCT00550992|Analgesics|analgesics|mesh-ancestor
44234792|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
44234794|NCT00551005|Etoposide|etoposide|mesh-list
43902699|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
44234795|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234796|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234797|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43902836|NCT00116207|Antioxidants|antioxidants|mesh-list
43902913|NCT00118209|Hormones|hormones|mesh-ancestor
44234798|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234799|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234800|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234801|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44234802|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234803|NCT00551005|Analgesics|analgesics|mesh-ancestor
44234804|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
44234805|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234806|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234807|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234808|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903134|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234809|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44234810|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44234811|NCT00551018|Tenofovir|tenofovir|mesh-list
44234812|NCT00551018|Emtricitabine|emtricitabine|mesh-list
44234813|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
44234814|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234815|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44234816|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43903198|NCT00122447|Vitamins|vitamins|mesh-ancestor
44234817|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234818|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234819|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44234820|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44234821|NCT00551044|Bicalutamide|bicalutamide|mesh-list
44234822|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
44234823|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
44234824|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903278|NCT00124579|Bortezomib|bortezomib|mesh-list
44234825|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234826|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234827|NCT00551096|Gemcitabine|gemcitabine|mesh-list
44234828|NCT00551096|Capecitabine|capecitabine|mesh-list
44234829|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234830|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
44234831|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234832|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234833|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
44234834|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234835|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903406|NCT00128180|Hormones|hormones|mesh-ancestor
44138397|NCT00171015|Valsartan|valsartan|mesh-list
44234836|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234837|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
44234838|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234840|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
44234841|NCT00551122|Gemcitabine|gemcitabine|mesh-list
44234842|NCT00551122|Paclitaxel|paclitaxel|mesh-list
44234843|NCT00551122|Cisplatin|cisplatin|mesh-list
44234844|NCT00551122|Ifosfamide|ifosfamide|mesh-list
44234845|NCT00551122|Lenograstim|lenograstim|mesh-list
44234846|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234847|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234848|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234849|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234850|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234851|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234852|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234853|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
44234854|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
44234855|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234856|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234857|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234858|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
44234859|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234860|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44234861|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234862|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
44234863|NCT00551239|Rituximab|rituximab|mesh-list
44234864|NCT00551239|Fludarabine|fludarabine|mesh-list
44234865|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
44234866|NCT00551239|Pixantrone|pixantrone|mesh-list
44234867|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44234868|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234869|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
44234870|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234871|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234872|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234873|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
44234874|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234875|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234876|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44234877|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44234878|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234879|NCT00551252|Gemcitabine|gemcitabine|mesh-list
44234880|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
44234881|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44234882|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
44234883|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234884|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234885|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
44234886|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44234887|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234888|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234889|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
44234890|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234891|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44234892|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
44234893|NCT00551265|Oregovomab|oregovomab|mesh-list
44234894|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44234895|NCT00551265|Antibodies|antibodies|mesh-list
44234896|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
44234897|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44234899|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
44234900|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234901|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234902|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234903|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
44234904|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234905|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234906|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44234907|NCT00551317|Darapladib|darapladib|mesh-list
44234908|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
43903887|NCT00156936|Naltrexone|naltrexone|mesh-list
44234910|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234911|NCT00551343|Exenatide|exenatide|mesh-list
44234912|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234913|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234914|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44234915|NCT00551343|Incretins|incretins|mesh-ancestor
44234916|NCT00551343|Hormones|hormones|mesh-ancestor
44234917|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234918|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
44234919|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234920|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234921|NCT00551382|Montelukast|montelukast|mesh-list
44234922|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44234923|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44234924|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44234925|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
44234926|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234927|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234928|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44234929|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44234930|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234931|NCT00551512|Cisplatin|cisplatin|mesh-list
44234932|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234933|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
44234934|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234935|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234936|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
44234937|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234938|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234939|NCT00551577|Carboplatin|carboplatin|mesh-list
44234940|NCT00551577|Docetaxel|docetaxel|mesh-list
44234941|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234942|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234943|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234944|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234945|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234946|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44234947|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44234948|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234949|NCT00551590|Incretins|incretins|mesh-ancestor
44234950|NCT00551590|Hormones|hormones|mesh-ancestor
44234951|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44234952|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44234953|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44234954|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234955|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234956|NCT00551733|Paclitaxel|paclitaxel|mesh-list
44234957|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44234958|NCT00551733|Carboplatin|carboplatin|mesh-list
44234959|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44234960|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44234961|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234962|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
44234963|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
44234964|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
44234965|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234966|NCT00551824|Mitomycins|mitomycins|mesh-list
44234967|NCT00551824|Mitomycin|mitomycin|mesh-list
44234968|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44234969|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234970|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
44234971|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234972|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44234973|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234974|NCT00551850|MP 412|mp 412|mesh-list
44234975|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234976|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43904632|NCT00185900|Analgesics|analgesics|mesh-ancestor
44234977|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234978|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234979|NCT00551889|Celecoxib|celecoxib|mesh-list
44234980|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
44234981|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44234982|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
44234983|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44234984|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44234985|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44234986|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
44234987|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44234988|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44234989|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44234990|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44234991|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44234992|NCT00551889|Analgesics|analgesics|mesh-ancestor
44234993|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
44234994|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44234995|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44234996|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44234997|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44234998|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44234999|NCT00551954|Acarbose|acarbose|mesh-list
44235000|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44235001|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235002|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235003|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235004|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235005|NCT00552149|Cetuximab|cetuximab|mesh-list
44235006|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235007|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235008|NCT00552201|Tacrolimus|tacrolimus|mesh-list
44235009|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235010|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
44235011|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235012|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44235013|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235014|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235015|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
44235016|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235017|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235018|NCT00552266|Methylphenidate|methylphenidate|mesh-list
44235019|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44235020|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235021|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44235022|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44235023|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44235024|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235025|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
43905243|NCT00202722|Remifentanil|remifentanil|mesh-list
44235026|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458684|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44458685|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44458686|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
43905380|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44458687|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458688|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44458689|NCT01592045|Aldesleukin|aldesleukin|mesh-list
44458690|NCT01592045|Molgramostim|molgramostim|mesh-list
44458691|NCT01592045|Dinutuximab|dinutuximab|mesh-list
44458692|NCT01592045|Isotretinoin|isotretinoin|mesh-list
44458693|NCT01592045|Sargramostim|sargramostim|mesh-list
44458694|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905463|NCT00217399|Sorafenib|sorafenib|mesh-list
44458695|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44458696|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44458697|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
44458698|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458699|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458700|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
44458701|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458702|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
44458703|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458704|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458705|NCT01591785|Retapamulin|retapamulin|mesh-list
44458707|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458708|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458709|NCT01591785|Emollients|emollients|mesh-ancestor
44458710|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458711|NCT01591616|Lidocaine|lidocaine|mesh-list
44458712|NCT01591616|Prilocaine|prilocaine|mesh-list
44458713|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
44458714|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
44458715|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458716|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458717|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
44458718|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458719|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44458720|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44458721|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44458722|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905521|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
44458723|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458724|NCT01591460|Ribavirin|ribavirin|mesh-list
44458725|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44458726|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
44458727|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
44458728|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458729|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
44458730|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458731|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
44458732|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458733|NCT01591382|Ketamine|ketamine|mesh-list
44458734|NCT01591382|Hydromorphone|hydromorphone|mesh-list
44458735|NCT01591382|Analgesics|analgesics|mesh-ancestor
44458736|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
44458737|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458738|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458739|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44458740|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44458741|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
44458742|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
44235027|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
44235028|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235029|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235030|NCT00552461|Rituximab|rituximab|mesh-list
44235031|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235032|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235033|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
44235034|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235035|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235036|NCT00552500|Valproic Acid|valproic acid|mesh-list
44235038|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235039|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235040|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
44235041|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235042|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235043|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
44235044|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44235045|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235046|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235047|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
44235048|NCT00552630|Penicillamine|penicillamine|mesh-list
44235049|NCT00552630|Antidotes|antidotes|mesh-ancestor
44235050|NCT00552630|Protective Agents|protective agents|mesh-ancestor
44235051|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235052|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
44235053|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
44235054|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235055|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235057|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44235058|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235059|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235061|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
44235062|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235063|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
44235064|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235065|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44235066|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44235067|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44235068|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44235069|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235070|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235071|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235072|NCT00552682|Analgesics|analgesics|mesh-ancestor
44235073|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
44235074|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235075|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
44235076|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235077|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
44235078|NCT00552734|Insulin|insulin|mesh-list
44235079|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44235080|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235081|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235082|NCT00552747|Fenofibrate|fenofibrate|mesh-list
44235083|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44235084|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
44235085|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235086|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44235087|NCT00552799|Penicillins|penicillins|mesh-list
44235088|NCT00552799|Penicillin V|penicillin v|mesh-list
44235089|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44235090|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235091|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
44235092|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44235093|NCT00552864|Ropivacaine|ropivacaine|mesh-list
44235094|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
44235095|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
44235096|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
43906264|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235097|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235098|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235099|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
44235100|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235101|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
44235102|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235103|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235104|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
44235105|NCT00553072|Analgesics|analgesics|mesh-ancestor
44235106|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
44235107|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235108|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235109|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
44235110|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235111|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44235112|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
44235113|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44235114|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44235115|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235116|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44235117|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
43906301|NCT00248547|Dexamethasone|dexamethasone|mesh-list
44235120|NCT00553124|Selenium|selenium|mesh-list
44235121|NCT00553124|Vitamins|vitamins|mesh-ancestor
44235122|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
44235123|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235124|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
44235125|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235126|NCT00553124|Protective Agents|protective agents|mesh-ancestor
44235127|NCT00553124|Trace Elements|trace elements|mesh-ancestor
44235128|NCT00553137|Fluconazole|fluconazole|mesh-list
44235129|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
44235130|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235131|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44235132|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44235133|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906509|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235134|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235135|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44235136|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
44235137|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235138|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235139|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44235140|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44235141|NCT00553189|Topotecan|topotecan|mesh-list
44235142|NCT00553189|Veliparib|veliparib|mesh-list
44235143|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44235144|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906649|NCT00257933|Hormones|hormones|mesh-ancestor
44235145|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235146|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235147|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235148|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44235149|NCT00553293|Hormones|hormones|mesh-list
44235150|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44235151|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235152|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235153|NCT00553345|Vitamin E|vitamin e|mesh-list
44235154|NCT00553345|Selenium|selenium|mesh-list
43907008|NCT00271219|Narcotics|narcotics|mesh-ancestor
44138546|NCT00171418|Tegaserod|tegaserod|mesh-list
43907194|NCT00282828|Clonazepam|clonazepam|mesh-list
43907264|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
44235156|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
44235157|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235158|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
44235159|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235160|NCT00553345|Protective Agents|protective agents|mesh-ancestor
44235161|NCT00553345|Trace Elements|trace elements|mesh-ancestor
44235162|NCT00553423|Lactulose|lactulose|mesh-list
44235163|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235164|NCT00553449|Rabeprazole|rabeprazole|mesh-list
44235165|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43907337|NCT00287872|Thalidomide|thalidomide|mesh-list
44235166|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43907475|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
44235167|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44235168|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235169|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235171|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44235172|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
44235173|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44235174|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235175|NCT00553553|Morphine|morphine|mesh-list
44235176|NCT00553553|Remifentanil|remifentanil|mesh-list
43888554|NCT04536675|Bromides|bromides|mesh-list
44235177|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44235178|NCT00553553|Narcotics|narcotics|mesh-ancestor
44235179|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235180|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235181|NCT00553553|Analgesics|analgesics|mesh-ancestor
44235182|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
44235183|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235184|NCT00553618|Aldesleukin|aldesleukin|mesh-list
44235185|NCT00553618|Dacarbazine|dacarbazine|mesh-list
44235186|NCT00553618|Interleukin-2|interleukin-2|mesh-list
44235187|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44235188|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
44235189|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907956|NCT05266937|Paclitaxel|paclitaxel|mesh-list
44235190|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235191|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44235192|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44235193|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
44235194|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235195|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44235196|NCT00553618|Analgesics|analgesics|mesh-ancestor
44235197|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
44235199|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235200|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
44235201|NCT00553683|Poly ICLC|poly iclc|mesh-list
44235202|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235203|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
44235204|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235205|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235206|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44235207|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
44235208|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235209|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235210|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44235211|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
44235212|NCT00553709|Nicotine|nicotine|mesh-list
44235213|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44235214|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
44235215|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235216|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235217|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44235218|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44235219|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
44235220|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235221|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235222|NCT00553722|Eplerenone|eplerenone|mesh-list
44235223|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44235224|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
43908465|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
44235225|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235226|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235227|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44235228|NCT00553722|Diuretics|diuretics|mesh-ancestor
44235229|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
44235230|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44235231|NCT00553748|Alovudine|alovudine|mesh-list
44235232|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
44235233|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235234|NCT00553878|Dutasteride|dutasteride|mesh-list
44235235|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44235236|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44235237|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235238|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235239|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
43908859|NCT00310050|Pemetrexed|pemetrexed|mesh-list
44235240|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235241|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235242|NCT00553930|Interferons|interferons|mesh-list
44235243|NCT00553930|Ribavirin|ribavirin|mesh-list
44235244|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
44235245|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
44235246|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44235247|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908925|NCT00312923|Policosanol|policosanol|mesh-list
44235248|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
44235249|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235250|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
44235251|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235252|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
44235253|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235255|NCT00553943|Rituximab|rituximab|mesh-list
43909058|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
44235256|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235257|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235258|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
43909705|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910085|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
44235259|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235260|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235261|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235262|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
43910155|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910224|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235263|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235264|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
44235265|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235266|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910541|NCT00360360|Paclitaxel|paclitaxel|mesh-list
43910592|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
44235267|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44235268|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44235269|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43911048|NCT05287100|Midodrine|midodrine|mesh-list
44235271|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
44235272|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911672|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911776|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
44235273|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235275|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235276|NCT00554086|Bicalutamide|bicalutamide|mesh-list
44235277|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
44235278|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44235279|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235280|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235281|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235283|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912296|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44114808|NCT00100594|Lamivudine|lamivudine|mesh-list
44235284|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912825|NCT00388414|Analgesics|analgesics|mesh-ancestor
43912958|NCT00390559|Nicotine|nicotine|mesh-list
43913259|NCT00395876|Tenecteplase|tenecteplase|mesh-list
43913322|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
43913395|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913772|NCT00410488|BB 1101|bb 1101|mesh-list
43913846|NCT00411411|Incretins|incretins|mesh-ancestor
44235285|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235286|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914251|NCT00423683|PENTA|penta|mesh-list
44235287|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
43914594|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
43914746|NCT00433745|Vaccines|vaccines|mesh-list
43914913|NCT00438971|Analgesics|analgesics|mesh-ancestor
44235288|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235289|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
43915129|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915355|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
43915431|NCT00452374|Cytarabine|cytarabine|mesh-list
43915796|NCT00459810|Estrogens|estrogens|mesh-ancestor
44235290|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235291|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43916022|NCT00464685|Dexamethasone|dexamethasone|mesh-list
43916093|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43916174|NCT00470301|Paclitaxel|paclitaxel|mesh-list
43916469|NCT00476242|Naltrexone|naltrexone|mesh-list
44235292|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43916763|NCT00482677|Temozolomide|temozolomide|mesh-list
44235293|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44235294|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
43916844|NCT00485485|Docetaxel|docetaxel|mesh-list
44235295|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916984|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
43917061|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917150|NCT00492973|Hormones|hormones|mesh-ancestor
44235296|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44235297|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44235298|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235299|NCT00554164|Prednisone|prednisone|mesh-list
44235300|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
44235302|NCT00554164|Vincristine|vincristine|mesh-list
43917446|NCT00501891|Growth Substances|growth substances|mesh-ancestor
43917534|NCT00504023|Imiquimod|imiquimod|mesh-list
43917747|NCT00509002|Gefitinib|gefitinib|mesh-list
43917826|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
43917974|NCT00514709|Vaccines|vaccines|mesh-list
43918231|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43918457|NCT00527124|Hormones|hormones|mesh-ancestor
44235304|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
43918751|NCT00532480|Analgesics|analgesics|mesh-ancestor
43918896|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
43919350|NCT00544778|Irinotecan|irinotecan|mesh-list
43919419|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919498|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43919573|NCT00551707|Hormones|hormones|mesh-ancestor
43919647|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235305|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235306|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920024|NCT05621434|Maleic acid|maleic acid|mesh-list
44235307|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43920476|NCT02949284|Hormones|hormones|mesh-list
44235309|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920694|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667017|NCT01722240|Hormones|hormones|mesh-ancestor
43920955|NCT05193994|Lamivudine|lamivudine|mesh-list
43921037|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
44235310|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921125|NCT04703621|Daratumumab|daratumumab|mesh-list
44235311|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44235312|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235313|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44235314|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235315|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235316|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921634|NCT00398307|Cisplatin|cisplatin|mesh-list
44235317|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
43922010|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
44139550|NCT00175695|Protein C|protein c|mesh-list
44235318|NCT00554164|Hormones|hormones|mesh-ancestor
43922195|NCT04560179|Tobramycin|tobramycin|mesh-list
43668621|NCT02607748|Listerine|listerine|mesh-list
43922476|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235319|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235320|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44235321|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44235323|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
44235324|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44235325|NCT00554177|Mifepristone|mifepristone|mesh-list
44235326|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44235327|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
43922551|NCT03094286|Durvalumab|durvalumab|mesh-list
43922623|NCT02897700|Epirubicin|epirubicin|mesh-list
43922692|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
44235328|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44235329|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235330|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43922856|NCT00571493|Melphalan|melphalan|mesh-list
44235331|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44235332|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44235333|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
43923170|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
43923244|NCT00578461|Cytarabine|cytarabine|mesh-list
43923369|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
44235334|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44235335|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44235336|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
43923989|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235337|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139866|NCT00176774|Irinotecan|irinotecan|mesh-list
44235339|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44139936|NCT00176995|Eflornithine|eflornithine|mesh-list
43925046|NCT00542087|Analgesics|analgesics|mesh-ancestor
44235340|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44235341|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
43925250|NCT00588406|Albuterol|albuterol|mesh-list
44235342|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925634|NCT00595153|Hormones|hormones|mesh-ancestor
43925701|NCT00596271|Vaccines|vaccines|mesh-list
44140011|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235343|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925945|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
43926321|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
43926394|NCT00611468|Topotecan|topotecan|mesh-list
44235344|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44235345|NCT00554203|Analgesics|analgesics|mesh-ancestor
44157424|NCT00234429|Gefitinib|gefitinib|mesh-list
43926657|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926763|NCT00617539|Irinotecan|irinotecan|mesh-list
43926805|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
43927040|NCT00624195|Etravirine|etravirine|mesh-list
44235346|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
43927593|NCT00635232|Irbesartan|irbesartan|mesh-list
44235347|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235348|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140090|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928144|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
43928368|NCT00657917|Paromomycin|paromomycin|mesh-list
43928446|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
44235349|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235350|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928682|NCT00662155|Zolpidem|zolpidem|mesh-list
44235351|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235352|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
43928974|NCT00668564|Busulfan|busulfan|mesh-list
44235353|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
43929058|NCT00670241|Hormones|hormones|mesh-ancestor
44235354|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
43929278|NCT00674115|Omeprazole|omeprazole|mesh-list
44235355|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235356|NCT00554242|Protective Agents|protective agents|mesh-ancestor
44235357|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235358|NCT00554242|Vitamins|vitamins|mesh-ancestor
43929848|NCT00689078|Prednisolone|prednisolone|mesh-list
44235359|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
43929925|NCT00691002|Vitamins|vitamins|mesh-ancestor
44235360|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44235361|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458743|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930261|NCT00699803|Prednisolone|prednisolone|mesh-list
44080013|NCT04777851|Nivolumab|nivolumab|mesh-list
44458744|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43930790|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458745|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43930943|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
43931093|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43931171|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931554|NCT00731588|Biotin|biotin|mesh-list
43931573|NCT00732654|Caseins|caseins|mesh-list
43932163|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43932312|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932692|NCT00761930|Listerine|listerine|mesh-list
43932768|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43933459|NCT00777062|Naltrexone|naltrexone|mesh-list
44458746|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933611|NCT00781898|Naltrexone|naltrexone|mesh-list
43933731|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
43933883|NCT00788255|Oxytocin|oxytocin|mesh-list
43934029|NCT00790062|Oxytocin|oxytocin|mesh-list
43934622|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
43934697|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
43934773|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43934933|NCT00807768|Paclitaxel|paclitaxel|mesh-list
44140529|NCT00179725|Doxorubicin|doxorubicin|mesh-list
43935271|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935604|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
43935677|NCT04661280|Donepezil|donepezil|mesh-list
43935831|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935915|NCT03500731|Rituximab|rituximab|mesh-list
44458747|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458748|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44458749|NCT01591382|Narcotics|narcotics|mesh-ancestor
43936615|NCT00828347|Vitamins|vitamins|mesh-ancestor
44458751|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43937062|NCT00838162|Ritonavir|ritonavir|mesh-list
43937144|NCT00841828|Docetaxel|docetaxel|mesh-list
44458753|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43937326|NCT00845507|Exenatide|exenatide|mesh-list
43937474|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
43937621|NCT00857961|Testosterone|testosterone|mesh-list
43937698|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43937775|NCT00860457|Growth Substances|growth substances|mesh-ancestor
43938058|NCT00867789|Trimethoprim|trimethoprim|mesh-list
43938210|NCT00870363|Efavirenz|efavirenz|mesh-list
43938354|NCT00875277|Betamethasone|betamethasone|mesh-list
43938630|NCT00883675|Docetaxel|docetaxel|mesh-list
43938776|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
44458754|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458755|NCT01590797|Metformin|metformin|mesh-list
44458756|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44458757|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458758|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939592|NCT00912301|Cathartics|cathartics|mesh-ancestor
43939786|NCT00919191|Analgesics|analgesics|mesh-ancestor
43939942|NCT00924209|Gemcitabine|gemcitabine|mesh-list
44458760|NCT01590797|Hormones|hormones|mesh-ancestor
43940165|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940296|NCT00931489|Growth Substances|growth substances|mesh-ancestor
44458761|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458762|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44458763|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
44458764|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940516|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
44458765|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940740|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
43940817|NCT00944450|Hormones|hormones|mesh-ancestor
44458770|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44140875|NCT00181142|Daclizumab|daclizumab|mesh-list
43941927|NCT00974246|Hormones|hormones|mesh-ancestor
43942481|NCT00989911|Bosentan|bosentan|mesh-list
43942708|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458771|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458772|NCT01590771|Incretins|incretins|mesh-ancestor
44458773|NCT01590771|Hormones|hormones|mesh-ancestor
44458774|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458775|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44458776|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943967|NCT05388500|Paclitaxel|paclitaxel|mesh-list
44458777|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944039|NCT04998617|Analgesics|analgesics|mesh-ancestor
44458778|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458779|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44458780|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235363|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44235364|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44235365|NCT00554346|Analgesics|analgesics|mesh-ancestor
44235366|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
44235367|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235368|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945079|NCT05593731|Melatonin|melatonin|mesh-list
44235369|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945146|NCT05583188|Gemcitabine|gemcitabine|mesh-list
44235370|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945425|NCT05224388|Heparin|heparin|mesh-list
43945489|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43945611|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
44141285|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43945700|NCT04291209|Expectorants|expectorants|mesh-ancestor
43945847|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
44235371|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44235372|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946270|NCT01034553|Bortezomib|bortezomib|mesh-list
44235373|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946858|NCT01053507|Analgesics|analgesics|mesh-ancestor
44235374|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235375|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
44235376|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947234|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
44141449|NCT00182819|Temozolomide|temozolomide|mesh-list
43947416|NCT01074177|Afatinib|afatinib|mesh-list
44235377|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44235378|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
43947713|NCT01083706|Azacitidine|azacitidine|mesh-list
44235379|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235380|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44235381|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43948104|NCT01096680|Modafinil|modafinil|mesh-list
44235382|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948248|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
43948292|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948522|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
43948599|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948670|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43948858|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
43948942|NCT01118741|Disulfiram|disulfiram|mesh-list
44235383|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235384|NCT00554424|Lidocaine|lidocaine|mesh-list
44235385|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
44235386|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
44235387|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949167|NCT05307458|Buprenorphine|buprenorphine|mesh-list
43949221|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949297|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949372|NCT04974151|Hematinics|hematinics|mesh-ancestor
44141623|NCT00183859|Irinotecan|irinotecan|mesh-list
43949530|NCT04224766|Bupivacaine|bupivacaine|mesh-list
43949622|NCT03872947|Antidotes|antidotes|mesh-ancestor
44235388|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235389|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
43949922|NCT02066623|Everolimus|everolimus|mesh-list
43950148|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
43950690|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
43950845|NCT01154192|Dexamethasone|dexamethasone|mesh-list
43950912|NCT01158703|Aspirin|aspirin|mesh-list
44235390|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950995|NCT01159054|Niacin|niacin|mesh-list
44141773|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951375|NCT01170715|Analgesics|analgesics|mesh-ancestor
43951602|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
44235391|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44235392|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43952660|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
43952810|NCT01212484|Carbidopa|carbidopa|mesh-list
43952881|NCT01213576|Albendazole|albendazole|mesh-list
43953134|NCT01216761|Iodine|iodine|mesh-list
43953608|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43953685|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
43953759|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235393|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43953909|NCT01234922|Protective Agents|protective agents|mesh-ancestor
43954074|NCT01242241|Propofol|propofol|mesh-list
44235394|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954441|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
43954538|NCT01252732|Vancomycin|vancomycin|mesh-list
44142003|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43954918|NCT01267864|Ketorolac|ketorolac|mesh-list
43955452|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955601|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
44235395|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235396|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
43955898|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955931|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43956079|NCT01305213|Bevacizumab|bevacizumab|mesh-list
43956154|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956230|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44235397|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43956561|NCT01318356|Doxycycline|doxycycline|mesh-list
43956781|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
43956920|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
43957003|NCT01331694|Hormones|hormones|mesh-ancestor
43957075|NCT01332500|Naproxen|naproxen|mesh-list
43957365|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
43957520|NCT01346397|Tacrolimus|tacrolimus|mesh-list
43957626|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957999|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958195|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
44235398|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235400|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235401|NCT00554476|Triamcinolone|triamcinolone|mesh-list
44235402|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44235403|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44235404|NCT00554476|Indomethacin|indomethacin|mesh-list
44235405|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44235406|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235407|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
44235408|NCT00554476|Hormones|hormones|mesh-ancestor
43958783|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
43959002|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959152|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
43959242|NCT01399827|Amphetamine|amphetamine|mesh-list
43959315|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959393|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
43959670|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43959748|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
43959897|NCT01425853|Celecoxib|celecoxib|mesh-list
43960281|NCT01435174|Ranolazine|ranolazine|mesh-list
44236610|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236611|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236612|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
43961045|NCT01468532|Hormones|hormones|mesh-ancestor
43961242|NCT01474200|Furosemide|furosemide|mesh-list
43961387|NCT01477463|Vitamins|vitamins|mesh-list
43961696|NCT01488279|Dexamethasone|dexamethasone|mesh-list
43962075|NCT01498978|Ipilimumab|ipilimumab|mesh-list
44236613|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44236614|NCT00560118|Fotemustine|fotemustine|mesh-list
43962285|NCT01507779|Vaccines|vaccines|mesh-list
44236615|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962366|NCT01509807|Morphine|morphine|mesh-list
43962533|NCT01513902|Tofacitinib|tofacitinib|mesh-list
44236616|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44236617|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
43963243|NCT01535573|Dexetimide|dexetimide|mesh-list
44236618|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236619|NCT00560170|Simvastatin|simvastatin|mesh-list
43963653|NCT01546454|Hormones|hormones|mesh-ancestor
43963669|NCT01547000|Guanfacine|guanfacine|mesh-list
43963927|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964453|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964539|NCT01579305|Lidocaine|lidocaine|mesh-list
43964602|NCT01581658|Empagliflozin|empagliflozin|mesh-list
44142854|NCT00187993|Hormones|hormones|mesh-list
43964800|NCT01587027|Diuretics|diuretics|mesh-ancestor
43965453|NCT05200442|Cetuximab|cetuximab|mesh-list
43965923|NCT05550532|Aticaprant|aticaprant|mesh-list
43966070|NCT05326464|Tofacitinib|tofacitinib|mesh-list
44143100|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
43966655|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966731|NCT03977233|Leucovorin|leucovorin|mesh-list
43966947|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967320|NCT01229878|Vitamin D|vitamin d|mesh-list
43967400|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44143155|NCT00189033|Psyllium|psyllium|mesh-list
43967593|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
43967767|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967840|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
43968011|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
43968160|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
43968395|NCT01611662|Cisplatin|cisplatin|mesh-list
43968454|NCT01614509|Triamcinolone|triamcinolone|mesh-list
43969084|NCT01639352|Pasireotide|pasireotide|mesh-list
43969158|NCT01640340|Dexamethasone|dexamethasone|mesh-list
44236621|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44235409|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235410|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235411|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235412|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
43969941|NCT01666210|Dexamethasone|dexamethasone|mesh-list
44235413|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235414|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235415|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44235416|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44235418|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
44235419|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235420|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235421|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
44235422|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
43970375|NCT01686646|Acetaminophen|acetaminophen|mesh-list
44235423|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44235424|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44235425|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44235427|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
43970812|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
44235428|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970957|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
43971031|NCT01708590|Brodalumab|brodalumab|mesh-list
44236622|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44235429|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235430|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
44235431|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235432|NCT00554528|Meloxicam|meloxicam|mesh-list
44235433|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44236623|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44235434|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43971536|NCT01728636|Coagulants|coagulants|mesh-ancestor
44235435|NCT00554528|Analgesics|analgesics|mesh-ancestor
44235436|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
44235437|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236624|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
43971765|NCT05316675|Isotretinoin|isotretinoin|mesh-list
44235438|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235439|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235440|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235441|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44235442|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43971911|NCT05161338|Estradiol|estradiol|mesh-list
44235443|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235444|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235445|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44235446|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43972242|NCT04425239|Antidotes|antidotes|mesh-ancestor
43972433|NCT04007874|Estrogens|estrogens|mesh-ancestor
43972579|NCT03781752|Methylphenidate|methylphenidate|mesh-list
44235448|NCT00554632|Norgestimate|norgestimate|mesh-list
43972825|NCT02620865|Antidotes|antidotes|mesh-ancestor
44235451|NCT00554632|Estradiol|estradiol|mesh-list
44235452|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43973333|NCT01743976|Donepezil|donepezil|mesh-list
44235453|NCT00554632|Estrogens|estrogens|mesh-ancestor
43973543|NCT01748799|Ethanol|ethanol|mesh-list
43973862|NCT01757561|Propofol|propofol|mesh-list
43973921|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973988|NCT01763645|Paclitaxel|paclitaxel|mesh-list
43974049|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974215|NCT01769586|Midazolam|midazolam|mesh-list
43974575|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43974734|NCT01789814|Clopidogrel|clopidogrel|mesh-list
44236625|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975177|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43975429|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236627|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44236628|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976345|NCT01854177|Aprepitant|aprepitant|mesh-list
43976498|NCT01861002|Cytarabine|cytarabine|mesh-list
44144006|NCT00191126|Cisplatin|cisplatin|mesh-list
44144059|NCT00191243|Antiviral Agents|antiviral agents|mesh-ancestor
44236630|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43977383|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
43977507|NCT02979327|Adderall|adderall|mesh-list
43977661|NCT01794143|Hormones|hormones|mesh-ancestor
44236631|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44236632|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978002|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236633|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978324|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
44236634|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236635|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236636|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43978984|NCT01933776|Vaccines|vaccines|mesh-list
43979068|NCT01937026|Probenecid|probenecid|mesh-list
43979633|NCT01960387|Cytarabine|cytarabine|mesh-list
43979685|NCT01963078|Oxytocin|oxytocin|mesh-list
43979973|NCT01973335|Bumetanide|bumetanide|mesh-list
44144430|NCT00191841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236638|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236639|NCT00560274|Ribavirin|ribavirin|mesh-list
44236640|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43980578|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
43889834|NCT04288713|Eculizumab|eculizumab|mesh-list
43980973|NCT02008942|Aspirin|aspirin|mesh-list
44236641|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
43981448|NCT02033993|Paclitaxel|paclitaxel|mesh-list
43981515|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
43981907|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43982208|NCT02066727|Analgesics|analgesics|mesh-ancestor
43982297|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236642|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982603|NCT02080273|Listerine|listerine|mesh-list
43982746|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
44236643|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
44236644|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983639|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
43984318|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
43984469|NCT02158520|Growth Substances|growth substances|mesh-ancestor
44236648|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44236649|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44236650|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
44236651|NCT00560300|Calcium|calcium|mesh-list
43984730|NCT02168660|Vitamin D|vitamin d|mesh-list
44236652|NCT00560300|Sevelamer|sevelamer|mesh-list
43984947|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
44235455|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235456|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235457|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44235458|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
44235459|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44235460|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44235461|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43985145|NCT02181075|Hematinics|hematinics|mesh-ancestor
44235462|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44235463|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44235464|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44235465|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
44235466|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235467|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44235468|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44235469|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235470|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235471|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
44235472|NCT00554710|Budesonide|budesonide|mesh-list
44235473|NCT00554710|Azathioprine|azathioprine|mesh-list
44235474|NCT00554710|Infliximab|infliximab|mesh-list
44235475|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235476|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
44235477|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
44235478|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235479|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235480|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235481|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
44235482|NCT00554710|Hormones|hormones|mesh-ancestor
44115276|NCT00102154|Gaboxadol|gaboxadol|mesh-list
44235483|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235484|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44235485|NCT00554710|Protective Agents|protective agents|mesh-ancestor
44235486|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235487|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44235488|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44235489|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
44235490|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44235491|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235492|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
44235493|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235494|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235495|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235496|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
44235497|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44235498|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235499|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44235500|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235501|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235502|NCT00554827|Vitamins|vitamins|mesh-list
44235503|NCT00554827|Folic Acid|folic acid|mesh-list
43985600|NCT02201212|Everolimus|everolimus|mesh-list
43985899|NCT02214420|Ribavirin|ribavirin|mesh-list
44235504|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
44235505|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
43986370|NCT02233296|Lasmiditan|lasmiditan|mesh-list
44235506|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
43986679|NCT02249585|Iodine|iodine|mesh-list
43986821|NCT02255110|Doxorubicin|doxorubicin|mesh-list
44235507|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44235508|NCT00554827|Aminopterin|aminopterin|mesh-list
44235509|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
43888791|NCT04533243|Fentanyl|fentanyl|mesh-list
44235510|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235511|NCT00554827|Hematinics|hematinics|mesh-ancestor
44235512|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44235513|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235514|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235515|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235516|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
43987246|NCT02282514|Rituximab|rituximab|mesh-list
44235517|NCT00554918|Prednisolone|prednisolone|mesh-list
44235519|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235520|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44235521|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44235522|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44235523|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988099|NCT02319486|Carboplatin|carboplatin|mesh-list
44235524|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43988469|NCT02337933|Analgesics|analgesics|mesh-ancestor
43988667|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
44235525|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
44235526|NCT00554918|Hormones|hormones|mesh-ancestor
44236653|NCT00560300|Vitamins|vitamins|mesh-ancestor
43724481|NCT02603965|Copper|copper|mesh-list
44236655|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989611|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43989684|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
43989776|NCT02393378|Hematinics|hematinics|mesh-ancestor
43989842|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43989918|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43989992|NCT02406885|Apixaban|apixaban|mesh-list
43990067|NCT02412982|Enoxaparin|enoxaparin|mesh-list
43990100|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990400|NCT02430818|Ketamine|ketamine|mesh-list
43990475|NCT02432716|Insulin|insulin|mesh-list
43990515|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43990602|NCT02439281|Clonidine|clonidine|mesh-list
43990741|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
43990894|NCT02458690|Serotonin|serotonin|mesh-list
43991200|NCT02471651|Dexamethasone|dexamethasone|mesh-list
44236656|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236657|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44236658|NCT00560300|Antacids|antacids|mesh-ancestor
43991961|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236659|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236660|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43992433|NCT02525653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43992585|NCT02531971|Analgesics|analgesics|mesh-ancestor
43992658|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
44235527|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235528|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235529|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993006|NCT02547012|Tetracycline|tetracycline|mesh-list
44235530|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43993231|NCT02562521|Nicotine|nicotine|mesh-list
43993358|NCT02567968|Caffeine|caffeine|mesh-list
43993425|NCT02571439|Ropivacaine|ropivacaine|mesh-list
43993578|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
44235531|NCT00555022|Bromides|bromides|mesh-list
44235532|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
43728247|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
44145560|NCT00195455|Estradiol|estradiol|mesh-list
43994078|NCT03807440|Metformin|metformin|mesh-list
44145602|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
43728819|NCT02575248|Dienogest|dienogest|mesh-list
43994539|NCT05363007|Antidotes|antidotes|mesh-ancestor
43994760|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
44235533|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44235535|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235536|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995302|NCT02605304|Ribavirin|ribavirin|mesh-list
43995508|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
43995581|NCT02621060|Antacids|antacids|mesh-ancestor
44235537|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44235538|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44235539|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
43996354|NCT05553314|Carvedilol|carvedilol|mesh-list
44145904|NCT00196586|Analgesics|analgesics|mesh-ancestor
43996518|NCT05343481|Nivolumab|nivolumab|mesh-list
43996665|NCT05084859|Hormones|hormones|mesh-ancestor
43997172|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43997260|NCT02369406|Lamivudine|lamivudine|mesh-list
44235540|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43997659|NCT02659501|Bupivacaine|bupivacaine|mesh-list
43997814|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43997889|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43998758|NCT02733588|Glucagon|glucagon|mesh-list
44235542|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235543|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235544|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
44235545|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
44235546|NCT00555087|Testosterone|testosterone|mesh-list
44235547|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
44235548|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
44235549|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44235550|NCT00555087|Androgens|androgens|mesh-ancestor
44235551|NCT00555087|Hormones|hormones|mesh-ancestor
44236661|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44236662|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236663|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44236665|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
44236666|NCT00560326|Tacrolimus|tacrolimus|mesh-list
43999291|NCT05411471|Vaccines|vaccines|mesh-list
44236667|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236668|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
44235552|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999669|NCT04868409|Rocuronium|rocuronium|mesh-list
44235553|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235554|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43999884|NCT04408625|Rituximab|rituximab|mesh-list
44235556|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
44235557|NCT00555100|Dexamethasone|dexamethasone|mesh-list
44235558|NCT00555100|Lenalidomide|lenalidomide|mesh-list
44235559|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235560|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
44235561|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
44235562|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235563|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000676|NCT00619931|APD791|apd791|mesh-list
44235564|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235565|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
44235566|NCT00555100|Hormones|hormones|mesh-ancestor
44000743|NCT00059930|Vitamins|vitamins|mesh-ancestor
44236669|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235567|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235568|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44235569|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001368|NCT05364515|Hormones|hormones|mesh-ancestor
44235570|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
44001419|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
44001490|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235572|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235573|NCT00555100|Growth Substances|growth substances|mesh-ancestor
44001651|NCT04969211|Iloperidone|iloperidone|mesh-list
44235574|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235575|NCT00555139|Alprazolam|alprazolam|mesh-list
44235576|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44001821|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44001894|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001965|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44002035|NCT04522206|Oxycodone|oxycodone|mesh-list
44002106|NCT04449965|Povidone|povidone|mesh-list
44002331|NCT03970655|Bupivacaine|bupivacaine|mesh-list
44002414|NCT03910972|Vaccines|vaccines|mesh-list
44002544|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
44235577|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235578|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235579|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44235580|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44235581|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235582|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
44003070|NCT02661971|Vitamins|vitamins|mesh-ancestor
44235583|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
43888867|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
44003292|NCT01854255|Doxorubicin|doxorubicin|mesh-list
44235584|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003368|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
44003455|NCT05454332|Caffeine|caffeine|mesh-list
44235585|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235586|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44235587|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44235588|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44235589|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
44236670|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44235590|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004082|NCT04358393|Azacitidine|azacitidine|mesh-list
44235591|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44236671|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004600|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
44235592|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44235593|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235595|NCT00555256|Sunitinib|sunitinib|mesh-list
44235596|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235597|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44235598|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235599|NCT00555256|Growth Substances|growth substances|mesh-ancestor
44235600|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235601|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
44004789|NCT02756572|Cyclosporins|cyclosporins|mesh-list
44004884|NCT02762331|Vitamins|vitamins|mesh-ancestor
44004936|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44146795|NCT00199095|Methotrexate|methotrexate|mesh-list
44235602|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44235603|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235604|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235605|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44005440|NCT05453500|Antibodies|antibodies|mesh-list
44235606|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005511|NCT05323721|Piperaquine|piperaquine|mesh-list
44005616|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44235607|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235608|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
44005835|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235609|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235610|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
44235612|NCT00555334|Entecavir|entecavir|mesh-list
44235613|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44235614|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44235615|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44006834|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
44235616|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235617|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
44006980|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
44007053|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44235618|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235619|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44235620|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44235621|NCT00555347|Modafinil|modafinil|mesh-list
44235622|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44007401|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
44235623|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007578|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44007652|NCT02812771|Efinaconazole|efinaconazole|mesh-list
44235624|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44007788|NCT02829983|Clarithromycin|clarithromycin|mesh-list
44007863|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
44235625|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44008069|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
44235626|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44008142|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008292|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
44235627|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008405|NCT02896907|Vitamins|vitamins|mesh-list
44235628|NCT00555373|Sirolimus|sirolimus|mesh-list
44235629|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44235630|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235631|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235632|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235633|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
44235634|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235635|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
44235636|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009317|NCT02951702|Vancomycin|vancomycin|mesh-list
44009542|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44009618|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009691|NCT02975297|Exenatide|exenatide|mesh-list
44235639|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235640|NCT00555386|Protective Agents|protective agents|mesh-ancestor
44009772|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
44235641|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235642|NCT00555386|Trace Elements|trace elements|mesh-ancestor
44009918|NCT02996591|Midazolam|midazolam|mesh-list
44235643|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
44235644|NCT00555399|Temozolomide|temozolomide|mesh-list
44235645|NCT00555399|Vorinostat|vorinostat|mesh-list
44235646|NCT00555399|Isotretinoin|isotretinoin|mesh-list
44010062|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235647|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44235648|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
44010167|NCT03012477|Cisplatin|cisplatin|mesh-list
44235649|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235651|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44235652|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235653|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
44235654|NCT00555412|Loxapine|loxapine|mesh-list
44235655|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44235656|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44235657|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235658|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235659|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235660|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44235662|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011178|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44235663|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011329|NCT03096730|Sufentanil|sufentanil|mesh-list
44235665|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235666|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235667|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
44235668|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235669|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235670|NCT00555594|Bevacizumab|bevacizumab|mesh-list
44011808|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44011895|NCT03136328|Edotreotide|edotreotide|mesh-list
44011970|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
44235671|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235673|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44012212|NCT05359068|Valsartan|valsartan|mesh-list
44157783|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
44235674|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235675|NCT00555594|Growth Substances|growth substances|mesh-ancestor
44012416|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44235676|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012545|NCT05405439|Hormones|hormones|mesh-ancestor
44235677|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235678|NCT00555607|Prednisolone|prednisolone|mesh-list
44012852|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44147808|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
44235679|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235680|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
44235681|NCT00555607|Hormones|hormones|mesh-ancestor
44235682|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44235683|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235684|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44080661|NCT03933865|Ketamine|ketamine|mesh-list
44235685|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235686|NCT00555776|Gabapentin|gabapentin|mesh-list
44235687|NCT00555776|Analgesics|analgesics|mesh-ancestor
44235688|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
44235689|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013331|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235690|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235692|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44235693|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44013803|NCT03182920|Lasmiditan|lasmiditan|mesh-list
44013882|NCT03192826|Dipivefrin|dipivefrin|mesh-list
44235694|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235695|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44235696|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44235697|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44235698|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235699|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235700|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
44235701|NCT00555854|Benzocaine|benzocaine|mesh-list
44235702|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
44235703|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
44235704|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235705|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014029|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235706|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
44014240|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
44014524|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
44235707|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014617|NCT03279237|Vitamins|vitamins|mesh-ancestor
44235708|NCT00555867|Anastrozole|anastrozole|mesh-list
44235709|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44235710|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235711|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44147984|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
44015175|NCT03352323|Phenylephrine|phenylephrine|mesh-list
44015254|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44235712|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44235713|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015549|NCT03398278|Oxycodone|oxycodone|mesh-list
44015798|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
44235714|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015876|NCT03449433|Insulin|insulin|mesh-list
44235716|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
44236672|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236673|NCT00560378|Tacrolimus|tacrolimus|mesh-list
44016480|NCT03537274|Interferons|interferons|mesh-list
44016600|NCT03565666|Insulin|insulin|mesh-list
44148181|NCT00203528|Valproic Acid|valproic acid|mesh-list
44236674|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236675|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
44236676|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236677|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44235717|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236678|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017887|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44017962|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235718|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018048|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
44235719|NCT00555984|Remifentanil|remifentanil|mesh-list
44235720|NCT00555984|Propofol|propofol|mesh-list
44018293|NCT04081324|Lasmiditan|lasmiditan|mesh-list
44235722|NCT00555984|Anesthetics|anesthetics|mesh-list
44235723|NCT00555984|Sevoflurane|sevoflurane|mesh-list
44018737|NCT03933618|Anastrozole|anastrozole|mesh-list
44235724|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44235725|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018960|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
44235726|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235727|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
44019503|NCT03734601|Tacrolimus|tacrolimus|mesh-list
44235728|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44019758|NCT03109418|Ketamine|ketamine|mesh-list
44235729|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44235730|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44235731|NCT00555984|Narcotics|narcotics|mesh-ancestor
44235733|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
44235734|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235736|NCT00556023|Tremelimumab|tremelimumab|mesh-list
44021124|NCT01893359|Riboflavin|riboflavin|mesh-list
44021350|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
44021422|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
44235737|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235738|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
44021799|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
44021873|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
44022102|NCT01340573|Interferons|interferons|mesh-list
44235739|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022301|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43752897|NCT02488291|Dsuvia|dsuvia|mesh-list
44022898|NCT00996502|Growth Substances|growth substances|mesh-ancestor
44235740|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235741|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
44023123|NCT00924807|Sorafenib|sorafenib|mesh-list
44023347|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
44235742|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023660|NCT00728845|Paclitaxel|paclitaxel|mesh-list
44235743|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235744|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235745|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
44023830|NCT00684255|Busulfan|busulfan|mesh-list
44023981|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
44024136|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
44235746|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235747|NCT00556062|Vaccines|vaccines|mesh-list
44235748|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
44235749|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235750|NCT00556088|Paclitaxel|paclitaxel|mesh-list
44235751|NCT00556088|Bevacizumab|bevacizumab|mesh-list
44024658|NCT04954638|Eusol|eusol|mesh-list
44235752|NCT00556088|Carboplatin|carboplatin|mesh-list
44235753|NCT00556088|Panobinostat|panobinostat|mesh-list
44235754|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44024910|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235755|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235756|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44235757|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025184|NCT02500576|Analgesics|analgesics|mesh-ancestor
44235758|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025369|NCT00521924|Amebicides|amebicides|mesh-ancestor
44025438|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235759|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025898|NCT00268450|Paclitaxel|paclitaxel|mesh-list
44026027|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
44026176|NCT00019747|Thalidomide|thalidomide|mesh-list
44026256|NCT04422210|Carboplatin|carboplatin|mesh-list
44026404|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026618|NCT00000215|Pergolide|pergolide|mesh-list
44235760|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235761|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44026921|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
44027080|NCT00000273|Fentanyl|fentanyl|mesh-list
44027142|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027446|NCT00000311|Methadone|methadone|mesh-list
44235762|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235763|NCT00556088|Growth Substances|growth substances|mesh-ancestor
44235764|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235765|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235766|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44235767|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235768|NCT00556127|Cytarabine|cytarabine|mesh-list
44235769|NCT00556127|Dexamethasone|dexamethasone|mesh-list
44235770|NCT00556127|Prednisone|prednisone|mesh-list
44235771|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
44235772|NCT00556127|Melphalan|melphalan|mesh-list
44235773|NCT00556127|Carmustine|carmustine|mesh-list
44235774|NCT00556127|Rituximab|rituximab|mesh-list
44027824|NCT00000372|Clozapine|clozapine|mesh-list
44027954|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
44028106|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
44028254|NCT00000483|Clofibrate|clofibrate|mesh-list
44235775|NCT00556127|Etoposide|etoposide|mesh-list
44235776|NCT00556127|Vincristine|vincristine|mesh-list
44235777|NCT00556127|Epirubicin|epirubicin|mesh-list
44235778|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
44235779|NCT00556127|Lenograstim|lenograstim|mesh-list
44028867|NCT00000658|Vitamins|vitamins|mesh-ancestor
44029016|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029101|NCT00000701|Zidovudine|zidovudine|mesh-list
44235780|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44029387|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
44080751|NCT03779789|Citalopram|citalopram|mesh-list
44235782|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235783|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235784|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44235785|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
44030250|NCT00000878|Lamivudine|lamivudine|mesh-list
44235786|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030625|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
44030853|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
44031089|NCT00001009|Dextrans|dextrans|mesh-list
44235787|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031839|NCT00001311|Heparin|heparin|mesh-list
44235788|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44235789|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44032144|NCT00001535|Interleukin-2|interleukin-2|mesh-list
44235790|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44235791|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
44235792|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
44235793|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032858|NCT00001997|Analgesics|analgesics|mesh-ancestor
44235794|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44235795|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
44032996|NCT00002013|Zidovudine|zidovudine|mesh-list
44235797|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033445|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
44235798|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44235799|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44033514|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235800|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44235801|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235802|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235803|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235804|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
44235805|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
44235806|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034708|NCT00002202|Amprenavir|amprenavir|mesh-list
44235807|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44035021|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
44235808|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44235809|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44235810|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235811|NCT00556127|Analgesics|analgesics|mesh-ancestor
44235812|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
44035687|NCT00002307|Zidovudine|zidovudine|mesh-list
44035905|NCT00002333|Zalcitabine|zalcitabine|mesh-list
44235813|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44036129|NCT00002361|Ritonavir|ritonavir|mesh-list
44036278|NCT00002375|Nelfinavir|nelfinavir|mesh-list
44036360|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44235814|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
44036659|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
44157878|NCT00235521|Iloprost|iloprost|mesh-list
44235815|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235816|NCT00556192|Rituximab|rituximab|mesh-list
44235817|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235818|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235819|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
44037358|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
44037445|NCT00002476|Antidotes|antidotes|mesh-ancestor
44037513|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
44235820|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235821|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037890|NCT00002514|Methotrexate|methotrexate|mesh-list
44235823|NCT00556205|Sunitinib|sunitinib|mesh-list
44038124|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
44235824|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235825|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235826|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44038356|NCT00002534|Cytarabine|cytarabine|mesh-list
44235827|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235829|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235830|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44149472|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
44039221|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235831|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44235832|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235833|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235834|NCT00556257|Cyclosporine|cyclosporine|mesh-list
44235835|NCT00556257|Cyclosporins|cyclosporins|mesh-list
44039954|NCT00002654|Cobalt|cobalt|mesh-list
44235836|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040574|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
44040881|NCT00002722|Antidotes|antidotes|mesh-ancestor
44040960|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
44041370|NCT00002764|Ifosfamide|ifosfamide|mesh-list
44041502|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
44041733|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44149530|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
44042174|NCT00002814|Paclitaxel|paclitaxel|mesh-list
44042486|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
44042565|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
44235837|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235838|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235839|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
44235840|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235841|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
44235842|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042717|NCT00002855|Ketoconazole|ketoconazole|mesh-list
44235843|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44235844|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235845|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44235846|NCT00556270|Fentanyl|fentanyl|mesh-list
44235847|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44235848|NCT00556270|Narcotics|narcotics|mesh-ancestor
44043491|NCT00002943|Etoposide|etoposide|mesh-list
44235849|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235850|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235851|NCT00556270|Analgesics|analgesics|mesh-ancestor
44235852|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
44235853|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235854|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44235855|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44235856|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
44235857|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
44458781|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
44044083|NCT00003008|Saquinavir|saquinavir|mesh-list
44458783|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44044383|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149623|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
44044590|NCT00003061|Cytarabine|cytarabine|mesh-list
44458784|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044876|NCT00003087|Cisplatin|cisplatin|mesh-list
44458785|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44115783|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
44458786|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458787|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045869|NCT00003202|Cisplatin|cisplatin|mesh-list
44458788|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458789|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44458790|NCT01590433|Exenatide|exenatide|mesh-list
44458791|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458792|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046762|NCT00003297|Topotecan|topotecan|mesh-list
44458793|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44458794|NCT01590433|Incretins|incretins|mesh-ancestor
44458796|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047207|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
44458797|NCT01590082|Doxycycline|doxycycline|mesh-list
44458798|NCT01590082|Temozolomide|temozolomide|mesh-list
44047594|NCT00003397|Hormones|hormones|mesh-ancestor
44047752|NCT00003405|Analgesics|analgesics|mesh-ancestor
44458799|NCT01590082|Ipilimumab|ipilimumab|mesh-list
44458800|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44458801|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
44458802|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458803|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458804|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458805|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44458806|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458807|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458808|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
44458809|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458810|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44235858|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44235859|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44235860|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235861|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44235862|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44235863|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44048315|NCT00003467|Carmustine|carmustine|mesh-list
44049032|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049186|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
44049646|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049801|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
44235864|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235865|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
44235866|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235867|NCT00556348|Bevacizumab|bevacizumab|mesh-list
44050021|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235868|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050486|NCT00003745|Topotecan|topotecan|mesh-list
44050557|NCT00003757|Rituximab|rituximab|mesh-list
44050703|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
44050879|NCT00003803|Gemcitabine|gemcitabine|mesh-list
44235869|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051190|NCT00003849|Rituximab|rituximab|mesh-list
44051260|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
44051492|NCT00003893|Epirubicin|epirubicin|mesh-list
44051562|NCT00003902|Capecitabine|capecitabine|mesh-list
44051638|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051715|NCT00003928|Immunologic Factors|immunologic factors|mesh-ancestor
44051992|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052372|NCT00004005|Antidotes|antidotes|mesh-ancestor
44052449|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235870|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44235871|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44235872|NCT00556348|Growth Substances|growth substances|mesh-ancestor
44235873|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149851|NCT00209118|Paroxetine|paroxetine|mesh-list
44235874|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44235875|NCT00556361|Ketamine|ketamine|mesh-list
44053609|NCT00004184|Antacids|antacids|mesh-ancestor
44235877|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
44235878|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235879|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054103|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054405|NCT00004276|Thalidomide|thalidomide|mesh-list
44054490|NCT00004310|Clomipramine|clomipramine|mesh-list
44235880|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44055017|NCT00004438|Leuprolide|leuprolide|mesh-list
44055090|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44235881|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44235882|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
44055256|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
44055411|NCT00004581|Ritonavir|ritonavir|mesh-list
44235884|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44055477|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055545|NCT00004652|Pimozide|pimozide|mesh-list
44055617|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44055991|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
44056068|NCT00004794|Cidofovir|cidofovir|mesh-list
44235885|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44235886|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44056443|NCT00004871|Azacitidine|azacitidine|mesh-list
44057182|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057254|NCT00005021|Paclitaxel|paclitaxel|mesh-list
44057332|NCT00005029|Topotecan|topotecan|mesh-list
44235887|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44057511|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
44057586|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057664|NCT00005089|Hormones|hormones|mesh-ancestor
44235888|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235889|NCT00556387|Ketamine|ketamine|mesh-list
44235890|NCT00556387|Analgesics|analgesics|mesh-ancestor
44057886|NCT00005575|Imipramine|imipramine|mesh-list
44235891|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
44058393|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235892|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44235893|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058471|NCT00005627|Carboplatin|carboplatin|mesh-list
44235894|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44235895|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44235896|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
44235897|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
44235898|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44235899|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44059018|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
44059319|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059625|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081003|NCT03151876|Busulfan|busulfan|mesh-list
44235901|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235902|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235904|NCT00556413|Fluorouracil|fluorouracil|mesh-list
44235905|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
44235906|NCT00556413|Irinotecan|irinotecan|mesh-list
44235907|NCT00556413|Cetuximab|cetuximab|mesh-list
44235908|NCT00556413|Calcium|calcium|mesh-list
44235909|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
44235910|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44235911|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235912|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
44235913|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235914|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235915|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235916|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235917|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
44060085|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060234|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235918|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44235919|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44235920|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235921|NCT00556413|Antidotes|antidotes|mesh-ancestor
44235922|NCT00556413|Protective Agents|protective agents|mesh-ancestor
44235923|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
44235924|NCT00556413|Vitamins|vitamins|mesh-ancestor
44060614|NCT00005987|Analgesics|analgesics|mesh-ancestor
44235925|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
44235926|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44235927|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
44235928|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44235930|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235931|NCT00556465|Expectorants|expectorants|mesh-ancestor
44235932|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44235934|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
44061200|NCT05680857|Ubiquinone|ubiquinone|mesh-list
44061354|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44235935|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235936|NCT00556465|Protective Agents|protective agents|mesh-ancestor
44235937|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235938|NCT00556465|Antidotes|antidotes|mesh-ancestor
44235939|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44061758|NCT05431543|Miotics|miotics|mesh-ancestor
44235940|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
44235941|NCT00556608|Hylan|hylan|mesh-list
44235942|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44235943|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
44235944|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235945|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
44235946|NCT00556608|Protective Agents|protective agents|mesh-ancestor
44235947|NCT00556621|Gemcitabine|gemcitabine|mesh-list
44235948|NCT00556621|Cisplatin|cisplatin|mesh-list
44235949|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062147|NCT04803084|TEMPO|tempo|mesh-list
44235950|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44235951|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
44235952|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235953|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
44235954|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235955|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44235956|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44235957|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
44235958|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235960|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44235961|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44062482|NCT04355572|Vitamin D|vitamin d|mesh-list
44235962|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062653|NCT04083950|Aspirin|aspirin|mesh-list
44235963|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235964|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
44235965|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44235966|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44235967|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44235968|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44063123|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150512|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
44063977|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
44235969|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44235970|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44064854|NCT00006275|Vitamins|vitamins|mesh-ancestor
44064918|NCT00006294|Diuretics|diuretics|mesh-ancestor
44235971|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44235972|NCT00556699|Rituximab|rituximab|mesh-list
44235973|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44065140|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44235974|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44235976|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235977|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44235978|NCT00556959|Clonidine|clonidine|mesh-list
44235979|NCT00556959|Analgesics|analgesics|mesh-ancestor
44235980|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
44235981|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065711|NCT00006459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065788|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
44065864|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
44235982|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235983|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44235985|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
44150735|NCT00211328|Anecortave|anecortave|mesh-list
44235986|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44066995|NCT00008268|Melphalan|melphalan|mesh-list
44067063|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067137|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44235987|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44235989|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44067619|NCT00000136|Foscarnet|foscarnet|mesh-list
44067689|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44235990|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44235991|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44235992|NCT00557011|Amphetamine|amphetamine|mesh-list
44068074|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
44068230|NCT00000466|Progesterone|progesterone|mesh-list
44235993|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44235995|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44235996|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44235997|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
44235998|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
44235999|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236000|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
44236001|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236002|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236003|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236004|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44236005|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236006|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236007|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44236008|NCT00557102|Leucovorin|leucovorin|mesh-list
44236009|NCT00557102|Fluorouracil|fluorouracil|mesh-list
44236010|NCT00557102|Irinotecan|irinotecan|mesh-list
44236011|NCT00557102|Cetuximab|cetuximab|mesh-list
44236012|NCT00557102|Calcium|calcium|mesh-list
44236013|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
44236014|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236015|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236016|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
44236017|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236018|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236019|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236020|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069212|NCT00000644|Clarithromycin|clarithromycin|mesh-list
44236022|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44069496|NCT00000690|Dextrans|dextrans|mesh-list
44236023|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44069650|NCT00000720|Zidovudine|zidovudine|mesh-list
44236024|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069733|NCT00000745|Vaccines|vaccines|mesh-list
44236026|NCT00557102|Protective Agents|protective agents|mesh-ancestor
44069944|NCT00000793|Mexiletine|mexiletine|mesh-list
44236027|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44236028|NCT00557102|Vitamins|vitamins|mesh-ancestor
44070477|NCT00000922|Lamivudine|lamivudine|mesh-list
44236029|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
44070551|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
44236030|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236031|NCT00557180|Beclomethasone|beclomethasone|mesh-list
44236032|NCT00557180|Bromides|bromides|mesh-list
44236033|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
44236034|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44070957|NCT00001029|Didanosine|didanosine|mesh-list
44071111|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236035|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44071195|NCT00001084|Lamivudine|lamivudine|mesh-list
44236036|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
44236037|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236038|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236039|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236040|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236041|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
44236042|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44236043|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
44236044|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116048|NCT00104715|Goserelin|goserelin|mesh-list
44236045|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236046|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44236047|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44236048|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44071671|NCT00001482|Gabapentin|gabapentin|mesh-list
44236049|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236050|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
44236051|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236052|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
44236053|NCT00557180|Hormones|hormones|mesh-ancestor
44236054|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236055|NCT00557206|Docetaxel|docetaxel|mesh-list
44236056|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
44236057|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236058|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44236059|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44236060|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236061|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236062|NCT00557219|Fenoldopam|fenoldopam|mesh-list
44236063|NCT00557219|Ketanserin|ketanserin|mesh-list
44236064|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236065|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44236066|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
44236067|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
44236068|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236069|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236070|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236071|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236072|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44236073|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
44236074|NCT00557232|Bevacizumab|bevacizumab|mesh-list
44236075|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236076|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236077|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44236078|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44236079|NCT00557232|Growth Substances|growth substances|mesh-ancestor
44236080|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236081|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
44236082|NCT00557427|Fluoxetine|fluoxetine|mesh-list
44236083|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44236084|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236085|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236086|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236087|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236088|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
44236089|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236090|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44236091|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
44236092|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236093|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44236094|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44236095|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236096|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44236097|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44236098|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236099|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
44072147|NCT05641506|Niraparib|niraparib|mesh-list
44236101|NCT00557544|Metoclopramide|metoclopramide|mesh-list
44236102|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
44236103|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
44236104|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116063|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
44236105|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236106|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236107|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44236108|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44236109|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
44236110|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236111|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236112|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44236113|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236114|NCT00557544|Analgesics|analgesics|mesh-ancestor
44236115|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
44236116|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236117|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072292|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
44236118|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44236119|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072524|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
44236121|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236122|NCT00557700|Bromides|bromides|mesh-list
44236123|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
44236124|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44236125|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
44236126|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073331|NCT04908371|Lidocaine|lidocaine|mesh-list
44236127|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236128|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44073976|NCT04142983|Vaccines|vaccines|mesh-list
44236129|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236130|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
44074329|NCT03746106|Trimethoprim|trimethoprim|mesh-list
44236131|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44236132|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
44236133|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074613|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074771|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
44074917|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
44151448|NCT00214318|Metoprolol|metoprolol|mesh-list
44075085|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
44236134|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075161|NCT02454933|Durvalumab|durvalumab|mesh-list
44236135|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
44236136|NCT00557713|Bevacizumab|bevacizumab|mesh-list
44075311|NCT01902173|Trametinib|trametinib|mesh-list
44236137|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075388|NCT00777036|Dasatinib|dasatinib|mesh-list
44236138|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236139|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44236140|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44236141|NCT00557713|Growth Substances|growth substances|mesh-ancestor
44151516|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44236142|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236143|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
44236144|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
44236145|NCT00557739|Nortriptyline|nortriptyline|mesh-list
44076668|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
44236146|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236147|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076989|NCT00014274|Vinblastine|vinblastine|mesh-list
44236148|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44236149|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44236150|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
44236151|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236152|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44236153|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236154|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44078107|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078870|NCT00017862|Reslizumab|reslizumab|mesh-list
44079013|NCT00018200|Fluoxetine|fluoxetine|mesh-list
44236155|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151675|NCT00215163|Paroxetine|paroxetine|mesh-list
44236157|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236158|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236159|NCT00557791|Ranibizumab|ranibizumab|mesh-list
44079380|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
44236160|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44079455|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236171|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
44236161|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44079528|NCT05525325|Anesthetics|anesthetics|mesh-list
44236162|NCT00557791|Growth Substances|growth substances|mesh-ancestor
44236163|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236164|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
44079977|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236165|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236166|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
44236167|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44236168|NCT00557817|Hematinics|hematinics|mesh-ancestor
44236169|NCT00557843|Bupivacaine|bupivacaine|mesh-list
44080732|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
44081069|NCT03151707|Niacin|niacin|mesh-list
44236170|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44081274|NCT03150810|Temozolomide|temozolomide|mesh-list
44119425|NCT00117520|Caffeine|caffeine|mesh-list
44119724|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44236481|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236482|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44236484|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
44236485|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236486|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44236487|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44236488|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119878|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119990|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
44120062|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120133|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
44120211|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
44120361|NCT00120796|Lamivudine|lamivudine|mesh-list
44154604|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44120451|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
44236489|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236490|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44121387|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
44121503|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
44121577|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121725|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
44236492|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44236493|NCT00559494|Minocycline|minocycline|mesh-list
44121956|NCT00125892|Analgesics|analgesics|mesh-ancestor
44236494|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122089|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
44236495|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122187|NCT00126451|Vorinostat|vorinostat|mesh-list
44122391|NCT00127257|Diazepam|diazepam|mesh-list
44236496|NCT00559546|Montelukast|montelukast|mesh-list
44122521|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44236497|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44122675|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
44122891|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
44123097|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123460|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123560|NCT02778685|Letrozole|letrozole|mesh-list
44123924|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124000|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
44236498|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44124248|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124325|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44124399|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44236499|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44124652|NCT00133523|Vaccines|vaccines|mesh-list
44124802|NCT00134030|Methotrexate|methotrexate|mesh-list
44236500|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
44236684|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458853|NCT01589445|Pioglitazone|pioglitazone|mesh-list
44125372|NCT00135577|Alvimopan|alvimopan|mesh-list
44125590|NCT00136175|Paclitaxel|paclitaxel|mesh-list
44458855|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236685|NCT00560443|Ketorolac|ketorolac|mesh-list
44125886|NCT00136942|Atorvastatin|atorvastatin|mesh-list
44126098|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
44236686|NCT00560443|Tramadol|tramadol|mesh-list
44126153|NCT00137735|Gabapentin|gabapentin|mesh-list
44236501|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236502|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126510|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
44126620|NCT00139230|Leucovorin|leucovorin|mesh-list
44127059|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
44127187|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44236503|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44127545|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
44127826|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236504|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128118|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128191|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128351|NCT00143975|Cytarabine|cytarabine|mesh-list
44128388|NCT00144066|Gefitinib|gefitinib|mesh-list
44128455|NCT00144209|Levodopa|levodopa|mesh-list
44128774|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
44128849|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44128928|NCT05462236|Irinotecan|irinotecan|mesh-list
44129006|NCT05367336|Analgesics|analgesics|mesh-ancestor
44129157|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
44129228|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44129338|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129416|NCT04720781|Esomeprazole|esomeprazole|mesh-list
44129545|NCT04334759|Cisplatin|cisplatin|mesh-list
44236505|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236507|NCT00559676|Fluorouracil|fluorouracil|mesh-list
44236508|NCT00559676|Capecitabine|capecitabine|mesh-list
44130577|NCT00146016|Analgesics|analgesics|mesh-ancestor
44236509|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
44236510|NCT00559676|Irinotecan|irinotecan|mesh-list
44236511|NCT00559676|Calcium|calcium|mesh-list
44236512|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
44130892|NCT00146783|Renal Agents|renal agents|mesh-ancestor
44131118|NCT00147680|Paclitaxel|paclitaxel|mesh-list
44131186|NCT00147875|Hormones|hormones|mesh-ancestor
44131259|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131409|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131581|NCT00148837|Ribavirin|ribavirin|mesh-list
44131738|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
44131808|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
44131900|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
44131999|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44132368|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132450|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
44236513|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236514|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236515|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
44132695|NCT00151827|Diuretics|diuretics|mesh-ancestor
44132989|NCT00152633|Losartan|losartan|mesh-list
43852010|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852161|NCT03869450|Lidocaine|lidocaine|mesh-list
43852423|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852587|NCT03825796|Cytarabine|cytarabine|mesh-list
43852895|NCT03805607|Analgesics|analgesics|mesh-ancestor
43852930|NCT03805022|Ifosfamide|ifosfamide|mesh-list
43853013|NCT03794037|Hormones|hormones|mesh-ancestor
43853157|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853321|NCT03773666|Durvalumab|durvalumab|mesh-list
43853604|NCT03744026|Carboplatin|carboplatin|mesh-list
43853745|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853821|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
44236516|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854253|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
44236517|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236518|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236519|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236520|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
44236521|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44236522|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43854494|NCT03666559|Azacitidine|azacitidine|mesh-list
44236523|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236524|NCT00559676|Antidotes|antidotes|mesh-ancestor
44236525|NCT00559676|Protective Agents|protective agents|mesh-ancestor
43854965|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
44236526|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
44236527|NCT00559676|Vitamins|vitamins|mesh-ancestor
44236528|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
44236529|NCT00559689|Budesonide|budesonide|mesh-list
43855308|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
43855513|NCT03559348|Leucovorin|leucovorin|mesh-list
43855585|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
44236530|NCT00559689|Beclomethasone|beclomethasone|mesh-list
43855739|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44236531|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855812|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43855885|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236532|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43856440|NCT03450122|Analgesics|analgesics|mesh-ancestor
44236534|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856579|NCT03435718|Oxfendazole|oxfendazole|mesh-list
43856658|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44133609|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
43856848|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857140|NCT03367013|Lactoferrin|lactoferrin|mesh-list
44236535|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857343|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
44236536|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236537|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
43857964|NCT03274258|Nivolumab|nivolumab|mesh-list
44236539|NCT00559689|Hormones|hormones|mesh-ancestor
43858189|NCT03243019|Sirolimus|sirolimus|mesh-list
44236540|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44236541|NCT00559702|Natalizumab|natalizumab|mesh-list
44236542|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
44236543|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236544|NCT00559715|Bevacizumab|bevacizumab|mesh-list
44236545|NCT00559715|Ranibizumab|ranibizumab|mesh-list
44236546|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236547|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236548|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44236549|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44236550|NCT00559715|Growth Substances|growth substances|mesh-ancestor
44236551|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236552|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44236553|NCT00559741|Leucovorin|leucovorin|mesh-list
43858322|NCT03231722|Vitamins|vitamins|mesh-ancestor
44236555|NCT00559741|Irinotecan|irinotecan|mesh-list
44236556|NCT00559741|Cetuximab|cetuximab|mesh-list
43858681|NCT03174197|Temozolomide|temozolomide|mesh-list
44236557|NCT00559741|Calcium|calcium|mesh-list
44236558|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
43858911|NCT03136146|Bortezomib|bortezomib|mesh-list
43859063|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
43859215|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44236559|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43859322|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
43859405|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
43859474|NCT03077451|Nelfinavir|nelfinavir|mesh-list
44236560|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236561|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
44236562|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236563|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859955|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236564|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860080|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
44236565|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860160|NCT03007147|Hormones|hormones|mesh-ancestor
44236566|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
43860309|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43860383|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44236567|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860602|NCT02954055|Paclitaxel|paclitaxel|mesh-list
44236568|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860830|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
44236569|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236570|NCT00559741|Antidotes|antidotes|mesh-ancestor
44236571|NCT00559741|Protective Agents|protective agents|mesh-ancestor
44236572|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
44236573|NCT00559741|Vitamins|vitamins|mesh-ancestor
44236574|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
44236575|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236576|NCT00559858|Pyridoxine|pyridoxine|mesh-list
44236577|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
43861647|NCT02757885|Thiotepa|thiotepa|mesh-list
43862238|NCT02703610|Narcotics|narcotics|mesh-ancestor
44236580|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
43862557|NCT02652429|Protective Agents|protective agents|mesh-ancestor
43862719|NCT02627846|Lidocaine|lidocaine|mesh-list
44134054|NCT00156689|Levetiracetam|levetiracetam|mesh-list
43862791|NCT02620189|Adalimumab|adalimumab|mesh-list
43862863|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862937|NCT02594111|Colchicine|colchicine|mesh-list
43863405|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236581|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236582|NCT00559975|Vaccines|vaccines|mesh-list
44236583|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
43863808|NCT02427620|Antibodies|antibodies|mesh-list
43863957|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
43864032|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43864111|NCT02387203|Amoxicillin|amoxicillin|mesh-list
43864254|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236584|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864613|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
44236172|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44236586|NCT00560079|Dipyridamole|dipyridamole|mesh-list
43865127|NCT02135874|Rituximab|rituximab|mesh-list
43865202|NCT02124421|Carboplatin|carboplatin|mesh-list
43865871|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
43865947|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43866099|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866281|NCT01829568|Rituximab|rituximab|mesh-list
43866435|NCT01787487|Azacitidine|azacitidine|mesh-list
43866510|NCT01763580|Hormones|hormones|mesh-ancestor
43866582|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43866745|NCT01668849|Fentanyl|fentanyl|mesh-list
43866811|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44236588|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867309|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
44236589|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236591|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236592|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43868073|NCT00880594|Desipramine|desipramine|mesh-list
43868294|NCT00784823|Bortezomib|bortezomib|mesh-list
43868382|NCT00716443|Lidocaine|lidocaine|mesh-list
44236594|NCT00560079|Protective Agents|protective agents|mesh-ancestor
44236595|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868912|NCT00256399|Alfuzosin|alfuzosin|mesh-list
44236596|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43869103|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236597|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236598|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
44236599|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
44237497|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44237498|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44237499|NCT00564174|Analgesics|analgesics|mesh-ancestor
44237500|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
44237501|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44237502|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237503|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237504|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44237505|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44237506|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44237507|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237508|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44237509|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44237510|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237511|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
44237512|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
44237513|NCT00564187|Irbesartan|irbesartan|mesh-list
44237514|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44237515|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44237516|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44237779|NCT00564993|Protective Agents|protective agents|mesh-ancestor
44237780|NCT00565006|Anacetrapib|anacetrapib|mesh-list
44237781|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44237782|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44237783|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
44237784|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237785|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44237786|NCT00565019|Triamcinolone|triamcinolone|mesh-list
44237787|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44237788|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44237789|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44237790|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44237791|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
44237792|NCT00565019|Hormones|hormones|mesh-ancestor
44237793|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44237794|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44237795|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44237796|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
44237797|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237798|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237799|NCT00565097|Lanreotide|lanreotide|mesh-list
44237800|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237801|NCT00565123|Levofloxacin|levofloxacin|mesh-list
44237802|NCT00565123|Ofloxacin|ofloxacin|mesh-list
44237803|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44237804|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44237805|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44237806|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44237808|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44237809|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44237810|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44237811|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44237812|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44237813|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44237814|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44237815|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44238497|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
44238498|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238499|NCT00568113|Protective Agents|protective agents|mesh-ancestor
44238500|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238501|NCT00568113|Antidotes|antidotes|mesh-ancestor
44238503|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44238504|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44238505|NCT00568152|Analgesics|analgesics|mesh-ancestor
44238506|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
43891532|NCT01426529|Norepinephrine|norepinephrine|mesh-list
44238507|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44238508|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44238509|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44238510|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44238511|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44238696|NCT00568971|Docetaxel|docetaxel|mesh-list
44238697|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44238698|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44238699|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44238700|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44238701|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44238702|NCT00568984|Metformin|metformin|mesh-list
44238703|NCT00568984|Repaglinide|repaglinide|mesh-list
44238704|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43884499|NCT04595942|Midodrine|midodrine|mesh-list
44240554|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44240555|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44240556|NCT00580931|Niacinamide|niacinamide|mesh-list
44240557|NCT00580931|Niacin|niacin|mesh-list
44240558|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
44240559|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
44240560|NCT00580931|Vitamins|vitamins|mesh-ancestor
44240561|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
44240562|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240563|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44240564|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
44240565|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44240566|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44240567|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44240568|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
44240569|NCT00581009|Sertraline|sertraline|mesh-list
44240570|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
44240934|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
44240935|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44240936|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44240937|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44240938|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44240939|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240941|NCT00584779|Analgesics|analgesics|mesh-ancestor
44240942|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
44240943|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44240944|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44240945|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
44240946|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44240947|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44241145|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241146|NCT00586794|Urological Agents|urological agents|mesh-ancestor
44241147|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44241148|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241149|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241150|NCT00586911|Betaine|betaine|mesh-list
44241151|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44241152|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
44241153|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44241154|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
44236173|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44241155|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44241156|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44241216|NCT00587496|Aspirin|aspirin|mesh-list
44241341|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
44241387|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44241388|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44241389|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44242007|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242008|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
44242009|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44242011|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
44242012|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
44242013|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44242014|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242015|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
44242016|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44242017|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
44242018|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44242806|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44242808|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44242809|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
44242810|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44242811|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242812|NCT00598637|Everolimus|everolimus|mesh-list
44242813|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242814|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44242815|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
44242854|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44242855|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
44242856|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
44242857|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
44244736|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44244737|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244738|NCT05145413|Urological Agents|urological agents|mesh-ancestor
44244739|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44244740|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44244741|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44244742|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44244744|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244745|NCT05135104|Palbociclib|palbociclib|mesh-list
44244746|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44244747|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44244748|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44244749|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44244750|NCT05125146|Trazodone|trazodone|mesh-list
44244751|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44244752|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116538|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459827|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459828|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459829|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44459831|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44459832|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44459833|NCT01573767|Fluticasone|fluticasone|mesh-list
44459834|NCT01573767|Xhance|xhance|mesh-list
44459835|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44459836|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44459837|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
44459838|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459839|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459840|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44459841|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
44459842|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44459843|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44459844|NCT01573442|Testosterone|testosterone|mesh-list
44459845|NCT01573442|Androgens|androgens|mesh-ancestor
44459846|NCT01573442|Hormones|hormones|mesh-ancestor
44459847|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44459848|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459849|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
44459850|NCT01573000|Antibodies|antibodies|mesh-list
44459851|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
44459852|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
44459853|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236174|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
44236175|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44459854|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44459855|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
44459856|NCT01572844|Antidotes|antidotes|mesh-ancestor
44459857|NCT01572844|Protective Agents|protective agents|mesh-ancestor
44459858|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44459859|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
44459860|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44459861|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
44459862|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44459863|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44459864|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
44244845|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44244846|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44244847|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44244848|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
44244850|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
44244851|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44245231|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245233|NCT04759833|Prucalopride|prucalopride|mesh-list
44245234|NCT04759833|Laxatives|laxatives|mesh-ancestor
44245235|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44245236|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44245237|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44245238|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
44245239|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245240|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245241|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245242|NCT04753749|Aspirin|aspirin|mesh-list
44245243|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44245244|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44245245|NCT04753749|Analgesics|analgesics|mesh-ancestor
44245246|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
44245247|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44245248|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245249|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44245250|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44245251|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44245252|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44245253|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245254|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44245255|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44245256|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44245257|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
44245258|NCT04748523|Mirtazapine|mirtazapine|mesh-list
44245259|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
44245260|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44245261|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44245262|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
44245263|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
44245264|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44245265|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44245266|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44245267|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44245268|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44245269|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44245270|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44245271|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44245272|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44245273|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44245274|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44245275|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44245276|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
44247270|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44247272|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44247273|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44247274|NCT02899000|Doxycycline|doxycycline|mesh-list
44247275|NCT02899000|Adapalene|adapalene|mesh-list
44081838|NCT01807000|Prucalopride|prucalopride|mesh-list
44247276|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44247277|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44247278|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44247279|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
44247280|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43646235|NCT03341156|Thrombin|thrombin|mesh-list
44247429|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
44247430|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44247431|NCT02310321|Cytarabine|cytarabine|mesh-list
44247432|NCT02310321|Idarubicin|idarubicin|mesh-list
44247433|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43646394|NCT03148327|Durvalumab|durvalumab|mesh-list
44247471|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44247472|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
44247473|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248432|NCT00603434|Methylphenidate|methylphenidate|mesh-list
44248433|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44248434|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248435|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44248436|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44248437|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44248438|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248439|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
44248440|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44248442|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44248443|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44248444|NCT00603759|Analgesics|analgesics|mesh-ancestor
44248445|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
44248446|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44248447|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44248448|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44248449|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44248450|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44248451|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44248452|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248453|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248454|NCT00603772|Tretinoin|tretinoin|mesh-list
44248455|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44248456|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
44248457|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44248542|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248544|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44248545|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44248546|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248547|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43647233|NCT02208375|Olaparib|olaparib|mesh-list
44248753|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248754|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44248755|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44248756|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248757|NCT00606060|Factor VIII|factor viii|mesh-list
44248758|NCT00606060|Coagulants|coagulants|mesh-ancestor
44248759|NCT00606099|Adefovir|adefovir|mesh-list
44248760|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44248761|NCT00606099|Telbivudine|telbivudine|mesh-list
44248762|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
44248763|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44248764|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44248765|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44248766|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44248767|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44248932|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
44249034|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
44249035|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44249036|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44249037|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249038|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44249039|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
44249040|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249041|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43902340|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44249042|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
44249043|NCT00607685|Protective Agents|protective agents|mesh-ancestor
44249044|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
44249045|NCT00607711|Ifosfamide|ifosfamide|mesh-list
44249046|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44249047|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
43647643|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44249361|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44249362|NCT00609596|Dutasteride|dutasteride|mesh-list
44249363|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44460494|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44460495|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460497|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44460498|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
44460499|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
44250325|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44250326|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250327|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
44250328|NCT03007329|Exenatide|exenatide|mesh-list
44250329|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44250330|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250331|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44250332|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250333|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44250334|NCT03007329|Incretins|incretins|mesh-ancestor
44250402|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250403|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44250404|NCT01898793|Aldesleukin|aldesleukin|mesh-list
44250405|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
44250406|NCT01898793|Fludarabine|fludarabine|mesh-list
44250407|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
44250408|NCT01898793|Interleukin-2|interleukin-2|mesh-list
44250409|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44250410|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
44250411|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250412|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44250413|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44250414|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
44250415|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250416|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250417|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44250418|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44250419|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
44250509|NCT00588185|Testosterone|testosterone|mesh-list
44250510|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
44250511|NCT00588185|Androgens|androgens|mesh-ancestor
44250512|NCT00588185|Hormones|hormones|mesh-ancestor
44250513|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44250514|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250515|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
44250516|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250517|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
44250518|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44250519|NCT05333250|Modafinil|modafinil|mesh-list
44250520|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44250521|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250522|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44250523|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44250568|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44250569|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
44250570|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44250571|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44250572|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44250573|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44250574|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44250575|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
44250576|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44250577|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250578|NCT05332106|Androgens|androgens|mesh-ancestor
44250579|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
44250580|NCT05332028|Fentanyl|fentanyl|mesh-list
44250581|NCT05332028|Bupivacaine|bupivacaine|mesh-list
44250582|NCT05332028|Propofol|propofol|mesh-list
44250583|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
44250584|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
44250585|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250586|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250587|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
44250629|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44250630|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44250631|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44250632|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250634|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44250635|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
44250636|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250637|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250638|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
44250639|NCT05287360|Apatinib|apatinib|mesh-list
44250640|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44250641|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44250642|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44250643|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44250644|NCT05280743|Oxycodone|oxycodone|mesh-list
44250645|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44250646|NCT05280743|Narcotics|narcotics|mesh-ancestor
44250647|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44250648|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44250649|NCT05280743|Analgesics|analgesics|mesh-ancestor
44250650|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
44250651|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44250652|NCT05263453|Vemurafenib|vemurafenib|mesh-list
44251040|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
44251041|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44251042|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44251043|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251044|NCT02339922|Rituximab|rituximab|mesh-list
44251045|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44251046|NCT02339922|Ixazomib|ixazomib|mesh-list
44251047|NCT02339922|Antibodies|antibodies|mesh-list
44251048|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
44251049|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44251050|NCT02339922|Glycine|glycine|mesh-list
44251051|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
44251052|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251053|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251054|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251055|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251056|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
44251057|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251058|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
44251059|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251060|NCT01497509|Epinephrine|epinephrine|mesh-list
44251061|NCT01497509|Racepinephrine|racepinephrine|mesh-list
44251062|NCT01497509|Fentanyl|fentanyl|mesh-list
44251063|NCT01497509|Bupivacaine|bupivacaine|mesh-list
44251064|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
44251065|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251066|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
44251207|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251208|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251210|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
44251211|NCT05334316|Hormones|hormones|mesh-ancestor
44251212|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251213|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251214|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251215|NCT05334251|Anesthetics|anesthetics|mesh-list
44251216|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251217|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251218|NCT05334043|Curcumin|curcumin|mesh-list
44251219|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44251220|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44251221|NCT05334043|Analgesics|analgesics|mesh-ancestor
44251222|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
44251223|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251224|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251225|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251226|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251227|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251228|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251229|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251230|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
44251231|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251232|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251233|NCT05333744|Prednisone|prednisone|mesh-list
44251236|NCT05333744|Hormones|hormones|mesh-ancestor
44251237|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251238|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251239|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251240|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251241|NCT05333731|Oxytocin|oxytocin|mesh-list
44251242|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
44251317|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44251318|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44251319|NCT05306379|Simvastatin|simvastatin|mesh-list
44251320|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44251321|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44251322|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
44251323|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251324|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44251325|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44251326|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251327|NCT05304663|Lomustine|lomustine|mesh-list
44251328|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44251329|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
44251330|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251331|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251332|NCT05288777|Capecitabine|capecitabine|mesh-list
44251333|NCT05288777|Trastuzumab|trastuzumab|mesh-list
44251334|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44251335|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44251336|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
44251337|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251338|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251339|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251340|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251341|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251342|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251343|NCT05258747|Olaparib|olaparib|mesh-list
43649539|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
44251521|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251522|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
44251523|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251524|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251525|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44251526|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44251527|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
44251528|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251529|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44251530|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251531|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
44251532|NCT05018520|Hormones|hormones|mesh-ancestor
44251533|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44251534|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44251535|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44251536|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44251537|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44251538|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44251539|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44251540|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44460705|NCT01559454|Methadone|methadone|mesh-list
44460706|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44460707|NCT01559454|Naloxone|naloxone|mesh-list
44460708|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44460709|NCT01559454|Narcotics|narcotics|mesh-ancestor
44460710|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44460711|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460712|NCT01559454|Analgesics|analgesics|mesh-ancestor
44460713|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
44460714|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44460768|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251956|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251957|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251958|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44236178|NCT00557921|Clopidogrel|clopidogrel|mesh-list
44251959|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
44251960|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251961|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251962|NCT04460248|Rituximab|rituximab|mesh-list
44251963|NCT04460248|Lenalidomide|lenalidomide|mesh-list
44251964|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
44251965|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44251966|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44251967|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
44251968|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251969|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44251970|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44251971|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44251972|NCT04460248|Growth Substances|growth substances|mesh-ancestor
44251973|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
44251974|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44251975|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44251976|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251977|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
44251978|NCT04456439|Promethazine|promethazine|mesh-list
44251979|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
44251980|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
44251981|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44251982|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44251983|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44251984|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44251985|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44251986|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
44251987|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
44251988|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
44251989|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44251990|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
44251991|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
44251992|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44251993|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44251994|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
44251995|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
44251996|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44251997|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44251998|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43650085|NCT03016884|Vaccines|vaccines|mesh-list
44460799|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44460800|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43650123|NCT03016715|Sirolimus|sirolimus|mesh-list
44252178|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44252179|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44252180|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
44252181|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44252182|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44252183|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
44252184|NCT04004078|Clotrimazole|clotrimazole|mesh-list
44252185|NCT04004078|Miconazole|miconazole|mesh-list
44252186|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44252187|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44252188|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44252189|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44252190|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44252191|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44252192|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44253215|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
43824614|NCT05510141|Analgesics|analgesics|mesh-ancestor
44253810|NCT04200417|Mitomycins|mitomycins|mesh-list
44253811|NCT04200417|Mitomycin|mitomycin|mesh-list
44253812|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
44253813|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44253814|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44253815|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
44253816|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44253817|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44253818|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44253819|NCT04188873|Varenicline|varenicline|mesh-list
44253820|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44253821|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254873|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44254874|NCT00612287|Narcotics|narcotics|mesh-ancestor
44254875|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44254876|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254877|NCT00612287|Analgesics|analgesics|mesh-ancestor
44254878|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
44254879|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44254880|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44254881|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
44254882|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44254883|NCT00612469|Listerine|listerine|mesh-list
44254884|NCT00612469|Vancomycin|vancomycin|mesh-list
44254885|NCT00612469|Fluorides|fluorides|mesh-list
44254886|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
44254887|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
44254888|NCT00612469|Protective Agents|protective agents|mesh-ancestor
44254889|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254890|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44254891|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254892|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
44254893|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
44254971|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
44254972|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44254973|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
44254974|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44254975|NCT00612794|Exenatide|exenatide|mesh-list
44254976|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44254977|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44254978|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44254979|NCT00612794|Incretins|incretins|mesh-ancestor
44254980|NCT00612794|Hormones|hormones|mesh-ancestor
44116992|NCT00108979|Citalopram|citalopram|mesh-list
44254981|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44254982|NCT00612859|Levetiracetam|levetiracetam|mesh-list
44254983|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
44254984|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
44254985|NCT00612898|Lamivudine|lamivudine|mesh-list
44254986|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44254987|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44255458|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255459|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255492|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44255493|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
44255494|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44255495|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44255496|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44255497|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
44255498|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
44255499|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
44255500|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44255501|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44255502|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44255503|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44256009|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256011|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256012|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256013|NCT00618228|Balsalazide|balsalazide|mesh-list
44256014|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44256015|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256016|NCT00618228|Analgesics|analgesics|mesh-ancestor
44256017|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
44256018|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256019|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256020|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256021|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256022|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256023|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
44256024|NCT00618241|Lamotrigine|lamotrigine|mesh-list
44256025|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256026|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256027|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
44256028|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256029|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44256030|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44256031|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256032|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236179|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44236180|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256033|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
44256034|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44256373|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44256374|NCT00619710|Cilastatin|cilastatin|mesh-list
44256375|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256376|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256377|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256378|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256379|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256380|NCT00619840|Methylphenidate|methylphenidate|mesh-list
44256381|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44256382|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256383|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44256384|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44256385|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256386|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256387|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
44256388|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256389|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44256390|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
44256391|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256392|NCT00619944|Ritonavir|ritonavir|mesh-list
44256393|NCT00619944|Lopinavir|lopinavir|mesh-list
44256394|NCT00619944|Lumefantrine|lumefantrine|mesh-list
44256395|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44256396|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44256720|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256721|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256723|NCT00621361|Etoposide|etoposide|mesh-list
44257122|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257124|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257126|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44257127|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44257128|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44257129|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
44257130|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257131|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257132|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44257133|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257134|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
44258290|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44258292|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44258293|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44258294|NCT00628810|Growth Substances|growth substances|mesh-ancestor
44258295|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258296|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
44258297|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258298|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
44258299|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258300|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258301|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258302|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
44258303|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44258304|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258305|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258306|NCT00628810|Antidotes|antidotes|mesh-ancestor
44258307|NCT00628810|Protective Agents|protective agents|mesh-ancestor
44258308|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
44258309|NCT00628810|Vitamins|vitamins|mesh-ancestor
44258310|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
44258311|NCT00628914|Dexetimide|dexetimide|mesh-list
44258312|NCT00628914|Eszopiclone|eszopiclone|mesh-list
44258313|NCT00628914|Citalopram|citalopram|mesh-list
44258314|NCT00628914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44258315|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258316|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258317|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258318|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236181|NCT00557921|Analgesics|analgesics|mesh-ancestor
44082244|NCT01466478|Calcitriol|calcitriol|mesh-list
44258319|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
44258320|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258598|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258599|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43655159|NCT02971345|Iodine|iodine|mesh-list
44259524|NCT00634725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259525|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259526|NCT00634725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259527|NCT00634725|Immunologic Factors|immunologic factors|mesh-ancestor
44259528|NCT00634725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259529|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44461909|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
44461910|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461911|NCT01537042|Rotigotine|rotigotine|mesh-list
44461912|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
44461913|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
44461914|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260209|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260211|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260212|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260213|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260214|NCT00637715|Alfuzosin|alfuzosin|mesh-list
44260215|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44260216|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44260217|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44260218|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44260219|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260528|NCT00639015|Norepinephrine|norepinephrine|mesh-list
44260529|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44260530|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
44260531|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
44260532|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260533|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260534|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
44260535|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44260536|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
44260537|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656219|NCT02962830|Analgesics|analgesics|mesh-ancestor
44260636|NCT00639756|Allopurinol|allopurinol|mesh-list
44260740|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
44260741|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260742|NCT00640094|Protective Agents|protective agents|mesh-ancestor
44260743|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260744|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260779|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260780|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
44260781|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260782|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44260783|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44260784|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43656419|NCT02961816|Busulfan|busulfan|mesh-list
44260892|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260893|NCT00640705|Diclofenac|diclofenac|mesh-list
44260894|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260895|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260896|NCT00640705|Analgesics|analgesics|mesh-ancestor
44260897|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
44260898|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260899|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260900|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260901|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260902|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260903|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260904|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260905|NCT00640744|Atorvastatin|atorvastatin|mesh-list
44260906|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44260907|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44260908|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
44260909|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260910|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44260911|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44260912|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260913|NCT00640796|Aldesleukin|aldesleukin|mesh-list
44260914|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
44260915|NCT00640796|Fludarabine|fludarabine|mesh-list
44260916|NCT00640796|Interleukin-2|interleukin-2|mesh-list
44260917|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260918|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
44260919|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260972|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44260973|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44260974|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44260975|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44260976|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44260977|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44260978|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44260979|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44260980|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44260981|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44260982|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44260983|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
44260984|NCT00640939|Diclofenac|diclofenac|mesh-list
43656610|NCT02959762|Vitamins|vitamins|mesh-list
44462020|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462021|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462022|NCT01535443|Bromfenac|bromfenac|mesh-list
44462023|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44462024|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44462025|NCT01535443|Analgesics|analgesics|mesh-ancestor
44462026|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
44462027|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462028|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462029|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462030|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462031|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
44462032|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44462033|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44462034|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462035|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44462036|NCT01535287|Analgesics|analgesics|mesh-ancestor
44261026|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44261028|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
44261029|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261030|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44261031|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44261032|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261033|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261034|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
44261035|NCT00641095|Rituximab|rituximab|mesh-list
44261036|NCT00641095|Fludarabine|fludarabine|mesh-list
44261037|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261054|NCT00641173|Paroxetine|paroxetine|mesh-list
44261055|NCT00641173|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44261056|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44261057|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261058|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261059|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261060|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
44261061|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261062|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44261063|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
44261064|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261065|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44261066|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261067|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261068|NCT00641212|Budesonide|budesonide|mesh-list
44261069|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261070|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261071|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
44261072|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261073|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261074|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261075|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261076|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
44261077|NCT00641212|Hormones|hormones|mesh-ancestor
43700486|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44236182|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
44236183|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236184|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082395|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
44261078|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261079|NCT00641264|Omeprazole|omeprazole|mesh-list
44261080|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44261081|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261082|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44261083|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261084|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261085|NCT00641329|Clonidine|clonidine|mesh-list
44261086|NCT00641329|Analgesics|analgesics|mesh-ancestor
44261087|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
44261088|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261089|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261090|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44261091|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
44261092|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
43656726|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44261116|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261117|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261118|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261119|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261120|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
44261121|NCT00641446|Hormones|hormones|mesh-ancestor
44261122|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261123|NCT00641472|Budesonide|budesonide|mesh-list
44261124|NCT00641472|Montelukast|montelukast|mesh-list
44261125|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261126|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261127|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
44261128|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261129|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261130|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261131|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261132|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
44261133|NCT00641472|Hormones|hormones|mesh-ancestor
44261134|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261135|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44261136|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
44261137|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44261138|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44261139|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261140|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
44261141|NCT00641589|Hematinics|hematinics|mesh-ancestor
44261142|NCT00641602|Esomeprazole|esomeprazole|mesh-list
44261143|NCT00641602|Lansoprazole|lansoprazole|mesh-list
44261144|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
44261145|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44261171|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261172|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44261173|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44261174|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
44261175|NCT00641680|Hormones|hormones|mesh-ancestor
44261176|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261177|NCT00641693|Budesonide|budesonide|mesh-list
44261178|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261179|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261180|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
44261181|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261182|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261183|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261184|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261185|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
44261186|NCT00641693|Hormones|hormones|mesh-ancestor
44261187|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261188|NCT00641758|Pycnogenols|pycnogenols|mesh-list
44261189|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44261190|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
44261191|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261192|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
44261193|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261194|NCT00641758|Protective Agents|protective agents|mesh-ancestor
44261195|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44261196|NCT00641810|Caffeine|caffeine|mesh-list
43656824|NCT02958566|Analgesics|analgesics|mesh-ancestor
44261229|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261230|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261231|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44261232|NCT00641979|Budesonide|budesonide|mesh-list
44261233|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261234|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261235|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
44261316|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261317|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261318|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
44261319|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261320|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261321|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261322|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261323|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
44261324|NCT00642187|Hormones|hormones|mesh-ancestor
44261325|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261326|NCT00642226|Triamcinolone|triamcinolone|mesh-list
44261327|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261328|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
44261329|NCT00642226|Hormones|hormones|mesh-ancestor
44261330|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261331|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261332|NCT00642252|Fluorides|fluorides|mesh-list
44261333|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
44261334|NCT00642252|Protective Agents|protective agents|mesh-ancestor
44261335|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261336|NCT00642291|Emtricitabine|emtricitabine|mesh-list
44261337|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
44261338|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261339|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44261340|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44261341|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261342|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261343|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44261344|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44261345|NCT00642330|Ibuprofen|ibuprofen|mesh-list
44261346|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44261347|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261348|NCT00642330|Analgesics|analgesics|mesh-ancestor
44261373|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261374|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44261375|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44261376|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44261377|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261378|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261379|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261380|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
44261381|NCT00642434|Protective Agents|protective agents|mesh-ancestor
44261382|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44261383|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261384|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44261385|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44261386|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44261387|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44261388|NCT00642499|Dronabinol|dronabinol|mesh-list
44261389|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
44261390|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261391|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261392|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261393|NCT00642499|Analgesics|analgesics|mesh-ancestor
44261394|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
44261395|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261396|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44261397|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44261398|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657001|NCT02957435|Diuretics|diuretics|mesh-ancestor
44462100|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462101|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462102|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44462103|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44462104|NCT01534962|Ranolazine|ranolazine|mesh-list
44462105|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44462106|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117416|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44462107|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462108|NCT01534637|Gemcitabine|gemcitabine|mesh-list
44261502|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
44261503|NCT00642915|Glimepiride|glimepiride|mesh-list
44261504|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44261505|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261506|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44261507|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261508|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
44261509|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
44261510|NCT00642967|Hematinics|hematinics|mesh-ancestor
44261511|NCT00642980|Clindamycin|clindamycin|mesh-list
44261512|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
44261513|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
44261514|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261515|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261516|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44261517|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261518|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261519|NCT00643071|Tacrolimus|tacrolimus|mesh-list
44261716|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44261717|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261719|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462126|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44261955|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261992|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261993|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261994|NCT00645151|Atorvastatin|atorvastatin|mesh-list
44261995|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44261996|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44262028|NCT00645242|Fluconazole|fluconazole|mesh-list
44262029|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
44262030|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262031|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44262032|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44262033|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262034|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262035|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44262036|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
44262037|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262038|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262108|NCT00645398|Pregabalin|pregabalin|mesh-list
44262109|NCT00645398|Analgesics|analgesics|mesh-ancestor
43916530|NCT00477451|Alprazolam|alprazolam|mesh-list
44262110|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
44262111|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657388|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
44262140|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262141|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44262142|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44262144|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262145|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
44262146|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262147|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262148|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262149|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262150|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262151|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262152|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262153|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44262154|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
44262304|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262305|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262307|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44262308|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
44262309|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
44236185|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262310|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262311|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262312|NCT00646035|Vitamins|vitamins|mesh-ancestor
44262313|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
44262314|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44262315|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44262316|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
44262317|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
44262318|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262319|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262320|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44262321|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44262322|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
44262518|NCT00646659|Docetaxel|docetaxel|mesh-list
44262519|NCT00646659|Fluorouracil|fluorouracil|mesh-list
44262520|NCT00646659|Cetuximab|cetuximab|mesh-list
44262521|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262522|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
44262523|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
44262524|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
44262525|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262526|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
44262527|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262528|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262529|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
44262530|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262531|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44262810|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262812|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
44262813|NCT00647686|Fentanyl|fentanyl|mesh-list
44262814|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44262815|NCT00647686|Narcotics|narcotics|mesh-ancestor
44262816|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262817|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262818|NCT00647686|Analgesics|analgesics|mesh-ancestor
44262819|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
44262869|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44262870|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262871|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262872|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262874|NCT00647816|Propranolol|propranolol|mesh-list
44262875|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44262876|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44262877|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262878|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262879|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262880|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262881|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44262882|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262883|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
44262884|NCT00647829|Valdecoxib|valdecoxib|mesh-list
44262885|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44262886|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44262887|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262888|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262889|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44262890|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44262891|NCT00647829|Analgesics|analgesics|mesh-ancestor
44262892|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
44262893|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657733|NCT02950948|Hormones|hormones|mesh-ancestor
44262948|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262949|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262950|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44262998|NCT00648011|Diuretics|diuretics|mesh-ancestor
44262999|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263000|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263001|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263002|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700487|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
44117547|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
44263003|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263004|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263005|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263006|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263007|NCT00648024|Anagrelide|anagrelide|mesh-list
44263008|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44263009|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44263010|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263011|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44263012|NCT00648050|Verapamil|verapamil|mesh-list
44263013|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263014|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44263015|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263016|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263017|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44263018|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263019|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263020|NCT00648063|Letrozole|letrozole|mesh-list
44263021|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263022|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43657791|NCT02950441|Niacin|niacin|mesh-list
44263056|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263057|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263058|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263059|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263060|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263061|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263091|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263092|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263094|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44263095|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263096|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44263097|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44263098|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263099|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44263100|NCT00648258|Naproxen|naproxen|mesh-list
44263101|NCT00648258|Valdecoxib|valdecoxib|mesh-list
44263102|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263163|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263165|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
44263166|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
43825422|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44263200|NCT00648388|Protective Agents|protective agents|mesh-ancestor
44263201|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44263202|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44263203|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263238|NCT00648440|Midodrine|midodrine|mesh-list
44263239|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
44263240|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
44263241|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263343|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263344|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263345|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263346|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263347|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
44263348|NCT00648622|Protective Agents|protective agents|mesh-ancestor
44263349|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44117618|NCT00111020|Sorafenib|sorafenib|mesh-list
44263350|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263351|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44263352|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263353|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44263354|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44263355|NCT00648661|Dexetimide|dexetimide|mesh-list
44263356|NCT00648661|Citalopram|citalopram|mesh-list
44263357|NCT00648661|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263358|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263359|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263360|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263361|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263362|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
44263363|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263364|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44263365|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263366|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263367|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44263368|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43657891|NCT02949492|Interleukin-2|interleukin-2|mesh-list
44263612|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263613|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44263614|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
44263615|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263616|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263617|NCT00649103|Quinapril|quinapril|mesh-list
44263618|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263619|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263620|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462204|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263621|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263622|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263624|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263656|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263657|NCT00649168|Bromocriptine|bromocriptine|mesh-list
44263658|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44263659|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44263660|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
44263661|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263662|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263663|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
44263664|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
44263665|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263693|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263694|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263695|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263696|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
44263697|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
44263698|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263699|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44263700|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263701|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263702|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263703|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263704|NCT00649259|Oxybutynin|oxybutynin|mesh-list
44263705|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
44263706|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
44263707|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263708|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263709|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263710|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263858|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263859|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263860|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263861|NCT00649532|Ondansetron|ondansetron|mesh-list
44263862|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
44264212|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44264213|NCT00650195|Metolazone|metolazone|mesh-list
44264214|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264215|NCT00650195|Diuretics|diuretics|mesh-ancestor
44264216|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
44264217|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264218|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44264219|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264220|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264221|NCT00650208|Lamotrigine|lamotrigine|mesh-list
44264222|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
43658325|NCT02946060|TEMPO|tempo|mesh-list
44264261|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264262|NCT00650299|Alprazolam|alprazolam|mesh-list
44264263|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44264264|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264265|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264266|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44264267|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264268|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264269|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
44264270|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
44264271|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264272|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264273|NCT00650312|Metformin|metformin|mesh-list
44264274|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264275|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264276|NCT00650325|Sertraline|sertraline|mesh-list
44264277|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
44264278|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264279|NCT00650325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44264280|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44264281|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264282|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264283|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462272|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44462273|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44264584|NCT00651105|Vildagliptin|vildagliptin|mesh-list
44264585|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264586|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264587|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44264588|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
44264589|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264691|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44264692|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44264693|NCT00651547|Budesonide|budesonide|mesh-list
44264694|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
44264695|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264696|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264697|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
44264698|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264699|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264700|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264701|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264702|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
44264703|NCT00651547|Hormones|hormones|mesh-ancestor
44264704|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264705|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264706|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264707|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264708|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264709|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264710|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264711|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
44264712|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
44265026|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265028|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265029|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265063|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265064|NCT00652782|Rolofylline|rolofylline|mesh-list
44265065|NCT00652782|Diuretics|diuretics|mesh-ancestor
44265066|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265067|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265068|NCT00652795|Doxycycline|doxycycline|mesh-list
44265069|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44265070|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265071|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
44265072|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44265565|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265566|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265567|NCT00654446|Simvastatin|simvastatin|mesh-list
44265568|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265569|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265570|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
44265571|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265572|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265573|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265574|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265575|NCT00654459|Policosanol|policosanol|mesh-list
44265576|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265577|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265578|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
44265579|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265580|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265581|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44265582|NCT00654485|Atorvastatin|atorvastatin|mesh-list
44265661|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265662|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265663|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265848|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265849|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44265850|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265851|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265852|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44265853|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44265855|NCT00655655|Vatalanib|vatalanib|mesh-list
44265856|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265857|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659091|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44266112|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44266113|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44266114|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44266115|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44266116|NCT00656773|Sufentanil|sufentanil|mesh-list
44266117|NCT00656773|Morphine|morphine|mesh-list
44266118|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44266119|NCT00656773|Narcotics|narcotics|mesh-ancestor
44266120|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266121|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266243|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
44266244|NCT00657384|Coagulants|coagulants|mesh-ancestor
44266245|NCT00657397|Methadone|methadone|mesh-list
44266246|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44266247|NCT00657397|Narcotics|narcotics|mesh-ancestor
44266248|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266249|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266250|NCT00657397|Analgesics|analgesics|mesh-ancestor
44266251|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
44266252|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266253|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
44266254|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
44266255|NCT00657410|Dexamethasone|dexamethasone|mesh-list
44266256|NCT00657410|Prednisone|prednisone|mesh-list
44266257|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266258|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
44266259|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
44266260|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266261|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266262|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266263|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
44266343|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266344|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
44266345|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266346|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266347|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266348|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
44266349|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266350|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
44266351|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44266352|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44266353|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266354|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44266355|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44266356|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
44266357|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266429|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
44266430|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266431|NCT00657943|Coagulants|coagulants|mesh-ancestor
44266432|NCT00657982|Everolimus|everolimus|mesh-list
44266433|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266434|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266435|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
44266436|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266437|NCT00657995|Pancrelipase|pancrelipase|mesh-list
44266438|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266439|NCT00658099|Insulin|insulin|mesh-list
44266440|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44266441|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
44266442|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
44266443|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
44266444|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
43659310|NCT02939482|Triamcinolone|triamcinolone|mesh-list
44266479|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659356|NCT02939248|Morphine|morphine|mesh-list
44267318|NCT00662454|Estrogens|estrogens|mesh-ancestor
44267319|NCT00662454|Hormones|hormones|mesh-ancestor
44267320|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267321|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267322|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44267383|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44267384|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
44267385|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44267386|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267387|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
43659842|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
44267613|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267614|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267615|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267616|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267617|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267618|NCT00663845|Urological Agents|urological agents|mesh-ancestor
44267619|NCT00663884|Voglibose|voglibose|mesh-list
44267620|NCT00663884|Mitiglinide|mitiglinide|mesh-list
44267621|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44267622|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267623|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44267624|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267625|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267626|NCT00663897|Lansoprazole|lansoprazole|mesh-list
44267627|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
44267628|NCT00663897|Mosapride|mosapride|mesh-list
44267629|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44267630|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44267631|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44267632|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267633|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267634|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44267635|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
44267636|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267637|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267638|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44267639|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44267640|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267929|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267930|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267932|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
44267933|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267934|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44267935|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44268006|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
44268007|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268097|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44268098|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44268099|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44268100|NCT00666055|Ritonavir|ritonavir|mesh-list
44268101|NCT00666055|Lopinavir|lopinavir|mesh-list
44268102|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44268103|NCT00666055|Tenofovir|tenofovir|mesh-list
44268104|NCT00666055|Lamivudine|lamivudine|mesh-list
44268105|NCT00666055|Zidovudine|zidovudine|mesh-list
44268106|NCT00666055|Emtricitabine|emtricitabine|mesh-list
44268107|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
44268108|NCT00666055|Maraviroc|maraviroc|mesh-list
44268109|NCT00666055|Efavirenz|efavirenz|mesh-list
44268194|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268195|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660259|NCT02933437|Ajmaline|ajmaline|mesh-list
44268277|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268279|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268280|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43922709|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268281|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44268282|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
44268283|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
44268284|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268286|NCT00666692|Bevacizumab|bevacizumab|mesh-list
44268287|NCT00666692|Carboplatin|carboplatin|mesh-list
44236188|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44236189|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082971|NCT00846703|Hormones|hormones|mesh-ancestor
44268288|NCT00666692|Volociximab|volociximab|mesh-list
44268289|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44268290|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268291|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268292|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268293|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268294|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268295|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268296|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268297|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44268298|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44268299|NCT00666692|Growth Substances|growth substances|mesh-ancestor
44268300|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268301|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
44268302|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
44268303|NCT00666770|Gabapentin|gabapentin|mesh-list
44268304|NCT00666770|Analgesics|analgesics|mesh-ancestor
44268366|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268367|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268368|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268369|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44268370|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268371|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268372|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
44268373|NCT00666991|Paclitaxel|paclitaxel|mesh-list
44268374|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268397|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268398|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268399|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
44268400|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
44268401|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268402|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268404|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268405|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
44268406|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268407|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44268408|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268409|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268410|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44268411|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
44268412|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44268413|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
44268414|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268415|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268416|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44268417|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44268418|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268419|NCT00667082|Vorinostat|vorinostat|mesh-list
44268420|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44268421|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44268422|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268423|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268424|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268425|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268426|NCT00667108|Gabapentin|gabapentin|mesh-list
44268427|NCT00667108|Analgesics|analgesics|mesh-ancestor
44268428|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
43660355|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
44268513|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268514|NCT00667485|Sirolimus|sirolimus|mesh-list
44268515|NCT00667485|Bevacizumab|bevacizumab|mesh-list
44268516|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268517|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268518|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44268519|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44268520|NCT00667485|Growth Substances|growth substances|mesh-ancestor
44268521|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268522|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
44268523|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268524|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268525|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44268526|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
44268527|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268528|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
44268529|NCT00667498|Metformin|metformin|mesh-list
44268645|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268646|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268647|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268648|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268649|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268650|NCT00668096|Urological Agents|urological agents|mesh-ancestor
44268651|NCT00668109|Tadalafil|tadalafil|mesh-list
44268652|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268822|NCT00668941|Alendronate|alendronate|mesh-list
44268823|NCT00668941|Teriparatide|teriparatide|mesh-list
44268824|NCT00668941|Calcium|calcium|mesh-list
44268825|NCT00668941|Vitamins|vitamins|mesh-ancestor
44268826|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
44268827|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660509|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44269002|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269003|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269005|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
44269006|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269007|NCT00669812|Cytarabine|cytarabine|mesh-list
44269008|NCT00669812|Prednisolone|prednisolone|mesh-list
44269077|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44269078|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44269079|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
44269080|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269081|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269082|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269083|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
44269084|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269085|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269086|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44269087|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269088|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269089|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269090|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269091|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44269092|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44269093|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
44269094|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269095|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
44269096|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269097|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660617|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269300|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269301|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269302|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44269303|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269304|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269305|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
44269306|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44269307|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44269308|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
44269309|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269310|NCT00671203|Erythromycin|erythromycin|mesh-list
44269311|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
44269312|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44269313|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
44269314|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269315|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269316|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269317|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44269318|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269319|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269320|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
44269321|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44269322|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44118008|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269323|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269324|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
44236190|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44236191|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44236192|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269325|NCT00671281|Coagulants|coagulants|mesh-ancestor
44269326|NCT00671320|Diclofenac|diclofenac|mesh-list
44269327|NCT00671320|Valdecoxib|valdecoxib|mesh-list
44269328|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44269329|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44269330|NCT00671320|Analgesics|analgesics|mesh-ancestor
43825714|NCT05285124|Melatonin|melatonin|mesh-list
44269498|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44269499|NCT00672347|Narcotics|narcotics|mesh-ancestor
44269500|NCT00672347|Analgesics|analgesics|mesh-ancestor
44269501|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269502|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
44269503|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
43660824|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
44269793|NCT00674232|Misoprostol|misoprostol|mesh-list
44269794|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44269795|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
44269796|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269797|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269798|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44269799|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269800|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
44269801|NCT00674245|Pantoprazole|pantoprazole|mesh-list
44269802|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44269803|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269804|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44269805|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269806|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269807|NCT00674310|Ropinirole|ropinirole|mesh-list
44269808|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44269809|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44269810|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
44269811|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
44269812|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270033|NCT00675714|Testosterone|testosterone|mesh-list
44270034|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
44270035|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
43661058|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270093|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44270094|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44270095|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270126|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
44270127|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270128|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270129|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270130|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44270132|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
44270133|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270134|NCT00676156|Protective Agents|protective agents|mesh-ancestor
44270135|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270137|NCT00676156|Vitamins|vitamins|mesh-ancestor
44270138|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
44270192|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270193|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270194|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270195|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44270196|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44270197|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462755|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44462756|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44462757|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
44462758|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462759|NCT01524796|Pregabalin|pregabalin|mesh-list
44462760|NCT01524796|Analgesics|analgesics|mesh-ancestor
44462761|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
44270245|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
44270246|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44270247|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270248|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270249|NCT00676819|Insulin|insulin|mesh-list
44236193|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
44270250|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44270251|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
44270252|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270253|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270254|NCT00676845|Olmesartan|olmesartan|mesh-list
44270255|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44270256|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270257|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44270258|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44270259|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270260|NCT00676871|Blinatumomab|blinatumomab|mesh-list
44270261|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270262|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
44270263|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44270264|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44270265|NCT00676936|Prednisolone|prednisolone|mesh-list
44270266|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
44270267|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44270268|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
44270269|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270270|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
44270271|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
44270272|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270273|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270274|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270275|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
44270276|NCT00676936|Hormones|hormones|mesh-ancestor
44270277|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270278|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44270279|NCT00676936|Protective Agents|protective agents|mesh-ancestor
44270280|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44270281|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270282|NCT00677001|R 306465|r 306465|mesh-list
44270359|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270360|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
44270361|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270362|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270363|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
44270364|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270365|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270366|NCT00677521|Acarbose|acarbose|mesh-list
44270367|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44270368|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270369|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270370|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270371|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270372|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
44270373|NCT00677664|Mannitol|mannitol|mesh-list
44270374|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
44270375|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44270376|NCT00677664|Diuretics|diuretics|mesh-ancestor
44270377|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
44270378|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270379|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44270380|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
44270381|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270382|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44270383|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44270384|NCT00677729|Albuterol|albuterol|mesh-list
44270385|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44270386|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
44270412|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
44270413|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44270414|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44270415|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270416|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270417|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
44270418|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44270419|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44270420|NCT00678106|Dalbavancin|dalbavancin|mesh-list
44270421|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270422|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270423|NCT00678132|Gemcitabine|gemcitabine|mesh-list
44270424|NCT00678132|Cisplatin|cisplatin|mesh-list
44270425|NCT00678132|Olaparib|olaparib|mesh-list
44236194|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44270426|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270427|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44270428|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
44270429|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270430|NCT00678132|Antiviral Agents|antiviral agents|mesh-ancestor
44270431|NCT00678132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270432|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270433|NCT00678132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270434|NCT00678132|Immunologic Factors|immunologic factors|mesh-ancestor
43661213|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44270475|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
44270476|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270477|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270478|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270479|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44270480|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270481|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270482|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270483|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270484|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44270485|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44270486|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
44270487|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270488|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270489|NCT00678314|Ropivacaine|ropivacaine|mesh-list
44270490|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44270491|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
44270492|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270493|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270494|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
44270495|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270496|NCT00678327|Prednisolone|prednisolone|mesh-list
44270497|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
44270498|NCT00678327|Dacarbazine|dacarbazine|mesh-list
44270499|NCT00678327|Doxorubicin|doxorubicin|mesh-list
44270500|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43924717|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
44270502|NCT00678327|Vincristine|vincristine|mesh-list
44270503|NCT00678327|Bleomycin|bleomycin|mesh-list
44270504|NCT00678327|Vinblastine|vinblastine|mesh-list
44270505|NCT00678327|Procarbazine|procarbazine|mesh-list
44270506|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270507|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
44270508|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270509|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44270510|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44270511|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
43661227|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44462777|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462778|NCT01524770|Dulaglutide|dulaglutide|mesh-list
44462779|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462780|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462781|NCT01524679|Interferons|interferons|mesh-list
44462782|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
44462783|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
44462784|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44462785|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462786|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
44462787|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462788|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
44462789|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462790|NCT01524627|Varenicline|varenicline|mesh-list
44462791|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44462792|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44462793|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
44118224|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
44462794|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661240|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270540|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270541|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270542|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
44270543|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44270544|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44270545|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
44270546|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270547|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270548|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44270549|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44270550|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270585|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44270586|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270587|NCT00678626|Docetaxel|docetaxel|mesh-list
44270588|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270613|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270614|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270615|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44270616|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270617|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270618|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270619|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44270620|NCT00678769|Sirolimus|sirolimus|mesh-list
44270621|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44270622|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270623|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270624|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44270625|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270626|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
44270627|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270628|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
44270629|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270630|NCT00678782|Etanercept|etanercept|mesh-list
44270631|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44270632|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44270633|NCT00678782|Analgesics|analgesics|mesh-ancestor
44270634|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
44270635|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270636|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270655|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270656|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44270657|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
44270658|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270659|NCT00678977|Antiviral Agents|antiviral agents|mesh-ancestor
44270660|NCT00678977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270661|NCT00678977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270662|NCT00678977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270663|NCT00678977|Immunologic Factors|immunologic factors|mesh-ancestor
44270664|NCT00678977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270665|NCT00678990|Heparin|heparin|mesh-list
44270666|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
44270667|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44270668|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44270669|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270670|NCT00679068|Bosentan|bosentan|mesh-list
44270671|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270672|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44270673|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270674|NCT00679146|Ketoprofen|ketoprofen|mesh-list
44270675|NCT00679146|Colchicine|colchicine|mesh-list
44270676|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44270677|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44270678|NCT00679146|Analgesics|analgesics|mesh-ancestor
44270679|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
44270680|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270681|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270682|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270683|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44270684|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44270685|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270686|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270687|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
44270688|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44270689|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44270690|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44270691|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270692|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44270693|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
44270733|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44270734|NCT00679458|Narcotics|narcotics|mesh-ancestor
44270735|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270737|NCT00679458|Analgesics|analgesics|mesh-ancestor
44270738|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
44270739|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270740|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44270741|NCT00679484|Candesartan|candesartan|mesh-list
44270742|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
44270743|NCT00679484|Olmesartan|olmesartan|mesh-list
44270744|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44270745|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270746|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44270747|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43925000|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
44270748|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270749|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44270750|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270751|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270752|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
44270753|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270754|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270755|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44270756|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270758|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44270759|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
44270760|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270874|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43661345|NCT02924233|Nivolumab|nivolumab|mesh-list
44271158|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271159|NCT00681525|Atorvastatin|atorvastatin|mesh-list
44271161|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
44271162|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44271163|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44271164|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
44271165|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271166|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44271167|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44271168|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271169|NCT00681603|Bevacizumab|bevacizumab|mesh-list
44271170|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271171|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271172|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44271173|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44271174|NCT00681603|Growth Substances|growth substances|mesh-ancestor
44271175|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271176|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
44271177|NCT00681720|Flumazenil|flumazenil|mesh-list
44271178|NCT00681720|Antidotes|antidotes|mesh-ancestor
44271179|NCT00681720|Protective Agents|protective agents|mesh-ancestor
44271180|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271181|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
44271182|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
44271183|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271184|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271185|NCT00681733|Pioglitazone|pioglitazone|mesh-list
44271186|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
44271187|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44271318|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
44271319|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271320|NCT00682149|Ascorbic Acid|ascorbic acid|mesh-list
44271321|NCT00682149|Vitamins|vitamins|mesh-ancestor
44271322|NCT00682149|Micronutrients|micronutrients|mesh-ancestor
44271323|NCT00682149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271324|NCT00682149|Antioxidants|antioxidants|mesh-ancestor
44271400|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271401|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
44271402|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
44271403|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44271404|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
44271405|NCT00682656|Azithromycin|azithromycin|mesh-list
44271406|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44271407|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44271408|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271409|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44271410|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44271411|NCT00682721|Valacyclovir|valacyclovir|mesh-list
44236195|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44271412|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
44271413|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271414|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
44271415|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44271416|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44271417|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44271418|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44271419|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271420|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
44271564|NCT00683514|Cisplatin|cisplatin|mesh-list
44271565|NCT00683514|Vinorelbine|vinorelbine|mesh-list
44271566|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271567|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271568|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271569|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271570|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271571|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271572|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
44271573|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271684|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271686|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44271687|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44271688|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271689|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271690|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
44271691|NCT00684164|Conivaptan|conivaptan|mesh-list
44271692|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44271693|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271694|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
44271695|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271696|NCT00684190|Esomeprazole|esomeprazole|mesh-list
44271697|NCT00684190|Lesogaberan|lesogaberan|mesh-list
44271698|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44271699|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271700|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44271701|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271702|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271703|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44271704|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
44271865|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271866|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271867|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271868|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271869|NCT00685100|Triamcinolone|triamcinolone|mesh-list
44271870|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271871|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
44271872|NCT00685100|Hormones|hormones|mesh-ancestor
44271873|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271874|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271875|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44271876|NCT00685126|Albuterol|albuterol|mesh-list
44271877|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271878|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
44271879|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271880|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271881|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271882|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271883|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
44271884|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271885|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271886|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271887|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44272058|NCT00685906|Estradiol|estradiol|mesh-list
44272059|NCT00685906|Estrogens|estrogens|mesh-ancestor
44272060|NCT00685906|Hormones|hormones|mesh-ancestor
44272061|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272062|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272063|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44272064|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
44272065|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44272066|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44083538|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272067|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44272068|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44272069|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44272070|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44272071|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43661857|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462956|NCT01521364|Clarithromycin|clarithromycin|mesh-list
44462957|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272145|NCT00686322|Paclitaxel|paclitaxel|mesh-list
44272146|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44272147|NCT00686322|Cisplatin|cisplatin|mesh-list
43661921|NCT02919293|Vaccines|vaccines|mesh-list
44272290|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272291|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44272292|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44272293|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272294|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272295|NCT00687388|Urological Agents|urological agents|mesh-ancestor
44272296|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272297|NCT00687466|Insulin|insulin|mesh-list
44272298|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272299|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272300|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
44272301|NCT00687518|Hematinics|hematinics|mesh-ancestor
44272302|NCT00687622|Trametinib|trametinib|mesh-list
44272303|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272304|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44272305|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272306|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272307|NCT00687648|Prednisolone|prednisolone|mesh-list
44272308|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
44272309|NCT00687648|Methotrexate|methotrexate|mesh-list
44272310|NCT00687648|Letrozole|letrozole|mesh-list
44272311|NCT00687648|Anastrozole|anastrozole|mesh-list
44272312|NCT00687648|Exemestane|exemestane|mesh-list
44272313|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272314|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
44272315|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272316|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272317|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44272318|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
44272319|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272320|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272321|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44272322|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44272323|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
44272421|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118466|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272422|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272423|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272424|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44272425|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44272427|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44272428|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272429|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272430|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272431|NCT00688363|Chrysarobin|chrysarobin|mesh-list
44272432|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272433|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272434|NCT00688363|Analgesics|analgesics|mesh-ancestor
44272435|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
44272436|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272437|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272438|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272439|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272440|NCT00688402|Lesogaberan|lesogaberan|mesh-list
44272441|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44272442|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44272443|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
44272444|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
44272445|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272446|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272447|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272448|NCT00688428|Aspirin|aspirin|mesh-list
44272449|NCT00688428|Esomeprazole|esomeprazole|mesh-list
44272450|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272451|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272452|NCT00688428|Analgesics|analgesics|mesh-ancestor
44272801|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
44272802|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272803|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272804|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44272805|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272806|NCT00689832|Fluticasone|fluticasone|mesh-list
44272807|NCT00689832|Tacrolimus|tacrolimus|mesh-list
44272808|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272809|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
44272810|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272811|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44272812|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272813|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272814|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272815|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44272816|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
44272817|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272818|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272819|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272820|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44272821|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44272822|NCT00689845|Cytarabine|cytarabine|mesh-list
44272823|NCT00689845|Prednisone|prednisone|mesh-list
44272824|NCT00689845|Prednisolone|prednisolone|mesh-list
44272825|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
44272826|NCT00689845|Ifosfamide|ifosfamide|mesh-list
44272827|NCT00689845|Rituximab|rituximab|mesh-list
44272828|NCT00689845|Doxorubicin|doxorubicin|mesh-list
44272829|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44272830|NCT00689845|Methotrexate|methotrexate|mesh-list
44272831|NCT00689845|Etoposide|etoposide|mesh-list
44272832|NCT00689845|Vincristine|vincristine|mesh-list
44272833|NCT00689845|Bleomycin|bleomycin|mesh-list
44272834|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
44272835|NCT00689845|Vindesine|vindesine|mesh-list
44272913|NCT00690118|Pioglitazone|pioglitazone|mesh-list
44272914|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272915|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272916|NCT00690170|Ketamine|ketamine|mesh-list
44272917|NCT00690170|Nicotine|nicotine|mesh-list
44272918|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44272919|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
44272920|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272921|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272922|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44272923|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44272924|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
44272925|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272926|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272927|NCT00690170|Analgesics|analgesics|mesh-ancestor
44272928|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
44272929|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44272930|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44272931|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
44272932|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
44272933|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44272934|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44272935|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44272936|NCT00690222|Mydriatics|mydriatics|mesh-list
44272937|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
44272938|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272939|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462958|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462959|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44462960|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462961|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462962|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44462963|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44462964|NCT01521117|Donepezil|donepezil|mesh-list
44462965|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44462966|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462967|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462968|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462969|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462970|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462971|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
44462972|NCT01520987|Opicapone|opicapone|mesh-list
44462973|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44462974|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462975|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462976|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44462977|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44273169|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44273171|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44273172|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273173|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273174|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273175|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
44273176|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44273177|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
44273285|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
44273286|NCT00692120|Vitamins|vitamins|mesh-list
44273287|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
44273288|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273289|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44273290|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44462994|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44462995|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
44462996|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
44462997|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462998|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
44462999|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463000|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
44463001|NCT01519947|Hematinics|hematinics|mesh-ancestor
44463002|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44463003|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
44463004|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463005|NCT01519817|Vaccines|vaccines|mesh-list
44463006|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
44463007|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463008|NCT01519791|Methotrexate|methotrexate|mesh-list
44463009|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
44463010|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44463011|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
44463012|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44463013|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463014|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44463015|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
44463016|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463017|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273292|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273437|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273438|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273439|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
43927767|NCT00640822|Vitamins|vitamins|mesh-ancestor
44273440|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273441|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273442|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
44273443|NCT00693030|Sirolimus|sirolimus|mesh-list
44273444|NCT00693030|Paclitaxel|paclitaxel|mesh-list
44273445|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273446|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273447|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273448|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273449|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273450|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273451|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273452|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273453|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273454|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
44273455|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273456|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
43825860|NCT04730206|Camostat|camostat|mesh-list
44273627|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273629|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44273630|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273631|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700488|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44273632|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273633|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44273634|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
44273635|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273636|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273637|NCT00693576|Simvastatin|simvastatin|mesh-list
44273638|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44273639|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44273640|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
44273641|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273642|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44273643|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44273644|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273646|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
44273647|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
44273648|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44273649|NCT00693589|Vitamins|vitamins|mesh-ancestor
44273650|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
44273651|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273652|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44273653|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44273654|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
44273655|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273721|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44273722|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
44273723|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273724|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273725|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273726|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44273727|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273728|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44463019|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463020|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44463021|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44463022|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
44463023|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463024|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44463025|NCT01519778|Tedizolid|tedizolid|mesh-list
44463026|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273729|NCT00693927|Fludarabine|fludarabine|mesh-list
44273730|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273731|NCT00693966|Vaccines|vaccines|mesh-list
43662636|NCT02912637|Xenon|xenon|mesh-list
44273782|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273783|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273784|NCT00694200|Bevacizumab|bevacizumab|mesh-list
44273785|NCT00694200|Vinorelbine|vinorelbine|mesh-list
44273786|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44273787|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273788|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44273789|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44273790|NCT00694200|Growth Substances|growth substances|mesh-ancestor
44273791|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273792|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44273793|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273794|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273795|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273796|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273797|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273798|NCT00694252|Lapatinib|lapatinib|mesh-list
44273799|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273800|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44273801|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463027|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928102|NCT00652145|Mesalamine|mesalamine|mesh-list
44273802|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273803|NCT00694291|Sorafenib|sorafenib|mesh-list
44273804|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273805|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44273806|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273807|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273808|NCT00694317|Zaleplon|zaleplon|mesh-list
44273809|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
44273810|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44083841|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273811|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273812|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273813|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
44273814|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
44273815|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273816|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273817|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44273818|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
44273819|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44273820|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44273821|NCT00694408|Prednisolone|prednisolone|mesh-list
44273822|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
44273823|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
44273824|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44273825|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44273826|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44273827|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44273854|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273855|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273857|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44273858|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273859|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273860|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44273861|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44273862|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44273863|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44273864|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44273865|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44273866|NCT00694694|Azithromycin|azithromycin|mesh-list
44273867|NCT00694694|Artesunate|artesunate|mesh-list
44273868|NCT00694694|Lumefantrine|lumefantrine|mesh-list
44273869|NCT00694694|Artemether|artemether|mesh-list
44273870|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44273871|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273872|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273873|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
44273874|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44273875|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44273876|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928184|NCT00654329|Narcotics|narcotics|mesh-ancestor
44273991|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44273992|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273993|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
44273994|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44273995|NCT00695630|Flumazenil|flumazenil|mesh-list
44273996|NCT00695630|Antidotes|antidotes|mesh-ancestor
44273997|NCT00695630|Protective Agents|protective agents|mesh-ancestor
44273998|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273999|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
44274000|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
44274001|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274002|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274003|NCT00695643|Mesalamine|mesalamine|mesh-list
44274004|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274005|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274006|NCT00695643|Analgesics|analgesics|mesh-ancestor
44274007|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
44274008|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274009|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274010|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274011|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274012|NCT00695682|Infliximab|infliximab|mesh-list
44274013|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
44274014|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274015|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463028|NCT01519765|Misoprostol|misoprostol|mesh-list
44463029|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44463030|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
44463031|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44463032|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463033|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44463034|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44463035|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
44463036|NCT01519700|Lenograstim|lenograstim|mesh-list
44463037|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44463038|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
44463039|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463040|NCT01519674|Insulin|insulin|mesh-list
44274016|NCT00695929|Simendan|simendan|mesh-list
44274017|NCT00695929|Milrinone|milrinone|mesh-list
44274018|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44274019|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44274020|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44274021|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44274022|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274023|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274024|NCT00695929|Protective Agents|protective agents|mesh-ancestor
44274025|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274026|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274027|NCT00695994|Gemcitabine|gemcitabine|mesh-list
44274086|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274087|NCT00696111|Leuprolide|leuprolide|mesh-list
44274088|NCT00696111|Progesterone|progesterone|mesh-list
44274089|NCT00696111|Estrogens|estrogens|mesh-list
44274090|NCT00696111|Progestins|progestins|mesh-ancestor
43928416|NCT00658736|Triamcinolone|triamcinolone|mesh-list
44274091|NCT00696111|Hormones|hormones|mesh-ancestor
44274092|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274093|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274094|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44274095|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
44274096|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44274097|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44274098|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274099|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
44274100|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
44274101|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44274102|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274103|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274104|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
44274105|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44274106|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
44274107|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44274108|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274109|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44274110|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44274111|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44274112|NCT00696215|Rasagiline|rasagiline|mesh-list
44274235|NCT00696826|Hormones|hormones|mesh-ancestor
44274236|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274237|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44274238|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44274239|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463042|NCT01519674|Metformin|metformin|mesh-list
44274240|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274241|NCT00696930|Edotreotide|edotreotide|mesh-list
44274242|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44274243|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274244|NCT00696956|Paclitaxel|paclitaxel|mesh-list
44274245|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44274246|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274247|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
44274248|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
44274249|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
44274250|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274251|NCT00696969|Amphotericin B|amphotericin b|mesh-list
44274252|NCT00696969|Paromomycin|paromomycin|mesh-list
44274253|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44274254|NCT00696969|Miltefosine|miltefosine|mesh-list
44274255|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44274256|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
44274257|NCT00696969|Amebicides|amebicides|mesh-ancestor
44274258|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44274259|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44274260|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274261|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274262|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
44274263|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274264|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44274265|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44083989|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274266|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44274267|NCT00696982|Glyburide|glyburide|mesh-list
44274268|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274269|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274270|NCT00696982|Incretins|incretins|mesh-ancestor
44463084|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44463085|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463086|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463087|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
44463088|NCT01519245|Coagulants|coagulants|mesh-ancestor
44463089|NCT01519167|Fentanyl|fentanyl|mesh-list
44463090|NCT01519167|Midazolam|midazolam|mesh-list
44463091|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
44463092|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44463093|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274413|NCT00697567|Vaccines|vaccines|mesh-list
44274414|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
44274415|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274416|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44274417|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44274418|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44274419|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274420|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274421|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44274422|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44274423|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44274424|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
44274425|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274479|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44274481|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44274482|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
44274483|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274484|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274485|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44274486|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44274487|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
44274488|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274489|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44274490|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44274491|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44274492|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44274493|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44274494|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44274495|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44274496|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44274497|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44274498|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
44274499|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44274500|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44274501|NCT00697905|Gemcitabine|gemcitabine|mesh-list
44274502|NCT00697905|Cisplatin|cisplatin|mesh-list
44274503|NCT00697905|Carboplatin|carboplatin|mesh-list
44274531|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274532|NCT00698269|Insulin|insulin|mesh-list
44274533|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44274534|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
44274535|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
44274536|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44274537|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
44274538|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
44274539|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44274540|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274541|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274542|NCT00698334|Rifampin|rifampin|mesh-list
44274543|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
44274544|NCT00698334|Ethambutol|ethambutol|mesh-list
44274545|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44274546|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
44274547|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274548|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274549|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
44274550|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44274551|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274552|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662905|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274609|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274610|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274611|NCT00698724|Analgesics|analgesics|mesh-ancestor
44274612|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
44274613|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274614|NCT00698763|Simendan|simendan|mesh-list
44274615|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44274616|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
44274617|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44274618|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44274619|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274620|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274621|NCT00698763|Protective Agents|protective agents|mesh-ancestor
44274622|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274623|NCT00698776|Lenalidomide|lenalidomide|mesh-list
44274624|NCT00698776|KRN 7000|krn 7000|mesh-list
44274625|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
44274626|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274627|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44274628|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44274629|NCT00698776|Growth Substances|growth substances|mesh-ancestor
44274630|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
44274631|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274632|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44274633|NCT00698802|Insulin|insulin|mesh-list
44274634|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44274635|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274636|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274637|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43928945|NCT00668434|Prednisone|prednisone|mesh-list
44274638|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274639|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44274640|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44274641|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44274642|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274643|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274644|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274645|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274646|NCT00699023|Simvastatin|simvastatin|mesh-list
44274647|NCT00699023|Ezetimibe|ezetimibe|mesh-list
44463111|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44463112|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44463113|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463114|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
44463115|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
44463116|NCT01519089|Tofacitinib|tofacitinib|mesh-list
44463117|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463118|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274858|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274859|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274860|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
44274861|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
44274862|NCT00700024|Testosterone|testosterone|mesh-list
44274863|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
44274864|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
44274865|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44274866|NCT00700024|Androgens|androgens|mesh-ancestor
44274867|NCT00700024|Hormones|hormones|mesh-ancestor
44274868|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274869|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274870|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44274871|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274872|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
44274873|NCT00700037|Atorvastatin|atorvastatin|mesh-list
44274874|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44274875|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44274876|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
44274877|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274878|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44274879|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44274880|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274881|NCT00700128|Frovatriptan|frovatriptan|mesh-list
44274882|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44274883|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
44274884|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274885|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274886|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274887|NCT00700154|Insulin|insulin|mesh-list
44274888|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44274889|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
44274890|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274891|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274892|NCT00700193|Vaccines|vaccines|mesh-list
44274893|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
44274894|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274895|NCT00700284|Dapivirine|dapivirine|mesh-list
44274896|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44274897|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44274898|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
44274899|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274900|NCT00700297|Colchicine|colchicine|mesh-list
44274901|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
44274902|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274903|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275050|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44275051|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275052|NCT00701298|Interferons|interferons|mesh-list
44275053|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
44275054|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
44275055|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44275056|NCT00701298|Decitabine|decitabine|mesh-list
43674304|NCT00373711|Iodine|iodine|mesh-list
44275057|NCT00701298|Azacitidine|azacitidine|mesh-list
44275058|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275059|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
44275060|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275061|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
44275062|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275063|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275064|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
44275065|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275066|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275067|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44275068|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44275069|NCT00701337|Estradiol|estradiol|mesh-list
44463136|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44463137|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44463138|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463139|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463140|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463141|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
44463142|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44463143|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463144|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463145|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44463146|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44463147|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463148|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463149|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463150|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44463151|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
44463152|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44463153|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463154|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44463155|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43929455|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44275097|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275098|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44275099|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275100|NCT00701740|Isotretinoin|isotretinoin|mesh-list
44275101|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
44275102|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275103|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
44275104|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44275105|NCT00701740|Protective Agents|protective agents|mesh-ancestor
44275106|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275107|NCT00701792|Liver Extracts|liver extracts|mesh-list
44275108|NCT00701792|Hematinics|hematinics|mesh-ancestor
44275109|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
44275241|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119031|NCT00116181|Etanercept|etanercept|mesh-list
44236196|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44084186|NCT00275054|Rituximab|rituximab|mesh-list
44275242|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275243|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
43929586|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
44275244|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275245|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275246|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275247|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275248|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275249|NCT00702572|Growth Substances|growth substances|mesh-ancestor
44275250|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275251|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275252|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44275253|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275254|NCT00702637|Modafinil|modafinil|mesh-list
44275255|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44275256|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275257|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44275258|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44275259|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44275260|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275261|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44275262|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
44275263|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275264|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44275265|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44275266|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275267|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275268|NCT00702728|Furosemide|furosemide|mesh-list
44275269|NCT00702728|Diuretics|diuretics|mesh-ancestor
44275270|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
44275271|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275272|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44275273|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663177|NCT05287568|Cc-486|cc-486|mesh-list
44275500|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275501|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275502|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44275503|NCT00703703|Darifenacin|darifenacin|mesh-list
44275504|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44275505|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44275506|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
44275507|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275508|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275509|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275510|NCT00703703|Urological Agents|urological agents|mesh-ancestor
44275511|NCT00703742|Citalopram|citalopram|mesh-list
44275512|NCT00703742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44275513|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44275514|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44275515|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275516|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275517|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
44275518|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275519|NCT00703742|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44275520|NCT00703742|Antidepressive Agents|antidepressive agents|mesh-ancestor
44275521|NCT00703742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275522|NCT00703755|Metformin|metformin|mesh-list
44275523|NCT00703755|Fenofibrate|fenofibrate|mesh-list
44275524|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275525|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275526|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275527|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
44275528|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275529|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44463156|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44463157|NCT01518309|Pimavanserin|pimavanserin|mesh-list
44463158|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44463159|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44463160|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44463163|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463164|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463165|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44463166|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44463167|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
44463168|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463169|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463170|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
44463171|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44275530|NCT00703807|Everolimus|everolimus|mesh-list
44275531|NCT00703807|Topotecan|topotecan|mesh-list
44275532|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275533|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275534|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
44275535|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275536|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44275537|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275702|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
44275703|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275704|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275705|NCT00704756|Ribavirin|ribavirin|mesh-list
44275706|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44275707|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
44275708|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
44275709|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275710|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
44275711|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275712|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
44275713|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275714|NCT00704821|Docetaxel|docetaxel|mesh-list
44275715|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275716|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275717|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275718|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275719|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275720|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
44275721|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275722|NCT00704899|Amitriptyline|amitriptyline|mesh-list
44275723|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44275724|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
44275725|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275726|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44275727|NCT00704899|Analgesics|analgesics|mesh-ancestor
44275728|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
44275729|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275730|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275731|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44275732|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44275733|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44275874|NCT00705549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275875|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275876|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275877|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275878|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275880|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
44275881|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
44463191|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463192|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44463193|NCT01518192|Doxycycline|doxycycline|mesh-list
44463194|NCT01518192|Cefuroxime|cefuroxime|mesh-list
44463195|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
43930308|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
44463196|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463197|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463198|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
44463199|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119167|NCT00116623|Indomethacin|indomethacin|mesh-list
44463200|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44275957|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
44275958|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275959|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275960|NCT00706069|Capecitabine|capecitabine|mesh-list
44275961|NCT00706069|Vinorelbine|vinorelbine|mesh-list
43700489|NCT02730949|Folic Acid|folic acid|mesh-list
44463213|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463215|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
44463216|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463217|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44463218|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44463219|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
44463220|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463221|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44463222|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44463223|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463224|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
44463225|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44463226|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44463227|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
44276408|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44276409|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276410|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44276411|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44276412|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276413|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276414|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44276415|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44276416|NCT00708812|Growth Substances|growth substances|mesh-ancestor
44276417|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276418|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
44276419|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
44276420|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276421|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276422|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44276423|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44276424|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276425|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276426|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276427|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44276428|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
44276429|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276430|NCT00709046|Pantoprazole|pantoprazole|mesh-list
44276431|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44276432|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276433|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44276434|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276435|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276436|NCT00709137|Amiloride|amiloride|mesh-list
44276437|NCT00709137|Spironolactone|spironolactone|mesh-list
44276467|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
44276468|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44276469|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44276470|NCT00709215|Cordycepin|cordycepin|mesh-list
44276471|NCT00709215|Pentostatin|pentostatin|mesh-list
44276472|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276473|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44276474|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276475|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276476|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
44276477|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276478|NCT00709254|Fentanyl|fentanyl|mesh-list
44276479|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276480|NCT00709254|Narcotics|narcotics|mesh-ancestor
44276481|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276510|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44276511|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44276513|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276514|NCT00709332|Vitamins|vitamins|mesh-ancestor
44276515|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
44276516|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44276517|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44276518|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44276519|NCT00709423|Moxaverine|moxaverine|mesh-list
44276520|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
44276521|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
44276522|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276523|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276524|NCT00709436|Ketamine|ketamine|mesh-list
44276526|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
44276527|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276528|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276529|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44276530|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44276776|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276777|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276778|NCT00711295|Vaccines|vaccines|mesh-list
44276779|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
44276780|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276781|NCT00711308|Vitamin K|vitamin k|mesh-list
44276782|NCT00711308|Tinzaparin|tinzaparin|mesh-list
44276783|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44276784|NCT00711308|Dalteparin|dalteparin|mesh-list
44276785|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
44276786|NCT00711308|Vitamins|vitamins|mesh-ancestor
44276787|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
44276788|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276789|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44276790|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44276791|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276792|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
44276793|NCT00711308|Coagulants|coagulants|mesh-ancestor
44276794|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
44276795|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44276796|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44276797|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276798|NCT00711620|Thymalfasin|thymalfasin|mesh-list
44276799|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44276800|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
44276801|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276802|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
44276803|NCT00711698|Narcotics|narcotics|mesh-ancestor
43826067|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
44276879|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44276880|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44276881|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
44276882|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276883|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276884|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44276885|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
44276886|NCT00712049|Niacin|niacin|mesh-list
44276887|NCT00712049|Niacinamide|niacinamide|mesh-list
44276888|NCT00712049|Simvastatin|simvastatin|mesh-list
44276889|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44276890|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44276891|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
44276892|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463299|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463300|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463301|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44463302|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44463303|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
44463304|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463305|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44463306|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463307|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
44463308|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44277029|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277030|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44277031|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44277032|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44277033|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
43663763|NCT03719092|Vitamins|vitamins|mesh-list
44277061|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277063|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44277064|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44277065|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277066|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44277067|NCT00712686|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44277068|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44277069|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277070|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277071|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277072|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
44277073|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
44277074|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
44277075|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
44277076|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44277077|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43663780|NCT03694262|Growth Substances|growth substances|mesh-ancestor
44277107|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44277108|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44277109|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931464|NCT00728910|Vitamins|vitamins|mesh-ancestor
44277110|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277111|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277112|NCT00712790|Sorafenib|sorafenib|mesh-list
44277113|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277114|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44277115|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277116|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277117|NCT00712855|Sorafenib|sorafenib|mesh-list
44277118|NCT00712855|Mapatumumab|mapatumumab|mesh-list
44277119|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277299|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
44277300|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277301|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277302|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
44277303|NCT00713921|Fesoterodine|fesoterodine|mesh-list
44277304|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44277305|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44277306|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
44277307|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277308|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277309|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277310|NCT00713921|Urological Agents|urological agents|mesh-ancestor
44277311|NCT00713947|Amoxicillin|amoxicillin|mesh-list
44277312|NCT00713947|Metronidazole|metronidazole|mesh-list
44277313|NCT00713947|Clarithromycin|clarithromycin|mesh-list
44277348|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
44277349|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277350|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44277351|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
44277352|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44277353|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44277354|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44463346|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44463347|NCT01516216|Growth Substances|growth substances|mesh-ancestor
44463348|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463349|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
44463350|NCT01516216|Vitamins|vitamins|mesh-ancestor
44463351|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
44463352|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44277387|NCT00714246|Carboplatin|carboplatin|mesh-list
44277388|NCT00714246|Docetaxel|docetaxel|mesh-list
44277389|NCT00714246|Bortezomib|bortezomib|mesh-list
44277390|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277391|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44277392|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277393|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44154491|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44277394|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277395|NCT00714376|Docetaxel|docetaxel|mesh-list
44277396|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277397|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44277398|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277399|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44277400|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277401|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
44277402|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44277403|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
44277404|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277405|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277406|NCT00714519|Castor Oil|castor oil|mesh-list
44277407|NCT00714519|Cathartics|cathartics|mesh-ancestor
44277408|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277409|NCT00714558|Fentanyl|fentanyl|mesh-list
44277410|NCT00714558|Naltrexone|naltrexone|mesh-list
44277411|NCT00714558|Naloxone|naloxone|mesh-list
44277412|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44277413|NCT00714558|Narcotics|narcotics|mesh-ancestor
44277414|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277415|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277416|NCT00714558|Analgesics|analgesics|mesh-ancestor
44277417|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
44277418|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277419|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44277420|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44277421|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
44277476|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44277477|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277478|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277480|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277481|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277482|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277483|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277484|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
44277485|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277486|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
44277487|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277488|NCT00714961|Clopidogrel|clopidogrel|mesh-list
44277489|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664013|NCT05426525|Empagliflozin|empagliflozin|mesh-list
44277515|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44277516|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44277517|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277519|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
44277520|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
44277521|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277522|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277523|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44277524|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277525|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44277526|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44277527|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
44277528|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
44277529|NCT00715091|Diclofenac|diclofenac|mesh-list
44277530|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44277531|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44277532|NCT00715091|Analgesics|analgesics|mesh-ancestor
44277533|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
44277534|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277535|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277564|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44277565|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277566|NCT00715377|Benztropine|benztropine|mesh-list
44277567|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44277568|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44277569|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
44277570|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
44277571|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277572|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277573|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44277574|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44119377|NCT00117377|Analgesics|analgesics|mesh-ancestor
44277575|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44277576|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277577|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277578|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44277579|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44277580|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277581|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
44277582|NCT00715455|Heparin|heparin|mesh-list
44277583|NCT00715455|Calcium heparin|calcium heparin|mesh-list
44277584|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
44277612|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44277614|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277616|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44277617|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
44277618|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277619|NCT00715715|Prednisone|prednisone|mesh-list
44277620|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277621|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
44277622|NCT00715715|Hormones|hormones|mesh-ancestor
44277623|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277624|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277625|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44277658|NCT00715871|Nicotine|nicotine|mesh-list
44277659|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44277660|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
44277661|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277662|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277663|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44277664|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44277665|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
44277666|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664131|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
44463359|NCT01516216|Protective Agents|protective agents|mesh-ancestor
44463360|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44463361|NCT01516008|Tapentadol|tapentadol|mesh-list
44463362|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44463363|NCT01516008|Narcotics|narcotics|mesh-ancestor
44463364|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44463365|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463366|NCT01516008|Analgesics|analgesics|mesh-ancestor
44463367|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
44463368|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463369|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44463370|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44463371|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463372|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463373|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463374|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463375|NCT01515865|Midodrine|midodrine|mesh-list
44463376|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
44463377|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
44463378|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463379|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463380|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44463417|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44277712|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277713|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44277714|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
44277715|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277716|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277717|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44277718|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277719|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44277720|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277721|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
44277722|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44277723|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44278024|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278026|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278027|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278028|NCT00718146|Vaccines|vaccines|mesh-list
44278055|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278056|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278057|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
44278058|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278059|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278060|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278061|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278062|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278063|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
44278064|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44278065|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44278066|NCT00718406|Metoprolol|metoprolol|mesh-list
44278067|NCT00718406|Morphine|morphine|mesh-list
44278068|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44278069|NCT00718406|Narcotics|narcotics|mesh-ancestor
44278070|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278071|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278072|NCT00718406|Analgesics|analgesics|mesh-ancestor
44278073|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
44278074|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278075|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44278076|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44278077|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
44278078|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
44278079|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44278080|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44236197|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
43664402|NCT04910100|Timolol|timolol|mesh-list
44278116|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278117|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44278118|NCT00718705|Josamycin|josamycin|mesh-list
44278119|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278535|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278537|NCT00720577|Losartan|losartan|mesh-list
44278538|NCT00720577|Simvastatin|simvastatin|mesh-list
44278539|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44278540|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44278541|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
44278542|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278543|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44278544|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44278545|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278546|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278547|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278548|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44278549|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44278550|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44278551|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44278552|NCT00720590|Ritonavir|ritonavir|mesh-list
44278553|NCT00720590|Lopinavir|lopinavir|mesh-list
44278554|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44278555|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44278556|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44278557|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44278558|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278593|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278594|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278595|NCT00720811|Analgesics|analgesics|mesh-ancestor
44278596|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
44278597|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278598|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278599|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
43664765|NCT04061161|Bromides|bromides|mesh-list
44278816|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278817|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
43933199|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
44278819|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
44278820|NCT00722033|Indomethacin|indomethacin|mesh-list
44278854|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44278855|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
44278856|NCT00722176|Risperidone|risperidone|mesh-list
44278857|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44278858|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
44278859|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278860|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278861|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278916|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278918|NCT00722735|Finafloxacin|finafloxacin|mesh-list
44278919|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278920|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278921|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278922|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278923|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278924|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278925|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278926|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44278957|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44278958|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278959|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44278960|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
44278961|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278962|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44278963|NCT00722969|Sorafenib|sorafenib|mesh-list
44278964|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278965|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44278995|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
44278996|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278997|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44278998|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44278999|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
44279000|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
44236198|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236199|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44279001|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44279002|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44279003|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44279004|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44279005|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
44279006|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
44279007|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279008|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279010|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
44279011|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44279105|NCT00723658|Melphalan|melphalan|mesh-list
44279106|NCT00723658|Carmustine|carmustine|mesh-list
44279107|NCT00723658|Rituximab|rituximab|mesh-list
44279108|NCT00723658|Doxorubicin|doxorubicin|mesh-list
44279109|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44279110|NCT00723658|Etoposide|etoposide|mesh-list
44279111|NCT00723658|Bortezomib|bortezomib|mesh-list
44279286|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279287|NCT00724386|Paclitaxel|paclitaxel|mesh-list
44279288|NCT00724386|Vinorelbine|vinorelbine|mesh-list
44279289|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44279290|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279372|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44279373|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44279374|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44279375|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
44279376|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279377|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279378|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279380|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44279381|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
44279382|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
44279383|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
44279384|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
44279385|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279386|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279387|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
44279388|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
44279389|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
44279390|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279391|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463546|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
44463547|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463548|NCT01511107|Amoxicillin|amoxicillin|mesh-list
44463549|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
44463550|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
44463551|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44463552|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463553|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463554|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44463555|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463556|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279490|NCT00726258|Ketamine|ketamine|mesh-list
44279491|NCT00726258|Analgesics|analgesics|mesh-ancestor
44279492|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
44279493|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279494|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279495|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44279496|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44279600|NCT05373680|Empagliflozin|empagliflozin|mesh-list
44279601|NCT05373680|Biguanides|biguanides|mesh-list
44279602|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279603|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279604|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44279605|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279606|NCT05373277|Ticagrelor|ticagrelor|mesh-list
44279607|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44279608|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44279634|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44279635|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44279636|NCT05373134|Protective Agents|protective agents|mesh-ancestor
44279637|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236200|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236201|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44236202|NCT00557934|Dobutamine|dobutamine|mesh-list
44279638|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
44279639|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44279640|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
44279641|NCT05373108|Macitentan|macitentan|mesh-list
44279642|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44279643|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44279644|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279645|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44279646|NCT05373004|Empagliflozin|empagliflozin|mesh-list
44279647|NCT05373004|Enalapril|enalapril|mesh-list
44279648|NCT05373004|Enalaprilat|enalaprilat|mesh-list
44279649|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44279650|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279651|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279652|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279727|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44279728|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44279730|NCT04956627|Phenytoin|phenytoin|mesh-list
44279731|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
44279732|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
44279733|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279734|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44279735|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44279736|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665730|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280160|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280161|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280162|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280163|NCT00321698|Docetaxel|docetaxel|mesh-list
44280164|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280165|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44280166|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44280167|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119664|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280168|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280169|NCT00726804|Adalimumab|adalimumab|mesh-list
44280170|NCT00726804|Etanercept|etanercept|mesh-list
44280171|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280172|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280173|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280174|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280175|NCT00726804|Analgesics|analgesics|mesh-ancestor
44280176|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
44280177|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280178|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280179|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280180|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280181|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
44280182|NCT00726869|Elotuzumab|elotuzumab|mesh-list
44280497|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280498|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281497|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44281499|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44281500|NCT00733720|Narcotics|narcotics|mesh-ancestor
44281501|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281502|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281503|NCT00733720|Analgesics|analgesics|mesh-ancestor
44281504|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
44281505|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281506|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44281507|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44281508|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
44281509|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281510|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281511|NCT00733811|Deferiprone|deferiprone|mesh-list
44281512|NCT00733811|Deferoxamine|deferoxamine|mesh-list
44281540|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281541|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
44281542|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281543|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236203|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44281545|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44281546|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44281547|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44281548|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281549|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281550|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281551|NCT00734123|Aspirin|aspirin|mesh-list
44281552|NCT00734123|Rimonabant|rimonabant|mesh-list
44281553|NCT00734123|Enalapril|enalapril|mesh-list
44281554|NCT00734123|Clopidogrel|clopidogrel|mesh-list
44281555|NCT00734123|Atorvastatin|atorvastatin|mesh-list
44281556|NCT00734123|Simvastatin|simvastatin|mesh-list
44281557|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44281558|NCT00734123|Diuretics|diuretics|mesh-list
44281559|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44281560|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44281561|NCT00734123|Analgesics|analgesics|mesh-ancestor
44281562|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
44281581|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44281582|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
44281583|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281584|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
44281585|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44281586|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
44281587|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44281588|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44281589|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44281590|NCT00734123|Hormones|hormones|mesh-ancestor
44281591|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281592|NCT00734279|Leuprolide|leuprolide|mesh-list
44281593|NCT00734279|Ganirelix|ganirelix|mesh-list
44281594|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44281595|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
44281596|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281597|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119736|NCT00118794|Artemether|artemether|mesh-list
44281598|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44281599|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281600|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
44281601|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281602|NCT00734318|Fluticasone|fluticasone|mesh-list
44281603|NCT00734318|Xhance|xhance|mesh-list
44281604|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
44281605|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44281606|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
44281607|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281608|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667085|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
44282388|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282505|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44282506|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44282507|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44282508|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44282509|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282510|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
44282511|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44282512|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282513|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282514|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44282515|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
44282516|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282517|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
44282518|NCT00739986|Semapimod|semapimod|mesh-list
44282519|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44282520|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44282521|NCT00739986|Analgesics|analgesics|mesh-ancestor
44282522|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
44282523|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282528|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
44282530|NCT00740064|Abacavir|abacavir|mesh-list
44282531|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
44282532|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44282533|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282534|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700490|NCT02730949|Inositol|inositol|mesh-list
44282535|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282536|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
44282537|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282538|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282539|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282540|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44282541|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44282542|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44282543|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44282544|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
44282545|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282547|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282548|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282549|NCT00740103|Semapimod|semapimod|mesh-list
44282550|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44282551|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44282552|NCT00740103|Analgesics|analgesics|mesh-ancestor
44282553|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
44282554|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282555|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282556|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282557|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282558|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282559|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
44282560|NCT00740142|Lactulose|lactulose|mesh-list
44282561|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
44282562|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282563|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44282564|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44282565|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282566|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282567|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282568|NCT00740168|Bevacizumab|bevacizumab|mesh-list
44282569|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282570|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282571|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282572|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282573|NCT00740168|Growth Substances|growth substances|mesh-ancestor
44282574|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282575|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282576|NCT00740194|Estradiol|estradiol|mesh-list
44282577|NCT00740194|Estrogens|estrogens|mesh-ancestor
44282578|NCT00740194|Hormones|hormones|mesh-ancestor
44282579|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282580|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282581|NCT00740259|Flunarizine|flunarizine|mesh-list
44282582|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
44282583|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44282584|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282585|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282586|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282587|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282588|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44282589|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
44282590|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
44282591|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282592|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282594|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
44282600|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44282601|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44282602|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44282603|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282604|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282605|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44282606|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282607|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282608|NCT00740363|Incretins|incretins|mesh-ancestor
44282609|NCT00740363|Hormones|hormones|mesh-ancestor
44282610|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282611|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44282612|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
44282613|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236204|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
44236205|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
44282614|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282616|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44282617|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282618|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282619|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282620|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
44282621|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282622|NCT00740415|Dexamethasone|dexamethasone|mesh-list
44282623|NCT00740415|Rituximab|rituximab|mesh-list
44282624|NCT00740415|Bortezomib|bortezomib|mesh-list
44282625|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44282626|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282627|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282628|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
44282629|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282630|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282631|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282632|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
44282633|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
44282634|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282635|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282636|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
44282637|NCT00740415|Hormones|hormones|mesh-ancestor
44282638|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282639|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44282640|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44282641|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
44282642|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282643|NCT00740467|Cyclosporine|cyclosporine|mesh-list
44282644|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
44282645|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
44282646|NCT00740467|Busulfan|busulfan|mesh-list
44282647|NCT00740467|Fludarabine|fludarabine|mesh-list
44282648|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
44282649|NCT00740467|Cyclosporins|cyclosporins|mesh-list
44282650|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44282651|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282652|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
44282653|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282654|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282655|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44282656|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
44282657|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282658|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937215|NCT00843531|Everolimus|everolimus|mesh-list
44282659|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44282660|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282661|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
44282662|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463938|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44463939|NCT01502228|Growth Substances|growth substances|mesh-ancestor
44463940|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463941|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44463942|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463943|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463944|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463946|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
44463947|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463948|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
44463949|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463950|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
44282745|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282747|NCT00741169|Simeprevir|simeprevir|mesh-list
44282797|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282798|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282799|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282800|NCT00741325|Plerixafor|plerixafor|mesh-list
44282801|NCT00741325|Lenograstim|lenograstim|mesh-list
44282802|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44282830|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
44282831|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282832|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282833|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282834|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
44282835|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282836|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282837|NCT00741429|Insulin|insulin|mesh-list
44282838|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282839|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282840|NCT00741507|Ethanol|ethanol|mesh-list
44282841|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44282842|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282843|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282844|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282845|NCT00741585|Atenolol|atenolol|mesh-list
44282846|NCT00741585|Amlodipine|amlodipine|mesh-list
44282847|NCT00741585|Valsartan|valsartan|mesh-list
44282848|NCT00741585|Telmisartan|telmisartan|mesh-list
44282849|NCT00741585|Carvedilol|carvedilol|mesh-list
44282850|NCT00741585|Candesartan|candesartan|mesh-list
44282851|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
44282852|NCT00741585|Ramipril|ramipril|mesh-list
44282853|NCT00741585|Olmesartan|olmesartan|mesh-list
44282854|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44282855|NCT00741585|Enalapril|enalapril|mesh-list
44282856|NCT00741585|Enalaprilat|enalaprilat|mesh-list
44282857|NCT00741585|Lisinopril|lisinopril|mesh-list
44282871|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44282872|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44282873|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44282874|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282875|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282876|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
44282877|NCT00741585|Protective Agents|protective agents|mesh-ancestor
44282878|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44282879|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44282880|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44282881|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44282882|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282883|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44282884|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44282885|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
44282886|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
44282887|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282888|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44282889|NCT00741663|Furosemide|furosemide|mesh-list
44282890|NCT00741663|Spironolactone|spironolactone|mesh-list
44282891|NCT00741663|Diuretics|diuretics|mesh-ancestor
44282892|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
44282893|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282894|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44282895|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282896|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282897|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44282898|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44282899|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282900|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44282901|NCT00741741|Rilpivirine|rilpivirine|mesh-list
44282902|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44282903|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282904|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282905|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282906|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
44282907|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282908|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282909|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282910|NCT00741767|Fluticasone|fluticasone|mesh-list
44282911|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44282912|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44282913|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282914|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44282915|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
44282916|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282917|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667842|NCT04635007|Misoprostol|misoprostol|mesh-list
44282922|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44282923|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44282924|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44282925|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282926|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282927|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282928|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
44282929|NCT00741767|Hormones|hormones|mesh-ancestor
44282930|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282931|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
44282932|NCT00741780|Plerixafor|plerixafor|mesh-list
44282933|NCT00741780|Lenograstim|lenograstim|mesh-list
44282934|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44282935|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
44282936|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282937|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282938|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282939|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
44282940|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282941|NCT00741845|Metronidazole|metronidazole|mesh-list
44282942|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282943|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282944|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44282945|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44282946|NCT00741884|Varenicline|varenicline|mesh-list
44282947|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44282948|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44282949|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
44282950|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282951|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282952|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282953|NCT00741897|Fexofenadine|fexofenadine|mesh-list
44282954|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44282955|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44282956|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44282957|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
44282958|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
44282959|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282960|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282961|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282962|NCT00741910|Semapimod|semapimod|mesh-list
44282963|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44282964|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44282965|NCT00741910|Analgesics|analgesics|mesh-ancestor
44282966|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
44282967|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282968|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282969|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282970|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282971|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282972|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
44282973|NCT00741949|Propofol|propofol|mesh-list
44282974|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44282975|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282976|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282977|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44282978|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
44282979|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
44282980|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
44282981|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282982|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44282983|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44282984|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282985|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282986|NCT00742014|Urological Agents|urological agents|mesh-ancestor
44282987|NCT00742040|Captopril|captopril|mesh-list
44282988|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44283001|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283002|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283003|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283005|NCT00742092|Miglustat|miglustat|mesh-list
44283006|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283007|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283008|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283009|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44236207|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283010|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
44283011|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283012|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44283013|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283014|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283015|NCT00742144|Ofatumumab|ofatumumab|mesh-list
44283016|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283017|NCT00742157|Hormones|hormones|mesh-list
44283018|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283019|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283020|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
44283021|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44283022|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
44283023|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283024|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283025|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283026|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283027|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44283028|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44283029|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44283030|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283031|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283032|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283033|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
44283034|NCT00742287|Procyanidin|procyanidin|mesh-list
44283035|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
44283036|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283037|NCT00742287|Protective Agents|protective agents|mesh-ancestor
44283038|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283039|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44283040|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44283041|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283042|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
44283043|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283044|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
44283045|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283046|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283047|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44283048|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
44283077|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283078|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283079|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283080|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
44283081|NCT00742404|Hormones|hormones|mesh-ancestor
44283082|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283083|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283084|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283085|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44283086|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44283087|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44283088|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283089|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463978|NCT01500434|Ticlopidine|ticlopidine|mesh-list
44463979|NCT01500434|Clopidogrel|clopidogrel|mesh-list
44463980|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463981|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463982|NCT01500434|Analgesics|analgesics|mesh-ancestor
44464006|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44464007|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44464008|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464009|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464010|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464011|NCT01500382|Urological Agents|urological agents|mesh-ancestor
44464012|NCT01500317|Oxycodone|oxycodone|mesh-list
44464013|NCT01500317|Tapentadol|tapentadol|mesh-list
44464014|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44464015|NCT01500317|Narcotics|narcotics|mesh-ancestor
44464016|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937741|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
44283090|NCT00742638|Valproic Acid|valproic acid|mesh-list
44283091|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44283092|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
44283093|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283094|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44283095|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44283096|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283097|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283098|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
44283099|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283100|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283101|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
44283102|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283103|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
44283104|NCT00742690|Terlipressin|terlipressin|mesh-list
44283106|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44283107|NCT00742768|Vitamins|vitamins|mesh-list
44283108|NCT00742768|Vitamin K|vitamin k|mesh-list
44283109|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
44283110|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
44283111|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283112|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44283113|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44283114|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283115|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
44283116|NCT00742768|Coagulants|coagulants|mesh-ancestor
44283117|NCT00742807|Alfentanil|alfentanil|mesh-list
44283118|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44283119|NCT00742807|Narcotics|narcotics|mesh-ancestor
44283120|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283121|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283122|NCT00742807|Analgesics|analgesics|mesh-ancestor
44283123|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
44283124|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283125|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44283126|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
44283127|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
44283128|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
44283129|NCT00742820|Calcium|calcium|mesh-list
44283130|NCT00742820|Calcium acetate|calcium acetate|mesh-list
44283131|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283132|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283133|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44283134|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
44283135|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
44283136|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283137|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44283138|NCT00742846|Triamcinolone|triamcinolone|mesh-list
44283139|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44283140|NCT00742846|Lidocaine|lidocaine|mesh-list
44283141|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44283142|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
44283143|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
44283144|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283145|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283146|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
44283147|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283148|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283149|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44283150|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44283151|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283152|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283153|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283154|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
44283155|NCT00742846|Hormones|hormones|mesh-ancestor
44283156|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283157|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283158|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
44283159|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283161|NCT00742911|Disulfiram|disulfiram|mesh-list
44283162|NCT00742911|Trace Elements|trace elements|mesh-ancestor
44283163|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
44283164|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283165|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44283166|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44283167|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283168|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283170|NCT00742937|Vitamins|vitamins|mesh-ancestor
44283171|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
44283172|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283173|NCT00742976|Insulin|insulin|mesh-list
44283174|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44283175|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
44283176|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
44283177|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
44283178|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
44283179|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283180|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283181|NCT00743028|Navitoclax|navitoclax|mesh-list
44283185|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283187|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283188|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283189|NCT00743470|Ritonavir|ritonavir|mesh-list
44283190|NCT00743470|Lopinavir|lopinavir|mesh-list
44283191|NCT00743470|Rifabutin|rifabutin|mesh-list
44283192|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44283193|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44283194|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
44283195|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283196|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283197|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283198|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283199|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
44283200|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283201|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44283202|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44283203|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44283204|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44283205|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
44283206|NCT00743496|Antibodies|antibodies|mesh-list
44283207|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
44283208|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283209|NCT00743587|Naproxen|naproxen|mesh-list
44283210|NCT00743587|Oxycodone|oxycodone|mesh-list
44283211|NCT00743587|Tramadol|tramadol|mesh-list
44283212|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44283213|NCT00743587|Narcotics|narcotics|mesh-ancestor
44283214|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283215|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283216|NCT00743587|Analgesics|analgesics|mesh-ancestor
44283217|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
44283218|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283219|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44283220|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283221|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283222|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283223|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
44283224|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44283225|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283226|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283227|NCT00743678|Cetuximab|cetuximab|mesh-list
44283228|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44283229|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283230|NCT00743743|Resveratrol|resveratrol|mesh-list
44283231|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
44283232|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283233|NCT00743743|Protective Agents|protective agents|mesh-ancestor
44283234|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283235|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283236|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44283237|NCT00743782|Hormones|hormones|mesh-list
44283238|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
44283239|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283240|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283241|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283242|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
44283243|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44283244|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44283245|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283246|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283247|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283248|NCT00743834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44283249|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43700491|NCT02730949|Hematinics|hematinics|mesh-ancestor
44283250|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283251|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283254|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44283255|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
44283256|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44283257|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44283258|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283259|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44283260|NCT00743847|Varenicline|varenicline|mesh-list
44283261|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44283262|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44283263|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
44283264|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283265|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283266|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283267|NCT00743860|Darapladib|darapladib|mesh-list
44283268|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44283269|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283270|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283271|NCT00743873|Mitogens|mitogens|mesh-list
44283272|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44283273|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283274|NCT00743886|Mitogens|mitogens|mesh-list
44283275|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44283276|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283277|NCT00743912|Rifaximin|rifaximin|mesh-list
44283278|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44283279|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283280|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283281|NCT00743964|Cisplatin|cisplatin|mesh-list
44283282|NCT00743964|Capecitabine|capecitabine|mesh-list
44283283|NCT00743964|Epirubicin|epirubicin|mesh-list
44283284|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283285|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44283286|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
44283287|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283288|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44283289|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44283290|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44283291|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283292|NCT00743990|Camphor|camphor|mesh-list
44283293|NCT00743990|Menthol|menthol|mesh-list
44283294|NCT00743990|Petrolatum|petrolatum|mesh-list
44283295|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
44283296|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
44283297|NCT00743990|Emollients|emollients|mesh-ancestor
44283298|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44283299|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283300|NCT00744016|Mesalamine|mesalamine|mesh-list
44283301|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44283302|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283303|NCT00744016|Analgesics|analgesics|mesh-ancestor
44283304|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
44283305|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283306|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283307|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283308|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283309|NCT00744081|Topotecan|topotecan|mesh-list
44283310|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
44283311|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44283312|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44283313|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283314|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283315|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283316|NCT00744081|Analgesics|analgesics|mesh-ancestor
44283317|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
44283318|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283319|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283320|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44283321|NCT00744107|Cobalt|cobalt|mesh-list
44283322|NCT00744107|Trace Elements|trace elements|mesh-ancestor
44283323|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
44283324|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283325|NCT00744185|Propranolol|propranolol|mesh-list
44283326|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44283331|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283332|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283333|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283335|NCT00744224|Exenatide|exenatide|mesh-list
44283336|NCT00744224|Prednisolone|prednisolone|mesh-list
44283337|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44283338|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
44283339|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44283340|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
44283341|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44283342|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
44283343|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283344|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
44283345|NCT00744224|Hormones|hormones|mesh-ancestor
44283346|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283347|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283348|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283349|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283350|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
44283351|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
44283352|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283353|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283354|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44283355|NCT00744224|Protective Agents|protective agents|mesh-ancestor
44283356|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283357|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44283358|NCT00744224|Incretins|incretins|mesh-ancestor
44283359|NCT00744250|Pancrelipase|pancrelipase|mesh-list
44283360|NCT00744250|Pancreatin|pancreatin|mesh-list
44283361|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283362|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
44283363|NCT00744302|Calcium|calcium|mesh-list
44283364|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283365|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283366|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44464017|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464018|NCT01500317|Analgesics|analgesics|mesh-ancestor
44464019|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
44464020|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464021|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44464022|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44464023|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464024|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464025|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
44464026|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464027|NCT01500278|Adalimumab|adalimumab|mesh-list
44464028|NCT01500278|Methotrexate|methotrexate|mesh-list
44464029|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
44464030|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44464031|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
44464032|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464033|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464034|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44464035|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
44464036|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464037|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464038|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
44464039|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464040|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43938023|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
44464041|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464042|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
44283368|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44283369|NCT00744354|Bortezomib|bortezomib|mesh-list
44283370|NCT00744354|Vorinostat|vorinostat|mesh-list
44283371|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44283391|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283392|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283393|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283394|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
44154586|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
44283395|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283396|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44283397|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44283398|NCT00744419|Pantoprazole|pantoprazole|mesh-list
44283399|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44283400|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283401|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44283402|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283403|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283404|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
44283405|NCT00744445|Hematinics|hematinics|mesh-ancestor
44283406|NCT00744536|Lenalidomide|lenalidomide|mesh-list
44283407|NCT00744536|Melphalan|melphalan|mesh-list
44283408|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
44283409|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283410|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44283411|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44283412|NCT00744536|Growth Substances|growth substances|mesh-ancestor
44283413|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
44283414|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283415|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44283416|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
44283417|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283418|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44283419|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283420|NCT00744549|Vitamin D|vitamin d|mesh-list
44283421|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
44283422|NCT00744549|Vitamins|vitamins|mesh-list
44283423|NCT00744549|Vitamin E|vitamin e|mesh-list
44283424|NCT00744549|Selenium|selenium|mesh-list
44283425|NCT00744549|Lycopene|lycopene|mesh-list
44283426|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
44283427|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283471|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283472|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
44283473|NCT00744770|Rilpivirine|rilpivirine|mesh-list
44283474|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44283475|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44283476|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283477|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283478|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
44283479|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283480|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283481|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283482|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
44283483|NCT00744809|Efavirenz|efavirenz|mesh-list
44283484|NCT00744809|Rilpivirine|rilpivirine|mesh-list
44283485|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44283486|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283487|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44283488|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44283489|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283490|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283491|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283492|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44283493|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44283494|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
44283495|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44283496|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44283497|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44283498|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44283499|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44283500|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44283501|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283502|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283503|NCT00744887|Darunavir|darunavir|mesh-list
44283504|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44283505|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44283506|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
44283507|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283508|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283509|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283510|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283511|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
44283512|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283513|NCT00744900|Cisplatin|cisplatin|mesh-list
44283514|NCT00744900|Pemetrexed|pemetrexed|mesh-list
44283515|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938182|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
44283516|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283517|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283518|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44283519|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44283520|NCT00744913|Nicotine|nicotine|mesh-list
44283521|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44283522|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
44283523|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283524|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283525|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44283526|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44283527|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
44283528|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283529|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283530|NCT00745004|Ondansetron|ondansetron|mesh-list
44283535|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283536|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
44283537|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44283538|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44283539|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
44283540|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283541|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283542|NCT00745004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44283543|NCT00745004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44283544|NCT00745004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283545|NCT00745004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283546|NCT00745004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44283547|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
44283548|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283549|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
44283550|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
44283551|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283552|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283553|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283554|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283555|NCT00745069|Tapentadol|tapentadol|mesh-list
44283556|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44283557|NCT00745069|Narcotics|narcotics|mesh-ancestor
44283558|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283559|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283560|NCT00745069|Analgesics|analgesics|mesh-ancestor
44283561|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
44283562|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283563|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44283564|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44283565|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283566|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283567|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283568|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283569|NCT00745147|Laxatives|laxatives|mesh-list
44283570|NCT00745147|Lactulose|lactulose|mesh-list
44283571|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283572|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44283573|NCT00745173|Estrogens|estrogens|mesh-ancestor
44283574|NCT00745173|Hormones|hormones|mesh-ancestor
44283575|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283576|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283577|NCT00745186|Glucagon|glucagon|mesh-list
44283578|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283579|NCT00745186|Hormones|hormones|mesh-ancestor
44283580|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283581|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283582|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
44283583|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44283584|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
44283585|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283586|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283587|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283588|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283589|NCT00745225|Pioglitazone|pioglitazone|mesh-list
44283590|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44464043|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283591|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283592|NCT00745407|Fenofibrate|fenofibrate|mesh-list
44283593|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44283594|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
44283595|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283596|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44283597|NCT00745433|Metformin|metformin|mesh-list
44283598|NCT00745433|Repaglinide|repaglinide|mesh-list
44283599|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283600|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283601|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
44283610|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283611|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
44283612|NCT00745589|Sevelamer|sevelamer|mesh-list
44283613|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
44283614|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
44283615|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283616|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44283617|NCT00745693|BQ 788|bq 788|mesh-list
44283618|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283619|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44283620|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283621|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44283622|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
44283623|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
44283624|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283625|NCT00745914|Pioglitazone|pioglitazone|mesh-list
44283626|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283627|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283628|NCT00745953|Valsartan|valsartan|mesh-list
44283629|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44283630|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283631|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44283632|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44283633|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283634|NCT00745953|Diuretics|diuretics|mesh-ancestor
44283635|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
44283636|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283637|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44283638|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283639|NCT00746031|Goserelin|goserelin|mesh-list
44283640|NCT00746031|Cetrorelix|cetrorelix|mesh-list
44283641|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44283642|NCT00746031|Hormones|hormones|mesh-ancestor
44283643|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283644|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283645|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283646|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283647|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44283648|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
44283649|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44283650|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44283651|NCT00746070|Spironolactone|spironolactone|mesh-list
44283652|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44283653|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
44283654|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283655|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283656|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44283657|NCT00746070|Diuretics|diuretics|mesh-ancestor
44283658|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
44283659|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
44283660|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283661|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120566|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464044|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44464045|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464046|NCT01500226|Dexamethasone|dexamethasone|mesh-list
44283662|NCT00746447|Mesalamine|mesalamine|mesh-list
43667910|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
44283686|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283687|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44283688|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44283689|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283690|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283691|NCT00746655|Cisplatin|cisplatin|mesh-list
44283692|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283693|NCT00746681|Pregabalin|pregabalin|mesh-list
44283694|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44283695|NCT00746681|Analgesics|analgesics|mesh-ancestor
44283696|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
44283697|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283698|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283699|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
44283700|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44283701|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283702|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283703|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283704|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44283705|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44283706|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283707|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283708|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44283709|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44283710|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
44283711|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283712|NCT00746681|Urological Agents|urological agents|mesh-ancestor
44283713|NCT00746720|Etoricoxib|etoricoxib|mesh-list
44283714|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44283724|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283725|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283726|NCT00746746|Interferons|interferons|mesh-list
44283727|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
44283728|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
44283729|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44283730|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283731|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
44283732|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283733|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
44283734|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464047|NCT01500226|Granisetron|granisetron|mesh-list
44464048|NCT01500226|Rolapitant|rolapitant|mesh-list
44464049|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283735|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44283736|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44283737|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283738|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283739|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283740|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
44283741|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283742|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
44283743|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
44283744|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44283745|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44283746|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283747|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283748|NCT00746967|Urological Agents|urological agents|mesh-ancestor
44120648|NCT00121550|Clarithromycin|clarithromycin|mesh-list
44283749|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
44283750|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44283751|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283752|NCT00747097|Gemcitabine|gemcitabine|mesh-list
44283753|NCT00747097|Cetuximab|cetuximab|mesh-list
44283754|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44283755|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
44283756|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283757|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283758|NCT00747097|Antiviral Agents|antiviral agents|mesh-ancestor
44283759|NCT00747097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283760|NCT00747097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283761|NCT00747097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283762|NCT00747097|Immunologic Factors|immunologic factors|mesh-ancestor
44283763|NCT00747097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283764|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44283765|NCT00747110|Budesonide|budesonide|mesh-list
44283766|NCT00747110|Mesalamine|mesalamine|mesh-list
44283767|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283768|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44283769|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
44283770|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283771|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283772|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283773|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283774|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
44283775|NCT00747110|Hormones|hormones|mesh-ancestor
43667926|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283779|NCT00747110|Analgesics|analgesics|mesh-ancestor
44283780|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
44283781|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283782|NCT00747279|Insulin|insulin|mesh-list
44283783|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283784|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283785|NCT00747305|Sunitinib|sunitinib|mesh-list
44283786|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283787|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44283788|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44283789|NCT00747305|Growth Substances|growth substances|mesh-ancestor
44283790|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283791|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
44283792|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44283793|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283794|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283795|NCT00747331|Fenoldopam|fenoldopam|mesh-list
44283796|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283797|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44283798|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
44283799|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
44283800|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283801|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283802|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283803|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44283804|NCT00747383|Glimepiride|glimepiride|mesh-list
44283805|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283806|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283807|NCT00747383|Incretins|incretins|mesh-ancestor
44283808|NCT00747383|Hormones|hormones|mesh-ancestor
44283809|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283810|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44283811|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
44283812|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283813|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283814|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283815|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283816|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
44283817|NCT00747409|Insulin|insulin|mesh-list
44283818|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44283819|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
44283820|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
44283821|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
44283822|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44283823|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
44283824|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
44283825|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
44283826|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283827|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283828|NCT00747487|Idebenone|idebenone|mesh-list
44283829|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
44283830|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283831|NCT00747487|Protective Agents|protective agents|mesh-ancestor
44283832|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283833|NCT00747526|Rabeprazole|rabeprazole|mesh-list
44283834|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44283835|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283836|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44283837|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283838|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283839|NCT00747539|Interferons|interferons|mesh-list
44283840|NCT00747539|Ribavirin|ribavirin|mesh-list
44283841|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
44283842|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283843|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
44283844|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283845|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
44283846|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283869|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283870|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283872|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44283873|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
44283874|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236208|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44283875|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
44283876|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44283877|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283878|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283879|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283880|NCT00747721|Analgesics|analgesics|mesh-ancestor
44283881|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
44283882|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464050|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
44283883|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44283884|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44283885|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44283886|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283887|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283888|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283889|NCT00747799|Cisplatin|cisplatin|mesh-list
44283890|NCT00747799|Fluorouracil|fluorouracil|mesh-list
44283891|NCT00747799|Sorafenib|sorafenib|mesh-list
44283892|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283893|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
44283894|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283895|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44283896|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283897|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
44283900|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283901|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
44283902|NCT00747877|Melphalan|melphalan|mesh-list
44283903|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283904|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
44283905|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283906|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283907|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44283908|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
44283909|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283910|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283911|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44283912|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44283913|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44283914|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44283915|NCT00747968|Exenatide|exenatide|mesh-list
44283916|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44283917|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283918|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44283919|NCT00747968|Incretins|incretins|mesh-ancestor
44283920|NCT00747968|Hormones|hormones|mesh-ancestor
44283921|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283922|NCT00748007|Rivastigmine|rivastigmine|mesh-list
44283923|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44283924|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283925|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283926|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
44283927|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283928|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283929|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44283930|NCT00748007|Protective Agents|protective agents|mesh-ancestor
44283931|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44283932|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283933|NCT00748059|Propranolol|propranolol|mesh-list
44283934|NCT00748059|Atropine|atropine|mesh-list
44283935|NCT00748059|Clonidine|clonidine|mesh-list
44283936|NCT00748059|Nitroprusside|nitroprusside|mesh-list
44283937|NCT00748059|Methyldopa|methyldopa|mesh-list
44283938|NCT00748059|Phenylephrine|phenylephrine|mesh-list
44283939|NCT00748059|Isoproterenol|isoproterenol|mesh-list
44283940|NCT00748059|Metoclopramide|metoclopramide|mesh-list
44283941|NCT00748059|Yohimbine|yohimbine|mesh-list
44283942|NCT00748059|Tyramine|tyramine|mesh-list
44283943|NCT00748059|Edrophonium|edrophonium|mesh-list
44283944|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44283945|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44283946|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283947|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283948|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283949|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283950|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283951|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283952|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
44283953|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44283954|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
44283955|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
44283956|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283957|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
44283958|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43938597|NCT00883168|Fluticasone|fluticasone|mesh-list
44283959|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
44283960|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283961|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44283962|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44283963|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44283964|NCT00748059|Protective Agents|protective agents|mesh-ancestor
44283965|NCT00748059|Analgesics|analgesics|mesh-ancestor
44283966|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
44283967|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
44283968|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44283969|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44283970|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44283971|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283972|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
44284009|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284010|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284011|NCT00748176|Anesthetics|anesthetics|mesh-list
44284012|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284013|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464051|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
44464052|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464053|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464054|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464055|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
44464056|NCT01500226|Hormones|hormones|mesh-ancestor
44464057|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464058|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464059|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464060|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464061|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
44464062|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464063|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464064|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44464065|NCT01500213|Dexamethasone|dexamethasone|mesh-list
44464066|NCT01500213|Granisetron|granisetron|mesh-list
44464067|NCT01500213|Rolapitant|rolapitant|mesh-list
44464068|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464069|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
44464070|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
44464071|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284014|NCT00748202|Complement C1s|complement c1s|mesh-list
44284015|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44284016|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44284017|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
44284018|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284019|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44284020|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284021|NCT00748345|Caspofungin|caspofungin|mesh-list
44284022|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
44284023|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284024|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284025|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284026|NCT00748358|Sunitinib|sunitinib|mesh-list
44284027|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284028|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44284029|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44284030|NCT00748358|Growth Substances|growth substances|mesh-ancestor
44284031|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284032|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284033|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284034|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284035|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284036|NCT00748371|Aspirin|aspirin|mesh-list
44284037|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284038|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284039|NCT00748371|Analgesics|analgesics|mesh-ancestor
44284040|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
44284041|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284042|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284043|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284044|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284045|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44284046|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44284047|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284048|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44284049|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44284050|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284051|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
44284052|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
44284053|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44284054|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
44284055|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284089|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284090|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284091|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284092|NCT00748787|Psyllium|psyllium|mesh-list
44284093|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
44284094|NCT00748787|Cathartics|cathartics|mesh-ancestor
44284095|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284096|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
44284100|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284101|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284102|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
44284103|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
44284104|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
44284105|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284107|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44284108|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44284109|NCT00749021|Growth Substances|growth substances|mesh-ancestor
44284110|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284111|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284112|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284113|NCT00749047|Pioglitazone|pioglitazone|mesh-list
44284114|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44284115|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284116|NCT00749099|Pancrelipase|pancrelipase|mesh-list
44284117|NCT00749099|Pancreatin|pancreatin|mesh-list
44284118|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284119|NCT00749112|Rituximab|rituximab|mesh-list
44284120|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
44284121|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44284122|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284123|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
44284124|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284125|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284126|NCT00749138|Tamoxifen|tamoxifen|mesh-list
44284127|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44284128|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
44284129|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284130|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284131|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44284132|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284133|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44284134|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44284135|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44284136|NCT00749346|Pemetrexed|pemetrexed|mesh-list
44284137|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284138|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284139|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284140|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44284141|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44284142|NCT00749359|Paroxetine|paroxetine|mesh-list
44284143|NCT00749359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44284144|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44284145|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44284146|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284147|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284148|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
44284149|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284150|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44284151|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
44284152|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44284153|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44284154|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284155|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284156|NCT00749385|Naproxen|naproxen|mesh-list
44284157|NCT00749385|Esomeprazole|esomeprazole|mesh-list
44284158|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44284159|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284160|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44284161|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464072|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284162|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284163|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284164|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284165|NCT00749385|Analgesics|analgesics|mesh-ancestor
43826674|NCT05495620|Dexamethasone|dexamethasone|mesh-list
44285704|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44285705|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285706|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44285707|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285708|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285709|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285710|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285711|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285712|NCT00755976|Analgesics|analgesics|mesh-ancestor
44285713|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
44285794|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44285795|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44285796|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285797|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
44285798|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285799|NCT00757016|Triamcinolone|triamcinolone|mesh-list
44285800|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44285801|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44285802|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44285803|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285804|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
44285805|NCT00757016|Hormones|hormones|mesh-ancestor
44285806|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285807|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285808|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285809|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
44285810|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285811|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285812|NCT00757029|Norepinephrine|norepinephrine|mesh-list
44285813|NCT00757029|Methylphenidate|methylphenidate|mesh-list
44285814|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44285815|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285816|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44285817|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44285818|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285819|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285820|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
44285821|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940485|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
44285822|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44285823|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44285824|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285825|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
44285854|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44285855|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285856|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
44285857|NCT00757315|Triamcinolone|triamcinolone|mesh-list
44285858|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44285859|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44285860|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44285861|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285862|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
44285863|NCT00757315|Hormones|hormones|mesh-ancestor
44285864|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285865|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285866|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285867|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
44285868|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285869|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285870|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
44285871|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44285872|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44285873|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285890|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285891|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285892|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285893|NCT00757458|Propofol|propofol|mesh-list
44285894|NCT00757458|Edetic Acid|edetic acid|mesh-list
44285895|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
44285896|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44285897|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285898|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285899|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44285900|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
44285901|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
44285902|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
44285903|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44285904|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
44285905|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
44285906|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285907|NCT00757458|Antidotes|antidotes|mesh-ancestor
44285908|NCT00757458|Protective Agents|protective agents|mesh-ancestor
44285909|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44285910|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44285911|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285912|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285913|NCT00757523|Analgesics|analgesics|mesh-ancestor
44285914|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
44285915|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285916|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285917|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285918|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285919|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44285920|NCT00757549|Cisplatin|cisplatin|mesh-list
44285921|NCT00757549|Cetuximab|cetuximab|mesh-list
44285922|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44285923|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285924|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285925|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44285926|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285927|NCT00757679|Milnacipran|milnacipran|mesh-list
44285928|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
44285929|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44285930|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44285931|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285932|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285933|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831636|NCT05303792|Rituximab|rituximab|mesh-list
44286135|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286137|NCT05434377|Vitamin D|vitamin d|mesh-list
44286138|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
44286139|NCT05434377|Vitamins|vitamins|mesh-ancestor
44286140|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
44286141|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286142|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44286143|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44286144|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
44286145|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286146|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286147|NCT05428306|Acetaminophen|acetaminophen|mesh-list
44286148|NCT05428306|Ibuprofen|ibuprofen|mesh-list
44286149|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286150|NCT05428306|Analgesics|analgesics|mesh-ancestor
44286151|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
44286152|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286190|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
44286191|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286304|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286305|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44286306|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286307|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286308|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
44286309|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286310|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
44286311|NCT05122221|Fludarabine|fludarabine|mesh-list
44286312|NCT05122221|Interleukin-2|interleukin-2|mesh-list
44286313|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286314|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
44286315|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286316|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286317|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44286338|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286339|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286340|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44286341|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
44286342|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44286343|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44286344|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44286345|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286346|NCT04984759|Primaquine|primaquine|mesh-list
44286347|NCT04984759|Tafenoquine|tafenoquine|mesh-list
44286348|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
44286349|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44286350|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44286351|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286352|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
44286353|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286354|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286355|NCT04908579|Ketamine|ketamine|mesh-list
44286356|NCT04908579|Bupivacaine|bupivacaine|mesh-list
44286357|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286358|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
44286359|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286360|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286361|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
44286362|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286363|NCT04908579|Analgesics|analgesics|mesh-ancestor
44286364|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44286365|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44286366|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
44286367|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44286368|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44286369|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286370|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286371|NCT04767061|Propranolol|propranolol|mesh-list
44464210|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464211|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44464212|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44464213|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464214|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464215|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
44464216|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464217|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
44464218|NCT01498822|Levetiracetam|levetiracetam|mesh-list
44464219|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
44464220|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
44464221|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44464222|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44464223|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464224|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464225|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44464226|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44464227|NCT01498679|Fluticasone|fluticasone|mesh-list
44464228|NCT01498679|Xhance|xhance|mesh-list
44464229|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464230|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44464231|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
44464232|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464233|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286627|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286628|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286629|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44286630|NCT02870920|Durvalumab|durvalumab|mesh-list
44286975|NCT00759460|Sertindole|sertindole|mesh-list
44286976|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
44286977|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
44286978|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286979|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286980|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286981|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44286982|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44286983|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286984|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44286985|NCT00759460|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44286986|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286987|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286988|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286989|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287035|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44287036|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287037|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287039|NCT00759993|Trace Elements|trace elements|mesh-ancestor
44287040|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
44287041|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287042|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
44287043|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287044|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287045|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44287046|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287047|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287048|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287049|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287050|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43711434|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
44287116|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287117|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287118|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287119|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287151|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44287152|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287153|NCT00761228|Apomorphine|apomorphine|mesh-list
44287155|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287156|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
44287157|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287158|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287159|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
44287160|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
44287161|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287162|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287399|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287400|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
44287401|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287402|NCT00762671|Protective Agents|protective agents|mesh-ancestor
44287403|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44287404|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287405|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44287406|NCT00762736|Pioglitazone|pioglitazone|mesh-list
44287407|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44287408|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287409|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287410|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44287411|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44287412|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287413|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
44287414|NCT00762749|Promethazine|promethazine|mesh-list
44287415|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44287416|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44287417|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287418|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287419|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
44287421|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
44287422|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287423|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
44287424|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
44287425|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287426|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43831779|NCT05299008|Bethanechol|bethanechol|mesh-list
44287595|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44287596|NCT00763789|Narcotics|narcotics|mesh-ancestor
44287597|NCT00763789|Analgesics|analgesics|mesh-ancestor
44287598|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
44287599|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287600|NCT00763880|Lidocaine|lidocaine|mesh-list
44287601|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
44287602|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
44287603|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121237|NCT00123331|Cyclosporine|cyclosporine|mesh-list
44287604|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287605|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
44287606|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287607|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44287608|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44287609|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44287610|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287611|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287612|NCT00763893|Losartan|losartan|mesh-list
44287613|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44287614|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44287615|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44287616|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44287617|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287618|NCT00763906|Norepinephrine|norepinephrine|mesh-list
44287619|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44287620|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44287621|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44287622|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287623|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287624|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287740|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287741|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44287742|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287773|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
44287774|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287776|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287777|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287778|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287779|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287780|NCT00764725|Analgesics|analgesics|mesh-ancestor
44287781|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
44287782|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287783|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287784|NCT00764816|Caseins|caseins|mesh-list
44287785|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
43712029|NCT02686021|Analgesics|analgesics|mesh-ancestor
44287820|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44287821|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287823|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
44287824|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287825|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287826|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
44287827|NCT00764907|Hormones|hormones|mesh-ancestor
44287828|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287829|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44287830|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44287831|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44287861|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287862|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287864|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44287865|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287866|NCT00765024|Ivermectin|ivermectin|mesh-list
44287867|NCT00765024|Albendazole|albendazole|mesh-list
44287868|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44287869|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287870|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
44287871|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
44287872|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44287873|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44287874|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287875|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287876|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287877|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712117|NCT02685345|Firuglipel|firuglipel|mesh-list
44287888|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
44287889|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287890|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44287891|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44287892|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
44287893|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44287894|NCT00765167|Triclosan|triclosan|mesh-list
44287895|NCT00765167|Fluorides|fluorides|mesh-list
44287896|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
44287897|NCT00765167|Protective Agents|protective agents|mesh-ancestor
44287898|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287899|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44287900|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287901|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
44287902|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287903|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44287904|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44287905|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
44287906|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287907|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44287908|NCT00765271|Ritonavir|ritonavir|mesh-list
44287909|NCT00765271|Darunavir|darunavir|mesh-list
44287910|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
44287911|NCT00765271|Abacavir|abacavir|mesh-list
44287912|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44287913|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44287914|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
44287915|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287916|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287917|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44287918|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44287919|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
44287920|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287921|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44287922|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44287923|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44287924|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44287925|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44287926|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44287927|NCT00765427|Retinol acetate|retinol acetate|mesh-list
44287928|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44287929|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
44287930|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287931|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44287933|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287934|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44287935|NCT00765557|Laxatives|laxatives|mesh-ancestor
44287936|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287937|NCT00765921|Ranibizumab|ranibizumab|mesh-list
44287938|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44287939|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44287940|NCT00765921|Growth Substances|growth substances|mesh-ancestor
44287941|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287942|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
44287943|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287944|NCT00765934|Lidocaine|lidocaine|mesh-list
44287945|NCT00765934|Tetracaine|tetracaine|mesh-list
44287969|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44287970|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287971|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44287972|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44287973|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
44121356|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
44287974|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287975|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44287976|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44287977|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287978|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44287979|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44287980|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44236210|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44086612|NCT00021671|Erythromycin|erythromycin|mesh-list
44287981|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287982|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287983|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287984|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44287985|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44287986|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
44287987|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287988|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287989|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44287990|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44287991|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
44287992|NCT00766155|Capecitabine|capecitabine|mesh-list
44287993|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
44288023|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288024|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288025|NCT00766246|Growth Substances|growth substances|mesh-ancestor
44288026|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288027|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288028|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44288029|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44288030|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44288031|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288032|NCT00766285|Vaccines|vaccines|mesh-list
44288033|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
44288034|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288035|NCT00766337|Sirolimus|sirolimus|mesh-list
44288036|NCT00766337|Ranibizumab|ranibizumab|mesh-list
44288037|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288074|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288096|NCT00766480|Cisplatin|cisplatin|mesh-list
44288097|NCT00766480|Fluorouracil|fluorouracil|mesh-list
44288098|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288099|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
44288100|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288101|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44288102|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288103|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
44288104|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288105|NCT00766545|Cilostazol|cilostazol|mesh-list
44288106|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44288107|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
44288108|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288109|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288110|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44288111|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
44288112|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44288113|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44288114|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288115|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44288116|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288117|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44288118|NCT00766545|Protective Agents|protective agents|mesh-ancestor
44288119|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44288120|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44288121|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288122|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
44288123|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
44288124|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44288125|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
44288142|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288143|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288144|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44288145|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44288146|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288147|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44288148|NCT00766805|Diuretics|diuretics|mesh-ancestor
44288149|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44288150|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44288151|NCT00766818|Lopinavir|lopinavir|mesh-list
44288152|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44288153|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44236211|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288154|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288155|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288156|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288158|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44288159|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
44288160|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288161|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44288162|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288163|NCT00766857|Insulin|insulin|mesh-list
44288164|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44288165|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
44288166|NCT00766857|Exenatide|exenatide|mesh-list
44288167|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288168|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288169|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44288170|NCT00766857|Incretins|incretins|mesh-ancestor
44288171|NCT00766857|Hormones|hormones|mesh-ancestor
44288172|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288173|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44288174|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44288175|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288176|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288177|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288178|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288179|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288180|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44288181|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
44288182|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288183|NCT00766896|Aspirin|aspirin|mesh-list
43712360|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
44288200|NCT00766909|Tacrolimus|tacrolimus|mesh-list
44288201|NCT00766909|Cyclosporins|cyclosporins|mesh-list
44288202|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288203|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
44288204|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288205|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44288206|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288207|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288208|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
44288209|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288210|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
44288211|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464423|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44464424|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
44464425|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464426|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44464427|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44464428|NCT01495000|Denosumab|denosumab|mesh-list
44464429|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44464430|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464431|NCT01494987|Glimepiride|glimepiride|mesh-list
44464432|NCT01494987|Ranolazine|ranolazine|mesh-list
44464433|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44464434|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44464435|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464436|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943055|NCT01003080|Hemostatics|hemostatics|mesh-list
44288212|NCT00767091|Rivastigmine|rivastigmine|mesh-list
44288213|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44288214|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288215|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288216|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
44288217|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288218|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288219|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44288220|NCT00767091|Protective Agents|protective agents|mesh-ancestor
44288221|NCT00767117|Ritonavir|ritonavir|mesh-list
44288222|NCT00767117|Lopinavir|lopinavir|mesh-list
44288223|NCT00767117|Etravirine|etravirine|mesh-list
44288224|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44288225|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44288226|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
44236212|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288227|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288254|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288255|NCT00767286|Cobalt|cobalt|mesh-list
44288256|NCT00767286|Goserelin|goserelin|mesh-list
44288257|NCT00767286|Flutamide|flutamide|mesh-list
44288258|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44288259|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288260|NCT00767286|Trace Elements|trace elements|mesh-ancestor
44288261|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
44288262|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288263|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
44288264|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288265|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288266|NCT00767468|Sorafenib|sorafenib|mesh-list
44288267|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288268|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44288269|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288270|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288271|NCT00767481|Travoprost|travoprost|mesh-list
44288272|NCT00767481|Brinzolamide|brinzolamide|mesh-list
44288273|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44288274|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44288275|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288309|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288311|NCT00767663|Dipyridamole|dipyridamole|mesh-list
44288312|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44288313|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288314|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288315|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44288316|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288345|NCT00767728|Mesalamine|mesalamine|mesh-list
44288346|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44288347|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44288348|NCT00767728|Analgesics|analgesics|mesh-ancestor
44288349|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
44288350|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288351|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288352|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44288353|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288354|NCT00767754|Paroxetine|paroxetine|mesh-list
44288355|NCT00767754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44288356|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288357|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288358|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288359|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288360|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
44288361|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288362|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44288363|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
44288364|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288385|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
44121544|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288386|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44288387|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288388|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288389|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44288390|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44288391|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44288392|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44288393|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44288394|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44288395|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44288396|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44288397|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
44288398|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44288399|NCT00768131|Paclitaxel|paclitaxel|mesh-list
44288400|NCT00768131|Carboplatin|carboplatin|mesh-list
44288401|NCT00768131|Cetuximab|cetuximab|mesh-list
44288402|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44288403|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288404|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
44288405|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
44288406|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44288407|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288408|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44288410|NCT00768157|Entecavir|entecavir|mesh-list
44288411|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
44288412|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44288413|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44288414|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288415|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288416|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288443|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288444|NCT00768391|Olaratumab|olaratumab|mesh-list
44288445|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288446|NCT00768404|Phentermine|phentermine|mesh-list
44288447|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44288448|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288449|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
44288450|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44288451|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
44288452|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
44288453|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288454|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288455|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288456|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288457|NCT00768456|Ropivacaine|ropivacaine|mesh-list
44288458|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
44288459|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
44288460|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288461|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288462|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
44288463|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288464|NCT00768508|Naltrexone|naltrexone|mesh-list
44288465|NCT00768508|Ondansetron|ondansetron|mesh-list
44288466|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44288495|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288496|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288497|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288498|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44288499|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288500|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288501|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288502|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44288503|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
44288504|NCT00768638|Atorvastatin|atorvastatin|mesh-list
44288505|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44288506|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44288507|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
44288508|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288509|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44288510|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44288511|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288512|NCT00768677|Topiramate|topiramate|mesh-list
44288547|NCT00768859|Paclitaxel|paclitaxel|mesh-list
44288548|NCT00768859|Carboplatin|carboplatin|mesh-list
44288549|NCT00768859|Trastuzumab|trastuzumab|mesh-list
43712687|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
44464465|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
44288558|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44288585|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288586|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288587|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
44288588|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288589|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44288590|NCT00769093|Hematinics|hematinics|mesh-ancestor
44288591|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44288592|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44288593|NCT00769145|Ranibizumab|ranibizumab|mesh-list
44288594|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288595|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288596|NCT00769145|Growth Substances|growth substances|mesh-ancestor
44288597|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288598|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288599|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288600|NCT00769158|Topiramate|topiramate|mesh-list
44288601|NCT00769158|Naltrexone|naltrexone|mesh-list
44236213|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288602|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44288603|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44288604|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288605|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
44288606|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288626|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44288627|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43943452|NCT01010282|Laxatives|laxatives|mesh-ancestor
44288628|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44288629|NCT00769210|Simvastatin|simvastatin|mesh-list
44288630|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44288631|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44288632|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
44288633|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288634|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44288635|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44288636|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288637|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
44288638|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
44288639|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
44288640|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288641|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
44288642|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288643|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288644|NCT00769288|Growth Substances|growth substances|mesh-ancestor
44288645|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288647|NCT00769405|Fluorouracil|fluorouracil|mesh-list
44288648|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
44288649|NCT00769405|Calcium|calcium|mesh-list
44288650|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
44288651|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44288652|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288653|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
44288654|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288655|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44288656|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288657|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288658|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
44288659|NCT00769405|Antidotes|antidotes|mesh-ancestor
44288660|NCT00769405|Protective Agents|protective agents|mesh-ancestor
44288675|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288676|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
44288677|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44288678|NCT00769522|Rituximab|rituximab|mesh-list
44288679|NCT00769522|Fludarabine|fludarabine|mesh-list
44288680|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288681|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
44288682|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288683|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288684|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44288685|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
44288686|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288687|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288688|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44288689|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44288690|NCT00769548|Goserelin|goserelin|mesh-list
44288691|NCT00769548|Flutamide|flutamide|mesh-list
44288692|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44288693|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288694|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
44288695|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288696|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288697|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288698|NCT00769587|Thalidomide|thalidomide|mesh-list
44288699|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288700|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
44288701|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288702|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
44288703|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288704|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288705|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288706|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288707|NCT00769587|Growth Substances|growth substances|mesh-ancestor
44288708|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288709|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288710|NCT00769873|Heparin|heparin|mesh-list
44288711|NCT00769873|Enoxaparin|enoxaparin|mesh-list
44288712|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44288713|NCT00769873|Tinzaparin|tinzaparin|mesh-list
44288714|NCT00769873|Dalteparin|dalteparin|mesh-list
44288715|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
44288716|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44288717|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44288718|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288719|NCT00769990|Genistein|genistein|mesh-list
44288720|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44288721|NCT00769990|Protective Agents|protective agents|mesh-ancestor
44288722|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288723|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288724|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44288761|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44288762|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288781|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288782|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288783|NCT00770354|Letrozole|letrozole|mesh-list
44288784|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288785|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44288786|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44288787|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288788|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288789|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44288790|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288791|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288792|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288793|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
44288794|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44288795|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44288796|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44288797|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288798|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288799|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
44288800|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288801|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288802|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44288803|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288804|NCT00770445|Insulin|insulin|mesh-list
44288805|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44288806|NCT00770445|Metformin|metformin|mesh-list
44288807|NCT00770445|Pioglitazone|pioglitazone|mesh-list
44288808|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288809|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288810|NCT00770471|Temozolomide|temozolomide|mesh-list
44288811|NCT00770471|Veliparib|veliparib|mesh-list
44288812|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44288813|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
44288878|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288880|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
44288881|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44288882|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44288883|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288884|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288885|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288886|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288887|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44288888|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288889|NCT00770718|Thrombin|thrombin|mesh-list
44288890|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
44288891|NCT00770718|Coagulants|coagulants|mesh-ancestor
44288892|NCT00770731|Sirolimus|sirolimus|mesh-list
44288917|NCT00770744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44288918|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288919|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288920|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288921|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288923|NCT00770796|Atorvastatin|atorvastatin|mesh-list
44288924|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44288925|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44288926|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
44288927|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288928|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44288929|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44288930|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288931|NCT00770835|Metformin|metformin|mesh-list
44288932|NCT00770835|Pioglitazone|pioglitazone|mesh-list
44288933|NCT00770835|Glyburide|glyburide|mesh-list
44288934|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288935|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288936|NCT00770900|Montelukast|montelukast|mesh-list
44288937|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44288938|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
44288939|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44288940|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288941|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713034|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464489|NCT01494350|Gentamicins|gentamicins|mesh-list
44464490|NCT01494350|Paromomycin|paromomycin|mesh-list
44464491|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464492|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464493|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44464494|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464495|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464496|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44464497|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44464498|NCT01494038|Isoniazid|isoniazid|mesh-list
44464499|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
44464500|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464501|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464502|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44464503|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44464504|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
44464505|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464506|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44464507|NCT01493687|Azelaic acid|azelaic acid|mesh-list
44464508|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464509|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
44464510|NCT01493557|Pantoprazole|pantoprazole|mesh-list
44464511|NCT01493557|Dabigatran|dabigatran|mesh-list
44288960|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288962|NCT00771017|Goserelin|goserelin|mesh-list
44288963|NCT00771017|Bicalutamide|bicalutamide|mesh-list
44288964|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44288965|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
44288966|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44288967|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288968|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44288969|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288970|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
44288971|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288972|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288973|NCT00771043|Natalizumab|natalizumab|mesh-list
44288974|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
44288975|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288976|NCT00771147|Sorafenib|sorafenib|mesh-list
44288977|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288978|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44288979|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412321|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44289007|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
44289008|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289009|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289010|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289011|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289012|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44289013|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
44289014|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289015|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289016|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44289017|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289018|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
44289019|NCT00771342|Protective Agents|protective agents|mesh-ancestor
44289020|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
44289021|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43943843|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289022|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
44289023|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289024|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289025|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289026|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289058|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
44289059|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289060|NCT00771459|Ropivacaine|ropivacaine|mesh-list
44289061|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44289062|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
44289063|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289064|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289065|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
44289066|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289068|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44289097|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
44289098|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44289099|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44289100|NCT00771641|Cobalt|cobalt|mesh-list
44289101|NCT00771641|Trace Elements|trace elements|mesh-ancestor
44289102|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
44289103|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289104|NCT00771680|Insulin|insulin|mesh-list
44289105|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44289106|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
44289107|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
44289108|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44289109|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
44289110|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
44289111|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44289112|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44289139|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289140|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289141|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289142|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289143|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44289144|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289145|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289146|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
44289147|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289148|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289149|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44289150|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44289151|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289152|NCT00772135|Urological Agents|urological agents|mesh-ancestor
44289153|NCT00772161|Methylphenidate|methylphenidate|mesh-list
44289154|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44289155|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289156|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44289157|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44289158|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713271|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289193|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44289194|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44289195|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289196|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44289197|NCT00772356|Insulin|insulin|mesh-list
44289198|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44289199|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43713320|NCT02677532|Analgesics|analgesics|mesh-ancestor
44289231|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44289232|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44289233|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
44289234|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
44289235|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289236|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44289237|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44289238|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289337|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289338|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289339|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289340|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236215|NCT00557960|Amphetamine|amphetamine|mesh-list
44289341|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289342|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44289343|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44289344|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44289345|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289346|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289347|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
44289348|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289349|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289350|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44464527|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464528|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44464529|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
44464530|NCT01493531|Protective Agents|protective agents|mesh-ancestor
44464531|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464567|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44464568|NCT01492400|Growth Substances|growth substances|mesh-ancestor
43944147|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464569|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
44289371|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44289372|NCT00773084|Protective Agents|protective agents|mesh-ancestor
44289373|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
44289374|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289375|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289376|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44289377|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
44289378|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44289379|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44289380|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44289381|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289382|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289383|NCT00773188|Bevacizumab|bevacizumab|mesh-list
44289384|NCT00773188|Cisplatin|cisplatin|mesh-list
44289385|NCT00773188|Vinorelbine|vinorelbine|mesh-list
44289386|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289387|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289388|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44289389|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44289390|NCT00773188|Growth Substances|growth substances|mesh-ancestor
44289391|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289392|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44289393|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44289394|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289395|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289396|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44289397|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289398|NCT00773201|Sotalol|sotalol|mesh-list
44289399|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44289400|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289401|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289402|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289403|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289404|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289435|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
44289436|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44289437|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44289438|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289439|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289440|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44289441|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289442|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289443|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289444|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289445|NCT00773630|Cilostazol|cilostazol|mesh-list
44289446|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44289447|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
44289448|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289473|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44289474|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
44289475|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289476|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289477|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44289478|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44289479|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289480|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289481|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289482|NCT00773916|Methylphenidate|methylphenidate|mesh-list
44289483|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44289484|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289485|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44289486|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44289487|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289488|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289489|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
44289490|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289491|NCT00774007|Mesalamine|mesalamine|mesh-list
44289492|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44289493|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44289494|NCT00774007|Analgesics|analgesics|mesh-ancestor
44289495|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
44289496|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289519|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289520|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289521|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289522|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289523|NCT00774241|Bevacizumab|bevacizumab|mesh-list
44289524|NCT00774241|Docetaxel|docetaxel|mesh-list
44289525|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289526|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289527|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44289528|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44289529|NCT00774241|Growth Substances|growth substances|mesh-ancestor
44289530|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289531|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
44289532|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289533|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289534|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
44289535|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289536|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
44289537|NCT00774280|Busulfan|busulfan|mesh-list
44289538|NCT00774280|Fludarabine|fludarabine|mesh-list
44289539|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289540|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
44289541|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289542|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289543|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44289544|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
44289545|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289546|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289547|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44289548|NCT00774319|Cisplatin|cisplatin|mesh-list
44289549|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289550|NCT00774358|Aldesleukin|aldesleukin|mesh-list
44289585|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289586|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44289587|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44289604|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289605|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289606|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44289607|NCT00774540|Ketorolac|ketorolac|mesh-list
44289608|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44289609|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44289610|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44289611|NCT00774540|Analgesics|analgesics|mesh-ancestor
44289612|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
44289613|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289614|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289615|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289616|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289617|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44289618|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289619|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289620|NCT00774605|Varenicline|varenicline|mesh-list
44289621|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44289622|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44289623|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289624|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289625|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289626|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289627|NCT00774644|Clarithromycin|clarithromycin|mesh-list
44289628|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289629|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289630|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289631|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289632|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289633|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289634|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289635|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
44289636|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289637|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289638|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
44289639|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289640|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44289641|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289642|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289643|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289644|NCT00774696|Clarithromycin|clarithromycin|mesh-list
44289645|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464577|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464578|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464579|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44122108|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
44464580|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464581|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464582|NCT01491919|Lisinopril|lisinopril|mesh-list
44464583|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44464584|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
44464585|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464586|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464587|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44464588|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44464589|NCT01491919|Protective Agents|protective agents|mesh-ancestor
44464590|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464591|NCT01491841|Rituximab|rituximab|mesh-list
44464592|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44464593|NCT01491841|Pixantrone|pixantrone|mesh-list
44464594|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464595|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464613|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44464614|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
44464615|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464616|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944433|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289666|NCT00774813|Citalopram|citalopram|mesh-list
44289667|NCT00774813|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44289668|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44289669|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289670|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289671|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289672|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
44289673|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289674|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44289675|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44289676|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44289677|NCT00774878|Fulvestrant|fulvestrant|mesh-list
44289678|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44289679|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289680|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44289681|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44289682|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
44289683|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289684|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289685|NCT00774904|Losartan|losartan|mesh-list
44289686|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44289687|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289688|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44289689|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44289690|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289691|NCT00774969|Metronidazole|metronidazole|mesh-list
44289692|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289693|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289694|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44289695|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44289696|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
44289697|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
44289713|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44289714|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289715|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44289716|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44289717|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44289718|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289719|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44289720|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44289721|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44289722|NCT00775073|Bevacizumab|bevacizumab|mesh-list
44289723|NCT00775073|Everolimus|everolimus|mesh-list
44289724|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289725|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122176|NCT00126399|Doxycycline|doxycycline|mesh-list
44289726|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44289727|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44289728|NCT00775073|Growth Substances|growth substances|mesh-ancestor
44289729|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289730|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
44289731|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289732|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
44289733|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44289734|NCT00775086|Norelgestromin|norelgestromin|mesh-list
44289735|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
44289736|NCT00775086|Estradiol|estradiol|mesh-list
44289737|NCT00775086|Estrogens|estrogens|mesh-ancestor
44289738|NCT00775086|Hormones|hormones|mesh-ancestor
44289739|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289740|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289741|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44289742|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44289743|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44289744|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44289745|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44289746|NCT00775125|Ritonavir|ritonavir|mesh-list
44289747|NCT00775125|Darunavir|darunavir|mesh-list
44289748|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
44289749|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44289750|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44289751|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
44289752|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289753|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289754|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289755|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289756|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
44289763|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289764|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289765|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289766|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289767|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289768|NCT00775164|Metformin|metformin|mesh-list
44289769|NCT00775164|Pioglitazone|pioglitazone|mesh-list
44289770|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44289771|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289772|NCT00775177|Doxycycline|doxycycline|mesh-list
44289773|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289774|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289775|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
44289776|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44289777|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44289778|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44289779|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44289780|NCT00775242|Estradiol|estradiol|mesh-list
44289781|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44289782|NCT00775242|Estrogens|estrogens|mesh-list
44289783|NCT00775242|Progesterone|progesterone|mesh-list
44289784|NCT00775242|Progestins|progestins|mesh-list
44289785|NCT00775242|Hormones|hormones|mesh-ancestor
44426842|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236216|NCT00557960|Adderall|adderall|mesh-list
44236217|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44289786|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289787|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289788|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44289789|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
44289790|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44289791|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44289792|NCT00775255|Clarithromycin|clarithromycin|mesh-list
44289793|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289794|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289795|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289796|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289797|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289798|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289799|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289800|NCT00775294|Maraviroc|maraviroc|mesh-list
44289801|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44289802|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44289803|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289804|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289805|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289806|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
44289807|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289808|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44289809|NCT00775359|Fenofibrate|fenofibrate|mesh-list
44289810|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44289811|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
44289812|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289813|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44289814|NCT00775372|Clarithromycin|clarithromycin|mesh-list
44289815|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289816|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289817|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289818|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289819|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289820|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289821|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289822|NCT00775489|Beclomethasone|beclomethasone|mesh-list
44289823|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289824|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
44289840|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
44289841|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
44289842|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289843|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289844|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44289845|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44289846|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289847|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289848|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289849|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289850|NCT00775619|Carvedilol|carvedilol|mesh-list
44289851|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44289852|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289853|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289854|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289855|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289856|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289857|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289858|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
44289859|NCT00775619|Protective Agents|protective agents|mesh-ancestor
44289860|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289861|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289862|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289863|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289864|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44289865|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44289866|NCT00775632|Cyclosporine|cyclosporine|mesh-list
44289867|NCT00775632|Methotrexate|methotrexate|mesh-list
44289868|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
44289869|NCT00775632|Cyclosporins|cyclosporins|mesh-list
44236218|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44087542|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289870|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44289871|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
44289872|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44289873|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289874|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44289875|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
44289876|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289877|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289878|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
44289879|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289880|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44289881|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289882|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
44289883|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289888|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289890|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44289891|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289892|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289893|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
44289894|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289895|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289896|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44289897|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44289898|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289899|NCT00775736|Insulin|insulin|mesh-list
44289900|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44289901|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
44289902|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
44289903|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44289904|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
44289905|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44289906|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44289907|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289908|NCT00775749|Nicotine|nicotine|mesh-list
44289909|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44289910|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
44289911|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289912|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289913|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44289914|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44289915|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289916|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289917|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289918|NCT00775762|Aspirin|aspirin|mesh-list
44289919|NCT00775762|Clopidogrel|clopidogrel|mesh-list
44289920|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44289921|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44289922|NCT00775762|Analgesics|analgesics|mesh-ancestor
44289923|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
44289924|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289925|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289926|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289927|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289928|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44289929|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44289930|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289931|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44289932|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44289933|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289934|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
44289935|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44289936|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44289937|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44289938|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
44289939|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289940|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44289941|NCT00775814|Candesartan|candesartan|mesh-list
44289942|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44236219|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236220|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236221|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236223|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236224|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289943|NCT00775814|Diuretics|diuretics|mesh-ancestor
44289944|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
44122383|NCT00127140|Vorinostat|vorinostat|mesh-list
44289945|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289946|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44289947|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289948|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713915|NCT02672488|Metformin|metformin|mesh-list
44289960|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289963|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44289964|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
44289965|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
44289966|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289967|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289968|NCT00775905|Amlodipine|amlodipine|mesh-list
44289969|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289970|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289971|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289972|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289973|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289974|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289975|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289976|NCT00775918|Doxycycline|doxycycline|mesh-list
44289977|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289978|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289979|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
44289980|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44289981|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44289982|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
44289983|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
44289984|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44289985|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44289986|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289987|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289988|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44289989|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
44289990|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
44289991|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289992|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289993|NCT00776022|Cetirizine|cetirizine|mesh-list
44289994|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44289995|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44289996|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44289997|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
44289998|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
44289999|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290000|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290001|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290002|NCT00776074|Leuprolide|leuprolide|mesh-list
44290003|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44290004|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
44290005|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44290006|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290007|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44290008|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290023|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44290024|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44290026|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44290027|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44290028|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44236225|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44087697|NCT00023972|Exatecan|exatecan|mesh-list
44290029|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
44290030|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
44290031|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290032|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290033|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290034|NCT00776217|Loratadine|loratadine|mesh-list
44290035|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
44290036|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290037|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44290038|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44290039|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44290040|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
44290041|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
44290042|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290043|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290044|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290045|NCT00776282|Loratadine|loratadine|mesh-list
44290046|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
44290047|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290048|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44290049|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44290050|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44290051|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
44290052|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
44290053|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290054|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290055|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290056|NCT00776334|Fosinopril|fosinopril|mesh-list
44290057|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290058|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290059|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290060|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290061|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290062|NCT00776347|Donepezil|donepezil|mesh-list
44290063|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44290064|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290065|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290066|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
44290083|NCT00776477|Analgesics|analgesics|mesh-ancestor
44290084|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
44290085|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290086|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290087|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290088|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290089|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44290090|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44290091|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290092|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44290093|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44290094|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290095|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
44290096|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44290097|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44290098|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44290099|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
44290100|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290101|NCT00776490|Glimepiride|glimepiride|mesh-list
44290102|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44290103|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290104|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290105|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944885|NCT01029054|Dexamethasone|dexamethasone|mesh-list
44290106|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
44290107|NCT00776503|Vorinostat|vorinostat|mesh-list
44290108|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290109|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44290110|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290111|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290112|NCT00776516|Rifampin|rifampin|mesh-list
44290113|NCT00776516|Mirabegron|mirabegron|mesh-list
44290114|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44290115|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
44290116|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290117|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290118|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
44290119|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44290120|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290121|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290122|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44290123|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44290124|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44290125|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44290136|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290137|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464618|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464619|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464620|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
44464621|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464622|NCT01491607|Vaccines|vaccines|mesh-list
44464623|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
44464624|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464625|NCT01491035|Vortioxetine|vortioxetine|mesh-list
44464626|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
44464627|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464628|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44464629|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464630|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464631|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464632|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44464633|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44464634|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464635|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464636|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464637|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
44464638|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44464639|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44464640|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44464641|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464642|NCT01490918|Metformin|metformin|mesh-list
44464643|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44464644|NCT01490918|Acarbose|acarbose|mesh-list
44464645|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44464646|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464647|NCT01490918|Incretins|incretins|mesh-ancestor
44464648|NCT01490918|Hormones|hormones|mesh-ancestor
44464649|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464650|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44464651|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44464652|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464653|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464654|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44464655|NCT01490866|Leucovorin|leucovorin|mesh-list
44464656|NCT01490866|Bevacizumab|bevacizumab|mesh-list
44464657|NCT01490866|Fluorouracil|fluorouracil|mesh-list
44464658|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
44464659|NCT01490866|Axitinib|axitinib|mesh-list
44290139|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44290140|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290141|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290142|NCT00776620|Glimepiride|glimepiride|mesh-list
44290143|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44290144|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290145|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290146|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290147|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
44290148|NCT00776633|Aspirin|aspirin|mesh-list
44290161|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44290162|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44290163|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290164|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
44290165|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44290166|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44236227|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
44290167|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44290168|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
44290169|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290170|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44290171|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290172|NCT00776646|Diuretics|diuretics|mesh-ancestor
44290173|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290174|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290175|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44290176|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290177|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290178|NCT00776672|Fosinopril|fosinopril|mesh-list
44290179|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290180|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290181|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290182|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290183|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290184|NCT00776698|Bevacizumab|bevacizumab|mesh-list
44290185|NCT00776698|Cisplatin|cisplatin|mesh-list
44290186|NCT00776698|Etoposide|etoposide|mesh-list
44290187|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44290188|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290189|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290190|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290191|NCT00776698|Growth Substances|growth substances|mesh-ancestor
44290192|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290193|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290194|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44290195|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290196|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290197|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290198|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290199|NCT00776724|Docetaxel|docetaxel|mesh-list
44290200|NCT00776724|Epirubicin|epirubicin|mesh-list
44290201|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290202|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44290203|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44290204|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44290205|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290206|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44290207|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290208|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290209|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290232|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290233|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290234|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290235|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290236|NCT00776828|Cilostazol|cilostazol|mesh-list
44290237|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44290238|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
44290239|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290240|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290241|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44290242|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
44290243|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44290244|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44290245|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290246|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44290247|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
44290248|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44290249|NCT00776828|Protective Agents|protective agents|mesh-ancestor
44290250|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44290251|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44290252|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290253|NCT00776841|Cholic Acids|cholic acids|mesh-list
44290254|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
44290255|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290256|NCT00777114|Bortezomib|bortezomib|mesh-list
44290257|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290258|NCT00777166|Oxytocin|oxytocin|mesh-list
44290259|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
44290260|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44290261|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290276|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44290277|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290278|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44290280|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44290281|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290282|NCT00777322|Riboflavin|riboflavin|mesh-list
44290283|NCT00777322|Dextrans|dextrans|mesh-list
44290284|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
44290285|NCT00777322|Vitamins|vitamins|mesh-ancestor
44290286|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
44290287|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290288|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44290289|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290290|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
44290291|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
44290292|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
44290293|NCT00777413|Minocycline|minocycline|mesh-list
44290294|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290295|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290296|NCT00777439|Domperidone|domperidone|mesh-list
44290297|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290298|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
44290299|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
44290300|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290301|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290302|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290303|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44290304|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
44290305|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290306|NCT00777478|Sunitinib|sunitinib|mesh-list
44290307|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290308|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290309|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290310|NCT00777478|Growth Substances|growth substances|mesh-ancestor
44290311|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290312|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290313|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44290314|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290315|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290316|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44290317|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290318|NCT00777504|Growth Substances|growth substances|mesh-ancestor
44290319|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290320|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290321|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290322|NCT00777517|Atorvastatin|atorvastatin|mesh-list
44290323|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44290324|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44290333|NCT00777543|Analgesics|analgesics|mesh-ancestor
44290334|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
44290335|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290336|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290337|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290338|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290339|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
44290340|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290341|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44290342|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290343|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44290344|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
44290345|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290346|NCT00777543|Protective Agents|protective agents|mesh-ancestor
44290347|NCT00777569|Nicotine|nicotine|mesh-list
44290348|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44290349|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
44290350|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290351|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290352|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44290353|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44290354|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
44290355|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290356|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290357|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
44290358|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290359|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236228|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290360|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290361|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290362|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290363|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290364|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290366|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
44290367|NCT00777673|Bevacizumab|bevacizumab|mesh-list
44290368|NCT00777673|Carboplatin|carboplatin|mesh-list
44290369|NCT00777673|Doxorubicin|doxorubicin|mesh-list
44290370|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44290371|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44290372|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290373|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44290374|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44290375|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44290376|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290377|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290378|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
44290379|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290380|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290381|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44290382|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
44290383|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44290384|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44290385|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290386|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290387|NCT00777673|Growth Substances|growth substances|mesh-ancestor
44290388|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290389|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44290390|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290412|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290414|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290415|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290416|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44290417|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290418|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
44290419|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290420|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
44290421|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290422|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44290423|NCT00777972|Fosinopril|fosinopril|mesh-list
44290424|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290425|NCT00777972|Diuretics|diuretics|mesh-ancestor
44290426|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290427|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290428|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44290429|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290430|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290431|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290432|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290433|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290434|NCT00777985|Bosentan|bosentan|mesh-list
44290435|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290436|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44290437|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290438|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
44290439|NCT00777998|Thalidomide|thalidomide|mesh-list
44290440|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290441|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
44290442|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290443|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
43714393|NCT02668796|Estradiol|estradiol|mesh-list
44290469|NCT00778011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290470|NCT00778011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44290471|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44290472|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44290473|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
44290474|NCT00778024|Fluoxetine|fluoxetine|mesh-list
44290475|NCT00778024|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44122794|NCT05554328|Olaparib|olaparib|mesh-list
44290476|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44290477|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290478|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236229|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
44290479|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290480|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
44290481|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290482|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44290483|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
44290484|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290485|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44290486|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44290487|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290488|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
44290489|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44290490|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
44290491|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290492|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43714444|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290509|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44290510|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44290511|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44290512|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44290513|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290514|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290515|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
44290516|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44290517|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
44290518|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290519|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
44290520|NCT00778076|Protective Agents|protective agents|mesh-ancestor
44290521|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44290522|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
44290523|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44290524|NCT00778089|Protective Agents|protective agents|mesh-ancestor
44290525|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290526|NCT00778115|Simethicone|simethicone|mesh-list
44290527|NCT00778115|Loperamide|loperamide|mesh-list
44290528|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
44290529|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290530|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
44290531|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290532|NCT00778115|Emollients|emollients|mesh-ancestor
44290533|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290534|NCT00778128|Gemcitabine|gemcitabine|mesh-list
44290535|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44290536|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
44290537|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290538|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290539|NCT00778128|Antiviral Agents|antiviral agents|mesh-ancestor
44290540|NCT00778128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290541|NCT00778128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290542|NCT00778128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290543|NCT00778128|Immunologic Factors|immunologic factors|mesh-ancestor
44290544|NCT00778128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290545|NCT00778141|Metformin|metformin|mesh-list
44290546|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290547|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290548|NCT00778180|Furosemide|furosemide|mesh-list
44290549|NCT00778180|Diuretics|diuretics|mesh-ancestor
44290550|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290551|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290569|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290570|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44290571|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44290572|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290573|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
44290574|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44290575|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44290576|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44290577|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
44290578|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290579|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44290580|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
44290581|NCT00778232|Gabapentin|gabapentin|mesh-list
44290582|NCT00778232|Analgesics|analgesics|mesh-ancestor
44290583|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
44426844|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
44290584|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290585|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290586|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
44290587|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44290588|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290589|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290590|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290591|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44290592|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44290593|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290594|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290595|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
44290596|NCT00778245|Cefprozil|cefprozil|mesh-list
44290597|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290598|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290599|NCT00778271|Gabapentin|gabapentin|mesh-list
44290600|NCT00778271|Analgesics|analgesics|mesh-ancestor
44290601|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
44290602|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290603|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290604|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
44290605|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44290606|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290607|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832072|NCT05281471|Cisplatin|cisplatin|mesh-list
44290619|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290620|NCT00778349|Metformin|metformin|mesh-list
44290621|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290622|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290623|NCT00778401|Gabapentin|gabapentin|mesh-list
44290624|NCT00778401|Analgesics|analgesics|mesh-ancestor
44290625|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
44290626|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290627|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290628|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
44290629|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44290630|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290631|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290632|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290633|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44290634|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44290635|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290636|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290637|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
44290638|NCT00778414|Amoxicillin|amoxicillin|mesh-list
44290639|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
44290640|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
44290641|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44290642|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290643|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290644|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122920|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290645|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290646|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44290647|NCT00778427|Metformin|metformin|mesh-list
44290648|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290649|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464660|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464661|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464662|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44464663|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44464664|NCT01490866|Growth Substances|growth substances|mesh-ancestor
44464665|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464666|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44464667|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
44464668|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464669|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44464670|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290650|NCT00778466|Metformin|metformin|mesh-list
44290651|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290652|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290653|NCT00778505|Remifentanil|remifentanil|mesh-list
44290654|NCT00778505|Propofol|propofol|mesh-list
44290655|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44290656|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290657|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236230|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44236231|NCT00558051|Vaccines|vaccines|mesh-list
44236232|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
44290658|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44290659|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
44290660|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
44290696|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290697|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44290698|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44290716|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290717|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290718|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290719|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290720|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44290721|NCT00778713|Fosinopril|fosinopril|mesh-list
44290722|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290723|NCT00778713|Diuretics|diuretics|mesh-ancestor
44290724|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290725|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290726|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44290727|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290728|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290729|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290730|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290731|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290732|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44290733|NCT00778726|Benazepril|benazepril|mesh-list
44290734|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290735|NCT00778726|Diuretics|diuretics|mesh-ancestor
44290736|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290737|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290738|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44290739|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290740|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290741|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44290742|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290743|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290744|NCT00778739|Cefprozil|cefprozil|mesh-list
44290745|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290746|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290747|NCT00778752|Lenalidomide|lenalidomide|mesh-list
44290748|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
44290749|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290750|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290751|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290752|NCT00778752|Growth Substances|growth substances|mesh-ancestor
44290753|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
43714685|NCT02666170|Vitamins|vitamins|mesh-ancestor
44290768|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290770|NCT00778778|Cefprozil|cefprozil|mesh-list
44290771|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290772|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290773|NCT00778791|Metformin|metformin|mesh-list
44290774|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290775|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290776|NCT00778908|Cisplatin|cisplatin|mesh-list
44290777|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290778|NCT00778973|Sertraline|sertraline|mesh-list
44290779|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
44290780|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290781|NCT00778973|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44290782|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44290783|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290784|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290785|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290786|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
44290787|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290788|NCT00779012|Infliximab|infliximab|mesh-list
44290789|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290790|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290791|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290792|NCT00779051|Zolpidem|zolpidem|mesh-list
44290793|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44088287|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290794|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44290795|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290796|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290797|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44290798|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
44290799|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
44290800|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290801|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290802|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
44290803|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44290804|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
44290805|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44290806|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
44290807|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290808|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290809|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
44290810|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
44290811|NCT00779129|Doxorubicin|doxorubicin|mesh-list
44290812|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290813|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
44290819|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290820|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44290821|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44290822|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44290823|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290824|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290825|NCT00779194|Sirolimus|sirolimus|mesh-list
44290826|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290827|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290828|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44290829|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290830|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
44290831|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290832|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
44290833|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290834|NCT00779220|Methotrexate|methotrexate|mesh-list
44290835|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
44290836|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44290837|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
44290838|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44290839|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290840|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44290841|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
44290842|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290843|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290844|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290845|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290846|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44290847|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290848|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
44290849|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290850|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44290851|NCT00779233|Zidovudine|zidovudine|mesh-list
44290852|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
44290853|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290854|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44290855|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44290856|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290857|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
44290858|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290859|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44290860|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44290861|NCT00779350|Sertraline|sertraline|mesh-list
44290862|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
44290863|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290864|NCT00779350|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44290865|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44290866|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290867|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290868|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290869|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
44290870|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290871|NCT00779376|Zidovudine|zidovudine|mesh-list
44236233|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290872|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
44290873|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290874|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44290875|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44290876|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290877|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
44290878|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290879|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44290880|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44290881|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44123113|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290896|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290897|NCT00779454|Gemcitabine|gemcitabine|mesh-list
44290898|NCT00779454|Capecitabine|capecitabine|mesh-list
44290899|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
44290900|NCT00779454|Panitumumab|panitumumab|mesh-list
44290901|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44290902|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
44290903|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290904|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290905|NCT00779454|Antiviral Agents|antiviral agents|mesh-ancestor
44290906|NCT00779454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290907|NCT00779454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290908|NCT00779454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290909|NCT00779454|Immunologic Factors|immunologic factors|mesh-ancestor
44290910|NCT00779454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290911|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44290912|NCT00779493|Curcumin|curcumin|mesh-list
44290913|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290914|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44290915|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290916|NCT00779493|Analgesics|analgesics|mesh-ancestor
44290917|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
44290918|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290919|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290920|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290921|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290922|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290923|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290924|NCT00779649|Bisacodyl|bisacodyl|mesh-list
44290925|NCT00779649|Cathartics|cathartics|mesh-ancestor
44290926|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290927|NCT00779649|Laxatives|laxatives|mesh-ancestor
44290928|NCT00779714|Cytarabine|cytarabine|mesh-list
44290929|NCT00779714|Paclitaxel|paclitaxel|mesh-list
44290930|NCT00779714|Cisplatin|cisplatin|mesh-list
44290931|NCT00779714|Dacarbazine|dacarbazine|mesh-list
44290932|NCT00779714|Treosulfan|treosulfan|mesh-list
44290933|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44290934|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290935|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44290936|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44290937|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44290938|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290939|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44290940|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
44290941|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
44290942|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290943|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290952|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44290953|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44290954|NCT00779792|Clobetasol|clobetasol|mesh-list
44290955|NCT00779792|Mineral Oil|mineral oil|mesh-list
44290956|NCT00779792|Tacrolimus|tacrolimus|mesh-list
44290957|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44290958|NCT00779792|Glycerol|glycerol|mesh-list
44290959|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290960|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
44290961|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290962|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44290963|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290964|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290965|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290966|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
44290967|NCT00779792|Hormones|hormones|mesh-ancestor
44088449|NCT00025441|Dactinomycin|dactinomycin|mesh-list
44290968|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44290969|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44290970|NCT00779792|Protective Agents|protective agents|mesh-ancestor
44290971|NCT00779792|Emollients|emollients|mesh-ancestor
44290972|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290973|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
44290974|NCT00779805|Ephedrine|ephedrine|mesh-list
44290975|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44290976|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
44290977|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290978|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290979|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44290980|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
44290981|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
44290982|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44290983|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44290984|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
44290985|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44290986|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290987|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290988|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
44290989|NCT00779831|Ephedrine|ephedrine|mesh-list
44290990|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44290991|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
44290992|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290993|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290994|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44290995|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
44290996|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
44290997|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44290998|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44290999|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
44291000|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291001|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291002|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291003|NCT00779896|Tazarotene|tazarotene|mesh-list
44291004|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
44291005|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
44291006|NCT00779922|Lenalidomide|lenalidomide|mesh-list
44291007|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
44291008|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291009|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43714802|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291037|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44291038|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291039|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291040|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44291041|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
44291042|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
44291043|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291044|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291045|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
44291046|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291047|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291048|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44291049|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
44291050|NCT00780104|Analgesics|analgesics|mesh-ancestor
44291051|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
44291052|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291053|NCT00780169|Sorafenib|sorafenib|mesh-list
44291054|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291055|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291056|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291057|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291058|NCT00780182|Brincidofovir|brincidofovir|mesh-list
44291059|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
44291091|NCT00780637|Bradykinin|bradykinin|mesh-list
44291092|NCT00780637|Kininogens|kininogens|mesh-list
44291093|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291094|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44291095|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44291096|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291097|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291098|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44236235|NCT00558077|Clomiphene|clomiphene|mesh-list
44236236|NCT00558077|Enclomiphene|enclomiphene|mesh-list
44291099|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44291100|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44291101|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44291102|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291103|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291104|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291198|NCT00781196|Hematinics|hematinics|mesh-ancestor
44291311|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
44291312|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44291313|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291314|NCT00781625|Renal Agents|renal agents|mesh-ancestor
44291492|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44291493|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291494|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44291495|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291496|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44291497|NCT00783081|Protective Agents|protective agents|mesh-ancestor
44291498|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44291499|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44291500|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291501|NCT00783107|Cyclosporine|cyclosporine|mesh-list
44291502|NCT00783107|Cyclosporins|cyclosporins|mesh-list
44291503|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291577|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
44291578|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
44291579|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412322|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44291651|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291652|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291653|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44291687|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44291688|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291689|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291690|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
44291691|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44291692|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44464692|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291784|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291785|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
44291786|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
44291787|NCT00784511|Vitamin D|vitamin d|mesh-list
44291856|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44291857|NCT00784862|Tamoxifen|tamoxifen|mesh-list
44291858|NCT00784862|Anastrozole|anastrozole|mesh-list
44291859|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44291860|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291861|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291862|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291863|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44291864|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291865|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44291866|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44291867|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291868|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44291869|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44291870|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291871|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291872|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44291873|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44291874|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291995|NCT00785421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291996|NCT00785421|Immunologic Factors|immunologic factors|mesh-ancestor
44291997|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291999|NCT00785421|Protective Agents|protective agents|mesh-ancestor
44292000|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
44292001|NCT00785421|Vitamins|vitamins|mesh-ancestor
44292002|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
44292003|NCT00785421|Hematinics|hematinics|mesh-ancestor
44292004|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
44292005|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43611366|NCT03172533|Estrogens|estrogens|mesh-ancestor
44292006|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44292007|NCT00785434|Citalopram|citalopram|mesh-list
44292008|NCT00785434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44292009|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44292037|NCT00785551|Quinine|quinine|mesh-list
44292038|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
44292039|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44292040|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44292041|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292042|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44292043|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292044|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44292045|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292046|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44292047|NCT00785551|Analgesics|analgesics|mesh-ancestor
44292048|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
44292049|NCT00785603|Tramadol|tramadol|mesh-list
44292050|NCT00785603|Paroxetine|paroxetine|mesh-list
44292051|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44292052|NCT00785603|Narcotics|narcotics|mesh-ancestor
44292053|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292054|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292055|NCT00785603|Analgesics|analgesics|mesh-ancestor
44292056|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
43715629|NCT02659306|Metformin|metformin|mesh-list
44292086|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44292087|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44292088|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292089|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292090|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44292091|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292092|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292093|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44292094|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44292095|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
44292096|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715670|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292116|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292117|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464759|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44464760|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
44464761|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464762|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464763|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
44464764|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464765|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44464766|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44464767|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44464768|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44464769|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44464770|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44464771|NCT01490086|Aripiprazole|aripiprazole|mesh-list
44464773|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
44464774|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464775|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44464776|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464777|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464778|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464779|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
44464780|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
43946822|NCT01052701|Ribavirin|ribavirin|mesh-list
44292118|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44292119|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44292120|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44292122|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123367|NCT04063163|Etoposide|etoposide|mesh-list
44123430|NCT03928366|Propofol|propofol|mesh-list
44292123|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44292124|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44292125|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292126|NCT00786149|Varenicline|varenicline|mesh-list
44292127|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44292128|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44292129|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
43715712|NCT02658838|Heparin|heparin|mesh-list
44292149|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44292150|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292151|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292152|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292153|NCT00786305|Amikacin|amikacin|mesh-list
44292154|NCT00786305|Ceftazidime|ceftazidime|mesh-list
44292155|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292156|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292157|NCT00786318|Ziprasidone|ziprasidone|mesh-list
44292158|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44292159|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
44292160|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292161|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292162|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292163|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44292164|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292165|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292166|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292167|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44292168|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
44292169|NCT00786331|Carboplatin|carboplatin|mesh-list
44292170|NCT00786331|Pemetrexed|pemetrexed|mesh-list
44292171|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292172|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292173|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292174|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44292175|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44292176|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
44292177|NCT00786370|Propofol|propofol|mesh-list
44292178|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44292179|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292180|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292181|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44292182|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
43715775|NCT02658721|Diclofenac|diclofenac|mesh-list
44292215|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292217|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44292218|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44292219|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292220|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292221|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44292222|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44292223|NCT00786669|Cefixime|cefixime|mesh-list
44292224|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
44292225|NCT00786669|Bevacizumab|bevacizumab|mesh-list
44292244|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44292245|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44292246|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
44292247|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292248|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292250|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44292251|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44292252|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44292253|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292254|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292255|NCT00786734|Pitavastatin|pitavastatin|mesh-list
44292256|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44292257|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44292258|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44292259|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
44123431|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44292260|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292261|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292262|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44292263|NCT00786851|Lenalidomide|lenalidomide|mesh-list
44292264|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
44292265|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292266|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292267|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292268|NCT00786851|Growth Substances|growth substances|mesh-ancestor
44292269|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292270|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292272|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
44292273|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44292274|NCT00787007|Estrogens|estrogens|mesh-ancestor
44292275|NCT00787007|Hormones|hormones|mesh-ancestor
44292276|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292277|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292278|NCT00787111|Fluoxetine|fluoxetine|mesh-list
44152367|NCT00216762|Rituximab|rituximab|mesh-list
44292279|NCT00787111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44292280|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44292281|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292294|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
44292295|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292296|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
44292297|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292298|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
44292299|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292300|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292301|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292302|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292303|NCT00787410|Gefitinib|gefitinib|mesh-list
44292304|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292305|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292306|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292307|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292308|NCT00787436|Thalidomide|thalidomide|mesh-list
44292309|NCT00787436|Timolol|timolol|mesh-list
44292310|NCT00787436|Propranolol|propranolol|mesh-list
44292311|NCT00787436|Nadolol|nadolol|mesh-list
44292312|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292313|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
44292314|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292315|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
44292316|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292317|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292318|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292319|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292320|NCT00787436|Growth Substances|growth substances|mesh-ancestor
44292321|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292322|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292323|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44292324|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44292325|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44292326|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292327|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292328|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44292329|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44292330|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
44292331|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
44292332|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
44292333|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292334|NCT00787462|Pregabalin|pregabalin|mesh-list
44292335|NCT00787462|Analgesics|analgesics|mesh-ancestor
44292336|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
44292337|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292338|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292339|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
44292340|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44292341|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292342|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292376|NCT00787657|Interferon-beta|interferon-beta|mesh-list
44123503|NCT03399838|Analgesics|analgesics|mesh-ancestor
44292377|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
44292378|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292379|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
44292380|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292381|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
44292382|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292383|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43832205|NCT05279092|BB 1101|bb 1101|mesh-list
44292444|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292446|NCT00788060|Everolimus|everolimus|mesh-list
44292447|NCT00788060|Sunitinib|sunitinib|mesh-list
44292448|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292449|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292450|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
44292451|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292452|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292453|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292454|NCT00788060|Growth Substances|growth substances|mesh-ancestor
44292455|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292456|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292457|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292458|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292459|NCT00788099|Gemcitabine|gemcitabine|mesh-list
44292460|NCT00788099|Sorafenib|sorafenib|mesh-list
44292461|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44292462|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
44292463|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292464|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292465|NCT00788099|Antiviral Agents|antiviral agents|mesh-ancestor
44292466|NCT00788099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292467|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292468|NCT00788099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292469|NCT00788099|Immunologic Factors|immunologic factors|mesh-ancestor
44292484|NCT00788164|Imiquimod|imiquimod|mesh-list
44292485|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44292486|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
44292487|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292488|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292489|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
44292490|NCT00788242|Insulin|insulin|mesh-list
44292491|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44292492|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292493|NCT00788294|Tanezumab|tanezumab|mesh-list
44292494|NCT00788294|Analgesics|analgesics|mesh-ancestor
44292495|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
44292496|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292497|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292498|NCT00788320|Vitamin D|vitamin d|mesh-list
44292499|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
44292500|NCT00788320|Vitamins|vitamins|mesh-ancestor
44292501|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
44292502|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292503|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44292504|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44292505|NCT00788333|Trastuzumab|trastuzumab|mesh-list
44292506|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44292507|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292508|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44292509|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44292510|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44292528|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44292529|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292530|NCT00788515|Lormetazepam|lormetazepam|mesh-list
44292531|NCT00788515|Volinanserin|volinanserin|mesh-list
44292532|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44292533|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292534|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292535|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44292536|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
44292537|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292538|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292539|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
44292540|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292541|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292542|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44292543|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
44292544|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292545|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292546|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292547|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292548|NCT00788580|Sirolimus|sirolimus|mesh-list
44292549|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292550|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292551|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292552|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292553|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
44292554|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292555|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
44292556|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292557|NCT00788606|Bevacizumab|bevacizumab|mesh-list
43947277|NCT01066520|Diclofenac|diclofenac|mesh-list
44292559|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44292560|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292561|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292562|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292563|NCT00788606|Growth Substances|growth substances|mesh-ancestor
43611367|NCT03172533|Hormones|hormones|mesh-ancestor
44236237|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
44292564|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292565|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292566|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
44292596|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292597|NCT00788931|Paclitaxel|paclitaxel|mesh-list
44292598|NCT00788931|Trastuzumab|trastuzumab|mesh-list
44292599|NCT00788931|Panobinostat|panobinostat|mesh-list
44292600|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44292601|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292602|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
44292603|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
44292604|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
44292605|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292606|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44292607|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44292608|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292609|NCT00789061|Lansoprazole|lansoprazole|mesh-list
44292610|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44292611|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44292612|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44292613|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292614|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292717|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
44292718|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44292719|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292720|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292721|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44292722|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44292723|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292724|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292725|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292726|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44292727|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
44123578|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
44292728|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44292729|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292730|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44292731|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44292732|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44292733|NCT00789620|Lidocaine|lidocaine|mesh-list
44292734|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44292735|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
44292736|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292737|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292738|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
44292739|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292740|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44292741|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44292742|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44292743|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292744|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292790|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292791|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292792|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
44292793|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292794|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292795|NCT00790075|Risperidone|risperidone|mesh-list
44292862|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44292863|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
44292864|NCT00790387|Heparin|heparin|mesh-list
44292865|NCT00790387|Enoxaparin|enoxaparin|mesh-list
44292866|NCT00790387|Calcium heparin|calcium heparin|mesh-list
44292867|NCT00790387|Tirofiban|tirofiban|mesh-list
44292868|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
44292869|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44292870|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44292871|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292872|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44292873|NCT00790413|Rituximab|rituximab|mesh-list
44292874|NCT00790413|Fludarabine|fludarabine|mesh-list
44292875|NCT00790413|Thiotepa|thiotepa|mesh-list
44292876|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44292877|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44236238|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236239|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236240|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44236241|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44236242|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292878|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292879|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
44292880|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292881|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292882|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292883|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292884|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44292885|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
44292886|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44292887|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292888|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44292889|NCT00790439|Cyclosporine|cyclosporine|mesh-list
44292890|NCT00790439|Sirolimus|sirolimus|mesh-list
44292891|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
44292892|NCT00790439|Heparin|heparin|mesh-list
44292893|NCT00790439|Calcium heparin|calcium heparin|mesh-list
44292894|NCT00790439|Dextrans|dextrans|mesh-list
44292895|NCT00790439|Tacrolimus|tacrolimus|mesh-list
44292896|NCT00790439|Cyclosporins|cyclosporins|mesh-list
44292897|NCT00790439|Basiliximab|basiliximab|mesh-list
44292932|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292933|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292935|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292986|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44292987|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44292989|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
44292990|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292991|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292992|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292993|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292994|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
44292995|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44292996|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292997|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292998|NCT00790998|Ivermectin|ivermectin|mesh-list
44292999|NCT00790998|Moxidectin|moxidectin|mesh-list
44293000|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44293001|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293002|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
44293003|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
44293004|NCT00791011|Bortezomib|bortezomib|mesh-list
44293005|NCT00791011|Vorinostat|vorinostat|mesh-list
44293006|NCT00791011|Conatumumab|conatumumab|mesh-list
44293007|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293008|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44293009|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293010|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293011|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293012|NCT00791024|Lidocaine|lidocaine|mesh-list
44293013|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
44293014|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
44293015|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293038|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293039|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293040|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
44293041|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293042|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293043|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293044|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293045|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293046|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293047|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293048|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293049|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
44293050|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611480|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293051|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293052|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293053|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293054|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
44293055|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293056|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293057|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293058|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293059|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293060|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293061|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293062|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293063|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
44293089|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293090|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293091|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
44293092|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293093|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293094|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293095|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293096|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
44293097|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
44293098|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44293099|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
44293100|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44293101|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293102|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44293103|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293104|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293105|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293106|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293107|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293108|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293109|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293110|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293111|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
43716432|NCT02653742|Fentanyl|fentanyl|mesh-list
44293144|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293145|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44293146|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293147|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293148|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293149|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293150|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43716480|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
44293221|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44293222|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44293223|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293248|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293249|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
44293250|NCT00791856|Testosterone|testosterone|mesh-list
44293251|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
44293252|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
44293253|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44293254|NCT00791856|Androgens|androgens|mesh-ancestor
44293255|NCT00791856|Hormones|hormones|mesh-ancestor
44293256|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293257|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293258|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293259|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293260|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
44293261|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
44293262|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
44293263|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44293264|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44293265|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293266|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
44293267|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
44293268|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
44293269|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293270|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293271|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293272|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44236243|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44236244|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
44293273|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
44293297|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293298|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293299|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44293300|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
44293301|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293303|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44293304|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44293305|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293306|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293307|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44293308|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293309|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293310|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44293311|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
44293312|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
44293313|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
44293314|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
44293315|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293316|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293317|NCT00792246|Voriconazole|voriconazole|mesh-list
44293318|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
44293319|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293320|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43716635|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44464821|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44464822|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
44464823|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44464824|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464825|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44464826|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
44464827|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44464828|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44464829|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
44464830|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464832|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
44464833|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
44464834|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464835|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293329|NCT00792324|Efavirenz|efavirenz|mesh-list
44293330|NCT00792324|Etravirine|etravirine|mesh-list
44293331|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44293332|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44293366|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44293367|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44293368|NCT00792376|Analgesics|analgesics|mesh-ancestor
44293369|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
43716734|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44293402|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44293403|NCT00792714|Diuretics|diuretics|mesh-ancestor
44293404|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
44293405|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293406|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44293407|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44293432|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293433|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44293434|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293435|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293436|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293437|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
44293438|NCT00792818|Protective Agents|protective agents|mesh-ancestor
44293439|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44293440|NCT00792857|Vitamins|vitamins|mesh-ancestor
44293441|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
44293442|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293443|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44293444|NCT00793052|Dexamethasone|dexamethasone|mesh-list
44293445|NCT00793052|Etoricoxib|etoricoxib|mesh-list
44293446|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293447|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
44293448|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
44293449|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236245|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44293450|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293451|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293452|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
44293453|NCT00793052|Hormones|hormones|mesh-ancestor
44293454|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293455|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293456|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293457|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44293458|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44293702|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
44293703|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
44293704|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293705|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
44293706|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
44293707|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44293708|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44293709|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44293710|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293711|NCT00794638|Rituximab|rituximab|mesh-list
44293712|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44293713|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293714|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293715|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
44293716|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293717|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293718|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293719|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
44293720|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293721|NCT00794703|Itraconazole|itraconazole|mesh-list
44293722|NCT00794703|Micafungin|micafungin|mesh-list
44293723|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
44293724|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293725|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44293726|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44293727|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293728|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293729|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44293730|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44293731|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293732|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293733|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44293734|NCT00794755|Vitamin K|vitamin k|mesh-list
44293735|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
44293736|NCT00794755|Vitamins|vitamins|mesh-ancestor
44293737|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
44293903|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293904|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293906|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44293907|NCT00795587|Diuretics|diuretics|mesh-ancestor
43717208|NCT02649478|Hormones|hormones|mesh-ancestor
44293940|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293941|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
44293942|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293943|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293944|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293945|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
44293946|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44293947|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293949|NCT00795678|Antiviral Agents|antiviral agents|mesh-ancestor
44293950|NCT00795678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293951|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464881|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44464882|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464883|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464884|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464885|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44464886|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44464887|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464888|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464889|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236246|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44236247|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44464890|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
44464891|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44294199|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294200|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294201|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294202|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
44294203|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294204|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294205|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
44294206|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294207|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294208|NCT00796497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294209|NCT00796497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294210|NCT00796497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294211|NCT00796497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294212|NCT00796497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44294213|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294214|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294215|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294216|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294217|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294218|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294219|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294333|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44294334|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44294335|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
44294336|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
44294337|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294338|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44294339|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44294340|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294341|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294342|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44294343|NCT00797264|Narcotics|narcotics|mesh-ancestor
44294344|NCT00797303|Bevacizumab|bevacizumab|mesh-list
44294345|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294346|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294347|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44294348|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44294349|NCT00797303|Growth Substances|growth substances|mesh-ancestor
44294350|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294351|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
44294352|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
44294353|NCT00797394|Urological Agents|urological agents|mesh-ancestor
44294354|NCT00797420|Fluconazole|fluconazole|mesh-list
44294355|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
44294356|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294392|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
44294393|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44464914|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44294638|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
44294639|NCT00798616|Hormones|hormones|mesh-ancestor
44294640|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294641|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44294642|NCT00798616|Protective Agents|protective agents|mesh-ancestor
44294643|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44294644|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294645|NCT00798772|Micronutrients|micronutrients|mesh-list
44294646|NCT00798772|Trace Elements|trace elements|mesh-list
44294647|NCT00798772|Antioxidants|antioxidants|mesh-list
44294773|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294774|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294775|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294776|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44294777|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44294778|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
44294779|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44294780|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
44294781|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
44294782|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
44294783|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44294784|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44294785|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294786|NCT00799175|Analgesics|analgesics|mesh-ancestor
44294787|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294788|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294789|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44294790|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294792|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294793|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294794|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
44294795|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294796|NCT00799201|Naloxone|naloxone|mesh-list
44294797|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44294798|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294799|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
44294800|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294801|NCT00799214|Metronidazole|metronidazole|mesh-list
44294802|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294803|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44294804|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44294805|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44294806|NCT00799240|Cisplatin|cisplatin|mesh-list
44294807|NCT00799240|Pemetrexed|pemetrexed|mesh-list
44294808|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44294809|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294810|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294811|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294812|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44294813|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44294814|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
44294815|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294816|NCT00799448|Insulin|insulin|mesh-list
44294817|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44294818|NCT00799448|Repaglinide|repaglinide|mesh-list
44294819|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
44294820|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
44294821|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
44294822|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44294823|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294824|NCT00799513|Lenalidomide|lenalidomide|mesh-list
44294825|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
44294826|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294827|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44294828|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44294829|NCT00799513|Growth Substances|growth substances|mesh-ancestor
44294830|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
44294831|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294832|NCT00799539|Prednisone|prednisone|mesh-list
44294848|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
44294849|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
44294850|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294852|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44294853|NCT00799682|Latanoprost|latanoprost|mesh-list
44294854|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44294855|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44294856|NCT00799760|Oseltamivir|oseltamivir|mesh-list
44294857|NCT00799760|Zanamivir|zanamivir|mesh-list
44294858|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
44294859|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294860|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294861|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294862|NCT00799838|Amoxicillin|amoxicillin|mesh-list
44294863|NCT00799838|Ketoprofen|ketoprofen|mesh-list
44294864|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44294865|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294866|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44294867|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294868|NCT00799838|Analgesics|analgesics|mesh-ancestor
44294869|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
44294870|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294871|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294872|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294873|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949511|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
44294874|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44236248|NCT00558090|Morphine|morphine|mesh-list
44294875|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294876|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294877|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44294878|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
44294879|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294880|NCT00799890|Protective Agents|protective agents|mesh-ancestor
44294881|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294882|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44294883|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44294884|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294885|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44294886|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44294887|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44294888|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294917|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464943|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464944|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
44464945|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464946|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464947|NCT01486966|Insulin|insulin|mesh-list
44464948|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44464949|NCT01486966|Metformin|metformin|mesh-list
44464950|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
44464951|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
44464952|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
44464953|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
44464954|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
44464955|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44464956|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464957|NCT01486927|Factor VIII|factor viii|mesh-list
44464958|NCT01486927|Coagulants|coagulants|mesh-ancestor
44464959|NCT01486758|Azithromycin|azithromycin|mesh-list
44464960|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464961|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464962|NCT01485991|Simeprevir|simeprevir|mesh-list
44464963|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
44294930|NCT00800280|Cimetidine|cimetidine|mesh-list
44294931|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44294932|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294933|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44294934|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
44294935|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
44294936|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294937|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294938|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294939|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44294940|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44294941|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294942|NCT00800293|Betamethasone|betamethasone|mesh-list
44294943|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
44294944|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44294945|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
44294946|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44294947|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294948|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
44294949|NCT00800293|Hormones|hormones|mesh-ancestor
44294950|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294951|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294952|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44294953|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
44294954|NCT00800306|Simendan|simendan|mesh-list
44295027|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295028|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
44295029|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44295030|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44295031|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295032|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44295033|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44295034|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44295035|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295036|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295037|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
44295038|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089466|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
44295039|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295040|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718074|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
44295329|NCT00801853|Interleukin-4|interleukin-4|mesh-list
44295330|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44295331|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
44295332|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295333|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295334|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295335|NCT00801866|Bevacizumab|bevacizumab|mesh-list
44295336|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295337|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295338|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44295339|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44295340|NCT00801866|Growth Substances|growth substances|mesh-ancestor
44295341|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295342|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44464974|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464975|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44464976|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
44464977|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464978|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
44464979|NCT01485796|Antibodies|antibodies|mesh-list
44464980|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
44464981|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44464982|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44464983|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
44464984|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464985|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44464986|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44464987|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464988|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464989|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464990|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464991|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44295351|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295353|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295354|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295355|NCT00801905|Analgesics|analgesics|mesh-ancestor
44295356|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
44295357|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295358|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295359|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295360|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295361|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
44295362|NCT00801918|Ifosfamide|ifosfamide|mesh-list
44295363|NCT00801918|Etoposide|etoposide|mesh-list
44295364|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
44295365|NCT00801918|Interleukin-2|interleukin-2|mesh-list
44295366|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295367|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
44295368|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295369|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295370|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44295371|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
44295372|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295373|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295374|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44295375|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295376|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44295377|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44295378|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295379|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295380|NCT00801918|Analgesics|analgesics|mesh-ancestor
44295381|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
44295382|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295383|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
44295384|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44295385|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44295386|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295387|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295388|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612240|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
44236249|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295389|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295390|NCT00801944|Urological Agents|urological agents|mesh-ancestor
44295391|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
44295392|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44295393|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44295394|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44295395|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44295396|NCT00801957|Tacrolimus|tacrolimus|mesh-list
44295397|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295398|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
44295399|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295400|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44295401|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295402|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295439|NCT00802087|Acetaminophen|acetaminophen|mesh-list
44295440|NCT00802087|Hydrocodone|hydrocodone|mesh-list
44295441|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295479|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295495|NCT00802308|Analgesics|analgesics|mesh-ancestor
44295496|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
44295497|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295498|NCT00802321|Dutasteride|dutasteride|mesh-list
44295499|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44295500|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44295501|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295502|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295503|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44295504|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295505|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295506|NCT00802334|Ritonavir|ritonavir|mesh-list
44295507|NCT00802334|Lopinavir|lopinavir|mesh-list
44295508|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44295509|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44295510|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
44295511|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295512|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295513|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44295514|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44295515|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
44295516|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295517|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44295518|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44295519|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
44295520|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44295521|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44295522|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44295523|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295524|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295525|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295526|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295527|NCT00802373|Urological Agents|urological agents|mesh-ancestor
44295528|NCT00802451|Mesalamine|mesalamine|mesh-list
44295529|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295530|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295531|NCT00802451|Analgesics|analgesics|mesh-ancestor
44295532|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
44295533|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295534|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295535|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295536|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295537|NCT00802568|Fludarabine|fludarabine|mesh-list
44295538|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
44295539|NCT00802568|Busulfan|busulfan|mesh-list
44295540|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44295541|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295553|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295554|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295555|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
44295556|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295557|NCT00802594|Pafuramidine|pafuramidine|mesh-list
44295558|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44295559|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44295560|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44295561|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295562|NCT00802646|Epinephrine|epinephrine|mesh-list
44295563|NCT00802646|Fentanyl|fentanyl|mesh-list
44295564|NCT00802646|Bupivacaine|bupivacaine|mesh-list
44295565|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295566|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
44295567|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295568|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295569|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
44295570|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295571|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295572|NCT00802646|Narcotics|narcotics|mesh-ancestor
44295573|NCT00802646|Analgesics|analgesics|mesh-ancestor
44295574|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44295575|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44295576|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
44295577|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44295578|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44295579|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
44295580|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295581|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295582|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44295583|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44295584|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
44295585|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44295586|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44295587|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
44295588|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
44295589|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44295590|NCT00802802|Efavirenz|efavirenz|mesh-list
44295591|NCT00802802|Rifampin|rifampin|mesh-list
44295592|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44295593|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44295594|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295595|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295596|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
44295597|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295598|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44295599|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44295600|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44295601|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44295602|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44295603|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44295604|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44295616|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295617|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295618|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295619|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295620|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295621|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295622|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
44295623|NCT00802828|Famotidine|famotidine|mesh-list
44295624|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44295625|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295626|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44295627|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
44295628|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
44295629|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295630|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295631|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295632|NCT00802906|Bevacizumab|bevacizumab|mesh-list
44295633|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295634|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295635|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44295636|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44295637|NCT00802906|Growth Substances|growth substances|mesh-ancestor
44295638|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295639|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
44295640|NCT00802958|Clobetasol|clobetasol|mesh-list
44295641|NCT00802958|Halobetasol|halobetasol|mesh-list
44295642|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44295643|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295644|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
44295645|NCT00802958|Hormones|hormones|mesh-ancestor
44426845|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236250|NCT00558090|Narcotics|narcotics|mesh-ancestor
44295646|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295647|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295648|NCT00803166|Clobetasol|clobetasol|mesh-list
44295649|NCT00803166|Halobetasol|halobetasol|mesh-list
44295650|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44295651|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295652|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
44295653|NCT00803166|Hormones|hormones|mesh-ancestor
44295654|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295655|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295656|NCT00803192|Famotidine|famotidine|mesh-list
44295657|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44295658|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295659|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44295660|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
44295661|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
44295662|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295663|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295664|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295665|NCT00803218|Fluticasone|fluticasone|mesh-list
44295666|NCT00803218|Xhance|xhance|mesh-list
44295667|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295668|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44295677|NCT00803309|Ribavirin|ribavirin|mesh-list
44295678|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
44295679|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
44295680|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44295681|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295682|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
44295683|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295684|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
44295685|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295686|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
44295687|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295688|NCT00803335|Estrogens|estrogens|mesh-list
44295689|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44295690|NCT00803335|Hormones|hormones|mesh-ancestor
44295691|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295692|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295693|NCT00803374|Ipilimumab|ipilimumab|mesh-list
44295694|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44295695|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295696|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295697|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44295698|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295699|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
44295700|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295701|NCT00803387|Travoprost|travoprost|mesh-list
44295702|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44295703|NCT00803439|Clobetasol|clobetasol|mesh-list
44295704|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295705|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
44295706|NCT00803439|Hormones|hormones|mesh-ancestor
44124358|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295707|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295708|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295709|NCT00803465|Fluticasone|fluticasone|mesh-list
44295711|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295712|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44295713|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
44295714|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295715|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295716|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44295717|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
43950353|NCT01141491|Vaccines|vaccines|mesh-list
44295718|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
44295719|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44295720|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
44295721|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
44295722|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295723|NCT00803530|Protective Agents|protective agents|mesh-ancestor
44295724|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295725|NCT00803530|Vitamins|vitamins|mesh-ancestor
44295726|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
44295727|NCT00803556|Paclitaxel|paclitaxel|mesh-list
44295728|NCT00803556|Trastuzumab|trastuzumab|mesh-list
44236251|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295729|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295730|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295731|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44154883|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154884|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44154885|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44154886|NCT00225290|Growth Substances|growth substances|mesh-ancestor
44154887|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
44154888|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154889|NCT00225303|Etravirine|etravirine|mesh-list
44154890|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44154891|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44154892|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154893|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154894|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
44154895|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154896|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
44154897|NCT00225342|Gliclazide|gliclazide|mesh-list
44154898|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154899|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154900|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
44154901|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44295732|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44295733|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44295734|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295735|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295763|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295765|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295766|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
44295767|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295768|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295769|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295770|NCT00803803|Pilocarpine|pilocarpine|mesh-list
44295771|NCT00803803|Miotics|miotics|mesh-ancestor
44295772|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
44295773|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295774|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124404|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
44124405|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124406|NCT00132899|Methotrexate|methotrexate|mesh-list
44124407|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44124408|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
44124409|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44124410|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124411|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44124412|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
44124413|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124414|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124415|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124416|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124417|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124418|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295775|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44295776|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44295777|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295778|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295779|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295780|NCT00803816|Everolimus|everolimus|mesh-list
44295781|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295782|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647157|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
43647158|NCT02303821|Methotrexate|methotrexate|mesh-list
43647159|NCT02303821|Vincristine|vincristine|mesh-list
43647160|NCT02303821|Daunorubicin|daunorubicin|mesh-list
43647161|NCT02303821|Asparaginase|asparaginase|mesh-list
43647162|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
44295783|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
44295784|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295794|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295796|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44295797|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44295798|NCT00803868|Varenicline|varenicline|mesh-list
44295799|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44295800|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44295801|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295802|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295803|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295804|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295806|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
44295807|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44295808|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295809|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295810|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
44464995|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464996|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464997|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44464998|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464999|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
44465000|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44465001|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44465002|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
44465003|NCT01485614|Metformin|metformin|mesh-list
44465004|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44465005|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465006|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465007|NCT01485614|Incretins|incretins|mesh-ancestor
44465008|NCT01485614|Hormones|hormones|mesh-ancestor
44465009|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465010|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44465011|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465012|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465013|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465014|NCT01485172|Ropinirole|ropinirole|mesh-list
44465015|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44465016|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44465017|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
44465018|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
44124461|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465019|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465020|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465021|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465022|NCT01485094|Pregabalin|pregabalin|mesh-list
44465023|NCT01485094|Analgesics|analgesics|mesh-ancestor
44089835|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44465024|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
44465025|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465026|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465027|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
44465028|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44465029|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465030|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465031|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44465032|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44465033|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44465034|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465035|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465054|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44295811|NCT00803933|Pentamidine|pentamidine|mesh-list
44295812|NCT00803933|Pafuramidine|pafuramidine|mesh-list
44295813|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
44295814|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295815|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44295816|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44295817|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44295819|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295820|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295821|NCT00803946|Analgesics|analgesics|mesh-ancestor
44295822|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
44124462|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124463|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44124464|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
44124465|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124466|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124467|NCT00133185|Losartan|losartan|mesh-list
44124468|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44124469|NCT00133185|Telmisartan|telmisartan|mesh-list
44124470|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44124471|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124472|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44124473|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44295823|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295824|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295825|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295826|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295827|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295828|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295829|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295830|NCT00803972|Insulin|insulin|mesh-list
44295831|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44295832|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
44295833|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44295834|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295835|NCT00804050|Vitamins|vitamins|mesh-list
44295836|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
44295837|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295838|NCT00804115|Timolol|timolol|mesh-list
44295839|NCT00804115|Latanoprost|latanoprost|mesh-list
44295840|NCT00804115|Pilocarpine|pilocarpine|mesh-list
44295841|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44295842|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44295843|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
44295844|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295845|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295846|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295847|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44295881|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44295882|NCT00804297|Octreotide|octreotide|mesh-list
44295883|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295884|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44295885|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295886|NCT00804310|Lapatinib|lapatinib|mesh-list
44295887|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295888|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44295889|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295926|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295927|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295946|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295948|NCT00804531|Protective Agents|protective agents|mesh-ancestor
44295949|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44295950|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295951|NCT00804622|Tenofovir|tenofovir|mesh-list
44295952|NCT00804622|Telbivudine|telbivudine|mesh-list
44295953|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
44295954|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295955|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44295956|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44295957|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295958|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236252|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295959|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44124541|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295960|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44295961|NCT00804674|Bupivacaine|bupivacaine|mesh-list
44295962|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295963|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
44295964|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295965|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295966|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
44295967|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295968|NCT00804752|Vitamin D|vitamin d|mesh-list
44295969|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
44295970|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
44295971|NCT00804752|Vitamins|vitamins|mesh-list
44295972|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
44295973|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295974|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44295975|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44295976|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44295977|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
44295978|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44295979|NCT00804830|Bevacizumab|bevacizumab|mesh-list
44295980|NCT00804830|Doxorubicin|doxorubicin|mesh-list
44295981|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295982|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295983|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296008|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296009|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44296010|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296011|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124542|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124543|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124544|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44124545|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44124546|NCT00133315|Analgesics|analgesics|mesh-ancestor
44124552|NCT00133328|Valsartan|valsartan|mesh-list
44296012|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296013|NCT00804921|Bevacizumab|bevacizumab|mesh-list
44296014|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44296015|NCT00804921|Acetazolamide|acetazolamide|mesh-list
44296016|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296017|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296018|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296019|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296020|NCT00804921|Growth Substances|growth substances|mesh-ancestor
44296021|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296022|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
44124568|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124569|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124570|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44124571|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702679|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44296023|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44296024|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44296025|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44296026|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44296027|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
44296028|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296029|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296030|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
44296031|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43718926|NCT02639767|Pemetrexed|pemetrexed|mesh-list
44296067|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296069|NCT00805064|Bevacizumab|bevacizumab|mesh-list
43718975|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44296095|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296096|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44296097|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44296098|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44296099|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
44296100|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296101|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44296102|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
44296103|NCT00805116|Vitamins|vitamins|mesh-ancestor
44296104|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
44296105|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296106|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
44296107|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296108|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
44296109|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44296110|NCT00805233|Bromfenac|bromfenac|mesh-list
44296111|NCT00805233|Ranibizumab|ranibizumab|mesh-list
44296112|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296113|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296114|NCT00805233|Growth Substances|growth substances|mesh-ancestor
44296115|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296116|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
43832501|NCT05260359|Ethanol|ethanol|mesh-list
44296127|NCT00805298|Racepinephrine|racepinephrine|mesh-list
44296128|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
44296129|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296130|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
44296131|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
44296132|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296133|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296134|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296135|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
44296136|NCT00805298|Hormones|hormones|mesh-ancestor
44296137|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296138|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44296139|NCT00805298|Protective Agents|protective agents|mesh-ancestor
44296140|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44296141|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44296142|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
44296143|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296144|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296145|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44296146|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44296147|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44296148|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44296149|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
44296150|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
44296151|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44296152|NCT00805311|Aspirin|aspirin|mesh-list
44296153|NCT00805311|Losartan|losartan|mesh-list
44296154|NCT00805311|Amlodipine|amlodipine|mesh-list
44296155|NCT00805311|Atorvastatin|atorvastatin|mesh-list
44296156|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296157|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296158|NCT00805311|Analgesics|analgesics|mesh-ancestor
44296159|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
44296160|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296161|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296162|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296163|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296164|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44296165|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44296166|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296167|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44296168|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44296169|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296170|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
44296171|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44296172|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44296173|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
44296174|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44296175|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44296176|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44296177|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44296178|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296179|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44296180|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44296181|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43847495|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296190|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
44296191|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44296192|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
44296193|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296194|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
44296196|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296197|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296198|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296199|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296200|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
44296201|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
44296202|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296203|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296204|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44296205|NCT00805519|Protective Agents|protective agents|mesh-ancestor
44296206|NCT00805519|Amebicides|amebicides|mesh-ancestor
44296207|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44296208|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44296209|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296210|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
44296211|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296212|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296213|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296214|NCT00805519|Analgesics|analgesics|mesh-ancestor
44296215|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
44296216|NCT00805519|Filaricides|filaricides|mesh-ancestor
44296217|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
44296218|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
44296219|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
44296220|NCT00805558|Metronidazole|metronidazole|mesh-list
44296221|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
44296222|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44296223|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44296224|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296225|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44296226|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44296227|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296228|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296229|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124686|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
44124687|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124688|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44124689|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124690|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124691|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44124692|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
44124693|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
44124694|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124695|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44124696|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44124697|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44124698|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44124699|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124700|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44124701|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44124702|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124703|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44296230|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44296231|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
44296232|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44296233|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296234|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44296235|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44296236|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44296237|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44296238|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44296239|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44296240|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44296241|NCT00805649|Dexamethasone|dexamethasone|mesh-list
44296242|NCT00805649|Bevacizumab|bevacizumab|mesh-list
44296243|NCT00805649|Temazepam|temazepam|mesh-list
44296244|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296245|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296246|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296247|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296248|NCT00805649|Growth Substances|growth substances|mesh-ancestor
44296249|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296261|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296264|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44296265|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
44296266|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
44296267|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296268|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296269|NCT00805662|Oxytocin|oxytocin|mesh-list
44296270|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
44296271|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44296272|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296273|NCT00805701|Dutasteride|dutasteride|mesh-list
44296274|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44296275|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44296276|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296277|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296278|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
44296279|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296280|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465055|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465056|NCT01484873|Exenatide|exenatide|mesh-list
44465057|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465058|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465059|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44465060|NCT01484873|Incretins|incretins|mesh-ancestor
44465061|NCT01484873|Hormones|hormones|mesh-ancestor
44465062|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465063|NCT01484691|Budesonide|budesonide|mesh-list
44465064|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465065|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44465067|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465068|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465069|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465070|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465071|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
44465072|NCT01484691|Hormones|hormones|mesh-ancestor
44465073|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465074|NCT01484561|Tofacitinib|tofacitinib|mesh-list
44465075|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465076|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465077|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465078|NCT01484496|Belimumab|belimumab|mesh-list
44465079|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465080|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
44465081|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465082|NCT01484431|Tadalafil|tadalafil|mesh-list
44465083|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
44465084|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44465085|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44465086|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465095|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
44465096|NCT01483690|Methotrexate|methotrexate|mesh-list
44465097|NCT01483690|Vincristine|vincristine|mesh-list
44465098|NCT01483690|Decitabine|decitabine|mesh-list
44465099|NCT01483690|Asparaginase|asparaginase|mesh-list
44465100|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
44465101|NCT01483690|Vorinostat|vorinostat|mesh-list
44465102|NCT01483690|Pegaspargase|pegaspargase|mesh-list
44465103|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44465104|NCT01483690|BB 1101|bb 1101|mesh-list
44465105|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465106|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
44124761|NCT00133822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44124762|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44124763|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124764|NCT00133848|Retapamulin|retapamulin|mesh-list
44124765|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124766|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124767|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
44124768|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44124769|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124770|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124771|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
44124772|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124773|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124774|NCT00133874|Retapamulin|retapamulin|mesh-list
44124775|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124776|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124777|NCT00133887|Sirolimus|sirolimus|mesh-list
44124778|NCT00133887|Cyclosporine|cyclosporine|mesh-list
44124779|NCT00133887|Tacrolimus|tacrolimus|mesh-list
44124780|NCT00133887|Cyclosporins|cyclosporins|mesh-list
44124781|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124782|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
44124783|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124784|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44124785|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465107|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
44465108|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465109|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465110|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465111|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
44465112|NCT01483690|Hormones|hormones|mesh-ancestor
44296282|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44296283|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296284|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
44296285|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296286|NCT00806169|Triamcinolone|triamcinolone|mesh-list
44296287|NCT00806169|Bevacizumab|bevacizumab|mesh-list
44296288|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296289|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296290|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296291|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296292|NCT00806169|Growth Substances|growth substances|mesh-ancestor
44296293|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296294|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296295|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296296|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
44124786|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124787|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124788|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124789|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124790|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124791|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
44124792|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124793|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124794|NCT00134030|Interferons|interferons|mesh-list
44124795|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
44124796|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
44124797|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44124798|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44124799|NCT00134030|Cisplatin|cisplatin|mesh-list
44124800|NCT00134030|Doxorubicin|doxorubicin|mesh-list
44124801|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44124803|NCT00134030|Etoposide|etoposide|mesh-list
44124804|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
44124805|NCT00134030|Ifosfamide|ifosfamide|mesh-list
44124806|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
44124807|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
44124808|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296297|NCT00806169|Hormones|hormones|mesh-ancestor
44296298|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296299|NCT00806247|Tapentadol|tapentadol|mesh-list
44296300|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44296301|NCT00806247|Narcotics|narcotics|mesh-ancestor
44296302|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296303|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296304|NCT00806247|Analgesics|analgesics|mesh-ancestor
44296305|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
44296306|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296307|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44296308|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44296309|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296310|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124809|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124810|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44124811|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44124812|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124813|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124814|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44124815|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
44124816|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44124817|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124818|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44124819|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
44124820|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124821|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124822|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647200|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43647201|NCT02303821|Analgesics|analgesics|mesh-ancestor
43647202|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
44296311|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
44296312|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296313|NCT00806299|Loperamide|loperamide|mesh-list
44296314|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
44296315|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296316|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44296317|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
44296318|NCT00806468|Coagulants|coagulants|mesh-ancestor
44236254|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
44090242|NCT00028990|Paclitaxel|paclitaxel|mesh-list
44296319|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44296320|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
44296321|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296322|NCT00806481|Sevelamer|sevelamer|mesh-list
44296323|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
44296324|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
44296325|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296359|NCT00806741|Protective Agents|protective agents|mesh-ancestor
44296360|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296362|NCT00806754|Azelastine|azelastine|mesh-list
44296363|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
44296364|NCT00806754|Hormones|hormones|mesh-ancestor
44296365|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296366|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296367|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44296389|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296390|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44296391|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
44296392|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296393|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296394|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
44296395|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296396|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
44296397|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44296398|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44296399|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
44296400|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44296401|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44296402|NCT00806871|Prednisolone|prednisolone|mesh-list
44296403|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
44296404|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44296405|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
44296406|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296407|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
44296408|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
44296409|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296410|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296411|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296412|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
44296413|NCT00806871|Hormones|hormones|mesh-ancestor
44296414|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296415|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44296416|NCT00806871|Protective Agents|protective agents|mesh-ancestor
44296417|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296418|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296419|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
44296420|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44296421|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296422|NCT00806910|Conivaptan|conivaptan|mesh-list
44296437|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44296438|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
44296439|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124873|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44124874|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44124875|NCT00134173|Atorvastatin|atorvastatin|mesh-list
44124876|NCT00134173|Torcetrapib|torcetrapib|mesh-list
44124877|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124878|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124879|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
44124880|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124881|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124882|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44296440|NCT00806923|Antiviral Agents|antiviral agents|mesh-ancestor
44296441|NCT00806923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296442|NCT00806923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296443|NCT00806923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296444|NCT00806923|Immunologic Factors|immunologic factors|mesh-ancestor
44296445|NCT00806936|Insulin|insulin|mesh-list
44296446|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44296447|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44296448|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296449|NCT00806962|Vaccines|vaccines|mesh-list
44296450|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
44296451|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296452|NCT00807053|Ciclesonide|ciclesonide|mesh-list
44296453|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
44296454|NCT00807053|Hormones|hormones|mesh-ancestor
44296455|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296456|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296457|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44296458|NCT00807066|Gefitinib|gefitinib|mesh-list
44296459|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296460|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44236255|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236256|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
44296461|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296462|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296463|NCT00807079|Carboplatin|carboplatin|mesh-list
44296464|NCT00807079|Topotecan|topotecan|mesh-list
44296465|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296466|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44296467|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44296468|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296469|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296470|NCT00807118|Fesoterodine|fesoterodine|mesh-list
44124883|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124884|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
44124917|NCT00134355|Vatalanib|vatalanib|mesh-list
44296471|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44296472|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44296473|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
44296474|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296475|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296476|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296477|NCT00807118|Urological Agents|urological agents|mesh-ancestor
44296478|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
44296479|NCT00807196|Rituximab|rituximab|mesh-list
44296480|NCT00807196|Fludarabine|fludarabine|mesh-list
44296481|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296482|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
43832554|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
44296497|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124918|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44124919|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124920|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124921|NCT00134368|Etanercept|etanercept|mesh-list
44124922|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44124923|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44124924|NCT00134368|Analgesics|analgesics|mesh-ancestor
44124925|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
44124926|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124927|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124928|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124929|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647211|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
43647212|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
43647213|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647214|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296499|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296500|NCT00807261|Gemcitabine|gemcitabine|mesh-list
44296501|NCT00807261|Docetaxel|docetaxel|mesh-list
44296502|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44296503|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
44296504|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296505|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296506|NCT00807261|Antiviral Agents|antiviral agents|mesh-ancestor
44296507|NCT00807261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296508|NCT00807261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296509|NCT00807261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296510|NCT00807261|Immunologic Factors|immunologic factors|mesh-ancestor
44296511|NCT00807261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296512|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
44296513|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
44296514|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
44296515|NCT00807326|Simethicone|simethicone|mesh-list
44296516|NCT00807326|Loperamide|loperamide|mesh-list
44296517|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
44296518|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296519|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
44296520|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296521|NCT00807326|Emollients|emollients|mesh-ancestor
44296522|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44296523|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
44296524|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44296525|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296526|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
44296527|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296528|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44296529|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44296530|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296531|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296532|NCT00807521|Dexamethasone|dexamethasone|mesh-list
44124930|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124931|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124932|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
44124933|NCT00134394|Etanercept|etanercept|mesh-list
44124934|NCT00134394|Tacrolimus|tacrolimus|mesh-list
44124935|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124936|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
44124937|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124938|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44296533|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296534|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
44296535|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
44296536|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296537|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296538|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296539|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
44296540|NCT00807521|Hormones|hormones|mesh-ancestor
44296545|NCT00807534|Ipratropium|ipratropium|mesh-list
44296546|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
44296547|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44296548|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
44296549|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296550|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296551|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44426846|NCT02207634|Evolocumab|evolocumab|mesh-list
44236257|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44296552|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44296553|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44296554|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
44296555|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296556|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296557|NCT00807625|Copper|copper|mesh-list
44296558|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44296559|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
44296560|NCT00807625|Trace Elements|trace elements|mesh-ancestor
44296561|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
44296562|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296563|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44296564|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
44296565|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44296566|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44124963|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
44124964|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154905|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154906|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44154907|NCT00225433|Ganirelix|ganirelix|mesh-list
44154908|NCT00225433|Hormones|hormones|mesh-ancestor
44154909|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154910|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154911|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
44154912|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44296567|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44296568|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296569|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296570|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44296571|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44296572|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44296573|NCT00807690|Tacrolimus|tacrolimus|mesh-list
44296574|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296575|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
44296576|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296577|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44296578|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296579|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296580|NCT00807755|Carboplatin|carboplatin|mesh-list
44296581|NCT00807755|Etoposide|etoposide|mesh-list
44296582|NCT00807755|Everolimus|everolimus|mesh-list
44296583|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296584|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44296585|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44296586|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44296587|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296588|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296589|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296590|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
44296591|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465113|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465114|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44465115|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465116|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465117|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465118|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465119|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44465120|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
44465121|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44465122|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465124|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465125|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44465126|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465127|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
44465128|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44465129|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44465130|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44465144|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465145|NCT01483651|Hormones|hormones|mesh-ancestor
44465146|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465147|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
44465148|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44465149|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
44465150|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465151|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465152|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465153|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465154|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
44465155|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44465156|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
44465157|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465158|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465159|NCT01483599|Adalimumab|adalimumab|mesh-list
44465160|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465161|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44465162|NCT01483144|Eflornithine|eflornithine|mesh-list
44465163|NCT01483144|Sulindac|sulindac|mesh-list
44465164|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465165|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44465166|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44465167|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44465168|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465169|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44465170|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124999|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125000|NCT00134641|Gemcitabine|gemcitabine|mesh-list
44125001|NCT00134641|Vinorelbine|vinorelbine|mesh-list
44125002|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44125003|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
44125004|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125005|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125006|NCT00134641|Antiviral Agents|antiviral agents|mesh-ancestor
44125007|NCT00134641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125008|NCT00134641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125009|NCT00134641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125010|NCT00134641|Immunologic Factors|immunologic factors|mesh-ancestor
44125011|NCT00134641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125012|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44125013|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125014|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125015|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125016|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44125017|NCT00134654|Estrogens|estrogens|mesh-ancestor
44125019|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125020|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125027|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465171|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465172|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44465173|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44465174|NCT01483144|Analgesics|analgesics|mesh-ancestor
44465175|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
44465176|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296592|NCT00807807|Folic Acid|folic acid|mesh-list
44296593|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
44296594|NCT00807807|Hematinics|hematinics|mesh-ancestor
44296595|NCT00807807|Vitamins|vitamins|mesh-ancestor
44296596|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
44296597|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296598|NCT00807872|Antibodies|antibodies|mesh-list
44296599|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44296600|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
44296601|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296602|NCT00807950|Simvastatin|simvastatin|mesh-list
44296603|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44296604|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44296605|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
44296606|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296607|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44296608|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44296609|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296624|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296625|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44296626|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44296627|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44296628|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44296629|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44296631|NCT00808054|Prilocaine|prilocaine|mesh-list
44296632|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44296633|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
44296634|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296635|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125028|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44125029|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44125030|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125031|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296636|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
44296637|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296638|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44296639|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44296640|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44296641|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296642|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296643|NCT00808145|Gemcitabine|gemcitabine|mesh-list
44296644|NCT00808145|Cisplatin|cisplatin|mesh-list
44296645|NCT00808145|Sorafenib|sorafenib|mesh-list
44296646|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296647|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44296648|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
44296649|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296650|NCT00808145|Antiviral Agents|antiviral agents|mesh-ancestor
44125061|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125062|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125063|NCT00134745|Estradiol|estradiol|mesh-list
44125064|NCT00134745|Estrogens|estrogens|mesh-ancestor
44125065|NCT00134745|Hormones|hormones|mesh-ancestor
44125066|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125067|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647221|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43647222|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647223|NCT02222740|Hydrocodone|hydrocodone|mesh-list
43647224|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44296651|NCT00808145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296652|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296653|NCT00808145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296654|NCT00808145|Immunologic Factors|immunologic factors|mesh-ancestor
44296655|NCT00808145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296656|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44296657|NCT00808171|Lidocaine|lidocaine|mesh-list
44296658|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
44296659|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
44296660|NCT00808171|Prilocaine|prilocaine|mesh-list
44296661|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44125068|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44125069|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44125070|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125071|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
44125072|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44125073|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44125074|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44125075|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125076|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125077|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
43647225|NCT02222740|Narcotics|narcotics|mesh-ancestor
43647226|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647228|NCT02222740|Analgesics|analgesics|mesh-ancestor
43647229|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
43647230|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647231|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
43647232|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647234|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43647235|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647236|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647237|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647238|NCT02197156|Acetaminophen|acetaminophen|mesh-list
43647239|NCT02197156|Hydrocodone|hydrocodone|mesh-list
43647240|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43647241|NCT02197156|Analgesics|analgesics|mesh-ancestor
43647242|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
43647243|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647244|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647245|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
43647246|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43647247|NCT02197156|Narcotics|narcotics|mesh-ancestor
44296662|NCT00808171|Anesthetics|anesthetics|mesh-list
44236259|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296663|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296664|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296665|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
43951365|NCT01170533|Omeprazole|omeprazole|mesh-list
44296666|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296667|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44125078|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125079|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125080|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44125081|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125082|NCT00134875|Buprenorphine|buprenorphine|mesh-list
43647249|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
43647250|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647251|NCT02193191|Plerixafor|plerixafor|mesh-list
43647252|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43647253|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43647254|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
43647255|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647256|NCT02187354|Blinatumomab|blinatumomab|mesh-list
43824091|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824092|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824093|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43824094|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296668|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44296669|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44296695|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
44296696|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296697|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44296698|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44296699|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296701|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44296702|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
44296703|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296704|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
44296705|NCT00808275|Calcium|calcium|mesh-list
44296706|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44296707|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296708|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44296709|NCT00808314|Dipyridamole|dipyridamole|mesh-list
44296710|NCT00808314|Regadenoson|regadenoson|mesh-list
44296711|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44296712|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296713|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296714|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44296715|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
44296716|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44296717|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44296718|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
43719502|NCT02635607|Hormones|hormones|mesh-ancestor
44125083|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44125084|NCT00134875|Naloxone|naloxone|mesh-list
44125085|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44125086|NCT00134875|Narcotics|narcotics|mesh-ancestor
44125087|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125088|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125089|NCT00134875|Analgesics|analgesics|mesh-ancestor
44125090|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
44125091|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125092|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44125093|NCT00134888|Buprenorphine|buprenorphine|mesh-list
44125094|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44125095|NCT00134888|Naloxone|naloxone|mesh-list
44125096|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44125097|NCT00134888|Narcotics|narcotics|mesh-ancestor
44125098|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125099|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125110|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
44296749|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296750|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44296751|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44296752|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44296753|NCT00808392|Vaccines|vaccines|mesh-list
44296754|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
44296755|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296756|NCT00808418|Docetaxel|docetaxel|mesh-list
44296757|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296758|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44296759|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44296760|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44296761|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296762|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43832593|NCT05256108|Oxycodone|oxycodone|mesh-list
44297575|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44297576|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44297577|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297578|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
44297579|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44297580|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44297581|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
44297582|NCT00812760|Levodopa|levodopa|mesh-list
44297583|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44297584|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44297585|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
44297586|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297587|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297588|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297631|NCT00812864|Capecitabine|capecitabine|mesh-list
44297632|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297633|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
44297634|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297635|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297637|NCT00812994|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44297638|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44297639|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44297640|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297641|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236260|NCT00558142|Expectorants|expectorants|mesh-ancestor
44090576|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297642|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
44297643|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297644|NCT00812994|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44297645|NCT00812994|Antidepressive Agents|antidepressive agents|mesh-ancestor
44297681|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297682|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44297683|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720152|NCT02631668|Vitamins|vitamins|mesh-ancestor
44297744|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44297746|NCT00813696|Cisplatin|cisplatin|mesh-list
44297747|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297748|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297749|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
44297750|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297751|NCT00813696|Antiviral Agents|antiviral agents|mesh-ancestor
44297752|NCT00813696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297753|NCT00813696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297754|NCT00813696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297755|NCT00813696|Immunologic Factors|immunologic factors|mesh-ancestor
43720207|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44125113|NCT00134953|Rivastigmine|rivastigmine|mesh-list
44125171|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297789|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297790|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297791|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
44297792|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297793|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44297794|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
44297795|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720224|NCT02631239|Dexamethasone|dexamethasone|mesh-list
44297889|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297890|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297891|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297922|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297923|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297924|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
44297925|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297926|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
44297927|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297928|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297929|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297930|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44297932|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44297933|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
44297970|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
43720320|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
44298018|NCT00815022|Bupivacaine|bupivacaine|mesh-list
44298019|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
44298020|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
44298021|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298022|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298023|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
44298024|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298025|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44125172|NCT00135018|Celecoxib|celecoxib|mesh-list
44125173|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44125174|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125175|NCT00135018|Analgesics|analgesics|mesh-ancestor
44125176|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
44125177|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125178|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125179|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44298026|NCT00815022|Narcotics|narcotics|mesh-ancestor
44298027|NCT00815022|Analgesics|analgesics|mesh-ancestor
44298028|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44298029|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44298030|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
44298031|NCT00815048|Atropine|atropine|mesh-list
44298032|NCT00815048|Fentanyl|fentanyl|mesh-list
44298033|NCT00815048|Remifentanil|remifentanil|mesh-list
44298034|NCT00815048|Succinylcholine|succinylcholine|mesh-list
44298035|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44298037|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298038|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298039|NCT00815048|Analgesics|analgesics|mesh-ancestor
44298040|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
44298041|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298077|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298078|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44298079|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
44298080|NCT00815269|Sevoflurane|sevoflurane|mesh-list
44298081|NCT00815269|Desflurane|desflurane|mesh-list
44298082|NCT00815269|Isoflurane|isoflurane|mesh-list
44298083|NCT00815269|Halothane|halothane|mesh-list
44298199|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
44298200|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298201|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298202|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125203|NCT00135122|Prednisolone|prednisolone|mesh-list
44125204|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44125205|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
44125206|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44125207|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
44125208|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44125209|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
44125210|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125211|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
44125212|NCT00135122|Hormones|hormones|mesh-ancestor
44125213|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125214|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125215|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125216|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125217|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
44125218|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
44125219|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125220|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125221|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44125222|NCT00135122|Protective Agents|protective agents|mesh-ancestor
44125223|NCT00135135|Carboplatin|carboplatin|mesh-list
44125224|NCT00135135|Doxorubicin|doxorubicin|mesh-list
44125225|NCT00135135|Irinotecan|irinotecan|mesh-list
44125226|NCT00135135|Etoposide|etoposide|mesh-list
44125227|NCT00135135|Melphalan|melphalan|mesh-list
44125228|NCT00135135|Topotecan|topotecan|mesh-list
44298203|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298204|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
44298205|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298206|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44298207|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298240|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44298241|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298242|NCT00816283|Dasatinib|dasatinib|mesh-list
44298243|NCT00816283|Vorinostat|vorinostat|mesh-list
44298244|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298245|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44298246|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298247|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298319|NCT00816634|Capecitabine|capecitabine|mesh-list
43832770|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298460|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44298461|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44298462|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44298463|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44298464|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44298466|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
44298529|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298530|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298531|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44465290|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125229|NCT00135135|Gefitinib|gefitinib|mesh-list
44125230|NCT00135135|Tretinoin|tretinoin|mesh-list
44125231|NCT00135135|Isotretinoin|isotretinoin|mesh-list
44125232|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125233|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125234|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125235|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125236|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125237|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125238|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44125239|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44125240|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44125241|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
44125242|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44465291|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465292|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465293|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465294|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44465295|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
44465296|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44465297|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44465298|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44465299|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
44465300|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720580|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
44298577|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298578|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298579|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
44298580|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298581|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298582|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
44298583|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298584|NCT00817622|Vitamin E|vitamin e|mesh-list
44298585|NCT00817622|Vitamins|vitamins|mesh-ancestor
44298586|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
44298587|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298588|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
44298589|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298590|NCT00817622|Protective Agents|protective agents|mesh-ancestor
44298591|NCT00817648|Risperidone|risperidone|mesh-list
44298592|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44298593|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44298594|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
44298595|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298596|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298597|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298598|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44298599|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44298600|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298601|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298602|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44298603|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
44298604|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
44298605|NCT00817661|Vitamin A|vitamin a|mesh-list
44298702|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298703|NCT00818103|Interferons|interferons|mesh-list
44298704|NCT00818103|Atorvastatin|atorvastatin|mesh-list
44298705|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298706|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
44298768|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298769|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
44298770|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44298771|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298772|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298773|NCT00818584|Micafungin|micafungin|mesh-list
44298774|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
44298775|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298830|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
44298831|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298832|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
44298833|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44298834|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44298835|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44298836|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298837|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298838|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
44298839|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298840|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298841|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43832809|NCT05249972|Calcitriol|calcitriol|mesh-list
44299000|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299002|NCT00819988|Analgesics|analgesics|mesh-ancestor
44299003|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
44299004|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299005|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299006|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
44299007|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44299008|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299009|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299010|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44299011|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44299012|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299013|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299039|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44299040|NCT00820326|Dolasetron|dolasetron|mesh-list
44299041|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
44299042|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
44299043|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299044|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299045|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299046|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44299047|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
44299048|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299049|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299050|NCT00820352|Bosentan|bosentan|mesh-list
44299051|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299052|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44299053|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299054|NCT00820404|BLI-489|bli-489|mesh-list
44299055|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44299056|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299057|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299058|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299059|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299159|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299160|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299162|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44299193|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
44299194|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
44299195|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299196|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44465359|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465360|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44465361|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44465362|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465363|NCT01478594|Bevacizumab|bevacizumab|mesh-list
44465364|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465365|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465366|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43720921|NCT02626559|Bupivacaine|bupivacaine|mesh-list
44465400|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
44465402|NCT01478048|Elotuzumab|elotuzumab|mesh-list
44465403|NCT01478048|BB 1101|bb 1101|mesh-list
44465404|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465405|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
44465406|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
44465407|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299208|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299209|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44299246|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44299247|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44299248|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44299249|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44299314|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44299315|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299317|NCT00821912|Docetaxel|docetaxel|mesh-list
44299318|NCT00821912|Capecitabine|capecitabine|mesh-list
44299319|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299320|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299321|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299322|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299350|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
44299352|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44299353|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44299354|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44299355|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299356|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299357|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299358|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299359|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299360|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299361|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44299362|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44299363|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44299364|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44299365|NCT00822133|Lidocaine|lidocaine|mesh-list
44299366|NCT00822133|Ketamine|ketamine|mesh-list
44299367|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
44299437|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299438|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299439|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
44299440|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299441|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299442|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299443|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44299444|NCT00822419|Lidocaine|lidocaine|mesh-list
44299477|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299478|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44299479|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299480|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
44299481|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44299482|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44299483|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44299520|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44299521|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299522|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721098|NCT02625168|Afatinib|afatinib|mesh-list
44299559|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299560|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44465441|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465442|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44465444|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44465445|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465446|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
44465447|NCT01477333|Treprostinil|treprostinil|mesh-list
44465448|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44465449|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44465450|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44465451|NCT01476475|Insulin|insulin|mesh-list
44465452|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44299607|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236261|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
44299609|NCT00823238|Ceftazidime|ceftazidime|mesh-list
44299610|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299611|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299612|NCT00823290|Sorafenib|sorafenib|mesh-list
44299681|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44299682|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
44299683|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44299755|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43721253|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
44465511|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299866|NCT00825019|Paroxetine|paroxetine|mesh-list
44299867|NCT00825019|Amibegron|amibegron|mesh-list
44299868|NCT00825019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44299869|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44299924|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299926|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299927|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
44299928|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44299929|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44299930|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
44299931|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299932|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299933|NCT00825071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44299934|NCT00825071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299935|NCT00825071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299936|NCT00825071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299937|NCT00825071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44299938|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
44299939|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44299940|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299975|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299976|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299977|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299978|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44299979|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
44299980|NCT00825149|Hormones|hormones|mesh-ancestor
44300008|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
44300009|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
44300010|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300012|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44300013|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
44300014|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
44300015|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44300016|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44300017|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300018|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44300019|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44300020|NCT00825422|Ropivacaine|ropivacaine|mesh-list
44300021|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
44300022|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
44300023|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300141|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300142|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
44300143|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44300144|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44300145|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
44300146|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300147|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300148|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300149|NCT00826527|Urological Agents|urological agents|mesh-ancestor
44300150|NCT00826553|Midazolam|midazolam|mesh-list
44300151|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
44300152|NCT00826553|Lorazepam|lorazepam|mesh-list
44300153|NCT00826553|Propofol|propofol|mesh-list
44300154|NCT00826553|GABA Agonists|gaba agonists|mesh-list
44300155|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44300184|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44300185|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300186|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300187|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44300188|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44300189|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
44300190|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300191|NCT00826644|Cisplatin|cisplatin|mesh-list
44300192|NCT00826644|Etoposide|etoposide|mesh-list
44300193|NCT00826644|Belotecan|belotecan|mesh-list
44300194|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300195|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44300196|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44300197|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44300198|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300199|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300200|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44300201|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
44300202|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
44300331|NCT00827411|Aspirin|aspirin|mesh-list
44300332|NCT00827411|Clopidogrel|clopidogrel|mesh-list
44300333|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44300334|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44300335|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300336|NCT00827411|Analgesics|analgesics|mesh-ancestor
44300337|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
44300338|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300339|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300340|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300341|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300342|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44300343|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44300344|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300345|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44300375|NCT00827684|Sirolimus|sirolimus|mesh-list
44300376|NCT00827684|Irinotecan|irinotecan|mesh-list
44300377|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44300378|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44300379|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300380|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300381|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300382|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300383|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300384|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44300385|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
44300386|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44300387|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
44300388|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300389|NCT00827814|Dutasteride|dutasteride|mesh-list
44300420|NCT00828087|Everolimus|everolimus|mesh-list
44300421|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300422|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44300423|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
44300424|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300425|NCT00828087|Trace Elements|trace elements|mesh-ancestor
44300426|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
44300427|NCT00828230|Budesonide|budesonide|mesh-list
44300428|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300429|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300430|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
44300431|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300432|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300433|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300469|NCT00828503|Everolimus|everolimus|mesh-list
44465561|NCT01474512|Ixekizumab|ixekizumab|mesh-list
44465562|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300489|NCT00828763|Dolutegravir|dolutegravir|mesh-list
44300490|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44300491|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44300492|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300493|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300494|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44300495|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44300525|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44300526|NCT00828802|Growth Substances|growth substances|mesh-ancestor
44300527|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
44300528|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300529|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44300530|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
44300531|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300532|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300533|NCT00828815|Etravirine|etravirine|mesh-list
44300534|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44300535|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44236262|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44300536|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300537|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300538|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
44300539|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300574|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44300575|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44300640|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300641|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300642|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44300694|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44300695|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300696|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300697|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44300698|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300699|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44300700|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44300701|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44300702|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44300704|NCT00829777|Lactulose|lactulose|mesh-list
44300705|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44300735|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300737|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300738|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
44300739|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44300740|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300741|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300742|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
44300743|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44300744|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
44300745|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300746|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300747|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
44300809|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44300842|NCT00830505|Xhance|xhance|mesh-list
44300843|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44300844|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44300845|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300846|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300847|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
44300848|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300849|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300850|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300851|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465565|NCT01474486|Micronutrients|micronutrients|mesh-list
44465566|NCT01474486|Trace Elements|trace elements|mesh-list
44465567|NCT01474486|Vitamins|vitamins|mesh-ancestor
44465568|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465569|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
44465570|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44465571|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44465572|NCT01474239|Bevacizumab|bevacizumab|mesh-list
44465573|NCT01474239|Fotemustine|fotemustine|mesh-list
44465574|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465575|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300909|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44300910|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
44300911|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44300912|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44300913|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44300914|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
44300915|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300916|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300917|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44300918|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44300983|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300984|NCT00831597|Rituximab|rituximab|mesh-list
44300985|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44300986|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44300987|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300988|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
44236263|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
44300989|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300990|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300991|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43721925|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
44301092|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44301094|NCT00832364|Acitretin|acitretin|mesh-list
44301095|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44301096|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301097|NCT00832364|Analgesics|analgesics|mesh-ancestor
44301098|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
44301099|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301100|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301101|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301102|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301103|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301104|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301105|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
44301106|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
44301107|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301146|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44465619|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44465620|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
44465621|NCT01473732|Everolimus|everolimus|mesh-list
44465622|NCT01473732|Tacrolimus|tacrolimus|mesh-list
44465623|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465624|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
44465625|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465626|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44465627|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465628|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465629|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955985|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
44465630|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44301172|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
44301173|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44301174|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44301175|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301176|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301177|NCT00833079|Tacrolimus|tacrolimus|mesh-list
44301178|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301179|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
44301180|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301372|NCT00834600|Olmesartan|olmesartan|mesh-list
44301373|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44301374|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44301375|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44301376|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722044|NCT02619201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44301410|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44301411|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44301412|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301413|NCT00834860|Ribavirin|ribavirin|mesh-list
44301414|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44301444|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
44301445|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301446|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301447|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301448|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301449|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301450|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301451|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301452|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44301453|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
44301454|NCT00835393|Pantoprazole|pantoprazole|mesh-list
44301455|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44465635|NCT01473602|Vitamin D|vitamin d|mesh-list
44465636|NCT01473602|Teriparatide|teriparatide|mesh-list
44465637|NCT01473602|Calcium|calcium|mesh-list
44465638|NCT01473602|Vitamins|vitamins|mesh-ancestor
44465639|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
44465640|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465641|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44465642|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44465643|NCT01473589|Vitamin D|vitamin d|mesh-list
44465644|NCT01473589|Teriparatide|teriparatide|mesh-list
44465645|NCT01473589|Calcium|calcium|mesh-list
44465646|NCT01473589|Vitamins|vitamins|mesh-ancestor
44465647|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
44465648|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465649|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44465650|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44465651|NCT01473563|Pemetrexed|pemetrexed|mesh-list
44465652|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465653|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465654|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465655|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44465656|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44465657|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44465658|NCT01473524|Cathartics|cathartics|mesh-ancestor
44465659|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465660|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
44465661|NCT01473420|Hematinics|hematinics|mesh-ancestor
44465662|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
44465663|NCT01473407|Hematinics|hematinics|mesh-ancestor
44465664|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44465665|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
44465666|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465667|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44465668|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44465669|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722103|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44465697|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44465698|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44465699|NCT01472965|Ethanol|ethanol|mesh-list
44465700|NCT01472965|Heparin|heparin|mesh-list
44465701|NCT01472965|Calcium heparin|calcium heparin|mesh-list
44465702|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
43956363|NCT01312818|Vorinostat|vorinostat|mesh-list
44465703|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44301472|NCT00835627|Sertraline|sertraline|mesh-list
44301473|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301474|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301475|NCT00835627|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301476|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301477|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301478|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301479|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301480|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
44301481|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301482|NCT00835744|Clomiphene|clomiphene|mesh-list
44301518|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301519|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
44301520|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
44301521|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301548|NCT00836212|Lopinavir|lopinavir|mesh-list
44301549|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44301550|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44301551|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301552|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301553|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
44301554|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301555|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44301556|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44301557|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44301558|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44301559|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44301560|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44301561|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44301562|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44301563|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301564|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44301565|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44301566|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44301567|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
44301600|NCT00836485|Analgesics|analgesics|mesh-ancestor
44301601|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
44301602|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301603|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301604|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301605|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301606|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44301607|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44301608|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44301609|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
44301610|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
43722250|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
44301641|NCT00836667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301642|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301643|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301644|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301645|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301646|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
44301647|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301649|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44301650|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44301651|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44301652|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
44301653|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301681|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
44301682|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44301683|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301684|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301685|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44301686|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44301687|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44301689|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301691|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
44301692|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301693|NCT00837174|Bortezomib|bortezomib|mesh-list
44301694|NCT00837174|Vorinostat|vorinostat|mesh-list
44301695|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301696|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44301697|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833033|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44301732|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301733|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301734|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301735|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301763|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301764|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
44301765|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
44465704|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44465705|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301767|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301768|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301769|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301770|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301771|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301772|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301773|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
44301774|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
44301775|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125804|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301776|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722324|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
44301840|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301842|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
44301843|NCT00837941|Promethazine|promethazine|mesh-list
44301845|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44301846|NCT00837941|Analgesics|analgesics|mesh-ancestor
44301948|NCT00838305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301949|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301950|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301951|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301952|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301953|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
44301954|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301955|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44301956|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301957|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301997|NCT00838656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302030|NCT00838838|Androgens|androgens|mesh-ancestor
44302031|NCT00838838|Hormones|hormones|mesh-ancestor
44091290|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302032|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302033|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302034|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302035|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302036|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
44302037|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
44302038|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302039|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302040|NCT00838955|Sirolimus|sirolimus|mesh-list
44302078|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302079|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302080|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722533|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
44302187|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302188|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302189|NCT00839501|Acetazolamide|acetazolamide|mesh-list
44302190|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
44302191|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44302192|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302193|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302194|NCT00839501|Diuretics|diuretics|mesh-ancestor
44302195|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
44302196|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302197|NCT00839553|Minocycline|minocycline|mesh-list
44302198|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302199|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465706|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44465707|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302221|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
44302222|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302223|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43722631|NCT02615496|Aflibercept|aflibercept|mesh-list
44302251|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302252|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
44302253|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44302254|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44302255|NCT00840112|Vitamin E|vitamin e|mesh-list
44302256|NCT00840112|Tocopherols|tocopherols|mesh-list
44302257|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
44302258|NCT00840112|Vitamins|vitamins|mesh-ancestor
44302259|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
44302260|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302261|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
44302262|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302263|NCT00840112|Protective Agents|protective agents|mesh-ancestor
44302264|NCT00840125|Docetaxel|docetaxel|mesh-list
44302265|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44302266|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302267|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44302268|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125872|NCT00136851|Benazepril|benazepril|mesh-list
44302269|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44302270|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302271|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44302272|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302297|NCT00840333|Ofloxacin|ofloxacin|mesh-list
44302298|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44302299|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302300|NCT00840333|Renal Agents|renal agents|mesh-ancestor
44302301|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302302|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302303|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302304|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302305|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302306|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302307|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44302308|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44302309|NCT00840346|Panobinostat|panobinostat|mesh-list
44302310|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302311|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44302312|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302313|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302314|NCT00840385|Vidarabine|vidarabine|mesh-list
44302315|NCT00840385|Fludarabine|fludarabine|mesh-list
44302316|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
44302317|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302318|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302319|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
44302320|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302321|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302353|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44302354|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302355|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302356|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302357|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302359|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302360|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302361|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44302362|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
44302363|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43722675|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
44302399|NCT00840684|Daunorubicin|daunorubicin|mesh-list
44302400|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
44302401|NCT00840684|Amsacrine|amsacrine|mesh-list
44302402|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302403|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
44302404|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302437|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
44302438|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302439|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302440|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302441|NCT00840931|Growth Substances|growth substances|mesh-ancestor
44302442|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302443|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302445|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
44302474|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302475|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44302476|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302477|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
44302478|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44302479|NCT00841191|Siltuximab|siltuximab|mesh-list
44302480|NCT00841191|Antibodies|antibodies|mesh-list
44302481|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
44302482|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44302483|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
44302484|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302485|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302486|NCT00841256|Glycerol|glycerol|mesh-list
44302487|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44302488|NCT00841256|Protective Agents|protective agents|mesh-ancestor
44302489|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302490|NCT00841373|Ranibizumab|ranibizumab|mesh-list
44302491|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302492|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302493|NCT00841373|Growth Substances|growth substances|mesh-ancestor
43722762|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
44465736|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465738|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465739|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44465740|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44465741|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44465742|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44465743|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44465744|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44465745|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44465746|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44465747|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
44465748|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44465749|NCT01472185|Ranolazine|ranolazine|mesh-list
44465750|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44465751|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465752|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465753|NCT01472081|Nivolumab|nivolumab|mesh-list
44465754|NCT01472081|Ipilimumab|ipilimumab|mesh-list
44465755|NCT01472081|Sunitinib|sunitinib|mesh-list
44465790|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44465791|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44236264|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236265|NCT00558142|Protective Agents|protective agents|mesh-ancestor
44091444|NCT00032084|Bupropion|bupropion|mesh-list
44302509|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
44302510|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302511|NCT00841581|Ranibizumab|ranibizumab|mesh-list
44302512|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302614|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302615|NCT00841945|Prednisone|prednisone|mesh-list
44302616|NCT00841945|Rituximab|rituximab|mesh-list
44302617|NCT00841945|Doxorubicin|doxorubicin|mesh-list
44302618|NCT00841945|Vincristine|vincristine|mesh-list
44302619|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44302620|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302621|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
44302622|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302623|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302624|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44302625|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302626|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302627|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302628|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722840|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
44302665|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44302697|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
44302698|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302699|NCT00842400|Renal Agents|renal agents|mesh-ancestor
44302700|NCT00842452|Topotecan|topotecan|mesh-list
44302701|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44302702|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302703|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302704|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302705|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302706|NCT00842491|Cisplatin|cisplatin|mesh-list
44302707|NCT00842491|Capecitabine|capecitabine|mesh-list
44302708|NCT00842491|Endostar protein|endostar protein|mesh-list
44302709|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722890|NCT02613455|Hormones|hormones|mesh-ancestor
44302745|NCT00842595|Vinorelbine|vinorelbine|mesh-list
44302746|NCT00842595|Ifosfamide|ifosfamide|mesh-list
44302747|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
44302748|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44302749|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722921|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
44302776|NCT00842660|Antiviral Agents|antiviral agents|mesh-ancestor
44302777|NCT00842660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302778|NCT00842660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302779|NCT00842660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302780|NCT00842660|Immunologic Factors|immunologic factors|mesh-ancestor
44126012|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
44302781|NCT00842660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302782|NCT00842686|Bevacizumab|bevacizumab|mesh-list
44302783|NCT00842686|Capecitabine|capecitabine|mesh-list
44302784|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44302785|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302786|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302787|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302788|NCT00842686|Growth Substances|growth substances|mesh-ancestor
44302789|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302790|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302791|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302792|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
44302793|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302794|NCT00842894|Insulin|insulin|mesh-list
44302795|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44302826|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302827|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302828|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
44302829|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
44302830|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302831|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302832|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44302833|NCT00842933|Protective Agents|protective agents|mesh-ancestor
44302834|NCT00842998|Trastuzumab|trastuzumab|mesh-list
44302835|NCT00842998|Lapatinib|lapatinib|mesh-list
44302836|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44302837|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722977|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
44302883|NCT00843570|Estradiol|estradiol|mesh-list
44302884|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44302885|NCT00843570|Progesterone|progesterone|mesh-list
44302886|NCT00843570|Estrogens|estrogens|mesh-ancestor
44302887|NCT00843570|Hormones|hormones|mesh-ancestor
44302888|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302889|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302890|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44302891|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
44302892|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44302893|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44302894|NCT00843570|Progestins|progestins|mesh-ancestor
44302895|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44302896|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
44302897|NCT00843661|Ezetimibe|ezetimibe|mesh-list
44302898|NCT00843661|Pravastatin|pravastatin|mesh-list
44302899|NCT00843661|Fenofibrate|fenofibrate|mesh-list
44302900|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44302901|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44302902|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
43723023|NCT02612649|Ramosetron|ramosetron|mesh-list
44302933|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302935|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44302936|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
44302937|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44302938|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44302939|NCT00844064|Trabedersen|trabedersen|mesh-list
44302940|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302941|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
44302942|NCT00844142|Etanercept|etanercept|mesh-list
44302943|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44302944|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302945|NCT00844142|Analgesics|analgesics|mesh-ancestor
44302946|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
44302947|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723063|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302982|NCT00844207|Filaricides|filaricides|mesh-ancestor
44302983|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
44302984|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
44302985|NCT00844233|Irinotecan|irinotecan|mesh-list
44302986|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44302987|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302988|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723106|NCT02612233|Pregabalin|pregabalin|mesh-list
44303049|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303050|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303051|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44303052|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
44303053|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723160|NCT02612220|Hemostatics|hemostatics|mesh-list
44303083|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303084|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44303085|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303087|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
44303088|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303089|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303090|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303091|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303092|NCT00844740|Cinacalcet|cinacalcet|mesh-list
44303093|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44303094|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303095|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44303096|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
44303097|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303125|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44303126|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44303127|NCT00845104|Growth Substances|growth substances|mesh-ancestor
44303128|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303129|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
44303130|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
44303131|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303132|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303134|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236266|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303135|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303136|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
44303137|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
44303138|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303139|NCT00845156|Protective Agents|protective agents|mesh-ancestor
44303140|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303141|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
44303142|NCT00845156|Vitamins|vitamins|mesh-ancestor
44303143|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
44303144|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
44303145|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303146|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303147|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303148|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303176|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
44303177|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44303178|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44303179|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44303180|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
44303181|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
44303182|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303183|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303184|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303185|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44303186|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
44303187|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303188|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44303189|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303190|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
44303191|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44303222|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44303223|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303224|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44303225|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44303226|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44303227|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303228|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303229|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44303230|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44303231|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
44303232|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
44303233|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303234|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44303235|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44303236|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
44303237|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303267|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303269|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44303270|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44303271|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303272|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44303273|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44303274|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44303275|NCT00845819|Iodine|iodine|mesh-list
44303276|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
44303277|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44303278|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
44303279|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
44303280|NCT00845819|Nystatin|nystatin|mesh-list
44303317|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44303318|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
44303319|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303320|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303355|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
44303356|NCT00848562|Vitamins|vitamins|mesh-ancestor
44303357|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
44303358|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303359|NCT00848640|Sorafenib|sorafenib|mesh-list
44303360|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303361|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303396|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43723321|NCT02610881|Iron|iron|mesh-list
44236267|NCT00558142|Antidotes|antidotes|mesh-ancestor
44236268|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
44236269|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44303464|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303465|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723348|NCT02610829|Vitamins|vitamins|mesh-ancestor
44303500|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44303501|NCT00849160|Darunavir|darunavir|mesh-list
44303502|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44303503|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44303504|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
44303505|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303542|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303543|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303564|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303565|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303566|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303567|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303568|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
44303569|NCT00849459|Interleukin-12|interleukin-12|mesh-list
44303570|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44303571|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
44303572|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303573|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44303574|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44303575|NCT00849459|Growth Substances|growth substances|mesh-ancestor
44303576|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44303577|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303578|NCT00849511|Melatonin|melatonin|mesh-list
44303579|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
44303580|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303581|NCT00849511|Protective Agents|protective agents|mesh-ancestor
44303582|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303583|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303584|NCT00849537|Triamcinolone|triamcinolone|mesh-list
44303585|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303586|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
44303587|NCT00849537|Hormones|hormones|mesh-ancestor
44303588|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303589|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303590|NCT00849550|Bevacizumab|bevacizumab|mesh-list
44126269|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44303591|NCT00849550|Capecitabine|capecitabine|mesh-list
44303592|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
44303593|NCT00849550|Everolimus|everolimus|mesh-list
44303594|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303595|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303596|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44303597|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44303598|NCT00849550|Growth Substances|growth substances|mesh-ancestor
44303599|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303619|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303620|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44303621|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44303622|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44303623|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303624|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
44303625|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303626|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303627|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
44303628|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303629|NCT00849615|Antidotes|antidotes|mesh-ancestor
44303630|NCT00849615|Protective Agents|protective agents|mesh-ancestor
44303631|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
44303632|NCT00849615|Vitamins|vitamins|mesh-ancestor
44303633|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
44303634|NCT00849615|Hematinics|hematinics|mesh-ancestor
44303635|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
43723443|NCT02609802|Desflurane|desflurane|mesh-list
44303662|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
44303663|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303664|NCT00850044|Ritonavir|ritonavir|mesh-list
44303665|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44303666|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44303667|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
44236270|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44303668|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303669|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303670|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44303671|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44303672|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
44303673|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303674|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44303675|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44303676|NCT00850122|Cefazolin|cefazolin|mesh-list
44303677|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303678|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303679|NCT00850161|Insulin|insulin|mesh-list
44303680|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44303681|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
44303682|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44303683|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303684|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
44303686|NCT00850382|Cytarabine|cytarabine|mesh-list
44303720|NCT00850850|Physostigmine|physostigmine|mesh-list
44303721|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44303722|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303723|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303724|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
44303725|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303726|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303762|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465852|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44465853|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465854|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
44465855|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465856|NCT01471093|Protective Agents|protective agents|mesh-ancestor
44465857|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465858|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465887|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465888|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303771|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
44303772|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
44303773|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303774|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303775|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
44303776|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303777|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303778|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44303779|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44303780|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303781|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303782|NCT00851565|Infliximab|infliximab|mesh-list
44303783|NCT00851565|Antibodies|antibodies|mesh-list
44303784|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
44303785|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303786|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
43723596|NCT02609334|Pemirolast|pemirolast|mesh-list
44303819|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303820|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303821|NCT00852046|Analgesics|analgesics|mesh-ancestor
44303822|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
44303823|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303824|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44303825|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44303826|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44303827|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303828|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303829|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303856|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
44303857|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303858|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303859|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
44303860|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
44303861|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
44303862|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303863|NCT00852228|Cetuximab|cetuximab|mesh-list
44303864|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
44303865|NCT00852228|Irinotecan|irinotecan|mesh-list
44236271|NCT00558181|Prednisolone|prednisolone|mesh-list
44236272|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
44303866|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303867|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303868|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44303869|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44303870|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303871|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303872|NCT00852332|Curcumin|curcumin|mesh-list
44303873|NCT00852332|Docetaxel|docetaxel|mesh-list
44303874|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303875|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44303876|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44303877|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723653|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44303910|NCT00852410|Racepinephrine|racepinephrine|mesh-list
44303911|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
44303912|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
44303913|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
44303914|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303915|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303916|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
44303917|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303918|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303919|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44303920|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44465889|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
44303944|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44303945|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44303946|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303947|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303948|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
44303949|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
44303950|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44303951|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
44303952|NCT00852436|Pregabalin|pregabalin|mesh-list
44303953|NCT00852436|Analgesics|analgesics|mesh-ancestor
44303954|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
44303955|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303956|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303957|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
44303958|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44303959|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303960|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303961|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44303962|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44303963|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44303964|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303965|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44303966|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
44303967|NCT00852566|Dasatinib|dasatinib|mesh-list
44303968|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303969|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303970|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303971|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303972|NCT00852579|Azithromycin|azithromycin|mesh-list
44303973|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303974|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303975|NCT00852670|Ponesimod|ponesimod|mesh-list
44303976|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44304011|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304012|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304013|NCT00852787|Protective Agents|protective agents|mesh-ancestor
44304014|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304049|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304050|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44304051|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304052|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44304053|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304054|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
44304055|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304056|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44304057|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
44091868|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
43723781|NCT02607657|Diuretics|diuretics|mesh-ancestor
44304090|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
44304091|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44304092|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
44304093|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44304094|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44304095|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
43723825|NCT02607410|Insulin|insulin|mesh-list
44304127|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
44304128|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44304129|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44304130|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
44304131|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
44304132|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304133|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44304134|NCT00853320|Oxycodone|oxycodone|mesh-list
44304135|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304136|NCT00853320|Narcotics|narcotics|mesh-ancestor
44304137|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304138|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304139|NCT00853320|Analgesics|analgesics|mesh-ancestor
44304140|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
43723857|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
44304166|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304167|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304168|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44304169|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304171|NCT00853554|Hydromorphone|hydromorphone|mesh-list
44304172|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304173|NCT00853554|Narcotics|narcotics|mesh-ancestor
44304174|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304175|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304176|NCT00853554|Analgesics|analgesics|mesh-ancestor
44304177|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
44304178|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304179|NCT00853684|Capecitabine|capecitabine|mesh-list
44304180|NCT00853684|Endostar protein|endostar protein|mesh-list
44304181|NCT00853684|Endostatins|endostatins|mesh-list
44304182|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304183|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
44304184|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723909|NCT02607371|Apixaban|apixaban|mesh-list
44304207|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304208|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
44304209|NCT00853736|Oxycodone|oxycodone|mesh-list
44304210|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304211|NCT00853736|Narcotics|narcotics|mesh-ancestor
44304212|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304213|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304214|NCT00853736|Analgesics|analgesics|mesh-ancestor
44304215|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
44304216|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304217|NCT00853866|Reboxetine|reboxetine|mesh-list
44304218|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
44304219|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44304220|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44304221|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44304222|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44304223|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304224|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44304225|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304226|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304227|NCT00853879|Vitamins|vitamins|mesh-list
44304228|NCT00853879|Folic Acid|folic acid|mesh-list
44304229|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
44304230|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
44304231|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
44304232|NCT00853879|Pyridoxal|pyridoxal|mesh-list
44304233|NCT00853879|Pyridoxine|pyridoxine|mesh-list
44304234|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
44304235|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
44304236|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304237|NCT00853879|Hematinics|hematinics|mesh-ancestor
44304238|NCT00853892|Oxycodone|oxycodone|mesh-list
44304268|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304269|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44091945|NCT00033553|Gemcitabine|gemcitabine|mesh-list
44304270|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304271|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304272|NCT00854035|Incretins|incretins|mesh-ancestor
44304273|NCT00854035|Hormones|hormones|mesh-ancestor
44304274|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304275|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44304276|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
44304277|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304278|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304279|NCT00854139|Cyclosporine|cyclosporine|mesh-list
44304280|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
44304281|NCT00854139|Cyclosporins|cyclosporins|mesh-list
43723959|NCT02607111|Dalteparin|dalteparin|mesh-list
44304315|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44304316|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304317|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
44304318|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304319|NCT00854256|Mitomycins|mitomycins|mesh-list
44304320|NCT00854256|Mitomycin|mitomycin|mesh-list
44304321|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44304322|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304323|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
43724015|NCT02606981|Vitamins|vitamins|mesh-list
44304349|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44304350|NCT00854503|Simvastatin|simvastatin|mesh-list
44304351|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44304352|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44304353|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
44304354|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304355|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44304356|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44304357|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304358|NCT00854529|Bevacizumab|bevacizumab|mesh-list
44304359|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44304360|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304361|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44304362|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44304363|NCT00854529|Growth Substances|growth substances|mesh-ancestor
44304364|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304365|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44304366|NCT00854633|Lactoferrin|lactoferrin|mesh-list
44304367|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
44304368|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304369|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304370|NCT00854646|ON 01910|on 01910|mesh-list
44304371|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304372|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44304394|NCT00854763|Olmesartan|olmesartan|mesh-list
44304395|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44304396|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44304397|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44304398|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304399|NCT00854776|Lansoprazole|lansoprazole|mesh-list
44304400|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
44304401|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44304402|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44304403|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304404|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44304405|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304406|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304407|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44304408|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
44304409|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304410|NCT00854776|Antacids|antacids|mesh-ancestor
44304411|NCT00854802|Ribavirin|ribavirin|mesh-list
44304412|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44304413|NCT00854802|Cyclosporine|cyclosporine|mesh-list
44304414|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
44304415|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304416|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
44304417|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304418|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
44304419|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
44304420|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304421|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304422|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
44304423|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724080|NCT02606539|Leucovorin|leucovorin|mesh-list
44465894|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304504|NCT00855361|Rabeprazole|rabeprazole|mesh-list
44304505|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44304506|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304507|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44304508|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304509|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304510|NCT00855387|Pancrelipase|pancrelipase|mesh-list
44304511|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304512|NCT00855517|Latanoprost|latanoprost|mesh-list
44304513|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44304514|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44304515|NCT00855530|Amibegron|amibegron|mesh-list
43724185|NCT02605811|Temozolomide|temozolomide|mesh-list
44304540|NCT00855777|Etoricoxib|etoricoxib|mesh-list
44304541|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44304542|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44304543|NCT00855777|Analgesics|analgesics|mesh-ancestor
44304544|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
44304545|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304546|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304547|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304548|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304549|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44304550|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304551|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304552|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44304553|NCT00855881|Tegafur|tegafur|mesh-list
44304554|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304555|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
44304556|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304557|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304558|NCT00855972|Naltrexone|naltrexone|mesh-list
44304559|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44304560|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44304561|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304562|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
44304563|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304564|NCT00856037|Doxorubicin|doxorubicin|mesh-list
43724229|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
44304594|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44304595|NCT00856310|Analgesics|analgesics|mesh-ancestor
44304596|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
44304597|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304598|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304599|NCT00856362|Moxidectin|moxidectin|mesh-list
44304600|NCT00856362|Midazolam|midazolam|mesh-list
44304601|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44304602|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44304603|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304604|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304605|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44304606|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44304607|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44304608|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44304609|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
44304610|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
44304640|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44304641|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
44304642|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304643|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304644|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304645|NCT00856570|Urological Agents|urological agents|mesh-ancestor
44304646|NCT00856596|Sertaconazole|sertaconazole|mesh-list
44304647|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
44304648|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304650|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44304651|NCT00856622|Latanoprost|latanoprost|mesh-list
44304652|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44304653|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44304654|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44304655|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
44304656|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724302|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304673|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304674|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304675|NCT00856804|Ribavirin|ribavirin|mesh-list
44304676|NCT00856804|Thalidomide|thalidomide|mesh-list
44304677|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
44304678|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304679|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
44304680|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304681|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304682|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
44304683|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304684|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
44304685|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304686|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44304687|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44304688|NCT00856804|Growth Substances|growth substances|mesh-ancestor
44304689|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
44304690|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304691|NCT00856882|Caseins|caseins|mesh-list
44304692|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
44304693|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
44304694|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304695|NCT00856960|Losartan|losartan|mesh-list
44304696|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44304697|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44304698|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44304699|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44304700|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304701|NCT00857038|Doxycycline|doxycycline|mesh-list
44304702|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304703|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304704|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
44304705|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44304706|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44304707|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
44304708|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
44304709|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44304710|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
44304711|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44304712|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44304741|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44304742|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44304743|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44304744|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44304745|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
44304746|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304747|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304748|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304750|NCT00857168|Androgens|androgens|mesh-ancestor
44304751|NCT00857168|Hormones|hormones|mesh-ancestor
44304752|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304753|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304754|NCT00857324|Vorinostat|vorinostat|mesh-list
44304755|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304756|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44304757|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304758|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304759|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
44304774|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304775|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44465915|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465916|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
44465917|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465918|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465919|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465920|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
44465921|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465922|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44465923|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44465924|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44465925|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44465926|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
44465927|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465928|NCT01470144|Epoprostenol|epoprostenol|mesh-list
44465929|NCT01470144|Tezosentan|tezosentan|mesh-list
44465931|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43959680|NCT01416584|Methadone|methadone|mesh-list
44304776|NCT00857519|Carboplatin|carboplatin|mesh-list
44304777|NCT00857519|Melphalan|melphalan|mesh-list
44304778|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304779|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44304780|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
44304781|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304782|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44304783|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304784|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
44304785|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304786|NCT00857558|Saxagliptin|saxagliptin|mesh-list
44304787|NCT00857558|Incretins|incretins|mesh-ancestor
44304788|NCT00857558|Hormones|hormones|mesh-ancestor
44304789|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304790|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304791|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44304792|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44304793|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304794|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304795|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304796|NCT00857597|Esomeprazole|esomeprazole|mesh-list
44304797|NCT00857597|Omeprazole|omeprazole|mesh-list
44304798|NCT00857597|Rabeprazole|rabeprazole|mesh-list
44304799|NCT00857597|Pantoprazole|pantoprazole|mesh-list
44304800|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44304801|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44304802|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304803|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304804|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304833|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304834|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44304835|NCT00857909|Diuretics|diuretics|mesh-ancestor
44304836|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
44304837|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44304838|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44304839|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44304840|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304841|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44304842|NCT00857935|Permethrin|permethrin|mesh-list
44304843|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304844|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304845|NCT00857987|Expectorants|expectorants|mesh-list
44304846|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44304847|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44304848|NCT00858195|Indomethacin|indomethacin|mesh-list
44304849|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44304850|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44304851|NCT00858195|Analgesics|analgesics|mesh-ancestor
44304862|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304863|NCT00858273|Insulin|insulin|mesh-list
44304864|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44304865|NCT00858273|Antioxidants|antioxidants|mesh-list
44304866|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304867|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304868|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304869|NCT00858273|Protective Agents|protective agents|mesh-ancestor
44304870|NCT00858299|Valsartan|valsartan|mesh-list
44304871|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44304872|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44304873|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44304874|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304875|NCT00858325|Daptomycin|daptomycin|mesh-list
44304876|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304877|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304878|NCT00858338|Floxuridine|floxuridine|mesh-list
44304879|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304880|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
44304881|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304882|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304883|NCT00858377|Complement Factor H|complement factor h|mesh-list
44304884|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44304885|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304886|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
44304887|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304888|NCT00858429|Capecitabine|capecitabine|mesh-list
44304889|NCT00858429|Doxifluridine|doxifluridine|mesh-list
44304890|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304891|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
44304892|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304893|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304894|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304895|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
44304896|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304897|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
44304898|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44304899|NCT00858455|Dolutegravir|dolutegravir|mesh-list
44304900|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44304901|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44304902|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304903|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304904|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44304905|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44304906|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
44304907|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304908|NCT00858624|Ketamine|ketamine|mesh-list
44304909|NCT00858624|Analgesics|analgesics|mesh-ancestor
44304910|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
44304911|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304912|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304913|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44304914|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44304915|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
44304945|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44304946|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304947|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44304948|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44304949|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304950|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
44304951|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44304952|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44304953|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44304954|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
44304955|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304956|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
44304957|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44304958|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304959|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
44304995|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304996|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304997|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
44304999|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305000|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43959900|NCT01425853|Analgesics|analgesics|mesh-ancestor
44305001|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305069|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305070|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44305071|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
44305072|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
44305073|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
44305074|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305075|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305076|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44305077|NCT00859885|Clopidogrel|clopidogrel|mesh-list
44305078|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126763|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44305079|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724613|NCT02603068|Treprostinil|treprostinil|mesh-list
44305107|NCT00860275|Fluconazole|fluconazole|mesh-list
44305108|NCT00860275|Ketoconazole|ketoconazole|mesh-list
44305109|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
44305110|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305111|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44305112|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44305113|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305114|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305115|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44236273|NCT00558181|Rituximab|rituximab|mesh-list
44092288|NCT00034502|Irinotecan|irinotecan|mesh-list
44305116|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
44305117|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305118|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960050|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
44305119|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44305120|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44305121|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44305122|NCT00860340|Spironolactone|spironolactone|mesh-list
44305160|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
44305161|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305219|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305220|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44305221|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
44305222|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
44305223|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44305224|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305225|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305226|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44305227|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44305228|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305229|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305230|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305231|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44305262|NCT00861094|Antidotes|antidotes|mesh-ancestor
44305263|NCT00861094|Protective Agents|protective agents|mesh-ancestor
44305264|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
44305265|NCT00861094|Vitamins|vitamins|mesh-ancestor
44305266|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
44305267|NCT00861094|Hematinics|hematinics|mesh-ancestor
43960199|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44305268|NCT00861107|Vaccines|vaccines|mesh-list
44305269|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
44305270|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305271|NCT00861120|Doxorubicin|doxorubicin|mesh-list
44305272|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44305273|NCT00861120|Panitumumab|panitumumab|mesh-list
44305274|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44305275|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305312|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305313|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44305314|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44305315|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465976|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
44465977|NCT01469065|Vitamins|vitamins|mesh-ancestor
44465978|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
44465979|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465980|NCT01469052|Axitinib|axitinib|mesh-list
44465981|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465982|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465983|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465984|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465985|NCT01469013|Methotrexate|methotrexate|mesh-list
44465986|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44465987|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
44465988|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44465989|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465990|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465991|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
44465992|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465993|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466015|NCT01468909|Paclitaxel|paclitaxel|mesh-list
44305368|NCT00861445|Lacosamide|lacosamide|mesh-list
44305369|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
44305370|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44305371|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44305372|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305373|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305374|NCT00861510|ON 01910|on 01910|mesh-list
44305375|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305376|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44305377|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305378|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305380|NCT00861523|Promethazine|promethazine|mesh-list
44305381|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
44305382|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
44305383|NCT00861523|Vitamins|vitamins|mesh-ancestor
44305384|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
44305385|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305386|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
44305387|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44305388|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44305389|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
44305390|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
44305391|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305392|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305393|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44305394|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44305395|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44305396|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305397|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
44305398|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
44305399|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
44305400|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305401|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
44305440|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305464|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44305465|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
44305466|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305467|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
44305468|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305470|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305471|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305472|NCT00861926|Beclomethasone|beclomethasone|mesh-list
44305473|NCT00861926|Albuterol|albuterol|mesh-list
44305474|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
44305475|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44305476|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
44305477|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305478|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305479|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44305480|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
44305481|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44305482|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44305483|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44305484|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305485|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305486|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305487|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
44305488|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305489|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305490|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
44305491|NCT00861926|Hormones|hormones|mesh-ancestor
44305515|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305516|NCT00862043|Urological Agents|urological agents|mesh-ancestor
44305517|NCT00862095|Topiramate|topiramate|mesh-list
44305518|NCT00862095|Propranolol|propranolol|mesh-list
44305519|NCT00862095|Amitriptyline|amitriptyline|mesh-list
44305520|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44305521|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44305522|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305523|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305524|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305525|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305526|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305527|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305528|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
44305529|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
44305530|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44305531|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44305532|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
44305533|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305534|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44305535|NCT00862095|Analgesics|analgesics|mesh-ancestor
44305536|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
44305537|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092423|NCT00034697|Temozolomide|temozolomide|mesh-list
44305538|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44305539|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305557|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44305558|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
44305559|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44305560|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44305561|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44305562|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305563|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305564|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305565|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305566|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
44305568|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305569|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
44305570|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305571|NCT00862329|Caseins|caseins|mesh-list
44305572|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
44305573|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
44305574|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305575|NCT00862342|Bevacizumab|bevacizumab|mesh-list
44305576|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44305577|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305578|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44305579|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44305580|NCT00862342|Growth Substances|growth substances|mesh-ancestor
44305581|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305582|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
44305583|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
44305584|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305585|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
44305586|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44305587|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
44305588|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305589|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305590|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44305591|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
44305592|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44305593|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43833290|NCT05218889|Gemcitabine|gemcitabine|mesh-list
44305655|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
44305656|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44305657|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305658|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
44305659|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
44305660|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44305661|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44305662|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305663|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305664|NCT00862888|Urological Agents|urological agents|mesh-ancestor
44305665|NCT00862966|Heparin|heparin|mesh-list
44305697|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305698|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44305699|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44305700|NCT00863239|Interferons|interferons|mesh-list
44305702|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
44305703|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
44305704|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44305705|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305706|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
44305707|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305708|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
44305709|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305710|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
44466035|NCT01468818|Fludarabine|fludarabine|mesh-list
44466036|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305721|NCT00863291|Buprenorphine|buprenorphine|mesh-list
44305722|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44305723|NCT00863291|Narcotics|narcotics|mesh-ancestor
44305724|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305725|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305726|NCT00863291|Analgesics|analgesics|mesh-ancestor
44305727|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
44305728|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305729|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44305730|NCT00863395|Lidocaine|lidocaine|mesh-list
44305731|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
44305732|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
44305733|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725122|NCT02600273|Nicotine|nicotine|mesh-list
44305767|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44305768|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
44305769|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
44305770|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305771|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44305772|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44305773|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44305796|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44305797|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44305799|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
44305800|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305801|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44305802|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305803|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305804|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44305805|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44305806|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44305807|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44305808|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44305809|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44305810|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44305811|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44305812|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44305814|NCT00863733|Vadimezan|vadimezan|mesh-list
44305815|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305816|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305817|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305818|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
44305819|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44305820|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
44305821|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305822|NCT00863785|Expectorants|expectorants|mesh-ancestor
44305823|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
44305824|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44305882|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305883|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305884|NCT00863915|Ramipril|ramipril|mesh-list
44305885|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44305886|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
44305887|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305888|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305889|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305890|NCT00863941|Bupropion|bupropion|mesh-list
44305891|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44305892|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
44305893|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305894|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44305895|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305896|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305897|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305898|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
44305899|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305900|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305901|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44305902|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44305903|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305904|NCT00863980|Telmisartan|telmisartan|mesh-list
44305905|NCT00863980|Candesartan|candesartan|mesh-list
44305906|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
44305907|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305908|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44305909|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44305910|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305911|NCT00864006|Valproic Acid|valproic acid|mesh-list
44305971|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
44305972|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
44305973|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305975|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44305976|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
44305977|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305978|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305979|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44305980|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44305981|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44305982|NCT00864149|Carvedilol|carvedilol|mesh-list
44305983|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44305984|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44305985|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305986|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305987|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305988|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305989|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305990|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
44305991|NCT00864149|Protective Agents|protective agents|mesh-ancestor
44305992|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44305993|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305994|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44305995|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
44305996|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44305997|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44305998|NCT00864162|Ramipril|ramipril|mesh-list
44305999|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44306000|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
44306026|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306028|NCT00864279|Cetirizine|cetirizine|mesh-list
44306029|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44306030|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44306031|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44306032|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
44306033|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
44306034|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306035|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306036|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306037|NCT00864305|Gabapentin|gabapentin|mesh-list
44306038|NCT00864305|Analgesics|analgesics|mesh-ancestor
44306039|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
44306040|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306041|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306042|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
44306043|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306044|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306045|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306046|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306047|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306048|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306073|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306074|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306075|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
44306076|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306077|NCT00864357|Ibuprofen|ibuprofen|mesh-list
44306078|NCT00864357|Oxycodone|oxycodone|mesh-list
44306079|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44306080|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44306081|NCT00864357|Analgesics|analgesics|mesh-ancestor
44306082|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
44306083|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306084|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306085|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306086|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306087|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44306088|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306089|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306090|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44306091|NCT00864357|Narcotics|narcotics|mesh-ancestor
44306092|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306093|NCT00864396|Lansoprazole|lansoprazole|mesh-list
44306094|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44306095|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44306096|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44306097|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306098|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306121|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44306123|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44306124|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44306125|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306126|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306127|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306128|NCT00864474|Maraviroc|maraviroc|mesh-list
44306129|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44306130|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44306131|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306132|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44306133|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44306134|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
44306135|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306136|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44306137|NCT00864500|Clobetasol|clobetasol|mesh-list
44306138|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306139|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
44306140|NCT00864500|Hormones|hormones|mesh-ancestor
44306141|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306142|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306143|NCT00864526|Ibuprofen|ibuprofen|mesh-list
44306144|NCT00864526|Oxycodone|oxycodone|mesh-list
44306145|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44306146|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44306147|NCT00864526|Analgesics|analgesics|mesh-ancestor
44306148|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
43725453|NCT02597699|Lidocaine|lidocaine|mesh-list
44306176|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306177|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306178|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44306179|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306180|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44306181|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
44306182|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
44306183|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306184|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306185|NCT00864604|Nabumetone|nabumetone|mesh-list
44306186|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44306187|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44306188|NCT00864604|Analgesics|analgesics|mesh-ancestor
44306189|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
44306190|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306191|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306192|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306193|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306194|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44306195|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44306196|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725499|NCT02597361|Irbesartan|irbesartan|mesh-list
44306228|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306229|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44306230|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306231|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306232|NCT00864760|Gabapentin|gabapentin|mesh-list
44306233|NCT00864760|Analgesics|analgesics|mesh-ancestor
44306234|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
44306235|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306236|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306237|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
44306238|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306268|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44306269|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44306270|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44306271|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44306272|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
44306273|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44306274|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
44306275|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612241|NCT03167177|Bevacizumab|bevacizumab|mesh-list
44306276|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306277|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44306278|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44306279|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44306280|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306281|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
44306303|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306305|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
44306306|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44306307|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306308|NCT00864838|Diuretics|diuretics|mesh-ancestor
44306309|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
44306310|NCT00864864|Sunitinib|sunitinib|mesh-list
44306311|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306312|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44306313|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44306314|NCT00864864|Growth Substances|growth substances|mesh-ancestor
44306315|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306316|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
44306317|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44306318|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306319|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306321|NCT00864890|Citalopram|citalopram|mesh-list
44306322|NCT00864890|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44306323|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306324|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306325|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306326|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306327|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
44306328|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306329|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306330|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306331|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306332|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44306333|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306334|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
44306370|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306402|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306403|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
44306404|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306405|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306448|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306449|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306450|NCT00865137|Tacrolimus|tacrolimus|mesh-list
44306451|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44306452|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
44306453|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306454|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43961337|NCT01475643|Hormones|hormones|mesh-ancestor
44306455|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306456|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306457|NCT00865176|Eplerenone|eplerenone|mesh-list
44306458|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44306459|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306460|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306461|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306462|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44306463|NCT00865176|Diuretics|diuretics|mesh-ancestor
44306464|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
44306465|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306466|NCT00865215|Propranolol|propranolol|mesh-list
44306467|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44306468|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306469|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306470|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306471|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306472|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306473|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44306474|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306475|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306476|NCT00865241|Metformin|metformin|mesh-list
44306477|NCT00865241|Glyburide|glyburide|mesh-list
44306478|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306479|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236274|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44306480|NCT00865267|Halobetasol|halobetasol|mesh-list
44306481|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44306482|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
44306483|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44306484|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44306485|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306486|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
44306487|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
44306488|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306489|NCT00865371|Bupropion|bupropion|mesh-list
44306490|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306491|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306492|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306493|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44306494|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306495|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306496|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306497|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
44306498|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127280|NCT00140998|Estradiol|estradiol|mesh-list
44306499|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306500|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44306501|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43725726|NCT02595554|Paclitaxel|paclitaxel|mesh-list
43833380|NCT05214573|Hormones|hormones|mesh-ancestor
44306570|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306571|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44306572|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306573|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306574|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306575|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
44306591|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
44306592|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44306593|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
44306594|NCT00865540|Ketorolac|ketorolac|mesh-list
44306595|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44306596|NCT00865540|Nepafenac|nepafenac|mesh-list
44306597|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44306598|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
44306599|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306600|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
44306601|NCT00865540|Hormones|hormones|mesh-ancestor
44306602|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306603|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306604|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44306605|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306606|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
44306607|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
44306608|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306609|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44306610|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44306611|NCT00865540|Protective Agents|protective agents|mesh-ancestor
44306612|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44306613|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44306614|NCT00865540|Analgesics|analgesics|mesh-ancestor
44306615|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
44306616|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306617|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44306618|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306619|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306620|NCT00865605|Clobetasol|clobetasol|mesh-list
44306621|NCT00865605|Halobetasol|halobetasol|mesh-list
44306622|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44306623|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306624|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
44306625|NCT00865605|Hormones|hormones|mesh-ancestor
44306626|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306627|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306628|NCT00865618|Eplerenone|eplerenone|mesh-list
44306629|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44306630|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426847|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44306631|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306632|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306633|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44306662|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306663|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306664|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306665|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
44306666|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
44306667|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306668|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306669|NCT00865670|Azithromycin|azithromycin|mesh-list
44306670|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44306671|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306672|NCT00865696|Mirtazapine|mirtazapine|mesh-list
44306673|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306674|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306675|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44306676|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
44306677|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
44306678|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306679|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306680|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306710|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306711|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306712|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44306713|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44306714|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
44306715|NCT00865891|Nifedipine|nifedipine|mesh-list
44306716|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44306717|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306718|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306719|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44306720|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306721|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306722|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
44306723|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44306724|NCT00865917|Metoprolol|metoprolol|mesh-list
44306725|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44306742|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306744|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
44306745|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306746|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306747|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306748|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306749|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44466041|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
44306750|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306751|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
44306752|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
44306753|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306754|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44306755|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44306756|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44306757|NCT00865982|Cisplatin|cisplatin|mesh-list
44306758|NCT00865982|Docetaxel|docetaxel|mesh-list
44306759|NCT00865982|Capecitabine|capecitabine|mesh-list
44306760|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306761|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
44306762|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
44306763|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
44306764|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306765|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44306766|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
44306767|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44306768|NCT00866008|Ganirelix|ganirelix|mesh-list
44306769|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
44306770|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44306771|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
44306772|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44306773|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306774|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44306775|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44306776|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236276|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44306777|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306778|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306779|NCT00866021|Ritonavir|ritonavir|mesh-list
44306780|NCT00866021|Lopinavir|lopinavir|mesh-list
44306781|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44127412|NCT00141336|Pregabalin|pregabalin|mesh-list
44306815|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44306816|NCT00866229|Simvastatin|simvastatin|mesh-list
44306817|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44306818|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44306819|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
44306820|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306821|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43725931|NCT02593942|Remifentanil|remifentanil|mesh-list
44306856|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306857|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306858|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306859|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44306882|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44306884|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44306885|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44306886|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306887|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306888|NCT00866593|Dexetimide|dexetimide|mesh-list
44306889|NCT00866593|Citalopram|citalopram|mesh-list
44306890|NCT00866593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44306891|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306892|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306893|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306894|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306895|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
44306896|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306897|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306898|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306899|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306900|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44306901|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306902|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
44306903|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
44306904|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306905|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44306906|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44306907|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466043|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466044|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44466046|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44466047|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
44466048|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466049|NCT01468233|Adalimumab|adalimumab|mesh-list
44466050|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466051|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466052|NCT01468207|Adalimumab|adalimumab|mesh-list
44466053|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466054|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466055|NCT01468181|Dulaglutide|dulaglutide|mesh-list
44466056|NCT01468181|Biguanides|biguanides|mesh-list
44466057|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44466058|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44466059|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44466060|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466061|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466062|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466063|NCT01467661|Anagrelide|anagrelide|mesh-list
44466064|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44466065|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44466066|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466067|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44466068|NCT01467583|PENTA|penta|mesh-list
44466069|NCT01467583|Fondaparinux|fondaparinux|mesh-list
44466070|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44466071|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
44466072|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44127482|NCT00141414|Pregabalin|pregabalin|mesh-list
44466073|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466074|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236277|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833427|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306952|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726078|NCT02593383|Adapalene|adapalene|mesh-list
44307050|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
44307051|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307052|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
44307053|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
44307054|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307055|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307056|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
44307057|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307058|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307059|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307060|NCT00867737|Fluticasone|fluticasone|mesh-list
44307061|NCT00867737|Budesonide|budesonide|mesh-list
44307062|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
44307063|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44307064|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44307065|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44307066|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307067|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44307068|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
44307069|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307070|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307071|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44307072|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
44307073|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307074|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44307075|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
44307076|NCT00867737|Hormones|hormones|mesh-ancestor
44307077|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307078|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43961925|NCT01495572|Aldesleukin|aldesleukin|mesh-list
44307093|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
44307094|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307095|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307096|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
44307097|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
44307098|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44307099|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
44307100|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307101|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307102|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44307103|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44307104|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44307105|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44307106|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44307107|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307108|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307109|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307110|NCT00868062|Polygeline|polygeline|mesh-list
44307111|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
44307112|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
44307113|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
44307114|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44307115|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
44307116|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44307117|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307118|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44307119|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44307120|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44307121|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
44307122|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44307123|NCT00868283|Protective Agents|protective agents|mesh-ancestor
44307124|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307125|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
44307126|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
44307127|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44307128|NCT00868413|Rituximab|rituximab|mesh-list
44307129|NCT00868413|Fludarabine|fludarabine|mesh-list
44307130|NCT00868413|Navitoclax|navitoclax|mesh-list
44307131|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307132|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
44236278|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
44307133|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307134|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307135|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44307136|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
44307137|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307138|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307139|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44307178|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307179|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307180|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307212|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307214|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307215|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44307216|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307217|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307218|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307219|NCT00868738|Vitamin D|vitamin d|mesh-list
44307220|NCT00868738|Vitamins|vitamins|mesh-ancestor
44307221|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
44307222|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307223|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44307224|NCT00868764|Granisetron|granisetron|mesh-list
44307225|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
44466107|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
44466108|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44466109|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44466110|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466111|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
44466112|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466113|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
44466114|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466115|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
44466116|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466117|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
44466118|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44466119|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
44466120|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466121|NCT01467466|Expectorants|expectorants|mesh-ancestor
44466122|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44466123|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44466124|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
44466125|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466126|NCT01467466|Protective Agents|protective agents|mesh-ancestor
44466127|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466128|NCT01467466|Antidotes|antidotes|mesh-ancestor
44466129|NCT01467076|Alprostadil|alprostadil|mesh-list
43726279|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
44307235|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307237|NCT00868829|Sirolimus|sirolimus|mesh-list
44307238|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307239|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726332|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
44307268|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307269|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
44307270|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307271|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44307273|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307274|NCT00869063|Diclofenac|diclofenac|mesh-list
44307275|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44307276|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44307277|NCT00869063|Analgesics|analgesics|mesh-ancestor
44307278|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
44307279|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307280|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307281|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307282|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307283|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44307284|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307285|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307304|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307305|NCT00869219|Nepafenac|nepafenac|mesh-list
44307306|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44307307|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236279|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307308|NCT00869219|Analgesics|analgesics|mesh-ancestor
44307309|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
44307310|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307311|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307312|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307313|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307314|NCT00869271|Leucovorin|leucovorin|mesh-list
44307315|NCT00869271|Fluorouracil|fluorouracil|mesh-list
44307316|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
44307317|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
44307318|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307319|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307320|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307321|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307322|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
44307323|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307324|NCT00869271|Antidotes|antidotes|mesh-ancestor
44307325|NCT00869271|Protective Agents|protective agents|mesh-ancestor
44307326|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
44307327|NCT00869271|Vitamins|vitamins|mesh-ancestor
44307328|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
44307329|NCT00869310|Dexamethasone|dexamethasone|mesh-list
44307330|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
44307331|NCT00869310|Aprepitant|aprepitant|mesh-list
44307332|NCT00869310|Metoclopramide|metoclopramide|mesh-list
44307333|NCT00869310|BB 1101|bb 1101|mesh-list
44307334|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307335|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
44307336|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
44307337|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307338|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307339|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307340|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
44307341|NCT00869310|Hormones|hormones|mesh-ancestor
44307342|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307356|NCT00869427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307358|NCT00869427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307359|NCT00869427|Protective Agents|protective agents|mesh-ancestor
44307360|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44307361|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307362|NCT00869570|Capecitabine|capecitabine|mesh-list
44307363|NCT00869570|Sorafenib|sorafenib|mesh-list
44307364|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307365|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
44307366|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307367|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307368|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307369|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307370|NCT00869596|Fluticasone|fluticasone|mesh-list
44307372|NCT00869596|Albuterol|albuterol|mesh-list
44307373|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307374|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44307375|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
44307376|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307377|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307378|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44307379|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44307380|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307381|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44307382|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
44307383|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44307384|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44307385|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44307386|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44307387|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307388|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307389|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307390|NCT00869700|Lumefantrine|lumefantrine|mesh-list
44307391|NCT00869700|Artemether|artemether|mesh-list
44307392|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44307393|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
44307394|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44307395|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44307396|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307397|NCT00869752|Cisplatin|cisplatin|mesh-list
44093200|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
44307398|NCT00869752|Etoposide|etoposide|mesh-list
44307399|NCT00869752|Antibodies|antibodies|mesh-list
44307400|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44307401|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
44307402|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307403|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307404|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44307417|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307419|NCT00869856|Hematinics|hematinics|mesh-ancestor
44307420|NCT00869869|Melatonin|melatonin|mesh-list
44307421|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
44307422|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307423|NCT00869869|Protective Agents|protective agents|mesh-ancestor
44307424|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307425|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307426|NCT00869908|Insulin|insulin|mesh-list
44307427|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44307428|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
44307429|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
44307430|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44307431|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
44307432|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
44307433|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44307434|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307435|NCT00869973|Dexamethasone|dexamethasone|mesh-list
44307436|NCT00869973|Aprepitant|aprepitant|mesh-list
44307437|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307438|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
44307439|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
44307440|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307441|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307442|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307443|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
44307444|NCT00869973|Hormones|hormones|mesh-ancestor
44307445|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307446|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44307447|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307448|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44307449|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307450|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307451|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44307452|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44307453|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307454|NCT00870038|Paclitaxel|paclitaxel|mesh-list
44307455|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44307456|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307457|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307458|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307459|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307460|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307461|NCT00870142|Amlodipine|amlodipine|mesh-list
44307462|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307463|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44307464|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307465|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307491|NCT00870298|Warfarin|warfarin|mesh-list
44307492|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
44307493|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44307494|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307495|NCT00870298|Renal Agents|renal agents|mesh-ancestor
44307496|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
44307497|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44307498|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44307499|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44307500|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307501|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307502|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44307503|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44307504|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44307505|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
44307506|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
44307507|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236280|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307508|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307509|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307510|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
44307511|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307512|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307513|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307514|NCT00870337|Everolimus|everolimus|mesh-list
44307541|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307542|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307543|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307544|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307545|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44307546|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307547|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307548|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307549|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
44307550|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307552|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307553|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44307554|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307555|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307556|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44307557|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307558|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
44307559|NCT00870636|Bevacizumab|bevacizumab|mesh-list
43726560|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44466183|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
44466184|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466185|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466186|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
44466187|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466188|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44466189|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44466190|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44466191|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466192|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466193|NCT01466387|Vaccines|vaccines|mesh-list
44466194|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
44466195|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466196|NCT01466348|Acetaminophen|acetaminophen|mesh-list
44466197|NCT01466348|Caffeine|caffeine|mesh-list
44466198|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466199|NCT01466348|Analgesics|analgesics|mesh-ancestor
44466200|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
44466201|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466202|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466203|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
44466204|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44466205|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43833460|NCT05209490|Iodine|iodine|mesh-list
44307580|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
44307581|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307582|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307583|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44307584|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44307585|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44307586|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307587|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
44307588|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44307589|NCT00870883|Deferoxamine|deferoxamine|mesh-list
44307590|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
44307591|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307592|NCT00870883|Expectorants|expectorants|mesh-ancestor
44307593|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
44307594|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44307595|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
44307596|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307597|NCT00870883|Protective Agents|protective agents|mesh-ancestor
44307598|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307599|NCT00870883|Antidotes|antidotes|mesh-ancestor
44307600|NCT00870883|Siderophores|siderophores|mesh-ancestor
44307601|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44236281|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307602|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
44307603|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
44307604|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
44307606|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44307607|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307608|NCT00870961|Vitamins|vitamins|mesh-ancestor
44307609|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
44307610|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44307611|NCT00870987|Vaccines|vaccines|mesh-list
44307612|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
44307613|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307614|NCT00871039|Midazolam|midazolam|mesh-list
44307615|NCT00871039|Propofol|propofol|mesh-list
44307616|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44307617|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307618|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307619|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44307620|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
44307621|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
44307622|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44307623|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44307659|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44307661|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
44307662|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307663|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307664|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307731|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307733|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307768|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
44307769|NCT00871910|Hormones|hormones|mesh-ancestor
44307770|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307771|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44307804|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307805|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
44307806|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307807|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307808|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44307809|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44307810|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307811|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307812|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307813|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44307837|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307838|NCT00872365|Micronutrients|micronutrients|mesh-list
44307839|NCT00872365|Trace Elements|trace elements|mesh-list
44307840|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307842|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44307843|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127877|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
44307844|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44307845|NCT00872378|Incretins|incretins|mesh-ancestor
44307846|NCT00872378|Hormones|hormones|mesh-ancestor
44307847|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307848|NCT00872417|Lamivudine|lamivudine|mesh-list
44307849|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44307850|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44307851|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307852|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307853|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
44307854|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307855|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44307856|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44307857|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
44307858|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44307859|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44307860|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307861|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
44307862|NCT00872469|Coagulants|coagulants|mesh-ancestor
44307875|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307877|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44307878|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
44307879|NCT00872625|Docetaxel|docetaxel|mesh-list
44307880|NCT00872625|Fluorouracil|fluorouracil|mesh-list
44307881|NCT00872625|Epirubicin|epirubicin|mesh-list
44307882|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307883|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
44307884|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307885|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307886|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44307887|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
44307888|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307889|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307890|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44307891|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307892|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307893|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307894|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
44307895|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307896|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44307897|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44307898|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44307899|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307900|NCT00872651|Timolol|timolol|mesh-list
44307901|NCT00872651|Travoprost|travoprost|mesh-list
44307902|NCT00872651|Latanoprost|latanoprost|mesh-list
44307903|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44307904|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44307905|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307906|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307907|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307908|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307909|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44307910|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307911|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44307912|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44307913|NCT00872664|Carotenoids|carotenoids|mesh-list
44307914|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
44307915|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307916|NCT00872664|Protective Agents|protective agents|mesh-ancestor
44307917|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466209|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44466210|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
44466211|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466212|NCT01466270|Donepezil|donepezil|mesh-list
44466213|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44466214|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466215|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307929|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
44307930|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307931|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44307932|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307933|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307934|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44307935|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307936|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307937|NCT00872924|Sumatriptan|sumatriptan|mesh-list
44307938|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44307939|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44307940|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44307941|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
44307942|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307943|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307944|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307945|NCT00872963|Vaccines|vaccines|mesh-list
44307946|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
44307947|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307948|NCT00872976|Dasatinib|dasatinib|mesh-list
43726866|NCT02587260|Clopidogrel|clopidogrel|mesh-list
44307978|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307979|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
44307980|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307981|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307982|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307984|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
44307985|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236284|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307986|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307987|NCT00873223|Incretins|incretins|mesh-ancestor
44307988|NCT00873223|Hormones|hormones|mesh-ancestor
44307989|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307990|NCT00873236|Interferons|interferons|mesh-list
44307991|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
44307992|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
44308028|NCT00873353|Capecitabine|capecitabine|mesh-list
44308029|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44308030|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308031|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
44308032|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308033|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308034|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44308035|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308066|NCT00873483|Progestins|progestins|mesh-ancestor
44308067|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44308068|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
44308069|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
44308070|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44308071|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44308072|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308073|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308074|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308075|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308077|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44308078|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308108|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44308109|NCT00873639|Insulin|insulin|mesh-list
44308110|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44308111|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
44308112|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
44308113|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44308114|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308115|NCT00873652|Vaccines|vaccines|mesh-list
44308116|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
44308117|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308118|NCT00873756|Bevacizumab|bevacizumab|mesh-list
44308119|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308120|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308121|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308122|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308159|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
44308176|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
44128030|NCT00143065|Rituximab|rituximab|mesh-list
44308177|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308178|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44308179|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
44308180|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308181|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44308182|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44308183|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308184|NCT00873886|Oseltamivir|oseltamivir|mesh-list
44308185|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
44308186|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308187|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308188|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308189|NCT00873925|Vitamin D|vitamin d|mesh-list
44308190|NCT00873925|Vitamins|vitamins|mesh-ancestor
44308191|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
44308192|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308193|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44308194|NCT00873951|Caseins|caseins|mesh-list
44308195|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
44308196|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
44308197|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308198|NCT00874003|Mirtazapine|mirtazapine|mesh-list
44308199|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
44308200|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308201|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44308202|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
44308203|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
44308204|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093570|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308205|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308206|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308207|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44308208|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308209|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308210|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44308211|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44308212|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44308213|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
44308214|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44308215|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43963076|NCT01531959|Midodrine|midodrine|mesh-list
44308252|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44308253|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44308288|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44308290|NCT00874328|Cisplatin|cisplatin|mesh-list
44308291|NCT00874328|Irinotecan|irinotecan|mesh-list
44308292|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308293|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44308294|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308295|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308399|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308400|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308401|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308402|NCT00874744|Growth Substances|growth substances|mesh-ancestor
44308403|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308404|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
44128093|NCT00143169|Parecoxib|parecoxib|mesh-list
44308405|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44308406|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
44308408|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44308409|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308410|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
44308411|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308412|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308413|NCT00874809|Insulin|insulin|mesh-list
44308414|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
44308415|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44308416|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308417|NCT00874861|Poly ICLC|poly iclc|mesh-list
44308418|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
44308419|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
44308420|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308421|NCT00874874|Sorafenib|sorafenib|mesh-list
44308422|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308423|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44308424|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308425|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308426|NCT00874926|Factor VIII|factor viii|mesh-list
44308427|NCT00874926|Coagulants|coagulants|mesh-ancestor
44308428|NCT00874978|Lenalidomide|lenalidomide|mesh-list
44308429|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
44308430|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308431|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308432|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308433|NCT00874978|Growth Substances|growth substances|mesh-ancestor
44308434|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308435|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308436|NCT00875030|Artesunate|artesunate|mesh-list
43727075|NCT02586051|Antibodies|antibodies|mesh-list
44308496|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44308497|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
44308498|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308499|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44308500|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
44308501|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44308502|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
44308503|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308504|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727105|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44308570|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308571|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308572|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44308573|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
44308574|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
44308575|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308576|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44308577|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44308578|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44308579|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
44308580|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308581|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308582|NCT00876226|Citalopram|citalopram|mesh-list
44308583|NCT00876226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44308584|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44308585|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727161|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
44308615|NCT00876434|Sirolimus|sirolimus|mesh-list
44308616|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308617|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308618|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44308619|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308691|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308693|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
44308694|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44308730|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44308731|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
44308732|NCT00877110|Vincristine|vincristine|mesh-list
44308733|NCT00877110|Topotecan|topotecan|mesh-list
44128165|NCT00143338|Insulin|insulin|mesh-list
44308734|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308772|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
44308773|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44308845|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44308846|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44308847|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
44308848|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308849|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
44308850|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44308904|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44308905|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
44308906|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308907|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308908|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44308909|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44308910|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
44308911|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308912|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44308913|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44308914|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44308915|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44308916|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44308917|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44308918|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44308919|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44308978|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44308979|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308980|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308981|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44308982|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44308983|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44308984|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727371|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
44309015|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309016|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44309017|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44309018|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44309019|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44309020|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44309021|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309022|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309023|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309024|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309025|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44309026|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
44152520|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
43727405|NCT02583698|Carvedilol|carvedilol|mesh-list
44309056|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309058|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44309059|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44309060|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309061|NCT00878943|Urological Agents|urological agents|mesh-ancestor
44309062|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
44128221|NCT00143533|Irinotecan|irinotecan|mesh-list
44309063|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44309064|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309065|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309066|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44309067|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44309068|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309069|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309102|NCT00879099|Timolol|timolol|mesh-list
44309103|NCT00879099|Paroxetine|paroxetine|mesh-list
44309104|NCT00879099|Maleic acid|maleic acid|mesh-list
44309105|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44309106|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44309107|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
44309108|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727435|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44309139|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
44309140|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
44309141|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309142|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44309143|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44309144|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
44309145|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309146|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44309147|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309148|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309149|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309182|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309183|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309184|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309185|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309187|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
44309188|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309189|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309190|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466377|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
44466378|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44466379|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466380|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466381|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
44466382|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44466383|NCT01464424|Bimatoprost|bimatoprost|mesh-list
44309192|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44309193|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
44309194|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
44309223|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309225|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44309226|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309227|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44309228|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
44309229|NCT00880178|Vitamins|vitamins|mesh-ancestor
44309230|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
44309231|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309232|NCT00880243|Cytarabine|cytarabine|mesh-list
44309233|NCT00880243|Etoposide|etoposide|mesh-list
44309234|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
44309235|NCT00880243|Daunorubicin|daunorubicin|mesh-list
44309236|NCT00880243|Molgramostim|molgramostim|mesh-list
44309237|NCT00880243|Sargramostim|sargramostim|mesh-list
44309238|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309239|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309240|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44309241|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44309242|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727544|NCT02583217|Ketamine|ketamine|mesh-list
44236285|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236286|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
44236288|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810298|NCT04862377|Budesonide|budesonide|mesh-list
44309311|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44309312|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309379|NCT00880828|Acetaminophen|acetaminophen|mesh-list
44309411|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44309413|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44309414|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309415|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309416|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309417|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
44309418|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309419|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309420|NCT00881101|Paclitaxel|paclitaxel|mesh-list
44309421|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309422|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309423|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44309424|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44309425|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
44309542|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309543|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
44309544|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309545|NCT00881387|Antiviral Agents|antiviral agents|mesh-ancestor
44309546|NCT00881387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309547|NCT00881387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309548|NCT00881387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309549|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309550|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
43727712|NCT02582476|Bumetanide|bumetanide|mesh-list
44309588|NCT00881556|Lorazepam|lorazepam|mesh-list
44309589|NCT00881556|Tacrolimus|tacrolimus|mesh-list
44309590|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727728|NCT02582177|Clotrimazole|clotrimazole|mesh-list
44309620|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309621|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
44309622|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309623|NCT00881595|Temozolomide|temozolomide|mesh-list
44309624|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309625|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
44309626|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309627|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309628|NCT00881634|Cetirizine|cetirizine|mesh-list
44309629|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
44309630|NCT00881634|Ephedrine|ephedrine|mesh-list
44309631|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44309632|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44309633|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44309634|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
44309635|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
44309636|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727763|NCT02582203|Vancomycin|vancomycin|mesh-list
44466385|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44466386|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44466387|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44466388|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44466389|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44466390|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466391|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466392|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44309762|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44309763|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
44309764|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309765|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
44309766|NCT00882232|Protective Agents|protective agents|mesh-ancestor
44309767|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
44309768|NCT00882323|Fludarabine|fludarabine|mesh-list
44309769|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
43727809|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
44309863|NCT00882765|Protective Agents|protective agents|mesh-ancestor
44309864|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309865|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309866|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44309867|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309868|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309869|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
44309870|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44309871|NCT00882765|Estrogens|estrogens|mesh-ancestor
44309872|NCT00882765|Hormones|hormones|mesh-ancestor
44309873|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309874|NCT00882856|Bisoprolol|bisoprolol|mesh-list
44309875|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309876|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
44309877|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
43727857|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
44309910|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44309911|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309912|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309913|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309914|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309915|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44309916|NCT00883064|Protective Agents|protective agents|mesh-ancestor
44309917|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309918|NCT00883155|Bupropion|bupropion|mesh-list
44309919|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44309981|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
44309982|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309984|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44309985|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
44309986|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44309987|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309988|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44309989|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44309990|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44466403|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43833650|NCT05200052|Colchicine|colchicine|mesh-list
44310011|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310012|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
44310013|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310014|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310016|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44310017|NCT00883935|Dolutegravir|dolutegravir|mesh-list
44310018|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44310019|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44310020|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44310021|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310022|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310023|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44310024|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44310051|NCT00884416|Sorafenib|sorafenib|mesh-list
44310052|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310053|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310054|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310055|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310056|NCT00884442|Nifedipine|nifedipine|mesh-list
44310057|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44310058|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44310059|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128429|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44310060|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44310061|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310062|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310063|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
44310064|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44310065|NCT00884481|Natalizumab|natalizumab|mesh-list
44310066|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
44310067|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310068|NCT00884494|Insulin|insulin|mesh-list
44310069|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43727944|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44310106|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43727970|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
44310140|NCT00884767|Protective Agents|protective agents|mesh-ancestor
44310141|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
44310142|NCT00884767|Vitamins|vitamins|mesh-ancestor
44310143|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
44310144|NCT00884819|Fenofibrate|fenofibrate|mesh-list
44310145|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44310146|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
44310147|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310148|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44310149|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44310179|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44310180|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44310181|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44310182|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
44310183|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44310184|NCT00885066|Gemcitabine|gemcitabine|mesh-list
44310185|NCT00885066|Capecitabine|capecitabine|mesh-list
44310186|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44310187|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44310188|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
44310189|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310190|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310191|NCT00885066|Antiviral Agents|antiviral agents|mesh-ancestor
44310192|NCT00885066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310193|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310223|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
44310224|NCT00885326|Bevacizumab|bevacizumab|mesh-list
44310225|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310226|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
44310227|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310228|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44310229|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44310230|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
44128430|NCT00144183|Zidovudine|zidovudine|mesh-list
44310231|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310232|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310233|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44310234|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44310235|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310236|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310237|NCT00885326|Growth Substances|growth substances|mesh-ancestor
44310238|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310239|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44310240|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44310241|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
44310242|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44310243|NCT00885443|Propofol|propofol|mesh-list
44310373|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44310374|NCT00886028|Cisplatin|cisplatin|mesh-list
44310375|NCT00886028|Doxorubicin|doxorubicin|mesh-list
44310376|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44310377|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310378|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44310379|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44310380|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310381|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310382|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310383|NCT00886106|Midazolam|midazolam|mesh-list
44310384|NCT00886106|Remifentanil|remifentanil|mesh-list
44310385|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44310386|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44310387|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310388|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310389|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44310390|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310391|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310392|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44310393|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
44310394|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
44310395|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
44310396|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
44310397|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310433|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44310434|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
44310435|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
44310501|NCT00886574|Protective Agents|protective agents|mesh-ancestor
44310502|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44310503|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44310504|NCT00886678|Carboplatin|carboplatin|mesh-list
44310505|NCT00886678|Pemetrexed|pemetrexed|mesh-list
44310506|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310507|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310508|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236289|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44310509|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44310510|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44310511|NCT00886717|Paclitaxel|paclitaxel|mesh-list
44310512|NCT00886717|Carboplatin|carboplatin|mesh-list
44310513|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44310514|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310515|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
43847533|NCT04094688|Vitamin D|vitamin d|mesh-list
44310544|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
44310545|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310546|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44310547|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44310548|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44310549|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310550|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310551|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310552|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310553|NCT00886990|Ritonavir|ritonavir|mesh-list
44310554|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44310555|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44310556|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
44310557|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128474|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44310558|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728134|NCT02578823|Antipyretics|antipyretics|mesh-list
44310693|NCT00887627|Conivaptan|conivaptan|mesh-list
44310694|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44310695|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310696|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
44310697|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466434|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44466435|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
44466436|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466437|NCT01463098|Zolpidem|zolpidem|mesh-list
44310820|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44310821|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44310822|NCT00888797|Analgesics|analgesics|mesh-ancestor
44310823|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
44310824|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310825|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310826|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44310827|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44310828|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44310829|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310858|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
44310859|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310860|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310861|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310862|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
44310863|NCT00888901|Hormones|hormones|mesh-ancestor
44310864|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310865|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44310866|NCT00888901|Protective Agents|protective agents|mesh-ancestor
44310867|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310868|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310869|NCT00889018|Carboplatin|carboplatin|mesh-list
44310870|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310871|NCT00889044|Clopidogrel|clopidogrel|mesh-list
44310872|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44310873|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44310874|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44310875|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44310909|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44310910|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310911|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310912|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
44310913|NCT00889161|Curcumin|curcumin|mesh-list
44310914|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43728297|NCT02577783|Dexamethasone|dexamethasone|mesh-list
44310947|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
44310948|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310949|NCT00889356|Clindamycin|clindamycin|mesh-list
44310950|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
44310951|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
44310952|NCT00889356|Amphotericin B|amphotericin b|mesh-list
44310953|NCT00889356|Tetracycline|tetracycline|mesh-list
44310954|NCT00889356|Ketoconazole|ketoconazole|mesh-list
44310955|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44310956|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310957|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310958|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44310959|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466484|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44466485|NCT01462695|Growth Substances|growth substances|mesh-ancestor
44466520|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44128545|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466521|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44311013|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
44311014|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311015|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311016|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44311090|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311092|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44311124|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311125|NCT00890188|Growth Substances|growth substances|mesh-ancestor
44311126|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311127|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311128|NCT00890214|Epoprostenol|epoprostenol|mesh-list
44311129|NCT00890214|Heparin|heparin|mesh-list
44311130|NCT00890214|Calcium heparin|calcium heparin|mesh-list
44311131|NCT00890214|Tezosentan|tezosentan|mesh-list
44311132|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
44311133|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44311134|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44311135|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311136|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311167|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44311168|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
44311169|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311170|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311171|NCT00890318|Ketoconazole|ketoconazole|mesh-list
44311172|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
44311173|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311174|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44311175|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44311176|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311177|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311178|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44311179|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
44311214|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311215|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311216|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44311217|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44311218|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
44311219|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44311220|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44311251|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311252|NCT00890643|Prazosin|prazosin|mesh-list
44311253|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311254|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44311255|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44311256|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44311257|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
44311258|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311259|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311260|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311261|NCT00890708|Voriconazole|voriconazole|mesh-list
44311262|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
44311263|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728515|NCT02576600|Narcotics|narcotics|mesh-ancestor
44311294|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44311295|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311296|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128610|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
44311297|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44311298|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
44311299|NCT00890942|Naloxone|naloxone|mesh-list
44311300|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44311301|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311302|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
44152554|NCT00217386|Etanercept|etanercept|mesh-list
44311303|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311335|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44311336|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
44311337|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311338|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44311339|NCT00891072|Protective Agents|protective agents|mesh-ancestor
44311340|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44311341|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
44311342|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44311343|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44311344|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44311345|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44311346|NCT00891150|Oxytocin|oxytocin|mesh-list
44311347|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
43728603|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
44311419|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311420|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311422|NCT00891397|Analgesics|analgesics|mesh-ancestor
44311423|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
43728664|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
44466542|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466543|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
44466544|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311522|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311523|NCT00891761|Dexamethasone|dexamethasone|mesh-list
44311524|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
44311525|NCT00891761|Ondansetron|ondansetron|mesh-list
44311526|NCT00891761|Casopitant|casopitant|mesh-list
44311527|NCT00891761|BB 1101|bb 1101|mesh-list
44311528|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311529|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
44311530|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
44311531|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311532|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311533|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311534|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
44311535|NCT00891761|Hormones|hormones|mesh-ancestor
44311536|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311537|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311538|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311742|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311743|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311744|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
44311745|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311746|NCT00892827|Rituximab|rituximab|mesh-list
44311747|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44311748|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311749|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
44311750|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311751|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311752|NCT00892892|Nitrendipine|nitrendipine|mesh-list
44311788|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311789|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
44311790|NCT00892996|Hormones|hormones|mesh-ancestor
44311791|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311828|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466551|NCT01462318|Omeprazole|omeprazole|mesh-list
44311884|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311885|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311886|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311887|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311888|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
44311889|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44311890|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311891|NCT00893412|Tramadol|tramadol|mesh-list
43728940|NCT02574663|Leucovorin|leucovorin|mesh-list
44312085|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312086|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312087|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312088|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312089|NCT00894010|Carbamazepine|carbamazepine|mesh-list
44312090|NCT00894010|Levetiracetam|levetiracetam|mesh-list
44312091|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
44312092|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
44312093|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
44312094|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44236290|NCT00558181|Protective Agents|protective agents|mesh-ancestor
44312095|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312096|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312097|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44312098|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312100|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
44312101|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312102|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44312103|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729045|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312134|NCT00894283|Fondaparinux|fondaparinux|mesh-list
44312135|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
44312136|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312137|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312138|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312139|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44312140|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
44312141|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44312142|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
44312143|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312144|NCT00894374|Artesunate|artesunate|mesh-list
44312145|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
44312146|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44312216|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
44312217|NCT00894751|Propofol|propofol|mesh-list
44312218|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44312219|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312220|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312221|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44312222|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
44312223|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
44312224|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312225|NCT00894751|Analgesics|analgesics|mesh-ancestor
44312226|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
44312227|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312228|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44312257|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312258|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466553|NCT01462318|Daclizumab|daclizumab|mesh-list
44466554|NCT01462318|Vitamins|vitamins|mesh-ancestor
44466555|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
44312259|NCT00894998|Heparin|heparin|mesh-list
44312260|NCT00894998|Calcium heparin|calcium heparin|mesh-list
44312261|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
44312262|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312263|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312264|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312265|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
44312266|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44312267|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44312268|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312269|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
44312270|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312271|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312272|NCT00895076|Dexamethasone|dexamethasone|mesh-list
44312273|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312274|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
44312275|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
44312310|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312311|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312312|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312313|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312347|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
44312348|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312349|NCT00895557|Varenicline|varenicline|mesh-list
44312350|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44312351|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44312352|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
44312353|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312354|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312355|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312417|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312418|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426848|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44312420|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44312421|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44312422|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44312423|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312424|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312425|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312426|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44312427|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44312428|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
44312429|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
44312430|NCT00895882|Interferons|interferons|mesh-list
44312431|NCT00895882|Ribavirin|ribavirin|mesh-list
44312432|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312467|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44312469|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
44312470|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
44312502|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44312503|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312505|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
44312506|NCT00896519|Rituximab|rituximab|mesh-list
44312507|NCT00896519|Doxorubicin|doxorubicin|mesh-list
44312508|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44312509|NCT00896519|Vincristine|vincristine|mesh-list
44312510|NCT00896519|Sargramostim|sargramostim|mesh-list
44312511|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312512|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
44312513|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312514|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312515|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312516|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
44312543|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
44312544|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
44312545|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
44312546|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
44312547|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312548|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312549|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44155135|NCT00226200|Omalizumab|omalizumab|mesh-list
44312550|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44312551|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44312552|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44312553|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
44312554|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44312555|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312556|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44312557|NCT00896571|Estrogens|estrogens|mesh-ancestor
44312558|NCT00896571|Hormones|hormones|mesh-ancestor
44312559|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312560|NCT00896714|Anesthetics|anesthetics|mesh-list
44312561|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312562|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466579|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
44466580|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44466581|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312579|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44312580|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312611|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44312612|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312613|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44312614|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44312615|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312616|NCT00897065|Antibodies|antibodies|mesh-list
44312617|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
44312618|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312619|NCT00897130|Azacitidine|azacitidine|mesh-list
44312620|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44312621|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
44312622|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312623|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312656|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
44312657|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312658|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
44312659|NCT00897871|Carboplatin|carboplatin|mesh-list
44312660|NCT00897871|Etoposide|etoposide|mesh-list
44312661|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
44312662|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312663|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
44094297|NCT02544815|Digoxin|digoxin|mesh-list
44312664|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312665|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312666|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312667|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
44312668|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312669|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312692|NCT00898287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312693|NCT00898287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312694|NCT00898287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312695|NCT00898287|Immunologic Factors|immunologic factors|mesh-ancestor
44312696|NCT00898287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312697|NCT00898417|Paclitaxel|paclitaxel|mesh-list
44312698|NCT00898417|Bevacizumab|bevacizumab|mesh-list
44312699|NCT00898417|Carboplatin|carboplatin|mesh-list
44312700|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312701|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312702|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312703|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312704|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312705|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312706|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312707|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44128806|NCT05589753|Diuretics|diuretics|mesh-ancestor
44312708|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44312709|NCT00898417|Growth Substances|growth substances|mesh-ancestor
44312710|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312711|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
44312712|NCT00898508|Antibodies|antibodies|mesh-list
44312713|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
44312714|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312715|NCT00898534|Chrysarobin|chrysarobin|mesh-list
44312716|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312717|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312718|NCT00898534|Analgesics|analgesics|mesh-ancestor
44312719|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
44312720|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466639|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44466640|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466641|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466642|NCT01461096|Vaccines|vaccines|mesh-list
44466643|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
44466644|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466645|NCT01461057|Cisplatin|cisplatin|mesh-list
44466646|NCT01461057|Capecitabine|capecitabine|mesh-list
44466674|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44466675|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44466676|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44466677|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466678|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466679|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466680|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44466681|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
44466682|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44466683|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44466684|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466685|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312730|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312731|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312732|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44312733|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44312763|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44312764|NCT00899197|Tamoxifen|tamoxifen|mesh-list
44312765|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44312766|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
44312767|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312768|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312769|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312770|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312771|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44312772|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44312773|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44312774|NCT00899483|Insulin|insulin|mesh-list
44236291|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312775|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44312776|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312777|NCT00899587|Enalapril|enalapril|mesh-list
44312778|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44312808|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
44312810|NCT00900172|Paclitaxel|paclitaxel|mesh-list
44312811|NCT00900172|Bevacizumab|bevacizumab|mesh-list
44312812|NCT00900172|Carboplatin|carboplatin|mesh-list
44312813|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312814|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312815|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312816|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312817|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312818|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312819|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312820|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44312821|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44312822|NCT00900172|Growth Substances|growth substances|mesh-ancestor
44312823|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312824|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44312825|NCT00900445|Prednisone|prednisone|mesh-list
44312861|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312863|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44312864|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
44312892|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312893|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312894|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44312895|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
44312896|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44312897|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44312898|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44312899|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44312900|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312901|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312902|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
43729531|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312932|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
44312933|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312934|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312935|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312936|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
44312937|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312938|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312939|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44312940|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312941|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312942|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312943|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312944|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312945|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44312946|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
43729621|NCT02570477|Vancomycin|vancomycin|mesh-list
44313077|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
44313078|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313079|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
44313080|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313082|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
44313083|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44313084|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313085|NCT00901823|Diazoxide|diazoxide|mesh-list
44313086|NCT00901823|Choline|choline|mesh-list
44313087|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
44313088|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44313089|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
44313090|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313091|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313092|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44313093|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
44313094|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313095|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313096|NCT00901849|Sirolimus|sirolimus|mesh-list
44313097|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44236292|NCT00558298|Risperidone|risperidone|mesh-list
44236293|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44236294|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
44236295|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236296|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236297|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236298|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44236299|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44236300|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44236301|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44236302|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44236303|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
44236304|NCT00558337|Levodopa|levodopa|mesh-list
44236305|NCT00558337|Carbidopa|carbidopa|mesh-list
44313098|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313099|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967923|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
44313154|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44313155|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313156|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313157|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313158|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313159|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313160|NCT00902187|Urological Agents|urological agents|mesh-ancestor
44313161|NCT00902395|Midazolam|midazolam|mesh-list
44313162|NCT00902395|Ketamine|ketamine|mesh-list
44313163|NCT00902395|Analgesics|analgesics|mesh-ancestor
44313164|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
44313165|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313166|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313167|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44313168|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44313169|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
44313170|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
44313171|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313172|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44313173|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44313174|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313175|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313176|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44313177|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44466704|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44466705|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44466707|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466708|NCT01460342|Urological Agents|urological agents|mesh-ancestor
44466709|NCT01460290|Asenapine|asenapine|mesh-list
44313331|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313332|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44313333|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
44313334|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44313335|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313336|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44313337|NCT00902967|Atorvastatin|atorvastatin|mesh-list
44313338|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44313339|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44313399|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44313400|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44313402|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313403|NCT00903214|Riluzole|riluzole|mesh-list
44313404|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
44313405|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44152622|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
44313406|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44313407|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313408|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313409|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313410|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44313411|NCT00903214|Protective Agents|protective agents|mesh-ancestor
44313412|NCT00903227|Fluticasone|fluticasone|mesh-list
44313413|NCT00903227|Xhance|xhance|mesh-list
44313414|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313415|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44313416|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
44313417|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313418|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313419|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44313420|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
43968266|NCT01607411|Fluorides|fluorides|mesh-list
44313421|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313486|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313487|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
44313488|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313489|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968319|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
44313490|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313491|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313492|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313493|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313494|NCT00903942|Paclitaxel|paclitaxel|mesh-list
44313495|NCT00903942|Carboplatin|carboplatin|mesh-list
44313496|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44313497|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44313498|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313499|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
44313500|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44313501|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
43729916|NCT02568488|Metformin|metformin|mesh-list
44313523|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313524|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313525|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313526|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313527|NCT00904059|Asunaprevir|asunaprevir|mesh-list
44313528|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
44313529|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313530|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313531|NCT00904085|Oxymorphone|oxymorphone|mesh-list
44313532|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44313533|NCT00904085|Narcotics|narcotics|mesh-ancestor
44313534|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313535|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313536|NCT00904085|Analgesics|analgesics|mesh-ancestor
44313537|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
44313538|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313539|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44313540|NCT00904098|Frovatriptan|frovatriptan|mesh-list
44313541|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44313542|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
44313543|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313544|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313545|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313546|NCT00904111|Lidocaine|lidocaine|mesh-list
44313547|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313548|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
44313549|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313550|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313551|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
43833899|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
44313608|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44313609|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
44313610|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
44313611|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466747|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44466748|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
44466749|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44426849|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
44236306|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44236307|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43889561|NCT04417088|Carboplatin|carboplatin|mesh-list
44236308|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44236309|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
44236310|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236311|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236312|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236313|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44236314|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236315|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44236316|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
44236317|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
44236318|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44236319|NCT00558376|Laxatives|laxatives|mesh-ancestor
44236320|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236321|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
44466750|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466751|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466752|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466753|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466754|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466755|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44313662|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313663|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313664|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313698|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44313699|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44313700|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313701|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313779|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
44313781|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44313782|NCT00905047|Leucovorin|leucovorin|mesh-list
44313783|NCT00905047|Folic Acid|folic acid|mesh-list
44313784|NCT00905047|Tegafur|tegafur|mesh-list
44313785|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
44313786|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313787|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
44313788|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313789|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313790|NCT00905047|Antidotes|antidotes|mesh-ancestor
44313791|NCT00905047|Protective Agents|protective agents|mesh-ancestor
44313792|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313793|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
44313794|NCT00905047|Vitamins|vitamins|mesh-ancestor
44313795|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
44313796|NCT00905047|Hematinics|hematinics|mesh-ancestor
44313797|NCT00905073|Cyclosporine|cyclosporine|mesh-list
44313798|NCT00905073|Methotrexate|methotrexate|mesh-list
44313799|NCT00905073|Cyclosporins|cyclosporins|mesh-list
44313800|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44313801|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
44313802|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44313803|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313804|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313805|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
43730109|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44313842|NCT00905229|Vitamin K|vitamin k|mesh-list
44313843|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
44236323|NCT00558480|Vitamins|vitamins|mesh-list
44236324|NCT00558480|Vitamin A|vitamin a|mesh-list
44236325|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
44313844|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
44313845|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313901|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44313902|NCT00905814|Axitinib|axitinib|mesh-list
44313903|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313904|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313905|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313906|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313907|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44313909|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313910|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44313911|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313912|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313913|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313914|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44313915|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44313916|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313917|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44313918|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44313919|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44313920|NCT00905905|Simvastatin|simvastatin|mesh-list
44313921|NCT00905905|Ezetimibe|ezetimibe|mesh-list
44313922|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44313957|NCT00905983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313958|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
44313959|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
44313960|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
44313962|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44314041|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44314042|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44314043|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44314044|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44314045|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
44314046|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
44314047|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314048|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314049|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
44466808|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
44466809|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
44466810|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44466811|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44466812|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466813|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466814|NCT01458366|Carboplatin|carboplatin|mesh-list
44466815|NCT01458366|Etoposide|etoposide|mesh-list
44466816|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
44466817|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44466818|NCT01458366|Ofatumumab|ofatumumab|mesh-list
44466819|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314088|NCT00906451|Simvastatin|simvastatin|mesh-list
44314089|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44314090|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44314150|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314151|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44314152|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44314153|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44314154|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314155|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44314156|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314157|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314158|NCT00907036|Cyclosporine|cyclosporine|mesh-list
44314159|NCT00907036|Fludarabine|fludarabine|mesh-list
44314160|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
44314161|NCT00907036|Melphalan|melphalan|mesh-list
44314162|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
44314197|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314198|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314199|NCT00907166|Antiviral Agents|antiviral agents|mesh-ancestor
44314200|NCT00907166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236326|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
44236327|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236328|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
44236329|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314201|NCT00907166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314202|NCT00907166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314230|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44314231|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314232|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314233|NCT00907452|Thalidomide|thalidomide|mesh-list
44314234|NCT00907452|Dexamethasone|dexamethasone|mesh-list
44314235|NCT00907452|Prednisone|prednisone|mesh-list
44314236|NCT00907452|Lenalidomide|lenalidomide|mesh-list
44314237|NCT00907452|Melphalan|melphalan|mesh-list
44314238|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314239|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
44314241|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314242|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314243|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314244|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
44314245|NCT00907452|Hormones|hormones|mesh-ancestor
44314246|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314247|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314248|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314249|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
44314250|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314251|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314266|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
44314267|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314268|NCT00907504|Antiviral Agents|antiviral agents|mesh-ancestor
44314269|NCT00907504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314270|NCT00907504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314271|NCT00907504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314272|NCT00907504|Immunologic Factors|immunologic factors|mesh-ancestor
44314273|NCT00907504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314274|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
44314275|NCT00907608|Hematinics|hematinics|mesh-ancestor
44314276|NCT00907751|Rituximab|rituximab|mesh-list
44314277|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129175|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
44314278|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314279|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
44314280|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314281|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314282|NCT00907764|Regadenoson|regadenoson|mesh-list
44314283|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44314284|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44314285|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
44314286|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
44314287|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314288|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314289|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314290|NCT00907829|Lidocaine|lidocaine|mesh-list
44314291|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
44314292|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
44314293|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314294|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314295|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
44314296|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314297|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44314298|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44314299|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44314300|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44314301|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314302|NCT00907894|Telbivudine|telbivudine|mesh-list
44314303|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
44314304|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314305|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44314306|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314307|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314308|NCT00907972|Vitamin D|vitamin d|mesh-list
44236330|NCT00558480|Protective Agents|protective agents|mesh-ancestor
44236331|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44236332|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314310|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
44314311|NCT00907972|Vitamins|vitamins|mesh-list
44314345|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314346|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314348|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314349|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
44314380|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44314381|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44314382|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
44314383|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44314384|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44314385|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314386|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969244|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
44314387|NCT00908167|Cytarabine|cytarabine|mesh-list
44314389|NCT00908167|Sorafenib|sorafenib|mesh-list
44314390|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314391|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
44314392|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314393|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314394|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
44314395|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314396|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314428|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466820|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44466821|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44466822|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466824|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466825|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44466826|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
44466827|NCT01458275|Ciclesonide|ciclesonide|mesh-list
44466828|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
44466829|NCT01458275|Hormones|hormones|mesh-ancestor
44129229|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44129260|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
44466830|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466831|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314433|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314434|NCT00908219|Growth Substances|growth substances|mesh-ancestor
44314435|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314436|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314437|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
44314438|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44314439|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314440|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314441|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314442|NCT00908297|Ubiquinone|ubiquinone|mesh-list
44314443|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
44314444|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
44314445|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314446|NCT00908297|Vitamins|vitamins|mesh-ancestor
44314447|NCT00908323|Vaccines|vaccines|mesh-list
44314448|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
44314449|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314450|NCT00908336|Docetaxel|docetaxel|mesh-list
44314451|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44314452|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314453|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
44314454|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
44314455|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
44314510|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314511|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44314513|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44314514|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
44314515|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44314516|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44314517|NCT00908713|Prednisolone|prednisolone|mesh-list
44314518|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
44314519|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44314520|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
44314521|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236333|NCT00558493|Clevudine|clevudine|mesh-list
44314522|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
44314523|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
44314524|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314525|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314526|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314527|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
44314528|NCT00908713|Hormones|hormones|mesh-ancestor
44314529|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314530|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44314531|NCT00908713|Protective Agents|protective agents|mesh-ancestor
44314532|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314533|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314534|NCT00908726|Propofol|propofol|mesh-list
44314535|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44314536|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314537|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314538|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44314539|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
44314540|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
44314570|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
44314571|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314572|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314573|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44314574|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
44314575|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314576|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44314577|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
44314578|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
44314579|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
44314580|NCT00908921|Glimepiride|glimepiride|mesh-list
44314581|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44314582|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314583|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314584|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314585|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
44314586|NCT00908986|Rituximab|rituximab|mesh-list
43730529|NCT02563782|Tacrolimus|tacrolimus|mesh-list
44314615|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314616|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314617|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314618|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314619|NCT00909129|Interferons|interferons|mesh-list
44314620|NCT00909129|Ribavirin|ribavirin|mesh-list
44314621|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
44314622|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44314623|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314624|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
44314625|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314626|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
44314627|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314628|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
44314629|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314630|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
44314631|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44314632|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314633|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
43730551|NCT02563795|Narcotics|narcotics|mesh-ancestor
44314683|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314684|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314686|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314687|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
44314688|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44314689|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314690|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314691|NCT00909519|Diuretics|diuretics|mesh-ancestor
44314692|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
44314693|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44314694|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44314695|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44314696|NCT00909571|Tacrolimus|tacrolimus|mesh-list
44314697|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314698|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
44314699|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314700|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44236334|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
44236335|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236336|NCT00558506|Abatacept|abatacept|mesh-list
44094860|NCT00039429|Atrasentan|atrasentan|mesh-list
44314701|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314702|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314703|NCT00909688|BLI-489|bli-489|mesh-list
44314704|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44314805|NCT00910221|Atorvastatin|atorvastatin|mesh-list
44314806|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44314807|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44314808|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
44314809|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314810|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44314811|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44314812|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466854|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44466855|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44466856|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
44466857|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466858|NCT01458106|Factor VIII|factor viii|mesh-list
44466859|NCT01458106|Coagulants|coagulants|mesh-ancestor
44466860|NCT01457950|Denosumab|denosumab|mesh-list
44466861|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44466862|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466863|NCT01457924|Ofatumumab|ofatumumab|mesh-list
44466864|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44466896|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466897|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466898|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
44466899|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466900|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
44466901|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466902|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44466903|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466904|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314827|NCT00910390|Growth Substances|growth substances|mesh-ancestor
44314828|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314829|NCT00910416|Remifentanil|remifentanil|mesh-list
44314830|NCT00910416|Propofol|propofol|mesh-list
44314831|NCT00910416|Sevoflurane|sevoflurane|mesh-list
44314832|NCT00910416|Atracurium|atracurium|mesh-list
44314833|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44314834|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314835|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314836|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44314837|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
44314838|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
44314839|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44314840|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44314841|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44314842|NCT00910416|Narcotics|narcotics|mesh-ancestor
44314843|NCT00910416|Analgesics|analgesics|mesh-ancestor
44314844|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
44314845|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314846|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44314847|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44314848|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44314881|NCT00910637|Gestodene|gestodene|mesh-list
44314882|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44314883|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44314884|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44314885|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
44314886|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44314887|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969794|NCT01661621|Urological Agents|urological agents|mesh-ancestor
44314888|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44314889|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44314890|NCT00910637|Progestins|progestins|mesh-ancestor
44315011|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315013|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315014|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
44315015|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236337|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44315016|NCT00911235|Fluconazole|fluconazole|mesh-list
44315017|NCT00911235|Fesoterodine|fesoterodine|mesh-list
44315018|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
44315019|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315020|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44315021|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43730762|NCT02562664|Metformin|metformin|mesh-list
44315049|NCT00911287|Analgesics|analgesics|mesh-ancestor
44315050|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
44315051|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315052|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44315053|NCT00911313|Metformin|metformin|mesh-list
44315054|NCT00911313|Letrozole|letrozole|mesh-list
44315055|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44315056|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315057|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315058|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44315059|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44315060|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315061|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315062|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44315063|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
44315064|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315065|NCT00911339|Atorvastatin|atorvastatin|mesh-list
43730783|NCT02562300|Misoprostol|misoprostol|mesh-list
44315134|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315136|NCT00912119|Coagulants|coagulants|mesh-ancestor
44315137|NCT00912145|Alprazolam|alprazolam|mesh-list
44315138|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44315139|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315140|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315141|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44315142|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315143|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315144|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
44315145|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
44315146|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315147|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315148|NCT00912171|Budesonide|budesonide|mesh-list
44315149|NCT00912171|Montelukast|montelukast|mesh-list
44315150|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315151|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315152|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
44315153|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315154|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315155|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315156|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315157|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
44315158|NCT00912171|Hormones|hormones|mesh-ancestor
44315159|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315160|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44315161|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
44315162|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44315163|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44315164|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315165|NCT00912262|Capsaicin|capsaicin|mesh-list
44315166|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
44315167|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
44315168|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
44315169|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315170|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315171|NCT00912275|Vinorelbine|vinorelbine|mesh-list
44315172|NCT00912275|Lapatinib|lapatinib|mesh-list
44315173|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44315174|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315175|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315176|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44315177|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44315178|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315207|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
44315208|NCT00912444|Docetaxel|docetaxel|mesh-list
44315209|NCT00912444|Doxorubicin|doxorubicin|mesh-list
44315210|NCT00912444|Epirubicin|epirubicin|mesh-list
44315211|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236338|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236339|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315212|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
44315213|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315214|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315215|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44315216|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
44315217|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315218|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315255|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730924|NCT02561468|Analgesics|analgesics|mesh-ancestor
44315290|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
44315291|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315292|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315293|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315294|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315295|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44315427|NCT00913341|Alprazolam|alprazolam|mesh-list
44315428|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44315429|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315430|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315431|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44315432|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315433|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315434|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
44315435|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
44315436|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155283|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315437|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315438|NCT00913367|Insulin|insulin|mesh-list
44315439|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44315440|NCT00913367|Metformin|metformin|mesh-list
44315441|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
44315442|NCT00913367|Glimepiride|glimepiride|mesh-list
44315443|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44315444|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315445|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44315446|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315477|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44315478|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315479|NCT00913549|Clemastine|clemastine|mesh-list
44315480|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
44315481|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
44315482|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44315483|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
44315484|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
44315485|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315486|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315487|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315488|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44315489|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43731043|NCT02560155|Mupirocin|mupirocin|mesh-list
44315583|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315584|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315585|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315586|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315587|NCT00913848|Valproic Acid|valproic acid|mesh-list
44315588|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
44315589|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315590|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315591|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
44315592|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315593|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315594|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
44315595|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315596|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315597|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315598|NCT00913861|Fentanyl|fentanyl|mesh-list
44315599|NCT00913861|Propofol|propofol|mesh-list
44315600|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44315601|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315602|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315603|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44095079|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
44315604|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
44315954|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315955|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315956|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44315957|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44315958|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315960|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315961|NCT00915408|Dexamethasone|dexamethasone|mesh-list
44315962|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
44315963|NCT00915408|Lenalidomide|lenalidomide|mesh-list
44315964|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315965|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
44315966|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315967|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315968|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44315969|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
44315970|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315971|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316056|NCT00915733|Clopidogrel|clopidogrel|mesh-list
44316057|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44316058|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44316059|NCT00915733|Analgesics|analgesics|mesh-ancestor
44316060|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
44316061|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316062|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316064|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316065|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44129526|NCT04341181|Trastuzumab|trastuzumab|mesh-list
44316066|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44316067|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316068|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44316069|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44316070|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316120|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316121|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
44316122|NCT00915837|Hormones|hormones|mesh-ancestor
44316123|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316124|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316125|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316126|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
44316127|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316128|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316129|NCT00915850|Cisplatin|cisplatin|mesh-list
44316130|NCT00915850|Docetaxel|docetaxel|mesh-list
44316131|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316132|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316133|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316134|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
43970989|NCT01707420|Gabapentin|gabapentin|mesh-list
44316135|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316199|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
44316200|NCT00916123|Hormones|hormones|mesh-ancestor
44316201|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316202|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316203|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316204|NCT00916201|Cannabidiol|cannabidiol|mesh-list
44316205|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
44316206|NCT00916253|Modafinil|modafinil|mesh-list
44316207|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44316208|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316209|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44316210|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44316211|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44316212|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316213|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44466990|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466991|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
44466992|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44466993|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467030|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467031|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834034|NCT05169008|Vaccines|vaccines|mesh-list
44316411|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236340|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236341|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
44236342|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236343|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316412|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
44316413|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834068|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
44316518|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316519|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44316520|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
44316521|NCT00918190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44316522|NCT00918307|Varenicline|varenicline|mesh-list
44316523|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44316524|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44316525|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
44316526|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316527|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316528|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316529|NCT00918320|Temozolomide|temozolomide|mesh-list
44316530|NCT00918320|Topotecan|topotecan|mesh-list
43731542|NCT02557087|Meperidine|meperidine|mesh-list
44129599|NCT04168112|Hormones|hormones|mesh-ancestor
44316560|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316561|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316562|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44316563|NCT00918489|Vorinostat|vorinostat|mesh-list
44316564|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316565|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44316566|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316567|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316568|NCT00918528|Mitomycins|mitomycins|mesh-list
44316569|NCT00918528|Mitomycin|mitomycin|mesh-list
44316570|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44316571|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316606|NCT00919022|Cyproterone|cyproterone|mesh-list
44316607|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
44316608|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44316609|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316610|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316611|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316666|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316667|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316668|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316669|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44316670|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316671|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316672|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44316673|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44316674|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44316675|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
44316676|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44316677|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44316678|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
44316679|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44316680|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44316809|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
44316810|NCT00920088|Midazolam|midazolam|mesh-list
44316811|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
44316812|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44316813|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44316814|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316815|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316816|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44316817|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316818|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316819|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44316820|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
44316821|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
44316822|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
44316823|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
44316824|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316825|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316826|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44316827|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44316828|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316829|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316830|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316831|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316832|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
44316833|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316834|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44316835|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44316836|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
44316837|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
44316986|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
44316987|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316988|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316989|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316990|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
44316991|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316992|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316993|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316994|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316995|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44316996|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317033|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317034|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317035|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
44317106|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317107|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
44317108|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317109|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
44317110|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317111|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44467103|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467104|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44467105|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467106|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467107|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44467108|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44467109|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44467141|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467142|NCT01453595|Dactolisib|dactolisib|mesh-list
44467143|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467144|NCT01453374|Naltrexone|naltrexone|mesh-list
44467145|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44317131|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
44317132|NCT05674201|Remifentanil|remifentanil|mesh-list
44317133|NCT05674201|Propofol|propofol|mesh-list
44317134|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44317135|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317136|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317161|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44317162|NCT05673928|Maytansine|maytansine|mesh-list
44317163|NCT05673928|Tucatinib|tucatinib|mesh-list
44317164|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317165|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317166|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44317167|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317168|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317169|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44317170|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317171|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317172|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317173|NCT05673889|Dabigatran|dabigatran|mesh-list
44317174|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
44317175|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44317176|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
44129674|NCT03879122|Docetaxel|docetaxel|mesh-list
44317177|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317178|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317179|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
44317180|NCT05673811|Gemcitabine|gemcitabine|mesh-list
44317181|NCT05673811|Paclitaxel|paclitaxel|mesh-list
44317182|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44317183|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095236|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317184|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317185|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317186|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
44317187|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317188|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317250|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44317251|NCT05659290|Growth Substances|growth substances|mesh-ancestor
44317252|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317253|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
44317254|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317255|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
44317256|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317258|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44317259|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44317260|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317261|NCT05656599|Letermovir|letermovir|mesh-list
44317262|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44317263|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317264|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317265|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317266|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
44317267|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317268|NCT05647122|Osimertinib|osimertinib|mesh-list
44317269|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317270|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317271|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467158|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972216|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
44317288|NCT05615623|Doxorubicin|doxorubicin|mesh-list
44317289|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44317290|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317291|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44317292|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317293|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317294|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317295|NCT05601674|Anesthetics|anesthetics|mesh-list
44317296|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317297|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317298|NCT05601531|Calcitriol|calcitriol|mesh-list
44317299|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44317300|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317301|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43731940|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
44317337|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317338|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
44317339|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317340|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317341|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44317342|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44317343|NCT05551897|Itraconazole|itraconazole|mesh-list
44317406|NCT05518877|Ketamine|ketamine|mesh-list
44317407|NCT05518877|Analgesics|analgesics|mesh-ancestor
44317408|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
44317409|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317410|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317411|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44317412|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44317413|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
44317437|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
44317438|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317440|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317441|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317442|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
44317443|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317444|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44317445|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44317446|NCT05472779|Estradiol|estradiol|mesh-list
44317447|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44317448|NCT05472779|Estrogens|estrogens|mesh-ancestor
44317449|NCT05472779|Hormones|hormones|mesh-ancestor
44317450|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317451|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317452|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44317453|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
44317454|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317455|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44317456|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
44317457|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317458|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317459|NCT05465941|Irinotecan|irinotecan|mesh-list
44317460|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44317461|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317462|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317463|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317492|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
44317493|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
44317494|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317495|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317496|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
44317497|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317498|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
44317499|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44317500|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
44317501|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317502|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317503|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44317504|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44317505|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44317506|NCT05443971|Durvalumab|durvalumab|mesh-list
44317507|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
44317508|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317526|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317527|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317528|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317529|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44317530|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44317531|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317532|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317534|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
44317535|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467159|NCT01453153|Gemcitabine|gemcitabine|mesh-list
44467160|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467161|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
44467162|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467163|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467164|NCT01453153|Antiviral Agents|antiviral agents|mesh-ancestor
44467165|NCT01453153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467166|NCT01453153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467167|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129855|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467168|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
44467169|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467170|NCT01453140|Sirolimus|sirolimus|mesh-list
44467171|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
44467172|NCT01453140|Interleukin-2|interleukin-2|mesh-list
44467173|NCT01453140|Azacitidine|azacitidine|mesh-list
44467174|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467175|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
44467176|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467177|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467178|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44467179|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
44467180|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467181|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467182|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44467183|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467184|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467185|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467186|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
44467187|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44467188|NCT01453140|Analgesics|analgesics|mesh-ancestor
44467189|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
44467190|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317567|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317568|NCT05393271|Midazolam|midazolam|mesh-list
44317569|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44317570|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612242|NCT03167177|Fluorouracil|fluorouracil|mesh-list
44458812|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458813|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44458814|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
44458815|NCT01589822|Coagulants|coagulants|mesh-ancestor
44458816|NCT01589653|Insulin|insulin|mesh-list
44458817|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44458818|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
44458819|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
44458820|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44317571|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317572|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317573|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44317574|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44317575|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317576|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44317577|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
44317578|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
44317579|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
44317580|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
44317581|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732140|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44317611|NCT05388006|Durvalumab|durvalumab|mesh-list
44317612|NCT05388006|Venetoclax|venetoclax|mesh-list
44317613|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
44317614|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
44317615|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317616|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
44317617|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317618|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317619|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
44317620|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317621|NCT05370040|Vaccines|vaccines|mesh-list
44317622|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
44317623|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317624|NCT05354674|Bevacizumab|bevacizumab|mesh-list
44317625|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317626|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317627|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44317628|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43732172|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
44317654|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44317655|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44129921|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44317656|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317657|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317658|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317659|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44317660|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44317661|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317662|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317663|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317664|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
44317665|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44317666|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
44317667|NCT05275010|Trastuzumab|trastuzumab|mesh-list
44317668|NCT05275010|Pertuzumab|pertuzumab|mesh-list
44317669|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317670|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317671|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
44317672|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
44317673|NCT05269381|Sargramostim|sargramostim|mesh-list
44317674|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317675|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
44317676|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317677|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317678|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44317713|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317715|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317716|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612243|NCT03167177|Capecitabine|capecitabine|mesh-list
44458821|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
44317717|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44317718|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44317719|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317720|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44317721|NCT05141721|Leucovorin|leucovorin|mesh-list
44317722|NCT05141721|Bevacizumab|bevacizumab|mesh-list
44317751|NCT05109234|Brivaracetam|brivaracetam|mesh-list
44317752|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
44317753|NCT04992507|Anesthetics|anesthetics|mesh-list
44317754|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317755|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317756|NCT04982848|Talazoparib|talazoparib|mesh-list
44317757|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44317758|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317759|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317760|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317761|NCT04965597|Methotrexate|methotrexate|mesh-list
44317762|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
44317763|NCT04965597|Fludarabine|fludarabine|mesh-list
44317764|NCT04965597|Treosulfan|treosulfan|mesh-list
44317765|NCT04965597|Busulfan|busulfan|mesh-list
44317766|NCT04965597|Tacrolimus|tacrolimus|mesh-list
44317767|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
44317768|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44317769|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
44317770|NCT04965597|Antibodies|antibodies|mesh-list
44317802|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317804|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317805|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
44467211|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467212|NCT01452789|Morphine|morphine|mesh-list
44467213|NCT01452789|Buprenorphine|buprenorphine|mesh-list
44467214|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44467215|NCT01452789|Narcotics|narcotics|mesh-ancestor
44467216|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467217|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317810|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317811|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317812|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317813|NCT04892446|Dexamethasone|dexamethasone|mesh-list
44317814|NCT04892446|Bortezomib|bortezomib|mesh-list
44317815|NCT04892446|Daratumumab|daratumumab|mesh-list
44317816|NCT04892446|Pomalidomide|pomalidomide|mesh-list
44317817|NCT04892446|Magrolimab|magrolimab|mesh-list
44317818|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317819|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
44317820|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
44317821|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317822|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317858|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44317859|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
44317860|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
44317861|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
44317923|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
44317924|NCT04752384|Buprenorphine|buprenorphine|mesh-list
44317925|NCT04752384|Tramadol|tramadol|mesh-list
44317926|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44317927|NCT04752384|Narcotics|narcotics|mesh-ancestor
44317928|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317929|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317930|NCT04752384|Analgesics|analgesics|mesh-ancestor
44317931|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
44317932|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317933|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44317934|NCT04743804|Ravulizumab|ravulizumab|mesh-list
44317935|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44317936|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317937|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
44317938|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317939|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317940|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
44317941|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317942|NCT04708496|Efavirenz|efavirenz|mesh-list
44317943|NCT04708496|Dolutegravir|dolutegravir|mesh-list
44317944|NCT04708496|Lumefantrine|lumefantrine|mesh-list
44317945|NCT04708496|Artemether|artemether|mesh-list
44317946|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44317947|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44458822|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44458823|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
44458824|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458825|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458826|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
44458827|NCT01589497|Rifampin|rifampin|mesh-list
44458828|NCT01589497|Isoniazid|isoniazid|mesh-list
44458829|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
44458830|NCT01589497|Ethambutol|ethambutol|mesh-list
44458831|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458832|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458833|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44458834|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44458835|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458836|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458837|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458838|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44458839|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
44458840|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
44458841|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44458842|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44458843|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44458844|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44458845|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44458846|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44458847|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44095539|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
44317948|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317949|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317950|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318046|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318047|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318048|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44318049|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44318050|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318051|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44318088|NCT04606264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44318089|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318090|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44318092|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
43973076|NCT01734551|Analgesics|analgesics|mesh-ancestor
44467263|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318169|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
44318170|NCT04418661|Adagrasib|adagrasib|mesh-list
44318171|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318172|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318173|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44318175|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
43732542|NCT02549261|Cisplatin|cisplatin|mesh-list
44318211|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
44318212|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318213|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44318214|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44318215|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732566|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318243|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318244|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318245|NCT04323956|Prednisone|prednisone|mesh-list
44318246|NCT04323956|Cortisone|cortisone|mesh-list
44318247|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
44318248|NCT04323956|Rituximab|rituximab|mesh-list
44318249|NCT04323956|Doxorubicin|doxorubicin|mesh-list
44318250|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44318251|NCT04323956|Vincristine|vincristine|mesh-list
44318252|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44318253|NCT04323956|Antibodies|antibodies|mesh-list
44318254|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
44318255|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318256|NCT04323956|Lenograstim|lenograstim|mesh-list
44318257|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318258|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
44318259|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318260|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318261|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318262|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
43732598|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
44318298|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318299|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318300|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318301|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318302|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318330|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44318331|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44318333|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318334|NCT04228965|Varenicline|varenicline|mesh-list
44318335|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44318336|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44318337|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
44318338|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318339|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318340|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318341|NCT04227184|Trospium chloride|trospium chloride|mesh-list
44318342|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
44318343|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
44318344|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318345|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318346|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44318347|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44318348|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
44318349|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318378|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318379|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318380|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318381|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
44318382|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318383|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318384|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318385|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318386|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
44318387|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44318388|NCT04119024|Analgesics|analgesics|mesh-ancestor
44318389|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
44318390|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318391|NCT04097470|Decitabine|decitabine|mesh-list
44318392|NCT04097470|Midostaurin|midostaurin|mesh-list
44318393|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318394|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
44318395|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318397|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732630|NCT02549118|Tenoxicam|tenoxicam|mesh-list
44467297|NCT01451723|Protective Agents|protective agents|mesh-ancestor
44095657|NCT00041327|Etoposide|etoposide|mesh-list
44467298|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467299|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44467300|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43732651|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
44318402|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318430|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44318431|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318432|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44318434|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318435|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318436|NCT04005339|Leucovorin|leucovorin|mesh-list
44318437|NCT04005339|Fluorouracil|fluorouracil|mesh-list
44318438|NCT04005339|Irinotecan|irinotecan|mesh-list
44318439|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
44318440|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318441|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318442|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318443|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318444|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
44318445|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318446|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44318469|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318470|NCT03870529|Vitamins|vitamins|mesh-list
44318471|NCT03870529|Vitamin A|vitamin a|mesh-list
44318472|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
44318473|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
44318474|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
44318475|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318476|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
44318477|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318478|NCT03870529|Protective Agents|protective agents|mesh-ancestor
44318479|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44318480|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318481|NCT03829020|Metformin|metformin|mesh-list
44318482|NCT03829020|Nelfinavir|nelfinavir|mesh-list
44318483|NCT03829020|Bortezomib|bortezomib|mesh-list
44318484|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44318485|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318486|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318487|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44318488|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44318489|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
44318490|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318491|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318492|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44318493|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44318494|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
44318495|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318496|NCT03798314|Nivolumab|nivolumab|mesh-list
44318497|NCT03798314|Pomalidomide|pomalidomide|mesh-list
44318498|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318499|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318500|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318501|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318561|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318562|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318563|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467335|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467336|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467337|NCT01451515|Cytarabine|cytarabine|mesh-list
44467338|NCT01451515|Dexamethasone|dexamethasone|mesh-list
44467339|NCT01451515|Prednisone|prednisone|mesh-list
44467340|NCT01451515|Prednisolone|prednisolone|mesh-list
44467341|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
44467342|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
44467343|NCT01451515|Doxorubicin|doxorubicin|mesh-list
44467344|NCT01451515|Methotrexate|methotrexate|mesh-list
44467345|NCT01451515|Etoposide|etoposide|mesh-list
44467346|NCT01451515|Vincristine|vincristine|mesh-list
44467347|NCT01451515|Daunorubicin|daunorubicin|mesh-list
44467348|NCT01451515|Asparaginase|asparaginase|mesh-list
44467376|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44467377|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
44467378|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44467379|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467380|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458848|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44467381|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467382|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467383|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467384|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
44467385|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467386|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467387|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467388|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467389|NCT01451398|Insulin|insulin|mesh-list
44467390|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44467391|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467392|NCT01451203|Methotrexate|methotrexate|mesh-list
44467393|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
44467394|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44467395|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
43732801|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
44318588|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44318589|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44318590|NCT03712904|Aflibercept|aflibercept|mesh-list
44318591|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
44318592|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44318593|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318594|NCT03712904|Growth Substances|growth substances|mesh-ancestor
44318595|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318596|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
44318597|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318598|NCT03691350|Nicotine|nicotine|mesh-list
44318599|NCT03691350|Dimercaprol|dimercaprol|mesh-list
44318600|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44318601|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
44318602|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318603|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318604|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44318605|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44318606|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
44318607|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318608|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318609|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
44318610|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
44318611|NCT03667690|Fluconazole|fluconazole|mesh-list
44318612|NCT03667690|Caspofungin|caspofungin|mesh-list
44318613|NCT03667690|Rezafungin|rezafungin|mesh-list
44318614|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
44318615|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732847|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
44318648|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318649|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318650|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318651|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
44318652|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318653|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318654|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
44318719|NCT03557619|Hormones|hormones|mesh-ancestor
44318720|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318721|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318722|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44318723|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
44318724|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44318725|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44318726|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318727|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44318728|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44318729|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44318730|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44318731|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
44318732|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
44318733|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318734|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318735|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
44318736|NCT03502577|Fludarabine|fludarabine|mesh-list
44318737|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318738|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
44318764|NCT03455556|Atezolizumab|atezolizumab|mesh-list
44318765|NCT03455556|Maytansine|maytansine|mesh-list
44458849|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44458850|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
44458851|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44458852|NCT01589445|Metformin|metformin|mesh-list
44236344|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
44236345|NCT00558623|Calcium|calcium|mesh-list
44152712|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
44318766|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318767|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318768|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
44318769|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318770|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44318771|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318772|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318773|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318774|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318775|NCT03432741|Gemcitabine|gemcitabine|mesh-list
44318776|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
44318777|NCT03432741|Rituximab|rituximab|mesh-list
44318778|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44318779|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
44318780|NCT03432741|Nivolumab|nivolumab|mesh-list
44318781|NCT03432741|Trastuzumab|trastuzumab|mesh-list
44318782|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
44318783|NCT03432741|Daratumumab|daratumumab|mesh-list
44318784|NCT03432741|Romidepsin|romidepsin|mesh-list
44318785|NCT03432741|Belinostat|belinostat|mesh-list
44318786|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44318787|NCT03432741|Antibodies|antibodies|mesh-list
44318788|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
44318789|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318790|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44318819|NCT03324984|Bupivacaine|bupivacaine|mesh-list
44318820|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
44318821|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
44318822|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
44318823|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318824|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318825|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
44318826|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318827|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
44318828|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318829|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318830|NCT03294460|Ethanol|ethanol|mesh-list
44318831|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44318832|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318833|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318867|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318868|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
44318869|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318870|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318871|NCT02807636|Gemcitabine|gemcitabine|mesh-list
44318872|NCT02807636|Cisplatin|cisplatin|mesh-list
44318896|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318897|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
44318898|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318899|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318900|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318901|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
44318902|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318909|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
44318911|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44318912|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318913|NCT02537509|Vitamins|vitamins|mesh-ancestor
44318914|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
44318915|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44318916|NCT02393248|Gemcitabine|gemcitabine|mesh-list
44318917|NCT02393248|Cisplatin|cisplatin|mesh-list
44318918|NCT02393248|Docetaxel|docetaxel|mesh-list
44318919|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
44318920|NCT02393248|Trastuzumab|trastuzumab|mesh-list
44318921|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318922|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318923|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
44318924|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318926|NCT02393248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318993|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44318994|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318995|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318996|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318997|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44318998|NCT01712620|Diuretics|diuretics|mesh-ancestor
44318999|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
44467397|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467398|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467399|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
44467400|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467401|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467402|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467403|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467404|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467405|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467406|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
44467407|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467408|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44319026|NCT01005914|Cytarabine|cytarabine|mesh-list
44319027|NCT01005914|Dexamethasone|dexamethasone|mesh-list
44319028|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
44319029|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44319030|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44319031|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
44319032|NCT01005914|Doxorubicin|doxorubicin|mesh-list
44319033|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44319034|NCT01005914|Methotrexate|methotrexate|mesh-list
44319035|NCT01005914|Vincristine|vincristine|mesh-list
44319070|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319071|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44319072|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44319073|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
43974033|NCT01766024|Interferons|interferons|mesh-list
44319201|NCT00921245|Urological Agents|urological agents|mesh-ancestor
44319232|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319233|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319234|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319235|NCT00921414|Rituximab|rituximab|mesh-list
44319236|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319237|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319238|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
44319239|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319240|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319241|NCT00921505|Acetaminophen|acetaminophen|mesh-list
44319242|NCT00921505|Ibuprofen|ibuprofen|mesh-list
44319243|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319244|NCT00921505|Analgesics|analgesics|mesh-ancestor
44319245|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
44319276|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44130334|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
44319277|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44319279|NCT00921622|Vitamins|vitamins|mesh-list
44319280|NCT00921622|Ascorbic Acid|ascorbic acid|mesh-list
44319281|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
44319282|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319283|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44319284|NCT00921622|Antioxidants|antioxidants|mesh-ancestor
44319285|NCT00921622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319286|NCT00921622|Protective Agents|protective agents|mesh-ancestor
44319287|NCT00921661|Aflibercept|aflibercept|mesh-list
44319288|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319364|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
44467486|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
44467487|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
44319383|NCT00922389|Lenograstim|lenograstim|mesh-list
44319384|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44319385|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
44319386|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319388|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319389|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319390|NCT00922467|Esmolol|esmolol|mesh-list
44319391|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44319439|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319440|NCT00922597|Factor VIII|factor viii|mesh-list
44319441|NCT00922597|Coagulants|coagulants|mesh-ancestor
44319442|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
44319443|NCT00922610|Hematinics|hematinics|mesh-ancestor
44319445|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319446|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319447|NCT00922844|Sevoflurane|sevoflurane|mesh-list
44319448|NCT00922844|Isoflurane|isoflurane|mesh-list
44319449|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44319450|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44319451|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
44319452|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
44319453|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319454|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319455|NCT00922896|Gemcitabine|gemcitabine|mesh-list
44319456|NCT00922896|Cisplatin|cisplatin|mesh-list
44319457|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44319490|NCT00923234|Growth Substances|growth substances|mesh-ancestor
44319491|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319492|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319493|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319495|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319496|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319497|NCT00923247|Bortezomib|bortezomib|mesh-list
44319498|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319499|NCT00923299|Trastuzumab|trastuzumab|mesh-list
44319500|NCT00923299|Cetuximab|cetuximab|mesh-list
44319553|NCT00923676|Fenofibrate|fenofibrate|mesh-list
44319554|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44319555|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44319556|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
44319557|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319558|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44319559|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44319560|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319561|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
44319562|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319563|NCT00923806|Aldesleukin|aldesleukin|mesh-list
44319564|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319565|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44319566|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44319567|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
44319568|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319569|NCT00923962|Adenosine|adenosine|mesh-list
44319570|NCT00923962|Glucagon|glucagon|mesh-list
44319571|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44319572|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44319573|NCT00923962|Hormones|hormones|mesh-ancestor
44319602|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
44319603|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319604|NCT00924222|Propofol|propofol|mesh-list
44319605|NCT00924222|Sevoflurane|sevoflurane|mesh-list
44319606|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44319607|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319608|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319609|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44319610|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
44319611|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
44319612|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44319613|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44467488|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467489|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
44467490|NCT01449955|Sirolimus|sirolimus|mesh-list
44467491|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467492|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467526|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467527|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467528|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467529|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467530|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467531|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467532|NCT01449630|Celecoxib|celecoxib|mesh-list
44467533|NCT01449630|LY3031207|ly3031207|mesh-list
44467534|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44467535|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319626|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43612244|NCT03167177|Nivolumab|nivolumab|mesh-list
44236346|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44236347|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236348|NCT00558623|Antacids|antacids|mesh-ancestor
44319627|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319628|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
44319629|NCT00924586|Landiolol|landiolol|mesh-list
44319630|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44319660|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319661|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319662|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44319663|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44319664|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319665|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319667|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
44319668|NCT00925093|Vancomycin|vancomycin|mesh-list
44319669|NCT00925093|Linezolid|linezolid|mesh-list
44319670|NCT00925093|Teicoplanin|teicoplanin|mesh-list
44319671|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319672|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319673|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44319699|NCT00925457|Domperidone|domperidone|mesh-list
44319700|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44319701|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319702|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319703|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
44319704|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
44319705|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319706|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319707|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44319708|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44319709|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
44319710|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319711|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
44319712|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44319713|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319714|NCT00925730|Analgesics|analgesics|mesh-ancestor
44319715|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
44319716|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319717|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319718|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319719|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319720|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
44319721|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319786|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44319787|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319788|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
44319789|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319790|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
44319791|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319792|NCT00926302|Levetiracetam|levetiracetam|mesh-list
44319793|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
44319794|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
44319795|NCT00926315|Calcitriol|calcitriol|mesh-list
44319796|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44319797|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319798|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44319799|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319800|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319801|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44319802|NCT00926315|Vitamins|vitamins|mesh-ancestor
44319803|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
44319804|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44319805|NCT00926341|Pioglitazone|pioglitazone|mesh-list
44319806|NCT00926341|Telmisartan|telmisartan|mesh-list
43733634|NCT04731779|Cannabidiol|cannabidiol|mesh-list
44319929|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44319930|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44319931|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44319932|NCT00926835|Lamotrigine|lamotrigine|mesh-list
44319933|NCT00926835|Dexetimide|dexetimide|mesh-list
44319934|NCT00926835|Aripiprazole|aripiprazole|mesh-list
44319935|NCT00926835|Mirtazapine|mirtazapine|mesh-list
44319936|NCT00926835|Citalopram|citalopram|mesh-list
44319937|NCT00926835|Bupropion|bupropion|mesh-list
44319938|NCT00926835|Paroxetine|paroxetine|mesh-list
44319939|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44319940|NCT00926835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44319998|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
43733759|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
44320027|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
44320029|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320030|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320031|NCT00927004|Analgesics|analgesics|mesh-ancestor
44320032|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
44320033|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320034|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320035|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320036|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320037|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44320038|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320039|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320040|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320041|NCT00927030|Melatonin|melatonin|mesh-list
43733782|NCT04034004|Naloxone|naloxone|mesh-list
44320127|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320128|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320129|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320131|NCT00927602|Fondaparinux|fondaparinux|mesh-list
44320132|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44320133|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
44320134|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44320135|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
44320136|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320137|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320138|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
44320139|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44320140|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44320141|NCT00927615|Abciximab|abciximab|mesh-list
44320142|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
44320143|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44320196|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320197|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44320198|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320199|NCT00927836|Lenograstim|lenograstim|mesh-list
44320200|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44320201|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
44320202|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320203|NCT00927875|Carboplatin|carboplatin|mesh-list
44320204|NCT00927875|Etoposide|etoposide|mesh-list
44320205|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320258|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320259|NCT00928330|Trastuzumab|trastuzumab|mesh-list
44320260|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44320261|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320262|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320263|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
44320264|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
44320265|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
44320266|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733830|NCT03912298|Narcotics|narcotics|mesh-ancestor
44320377|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320379|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44320380|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
44320381|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320382|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320383|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44320384|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
44320385|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44320386|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44320387|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44320388|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733931|NCT02542930|Thymalfasin|thymalfasin|mesh-list
44320442|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
44320444|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320445|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320446|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
44320447|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320448|NCT00930072|Analgesics|analgesics|mesh-ancestor
44320449|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44320450|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
44320451|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
44320452|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44320453|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44320454|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44320455|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44320456|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320457|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320458|NCT00930098|Clofarabine|clofarabine|mesh-list
44320459|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320460|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
44320461|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320462|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320463|NCT00930189|Triamcinolone|triamcinolone|mesh-list
44320464|NCT00930189|Ranibizumab|ranibizumab|mesh-list
44320465|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320466|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320467|NCT00930189|Growth Substances|growth substances|mesh-ancestor
44320468|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320469|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320470|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320528|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320570|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320571|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320572|NCT00930670|Esomeprazole|esomeprazole|mesh-list
44320721|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320722|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
44320723|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320724|NCT00931203|Celecoxib|celecoxib|mesh-list
44320725|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320726|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320727|NCT00931203|Analgesics|analgesics|mesh-ancestor
44130584|NCT00146042|Docetaxel|docetaxel|mesh-list
44320728|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
44320729|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320730|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320731|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320732|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320821|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
44320822|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320823|NCT00931697|Mefloquine|mefloquine|mesh-list
44320824|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
44320825|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44320826|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44320827|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320828|NCT00931736|Rifampin|rifampin|mesh-list
44320829|NCT00931736|Isoniazid|isoniazid|mesh-list
44320830|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44320831|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
44320832|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44320833|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320834|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
44320835|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44320836|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320837|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320838|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44320839|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44320840|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44320841|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44320842|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43975808|NCT01833546|Gemcitabine|gemcitabine|mesh-list
44320843|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44320844|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44320845|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44320846|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
44320872|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320873|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320874|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320875|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320876|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320877|NCT00931866|Diclofenac|diclofenac|mesh-list
44320878|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320879|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320880|NCT00931866|Analgesics|analgesics|mesh-ancestor
44320881|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
44320882|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320883|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096212|NCT00043082|Carboplatin|carboplatin|mesh-list
44320884|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320885|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320886|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320887|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320888|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320889|NCT00931957|Prednisolone|prednisolone|mesh-list
44320890|NCT00931957|Etanercept|etanercept|mesh-list
44320891|NCT00931957|Methotrexate|methotrexate|mesh-list
44320892|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44320893|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
44320894|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44320895|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734363|NCT02540512|Narcotics|narcotics|mesh-ancestor
44467597|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
44467598|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467599|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44467600|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467601|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467602|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467603|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44467604|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44467605|NCT01448213|Fluorometholone|fluorometholone|mesh-list
44467606|NCT01448213|Prednisolone|prednisolone|mesh-list
44467607|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44467608|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
44467609|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44467610|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
44467611|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44467612|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
44467613|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734398|NCT02540395|Hormones|hormones|mesh-ancestor
44321011|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44321012|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321013|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
44321014|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
44321015|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44321044|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44321045|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
44321046|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
44321047|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44321048|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
44321049|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321050|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44321051|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44321052|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130712|NCT00146484|Insulin|insulin|mesh-list
44321053|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321054|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321055|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44321056|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
44321057|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321135|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44321136|NCT00933283|Methadone|methadone|mesh-list
44321137|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44321138|NCT00933283|Narcotics|narcotics|mesh-ancestor
44321139|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44321140|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321141|NCT00933283|Analgesics|analgesics|mesh-ancestor
44321142|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
44321143|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321144|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
44321145|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321146|NCT00933309|Metformin|metformin|mesh-list
44321147|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
44321148|NCT00933309|Exemestane|exemestane|mesh-list
44321149|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321150|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321151|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321152|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44321153|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44321154|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321155|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321190|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44321191|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44321193|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
44321194|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44321195|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44321256|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734597|NCT02538627|Trametinib|trametinib|mesh-list
44321281|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321282|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321283|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44321284|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321285|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44321286|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44321287|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44321288|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44321289|NCT00933816|Cisplatin|cisplatin|mesh-list
44321290|NCT00933816|Fluorouracil|fluorouracil|mesh-list
44321291|NCT00933816|Sorafenib|sorafenib|mesh-list
44321292|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321293|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
44321294|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321295|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44321296|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321297|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
44321298|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321299|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44321300|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321301|NCT00933894|Citalopram|citalopram|mesh-list
44321302|NCT00933894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44321303|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44321304|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321305|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321306|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321336|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
44321337|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321338|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44321339|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44321340|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321341|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
44467633|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
44467634|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130743|NCT00146549|Paclitaxel|paclitaxel|mesh-list
44467635|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467636|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
44467637|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467638|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44467639|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
44467640|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
44467641|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
44467642|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44467643|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
44467644|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
44467645|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44321544|NCT00934973|Mebeverine|mebeverine|mesh-list
44321545|NCT00934973|Alverine|alverine|mesh-list
44321546|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
44321547|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
44321548|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
44321549|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321550|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321551|NCT00935116|Etoricoxib|etoricoxib|mesh-list
44321552|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44321553|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321554|NCT00935116|Analgesics|analgesics|mesh-ancestor
44321555|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
44321556|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321557|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321558|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321559|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321560|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44321561|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44321562|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321563|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321564|NCT00935194|Oseltamivir|oseltamivir|mesh-list
44321565|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
44321566|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152765|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321567|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321568|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321569|NCT00935246|Dexetimide|dexetimide|mesh-list
44321570|NCT00935246|Citalopram|citalopram|mesh-list
44321571|NCT00935246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44321572|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43734843|NCT02537392|Vitamins|vitamins|mesh-ancestor
44321837|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44321838|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44321839|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321840|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44321842|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321843|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321844|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44321845|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321846|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321847|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321848|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44321850|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44321851|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321852|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44321853|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44321854|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
43735017|NCT02535910|Calcifediol|calcifediol|mesh-list
44321931|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44321932|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321933|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321934|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
44321935|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
44321936|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44321937|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
44321939|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321940|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321941|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321942|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321943|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321944|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321945|NCT00936793|Ritonavir|ritonavir|mesh-list
44321946|NCT00936793|Darunavir|darunavir|mesh-list
44321947|NCT00936793|Beclomethasone|beclomethasone|mesh-list
44321948|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44321949|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44321950|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321951|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735076|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44321979|NCT00936988|Cinacalcet|cinacalcet|mesh-list
44321980|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44321981|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321982|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44321983|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321984|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321985|NCT00937027|Aminopterin|aminopterin|mesh-list
44321986|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44321987|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321988|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321989|NCT00937079|Exenatide|exenatide|mesh-list
44321990|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321991|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321992|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44321993|NCT00937079|Incretins|incretins|mesh-ancestor
44321994|NCT00937079|Hormones|hormones|mesh-ancestor
44321995|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321996|NCT00937092|Dopamine|dopamine|mesh-list
44322053|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322054|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44322055|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322057|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322058|NCT00937300|Analgesics|analgesics|mesh-ancestor
44322059|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
44322060|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322062|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322063|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44322064|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44322065|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44322066|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322067|NCT00937482|Cediranib|cediranib|mesh-list
44322068|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322069|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322070|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322071|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44322072|NCT00937508|Varenicline|varenicline|mesh-list
44322073|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44322074|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44322075|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
44322076|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467723|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44467724|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44467725|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322127|NCT00937911|Darexaban|darexaban|mesh-list
44322128|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44322129|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
44322130|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44322131|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
44322132|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155406|NCT00226915|Paclitaxel|paclitaxel|mesh-list
44322133|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322134|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
44322135|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
44322136|NCT00937924|Promethazine|promethazine|mesh-list
44322137|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44322138|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44322172|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
44322173|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322174|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44322175|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
44322176|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322177|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44322178|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44322528|NCT00940303|Leucovorin|leucovorin|mesh-list
44322529|NCT00940303|Bevacizumab|bevacizumab|mesh-list
44322530|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
44322531|NCT00940303|Irinotecan|irinotecan|mesh-list
44322532|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44322533|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322534|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44322535|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44322536|NCT00940303|Growth Substances|growth substances|mesh-ancestor
44322537|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322538|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
44322539|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44322540|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44322541|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322542|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322543|NCT00940303|Antidotes|antidotes|mesh-ancestor
44322544|NCT00940303|Protective Agents|protective agents|mesh-ancestor
44322545|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
44322546|NCT00940303|Vitamins|vitamins|mesh-ancestor
44322547|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
44322548|NCT00940381|Sirolimus|sirolimus|mesh-list
44322549|NCT00940381|Cetuximab|cetuximab|mesh-list
44322550|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44322551|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322552|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44322553|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322554|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44322555|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
44322556|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322557|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
44322558|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322559|NCT00940420|Ribavirin|ribavirin|mesh-list
44322560|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44322561|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
44322562|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
44322563|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322564|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
44322565|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322566|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
44322567|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322568|NCT00940472|Metformin|metformin|mesh-list
44322569|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322570|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322572|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
44322573|NCT00940524|Methotrexate|methotrexate|mesh-list
44322600|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
44322601|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322602|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44322604|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
44322605|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322606|NCT00940550|Melatonin|melatonin|mesh-list
44322607|NCT00940550|Zolpidem|zolpidem|mesh-list
44322608|NCT00940550|Temazepam|temazepam|mesh-list
44322609|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
44322610|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322611|NCT00940550|Protective Agents|protective agents|mesh-ancestor
44322612|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322613|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322614|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44155408|NCT00226915|Carboplatin|carboplatin|mesh-list
44322615|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44322616|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44322617|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
44322618|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
44322619|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130946|NCT00147121|Rituximab|rituximab|mesh-list
44322620|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44322621|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322622|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322649|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322651|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44322652|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44322653|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44322654|NCT00940680|Losartan|losartan|mesh-list
44322655|NCT00940680|Amlodipine|amlodipine|mesh-list
44322656|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44322657|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44322658|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322659|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322660|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322661|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322662|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322663|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44322664|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44322665|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44322666|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44322667|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44322697|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44322698|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322699|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44322700|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44322701|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322702|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
44322703|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44322704|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44322705|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44322706|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
44322707|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322708|NCT00940836|Acetaminophen|acetaminophen|mesh-list
44322709|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
44322710|NCT00940836|Phenylephrine|phenylephrine|mesh-list
43735640|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322731|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
44322732|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322733|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44322734|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
44322735|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
44322736|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44322737|NCT00940862|Adalimumab|adalimumab|mesh-list
44322738|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322739|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322740|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
44322741|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44322742|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322743|NCT00940953|Azelastine|azelastine|mesh-list
44322744|NCT00940953|Budesonide|budesonide|mesh-list
44322745|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322746|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44322747|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
44236349|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236350|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236351|NCT00558662|Monensin|monensin|mesh-list
44236352|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
44236353|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236354|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44236355|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44236356|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
44130952|NCT00147160|Temozolomide|temozolomide|mesh-list
44236357|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
44236358|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
44236359|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236360|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236361|NCT00558662|Ionophores|ionophores|mesh-ancestor
44236362|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096533|NCT00043927|Cisplatin|cisplatin|mesh-list
44322748|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322749|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322750|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44322751|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
44322752|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
44322753|NCT00940953|Hormones|hormones|mesh-ancestor
44322754|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322755|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44322756|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322757|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322758|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44322759|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44322760|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44322761|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
44322762|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
44322763|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322764|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
43735684|NCT00727090|Conivaptan|conivaptan|mesh-list
44322916|NCT00941499|Growth Substances|growth substances|mesh-ancestor
44322917|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322918|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
44322919|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
44322920|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
44322921|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322922|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322923|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322924|NCT00941499|Antidotes|antidotes|mesh-ancestor
44322925|NCT00941499|Protective Agents|protective agents|mesh-ancestor
44322926|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
44322928|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
44322929|NCT00941525|Latanoprost|latanoprost|mesh-list
44322930|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44322931|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44322932|NCT00941616|Factor VIII|factor viii|mesh-list
44322933|NCT00941616|Coagulants|coagulants|mesh-ancestor
44467747|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467748|NCT01445886|Calcitriol|calcitriol|mesh-list
44467749|NCT01445886|Calcipotriene|calcipotriene|mesh-list
44322934|NCT00941785|Amodiaquine|amodiaquine|mesh-list
44322935|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
44322936|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44322937|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44322938|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322939|NCT00941811|Imiquimod|imiquimod|mesh-list
44322940|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44322941|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
43735801|NCT05300347|Adenosine|adenosine|mesh-list
44323023|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236363|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
44236364|NCT00558818|Clevudine|clevudine|mesh-list
44236365|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
44236366|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44236367|NCT00558883|Acarbose|acarbose|mesh-list
44236368|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44323024|NCT00942344|Losartan|losartan|mesh-list
44323025|NCT00942344|Amlodipine|amlodipine|mesh-list
44323026|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323027|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44323028|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323029|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323030|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44323031|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323032|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
44323033|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44323034|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44323035|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44323064|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323065|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323066|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44323067|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44323068|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323069|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44323070|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
44323071|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
44323072|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
44323073|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
44323074|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323075|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323076|NCT00942565|Acetaminophen|acetaminophen|mesh-list
44323078|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323079|NCT00942565|Analgesics|analgesics|mesh-ancestor
44323080|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
44323081|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323082|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323147|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323148|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323149|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44323150|NCT00942838|Cisplatin|cisplatin|mesh-list
44323151|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323152|NCT00942864|Ranibizumab|ranibizumab|mesh-list
44323153|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44323154|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44323155|NCT00942864|Growth Substances|growth substances|mesh-ancestor
44323156|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323157|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
44323158|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323159|NCT00943059|Acipimox|acipimox|mesh-list
44323160|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44323161|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
43977985|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
44323162|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323163|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323164|NCT00943137|Fluorouracil|fluorouracil|mesh-list
44323165|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
44323229|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44323230|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
44323231|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323232|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323233|NCT00943501|Liraglutide|liraglutide|mesh-list
44323234|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323235|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323236|NCT00943501|Incretins|incretins|mesh-ancestor
44323237|NCT00943501|Hormones|hormones|mesh-ancestor
44323271|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44323272|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44323274|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
44467750|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467751|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44131079|NCT00147615|Diuretics|diuretics|mesh-ancestor
44236369|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236370|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236371|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44236372|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236373|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
44236374|NCT00558961|Chlorambucil|chlorambucil|mesh-list
44467752|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467753|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44467784|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323276|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44323277|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
44323278|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323279|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323280|NCT00943748|Deferiprone|deferiprone|mesh-list
44323281|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44323282|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
44323283|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
44323284|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323285|NCT00943839|Sunitinib|sunitinib|mesh-list
44323286|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323287|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44323385|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44323387|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
44323388|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323389|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323390|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323391|NCT00944346|Metformin|metformin|mesh-list
44323392|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323393|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323394|NCT00944359|Zinc|zinc|mesh-list
44323395|NCT00944359|Trace Elements|trace elements|mesh-ancestor
44323396|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
44323429|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44323430|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
44323431|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323432|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323433|NCT00944463|Antiviral Agents|antiviral agents|mesh-ancestor
44323434|NCT00944463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323435|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323436|NCT00944463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323437|NCT00944463|Immunologic Factors|immunologic factors|mesh-ancestor
44323438|NCT00944463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323439|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44323440|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44323441|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323526|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44323527|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44323528|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323529|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323559|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323560|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323561|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44323562|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44323563|NCT00945022|Anesthetics|anesthetics|mesh-list
44323564|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323565|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323566|NCT00945178|Naproxen|naproxen|mesh-list
44323567|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44323568|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323569|NCT00945178|Analgesics|analgesics|mesh-ancestor
44323570|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
44323571|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323572|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323599|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323600|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323601|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
44323602|NCT00945373|Calcium|calcium|mesh-list
44323603|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44323604|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323605|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
44323606|NCT00945373|Coagulants|coagulants|mesh-ancestor
44323607|NCT00945438|Vaccines|vaccines|mesh-list
44323608|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
44323609|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323610|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
44323611|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44323612|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
44323613|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323614|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323615|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44323616|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44323617|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44323618|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
44323619|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736153|NCT04928300|Analgesics|analgesics|mesh-ancestor
44323631|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323632|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
44323633|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323634|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
44323669|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323670|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323671|NCT00946036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44323672|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323673|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323674|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323675|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323704|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323705|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
44323706|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323707|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323708|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323709|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
44323710|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323711|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323712|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44323714|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
44323715|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
44323716|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323717|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323718|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323719|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
44323720|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323721|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44323722|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
44323723|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323755|NCT00946556|Valacyclovir|valacyclovir|mesh-list
44323756|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
44323757|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323758|NCT00946595|Ritonavir|ritonavir|mesh-list
44323759|NCT00946595|Lopinavir|lopinavir|mesh-list
44323760|NCT00946595|Tenofovir|tenofovir|mesh-list
44323761|NCT00946595|Efavirenz|efavirenz|mesh-list
44323762|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44323763|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44323764|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323765|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323766|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736338|NCT04394182|Ritonavir|ritonavir|mesh-list
44323791|NCT00946621|Ramipril|ramipril|mesh-list
44323792|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44323793|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323794|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323795|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323796|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323797|NCT00946673|Vorinostat|vorinostat|mesh-list
44323798|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323799|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44323800|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323801|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323802|NCT00946686|Leflunomide|leflunomide|mesh-list
44323803|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323804|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323805|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323806|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
44323807|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323808|NCT00946725|Atenolol|atenolol|mesh-list
44323809|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44323810|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323811|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
44323812|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
43736372|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323831|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323832|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
44323833|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323834|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323835|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
44323836|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
44323837|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44323838|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44323839|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323840|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323841|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323842|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323844|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323845|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44323846|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44323847|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323848|NCT00946907|Aspirin|aspirin|mesh-list
44323849|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44323850|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323851|NCT00946907|Analgesics|analgesics|mesh-ancestor
44323852|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
44323853|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323854|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323855|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323856|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323857|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44323858|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44323859|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323860|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44323861|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44323862|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323863|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
44323864|NCT00946946|Mesalamine|mesalamine|mesh-list
44323865|NCT00946946|Azathioprine|azathioprine|mesh-list
43834592|NCT05115513|Dronabinol|dronabinol|mesh-list
44323895|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44323896|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323897|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
44323899|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
44323900|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323901|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
44323902|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
44323903|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323904|NCT00947076|Fluoxetine|fluoxetine|mesh-list
44323905|NCT00947076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44323906|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323907|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323908|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323909|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323910|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
44323947|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44323949|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
44323950|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323978|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323979|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323980|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44323981|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
44323982|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44323983|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323984|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44323985|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43612245|NCT03167177|Avelumab|avelumab|mesh-list
44323986|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44323988|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44323990|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
44323991|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44323992|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
44323993|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323994|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323995|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44323996|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
44467821|NCT01444898|Exenatide|exenatide|mesh-list
44467822|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44467823|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467824|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44467825|NCT01444898|Incretins|incretins|mesh-ancestor
44467826|NCT01444898|Hormones|hormones|mesh-ancestor
44467827|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467828|NCT01444781|Vaccines|vaccines|mesh-list
44467829|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44467830|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
44324044|NCT00947843|Clopidogrel|clopidogrel|mesh-list
44324045|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324046|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324047|NCT00947843|Analgesics|analgesics|mesh-ancestor
44324048|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
44324049|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324050|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324051|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324052|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324053|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44324054|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44324055|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324084|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324085|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324086|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
44324087|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
44324088|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324089|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324090|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
44324091|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44324092|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
44324093|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
44324094|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324095|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324096|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324097|NCT00948103|Analgesics|analgesics|mesh-ancestor
44324098|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
44324099|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324100|NCT00948168|Exenatide|exenatide|mesh-list
44324101|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324133|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
44324134|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324135|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324136|NCT00948649|Varenicline|varenicline|mesh-list
44324137|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44324138|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44324139|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
44324140|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324141|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324142|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324143|NCT00948662|Ketoconazole|ketoconazole|mesh-list
44324144|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
44324145|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324146|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44324147|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44324183|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324244|NCT00949247|Growth Substances|growth substances|mesh-ancestor
44324245|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324246|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
44324247|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
44324248|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
43979190|NCT01941628|Rocuronium|rocuronium|mesh-list
44467916|NCT01443078|Cisplatin|cisplatin|mesh-list
44467917|NCT01443078|Carboplatin|carboplatin|mesh-list
44467918|NCT01443078|Docetaxel|docetaxel|mesh-list
44467919|NCT01443078|Pemetrexed|pemetrexed|mesh-list
44324268|NCT00949377|Bromides|bromides|mesh-list
44324269|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
44324270|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
44324271|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43736606|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324297|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324298|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324299|NCT00949546|Analgesics|analgesics|mesh-ancestor
44324300|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
44324301|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324302|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324303|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324304|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324305|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324306|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324307|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
44324308|NCT00949572|Vaccines|vaccines|mesh-list
44324309|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
44324310|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
44324311|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324312|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44324313|NCT00949598|Tamoxifen|tamoxifen|mesh-list
44324314|NCT00949598|Letrozole|letrozole|mesh-list
44324315|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324316|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324317|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44324318|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44324319|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324320|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44324321|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324322|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736625|NCT05359627|Polymyxins|polymyxins|mesh-list
44324356|NCT00949832|Calcium|calcium|mesh-list
44324357|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
44324358|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324359|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324360|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44324361|NCT00949949|Gemcitabine|gemcitabine|mesh-list
44324362|NCT00949949|Cisplatin|cisplatin|mesh-list
44324363|NCT00949949|Everolimus|everolimus|mesh-list
44324364|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324365|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324366|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
43736673|NCT05357820|Itraconazole|itraconazole|mesh-list
44324398|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
44324399|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44324400|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44324401|NCT00950105|Semapimod|semapimod|mesh-list
44324402|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324403|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324404|NCT00950105|Analgesics|analgesics|mesh-ancestor
44324405|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
44324406|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324407|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324408|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324433|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324434|NCT00950261|Cisplatin|cisplatin|mesh-list
44324435|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324436|NCT00950339|Omeprazole|omeprazole|mesh-list
44324437|NCT00950339|Pantoprazole|pantoprazole|mesh-list
44324438|NCT00950339|Famotidine|famotidine|mesh-list
44324439|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324440|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324441|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44324442|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324443|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324444|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44324445|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
44324446|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
44324447|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324448|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324449|NCT00950391|Tacrolimus|tacrolimus|mesh-list
44324450|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324451|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
44324452|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324453|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44236375|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324454|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324455|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324456|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
44324457|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
44324458|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44324459|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44324460|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736728|NCT05357430|Propofol|propofol|mesh-list
44324491|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324492|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324493|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44324494|NCT00950677|Incretins|incretins|mesh-ancestor
44324495|NCT00950677|Hormones|hormones|mesh-ancestor
44467920|NCT01443078|Vinorelbine|vinorelbine|mesh-list
44324496|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324497|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44324498|NCT00950794|Tulobuterol|tulobuterol|mesh-list
44324499|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44324500|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
43736767|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
44324530|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44324531|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
44324532|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44324533|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44324534|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324535|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44324536|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324537|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324538|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44324539|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44324540|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44324541|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
44324542|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324551|NCT00951236|Cortisone|cortisone|mesh-list
44324552|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324553|NCT00951431|Esomeprazole|esomeprazole|mesh-list
44324554|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324555|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324556|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44324557|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324558|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324559|NCT00951444|Gemcitabine|gemcitabine|mesh-list
44324560|NCT00951444|Carboplatin|carboplatin|mesh-list
44324561|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324562|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324563|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
44324564|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324565|NCT00951444|Antiviral Agents|antiviral agents|mesh-ancestor
44324566|NCT00951444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324567|NCT00951444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324568|NCT00951444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324569|NCT00951444|Immunologic Factors|immunologic factors|mesh-ancestor
44324570|NCT00951444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324571|NCT00951574|Nadroparin|nadroparin|mesh-list
44324572|NCT00951574|Calcium|calcium|mesh-list
43736812|NCT05355597|Clonidine|clonidine|mesh-list
44324605|NCT00952003|Docetaxel|docetaxel|mesh-list
44324606|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
44324607|NCT00952003|Irinotecan|irinotecan|mesh-list
44324608|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324609|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324610|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44131447|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
44324633|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44324634|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324635|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
44324636|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324637|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44324639|NCT00952029|Bevacizumab|bevacizumab|mesh-list
44324640|NCT00952029|Fluorouracil|fluorouracil|mesh-list
44324641|NCT00952029|Irinotecan|irinotecan|mesh-list
44324642|NCT00952029|Calcium|calcium|mesh-list
44324643|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
44324644|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324645|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324646|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44324647|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44324648|NCT00952029|Growth Substances|growth substances|mesh-ancestor
44324649|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324650|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44324651|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324652|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
44324653|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324654|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324655|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324656|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
44324657|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44324658|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44324659|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324660|NCT00952029|Antidotes|antidotes|mesh-ancestor
44324661|NCT00952029|Protective Agents|protective agents|mesh-ancestor
44324690|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
44324691|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
44324692|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44324693|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324694|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324695|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44324696|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324697|NCT00952432|Analgesics|analgesics|mesh-ancestor
44324698|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
44324699|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324700|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44324701|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324702|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324703|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44324704|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44324705|NCT00952497|Cisplatin|cisplatin|mesh-list
44324706|NCT00952497|Capecitabine|capecitabine|mesh-list
44324707|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324708|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324709|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
44324710|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324744|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44324745|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324746|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324747|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324748|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44324749|NCT00952861|Doxycycline|doxycycline|mesh-list
44324750|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324751|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324752|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
44324753|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44324754|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44324755|NCT00952913|Lansoprazole|lansoprazole|mesh-list
44324756|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
44324789|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324791|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
44324792|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324793|NCT00953108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44324794|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
44324795|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44467958|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44467960|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
44467961|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467962|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467963|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
44467964|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467965|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467966|NCT01442688|Amoxicillin|amoxicillin|mesh-list
44467967|NCT01442688|Mesalamine|mesalamine|mesh-list
44467968|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467969|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467970|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44467971|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44467972|NCT01442688|Analgesics|analgesics|mesh-ancestor
44467973|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
44467974|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324830|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324832|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
44324833|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44324834|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324835|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
44324836|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44324837|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
44324838|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44324867|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44324868|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324869|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44324870|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44324871|NCT00953459|Growth Substances|growth substances|mesh-ancestor
44324872|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324873|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44324874|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324875|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324876|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324877|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44324878|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44324879|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
44324880|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324881|NCT00953498|Pioglitazone|pioglitazone|mesh-list
44324882|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
44324883|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324884|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324885|NCT00953537|Capecitabine|capecitabine|mesh-list
43737068|NCT05265910|Analgesics|analgesics|mesh-ancestor
44324913|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
44324914|NCT00953771|Danazol|danazol|mesh-list
44324915|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44324916|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324917|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324918|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324919|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44324920|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44324921|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324922|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324923|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
44324924|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324925|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324926|NCT00954005|Gemcitabine|gemcitabine|mesh-list
44324927|NCT00954005|Rituximab|rituximab|mesh-list
44324928|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
44324929|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324930|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324931|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
44324932|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324933|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324965|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324966|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324967|NCT00954200|Analgesics|analgesics|mesh-ancestor
44324968|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
44324969|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324970|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324971|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324972|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324973|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44324974|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324975|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325008|NCT00954486|Hematinics|hematinics|mesh-ancestor
44325009|NCT00954525|Ascorbic Acid|ascorbic acid|mesh-list
44325010|NCT00954525|Gemcitabine|gemcitabine|mesh-list
44325011|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44325012|NCT00954525|Vitamins|vitamins|mesh-ancestor
44325013|NCT00954525|Micronutrients|micronutrients|mesh-ancestor
44325014|NCT00954525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325015|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44325016|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
44325017|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737134|NCT05220280|Infliximab|infliximab|mesh-list
44325052|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44325054|NCT00954642|Bevacizumab|bevacizumab|mesh-list
44325055|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325056|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325057|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325058|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325089|NCT00954889|Tamsulosin|tamsulosin|mesh-list
44325090|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44236376|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44236377|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325091|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44325092|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44325093|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44325094|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325095|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325096|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325097|NCT00954889|Urological Agents|urological agents|mesh-ancestor
44325098|NCT00954902|Antioxidants|antioxidants|mesh-list
44325099|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325100|NCT00954902|Protective Agents|protective agents|mesh-ancestor
44468014|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44468015|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44468016|NCT01442064|Growth Substances|growth substances|mesh-ancestor
44468053|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44468054|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44468055|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44325139|NCT00955240|Cisplatin|cisplatin|mesh-list
44325140|NCT00955240|Fluorouracil|fluorouracil|mesh-list
44325141|NCT00955240|Cetuximab|cetuximab|mesh-list
44325142|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325143|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
44325144|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325145|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44325146|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325147|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
44325148|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325149|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325150|NCT00955318|Apomorphine|apomorphine|mesh-list
44325151|NCT00955318|Emetics|emetics|mesh-ancestor
44325152|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325153|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
44325186|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325187|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325188|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325189|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325191|NCT00955773|Trametinib|trametinib|mesh-list
44325192|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325193|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325226|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325227|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325228|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325229|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325230|NCT00956098|Oltipraz|oltipraz|mesh-list
44325231|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
44325232|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325233|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
44325234|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43737346|NCT05002946|Naltrexone|naltrexone|mesh-list
44325274|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
44325305|NCT00956267|Letrozole|letrozole|mesh-list
44325306|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325307|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44325308|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44325309|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325310|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325311|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44325312|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
44325313|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325314|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325315|NCT00956306|Udenafil|udenafil|mesh-list
43737384|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
44325350|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325352|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325353|NCT00956436|Hematinics|hematinics|mesh-ancestor
44325354|NCT00956462|Dexamethasone|dexamethasone|mesh-list
44325355|NCT00956462|Ketorolac|ketorolac|mesh-list
44325356|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44325357|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325358|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
44325388|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44325389|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325390|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
44325391|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
44325392|NCT00956748|Dexamethasone|dexamethasone|mesh-list
44325393|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325394|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
44325395|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
44325396|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325397|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325398|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325399|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
44325400|NCT00956748|Hormones|hormones|mesh-ancestor
44325401|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737413|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
44468064|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44468065|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468066|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44468067|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44131706|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468068|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468069|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468070|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468071|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468072|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468073|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44468074|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468075|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468076|NCT01441414|Axitinib|axitinib|mesh-list
44468077|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468078|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44468079|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468080|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468081|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
44468082|NCT01441180|Ribavirin|ribavirin|mesh-list
44468083|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
44468084|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980419|NCT01987752|Timolol|timolol|mesh-list
44325421|NCT00956982|Interferons|interferons|mesh-list
44325422|NCT00956982|Ribavirin|ribavirin|mesh-list
44325423|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
44325424|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
44325425|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44325452|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325453|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44325454|NCT00957125|Growth Substances|growth substances|mesh-ancestor
44325455|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325456|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325457|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325458|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325459|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325460|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325461|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44325462|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44325463|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44325464|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325465|NCT00957177|Pregabalin|pregabalin|mesh-list
44325466|NCT00957177|Analgesics|analgesics|mesh-ancestor
44325467|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
44325468|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325469|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325470|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
44325471|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44325472|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325473|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325500|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
44325501|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
44325502|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325503|NCT00957216|Vitamins|vitamins|mesh-ancestor
44325504|NCT00957320|Sirolimus|sirolimus|mesh-list
44325505|NCT00957320|Asparaginase|asparaginase|mesh-list
44325506|NCT00957320|Pegaspargase|pegaspargase|mesh-list
44325507|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44325508|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325509|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44325510|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325511|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
44325512|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325513|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
44097345|NCT00046111|Topotecan|topotecan|mesh-list
44325514|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325515|NCT00957346|Misoprostol|misoprostol|mesh-list
44325516|NCT00957346|Mifepristone|mifepristone|mesh-list
44325517|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44325518|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
44325519|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44325520|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325521|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44325553|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325554|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325555|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325556|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44325557|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44325558|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44325559|NCT00957866|Interferons|interferons|mesh-list
44325561|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325562|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
44325563|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325600|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
44325601|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
44325602|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325603|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44325604|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44325637|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325638|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325639|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44325640|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44325641|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325642|NCT00958386|Irinotecan|irinotecan|mesh-list
44325643|NCT00958386|Panitumumab|panitumumab|mesh-list
44325656|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
44325658|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325659|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325660|NCT00958451|Vitamins|vitamins|mesh-ancestor
44325661|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
44325662|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44325663|NCT05352373|Calcium|calcium|mesh-list
44325664|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325665|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325666|NCT05352191|Beclomethasone|beclomethasone|mesh-list
44325667|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325668|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
44325669|NCT05352191|Hormones|hormones|mesh-ancestor
44325670|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325671|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325672|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44325673|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
44325674|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
44325675|NCT05352165|Fluorouracil|fluorouracil|mesh-list
44325676|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325677|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325678|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
44325679|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325680|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44325681|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325682|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
44325683|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325684|NCT05352126|Disinfectants|disinfectants|mesh-list
44325685|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325686|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
44325687|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325688|NCT05351788|Cisplatin|cisplatin|mesh-list
44325689|NCT05351788|Carboplatin|carboplatin|mesh-list
44325690|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325691|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44325692|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44325693|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325694|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325695|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325696|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325697|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44325698|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44325699|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44325700|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
44325701|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325702|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737712|NCT04505410|Ustekinumab|ustekinumab|mesh-list
44325720|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44325721|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
44325722|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325723|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44325724|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44325725|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325726|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
44325727|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44325728|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44325729|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325730|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
44325731|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44325732|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
44325733|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325734|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325735|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43737778|NCT04460066|Paclitaxel|paclitaxel|mesh-list
44325767|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325769|NCT05350384|Protective Agents|protective agents|mesh-ancestor
44325770|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44325771|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325772|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44325773|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325774|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325775|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
44325776|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
44325777|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325778|NCT05280457|Nivolumab|nivolumab|mesh-list
44325805|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325806|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325807|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325808|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
44325809|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
44325811|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
44325812|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44325813|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44325814|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44325815|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325816|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
44325817|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44325818|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44325819|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44325820|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44325821|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325822|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325823|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325824|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44325825|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44325866|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325867|NCT04966663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325868|NCT04966663|Immunologic Factors|immunologic factors|mesh-ancestor
44325869|NCT04966663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325870|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325871|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44325872|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44325873|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44325874|NCT04919369|Vitamins|vitamins|mesh-list
44325875|NCT04919369|Vitamin A|vitamin a|mesh-list
44325876|NCT04919369|Atezolizumab|atezolizumab|mesh-list
44325877|NCT04919369|Tretinoin|tretinoin|mesh-list
44325878|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
44325912|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325913|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44325915|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325916|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325917|NCT04722718|Paclitaxel|paclitaxel|mesh-list
44325918|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44426850|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325945|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325946|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325947|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44325948|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44325949|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325951|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325952|NCT04699604|Levocetirizine|levocetirizine|mesh-list
44325953|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44325954|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44325955|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
44325956|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
44325957|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325958|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325959|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325960|NCT04678089|Bortezomib|bortezomib|mesh-list
44325961|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325962|NCT04619082|Tenofovir|tenofovir|mesh-list
44325963|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
44325964|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325965|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44325994|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
44325995|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325996|NCT04534023|Protective Agents|protective agents|mesh-ancestor
44325997|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325998|NCT04492956|Ecopipam|ecopipam|mesh-list
44325999|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44326000|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44326001|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326002|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326003|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44326004|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44326005|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
44326006|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326007|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326008|NCT04488952|Anesthetics|anesthetics|mesh-list
44326009|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326010|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326011|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
44326012|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
44468162|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468163|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44468164|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44468165|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468166|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468167|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44468168|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
44468169|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738049|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
44326073|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326075|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44326076|NCT03973177|Phenol|phenol|mesh-list
44326077|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
44326078|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44326079|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44326080|NCT03973177|Prednisolone|prednisolone|mesh-list
44326081|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
44326082|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44326083|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
43834840|NCT05096663|Hormones|hormones|mesh-ancestor
44326109|NCT03891446|Bimatoprost|bimatoprost|mesh-list
44326110|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44326111|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
44326112|NCT03867383|Calcium|calcium|mesh-list
44326113|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44326114|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326115|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326116|NCT03824561|Vedolizumab|vedolizumab|mesh-list
44326117|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326118|NCT03741101|Trametinib|trametinib|mesh-list
44326119|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326120|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44326121|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326122|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326123|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
44326124|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44326125|NCT03641547|Cisplatin|cisplatin|mesh-list
44326126|NCT03641547|Capecitabine|capecitabine|mesh-list
44326127|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326128|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326129|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
44326130|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326131|NCT03581240|Eflornithine|eflornithine|mesh-list
44326132|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326133|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44326167|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326168|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326169|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
44326170|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326171|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44326172|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44326173|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43738121|NCT04034862|Lamivudine|lamivudine|mesh-list
44326206|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326207|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326208|NCT02879409|Insulin|insulin|mesh-list
44326209|NCT02879409|Metformin|metformin|mesh-list
44326210|NCT02879409|Pioglitazone|pioglitazone|mesh-list
44326211|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44326212|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
44326213|NCT02879409|Liraglutide|liraglutide|mesh-list
44326214|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44326215|NCT02879409|Gliclazide|gliclazide|mesh-list
44326216|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326217|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326218|NCT02879409|Incretins|incretins|mesh-ancestor
44326253|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468171|NCT01439568|Carboplatin|carboplatin|mesh-list
44468172|NCT01439568|Etoposide|etoposide|mesh-list
44326274|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
44326275|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326309|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44326310|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44326311|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326312|NCT00958750|Minoxidil|minoxidil|mesh-list
44326313|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44326314|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
44326315|NCT00958854|Thalidomide|thalidomide|mesh-list
44326340|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326342|NCT00959062|Analgesics|analgesics|mesh-ancestor
44326343|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
44326344|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132061|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44326345|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326346|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44326347|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
44326348|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
44326349|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44326350|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44326351|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44326352|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44326353|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326354|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326355|NCT00959075|Thiamine|thiamine|mesh-list
44326356|NCT00959075|Vitamins|vitamins|mesh-ancestor
44326357|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
44326358|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326359|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
44326360|NCT00959101|Metformin|metformin|mesh-list
44326361|NCT00959101|Repaglinide|repaglinide|mesh-list
44326362|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326363|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326364|NCT00959218|Dronabinol|dronabinol|mesh-list
44326365|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
44326366|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326367|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44326394|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
44326395|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326396|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
44326397|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326398|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44326399|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44326400|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44326401|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44326402|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
44326403|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44326404|NCT00959335|Bicalutamide|bicalutamide|mesh-list
44326405|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
44326406|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44326407|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326408|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326409|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326411|NCT00959387|Cisplatin|cisplatin|mesh-list
44326412|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44326413|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326449|NCT00959517|Artesunate|artesunate|mesh-list
44326450|NCT00959517|Chloroquine|chloroquine|mesh-list
44326451|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
44326452|NCT00959517|Primaquine|primaquine|mesh-list
44326453|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
44326483|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
44326484|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
44326485|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326486|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326487|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
44326488|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326489|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44326490|NCT00959621|Aspirin|aspirin|mesh-list
44326491|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326492|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326493|NCT00959621|Analgesics|analgesics|mesh-ancestor
44326494|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
44326495|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326496|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468205|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44468206|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44468207|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44468208|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468209|NCT01439282|Capecitabine|capecitabine|mesh-list
44468210|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44468211|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
44468212|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468213|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468214|NCT01439204|Abatacept|abatacept|mesh-list
44468215|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44468216|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468217|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468218|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44468219|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
44468220|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468221|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468222|NCT01439126|Clonidine|clonidine|mesh-list
44468223|NCT01439126|Analgesics|analgesics|mesh-ancestor
44468224|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
44326529|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326531|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326532|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
44326533|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326534|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326535|NCT00959972|Nicotine|nicotine|mesh-list
44326566|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326567|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44326568|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44326569|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
44326570|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
44326571|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326572|NCT00960284|Gemcitabine|gemcitabine|mesh-list
44326573|NCT00960284|Cisplatin|cisplatin|mesh-list
44326574|NCT00960284|Fluorouracil|fluorouracil|mesh-list
44326575|NCT00960284|Capecitabine|capecitabine|mesh-list
44326576|NCT00960284|Epirubicin|epirubicin|mesh-list
44326577|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326578|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326579|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
44326580|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326581|NCT00960284|Antiviral Agents|antiviral agents|mesh-ancestor
44326614|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326615|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326616|NCT00960453|Incretins|incretins|mesh-ancestor
44326617|NCT00960453|Hormones|hormones|mesh-ancestor
44097674|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44326618|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326619|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44326620|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326621|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326622|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326655|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44326657|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
44326658|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326659|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326660|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44326661|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44326662|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44326663|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834910|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
44326691|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326692|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44326693|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326694|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326695|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
44326696|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44326697|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44326698|NCT00960830|Mirtazapine|mirtazapine|mesh-list
44326699|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
44326700|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44326701|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44326702|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
44326703|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
44326704|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326705|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326706|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326707|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44326708|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44326709|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326710|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44326711|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44326750|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44326784|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326785|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44326786|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44326787|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
44326788|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
44326824|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44326855|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468235|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468236|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
44468237|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44468238|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44468239|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468240|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44468241|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44468242|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
44468243|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44468244|NCT01439009|Tolvaptan|tolvaptan|mesh-list
44468245|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44468246|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468247|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
44326918|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326919|NCT00962442|Antidotes|antidotes|mesh-ancestor
44326920|NCT00962507|Everolimus|everolimus|mesh-list
44326921|NCT00962507|Panobinostat|panobinostat|mesh-list
44326922|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326923|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44326955|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44326956|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
44326957|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44326958|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44326959|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44326960|NCT00962663|Ibuprofen|ibuprofen|mesh-list
44326961|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326962|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236378|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236379|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44236380|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
44236381|NCT00559026|Dacarbazine|dacarbazine|mesh-list
44236382|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326963|NCT00962663|Analgesics|analgesics|mesh-ancestor
44326964|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
44326965|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326966|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834947|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
44327183|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44327184|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44327185|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327186|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44327187|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
44327188|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
44327189|NCT00964041|Cycloserine|cycloserine|mesh-list
44327190|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44327191|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327193|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44327194|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
44327195|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44327196|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
44327197|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327198|NCT00964080|Leucovorin|leucovorin|mesh-list
44327199|NCT00964080|Fluorouracil|fluorouracil|mesh-list
44327200|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
44327201|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
44327202|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327203|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327228|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44327229|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44327230|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44327231|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
44327232|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
44327233|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
44327234|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
44327235|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327236|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327237|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44327238|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327239|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
44327240|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327241|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44327242|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327243|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44327244|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44327245|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44327246|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44327247|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44327248|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44327249|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44327250|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
44327251|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44327252|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
44327253|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44327254|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327255|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
44327256|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327257|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44327258|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44327288|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327289|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327290|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
44327291|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327292|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44327293|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44327294|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44327295|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44327296|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44327297|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44327298|NCT00964184|Metformin|metformin|mesh-list
44327383|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44327384|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44327385|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327386|NCT00964639|Ropivacaine|ropivacaine|mesh-list
44327387|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
44327388|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
44327389|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327390|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327391|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
44327392|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327393|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44327394|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
44327463|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
44327464|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
44327465|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44327466|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44327467|NCT00964964|Insulin|insulin|mesh-list
44327468|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44327469|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
44327470|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327471|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327472|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
44327473|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44327612|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
44327748|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44327749|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
44327750|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327751|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327752|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44327753|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43835055|NCT05079763|Monolaurin|monolaurin|mesh-list
44327856|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44327857|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44327858|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327859|NCT00967031|Capecitabine|capecitabine|mesh-list
44327860|NCT00967031|Lapatinib|lapatinib|mesh-list
44327861|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327862|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
44327863|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327864|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327865|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44327866|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327867|NCT00967057|Dexamethasone|dexamethasone|mesh-list
44327868|NCT00967057|Methotrexate|methotrexate|mesh-list
44327869|NCT00967057|Vincristine|vincristine|mesh-list
44327870|NCT00967057|Asparaginase|asparaginase|mesh-list
44327871|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
44327872|NCT00967057|Idarubicin|idarubicin|mesh-list
44327873|NCT00967057|Pegaspargase|pegaspargase|mesh-list
44327874|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327875|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
44327876|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
44327877|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327878|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327879|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44327880|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
44327881|NCT00967057|Hormones|hormones|mesh-ancestor
44327882|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327883|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739439|NCT01472562|Rituximab|rituximab|mesh-list
44327908|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44327909|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
44327910|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327911|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327912|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44327913|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44327914|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327915|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327916|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327917|NCT00967096|Rifaximin|rifaximin|mesh-list
44327918|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097890|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44327919|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327920|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44327921|NCT00967109|Chrysarobin|chrysarobin|mesh-list
44327922|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44327923|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327924|NCT00967109|Analgesics|analgesics|mesh-ancestor
44327925|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
44327926|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327927|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327928|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327929|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327930|NCT00967135|Pregabalin|pregabalin|mesh-list
44327931|NCT00967135|Analgesics|analgesics|mesh-ancestor
44327932|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
44327933|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327990|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44327991|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44327992|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468306|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44468307|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44468308|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468309|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
44468310|NCT01438151|Infliximab|infliximab|mesh-list
44468311|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468312|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44468313|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468314|NCT01438060|Aripiprazole|aripiprazole|mesh-list
44468315|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468316|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468317|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468318|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468319|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468320|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982963|NCT02092168|Opicapone|opicapone|mesh-list
44468321|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
44327993|NCT00967408|Citalopram|citalopram|mesh-list
44327994|NCT00967408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44328025|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328026|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
44328027|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328028|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44328029|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44328030|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328031|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328032|NCT00967538|Etanercept|etanercept|mesh-list
44328033|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44328034|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328035|NCT00967538|Analgesics|analgesics|mesh-ancestor
44328083|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328084|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328085|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
44328086|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44328087|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44328088|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328089|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328090|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44328091|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44328092|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328093|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328094|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
44328095|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43739654|NCT02534337|Leucovorin|leucovorin|mesh-list
44328131|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328132|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328195|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
44328196|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328197|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328198|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328199|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328200|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
44328201|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328202|NCT00968435|Bevacizumab|bevacizumab|mesh-list
44328203|NCT00968435|Cetuximab|cetuximab|mesh-list
44328204|NCT00968435|Cisplatin|cisplatin|mesh-list
44328205|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328206|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328207|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328208|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328209|NCT00968435|Growth Substances|growth substances|mesh-ancestor
44328210|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328211|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328239|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
44328240|NCT00968578|Hormones|hormones|mesh-ancestor
44328241|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328242|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44328243|NCT00968578|Protective Agents|protective agents|mesh-ancestor
44328244|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328245|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328246|NCT00968591|Everolimus|everolimus|mesh-list
44328247|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328248|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328249|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
44328250|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328251|NCT00968682|Trastuzumab|trastuzumab|mesh-list
44328252|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328253|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132413|NCT00151203|Clarithromycin|clarithromycin|mesh-list
44328254|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
44328255|NCT00968734|Vitamin D|vitamin d|mesh-list
44328256|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44328285|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328286|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
44328287|NCT00968877|Vitamin D|vitamin d|mesh-list
44328288|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44328289|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328290|NCT00968877|Vitamins|vitamins|mesh-ancestor
44328291|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
44328292|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44328293|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
44328294|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44328295|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44328296|NCT00968903|Prednisolone|prednisolone|mesh-list
44328297|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
44328298|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44328299|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
44328300|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328301|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
44328302|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
44328303|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328304|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328305|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328368|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44328369|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328370|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328371|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328372|NCT00969163|Testosterone|testosterone|mesh-list
44328373|NCT00969163|Androgens|androgens|mesh-ancestor
44328375|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328376|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328377|NCT00969176|Acetaminophen|acetaminophen|mesh-list
44328378|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328379|NCT00969176|Analgesics|analgesics|mesh-ancestor
44328380|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
44328381|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328382|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468350|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468352|NCT01437995|Hormones|hormones|mesh-ancestor
44468353|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468354|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
44468355|NCT01437878|Iloprost|iloprost|mesh-list
44468356|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44468357|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
44468358|NCT01437540|Bromides|bromides|mesh-list
44468359|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
44468360|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468361|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
44468362|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236384|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236385|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236386|NCT00559052|Pancrelipase|pancrelipase|mesh-list
44236387|NCT00559052|Pancreatin|pancreatin|mesh-list
44236388|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236389|NCT00559156|Cisplatin|cisplatin|mesh-list
44236390|NCT00559156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44236391|NCT00559169|Verapamil|verapamil|mesh-list
44236392|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44236393|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44236394|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236395|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098038|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
44468363|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468364|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468365|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468366|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44468367|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44328528|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328529|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328530|NCT00970450|Acetaminophen|acetaminophen|mesh-list
44328531|NCT00970450|Tropisetron|tropisetron|mesh-list
44328532|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328533|NCT00970450|Analgesics|analgesics|mesh-ancestor
44328534|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
44328535|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740066|NCT02532023|Curcumin|curcumin|mesh-list
44328794|NCT00971763|Gemcitabine|gemcitabine|mesh-list
44328795|NCT00971763|Prednisolone|prednisolone|mesh-list
44328796|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
44328797|NCT00971763|Rituximab|rituximab|mesh-list
44328798|NCT00971763|Vincristine|vincristine|mesh-list
44328799|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328800|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
44328801|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328802|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328803|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328804|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
44328805|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328858|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328860|NCT00971893|Protective Agents|protective agents|mesh-ancestor
44328861|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328862|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328863|NCT00972075|Melatonin|melatonin|mesh-list
44328864|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
44328865|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328866|NCT00972075|Protective Agents|protective agents|mesh-ancestor
44329015|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329016|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329049|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329050|NCT00972881|Capecitabine|capecitabine|mesh-list
44329051|NCT00972881|Irinotecan|irinotecan|mesh-list
44329052|NCT00972881|Cetuximab|cetuximab|mesh-list
44329053|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329054|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
44329055|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329056|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468422|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44468424|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
44468425|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468426|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
44468427|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
44468428|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
44468429|NCT01436305|Abatacept|abatacept|mesh-list
44468430|NCT01436305|Tacrolimus|tacrolimus|mesh-list
44468431|NCT01436305|Basiliximab|basiliximab|mesh-list
44468432|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44468433|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
44468434|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468435|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43740622|NCT02528526|Inositol|inositol|mesh-list
44329068|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
44329069|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44329070|NCT00972933|Ipilimumab|ipilimumab|mesh-list
44329071|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329072|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329073|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44329074|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329075|NCT00972946|Dextrans|dextrans|mesh-list
44329076|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
44329077|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
44329078|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
44329079|NCT00972985|Lorazepam|lorazepam|mesh-list
44329080|NCT00972985|Methylphenidate|methylphenidate|mesh-list
44329081|NCT00972985|Modafinil|modafinil|mesh-list
44329082|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44329083|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329112|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44329113|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44329114|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44329116|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
44329117|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44329118|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329119|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329120|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329121|NCT00973115|Simvastatin|simvastatin|mesh-list
44329122|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329123|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329124|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
44329125|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329126|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329157|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44329158|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44329159|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329160|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329161|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44329162|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44329163|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
44329164|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329165|NCT00973232|Acetaminophen|acetaminophen|mesh-list
44329166|NCT00973232|Tramadol|tramadol|mesh-list
44329167|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44329168|NCT00973232|Analgesics|analgesics|mesh-ancestor
44329169|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
44329170|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329171|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329198|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329199|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329200|NCT00973323|Warfarin|warfarin|mesh-list
44329201|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
44329202|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
44329203|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44329204|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
44329205|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44329206|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329207|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329208|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329209|NCT00973336|Vitamin D|vitamin d|mesh-list
44329210|NCT00973336|Calcium|calcium|mesh-list
44329211|NCT00973336|Vitamins|vitamins|mesh-ancestor
44329212|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
44329213|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329214|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44329215|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44329216|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
44329217|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44329218|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329219|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44329220|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44329247|NCT00973609|Bevacizumab|bevacizumab|mesh-list
44329248|NCT00973609|Fluorouracil|fluorouracil|mesh-list
44329249|NCT00973609|Capecitabine|capecitabine|mesh-list
44329250|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329251|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329252|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329253|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329254|NCT00973609|Growth Substances|growth substances|mesh-ancestor
44329255|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329256|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329257|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
44329258|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329259|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329260|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329261|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
44329262|NCT00973609|Hematinics|hematinics|mesh-ancestor
44329263|NCT00973609|Vitamins|vitamins|mesh-ancestor
44329264|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
44329265|NCT00973687|Dexamethasone|dexamethasone|mesh-list
44329266|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329267|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
44329268|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
44329269|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329270|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329271|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44329301|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44329303|NCT00973869|Analgesics|analgesics|mesh-ancestor
44329304|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
44329305|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329306|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329307|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329308|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329309|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329310|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329311|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329312|NCT00973882|Carboplatin|carboplatin|mesh-list
44329313|NCT00973882|Etoposide|etoposide|mesh-list
44329314|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329495|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329496|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44329497|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44329498|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44329499|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329500|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44329501|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
44329502|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44329503|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329504|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
44329505|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44329506|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44329507|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44329508|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44329509|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
44329510|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329512|NCT00974792|Protective Agents|protective agents|mesh-ancestor
44329547|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
44329548|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329549|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329550|NCT00975052|Metformin|metformin|mesh-list
44329551|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44329552|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329553|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329554|NCT00975052|Incretins|incretins|mesh-ancestor
44329613|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44329614|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329615|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329616|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44329617|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44329618|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
44329619|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329620|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
44329621|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
44329622|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44329623|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44329624|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329625|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329626|NCT00975494|Urological Agents|urological agents|mesh-ancestor
44329627|NCT00975533|Insulin|insulin|mesh-list
44329628|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43741070|NCT02526199|Dexamethasone|dexamethasone|mesh-list
44329663|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
44329664|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
44329665|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329666|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44329667|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329668|NCT00975819|Sirolimus|sirolimus|mesh-list
43835197|NCT05067933|Vaccines|vaccines|mesh-list
44329704|NCT00975897|Vitamins|vitamins|mesh-ancestor
44329705|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
44329706|NCT00975910|Lidocaine|lidocaine|mesh-list
44329707|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
44329708|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
44329709|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329710|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329735|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329736|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44329738|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329739|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44329740|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
44329741|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329742|NCT00976066|Naltrexone|naltrexone|mesh-list
44329743|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44329744|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43984788|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
44329745|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329746|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
44329747|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329748|NCT00976092|Heparin|heparin|mesh-list
44329749|NCT00976092|Calcium heparin|calcium heparin|mesh-list
44329750|NCT00976092|Bivalirudin|bivalirudin|mesh-list
44329751|NCT00976092|Clopidogrel|clopidogrel|mesh-list
44329752|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44329753|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44329754|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44329784|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329785|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329786|NCT00976222|Growth Substances|growth substances|mesh-ancestor
44329787|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329788|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329789|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329790|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44329791|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329792|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329793|NCT00976261|Incretins|incretins|mesh-ancestor
44329794|NCT00976261|Hormones|hormones|mesh-ancestor
44329795|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329796|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44329797|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329798|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468519|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44468520|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468521|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468522|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468523|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468524|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468525|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44468526|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44468527|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44468528|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468552|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468553|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468555|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329828|NCT00976690|Mesalamine|mesalamine|mesh-list
44329829|NCT00976690|Azathioprine|azathioprine|mesh-list
44329830|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
44329831|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098267|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
44329832|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329833|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329834|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329835|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
44329836|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329837|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329838|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44329839|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44329840|NCT00976690|Analgesics|analgesics|mesh-ancestor
44329841|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
44329842|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329843|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329845|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329846|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329847|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
44329882|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329884|NCT00976976|Docetaxel|docetaxel|mesh-list
44329885|NCT00976976|Capecitabine|capecitabine|mesh-list
44329886|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329887|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
43741296|NCT02524743|Analgesics|analgesics|mesh-ancestor
44329967|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329968|NCT00977288|Atorvastatin|atorvastatin|mesh-list
44329969|NCT00977288|Anacetrapib|anacetrapib|mesh-list
44329970|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329971|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329972|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
44329973|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329974|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329975|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329976|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329978|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
44329979|NCT00977301|Olanzapine|olanzapine|mesh-list
44329980|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44329981|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44329982|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329983|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329984|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329985|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44329986|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44329987|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
44329988|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329989|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44329990|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330018|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330019|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44330020|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330021|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330022|NCT00977444|Prednisolone|prednisolone|mesh-list
44330023|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44330024|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
44330025|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44330026|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
44330027|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44330028|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
44330029|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330030|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
44330031|NCT00977444|Hormones|hormones|mesh-ancestor
44330032|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330033|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330034|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44330035|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330071|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44330072|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330073|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
44330074|NCT00977873|Vitamin D|vitamin d|mesh-list
44330075|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330076|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330077|NCT00977873|Vitamins|vitamins|mesh-ancestor
44330111|NCT00978172|Mefloquine|mefloquine|mesh-list
44330112|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
44330113|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44330114|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44098333|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330115|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330116|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330117|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
44330118|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
44330119|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44330120|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
44330153|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330154|NCT00978393|Liraglutide|liraglutide|mesh-list
44330155|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330156|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330157|NCT00978393|Incretins|incretins|mesh-ancestor
44330159|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330160|NCT00978471|Thiotepa|thiotepa|mesh-list
44330161|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44330162|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
44330194|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330196|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330197|NCT00978718|Trace Elements|trace elements|mesh-ancestor
44330198|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
44330199|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44330200|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330201|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330202|NCT00978796|Incretins|incretins|mesh-ancestor
44330203|NCT00978796|Hormones|hormones|mesh-ancestor
44330204|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330303|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44330304|NCT00979589|Analgesics|analgesics|mesh-ancestor
44330446|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330447|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330448|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330449|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330450|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330474|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330475|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330476|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44330477|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330478|NCT00980551|Carboplatin|carboplatin|mesh-list
44330479|NCT00980551|Vincristine|vincristine|mesh-list
44330480|NCT00980551|Topotecan|topotecan|mesh-list
44330481|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330482|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44330483|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330484|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330485|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330486|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330487|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44330488|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44330489|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330491|NCT00980603|Docetaxel|docetaxel|mesh-list
44330492|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330493|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330494|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330495|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330496|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330497|NCT00980616|Ropivacaine|ropivacaine|mesh-list
44330498|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
44330499|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
44330500|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330501|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330502|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
44330503|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330504|NCT00980707|Fluticasone|fluticasone|mesh-list
44330537|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
44330538|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330539|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330540|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330541|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330542|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44330543|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44330544|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330545|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330546|NCT00981318|Ritonavir|ritonavir|mesh-list
44132908|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44330547|NCT00981318|Lopinavir|lopinavir|mesh-list
44330548|NCT00981318|Maraviroc|maraviroc|mesh-list
44330582|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330583|NCT00981591|Iloprost|iloprost|mesh-list
44330584|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44330585|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
44330586|NCT00981708|Dexamethasone|dexamethasone|mesh-list
44330587|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
44330588|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
44330589|NCT00981708|Lenalidomide|lenalidomide|mesh-list
44330590|NCT00981708|BB 1101|bb 1101|mesh-list
44330658|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44330659|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
44330660|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
44330661|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44330662|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
44330663|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330664|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330665|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
44330666|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44330667|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44330668|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44330669|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44330701|NCT00981929|Analgesics|analgesics|mesh-ancestor
44330702|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
44330703|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330704|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
44330705|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330706|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330707|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330708|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330709|NCT00981955|Caffeine|caffeine|mesh-list
44330710|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44330711|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330712|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43835377|NCT05058976|Vitamin D|vitamin d|mesh-list
44330773|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330774|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330775|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330776|NCT00982540|Caspofungin|caspofungin|mesh-list
44330777|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
44330778|NCT00982540|Clotrimazole|clotrimazole|mesh-list
44330779|NCT00982540|Miconazole|miconazole|mesh-list
44330780|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330781|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330782|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330783|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44330784|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44330785|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330786|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44330787|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
44330816|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330817|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
44330818|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330819|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
44330820|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
44330821|NCT00982722|Vitamin D|vitamin d|mesh-list
44330822|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
44330823|NCT00982722|Calcium|calcium|mesh-list
44330824|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330825|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330826|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44330827|NCT00982722|Vitamins|vitamins|mesh-ancestor
44330828|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
44330829|NCT00982722|Antacids|antacids|mesh-ancestor
44330830|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330831|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330832|NCT00982800|Gabapentin|gabapentin|mesh-list
44330833|NCT00982800|Analgesics|analgesics|mesh-ancestor
44330894|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330895|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330896|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330897|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
44330898|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
44330899|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44330900|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44330901|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44330902|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44330903|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330904|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330905|NCT00983138|Asparaginase|asparaginase|mesh-list
44330906|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330907|NCT00983151|Tramadol|tramadol|mesh-list
44330908|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330909|NCT00983151|Narcotics|narcotics|mesh-ancestor
44330910|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330911|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330912|NCT00983151|Analgesics|analgesics|mesh-ancestor
44330913|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
44330914|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330979|NCT00983424|Paclitaxel|paclitaxel|mesh-list
44330980|NCT00983424|Cyclosporins|cyclosporins|mesh-list
44330981|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44330982|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330983|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330984|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44331047|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331048|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44331049|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
44331050|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331051|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331052|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44331053|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331054|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44331055|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44331056|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331057|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331058|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331059|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
44331119|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44331121|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331122|NCT00984438|Bevacizumab|bevacizumab|mesh-list
44331123|NCT00984438|Irinotecan|irinotecan|mesh-list
44331124|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331125|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331126|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44331127|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44331128|NCT00984438|Growth Substances|growth substances|mesh-ancestor
44331129|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331239|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
44331240|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44331241|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
44331242|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331243|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
44331244|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
44331245|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331246|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331247|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331248|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
44331249|NCT00984984|Hormones|hormones|mesh-ancestor
44331250|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331251|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44331252|NCT00984984|Protective Agents|protective agents|mesh-ancestor
44331280|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44331281|NCT00985322|Ramipril|ramipril|mesh-list
44331282|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
44331283|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44331284|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44331285|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331286|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331287|NCT00985348|Levetiracetam|levetiracetam|mesh-list
44331288|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
44331289|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
44331290|NCT00985361|Vitamin D|vitamin d|mesh-list
44331291|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
44331292|NCT00985361|Vitamins|vitamins|mesh-list
44331293|NCT00985361|Ascorbic Acid|ascorbic acid|mesh-list
44331294|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
44331295|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331296|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43612537|NCT03165409|Ipilimumab|ipilimumab|mesh-list
44098577|NCT00049569|Vitamins|vitamins|mesh-ancestor
44331297|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44331298|NCT00985361|Antioxidants|antioxidants|mesh-ancestor
44331400|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44331402|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
44331403|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331404|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331405|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44331406|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
44331407|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44331470|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
44331471|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331472|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44331473|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44331474|NCT00986609|Poly I-C|poly i-c|mesh-list
44331475|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44331476|NCT00986609|Vaccines|vaccines|mesh-list
44331477|NCT00986609|Poly ICLC|poly iclc|mesh-list
44331478|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
44331479|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331480|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
44331481|NCT00986609|Laxatives|laxatives|mesh-ancestor
44331482|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331483|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
44331552|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
44331553|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
44331554|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742390|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44331644|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331645|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
44331646|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331647|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331648|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44331649|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44331650|NCT00987493|Growth Substances|growth substances|mesh-ancestor
44331651|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
44331652|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44331653|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
44331654|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331655|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
44331656|NCT00987636|Diphosphonates|diphosphonates|mesh-list
44331657|NCT00987636|Busulfan|busulfan|mesh-list
44331658|NCT00987636|Treosulfan|treosulfan|mesh-list
44331659|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
44331660|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331661|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331751|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44331752|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44331753|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331755|NCT00988026|Lymecycline|lymecycline|mesh-list
44331756|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331757|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331758|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
44331759|NCT00988039|Lopinavir|lopinavir|mesh-list
44331760|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44331761|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331762|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
44331763|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331764|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44331765|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44331766|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331767|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331768|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44331769|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44331770|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
44331807|NCT00988520|Propofol|propofol|mesh-list
44331808|NCT00988520|Sevoflurane|sevoflurane|mesh-list
44331809|NCT00988520|Rocuronium|rocuronium|mesh-list
44331810|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44331811|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331812|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331813|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44331814|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
44331830|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44331832|NCT00988715|Cyclosporine|cyclosporine|mesh-list
44331833|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
44331834|NCT00988715|Fludarabine|fludarabine|mesh-list
44098639|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
44331835|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
44331836|NCT00988715|Cyclosporins|cyclosporins|mesh-list
44331837|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331838|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331839|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
44331840|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331841|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331842|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
44331843|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331844|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331845|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
44331846|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331847|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44331848|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331849|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44331850|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44331851|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44331852|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
44331853|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331854|NCT00988728|Olanzapine|olanzapine|mesh-list
44331855|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
43986909|NCT02258412|Ethanol|ethanol|mesh-list
44331856|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
44331857|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331858|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331859|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331860|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44331861|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43852038|NCT03879694|Sargramostim|sargramostim|mesh-list
44331862|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331863|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44331864|NCT00988728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44331865|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44331866|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331867|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331868|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331869|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
44331870|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44331871|NCT00988780|Efavirenz|efavirenz|mesh-list
44331995|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
43835540|NCT05042102|Donepezil|donepezil|mesh-list
44332055|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44332057|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44332058|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
44332059|NCT00989651|Antibodies|antibodies|mesh-list
44332060|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
44332061|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44332062|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
44332063|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332064|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332065|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332066|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332167|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
44332169|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
44332170|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
44332171|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
44332172|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44332173|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332174|NCT00990158|Vitamin K|vitamin k|mesh-list
44332175|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
44332176|NCT00990158|Vitamins|vitamins|mesh-ancestor
44332177|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
44332178|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332179|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44332180|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44332181|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332182|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
44332183|NCT00990158|Coagulants|coagulants|mesh-ancestor
44332184|NCT00990197|Nicotine|nicotine|mesh-list
44332185|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44332186|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
44332187|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332188|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332189|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44332190|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44332191|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
44098715|NCT00050141|Tipifarnib|tipifarnib|mesh-list
44332192|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332193|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332194|NCT00990223|Eplerenone|eplerenone|mesh-list
44332195|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44332196|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
44332197|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44332198|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332199|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44332200|NCT00990223|Diuretics|diuretics|mesh-ancestor
44332201|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
44332202|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44332241|NCT00990418|Narcotics|narcotics|mesh-ancestor
43742889|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44332307|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332308|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44332309|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44332405|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
44332406|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332407|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44332408|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
44332409|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44332411|NCT00991211|Vincristine|vincristine|mesh-list
43852109|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
44332412|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332413|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
44332414|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332415|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332446|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
44332447|NCT00991627|Morphine|morphine|mesh-list
44332448|NCT00991627|Bupivacaine|bupivacaine|mesh-list
44332449|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
44332450|NCT00991627|Anesthetics|anesthetics|mesh-list
44332451|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332452|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332453|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
44332454|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332455|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44332456|NCT00991627|Narcotics|narcotics|mesh-ancestor
44332457|NCT00991627|Analgesics|analgesics|mesh-ancestor
44332502|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332503|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
44332504|NCT00991744|Hormones|hormones|mesh-ancestor
44332505|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44332506|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44332507|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
44332508|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
44332509|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332510|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44332511|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44332512|NCT00991744|Protective Agents|protective agents|mesh-ancestor
44332513|NCT00991783|Digoxin|digoxin|mesh-list
44332514|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44332515|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44332516|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332517|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332518|NCT00991783|Protective Agents|protective agents|mesh-ancestor
43987544|NCT02290444|Hormones|hormones|mesh-list
44332519|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332521|NCT00991796|Carboplatin|carboplatin|mesh-list
43743093|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332571|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332573|NCT05408208|Methotrexate|methotrexate|mesh-list
44332574|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44332575|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
44332576|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44332577|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332578|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44332579|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
44332580|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332581|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332582|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332583|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332584|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44332585|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332619|NCT05408065|Protective Agents|protective agents|mesh-ancestor
44332620|NCT05408000|Propofol|propofol|mesh-list
44332621|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44332622|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332623|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332624|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44332625|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
44332626|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
44332627|NCT05407870|Propofol|propofol|mesh-list
44332628|NCT05407870|Etomidate|etomidate|mesh-list
44332629|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44332720|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
44332721|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
44333125|NCT05088356|Tacrolimus|tacrolimus|mesh-list
44333126|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
44333127|NCT05088356|Lenograstim|lenograstim|mesh-list
44333128|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333363|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44333365|NCT04382352|Antibodies|antibodies|mesh-list
44333366|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
44333367|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44333368|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
44333369|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333370|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333371|NCT04298606|Vaccines|vaccines|mesh-list
44333372|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44333373|NCT04298606|Mitogens|mitogens|mesh-list
44333374|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
44333375|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333376|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333377|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743746|NCT04278404|Gabapentin|gabapentin|mesh-list
44333444|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44333445|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44333446|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
44333447|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333448|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333449|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44333450|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333521|NCT03405792|Temozolomide|temozolomide|mesh-list
44333522|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333523|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333524|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44333525|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
44333526|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333527|NCT03377491|Gemcitabine|gemcitabine|mesh-list
44333528|NCT03377491|Paclitaxel|paclitaxel|mesh-list
44333529|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44333530|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333531|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333579|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333580|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333581|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333582|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
44333583|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333584|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
44333585|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333586|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
44333587|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333588|NCT03253913|Protective Agents|protective agents|mesh-ancestor
44333589|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333590|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44333591|NCT03229499|Anastrozole|anastrozole|mesh-list
44333592|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44333593|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333594|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44333595|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44333596|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333597|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333598|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44333599|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426851|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333600|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333601|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333602|NCT03186638|Ibuprofen|ibuprofen|mesh-list
44333647|NCT02176967|Etoposide|etoposide|mesh-list
44333648|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
44333649|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
44333650|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333651|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
44333652|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333653|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333654|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44333655|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
44333656|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333657|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333658|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44333659|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333660|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44333661|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44333662|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333663|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852255|NCT03864419|Hormones|hormones|mesh-ancestor
44333664|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
44333665|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
44333666|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333667|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333668|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333669|NCT01976390|Sirolimus|sirolimus|mesh-list
44333670|NCT01976390|Everolimus|everolimus|mesh-list
44333671|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333672|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333673|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
44333674|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333675|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333676|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333677|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333678|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
44333679|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44333680|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44333708|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333709|NCT05213481|Tepotinib|tepotinib|mesh-list
44333710|NCT05213481|Carbamazepine|carbamazepine|mesh-list
44333711|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
44333712|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
44333713|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44333714|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333715|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333716|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44333717|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44333718|NCT05213481|Analgesics|analgesics|mesh-ancestor
44333719|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
44333720|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333721|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44333722|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333723|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333724|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44333725|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44333726|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333727|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
44333728|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44333729|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333850|NCT04664738|Coagulants|coagulants|mesh-ancestor
44333851|NCT04626141|Abaloparatide|abaloparatide|mesh-list
44333852|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44333853|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333854|NCT04597697|Insulin|insulin|mesh-list
44333855|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333856|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333857|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
44333858|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
44333859|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
44333860|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333861|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44333862|NCT04558281|Ropivacaine|ropivacaine|mesh-list
44333863|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
44333864|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
44333865|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333974|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333975|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333977|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333978|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333979|NCT04273061|Atezolizumab|atezolizumab|mesh-list
44333980|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333981|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
44333982|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333983|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333984|NCT04192266|Estradiol|estradiol|mesh-list
44333985|NCT04192266|Estrogens|estrogens|mesh-ancestor
44333986|NCT04192266|Hormones|hormones|mesh-ancestor
44333987|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333988|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333989|NCT04139525|Heparin|heparin|mesh-list
44333990|NCT04139525|Calcium heparin|calcium heparin|mesh-list
44333991|NCT04139525|Citric Acid|citric acid|mesh-list
44333992|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
44333993|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
44333994|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44333995|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
44333996|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
43744313|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989156|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
44334053|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334054|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44334055|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
44334056|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
44334057|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44334058|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44334059|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44334060|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
44334061|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334062|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334063|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44334064|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44334185|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334187|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44334188|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
43744470|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334318|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44334319|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44334320|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44334397|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44334398|NCT00992199|Cisplatin|cisplatin|mesh-list
44334399|NCT00992199|Fluorouracil|fluorouracil|mesh-list
44334400|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334401|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
44334402|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334403|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334404|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334405|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
44334406|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334407|NCT00992238|Flavoxate|flavoxate|mesh-list
44334408|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
44334409|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
44334410|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334411|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334412|NCT00992238|Urological Agents|urological agents|mesh-ancestor
44334413|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
44334439|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334440|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
44334441|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334442|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334443|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334444|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334445|NCT00992355|Analgesics|analgesics|mesh-ancestor
44334446|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
44334447|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334448|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44334449|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44334452|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334453|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334454|NCT00992381|Analgesics|analgesics|mesh-ancestor
44334455|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
44334456|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334457|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334458|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334459|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334460|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
44334461|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44334462|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334528|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
44334529|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334530|NCT00992706|Doxorubicin|doxorubicin|mesh-list
44334531|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44334532|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44334533|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744746|NCT03055013|Nivolumab|nivolumab|mesh-list
44334583|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44334584|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44334585|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334586|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334588|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334589|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334590|NCT00993070|Capsaicin|capsaicin|mesh-list
44334591|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
44334592|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44334593|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
44334594|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334595|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334596|NCT00993096|Insulin|insulin|mesh-list
44334597|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44334598|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
44334599|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
44334600|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44334601|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
44334602|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44334603|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
44334604|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334605|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334606|NCT00993109|Valsartan|valsartan|mesh-list
44334607|NCT00993109|Nifedipine|nifedipine|mesh-list
44334608|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334609|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44334610|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44334611|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334612|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44334613|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334614|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44334615|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334616|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
44334617|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
43744818|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989986|NCT02406443|Hormones|hormones|mesh-ancestor
44334910|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
44334911|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334912|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44334913|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334914|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334915|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334916|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44334917|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44334918|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44334919|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44334920|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
44334921|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44334955|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334956|NCT00994903|Simvastatin|simvastatin|mesh-list
44334957|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44334958|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44334959|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
44334961|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44334991|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334992|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44334993|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44334994|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44334995|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44334996|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44334997|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44334998|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44334999|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335000|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335001|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
44335002|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
44335003|NCT00994981|Analgesics|analgesics|mesh-ancestor
44335004|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
44335005|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335006|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335036|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335037|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335038|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335039|NCT00995046|Factor VIII|factor viii|mesh-list
44335040|NCT00995046|Coagulants|coagulants|mesh-ancestor
44335041|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44335042|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
44335043|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44335044|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44335045|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
44335046|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335047|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44335048|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44335049|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335050|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335052|NCT00995293|Docetaxel|docetaxel|mesh-list
44335090|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335091|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335092|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
44335093|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44335216|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335217|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335218|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335219|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44335220|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
44335221|NCT00996099|Insulin|insulin|mesh-list
44335222|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44335223|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44335260|NCT00996190|Protective Agents|protective agents|mesh-ancestor
43990315|NCT02423980|Hormones|hormones|mesh-ancestor
44335262|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
44335318|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44335319|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335320|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
44335321|NCT00996697|Hormones|hormones|mesh-ancestor
44335322|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335323|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44335394|NCT00997022|Sorafenib|sorafenib|mesh-list
44335395|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335396|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335397|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745488|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44335485|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44335486|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335487|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
44335488|NCT00997477|Hormones|hormones|mesh-ancestor
44335489|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335490|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44335491|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44335492|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44335493|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
44335494|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335495|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335496|NCT00997542|Allopurinol|allopurinol|mesh-list
44335497|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
44335498|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335500|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
44335501|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335561|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44335562|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44335563|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44335564|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335565|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335566|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
44335567|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335568|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335569|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44335570|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335572|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335573|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335698|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44335699|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44335700|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
44335701|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133094|NCT00152841|Vitamin E|vitamin e|mesh-list
44335702|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335703|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
44335704|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
44335705|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335706|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335707|NCT00998608|Risperidone|risperidone|mesh-list
44335708|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44335709|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
44335710|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335711|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335712|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335713|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44335714|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335715|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335716|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335717|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43990808|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335718|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
44335719|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
44335720|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
44335721|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335722|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335723|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335724|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
44335725|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335726|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335727|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335728|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44335729|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44335730|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335731|NCT00998686|Incretins|incretins|mesh-ancestor
44335732|NCT00998686|Hormones|hormones|mesh-ancestor
44335733|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335734|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44335735|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
44335736|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335798|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44335799|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335800|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335801|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44335802|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
44335803|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
44335804|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335805|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335806|NCT00999232|Erythromycin|erythromycin|mesh-list
44335807|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
44335808|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44335809|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
44335810|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335811|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335812|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426852|NCT02207621|Timolol|timolol|mesh-list
44335849|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336086|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336087|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44336089|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44336090|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44336091|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336092|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336093|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746106|NCT01242267|Growth Substances|growth substances|mesh-ancestor
44336129|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336215|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44336216|NCT01001637|Curcumin|curcumin|mesh-list
44336217|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44336218|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44336219|NCT01001637|Analgesics|analgesics|mesh-ancestor
44336220|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
44336221|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336222|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336223|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336224|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336225|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336226|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336227|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336228|NCT01001676|Paclitaxel|paclitaxel|mesh-list
44336229|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44336230|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336231|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336232|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336233|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336234|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336235|NCT01001754|Ribavirin|ribavirin|mesh-list
44336236|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44336237|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
44336238|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336239|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
44336240|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336241|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
44336242|NCT01001780|Rituximab|rituximab|mesh-list
44336243|NCT01001780|Pentostatin|pentostatin|mesh-list
44336244|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336245|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
44336246|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336247|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336248|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336249|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
44336250|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336251|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336252|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336253|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44336254|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44336255|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336256|NCT01001845|Vitamin E|vitamin e|mesh-list
44336257|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
44336258|NCT01001845|Tocopherols|tocopherols|mesh-list
44336259|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
44336260|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336261|NCT01001845|Protective Agents|protective agents|mesh-ancestor
44336262|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336263|NCT01001845|Vitamins|vitamins|mesh-ancestor
44336264|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
44336265|NCT01001871|Vitamins|vitamins|mesh-list
44336266|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
44336267|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336268|NCT01001897|Misoprostol|misoprostol|mesh-list
44336269|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44336270|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
44336271|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44336272|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336273|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44336274|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336275|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
44336276|NCT01001962|Metformin|metformin|mesh-list
44336277|NCT01001962|Empagliflozin|empagliflozin|mesh-list
43549249|NCT03634514|Hormones|hormones|mesh-list
44336463|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152992|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44336464|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336465|NCT01003847|Fenofibrate|fenofibrate|mesh-list
44336466|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44336467|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
44336468|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336469|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44336470|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
44336471|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44336506|NCT01004315|Urological Agents|urological agents|mesh-ancestor
44336508|NCT01004380|Farletuzumab|farletuzumab|mesh-list
44336509|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336537|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336538|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336539|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336540|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
44336541|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
44336542|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336543|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336544|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
44336545|NCT01004497|Hormones|hormones|mesh-ancestor
44336546|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336547|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44336548|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
44336549|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336550|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44336551|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
44336552|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
44336553|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336554|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44336555|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336556|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336557|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336558|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43746502|NCT02523820|Xhance|xhance|mesh-list
44336743|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
44336744|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746626|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44336831|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336832|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336833|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44336834|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44336835|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44336836|NCT01005979|Growth Substances|growth substances|mesh-ancestor
44336837|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
44336838|NCT01006031|Interferons|interferons|mesh-list
44336839|NCT01006031|Ribavirin|ribavirin|mesh-list
44336840|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
44336841|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
44336842|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44336843|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336844|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
44336845|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336846|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
44336847|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336848|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
44336849|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336850|NCT01006057|Insulin|insulin|mesh-list
44337273|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337274|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337275|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44337277|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747012|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
44337421|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44337422|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44337423|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44337424|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
44337425|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
44337426|NCT01010048|Nifedipine|nifedipine|mesh-list
44337427|NCT01010048|Bromides|bromides|mesh-list
44337428|NCT01010048|Propantheline|propantheline|mesh-list
44337429|NCT01010048|Tamsulosin|tamsulosin|mesh-list
44337430|NCT01010048|Progesterone|progesterone|mesh-list
44337431|NCT01010048|Progestins|progestins|mesh-ancestor
44337433|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337434|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236396|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337469|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337471|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
44337472|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337506|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
44337507|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337508|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337509|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337510|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
44337511|NCT01010243|Hormones|hormones|mesh-ancestor
44337512|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852661|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
44337513|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835866|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
44337575|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44337576|NCT01010516|Fenofibrate|fenofibrate|mesh-list
44337577|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44337578|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337580|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337581|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337582|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337583|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337584|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
44337585|NCT01010516|Vitamins|vitamins|mesh-ancestor
44337586|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
44337587|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337588|NCT01010581|Folic Acid|folic acid|mesh-list
44337589|NCT01010581|Methotrexate|methotrexate|mesh-list
44337590|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44337591|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
44337592|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44337593|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337625|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
44337626|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337627|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
44337628|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337630|NCT01010698|Cimetidine|cimetidine|mesh-list
44337631|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
44337632|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337633|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44337634|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337635|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44337636|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
44337637|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
44337638|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747198|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337670|NCT01010945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337671|NCT01010945|Immunologic Factors|immunologic factors|mesh-ancestor
44337672|NCT01010945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337673|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337675|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
44337676|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337677|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337678|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
43747226|NCT02518763|Vitamin D|vitamin d|mesh-list
44337714|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337715|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337716|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44337717|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
44337718|NCT01011062|Losartan|losartan|mesh-list
44337719|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44337720|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337755|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43747294|NCT02518451|Valsartan|valsartan|mesh-list
44337784|NCT01011348|Vitamins|vitamins|mesh-ancestor
44337785|NCT01011374|Ranibizumab|ranibizumab|mesh-list
44337786|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44337787|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44337788|NCT01011374|Growth Substances|growth substances|mesh-ancestor
44337789|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337790|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44337791|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337792|NCT01011426|Bisacodyl|bisacodyl|mesh-list
44337793|NCT01011426|Cathartics|cathartics|mesh-ancestor
44337794|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44236397|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337795|NCT01011426|Laxatives|laxatives|mesh-ancestor
44337796|NCT01011452|Montelukast|montelukast|mesh-list
44337797|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44337798|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337799|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44337800|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
44337801|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337802|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337803|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44337804|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44338108|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338109|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
44338110|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
44338111|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338112|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338113|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338114|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
44338116|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338117|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338118|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338119|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44338151|NCT01013454|Varenicline|varenicline|mesh-list
44338152|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44338153|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44338154|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
44338155|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338156|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338157|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338158|NCT01013480|Baclofen|baclofen|mesh-list
44338159|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44338160|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338161|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44338190|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338192|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338193|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44338194|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44338195|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338196|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44338197|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44338198|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338199|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
44338200|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44338201|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
44338202|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44338203|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
44338204|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44338205|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44338206|NCT01013532|Protective Agents|protective agents|mesh-ancestor
44338241|NCT01013805|Leucovorin|leucovorin|mesh-list
44338242|NCT01013805|Fluorouracil|fluorouracil|mesh-list
44338243|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
44338244|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
44338245|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338246|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338247|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338248|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338249|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
44338282|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44338283|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44338284|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44338285|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44338286|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44338287|NCT01014052|Retinol acetate|retinol acetate|mesh-list
44338288|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44338289|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
44338290|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338291|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44338292|NCT01014052|Protective Agents|protective agents|mesh-ancestor
44338293|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338326|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338327|NCT01014234|Cyclosporine|cyclosporine|mesh-list
44338328|NCT01014234|Sirolimus|sirolimus|mesh-list
44338329|NCT01014234|Cyclosporins|cyclosporins|mesh-list
44338330|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338331|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338332|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338333|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
44338334|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338335|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
44338336|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338372|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44338373|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44338446|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338612|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338613|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
44338614|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338615|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338616|NCT01015417|Amoxicillin|amoxicillin|mesh-list
43747676|NCT05337137|Nivolumab|nivolumab|mesh-list
44338676|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44338677|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338678|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338679|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
44338680|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338681|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338682|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747719|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
44338745|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
44338746|NCT01015937|Turmeric extract|turmeric extract|mesh-list
44338747|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44338748|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338749|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44338750|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44338751|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338752|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338753|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338754|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
44338755|NCT01015937|Protective Agents|protective agents|mesh-ancestor
44338756|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338757|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44338818|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44338819|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44338820|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338821|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338822|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338823|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44338905|NCT01016990|Valproic Acid|valproic acid|mesh-list
44338906|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
44338907|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338908|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338909|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
44338910|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338911|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338912|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
44338913|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44338914|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338915|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44338916|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44338917|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44338918|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338919|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44339002|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339003|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44339004|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339005|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44339006|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44339007|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44339008|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44339009|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44339010|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
44339011|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339012|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339013|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236398|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
44339015|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339016|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44339017|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852886|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
44339018|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339019|NCT01017744|Anesthetics|anesthetics|mesh-list
44339020|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747865|NCT04921033|Hormones|hormones|mesh-ancestor
44339088|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
44339089|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339090|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
44339091|NCT01017939|Hormones|hormones|mesh-ancestor
44339092|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747904|NCT04833413|Insulin|insulin|mesh-list
44339150|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44339151|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44339152|NCT01018381|Ethanol|ethanol|mesh-list
44339153|NCT01018381|Entecavir|entecavir|mesh-list
44339154|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44339155|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339156|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339157|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339158|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
44339159|NCT01018446|Busulfan|busulfan|mesh-list
44339160|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
44339161|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339287|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
44339288|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339289|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44339291|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339292|NCT01019291|Formaldehyde|formaldehyde|mesh-list
44339325|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
44339326|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339327|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
44339328|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339329|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
44339330|NCT01019447|Triclosan|triclosan|mesh-list
44339331|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44339332|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44339333|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44339334|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44339335|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
44339409|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44339410|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339411|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44339460|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339461|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
43994545|NCT05362994|Sirolimus|sirolimus|mesh-list
44339462|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44339463|NCT01020214|Olmesartan|olmesartan|mesh-list
44339464|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44339465|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44339466|NCT01020214|Diuretics|diuretics|mesh-ancestor
44339467|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
44339468|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339469|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44339470|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339471|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339472|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44339473|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44339474|NCT01020253|Alendronate|alendronate|mesh-list
44339508|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
44339509|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339510|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339511|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339512|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44339513|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44339514|NCT01020357|Caffeine|caffeine|mesh-list
44339515|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
44339516|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339544|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
44339545|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339546|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44339547|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44236399|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
44339548|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339549|NCT01020630|Sunitinib|sunitinib|mesh-list
44339550|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339551|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44339552|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44339553|NCT01020630|Growth Substances|growth substances|mesh-ancestor
44339554|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339555|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44339556|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44339557|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339558|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339559|NCT01020643|Propofol|propofol|mesh-list
44339560|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44339561|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339562|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339563|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44339564|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
44339565|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
44339589|NCT01020734|Cyclosporine|cyclosporine|mesh-list
44339590|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
44339591|NCT01020734|Busulfan|busulfan|mesh-list
44339592|NCT01020734|Methotrexate|methotrexate|mesh-list
44339593|NCT01020734|Fludarabine|fludarabine|mesh-list
44339594|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
44339595|NCT01020734|Cyclosporins|cyclosporins|mesh-list
44339596|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44339597|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339598|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
44339599|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339600|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339601|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339602|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
44339603|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339604|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339605|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44339606|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44339607|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
44339608|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44339609|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44339610|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
44339611|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
44339612|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339613|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44339614|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44339615|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
44339616|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339617|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44339618|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44339619|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
44339647|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339648|NCT01021163|Protective Agents|protective agents|mesh-ancestor
44339649|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339650|NCT01021163|Antidotes|antidotes|mesh-ancestor
44339651|NCT01021176|Diltiazem|diltiazem|mesh-list
44339652|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44339653|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44339654|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339655|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339656|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339657|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339658|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
44339659|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
44339660|NCT01021267|Urological Agents|urological agents|mesh-ancestor
44339661|NCT01021358|Ketoconazole|ketoconazole|mesh-list
44339662|NCT01021358|Navitoclax|navitoclax|mesh-list
44339663|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
44339664|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339665|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44339666|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44339667|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339668|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339669|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44339693|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236400|NCT00559195|Hematinics|hematinics|mesh-ancestor
44339694|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44339695|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44339696|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339697|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
44339698|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44339699|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44339700|NCT01021501|Nifedipine|nifedipine|mesh-list
44339701|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44339702|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339703|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339704|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339705|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339706|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
44339707|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
44339708|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44339709|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44339710|NCT01021540|Hormones|hormones|mesh-ancestor
44339711|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339712|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339713|NCT01021566|Methadone|methadone|mesh-list
44339714|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44339715|NCT01021566|Narcotics|narcotics|mesh-ancestor
44339716|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339717|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339718|NCT01021566|Analgesics|analgesics|mesh-ancestor
44339719|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
44339753|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44339754|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339755|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339756|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
44339757|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44339758|NCT01021735|Adalimumab|adalimumab|mesh-list
44339759|NCT01021735|Etanercept|etanercept|mesh-list
44339760|NCT01021735|Rituximab|rituximab|mesh-list
44339761|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339762|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339800|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44339801|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339829|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
44339830|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339831|NCT01022047|Budesonide|budesonide|mesh-list
44339832|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339833|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44339834|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
44339835|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339836|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339837|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44339838|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339839|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
44339840|NCT01022047|Hormones|hormones|mesh-ancestor
44339841|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339842|NCT01022125|Simeprevir|simeprevir|mesh-list
44339843|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
44339844|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339845|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
44339846|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339882|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
44339883|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
44339884|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339885|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339886|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44339921|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339922|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339923|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44339924|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44339925|NCT01022541|Growth Substances|growth substances|mesh-ancestor
43748450|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
44340021|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
44340022|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340023|NCT01022983|Simendan|simendan|mesh-list
44340024|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44340025|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
44340026|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44340027|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44340061|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340062|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340063|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44340064|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44340065|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340066|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44340067|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44340068|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340069|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
44340070|NCT01023334|Lidocaine|lidocaine|mesh-list
44340188|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340189|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340190|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
44340192|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340193|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44340194|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340195|NCT01024140|Citalopram|citalopram|mesh-list
44340196|NCT01024140|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44340197|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44340198|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340199|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340200|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340201|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
43748592|NCT02516774|Adalimumab|adalimumab|mesh-list
44340228|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340229|NCT01024205|Growth Substances|growth substances|mesh-ancestor
44340230|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340231|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340232|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44340233|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340234|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340235|NCT01024270|Misoprostol|misoprostol|mesh-list
44340236|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44340237|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
44340238|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44340239|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340240|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44340241|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340242|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
44340243|NCT01024322|Diclofenac|diclofenac|mesh-list
44340244|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
44340245|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44340246|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
44340247|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44340248|NCT01024322|Prednisolone|prednisolone|mesh-list
44340249|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44340335|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340426|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340427|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340428|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44340429|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44340430|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44340431|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340432|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
44340585|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340587|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
44340588|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
44340589|NCT01026363|Calcitriol|calcitriol|mesh-list
44340590|NCT01026363|Vitamins|vitamins|mesh-list
44340591|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
44340592|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340593|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44340594|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44340677|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44340679|NCT01026610|Entecavir|entecavir|mesh-list
44340680|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
44340681|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340682|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
44340683|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44340684|NCT01026636|Cephalosporins|cephalosporins|mesh-list
44340685|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340717|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236401|NCT00559286|Telmisartan|telmisartan|mesh-list
44340718|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44340720|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340721|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340722|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44340723|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44340724|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
44340725|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340751|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44340752|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340753|NCT01026961|Protective Agents|protective agents|mesh-ancestor
44340754|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
44340755|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44340756|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44340757|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
44340758|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
44340759|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44340760|NCT01026987|Plerixafor|plerixafor|mesh-list
44340761|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44340762|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44340763|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
44340764|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340765|NCT01027065|Tenofovir|tenofovir|mesh-list
44340766|NCT01027065|Entecavir|entecavir|mesh-list
44340767|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
44340768|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340769|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44340770|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44340771|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340772|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340773|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44340774|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44340775|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
44340776|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
44340777|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44340778|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44340813|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340814|NCT01027481|Growth Substances|growth substances|mesh-ancestor
44340815|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340816|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340817|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340818|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
44340819|NCT01027494|Dexamethasone|dexamethasone|mesh-list
44340820|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340821|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
44340851|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
44340852|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
44340853|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44340854|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44340855|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340856|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
44340857|NCT01027546|Coagulants|coagulants|mesh-ancestor
44340858|NCT01027611|Lidocaine|lidocaine|mesh-list
44340859|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
44340860|NCT01027611|Propoxycaine|propoxycaine|mesh-list
44340861|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340862|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
44340863|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340864|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340865|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
43748963|NCT02514629|Testosterone|testosterone|mesh-list
44340910|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
44340911|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340912|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44340913|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44340915|NCT01028079|Ibuprofen|ibuprofen|mesh-list
44340916|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44340917|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340918|NCT01028079|Analgesics|analgesics|mesh-ancestor
44340919|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
44340920|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340921|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340922|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340923|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340924|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44340925|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44340926|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340927|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44340962|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340963|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340964|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340965|NCT01028261|CKD732|ckd732|mesh-list
44340966|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340967|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340968|NCT01028261|Growth Substances|growth substances|mesh-ancestor
44340969|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340970|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341000|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341001|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44341002|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341003|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341004|NCT01028339|Mannitol|mannitol|mesh-list
44341005|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44341006|NCT01028339|Diuretics|diuretics|mesh-ancestor
44341007|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
44341008|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341009|NCT01028404|Insulin|insulin|mesh-list
44341010|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44341011|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
44341012|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
44341013|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44341014|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748985|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
44341040|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341041|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341042|NCT01028495|Antiviral Agents|antiviral agents|mesh-ancestor
44341043|NCT01028495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341044|NCT01028495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341045|NCT01028495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341046|NCT01028495|Immunologic Factors|immunologic factors|mesh-ancestor
44341047|NCT01028495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341048|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44341049|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341050|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341051|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341052|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341053|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44341054|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341055|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341056|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341057|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44341058|NCT01028534|Olmesartan|olmesartan|mesh-list
44341059|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44341060|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
44341061|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
44341062|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44341129|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341130|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341131|NCT01028924|Teduglutide|teduglutide|mesh-list
44341132|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341133|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44341134|NCT01028924|Protective Agents|protective agents|mesh-ancestor
44341135|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341136|NCT01028950|Darexaban|darexaban|mesh-list
44341137|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44341138|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
44341139|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44341140|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
44341141|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341142|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341143|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
44155575|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44341177|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44341178|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44341179|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44341180|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
44341181|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341182|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341183|NCT01029275|Octreotide|octreotide|mesh-list
44341184|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341185|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341186|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341187|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44341265|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341266|NCT01029821|Heparin|heparin|mesh-list
44341267|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44341268|NCT01029821|Tinzaparin|tinzaparin|mesh-list
44341269|NCT01029821|Dalteparin|dalteparin|mesh-list
44341270|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
44341271|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44145854|NCT00196378|Estrogens|estrogens|mesh-list
44341272|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341273|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341274|NCT01029847|Adalimumab|adalimumab|mesh-list
44341275|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341276|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341277|NCT01030016|Atenolol|atenolol|mesh-list
44341278|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44341279|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44341280|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44341281|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341282|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341283|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341284|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44341285|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44341286|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
44341287|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
44341288|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341289|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44341290|NCT01030042|Leucovorin|leucovorin|mesh-list
44341291|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
44341316|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341317|NCT01030094|Topiramate|topiramate|mesh-list
44341318|NCT01030094|Carbamazepine|carbamazepine|mesh-list
44341319|NCT01030094|Valproic Acid|valproic acid|mesh-list
44341320|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
44341321|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44341322|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341323|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341324|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341325|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
44341326|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341327|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
44341328|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44341329|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44341330|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341331|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44341332|NCT01030094|Analgesics|analgesics|mesh-ancestor
44341333|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
44341334|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341335|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44341336|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341337|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44341338|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44341339|NCT01030120|Etanercept|etanercept|mesh-list
44341340|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44341341|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44341342|NCT01030120|Analgesics|analgesics|mesh-ancestor
44341343|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
44341534|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
44341535|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341536|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44341537|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44341538|NCT01031667|Cilostazol|cilostazol|mesh-list
44341539|NCT01031667|Probucol|probucol|mesh-list
44341540|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44341541|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
44341542|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749278|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
44341577|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341579|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44341580|NCT01031901|Sirolimus|sirolimus|mesh-list
44341581|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341610|NCT01032031|Protective Agents|protective agents|mesh-ancestor
44341611|NCT01032057|Gemcitabine|gemcitabine|mesh-list
44341612|NCT01032057|Capecitabine|capecitabine|mesh-list
44341613|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341614|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
44341615|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341616|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341617|NCT01032057|Antiviral Agents|antiviral agents|mesh-ancestor
44341618|NCT01032057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341619|NCT01032057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341620|NCT01032057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341621|NCT01032057|Immunologic Factors|immunologic factors|mesh-ancestor
44341622|NCT01032057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341623|NCT01032083|Citalopram|citalopram|mesh-list
44341624|NCT01032083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341625|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341626|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341627|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749338|NCT02511483|Analgesics|analgesics|mesh-ancestor
44341661|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341662|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341663|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
44341664|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44341665|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341666|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
44341667|NCT01032213|Analgesics|analgesics|mesh-ancestor
43749364|NCT02511405|Bevacizumab|bevacizumab|mesh-list
44341701|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
44341702|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341703|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341704|NCT01032668|Clopidogrel|clopidogrel|mesh-list
44341705|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44341706|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43749384|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341782|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341783|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341784|NCT01033396|Fexofenadine|fexofenadine|mesh-list
44341785|NCT01033396|Terfenadine|terfenadine|mesh-list
44341786|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44341787|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44341788|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44341789|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
44341790|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
44341791|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341792|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341793|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341794|NCT01033409|Vaccines|vaccines|mesh-list
44341795|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
43853358|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44341796|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341797|NCT01033461|Calcium|calcium|mesh-list
44341798|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341799|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341800|NCT01033500|Abatacept|abatacept|mesh-list
44341801|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44341802|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341803|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341804|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341805|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
44341806|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341807|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341808|NCT01033526|Aspirin|aspirin|mesh-list
44341809|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44341810|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44341811|NCT01033526|Analgesics|analgesics|mesh-ancestor
44341812|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
44341813|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341814|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341958|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341960|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
44341961|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341962|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341996|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
44341997|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341998|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341999|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44342000|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
44342001|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
44342002|NCT01034956|Protective Agents|protective agents|mesh-ancestor
44342003|NCT01034995|Citalopram|citalopram|mesh-list
44236402|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44342004|NCT01034995|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44342075|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342076|NCT01035580|Curcumin|curcumin|mesh-list
44342077|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342112|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342113|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342114|NCT01035983|Frovatriptan|frovatriptan|mesh-list
44342115|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44342116|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
44342117|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342118|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342119|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342138|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44342139|NCT01036399|Growth Substances|growth substances|mesh-ancestor
44342140|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
44342141|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342142|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
44342143|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44342144|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44342145|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342146|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
44342147|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342148|NCT01036659|Ecallantide|ecallantide|mesh-list
44342150|NCT01036659|Kallikreins|kallikreins|mesh-list
44342151|NCT01036659|Kininogens|kininogens|mesh-list
44342152|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
44342153|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44342154|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
44342155|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342156|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342157|NCT01036659|Analgesics|analgesics|mesh-ancestor
44342158|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
44342159|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342160|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342161|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342162|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43853426|NCT03755440|Antibodies|antibodies|mesh-list
44342163|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342164|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342165|NCT01036659|Coagulants|coagulants|mesh-ancestor
44342166|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44342167|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
44342168|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44342169|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44342170|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
44342171|NCT01036841|Coagulants|coagulants|mesh-ancestor
44342172|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44342173|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
44342174|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342175|NCT01036854|Ondansetron|ondansetron|mesh-list
44342176|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
44342177|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
44342178|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342256|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44342258|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342259|NCT01037465|Protective Agents|protective agents|mesh-ancestor
44342260|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342261|NCT01037465|Antidotes|antidotes|mesh-ancestor
44342262|NCT01037491|Aspirin|aspirin|mesh-list
44342263|NCT01037491|Rabeprazole|rabeprazole|mesh-list
44342264|NCT01037491|Clopidogrel|clopidogrel|mesh-list
44342265|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342266|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44342267|NCT01037491|Analgesics|analgesics|mesh-ancestor
44342268|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
44342269|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342270|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342271|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342272|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342273|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44342274|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44342275|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342276|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44342277|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44342278|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236403|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44342279|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
44342280|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44342281|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44342327|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
44342328|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342329|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44342330|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342331|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342332|NCT01037842|Mitiglinide|mitiglinide|mesh-list
44342333|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44342334|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342335|NCT01037959|Norfloxacin|norfloxacin|mesh-list
44342336|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342337|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342338|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44342339|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342340|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342341|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342342|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342343|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44342344|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44342345|NCT01037998|Gefitinib|gefitinib|mesh-list
44342427|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342429|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342430|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
44342431|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44342486|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342487|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44342488|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
44342489|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342490|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342492|NCT01038661|Docetaxel|docetaxel|mesh-list
44342493|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342494|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342495|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
44342496|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342497|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342498|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44342499|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
44342500|NCT01038817|Protective Agents|protective agents|mesh-ancestor
44342501|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342502|NCT01038882|Midazolam|midazolam|mesh-list
44342503|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44342504|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44342505|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342506|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342507|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44342558|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
44342559|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342560|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
44342561|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
44342562|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342563|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342564|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342565|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
44342566|NCT01039103|Hormones|hormones|mesh-ancestor
44342685|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342686|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342687|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44342688|NCT01039740|Mirtazapine|mirtazapine|mesh-list
44342689|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
44342690|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44342691|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44342692|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
44342693|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
44342694|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342695|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342696|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342697|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44236404|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44100281|NCT00054392|Gemcitabine|gemcitabine|mesh-list
44342698|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44342699|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342720|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
44342721|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342722|NCT01039948|Gefitinib|gefitinib|mesh-list
44342723|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342724|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44342725|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342726|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342727|NCT01039974|Ketoconazole|ketoconazole|mesh-list
44342728|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
44342729|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342730|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44342731|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44342732|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342733|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342734|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44342735|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
43853571|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44342736|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342737|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342738|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44342739|NCT01040078|Vaccines|vaccines|mesh-list
44342740|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
44342741|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342742|NCT01040091|Tenofovir|tenofovir|mesh-list
44342743|NCT01040091|Emtricitabine|emtricitabine|mesh-list
44342744|NCT01040091|Efavirenz|efavirenz|mesh-list
44342745|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44342746|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
44342747|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342748|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44342749|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44342750|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342751|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342752|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44342914|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
44342915|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342916|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342917|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44342918|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44342919|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44342920|NCT01041170|Rimonabant|rimonabant|mesh-list
44342921|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44342922|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44342923|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44342924|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342925|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342926|NCT01041170|Hormones|hormones|mesh-ancestor
44342995|NCT01041625|Apremilast|apremilast|mesh-list
44342996|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342997|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750274|NCT02505841|Curare|curare|mesh-list
44343031|NCT01041872|Propofol|propofol|mesh-list
44343032|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
44343033|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
44343034|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343035|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343089|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44343090|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343091|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343092|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
44343093|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343094|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343095|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
44343096|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
44343097|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44343098|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343099|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44343135|NCT01042704|Dexamethasone|dexamethasone|mesh-list
44100347|NCT00054457|Docetaxel|docetaxel|mesh-list
44343136|NCT01042704|Lenalidomide|lenalidomide|mesh-list
44343137|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44343168|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
44343169|NCT01042717|Plerixafor|plerixafor|mesh-list
44343170|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44343171|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44343172|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
44343173|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343174|NCT01042730|Pitavastatin|pitavastatin|mesh-list
44343175|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44343176|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44343177|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44343178|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
44343179|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343180|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853610|NCT03742297|Prednisone|prednisone|mesh-list
44343228|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44343229|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44343230|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44343231|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343232|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343233|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44343234|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44343235|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
44343236|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343237|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44343238|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44343300|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
44343301|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343302|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343332|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343333|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343334|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343335|NCT01043666|Urological Agents|urological agents|mesh-ancestor
44343336|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44343337|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44343338|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44343339|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44343340|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
44343341|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44343374|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44343375|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44343376|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44343377|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343378|NCT01044095|Vaccines|vaccines|mesh-list
44343379|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
44343380|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343381|NCT01044186|Deferasirox|deferasirox|mesh-list
44343382|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44343383|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
44343384|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
44343385|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343386|NCT01044199|Vaccines|vaccines|mesh-list
44343387|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
43750564|NCT02504359|Tacrolimus|tacrolimus|mesh-list
44343414|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43998597|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343415|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343417|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343418|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343419|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343420|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
44343422|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343423|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343424|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
44343425|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343426|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343427|NCT01044342|Donepezil|donepezil|mesh-list
44343428|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44343429|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343430|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343431|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
43750609|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343471|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44343472|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44343473|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343474|NCT01044992|Levodopa|levodopa|mesh-list
44343475|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44343476|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44343477|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
44343478|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343479|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343480|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343481|NCT01045018|Mesalamine|mesalamine|mesh-list
44343482|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44343483|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44343484|NCT01045018|Analgesics|analgesics|mesh-ancestor
44343485|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
44343486|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343487|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343488|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343489|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343490|NCT01045083|Methylphenidate|methylphenidate|mesh-list
44343491|NCT01045083|Citalopram|citalopram|mesh-list
44343492|NCT01045083|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44343493|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44343494|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750676|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
44343522|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343523|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
44343524|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343525|NCT01045304|Gemcitabine|gemcitabine|mesh-list
44343526|NCT01045304|Carboplatin|carboplatin|mesh-list
44343527|NCT01045304|Iniparib|iniparib|mesh-list
44343528|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343529|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343530|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
44343531|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343532|NCT01045304|Antiviral Agents|antiviral agents|mesh-ancestor
44343533|NCT01045304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343534|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343535|NCT01045304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343536|NCT01045304|Immunologic Factors|immunologic factors|mesh-ancestor
44343537|NCT01045304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343538|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44343539|NCT01045369|Etravirine|etravirine|mesh-list
44343540|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44343541|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44343542|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750725|NCT02503943|Incretins|incretins|mesh-ancestor
44343611|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
44343613|NCT01045889|Rituximab|rituximab|mesh-list
44343614|NCT01045889|Etoposide|etoposide|mesh-list
44343615|NCT01045889|Vincristine|vincristine|mesh-list
44343616|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343675|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343676|NCT01045941|Antiviral Agents|antiviral agents|mesh-ancestor
44343678|NCT01045941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343679|NCT01045941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343680|NCT01045941|Immunologic Factors|immunologic factors|mesh-ancestor
44343681|NCT01045941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343682|NCT01045954|Insulin|insulin|mesh-list
44343683|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
44343684|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
44343685|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343686|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343687|NCT01045980|Vitamin D|vitamin d|mesh-list
44343688|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
44343689|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
44343690|NCT01045980|Vitamins|vitamins|mesh-list
44343691|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
44343692|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343693|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44343694|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44343695|NCT01046006|Dexamethasone|dexamethasone|mesh-list
44343696|NCT01046006|Rituximab|rituximab|mesh-list
44343697|NCT01046006|Bortezomib|bortezomib|mesh-list
44343698|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343699|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343700|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
44343701|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343702|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343703|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343704|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
44343705|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
44343706|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343707|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343708|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
44343736|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343738|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44343739|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
44343740|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44343741|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44343742|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44343743|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343744|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343745|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
44343746|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343747|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343748|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44343749|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44343750|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343751|NCT01046227|Vaccines|vaccines|mesh-list
44343752|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
44343753|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343754|NCT01046240|Palonosetron|palonosetron|mesh-list
44343755|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
44343783|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343784|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44343785|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44343787|NCT01046461|Aprepitant|aprepitant|mesh-list
44343788|NCT01046461|Ramosetron|ramosetron|mesh-list
44343789|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343790|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
44343791|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
44343792|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343793|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343794|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343795|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
44343796|NCT01046461|Hormones|hormones|mesh-ancestor
44343797|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343798|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343799|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343800|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44343801|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750886|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343990|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
44343991|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343992|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343993|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44343994|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343995|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343996|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
44343997|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44343998|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343999|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44344000|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44344001|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
44344002|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344003|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344005|NCT01047098|Trace Elements|trace elements|mesh-ancestor
44344006|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
44344007|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344008|NCT01047202|Vaccines|vaccines|mesh-list
44344009|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
44344010|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344011|NCT01047215|Aripiprazole|aripiprazole|mesh-list
44344012|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44344013|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
44344014|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344015|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44344016|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344017|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344018|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344108|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44344111|NCT01047748|Digoxin|digoxin|mesh-list
44344112|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44344113|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44344114|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344115|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344116|NCT01047748|Protective Agents|protective agents|mesh-ancestor
44344117|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344118|NCT01047774|Caseins|caseins|mesh-list
44344119|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
44344120|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
43853829|NCT03726268|Methadone|methadone|mesh-list
44344121|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344122|NCT01047891|Sorafenib|sorafenib|mesh-list
44344123|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344124|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44344125|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344126|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344127|NCT01047956|Methadone|methadone|mesh-list
44344162|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344163|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
44344164|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344165|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344166|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344167|NCT01048034|Hematinics|hematinics|mesh-ancestor
44344168|NCT01048047|Amlodipine|amlodipine|mesh-list
44344169|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44344170|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44344324|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44344325|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
44344326|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344327|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44344328|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44344329|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344330|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344331|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
44344333|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344334|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44344335|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44344370|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
44344371|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344372|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43751314|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
44344403|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44344405|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44344406|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344407|NCT01049347|Analgesics|analgesics|mesh-ancestor
44344408|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
44344409|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344410|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44344411|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44344412|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
44344554|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44344555|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44344556|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44344557|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
44344558|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344559|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44344560|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44344562|NCT01049646|Giapreza|giapreza|mesh-list
44344563|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
44344564|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44344565|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44344566|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
44344567|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344568|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344569|NCT01049672|Alfentanil|alfentanil|mesh-list
44344570|NCT01049672|Heroin|heroin|mesh-list
44344571|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44344572|NCT01049672|Narcotics|narcotics|mesh-ancestor
44344573|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344574|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344575|NCT01049672|Analgesics|analgesics|mesh-ancestor
44158099|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
44344576|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
44344577|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344578|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44344579|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
44344580|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
44344581|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44344582|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
44344583|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344584|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
44344610|NCT01049854|Vidarabine|vidarabine|mesh-list
44344611|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
44344612|NCT01049854|Thiotepa|thiotepa|mesh-list
44344613|NCT01049854|Busulfan|busulfan|mesh-list
44344614|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
44344615|NCT01049854|Fludarabine|fludarabine|mesh-list
44344616|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44344617|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344618|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
44344619|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344620|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344621|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344622|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
44344623|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344624|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344625|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44344626|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344627|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
44344628|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
44344629|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344630|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
44344631|NCT01049880|Gemcitabine|gemcitabine|mesh-list
44344632|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344633|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
44344634|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344635|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344636|NCT01049880|Antiviral Agents|antiviral agents|mesh-ancestor
44344658|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344659|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
44344660|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344661|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344662|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344663|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44344664|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44344666|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44344667|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44344668|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344669|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344670|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44344671|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344672|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344673|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
44344674|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344675|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
44344676|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
44344677|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44344678|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44344679|NCT01050114|Urological Agents|urological agents|mesh-ancestor
44344680|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
44344681|NCT01050270|Ondansetron|ondansetron|mesh-list
44344682|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44344683|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
44344684|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
44344685|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344686|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344687|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344688|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
44344689|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
44344690|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44344691|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
43751504|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
44344766|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344768|NCT01050426|Vitamins|vitamins|mesh-ancestor
44344769|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
44344770|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44344771|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344772|NCT01050452|Ivermectin|ivermectin|mesh-list
44344872|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344873|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344874|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
44344875|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
44344876|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
44344877|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
44133245|NCT00153192|Dronabinol|dronabinol|mesh-list
44344878|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344879|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
44344880|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751651|NCT02496754|Hormones|hormones|mesh-ancestor
44344913|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44344914|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
44344915|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344916|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
44344917|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344918|NCT01051011|Metformin|metformin|mesh-list
44344919|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
44344920|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44344921|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44344955|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44344956|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344958|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44344990|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344991|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344992|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44344993|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44344994|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44344995|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
44344996|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344997|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44344998|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44344999|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345000|NCT01051427|Hemostatics|hemostatics|mesh-list
44345001|NCT01051427|Surgiflo|surgiflo|mesh-list
44345002|NCT01051427|Coagulants|coagulants|mesh-ancestor
44345003|NCT01051479|Choline|choline|mesh-list
44345037|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345039|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44345040|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44345041|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44345042|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345072|NCT01051934|Paclitaxel|paclitaxel|mesh-list
44345073|NCT01051934|Bevacizumab|bevacizumab|mesh-list
44345074|NCT01051934|Carboplatin|carboplatin|mesh-list
44345075|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44345076|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345077|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44345078|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
44345079|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
44345080|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345081|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44345082|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345083|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345084|NCT01051934|Growth Substances|growth substances|mesh-ancestor
44345085|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345086|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345087|NCT01051947|Metoprolol|metoprolol|mesh-list
44345113|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345114|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345115|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345116|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345118|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
44345119|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
44345120|NCT01052051|Calcium|calcium|mesh-list
44345121|NCT01052051|Vitamins|vitamins|mesh-ancestor
44345122|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
44345123|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345124|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44345125|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44345126|NCT01052051|Antacids|antacids|mesh-ancestor
44345127|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345128|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345129|NCT01052129|Naproxen|naproxen|mesh-list
44345130|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345131|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345132|NCT01052129|Analgesics|analgesics|mesh-ancestor
44100772|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
44345133|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
44345134|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345135|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345173|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345208|NCT01052389|Olanzapine|olanzapine|mesh-list
44345209|NCT01052389|Aripiprazole|aripiprazole|mesh-list
44345210|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
44345211|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
44345212|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
44345213|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751892|NCT02495285|Polygeline|polygeline|mesh-list
44345272|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
44345273|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345274|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44345275|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
44345276|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
44345277|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44345278|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44345279|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44345280|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
44345281|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345282|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345283|NCT01052792|Naproxen|naproxen|mesh-list
44345284|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345285|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345286|NCT01052792|Analgesics|analgesics|mesh-ancestor
44345287|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
44345288|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345289|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345290|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345291|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345292|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
43751923|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
44345323|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345324|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345325|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
44345326|NCT01052961|Oseltamivir|oseltamivir|mesh-list
44345327|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
44345328|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345329|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345330|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345331|NCT01052974|Ropivacaine|ropivacaine|mesh-list
44345332|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
44345333|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
44345334|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345362|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44345363|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44345364|NCT01053026|Olmesartan|olmesartan|mesh-list
44345365|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44345366|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44345367|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44345368|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345369|NCT01053039|Morphine|morphine|mesh-list
44345370|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44345371|NCT01053039|Narcotics|narcotics|mesh-ancestor
44345372|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345373|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345374|NCT01053039|Analgesics|analgesics|mesh-ancestor
44345375|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
44345376|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345377|NCT01053065|Atorvastatin|atorvastatin|mesh-list
44345378|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
44345379|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
44345380|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44345381|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44345435|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345436|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345437|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345438|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345439|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43836422|NCT04972123|Caffeine|caffeine|mesh-list
44345470|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345471|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
44345472|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345473|NCT01053390|Antidotes|antidotes|mesh-ancestor
44100848|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44345474|NCT01053390|Protective Agents|protective agents|mesh-ancestor
44345475|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
44345477|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
44345478|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44345479|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44345480|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44345481|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345482|NCT01053390|Hormones|hormones|mesh-ancestor
44345483|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345484|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44345485|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
44345486|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345487|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345499|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345501|NCT01053481|Vitamins|vitamins|mesh-ancestor
44345502|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
44345503|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345504|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44345505|NCT01053520|Navitoclax|navitoclax|mesh-list
44345506|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345507|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
44345508|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345509|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
44345510|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345511|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345513|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44345514|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345515|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44345516|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345517|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44345518|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
44345519|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
44345520|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345521|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345522|NCT01053611|Remifentanil|remifentanil|mesh-list
44345523|NCT01053611|Propofol|propofol|mesh-list
44345524|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44345525|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345526|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345527|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44345528|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
44345529|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
44345530|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44345531|NCT01053611|Narcotics|narcotics|mesh-ancestor
44345532|NCT01053611|Analgesics|analgesics|mesh-ancestor
44345533|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
44345534|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345535|NCT01053637|Acetaminophen|acetaminophen|mesh-list
44345536|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44345537|NCT01053637|Hydrocodone|hydrocodone|mesh-list
44345538|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345539|NCT01053637|Analgesics|analgesics|mesh-ancestor
44345540|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
44345541|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345542|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345543|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
44345544|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44345545|NCT01053637|Narcotics|narcotics|mesh-ancestor
44345546|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345547|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
44345548|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44345549|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345550|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345551|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345552|NCT01053650|Acetaminophen|acetaminophen|mesh-list
44345579|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345580|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345581|NCT01053871|Fentanyl|fentanyl|mesh-list
44345582|NCT01053871|Midazolam|midazolam|mesh-list
44345583|NCT01053871|Propofol|propofol|mesh-list
44345584|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44345585|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345586|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100932|NCT00055939|Exatecan|exatecan|mesh-list
44345587|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44345588|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
44345589|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
44345590|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44345591|NCT01053871|Narcotics|narcotics|mesh-ancestor
44345592|NCT01053871|Analgesics|analgesics|mesh-ancestor
44345593|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
44345594|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345595|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44345596|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44345597|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345598|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345599|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
44345600|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
44345601|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345602|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345603|NCT01053884|Anidulafungin|anidulafungin|mesh-list
44345655|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
44345656|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44345657|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345658|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345659|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345660|NCT01054105|Iloprost|iloprost|mesh-list
44345661|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44345662|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
44345663|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44345664|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44000776|NCT05451472|Calcium|calcium|mesh-list
44345665|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345666|NCT01054118|Incretins|incretins|mesh-ancestor
44345668|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345669|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44345670|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44345698|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
44345699|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345701|NCT01054508|Niacin|niacin|mesh-list
44345702|NCT01054508|Niacinamide|niacinamide|mesh-list
44345703|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
44345704|NCT01054508|Vitamins|vitamins|mesh-ancestor
44345705|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
44345706|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345707|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44345708|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
44345709|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345710|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44345711|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44345712|NCT01054547|Anesthetics|anesthetics|mesh-list
44345713|NCT01054547|Ropivacaine|ropivacaine|mesh-list
44345714|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345715|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345716|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
44345717|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
43752257|NCT02492373|Clobetasol|clobetasol|mesh-list
44345744|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345745|NCT01054872|Vaccines|vaccines|mesh-list
44345746|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
44345747|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345748|NCT01055041|Budesonide|budesonide|mesh-list
44345749|NCT01055041|Doxofylline|doxofylline|mesh-list
44345750|NCT01055041|Montelukast|montelukast|mesh-list
44345751|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345752|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44345753|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
44345754|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345755|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345756|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44345757|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
44345758|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
44345759|NCT01055041|Hormones|hormones|mesh-ancestor
44345760|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345761|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44345762|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
44345763|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43854241|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133284|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
44345764|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44345765|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345766|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
44345767|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43752302|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
44345796|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44345797|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345798|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345799|NCT01055249|Analgesics|analgesics|mesh-ancestor
44345800|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
44345801|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345802|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345803|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345804|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345805|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44345806|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345807|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345808|NCT01055301|Thalidomide|thalidomide|mesh-list
44345809|NCT01055301|Dexamethasone|dexamethasone|mesh-list
44345810|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
44345812|NCT01055301|Doxorubicin|doxorubicin|mesh-list
44345813|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44345814|NCT01055301|Etoposide|etoposide|mesh-list
44345815|NCT01055301|Lenalidomide|lenalidomide|mesh-list
44345850|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345851|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345852|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44345853|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345854|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44345885|NCT01055418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345887|NCT01055418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345888|NCT01055418|Protective Agents|protective agents|mesh-ancestor
44345889|NCT01055431|Iron|iron|mesh-list
44345890|NCT01055431|Trace Elements|trace elements|mesh-ancestor
44345891|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
44345892|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345893|NCT01055470|Diclofenac|diclofenac|mesh-list
44345894|NCT01055470|Lornoxicam|lornoxicam|mesh-list
44345895|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345896|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345897|NCT01055470|Analgesics|analgesics|mesh-ancestor
43752397|NCT02491320|Letrozole|letrozole|mesh-list
44345940|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44345941|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345942|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345943|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
44345944|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345945|NCT01055795|Bevacizumab|bevacizumab|mesh-list
44345946|NCT01055795|Everolimus|everolimus|mesh-list
44345947|NCT01055795|Panobinostat|panobinostat|mesh-list
44345948|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44345949|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345950|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345951|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345952|NCT01055795|Growth Substances|growth substances|mesh-ancestor
44345953|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345954|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345955|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345956|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
44345957|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44345958|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345959|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345960|NCT01055808|Insulin|insulin|mesh-list
44345961|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345993|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345994|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44345996|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
44345997|NCT01056042|Gestodene|gestodene|mesh-list
44345998|NCT01056042|Estradiol|estradiol|mesh-list
44345999|NCT01056042|Estrogens|estrogens|mesh-ancestor
44346000|NCT01056042|Hormones|hormones|mesh-ancestor
44146444|NCT00198536|Ecabet|ecabet|mesh-list
44346001|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346002|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346003|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44346004|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
44346005|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44236405|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346029|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
44346030|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346032|NCT01056237|Azathioprine|azathioprine|mesh-list
44346033|NCT01056237|Tacrolimus|tacrolimus|mesh-list
44346034|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346035|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
44346036|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346037|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44346038|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346039|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346040|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44346041|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346042|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44346043|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
44346044|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346045|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346046|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
44346047|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44346048|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346049|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
44346050|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
44346051|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346052|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
44346053|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
44346054|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346055|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346056|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
44346118|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
44346119|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346120|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44346121|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44346122|NCT01056679|Growth Substances|growth substances|mesh-ancestor
44346123|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
44346124|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346125|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346126|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346127|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346128|NCT01056705|Vaccines|vaccines|mesh-list
44346129|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
44346130|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346131|NCT01056757|Ribavirin|ribavirin|mesh-list
44346132|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
44346133|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346134|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
44346135|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346136|NCT01056835|Epoprostenol|epoprostenol|mesh-list
44346137|NCT01056835|Tezosentan|tezosentan|mesh-list
44346138|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44346139|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44346140|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346171|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346172|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44346173|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44346174|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
44346175|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346176|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346177|NCT01057160|Rizatriptan|rizatriptan|mesh-list
44346178|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44346179|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
44346180|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346181|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346182|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346183|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
44346184|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44346185|NCT01057186|Sevelamer|sevelamer|mesh-list
43752650|NCT02489240|Vitamin D|vitamin d|mesh-list
44346285|NCT01057511|Progesterone|progesterone|mesh-list
44346286|NCT01057511|Progestins|progestins|mesh-ancestor
44346287|NCT01057511|Hormones|hormones|mesh-ancestor
43752744|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44346370|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346372|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44346374|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
44346375|NCT01058109|Calcium|calcium|mesh-list
44346376|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44346377|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346378|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44346379|NCT01058174|Fluconazole|fluconazole|mesh-list
44346380|NCT01058174|Amphotericin B|amphotericin b|mesh-list
44346381|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44346382|NCT01058174|Caspofungin|caspofungin|mesh-list
44346383|NCT01058174|Micafungin|micafungin|mesh-list
44346384|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
44346385|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346386|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44346387|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44346388|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346389|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346390|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44346490|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346491|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346525|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
44346526|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346527|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346528|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
44346529|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
44346530|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346531|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44346532|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346533|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346565|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346566|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44346567|NCT01059383|Esomeprazole|esomeprazole|mesh-list
44346568|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44346569|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346570|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44346571|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346572|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346573|NCT01059396|Propranolol|propranolol|mesh-list
44346574|NCT01059396|Carvedilol|carvedilol|mesh-list
44346668|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346669|NCT01060137|Fentanyl|fentanyl|mesh-list
44346670|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44346671|NCT01060137|Narcotics|narcotics|mesh-ancestor
44346672|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346673|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346707|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44346708|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346709|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346710|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44346711|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44346712|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44346713|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
44346714|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346715|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346716|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44346779|NCT01060501|Interferons|interferons|mesh-list
44346780|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
44346781|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
44346782|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346783|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
44346784|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346785|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
44346786|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346787|NCT01060501|Antidotes|antidotes|mesh-ancestor
44346788|NCT01060501|Protective Agents|protective agents|mesh-ancestor
44346789|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44346790|NCT01060501|Vitamins|vitamins|mesh-ancestor
44346791|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
44346792|NCT01060501|Hematinics|hematinics|mesh-ancestor
44346793|NCT01060514|Vinorelbine|vinorelbine|mesh-list
44346794|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346795|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346796|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346828|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
44346829|NCT01060683|Chrysarobin|chrysarobin|mesh-list
44346830|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346831|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346833|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
44346834|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346835|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346836|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346837|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346838|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
44346866|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44346867|NCT01060774|Lidocaine|lidocaine|mesh-list
44346868|NCT01060774|Bupivacaine|bupivacaine|mesh-list
44346869|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
44346870|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
44346871|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346872|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346873|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
44346874|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346875|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44346876|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44346877|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44346878|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346879|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346880|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44346881|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346882|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
44346883|NCT01060787|Hormones|hormones|mesh-ancestor
44346884|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346885|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346886|NCT01060826|Somatostatin|somatostatin|mesh-list
44346914|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44346915|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346917|NCT01060930|Norepinephrine|norepinephrine|mesh-list
44346918|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44346919|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44346920|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44346921|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
44346922|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346923|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346924|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346925|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44346926|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44346927|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
44346928|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346929|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44346930|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44346931|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
44346933|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43753204|NCT02486133|Ritonavir|ritonavir|mesh-list
44346966|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346967|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346968|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44346969|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44346970|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346972|NCT01061112|Analgesics|analgesics|mesh-ancestor
44346973|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
44346974|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347081|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347112|NCT01062139|Levocetirizine|levocetirizine|mesh-list
44347113|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44347114|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44347115|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
44347116|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
44347117|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347118|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347119|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347120|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44347121|NCT01062152|Lenalidomide|lenalidomide|mesh-list
44347122|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
44347123|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347161|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43753359|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
44347199|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44347264|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44347265|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347266|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44347267|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44347268|NCT01063010|Growth Substances|growth substances|mesh-ancestor
44347295|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44347296|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347298|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
44347299|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347301|NCT01063179|Prednisone|prednisone|mesh-list
44347302|NCT01063179|Bortezomib|bortezomib|mesh-list
44347303|NCT01063179|Melphalan|melphalan|mesh-list
44347304|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347305|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
44347306|NCT01063179|Hormones|hormones|mesh-ancestor
44347307|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347308|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347309|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44347310|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347311|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44347312|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
44347313|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347314|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44347315|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347316|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
44347317|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
44347318|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347340|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
44347341|NCT01063192|Vitamins|vitamins|mesh-ancestor
44347342|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
44347343|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
44347344|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44347345|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
44347346|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347347|NCT01063205|Expectorants|expectorants|mesh-ancestor
44347348|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
44347349|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44347350|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
44347351|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347352|NCT01063205|Protective Agents|protective agents|mesh-ancestor
44347353|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347354|NCT01063205|Antidotes|antidotes|mesh-ancestor
44347355|NCT01063218|Emollients|emollients|mesh-list
44347356|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
44347357|NCT01063257|Clofarabine|clofarabine|mesh-list
44347358|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347359|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
44347360|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347361|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347362|NCT01063426|Enoxaparin|enoxaparin|mesh-list
44347363|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
44347364|NCT01063426|Atorvastatin|atorvastatin|mesh-list
44347365|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44347366|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44347367|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
44347368|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002459|NCT03818776|Durvalumab|durvalumab|mesh-list
44347369|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44347370|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44347371|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347372|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
44347373|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44347374|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44347433|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44347434|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
44347435|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347436|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347467|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
44347468|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44347469|NCT01063842|Narcotics|narcotics|mesh-ancestor
44347470|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347472|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44347473|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347474|NCT01063920|Analgesics|analgesics|mesh-ancestor
44347475|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
44347476|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347477|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347478|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347479|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44347480|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
44347481|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44347482|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347518|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
44347519|NCT01064154|Protective Agents|protective agents|mesh-ancestor
44347545|NCT01064232|Risperidone|risperidone|mesh-list
44347546|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44347547|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
44347548|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347549|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347550|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347551|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44347552|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44347553|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347554|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44347555|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44347556|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
44347557|NCT01064271|Risperidone|risperidone|mesh-list
44347558|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44347559|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
44347560|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347561|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347562|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347563|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44347564|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43753619|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347628|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347629|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347630|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347631|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44347632|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44347633|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
44347634|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347635|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44347636|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
44347638|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
44347639|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44347640|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347641|NCT01064999|Capecitabine|capecitabine|mesh-list
44347642|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
44347643|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347644|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
44347645|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347667|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347668|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347669|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44347670|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44347671|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
44347672|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347673|NCT01065194|Simendan|simendan|mesh-list
44347674|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44347675|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347676|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44347677|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44347678|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347679|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347680|NCT01065194|Protective Agents|protective agents|mesh-ancestor
44347681|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347682|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
44347683|NCT01065220|Testolactone|testolactone|mesh-list
44347684|NCT01065220|Lynestrenol|lynestrenol|mesh-list
44347685|NCT01065220|Estradiol|estradiol|mesh-list
44347686|NCT01065220|Cyproterone|cyproterone|mesh-list
44347687|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
44347688|NCT01065220|Estrogens|estrogens|mesh-ancestor
44347689|NCT01065220|Hormones|hormones|mesh-ancestor
44347690|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347691|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347692|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44101423|NCT00057798|Antiviral Agents|antiviral agents|mesh-ancestor
44347693|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
44347694|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347695|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44347696|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
44347697|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
44347698|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347699|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44347730|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
44347731|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347732|NCT01065376|Cabergoline|cabergoline|mesh-list
44347733|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44347734|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44347735|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
44347736|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
44347737|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347738|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347739|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347740|NCT01065467|Panobinostat|panobinostat|mesh-list
44347741|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347776|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44347777|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347778|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
44347779|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347816|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
43753774|NCT02482740|Letrozole|letrozole|mesh-list
44347854|NCT01065961|Hormones|hormones|mesh-ancestor
44347855|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347856|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44347857|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347858|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
44347917|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347918|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
44347919|NCT01066351|Hematinics|hematinics|mesh-ancestor
44347921|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347922|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44347923|NCT01066377|Renal Agents|renal agents|mesh-ancestor
44347924|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
44347925|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44347926|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44347927|NCT01066403|Pergolide|pergolide|mesh-list
44347928|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
44347929|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
44347930|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347931|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347932|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347955|NCT01066494|Cytarabine|cytarabine|mesh-list
44347956|NCT01066494|Amonafide|amonafide|mesh-list
44347957|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347958|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
44347959|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347960|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347961|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
44347962|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347963|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347964|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
44347965|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347966|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347967|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44347968|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347969|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44347970|NCT01066559|Protective Agents|protective agents|mesh-ancestor
44347971|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347972|NCT01066572|Lisinopril|lisinopril|mesh-list
44347973|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44347974|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
44347975|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347976|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347977|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44347978|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44347979|NCT01066572|Protective Agents|protective agents|mesh-ancestor
44347980|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347981|NCT01066598|Rituximab|rituximab|mesh-list
44347982|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44347983|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347984|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
44348092|NCT01066988|Emollients|emollients|mesh-list
44348093|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44348094|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44348095|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348096|NCT01067053|Bevacizumab|bevacizumab|mesh-list
44348097|NCT01067053|Capecitabine|capecitabine|mesh-list
44348098|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
44348099|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348100|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348101|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348102|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348103|NCT01067053|Growth Substances|growth substances|mesh-ancestor
44348104|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847850|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
44348158|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44348159|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
44348160|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44348161|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348162|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44348163|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
44348164|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348165|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44348166|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44348167|NCT01067391|Tadalafil|tadalafil|mesh-list
44348168|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348169|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44348170|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44348171|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348172|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348173|NCT01067391|Urological Agents|urological agents|mesh-ancestor
44348174|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
44348175|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
44348176|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44348177|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44348178|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348179|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348180|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348181|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348182|NCT01067430|Diclofenac|diclofenac|mesh-list
44348183|NCT01067430|Etoricoxib|etoricoxib|mesh-list
44348184|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44348185|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348186|NCT01067430|Analgesics|analgesics|mesh-ancestor
44348187|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
44348188|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348189|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348244|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348245|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
44348246|NCT01067638|Coagulants|coagulants|mesh-ancestor
44348247|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
44348248|NCT01067677|Promethazine|promethazine|mesh-list
44348249|NCT01067677|Ondansetron|ondansetron|mesh-list
44348250|NCT01067677|Metoclopramide|metoclopramide|mesh-list
44348251|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
44348252|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
44348253|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348254|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348255|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348256|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
44348257|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348258|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44348259|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
44348260|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754038|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348296|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
44348297|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
44348298|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348299|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348300|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43754084|NCT02480751|Beraprost|beraprost|mesh-list
44348335|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348336|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44348337|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43612690|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44236408|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44236409|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44236410|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44236411|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
44236412|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236413|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101574|NCT00058292|Etoposide|etoposide|mesh-list
44348338|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44348339|NCT01068054|Cyclosporine|cyclosporine|mesh-list
44348340|NCT01068054|Tacrolimus|tacrolimus|mesh-list
44348341|NCT01068054|Cyclosporins|cyclosporins|mesh-list
44348342|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754122|NCT02480088|Palonosetron|palonosetron|mesh-list
44348510|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44348511|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348512|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348513|NCT01068925|Dolutegravir|dolutegravir|mesh-list
44348514|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44348515|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44348516|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348517|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348518|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44348519|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44348520|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
44348521|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348522|NCT01068977|Bevacizumab|bevacizumab|mesh-list
44348523|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44348524|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348525|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348526|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348527|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348528|NCT01068977|Growth Substances|growth substances|mesh-ancestor
44348529|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348530|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348531|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
44348532|NCT01069042|Enalapril|enalapril|mesh-list
44348533|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44348534|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
44348535|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348564|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348565|NCT01069094|Leuprolide|leuprolide|mesh-list
44348566|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44348567|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
44348568|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348569|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348570|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44348572|NCT01069133|Rifaximin|rifaximin|mesh-list
44348573|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44348574|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348575|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348576|NCT01069159|Propranolol|propranolol|mesh-list
44348577|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44348578|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44348579|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348580|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348581|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348582|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348583|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43754242|NCT02479204|Atenolol|atenolol|mesh-list
44348710|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44348711|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44348712|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44348713|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44348714|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348715|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348716|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348717|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348718|NCT01070030|Diuretics|diuretics|mesh-ancestor
44348719|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
44236415|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44236416|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44236417|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44236418|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44236419|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44236420|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44236421|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236422|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236423|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236424|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
44348751|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348753|NCT01070225|Propranolol|propranolol|mesh-list
44348754|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348755|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44348756|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44348757|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348758|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348759|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348760|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854817|NCT03632720|Vaccines|vaccines|mesh-list
44133420|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348761|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44348762|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44348786|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348787|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44348788|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44348789|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348790|NCT01070407|Cloricromen|cloricromen|mesh-list
44348791|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44348792|NCT01070446|Choline|choline|mesh-list
44348793|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
44348794|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44348795|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
44348796|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348797|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348798|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44348799|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
44348800|NCT01070472|Misoprostol|misoprostol|mesh-list
44348801|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44348802|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
44348803|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348804|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348805|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44348806|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348807|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
44348808|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44348809|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348810|NCT01070511|Tadalafil|tadalafil|mesh-list
44348811|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348812|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44348813|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44348814|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348815|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348816|NCT01070511|Urological Agents|urological agents|mesh-ancestor
44348848|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348849|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44348851|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44348852|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
44348853|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
44348854|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44348855|NCT01070641|Carvedilol|carvedilol|mesh-list
44348856|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44348857|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43754420|NCT02478879|Teriparatide|teriparatide|mesh-list
44101707|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
44348888|NCT01070706|Paclitaxel|paclitaxel|mesh-list
44348889|NCT01070706|Sunitinib|sunitinib|mesh-list
44348890|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44348891|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348892|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348893|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348894|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348895|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348896|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348897|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
44348898|NCT01070706|Antiviral Agents|antiviral agents|mesh-ancestor
43754465|NCT02478710|Vancomycin|vancomycin|mesh-list
44348972|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44348973|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348974|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348975|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348976|NCT01070862|Growth Substances|growth substances|mesh-ancestor
44348977|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348978|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348979|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44348980|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348981|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348982|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348984|NCT01070875|Calcium heparin|calcium heparin|mesh-list
44348985|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
44348986|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44348987|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44348988|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348989|NCT01070927|R04929097|r04929097|mesh-list
44348990|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349016|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44349017|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349019|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349020|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44349021|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349022|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349023|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
44349024|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349025|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44349026|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
44349027|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349028|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44349029|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349030|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349031|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349032|NCT01071161|Azithromycin|azithromycin|mesh-list
44349033|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349034|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349035|NCT01071174|Dapivirine|dapivirine|mesh-list
44349036|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44349037|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44349064|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349065|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349066|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44349067|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
44349068|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
44349069|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
44349070|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
44349071|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349072|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349073|NCT01071369|Betamethasone|betamethasone|mesh-list
44349074|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
44349075|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44349076|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
44349077|NCT01071369|Lidocaine|lidocaine|mesh-list
44349078|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44349079|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
44349080|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
44349081|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349082|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349083|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
44349084|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349085|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44349086|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44153084|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349087|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44349187|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349188|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349239|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44349240|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349241|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
44349242|NCT01072695|Ribavirin|ribavirin|mesh-list
44349243|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44349244|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
44349245|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349246|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
44349247|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349248|NCT01072734|Vaccines|vaccines|mesh-list
44349249|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
44349250|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349251|NCT01072747|Heparin|heparin|mesh-list
44349252|NCT01072747|Calcium heparin|calcium heparin|mesh-list
44349253|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
44349254|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44349255|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44349289|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44349290|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44349291|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349292|NCT01073007|Simvastatin|simvastatin|mesh-list
44349293|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44349294|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349295|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
44349296|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349510|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44349511|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44349512|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349513|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349514|NCT01073839|Gemcitabine|gemcitabine|mesh-list
44349515|NCT01073839|Cisplatin|cisplatin|mesh-list
44349516|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349517|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44349518|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
44349519|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349520|NCT01073839|Antiviral Agents|antiviral agents|mesh-ancestor
44349521|NCT01073839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349522|NCT01073839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349523|NCT01073839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349524|NCT01073839|Immunologic Factors|immunologic factors|mesh-ancestor
44349525|NCT01073839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349526|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
44349527|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
44349528|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44349553|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
44349554|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349555|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349556|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44349557|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44349558|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44349559|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44349560|NCT01073995|Triamcinolone|triamcinolone|mesh-list
44349561|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44349562|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44349563|NCT01073995|Bupivacaine|bupivacaine|mesh-list
44349564|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44349565|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
44349566|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
44349567|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349568|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349569|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
44349570|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349571|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349572|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
44349573|NCT01073995|Hormones|hormones|mesh-ancestor
44349574|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349610|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349611|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44349637|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236679|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349638|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44349639|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349640|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349642|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349643|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349644|NCT01074346|Interferons|interferons|mesh-list
44349645|NCT01074346|Interferon-beta|interferon-beta|mesh-list
44349646|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
44349647|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349648|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
44349649|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349650|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
44349651|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349652|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44349653|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
44349654|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
44349655|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349656|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
44349657|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349658|NCT01074359|Protective Agents|protective agents|mesh-ancestor
44349659|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349660|NCT01074411|Carboplatin|carboplatin|mesh-list
44349661|NCT01074411|Bortezomib|bortezomib|mesh-list
44349662|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349663|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43754911|NCT02476136|Fluoxetine|fluoxetine|mesh-list
44349699|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349700|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44349737|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
44349738|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349739|NCT01074723|Protective Agents|protective agents|mesh-ancestor
44349740|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349774|NCT01074892|Hormones|hormones|mesh-ancestor
44349775|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349776|NCT01074905|Artesunate|artesunate|mesh-list
44349777|NCT01074905|Chloroquine|chloroquine|mesh-list
44349778|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44349779|NCT01074905|Primaquine|primaquine|mesh-list
44349780|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
44349781|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44349813|NCT01075022|Vitamin D|vitamin d|mesh-list
44349814|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
44349815|NCT01075022|Vitamins|vitamins|mesh-ancestor
44349816|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
44349817|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349818|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44349819|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44349820|NCT01075113|Sorafenib|sorafenib|mesh-list
44349821|NCT01075113|Vorinostat|vorinostat|mesh-list
44349822|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349823|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44349824|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349825|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349826|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44349827|NCT01075126|Valproic Acid|valproic acid|mesh-list
44349828|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349829|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559028|NCT04453852|Vaccines|vaccines|mesh-list
44349894|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44349895|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349896|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349897|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349899|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349900|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44349901|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
44349902|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349903|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44349904|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44349905|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349906|NCT01075555|Sorafenib|sorafenib|mesh-list
44349937|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
44349938|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349939|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349940|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44349941|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44349942|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349943|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349944|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349945|NCT01075698|Telmisartan|telmisartan|mesh-list
44349946|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349947|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44349948|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44349949|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349950|NCT01075711|Prednisone|prednisone|mesh-list
44350010|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350011|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44350012|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44350013|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44350014|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350015|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350016|NCT01075945|Lumefantrine|lumefantrine|mesh-list
44350017|NCT01075945|Artemether|artemether|mesh-list
44350018|NCT01075945|Piperaquine|piperaquine|mesh-list
44350019|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44350020|NCT01075945|Artenimol|artenimol|mesh-list
44350021|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
44350022|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44350023|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44350024|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350025|NCT01076062|Misoprostol|misoprostol|mesh-list
44350054|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350055|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350056|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44350057|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
44350058|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
44350059|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350060|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44350061|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44350062|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44350063|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350064|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350065|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350066|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
44350067|NCT01076439|Fluticasone|fluticasone|mesh-list
44350069|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44350070|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350071|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44350072|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
44350073|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350074|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350105|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44350106|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350108|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44350109|NCT01076491|Diuretics|diuretics|mesh-ancestor
44350110|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
44350111|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350112|NCT01076530|Temozolomide|temozolomide|mesh-list
44350113|NCT01076530|Vorinostat|vorinostat|mesh-list
44350114|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44350115|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
44350116|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350142|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44350143|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44350144|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44350145|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
44350146|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350147|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350148|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44350149|NCT01076582|Estrogens|estrogens|mesh-ancestor
44350150|NCT01076582|Hormones|hormones|mesh-ancestor
44350151|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350152|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44350153|NCT01076582|Progestins|progestins|mesh-ancestor
44350154|NCT01076595|Interferons|interferons|mesh-list
44350155|NCT01076595|Interferon-beta|interferon-beta|mesh-list
44350156|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
44350157|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350158|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
43612829|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
44350159|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350160|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
44350161|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350162|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350164|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
44350165|NCT01076621|Estradiol|estradiol|mesh-list
44350166|NCT01076621|Estrogens|estrogens|mesh-ancestor
44350167|NCT01076621|Hormones|hormones|mesh-ancestor
44350168|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755312|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44350205|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44350240|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
44350241|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350242|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44350243|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44350244|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350245|NCT01077427|Gemcitabine|gemcitabine|mesh-list
44350246|NCT01077427|Cisplatin|cisplatin|mesh-list
44350247|NCT01077427|Capecitabine|capecitabine|mesh-list
44350274|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
44350275|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44350276|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
44350277|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
44350278|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350279|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350280|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44350281|NCT01077505|Incretins|incretins|mesh-ancestor
44350282|NCT01077505|Hormones|hormones|mesh-ancestor
44350283|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350284|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44350285|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44350286|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44350287|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44350288|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44350289|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44350290|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
44350291|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350292|NCT01077570|Repaglinide|repaglinide|mesh-list
44350293|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350326|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350327|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350328|NCT01077752|Acetaminophen|acetaminophen|mesh-list
44350329|NCT01077752|Lidocaine|lidocaine|mesh-list
44350330|NCT01077752|Morphine|morphine|mesh-list
44350331|NCT01077752|Ropivacaine|ropivacaine|mesh-list
44350332|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
44350333|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
44350334|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350335|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350336|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
44350366|NCT01077999|Panitumumab|panitumumab|mesh-list
44350367|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44350368|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350369|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44350370|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44350371|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44350372|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350373|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350374|NCT01078038|Sirolimus|sirolimus|mesh-list
44350375|NCT01078038|Everolimus|everolimus|mesh-list
44350376|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350377|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350378|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
44350379|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350380|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350381|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755488|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
44350413|NCT01078714|Diuretics|diuretics|mesh-ancestor
44350414|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
44350415|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350416|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44350417|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350418|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350419|NCT01078779|Chloroquine|chloroquine|mesh-list
43612830|NCT03162406|Vitamins|vitamins|mesh-ancestor
44102041|NCT00060385|Prednisone|prednisone|mesh-list
44350420|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44350421|NCT01078779|Amebicides|amebicides|mesh-ancestor
44350422|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44350423|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44350424|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350425|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
44350426|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350490|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
44350491|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350531|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
44350532|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44350533|NCT01079312|Narcotics|narcotics|mesh-ancestor
44350534|NCT01079312|Analgesics|analgesics|mesh-ancestor
44350535|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
44350536|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350537|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44350539|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44350540|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350541|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44350542|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350543|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350544|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44350545|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44350546|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
44350547|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350548|NCT01079351|Carbamazepine|carbamazepine|mesh-list
44350549|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
44350550|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
44350551|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44350552|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350553|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350554|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44350555|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350556|NCT01079351|Analgesics|analgesics|mesh-ancestor
44350557|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
44350558|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350559|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44350560|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350561|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350562|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44350563|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44350564|NCT01079364|Insulin|insulin|mesh-list
44350565|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44350566|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
44350567|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
44350568|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
44350569|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44350570|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350571|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350572|NCT01079455|Corticosterone|corticosterone|mesh-list
44350573|NCT01079455|Bupivacaine|bupivacaine|mesh-list
44350574|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
44350608|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
44350609|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350610|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350611|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350612|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
44350613|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350614|NCT01079715|Propranolol|propranolol|mesh-list
44350615|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44350616|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44350617|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350648|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350650|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
44350651|NCT01079910|Protective Agents|protective agents|mesh-ancestor
44350652|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350653|NCT01079923|Vitamin D|vitamin d|mesh-list
44350654|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
44350655|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
44350656|NCT01079923|Vitamins|vitamins|mesh-list
44350657|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
44350658|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350659|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44350660|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44350661|NCT01080027|Interferons|interferons|mesh-list
44350662|NCT01080027|Interferon-beta|interferon-beta|mesh-list
44350723|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350724|NCT01080534|Tacrolimus|tacrolimus|mesh-list
44350725|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350726|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
44350727|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350728|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350729|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350730|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350768|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350811|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44350812|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350813|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350814|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
44350815|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
44350816|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350817|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44350818|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44350820|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350821|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350822|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
44350823|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
44350824|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350825|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44350826|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44350827|NCT01080846|Misoprostol|misoprostol|mesh-list
43755795|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
44350856|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44350857|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44350858|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350859|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350861|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44350862|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
44350863|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44350864|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44350865|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
44350866|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350867|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350868|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44350869|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43855290|NCT03583086|Nivolumab|nivolumab|mesh-list
44350870|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
44350871|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350872|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44350873|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44350874|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
44350897|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350899|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44350900|NCT01081431|Growth Substances|growth substances|mesh-ancestor
44350901|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44350902|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350903|NCT01081535|Ketorolac|ketorolac|mesh-list
44350904|NCT01081535|Fentanyl|fentanyl|mesh-list
44350905|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44350906|NCT01081535|Narcotics|narcotics|mesh-ancestor
44350907|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350908|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350909|NCT01081535|Analgesics|analgesics|mesh-ancestor
44350910|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
44350911|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350912|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44350913|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44350914|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
44350915|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
44350916|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44350917|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350918|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350919|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350920|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44350921|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350922|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350923|NCT01081548|Atorvastatin|atorvastatin|mesh-list
44350924|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44350925|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44350952|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44350953|NCT01081639|Hormones|hormones|mesh-ancestor
44350954|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350955|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350956|NCT01081652|Progesterone|progesterone|mesh-list
44350957|NCT01081652|Progestins|progestins|mesh-ancestor
44350958|NCT01081652|Hormones|hormones|mesh-ancestor
44350959|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350960|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350961|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44350962|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
44350963|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350964|NCT01081704|Ustekinumab|ustekinumab|mesh-list
44350965|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350966|NCT01081717|Golimumab|golimumab|mesh-list
44350967|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44350968|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350969|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350970|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
44350971|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350972|NCT01081730|Ustekinumab|ustekinumab|mesh-list
44350973|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351129|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
44351130|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44351131|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351132|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351133|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351134|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351135|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351136|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44351137|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44351138|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44351139|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351140|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351141|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351142|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351143|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351144|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
44351145|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351146|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351147|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
44351148|NCT01082315|Cetuximab|cetuximab|mesh-list
44351149|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351150|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351151|NCT01082341|Vaccines|vaccines|mesh-list
44351152|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
44351153|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351154|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
44351155|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44351156|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
44351157|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351158|NCT01082445|Expectorants|expectorants|mesh-ancestor
44351159|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
44351160|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44351161|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
44351162|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351163|NCT01082445|Protective Agents|protective agents|mesh-ancestor
44351164|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351165|NCT01082445|Antidotes|antidotes|mesh-ancestor
44351186|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351187|NCT01082471|Analgesics|analgesics|mesh-ancestor
44351188|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
44351189|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351190|NCT01082484|Treprostinil|treprostinil|mesh-list
44351191|NCT01082484|Iloprost|iloprost|mesh-list
44351192|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44351193|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44351194|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
44351195|NCT01082510|Tegafur|tegafur|mesh-list
44351196|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351197|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
44351198|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236681|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44351199|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351200|NCT01082627|Somatostatin|somatostatin|mesh-list
44351201|NCT01082627|Hormones|hormones|mesh-ancestor
44351202|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351203|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351204|NCT01082679|Buprenorphine|buprenorphine|mesh-list
44351205|NCT01082679|Methadone|methadone|mesh-list
44351206|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44351207|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351208|NCT01082679|Narcotics|narcotics|mesh-ancestor
44351209|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351210|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351211|NCT01082679|Analgesics|analgesics|mesh-ancestor
44351212|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
44351213|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351214|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44351215|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
44351216|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
44351217|NCT01082705|Lumefantrine|lumefantrine|mesh-list
44351218|NCT01082705|Artemether|artemether|mesh-list
44351219|NCT01082705|Piperaquine|piperaquine|mesh-list
44351220|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44351221|NCT01082705|Artenimol|artenimol|mesh-list
44351252|NCT01082744|Ropivacaine|ropivacaine|mesh-list
44351253|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
44351254|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
44351255|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351256|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351257|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
44351258|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351259|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351260|NCT01082744|Narcotics|narcotics|mesh-ancestor
44351261|NCT01082744|Analgesics|analgesics|mesh-ancestor
44351262|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44351263|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44351264|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
44351265|NCT01082796|Glipizide|glipizide|mesh-list
44351266|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44351267|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351268|NCT01082809|Sunitinib|sunitinib|mesh-list
44351269|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351270|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44351271|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44351272|NCT01082809|Growth Substances|growth substances|mesh-ancestor
44351464|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351465|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351466|NCT01084031|Propofol|propofol|mesh-list
44351467|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44351468|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351505|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
44351506|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44351507|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44351508|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44351542|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351543|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
44351544|NCT01084473|Morphine|morphine|mesh-list
44351545|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44351546|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351547|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351548|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44351549|NCT01084473|Analgesics|analgesics|mesh-ancestor
44351579|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351580|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351581|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351582|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351583|NCT01084876|Paclitaxel|paclitaxel|mesh-list
44351584|NCT01084876|Trastuzumab|trastuzumab|mesh-list
44351585|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351586|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351587|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351588|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351589|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351590|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351591|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351592|NCT01084902|Latanoprost|latanoprost|mesh-list
44351593|NCT01084902|Brinzolamide|brinzolamide|mesh-list
44351594|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44351595|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44351596|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44351597|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756420|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44351628|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
44351629|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351630|NCT01085149|Simvastatin|simvastatin|mesh-list
44351631|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44351632|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351633|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
44351634|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351635|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44351636|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44351637|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351638|NCT01085383|Aripiprazole|aripiprazole|mesh-list
44351639|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
43756465|NCT02466347|Fluticasone|fluticasone|mesh-list
44351672|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44351673|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44351674|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351675|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
44351676|NCT01085487|Coagulants|coagulants|mesh-ancestor
44351677|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
44351678|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351769|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
44351770|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
44351771|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351772|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44351773|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44351774|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351775|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44351776|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351777|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351778|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
44351779|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44351780|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44351781|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
44351782|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
44351783|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351784|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351815|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44351816|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351817|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
44351818|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351819|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44351820|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44351821|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351822|NCT01086046|Heparin|heparin|mesh-list
44351823|NCT01086046|Enoxaparin|enoxaparin|mesh-list
44351824|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44351825|NCT01086046|Tinzaparin|tinzaparin|mesh-list
44351826|NCT01086046|Dalteparin|dalteparin|mesh-list
44351827|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
44351828|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44351829|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44351830|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351831|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44351832|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
44351868|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44351869|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44351871|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44351872|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44351899|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44351900|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44351901|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351902|NCT01086553|Budesonide|budesonide|mesh-list
44351903|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44351904|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44351905|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
44351906|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351907|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351908|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44351909|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
44351910|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
44351912|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351913|NCT01086579|Paclitaxel|paclitaxel|mesh-list
44351914|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44351915|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351916|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351917|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351918|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351919|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351920|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351956|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351957|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44351958|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44351959|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44351960|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44351961|NCT01086956|Sufentanil|sufentanil|mesh-list
44351998|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351999|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
44352000|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352001|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44352002|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
44352040|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352107|NCT01087632|Red yeast rice|red yeast rice|mesh-list
44352108|NCT01087632|Hematinics|hematinics|mesh-ancestor
44352109|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
44352138|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352139|NCT01087749|Diuretics|diuretics|mesh-ancestor
44352140|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
44352141|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352142|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44352143|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352144|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44352145|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44352146|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
44352147|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352148|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352149|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44352150|NCT01087840|Tenofovir|tenofovir|mesh-list
44352151|NCT01087840|Emtricitabine|emtricitabine|mesh-list
44352152|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
44352153|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
44352154|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756886|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352207|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352209|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352210|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44352211|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44352212|NCT01088022|Dexamethasone|dexamethasone|mesh-list
44352213|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
44352214|NCT01088022|Aprepitant|aprepitant|mesh-list
44352215|NCT01088022|Palonosetron|palonosetron|mesh-list
44352216|NCT01088022|BB 1101|bb 1101|mesh-list
44352217|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352218|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
44352219|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
44352250|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44352251|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
44352252|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352253|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
44352254|NCT01088191|Protective Agents|protective agents|mesh-ancestor
44352255|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
44352256|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44352257|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352258|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352259|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44352260|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352261|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352325|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44352326|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
44352327|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44352328|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352329|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
44102414|NCT00061360|Cyclosporine|cyclosporine|mesh-list
44352330|NCT01088555|Antidotes|antidotes|mesh-ancestor
44352331|NCT01088555|Protective Agents|protective agents|mesh-ancestor
44352332|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352333|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
44352334|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352335|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
44352336|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352337|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352338|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
44352339|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
44352340|NCT01088594|Pioglitazone|pioglitazone|mesh-list
44352341|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
44352342|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352343|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352344|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44352345|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44352346|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352347|NCT01088620|Cisplatin|cisplatin|mesh-list
44352348|NCT01088620|Pemetrexed|pemetrexed|mesh-list
44352416|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352417|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352418|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352419|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
44352421|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352422|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44352477|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352478|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
44352479|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352480|NCT01089088|Antiviral Agents|antiviral agents|mesh-ancestor
44352481|NCT01089088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352482|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352483|NCT01089088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352484|NCT01089088|Immunologic Factors|immunologic factors|mesh-ancestor
44352485|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352486|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44352487|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44352488|NCT01089088|Growth Substances|growth substances|mesh-ancestor
44352523|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44352525|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
44007476|NCT02794441|Hormones|hormones|mesh-ancestor
44352526|NCT01089348|Metronidazole|metronidazole|mesh-list
43757191|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352610|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352612|NCT01090037|Beraprost|beraprost|mesh-list
44352613|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44352614|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352615|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44352616|NCT01090128|Paclitaxel|paclitaxel|mesh-list
44352617|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
44352618|NCT01090128|Doxorubicin|doxorubicin|mesh-list
44352619|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44352620|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44352621|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352622|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352623|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
44352624|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44352625|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352626|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352627|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
44352628|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352685|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352686|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352687|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
44352688|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352689|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
44352690|NCT01090661|Mipomersen|mipomersen|mesh-list
44352691|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44352692|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352693|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352694|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44352695|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44352696|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352697|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352698|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352699|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44352700|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
44352701|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352702|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352703|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44352704|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44352705|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44352706|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44352707|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44352708|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
44352709|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44352738|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44352739|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44352740|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352741|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352743|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352744|NCT01090778|Hormones|hormones|mesh-list
44352745|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352746|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007688|NCT02815644|Incretins|incretins|mesh-ancestor
44352748|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44352749|NCT01090830|Bevacizumab|bevacizumab|mesh-list
44352750|NCT01090830|Carboplatin|carboplatin|mesh-list
44352751|NCT01090830|Belinostat|belinostat|mesh-list
44352752|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44352753|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352754|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352780|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44352781|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352782|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
44352783|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352784|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44352785|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44352786|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352787|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352788|NCT01091012|Urological Agents|urological agents|mesh-ancestor
44352789|NCT01091051|Ustekinumab|ustekinumab|mesh-list
44352790|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
44352791|NCT01091077|Naringenin|naringenin|mesh-list
44352792|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44352793|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352794|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44352795|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44352796|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352797|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007749|NCT02822950|Avibactam|avibactam|mesh-list
44352798|NCT01091207|Sorafenib|sorafenib|mesh-list
44352799|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352800|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44352801|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757368|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
44352831|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44352832|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
44352833|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352834|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352835|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
44352836|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44352837|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352838|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44352839|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352840|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352841|NCT01091415|Calcium|calcium|mesh-list
44352842|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352843|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352844|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
44352845|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352916|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44352917|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44352918|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44352919|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44352920|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44352921|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
44352922|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
44352923|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
44352924|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
44352925|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
44352926|NCT01091870|Citric Acid|citric acid|mesh-list
44352927|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
44352959|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
44352960|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352961|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44352962|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
44352963|NCT01092221|Protective Agents|protective agents|mesh-ancestor
44352964|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352965|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
44352966|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44352967|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352968|NCT01092351|Renal Agents|renal agents|mesh-ancestor
44352969|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352970|NCT01092455|Heparin|heparin|mesh-list
44352971|NCT01092455|Calcium heparin|calcium heparin|mesh-list
44352972|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
44352973|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44353004|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353005|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
44353006|NCT01092533|Hormones|hormones|mesh-ancestor
44353007|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353008|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353009|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44353010|NCT01092572|Simvastatin|simvastatin|mesh-list
44353011|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44353012|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44353013|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
44353014|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353015|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43757593|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353078|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44353080|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44353081|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44353082|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353083|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353084|NCT01092975|Protective Agents|protective agents|mesh-ancestor
44353086|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44353087|NCT01093092|Gemcitabine|gemcitabine|mesh-list
44353088|NCT01093092|Cisplatin|cisplatin|mesh-list
44353089|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353090|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353091|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
44353092|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353093|NCT01093092|Antiviral Agents|antiviral agents|mesh-ancestor
44353094|NCT01093092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353095|NCT01093092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353096|NCT01093092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353097|NCT01093092|Immunologic Factors|immunologic factors|mesh-ancestor
44353098|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353099|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44353100|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43757653|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44353125|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44353126|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44353127|NCT01093235|Growth Substances|growth substances|mesh-ancestor
44353128|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44353129|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44353130|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44353131|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44353132|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
44353133|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353134|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44353135|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44353136|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44353137|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353138|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
44353139|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
44353140|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353141|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
44353142|NCT01093274|Cathartics|cathartics|mesh-ancestor
44353143|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353145|NCT01093300|Everolimus|everolimus|mesh-list
44353146|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44353147|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353148|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
44353149|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
44353150|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
44353151|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353254|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44353255|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44353256|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44353257|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
44353258|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353259|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353260|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353261|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44353262|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353263|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44353264|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353265|NCT01094340|Thalidomide|thalidomide|mesh-list
44353266|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353267|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
44353268|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353269|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
44353270|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353271|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353272|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44353273|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44353274|NCT01094340|Growth Substances|growth substances|mesh-ancestor
44353275|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
44353312|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44353313|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
44353314|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
44353315|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44353316|NCT01094457|Protective Agents|protective agents|mesh-ancestor
44353421|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44353422|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44353423|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44353424|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353425|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353426|NCT01095133|Amiloride|amiloride|mesh-list
44353427|NCT01095133|Diuretics|diuretics|mesh-ancestor
44353428|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
44353488|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353489|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
44353490|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353491|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44353492|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
44353493|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353494|NCT01095484|Rotigotine|rotigotine|mesh-list
44353495|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
44353496|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
43757992|NCT02456948|Minocycline|minocycline|mesh-list
44353528|NCT01095731|Acetic Acid|acetic acid|mesh-list
44353529|NCT01095731|Retinol acetate|retinol acetate|mesh-list
44353530|NCT01095731|Glycine|glycine|mesh-list
44353531|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
44353532|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353533|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353534|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353535|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353536|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353537|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44353538|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
44353539|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44353540|NCT01095731|Protective Agents|protective agents|mesh-ancestor
43758054|NCT02456597|Lidocaine|lidocaine|mesh-list
44353602|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
44353603|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44353604|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353605|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353606|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
44353607|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44353608|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353609|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353610|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44353611|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353612|NCT01096121|Enalapril|enalapril|mesh-list
44353613|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44353615|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353616|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353617|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44353618|NCT01096199|Cisplatin|cisplatin|mesh-list
44353619|NCT01096199|Everolimus|everolimus|mesh-list
44353620|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353621|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353622|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
44353623|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353624|NCT01096212|Sevoflurane|sevoflurane|mesh-list
44353625|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44353626|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44353627|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
44353628|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
44353629|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353630|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353631|NCT01096225|Vaccines|vaccines|mesh-list
44353632|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
43758116|NCT02456428|Glimepiride|glimepiride|mesh-list
44353712|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
44353714|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
44353715|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44353716|NCT01096693|Substance P|substance p|mesh-list
44353717|NCT01096693|Neurokinin A|neurokinin a|mesh-list
44353718|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353746|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353748|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44353749|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353750|NCT01096745|Gemcitabine|gemcitabine|mesh-list
44353751|NCT01096745|Cisplatin|cisplatin|mesh-list
44353752|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353753|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353754|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
44353755|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353756|NCT01096745|Antiviral Agents|antiviral agents|mesh-ancestor
44353757|NCT01096745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353758|NCT01096745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353759|NCT01096745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353760|NCT01096745|Immunologic Factors|immunologic factors|mesh-ancestor
44353761|NCT01096745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353762|NCT01096797|Sevoflurane|sevoflurane|mesh-list
44353763|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44353764|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44353793|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353794|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353795|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353796|NCT01097213|Ethanol|ethanol|mesh-list
44353797|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44353798|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353799|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353800|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353801|NCT01097252|Cisplatin|cisplatin|mesh-list
44353802|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353803|NCT01097265|Capecitabine|capecitabine|mesh-list
44353804|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
44353805|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353806|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
44353807|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353808|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353810|NCT01097278|Vitamin D|vitamin d|mesh-list
44353856|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
44353857|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353858|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
44353859|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44353860|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
44353861|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
44353862|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44353863|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44353864|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44353865|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44353866|NCT01097551|Protective Agents|protective agents|mesh-ancestor
44353867|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
44353940|NCT01098344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102791|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353941|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353942|NCT01098344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353943|NCT01098344|Immunologic Factors|immunologic factors|mesh-ancestor
44353944|NCT01098344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353945|NCT01098357|Becaplermin|becaplermin|mesh-list
44353975|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44353976|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353977|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353978|NCT01098513|Dolutegravir|dolutegravir|mesh-list
44353979|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44353980|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44353981|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353982|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353983|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44353984|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44353985|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
44353986|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353987|NCT01098526|Efavirenz|efavirenz|mesh-list
44353988|NCT01098526|Dolutegravir|dolutegravir|mesh-list
44353989|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44353990|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44354017|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354018|NCT01098890|Plasminogen|plasminogen|mesh-list
44354019|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44354020|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44354021|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44354022|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354023|NCT01098994|Vitamin E|vitamin e|mesh-list
44354024|NCT01098994|Tocopherols|tocopherols|mesh-list
44354025|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
44354026|NCT01098994|Vitamins|vitamins|mesh-ancestor
44354027|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
44354028|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354029|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
44354030|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354031|NCT01098994|Protective Agents|protective agents|mesh-ancestor
44354032|NCT01099059|Amantadine|amantadine|mesh-list
44354033|NCT01099059|Methylphenidate|methylphenidate|mesh-list
44354034|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44354035|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354036|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44354037|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43758620|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
44354239|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354240|NCT01100216|Nicotine|nicotine|mesh-list
44354241|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44354242|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
44354243|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354244|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354245|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44354246|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44354247|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
44354248|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354310|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44354311|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44354312|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44354346|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354347|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354348|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43758659|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
44354433|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44354434|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44354435|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44354436|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354437|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354438|NCT01101659|Ketamine|ketamine|mesh-list
44354439|NCT01101659|Analgesics|analgesics|mesh-ancestor
44354440|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
44354441|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354442|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758759|NCT02453022|Omeprazole|omeprazole|mesh-list
44354458|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
44354459|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354460|NCT01101685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44354461|NCT01101685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44354462|NCT01101685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44354464|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
44354465|NCT01101698|Vitamins|vitamins|mesh-list
44354466|NCT01101698|Vitamin K|vitamin k|mesh-list
44354467|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
44354468|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
44354469|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354470|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354471|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354472|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44354473|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44354474|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354475|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
44354476|NCT01101698|Coagulants|coagulants|mesh-ancestor
44354477|NCT01101776|Interferons|interferons|mesh-list
44354478|NCT01101776|Interferon-beta|interferon-beta|mesh-list
44354479|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
44354480|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354481|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
44354482|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354483|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
44354484|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354485|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44354486|NCT01101789|Triclosan|triclosan|mesh-list
44354487|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354488|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354489|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44354490|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354491|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
44354492|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354493|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354494|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
44354495|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44354496|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354497|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44354498|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
44354530|NCT01102101|Remifentanil|remifentanil|mesh-list
44354531|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44354532|NCT01102101|Narcotics|narcotics|mesh-ancestor
44354533|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354534|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354535|NCT01102101|Analgesics|analgesics|mesh-ancestor
44354536|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
44354537|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354539|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
44354540|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354572|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354574|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44354575|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354576|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
44354577|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44354578|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44354579|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44354580|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
43758892|NCT02452307|Coagulants|coagulants|mesh-ancestor
44354606|NCT01102595|Bevacizumab|bevacizumab|mesh-list
44354607|NCT01102595|Temozolomide|temozolomide|mesh-list
44354608|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44354609|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44147291|NCT00200525|Emetics|emetics|mesh-ancestor
44354610|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44354611|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44354612|NCT01102595|Growth Substances|growth substances|mesh-ancestor
44354613|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354614|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44354615|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44354616|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
44354617|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354618|NCT01102608|Ifosfamide|ifosfamide|mesh-list
44354619|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44354620|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
44354621|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354622|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102884|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354623|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44354624|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354661|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354662|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354663|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354664|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
44354781|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44354782|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
43759090|NCT02451072|Ketanserin|ketanserin|mesh-list
44354844|NCT01103830|Artenimol|artenimol|mesh-list
44354845|NCT01103830|Artemisinins|artemisinins|mesh-list
44354846|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44354847|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44354848|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354849|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354850|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44354851|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43759146|NCT02450786|Donepezil|donepezil|mesh-list
44354877|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354878|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354879|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
44354880|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
44354882|NCT01104259|Vinorelbine|vinorelbine|mesh-list
44354884|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354885|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44354886|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44354887|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44354888|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44354889|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354890|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44354891|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354892|NCT01104298|Doxorubicin|doxorubicin|mesh-list
44354893|NCT01104298|Trabectedin|trabectedin|mesh-list
44354894|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44354895|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354896|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44354897|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44354898|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759188|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
44354964|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354965|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44354966|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354967|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354969|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354970|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354971|NCT01104883|Trace Elements|trace elements|mesh-ancestor
44354972|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
44355005|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44355006|NCT01105208|Cephalexin|cephalexin|mesh-list
44355007|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355008|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355009|NCT01105234|Vitamin D|vitamin d|mesh-list
44355010|NCT01105234|Calcipotriene|calcipotriene|mesh-list
44355011|NCT01105234|Vitamins|vitamins|mesh-ancestor
44355012|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
44355040|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355041|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355042|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44355043|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355044|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355045|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355047|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355048|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
44355049|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355050|NCT01105338|Protective Agents|protective agents|mesh-ancestor
44355051|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355052|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44355053|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44355054|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355055|NCT01105351|Folic Acid|folic acid|mesh-list
44355056|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
44355057|NCT01105351|Hematinics|hematinics|mesh-ancestor
44355058|NCT01105351|Vitamins|vitamins|mesh-ancestor
44102960|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355059|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
43759326|NCT02449746|Antibodies|antibodies|mesh-list
44355090|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355092|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355093|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44355094|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355095|NCT01105611|Ritonavir|ritonavir|mesh-list
44355096|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44355097|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
44355098|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44355099|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44355100|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
44355101|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759365|NCT02450058|Epirubicin|epirubicin|mesh-list
44355125|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44355126|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355127|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
44355128|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355129|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44355130|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
44355131|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44355132|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
44355133|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
44355135|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355136|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355137|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
44355138|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355139|NCT01106053|Pramipexole|pramipexole|mesh-list
44355140|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
44355141|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355142|NCT01106053|Protective Agents|protective agents|mesh-ancestor
44355143|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355144|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44355145|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44355146|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
44355147|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
44355148|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355149|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
44355150|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355151|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44355183|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355184|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
44355185|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355186|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44355187|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44355188|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355189|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
44355190|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44355191|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44355192|NCT01106547|Prednisolone|prednisolone|mesh-list
44355193|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
44355194|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43759468|NCT02449252|Prednisone|prednisone|mesh-list
44355290|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
44355327|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355328|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355329|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
44355358|NCT01107782|Urological Agents|urological agents|mesh-ancestor
44355359|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
44355361|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
44355362|NCT01107808|Metformin|metformin|mesh-list
44355363|NCT01107808|Calcium|calcium|mesh-list
44355364|NCT01107808|Vitamins|vitamins|mesh-ancestor
44355365|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
44355366|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355367|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44355368|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44355369|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44355370|NCT01107938|Esomeprazole|esomeprazole|mesh-list
44355371|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44355372|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44355373|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44355374|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355375|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355407|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44236682|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44355408|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355409|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
44355410|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355411|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355412|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
44355413|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355414|NCT01108107|Capecitabine|capecitabine|mesh-list
44355415|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
44355416|NCT01108107|Panitumumab|panitumumab|mesh-list
44355417|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355418|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
44355419|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355420|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355453|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355454|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355456|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
44355457|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
44355458|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355459|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355460|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
44355461|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355462|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44355463|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44355719|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43759926|NCT02446704|Temozolomide|temozolomide|mesh-list
44355774|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355776|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44355777|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355778|NCT01110031|Ofatumumab|ofatumumab|mesh-list
44355779|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355780|NCT01110226|Cisplatin|cisplatin|mesh-list
44356102|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356103|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356104|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356254|NCT01113047|Amlodipine|amlodipine|mesh-list
44356398|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356399|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44356400|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44356401|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
44356402|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356403|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356404|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44356405|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356406|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
44356407|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
44356408|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356409|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356531|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
44356532|NCT01115179|Propofol|propofol|mesh-list
44356533|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44356534|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44356535|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356536|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356537|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44356538|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
44356539|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
44356540|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44356541|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44356542|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44356543|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
44356544|NCT01115322|Tazarotene|tazarotene|mesh-list
44356545|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356905|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
44356906|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44356907|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44356908|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356909|NCT01117116|Fluticasone|fluticasone|mesh-list
44356911|NCT01117116|Budesonide|budesonide|mesh-list
44356912|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
44356913|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44356914|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356915|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44356916|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
44356917|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356918|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356948|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356949|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44356950|NCT01117220|Ziprasidone|ziprasidone|mesh-list
44356951|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44356952|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
44356953|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356954|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356955|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356956|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44356957|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356958|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356959|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356960|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44356961|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
44357059|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44357060|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44357061|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
44357062|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357063|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357064|NCT01118429|Urological Agents|urological agents|mesh-ancestor
44357065|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
44357066|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
44357067|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357068|NCT01118559|Darexaban|darexaban|mesh-list
44357069|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44357070|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
44357071|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44357072|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
44357073|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357074|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357075|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
44357076|NCT01118572|Celecoxib|celecoxib|mesh-list
44357077|NCT01118572|Etodolac|etodolac|mesh-list
44357078|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44357079|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44357080|NCT01118572|Analgesics|analgesics|mesh-ancestor
44357081|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
44357082|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671087|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44357114|NCT01118871|Ritonavir|ritonavir|mesh-list
44357115|NCT01118871|Darunavir|darunavir|mesh-list
44357116|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44357117|NCT01118871|Etravirine|etravirine|mesh-list
44357118|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44357119|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44357120|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
44357121|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357122|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357124|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44357158|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357159|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357161|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44357162|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
44357163|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357164|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43671178|NCT05103904|Lenvatinib|lenvatinib|mesh-list
44357193|NCT01119209|Ropivacaine|ropivacaine|mesh-list
44357194|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
44357195|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
44357196|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357197|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357198|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
44133557|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
44357199|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357200|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44357201|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44357202|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44357203|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357204|NCT01119430|Fluoxetine|fluoxetine|mesh-list
44357205|NCT01119430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44357206|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44357207|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357208|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357274|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357276|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44357277|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
44357278|NCT01119638|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44357279|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44357280|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357281|NCT01119638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44357282|NCT01119638|Antidepressive Agents|antidepressive agents|mesh-ancestor
44357283|NCT01119651|Tazarotene|tazarotene|mesh-list
44357284|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357285|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
44357286|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
44357287|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44357288|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
44357289|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357290|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357291|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
44357292|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357324|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357325|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44357326|NCT01120119|Vitamins|vitamins|mesh-ancestor
44357327|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
44357328|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44357329|NCT01120158|Paclitaxel|paclitaxel|mesh-list
44357330|NCT01120158|Bevacizumab|bevacizumab|mesh-list
44357331|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44357332|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357333|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44357334|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44357335|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44357336|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357368|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44357369|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44357370|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357371|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357372|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357373|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357374|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357376|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44357377|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44357378|NCT01120340|Analgesics|analgesics|mesh-ancestor
44357407|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357408|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44357410|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357411|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357412|NCT01120561|Trastuzumab|trastuzumab|mesh-list
44357413|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44357414|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357415|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357416|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
44357417|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44357418|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44357419|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357420|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44357421|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44357422|NCT01120665|Estradiol|estradiol|mesh-list
44357447|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357448|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
44357449|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357450|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
44357451|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357452|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44357453|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357454|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357455|NCT01120912|Insulin|insulin|mesh-list
44357456|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357457|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357458|NCT01121016|Montelukast|montelukast|mesh-list
44357459|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44357460|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44357461|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44357463|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357464|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357465|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44357466|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44357467|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357468|NCT01121042|Ondansetron|ondansetron|mesh-list
44357469|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
44357470|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
44357471|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357472|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357473|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357528|NCT01121276|Insulin|insulin|mesh-list
44357529|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44357530|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
44357531|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
44357532|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44357533|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357534|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357535|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
44357536|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357537|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357538|NCT01121354|Cefazolin|cefazolin|mesh-list
44357539|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357540|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357541|NCT01121458|Clevidipine|clevidipine|mesh-list
44357542|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44357543|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357544|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357545|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357546|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357547|NCT01121497|Physostigmine|physostigmine|mesh-list
44357580|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357581|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
44357582|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357583|NCT01121770|PENTA|penta|mesh-list
44357584|NCT01121770|Fondaparinux|fondaparinux|mesh-list
44357585|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44357586|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
44357587|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44357588|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
44357589|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357590|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357591|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
44357592|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44357627|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357628|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44357629|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357630|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357631|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
44357632|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357633|NCT01121848|Antidotes|antidotes|mesh-ancestor
44357634|NCT01121848|Protective Agents|protective agents|mesh-ancestor
44357635|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
44357636|NCT01121848|Vitamins|vitamins|mesh-ancestor
44357698|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
44357699|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
44357700|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44357701|NCT01122342|Androgens|androgens|mesh-ancestor
44357702|NCT01122342|Hormones|hormones|mesh-ancestor
44357703|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357704|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357705|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44357706|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357707|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
44357708|NCT01122368|Micafungin|micafungin|mesh-list
44357709|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
44357710|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357711|NCT01122407|Trimethaphan|trimethaphan|mesh-list
44357712|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
44357713|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357714|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44357751|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43671604|NCT04262817|Nicotine|nicotine|mesh-list
44357782|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44357783|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44357784|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
44357785|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357786|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44357787|NCT01122771|Amphotericin B|amphotericin b|mesh-list
44357788|NCT01122771|Paromomycin|paromomycin|mesh-list
44357789|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44357790|NCT01122771|Miltefosine|miltefosine|mesh-list
44357791|NCT01122771|Amebicides|amebicides|mesh-ancestor
44357792|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44357793|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44357794|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357795|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357829|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
44357830|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
44357831|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357832|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357833|NCT01123031|Esomeprazole|esomeprazole|mesh-list
44357834|NCT01123031|Lansoprazole|lansoprazole|mesh-list
44357835|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
44357836|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44357871|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44012958|NCT03113500|Antibodies|antibodies|mesh-list
44357872|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357874|NCT01123408|Olanzapine|olanzapine|mesh-list
44357875|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
44357876|NCT01123408|Clozapine|clozapine|mesh-list
44357877|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
44357878|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
44357906|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44357907|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357908|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
44357909|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357910|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44357911|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44357912|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44357913|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357914|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44357915|NCT01123486|Hydromorphone|hydromorphone|mesh-list
44357916|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44357917|NCT01123486|Narcotics|narcotics|mesh-ancestor
44357918|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357919|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357920|NCT01123486|Analgesics|analgesics|mesh-ancestor
44357921|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
44357922|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357923|NCT01123525|Adenosine|adenosine|mesh-list
44357924|NCT01123525|Analgesics|analgesics|mesh-ancestor
44357925|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
44357926|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671709|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357960|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357961|NCT01123564|Growth Substances|growth substances|mesh-ancestor
44357962|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357963|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357964|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357966|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357993|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357994|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44357995|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44357996|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44357997|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357998|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357999|NCT01124032|Methylphenidate|methylphenidate|mesh-list
44358000|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44358001|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358002|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44358003|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44358004|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358005|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358006|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
44358007|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236683|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44358009|NCT01124058|Calcium heparin|calcium heparin|mesh-list
44358010|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44358011|NCT01124058|Tinzaparin|tinzaparin|mesh-list
44358050|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44358051|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44358052|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44358053|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358081|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44358082|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44358084|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
44358085|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358086|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358087|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44358088|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44358089|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44358090|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44358091|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358092|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358093|NCT01124487|Insulin|insulin|mesh-list
44358094|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44358095|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358096|NCT01124500|Methylphenidate|methylphenidate|mesh-list
44358097|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44358098|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358099|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44358100|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43671832|NCT03639389|Morphine|morphine|mesh-list
44358197|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
44358198|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358199|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358200|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
44358201|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358202|NCT01125020|Antiviral Agents|antiviral agents|mesh-ancestor
44358335|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
44358336|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358337|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44358338|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44358339|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44358340|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44358341|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
44358342|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44358344|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44358345|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358346|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
44358347|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358348|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358349|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
44358350|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358351|NCT01125891|Gemcitabine|gemcitabine|mesh-list
44358352|NCT01125891|ON 01910|on 01910|mesh-list
43672082|NCT03026517|Phenformin|phenformin|mesh-list
44358447|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44358448|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44358449|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856543|NCT03438318|Atezolizumab|atezolizumab|mesh-list
44358450|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358452|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
44358453|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358454|NCT01126229|Protective Agents|protective agents|mesh-ancestor
44358592|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358593|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
44358594|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
44358595|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44358596|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358597|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358598|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358599|NCT01127204|Lamivudine|lamivudine|mesh-list
44358600|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44358601|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44358602|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358603|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358605|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358606|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44358630|NCT01127295|Exemestane|exemestane|mesh-list
44358631|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358632|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44358633|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44358634|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358635|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358636|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44358637|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
44358638|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44358639|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358640|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44358641|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44358642|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44358643|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44358645|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44358646|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358647|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44358648|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358649|NCT01127360|Bevacizumab|bevacizumab|mesh-list
44358650|NCT01127360|Ranibizumab|ranibizumab|mesh-list
44358651|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358652|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358653|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358654|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358655|NCT01127360|Growth Substances|growth substances|mesh-ancestor
44358656|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358657|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358658|NCT01127386|Lenalidomide|lenalidomide|mesh-list
44358940|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358941|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44358942|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358943|NCT01129388|Omeprazole|omeprazole|mesh-list
44358944|NCT01129388|Clopidogrel|clopidogrel|mesh-list
44358945|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358946|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358947|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358948|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358949|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
44358950|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358951|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358952|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358986|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44358987|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358988|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358989|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
43856623|NCT03434678|Narcotics|narcotics|mesh-ancestor
44358990|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359225|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44359227|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359228|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359229|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
44359230|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44359231|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359232|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359233|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44359234|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44359235|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359236|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359237|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359238|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44359239|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
44359240|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44359436|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359437|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359438|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
44359485|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44359486|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359487|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359488|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359489|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
44359490|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359491|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359492|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359493|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359494|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359495|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
44359496|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359497|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359498|NCT01131780|Ibuprofen|ibuprofen|mesh-list
44359499|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
44359500|NCT01131780|Ephedrine|ephedrine|mesh-list
44359501|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359502|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359503|NCT01131780|Analgesics|analgesics|mesh-ancestor
44359504|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
44359505|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359506|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359507|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359508|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359757|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44359758|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44359759|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44359760|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359761|NCT01132599|Choline|choline|mesh-list
44359762|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
44359763|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44359764|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
44359765|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359766|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359767|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44359768|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
44359769|NCT01132638|Esomeprazole|esomeprazole|mesh-list
44359770|NCT01132638|Pantoprazole|pantoprazole|mesh-list
44359771|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44359772|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359773|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44359774|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359775|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359776|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
44359777|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44359778|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44359779|NCT01132677|Prednisolone|prednisolone|mesh-list
44359780|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
44359781|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44359782|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
44359783|NCT01132677|Hylan|hylan|mesh-list
44359784|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359785|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
44360062|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44360063|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
44360064|NCT01133912|Antiviral Agents|antiviral agents|mesh-ancestor
44360065|NCT01133912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360066|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360067|NCT01133912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360068|NCT01133912|Immunologic Factors|immunologic factors|mesh-ancestor
44360069|NCT01133912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360220|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360221|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360222|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44360223|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360224|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360225|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360226|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44360227|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44360228|NCT01134718|Simeprevir|simeprevir|mesh-list
44360229|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
44360230|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360231|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
44360232|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360233|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360234|NCT01134848|Morphine|morphine|mesh-list
44360235|NCT01134848|Secretin|secretin|mesh-list
44360236|NCT01134848|Neostigmine|neostigmine|mesh-list
44360237|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44015317|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
44360238|NCT01134848|Narcotics|narcotics|mesh-ancestor
44360239|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360240|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360241|NCT01134848|Analgesics|analgesics|mesh-ancestor
44360242|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
44360243|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360244|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44360245|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360246|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360247|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360248|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43673428|NCT01904409|Rifaximin|rifaximin|mesh-list
44360381|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360382|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360383|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360384|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
44360385|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360386|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
44360543|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44360544|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360545|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360546|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360547|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360548|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360549|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44360550|NCT01136551|Protective Agents|protective agents|mesh-ancestor
44360551|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
44360552|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44360553|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44360554|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360555|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
44360670|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44360671|NCT01137591|Analgesics|analgesics|mesh-ancestor
44360672|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
44360673|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360674|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360675|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
44360676|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
43673741|NCT01777555|Levodopa|levodopa|mesh-list
44360896|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360897|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44360898|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360899|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856729|NCT03422523|Rituximab|rituximab|mesh-list
44360900|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360901|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
44360902|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44360903|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
44360904|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360905|NCT01138956|Expectorants|expectorants|mesh-ancestor
44360906|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
44360907|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44360908|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
44360909|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360910|NCT01138956|Protective Agents|protective agents|mesh-ancestor
44360911|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360912|NCT01138956|Antidotes|antidotes|mesh-ancestor
44360913|NCT01139138|Irinotecan|irinotecan|mesh-list
44360914|NCT01139138|Everolimus|everolimus|mesh-list
44360915|NCT01139138|Panitumumab|panitumumab|mesh-list
44360916|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44361093|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361095|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361096|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
44361097|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361098|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44361099|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44361100|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44361101|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44361102|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44361103|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
44361104|NCT01140425|PF 232798|pf 232798|mesh-list
44361105|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44361106|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361107|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44361108|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44361109|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361233|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361234|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
44361235|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
44361236|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361237|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361238|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361239|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
44361240|NCT01140984|Hormones|hormones|mesh-ancestor
44361241|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361242|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44361243|NCT01140984|Protective Agents|protective agents|mesh-ancestor
44361244|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44361245|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361246|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44361247|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44361248|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
44361249|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361250|NCT01141036|Midazolam|midazolam|mesh-list
44361251|NCT01141036|Propofol|propofol|mesh-list
44361252|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44361253|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361254|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361255|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44361256|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
44361257|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
44361258|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44361259|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44361260|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44361261|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44361262|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
44361263|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
44361264|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361265|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361266|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
44361267|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44361268|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44361269|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361270|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
44361271|NCT01141127|Coagulants|coagulants|mesh-ancestor
44361272|NCT01141153|Aspirin|aspirin|mesh-list
44361273|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
44361297|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
44361298|NCT01141192|Vitamins|vitamins|mesh-ancestor
44361299|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
44361300|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361301|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44361302|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361303|NCT01141244|Sirolimus|sirolimus|mesh-list
44361304|NCT01141244|Irinotecan|irinotecan|mesh-list
44361305|NCT01141244|Temozolomide|temozolomide|mesh-list
44361306|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44361307|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44361308|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361309|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361310|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361311|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44361312|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
44361313|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44361314|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361315|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44361316|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
44361317|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361318|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
44361319|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361320|NCT01141296|Fenofibrate|fenofibrate|mesh-list
44361321|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44361322|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
43674274|NCT00712582|Rituximab|rituximab|mesh-list
43674342|NCT02893995|Treprostinil|treprostinil|mesh-list
44361471|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44361472|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612831|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
44103746|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
44361473|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361474|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361506|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361507|NCT01142492|Interferons|interferons|mesh-list
44361508|NCT01142492|Interferon-beta|interferon-beta|mesh-list
44361509|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
44361510|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361511|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
44361512|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361513|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
44361514|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361515|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361516|NCT01142505|Mannitol|mannitol|mesh-list
44361517|NCT01142505|Montelukast|montelukast|mesh-list
44361518|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43674477|NCT02893371|Bupropion|bupropion|mesh-list
44361697|NCT01143987|Cinacalcet|cinacalcet|mesh-list
44361698|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361699|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016740|NCT03593538|Metformin|metformin|mesh-list
43827504|NCT05487885|Ketamine|ketamine|mesh-list
44362186|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362188|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
44362189|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362190|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362191|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362192|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
44362193|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44362287|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44362288|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362289|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362290|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362291|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44362292|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44362293|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362294|NCT01147523|Vitamin E|vitamin e|mesh-list
44362295|NCT01147523|Spironolactone|spironolactone|mesh-list
44362296|NCT01147523|Vitamins|vitamins|mesh-ancestor
44362297|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
44362298|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362299|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
44362300|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362301|NCT01147523|Protective Agents|protective agents|mesh-ancestor
44362302|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44362303|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362304|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362305|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44362306|NCT01147523|Diuretics|diuretics|mesh-ancestor
44362307|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
44362308|NCT01147588|Esomeprazole|esomeprazole|mesh-list
44362309|NCT01147588|Omeprazole|omeprazole|mesh-list
44362310|NCT01147588|Lansoprazole|lansoprazole|mesh-list
44362311|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
44362312|NCT01147588|Clopidogrel|clopidogrel|mesh-list
43675174|NCT02886377|Antibodies|antibodies|mesh-list
44362338|NCT01147705|Allopurinol|allopurinol|mesh-list
44362339|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
44362340|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362341|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362342|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
44362343|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362344|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44362345|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
44362346|NCT01147705|Protective Agents|protective agents|mesh-ancestor
44362347|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362348|NCT01147718|Digoxin|digoxin|mesh-list
44362349|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
44362350|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44362351|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44362352|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362353|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362354|NCT01147718|Protective Agents|protective agents|mesh-ancestor
44362355|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362356|NCT01147718|Incretins|incretins|mesh-ancestor
44362357|NCT01147718|Hormones|hormones|mesh-ancestor
44362358|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362439|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362440|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362442|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44362443|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362444|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362445|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362446|NCT01148264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362447|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362448|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362449|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362450|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362451|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
44362452|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44362453|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44362454|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
44362455|NCT01148277|Fentanyl|fentanyl|mesh-list
44362456|NCT01148277|Midazolam|midazolam|mesh-list
44362457|NCT01148277|Propofol|propofol|mesh-list
44362458|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44362459|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362521|NCT01148446|Vinblastine|vinblastine|mesh-list
44362522|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362523|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
44362524|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362525|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362526|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362527|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
44362528|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362529|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362530|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44362531|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43675345|NCT02885311|Naltrexone|naltrexone|mesh-list
44362567|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675370|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
44362596|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362597|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362598|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
44362599|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362600|NCT01148667|Caseins|caseins|mesh-list
44362601|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
44362602|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
44362603|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362604|NCT01148901|Infliximab|infliximab|mesh-list
44362605|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44362606|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362607|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362608|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44362609|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44362610|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
44362611|NCT01148992|Lofexidine|lofexidine|mesh-list
44362612|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44362613|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44362614|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362615|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
44362616|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362825|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362826|NCT01149954|Analgesics|analgesics|mesh-ancestor
44362827|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
44362828|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362829|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362830|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362831|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362832|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44362833|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362834|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362835|NCT01149967|Dexetimide|dexetimide|mesh-list
44362836|NCT01149967|Citalopram|citalopram|mesh-list
44362837|NCT01149967|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362838|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43613063|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362840|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362841|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362842|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
44362843|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362844|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44362845|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44362846|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362847|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44362848|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44362849|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
44362878|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
44362879|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362880|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362881|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44362882|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362883|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44362884|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
44362885|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44362886|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362888|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362889|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
44362890|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362891|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
44362892|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
44362893|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44362894|NCT01150162|Omeprazole|omeprazole|mesh-list
44362895|NCT01150162|Rebamipide|rebamipide|mesh-list
44362896|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44363146|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44363148|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363149|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363150|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363151|NCT01152372|Insulin|insulin|mesh-list
44363152|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363153|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363154|NCT01152476|Remifentanil|remifentanil|mesh-list
44363155|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44363156|NCT01152476|Narcotics|narcotics|mesh-ancestor
44363157|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363158|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363159|NCT01152476|Analgesics|analgesics|mesh-ancestor
44363160|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
44363161|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363162|NCT01152593|Mupirocin|mupirocin|mesh-list
44363163|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363164|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363282|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44363283|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44363284|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363285|NCT01153204|Urological Agents|urological agents|mesh-ancestor
44363286|NCT01153217|Tenofovir|tenofovir|mesh-list
44363287|NCT01153217|Abacavir|abacavir|mesh-list
44363288|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
44363289|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363290|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44363291|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44363292|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363293|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363294|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44363295|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44363296|NCT01153243|Vitamin D|vitamin d|mesh-list
44363297|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
44363298|NCT01153243|Vitamins|vitamins|mesh-ancestor
44363299|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
44363300|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363301|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44363302|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363303|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
44363304|NCT01153256|Analgesics|analgesics|mesh-ancestor
44363305|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
44363306|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363307|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363308|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
43675904|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
44363341|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363342|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44363343|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363344|NCT01153659|Esomeprazole|esomeprazole|mesh-list
44363345|NCT01153659|Rabeprazole|rabeprazole|mesh-list
44363346|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44363347|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363348|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44363396|NCT01153919|Ribavirin|ribavirin|mesh-list
44363397|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
44363398|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
44363399|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44363400|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363401|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
44363402|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363403|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
44363404|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363405|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
44363406|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363407|NCT01154114|Darapladib|darapladib|mesh-list
44363408|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44363409|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363410|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363411|NCT01154348|Metformin|metformin|mesh-list
43827654|NCT05487001|Hormones|hormones|mesh-ancestor
44363439|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363441|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363442|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44363443|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
44363444|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363445|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363446|NCT01154400|Caseins|caseins|mesh-list
44363447|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
44363448|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
44363449|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363450|NCT01154426|Gemcitabine|gemcitabine|mesh-list
44363451|NCT01154426|Veliparib|veliparib|mesh-list
44363452|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44363453|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
44363454|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363455|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363456|NCT01154426|Antiviral Agents|antiviral agents|mesh-ancestor
44363457|NCT01154426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363491|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363492|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
44363493|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363494|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44363495|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
44363496|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363498|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
44363499|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
44363500|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363533|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363535|NCT01154803|Trace Elements|trace elements|mesh-list
43676074|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363585|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
44363586|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44363587|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44363588|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44363589|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44363590|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44363591|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44363592|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44363593|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44363594|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44363595|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
44363749|NCT01155908|Benazepril|benazepril|mesh-list
44363750|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44363751|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44363752|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363753|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363754|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363755|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363756|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
44104050|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363757|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44363758|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
44363759|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363760|NCT01155921|Risperidone|risperidone|mesh-list
44363761|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44363762|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
44363763|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363764|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363765|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363766|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44363767|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44363768|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363769|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363770|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44363771|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
44363772|NCT01155934|Risperidone|risperidone|mesh-list
44363773|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44363774|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
44363775|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676277|NCT02877641|Vitamin D|vitamin d|mesh-list
44363828|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
44363829|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363830|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363831|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44363832|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363833|NCT01156350|Fludarabine|fludarabine|mesh-list
44363834|NCT01156350|Busulfan|busulfan|mesh-list
44363835|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363836|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363837|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363838|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
44363839|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363840|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
44363841|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44363842|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44363843|NCT01156389|Ritonavir|ritonavir|mesh-list
44363844|NCT01156389|Artesunate|artesunate|mesh-list
44363845|NCT01156389|Pyronaridine|pyronaridine|mesh-list
44363846|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44363847|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44363848|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
44363849|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363850|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363851|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44363852|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44363853|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
44363854|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363855|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44363856|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44363906|NCT01156779|Hormones|hormones|mesh-ancestor
44363907|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363908|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
44363909|NCT01156857|Progestins|progestins|mesh-list
44363910|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44363911|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
44363912|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363913|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363914|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44363915|NCT01156857|Hormones|hormones|mesh-ancestor
44363916|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363917|NCT01156883|Cytarabine|cytarabine|mesh-list
44363918|NCT01156883|Dexamethasone|dexamethasone|mesh-list
44363919|NCT01156883|Prednisone|prednisone|mesh-list
43676394|NCT02876354|Vitamin K|vitamin k|mesh-list
44364005|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44364006|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364008|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364009|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44364010|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44364011|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364012|NCT01157026|Tamoxifen|tamoxifen|mesh-list
44364013|NCT01157026|Tocotrienols|tocotrienols|mesh-list
44364131|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44364132|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364133|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364134|NCT01157559|Ziprasidone|ziprasidone|mesh-list
44364135|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44364136|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
44364137|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364138|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364139|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364140|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44364141|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44364142|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364143|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364144|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44364145|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
44364147|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44364148|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44364149|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
44364150|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
44364151|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364152|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364153|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44364154|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44364155|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44364156|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44364216|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
44364217|NCT01157975|Hormones|hormones|mesh-ancestor
44364218|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364219|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364220|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364221|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364222|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364223|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43676603|NCT02874989|Dasatinib|dasatinib|mesh-list
44364292|NCT01158612|Hormones|hormones|mesh-list
44364293|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364294|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364295|NCT01158729|Antithrombins|antithrombins|mesh-list
44364296|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
44364297|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44364298|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364299|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364300|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364356|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44364357|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364358|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
44364359|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44364360|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44364361|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
44364362|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364363|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44364364|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44364365|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364366|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364367|NCT01159145|Omeprazole|omeprazole|mesh-list
44364368|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44364369|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364370|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44364371|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364372|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364373|NCT01159158|Nateglinide|nateglinide|mesh-list
44364374|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364375|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364376|NCT01159210|Thrombin|thrombin|mesh-list
44364377|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
44364378|NCT01159210|Coagulants|coagulants|mesh-ancestor
44364379|NCT01159236|Paclitaxel|paclitaxel|mesh-list
44364380|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
44364381|NCT01159236|Bevacizumab|bevacizumab|mesh-list
44364382|NCT01159236|Doxorubicin|doxorubicin|mesh-list
44364383|NCT01159236|Fluorouracil|fluorouracil|mesh-list
44364384|NCT01159236|Epirubicin|epirubicin|mesh-list
44364385|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364613|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
44364615|NCT01160419|Folic Acid|folic acid|mesh-list
44364616|NCT01160419|Docetaxel|docetaxel|mesh-list
44364617|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
44236426|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364619|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364620|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364621|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364622|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364623|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364624|NCT01160419|Antidotes|antidotes|mesh-ancestor
44364625|NCT01160419|Protective Agents|protective agents|mesh-ancestor
44364626|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364627|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
44364628|NCT01160419|Vitamins|vitamins|mesh-ancestor
44364629|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
44364630|NCT01160419|Hematinics|hematinics|mesh-ancestor
44364631|NCT01160432|Methadone|methadone|mesh-list
44364632|NCT01160432|Naloxone|naloxone|mesh-list
44364633|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44364693|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44364694|NCT01160900|Bivalirudin|bivalirudin|mesh-list
44364695|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44364696|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44364697|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
44364698|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44364699|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364700|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364701|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364702|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
44364703|NCT01160926|Cediranib|cediranib|mesh-list
44364704|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364705|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364706|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364816|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364817|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364819|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364820|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364821|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364822|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44364823|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
44364824|NCT01161186|Antiviral Agents|antiviral agents|mesh-ancestor
44364825|NCT01161186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365174|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
44365175|NCT01164046|Bemiparin|bemiparin|mesh-list
44365176|NCT01164046|Certoparin|certoparin|mesh-list
44365177|NCT01164046|Vitamins|vitamins|mesh-ancestor
44365178|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
44365179|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365180|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
44365181|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44365182|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44365183|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365184|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44365185|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
44365186|NCT01164046|Coagulants|coagulants|mesh-ancestor
44365187|NCT01164059|Haloperidol|haloperidol|mesh-list
44365188|NCT01164059|Olanzapine|olanzapine|mesh-list
44365189|NCT01164059|Aripiprazole|aripiprazole|mesh-list
44365190|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44365191|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
44365192|NCT01164059|Flupenthixol|flupenthixol|mesh-list
44365193|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44365194|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
44365195|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
44365196|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365197|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365198|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365199|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44365200|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44365201|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365202|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365203|NCT01164059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44365204|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365205|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365206|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365207|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365208|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
43677277|NCT02869035|Analgesics|analgesics|mesh-ancestor
44365227|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365228|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44365229|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365230|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365232|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365233|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365234|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
44365235|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365236|NCT01164189|Bevacizumab|bevacizumab|mesh-list
44365237|NCT01164189|Temozolomide|temozolomide|mesh-list
44365238|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365239|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365240|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365241|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44365242|NCT01164189|Growth Substances|growth substances|mesh-ancestor
44365243|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365244|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44365245|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44365246|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
44365247|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365248|NCT01164215|Leucovorin|leucovorin|mesh-list
44365249|NCT01164215|Fluorouracil|fluorouracil|mesh-list
44365250|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
44365251|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
44365252|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365253|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
44365254|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365255|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365256|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365257|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365258|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
44365259|NCT01164215|Antidotes|antidotes|mesh-ancestor
44365260|NCT01164215|Protective Agents|protective agents|mesh-ancestor
44365261|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
44365262|NCT01164215|Vitamins|vitamins|mesh-ancestor
44365263|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
44365264|NCT01164267|Everolimus|everolimus|mesh-list
43677330|NCT02868827|Vitamins|vitamins|mesh-ancestor
44365355|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365357|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44365358|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44365359|NCT01164813|Analgesics|analgesics|mesh-ancestor
44365360|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
44365361|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365362|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365363|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365364|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365365|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44365366|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44365367|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365368|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365369|NCT01164826|Nabumetone|nabumetone|mesh-list
44365370|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44365371|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44365372|NCT01164826|Analgesics|analgesics|mesh-ancestor
44365405|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44365406|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44365407|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365408|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677415|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365461|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365462|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
44365463|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44365464|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44365465|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365466|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44365467|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44365468|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
44365469|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365470|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365471|NCT01165580|Valganciclovir|valganciclovir|mesh-list
44365472|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
44365473|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365474|NCT01165814|Naproxen|naproxen|mesh-list
44236427|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
44365475|NCT01165814|Tramadol|tramadol|mesh-list
44365476|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44365477|NCT01165814|Narcotics|narcotics|mesh-ancestor
44365478|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365479|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365480|NCT01165814|Analgesics|analgesics|mesh-ancestor
44365481|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
43857398|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
44365482|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365483|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44365484|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44365485|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365486|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365487|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
44365488|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44365489|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365490|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365491|NCT01165866|Ondansetron|ondansetron|mesh-list
44365492|NCT01165866|Metoclopramide|metoclopramide|mesh-list
44365493|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
44365494|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
44365495|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365496|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365497|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365498|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
44365499|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44365500|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44365501|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
44365502|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365503|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365504|NCT01165866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44365505|NCT01165866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44365506|NCT01165866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365591|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44365592|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
44365593|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
44365594|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365595|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365596|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366002|NCT01168817|Urological Agents|urological agents|mesh-ancestor
44366003|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
44366004|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366005|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366006|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44366007|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44366008|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366009|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366010|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366011|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44366012|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44366013|NCT01169012|Clofarabine|clofarabine|mesh-list
44366014|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366015|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
44366016|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366017|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366018|NCT01169025|Fentanyl|fentanyl|mesh-list
44366019|NCT01169025|Ketamine|ketamine|mesh-list
44366020|NCT01169025|Analgesics|analgesics|mesh-ancestor
44366021|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
44366022|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366023|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366024|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44366025|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44366026|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
44366027|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
44366028|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677873|NCT02865564|Gentamicins|gentamicins|mesh-list
44366142|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44366144|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44366145|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366146|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366147|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366148|NCT01169688|Protective Agents|protective agents|mesh-ancestor
44366149|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
44366150|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44366151|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44366309|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
43857469|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366310|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44366311|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44366312|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44366313|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366314|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366315|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366316|NCT01170442|Vitamin D|vitamin d|mesh-list
44366317|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
44366318|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
44366319|NCT01170442|Vitamins|vitamins|mesh-list
44366320|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
44366321|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366322|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366323|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366324|NCT01170468|Vitamin D|vitamin d|mesh-list
44366325|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
44366326|NCT01170468|Vitamins|vitamins|mesh-ancestor
44366327|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
44366350|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
44366351|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021503|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
44366352|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44366353|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44366354|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366356|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
44366357|NCT01170637|Ephedrine|ephedrine|mesh-list
44366358|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44366359|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366360|NCT01170637|Analgesics|analgesics|mesh-ancestor
44366361|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
44366362|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366363|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366364|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366365|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366366|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44366367|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366368|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366369|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44366370|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
44366371|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44366372|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366373|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
44366374|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44366375|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44366376|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
44366377|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366378|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366379|NCT01170767|Bevacizumab|bevacizumab|mesh-list
43678187|NCT02863276|Insulin|insulin|mesh-list
44366618|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
44366619|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366620|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
44366621|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366622|NCT01172405|Ibuprofen|ibuprofen|mesh-list
44366623|NCT01172405|Caffeine|caffeine|mesh-list
44366624|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44366625|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366626|NCT01172405|Analgesics|analgesics|mesh-ancestor
44366627|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
44366628|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366629|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366630|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366631|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366632|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44366633|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366634|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367499|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367500|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367501|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367502|NCT01177514|Gabapentin|gabapentin|mesh-list
44367729|NCT01178788|Progesterone|progesterone|mesh-list
44367730|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43857538|NCT03321981|Vinorelbine|vinorelbine|mesh-list
44236428|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44104468|NCT00069498|Mesalamine|mesalamine|mesh-list
44367731|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44367732|NCT01178788|Progestins|progestins|mesh-ancestor
44367876|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367877|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367878|NCT01179724|Pantoprazole|pantoprazole|mesh-list
44367879|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44367880|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44367881|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367882|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367883|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368050|NCT01180569|Growth Substances|growth substances|mesh-ancestor
44368051|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368052|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368053|NCT01180621|Vaccines|vaccines|mesh-list
44368054|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
44368055|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368056|NCT01180725|Psyllium|psyllium|mesh-list
44368057|NCT01180725|Cathartics|cathartics|mesh-ancestor
44368058|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368059|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44368060|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44368061|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368062|NCT01180816|Temozolomide|temozolomide|mesh-list
44368063|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44368064|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
44368065|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023363|NCT00822679|Eszopiclone|eszopiclone|mesh-list
44368066|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368068|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
44368069|NCT01180933|Hematinics|hematinics|mesh-ancestor
44368070|NCT01180933|Vitamins|vitamins|mesh-ancestor
44368071|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
44368072|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368073|NCT01180946|Vitamin D|vitamin d|mesh-list
44368074|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
44368075|NCT01180946|Vitamins|vitamins|mesh-ancestor
44368076|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
44368077|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368078|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368079|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44368080|NCT01180959|Bevacizumab|bevacizumab|mesh-list
44368081|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44368082|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368083|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368084|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368085|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44368086|NCT01180959|Growth Substances|growth substances|mesh-ancestor
44368087|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368088|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368183|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368184|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368185|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44368186|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44368187|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44368188|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368189|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44368190|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44368191|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44368192|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368193|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44368194|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44368195|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44368196|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
44368197|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368198|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368199|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44368200|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44368201|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44368202|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368203|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368204|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368205|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368206|NCT01181505|Urological Agents|urological agents|mesh-ancestor
44368207|NCT01181544|Heparin|heparin|mesh-list
44368208|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
44368209|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44368210|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44368211|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368212|NCT01181570|Adalimumab|adalimumab|mesh-list
44368213|NCT01181570|Mannitol|mannitol|mesh-list
44368214|NCT01181570|Citric Acid|citric acid|mesh-list
44368235|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
44368236|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368237|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368238|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368239|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368240|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44368241|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44368242|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368243|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368244|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44368245|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368246|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
44368247|NCT01181934|Nicotine|nicotine|mesh-list
44368248|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44368249|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
44368250|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368251|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368252|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44368253|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44368254|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368255|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368256|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368257|NCT01181960|Risperidone|risperidone|mesh-list
44368258|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44368259|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
44368260|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44368261|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
44368262|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368263|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368264|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368265|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368266|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368267|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368268|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44368269|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
44368270|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44368390|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44368391|NCT01182974|Analgesics|analgesics|mesh-ancestor
44368459|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44368461|NCT01183611|Vaccines|vaccines|mesh-list
44368462|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
44368463|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368464|NCT01183624|Analgesics|analgesics|mesh-list
44368465|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
44368466|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679739|NCT05382741|Durvalumab|durvalumab|mesh-list
44368497|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
44368498|NCT01183676|Valproic Acid|valproic acid|mesh-list
44368499|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
44368500|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368501|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368502|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
44368503|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368504|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368505|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
44368506|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43857619|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
44368507|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368509|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44368510|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
44368511|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368512|NCT01183767|Protective Agents|protective agents|mesh-ancestor
44368513|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368514|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44368671|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44368672|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44368673|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
44368674|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
44368676|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
44368677|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368678|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
44368679|NCT01185067|Resveratrol|resveratrol|mesh-list
44368680|NCT01185067|Antioxidants|antioxidants|mesh-list
44368681|NCT01185067|Quercetin|quercetin|mesh-list
44368682|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368683|NCT01185067|Protective Agents|protective agents|mesh-ancestor
44368684|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368685|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368686|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368687|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44368688|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368689|NCT01185119|Glucagon|glucagon|mesh-list
44368713|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368714|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368715|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368716|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
44368717|NCT01185197|Hormones|hormones|mesh-ancestor
44368718|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368719|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368720|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44368721|NCT01185223|Valganciclovir|valganciclovir|mesh-list
44368722|NCT01185223|Ganciclovir|ganciclovir|mesh-list
44368723|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44368724|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
44368725|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368726|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44368727|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368728|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368729|NCT01185236|Atorvastatin|atorvastatin|mesh-list
44368730|NCT01185236|Simvastatin|simvastatin|mesh-list
44368731|NCT01185236|Ezetimibe|ezetimibe|mesh-list
44368732|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44368733|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44368734|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
44368735|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368736|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44368737|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44368738|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368739|NCT01185262|Rituximab|rituximab|mesh-list
44368740|NCT01185262|Lenalidomide|lenalidomide|mesh-list
44368741|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368742|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368743|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
44368744|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368745|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368746|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368747|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44368748|NCT01185262|Growth Substances|growth substances|mesh-ancestor
44368749|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368750|NCT01185405|Voriconazole|voriconazole|mesh-list
44368751|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
44368752|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368753|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44368754|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44368755|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368756|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857684|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44368757|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44368758|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
44368759|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368760|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679921|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44369073|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44369074|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44369075|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369076|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44369077|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
43613467|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
44236429|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
44369078|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369185|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
44369186|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369187|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44369188|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44369189|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
44369190|NCT01187485|Testosterone|testosterone|mesh-list
44369191|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
44369192|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
44369193|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44369194|NCT01187485|Androgens|androgens|mesh-ancestor
44369195|NCT01187485|Hormones|hormones|mesh-ancestor
44369196|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369197|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369198|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44369199|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369200|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
44369201|NCT01187537|Bupivacaine|bupivacaine|mesh-list
44369202|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
44369203|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
44369204|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369205|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369206|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
44369207|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369208|NCT01187589|Albuterol|albuterol|mesh-list
44369209|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44369210|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
44369211|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369212|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369213|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44369214|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369215|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
44369216|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43680258|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369487|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369488|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44369489|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44369490|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680464|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369735|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
44369736|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369737|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369738|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369739|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369740|NCT01190553|Analgesics|analgesics|mesh-ancestor
44369741|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
44369742|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369743|NCT01190670|Tacrolimus|tacrolimus|mesh-list
44369744|NCT01190670|Peficitinib|peficitinib|mesh-list
44369745|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369746|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
44369747|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369748|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44369749|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369784|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369786|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43857827|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44369787|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
43828175|NCT05480384|Nivolumab|nivolumab|mesh-list
44370075|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370076|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44370077|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44370078|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370079|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
44370080|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44370224|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44370225|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
44370226|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44370227|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
44370228|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44370229|NCT01193504|Prednisolone|prednisolone|mesh-list
44370230|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44370231|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
43680916|NCT04384562|Reboxetine|reboxetine|mesh-list
44370360|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370361|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
44370362|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370363|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44370364|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44370365|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
44370366|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370367|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370368|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44370369|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370370|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
44370371|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
44370372|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370373|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370374|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
44370541|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370542|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370543|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370544|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44370545|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44370546|NCT01196507|Carvedilol|carvedilol|mesh-list
44370547|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44370548|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44370549|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
44370802|NCT01198249|Losartan|losartan|mesh-list
44370803|NCT01198249|Amlodipine|amlodipine|mesh-list
44370804|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44370805|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44370806|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370807|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370808|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370809|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370810|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370811|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370812|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370813|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44370814|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44370815|NCT01198249|Diuretics|diuretics|mesh-ancestor
44370816|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
44370817|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44370818|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44370819|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
44370962|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44370963|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
44370964|NCT01198860|Protective Agents|protective agents|mesh-ancestor
44370965|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370966|NCT01198860|Vitamins|vitamins|mesh-ancestor
44370967|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
44370968|NCT01198912|Doxycycline|doxycycline|mesh-list
44370969|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370970|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370971|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
44370972|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44155657|NCT00227773|Somatostatin|somatostatin|mesh-list
44370973|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44370974|NCT01198925|Piperacillin|piperacillin|mesh-list
44370975|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370976|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370977|NCT01198938|Melatonin|melatonin|mesh-list
44370978|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
44370979|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370980|NCT01198938|Protective Agents|protective agents|mesh-ancestor
44370981|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681370|NCT03667651|Decanoic acid|decanoic acid|mesh-list
44371081|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371082|NCT01199458|Alfentanil|alfentanil|mesh-list
44371083|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44371084|NCT01199458|Narcotics|narcotics|mesh-ancestor
44371085|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371086|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371087|NCT01199458|Analgesics|analgesics|mesh-ancestor
44371088|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
44371089|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371090|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44371091|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
44371092|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
44371093|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44236430|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371094|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
44371095|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44371096|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
44371097|NCT01199523|Mirabegron|mirabegron|mesh-list
44371098|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371099|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371100|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44371101|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44371102|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371103|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371104|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371105|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681491|NCT03477396|Estrogens|estrogens|mesh-list
44371139|NCT01199783|Daptomycin|daptomycin|mesh-list
44371140|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371141|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371142|NCT01199835|Calcium|calcium|mesh-list
44371143|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371144|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371145|NCT01199900|Prednisone|prednisone|mesh-list
44371146|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371147|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
44371148|NCT01199900|Hormones|hormones|mesh-ancestor
43828377|NCT05478330|Flutamide|flutamide|mesh-list
44371264|NCT01200641|Protective Agents|protective agents|mesh-ancestor
44371265|NCT01200654|Linezolid|linezolid|mesh-list
44371266|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371267|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371268|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44371269|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371270|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371271|NCT01200693|Sirolimus|sirolimus|mesh-list
44371272|NCT01200693|Everolimus|everolimus|mesh-list
44371273|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371274|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371275|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
44371276|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371277|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371278|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371279|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371280|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
44371281|NCT01200706|Amoxicillin|amoxicillin|mesh-list
44371282|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371283|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371284|NCT01200732|Tadalafil|tadalafil|mesh-list
44371285|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
44371286|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44371371|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44371372|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
44371373|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371374|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44371375|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44371376|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371377|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371378|NCT01201278|Insulin|insulin|mesh-list
44371379|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44371380|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
44371381|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44371382|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026874|NCT00000244|Dynorphins|dynorphins|mesh-list
44371383|NCT01201499|Morphine|morphine|mesh-list
44371384|NCT01201499|Remifentanil|remifentanil|mesh-list
44371385|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44371386|NCT01201499|Narcotics|narcotics|mesh-ancestor
44371387|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371388|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371389|NCT01201499|Analgesics|analgesics|mesh-ancestor
44371526|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44371528|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371529|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371530|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
44371531|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43828426|NCT05477615|Lazertinib|lazertinib|mesh-list
44371769|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44371770|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371771|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426853|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44371772|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371774|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44027312|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371775|NCT01203696|Amlodipine|amlodipine|mesh-list
44371776|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44371777|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44371778|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44371779|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371780|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371781|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371782|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
44371783|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
44371784|NCT01203709|Tacrolimus|tacrolimus|mesh-list
44371785|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371998|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371999|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372000|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
44372001|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372002|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
44372003|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372004|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
44372005|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372006|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372008|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372009|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
44372010|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44372011|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372012|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44372013|NCT01204476|Everolimus|everolimus|mesh-list
44372014|NCT01204476|Octreotide|octreotide|mesh-list
44372015|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44372016|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682217|NCT00221988|Levetiracetam|levetiracetam|mesh-list
44372044|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372045|NCT01204801|Doxorubicin|doxorubicin|mesh-list
44372046|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44372047|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44372048|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372049|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44372050|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372051|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372052|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372053|NCT01204840|Hormones|hormones|mesh-list
44372054|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372055|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372056|NCT01204996|Gemcitabine|gemcitabine|mesh-list
44372057|NCT01204996|Paclitaxel|paclitaxel|mesh-list
44372058|NCT01204996|Docetaxel|docetaxel|mesh-list
44372059|NCT01204996|Carboplatin|carboplatin|mesh-list
44372060|NCT01204996|Doxorubicin|doxorubicin|mesh-list
44372061|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44372062|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372063|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372064|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372065|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
44372066|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372601|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
44372602|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372603|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372604|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44372605|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44372606|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
44372608|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372609|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44372639|NCT05624008|Methamphetamine|methamphetamine|mesh-list
44372640|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44372641|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372642|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
44372643|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
44372644|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372645|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
44372646|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372647|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236431|NCT00559351|Cisplatin|cisplatin|mesh-list
44104963|NCT00070525|Tipifarnib|tipifarnib|mesh-list
44372648|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
44372649|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44372650|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44372651|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44372652|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44372671|NCT05623111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372672|NCT05623111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372673|NCT05623111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44372674|NCT05623111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44372675|NCT05623111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372676|NCT05623111|Cholinergic Agents|cholinergic agents|mesh-ancestor
44372677|NCT05623111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372678|NCT05622994|Rimonabant|rimonabant|mesh-list
44372679|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44372680|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44372681|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44372682|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372683|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372684|NCT05622994|Hormones|hormones|mesh-ancestor
44372685|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372686|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372687|NCT05622916|Ethanol|ethanol|mesh-list
44372688|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44372689|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372690|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372691|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372692|NCT05622890|Maytansine|maytansine|mesh-list
44372693|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372694|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372695|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372696|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44372697|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372698|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372699|NCT05622812|Lidocaine|lidocaine|mesh-list
44372700|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
44372701|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
44372702|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372703|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372704|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
44372705|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372706|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44372707|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44372709|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682741|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372735|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44372736|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372737|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372738|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44372739|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44372740|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44372741|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
44372742|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
44372743|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372744|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372745|NCT05593094|Trastuzumab|trastuzumab|mesh-list
44372746|NCT05593094|Pertuzumab|pertuzumab|mesh-list
44372747|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44372748|NCT05593094|Maytansine|maytansine|mesh-list
44372749|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372750|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372751|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372752|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
44372753|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372754|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372755|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372759|NCT05577117|Fentanyl|fentanyl|mesh-list
44372760|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
44372786|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372787|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372788|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372789|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44372790|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372791|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372792|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44372793|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44372794|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372795|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372796|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372798|NCT05555329|Pomalidomide|pomalidomide|mesh-list
44372799|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
44372800|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372801|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44372802|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44372803|NCT05555329|Growth Substances|growth substances|mesh-ancestor
44372804|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44372805|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372806|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372830|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
44372831|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372832|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372833|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372834|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372835|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44372836|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372837|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372839|NCT05520749|Hematinics|hematinics|mesh-ancestor
44372840|NCT05513391|Vaccines|vaccines|mesh-list
44372841|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
44372842|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372843|NCT05511025|Acetaminophen|acetaminophen|mesh-list
44372844|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44372845|NCT05511025|Analgesics|analgesics|mesh-ancestor
44372846|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
44372847|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372848|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372849|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
44372850|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
44372851|NCT05435313|Irinotecan|irinotecan|mesh-list
44372852|NCT05435313|Raltitrexed|raltitrexed|mesh-list
44372853|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372854|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44372855|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372856|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372857|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682789|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
44372886|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44372887|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
44372888|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372889|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
44372890|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
44372891|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372892|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372893|NCT05269355|Dacarbazine|dacarbazine|mesh-list
44372894|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44372895|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
44372896|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372897|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372898|NCT05264974|Vaccines|vaccines|mesh-list
44372899|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
44372900|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372901|NCT05260008|Epinephrine|epinephrine|mesh-list
44372902|NCT05260008|Bupivacaine|bupivacaine|mesh-list
44372903|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
44372904|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
44372905|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372906|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682813|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44372927|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44372928|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372929|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372930|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44105121|NCT00071266|Niacin|niacin|mesh-list
44372931|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44372932|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372933|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372934|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44372935|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44372936|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
44372937|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372938|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
44372939|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44372940|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44372941|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44372942|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44372943|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44372944|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44372945|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44372946|NCT05255159|Furosemide|furosemide|mesh-list
44372947|NCT05255159|Diuretics|diuretics|mesh-ancestor
44372948|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
44372949|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372950|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44372951|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44372952|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372953|NCT05216432|Fulvestrant|fulvestrant|mesh-list
44372954|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44372955|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372956|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44372957|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43682827|NCT02845908|Antidotes|antidotes|mesh-ancestor
44372993|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
44372994|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373015|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44373016|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44373017|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
44373018|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373019|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44373020|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44373021|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373022|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44373023|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44373024|NCT05030818|Analgesics|analgesics|mesh-ancestor
44373025|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
44373026|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373027|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373028|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373029|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373030|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44373031|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44373032|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373033|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44373034|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
44373035|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44373036|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
44373037|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44373038|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44373039|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
44373040|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44373041|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
44373042|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373043|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373044|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44373045|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373046|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373047|NCT05027594|Dexamethasone|dexamethasone|mesh-list
44373048|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373049|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
44373050|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
44373069|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373070|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373071|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
44373072|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
44373074|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373075|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373076|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
44373077|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373078|NCT05026905|Antidotes|antidotes|mesh-ancestor
44373079|NCT05026905|Protective Agents|protective agents|mesh-ancestor
44373080|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
44373081|NCT05026905|Vitamins|vitamins|mesh-ancestor
44373082|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
44373083|NCT04979806|Meropenem|meropenem|mesh-list
44373084|NCT04979806|Cefepime|cefepime|mesh-list
44373085|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373086|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373087|NCT04925375|Abatacept|abatacept|mesh-list
44373088|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373089|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373090|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373091|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373092|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
44373093|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373094|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373095|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
44373096|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44373097|NCT04910269|Antibodies|antibodies|mesh-list
44373098|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
44373099|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373100|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
44373101|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373102|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
44373103|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44373104|NCT04897217|Megestrol|megestrol|mesh-list
44373105|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
44373106|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
44373107|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44373108|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
44373109|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373125|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
44373126|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
44373127|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44373128|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44373129|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44373130|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373131|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373132|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373133|NCT04860713|Aspirin|aspirin|mesh-list
44373134|NCT04860713|Ketamine|ketamine|mesh-list
44373135|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44373136|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44373137|NCT04860713|Analgesics|analgesics|mesh-ancestor
44373138|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
44373139|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373140|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373141|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373142|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373143|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44373144|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44373145|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373146|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373147|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44373148|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373149|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
44373150|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44373151|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44373152|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
44373153|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
44373154|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373155|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44373156|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44373157|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373158|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
44373159|NCT04848064|Fludarabine|fludarabine|mesh-list
44373160|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
44373161|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
44373162|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
44373163|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373164|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
44236432|NCT00559351|Fluorouracil|fluorouracil|mesh-list
44373165|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373166|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373167|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44373168|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
44412299|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
44373189|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
44373190|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373191|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373192|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44373193|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44373194|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373195|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373196|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44373197|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44373198|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44373199|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
44373200|NCT04670679|Cetuximab|cetuximab|mesh-list
44373201|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373202|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373203|NCT04639011|Norepinephrine|norepinephrine|mesh-list
44373204|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44373205|NCT04639011|Serotonin|serotonin|mesh-list
44373206|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44373207|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44373208|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44373209|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373210|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373211|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373212|NCT04639011|Analgesics|analgesics|mesh-ancestor
44373213|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
44373214|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373215|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
44373216|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44373217|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
44373218|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44373219|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44373220|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373221|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
44373222|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
43682951|NCT02844894|Esmolol|esmolol|mesh-list
44373245|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373246|NCT04521686|Gemcitabine|gemcitabine|mesh-list
44028847|NCT00000658|Hormones|hormones|mesh-ancestor
44373247|NCT04521686|Cisplatin|cisplatin|mesh-list
44373248|NCT04521686|Durvalumab|durvalumab|mesh-list
44373249|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373250|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373251|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
44373252|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373253|NCT04521686|Antiviral Agents|antiviral agents|mesh-ancestor
44373254|NCT04521686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373255|NCT04521686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373256|NCT04521686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373257|NCT04521686|Immunologic Factors|immunologic factors|mesh-ancestor
44373258|NCT04521686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373259|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373260|NCT04506086|Blinatumomab|blinatumomab|mesh-list
44373261|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373263|NCT04484818|Goserelin|goserelin|mesh-list
44373264|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44373265|NCT04484818|Tryptophan|tryptophan|mesh-list
44373266|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
44373267|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373268|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373269|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44373270|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
44373271|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373272|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373273|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373274|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
44373275|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44373276|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
44373277|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44426854|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44105317|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44373278|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44373348|NCT04246762|Vitamin K|vitamin k|mesh-list
44373349|NCT04246762|Midazolam|midazolam|mesh-list
44373350|NCT04246762|Caffeine|caffeine|mesh-list
44373351|NCT04246762|Omeprazole|omeprazole|mesh-list
44373352|NCT04246762|Warfarin|warfarin|mesh-list
44373353|NCT04246762|Vitamins|vitamins|mesh-ancestor
44373354|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
44373355|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373356|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44373357|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44373358|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373359|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44373360|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44373361|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44373362|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44373363|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
44373364|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
44373365|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
44373366|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
43683023|NCT02844153|Metformin|metformin|mesh-list
44373400|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44373402|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373403|NCT04218409|Analgesics|analgesics|mesh-ancestor
44373404|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
44373405|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373406|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44373437|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373438|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373439|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
44373440|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373441|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373442|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373444|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373445|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373446|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
44373447|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373448|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373449|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
44373450|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373513|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373514|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373515|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
44373516|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373517|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373518|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
44373519|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373520|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44373521|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44373522|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44373523|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373524|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373525|NCT03800134|Gemcitabine|gemcitabine|mesh-list
44373526|NCT03800134|Paclitaxel|paclitaxel|mesh-list
44373527|NCT03800134|Cisplatin|cisplatin|mesh-list
44373528|NCT03800134|Carboplatin|carboplatin|mesh-list
44373529|NCT03800134|Pemetrexed|pemetrexed|mesh-list
44373530|NCT03800134|Durvalumab|durvalumab|mesh-list
44373531|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373532|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373564|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373565|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373566|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373567|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373568|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373569|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373570|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373571|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44373572|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44373573|NCT03740165|Growth Substances|growth substances|mesh-ancestor
44373574|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373575|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
43683033|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373604|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373606|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373607|NCT03492125|Rituximab|rituximab|mesh-list
44373608|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
44373609|NCT03492125|Venetoclax|venetoclax|mesh-list
44373610|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
44373611|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373612|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373613|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
44373614|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373615|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373616|NCT03490760|Durvalumab|durvalumab|mesh-list
44373617|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373618|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373619|NCT03483038|Irinotecan|irinotecan|mesh-list
44373620|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44373621|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44373622|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373657|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
44373658|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373659|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373660|NCT03293784|Nivolumab|nivolumab|mesh-list
44373661|NCT03293784|Ipilimumab|ipilimumab|mesh-list
44373662|NCT03293784|Infliximab|infliximab|mesh-list
44373692|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44373693|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373709|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
44373738|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44373739|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
44373740|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373741|NCT02966873|Expectorants|expectorants|mesh-ancestor
44373742|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
44373743|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44373744|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
44373745|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373746|NCT02966873|Protective Agents|protective agents|mesh-ancestor
44373747|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373748|NCT02966873|Antidotes|antidotes|mesh-ancestor
44373749|NCT02945800|Gemcitabine|gemcitabine|mesh-list
44373750|NCT02945800|Paclitaxel|paclitaxel|mesh-list
44373751|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373752|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373753|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373754|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373755|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373756|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373757|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373758|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
44373759|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
43828512|NCT05476679|Celecoxib|celecoxib|mesh-list
44373783|NCT02798523|Protective Agents|protective agents|mesh-ancestor
44373784|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373785|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373786|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
44373787|NCT02722668|Sirolimus|sirolimus|mesh-list
44373788|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
44373789|NCT02722668|Fludarabine|fludarabine|mesh-list
44373790|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44373791|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373792|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
44373793|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373794|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373795|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44373796|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
44373797|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373798|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373799|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44373800|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44373801|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44373802|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
44373803|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373804|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373805|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373806|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
44373807|NCT02401347|Talazoparib|talazoparib|mesh-list
44029430|NCT00000732|Zidovudine|zidovudine|mesh-list
44373808|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44373809|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373810|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373826|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373827|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373828|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44373829|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44373830|NCT01649947|Growth Substances|growth substances|mesh-ancestor
44373831|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373832|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
44373833|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
44373834|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44373835|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44373836|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373837|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373838|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373840|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
44373841|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44373842|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
44373843|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373844|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373845|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373846|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44373847|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373848|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373850|NCT00980954|Cisplatin|cisplatin|mesh-list
44373851|NCT00980954|Carboplatin|carboplatin|mesh-list
44373852|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373853|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373854|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373855|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373856|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373857|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373858|NCT00956930|Doxorubicin|doxorubicin|mesh-list
44373859|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44373860|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44373861|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373862|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44373863|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44373864|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373865|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373866|NCT00131235|Azithromycin|azithromycin|mesh-list
44373867|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
44373868|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
44373869|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44373870|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373871|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373964|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44373965|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373966|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
44373967|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373968|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
44373969|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
44373970|NCT05624866|Triamcinolone|triamcinolone|mesh-list
44373971|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
44373972|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44373973|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373974|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373975|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44373976|NCT05624866|Analgesics|analgesics|mesh-ancestor
44373977|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
44373978|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373979|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44373980|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44373981|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44373982|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373983|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373984|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373985|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373986|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
44373987|NCT05624866|Hormones|hormones|mesh-ancestor
44373988|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373989|NCT05624853|Pregabalin|pregabalin|mesh-list
44373990|NCT05624853|Analgesics|analgesics|mesh-ancestor
44373991|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
44373992|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44236433|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373993|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373994|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
44373995|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44373996|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44373997|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858526|NCT03199300|Bleomycin|bleomycin|mesh-list
44373998|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44373999|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44374000|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44374001|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374002|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374120|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374121|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44374122|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
44374123|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374124|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374125|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44374126|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374127|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374128|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
44374129|NCT05471817|Dabigatran|dabigatran|mesh-list
44374130|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
44374131|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44374132|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
44374133|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374134|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374135|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
44374136|NCT05471076|Complement C4b|complement c4b|mesh-list
43683357|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
44374270|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44374271|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374272|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374273|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44374274|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44374275|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374276|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374277|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
44374278|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
44374279|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
44374280|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
44374281|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374282|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374283|NCT05694416|Cisplatin|cisplatin|mesh-list
44374284|NCT05694416|Etoposide|etoposide|mesh-list
44374285|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374286|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374287|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44374288|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44374289|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374290|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374291|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
44374292|NCT05694364|Fludarabine|fludarabine|mesh-list
44374293|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374294|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
44374295|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374296|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374297|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44374298|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
44374299|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374300|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374301|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44374302|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
44374303|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44374304|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
44374305|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374306|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
44374307|NCT05694286|Protective Agents|protective agents|mesh-ancestor
44374308|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44374309|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44374310|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
44374311|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374312|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44374313|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44236434|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
44374314|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374315|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374316|NCT05694221|Metformin|metformin|mesh-list
44374317|NCT05694221|Digoxin|digoxin|mesh-list
44374318|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374319|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374320|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44374321|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44374322|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374323|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374324|NCT05694221|Protective Agents|protective agents|mesh-ancestor
44374325|NCT05694130|Prednisolone|prednisolone|mesh-list
44374326|NCT05694130|Tacrolimus|tacrolimus|mesh-list
44374327|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374328|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
44374329|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374330|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44374331|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374332|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374333|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374523|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374524|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374525|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
44374527|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374528|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
44374529|NCT05660967|Lenalidomide|lenalidomide|mesh-list
44374530|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
44374531|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374532|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44374533|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44374534|NCT05660967|Growth Substances|growth substances|mesh-ancestor
44374535|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
44374536|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374537|NCT05659147|Secretin|secretin|mesh-list
44374538|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374539|NCT05659147|Hormones|hormones|mesh-ancestor
44374540|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374541|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374542|NCT05658575|Dapansutrile|dapansutrile|mesh-list
44374543|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374544|NCT05651594|Leucovorin|leucovorin|mesh-list
44374545|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
44374546|NCT05651594|Fluorouracil|fluorouracil|mesh-list
44374547|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
44374548|NCT05651594|Propranolol|propranolol|mesh-list
44374549|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374550|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374551|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
44374552|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374553|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374554|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374555|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
44374556|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374557|NCT05651594|Antidotes|antidotes|mesh-ancestor
44374558|NCT05651594|Protective Agents|protective agents|mesh-ancestor
44374559|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
44374560|NCT05651594|Vitamins|vitamins|mesh-ancestor
44374561|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
44374562|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44374563|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44374564|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44374678|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374679|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374680|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44374681|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44374682|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
44374683|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374684|NCT05473364|Acetazolamide|acetazolamide|mesh-list
44374685|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
44374686|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44374687|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374688|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374690|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
44374691|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858670|NCT03175432|Antibodies|antibodies|mesh-list
44105656|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
44374692|NCT05472623|Nivolumab|nivolumab|mesh-list
44374693|NCT05472623|Adagrasib|adagrasib|mesh-list
44374694|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374769|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374770|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44374771|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44374772|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
44374773|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374774|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374775|NCT05329766|Leucovorin|leucovorin|mesh-list
44374776|NCT05329766|Fluorouracil|fluorouracil|mesh-list
44374777|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
44374778|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
44374779|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374780|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374781|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374782|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374783|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
44374784|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374785|NCT05329766|Antidotes|antidotes|mesh-ancestor
44374786|NCT05329766|Protective Agents|protective agents|mesh-ancestor
44374787|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
44374788|NCT05329766|Vitamins|vitamins|mesh-ancestor
44374789|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
44374790|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44374791|NCT05312762|Chitosan|chitosan|mesh-list
44374792|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44374793|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44374794|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
44374795|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374796|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44374797|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
44374798|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
44374799|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
44374800|NCT05312762|Coagulants|coagulants|mesh-ancestor
44374801|NCT05312762|Laxatives|laxatives|mesh-ancestor
44374802|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374803|NCT05309616|Ixekizumab|ixekizumab|mesh-list
44374804|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
44374805|NCT05305560|Ivermectin|ivermectin|mesh-list
43683815|NCT00751218|Cetirizine|cetirizine|mesh-list
44375271|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
44375272|NCT04703101|Vitamins|vitamins|mesh-ancestor
44375273|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
44375274|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44375275|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
44375276|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375277|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375278|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375279|NCT04676646|Spironolactone|spironolactone|mesh-list
44375280|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44375281|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44375282|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375283|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375284|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44375285|NCT04676646|Diuretics|diuretics|mesh-ancestor
44375286|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
44375287|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44375288|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375289|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375290|NCT04665037|Posaconazole|posaconazole|mesh-list
44375291|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
44375292|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375293|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44375294|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44375295|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44375296|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44375297|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44375481|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44375483|NCT04216316|Carboplatin|carboplatin|mesh-list
44375484|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
44375485|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375486|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375487|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
44375488|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375489|NCT04216316|Antiviral Agents|antiviral agents|mesh-ancestor
44375491|NCT04216316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375492|NCT04216316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375493|NCT04216316|Immunologic Factors|immunologic factors|mesh-ancestor
44375494|NCT04216316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375495|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375497|NCT04199117|Varenicline|varenicline|mesh-list
44375498|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44375499|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
44375500|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375530|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375532|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44375533|NCT04140162|Dexamethasone|dexamethasone|mesh-list
44375534|NCT04140162|Lenalidomide|lenalidomide|mesh-list
44375535|NCT04140162|Bortezomib|bortezomib|mesh-list
44375536|NCT04140162|Daratumumab|daratumumab|mesh-list
44375537|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375538|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
44375539|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
44375540|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375541|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375542|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375543|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
44375544|NCT04140162|Hormones|hormones|mesh-ancestor
44375570|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375571|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375572|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
44375573|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375574|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375575|NCT04068597|Growth Substances|growth substances|mesh-ancestor
44375576|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375577|NCT04058366|Ivacaftor|ivacaftor|mesh-list
44375578|NCT04058366|Elexacaftor|elexacaftor|mesh-list
44375579|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44375580|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44375581|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375582|NCT04058067|Aflibercept|aflibercept|mesh-list
44375583|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375584|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375585|NCT04058067|Growth Substances|growth substances|mesh-ancestor
44375586|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375587|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375588|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375589|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
44375590|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375591|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
44375592|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375593|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375687|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
44375688|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375689|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44375690|NCT03894891|Cisplatin|cisplatin|mesh-list
44375691|NCT03894891|Docetaxel|docetaxel|mesh-list
44375692|NCT03894891|Nivolumab|nivolumab|mesh-list
44375693|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375694|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375695|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375696|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
43828636|NCT05475665|Amlodipine|amlodipine|mesh-list
44375757|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
44375758|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375759|NCT03746041|Abaloparatide|abaloparatide|mesh-list
44375760|NCT03746041|Bevacizumab|bevacizumab|mesh-list
44375761|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375762|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375763|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375764|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375765|NCT03746041|Growth Substances|growth substances|mesh-ancestor
44375766|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375767|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375768|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44375769|NCT03745326|Aldesleukin|aldesleukin|mesh-list
44375770|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
44375771|NCT03745326|Fludarabine|fludarabine|mesh-list
44375772|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375802|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44375803|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375804|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
44375805|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44375806|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375807|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375808|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44375809|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44375810|NCT03625648|Protective Agents|protective agents|mesh-ancestor
44375811|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375812|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
44375813|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44375814|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
44375815|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
44375816|NCT03602612|Fludarabine|fludarabine|mesh-list
44375817|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375818|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
44375819|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375820|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375821|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375822|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
44375823|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375824|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375825|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375826|NCT03599453|Interferons|interferons|mesh-list
44375827|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
44375828|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
44375829|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44375830|NCT03599453|Poly I-C|poly i-c|mesh-list
44375831|NCT03599453|Celecoxib|celecoxib|mesh-list
44375832|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
44375833|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
44375898|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375899|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375900|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375901|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44376094|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44376095|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376096|NCT03068624|Analgesics|analgesics|mesh-ancestor
44376097|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
44376098|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684737|NCT02840162|Celecoxib|celecoxib|mesh-list
44376158|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376159|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376161|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376162|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
44376216|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44376217|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376218|NCT02428985|Riociguat|riociguat|mesh-list
44376219|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
44376220|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376230|NCT02327455|Dobutamine|dobutamine|mesh-list
44376231|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44376232|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
44376233|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
44376234|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376235|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376236|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43684858|NCT02839538|Anesthetics|anesthetics|mesh-list
44376331|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44376332|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376333|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44376334|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44376335|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44376336|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376337|NCT01419561|Zidovudine|zidovudine|mesh-list
44376338|NCT01419561|Rituximab|rituximab|mesh-list
44376339|NCT01419561|Doxorubicin|doxorubicin|mesh-list
44376340|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44376341|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376342|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376360|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376361|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376362|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
44376363|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376364|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376365|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376366|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376367|NCT01192568|Oxybutynin|oxybutynin|mesh-list
44376368|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
44376369|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
44376370|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376371|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376372|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44376373|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44376374|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
44376375|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376376|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376377|NCT01192568|Urological Agents|urological agents|mesh-ancestor
44376378|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
44376379|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
44376380|NCT01028716|Fludarabine|fludarabine|mesh-list
44376381|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
44376382|NCT01028716|Tacrolimus|tacrolimus|mesh-list
44376383|NCT01028716|Lenograstim|lenograstim|mesh-list
44376384|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376385|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
44376386|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376387|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376388|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376389|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
44376390|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376391|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376392|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376393|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376394|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
44376395|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44376396|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376397|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44376398|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43684926|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
44376481|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
44376482|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376483|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376485|NCT05096312|Adapalene|adapalene|mesh-list
44376486|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44376487|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44376488|NCT05096312|Trace Elements|trace elements|mesh-ancestor
44376489|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
44376490|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376491|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44376492|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44376493|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376494|NCT05096312|Analgesics|analgesics|mesh-ancestor
44376495|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
44376496|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376497|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376498|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376499|NCT05091528|Capecitabine|capecitabine|mesh-list
44376500|NCT05091528|Trastuzumab|trastuzumab|mesh-list
44376501|NCT05091528|Tucatinib|tucatinib|mesh-list
44376502|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376503|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
44376504|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376535|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44376536|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376537|NCT05063136|Capecitabine|capecitabine|mesh-list
44376538|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376539|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
44376540|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376541|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376542|NCT05053971|Entinostat|entinostat|mesh-list
44376543|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44376544|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376545|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376546|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376547|NCT05050318|Vaccines|vaccines|mesh-list
44376548|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
44376549|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376615|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44376616|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
44376617|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44376618|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44376619|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
44376620|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376621|NCT04980040|Alogliptin|alogliptin|mesh-list
44376622|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44376623|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376624|NCT04980040|Incretins|incretins|mesh-ancestor
44376625|NCT04980040|Hormones|hormones|mesh-ancestor
44376626|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376627|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43685173|NCT02838030|Aspirin|aspirin|mesh-list
44376657|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376658|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44376659|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376660|NCT04919317|Dexamethasone|dexamethasone|mesh-list
44376661|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376662|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
44376663|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
44376664|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376665|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376666|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376667|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
44376668|NCT04919317|Hormones|hormones|mesh-ancestor
44376669|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376670|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44376671|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376672|NCT04907032|Mirabegron|mirabegron|mesh-list
44376673|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44376699|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376700|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376701|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
44376702|NCT04873583|Hormones|hormones|mesh-ancestor
44376703|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376704|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44376705|NCT04873583|Protective Agents|protective agents|mesh-ancestor
44376706|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44376707|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376708|NCT04860518|Dexamethasone|dexamethasone|mesh-list
44376709|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376710|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
44376711|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
44376712|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376713|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376714|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376715|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
44376716|NCT04860518|Hormones|hormones|mesh-ancestor
44376717|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376718|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44376719|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376720|NCT04854707|Menotropins|menotropins|mesh-list
44376721|NCT04854707|Hormones|hormones|mesh-list
44376722|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44412302|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44376743|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613468|NCT05549154|Vitamins|vitamins|mesh-list
44106026|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376744|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376745|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44376746|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44376747|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376748|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44376749|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
44376750|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
44376751|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
44376752|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
44376753|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859046|NCT03126916|Melphalan|melphalan|mesh-list
44376754|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376755|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
44376756|NCT04799782|Mirtazapine|mirtazapine|mesh-list
44376757|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
44376758|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376759|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44376760|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
44376761|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
44376762|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376763|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376764|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376765|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44376766|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44376767|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376768|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44376769|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44376770|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44376771|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
44376772|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44376773|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44376774|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
44376775|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44376776|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
44376803|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376804|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44376805|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44376806|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376807|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
44376808|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376810|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
44376811|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
44376812|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376813|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376814|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
44376815|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376816|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
44376817|NCT04737278|Niacin|niacin|mesh-list
44376818|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
44376819|NCT04737278|Vitamins|vitamins|mesh-ancestor
44376820|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
44376821|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376822|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44376823|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
44376824|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376825|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44376880|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
44376881|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376882|NCT04647916|Camptothecin|camptothecin|mesh-list
44376884|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
44376885|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
44376886|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376887|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44376888|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376889|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44376890|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376891|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376892|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376893|NCT04646109|Azithromycin|azithromycin|mesh-list
44376894|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
44376956|NCT04578015|Metronidazole|metronidazole|mesh-list
44376957|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376958|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376959|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44236435|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376960|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376961|NCT04575038|Brequinar|brequinar|mesh-list
44376962|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376963|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376964|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376965|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376966|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
44376967|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376968|NCT04572997|Apremilast|apremilast|mesh-list
44376969|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44376970|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376971|NCT04572997|Analgesics|analgesics|mesh-ancestor
44376972|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
44376973|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376974|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376975|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376976|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376977|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44376978|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44376979|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376980|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376981|NCT04558125|Heparin|heparin|mesh-list
44376982|NCT04558125|Calcium heparin|calcium heparin|mesh-list
44376983|NCT04558125|Enoxaparin|enoxaparin|mesh-list
44376984|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44376985|NCT04558125|Tinzaparin|tinzaparin|mesh-list
44377050|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
44377051|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44377052|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44377053|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377054|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44377055|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
44377056|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
44377057|NCT04537078|Estrogens|estrogens|mesh-ancestor
44377058|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44377059|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44377060|NCT04534491|Oxybutynin|oxybutynin|mesh-list
44377061|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
44377062|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
44377063|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377064|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377065|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44377066|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44377088|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44377089|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377090|NCT04531813|Butenafine|butenafine|mesh-list
44377091|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
44377092|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377093|NCT04531540|Butenafine|butenafine|mesh-list
44377094|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
44377095|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377096|NCT04531527|Butenafine|butenafine|mesh-list
44377097|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
43859161|NCT03115151|Hydromorphone|hydromorphone|mesh-list
44377098|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377099|NCT04531098|Vaccines|vaccines|mesh-list
44377100|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
44377101|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377102|NCT04529850|Cisplatin|cisplatin|mesh-list
44377103|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
44377104|NCT04529850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377105|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
44377106|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377107|NCT04529850|Protective Agents|protective agents|mesh-ancestor
44377108|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377109|NCT04526574|Vaccines|vaccines|mesh-list
44377110|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44377111|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
44377112|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377113|NCT04523831|Doxycycline|doxycycline|mesh-list
44377114|NCT04523831|Ivermectin|ivermectin|mesh-list
44377115|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377116|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377117|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
44377118|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377119|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44236436|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153448|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
44377155|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
44377156|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377157|NCT04498832|Vaccines|vaccines|mesh-list
44377158|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
44377159|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377211|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44377212|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
44377213|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377214|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377215|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
44377216|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44377217|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377218|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44377219|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44377220|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44377221|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44377222|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44377223|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44377224|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44377225|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44377226|NCT04493931|Protective Agents|protective agents|mesh-ancestor
44377227|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44377228|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377229|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44377230|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
44377231|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
44377232|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44377233|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44377234|NCT04492475|Interferons|interferons|mesh-list
44377235|NCT04492475|Interferon-beta|interferon-beta|mesh-list
44377236|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
44377238|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377239|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
44377240|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377241|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
44377242|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377243|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44377244|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
44377245|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377246|NCT04490499|Vaccines|vaccines|mesh-list
44377247|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
44377248|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377249|NCT04489732|Interferons|interferons|mesh-list
43685693|NCT02833610|Denosumab|denosumab|mesh-list
44377319|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
44377320|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377340|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44377341|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
44377342|NCT04439266|Crizotinib|crizotinib|mesh-list
44377343|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377344|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44377345|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377346|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377347|NCT04439253|Crizotinib|crizotinib|mesh-list
44377348|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377349|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44377350|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377351|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377352|NCT04439214|Nivolumab|nivolumab|mesh-list
44377353|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377354|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377355|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44377356|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377357|NCT04439110|Trastuzumab|trastuzumab|mesh-list
44377358|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44377359|NCT04439110|Maytansine|maytansine|mesh-list
44377360|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
44377361|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377362|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377363|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44377364|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44377365|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44377366|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44377367|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377368|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
44377369|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377370|NCT04432376|Miconazole|miconazole|mesh-list
44377371|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
44377372|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377373|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44377374|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44377375|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685751|NCT02833688|Analgesics|analgesics|mesh-ancestor
44377393|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377394|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
44377395|NCT04428424|Etanercept|etanercept|mesh-list
44377396|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377397|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377398|NCT04428424|Analgesics|analgesics|mesh-ancestor
44377399|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
44377400|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377401|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377402|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377403|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377404|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377405|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377406|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
44377407|NCT04428411|Etanercept|etanercept|mesh-list
44377408|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377409|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377410|NCT04428411|Analgesics|analgesics|mesh-ancestor
44377411|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
44377412|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377413|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377414|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377415|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377416|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377417|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377418|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
44377419|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
44377420|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
44377421|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377422|NCT04425863|Aspirin|aspirin|mesh-list
44377423|NCT04425863|Ivermectin|ivermectin|mesh-list
44377424|NCT04425863|Dexamethasone|dexamethasone|mesh-list
44377425|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
44377426|NCT04425863|Enoxaparin|enoxaparin|mesh-list
44377427|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44377428|NCT04425863|BB 1101|bb 1101|mesh-list
44377429|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377430|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
44377431|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
43685807|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44377533|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377534|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
44377535|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44377536|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44377537|NCT04405167|Growth Substances|growth substances|mesh-ancestor
44377538|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
44377539|NCT04403399|Varenicline|varenicline|mesh-list
44377540|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44377541|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44377619|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377621|NCT04396639|Coagulants|coagulants|mesh-ancestor
44377622|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
44377623|NCT04393493|Furosemide|furosemide|mesh-list
44377624|NCT04393493|Spironolactone|spironolactone|mesh-list
44377625|NCT04393493|Diuretics|diuretics|mesh-ancestor
44377626|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
44377627|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377628|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44377629|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377630|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377631|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44377632|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
44377633|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106257|NCT00075465|Docetaxel|docetaxel|mesh-list
44377634|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44377635|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44377636|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44377637|NCT04391842|Diclofenac|diclofenac|mesh-list
44377638|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377639|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377640|NCT04391842|Analgesics|analgesics|mesh-ancestor
44377641|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
44377642|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377643|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377644|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377645|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377646|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44377647|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377648|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377649|NCT04389840|Heparin|heparin|mesh-list
44377650|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
44377651|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44377652|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44377685|NCT04380142|Levodopa|levodopa|mesh-list
44377686|NCT04380142|Carbidopa|carbidopa|mesh-list
44377687|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44377688|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44377689|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
44377690|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377691|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377692|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377693|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44377694|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377695|NCT04377308|Fluoxetine|fluoxetine|mesh-list
44377805|NCT04346628|Favipiravir|favipiravir|mesh-list
44377806|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
44377807|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377808|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
44377809|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377810|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377811|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
44377812|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377813|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377814|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377815|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377816|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377817|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43828782|NCT05470283|Furosemide|furosemide|mesh-list
44377848|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44377849|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
44377850|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
44377851|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377852|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44377853|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44377854|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
44377855|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377856|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
44377857|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377858|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377859|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377860|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828801|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377929|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377930|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377931|NCT04311177|Losartan|losartan|mesh-list
44377932|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44377933|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44377934|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44377935|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44377936|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377937|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
43686220|NCT02830139|Cisplatin|cisplatin|mesh-list
44378152|NCT04232943|Vaccines|vaccines|mesh-list
44378153|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
44378154|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378155|NCT04230213|Adalimumab|adalimumab|mesh-list
44378156|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686407|NCT02828228|Vitamin D|vitamin d|mesh-list
44378203|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
44378204|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44378205|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
44378206|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378207|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378208|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
44378209|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44378210|NCT04219358|Protective Agents|protective agents|mesh-ancestor
44378211|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378212|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
44378213|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378214|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378215|NCT04218110|Ethanol|ethanol|mesh-list
44378216|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
44378217|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44378218|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44378219|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378220|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378221|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378222|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
44378223|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378224|NCT04210310|Oxytocin|oxytocin|mesh-list
44378225|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
44378226|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44378227|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378228|NCT04207840|Epinephrine|epinephrine|mesh-list
44378229|NCT04207840|Racepinephrine|racepinephrine|mesh-list
44378230|NCT04207840|Albuterol|albuterol|mesh-list
44378231|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
44378232|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44378233|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44378234|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378235|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378236|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378237|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378238|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44378239|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44378240|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
44378241|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378242|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44378243|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44378271|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
44378272|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378273|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378274|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
44378275|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378276|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378277|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44378278|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44378279|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44378280|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378281|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378282|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44378283|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
44378284|NCT04186806|Muramidase|muramidase|mesh-list
44378285|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378286|NCT04179461|Vitamin D|vitamin d|mesh-list
44378287|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
44378288|NCT04179461|Fluticasone|fluticasone|mesh-list
44378289|NCT04179461|Xhance|xhance|mesh-list
44378290|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
44378291|NCT04179461|Cetirizine|cetirizine|mesh-list
44378292|NCT04179461|Loratadine|loratadine|mesh-list
44378293|NCT04179461|Azithromycin|azithromycin|mesh-list
44378294|NCT04179461|Budesonide|budesonide|mesh-list
44378295|NCT04179461|Beclomethasone|beclomethasone|mesh-list
44378296|NCT04179461|Emollients|emollients|mesh-list
44378318|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378319|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378320|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378321|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44378322|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44378323|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44378324|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378325|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378326|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378327|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
44378328|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44378329|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
43613469|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
44378330|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44378332|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
44378333|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
44378334|NCT04177862|Fentanyl|fentanyl|mesh-list
44378335|NCT04177862|Sufentanil|sufentanil|mesh-list
44378336|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44378337|NCT04177862|Narcotics|narcotics|mesh-ancestor
44378338|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378339|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378340|NCT04177862|Analgesics|analgesics|mesh-ancestor
44378341|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
44378342|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378343|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44378344|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44378345|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
44378346|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
44378347|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
44378348|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378349|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378350|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44378434|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378436|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
44378437|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378438|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44378439|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44378440|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44378441|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
44378442|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
44378443|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378444|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378445|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378446|NCT04161144|Sirolimus|sirolimus|mesh-list
44378447|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378448|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378449|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44378450|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378451|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
44378452|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44378453|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
44378454|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378455|NCT04160091|FX006|fx006|mesh-list
44378456|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378457|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
44378458|NCT04160091|Hormones|hormones|mesh-ancestor
44378459|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378460|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378504|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378506|NCT04147715|Midazolam|midazolam|mesh-list
44378507|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44378508|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44378509|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378510|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378511|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44378512|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44378513|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378514|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44378515|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
44378516|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
44378517|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
44378518|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
44378519|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378520|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378521|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44378522|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44378523|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378524|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44378525|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44378526|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
44378527|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378528|NCT04142242|Vaccines|vaccines|mesh-list
44378529|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
44378530|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378531|NCT04140292|Vitamin D|vitamin d|mesh-list
44378532|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
44378533|NCT04140292|Vitamins|vitamins|mesh-ancestor
44378534|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
44378535|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378536|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44378537|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44378596|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
44378597|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378598|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378599|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
44378600|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378601|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378602|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44378603|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44378604|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378605|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412305|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
44378670|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378671|NCT04105972|Ivacaftor|ivacaftor|mesh-list
44378672|NCT04105972|Elexacaftor|elexacaftor|mesh-list
44378673|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44378674|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378675|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378676|NCT04102345|Zolpidem|zolpidem|mesh-list
44378677|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44378678|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44378679|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378680|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378681|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44378682|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
44378683|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
44378684|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378685|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378686|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
44378687|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378688|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378689|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44378690|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
44378691|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378692|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44378693|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44378694|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378695|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378696|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44378697|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44378698|NCT04095858|Methotrexate|methotrexate|mesh-list
44378850|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44378851|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378852|NCT04052620|Diclofenac|diclofenac|mesh-list
44378853|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44378854|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378855|NCT04052620|Analgesics|analgesics|mesh-ancestor
44378856|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
44378857|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378858|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378859|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378860|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686881|NCT02824510|Insulin|insulin|mesh-list
44035308|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
44379165|NCT03988907|Midazolam|midazolam|mesh-list
44379166|NCT03988907|Risdiplam|risdiplam|mesh-list
44379167|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44379168|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44379169|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379170|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379171|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44379172|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379173|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379174|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44379175|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
44379176|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
44379177|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
44379178|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
44379179|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379180|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379181|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44379182|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379183|NCT03988842|Heparin|heparin|mesh-list
44379380|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106557|NCT00076323|Primaquine|primaquine|mesh-list
44379381|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
44379382|NCT03958656|Fludarabine|fludarabine|mesh-list
44379383|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44379384|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
44379385|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379386|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379387|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44379388|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
44379389|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687190|NCT02821520|Verteporfin|verteporfin|mesh-list
44379452|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379453|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379454|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379456|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44379457|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379458|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379459|NCT03952650|Amebicides|amebicides|mesh-ancestor
44379460|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44379640|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44379641|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44379642|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
44379643|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379644|NCT03921151|Mirtazapine|mirtazapine|mesh-list
44379645|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
44379646|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379647|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43859581|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
44379648|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
44379649|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
44379650|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379651|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379652|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379653|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44379654|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379655|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379690|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44379691|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379692|NCT03912337|Analgesics|analgesics|mesh-ancestor
44379693|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
44379694|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379724|NCT03903822|PF-06700841|pf-06700841|mesh-list
44379725|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44379726|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379727|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379728|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44379729|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44379730|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379731|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379732|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379733|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379734|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44379735|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44379736|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44379737|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379738|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687423|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
44379881|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379883|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
44379884|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379885|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44379886|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44379887|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44379888|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
44379889|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
44379890|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379891|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379892|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379893|NCT03882424|Bevacizumab|bevacizumab|mesh-list
44379894|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379895|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379896|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44379897|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44106641|NCT00076674|Levodopa|levodopa|mesh-list
44379898|NCT03882424|Growth Substances|growth substances|mesh-ancestor
44379899|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379900|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
44380129|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
44380130|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380193|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380194|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380195|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
44380196|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
44380197|NCT03840811|Cefixime|cefixime|mesh-list
44380198|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380199|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380200|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44380201|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380354|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380355|NCT03823391|Adalimumab|adalimumab|mesh-list
44380356|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380357|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380358|NCT03823378|Upadacitinib|upadacitinib|mesh-list
44380359|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44380360|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44380361|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380362|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380363|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380364|NCT03823287|Aflibercept|aflibercept|mesh-list
44380365|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44380366|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44380367|NCT03823287|Growth Substances|growth substances|mesh-ancestor
44380368|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380401|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44380402|NCT03818399|Narcotics|narcotics|mesh-ancestor
44380403|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380404|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380405|NCT03818399|Analgesics|analgesics|mesh-ancestor
44380406|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
44380407|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380408|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44380409|NCT03818321|Methenamine|methenamine|mesh-list
44380410|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
44380411|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
44380412|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44380445|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
44380446|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
44380447|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
44380448|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380449|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380450|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44380451|NCT03817853|Protective Agents|protective agents|mesh-ancestor
44380452|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380453|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
44380454|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380455|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380456|NCT03815175|Aspirin|aspirin|mesh-list
44380559|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380560|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44380561|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380562|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380563|NCT03800173|Galidesivir|galidesivir|mesh-list
44380564|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
44380565|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380566|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
44380567|NCT03799627|Glycine|glycine|mesh-list
44380568|NCT03799627|Hematinics|hematinics|mesh-ancestor
44380569|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
44380570|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380571|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380572|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380573|NCT03796728|Lidocaine|lidocaine|mesh-list
44380574|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
44380575|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
44380576|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380599|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380600|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44380601|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44380602|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
44236438|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
44106697|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
44380603|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
44380604|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380605|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44380606|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44380607|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380608|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380609|NCT03791398|Nivolumab|nivolumab|mesh-list
44380610|NCT03791398|TIC10 compound|tic10 compound|mesh-list
44380611|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380612|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380613|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44380614|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380615|NCT03789292|Adalimumab|adalimumab|mesh-list
44380616|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380617|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380618|NCT03789110|Nivolumab|nivolumab|mesh-list
44380619|NCT03789110|Ipilimumab|ipilimumab|mesh-list
44380620|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380621|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380622|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44380623|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380624|NCT03788967|Ertapenem|ertapenem|mesh-list
44380685|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380686|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380687|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380688|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
44380690|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44380691|NCT03780244|Diuretics|diuretics|mesh-ancestor
44380692|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
44380693|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380694|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
44380695|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44380696|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
44380697|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380698|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
44380699|NCT03777917|Protective Agents|protective agents|mesh-ancestor
44380700|NCT03774576|Itraconazole|itraconazole|mesh-list
44380701|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
44380702|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380703|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44380704|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44380705|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380706|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380707|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44380708|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
44412306|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380860|NCT03757715|Bupivacaine|bupivacaine|mesh-list
44380861|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380862|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
44380863|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
44380864|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380865|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380866|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380867|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
44380869|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380870|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44380871|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380872|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
44380873|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
44380874|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380875|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
44380876|NCT03757234|Levofloxacin|levofloxacin|mesh-list
44380877|NCT03757234|Ofloxacin|ofloxacin|mesh-list
44380878|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44380879|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380880|NCT03757234|Renal Agents|renal agents|mesh-ancestor
44380881|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380882|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44380883|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380884|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380885|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236439|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236440|NCT00559429|Docetaxel|docetaxel|mesh-list
44380917|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44380918|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44380919|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
44380920|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
44380921|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380922|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44380923|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44380924|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380925|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380926|NCT03753204|Furosemide|furosemide|mesh-list
44380927|NCT03753204|Diuretics|diuretics|mesh-ancestor
44381005|NCT03739528|Levofloxacin|levofloxacin|mesh-list
44381006|NCT03739528|Ofloxacin|ofloxacin|mesh-list
44381007|NCT03739528|Tobramycin|tobramycin|mesh-list
44381008|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44381009|NCT03739528|Dexamethasone|dexamethasone|mesh-list
44381010|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
44381011|NCT03739528|BB 1101|bb 1101|mesh-list
44381012|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381013|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
44381014|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
44381015|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381016|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381017|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381018|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
44381019|NCT03739528|Hormones|hormones|mesh-ancestor
44381102|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381103|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381104|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44381105|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44381106|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381344|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381345|NCT03708211|Esomeprazole|esomeprazole|mesh-list
44381346|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44381365|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381366|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381367|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381368|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381370|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44381371|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381372|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44381373|NCT03700892|Protective Agents|protective agents|mesh-ancestor
44381374|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381375|NCT03697993|Levofloxacin|levofloxacin|mesh-list
44381376|NCT03697993|Ofloxacin|ofloxacin|mesh-list
44381377|NCT03697993|Fosfomycin|fosfomycin|mesh-list
44381378|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44381379|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381380|NCT03697993|Renal Agents|renal agents|mesh-ancestor
44381381|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381382|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44381383|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381384|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381385|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381386|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381387|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44381388|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44381389|NCT03697252|Xanomeline|xanomeline|mesh-list
44381390|NCT03697252|Trospium chloride|trospium chloride|mesh-list
44381391|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
44381392|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
44381393|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381394|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381395|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44381396|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44381397|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
44381398|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381399|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381400|NCT03697252|Urological Agents|urological agents|mesh-ancestor
44381401|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44381585|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381586|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44381587|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44381588|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381589|NCT03686813|Urological Agents|urological agents|mesh-ancestor
44381590|NCT03685344|Durvalumab|durvalumab|mesh-list
44381591|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44381592|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44381593|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381594|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381595|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
44381596|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381597|NCT03684642|Metformin|metformin|mesh-list
44381598|NCT03684642|Dulaglutide|dulaglutide|mesh-list
44381599|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
44381600|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381601|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381602|NCT03684044|Baloxavir|baloxavir|mesh-list
44381603|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
44381604|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381605|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381606|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381607|NCT03682705|Upadacitinib|upadacitinib|mesh-list
44381608|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44381609|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44381610|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381611|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381612|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381613|NCT03682367|Gabapentin|gabapentin|mesh-list
44381614|NCT03682367|Analgesics|analgesics|mesh-ancestor
44381615|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
44381616|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381884|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381885|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381886|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44381887|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381888|NCT03654326|Naproxen|naproxen|mesh-list
44381889|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43689156|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
44381926|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44381927|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44381957|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381959|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381960|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
44381961|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381962|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44381963|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381964|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381965|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
44381966|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381967|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381968|NCT03643952|Daptomycin|daptomycin|mesh-list
44381969|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381970|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381971|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
44381972|NCT03643575|Guaifenesin|guaifenesin|mesh-list
44382189|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44382190|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44382191|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382192|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382193|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44382194|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44382195|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44382196|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44382197|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
44382198|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689390|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382305|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
44382306|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44382308|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44382309|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382310|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
44382311|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382312|NCT03614975|Vaccines|vaccines|mesh-list
44382313|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
44382314|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382315|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
44236441|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44382316|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44382317|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382318|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44382319|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44382320|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382321|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382322|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382323|NCT03608774|Azithromycin|azithromycin|mesh-list
44382521|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44382522|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44382523|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382524|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382525|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382526|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44382527|NCT03591406|Hematinics|hematinics|mesh-ancestor
44382528|NCT03591146|Ropivacaine|ropivacaine|mesh-list
44382529|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382530|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
44382531|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382532|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382533|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
44382534|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382535|NCT03590743|Apixaban|apixaban|mesh-list
44382536|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44382537|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
44382538|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44382539|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
44382540|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382541|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382542|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
44382543|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44382573|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382574|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44382575|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
44382576|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44382577|NCT03587636|Bupivacaine|bupivacaine|mesh-list
44382578|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382579|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
44382580|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382581|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382582|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
44382583|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382584|NCT03587584|Bupivacaine|bupivacaine|mesh-list
44382621|NCT03586544|Albuterol|albuterol|mesh-list
44382733|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44382734|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
44382735|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382736|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689704|NCT02801357|Lofexidine|lofexidine|mesh-list
44382769|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44382770|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382772|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44382773|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44382774|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
44382775|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382907|NCT03566979|Naproxen|naproxen|mesh-list
44382908|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382909|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382910|NCT03566979|Analgesics|analgesics|mesh-ancestor
44382911|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
44382912|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382913|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382914|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382915|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382916|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
44382917|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44382918|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382919|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382920|NCT03566810|Metformin|metformin|mesh-list
44382921|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44382922|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382923|NCT03566485|Atezolizumab|atezolizumab|mesh-list
44382956|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44382957|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44382958|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
44382959|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44382960|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44382962|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
44382963|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44382964|NCT03560739|Ofatumumab|ofatumumab|mesh-list
44382965|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44382996|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382997|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
44382998|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382999|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44383000|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383002|NCT03557931|Risperidone|risperidone|mesh-list
44383003|NCT03557931|Aripiprazole|aripiprazole|mesh-list
44383004|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44383005|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44383006|NCT03557931|Ziprasidone|ziprasidone|mesh-list
44383007|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44383008|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
44383009|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44383010|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
44383044|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
44383045|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
44383046|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383047|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383048|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383243|NCT03540030|Gabapentin|gabapentin|mesh-list
44383244|NCT03540030|Propofol|propofol|mesh-list
44383245|NCT03540030|Sevoflurane|sevoflurane|mesh-list
44383246|NCT03540030|Desflurane|desflurane|mesh-list
44383247|NCT03540030|Rocuronium|rocuronium|mesh-list
44383248|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
44383249|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
44383250|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
44383251|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383252|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383253|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
44383254|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383255|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44383256|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44383315|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383316|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383317|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44383318|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44383319|NCT03535194|Mirikizumab|mirikizumab|mesh-list
44383320|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383321|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383322|NCT03535194|Analgesics|analgesics|mesh-ancestor
44383323|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
44383324|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383325|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383326|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383465|NCT03521193|Analgesics|analgesics|mesh-ancestor
44383466|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
44383467|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383468|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383469|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383470|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383471|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44383472|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44383595|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383597|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44383598|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383599|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
44383600|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
44383601|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383602|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383603|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
44383604|NCT03518112|Hormones|hormones|mesh-ancestor
44383605|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383606|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44383607|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44383608|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614004|NCT04553692|Protective Agents|protective agents|mesh-ancestor
44383609|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44383610|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44383611|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44383612|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
44383613|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44383647|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383649|NCT03515941|Fluorouracil|fluorouracil|mesh-list
44383650|NCT03515941|Capecitabine|capecitabine|mesh-list
44383651|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
44383652|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
44383653|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383654|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44383655|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383656|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44383690|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
44383691|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44383692|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383693|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44383694|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44383695|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44383696|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44383697|NCT03510910|Acetaminophen|acetaminophen|mesh-list
44383698|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383699|NCT03510910|Analgesics|analgesics|mesh-ancestor
44383700|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
44383739|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383883|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44040347|NCT00002688|Cyclosporine|cyclosporine|mesh-list
44383885|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44383886|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
44383887|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
44383888|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
44383889|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
44383919|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
44383920|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
44383921|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383922|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383923|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383924|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44383925|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44383926|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383927|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44383928|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44383929|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
44383930|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383931|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383970|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44383971|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44383972|NCT03488225|Antibodies|antibodies|mesh-list
44383973|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
44383974|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44383975|NCT03488225|BB 1101|bb 1101|mesh-list
44384178|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
44384179|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384180|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44384181|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384182|NCT03479216|Analgesics|analgesics|mesh-ancestor
43829335|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
44384559|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384560|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44384561|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
44384562|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384563|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384564|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384565|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384566|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44384567|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384568|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
44384569|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384570|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44384571|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
44384572|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43860052|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
44384573|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44384574|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384575|NCT03449758|Amebicides|amebicides|mesh-ancestor
43691069|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44384675|NCT03442569|Panitumumab|panitumumab|mesh-list
44107154|NCT00078390|S 3304|s 3304|mesh-list
44384676|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384710|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384711|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384712|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44384713|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384714|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
44384715|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
44384812|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44384813|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
44384814|NCT03434119|Lixisenatide|lixisenatide|mesh-list
44384815|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384816|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384817|NCT03433755|Evolocumab|evolocumab|mesh-list
44384818|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44384819|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44384820|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
44384821|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384822|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44384823|NCT03433703|Lenvatinib|lenvatinib|mesh-list
44384824|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384825|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44384826|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384827|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384828|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
44384829|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384830|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384831|NCT03432858|Vancomycin|vancomycin|mesh-list
44384832|NCT03432858|Cefazolin|cefazolin|mesh-list
44384833|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384834|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384835|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44384836|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
44384837|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384838|NCT03431337|Amoxicillin|amoxicillin|mesh-list
44384839|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384840|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384841|NCT03430986|Lidocaine|lidocaine|mesh-list
44384842|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
44384843|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
44384892|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
44384893|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
44384894|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
44384895|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384896|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384897|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
44384898|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
44384899|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384900|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384901|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384902|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
44384903|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
44384904|NCT03427619|Picibanil|picibanil|mesh-list
44385111|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44385112|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385113|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44385114|NCT03409276|Vaccines|vaccines|mesh-list
44385115|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
44385116|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385117|NCT03408873|Aripiprazole|aripiprazole|mesh-list
44385118|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
44385143|NCT03408483|Epinephrine|epinephrine|mesh-list
44385144|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
44385145|NCT03408483|Bupivacaine|bupivacaine|mesh-list
44385146|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
44385147|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
44385148|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385149|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860122|NCT03007147|Leucovorin|leucovorin|mesh-list
44385150|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
44385151|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385152|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44385153|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385154|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385155|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385156|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385157|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44107210|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
44385158|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44385159|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
44385160|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385161|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385163|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
44385164|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44385165|NCT03408483|Narcotics|narcotics|mesh-ancestor
44385166|NCT03408483|Analgesics|analgesics|mesh-ancestor
44385167|NCT03407430|Pregabalin|pregabalin|mesh-list
44385168|NCT03407430|Analgesics|analgesics|mesh-ancestor
44385169|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
44385366|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385367|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44385368|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385369|NCT03393000|Vitamins|vitamins|mesh-ancestor
44385370|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
44385371|NCT03391765|Tilavonemab|tilavonemab|mesh-list
44042031|NCT00002805|Cobalt|cobalt|mesh-list
44385372|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
44385373|NCT03391284|Acetaminophen|acetaminophen|mesh-list
44385374|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44385375|NCT03391284|Analgesics|analgesics|mesh-ancestor
44385376|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
44385377|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385378|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385379|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
44385380|NCT03390426|Anesthetics|anesthetics|mesh-list
44385381|NCT03390426|Mepivacaine|mepivacaine|mesh-list
44385382|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
44385383|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385384|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385385|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
44385430|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
44385432|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385433|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385434|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385435|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44385436|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
44385437|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44385438|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385439|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385440|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385441|NCT03387462|Tenofovir|tenofovir|mesh-list
44385442|NCT03387462|Emtricitabine|emtricitabine|mesh-list
44385443|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
44385475|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385477|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385478|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385479|NCT03386474|Growth Substances|growth substances|mesh-ancestor
44385480|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385481|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385482|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385483|NCT03386448|Scopolamine|scopolamine|mesh-list
44385484|NCT03386448|Naltrexone|naltrexone|mesh-list
44385485|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44385486|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44385515|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385517|NCT03384316|Vaccines|vaccines|mesh-list
44385518|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
44385519|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385520|NCT03383783|Listerine|listerine|mesh-list
44385521|NCT03383783|Fluorides|fluorides|mesh-list
44042186|NCT00002816|Cobalt|cobalt|mesh-list
44385522|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
44385523|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
44385524|NCT03383783|Protective Agents|protective agents|mesh-ancestor
44385525|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385526|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44385527|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385528|NCT03383692|Ritonavir|ritonavir|mesh-list
44385592|NCT03381248|Protective Agents|protective agents|mesh-ancestor
44385593|NCT03380429|Albuterol|albuterol|mesh-list
44385594|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44385595|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
44385596|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385597|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385599|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385601|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44385602|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44385603|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44385604|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385605|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385606|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385607|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385608|NCT03380390|Phenylephrine|phenylephrine|mesh-list
44385609|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
44385610|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44385611|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385612|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385649|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44385650|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44385852|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385853|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385854|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385855|NCT03362190|Ranibizumab|ranibizumab|mesh-list
44385856|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385857|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385858|NCT03362190|Growth Substances|growth substances|mesh-ancestor
44385927|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385928|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44385929|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
44385930|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
44385931|NCT03359174|Tretinoin|tretinoin|mesh-list
44385932|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385933|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
44385989|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385990|NCT03353740|Edetic Acid|edetic acid|mesh-list
44385991|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44385992|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
44385993|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
44385994|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385995|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
44385996|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44385997|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44385998|NCT03352414|Alvimopan|alvimopan|mesh-list
44385999|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386000|NCT03351608|Atropine|atropine|mesh-list
44386001|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
44386002|NCT03351608|Neostigmine|neostigmine|mesh-list
44386003|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44386004|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44386005|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44386006|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
44386007|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386008|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386009|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44386010|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44386011|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
44386012|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
44386013|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44386014|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44386015|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
44386016|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386017|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386018|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44386019|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386020|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44386021|NCT03351478|Empagliflozin|empagliflozin|mesh-list
44386022|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44386023|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44386024|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386025|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386026|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386027|NCT03351244|BI 409306|bi 409306|mesh-list
44386028|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44386082|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386083|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44386084|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44386085|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44386086|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44386087|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
44386137|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386138|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
44386139|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
44386140|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386141|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386142|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44386143|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44386144|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
44386145|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44386146|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44386147|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44386148|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44386149|NCT03345836|Upadacitinib|upadacitinib|mesh-list
44386150|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44386151|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44386152|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386227|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386259|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386260|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386261|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
44386262|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386263|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386264|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386265|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386266|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
43692230|NCT02782312|Hormones|hormones|mesh-ancestor
44386380|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
44386381|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
44386382|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386383|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
44386384|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386430|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386431|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44386432|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
44386433|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386434|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386436|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
44386437|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386438|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386439|NCT03334903|Gabapentin|gabapentin|mesh-list
44386440|NCT03334903|Analgesics|analgesics|mesh-ancestor
44386441|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
44386442|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386443|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386444|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
44386445|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44386446|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386447|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386448|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386449|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44386450|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44386451|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386452|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386453|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
44386454|NCT03334747|Lumefantrine|lumefantrine|mesh-list
44386455|NCT03334747|Artemether|artemether|mesh-list
44386456|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44386457|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
44386458|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386459|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386460|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386461|NCT03334721|Gabapentin|gabapentin|mesh-list
44386462|NCT03334721|Analgesics|analgesics|mesh-ancestor
44386463|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
44386464|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386465|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386466|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
44386467|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44386468|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386469|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107445|NCT00079235|Sirolimus|sirolimus|mesh-list
44386582|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
44386583|NCT05681728|Epirubicin|epirubicin|mesh-list
44386584|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44386585|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386586|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
44386587|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
44386588|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
44386589|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386590|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386591|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
44386592|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386593|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386594|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386595|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
44386596|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386597|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386598|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44386599|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44386600|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44386601|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386602|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
44386603|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386604|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
44386605|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386606|NCT05681702|Aspirin|aspirin|mesh-list
44386607|NCT05681702|Clopidogrel|clopidogrel|mesh-list
44386608|NCT05681702|Ticagrelor|ticagrelor|mesh-list
44386609|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44386610|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44386611|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386612|NCT05681702|Analgesics|analgesics|mesh-ancestor
44386613|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
44386645|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386646|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386647|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386649|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
44386650|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386651|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44386652|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44386653|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44386764|NCT05681260|Methotrexate|methotrexate|mesh-list
44386765|NCT05681260|Etoposide|etoposide|mesh-list
44386766|NCT05681260|Vincristine|vincristine|mesh-list
44386767|NCT05681260|Bortezomib|bortezomib|mesh-list
44386768|NCT05681260|Daunorubicin|daunorubicin|mesh-list
44386769|NCT05681260|Asparaginase|asparaginase|mesh-list
44386770|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
44386771|NCT05681260|Vindesine|vindesine|mesh-list
44386772|NCT05681260|Pegaspargase|pegaspargase|mesh-list
44386773|NCT05681260|BB 1101|bb 1101|mesh-list
44386774|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386775|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
44386776|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386777|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386778|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386779|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
44386780|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386781|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386782|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386783|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386784|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
44386785|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
44386786|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386787|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386788|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
44386789|NCT05681260|Hormones|hormones|mesh-ancestor
44386790|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386791|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44387082|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44387083|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44387084|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44387085|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
44387086|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44387087|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387088|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
44387089|NCT05433272|Vaccines|vaccines|mesh-list
44387092|NCT05432804|Temozolomide|temozolomide|mesh-list
44387093|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44387094|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
44387264|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387265|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387266|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387267|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387269|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44387270|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387271|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387405|NCT05048264|Antiemetics|antiemetics|mesh-ancestor
44387406|NCT05048264|Autonomic Agents|autonomic agents|mesh-ancestor
44387407|NCT05048264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387408|NCT05048264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387409|NCT05048264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44387410|NCT05048264|Glucocorticoids|glucocorticoids|mesh-ancestor
44387411|NCT05048264|Hormones|hormones|mesh-ancestor
44387543|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44387545|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387546|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387547|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44387641|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
44387642|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387643|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44387644|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387645|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387646|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
43693195|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
44387671|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387673|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387674|NCT04756128|Colchicine|colchicine|mesh-list
44387675|NCT04756128|Naltrexone|naltrexone|mesh-list
44387676|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44387677|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44387678|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387679|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
44387680|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387681|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
44387682|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387683|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387684|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387685|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387686|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387687|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387688|NCT04751669|Trace Elements|trace elements|mesh-list
44387689|NCT04751669|Micronutrients|micronutrients|mesh-list
44387690|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387691|NCT04745026|Cannabidiol|cannabidiol|mesh-list
44387692|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
44387693|NCT04731233|Triamcinolone|triamcinolone|mesh-list
44387694|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44387695|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44387730|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44387731|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43693226|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44387795|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44044588|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387796|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44387798|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387799|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44387800|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
44387801|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387802|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387803|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44387804|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44387805|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387806|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
44387807|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
44387808|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387809|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107591|NCT00079443|Romidepsin|romidepsin|mesh-list
44387810|NCT04417517|Azacitidine|azacitidine|mesh-list
44387811|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44387812|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
44387813|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387814|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387815|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387945|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
44387946|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387947|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44387948|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387949|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44387950|NCT04053634|Benralizumab|benralizumab|mesh-list
44387951|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44387952|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44388038|NCT03914625|Pegaspargase|pegaspargase|mesh-list
44388039|NCT03914625|Thioguanine|thioguanine|mesh-list
44388040|NCT03914625|Blinatumomab|blinatumomab|mesh-list
44388041|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44388042|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
44388044|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
44388045|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44388046|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44388047|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44388048|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
44388049|NCT03914625|BB 1101|bb 1101|mesh-list
44388050|NCT03914625|Calcium|calcium|mesh-list
44388051|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
44388052|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
44388053|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388054|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
44388055|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388056|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388057|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44388058|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
44388059|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388060|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388061|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44388062|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44388063|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
44388064|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
44388065|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388066|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44388067|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
44388068|NCT03914625|Hormones|hormones|mesh-ancestor
44388069|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388070|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44388071|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
44388072|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388073|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44388074|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44388075|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388076|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44388077|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44388102|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44388103|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44388105|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388106|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388107|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44388108|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388109|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388110|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
44388111|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388112|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44388113|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
44044976|NCT00003101|Vincristine|vincristine|mesh-list
44388114|NCT03867487|Empagliflozin|empagliflozin|mesh-list
44388115|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44388116|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388117|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388118|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388119|NCT03801876|Paclitaxel|paclitaxel|mesh-list
44388120|NCT03801876|Docetaxel|docetaxel|mesh-list
44388121|NCT03801876|Carboplatin|carboplatin|mesh-list
44388122|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44388123|NCT03801876|Fluorouracil|fluorouracil|mesh-list
44388124|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388125|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388126|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388127|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
44388128|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
43693525|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388195|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388196|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44388197|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
44388198|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388200|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388201|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388202|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44388203|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388204|NCT03603912|Metformin|metformin|mesh-list
44388205|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388206|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388207|NCT03599622|BMS-986165|bms-986165|mesh-list
44388208|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44388378|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388379|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388380|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44388381|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44388382|NCT03093155|Growth Substances|growth substances|mesh-ancestor
44388383|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388384|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
44388385|NCT02998528|Gemcitabine|gemcitabine|mesh-list
44388386|NCT02998528|Paclitaxel|paclitaxel|mesh-list
44388387|NCT02998528|Vinorelbine|vinorelbine|mesh-list
44388388|NCT02998528|Docetaxel|docetaxel|mesh-list
44388389|NCT02998528|Cisplatin|cisplatin|mesh-list
44388390|NCT02998528|Carboplatin|carboplatin|mesh-list
44388391|NCT02998528|Nivolumab|nivolumab|mesh-list
44388392|NCT02998528|Pemetrexed|pemetrexed|mesh-list
44388393|NCT02998528|Ipilimumab|ipilimumab|mesh-list
44388394|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388395|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388518|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44388519|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
44388520|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44388521|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388522|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
44388523|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
44388524|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388525|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44388526|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44388527|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44388553|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44388554|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
44388555|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
44388556|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
44388557|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388558|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44388559|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44388560|NCT02117791|Riociguat|riociguat|mesh-list
44388561|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
44388562|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388563|NCT01996865|Rituximab|rituximab|mesh-list
44388564|NCT01996865|Lenalidomide|lenalidomide|mesh-list
44388565|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388566|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388567|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
44388568|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388569|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388570|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44388571|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44388572|NCT01996865|Growth Substances|growth substances|mesh-ancestor
44388573|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
44388574|NCT01964547|Nabiximols|nabiximols|mesh-list
44388575|NCT01964547|Analgesics|analgesics|mesh-ancestor
44388576|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
44388577|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388578|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388579|NCT01719640|Insulin|insulin|mesh-list
44388606|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44388607|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388608|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388609|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388610|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
44388611|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388612|NCT00536172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44388613|NCT00536172|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388614|NCT00536172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388615|NCT03333109|Erenumab|erenumab|mesh-list
44388616|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44388617|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388618|NCT03333109|Analgesics|analgesics|mesh-ancestor
44388619|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
44388620|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388621|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388622|NCT03332771|Metformin|metformin|mesh-list
44388623|NCT03332771|Glimepiride|glimepiride|mesh-list
44388624|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44388625|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388626|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388627|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44388653|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44388654|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44388655|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
44388656|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388657|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44388659|NCT03331315|Ketorolac|ketorolac|mesh-list
44388660|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44388661|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44388662|NCT03331315|Analgesics|analgesics|mesh-ancestor
44388663|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
44388664|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388665|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388666|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860713|NCT02937272|Paclitaxel|paclitaxel|mesh-list
44388667|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388668|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44388669|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44388670|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388671|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388672|NCT03330847|Olaparib|olaparib|mesh-list
44388673|NCT03330847|Adavosertib|adavosertib|mesh-list
43693862|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388708|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
44388709|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
44388710|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
44388711|NCT03328832|Thrombin|thrombin|mesh-list
44388746|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44388747|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388748|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388749|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44388750|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388847|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388848|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388849|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44388850|NCT03321006|Analgesics|analgesics|mesh-ancestor
44388851|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
44388852|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
44388853|NCT03320941|Licogliflozin|licogliflozin|mesh-list
44388854|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44388855|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388856|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388857|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388858|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
44388859|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44388860|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44388931|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388932|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
44388933|NCT03316131|Febuxostat|febuxostat|mesh-list
44388934|NCT03316131|Verinurad|verinurad|mesh-list
44388935|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44388936|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388937|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388938|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388939|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
44388940|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43860755|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
44388941|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44388942|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44388943|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44388944|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388945|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388946|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388947|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388948|NCT03315793|Analgesics|analgesics|mesh-ancestor
44388949|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
44388950|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388951|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388952|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388953|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
44388954|NCT03314662|Vaccines|vaccines|mesh-list
44388955|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44388956|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
43694095|NCT02770222|Rifampin|rifampin|mesh-list
44389072|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389201|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44389202|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44389203|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44389204|NCT03305081|Trace Elements|trace elements|mesh-ancestor
44389346|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389347|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389348|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
44389349|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389350|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44389351|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
43694383|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
44389387|NCT03293654|Growth Substances|growth substances|mesh-ancestor
43694423|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
44389438|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389440|NCT03289676|Nicotine|nicotine|mesh-list
44389441|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44389442|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
44389443|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389444|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389445|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44389446|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44389447|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
44389448|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389449|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389450|NCT03289533|Avelumab|avelumab|mesh-list
44389451|NCT03289533|Axitinib|axitinib|mesh-list
44389452|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389453|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389454|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44389455|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389456|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389457|NCT03289208|Edaravone|edaravone|mesh-list
44389458|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44389459|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
44389460|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389461|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44389462|NCT03289208|Protective Agents|protective agents|mesh-ancestor
44389463|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389464|NCT03288987|Leucovorin|leucovorin|mesh-list
44389465|NCT03288987|Bevacizumab|bevacizumab|mesh-list
44389466|NCT03288987|Fluorouracil|fluorouracil|mesh-list
44389467|NCT03288987|Irinotecan|irinotecan|mesh-list
44046406|NCT00003253|Paclitaxel|paclitaxel|mesh-list
44389468|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389469|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389470|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44389471|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44389472|NCT03288987|Growth Substances|growth substances|mesh-ancestor
44389509|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
44389510|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43694489|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
44389612|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44389613|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389614|NCT03278626|Paclitaxel|paclitaxel|mesh-list
44236443|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44389615|NCT03278626|Carboplatin|carboplatin|mesh-list
44389616|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44389617|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389618|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44389619|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44389620|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44389621|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389622|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44389623|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
44389624|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389625|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389626|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44389627|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
44389628|NCT03276975|Coagulants|coagulants|mesh-ancestor
44389629|NCT03276078|Bromides|bromides|mesh-list
44389630|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
44389631|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44389632|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
44389633|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389634|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389635|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43694556|NCT02767752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44389721|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389723|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44389724|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44389725|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389726|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389727|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389728|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389729|NCT03271151|Analgesics|analgesics|mesh-ancestor
44389730|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
44389731|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389732|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
44389733|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389734|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
44389735|NCT03270644|Propranolol|propranolol|mesh-list
44389736|NCT03270644|Lasmiditan|lasmiditan|mesh-list
44389737|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44389738|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44389739|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
44389740|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389741|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389742|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389743|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44389744|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44389745|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44389746|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44389747|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
44389748|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44389749|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44389750|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44389751|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
44389752|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389753|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44389927|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44389928|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
44389929|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389931|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
44389932|NCT03258762|Calcium|calcium|mesh-list
44389933|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
44389934|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44389935|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389936|NCT03258762|Antidotes|antidotes|mesh-ancestor
44389937|NCT03258762|Protective Agents|protective agents|mesh-ancestor
44389938|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
44389939|NCT03258762|Vitamins|vitamins|mesh-ancestor
44389940|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
44389941|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
44389942|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44389943|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44390026|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390027|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390029|NCT03255824|Midazolam|midazolam|mesh-list
44236444|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107891|NCT00080444|Dexamethasone|dexamethasone|mesh-list
44390030|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
44390031|NCT03255824|Propofol|propofol|mesh-list
44390032|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44390033|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390034|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390035|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44390036|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
44390037|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
44390038|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44390039|NCT03255824|Analgesics|analgesics|mesh-ancestor
44390040|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
44390041|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390042|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44390043|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44390044|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44390164|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44390165|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44390166|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44390167|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694936|NCT02765347|Metformin|metformin|mesh-list
44390355|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390356|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44390357|NCT03237065|Hematinics|hematinics|mesh-ancestor
44390358|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
44390359|NCT03236506|Grazoprevir|grazoprevir|mesh-list
44390360|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44390361|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
44390362|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390363|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
44390364|NCT03235154|Velpatasvir|velpatasvir|mesh-list
44390365|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44390366|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
44390367|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390368|NCT03235050|Liraglutide|liraglutide|mesh-list
44390369|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390370|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390371|NCT03235050|Incretins|incretins|mesh-ancestor
44390372|NCT03235050|Hormones|hormones|mesh-ancestor
44390373|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390374|NCT03234907|Vedolizumab|vedolizumab|mesh-list
44390375|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390376|NCT03234036|Ritonavir|ritonavir|mesh-list
44390377|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
44390378|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44390379|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44390380|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
44390381|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390382|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390412|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44390413|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
44390414|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390415|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390416|NCT03231371|Adenosine|adenosine|mesh-list
44390417|NCT03231371|Analgesics|analgesics|mesh-ancestor
44390418|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
44390419|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390420|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390421|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44390422|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
44390423|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44390424|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
44390425|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
44390426|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390478|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44047537|NCT00003394|Paclitaxel|paclitaxel|mesh-list
44390480|NCT03226275|Bisoprolol|bisoprolol|mesh-list
44390481|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44390482|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43861006|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
43861007|NCT02905591|Protective Agents|protective agents|mesh-ancestor
44390483|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44390484|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390485|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44390486|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390487|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
44236445|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44390488|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
44390489|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
44390490|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390491|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44390492|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44390493|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44390494|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
44390495|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44047605|NCT00003398|Thiotepa|thiotepa|mesh-list
44390496|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
44390497|NCT03226249|Doxorubicin|doxorubicin|mesh-list
44390498|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44390499|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
44390500|NCT03226249|Dacarbazine|dacarbazine|mesh-list
44390501|NCT03226249|Vinblastine|vinblastine|mesh-list
44390566|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390567|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390568|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44390569|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44390570|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44390571|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390572|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047691|NCT00003401|Hormones|hormones|mesh-ancestor
44390573|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43695261|NCT02762838|Hematinics|hematinics|mesh-ancestor
44390667|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390669|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
44390670|NCT03213457|Estradiol|estradiol|mesh-list
44390671|NCT03213457|Estrogens|estrogens|mesh-ancestor
44390672|NCT03213457|Hormones|hormones|mesh-ancestor
44390673|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390674|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390675|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44390676|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
44390677|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390678|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44390679|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44390680|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44390681|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44390682|NCT03211858|Insulin|insulin|mesh-list
44390774|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390775|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
44390776|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390777|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44390778|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390779|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390780|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
44390781|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390782|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44390783|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390784|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390785|NCT03206788|Losartan|losartan|mesh-list
44390786|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44390787|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43695401|NCT02762123|Analgesics|analgesics|mesh-ancestor
44390953|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44390954|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390955|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44390956|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390999|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
44391000|NCT03196349|Apixaban|apixaban|mesh-list
44391001|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
44391002|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44391003|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
44391004|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44391005|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
44391006|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391007|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391008|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44391009|NCT03193047|Evolocumab|evolocumab|mesh-list
44391010|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44391011|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44391012|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
44391013|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108035|NCT00080795|Cisplatin|cisplatin|mesh-list
44108038|NCT00080795|Ifosfamide|ifosfamide|mesh-list
44391014|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44391015|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391016|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391017|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391018|NCT03192488|Cetirizine|cetirizine|mesh-list
44391019|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44391020|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44391021|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44391022|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
44391023|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
44391024|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391025|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391186|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44391187|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44391188|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44391189|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44391190|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695725|NCT02760095|Vitamin A|vitamin a|mesh-list
44391225|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44391226|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
44391227|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391228|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391229|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
44391230|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391231|NCT03176238|Everolimus|everolimus|mesh-list
44391232|NCT03176238|Exemestane|exemestane|mesh-list
44391267|NCT03175120|Insulin|insulin|mesh-list
44391268|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44391269|NCT03175120|Liraglutide|liraglutide|mesh-list
44391270|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
44391702|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44391703|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
44391704|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391705|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
44391707|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391928|NCT03131479|Licogliflozin|licogliflozin|mesh-list
44391929|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44391930|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391931|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44392029|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44392031|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44392032|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392033|NCT03123471|Analgesics|analgesics|mesh-ancestor
44392034|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
44392035|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392036|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392037|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392038|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392039|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44392040|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44392041|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392042|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392043|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44392044|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44392045|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44392046|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44392047|NCT03122860|Lorecivivint|lorecivivint|mesh-list
44392048|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392049|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
43829953|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
44392082|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392084|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44392085|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
44392086|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392087|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392088|NCT03120351|Lidocaine|lidocaine|mesh-list
44392089|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392090|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
44392091|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392092|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392093|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
43614005|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
44108110|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392119|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392120|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392121|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44392122|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44392123|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
44392124|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392125|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392126|NCT03118765|Bromides|bromides|mesh-list
44392127|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44392128|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
44392129|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392130|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
44392131|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392132|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392133|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392134|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392135|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
44392136|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44392137|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392138|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392139|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392140|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
44392141|NCT03118739|Febuxostat|febuxostat|mesh-list
44392326|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392327|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
43696632|NCT02753855|Telavancin|telavancin|mesh-list
44392360|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
44392362|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44392363|NCT03103087|Relugolix|relugolix|mesh-list
44392364|NCT03103087|Estrogens|estrogens|mesh-ancestor
44392365|NCT03103087|Hormones|hormones|mesh-ancestor
44392366|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392367|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392368|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44392369|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
44392447|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44392472|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44392473|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392474|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392475|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392476|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392477|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
44392478|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392479|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392480|NCT03098550|Nivolumab|nivolumab|mesh-list
44392481|NCT03098550|Daratumumab|daratumumab|mesh-list
44392482|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392483|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392484|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44392485|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392486|NCT03098030|Irinotecan|irinotecan|mesh-list
44392487|NCT03098030|Topotecan|topotecan|mesh-list
44392488|NCT03098030|Dinutuximab|dinutuximab|mesh-list
44392489|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44392490|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44392491|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392492|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392493|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392494|NCT03097861|Lubiprostone|lubiprostone|mesh-list
44392495|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43829995|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
44392663|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44392664|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392666|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44392667|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
44392668|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392669|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392670|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44392671|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44392672|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392673|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392901|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44392902|NCT03080493|Narcotics|narcotics|mesh-ancestor
44108186|NCT00080951|Antidotes|antidotes|mesh-ancestor
44392903|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
44392904|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392905|NCT03080493|Laxatives|laxatives|mesh-ancestor
44392906|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392907|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
44392908|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392909|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
44392910|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392911|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392912|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392913|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392914|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44392915|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
44392916|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392917|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392918|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44392919|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
44392920|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
44392921|NCT03079102|Protective Agents|protective agents|mesh-ancestor
44392922|NCT03078907|Selexipag|selexipag|mesh-list
44392923|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44392924|NCT03078556|Lamivudine|lamivudine|mesh-list
44392925|NCT03078556|Dolutegravir|dolutegravir|mesh-list
44392926|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44392927|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44392928|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392929|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392930|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
44392952|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44392953|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44392954|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392955|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392956|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44392957|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44392958|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44392959|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44392960|NCT03077698|Megestrol|megestrol|mesh-list
44392961|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
44392962|NCT03077698|Progestins|progestins|mesh-list
44392963|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
44392964|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44392965|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44392966|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44392967|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
44392968|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44392969|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392970|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44392971|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44392972|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44392973|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392974|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
44392975|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44392976|NCT03077698|Hormones|hormones|mesh-ancestor
44392977|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392978|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
44392979|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
44392980|NCT03077659|Paclitaxel|paclitaxel|mesh-list
44392981|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392982|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392983|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392984|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392985|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
44393016|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393018|NCT03076970|Lasmiditan|lasmiditan|mesh-list
44393019|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44393020|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44393021|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44393022|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
44393023|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697064|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
44393058|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44393059|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44393060|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393061|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393062|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393063|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393064|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44393093|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393095|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
44393096|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393097|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393098|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393099|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44393100|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44393101|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393102|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393103|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
44393104|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393105|NCT03073980|Acetaminophen|acetaminophen|mesh-list
44393106|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393107|NCT03073980|Analgesics|analgesics|mesh-ancestor
44393108|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
44393109|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393110|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393111|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
44393112|NCT03073213|Ixekizumab|ixekizumab|mesh-list
44393113|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697197|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
44393176|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
44393177|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393178|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44393179|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44393180|NCT03070171|Dabigatran|dabigatran|mesh-list
44393181|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
44393182|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44393183|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
44393184|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393185|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393186|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
44393187|NCT03070002|Denosumab|denosumab|mesh-list
44393188|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44393189|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393190|NCT03069482|Nicotine|nicotine|mesh-list
44393191|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44393192|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
44393193|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393194|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393195|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44393196|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44393197|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393198|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393199|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393201|NCT03069352|Venetoclax|venetoclax|mesh-list
44393225|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393226|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393228|NCT03068455|Ipilimumab|ipilimumab|mesh-list
44393229|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393230|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393231|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393232|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393233|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44393234|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44393235|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
44393236|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393237|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44393238|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393239|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393240|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393241|NCT03066830|Metformin|metformin|mesh-list
44393242|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44393243|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393244|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108339|NCT00081575|Tigecycline|tigecycline|mesh-list
44393245|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44393246|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393247|NCT03066804|Valsartan|valsartan|mesh-list
44393248|NCT03066804|Enalapril|enalapril|mesh-list
44393249|NCT03066804|Enalaprilat|enalaprilat|mesh-list
44393250|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43697256|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393278|NCT03066193|Analgesics|analgesics|mesh-ancestor
44393279|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
44393280|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393281|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44393282|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44393283|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393284|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393285|NCT03066193|Hormones|hormones|mesh-ancestor
44393286|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393287|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44393288|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393289|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44393290|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
44393291|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393292|NCT03065933|Clonidine|clonidine|mesh-list
44393293|NCT03065933|Analgesics|analgesics|mesh-ancestor
44393294|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
44393295|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393296|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393322|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393323|NCT03063632|Interferons|interferons|mesh-list
44393324|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
44393325|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
44393326|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393327|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393328|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
44393329|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393330|NCT03063086|Fluticasone|fluticasone|mesh-list
44393331|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44393332|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393333|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44393334|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
44393335|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393336|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393337|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44393338|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
44393339|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393340|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44393341|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44393342|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44393343|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393344|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393370|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44393371|NCT03060512|Laxatives|laxatives|mesh-ancestor
44393372|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393373|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44393374|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393375|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
44393376|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393377|NCT03060447|Vesatolimod|vesatolimod|mesh-list
44393378|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
44393379|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393380|NCT03058692|Vaccines|vaccines|mesh-list
44393381|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
44393382|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393383|NCT03057977|Empagliflozin|empagliflozin|mesh-list
44393384|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44393385|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393386|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393387|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393388|NCT03057951|Empagliflozin|empagliflozin|mesh-list
44393389|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44393390|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393469|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393470|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44108412|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44393471|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44393472|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393473|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393474|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44393475|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
44393476|NCT03055221|Treprostinil|treprostinil|mesh-list
44393477|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393478|NCT03054870|Xenon|xenon|mesh-list
44393479|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44393480|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
44393481|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
44393482|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393483|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393484|NCT03053427|Gabapentin|gabapentin|mesh-list
44393485|NCT03053427|Analgesics|analgesics|mesh-ancestor
44393486|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
44393487|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393488|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393489|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
44393490|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44393491|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44393492|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393493|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393494|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44393495|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44393496|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393497|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393498|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
44393499|NCT03053063|Selonsertib|selonsertib|mesh-list
44393500|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44393501|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697492|NCT03508570|Nivolumab|nivolumab|mesh-list
44393557|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44393558|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393559|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44393560|NCT03051100|Atorvastatin|atorvastatin|mesh-list
44393561|NCT03051100|Ezetimibe|ezetimibe|mesh-list
44393628|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
44393629|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393656|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393658|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393659|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393660|NCT03048747|Tolvaptan|tolvaptan|mesh-list
44393661|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44393662|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393663|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
44393664|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393665|NCT03048500|Metformin|metformin|mesh-list
44393666|NCT03048500|Nivolumab|nivolumab|mesh-list
44393667|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393668|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393669|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393670|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393671|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393672|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393673|NCT03048422|Tenofovir|tenofovir|mesh-list
44393674|NCT03048422|Emtricitabine|emtricitabine|mesh-list
44393675|NCT03048422|Efavirenz|efavirenz|mesh-list
44393676|NCT03048422|Dolutegravir|dolutegravir|mesh-list
44393677|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44393689|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44393690|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44393691|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44393692|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44393693|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44393695|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44393696|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44393697|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393698|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44393699|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44393700|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393701|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44108485|NCT00082199|Aripiprazole|aripiprazole|mesh-list
44393702|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393703|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393704|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393706|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44393707|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393708|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44393709|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393710|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
44393711|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393712|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
44393713|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393714|NCT03046446|FX006|fx006|mesh-list
44393715|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393716|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
44393717|NCT03046446|Hormones|hormones|mesh-ancestor
44393718|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393719|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393720|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393721|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
44393722|NCT03045328|Venetoclax|venetoclax|mesh-list
44393723|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393724|NCT03044886|Vitamin D|vitamin d|mesh-list
44393725|NCT03044886|Vitamins|vitamins|mesh-ancestor
44393726|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
44393727|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393728|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44393729|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
44393730|NCT03044730|Capecitabine|capecitabine|mesh-list
44393731|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393732|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393733|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44393734|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
44393735|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393736|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
44393737|NCT03043664|Lanreotide|lanreotide|mesh-list
44393758|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393759|NCT03041792|Liraglutide|liraglutide|mesh-list
44393760|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393761|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393762|NCT03041792|Incretins|incretins|mesh-ancestor
44393763|NCT03041792|Hormones|hormones|mesh-ancestor
44393764|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393765|NCT03041701|Dasatinib|dasatinib|mesh-list
44393766|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393767|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393768|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44393769|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393770|NCT03041311|Carboplatin|carboplatin|mesh-list
44393771|NCT03041311|Etoposide|etoposide|mesh-list
44393772|NCT03041311|Atezolizumab|atezolizumab|mesh-list
44393773|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393774|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44393775|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44393776|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44393777|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393778|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393779|NCT03041181|Gemcitabine|gemcitabine|mesh-list
44393780|NCT03041181|Docetaxel|docetaxel|mesh-list
44393781|NCT03041181|Nivolumab|nivolumab|mesh-list
44393782|NCT03041181|Pemetrexed|pemetrexed|mesh-list
44393783|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44393784|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
44393785|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393786|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393787|NCT03041181|Antiviral Agents|antiviral agents|mesh-ancestor
44393788|NCT03041181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393789|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393790|NCT03041181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393791|NCT03041181|Immunologic Factors|immunologic factors|mesh-ancestor
44393825|NCT03038880|Ranibizumab|ranibizumab|mesh-list
44393826|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44393827|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44393828|NCT03038880|Growth Substances|growth substances|mesh-ancestor
44393829|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393830|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
44393831|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393960|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393961|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393962|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
44393963|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
44393998|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393999|NCT03029650|Scopolamine|scopolamine|mesh-list
44394000|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44394001|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44394002|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
44394040|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
44394041|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44394060|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394061|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394062|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394063|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
44394065|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394066|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394067|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394068|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44394069|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
44394070|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394071|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
44394072|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44394073|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44394074|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44394075|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44394076|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394077|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44394078|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394079|NCT03028012|Analgesics|analgesics|mesh-ancestor
44394080|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394081|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44394082|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394083|NCT03027557|Denosumab|denosumab|mesh-list
44394084|NCT03027557|Cinacalcet|cinacalcet|mesh-list
44394085|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44394086|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394087|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44394088|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44394089|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44394090|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394091|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44394092|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
44394093|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44394094|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44394095|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394096|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
43861522|NCT02781883|Decitabine|decitabine|mesh-list
44394117|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394118|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394119|NCT03023878|Dexamethasone|dexamethasone|mesh-list
44394120|NCT03023878|Blinatumomab|blinatumomab|mesh-list
44394121|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394122|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
44394123|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
44394124|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394125|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394126|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394127|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
44394128|NCT03023878|Hormones|hormones|mesh-ancestor
44394129|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394130|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394131|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394132|NCT03023722|Maytansine|maytansine|mesh-list
44394133|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44394134|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394135|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394136|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394137|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394138|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394139|NCT03023423|Atezolizumab|atezolizumab|mesh-list
44394140|NCT03023423|Daratumumab|daratumumab|mesh-list
44108599|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44394141|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394142|NCT03023046|Prednisone|prednisone|mesh-list
44394143|NCT03023046|Cortisone|cortisone|mesh-list
44394144|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
44394145|NCT03023046|Rituximab|rituximab|mesh-list
44394146|NCT03023046|Doxorubicin|doxorubicin|mesh-list
44394147|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44394148|NCT03023046|Etoposide|etoposide|mesh-list
44394149|NCT03023046|Vincristine|vincristine|mesh-list
44394150|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
44394151|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
44394152|NCT03023046|Daunorubicin|daunorubicin|mesh-list
44394166|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394167|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44394168|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44394169|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44394170|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44394171|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394172|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394173|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
44394174|NCT03023046|Hormones|hormones|mesh-ancestor
44394175|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394176|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394177|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44394178|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394179|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394180|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394181|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44394182|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
44394183|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
44394184|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
44394185|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44394186|NCT03022981|Velpatasvir|velpatasvir|mesh-list
44394187|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
44394188|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394189|NCT03022578|Lomustine|lomustine|mesh-list
44394190|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44394191|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
44394192|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394193|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394194|NCT03021642|Tepotinib|tepotinib|mesh-list
44394195|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394196|NCT03021486|Haloperidol|haloperidol|mesh-list
44394197|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
44394198|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
44394199|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
44394200|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
44394201|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861588|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394202|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394203|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394204|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44394205|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394206|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394207|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394208|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44051606|NCT00003913|Busulfan|busulfan|mesh-list
44394209|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
44394210|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394211|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394212|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44394213|NCT03021018|Lorazepam|lorazepam|mesh-list
44394214|NCT03021018|Brivaracetam|brivaracetam|mesh-list
43698008|NCT02749656|Hormones|hormones|mesh-ancestor
43698016|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698018|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698019|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698020|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44394306|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394307|NCT03018340|Pimavanserin|pimavanserin|mesh-list
44394308|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44394309|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44394310|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44394311|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394312|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44108680|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
44394313|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394314|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394315|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44394316|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44394317|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
44394361|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394362|NCT03017235|Antacids|antacids|mesh-ancestor
44394363|NCT03016598|Oxytocin|oxytocin|mesh-list
44394364|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
44394365|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44394366|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394367|NCT03015532|Bupivacaine|bupivacaine|mesh-list
44394368|NCT03015532|Ropivacaine|ropivacaine|mesh-list
44394369|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
44394370|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
44394371|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394372|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394373|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
44394374|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394375|NCT03015220|Dulaglutide|dulaglutide|mesh-list
44394376|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394377|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394378|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44394379|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
44394380|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394381|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394382|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394383|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394384|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44394385|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394386|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
44394387|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
44394388|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394389|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394390|NCT03012828|Moxidectin|moxidectin|mesh-list
44394391|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
44394392|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44394784|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44394786|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394787|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394788|NCT02997163|Talazoparib|talazoparib|mesh-list
44394789|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44394790|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394791|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394792|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394793|NCT02996682|Ribavirin|ribavirin|mesh-list
44394794|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44394795|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
44394796|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394797|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
43698314|NCT02747316|Iron|iron|mesh-list
44394959|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394960|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394961|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44394962|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44394963|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
44394964|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394965|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44394966|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394967|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394968|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394969|NCT02991040|Lidocaine|lidocaine|mesh-list
44394970|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44394971|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
44394972|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394973|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394974|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
44394975|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394976|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44394977|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44394978|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44394979|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395058|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44395059|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44395061|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395062|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44395063|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395064|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395065|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395066|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44395067|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
44395068|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395069|NCT02986139|Etanercept|etanercept|mesh-list
44395070|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44395071|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44395072|NCT02986139|Analgesics|analgesics|mesh-ancestor
44395073|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
44395074|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395075|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395076|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395077|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395078|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395079|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395080|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
44395081|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44395261|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44395262|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
44395263|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
44395264|NCT02980523|Protective Agents|protective agents|mesh-ancestor
44395265|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
44395266|NCT02980133|Fluticasone|fluticasone|mesh-list
44395267|NCT02980133|Xhance|xhance|mesh-list
44395268|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44395269|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395270|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44395271|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
44395272|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395273|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395274|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44395275|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
44395276|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395277|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44395278|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44395279|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44395280|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44395281|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395282|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395362|NCT02974010|Ketamine|ketamine|mesh-list
44395363|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44395364|NCT02974010|Analgesics|analgesics|mesh-ancestor
44395365|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
44395366|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395623|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44395624|NCT02968173|Palivizumab|palivizumab|mesh-list
44395625|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
44395626|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395627|NCT02967679|Biotin|biotin|mesh-list
44395654|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44395655|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395656|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
44395657|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44395658|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
44395659|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44395660|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44395661|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395662|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
44395663|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
44395664|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44395665|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
44395666|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395667|NCT02965378|Docetaxel|docetaxel|mesh-list
44395668|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395669|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44395670|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44395671|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44395672|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395673|NCT02964247|Liraglutide|liraglutide|mesh-list
44395675|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395677|NCT02964247|Hormones|hormones|mesh-ancestor
44395705|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44053116|NCT00004110|Etoposide|etoposide|mesh-list
44395706|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
44395707|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44395708|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
44395709|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
44395710|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44395711|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44395712|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
44395713|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395714|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395715|NCT02963493|Dexamethasone|dexamethasone|mesh-list
44395716|NCT02963493|Melphalan|melphalan|mesh-list
44395717|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395718|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
44395719|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
44395720|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395721|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395722|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395723|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
44395724|NCT02963493|Hormones|hormones|mesh-ancestor
44395800|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44395801|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395802|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44395803|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395804|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395805|NCT02960854|Nivolumab|nivolumab|mesh-list
44395806|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395807|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395808|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44395809|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395810|NCT02960490|Quetmolimab|quetmolimab|mesh-list
44395811|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395812|NCT02960438|Quetmolimab|quetmolimab|mesh-list
44395813|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395814|NCT02959983|Eluxadoline|eluxadoline|mesh-list
44395815|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395816|NCT02959970|Dapsone|dapsone|mesh-list
44395817|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395818|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
44395819|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44395820|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43698980|NCT02741817|Aspirin|aspirin|mesh-list
44396275|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44396277|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44396278|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396279|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
44396323|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
44396324|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396325|NCT02942576|Warfarin|warfarin|mesh-list
44396326|NCT02942576|Edoxaban|edoxaban|mesh-list
44396327|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
44396328|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
44396329|NCT02942576|Fluindione|fluindione|mesh-list
44396330|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
44396331|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44396332|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
44396333|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44396334|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396335|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396336|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396337|NCT02942485|Metronidazole|metronidazole|mesh-list
44396373|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
44396374|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396375|NCT02940860|Hematinics|hematinics|mesh-ancestor
44396376|NCT02940730|Dalbavancin|dalbavancin|mesh-list
44396377|NCT02940730|Teicoplanin|teicoplanin|mesh-list
44396378|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44396379|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396380|NCT02940691|Grazoprevir|grazoprevir|mesh-list
44396446|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396447|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396448|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
44396450|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396457|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
44396662|NCT02928029|Bortezomib|bortezomib|mesh-list
44396663|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44396664|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396665|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
44396666|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
44396667|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396668|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396669|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396670|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
44396671|NCT02928029|Hormones|hormones|mesh-ancestor
44396672|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396673|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396674|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396675|NCT02927938|Cytarabine|cytarabine|mesh-list
44396676|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44396677|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
44396678|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830345|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
44396699|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396700|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44396701|NCT02927834|Prednisone|prednisone|mesh-list
44396702|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396703|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
44396704|NCT02927834|Hormones|hormones|mesh-ancestor
44396705|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396706|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396707|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396708|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396709|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44396710|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396711|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44396712|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054228|NCT00004251|Letrozole|letrozole|mesh-list
44396713|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396715|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
44396716|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396717|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396718|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396719|NCT02926950|Metformin|metformin|mesh-list
44396720|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44396721|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396722|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396723|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44396724|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396725|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44396726|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44396727|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396728|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396729|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396834|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396836|NCT02923921|Leucovorin|leucovorin|mesh-list
44396837|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
44396838|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396840|NCT02923921|Protective Agents|protective agents|mesh-ancestor
44396841|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396842|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
44396843|NCT02923921|Vitamins|vitamins|mesh-ancestor
44396844|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
44396845|NCT02923115|Enoxaparin|enoxaparin|mesh-list
44396846|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
44396847|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44396848|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44396849|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396850|NCT02921919|Talazoparib|talazoparib|mesh-list
44396851|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44396852|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396853|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396854|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396855|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
44396856|NCT02921763|Progestins|progestins|mesh-ancestor
44396857|NCT02921763|Hormones|hormones|mesh-ancestor
44396858|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054376|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
44396859|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396860|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44396861|NCT02921750|Laxatives|laxatives|mesh-ancestor
44396862|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396863|NCT02920528|Ketamine|ketamine|mesh-list
44396897|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396898|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396899|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
44396900|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44396901|NCT02919761|Hormones|hormones|mesh-ancestor
44396902|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699624|NCT02737124|Analgesics|analgesics|mesh-ancestor
44396980|NCT02917941|Growth Substances|growth substances|mesh-ancestor
44396981|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
44396982|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396983|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861907|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
44396984|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396985|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44396986|NCT02917031|Saxagliptin|saxagliptin|mesh-list
44396987|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396988|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396989|NCT02917031|Incretins|incretins|mesh-ancestor
44396990|NCT02917031|Hormones|hormones|mesh-ancestor
44396991|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396992|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44396993|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396994|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396995|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397026|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397027|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397028|NCT02915978|Analgesics|analgesics|mesh-ancestor
44397029|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
44397030|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397031|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44397032|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44397033|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
44397034|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
44397036|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
44397037|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397038|NCT02915302|Vaccines|vaccines|mesh-list
44397039|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
44397040|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397326|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44397327|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
44397328|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397329|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397330|NCT02901054|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44397331|NCT02901054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44397332|NCT02901054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397333|NCT02901054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397334|NCT02901054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44397335|NCT02900378|Valsartan|valsartan|mesh-list
44397336|NCT02900378|Enalapril|enalapril|mesh-list
44397337|NCT02900378|Enalaprilat|enalaprilat|mesh-list
44109056|NCT00083707|Thalidomide|thalidomide|mesh-list
44397338|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44397339|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44397340|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44397341|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44397342|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397343|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44397344|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397345|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397452|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397575|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397576|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397578|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44397579|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
44397580|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
44397581|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397582|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44397583|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44397584|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397585|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397586|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44397587|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44397588|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397589|NCT02887183|Valsartan|valsartan|mesh-list
43700096|NCT02733458|Gemcitabine|gemcitabine|mesh-list
44397625|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397626|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44397627|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397628|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
44397691|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397692|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44397694|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397695|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397696|NCT02875392|Fucoidan|fucoidan|mesh-list
44397697|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397698|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397699|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
44397737|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397738|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397771|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
44397772|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44397773|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44397774|NCT02874742|Growth Substances|growth substances|mesh-ancestor
44397775|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
44397777|NCT02873754|Nicotine|nicotine|mesh-list
44397778|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44397779|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
44397780|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700253|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
44397989|NCT02864316|Nivolumab|nivolumab|mesh-list
44397990|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397991|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397992|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397993|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397994|NCT02863575|Ibuprofen|ibuprofen|mesh-list
44397995|NCT02863575|Caffeine|caffeine|mesh-list
44397996|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44397997|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397998|NCT02863575|Analgesics|analgesics|mesh-ancestor
44397999|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
44398000|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055450|NCT00004583|Ritonavir|ritonavir|mesh-list
44398001|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398002|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398003|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398004|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44398005|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700310|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44398030|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398032|NCT02862730|Pancreatin|pancreatin|mesh-list
44398033|NCT02862730|Hormones|hormones|mesh-list
44398034|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398035|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398037|NCT02862600|Perhexiline|perhexiline|mesh-list
44398038|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44398039|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398040|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398041|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44398042|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398043|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
44398044|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44398045|NCT02862574|Methotrexate|methotrexate|mesh-list
44398046|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44398047|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
44398048|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398049|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398050|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398051|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
44398086|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44398087|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
44398088|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398089|NCT02862106|Vaccines|vaccines|mesh-list
44398090|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
44398091|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398092|NCT02861664|Fluorides|fluorides|mesh-list
44398093|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
44398259|NCT02855359|Rituximab|rituximab|mesh-list
44398294|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398295|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
44398296|NCT02854631|Hormones|hormones|mesh-ancestor
44398297|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398298|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398406|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
44398407|NCT02852265|Etonogestrel|etonogestrel|mesh-list
44398408|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398409|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398410|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44398411|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44398412|NCT02852005|Vaccines|vaccines|mesh-list
44398413|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
44398414|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398415|NCT02851407|Defibrotide|defibrotide|mesh-list
44398416|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44398417|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44398418|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398419|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44398420|NCT02850965|Adalimumab|adalimumab|mesh-list
44398421|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398422|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398423|NCT02850276|Bromides|bromides|mesh-list
44398424|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44398425|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
44398426|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44398450|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
44398451|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398452|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44398453|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44398454|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44398455|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398456|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398457|NCT02849509|Vitamin K|vitamin k|mesh-list
44398458|NCT02849509|Dabigatran|dabigatran|mesh-list
44398459|NCT02849509|Vitamins|vitamins|mesh-ancestor
44398460|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
44398461|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398462|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
44398463|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44398464|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398465|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398466|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398467|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
44398468|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44398469|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44398470|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
44398471|NCT02849509|Coagulants|coagulants|mesh-ancestor
44398472|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44398473|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44109171|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398474|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398475|NCT02849080|Incretins|incretins|mesh-ancestor
44398476|NCT02849080|Hormones|hormones|mesh-ancestor
44398477|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398478|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44398536|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398700|NCT02847637|Factor VIII|factor viii|mesh-list
44398701|NCT02847637|Coagulants|coagulants|mesh-ancestor
44398702|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
44398800|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
44398801|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398802|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44398803|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398804|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
44398805|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398806|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398807|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398808|NCT02831764|Tenofovir|tenofovir|mesh-list
44399630|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399631|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399632|NCT02791763|Glycine|glycine|mesh-list
44399633|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
44399634|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399635|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399636|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399637|NCT02791490|Metformin|metformin|mesh-list
44399638|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44399639|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44399640|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399641|NCT02791490|Incretins|incretins|mesh-ancestor
44399642|NCT02791490|Hormones|hormones|mesh-ancestor
44399643|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399644|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44399645|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
44399646|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399673|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44399674|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44399676|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
44399677|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44399678|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399679|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
44399680|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44399681|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44399682|NCT02788513|BI 425809|bi 425809|mesh-list
44399683|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
44399684|NCT02788474|Nintedanib|nintedanib|mesh-list
44399685|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399686|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399687|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399688|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399689|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44399690|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44399691|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44399692|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44399729|NCT02785900|Azacitidine|azacitidine|mesh-list
44399817|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44399819|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
44399820|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399821|NCT02781506|Nivolumab|nivolumab|mesh-list
44399822|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399823|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399824|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44399825|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399826|NCT02781311|Finasteride|finasteride|mesh-list
44399827|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44399862|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399863|NCT02778867|Fluticasone|fluticasone|mesh-list
44400015|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400016|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400017|NCT02770820|Analgesics|analgesics|mesh-ancestor
44400018|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
43614006|NCT04553692|Vitamins|vitamins|mesh-ancestor
44400019|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400020|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400022|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44400194|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400195|NCT02764333|Durvalumab|durvalumab|mesh-list
44400231|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400232|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400233|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400234|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
44400235|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400289|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400291|NCT02761057|Crizotinib|crizotinib|mesh-list
44400292|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400293|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44400294|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44400295|NCT02761057|Growth Substances|growth substances|mesh-ancestor
44400296|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400297|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
44400298|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44400299|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400300|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400301|NCT02760407|Adalimumab|adalimumab|mesh-list
44400302|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400303|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400304|NCT02760069|Ondansetron|ondansetron|mesh-list
44400305|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
44400306|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
44400397|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400398|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400400|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
44400401|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400402|NCT02757352|Ixekizumab|ixekizumab|mesh-list
44400403|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
44400404|NCT02756832|Alogliptin|alogliptin|mesh-list
44400405|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44400406|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400407|NCT02756832|Incretins|incretins|mesh-ancestor
44400408|NCT02756832|Hormones|hormones|mesh-ancestor
44400409|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400410|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44400411|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44400412|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400413|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400414|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44400415|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44400416|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44400417|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400418|NCT02756611|Venetoclax|venetoclax|mesh-list
44400419|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400420|NCT02756403|Azithromycin|azithromycin|mesh-list
44400453|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44400454|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400455|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400456|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400457|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
44400458|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
44400459|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44400460|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
44400461|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
44400462|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400463|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400532|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400534|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44400535|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43702122|NCT02720341|Armin|armin|mesh-list
44400571|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
44400573|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
44400574|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400575|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400576|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44400577|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109320|NCT04920981|Atezolizumab|atezolizumab|mesh-list
44400578|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400645|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400646|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400647|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400648|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400649|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
44400650|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44400651|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
44400652|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400653|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44400654|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400655|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
44400656|NCT02748512|Hormones|hormones|mesh-ancestor
44400657|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400658|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400659|NCT02748213|Docetaxel|docetaxel|mesh-list
44400660|NCT02748213|Capecitabine|capecitabine|mesh-list
44400661|NCT02748213|Trastuzumab|trastuzumab|mesh-list
44400662|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400885|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44400887|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400888|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400889|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400890|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
44400891|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44400892|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44400893|NCT02741245|Ezetimibe|ezetimibe|mesh-list
44400894|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44400895|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44400896|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
44400932|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400933|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400934|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
44400935|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
44400936|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44400937|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401081|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401082|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44401083|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44401085|NCT02734862|Caspofungin|caspofungin|mesh-list
44401086|NCT02734862|Rezafungin|rezafungin|mesh-list
44401087|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
44401088|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401089|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44401090|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401091|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401206|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44401207|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
44401208|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401209|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401210|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44401211|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44401212|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401213|NCT02731131|Ribavirin|ribavirin|mesh-list
44401214|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44401215|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
44401216|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401217|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
44401218|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401219|NCT02730871|Timolol|timolol|mesh-list
44401220|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44401221|NCT02730871|Travoprost|travoprost|mesh-list
44401222|NCT02730871|Brinzolamide|brinzolamide|mesh-list
44401223|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44401224|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44401225|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401226|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401227|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401228|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401229|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44401230|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43702540|NCT02716428|Ribavirin|ribavirin|mesh-list
44401349|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401350|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
44153649|NCT00221156|Acarbose|acarbose|mesh-list
44401351|NCT02727660|Hormones|hormones|mesh-ancestor
44401352|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401353|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44401354|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44401355|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44401356|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401357|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401358|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401359|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
44401360|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44401361|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401362|NCT02727322|Renal Agents|renal agents|mesh-ancestor
44401363|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401364|NCT02726399|Cisplatin|cisplatin|mesh-list
44401365|NCT02726399|Capecitabine|capecitabine|mesh-list
44401366|NCT02726399|Trastuzumab|trastuzumab|mesh-list
44401367|NCT02726399|Ramucirumab|ramucirumab|mesh-list
44401368|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401542|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44401543|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
44401544|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44401545|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401546|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44401547|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44401548|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
44401549|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44401550|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401551|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401552|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44401553|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44401554|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
44401622|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401623|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44401624|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401625|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401626|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401627|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44401628|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401629|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401630|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401631|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401632|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44401633|NCT02720198|Analgesics|analgesics|mesh-ancestor
43702781|NCT02714725|Propofol|propofol|mesh-list
44401878|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401879|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44401880|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401881|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401942|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401944|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44401945|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401946|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401947|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44401948|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44401949|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44401950|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401951|NCT02709655|Vortioxetine|vortioxetine|mesh-list
44401952|NCT02709655|Fluoxetine|fluoxetine|mesh-list
44401953|NCT02709655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44401954|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401955|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401956|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401957|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401958|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
44401959|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401960|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44401961|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
43703003|NCT02713139|Miconazole|miconazole|mesh-list
44402051|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44402052|NCT02707757|Hematinics|hematinics|mesh-ancestor
44402054|NCT02707640|Pirfenidone|pirfenidone|mesh-list
44402055|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44402056|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
44402057|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402058|NCT02707640|Expectorants|expectorants|mesh-ancestor
44402059|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402060|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44402061|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
44402062|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402063|NCT02707640|Protective Agents|protective agents|mesh-ancestor
44402064|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402065|NCT02707640|Antidotes|antidotes|mesh-ancestor
44402066|NCT02707640|Analgesics|analgesics|mesh-ancestor
44402067|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
44402068|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402069|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402070|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402071|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402072|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402073|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402074|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
43703098|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402175|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402176|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402177|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44402178|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402179|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402180|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402181|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
44402182|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44402183|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402184|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402185|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402186|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44402187|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44402188|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402238|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
44402239|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
44402240|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44402241|NCT02700841|Melphalan|melphalan|mesh-list
44402242|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
44402243|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44402244|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
44402245|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402246|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402247|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44402248|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703212|NCT02711943|Levofloxacin|levofloxacin|mesh-list
44402277|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402278|NCT02699450|Ranibizumab|ranibizumab|mesh-list
44402279|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44402280|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44402281|NCT02699450|Growth Substances|growth substances|mesh-ancestor
44402282|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402283|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44402284|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402285|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44402286|NCT02699125|Guanfacine|guanfacine|mesh-list
44402287|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44402288|NCT02699125|Diuretics|diuretics|mesh-ancestor
44402289|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
44402290|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402291|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44402292|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402293|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402294|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44402295|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44402322|NCT02698410|Temozolomide|temozolomide|mesh-list
44402324|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44402325|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
44402326|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402327|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402328|NCT02698293|Vitamin D|vitamin d|mesh-list
44402329|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
44402330|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
44402331|NCT02698293|Vitamins|vitamins|mesh-list
44402332|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
44402333|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402334|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44402335|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44402336|NCT02697916|Aspirin|aspirin|mesh-list
44402337|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402338|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402339|NCT02697916|Analgesics|analgesics|mesh-ancestor
44402340|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
44402341|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402342|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402343|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402344|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402345|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44402346|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43830857|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402377|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402378|NCT02696434|Naltrexone|naltrexone|mesh-list
44402379|NCT02696434|Buprenorphine|buprenorphine|mesh-list
44402380|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44402381|NCT02696434|Narcotics|narcotics|mesh-ancestor
44402382|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402383|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402384|NCT02696434|Analgesics|analgesics|mesh-ancestor
44402385|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
44402386|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402387|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44402388|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44402389|NCT02696226|Aspirin|aspirin|mesh-list
44402390|NCT02696226|Warfarin|warfarin|mesh-list
44402391|NCT02696226|Clopidogrel|clopidogrel|mesh-list
44402392|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402393|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402394|NCT02696226|Analgesics|analgesics|mesh-ancestor
44402498|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402499|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
44402500|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402535|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402536|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402537|NCT02691572|Acetaminophen|acetaminophen|mesh-list
44402538|NCT02691572|Ketorolac|ketorolac|mesh-list
44402539|NCT02691572|Fentanyl|fentanyl|mesh-list
44402540|NCT02691572|Bupivacaine|bupivacaine|mesh-list
44402658|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44402659|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
44402660|NCT02688530|Hormones|hormones|mesh-ancestor
44402661|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402662|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44402664|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
44402665|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402666|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402667|NCT02688387|Ambrisentan|ambrisentan|mesh-list
44402668|NCT02688387|Tadalafil|tadalafil|mesh-list
44402669|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
44402670|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44402671|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44402672|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402673|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402674|NCT02688387|Urological Agents|urological agents|mesh-ancestor
44402675|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44402676|NCT02688088|Midazolam|midazolam|mesh-list
44402677|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
44402678|NCT02688088|Caffeine|caffeine|mesh-list
44402679|NCT02688088|Warfarin|warfarin|mesh-list
44402680|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44402681|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703509|NCT02710552|Amlodipine|amlodipine|mesh-list
44402919|NCT02679274|Androgens|androgens|mesh-ancestor
44402920|NCT02679274|Hormones|hormones|mesh-ancestor
44402921|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402922|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402923|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44402924|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402925|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
44402926|NCT02678416|Acetaminophen|acetaminophen|mesh-list
44402927|NCT02678416|Morphine|morphine|mesh-list
44109568|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402929|NCT02678416|Narcotics|narcotics|mesh-ancestor
44402930|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402931|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402932|NCT02678416|Analgesics|analgesics|mesh-ancestor
44402933|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
44402934|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402968|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402970|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44402971|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44402972|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44402973|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44402974|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44402975|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
44402976|NCT02676895|Vaccines|vaccines|mesh-list
44402977|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
44403107|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403108|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403109|NCT02668393|Docetaxel|docetaxel|mesh-list
44403110|NCT02668393|Nintedanib|nintedanib|mesh-list
44403172|NCT02663895|Treprostinil|treprostinil|mesh-list
44403173|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44403174|NCT02663687|Complement C1s|complement c1s|mesh-list
44403175|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44403176|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44403177|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
44403178|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403179|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44403180|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44403181|NCT02663674|Fluconazole|fluconazole|mesh-list
44403182|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
44403183|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403184|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44403185|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44403186|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403187|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403188|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44403189|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
43703869|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44403290|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403291|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44403292|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403293|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
44403294|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
44403295|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403296|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403394|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403395|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403396|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403397|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403398|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403399|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403401|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44403402|NCT02658149|Epinephrine|epinephrine|mesh-list
44403403|NCT02658149|Morphine|morphine|mesh-list
44403439|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403440|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403441|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403442|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403443|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403659|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
44403660|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44403661|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403662|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44403663|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403664|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403665|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403666|NCT02650921|Lidocaine|lidocaine|mesh-list
44403667|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
44403668|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
44403669|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403671|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
44403672|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403704|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403705|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403706|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44403707|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44403708|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
44403709|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44403710|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44403711|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44403713|NCT02648347|Hematinics|hematinics|mesh-ancestor
44403778|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44403779|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44403780|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44403781|NCT02646124|Naproxen|naproxen|mesh-list
44403782|NCT02646124|Diazepam|diazepam|mesh-list
44403783|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403784|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403785|NCT02646124|Analgesics|analgesics|mesh-ancestor
44403786|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
44403787|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403788|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403789|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403790|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403791|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
44403792|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403793|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403794|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403795|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44403955|NCT02639338|Velpatasvir|velpatasvir|mesh-list
44403956|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
44403957|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403958|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
44403959|NCT02639247|Velpatasvir|velpatasvir|mesh-list
44403960|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
44403961|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403962|NCT02639182|Axitinib|axitinib|mesh-list
44403963|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403964|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44403965|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403992|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44403993|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
44403994|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403995|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44403996|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44403997|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403998|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403999|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
44404000|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404001|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44404002|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44404003|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404004|NCT02638012|Hemostatics|hemostatics|mesh-list
44404005|NCT02638012|Coagulants|coagulants|mesh-ancestor
44404006|NCT02637895|Vortioxetine|vortioxetine|mesh-list
44404007|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
44404008|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44404009|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44404010|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43704442|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
44404069|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
44404070|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
44404071|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404072|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404073|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404074|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44404075|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44404076|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404077|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44404078|NCT02635984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44404079|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44404080|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43862647|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
43830988|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44404112|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404113|NCT02635204|Clobetasol|clobetasol|mesh-list
44404114|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404115|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
44404116|NCT02635204|Hormones|hormones|mesh-ancestor
44404117|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404118|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404119|NCT02634801|Methotrexate|methotrexate|mesh-list
44404120|NCT02634801|Ixekizumab|ixekizumab|mesh-list
44404121|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44404122|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
44404123|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44404124|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704496|NCT04862962|Ezetimibe|ezetimibe|mesh-list
44404153|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
44404154|NCT02634580|Ezetimibe|ezetimibe|mesh-list
44404155|NCT02634580|Evolocumab|evolocumab|mesh-list
44404156|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44404157|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44404158|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44404159|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
44404160|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404161|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44404162|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
44404163|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404164|NCT02634346|Olanzapine|olanzapine|mesh-list
44404165|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
44404166|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
44404167|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404168|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404169|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404170|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44404171|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44404285|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404286|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
44404287|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404288|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404289|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404361|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
44404362|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404363|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404364|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44404365|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44404397|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404398|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404399|NCT02628600|Amikacin|amikacin|mesh-list
44404400|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404401|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404402|NCT02627677|Ponatinib|ponatinib|mesh-list
44404403|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404404|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404405|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404406|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404407|NCT02627274|Trastuzumab|trastuzumab|mesh-list
44404408|NCT02627274|Cetuximab|cetuximab|mesh-list
44404445|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44404446|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
44404447|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
44404448|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44404483|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404484|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44404485|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404486|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404488|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
44404489|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404490|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404491|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
44404529|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44404530|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44404531|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404655|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404657|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
44404658|NCT02616783|Lamivudine|lamivudine|mesh-list
44404659|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43614007|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
44404660|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44404661|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404662|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404663|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
44404664|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404665|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44404666|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44404667|NCT02616614|Clindamycin|clindamycin|mesh-list
44404668|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
44404669|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
44404771|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404772|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404773|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
44404774|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44404775|NCT02613871|Ledipasvir|ledipasvir|mesh-list
44404776|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
44404777|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404778|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
44404868|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404869|NCT02611882|Edetic Acid|edetic acid|mesh-list
44404870|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
44404871|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44404909|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404910|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404911|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705059|NCT03612791|Cisplatin|cisplatin|mesh-list
44404948|NCT02609399|Oseltamivir|oseltamivir|mesh-list
44404949|NCT02609399|Peramivir|peramivir|mesh-list
44404950|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
44404951|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405041|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44405043|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44405044|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
44405045|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405046|NCT02605824|Expectorants|expectorants|mesh-ancestor
44405047|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44405048|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44405049|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
44405050|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405051|NCT02605824|Protective Agents|protective agents|mesh-ancestor
44405052|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405053|NCT02605824|Antidotes|antidotes|mesh-ancestor
44405054|NCT02605642|Infliximab|infliximab|mesh-list
44405055|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405056|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405057|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405058|NCT02605174|Lasmiditan|lasmiditan|mesh-list
44405059|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44405060|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
44405283|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405284|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862773|NCT02620761|Fenoldopam|fenoldopam|mesh-list
44405358|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
44405359|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405389|NCT02596971|Vincristine|vincristine|mesh-list
44405390|NCT02596971|Atezolizumab|atezolizumab|mesh-list
44405391|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
44405392|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405393|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
44405394|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405395|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405396|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44405397|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
44405398|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405399|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405400|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44405401|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405402|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44405403|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44405404|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44405405|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705430|NCT05073003|Vaccines|vaccines|mesh-list
44405473|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44405474|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405475|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
44405476|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44405477|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
44405478|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44405479|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44405480|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44405481|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405482|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44405483|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44405484|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44405485|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44405520|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44405521|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
44405522|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405523|NCT02593786|Nivolumab|nivolumab|mesh-list
44405559|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405560|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
44405561|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405562|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405563|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847410|NCT04110301|Antibodies|antibodies|mesh-list
44405599|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405600|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405601|NCT02590003|Paclitaxel|paclitaxel|mesh-list
44405602|NCT02590003|Carboplatin|carboplatin|mesh-list
44405636|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405637|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405638|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44405639|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
44405640|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405667|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
44405668|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405669|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
44405670|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
44405671|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405672|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405673|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405674|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
44405675|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
44405676|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405677|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405678|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
44405679|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
44405680|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
44405681|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405682|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405683|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
44134097|NCT00157066|Vitamin D|vitamin d|mesh-list
44405684|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405685|NCT02587065|Interferons|interferons|mesh-list
44405686|NCT02587065|Interferon-beta|interferon-beta|mesh-list
44405687|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
44405688|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405689|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
44405690|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405723|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405724|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405725|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405726|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
44405727|NCT02585999|Ortho Evra|ortho evra|mesh-list
44405728|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44405729|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405730|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44405731|NCT02585960|Factor VIII|factor viii|mesh-list
44405732|NCT02585960|BAX 855|bax 855|mesh-list
44405733|NCT02585960|Coagulants|coagulants|mesh-ancestor
44405734|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44405768|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405769|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405770|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405771|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405772|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405773|NCT02584504|Atorvastatin|atorvastatin|mesh-list
44405774|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44405775|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44405776|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
44405777|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405778|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44109886|NCT02966665|Fexofenadine|fexofenadine|mesh-list
44109887|NCT02966665|Valsartan|valsartan|mesh-list
44405905|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44405906|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405907|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405908|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405909|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405910|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405911|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
44405912|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405913|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44405914|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405915|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
44405916|NCT02582632|Ritonavir|ritonavir|mesh-list
44405917|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44405918|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44405919|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405920|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705826|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405980|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405981|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405982|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405983|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405984|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
44405985|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405986|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44405987|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405988|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
44405990|NCT02581163|Ribavirin|ribavirin|mesh-list
44405991|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44406022|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44406023|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406025|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406026|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
44406027|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406028|NCT02580058|Doxorubicin|doxorubicin|mesh-list
44406029|NCT02580058|Avelumab|avelumab|mesh-list
44406030|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44406031|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705881|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406068|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
44406069|NCT02579863|Hormones|hormones|mesh-ancestor
44412311|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44406364|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44406365|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44406366|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
44406367|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406368|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44406369|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44406370|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406371|NCT02574845|Diuretics|diuretics|mesh-ancestor
44406372|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
44406441|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44406442|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44406443|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44406444|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406445|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406446|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406447|NCT02573493|Paclitaxel|paclitaxel|mesh-list
44406448|NCT02573493|Cisplatin|cisplatin|mesh-list
44406449|NCT02573493|Cetuximab|cetuximab|mesh-list
44406450|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406451|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406452|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406453|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406454|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406617|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406618|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406619|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44406621|NCT02569242|Docetaxel|docetaxel|mesh-list
44406622|NCT02569242|Nivolumab|nivolumab|mesh-list
44406623|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406624|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406625|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406626|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406627|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406628|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406629|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406630|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44406631|NCT02568683|Vincristine|vincristine|mesh-list
44406632|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406757|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44406888|NCT02562716|Pancrelipase|pancrelipase|mesh-list
44406890|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406891|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406892|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406893|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406894|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406895|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406896|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406897|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
44406898|NCT02562716|Antiviral Agents|antiviral agents|mesh-ancestor
44406899|NCT02562716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406900|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406901|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406902|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
44406903|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406904|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43706609|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407139|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407140|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44407141|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44407142|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44407143|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44407145|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407146|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407147|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44407148|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
44407149|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44407150|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407151|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407152|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
44407153|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407154|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407155|NCT02556203|Analgesics|analgesics|mesh-ancestor
44407156|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
44407157|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407158|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407159|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407160|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44407161|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44407162|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407163|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
44407164|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44407165|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
44407166|NCT02556203|Coagulants|coagulants|mesh-ancestor
44407167|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
44407168|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44407169|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
44407170|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44407171|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407172|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407173|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407174|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
44407175|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
44407269|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44407270|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407271|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
44407272|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44407273|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407274|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407275|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44407276|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44407277|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44407278|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44407279|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44110036|NCT00083902|Thalidomide|thalidomide|mesh-list
44407280|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44407281|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44407282|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44407283|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
44407284|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44407285|NCT02554279|Menotropins|menotropins|mesh-list
44407286|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44407287|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
44407288|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44407289|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407290|NCT02553928|Memantine|memantine|mesh-list
44407291|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44407292|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44407328|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44407329|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44407344|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407346|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407347|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
44407348|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407349|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
44407350|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407351|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407352|NCT02552147|Nicotine|nicotine|mesh-list
44407353|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44407354|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
44407355|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407356|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407357|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44407358|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44407359|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
44407360|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407361|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407362|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
44407363|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407364|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407365|NCT02551991|Leucovorin|leucovorin|mesh-list
44407366|NCT02551991|Fluorouracil|fluorouracil|mesh-list
44407367|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
44407368|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
44407369|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407370|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44407371|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407372|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407373|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
44407374|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407375|NCT02551991|Antidotes|antidotes|mesh-ancestor
44407376|NCT02551991|Protective Agents|protective agents|mesh-ancestor
44407377|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
44407378|NCT02551991|Vitamins|vitamins|mesh-ancestor
44407379|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
44407380|NCT02551874|Metformin|metformin|mesh-list
44407381|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
44407382|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
44407383|NCT02551874|Saxagliptin|saxagliptin|mesh-list
44407384|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407385|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407386|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44065032|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
44407387|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407407|NCT02551159|Cisplatin|cisplatin|mesh-list
44407408|NCT02551159|Carboplatin|carboplatin|mesh-list
44407409|NCT02551159|Fluorouracil|fluorouracil|mesh-list
44407410|NCT02551159|Cetuximab|cetuximab|mesh-list
44407411|NCT02551159|Durvalumab|durvalumab|mesh-list
44407412|NCT02551159|Tremelimumab|tremelimumab|mesh-list
44407413|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44407414|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407415|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
44407416|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407417|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44407418|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407419|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
44407420|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407421|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407422|NCT02551055|Paclitaxel|paclitaxel|mesh-list
44407423|NCT02551055|Docetaxel|docetaxel|mesh-list
44407424|NCT02551055|Serabelisib|serabelisib|mesh-list
44407425|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44407426|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407427|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44407428|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44407429|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44407430|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407431|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407432|NCT02550795|Dexamethasone|dexamethasone|mesh-list
44407433|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
44407434|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407435|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
44407436|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
44407437|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407438|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407439|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407440|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
44407441|NCT02550795|Hormones|hormones|mesh-ancestor
44407442|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407443|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44407444|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407445|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44407475|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
44407476|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407477|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407478|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44407479|NCT02550652|Protective Agents|protective agents|mesh-ancestor
44407480|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407481|NCT02550288|Atorvastatin|atorvastatin|mesh-list
44407482|NCT02550288|Ezetimibe|ezetimibe|mesh-list
44407483|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44407484|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44407485|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
44407486|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407487|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44407488|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44407489|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407519|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44407520|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44407521|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
44407522|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407523|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407524|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407525|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44407526|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407527|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44407528|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
44407529|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
44407530|NCT02548962|Dexamethasone|dexamethasone|mesh-list
44407531|NCT02548962|Pomalidomide|pomalidomide|mesh-list
44407532|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407533|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
44407534|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
44407535|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407536|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407603|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407604|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44407605|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407606|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44407607|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
44407608|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407609|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
44407610|NCT02547454|Hematinics|hematinics|mesh-ancestor
44407611|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44407612|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43707176|NCT02702622|Provitamins|provitamins|mesh-list
44407645|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407646|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44407647|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
44407648|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
44407649|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407650|NCT02546765|Analgesics|analgesics|mesh-ancestor
44407651|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
44407652|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407653|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44407654|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44407655|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44407656|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407746|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407747|NCT02544217|Protective Agents|protective agents|mesh-ancestor
44407748|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407749|NCT02544152|Lubiprostone|lubiprostone|mesh-list
44407750|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44407864|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
44407865|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407866|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407867|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407868|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407869|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44407870|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407871|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407872|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407873|NCT02539368|Infliximab|infliximab|mesh-list
44407874|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407875|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407876|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407877|NCT02538965|Lenalidomide|lenalidomide|mesh-list
44407878|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
44407879|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407880|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44407881|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44407882|NCT02538965|Growth Substances|growth substances|mesh-ancestor
44407883|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44407884|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407885|NCT02538614|Idelalisib|idelalisib|mesh-list
44407886|NCT02538614|BI 836826|bi 836826|mesh-list
44407887|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407888|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407901|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407902|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407903|NCT02536976|Urological Agents|urological agents|mesh-ancestor
44407904|NCT02536846|Olanzapine|olanzapine|mesh-list
44407905|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
44407906|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
44407907|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407908|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407909|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407910|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44407911|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44407912|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44407913|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44407914|NCT02536846|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44407915|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44407916|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44407917|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407918|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407919|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
44407920|NCT02536833|Lorecivivint|lorecivivint|mesh-list
44407921|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407922|NCT02536664|Rituximab|rituximab|mesh-list
44407923|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407924|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407925|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
44407926|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407927|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407928|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
44407929|NCT02536313|Velpatasvir|velpatasvir|mesh-list
44407930|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
44407931|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407932|NCT02535715|Insulin|insulin|mesh-list
44407933|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44407934|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407935|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407936|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
44407937|NCT02535416|Promethazine|promethazine|mesh-list
44407938|NCT02535416|Cetirizine|cetirizine|mesh-list
44407939|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44407940|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44407941|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44407942|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407943|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44407944|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
44407945|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
44407946|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407947|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
44407948|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
44407949|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407950|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44407951|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
44407952|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
44407953|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407974|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407975|NCT02534883|Misoprostol|misoprostol|mesh-list
44407976|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44407977|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
44407978|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44407979|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407980|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44407981|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407982|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
44407983|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
44407984|NCT02533674|Gemcitabine|gemcitabine|mesh-list
44407985|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44407986|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
44407987|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407988|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407989|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
44407990|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407991|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407992|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407993|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
44407994|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407995|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44407996|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44407997|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407998|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407999|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
44408000|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408001|NCT02533453|Exenatide|exenatide|mesh-list
44408002|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408003|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408004|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44408005|NCT02533453|Incretins|incretins|mesh-ancestor
44408040|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408042|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44408043|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44408044|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44408045|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44408073|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
44408074|NCT02531633|Hormones|hormones|mesh-ancestor
44408075|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408076|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408077|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408078|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408079|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
44408080|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
44408081|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44408082|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408083|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44408084|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44408085|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408086|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408087|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408088|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44408089|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
44408090|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408091|NCT02531113|Ozanimod|ozanimod|mesh-list
44408092|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44408093|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408094|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408263|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44408264|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44408265|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408266|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44408267|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44110348|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
44408268|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
44408269|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44408270|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408271|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44408272|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
44408273|NCT02524145|Protective Agents|protective agents|mesh-ancestor
44408274|NCT02523599|Bupivacaine|bupivacaine|mesh-list
44408275|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
44408276|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
44408277|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408278|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408311|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44408312|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408313|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408314|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44408315|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44408316|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44408317|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44408318|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44408319|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
44408320|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
44408321|NCT02522325|Cocaine|cocaine|mesh-list
44408567|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408568|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
44408569|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408570|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408571|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408572|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
44408573|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408574|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408575|NCT02516202|Estradiol|estradiol|mesh-list
44408576|NCT02516202|Estrogens|estrogens|mesh-ancestor
44408577|NCT02516202|Hormones|hormones|mesh-ancestor
44408578|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408579|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408811|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408812|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408813|NCT02509312|Ketorolac|ketorolac|mesh-list
44408814|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408815|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408816|NCT02509312|Analgesics|analgesics|mesh-ancestor
44408817|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
44408818|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408819|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408820|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408821|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408822|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44408823|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408824|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408825|NCT02509078|Cisatracurium|cisatracurium|mesh-list
43708106|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408889|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408890|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408891|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
44408892|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408893|NCT02505945|Omeprazole|omeprazole|mesh-list
44408894|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44408895|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44408896|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44408897|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408913|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
44408914|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150728|NCT00211315|Anecortave|anecortave|mesh-list
44408915|NCT02504827|Ceftazidime|ceftazidime|mesh-list
44408916|NCT02504827|Avibactam|avibactam|mesh-list
44408917|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44408918|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44408919|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408920|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44408921|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408922|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408923|NCT02504671|Folic Acid|folic acid|mesh-list
44408924|NCT02504671|Hematinics|hematinics|mesh-ancestor
44408925|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
44408926|NCT02504671|Vitamins|vitamins|mesh-ancestor
44408927|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
44408928|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408929|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
44408930|NCT02504541|Testosterone|testosterone|mesh-list
44408931|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
44408932|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
44408933|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44408934|NCT02504541|Androgens|androgens|mesh-ancestor
44408935|NCT02504541|Hormones|hormones|mesh-ancestor
44408936|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408937|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408938|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408939|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408940|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
44408941|NCT02504320|Febuxostat|febuxostat|mesh-list
44408942|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
44408943|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408944|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
44408945|NCT02504294|Hematinics|hematinics|mesh-ancestor
44408946|NCT02504268|Methotrexate|methotrexate|mesh-list
44408947|NCT02504268|Abatacept|abatacept|mesh-list
44408948|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44408949|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
44408950|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44408951|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408952|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44408953|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
44408954|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408955|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408956|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408957|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408958|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44408988|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408989|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
44408990|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44408991|NCT02503540|Aflibercept|aflibercept|mesh-list
44408992|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44408993|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44408994|NCT02503540|Growth Substances|growth substances|mesh-ancestor
44408995|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408996|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
44408997|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408998|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
44408999|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409000|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409001|NCT02503085|Ibuprofen|ibuprofen|mesh-list
44409002|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44409003|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409004|NCT02503085|Analgesics|analgesics|mesh-ancestor
44409041|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44409043|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44409059|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44409060|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409061|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409062|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409063|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409064|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409065|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44409066|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066731|NCT00008021|Paclitaxel|paclitaxel|mesh-list
44409067|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
44409068|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44409069|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44409071|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409072|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409073|NCT02501473|Rituximab|rituximab|mesh-list
44409074|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
44409075|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409076|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409077|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
44409078|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409079|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409080|NCT02501161|Insulin|insulin|mesh-list
44409081|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44409082|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
44409083|NCT02501161|Liraglutide|liraglutide|mesh-list
44409085|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409086|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409087|NCT02501161|Incretins|incretins|mesh-ancestor
44409088|NCT02501161|Hormones|hormones|mesh-ancestor
44409089|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409090|NCT02500979|Insulin|insulin|mesh-list
44409091|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44409092|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
44409093|NCT02500979|Pramlintide|pramlintide|mesh-list
44409094|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44409095|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409096|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409097|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
44409098|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44409099|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44409100|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409101|NCT02500901|Niraparib|niraparib|mesh-list
44409102|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44409103|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863354|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409104|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708284|NCT05059860|Insulin|insulin|mesh-list
44409310|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409343|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409344|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409345|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44409346|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44409347|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409348|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44409349|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44409350|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409410|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409411|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409589|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409591|NCT02492984|Coagulants|coagulants|mesh-ancestor
44409592|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
44409593|NCT02492841|Calcium|calcium|mesh-list
43708686|NCT04315350|Prednisolone|prednisolone|mesh-list
44409692|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44409693|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409694|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409695|NCT02489500|Bortezomib|bortezomib|mesh-list
44409696|NCT02489500|Melphalan|melphalan|mesh-list
44409697|NCT02489500|Lenograstim|lenograstim|mesh-list
44409698|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409699|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44409700|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
44412316|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44409774|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409775|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409777|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44409778|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44409779|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409780|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409781|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409782|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
44409783|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44409784|NCT02487030|Ledipasvir|ledipasvir|mesh-list
44409785|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
44409786|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409787|NCT02486952|Prednisone|prednisone|mesh-list
44409788|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
44409789|NCT02486952|Rituximab|rituximab|mesh-list
44409790|NCT02486952|Vincristine|vincristine|mesh-list
44409791|NCT02486952|Doxorubicin|doxorubicin|mesh-list
44409792|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44409793|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409794|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
44409795|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409796|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409797|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44409798|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
44409799|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409800|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409801|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44409802|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863429|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409854|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44409855|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409856|NCT02486406|Ritonavir|ritonavir|mesh-list
44409857|NCT02486406|Ribavirin|ribavirin|mesh-list
44409858|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44409859|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44409860|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409861|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409862|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409863|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44409864|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44409865|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
44409866|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409867|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44409868|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409869|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
44409870|NCT02486302|Etanercept|etanercept|mesh-list
44409871|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44409872|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409873|NCT02486302|Analgesics|analgesics|mesh-ancestor
44409874|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
44409875|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409876|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409877|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409878|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409879|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409880|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409881|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
44409882|NCT02485691|Prednisone|prednisone|mesh-list
44409883|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
44409884|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409885|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
44409886|NCT02485691|Hormones|hormones|mesh-ancestor
44409887|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409888|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409889|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708841|NCT03838263|Nivolumab|nivolumab|mesh-list
44409956|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44409957|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44409958|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44409959|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
44409960|NCT04306367|Olaparib|olaparib|mesh-list
44409961|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409962|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412317|NCT02422186|Sertraline|sertraline|mesh-list
44410033|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
44410034|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410035|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410036|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
44410037|NCT02482298|Ticagrelor|ticagrelor|mesh-list
44410038|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44410039|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44410040|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44410041|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44410042|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
44410043|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410044|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410045|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410046|NCT02482129|Dexamethasone|dexamethasone|mesh-list
44410047|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44410048|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44410049|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410050|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
44410051|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
44410052|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410053|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410054|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410055|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
44410056|NCT02482129|Hormones|hormones|mesh-ancestor
44410057|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410058|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44410059|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410060|NCT02481947|Laxatives|laxatives|mesh-list
44410061|NCT02481947|Lubiprostone|lubiprostone|mesh-list
44410062|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44110629|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
44410063|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410064|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410065|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410066|NCT02481934|Lenalidomide|lenalidomide|mesh-list
44410067|NCT02481934|Bortezomib|bortezomib|mesh-list
44410068|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
44410069|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410070|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44410071|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44410072|NCT02481934|Growth Substances|growth substances|mesh-ancestor
44410073|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44410074|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410075|NCT02481830|Nivolumab|nivolumab|mesh-list
44410076|NCT02481830|Topotecan|topotecan|mesh-list
44410102|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44410104|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
44410105|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44410106|NCT02481310|Glycine|glycine|mesh-list
44410107|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44410108|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
44410109|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410110|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410111|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44410112|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
44410113|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410114|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410115|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44410116|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44410117|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44410118|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44410119|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410120|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410121|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
44410122|NCT02481310|Hormones|hormones|mesh-ancestor
44410123|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410124|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44410125|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44410126|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
44410127|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44410128|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709094|NCT02364713|Topotecan|topotecan|mesh-list
44410160|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410162|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410163|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410164|NCT02480114|Acetaminophen|acetaminophen|mesh-list
44410165|NCT02480114|Ibuprofen|ibuprofen|mesh-list
44410166|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44410167|NCT02480114|Fentanyl|fentanyl|mesh-list
44410168|NCT02480114|Oxycodone|oxycodone|mesh-list
44410169|NCT02480114|Hydrocodone|hydrocodone|mesh-list
44410170|NCT02480114|Gabapentin|gabapentin|mesh-list
44410171|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44410172|NCT02480114|Narcotics|narcotics|mesh-ancestor
44410173|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410174|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410225|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410226|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410227|NCT02479230|Gemcitabine|gemcitabine|mesh-list
44410228|NCT02479230|Vaccines|vaccines|mesh-list
44410229|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
44410230|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410231|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44410232|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
43863556|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44410233|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410234|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410235|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
44410236|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410237|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410238|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44410239|NCT02478463|Cabotegravir|cabotegravir|mesh-list
44410240|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44410241|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44410242|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410243|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110705|NCT00085579|Sargramostim|sargramostim|mesh-list
44410244|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410245|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410246|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
44410247|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410248|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
44410249|NCT02478398|Loratadine|loratadine|mesh-list
44410250|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44410251|NCT02478398|Epinephrine|epinephrine|mesh-list
44410252|NCT02478398|Albuterol|albuterol|mesh-list
44410253|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44410254|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44410255|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
44410256|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410257|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410258|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410259|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44410260|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44410261|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
44410262|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410263|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44410264|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
44410265|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
44410288|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
44410289|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410290|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410291|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
44410292|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410293|NCT02478164|Ponatinib|ponatinib|mesh-list
44410294|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410295|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410296|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410297|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410298|NCT02477839|Lacosamide|lacosamide|mesh-list
44410299|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
44410300|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44410301|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44410302|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410303|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410304|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44410305|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410306|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410307|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
44410308|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410310|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44410311|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44410312|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
44410313|NCT02477215|Dexamethasone|dexamethasone|mesh-list
44410314|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44410315|NCT02477215|Ixazomib|ixazomib|mesh-list
44410316|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410317|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
44410318|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
44410319|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410350|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
44410351|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410352|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44410353|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44410354|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
44410355|NCT02476422|Ibuprofen|ibuprofen|mesh-list
44410356|NCT02476422|Diclofenac|diclofenac|mesh-list
44410357|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44410358|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410359|NCT02476422|Analgesics|analgesics|mesh-ancestor
44410360|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
43709230|NCT01672255|Fluoxetine|fluoxetine|mesh-list
44410498|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44410499|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410501|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410502|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410503|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44410504|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410505|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
44410506|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44110780|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410507|NCT02472886|Ledipasvir|ledipasvir|mesh-list
44410508|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
44410774|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410775|NCT02463331|Amebicides|amebicides|mesh-ancestor
44410776|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44410777|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44410778|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410779|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
44410780|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410781|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44410782|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410783|NCT02463331|Analgesics|analgesics|mesh-ancestor
44410784|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
44410785|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410786|NCT02463331|Filaricides|filaricides|mesh-ancestor
43709510|NCT05368181|Hormones|hormones|mesh-ancestor
44410816|NCT02462473|Aripiprazole|aripiprazole|mesh-list
44410817|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44410818|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44410819|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44410820|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
44410821|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410822|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410823|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410824|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44410825|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44410826|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410827|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410828|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44410829|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
44410830|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
44410831|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
44410832|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410833|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410834|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44410985|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410986|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410987|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
44410988|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410989|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
44410990|NCT02457247|Antacids|antacids|mesh-ancestor
44410991|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410992|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410993|NCT02457195|Granisetron|granisetron|mesh-list
44410994|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
44410995|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
44410996|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410997|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410998|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410999|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44411036|NCT02455557|Sargramostim|sargramostim|mesh-list
44411061|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411062|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411063|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44411064|NCT02455518|Narcotics|narcotics|mesh-ancestor
44411065|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411066|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
44411067|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411068|NCT02455336|Fenofibrate|fenofibrate|mesh-list
44411069|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44411070|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
44411071|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411072|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44411073|NCT02455076|Exenatide|exenatide|mesh-list
44411074|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
44411075|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411076|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411077|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44411078|NCT02455076|Incretins|incretins|mesh-ancestor
44411079|NCT02455076|Hormones|hormones|mesh-ancestor
44411080|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411081|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44411082|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44411083|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44411085|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44411086|NCT02454608|Verapamil|verapamil|mesh-list
44411087|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44411215|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
44411216|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411266|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
44411267|NCT02450552|Ezogabine|ezogabine|mesh-list
44411268|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
44411269|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411270|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411271|NCT02450539|Docetaxel|docetaxel|mesh-list
44411272|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411273|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
44411274|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
44411275|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44411276|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411277|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
44411278|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44411279|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43831585|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411353|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44411354|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44411355|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
44411356|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411357|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411358|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
44411359|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411360|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411361|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411362|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
44411363|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411364|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44411365|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44411366|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44411367|NCT02448446|Ranibizumab|ranibizumab|mesh-list
44411368|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44411369|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44411370|NCT02448446|Growth Substances|growth substances|mesh-ancestor
44411371|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411372|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44411373|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411374|NCT02448381|Hypericin|hypericin|mesh-list
44411375|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
44411376|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44411528|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411529|NCT02445339|Naltrexone|naltrexone|mesh-list
44411530|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44411531|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44411532|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411533|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
44411534|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411535|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
44411536|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411537|NCT02444533|Bupivacaine|bupivacaine|mesh-list
44411562|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411563|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411564|NCT02443155|Liraglutide|liraglutide|mesh-list
44411565|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411566|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411567|NCT02443155|Incretins|incretins|mesh-ancestor
44411568|NCT02443155|Hormones|hormones|mesh-ancestor
44411569|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411570|NCT02443103|Guanabenz|guanabenz|mesh-list
44411571|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44411572|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44411574|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411575|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411576|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411577|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411578|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411579|NCT02442349|Osimertinib|osimertinib|mesh-list
44411580|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411581|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411582|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411583|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411584|NCT02442310|Deferiprone|deferiprone|mesh-list
44411585|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44411586|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
44411587|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
44411588|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411589|NCT02442284|Ritonavir|ritonavir|mesh-list
44411950|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710261|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
44411959|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411960|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411962|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411963|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44411964|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44411965|NCT02432846|Growth Substances|growth substances|mesh-ancestor
44411966|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411967|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
44411968|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411969|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411970|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411971|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
44411972|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411973|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411974|NCT02432040|Atorvastatin|atorvastatin|mesh-list
44411975|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44411976|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44411977|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
44411978|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411979|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44411980|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44411981|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411982|NCT02431806|Milnacipran|milnacipran|mesh-list
44411983|NCT02431806|Fluoxetine|fluoxetine|mesh-list
44411984|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
44411985|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44411986|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44411987|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411988|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411989|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411990|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
44411991|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411992|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44411993|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
44411994|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44411995|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44411996|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44411997|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411998|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44411999|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44412000|NCT02431806|Analgesics|analgesics|mesh-ancestor
44412001|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
44412002|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412003|NCT02431676|Metformin|metformin|mesh-list
44412004|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412005|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412006|NCT02431559|Doxorubicin|doxorubicin|mesh-list
44412007|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44412008|NCT02431559|Durvalumab|durvalumab|mesh-list
44412009|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412010|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412011|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412012|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44412013|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412014|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412015|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44412039|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44412040|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44412041|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44412042|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412043|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44412044|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44412045|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44412046|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111006|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412047|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412048|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
44412049|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412050|NCT02430480|Goserelin|goserelin|mesh-list
44412051|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412052|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412053|NCT02430311|Paclitaxel|paclitaxel|mesh-list
44412054|NCT02430311|Olaparib|olaparib|mesh-list
44412055|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412056|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412057|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412058|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412059|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412060|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412061|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44412062|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412063|NCT02429934|Abatacept|abatacept|mesh-list
44412064|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44412065|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412066|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412067|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412077|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412078|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412079|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412080|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44412081|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44412082|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412083|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412084|NCT02429258|Metformin|metformin|mesh-list
44412085|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
44412086|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412087|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412088|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412089|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412090|NCT02428855|Dasatinib|dasatinib|mesh-list
44412091|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412092|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44412093|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412094|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412095|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
44412096|NCT02428699|Liver Extracts|liver extracts|mesh-list
44412097|NCT02428699|Hematinics|hematinics|mesh-ancestor
44412098|NCT02428699|Vitamins|vitamins|mesh-ancestor
44412099|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
44412100|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412101|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44412102|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44412103|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412104|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412105|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44412106|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412107|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412108|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
44412109|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412110|NCT02428296|Sirolimus|sirolimus|mesh-list
44412111|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412112|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412113|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412114|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412115|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
44412116|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412117|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
44412118|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412119|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44412120|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412121|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412122|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
44412123|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412124|NCT02427958|Leuprolide|leuprolide|mesh-list
44412125|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44412126|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
44412127|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43614008|NCT04540692|Paclitaxel|paclitaxel|mesh-list
44236446|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111096|NCT00087048|Topotecan|topotecan|mesh-list
44412128|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412129|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412130|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412131|NCT02427841|Gemcitabine|gemcitabine|mesh-list
44412132|NCT02427841|Paclitaxel|paclitaxel|mesh-list
44412133|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44412220|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44412221|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44412222|NCT02425826|Growth Substances|growth substances|mesh-ancestor
44412223|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44412224|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412225|NCT02425111|Vedolizumab|vedolizumab|mesh-list
44412226|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412227|NCT02425098|Vaccines|vaccines|mesh-list
44412228|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
44412229|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412230|NCT02424734|Ampicillin|ampicillin|mesh-list
44412231|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44412232|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412233|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412234|NCT02424630|Ropivacaine|ropivacaine|mesh-list
44412235|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
44412236|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
44412237|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412238|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412332|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
44412333|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
44412334|NCT02421887|Antioxidants|antioxidants|mesh-list
44412335|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412336|NCT02421887|Protective Agents|protective agents|mesh-ancestor
44412337|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412338|NCT02421588|Doxorubicin|doxorubicin|mesh-list
44412339|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44412341|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412342|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412343|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412344|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44412345|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412346|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412347|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44412348|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43863955|NCT02403986|Lidocaine|lidocaine|mesh-list
44412349|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412350|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412351|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412352|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412353|NCT02421419|Dexamethasone|dexamethasone|mesh-list
44412354|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
44412355|NCT02421419|Lidocaine|lidocaine|mesh-list
44412356|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44412357|NCT02421419|BB 1101|bb 1101|mesh-list
44412358|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412359|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
44412360|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
44412361|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412362|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412363|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412364|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
44412365|NCT02421419|Hormones|hormones|mesh-ancestor
44412366|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412367|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412368|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412369|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
44412370|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
44412371|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412372|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
44412373|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44412374|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44412375|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44412376|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614009|NCT04540692|Docetaxel|docetaxel|mesh-list
44236447|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44236448|NCT00559429|Analgesics|analgesics|mesh-ancestor
44412377|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412378|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412379|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412381|NCT02421120|Ceftolozane|ceftolozane|mesh-list
44412382|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44412383|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43644227|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412416|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412418|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44412419|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412420|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
44412421|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
44412422|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412423|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412424|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
44412425|NCT02420717|Hormones|hormones|mesh-ancestor
44412426|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412427|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412428|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412429|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412430|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412431|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412460|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44412461|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
44412462|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412463|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412464|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44412465|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412466|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44412467|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
44412469|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44412470|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
44412471|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
44412472|NCT02420262|Liraglutide|liraglutide|mesh-list
44412473|NCT02420262|Xultophy|xultophy|mesh-list
44412474|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412475|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412476|NCT02420262|Incretins|incretins|mesh-ancestor
44412477|NCT02420262|Hormones|hormones|mesh-ancestor
44412478|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412479|NCT02420223|Propranolol|propranolol|mesh-list
44412480|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44412500|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412501|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
44412502|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
44412503|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412504|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412505|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412506|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
44412508|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412509|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412510|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412511|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412512|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412513|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44412514|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412515|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412516|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44412517|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
44412518|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412519|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412520|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
44412521|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412522|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44412523|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412524|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
44412525|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412526|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44412527|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
44412528|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412529|NCT02419755|Analgesics|analgesics|mesh-ancestor
44412530|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
44412531|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44412532|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
44412533|NCT02419612|Glimepiride|glimepiride|mesh-list
44412534|NCT02419612|Saxagliptin|saxagliptin|mesh-list
44412535|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412536|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412537|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412538|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644328|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
44412575|NCT02419469|Daunorubicin|daunorubicin|mesh-list
44412576|NCT02419469|Asparaginase|asparaginase|mesh-list
44412577|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
44412579|NCT02419469|Pegaspargase|pegaspargase|mesh-list
44412580|NCT02419469|Thioguanine|thioguanine|mesh-list
44412581|NCT02419469|BB 1101|bb 1101|mesh-list
44412582|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412593|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
44412594|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
44412595|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412596|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412597|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
44412598|NCT02419469|Hormones|hormones|mesh-ancestor
44412599|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412600|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412601|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412602|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412603|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44412604|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412605|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44412606|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
44412607|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412608|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412609|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
44412610|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412611|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44412612|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44412613|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
44412614|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412615|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412616|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412617|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412618|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412619|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412620|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44412621|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44412622|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412623|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412624|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44412625|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412626|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412627|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
44412628|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412629|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
44412630|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
44412631|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412632|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412633|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44412634|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
44412635|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
44412636|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412637|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412638|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412639|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44412640|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
44412641|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44412642|NCT02418754|Aflibercept|aflibercept|mesh-list
44412643|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44412644|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44412652|NCT02418585|Sertraline|sertraline|mesh-list
44412653|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
44412654|NCT02418585|Esketamine|esketamine|mesh-list
44412655|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44412656|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44412657|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426855|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44236449|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
44412658|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412659|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412660|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
44412661|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412662|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44412663|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44412664|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412665|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44412666|NCT02418585|Analgesics|analgesics|mesh-ancestor
44412667|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
44412668|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
44412669|NCT02418182|Acetaminophen|acetaminophen|mesh-list
44412670|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44412671|NCT02418182|Analgesics|analgesics|mesh-ancestor
44412672|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
44412673|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412674|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412675|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
44412676|NCT02417961|Benralizumab|benralizumab|mesh-list
44412677|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44412678|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44412679|NCT02417935|Pregabalin|pregabalin|mesh-list
44412680|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44412681|NCT02417935|Analgesics|analgesics|mesh-ancestor
44412682|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
44412683|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412684|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412685|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
44412686|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44412687|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412688|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412689|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44412690|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44412691|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44412692|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412693|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44412694|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44412695|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44412696|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412697|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
44412699|NCT02417246|Metoprolol|metoprolol|mesh-list
44412700|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44412701|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44412702|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
44412703|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
44412704|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412705|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412706|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44412707|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44412708|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44412709|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
44412710|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412711|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412712|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44412726|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44412727|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412728|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44412729|NCT02417064|Analgesics|analgesics|mesh-ancestor
44412730|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
44412731|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
44412732|NCT02416934|Dexamethasone|dexamethasone|mesh-list
44412733|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412734|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
44412735|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
44412736|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412737|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412738|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412739|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
44412740|NCT02416934|Hormones|hormones|mesh-ancestor
44412741|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412742|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412743|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412744|NCT02416908|Cytarabine|cytarabine|mesh-list
44412745|NCT02416908|Plerixafor|plerixafor|mesh-list
44412746|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
44412747|NCT02416908|Cladribine|cladribine|mesh-list
44412748|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412749|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
44412750|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412751|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412752|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
44412753|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412754|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412755|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
44412756|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412757|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44412758|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44412759|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44412760|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44412761|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
44070503|NCT00000926|Nonoxynol|nonoxynol|mesh-list
44412762|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412763|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412764|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44412765|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44412766|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
44412767|NCT02416180|Hormones|hormones|mesh-ancestor
44412768|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412769|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
44412770|NCT02415959|Pancrelipase|pancrelipase|mesh-list
44412771|NCT02415959|Pancreatin|pancreatin|mesh-list
44412772|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412773|NCT02415595|BMS-955176|bms-955176|mesh-list
44412774|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44412803|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
44412804|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44412805|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412806|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
44412807|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44412808|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
44412809|NCT02415400|Coagulants|coagulants|mesh-ancestor
44412810|NCT02415127|Interferons|interferons|mesh-list
44412811|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
44412812|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412813|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
44412814|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412815|NCT02414958|Empagliflozin|empagliflozin|mesh-list
44412816|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412817|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412818|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412819|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412820|NCT02414932|Midazolam|midazolam|mesh-list
44412821|NCT02414932|Ketamine|ketamine|mesh-list
44412822|NCT02414932|Analgesics|analgesics|mesh-ancestor
44412823|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
44412824|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412832|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44412833|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412834|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412835|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44412836|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44412837|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44412838|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44412839|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44412840|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
44412841|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
44412842|NCT02414854|Albuterol|albuterol|mesh-list
44412843|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44412844|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
44412845|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412846|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412847|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44412848|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
44412849|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
44412850|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412851|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44412852|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44412853|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44412854|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
44412855|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412856|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412857|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44412858|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412859|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
44412860|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44412861|NCT02413593|Ledipasvir|ledipasvir|mesh-list
44412862|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
44412863|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412864|NCT02413489|Daratumumab|daratumumab|mesh-list
44412865|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412866|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
44412867|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412868|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412869|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412870|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412871|NCT02413346|Sarecycline|sarecycline|mesh-list
44412872|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412873|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412874|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412875|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
44412876|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44412877|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
44412878|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412879|NCT02412878|Dexamethasone|dexamethasone|mesh-list
43864287|NCT02344472|Trastuzumab|trastuzumab|mesh-list
44412880|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412881|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
44412882|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
44412883|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412884|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412885|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412886|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
44412887|NCT02412878|Hormones|hormones|mesh-ancestor
44412888|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412889|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412890|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412891|NCT02412761|Amlodipine|amlodipine|mesh-list
44412892|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44412901|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44412902|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412903|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412904|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
44412905|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
44412906|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412907|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44412908|NCT02412761|Protective Agents|protective agents|mesh-ancestor
44412909|NCT02412722|Paclitaxel|paclitaxel|mesh-list
44412910|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412911|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412912|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412913|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412914|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412915|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412917|NCT02412670|Cisplatin|cisplatin|mesh-list
44412918|NCT02412670|Carboplatin|carboplatin|mesh-list
44412919|NCT02412670|Doxorubicin|doxorubicin|mesh-list
44412920|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44412921|NCT02412670|Methotrexate|methotrexate|mesh-list
44412922|NCT02412670|Vinblastine|vinblastine|mesh-list
44412923|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412924|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412925|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
44412926|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412927|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
44412928|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412929|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412930|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412931|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
44412932|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412933|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44412934|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44412935|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44412936|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44412937|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
44412938|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44111477|NCT00088270|Antidotes|antidotes|mesh-ancestor
44412939|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412940|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44412941|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412942|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44412943|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412944|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412945|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412946|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412947|NCT02412657|Dexamethasone|dexamethasone|mesh-list
44412948|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412949|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
44412950|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
44412951|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412952|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412953|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412954|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
44412955|NCT02412657|Hormones|hormones|mesh-ancestor
44412956|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412957|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412958|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412959|NCT02412631|Varenicline|varenicline|mesh-list
44412960|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44412980|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44412981|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44412982|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
44412983|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412984|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
44412985|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44412986|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44412987|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44412988|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
44412989|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44412990|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44412991|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44412992|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
44412993|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412994|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412995|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44412996|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44412997|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44412998|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44412999|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413000|NCT02412371|Paclitaxel|paclitaxel|mesh-list
44413001|NCT02412371|Carboplatin|carboplatin|mesh-list
44413002|NCT02412371|Veliparib|veliparib|mesh-list
44413003|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44413004|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413005|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413006|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413007|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413008|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413009|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44413010|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413011|NCT02412111|Ivacaftor|ivacaftor|mesh-list
44413012|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44413013|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413026|NCT02411448|Gefitinib|gefitinib|mesh-list
44413027|NCT02411448|Osimertinib|osimertinib|mesh-list
44413028|NCT02411448|Ramucirumab|ramucirumab|mesh-list
44413029|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413030|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44413031|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413032|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413033|NCT02411292|Enoxaparin|enoxaparin|mesh-list
44413034|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
44413035|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44413036|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44413037|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413038|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44413039|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
44413040|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
44426856|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44111555|NCT00088582|Hormones|hormones|mesh-ancestor
44413041|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413042|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
44413043|NCT02410772|Rifapentine|rifapentine|mesh-list
44413044|NCT02410772|Rifampin|rifampin|mesh-list
44413045|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44413046|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413047|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44413048|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44413049|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413050|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413051|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413052|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44413053|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
44413054|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
44413055|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413056|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44413057|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44413058|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44413059|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44413060|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44413061|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44413063|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44413064|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44413065|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44413066|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413067|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413068|NCT02460224|Spartalizumab|spartalizumab|mesh-list
44413069|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44413070|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413071|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413072|NCT02410551|Fludarabine|fludarabine|mesh-list
44413073|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
44413074|NCT02410551|Busulfan|busulfan|mesh-list
44413091|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413092|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413093|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44413094|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44413095|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413096|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413097|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413098|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
44413099|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44413100|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413101|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413102|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
44413103|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413104|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44413105|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44413106|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413107|NCT02409680|Aspirin|aspirin|mesh-list
44413108|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44413109|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413110|NCT02409680|Analgesics|analgesics|mesh-ancestor
44413111|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
44413112|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413113|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413114|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413115|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413116|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44413117|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44413118|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413119|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44413120|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44413121|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413122|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
44413123|NCT02409368|Nivolumab|nivolumab|mesh-list
44413124|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413125|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413126|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44413127|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44236450|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413128|NCT02409355|Gemcitabine|gemcitabine|mesh-list
44413129|NCT02409355|Cisplatin|cisplatin|mesh-list
44413130|NCT02409355|Carboplatin|carboplatin|mesh-list
44413131|NCT02409355|Atezolizumab|atezolizumab|mesh-list
44413148|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413149|NCT02408120|Insulin|insulin|mesh-list
44413150|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44413151|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
44413152|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
44413153|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
44413154|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44413155|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44413156|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413157|NCT02408068|Dexamethasone|dexamethasone|mesh-list
44413158|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
44413159|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44413160|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43864504|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413161|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44413162|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413163|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
44413164|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
44413165|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413166|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413167|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413168|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
44413169|NCT02408068|Hormones|hormones|mesh-ancestor
44413170|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413171|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413172|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413173|NCT02408016|Aldesleukin|aldesleukin|mesh-list
44413174|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
44413175|NCT02408016|Interleukin-2|interleukin-2|mesh-list
44413176|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413177|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
44413178|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413179|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413180|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44413181|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
44413182|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413183|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413184|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44413185|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413186|NCT02408016|Analgesics|analgesics|mesh-ancestor
44413187|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
44413188|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413189|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413216|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413217|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
44413218|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413219|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413220|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44413221|NCT02406586|Carvedilol|carvedilol|mesh-list
44413222|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44413223|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44413224|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44413225|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44413226|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413227|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413228|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413229|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44413230|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
44413231|NCT02406586|Protective Agents|protective agents|mesh-ancestor
44413232|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44413233|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413234|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44413235|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
44413236|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44413267|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
44413268|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44413269|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44413270|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413271|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44070979|NCT00001032|Zidovudine|zidovudine|mesh-list
44413273|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
44413274|NCT02406248|Ticagrelor|ticagrelor|mesh-list
44413275|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44413276|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44413277|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44413278|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44413279|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
44413280|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413281|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413292|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413293|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413294|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
44413295|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413296|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44413297|NCT02404493|Decanoic acid|decanoic acid|mesh-list
44413298|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
44413299|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413300|NCT02404441|Spartalizumab|spartalizumab|mesh-list
44413301|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44413302|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413303|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413304|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44413305|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44413306|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
44413307|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413308|NCT02404220|Dexamethasone|dexamethasone|mesh-list
44413309|NCT02404220|Vincristine|vincristine|mesh-list
44413310|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413311|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
44413312|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
44413313|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413314|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413315|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413316|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
44413317|NCT02404220|Hormones|hormones|mesh-ancestor
44413318|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413319|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413320|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413321|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44413322|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413323|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413324|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413325|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413326|NCT02404103|Flunisolide|flunisolide|mesh-list
44413327|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413328|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413329|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413330|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
44413331|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
44413332|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413333|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413334|NCT02403674|Tenofovir|tenofovir|mesh-list
44413335|NCT02403674|Lamivudine|lamivudine|mesh-list
44413336|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44413337|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
44413338|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413339|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44413340|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413341|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413342|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413343|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413344|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413345|NCT02403635|Midazolam|midazolam|mesh-list
44071067|NCT00001045|Zidovudine|zidovudine|mesh-list
44413346|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413364|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44413365|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413366|NCT02402933|Hormones|hormones|mesh-ancestor
44413367|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413368|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413369|NCT02402933|Incretins|incretins|mesh-ancestor
44413370|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
44413371|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44413372|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44413373|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153873|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413374|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
44413375|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413376|NCT02401529|Acetaminophen|acetaminophen|mesh-list
44413377|NCT02401529|Dexamethasone|dexamethasone|mesh-list
44413378|NCT02401529|Prednisolone|prednisolone|mesh-list
44413379|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413380|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
44413381|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
44413382|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413383|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413384|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413385|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
44413386|NCT02401529|Hormones|hormones|mesh-ancestor
44413387|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413388|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413389|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413390|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413391|NCT02401529|Analgesics|analgesics|mesh-ancestor
44413392|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
44413393|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
44413394|NCT02401256|Efavirenz|efavirenz|mesh-list
44413395|NCT02401256|Bupropion|bupropion|mesh-list
44413396|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44413397|NCT02401256|Montelukast|montelukast|mesh-list
44413398|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44413399|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44413400|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
44413401|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413402|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44413403|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44413404|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413405|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44413406|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
44413407|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413433|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44413435|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413436|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44413437|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413438|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413439|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413440|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413441|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413442|NCT02400749|Apremilast|apremilast|mesh-list
44413443|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44413444|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413445|NCT02400749|Analgesics|analgesics|mesh-ancestor
44413446|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
44413447|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413448|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413449|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413450|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413451|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44413457|NCT02400580|Analgesics|analgesics|mesh-ancestor
44413458|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
44413459|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413460|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413461|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
44413462|NCT02400476|Budesonide|budesonide|mesh-list
44413463|NCT02400476|Loperamide|loperamide|mesh-list
44413464|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
44413465|NCT02400476|Colestipol|colestipol|mesh-list
44413466|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413467|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44413468|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
44413469|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413470|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413471|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413472|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413473|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
44413474|NCT02400476|Hormones|hormones|mesh-ancestor
44413475|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413476|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413477|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44413478|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
44236451|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413479|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413480|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44413481|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
44413482|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
44413483|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
44413484|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413485|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413486|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413487|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
44413488|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
44413489|NCT02400333|Ticagrelor|ticagrelor|mesh-list
44413490|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44413491|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44413492|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44413493|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44413494|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
44413495|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413496|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413497|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413499|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
44413500|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413501|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413502|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
44413503|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
44413504|NCT02399449|Hematinics|hematinics|mesh-ancestor
44413505|NCT02399163|Fluorides|fluorides|mesh-list
44413506|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
44413507|NCT02399163|Protective Agents|protective agents|mesh-ancestor
44413508|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413509|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44413510|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44413511|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
44413512|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413513|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413514|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413515|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413516|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44413517|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44413518|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44413519|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
44413520|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413521|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413558|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413560|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413575|NCT02397096|Cobicistat|cobicistat|mesh-list
44413576|NCT02397096|Elvitegravir|elvitegravir|mesh-list
44413577|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44413578|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
44413579|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44413580|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413581|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413582|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413583|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413584|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
44413585|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413586|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44413587|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44413588|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413589|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44413590|NCT02396953|Lanreotide|lanreotide|mesh-list
44413591|NCT02396953|Somatostatin|somatostatin|mesh-list
44413592|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413593|NCT02396953|Hormones|hormones|mesh-ancestor
44413594|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413595|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413596|NCT02396758|Plasminogen|plasminogen|mesh-list
44413597|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44413598|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44413599|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44413600|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111857|NCT00089518|Valsartan|valsartan|mesh-list
44413601|NCT02396537|Lidocaine|lidocaine|mesh-list
44413602|NCT02396537|Midazolam|midazolam|mesh-list
44413603|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
44413604|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
44413605|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413606|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413607|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
44413608|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413609|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44413610|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44413611|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44413612|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413613|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413614|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413615|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44413616|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413617|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413618|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413619|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44413620|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
44413621|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
44413622|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
44413623|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413624|NCT02396316|Aflibercept|aflibercept|mesh-list
44413625|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44413651|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413652|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413653|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44413654|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44413655|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44413656|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44413657|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413658|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413659|NCT02395172|Docetaxel|docetaxel|mesh-list
44413660|NCT02395172|Avelumab|avelumab|mesh-list
44413661|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413662|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413663|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413664|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413665|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413666|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413667|NCT02395081|Vitamin D|vitamin d|mesh-list
44413668|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
44413669|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
44413670|NCT02395081|Vitamins|vitamins|mesh-list
44413671|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
44413672|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413673|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44413674|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44413675|NCT02395055|Adalimumab|adalimumab|mesh-list
44413685|NCT02394340|Luliconazole|luliconazole|mesh-list
44413687|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44413688|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413689|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44413690|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413691|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413692|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
44413693|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413694|NCT02394028|Etrolizumab|etrolizumab|mesh-list
44413695|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413696|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
44413697|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413698|NCT02393755|Capecitabine|capecitabine|mesh-list
44413699|NCT02393755|Nintedanib|nintedanib|mesh-list
44413700|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44413701|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
44413702|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413703|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413704|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44413705|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413706|NCT02393547|Varenicline|varenicline|mesh-list
44413707|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44413708|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44413709|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
44413710|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864847|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413711|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413712|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413714|NCT02393209|Serabelisib|serabelisib|mesh-list
44413715|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413716|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413717|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413718|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413719|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413720|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413721|NCT02392624|Omalizumab|omalizumab|mesh-list
44413722|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44413723|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413724|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413725|NCT02392611|Fulvestrant|fulvestrant|mesh-list
44413726|NCT02392611|Exemestane|exemestane|mesh-list
44413727|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44413728|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413729|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44413730|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44413731|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
44413732|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413733|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413734|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44413735|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44413736|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413737|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413738|NCT02392507|Paclitaxel|paclitaxel|mesh-list
44413739|NCT02392507|Carboplatin|carboplatin|mesh-list
44413740|NCT02392507|Necitumumab|necitumumab|mesh-list
44413741|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44413756|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413757|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413758|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413759|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413760|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413761|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44413762|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413763|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
44413764|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44413765|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413766|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
44413768|NCT02392377|Protective Agents|protective agents|mesh-ancestor
44413769|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
44413770|NCT02392377|Vitamins|vitamins|mesh-ancestor
44413771|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
44413772|NCT02392234|Ivacaftor|ivacaftor|mesh-list
44413773|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44413774|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413775|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413776|NCT02392104|Warfarin|warfarin|mesh-list
44413777|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
44413778|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
44413779|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44413780|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413781|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413782|NCT02391545|Rituximab|rituximab|mesh-list
44413783|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
44413784|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413785|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413786|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
44413787|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413788|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413789|NCT02391337|Digoxin|digoxin|mesh-list
44413790|NCT02391337|Bisoprolol|bisoprolol|mesh-list
44413791|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44413792|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44413793|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413794|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413795|NCT02391337|Protective Agents|protective agents|mesh-ancestor
44413796|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413797|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44413798|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
44413799|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
44236452|NCT00559455|Leucovorin|leucovorin|mesh-list
44236453|NCT00559455|Fluorouracil|fluorouracil|mesh-list
44413800|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413801|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44413802|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44413803|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44413818|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413819|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413820|NCT02390219|Ivacaftor|ivacaftor|mesh-list
44413821|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44413822|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413823|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413824|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
44413825|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413826|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44413827|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44413828|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
44413829|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413830|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413831|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413832|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413833|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
44413834|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
44413835|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44413836|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44413837|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
44413838|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413839|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413840|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
44413841|NCT02389829|Promethazine|promethazine|mesh-list
44413842|NCT02389829|Hydromorphone|hydromorphone|mesh-list
44413843|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
44413844|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44413845|NCT02389829|Narcotics|narcotics|mesh-ancestor
44413846|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413847|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413848|NCT02389829|Analgesics|analgesics|mesh-ancestor
44413849|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
44413850|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413851|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44413852|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44413853|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
44413854|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
44413855|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
44413856|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
44413857|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413858|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44413859|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
44413860|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
44413861|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413862|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413863|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44413864|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
44413865|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413878|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44413879|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44413880|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413881|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413882|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413883|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
44413884|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44413885|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44413886|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44413887|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44413889|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413890|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44413891|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864975|NCT02159989|Aflibercept|aflibercept|mesh-list
44413892|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413893|NCT02389452|Hylan|hylan|mesh-list
44413894|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
44413895|NCT02389452|Protective Agents|protective agents|mesh-ancestor
44413896|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413897|NCT02388997|Omalizumab|omalizumab|mesh-list
44413898|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44413899|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413900|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413901|NCT02388737|Lansoprazole|lansoprazole|mesh-list
44413902|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
44413903|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44413904|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413905|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44413906|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413907|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413908|NCT02388724|Lansoprazole|lansoprazole|mesh-list
44413909|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
44413910|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44413911|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413912|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44413913|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413914|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413915|NCT02388191|Naproxen|naproxen|mesh-list
44413916|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44413917|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413918|NCT02388191|Analgesics|analgesics|mesh-ancestor
44413919|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
44413920|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413921|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413922|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413923|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413924|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
44413925|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44413926|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413927|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413928|NCT02388165|Vaccines|vaccines|mesh-list
44413947|NCT02387957|Aflibercept|aflibercept|mesh-list
44413948|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413949|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413950|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44413951|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44413952|NCT02387957|Growth Substances|growth substances|mesh-ancestor
44413953|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413954|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44413955|NCT02387762|Methotrexate|methotrexate|mesh-list
44413956|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
44413957|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44413958|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
44413959|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44413960|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413961|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44413962|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
44413963|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413964|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413965|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
44413966|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413967|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44413968|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413969|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
44413970|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413971|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413972|NCT02387580|Artefenomel|artefenomel|mesh-list
44413973|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
44413974|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44413975|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44413976|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413977|NCT02387372|Tazobactam|tazobactam|mesh-list
44413978|NCT02387372|Ceftolozane|ceftolozane|mesh-list
43865115|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
44413979|NCT02387372|Cephalosporins|cephalosporins|mesh-list
44413980|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44413981|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
44413982|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44413983|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413984|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44414014|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414016|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44414017|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
44414018|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414019|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44414020|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44112161|NCT00091052|Sargramostim|sargramostim|mesh-list
44414021|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44414022|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414023|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44414024|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44414026|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
44414027|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414028|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44414029|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44414030|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414031|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414059|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414060|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414061|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
44414062|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414064|NCT02384850|Protective Agents|protective agents|mesh-ancestor
44414065|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
44414066|NCT02384850|Vitamins|vitamins|mesh-ancestor
44414067|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
44414068|NCT02384850|Hematinics|hematinics|mesh-ancestor
44414069|NCT02384395|Lamivudine|lamivudine|mesh-list
44414070|NCT02384395|Abacavir|abacavir|mesh-list
44414071|NCT02384395|Dolutegravir|dolutegravir|mesh-list
44414072|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44414073|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414074|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414093|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414094|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44414095|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44414096|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414098|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414099|NCT02383758|Bisacodyl|bisacodyl|mesh-list
44414100|NCT02383758|Glycerol|glycerol|mesh-list
44414101|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44414102|NCT02383758|Protective Agents|protective agents|mesh-ancestor
44414103|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414104|NCT02383758|Cathartics|cathartics|mesh-ancestor
44414105|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414106|NCT02383758|Laxatives|laxatives|mesh-ancestor
44414107|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
44414108|NCT02383589|Rituximab|rituximab|mesh-list
44414109|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414110|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414111|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
44414112|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414113|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414114|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44414115|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44414116|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
44414117|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414118|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414119|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414120|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414121|NCT02383433|Gemcitabine|gemcitabine|mesh-list
44414122|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414123|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
44414124|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414125|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414126|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
44414127|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414128|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414129|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414146|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414147|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
44414148|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414149|NCT02382016|Macitentan|macitentan|mesh-list
44414150|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44414151|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44414152|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426857|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
44414153|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44414155|NCT02380742|Prilocaine|prilocaine|mesh-list
44414156|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44414157|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
44414158|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
44414159|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414160|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414161|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
44414162|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414163|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44414164|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44414165|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44414166|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414167|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414168|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44414169|NCT02380287|Antibodies|antibodies|mesh-list
44414170|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44414171|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
44414172|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414173|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44414174|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44414175|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
44414176|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44414177|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
44414178|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414179|NCT02379637|Expectorants|expectorants|mesh-ancestor
44414180|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414181|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44414182|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
44414183|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414184|NCT02379637|Protective Agents|protective agents|mesh-ancestor
44414185|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414186|NCT02379637|Antidotes|antidotes|mesh-ancestor
44414187|NCT02379390|Prednisone|prednisone|mesh-list
44414188|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
44414216|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44414217|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
44414218|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414219|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44414220|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44414221|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
44414222|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44414223|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414225|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
44414226|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44414227|NCT02379091|Leucovorin|leucovorin|mesh-list
44414228|NCT02379091|Folic Acid|folic acid|mesh-list
44414229|NCT02379091|Methotrexate|methotrexate|mesh-list
44414230|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
44414231|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44414232|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
44414270|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414271|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414288|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414290|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414291|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414292|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44414293|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414294|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
44414295|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414296|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414297|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44414298|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44414299|NCT02376790|Analgesics|analgesics|mesh-ancestor
44414300|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
44414301|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414302|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44414303|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414304|NCT02376166|Metformin|metformin|mesh-list
44414305|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414306|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414307|NCT02375971|Ranibizumab|ranibizumab|mesh-list
44414308|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44414309|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44414310|NCT02375971|Growth Substances|growth substances|mesh-ancestor
44236454|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
44414311|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414312|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44414313|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414314|NCT02375724|Bromides|bromides|mesh-list
44414315|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
44414316|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
44414317|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414318|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414319|NCT02374957|Cilostazol|cilostazol|mesh-list
44414320|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44414321|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
44414322|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414323|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414324|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44414325|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414326|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44414327|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44414328|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414360|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414361|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414362|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414363|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
44414364|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414365|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414366|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414367|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414368|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44414369|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414370|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
44414371|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414433|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44414434|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44414435|NCT02372383|Azithromycin|azithromycin|mesh-list
44414436|NCT02372383|Rifampin|rifampin|mesh-list
44414437|NCT02372383|Ethambutol|ethambutol|mesh-list
44414438|NCT02372383|Pancrelipase|pancrelipase|mesh-list
44414439|NCT02372383|Pancreatin|pancreatin|mesh-list
44414440|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414441|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865258|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
44414442|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44414443|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
44414444|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
44414445|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414446|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414447|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414448|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44414449|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44414450|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44414451|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44414452|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44414453|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44414454|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414455|NCT02372253|Verapamil|verapamil|mesh-list
44414456|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44414457|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44414490|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
44414491|NCT02371629|Bromides|bromides|mesh-list
44414492|NCT02371629|Albuterol|albuterol|mesh-list
44414493|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
44414494|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44414495|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
44414530|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414531|NCT02370784|Atorvastatin|atorvastatin|mesh-list
44414532|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44414533|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44414534|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
44414535|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414536|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44414571|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414572|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414573|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414575|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414576|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414606|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
44414607|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414608|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44414609|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414611|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
44414612|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44414613|NCT02369341|Vaccines|vaccines|mesh-list
44414614|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
44414615|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414616|NCT02369159|Oseltamivir|oseltamivir|mesh-list
44414617|NCT02369159|Peramivir|peramivir|mesh-list
44414618|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
44414619|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414620|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414621|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414622|NCT02368314|Enoxaparin|enoxaparin|mesh-list
44414623|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
44414624|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
44414625|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44414649|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414650|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414651|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44414652|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414654|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414655|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414656|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414657|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414658|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414659|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414660|NCT02367131|Empagliflozin|empagliflozin|mesh-list
44414661|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44414662|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414663|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414664|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414665|NCT02366767|Insulin|insulin|mesh-list
44414666|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414667|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414668|NCT02366689|Triclosan|triclosan|mesh-list
44414669|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
44414670|NCT02366689|Fluorides|fluorides|mesh-list
44414671|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
44414672|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
44414673|NCT02366689|Protective Agents|protective agents|mesh-ancestor
44414674|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414675|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44414676|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414677|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44414703|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414705|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44414706|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44414707|NCT02366143|Growth Substances|growth substances|mesh-ancestor
44414708|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414709|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
44414710|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
44414711|NCT02366130|Denosumab|denosumab|mesh-list
44414712|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44414713|NCT02366130|Hormones|hormones|mesh-list
44414714|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44414715|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414716|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44414717|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414718|NCT02366091|Methotrexate|methotrexate|mesh-list
44414719|NCT02366091|Colchicine|colchicine|mesh-list
44414720|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44414721|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
44414722|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414723|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414724|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414725|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
44426858|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414760|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414761|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44414762|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44414763|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44414764|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44414765|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414766|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
44414767|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414782|NCT02365233|Incretins|incretins|mesh-ancestor
44414783|NCT02365233|Hormones|hormones|mesh-ancestor
44414784|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44414785|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
44414786|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414787|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414788|NCT02364999|Paclitaxel|paclitaxel|mesh-list
44414789|NCT02364999|Bevacizumab|bevacizumab|mesh-list
44414790|NCT02364999|Carboplatin|carboplatin|mesh-list
44414791|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414792|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414793|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414794|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414795|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414796|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414797|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414798|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44414799|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44414800|NCT02364999|Growth Substances|growth substances|mesh-ancestor
44414801|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414802|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
44414803|NCT02364947|Nalmefene|nalmefene|mesh-list
44414804|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44414805|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414806|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
44414807|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414808|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44414809|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
44414810|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414811|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
44414812|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414813|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414814|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
44414815|NCT02363946|Promethazine|promethazine|mesh-list
44414816|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44414817|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44414818|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414819|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414820|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
44414821|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
44414822|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
44414823|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414824|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
44414825|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
44414826|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414827|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44414828|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
44414829|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
44414830|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414842|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414843|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414844|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414845|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44414846|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
44414847|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414848|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414849|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
44414850|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
44414851|NCT02363283|Immunotoxins|immunotoxins|mesh-list
44414852|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44414853|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
44414854|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414855|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414856|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414857|NCT02362503|Fostemsavir|fostemsavir|mesh-list
44414858|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44414859|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44414860|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
44414861|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414862|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44414863|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44414864|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414865|NCT02362451|Vaccines|vaccines|mesh-list
44414866|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
44414867|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414868|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
44414869|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44414870|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
44414871|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414872|NCT02362425|Expectorants|expectorants|mesh-ancestor
44414873|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414874|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44414875|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
44414876|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414877|NCT02362425|Protective Agents|protective agents|mesh-ancestor
44414878|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414879|NCT02362425|Antidotes|antidotes|mesh-ancestor
44414880|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44072555|NCT05634564|Paclitaxel|paclitaxel|mesh-list
44414881|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
44414882|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414883|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44414884|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44414885|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414886|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414887|NCT02362269|Vitamin D|vitamin d|mesh-list
44414888|NCT02362269|Vitamins|vitamins|mesh-ancestor
44414889|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
44414890|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414891|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44414892|NCT02360995|Triclosan|triclosan|mesh-list
44414893|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
44414894|NCT02360995|Fluorides|fluorides|mesh-list
44414895|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
44414896|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
44414911|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414912|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414914|NCT02360280|Ketamine|ketamine|mesh-list
44414915|NCT02360280|Analgesics|analgesics|mesh-ancestor
44414916|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
44414917|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414918|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414919|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44414920|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44414921|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
44414922|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
44414923|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414924|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44414925|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44414926|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414927|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414928|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44414929|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44414930|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44414931|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44414932|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414933|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
44414934|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
44414935|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
44414936|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414937|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
44414938|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414939|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414940|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44414941|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
44414942|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414943|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414944|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44414945|NCT02360098|Anesthetics|anesthetics|mesh-list
44414946|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414947|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414948|NCT02359994|Hemostatics|hemostatics|mesh-list
44414949|NCT02359994|Coagulants|coagulants|mesh-ancestor
44414950|NCT02359903|Infliximab|infliximab|mesh-list
44236455|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
44414951|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414952|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414953|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414954|NCT02359877|Interferons|interferons|mesh-list
44414955|NCT02359877|Interferon-beta|interferon-beta|mesh-list
44414956|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
44414957|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414973|NCT02359435|Amoxicillin|amoxicillin|mesh-list
44414974|NCT02359435|Metronidazole|metronidazole|mesh-list
44414975|NCT02359435|Clarithromycin|clarithromycin|mesh-list
44414976|NCT02359435|Pantoprazole|pantoprazole|mesh-list
44414977|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414978|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414979|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44414980|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44414981|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44414982|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414983|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414984|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44414985|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44414986|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44414987|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414988|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44414989|NCT02358863|Leucovorin|leucovorin|mesh-list
44414990|NCT02358863|Cisplatin|cisplatin|mesh-list
44414991|NCT02358863|Docetaxel|docetaxel|mesh-list
44414992|NCT02358863|Capecitabine|capecitabine|mesh-list
44414993|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
44414994|NCT02358863|Irinotecan|irinotecan|mesh-list
44414995|NCT02358863|Epirubicin|epirubicin|mesh-list
44414996|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414997|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414998|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414999|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
44415000|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415001|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44415002|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
44415003|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44415004|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44415005|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415006|NCT02358863|Antidotes|antidotes|mesh-ancestor
44415007|NCT02358863|Protective Agents|protective agents|mesh-ancestor
44415008|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415009|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
44415010|NCT02358863|Vitamins|vitamins|mesh-ancestor
44415011|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
44415012|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44415013|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44415014|NCT02358668|PAZ320|paz320|mesh-list
44415015|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415016|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415017|NCT02358538|Ganaxolone|ganaxolone|mesh-list
44415018|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
44415019|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415048|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44415049|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415050|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415051|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
44415052|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415053|NCT02358044|Ribavirin|ribavirin|mesh-list
44415054|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
44415055|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44415056|NCT02358044|Grazoprevir|grazoprevir|mesh-list
44415057|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44415058|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
44415059|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415060|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
44415061|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415062|NCT02357979|Fluorides|fluorides|mesh-list
44415063|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
44415064|NCT02357979|Protective Agents|protective agents|mesh-ancestor
44415065|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415066|NCT02357901|Buprenorphine|buprenorphine|mesh-list
44415091|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415093|NCT02357459|Hormones|hormones|mesh-ancestor
44415094|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614010|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
44112638|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415095|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415096|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415097|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
44415098|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415099|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415100|NCT02357368|Copper|copper|mesh-list
44415101|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44415102|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
44415103|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
44415104|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
44415105|NCT02357368|Etonogestrel|etonogestrel|mesh-list
44415106|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44415107|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415108|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44415109|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44415110|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44072752|NCT05564377|Vitamins|vitamins|mesh-ancestor
44415111|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44415112|NCT02357368|Trace Elements|trace elements|mesh-ancestor
44415113|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
44415114|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44415134|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415135|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415136|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415137|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44415138|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44415139|NCT02356588|Sufentanil|sufentanil|mesh-list
44415140|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44415141|NCT02356588|Narcotics|narcotics|mesh-ancestor
44415142|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415143|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415144|NCT02356588|Analgesics|analgesics|mesh-ancestor
44415145|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
44415146|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415147|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44415148|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44415149|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
44415150|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
44415151|NCT02356562|Ritonavir|ritonavir|mesh-list
44415152|NCT02356562|Ribavirin|ribavirin|mesh-list
44415153|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
44415154|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44415155|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44415156|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44415157|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415158|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415159|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44415160|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44415161|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
44415162|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415163|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44415164|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44415165|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
44415166|NCT02355665|Nicotine|nicotine|mesh-list
44415167|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44415168|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
44415169|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415170|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415171|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44415172|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44415198|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415200|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415201|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415202|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44415203|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
44415204|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415205|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415206|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44415207|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44415208|NCT02354690|Analgesics|analgesics|mesh-ancestor
44415209|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
44415210|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415211|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44415212|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415213|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44415214|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
44415215|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415216|NCT02354586|Niraparib|niraparib|mesh-list
44415217|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44415218|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415219|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415220|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415221|NCT02354508|Pasireotide|pasireotide|mesh-list
44415240|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415241|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415242|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415243|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415244|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44415245|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415246|NCT02353572|Dexamethasone|dexamethasone|mesh-list
44415247|NCT02353572|Bortezomib|bortezomib|mesh-list
44415248|NCT02353572|Melphalan|melphalan|mesh-list
44415249|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415250|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
44415251|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
44415252|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415253|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415254|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415255|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
44415256|NCT02353572|Hormones|hormones|mesh-ancestor
44415257|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415258|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44415259|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415260|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44415261|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
44415262|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415263|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44415264|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415265|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
44415266|NCT02353468|Dexamethasone|dexamethasone|mesh-list
44415267|NCT02353468|Lenalidomide|lenalidomide|mesh-list
44415268|NCT02353468|Bortezomib|bortezomib|mesh-list
44415269|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415270|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
44415271|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
44415272|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415273|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415274|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415275|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
44415301|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44415302|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44415303|NCT02352090|Estradiol|estradiol|mesh-list
44415304|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44415305|NCT02352090|Nandrolone|nandrolone|mesh-list
44415306|NCT02352090|Estrogens|estrogens|mesh-ancestor
44415307|NCT02352090|Hormones|hormones|mesh-ancestor
44415308|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415309|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415310|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44415311|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
44415312|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44415313|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44415314|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44415315|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44415316|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44415317|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
44415318|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44415319|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415320|NCT02352090|Androgens|androgens|mesh-ancestor
44415321|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
44415322|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
44415323|NCT02351960|Lansoprazole|lansoprazole|mesh-list
44415338|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415339|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415340|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44415341|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44073037|NCT05312372|Paclitaxel|paclitaxel|mesh-list
44415342|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112806|NCT00093548|Vaccines|vaccines|mesh-list
44415343|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415344|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
44415345|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44415346|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44415347|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415348|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44415349|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44415350|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44415351|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415352|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
44415354|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
43865673|NCT01996293|Lamotrigine|lamotrigine|mesh-list
44415355|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44415356|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44415357|NCT02351180|Beclomethasone|beclomethasone|mesh-list
44415358|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415359|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
44415360|NCT02351180|Hormones|hormones|mesh-ancestor
44415361|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415362|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415363|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415364|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415365|NCT02351167|Nicotine|nicotine|mesh-list
44415366|NCT02351167|Varenicline|varenicline|mesh-list
44415367|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44415368|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
44415369|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415370|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415371|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44415372|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44415373|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415374|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415375|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415376|NCT02350478|Linagliptin|linagliptin|mesh-list
44415377|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415378|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415379|NCT02350478|Incretins|incretins|mesh-ancestor
44415380|NCT02350478|Hormones|hormones|mesh-ancestor
44415381|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415382|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44415383|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
44415384|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415393|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415394|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415395|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44415396|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44415397|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44415398|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
44415399|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
44415400|NCT02349633|Palbociclib|palbociclib|mesh-list
44415401|NCT02349633|Avelumab|avelumab|mesh-list
44415402|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415403|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44415404|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415405|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415406|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415407|NCT02349542|Bupivacaine|bupivacaine|mesh-list
44415408|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44415409|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
44415410|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415411|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415412|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
44415413|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415414|NCT02349451|Adalimumab|adalimumab|mesh-list
44415415|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415416|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415417|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44415418|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44415419|NCT02349386|Estradiol|estradiol|mesh-list
44415420|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44415421|NCT02349386|Estrogens|estrogens|mesh-ancestor
44415422|NCT02349386|Hormones|hormones|mesh-ancestor
43865741|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43865848|NCT01949337|Prednisone|prednisone|mesh-list
44415423|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415424|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415425|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44415426|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
44415427|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44415428|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44415429|NCT02349295|Ixekizumab|ixekizumab|mesh-list
44415430|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415431|NCT02349061|Ustekinumab|ustekinumab|mesh-list
44415432|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415433|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
44415434|NCT02349048|Simeprevir|simeprevir|mesh-list
44415435|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
44415436|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415437|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44415438|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415439|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415440|NCT02348723|Warfarin|warfarin|mesh-list
44415441|NCT02348723|Dabigatran|dabigatran|mesh-list
44415442|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
44415443|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
44415444|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44415445|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
44415446|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865849|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865850|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
43865851|NCT01949337|Hormones|hormones|mesh-ancestor
43865852|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865853|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865854|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865855|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865856|NCT01947023|Lapatinib|lapatinib|mesh-list
43865857|NCT01947023|Dabrafenib|dabrafenib|mesh-list
43865858|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865859|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865860|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865861|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134345|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134346|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134347|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134348|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44134349|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134350|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
44134351|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
44134352|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415447|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415448|NCT02348489|Guadecitabine|guadecitabine|mesh-list
44415449|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415450|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
44415451|NCT02348216|Fludarabine|fludarabine|mesh-list
44415452|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415481|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415482|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415483|NCT02347332|Methotrexate|methotrexate|mesh-list
44415484|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44415485|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
44415486|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44415487|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415488|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44415489|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
44415490|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415491|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415492|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415493|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415494|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44415495|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415496|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
44415497|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415511|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
44415512|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415513|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
44415514|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415515|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415516|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415517|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415518|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44415519|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44415520|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415521|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415522|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415523|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415524|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44415525|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44415526|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44415527|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415528|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
44415529|NCT02347072|Bromides|bromides|mesh-list
44415530|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
44415531|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
44415532|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415533|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
44415534|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415535|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415536|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415537|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415538|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43614330|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
44415539|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44415540|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415541|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415542|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415543|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415544|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
44415545|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44415546|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415547|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
44415548|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44415549|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44415550|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
44415551|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44415552|NCT02346721|Velpatasvir|velpatasvir|mesh-list
44415553|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
44415554|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415555|NCT02346370|Docetaxel|docetaxel|mesh-list
44415556|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415557|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
44415558|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
44415559|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
44415585|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415586|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44415587|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44415589|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415590|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44415591|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44415592|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44415593|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44415594|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44415595|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415596|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415597|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
44415598|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415599|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44415600|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44415601|NCT02345161|Budesonide|budesonide|mesh-list
44415602|NCT02345161|Albuterol|albuterol|mesh-list
44415603|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
44415604|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44415605|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415618|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415619|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415620|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415621|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
44415622|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44415623|NCT02344342|Diuretics|diuretics|mesh-list
44415624|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
44415625|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415626|NCT02344004|Amikacin|amikacin|mesh-list
44415627|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415628|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415629|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
44415630|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415631|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415632|NCT02343939|Cytarabine|cytarabine|mesh-list
44415633|NCT02343939|Azacitidine|azacitidine|mesh-list
44415634|NCT02343939|Decitabine|decitabine|mesh-list
44415635|NCT02343939|Daunorubicin|daunorubicin|mesh-list
44415636|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44415637|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
44415638|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415639|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415640|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
44073285|NCT05002569|Nivolumab|nivolumab|mesh-list
44415641|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415642|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415643|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
44415644|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415645|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415646|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44415647|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44415648|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44415650|NCT02343549|Temozolomide|temozolomide|mesh-list
44112957|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44415651|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415652|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415653|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415654|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415655|NCT02343549|Growth Substances|growth substances|mesh-ancestor
44415656|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415657|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415658|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44415659|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
44415660|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415661|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
44415662|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
44415663|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415664|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
44415665|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415666|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415667|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415681|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866005|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
44415682|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
44415683|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415684|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415685|NCT02343263|Bupivacaine|bupivacaine|mesh-list
44415686|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44415687|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
44415688|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
44415689|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415690|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415691|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
44415692|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415693|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
44415694|NCT02343263|Coagulants|coagulants|mesh-ancestor
44415695|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44415696|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415697|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415698|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
44415699|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415700|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
44415701|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415702|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44415703|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415704|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415705|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
44415706|NCT02342886|Rifampin|rifampin|mesh-list
44415707|NCT02342886|Isoniazid|isoniazid|mesh-list
44415708|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
44415709|NCT02342886|Ethambutol|ethambutol|mesh-list
44415710|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415711|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415712|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44415713|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44415714|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415715|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415716|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415717|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44415718|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
44415719|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
44415720|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44415721|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44415722|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44415723|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44415724|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44415725|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44415726|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44415727|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44415728|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44415739|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415740|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415741|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415742|NCT02342418|Tedizolid|tedizolid|mesh-list
44415743|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
44415744|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415745|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415746|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
44415747|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44415748|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
44415749|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415750|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
44415751|NCT02342223|Protective Agents|protective agents|mesh-ancestor
44415753|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415754|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415755|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44415756|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415757|NCT02341482|Itraconazole|itraconazole|mesh-list
44415758|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
44415759|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415760|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44415761|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44415762|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415763|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415764|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44415765|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
44415766|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415767|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415768|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44415769|NCT02341456|Paclitaxel|paclitaxel|mesh-list
44415770|NCT02341456|Carboplatin|carboplatin|mesh-list
44415771|NCT02341456|Adavosertib|adavosertib|mesh-list
44415772|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44415773|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415774|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44415775|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44415776|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44415777|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415778|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415779|NCT02341417|Cinacalcet|cinacalcet|mesh-list
44415780|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44415781|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415782|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44415783|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
44415784|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415785|NCT02340975|Durvalumab|durvalumab|mesh-list
44415786|NCT02340975|Tremelimumab|tremelimumab|mesh-list
44415787|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44415788|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415789|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415790|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
44415791|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415792|NCT02340962|Interferons|interferons|mesh-list
44415807|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415808|NCT02340949|Antidotes|antidotes|mesh-ancestor
44415809|NCT02340949|Protective Agents|protective agents|mesh-ancestor
44415810|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415811|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
44415812|NCT02340949|Vitamins|vitamins|mesh-ancestor
44415813|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
44415814|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415815|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415816|NCT02340949|Growth Substances|growth substances|mesh-ancestor
44415817|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415818|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
44415819|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415820|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44415821|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415822|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
44415823|NCT02340819|Teduglutide|teduglutide|mesh-list
44415824|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415825|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44415826|NCT02340819|Protective Agents|protective agents|mesh-ancestor
44415827|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415828|NCT02340520|Theophylline|theophylline|mesh-list
44415829|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415830|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
44415831|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415832|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415833|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44236456|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415834|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
43866072|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
44415835|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44415836|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415837|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415838|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
44415839|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44415840|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44415841|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
44415842|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415843|NCT02340221|Fulvestrant|fulvestrant|mesh-list
44415844|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44415845|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415846|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44415847|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44415848|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
44415849|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415850|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415851|NCT02340000|Amoxicillin|amoxicillin|mesh-list
44415852|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
44415853|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
44415854|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44415866|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44415867|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415868|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415869|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415870|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415871|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415872|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44415873|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415875|NCT02339506|Hormones|hormones|mesh-ancestor
44415876|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415877|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415878|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
44415879|NCT02339155|Promethazine|promethazine|mesh-list
44415880|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44415881|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44415882|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415883|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415884|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
44415885|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
44415886|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
44415887|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415888|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
44415889|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
44415890|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415891|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44415892|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
44415893|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
44415894|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415895|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415896|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44415897|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
44415898|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415899|NCT02338999|Pioglitazone|pioglitazone|mesh-list
44415900|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415901|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415902|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
44415903|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44415904|NCT02338362|Fluticasone|fluticasone|mesh-list
44415905|NCT02338362|Xhance|xhance|mesh-list
44415906|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415907|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415908|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
44415909|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415910|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415911|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415912|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415913|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
44415914|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44415915|NCT02338193|Metformin|metformin|mesh-list
44415916|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
44415930|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44415931|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415932|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
44415933|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415934|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44415935|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415936|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
44415937|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415938|NCT02337946|Antidotes|antidotes|mesh-ancestor
44415939|NCT02337946|Protective Agents|protective agents|mesh-ancestor
44415940|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
44415942|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
44415943|NCT02337907|Donepezil|donepezil|mesh-list
44415944|NCT02337907|BI 409306|bi 409306|mesh-list
44415945|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44415946|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415947|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415948|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415949|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415950|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415951|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
44415952|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44415953|NCT02337491|Bevacizumab|bevacizumab|mesh-list
44415954|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
44415955|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415956|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415957|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415958|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415959|NCT02337491|Growth Substances|growth substances|mesh-ancestor
44415960|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415961|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415962|NCT02337478|Vincristine|vincristine|mesh-list
44415963|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44415964|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415965|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
44415966|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
44415967|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
44415968|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415969|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44415970|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44415971|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415972|NCT02336607|Metoprolol|metoprolol|mesh-list
44415973|NCT02336607|Felodipine|felodipine|mesh-list
44415974|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44415975|NCT02336607|Lisinopril|lisinopril|mesh-list
44415976|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44415977|NCT02336607|Diuretics|diuretics|mesh-ancestor
44415978|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
44415979|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415980|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44415981|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416002|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416003|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416004|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416005|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
44416006|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416007|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
44416008|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416009|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416010|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416011|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
44416012|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416013|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
44416014|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416015|NCT02336165|Bevacizumab|bevacizumab|mesh-list
44416016|NCT02336165|Durvalumab|durvalumab|mesh-list
44416017|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416018|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416019|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416020|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416021|NCT02336165|Growth Substances|growth substances|mesh-ancestor
44416022|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416023|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416024|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
44416025|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44416026|NCT02336074|Vorinostat|vorinostat|mesh-list
44416027|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416028|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44073701|NCT04594694|Bezafibrate|bezafibrate|mesh-list
44416029|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416030|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416031|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44416032|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
44416033|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416034|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44416064|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416065|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44416066|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44416067|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44416068|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416069|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416070|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416071|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416072|NCT02335346|Analgesics|analgesics|mesh-ancestor
44416073|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
44416074|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416075|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
44416076|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44416077|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
44416078|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
44416079|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
44416080|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44416081|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44416098|NCT02334215|Methadone|methadone|mesh-list
44416099|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44416100|NCT02334215|Narcotics|narcotics|mesh-ancestor
44416101|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416102|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416103|NCT02334215|Analgesics|analgesics|mesh-ancestor
44416104|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
44416105|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416106|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
44416107|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
44416108|NCT02333383|Adalimumab|adalimumab|mesh-list
44416109|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416110|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416111|NCT02332889|Decitabine|decitabine|mesh-list
44416112|NCT02332889|Poly ICLC|poly iclc|mesh-list
44416113|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416114|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
44416115|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416116|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416117|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416118|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
44416119|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
44416120|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416121|NCT02332824|Candesartan|candesartan|mesh-list
44416122|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
44416123|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
44416124|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416125|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44416126|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44416127|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416128|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416129|NCT02332720|Ribavirin|ribavirin|mesh-list
44416130|NCT02332720|Grazoprevir|grazoprevir|mesh-list
44416131|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
44416132|NCT02332720|Ruzasvir|ruzasvir|mesh-list
44416133|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
44416134|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416135|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
44416136|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416137|NCT02332707|Ribavirin|ribavirin|mesh-list
44416138|NCT02332707|Grazoprevir|grazoprevir|mesh-list
44416139|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
44416140|NCT02332707|Ruzasvir|ruzasvir|mesh-list
44416169|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416170|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
44416171|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416172|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
44416173|NCT02331368|Lenalidomide|lenalidomide|mesh-list
44416174|NCT02331368|Melphalan|melphalan|mesh-list
44416175|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416176|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416177|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
44416178|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416179|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416180|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416182|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416183|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44416184|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
44416185|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416186|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44416207|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416208|NCT02328040|Insulin|insulin|mesh-list
44416209|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44416210|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44416211|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
44416212|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416213|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416214|NCT02328040|Incretins|incretins|mesh-ancestor
44416215|NCT02328040|Hormones|hormones|mesh-ancestor
44416216|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416217|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44416218|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416219|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416220|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416221|NCT02327169|Paclitaxel|paclitaxel|mesh-list
44416222|NCT02327169|Irinotecan|irinotecan|mesh-list
44416223|NCT02327169|Cetuximab|cetuximab|mesh-list
44416224|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44416225|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416226|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416227|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
44416228|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
44416229|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416230|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44416231|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44416232|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416233|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416234|NCT02327013|Vortioxetine|vortioxetine|mesh-list
44416235|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
44416236|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44416237|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44416238|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44416239|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416240|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416241|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44416242|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44416251|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
44416252|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44416253|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44416254|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416255|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
44416256|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416257|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
44416258|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416259|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
44416260|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416261|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416262|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
44416263|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416264|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
44416265|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416266|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416267|NCT02326025|Doxorubicin|doxorubicin|mesh-list
44416268|NCT02326025|Olaratumab|olaratumab|mesh-list
44416269|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44416270|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416271|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44416272|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44416273|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416274|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416276|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44416277|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416278|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416279|NCT02325713|Praziquantel|praziquantel|mesh-list
44416280|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
44416281|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44416282|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416283|NCT02325518|Timolol|timolol|mesh-list
44416284|NCT02325518|Dorzolamide|dorzolamide|mesh-list
44416285|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44416286|NCT02325518|Maleic acid|maleic acid|mesh-list
44416287|NCT02325518|Brinzolamide|brinzolamide|mesh-list
44416288|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44416289|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44416290|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44416291|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
44416292|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416293|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416294|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416295|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44416296|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416297|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416298|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44416299|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
44416300|NCT02325414|Diphosphonates|diphosphonates|mesh-list
44416301|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44416302|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416303|NCT02325401|Metformin|metformin|mesh-list
44416304|NCT02325401|Cisplatin|cisplatin|mesh-list
44416305|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416306|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416307|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416337|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416338|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416340|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44416341|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416342|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416344|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
44416345|NCT02324153|Vitamins|vitamins|mesh-ancestor
44416346|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
43866366|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
44416347|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416348|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44416349|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416350|NCT02323334|Itraconazole|itraconazole|mesh-list
44416351|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
44416379|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416381|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44416382|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
44416383|NCT02322281|Gemcitabine|gemcitabine|mesh-list
44416384|NCT02322281|Paclitaxel|paclitaxel|mesh-list
44416385|NCT02322281|Docetaxel|docetaxel|mesh-list
44416386|NCT02322281|Pemetrexed|pemetrexed|mesh-list
44416387|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44416388|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416389|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416390|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44416391|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44416392|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416393|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416394|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
44416395|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
44416396|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416397|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416398|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416424|NCT02322047|Prazosin|prazosin|mesh-list
44416425|NCT02322047|Naltrexone|naltrexone|mesh-list
44416426|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44416427|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44416428|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416429|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
44416430|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416431|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416432|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44416433|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44416434|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44416435|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44416436|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416437|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416438|NCT02321930|Tofacitinib|tofacitinib|mesh-list
44416439|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416440|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416441|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416442|NCT02321800|Imipenem|imipenem|mesh-list
44416443|NCT02321800|Cilastatin|cilastatin|mesh-list
44416444|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416445|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416446|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416473|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44416474|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
44416475|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44416476|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
44416477|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416478|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416479|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416480|NCT02320396|Desloratadine|desloratadine|mesh-list
44416481|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44416482|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416483|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416484|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416485|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416486|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44416487|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44416488|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
44416489|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
44416490|NCT02320149|Sarecycline|sarecycline|mesh-list
44416491|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416492|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416493|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416512|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
43866437|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
44416513|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416514|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
44416515|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416516|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
44416517|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416518|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416519|NCT02319148|Itraconazole|itraconazole|mesh-list
44416520|NCT02319148|Verapamil|verapamil|mesh-list
44416521|NCT02319148|Diltiazem|diltiazem|mesh-list
44416522|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
44416523|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416524|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44416525|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44416526|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416527|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416528|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44416529|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
44416530|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416531|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416532|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44416533|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44416534|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44416535|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416536|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44416537|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
44416538|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416539|NCT02319044|Durvalumab|durvalumab|mesh-list
44416540|NCT02319044|Tremelimumab|tremelimumab|mesh-list
44416541|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44416542|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416543|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416544|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
44416545|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416546|NCT02319031|Ribavirin|ribavirin|mesh-list
44416547|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
44416548|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
44416549|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416550|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
44416551|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416552|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43614448|NCT03922542|Vitamins|vitamins|mesh-ancestor
44416589|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416590|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
44416594|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416595|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416597|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416598|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416599|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416600|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
44416601|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416602|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416603|NCT02317510|Anesthetics|anesthetics|mesh-list
44416604|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416605|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416606|NCT02317016|Osimertinib|osimertinib|mesh-list
44416607|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44416608|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44416609|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44416610|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
44416611|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416612|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44416613|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44416614|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416615|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416616|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416618|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44416619|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
44416620|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
44416621|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
44416622|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416623|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416624|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416625|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44416626|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416627|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44416628|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44416629|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44416630|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44416631|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44416632|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44416633|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
44416634|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
44416635|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
44416636|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
44416637|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416638|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416639|NCT02316613|Rituximab|rituximab|mesh-list
44416640|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416641|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416642|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
44416643|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416644|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416645|NCT02316353|Complement C1s|complement c1s|mesh-list
44416646|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44416647|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44416648|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
44416649|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416650|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44416651|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416652|NCT02316171|Mitomycins|mitomycins|mesh-list
44416653|NCT02316171|Mitomycin|mitomycin|mesh-list
44416654|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44416655|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416656|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
44416657|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416658|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416659|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416660|NCT02315625|Everolimus|everolimus|mesh-list
44416661|NCT02315625|Sunitinib|sunitinib|mesh-list
44416680|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44416681|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416682|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44416683|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
44416684|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44416685|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416686|NCT02314143|Trametinib|trametinib|mesh-list
44416687|NCT02314143|Dabrafenib|dabrafenib|mesh-list
44416688|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416689|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416690|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416691|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416692|NCT02314117|Cisplatin|cisplatin|mesh-list
44416693|NCT02314117|Fluorouracil|fluorouracil|mesh-list
44416694|NCT02314117|Capecitabine|capecitabine|mesh-list
44416695|NCT02314117|Ramucirumab|ramucirumab|mesh-list
44416696|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416697|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
44416698|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416699|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416700|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416701|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
44416702|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416703|NCT02313909|Aspirin|aspirin|mesh-list
44416704|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
44416705|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44416706|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44416707|NCT02313909|Analgesics|analgesics|mesh-ancestor
44416708|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
44416709|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416710|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416711|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416712|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416713|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44416714|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44416715|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074387|NCT03667482|Cetuximab|cetuximab|mesh-list
44416716|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44416717|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44416718|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416729|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416731|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44416732|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416733|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416734|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416735|NCT02312219|Folic Acid|folic acid|mesh-list
44416736|NCT02312219|Methotrexate|methotrexate|mesh-list
44416737|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44416738|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
44416739|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44416740|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416741|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416742|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
44416743|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416744|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416745|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416746|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416747|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44416748|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416749|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
44416750|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416751|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416752|NCT02312219|Hematinics|hematinics|mesh-ancestor
44416753|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
44416754|NCT02312219|Vitamins|vitamins|mesh-ancestor
44416755|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
44416756|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44416757|NCT02312063|Glimepiride|glimepiride|mesh-list
44416758|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416759|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416760|NCT02312063|Incretins|incretins|mesh-ancestor
44416761|NCT02312063|Hormones|hormones|mesh-ancestor
44416762|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416763|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44416764|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416765|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416766|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416767|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44416768|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416769|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
44416770|NCT02311881|Acetaminophen|acetaminophen|mesh-list
44113662|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44416771|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44416772|NCT02311881|Analgesics|analgesics|mesh-ancestor
44416773|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
44416774|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416775|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416776|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
44416777|NCT02311478|Copper|copper|mesh-list
44416778|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
44416779|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44416780|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416781|NCT02311478|Trace Elements|trace elements|mesh-ancestor
44416782|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
44416783|NCT02311361|Durvalumab|durvalumab|mesh-list
44416784|NCT02311361|Tremelimumab|tremelimumab|mesh-list
44416785|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416796|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416797|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44416798|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44074526|NCT03574402|Gemcitabine|gemcitabine|mesh-list
44416799|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416800|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416801|NCT02310750|PF-06700841|pf-06700841|mesh-list
44416802|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416803|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416804|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416805|NCT02310672|Macitentan|macitentan|mesh-list
44416806|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44416807|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44416808|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416809|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44416810|NCT02310581|Buprenorphine|buprenorphine|mesh-list
44416811|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44416812|NCT02310581|Narcotics|narcotics|mesh-ancestor
44416813|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416814|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416815|NCT02310581|Analgesics|analgesics|mesh-ancestor
44416816|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
44416817|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416818|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44416819|NCT02310568|PF-06372865|pf-06372865|mesh-list
44416820|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
44416821|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
44416822|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416823|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416824|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416825|NCT02309515|Lenalidomide|lenalidomide|mesh-list
44416826|NCT02309515|Vaccines|vaccines|mesh-list
44416827|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
44416828|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416829|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416830|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416831|NCT02309515|Growth Substances|growth substances|mesh-ancestor
44416832|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416833|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416834|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
44416835|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44416836|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
44416837|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44416838|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416839|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416840|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416841|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
44416842|NCT02309359|Methotrexate|methotrexate|mesh-list
44416843|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44416844|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
44416845|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44416846|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416847|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416848|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
44416849|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416859|NCT02308748|Lidocaine|lidocaine|mesh-list
44416860|NCT02308748|Mexiletine|mexiletine|mesh-list
44416861|NCT02308748|Dofetilide|dofetilide|mesh-list
44416862|NCT02308748|Diltiazem|diltiazem|mesh-list
44416863|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
44236457|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416864|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
44416865|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416866|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416867|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
44416868|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416869|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44416870|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44416871|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44416872|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416873|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416874|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416875|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416876|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44416877|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44416878|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416879|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416880|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44416881|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44416882|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44416883|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
44416884|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44416885|NCT02308540|Vaccines|vaccines|mesh-list
44416886|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44416887|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
44416888|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416889|NCT02308228|Metformin|metformin|mesh-list
44416890|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416891|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416892|NCT02308163|Etanercept|etanercept|mesh-list
44416893|NCT02308163|Peficitinib|peficitinib|mesh-list
44416894|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44416895|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44416896|NCT02308163|Analgesics|analgesics|mesh-ancestor
44416897|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
44416898|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416899|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416900|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416901|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416902|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416903|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416904|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
44416905|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416906|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416907|NCT02308124|Midodrine|midodrine|mesh-list
44416908|NCT02308124|Bromides|bromides|mesh-list
44416909|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44416910|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
44416911|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
44416912|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
44416913|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416914|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416915|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44416916|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44416943|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416944|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416945|NCT02307682|Growth Substances|growth substances|mesh-ancestor
44416946|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416947|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416948|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416949|NCT02307513|Apremilast|apremilast|mesh-list
44416950|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44416951|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074658|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
44416952|NCT02307513|Analgesics|analgesics|mesh-ancestor
44416953|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
44416954|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416955|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416956|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416957|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416958|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44416959|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44416960|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416961|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416962|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
44416963|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416964|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416965|NCT02306694|Factor VIII|factor viii|mesh-list
44416966|NCT02306694|Coagulants|coagulants|mesh-ancestor
44416979|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44416980|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416981|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
43866723|NCT01676402|Vaccines|vaccines|mesh-list
44416982|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416983|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416985|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
44416986|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
44416987|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
44416988|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416989|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416990|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416991|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44416992|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416993|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44416994|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44416995|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44416996|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
44416997|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
44416998|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416999|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417000|NCT02305758|Bevacizumab|bevacizumab|mesh-list
44417001|NCT02305758|Fluorouracil|fluorouracil|mesh-list
44417002|NCT02305758|Veliparib|veliparib|mesh-list
44417003|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417004|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417005|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44417006|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44417007|NCT02305758|Growth Substances|growth substances|mesh-ancestor
44417008|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417009|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
44417010|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
44417011|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417012|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417013|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417014|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
44417015|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44417016|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417017|NCT02305563|Cytarabine|cytarabine|mesh-list
44417018|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417019|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
44417020|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417021|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417022|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
44417023|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417024|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417025|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
44074732|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44417026|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417027|NCT02305238|Aflibercept|aflibercept|mesh-list
44417028|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44417041|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44417042|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44417043|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417044|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
44417045|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
44417046|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44417047|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44417048|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417049|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417050|NCT02304705|Urological Agents|urological agents|mesh-ancestor
44417051|NCT02304484|Evolocumab|evolocumab|mesh-list
44417052|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44417053|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44417054|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
44417055|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417056|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44417057|NCT02304302|Memantine|memantine|mesh-list
44417058|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44417059|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44417060|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
44417061|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417062|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417063|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417064|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44417065|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44417066|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44417067|NCT02303262|Gemcitabine|gemcitabine|mesh-list
44417068|NCT02303262|Mocetinostat|mocetinostat|mesh-list
44417069|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417070|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
44417071|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417072|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417073|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
44417074|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417075|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417076|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417077|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
44417078|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417079|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44417081|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44417082|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
44417083|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417084|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417085|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44417086|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44417087|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
44417088|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417089|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417090|NCT02302846|Ixazomib|ixazomib|mesh-list
44417111|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
44417112|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44417113|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417114|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417115|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44417116|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417117|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
44417118|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417119|NCT02301988|Paclitaxel|paclitaxel|mesh-list
44417120|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417121|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417122|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417123|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417124|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417125|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417126|NCT02301975|Fluticasone|fluticasone|mesh-list
44417128|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44417129|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417130|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44417131|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
44417132|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417133|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417134|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44417135|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44417136|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417137|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44417138|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44417139|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44417140|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44417141|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44417142|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417143|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417144|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
44417145|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44417172|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44417173|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417174|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44417175|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44417176|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44417177|NCT02301143|Gemcitabine|gemcitabine|mesh-list
44417178|NCT02301143|Paclitaxel|paclitaxel|mesh-list
44417179|NCT02301143|Capecitabine|capecitabine|mesh-list
44417180|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417181|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417182|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417183|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417184|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417185|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417186|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417187|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
44417188|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
44417189|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417190|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417191|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417192|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
44417193|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417221|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417222|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417223|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417224|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44417225|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417226|NCT02300259|Itraconazole|itraconazole|mesh-list
44417227|NCT02300259|Diltiazem|diltiazem|mesh-list
44417228|NCT02300259|Tadalafil|tadalafil|mesh-list
44417229|NCT02300259|Simvastatin|simvastatin|mesh-list
44417230|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44417231|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44417232|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
44417233|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417234|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44417235|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44417236|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417237|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
44417238|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417239|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44417240|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44417241|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44417242|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417243|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417244|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417265|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44417267|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
44417268|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417269|NCT02299388|Liraglutide|liraglutide|mesh-list
44417270|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417271|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417272|NCT02299388|Incretins|incretins|mesh-ancestor
44417273|NCT02299388|Hormones|hormones|mesh-ancestor
44417274|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417275|NCT02299375|Albuterol|albuterol|mesh-list
44417276|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44417277|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
44417278|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417279|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417280|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44417281|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
44417282|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
44417283|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417284|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44417285|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44417286|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44417287|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
44417288|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417289|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417290|NCT02299336|Aflibercept|aflibercept|mesh-list
44417291|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44417292|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44417293|NCT02299336|Growth Substances|growth substances|mesh-ancestor
44417294|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417322|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417323|NCT02298192|Liraglutide|liraglutide|mesh-list
44417325|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417326|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417327|NCT02298192|Incretins|incretins|mesh-ancestor
44417328|NCT02298192|Hormones|hormones|mesh-ancestor
44417330|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44417331|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44417332|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44417333|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
44417334|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417335|NCT02298179|Antacids|antacids|mesh-ancestor
44417336|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417337|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44417338|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44417339|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
44417340|NCT02298023|Coagulants|coagulants|mesh-ancestor
44417341|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44417342|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44417355|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
44417356|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
44417357|NCT02297503|Protective Agents|protective agents|mesh-ancestor
44417358|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
44417359|NCT02296931|Analgesics|analgesics|mesh-ancestor
44417360|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
44417361|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417362|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417363|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
44417364|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417365|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44417366|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
44417367|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44417368|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417369|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417370|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44417371|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
44417372|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417373|NCT02296892|Midazolam|midazolam|mesh-list
44417374|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44417375|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44417376|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417377|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417378|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44417379|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44417380|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44417381|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44417382|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
44417383|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
44417384|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
44417385|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
44417386|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417387|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417388|NCT02296840|Acetaminophen|acetaminophen|mesh-list
44417389|NCT02296840|Ibuprofen|ibuprofen|mesh-list
44417390|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44417391|NCT02296840|Hydrocodone|hydrocodone|mesh-list
44417392|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417393|NCT02296840|Analgesics|analgesics|mesh-ancestor
44417394|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
44417395|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417396|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417397|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
44417398|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417399|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417400|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417401|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44417402|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417426|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
44417427|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44417428|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44417429|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417430|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417431|NCT02296112|Trametinib|trametinib|mesh-list
44417432|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417433|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44417434|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417435|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417436|NCT02295774|Methylene Blue|methylene blue|mesh-list
44417437|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154036|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44417438|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417439|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
44417440|NCT02295280|Promethazine|promethazine|mesh-list
44417441|NCT02295280|Codeine|codeine|mesh-list
44417442|NCT02295280|Metoclopramide|metoclopramide|mesh-list
44417443|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44417444|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44417445|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417446|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417447|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44417448|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
44417449|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
44417450|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417451|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
44417452|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
44417464|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
44417465|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44417466|NCT02295280|Narcotics|narcotics|mesh-ancestor
44417467|NCT02295280|Analgesics|analgesics|mesh-ancestor
44417468|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
44417469|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
44417470|NCT02294786|Capecitabine|capecitabine|mesh-list
44417471|NCT02294786|Lapatinib|lapatinib|mesh-list
44417472|NCT02294786|Octreotide|octreotide|mesh-list
44417473|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417474|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
44417475|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417476|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417477|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44417478|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417479|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44417480|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44417481|NCT02294773|Letrozole|letrozole|mesh-list
44417482|NCT02294773|Clomiphene|clomiphene|mesh-list
44417483|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417484|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44417485|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44417486|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417487|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417488|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44417489|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417490|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417491|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075226|NCT02419495|Vitamins|vitamins|mesh-ancestor
44417492|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44417493|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
44417494|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417495|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44417496|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44417498|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44417499|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417500|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417501|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
44417502|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44417503|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
44417504|NCT02294604|Povidone|povidone|mesh-list
44417505|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44417506|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417507|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
44417508|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417509|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
44417510|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
44417511|NCT02294474|Insulin|insulin|mesh-list
44417512|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44417513|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
44417514|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
44417515|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417516|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417517|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
44417518|NCT02294396|Mirabegron|mirabegron|mesh-list
44417541|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417542|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
44417543|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417544|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44417545|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43614449|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
44417546|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417548|NCT02294019|Ibuprofen|ibuprofen|mesh-list
44417549|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417550|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417551|NCT02294019|Analgesics|analgesics|mesh-ancestor
44417552|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
44417553|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417554|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417555|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417556|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417557|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44417558|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417559|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417560|NCT02293993|Guadecitabine|guadecitabine|mesh-list
44417561|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417562|NCT02293902|Folic Acid|folic acid|mesh-list
44417563|NCT02293902|Methotrexate|methotrexate|mesh-list
44417564|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44417565|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
44417566|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417567|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417568|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417569|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
44417570|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417597|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
44417598|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417599|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417600|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417601|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417602|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44417603|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44417604|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417605|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44417606|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44417607|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417609|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44417610|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44417611|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44417612|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
44417613|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417614|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44417615|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
44417616|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44417617|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
44417618|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
44417619|NCT02292784|Atosiban|atosiban|mesh-list
44417620|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417621|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417655|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417658|NCT02291913|Letrozole|letrozole|mesh-list
44417659|NCT02291913|Fulvestrant|fulvestrant|mesh-list
44417660|NCT02291913|Anastrozole|anastrozole|mesh-list
44417661|NCT02291913|Exemestane|exemestane|mesh-list
44417662|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417663|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417664|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
44417665|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417682|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44417683|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
44417684|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44417685|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44417686|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417687|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
44417688|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417689|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
44417690|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417691|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417692|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44417693|NCT02291419|Aspirin|aspirin|mesh-list
44417694|NCT02291419|Ticagrelor|ticagrelor|mesh-list
44417695|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417696|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417697|NCT02291419|Analgesics|analgesics|mesh-ancestor
44114203|NCT00098397|Romidepsin|romidepsin|mesh-list
44417698|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
44417699|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417700|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417701|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417702|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417703|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44417704|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44417705|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417706|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44417707|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44417708|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417709|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
44417710|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44417711|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44417712|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44417713|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
44417714|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417715|NCT02291289|Bevacizumab|bevacizumab|mesh-list
44417716|NCT02291289|Trastuzumab|trastuzumab|mesh-list
44417717|NCT02291289|Cetuximab|cetuximab|mesh-list
44417718|NCT02291289|Pertuzumab|pertuzumab|mesh-list
44417719|NCT02291289|Capecitabine|capecitabine|mesh-list
44417720|NCT02291289|Fluorouracil|fluorouracil|mesh-list
44417721|NCT02291289|Atezolizumab|atezolizumab|mesh-list
44075431|NCT00017407|Paclitaxel|paclitaxel|mesh-list
44417742|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44417743|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417744|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417746|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44417747|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44417748|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44417749|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
44417750|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
44417751|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
44417752|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
44417753|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417754|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417755|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44417756|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
44417757|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417758|NCT02289950|Farletuzumab|farletuzumab|mesh-list
44417759|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417760|NCT02289898|Gemcitabine|gemcitabine|mesh-list
44417761|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44417762|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417763|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
44417764|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417765|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417766|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
44417767|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417768|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417769|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417770|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
44417771|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417772|NCT02289833|Trastuzumab|trastuzumab|mesh-list
44417773|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44417774|NCT02289833|Maytansine|maytansine|mesh-list
44417775|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417807|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417808|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417809|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44417810|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44417811|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417812|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417813|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44417814|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44417826|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417827|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
44417828|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417829|NCT02288325|Milnacipran|milnacipran|mesh-list
44417830|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
44417831|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44417832|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44417833|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44236458|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417834|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417835|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417836|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417837|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
44417838|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44417839|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417840|NCT02288325|Analgesics|analgesics|mesh-ancestor
44417841|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
44417842|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417843|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44417844|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
44417845|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44417846|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44417847|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417848|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075540|NCT00009217|Haloperidol|haloperidol|mesh-list
44417849|NCT02287623|Bupivacaine|bupivacaine|mesh-list
44417850|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
44417851|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
44417852|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417853|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417854|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
44417855|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417856|NCT02287610|Prednisone|prednisone|mesh-list
44417857|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417858|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
44417859|NCT02287610|Hormones|hormones|mesh-ancestor
44417860|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417861|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417862|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44417863|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417864|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
44417865|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44417866|NCT02287467|Antibodies|antibodies|mesh-list
44417867|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
44417868|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44417869|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
44417870|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417871|NCT02287402|Voglibose|voglibose|mesh-list
44417872|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417873|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417874|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44417875|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417883|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
44417884|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417885|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417886|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
44417887|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417888|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44417889|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44417890|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44417891|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417892|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417893|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
44417894|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417895|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417896|NCT02286895|Vaccines|vaccines|mesh-list
44417897|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
44417898|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417899|NCT02286843|Trastuzumab|trastuzumab|mesh-list
44417900|NCT02286843|Pertuzumab|pertuzumab|mesh-list
44417901|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417902|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417903|NCT02285998|Vaccines|vaccines|mesh-list
44417904|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
44417905|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417906|NCT02285920|Spironolactone|spironolactone|mesh-list
44417907|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44417908|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417909|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417910|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417911|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44417912|NCT02285920|Diuretics|diuretics|mesh-ancestor
44417913|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
44417914|NCT02285855|Metformin|metformin|mesh-list
44417915|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417916|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417917|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
44417918|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
44417919|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417920|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44417921|NCT02285153|Aspirin|aspirin|mesh-list
44417922|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44417923|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417924|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417925|NCT02285153|Analgesics|analgesics|mesh-ancestor
44417926|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
44417927|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417928|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417929|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417930|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417931|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44417932|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44417933|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417934|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44417935|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44417936|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417937|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
44417938|NCT02285062|Prednisone|prednisone|mesh-list
44417939|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
44417940|NCT02285062|Rituximab|rituximab|mesh-list
44417941|NCT02285062|Doxorubicin|doxorubicin|mesh-list
44417942|NCT02285062|Vincristine|vincristine|mesh-list
44417943|NCT02285062|Lenalidomide|lenalidomide|mesh-list
44417962|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44417963|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417964|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417965|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417966|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417967|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44417968|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44417969|NCT02285062|Growth Substances|growth substances|mesh-ancestor
44417970|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
44417971|NCT02285010|Pregabalin|pregabalin|mesh-list
44417972|NCT02285010|Analgesics|analgesics|mesh-ancestor
44417973|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
44417974|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417975|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417976|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
44417977|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44417978|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417979|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417980|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44417981|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44417982|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44417983|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417984|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44417985|NCT02284906|Pioglitazone|pioglitazone|mesh-list
44417986|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417987|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417988|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44417989|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
44417990|NCT02284893|Saxagliptin|saxagliptin|mesh-list
44417991|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44417992|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417993|NCT02284893|Incretins|incretins|mesh-ancestor
44417994|NCT02284893|Hormones|hormones|mesh-ancestor
44417995|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417996|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44417997|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418028|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418029|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
44418030|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44418031|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44418032|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418034|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
44418035|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418036|NCT02283658|Everolimus|everolimus|mesh-list
44418038|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418039|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418048|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418049|NCT02283294|Warfarin|warfarin|mesh-list
44418050|NCT02283294|Apixaban|apixaban|mesh-list
44418051|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
44418052|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44418053|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
44418054|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44418055|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418056|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418057|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418058|NCT02282813|Calcitriol|calcitriol|mesh-list
44418059|NCT02282813|Calcifediol|calcifediol|mesh-list
44418060|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44418061|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44418062|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418063|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44418064|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418065|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418066|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44418067|NCT02282813|Vitamins|vitamins|mesh-ancestor
44418068|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
44418069|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44418070|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
44418071|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44418072|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44418073|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418074|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
44418075|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
44418076|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44418077|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44418078|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44418079|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418080|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418081|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418083|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44418084|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418085|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418086|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418087|NCT02282293|Piperaquine|piperaquine|mesh-list
44418088|NCT02282293|Trimethoprim|trimethoprim|mesh-list
44418089|NCT02282293|Artenimol|artenimol|mesh-list
44418090|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
44418091|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
44418092|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44418093|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44418094|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418095|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44418096|NCT02282293|Renal Agents|renal agents|mesh-ancestor
44418097|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44418098|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418099|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418100|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44418101|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44418102|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44418103|NCT02282020|Olaparib|olaparib|mesh-list
44418104|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44418105|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418114|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44418115|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418116|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44418117|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418118|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418119|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44418120|NCT02281760|Protective Agents|protective agents|mesh-ancestor
44418121|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418122|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44418123|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
44418124|NCT02281552|Tofacitinib|tofacitinib|mesh-list
44418125|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44418126|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418127|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418128|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44418130|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418131|NCT02280421|Cyclosporine|cyclosporine|mesh-list
44418132|NCT02280421|Cyclosporins|cyclosporins|mesh-list
44418133|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418134|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418135|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418136|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
44418137|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418138|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
44418139|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418140|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
44418141|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418142|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44418143|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
44418144|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44418145|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075846|NCT00009958|Vaccines|vaccines|mesh-list
44418146|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418147|NCT02280044|Rifaximin|rifaximin|mesh-list
44418148|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44418149|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418150|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418151|NCT02279862|Ipilimumab|ipilimumab|mesh-list
44418152|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418153|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418154|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44418155|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418156|NCT02279732|Paclitaxel|paclitaxel|mesh-list
44418157|NCT02279732|Carboplatin|carboplatin|mesh-list
44418158|NCT02279732|Ipilimumab|ipilimumab|mesh-list
44418159|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44418160|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418161|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44418162|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44418163|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44418164|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418165|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418166|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44418167|NCT02279719|Sorafenib|sorafenib|mesh-list
44418168|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418169|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44418170|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418182|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44418183|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44418184|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418185|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418186|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418187|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44418188|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44418189|NCT02278471|Losartan|losartan|mesh-list
44418190|NCT02278471|Amlodipine|amlodipine|mesh-list
44418191|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44418192|NCT02278471|Atorvastatin|atorvastatin|mesh-list
44418193|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44418194|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44418195|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
44418196|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418197|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418198|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44418199|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418200|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44418201|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44418202|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418203|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44418204|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418205|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
44418206|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44418207|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44418208|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44114521|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418209|NCT02278471|Diuretics|diuretics|mesh-ancestor
44418210|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
44418211|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44418212|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
44418213|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
44418214|NCT02278341|Hematinics|hematinics|mesh-ancestor
44418215|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
44418216|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44418217|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44418218|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418219|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
44418220|NCT02278263|Coagulants|coagulants|mesh-ancestor
44418221|NCT02278003|Propofol|propofol|mesh-list
44418222|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44418223|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418224|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418225|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44418226|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
44418227|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
44418228|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44418229|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418230|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867508|NCT01319981|Cytarabine|cytarabine|mesh-list
44418231|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
44418232|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418233|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44418245|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
44418246|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418247|NCT02276560|Gemcitabine|gemcitabine|mesh-list
44418248|NCT02276560|Paclitaxel|paclitaxel|mesh-list
44418249|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44418250|NCT02276560|Cisplatin|cisplatin|mesh-list
44418251|NCT02276560|Pemetrexed|pemetrexed|mesh-list
44418252|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44418253|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418254|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
44418255|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
44418256|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
44418257|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418258|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44418259|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
44418260|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
44418261|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418262|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418263|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418264|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
44418265|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418266|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44418267|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418268|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44418269|NCT02276482|Metronidazole|metronidazole|mesh-list
44418270|NCT02276482|Vancomycin|vancomycin|mesh-list
44418271|NCT02276482|Clindamycin|clindamycin|mesh-list
44418272|NCT02276482|Cefazolin|cefazolin|mesh-list
44418273|NCT02276482|Linezolid|linezolid|mesh-list
44418274|NCT02276482|Cephalexin|cephalexin|mesh-list
44418275|NCT02276482|Aztreonam|aztreonam|mesh-list
44418276|NCT02276482|Tedizolid|tedizolid|mesh-list
44418277|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418278|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44418279|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44418280|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44418281|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418282|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418283|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
44418284|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
44418285|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44418286|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
44418287|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418288|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418289|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44418290|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
44418291|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
44418292|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44418293|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418294|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418295|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418296|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44418302|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418303|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
44418304|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418306|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418307|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44418308|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418309|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418310|NCT02275780|Ritonavir|ritonavir|mesh-list
44418311|NCT02275780|Darunavir|darunavir|mesh-list
44418312|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44418313|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44418314|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44418315|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418316|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418317|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418318|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44418319|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44418320|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
44418321|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418322|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44418323|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44418324|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44418325|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418326|NCT02275611|Oxytocin|oxytocin|mesh-list
44418327|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
44418328|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44418329|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418330|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
44418331|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
44418332|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44418333|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
44418334|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418335|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418336|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44418337|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
44418338|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
44418339|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44418340|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418341|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418342|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418343|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44418344|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44418345|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44418346|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44418347|NCT02275338|Lanreotide|lanreotide|mesh-list
44418348|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418349|NCT02275052|Albuterol|albuterol|mesh-list
44418350|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44418351|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
44418352|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418353|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418354|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44418355|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
44418356|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
44418357|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44418358|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44418359|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44418360|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44418361|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
44418362|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418363|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418364|NCT02274948|Metformin|metformin|mesh-list
44418365|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418385|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418386|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418387|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418388|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418389|NCT02274766|Analgesics|analgesics|mesh-ancestor
44418390|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
44418391|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418392|NCT02274311|Clomiphene|clomiphene|mesh-list
44418393|NCT02274311|Enclomiphene|enclomiphene|mesh-list
44418394|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
44418395|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44418396|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44418397|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418398|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418399|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44418400|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
44418401|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44418402|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44418403|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44418404|NCT02274038|Pemetrexed|pemetrexed|mesh-list
44418405|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418406|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418407|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418408|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44418409|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418410|NCT02273973|Letrozole|letrozole|mesh-list
44134541|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
44418411|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418412|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44418413|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44418414|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418415|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418416|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44418417|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
44418418|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418439|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418440|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44418441|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418442|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418443|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418444|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
44418445|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
44418446|NCT02272842|Vitamins|vitamins|mesh-ancestor
44418447|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
44418448|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418449|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
44418450|NCT02272842|Hematinics|hematinics|mesh-ancestor
44418451|NCT02272816|Carboplatin|carboplatin|mesh-list
44418452|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418453|NCT02272803|Dexamethasone|dexamethasone|mesh-list
44418454|NCT02272803|Lenalidomide|lenalidomide|mesh-list
44418455|NCT02272803|Elotuzumab|elotuzumab|mesh-list
44418456|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418457|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
44418458|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
44418459|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418460|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418461|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418462|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
44418463|NCT02272803|Hormones|hormones|mesh-ancestor
44418464|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418465|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44418466|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418467|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
44418468|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44418469|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44418470|NCT02272803|Growth Substances|growth substances|mesh-ancestor
44418471|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
44418472|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
44418473|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418474|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44418475|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418476|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418477|NCT02272725|Ibuprofen|ibuprofen|mesh-list
44418487|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418488|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418489|NCT02272413|Bevacizumab|bevacizumab|mesh-list
44418490|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418491|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418492|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44418493|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44418494|NCT02272413|Growth Substances|growth substances|mesh-ancestor
44418496|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
44418497|NCT02271984|Praziquantel|praziquantel|mesh-list
44418498|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
44418499|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44418500|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418501|NCT02271854|Diclofenac|diclofenac|mesh-list
44418502|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418503|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418504|NCT02271854|Analgesics|analgesics|mesh-ancestor
44418505|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
44418506|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418507|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418508|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418509|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418510|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44418511|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418512|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418513|NCT02271594|Insulin|insulin|mesh-list
44418514|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418515|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418516|NCT02270983|Linaclotide|linaclotide|mesh-list
44418517|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44418518|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
44418519|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418520|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418521|NCT02270944|Vaccines|vaccines|mesh-list
44418522|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
44418523|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418524|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
44418525|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44418526|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44418527|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44418528|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44418529|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418530|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418531|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418532|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418533|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076256|NCT00011635|Silymarin|silymarin|mesh-list
44418534|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44418535|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418536|NCT02270242|Aspirin|aspirin|mesh-list
44418537|NCT02270242|Ticagrelor|ticagrelor|mesh-list
44418538|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418539|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418540|NCT02270242|Analgesics|analgesics|mesh-ancestor
44418541|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
44418571|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
44418572|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418573|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418574|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418575|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
44418576|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418577|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44418578|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44418579|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418580|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44418581|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
44418582|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418583|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44418584|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44418585|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44418586|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44418600|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418601|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418602|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44418604|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
44418605|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
44418606|NCT02269163|Antibodies|antibodies|mesh-list
44418607|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
44418608|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44418609|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44418611|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
44418612|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418613|NCT02268864|Simeprevir|simeprevir|mesh-list
44418614|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
44418615|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418616|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418617|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418618|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418619|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
44418620|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
44418621|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44418622|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
44418623|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418624|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418625|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44418626|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
44418627|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44418628|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44418629|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44418630|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44418631|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418632|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418633|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44418634|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44418635|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44418636|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418637|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
44418638|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44418639|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418640|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418641|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418642|NCT02268058|Acetaminophen|acetaminophen|mesh-list
44418643|NCT02268058|Ibuprofen|ibuprofen|mesh-list
44418644|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418645|NCT02268058|Analgesics|analgesics|mesh-ancestor
44418655|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418657|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418658|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418659|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
44418660|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418661|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418662|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
44418663|NCT02267746|Tazarotene|tazarotene|mesh-list
44418664|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44418665|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
44418666|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
44418667|NCT02267746|Vitamins|vitamins|mesh-ancestor
44418668|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
44418669|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418670|NCT02267187|Anesthetics|anesthetics|mesh-list
44418671|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418672|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418673|NCT02266888|Rituximab|rituximab|mesh-list
44418674|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418675|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418676|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
44418677|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418678|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418679|NCT02266706|Tazobactam|tazobactam|mesh-list
44418680|NCT02266706|Ceftolozane|ceftolozane|mesh-list
44418681|NCT02266706|Cephalosporins|cephalosporins|mesh-list
44076406|NCT00012090|Bicalutamide|bicalutamide|mesh-list
44418682|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44418683|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
44418684|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44418685|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418686|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44418687|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418688|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418689|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44418690|NCT02266706|Renal Agents|renal agents|mesh-ancestor
44418691|NCT02266433|Dexamethasone|dexamethasone|mesh-list
44418692|NCT02266433|Ketorolac|ketorolac|mesh-list
44418693|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418694|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
44418695|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
44418696|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418697|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418698|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418699|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
44418700|NCT02266433|Hormones|hormones|mesh-ancestor
44418701|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418702|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44418703|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418704|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418705|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418706|NCT02266433|Analgesics|analgesics|mesh-ancestor
44418707|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
44418708|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418709|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44418710|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418741|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44418742|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44418743|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
44418744|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
44418745|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418746|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418747|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418748|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
44418749|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44418750|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44418751|NCT02265510|Growth Substances|growth substances|mesh-ancestor
44418752|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
44418753|NCT02265237|Ritonavir|ritonavir|mesh-list
44418754|NCT02265237|Ribavirin|ribavirin|mesh-list
44418755|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44418756|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44418779|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44418780|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418781|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44418783|NCT02264821|Ropivacaine|ropivacaine|mesh-list
44418784|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
44418785|NCT02264821|Anesthetics|anesthetics|mesh-list
44418786|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44418787|NCT02264821|Narcotics|narcotics|mesh-ancestor
44418788|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418789|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418790|NCT02264821|Analgesics|analgesics|mesh-ancestor
44418791|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
44418792|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418793|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
44418794|NCT02264574|Chlorambucil|chlorambucil|mesh-list
44418795|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418796|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418797|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44418798|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
44418799|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418800|NCT02263547|Teriflunomide|teriflunomide|mesh-list
44418801|NCT02263547|Colestipol|colestipol|mesh-list
44418802|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418803|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418804|NCT02263547|Analgesics|analgesics|mesh-ancestor
44418805|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
44418806|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418807|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418808|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418835|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44418836|NCT02263079|Interferons|interferons|mesh-list
44418837|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
44418838|NCT02263079|Lamivudine|lamivudine|mesh-list
44418839|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
44418840|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44418841|NCT02263079|Entecavir|entecavir|mesh-list
44418842|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418843|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
44418844|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418845|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
44418846|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418847|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43614875|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44114951|NCT00100971|Vaccines|vaccines|mesh-list
44418848|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418849|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418850|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418851|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44418852|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44418853|NCT02262754|Naproxen|naproxen|mesh-list
44418854|NCT02262754|PF-06372865|pf-06372865|mesh-list
44418855|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418856|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418857|NCT02262754|Analgesics|analgesics|mesh-ancestor
44418890|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44418891|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44418892|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418893|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418894|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418895|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418896|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418897|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44418898|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418920|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44418922|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418923|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418924|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44418925|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418926|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418927|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
44418928|NCT02260934|Hormones|hormones|mesh-ancestor
44418929|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418930|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44418931|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418932|NCT02260934|Analgesics|analgesics|mesh-ancestor
44418933|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
44418934|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418935|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
44418936|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
44418937|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
44418938|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418939|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44418940|NCT02260934|Protective Agents|protective agents|mesh-ancestor
44418941|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44418942|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44418943|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418944|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
44418945|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
44418946|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44418947|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
44418948|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
44418949|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418950|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44418951|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
44418952|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44418953|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44418954|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
44418979|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418980|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418981|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44418982|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418983|NCT02260635|Evacetrapib|evacetrapib|mesh-list
44418984|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44418985|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44418986|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
44418987|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418988|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418989|NCT02260492|Fluticasone|fluticasone|mesh-list
44418991|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44418992|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44418993|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418994|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44418995|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
44418996|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154136|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
44418997|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418998|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44418999|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44419000|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
44419001|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44419002|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44419003|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44419004|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44419005|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419006|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419039|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44419040|NCT02260258|Rocuronium|rocuronium|mesh-list
44419041|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44419042|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44419043|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44419044|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419061|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
44419062|NCT02259348|Melphalan|melphalan|mesh-list
44419063|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
44419064|NCT02259348|Thiotepa|thiotepa|mesh-list
44419065|NCT02259348|Rituximab|rituximab|mesh-list
44419066|NCT02259348|Fludarabine|fludarabine|mesh-list
44419067|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
44419068|NCT02259348|Interleukin-2|interleukin-2|mesh-list
44419069|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419070|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
44419071|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419072|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419073|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419074|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
44419075|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419076|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419077|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44419078|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419079|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419080|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
44419081|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
44419082|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419083|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44419084|NCT02259348|Analgesics|analgesics|mesh-ancestor
44419085|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
44419086|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419087|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44419088|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44419089|NCT02259231|Nivolumab|nivolumab|mesh-list
44419090|NCT02259231|Ipilimumab|ipilimumab|mesh-list
44419091|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419092|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419093|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44419094|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419095|NCT02259088|Ranibizumab|ranibizumab|mesh-list
44419096|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44419097|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44419098|NCT02259088|Growth Substances|growth substances|mesh-ancestor
44419099|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419100|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44419101|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419102|NCT02259010|Itraconazole|itraconazole|mesh-list
44419103|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
44419104|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419105|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44419106|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44419107|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419141|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419142|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419143|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44419144|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419145|NCT02258334|Vaccines|vaccines|mesh-list
44419146|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
44419163|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44419164|NCT02257632|Growth Substances|growth substances|mesh-ancestor
43615550|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44419172|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
44419173|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419174|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419175|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
44419176|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419177|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419178|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419179|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
44419180|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419186|NCT02257385|Albuterol|albuterol|mesh-list
44419187|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
44419188|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44419189|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
44419190|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419191|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419192|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44419193|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
44419194|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
44419195|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44419196|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
44419197|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419198|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419199|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
44419200|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44419201|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44419202|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44419203|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44419204|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419205|NCT02257372|Albuterol|albuterol|mesh-list
44419206|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44419207|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
44419222|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419223|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419224|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
44419225|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419226|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
44419227|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419228|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419229|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419230|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
44419231|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419232|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
44419233|NCT02256969|Prednisolone|prednisolone|mesh-list
44419234|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44419235|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
44419236|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44419237|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
44419238|NCT02256969|Mineral Oil|mineral oil|mesh-list
44419239|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44419240|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
44419241|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419242|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
44419243|NCT02256969|Hormones|hormones|mesh-ancestor
44419244|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419245|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419246|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419247|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419248|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
44419249|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
44419250|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419251|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419252|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44419254|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44419255|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419256|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44419257|NCT02256969|Renal Agents|renal agents|mesh-ancestor
44419258|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44419259|NCT02256969|Emollients|emollients|mesh-ancestor
44419260|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44419261|NCT02256540|Resveratrol|resveratrol|mesh-list
44419262|NCT02256540|Estradiol|estradiol|mesh-list
44419263|NCT02256540|Estrogens|estrogens|mesh-ancestor
44419264|NCT02256540|Hormones|hormones|mesh-ancestor
44419265|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419266|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419267|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
44419268|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419299|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868097|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419301|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419302|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419303|NCT02255565|Methylphenidate|methylphenidate|mesh-list
44419304|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44419305|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419306|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44419307|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44419308|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419329|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419331|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419332|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419333|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44419334|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419335|NCT02254681|Gemcitabine|gemcitabine|mesh-list
44419336|NCT02254681|Cisplatin|cisplatin|mesh-list
44419337|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419338|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419339|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
44419340|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419341|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
44419342|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419343|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419344|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419345|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
44419346|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419347|NCT02254551|Bortezomib|bortezomib|mesh-list
44419348|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419349|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
44419350|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44419352|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44419353|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419354|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419355|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
44419356|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419357|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419358|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44419359|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419360|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44419361|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419362|NCT05651126|Psilocybin|psilocybin|mesh-list
44419373|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44419374|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
44419375|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419376|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419377|NCT05650879|Trastuzumab|trastuzumab|mesh-list
44419378|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44419379|NCT05650879|Maytansine|maytansine|mesh-list
44419380|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419381|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419382|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44419383|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419384|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419385|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419386|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419387|NCT05650775|Methylphenidate|methylphenidate|mesh-list
44419388|NCT05650775|Adderall|adderall|mesh-list
44236459|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44236460|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
44419389|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44419390|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419391|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44419392|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44419393|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419394|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419395|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
44419396|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419397|NCT05650723|Venetoclax|venetoclax|mesh-list
44419398|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
44419399|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
44419400|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419401|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419402|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44419403|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419404|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419405|NCT05650554|Vaccines|vaccines|mesh-list
44419406|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
44419407|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419408|NCT05650476|Talazoparib|talazoparib|mesh-list
44419409|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44419410|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419411|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419412|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419413|NCT05650437|Vitamin D|vitamin d|mesh-list
44419414|NCT05650437|Vitamins|vitamins|mesh-ancestor
44419415|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
44419416|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419417|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44419418|NCT05650268|Vitamin D|vitamin d|mesh-list
44419419|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
44419420|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
44419421|NCT05650268|Vitamins|vitamins|mesh-list
44419422|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
44419423|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419424|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44419425|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44419426|NCT05650216|Paclitaxel|paclitaxel|mesh-list
44419427|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44419444|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
44419445|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
44419446|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419447|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419448|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419449|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44419450|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44419451|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419452|NCT05650008|Anesthetics|anesthetics|mesh-list
44419453|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419454|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419455|NCT05649956|Letrozole|letrozole|mesh-list
44419456|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419457|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44419458|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44419459|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419460|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419461|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44419462|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
44419463|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419464|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419466|NCT05649943|Hormones|hormones|mesh-ancestor
44419467|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419468|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419469|NCT05649748|Treprostinil|treprostinil|mesh-list
44419470|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44419471|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
44419472|NCT05649618|Fludarabine|fludarabine|mesh-list
44419473|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419474|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
44419475|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115272|NCT00102141|Diuretics|diuretics|mesh-ancestor
44419476|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419477|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419478|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
44419479|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419480|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419481|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44419482|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
44419483|NCT05649605|Testosterone|testosterone|mesh-list
44419484|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
44419485|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
44419486|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44419508|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419509|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44419510|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44419511|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
44419512|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419513|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419514|NCT05649228|Capsaicin|capsaicin|mesh-list
44419515|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
44419516|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44419517|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
44419518|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419519|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419520|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44419521|NCT05649111|Difluprednate|difluprednate|mesh-list
44419522|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44419523|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
44419524|NCT05649111|Hormones|hormones|mesh-ancestor
44419525|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419526|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419527|NCT05649085|Cobalt|cobalt|mesh-list
44419528|NCT05649085|Chromium|chromium|mesh-list
44419529|NCT05649085|Trace Elements|trace elements|mesh-ancestor
44419530|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
44419531|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419532|NCT05649059|Cannabidiol|cannabidiol|mesh-list
44419533|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
44077268|NCT00014755|Hormones|hormones|mesh-ancestor
44419534|NCT05649020|Prilocaine|prilocaine|mesh-list
44419535|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
44419536|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
44419537|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419538|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419539|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
44419540|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419541|NCT05648994|Paclitaxel|paclitaxel|mesh-list
44419542|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
44419543|NCT05648994|Fludarabine|fludarabine|mesh-list
44419544|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44419569|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419570|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419571|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44419573|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419574|NCT05648591|Iloperidone|iloperidone|mesh-list
44419575|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44419576|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44419577|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419578|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419579|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44419580|NCT05648526|Ketamine|ketamine|mesh-list
44419581|NCT05648526|Analgesics|analgesics|mesh-ancestor
44419582|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
44419583|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419584|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419585|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44419586|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44419587|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
44419588|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
44419589|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419590|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44419591|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44419592|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419602|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830479|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44419616|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419617|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419618|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44419619|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44419620|NCT05648032|Triamcinolone|triamcinolone|mesh-list
44419621|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44419622|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44419623|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44419624|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419625|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
44419626|NCT05648032|Hormones|hormones|mesh-ancestor
44419627|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419628|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419629|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419630|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
44419631|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419632|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419645|NCT05647993|Azithromycin|azithromycin|mesh-list
44419646|NCT05647993|Cefazolin|cefazolin|mesh-list
44419647|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44419648|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419649|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
44419650|NCT05647954|Temozolomide|temozolomide|mesh-list
44419651|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
44419652|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419653|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419654|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419655|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
44419656|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419657|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44419658|NCT05647954|Estrogens|estrogens|mesh-ancestor
44419659|NCT05647954|Hormones|hormones|mesh-ancestor
44419678|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419679|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44419680|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44419682|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44077410|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
44419683|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419684|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419685|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44419687|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44419688|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44419689|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44419690|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
44419691|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
44419692|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
44419693|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
44419694|NCT05647512|Dexamethasone|dexamethasone|mesh-list
44236461|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419695|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419696|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
44419697|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
44419698|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419699|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419700|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419701|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
44419702|NCT05647512|Hormones|hormones|mesh-ancestor
44419703|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419704|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419705|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419706|NCT05647408|Dexamethasone|dexamethasone|mesh-list
44419707|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419708|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
44419709|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
44419710|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419711|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419712|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419713|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
44419714|NCT05647408|Hormones|hormones|mesh-ancestor
44419715|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419738|NCT05647330|Immunologic Factors|immunologic factors|mesh-ancestor
44419739|NCT05647330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419740|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
44419741|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44419742|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44419743|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419745|NCT05647278|Esomeprazole|esomeprazole|mesh-list
44419746|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44419747|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419748|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44419749|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419750|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419751|NCT05647265|Nivolumab|nivolumab|mesh-list
44419752|NCT05647265|Ipilimumab|ipilimumab|mesh-list
44419753|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419754|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419755|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44419756|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419758|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
44419759|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
44419760|NCT05646992|Azathioprine|azathioprine|mesh-list
44419761|NCT05646992|Tacrolimus|tacrolimus|mesh-list
44419762|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419763|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
44419764|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419765|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44419766|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419767|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419768|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
44419769|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419782|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419783|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419784|NCT05646719|Phentolamine|phentolamine|mesh-list
44419785|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44419786|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44419787|NCT05646719|Pilocarpine|pilocarpine|mesh-list
44419788|NCT05646719|Miotics|miotics|mesh-ancestor
44419789|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
44419790|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419791|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419792|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44419793|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44419794|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
44419795|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419796|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419797|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44419798|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44419799|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419800|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44419801|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
44419802|NCT05646693|Antacids|antacids|mesh-ancestor
44419803|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419804|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419806|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
44419807|NCT05646394|Aspirin|aspirin|mesh-list
44419808|NCT05646394|Vitamins|vitamins|mesh-list
44419809|NCT05646394|Vitamin K|vitamin k|mesh-list
44419810|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44419811|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
44419812|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419813|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44419814|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44419815|NCT05646394|Analgesics|analgesics|mesh-ancestor
44419816|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
44419817|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419818|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419819|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419820|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44419821|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44419822|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419823|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44419824|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419825|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
44419826|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44419827|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
44419828|NCT05646394|Coagulants|coagulants|mesh-ancestor
44419829|NCT05646303|Psilocybin|psilocybin|mesh-list
44419830|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
43868428|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419831|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419832|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44419833|NCT05646264|S 20098|s 20098|mesh-list
44419845|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
44419847|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419848|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419849|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
44419850|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419851|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
44419852|NCT05644873|Analgesics|analgesics|mesh-ancestor
44419853|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
44419854|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419855|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419856|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
44419857|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419858|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44419859|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
44419860|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44419861|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419862|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419863|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44419864|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
44419865|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44419866|NCT05644145|Vaccines|vaccines|mesh-list
44419867|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
44419868|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419869|NCT05643846|Bupivacaine|bupivacaine|mesh-list
44419870|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
44419871|NCT05643846|Anesthetics|anesthetics|mesh-list
44419872|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419873|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419874|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
44419875|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419876|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
44419877|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419878|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419879|NCT05642702|Vitamins|vitamins|mesh-list
44419880|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
44419881|NCT05642702|Niacinamide|niacinamide|mesh-list
44419883|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
44419884|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44419885|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
44419886|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419887|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
44419888|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419889|NCT05642702|Protective Agents|protective agents|mesh-ancestor
44419890|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
44419891|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44419892|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
44419893|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44419894|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
44419896|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
44419897|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
44419898|NCT05642182|Vitamins|vitamins|mesh-list
44419899|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
44419900|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419910|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419911|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419912|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
44419913|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419914|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419915|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
44419916|NCT05640934|Melatonin|melatonin|mesh-list
44419917|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
44419918|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419919|NCT05640934|Protective Agents|protective agents|mesh-ancestor
44419920|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419921|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419922|NCT05640596|Betamethasone|betamethasone|mesh-list
44419923|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419924|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
44419925|NCT05640596|Hormones|hormones|mesh-ancestor
44419926|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419927|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419928|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44419929|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44419930|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
44419931|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44419932|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44419933|NCT05640375|Prednisolone|prednisolone|mesh-list
44419934|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
44419935|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44419936|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
44419937|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419938|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
44419939|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
44419940|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419941|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419942|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419943|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
44419944|NCT05640375|Hormones|hormones|mesh-ancestor
44419945|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419946|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44419947|NCT05640375|Protective Agents|protective agents|mesh-ancestor
44419948|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419949|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419950|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44419951|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44419952|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419953|NCT05631041|Silymarin|silymarin|mesh-list
44419954|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
44419955|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419956|NCT05631041|Protective Agents|protective agents|mesh-ancestor
44419957|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419958|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
44419959|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44419960|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419961|NCT05630833|Renal Agents|renal agents|mesh-ancestor
44419962|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44419963|NCT05625776|Capsaicin|capsaicin|mesh-list
44419964|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
44419965|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44419966|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
44419978|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419979|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44419980|NCT05621616|Mirabegron|mirabegron|mesh-list
44419981|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44419982|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44419983|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44419984|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419985|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419986|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419987|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419988|NCT05621616|Urological Agents|urological agents|mesh-ancestor
44419989|NCT05619653|Prednisolone|prednisolone|mesh-list
44115590|NCT00101998|Alvimopan|alvimopan|mesh-list
44419990|NCT05619653|Losartan|losartan|mesh-list
44419991|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44419992|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
44419993|NCT05619653|Hormones|hormones|mesh-ancestor
44419994|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419995|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419996|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419997|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419998|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44419999|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420000|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44420001|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44420002|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420003|NCT05617209|Thrombin|thrombin|mesh-list
44420004|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
44420005|NCT05617209|Coagulants|coagulants|mesh-ancestor
44420006|NCT05615948|Ketamine|ketamine|mesh-list
44420007|NCT05615948|Analgesics|analgesics|mesh-ancestor
44420008|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
44420009|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420010|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420011|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420012|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44420013|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44420014|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
44420015|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
44420016|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420017|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44420018|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44420019|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420020|NCT05608057|Ascorbic Acid|ascorbic acid|mesh-list
44420021|NCT05608057|Vitamins|vitamins|mesh-ancestor
44420022|NCT05608057|Micronutrients|micronutrients|mesh-ancestor
44420023|NCT05608057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420024|NCT05608057|Antioxidants|antioxidants|mesh-ancestor
44420025|NCT05608057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420026|NCT05608057|Protective Agents|protective agents|mesh-ancestor
44420027|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
44420028|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420051|NCT05597878|Ketorolac|ketorolac|mesh-list
44420052|NCT05597878|Ketamine|ketamine|mesh-list
44420053|NCT05597878|Oxycodone|oxycodone|mesh-list
44420054|NCT05597878|Analgesics|analgesics|mesh-ancestor
44420055|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
44420056|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420057|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420058|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44420059|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44420060|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
44420061|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
44420062|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420063|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44420064|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44420065|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420066|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420067|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420068|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
44420069|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44420070|NCT05597878|Narcotics|narcotics|mesh-ancestor
44420071|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44420072|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420073|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420074|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44420075|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420076|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
44420077|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44420078|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420079|NCT05595603|Gentamicins|gentamicins|mesh-list
44420080|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44420081|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420082|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420089|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420090|NCT05592223|Isoniazid|isoniazid|mesh-list
44420091|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
44420092|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
44420093|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420094|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420095|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44420096|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44420097|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
44420098|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420099|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44420100|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44420101|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
44420102|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420103|NCT05590624|Phentermine|phentermine|mesh-list
44420104|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44420105|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420106|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
44420107|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44420108|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
44420109|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
44420110|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420111|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420112|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420113|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420114|NCT05587374|Gemcitabine|gemcitabine|mesh-list
44420115|NCT05587374|Cisplatin|cisplatin|mesh-list
44420116|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44420117|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420118|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44420119|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
44420120|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420121|NCT05587374|Antiviral Agents|antiviral agents|mesh-ancestor
44420122|NCT05587374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420123|NCT05587374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420124|NCT05587374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420125|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
44420126|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420127|NCT05582707|Pioglitazone|pioglitazone|mesh-list
44420128|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44420129|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420130|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
44420131|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420132|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420133|NCT05576662|Ritonavir|ritonavir|mesh-list
44420134|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44420135|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44420136|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420137|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420138|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420139|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420140|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420141|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
44420142|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420143|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44420144|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44420145|NCT05565235|Nalbuphine|nalbuphine|mesh-list
44420146|NCT05565235|Bupivacaine|bupivacaine|mesh-list
44420147|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
44420148|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
44420149|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420150|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420151|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
44420163|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
44420164|NCT05560360|Efavirenz|efavirenz|mesh-list
44420165|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44420166|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44420167|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420168|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420169|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
44420170|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420171|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44420172|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44420173|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44420174|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44420175|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44420176|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44420177|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
44420178|NCT05554939|Fludarabine|fludarabine|mesh-list
44420179|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
44420180|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420181|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
44420182|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420183|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420184|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44420185|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
44420186|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420187|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420188|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44420189|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44420190|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
44420191|NCT05545319|Ritonavir|ritonavir|mesh-list
44420192|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44420193|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44420194|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420195|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420196|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420197|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420198|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420199|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
44420200|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420201|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44420202|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44420203|NCT05544786|Ritonavir|ritonavir|mesh-list
44420204|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44420205|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44420206|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420207|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420208|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420209|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420210|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420211|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
44420212|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420213|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44420236|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
44420237|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420238|NCT05544071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44420239|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44420240|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420241|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420242|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420243|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
44420244|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420245|NCT05536219|Antibodies|antibodies|mesh-list
44420246|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
44420247|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420248|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
44420249|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420250|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420251|NCT05497583|Factor VIII|factor viii|mesh-list
44420252|NCT05497583|Coagulants|coagulants|mesh-ancestor
44420253|NCT05493566|Aldesleukin|aldesleukin|mesh-list
44420254|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
44420255|NCT05493566|Interleukin-2|interleukin-2|mesh-list
44420256|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420257|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420258|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420259|NCT05493566|Analgesics|analgesics|mesh-ancestor
44420260|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
44420261|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420262|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420263|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420264|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420265|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
44420266|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420267|NCT05483010|Atorvastatin|atorvastatin|mesh-list
44420300|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44420301|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420302|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420303|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
44420304|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420305|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420306|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
44420307|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
44420308|NCT05436054|Cathartics|cathartics|mesh-ancestor
44420309|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44420310|NCT05429463|Paclitaxel|paclitaxel|mesh-list
44420311|NCT05429463|Carboplatin|carboplatin|mesh-list
44420312|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44420313|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44420314|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420315|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
44420316|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
44420317|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
44420345|NCT05364762|Tacrolimus|tacrolimus|mesh-list
44420346|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420347|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
44420348|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420349|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420350|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44420351|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
44420352|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420353|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420354|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44420355|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44420356|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078311|NCT00016939|Alvocidib|alvocidib|mesh-list
44420357|NCT05358587|Anesthetics|anesthetics|mesh-list
44420358|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
44420359|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44420360|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420361|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420362|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
44420363|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420400|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420401|NCT05327738|Atezolizumab|atezolizumab|mesh-list
44420402|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44420436|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44420437|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44420438|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
44420439|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
44420440|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420441|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44420442|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44420443|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420471|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420472|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
44420473|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420474|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
44420475|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
44420476|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
44420477|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44420478|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44420479|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420480|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420481|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420482|NCT05253833|Allopurinol|allopurinol|mesh-list
44420483|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
44420484|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420485|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420486|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
44420487|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420488|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44420489|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
44420490|NCT05253833|Protective Agents|protective agents|mesh-ancestor
44420527|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420553|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420554|NCT05206084|Sirolimus|sirolimus|mesh-list
44420555|NCT05206084|Everolimus|everolimus|mesh-list
44420556|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420557|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420558|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
44420559|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420560|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420561|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420562|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44420563|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
44420564|NCT05198362|Metoprolol|metoprolol|mesh-list
44420568|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
44420569|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420570|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420571|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44420572|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44420573|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44420574|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420575|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420597|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420598|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420600|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420601|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44420602|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420603|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420604|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
44420605|NCT05152420|Apixaban|apixaban|mesh-list
44420606|NCT05152420|Edoxaban|edoxaban|mesh-list
44420607|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44420608|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
44420609|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44420610|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420611|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420612|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420613|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
44420614|NCT05147415|Metoprolol|metoprolol|mesh-list
44420615|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44420616|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420617|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
44420618|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
44420619|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420620|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420621|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44420622|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44420623|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44420624|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420625|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420626|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420627|NCT05142228|Erenumab|erenumab|mesh-list
44420661|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
44420662|NCT05114460|Naloxone|naloxone|mesh-list
44420663|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44420664|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420665|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
44420666|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420667|NCT05111574|Nivolumab|nivolumab|mesh-list
44420690|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44420691|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44420692|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420693|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420694|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420696|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
44420697|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420698|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44420699|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44420700|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44420701|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420702|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420703|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420704|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420705|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420706|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44420707|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43868921|NCT00254384|Cisplatin|cisplatin|mesh-list
44420708|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420709|NCT05069740|Analgesics|analgesics|mesh-ancestor
44420710|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
44420711|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420712|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420713|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420715|NCT05065970|Felzartamab|felzartamab|mesh-list
44420751|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44420752|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420753|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
44420754|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
44420755|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44420762|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420763|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
44420764|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420765|NCT05011513|Ritonavir|ritonavir|mesh-list
44420766|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44420767|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44420768|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
44420769|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420770|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420771|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420772|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420773|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
44420774|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420775|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44420776|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44420777|NCT05007821|Linezolid|linezolid|mesh-list
44420778|NCT05007821|Bedaquiline|bedaquiline|mesh-list
44420779|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
44420780|NCT05007821|Clofazimine|clofazimine|mesh-list
44420781|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420782|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420783|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44420784|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420785|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420786|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
44420787|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420788|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
44420789|NCT05006573|Benralizumab|benralizumab|mesh-list
44420790|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44420791|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44420792|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
44420793|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420794|NCT04988308|Adalimumab|adalimumab|mesh-list
44420795|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420796|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420797|NCT04984798|Vitamin E|vitamin e|mesh-list
44420798|NCT04984798|Tocopherols|tocopherols|mesh-list
44420799|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
44420800|NCT04984798|Vitamins|vitamins|mesh-ancestor
44420801|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
44420802|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420803|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
44420804|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420805|NCT04984798|Protective Agents|protective agents|mesh-ancestor
44420806|NCT04974528|Insulin|insulin|mesh-list
44420807|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44420808|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
44420809|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
44420810|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
44420811|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
44420812|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
44420813|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
44420814|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44420815|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420816|NCT04969276|Vaccines|vaccines|mesh-list
44420817|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
44420818|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420819|NCT04969198|Nicotine|nicotine|mesh-list
44420820|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44420822|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420823|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420824|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44420825|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44420826|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
44420827|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420836|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420837|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
44420838|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44236463|NCT00559455|Protective Agents|protective agents|mesh-ancestor
44420840|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
44420841|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44420842|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44420843|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420844|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420845|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44420846|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44420847|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420848|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44420849|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
44420850|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
44420851|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
44420852|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
44420853|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420854|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420855|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44420856|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420857|NCT04957368|Analgesics|analgesics|mesh-ancestor
44420858|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
44420859|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420860|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
44420861|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
44420862|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
44420863|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
44420864|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420865|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420867|NCT04928703|Analgesics|analgesics|mesh-ancestor
44420868|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
44420869|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420870|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420871|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44420872|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44420873|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
44420874|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
44420875|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420876|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44420877|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44420878|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420879|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420880|NCT04925284|Bevacizumab|bevacizumab|mesh-list
44420881|NCT04925284|Nivolumab|nivolumab|mesh-list
44420882|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420883|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420884|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44420885|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44420886|NCT04925284|Growth Substances|growth substances|mesh-ancestor
44420887|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420888|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44420889|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44420890|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420891|NCT04907851|Denosumab|denosumab|mesh-list
44420892|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
44420928|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420929|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420930|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420944|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420946|NCT04810156|Prednisone|prednisone|mesh-list
44420947|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
44420948|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44420949|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44420950|NCT04810156|Prednisolone|prednisolone|mesh-list
44420951|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
44420952|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44420953|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44420954|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
44420955|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420956|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
44420957|NCT04810156|Hormones|hormones|mesh-ancestor
44420958|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44420959|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420960|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44420961|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420962|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44420963|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44420964|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
44420965|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420966|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420967|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420968|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420969|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
44420970|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
44420971|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420972|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44420973|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44420974|NCT04810156|Protective Agents|protective agents|mesh-ancestor
44420975|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44420976|NCT04792567|Siponimod|siponimod|mesh-list
44420977|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44420978|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420979|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420980|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
44420981|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420982|NCT04791566|Dexamethasone|dexamethasone|mesh-list
44420983|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420984|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
44420985|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
44420986|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420987|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420988|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44420989|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
44420990|NCT04791566|Hormones|hormones|mesh-ancestor
44421007|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44421008|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44421009|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421010|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421011|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44421012|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44421013|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
44421014|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
44421015|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44421016|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44421017|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44421018|NCT04791059|Narcotics|narcotics|mesh-ancestor
44421019|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44421020|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44421021|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421022|NCT04781647|Interferons|interferons|mesh-list
44421023|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
44421024|NCT04781647|Entecavir|entecavir|mesh-list
44421025|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421026|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
44421027|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421028|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
44421029|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421030|NCT04762498|Methotrexate|methotrexate|mesh-list
44421031|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44421032|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
44421033|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44421034|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421035|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44421036|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
44421037|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421038|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421039|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44421040|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421041|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44421042|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421043|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
44421044|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421045|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421046|NCT04756726|Dexamethasone|dexamethasone|mesh-list
44421047|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421048|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
44421049|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
44421063|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421064|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44236464|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
44421065|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44421066|NCT04745299|Protective Agents|protective agents|mesh-ancestor
44421067|NCT04740931|Aflibercept|aflibercept|mesh-list
44421068|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44421069|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44421070|NCT04740931|Growth Substances|growth substances|mesh-ancestor
44421071|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421072|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44421073|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421074|NCT04740905|Aflibercept|aflibercept|mesh-list
44421075|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44421076|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44421077|NCT04740905|Growth Substances|growth substances|mesh-ancestor
44421078|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421079|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
44421080|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421081|NCT04736173|Paclitaxel|paclitaxel|mesh-list
44421082|NCT04736173|Carboplatin|carboplatin|mesh-list
44421083|NCT04736173|Pemetrexed|pemetrexed|mesh-list
44421084|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421085|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421086|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421087|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421088|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421089|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421090|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421091|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44421092|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421093|NCT04730349|Nivolumab|nivolumab|mesh-list
44421094|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421095|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421096|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44421097|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421098|NCT04729608|Paclitaxel|paclitaxel|mesh-list
44421099|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421100|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421101|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421102|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421103|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421104|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421105|NCT04721015|Docetaxel|docetaxel|mesh-list
44421106|NCT04721015|Osimertinib|osimertinib|mesh-list
43869173|NCT04783753|Quinidine|quinidine|mesh-list
44421107|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421108|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421109|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421110|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421141|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421143|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44421144|NCT04659317|Narcotics|narcotics|mesh-ancestor
44421145|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421146|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421147|NCT04659317|Analgesics|analgesics|mesh-ancestor
44421148|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
44421149|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421150|NCT04654208|Palbociclib|palbociclib|mesh-list
44421151|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421152|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421153|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421154|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421155|NCT04652960|Nivolumab|nivolumab|mesh-list
44421167|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44421168|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421169|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44421171|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44421172|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421173|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421174|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44421175|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44421176|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44421177|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421178|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
44421179|NCT04638881|Analgesics|analgesics|mesh-ancestor
44421180|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
44421181|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421182|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421183|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
44421184|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421185|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44421186|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
44421187|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44421188|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44421189|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421190|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44079226|NCT00512070|Olanzapine|olanzapine|mesh-list
44421191|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
44421192|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44421193|NCT04625257|Antibodies|antibodies|mesh-list
44421194|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
44421195|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421196|NCT04623931|Temozolomide|temozolomide|mesh-list
44421197|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44421198|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
44421199|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421200|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421201|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
44421202|NCT04621526|Ketamine|ketamine|mesh-list
44421203|NCT04621526|Propofol|propofol|mesh-list
44421204|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44421205|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421206|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421207|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44421208|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
44421209|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
44421210|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421211|NCT04621526|Analgesics|analgesics|mesh-ancestor
44421212|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
44421213|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421214|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44421215|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44421226|NCT04612751|Durvalumab|durvalumab|mesh-list
44421227|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421228|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421229|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
44421230|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44421231|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421232|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421233|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421234|NCT04608331|Analgesics|analgesics|mesh-ancestor
44421235|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
44421236|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421237|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44421238|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44421239|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44421240|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
44421241|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421242|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421243|NCT04606446|Letrozole|letrozole|mesh-list
44421244|NCT04606446|Fulvestrant|fulvestrant|mesh-list
44421245|NCT04606446|Palbociclib|palbociclib|mesh-list
44421246|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421247|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44421248|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44421249|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421250|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421251|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44421252|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
44421253|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421254|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421255|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421256|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44421257|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421258|NCT04589546|Niacinamide|niacinamide|mesh-list
44421259|NCT04589546|Niacin|niacin|mesh-list
44421260|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
44421261|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
44421262|NCT04589546|Vitamins|vitamins|mesh-ancestor
44421263|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
44421264|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421265|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44421266|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
44421267|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421269|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44421270|NCT04586985|Midazolam|midazolam|mesh-list
44421271|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44421272|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44421273|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421274|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421275|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44421276|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44421277|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421278|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44421279|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
44421280|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
44421281|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
44421295|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421297|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421298|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
44421299|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
44421300|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421301|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
44421302|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44421303|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
44421304|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421305|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421306|NCT04569747|Tamoxifen|tamoxifen|mesh-list
44421307|NCT04569747|Trastuzumab|trastuzumab|mesh-list
44421308|NCT04569747|Pertuzumab|pertuzumab|mesh-list
44421309|NCT04569747|Letrozole|letrozole|mesh-list
44421310|NCT04569747|Anastrozole|anastrozole|mesh-list
44421311|NCT04569747|Leuprolide|leuprolide|mesh-list
44421312|NCT04569747|Exemestane|exemestane|mesh-list
44421313|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421314|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421315|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44421316|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44421317|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421318|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421319|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44421320|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
44421321|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421322|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421323|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421324|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44421325|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44421326|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44421327|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44421328|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
44421329|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44421330|NCT04569084|Edaravone|edaravone|mesh-list
44421331|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44421332|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
44421333|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421334|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44421335|NCT04569084|Protective Agents|protective agents|mesh-ancestor
44421336|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421337|NCT04564872|Linagliptin|linagliptin|mesh-list
44421338|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44421339|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421340|NCT04564872|Incretins|incretins|mesh-ancestor
44421341|NCT04564872|Hormones|hormones|mesh-ancestor
44421355|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421356|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
44421357|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421358|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421359|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44421360|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
44421361|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421362|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421363|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44421365|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44421366|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421367|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
44421368|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421369|NCT04546126|Dexamethasone|dexamethasone|mesh-list
44421370|NCT04546126|Cosyntropin|cosyntropin|mesh-list
44421371|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421372|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
44421373|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
44421374|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421375|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421376|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421377|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
44421378|NCT04546126|Hormones|hormones|mesh-ancestor
44421379|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421380|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421381|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421382|NCT04536467|Goserelin|goserelin|mesh-list
44421383|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421384|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421385|NCT04532372|Leflunomide|leflunomide|mesh-list
44421386|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421387|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421388|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421389|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
44421390|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421391|NCT04531982|Pimavanserin|pimavanserin|mesh-list
44421392|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44421393|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44421394|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44421395|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44421396|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421397|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421398|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421399|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44421400|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44421401|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
44421402|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421412|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421414|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
44079439|NCT05567562|Clopidogrel|clopidogrel|mesh-list
44421415|NCT04525547|Nintedanib|nintedanib|mesh-list
44421416|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421417|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421418|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421419|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421420|NCT04524689|Cisplatin|cisplatin|mesh-list
44421421|NCT04524689|Carboplatin|carboplatin|mesh-list
44421422|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
44421423|NCT04524689|Pemetrexed|pemetrexed|mesh-list
44421424|NCT04524689|Maytansine|maytansine|mesh-list
44421425|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421426|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421427|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421428|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421429|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44421430|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421431|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421432|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421433|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421434|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421435|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44421436|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44421437|NCT04522973|Ethanol|ethanol|mesh-list
44421438|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44421439|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421440|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421441|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421442|NCT04513184|Dexamethasone|dexamethasone|mesh-list
44421443|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
44421444|NCT04513184|BB 1101|bb 1101|mesh-list
44421445|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421446|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
44421447|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
43830480|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44421448|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421449|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421450|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421451|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
44421452|NCT04513184|Hormones|hormones|mesh-ancestor
44421453|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421454|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421455|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421456|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
44421457|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421458|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421459|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
44421460|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421461|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421462|NCT04504669|Durvalumab|durvalumab|mesh-list
44421463|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421464|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421465|NCT04485104|Cannabidiol|cannabidiol|mesh-list
44421466|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
44079513|NCT05527704|Albuterol|albuterol|mesh-list
44421467|NCT04481009|Gemcitabine|gemcitabine|mesh-list
44421481|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
44421482|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421483|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
44421484|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421485|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421487|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421488|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421489|NCT04471428|Docetaxel|docetaxel|mesh-list
44421490|NCT04471428|Atezolizumab|atezolizumab|mesh-list
44421491|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421492|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421493|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421494|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421495|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421496|NCT04468984|Navitoclax|navitoclax|mesh-list
44421497|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421498|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
44421499|NCT04464759|Nivolumab|nivolumab|mesh-list
44421500|NCT04464759|Ipilimumab|ipilimumab|mesh-list
44421501|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421502|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421503|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44421504|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421505|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
44421506|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44421507|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44421508|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421509|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421510|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421511|NCT04464512|Sufentanil|sufentanil|mesh-list
44421512|NCT04464512|Buprenorphine|buprenorphine|mesh-list
44421513|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44421514|NCT04464512|Narcotics|narcotics|mesh-ancestor
44421515|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421516|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421517|NCT04464512|Analgesics|analgesics|mesh-ancestor
44421518|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
44421519|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421520|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44421521|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44421522|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44421523|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
44421524|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
44421525|NCT04458922|Atezolizumab|atezolizumab|mesh-list
44421526|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44421527|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421528|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
44421529|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421530|NCT04458259|Axitinib|axitinib|mesh-list
44421531|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421548|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
44421549|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421550|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421551|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44421552|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421553|NCT04428385|Artemisinins|artemisinins|mesh-list
44421554|NCT04428385|Artemisinin|artemisinin|mesh-list
44421555|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
44421556|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44421557|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44421558|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421559|NCT04426968|Interferons|interferons|mesh-list
44421560|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421561|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
44421562|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421563|NCT04421378|Bevacizumab|bevacizumab|mesh-list
44421564|NCT04421378|Temozolomide|temozolomide|mesh-list
44421565|NCT04421378|Carmustine|carmustine|mesh-list
44421566|NCT04421378|Lomustine|lomustine|mesh-list
44421567|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421568|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421569|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44421570|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44421571|NCT04421378|Growth Substances|growth substances|mesh-ancestor
44421572|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421573|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
44421574|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44421575|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
44421576|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421577|NCT04390581|Lidocaine|lidocaine|mesh-list
44421578|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
44421579|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
44421580|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421581|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421582|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
44421583|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421584|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44421585|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44421586|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44421587|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44421588|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421600|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44421601|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44421602|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421603|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421604|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421605|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421606|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
44421607|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44421608|NCT04327934|Testosterone|testosterone|mesh-list
44421609|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
44421610|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
44421611|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44421612|NCT04327934|Hormones|hormones|mesh-ancestor
44421613|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421614|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421615|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421616|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421617|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
44421618|NCT04327934|Androgens|androgens|mesh-ancestor
44421619|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
44421620|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421621|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421623|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421624|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421625|NCT04311502|Pyridoxine|pyridoxine|mesh-list
44421626|NCT04311502|Pyridoxal|pyridoxal|mesh-list
44421627|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
44421628|NCT04311502|Rifampin|rifampin|mesh-list
44421629|NCT04311502|Rifapentine|rifapentine|mesh-list
44421630|NCT04311502|Clofazimine|clofazimine|mesh-list
44421631|NCT04311502|Isoniazid|isoniazid|mesh-list
44421632|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
44421633|NCT04311502|Ethambutol|ethambutol|mesh-list
44421634|NCT04311502|Vitamins|vitamins|mesh-ancestor
44421635|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
44421636|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421637|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
44421638|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44421639|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
44421640|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44421641|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421642|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
43830481|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44236467|NCT00559481|Ketoconazole|ketoconazole|mesh-list
44421643|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421644|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421645|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421646|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44421647|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44421648|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44421649|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44421650|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44421651|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44421652|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44421653|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44421654|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
44421670|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
44421671|NCT04307576|Hormones|hormones|mesh-ancestor
44421672|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421673|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421674|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421675|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44421676|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44421677|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44421678|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421679|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421680|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421681|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421682|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421683|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421684|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421685|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421686|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44421687|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
44421688|NCT04306315|Brodalumab|brodalumab|mesh-list
44421689|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
44421690|NCT04285853|Oxycodone|oxycodone|mesh-list
44421691|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44421692|NCT04285853|Narcotics|narcotics|mesh-ancestor
44421693|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421694|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421695|NCT04285853|Analgesics|analgesics|mesh-ancestor
44421696|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
44421697|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421698|NCT04267081|Venetoclax|venetoclax|mesh-list
44421699|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421700|NCT04266275|Curcumin|curcumin|mesh-list
44421701|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44421702|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421703|NCT04266275|Analgesics|analgesics|mesh-ancestor
44421704|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
44421705|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421706|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421707|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421708|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421709|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421710|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421711|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421712|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44421713|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44421714|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44421715|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421716|NCT04259658|Calcium|calcium|mesh-list
44421754|NCT04225767|Calcium|calcium|mesh-list
44421766|NCT04224493|Growth Substances|growth substances|mesh-ancestor
44421767|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
44421769|NCT04222504|Emtricitabine|emtricitabine|mesh-list
44421770|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
44421771|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421772|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44421773|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421774|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421775|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421776|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44421777|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44421778|NCT04207190|Talazoparib|talazoparib|mesh-list
44421779|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
44421780|NCT04207190|Calicheamicins|calicheamicins|mesh-list
44421781|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44421782|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421783|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421784|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421785|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421786|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44421787|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
44421788|NCT04196413|Fludarabine|fludarabine|mesh-list
44421789|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421790|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
44421791|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421792|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421793|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44421794|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
44421795|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421796|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421797|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44421798|NCT04190550|Cytarabine|cytarabine|mesh-list
44421799|NCT04190550|Idarubicin|idarubicin|mesh-list
44421800|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44421801|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
44421802|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421803|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421804|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
44421805|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421806|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421807|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
44421808|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421809|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44421810|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44421811|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44421812|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421813|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44421814|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421815|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421816|NCT04178642|Idarubicin|idarubicin|mesh-list
44421817|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
44421830|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421831|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421832|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421833|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421834|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421835|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421836|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44421837|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421838|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
44421839|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
44421840|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44421841|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421842|NCT04157348|Benralizumab|benralizumab|mesh-list
44421843|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44421844|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
44421845|NCT04145440|Felzartamab|felzartamab|mesh-list
44421846|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421847|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
44421848|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421849|NCT04129736|Teriflunomide|teriflunomide|mesh-list
44421850|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44421851|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421852|NCT04129736|Analgesics|analgesics|mesh-ancestor
44421853|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
44421854|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421855|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421856|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421857|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421858|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421859|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
44421860|NCT04129502|Cisplatin|cisplatin|mesh-list
44421861|NCT04129502|Carboplatin|carboplatin|mesh-list
44421862|NCT04129502|Pemetrexed|pemetrexed|mesh-list
44421863|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421864|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421865|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421866|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44421867|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44421868|NCT04114539|Ecopipam|ecopipam|mesh-list
44421869|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44421870|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44421871|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421872|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421873|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421874|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44421875|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
44421876|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421877|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421878|NCT04093323|Interferons|interferons|mesh-list
44421879|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
44421880|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
44421881|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44421899|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421900|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421901|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44421903|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421904|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421905|NCT04091217|Bevacizumab|bevacizumab|mesh-list
44421906|NCT04091217|Atezolizumab|atezolizumab|mesh-list
44421907|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421908|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421909|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44421910|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44421911|NCT04091217|Growth Substances|growth substances|mesh-ancestor
44421912|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421913|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
44421914|NCT04076462|Octreotide|octreotide|mesh-list
44421915|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421916|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421917|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421918|NCT04060277|Acetic Acid|acetic acid|mesh-list
44421919|NCT04060277|Letermovir|letermovir|mesh-list
44421920|NCT04060277|Vaccines|vaccines|mesh-list
44421921|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
44421922|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421923|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44421924|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421925|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421926|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421927|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421928|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44421929|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
44421930|NCT04050436|Cemiplimab|cemiplimab|mesh-list
44421931|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421932|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421933|NCT04028050|Carboplatin|carboplatin|mesh-list
44421934|NCT04028050|Etoposide|etoposide|mesh-list
44421935|NCT04028050|Atezolizumab|atezolizumab|mesh-list
44421936|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421937|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421938|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44421939|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44421950|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44421951|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
44421952|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421953|NCT04013555|Expectorants|expectorants|mesh-ancestor
44421954|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
44421955|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44421956|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
44421957|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421958|NCT04013555|Protective Agents|protective agents|mesh-ancestor
44421959|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421960|NCT04013555|Antidotes|antidotes|mesh-ancestor
44421961|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44421962|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
44421963|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421964|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
44421965|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421966|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
44421967|NCT04001647|Nitroprusside|nitroprusside|mesh-list
44236468|NCT00559481|Dexamethasone|dexamethasone|mesh-list
44421968|NCT04001647|Acetylcholine|acetylcholine|mesh-list
44421970|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
44421971|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421972|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
44421973|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421974|NCT04001647|Protective Agents|protective agents|mesh-ancestor
44421975|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44421976|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
44421977|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44421978|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44421979|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
44421980|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421981|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
44421982|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
44421983|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
44421984|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421985|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421986|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421987|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44421988|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44421989|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421990|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44421991|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44421992|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
44421993|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421994|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421995|NCT03943901|Prednisone|prednisone|mesh-list
44421996|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
44421997|NCT03943901|Rituximab|rituximab|mesh-list
44421998|NCT03943901|Doxorubicin|doxorubicin|mesh-list
44421999|NCT03943901|Vincristine|vincristine|mesh-list
44422000|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422001|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
44422002|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422003|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422004|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422005|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
44422006|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422007|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422008|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422033|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
44422034|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422035|NCT03934684|Dexamethasone|dexamethasone|mesh-list
44422036|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
44422037|NCT03934684|Lenalidomide|lenalidomide|mesh-list
44422038|NCT03934684|BB 1101|bb 1101|mesh-list
44422039|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422040|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
44422041|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
44422042|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422043|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422044|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422045|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
44422046|NCT03934684|Hormones|hormones|mesh-ancestor
44422047|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422048|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422049|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422050|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
44422051|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422052|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422053|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
44422054|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44422055|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44422056|NCT03934684|Growth Substances|growth substances|mesh-ancestor
44422057|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44422058|NCT03905889|Sunitinib|sunitinib|mesh-list
44422059|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422060|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44422091|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422093|NCT03875092|Paclitaxel|paclitaxel|mesh-list
44422094|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44422095|NCT03875092|Carboplatin|carboplatin|mesh-list
44422096|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
44422097|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422098|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422100|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422101|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422122|NCT03846765|Protective Agents|protective agents|mesh-ancestor
44422123|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44422124|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44422125|NCT03840148|Meropenem|meropenem|mesh-list
44422126|NCT03840148|Cefepime|cefepime|mesh-list
44422127|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44422128|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422129|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
44422130|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44422131|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44422132|NCT03822897|Cisplatin|cisplatin|mesh-list
44422133|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422134|NCT03800693|Leucovorin|leucovorin|mesh-list
44422135|NCT03800693|Fluorouracil|fluorouracil|mesh-list
44422136|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
44422137|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
44422138|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422139|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422140|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422141|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422142|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
44422143|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422144|NCT03800693|Antidotes|antidotes|mesh-ancestor
44422145|NCT03800693|Protective Agents|protective agents|mesh-ancestor
44422146|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
44422147|NCT03800693|Vitamins|vitamins|mesh-ancestor
44422148|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
44422149|NCT03783182|Betamethasone|betamethasone|mesh-list
44422150|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
44422151|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44422152|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
44422153|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44422154|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
44422155|NCT03783182|Hormones|hormones|mesh-ancestor
44422156|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422157|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422166|NCT03778554|Metoprolol|metoprolol|mesh-list
44422167|NCT03778554|Carvedilol|carvedilol|mesh-list
44422168|NCT03778554|Nebivolol|nebivolol|mesh-list
44422169|NCT03778554|Bisoprolol|bisoprolol|mesh-list
44422170|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44422171|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44422172|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
44422173|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
44422174|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422175|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422176|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44422177|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44422178|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44422179|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
44422180|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44422181|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422182|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
44422183|NCT03778554|Protective Agents|protective agents|mesh-ancestor
44422184|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44422185|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44422186|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44422187|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44422188|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44422189|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44422190|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44422191|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44422192|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44422193|NCT03775486|Gemcitabine|gemcitabine|mesh-list
44422194|NCT03775486|Paclitaxel|paclitaxel|mesh-list
44422195|NCT03775486|Cisplatin|cisplatin|mesh-list
44422196|NCT03775486|Carboplatin|carboplatin|mesh-list
44422197|NCT03775486|Pemetrexed|pemetrexed|mesh-list
44422198|NCT03775486|Durvalumab|durvalumab|mesh-list
44422199|NCT03775486|Olaparib|olaparib|mesh-list
44422200|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44422201|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422202|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422203|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422204|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422205|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422206|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422207|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422208|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
44422209|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
44422210|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422211|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422212|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422213|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
44422214|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422215|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44422216|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422217|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422218|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44422219|NCT03774875|Apremilast|apremilast|mesh-list
44422220|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44422221|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44422222|NCT03774875|Analgesics|analgesics|mesh-ancestor
44422223|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
44422224|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422254|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422256|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
44422257|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44422258|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44422259|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422260|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422261|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44422262|NCT03769181|Cemiplimab|cemiplimab|mesh-list
44422263|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422264|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422265|NCT03768570|Durvalumab|durvalumab|mesh-list
44422266|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422287|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422294|NCT03703297|Durvalumab|durvalumab|mesh-list
44422295|NCT03703297|Tremelimumab|tremelimumab|mesh-list
44422296|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422297|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422298|NCT03682276|Nivolumab|nivolumab|mesh-list
44422299|NCT03682276|Ipilimumab|ipilimumab|mesh-list
44422300|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422301|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422302|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44422303|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422304|NCT03653507|Capecitabine|capecitabine|mesh-list
44422305|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
44422306|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422307|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
44422308|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422309|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422310|NCT03635788|Rilpivirine|rilpivirine|mesh-list
44422311|NCT03635788|Cabotegravir|cabotegravir|mesh-list
44422312|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44422313|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422314|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422315|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422316|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
44422317|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422318|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44422319|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44422320|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44422321|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44422322|NCT03624101|Ivacaftor|ivacaftor|mesh-list
44422355|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422356|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422357|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422358|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422359|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422360|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422361|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422362|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44422363|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43616356|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
44116976|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44422379|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44422381|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422382|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44422383|NCT03563222|SMOFlipid|smoflipid|mesh-list
44422384|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44422385|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44422386|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44422387|NCT03560349|Lidocaine|lidocaine|mesh-list
44422388|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
44422389|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
44422390|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44422391|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422392|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
44422393|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422394|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44422395|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44422396|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44422397|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44422398|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422399|NCT03544281|Dexamethasone|dexamethasone|mesh-list
44422400|NCT03544281|Lenalidomide|lenalidomide|mesh-list
44422401|NCT03544281|Bortezomib|bortezomib|mesh-list
44422402|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422403|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
44422404|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
44422405|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422406|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422407|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422408|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
44422409|NCT03544281|Hormones|hormones|mesh-ancestor
44422410|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422411|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422412|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422413|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
44422414|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44422415|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44422416|NCT03544281|Growth Substances|growth substances|mesh-ancestor
44422417|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44422418|NCT03541902|Sunitinib|sunitinib|mesh-list
44422419|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422420|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44422432|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422433|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
44422434|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422435|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44422436|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44422438|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
44422439|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
44422440|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422441|NCT03507491|Gemcitabine|gemcitabine|mesh-list
44422442|NCT03507491|Paclitaxel|paclitaxel|mesh-list
44422443|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422444|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422445|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422446|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422447|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422448|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422449|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422450|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
44422451|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
44422452|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422453|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422454|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422455|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
44422456|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422458|NCT03505320|Folic Acid|folic acid|mesh-list
44422459|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
44422460|NCT03505320|Nivolumab|nivolumab|mesh-list
44422461|NCT03505320|Fluorouracil|fluorouracil|mesh-list
44422462|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
44422463|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
44422464|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422465|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155683|NCT00227942|Zolpidem|zolpidem|mesh-list
44422467|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422469|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422470|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
44422471|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422472|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44422473|NCT03505320|Antidotes|antidotes|mesh-ancestor
44422474|NCT03505320|Protective Agents|protective agents|mesh-ancestor
44422475|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
44422476|NCT03505320|Vitamins|vitamins|mesh-ancestor
44422477|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
44422478|NCT03505320|Hematinics|hematinics|mesh-ancestor
44422479|NCT03498716|Paclitaxel|paclitaxel|mesh-list
44422480|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
44422481|NCT03498716|Doxorubicin|doxorubicin|mesh-list
44422482|NCT03498716|Atezolizumab|atezolizumab|mesh-list
44422483|NCT03498716|Epirubicin|epirubicin|mesh-list
44422517|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422518|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422519|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44422520|NCT03475186|Ramipril|ramipril|mesh-list
44422521|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44422522|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
44422523|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422536|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44422537|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
44422538|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422539|NCT03368729|Trastuzumab|trastuzumab|mesh-list
44422540|NCT03368729|Niraparib|niraparib|mesh-list
44422541|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422542|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422543|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44422544|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422545|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422546|NCT03341078|Ibudilast|ibudilast|mesh-list
44422547|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44422548|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
44422549|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422550|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422551|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44422552|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44422553|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44422554|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422555|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422556|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44422557|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44422558|NCT03312699|Vaccines|vaccines|mesh-list
44422559|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
44422560|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422561|NCT03301857|Denosumab|denosumab|mesh-list
44422562|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
44422563|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
44422564|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
44422565|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422566|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44422567|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44422568|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44422569|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
44422570|NCT03263559|Thiotepa|thiotepa|mesh-list
44422571|NCT03263559|Fludarabine|fludarabine|mesh-list
44422572|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
44422573|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
44422574|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080568|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
44422575|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
44422576|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422577|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422578|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422579|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
44422580|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422581|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422582|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422583|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
44422605|NCT03253263|Mecasermin|mecasermin|mesh-list
44422606|NCT03253263|Growth Substances|growth substances|mesh-ancestor
44422607|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422608|NCT03215030|Dexamethasone|dexamethasone|mesh-list
44422609|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422610|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
44422611|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
44422612|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422613|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422614|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422615|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
44422616|NCT03215030|Hormones|hormones|mesh-ancestor
44422617|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422618|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422619|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422620|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
44422621|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422622|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422623|NCT03178864|Heparin|heparin|mesh-list
44422624|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
44422625|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
44422626|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44422627|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44422628|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422629|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44422630|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
44422631|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44422632|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
44422633|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422634|NCT03172494|Insulin|insulin|mesh-list
44422635|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44422636|NCT03172494|Liraglutide|liraglutide|mesh-list
44422637|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
44422638|NCT03172494|Xultophy|xultophy|mesh-list
44422639|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44422640|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422641|NCT03172494|Incretins|incretins|mesh-ancestor
44422642|NCT03172494|Hormones|hormones|mesh-ancestor
44422665|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422666|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422668|NCT03119064|Temozolomide|temozolomide|mesh-list
44422669|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44422670|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44422671|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422672|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422673|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422674|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422675|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
44422676|NCT03101748|Paclitaxel|paclitaxel|mesh-list
44422677|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
44422678|NCT03101748|Doxorubicin|doxorubicin|mesh-list
44422679|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44422680|NCT03101748|Trastuzumab|trastuzumab|mesh-list
44422681|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44422682|NCT03101748|Daunorubicin|daunorubicin|mesh-list
44422683|NCT03101748|Pertuzumab|pertuzumab|mesh-list
44422684|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44422685|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44422686|NCT03101748|Antibodies|antibodies|mesh-list
44422687|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
44422688|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44422689|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422690|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422691|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422692|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422693|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422730|NCT03029000|Lenograstim|lenograstim|mesh-list
44422731|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44422767|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44422768|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422771|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422785|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
44422786|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44422787|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
44422788|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44422789|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422790|NCT02991456|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44422791|NCT02991456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44422792|NCT02991456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44422793|NCT02991456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44422794|NCT02991456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44422795|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44422796|NCT02987686|Infliximab|infliximab|mesh-list
44422797|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44422798|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422799|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422800|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44422801|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422802|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422803|NCT02975999|Vasopressins|vasopressins|mesh-list
44422804|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
44422805|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
44422807|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44422808|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44422809|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
44422810|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422811|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
44422812|NCT02960646|Melphalan|melphalan|mesh-list
44422813|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
44422814|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44422815|NCT02960646|Rituximab|rituximab|mesh-list
44422816|NCT02960646|Fludarabine|fludarabine|mesh-list
44422817|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
44422818|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44422819|NCT02960646|Tacrolimus|tacrolimus|mesh-list
44422820|NCT02960646|Antibodies|antibodies|mesh-list
44422821|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
44422822|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44422823|NCT02960646|Lenograstim|lenograstim|mesh-list
44422824|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422825|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
44422826|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422827|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422828|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422829|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
44422830|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422831|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422832|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422833|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422834|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
44422835|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44422836|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422873|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422874|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
44422875|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422876|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422913|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422914|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422915|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44422944|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422945|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422946|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422947|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422948|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422949|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44422950|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422951|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44422952|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422954|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44422955|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44422956|NCT02797548|Analgesics|analgesics|mesh-ancestor
44422957|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
44422958|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422959|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422960|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422961|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422976|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422977|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422978|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422979|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422980|NCT02774421|Trastuzumab|trastuzumab|mesh-list
44422981|NCT02774421|Molgramostim|molgramostim|mesh-list
44422982|NCT02774421|Sargramostim|sargramostim|mesh-list
44422983|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422984|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422985|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
44422986|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422987|NCT02743364|Simvastatin|simvastatin|mesh-list
44422988|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44422989|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44422990|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
44422991|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422992|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44422993|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44422994|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422995|NCT02728102|Lenalidomide|lenalidomide|mesh-list
44422996|NCT02728102|Melphalan|melphalan|mesh-list
44422997|NCT02728102|Molgramostim|molgramostim|mesh-list
44422998|NCT02728102|Vaccines|vaccines|mesh-list
44422999|NCT02728102|Sargramostim|sargramostim|mesh-list
44423000|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
44423001|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423002|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423003|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423004|NCT02728102|Growth Substances|growth substances|mesh-ancestor
44423005|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423006|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423007|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423008|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
44423009|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423010|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423011|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423012|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44423013|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
44423014|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423015|NCT02698254|Bevacizumab|bevacizumab|mesh-list
44423016|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44423017|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
44423018|NCT02698254|Antibodies|antibodies|mesh-list
44423019|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
44423020|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44423021|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
44423022|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423023|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423050|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423051|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44423052|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423053|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423055|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44423056|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423057|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423058|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423059|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423060|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
44423061|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44423062|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
44423063|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423064|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
44423065|NCT02588872|Protective Agents|protective agents|mesh-ancestor
44423066|NCT02530463|Nivolumab|nivolumab|mesh-list
44423067|NCT02530463|Ipilimumab|ipilimumab|mesh-list
44423068|NCT02530463|Azacitidine|azacitidine|mesh-list
44423069|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423070|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423071|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43616459|NCT02790138|Vedolizumab|vedolizumab|mesh-list
44423103|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44423105|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423106|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423107|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44423108|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423109|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423110|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423111|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423112|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44423113|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44423114|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44423115|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
44423116|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423117|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423134|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423135|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423136|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
44423137|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423138|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44423139|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423140|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423142|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44423143|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423144|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44423145|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
44423146|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
44423147|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423148|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423149|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423150|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44423151|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44423152|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423153|NCT02217709|Phenelzine|phenelzine|mesh-list
44081114|NCT03151499|Rifampin|rifampin|mesh-list
44423154|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
44423155|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44423156|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44423157|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423158|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423159|NCT02179086|Temozolomide|temozolomide|mesh-list
44423160|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423161|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
44423162|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423163|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423164|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
44423165|NCT02161783|Fludarabine|fludarabine|mesh-list
44423166|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423167|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
44423168|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423169|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423170|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423171|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
44423172|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423173|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423174|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423176|NCT02158507|Veliparib|veliparib|mesh-list
44423177|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423198|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423199|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423200|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423202|NCT02106988|Hormones|hormones|mesh-ancestor
44423203|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423204|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423205|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423206|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44423207|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44423208|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423209|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423210|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423211|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423212|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
44423213|NCT02074631|Vitamin D|vitamin d|mesh-list
44423214|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
43871365|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423215|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
44423216|NCT02074631|Pamidronate|pamidronate|mesh-list
44423217|NCT02074631|Calcium|calcium|mesh-list
44423218|NCT02074631|Vitamins|vitamins|mesh-ancestor
44423219|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
44423220|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423221|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44423222|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44423223|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
44423224|NCT02065362|Fludarabine|fludarabine|mesh-list
44423225|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423226|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
44423227|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423228|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423229|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081183|NCT03151343|Empagliflozin|empagliflozin|mesh-list
44423230|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
44423231|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423242|NCT02000089|Secretin|secretin|mesh-list
44423243|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423244|NCT02000089|Hormones|hormones|mesh-ancestor
44423245|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423246|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423247|NCT01975064|Propofol|propofol|mesh-list
44423248|NCT01975064|Sevoflurane|sevoflurane|mesh-list
44423249|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44423250|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423251|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423252|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44423253|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
44423254|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
44423255|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44423256|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44423257|NCT01953120|Abatacept|abatacept|mesh-list
44423258|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44423259|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423260|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423261|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423262|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
44423263|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423264|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423265|NCT01942135|Fulvestrant|fulvestrant|mesh-list
44423266|NCT01942135|Palbociclib|palbociclib|mesh-list
44423267|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423268|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423269|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44423270|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44423271|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
44423272|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423273|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423274|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44423275|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423276|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423277|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44423278|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423279|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44423280|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423281|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423282|NCT01792583|Modafinil|modafinil|mesh-list
44423283|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44423284|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423285|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44423286|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44423287|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44423288|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423289|NCT01747447|Vitamin D|vitamin d|mesh-list
44423290|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
44423291|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
44423293|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
44423294|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423317|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423318|NCT01269463|Methylphenidate|methylphenidate|mesh-list
44423319|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44423320|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423321|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44423322|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44423323|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44423324|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423325|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
44423326|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423328|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423329|NCT01068249|Everolimus|everolimus|mesh-list
44423330|NCT01068249|Letrozole|letrozole|mesh-list
44423331|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423332|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423333|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
44423334|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423335|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44423336|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44423337|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423338|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423339|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44423340|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
44423341|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423342|NCT01038778|Aldesleukin|aldesleukin|mesh-list
44423343|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
44423344|NCT01038778|Interleukin-2|interleukin-2|mesh-list
44423345|NCT01038778|Entinostat|entinostat|mesh-list
44423346|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44423368|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44423369|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
44423370|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423371|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423373|NCT00942331|Bevacizumab|bevacizumab|mesh-list
44423374|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44423375|NCT00942331|Cisplatin|cisplatin|mesh-list
44423376|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
44423377|NCT00942331|Antibodies|antibodies|mesh-list
44423378|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
44423379|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44423380|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
44423381|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423382|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423383|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423384|NCT00942331|Growth Substances|growth substances|mesh-ancestor
44423385|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423386|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423387|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
44423388|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44423389|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
44423390|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423391|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
44423392|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423393|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423394|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423395|NCT00851136|Bevacizumab|bevacizumab|mesh-list
44423396|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423397|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423398|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423399|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423434|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423435|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423436|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
44423437|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423438|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423439|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423440|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423452|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423454|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44423455|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44423456|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44423543|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423544|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44236470|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44423545|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44423546|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44423547|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
44423548|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423549|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44423550|NCT00119366|Trace Elements|trace elements|mesh-ancestor
44423551|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
44423552|NCT00098475|Thalidomide|thalidomide|mesh-list
44423553|NCT00098475|Dexamethasone|dexamethasone|mesh-list
44423554|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
44423555|NCT00098475|Lenalidomide|lenalidomide|mesh-list
44423556|NCT00098475|Ichthammol|ichthammol|mesh-list
44423557|NCT00098475|BB 1101|bb 1101|mesh-list
44423558|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423559|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
44423560|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
44423561|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423562|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423563|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423564|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
44423565|NCT00098475|Hormones|hormones|mesh-ancestor
44423566|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423567|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423568|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423569|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
44423570|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423571|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423572|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
44423573|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423574|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423602|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423603|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44423604|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423606|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44423607|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423608|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423609|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423610|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
44423611|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44423612|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423613|NCT05652374|Renal Agents|renal agents|mesh-ancestor
44423614|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423615|NCT05651789|Propranolol|propranolol|mesh-list
44423616|NCT05651789|Carvedilol|carvedilol|mesh-list
44423617|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44423618|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44423619|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
44423630|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44423631|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44423633|NCT05651750|Fluticasone|fluticasone|mesh-list
44423635|NCT05651750|Montelukast|montelukast|mesh-list
44423636|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423637|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44423638|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
44423639|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423640|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423641|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44423642|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
44423643|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44423644|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44423645|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44423646|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
44423647|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423648|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44423649|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44423650|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423651|NCT05651633|Lidocaine|lidocaine|mesh-list
44423652|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
44423653|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
44423654|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423655|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423656|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
44423657|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423658|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44423659|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44423660|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44423661|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44423662|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423663|NCT05651607|Cannabidiol|cannabidiol|mesh-list
44423664|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
44423665|NCT05651464|Vancomycin|vancomycin|mesh-list
44423666|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423667|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423668|NCT05651399|Propofol|propofol|mesh-list
44423669|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44423670|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423671|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423672|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44423673|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
44423675|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
44423676|NCT05651373|Prednisone|prednisone|mesh-list
44423677|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
44423678|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423679|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
44423680|NCT05651373|Hormones|hormones|mesh-ancestor
44423681|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423682|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423693|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
44423695|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
44423696|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423697|NCT05651347|Protective Agents|protective agents|mesh-ancestor
44423698|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423699|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423700|NCT05651269|Gemcitabine|gemcitabine|mesh-list
44423701|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44423702|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
44423703|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423704|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423705|NCT05651269|Antiviral Agents|antiviral agents|mesh-ancestor
44423706|NCT05651269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423707|NCT05651269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423708|NCT05651269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423709|NCT05651269|Immunologic Factors|immunologic factors|mesh-ancestor
44423710|NCT05651269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423711|NCT05648916|Celecoxib|celecoxib|mesh-list
44423712|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44423713|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44423714|NCT05648916|Analgesics|analgesics|mesh-ancestor
44423715|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
44423716|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423717|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423718|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423719|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423720|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44423721|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44423722|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423723|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423724|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
44423725|NCT05648058|Promethazine|promethazine|mesh-list
44423726|NCT05648058|Nefopam|nefopam|mesh-list
44423727|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44423728|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44423729|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423730|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423731|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
44423732|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
44423733|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
44423734|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423735|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
44423736|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
44423737|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423738|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44423739|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
44423740|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
44423741|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830482|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423742|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423743|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44423744|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
44423745|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
44423746|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44423762|NCT05639712|Oxycodone|oxycodone|mesh-list
44423763|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44423764|NCT05639712|Narcotics|narcotics|mesh-ancestor
44423765|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423766|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423767|NCT05639712|Analgesics|analgesics|mesh-ancestor
44423768|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
44423769|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423770|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44423771|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44423772|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
44423773|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
44423774|NCT05633979|Trastuzumab|trastuzumab|mesh-list
44423775|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423776|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423777|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
44423778|NCT05616468|Fludarabine|fludarabine|mesh-list
44423779|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423780|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
44423781|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423782|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423783|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423784|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
44423785|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423786|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423787|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423788|NCT05605899|Prednisone|prednisone|mesh-list
44423789|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
44423790|NCT05605899|Rituximab|rituximab|mesh-list
44423791|NCT05605899|Doxorubicin|doxorubicin|mesh-list
44423792|NCT05605899|Fludarabine|fludarabine|mesh-list
44423793|NCT05605899|Etoposide|etoposide|mesh-list
44423794|NCT05605899|Vincristine|vincristine|mesh-list
44423795|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423796|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
44423797|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423798|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423799|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423800|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
44423801|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423802|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423803|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423804|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423805|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44423806|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44423821|NCT05577845|Ramosetron|ramosetron|mesh-list
44423822|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
44423823|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
44423824|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423825|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423826|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423827|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44423828|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
44423829|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423830|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423831|NCT05565560|Apremilast|apremilast|mesh-list
44423832|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44423833|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44423834|NCT05565560|Analgesics|analgesics|mesh-ancestor
44423835|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
44423836|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423837|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423838|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423839|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423840|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44423841|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44423842|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423843|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423844|NCT05554679|Metformin|metformin|mesh-list
44423845|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44423846|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423847|NCT05552443|Hydromorphone|hydromorphone|mesh-list
44423848|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44423849|NCT05552443|Narcotics|narcotics|mesh-ancestor
44423850|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423851|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423852|NCT05552443|Analgesics|analgesics|mesh-ancestor
44423853|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
44423854|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423855|NCT05546515|Suvorexant|suvorexant|mesh-list
44423856|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
44423857|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44423858|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44423859|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423860|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423861|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423862|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423863|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
44423864|NCT05496894|Analgesics|analgesics|mesh-ancestor
44423865|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
44423866|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423867|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423883|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44423884|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44423885|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44423886|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423887|NCT05470985|Ozanimod|ozanimod|mesh-list
44423888|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44423889|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423890|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423891|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
44423892|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423893|NCT05438602|Ritonavir|ritonavir|mesh-list
44423894|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44423895|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44423896|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
44423897|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423898|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423899|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44423900|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44423901|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
44423902|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423903|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44423904|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44423905|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
44423906|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44423907|NCT05351684|Dolutegravir|dolutegravir|mesh-list
44423908|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44423909|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44423910|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423911|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423912|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44423913|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44423914|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
44423915|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423916|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
44423917|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423918|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423919|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
44423920|NCT05310786|Narcotics|narcotics|mesh-ancestor
44423921|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423922|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423923|NCT05310786|Analgesics|analgesics|mesh-ancestor
44423924|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
44423925|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423926|NCT05259722|Alitretinoin|alitretinoin|mesh-list
44423927|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423928|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
44423945|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
44423946|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423947|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423948|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423949|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
44423950|NCT05231629|Hormones|hormones|mesh-ancestor
44423951|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423952|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423953|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423954|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
44423955|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423956|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423957|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44423958|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
44423959|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423960|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423961|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
44423962|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423963|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423964|NCT05231629|Growth Substances|growth substances|mesh-ancestor
44423965|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423967|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44423968|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
44423969|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423970|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423971|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423972|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
44423973|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44423974|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44423975|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423977|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
44423978|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423979|NCT05171387|Androgens|androgens|mesh-list
44423980|NCT05171387|Hormones|hormones|mesh-ancestor
44423981|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423982|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423983|NCT05131646|Axitinib|axitinib|mesh-list
44423984|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423985|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44423986|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423987|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423988|NCT05108974|Choline|choline|mesh-list
44423989|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
44423990|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44423991|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
44424004|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
44424005|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44424006|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44424007|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44424008|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424009|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
44424010|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44424011|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44424012|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
44424013|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
44424014|NCT05031897|Melphalan|melphalan|mesh-list
44424015|NCT05031897|Fludarabine|fludarabine|mesh-list
44424016|NCT05031897|Tacrolimus|tacrolimus|mesh-list
44424017|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424018|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
44424019|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424020|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424021|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424022|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
43871738|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44424023|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424024|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424025|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424026|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44424027|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424028|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44424029|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44424030|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
44424031|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44424032|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424040|NCT05026320|Diclofenac|diclofenac|mesh-list
44424041|NCT05026320|Naproxen|naproxen|mesh-list
44424042|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44424043|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44424044|NCT05026320|Analgesics|analgesics|mesh-ancestor
44424045|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
44424046|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424047|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424048|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424049|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424050|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44424051|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424052|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424061|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
44424062|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424063|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424064|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424066|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424067|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424068|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44424069|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424070|NCT04941898|Factor VIII|factor viii|mesh-list
44424071|NCT04941898|BAX 855|bax 855|mesh-list
44424072|NCT04941898|Coagulants|coagulants|mesh-ancestor
44424073|NCT04919226|Leucovorin|leucovorin|mesh-list
44424074|NCT04919226|Folic Acid|folic acid|mesh-list
44424075|NCT04919226|Fluorouracil|fluorouracil|mesh-list
44424076|NCT04919226|Capecitabine|capecitabine|mesh-list
44424077|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
44424078|NCT04919226|Everolimus|everolimus|mesh-list
44424079|NCT04919226|Temozolomide|temozolomide|mesh-list
44424080|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44424081|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
44424082|NCT04919226|Edotreotide|edotreotide|mesh-list
44424083|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
44424084|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
44424085|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424086|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424087|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424088|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424089|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
44424090|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424091|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424092|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
44424093|NCT04919226|Antidotes|antidotes|mesh-ancestor
44424094|NCT04919226|Protective Agents|protective agents|mesh-ancestor
44424095|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
44424096|NCT04919226|Vitamins|vitamins|mesh-ancestor
44424097|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
44424098|NCT04919226|Hematinics|hematinics|mesh-ancestor
44424099|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44424100|NCT04892953|Gemcitabine|gemcitabine|mesh-list
44424101|NCT04892953|Paclitaxel|paclitaxel|mesh-list
44424102|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44424103|NCT04892953|Carboplatin|carboplatin|mesh-list
44424104|NCT04892953|Pemetrexed|pemetrexed|mesh-list
44424105|NCT04892953|Durvalumab|durvalumab|mesh-list
44424106|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
44424107|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424108|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
44424109|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424110|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424111|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424112|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424113|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424114|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424115|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424116|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
44424117|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
44424118|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424119|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424120|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424121|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
44424122|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424123|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44424134|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44424135|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424136|NCT04825678|Analgesics|analgesics|mesh-ancestor
44424137|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
44424138|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424139|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424140|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424141|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
44424142|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424144|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
44424145|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44424146|NCT04781088|Lenvatinib|lenvatinib|mesh-list
44424147|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424148|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424149|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424150|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424151|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424152|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424153|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424154|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44424155|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424156|NCT04780204|Tenofovir|tenofovir|mesh-list
44424157|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
44424158|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424159|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44424160|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424161|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424162|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424163|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44424164|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44424165|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44424166|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
44424167|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44424168|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44424169|NCT04776096|Analgesics|analgesics|mesh-ancestor
44424170|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
44424171|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424172|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424173|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424174|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424175|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44424176|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44424177|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44424178|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
44424179|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
44424180|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424181|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424182|NCT04746495|Eplerenone|eplerenone|mesh-list
44424183|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44424184|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
44424185|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424255|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424256|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424257|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424258|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
44424259|NCT04626791|Hormones|hormones|mesh-ancestor
43871866|NCT04762901|Paclitaxel|paclitaxel|mesh-list
43871870|NCT04762901|Niraparib|niraparib|mesh-list
44424260|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424261|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424262|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424263|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
44424264|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
44424265|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424266|NCT04596826|Dronabinol|dronabinol|mesh-list
44424267|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
44424268|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424269|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44424270|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44424271|NCT04596826|Analgesics|analgesics|mesh-ancestor
44424272|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
44424273|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424334|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424336|NCT04499677|Lopinavir|lopinavir|mesh-list
44424337|NCT04499677|Favipiravir|favipiravir|mesh-list
44424338|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44424339|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44424340|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424341|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424342|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424343|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44424344|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44424347|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44424348|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44424349|NCT04450836|Trifluridine|trifluridine|mesh-list
44424350|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
44424351|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424352|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
44424353|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424354|NCT04420624|Colchicine|colchicine|mesh-list
44424355|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
44424356|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424357|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424358|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424359|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424385|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44424386|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424387|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424388|NCT04269200|Paclitaxel|paclitaxel|mesh-list
44424389|NCT04269200|Carboplatin|carboplatin|mesh-list
44424390|NCT04269200|Durvalumab|durvalumab|mesh-list
44424391|NCT04269200|Olaparib|olaparib|mesh-list
44424392|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424393|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424394|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424395|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424396|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424397|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424398|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424399|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424400|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
44424401|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424402|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44424403|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424404|NCT04251819|Baclofen|baclofen|mesh-list
44424405|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44424406|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424407|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44424408|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424438|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44424439|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
44424440|NCT04227288|Calcipotriene|calcipotriene|mesh-list
44424441|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44424442|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424443|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
44424444|NCT04227288|Hormones|hormones|mesh-ancestor
44424445|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424446|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424447|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44424448|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
44424449|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44424450|NCT04219540|Buprenorphine|buprenorphine|mesh-list
44424451|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44424452|NCT04219540|Narcotics|narcotics|mesh-ancestor
44424481|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44424483|NCT04105270|Cisplatin|cisplatin|mesh-list
44424484|NCT04105270|Carboplatin|carboplatin|mesh-list
44424485|NCT04105270|Pemetrexed|pemetrexed|mesh-list
44424486|NCT04105270|Durvalumab|durvalumab|mesh-list
44424487|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424488|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424489|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424490|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44424491|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424492|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424493|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
44424494|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44424495|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44424496|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44424497|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44424498|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424514|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44236471|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44424515|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424516|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44424517|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44424518|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424520|NCT04062266|Azacitidine|azacitidine|mesh-list
44424521|NCT04062266|Venetoclax|venetoclax|mesh-list
44424522|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424523|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
44424524|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424525|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424526|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424527|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
44424528|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44424529|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424530|NCT04042831|Olaparib|olaparib|mesh-list
44082499|NCT01465152|Metformin|metformin|mesh-list
44424531|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44424532|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424533|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424534|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424535|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
44424536|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44424537|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424538|NCT04020341|Renal Agents|renal agents|mesh-ancestor
44424539|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44424540|NCT03998293|Somatostatin|somatostatin|mesh-list
44424541|NCT03998293|Hormones|hormones|mesh-ancestor
44424542|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424543|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424544|NCT03978611|Ipilimumab|ipilimumab|mesh-list
44424545|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424546|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424547|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44424548|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424549|NCT03967977|Gemcitabine|gemcitabine|mesh-list
44424550|NCT03967977|Cisplatin|cisplatin|mesh-list
44424551|NCT03967977|Carboplatin|carboplatin|mesh-list
44424552|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424553|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424554|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
44424555|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424594|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
44424595|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424596|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424609|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424610|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424611|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44424612|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44424613|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424614|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424615|NCT03770416|Nivolumab|nivolumab|mesh-list
44424616|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424617|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424618|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44424619|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424620|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
44424621|NCT03766126|Fludarabine|fludarabine|mesh-list
44424622|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424623|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
44424624|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424625|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424626|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424627|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
44424628|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424629|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424630|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424631|NCT03762018|Bevacizumab|bevacizumab|mesh-list
44424632|NCT03762018|Carboplatin|carboplatin|mesh-list
44424633|NCT03762018|Pemetrexed|pemetrexed|mesh-list
44424634|NCT03762018|Atezolizumab|atezolizumab|mesh-list
44236472|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44424635|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424636|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424637|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44424638|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44424639|NCT03762018|Growth Substances|growth substances|mesh-ancestor
44424640|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424641|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44424642|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424643|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424644|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44424645|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424646|NCT03752684|Calcium|calcium|mesh-list
44424647|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44424648|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424649|NCT03734029|Gemcitabine|gemcitabine|mesh-list
44424650|NCT03734029|Paclitaxel|paclitaxel|mesh-list
44424651|NCT03734029|Camptothecin|camptothecin|mesh-list
44424652|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44424653|NCT03734029|Capecitabine|capecitabine|mesh-list
44424654|NCT03734029|Trastuzumab|trastuzumab|mesh-list
44424655|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
44424656|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424657|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424658|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424659|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424677|NCT03710772|Dexamethasone|dexamethasone|mesh-list
44424678|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
44424679|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
44424680|NCT03710772|Rituximab|rituximab|mesh-list
44424681|NCT03710772|Doxorubicin|doxorubicin|mesh-list
44424682|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44424683|NCT03710772|Methotrexate|methotrexate|mesh-list
44424684|NCT03710772|Vincristine|vincristine|mesh-list
44424685|NCT03710772|Venetoclax|venetoclax|mesh-list
44424686|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44424687|NCT03710772|Antibodies|antibodies|mesh-list
44424688|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
44424689|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424690|NCT03710772|BB 1101|bb 1101|mesh-list
44424691|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424692|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
44424693|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424694|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424695|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424696|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
44424697|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424698|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424699|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424700|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424701|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
44424702|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
44424703|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424704|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44424705|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
44424706|NCT03710772|Hormones|hormones|mesh-ancestor
44424707|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424708|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424709|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424710|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424711|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44424712|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424713|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424714|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44424715|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
44424716|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44424717|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424718|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
44424730|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424731|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424732|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
44424733|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424734|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44424735|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44424736|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830483|NCT05360732|Folfirinox|folfirinox|mesh-list
44236474|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
44236475|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
44236476|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424737|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424738|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44424739|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
44424740|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424741|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
44424742|NCT03654768|Dasatinib|dasatinib|mesh-list
44424743|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44424744|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424745|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44424746|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424747|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424748|NCT03651128|Dexamethasone|dexamethasone|mesh-list
44424749|NCT03651128|Lenalidomide|lenalidomide|mesh-list
44424750|NCT03651128|Bortezomib|bortezomib|mesh-list
44424751|NCT03651128|Daratumumab|daratumumab|mesh-list
44424752|NCT03651128|Pomalidomide|pomalidomide|mesh-list
44424753|NCT03651128|Ixazomib|ixazomib|mesh-list
44424754|NCT03651128|Elotuzumab|elotuzumab|mesh-list
44424755|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424756|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
44424757|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
44424758|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424759|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424760|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44424761|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
44424762|NCT03651128|Hormones|hormones|mesh-ancestor
44424763|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424764|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424765|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424766|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
44424767|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44424768|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44424769|NCT03651128|Growth Substances|growth substances|mesh-ancestor
44424770|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
44424771|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424772|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424773|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424774|NCT03631043|Lenalidomide|lenalidomide|mesh-list
44424775|NCT03631043|Vaccines|vaccines|mesh-list
44424776|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
44424777|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424778|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44424779|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44424780|NCT03631043|Growth Substances|growth substances|mesh-ancestor
44424781|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44424782|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424783|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
44424784|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424821|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44424845|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44424847|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424848|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424849|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44424850|NCT03418649|Diuretics|diuretics|mesh-ancestor
44424851|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
44424852|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44424853|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
44424854|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
44424855|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424856|NCT03355469|Metformin|metformin|mesh-list
44424857|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44424858|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424859|NCT03350035|Ganaxolone|ganaxolone|mesh-list
44424860|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
44424861|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424862|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424863|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424864|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
44424865|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
44424866|NCT03224507|Dexamethasone|dexamethasone|mesh-list
44424867|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
44424868|NCT03224507|Lenalidomide|lenalidomide|mesh-list
44424869|NCT03224507|Daratumumab|daratumumab|mesh-list
44424870|NCT03224507|BB 1101|bb 1101|mesh-list
44424871|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424872|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424873|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
44424874|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
44424890|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
44424892|NCT03220477|Guadecitabine|guadecitabine|mesh-list
44424893|NCT03220477|Mocetinostat|mocetinostat|mesh-list
44424894|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424895|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424896|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44424897|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424898|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424900|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424901|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424902|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44424903|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424904|NCT03148418|Atezolizumab|atezolizumab|mesh-list
44424905|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424906|NCT03127007|Atezolizumab|atezolizumab|mesh-list
44424907|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424908|NCT03121586|Pimavanserin|pimavanserin|mesh-list
44424909|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44424910|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44424911|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44424912|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44424913|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44424914|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424915|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44424916|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44424917|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44424918|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
44424919|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424920|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424921|NCT03109847|Metformin|metformin|mesh-list
44424922|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44424923|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424924|NCT03039413|Copper|copper|mesh-list
44424925|NCT03039413|Trace Elements|trace elements|mesh-ancestor
44424926|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
44424927|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424928|NCT02978222|Molgramostim|molgramostim|mesh-list
44424929|NCT02978222|Sargramostim|sargramostim|mesh-list
44424930|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
44424931|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424932|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424933|NCT02901184|Spironolactone|spironolactone|mesh-list
44424966|NCT02626455|Doxorubicin|doxorubicin|mesh-list
44424967|NCT02626455|Vincristine|vincristine|mesh-list
44424968|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424969|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
44424970|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424971|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424972|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424973|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
44424974|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424993|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44424994|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44424995|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424996|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424997|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
44424998|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424999|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44425000|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
44425001|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44425002|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
44425003|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
44425004|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44425005|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44425006|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425007|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616598|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425008|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425010|NCT02539459|Everolimus|everolimus|mesh-list
44425011|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425012|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425013|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
44425014|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425015|NCT02520063|Everolimus|everolimus|mesh-list
44425016|NCT02520063|Letrozole|letrozole|mesh-list
44425017|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425018|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425019|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
44425020|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425021|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44425022|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44425023|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425024|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425025|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44425026|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425027|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425028|NCT02476786|Tamoxifen|tamoxifen|mesh-list
44425029|NCT02476786|Fulvestrant|fulvestrant|mesh-list
44425049|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425050|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
44425051|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
44425052|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425053|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425054|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425055|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
44425056|NCT02469519|Hormones|hormones|mesh-ancestor
44425057|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425058|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44425059|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425060|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44425061|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
44425062|NCT02399410|Bevacizumab|bevacizumab|mesh-list
44425063|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
44425064|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44425065|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425066|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44425067|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44425068|NCT02399410|Growth Substances|growth substances|mesh-ancestor
43872231|NCT04756622|Antidotes|antidotes|mesh-ancestor
44425069|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425070|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44425071|NCT02389218|Sotalol|sotalol|mesh-list
44425072|NCT02389218|Flecainide|flecainide|mesh-list
44425073|NCT02389218|Propafenone|propafenone|mesh-list
44425074|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44425075|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425076|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425077|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425078|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425079|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425080|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425081|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
44425082|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
44425083|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425101|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44425102|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425103|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44425104|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
44425105|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425106|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44425107|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
44425109|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425110|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425111|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44425112|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44425113|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425114|NCT02101281|Mitogens|mitogens|mesh-list
44425115|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425116|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425117|NCT01869114|Sirolimus|sirolimus|mesh-list
44425118|NCT01869114|Azacitidine|azacitidine|mesh-list
44118508|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425119|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44425120|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
44425121|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425122|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425123|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425124|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44425125|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425126|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44425127|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
44425128|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425129|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
44425130|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425131|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44425132|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
44425133|NCT01645475|Coagulants|coagulants|mesh-ancestor
44425134|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44425135|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425136|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425137|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
44425138|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44425139|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44425140|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
44425141|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
44425174|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44425175|NCT00846430|Celecoxib|celecoxib|mesh-list
44425176|NCT00846430|Vincristine|vincristine|mesh-list
44425177|NCT00846430|Temozolomide|temozolomide|mesh-list
44425178|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425179|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
44425180|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425181|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44425182|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
44425183|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
44425184|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425185|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425195|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425196|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425197|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44425198|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44425199|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425200|NCT00346125|Doxorubicin|doxorubicin|mesh-list
43872298|NCT04755543|Cisplatin|cisplatin|mesh-list
44425201|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44425202|NCT00346125|Ifosfamide|ifosfamide|mesh-list
44425203|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44425204|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44425205|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425206|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44425207|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44425208|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425209|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425210|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44425211|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
44425212|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44425213|NCT00300768|Ivermectin|ivermectin|mesh-list
44425214|NCT00300768|Moxidectin|moxidectin|mesh-list
44425215|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44425216|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425217|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
44425218|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
44425219|NCT02254304|Interferons|interferons|mesh-list
44425220|NCT02254304|Interferon-beta|interferon-beta|mesh-list
44425221|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
44425222|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425223|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
44425224|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425225|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
44425226|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425227|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44425228|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44425229|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425230|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425231|NCT02254291|Incretins|incretins|mesh-ancestor
44425232|NCT02254291|Hormones|hormones|mesh-ancestor
44425233|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616823|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
44425235|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
44425236|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425237|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425238|NCT02254278|Cisplatin|cisplatin|mesh-list
44425239|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425240|NCT02253992|Nivolumab|nivolumab|mesh-list
44425241|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44425242|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425243|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44425244|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425245|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
44425246|NCT02253654|Hematinics|hematinics|mesh-ancestor
44425247|NCT02252965|Metformin|metformin|mesh-list
44425248|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425249|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425250|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
44425251|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44425281|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44425282|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44425283|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425284|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425285|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44425286|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44425287|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
44425288|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44425289|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425290|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44425291|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
44425292|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44425293|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425294|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44425295|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425296|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
44425297|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425319|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425320|NCT02250651|Timolol|timolol|mesh-list
44425321|NCT02250651|Bimatoprost|bimatoprost|mesh-list
44425322|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44425323|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425324|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425325|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425326|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425327|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425328|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425329|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425330|NCT02249949|Efatutazone|efatutazone|mesh-list
44425331|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425332|NCT02249767|Tretinoin|tretinoin|mesh-list
44425333|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425334|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
44425335|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44425336|NCT02249182|Ribavirin|ribavirin|mesh-list
44425337|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
44425338|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44425339|NCT02249182|Ledipasvir|ledipasvir|mesh-list
44425340|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
44425341|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425342|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
44425343|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425344|NCT02249091|Cytarabine|cytarabine|mesh-list
44425345|NCT02249091|Idarubicin|idarubicin|mesh-list
44425346|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44425347|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
44425348|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425349|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425350|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
44425351|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425352|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425353|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
44425364|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425366|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44425367|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43617229|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
44118659|NCT00114816|Capecitabine|capecitabine|mesh-list
44425368|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425369|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425370|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425371|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425372|NCT02248480|Analgesics|analgesics|mesh-ancestor
44425373|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
44425374|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425375|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
44425376|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44425377|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
44425378|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
44425379|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44425380|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425381|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44425382|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44425383|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425384|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425385|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425386|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44425387|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44425388|NCT02247804|Timolol|timolol|mesh-list
44425389|NCT02247804|Bimatoprost|bimatoprost|mesh-list
44425390|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44425391|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425392|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425393|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425394|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425395|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425396|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425397|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425398|NCT02247466|Rocuronium|rocuronium|mesh-list
44425399|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44425400|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44425401|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44425402|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425403|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425404|NCT02247440|Interferons|interferons|mesh-list
44425405|NCT02247440|Ribavirin|ribavirin|mesh-list
44425406|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425407|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
44425408|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425409|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
44425410|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425411|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44425412|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
44425413|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425432|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
44425433|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425434|NCT02246660|Protective Agents|protective agents|mesh-ancestor
44425435|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425436|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425437|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44425438|NCT02246647|Mannitol|mannitol|mesh-list
44425439|NCT02246647|Lactulose|lactulose|mesh-list
44425440|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44425441|NCT02246647|Diuretics|diuretics|mesh-ancestor
44425442|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425443|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425444|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425445|NCT02246621|Letrozole|letrozole|mesh-list
44425446|NCT02246621|Anastrozole|anastrozole|mesh-list
44425447|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425448|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44425449|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44425450|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425451|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425452|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44425453|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425454|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425455|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425456|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44118739|NCT00115102|Narcotics|narcotics|mesh-ancestor
44425457|NCT02246582|Insulin|insulin|mesh-list
44425458|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425459|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083399|NCT00276835|Hormones|hormones|mesh-ancestor
44425460|NCT02246218|Glycerol|glycerol|mesh-list
44425461|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44425462|NCT02246218|Protective Agents|protective agents|mesh-ancestor
44425463|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425464|NCT02244944|Ezetimibe|ezetimibe|mesh-list
44425465|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44425466|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44425467|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
44425468|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425469|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44425470|NCT02244619|Acetaminophen|acetaminophen|mesh-list
44425471|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425485|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425486|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425487|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425488|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44425489|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
44425490|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425491|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425492|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44425493|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44425494|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44425496|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
44425497|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425498|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
44425499|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425500|NCT02243202|Canagliflozin|canagliflozin|mesh-list
44425501|NCT02243202|Phentermine|phentermine|mesh-list
44425502|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44425503|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425504|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425505|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425506|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44425507|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
44425508|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44425509|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
44425510|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
44425511|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425512|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425513|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425514|NCT02243176|Saxagliptin|saxagliptin|mesh-list
44425515|NCT02243176|Acarbose|acarbose|mesh-list
44425516|NCT02243176|Incretins|incretins|mesh-ancestor
44425517|NCT02243176|Hormones|hormones|mesh-ancestor
44425518|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425519|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425520|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44425521|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
44425522|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425523|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425524|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425525|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44425526|NCT02242487|Levodopa|levodopa|mesh-list
44425527|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44425528|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44425529|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
44425530|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425531|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425532|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425533|NCT02242305|Scopolamine|scopolamine|mesh-list
44425534|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44425566|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44425567|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
44425568|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
44425569|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
44425570|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44425571|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44425572|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425573|NCT02242201|Analgesics|analgesics|mesh-ancestor
44236477|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425574|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425575|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425576|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44425577|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425608|NCT02241512|Ibuprofen|ibuprofen|mesh-list
44425609|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44083544|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
44425610|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425611|NCT02241512|Analgesics|analgesics|mesh-ancestor
44425612|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
44425613|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425614|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425615|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425616|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425617|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44425618|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425619|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425621|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44425622|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425623|NCT02240693|BI 409306|bi 409306|mesh-list
44425646|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44425647|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44425648|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425649|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425650|NCT02240121|Rifaximin|rifaximin|mesh-list
44425651|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44425652|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425653|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425654|NCT02240108|Rifaximin|rifaximin|mesh-list
44425655|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44425656|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425657|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425658|NCT02239926|Ranolazine|ranolazine|mesh-list
44425659|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44425660|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425661|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425662|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
44425663|NCT02239692|Cathartics|cathartics|mesh-ancestor
44425664|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425665|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44425666|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44425667|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
44425668|NCT02239510|Linaclotide|linaclotide|mesh-list
44425669|NCT02239510|Sennosides|sennosides|mesh-list
44425670|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44425671|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
44425672|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425673|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425674|NCT02239510|Laxatives|laxatives|mesh-ancestor
44425675|NCT02239120|Dabigatran|dabigatran|mesh-list
44425706|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425707|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425708|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44425709|NCT02238626|Protective Agents|protective agents|mesh-ancestor
44425710|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44425711|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
44425712|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425713|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44425714|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
44425715|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44425762|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44425763|NCT02236988|Growth Substances|growth substances|mesh-ancestor
44425764|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44425765|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425766|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
44425767|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44425768|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44425769|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44425770|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
44425771|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425772|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425773|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425774|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
44425775|NCT02236520|Spironolactone|spironolactone|mesh-list
44425776|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44425777|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425778|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425779|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425780|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44425781|NCT02236520|Diuretics|diuretics|mesh-ancestor
44425782|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425783|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425784|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44425785|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425786|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425787|NCT02236130|Acetaminophen|acetaminophen|mesh-list
44425788|NCT02236130|Morphine|morphine|mesh-list
44425789|NCT02236130|Hydrocodone|hydrocodone|mesh-list
44425790|NCT02236130|Analgesics|analgesics|mesh-list
44425791|NCT02236130|Anesthetics|anesthetics|mesh-list
44425792|NCT02236130|Ropivacaine|ropivacaine|mesh-list
44425793|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
44425794|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425795|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425796|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44425797|NCT02236130|Narcotics|narcotics|mesh-ancestor
44425798|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
44425799|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425800|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425801|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
44425802|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
44425803|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
44425804|NCT02235311|Pantoprazole|pantoprazole|mesh-list
44425805|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44425806|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425807|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44425808|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425809|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425810|NCT02235298|Metformin|metformin|mesh-list
44425811|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
44425812|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425813|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425814|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44425815|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425816|NCT02235077|Spironolactone|spironolactone|mesh-list
44425817|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44425827|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425828|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425829|NCT02234362|Vortioxetine|vortioxetine|mesh-list
44425830|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
44425831|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44425832|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44425833|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44425834|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425835|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425836|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44425837|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44425838|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425839|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425840|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425841|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
44425842|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44425843|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44425844|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44425845|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44425846|NCT02234141|Selonsertib|selonsertib|mesh-list
44425847|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44425848|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425849|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425850|NCT02233803|Budesonide|budesonide|mesh-list
44425851|NCT02233803|Albuterol|albuterol|mesh-list
44425852|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44425853|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425854|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44425855|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
44236478|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425856|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425857|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425858|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44425859|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
44425860|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
44425861|NCT02233803|Hormones|hormones|mesh-ancestor
44425862|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425863|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
44425864|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44425865|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44425866|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44425867|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44425868|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425869|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425870|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425871|NCT02233647|Cocaine|cocaine|mesh-list
44425872|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
44425873|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
44425874|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425875|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425876|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
44425877|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425878|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44425879|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44425880|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44425907|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44425908|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44425909|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425910|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
44425911|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
44425912|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44425913|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44425914|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425915|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425916|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425917|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425918|NCT02232178|Bupivacaine|bupivacaine|mesh-list
44425919|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
44425920|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
44425921|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425922|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425923|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
44425924|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425925|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44425926|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44425955|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425956|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
44425957|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425958|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425959|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44425960|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425962|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
44425963|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
44425964|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425965|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425966|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425967|NCT02230891|Carvedilol|carvedilol|mesh-list
44425968|NCT02230891|Spironolactone|spironolactone|mesh-list
44425969|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44425970|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425971|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425981|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425982|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
44425983|NCT02230891|Protective Agents|protective agents|mesh-ancestor
44425984|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44425985|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425986|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44425987|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
44425988|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44236479|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
44425989|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44425990|NCT02230527|Clopidogrel|clopidogrel|mesh-list
44425992|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44425993|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44425994|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44425995|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44425996|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
44425997|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425998|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425999|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426000|NCT02230332|Alendronate|alendronate|mesh-list
44426001|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44426002|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426003|NCT02230306|Vemurafenib|vemurafenib|mesh-list
44426004|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872720|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
44426005|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44426006|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426007|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426008|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
44426009|NCT02230189|Miotics|miotics|mesh-ancestor
44426010|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
44426011|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426012|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426013|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44426014|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44426015|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44426016|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44426017|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44426018|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426019|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426020|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426021|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
44426022|NCT02229539|Promethazine|promethazine|mesh-list
44426023|NCT02229539|Lidocaine|lidocaine|mesh-list
44426024|NCT02229539|Doxepin|doxepin|mesh-list
44426025|NCT02229539|Antacids|antacids|mesh-list
44426026|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
44426027|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
44426028|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426029|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426030|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
44426031|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426032|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44426033|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44426034|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44426035|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426063|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426065|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
44426066|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
44426067|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
44426068|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426069|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426070|NCT02229227|Incretins|incretins|mesh-ancestor
44426072|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426073|NCT02229214|Topiramate|topiramate|mesh-list
44426074|NCT02229214|Phentermine|phentermine|mesh-list
44426075|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
44426076|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426077|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426078|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44426079|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
44426080|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44426081|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
44426082|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
44426083|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426120|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
44426121|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426122|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44426149|NCT02226562|Protective Agents|protective agents|mesh-ancestor
44426150|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426151|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44426152|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426153|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
44426154|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44426155|NCT02226549|Ledipasvir|ledipasvir|mesh-list
44426156|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
44426157|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426158|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44426159|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44426160|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44426161|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
44426162|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426163|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44426164|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44426165|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426166|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44426167|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44426168|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426169|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44426186|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426187|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
44426188|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426189|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426190|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44426191|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
44426192|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426193|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426194|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44426195|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44426196|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
44426197|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426198|NCT02225353|Progesterone|progesterone|mesh-list
44426199|NCT02225353|Progestins|progestins|mesh-ancestor
44426201|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426202|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426203|NCT02224846|Tadalafil|tadalafil|mesh-list
44426204|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
44426205|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44426206|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44426207|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426208|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426209|NCT02224846|Urological Agents|urological agents|mesh-ancestor
44426210|NCT02224703|Cannabidiol|cannabidiol|mesh-list
44426211|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
44426212|NCT02224690|Cannabidiol|cannabidiol|mesh-list
44426213|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
44426214|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
44426215|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44426216|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44426217|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426218|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
44426219|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426220|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
44426221|NCT02224599|Imiquimod|imiquimod|mesh-list
44426222|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426223|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
44426224|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426225|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426226|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44426227|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
44426263|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44426264|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
44426265|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
44426266|NCT02224157|Hormones|hormones|mesh-ancestor
44426291|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426292|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
44426293|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426294|NCT02222922|Fluconazole|fluconazole|mesh-list
44426295|NCT02222922|Avelumab|avelumab|mesh-list
44426296|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426297|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426298|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
44426299|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426300|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44426301|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426302|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830484|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426303|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426305|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426306|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426307|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426308|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44426309|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44426310|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
44426311|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44426312|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44426313|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426314|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
44426328|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426329|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426330|NCT02222246|Morphine|morphine|mesh-list
44426331|NCT02222246|Hydromorphone|hydromorphone|mesh-list
44426332|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44426333|NCT02222246|Narcotics|narcotics|mesh-ancestor
44426334|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426335|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426336|NCT02222246|Analgesics|analgesics|mesh-ancestor
44426337|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
44426338|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426339|NCT02222207|Ranibizumab|ranibizumab|mesh-list
44426340|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44426341|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44426342|NCT02222207|Growth Substances|growth substances|mesh-ancestor
44426343|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426344|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
44426345|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426346|NCT02221674|Tapentadol|tapentadol|mesh-list
44426347|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44426348|NCT02221674|Narcotics|narcotics|mesh-ancestor
44426349|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426350|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426351|NCT02221674|Analgesics|analgesics|mesh-ancestor
44426352|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
44426353|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426354|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44426355|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44426356|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426357|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426358|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
44426359|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426360|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44426361|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44426362|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44426363|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426364|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426365|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426366|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426367|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426368|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44426369|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426370|NCT02221284|Alogliptin|alogliptin|mesh-list
44426371|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426372|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426373|NCT02221284|Incretins|incretins|mesh-ancestor
44426374|NCT02221284|Hormones|hormones|mesh-ancestor
44426375|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426376|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44426411|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44426412|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426413|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426414|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
44426415|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
44426426|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44426427|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426428|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426429|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
44426430|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44426431|NCT02219685|Ledipasvir|ledipasvir|mesh-list
44236480|NCT00559481|Hormones|hormones|mesh-ancestor
44426432|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
44426433|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426435|NCT02219477|Ribavirin|ribavirin|mesh-list
44426436|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44426437|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44426438|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426439|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426440|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426441|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44426442|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44426443|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
44426444|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426445|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44426446|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426447|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
44084492|NCT00129922|Paclitaxel|paclitaxel|mesh-list
44426448|NCT02219087|Bupivacaine|bupivacaine|mesh-list
44426449|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
44426450|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
44426451|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426452|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426453|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
44426454|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426455|NCT02219009|Aripiprazole|aripiprazole|mesh-list
44426456|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
44426457|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426458|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44426459|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44426460|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426461|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426462|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
44426463|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
44426464|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426465|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426466|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44426467|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44426468|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
44426469|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44426470|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44426471|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44426472|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44426473|NCT02218736|Aticaprant|aticaprant|mesh-list
44426474|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
44426475|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426476|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
44426477|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426478|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44426509|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
44426511|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426512|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
44426513|NCT02217566|Hormones|hormones|mesh-ancestor
44426514|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426515|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426516|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44426517|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426518|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44426519|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872931|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426520|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426521|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
44426522|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426523|NCT02217501|Aspirin|aspirin|mesh-list
44426524|NCT02217501|Clopidogrel|clopidogrel|mesh-list
44426547|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426549|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44426550|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
44426551|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426552|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
44426553|NCT02217410|Tacrolimus|tacrolimus|mesh-list
44426554|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426555|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
44426556|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426557|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44426558|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426559|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426560|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44426561|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426562|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44426563|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
44426564|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426565|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426566|NCT02217345|Hormones|hormones|mesh-list
44426567|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426568|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426569|NCT02217332|Pramipexole|pramipexole|mesh-list
44426570|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
44426571|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426572|NCT02217332|Protective Agents|protective agents|mesh-ancestor
44426573|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426605|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426606|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
44426607|NCT02216071|Dexamethasone|dexamethasone|mesh-list
44426608|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
44426609|NCT02216071|BB 1101|bb 1101|mesh-list
44426610|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426611|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
44426612|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
44426613|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426614|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426615|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426616|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
44426617|NCT02216071|Hormones|hormones|mesh-ancestor
44426618|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426619|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44426620|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426621|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426622|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426633|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
44426634|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426635|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426636|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44426637|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
44426638|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426639|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426640|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44426641|NCT02215252|Pregabalin|pregabalin|mesh-list
44426642|NCT02215252|Analgesics|analgesics|mesh-ancestor
44426643|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
44426644|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426645|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426646|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
44426647|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44426648|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426649|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426650|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44426651|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44426652|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44426653|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426654|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426655|NCT02214225|Vaccines|vaccines|mesh-list
44426656|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
44426657|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426658|NCT02214121|Ticagrelor|ticagrelor|mesh-list
44426659|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426660|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44426661|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44426662|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44426663|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
44426664|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426665|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426666|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426667|NCT02213380|Anesthetics|anesthetics|mesh-list
44426668|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426669|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426670|NCT02213263|Rituximab|rituximab|mesh-list
44707255|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707256|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
44707257|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707258|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707259|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44707260|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707261|NCT01432821|Apomorphine|apomorphine|mesh-list
44707262|NCT01432821|Emetics|emetics|mesh-ancestor
44707263|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707264|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
44707265|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707266|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44707267|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
44707268|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
44707269|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707270|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707271|NCT01432873|Selenium|selenium|mesh-list
44707272|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
44707273|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707274|NCT01432873|Protective Agents|protective agents|mesh-ancestor
44707275|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707276|NCT01432873|Trace Elements|trace elements|mesh-ancestor
44707277|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
44707278|NCT01432977|Acetaminophen|acetaminophen|mesh-list
44707279|NCT01432977|Droperidol|droperidol|mesh-list
44707280|NCT01432977|Ondansetron|ondansetron|mesh-list
44707281|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44707282|NCT01432977|Analgesics|analgesics|mesh-ancestor
44707283|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
44707284|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707285|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707286|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
44707287|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
44707288|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
44707289|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44707290|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
44707291|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
44707292|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44707293|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
44707294|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707295|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707296|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44707297|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44707298|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707299|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44707300|NCT01432977|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44707301|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44707302|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44707303|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44707304|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
44707305|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44707306|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
44707307|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707308|NCT01433289|Protective Agents|protective agents|mesh-ancestor
44707309|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707310|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44707311|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44707312|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707313|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44707314|NCT01433328|Lidocaine|lidocaine|mesh-list
44707315|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
44707316|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
44707317|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707318|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707319|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
44707320|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707321|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44707322|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44707323|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44707324|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707325|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707326|NCT01433445|Panobinostat|panobinostat|mesh-list
44707327|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707328|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44707329|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830485|NCT05360277|Capecitabine|capecitabine|mesh-list
44707330|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707332|NCT01433614|Capecitabine|capecitabine|mesh-list
44707333|NCT01433614|Epirubicin|epirubicin|mesh-list
44707334|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44707335|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707336|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
44707337|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
44707338|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
44707339|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707340|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707341|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
44707342|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44707343|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44707344|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44707345|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707346|NCT01433627|Hirudins|hirudins|mesh-list
44707347|NCT01433627|Bivalirudin|bivalirudin|mesh-list
44707348|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
44707349|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44707350|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
44707351|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707352|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707353|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
44707354|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44707355|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44707356|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
44707357|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44707358|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707359|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707360|NCT01433705|Regadenoson|regadenoson|mesh-list
44707361|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707362|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44707363|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44707364|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
44707365|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
44707366|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707367|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707368|NCT01433757|Ampicillin|ampicillin|mesh-list
44707369|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44707370|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707371|NCT01433770|Alefacept|alefacept|mesh-list
44707372|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
44707373|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
44707374|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707375|NCT01433887|Ribavirin|ribavirin|mesh-list
44707376|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44707377|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
44707378|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707379|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
44707380|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135241|NCT00160875|Cisplatin|cisplatin|mesh-list
44707381|NCT01433900|Latanoprost|latanoprost|mesh-list
44707382|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44707383|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44707384|NCT01433952|Thiamine|thiamine|mesh-list
44707385|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
44707386|NCT01433952|Vitamins|vitamins|mesh-ancestor
44707387|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
44707388|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707389|NCT01434017|Dexamethasone|dexamethasone|mesh-list
44707390|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
44707391|NCT01434017|Droperidol|droperidol|mesh-list
44707392|NCT01434017|Ondansetron|ondansetron|mesh-list
44707393|NCT01434017|BB 1101|bb 1101|mesh-list
44707394|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707395|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
44707396|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
44707397|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707398|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707399|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44707400|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
44707401|NCT01434017|Hormones|hormones|mesh-ancestor
44707402|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707403|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44707404|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707405|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
44154528|NCT00224068|Hematinics|hematinics|mesh-ancestor
44707407|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707408|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
44707409|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44707410|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44707411|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
44707412|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707413|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44707414|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258858|NCT00631124|Diuretics|diuretics|mesh-ancestor
44707415|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707416|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44707417|NCT01434017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44707418|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44707419|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44707420|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44707422|NCT01434069|Leucovorin|leucovorin|mesh-list
44707423|NCT01434069|Fluorouracil|fluorouracil|mesh-list
44707424|NCT01434069|Pasireotide|pasireotide|mesh-list
44707425|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
44707426|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707427|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707428|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707429|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707430|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
44707431|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707432|NCT01434069|Antidotes|antidotes|mesh-ancestor
44707433|NCT01434069|Protective Agents|protective agents|mesh-ancestor
44707434|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
44707435|NCT01434069|Vitamins|vitamins|mesh-ancestor
44707436|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
44707437|NCT01434069|Hormones|hormones|mesh-ancestor
44707438|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707439|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
44707440|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707441|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
44707442|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707443|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707444|NCT01434134|Metoprolol|metoprolol|mesh-list
44707445|NCT01434134|Candesartan|candesartan|mesh-list
44707446|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44707447|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707448|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
44707449|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
44707450|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707451|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707452|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44707453|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44707454|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707455|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707456|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707457|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707458|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44707459|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44707460|NCT01434147|Bevacizumab|bevacizumab|mesh-list
44707461|NCT01434147|Capecitabine|capecitabine|mesh-list
44707462|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
44707463|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707464|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707465|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44707466|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44707467|NCT01434147|Growth Substances|growth substances|mesh-ancestor
44707468|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707469|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
44707470|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707471|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
44707472|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707473|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
44707474|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44707475|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
44707476|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44707477|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707478|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44707479|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44707480|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44707481|NCT01434173|Amoxicillin|amoxicillin|mesh-list
44707482|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
44707483|NCT01434173|Clarithromycin|clarithromycin|mesh-list
44707484|NCT01434173|Doxycycline|doxycycline|mesh-list
44707485|NCT01434173|Levofloxacin|levofloxacin|mesh-list
44707486|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
44707487|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
44707489|NCT01434173|Telithromycin|telithromycin|mesh-list
44707490|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44707491|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44707492|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707493|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44707494|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44707495|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707496|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707497|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707498|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44707499|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
44707500|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44707501|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707502|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44707503|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44707504|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44707505|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44707506|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44707507|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44707508|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
44707509|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44707510|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44707511|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44707512|NCT01434173|Renal Agents|renal agents|mesh-ancestor
44707513|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44707514|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44707515|NCT01434212|Interferons|interferons|mesh-list
44707516|NCT01434212|Ribavirin|ribavirin|mesh-list
44707517|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
44707518|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
44707519|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707520|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
44707521|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707522|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
44707523|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707524|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
44707525|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707526|NCT01434225|Bumetanide|bumetanide|mesh-list
44707527|NCT01434225|Diuretics|diuretics|mesh-ancestor
44707528|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
44707529|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707530|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44707531|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707532|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707533|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
44707534|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44707535|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44707536|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44707537|NCT01434303|Trastuzumab|trastuzumab|mesh-list
44707538|NCT01434303|Lapatinib|lapatinib|mesh-list
44707539|NCT01434303|Entinostat|entinostat|mesh-list
44707540|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44707541|NCT01434303|Antibodies|antibodies|mesh-list
44707542|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
44707543|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44707544|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44707545|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
44707546|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707547|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707548|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44707549|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707550|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707551|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44707552|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44707553|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
44707554|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707555|NCT01434381|Antacids|antacids|mesh-ancestor
44707556|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707557|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44707558|NCT01434394|Cetuximab|cetuximab|mesh-list
44707559|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707560|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707561|NCT01434459|Gemcitabine|gemcitabine|mesh-list
44707562|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707563|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
44707564|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707565|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707566|NCT01434459|Antiviral Agents|antiviral agents|mesh-ancestor
44707567|NCT01434459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707568|NCT01434459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707569|NCT01434459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707570|NCT01434459|Immunologic Factors|immunologic factors|mesh-ancestor
44707571|NCT01434459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707572|NCT01434849|Timolol|timolol|mesh-list
44707573|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44707574|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707575|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707576|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707577|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707578|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707579|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44707580|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707581|NCT01434862|Pramlintide|pramlintide|mesh-list
44707582|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44707583|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44707584|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707585|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
44707586|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44707587|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44707588|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707589|NCT01434888|Timolol|timolol|mesh-list
44707590|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44707591|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44707592|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44259022|NCT00632333|Cisplatin|cisplatin|mesh-list
44707593|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707594|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873329|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
44707595|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707596|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707597|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707598|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44707599|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707600|NCT01434901|Bethanechol|bethanechol|mesh-list
44707601|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44707602|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
44707603|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707604|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707605|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44707606|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44707607|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
44707608|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707609|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707611|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707612|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44707613|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44707614|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
44707615|NCT01435083|Coagulants|coagulants|mesh-ancestor
44707616|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44707617|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
44707618|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707619|NCT01435161|Telmisartan|telmisartan|mesh-list
44707620|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
44707621|NCT01435161|Nifedipine|nifedipine|mesh-list
44707622|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44707623|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44707624|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707625|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44707626|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707627|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44707628|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707629|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
44707631|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44707632|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44707633|NCT01435200|Hematinics|hematinics|mesh-ancestor
44707634|NCT01435213|Insulin|insulin|mesh-list
44707635|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44707636|NCT01435213|Ketamine|ketamine|mesh-list
44707637|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44707638|NCT01435213|Atipamezole|atipamezole|mesh-list
44707639|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44707640|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707641|NCT01435213|Analgesics|analgesics|mesh-ancestor
44707642|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
44707643|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707644|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44707645|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44707646|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
44707647|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
44707648|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707649|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44707650|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44707651|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707652|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707653|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44707654|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44707655|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707656|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707657|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44707658|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44707659|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707660|NCT01435252|Cetuximab|cetuximab|mesh-list
44707661|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707662|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707663|NCT01435291|Tacrolimus|tacrolimus|mesh-list
44707664|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707665|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
44707666|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707667|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44707668|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707669|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707670|NCT01435343|Cytarabine|cytarabine|mesh-list
44707671|NCT01435343|Plerixafor|plerixafor|mesh-list
44707672|NCT01435343|Fludarabine|fludarabine|mesh-list
44707673|NCT01435343|Idarubicin|idarubicin|mesh-list
44707674|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707675|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44707676|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
44707677|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707678|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707679|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
44707680|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707681|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
44707682|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707683|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44707684|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44707685|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44707686|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707687|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44707688|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44707689|NCT01435395|Bevacizumab|bevacizumab|mesh-list
44707690|NCT01435395|Temozolomide|temozolomide|mesh-list
44707691|NCT01435395|Bortezomib|bortezomib|mesh-list
44707692|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707693|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707694|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44707695|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44707696|NCT01435395|Growth Substances|growth substances|mesh-ancestor
44707697|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707698|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
44707699|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44707700|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
44707701|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707702|NCT01435486|Caffeine|caffeine|mesh-list
44707703|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
44707704|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707705|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44707706|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707707|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44707708|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707709|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44707710|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44707711|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
44707712|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707713|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
44707714|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707715|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
44707716|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707717|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707718|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44707719|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
44707720|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707721|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707722|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44707723|NCT01435707|Triamcinolone|triamcinolone|mesh-list
44707724|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44707725|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44707726|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44707727|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707728|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
44707729|NCT01435707|Hormones|hormones|mesh-ancestor
44707730|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707731|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707732|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707733|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
44707734|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707735|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707736|NCT01435837|Caffeine|caffeine|mesh-list
44707737|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44707738|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707739|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44707740|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707741|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707742|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44707744|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
44707745|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707746|NCT01435902|Fluticasone|fluticasone|mesh-list
44707747|NCT01435902|Xhance|xhance|mesh-list
44707748|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707749|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44707750|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
44707751|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707752|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707753|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44707754|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
44707755|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
44707756|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44707757|NCT01435915|Ropinirole|ropinirole|mesh-list
44707758|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44707759|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44707760|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
44707761|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
44707762|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707763|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707764|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707765|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44707766|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44707767|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44707768|NCT01435941|Analgesics|analgesics|mesh-ancestor
44707769|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
44707770|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707771|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707772|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707773|NCT01435954|Doxazosin|doxazosin|mesh-list
44707774|NCT01435954|Tamsulosin|tamsulosin|mesh-list
44707775|NCT01435954|Finasteride|finasteride|mesh-list
44707776|NCT01435954|Silodosin|silodosin|mesh-list
44707777|NCT01435954|Terazosin|terazosin|mesh-list
44707778|NCT01435954|Alfuzosin|alfuzosin|mesh-list
44707779|NCT01435954|Dutasteride|dutasteride|mesh-list
44707780|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44707781|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44707782|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707783|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707784|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707785|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707786|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707787|NCT01435954|Urological Agents|urological agents|mesh-ancestor
44707788|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44707789|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44707790|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707791|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
44707792|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707793|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707794|NCT01435980|Exenatide|exenatide|mesh-list
44707795|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44707796|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707797|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44707798|NCT01435980|Incretins|incretins|mesh-ancestor
44707799|NCT01435980|Hormones|hormones|mesh-ancestor
44707800|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707801|NCT01436123|Everolimus|everolimus|mesh-list
44707802|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707803|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44707804|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
44707805|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707806|NCT01436188|Ibuprofen|ibuprofen|mesh-list
44707807|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44707808|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44707809|NCT01436188|Analgesics|analgesics|mesh-ancestor
44707810|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
44707811|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707812|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707813|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44707814|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44707815|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44707816|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707817|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707818|NCT01436422|Vaccines|vaccines|mesh-list
44707819|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
44707820|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707821|NCT01436474|Varenicline|varenicline|mesh-list
44707822|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44707823|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44707824|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
44707825|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707826|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707827|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707828|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44707829|NCT01436513|Estrogens|estrogens|mesh-ancestor
44707830|NCT01436513|Hormones|hormones|mesh-ancestor
44707831|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707832|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707833|NCT01436539|Adefovir|adefovir|mesh-list
44707834|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44707835|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
44707836|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
44707837|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707838|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44707839|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44707840|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707841|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707842|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44707843|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
44707844|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44707845|NCT01436578|Posaconazole|posaconazole|mesh-list
44707846|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
44707847|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707848|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44707849|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44707850|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44707851|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44707852|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44707853|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707854|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707856|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44707857|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707858|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707859|NCT01436825|Factor VIII|factor viii|mesh-list
44707860|NCT01436825|Coagulants|coagulants|mesh-ancestor
44707861|NCT01436838|Interferons|interferons|mesh-list
44707862|NCT01436838|Interferon-beta|interferon-beta|mesh-list
44707863|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
44707864|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707865|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
44707866|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707867|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
44707868|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707869|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44707870|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
44707871|NCT01436916|Vitamin D|vitamin d|mesh-list
44707872|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44707873|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707874|NCT01436916|Vitamins|vitamins|mesh-ancestor
44707875|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
44707876|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44707877|NCT01436929|Silymarin|silymarin|mesh-list
44707878|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
44707879|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707880|NCT01436929|Protective Agents|protective agents|mesh-ancestor
44707881|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707882|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
44707883|NCT01436994|Carbimazole|carbimazole|mesh-list
44707884|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
44707885|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707886|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
44707887|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
44707888|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707889|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707890|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44707891|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
44707892|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707893|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44707894|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44707895|NCT01437046|Doxazosin|doxazosin|mesh-list
44707896|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707897|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44707898|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44707899|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44707900|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707901|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707902|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707903|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707904|NCT01437189|Sertraline|sertraline|mesh-list
44707905|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
44707906|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44707907|NCT01437189|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44707908|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44707909|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707910|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707911|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707912|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
44707913|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707914|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
44707915|NCT01437228|Povidone|povidone|mesh-list
44707916|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
44707917|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
44236483|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707918|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44707919|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44707920|NCT01437293|Carbidopa|carbidopa|mesh-list
44707921|NCT01437293|Entacapone|entacapone|mesh-list
44707922|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44707923|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44707924|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
44707925|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707926|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707927|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707928|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44707929|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44707930|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44707931|NCT01437306|Lofexidine|lofexidine|mesh-list
44707932|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707933|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44707934|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707935|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
44707936|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44707937|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44707938|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44707939|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44707940|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44707941|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707942|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707943|NCT01437371|Ramipril|ramipril|mesh-list
44707944|NCT01437371|Enalapril|enalapril|mesh-list
44707945|NCT01437371|Lisinopril|lisinopril|mesh-list
44707946|NCT01437371|Captopril|captopril|mesh-list
44707947|NCT01437371|Trandolapril|trandolapril|mesh-list
44707948|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44707949|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44707950|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
44707951|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707952|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44707953|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44707954|NCT01437371|Protective Agents|protective agents|mesh-ancestor
44707955|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707956|NCT01437462|Propofol|propofol|mesh-list
44707957|NCT01437462|Sevoflurane|sevoflurane|mesh-list
44707958|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44707959|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44707960|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707961|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44707962|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
44707963|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
44707964|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44707965|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44707966|NCT01437566|Fulvestrant|fulvestrant|mesh-list
44707967|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44707968|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707969|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44707970|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44707971|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
44707972|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44707973|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707974|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
44707975|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44707976|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707977|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707978|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
44707979|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707980|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707981|NCT01437592|Insulin|insulin|mesh-list
44707982|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44707983|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707984|NCT01437618|Bevacizumab|bevacizumab|mesh-list
44707985|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44707986|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44707987|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44707988|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44707989|NCT01437618|Growth Substances|growth substances|mesh-ancestor
44707990|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707991|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
44707992|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
44707993|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44707994|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44707995|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44707996|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
44707997|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44707998|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44707999|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
44708000|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44708001|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44708002|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
44708003|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708004|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708005|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708006|NCT01437670|Urological Agents|urological agents|mesh-ancestor
44708007|NCT01437696|Vitamin D|vitamin d|mesh-list
44708008|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
44708009|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
44708010|NCT01437696|Vitamins|vitamins|mesh-list
44708011|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
44708012|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708013|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44708014|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44708015|NCT01437748|Bromides|bromides|mesh-list
44708016|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
44708017|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44708018|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
44708019|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708020|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708021|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44708022|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44708023|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
44708024|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44708025|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
44708026|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708027|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708028|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
44708029|NCT01437800|Metformin|metformin|mesh-list
44708030|NCT01437800|Glimepiride|glimepiride|mesh-list
44708031|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708032|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708033|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44708034|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708035|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
44708036|NCT01437813|Metformin|metformin|mesh-list
44708037|NCT01437813|Glimepiride|glimepiride|mesh-list
44708038|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708039|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708040|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44708041|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708042|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
44708043|NCT01437826|Selenium|selenium|mesh-list
44708044|NCT01437826|Antioxidants|antioxidants|mesh-list
44708045|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708046|NCT01437826|Protective Agents|protective agents|mesh-ancestor
44708047|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708048|NCT01437826|Trace Elements|trace elements|mesh-ancestor
44708049|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
44708050|NCT01437839|Apixaban|apixaban|mesh-list
44708051|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44708052|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
44708053|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44708054|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
44708055|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708056|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708057|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
44708058|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44708059|NCT01437982|Prednisolone|prednisolone|mesh-list
44708060|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44708061|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
44708062|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44708063|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
44708064|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44708065|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
44708066|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708067|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
44708068|NCT01437982|Hormones|hormones|mesh-ancestor
44708069|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708070|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708071|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44708072|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708073|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
44708074|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
43873646|NCT05314153|Brexanolone|brexanolone|mesh-list
44708075|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708076|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708077|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44708078|NCT01437982|Protective Agents|protective agents|mesh-ancestor
44708079|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44708080|NCT01438021|Methotrexate|methotrexate|mesh-list
44708081|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44708082|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
44708083|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44708084|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708085|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708086|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
44708087|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708088|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708089|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708090|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708091|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44708092|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708093|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
44708094|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708095|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44708096|NCT01438086|Mecasermin|mecasermin|mesh-list
44708097|NCT01438086|Growth Substances|growth substances|mesh-ancestor
44708098|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708099|NCT01438112|Gemcitabine|gemcitabine|mesh-list
44708100|NCT01438112|Interferons|interferons|mesh-list
44708101|NCT01438112|Mitomycins|mitomycins|mesh-list
44708102|NCT01438112|Mitomycin|mitomycin|mesh-list
44708103|NCT01438112|Valrubicin|valrubicin|mesh-list
44708104|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708105|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
44708106|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708107|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708108|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
44708109|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708110|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708111|NCT01438112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708112|NCT01438112|Immunologic Factors|immunologic factors|mesh-ancestor
44708113|NCT01438112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708114|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708115|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
44708116|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44708117|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44708118|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44708119|NCT01438190|Metformin|metformin|mesh-list
44708120|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708121|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708122|NCT01438320|Quercetin|quercetin|mesh-list
44708123|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
44708124|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708125|NCT01438320|Protective Agents|protective agents|mesh-ancestor
44708126|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708127|NCT05602272|Anesthetics|anesthetics|mesh-list
44708128|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708129|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708130|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44708131|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708132|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708133|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708134|NCT05563389|Atorvastatin|atorvastatin|mesh-list
44708135|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44708136|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44708137|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
44708138|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708139|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44708140|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44708141|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708142|NCT05554393|Cytarabine|cytarabine|mesh-list
44708143|NCT05554393|Azacitidine|azacitidine|mesh-list
44708144|NCT05554393|Daunorubicin|daunorubicin|mesh-list
44708145|NCT05554393|Venetoclax|venetoclax|mesh-list
44708146|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708147|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
44708148|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708149|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708150|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
44708151|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708152|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708153|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
44708154|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708155|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708156|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708157|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44708158|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44708159|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44708160|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
44708161|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44708162|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44708163|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708164|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708165|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708166|NCT05525013|Simvastatin|simvastatin|mesh-list
44708167|NCT05525013|Calcium|calcium|mesh-list
44708168|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44708169|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708170|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44708171|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44708172|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
44708173|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708174|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44708175|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44708176|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708177|NCT05511766|Allopurinol|allopurinol|mesh-list
44708178|NCT05511766|Atorvastatin|atorvastatin|mesh-list
44708179|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44708180|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44708181|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
44708182|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708183|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44708184|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44708185|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708186|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
44708187|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708188|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44708189|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
44708190|NCT05511766|Protective Agents|protective agents|mesh-ancestor
44708191|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708192|NCT05465174|Nivolumab|nivolumab|mesh-list
44708193|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708194|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708195|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44708196|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708197|NCT05427630|Dronabinol|dronabinol|mesh-list
44708198|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
44708199|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708200|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44708201|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708202|NCT05427630|Analgesics|analgesics|mesh-ancestor
44708203|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
44708204|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708205|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44708206|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44708207|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708208|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708209|NCT05427630|Hormones|hormones|mesh-ancestor
44708210|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708211|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
44708212|NCT05418088|Fludarabine|fludarabine|mesh-list
44708213|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
44708214|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708215|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
44708216|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708217|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708218|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708219|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
44708220|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708221|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708222|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44708223|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708224|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
44708225|NCT05387525|Diclofenac|diclofenac|mesh-list
44708226|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
44708227|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44708228|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708229|NCT05387525|Analgesics|analgesics|mesh-ancestor
44708230|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
44708231|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708232|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708233|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708234|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708235|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44708236|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708237|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708238|NCT05382312|Bedaquiline|bedaquiline|mesh-list
44708239|NCT05382312|GSK656|gsk656|mesh-list
44708240|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
44708241|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708242|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708243|NCT05371275|Palbociclib|palbociclib|mesh-list
44708244|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708245|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44708246|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708247|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708248|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44708249|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44708250|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708251|NCT05343507|Ketamine|ketamine|mesh-list
44708252|NCT05343507|Analgesics|analgesics|mesh-ancestor
44708253|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
44708254|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708255|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708256|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44708257|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44708258|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
44708259|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
44708260|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708261|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44708262|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44708263|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708264|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708265|NCT05295927|Prednisone|prednisone|mesh-list
44708266|NCT05295927|Prednisolone|prednisolone|mesh-list
44708267|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
44708268|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708269|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
44708270|NCT05295927|Hormones|hormones|mesh-ancestor
44708271|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708272|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708273|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44708274|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708275|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44708276|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708277|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708278|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
44708279|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44708280|NCT05218733|Fentanyl|fentanyl|mesh-list
44708281|NCT05218733|Morphine|morphine|mesh-list
44708282|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
44708283|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708284|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708285|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44708286|NCT05218733|Narcotics|narcotics|mesh-ancestor
44708287|NCT05218733|Analgesics|analgesics|mesh-ancestor
44708288|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
44708289|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708290|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44708291|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44708292|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
44708293|NCT05213832|Isoflurane|isoflurane|mesh-list
44708294|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44708295|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
44708296|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
44708297|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708298|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708299|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44708300|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44708301|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44708302|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
44708303|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708304|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708305|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708306|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708307|NCT05197439|Analgesics|analgesics|mesh-ancestor
44708308|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
44708309|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708310|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44708311|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44708312|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44708313|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44708314|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708315|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708316|NCT05164159|Propofol|propofol|mesh-list
44708317|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708318|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708319|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708320|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44708321|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
44708322|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
44708323|NCT05164146|Propofol|propofol|mesh-list
44708324|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708325|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708326|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708327|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44708328|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
44708329|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
44708330|NCT05153070|Cyclosporine|cyclosporine|mesh-list
44708331|NCT05153070|Cyclosporins|cyclosporins|mesh-list
44708332|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708333|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708334|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708335|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
44708336|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708337|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
44708338|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708339|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708340|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708341|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44708342|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
44708343|NCT05129748|Mannitol|mannitol|mesh-list
44708344|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44708345|NCT05129748|Diuretics|diuretics|mesh-ancestor
44708346|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
44708347|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708348|NCT05129748|Antidotes|antidotes|mesh-ancestor
44708349|NCT05129748|Protective Agents|protective agents|mesh-ancestor
44708350|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
44708351|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708352|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
44708353|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708354|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708355|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
44708356|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
44708357|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
44708358|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708359|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708360|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708361|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708362|NCT05111431|Analgesics|analgesics|mesh-ancestor
44708363|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
44708364|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708365|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44708367|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44708368|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
44708369|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708370|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708371|NCT05094154|Penicillins|penicillins|mesh-list
44708372|NCT05094154|Cephalosporins|cephalosporins|mesh-list
44708373|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708374|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708375|NCT05081180|Lenvatinib|lenvatinib|mesh-list
44708376|NCT05081180|Avelumab|avelumab|mesh-list
44708377|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708378|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44708379|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708380|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708381|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708382|NCT05060731|Iron|iron|mesh-list
44708383|NCT05060731|Trace Elements|trace elements|mesh-ancestor
44708384|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
44708385|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708386|NCT04965298|Lansoprazole|lansoprazole|mesh-list
44708387|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
44708388|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44708389|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708390|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44708391|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708392|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708393|NCT04956939|Levodopa|levodopa|mesh-list
44708394|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44708395|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44708396|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
44708397|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708398|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708399|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708400|NCT04955470|Midazolam|midazolam|mesh-list
44708401|NCT04955470|Ketamine|ketamine|mesh-list
43873933|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
44708402|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44708403|NCT04955470|Analgesics|analgesics|mesh-ancestor
44708404|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
44708405|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708406|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708407|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44708408|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44708409|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
44708410|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
44708411|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708412|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44708413|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44708414|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708415|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708416|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44708417|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708418|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44708419|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44708420|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44708421|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
44708422|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
44708423|NCT04938557|Insulin|insulin|mesh-list
44708424|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44708425|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708426|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708427|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
44708428|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708429|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
44708430|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708431|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708432|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44708433|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
44708434|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708435|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708436|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708437|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708438|NCT04922567|Prednisone|prednisone|mesh-list
44708439|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
44708440|NCT04922567|Doxorubicin|doxorubicin|mesh-list
44708442|NCT04922567|Lenalidomide|lenalidomide|mesh-list
44708443|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708444|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
44708445|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708446|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708447|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708448|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
44708449|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708450|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708451|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44708452|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708453|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44708454|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44708455|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708456|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708457|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
44708458|NCT04922567|Hormones|hormones|mesh-ancestor
44708459|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708460|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44708461|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44708462|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44708463|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44708464|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44708465|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44708466|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44708467|NCT04922567|Growth Substances|growth substances|mesh-ancestor
44708468|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44708469|NCT04906278|Oxytocin|oxytocin|mesh-list
44708470|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
44708471|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44708472|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708473|NCT04850222|Fluoxetine|fluoxetine|mesh-list
44708474|NCT04850222|Calcium|calcium|mesh-list
44708475|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44708476|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708477|NCT04850222|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44708478|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44708479|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44708480|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708481|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708482|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
44708483|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44708484|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
44708485|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44708486|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44708487|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44708488|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708489|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
44708490|NCT04801966|Nivolumab|nivolumab|mesh-list
44708491|NCT04801966|Atezolizumab|atezolizumab|mesh-list
44708493|NCT04801966|Palbociclib|palbociclib|mesh-list
44708494|NCT04801966|Trametinib|trametinib|mesh-list
44708495|NCT04801966|Vemurafenib|vemurafenib|mesh-list
44708496|NCT04801966|Dabrafenib|dabrafenib|mesh-list
44708497|NCT04801966|Talazoparib|talazoparib|mesh-list
44708498|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708499|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708500|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44708501|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708502|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44708503|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708504|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44708505|NCT04800692|Verapamil|verapamil|mesh-list
44708506|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44708507|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44708508|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44708509|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708510|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44708511|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708512|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44708513|NCT04787848|Bromides|bromides|mesh-list
44708514|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
44708515|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
44708517|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708518|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
44708519|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708520|NCT04761627|Ustekinumab|ustekinumab|mesh-list
44708521|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708522|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
44708523|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708524|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708525|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
44708526|NCT04660799|Promethazine|promethazine|mesh-list
44708527|NCT04660799|Prednisone|prednisone|mesh-list
44708528|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
44708529|NCT04660799|Rituximab|rituximab|mesh-list
44708530|NCT04660799|Doxorubicin|doxorubicin|mesh-list
44708531|NCT04660799|Vincristine|vincristine|mesh-list
44708532|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44708533|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
44708534|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708535|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
44708536|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708537|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708538|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708539|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
44708540|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708541|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708542|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44708543|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708544|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44708545|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43874031|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44708546|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44708547|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708548|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708549|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
44708550|NCT04660799|Hormones|hormones|mesh-ancestor
44708551|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708552|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44708553|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44708554|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
44708555|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
44708556|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
44708557|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
44708558|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708559|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44708560|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44708561|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708562|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
44708563|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
44708564|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
44708565|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
44708566|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708567|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
44708568|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708569|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44708570|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
44708571|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708572|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
44708573|NCT04636632|Aprepitant|aprepitant|mesh-list
44708574|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
44708575|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
44708576|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708577|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708578|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708579|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44708580|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708581|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708582|NCT04597372|Tamsulosin|tamsulosin|mesh-list
44708583|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44708584|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44708585|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44708586|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
44708587|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708588|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708589|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708590|NCT04597372|Urological Agents|urological agents|mesh-ancestor
44708591|NCT04588688|Mifepristone|mifepristone|mesh-list
44708592|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44708593|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
44708594|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44708595|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708596|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44708597|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44708598|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44708599|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
44708600|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44708601|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44708602|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
44708603|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708604|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
44708605|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44708606|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44708607|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44708608|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44708609|NCT04585542|Laxatives|laxatives|mesh-ancestor
44708610|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708611|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
44708612|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
43874100|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
44708613|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708614|NCT04502602|Niraparib|niraparib|mesh-list
44708615|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44708616|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708617|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708618|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708619|NCT04375202|Colchicine|colchicine|mesh-list
44708620|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
44708621|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708622|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
44708623|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
44708624|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
44708625|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708626|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708627|NCT04360044|Dronabinol|dronabinol|mesh-list
44708628|NCT04360044|Cannabidiol|cannabidiol|mesh-list
44708629|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
44708630|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
44708631|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708632|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44708633|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708634|NCT04360044|Analgesics|analgesics|mesh-ancestor
44708635|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
44708636|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708637|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44708638|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44708639|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708640|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708641|NCT04360044|Hormones|hormones|mesh-ancestor
44708642|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708643|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
44708644|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44708645|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44708646|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708647|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
44708648|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708649|NCT04343885|Docetaxel|docetaxel|mesh-list
44708650|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
44708651|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708652|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44708653|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44708654|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44708655|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708656|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44708657|NCT04332393|Metformin|metformin|mesh-list
44708658|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708659|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708660|NCT04329572|Azithromycin|azithromycin|mesh-list
44708661|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
44708662|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708663|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708664|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
44708665|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44708666|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44708667|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708668|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708669|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708670|NCT04322552|Apatinib|apatinib|mesh-list
44708671|NCT04322552|Digoxin|digoxin|mesh-list
44708672|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708673|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44708674|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708675|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708676|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44708677|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44708678|NCT04322552|Protective Agents|protective agents|mesh-ancestor
44708679|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708680|NCT04322305|Pregabalin|pregabalin|mesh-list
44708681|NCT04322305|Analgesics|analgesics|mesh-ancestor
44708682|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
44708683|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708684|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708685|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
44708686|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44708687|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44708688|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708689|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44708690|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44708691|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44708692|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708693|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44708694|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44708695|NCT04318405|Hematinics|hematinics|mesh-ancestor
44708696|NCT04189848|Dulaglutide|dulaglutide|mesh-list
44708697|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708698|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708699|NCT04156334|Anesthetics|anesthetics|mesh-list
44708700|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708701|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708702|NCT04083170|Vidarabine|vidarabine|mesh-list
44708703|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
44708704|NCT04083170|Thiotepa|thiotepa|mesh-list
44708705|NCT04083170|Fludarabine|fludarabine|mesh-list
44708706|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
44708707|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708708|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
44708709|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708710|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708711|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708712|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
44708713|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708714|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708715|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44708716|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708717|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
44708718|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
44708719|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708720|NCT04078906|SMOFlipid|smoflipid|mesh-list
44708721|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
44708722|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44708723|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44708724|NCT03981523|Benzonidazole|benzonidazole|mesh-list
44708725|NCT03981523|Nifurtimox|nifurtimox|mesh-list
44708726|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708727|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
44708728|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708729|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44708730|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44708731|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44708732|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708733|NCT03980171|Lenalidomide|lenalidomide|mesh-list
44708734|NCT03980171|Venetoclax|venetoclax|mesh-list
44708735|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
44708736|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
44708737|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708738|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44708739|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44708740|NCT03980171|Growth Substances|growth substances|mesh-ancestor
44708741|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44708742|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708743|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708744|NCT03979365|Tacrolimus|tacrolimus|mesh-list
44708745|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708746|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
44708747|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708748|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44708749|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708750|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708751|NCT03901339|Gemcitabine|gemcitabine|mesh-list
44708752|NCT03901339|Capecitabine|capecitabine|mesh-list
44708753|NCT03901339|Vinorelbine|vinorelbine|mesh-list
44708754|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708755|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
44708756|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708757|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708758|NCT03901339|Antiviral Agents|antiviral agents|mesh-ancestor
44708759|NCT03901339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708760|NCT03901339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708761|NCT03901339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708762|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
44708763|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708764|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44708765|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
44708766|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
44708767|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
44708768|NCT03860077|Nicotine|nicotine|mesh-list
44708769|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44708770|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
44708771|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708772|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708773|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44708774|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44708775|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
44708776|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708777|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708778|NCT03697512|Rituximab|rituximab|mesh-list
44708779|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708780|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708781|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
44708782|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708783|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708784|NCT03671746|Ketorolac|ketorolac|mesh-list
44708785|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44708786|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708787|NCT03671746|Analgesics|analgesics|mesh-ancestor
44708788|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
44708789|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708790|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708791|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708792|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708793|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44708794|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708795|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708796|NCT03558724|Bevacizumab|bevacizumab|mesh-list
44708797|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708798|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708799|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44708800|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44708801|NCT03558724|Growth Substances|growth substances|mesh-ancestor
44708802|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708803|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
44708804|NCT03512496|Caffeine|caffeine|mesh-list
44708805|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44708806|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708807|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44708808|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708809|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708810|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44708811|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44708812|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
44708813|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708814|NCT03495960|Rituximab|rituximab|mesh-list
44708815|NCT03495960|Methotrexate|methotrexate|mesh-list
44708816|NCT03495960|Lenalidomide|lenalidomide|mesh-list
44708817|NCT03495960|Temozolomide|temozolomide|mesh-list
44708819|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708820|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708821|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
44708822|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708823|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708824|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44708825|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
44708826|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44708827|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44708829|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708830|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
44708831|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708832|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44708833|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44708834|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44708835|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44708836|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44708837|NCT03495960|Growth Substances|growth substances|mesh-ancestor
44708838|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
44708839|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708840|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
44708841|NCT03416127|Metformin|metformin|mesh-list
44708842|NCT03416127|Propolis|propolis|mesh-list
44708843|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708844|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708845|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708846|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
44708847|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708848|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708849|NCT03293069|Deferiprone|deferiprone|mesh-list
44708850|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44708851|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
44708852|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
44708853|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708854|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
44708855|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
44708856|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708857|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
44708858|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708859|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708860|NCT03250975|Azithromycin|azithromycin|mesh-list
44708861|NCT03250975|Budesonide|budesonide|mesh-list
44708862|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708863|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44708864|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
44708865|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708866|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708867|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44708868|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44708869|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
44708870|NCT03250975|Hormones|hormones|mesh-ancestor
44708871|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44708872|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708873|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708874|NCT03232346|Buprenorphine|buprenorphine|mesh-list
44708875|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44708876|NCT03232346|Narcotics|narcotics|mesh-ancestor
44708877|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708878|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708879|NCT03232346|Analgesics|analgesics|mesh-ancestor
44708880|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
44708881|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708882|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44708883|NCT03227731|Tenofovir|tenofovir|mesh-list
44708884|NCT03227731|Emtricitabine|emtricitabine|mesh-list
44708885|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44708886|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
44708887|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708888|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44708889|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44708890|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708891|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708892|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44708893|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44708894|NCT03200015|Metformin|metformin|mesh-list
44708895|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44708896|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708902|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
44708903|NCT03193281|Dasatinib|dasatinib|mesh-list
44708904|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708905|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44708906|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708907|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708908|NCT03149640|Amikacin|amikacin|mesh-list
44708909|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44708910|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44708911|NCT03098355|Interleukin-2|interleukin-2|mesh-list
44708912|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708913|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708914|NCT03098355|Analgesics|analgesics|mesh-ancestor
44708915|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
44708916|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708917|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708918|NCT02986334|Naproxen|naproxen|mesh-list
44708919|NCT02986334|Omeprazole|omeprazole|mesh-list
44708920|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44708921|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44708922|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44708923|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708924|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708925|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44708926|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44708927|NCT02986334|Analgesics|analgesics|mesh-ancestor
44708928|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
44708929|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708930|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708931|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708932|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44708933|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
44708934|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44708935|NCT02927769|Nivolumab|nivolumab|mesh-list
44708936|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44708937|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44708938|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708939|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708940|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44708941|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708942|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44708943|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
44708944|NCT02820857|Bevacizumab|bevacizumab|mesh-list
44708945|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708946|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708947|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44708948|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44708949|NCT02820857|Growth Substances|growth substances|mesh-ancestor
44708950|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708951|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
44708952|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
44708953|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44708954|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
44708955|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44708956|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708957|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44708958|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
44708959|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44708960|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
44708961|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708962|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44708963|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44708964|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
44708965|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
44708966|NCT02760329|Protective Agents|protective agents|mesh-ancestor
44708967|NCT02668289|Anesthetics|anesthetics|mesh-list
44708968|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44708969|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44708970|NCT02655315|Deferiprone|deferiprone|mesh-list
44708971|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44708972|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
44708973|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
44708974|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708976|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708977|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708978|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44708979|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708980|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
44708981|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708983|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44708984|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708985|NCT02436733|Cisplatin|cisplatin|mesh-list
44708986|NCT02436733|Pemetrexed|pemetrexed|mesh-list
44708987|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44708988|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44708989|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44708990|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44708991|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44708992|NCT02426502|Cyclosporine|cyclosporine|mesh-list
44708993|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
44708994|NCT02426502|Prednisone|prednisone|mesh-list
44708995|NCT02426502|Azathioprine|azathioprine|mesh-list
44708996|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
44708997|NCT02426502|Cyclosporins|cyclosporins|mesh-list
44708998|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44708999|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
44709000|NCT02426502|Hormones|hormones|mesh-ancestor
44709001|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709002|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709003|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44709004|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709005|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709006|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709007|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709008|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
44709009|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
44709010|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709011|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
44709012|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44709013|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44709014|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44709015|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44709016|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
44709017|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44709018|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
44709019|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709020|NCT02275156|Evolocumab|evolocumab|mesh-list
44709021|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709022|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709023|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
43874532|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709024|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709025|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709026|NCT02124902|Carboplatin|carboplatin|mesh-list
44709027|NCT02124902|Docetaxel|docetaxel|mesh-list
44709028|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709029|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709030|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709031|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709032|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709033|NCT02067182|Dabigatran|dabigatran|mesh-list
44709034|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
44709035|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44709036|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
44709037|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709038|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709039|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
44709040|NCT01877837|Fludarabine|fludarabine|mesh-list
44709041|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
44709042|NCT01877837|Melphalan|melphalan|mesh-list
44709071|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709072|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709073|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
44709074|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709075|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709076|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
44709077|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709107|NCT00523341|Denosumab|denosumab|mesh-list
44709108|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44709109|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709110|NCT00364013|Panitumumab|panitumumab|mesh-list
44709111|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709112|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709113|NCT00345839|Cinacalcet|cinacalcet|mesh-list
44709114|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44709115|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709116|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44709117|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
44236491|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
44709118|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709119|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
44709120|NCT00330759|Denosumab|denosumab|mesh-list
44709121|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44709122|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709123|NCT00113763|Panitumumab|panitumumab|mesh-list
44709124|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709125|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709126|NCT01438359|Furosemide|furosemide|mesh-list
44709127|NCT01438359|Diuretics|diuretics|mesh-ancestor
44709128|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
44709129|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709130|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44709131|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709132|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709133|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44709134|NCT01438372|Hematinics|hematinics|mesh-ancestor
44709135|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
44709136|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44709137|NCT01438515|Doxycycline|doxycycline|mesh-list
44709138|NCT01438515|Rifampin|rifampin|mesh-list
44709139|NCT01438515|Mupirocin|mupirocin|mesh-list
44709140|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44709141|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709142|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
44709143|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44709144|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44709145|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
44709146|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44709147|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44709148|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44709149|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
44709150|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
44709151|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44709152|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709153|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709154|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44709155|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44709156|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44709157|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44709158|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44709159|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44709160|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44709161|NCT01438554|Trametinib|trametinib|mesh-list
44709162|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709163|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44709164|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709165|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709166|NCT01438567|Oxycodone|oxycodone|mesh-list
44709167|NCT01438567|Naloxone|naloxone|mesh-list
44709168|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44709169|NCT01438567|Narcotics|narcotics|mesh-ancestor
44709170|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709171|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709172|NCT01438567|Analgesics|analgesics|mesh-ancestor
44709173|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
44709174|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709175|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44709176|NCT01438580|Aspirin|aspirin|mesh-list
44709177|NCT01438580|Warfarin|warfarin|mesh-list
44709178|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44709179|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44709180|NCT01438580|Analgesics|analgesics|mesh-ancestor
44709181|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
44709182|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709183|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709184|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44709185|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44709186|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44709187|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44709188|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709189|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44709190|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44709191|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709192|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
44709193|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
44709194|NCT01438632|Insulin|insulin|mesh-list
44709195|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709196|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709197|NCT01438723|Metformin|metformin|mesh-list
44709198|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709199|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709200|NCT01438736|Etonogestrel|etonogestrel|mesh-list
44709201|NCT01438736|Desogestrel|desogestrel|mesh-list
44709202|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44709203|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
44709204|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44709205|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260708|NCT00640029|Analgesics|analgesics|mesh-ancestor
44709206|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44709207|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44709208|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44709209|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44709210|NCT01438736|Progestins|progestins|mesh-ancestor
44709211|NCT01438736|Hormones|hormones|mesh-ancestor
44709212|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709213|NCT01438749|Diazepam|diazepam|mesh-list
44709214|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44709215|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
44709216|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
44709217|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
44709218|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709219|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709220|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709221|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44709222|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709223|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44709224|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44709225|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44709226|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44709227|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709228|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44709229|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
44709230|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
44709231|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
44709232|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
44709233|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709234|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709235|NCT01438866|Fluorides|fluorides|mesh-list
44709236|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
44709237|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
44709238|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
44709239|NCT01438866|Protective Agents|protective agents|mesh-ancestor
44709240|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709241|NCT01438944|Nicotine|nicotine|mesh-list
44709242|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44709243|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
44709244|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709245|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709246|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44709247|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44709248|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44709249|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709250|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709251|NCT01439100|Oxycodone|oxycodone|mesh-list
44709252|NCT01439100|Naloxone|naloxone|mesh-list
44709253|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44709254|NCT01439100|Narcotics|narcotics|mesh-ancestor
44709255|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709256|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709257|NCT01439100|Analgesics|analgesics|mesh-ancestor
44709258|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
44709259|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709260|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44709261|NCT01439152|Maytansine|maytansine|mesh-list
44709262|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
44709263|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44709264|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709265|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709266|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709267|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709268|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709269|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
44709270|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709272|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709273|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709274|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44709275|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44709276|NCT01439178|Growth Substances|growth substances|mesh-ancestor
44709277|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709278|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
44709279|NCT01439191|Vinorelbine|vinorelbine|mesh-list
44709280|NCT01439191|Antibodies|antibodies|mesh-list
44709281|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
44709282|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709283|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44709284|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709285|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709286|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709287|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709288|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709290|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44709291|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709292|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709293|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44709294|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709295|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709296|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
44709297|NCT01439243|Donepezil|donepezil|mesh-list
44709298|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44709299|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709300|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709301|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
44709302|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709303|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709304|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
44709305|NCT01439399|Lidocaine|lidocaine|mesh-list
44709306|NCT01439399|Ketamine|ketamine|mesh-list
44709307|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
44709308|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
44709309|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709310|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709311|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
44709312|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709313|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44709314|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44709315|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44709316|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709317|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709318|NCT01439399|Analgesics|analgesics|mesh-ancestor
44709319|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44709320|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44709321|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
44709322|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44709323|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44709324|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709325|NCT01439438|Topiramate|topiramate|mesh-list
44709326|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
44709327|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709328|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709329|NCT01439542|Hormones|hormones|mesh-list
44709330|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44709331|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709332|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709333|NCT01439750|Rituximab|rituximab|mesh-list
44709334|NCT01439750|Bortezomib|bortezomib|mesh-list
44709335|NCT01439750|Cladribine|cladribine|mesh-list
44709336|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709337|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709338|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
44709339|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709340|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44709341|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709342|NCT01439984|Clomipramine|clomipramine|mesh-list
44709343|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44121164|NCT00122941|Micronutrients|micronutrients|mesh-list
44709344|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
44709345|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709346|NCT01439984|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44709347|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44709348|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709349|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709350|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709351|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
44709352|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709353|NCT01440062|Vitamin D|vitamin d|mesh-list
44709354|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
44709355|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
44709356|NCT01440062|Vitamins|vitamins|mesh-list
44709357|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
44709358|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874780|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44709359|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44709360|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44709361|NCT01440088|Doxorubicin|doxorubicin|mesh-list
44709362|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44709363|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44709364|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709365|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44709366|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44709367|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709368|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709369|NCT01440114|Fentanyl|fentanyl|mesh-list
44709370|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44709371|NCT01440114|Narcotics|narcotics|mesh-ancestor
44709372|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709373|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709374|NCT01440114|Analgesics|analgesics|mesh-ancestor
44709375|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
44709376|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709377|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44709378|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44709379|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
44709380|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
44709381|NCT01440127|Metformin|metformin|mesh-list
44709382|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709383|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709384|NCT01440140|Insulin|insulin|mesh-list
44709385|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709386|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709387|NCT01440270|Cetuximab|cetuximab|mesh-list
44709388|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709389|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709390|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44709391|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44709392|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709393|NCT01440335|Fenoterol|fenoterol|mesh-list
44709394|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44709395|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
44709396|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709397|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709398|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44709399|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
44709400|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
44709401|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
44709402|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44709403|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44709404|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44709405|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44709406|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44709407|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709408|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709409|NCT01440361|Belimumab|belimumab|mesh-list
44709410|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709411|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
44709412|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709413|NCT01440400|Anesthetics|anesthetics|mesh-list
44709414|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709415|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709416|NCT01440439|Insulin|insulin|mesh-list
44709417|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44709418|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
44709419|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
44709420|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709421|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709422|NCT01440582|Dexamethasone|dexamethasone|mesh-list
44709423|NCT01440582|Lenalidomide|lenalidomide|mesh-list
44709424|NCT01440582|Bortezomib|bortezomib|mesh-list
44709425|NCT01440582|Panobinostat|panobinostat|mesh-list
44709426|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44709427|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
44709428|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
44709429|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709430|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709431|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709432|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
44709433|NCT01440582|Hormones|hormones|mesh-ancestor
44709434|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709435|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44709436|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709437|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
44709438|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44709439|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44709440|NCT01440582|Growth Substances|growth substances|mesh-ancestor
44709441|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
44709442|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44709443|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709444|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709445|NCT01440608|Albendazole|albendazole|mesh-list
44709446|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
44709447|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44709448|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709449|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
44709450|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44709451|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44709452|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709453|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709454|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709455|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709456|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709457|NCT01440621|Pyridoxine|pyridoxine|mesh-list
44709458|NCT01440621|Modafinil|modafinil|mesh-list
44709459|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44709460|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709461|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44709462|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44709463|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44709464|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709465|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
44709466|NCT01440621|Vitamins|vitamins|mesh-ancestor
44709467|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
44709468|NCT01440673|Aprepitant|aprepitant|mesh-list
44709469|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
44709470|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
44709471|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709472|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709473|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709474|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44709475|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709476|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709477|NCT01440725|Mitogens|mitogens|mesh-list
44709478|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709479|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709480|NCT01440751|Mitomycins|mitomycins|mesh-list
44709481|NCT01440751|Mitomycin|mitomycin|mesh-list
44709482|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44709483|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709484|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
44709485|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709486|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44709487|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709488|NCT01440790|Vitamins|vitamins|mesh-list
44709489|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
44709490|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
43874842|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44709491|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709492|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
44709493|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709495|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
44709496|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44709497|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44709498|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709499|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709500|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709501|NCT01440842|Insulin|insulin|mesh-list
44709502|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44709503|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709504|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709505|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
44709506|NCT01440933|Analgesics|analgesics|mesh-ancestor
44709507|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
44709508|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709509|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709510|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
44709511|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709512|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44709513|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
44709514|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44709515|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709516|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709517|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44709518|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
44709519|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44709520|NCT01440985|Nicotine|nicotine|mesh-list
44709521|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44709522|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
44709523|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709524|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709525|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44709526|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44709527|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
44709528|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709529|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709530|NCT01440998|Paclitaxel|paclitaxel|mesh-list
44709531|NCT01440998|Carboplatin|carboplatin|mesh-list
44709532|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44709533|NCT01440998|Dasatinib|dasatinib|mesh-list
44709534|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44709535|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709536|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709537|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709538|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709539|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709540|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44709541|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709542|NCT01441128|Crizotinib|crizotinib|mesh-list
44709543|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709544|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44709545|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709546|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709547|NCT01441193|Vaccines|vaccines|mesh-list
44709548|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
44709549|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709550|NCT01441206|Rifampin|rifampin|mesh-list
44709551|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44709552|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
44709553|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44709554|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709555|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
44709556|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44709557|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709558|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709559|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44709560|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44709561|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44709562|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44709563|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44709564|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44709565|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44709566|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44709567|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709568|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709571|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709572|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44709573|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
44709574|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709575|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709576|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44709577|NCT01441284|Pramipexole|pramipexole|mesh-list
44709578|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
44709579|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709580|NCT01441284|Protective Agents|protective agents|mesh-ancestor
44709581|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709582|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44709583|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44709584|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
44709585|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
44709586|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709587|NCT01441297|Nintedanib|nintedanib|mesh-list
44709588|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709589|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44709590|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709591|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709592|NCT01441388|Bevacizumab|bevacizumab|mesh-list
44709593|NCT01441388|Sunitinib|sunitinib|mesh-list
44709594|NCT01441388|Sorafenib|sorafenib|mesh-list
44709595|NCT01441388|Axitinib|axitinib|mesh-list
44709596|NCT01441388|Crizotinib|crizotinib|mesh-list
44709597|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709598|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709599|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44709600|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44709601|NCT01441388|Growth Substances|growth substances|mesh-ancestor
44709602|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709603|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
44709604|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44709605|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709606|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709607|NCT01441427|Lenograstim|lenograstim|mesh-list
44709608|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44709609|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
44709610|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709611|NCT01441505|Midazolam|midazolam|mesh-list
44709612|NCT01441505|Ketamine|ketamine|mesh-list
44709613|NCT01441505|Analgesics|analgesics|mesh-ancestor
44709614|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
44709615|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709616|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709617|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44709618|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44709619|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
44709620|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
44709621|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709622|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44709623|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44709624|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709625|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709626|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44709627|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44709628|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44709629|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44709630|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709631|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
44709632|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
44709633|NCT01441531|Gabapentin|gabapentin|mesh-list
44709634|NCT01441531|Analgesics|analgesics|mesh-ancestor
44709635|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
44709636|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709637|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709638|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
44709639|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44709640|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44709641|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709642|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709643|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44709644|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44709645|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709646|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709648|NCT01441557|Amifampridine|amifampridine|mesh-list
44709649|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44709650|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709651|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709652|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44709653|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709654|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709655|NCT01441700|Anesthetics|anesthetics|mesh-list
44709656|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709657|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709658|NCT01441804|Ribavirin|ribavirin|mesh-list
44709659|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44709660|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
44709661|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
44709662|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709663|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
44709664|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709665|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
44709666|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709667|NCT01441869|Metformin|metformin|mesh-list
44709668|NCT01441869|Saxagliptin|saxagliptin|mesh-list
44709669|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709670|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709671|NCT01441869|Incretins|incretins|mesh-ancestor
44709672|NCT01441869|Hormones|hormones|mesh-ancestor
44709673|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709674|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44709675|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
44709676|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709677|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709678|NCT01441908|Pravastatin|pravastatin|mesh-list
44709679|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709680|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709681|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
44709682|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709683|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709684|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44709685|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709686|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
44709687|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709688|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
44709689|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44709690|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44709691|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709692|NCT01441934|Urological Agents|urological agents|mesh-ancestor
44709693|NCT01441986|Amantadine|amantadine|mesh-list
44709694|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
44709695|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
44709696|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
44709697|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44709698|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44709699|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709700|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709701|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709702|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44709703|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44709704|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
44709705|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709706|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
44709707|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44709708|NCT01441986|Analgesics|analgesics|mesh-ancestor
44709709|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
44709710|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709711|NCT01442025|Infliximab|infliximab|mesh-list
44709712|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
44709713|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709714|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44709715|NCT01442168|Atovaquone|atovaquone|mesh-list
44709716|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709717|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
44709718|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44709719|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44709720|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709721|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709722|NCT01442272|Calcifediol|calcifediol|mesh-list
44709723|NCT01442272|Vitamins|vitamins|mesh-ancestor
44709724|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
44709725|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709726|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44709727|NCT01442311|Interferons|interferons|mesh-list
44709728|NCT01442311|Ribavirin|ribavirin|mesh-list
44709729|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
44709730|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
44709731|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44709732|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709733|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
44709734|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709735|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
44709736|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709737|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
44709738|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709739|NCT01442428|Dexamethasone|dexamethasone|mesh-list
44261240|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
44709740|NCT01442428|Naproxen|naproxen|mesh-list
44709741|NCT01442428|Atorvastatin|atorvastatin|mesh-list
44709742|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44709743|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
44709744|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
44709745|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709746|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709747|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44709748|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
44709749|NCT01442428|Hormones|hormones|mesh-ancestor
44709750|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44709751|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44709752|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709753|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709754|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709755|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
44709756|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709757|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709758|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44709759|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709760|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44709761|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44709762|NCT01442428|Analgesics|analgesics|mesh-ancestor
44709763|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
44709764|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44709765|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
44709766|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44709767|NCT01442519|Mitomycins|mitomycins|mesh-list
44709768|NCT01442519|Mitomycin|mitomycin|mesh-list
44709769|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
44709770|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44709771|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709772|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
44709773|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709774|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44709775|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709776|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44709777|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
44709778|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709779|NCT01442532|Midazolam|midazolam|mesh-list
44709780|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44709781|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44709782|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709783|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709784|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44709785|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44709786|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709787|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44709788|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
44709789|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
44709790|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
44709791|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
44709792|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709793|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709794|NCT01442558|Bupivacaine|bupivacaine|mesh-list
44709795|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
44709796|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
44709797|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709798|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709799|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
44709800|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709801|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
44709802|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44709803|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
44709804|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709805|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
44709806|NCT01442571|Protective Agents|protective agents|mesh-ancestor
44709807|NCT01442610|Rasagiline|rasagiline|mesh-list
44709808|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44709809|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709810|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709811|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44709812|NCT01442610|Protective Agents|protective agents|mesh-ancestor
44709813|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709814|NCT01442662|Gemcitabine|gemcitabine|mesh-list
44709815|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709816|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
44709817|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709818|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709819|NCT01442662|Antiviral Agents|antiviral agents|mesh-ancestor
44709820|NCT01442662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709821|NCT01442662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709822|NCT01442662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709823|NCT01442662|Immunologic Factors|immunologic factors|mesh-ancestor
44709824|NCT01442662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709825|NCT01442701|Triclosan|triclosan|mesh-list
44709826|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44709827|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709828|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44709829|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709830|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
44709831|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709832|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709833|NCT01442727|Selenium|selenium|mesh-list
44709834|NCT01442727|Selenious Acid|selenious acid|mesh-list
44709835|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
44709836|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
44709837|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709838|NCT01442727|Protective Agents|protective agents|mesh-ancestor
44709839|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709840|NCT01442727|Trace Elements|trace elements|mesh-ancestor
44709841|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
44709842|NCT01442766|Donepezil|donepezil|mesh-list
44709843|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44709844|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709845|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709846|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
44709847|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709848|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709849|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
44709850|NCT01442818|Hydromorphone|hydromorphone|mesh-list
44709851|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44709852|NCT01442818|Narcotics|narcotics|mesh-ancestor
44709853|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709854|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709855|NCT01442818|Analgesics|analgesics|mesh-ancestor
44709856|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
44709857|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709858|NCT01442870|Metformin|metformin|mesh-list
44709859|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709860|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709861|NCT01442909|Docetaxel|docetaxel|mesh-list
44709862|NCT01442909|Pemetrexed|pemetrexed|mesh-list
44709863|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709864|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709865|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709866|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
44121649|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
44709867|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709868|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709869|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44709870|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44709871|NCT01442935|Leucovorin|leucovorin|mesh-list
44709872|NCT01442935|Folic Acid|folic acid|mesh-list
44709873|NCT01442935|Bevacizumab|bevacizumab|mesh-list
44709874|NCT01442935|Cetuximab|cetuximab|mesh-list
44709875|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
44709876|NCT01442935|Irinotecan|irinotecan|mesh-list
44709877|NCT01442935|Fluorouracil|fluorouracil|mesh-list
44709878|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
44709879|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709880|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709881|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44709882|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44709883|NCT01442935|Growth Substances|growth substances|mesh-ancestor
44709884|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709885|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
44709886|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44709887|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44709888|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709889|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709890|NCT01442935|Antidotes|antidotes|mesh-ancestor
44709891|NCT01442935|Protective Agents|protective agents|mesh-ancestor
44709892|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
44709893|NCT01442935|Vitamins|vitamins|mesh-ancestor
44709894|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
44709895|NCT01442935|Hematinics|hematinics|mesh-ancestor
44709896|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
44709897|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709898|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709899|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
44709900|NCT01442974|Gemcitabine|gemcitabine|mesh-list
44709901|NCT01442974|Paclitaxel|paclitaxel|mesh-list
44709902|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44709903|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709904|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
44709905|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
44709906|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
44709907|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709908|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709909|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
44709910|NCT01442974|Antiviral Agents|antiviral agents|mesh-ancestor
44709911|NCT01442974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709912|NCT01442974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875193|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
44709913|NCT01442974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709914|NCT01442974|Immunologic Factors|immunologic factors|mesh-ancestor
44709915|NCT01442974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709916|NCT01442987|Irbesartan|irbesartan|mesh-list
44709917|NCT01442987|Atorvastatin|atorvastatin|mesh-list
44709918|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44709919|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44709920|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
44709921|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709922|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44709923|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44709924|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44709925|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44709926|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44709927|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44709928|NCT01443065|Leucovorin|leucovorin|mesh-list
44709929|NCT01443065|Folic Acid|folic acid|mesh-list
44709930|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
44709931|NCT01443065|Panitumumab|panitumumab|mesh-list
44709932|NCT01443065|Fluorouracil|fluorouracil|mesh-list
44709933|NCT01443065|Rilotumumab|rilotumumab|mesh-list
44709934|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
44709935|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709936|NCT01443065|Antidotes|antidotes|mesh-ancestor
44709937|NCT01443065|Protective Agents|protective agents|mesh-ancestor
44709938|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709939|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
44709940|NCT01443065|Vitamins|vitamins|mesh-ancestor
44709941|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
44709942|NCT01443065|Hematinics|hematinics|mesh-ancestor
44709943|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44709944|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
44709945|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709946|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44709947|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709948|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
44709949|NCT01443104|Sirolimus|sirolimus|mesh-list
44709950|NCT01443104|Everolimus|everolimus|mesh-list
44709951|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44709952|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44709953|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
44709954|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709955|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44709956|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44709957|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44709958|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
44709959|NCT01443117|Vaccines|vaccines|mesh-list
44709960|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
44709961|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709962|NCT01443169|Pregabalin|pregabalin|mesh-list
44709963|NCT01443169|Analgesics|analgesics|mesh-ancestor
44709964|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
44709965|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44709966|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709967|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
44709968|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44709969|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709970|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709971|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44709972|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44709973|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44709974|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44709975|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709977|NCT01443195|Trace Elements|trace elements|mesh-ancestor
44709978|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
44709979|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709980|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43875327|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709981|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44709982|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44709983|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44709984|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44709985|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44709986|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709987|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
44709988|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44709989|NCT01443221|Metformin|metformin|mesh-list
44709990|NCT01443221|Mitiglinide|mitiglinide|mesh-list
44709991|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44709992|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709993|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
44709994|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44709995|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44709996|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
44709997|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44709998|NCT01443325|Lidocaine|lidocaine|mesh-list
44709999|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44710000|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
44710001|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710002|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710003|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
44710004|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710005|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710006|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44710007|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44710008|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44710009|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710010|NCT01443338|Acitretin|acitretin|mesh-list
44710011|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
44710012|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710013|NCT01443377|Panitumumab|panitumumab|mesh-list
44710014|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710015|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710016|NCT01443416|Vaccines|vaccines|mesh-list
44710017|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44710018|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
44710019|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710020|NCT01443429|Beraprost|beraprost|mesh-list
44710021|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710022|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
44710023|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44710024|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44710025|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44710026|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44710027|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44710028|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710029|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710030|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710031|NCT01443520|Analgesics|analgesics|mesh-ancestor
44710032|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
44710033|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710034|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44710035|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710036|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
44710037|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44710038|NCT01443572|Anesthetics|anesthetics|mesh-list
44710039|NCT01443572|Sevoflurane|sevoflurane|mesh-list
44710040|NCT01443572|Desflurane|desflurane|mesh-list
44710041|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710042|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710043|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710044|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44710045|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
44710046|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44710047|NCT01443624|Hematinics|hematinics|mesh-ancestor
44710048|NCT01443676|Bevacizumab|bevacizumab|mesh-list
44710049|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710050|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710051|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44710052|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44710053|NCT01443676|Growth Substances|growth substances|mesh-ancestor
44710054|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710055|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
44710056|NCT01443741|Insulin|insulin|mesh-list
44710057|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44710058|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44710059|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710060|NCT01443780|Selenium|selenium|mesh-list
44710061|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
44710062|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710063|NCT01443780|Protective Agents|protective agents|mesh-ancestor
44710064|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710065|NCT01443780|Trace Elements|trace elements|mesh-ancestor
44710066|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
44710067|NCT01443806|Oseltamivir|oseltamivir|mesh-list
44710068|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
44710069|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710070|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710071|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710072|NCT01443897|Vitamin D|vitamin d|mesh-list
44710073|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
44710074|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
44710075|NCT01443897|Vitamins|vitamins|mesh-list
44710076|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
44710077|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710078|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44710079|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44710080|NCT01443988|Travoprost|travoprost|mesh-list
44710081|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710082|NCT01444001|Vaccines|vaccines|mesh-list
44710083|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44710084|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
44710085|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710086|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
44710087|NCT01444118|Vaccines|vaccines|mesh-list
44710088|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44710089|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
44710090|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710091|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710092|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710093|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44710094|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
44710095|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710096|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710097|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44710098|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44710099|NCT01444131|Nicotine|nicotine|mesh-list
44710100|NCT01444131|Varenicline|varenicline|mesh-list
44710101|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44710102|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
44710103|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710104|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710105|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44710106|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44710107|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
44710108|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710109|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710110|NCT01444196|Desloratadine|desloratadine|mesh-list
44710111|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44710112|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
44710113|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710114|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710115|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875395|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44710116|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44710117|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44710118|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
44710119|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
44710120|NCT01444248|Metformin|metformin|mesh-list
44710121|NCT01444248|Glimepiride|glimepiride|mesh-list
44710122|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44710123|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710124|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710125|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710126|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
44710128|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44710129|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
44710130|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710131|NCT01444352|Vaccines|vaccines|mesh-list
44710132|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44710133|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
44710134|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710135|NCT01444469|Azithromycin|azithromycin|mesh-list
44710136|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710137|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710138|NCT01444521|Cisplatin|cisplatin|mesh-list
44710139|NCT01444521|Irinotecan|irinotecan|mesh-list
44710140|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710141|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44710142|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44710143|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710144|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710145|NCT01444547|Paclitaxel|paclitaxel|mesh-list
44710146|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44710147|NCT01444547|Cisplatin|cisplatin|mesh-list
44710148|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44710149|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710150|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
44710151|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
44710152|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
44710153|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710154|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
44710155|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44710156|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
44710157|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44710158|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710159|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710160|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710161|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
44710162|NCT01444612|Heparin|heparin|mesh-list
44710163|NCT01444612|Calcium heparin|calcium heparin|mesh-list
44710164|NCT01444612|Enoxaparin|enoxaparin|mesh-list
44710165|NCT01444612|Dalteparin|dalteparin|mesh-list
44710166|NCT01444612|Tinzaparin|tinzaparin|mesh-list
44710167|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44710168|NCT01444612|PENTA|penta|mesh-list
44710169|NCT01444612|Fondaparinux|fondaparinux|mesh-list
44710170|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
44710171|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44710172|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44710173|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710174|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44710175|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
44710176|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44710177|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710178|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710180|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710181|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44710182|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44710183|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710184|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710185|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
44710186|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44710187|NCT01444807|Sorafenib|sorafenib|mesh-list
44710188|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710189|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44710190|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710191|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710192|NCT01444833|Candesartan|candesartan|mesh-list
44710193|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710194|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44710195|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44710196|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710197|NCT01444846|Ebselen|ebselen|mesh-list
44710198|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44710199|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44710200|NCT01444846|Analgesics|analgesics|mesh-ancestor
44710201|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
44710202|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710203|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710204|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44710205|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710206|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44710207|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710208|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
44710209|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710210|NCT01444846|Protective Agents|protective agents|mesh-ancestor
44710211|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44710212|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710213|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44710214|NCT01444885|Amlodipine|amlodipine|mesh-list
44710215|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
44710216|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710217|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44710218|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44710219|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710220|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44710221|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710222|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44710223|NCT01444976|Midazolam|midazolam|mesh-list
44710224|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
44710225|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710226|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710227|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44710228|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44710229|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44710230|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44710231|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710232|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44710233|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
44710234|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
44710235|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
44710236|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710237|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710238|NCT01445106|Nelfinavir|nelfinavir|mesh-list
44710239|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44710240|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44710241|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710242|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710244|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44710245|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44710246|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
44710247|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710248|NCT01445119|Carboplatin|carboplatin|mesh-list
44710249|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710250|NCT01445210|Ropivacaine|ropivacaine|mesh-list
44710251|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
44710252|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
44710253|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710254|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710255|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
44710256|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710257|NCT01445223|Ritonavir|ritonavir|mesh-list
44710258|NCT01445223|Lopinavir|lopinavir|mesh-list
44710259|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44710260|NCT01445223|Efavirenz|efavirenz|mesh-list
44710261|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44710262|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44710263|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710264|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710265|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710266|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44710267|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44710268|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
44710269|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710270|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44710271|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44710272|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44710273|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44710285|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44710286|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710287|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710288|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
44710289|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710290|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710291|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710292|NCT01445262|Levocetirizine|levocetirizine|mesh-list
44710293|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44710294|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44710295|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
44710296|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
44710297|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710298|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710299|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710300|NCT01445340|Romidepsin|romidepsin|mesh-list
44710301|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44710302|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710303|NCT01445379|Ipilimumab|ipilimumab|mesh-list
44710304|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710305|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710306|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44710307|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710308|NCT01445392|Cisplatin|cisplatin|mesh-list
44710309|NCT01445392|Pemetrexed|pemetrexed|mesh-list
44710310|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44710311|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710312|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710313|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710314|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44710315|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44710316|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
44710317|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710318|NCT01445405|Cisplatin|cisplatin|mesh-list
44710319|NCT01445405|Cetuximab|cetuximab|mesh-list
44710320|NCT01445405|Bortezomib|bortezomib|mesh-list
44710321|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710322|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710323|NCT01445418|Carboplatin|carboplatin|mesh-list
44710324|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710325|NCT01445431|Mineral Oil|mineral oil|mesh-list
44710326|NCT01445431|Emollients|emollients|mesh-ancestor
44710327|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710328|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
44710329|NCT01445522|Veliparib|veliparib|mesh-list
44710330|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710331|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
44710332|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710333|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710334|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44710335|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
44710336|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710337|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710338|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43875563|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44710339|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44710340|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710342|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710343|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44710344|NCT01445561|Analgesics|analgesics|mesh-ancestor
44710345|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
44710346|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710347|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710348|NCT01445587|Bortezomib|bortezomib|mesh-list
44710349|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710350|NCT01445600|Retapamulin|retapamulin|mesh-list
44710351|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710352|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710353|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
44710354|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44710355|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710356|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710357|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44710358|NCT01445639|Analgesics|analgesics|mesh-ancestor
44710359|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
44710360|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710361|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44710362|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44710363|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44710364|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
44710365|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710366|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710367|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44710368|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44710369|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710370|NCT01445743|Vaccines|vaccines|mesh-list
44710371|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
44710372|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710373|NCT01445756|Lidocaine|lidocaine|mesh-list
44710374|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
44710375|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
44710376|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710377|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710378|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
44710379|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710380|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710381|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44710382|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44710383|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44710384|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710385|NCT01445860|Simvastatin|simvastatin|mesh-list
44710386|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44710387|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44710388|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
44710389|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710390|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44710391|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44710392|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710393|NCT01445938|Lumefantrine|lumefantrine|mesh-list
44710394|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
44710395|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44710396|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44710397|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710398|NCT01445964|Atenolol|atenolol|mesh-list
44710399|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710400|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710401|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
44710402|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
44710403|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710404|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710405|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44710406|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44710407|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44710408|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
44710409|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710410|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710411|NCT01446094|Regadenoson|regadenoson|mesh-list
44710412|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44710413|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44710414|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
44710415|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
44710416|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710417|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710418|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710420|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
44710421|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
44710422|NCT01446107|Protective Agents|protective agents|mesh-ancestor
44710423|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710424|NCT01446120|Insulin|insulin|mesh-list
44710425|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44710426|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
44710427|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
44710428|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
44710429|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44710430|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710431|NCT01446211|Gusperimus|gusperimus|mesh-list
44710432|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
44710433|NCT01446211|Methotrexate|methotrexate|mesh-list
44710434|NCT01446211|Azathioprine|azathioprine|mesh-list
44710435|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
44710436|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710437|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
44710438|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710439|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710440|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44710441|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
44710442|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710443|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710444|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44710445|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44710446|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
44710447|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44710448|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44710449|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
44710450|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710451|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710452|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44710453|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44710454|NCT01446211|Hormones|hormones|mesh-ancestor
44710455|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44710456|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44710457|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44710458|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44710459|NCT01446211|Protective Agents|protective agents|mesh-ancestor
44710460|NCT01446276|Resveratrol|resveratrol|mesh-list
44710461|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
44710462|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710463|NCT01446276|Protective Agents|protective agents|mesh-ancestor
44710464|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710465|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710466|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710467|NCT01446328|Olanzapine|olanzapine|mesh-list
44710468|NCT01446328|Aripiprazole|aripiprazole|mesh-list
44710469|NCT01446328|Amisulpride|amisulpride|mesh-list
44710470|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
44710471|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
44710472|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710473|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710474|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710475|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44710476|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44710477|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710478|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710479|NCT01446328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44710480|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44710481|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44710482|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710483|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710484|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
44710485|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
44710486|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
44710487|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
44710488|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44710489|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44710490|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44710491|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44710492|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44710493|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44710494|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44710495|NCT01446445|Valganciclovir|valganciclovir|mesh-list
44710496|NCT01446445|Ganciclovir|ganciclovir|mesh-list
44710497|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44710498|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
44710499|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710500|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44710501|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710502|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710503|NCT01446458|Folfirinox|folfirinox|mesh-list
44710504|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710505|NCT01446484|Cyclosporine|cyclosporine|mesh-list
44710506|NCT01446484|Sirolimus|sirolimus|mesh-list
44710507|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
44710508|NCT01446484|Everolimus|everolimus|mesh-list
44710509|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
44710510|NCT01446484|Tacrolimus|tacrolimus|mesh-list
44710511|NCT01446484|Cyclosporins|cyclosporins|mesh-list
44710512|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710513|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
44710514|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710515|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44710516|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710517|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710518|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
44710519|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710520|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710521|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710522|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710523|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44710524|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44710525|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
44710526|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710527|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710528|NCT01446497|Timolol|timolol|mesh-list
44710529|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44710530|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44710531|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44710532|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
44710533|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710534|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710535|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710536|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710537|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710538|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44710539|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44710540|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44710541|NCT01446523|Lactulose|lactulose|mesh-list
44710542|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710543|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44710544|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
44710545|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710546|NCT01446679|Atorvastatin|atorvastatin|mesh-list
44710547|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44710548|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44710549|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
44710550|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710551|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44710552|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44710553|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710555|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710556|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
44710557|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
44710558|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
44710559|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710560|NCT01446783|Mecasermin|mecasermin|mesh-list
44710561|NCT01446783|Growth Substances|growth substances|mesh-ancestor
44710562|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710563|NCT01446900|Rituximab|rituximab|mesh-list
44710564|NCT01446900|Cladribine|cladribine|mesh-list
44710565|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710566|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710567|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
44710568|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710569|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710570|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710571|NCT01446926|Vaccines|vaccines|mesh-list
44710572|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44710573|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
44710574|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710575|NCT01446952|Vitamin E|vitamin e|mesh-list
44710576|NCT01446952|Tocopherols|tocopherols|mesh-list
44710577|NCT01446952|Tocotrienols|tocotrienols|mesh-list
44710578|NCT01446952|Vitamins|vitamins|mesh-ancestor
44710579|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
44710580|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710581|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
44710582|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710583|NCT01446952|Protective Agents|protective agents|mesh-ancestor
44710584|NCT01446978|Vaccines|vaccines|mesh-list
44710585|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
44710586|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710587|NCT01447043|Ranibizumab|ranibizumab|mesh-list
44710588|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44710589|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44710590|NCT01447043|Growth Substances|growth substances|mesh-ancestor
44710591|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710592|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44710593|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710594|NCT01447069|Albuterol|albuterol|mesh-list
44710595|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44710596|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
44710597|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710598|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710599|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44710600|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
44710601|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
44710602|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44710603|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44710604|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44710605|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44710606|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
44710607|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710608|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710609|NCT01447095|Epoprostenol|epoprostenol|mesh-list
44710610|NCT01447095|Tezosentan|tezosentan|mesh-list
44710611|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43875775|NCT04720573|Neostigmine|neostigmine|mesh-list
44710612|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710613|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
44710614|NCT01447160|Cortisone|cortisone|mesh-list
44710615|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44710616|NCT01447173|Vitamin D|vitamin d|mesh-list
44710617|NCT01447173|Vitamins|vitamins|mesh-ancestor
44710618|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
44710619|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710620|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44710621|NCT01447212|Hydromorphone|hydromorphone|mesh-list
44710623|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44710624|NCT01447212|Narcotics|narcotics|mesh-ancestor
44710625|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710626|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710627|NCT01447212|Analgesics|analgesics|mesh-ancestor
44710628|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
44710629|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710630|NCT01447355|Vitamin D|vitamin d|mesh-list
44710631|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
44710632|NCT01447355|Vitamins|vitamins|mesh-ancestor
44710634|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710635|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44710636|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44710637|NCT01447368|Cinacalcet|cinacalcet|mesh-list
44710638|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44710639|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710640|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44710641|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
44710642|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44710643|NCT01447394|Interferons|interferons|mesh-list
44710644|NCT01447394|Ribavirin|ribavirin|mesh-list
44710645|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
44710646|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
44710647|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44710648|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710649|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
44710650|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710651|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
44710652|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710653|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
44710654|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710655|NCT01447485|Valsartan|valsartan|mesh-list
44710656|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710657|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44710658|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44710659|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710660|NCT01447550|Bosentan|bosentan|mesh-list
44710661|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710662|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44710663|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710664|NCT01447563|Clopidogrel|clopidogrel|mesh-list
44710665|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710666|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44710667|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44710668|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44710669|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
44710670|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710671|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710672|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710673|NCT01447589|Nelfinavir|nelfinavir|mesh-list
44710674|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44710675|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44710676|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710677|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710678|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710679|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44710680|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44710681|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
44710682|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710683|NCT01447654|Losartan|losartan|mesh-list
44710684|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710685|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710686|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44710687|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44710688|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710689|NCT01447797|Irbesartan|irbesartan|mesh-list
44710690|NCT01447797|Atorvastatin|atorvastatin|mesh-list
44710691|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44710692|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44710693|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
44710694|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710695|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44710696|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44710697|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710698|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710699|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44710700|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44710701|NCT01447862|Ibutilide|ibutilide|mesh-list
44710702|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710703|NCT01447875|Propofol|propofol|mesh-list
44710704|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44710705|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710706|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710707|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44710708|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
44710709|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
44710710|NCT01447979|Pancrelipase|pancrelipase|mesh-list
44710711|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710712|NCT01447992|Pancrelipase|pancrelipase|mesh-list
44710713|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710714|NCT01448018|Ranibizumab|ranibizumab|mesh-list
44710715|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44710716|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44710717|NCT01448018|Growth Substances|growth substances|mesh-ancestor
44710718|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710719|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
44710720|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710721|NCT01448031|Esomeprazole|esomeprazole|mesh-list
44710722|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44710723|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710724|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44710725|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710726|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710727|NCT01448070|Insulin|insulin|mesh-list
44710728|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44710729|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44710730|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710731|NCT01448096|Rituximab|rituximab|mesh-list
44710732|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710733|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710734|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
44710735|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710736|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710737|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
44710738|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44710739|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44710740|NCT01448174|Atorvastatin|atorvastatin|mesh-list
44710741|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44710742|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44710743|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
44710744|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710745|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44710746|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44710747|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710748|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44710749|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
44710750|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710751|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44710752|NCT01448291|Etonogestrel|etonogestrel|mesh-list
44710753|NCT01448291|NuvaRing|nuvaring|mesh-list
44710754|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
44710755|NCT01448291|Estradiol|estradiol|mesh-list
44710756|NCT01448291|Estrogens|estrogens|mesh-ancestor
44710757|NCT01448291|Hormones|hormones|mesh-ancestor
44710758|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44710759|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710760|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44710761|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44710762|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44710763|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44710764|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44710765|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44710766|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44710767|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
44710768|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710769|NCT01448330|Aspirin|aspirin|mesh-list
44710770|NCT01448330|Clopidogrel|clopidogrel|mesh-list
44710771|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44710772|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44710773|NCT01448330|Analgesics|analgesics|mesh-ancestor
44710774|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
44710775|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710776|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710777|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44710778|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710779|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44710780|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44710781|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710782|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710783|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44710784|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710785|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
44710786|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44710787|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44710788|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44710789|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
44710790|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710791|NCT01448395|Avibactam|avibactam|mesh-list
44710792|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44710793|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710794|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710795|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710796|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710797|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
44710798|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44710799|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44710800|NCT01448499|Clozapine|clozapine|mesh-list
44710801|NCT01448499|Amisulpride|amisulpride|mesh-list
44710802|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44710803|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
44710804|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710805|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710806|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710807|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44710808|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44710809|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710810|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710811|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
44710812|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
44710813|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44710814|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
44710815|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44710816|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
44710817|NCT01448642|Atorvastatin|atorvastatin|mesh-list
44710818|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44710819|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44710820|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
44710821|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710822|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44710823|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43875923|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
44710824|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710825|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44710826|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44710827|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44710828|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710829|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710830|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710831|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44710832|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44710833|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
44710834|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710835|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710836|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44710837|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44710838|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
44710839|NCT01448733|Clindamycin|clindamycin|mesh-list
44710840|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
44710841|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
44710842|NCT01448733|Tretinoin|tretinoin|mesh-list
44710843|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44710844|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710845|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710846|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44710847|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710848|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710849|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710850|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710851|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
44710852|NCT01448746|Heparin|heparin|mesh-list
44710853|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44710854|NCT01448746|Tinzaparin|tinzaparin|mesh-list
44710856|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
44710857|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44710858|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44710859|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710860|NCT01448772|Dronabinol|dronabinol|mesh-list
44710861|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
44710862|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710863|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710864|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44710865|NCT01448772|Analgesics|analgesics|mesh-ancestor
44710866|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
44710867|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710868|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44710869|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44710870|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710871|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710872|NCT01448772|Hormones|hormones|mesh-ancestor
44710873|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44710874|NCT01448798|Thrombin|thrombin|mesh-list
44710875|NCT01448798|Hemostatics|hemostatics|mesh-list
44710876|NCT01448798|Coagulants|coagulants|mesh-ancestor
44710877|NCT01448837|Timolol|timolol|mesh-list
44710878|NCT01448837|Bimatoprost|bimatoprost|mesh-list
44710879|NCT01448837|Latanoprost|latanoprost|mesh-list
44710880|NCT01448837|Cloprostenol|cloprostenol|mesh-list
44710881|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44710882|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44710883|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
44710884|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155791|NCT00228254|Vitamins|vitamins|mesh-ancestor
44710885|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710886|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710887|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44710888|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710889|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44710890|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44710891|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
44710892|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44710893|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
44710894|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44710895|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44710896|NCT01448993|Azithromycin|azithromycin|mesh-list
44710897|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710898|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710899|NCT01449045|Lumefantrine|lumefantrine|mesh-list
44710900|NCT01449045|Artemether|artemether|mesh-list
44710901|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44710902|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
44710903|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44710904|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44710905|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710906|NCT01449110|Resveratrol|resveratrol|mesh-list
44710907|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
44710908|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710909|NCT01449110|Protective Agents|protective agents|mesh-ancestor
44710910|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710911|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710912|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44710913|NCT01449123|Mannitol|mannitol|mesh-list
44710914|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44710915|NCT01449123|Diuretics|diuretics|mesh-ancestor
44710916|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
44710917|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710918|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44710919|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710920|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
44710921|NCT01449188|Ondansetron|ondansetron|mesh-list
44710922|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44710923|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710924|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44710925|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44710926|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710927|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710928|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710929|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710930|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
44710931|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
44710932|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710933|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710934|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
44710935|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44710936|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44710937|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
44710938|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710939|NCT01449188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44710940|NCT01449188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44710941|NCT01449188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44710942|NCT01449188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44710943|NCT01449188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44710944|NCT01449253|Bosentan|bosentan|mesh-list
44710945|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
44710946|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44710947|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44710948|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44710949|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710950|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710951|NCT01449253|Urological Agents|urological agents|mesh-ancestor
44710952|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44710953|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44710954|NCT01449344|Cytarabine|cytarabine|mesh-list
44710955|NCT01449344|Dexamethasone|dexamethasone|mesh-list
44710956|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
44710957|NCT01449344|Rituximab|rituximab|mesh-list
44710958|NCT01449344|Bortezomib|bortezomib|mesh-list
44710959|NCT01449344|BB 1101|bb 1101|mesh-list
44710960|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710961|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710962|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
44710963|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710964|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44710965|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44710966|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
44710967|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
44710968|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710969|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44710970|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
44710971|NCT01449344|Hormones|hormones|mesh-ancestor
44710972|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44710973|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44710974|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
44710975|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44710976|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710977|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44710978|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
44710979|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
44710980|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44710981|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44710982|NCT01449357|Zalutumumab|zalutumumab|mesh-list
44710983|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44710984|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44710985|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
44710986|NCT01449435|Miotics|miotics|mesh-ancestor
44710987|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
44710988|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44710989|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44710990|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44710991|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44710992|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44710993|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44710994|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44710995|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
44710996|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44710997|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44710998|NCT01449448|Triamcinolone|triamcinolone|mesh-list
44710999|NCT01449448|Ketorolac|ketorolac|mesh-list
44711000|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711001|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
44711002|NCT01449448|Hormones|hormones|mesh-ancestor
44711003|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711004|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711005|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122748|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
44711006|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711007|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44711008|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711009|NCT01449448|Analgesics|analgesics|mesh-ancestor
44711010|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
44711011|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711012|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711013|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44711014|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
44711015|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44711016|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44711017|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711018|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
44711019|NCT01449552|Coagulants|coagulants|mesh-ancestor
44711020|NCT01449565|Naltrexone|naltrexone|mesh-list
44711021|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44711022|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44711023|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711024|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
44711025|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711026|NCT01449578|Pramipexole|pramipexole|mesh-list
44711027|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
44711028|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711029|NCT01449578|Protective Agents|protective agents|mesh-ancestor
44711030|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711031|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44711032|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44711033|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
44711034|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
44711035|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711036|NCT01449617|Aspirin|aspirin|mesh-list
44711037|NCT01449617|Clopidogrel|clopidogrel|mesh-list
44711038|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44711039|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711040|NCT01449617|Analgesics|analgesics|mesh-ancestor
44711041|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
44711042|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711043|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711044|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711045|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711046|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44711047|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44711048|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711049|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44711050|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44711051|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711052|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
44711053|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44711054|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44711055|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44711056|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
44711057|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711058|NCT01449799|Fluticasone|fluticasone|mesh-list
44711059|NCT01449799|Xhance|xhance|mesh-list
44711060|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711061|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44711062|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
44711063|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711064|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711065|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44711066|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44711067|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44711068|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44711069|NCT01449825|Bevacizumab|bevacizumab|mesh-list
44711070|NCT01449825|Sunitinib|sunitinib|mesh-list
44711071|NCT01449825|Sorafenib|sorafenib|mesh-list
44711072|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44711073|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711074|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44711075|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44711076|NCT01449825|Growth Substances|growth substances|mesh-ancestor
44711077|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711078|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
44711079|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44711080|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617517|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44711081|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711082|NCT01449877|Trimethoprim|trimethoprim|mesh-list
44711083|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44711084|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
44711085|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44711086|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711087|NCT01449877|Renal Agents|renal agents|mesh-ancestor
44711088|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
44711089|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44711090|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44711091|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44711092|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711093|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711094|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44711095|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44711096|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44711097|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711098|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
44711099|NCT01450163|Pregabalin|pregabalin|mesh-list
44711100|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711101|NCT01450163|Analgesics|analgesics|mesh-ancestor
44711102|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
44711103|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711104|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711105|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
44711106|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44711107|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711108|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711109|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711110|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44711111|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44711112|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711113|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44711114|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44711115|NCT01450995|Sumatriptan|sumatriptan|mesh-list
44711116|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44711117|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44711118|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44711119|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
44711120|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711121|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711122|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711123|NCT01451320|Plasminogen|plasminogen|mesh-list
44711124|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44711125|NCT01451320|Streptokinase|streptokinase|mesh-list
44711126|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44711127|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44711128|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711129|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
44711130|NCT01451489|Tacrolimus|tacrolimus|mesh-list
44711131|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711132|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
44711133|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711134|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711135|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44711136|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
44711137|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711138|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711139|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44711140|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44711141|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711142|NCT01451853|Ebselen|ebselen|mesh-list
44711143|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44711144|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711145|NCT01451853|Analgesics|analgesics|mesh-ancestor
44711146|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
44711147|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711148|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711149|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711150|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711151|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44711152|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44711153|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
44711154|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711155|NCT01451853|Protective Agents|protective agents|mesh-ancestor
44711156|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44711157|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711158|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44711159|NCT01452243|Vitamin D|vitamin d|mesh-list
44711160|NCT01452243|Calcium|calcium|mesh-list
44711161|NCT01452243|Vitamins|vitamins|mesh-ancestor
44711162|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
44711163|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711164|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711165|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44711166|NCT01452256|Propofol|propofol|mesh-list
44711167|NCT01452256|Desflurane|desflurane|mesh-list
44711168|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44711169|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711170|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711171|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44711172|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
44711173|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
44711174|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44711175|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44711176|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44711177|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
44711178|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711179|NCT01452607|Ebselen|ebselen|mesh-list
44711180|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44711181|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711182|NCT01452607|Analgesics|analgesics|mesh-ancestor
44711183|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
44711184|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711185|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711186|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711187|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711188|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44711189|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44711190|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
44711191|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711192|NCT01452607|Protective Agents|protective agents|mesh-ancestor
44711193|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44711194|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711195|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44711196|NCT01453062|Ofatumumab|ofatumumab|mesh-list
44711197|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711198|NCT01453283|Trabectedin|trabectedin|mesh-list
44711199|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44262698|NCT00647192|Eplerenone|eplerenone|mesh-list
44711200|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
44711201|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711203|NCT01454700|Insulin|insulin|mesh-list
44711204|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711205|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711206|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711207|NCT01454869|Heparin|heparin|mesh-list
44711208|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
44711209|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44711210|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44711211|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711212|NCT01455350|Lidocaine|lidocaine|mesh-list
44711213|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
44711214|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
44711215|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711216|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711217|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
44711218|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711219|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44711220|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44711221|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44711222|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711223|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711224|NCT01455636|Micronutrients|micronutrients|mesh-list
44711225|NCT01455636|Trace Elements|trace elements|mesh-list
44711226|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
44711227|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711228|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44711229|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711230|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
44711231|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44711232|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44711233|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711234|NCT01456507|Naltrexone|naltrexone|mesh-list
44711235|NCT01456507|Oxycodone|oxycodone|mesh-list
44711236|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44711237|NCT01456507|Narcotics|narcotics|mesh-ancestor
44711238|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711239|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711240|NCT01456507|Analgesics|analgesics|mesh-ancestor
44711241|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
44711242|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711243|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44711244|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44711245|NCT01456585|Gemcitabine|gemcitabine|mesh-list
44711246|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44711247|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
44711248|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711249|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711250|NCT01456585|Antiviral Agents|antiviral agents|mesh-ancestor
44711251|NCT01456585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711252|NCT01456585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711253|NCT01456585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711254|NCT01456585|Immunologic Factors|immunologic factors|mesh-ancestor
44711255|NCT01456585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711256|NCT01456650|Glyburide|glyburide|mesh-list
44711257|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711258|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711259|NCT01457040|Etoposide|etoposide|mesh-list
44711260|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
44711261|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44711262|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711263|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44711264|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44711265|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711266|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711268|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
44711269|NCT01457508|Antidotes|antidotes|mesh-ancestor
44711270|NCT01457508|Protective Agents|protective agents|mesh-ancestor
44711271|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711272|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
44711273|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
44711274|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711275|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44711276|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
44711277|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44711278|NCT01458431|Anesthetics|anesthetics|mesh-list
44711279|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
44711280|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
44711281|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711282|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711283|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
44711284|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711285|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
44711286|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44711287|NCT01459445|Metformin|metformin|mesh-list
44711288|NCT01459445|Drospirenone|drospirenone|mesh-list
44711289|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44711290|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711291|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711292|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44711293|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44711294|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44711295|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
44711296|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44711297|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44711298|NCT01459445|Estrogens|estrogens|mesh-ancestor
44711299|NCT01459445|Hormones|hormones|mesh-ancestor
44711300|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711301|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44711302|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
44711303|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44711304|NCT01459445|Diuretics|diuretics|mesh-ancestor
44711305|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
44711306|NCT01460030|Cinacalcet|cinacalcet|mesh-list
43617518|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44711308|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711309|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44711310|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
44711311|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711312|NCT01460069|Liraglutide|liraglutide|mesh-list
44711313|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711314|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711315|NCT01460069|Incretins|incretins|mesh-ancestor
44711316|NCT01460069|Hormones|hormones|mesh-ancestor
44711317|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711318|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44711319|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
44711320|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711321|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
44711322|NCT01460212|Citalopram|citalopram|mesh-list
44711323|NCT01460212|Fluoxetine|fluoxetine|mesh-list
44711324|NCT01460212|Paroxetine|paroxetine|mesh-list
44711325|NCT01460212|Sertraline|sertraline|mesh-list
44711326|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
44711327|NCT01460212|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44711328|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44711329|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711330|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711331|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711332|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
44711333|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711334|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44711335|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44711336|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44711337|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44711338|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711339|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44711340|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44711341|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711342|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44711343|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44711344|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
44711345|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44711346|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44711347|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44711348|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711349|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711350|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44711351|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711352|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711353|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44711354|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711355|NCT01460420|Lenalidomide|lenalidomide|mesh-list
44711356|NCT01460420|Bortezomib|bortezomib|mesh-list
44711357|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
44711358|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711359|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44711360|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44711361|NCT01460420|Growth Substances|growth substances|mesh-ancestor
44711362|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
44711363|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711364|NCT01460498|Azacitidine|azacitidine|mesh-list
44711365|NCT01460498|Decitabine|decitabine|mesh-list
44711366|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44711367|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
44711368|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711369|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711370|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711371|NCT01460537|Gemcitabine|gemcitabine|mesh-list
44711372|NCT01460537|Cisplatin|cisplatin|mesh-list
44711373|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711374|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44711375|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
44711376|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711377|NCT01460537|Antiviral Agents|antiviral agents|mesh-ancestor
44711378|NCT01460537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711379|NCT01460537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711381|NCT01460537|Immunologic Factors|immunologic factors|mesh-ancestor
44711382|NCT01460537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711383|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
44711384|NCT01460563|Analgesics|analgesics|mesh-ancestor
44711385|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
44711386|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711387|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711388|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
44711389|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711390|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44711391|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
44711392|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44711393|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711394|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711395|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711396|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
44711397|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44711398|NCT01460602|Rituximab|rituximab|mesh-list
44711399|NCT01460602|Bortezomib|bortezomib|mesh-list
44711400|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44711401|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711402|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
44711403|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711404|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44711405|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
44711406|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711407|NCT01460667|Acetaminophen|acetaminophen|mesh-list
44711408|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711409|NCT01460667|Analgesics|analgesics|mesh-ancestor
44711410|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
44711411|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711412|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711413|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
44711414|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
44711415|NCT01460693|Dasatinib|dasatinib|mesh-list
44711416|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711417|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44711418|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711419|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711420|NCT01460706|Edotreotide|edotreotide|mesh-list
44711421|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44711422|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711424|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711425|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711426|NCT01460836|Tobramycin|tobramycin|mesh-list
44711427|NCT01460836|Aztreonam|aztreonam|mesh-list
44711428|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711429|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711430|NCT01460888|Olaparib|olaparib|mesh-list
44711431|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44711432|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711433|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711434|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711435|NCT01460979|Sirolimus|sirolimus|mesh-list
44711436|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711437|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711438|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44711439|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711440|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
44711441|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711442|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
44711443|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711444|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
44711445|NCT01461018|Antibodies|antibodies|mesh-list
44711446|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
44711447|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44711448|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44711449|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
44711450|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711451|NCT01461031|Nefopam|nefopam|mesh-list
44711452|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711453|NCT01461031|Analgesics|analgesics|mesh-ancestor
44711454|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
44711455|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123171|NCT04539236|Growth Substances|growth substances|mesh-ancestor
44711456|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711457|NCT01461174|Memantine|memantine|mesh-list
44711458|NCT01461174|Modafinil|modafinil|mesh-list
44711459|NCT01461174|Donepezil|donepezil|mesh-list
44711460|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44711461|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711462|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711463|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44711464|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711465|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711466|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
44711467|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44711468|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44711469|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
44711470|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44711471|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44711472|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44711473|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44711474|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44711475|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44711477|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
44711478|NCT01461460|Tedizolid|tedizolid|mesh-list
44711479|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
44711480|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711481|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711482|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44711483|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44711484|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711485|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711486|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711487|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44711488|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
44711489|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711490|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711491|NCT01461616|Insulin|insulin|mesh-list
44711492|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711493|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
44711494|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
44711495|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711496|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711497|NCT01461746|Cisplatin|cisplatin|mesh-list
44711498|NCT01461746|Docetaxel|docetaxel|mesh-list
44711499|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711500|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
44711501|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
44711502|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
44711503|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711504|NCT01461759|Cisplatin|cisplatin|mesh-list
44711505|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711506|NCT01461772|Cisplatin|cisplatin|mesh-list
44711507|NCT01461772|Carboplatin|carboplatin|mesh-list
44711508|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711509|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44711510|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
44711511|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711512|NCT01462006|Sirolimus|sirolimus|mesh-list
44711513|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711514|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711515|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44711516|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711517|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
44711518|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711519|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
44711520|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711521|NCT01462058|Vitamin D|vitamin d|mesh-list
44711522|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
44711523|NCT01462058|Vitamins|vitamins|mesh-ancestor
44711524|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
44135827|NCT00162591|Analgesics|analgesics|mesh-ancestor
44711525|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711526|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44711527|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711528|NCT01462149|Carboplatin|carboplatin|mesh-list
44711529|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711530|NCT01462214|Everolimus|everolimus|mesh-list
44711531|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711532|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711533|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
44711534|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711535|NCT01462422|Misoprostol|misoprostol|mesh-list
44711536|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44711537|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
44711538|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44711539|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711540|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44711541|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44711542|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
44711543|NCT01462474|Cisplatin|cisplatin|mesh-list
44711544|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711545|NCT01462487|Zanamivir|zanamivir|mesh-list
44711546|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
44711547|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711548|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711549|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711550|NCT01462500|Miltefosine|miltefosine|mesh-list
44711551|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
44711552|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711553|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711554|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44711555|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44711556|NCT01462617|Nemiralisib|nemiralisib|mesh-list
44711557|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44711558|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711559|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711560|NCT01462669|Ezogabine|ezogabine|mesh-list
44711561|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
44711562|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711563|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711564|NCT01462968|Heparin|heparin|mesh-list
44711565|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
44711566|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44711567|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44711568|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711569|NCT01463046|Cytarabine|cytarabine|mesh-list
44711570|NCT01463046|Daunorubicin|daunorubicin|mesh-list
44711571|NCT01463046|Panobinostat|panobinostat|mesh-list
44711572|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44711573|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
44711574|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711575|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711576|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
44711577|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711578|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711579|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
44711580|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711581|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44711582|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44711583|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44711584|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711585|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44711586|NCT01463150|Clopidogrel|clopidogrel|mesh-list
44711587|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44711588|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44711589|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43876606|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44711590|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44711591|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44711592|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
44711593|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711594|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711595|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711596|NCT01463163|Ticagrelor|ticagrelor|mesh-list
44711597|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44711598|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44711599|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44711600|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44711601|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44711602|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
44711603|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711604|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711605|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711606|NCT01463215|Ambroxol|ambroxol|mesh-list
44711607|NCT01463215|Expectorants|expectorants|mesh-ancestor
44711608|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
44711609|NCT01463228|Metformin|metformin|mesh-list
44711610|NCT01463228|Canagliflozin|canagliflozin|mesh-list
44711611|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711612|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711613|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44711614|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711615|NCT01463280|Lidocaine|lidocaine|mesh-list
44711616|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44711617|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
44711618|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711619|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711620|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
44711621|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711622|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44711623|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44711624|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44711625|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711626|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711627|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
44711628|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44711629|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711630|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711631|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711633|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
44711634|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711635|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44711636|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44711637|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44711638|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
44711639|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711640|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711641|NCT01463371|Azithromycin|azithromycin|mesh-list
44711642|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711643|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711645|NCT01463592|Interferons|interferons|mesh-list
44711646|NCT01463592|Ribavirin|ribavirin|mesh-list
44711647|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
44711648|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
44711649|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
44711650|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711651|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
44711652|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711653|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
44711654|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711655|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
44711656|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711657|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44711658|NCT01463592|Trace Elements|trace elements|mesh-ancestor
44711659|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
44711660|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
44711661|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44711662|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711663|NCT01463735|Vitamin E|vitamin e|mesh-list
44711664|NCT01463735|Vitamins|vitamins|mesh-ancestor
44711665|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
44711666|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711667|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
44711668|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711669|NCT01463735|Protective Agents|protective agents|mesh-ancestor
44711670|NCT01463774|Metformin|metformin|mesh-list
44711671|NCT01463774|Canagliflozin|canagliflozin|mesh-list
44711672|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711673|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711674|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44711675|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711676|NCT01463813|Vitamin D|vitamin d|mesh-list
44711677|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
44711678|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
44711679|NCT01463813|Vitamins|vitamins|mesh-list
44711680|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
44711681|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711682|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44711683|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711684|NCT01463852|Vincristine|vincristine|mesh-list
44711685|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44711686|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711688|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44711689|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44711690|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711691|NCT01463865|Ropivacaine|ropivacaine|mesh-list
44711692|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
44711693|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
44711694|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711695|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711696|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
44711697|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711698|NCT01463956|Interferons|interferons|mesh-list
44711699|NCT01463956|Ribavirin|ribavirin|mesh-list
44711700|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711701|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
44711702|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711703|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
44711704|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711705|NCT01464008|Interferons|interferons|mesh-list
44711706|NCT01464008|Ribavirin|ribavirin|mesh-list
44711707|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
44711708|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
44711709|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44711710|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711711|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
44711712|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711713|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
44711714|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711715|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
44711716|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711717|NCT01464060|Amoxicillin|amoxicillin|mesh-list
44711718|NCT01464060|Metronidazole|metronidazole|mesh-list
44711719|NCT01464060|Clarithromycin|clarithromycin|mesh-list
44711720|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711721|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711723|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44711724|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44711725|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711726|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711727|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44711728|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44711729|NCT01464099|Insulin|insulin|mesh-list
44711730|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711731|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
44711732|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
44711733|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44711734|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711735|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711736|NCT01464112|Dexamethasone|dexamethasone|mesh-list
44711737|NCT01464112|Bortezomib|bortezomib|mesh-list
44711738|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711739|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
44711740|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
44711741|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711742|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711743|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44711744|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
44711745|NCT01464112|Hormones|hormones|mesh-ancestor
44711746|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711747|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44711748|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711749|NCT01464125|Azithromycin|azithromycin|mesh-list
44711750|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
44711751|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711752|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711753|NCT01464138|Clindamycin|clindamycin|mesh-list
44711754|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
44711755|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
44711756|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
44711757|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711758|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711759|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44711760|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711761|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711762|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44711763|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
44711764|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44711765|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711766|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711767|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44711768|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44711769|NCT01464242|Protective Agents|protective agents|mesh-ancestor
44711770|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711771|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
44711772|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44711773|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
44711774|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44711775|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44711776|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711777|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44711778|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
44711779|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711780|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
44711781|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44711782|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
44711783|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44711784|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44711785|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711786|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711787|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
44711788|NCT01464476|Azimilide|azimilide|mesh-list
44711789|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44711790|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44711791|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44711792|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876744|NCT04709172|Cefditoren|cefditoren|mesh-list
44711793|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711794|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711795|NCT01464489|Atropine|atropine|mesh-list
44711796|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44711797|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44711798|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44711799|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
44711800|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711801|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711802|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44711803|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44711804|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
44711805|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
44711806|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44711807|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44711808|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
44711809|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711810|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711811|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44711812|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44711813|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44711814|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
44711815|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711816|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44711817|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44711818|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711819|NCT01466712|Beclomethasone|beclomethasone|mesh-list
44711820|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
44711821|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
44711822|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44711823|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
44711824|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711825|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711826|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44711827|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
44711828|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44711829|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44711830|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44711831|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
44711832|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711833|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711834|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
44711835|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44711836|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
44711837|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711839|NCT01466712|Hormones|hormones|mesh-ancestor
44711840|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711841|NCT01466829|Hormones|hormones|mesh-list
44711842|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
44711843|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44711844|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711845|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44711846|NCT01466855|Topotecan|topotecan|mesh-list
44711847|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44711848|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44711849|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711850|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711851|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711852|NCT01466959|Acetic Acid|acetic acid|mesh-list
44711853|NCT01466959|Retinol acetate|retinol acetate|mesh-list
44711854|NCT01466959|Citric Acid|citric acid|mesh-list
44711855|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
44711856|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
43876798|NCT04709081|Itraconazole|itraconazole|mesh-list
44711857|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44711858|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
44711859|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
44711860|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711861|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44711862|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711863|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711864|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44711865|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
44711866|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711867|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44711868|NCT01466959|Protective Agents|protective agents|mesh-ancestor
44263405|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
44711869|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711870|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
44711871|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44711872|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711873|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44711874|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
44711875|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711876|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711877|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711878|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711879|NCT01467115|Leucovorin|leucovorin|mesh-list
44711880|NCT01467115|Cisplatin|cisplatin|mesh-list
44711881|NCT01467115|Docetaxel|docetaxel|mesh-list
44711882|NCT01467115|Fluorouracil|fluorouracil|mesh-list
44711883|NCT01467115|Cetuximab|cetuximab|mesh-list
44711884|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
44711885|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
44711886|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711887|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
44711888|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
44711889|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
44711890|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711891|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
44711892|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44711893|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44711894|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
44711895|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711896|NCT01467115|Antidotes|antidotes|mesh-ancestor
44711897|NCT01467115|Protective Agents|protective agents|mesh-ancestor
44711898|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
44711899|NCT01467115|Vitamins|vitamins|mesh-ancestor
44711900|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
44711901|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44711902|NCT01467115|Hematinics|hematinics|mesh-ancestor
44711903|NCT01467141|Insulin|insulin|mesh-list
44711904|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711905|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
44711906|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
44711907|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
44711908|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
44711909|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711910|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711911|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44711912|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44711913|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711914|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44711915|NCT01467258|Amantadine|amantadine|mesh-list
44711916|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44711917|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44711918|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
44711919|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711920|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
44711921|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44711922|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711923|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711924|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44711925|NCT01467258|Analgesics|analgesics|mesh-ancestor
44711926|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
44711927|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711928|NCT01467297|Levofloxacin|levofloxacin|mesh-list
44711929|NCT01467297|Ofloxacin|ofloxacin|mesh-list
44711930|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44711931|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711932|NCT01467297|Renal Agents|renal agents|mesh-ancestor
44711933|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44711934|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44711935|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44711936|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711937|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711938|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711939|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44711940|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44711941|NCT01467310|Trametinib|trametinib|mesh-list
44711942|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44711943|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44711944|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263475|NCT00648921|Olanzapine|olanzapine|mesh-list
44711945|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711946|NCT01467323|Insulin|insulin|mesh-list
44711947|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711948|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
44711949|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
44711950|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711951|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711952|NCT01467362|Desonide|desonide|mesh-list
44711953|NCT01467362|V0034CR|v0034cr|mesh-list
44711954|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44711955|NCT01467362|Emollients|emollients|mesh-ancestor
44711956|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
44711957|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
44711958|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
44711959|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711960|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711961|NCT01467401|Insulin|insulin|mesh-list
44711962|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44711963|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
44711964|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
44711965|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711966|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711967|NCT01467414|Insulin|insulin|mesh-list
44711968|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44711969|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711970|NCT01467518|Dolutegravir|dolutegravir|mesh-list
44711971|NCT01467518|Methadone|methadone|mesh-list
44711972|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44711973|NCT01467518|Narcotics|narcotics|mesh-ancestor
44711974|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44711975|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44711976|NCT01467518|Analgesics|analgesics|mesh-ancestor
44711977|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
44711978|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44711979|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
44711980|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44711981|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44711982|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44711983|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711984|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711985|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44711986|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44711987|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
44711988|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44711989|NCT01467531|Dolutegravir|dolutegravir|mesh-list
44711990|NCT01467531|Cabotegravir|cabotegravir|mesh-list
44711991|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44711992|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44711993|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44711994|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44711995|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44711996|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44711997|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
44711998|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712000|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
44712001|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
44712002|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
44712003|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44712004|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712005|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
44712006|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712007|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44712008|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44712009|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44712010|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712011|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712012|NCT01467648|Doripenem|doripenem|mesh-list
44712013|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712014|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712015|NCT01467687|Verapamil|verapamil|mesh-list
44712016|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44712017|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44712018|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712019|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712020|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712021|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712022|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712023|NCT01467804|Sertraline|sertraline|mesh-list
44712024|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712025|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712026|NCT01467804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44712027|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44712028|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263623|NCT00649116|Metoprolol|metoprolol|mesh-list
44712029|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712030|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712031|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
44712032|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712033|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
44712034|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712036|NCT01467986|Irinotecan|irinotecan|mesh-list
44712037|NCT01467986|Temozolomide|temozolomide|mesh-list
44712038|NCT01467986|Dasatinib|dasatinib|mesh-list
44712039|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44712040|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44712041|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712042|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712043|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712044|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44712045|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
44712046|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712047|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712048|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44712049|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
44712050|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712051|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
44712052|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712053|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712054|NCT01468025|Naproxen|naproxen|mesh-list
44712055|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44712056|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44712057|NCT01468025|Analgesics|analgesics|mesh-ancestor
44712058|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
44712059|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712060|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712061|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712062|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712063|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
44712064|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44712065|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712066|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712068|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44712069|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44712070|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44712071|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712072|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712073|NCT01468038|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44712074|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44712075|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712076|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712077|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712078|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
44712079|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44712080|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712081|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44712082|NCT01468051|Vaccines|vaccines|mesh-list
44712083|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
44712084|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712085|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44712086|NCT01468051|Antacids|antacids|mesh-ancestor
44712087|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712088|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712089|NCT01468155|Dabigatran|dabigatran|mesh-list
44712090|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
44712091|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44712092|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
44712093|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712094|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712095|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
44712096|NCT01468259|Droxidopa|droxidopa|mesh-list
44712097|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44712098|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44712099|NCT01468272|Beclomethasone|beclomethasone|mesh-list
44712100|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
44712101|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44712102|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
44712103|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712104|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712105|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44712106|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
44712107|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44712108|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44712109|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44712110|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
44712111|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712112|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712113|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712114|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
44712115|NCT01468272|Hormones|hormones|mesh-ancestor
44712116|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712117|NCT01468285|Betahistine|betahistine|mesh-list
44712118|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712119|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
44712120|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
44712121|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712122|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712123|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712124|NCT01468389|Capecitabine|capecitabine|mesh-list
44712125|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712126|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
44712127|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712128|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712130|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44712131|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712132|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
44712133|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44712134|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44712135|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44712136|NCT01468441|Cetrorelix|cetrorelix|mesh-list
44712137|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
44712138|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44712139|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
44712140|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44712141|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712142|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44712143|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44712144|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712145|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44712146|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
44712147|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712148|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712149|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
44712150|NCT01468480|Calcium|calcium|mesh-list
44712151|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712152|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712153|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44712154|NCT01468519|Insulin|insulin|mesh-list
44712155|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44712156|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712157|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712158|NCT01468545|Iloprost|iloprost|mesh-list
44712159|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712160|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712161|NCT01468571|Spironolactone|spironolactone|mesh-list
44712162|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44712163|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712164|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712165|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712166|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44712167|NCT01468571|Diuretics|diuretics|mesh-ancestor
44712168|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
44712169|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44712170|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44712171|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44712172|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712173|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712174|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712175|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712176|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712177|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712178|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
44263773|NCT00649376|Fexofenadine|fexofenadine|mesh-list
43877075|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
44712179|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712180|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712181|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712182|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712183|NCT01468714|Ketoconazole|ketoconazole|mesh-list
44712184|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
44712185|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712186|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44712187|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44712188|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712189|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712190|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44712191|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712192|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712193|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712194|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44712195|NCT01468740|Prednisone|prednisone|mesh-list
44712196|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
44712197|NCT01468740|Dacarbazine|dacarbazine|mesh-list
44712198|NCT01468740|Doxorubicin|doxorubicin|mesh-list
44712199|NCT01468740|Etoposide|etoposide|mesh-list
44712200|NCT01468740|Vincristine|vincristine|mesh-list
44712201|NCT01468740|Bleomycin|bleomycin|mesh-list
44712202|NCT01468740|Vinblastine|vinblastine|mesh-list
44712203|NCT01468740|Procarbazine|procarbazine|mesh-list
44712204|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712205|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
44712206|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712207|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712208|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44712209|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
44712210|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712211|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712212|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44712214|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44712215|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44712216|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712217|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712218|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
44712219|NCT01468740|Hormones|hormones|mesh-ancestor
44712220|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712221|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44712222|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44712223|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712224|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712225|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712226|NCT01469143|Insulin|insulin|mesh-list
44712227|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44712228|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
44712229|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
44712230|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44712231|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712232|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712233|NCT01469169|Iloprost|iloprost|mesh-list
44712234|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712235|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712236|NCT01469338|Prednisone|prednisone|mesh-list
44712237|NCT01469338|Octreotide|octreotide|mesh-list
44712238|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712239|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
44712240|NCT01469338|Hormones|hormones|mesh-ancestor
44712241|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712242|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712243|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44712244|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712245|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712246|NCT01469351|Liraglutide|liraglutide|mesh-list
44712247|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712248|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712249|NCT01469351|Incretins|incretins|mesh-ancestor
44712250|NCT01469351|Hormones|hormones|mesh-ancestor
44712251|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712252|NCT01469416|Clopidogrel|clopidogrel|mesh-list
44712253|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44712254|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712255|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44712256|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44712257|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44712258|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
44712259|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712260|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712261|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712262|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44712263|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44712264|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
44712265|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44712266|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44712267|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712268|NCT01469468|Simvastatin|simvastatin|mesh-list
44712269|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44712270|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44712271|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
44712272|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712273|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44712274|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44712275|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712276|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44712277|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712278|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712279|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
44712280|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44712281|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
44712282|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712283|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
44712284|NCT01469507|Protective Agents|protective agents|mesh-ancestor
44712286|NCT01469520|Zidovudine|zidovudine|mesh-list
44712287|NCT01469520|Nevirapine|nevirapine|mesh-list
44712288|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44712289|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44712290|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712291|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712292|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
44712293|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712294|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44712295|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44712296|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
44712297|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44712298|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44712299|NCT01469559|Insulin|insulin|mesh-list
44712300|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712301|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712302|NCT01469572|Everolimus|everolimus|mesh-list
44712303|NCT01469572|Pasireotide|pasireotide|mesh-list
44712304|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712305|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712306|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
44712307|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712308|NCT01469572|Hormones|hormones|mesh-ancestor
44712309|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712310|NCT01469598|Gemcitabine|gemcitabine|mesh-list
44712311|NCT01469598|Docetaxel|docetaxel|mesh-list
44712312|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712313|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
44712314|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712315|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712316|NCT01469598|Antiviral Agents|antiviral agents|mesh-ancestor
43877200|NCT04704622|Analgesics|analgesics|mesh-ancestor
44712317|NCT01469598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712318|NCT01469598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712319|NCT01469598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712320|NCT01469598|Immunologic Factors|immunologic factors|mesh-ancestor
44712321|NCT01469598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712322|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712323|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712324|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712325|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
44712326|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44712327|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712328|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712329|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712330|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44712331|NCT01469624|Protective Agents|protective agents|mesh-ancestor
44712332|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712333|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712334|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44712335|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
44712336|NCT01469650|Vitamin D|vitamin d|mesh-list
44712337|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
44712338|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
44712339|NCT01469650|Vitamins|vitamins|mesh-list
44712340|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
44712341|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712342|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44712343|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712344|NCT01469702|Azithromycin|azithromycin|mesh-list
44712345|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712346|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712347|NCT01469884|Cyclosporine|cyclosporine|mesh-list
44712348|NCT01469884|Everolimus|everolimus|mesh-list
44712349|NCT01469884|Tacrolimus|tacrolimus|mesh-list
44712350|NCT01469884|Cyclosporins|cyclosporins|mesh-list
44712351|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712352|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
44712353|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712354|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44712355|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712356|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712357|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
44712358|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712359|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44712360|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617548|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
44712362|NCT01469975|Edetic Acid|edetic acid|mesh-list
44712363|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
44712364|NCT01469975|Antidotes|antidotes|mesh-ancestor
44712365|NCT01469975|Protective Agents|protective agents|mesh-ancestor
44712366|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712367|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
44712368|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
44712369|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712370|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44712371|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
44712372|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44712373|NCT01469988|Testosterone|testosterone|mesh-list
44712374|NCT01469988|Androgens|androgens|mesh-ancestor
44712375|NCT01469988|Hormones|hormones|mesh-ancestor
44712376|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712377|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712378|NCT01470040|Aspirin|aspirin|mesh-list
44712379|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44712380|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44712381|NCT01470040|Analgesics|analgesics|mesh-ancestor
44712382|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
44712383|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712384|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712385|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712386|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712387|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44712388|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44712389|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712390|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712391|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44712392|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712393|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
44712394|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
44712395|NCT01470053|Azelastine|azelastine|mesh-list
44712396|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712397|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44712398|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44712399|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44712400|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
44712401|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712402|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712403|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44712404|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
44712405|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44712406|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712407|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712408|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44712409|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44712410|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
44712411|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
44712412|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712413|NCT01470092|Tibolone|tibolone|mesh-list
44712414|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
44712415|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712416|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712417|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712418|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44712419|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44712420|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712421|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44712422|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
44712423|NCT01470092|Hormones|hormones|mesh-ancestor
44712424|NCT01470157|Ketamine|ketamine|mesh-list
44712425|NCT01470157|Analgesics|analgesics|mesh-ancestor
44712426|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
44712427|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712428|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712429|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44712430|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44712431|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
44712432|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
44712433|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44712434|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44712435|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44712436|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712437|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712438|NCT01470209|Everolimus|everolimus|mesh-list
44712439|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712440|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712441|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
44712442|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712443|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
44712444|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44712445|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44712446|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712447|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712448|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712449|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44712450|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44712451|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44712452|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44712453|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712454|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712455|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712456|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712457|NCT01470339|Analgesics|analgesics|mesh-ancestor
44712458|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
44712459|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712460|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712461|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712462|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
44712463|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44712464|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44712465|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44712466|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712467|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712468|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712469|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712470|NCT01470352|Analgesics|analgesics|mesh-ancestor
44712471|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
44712472|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712473|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712474|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712475|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
44712476|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
44712477|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712478|NCT01470456|Rituximab|rituximab|mesh-list
44712479|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712480|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712481|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
44712482|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712483|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712484|NCT01470495|Sorafenib|sorafenib|mesh-list
44712485|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712486|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712487|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712488|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712489|NCT01470690|Omeprazole|omeprazole|mesh-list
44712490|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44712491|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712492|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44712493|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712494|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712495|NCT01470742|Capecitabine|capecitabine|mesh-list
44712496|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712497|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
44712498|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712499|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712500|NCT01470755|Albuterol|albuterol|mesh-list
44712501|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44712502|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
44712503|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712504|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712505|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44712506|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
44712507|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
44712508|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44712509|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44712510|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44712511|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44712512|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
44712513|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712514|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712515|NCT01470794|Flucytosine|flucytosine|mesh-list
44712516|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
44712517|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712518|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
44712519|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712520|NCT01470807|Pancrelipase|pancrelipase|mesh-list
44712521|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712522|NCT01470937|Acarbose|acarbose|mesh-list
44712523|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44712524|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712525|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712526|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712527|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712528|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
44712529|NCT01471067|Rituximab|rituximab|mesh-list
44712530|NCT01471067|Fludarabine|fludarabine|mesh-list
44712531|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
44712532|NCT01471067|Melphalan|melphalan|mesh-list
44712533|NCT01471067|Busulfan|busulfan|mesh-list
44712534|NCT01471067|Clofarabine|clofarabine|mesh-list
44712535|NCT01471067|Tacrolimus|tacrolimus|mesh-list
44712536|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
44712537|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44712538|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712539|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712540|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
44712541|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712542|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712543|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712544|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
44712545|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712546|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44264123|NCT00650000|Modafinil|modafinil|mesh-list
44712547|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712548|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44712549|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712550|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44712551|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44712552|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
44712553|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712554|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44712555|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
44712556|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44712557|NCT01471132|Paclitaxel|paclitaxel|mesh-list
44712558|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
44712559|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44712560|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712561|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712562|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712563|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712564|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712565|NCT01471145|Naltrexone|naltrexone|mesh-list
44712566|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44712567|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44712568|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712569|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
44712570|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712571|NCT01471158|Timolol|timolol|mesh-list
44712572|NCT01471158|Dorzolamide|dorzolamide|mesh-list
44712573|NCT01471158|Maleic acid|maleic acid|mesh-list
44712574|NCT01471158|Brinzolamide|brinzolamide|mesh-list
44712575|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44712576|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44712577|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44712578|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712579|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712580|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712581|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44712582|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44712584|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44712585|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44712586|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44712587|NCT01471262|Liver Extracts|liver extracts|mesh-list
44712588|NCT01471262|Hematinics|hematinics|mesh-ancestor
44712589|NCT01471275|Metformin|metformin|mesh-list
44712590|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712591|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712592|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44712593|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44712594|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712595|NCT01471470|Bevacizumab|bevacizumab|mesh-list
44712596|NCT01471470|Cisplatin|cisplatin|mesh-list
44712597|NCT01471470|Docetaxel|docetaxel|mesh-list
44712598|NCT01471470|Capecitabine|capecitabine|mesh-list
44712599|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712600|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712601|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44712602|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44712603|NCT01471470|Growth Substances|growth substances|mesh-ancestor
44712604|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712605|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
44712606|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712607|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712608|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712609|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712610|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712611|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
44712612|NCT01471535|Interferons|interferons|mesh-list
44712613|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
44712614|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
44712615|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44712616|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712617|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
44712618|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712619|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
44712620|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712621|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
44712622|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
44712623|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44712624|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712625|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712626|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
44712627|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44712628|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44712629|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712630|NCT01471678|Tamsulosin|tamsulosin|mesh-list
44712631|NCT01471678|Dutasteride|dutasteride|mesh-list
44712632|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44712633|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44712634|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44712635|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
44712636|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712637|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712638|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712639|NCT01471678|Urological Agents|urological agents|mesh-ancestor
44712640|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44712641|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44712642|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712643|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712644|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712645|NCT01471704|Verapamil|verapamil|mesh-list
44712646|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44712647|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44712648|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712649|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712650|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712651|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712652|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712654|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
44712655|NCT01471730|Coagulants|coagulants|mesh-ancestor
44712656|NCT01471808|Metformin|metformin|mesh-list
44712657|NCT01471808|Pioglitazone|pioglitazone|mesh-list
44712658|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44712660|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712661|NCT01471808|Incretins|incretins|mesh-ancestor
44712662|NCT01471808|Hormones|hormones|mesh-ancestor
44712663|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712664|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44712665|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
44712666|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712667|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712668|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44712669|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
44712670|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712671|NCT01471847|Capecitabine|capecitabine|mesh-list
44712672|NCT01471847|Trastuzumab|trastuzumab|mesh-list
44712673|NCT01471847|Lapatinib|lapatinib|mesh-list
44712674|NCT01471847|Dactolisib|dactolisib|mesh-list
44712675|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712676|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
44712677|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712678|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712679|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712680|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712681|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712682|NCT01471886|Ketorolac|ketorolac|mesh-list
44712683|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44712684|NCT01471886|Naproxen|naproxen|mesh-list
44712685|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44712686|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44712687|NCT01471886|Analgesics|analgesics|mesh-ancestor
44712688|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
44712689|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712690|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712691|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712692|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712693|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44712694|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712695|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712696|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
44712697|NCT01471899|Ketorolac|ketorolac|mesh-list
44712698|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44712699|NCT01471899|Naproxen|naproxen|mesh-list
44712700|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44712701|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44712702|NCT01471899|Analgesics|analgesics|mesh-ancestor
44712703|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
44712704|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44712705|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712706|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712707|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44712708|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44712709|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712710|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712711|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
44712712|NCT01471925|Esomeprazole|esomeprazole|mesh-list
44712713|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44712714|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712715|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44712716|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712717|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712718|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44712719|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712720|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712721|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712722|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712723|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44712724|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44712725|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712726|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712727|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43877533|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
44712728|NCT01471990|Protective Agents|protective agents|mesh-ancestor
44712729|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712730|NCT01471990|Growth Substances|growth substances|mesh-ancestor
44712731|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712732|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712734|NCT01472016|Cetuximab|cetuximab|mesh-list
44712735|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44712736|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712737|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712738|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712739|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712740|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712741|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712742|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712743|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712744|NCT01472029|Leucovorin|leucovorin|mesh-list
44712745|NCT01472029|Docetaxel|docetaxel|mesh-list
44712746|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
44712747|NCT01472029|Trastuzumab|trastuzumab|mesh-list
44712748|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712749|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
44712750|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
44712751|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
44712752|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712753|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712754|NCT01472029|Antidotes|antidotes|mesh-ancestor
44712755|NCT01472029|Protective Agents|protective agents|mesh-ancestor
44712756|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712757|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
44712758|NCT01472029|Vitamins|vitamins|mesh-ancestor
44712759|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
44712760|NCT01472055|Fludarabine|fludarabine|mesh-list
44712761|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712762|NCT01472146|Doxorubicin|doxorubicin|mesh-list
44712763|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712764|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44712765|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44712766|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44712767|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712768|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712769|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
44712770|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44712771|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712772|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712773|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44712774|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44712775|NCT01472263|Protective Agents|protective agents|mesh-ancestor
44712776|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712777|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
44712778|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44712779|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
44712780|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44712781|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
44712782|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44712783|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44712784|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44712785|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
44712786|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44712787|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712788|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44712789|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44712790|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44712791|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44712792|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712793|NCT01472406|Pancrelipase|pancrelipase|mesh-list
44712794|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712795|NCT01472497|Pioglitazone|pioglitazone|mesh-list
44712796|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43877662|NCT04698213|Avelumab|avelumab|mesh-list
44712798|NCT01472510|Ranibizumab|ranibizumab|mesh-list
44712799|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44712800|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44712801|NCT01472510|Growth Substances|growth substances|mesh-ancestor
44712802|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712803|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
44712804|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712805|NCT01472640|Liraglutide|liraglutide|mesh-list
44712806|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712807|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712808|NCT01472640|Incretins|incretins|mesh-ancestor
44712809|NCT01472640|Hormones|hormones|mesh-ancestor
44712810|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712811|NCT01472653|Cisplatin|cisplatin|mesh-list
44712812|NCT01472653|Cetuximab|cetuximab|mesh-list
44712813|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712814|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712815|NCT01472666|Caseins|caseins|mesh-list
44712816|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
44712817|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
44712818|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712819|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44712820|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
44712821|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712822|NCT01472770|Gemcitabine|gemcitabine|mesh-list
44712823|NCT01472770|Capecitabine|capecitabine|mesh-list
44712824|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712825|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
44712826|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712827|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712828|NCT01472770|Antiviral Agents|antiviral agents|mesh-ancestor
44712829|NCT01472770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712830|NCT01472770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712831|NCT01472770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712832|NCT01472770|Immunologic Factors|immunologic factors|mesh-ancestor
44712833|NCT01472770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712834|NCT01472783|Veliparib|veliparib|mesh-list
44712835|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44712836|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712837|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712838|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712839|NCT01472796|Vitamin D|vitamin d|mesh-list
44712840|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
44712841|NCT01472796|Vitamins|vitamins|mesh-ancestor
44712842|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
44712843|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712844|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44712845|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712846|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44712847|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
44712848|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44712849|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
44712850|NCT01472913|Coagulants|coagulants|mesh-ancestor
44712851|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44712852|NCT01472926|Plasminogen|plasminogen|mesh-list
44712853|NCT01472926|Tenecteplase|tenecteplase|mesh-list
44712854|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44712855|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44712856|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712857|NCT01472978|Metronidazole|metronidazole|mesh-list
44712858|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712859|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44712860|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44712861|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44712862|NCT01473043|Axitinib|axitinib|mesh-list
44712863|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712864|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44712865|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712866|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712867|NCT01473069|Ketoconazole|ketoconazole|mesh-list
44712868|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
44712869|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712870|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44712871|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44712872|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712873|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712874|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44712875|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712876|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712877|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712878|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44712879|NCT01473147|Exenatide|exenatide|mesh-list
44712880|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44712881|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712882|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44712883|NCT01473147|Incretins|incretins|mesh-ancestor
44712884|NCT01473147|Hormones|hormones|mesh-ancestor
44712885|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712886|NCT01473173|Esomeprazole|esomeprazole|mesh-list
44712887|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44712888|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44712889|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44712890|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712891|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712892|NCT01473251|Bevacizumab|bevacizumab|mesh-list
44712893|NCT01473251|Ranibizumab|ranibizumab|mesh-list
44712894|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712895|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712896|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44712897|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44712898|NCT01473251|Growth Substances|growth substances|mesh-ancestor
44712899|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712900|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
44712901|NCT01473277|Triamcinolone|triamcinolone|mesh-list
44712902|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44712903|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44712904|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44712905|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44712906|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44712907|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
44712908|NCT01473277|Hormones|hormones|mesh-ancestor
44712909|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712910|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712911|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712912|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
44712913|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712914|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712915|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44712916|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44712917|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
44712918|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44712919|NCT01473303|Leucovorin|leucovorin|mesh-list
44712920|NCT01473303|Fluorouracil|fluorouracil|mesh-list
44712921|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
44712922|NCT01473303|Irinotecan|irinotecan|mesh-list
44462231|NCT01533935|Olodaterol|olodaterol|mesh-list
44712923|NCT01473303|Calcium|calcium|mesh-list
44712924|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
44712925|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712926|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712927|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
44712928|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712929|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44712930|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712931|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712932|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
44712933|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44712934|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44712935|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712936|NCT01473303|Antidotes|antidotes|mesh-ancestor
43877809|NCT04696848|Durvalumab|durvalumab|mesh-list
43877810|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44712937|NCT01473303|Protective Agents|protective agents|mesh-ancestor
44712938|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
44712939|NCT01473303|Vitamins|vitamins|mesh-ancestor
44712940|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
44712941|NCT01473316|Ketoconazole|ketoconazole|mesh-list
44712942|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
44712943|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712944|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44712945|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44712946|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712947|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712948|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44712949|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
44712950|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44712951|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712952|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44712953|NCT01473472|Tenofovir|tenofovir|mesh-list
44712954|NCT01473472|Emtricitabine|emtricitabine|mesh-list
44712955|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44712956|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
44712957|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44712959|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44712960|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44712961|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712962|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44712963|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44712964|NCT01473537|Calcium|calcium|mesh-list
44712965|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44712966|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712967|NCT01473797|Cladribine|cladribine|mesh-list
44712968|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712969|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44712970|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
44712971|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712972|NCT01473810|Endocine|endocine|mesh-list
44712973|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44712974|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
44712975|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712976|NCT01473901|Temozolomide|temozolomide|mesh-list
44712977|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44712978|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
44712979|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712980|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44712981|NCT01473914|Vitamins|vitamins|mesh-list
44712982|NCT01473914|Vitamin E|vitamin e|mesh-list
44712983|NCT01473914|Tocopherols|tocopherols|mesh-list
44712984|NCT01473914|Tocotrienols|tocotrienols|mesh-list
44712985|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
44712987|NCT01473914|Selenium|selenium|mesh-list
44712988|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
44712989|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712990|NCT01473914|Trace Elements|trace elements|mesh-ancestor
44712991|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
44712992|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44712993|NCT01473914|Protective Agents|protective agents|mesh-ancestor
44712994|NCT01474174|Vaccines|vaccines|mesh-list
44712995|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
44264567|NCT00651066|Ritonavir|ritonavir|mesh-list
44712996|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44712997|NCT01474187|Capecitabine|capecitabine|mesh-list
44712998|NCT01474187|Irinotecan|irinotecan|mesh-list
44712999|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44713000|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
44713001|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713002|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713003|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44713004|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44713005|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713006|NCT01474265|Varenicline|varenicline|mesh-list
44713007|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44713008|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44713009|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713010|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713011|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713012|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713013|NCT01474304|Acetaminophen|acetaminophen|mesh-list
44713014|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713015|NCT01474304|Analgesics|analgesics|mesh-ancestor
44713016|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
44713017|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713018|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713019|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
44713020|NCT01474330|Pomalidomide|pomalidomide|mesh-list
44713021|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
44713022|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713023|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44713024|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44713025|NCT01474330|Growth Substances|growth substances|mesh-ancestor
44713026|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44713027|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713028|NCT01474382|Phentolamine|phentolamine|mesh-list
44713029|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44713030|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44713031|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713032|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713033|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713034|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713035|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44713037|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
44713038|NCT01474460|Vitamins|vitamins|mesh-ancestor
44713039|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
44713040|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713041|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44713042|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44713043|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713044|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
44713045|NCT01474460|Coagulants|coagulants|mesh-ancestor
44713046|NCT01474473|Calpastatin|calpastatin|mesh-list
44713047|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44713048|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
44713049|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713050|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713051|NCT01474499|Sorbitol|sorbitol|mesh-list
44713052|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44713053|NCT01474499|Glycerol|glycerol|mesh-list
44713054|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44713055|NCT01474499|Protective Agents|protective agents|mesh-ancestor
44713056|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713057|NCT01474499|Cathartics|cathartics|mesh-ancestor
44713058|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713059|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
44713060|NCT01474642|Cisplatin|cisplatin|mesh-list
44713061|NCT01474642|Capecitabine|capecitabine|mesh-list
44713062|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713063|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44713064|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
44713065|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713066|NCT01474902|Enoxaparin|enoxaparin|mesh-list
44713067|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
44713068|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44713069|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44713070|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713072|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44713073|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713074|NCT01475019|Orlistat|orlistat|mesh-list
44713075|NCT01475019|Sibutramine|sibutramine|mesh-list
44713076|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713077|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713078|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44713079|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44713080|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
44713081|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713082|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
44713083|NCT01475032|Beclomethasone|beclomethasone|mesh-list
44713084|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
44713085|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44713086|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
44713087|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713088|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713089|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44713090|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
44713091|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44713092|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713093|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713094|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713095|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713096|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713097|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44713098|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
44713099|NCT01475032|Hormones|hormones|mesh-ancestor
44713100|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713101|NCT01475227|Zinc|zinc|mesh-list
44713102|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
44713103|NCT01475227|Trace Elements|trace elements|mesh-ancestor
44713104|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
44713105|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713106|NCT01475227|Astringents|astringents|mesh-ancestor
44713107|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44713108|NCT01475266|Apaziquone|apaziquone|mesh-list
44713109|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713110|NCT01475279|Warfarin|warfarin|mesh-list
44713111|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
44713112|NCT01475318|Letrozole|letrozole|mesh-list
44713113|NCT01475318|Misoprostol|misoprostol|mesh-list
44713114|NCT01475318|Mifepristone|mifepristone|mesh-list
44713115|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713116|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44713117|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44713118|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713119|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713120|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44713121|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
44713122|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713123|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713124|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44713125|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
44713126|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44713127|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44713128|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713129|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
44713130|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44713131|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44713132|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44713133|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44713134|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
44713135|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44713136|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44713137|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
44713138|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44713139|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44713140|NCT01475552|Abciximab|abciximab|mesh-list
44713141|NCT01475552|Clopidogrel|clopidogrel|mesh-list
44713142|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264717|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44713143|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713144|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44713145|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44713146|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44713147|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44713148|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
44713149|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713150|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
44713151|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
44713152|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
44713153|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44713154|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44713155|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713156|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713157|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713158|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713159|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44713160|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
44713161|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
44713162|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
44713163|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
44713164|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
44713165|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
44713166|NCT01475617|Calcium|calcium|mesh-list
44713167|NCT01475617|Vitamins|vitamins|mesh-ancestor
44713168|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
44713169|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713170|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713171|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44713172|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
44713173|NCT01475617|Hematinics|hematinics|mesh-ancestor
44713174|NCT01475656|Levetiracetam|levetiracetam|mesh-list
44713175|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
44713176|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
44713177|NCT01475708|Doxycycline|doxycycline|mesh-list
44713178|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44713179|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713180|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
44713181|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44713182|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44713183|NCT01475760|Chitosan|chitosan|mesh-list
44713184|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44713185|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44713186|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
44713187|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713189|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
44713190|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
44713191|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
44713192|NCT01475760|Coagulants|coagulants|mesh-ancestor
44713193|NCT01475877|Bromfenac|bromfenac|mesh-list
44713194|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44713195|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713196|NCT01475877|Analgesics|analgesics|mesh-ancestor
44713197|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
44713198|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713199|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713200|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44713201|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713202|NCT01475890|Vitamin D|vitamin d|mesh-list
44713203|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
44713204|NCT01475890|Vitamins|vitamins|mesh-ancestor
44713205|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
44713206|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713207|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44713208|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713209|NCT01476007|Vitamins|vitamins|mesh-list
44713210|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
44713211|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
44713212|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
44713213|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
44713214|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713215|NCT01476007|Hematinics|hematinics|mesh-ancestor
44713216|NCT01476124|Morphine|morphine|mesh-list
44264792|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713217|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44713218|NCT01476124|Narcotics|narcotics|mesh-ancestor
43878006|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
44713219|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713220|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713221|NCT01476124|Analgesics|analgesics|mesh-ancestor
44713222|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
44713223|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713224|NCT01476137|Trametinib|trametinib|mesh-list
44713225|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713226|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44713227|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713228|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713229|NCT01476176|Acetaminophen|acetaminophen|mesh-list
44713230|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713231|NCT01476176|Analgesics|analgesics|mesh-ancestor
44713232|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
44713233|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713234|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713235|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
44713236|NCT01476189|Acetaminophen|acetaminophen|mesh-list
44713237|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713238|NCT01476189|Analgesics|analgesics|mesh-ancestor
44713239|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
44713240|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713241|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713242|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
44713243|NCT01476215|Acetaminophen|acetaminophen|mesh-list
44713244|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713245|NCT01476215|Analgesics|analgesics|mesh-ancestor
44713246|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
44713247|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713248|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713249|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
44713250|NCT01476280|Palonosetron|palonosetron|mesh-list
44713251|NCT01476280|Ramosetron|ramosetron|mesh-list
44713252|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
44713253|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
44713254|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713255|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713256|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713257|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44713258|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44713259|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
44713260|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713261|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713262|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44713263|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44713264|NCT01476358|Vitamin A|vitamin a|mesh-list
44713266|NCT01476358|Vitamins|vitamins|mesh-ancestor
44713267|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
44713268|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713269|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
44713270|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713271|NCT01476358|Protective Agents|protective agents|mesh-ancestor
44713272|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44713273|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713274|NCT01476410|Doxorubicin|doxorubicin|mesh-list
44713275|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44713276|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44713277|NCT01476410|Dacarbazine|dacarbazine|mesh-list
44713278|NCT01476410|Vinblastine|vinblastine|mesh-list
44713279|NCT01476410|Antibodies|antibodies|mesh-list
44713280|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
44713281|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44713282|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
44713283|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44713284|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
44713285|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713286|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44713287|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713288|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44713289|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44713290|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713291|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878068|NCT04692285|Zolpidem|zolpidem|mesh-list
44713292|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44713293|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44713294|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
44713295|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44713296|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44713297|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
44713298|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
44713299|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
44713300|NCT01476488|Tacrolimus|tacrolimus|mesh-list
44713301|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44713302|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
44713303|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713304|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44713305|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713306|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713307|NCT01476592|Resveratrol|resveratrol|mesh-list
44713308|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
44713309|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713310|NCT01476592|Protective Agents|protective agents|mesh-ancestor
44713311|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713312|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713313|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44713314|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
44713315|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44713316|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44713317|NCT01476683|Racecadotril|racecadotril|mesh-list
44713318|NCT01476683|Thiorphan|thiorphan|mesh-list
44713319|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
44713320|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713321|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44713322|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713323|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713324|NCT01476774|Buprenorphine|buprenorphine|mesh-list
44713325|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44713326|NCT01476774|Narcotics|narcotics|mesh-ancestor
44713327|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713328|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713329|NCT01476774|Analgesics|analgesics|mesh-ancestor
44713330|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
44713331|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713332|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44713333|NCT01476787|Rituximab|rituximab|mesh-list
44713334|NCT01476787|Lenalidomide|lenalidomide|mesh-list
44713335|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44713336|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44713337|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713338|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
44713339|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713340|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713341|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44713342|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44713343|NCT01476787|Growth Substances|growth substances|mesh-ancestor
44713344|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
44713345|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44713346|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
44713347|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713348|NCT01476800|Ketoconazole|ketoconazole|mesh-list
44713349|NCT01476800|Mirabegron|mirabegron|mesh-list
44713350|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
44713351|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713352|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44713353|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44713354|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713355|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713356|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44713357|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
44713358|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713359|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713360|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44713361|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44713362|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713363|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713364|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713365|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713366|NCT01476800|Urological Agents|urological agents|mesh-ancestor
44713367|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
44713368|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44713369|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44713370|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44713371|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713372|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713373|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713374|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713375|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
44713376|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44713377|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
44713378|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713379|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713380|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44713381|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
44713382|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713383|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713384|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44713385|NCT01477034|Vitamin D|vitamin d|mesh-list
44713386|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
44713387|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
44713388|NCT01477034|Vitamins|vitamins|mesh-list
44713389|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
44713390|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265012|NCT00652639|Clonazepam|clonazepam|mesh-list
44713391|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44713392|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713393|NCT01477060|Metformin|metformin|mesh-list
44713394|NCT01477060|Lapatinib|lapatinib|mesh-list
44713395|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44713396|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713397|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713398|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44713399|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713400|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713401|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44713402|NCT01477073|Hormones|hormones|mesh-ancestor
44713403|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713404|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713405|NCT01477112|Beta Carotene|beta carotene|mesh-list
44713406|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713407|NCT01477112|Provitamins|provitamins|mesh-ancestor
44713408|NCT01477112|Vitamins|vitamins|mesh-ancestor
44713409|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
44713410|NCT01477151|Anesthetics|anesthetics|mesh-list
44713411|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713412|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713413|NCT01477190|Morphine|morphine|mesh-list
44713414|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44713415|NCT01477190|Narcotics|narcotics|mesh-ancestor
44713416|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713417|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713418|NCT01477190|Analgesics|analgesics|mesh-ancestor
44713419|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
44713420|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713421|NCT01477203|Citalopram|citalopram|mesh-list
44713422|NCT01477203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44713423|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44713424|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713425|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713426|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713427|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
43878193|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713428|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713429|NCT01477203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44713430|NCT01477203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44713431|NCT01477203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713432|NCT01477242|Ondansetron|ondansetron|mesh-list
44713433|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
44713434|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
44713435|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713436|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713437|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713438|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
44713439|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44713440|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44713441|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
44713442|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713443|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713444|NCT01477242|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44713445|NCT01477242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44713446|NCT01477242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713447|NCT01477242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713448|NCT01477242|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44713449|NCT01477268|Sertraline|sertraline|mesh-list
44713450|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
44713451|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713452|NCT01477268|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44713453|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44713454|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713455|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713456|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713457|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
44713458|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713459|NCT01477294|Caffeine|caffeine|mesh-list
44713460|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44713461|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713462|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44713463|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265085|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44713464|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713465|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44713467|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
44713468|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713469|NCT01477385|Fluorides|fluorides|mesh-list
44713470|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
44713471|NCT01477385|Protective Agents|protective agents|mesh-ancestor
44713472|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713473|NCT01477411|Digoxin|digoxin|mesh-list
44713474|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44713475|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44713476|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713477|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713478|NCT01477411|Protective Agents|protective agents|mesh-ancestor
44713479|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713480|NCT01477424|Warfarin|warfarin|mesh-list
44713481|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
44713482|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44713483|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713484|NCT01477489|Veliparib|veliparib|mesh-list
44713485|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44713486|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713487|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713488|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713489|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43878286|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713490|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44713491|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
44713492|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713493|NCT01477580|Antacids|antacids|mesh-ancestor
44713494|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713495|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713496|NCT01477606|Cytarabine|cytarabine|mesh-list
44713497|NCT01477606|Daunorubicin|daunorubicin|mesh-list
44713498|NCT01477606|Midostaurin|midostaurin|mesh-list
44713499|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44713500|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
44713501|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713502|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713503|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
44713504|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713505|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44713506|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
44713507|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713508|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44713509|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44713510|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44713511|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713512|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44713513|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44713514|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44713515|NCT01477632|Norethindrone|norethindrone|mesh-list
44713516|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
44713517|NCT01477632|Estradiol|estradiol|mesh-list
44713518|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44713519|NCT01477632|Estrogens|estrogens|mesh-ancestor
44713520|NCT01477632|Hormones|hormones|mesh-ancestor
44713521|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713522|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713523|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44713524|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
44713525|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44713526|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44713527|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44713528|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44713529|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44713530|NCT01477736|Oxybutynin|oxybutynin|mesh-list
44713531|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
44713532|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44713533|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44713534|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44713535|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713536|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713537|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713538|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713539|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713540|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44713541|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713542|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
44713543|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
44713544|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44713545|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44713546|NCT01477736|Urological Agents|urological agents|mesh-ancestor
44713547|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
44713548|NCT01477801|Vitamin D|vitamin d|mesh-list
44713549|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713550|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713551|NCT01477801|Vitamins|vitamins|mesh-ancestor
44713552|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
44713553|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44713554|NCT01477840|Misoprostol|misoprostol|mesh-list
44713555|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44713556|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
44713557|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44713558|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713559|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44713560|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713561|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
44713562|NCT01477931|Bupropion|bupropion|mesh-list
44713563|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44713564|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
44713565|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713566|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44713567|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44713568|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713569|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713570|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
44713571|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713572|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713573|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44713574|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44713575|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713576|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44713577|NCT01477983|Flecainide|flecainide|mesh-list
44713578|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44713579|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44713580|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713581|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713582|NCT01478022|Ibuprofen|ibuprofen|mesh-list
44713583|NCT01478022|Isosorbide|isosorbide|mesh-list
44713584|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44713585|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44713586|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44713587|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713588|NCT01478022|Analgesics|analgesics|mesh-ancestor
44713589|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
44713590|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713591|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713592|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44713593|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713594|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44713595|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713596|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713597|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44713598|NCT01478022|Diuretics|diuretics|mesh-ancestor
44713599|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
44713600|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
44713601|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44713602|NCT01478035|Phenytoin|phenytoin|mesh-list
44713603|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
44713604|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44713605|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44713606|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713607|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713608|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44713609|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44713610|NCT01478074|Cytarabine|cytarabine|mesh-list
44713611|NCT01478074|Fludarabine|fludarabine|mesh-list
44713612|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713613|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44713614|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
44713615|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713616|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44713617|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
44713618|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713619|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
44713620|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713621|NCT01478165|Palonosetron|palonosetron|mesh-list
44713622|NCT01478165|Anesthetics|anesthetics|mesh-list
44713623|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713624|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713625|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
44713626|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
44136099|NCT00163345|Ciclesonide|ciclesonide|mesh-list
44713627|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713628|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713629|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44713630|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44713631|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
44713632|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713633|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713634|NCT01478230|Nicotine|nicotine|mesh-list
44713635|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44713636|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
44713637|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713638|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713639|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44713640|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44713641|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713642|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713643|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713644|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
44713645|NCT01478282|Dabigatran|dabigatran|mesh-list
44713646|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44713647|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
44713648|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44713649|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
44713650|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713651|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713652|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
44713653|NCT01478308|Metformin|metformin|mesh-list
44713654|NCT01478308|Prednisone|prednisone|mesh-list
44713655|NCT01478308|Docetaxel|docetaxel|mesh-list
44713656|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44713657|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713658|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713659|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
44713660|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
44713661|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
44713662|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713663|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44713664|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
44713665|NCT01478308|Hormones|hormones|mesh-ancestor
44713666|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713667|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44713668|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
44713669|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44713670|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
44713671|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713672|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
44713673|NCT01478386|Protective Agents|protective agents|mesh-ancestor
44713674|NCT01478490|Metoprolol|metoprolol|mesh-list
44713675|NCT01478490|Mirabegron|mirabegron|mesh-list
44713676|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44713677|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44713678|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
44713679|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
44713680|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713681|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713682|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44713683|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44713684|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44713685|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713686|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713687|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713688|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44713689|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713690|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713691|NCT01478490|Urological Agents|urological agents|mesh-ancestor
44713692|NCT01478503|Mirabegron|mirabegron|mesh-list
44713693|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44713694|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713695|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713696|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713697|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878423|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
44713698|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713699|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713700|NCT01478503|Urological Agents|urological agents|mesh-ancestor
44713701|NCT01478529|Mirabegron|mirabegron|mesh-list
44713702|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44713703|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713704|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713705|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713706|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713707|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713708|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713709|NCT01478529|Urological Agents|urological agents|mesh-ancestor
44713710|NCT01478568|Desipramine|desipramine|mesh-list
44713711|NCT01478568|Mirabegron|mirabegron|mesh-list
44713712|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44713713|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44713714|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44713715|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44713716|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713717|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713718|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713719|NCT01478568|Urological Agents|urological agents|mesh-ancestor
44713720|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44713721|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
44713722|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713723|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713724|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44713725|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44713726|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713727|NCT01478607|Capsaicin|capsaicin|mesh-list
44713728|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
44713729|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
44713730|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
44713731|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713732|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713733|NCT01478633|Galantamine|galantamine|mesh-list
44713734|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44713735|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713736|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713737|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
44713738|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713739|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713740|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44265364|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713741|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
44713742|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713743|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
44713744|NCT01478685|Paclitaxel|paclitaxel|mesh-list
44713745|NCT01478685|Carboplatin|carboplatin|mesh-list
44713746|NCT01478685|Azacitidine|azacitidine|mesh-list
44713747|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44713748|NCT01478685|Cc-486|cc-486|mesh-list
44713749|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44713750|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713751|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
44713752|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
44713753|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
44713754|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713755|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44713756|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
44713757|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713758|NCT01478724|Caseins|caseins|mesh-list
44713759|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
44713760|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
44713761|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713762|NCT01478737|Dexamethasone|dexamethasone|mesh-list
44713763|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
44713764|NCT01478737|BB 1101|bb 1101|mesh-list
44713765|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44713766|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
43878491|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44713767|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
44713768|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713769|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713770|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713771|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
44713772|NCT01478737|Hormones|hormones|mesh-ancestor
44713773|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713774|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44713775|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713776|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
44713777|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713778|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713779|NCT01478997|Acetaminophen|acetaminophen|mesh-list
44713780|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713781|NCT01478997|Analgesics|analgesics|mesh-ancestor
44713782|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
44713783|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713784|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713785|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
44713786|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44713787|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
44713788|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713789|NCT01479036|Docetaxel|docetaxel|mesh-list
44713790|NCT01479036|Epirubicin|epirubicin|mesh-list
44713791|NCT01479036|Endostatins|endostatins|mesh-list
44713792|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713793|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
44713794|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
44713795|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
44713796|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713797|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44713798|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44713799|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44713800|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713801|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44713802|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44713803|NCT01479036|Growth Substances|growth substances|mesh-ancestor
44713804|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713805|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
44713806|NCT01479075|Insulin|insulin|mesh-list
44713807|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44713808|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44713809|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713810|NCT01479088|Cinacalcet|cinacalcet|mesh-list
44713811|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713812|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713813|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44713814|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
44713815|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44713816|NCT01479114|Lenograstim|lenograstim|mesh-list
44713817|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44713818|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
44713819|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713820|NCT01479179|Trastuzumab|trastuzumab|mesh-list
44713821|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44713822|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713823|NCT01479192|Fenretinide|fenretinide|mesh-list
44713824|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713825|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44713826|NCT01479192|Protective Agents|protective agents|mesh-ancestor
44713827|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713828|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
44713829|NCT01479231|Lansoprazole|lansoprazole|mesh-list
44713830|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44713831|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44713832|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44713833|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713834|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713835|NCT01479244|Molgramostim|molgramostim|mesh-list
44713836|NCT01479244|Sargramostim|sargramostim|mesh-list
44713837|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
44713838|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713839|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713840|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44713841|NCT01479283|Cefazolin|cefazolin|mesh-list
44713842|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44713843|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713844|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
44713845|NCT01479296|Vaccines|vaccines|mesh-list
44713846|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
44713847|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713848|NCT01479361|Atovaquone|atovaquone|mesh-list
44713849|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713850|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
44713851|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44713852|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44713853|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713854|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713855|NCT01479504|Cisplatin|cisplatin|mesh-list
44713856|NCT01479504|Docetaxel|docetaxel|mesh-list
44713857|NCT01479504|Nedaplatin|nedaplatin|mesh-list
44713858|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713859|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
44713860|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
44713862|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713863|NCT01479556|Pregabalin|pregabalin|mesh-list
44713864|NCT01479556|Analgesics|analgesics|mesh-ancestor
44713865|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
44713866|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713867|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713868|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
44713869|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44713870|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713871|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713872|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713873|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44713874|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44713875|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713876|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713877|NCT01479634|Efavirenz|efavirenz|mesh-list
44713878|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44713879|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44713880|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713881|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713882|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
44713883|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713884|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44713885|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44713886|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44713887|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44713888|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44265512|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
44713889|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44713890|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
44713891|NCT01479751|Ketamine|ketamine|mesh-list
44713892|NCT01479751|Rocuronium|rocuronium|mesh-list
44713894|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
44713895|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713896|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713897|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44713898|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44713899|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
44713900|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
44713901|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44713902|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44713903|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44713904|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44713905|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713906|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44713907|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
44713908|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44713909|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713910|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713911|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
44713912|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44713913|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44713914|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44713915|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44713916|NCT01479881|Cyclosporine|cyclosporine|mesh-list
44713917|NCT01479881|Simeprevir|simeprevir|mesh-list
44713918|NCT01479881|Tacrolimus|tacrolimus|mesh-list
44713919|NCT01479881|Cyclosporins|cyclosporins|mesh-list
44713920|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44713921|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
44713922|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713923|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44713924|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713925|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713926|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
44713927|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713928|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
44713929|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44713930|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
44713931|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
44713932|NCT01479920|Fluoxetine|fluoxetine|mesh-list
44125443|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
44713933|NCT01479920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44713934|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44713935|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713936|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713938|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
44713939|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713940|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44713941|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
44713942|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44713943|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44713944|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44713945|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713946|NCT01479933|Vitamin D|vitamin d|mesh-list
44713947|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
44713948|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
44713949|NCT01479933|Vitamins|vitamins|mesh-list
44713950|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
44713951|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713952|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44713953|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713954|NCT01480050|Temozolomide|temozolomide|mesh-list
44713955|NCT01480050|Mibefradil|mibefradil|mesh-list
44713956|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44713957|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
44713958|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713959|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713960|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44713961|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44713962|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713963|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44713964|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265584|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44713965|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44713966|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44713967|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44713968|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713969|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
44713970|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44713971|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44713972|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713973|NCT01480141|Afatinib|afatinib|mesh-list
44713974|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713975|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878576|NCT04683458|Paclitaxel|paclitaxel|mesh-list
44713976|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44713977|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713978|NCT01480323|Aldesleukin|aldesleukin|mesh-list
44713979|NCT01480323|Ipilimumab|ipilimumab|mesh-list
44713980|NCT01480323|Interleukin-2|interleukin-2|mesh-list
44713981|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44713982|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44713983|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44713984|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44713985|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44713986|NCT01480323|Analgesics|analgesics|mesh-ancestor
44713987|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
44713988|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44713989|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44713990|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44713991|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44713992|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
44713993|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44713994|NCT01480336|Amiodarone|amiodarone|mesh-list
44713995|NCT01480336|Ranolazine|ranolazine|mesh-list
44713996|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44713997|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
44713998|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44713999|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714000|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714001|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44714002|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44458854|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44714003|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44714005|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44714006|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44714007|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44714008|NCT01480492|Telbivudine|telbivudine|mesh-list
44714009|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
44714010|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714011|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44714012|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714013|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714014|NCT01480531|Clevidipine|clevidipine|mesh-list
44714015|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44714016|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714017|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714018|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44714019|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714020|NCT01480609|Ezogabine|ezogabine|mesh-list
44714021|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
44714022|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714023|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714024|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
44714025|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44714026|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
44714027|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714028|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44714029|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
44714030|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44714031|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44714032|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
44714033|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714034|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44714035|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44714036|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714037|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714038|NCT01480752|Lornoxicam|lornoxicam|mesh-list
44714039|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44714040|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714041|NCT01480752|Analgesics|analgesics|mesh-ancestor
44714042|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
44714043|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714044|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714045|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714046|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714047|NCT01480765|Pregabalin|pregabalin|mesh-list
44714048|NCT01480765|Ketamine|ketamine|mesh-list
44714049|NCT01480765|Analgesics|analgesics|mesh-ancestor
44714050|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
44714051|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714052|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714053|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44714054|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44714055|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
44714056|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
44714057|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714058|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44714059|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44714060|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714061|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714062|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
44714063|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44714064|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714065|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44714066|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44714067|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44714068|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714069|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44714070|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44714071|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44714072|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44714073|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
44714074|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44714075|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714076|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44714077|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44714078|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44714079|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44714080|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44714081|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44714082|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44714083|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44714084|NCT01480791|Diuretics|diuretics|mesh-ancestor
44714085|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
44714086|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714087|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44714088|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714089|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714090|NCT01480817|Sorafenib|sorafenib|mesh-list
44714091|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714092|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714093|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714094|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714095|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
44714096|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
44714097|NCT01480869|Vitamin D|vitamin d|mesh-list
44714098|NCT01480869|Calcium|calcium|mesh-list
44714099|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44714100|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714101|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44714102|NCT01480869|Vitamins|vitamins|mesh-ancestor
44714103|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
44714104|NCT01480986|Cisplatin|cisplatin|mesh-list
44714105|NCT01480986|Irinotecan|irinotecan|mesh-list
44714106|NCT01480986|Octreotide|octreotide|mesh-list
44714107|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714108|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44714109|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44714110|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714111|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714112|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714113|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44714114|NCT01481194|Dexamethasone|dexamethasone|mesh-list
44714115|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
44714116|NCT01481194|Doxorubicin|doxorubicin|mesh-list
44714117|NCT01481194|Lenalidomide|lenalidomide|mesh-list
44714118|NCT01481194|Bortezomib|bortezomib|mesh-list
44714119|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714120|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
44714121|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714122|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714123|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44714124|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
44714125|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714126|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714127|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44714128|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714129|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
44714130|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
44714131|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714132|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714133|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
44714134|NCT01481194|Hormones|hormones|mesh-ancestor
44714135|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714136|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44714137|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44714138|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44714139|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44714140|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714141|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44714142|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44714143|NCT01481194|Growth Substances|growth substances|mesh-ancestor
44714144|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
44714145|NCT01481233|Colchicine|colchicine|mesh-list
44714146|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
44714147|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714148|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714149|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714150|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714151|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714152|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714154|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714155|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714156|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714157|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44714158|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44714159|NCT01481311|Bromides|bromides|mesh-list
44714160|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
44714161|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
44714162|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
44714163|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44714164|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44714165|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714166|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714167|NCT01481350|Urological Agents|urological agents|mesh-ancestor
44714168|NCT01481389|Theobromine|theobromine|mesh-list
44714169|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44714170|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
44714171|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714172|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714173|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44714174|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
44714175|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
44714176|NCT01481454|Vaccines|vaccines|mesh-list
44714177|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
44714178|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714179|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
44714180|NCT01481519|Dexamethasone|dexamethasone|mesh-list
44714181|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
44714182|NCT01481519|Povidone|povidone|mesh-list
44714183|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
44714184|NCT01481519|BB 1101|bb 1101|mesh-list
44714185|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714186|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
44714187|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
44714188|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714189|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714190|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714191|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
44714192|NCT01481519|Hormones|hormones|mesh-ancestor
44714193|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714194|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265835|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44714195|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714196|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714197|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714198|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714199|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
44714200|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
44714201|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44714202|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714203|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44714204|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44714205|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
44714206|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
44714207|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714208|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714209|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714210|NCT01481610|Diclofenac|diclofenac|mesh-list
44714211|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
44714212|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44714213|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714214|NCT01481610|Analgesics|analgesics|mesh-ancestor
44714215|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
44714216|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714217|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714218|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714219|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714220|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44714221|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714222|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714223|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44714225|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714226|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
44714227|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
44714228|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
44714229|NCT01481714|Citric Acid|citric acid|mesh-list
44714230|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
44714231|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44714232|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
44714233|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
44714234|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714235|NCT01481714|Cathartics|cathartics|mesh-ancestor
44714236|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714237|NCT01481714|Antacids|antacids|mesh-ancestor
44714239|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
44714240|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
44714241|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714242|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714243|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714244|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44714245|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44714246|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
44714247|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714248|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714249|NCT01481844|Amoxicillin|amoxicillin|mesh-list
44714250|NCT01481844|Metronidazole|metronidazole|mesh-list
44714251|NCT01481844|Clarithromycin|clarithromycin|mesh-list
44714252|NCT01481844|Tetracycline|tetracycline|mesh-list
44714253|NCT01481844|Tinidazole|tinidazole|mesh-list
44714254|NCT01481844|Lansoprazole|lansoprazole|mesh-list
44714255|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
44714256|NCT01481844|Bismuth|bismuth|mesh-list
44714257|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44714258|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44714259|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714260|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44714261|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44714262|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44714263|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714264|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714265|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44714266|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44714267|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44714268|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714269|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44714270|NCT01481844|Antacids|antacids|mesh-ancestor
44714271|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
44714272|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44714273|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
44714274|NCT01481870|Sorafenib|sorafenib|mesh-list
44714275|NCT01481870|Sunitinib|sunitinib|mesh-list
44714276|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714277|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714278|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714279|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714280|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44714281|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44714282|NCT01481870|Growth Substances|growth substances|mesh-ancestor
44714283|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714284|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
44714285|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44714286|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44714287|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
44714288|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714289|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714290|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44714291|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44714292|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44714293|NCT01482052|Vaccines|vaccines|mesh-list
44714294|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
44714295|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714296|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44714297|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44714298|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44714299|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
44714300|NCT01482117|Cilostazol|cilostazol|mesh-list
44714301|NCT01482117|Clopidogrel|clopidogrel|mesh-list
44714302|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44714303|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44714304|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44714305|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44714306|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
44714307|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714308|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714309|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714310|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44714311|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
44714312|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714313|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44714314|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44714315|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44714316|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44714317|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
44714318|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44714319|NCT01482117|Protective Agents|protective agents|mesh-ancestor
44714320|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44714321|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44714322|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714325|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714326|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714327|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
44714328|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714329|NCT01482299|Everolimus|everolimus|mesh-list
44714330|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714331|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714332|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
44714333|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714334|NCT01482338|Drospirenone|drospirenone|mesh-list
44714335|NCT01482338|Desogestrel|desogestrel|mesh-list
44714336|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44714337|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
44714338|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714339|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714340|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44714341|NCT01482338|Diuretics|diuretics|mesh-ancestor
44714342|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
44714343|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44714344|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44714345|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44714346|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
44714347|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44714348|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44714349|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44714350|NCT01482338|Progestins|progestins|mesh-ancestor
44714351|NCT01482338|Hormones|hormones|mesh-ancestor
44714352|NCT01482377|Cetuximab|cetuximab|mesh-list
44714353|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44714354|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44714355|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714356|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714357|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714358|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714359|NCT01482416|Estrogens|estrogens|mesh-list
44714360|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44714361|NCT01482416|Hormones|hormones|mesh-ancestor
44714362|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878998|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878999|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879000|NCT04678739|Remdesivir|remdesivir|mesh-list
43879001|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
43879002|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879003|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
43879004|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714363|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714364|NCT01482442|Sorafenib|sorafenib|mesh-list
44714365|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714366|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714367|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714368|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714369|NCT01482468|Palonosetron|palonosetron|mesh-list
44714370|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
44714371|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
44714372|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714373|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714374|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714375|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44714376|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44714377|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
44714378|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714379|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714381|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44714382|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
44714383|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
44714384|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714385|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266053|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
44714386|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
44714387|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714388|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714389|NCT01482559|Protective Agents|protective agents|mesh-ancestor
44714390|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
44714391|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44714392|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
44714393|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714394|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
44714395|NCT01482624|Protective Agents|protective agents|mesh-ancestor
44714396|NCT01482728|Dasatinib|dasatinib|mesh-list
44714397|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714398|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714399|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714400|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714401|NCT01482754|Rituximab|rituximab|mesh-list
44714402|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44714403|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714404|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
44714405|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714406|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714407|NCT01482897|Prednisolone|prednisolone|mesh-list
44714408|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44714409|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
44714410|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44714411|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
44714412|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44714413|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
44714414|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714415|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
44714416|NCT01482897|Hormones|hormones|mesh-ancestor
44714417|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714418|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714419|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44714420|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714421|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
44714422|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
44714423|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714424|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714425|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44714426|NCT01482897|Protective Agents|protective agents|mesh-ancestor
44714427|NCT01482936|Oxycodone|oxycodone|mesh-list
44714428|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44714429|NCT01482936|Narcotics|narcotics|mesh-ancestor
44714430|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714431|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714432|NCT01482936|Analgesics|analgesics|mesh-ancestor
44714433|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
44714434|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714435|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
44714436|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714437|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714438|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714439|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714440|NCT01483053|S 20098|s 20098|mesh-list
44714441|NCT01483053|Citalopram|citalopram|mesh-list
44714442|NCT01483053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44714443|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44714444|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714445|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714446|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714447|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
44125947|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
44714448|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714449|NCT01483053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44714450|NCT01483053|Antidepressive Agents|antidepressive agents|mesh-ancestor
44714451|NCT01483053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714452|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44714453|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714455|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44714456|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714457|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
44714458|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714459|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44266127|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
44714460|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714461|NCT01483274|Vaccines|vaccines|mesh-list
44714462|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
44714463|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714464|NCT01483300|Cisplatin|cisplatin|mesh-list
44714465|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714466|NCT01483365|Progesterone|progesterone|mesh-list
44714467|NCT01483365|Progestins|progestins|mesh-ancestor
44714468|NCT01483365|Hormones|hormones|mesh-ancestor
44714469|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714470|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714471|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
44714472|NCT01483508|Procyanidin|procyanidin|mesh-list
44714473|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
44714474|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714475|NCT01483508|Protective Agents|protective agents|mesh-ancestor
44714476|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714477|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44714478|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44714479|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714480|NCT01483638|Axitinib|axitinib|mesh-list
44714481|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714482|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714483|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714484|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714485|NCT01483729|Ritonavir|ritonavir|mesh-list
44714486|NCT01483729|Lactams|lactams|mesh-list
44714487|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44714488|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44714489|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714490|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714491|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714492|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44714493|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44714494|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
44714495|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714496|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44714497|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44714498|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44714499|NCT01483781|Canagliflozin|canagliflozin|mesh-list
44714500|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44714501|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714502|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44714503|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714504|NCT01483859|Liver Extracts|liver extracts|mesh-list
44714505|NCT01483859|Hematinics|hematinics|mesh-ancestor
44714506|NCT01483911|Gontivimab|gontivimab|mesh-list
44714507|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
44714508|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714509|NCT01484015|Cefepime|cefepime|mesh-list
44714510|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44714511|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714512|NCT01484080|Paclitaxel|paclitaxel|mesh-list
44714513|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44714514|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44714515|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714516|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714517|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714518|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714519|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714520|NCT01484145|Terbinafine|terbinafine|mesh-list
44714521|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
44714522|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714523|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714524|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714526|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44714527|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714528|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44714529|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44714530|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714531|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714532|NCT01484184|Levodopa|levodopa|mesh-list
44714533|NCT01484184|Buspirone|buspirone|mesh-list
44714534|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44714535|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44714536|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
44714537|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714538|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714539|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714540|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44714541|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44714542|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714543|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714544|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44266222|NCT00657228|Heparin|heparin|mesh-list
44714545|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
44714546|NCT01484262|Liraglutide|liraglutide|mesh-list
44714547|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44714548|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714549|NCT01484262|Incretins|incretins|mesh-ancestor
44714550|NCT01484262|Hormones|hormones|mesh-ancestor
44714551|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714552|NCT01484327|Carvedilol|carvedilol|mesh-list
44714553|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44714554|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44714555|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
44714556|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714557|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714558|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714559|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44714560|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
44714561|NCT01484327|Protective Agents|protective agents|mesh-ancestor
44714562|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44714563|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714564|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44714565|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
44714566|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44714567|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44714568|NCT01484457|Pancrelipase|pancrelipase|mesh-list
44714569|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714570|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44714571|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
44714572|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714573|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44714574|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44714575|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
44714576|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44714577|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714578|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44714579|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44714580|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44714581|NCT01484717|Nicotine|nicotine|mesh-list
44714582|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44714583|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
44714584|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714585|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714586|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44714587|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44714588|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
44714589|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714590|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714591|NCT01484756|Micronutrients|micronutrients|mesh-list
44714592|NCT01484756|Trace Elements|trace elements|mesh-list
44714593|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714594|NCT01484964|Peficitinib|peficitinib|mesh-list
44714595|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714596|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714597|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714598|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
44714599|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714601|NCT01484990|Carbidopa|carbidopa|mesh-list
44714602|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44714603|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44714604|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44714605|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
44714606|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714607|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714608|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714609|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44714610|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714611|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44714612|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
44714613|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
44714614|NCT01485003|Natalizumab|natalizumab|mesh-list
44714615|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
44714616|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714617|NCT01485068|Paclitaxel|paclitaxel|mesh-list
44714618|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266281|NCT00657449|Valdecoxib|valdecoxib|mesh-list
44714619|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714620|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714621|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714622|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714623|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714625|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44714626|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714627|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714628|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714629|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714630|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714631|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44714632|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44714633|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
44714634|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879184|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
44714635|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44714636|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714637|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44714638|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714639|NCT01485185|Gabapentin|gabapentin|mesh-list
44714640|NCT01485185|Donepezil|donepezil|mesh-list
44714641|NCT01485185|Analgesics|analgesics|mesh-ancestor
44714642|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
44714643|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714644|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714645|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
44714646|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44714647|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44714648|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714649|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714650|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44714651|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44714652|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714653|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714654|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
44714655|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44714656|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714657|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
44714658|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
44714659|NCT01485198|Acetaminophen|acetaminophen|mesh-list
44714660|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714661|NCT01485198|Analgesics|analgesics|mesh-ancestor
44714662|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
44714663|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714664|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714665|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
44714666|NCT01485211|Riboflavin|riboflavin|mesh-list
44714667|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
44714668|NCT01485211|Vitamins|vitamins|mesh-ancestor
44714669|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
44714670|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714671|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44714672|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
44714673|NCT01485224|Thalidomide|thalidomide|mesh-list
44714674|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714675|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
44714676|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714677|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
44714678|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44714679|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714680|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44714681|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44714682|NCT01485224|Growth Substances|growth substances|mesh-ancestor
44714683|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
44714684|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714686|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44714687|NCT01485315|Diuretics|diuretics|mesh-ancestor
44714688|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
44714689|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714690|NCT01485367|Adapalene|adapalene|mesh-list
44714691|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44714692|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714693|NCT01485367|Analgesics|analgesics|mesh-ancestor
44714694|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
44714695|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714696|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714697|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714698|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714699|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
44714700|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44714701|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
44714702|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714703|NCT01485445|Fluticasone|fluticasone|mesh-list
44714704|NCT01485445|Xhance|xhance|mesh-list
44714705|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714706|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44714707|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
44714708|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714709|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714710|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44714711|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
44714712|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
44714713|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44714714|NCT01485562|Misoprostol|misoprostol|mesh-list
44714715|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44714716|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
44714717|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44714718|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714719|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44714720|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714721|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
44714722|NCT01485653|Mepivacaine|mepivacaine|mesh-list
44714723|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
44714724|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
44714725|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714726|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714727|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
44714728|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714729|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
44714730|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
44714731|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714732|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
44714733|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714734|NCT01485692|Promethazine|promethazine|mesh-list
44714735|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
44714736|NCT01485692|Midazolam|midazolam|mesh-list
44714737|NCT01485692|Haloperidol|haloperidol|mesh-list
44714738|NCT01485692|Olanzapine|olanzapine|mesh-list
44714739|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
44714740|NCT01485692|Ziprasidone|ziprasidone|mesh-list
44714741|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44714742|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44714743|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714744|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714745|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44714747|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714748|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44714749|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
44714750|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
44714751|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
44714752|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
44714753|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714754|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714755|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
44714756|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
44714757|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714758|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714759|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44714760|NCT01485692|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44714761|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44714762|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714763|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
44714764|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44714765|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
44714766|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44714767|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44714768|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
44714769|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44714770|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44714771|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
44714772|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
44266503|NCT00658593|Antiviral Agents|antiviral agents|mesh-ancestor
44714773|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44714774|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44714775|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
44714776|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
44714777|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44714778|NCT01485718|Cathartics|cathartics|mesh-ancestor
44714779|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714780|NCT01485731|Nelfinavir|nelfinavir|mesh-list
44714781|NCT01485731|Cisplatin|cisplatin|mesh-list
44714782|NCT01485731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714783|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44714784|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44714785|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714786|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714787|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714788|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44714789|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44714790|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
44714791|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714792|NCT01485744|Leucovorin|leucovorin|mesh-list
44714793|NCT01485744|Fluorouracil|fluorouracil|mesh-list
44714794|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
44714795|NCT01485744|Irinotecan|irinotecan|mesh-list
44714796|NCT01485744|Folfirinox|folfirinox|mesh-list
44714797|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
44714798|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714799|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44714800|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714801|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714802|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
44714803|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714804|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44714805|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44714806|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714807|NCT01485744|Antidotes|antidotes|mesh-ancestor
44714808|NCT01485744|Protective Agents|protective agents|mesh-ancestor
44714809|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
44714810|NCT01485744|Vitamins|vitamins|mesh-ancestor
44714811|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
44714812|NCT01485809|Gefitinib|gefitinib|mesh-list
44714813|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714814|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714815|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714816|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714817|NCT01485822|Travoprost|travoprost|mesh-list
44714818|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44714819|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44714820|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44714821|NCT01485835|Dexamethasone|dexamethasone|mesh-list
44714822|NCT01485835|Bortezomib|bortezomib|mesh-list
44714823|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714824|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
44714825|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
44714826|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714827|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714828|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714829|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
44714830|NCT01485835|Hormones|hormones|mesh-ancestor
44714831|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44714832|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44714833|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714834|NCT01485848|Paclitaxel|paclitaxel|mesh-list
44714835|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44714836|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714837|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714838|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714839|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714840|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714841|NCT01485926|Carboplatin|carboplatin|mesh-list
44714842|NCT01485926|Docetaxel|docetaxel|mesh-list
44714843|NCT01485926|Trastuzumab|trastuzumab|mesh-list
44714844|NCT01485926|Lapatinib|lapatinib|mesh-list
44714845|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714846|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714847|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714848|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714849|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266516|NCT00658840|Capecitabine|capecitabine|mesh-list
44714850|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44714851|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714852|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714853|NCT01485939|Lidocaine|lidocaine|mesh-list
44714854|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
44714855|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
44714856|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714857|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714858|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
44714859|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714860|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44714861|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44714862|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44714863|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44714864|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714865|NCT01485978|Ramipril|ramipril|mesh-list
44714866|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44714867|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714868|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714869|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714870|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44714871|NCT01486004|Simeprevir|simeprevir|mesh-list
44714872|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
44714873|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714874|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714875|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714876|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714877|NCT01486017|Peficitinib|peficitinib|mesh-list
44714878|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714879|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714880|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714881|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
44714882|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714883|NCT01486082|Amoxicillin|amoxicillin|mesh-list
44714884|NCT01486082|Clarithromycin|clarithromycin|mesh-list
44714885|NCT01486082|Omeprazole|omeprazole|mesh-list
44714886|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44714887|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44714888|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44714889|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44714890|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44714891|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714892|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714893|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44714894|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44714895|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44714896|NCT01486251|Axitinib|axitinib|mesh-list
44714897|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714898|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44714899|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714900|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714901|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
44714902|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
44714903|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44714904|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44714905|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714907|NCT01486433|Simvastatin|simvastatin|mesh-list
44714908|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44714909|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714910|NCT01486433|Analgesics|analgesics|mesh-ancestor
44714911|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
44714912|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714913|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714914|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714915|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714916|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44714917|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44714918|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714919|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44714920|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44714921|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714922|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
44714923|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44714924|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44714925|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
44714926|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44714927|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44714928|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
44714929|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
44714930|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714931|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714932|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714933|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
44714934|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44714935|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714936|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714937|NCT01486485|Nafamostat|nafamostat|mesh-list
44714938|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44714939|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44714940|NCT01486485|Analgesics|analgesics|mesh-ancestor
44714941|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
44714942|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714943|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714944|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44714945|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44714946|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
44714947|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
44714948|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44714949|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714950|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44714951|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44714952|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44714953|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44714954|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
44714955|NCT01486511|Liver Extracts|liver extracts|mesh-list
44714956|NCT01486511|Hematinics|hematinics|mesh-ancestor
44714957|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44714958|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
44714959|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
44714960|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44714961|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
44714962|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
44714963|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44714964|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
44714965|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
44714966|NCT01486602|Paclitaxel|paclitaxel|mesh-list
44714967|NCT01486602|Carboplatin|carboplatin|mesh-list
44714968|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44714969|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44714970|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
44714971|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
44714972|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
44714973|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714974|NCT01486706|Gabapentin|gabapentin|mesh-list
44714975|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
44714976|NCT01486706|Analgesics|analgesics|mesh-ancestor
44714977|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
44714978|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44714979|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714980|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
44714981|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44714982|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43879509|NCT04670497|Epinephrine|epinephrine|mesh-list
44714983|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44714984|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44714985|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44714986|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44714987|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44714988|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44714989|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
44714990|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44714991|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44714992|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
44714993|NCT01486706|Urological Agents|urological agents|mesh-ancestor
44714994|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44714995|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
44714996|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44714997|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
44714998|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
44714999|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44715000|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715001|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715002|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
44715003|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
44715004|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44715005|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715006|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715008|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715009|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715010|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715011|NCT01486901|Insulin|insulin|mesh-list
44715012|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715013|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
44715014|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
44715015|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
44715016|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715017|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715018|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
44715019|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715020|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715021|NCT01486940|Insulin|insulin|mesh-list
44715022|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715023|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
44715024|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
44715025|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
44715026|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
44715027|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
44715028|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715029|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715030|NCT01486953|Sevoflurane|sevoflurane|mesh-list
44715031|NCT01486953|Desflurane|desflurane|mesh-list
44715032|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44715033|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44715034|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
44715035|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
44715036|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715037|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715038|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44715039|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44715040|NCT01486979|Estradiol|estradiol|mesh-list
44715041|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44715042|NCT01486979|Estrogens|estrogens|mesh-ancestor
44715043|NCT01486979|Hormones|hormones|mesh-ancestor
44715044|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715045|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715046|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44715048|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44715049|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44715050|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
44715051|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44715052|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715053|NCT01487096|Teriflunomide|teriflunomide|mesh-list
44715054|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715055|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715056|NCT01487096|Analgesics|analgesics|mesh-ancestor
44715057|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
44715058|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715059|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715060|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715061|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715062|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715063|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
44715064|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
44715065|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44715066|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715067|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44715068|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44715069|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715070|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715071|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715073|NCT01487226|Cisplatin|cisplatin|mesh-list
44715074|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44715075|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715076|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
44715077|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
44715078|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
44715079|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715080|NCT01487278|Misoprostol|misoprostol|mesh-list
44715081|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44715082|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
44715083|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44715084|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715085|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44715086|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44715087|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
44715088|NCT01487304|Hormones|hormones|mesh-list
44715089|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715090|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715091|NCT01487317|Rivastigmine|rivastigmine|mesh-list
44715092|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44715093|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715094|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715095|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715096|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715097|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715098|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44715099|NCT01487317|Protective Agents|protective agents|mesh-ancestor
44715100|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
44715101|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715102|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715103|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
44715104|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715105|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715106|NCT01487395|Donepezil|donepezil|mesh-list
44715107|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44715108|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715109|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715110|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715111|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715112|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715113|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
44715114|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
44715115|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715116|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715117|NCT01487421|Insulin|insulin|mesh-list
44715118|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715119|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
44715120|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
44715121|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126582|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
44715122|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715124|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715125|NCT01487512|Narcotics|narcotics|mesh-ancestor
44715126|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715127|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715128|NCT01487512|Analgesics|analgesics|mesh-ancestor
44715129|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
44715130|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715131|NCT01487564|Hydromorphone|hydromorphone|mesh-list
44715132|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715133|NCT01487564|Narcotics|narcotics|mesh-ancestor
44715134|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715135|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715136|NCT01487564|Analgesics|analgesics|mesh-ancestor
44715137|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
44715138|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715139|NCT01487629|Bevacizumab|bevacizumab|mesh-list
44715141|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44715142|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715143|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44715144|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44715145|NCT01487629|Growth Substances|growth substances|mesh-ancestor
44715146|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715147|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
44715148|NCT01487785|Gemcitabine|gemcitabine|mesh-list
44715149|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715150|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
44715151|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715152|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715153|NCT01487785|Antiviral Agents|antiviral agents|mesh-ancestor
44715154|NCT01487785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715155|NCT01487785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715156|NCT01487785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715157|NCT01487785|Immunologic Factors|immunologic factors|mesh-ancestor
44715158|NCT01487785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715159|NCT01487798|Insulin|insulin|mesh-list
44715160|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715161|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
44715162|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
44715163|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44715164|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715165|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715166|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
44715167|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
44715168|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44715169|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715170|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715171|NCT01487993|Metformin|metformin|mesh-list
44715172|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715173|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715174|NCT01488045|Fentanyl|fentanyl|mesh-list
44715175|NCT01488045|Midazolam|midazolam|mesh-list
44715176|NCT01488045|Propofol|propofol|mesh-list
44715177|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44715178|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715179|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715180|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44715181|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
44715182|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
44715183|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715184|NCT01488045|Narcotics|narcotics|mesh-ancestor
44715185|NCT01488045|Analgesics|analgesics|mesh-ancestor
44715186|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
44715187|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715188|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44715189|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44715190|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44715191|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715192|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
44715193|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
44715194|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715195|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715196|NCT01488136|Diazoxide|diazoxide|mesh-list
44715197|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44715198|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
44715199|NCT01488201|Brodalumab|brodalumab|mesh-list
44715200|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44715201|NCT01488227|Vitamin D|vitamin d|mesh-list
44715202|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
44715203|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
44715204|NCT01488227|Vitamins|vitamins|mesh-list
44715205|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
44715206|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715207|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44715208|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44715209|NCT01488253|Sirolimus|sirolimus|mesh-list
44715210|NCT01488253|Tacrolimus|tacrolimus|mesh-list
44715211|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715212|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
44715213|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715214|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44715215|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715216|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715217|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44715218|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715219|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44715220|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715221|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
44715222|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44715224|NCT01488266|Aripiprazole|aripiprazole|mesh-list
44715225|NCT01488266|Mirtazapine|mirtazapine|mesh-list
44715226|NCT01488266|Citalopram|citalopram|mesh-list
44715227|NCT01488266|Bupropion|bupropion|mesh-list
44715228|NCT01488266|Fluoxetine|fluoxetine|mesh-list
44715229|NCT01488266|Paroxetine|paroxetine|mesh-list
44715230|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44715231|NCT01488266|Sertraline|sertraline|mesh-list
44715232|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
44715233|NCT01488266|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44715234|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44715235|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715236|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715237|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715238|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
44715239|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715240|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44715241|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715242|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715243|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44715244|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
44715245|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44715246|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44715247|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715248|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44715249|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44715250|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715251|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
44715252|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44715253|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44715254|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44715255|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44715256|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44715257|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44715258|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44715259|NCT01488266|Analgesics|analgesics|mesh-ancestor
44715260|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
44715261|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44715262|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
44715263|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
44715264|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44715265|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44715266|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44715267|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44715268|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
44715269|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44715270|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715271|NCT01488305|Micronutrients|micronutrients|mesh-list
44715272|NCT01488305|Trace Elements|trace elements|mesh-list
44715273|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715274|NCT01488344|Nintedanib|nintedanib|mesh-list
44715275|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715276|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44715277|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715278|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715279|NCT01488396|Cyclosporine|cyclosporine|mesh-list
44715280|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44715281|NCT01488396|Cyclosporins|cyclosporins|mesh-list
44715282|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715283|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715284|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715285|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
44715286|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715287|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
44715288|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715289|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
44715290|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266972|NCT00660803|Fulvestrant|fulvestrant|mesh-list
44715291|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44715292|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44715293|NCT01488526|Tenofovir|tenofovir|mesh-list
44715294|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
44715295|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715296|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44715297|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44715298|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715299|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715300|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44715301|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44715302|NCT01488552|Metformin|metformin|mesh-list
44715303|NCT01488552|Gemcitabine|gemcitabine|mesh-list
44715304|NCT01488552|Paclitaxel|paclitaxel|mesh-list
44715305|NCT01488552|Folfirinox|folfirinox|mesh-list
44715306|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44715307|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715308|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44715309|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44715310|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44715311|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715312|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715313|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
44715314|NCT01488552|Antiviral Agents|antiviral agents|mesh-ancestor
44715315|NCT01488552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715316|NCT01488552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715317|NCT01488552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715318|NCT01488552|Immunologic Factors|immunologic factors|mesh-ancestor
44715319|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715320|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715321|NCT01488565|Azacitidine|azacitidine|mesh-list
44715322|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715323|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
44715324|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715325|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715326|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715327|NCT01488656|Vitamin D|vitamin d|mesh-list
44715328|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44715329|NCT01488656|Antioxidants|antioxidants|mesh-list
44715330|NCT01488656|Vitamins|vitamins|mesh-ancestor
44715331|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
44715332|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715333|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44715334|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715335|NCT01488656|Protective Agents|protective agents|mesh-ancestor
44715336|NCT01488734|Vitamin D|vitamin d|mesh-list
44715337|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
44715338|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
44715339|NCT01488734|Vitamins|vitamins|mesh-list
44715340|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
44715341|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715342|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44715343|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44715344|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44715345|NCT01488773|Montelukast|montelukast|mesh-list
44715346|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44715347|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
44715348|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715349|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715350|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44715351|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44715352|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44715353|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44715354|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44715355|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44715356|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715357|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715358|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44715359|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44715360|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879762|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715361|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44715362|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44715363|NCT01488838|Cisplatin|cisplatin|mesh-list
44715364|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715365|NCT01488955|Fosfomycin|fosfomycin|mesh-list
44715366|NCT01488955|Ibuprofen|ibuprofen|mesh-list
44715367|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715368|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715369|NCT01488955|Analgesics|analgesics|mesh-ancestor
44715370|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
44715371|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715372|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715373|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715374|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715375|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44715376|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715377|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715378|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44715379|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715380|NCT01489059|Ipilimumab|ipilimumab|mesh-list
44715381|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44715382|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715383|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44715384|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715385|NCT01489072|Remifentanil|remifentanil|mesh-list
44715386|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715387|NCT01489072|Narcotics|narcotics|mesh-ancestor
44715388|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715389|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715390|NCT01489072|Analgesics|analgesics|mesh-ancestor
44715391|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
44715392|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715393|NCT01489124|Imipenem|imipenem|mesh-list
44715394|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44715395|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715396|NCT01489137|Remifentanil|remifentanil|mesh-list
44715397|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715398|NCT01489137|Narcotics|narcotics|mesh-ancestor
44715399|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715400|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715401|NCT01489137|Analgesics|analgesics|mesh-ancestor
44715402|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
44715403|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715404|NCT01489202|Cobalt|cobalt|mesh-list
44715405|NCT01489202|Chromium|chromium|mesh-list
44715406|NCT01489202|Everolimus|everolimus|mesh-list
44715407|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715408|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715409|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
44715410|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715411|NCT01489202|Trace Elements|trace elements|mesh-ancestor
44715412|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
44715413|NCT01489228|Benzonidazole|benzonidazole|mesh-list
44715414|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715415|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
44267138|NCT00661336|Melphalan|melphalan|mesh-list
44715416|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715417|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44715418|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44715419|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44715420|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715421|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44715423|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715424|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715425|NCT01489319|Analgesics|analgesics|mesh-ancestor
44715426|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
44715427|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715428|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715429|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715430|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715431|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44715432|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715433|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715434|NCT01489371|Doxorubicin|doxorubicin|mesh-list
44715435|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44715436|NCT01489371|Interleukin-12|interleukin-12|mesh-list
44715437|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44715438|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715439|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44715440|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44715441|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715442|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715443|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44715444|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
44715445|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715446|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44715447|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44715448|NCT01489371|Growth Substances|growth substances|mesh-ancestor
44715449|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44715451|NCT01489410|Doxorubicin|doxorubicin|mesh-list
44715452|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44715453|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
44715454|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44715455|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715456|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44715457|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44715458|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715459|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715460|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44715461|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715462|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715463|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715464|NCT01489488|Riociguat|riociguat|mesh-list
44715465|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
44715466|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715467|NCT01489566|Fluorouracil|fluorouracil|mesh-list
44715468|NCT01489566|Mitomycins|mitomycins|mesh-list
44715469|NCT01489566|Mitomycin|mitomycin|mesh-list
44715470|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
44715471|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715472|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715473|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715474|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715475|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
44715476|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715477|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44715478|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
44715479|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44715480|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715481|NCT01489592|Turmeric extract|turmeric extract|mesh-list
44715482|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
44715483|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715484|NCT01489592|Protective Agents|protective agents|mesh-ancestor
44715485|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715486|NCT01489631|Sufentanil|sufentanil|mesh-list
44715487|NCT01489631|Gabapentin|gabapentin|mesh-list
44715488|NCT01489631|Bupivacaine|bupivacaine|mesh-list
44715489|NCT01489631|Ropivacaine|ropivacaine|mesh-list
44715490|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
44715491|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
44715492|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879894|NCT04664010|Ribavirin|ribavirin|mesh-list
44715493|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715494|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
44715495|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715497|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
44715498|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44715499|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44715500|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715501|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44715502|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44715503|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715504|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715505|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
44715506|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715507|NCT01489631|Narcotics|narcotics|mesh-ancestor
44715508|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44715509|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44715510|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
44715511|NCT01489644|Metformin|metformin|mesh-list
44715512|NCT01489644|Repaglinide|repaglinide|mesh-list
44715513|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715514|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715515|NCT01489683|Lidocaine|lidocaine|mesh-list
44715516|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
44715517|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
44715518|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715519|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715520|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
44715521|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715522|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44715523|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44715524|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44715525|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715526|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715527|NCT01489696|Tamsulosin|tamsulosin|mesh-list
44715528|NCT01489696|Mirabegron|mirabegron|mesh-list
44715529|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44715530|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44715531|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44715532|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
44715533|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715534|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715535|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715536|NCT01489696|Urological Agents|urological agents|mesh-ancestor
44715537|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44715538|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44715539|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44715540|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
44715541|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44715542|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44715543|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715544|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715545|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715546|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715547|NCT01489709|Urological Agents|urological agents|mesh-ancestor
44715548|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44715549|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44715550|NCT01489852|Estradiol|estradiol|mesh-list
44715551|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44715552|NCT01489852|Estrogens|estrogens|mesh-ancestor
44715553|NCT01489852|Hormones|hormones|mesh-ancestor
44715554|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715555|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715556|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44715557|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
44715558|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44715559|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44715560|NCT01489865|Fluorouracil|fluorouracil|mesh-list
44715561|NCT01489865|Veliparib|veliparib|mesh-list
44715562|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
44715563|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715564|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715565|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715566|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44267258|NCT00662233|Ifosfamide|ifosfamide|mesh-list
44715567|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
44715568|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715569|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44715570|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715571|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
44715572|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44715573|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44715574|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44715575|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715576|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715577|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715578|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715579|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715580|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44715581|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715582|NCT01489917|Heparin|heparin|mesh-list
44715583|NCT01489917|Hemostatics|hemostatics|mesh-list
44715584|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
44715585|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44715586|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44715587|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715588|NCT01489917|Coagulants|coagulants|mesh-ancestor
44715589|NCT01489943|Pioglitazone|pioglitazone|mesh-list
44715590|NCT01489943|Midazolam|midazolam|mesh-list
44715591|NCT01489943|Omeprazole|omeprazole|mesh-list
44715592|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44715593|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44715594|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44715595|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715596|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715597|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44715598|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44715599|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715600|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44715601|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
44715602|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
44715603|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
44715604|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
44715605|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715606|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715607|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44715608|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44715609|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
44715610|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44715611|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44715612|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715613|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715614|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44715615|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44715616|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44715617|NCT01489982|Zopiclone|zopiclone|mesh-list
44715618|NCT01489982|Doxepin|doxepin|mesh-list
44715619|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44715620|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715621|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715622|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44715623|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44715624|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
44715625|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715626|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
44715627|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
44715628|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715629|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715630|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
44715631|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
44715632|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715633|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715634|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715635|NCT01490047|Etanercept|etanercept|mesh-list
44715636|NCT01490047|Doxorubicin|doxorubicin|mesh-list
44715637|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44715638|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44715639|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715640|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44715641|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44715642|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715643|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715644|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715645|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715646|NCT01490047|Analgesics|analgesics|mesh-ancestor
44715647|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
44715648|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715649|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715650|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715651|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715652|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44715653|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715654|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
44715655|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
44715656|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715657|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715658|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
44715659|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715660|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715661|NCT01490203|Edetic Acid|edetic acid|mesh-list
44715662|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
44715663|NCT01490203|Antidotes|antidotes|mesh-ancestor
44715664|NCT01490203|Protective Agents|protective agents|mesh-ancestor
44715665|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715666|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
44715667|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
44715668|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715669|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44715670|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
44715671|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44715672|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44715673|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44715674|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715675|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44715676|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44715677|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715678|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715679|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
44715680|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715682|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44715683|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44715684|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
44715685|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715686|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44715687|NCT01490255|Amlodipine|amlodipine|mesh-list
44715688|NCT01490255|Ranolazine|ranolazine|mesh-list
44715689|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44715690|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44715691|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715692|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715693|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44715694|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715695|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
44715696|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44715697|NCT01490268|Sufentanil|sufentanil|mesh-list
44715698|NCT01490268|Dsuvia|dsuvia|mesh-list
44715699|NCT01490268|Hydromorphone|hydromorphone|mesh-list
44715700|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715701|NCT01490268|Narcotics|narcotics|mesh-ancestor
44715702|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715703|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715704|NCT01490268|Analgesics|analgesics|mesh-ancestor
44715705|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
44715706|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715707|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44715708|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44715709|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
44715710|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
44715711|NCT01490333|Vitamin D|vitamin d|mesh-list
44715712|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
44715713|NCT01490333|Vitamins|vitamins|mesh-ancestor
44715714|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
44715715|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715716|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44715717|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44715718|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44715719|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
44715720|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715721|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44715722|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44715723|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44715724|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
44715725|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715726|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44127130|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715727|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44715729|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
44715730|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715731|NCT01490437|Dexamethasone|dexamethasone|mesh-list
44715733|NCT01490437|Pemetrexed|pemetrexed|mesh-list
44715734|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715735|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715736|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
44715737|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
44715738|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715739|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44715740|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
44715741|NCT01490437|Hormones|hormones|mesh-ancestor
44715742|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715743|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44715744|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715745|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715746|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715747|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44715748|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44715749|NCT01490476|Everolimus|everolimus|mesh-list
44715750|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715751|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715752|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
44715753|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715754|NCT01490567|Donepezil|donepezil|mesh-list
44715755|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44715756|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715757|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715758|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715759|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715760|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715761|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
44715762|NCT01490658|Metformin|metformin|mesh-list
44715763|NCT01490658|Repaglinide|repaglinide|mesh-list
44715764|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715765|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715766|NCT01490671|Tenofovir|tenofovir|mesh-list
44715767|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
44715768|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715769|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44715770|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44715771|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715772|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715773|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44715774|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44715775|NCT01490749|Carboplatin|carboplatin|mesh-list
44715776|NCT01490749|Capecitabine|capecitabine|mesh-list
44715777|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
44715778|NCT01490749|Everolimus|everolimus|mesh-list
44715779|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715780|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715781|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
44715782|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715783|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44715784|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
44715785|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715786|NCT01490762|Insulin|insulin|mesh-list
44715787|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715788|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715789|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715790|NCT01490905|Ibuprofen|ibuprofen|mesh-list
44715791|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715792|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715793|NCT01490905|Analgesics|analgesics|mesh-ancestor
44715794|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
44715795|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715796|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715797|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715798|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715799|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44715800|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715801|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715802|NCT01490944|Iron|iron|mesh-list
44715803|NCT01490944|Folic Acid|folic acid|mesh-list
44715804|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
44715805|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
44715806|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
44715807|NCT01490944|Trace Elements|trace elements|mesh-ancestor
44715808|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
44715809|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715810|NCT01490944|Hematinics|hematinics|mesh-ancestor
44715811|NCT01490944|Vitamins|vitamins|mesh-ancestor
44715812|NCT01490996|Curcumin|curcumin|mesh-list
44715813|NCT01490996|Capecitabine|capecitabine|mesh-list
44715814|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44715815|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
44715816|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715817|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715818|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715819|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715820|NCT01490996|Analgesics|analgesics|mesh-ancestor
44715821|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
44715822|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715823|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715824|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715825|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715826|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715827|NCT01491009|Midazolam|midazolam|mesh-list
44715828|NCT01491009|Remifentanil|remifentanil|mesh-list
44715829|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44715830|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44715831|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715832|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715833|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44715834|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44715835|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44715836|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44715837|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
44715838|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
44715839|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
44715840|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
44715841|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715842|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715843|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44715844|NCT01491009|Narcotics|narcotics|mesh-ancestor
44715845|NCT01491009|Analgesics|analgesics|mesh-ancestor
44715846|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
44715847|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715848|NCT01491048|Tacrine|tacrine|mesh-list
44715849|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44715850|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715851|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715852|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
44715853|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715854|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715855|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44715856|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
44715857|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715858|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
44715859|NCT01491061|Ranolazine|ranolazine|mesh-list
44715860|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44715861|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715862|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715863|NCT01491100|Interferons|interferons|mesh-list
44715864|NCT01491100|Interferon-beta|interferon-beta|mesh-list
44715865|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
44715866|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715867|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
44715868|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715869|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
44715870|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715871|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44715872|NCT01491139|Cisplatin|cisplatin|mesh-list
44715873|NCT01491139|Olaparib|olaparib|mesh-list
44715874|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715875|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44715876|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715877|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715878|NCT01491191|Palmidrol|palmidrol|mesh-list
44715879|NCT01491191|Analgesics|analgesics|mesh-ancestor
44715880|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
44715882|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715883|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715884|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715885|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715886|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715887|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
44715888|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715889|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44715890|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44715891|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715892|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715894|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715895|NCT01491204|Paclitaxel|paclitaxel|mesh-list
44715896|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44715897|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715898|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44715899|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44715900|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44715901|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715902|NCT01491217|Paclitaxel|paclitaxel|mesh-list
44715903|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44715904|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44715905|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44715906|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44715907|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44715908|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715909|NCT01491256|Atorvastatin|atorvastatin|mesh-list
44715910|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44715911|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44715912|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
44715913|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715914|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44715915|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44715916|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715917|NCT01491295|Tenofovir|tenofovir|mesh-list
44715918|NCT01491295|Lamivudine|lamivudine|mesh-list
44715919|NCT01491295|Adefovir|adefovir|mesh-list
44715920|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
44715921|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715922|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44715923|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44715924|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715925|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715926|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44715927|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44715928|NCT01491321|Loxoprofen|loxoprofen|mesh-list
44715929|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44715930|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44715931|NCT01491321|Analgesics|analgesics|mesh-ancestor
44715932|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
44715933|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715934|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715935|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44715936|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44715937|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44715938|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44715939|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44715940|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
44715941|NCT01491503|Cetirizine|cetirizine|mesh-list
44715942|NCT01491503|Montelukast|montelukast|mesh-list
44715943|NCT01491503|Levocetirizine|levocetirizine|mesh-list
44715944|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44715945|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
44715946|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44715947|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
44715948|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44715949|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715950|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44715951|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44715952|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127328|NCT00141154|Celecoxib|celecoxib|mesh-list
44715953|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44715955|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
44715956|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
44715957|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44715958|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44715959|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44715960|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44715961|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44715962|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
44715964|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44715965|NCT01492062|Pancrelipase|pancrelipase|mesh-list
44715966|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44715967|NCT01492114|Resveratrol|resveratrol|mesh-list
44715968|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
44715969|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715970|NCT01492114|Protective Agents|protective agents|mesh-ancestor
44715971|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715972|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44715973|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44715974|NCT01492153|Insulin|insulin|mesh-list
44715975|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715976|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
44715977|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
44715978|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
44715979|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715980|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715981|NCT01492166|Insulin|insulin|mesh-list
44715982|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715983|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44715984|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715985|NCT01492179|Lidocaine|lidocaine|mesh-list
44715986|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44715987|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
44715988|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44715989|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44715990|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
44715991|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44715992|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44715993|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44715994|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44715995|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44715996|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44715997|NCT01492205|Insulin|insulin|mesh-list
44715998|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44715999|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716000|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716001|NCT01492218|Insulin|insulin|mesh-list
44716002|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716003|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716004|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716005|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44716006|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716007|NCT01492504|Asunaprevir|asunaprevir|mesh-list
44716008|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
44716009|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716010|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716011|NCT01492543|Tegafur|tegafur|mesh-list
44716012|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44716013|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
44716014|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716015|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716016|NCT01492556|Etoposide|etoposide|mesh-list
44716017|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716018|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716019|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44716020|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44716021|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716022|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716023|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
44716024|NCT01492608|Analgesics|analgesics|mesh-ancestor
44716025|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
44716026|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716027|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716028|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
44716029|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716030|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44716031|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
44716032|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44716033|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716034|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716035|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716036|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
44716037|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44716038|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44716039|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44716040|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44716041|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716042|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716043|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716044|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716045|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
44716046|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716047|NCT01492712|Propofol|propofol|mesh-list
44716048|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44716049|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716050|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716051|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44716052|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
44716053|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
44716054|NCT01492725|Plasminogen|plasminogen|mesh-list
44716055|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44716056|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44716057|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44716058|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716059|NCT01492881|Doxorubicin|doxorubicin|mesh-list
44716060|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44716061|NCT01492881|Bortezomib|bortezomib|mesh-list
44716062|NCT01492881|Vorinostat|vorinostat|mesh-list
44716063|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44716064|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716065|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44716066|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44716067|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716068|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716069|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44716070|NCT01492894|Cyclosporine|cyclosporine|mesh-list
44716071|NCT01492894|Sirolimus|sirolimus|mesh-list
44716072|NCT01492894|Tacrolimus|tacrolimus|mesh-list
44716073|NCT01492894|Cyclosporins|cyclosporins|mesh-list
44716074|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716075|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
44716076|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267754|NCT00664677|Masoprocol|masoprocol|mesh-list
44716077|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44716078|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716079|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716080|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
44716081|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716082|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716083|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716084|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44716085|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44716086|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716087|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
44716088|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
44716089|NCT01492920|Vitamins|vitamins|mesh-ancestor
44716090|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
44716091|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716092|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
44716093|NCT01492959|Insulin|insulin|mesh-list
44716094|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716095|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716096|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716097|NCT01492972|Leuprolide|leuprolide|mesh-list
44716098|NCT01492972|Goserelin|goserelin|mesh-list
44716099|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44716100|NCT01492972|Buserelin|buserelin|mesh-list
44716101|NCT01492972|Androgens|androgens|mesh-list
44716102|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44716103|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
43617881|NCT03135795|Narcotics|narcotics|mesh-ancestor
44716104|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44716105|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716106|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44716107|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716109|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716110|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
44716111|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44716112|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
44716113|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44716114|NCT01492985|Vaccines|vaccines|mesh-list
44716115|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
44716116|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716117|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
44716118|NCT01493050|Calcium|calcium|mesh-list
44716119|NCT01493050|Sevelamer|sevelamer|mesh-list
44716120|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716121|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716122|NCT01493050|Antacids|antacids|mesh-ancestor
44716123|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716124|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44716125|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
44716126|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
44716127|NCT01493102|Vasopressins|vasopressins|mesh-list
44716128|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
44716129|NCT01493102|Norepinephrine|norepinephrine|mesh-list
44716130|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44716131|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44716132|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
44716133|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716134|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716135|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716136|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
44716137|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
44716138|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716139|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44716140|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
44716141|NCT01493102|Coagulants|coagulants|mesh-ancestor
44716142|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44716143|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
44716144|NCT01493115|Insulin|insulin|mesh-list
44716145|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716146|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
44716147|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716148|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716149|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
44716150|NCT01493154|Vaccines|vaccines|mesh-list
44716151|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
44716152|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716153|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716154|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716155|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44716156|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
44716157|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716158|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716159|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44716160|NCT01493310|Paclitaxel|paclitaxel|mesh-list
44716161|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44716162|NCT01493310|Mifepristone|mifepristone|mesh-list
44716163|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716164|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716165|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716166|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716167|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716168|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716169|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44716170|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
44716171|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44716172|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716173|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44716174|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44716175|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44716176|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
44716177|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44716178|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44716179|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
44716180|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716181|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
44716182|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44716183|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44716184|NCT01493336|Capecitabine|capecitabine|mesh-list
44716185|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44716186|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
44716187|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716188|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716189|NCT01493388|Insulin|insulin|mesh-list
44716190|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716191|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716192|NCT01493440|Atosiban|atosiban|mesh-list
44716193|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
44716194|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716195|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716196|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
44716197|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44716198|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
44716199|NCT01493453|Fludarabine|fludarabine|mesh-list
44716200|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716201|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
43880506|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44716202|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716203|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716204|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44716205|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
44716206|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716207|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716208|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44716209|NCT01493479|Rituximab|rituximab|mesh-list
44716210|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44716211|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716212|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
44716213|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716214|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716215|NCT01493570|BI 409306|bi 409306|mesh-list
44716216|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44716217|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716218|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716219|NCT01493622|Minocycline|minocycline|mesh-list
44716220|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44716221|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716222|NCT01493635|Analgesics|analgesics|mesh-list
44716223|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
44716224|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716225|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716226|NCT01493648|Vitamin D|vitamin d|mesh-list
44716227|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
44716228|NCT01493648|Vitamins|vitamins|mesh-ancestor
44716229|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
44716230|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716231|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44716232|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716233|NCT01493674|Folic Acid|folic acid|mesh-list
44716234|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
44716235|NCT01493674|Hematinics|hematinics|mesh-ancestor
44716236|NCT01493674|Vitamins|vitamins|mesh-ancestor
44716237|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
44716238|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716239|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
44716240|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44716241|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
44716242|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44716243|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716244|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44716245|NCT01493843|Paclitaxel|paclitaxel|mesh-list
44716246|NCT01493843|Bevacizumab|bevacizumab|mesh-list
44716247|NCT01493843|Carboplatin|carboplatin|mesh-list
44716248|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716249|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716250|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716251|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716252|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716253|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617882|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
44716254|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44716255|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716256|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716257|NCT01493843|Growth Substances|growth substances|mesh-ancestor
44716258|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716259|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716260|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44716261|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44716262|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44716263|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44716264|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716266|NCT01493973|Hematinics|hematinics|mesh-ancestor
44716267|NCT01493986|Ropivacaine|ropivacaine|mesh-list
44716268|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716269|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
44716270|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716271|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716272|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
44716273|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716274|NCT01493999|Clopidogrel|clopidogrel|mesh-list
44716275|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44716276|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44716277|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44716278|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44716279|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44716280|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
44716281|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716282|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716283|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716284|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44716285|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44716286|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716287|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44716288|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44716289|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44716290|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
44716291|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716292|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44716293|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44716294|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716295|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
44716296|NCT01494155|Capecitabine|capecitabine|mesh-list
44716297|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44716298|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
44716299|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716300|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716301|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
44716302|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44716303|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44716304|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716305|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716306|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716307|NCT01494259|Epinephrine|epinephrine|mesh-list
44716308|NCT01494259|Bupivacaine|bupivacaine|mesh-list
44716309|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716310|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
44716311|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716312|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716313|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
44716314|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716315|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44716316|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44716317|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
44716318|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716319|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716320|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44716321|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44716322|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
44716323|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44716324|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
44716325|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
44716326|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
44716327|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44716328|NCT01494311|Lidocaine|lidocaine|mesh-list
44716329|NCT01494311|Tetracaine|tetracaine|mesh-list
44716330|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716331|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
44716332|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716333|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716334|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
44716335|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716336|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44716337|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44716338|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44268056|NCT00665977|Hormones|hormones|mesh-ancestor
44716339|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716340|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716341|NCT01494363|Leucovorin|leucovorin|mesh-list
44716342|NCT01494363|Fluorouracil|fluorouracil|mesh-list
44716343|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
44716344|NCT01494363|Irinotecan|irinotecan|mesh-list
44716345|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
44716346|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716347|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44716348|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716349|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716350|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
44716351|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716352|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44716353|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44716354|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716355|NCT01494363|Antidotes|antidotes|mesh-ancestor
44716356|NCT01494363|Protective Agents|protective agents|mesh-ancestor
44716357|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
44716358|NCT01494363|Vitamins|vitamins|mesh-ancestor
44716359|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
44716360|NCT01494402|Aspirin|aspirin|mesh-list
44716361|NCT01494402|Esomeprazole|esomeprazole|mesh-list
44716362|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44716363|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44716364|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44716365|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716366|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716367|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44716368|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44716369|NCT01494402|Analgesics|analgesics|mesh-ancestor
44716370|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
44716371|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716372|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716373|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716374|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716375|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44716376|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44716377|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44716378|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44716379|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
44716380|NCT01494415|Paclitaxel|paclitaxel|mesh-list
44716381|NCT01494415|Carboplatin|carboplatin|mesh-list
44716382|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716383|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716384|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716385|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716386|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716387|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716388|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
44716389|NCT01494441|Calcium|calcium|mesh-list
44716390|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716391|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716392|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44716393|NCT01494597|Cyclosporine|cyclosporine|mesh-list
44716394|NCT01494597|Isavuconazole|isavuconazole|mesh-list
44716395|NCT01494597|Cyclosporins|cyclosporins|mesh-list
44716396|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716397|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716398|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716399|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
44716400|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716401|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
43620382|NCT04631029|Etoposide|etoposide|mesh-list
44716403|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716404|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716405|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44716406|NCT01494636|Lidocaine|lidocaine|mesh-list
44716407|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44716408|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716409|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
44716410|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268135|NCT00666068|Hormones|hormones|mesh-list
44716411|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716412|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
44716413|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716414|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44716415|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44716416|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44716417|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716418|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716419|NCT01494688|Paclitaxel|paclitaxel|mesh-list
43880710|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716420|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716421|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716422|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716423|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716424|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716425|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716426|NCT01494714|Petrolatum|petrolatum|mesh-list
44716427|NCT01494714|Emollients|emollients|mesh-ancestor
44716428|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716429|NCT01494727|Amlodipine|amlodipine|mesh-list
44716430|NCT01494727|Valsartan|valsartan|mesh-list
44716431|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44716432|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44716433|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44716434|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716435|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716436|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716437|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716438|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
44716439|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44716440|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44716441|NCT01494740|Vaccines|vaccines|mesh-list
44716442|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
44716443|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716444|NCT01494805|Ranibizumab|ranibizumab|mesh-list
44716445|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716446|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716447|NCT01494805|Growth Substances|growth substances|mesh-ancestor
44716448|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716449|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716450|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716451|NCT01494857|Adalimumab|adalimumab|mesh-list
44716452|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716453|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716454|NCT01495026|Tamsulosin|tamsulosin|mesh-list
44716455|NCT01495026|Dutasteride|dutasteride|mesh-list
44716456|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44716457|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44716458|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44716459|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
44716460|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716461|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716462|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716463|NCT01495026|Urological Agents|urological agents|mesh-ancestor
44716464|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44716465|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44716466|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716467|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44716468|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716469|NCT01495039|Nystatin|nystatin|mesh-list
44716470|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44716471|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716472|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
44716473|NCT01495039|Ionophores|ionophores|mesh-ancestor
43620383|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
44716474|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716475|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716477|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
44716478|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716479|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716480|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
44716481|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716482|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716483|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
44716484|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44716485|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716486|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716488|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
44716489|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44716490|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
44716491|NCT01495117|Povidone|povidone|mesh-list
44716492|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44716493|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44716494|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716495|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
44716496|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716497|NCT01495117|Trace Elements|trace elements|mesh-ancestor
44716498|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
44716499|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716500|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
44716501|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
44716502|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
44716503|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716504|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44716505|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716506|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716507|NCT01495169|Iloperidone|iloperidone|mesh-list
44716508|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44716509|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44716510|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716511|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716512|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716513|NCT01495195|Selegiline|selegiline|mesh-list
44716514|NCT01495195|Donepezil|donepezil|mesh-list
44716515|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44716516|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716517|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716518|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
44716519|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716520|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716521|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
44716522|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
44716523|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716524|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44716525|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44716526|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44716527|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44716528|NCT01495195|Protective Agents|protective agents|mesh-ancestor
44716529|NCT01495208|Aflibercept|aflibercept|mesh-list
44716530|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716531|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716532|NCT01495208|Growth Substances|growth substances|mesh-ancestor
44716533|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716534|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716535|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716536|NCT01495260|Vitamin E|vitamin e|mesh-list
44716537|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
44716538|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
44716539|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44716540|NCT01495260|Vitamins|vitamins|mesh-ancestor
44716541|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
44716542|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716543|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
44716544|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716545|NCT01495260|Expectorants|expectorants|mesh-ancestor
44716546|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
44716547|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44716548|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
44716549|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716550|NCT01495260|Protective Agents|protective agents|mesh-ancestor
44716551|NCT01495260|Antidotes|antidotes|mesh-ancestor
44716552|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
44716553|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44716555|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44716556|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44716557|NCT01495338|Analgesics|analgesics|mesh-ancestor
44716558|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
44716559|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716560|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716561|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716562|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716563|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44268207|NCT00666393|Fentanyl|fentanyl|mesh-list
44716564|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44716565|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44716566|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
44716567|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
44716568|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716569|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716570|NCT01495351|Bortezomib|bortezomib|mesh-list
44716571|NCT01495351|Veliparib|veliparib|mesh-list
44716572|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716573|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44716574|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716575|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716576|NCT01495377|Remifentanil|remifentanil|mesh-list
44716577|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44716578|NCT01495377|Narcotics|narcotics|mesh-ancestor
44716579|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716580|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716581|NCT01495377|Analgesics|analgesics|mesh-ancestor
44716582|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
44716583|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716584|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
44716585|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
44716586|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44716587|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44716588|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716589|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716590|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716591|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716592|NCT01495468|Hormones|hormones|mesh-list
44716593|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716594|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716595|NCT01495520|Ranolazine|ranolazine|mesh-list
44716596|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44716597|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716598|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268285|NCT00666692|Paclitaxel|paclitaxel|mesh-list
44716599|NCT01495624|Dexamethasone|dexamethasone|mesh-list
44716600|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
44716601|NCT01495624|Ropivacaine|ropivacaine|mesh-list
44716602|NCT01495624|Anesthetics|anesthetics|mesh-list
44716603|NCT01495624|BB 1101|bb 1101|mesh-list
44716604|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716605|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
44716606|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
44716607|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716608|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716609|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44716610|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
44716611|NCT01495624|Hormones|hormones|mesh-ancestor
44716612|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716613|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44716614|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716615|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44716616|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716617|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716618|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716619|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716620|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
44716621|NCT01495715|Idebenone|idebenone|mesh-list
44716622|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
44716623|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716624|NCT01495715|Protective Agents|protective agents|mesh-ancestor
44716625|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716626|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44716628|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44716629|NCT01495845|Clopidogrel|clopidogrel|mesh-list
44716630|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44716631|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44716632|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44716633|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44716634|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
44716635|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880879|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716636|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716637|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716638|NCT01495884|Lapatinib|lapatinib|mesh-list
44716639|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716640|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44716641|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716642|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716643|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
44716644|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716645|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44716646|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716647|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716648|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
44716649|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716650|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716651|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44716652|NCT01495949|Thiopental|thiopental|mesh-list
44716653|NCT01495949|Etomidate|etomidate|mesh-list
44716654|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44716655|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716656|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716657|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44716658|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
44716659|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
44716660|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
44716661|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
44716662|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
44716663|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716664|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716665|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
44716666|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44716667|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44716668|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44716669|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716670|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716671|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
44268358|NCT00666939|Gabapentin|gabapentin|mesh-list
44716672|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716673|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716674|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44716675|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716676|NCT01496105|Lidocaine|lidocaine|mesh-list
44716677|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
44716678|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
44716679|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716680|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716681|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
44716682|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716683|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44716684|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44716685|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44716686|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716687|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716688|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
44716689|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44716690|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44716691|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716692|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
44716693|NCT01496196|Coagulants|coagulants|mesh-ancestor
44716694|NCT01496261|Aspirin|aspirin|mesh-list
44716695|NCT01496261|Clopidogrel|clopidogrel|mesh-list
44128048|NCT00143104|Insulin|insulin|mesh-list
44716696|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44716697|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44716698|NCT01496261|Analgesics|analgesics|mesh-ancestor
44716699|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
44716700|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716701|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716702|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716703|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716704|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44716705|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44716706|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716707|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44716708|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44716709|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716710|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
44716711|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44716712|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44716713|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44716714|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
44716715|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716716|NCT01496326|Ibuprofen|ibuprofen|mesh-list
44716717|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44716718|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44716719|NCT01496326|Analgesics|analgesics|mesh-ancestor
44716720|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
44716721|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716722|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716723|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716724|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716725|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44716726|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716727|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716728|NCT01496417|Abatacept|abatacept|mesh-list
44716729|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44716730|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716731|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716732|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716733|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
44716734|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716735|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716736|NCT01496443|Glimepiride|glimepiride|mesh-list
44716737|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44716738|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716739|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716740|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716741|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
44716742|NCT01496521|Aspirin|aspirin|mesh-list
44716743|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44716744|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44716745|NCT01496521|Analgesics|analgesics|mesh-ancestor
44716746|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
44716747|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716748|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716749|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716750|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716751|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44716752|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44716753|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716754|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44716755|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44716756|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716757|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
44716758|NCT01496534|Cisplatin|cisplatin|mesh-list
44716759|NCT01496534|Carboplatin|carboplatin|mesh-list
44716760|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716761|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
44716762|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44716763|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716764|NCT01496690|Pregabalin|pregabalin|mesh-list
44716765|NCT01496690|Analgesics|analgesics|mesh-ancestor
44716766|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
44716767|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716768|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716769|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
44716770|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44716771|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716772|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716773|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716774|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44716775|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44716776|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716777|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44716778|NCT01496742|Paclitaxel|paclitaxel|mesh-list
44716779|NCT01496742|Bevacizumab|bevacizumab|mesh-list
44716780|NCT01496742|Cisplatin|cisplatin|mesh-list
44716781|NCT01496742|Carboplatin|carboplatin|mesh-list
44716782|NCT01496742|Pemetrexed|pemetrexed|mesh-list
44716783|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716784|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716785|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716786|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716787|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716788|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716789|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44716790|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716791|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716792|NCT01496742|Growth Substances|growth substances|mesh-ancestor
44716793|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716794|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716795|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716796|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44716797|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44716798|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
44716799|NCT01496911|Levocetirizine|levocetirizine|mesh-list
44716800|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44716801|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44716802|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
44716803|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
44716804|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716805|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716806|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716807|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
44716808|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716809|NCT01496989|Interleukin-12|interleukin-12|mesh-list
44716810|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44716811|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
44716812|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716813|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716814|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716815|NCT01496989|Growth Substances|growth substances|mesh-ancestor
44716816|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716817|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716818|NCT01497002|Cytarabine|cytarabine|mesh-list
44716819|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44716820|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
44716821|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716822|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716823|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
44716824|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716825|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716826|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
44716827|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716828|NCT01497041|Docetaxel|docetaxel|mesh-list
44716829|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
44716830|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716831|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716832|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716833|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716834|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716835|NCT01497093|Thalidomide|thalidomide|mesh-list
44716836|NCT01497093|Dexamethasone|dexamethasone|mesh-list
44716837|NCT01497093|Bortezomib|bortezomib|mesh-list
44716838|NCT01497093|Pomalidomide|pomalidomide|mesh-list
44716839|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716840|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
44716841|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
44716842|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716843|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716844|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44716845|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
44716847|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44716848|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44716849|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716850|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
44716851|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44716852|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44716853|NCT01497093|Growth Substances|growth substances|mesh-ancestor
44716854|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44716855|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716856|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
44716857|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44716858|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716859|NCT01497132|Vitamin D|vitamin d|mesh-list
44716860|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
44716861|NCT01497132|Vitamins|vitamins|mesh-ancestor
44716862|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
44716863|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716864|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44716865|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44716866|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
44716867|NCT01497145|Hematinics|hematinics|mesh-ancestor
44716868|NCT01497288|Fentanyl|fentanyl|mesh-list
44716869|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44716870|NCT01497288|Narcotics|narcotics|mesh-ancestor
44716871|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44716872|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716873|NCT01497288|Analgesics|analgesics|mesh-ancestor
44716874|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
44716875|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44716876|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44716877|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44716878|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
44716879|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
44716880|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
44716881|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
44716882|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716883|NCT01497431|Selenium|selenium|mesh-list
44716884|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
44716885|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
44716886|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716887|NCT01497431|Protective Agents|protective agents|mesh-ancestor
44716888|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716889|NCT01497431|Trace Elements|trace elements|mesh-ancestor
44716890|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
44716891|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44716892|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716893|NCT01497444|Sorafenib|sorafenib|mesh-list
44716894|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716895|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44716896|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716897|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716899|NCT01497470|Carboplatin|carboplatin|mesh-list
44716900|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44716901|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716902|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44716903|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44716904|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44716905|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716906|NCT01497483|Cyclosporine|cyclosporine|mesh-list
44716907|NCT01497483|Pravastatin|pravastatin|mesh-list
44716908|NCT01497483|Cyclosporins|cyclosporins|mesh-list
44716909|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716910|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716911|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44716912|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
44716913|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716914|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
44716915|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44716916|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
44716917|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716918|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44716919|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44716920|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44716921|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
44716922|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44716923|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44716924|NCT01497522|Vildagliptin|vildagliptin|mesh-list
44716925|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716926|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716927|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44716928|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
44716929|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716930|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716931|NCT01497535|Insulin|insulin|mesh-list
44716932|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716933|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
44716934|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
44716935|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716936|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716937|NCT01497548|Methylphenidate|methylphenidate|mesh-list
44716938|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44716939|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716940|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44716941|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44716942|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44716943|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716944|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
44716945|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44716946|NCT01497561|Insulin|insulin|mesh-list
44716947|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716948|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
44716949|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
44716950|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
44716951|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
44716952|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716953|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716954|NCT01497574|Insulin|insulin|mesh-list
44716955|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716956|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
44716957|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
44716958|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716959|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716960|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
44716961|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716962|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716963|NCT01497600|Insulin|insulin|mesh-list
44716964|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44716965|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
44716966|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
44716967|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
44716968|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
44716969|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44716970|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716971|NCT01497626|Bortezomib|bortezomib|mesh-list
44716972|NCT01497626|Lapatinib|lapatinib|mesh-list
44716973|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716974|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44716975|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716976|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716977|NCT01497652|Rasagiline|rasagiline|mesh-list
43881186|NCT04645745|Folic Acid|folic acid|mesh-list
44716978|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44716979|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716980|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716981|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44716982|NCT01497652|Protective Agents|protective agents|mesh-ancestor
44716983|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44716984|NCT01497717|Adalimumab|adalimumab|mesh-list
44716985|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44716986|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44716987|NCT01497873|Topotecan|topotecan|mesh-list
44716988|NCT01497873|Belotecan|belotecan|mesh-list
44716989|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44716990|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44716991|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44716992|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716993|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44716994|NCT01497912|Atorvastatin|atorvastatin|mesh-list
44716995|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44716996|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44716997|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
44716998|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44716999|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717000|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717001|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717002|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
44717003|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44717004|NCT01497977|Estrogens|estrogens|mesh-ancestor
44717005|NCT01497977|Hormones|hormones|mesh-ancestor
44717006|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717007|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717008|NCT01497990|Ertapenem|ertapenem|mesh-list
44717009|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717010|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717011|NCT01498003|Tirofiban|tirofiban|mesh-list
44717012|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44717013|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44717014|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717015|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44717016|NCT01498016|Busulfan|busulfan|mesh-list
44717017|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
44717018|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717019|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717020|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
44717021|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717022|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44717023|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717024|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44717025|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
44717026|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44717027|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
44717028|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717029|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717030|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44717031|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44717032|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
44717033|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44717034|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44717035|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717036|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717037|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
44717038|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44717039|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717040|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717041|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717042|NCT01498380|Analgesics|analgesics|mesh-ancestor
44717043|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
44717044|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717045|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44717046|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44717047|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44717048|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
44717049|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717050|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717051|NCT01498406|Vitamin D|vitamin d|mesh-list
44717052|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
44717053|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
44717054|NCT01498406|Vitamins|vitamins|mesh-list
44717055|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
44717056|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717057|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44717058|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44717059|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44717060|NCT01498562|Gefitinib|gefitinib|mesh-list
44717061|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
44717062|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717063|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717064|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717065|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717066|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44717067|NCT01498718|Vaccines|vaccines|mesh-list
44717068|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
44717069|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717070|NCT01498783|Fluorouracil|fluorouracil|mesh-list
44717072|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717073|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717074|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717075|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717076|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
44717077|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717078|NCT01498796|Ketorolac|ketorolac|mesh-list
44717079|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44717080|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717081|NCT01498796|Analgesics|analgesics|mesh-ancestor
44717082|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
44717083|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717084|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717085|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717086|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717087|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44717088|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717089|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717090|NCT01498809|Midodrine|midodrine|mesh-list
44717091|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
44717092|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
44717093|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717094|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717095|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44717096|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44717097|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44717098|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44717099|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
44717100|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717101|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717102|NCT01498835|Sunitinib|sunitinib|mesh-list
44717103|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717104|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44717105|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717106|NCT01498835|Growth Substances|growth substances|mesh-ancestor
44717107|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717108|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
44717109|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717110|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717111|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717112|NCT01498861|Dolutegravir|dolutegravir|mesh-list
44717113|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
44717114|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44717115|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44717116|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44717117|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717118|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717119|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44717120|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44717121|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
44717122|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717123|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717124|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44717125|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717126|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717127|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717129|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717130|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717131|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44717132|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717133|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717134|NCT01498900|Repaglinide|repaglinide|mesh-list
44717135|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717136|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717137|NCT01498913|Repaglinide|repaglinide|mesh-list
44717138|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717139|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717140|NCT01498926|Insulin|insulin|mesh-list
44717141|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44717142|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
44717143|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717144|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717145|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
44717146|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717147|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717148|NCT01499004|Tofacitinib|tofacitinib|mesh-list
44717149|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717150|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717151|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717152|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
44717153|NCT01499069|Fesoterodine|fesoterodine|mesh-list
44717154|NCT01499069|Propiverine|propiverine|mesh-list
44717155|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44717156|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44717157|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44717158|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717159|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717160|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717161|NCT01499069|Urological Agents|urological agents|mesh-ancestor
44717162|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
44717163|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
44717164|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717165|NCT01499108|Liraglutide|liraglutide|mesh-list
44717166|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717167|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717168|NCT01499108|Incretins|incretins|mesh-ancestor
44717169|NCT01499108|Hormones|hormones|mesh-ancestor
44717170|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717171|NCT01499121|Sunitinib|sunitinib|mesh-list
44717172|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717173|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44717174|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717175|NCT01499121|Growth Substances|growth substances|mesh-ancestor
44717176|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717177|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
44717178|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717179|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717180|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717181|NCT01499225|Doxycycline|doxycycline|mesh-list
44717182|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717183|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717184|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
44717185|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44717186|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44717187|NCT01499251|Temozolomide|temozolomide|mesh-list
44717188|NCT01499251|Macitentan|macitentan|mesh-list
44717189|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44717190|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
44717191|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717192|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717193|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44717194|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44717195|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44717196|NCT01499407|Abciximab|abciximab|mesh-list
44717197|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
44717199|NCT01499433|Caspofungin|caspofungin|mesh-list
44717200|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
44717201|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717202|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717203|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717204|NCT01499446|Fluticasone|fluticasone|mesh-list
44717205|NCT01499446|Xhance|xhance|mesh-list
44717206|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717207|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44717208|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
44717209|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717210|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717211|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44717212|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
44717213|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717214|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44717216|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
44717217|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44717218|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717219|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717220|NCT01499485|Diuretics|diuretics|mesh-ancestor
44717221|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
43620384|NCT04631029|Atezolizumab|atezolizumab|mesh-list
44717222|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717223|NCT01499589|Anesthetics|anesthetics|mesh-list
44717224|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717225|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717226|NCT01499602|Norethindrone|norethindrone|mesh-list
44717227|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
44717228|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717229|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717230|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717231|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717232|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717233|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44717234|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717235|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44717236|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
44717237|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44717238|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44717239|NCT01499641|Prednisolone|prednisolone|mesh-list
44717240|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
44717241|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44717242|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
44717243|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717244|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
44717245|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
44717246|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717247|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717248|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717249|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
44717250|NCT01499641|Hormones|hormones|mesh-ancestor
44717251|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717252|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44717253|NCT01499641|Protective Agents|protective agents|mesh-ancestor
44717254|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717255|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717256|NCT01499693|Pantoprazole|pantoprazole|mesh-list
44717257|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44717258|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717259|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44717260|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717261|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717262|NCT01499758|Atorvastatin|atorvastatin|mesh-list
44717263|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717264|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717265|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
44717266|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717267|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717268|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717269|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717270|NCT01499771|Atorvastatin|atorvastatin|mesh-list
44717271|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717272|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717273|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
44717274|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717275|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717276|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717277|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717278|NCT01499875|Penicillin V|penicillin v|mesh-list
44717279|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717280|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717281|NCT01499953|PENTA|penta|mesh-list
44717282|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
44717283|NCT01499953|Fondaparinux|fondaparinux|mesh-list
44717284|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44717285|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
44717286|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44717287|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
44717288|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268972|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717289|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717290|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
44717291|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44717292|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44717293|NCT01500005|Vitamin D|vitamin d|mesh-list
44717294|NCT01500005|Vitamins|vitamins|mesh-ancestor
44717295|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
44717296|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717297|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44717298|NCT01500018|Phentermine|phentermine|mesh-list
44717299|NCT01500018|Ketamine|ketamine|mesh-list
44717300|NCT01500018|Analgesics|analgesics|mesh-ancestor
44717301|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
44717302|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717303|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717304|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44717305|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44717306|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
44717307|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
44717308|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717309|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44717310|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44717311|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717312|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717313|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44717314|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
44717315|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44717316|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
44717317|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
44717318|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
44717319|NCT01500070|Everolimus|everolimus|mesh-list
44717320|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717321|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717322|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
44717323|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717324|NCT01500161|Cytarabine|cytarabine|mesh-list
44717325|NCT01500161|Fludarabine|fludarabine|mesh-list
44717326|NCT01500161|Etoposide|etoposide|mesh-list
44717327|NCT01500161|Melphalan|melphalan|mesh-list
44717328|NCT01500161|Busulfan|busulfan|mesh-list
44717329|NCT01500161|Carmustine|carmustine|mesh-list
44717330|NCT01500161|Clofarabine|clofarabine|mesh-list
44717331|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717332|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717333|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
44717334|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717335|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717336|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
44717337|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717338|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44717339|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44717340|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717341|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717342|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
44717343|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717344|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44717345|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
44717346|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44717347|NCT01500408|Interferons|interferons|mesh-list
44717348|NCT01500408|Interferon-beta|interferon-beta|mesh-list
44717349|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
44717350|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717351|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
44717352|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717353|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
44717354|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717355|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44717356|NCT01500473|Desogestrel|desogestrel|mesh-list
44717357|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44717358|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717359|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717360|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717361|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269053|NCT00669890|Busulfan|busulfan|mesh-list
44717362|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717363|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717364|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44717365|NCT01500473|Progestins|progestins|mesh-ancestor
44717366|NCT01500473|Hormones|hormones|mesh-ancestor
44717367|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717368|NCT01500538|Vorinostat|vorinostat|mesh-list
44717369|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717370|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44717371|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717372|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717374|NCT01500577|Simvastatin|simvastatin|mesh-list
44717375|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717376|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717377|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
44717378|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717379|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717380|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717381|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717382|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44717383|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717384|NCT01500577|Analgesics|analgesics|mesh-ancestor
44717385|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
44717386|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717387|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717388|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717389|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717390|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44717391|NCT01500590|Ramipril|ramipril|mesh-list
44717392|NCT01500590|Irbesartan|irbesartan|mesh-list
44717393|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44717394|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44717395|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717396|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717397|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44717398|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44717399|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44717400|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
44717401|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
44717402|NCT01500785|Simendan|simendan|mesh-list
44717403|NCT01500785|Vitamins|vitamins|mesh-ancestor
44717404|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
44717405|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717406|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
44717407|NCT01500785|Hematinics|hematinics|mesh-ancestor
44717408|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44717409|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
44717410|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44717411|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44717412|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717413|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717414|NCT01500785|Protective Agents|protective agents|mesh-ancestor
44717415|NCT01500824|Crizotinib|crizotinib|mesh-list
44717416|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717417|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717418|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717419|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717420|NCT01500837|Levofloxacin|levofloxacin|mesh-list
44717421|NCT01500837|Ofloxacin|ofloxacin|mesh-list
44717422|NCT01500837|Rifampin|rifampin|mesh-list
44717423|NCT01500837|Clindamycin|clindamycin|mesh-list
44717424|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
44717425|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
44717426|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44717427|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717428|NCT01500837|Renal Agents|renal agents|mesh-ancestor
44717429|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717430|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44717431|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717432|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717433|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717434|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717435|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44717436|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44717437|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44717438|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
44717439|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
44717440|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44717441|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44717442|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44717443|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44717444|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44717445|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44128754|NCT05594121|Buprenorphine|buprenorphine|mesh-list
44717446|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44717447|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44717449|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44717451|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
44717452|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
44717453|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
44717454|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
44717455|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717456|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717457|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44717458|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44717459|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44717460|NCT01500863|Estradiol|estradiol|mesh-list
44717461|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44717462|NCT01500863|Progesterone|progesterone|mesh-list
44717463|NCT01500863|Estrogens|estrogens|mesh-ancestor
44717464|NCT01500863|Hormones|hormones|mesh-ancestor
44717465|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717466|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717467|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717468|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717469|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717470|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717471|NCT01500863|Progestins|progestins|mesh-ancestor
44717472|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
44717473|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717474|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717475|NCT01500915|Ranibizumab|ranibizumab|mesh-list
44717476|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44717477|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717478|NCT01500915|Growth Substances|growth substances|mesh-ancestor
44717479|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717480|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
44717481|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717482|NCT01500928|Insulin|insulin|mesh-list
44717483|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717484|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717485|NCT01500980|Chloroquine|chloroquine|mesh-list
44717486|NCT01500980|Primaquine|primaquine|mesh-list
44717487|NCT01500980|Amebicides|amebicides|mesh-ancestor
44717488|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44717489|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44717490|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717491|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
44717492|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717493|NCT01500993|Fluorouracil|fluorouracil|mesh-list
44717494|NCT01500993|Capecitabine|capecitabine|mesh-list
44717495|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
44717496|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717497|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717498|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717499|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717500|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
44717501|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717502|NCT01501032|Pancrelipase|pancrelipase|mesh-list
44717503|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717504|NCT01501084|Exenatide|exenatide|mesh-list
44717505|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44717506|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717507|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44717508|NCT01501084|Incretins|incretins|mesh-ancestor
44717509|NCT01501084|Hormones|hormones|mesh-ancestor
44717510|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717511|NCT01501123|Midazolam|midazolam|mesh-list
44717512|NCT01501123|Haloperidol|haloperidol|mesh-list
44717513|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
44717514|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44717515|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44717516|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717517|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717518|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44717519|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44717520|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44717521|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44717522|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
44717523|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
44717524|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
44717525|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
44717526|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717527|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717528|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
44717529|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
44717530|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717531|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717532|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44717533|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44717534|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
44717535|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44717536|NCT01501136|Gemcitabine|gemcitabine|mesh-list
44717537|NCT01501136|Dexamethasone|dexamethasone|mesh-list
44717538|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
44717539|NCT01501136|Cisplatin|cisplatin|mesh-list
44717540|NCT01501136|Etoposide|etoposide|mesh-list
44717541|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
44717542|NCT01501136|Ifosfamide|ifosfamide|mesh-list
44717543|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
44717544|NCT01501136|Pegaspargase|pegaspargase|mesh-list
44717545|NCT01501136|Asparaginase|asparaginase|mesh-list
44717546|NCT01501136|BB 1101|bb 1101|mesh-list
44717547|NCT01501136|Mesna|mesna|mesh-list
44717548|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717549|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
44717550|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
44717551|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717552|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717553|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717554|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
44717555|NCT01501136|Hormones|hormones|mesh-ancestor
44717556|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717557|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717558|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717559|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
44717560|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717561|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717562|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717563|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
44717564|NCT01501136|Antiviral Agents|antiviral agents|mesh-ancestor
44717565|NCT01501136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717566|NCT01501136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717567|NCT01501136|Immunologic Factors|immunologic factors|mesh-ancestor
44717568|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44717569|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44717570|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717571|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44717572|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
44717573|NCT01501136|Protective Agents|protective agents|mesh-ancestor
44717574|NCT01501149|Gemcitabine|gemcitabine|mesh-list
44717575|NCT01501149|Dexamethasone|dexamethasone|mesh-list
44717576|NCT01501149|Cisplatin|cisplatin|mesh-list
44717577|NCT01501149|Etoposide|etoposide|mesh-list
44717578|NCT01501149|Pegaspargase|pegaspargase|mesh-list
44717579|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717580|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
44717581|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
44717582|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717583|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717584|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717585|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
44717586|NCT01501149|Hormones|hormones|mesh-ancestor
44717587|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717588|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717589|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717590|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717591|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
44717592|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717593|NCT01501149|Antiviral Agents|antiviral agents|mesh-ancestor
44717594|NCT01501149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717595|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717596|NCT01501149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717597|NCT01501149|Immunologic Factors|immunologic factors|mesh-ancestor
44717598|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44717599|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44717600|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717601|NCT01501214|Atosiban|atosiban|mesh-list
44717602|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
44717603|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717604|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717606|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717607|NCT01501253|Amlodipine|amlodipine|mesh-list
44717608|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44717609|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44717610|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44717611|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717612|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44717613|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717614|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44717615|NCT01501344|Calcium|calcium|mesh-list
44717616|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44717617|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717618|NCT01501370|Dexamethasone|dexamethasone|mesh-list
44717619|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
44717620|NCT01501370|Lenalidomide|lenalidomide|mesh-list
44717621|NCT01501370|Vorinostat|vorinostat|mesh-list
44717622|NCT01501370|BB 1101|bb 1101|mesh-list
44717623|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717624|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
44717625|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
44717626|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717627|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717628|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44717629|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
44717630|NCT01501370|Hormones|hormones|mesh-ancestor
44717631|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717632|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717633|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717634|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44717635|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717636|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717637|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
44717638|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44717639|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717640|NCT01501370|Growth Substances|growth substances|mesh-ancestor
44717641|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44717642|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44717643|NCT01501396|Megestrol|megestrol|mesh-list
44717644|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
44717645|NCT01501396|Mirtazapine|mirtazapine|mesh-list
44717646|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
44717647|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44717648|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44717649|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
44717650|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
44717651|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717652|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717653|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717654|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44717655|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44717656|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717657|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44717658|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44717659|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44717660|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44717661|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44717662|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44717663|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
44717664|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44717665|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44717666|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717667|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717668|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717669|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717670|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717671|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44156163|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
44717672|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44717673|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717674|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
44717675|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44717676|NCT01501422|Estrogens|estrogens|mesh-list
44717677|NCT01501422|Hormones|hormones|mesh-ancestor
44717678|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717679|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717680|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
44717681|NCT01501435|Fenofibrate|fenofibrate|mesh-list
44717682|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717683|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717684|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
44717685|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717686|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717687|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44269412|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717688|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44717690|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44717691|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44717692|NCT01501448|Estradiol|estradiol|mesh-list
44717693|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44717694|NCT01501448|Estrogens|estrogens|mesh-ancestor
44717695|NCT01501448|Hormones|hormones|mesh-ancestor
44717696|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717697|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717698|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717699|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717700|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717701|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717702|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44717703|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717704|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44717705|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44717706|NCT01501487|Paclitaxel|paclitaxel|mesh-list
44717707|NCT01501487|Docetaxel|docetaxel|mesh-list
44717708|NCT01501487|Trastuzumab|trastuzumab|mesh-list
44717709|NCT01501487|Pertuzumab|pertuzumab|mesh-list
44717710|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44717711|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717712|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
44717713|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
44717714|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
44717715|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717716|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44717717|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44717718|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44717719|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717720|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717721|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44717722|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44717723|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717724|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
44717725|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717726|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
44717727|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
44717728|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717729|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44717730|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
44717731|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
44717732|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717733|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717734|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717735|NCT01501669|Capecitabine|capecitabine|mesh-list
44717736|NCT01501669|Irinotecan|irinotecan|mesh-list
44717737|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44717738|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
44717739|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717740|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717741|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44717742|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44717743|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717744|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
44717745|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44717746|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155162|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717747|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717748|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717749|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44717750|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44717751|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
44717752|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717753|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717754|NCT01501708|Voriconazole|voriconazole|mesh-list
44717755|NCT01501708|Amphotericin B|amphotericin b|mesh-list
44717756|NCT01501708|Caspofungin|caspofungin|mesh-list
44717757|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
44717758|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717759|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44717760|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44717761|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717762|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717763|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44717764|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
44717765|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717766|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717767|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44717769|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44717770|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44717771|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717772|NCT01501747|Acetaminophen|acetaminophen|mesh-list
44717773|NCT01501747|Cephalexin|cephalexin|mesh-list
44717774|NCT01501747|Ibuprofen|ibuprofen|mesh-list
44717775|NCT01501747|Caffeine|caffeine|mesh-list
44717776|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44717777|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717778|NCT01501747|Analgesics|analgesics|mesh-ancestor
44717779|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
44717780|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717781|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717782|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717783|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717784|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44717785|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717786|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717787|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
44717788|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44717789|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44717790|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44717791|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44717792|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
44717793|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717794|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717795|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717796|NCT01501760|Bevacizumab|bevacizumab|mesh-list
44717797|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44717798|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717799|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44717800|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44717801|NCT01501760|Growth Substances|growth substances|mesh-ancestor
44717802|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717803|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
44717804|NCT01501786|Ketamine|ketamine|mesh-list
44717805|NCT01501786|Propofol|propofol|mesh-list
44717806|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44717807|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717808|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717809|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44717810|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
44717811|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
44717812|NCT01501786|Analgesics|analgesics|mesh-ancestor
44717813|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
44717814|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717815|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44717816|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44717817|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44717818|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717819|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717820|NCT01501799|Adapalene|adapalene|mesh-list
44717821|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44717822|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717823|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44717824|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717825|NCT01501799|Analgesics|analgesics|mesh-ancestor
44717826|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
44717827|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717828|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881855|NCT04631315|Hormones|hormones|mesh-ancestor
44717829|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44717830|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717831|NCT01501890|Algestone|algestone|mesh-list
44717832|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44717833|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44717834|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44717835|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
44717836|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717837|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717838|NCT01501890|Progestins|progestins|mesh-ancestor
44717839|NCT01501890|Hormones|hormones|mesh-ancestor
44717840|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44717841|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44717842|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44717843|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
44717844|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44717845|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44717846|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44717847|NCT01501916|Vitamin D|vitamin d|mesh-list
44717848|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
44717849|NCT01501916|Vitamins|vitamins|mesh-ancestor
44717850|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
44717851|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717852|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44717853|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44717854|NCT01501942|Glycine|glycine|mesh-list
44717855|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
44717856|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717857|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717858|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717859|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
44717860|NCT01501968|Colistin|colistin|mesh-list
44717861|NCT01501968|Vitamins|vitamins|mesh-ancestor
44717862|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
44717863|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717864|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
44717865|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717866|NCT01501968|Protective Agents|protective agents|mesh-ancestor
44717867|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717868|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717869|NCT01502020|Imiquimod|imiquimod|mesh-list
44717870|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44717871|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
44717872|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717873|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717874|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
44717875|NCT01502046|Dronabinol|dronabinol|mesh-list
44717876|NCT01502046|Cannabidiol|cannabidiol|mesh-list
44717877|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
44717878|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
44717879|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717880|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44717881|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44717882|NCT01502046|Analgesics|analgesics|mesh-ancestor
44717883|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
44717884|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44717885|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44717886|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44717887|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44717888|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717889|NCT01502046|Hormones|hormones|mesh-ancestor
44717890|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44717891|NCT01502202|Pemetrexed|pemetrexed|mesh-list
44717892|NCT01502202|Gefitinib|gefitinib|mesh-list
44717893|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717894|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717895|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717896|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44717897|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44717898|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44717899|NCT01502241|Temozolomide|temozolomide|mesh-list
44717900|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44717901|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
44717902|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717903|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717904|NCT01502267|Rituximab|rituximab|mesh-list
44717905|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44717906|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44717907|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717908|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
44717909|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717910|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717912|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44717913|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
44717914|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717915|NCT01502280|Protective Agents|protective agents|mesh-ancestor
44717916|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717917|NCT01502280|Vitamins|vitamins|mesh-ancestor
44717918|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
44717919|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44717920|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717921|NCT01502358|Vaccines|vaccines|mesh-list
44717922|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
44717923|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717924|NCT01502592|Ipilimumab|ipilimumab|mesh-list
44717925|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44717926|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717927|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44717928|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717929|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44717930|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44717931|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717932|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
44717933|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44717934|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
44717935|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717936|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717937|NCT01502774|Cyclosporine|cyclosporine|mesh-list
44717938|NCT01502774|Cyclosporins|cyclosporins|mesh-list
44717939|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717940|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717941|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717942|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
44717943|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717944|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
44717945|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717946|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
44717947|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44717948|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44717949|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
44717950|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717951|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44717952|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44717953|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717954|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717955|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
44717957|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
44717958|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717959|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717960|NCT01502904|Sirolimus|sirolimus|mesh-list
44717961|NCT01502904|Pravastatin|pravastatin|mesh-list
44717962|NCT01502904|Pitavastatin|pitavastatin|mesh-list
44717963|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44717964|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44717965|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44717966|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44717967|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
44717968|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44717969|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
44717970|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717971|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717972|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717973|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
44717974|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717975|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717976|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717977|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717978|NCT01502943|Atorvastatin|atorvastatin|mesh-list
44717979|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717980|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717981|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44717982|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44717983|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
44717984|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44717985|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44717986|NCT01503008|Metformin|metformin|mesh-list
44717987|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44717988|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44717989|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44717990|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44717991|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44717992|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44717993|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44717994|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
44717995|NCT01503060|Lidocaine|lidocaine|mesh-list
44717996|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
44717997|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
44717998|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44717999|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718000|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
44718001|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718002|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44718003|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44718004|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44718005|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718006|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718007|NCT01503216|Vitamin D|vitamin d|mesh-list
44718008|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
44718009|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
44718010|NCT01503216|Vitamins|vitamins|mesh-ancestor
44718011|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
44718012|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718013|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44718014|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44718015|NCT01503242|Cyclosporine|cyclosporine|mesh-list
44718016|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
44718017|NCT01503242|Fludarabine|fludarabine|mesh-list
44718018|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
44718019|NCT01503242|Antibodies|antibodies|mesh-list
44718020|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44718021|NCT01503242|Cyclosporins|cyclosporins|mesh-list
44718022|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
44718023|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718024|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718025|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44718026|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
44718027|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718028|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718029|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718030|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
44718031|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718033|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718034|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44718035|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44718036|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44718037|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
44718038|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44718039|NCT01503359|Glycine|glycine|mesh-list
44718040|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
44718041|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718042|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718043|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718044|NCT01503372|Leucovorin|leucovorin|mesh-list
44718045|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
44718046|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718047|NCT01503372|Antidotes|antidotes|mesh-ancestor
44718048|NCT01503372|Protective Agents|protective agents|mesh-ancestor
44718049|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718050|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
44718051|NCT01503372|Vitamins|vitamins|mesh-ancestor
44718052|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
44718053|NCT01503385|Celecoxib|celecoxib|mesh-list
44718054|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44718055|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44718056|NCT01503385|Analgesics|analgesics|mesh-ancestor
44718057|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
44718058|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718059|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718060|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718061|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718062|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44718063|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44718064|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718065|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718066|NCT01503398|Olanzapine|olanzapine|mesh-list
44718067|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
44718068|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
44718069|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718070|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718071|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718072|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44718073|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718074|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718075|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718076|NCT01503398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44718077|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44718078|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718079|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718080|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718081|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
44718082|NCT01503424|Olanzapine|olanzapine|mesh-list
44718083|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
44718084|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
44718085|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718086|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718087|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718088|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44718089|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718090|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718091|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718092|NCT01503424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43882093|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718093|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44718094|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718095|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718096|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718097|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
44718098|NCT01503437|Olanzapine|olanzapine|mesh-list
44718099|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
44718100|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
44718101|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718102|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718103|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718104|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44718105|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718106|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718107|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718108|NCT01503437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44718109|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44718110|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718111|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718112|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718113|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
44718114|NCT01503450|Olanzapine|olanzapine|mesh-list
44718115|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
44718116|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
44718117|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718118|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718119|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718120|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44718121|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718122|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718123|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718124|NCT01503450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44718125|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44718126|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718127|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718128|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718129|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
44718130|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
44718131|NCT01503502|HH-GV-678|hh-gv-678|mesh-list
44718132|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718133|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44718134|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718135|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718136|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
44718137|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44718138|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44718139|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44718140|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718141|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718142|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718143|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718144|NCT01503580|Urological Agents|urological agents|mesh-ancestor
44718145|NCT01503593|Calcium|calcium|mesh-list
44718146|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44718147|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718148|NCT01503658|Aspirin|aspirin|mesh-list
44718149|NCT01503658|Clopidogrel|clopidogrel|mesh-list
44718150|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44718151|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44718152|NCT01503658|Analgesics|analgesics|mesh-ancestor
44718153|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
44718154|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718155|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718156|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718157|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718158|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44718159|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44718160|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718161|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44718162|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44718163|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718164|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
44718165|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44718166|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44718167|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44718168|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
44718169|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718170|NCT01503671|Atorvastatin|atorvastatin|mesh-list
44718171|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44718172|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44718173|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
44718174|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718175|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44718176|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44718177|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718178|NCT01503736|Citric Acid|citric acid|mesh-list
44718180|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
44718181|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
44718182|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44718183|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
44718184|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
44718185|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718186|NCT01503736|Hematinics|hematinics|mesh-ancestor
44718187|NCT01503788|Midazolam|midazolam|mesh-list
44718188|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44718189|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44718190|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718191|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718192|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44718193|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718194|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718195|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718196|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
44718198|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
44718199|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
44718200|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718201|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718202|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
44718203|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
44718204|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44718205|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
44718206|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718207|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718208|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44718209|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
44718210|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44718211|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
44718212|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718213|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718214|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
44718215|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
44718216|NCT01503801|Protective Agents|protective agents|mesh-ancestor
44718217|NCT01503905|Tamoxifen|tamoxifen|mesh-list
44718218|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
44718219|NCT01503905|Docetaxel|docetaxel|mesh-list
44718220|NCT01503905|Trastuzumab|trastuzumab|mesh-list
44718221|NCT01503905|Epirubicin|epirubicin|mesh-list
44718222|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718223|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
44718224|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718225|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718226|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44718227|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
44718228|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718229|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718230|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44718231|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44718232|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44718233|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44718234|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44718235|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44718236|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44718237|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44718238|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718239|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44718240|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
44718241|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718242|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44718243|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44718244|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44718245|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44718246|NCT01503918|Valacyclovir|valacyclovir|mesh-list
44718247|NCT01503918|Acyclovir|acyclovir|mesh-list
44718248|NCT01503918|Valganciclovir|valganciclovir|mesh-list
44718249|NCT01503918|Ganciclovir|ganciclovir|mesh-list
44718250|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44718251|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
44718252|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718253|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44718254|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718255|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718256|NCT01503983|Capecitabine|capecitabine|mesh-list
44718257|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
44718258|NCT01503983|Trastuzumab|trastuzumab|mesh-list
44718259|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44718260|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
44718261|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718262|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718263|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44718264|NCT01504074|Triamcinolone|triamcinolone|mesh-list
44718265|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44718266|NCT01504074|Levobunolol|levobunolol|mesh-list
44718267|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718268|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
44718269|NCT01504074|Hormones|hormones|mesh-ancestor
44718270|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718271|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718272|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718273|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44718274|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718275|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44718276|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44718277|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718278|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718279|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
44718280|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
44718281|NCT01504126|Propranolol|propranolol|mesh-list
44718282|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44718283|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44718284|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718285|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718286|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718287|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718288|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44718289|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718290|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
44718291|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44718292|NCT01504139|Estradiol|estradiol|mesh-list
44718293|NCT01504139|Progesterone|progesterone|mesh-list
44718294|NCT01504139|Estrogens|estrogens|mesh-ancestor
44718295|NCT01504139|Hormones|hormones|mesh-ancestor
44718296|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718297|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718298|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44718299|NCT01504139|Progestins|progestins|mesh-ancestor
44718300|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44718301|NCT01504178|Levodopa|levodopa|mesh-list
44718302|NCT01504178|Apomorphine|apomorphine|mesh-list
44718303|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44718304|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44718305|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43882296|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718306|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718307|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718308|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718309|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718310|NCT01504178|Analgesics|analgesics|mesh-ancestor
44718311|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
44718312|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718313|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
44718314|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718315|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
44718316|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44718317|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44718318|NCT01504178|Emetics|emetics|mesh-ancestor
44718319|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
44718320|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718321|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
44718322|NCT01504256|Leucovorin|leucovorin|mesh-list
44718323|NCT01504256|Docetaxel|docetaxel|mesh-list
44718324|NCT01504256|Fluorouracil|fluorouracil|mesh-list
44718325|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
44718326|NCT01504256|Catumaxomab|catumaxomab|mesh-list
44718327|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44718328|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
44718329|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718330|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44718331|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44718332|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44718333|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718334|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
44718335|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44718336|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718337|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
44718338|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718339|NCT01504256|Antidotes|antidotes|mesh-ancestor
44718340|NCT01504256|Protective Agents|protective agents|mesh-ancestor
44718341|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
44718342|NCT01504256|Vitamins|vitamins|mesh-ancestor
44718343|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
44718344|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718345|NCT01504282|Mitomycins|mitomycins|mesh-list
44718346|NCT01504282|Mitomycin|mitomycin|mesh-list
44718347|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44718348|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718349|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
44718350|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718351|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44718353|NCT01504295|Metadoxine|metadoxine|mesh-list
44718354|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44718355|NCT01504321|Moxonidine|moxonidine|mesh-list
44718356|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718357|NCT01504334|Pirfenidone|pirfenidone|mesh-list
44718358|NCT01504334|Analgesics|analgesics|mesh-ancestor
44718359|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
44718360|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718361|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718362|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44718363|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44718364|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718365|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718366|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718367|NCT01504347|Vaccines|vaccines|mesh-list
44718368|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
44718369|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270136|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
44718370|NCT01504386|Ropivacaine|ropivacaine|mesh-list
44718371|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
44718372|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
44718373|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718374|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718375|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
44718376|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718377|NCT01504490|Bexarotene|bexarotene|mesh-list
44718378|NCT01504490|Efatutazone|efatutazone|mesh-list
44718379|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718380|NCT01504503|Donepezil|donepezil|mesh-list
44718381|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44718382|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718383|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718384|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718385|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718386|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718387|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
44718388|NCT01504516|Donepezil|donepezil|mesh-list
44718389|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44718390|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718391|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718392|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718393|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718394|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718395|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
44718396|NCT01504542|Vaccines|vaccines|mesh-list
44718397|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
44718398|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718399|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44718400|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
44718401|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718402|NCT01504620|Insulin|insulin|mesh-list
44718403|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44718404|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718405|NCT01504646|Lyprinol|lyprinol|mesh-list
44718406|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44718407|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44718408|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718409|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718410|NCT01504659|Ketamine|ketamine|mesh-list
44718411|NCT01504659|Analgesics|analgesics|mesh-ancestor
44718412|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
44718413|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718414|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718415|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44718416|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718417|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
44718418|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
44718419|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718420|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44718421|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44718422|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718423|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718424|NCT01504724|Bevacizumab|bevacizumab|mesh-list
44718425|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44718426|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718427|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44718428|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44718429|NCT01504724|Growth Substances|growth substances|mesh-ancestor
44718430|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718431|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
44718432|NCT01504776|Bortezomib|bortezomib|mesh-list
44718433|NCT01504776|Panobinostat|panobinostat|mesh-list
44718434|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718435|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44718436|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718437|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718438|NCT01504828|Ramipril|ramipril|mesh-list
44718439|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44718440|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
44718441|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718442|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718443|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718444|NCT01504906|Cyclosporine|cyclosporine|mesh-list
44718445|NCT01504906|Ticagrelor|ticagrelor|mesh-list
44718446|NCT01504906|Cyclosporins|cyclosporins|mesh-list
44718447|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718448|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718449|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718450|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
44718451|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718452|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
44718453|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718454|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44718455|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718456|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44718457|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44718458|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44718459|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44718460|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44718461|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
44718462|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718463|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
44718464|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718465|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44718466|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718467|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718468|NCT01505049|Vaccines|vaccines|mesh-list
44718469|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
44718470|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718471|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44718472|NCT01505088|Dexamethasone|dexamethasone|mesh-list
44718473|NCT01505088|Prednisolone|prednisolone|mesh-list
44718474|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44718475|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
44718476|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44718477|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
44718478|NCT01505088|Citric Acid|citric acid|mesh-list
44718479|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
44718480|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44718481|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44718482|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44718483|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
44718484|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44718485|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718486|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
44718487|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
44718488|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718489|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718490|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718491|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
44718492|NCT01505088|Hormones|hormones|mesh-ancestor
44718493|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718494|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44718495|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718496|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
44718497|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44718498|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
44718499|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
44718500|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718501|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44718502|NCT01505088|Protective Agents|protective agents|mesh-ancestor
44718503|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44718504|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718505|NCT01505127|Amoxicillin|amoxicillin|mesh-list
44718506|NCT01505127|Clarithromycin|clarithromycin|mesh-list
44718507|NCT01505127|Lansoprazole|lansoprazole|mesh-list
44718508|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
44718509|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44718510|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718511|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44718512|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718513|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718514|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44718515|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44718516|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44718517|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718518|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44718520|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44718521|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718522|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718523|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718524|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
44718525|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
44718526|NCT01505231|Vasopressins|vasopressins|mesh-list
44718527|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
44718528|NCT01505231|Norepinephrine|norepinephrine|mesh-list
44718529|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44718530|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44718531|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718532|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718533|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718534|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718535|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
44718536|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
44718537|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718538|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44718539|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
44718540|NCT01505231|Coagulants|coagulants|mesh-ancestor
44718541|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44718542|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
44718543|NCT01505283|Lidocaine|lidocaine|mesh-list
44718544|NCT01505283|Sufentanil|sufentanil|mesh-list
44718545|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
44718546|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
44718547|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718548|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718549|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
44718550|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718551|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44718552|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44718553|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44718554|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718555|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718556|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44718557|NCT01505283|Narcotics|narcotics|mesh-ancestor
44718558|NCT01505283|Analgesics|analgesics|mesh-ancestor
44718559|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44718560|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718561|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
44718562|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44718563|NCT01505413|Gemcitabine|gemcitabine|mesh-list
44718564|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
44718565|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44718566|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44718567|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
44718568|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718569|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718570|NCT01505413|Antiviral Agents|antiviral agents|mesh-ancestor
44718571|NCT01505413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718572|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718573|NCT01505413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718574|NCT01505413|Immunologic Factors|immunologic factors|mesh-ancestor
44718575|NCT01505413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718576|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44718577|NCT01505426|Metformin|metformin|mesh-list
44718578|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
44718579|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44718580|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718581|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44718582|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718583|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
44718584|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44718585|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44718586|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718587|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718588|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718589|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718590|NCT01505439|Urological Agents|urological agents|mesh-ancestor
44718591|NCT01505504|Mirtazapine|mirtazapine|mesh-list
44718592|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
44718593|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718594|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718595|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718596|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
44718597|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718598|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718599|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718600|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44718601|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718602|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718603|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44718604|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44718605|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44718606|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718607|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44718608|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44718609|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
44718610|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44718611|NCT01505777|Mosapride|mosapride|mesh-list
44718612|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718613|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44718614|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
44718615|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718616|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718617|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718618|NCT01505790|Clopidogrel|clopidogrel|mesh-list
44718619|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44718620|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44718621|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44718622|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44718623|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44718624|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
44718625|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718626|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718627|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718628|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44718629|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
44718630|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718631|NCT01505894|BI 409306|bi 409306|mesh-list
44718632|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44718633|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718634|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718635|NCT01505920|Lidocaine|lidocaine|mesh-list
44718636|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
44718637|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
44718638|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718639|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718640|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
44718641|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718642|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44718643|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44718644|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44718645|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718646|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718647|NCT01505946|Thrombin|thrombin|mesh-list
44718648|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
44718649|NCT01505946|Coagulants|coagulants|mesh-ancestor
44718650|NCT01505998|Amlodipine|amlodipine|mesh-list
44718651|NCT01505998|Benazepril|benazepril|mesh-list
44718652|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718653|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44718654|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718655|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718656|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44718657|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718658|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
44718659|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44718660|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44718661|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718662|NCT01506011|Amlodipine|amlodipine|mesh-list
44718663|NCT01506011|Benazepril|benazepril|mesh-list
44718664|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718665|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44718666|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44718667|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718668|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44718669|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718671|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44718672|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
44718673|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718674|NCT01506024|Tacrine|tacrine|mesh-list
44718675|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44718676|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718677|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718678|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718679|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718680|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718681|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44718682|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
44718683|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718684|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
44718685|NCT01506037|Desloratadine|desloratadine|mesh-list
44718686|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44718687|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718688|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718689|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718690|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718691|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44718692|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718693|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718694|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
44718695|NCT01506050|Desloratadine|desloratadine|mesh-list
44718696|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44718697|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718698|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718699|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718700|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718701|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44718702|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718703|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718704|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
44718705|NCT01506063|Levocetirizine|levocetirizine|mesh-list
44718706|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44718707|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718708|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718709|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
44718710|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718711|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718712|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718713|NCT01506076|Levocetirizine|levocetirizine|mesh-list
44718714|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44718715|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718716|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718717|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
44718718|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718719|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718720|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718721|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44718722|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44718723|NCT01506115|Trioxsalen|trioxsalen|mesh-list
44718724|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718725|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44718726|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44718727|NCT01506167|Leucovorin|leucovorin|mesh-list
44718728|NCT01506167|Folic Acid|folic acid|mesh-list
44718729|NCT01506167|Bevacizumab|bevacizumab|mesh-list
44718730|NCT01506167|Fluorouracil|fluorouracil|mesh-list
44718731|NCT01506167|Capecitabine|capecitabine|mesh-list
44718732|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
44718733|NCT01506167|Irinotecan|irinotecan|mesh-list
44718734|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
44718735|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44718736|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718737|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44718738|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44718739|NCT01506167|Growth Substances|growth substances|mesh-ancestor
44718740|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718741|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
44718742|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
44718743|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718744|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44718745|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44718746|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
44718747|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44718748|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44718749|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718750|NCT01506167|Antidotes|antidotes|mesh-ancestor
44718751|NCT01506167|Protective Agents|protective agents|mesh-ancestor
44718752|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
44718753|NCT01506167|Vitamins|vitamins|mesh-ancestor
44718754|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
44718755|NCT01506167|Hematinics|hematinics|mesh-ancestor
44718756|NCT01506336|Sunitinib|sunitinib|mesh-list
44718757|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718758|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44718759|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44718760|NCT01506336|Growth Substances|growth substances|mesh-ancestor
44718761|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718762|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44718763|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44718764|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718765|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718766|NCT01506388|Misoprostol|misoprostol|mesh-list
44718767|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44718768|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
44718769|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44718770|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718771|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44718772|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718773|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
44718774|NCT01506414|Rituximab|rituximab|mesh-list
44718775|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44718776|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718777|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
44718778|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718779|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718780|NCT01506505|Aspirin|aspirin|mesh-list
44718781|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44718782|NCT01506505|Lisinopril|lisinopril|mesh-list
44718783|NCT01506505|Simvastatin|simvastatin|mesh-list
44718784|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44718785|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44718786|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
44718787|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718788|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44718789|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44718790|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718791|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718792|NCT01506505|Diuretics|diuretics|mesh-ancestor
44718793|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
44718794|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718795|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44718796|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620385|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
44718797|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44718798|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44718800|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
44718801|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718802|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718803|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44718804|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44718805|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44718806|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44718807|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44718808|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
44718809|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44718810|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
44718811|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44718812|NCT01506505|Protective Agents|protective agents|mesh-ancestor
44718813|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
44718814|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718815|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
44718816|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718817|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718818|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44718819|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
44718820|NCT01506557|Vitamin D|vitamin d|mesh-list
44718821|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44718822|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718823|NCT01506557|Vitamins|vitamins|mesh-ancestor
44718824|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
44718825|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44718826|NCT01506570|Vaccines|vaccines|mesh-list
44718827|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
44718828|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718829|NCT01506622|Fentanyl|fentanyl|mesh-list
44718830|NCT01506622|Propofol|propofol|mesh-list
44718831|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44718832|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718833|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718834|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718835|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
44718836|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
44718837|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44718838|NCT01506622|Narcotics|narcotics|mesh-ancestor
44718839|NCT01506622|Analgesics|analgesics|mesh-ancestor
44718840|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
44718841|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718842|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44718843|NCT01506635|Timolol|timolol|mesh-list
44718844|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44718845|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44718846|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718847|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718848|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718849|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718850|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44718851|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44718852|NCT01506713|Clopidogrel|clopidogrel|mesh-list
44718853|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44718854|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44718855|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44718856|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44718857|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
44718858|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718859|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718860|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718861|NCT01506739|Donepezil|donepezil|mesh-list
44718862|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44718863|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718864|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718865|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718866|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718867|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718868|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
44718869|NCT01506752|Donepezil|donepezil|mesh-list
44718870|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44236506|NCT00559676|Leucovorin|leucovorin|mesh-list
44718871|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718872|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718873|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718874|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718875|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718876|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
44718877|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
44718878|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44718879|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
44718880|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44718881|NCT01506765|Expectorants|expectorants|mesh-ancestor
44718882|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44718883|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44718884|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
44718885|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718886|NCT01506765|Protective Agents|protective agents|mesh-ancestor
44718887|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718888|NCT01506765|Antidotes|antidotes|mesh-ancestor
44718889|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
44718890|NCT01506791|Ephedrine|ephedrine|mesh-list
44718891|NCT01506791|Desloratadine|desloratadine|mesh-list
44718892|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44718893|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
44718894|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718895|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718896|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718897|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44718898|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44718899|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
44718900|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
44718901|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44718902|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
44718903|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718904|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44718905|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
44718906|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
44718907|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44718908|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44718909|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
44718910|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
44718911|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
44718912|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44718913|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44718914|NCT01506804|Prednisolone|prednisolone|mesh-list
44718915|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
44718916|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44718917|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
44718918|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44718919|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
44718920|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
44718921|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718922|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718923|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718924|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
44718925|NCT01506804|Hormones|hormones|mesh-ancestor
44718926|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718927|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44718928|NCT01506804|Protective Agents|protective agents|mesh-ancestor
44718929|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44718930|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718931|NCT01506895|Darapladib|darapladib|mesh-list
44718932|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44718933|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718934|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718935|NCT01506921|Ketamine|ketamine|mesh-list
44718936|NCT01506921|Esketamine|esketamine|mesh-list
44718937|NCT01506921|Analgesics|analgesics|mesh-ancestor
44718938|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
44718939|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718940|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718941|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44718942|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44718943|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
44718944|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
44718945|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718946|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44718947|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44718948|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718949|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718950|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
44718951|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718952|NCT01507064|Sorafenib|sorafenib|mesh-list
44718953|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718954|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44718955|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44718956|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718958|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44718959|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44718960|NCT01507077|Growth Substances|growth substances|mesh-ancestor
44718961|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718962|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
44718963|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44718964|NCT01507194|Ondansetron|ondansetron|mesh-list
44718965|NCT01507194|Vestipitant|vestipitant|mesh-list
44718966|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
44718967|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
44718968|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44718969|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718970|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44718971|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
44718972|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
44718973|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44718974|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
44718975|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44718976|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44718977|NCT01507194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44718978|NCT01507194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44718979|NCT01507194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44718980|NCT01507194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44718981|NCT01507194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44718982|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44718983|NCT01507272|Liraglutide|liraglutide|mesh-list
44718984|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44718985|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718986|NCT01507272|Incretins|incretins|mesh-ancestor
44718987|NCT01507272|Hormones|hormones|mesh-ancestor
44718988|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718989|NCT01507285|Liraglutide|liraglutide|mesh-list
44718990|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44718991|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718992|NCT01507285|Incretins|incretins|mesh-ancestor
44718993|NCT01507285|Hormones|hormones|mesh-ancestor
44718994|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44718995|NCT01507311|Liraglutide|liraglutide|mesh-list
44718996|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44718997|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44718998|NCT01507311|Incretins|incretins|mesh-ancestor
44718999|NCT01507311|Hormones|hormones|mesh-ancestor
44719000|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719001|NCT01507337|Liraglutide|liraglutide|mesh-list
44719002|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719003|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719004|NCT01507337|Incretins|incretins|mesh-ancestor
44719005|NCT01507337|Hormones|hormones|mesh-ancestor
44719006|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719007|NCT01507363|Gabapentin|gabapentin|mesh-list
44719008|NCT01507363|Analgesics|analgesics|mesh-ancestor
44719009|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
44719010|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719011|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719012|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
44719013|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44719014|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44719015|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719016|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44719017|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44719018|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44719019|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719020|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719021|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
44719022|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44719023|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719024|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270757|NCT00679523|Tavaborole|tavaborole|mesh-list
44719025|NCT01507389|Liraglutide|liraglutide|mesh-list
44719026|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719027|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719028|NCT01507389|Incretins|incretins|mesh-ancestor
44719029|NCT01507389|Hormones|hormones|mesh-ancestor
44719030|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719031|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
44719032|NCT01507428|Misonidazole|misonidazole|mesh-list
44719033|NCT01507428|Paclitaxel|paclitaxel|mesh-list
44719034|NCT01507428|Carboplatin|carboplatin|mesh-list
44719035|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44719036|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44719037|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44719038|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719039|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44719040|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44719041|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44719042|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719043|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44719044|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
44719045|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
44719046|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719047|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44719048|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44719049|NCT01507454|Estradiol|estradiol|mesh-list
44719050|NCT01507454|Estrogens|estrogens|mesh-ancestor
44719051|NCT01507454|Hormones|hormones|mesh-ancestor
44719052|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719053|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719054|NCT01507467|Nimorazole|nimorazole|mesh-list
44719055|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44719056|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44719057|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44719058|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719059|NCT01507480|Bevacizumab|bevacizumab|mesh-list
44719060|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719061|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719062|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44719063|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44719064|NCT01507480|Growth Substances|growth substances|mesh-ancestor
44719065|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719066|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
44719067|NCT01507519|Sirolimus|sirolimus|mesh-list
44719068|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44719069|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719070|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44719071|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719072|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
44719073|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719074|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
44719075|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719076|NCT01507558|Dexamethasone|dexamethasone|mesh-list
44719077|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
44719078|NCT01507558|BB 1101|bb 1101|mesh-list
44719079|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719080|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
44719081|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
44719082|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719083|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719084|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719085|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
44719086|NCT01507558|Hormones|hormones|mesh-ancestor
44719087|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719088|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44719089|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719090|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44719091|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719092|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719093|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
44719094|NCT01507597|Glucagon|glucagon|mesh-list
44719095|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44719096|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719097|NCT01507597|Hormones|hormones|mesh-ancestor
44426671|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719098|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719099|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719101|NCT01507701|Clonidine|clonidine|mesh-list
44719102|NCT01507701|Analgesics|analgesics|mesh-ancestor
44719138|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719139|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719140|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
44719141|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
44719142|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44719143|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44719144|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44719145|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
44719146|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
44719147|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719148|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719149|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
44719150|NCT01507857|Vaccines|vaccines|mesh-list
44719151|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
44719152|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270954|NCT00680433|Ketamine|ketamine|mesh-list
44719153|NCT01507922|Fenoverine|fenoverine|mesh-list
44719154|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
44719155|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
44719156|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719157|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719158|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44719159|NCT01507974|Amoxicillin|amoxicillin|mesh-list
44719160|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
44719161|NCT01507974|Cephalexin|cephalexin|mesh-list
44719162|NCT01507974|Cefuroxime|cefuroxime|mesh-list
44719163|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
44719164|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44719165|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44719166|NCT01507974|Trimethoprim|trimethoprim|mesh-list
44719167|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
44719168|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719169|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
44719170|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44719171|NCT01507974|Renal Agents|renal agents|mesh-ancestor
44719172|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
44719173|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44719174|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44719175|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44719176|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883017|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
44719177|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719178|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44719179|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44719180|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44719181|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44719182|NCT01508000|Bevacizumab|bevacizumab|mesh-list
44719183|NCT01508000|Panitumumab|panitumumab|mesh-list
44719184|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719185|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719186|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44719187|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44719188|NCT01508000|Growth Substances|growth substances|mesh-ancestor
44719189|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719190|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
44719191|NCT01508104|Everolimus|everolimus|mesh-list
44719192|NCT01508104|Dactolisib|dactolisib|mesh-list
44719193|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719194|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719195|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
44719196|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719197|NCT01507610|Sumatriptan|sumatriptan|mesh-list
44719198|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44719199|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44719200|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44719201|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
44719202|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719203|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719204|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719205|NCT01508143|Misoprostol|misoprostol|mesh-list
44719206|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44719207|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
44719208|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719209|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719210|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719211|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719212|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
44719213|NCT01508182|Metformin|metformin|mesh-list
44719214|NCT01508182|Canagliflozin|canagliflozin|mesh-list
44719215|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719216|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719217|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44719218|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719219|NCT01508195|Metformin|metformin|mesh-list
44719220|NCT01508195|Canagliflozin|canagliflozin|mesh-list
44719221|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719222|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719223|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44719224|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719225|NCT01508221|Vitamin E|vitamin e|mesh-list
44719226|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
44719227|NCT01508221|Vitamins|vitamins|mesh-ancestor
44719228|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
44719229|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719230|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
44719231|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719232|NCT01508221|Protective Agents|protective agents|mesh-ancestor
44719233|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44719234|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719235|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44719236|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44719237|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
44719238|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44719239|NCT01508260|Furosemide|furosemide|mesh-list
44719240|NCT01508260|Diuretics|diuretics|mesh-ancestor
44719241|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
44719242|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719243|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43883094|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
44719244|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44719245|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719246|NCT01508286|Ribavirin|ribavirin|mesh-list
44719247|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
44719248|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719249|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
44719250|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719251|NCT01508364|Sorafenib|sorafenib|mesh-list
44719252|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719253|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44719254|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719255|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719256|NCT01508429|Misoprostol|misoprostol|mesh-list
44719257|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44719258|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
44719259|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719260|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719261|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719262|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719263|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
44719264|NCT01508468|Rituximab|rituximab|mesh-list
44719265|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
44719266|NCT01508468|Giapreza|giapreza|mesh-list
44719267|NCT01508468|Calcium|calcium|mesh-list
44719268|NCT01508468|Diuretics|diuretics|mesh-list
44719269|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44719270|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44719271|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
44719272|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44719273|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719274|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719275|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
44719276|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719277|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44719278|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44719279|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
44719280|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44719281|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719282|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426672|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719283|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719284|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44719285|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44719286|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
44719287|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
44719288|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719289|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44719290|NCT01508494|Galantamine|galantamine|mesh-list
44719291|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44719292|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719293|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719294|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
44719295|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719296|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719297|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44719298|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
44719299|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719300|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
44719301|NCT01508572|Bevacizumab|bevacizumab|mesh-list
44719302|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719303|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719304|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44719305|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44719306|NCT01508572|Growth Substances|growth substances|mesh-ancestor
44719307|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719308|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
44719310|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
44719311|NCT01508611|Protective Agents|protective agents|mesh-ancestor
44719312|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719313|NCT01508637|Terazosin|terazosin|mesh-list
44719314|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44719315|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44719316|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44719317|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719318|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719319|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719320|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719321|NCT01508637|Urological Agents|urological agents|mesh-ancestor
44719322|NCT01508663|Everolimus|everolimus|mesh-list
44719323|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44719324|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719325|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719326|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
44719327|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719328|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
44719329|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719330|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719331|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44719332|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44719333|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
44719334|NCT01508806|Liraglutide|liraglutide|mesh-list
44719335|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719336|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719337|NCT01508806|Incretins|incretins|mesh-ancestor
44719338|NCT01508806|Hormones|hormones|mesh-ancestor
44719339|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719340|NCT01508845|Vitamin D|vitamin d|mesh-list
44719341|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
44719342|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
44719343|NCT01508845|Vitamins|vitamins|mesh-list
44719344|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
44719345|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719346|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44719347|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44719348|NCT01508858|Liraglutide|liraglutide|mesh-list
44719349|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
44719350|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44719351|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719352|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719353|NCT01508858|Incretins|incretins|mesh-ancestor
44719354|NCT01508858|Hormones|hormones|mesh-ancestor
44719355|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719356|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44719357|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
44719358|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719359|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44719360|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44719361|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44719362|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44719363|NCT01508858|Estrogens|estrogens|mesh-ancestor
44719364|NCT01508884|Imiquimod|imiquimod|mesh-list
44719365|NCT01508884|Vaccines|vaccines|mesh-list
44719366|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
44719367|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719368|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44719369|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719370|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
44719371|NCT01508897|Liraglutide|liraglutide|mesh-list
44719372|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719373|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719374|NCT01508897|Incretins|incretins|mesh-ancestor
44719375|NCT01508897|Hormones|hormones|mesh-ancestor
44719376|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719377|NCT01508923|Liraglutide|liraglutide|mesh-list
44271156|NCT00681460|Metformin|metformin|mesh-list
44719378|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719379|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719380|NCT01508923|Incretins|incretins|mesh-ancestor
44719381|NCT01508923|Hormones|hormones|mesh-ancestor
44719382|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719383|NCT01508949|Liraglutide|liraglutide|mesh-list
44719384|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719385|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719386|NCT01508949|Incretins|incretins|mesh-ancestor
44719387|NCT01508949|Hormones|hormones|mesh-ancestor
44719388|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719389|NCT01509001|Metformin|metformin|mesh-list
44719390|NCT01509001|Glimepiride|glimepiride|mesh-list
44719391|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719392|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719393|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44719394|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719395|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
44719396|NCT01509131|Bisacodyl|bisacodyl|mesh-list
44719397|NCT01509131|Cathartics|cathartics|mesh-ancestor
44719398|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719399|NCT01509131|Laxatives|laxatives|mesh-ancestor
44719400|NCT01509144|Vaccines|vaccines|mesh-list
44719401|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
44719402|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719403|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
44719404|NCT01509209|Ephedrine|ephedrine|mesh-list
44719405|NCT01509209|Levocetirizine|levocetirizine|mesh-list
44719406|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44719407|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44719408|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
44719409|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
44719410|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719411|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719412|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719413|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44719414|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
44719415|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719416|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44719417|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
44719418|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
44719419|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44719420|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44719421|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
44719422|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719423|NCT01509261|Lansoprazole|lansoprazole|mesh-list
44719424|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
44719425|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719426|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719427|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44719428|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719429|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719430|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
44719431|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
44719432|NCT01509300|Rituximab|rituximab|mesh-list
44719433|NCT01509300|Fludarabine|fludarabine|mesh-list
44719434|NCT01509300|Tacrolimus|tacrolimus|mesh-list
44719435|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44719436|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719437|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
44719438|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719439|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44719440|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44719441|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
44719442|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719443|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719444|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44719445|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719446|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44719447|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719448|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156389|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44719449|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44719450|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
44719451|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44719452|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271233|NCT00681902|Lidocaine|lidocaine|mesh-list
44719453|NCT01509365|Clopidogrel|clopidogrel|mesh-list
44719454|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44719455|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44719456|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44719457|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44719458|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
44719459|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719460|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719461|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719462|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44719463|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44719464|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
44719465|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719466|NCT01509469|Caseins|caseins|mesh-list
44719467|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
44719468|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
44719469|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719470|NCT01509521|Phenylephrine|phenylephrine|mesh-list
44719471|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
44719472|NCT01509521|Ephedrine|ephedrine|mesh-list
44719473|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
44719474|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44719475|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
44719476|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
44719477|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719478|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719479|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
44719480|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44719481|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
44719482|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44719483|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44719484|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44719485|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44719486|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719487|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719488|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719489|NCT01509521|Protective Agents|protective agents|mesh-ancestor
44719490|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44719491|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44719492|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44719493|NCT01509560|Everolimus|everolimus|mesh-list
44719494|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719495|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719496|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
44719497|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719498|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
44719499|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271313|NCT00682136|Ropivacaine|ropivacaine|mesh-list
44719500|NCT01509742|Liraglutide|liraglutide|mesh-list
44719501|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719502|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719503|NCT01509742|Incretins|incretins|mesh-ancestor
44719504|NCT01509742|Hormones|hormones|mesh-ancestor
44719505|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719506|NCT01509755|Liraglutide|liraglutide|mesh-list
44719507|NCT01509755|Glimepiride|glimepiride|mesh-list
44719509|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719510|NCT01509755|Incretins|incretins|mesh-ancestor
44719511|NCT01509755|Hormones|hormones|mesh-ancestor
44719512|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719513|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44719514|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719515|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
44719516|NCT01509911|Gemcitabine|gemcitabine|mesh-list
44719517|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44719518|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
44719519|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719520|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719521|NCT01509911|Antiviral Agents|antiviral agents|mesh-ancestor
44719522|NCT01509911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719523|NCT01509911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719524|NCT01509911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719525|NCT01509911|Immunologic Factors|immunologic factors|mesh-ancestor
44719526|NCT01509911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719527|NCT01509976|Triclosan|triclosan|mesh-list
44719528|NCT01509976|Triclocarban|triclocarban|mesh-list
44719529|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44719530|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719531|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44719532|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44719533|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
44719534|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719535|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44719536|NCT01510015|Risperidone|risperidone|mesh-list
44719537|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44719538|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
44719539|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719540|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719541|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719542|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44719543|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44719544|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719545|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44719546|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44719547|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
44719548|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
44719549|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719550|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719551|NCT01510132|Timolol|timolol|mesh-list
44719552|NCT01510132|Travoprost|travoprost|mesh-list
44719553|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44719554|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44719555|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
44719556|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719557|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719558|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719559|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44719560|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44719561|NCT01510171|Ticagrelor|ticagrelor|mesh-list
44719562|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44719563|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44719564|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44719565|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44719566|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44719567|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
44719568|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719569|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719570|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719571|NCT01510288|Ipilimumab|ipilimumab|mesh-list
44719572|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44719573|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719574|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44719575|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719576|NCT01510366|Vaccines|vaccines|mesh-list
44719577|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
44719578|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719579|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
44719580|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719581|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
44719583|NCT01510509|Everolimus|everolimus|mesh-list
44719584|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719585|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719586|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
44719587|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719588|NCT01510522|Metformin|metformin|mesh-list
44719589|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719590|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719591|NCT01510548|Adalimumab|adalimumab|mesh-list
44719592|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719593|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44719594|NCT01510561|Gemcitabine|gemcitabine|mesh-list
44719595|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44719596|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44719597|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44719598|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
44719599|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719600|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719601|NCT01510561|Antiviral Agents|antiviral agents|mesh-ancestor
44719602|NCT01510561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719603|NCT01510561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719604|NCT01510561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719605|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
44719606|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719607|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
44719608|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
44719609|NCT01510574|Misoprostol|misoprostol|mesh-list
44719610|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44719611|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
44719612|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719613|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719614|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719615|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719616|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
44719617|NCT01510613|Dexamethasone|dexamethasone|mesh-list
44719618|NCT01510613|Pomalidomide|pomalidomide|mesh-list
44719619|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719620|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
44719621|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
44719622|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719623|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719624|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719625|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
44719626|NCT01510613|Hormones|hormones|mesh-ancestor
44719627|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719628|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44719629|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719630|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
44719631|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44719632|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44719633|NCT01510613|Growth Substances|growth substances|mesh-ancestor
44719634|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
44719635|NCT01510626|Omalizumab|omalizumab|mesh-list
44719636|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44719637|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44719638|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
44719639|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
44719640|NCT01510665|Cathartics|cathartics|mesh-ancestor
44719641|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719642|NCT01510795|Spironolactone|spironolactone|mesh-list
44719643|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44719644|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
44719645|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719646|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719647|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44719648|NCT01510795|Diuretics|diuretics|mesh-ancestor
44719649|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
43883434|NCT04611373|Diuretics|diuretics|mesh-ancestor
44719650|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
44719651|NCT01510847|Androgens|androgens|mesh-ancestor
44719653|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719654|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719655|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44719656|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44719657|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719659|NCT01510977|Cathartics|cathartics|mesh-ancestor
44719660|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719661|NCT01510977|Laxatives|laxatives|mesh-ancestor
44719662|NCT01510990|Gefitinib|gefitinib|mesh-list
44719663|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719664|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44719665|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719666|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719667|NCT01511003|Tacrolimus|tacrolimus|mesh-list
44719668|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719669|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
44719670|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719671|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44719672|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719673|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719674|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
44719675|NCT01511029|Pramipexole|pramipexole|mesh-list
44719676|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44719677|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719678|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44719679|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44719680|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719681|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719682|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719683|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719684|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
44719685|NCT01511029|Protective Agents|protective agents|mesh-ancestor
44719686|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44719687|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44719688|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
44719689|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
44719690|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719691|NCT01511146|Gemcitabine|gemcitabine|mesh-list
44719692|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
44719693|NCT01511146|Mitomycins|mitomycins|mesh-list
44719694|NCT01511146|Mitomycin|mitomycin|mesh-list
44719695|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44719696|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
44719697|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719698|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719699|NCT01511146|Antiviral Agents|antiviral agents|mesh-ancestor
44719700|NCT01511146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719701|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719702|NCT01511146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719703|NCT01511146|Immunologic Factors|immunologic factors|mesh-ancestor
44719704|NCT01511146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719705|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44719706|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
44719707|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44719708|NCT01511159|Insulin|insulin|mesh-list
44719709|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44719710|NCT01511159|Liraglutide|liraglutide|mesh-list
44719711|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719712|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719713|NCT01511159|Incretins|incretins|mesh-ancestor
44719714|NCT01511159|Hormones|hormones|mesh-ancestor
44719715|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719716|NCT01511172|Metformin|metformin|mesh-list
44719717|NCT01511172|Liraglutide|liraglutide|mesh-list
44719718|NCT01511172|Glimepiride|glimepiride|mesh-list
44719719|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719720|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719721|NCT01511172|Incretins|incretins|mesh-ancestor
44719722|NCT01511172|Hormones|hormones|mesh-ancestor
43883498|NCT04610879|Levetiracetam|levetiracetam|mesh-list
44719723|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719724|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44719725|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719726|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
44719727|NCT01511185|Liraglutide|liraglutide|mesh-list
44719728|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719729|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719730|NCT01511185|Incretins|incretins|mesh-ancestor
44719731|NCT01511185|Hormones|hormones|mesh-ancestor
44719732|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719733|NCT01511198|Metformin|metformin|mesh-list
44719734|NCT01511198|Liraglutide|liraglutide|mesh-list
44719735|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719736|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719738|NCT01511198|Hormones|hormones|mesh-ancestor
44719739|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719740|NCT01511211|Dexamethasone|dexamethasone|mesh-list
44719741|NCT01511211|Ropivacaine|ropivacaine|mesh-list
44719742|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719743|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
44719744|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
44719745|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719746|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719747|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719748|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
44719749|NCT01511211|Hormones|hormones|mesh-ancestor
44719750|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719751|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44719752|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719753|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
44719754|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
44719755|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719756|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
44719757|NCT01511237|Lamivudine|lamivudine|mesh-list
44719758|NCT01511237|Zidovudine|zidovudine|mesh-list
44719759|NCT01511237|Nevirapine|nevirapine|mesh-list
44719760|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44719761|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44719762|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719763|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719764|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
44719765|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719766|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44719767|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44719768|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
44719769|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44719770|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44719771|NCT01511263|Amiodarone|amiodarone|mesh-list
44719772|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44719773|NCT01511263|Diuretics|diuretics|mesh-list
44719774|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
44719775|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719776|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
44719777|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44719778|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44719779|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719780|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44719781|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44719782|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44719783|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719784|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44719785|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44719786|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44719787|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
44719788|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719789|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44719790|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719791|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719792|NCT01511302|Budesonide|budesonide|mesh-list
44719793|NCT01511302|RNS60|rns60|mesh-list
44719794|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719795|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44719796|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
44719797|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719798|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719799|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44719800|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
44719801|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
44719802|NCT01511302|Hormones|hormones|mesh-ancestor
44719803|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719804|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44719805|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44719806|NCT01511302|Analgesics|analgesics|mesh-ancestor
44719807|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
44719808|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44719809|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44719811|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44719812|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44719813|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
44719814|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719815|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719816|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44719817|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
44719818|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
44719819|NCT01511367|Hormones|hormones|mesh-ancestor
44719820|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719821|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
44719822|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719823|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
44719824|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44719825|NCT01511471|Ticagrelor|ticagrelor|mesh-list
44719826|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44719827|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44719828|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44719829|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44719830|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
44719831|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719832|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719833|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719834|NCT01511562|Cytarabine|cytarabine|mesh-list
44719835|NCT01511562|Etoposide|etoposide|mesh-list
44719836|NCT01511562|Thiotepa|thiotepa|mesh-list
44719837|NCT01511562|Carmustine|carmustine|mesh-list
44719838|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44719839|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719840|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44719841|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44719842|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719843|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719844|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44719845|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
44719846|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
44719847|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719848|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719849|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
44719850|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719851|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883635|NCT04609189|Antacids|antacids|mesh-ancestor
44719852|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
44719853|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44719854|NCT01511627|Anesthetics|anesthetics|mesh-list
44719855|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719856|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719857|NCT01511692|Liraglutide|liraglutide|mesh-list
44719858|NCT01511692|Glimepiride|glimepiride|mesh-list
44719859|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44719860|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719861|NCT01511692|Incretins|incretins|mesh-ancestor
44719862|NCT01511692|Hormones|hormones|mesh-ancestor
44719863|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719864|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44719865|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44719866|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
44719867|NCT01511705|Ondansetron|ondansetron|mesh-list
44719868|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
44719869|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
44719870|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719871|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719872|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719873|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
44719874|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
44719875|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44719876|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
44719877|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719878|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719879|NCT01511705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44719880|NCT01511705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44719881|NCT01511705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719882|NCT01511705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44719883|NCT01511705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44719884|NCT01511718|Ondansetron|ondansetron|mesh-list
44719886|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
44719887|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719888|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719889|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719890|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
44719891|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44719892|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44719893|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
44719894|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719895|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719896|NCT01511718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44719897|NCT01511718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44719898|NCT01511718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44719899|NCT01511718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44719900|NCT01511718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44719901|NCT01511731|Famotidine|famotidine|mesh-list
44719902|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44719903|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44719904|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44719905|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
44719906|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
44719907|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44719908|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719909|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719910|NCT01511757|Fluconazole|fluconazole|mesh-list
44719911|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
44719912|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719913|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44719914|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44719915|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719916|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719917|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44719918|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
44719919|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719920|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719921|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44719922|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44719923|NCT01511770|Fluconazole|fluconazole|mesh-list
44719924|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
44719925|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44719926|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44719927|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44719928|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719929|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719930|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44719931|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
44719932|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719933|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719934|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44719935|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44719936|NCT01511822|Inositol|inositol|mesh-list
44719937|NCT01511822|Drospirenone|drospirenone|mesh-list
44719938|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44719939|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44719940|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44719941|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44719942|NCT01511822|Estradiol|estradiol|mesh-list
44719943|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44719944|NCT01511822|Estrogens|estrogens|mesh-ancestor
44719945|NCT01511822|Hormones|hormones|mesh-ancestor
44719946|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44719947|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719948|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44719949|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
44719950|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719951|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44719952|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44719953|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44719954|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
44719955|NCT01511822|Vitamins|vitamins|mesh-ancestor
44719956|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
44719957|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44719958|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
44719959|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44719961|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
44719962|NCT01511835|Folic Acid|folic acid|mesh-list
44719963|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
44719964|NCT01511835|Inositol|inositol|mesh-list
44719965|NCT01511835|Hematinics|hematinics|mesh-ancestor
44719966|NCT01511835|Vitamins|vitamins|mesh-ancestor
44719967|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
44719968|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719969|NCT01511848|Deferasirox|deferasirox|mesh-list
44719970|NCT01511848|Deferiprone|deferiprone|mesh-list
44719971|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44719972|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
44719973|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
44719974|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719975|NCT01511874|Leuprolide|leuprolide|mesh-list
44719976|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44719977|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
44719978|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44719979|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719980|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44719981|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44719982|NCT01511887|Ibuprofen|ibuprofen|mesh-list
43883718|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
44719983|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44719984|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44719985|NCT01511887|Analgesics|analgesics|mesh-ancestor
44719986|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
44719987|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44719988|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44719989|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44719990|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44719991|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44719992|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44719993|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44719994|NCT01511991|Sevoflurane|sevoflurane|mesh-list
44719995|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44719996|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44719997|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
44719998|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
44719999|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720000|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720001|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44720002|NCT01512004|Propiverine|propiverine|mesh-list
44720003|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44720004|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44720005|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
44720006|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720007|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720008|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720009|NCT01512004|Urological Agents|urological agents|mesh-ancestor
44720010|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
44720011|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
44720012|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720013|NCT01512017|Petrolatum|petrolatum|mesh-list
44720014|NCT01512017|Emollients|emollients|mesh-ancestor
44720015|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
44720016|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
44720017|NCT01512147|Propofol|propofol|mesh-list
44720018|NCT01512147|Isoflurane|isoflurane|mesh-list
44720019|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44720020|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720021|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720022|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44720023|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
44720024|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
44720025|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720026|NCT01512147|Analgesics|analgesics|mesh-ancestor
44720027|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
44720028|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720029|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44720030|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44720031|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44720032|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720033|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720042|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720043|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44720044|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44720045|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
44720046|NCT01512199|Paclitaxel|paclitaxel|mesh-list
44720047|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44720048|NCT01512199|Trastuzumab|trastuzumab|mesh-list
44720049|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44720050|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720051|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720052|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720053|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720054|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720055|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720056|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720057|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
44720058|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720068|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
44720069|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44720070|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720071|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720072|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720073|NCT01512355|Analgesics|analgesics|mesh-ancestor
44720074|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
44720075|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720076|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44720077|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44720078|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44720079|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720080|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720081|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720082|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44720083|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44720084|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44720085|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44720086|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720087|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720088|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720089|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44720090|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
44720091|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720092|NCT01512485|Clopidogrel|clopidogrel|mesh-list
44720093|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44720094|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44720095|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44720096|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44720097|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
44720098|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720099|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720100|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720101|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
44720102|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44720103|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
44720104|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
44426673|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
44720105|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720106|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720108|NCT01512511|Analgesics|analgesics|mesh-ancestor
44720109|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
44720110|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720111|NCT01512537|Vitamin D|vitamin d|mesh-list
44720112|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
44720113|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
44720114|NCT01512537|Vitamins|vitamins|mesh-list
44720115|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
44720116|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720117|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44720118|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44720119|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44720120|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
44720121|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
44271900|NCT00685230|Antivenins|antivenins|mesh-list
44720122|NCT01512680|Insulin|insulin|mesh-list
44720123|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720124|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720125|NCT01512784|Vaccines|vaccines|mesh-list
44720126|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
44720127|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720128|NCT01512862|Calcitriol|calcitriol|mesh-list
44720129|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44720130|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720131|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44720132|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44720133|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720134|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44720135|NCT01512862|Vitamins|vitamins|mesh-ancestor
44720136|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
44720137|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44720138|NCT01512901|Betamethasone|betamethasone|mesh-list
44720139|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
44720140|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44720141|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
44720142|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44720143|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720144|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
44720145|NCT01512901|Hormones|hormones|mesh-ancestor
44720146|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720147|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720148|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44720149|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44720150|NCT01512914|Ropivacaine|ropivacaine|mesh-list
44720151|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
44720152|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
44720153|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720154|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720155|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
44720156|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720157|NCT01512953|Lansoprazole|lansoprazole|mesh-list
44720158|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
44720159|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44720160|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44720161|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44720162|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720163|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720164|NCT01512966|Aflibercept|aflibercept|mesh-list
44720165|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44720166|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44720167|NCT01512966|Growth Substances|growth substances|mesh-ancestor
44720168|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720169|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
44720170|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720171|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
44720172|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720173|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720174|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44720175|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
44720176|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720177|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720178|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720179|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720181|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720182|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720183|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44720184|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
44720185|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720186|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720187|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720188|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720189|NCT01513070|Aspirin|aspirin|mesh-list
44720190|NCT01513070|Isosorbide|isosorbide|mesh-list
44720191|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44720192|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44720193|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44720194|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720195|NCT01513070|Analgesics|analgesics|mesh-ancestor
44720196|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
44720197|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720198|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720199|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720201|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720202|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720203|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720204|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44720205|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44720206|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720207|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
44720208|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44720209|NCT01513070|Diuretics|diuretics|mesh-ancestor
44720210|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
44720211|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
44720212|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44720213|NCT01513083|Trastuzumab|trastuzumab|mesh-list
44720214|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44720215|NCT01513083|Maytansine|maytansine|mesh-list
44720216|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720217|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720218|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720219|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720220|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720221|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720222|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720223|NCT01513174|Olaparib|olaparib|mesh-list
44720224|NCT01513174|Gefitinib|gefitinib|mesh-list
44720225|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44720226|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720227|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720228|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720229|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44720230|NCT01513200|Heparin|heparin|mesh-list
44720231|NCT01513200|Calcium heparin|calcium heparin|mesh-list
44720232|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
44720233|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720234|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720235|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720236|NCT01513499|Oxytocin|oxytocin|mesh-list
44720237|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
44720238|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44720239|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720240|NCT01513525|Liraglutide|liraglutide|mesh-list
44720241|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720242|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720243|NCT01513525|Incretins|incretins|mesh-ancestor
44720244|NCT01513525|Hormones|hormones|mesh-ancestor
44720245|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720246|NCT01513564|Morphine|morphine|mesh-list
44720247|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720248|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720249|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44720250|NCT01513564|Narcotics|narcotics|mesh-ancestor
44720251|NCT01513564|Analgesics|analgesics|mesh-ancestor
44720252|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
44720253|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720254|NCT01513603|Cytarabine|cytarabine|mesh-list
44720255|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
44720256|NCT01513603|Cladribine|cladribine|mesh-list
44720257|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44720258|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
44720259|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720260|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720261|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
44720262|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720263|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720264|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
44720265|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720266|NCT01513603|Analgesics|analgesics|mesh-ancestor
44720267|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
44720268|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720269|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720270|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720271|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720272|NCT01513668|Acetaminophen|acetaminophen|mesh-list
44720273|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720274|NCT01513668|Analgesics|analgesics|mesh-ancestor
44720275|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
44720276|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720277|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720278|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
44720279|NCT01513681|Lamotrigine|lamotrigine|mesh-list
44720280|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
44720281|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44720282|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44720283|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720284|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44720285|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720286|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44720287|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44720288|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720289|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720290|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44720291|NCT01513720|Lamotrigine|lamotrigine|mesh-list
44720292|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
44720293|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44720294|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44720295|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720296|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44720297|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720298|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44720299|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44720300|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720301|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720302|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44720303|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
44720304|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44720305|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720306|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720307|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720308|NCT01513772|Analgesics|analgesics|mesh-ancestor
44720309|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
44720310|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720311|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44720312|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44720313|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44720314|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720315|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720316|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720317|NCT01513785|Amoxicillin|amoxicillin|mesh-list
44720318|NCT01513785|Rabeprazole|rabeprazole|mesh-list
44720319|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720320|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720321|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44720322|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44720323|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44720324|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720325|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720326|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44720327|NCT01513863|Metronidazole|metronidazole|mesh-list
44720328|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720329|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720330|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44720331|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44720332|NCT01513941|Interferons|interferons|mesh-list
44720334|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
44720335|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
44720336|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44720337|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720338|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
44720339|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720340|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
44720341|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720342|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
44720343|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720344|NCT01514019|Acebutolol|acebutolol|mesh-list
44720345|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44720346|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44720347|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
44720348|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
44720349|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720350|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720351|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44720352|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44720353|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44720354|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720355|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720356|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720357|NCT01514110|Paclitaxel|paclitaxel|mesh-list
44720358|NCT01514110|Carboplatin|carboplatin|mesh-list
44720359|NCT01514110|Everolimus|everolimus|mesh-list
44720360|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720361|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720362|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720363|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720364|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720365|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720366|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720367|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
44720368|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720369|NCT01514123|Bevacizumab|bevacizumab|mesh-list
44720370|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720371|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720372|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44720373|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44720374|NCT01514123|Growth Substances|growth substances|mesh-ancestor
44720375|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720376|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
44720377|NCT01514175|Ibuprofen|ibuprofen|mesh-list
44720378|NCT01514175|Ketorolac|ketorolac|mesh-list
44720379|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44720380|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720381|NCT01514175|Analgesics|analgesics|mesh-ancestor
44720382|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
44720383|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720384|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720385|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720386|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720387|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44720388|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720389|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720390|NCT01514188|Doxorubicin|doxorubicin|mesh-list
44720391|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720392|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720393|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720394|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720395|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720396|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720397|NCT01514227|Aspirin|aspirin|mesh-list
44720398|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44720399|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720400|NCT01514227|Analgesics|analgesics|mesh-ancestor
44720401|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
44720402|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720403|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720404|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720405|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720406|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720407|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720408|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720409|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44720410|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44720411|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720412|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
44720413|NCT01514266|Curcumin|curcumin|mesh-list
44720414|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44720415|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720416|NCT01514266|Analgesics|analgesics|mesh-ancestor
44720417|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
44720418|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720419|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720420|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720421|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720422|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720423|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720424|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720425|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44720426|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44720427|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
44720428|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720429|NCT01514487|Liraglutide|liraglutide|mesh-list
44720430|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720431|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720432|NCT01514487|Incretins|incretins|mesh-ancestor
44720433|NCT01514487|Hormones|hormones|mesh-ancestor
44720434|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720435|NCT01514695|Fentanyl|fentanyl|mesh-list
44720436|NCT01514695|Midazolam|midazolam|mesh-list
44720437|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44720438|NCT01514695|Narcotics|narcotics|mesh-ancestor
44720439|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720440|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720441|NCT01514695|Analgesics|analgesics|mesh-ancestor
44720442|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
44720443|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720444|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44720445|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44720446|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
44720447|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
44720448|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44720449|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44720450|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44720451|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720452|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
44720453|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
44720454|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720455|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720457|NCT01514721|Travoprost|travoprost|mesh-list
44720458|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44720459|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44720460|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44720461|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720462|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720463|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720464|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44720465|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44720466|NCT01514812|Digoxin|digoxin|mesh-list
44720467|NCT01514812|Darexaban|darexaban|mesh-list
44720468|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44720469|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44720470|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720471|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720472|NCT01514812|Protective Agents|protective agents|mesh-ancestor
44720473|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720474|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44720475|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
44720476|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44720477|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720478|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
44720479|NCT01514825|Darexaban|darexaban|mesh-list
44720480|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44720481|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
44720482|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44720483|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720484|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720485|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720486|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
44720487|NCT01514838|Acarbose|acarbose|mesh-list
44720488|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
44720489|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44720490|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720491|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720492|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720493|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720494|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44720495|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
44720496|NCT01514851|Calcium|calcium|mesh-list
44720497|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44720498|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720499|NCT01514851|Antacids|antacids|mesh-ancestor
44720500|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720501|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44720502|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
44720503|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
44720504|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44720505|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44720506|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720507|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720508|NCT01514903|Urological Agents|urological agents|mesh-ancestor
44720509|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
44720510|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720511|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720512|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720513|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720514|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720515|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720516|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720517|NCT01514942|Folic Acid|folic acid|mesh-list
44720518|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
44720519|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
44720520|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
44720521|NCT01514942|Inositol|inositol|mesh-list
44720522|NCT01514942|Manganese|manganese|mesh-list
44720523|NCT01514942|Hematinics|hematinics|mesh-ancestor
44720524|NCT01514942|Vitamins|vitamins|mesh-ancestor
43884191|NCT04601701|Hormones|hormones|mesh-ancestor
44720525|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
44720526|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720527|NCT01514942|Trace Elements|trace elements|mesh-ancestor
44720528|NCT01514968|Cyclosporine|cyclosporine|mesh-list
44720529|NCT01514968|Ritonavir|ritonavir|mesh-list
44720530|NCT01514968|Cyclosporins|cyclosporins|mesh-list
44720531|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720532|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720533|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720534|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
44720535|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720536|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
44720537|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720538|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
44720539|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720540|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44720541|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44720542|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44720543|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720544|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44720545|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44720546|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
44720547|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44720548|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44720549|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
44720550|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720551|NCT01515020|Vancomycin|vancomycin|mesh-list
44720552|NCT01515020|Daptomycin|daptomycin|mesh-list
44720553|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720554|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720555|NCT01515137|Sulindac|sulindac|mesh-list
44720556|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44720557|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720558|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44720559|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720560|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720561|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44720562|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720563|NCT01515137|Analgesics|analgesics|mesh-ancestor
44720564|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
44720565|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720566|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720567|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720568|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720569|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44720571|NCT01515228|Everolimus|everolimus|mesh-list
44720572|NCT01515228|Cilostazol|cilostazol|mesh-list
44720573|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720574|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720575|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720576|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720577|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720578|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720579|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720580|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
44720581|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720582|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44720583|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
44720584|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720585|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44720586|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
44720587|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720588|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720589|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44720590|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
44720591|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44720592|NCT01515228|Protective Agents|protective agents|mesh-ancestor
44720593|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44720594|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44720595|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720596|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44720597|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44720598|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720599|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720600|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44720601|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44720602|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720603|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
44720604|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720605|NCT01515397|Polygeline|polygeline|mesh-list
44720606|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
44720607|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
44720608|NCT01515553|Liraglutide|liraglutide|mesh-list
44720609|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720610|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720611|NCT01515553|Incretins|incretins|mesh-ancestor
44720612|NCT01515553|Hormones|hormones|mesh-ancestor
44720613|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720614|NCT01515579|Liraglutide|liraglutide|mesh-list
44720615|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720616|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720617|NCT01515579|Incretins|incretins|mesh-ancestor
44720618|NCT01515579|Hormones|hormones|mesh-ancestor
44720619|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720620|NCT01515592|Liraglutide|liraglutide|mesh-list
44720621|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720622|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720623|NCT01515592|Incretins|incretins|mesh-ancestor
44720624|NCT01515592|Hormones|hormones|mesh-ancestor
44720625|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720626|NCT01515683|Anesthetics|anesthetics|mesh-list
44720627|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720628|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720629|NCT01515774|Pramipexole|pramipexole|mesh-list
44720630|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
44720631|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720632|NCT01515774|Protective Agents|protective agents|mesh-ancestor
44720633|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720634|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44720635|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44720636|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
44720637|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
44720638|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720640|NCT01515813|Emtricitabine|emtricitabine|mesh-list
44720641|NCT01515813|Efavirenz|efavirenz|mesh-list
44720642|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44720643|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44720644|NCT01515813|Pravastatin|pravastatin|mesh-list
44720645|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
44720646|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720647|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44720648|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44720649|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720650|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720651|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44720652|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44720653|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43884328|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44720654|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44720655|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44720656|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44720657|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44720658|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44720659|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44720660|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44720661|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
44720662|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44720663|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44720664|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
44720665|NCT01515826|Dexamethasone|dexamethasone|mesh-list
44720666|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
44720667|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44720668|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44720669|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44720670|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44720671|NCT01515826|BB 1101|bb 1101|mesh-list
44720672|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44720673|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
44720674|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
44720675|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720676|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720677|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44720678|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
44720679|NCT01515826|Hormones|hormones|mesh-ancestor
44720680|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720681|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44720682|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720683|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720684|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720685|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720686|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720687|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720688|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720689|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720690|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44720691|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
44720692|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44720693|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44720694|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44720695|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44720696|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
44720697|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
44720698|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
44720699|NCT01515839|Vinpocetine|vinpocetine|mesh-list
44720700|NCT01515839|Huperzine A|huperzine a|mesh-list
44720701|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
44720702|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720703|NCT01515839|Protective Agents|protective agents|mesh-ancestor
44720704|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720705|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
44720706|NCT01515839|Vitamins|vitamins|mesh-ancestor
44720707|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
44720708|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
44720709|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44720710|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720711|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
44720712|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720713|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44720714|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
44720715|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720716|NCT01515839|Expectorants|expectorants|mesh-ancestor
44720717|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
44720718|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44720719|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44720720|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
44720721|NCT01515852|Anesthetics|anesthetics|mesh-list
44720722|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720723|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720724|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44720725|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
44720726|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44720727|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720728|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44720729|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720730|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720731|NCT01516060|Efavirenz|efavirenz|mesh-list
44720732|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44720733|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44720734|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720735|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720736|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
44720737|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720738|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44720739|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44720740|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44720741|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44720742|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44720743|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44720744|NCT01516138|Insulin|insulin|mesh-list
44720745|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720746|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720747|NCT01516255|Liraglutide|liraglutide|mesh-list
44720748|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
44720749|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720750|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720751|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720752|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720753|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720754|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720755|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720756|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720757|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720758|NCT01516255|Incretins|incretins|mesh-ancestor
44720759|NCT01516255|Hormones|hormones|mesh-ancestor
44720760|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720761|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
44720762|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44720763|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720764|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720765|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720766|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720767|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720768|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720769|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720770|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44720771|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
44720772|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44720773|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720774|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44720775|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44720776|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44720777|NCT01516450|Belimumab|belimumab|mesh-list
44720778|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720779|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
44720780|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720781|NCT01516463|Bacitracin|bacitracin|mesh-list
44720782|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44720783|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720784|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720785|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
44720786|NCT01516554|Testosterone|testosterone|mesh-list
44720787|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
44720788|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
44720789|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44720790|NCT01516554|Androgens|androgens|mesh-ancestor
44720791|NCT01516554|Hormones|hormones|mesh-ancestor
44720792|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720793|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720794|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44720795|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720796|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
44720797|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
44720798|NCT01516567|Rituximab|rituximab|mesh-list
44720799|NCT01516567|Doxorubicin|doxorubicin|mesh-list
44720800|NCT01516567|Etoposide|etoposide|mesh-list
44720801|NCT01516567|Vincristine|vincristine|mesh-list
44720802|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720803|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
44720804|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720805|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720806|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44720807|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
44720808|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720809|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720810|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44720811|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720812|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720813|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720814|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720815|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720816|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720817|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720818|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720819|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720820|NCT01516580|Cytarabine|cytarabine|mesh-list
44720821|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
44720822|NCT01516580|Rituximab|rituximab|mesh-list
44720823|NCT01516580|Doxorubicin|doxorubicin|mesh-list
44720824|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44720825|NCT01516580|Methotrexate|methotrexate|mesh-list
44720826|NCT01516580|Vincristine|vincristine|mesh-list
44720827|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720828|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
44720829|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720830|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44720831|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44720832|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
44720833|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720834|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720835|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44720836|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720837|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720838|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44720839|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44720840|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720841|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44720842|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
44720843|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44720844|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44720845|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
44720846|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44720847|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44720848|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44720849|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
44720850|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720851|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44720852|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720853|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720854|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720855|NCT01516710|Liver Extracts|liver extracts|mesh-list
44720856|NCT01516710|Hematinics|hematinics|mesh-ancestor
44720857|NCT01516723|Sirolimus|sirolimus|mesh-list
44720858|NCT01516723|Everolimus|everolimus|mesh-list
44720859|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720860|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44720861|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
44720862|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720863|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720864|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720865|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44720866|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
44720867|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44720868|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720869|NCT01516814|Heparin|heparin|mesh-list
44720870|NCT01516814|Calcium heparin|calcium heparin|mesh-list
44720871|NCT01516814|Warfarin|warfarin|mesh-list
44720872|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
44720873|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
44720874|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720875|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720876|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720877|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44720878|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
44720879|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44720880|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720881|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720882|NCT01516840|Heparin|heparin|mesh-list
44720883|NCT01516840|Calcium heparin|calcium heparin|mesh-list
44720884|NCT01516840|Warfarin|warfarin|mesh-list
44720885|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
44720886|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
44720887|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44720888|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44720889|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720890|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44720891|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
44720892|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44720893|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720894|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720895|NCT01516866|Listerine|listerine|mesh-list
44720896|NCT01516866|Fluorides|fluorides|mesh-list
44720897|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
44720898|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
44720899|NCT01516866|Protective Agents|protective agents|mesh-ancestor
44720900|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720901|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44720902|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720903|NCT01516944|Capecitabine|capecitabine|mesh-list
44720904|NCT01516944|Tegafur|tegafur|mesh-list
44720905|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
44720906|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44720907|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
44720908|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720909|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720910|NCT01516996|Cisplatin|cisplatin|mesh-list
44720911|NCT01516996|Docetaxel|docetaxel|mesh-list
44720912|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
44720913|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720914|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720915|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720916|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720917|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720918|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44720919|NCT01517009|Cisplatin|cisplatin|mesh-list
44720920|NCT01517009|Docetaxel|docetaxel|mesh-list
44720921|NCT01517009|Capecitabine|capecitabine|mesh-list
44720922|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720923|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44720924|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44720925|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44720926|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720927|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44720928|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
44720930|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44720931|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
44720932|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720933|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720934|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44720935|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44720936|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
44720937|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720938|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720939|NCT01517165|Pioglitazone|pioglitazone|mesh-list
44720940|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720941|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720942|NCT01517308|Interferons|interferons|mesh-list
44720943|NCT01517308|Ribavirin|ribavirin|mesh-list
44720944|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
44720945|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
44720946|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44720947|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720948|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
44720949|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720950|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
44720951|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720952|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
44720953|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720954|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44720955|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44720956|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720957|NCT01517321|Incretins|incretins|mesh-ancestor
44720958|NCT01517321|Hormones|hormones|mesh-ancestor
44720959|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44720960|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44720961|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
44720962|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44720963|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44720964|NCT01517334|Minocycline|minocycline|mesh-list
44720965|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44720966|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44720967|NCT01517347|Interleukin-2|interleukin-2|mesh-list
44720968|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44720969|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44720970|NCT01517347|Analgesics|analgesics|mesh-ancestor
44720971|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
44720972|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44720973|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720974|NCT01517360|Oxytocin|oxytocin|mesh-list
44720975|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
44720976|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44720977|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720978|NCT01517399|Vitamin K|vitamin k|mesh-list
44720979|NCT01517399|Digoxin|digoxin|mesh-list
44720980|NCT01517399|Midazolam|midazolam|mesh-list
44720981|NCT01517399|Caffeine|caffeine|mesh-list
44720982|NCT01517399|Omeprazole|omeprazole|mesh-list
44720983|NCT01517399|Warfarin|warfarin|mesh-list
44720984|NCT01517399|Vitamins|vitamins|mesh-ancestor
44720985|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
44720986|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44720987|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44720988|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44720989|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44720990|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44720991|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44720992|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44720993|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44720994|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
44720995|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
44720996|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
44720997|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
44720998|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44720999|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721000|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
44721001|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44721002|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721003|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44721004|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884571|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
44721005|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44721006|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44721007|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44721008|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44721009|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
44721010|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721011|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44721012|NCT01517399|Protective Agents|protective agents|mesh-ancestor
44721013|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44721014|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44721016|NCT01517399|Coagulants|coagulants|mesh-ancestor
44721017|NCT01517490|Insulin|insulin|mesh-list
44721018|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44721019|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721020|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721021|NCT01517555|Acetaminophen|acetaminophen|mesh-list
44721022|NCT01517555|Liraglutide|liraglutide|mesh-list
44721023|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721024|NCT01517555|Analgesics|analgesics|mesh-ancestor
44721025|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
44721026|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721027|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721028|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
44721029|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721030|NCT01517555|Incretins|incretins|mesh-ancestor
44721031|NCT01517555|Hormones|hormones|mesh-ancestor
44721032|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721033|NCT01517568|Liraglutide|liraglutide|mesh-list
44721034|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721035|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721036|NCT01517568|Incretins|incretins|mesh-ancestor
44721037|NCT01517568|Hormones|hormones|mesh-ancestor
44721038|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721039|NCT01517607|Mesalamine|mesalamine|mesh-list
44721040|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44721041|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721042|NCT01517607|Analgesics|analgesics|mesh-ancestor
44721043|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
44721044|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721045|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721046|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44721047|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44721048|NCT01517724|Bortezomib|bortezomib|mesh-list
44721049|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721050|NCT01517815|Tazobactam|tazobactam|mesh-list
44721051|NCT01517815|Piperacillin|piperacillin|mesh-list
44721052|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44721053|NCT01517815|Doripenem|doripenem|mesh-list
44721054|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44721055|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721056|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44721057|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721058|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721059|NCT01517828|Midazolam|midazolam|mesh-list
44721060|NCT01517828|Ketamine|ketamine|mesh-list
44721061|NCT01517828|Analgesics|analgesics|mesh-ancestor
44721062|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
44721063|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721064|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721065|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44721066|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44721067|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
44721068|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
44721069|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721070|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44721071|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44721072|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884583|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
44721073|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721074|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44721075|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44721076|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44721077|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44721078|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721079|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
44721080|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
44721081|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
44721082|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
44721083|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44721084|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44721085|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721086|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721087|NCT01517854|Urological Agents|urological agents|mesh-ancestor
44721088|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
44721089|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44721090|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721091|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721092|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721093|NCT01517932|Analgesics|analgesics|mesh-ancestor
44721094|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
44721095|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721096|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44721097|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44721098|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44721099|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721100|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721101|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721103|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44721104|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721105|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44721106|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44721107|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
44721108|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721109|NCT01518062|Estrogens|estrogens|mesh-list
44721110|NCT01518062|Hormones|hormones|mesh-ancestor
44721111|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721112|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721113|NCT01518101|Metformin|metformin|mesh-list
44721114|NCT01518101|Liraglutide|liraglutide|mesh-list
44721115|NCT01518101|Vildagliptin|vildagliptin|mesh-list
44721116|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721117|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721118|NCT01518101|Incretins|incretins|mesh-ancestor
44721119|NCT01518101|Hormones|hormones|mesh-ancestor
44721120|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721121|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44721122|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721123|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721124|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721125|NCT01518166|Liraglutide|liraglutide|mesh-list
44721126|NCT01518166|Griseofulvin|griseofulvin|mesh-list
44721127|NCT01518166|Digoxin|digoxin|mesh-list
44721128|NCT01518166|Lisinopril|lisinopril|mesh-list
44721129|NCT01518166|Atorvastatin|atorvastatin|mesh-list
44721130|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44721131|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44721132|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
44721133|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721134|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44721135|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44721136|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721137|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721138|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721139|NCT01518166|Incretins|incretins|mesh-ancestor
44721140|NCT01518166|Hormones|hormones|mesh-ancestor
44721141|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721142|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721143|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44721144|NCT01518166|Protective Agents|protective agents|mesh-ancestor
44721145|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44721146|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721147|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721148|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
44721149|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721150|NCT01518231|Aspirin|aspirin|mesh-list
44721151|NCT01518231|Edaravone|edaravone|mesh-list
44721152|NCT01518231|Warfarin|warfarin|mesh-list
44721153|NCT01518231|Atorvastatin|atorvastatin|mesh-list
44721154|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44721155|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721156|NCT01518231|Analgesics|analgesics|mesh-ancestor
44721157|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
44721158|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721159|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721160|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44721161|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44721162|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44721163|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44721164|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721165|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44721166|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44721167|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721168|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
44721169|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44721170|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44721171|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
44721172|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44721173|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44721174|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
44721175|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44721176|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
44721177|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44721178|NCT01518231|Protective Agents|protective agents|mesh-ancestor
44721179|NCT01518413|Irinotecan|irinotecan|mesh-list
44721180|NCT01518413|Sorafenib|sorafenib|mesh-list
44721181|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44721182|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44721183|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721184|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721185|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721186|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44721187|NCT01518465|Dexamethasone|dexamethasone|mesh-list
44721188|NCT01518465|Lenalidomide|lenalidomide|mesh-list
44721189|NCT01518465|Dalteparin|dalteparin|mesh-list
44721190|NCT01518465|Tinzaparin|tinzaparin|mesh-list
44721191|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44721192|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44721193|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
44721194|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
44721195|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721196|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721197|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721198|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
44721199|NCT01518465|Hormones|hormones|mesh-ancestor
44721200|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721201|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44721202|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721203|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
44721204|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44721205|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44721206|NCT01518465|Growth Substances|growth substances|mesh-ancestor
44721207|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
44721208|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
44721209|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44721210|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44721211|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721212|NCT01518569|Urinastatin|urinastatin|mesh-list
44721213|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44721214|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44721215|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721216|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721217|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721218|NCT01518595|Bosentan|bosentan|mesh-list
43884797|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
44721219|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721220|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44721221|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721222|NCT01518608|Alfentanil|alfentanil|mesh-list
44721223|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44721224|NCT01518608|Narcotics|narcotics|mesh-ancestor
44721225|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721226|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721227|NCT01518608|Analgesics|analgesics|mesh-ancestor
44721228|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
44721229|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721230|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44721231|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
44721232|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
44721233|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44721234|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721235|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44721236|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721237|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721238|NCT01518634|Imipramine|imipramine|mesh-list
44721239|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44721240|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
44721241|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721242|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44721243|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44721244|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721245|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721246|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721247|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721248|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721249|NCT01518712|Metformin|metformin|mesh-list
44721250|NCT01518712|Canagliflozin|canagliflozin|mesh-list
44721251|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721252|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721253|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44721254|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721255|NCT01518725|Vitamin D|vitamin d|mesh-list
44721256|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
44721257|NCT01518725|Vitamins|vitamins|mesh-ancestor
44721258|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
44721259|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721260|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44721261|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721262|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44721263|NCT01518790|Laxatives|laxatives|mesh-ancestor
44721264|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721265|NCT01518855|Amlodipine|amlodipine|mesh-list
44721266|NCT01518855|Nifedipine|nifedipine|mesh-list
44721267|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721268|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44721269|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721270|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721271|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721272|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721273|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
44721274|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
44721275|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44721276|NCT01518933|Silybin|silybin|mesh-list
44721277|NCT01518933|Silymarin|silymarin|mesh-list
44721278|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
44721279|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721280|NCT01518933|Protective Agents|protective agents|mesh-ancestor
44721281|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721282|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44721283|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721284|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
44721285|NCT01518959|Vitamin D|vitamin d|mesh-list
44721286|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721287|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721288|NCT01518959|Vitamins|vitamins|mesh-ancestor
44721289|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
44721290|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44721291|NCT01518998|Amlodipine|amlodipine|mesh-list
44721292|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721293|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44721294|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721295|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721296|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721297|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721298|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
44721299|NCT01519011|Azacitidine|azacitidine|mesh-list
44721300|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44721301|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
44721302|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721303|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721304|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721305|NCT01519037|Cinacalcet|cinacalcet|mesh-list
44721306|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721307|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721308|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44721309|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44721310|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721311|NCT01519076|Coal Tar|coal tar|mesh-list
44721312|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
44721313|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
44721315|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721316|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721317|NCT01519128|Rilpivirine|rilpivirine|mesh-list
44721318|NCT01519128|Digoxin|digoxin|mesh-list
44721319|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721320|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44721321|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721322|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721323|NCT01519128|Protective Agents|protective agents|mesh-ancestor
44721324|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721325|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44721326|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44721327|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
44721328|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721329|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44721330|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44721331|NCT01519154|Ketamine|ketamine|mesh-list
44721332|NCT01519154|Propofol|propofol|mesh-list
44721333|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44721334|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721335|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721336|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44721337|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
44721338|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
44721339|NCT01519154|Analgesics|analgesics|mesh-ancestor
44721340|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
44721341|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721342|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44721343|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44721344|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44721345|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721346|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721347|NCT01519297|Irbesartan|irbesartan|mesh-list
44721348|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721349|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44721350|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44721351|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721352|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44721353|NCT01519310|Metronidazole|metronidazole|mesh-list
44721354|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
44721355|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721356|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44721357|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44721358|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44721359|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44721360|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721361|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721362|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721363|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44721364|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44721365|NCT01519336|Ritonavir|ritonavir|mesh-list
44721366|NCT01519336|Darunavir|darunavir|mesh-list
44721367|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44721368|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44721369|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721370|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721371|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721372|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44721373|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44721374|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
44721375|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721376|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44721377|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44721378|NCT01519401|Drospirenone|drospirenone|mesh-list
44721379|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44721380|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44721381|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44721382|NCT01519401|Estradiol|estradiol|mesh-list
44721383|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44721384|NCT01519401|Estrogens|estrogens|mesh-ancestor
44721385|NCT01519401|Hormones|hormones|mesh-ancestor
44721386|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721387|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721388|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44721389|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
44721390|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44721391|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44721392|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44721393|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44721394|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44721395|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
44721396|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44721397|NCT01519401|Diuretics|diuretics|mesh-ancestor
44721398|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
44721399|NCT01519544|Acetazolamide|acetazolamide|mesh-list
44721400|NCT01519544|Temazepam|temazepam|mesh-list
44721401|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
44721402|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44721403|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721404|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721405|NCT01519544|Diuretics|diuretics|mesh-ancestor
44721406|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
44721407|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721408|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44721409|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721410|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44721411|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44721412|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721413|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
44721415|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721416|NCT01519687|Tofisopam|tofisopam|mesh-list
44721417|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
44721418|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721419|NCT01519726|Midazolam|midazolam|mesh-list
44721420|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44721421|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44721422|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721423|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721424|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44721425|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44721426|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721427|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44721428|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
44721429|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
44721430|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
44721431|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
44721432|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721433|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721434|NCT01519752|Oxiconazole|oxiconazole|mesh-list
44721435|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
44721436|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721437|NCT01519856|Piribedil|piribedil|mesh-list
44721438|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44721439|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44721440|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
44721441|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
44721442|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721443|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721444|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721445|NCT01519986|Vitamin D|vitamin d|mesh-list
44721446|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
44721447|NCT01519986|Vitamins|vitamins|mesh-ancestor
44721448|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
44721449|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721450|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44721451|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721452|NCT01520012|Esomeprazole|esomeprazole|mesh-list
44721453|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44721454|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721455|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44721456|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721457|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721458|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44721459|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44721460|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721461|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44721462|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44721463|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44721464|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
44721465|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721466|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44721467|NCT01520103|Everolimus|everolimus|mesh-list
44721468|NCT01520103|Vinorelbine|vinorelbine|mesh-list
44721469|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721470|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44721471|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
44721472|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721473|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44721474|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44721475|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44721476|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44721477|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721478|NCT01520116|Timolol|timolol|mesh-list
44721479|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44721480|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44721481|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721482|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721483|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721484|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721485|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721486|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721487|NCT01520181|Lactams|lactams|mesh-list
44721488|NCT01520181|beta-Lactams|beta-lactams|mesh-list
44273291|NCT00692159|Pemetrexed|pemetrexed|mesh-list
44721489|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44721490|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721491|NCT01520285|Felodipine|felodipine|mesh-list
44721492|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721493|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721494|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44721495|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721496|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721497|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721498|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721499|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44721500|NCT01520298|Acetaminophen|acetaminophen|mesh-list
44721501|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721502|NCT01520298|Analgesics|analgesics|mesh-ancestor
44721503|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
44721504|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721505|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721506|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
44721507|NCT01520350|Aripiprazole|aripiprazole|mesh-list
44721508|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
44721509|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721510|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44721511|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44721512|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721513|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721514|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
44721515|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
44721516|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721517|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721518|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44721519|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44721520|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
44721521|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44721522|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44721523|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44721524|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44721525|NCT01520389|Irinotecan|irinotecan|mesh-list
44721526|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44721527|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44721528|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44721529|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721530|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721531|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721532|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
44721533|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721534|NCT01520415|Lidocaine|lidocaine|mesh-list
44721535|NCT01520415|Bupivacaine|bupivacaine|mesh-list
44721536|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
44721537|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
44721538|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721539|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721540|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
44721541|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721542|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721543|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44721544|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44721545|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721546|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721547|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44721548|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44721549|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721550|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721551|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44721552|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721553|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721554|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
44721555|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721556|NCT01520467|Anastrozole|anastrozole|mesh-list
44721557|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44721558|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721559|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44721560|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44721561|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721562|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721563|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44721564|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
44721565|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721566|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721567|NCT01520584|Vitamins|vitamins|mesh-list
44721568|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
44721569|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721570|NCT01520753|Insulin|insulin|mesh-list
44721571|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44721572|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
44721573|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
44721574|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44721575|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
44721576|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721577|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721578|NCT01520766|Methamphetamine|methamphetamine|mesh-list
44721579|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44721580|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721581|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
44721582|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
44721583|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721584|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
44721585|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721586|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721587|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721588|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44721589|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44721590|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721591|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44721592|NCT01520792|Acetaminophen|acetaminophen|mesh-list
44721593|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721594|NCT01520792|Analgesics|analgesics|mesh-ancestor
44721595|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
44721596|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721597|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721598|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
44721600|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44721601|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
44721602|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
44721603|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44721604|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
44721605|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721606|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721607|NCT01520831|Insulin|insulin|mesh-list
44721608|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44721609|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
44721610|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
44721611|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44721612|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
44721613|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44721614|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721615|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721616|NCT01520896|Ketoconazole|ketoconazole|mesh-list
44721618|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
44721619|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721620|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44721621|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44721622|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721623|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721624|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44721625|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
44721626|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721627|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721628|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44721629|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44721630|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
44721631|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721632|NCT01521130|Levetiracetam|levetiracetam|mesh-list
44721633|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
44721634|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
44721635|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
44721636|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721637|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
44721638|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721639|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721640|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44721641|NCT01521312|Saxagliptin|saxagliptin|mesh-list
44721642|NCT01521312|Incretins|incretins|mesh-ancestor
44721643|NCT01521312|Hormones|hormones|mesh-ancestor
44721644|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721645|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721646|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44721647|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721648|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721649|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721650|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721651|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44721652|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
44721653|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721654|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
44721655|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44721656|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44721657|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721658|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44721659|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44721660|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721661|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721662|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721663|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44721664|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
44721665|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44721666|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721667|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44721668|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44721669|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44721670|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44721671|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44721672|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
44721673|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721674|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721675|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44721676|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
44721677|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
44721678|NCT01521455|Hormones|hormones|mesh-ancestor
44721679|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721680|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
44721681|NCT01521481|Anesthetics|anesthetics|mesh-list
44721682|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721683|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721684|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44721685|NCT01521520|Hematinics|hematinics|mesh-ancestor
44721686|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44721687|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44721688|NCT01521572|Albuterol|albuterol|mesh-list
44721689|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44721690|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
44721691|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721692|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721693|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44721694|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
44721695|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
44721696|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44721697|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44721698|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44721699|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44721700|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721701|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721702|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721703|NCT01521624|Metformin|metformin|mesh-list
44721704|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721705|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721706|NCT01521689|Rituximab|rituximab|mesh-list
44721707|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44721708|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721709|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
44721710|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721711|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44721712|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44721713|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44721714|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44721715|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
44721716|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721717|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721718|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721719|NCT01521767|Urological Agents|urological agents|mesh-ancestor
44721720|NCT01521793|Retinol acetate|retinol acetate|mesh-list
44721721|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44721722|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
44721723|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721724|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44721725|NCT01521793|Protective Agents|protective agents|mesh-ancestor
44721726|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721727|NCT01521819|Ranibizumab|ranibizumab|mesh-list
44721728|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44721729|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44721730|NCT01521819|Growth Substances|growth substances|mesh-ancestor
44721731|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721732|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
44721733|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721734|NCT01521936|Vitamin D|vitamin d|mesh-list
44721735|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
44721736|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
44721737|NCT01521936|Vitamins|vitamins|mesh-list
44721738|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
44721739|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721740|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44721741|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721742|NCT01521962|Alogliptin|alogliptin|mesh-list
44721743|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721744|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721745|NCT01521962|Incretins|incretins|mesh-ancestor
44721746|NCT01521962|Hormones|hormones|mesh-ancestor
44721747|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721748|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44721749|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721750|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721751|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721752|NCT01521975|Adefovir|adefovir|mesh-list
44721753|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44721754|NCT01521975|Telbivudine|telbivudine|mesh-list
44721755|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
44721756|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721757|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44721758|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44721759|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721760|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721761|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
44721763|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
44721764|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721765|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721766|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
44721767|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721768|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721769|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
44721770|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44721771|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721772|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721773|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44721774|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
44721775|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44721776|NCT01522092|Citalopram|citalopram|mesh-list
44721777|NCT01522092|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44721778|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44721779|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44721780|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721781|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721782|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
44721783|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721784|NCT01522092|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44721785|NCT01522092|Antidepressive Agents|antidepressive agents|mesh-ancestor
44721786|NCT01522092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44721787|NCT01522105|Daptomycin|daptomycin|mesh-list
44721788|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44721789|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721790|NCT01522326|Ibuprofen|ibuprofen|mesh-list
44721791|NCT01522326|Metoclopramide|metoclopramide|mesh-list
44721792|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44721793|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721794|NCT01522326|Analgesics|analgesics|mesh-ancestor
44721795|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
44721796|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721797|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721798|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44721799|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44721800|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44721801|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721802|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721803|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
44721804|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
44721805|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721806|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44721807|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44721808|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
44721809|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721810|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44721811|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721812|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721813|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721814|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44721815|NCT01522534|Morphine|morphine|mesh-list
44721816|NCT01522534|Mepivacaine|mepivacaine|mesh-list
44721817|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44721818|NCT01522534|Narcotics|narcotics|mesh-ancestor
44721819|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721820|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721821|NCT01522534|Analgesics|analgesics|mesh-ancestor
44721822|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
44721823|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721824|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
44721825|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
44721826|NCT01522547|Pomalidomide|pomalidomide|mesh-list
44721827|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
44721828|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721829|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44721830|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44721831|NCT01522547|Growth Substances|growth substances|mesh-ancestor
44721832|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
44721833|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721834|NCT01522612|Leucovorin|leucovorin|mesh-list
44721835|NCT01522612|Fluorouracil|fluorouracil|mesh-list
44721836|NCT01522612|Cetuximab|cetuximab|mesh-list
44721837|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
44721838|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721839|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44721840|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721841|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44721842|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
44721843|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721844|NCT01522612|Antidotes|antidotes|mesh-ancestor
44721845|NCT01522612|Protective Agents|protective agents|mesh-ancestor
44721846|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
44721847|NCT01522612|Vitamins|vitamins|mesh-ancestor
44721848|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
44721849|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44721850|NCT01522625|Tenofovir|tenofovir|mesh-list
44721851|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
44721852|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721853|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44721854|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44721855|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721856|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721857|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44721858|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44721859|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44721860|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44721861|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
44721862|NCT01522729|Fentanyl|fentanyl|mesh-list
44721863|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44721864|NCT01522729|Narcotics|narcotics|mesh-ancestor
44721865|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44721866|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721867|NCT01522729|Analgesics|analgesics|mesh-ancestor
44721868|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
44721869|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721870|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44721871|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44721872|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
44721873|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
44721874|NCT01522768|Paclitaxel|paclitaxel|mesh-list
44721875|NCT01522768|Afatinib|afatinib|mesh-list
44721876|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44721877|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721878|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
44721879|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
44721880|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
44721881|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721882|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44721883|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721884|NCT01522820|Sirolimus|sirolimus|mesh-list
44721885|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44721886|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721887|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44721888|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721889|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
44721890|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44721891|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
44721892|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721893|NCT01522846|Heparin|heparin|mesh-list
44721894|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
44721895|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44721896|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44721897|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721898|NCT01522872|Dexamethasone|dexamethasone|mesh-list
44721899|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
44721900|NCT01522872|Bortezomib|bortezomib|mesh-list
44721901|NCT01522872|Pomalidomide|pomalidomide|mesh-list
44721902|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
44721903|NCT01522872|BB 1101|bb 1101|mesh-list
44721904|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44721905|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
44721906|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
44721907|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721908|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721909|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44721911|NCT01522872|Hormones|hormones|mesh-ancestor
44721912|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44721913|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44721915|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
44721916|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721917|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721918|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
44721919|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44721920|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44721921|NCT01522872|Growth Substances|growth substances|mesh-ancestor
44721922|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44721923|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44721924|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
44721925|NCT01522989|Fluorouracil|fluorouracil|mesh-list
44721926|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
44721927|NCT01522989|Palbociclib|palbociclib|mesh-list
44721928|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
44721929|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721930|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44721931|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721932|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44721933|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
44721934|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721935|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44721936|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44721937|NCT01523002|Artesunate|artesunate|mesh-list
44721938|NCT01523002|Pyronaridine|pyronaridine|mesh-list
44721939|NCT01523002|Metoprolol|metoprolol|mesh-list
44721940|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721941|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721942|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
44721943|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
44721944|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721945|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721946|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44721947|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44721948|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44721949|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721950|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721951|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721952|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
44721953|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44721954|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44721955|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44721956|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721957|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
44721958|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
44721959|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44721960|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
44721961|NCT01523015|Docetaxel|docetaxel|mesh-list
44721962|NCT01523015|Fluorouracil|fluorouracil|mesh-list
44721963|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
44721964|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44721965|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44721966|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44721967|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44721968|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44721969|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
44721970|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44721971|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44721972|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
44721973|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721974|NCT01523041|Insulin|insulin|mesh-list
44721975|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44721976|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
44721977|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
44721978|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44721979|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
44721980|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44721981|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721982|NCT01523054|Metoprolol|metoprolol|mesh-list
44132780|NCT00152126|Melphalan|melphalan|mesh-list
44721983|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44721984|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44721985|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
44721986|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
44273881|NCT00694759|Metformin|metformin|mesh-list
44721987|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44721988|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44721989|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44721990|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44721991|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44721992|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
44721993|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44721994|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885325|NCT04585438|Diclofenac|diclofenac|mesh-list
44721995|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
44721996|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44721997|NCT01523080|Acetaminophen|acetaminophen|mesh-list
44721998|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44721999|NCT01523080|Analgesics|analgesics|mesh-ancestor
44722000|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
44722001|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722002|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722003|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
44722004|NCT01523093|Ondansetron|ondansetron|mesh-list
44722005|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
44722006|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
44722007|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722008|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722009|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722010|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
44722011|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722012|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44722013|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
44722014|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722015|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722016|NCT01523093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44722017|NCT01523093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722018|NCT01523093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722019|NCT01523093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722020|NCT01523093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44722021|NCT01523119|Ondansetron|ondansetron|mesh-list
44722022|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
44722023|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
44722024|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722025|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722026|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722027|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
44722028|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722029|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44722030|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
44722031|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722032|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722033|NCT01523119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44722034|NCT01523119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722035|NCT01523119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722036|NCT01523119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722037|NCT01523119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44722038|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
44722039|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722040|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722041|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44722042|NCT01523314|Dexamethasone|dexamethasone|mesh-list
44722043|NCT01523314|Bevacizumab|bevacizumab|mesh-list
44722044|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44722045|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722046|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
44722047|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
44722048|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722049|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722050|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722051|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
44722052|NCT01523314|Hormones|hormones|mesh-ancestor
44722053|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722054|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44722055|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722056|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722057|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722058|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44722059|NCT01523314|Growth Substances|growth substances|mesh-ancestor
44722060|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722061|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44273952|NCT00695240|Bupivacaine|bupivacaine|mesh-list
44722062|NCT01523327|Uric Acid|uric acid|mesh-list
44722063|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
44722064|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722065|NCT01523327|Protective Agents|protective agents|mesh-ancestor
44722066|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722067|NCT01523379|Parecoxib|parecoxib|mesh-list
44722068|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44722069|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44722070|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722071|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722072|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44722073|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722074|NCT01523379|Analgesics|analgesics|mesh-ancestor
44722075|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
44722076|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722077|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722078|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722079|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722080|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
44722081|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44722082|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
44722083|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44722084|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
44722085|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722086|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722087|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
44722088|NCT01523431|Leucovorin|leucovorin|mesh-list
44722089|NCT01523431|Fluorouracil|fluorouracil|mesh-list
44722090|NCT01523431|Irinotecan|irinotecan|mesh-list
44722091|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
44722092|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722093|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44722094|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722095|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722096|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
44722097|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722098|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44722099|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722100|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722101|NCT01523431|Antidotes|antidotes|mesh-ancestor
44722102|NCT01523431|Protective Agents|protective agents|mesh-ancestor
44722103|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
44722104|NCT01523431|Vitamins|vitamins|mesh-ancestor
44722105|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
44722106|NCT01523483|Progesterone|progesterone|mesh-list
44722107|NCT01523483|Progestins|progestins|mesh-ancestor
44722108|NCT01523483|Hormones|hormones|mesh-ancestor
44722109|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722110|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722111|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
44722112|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
44722113|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722114|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
44722115|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722116|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722117|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
44722118|NCT01523574|Vitamin E|vitamin e|mesh-list
44722119|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
44722120|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
44722121|NCT01523574|Calcium|calcium|mesh-list
44722122|NCT01523574|Vitamins|vitamins|mesh-ancestor
44722123|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
44722124|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722125|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44722126|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44722127|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722128|NCT01523574|Analgesics|analgesics|mesh-ancestor
44722129|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
44722130|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722131|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
44722132|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722133|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44722134|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
44722135|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44722136|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722137|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722138|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
44722139|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44722141|NCT01523574|Protective Agents|protective agents|mesh-ancestor
44722142|NCT01523639|Metformin|metformin|mesh-list
44722143|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722144|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722145|NCT01523678|Paclitaxel|paclitaxel|mesh-list
44722146|NCT01523678|Carboplatin|carboplatin|mesh-list
44722147|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722148|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722149|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722150|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722151|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722152|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722153|NCT01523847|Doxorubicin|doxorubicin|mesh-list
44722154|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44722155|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722156|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44722157|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722158|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722159|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722160|NCT01523860|Rituximab|rituximab|mesh-list
44722161|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44722162|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
44722163|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722164|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722165|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
44722166|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722167|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722168|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722169|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
44722170|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722171|NCT01523860|Analgesics|analgesics|mesh-ancestor
44722172|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
44722173|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722174|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44722175|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722176|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722177|NCT01524068|Rituximab|rituximab|mesh-list
44722178|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722179|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722180|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
44722181|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722182|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722183|NCT01524081|Amoxicillin|amoxicillin|mesh-list
44722184|NCT01524081|Metronidazole|metronidazole|mesh-list
44722185|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
44722186|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
44722187|NCT01524081|Cefuroxime|cefuroxime|mesh-list
44722188|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
44722189|NCT01524081|Fluconazole|fluconazole|mesh-list
44722190|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44722191|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885491|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
44722192|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722193|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44722194|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44722195|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
44722196|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44722197|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44722198|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722199|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722200|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44722201|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
44722202|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722203|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722204|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44722205|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44722206|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44722207|NCT01524094|Leucovorin|leucovorin|mesh-list
44722208|NCT01524094|Fluorouracil|fluorouracil|mesh-list
44722209|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
44722210|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
44722211|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
44722212|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722213|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44722214|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722215|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722216|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
44722217|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722218|NCT01524094|Antidotes|antidotes|mesh-ancestor
44722219|NCT01524094|Protective Agents|protective agents|mesh-ancestor
44722220|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
44722221|NCT01524094|Vitamins|vitamins|mesh-ancestor
44722222|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
44722223|NCT01524237|Ketamine|ketamine|mesh-list
44722224|NCT01524237|Analgesics|analgesics|mesh-ancestor
44722225|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
44722226|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722227|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722228|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44722229|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44722230|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
44722231|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
44722232|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722233|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44722234|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44722235|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722236|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722237|NCT01524315|Vitamins|vitamins|mesh-list
44722238|NCT01524315|Thiamine|thiamine|mesh-list
44722239|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
44722240|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
44722241|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722242|NCT01524354|Anesthetics|anesthetics|mesh-list
44722243|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722244|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722245|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
44722246|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44722247|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722248|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722249|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722250|NCT01524367|Analgesics|analgesics|mesh-ancestor
44722251|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
44722252|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722253|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44722254|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44722255|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44722256|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
44722257|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722258|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722259|NCT01524432|Clotrimazole|clotrimazole|mesh-list
44722261|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
44722262|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44722263|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722264|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44722265|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44722266|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722267|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722268|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44722269|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
44722270|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722271|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722272|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44722273|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44722274|NCT01524445|Bortezomib|bortezomib|mesh-list
44722275|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722276|NCT01524497|Trazodone|trazodone|mesh-list
44722277|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44722278|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722279|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722280|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722281|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722282|NCT01524497|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44722283|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44722284|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722285|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722286|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722288|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44722289|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
44722290|NCT01524575|Gemcitabine|gemcitabine|mesh-list
44722291|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
44722292|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44722293|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
44722294|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722295|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722296|NCT01524575|Antiviral Agents|antiviral agents|mesh-ancestor
44722297|NCT01524575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722298|NCT01524575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722299|NCT01524575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722300|NCT01524575|Immunologic Factors|immunologic factors|mesh-ancestor
44722301|NCT01524575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722302|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44722303|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722304|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722305|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
44722306|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722307|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722308|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722309|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722310|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44722311|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722312|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722313|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
44722314|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722315|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722316|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722317|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722318|NCT01524705|Insulin|insulin|mesh-list
44722319|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44722320|NCT01524705|Metformin|metformin|mesh-list
44722321|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
44722322|NCT01524705|Exenatide|exenatide|mesh-list
44722323|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44722324|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722325|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722326|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44722327|NCT01524705|Incretins|incretins|mesh-ancestor
44722328|NCT01524705|Hormones|hormones|mesh-ancestor
44722329|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722330|NCT01524731|Dexamethasone|dexamethasone|mesh-list
44722331|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
44722332|NCT01524731|BB 1101|bb 1101|mesh-list
44722333|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722334|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
44722335|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
44722336|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722337|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722338|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722339|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
44722340|NCT01524731|Hormones|hormones|mesh-ancestor
44722341|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722342|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44722343|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722344|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
44722345|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722346|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722347|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
44722348|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44722349|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722350|NCT01524744|Analgesics|analgesics|mesh-ancestor
44722351|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
44722352|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722353|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722354|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722355|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722356|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722357|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722358|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
44722359|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44722360|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722361|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722362|NCT01524757|Pantoprazole|pantoprazole|mesh-list
44722363|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44722364|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722365|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44722366|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722367|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722368|NCT01524809|Insulin|insulin|mesh-list
44722369|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44722370|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
44722371|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
44722372|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44722373|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
44722374|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44722375|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722376|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722377|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
44722378|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
44722379|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
44722380|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722381|NCT01524861|Protective Agents|protective agents|mesh-ancestor
44722382|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722383|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
44722384|NCT01524861|Vitamins|vitamins|mesh-ancestor
44722385|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
44722386|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
44722387|NCT01524874|Vitamin D|vitamin d|mesh-list
44722388|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
44722389|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
44722390|NCT01524874|Calcitriol|calcitriol|mesh-list
44722391|NCT01524874|Vitamins|vitamins|mesh-list
44722392|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
44722393|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722394|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44722395|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44722396|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44722397|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722398|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722399|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44722400|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
44722401|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44722402|NCT01524939|Antibodies|antibodies|mesh-list
44722403|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
44722404|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
44722405|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722406|NCT01525004|Vaccines|vaccines|mesh-list
44722407|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
44722408|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722409|NCT01525043|Naproxen|naproxen|mesh-list
44722410|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44722411|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722412|NCT01525043|Analgesics|analgesics|mesh-ancestor
44722413|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
44722414|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722415|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722416|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722417|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722418|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
44722419|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44722420|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722421|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722422|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44722423|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44722424|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44722425|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722426|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
44722427|NCT01525394|Lenvatinib|lenvatinib|mesh-list
44722428|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44722429|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722430|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44722431|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722432|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722433|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722434|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722435|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44722436|NCT01525537|Sufentanil|sufentanil|mesh-list
44722437|NCT01525537|Dsuvia|dsuvia|mesh-list
44722438|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44722439|NCT01525537|Narcotics|narcotics|mesh-ancestor
44722440|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722441|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722442|NCT01525537|Analgesics|analgesics|mesh-ancestor
44722443|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
44722444|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722445|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44722446|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44722447|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
44722448|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
44722449|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
44722450|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722451|NCT01525706|Ethanol|ethanol|mesh-list
44722452|NCT01525706|Paclitaxel|paclitaxel|mesh-list
44722453|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44722454|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722455|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722456|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722457|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722458|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722459|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156813|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
44722460|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44722461|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722462|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722463|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722464|NCT01525719|Everolimus|everolimus|mesh-list
44722465|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722466|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722467|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
44722468|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722469|NCT01525771|Cisplatin|cisplatin|mesh-list
44722470|NCT01525771|Docetaxel|docetaxel|mesh-list
44722471|NCT01525771|Capecitabine|capecitabine|mesh-list
44722472|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722473|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722474|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722475|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722476|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722477|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44722478|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
44722479|NCT01525823|Metformin|metformin|mesh-list
44722480|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722481|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722482|NCT01525836|Rituximab|rituximab|mesh-list
44722483|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722484|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722485|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
44722486|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722487|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722488|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44722489|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44722490|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44722491|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722492|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44722493|NCT01525914|Dutasteride|dutasteride|mesh-list
44722494|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44722495|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44722496|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722497|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722498|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
44722499|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722500|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722501|NCT01525966|Paclitaxel|paclitaxel|mesh-list
44722502|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44722503|NCT01525966|Carboplatin|carboplatin|mesh-list
44722504|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722505|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722506|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722507|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722508|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722509|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722511|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44722512|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
44722513|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722514|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722515|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44722516|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44722517|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
44722518|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722519|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722520|NCT01526070|Aflibercept|aflibercept|mesh-list
44722521|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722522|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44722523|NCT01526070|Growth Substances|growth substances|mesh-ancestor
44722524|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722525|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722526|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722527|NCT01526083|Lacosamide|lacosamide|mesh-list
44722528|NCT01526083|Warfarin|warfarin|mesh-list
44722529|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
44722530|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
44722531|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44722532|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44722533|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722534|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722535|NCT01526096|Plerixafor|plerixafor|mesh-list
44722536|NCT01526096|Melphalan|melphalan|mesh-list
44722537|NCT01526096|Basiliximab|basiliximab|mesh-list
44722538|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722539|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
44722540|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722541|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722542|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44722543|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722544|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
44722545|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722547|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44722548|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
44722549|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722550|NCT01526122|Aspirin|aspirin|mesh-list
44722551|NCT01526122|Clopidogrel|clopidogrel|mesh-list
44722552|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44722553|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722554|NCT01526122|Analgesics|analgesics|mesh-ancestor
44722555|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
44722556|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722557|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722558|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722559|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722560|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44722561|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44722562|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722563|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44722564|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44722565|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722566|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
44722567|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44722568|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44722569|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44722570|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
44722571|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722572|NCT01526161|Fluticasone|fluticasone|mesh-list
44722573|NCT01526161|Xhance|xhance|mesh-list
44722574|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44722575|NCT01526161|Montelukast|montelukast|mesh-list
44722576|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722577|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44722578|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
44722579|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722580|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722581|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44722582|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44722583|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722584|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44722585|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44722586|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44722587|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44722588|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44722589|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722590|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722591|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44722592|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
44722593|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722594|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44722595|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44722596|NCT01526174|Golimumab|golimumab|mesh-list
44722597|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44722598|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722599|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722600|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
44722601|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722603|NCT01526278|Calcitriol|calcitriol|mesh-list
44722604|NCT01526278|Maxmarvil|maxmarvil|mesh-list
44722605|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44722606|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722607|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44722608|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44722609|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722610|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722611|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44722612|NCT01526278|Vitamins|vitamins|mesh-ancestor
44722613|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
44722614|NCT01526317|Metformin|metformin|mesh-list
44722615|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44722616|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722617|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722618|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722619|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722620|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
44722621|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722622|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722623|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722624|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722625|NCT01526369|Paclitaxel|paclitaxel|mesh-list
44722626|NCT01526369|Trastuzumab|trastuzumab|mesh-list
44722627|NCT01526369|Lapatinib|lapatinib|mesh-list
44722628|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722629|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722630|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722631|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722632|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722633|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722634|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722635|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44722636|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722637|NCT01526395|Propofol|propofol|mesh-list
44722638|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44722639|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722640|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722641|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44722642|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
44722643|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
44722644|NCT01526460|Atorvastatin|atorvastatin|mesh-list
44722645|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44722646|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722647|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722648|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
44722649|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722650|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722651|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722652|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722653|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
44722654|NCT01526499|Docetaxel|docetaxel|mesh-list
44722655|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722656|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
44722657|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722658|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722660|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
44722661|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722662|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722663|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44722664|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722665|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722666|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722667|NCT01526525|Acetaminophen|acetaminophen|mesh-list
44722668|NCT01526525|Parecoxib|parecoxib|mesh-list
44722669|NCT01526525|Ketamine|ketamine|mesh-list
44722670|NCT01526525|Morphine|morphine|mesh-list
44722671|NCT01526525|Tramadol|tramadol|mesh-list
44722672|NCT01526525|Analgesics|analgesics|mesh-ancestor
44722673|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
44722674|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722675|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722676|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44722677|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44722678|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
44722679|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
44722680|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722681|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44722682|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44722683|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722684|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722685|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44722686|NCT01526525|Narcotics|narcotics|mesh-ancestor
44722687|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44722688|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
44722689|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44722690|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44722691|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722692|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44722693|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722694|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722695|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
44722696|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
44722697|NCT01526564|Vitamins|vitamins|mesh-ancestor
44722698|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
44722699|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722700|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
44722701|NCT01526616|Metformin|metformin|mesh-list
44722702|NCT01526616|Spironolactone|spironolactone|mesh-list
44722703|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722704|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722705|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44722706|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
44722707|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722708|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44722709|NCT01526616|Diuretics|diuretics|mesh-ancestor
44722710|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
44722711|NCT01526694|Thalidomide|thalidomide|mesh-list
44722712|NCT01526694|Dexamethasone|dexamethasone|mesh-list
44722713|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44722714|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722715|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
44722716|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
44722717|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722718|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722719|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722720|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
44722721|NCT01526694|Hormones|hormones|mesh-ancestor
44722722|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722723|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44722724|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722725|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722726|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
44722727|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722728|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722729|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
44722730|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
44722731|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44722732|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722733|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722734|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43885989|NCT04574960|Gemcitabine|gemcitabine|mesh-list
44722736|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722737|NCT01526837|Bevacizumab|bevacizumab|mesh-list
44722738|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44722739|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722740|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722741|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44722742|NCT01526837|Growth Substances|growth substances|mesh-ancestor
44722743|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722744|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722745|NCT01526850|Cyclosporine|cyclosporine|mesh-list
44722746|NCT01526850|Cyclosporins|cyclosporins|mesh-list
44722747|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
44722748|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722749|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722750|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722751|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
44722752|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722754|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722755|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44722756|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722757|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44722758|NCT01526850|Hormones|hormones|mesh-ancestor
44722759|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722760|NCT01526876|Clevidipine|clevidipine|mesh-list
44722761|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44722762|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722763|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722764|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44722765|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722766|NCT01526941|Insulin|insulin|mesh-list
44722767|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44722768|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
44722769|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
44722770|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44722771|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
44722772|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44722773|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722774|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722775|NCT01526980|Insulin|insulin|mesh-list
44722776|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44722777|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
44722778|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
44722779|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44722780|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
44722781|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44722782|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722783|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722784|NCT01527019|Cephalosporins|cephalosporins|mesh-list
44722785|NCT01527019|Norfloxacin|norfloxacin|mesh-list
44722786|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44722787|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722788|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44722789|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722790|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722791|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722792|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722793|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44722794|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44722795|NCT01527032|Thalidomide|thalidomide|mesh-list
44722796|NCT01527032|Dexamethasone|dexamethasone|mesh-list
44722797|NCT01527032|Melphalan|melphalan|mesh-list
44722798|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722799|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
44722800|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
44722801|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722802|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722803|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44722804|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
44722805|NCT01527032|Hormones|hormones|mesh-ancestor
44722806|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852497|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722807|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44722808|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722809|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722810|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
44722811|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722812|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44722813|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722814|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
44722815|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
44722816|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44722817|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44722818|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722819|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44722820|NCT01527032|Growth Substances|growth substances|mesh-ancestor
44722821|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722822|NCT01527097|Atorvastatin|atorvastatin|mesh-list
44722823|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722824|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722825|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
44722826|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722827|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722828|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722829|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722831|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44722832|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
44722833|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
44722834|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722835|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722836|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722837|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44722838|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44722839|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44722840|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722841|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722842|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722843|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722844|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44722845|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44722846|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
44722847|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722848|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722849|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44722850|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44722851|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
44722852|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
44722853|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722854|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722855|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
44722856|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722857|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722858|NCT01527422|Prednisone|prednisone|mesh-list
44722859|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
44722860|NCT01527422|Doxorubicin|doxorubicin|mesh-list
44722861|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44722862|NCT01527422|Vincristine|vincristine|mesh-list
44722863|NCT01527422|Sargramostim|sargramostim|mesh-list
44722864|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44722865|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
44722866|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722867|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44722868|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44722869|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
44722870|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722871|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722872|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44722873|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44722874|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44722875|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44722876|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722877|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44722878|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
44722879|NCT01527422|Hormones|hormones|mesh-ancestor
44722880|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722881|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44722882|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722884|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722885|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722886|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44722887|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
44722888|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722889|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44722890|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44722891|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722892|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722893|NCT01527474|Citalopram|citalopram|mesh-list
44722894|NCT01527474|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44722895|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44722896|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722897|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722898|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722899|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
44722900|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722901|NCT01527474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44722902|NCT01527474|Antidepressive Agents|antidepressive agents|mesh-ancestor
44722903|NCT01527474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722904|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
44722905|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
44722906|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44722907|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722908|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722909|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
44722910|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
44722911|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722912|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722913|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
44722914|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
44722915|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722916|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722917|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44722918|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
44722919|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722920|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
44722921|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
44722922|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722923|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722924|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
44722925|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
44722926|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722927|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722928|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
44722929|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
44722930|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722931|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722932|NCT01527669|Lovastatin|lovastatin|mesh-list
44722933|NCT01527669|L 647318|l 647318|mesh-list
44722934|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
44722935|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44722936|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44722937|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
44722938|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722939|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44722940|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44722941|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722942|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
44722943|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
44722944|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
44722945|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722946|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722947|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
44722948|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722949|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44722950|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722951|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722952|NCT01527747|Saxagliptin|saxagliptin|mesh-list
44722953|NCT01527747|Incretins|incretins|mesh-ancestor
44722954|NCT01527747|Hormones|hormones|mesh-ancestor
44722955|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44722957|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44722958|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
44722959|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44722960|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722961|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44722962|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44722963|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44722964|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44722965|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44722966|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722967|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44722968|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722969|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
44722970|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44722971|NCT01527864|Paclitaxel|paclitaxel|mesh-list
44722972|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44722973|NCT01527864|Carboplatin|carboplatin|mesh-list
44722974|NCT01527864|Endostatins|endostatins|mesh-list
44722975|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44722976|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44722977|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44722978|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44722979|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44722980|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44722981|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44722982|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44722983|NCT01527864|Growth Substances|growth substances|mesh-ancestor
44722984|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722985|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
44722986|NCT01527890|Fentanyl|fentanyl|mesh-list
44722987|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44722988|NCT01527890|Narcotics|narcotics|mesh-ancestor
44722989|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44722990|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44722991|NCT01527890|Analgesics|analgesics|mesh-ancestor
44722992|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
44722993|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44722994|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44722995|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44722996|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
44722997|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
44722998|NCT01527903|Midazolam|midazolam|mesh-list
44722999|NCT01527903|Propofol|propofol|mesh-list
44723000|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44723001|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723002|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723003|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44723004|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
44723005|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
44723006|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44723007|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44723008|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723009|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723010|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
44723011|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
44723012|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723013|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723014|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
44723015|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
44723016|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44723017|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44723018|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723019|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
44723020|NCT01527968|Coagulants|coagulants|mesh-ancestor
44723021|NCT01527994|Aprepitant|aprepitant|mesh-list
44723022|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
44723023|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
44723024|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723025|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723026|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723027|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44723028|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852663|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44723029|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723030|NCT01528007|Naltrexone|naltrexone|mesh-list
44723031|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44723032|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44723033|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723034|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
44723035|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723036|NCT01528137|Lactoferrin|lactoferrin|mesh-list
44723037|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
44723038|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723039|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723040|NCT01528163|Methotrexate|methotrexate|mesh-list
44723041|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44723042|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
44723043|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44723044|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723045|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723046|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
44723047|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723048|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723049|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
44723050|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723051|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44723052|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723053|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
44723054|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44723055|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723056|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
44723057|NCT01528176|Vitamin D|vitamin d|mesh-list
44723058|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44723059|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723060|NCT01528176|Vitamins|vitamins|mesh-ancestor
44723061|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
44723062|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44723063|NCT01528371|Midazolam|midazolam|mesh-list
44723064|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44723065|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44723066|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723067|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723068|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44723069|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723070|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723071|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44723072|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
44723073|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
44723074|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
44723075|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
44723076|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723077|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723078|NCT01528501|Panobinostat|panobinostat|mesh-list
44723079|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723080|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44723081|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723082|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723083|NCT01528540|Pregabalin|pregabalin|mesh-list
44723084|NCT01528540|Antioxidants|antioxidants|mesh-list
44723085|NCT01528540|Analgesics|analgesics|mesh-ancestor
44723086|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
44723087|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723088|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723089|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
44723090|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44723091|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723092|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723093|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44723094|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44723095|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723096|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723097|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723098|NCT01528540|Protective Agents|protective agents|mesh-ancestor
44723099|NCT01528618|Gemcitabine|gemcitabine|mesh-list
44723100|NCT01528618|Cisplatin|cisplatin|mesh-list
44723101|NCT01528618|Fluorouracil|fluorouracil|mesh-list
44723102|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723103|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723104|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
44723105|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723106|NCT01528618|Antiviral Agents|antiviral agents|mesh-ancestor
44723107|NCT01528618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723108|NCT01528618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723109|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723110|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
44723111|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723112|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
44723113|NCT01528644|Iron|iron|mesh-list
44723114|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
44723115|NCT01528644|Calcium|calcium|mesh-list
44723116|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44723117|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723118|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44723119|NCT01528644|Trace Elements|trace elements|mesh-ancestor
44723120|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
44723121|NCT01528644|Hematinics|hematinics|mesh-ancestor
44723122|NCT01528722|Bupivacaine|bupivacaine|mesh-list
44723123|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
44723124|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
44723125|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723126|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723127|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
44723128|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723129|NCT01528800|Vitamin K|vitamin k|mesh-list
44723130|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
44723131|NCT01528800|Vitamins|vitamins|mesh-ancestor
44723132|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
44723133|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723134|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44723135|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44723136|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723137|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
44723138|NCT01528800|Coagulants|coagulants|mesh-ancestor
44723139|NCT01528813|Amorolfine|amorolfine|mesh-list
44723140|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
44723141|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723142|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
44723143|NCT01528826|Vinorelbine|vinorelbine|mesh-list
44723144|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723145|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44723146|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44723147|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44723148|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44723149|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723150|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
44723151|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44723152|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44723153|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723154|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
44723155|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44723156|NCT01528865|Tenofovir|tenofovir|mesh-list
44723157|NCT01528865|Lamivudine|lamivudine|mesh-list
44723158|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
44723159|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723160|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44723161|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723162|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723163|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723164|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44723165|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44723166|NCT01528930|Amikacin|amikacin|mesh-list
44723167|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723168|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723169|NCT01528943|Epoprostenol|epoprostenol|mesh-list
44723170|NCT01528943|Tezosentan|tezosentan|mesh-list
44723171|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44723172|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44723173|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
44723174|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
44723175|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44723176|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723177|NCT01529125|Lamivudine|lamivudine|mesh-list
44723178|NCT01529125|Zidovudine|zidovudine|mesh-list
44723179|NCT01529125|Nevirapine|nevirapine|mesh-list
44723180|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44723181|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723182|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723183|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723185|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723186|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44723187|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44723188|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
44723189|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44723190|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44723191|NCT01529138|Sirolimus|sirolimus|mesh-list
44723192|NCT01529138|Axitinib|axitinib|mesh-list
44723193|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723194|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723195|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44723196|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723197|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
44723198|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723199|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
44723200|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723201|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723202|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723203|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723204|NCT01529164|Leucovorin|leucovorin|mesh-list
44723205|NCT01529164|Fluorouracil|fluorouracil|mesh-list
44723206|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
44723207|NCT01529164|Endostar protein|endostar protein|mesh-list
44723208|NCT01529164|Endostatins|endostatins|mesh-list
44723209|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
44723210|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723211|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723212|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723213|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723214|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
44723215|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723216|NCT01529164|Antidotes|antidotes|mesh-ancestor
44723217|NCT01529164|Protective Agents|protective agents|mesh-ancestor
44723218|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
44723219|NCT01529164|Vitamins|vitamins|mesh-ancestor
44723220|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
44723221|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723222|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723223|NCT01529164|Growth Substances|growth substances|mesh-ancestor
44723224|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723225|NCT01529177|Metformin|metformin|mesh-list
44723226|NCT01529177|Citric Acid|citric acid|mesh-list
44723227|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
44723228|NCT01529177|Clomiphene|clomiphene|mesh-list
44723229|NCT01529177|Enclomiphene|enclomiphene|mesh-list
44723230|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
44723231|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44723232|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723233|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
44723234|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44723235|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
44723236|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
44723237|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723238|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44723239|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
44723240|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723241|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44723242|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
44275096|NCT00701597|Bosentan|bosentan|mesh-list
44723243|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44723244|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44723245|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44723247|NCT01529190|Analgesics|analgesics|mesh-ancestor
44723248|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
44723249|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723250|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723251|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
44723252|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44723253|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723254|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723255|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44723256|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44723257|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723258|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723259|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723261|NCT01529229|Betamethasone|betamethasone|mesh-list
44723262|NCT01529229|Desloratadine|desloratadine|mesh-list
44723263|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44723264|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44723265|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
44723266|NCT01529229|Hormones|hormones|mesh-ancestor
44723267|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723268|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723269|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44723270|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723271|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44723272|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
44723273|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44723274|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723275|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723276|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723277|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44723278|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44723279|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
44723280|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
44723281|NCT01529242|Prednisolone|prednisolone|mesh-list
44723282|NCT01529242|Betamethasone|betamethasone|mesh-list
44723283|NCT01529242|Desloratadine|desloratadine|mesh-list
44723284|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44723285|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44723286|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
44723287|NCT01529242|Hormones|hormones|mesh-ancestor
44723288|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723289|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723290|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44723291|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723292|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44723293|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
44723294|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44723295|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723296|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723297|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723298|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44723299|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44723300|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
44723301|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
44723302|NCT01529255|Telbivudine|telbivudine|mesh-list
44723303|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
44723304|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723305|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723306|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723307|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723308|NCT01529294|Iloperidone|iloperidone|mesh-list
44723309|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44723310|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723311|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723312|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723313|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723314|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
44723315|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44723316|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44723317|NCT01529320|Prednisolone|prednisolone|mesh-list
44723318|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
44275182|NCT00702182|Vinorelbine|vinorelbine|mesh-list
44723319|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
44723320|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44723321|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
44723322|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44723323|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
44723324|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
44723325|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723326|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723327|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723328|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
44723329|NCT01529320|Hormones|hormones|mesh-ancestor
44723330|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723331|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44723332|NCT01529320|Protective Agents|protective agents|mesh-ancestor
44723333|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44723334|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723336|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723337|NCT01529476|Levofloxacin|levofloxacin|mesh-list
44723338|NCT01529476|Ofloxacin|ofloxacin|mesh-list
44723339|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44723340|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723341|NCT01529476|Renal Agents|renal agents|mesh-ancestor
44723342|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723343|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44723344|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44723345|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723346|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723347|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723348|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44723349|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44723350|NCT01529528|Anagliptin|anagliptin|mesh-list
44723351|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44723352|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44723353|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723354|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723355|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44723356|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723357|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44723358|NCT01529541|Anagliptin|anagliptin|mesh-list
44723359|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44723360|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723361|NCT01529541|Incretins|incretins|mesh-ancestor
44723362|NCT01529541|Hormones|hormones|mesh-ancestor
44723363|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723364|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44723365|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
44723366|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723367|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723368|NCT01529554|Everolimus|everolimus|mesh-list
44723369|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723370|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723371|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
44723372|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723373|NCT01529619|Rivastigmine|rivastigmine|mesh-list
44723374|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44723375|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723376|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723377|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723378|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723379|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723380|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44723381|NCT01529619|Protective Agents|protective agents|mesh-ancestor
44723382|NCT01529710|Praziquantel|praziquantel|mesh-list
44723383|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
44723384|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44723385|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723386|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44723387|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44723388|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44723389|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723390|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723391|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44723392|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723393|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723394|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723395|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723396|NCT01529892|Methamphetamine|methamphetamine|mesh-list
44723397|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44723398|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723399|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
44723400|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
44723401|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723402|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
44723403|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723404|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723405|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44723406|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44723407|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44723408|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723409|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44723411|NCT01530022|Carbamazepine|carbamazepine|mesh-list
44723412|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
44723413|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44723414|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44723415|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156958|NCT00232817|Nicotine|nicotine|mesh-list
44723416|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723417|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
44723418|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723419|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723420|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723421|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723422|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44723423|NCT01530022|Analgesics|analgesics|mesh-ancestor
44723424|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
44723425|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723426|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44723427|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44723428|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
44723429|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44723430|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723431|NCT01530126|Becaplermin|becaplermin|mesh-list
44723432|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
44723433|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44723434|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723435|NCT01530126|Growth Substances|growth substances|mesh-ancestor
44723436|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723437|NCT01530152|Lidocaine|lidocaine|mesh-list
44723438|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
44723439|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
44723440|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723441|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723442|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
44723443|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723444|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44723445|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44723446|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44723447|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723448|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723449|NCT01530217|Ibuprofen|ibuprofen|mesh-list
44723450|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44723451|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44723452|NCT01530217|Analgesics|analgesics|mesh-ancestor
44723453|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
44723454|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723455|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723456|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44723457|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44723458|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44723459|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723460|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723461|NCT01530230|Oxytocin|oxytocin|mesh-list
44723462|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
44723463|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44723464|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723465|NCT01530295|Docetaxel|docetaxel|mesh-list
44723466|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723467|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
44723468|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
44723469|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
44723470|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723471|NCT01530308|Dopamine|dopamine|mesh-list
44723472|NCT01530308|Haloperidol|haloperidol|mesh-list
44723473|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
44723474|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
44723475|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
44723476|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
44723477|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
44723478|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723479|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723480|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723481|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44723482|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723483|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44723484|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
44723485|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723486|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723487|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44723488|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44723489|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
44723490|NCT01530308|Protective Agents|protective agents|mesh-ancestor
44723491|NCT01530386|Lacosamide|lacosamide|mesh-list
44723492|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
44723493|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44723494|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44723495|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723496|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723497|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44723498|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44723499|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723500|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44723501|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
44723502|NCT01530451|Coagulants|coagulants|mesh-ancestor
44723503|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44723504|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
44723505|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723506|NCT01530490|Cabergoline|cabergoline|mesh-list
44723507|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44723508|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
44723509|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
44723510|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44723511|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44723512|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
44723513|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
44723514|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723515|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723516|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723517|NCT01530503|Capecitabine|capecitabine|mesh-list
44723518|NCT01530503|Mitomycins|mitomycins|mesh-list
44723519|NCT01530503|Mitomycin|mitomycin|mesh-list
44723520|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723521|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
44723522|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723523|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723524|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44723525|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
44723526|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723527|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723528|NCT01530542|Oxycodone|oxycodone|mesh-list
44723529|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44723530|NCT01530542|Narcotics|narcotics|mesh-ancestor
44723531|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723532|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723533|NCT01530542|Analgesics|analgesics|mesh-ancestor
44723534|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
44723535|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723536|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
44723537|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
44723538|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723539|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723540|NCT01530594|Lenalidomide|lenalidomide|mesh-list
44723541|NCT01530594|Bortezomib|bortezomib|mesh-list
44723542|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
44723543|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723544|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723545|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723546|NCT01530594|Growth Substances|growth substances|mesh-ancestor
44723547|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723548|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723549|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
44723550|NCT01530607|Goserelin|goserelin|mesh-list
44723551|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723552|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
44723553|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723554|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44723555|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44723556|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
44723557|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723558|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723559|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44723560|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44723561|NCT01530620|Propiverine|propiverine|mesh-list
44723562|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
44723563|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
44723564|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723565|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723566|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44723567|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44723568|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723569|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723570|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723571|NCT01530620|Urological Agents|urological agents|mesh-ancestor
44723572|NCT01530698|Vaccines|vaccines|mesh-list
44723573|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
44723574|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723575|NCT01530711|Terlipressin|terlipressin|mesh-list
44723576|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44723577|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44723578|NCT01530737|Antithrombins|antithrombins|mesh-list
44723579|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
44723580|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44723581|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
44723582|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723583|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723584|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
44723585|NCT01530763|Amoxicillin|amoxicillin|mesh-list
44723586|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
44723587|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
44723588|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
44723589|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44723590|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44723591|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723592|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723593|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44723594|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723595|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723596|NCT01530815|Bupivacaine|bupivacaine|mesh-list
44723597|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
44723598|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
44723599|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723600|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723601|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
44723602|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723603|NCT01530984|Ipilimumab|ipilimumab|mesh-list
44723604|NCT01530984|Sargramostim|sargramostim|mesh-list
44723605|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44723606|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723607|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44723608|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723609|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
44723610|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723611|NCT01531049|Nicotine|nicotine|mesh-list
44723612|NCT01531049|Varenicline|varenicline|mesh-list
44723613|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44723614|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
44723615|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723616|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723617|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44723618|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44723619|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723620|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723621|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723622|NCT01531114|Ticagrelor|ticagrelor|mesh-list
44723623|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44723624|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44723625|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44723626|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44723627|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44723628|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
43620386|NCT04631029|Entinostat|entinostat|mesh-list
44723629|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723630|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723631|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723632|NCT01531140|Bisacodyl|bisacodyl|mesh-list
44723633|NCT01531140|Senna Extract|senna extract|mesh-list
44723634|NCT01531140|Sennosides|sennosides|mesh-list
44723635|NCT01531140|Cathartics|cathartics|mesh-ancestor
44723636|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723637|NCT01531140|Laxatives|laxatives|mesh-ancestor
44723638|NCT01531166|Interferons|interferons|mesh-list
44723639|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
44723640|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
44723641|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44723642|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723643|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
44723644|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723645|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
44723646|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723647|NCT01531192|Nystatin|nystatin|mesh-list
44723648|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723649|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723650|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
44723651|NCT01531192|Ionophores|ionophores|mesh-ancestor
44723652|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723653|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723654|NCT01531218|Azithromycin|azithromycin|mesh-list
44723655|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723656|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723657|NCT01531244|Dactinomycin|dactinomycin|mesh-list
44723658|NCT01531244|Cactinomycin|cactinomycin|mesh-list
44723659|NCT01531244|Melphalan|melphalan|mesh-list
44723660|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44723661|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
44723662|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723663|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723664|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44723665|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723666|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
44723667|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723668|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723669|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723670|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44723671|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44723672|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723673|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723674|NCT01531309|S 20098|s 20098|mesh-list
44723675|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44723676|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723677|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723678|NCT01531322|Vaccines|vaccines|mesh-list
44723679|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44723680|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
44723681|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723682|NCT01531361|Sorafenib|sorafenib|mesh-list
44723683|NCT01531361|Vemurafenib|vemurafenib|mesh-list
44723684|NCT01531361|Crizotinib|crizotinib|mesh-list
44723685|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723686|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723687|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723688|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723689|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
44723690|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723691|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
44723693|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
44723694|NCT01531517|Vitamins|vitamins|mesh-ancestor
44723695|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
44723696|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723697|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723698|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
44723699|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
44723700|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44723701|NCT01531569|Estrogens|estrogens|mesh-ancestor
44723702|NCT01531569|Hormones|hormones|mesh-ancestor
44723703|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723704|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723705|NCT01531582|Minocycline|minocycline|mesh-list
44723706|NCT01531582|Tetracycline|tetracycline|mesh-list
44723707|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723708|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723709|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44723710|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723711|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723713|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
44723714|NCT01531595|Irinotecan|irinotecan|mesh-list
44723715|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44723716|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723717|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723718|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723719|NCT01531595|Growth Substances|growth substances|mesh-ancestor
44723720|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723721|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723722|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44723723|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44723724|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723725|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723726|NCT01531647|Ritonavir|ritonavir|mesh-list
44723727|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
44723728|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44723729|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44723730|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44723731|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723732|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723733|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44723734|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44723735|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
44723736|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723737|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44723738|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44723739|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44723740|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44723741|NCT01531712|Gemcitabine|gemcitabine|mesh-list
44723742|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
44723743|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44723744|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723745|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
44723746|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723747|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723748|NCT01531712|Antiviral Agents|antiviral agents|mesh-ancestor
44723749|NCT01531712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723750|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723751|NCT01531712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723752|NCT01531712|Immunologic Factors|immunologic factors|mesh-ancestor
44723753|NCT01531712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723754|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723755|NCT01531764|Vinorelbine|vinorelbine|mesh-list
44723756|NCT01531764|Afatinib|afatinib|mesh-list
44723757|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44723758|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723759|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
44723760|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
44723761|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
44723762|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723763|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723764|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723765|NCT01531777|Apatinib|apatinib|mesh-list
44723766|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723767|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723768|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723769|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723770|NCT01531790|Carboplatin|carboplatin|mesh-list
44723771|NCT01531790|Pemetrexed|pemetrexed|mesh-list
44723772|NCT01531790|Endostar protein|endostar protein|mesh-list
44723773|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723774|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723775|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723776|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44723777|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44723778|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723779|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723780|NCT01531790|Growth Substances|growth substances|mesh-ancestor
44723781|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723782|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723783|NCT01531829|Heparin|heparin|mesh-list
44723784|NCT01531829|Plasminogen|plasminogen|mesh-list
44723785|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44723786|NCT01531829|Tinzaparin|tinzaparin|mesh-list
44723787|NCT01531829|Dalteparin|dalteparin|mesh-list
44723788|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44723789|NCT01531829|Nadroparin|nadroparin|mesh-list
44723790|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
44723791|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44723792|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44723793|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723794|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44723795|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723796|NCT01531855|Insulin|insulin|mesh-list
44723797|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
44723798|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
44723799|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44723800|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723801|NCT01531920|Ethanol|ethanol|mesh-list
44723802|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44723803|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723804|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723805|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723806|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44723807|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723808|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44723809|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723810|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723811|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44723812|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
44723813|NCT01532076|Coagulants|coagulants|mesh-ancestor
44723814|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
44723815|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723816|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
44723817|NCT01532115|Opicapone|opicapone|mesh-list
44723818|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723819|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723820|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44723821|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44723822|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723823|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723824|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723825|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44723826|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44723827|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44723828|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
44723829|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44723830|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723831|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723832|NCT01532232|Varenicline|varenicline|mesh-list
44723833|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44723834|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44723835|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723836|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723837|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723838|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723839|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
44723840|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44723841|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44723842|NCT01532466|Rocuronium|rocuronium|mesh-list
44723843|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44723844|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44723845|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44723846|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723847|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723848|NCT01532518|MEN 11420|men 11420|mesh-list
44723849|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44723850|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
44723851|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723852|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723853|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44723854|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44723855|NCT01532544|Heparin|heparin|mesh-list
44723856|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44723857|NCT01532544|Tinzaparin|tinzaparin|mesh-list
44723858|NCT01532544|Dalteparin|dalteparin|mesh-list
44723860|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
44723861|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44723862|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44723863|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723864|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44723865|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
44723866|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44723867|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44723868|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
44723869|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44723870|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44723871|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723872|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723873|NCT01532804|Bevacizumab|bevacizumab|mesh-list
44723874|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
44723875|NCT01532804|Raltitrexed|raltitrexed|mesh-list
44723876|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44723877|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723878|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723879|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723880|NCT01532804|Growth Substances|growth substances|mesh-ancestor
44723881|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723882|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723883|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44723884|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
44723885|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723886|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44723887|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723888|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44723889|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
44723890|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723891|NCT01532856|Thalidomide|thalidomide|mesh-list
44723892|NCT01532856|Dexamethasone|dexamethasone|mesh-list
44723893|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
44723894|NCT01532856|Prednisone|prednisone|mesh-list
44723895|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
44723896|NCT01532856|Melphalan|melphalan|mesh-list
44723897|NCT01532856|BB 1101|bb 1101|mesh-list
44723898|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44723899|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
44723900|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723901|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44723902|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44723903|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
44723904|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723905|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44723906|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44723907|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44723908|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
44723909|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
44723910|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723911|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723912|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
44723913|NCT01532856|Hormones|hormones|mesh-ancestor
44723914|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723915|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44723916|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
44723917|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723918|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
44723919|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44723920|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723921|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44723922|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44723923|NCT01532856|Growth Substances|growth substances|mesh-ancestor
44723924|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
44723925|NCT01532895|Hydromorphone|hydromorphone|mesh-list
44723926|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44723927|NCT01532895|Narcotics|narcotics|mesh-ancestor
44723928|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723929|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723930|NCT01532895|Analgesics|analgesics|mesh-ancestor
44723931|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
44723932|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723933|NCT01532960|Poly ICLC|poly iclc|mesh-list
43853464|NCT03749902|Misoprostol|misoprostol|mesh-list
44723934|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
44723935|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
44723936|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723938|NCT01533090|Cathartics|cathartics|mesh-ancestor
44723939|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44723940|NCT01533090|Laxatives|laxatives|mesh-ancestor
44723941|NCT01533129|Testosterone|testosterone|mesh-list
44723942|NCT01533129|Androgens|androgens|mesh-ancestor
44723943|NCT01533129|Hormones|hormones|mesh-ancestor
44723944|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44723945|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723946|NCT01533155|Quinidine|quinidine|mesh-list
44723947|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
44723948|NCT01533155|Morphine|morphine|mesh-list
44723949|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44723950|NCT01533155|Narcotics|narcotics|mesh-ancestor
44723951|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44723952|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723953|NCT01533155|Analgesics|analgesics|mesh-ancestor
44723954|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
44723955|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44723956|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44723957|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44723958|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
44723959|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723960|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723961|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44723962|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
44723963|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44723964|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44723965|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723966|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44723967|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44723968|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44723969|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44723970|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44723971|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44723972|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44723973|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44723974|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44723975|NCT01533220|Pheniramine|pheniramine|mesh-list
44723976|NCT01533220|Naphazoline|naphazoline|mesh-list
44723977|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44723978|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44723979|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44723980|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
44723981|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44723982|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44723983|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
44723984|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44723985|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
44723986|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
44723987|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
44723988|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44723989|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
44723990|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
44723991|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44723992|NCT01533272|Tenofovir|tenofovir|mesh-list
44723993|NCT01533272|Emtricitabine|emtricitabine|mesh-list
44723994|NCT01533272|Lopinavir|lopinavir|mesh-list
44723995|NCT01533272|Maraviroc|maraviroc|mesh-list
44723996|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
44723997|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44723998|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44723999|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44724000|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724001|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724002|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44724003|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44724004|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44724005|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44724006|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
44724007|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44724008|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724009|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44724010|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44724011|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44724012|NCT01533324|Leucovorin|leucovorin|mesh-list
44724013|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43887029|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44724014|NCT01533324|Antidotes|antidotes|mesh-ancestor
44724015|NCT01533324|Protective Agents|protective agents|mesh-ancestor
44724016|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724017|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
44724018|NCT01533324|Vitamins|vitamins|mesh-ancestor
44724019|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
44724020|NCT01533376|Timolol|timolol|mesh-list
44724021|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
44724022|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44724023|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44724024|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724025|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724026|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724027|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724028|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44724029|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44724030|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44724031|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44724032|NCT01533389|Silodosin|silodosin|mesh-list
44724033|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44724034|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44724035|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44724036|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724037|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724038|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724039|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724040|NCT01533389|Urological Agents|urological agents|mesh-ancestor
44724041|NCT01533441|Vitamin K|vitamin k|mesh-list
44724042|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
44724043|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
44724044|NCT01533441|Vitamins|vitamins|mesh-ancestor
44724045|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
44724046|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724047|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44724048|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44724049|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724050|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
44724051|NCT01533441|Coagulants|coagulants|mesh-ancestor
44724052|NCT01533506|Stiripentol|stiripentol|mesh-list
44724053|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
44724054|NCT01533545|Epinephrine|epinephrine|mesh-list
44724055|NCT01533545|Mepivacaine|mepivacaine|mesh-list
44724056|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44724057|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44724058|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724059|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724060|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724061|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724062|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44724063|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44724064|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
44724065|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724066|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44724067|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
44724068|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
44724069|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
44724070|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44724071|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
44724072|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
44724073|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724074|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
44724075|NCT01533558|Caspofungin|caspofungin|mesh-list
44724076|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
44724077|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724078|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887031|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
44724079|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724080|NCT01533662|Phenylephrine|phenylephrine|mesh-list
44724081|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
44724082|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44724083|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
44724084|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
44724085|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724086|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724087|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
44724088|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44724089|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
44724090|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44724091|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44724092|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44724093|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44724094|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724095|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276043|NCT00706862|Lactoferrin|lactoferrin|mesh-list
44724096|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724097|NCT01533662|Protective Agents|protective agents|mesh-ancestor
44724098|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44724099|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44724100|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724101|NCT01533740|Leucovorin|leucovorin|mesh-list
44724102|NCT01533740|Folic Acid|folic acid|mesh-list
44724103|NCT01533740|Bevacizumab|bevacizumab|mesh-list
44724104|NCT01533740|Fluorouracil|fluorouracil|mesh-list
44724105|NCT01533740|Irinotecan|irinotecan|mesh-list
44724106|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
44724107|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44724108|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724109|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44724110|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44724111|NCT01533740|Growth Substances|growth substances|mesh-ancestor
44724112|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724113|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
44724114|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
44724115|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724116|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724117|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724118|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
44724119|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44724120|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724121|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724122|NCT01533740|Antidotes|antidotes|mesh-ancestor
44724123|NCT01533740|Protective Agents|protective agents|mesh-ancestor
44724124|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
44724125|NCT01533740|Vitamins|vitamins|mesh-ancestor
44724126|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
44724127|NCT01533740|Hematinics|hematinics|mesh-ancestor
44724128|NCT01533818|Amoxicillin|amoxicillin|mesh-list
44724129|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724130|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724131|NCT01533870|Rifampin|rifampin|mesh-list
44724132|NCT01533870|Naloxegol|naloxegol|mesh-list
44724133|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44724134|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
44724135|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724136|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724137|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
44724138|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44724139|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724140|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724141|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44724142|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44724143|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44724144|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44724145|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44724146|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44724147|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44724148|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724149|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
43887093|NCT04558268|Folic Acid|folic acid|mesh-list
44724150|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724151|NCT01534026|Aspirin|aspirin|mesh-list
44724152|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724153|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724154|NCT01534026|Analgesics|analgesics|mesh-ancestor
44724155|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
44724156|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724157|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724158|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724159|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724160|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44724161|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44724162|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724163|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44724164|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44724165|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724166|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
44724167|NCT01534169|Dexamethasone|dexamethasone|mesh-list
44724168|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724169|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
44724170|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
44724171|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724172|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724173|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724174|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
44724175|NCT01534169|Hormones|hormones|mesh-ancestor
44724176|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724177|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44724178|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724179|NCT01534247|Metronidazole|metronidazole|mesh-list
44724180|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724181|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724182|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44724183|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44724184|NCT01534312|Mesalamine|mesalamine|mesh-list
44724185|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724186|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724187|NCT01534312|Analgesics|analgesics|mesh-ancestor
44724188|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
44724189|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724190|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724191|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724192|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724193|NCT01534442|Atropine|atropine|mesh-list
44724194|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44724195|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44724196|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44724197|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
44724198|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724199|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724200|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44724201|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44724202|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
44724203|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
44724204|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44724205|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44724206|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
44724207|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724208|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724209|NCT01534455|Lapatinib|lapatinib|mesh-list
44724210|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724211|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724212|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724213|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724214|NCT01534494|Psilocybin|psilocybin|mesh-list
44724215|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
44724216|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724217|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44724218|NCT01534546|Capecitabine|capecitabine|mesh-list
44724219|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
44724220|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724221|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
44724222|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724223|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724224|NCT01534585|Paclitaxel|paclitaxel|mesh-list
44724225|NCT01534585|Cisplatin|cisplatin|mesh-list
44724226|NCT01534585|Mitogens|mitogens|mesh-list
44724227|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44724228|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724229|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44724230|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44724231|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44724232|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724233|NCT01534702|Cytarabine|cytarabine|mesh-list
44724234|NCT01534702|Clofarabine|clofarabine|mesh-list
44724235|NCT01534702|Idarubicin|idarubicin|mesh-list
44724236|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724238|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724239|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724240|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
44724241|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724242|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724243|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
44724244|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724245|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44724246|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44724247|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724248|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724249|NCT01534754|Mesalamine|mesalamine|mesh-list
44724250|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724251|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724252|NCT01534754|Analgesics|analgesics|mesh-ancestor
44724253|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
44724254|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724255|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724256|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724257|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724258|NCT01534806|Ketorolac|ketorolac|mesh-list
44724259|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724260|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724261|NCT01534806|Analgesics|analgesics|mesh-ancestor
44724262|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
44724263|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724264|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724265|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724266|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724267|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44724268|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724269|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724270|NCT01534845|Temozolomide|temozolomide|mesh-list
44724271|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44724272|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
44724273|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724274|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724275|NCT01534858|Polihexanide|polihexanide|mesh-list
44724276|NCT01534858|Betaine|betaine|mesh-list
44724277|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724278|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
44724279|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44724280|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
44724281|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724282|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44724283|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
44724284|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724285|NCT01534884|Rituximab|rituximab|mesh-list
44724286|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44724287|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724288|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
44724289|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724290|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724291|NCT01534949|Rituximab|rituximab|mesh-list
44724292|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887173|NCT04557137|Somatostatin|somatostatin|mesh-list
44724293|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724294|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
44724295|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724296|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724297|NCT01535027|Alendronate|alendronate|mesh-list
44724298|NCT01535027|Teriparatide|teriparatide|mesh-list
44724299|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44724300|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44724301|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724302|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44724303|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44724304|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
44724305|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724306|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44724307|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44724308|NCT01535079|Ibuprofen|ibuprofen|mesh-list
44724309|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724310|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724311|NCT01535079|Analgesics|analgesics|mesh-ancestor
44724312|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
44724313|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724314|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724315|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724316|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724317|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44724318|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724319|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724320|NCT01535092|Silybin|silybin|mesh-list
44724321|NCT01535092|Protective Agents|protective agents|mesh-ancestor
44724322|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724323|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44724324|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724325|NCT01535157|Ketoconazole|ketoconazole|mesh-list
44724326|NCT01535157|Fenretinide|fenretinide|mesh-list
44724327|NCT01535157|Retinamide|retinamide|mesh-list
44724328|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
44724329|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724330|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44724331|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724332|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724333|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724334|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44724335|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
44724336|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724337|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724338|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44724339|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724340|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44724341|NCT01535157|Protective Agents|protective agents|mesh-ancestor
44724342|NCT01535170|Lactoferrin|lactoferrin|mesh-list
44724343|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724344|NCT01535183|Irinotecan|irinotecan|mesh-list
44724345|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44724346|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724347|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724348|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724349|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724350|NCT01535417|Celecoxib|celecoxib|mesh-list
44724351|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724352|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724353|NCT01535417|Analgesics|analgesics|mesh-ancestor
44724354|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
44724355|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724356|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724357|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724358|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724359|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44724360|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44724361|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724362|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724363|NCT01535469|Fluconazole|fluconazole|mesh-list
44724364|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
44724365|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724366|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44724367|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724368|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724369|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724370|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44724371|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
44724372|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724373|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724374|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44724375|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44724376|NCT01535495|Propranolol|propranolol|mesh-list
44724377|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44724378|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44724379|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724380|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724381|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724382|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724383|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44724384|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44724385|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
44724387|NCT01535547|Tacrolimus|tacrolimus|mesh-list
44724388|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724389|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
44724390|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724391|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44724392|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724393|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724394|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
44724395|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724396|NCT01535612|Insulin|insulin|mesh-list
44724397|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724398|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724399|NCT01535677|Metformin|metformin|mesh-list
44724400|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
44724401|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724402|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724403|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44724404|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724405|NCT01535690|Methylene Blue|methylene blue|mesh-list
44724406|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724407|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724408|NCT01535768|Travoprost|travoprost|mesh-list
44724409|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44724410|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44724411|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44724412|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44724413|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44724414|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44724415|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44724416|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724417|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724418|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724419|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724420|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
44724421|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44724422|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44724423|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724424|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
44724425|NCT01535781|Coagulants|coagulants|mesh-ancestor
44724426|NCT01535820|Ortho Evra|ortho evra|mesh-list
44724427|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44724428|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
44724429|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44724430|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724431|NCT01535859|Cabergoline|cabergoline|mesh-list
44724432|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44724433|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44724434|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
44724435|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
44276336|NCT00708396|Citalopram|citalopram|mesh-list
44724436|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724437|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724438|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724439|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44724440|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44724441|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
44724442|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724444|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44724445|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724446|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724447|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44724448|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724449|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
44724450|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724451|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
44724452|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724453|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44724454|NCT01536002|Propofol|propofol|mesh-list
44724455|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43853946|NCT03719105|Prednisone|prednisone|mesh-list
44724456|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724457|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724458|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44724459|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
44724460|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
44724462|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44724463|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
44724464|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
44724465|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44724466|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
44724467|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724468|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724469|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724470|NCT01536054|Sirolimus|sirolimus|mesh-list
44724471|NCT01536054|Sargramostim|sargramostim|mesh-list
44724472|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724473|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724474|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44724475|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724476|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
44724477|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724478|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
44724479|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724480|NCT01536132|Simendan|simendan|mesh-list
44724481|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44724482|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44724483|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44724484|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44724485|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724486|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724487|NCT01536132|Protective Agents|protective agents|mesh-ancestor
44724488|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724489|NCT01536158|Acetaminophen|acetaminophen|mesh-list
44724490|NCT01536158|Ibuprofen|ibuprofen|mesh-list
44724491|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44724492|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724493|NCT01536158|Analgesics|analgesics|mesh-ancestor
44724494|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
44724495|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724496|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887374|NCT04554303|Amlodipine|amlodipine|mesh-list
44724497|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724498|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724499|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44724500|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724501|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724502|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
44724503|NCT01536223|Cisplatin|cisplatin|mesh-list
44724504|NCT01536223|Docetaxel|docetaxel|mesh-list
44724505|NCT01536223|Fluorouracil|fluorouracil|mesh-list
44724506|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724507|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44724508|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44724509|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44724510|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724511|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
44724512|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724513|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724514|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
44724515|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724516|NCT01536249|Pramipexole|pramipexole|mesh-list
44724518|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44724519|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724520|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44724521|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
44724522|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
44724523|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724524|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724525|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724526|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44724527|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724528|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724529|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
44724530|NCT01536249|Protective Agents|protective agents|mesh-ancestor
44724531|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44724532|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44724533|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
44724534|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
44724535|NCT01536301|Morphine|morphine|mesh-list
44724536|NCT01536301|Oxycodone|oxycodone|mesh-list
44724537|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44724538|NCT01536301|Narcotics|narcotics|mesh-ancestor
44724539|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724540|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724541|NCT01536301|Analgesics|analgesics|mesh-ancestor
44724542|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
44724543|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724544|NCT01536314|Memantine|memantine|mesh-list
44724545|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44724546|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44724547|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
44724548|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724549|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724550|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724551|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44724552|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44724553|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44724554|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44724555|NCT01536431|Insulin|insulin|mesh-list
44724556|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44724557|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724558|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724559|NCT01536470|Norepinephrine|norepinephrine|mesh-list
44724560|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44724561|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44724562|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724563|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724564|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724565|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724566|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
44724567|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
44724568|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724569|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44724570|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
44724571|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
44724572|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724573|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724574|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724575|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
44724576|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
44724577|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724578|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724579|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724580|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
44724581|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
44724582|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724583|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724584|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724585|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
44724586|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
44724587|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724588|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724589|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724590|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
44724591|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
44724592|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724593|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724594|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724595|NCT01536665|Liraglutide|liraglutide|mesh-list
44724596|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724597|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724598|NCT01536665|Incretins|incretins|mesh-ancestor
44724599|NCT01536665|Hormones|hormones|mesh-ancestor
44724600|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724601|NCT01536691|Ondansetron|ondansetron|mesh-list
44724602|NCT01536691|Aprepitant|aprepitant|mesh-list
44724603|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
44724604|NCT01536691|Ramosetron|ramosetron|mesh-list
44724606|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
44724607|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724608|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724609|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724610|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
44724611|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44724612|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44724613|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
44724614|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724615|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724616|NCT01536691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44724617|NCT01536691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44724618|NCT01536691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724619|NCT01536691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44724620|NCT01536691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44724621|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44724622|NCT01536717|Carticaine|carticaine|mesh-list
44724623|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
44724624|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
44724625|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724626|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724627|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
44724628|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724629|NCT01536743|Palbociclib|palbociclib|mesh-list
44724630|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724631|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724632|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724633|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724634|NCT01536873|Dolutegravir|dolutegravir|mesh-list
44724635|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44724636|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44724637|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724638|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724639|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44724640|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44724641|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
44724642|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724643|NCT01537055|Amoxicillin|amoxicillin|mesh-list
44724644|NCT01537055|Levofloxacin|levofloxacin|mesh-list
44724645|NCT01537055|Ofloxacin|ofloxacin|mesh-list
44724646|NCT01537055|Lansoprazole|lansoprazole|mesh-list
44724647|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
44724648|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724649|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724650|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44724651|NCT01537055|Renal Agents|renal agents|mesh-ancestor
44724652|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44724653|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724654|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724655|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724656|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724657|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44724658|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724659|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44724660|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724661|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44724662|NCT01537094|Vitamins|vitamins|mesh-list
44724663|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
44724664|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
44724665|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724666|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
44724667|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724668|NCT01537094|Protective Agents|protective agents|mesh-ancestor
44724669|NCT01537107|Sirolimus|sirolimus|mesh-list
44724670|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44724671|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724672|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724673|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44724674|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724675|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
44724676|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724677|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
44724678|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724679|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43854172|NCT03703167|Rituximab|rituximab|mesh-list
44724680|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724681|NCT01537146|Ropivacaine|ropivacaine|mesh-list
44724682|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
44724683|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
44724684|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724685|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724686|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
44724687|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724688|NCT01537250|Levofloxacin|levofloxacin|mesh-list
44724689|NCT01537250|Ofloxacin|ofloxacin|mesh-list
44724690|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44724691|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724692|NCT01537250|Renal Agents|renal agents|mesh-ancestor
44724693|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724694|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44724695|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724696|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724697|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724698|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724699|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44724700|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724701|NCT01537354|Poractant alfa|poractant alfa|mesh-list
44724702|NCT01537354|Beractant|beractant|mesh-list
44724703|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44724704|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
44724705|NCT01537380|Cefazolin|cefazolin|mesh-list
44724706|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724707|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724708|NCT01537471|Meclizine|meclizine|mesh-list
44724709|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
44724710|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
44724711|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
44724712|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724713|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724714|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724715|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44724716|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
44724717|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
44724718|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724719|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724720|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44724721|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
44724722|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44724723|NCT01537575|Antibodies|antibodies|mesh-list
44724724|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
44724725|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44724726|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
44724727|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724728|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44724729|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724730|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44724731|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
44724732|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724733|NCT01537744|Azacitidine|azacitidine|mesh-list
44724734|NCT01537744|Romidepsin|romidepsin|mesh-list
44724735|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724736|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
44724737|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724738|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724739|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724740|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44724741|NCT01537770|Lidocaine|lidocaine|mesh-list
44724742|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
44724743|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
44724744|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724745|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724746|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
44724747|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724748|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44724749|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44724750|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44724751|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44724752|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724753|NCT01537809|Vitamin D|vitamin d|mesh-list
44724754|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
44724755|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
44724756|NCT01537809|Vitamins|vitamins|mesh-list
44724757|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
44724758|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724759|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44724760|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44724761|NCT01537861|Thalidomide|thalidomide|mesh-list
44724762|NCT01537861|Dexamethasone|dexamethasone|mesh-list
44724763|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
44724764|NCT01537861|Lenalidomide|lenalidomide|mesh-list
44724765|NCT01537861|Bortezomib|bortezomib|mesh-list
44724766|NCT01537861|Pomalidomide|pomalidomide|mesh-list
44724767|NCT01537861|Lenograstim|lenograstim|mesh-list
44724768|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724769|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
44724770|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724771|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724772|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44724773|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
44724774|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724775|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724776|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44724777|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724778|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
44724779|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
44724780|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724781|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724782|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
44724783|NCT01537861|Hormones|hormones|mesh-ancestor
44724784|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724785|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44724786|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44724787|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44724788|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44724789|NCT01537861|Growth Substances|growth substances|mesh-ancestor
44724790|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44724791|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
44724792|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724793|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724794|NCT01538095|Trebananib|trebananib|mesh-list
44724795|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44724796|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44724797|NCT01538095|Growth Substances|growth substances|mesh-ancestor
44724798|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724800|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724801|NCT01538108|Paclitaxel|paclitaxel|mesh-list
44724802|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44724803|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724804|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
44724805|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
44724806|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
44724807|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724808|NCT01538225|Nabiximols|nabiximols|mesh-list
44724809|NCT01538225|Analgesics|analgesics|mesh-ancestor
44724810|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
44724811|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724812|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724813|NCT01538316|Genistein|genistein|mesh-list
44724814|NCT01538316|Quercetin|quercetin|mesh-list
44724815|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
44724816|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724817|NCT01538316|Protective Agents|protective agents|mesh-ancestor
44724818|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724819|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44724820|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724821|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724822|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724823|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
44724824|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44724825|NCT01538316|Estrogens|estrogens|mesh-ancestor
44724826|NCT01538316|Hormones|hormones|mesh-ancestor
44724827|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724828|NCT01538329|Amantadine|amantadine|mesh-list
44724829|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44724830|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44724831|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
44724832|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724833|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
44724834|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724835|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724836|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724837|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44724838|NCT01538329|Analgesics|analgesics|mesh-ancestor
44724839|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
44724840|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724841|NCT01538381|Afatinib|afatinib|mesh-list
44724842|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724843|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724844|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724845|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724846|NCT01538394|Nicotine|nicotine|mesh-list
44724847|NCT01538394|Varenicline|varenicline|mesh-list
44724848|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44724849|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
44724850|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724851|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724852|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44724853|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44724854|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44724855|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724856|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724857|NCT01538446|Clopidogrel|clopidogrel|mesh-list
44724858|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44724859|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44724860|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44724861|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44724862|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44724863|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
44724864|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724865|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724866|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724867|NCT01538459|Dexamethasone|dexamethasone|mesh-list
44724868|NCT01538459|Bupivacaine|bupivacaine|mesh-list
44724869|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44724870|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
44724871|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
44724872|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724873|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724875|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
44724876|NCT01538459|Hormones|hormones|mesh-ancestor
44724877|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44724878|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44724879|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724880|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44724881|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
44724882|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44724883|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
44724884|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
44724885|NCT01538485|Vitamin D|vitamin d|mesh-list
44724886|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44724887|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724888|NCT01538485|Vitamins|vitamins|mesh-ancestor
44724889|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
44724890|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44724891|NCT01538511|Insulin|insulin|mesh-list
44724892|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44724893|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
44724894|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
44724895|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44724896|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
44724897|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44724898|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724899|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724900|NCT01538537|ON 01910|on 01910|mesh-list
44724901|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724902|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724903|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724904|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724905|NCT01538563|ON 01910|on 01910|mesh-list
44724906|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854359|NCT03678675|Ketorolac|ketorolac|mesh-list
44724907|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44724908|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724909|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724910|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
44724911|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724912|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724913|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
44724914|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44724915|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724916|NCT01538641|Gemcitabine|gemcitabine|mesh-list
44724917|NCT01538641|Rituximab|rituximab|mesh-list
44724918|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
44158768|NCT00237575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724919|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44724920|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724921|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
44724922|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724923|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44724924|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44724925|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
44724926|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724927|NCT01538641|Antiviral Agents|antiviral agents|mesh-ancestor
44724928|NCT01538641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724929|NCT01538641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724930|NCT01538641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44724931|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
44724932|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44724933|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44724934|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44724935|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44724936|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724937|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724938|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724939|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44724940|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44724941|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
44724942|NCT01538693|Dexetimide|dexetimide|mesh-list
44724943|NCT01538693|Citalopram|citalopram|mesh-list
44724944|NCT01538693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44724945|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44724946|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44724947|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724948|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724949|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
44724950|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724951|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44724952|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
44724953|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44724954|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44724955|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44724956|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
44724957|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
44724958|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44724959|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44724960|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44724961|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
44724962|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
44724963|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44724964|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724965|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44724966|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
44724967|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
44724968|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44724969|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44724970|NCT01538732|Alitretinoin|alitretinoin|mesh-list
44724971|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44724972|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
44724973|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
44724974|NCT01538771|Hematinics|hematinics|mesh-ancestor
44724975|NCT01538797|Ranitidine|ranitidine|mesh-list
44724976|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44724977|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44724978|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724979|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44724980|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
44724981|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
44724982|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724983|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724984|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724985|NCT01538849|Esomeprazole|esomeprazole|mesh-list
44724986|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44724987|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44724988|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44724989|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44724990|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724991|NCT01538875|Labetalol|labetalol|mesh-list
44724992|NCT01538875|Hydralazine|hydralazine|mesh-list
44724993|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44724994|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44724995|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
44724996|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44724997|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44724998|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44724999|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725000|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
44725001|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
44725002|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725003|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44725004|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44725005|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
44725006|NCT01538901|Imiquimod|imiquimod|mesh-list
44725007|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44725008|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
44725009|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725010|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725011|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
44725012|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44725013|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
44725014|NCT01538927|Coagulants|coagulants|mesh-ancestor
44725015|NCT01538940|Vaccines|vaccines|mesh-list
44725016|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
44725017|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725018|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44725019|NCT01538953|Disinfectants|disinfectants|mesh-list
44725020|NCT01538953|Eusol|eusol|mesh-list
44725021|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725022|NCT01539018|Sorafenib|sorafenib|mesh-list
44725023|NCT01539018|Tegafur|tegafur|mesh-list
44725024|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725025|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44725026|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725027|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725028|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44725029|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
44725030|NCT01539031|Donepezil|donepezil|mesh-list
44725031|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44725032|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725033|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725034|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
44725035|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725036|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725037|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
44725038|NCT01539044|Atropine|atropine|mesh-list
44725039|NCT01539044|Neostigmine|neostigmine|mesh-list
44725040|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44725041|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725042|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44725043|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
44725044|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725045|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725046|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44725047|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
44725048|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
44725049|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
44725050|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44725051|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44725052|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44725053|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725054|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725055|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44725056|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725057|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44725058|NCT01539174|Prednisone|prednisone|mesh-list
44725059|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
44725060|NCT01539174|Rituximab|rituximab|mesh-list
44725061|NCT01539174|Doxorubicin|doxorubicin|mesh-list
44725062|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44725063|NCT01539174|Vincristine|vincristine|mesh-list
44725064|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725065|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
44725066|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725067|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725068|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44725069|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
44725070|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725071|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725072|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44725073|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44725074|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44725075|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44725076|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44725077|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725078|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725079|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
44725080|NCT01539174|Hormones|hormones|mesh-ancestor
44725081|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725082|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725083|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44725084|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
44725085|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
44725086|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
44725087|NCT01539265|Silodosin|silodosin|mesh-list
44725088|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44725089|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44725090|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44725091|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
44725092|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725093|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725094|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725095|NCT01539265|Urological Agents|urological agents|mesh-ancestor
44725096|NCT01539330|Voriconazole|voriconazole|mesh-list
44725097|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
44725098|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725099|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44725100|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725101|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725102|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725103|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44725104|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44725105|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725106|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725107|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44725108|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
44725109|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44725110|NCT01539408|Misoprostol|misoprostol|mesh-list
44725111|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44725112|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
44725113|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44725114|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725115|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44725116|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725117|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
44725118|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
44725119|NCT01539473|Tedizolid|tedizolid|mesh-list
44725120|NCT01539473|Tyramine|tyramine|mesh-list
44725121|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44725122|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725123|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
44725124|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
44725125|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725126|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725127|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44725128|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725129|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725130|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277042|NCT00712647|Vitamin A|vitamin a|mesh-list
44725131|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44725132|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725133|NCT01539564|Minocycline|minocycline|mesh-list
44725134|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44725135|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725136|NCT01539577|Dexamethasone|dexamethasone|mesh-list
44725137|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725138|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
44725139|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
44725140|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725141|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725142|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725143|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
44725144|NCT01539577|Hormones|hormones|mesh-ancestor
44725145|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725146|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725147|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725148|NCT01539603|Sirolimus|sirolimus|mesh-list
44725149|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44725150|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725151|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44725152|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725153|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
44725154|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725155|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
44725156|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725157|NCT01539616|Fenofibrate|fenofibrate|mesh-list
44725158|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44725159|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
44725160|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725161|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44725162|NCT01539655|Omeprazole|omeprazole|mesh-list
44725163|NCT01539655|Ranitidine|ranitidine|mesh-list
44725164|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44725165|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44725166|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725167|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44725168|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725169|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725170|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44725171|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
44725172|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
44725173|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725174|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725175|NCT01539681|Sorafenib|sorafenib|mesh-list
44725176|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725177|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44725178|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725179|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725180|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
44725181|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44725182|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44725183|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44725184|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725185|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725186|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725187|NCT01539707|Urological Agents|urological agents|mesh-ancestor
44725188|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
44725189|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
44725190|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44725191|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
44725192|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44725193|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725194|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44725195|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44725196|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44725197|NCT01539733|Haloperidol|haloperidol|mesh-list
44725198|NCT01539733|Olanzapine|olanzapine|mesh-list
44725199|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
44725200|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
44725201|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
44725202|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725203|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725204|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725206|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725207|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725208|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725209|NCT01539733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44725210|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725211|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725212|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725213|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725214|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
44725215|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44725216|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
44725217|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44725218|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44725219|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
44725220|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725221|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
44725222|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725223|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725224|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44725225|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
44725226|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725227|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725228|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44725230|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44725231|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725232|NCT01540032|Analgesics|analgesics|mesh-ancestor
44725233|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
44725234|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725235|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725236|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725237|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725238|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44725239|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725240|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725241|NCT01540084|Propofol|propofol|mesh-list
44725242|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44725243|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725244|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725245|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44725246|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
44725247|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
44725248|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
44725249|NCT01540110|Docetaxel|docetaxel|mesh-list
44725250|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725251|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
44725252|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725253|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725254|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44725255|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
44725256|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725257|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725258|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44725259|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44725260|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44725261|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44725262|NCT01540136|Cisplatin|cisplatin|mesh-list
44725263|NCT01540136|Nedaplatin|nedaplatin|mesh-list
44725264|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725265|NCT01540240|Zidovudine|zidovudine|mesh-list
44725266|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
44725267|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725268|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44725269|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44725270|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725271|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
44725272|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725273|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44725274|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44725275|NCT01540435|Bevacizumab|bevacizumab|mesh-list
43854661|NCT03653247|Plerixafor|plerixafor|mesh-list
44725276|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44725277|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725278|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44725279|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44725280|NCT01540435|Growth Substances|growth substances|mesh-ancestor
44725281|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725282|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
44725283|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
44725284|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44725285|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725286|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725287|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725288|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725289|NCT01540500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44725290|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725291|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725292|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725293|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725294|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
44725295|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44725296|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
44725297|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44725298|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725299|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725300|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44725301|NCT01540526|Axitinib|axitinib|mesh-list
44725302|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725303|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44725304|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725305|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725306|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44725307|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44725308|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44725309|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44725310|NCT01540682|Cetuximab|cetuximab|mesh-list
44725311|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44725312|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725313|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44725314|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44725315|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
44725316|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725317|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725318|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44725319|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
44725320|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
44725321|NCT01540708|Hormones|hormones|mesh-ancestor
44725322|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725323|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
44725324|NCT01540721|Acetaminophen|acetaminophen|mesh-list
44725325|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725326|NCT01540721|Analgesics|analgesics|mesh-ancestor
44725327|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
44725328|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725329|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725330|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
44725331|NCT01540734|Acetaminophen|acetaminophen|mesh-list
44725332|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725333|NCT01540734|Analgesics|analgesics|mesh-ancestor
44725334|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
44725335|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725336|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725337|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
44725338|NCT01540747|Folic Acid|folic acid|mesh-list
44725339|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
44725340|NCT01540747|Inositol|inositol|mesh-list
44725341|NCT01540747|Melatonin|melatonin|mesh-list
44725342|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
44725343|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725344|NCT01540747|Protective Agents|protective agents|mesh-ancestor
44725345|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725346|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725347|NCT01540747|Hematinics|hematinics|mesh-ancestor
44725348|NCT01540747|Vitamins|vitamins|mesh-ancestor
44725349|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
44725352|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
44725353|NCT01540812|Prednisone|prednisone|mesh-list
44725354|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
44725355|NCT01540812|Fludarabine|fludarabine|mesh-list
44725356|NCT01540812|Vincristine|vincristine|mesh-list
44725357|NCT01540812|Daunorubicin|daunorubicin|mesh-list
44725358|NCT01540812|Idarubicin|idarubicin|mesh-list
44725359|NCT01540812|Methotrexate|methotrexate|mesh-list
44725360|NCT01540812|Pegaspargase|pegaspargase|mesh-list
44725361|NCT01540812|Asparaginase|asparaginase|mesh-list
44725362|NCT01540812|BB 1101|bb 1101|mesh-list
44725363|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725364|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
44725365|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
44725366|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725367|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725368|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725369|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
44725370|NCT01540812|Hormones|hormones|mesh-ancestor
44725371|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725372|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725373|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725374|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
44725375|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725376|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725377|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44725378|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
44725379|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725380|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
44725381|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
44725382|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725383|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44725384|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44725385|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44725386|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44725387|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44725388|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44725389|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44725390|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44725391|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
44725392|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44725393|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44725394|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44725395|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725396|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44725397|NCT01540877|Anesthetics|anesthetics|mesh-list
44725398|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44725399|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
44725400|NCT01540877|Capsaicin|capsaicin|mesh-list
44725401|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725402|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725403|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
44725404|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725405|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
44725406|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
44725407|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44725408|NCT01541059|Ropivacaine|ropivacaine|mesh-list
44725409|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
44725410|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
44725411|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725412|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725413|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
44725414|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725415|NCT01541072|Lenograstim|lenograstim|mesh-list
44725416|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44725417|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
44725418|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725419|NCT01541085|Ritonavir|ritonavir|mesh-list
44725420|NCT01541085|Darunavir|darunavir|mesh-list
44725421|NCT01541085|Efavirenz|efavirenz|mesh-list
44725422|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44725423|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44725424|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
44725425|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725426|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854803|NCT03638375|Interferons|interferons|mesh-list
44725427|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44725428|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44725429|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
44725430|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725431|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44725432|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725433|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44725434|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44725435|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44725436|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44725437|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44725438|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44725439|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44725440|NCT01541124|Morphine|morphine|mesh-list
44725441|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44725442|NCT01541124|Narcotics|narcotics|mesh-ancestor
44725443|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725444|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725445|NCT01541124|Analgesics|analgesics|mesh-ancestor
44725446|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
44725447|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725448|NCT01541137|Diclofenac|diclofenac|mesh-list
44725449|NCT01541137|Parecoxib|parecoxib|mesh-list
44725450|NCT01541137|Valdecoxib|valdecoxib|mesh-list
44725451|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44725452|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725453|NCT01541137|Analgesics|analgesics|mesh-ancestor
44725454|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
44725455|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725456|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725457|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725458|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725459|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44725460|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725461|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725462|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44725463|NCT01541189|Valsartan|valsartan|mesh-list
44725464|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725465|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44725466|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44725467|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725468|NCT01541267|Telmisartan|telmisartan|mesh-list
44725469|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725470|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44725471|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44725472|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725473|NCT01541280|Azacitidine|azacitidine|mesh-list
44725474|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44725475|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
44725476|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725477|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725478|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725479|NCT01541293|Lidocaine|lidocaine|mesh-list
44725480|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
44725481|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
44725482|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725483|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725484|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
44725485|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725486|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725487|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44725488|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44725489|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725490|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725491|NCT01541332|Dexamethasone|dexamethasone|mesh-list
44725492|NCT01541332|Doxorubicin|doxorubicin|mesh-list
44725493|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44725494|NCT01541332|Pomalidomide|pomalidomide|mesh-list
44725495|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725496|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
44725497|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
44725498|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725499|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725500|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725501|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
44725502|NCT01541332|Hormones|hormones|mesh-ancestor
44725503|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725504|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725505|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725506|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44725507|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44725508|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44725509|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725510|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725511|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
44725512|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44725513|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44725514|NCT01541332|Growth Substances|growth substances|mesh-ancestor
44725515|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44725516|NCT01541436|Capsaicin|capsaicin|mesh-list
44725517|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
44725518|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
44725519|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
44725520|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725521|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725522|NCT01541475|Dexetimide|dexetimide|mesh-list
44725523|NCT01541475|Citalopram|citalopram|mesh-list
44725524|NCT01541475|Bupropion|bupropion|mesh-list
44725525|NCT01541475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44725526|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725527|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725528|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725529|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725530|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
44725531|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725532|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44725533|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
44725534|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725535|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44725536|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44725537|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
44725538|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
44725539|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725540|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44725541|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44725542|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
44725543|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44725544|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
44725545|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44725546|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725547|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725548|NCT01541605|Methylphenidate|methylphenidate|mesh-list
44725549|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44725550|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725551|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44725552|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725553|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725554|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725555|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
44725556|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725557|NCT01541631|Albendazole|albendazole|mesh-list
44725558|NCT01541631|Praziquantel|praziquantel|mesh-list
44725559|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
44725560|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44725561|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725562|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
44725563|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44725564|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44725565|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
44725566|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
44725567|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
44725568|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725569|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725570|NCT01541670|Antibodies|antibodies|mesh-list
44725571|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
44725572|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725573|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44725574|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44725577|NCT01541943|Atorvastatin|atorvastatin|mesh-list
44725578|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44725579|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44725580|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
44725581|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725582|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44725583|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44725584|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725585|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725586|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725587|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44725588|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44725589|NCT01541956|Metformin|metformin|mesh-list
44725590|NCT01541956|Vildagliptin|vildagliptin|mesh-list
44725591|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725592|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725593|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44725594|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
44725595|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725596|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725597|NCT01542047|Carboplatin|carboplatin|mesh-list
44725598|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725599|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
44725600|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
44725601|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44725602|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725603|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725604|NCT01542099|Remifentanil|remifentanil|mesh-list
44725605|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44725606|NCT01542099|Narcotics|narcotics|mesh-ancestor
44725607|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725608|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725609|NCT01542099|Analgesics|analgesics|mesh-ancestor
44725610|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
44725611|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725612|NCT01542138|Niacinamide|niacinamide|mesh-list
44725613|NCT01542138|Niacin|niacin|mesh-list
44725614|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
44725615|NCT01542138|Desonide|desonide|mesh-list
44725616|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
44725617|NCT01542138|Vitamins|vitamins|mesh-ancestor
44725618|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
44725619|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725620|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44725621|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
44725622|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725623|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44725624|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
44725625|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725626|NCT01542190|Ketorolac|ketorolac|mesh-list
44725627|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44725628|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44725629|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725630|NCT01542190|Analgesics|analgesics|mesh-ancestor
44725631|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
44725632|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725633|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725634|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725635|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725636|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44725637|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725638|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725639|NCT01542242|Liraglutide|liraglutide|mesh-list
44725640|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725641|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725642|NCT01542242|Incretins|incretins|mesh-ancestor
44725643|NCT01542242|Hormones|hormones|mesh-ancestor
44725644|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725645|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
44725646|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44725647|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725648|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725649|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44725650|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44725651|NCT01542268|Protective Agents|protective agents|mesh-ancestor
44725652|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725653|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
44725654|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44725656|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
44725657|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725658|NCT01542424|Insulin|insulin|mesh-list
44725659|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44725660|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
44725661|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
44725662|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
44725663|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44725664|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725665|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725666|NCT01542437|Afatinib|afatinib|mesh-list
44725667|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725668|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44725669|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725670|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725671|NCT01542450|Insulin|insulin|mesh-list
44725672|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44725673|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
44725674|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
44725675|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
44725676|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
44725677|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725678|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725679|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
44725680|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725681|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725682|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
44725683|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725684|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725685|NCT01542489|Insulin|insulin|mesh-list
44725686|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44725687|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
44725688|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
44725689|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44725690|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277615|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44725691|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
44725693|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
44725694|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725695|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725696|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
44725697|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725698|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725699|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
44725700|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44725701|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725702|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725703|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44725704|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
44725705|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44725706|NCT01542710|Timolol|timolol|mesh-list
44725707|NCT01542710|Bimatoprost|bimatoprost|mesh-list
44725708|NCT01542710|Travoprost|travoprost|mesh-list
44725709|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44725710|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44725711|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
44725712|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725713|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725714|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725715|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725716|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725717|NCT01542723|Nadroparin|nadroparin|mesh-list
44725718|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
44725719|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44725720|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44725721|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725722|NCT01542762|Nadroparin|nadroparin|mesh-list
44725724|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44725725|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44725726|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725727|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
44725728|NCT01542801|Norfloxacin|norfloxacin|mesh-list
44725729|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44725730|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725731|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44725732|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44725733|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725734|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725735|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725736|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44725737|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725738|NCT01542827|Analgesics|analgesics|mesh-list
44725739|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
44725740|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725741|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725742|NCT01542918|Rituximab|rituximab|mesh-list
44725743|NCT01542918|Lenalidomide|lenalidomide|mesh-list
44725744|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44725745|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725746|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
44725747|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725748|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725749|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44725750|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44725751|NCT01542918|Growth Substances|growth substances|mesh-ancestor
44725752|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
44725753|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44725754|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
44725755|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725756|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44725757|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44725758|NCT01543139|Valproic Acid|valproic acid|mesh-list
44725759|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
44725760|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725761|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725762|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
44725763|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725764|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725765|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
44725766|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725767|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725768|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725769|NCT01543165|Ketorolac|ketorolac|mesh-list
44725770|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44725771|NCT01543165|Morphine|morphine|mesh-list
44725772|NCT01543165|Analgesics|analgesics|mesh-list
44725773|NCT01543165|Nefopam|nefopam|mesh-list
44725774|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44725775|NCT01543165|Narcotics|narcotics|mesh-ancestor
44725776|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725777|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725778|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
44725779|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725780|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44725781|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725782|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725783|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725784|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44725785|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725786|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725787|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
44725788|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44725789|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44725790|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725791|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725792|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
44725793|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725794|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725795|NCT01543347|Temocillin|temocillin|mesh-list
44725796|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855117|NCT03602560|Seladelpar|seladelpar|mesh-list
44725797|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725799|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44725800|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44725801|NCT01543386|Analgesics|analgesics|mesh-ancestor
44159673|NCT00239486|Pramipexole|pramipexole|mesh-list
44725802|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
44725803|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725804|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725805|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725806|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44725807|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725808|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725809|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725810|NCT01543399|Tibolone|tibolone|mesh-list
44725811|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
44725812|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44725813|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725814|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725815|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725816|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725817|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725818|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44725819|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
44725820|NCT01543399|Hormones|hormones|mesh-ancestor
44725821|NCT01543464|Temozolomide|temozolomide|mesh-list
44725822|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44725823|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
44725824|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725825|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725826|NCT01543555|Atorvastatin|atorvastatin|mesh-list
44725827|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44725828|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44725829|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
44725830|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725831|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44725832|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44725833|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725834|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
44725835|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
44725836|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725837|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725838|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725839|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
44725840|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725841|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725842|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725843|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
44725844|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44725845|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
44725846|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725847|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
44725848|NCT01543737|Protective Agents|protective agents|mesh-ancestor
44725849|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
44725850|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44725851|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725852|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725853|NCT01543906|Retinol acetate|retinol acetate|mesh-list
44725854|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44725855|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
44725856|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725857|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44725858|NCT01543906|Protective Agents|protective agents|mesh-ancestor
44725859|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725860|NCT01543932|Clopidogrel|clopidogrel|mesh-list
44725861|NCT01543932|Ticagrelor|ticagrelor|mesh-list
44725862|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44725863|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44725864|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44725865|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44725866|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44725867|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
44725868|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725869|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725871|NCT01543945|Dexamethasone|dexamethasone|mesh-list
44725872|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
44725873|NCT01543945|Ondansetron|ondansetron|mesh-list
44725874|NCT01543945|Antiemetics|antiemetics|mesh-list
44725875|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
44725876|NCT01543945|BB 1101|bb 1101|mesh-list
44725877|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725878|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
44725879|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725880|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725881|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725882|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
44725883|NCT01543945|Hormones|hormones|mesh-ancestor
44725884|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725885|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44725886|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725887|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
44725888|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725889|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725890|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
44725891|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
44725892|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44725893|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
44725894|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725895|NCT01543945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44725896|NCT01543945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725897|NCT01543945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725898|NCT01543945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725899|NCT01543945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44725900|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44725901|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
44725902|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
44725903|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44725904|NCT01543971|Lenograstim|lenograstim|mesh-list
44725905|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44725906|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
44725907|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725908|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44725909|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
44725910|NCT01544140|Midazolam|midazolam|mesh-list
44725911|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44725912|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44725913|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725914|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725915|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44725916|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44725917|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44725918|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44725919|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
44725921|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
44725922|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
44725923|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725924|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725925|NCT01544192|Tocopherols|tocopherols|mesh-list
44725926|NCT01544192|Vitamin E|vitamin e|mesh-list
44725927|NCT01544192|Tocotrienols|tocotrienols|mesh-list
44725928|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
44725929|NCT01544192|Antioxidants|antioxidants|mesh-list
44725930|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725931|NCT01544192|Protective Agents|protective agents|mesh-ancestor
44725932|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725933|NCT01544192|Vitamins|vitamins|mesh-ancestor
44725934|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
44725935|NCT01544283|Triamcinolone|triamcinolone|mesh-list
44725936|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44725937|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44725938|NCT01544283|Lidocaine|lidocaine|mesh-list
44725939|NCT01544283|Tetracaine|tetracaine|mesh-list
44725940|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44725941|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
44725942|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
44725943|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44725944|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725945|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
44725946|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725947|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44725948|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44725949|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44725950|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44725951|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725952|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44725953|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
44725954|NCT01544283|Hormones|hormones|mesh-ancestor
44725955|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44725956|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44725957|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
44725958|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725959|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
44725960|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725961|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
44725962|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
44725963|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44725964|NCT01544504|Norepinephrine|norepinephrine|mesh-list
44725965|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44725966|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44725967|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
44725968|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44725969|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725970|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44725971|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
44725972|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
44725973|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44725974|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44725975|NCT01544517|Amoxicillin|amoxicillin|mesh-list
44725976|NCT01544517|Levofloxacin|levofloxacin|mesh-list
44725977|NCT01544517|Ofloxacin|ofloxacin|mesh-list
44725978|NCT01544517|Tinidazole|tinidazole|mesh-list
44725979|NCT01544517|Esomeprazole|esomeprazole|mesh-list
44725980|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44725981|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44725982|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44725983|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44725984|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44725985|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44725986|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44725987|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44725988|NCT01544517|Renal Agents|renal agents|mesh-ancestor
44725989|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44725990|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44725991|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44725992|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44725993|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44725994|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
44725995|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44725996|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44725997|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44725998|NCT01544634|Beclomethasone|beclomethasone|mesh-list
44725999|NCT01544634|Propranolol|propranolol|mesh-list
44726000|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44726001|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44726002|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44726003|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726004|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726005|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726006|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44726007|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726008|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726009|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726010|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
44726011|NCT01544634|Hormones|hormones|mesh-ancestor
44726012|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726013|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44726014|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44726015|NCT01544673|Linezolid|linezolid|mesh-list
44726016|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44726017|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726018|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44726019|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726020|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726021|NCT01544725|Ketamine|ketamine|mesh-list
44726022|NCT01544725|Propofol|propofol|mesh-list
44726023|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726024|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726025|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726026|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726027|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
44726028|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
44726029|NCT01544725|Analgesics|analgesics|mesh-ancestor
44726030|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
44726031|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726032|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44726033|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44726034|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44726035|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726036|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726037|NCT01544751|Metformin|metformin|mesh-list
44726038|NCT01544751|Atorvastatin|atorvastatin|mesh-list
44726039|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726068|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
44726069|NCT01544842|Hormones|hormones|mesh-ancestor
44726070|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726071|NCT01544881|Insulin|insulin|mesh-list
44726072|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726073|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726074|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44726075|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
44726076|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44726077|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
44726078|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726079|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726080|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44726081|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44726082|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44726083|NCT01544907|Paclitaxel|paclitaxel|mesh-list
44277990|NCT00717938|Cisplatin|cisplatin|mesh-list
44726084|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44726085|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726086|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44726087|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44726088|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44726089|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726091|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44726092|NCT01544959|Esmolol|esmolol|mesh-list
44726093|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726094|NCT01544959|Narcotics|narcotics|mesh-ancestor
44726095|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726096|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726097|NCT01544959|Analgesics|analgesics|mesh-ancestor
44726098|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
44726099|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726100|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44726101|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726102|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
44726103|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
44726104|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44726105|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44726106|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726107|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726108|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44726109|NCT01544972|Acetaminophen|acetaminophen|mesh-list
44726110|NCT01544972|Ibuprofen|ibuprofen|mesh-list
44726111|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44726112|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44726113|NCT01544972|Analgesics|analgesics|mesh-ancestor
44726114|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
44726115|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726116|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726117|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726118|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726119|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44726120|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726121|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726122|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
44726123|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44726124|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726125|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726126|NCT01545024|Incretins|incretins|mesh-ancestor
44726127|NCT01545024|Hormones|hormones|mesh-ancestor
44726128|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726129|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44726130|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
44726131|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726132|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726133|NCT01545284|Acitretin|acitretin|mesh-list
44726134|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
44726135|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
44726136|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
44726137|NCT01545297|Remifentanil|remifentanil|mesh-list
44726138|NCT01545297|Propofol|propofol|mesh-list
44726139|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726140|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726141|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726142|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726143|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
44726144|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
44726145|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44726146|NCT01545297|Analgesics|analgesics|mesh-ancestor
44726147|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
44726148|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726149|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44726150|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44726151|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44726152|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44726153|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726154|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726155|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726156|NCT01545297|Narcotics|narcotics|mesh-ancestor
44726157|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
44726158|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726159|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726160|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726161|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726162|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44726163|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
44726164|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726165|NCT01545479|Captopril|captopril|mesh-list
44726166|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44726167|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
44726168|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726169|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726170|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726171|NCT01545557|Lidocaine|lidocaine|mesh-list
44726172|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
44726173|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
44726174|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
44726175|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726176|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726177|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
44726178|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726179|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44726180|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44726181|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44726182|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726183|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726184|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44726185|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
44726186|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
44726187|NCT01545557|Protective Agents|protective agents|mesh-ancestor
44726188|NCT01545635|Thrombin|thrombin|mesh-list
44726189|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
44726190|NCT01545635|Coagulants|coagulants|mesh-ancestor
44726191|NCT01545778|Oxycodone|oxycodone|mesh-list
44726192|NCT01545778|Tapentadol|tapentadol|mesh-list
44726193|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726194|NCT01545778|Narcotics|narcotics|mesh-ancestor
44726195|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726196|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726197|NCT01545778|Analgesics|analgesics|mesh-ancestor
44726198|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
44726199|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726200|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44726201|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44726202|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726203|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726204|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44726205|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726206|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
44726207|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726208|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726209|NCT01545804|Lenalidomide|lenalidomide|mesh-list
44726210|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
44726211|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726212|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44726213|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44726214|NCT01545804|Growth Substances|growth substances|mesh-ancestor
44726215|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
44726216|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726217|NCT01545830|Vitamin D|vitamin d|mesh-list
44726218|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
44726219|NCT01545830|Vitamins|vitamins|mesh-ancestor
44726220|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
44726221|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726222|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44726223|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44726224|NCT01545856|Levodopa|levodopa|mesh-list
44726225|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44726226|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44726227|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
44726228|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726229|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726230|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726231|NCT01545947|Azacitidine|azacitidine|mesh-list
44726232|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44726233|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44726234|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
44726235|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726236|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726237|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726238|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726239|NCT01546051|BCI-838|bci-838|mesh-list
44726240|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44726241|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44726242|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726243|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726244|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278168|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44726246|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726247|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726248|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726249|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44726250|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44726251|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44726252|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
44726253|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
44726254|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726255|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726256|NCT01546103|Vitamin D|vitamin d|mesh-list
44726257|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
44726258|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
44726259|NCT01546103|Vitamins|vitamins|mesh-list
44726260|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
44726261|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726262|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44726263|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44726264|NCT01546116|Lamivudine|lamivudine|mesh-list
44726265|NCT01546116|Adefovir|adefovir|mesh-list
44726266|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44726267|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44726268|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44726269|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726270|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726271|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
44726272|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726273|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44726274|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44726275|NCT01546389|Chloroquine|chloroquine|mesh-list
44726276|NCT01546389|Amebicides|amebicides|mesh-ancestor
44726277|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44726278|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44726279|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726280|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
44726281|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726282|NCT01546558|Metformin|metformin|mesh-list
44726283|NCT01546558|Ranolazine|ranolazine|mesh-list
44726284|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726285|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726286|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44726287|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726288|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726289|NCT01546597|Metformin|metformin|mesh-list
44726290|NCT01546597|Ranolazine|ranolazine|mesh-list
44726291|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726292|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726293|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44726294|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726295|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726296|NCT01546701|Morphine|morphine|mesh-list
44726297|NCT01546701|Buprenorphine|buprenorphine|mesh-list
44726298|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726299|NCT01546701|Narcotics|narcotics|mesh-ancestor
44726300|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726301|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726302|NCT01546701|Analgesics|analgesics|mesh-ancestor
44726303|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
44726304|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726305|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44726306|NCT01546896|Alprazolam|alprazolam|mesh-list
44726307|NCT01546896|Buspirone|buspirone|mesh-list
44726308|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726309|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726310|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726311|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44726312|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44726313|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44726314|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
44726315|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
44726316|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726317|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726318|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44726319|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
44726320|NCT01546935|Oseltamivir|oseltamivir|mesh-list
44726321|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
44278256|NCT00719420|Omeprazole|omeprazole|mesh-list
44726322|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726323|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726324|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726325|NCT01546961|Chloroquine|chloroquine|mesh-list
44726326|NCT01546961|Amebicides|amebicides|mesh-ancestor
44726327|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44726328|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44726329|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726330|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
44726331|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726332|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
44726333|NCT01547104|Glimepiride|glimepiride|mesh-list
44726334|NCT01547104|Linagliptin|linagliptin|mesh-list
44726335|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44726336|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726337|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726338|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726339|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
44726340|NCT01547104|Incretins|incretins|mesh-ancestor
44726341|NCT01547104|Hormones|hormones|mesh-ancestor
44726342|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726343|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44726344|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
44726345|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726346|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726347|NCT01547143|Cyclosporine|cyclosporine|mesh-list
44726348|NCT01547143|Dexamethasone|dexamethasone|mesh-list
44726349|NCT01547143|Etoposide|etoposide|mesh-list
44726350|NCT01547143|Cyclosporins|cyclosporins|mesh-list
44726352|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726353|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
44726354|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
44726355|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726356|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726357|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726358|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
44726359|NCT01547143|Hormones|hormones|mesh-ancestor
44726360|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726361|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44726362|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726363|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726364|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726365|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44726366|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44726367|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44726368|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726369|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
44726370|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
44726371|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726372|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44726373|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726374|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44726375|NCT01547169|Insulin|insulin|mesh-list
44726376|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44726377|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
44726378|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726379|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726380|NCT01547221|Clotrimazole|clotrimazole|mesh-list
44726381|NCT01547221|Miconazole|miconazole|mesh-list
44726382|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44726383|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726384|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
44726385|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44726386|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44726387|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726388|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726389|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44726390|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
44726391|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726392|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726393|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44726394|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44726395|NCT01547312|Interferons|interferons|mesh-list
44726396|NCT01547312|Ribavirin|ribavirin|mesh-list
44726397|NCT01547312|Grazoprevir|grazoprevir|mesh-list
44726398|NCT01547312|Liver Extracts|liver extracts|mesh-list
44726399|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726400|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
44726401|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726402|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
44726403|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726404|NCT01547312|Hematinics|hematinics|mesh-ancestor
44726405|NCT01547325|Doxycycline|doxycycline|mesh-list
44726406|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44726407|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726408|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
44726409|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44726410|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44726411|NCT01547377|Zinc|zinc|mesh-list
44726412|NCT01547377|Selenium|selenium|mesh-list
44726413|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44726414|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44726415|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726416|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
44726417|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726418|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726419|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726420|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726421|NCT01547377|Trace Elements|trace elements|mesh-ancestor
44726422|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
44726423|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726424|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
44726425|NCT01547377|Protective Agents|protective agents|mesh-ancestor
44726426|NCT01547416|Fentanyl|fentanyl|mesh-list
44726427|NCT01547416|Ropivacaine|ropivacaine|mesh-list
44726428|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44726429|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
44726430|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726431|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726432|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
44726433|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726434|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726435|NCT01547416|Narcotics|narcotics|mesh-ancestor
44726436|NCT01547416|Analgesics|analgesics|mesh-ancestor
44726437|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44726438|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726439|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
44726440|NCT01547455|Atorvastatin|atorvastatin|mesh-list
44726441|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44726442|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726443|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
44726444|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726445|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726446|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726447|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726448|NCT01547494|Vitamins|vitamins|mesh-list
44726449|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
44726450|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726451|NCT01547520|Meperidine|meperidine|mesh-list
44726452|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726453|NCT01547520|Narcotics|narcotics|mesh-ancestor
44726454|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726455|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726456|NCT01547520|Analgesics|analgesics|mesh-ancestor
44726457|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
44726458|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726459|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44726460|NCT01547546|GDC-0084|gdc-0084|mesh-list
44726461|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726462|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726463|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
44726464|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44726465|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726466|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726468|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44726469|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
44726470|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44726471|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726472|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44726473|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
44726474|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726475|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726476|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44726477|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726478|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44726479|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726480|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
44726481|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726482|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44726483|NCT01548027|Anesthetics|anesthetics|mesh-list
44726484|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
44726485|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726486|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726487|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
44726488|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726489|NCT01548066|Valproic Acid|valproic acid|mesh-list
44726490|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
44726491|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726492|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726493|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
44726494|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726495|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726496|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
44726497|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44726498|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726499|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44726500|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44726501|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44726502|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726504|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
44726505|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726506|NCT01548144|Pemetrexed|pemetrexed|mesh-list
44726507|NCT01548144|Crizotinib|crizotinib|mesh-list
44726508|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726509|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726510|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726511|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44726512|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44726513|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726514|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44726515|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44726516|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726517|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
44726518|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726519|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726520|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726521|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726522|NCT01548170|Ketoconazole|ketoconazole|mesh-list
44726523|NCT01548170|Sunitinib|sunitinib|mesh-list
44726524|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726525|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44726526|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44726527|NCT01548170|Growth Substances|growth substances|mesh-ancestor
44726528|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726529|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44726530|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726531|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726532|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726533|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
44726534|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726535|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44726536|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44726537|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44726538|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44726539|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726540|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44726542|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726543|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726544|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726545|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44726546|NCT01548209|Analgesics|analgesics|mesh-ancestor
44726547|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
44726548|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726549|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44726550|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44726551|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44726552|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44726553|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726554|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726555|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
44726556|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
44726557|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44726558|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726559|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726560|NCT01548248|Insulin|insulin|mesh-list
44726561|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44726562|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
44726563|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
44726564|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726565|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726566|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
44726567|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44726568|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44726569|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726570|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44726571|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44726572|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
44726573|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726574|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726575|NCT01548326|Atorvastatin|atorvastatin|mesh-list
44726576|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44726577|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726578|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
44726579|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726580|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726581|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726582|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726583|NCT01548482|Sirolimus|sirolimus|mesh-list
44726584|NCT01548482|Trebananib|trebananib|mesh-list
44726585|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44726586|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726587|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44726588|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726589|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
44726590|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726591|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
44726592|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726593|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44726594|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44726595|NCT01548482|Growth Substances|growth substances|mesh-ancestor
44726596|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
44726597|NCT01548521|Oxytocin|oxytocin|mesh-list
44726598|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
44726599|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44726600|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726601|NCT01548560|Dapivirine|dapivirine|mesh-list
44726602|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44726603|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44726604|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
44726605|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726606|NCT01548612|Nitroprusside|nitroprusside|mesh-list
44726607|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726608|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726609|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44726610|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726611|NCT01548677|Trastuzumab|trastuzumab|mesh-list
44726612|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44726613|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726614|NCT01548703|BCI-838|bci-838|mesh-list
44726615|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44726616|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44726617|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726618|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726619|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726620|NCT01548794|Lidocaine|lidocaine|mesh-list
44726621|NCT01548794|Bupivacaine|bupivacaine|mesh-list
44726622|NCT01548794|Anesthetics|anesthetics|mesh-list
44726623|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
44726624|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726625|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726626|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
44726627|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726628|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44726629|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44726630|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44726631|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726632|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726633|NCT01548807|Everolimus|everolimus|mesh-list
44726634|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726635|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726636|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
44726637|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726638|NCT01548859|Midazolam|midazolam|mesh-list
44726639|NCT01548859|Sevoflurane|sevoflurane|mesh-list
44726640|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44726641|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726642|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726643|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726644|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44726645|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44726646|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44726647|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726648|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
44726649|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
44726650|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
44726651|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
44726652|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726653|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726654|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44726655|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44726656|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
44726657|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44726658|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
44726659|NCT01548911|Calicheamicins|calicheamicins|mesh-list
44726660|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44726661|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726662|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44726663|NCT01548924|Paclitaxel|paclitaxel|mesh-list
44726664|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44726665|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726666|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
44726667|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44726668|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44726669|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726670|NCT01548950|Bosentan|bosentan|mesh-list
44726671|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
44726672|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726673|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44726674|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44726675|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726676|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726677|NCT01548950|Urological Agents|urological agents|mesh-ancestor
44726678|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726679|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44726680|NCT01549093|Gemcitabine|gemcitabine|mesh-list
44726681|NCT01549093|Carboplatin|carboplatin|mesh-list
44726682|NCT01549093|Endostar protein|endostar protein|mesh-list
44726683|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726684|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44726685|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
44726686|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726687|NCT01549093|Antiviral Agents|antiviral agents|mesh-ancestor
44726688|NCT01549093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726689|NCT01549093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726691|NCT01549093|Immunologic Factors|immunologic factors|mesh-ancestor
44726692|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726693|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44726694|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44726695|NCT01549093|Growth Substances|growth substances|mesh-ancestor
44726696|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44726697|NCT01549158|Torsemide|torsemide|mesh-list
44726698|NCT01549158|Furosemide|furosemide|mesh-list
44726699|NCT01549158|Diuretics|diuretics|mesh-ancestor
44726700|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
44726701|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726702|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44726703|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726704|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726705|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726706|NCT01549171|Iloprost|iloprost|mesh-list
44726707|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44726708|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726709|NCT01549236|Benzonidazole|benzonidazole|mesh-list
44726710|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726711|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
44726712|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726713|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44726714|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44726715|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44726716|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726717|NCT01549301|Lenograstim|lenograstim|mesh-list
44726718|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44726719|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
44726720|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726721|NCT01549418|Aspirin|aspirin|mesh-list
44726722|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44726723|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44726724|NCT01549418|Analgesics|analgesics|mesh-ancestor
44726725|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
44726726|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726727|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726728|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726729|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726730|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44726731|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44726732|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726733|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44726734|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44726735|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726736|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
44726737|NCT01549431|Dexamethasone|dexamethasone|mesh-list
44726738|NCT01549431|Panobinostat|panobinostat|mesh-list
44726739|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726740|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
44726741|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
44726742|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726743|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726744|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726745|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
44726746|NCT01549431|Hormones|hormones|mesh-ancestor
44726747|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726748|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44726749|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726750|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44726751|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726752|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726753|NCT01549496|Amlodipine|amlodipine|mesh-list
44726754|NCT01549496|Diltiazem|diltiazem|mesh-list
44726755|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726756|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44726757|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726758|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726759|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44726760|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726761|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726762|NCT01549548|Ponatinib|ponatinib|mesh-list
44726763|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726764|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726765|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726766|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726767|NCT01549574|Crizotinib|crizotinib|mesh-list
44726768|NCT01549574|Esomeprazole|esomeprazole|mesh-list
44726769|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44726770|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726771|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44726772|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726773|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726774|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726775|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44726776|NCT01549600|Psyllium|psyllium|mesh-list
44726777|NCT01549600|Cathartics|cathartics|mesh-ancestor
44726778|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726779|NCT01549691|Alprazolam|alprazolam|mesh-list
44726780|NCT01549691|Zopiclone|zopiclone|mesh-list
44726781|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726782|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726783|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726784|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44726785|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44726786|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44726787|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
44726788|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
44726789|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44726790|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726791|NCT01549704|Ropivacaine|ropivacaine|mesh-list
44726792|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
44726793|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
44726794|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726795|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726796|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
44726797|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726798|NCT01549743|Celecoxib|celecoxib|mesh-list
44726799|NCT01549743|Rebamipide|rebamipide|mesh-list
44726800|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44726801|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44726802|NCT01549743|Analgesics|analgesics|mesh-ancestor
44726803|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
44726804|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726805|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726806|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726807|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726808|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44726809|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44726810|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726811|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726812|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44726813|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726814|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
44726815|NCT01549743|Protective Agents|protective agents|mesh-ancestor
44726816|NCT01549795|Capecitabine|capecitabine|mesh-list
44726817|NCT01549795|Liver Extracts|liver extracts|mesh-list
44726818|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44726819|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
44726820|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726821|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726822|NCT01549795|Hematinics|hematinics|mesh-ancestor
44726823|NCT01549847|Piracetam|piracetam|mesh-list
44726824|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44726825|NCT01549847|Protective Agents|protective agents|mesh-ancestor
44726826|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726827|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
44726828|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
44278746|NCT00721552|Prednisolone|prednisolone|mesh-list
44726829|NCT01549938|Vitamin D|vitamin d|mesh-list
44726830|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44726831|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726832|NCT01549938|Vitamins|vitamins|mesh-ancestor
44726833|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
44726834|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44726835|NCT01549990|Sevoflurane|sevoflurane|mesh-list
44726836|NCT01549990|Desflurane|desflurane|mesh-list
44726837|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44726838|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44726839|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
44726840|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
44726841|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726842|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726843|NCT01550055|Irinotecan|irinotecan|mesh-list
44726844|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44726845|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44726846|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726847|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726848|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726849|NCT01550107|Allopurinol|allopurinol|mesh-list
44726850|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
44726851|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726852|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726853|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
44726854|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726855|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44726856|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
44726857|NCT01550107|Protective Agents|protective agents|mesh-ancestor
44726858|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726859|NCT01550146|Dexamethasone|dexamethasone|mesh-list
44726860|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
44726861|NCT01550146|BB 1101|bb 1101|mesh-list
44726862|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726863|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
44726864|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
44726865|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726866|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726867|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44726868|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
44726869|NCT01550146|Hormones|hormones|mesh-ancestor
44726870|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726871|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44726872|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726873|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
44726874|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726875|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726876|NCT01550302|Bupivacaine|bupivacaine|mesh-list
44726877|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
44726878|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
44726879|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726880|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726881|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
44726882|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726883|NCT01550354|Alfentanil|alfentanil|mesh-list
44726884|NCT01550354|Propofol|propofol|mesh-list
44726885|NCT01550354|Rocuronium|rocuronium|mesh-list
44726886|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726887|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726888|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726889|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726890|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
44726891|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
44726892|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44726893|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44726894|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44726895|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726896|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726897|NCT01550354|Narcotics|narcotics|mesh-ancestor
44726898|NCT01550354|Analgesics|analgesics|mesh-ancestor
44726899|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
44726900|NCT01550419|Atorvastatin|atorvastatin|mesh-list
44726901|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44726902|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44726903|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
44726904|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726905|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726906|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44726907|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726908|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
44726909|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44726910|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
44726911|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726912|NCT01550432|Expectorants|expectorants|mesh-ancestor
44726913|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44726914|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44726915|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
44726916|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726917|NCT01550432|Protective Agents|protective agents|mesh-ancestor
44726918|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726919|NCT01550432|Antidotes|antidotes|mesh-ancestor
44726920|NCT01550445|Prednisolone|prednisolone|mesh-list
44726921|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44726922|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
44726923|NCT01550445|Hormones|hormones|mesh-ancestor
44726924|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726925|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726926|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44726927|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726928|NCT01550458|Mibefradil|mibefradil|mesh-list
44726929|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44726930|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44726931|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44726932|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726933|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44726934|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726935|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
44726936|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44726937|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44726938|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726939|NCT01550640|Remifentanil|remifentanil|mesh-list
44726940|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44726941|NCT01550640|Narcotics|narcotics|mesh-ancestor
44726942|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726943|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726944|NCT01550640|Analgesics|analgesics|mesh-ancestor
44726945|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
44726946|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44726947|NCT01550653|Liraglutide|liraglutide|mesh-list
44726948|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726949|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726950|NCT01550653|Incretins|incretins|mesh-ancestor
44726951|NCT01550653|Hormones|hormones|mesh-ancestor
43620387|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44726952|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726954|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44726955|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44726956|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726957|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44726958|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
44726959|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
44726960|NCT01550848|Gemcitabine|gemcitabine|mesh-list
44726961|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44726962|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44726963|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
44726964|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726965|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44726966|NCT01550848|Antiviral Agents|antiviral agents|mesh-ancestor
44726967|NCT01550848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726968|NCT01550848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726969|NCT01550848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44726970|NCT01550848|Immunologic Factors|immunologic factors|mesh-ancestor
44726971|NCT01550848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726972|NCT01550900|Metformin|metformin|mesh-list
44726973|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44726974|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726975|NCT01550926|Orlistat|orlistat|mesh-list
44726976|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726977|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726978|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44726979|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44726980|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
44726981|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
44726982|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44726983|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44726984|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44726985|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44726986|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726987|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44726989|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44726990|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
44726991|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44726992|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
44726993|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44726994|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44726995|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44726996|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44726997|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44726998|NCT01551225|Citalopram|citalopram|mesh-list
44726999|NCT01551225|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44727000|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44727001|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44727002|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727003|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727004|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
44727005|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727006|NCT01551225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44727007|NCT01551225|Antidepressive Agents|antidepressive agents|mesh-ancestor
44727008|NCT01551225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44727009|NCT01551290|Infliximab|infliximab|mesh-list
44727010|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
44727011|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727012|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727013|NCT01551329|Ketamine|ketamine|mesh-list
44727014|NCT01551329|Analgesics|analgesics|mesh-ancestor
44727015|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
44727016|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727017|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727018|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44727019|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44727020|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
44727021|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
44727022|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727023|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44727024|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43856180|NCT03482167|Niacinamide|niacinamide|mesh-list
44727025|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727026|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727027|NCT01551368|Nimodipine|nimodipine|mesh-list
44727028|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727029|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44727030|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160816|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727031|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727032|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44727033|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727034|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727035|NCT01551394|Gentamicins|gentamicins|mesh-list
44727036|NCT01551394|Meropenem|meropenem|mesh-list
44727037|NCT01551394|Ampicillin|ampicillin|mesh-list
44727038|NCT01551394|Cefotaxime|cefotaxime|mesh-list
44727039|NCT01551394|Cefoxitin|cefoxitin|mesh-list
44727040|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727041|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727042|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44727043|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727044|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727045|NCT01551459|Sunitinib|sunitinib|mesh-list
44727046|NCT01551459|Dacarbazine|dacarbazine|mesh-list
44727047|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727048|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727049|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727050|NCT01551459|Growth Substances|growth substances|mesh-ancestor
44727051|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727052|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727053|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727054|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727055|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727056|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44727057|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
44727058|NCT01551485|Zolpidem|zolpidem|mesh-list
44727059|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44727060|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44727061|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727062|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727063|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44727064|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
44727065|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
44727066|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727067|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727068|NCT01551511|Dronabinol|dronabinol|mesh-list
44727069|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
44727070|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727071|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44727072|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727073|NCT01551511|Analgesics|analgesics|mesh-ancestor
44727074|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
44727075|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727076|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44727077|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44727078|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727079|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727080|NCT01551511|Hormones|hormones|mesh-ancestor
44727081|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727082|NCT01551589|Cisplatin|cisplatin|mesh-list
44727083|NCT01551589|Docetaxel|docetaxel|mesh-list
44727084|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727085|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44727086|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44727087|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44727088|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727089|NCT01551615|Metformin|metformin|mesh-list
44727090|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727091|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727092|NCT01551628|BCT-100|bct-100|mesh-list
44727093|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727094|NCT01551641|Thalidomide|thalidomide|mesh-list
44727095|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727096|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
44727097|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727098|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
44727099|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727100|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727101|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727102|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727103|NCT01551641|Growth Substances|growth substances|mesh-ancestor
44727104|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727105|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727106|NCT01551667|Antibodies|antibodies|mesh-list
44727107|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
44727108|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727109|NCT01551680|Iniparib|iniparib|mesh-list
44727110|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44727111|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727112|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727113|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727114|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44727115|NCT01551719|Vancomycin|vancomycin|mesh-list
44727116|NCT01551719|Linezolid|linezolid|mesh-list
44727117|NCT01551719|Daptomycin|daptomycin|mesh-list
44727118|NCT01551719|Penicillins|penicillins|mesh-list
44727119|NCT01551719|Tigecycline|tigecycline|mesh-list
44727120|NCT01551719|Cephalosporins|cephalosporins|mesh-list
44279047|NCT00723385|Vitamin D|vitamin d|mesh-list
44727122|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727123|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44727124|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727125|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727126|NCT01551797|Acetaminophen|acetaminophen|mesh-list
44727127|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727128|NCT01551797|Analgesics|analgesics|mesh-ancestor
44727129|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
44727130|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727131|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727132|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
44727133|NCT01551810|Vaccines|vaccines|mesh-list
44727134|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
44727135|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727136|NCT01551823|Vaccines|vaccines|mesh-list
44727137|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
44727138|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727139|NCT01551836|Acetaminophen|acetaminophen|mesh-list
44727140|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727141|NCT01551836|Analgesics|analgesics|mesh-ancestor
44727142|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
44727143|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727144|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727145|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
44727146|NCT01552005|Saxagliptin|saxagliptin|mesh-list
44727147|NCT01552005|Incretins|incretins|mesh-ancestor
44727148|NCT01552005|Hormones|hormones|mesh-ancestor
44727149|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727150|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727151|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44727152|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
44727153|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727154|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727155|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727156|NCT01552018|Saxagliptin|saxagliptin|mesh-list
44727157|NCT01552018|Incretins|incretins|mesh-ancestor
44727158|NCT01552018|Hormones|hormones|mesh-ancestor
44727159|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727160|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727161|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44727162|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
44727163|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727164|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727165|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727166|NCT01552044|Spironolactone|spironolactone|mesh-list
44727167|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44727168|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
44727169|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727170|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727171|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44727172|NCT01552044|Diuretics|diuretics|mesh-ancestor
44727173|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
44727174|NCT01552122|Vitamin D|vitamin d|mesh-list
44727175|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
44727176|NCT01552122|Alendronate|alendronate|mesh-list
44727177|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
44727178|NCT01552122|Calcium|calcium|mesh-list
44727179|NCT01552122|Vitamins|vitamins|mesh-ancestor
44727180|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
44727181|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727182|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44727183|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44727184|NCT01552122|Antacids|antacids|mesh-ancestor
44727185|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727186|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727187|NCT01552148|Morphine|morphine|mesh-list
44727188|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44727189|NCT01552148|Narcotics|narcotics|mesh-ancestor
44727190|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727191|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727192|NCT01552148|Analgesics|analgesics|mesh-ancestor
44727193|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
44727194|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727195|NCT01552187|Colchicine|colchicine|mesh-list
44279123|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
44727196|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
44727197|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727198|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
44727199|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
44727200|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
44727201|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727202|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727203|NCT01552330|Artesunate|artesunate|mesh-list
44727204|NCT01552330|Primaquine|primaquine|mesh-list
44727205|NCT01552330|Pyronaridine|pyronaridine|mesh-list
44727206|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
44727207|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44727208|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44727209|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727210|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727211|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
44727212|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
44727213|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44727214|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
44727215|NCT01552629|Cyclosporine|cyclosporine|mesh-list
44727216|NCT01552629|Cyclosporins|cyclosporins|mesh-list
44727217|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727218|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727219|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727220|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
44727221|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727222|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
44727223|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727224|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
44727225|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727226|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44727227|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
44727228|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727229|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727230|NCT01552798|Aspirin|aspirin|mesh-list
44727231|NCT01552798|Acetaminophen|acetaminophen|mesh-list
44727232|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44727233|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727234|NCT01552798|Analgesics|analgesics|mesh-ancestor
44727235|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
44727236|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727237|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727238|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727239|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727240|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44727241|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44727242|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727243|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44727244|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44727245|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727246|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
44727247|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44727248|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
44727249|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44727250|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44727251|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44236533|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
44727252|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727253|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727254|NCT01552850|Oxycodone|oxycodone|mesh-list
44727255|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44727256|NCT01552850|Narcotics|narcotics|mesh-ancestor
44727257|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727258|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727259|NCT01552850|Analgesics|analgesics|mesh-ancestor
44727260|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
44727261|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727262|NCT01552863|Oxycodone|oxycodone|mesh-list
44727263|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44727264|NCT01552863|Narcotics|narcotics|mesh-ancestor
44727265|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727266|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727267|NCT01552863|Analgesics|analgesics|mesh-ancestor
44727268|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
44727269|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727270|NCT01552967|Capecitabine|capecitabine|mesh-list
44727271|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44727272|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
44727273|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727274|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727276|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727277|NCT01552993|Acetaminophen|acetaminophen|mesh-list
44727278|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727279|NCT01552993|Analgesics|analgesics|mesh-ancestor
44727280|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
44727281|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727282|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727283|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
44727284|NCT01553006|Cefditoren|cefditoren|mesh-list
44727285|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
44727286|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727287|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727288|NCT01553019|Gemcitabine|gemcitabine|mesh-list
44727289|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44727290|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
44727291|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727292|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727293|NCT01553019|Antiviral Agents|antiviral agents|mesh-ancestor
44727294|NCT01553019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727295|NCT01553019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727296|NCT01553019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727297|NCT01553019|Immunologic Factors|immunologic factors|mesh-ancestor
44727298|NCT01553019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727299|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
44727300|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44727301|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
44727302|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44727303|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727304|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44727305|NCT01553357|Dexamethasone|dexamethasone|mesh-list
44727306|NCT01553357|Lenalidomide|lenalidomide|mesh-list
44727307|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727308|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
44727309|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
44727310|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727311|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727312|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727313|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
44727314|NCT01553357|Hormones|hormones|mesh-ancestor
44161095|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727315|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727316|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44727317|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727318|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
44727319|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727320|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727321|NCT01553357|Growth Substances|growth substances|mesh-ancestor
44727322|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727323|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
44727324|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
44727325|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44727326|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44727327|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44727328|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727329|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727330|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727331|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44727332|NCT01553500|Cathartics|cathartics|mesh-ancestor
44727333|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727334|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44727335|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
44727336|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
44727337|NCT01553721|Udenafil|udenafil|mesh-list
44727338|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44727339|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44727340|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727341|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727342|NCT01553773|Estradiol|estradiol|mesh-list
44727343|NCT01553773|Estrogens|estrogens|mesh-ancestor
44727344|NCT01553773|Hormones|hormones|mesh-ancestor
44727345|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727346|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727347|NCT01553786|Lenalidomide|lenalidomide|mesh-list
44727348|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
44727349|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727350|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727351|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727352|NCT01553786|Growth Substances|growth substances|mesh-ancestor
44727353|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727354|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727355|NCT01553903|Tamoxifen|tamoxifen|mesh-list
44727356|NCT01553903|Letrozole|letrozole|mesh-list
44727357|NCT01553903|Anastrozole|anastrozole|mesh-list
44727358|NCT01553903|Exemestane|exemestane|mesh-list
44727359|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727360|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44727361|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44727362|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727363|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727364|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44727365|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
44727366|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727367|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727368|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44727369|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44727370|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44727371|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44727372|NCT01553942|Cisplatin|cisplatin|mesh-list
44727373|NCT01553942|Pemetrexed|pemetrexed|mesh-list
44727374|NCT01553942|Afatinib|afatinib|mesh-list
44727375|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727376|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727377|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727378|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44727379|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44727380|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727381|NCT01553981|Tadalafil|tadalafil|mesh-list
44727382|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727383|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44727384|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44727385|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727386|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727387|NCT01553981|Urological Agents|urological agents|mesh-ancestor
44727388|NCT01554059|Bevacizumab|bevacizumab|mesh-list
44727389|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
44727390|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44727391|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727392|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727393|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727394|NCT01554059|Growth Substances|growth substances|mesh-ancestor
44727395|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727396|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727397|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
44727398|NCT01554111|Cathartics|cathartics|mesh-ancestor
44727399|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727400|NCT01554124|Meropenem|meropenem|mesh-list
44727401|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727402|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727403|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44727404|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727405|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727406|NCT01554345|Vitamin E|vitamin e|mesh-list
44727407|NCT01554345|Selenium|selenium|mesh-list
44727408|NCT01554345|Vitamins|vitamins|mesh-ancestor
44727409|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
44727410|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727411|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
44727412|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727413|NCT01554345|Protective Agents|protective agents|mesh-ancestor
44727414|NCT01554345|Trace Elements|trace elements|mesh-ancestor
44727415|NCT01554397|Cisplatin|cisplatin|mesh-list
44727416|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727417|NCT01554540|Treprostinil|treprostinil|mesh-list
44727418|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727419|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44727420|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44727421|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44727422|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
44727423|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727424|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727425|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44727426|NCT01554631|Acarbose|acarbose|mesh-list
44727427|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44727428|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727429|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727430|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727431|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727432|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44727433|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44727434|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727435|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
44727436|NCT01554813|Vaccines|vaccines|mesh-list
44727437|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
44727438|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727439|NCT01554826|Vaccines|vaccines|mesh-list
44727440|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
44727441|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727442|NCT01554852|Thalidomide|thalidomide|mesh-list
44727443|NCT01554852|Dexamethasone|dexamethasone|mesh-list
44727444|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
44727445|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
44727446|NCT01554852|Melphalan|melphalan|mesh-list
44727447|NCT01554852|Lenalidomide|lenalidomide|mesh-list
44727448|NCT01554852|Bortezomib|bortezomib|mesh-list
44727449|NCT01554852|Vorinostat|vorinostat|mesh-list
44727450|NCT01554852|BB 1101|bb 1101|mesh-list
44727451|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727452|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
44727453|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727454|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727455|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44727456|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
44727457|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727458|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727459|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44727460|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727461|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
44727462|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
44727463|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727464|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727465|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
44727466|NCT01554852|Hormones|hormones|mesh-ancestor
44727467|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727468|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44727469|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
44727470|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727471|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727472|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727473|NCT01554852|Growth Substances|growth substances|mesh-ancestor
44727474|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727475|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
44727476|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727477|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727478|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44727480|NCT01554930|Mannitol|mannitol|mesh-list
44727481|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
44727482|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727483|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
44727484|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
44727485|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727486|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727487|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727488|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
44727489|NCT01554930|Hormones|hormones|mesh-ancestor
44727490|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727491|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44727492|NCT01554930|Protective Agents|protective agents|mesh-ancestor
44727493|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
44727494|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44727495|NCT01554930|Diuretics|diuretics|mesh-ancestor
44727496|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
44727497|NCT01554969|Capecitabine|capecitabine|mesh-list
44727498|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44727499|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
44727500|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727501|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727502|NCT01554995|Linezolid|linezolid|mesh-list
44727503|NCT01554995|Delpazolid|delpazolid|mesh-list
44727504|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727505|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727506|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44727507|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727508|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727509|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44727510|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44727511|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727512|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727513|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727514|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
44727515|NCT01555060|Hematinics|hematinics|mesh-ancestor
44727516|NCT01555099|Budesonide|budesonide|mesh-list
44727517|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727518|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44727519|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
44727520|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727521|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727522|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44727523|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
44727524|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
44727525|NCT01555099|Hormones|hormones|mesh-ancestor
44727526|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727527|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44727528|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44727529|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
44727530|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727531|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727532|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44727533|NCT01555112|Protective Agents|protective agents|mesh-ancestor
44727534|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44161305|NCT00244920|Hormones|hormones|mesh-list
44727535|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44727536|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727537|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727538|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
44727539|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727540|NCT01555190|Folic Acid|folic acid|mesh-list
44727541|NCT01555190|Inositol|inositol|mesh-list
44727542|NCT01555190|Hematinics|hematinics|mesh-ancestor
44727543|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
44727544|NCT01555190|Vitamins|vitamins|mesh-ancestor
44727545|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
44727546|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727547|NCT01555216|Ropivacaine|ropivacaine|mesh-list
44727548|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
44727549|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
44727550|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727551|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727553|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727554|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
44727555|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44727556|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44727557|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
44727558|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727559|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44727560|NCT01555476|Ibuprofen|ibuprofen|mesh-list
44727561|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44727562|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727563|NCT01555476|Analgesics|analgesics|mesh-ancestor
44727564|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
44727565|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727566|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727567|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727568|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727569|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44727570|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727571|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727572|NCT01555580|Molgramostim|molgramostim|mesh-list
44727573|NCT01555580|Sargramostim|sargramostim|mesh-list
44727574|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
44727575|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727576|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727577|NCT01555632|Atorvastatin|atorvastatin|mesh-list
44727578|NCT01555632|Calcium|calcium|mesh-list
44727579|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44727580|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727581|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44727582|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44727583|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
44727584|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727585|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44727586|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44727587|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727588|NCT01555658|Heparin|heparin|mesh-list
44727589|NCT01555658|Bivalirudin|bivalirudin|mesh-list
44727590|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
44727591|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44727592|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44727593|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727594|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
44727595|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44727596|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
44727597|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727598|NCT01555710|Carboplatin|carboplatin|mesh-list
44727599|NCT01555710|Etoposide|etoposide|mesh-list
44727600|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
44727601|NCT01555710|Ifosfamide|ifosfamide|mesh-list
44727602|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727603|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44727604|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44727605|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44727606|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727607|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727608|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44727609|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
44727610|NCT01555788|Pancrelipase|pancrelipase|mesh-list
44727611|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727612|NCT01555814|Amisulpride|amisulpride|mesh-list
44727613|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44727614|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44727615|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727616|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727617|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44727618|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44727619|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
44727620|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727621|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727622|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44727623|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
44727624|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44727625|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727626|NCT01555866|Isavuconazole|isavuconazole|mesh-list
44727627|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
44727628|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727629|NCT01555879|Abatacept|abatacept|mesh-list
44727630|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44727631|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727632|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727633|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727634|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
44727635|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727636|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727637|NCT01555918|Isavuconazole|isavuconazole|mesh-list
44727638|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
44727639|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727640|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
44727641|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44727642|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
44727643|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727644|NCT01555970|Expectorants|expectorants|mesh-ancestor
44727645|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
44727646|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44727647|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
44727648|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727649|NCT01555970|Protective Agents|protective agents|mesh-ancestor
44727650|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727651|NCT01555970|Antidotes|antidotes|mesh-ancestor
44727652|NCT01556035|Lenalidomide|lenalidomide|mesh-list
44727653|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
44727654|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727655|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727656|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727657|NCT01556035|Growth Substances|growth substances|mesh-ancestor
44727658|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727659|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727660|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44727661|NCT01556191|Fulvestrant|fulvestrant|mesh-list
44727662|NCT01556191|Gefitinib|gefitinib|mesh-list
44727663|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727664|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727665|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727666|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727667|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44727668|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44727669|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44727670|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
44727671|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727672|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727673|NCT01556321|Caffeine|caffeine|mesh-list
44727674|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44727675|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727676|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44727677|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727678|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727679|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44727680|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44727681|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
44727682|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727683|NCT01556334|Azithromycin|azithromycin|mesh-list
44727684|NCT01556334|Erythromycin|erythromycin|mesh-list
44727685|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
44727686|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44727687|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
44727688|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44727689|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727690|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727691|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44727692|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727693|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727694|NCT01556477|Lenalidomide|lenalidomide|mesh-list
44727695|NCT01556477|Azacitidine|azacitidine|mesh-list
44727696|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
44727697|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727698|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727699|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727700|NCT01556477|Growth Substances|growth substances|mesh-ancestor
44727702|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727703|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44727704|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
44727705|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727706|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727707|NCT01556529|Unithiol|unithiol|mesh-list
44727708|NCT01556529|Antidotes|antidotes|mesh-ancestor
44727709|NCT01556529|Protective Agents|protective agents|mesh-ancestor
44727710|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727711|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
44727712|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
44727713|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727714|NCT01556542|Paclitaxel|paclitaxel|mesh-list
44727715|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44727716|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727717|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
44727718|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
44727719|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44727720|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727721|NCT01556646|Tolvaptan|tolvaptan|mesh-list
44727722|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44727723|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727724|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
44727725|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727726|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
44727727|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
44727729|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727730|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727731|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
44727732|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44727733|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
44727734|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727735|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727736|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44727737|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
44727738|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44727739|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
44727740|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727741|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727742|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44727743|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727744|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
44727745|NCT01556698|Protective Agents|protective agents|mesh-ancestor
44727746|NCT01556737|Genistein|genistein|mesh-list
44727747|NCT01556737|Daidzein|daidzein|mesh-list
44727748|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44727749|NCT01556737|Protective Agents|protective agents|mesh-ancestor
44727750|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727751|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727752|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727753|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727754|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727755|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
44727756|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44727757|NCT01556737|Estrogens|estrogens|mesh-ancestor
44727758|NCT01556737|Hormones|hormones|mesh-ancestor
44727759|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727760|NCT01556815|Sorafenib|sorafenib|mesh-list
44727761|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
44727762|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727763|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727764|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727765|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727766|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44727767|NCT01556815|Estrogens|estrogens|mesh-ancestor
44727768|NCT01556815|Hormones|hormones|mesh-ancestor
44727769|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44727770|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727771|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44727772|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44727773|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44727774|NCT01557075|Atorvastatin|atorvastatin|mesh-list
44727775|NCT01557075|Pravastatin|pravastatin|mesh-list
44727776|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44727777|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44727779|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
44727780|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727781|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44727782|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727783|NCT01557114|Ipilimumab|ipilimumab|mesh-list
44727784|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44727785|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727786|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44727787|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727788|NCT01557127|Sorafenib|sorafenib|mesh-list
44727789|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727790|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727791|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727792|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727793|NCT01557140|Carvedilol|carvedilol|mesh-list
44727794|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44161570|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
44727795|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44727796|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44727797|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727798|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727799|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727800|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727801|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
44727802|NCT01557140|Protective Agents|protective agents|mesh-ancestor
44727803|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44727804|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44727805|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44727806|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727807|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44727808|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44727809|NCT01557153|Amlodipine|amlodipine|mesh-list
44727810|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727811|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44727812|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44727813|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727814|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44727815|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727816|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
44727817|NCT01557257|Naltrexone|naltrexone|mesh-list
44727818|NCT01557257|Oxycodone|oxycodone|mesh-list
44727819|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44727820|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44727821|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727822|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
44727823|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727824|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44727825|NCT01557257|Narcotics|narcotics|mesh-ancestor
44727826|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727827|NCT01557257|Analgesics|analgesics|mesh-ancestor
44727828|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
44727829|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44727830|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727831|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727832|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727833|NCT01557270|Analgesics|analgesics|mesh-ancestor
44727834|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
44727835|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727836|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44727837|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44727838|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44727839|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
44727840|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727841|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727842|NCT01557335|Aspirin|aspirin|mesh-list
44727843|NCT01557335|Omeprazole|omeprazole|mesh-list
44727844|NCT01557335|Clopidogrel|clopidogrel|mesh-list
44727845|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44727846|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727847|NCT01557335|Analgesics|analgesics|mesh-ancestor
43856934|NCT03390296|Avelumab|avelumab|mesh-list
44727848|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
44727849|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727850|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727851|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727852|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727853|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44727854|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44727855|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727856|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44727857|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44727858|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727860|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44727861|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44727862|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44727863|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
44727864|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727865|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44727866|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44727867|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44727868|NCT01557374|Abatacept|abatacept|mesh-list
44727869|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44727870|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727871|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727872|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44727873|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
44727874|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727875|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727876|NCT01557439|Levocetirizine|levocetirizine|mesh-list
44727877|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44727878|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44727879|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
44727880|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
44727881|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727882|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727883|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727884|NCT01557478|Melatonin|melatonin|mesh-list
44727885|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
44727886|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727887|NCT01557478|Protective Agents|protective agents|mesh-ancestor
44727888|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727889|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727890|NCT01557634|Insulin|insulin|mesh-list
44727891|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727892|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727893|NCT01557647|Treprostinil|treprostinil|mesh-list
44727894|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727895|NCT01557660|Treprostinil|treprostinil|mesh-list
44727896|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44727897|NCT01557712|Ketamine|ketamine|mesh-list
44727898|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44727899|NCT01557712|Analgesics|analgesics|mesh-ancestor
44727900|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
44727901|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727902|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727903|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44727904|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44727905|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
44727906|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
44727907|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727908|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44727909|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44727910|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44727911|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727912|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44727913|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44727914|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44727915|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44727916|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
44727917|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44727918|NCT01557764|Trastuzumab|trastuzumab|mesh-list
44727919|NCT01557764|Lapatinib|lapatinib|mesh-list
44727920|NCT01557764|Antibodies|antibodies|mesh-list
44727921|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44727922|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
44727923|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727924|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44727925|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727926|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44727927|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727928|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727929|NCT01557816|Naproxen|naproxen|mesh-list
44727930|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44727931|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727932|NCT01557816|Analgesics|analgesics|mesh-ancestor
44727933|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
44727934|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727935|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727936|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727937|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727938|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
44727939|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44727940|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44727941|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727942|NCT01557829|Silicon|silicon|mesh-list
44727943|NCT01557829|Trace Elements|trace elements|mesh-ancestor
44727944|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
44727945|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727946|NCT01557907|Insulin|insulin|mesh-list
44727947|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44727948|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44727949|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727950|NCT01557985|Bupivacaine|bupivacaine|mesh-list
44727951|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
44727952|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
44727953|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44727954|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727955|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
44727956|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727957|NCT01558011|Docetaxel|docetaxel|mesh-list
44727958|NCT01558011|Capecitabine|capecitabine|mesh-list
44727959|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
44727960|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727961|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44727962|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44727963|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44727964|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727965|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44727966|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
44727967|NCT01558167|Rituximab|rituximab|mesh-list
44727968|NCT01558167|Lenalidomide|lenalidomide|mesh-list
44727969|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44727970|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44727971|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44727972|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
44727973|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727974|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727975|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44727976|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44727977|NCT01558167|Growth Substances|growth substances|mesh-ancestor
44727978|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
44727979|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44727980|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
44727981|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727982|NCT01558193|Vitamins|vitamins|mesh-list
44727983|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
44727984|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
44727985|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44727986|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44727987|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44727988|NCT01558193|Analgesics|analgesics|mesh-ancestor
44727989|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
44727990|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44727991|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44727992|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44727993|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44727994|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
44727995|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44727996|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44727997|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44727998|NCT01558245|Kallikreins|kallikreins|mesh-list
44727999|NCT01558245|Coagulants|coagulants|mesh-ancestor
44728000|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
44728001|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
44728002|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44728003|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728004|NCT01558310|Ustekinumab|ustekinumab|mesh-list
44728005|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728006|NCT01558336|Praziquantel|praziquantel|mesh-list
44728007|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
44728008|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44728009|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728010|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44728011|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463588|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
44728012|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
44728013|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728014|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
44728015|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
44728016|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44728017|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44728018|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728019|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728020|NCT01558466|Urological Agents|urological agents|mesh-ancestor
44728021|NCT01558622|Ascorbic Acid|ascorbic acid|mesh-list
44728022|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44728023|NCT01558622|Ketoprofen|ketoprofen|mesh-list
44728024|NCT01558622|Meperidine|meperidine|mesh-list
44728025|NCT01558622|Tramadol|tramadol|mesh-list
44728026|NCT01558622|Vitamins|vitamins|mesh-ancestor
44728027|NCT01558622|Micronutrients|micronutrients|mesh-ancestor
44728028|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728029|NCT01558622|Antioxidants|antioxidants|mesh-ancestor
44728030|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728031|NCT01558622|Protective Agents|protective agents|mesh-ancestor
44728032|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728033|NCT01558622|Narcotics|narcotics|mesh-ancestor
44728034|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728035|NCT01558622|Analgesics|analgesics|mesh-ancestor
44728036|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
44728037|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728038|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44728039|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44728040|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728041|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728042|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44728043|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44728044|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728045|NCT01558648|Analgesics|analgesics|mesh-list
44728046|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
44728047|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728048|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728049|NCT01558713|Fentanyl|fentanyl|mesh-list
44728050|NCT01558713|Bupivacaine|bupivacaine|mesh-list
44728051|NCT01558713|Ropivacaine|ropivacaine|mesh-list
44728052|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
44728053|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728054|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
44728055|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728056|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728057|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
44728058|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728059|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728060|NCT01558713|Narcotics|narcotics|mesh-ancestor
44161855|NCT00246675|Furosemide|furosemide|mesh-list
44728061|NCT01558713|Analgesics|analgesics|mesh-ancestor
44728062|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44728063|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44728064|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
44728065|NCT01558830|Ranolazine|ranolazine|mesh-list
44728066|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44728067|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728068|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728069|NCT01558869|Capecitabine|capecitabine|mesh-list
44728070|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
44728071|NCT01558869|Irinotecan|irinotecan|mesh-list
44728072|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728073|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
44728074|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728075|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728076|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44728077|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728078|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728079|NCT01558934|Lofexidine|lofexidine|mesh-list
44728080|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44728081|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44728082|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728083|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
44728084|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728085|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44279925|NCT04130204|Colchicine|colchicine|mesh-list
44728086|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44728087|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44728088|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44728089|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728090|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728091|NCT01558960|Melphalan|melphalan|mesh-list
44728092|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44728093|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
44728094|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728095|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728096|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44728097|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728098|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
44728099|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728100|NCT01558986|Cefazolin|cefazolin|mesh-list
44728101|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728102|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728103|NCT01559025|Vildagliptin|vildagliptin|mesh-list
44728104|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44728105|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44728106|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728107|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
44728108|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728109|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728110|NCT01559051|Anesthetics|anesthetics|mesh-list
44728111|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728112|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728113|NCT01559142|Azathioprine|azathioprine|mesh-list
44728114|NCT01559142|Infliximab|infliximab|mesh-list
44728115|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728116|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728117|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728118|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
44728119|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728120|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728121|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728122|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728123|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
44728124|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728125|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44728126|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44728127|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44728128|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728129|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728130|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728131|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44728132|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44728133|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
44728134|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728135|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728136|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44728137|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44728138|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
44728139|NCT01559285|Ropivacaine|ropivacaine|mesh-list
44728140|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728141|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
44728142|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728143|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728144|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
44728145|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728146|NCT01559298|Aspirin|aspirin|mesh-list
44728147|NCT01559298|Clopidogrel|clopidogrel|mesh-list
44728148|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44728149|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44728150|NCT01559298|Analgesics|analgesics|mesh-ancestor
44728151|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
44728152|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728153|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728154|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728155|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728156|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44728157|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44728158|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728159|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44728160|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44728161|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728162|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
44728163|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44728164|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44728165|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44728166|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
44728167|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728168|NCT01559480|Desogestrel|desogestrel|mesh-list
44728169|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44728170|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44728171|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44728172|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
44728173|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44728174|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728175|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44728176|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44728177|NCT01559480|Progestins|progestins|mesh-ancestor
44728178|NCT01559480|Hormones|hormones|mesh-ancestor
44728179|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728180|NCT01559545|Metronidazole|metronidazole|mesh-list
44728181|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728182|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728183|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44728184|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44728185|NCT01559584|Triamcinolone|triamcinolone|mesh-list
44728186|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44728187|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44728188|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44728189|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728190|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
44728191|NCT01559584|Hormones|hormones|mesh-ancestor
44728192|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728193|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728194|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728195|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
44728196|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728197|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728198|NCT01559727|Prednisone|prednisone|mesh-list
44728199|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728200|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
44728201|NCT01559727|Hormones|hormones|mesh-ancestor
44728202|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728203|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728204|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728205|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728206|NCT01559740|Bupivacaine|bupivacaine|mesh-list
44728207|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728208|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
44728209|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728210|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728211|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
44728212|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728213|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44728214|NCT01559753|Amoxicillin|amoxicillin|mesh-list
44728215|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
44728216|NCT01559753|Tobramycin|tobramycin|mesh-list
44728217|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44728218|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
44728219|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
44728221|NCT01559753|Cefoxitin|cefoxitin|mesh-list
44728222|NCT01559753|Netilmicin|netilmicin|mesh-list
44728223|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728224|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44728225|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728226|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728227|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44728228|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
44728229|NCT01559974|Vitamin D|vitamin d|mesh-list
44728230|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44728231|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728232|NCT01559974|Vitamins|vitamins|mesh-ancestor
44728233|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
44728234|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44728235|NCT01560117|Rituximab|rituximab|mesh-list
44728236|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728237|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728238|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
44728239|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728240|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728241|NCT05570669|Simethicone|simethicone|mesh-list
44728242|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
44728243|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
44728244|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728245|NCT05570669|Emollients|emollients|mesh-ancestor
44728246|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728247|NCT05570669|Cathartics|cathartics|mesh-ancestor
44728248|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280151|NCT00732212|Hemostatics|hemostatics|mesh-list
44728255|NCT05570422|Cisplatin|cisplatin|mesh-list
44728256|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728257|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
44728258|NCT05570409|Prednisolone|prednisolone|mesh-list
44728259|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44728260|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
44728261|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44728262|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
44728263|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44728264|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
44728265|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44728266|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728267|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44728268|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
44728269|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728270|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728271|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728272|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728273|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728274|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
44728275|NCT05570409|Hormones|hormones|mesh-ancestor
44728276|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728277|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728278|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728279|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
44728280|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
44728281|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728282|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728283|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44728284|NCT05570409|Protective Agents|protective agents|mesh-ancestor
44728285|NCT05570383|Antacids|antacids|mesh-list
44728286|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728287|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728288|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
44728289|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728290|NCT05570084|Tamsulosin|tamsulosin|mesh-list
44728291|NCT05570084|Silodosin|silodosin|mesh-list
44728292|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44728293|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44728294|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44728295|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
44728296|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728297|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728298|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728299|NCT05570084|Urological Agents|urological agents|mesh-ancestor
44728300|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44728301|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728302|NCT05569668|Paclitaxel|paclitaxel|mesh-list
44728303|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44728304|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728305|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728306|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44728307|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728308|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728309|NCT05569655|Furosemide|furosemide|mesh-list
44728310|NCT05569655|Tolvaptan|tolvaptan|mesh-list
44728311|NCT05569655|Diuretics|diuretics|mesh-ancestor
44728312|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44728313|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728314|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44728315|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728316|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728317|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44728318|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44728319|NCT05569590|Propolis|propolis|mesh-list
44728320|NCT05569590|Fluorides|fluorides|mesh-list
44728321|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
44728322|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
44728323|NCT05569590|Protective Agents|protective agents|mesh-ancestor
44728324|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728325|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44728326|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728327|NCT05569577|Estrogens|estrogens|mesh-list
44728328|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
44280184|NCT00726960|Buprenorphine|buprenorphine|mesh-list
44728329|NCT05569577|Hormones|hormones|mesh-ancestor
44728330|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728331|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728333|NCT05569031|Lofexidine|lofexidine|mesh-list
44728334|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44728335|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44728336|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44728337|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728338|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728339|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728340|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728341|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162125|NCT00248131|Octreotide|octreotide|mesh-list
44728342|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
44728343|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728344|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44728345|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44728346|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
44728347|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728348|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44728349|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44728350|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44728351|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
44728352|NCT05568953|Vaccines|vaccines|mesh-list
44728353|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
44728354|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728355|NCT05568888|Thrombin|thrombin|mesh-list
44728356|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
44728357|NCT05568888|Coagulants|coagulants|mesh-ancestor
44728358|NCT05564741|Norepinephrine|norepinephrine|mesh-list
44728359|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44728360|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44728361|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
44728362|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728363|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728364|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728365|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
44728366|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
44728367|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728368|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44728370|NCT05561257|Vitamins|vitamins|mesh-ancestor
44728371|NCT05561257|Micronutrients|micronutrients|mesh-ancestor
44728372|NCT05561257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728373|NCT05561257|Antioxidants|antioxidants|mesh-ancestor
44728374|NCT05561257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728375|NCT05561257|Protective Agents|protective agents|mesh-ancestor
44728377|NCT05524935|Olaparib|olaparib|mesh-list
44728378|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728379|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728380|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44728381|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728382|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728383|NCT05522582|Methotrexate|methotrexate|mesh-list
44728384|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44728385|NCT05522582|Antibodies|antibodies|mesh-list
44728386|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44728387|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
44728388|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728389|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44728390|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
44728391|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44728392|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728393|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
44728394|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728395|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728396|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728397|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728398|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44728399|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728400|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728401|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44728402|NCT05491304|Dexamethasone|dexamethasone|mesh-list
44728403|NCT05491304|Etoposide|etoposide|mesh-list
44728404|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728405|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
44728406|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
44728407|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728408|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728409|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728410|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
44728411|NCT05491304|Hormones|hormones|mesh-ancestor
44728412|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728413|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728414|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728415|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44728416|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44728417|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728418|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728419|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728420|NCT05461794|Docetaxel|docetaxel|mesh-list
44728421|NCT05461794|Irinotecan|irinotecan|mesh-list
44728422|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728423|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728424|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
44728425|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728426|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728427|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44728428|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728429|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728430|NCT05391555|Remifentanil|remifentanil|mesh-list
44728431|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728432|NCT05391555|Narcotics|narcotics|mesh-ancestor
44728433|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728434|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728435|NCT05391555|Analgesics|analgesics|mesh-ancestor
44728436|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
44728437|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728438|NCT05388773|Cisplatin|cisplatin|mesh-list
44728439|NCT05388773|Carboplatin|carboplatin|mesh-list
44728440|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728441|NCT05388656|Estradiol|estradiol|mesh-list
44728442|NCT05388656|Progesterone|progesterone|mesh-list
44728443|NCT05388656|Estrogens|estrogens|mesh-ancestor
44728444|NCT05388656|Hormones|hormones|mesh-ancestor
43620501|NCT04186598|Nifedipine|nifedipine|mesh-list
44728445|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728446|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728447|NCT05388656|Progestins|progestins|mesh-ancestor
44728448|NCT05378113|Lidocaine|lidocaine|mesh-list
44728449|NCT05378113|Ondansetron|ondansetron|mesh-list
44728450|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728451|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
44728452|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728453|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728454|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
44728455|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728456|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44728457|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44728458|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44728459|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728460|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728461|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
44728462|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
44728463|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728464|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
44728465|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728466|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44728467|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
44728468|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728469|NCT05378113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44728470|NCT05378113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44728471|NCT05378113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728472|NCT05378113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44728473|NCT05372393|Anesthetics|anesthetics|mesh-list
44162251|NCT00248729|Midazolam|midazolam|mesh-list
44728474|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728475|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728476|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44728477|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728478|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728479|NCT05270057|Prednisone|prednisone|mesh-list
44728480|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
44728481|NCT05270057|Rituximab|rituximab|mesh-list
44728482|NCT05270057|Doxorubicin|doxorubicin|mesh-list
44728483|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44728484|NCT05270057|Etoposide|etoposide|mesh-list
44728485|NCT05270057|Vincristine|vincristine|mesh-list
44728486|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44728487|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728488|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
44728489|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728490|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728491|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44728492|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
44728493|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728494|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728495|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44728496|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728497|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44728498|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44728499|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728500|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728501|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728502|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
44728503|NCT05270057|Hormones|hormones|mesh-ancestor
44728504|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728505|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728506|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44728507|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728508|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44728509|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728510|NCT05229965|Acetaminophen|acetaminophen|mesh-list
44728511|NCT05229965|Codeine|codeine|mesh-list
44728512|NCT05229965|Caffeine|caffeine|mesh-list
44728513|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44728514|NCT05229965|Analgesics|analgesics|mesh-ancestor
44728515|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
44728516|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728517|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728518|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
44728519|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728520|NCT05229965|Narcotics|narcotics|mesh-ancestor
44728521|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728522|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
44728523|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44728524|NCT05229965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44728525|NCT05229965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44280418|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
44728526|NCT05229965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728527|NCT05229965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728528|NCT05229965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44728529|NCT05229965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44728530|NCT05229965|Purinergic Agents|purinergic agents|mesh-ancestor
44728531|NCT05229965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728532|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
44728534|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44728535|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44162309|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728536|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728537|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728538|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728539|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
44728540|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
44728541|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728542|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
44728543|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
44728544|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728545|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44728546|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
44728547|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
44728548|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728549|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728550|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44728551|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
44728552|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728553|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
44728554|NCT05166811|Analgesics|analgesics|mesh-ancestor
44728555|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
44728556|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728557|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728558|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
44728559|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728560|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44728561|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
44728562|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44728563|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728564|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728565|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44728566|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
44728567|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44728568|NCT05137080|Dexamethasone|dexamethasone|mesh-list
44728569|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728570|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
44728571|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
44728572|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728573|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728574|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728575|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
44728577|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728578|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728579|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728580|NCT05093322|Gemcitabine|gemcitabine|mesh-list
44728581|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728582|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
44728583|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728584|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728585|NCT05093322|Antiviral Agents|antiviral agents|mesh-ancestor
44728586|NCT05093322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728587|NCT05093322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728588|NCT05093322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728589|NCT05093322|Immunologic Factors|immunologic factors|mesh-ancestor
44728590|NCT05093322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728591|NCT04968106|Doxorubicin|doxorubicin|mesh-list
44728592|NCT04968106|Ifosfamide|ifosfamide|mesh-list
44728593|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44728594|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728595|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44728596|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728597|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728598|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728599|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44728600|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
44728601|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
44728602|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728603|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728604|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44162374|NCT00249210|Ofloxacin|ofloxacin|mesh-list
44728605|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728606|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728607|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728608|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728609|NCT04835506|Infliximab|infliximab|mesh-list
44728610|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728611|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728612|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728613|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
44728614|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44728615|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728616|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44728617|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728618|NCT04787731|Lidocaine|lidocaine|mesh-list
44728619|NCT04787731|Bupivacaine|bupivacaine|mesh-list
44728620|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
44728621|NCT04787731|Anesthetics|anesthetics|mesh-list
44728622|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728623|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728624|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
44728625|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728626|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44728627|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44728628|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44728629|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728630|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728631|NCT04763512|Caseins|caseins|mesh-list
44728632|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
44728633|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
44728634|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728635|NCT04713358|Nalmefene|nalmefene|mesh-list
44728636|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44728637|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728638|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
44728639|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728640|NCT04707872|Antibodies|antibodies|mesh-list
44728641|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
44728642|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728643|NCT04696952|Zopiclone|zopiclone|mesh-list
44728644|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44728645|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728646|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728647|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44728648|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728649|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728650|NCT04571619|Buprenorphine|buprenorphine|mesh-list
44728651|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728652|NCT04571619|Narcotics|narcotics|mesh-ancestor
44728653|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728654|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728655|NCT04571619|Analgesics|analgesics|mesh-ancestor
44728656|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
44728657|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728658|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44728659|NCT04499248|Bimatoprost|bimatoprost|mesh-list
44728660|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44728661|NCT04496999|Midostaurin|midostaurin|mesh-list
44728662|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728663|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44728664|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728665|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728666|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
44728667|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44728668|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728669|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44728670|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728671|NCT04474366|Ropivacaine|ropivacaine|mesh-list
44728672|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728673|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
44728674|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728675|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728676|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
44728677|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728678|NCT04464265|Propofol|propofol|mesh-list
44728679|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44728680|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728681|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728682|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44728683|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
44728684|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
44728685|NCT04437303|Anticoagulants|anticoagulants|mesh-list
44728686|NCT04424511|Azithromycin|azithromycin|mesh-list
44728687|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728688|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728689|NCT04421079|Resveratrol|resveratrol|mesh-list
44728690|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
44728691|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728692|NCT04421079|Protective Agents|protective agents|mesh-ancestor
44728693|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728694|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728695|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44728696|NCT04410406|Ivermectin|ivermectin|mesh-list
44728697|NCT04410406|Albendazole|albendazole|mesh-list
44728698|NCT04410406|Moxidectin|moxidectin|mesh-list
44728699|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
44728700|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728701|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44728702|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728703|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
44728704|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
44728705|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44728706|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44728707|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728708|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44728709|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728710|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728711|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
44728712|NCT04410406|Filaricides|filaricides|mesh-ancestor
44728713|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44728714|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728715|NCT04393506|Apatinib|apatinib|mesh-list
44728716|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44728717|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728718|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44728719|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728720|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728721|NCT04349826|Azithromycin|azithromycin|mesh-list
44728722|NCT04349826|Cefixime|cefixime|mesh-list
44728723|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728724|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728725|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
44728726|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728727|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728728|NCT04298853|Morphine|morphine|mesh-list
44728729|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44728730|NCT04298853|Narcotics|narcotics|mesh-ancestor
44728731|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728732|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728733|NCT04298853|Analgesics|analgesics|mesh-ancestor
44728734|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
44728735|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728736|NCT04232683|Tamsulosin|tamsulosin|mesh-list
44728737|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44728738|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44728739|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44728740|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
44728741|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728742|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728743|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728744|NCT04232683|Urological Agents|urological agents|mesh-ancestor
44728746|NCT04227483|Deflazacort|deflazacort|mesh-list
44728747|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728748|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
44728749|NCT04227483|Hormones|hormones|mesh-ancestor
44728750|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728751|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728752|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44728753|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728754|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728755|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
44728756|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
44728757|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44728758|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44728759|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728760|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
44728761|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
44280658|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
44728762|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728763|NCT04182672|Triamcinolone|triamcinolone|mesh-list
44728764|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44728765|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44728766|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44728767|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728768|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
44728769|NCT04182672|Hormones|hormones|mesh-ancestor
44728770|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728771|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728772|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728773|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
44728774|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728775|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728776|NCT04101227|Ondansetron|ondansetron|mesh-list
44728777|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
44728778|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
44728779|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728780|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728781|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44728782|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
44728783|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
44728784|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44728785|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
44728786|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728787|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728788|NCT04101227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44728789|NCT04101227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44728790|NCT04101227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728791|NCT04101227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728792|NCT04101227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44728793|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44728794|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728795|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728796|NCT04047004|Cisplatin|cisplatin|mesh-list
44728797|NCT04047004|Doxorubicin|doxorubicin|mesh-list
44728798|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728799|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44728800|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44728801|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728802|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728803|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728804|NCT03972280|Antibodies|antibodies|mesh-list
44728805|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44728806|NCT03972280|Lenograstim|lenograstim|mesh-list
44728807|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
44728808|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728809|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44728810|NCT03893435|Valsartan|valsartan|mesh-list
44728811|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44728812|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44728813|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44728814|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44728815|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728816|NCT03813121|Midazolam|midazolam|mesh-list
44728817|NCT03813121|Ketamine|ketamine|mesh-list
44728819|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
44728820|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728821|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728822|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44728823|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44728824|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
44728825|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
44728826|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728827|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44728828|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44728829|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728830|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728831|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44728832|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44728833|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44728834|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44728835|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728836|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
44728837|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
44728838|NCT03782064|Nivolumab|nivolumab|mesh-list
44162613|NCT00249977|Cisplatin|cisplatin|mesh-list
44728839|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728840|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728841|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44728842|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728843|NCT03710590|Nicotine|nicotine|mesh-list
44728844|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44728845|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
44728846|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728847|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728848|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44728849|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44728850|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
44728851|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728852|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728853|NCT03691714|Cetuximab|cetuximab|mesh-list
44728854|NCT03691714|Durvalumab|durvalumab|mesh-list
44728855|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728856|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728857|NCT03676764|Azithromycin|azithromycin|mesh-list
44728858|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728859|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728860|NCT03676725|Lidocaine|lidocaine|mesh-list
44728861|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
44728862|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
44728863|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728864|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728865|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
44728866|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280807|NCT00730288|Vaccines|vaccines|mesh-list
44728867|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44728868|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44728869|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44728870|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44728871|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728872|NCT03572049|Itraconazole|itraconazole|mesh-list
44728873|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44728874|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
44728875|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728876|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44728877|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44728878|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728879|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728880|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44728881|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
44728882|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44728883|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728884|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44728885|NCT03471507|Diclofenac|diclofenac|mesh-list
44162669|NCT00250185|Acetylcholine|acetylcholine|mesh-list
44728886|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44728887|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44728888|NCT03471507|Analgesics|analgesics|mesh-ancestor
44155635|NCT00227708|Docetaxel|docetaxel|mesh-list
44728889|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
44728890|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728891|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728892|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728893|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728894|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44728895|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728896|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728897|NCT03470922|Nivolumab|nivolumab|mesh-list
44728898|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728899|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728900|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44728901|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728902|NCT03468335|Irinotecan|irinotecan|mesh-list
44728903|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44728904|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44728905|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728906|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728907|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728908|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44728909|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728910|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728911|NCT03345810|Gemcitabine|gemcitabine|mesh-list
44728912|NCT03345810|Paclitaxel|paclitaxel|mesh-list
44728913|NCT03345810|Vinorelbine|vinorelbine|mesh-list
44728914|NCT03345810|Carboplatin|carboplatin|mesh-list
44728915|NCT03345810|Durvalumab|durvalumab|mesh-list
44728916|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44728917|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728918|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728919|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44728920|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728921|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728922|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728923|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
44728924|NCT03345810|Antiviral Agents|antiviral agents|mesh-ancestor
44728925|NCT03345810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728926|NCT03345810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728927|NCT03345810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728928|NCT03345810|Immunologic Factors|immunologic factors|mesh-ancestor
44728929|NCT03345810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728930|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728931|NCT03326947|Cisplatin|cisplatin|mesh-list
44728932|NCT03326947|Docetaxel|docetaxel|mesh-list
44728933|NCT03326947|Fluorouracil|fluorouracil|mesh-list
44728934|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728935|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44728936|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162738|NCT00250536|Nandrolone|nandrolone|mesh-list
44728937|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44728938|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728939|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
44728940|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44728941|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44728942|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
44728943|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728944|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
44728945|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728946|NCT03205423|Gabapentin|gabapentin|mesh-list
44728947|NCT03205423|Analgesics|analgesics|mesh-ancestor
44728948|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
44728949|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44728950|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728951|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
44728952|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44728953|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44728954|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44728955|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44728956|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44728957|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44728958|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44728959|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728960|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
44728961|NCT03104400|Adalimumab|adalimumab|mesh-list
44728962|NCT03104400|Upadacitinib|upadacitinib|mesh-list
44728963|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44728964|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728965|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44728966|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44728967|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728968|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728970|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44728971|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44728972|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728973|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728974|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44728975|NCT03008369|Lenvatinib|lenvatinib|mesh-list
44728976|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728977|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44728978|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44728979|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728980|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
44728981|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44728982|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728983|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728984|NCT02918409|Tobramycin|tobramycin|mesh-list
44728985|NCT02918409|Colistin|colistin|mesh-list
44728986|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44728987|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44728988|NCT02918006|Vaccines|vaccines|mesh-list
44728989|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
44728990|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44728991|NCT02917772|Nivolumab|nivolumab|mesh-list
44728992|NCT02917772|Ipilimumab|ipilimumab|mesh-list
44728993|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44728994|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44728995|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44728996|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44728997|NCT02909686|Curcumin|curcumin|mesh-list
44728998|NCT02909686|Resveratrol|resveratrol|mesh-list
44728999|NCT02909686|Pycnogenols|pycnogenols|mesh-list
44729000|NCT02909686|Turmeric extract|turmeric extract|mesh-list
44729001|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44162771|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
44729002|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729003|NCT02909686|Analgesics|analgesics|mesh-ancestor
44729004|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
44729005|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729006|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729007|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729008|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729009|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729010|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729011|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729012|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
44729013|NCT02909686|Protective Agents|protective agents|mesh-ancestor
44729014|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729015|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44729017|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44729018|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
44729019|NCT02713373|Cetuximab|cetuximab|mesh-list
44729020|NCT02713373|Antibodies|antibodies|mesh-list
44729021|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
44729022|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44729023|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
44729024|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729025|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729026|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
44729027|NCT02686593|Clofarabine|clofarabine|mesh-list
44729028|NCT02686593|Analgesics|analgesics|mesh-ancestor
44729029|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
44729030|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729031|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729032|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729033|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44729034|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44729035|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729036|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729037|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729038|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
44729039|NCT02658487|Cytarabine|cytarabine|mesh-list
44729040|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729041|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
44729042|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729043|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729044|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
44729045|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729046|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729047|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
44729048|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729049|NCT02583282|Doxycycline|doxycycline|mesh-list
44729050|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729051|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729052|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
44729053|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44729054|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44729056|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729057|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
44729058|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729059|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729060|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729061|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44729062|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44729063|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
44729064|NCT02546492|Hormones|hormones|mesh-ancestor
44729065|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729066|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729067|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729068|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729069|NCT02527564|Suvorexant|suvorexant|mesh-list
44729070|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44729071|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44729072|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729073|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729074|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44729075|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729076|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729077|NCT02339168|Metformin|metformin|mesh-list
44729078|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729079|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729080|NCT02184195|Olaparib|olaparib|mesh-list
44729081|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44729082|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729083|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729084|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729085|NCT02179749|Mifepristone|mifepristone|mesh-list
44729086|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44729087|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
44729088|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44729089|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729090|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44729091|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44729092|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44729093|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
44729094|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44729095|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44729096|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
44729097|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729098|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
44729099|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44729100|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44729101|NCT02065609|Trastuzumab|trastuzumab|mesh-list
44729102|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44729103|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729104|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
44729105|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44729106|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44729107|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729108|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
44729109|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
44729110|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729111|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44729112|NCT01703949|Nivolumab|nivolumab|mesh-list
44729113|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44729114|NCT01703949|Antibodies|antibodies|mesh-list
44729115|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
44729116|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44729117|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
44729118|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
44729119|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162907|NCT00251095|Paclitaxel|paclitaxel|mesh-list
44729120|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729121|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44729122|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729123|NCT00700882|Dasatinib|dasatinib|mesh-list
44729124|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729125|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44729126|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729127|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729129|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44729130|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44729131|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
44729132|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
44729133|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729134|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729135|NCT01561482|Metformin|metformin|mesh-list
44729136|NCT01561482|Simvastatin|simvastatin|mesh-list
44729137|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729138|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729139|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44729140|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44729141|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
44729142|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729143|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44729144|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44729145|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729146|NCT01561586|Cisplatin|cisplatin|mesh-list
44729147|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729148|NCT01562704|Acetaminophen|acetaminophen|mesh-list
44729149|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729150|NCT01562704|Analgesics|analgesics|mesh-ancestor
44729151|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
44729152|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729153|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729154|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
44729155|NCT01564095|Tryptophan|tryptophan|mesh-list
44729156|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44729157|NCT01564095|Tacrolimus|tacrolimus|mesh-list
44729158|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729159|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
44729160|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729161|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44729162|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729163|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729164|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44729165|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729166|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729167|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
44729168|NCT01564238|Calcium|calcium|mesh-list
44729169|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44729170|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729171|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44729172|NCT01564576|Bromides|bromides|mesh-list
44729173|NCT01564576|Rocuronium|rocuronium|mesh-list
44729174|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
44729175|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44729176|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44729177|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44729178|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729179|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729180|NCT01564823|Metronidazole|metronidazole|mesh-list
44729181|NCT01564823|Adalimumab|adalimumab|mesh-list
44729182|NCT01564823|Azathioprine|azathioprine|mesh-list
44729183|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729184|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729185|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729186|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729187|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44729188|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44729189|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
44236538|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
44729190|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729192|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729193|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729194|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
44729195|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729196|NCT01565239|Thrombin|thrombin|mesh-list
44729197|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
44729198|NCT01565239|Coagulants|coagulants|mesh-ancestor
44729199|NCT01565265|Cetrorelix|cetrorelix|mesh-list
44729200|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44729201|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44729202|NCT01565265|Hormones|hormones|mesh-ancestor
44729203|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729204|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729205|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44729206|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
44729207|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44729208|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
44729209|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
44729210|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44729211|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44729212|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44729213|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729214|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729215|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
44729216|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729217|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729218|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44729219|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729220|NCT01566422|Vancomycin|vancomycin|mesh-list
44729221|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729222|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729223|NCT01566760|Fesoterodine|fesoterodine|mesh-list
44729224|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44729225|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44729226|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
44729227|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729228|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729229|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729230|NCT01566760|Urological Agents|urological agents|mesh-ancestor
44729231|NCT01566890|Regadenoson|regadenoson|mesh-list
44729232|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44729233|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44729234|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
44729235|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
44729236|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729237|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729238|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729239|NCT01567072|Ibuprofen|ibuprofen|mesh-list
44729240|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44729241|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729242|NCT01567072|Analgesics|analgesics|mesh-ancestor
44729243|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
44729244|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729245|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729246|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729247|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729248|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44729249|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729250|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729251|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44729252|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
44729253|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44729254|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44729255|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729256|NCT01568632|Imetelstat|imetelstat|mesh-list
44729257|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
44729258|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163033|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44729259|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729260|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44729261|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
44729262|NCT01568645|Carvedilol|carvedilol|mesh-list
44729263|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729264|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44729265|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729266|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729267|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44729268|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44729269|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44729270|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729271|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729272|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44729274|NCT01568645|Protective Agents|protective agents|mesh-ancestor
44729275|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44729276|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729277|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44729278|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
44729279|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44729280|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44729281|NCT01568684|Citalopram|citalopram|mesh-list
44729282|NCT01568684|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44729283|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44729284|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729285|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729286|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729287|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
44729288|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729289|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44729290|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729291|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729292|NCT01569685|Sertraline|sertraline|mesh-list
44729293|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44729294|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729295|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729296|NCT01569685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44729297|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44729298|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729299|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729300|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729301|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
44729302|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729303|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44729304|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44729305|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44729306|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44729307|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
44729308|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729309|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729310|NCT01570088|Folic Acid|folic acid|mesh-list
44729311|NCT01570088|Hematinics|hematinics|mesh-ancestor
44729312|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
44729313|NCT01570088|Vitamins|vitamins|mesh-ancestor
44729314|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
44729315|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281244|NCT00732745|Docetaxel|docetaxel|mesh-list
44729316|NCT01570296|Gefitinib|gefitinib|mesh-list
44729317|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729318|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44729319|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163094|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729320|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729321|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44729322|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44729323|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
44729324|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729325|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729326|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44729327|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44729328|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
44729329|NCT01570478|Hormones|hormones|mesh-ancestor
44729330|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729331|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
44729332|NCT01570504|Ivermectin|ivermectin|mesh-list
44729333|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44729334|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729335|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44729336|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729337|NCT01570569|Losartan|losartan|mesh-list
44729338|NCT01570569|Midazolam|midazolam|mesh-list
44729339|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
44729340|NCT01570569|Caffeine|caffeine|mesh-list
44729341|NCT01570569|Omeprazole|omeprazole|mesh-list
44729342|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44729343|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44729344|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729345|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729346|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44729347|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729348|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729349|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44729350|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
44729351|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
44729352|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
44729353|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
44729354|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729355|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729356|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44729357|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44729358|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44729359|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44729360|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44729361|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729362|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44729363|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729364|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44729365|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44729366|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44729367|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44729368|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
44729369|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
44729370|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
44729371|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44729372|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44729373|NCT01570582|Gemcitabine|gemcitabine|mesh-list
44729374|NCT01570582|Paclitaxel|paclitaxel|mesh-list
44729375|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44729376|NCT01570582|Carboplatin|carboplatin|mesh-list
44729377|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44729378|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729379|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44729380|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44729381|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44729382|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729383|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729384|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
44729385|NCT01570582|Antiviral Agents|antiviral agents|mesh-ancestor
44729386|NCT01570582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729387|NCT01570582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729388|NCT01570582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729389|NCT01570582|Immunologic Factors|immunologic factors|mesh-ancestor
44729390|NCT01570582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729391|NCT01570608|Ranibizumab|ranibizumab|mesh-list
44729392|NCT01570608|Verteporfin|verteporfin|mesh-list
44729393|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44729394|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44729395|NCT01570608|Growth Substances|growth substances|mesh-ancestor
44729396|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729397|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
44729398|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729399|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44729400|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44729401|NCT01570660|Pioglitazone|pioglitazone|mesh-list
44729402|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729403|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729404|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
44729405|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729406|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
44729407|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729408|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729409|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44729410|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
44729411|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729412|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729413|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44729414|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
44729415|NCT01570790|Combretastatin|combretastatin|mesh-list
44729416|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44729417|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729418|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44729419|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44729420|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44729421|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729422|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44729423|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729424|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729425|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44729426|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729427|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729428|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729429|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44729430|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729431|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729432|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44729433|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729434|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163206|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
44729435|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729436|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44729437|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729438|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729439|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44729440|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729441|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729442|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729443|NCT01570985|Triamcinolone|triamcinolone|mesh-list
44729444|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44729445|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44729446|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44729447|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729448|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
44729449|NCT01570985|Hormones|hormones|mesh-ancestor
44729450|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729451|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729452|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729453|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
44729454|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729455|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729456|NCT01571024|Leucovorin|leucovorin|mesh-list
44729457|NCT01571024|Fluorouracil|fluorouracil|mesh-list
44729458|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
44729459|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
44729460|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729461|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729462|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729463|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729464|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
44729465|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729466|NCT01571024|Antidotes|antidotes|mesh-ancestor
44729467|NCT01571024|Protective Agents|protective agents|mesh-ancestor
44729468|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
44729469|NCT01571024|Vitamins|vitamins|mesh-ancestor
44729470|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
44729471|NCT01571037|Milrinone|milrinone|mesh-list
44729472|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44729473|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729474|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
44729475|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44729476|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44729477|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729478|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729479|NCT01571037|Protective Agents|protective agents|mesh-ancestor
44729480|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729481|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
44729483|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729484|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729485|NCT01571063|Vitamin D|vitamin d|mesh-list
44729486|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
44729487|NCT01571063|Vitamins|vitamins|mesh-ancestor
44729488|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
44729489|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729490|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44729491|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44729492|NCT01571167|Varenicline|varenicline|mesh-list
44729493|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44729494|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44729495|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44729496|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729497|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729498|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729499|NCT01571206|Infliximab|infliximab|mesh-list
44729500|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
44729501|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729502|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729503|NCT01571219|Infliximab|infliximab|mesh-list
44729504|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44729505|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729506|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729507|NCT01571323|Misoprostol|misoprostol|mesh-list
44729508|NCT01571323|Oxytocin|oxytocin|mesh-list
44729509|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
44729510|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44729511|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729512|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44729513|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
44729514|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44729515|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729516|NCT01571414|Ritonavir|ritonavir|mesh-list
44729517|NCT01571414|Lopinavir|lopinavir|mesh-list
44729518|NCT01571414|Efavirenz|efavirenz|mesh-list
44729519|NCT01571414|Rifampin|rifampin|mesh-list
44729520|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44729521|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44729522|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
44729523|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729524|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729525|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44729526|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44729527|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
44729528|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729529|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44729530|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44729531|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44729532|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44729533|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44729534|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44729535|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44729536|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44729537|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44729538|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44729539|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
44729540|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729541|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
44729542|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44729543|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44729544|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44729545|NCT01571570|Simeprevir|simeprevir|mesh-list
44236554|NCT00559741|Fluorouracil|fluorouracil|mesh-list
44729546|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
44729547|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729548|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
44729549|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729550|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729551|NCT01571583|Interferons|interferons|mesh-list
44729552|NCT01571583|Ribavirin|ribavirin|mesh-list
44729553|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
44729554|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
44729555|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44729556|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729557|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
44729558|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729559|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
44729560|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729561|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
44729562|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729563|NCT01571609|Insulin|insulin|mesh-list
44729564|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729565|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729566|NCT01571648|Azacitidine|azacitidine|mesh-list
44729567|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729568|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
44729569|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729570|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729571|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729572|NCT01571687|Antioxidants|antioxidants|mesh-list
44729573|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729574|NCT01571687|Protective Agents|protective agents|mesh-ancestor
44729575|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729576|NCT01571791|Ketorolac|ketorolac|mesh-list
44729577|NCT01571791|Lidocaine|lidocaine|mesh-list
44729578|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
44729579|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
44729580|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729581|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729582|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
44729583|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729584|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44729585|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44729586|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44729587|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729588|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729589|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44729590|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729591|NCT01571791|Analgesics|analgesics|mesh-ancestor
44729592|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729593|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729594|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44729595|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729596|NCT01571804|Pregabalin|pregabalin|mesh-list
44729597|NCT01571804|Analgesics|analgesics|mesh-ancestor
44729598|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
44729599|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729600|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729601|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
44729602|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44729603|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729604|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729605|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44729606|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44729607|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729608|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729609|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729610|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
44729611|NCT01571856|Astringents|astringents|mesh-ancestor
44729612|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729613|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
44729614|NCT01571882|Policosanol|policosanol|mesh-list
44729615|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44729616|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44729617|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
44729618|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729619|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44729620|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729622|NCT01571908|Succinylcholine|succinylcholine|mesh-list
44729623|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44729624|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44729625|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44729626|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729627|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729628|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44729629|NCT01571921|Tocotrienols|tocotrienols|mesh-list
44729630|NCT01571921|Vitamin E|vitamin e|mesh-list
44729631|NCT01571921|Tocopherols|tocopherols|mesh-list
44729632|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
44729633|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729634|NCT01571921|Protective Agents|protective agents|mesh-ancestor
44729635|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729636|NCT01571921|Vitamins|vitamins|mesh-ancestor
44729637|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
44729638|NCT01571960|Vaccines|vaccines|mesh-list
44729639|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
44729640|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729641|NCT01572012|Ondansetron|ondansetron|mesh-list
44729642|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
44729643|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
44729644|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729645|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729646|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729647|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
44729648|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44729649|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44729650|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
44729651|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729652|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729653|NCT01572012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44729654|NCT01572012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44729655|NCT01572012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729656|NCT01572012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729657|NCT01572012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44729658|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44729659|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44729660|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
44729661|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729662|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44729663|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729664|NCT01572116|Lidocaine|lidocaine|mesh-list
44729665|NCT01572116|Epinephrine|epinephrine|mesh-list
44729666|NCT01572116|Racepinephrine|racepinephrine|mesh-list
44729667|NCT01572116|Sufentanil|sufentanil|mesh-list
44729668|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
44729669|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
44729670|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
44729671|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729672|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729673|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
44729674|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729675|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44729676|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44729677|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44729678|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729679|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729680|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44729681|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44729682|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44729683|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729684|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44729685|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44729686|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
44729687|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44729688|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44729689|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
44729690|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
44729691|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44729692|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44729693|NCT01572116|Narcotics|narcotics|mesh-ancestor
44729694|NCT01572116|Analgesics|analgesics|mesh-ancestor
44729695|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44729696|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44729697|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
44729698|NCT01572129|Clopidogrel|clopidogrel|mesh-list
44729699|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729700|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44729701|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44729702|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44729703|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
44729704|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729705|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729706|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729707|NCT01572181|Fludarabine|fludarabine|mesh-list
44729709|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
44729710|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729711|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729712|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729713|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
44729714|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729715|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
44729716|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44729717|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44729718|NCT01572259|Hormones|hormones|mesh-list
44729719|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729720|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729721|NCT01572285|Dexamethasone|dexamethasone|mesh-list
44729722|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
44729723|NCT01572285|BB 1101|bb 1101|mesh-list
44729724|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729725|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
44729726|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
44729727|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729728|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729729|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729730|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
44729731|NCT01572285|Hormones|hormones|mesh-ancestor
44729732|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729733|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44729734|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729735|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
44729736|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729737|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729738|NCT01572324|Leucovorin|leucovorin|mesh-list
44729739|NCT01572324|Fluorouracil|fluorouracil|mesh-list
44729740|NCT01572324|Capecitabine|capecitabine|mesh-list
44729741|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
44729742|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
44729743|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729744|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729745|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729746|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729747|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
44729748|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729749|NCT01572324|Antidotes|antidotes|mesh-ancestor
44729750|NCT01572324|Protective Agents|protective agents|mesh-ancestor
44729751|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
44729752|NCT01572324|Vitamins|vitamins|mesh-ancestor
44729753|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
44729754|NCT01572350|Triamcinolone|triamcinolone|mesh-list
44729755|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44729756|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44729757|NCT01572350|Bevacizumab|bevacizumab|mesh-list
44729758|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44729759|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44729760|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729761|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44729762|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44729763|NCT01572350|Growth Substances|growth substances|mesh-ancestor
44729764|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729765|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44729766|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729767|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
44729768|NCT01572350|Hormones|hormones|mesh-ancestor
44729769|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729770|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729771|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
44729773|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729774|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
44729775|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
44729776|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44729777|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44729778|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729779|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729780|NCT01572363|Urological Agents|urological agents|mesh-ancestor
44729781|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
44729782|NCT01572454|Remifentanil|remifentanil|mesh-list
44729783|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44729784|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729785|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729786|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729787|NCT01572454|Analgesics|analgesics|mesh-ancestor
44729788|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
44163557|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729789|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729790|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44281736|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
44729791|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44729792|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44729793|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
44729794|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729795|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729796|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44729797|NCT01572454|Narcotics|narcotics|mesh-ancestor
44729798|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
44729799|NCT01572545|Denosumab|denosumab|mesh-list
44729800|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44729801|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729802|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
44729803|NCT01572558|Meropenem|meropenem|mesh-list
44729804|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729805|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729806|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44729807|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44729808|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729809|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729810|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729811|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44729812|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44729813|NCT01572597|Metronidazole|metronidazole|mesh-list
44729814|NCT01572597|Clarithromycin|clarithromycin|mesh-list
44729815|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
44729816|NCT01572597|Rabeprazole|rabeprazole|mesh-list
44729817|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44729818|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44729819|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44729820|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44729821|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44729822|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729823|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44729824|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729825|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729826|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44729827|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44729828|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44729829|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
44729830|NCT01572597|Expectorants|expectorants|mesh-ancestor
44729831|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
44729832|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44729833|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
44729834|NCT01572597|Protective Agents|protective agents|mesh-ancestor
44729835|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729836|NCT01572623|Clopidogrel|clopidogrel|mesh-list
44729837|NCT01572623|Atorvastatin|atorvastatin|mesh-list
44729838|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44729839|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44729840|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
44729841|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729842|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44729843|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44729844|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729845|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729846|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44729847|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44729848|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44729849|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
44729850|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729851|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729852|NCT01572649|Lixisenatide|lixisenatide|mesh-list
44729853|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729854|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729855|NCT01572688|Melphalan|melphalan|mesh-list
44729856|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44729857|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
44729858|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729859|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729860|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44729861|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44729862|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
44729863|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729864|NCT01572805|Melatonin|melatonin|mesh-list
44729865|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
44729866|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729867|NCT01572805|Protective Agents|protective agents|mesh-ancestor
44729868|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729869|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729871|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
44729872|NCT01572831|Protective Agents|protective agents|mesh-ancestor
44729873|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729874|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
44729875|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44729876|NCT01572857|Antibodies|antibodies|mesh-list
44729877|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
44729878|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729879|NCT01572961|Aspirin|aspirin|mesh-list
44729880|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44729881|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44729882|NCT01572961|Analgesics|analgesics|mesh-ancestor
44729883|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
44729884|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729885|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729886|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44729887|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44729888|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44729889|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44729890|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729891|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44729892|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44729893|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729894|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
44729895|NCT01573013|Iron|iron|mesh-list
44729896|NCT01573013|Trace Elements|trace elements|mesh-ancestor
44729897|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
44729898|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729899|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44729900|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44729901|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44729902|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
44729903|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729904|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44729905|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44729906|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729907|NCT01573286|Glucagon|glucagon|mesh-list
44729908|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44729909|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44729910|NCT01573286|Hormones|hormones|mesh-ancestor
44729911|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729912|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729913|NCT01573286|Incretins|incretins|mesh-ancestor
44729914|NCT01573338|Cisplatin|cisplatin|mesh-list
44729915|NCT01573338|Carboplatin|carboplatin|mesh-list
44729916|NCT01573338|Etoposide|etoposide|mesh-list
44729917|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729918|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44729919|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44729920|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44729921|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44729922|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729924|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
44729925|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44729926|NCT01573377|Cyproterone|cyproterone|mesh-list
44729927|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44729928|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729929|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44729930|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44729931|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44729932|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
44729933|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44729934|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44729935|NCT01573377|Estrogens|estrogens|mesh-ancestor
44729936|NCT01573377|Hormones|hormones|mesh-ancestor
44729937|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729938|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
44729939|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44729940|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729941|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44729942|NCT01573468|Capecitabine|capecitabine|mesh-list
44729943|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44729944|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
44729945|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729946|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44729947|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44729948|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
44729949|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44729950|NCT01573598|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44729951|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44729952|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44729953|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729954|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729955|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
44729956|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729957|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44729958|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44729959|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44729960|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44729961|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
44729962|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44729963|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729964|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44729965|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44729966|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44729967|NCT01573663|Dipropizine|dipropizine|mesh-list
44729968|NCT01573663|Ambroxol|ambroxol|mesh-list
44729969|NCT01573663|Expectorants|expectorants|mesh-ancestor
44729970|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
44729971|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
44729972|NCT01573715|Cisatracurium|cisatracurium|mesh-list
44729973|NCT01573715|Atracurium|atracurium|mesh-list
44729974|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44729975|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44729976|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729977|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729978|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44729979|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44729980|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44729981|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
44729982|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729983|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44729984|NCT01573741|Ketamine|ketamine|mesh-list
44729985|NCT01573741|Analgesics|analgesics|mesh-ancestor
44729986|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
44729987|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44729988|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44729989|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44729990|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44729991|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
44729992|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
44729993|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44729994|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44729995|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44729996|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44729997|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281952|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
44729998|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
44729999|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
44730000|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44730001|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44730002|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730003|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730004|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730005|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730007|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44730008|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730009|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44730010|NCT01573806|Incretins|incretins|mesh-ancestor
44730011|NCT01573806|Hormones|hormones|mesh-ancestor
44730012|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730013|NCT01573975|Clarithromycin|clarithromycin|mesh-list
44730014|NCT01573975|Rabeprazole|rabeprazole|mesh-list
44730015|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44730016|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730017|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44730018|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730019|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730020|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730021|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730022|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44730023|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44730024|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44730025|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
44730026|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730027|NCT01574027|Vitamin D|vitamin d|mesh-list
44730028|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
44730029|NCT01574027|Vitamins|vitamins|mesh-ancestor
44730030|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
44730031|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730032|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730033|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730034|NCT01574092|Cisplatin|cisplatin|mesh-list
44730035|NCT01574092|Irinotecan|irinotecan|mesh-list
44730036|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730037|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44730038|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44730039|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730040|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730041|NCT01574131|Fenofibrate|fenofibrate|mesh-list
44730042|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44730043|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
44730044|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730045|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44730046|NCT01574261|Inositol|inositol|mesh-list
44730047|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
44730048|NCT01574261|Vitamins|vitamins|mesh-ancestor
44730049|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
44730050|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730051|NCT01574313|Tocopherols|tocopherols|mesh-list
44730052|NCT01574313|Vitamin E|vitamin e|mesh-list
44730053|NCT01574313|Tocotrienols|tocotrienols|mesh-list
44730054|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
44730055|NCT01574313|Niacin|niacin|mesh-list
44730056|NCT01574313|Diphenidol|diphenidol|mesh-list
44730057|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
44730058|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730059|NCT01574313|Protective Agents|protective agents|mesh-ancestor
44730060|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730061|NCT01574313|Vitamins|vitamins|mesh-ancestor
44730062|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
44730063|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44730064|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
44730065|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44730066|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
44730067|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
44730068|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
44730069|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
44730070|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730071|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730072|NCT01574508|Insulin|insulin|mesh-list
44730073|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44730074|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44730075|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730076|NCT01574638|Rifapentine|rifapentine|mesh-list
44730077|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44730078|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
44730079|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730080|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730081|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
44730082|NCT01574742|Minocycline|minocycline|mesh-list
44730083|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730084|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730085|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
44730086|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44730087|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730088|NCT01575158|Citalopram|citalopram|mesh-list
44730089|NCT01575158|Clomipramine|clomipramine|mesh-list
44730090|NCT01575158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44730091|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44730092|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730093|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730094|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730095|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
44730096|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730097|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44730098|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
44730099|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44730100|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44730101|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
44730102|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44730103|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730104|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
44730105|NCT01575301|Liraglutide|liraglutide|mesh-list
44730106|NCT01575301|Exenatide|exenatide|mesh-list
44730107|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44730108|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730109|NCT01575301|Incretins|incretins|mesh-ancestor
44730110|NCT01575301|Hormones|hormones|mesh-ancestor
44730111|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730112|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44730113|NCT01575405|Tenofovir|tenofovir|mesh-list
44730114|NCT01575405|Glycerol|glycerol|mesh-list
44730115|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
44730116|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730117|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44730118|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730119|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730120|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730121|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730122|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730123|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44730124|NCT01575405|Protective Agents|protective agents|mesh-ancestor
44730125|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730126|NCT01575418|Tenofovir|tenofovir|mesh-list
44730127|NCT01575418|Glycerol|glycerol|mesh-list
44730128|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
44730129|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730130|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44730131|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730132|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730133|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730134|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730135|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730136|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44730137|NCT01575418|Protective Agents|protective agents|mesh-ancestor
44730138|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730139|NCT01575483|Saxagliptin|saxagliptin|mesh-list
44730140|NCT01575483|Incretins|incretins|mesh-ancestor
44730141|NCT01575483|Hormones|hormones|mesh-ancestor
44730142|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730143|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730144|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44730145|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730146|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730147|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730148|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44730149|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44730150|NCT01575613|Lumefantrine|lumefantrine|mesh-list
44730151|NCT01575613|Artemether|artemether|mesh-list
44730152|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44730153|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
44730154|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44730155|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44730156|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730157|NCT01575626|Sevoflurane|sevoflurane|mesh-list
44730158|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44730159|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44730160|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
44730161|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
44730162|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730163|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730164|NCT01575639|Prednisolone|prednisolone|mesh-list
44730165|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730166|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
44730167|NCT01575639|Hormones|hormones|mesh-ancestor
44730168|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730169|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730170|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730171|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730172|NCT01575652|Lisinopril|lisinopril|mesh-list
44730173|NCT01575652|Perindopril|perindopril|mesh-list
44730174|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44730175|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44730176|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730177|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730178|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44730179|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44730180|NCT01575652|Protective Agents|protective agents|mesh-ancestor
44730181|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730182|NCT01575678|Melatonin|melatonin|mesh-list
44730183|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
44730184|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730185|NCT01575678|Protective Agents|protective agents|mesh-ancestor
44730186|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730187|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730188|NCT01575717|Vitamin D|vitamin d|mesh-list
44730189|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
44730190|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
44730191|NCT01575717|Vitamins|vitamins|mesh-list
44730192|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
44730193|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730194|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730195|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730196|NCT01575782|Chloroquine|chloroquine|mesh-list
44730197|NCT01575782|Amebicides|amebicides|mesh-ancestor
44730198|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44730199|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44730200|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730201|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
44730202|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730203|NCT01575795|Ticagrelor|ticagrelor|mesh-list
44730204|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44730205|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44730206|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44730207|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44730208|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
44730209|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730210|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730211|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730212|NCT01576029|Docetaxel|docetaxel|mesh-list
44730213|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730214|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
44730215|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
44730216|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
44730217|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730219|NCT01576094|Milrinone|milrinone|mesh-list
44730220|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44730221|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
44730222|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44730223|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44730224|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730225|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730226|NCT01576094|Protective Agents|protective agents|mesh-ancestor
44730227|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730228|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44730229|NCT01576185|Sorafenib|sorafenib|mesh-list
44730230|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730231|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730232|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730233|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730234|NCT01576263|Ropivacaine|ropivacaine|mesh-list
44730235|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
44730236|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
44730237|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730238|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730239|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
44730240|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730241|NCT01576315|Itraconazole|itraconazole|mesh-list
44730242|NCT01576315|Voriconazole|voriconazole|mesh-list
44730243|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
44730244|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730245|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44730246|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44730247|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730248|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730249|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44730250|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730251|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730252|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730253|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44730254|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
44730255|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44730256|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730257|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730258|NCT01576419|Celecoxib|celecoxib|mesh-list
44730259|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44730260|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730261|NCT01576419|Analgesics|analgesics|mesh-ancestor
44730262|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
44730263|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730264|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730265|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730266|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730267|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44730268|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44730269|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730270|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730271|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44730272|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44730273|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730274|NCT01576627|Zinc|zinc|mesh-list
44730275|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
44730276|NCT01576627|Trace Elements|trace elements|mesh-ancestor
44730277|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
44730278|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730279|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
44730280|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
44730281|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44730282|NCT01576627|Protective Agents|protective agents|mesh-ancestor
44730283|NCT01576640|Bupropion|bupropion|mesh-list
44730284|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44730285|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
44730286|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44730287|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44730288|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44730289|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730290|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730291|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
44730292|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730293|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730294|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44730295|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44730296|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730297|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44730298|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44730299|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44730300|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730302|NCT01576692|Antibodies|antibodies|mesh-list
44730303|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
44730304|NCT01576692|Sargramostim|sargramostim|mesh-list
44730305|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
44730306|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730307|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730308|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730309|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730310|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
44730311|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730312|NCT01576731|Tenofovir|tenofovir|mesh-list
44730313|NCT01576731|Emtricitabine|emtricitabine|mesh-list
44730314|NCT01576731|Lopinavir|lopinavir|mesh-list
44730315|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
44730316|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
44730317|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730318|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44730319|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730320|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730321|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730322|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730323|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730324|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44730325|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44730326|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730327|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44730328|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44730329|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44730330|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44730331|NCT01576770|Lidocaine|lidocaine|mesh-list
44730332|NCT01576770|Tetracaine|tetracaine|mesh-list
44730333|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
44730334|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
44730335|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
44730336|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730337|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730338|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
44730339|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730340|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44730341|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44730342|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44730343|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730344|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730345|NCT01576848|Caseins|caseins|mesh-list
44730346|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
44730347|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
44730348|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730349|NCT01577017|Letrozole|letrozole|mesh-list
44730350|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44730351|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164115|NCT00254956|Ciclesonide|ciclesonide|mesh-list
44730352|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44730353|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730354|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730355|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44730356|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730357|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730358|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730359|NCT01577043|Racecadotril|racecadotril|mesh-list
44730360|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
44282337|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
44730361|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730362|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730363|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730364|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730365|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
44730366|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43620664|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
44730367|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730368|NCT01577121|Indomethacin|indomethacin|mesh-list
44730369|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44730370|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730371|NCT01577121|Analgesics|analgesics|mesh-ancestor
44730372|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
44730373|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730374|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730375|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730376|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730377|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
44730378|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
44730379|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730380|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44730381|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730382|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730383|NCT01577199|Clomiphene|clomiphene|mesh-list
44730384|NCT01577199|Enclomiphene|enclomiphene|mesh-list
44730385|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
44730386|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44730387|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730388|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730389|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730390|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44730391|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
44730392|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730393|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44730394|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44730395|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
44730396|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730397|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730398|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44730399|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44730400|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730401|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730402|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730403|NCT01577368|Tazobactam|tazobactam|mesh-list
44730404|NCT01577368|Piperacillin|piperacillin|mesh-list
44730405|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44730406|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730407|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730408|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44730409|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730410|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730411|NCT01577407|Nefopam|nefopam|mesh-list
44164175|NCT00255437|Hematinics|hematinics|mesh-ancestor
44730412|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730413|NCT01577407|Analgesics|analgesics|mesh-ancestor
44730414|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
44730415|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730416|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730417|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
44730418|NCT01577459|Tedizolid|tedizolid|mesh-list
44730419|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730420|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730421|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
44730422|NCT01577524|Povidone|povidone|mesh-list
44730423|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
44730424|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
44730425|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44730426|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730427|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44730428|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
44730429|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730430|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44730431|NCT01577589|Cephalosporins|cephalosporins|mesh-list
44730432|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730433|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730434|NCT01577693|Dutasteride|dutasteride|mesh-list
44730435|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44730436|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44730437|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730438|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730439|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730440|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730441|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730442|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44730443|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
44730444|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730445|NCT01577849|Vitamin D|vitamin d|mesh-list
44730446|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
44730447|NCT01577849|Vitamins|vitamins|mesh-ancestor
44730448|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
44730449|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730450|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730451|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730452|NCT01577862|Rifampin|rifampin|mesh-list
44730453|NCT01577862|Colistin|colistin|mesh-list
44730454|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44730455|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
44730456|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44730457|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730458|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
44730459|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730460|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730461|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730462|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44730463|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44730464|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44730465|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44730466|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44730467|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44730468|NCT01577914|Carvedilol|carvedilol|mesh-list
44730469|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44730470|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44730471|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
44730472|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730473|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730474|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730475|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44730476|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
44730477|NCT01577914|Protective Agents|protective agents|mesh-ancestor
44164239|NCT00255541|Glyburide|glyburide|mesh-list
44730478|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44730479|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730480|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730481|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
44730482|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44730483|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44730484|NCT01577940|Ropivacaine|ropivacaine|mesh-list
44730485|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44730487|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730488|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730489|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
44730490|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730491|NCT01577992|Levodopa|levodopa|mesh-list
44730492|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44730493|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44730494|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
44730495|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730496|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730497|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730498|NCT01578057|Ethanol|ethanol|mesh-list
44730499|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44730500|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730501|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730502|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730503|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
44730504|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730505|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
44730506|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
44730507|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44730508|NCT01578109|Sorafenib|sorafenib|mesh-list
44730509|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730510|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730511|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730512|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730513|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
44730515|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730516|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730517|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730518|NCT01578161|Analgesics|analgesics|mesh-ancestor
44730519|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
44730520|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730521|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44730522|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44730523|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44730524|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
44730525|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730526|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730527|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
44730528|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44730529|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730530|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730531|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730532|NCT01578174|Analgesics|analgesics|mesh-ancestor
44730533|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
44730534|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730535|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44730536|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44730537|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44730538|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
44730539|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730540|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730541|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
44730542|NCT01578200|Calcium|calcium|mesh-list
44164317|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
44730543|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730544|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730545|NCT01578200|Antacids|antacids|mesh-ancestor
44730546|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730547|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730548|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
44730549|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730550|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730551|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730552|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730553|NCT01578252|Ondansetron|ondansetron|mesh-list
44730554|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
44730555|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
44730556|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730557|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730558|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730559|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
44730560|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
44730561|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44730562|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
44730563|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730564|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730565|NCT01578252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44730566|NCT01578252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44730567|NCT01578252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730568|NCT01578252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44730569|NCT01578252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44730570|NCT01578265|Ondansetron|ondansetron|mesh-list
44730571|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
44730572|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
44730573|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730574|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730575|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730576|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
44730577|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
44730578|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44730579|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
44730580|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730581|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730582|NCT01578265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44730583|NCT01578265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44730584|NCT01578265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44730585|NCT01578265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44730586|NCT01578265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44730588|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44730589|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44730590|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
44730591|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730592|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730593|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730594|NCT01578304|Urological Agents|urological agents|mesh-ancestor
44730595|NCT01578343|Dexamethasone|dexamethasone|mesh-list
44730596|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
44730597|NCT01578343|Fludarabine|fludarabine|mesh-list
44730598|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
44730599|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
44730600|NCT01578343|Vorinostat|vorinostat|mesh-list
44730601|NCT01578343|BB 1101|bb 1101|mesh-list
44730602|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730603|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
44730604|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
44730605|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730606|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730607|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730608|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
44730609|NCT01578343|Hormones|hormones|mesh-ancestor
44730610|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730611|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730612|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730613|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730614|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730615|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730616|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44730617|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
44730618|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44730619|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
44730620|NCT01578343|Analgesics|analgesics|mesh-ancestor
44730621|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
44730622|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44730623|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44730624|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44730625|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
44730626|NCT01578434|Vitamin D|vitamin d|mesh-list
44730627|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
44730628|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
44730629|NCT01578434|Vitamins|vitamins|mesh-list
44730630|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
44730631|NCT01578434|Calcium|calcium|mesh-list
44730632|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
44282593|NCT00740285|Lidocaine|lidocaine|mesh-list
44730633|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730634|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730636|NCT01578434|Antacids|antacids|mesh-ancestor
44730637|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730638|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730639|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44730640|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
44730641|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44730642|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
44730643|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730644|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730645|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44730646|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44730647|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730648|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730649|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44730650|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44730651|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44730652|NCT01578473|Vitamin D|vitamin d|mesh-list
44730653|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
44730654|NCT01578473|Vitamins|vitamins|mesh-list
44730655|NCT01578473|Vitamin E|vitamin e|mesh-list
44730656|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
44730657|NCT01578473|Testosterone|testosterone|mesh-list
44730658|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
44730659|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
44730660|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44730661|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
44730662|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730663|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730665|NCT01578473|Hormones|hormones|mesh-ancestor
44730666|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730667|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730668|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730669|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
44730670|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
44730671|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730672|NCT01578473|Protective Agents|protective agents|mesh-ancestor
44730673|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730674|NCT01578564|SOR-C13|sor-c13|mesh-list
44730675|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730676|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44730677|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730678|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730679|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730680|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730681|NCT01578603|Calcium|calcium|mesh-list
44730682|NCT01578603|Caseins|caseins|mesh-list
44730683|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44730684|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730685|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
44730686|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
44730687|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730688|NCT01578629|Aspirin|aspirin|mesh-list
44730689|NCT01578629|Vitamin E|vitamin e|mesh-list
44730690|NCT01578629|Tocopherols|tocopherols|mesh-list
44730691|NCT01578629|Tocotrienols|tocotrienols|mesh-list
44730692|NCT01578629|Vitamins|vitamins|mesh-ancestor
44730693|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
44730694|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730695|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44730696|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730697|NCT01578629|Analgesics|analgesics|mesh-ancestor
44730698|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
44730699|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730700|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730701|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730702|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44730703|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44730704|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730705|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44730706|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44730707|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730708|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
44730709|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
44730710|NCT01578629|Protective Agents|protective agents|mesh-ancestor
44730711|NCT01578668|Cisplatin|cisplatin|mesh-list
44730712|NCT01578668|Pemetrexed|pemetrexed|mesh-list
44730713|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44730714|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730715|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730716|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730717|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44730718|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730719|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730720|NCT01578720|Aflibercept|aflibercept|mesh-list
44730721|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44730722|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44730723|NCT01578720|Growth Substances|growth substances|mesh-ancestor
44730724|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730725|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
44730726|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730727|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
44730728|NCT01578824|Miotics|miotics|mesh-ancestor
44730729|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
44730730|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730731|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730732|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44730733|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44730734|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44730735|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44730736|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44730737|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
44730738|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730739|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730740|NCT01578889|Vaccines|vaccines|mesh-list
44730741|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
44730742|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730743|NCT01578928|Pasireotide|pasireotide|mesh-list
44730744|NCT01578928|Hormones|hormones|mesh-ancestor
44730745|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730746|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730747|NCT01579019|Ritonavir|ritonavir|mesh-list
44730748|NCT01579019|Ribavirin|ribavirin|mesh-list
44730749|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44730750|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44730751|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44730752|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730753|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730754|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730755|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730756|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730757|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
44730758|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730759|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44730760|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44730761|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
44730762|NCT01579058|Bisoprolol|bisoprolol|mesh-list
44730763|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44730764|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
44730765|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
44730766|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730767|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730768|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44730769|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44730770|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44730771|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44730772|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730773|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730774|NCT01579110|Levamisole|levamisole|mesh-list
44730775|NCT01579110|Prednisone|prednisone|mesh-list
44730776|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730777|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
44730778|NCT01579110|Hormones|hormones|mesh-ancestor
44730779|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730780|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730781|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44282681|NCT00740571|Pregabalin|pregabalin|mesh-list
44730782|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730783|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44730784|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
44730785|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
44730787|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44730788|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730789|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730790|NCT01579149|Plerixafor|plerixafor|mesh-list
44730791|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44730792|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44730793|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
44730794|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44730795|NCT01579201|Carbetocin|carbetocin|mesh-list
44730796|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
44730797|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730798|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730799|NCT01579227|Tamoxifen|tamoxifen|mesh-list
44730800|NCT01579227|Tocotrienols|tocotrienols|mesh-list
44730801|NCT01579227|Vitamin E|vitamin e|mesh-list
44730802|NCT01579227|Tocopherols|tocopherols|mesh-list
44730803|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44730804|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730805|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730806|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730807|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730808|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730809|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44730810|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44730811|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730812|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
44426674|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730813|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730815|NCT01579227|Vitamins|vitamins|mesh-ancestor
44730816|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
44730817|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44730818|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44730819|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44730820|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730821|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730822|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730823|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730824|NCT01579279|Analgesics|analgesics|mesh-ancestor
44730825|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
44730826|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730827|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
44730828|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44730829|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
44730830|NCT01579383|Sumatriptan|sumatriptan|mesh-list
44730831|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44730832|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44730833|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44730834|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
44730835|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730836|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730837|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730838|NCT01579448|Vaccines|vaccines|mesh-list
44730839|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
44730840|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730841|NCT01579461|Mirabegron|mirabegron|mesh-list
44730842|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44730843|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44730844|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44730845|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
44730846|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730847|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730848|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730849|NCT01579461|Urological Agents|urological agents|mesh-ancestor
44730850|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
44730851|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44730852|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44730853|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44730854|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44730855|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730856|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
44730857|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44730858|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730859|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44164618|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
44730860|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730861|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
44730862|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44730863|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44730864|NCT01579539|Prednisolone|prednisolone|mesh-list
44730865|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
44730866|NCT01579539|Esomeprazole|esomeprazole|mesh-list
44730867|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44730868|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
44730869|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730870|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
44730871|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
44730872|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730873|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730874|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44730875|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
44730876|NCT01579539|Hormones|hormones|mesh-ancestor
44730877|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730878|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44730879|NCT01579539|Protective Agents|protective agents|mesh-ancestor
44730880|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730881|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730882|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44730883|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44730884|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859738|NCT03044977|Octreotide|octreotide|mesh-list
44730885|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730886|NCT01579630|Pemetrexed|pemetrexed|mesh-list
44730887|NCT01579630|Gefitinib|gefitinib|mesh-list
44730888|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730889|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730890|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730891|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44730892|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44730893|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730894|NCT01579695|Tesamorelin|tesamorelin|mesh-list
44730895|NCT01579695|Growth Substances|growth substances|mesh-ancestor
44730896|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730897|NCT01579734|Tamoxifen|tamoxifen|mesh-list
44730898|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44730899|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
44730900|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44730901|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730902|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730903|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730904|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44730905|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44730906|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44730907|NCT01579760|Aflibercept|aflibercept|mesh-list
44730908|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44730909|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44730910|NCT01579760|Growth Substances|growth substances|mesh-ancestor
44730911|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730912|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
44730913|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730914|NCT01579786|Acetaminophen|acetaminophen|mesh-list
44730915|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730916|NCT01579786|Analgesics|analgesics|mesh-ancestor
44730917|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
44730918|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730919|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730920|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
44730921|NCT01579838|Eculizumab|eculizumab|mesh-list
44730922|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44730923|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44730924|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
44730925|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730926|NCT01579864|Rocuronium|rocuronium|mesh-list
44730927|NCT01579864|Succinylcholine|succinylcholine|mesh-list
44730928|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44730929|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44730930|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44730931|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730932|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730933|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44730934|NCT01579890|Diclofenac|diclofenac|mesh-list
44730935|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44730936|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44730937|NCT01579890|Analgesics|analgesics|mesh-ancestor
44730938|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
44730939|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44730940|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730941|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44730942|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44730943|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44730944|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730945|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730946|NCT01579903|Factor VIII|factor viii|mesh-list
44730947|NCT01579903|Coagulants|coagulants|mesh-ancestor
44730948|NCT01579929|Cisplatin|cisplatin|mesh-list
44730949|NCT01579929|Etoposide|etoposide|mesh-list
44730950|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730951|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44730952|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44730953|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44730954|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730955|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730956|NCT01579994|Crizotinib|crizotinib|mesh-list
44730957|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730958|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44730959|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730960|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730961|NCT01580228|Ofatumumab|ofatumumab|mesh-list
44730962|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730963|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
44730964|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44730965|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44730966|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
44730967|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44730968|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
44730969|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44730970|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44730971|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44730972|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44730973|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44730974|NCT01581476|Quinapril|quinapril|mesh-list
44730975|NCT01581476|Atorvastatin|atorvastatin|mesh-list
44730976|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44730977|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44730978|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44730979|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
44730980|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730981|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44730982|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44730983|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730984|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
44730985|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44730986|NCT01582321|Cantharidin|cantharidin|mesh-list
44730987|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44730988|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730989|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
44730990|NCT01582438|Citric Acid|citric acid|mesh-list
44730991|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
44730992|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
44730993|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44730994|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
44730995|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
44730996|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44730997|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
44730998|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44730999|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44731000|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731001|NCT01582438|Urological Agents|urological agents|mesh-ancestor
44731002|NCT01582711|Isoniazid|isoniazid|mesh-list
44731003|NCT01582711|Rifapentine|rifapentine|mesh-list
44731004|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
44731005|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731006|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731007|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44731008|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44731009|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
44731010|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731011|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44731012|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44731013|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
44731014|NCT01583062|Amoxicillin|amoxicillin|mesh-list
44731015|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
44731016|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
44731017|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731018|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731019|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731020|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731021|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44731022|NCT01583426|Paclitaxel|paclitaxel|mesh-list
44731023|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44731024|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731025|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731026|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731027|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731028|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731029|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731030|NCT01583972|Vitamin A|vitamin a|mesh-list
44731031|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
44731032|NCT01583972|Vitamins|vitamins|mesh-ancestor
44731033|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
44731034|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731035|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
44731036|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731037|NCT01583972|Protective Agents|protective agents|mesh-ancestor
44731038|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44731039|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731040|NCT01584362|Oxfendazole|oxfendazole|mesh-list
44731041|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
44731042|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44731043|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731044|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
44731045|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
44731046|NCT01584921|Hematinics|hematinics|mesh-ancestor
44731047|NCT01586013|Propofol|propofol|mesh-list
44731048|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44731049|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731050|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731051|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44731052|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
44731053|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
44731054|NCT01586845|Cyclosporine|cyclosporine|mesh-list
44731055|NCT01586845|Tacrolimus|tacrolimus|mesh-list
44731056|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731057|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
44731058|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731059|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44731060|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731061|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731062|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
44731063|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731064|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
44731065|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731066|NCT01587339|Pregabalin|pregabalin|mesh-list
44731067|NCT01587339|Zonisamide|zonisamide|mesh-list
44731068|NCT01587339|Lacosamide|lacosamide|mesh-list
44731069|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44731070|NCT01587339|Ezogabine|ezogabine|mesh-list
44731071|NCT01587339|Analgesics|analgesics|mesh-ancestor
44731072|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
44731073|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731074|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731075|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
44731076|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44731077|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731078|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731079|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44731080|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44731081|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44731082|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731083|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44731084|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44731085|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44731086|NCT01587378|Metformin|metformin|mesh-list
44731087|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731088|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731089|NCT01587482|Paclitaxel|paclitaxel|mesh-list
44731090|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731091|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731092|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731093|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731094|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731095|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731096|NCT01587625|Oxytocin|oxytocin|mesh-list
44731097|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
44731098|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164856|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44731099|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731100|NCT01587820|Cisplatin|cisplatin|mesh-list
44731101|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731102|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44731103|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44731104|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731105|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
44731106|NCT01588171|Enoxaparin|enoxaparin|mesh-list
44731107|NCT01588171|Bemiparin|bemiparin|mesh-list
44731108|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
44731109|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44731110|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44426675|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731111|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731112|NCT01588873|Desogestrel|desogestrel|mesh-list
44731113|NCT01588873|NuvaRing|nuvaring|mesh-list
44731114|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44731115|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44731116|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44731117|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
44731118|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44731119|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731120|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44731121|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44731122|NCT01588873|Progestins|progestins|mesh-ancestor
44731123|NCT01588873|Hormones|hormones|mesh-ancestor
44731124|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731125|NCT01589367|Metformin|metformin|mesh-list
44731126|NCT01589367|Letrozole|letrozole|mesh-list
44731127|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731128|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731129|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731130|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44731131|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44731132|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731133|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731134|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44731135|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
44731136|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731137|NCT01589432|Lidocaine|lidocaine|mesh-list
44731138|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
44731139|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
44731140|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731141|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731142|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
44731143|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731144|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44731145|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44731146|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44731147|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731148|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731149|NCT01589614|Erythromycin|erythromycin|mesh-list
44731150|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
43605075|NCT03232034|Calcium|calcium|mesh-list
44731151|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44731152|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
44731153|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731154|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731155|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731156|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44731157|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731158|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731159|NCT01589861|Lapatinib|lapatinib|mesh-list
44731160|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731161|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44731162|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731163|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731164|NCT01590173|Prednisolone|prednisolone|mesh-list
44731165|NCT01590173|Heparin|heparin|mesh-list
44731166|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731167|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
44731168|NCT01590173|Hormones|hormones|mesh-ancestor
44731169|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731170|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731171|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44731172|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731173|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
44731174|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44731175|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44731176|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731177|NCT01590199|Everolimus|everolimus|mesh-list
44731178|NCT01590199|Pasireotide|pasireotide|mesh-list
44731179|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731180|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731181|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
44731182|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731184|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731185|NCT01590225|Ribavirin|ribavirin|mesh-list
44731186|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44731187|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
44731188|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
44731189|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731190|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
44731191|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731192|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
44731193|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731194|NCT01590303|Ascorbic Acid|ascorbic acid|mesh-list
44731195|NCT01590303|Vitamins|vitamins|mesh-ancestor
44731196|NCT01590303|Micronutrients|micronutrients|mesh-ancestor
44731197|NCT01590303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731198|NCT01590303|Antioxidants|antioxidants|mesh-ancestor
44731199|NCT01590303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731200|NCT01590303|Protective Agents|protective agents|mesh-ancestor
44731201|NCT01590342|Diclofenac|diclofenac|mesh-list
44731202|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44731203|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283169|NCT00742937|Vitamin A|vitamin a|mesh-list
44731204|NCT01590342|Analgesics|analgesics|mesh-ancestor
44731205|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
44731206|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164967|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
44731207|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731208|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731209|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731210|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44731211|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731212|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731213|NCT01590537|Copper|copper|mesh-list
44731214|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
44731215|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44731216|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
44731217|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44731218|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731219|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44731220|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44731221|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44731222|NCT01590537|Trace Elements|trace elements|mesh-ancestor
44731223|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
44731224|NCT01590641|Vesatolimod|vesatolimod|mesh-list
44731225|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
44731226|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731227|NCT01590654|Vesatolimod|vesatolimod|mesh-list
44731228|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
44731229|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731230|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
44731231|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44731232|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44731233|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44731234|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731235|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731236|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
44731237|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731238|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731239|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44731240|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731241|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44731242|NCT01590732|Carboplatin|carboplatin|mesh-list
44731243|NCT01590732|Etoposide|etoposide|mesh-list
44731244|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
44731245|NCT01590732|Ifosfamide|ifosfamide|mesh-list
44731246|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
44731247|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
44731248|NCT01590732|Romidepsin|romidepsin|mesh-list
44731249|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731250|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731251|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44731252|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44731253|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731254|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731255|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731256|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44731257|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
44731259|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
44731260|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731261|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731262|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731263|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44731264|NCT01590823|Dabigatran|dabigatran|mesh-list
44731265|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
44731266|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44731267|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
44731268|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731269|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731270|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
44731271|NCT01590836|Insulin|insulin|mesh-list
44731272|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44731273|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
44731274|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
44731275|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44731276|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731277|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
44731278|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
44731279|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44731280|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44731281|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731282|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44731283|NCT01590901|Probucol|probucol|mesh-list
44731284|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44731285|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44731286|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
44731287|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731288|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44731289|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
44731290|NCT01590901|Protective Agents|protective agents|mesh-ancestor
44731291|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731292|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
44731293|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731294|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
44731295|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731296|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44731297|NCT01591031|Sevoflurane|sevoflurane|mesh-list
44731298|NCT01591031|Rocuronium|rocuronium|mesh-list
44731299|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44731300|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44731301|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
44731302|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
44731303|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731304|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731305|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44731306|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44731307|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44731308|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731309|NCT01591070|Tacrolimus|tacrolimus|mesh-list
44731310|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731311|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
44731312|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731313|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44731314|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731315|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731316|NCT01591083|Esomeprazole|esomeprazole|mesh-list
44731317|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44165091|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
44731318|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731319|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44731320|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731321|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731322|NCT01591122|Prednisone|prednisone|mesh-list
44731323|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
44731324|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44731325|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
44731326|NCT01591122|Hormones|hormones|mesh-ancestor
44731327|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731328|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731329|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44731330|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731331|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44731332|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731333|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731334|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
44731335|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44731336|NCT01591135|Paclitaxel|paclitaxel|mesh-list
44731337|NCT01591135|Cisplatin|cisplatin|mesh-list
44731338|NCT01591135|Fluorouracil|fluorouracil|mesh-list
44731339|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44731340|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731341|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
44731342|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
44731343|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
44731344|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731345|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
44731346|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44731347|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44731348|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
44731349|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731350|NCT01591148|Propofol|propofol|mesh-list
44731351|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44731352|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731353|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731354|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44731355|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
44731356|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
44283367|NCT00744354|Doxorubicin|doxorubicin|mesh-list
44731358|NCT01591226|Caffeine|caffeine|mesh-list
44731359|NCT01591226|Citric Acid|citric acid|mesh-list
44731360|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
44731361|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
44731362|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44731363|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
44731364|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
44731365|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731366|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44731367|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731368|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44731369|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731370|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44731371|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44731372|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
44731373|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731374|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44731375|NCT01591226|Diuretics|diuretics|mesh-ancestor
44731376|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
44731377|NCT01591291|Ondansetron|ondansetron|mesh-list
44731378|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
44731379|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
44731380|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731381|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731382|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731383|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
44731384|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
44731385|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44731386|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
44731387|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44731388|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731389|NCT01591291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44731390|NCT01591291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44731391|NCT01591291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731392|NCT01591291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44731393|NCT01591291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44731394|NCT01591421|Panitumumab|panitumumab|mesh-list
44731395|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44731396|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44731397|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44731398|NCT01591434|Laxatives|laxatives|mesh-ancestor
44731399|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44731400|NCT01591551|Natalizumab|natalizumab|mesh-list
44731401|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
44731402|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731403|NCT01591668|Vesatolimod|vesatolimod|mesh-list
44731404|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
44731405|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731406|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44731407|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
44731408|NCT01591850|Ritonavir|ritonavir|mesh-list
44731409|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44731410|NCT01591850|Rifampin|rifampin|mesh-list
44731411|NCT01591850|Ketoconazole|ketoconazole|mesh-list
44731412|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44731413|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44731414|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44731415|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44731416|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731417|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44731418|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44731419|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
44731420|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731421|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44731422|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44731423|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44731424|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
44731425|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731426|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
44731427|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44731428|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44731429|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44731430|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44731431|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44731432|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44731433|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44731434|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
44731435|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44731436|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44731437|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
44731438|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44731439|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731440|NCT01591889|Tinidazole|tinidazole|mesh-list
44731441|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
44731442|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731443|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44731444|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44731445|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44731446|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44731447|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44731448|NCT01591902|Tesamorelin|tesamorelin|mesh-list
44731449|NCT01591902|Growth Substances|growth substances|mesh-ancestor
44731450|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731451|NCT01591980|Pregabalin|pregabalin|mesh-list
44731452|NCT01591980|Analgesics|analgesics|mesh-ancestor
44731453|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
44731454|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44731455|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44731456|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
44731457|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44731458|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44731459|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44731460|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44731461|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44731462|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44731463|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44731464|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44731465|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44731466|NCT01592019|Diclofenac|diclofenac|mesh-list
44731467|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44731468|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44731469|NCT01592019|Analgesics|analgesics|mesh-ancestor
44731470|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
44731471|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165231|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
44436769|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436770|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436771|NCT01987232|Carboplatin|carboplatin|mesh-list
44436772|NCT01987232|Etoposide|etoposide|mesh-list
44436773|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436774|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44436775|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44436776|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44436777|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436778|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436779|NCT01987102|Leucovorin|leucovorin|mesh-list
44436780|NCT01987102|Calcium|calcium|mesh-list
44462678|NCT01525407|Atorvastatin|atorvastatin|mesh-list
44462679|NCT01525407|Calcium|calcium|mesh-list
44462680|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44462681|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462682|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44462683|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44462684|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
44462685|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462686|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44462687|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44462688|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462689|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
44462690|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44462691|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462692|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462693|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462694|NCT01525225|Metformin|metformin|mesh-list
43660455|NCT02931591|Metformin|metformin|mesh-list
44436781|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
44436782|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44436783|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436784|NCT01987102|Antidotes|antidotes|mesh-ancestor
44436785|NCT01987102|Protective Agents|protective agents|mesh-ancestor
44436811|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436812|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
44436813|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436814|NCT01986751|Analgesics|analgesics|mesh-ancestor
44436815|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44436816|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
44436817|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
44436818|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44436819|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44436820|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44436821|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44436822|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436823|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436824|NCT01986231|Glucagon|glucagon|mesh-list
44436825|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436826|NCT01986231|Hormones|hormones|mesh-ancestor
44436827|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436828|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436829|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44436830|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44436831|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44436832|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436833|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436834|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44436869|NCT01985334|Bromides|bromides|mesh-list
44436870|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
44436871|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436872|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44436873|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44436908|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
44436909|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44436910|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44462695|NCT01525225|Saxagliptin|saxagliptin|mesh-list
44462696|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462697|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462698|NCT01525225|Incretins|incretins|mesh-ancestor
44462699|NCT01525225|Hormones|hormones|mesh-ancestor
44462700|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462701|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44462702|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
44462703|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462704|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462705|NCT01525082|Bevacizumab|bevacizumab|mesh-list
44462706|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44462707|NCT01525082|Capecitabine|capecitabine|mesh-list
44462708|NCT01525082|Temozolomide|temozolomide|mesh-list
44462709|NCT01525082|Antibodies|antibodies|mesh-list
44462710|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
44462711|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44462712|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462713|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44462714|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436911|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436912|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
44436913|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
44436914|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44436915|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
44436950|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436951|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436952|NCT01984242|Bevacizumab|bevacizumab|mesh-list
44436953|NCT01984242|Sunitinib|sunitinib|mesh-list
44436954|NCT01984242|Atezolizumab|atezolizumab|mesh-list
44436955|NCT01984242|Antibodies|antibodies|mesh-list
44436956|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44436957|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436958|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436992|NCT01984164|Protective Agents|protective agents|mesh-ancestor
44436993|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436994|NCT01984138|Estradiol|estradiol|mesh-list
44436995|NCT01984138|Estrogens|estrogens|mesh-ancestor
44436996|NCT01984138|Hormones|hormones|mesh-ancestor
44437029|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
44437030|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44437031|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44437032|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
44437034|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
44437035|NCT01983774|Esomeprazole|esomeprazole|mesh-list
44437036|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44437037|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437038|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44437039|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962660|NCT01516268|Narcotics|narcotics|mesh-ancestor
44095227|NCT00040391|Irinotecan|irinotecan|mesh-list
44437056|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
44437057|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44437058|NCT01983111|Narcotics|narcotics|mesh-ancestor
44437059|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437060|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44437061|NCT01982942|Ibudilast|ibudilast|mesh-list
44437062|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462715|NCT01525082|Growth Substances|growth substances|mesh-ancestor
44462716|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462717|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462718|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
44462719|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462720|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
44268748|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44268749|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44268750|NCT00668603|Estradiol|estradiol|mesh-list
44268751|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44268752|NCT00668603|Estrogens|estrogens|mesh-ancestor
44268753|NCT00668603|Hormones|hormones|mesh-ancestor
44268754|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268755|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268756|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44268757|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
44268758|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268759|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44268760|NCT00668616|Paclitaxel|paclitaxel|mesh-list
44268761|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44268762|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
44268763|NCT00668616|Epirubicin|epirubicin|mesh-list
44268764|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268765|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268766|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268767|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268768|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268769|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268770|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268771|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
43660484|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
44437063|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
44437064|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437065|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437066|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44437067|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44437068|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44437069|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437070|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437071|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44437072|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
44437073|NCT01982812|Levetiracetam|levetiracetam|mesh-list
44437074|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
44437075|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
44268772|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268774|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44268775|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
44268776|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44268777|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44268778|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268779|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268780|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268781|NCT00668642|Dutasteride|dutasteride|mesh-list
44268782|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44268783|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44268784|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268785|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268786|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
44268787|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268788|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437076|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
44437077|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
44437078|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44437079|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
44437080|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437081|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437082|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437083|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
44437084|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437085|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437086|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44437087|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44437088|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44437089|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
44437090|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437091|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437092|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437093|NCT01982435|Ranibizumab|ranibizumab|mesh-list
44437094|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44437095|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44437096|NCT01982435|Growth Substances|growth substances|mesh-ancestor
44437097|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437098|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
44437127|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437128|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437129|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437130|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44437131|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44437132|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437133|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437134|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44437135|NCT01980940|Protective Agents|protective agents|mesh-ancestor
44437136|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44437137|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
44437138|NCT01980888|Rituximab|rituximab|mesh-list
44437139|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44437140|NCT01980888|Idelalisib|idelalisib|mesh-list
44437141|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268789|NCT00668759|Amiodarone|amiodarone|mesh-list
44268790|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44268791|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268792|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44268793|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44268794|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268795|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44268796|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44268797|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268798|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268799|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44268800|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44268801|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44268802|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44268803|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44268804|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268805|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268806|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268807|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268808|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44268809|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44268810|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
44268811|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268812|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268813|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44268814|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44268815|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
44268816|NCT00668850|Insulin|insulin|mesh-list
44268817|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44268818|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44268819|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268820|NCT00668941|Vitamin D|vitamin d|mesh-list
44268821|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
44268829|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44268830|NCT00668967|Verapamil|verapamil|mesh-list
44268831|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44268832|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44268833|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44268834|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268835|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44268836|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268837|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268838|NCT00669149|Aspirin|aspirin|mesh-list
44268839|NCT00669149|Heparin|heparin|mesh-list
44268840|NCT00669149|Enoxaparin|enoxaparin|mesh-list
44268841|NCT00669149|Bivalirudin|bivalirudin|mesh-list
44268842|NCT00669149|Clopidogrel|clopidogrel|mesh-list
44268843|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44268844|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437142|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437143|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
44437144|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437145|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437146|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437175|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437176|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437177|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437178|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437179|NCT01979185|Simvastatin|simvastatin|mesh-list
44437180|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437181|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437182|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
44437183|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437184|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437185|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44437186|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437187|NCT01979016|Emollients|emollients|mesh-list
44437188|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437189|NCT01978236|Trametinib|trametinib|mesh-list
44437190|NCT01978236|Dabrafenib|dabrafenib|mesh-list
44437191|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437192|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437206|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
44437207|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437208|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
44437209|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44437210|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44437211|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437212|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44437213|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
44437214|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437215|NCT01977937|Gabapentin|gabapentin|mesh-list
44437216|NCT01977937|Analgesics|analgesics|mesh-ancestor
44437217|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
44437218|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437219|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437220|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
44437221|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44437222|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268846|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
44268847|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268848|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268849|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268850|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268851|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44268852|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44268853|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268854|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44268855|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44268856|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268857|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
44268858|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44268859|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44268860|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44268861|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
44268862|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268863|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
44268864|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
44268865|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44437223|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437224|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437225|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44437226|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44437227|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437228|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437229|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
44437230|NCT01977898|Morphine|morphine|mesh-list
44437231|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44437232|NCT01977898|Narcotics|narcotics|mesh-ancestor
44437233|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437234|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437235|NCT01977898|Analgesics|analgesics|mesh-ancestor
44437236|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
44437237|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437238|NCT01977794|Amlodipine|amlodipine|mesh-list
44437239|NCT01977794|Bisoprolol|bisoprolol|mesh-list
44437240|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44437241|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44437242|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437243|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437244|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44437245|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437246|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
44437247|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
44437248|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
44437249|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437250|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44437251|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44437252|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44268868|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44268869|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268870|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268871|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
44268872|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268873|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268874|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44268875|NCT00669344|Protective Agents|protective agents|mesh-ancestor
44268876|NCT00669370|Docetaxel|docetaxel|mesh-list
44268877|NCT00669370|Capecitabine|capecitabine|mesh-list
44268878|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268879|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268880|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268881|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268882|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268883|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44268884|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
44437253|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44437283|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437284|NCT01977456|Eptifibatide|eptifibatide|mesh-list
44437285|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44437286|NCT01977352|Bupivacaine|bupivacaine|mesh-list
44437287|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
44437288|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
44437289|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437290|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437291|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
44437292|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437293|NCT01976845|Midazolam|midazolam|mesh-list
44437294|NCT01976845|Propofol|propofol|mesh-list
44437295|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44437321|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44437322|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44437324|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
44437325|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44437326|NCT01976728|Hormones|hormones|mesh-ancestor
44437327|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437328|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437329|NCT01976624|Timolol|timolol|mesh-list
44437330|NCT01976624|Bimatoprost|bimatoprost|mesh-list
44437331|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44437332|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44437333|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
44437334|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437335|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437336|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437337|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44437338|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44437339|NCT01976507|Dabigatran|dabigatran|mesh-list
44437340|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
44437341|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44437342|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268886|NCT00669435|Amlodipine|amlodipine|mesh-list
44268887|NCT00669435|Simvastatin|simvastatin|mesh-list
44268888|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44268889|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44268890|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44268891|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268892|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44268893|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268894|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268895|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44268896|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44268897|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
44268898|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437375|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437376|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
44437377|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437378|NCT01975701|Infigratinib|infigratinib|mesh-list
44437379|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437380|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
44437381|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
44437382|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437383|NCT01975389|Bococizumab|bococizumab|mesh-list
44437384|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437393|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437394|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437395|NCT01975285|Dexamethasone|dexamethasone|mesh-list
44437396|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437397|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
44437398|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
44437399|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437400|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437401|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437402|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
44437403|NCT01975285|Hormones|hormones|mesh-ancestor
44437404|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437405|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44437406|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437408|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
44437409|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
44437410|NCT01975272|Trace Elements|trace elements|mesh-ancestor
44437411|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
44437412|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437413|NCT01975272|Hematinics|hematinics|mesh-ancestor
44437414|NCT01975246|Amlodipine|amlodipine|mesh-list
44437415|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44437416|NCT01975246|Telmisartan|telmisartan|mesh-list
44437417|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44437418|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44437419|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44437420|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437421|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437422|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44437423|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437424|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
44437425|NCT01975246|Diuretics|diuretics|mesh-ancestor
44437426|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
44437427|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44437428|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44268900|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268901|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44268902|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44268903|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44268904|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44268905|NCT00669487|Lamivudine|lamivudine|mesh-list
44268906|NCT00669487|Stavudine|stavudine|mesh-list
44268907|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44268908|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268909|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268910|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437429|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44437431|NCT01975220|Empagliflozin|empagliflozin|mesh-list
44437432|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437433|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437434|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44437435|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437436|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44437437|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
44437438|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437439|NCT01974752|Dacarbazine|dacarbazine|mesh-list
44437440|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437441|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
44437442|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437443|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437444|NCT01974323|Dapsone|dapsone|mesh-list
44437445|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437446|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
44437447|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44437448|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44437449|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44437450|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962661|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437470|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44437471|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437472|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437474|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437475|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44437476|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44437477|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
44437478|NCT01973387|Rituximab|rituximab|mesh-list
44437479|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437480|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437481|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
44437482|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437483|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437484|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44437485|NCT01973283|Citalopram|citalopram|mesh-list
44437486|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
44437487|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44437488|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44437489|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437490|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437491|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437492|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
44437493|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268911|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
44268912|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268913|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44268914|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44268915|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
44268916|NCT00669565|Bavituximab|bavituximab|mesh-list
44268917|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268918|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268919|NCT00669591|Bavituximab|bavituximab|mesh-list
44268920|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268921|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268922|NCT00669643|Rifampin|rifampin|mesh-list
44268923|NCT00669643|Dapsone|dapsone|mesh-list
44268924|NCT00669643|Clofazimine|clofazimine|mesh-list
44268925|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44268926|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
44268927|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268928|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268929|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
44268930|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268931|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268932|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660537|NCT02930954|Gemcitabine|gemcitabine|mesh-list
44437494|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44437495|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437496|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437497|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44437498|NCT01973283|Analgesics|analgesics|mesh-ancestor
44437499|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
44437500|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
44437501|NCT01973231|Liraglutide|liraglutide|mesh-list
44437502|NCT01973231|Lixisenatide|lixisenatide|mesh-list
44437503|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437504|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437505|NCT01973231|Incretins|incretins|mesh-ancestor
44437515|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
44437516|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437517|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437518|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437519|NCT01972841|Urological Agents|urological agents|mesh-ancestor
44437520|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44437521|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44437522|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44437523|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44437524|NCT01972789|Ranibizumab|ranibizumab|mesh-list
44437525|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44437526|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44437527|NCT01972789|Growth Substances|growth substances|mesh-ancestor
44437528|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437529|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44437530|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437531|NCT01972724|Metformin|metformin|mesh-list
44437532|NCT01972724|Pioglitazone|pioglitazone|mesh-list
44268933|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44268934|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44268935|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44268936|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44268937|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44268938|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44268940|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44268941|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44268942|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44268943|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268944|NCT00669656|Vitamin D|vitamin d|mesh-list
44268945|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
44268946|NCT00669656|Vitamins|vitamins|mesh-list
44268947|NCT00669656|Vitamin E|vitamin e|mesh-list
44268948|NCT00669656|Tocopherols|tocopherols|mesh-list
44268949|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
44268950|NCT00669656|Selenium|selenium|mesh-list
44268951|NCT00669656|Lycopene|lycopene|mesh-list
44268952|NCT00669656|Daidzein|daidzein|mesh-list
44268953|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
44437533|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437534|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437535|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
44437536|NCT01972659|Analgesics|analgesics|mesh-ancestor
44437537|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
44437538|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437539|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437540|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
44437541|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437542|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44437543|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
44437544|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44437545|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437546|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437547|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44437548|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
44437549|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44437550|NCT01972464|Progesterone|progesterone|mesh-list
44437551|NCT01972464|Progestins|progestins|mesh-ancestor
44437552|NCT01972464|Hormones|hormones|mesh-ancestor
44437553|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437554|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437555|NCT01972152|Glucagon|glucagon|mesh-list
44437556|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437557|NCT01972152|Hormones|hormones|mesh-ancestor
44437558|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437559|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437560|NCT01972074|Memantine|memantine|mesh-list
44437561|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44437562|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44437563|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
44437564|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437565|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437566|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437567|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268955|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44165900|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44268956|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44268957|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
44268958|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268959|NCT00669656|Protective Agents|protective agents|mesh-ancestor
44268960|NCT00669656|Trace Elements|trace elements|mesh-ancestor
44268961|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268962|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44268963|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44268964|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268965|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
44268966|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44268967|NCT00669656|Estrogens|estrogens|mesh-ancestor
44437568|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44437569|NCT01971645|Dexamethasone|dexamethasone|mesh-list
44437570|NCT01971645|Ropivacaine|ropivacaine|mesh-list
44437571|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437584|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437585|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
44437587|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44437588|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437589|NCT01971346|Analgesics|analgesics|mesh-ancestor
44437590|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
44437591|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437592|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437593|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437594|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437595|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437596|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44437597|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
44437598|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44437599|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44437600|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437601|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44437602|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44437603|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437604|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437605|NCT01970995|Menthol|menthol|mesh-list
44437606|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
44437607|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437608|NCT01970878|Bromides|bromides|mesh-list
44437609|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
44437610|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44437611|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
44437612|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437613|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437614|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44437615|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
44437616|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
44437617|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44437618|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
44437619|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437620|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437621|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
44437622|NCT01970540|Doxorubicin|doxorubicin|mesh-list
44437623|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44437624|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437625|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44437626|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44437627|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268968|NCT00669656|Hormones|hormones|mesh-ancestor
44268969|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268970|NCT00669695|Atorvastatin|atorvastatin|mesh-list
43923320|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
44268971|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44268973|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
44268974|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268975|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44268976|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44268977|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268978|NCT00669721|Heparin|heparin|mesh-list
44268979|NCT00669721|Calcium heparin|calcium heparin|mesh-list
44268980|NCT00669721|Nadroparin|nadroparin|mesh-list
44268981|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
44268982|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44268983|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165971|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
44268984|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268985|NCT00669747|Carboplatin|carboplatin|mesh-list
44268986|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268987|NCT00669773|Docetaxel|docetaxel|mesh-list
44268988|NCT00669773|Doxorubicin|doxorubicin|mesh-list
44268989|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44268990|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268991|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268992|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268993|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268994|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268995|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44268996|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268997|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268998|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268999|NCT00669786|Menotropins|menotropins|mesh-list
44269000|NCT00669786|Hormones|hormones|mesh-list
44269001|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44269004|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44269009|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
44269010|NCT00669812|Melphalan|melphalan|mesh-list
44269011|NCT00669812|Ifosfamide|ifosfamide|mesh-list
44269012|NCT00669812|Carmustine|carmustine|mesh-list
44269013|NCT00669812|Doxorubicin|doxorubicin|mesh-list
44269014|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44269015|NCT00669812|Methotrexate|methotrexate|mesh-list
44269016|NCT00669812|Etoposide|etoposide|mesh-list
44269017|NCT00669812|Vincristine|vincristine|mesh-list
44269018|NCT00669812|Epirubicin|epirubicin|mesh-list
44269019|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269020|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
44269021|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269022|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44269023|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44269024|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
44269025|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269026|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269027|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44269028|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44269029|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44437628|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437629|NCT01970527|Ipilimumab|ipilimumab|mesh-list
44437630|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437631|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437632|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44437633|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437657|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437658|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44437659|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437660|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437661|NCT01970462|Incretins|incretins|mesh-ancestor
44437662|NCT01970462|Hormones|hormones|mesh-ancestor
44437663|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437664|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44437665|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
44437666|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437667|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437668|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
44437669|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44437670|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
44437671|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437672|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
44437673|NCT01970397|Protective Agents|protective agents|mesh-ancestor
44437674|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44437675|NCT01970371|Meropenem|meropenem|mesh-list
44437676|NCT01970371|Colistin|colistin|mesh-list
44437677|NCT01970371|Tigecycline|tigecycline|mesh-list
44437678|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437679|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44437680|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437681|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437682|NCT01970241|Insulin|insulin|mesh-list
44437683|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44437684|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437698|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
44437699|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44269030|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269031|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269032|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44269033|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
44269034|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269035|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269036|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
44269037|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269038|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44269039|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44269040|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44269041|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
44269042|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269043|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44269044|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44269045|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44269046|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269047|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
44269048|NCT00669812|Hormones|hormones|mesh-ancestor
44269049|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437700|NCT01969721|Olodaterol|olodaterol|mesh-list
44437701|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437702|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44437703|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
44437704|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437705|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437706|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44437707|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44437708|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437709|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44437710|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
44437711|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44437712|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
44437713|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437714|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437715|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44437716|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44437717|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44437718|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44437719|NCT01969565|Dexamethasone|dexamethasone|mesh-list
44437720|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437721|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
44437722|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
44437723|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437724|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437725|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437726|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
44437727|NCT01969565|Hormones|hormones|mesh-ancestor
44437728|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437729|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44437730|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437731|NCT01969084|Linagliptin|linagliptin|mesh-list
44437732|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437733|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437734|NCT01969084|Incretins|incretins|mesh-ancestor
44269050|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44269051|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
44269052|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
44269054|NCT00669890|Methotrexate|methotrexate|mesh-list
44269055|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
44269056|NCT00669890|Tacrolimus|tacrolimus|mesh-list
44269057|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
44269058|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269059|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
44269060|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269061|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44269062|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44269063|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
44269064|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269065|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269066|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44269067|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44269068|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
44269069|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269070|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269071|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
44269072|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269073|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269074|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44269075|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44269076|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44269098|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44269099|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269100|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269101|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269102|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269103|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44269104|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44269105|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
44269106|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269107|NCT00670293|Raclopride|raclopride|mesh-list
44269108|NCT00670293|Methylphenidate|methylphenidate|mesh-list
44269109|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44269110|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269111|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44269112|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44437735|NCT01969084|Hormones|hormones|mesh-ancestor
44437736|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437737|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44437738|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44437739|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437740|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437741|NCT01969058|Isotretinoin|isotretinoin|mesh-list
44437742|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437743|NCT01968980|Bococizumab|bococizumab|mesh-list
44437744|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437745|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437746|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
43962662|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437776|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437778|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437779|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44437780|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44437781|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44437782|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437783|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437784|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44437785|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44437786|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
44437787|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
44437788|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437789|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44437790|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
44437791|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
44437826|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437827|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44437828|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44437862|NCT01967225|Linezolid|linezolid|mesh-list
44437863|NCT01967225|Tedizolid|tedizolid|mesh-list
44437864|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
44437865|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437866|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437867|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44437868|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962663|NCT01516268|Analgesics|analgesics|mesh-ancestor
44437904|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44437906|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269114|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269115|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
44269116|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269117|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44269118|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269119|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269120|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269121|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44269122|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44269123|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44269124|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
44269125|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269126|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269127|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44269128|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44269129|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44437907|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
44437908|NCT01965834|Fenofibrate|fenofibrate|mesh-list
44437909|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
44437943|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437944|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437945|NCT01965327|Interferons|interferons|mesh-list
44437946|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
44437947|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437948|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
44437949|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437950|NCT01964963|Alogliptin|alogliptin|mesh-list
44437951|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44437952|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437985|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437987|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096175|NCT00043004|Antidotes|antidotes|mesh-ancestor
44437988|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437989|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44437990|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44437991|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44437992|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437993|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438021|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44438022|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44438023|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438025|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44438026|NCT01964378|Narcotics|narcotics|mesh-ancestor
44438027|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438028|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438029|NCT01964378|Analgesics|analgesics|mesh-ancestor
44438030|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
44438031|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438032|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
44438033|NCT01964352|Olodaterol|olodaterol|mesh-list
44438034|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44438035|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
44438036|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269130|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
44269131|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44269132|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44269133|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269134|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
44269135|NCT00670345|Coagulants|coagulants|mesh-ancestor
44269136|NCT00670410|Fludarabine|fludarabine|mesh-list
44269137|NCT00670410|Busulfan|busulfan|mesh-list
44269138|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
44269139|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269140|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269141|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269142|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
44269143|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269144|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
44269145|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44269146|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44269147|NCT00670423|Sirolimus|sirolimus|mesh-list
44269148|NCT00670423|Bortezomib|bortezomib|mesh-list
44269149|NCT00670423|Tacrolimus|tacrolimus|mesh-list
44269150|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269151|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
44269152|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269153|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44269154|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269155|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269156|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269157|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269158|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438037|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438038|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438039|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438040|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
44438041|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44438042|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
44438043|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438062|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
44438063|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
44438064|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
44438065|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44438066|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438067|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
44438068|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44438069|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
44438070|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166309|NCT00263484|Hormones|hormones|mesh-ancestor
44438071|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438072|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44269159|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44269160|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
44269162|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44269163|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44269164|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269165|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44269166|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44269167|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44269168|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269169|NCT00670475|Piroxicam|piroxicam|mesh-list
44269170|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438073|NCT01962987|Diclofenac|diclofenac|mesh-list
44438074|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438075|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438076|NCT01962987|Analgesics|analgesics|mesh-ancestor
44438077|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
44438078|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438079|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438080|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438081|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438082|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44438083|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438084|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438085|NCT01962974|Golimumab|golimumab|mesh-list
44438086|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44438087|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438088|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438089|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
44438090|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438091|NCT01962948|Paclitaxel|paclitaxel|mesh-list
44438092|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44438093|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438094|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
44438095|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
44438096|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
44438097|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438098|NCT01962922|Tacrolimus|tacrolimus|mesh-list
44438099|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438174|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438175|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438209|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438211|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44438212|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44438213|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438214|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438245|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
44438246|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438247|NCT01959698|Rituximab|rituximab|mesh-list
44438248|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44438249|NCT01959698|Carboplatin|carboplatin|mesh-list
44438250|NCT01959698|Etoposide|etoposide|mesh-list
44438251|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
44438252|NCT01959698|Ifosfamide|ifosfamide|mesh-list
44438253|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
44438254|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
44438255|NCT01959698|Antibodies|antibodies|mesh-list
44438256|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
44438257|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44438258|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
44438259|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438260|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269172|NCT00670475|Analgesics|analgesics|mesh-ancestor
44269173|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
44269174|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269175|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269176|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269177|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44269178|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44269179|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269180|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269181|NCT00670501|Vitamin D|vitamin d|mesh-list
44269182|NCT00670501|Teriparatide|teriparatide|mesh-list
44269183|NCT00670501|Calcium|calcium|mesh-list
44269184|NCT00670501|Vitamins|vitamins|mesh-ancestor
44269185|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
44269186|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269187|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44269188|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44462721|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462722|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44462723|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
44462724|NCT01524991|Gemcitabine|gemcitabine|mesh-list
44438261|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438295|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438296|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438297|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44438298|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44438299|NCT01959672|Antidotes|antidotes|mesh-ancestor
44438300|NCT01959672|Protective Agents|protective agents|mesh-ancestor
44438301|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
44438302|NCT01959672|Vitamins|vitamins|mesh-ancestor
44438303|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
44438304|NCT01959672|Hematinics|hematinics|mesh-ancestor
44438305|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44438306|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44438307|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
44438308|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44438339|NCT01959334|Incretins|incretins|mesh-ancestor
44438340|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44438341|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44438342|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44438343|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44438344|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44438345|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44438346|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44438347|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44438348|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438349|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438350|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438351|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44438352|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44438382|NCT01959035|Aripiprazole|aripiprazole|mesh-list
44462726|NCT01524991|Ipilimumab|ipilimumab|mesh-list
44462727|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462728|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269189|NCT00670553|Panobinostat|panobinostat|mesh-list
44269190|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269191|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44269192|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269193|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269194|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44269195|NCT00670566|Irbesartan|irbesartan|mesh-list
44269196|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269197|NCT00670566|Diuretics|diuretics|mesh-ancestor
44269198|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
44269199|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269200|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44269201|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269202|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269203|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44269204|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44269205|NCT00670618|Fluorides|fluorides|mesh-list
44269206|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
44269207|NCT00670618|Protective Agents|protective agents|mesh-ancestor
44269208|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269209|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44269210|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
44269211|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269212|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44269213|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44269214|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
44269215|NCT00670670|Caseins|caseins|mesh-list
44269216|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43660699|NCT02929888|Aspirin|aspirin|mesh-list
44438383|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
44438384|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44438385|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44438386|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44438387|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438388|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438389|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
44438390|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
44438391|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269218|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269219|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269220|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269221|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
44269222|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
44269223|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
44269224|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269225|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269226|NCT00670696|Tetracaine|tetracaine|mesh-list
44269227|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
44269228|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
44438392|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438393|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44438394|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44438395|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
44438396|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44438397|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44438398|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44438399|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44438400|NCT01958918|Ranibizumab|ranibizumab|mesh-list
44438431|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438432|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44438433|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44438434|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438436|NCT01958476|Methadone|methadone|mesh-list
44438437|NCT01958476|Phenobarbital|phenobarbital|mesh-list
44438438|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44438439|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44438440|NCT01958476|Narcotics|narcotics|mesh-ancestor
44438441|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438442|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438443|NCT01958476|Analgesics|analgesics|mesh-ancestor
44438444|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
44438445|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438446|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
44438447|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438474|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
44438475|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438476|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438477|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438478|NCT01957215|Indomethacin|indomethacin|mesh-list
44438479|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438480|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438481|NCT01957215|Analgesics|analgesics|mesh-ancestor
44438482|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
44438483|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438484|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438485|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438486|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438487|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
44438488|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
44438489|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44438490|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44438492|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438493|NCT01957202|Levocabastine|levocabastine|mesh-list
44438494|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44438495|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44438522|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438523|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269229|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269230|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269231|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
44269232|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269233|NCT00670722|Insulin|insulin|mesh-list
44269234|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44269235|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
44269236|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
44269237|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44269238|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
44269239|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
44269240|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44269241|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269242|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269243|NCT00670761|Misoprostol|misoprostol|mesh-list
44269244|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44269245|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
44269246|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269247|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438524|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
44438525|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44438526|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44438527|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438528|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44438529|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44438530|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44438531|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438532|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438533|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
44438534|NCT01954251|Vaccines|vaccines|mesh-list
44438535|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
44438536|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438537|NCT01954121|Carbamazepine|carbamazepine|mesh-list
44438538|NCT01954121|Levetiracetam|levetiracetam|mesh-list
44438539|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
44438540|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
44438541|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
44438542|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44438543|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438544|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438570|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438571|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438572|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
44438573|NCT01953692|Lenalidomide|lenalidomide|mesh-list
44438574|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44438575|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438576|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
44438577|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438578|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438579|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438580|NCT01953692|Growth Substances|growth substances|mesh-ancestor
44438581|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438582|NCT01953328|Atorvastatin|atorvastatin|mesh-list
44438584|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44269248|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44269249|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269250|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
44269252|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44269253|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44269254|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269255|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44269256|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44269257|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269258|NCT00670787|Diuretics|diuretics|mesh-ancestor
44269259|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
44269260|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269261|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44269262|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269263|NCT00670813|Modafinil|modafinil|mesh-list
44438585|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44166565|NCT00264914|Satavaptan|satavaptan|mesh-list
44438586|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44438587|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
44438588|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438589|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44438590|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44438591|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438592|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
44438593|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438594|NCT01953003|Capecitabine|capecitabine|mesh-list
44438595|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438624|NCT01951417|Adapalene|adapalene|mesh-list
44438625|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44438626|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438627|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438628|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438629|NCT01951417|Analgesics|analgesics|mesh-ancestor
44438630|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
44438631|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438632|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438633|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438634|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438635|NCT01951378|Albuterol|albuterol|mesh-list
44438636|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44438637|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
44438638|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438639|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438640|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438641|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438642|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
44438643|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44438644|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44438672|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
44438673|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438674|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438675|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438676|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438677|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
44438678|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44438679|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438680|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269264|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44269265|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269266|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44269267|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44269268|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44269269|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269270|NCT00670878|Gemcitabine|gemcitabine|mesh-list
44269271|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269272|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
44269273|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269274|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269275|NCT00670878|Antiviral Agents|antiviral agents|mesh-ancestor
44269276|NCT00670878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269277|NCT00670878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438681|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44438682|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44438683|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
44438684|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438685|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44438686|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44438687|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
44438688|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
44438689|NCT01950819|Cyclosporine|cyclosporine|mesh-list
44438690|NCT01950819|Prednisone|prednisone|mesh-list
44438691|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
44438692|NCT01950819|Tacrolimus|tacrolimus|mesh-list
44438693|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
44438694|NCT01950819|Cyclosporins|cyclosporins|mesh-list
44438726|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44438727|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44438728|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44438729|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438730|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
44438731|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438732|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44438733|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
44438734|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44438735|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438736|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
44438737|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44438760|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44438761|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44438763|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44438764|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438765|NCT01949870|Gemcitabine|gemcitabine|mesh-list
44438766|NCT01949870|Cisplatin|cisplatin|mesh-list
44438767|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438768|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438769|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
44438770|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438771|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
44438772|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438773|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438774|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438775|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
44438776|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438777|NCT01949662|Lorazepam|lorazepam|mesh-list
44438778|NCT01949662|Haloperidol|haloperidol|mesh-list
44438779|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
44438780|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
44269278|NCT00670878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269279|NCT00670878|Immunologic Factors|immunologic factors|mesh-ancestor
44269280|NCT00670878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269281|NCT00671008|Insulin|insulin|mesh-list
44269282|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44269283|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
44269284|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
44269285|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
44269286|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44269287|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269288|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269289|NCT00671112|Everolimus|everolimus|mesh-list
44269290|NCT00671112|Bortezomib|bortezomib|mesh-list
44269291|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269292|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269293|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
44269294|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269295|NCT00671151|Theophylline|theophylline|mesh-list
44269296|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44269297|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
44269298|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269299|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269332|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269333|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269334|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269335|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44269336|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44269337|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269338|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269339|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44269340|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
44269341|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269342|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269343|NCT00671372|Bevacizumab|bevacizumab|mesh-list
44269344|NCT00671372|Cetuximab|cetuximab|mesh-list
44269345|NCT00671372|Irinotecan|irinotecan|mesh-list
44269346|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269347|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269348|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269349|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269350|NCT00671372|Growth Substances|growth substances|mesh-ancestor
44438781|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
44438782|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438783|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438784|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438785|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44438786|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44438787|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438788|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44438789|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44438826|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438827|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438858|NCT01948791|Protective Agents|protective agents|mesh-ancestor
44438859|NCT01947855|Empagliflozin|empagliflozin|mesh-list
44438860|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44438861|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438862|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44438863|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438864|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
44438865|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
44438866|NCT01946880|Chloroquine|chloroquine|mesh-list
44438867|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44438869|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438870|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
44438871|NCT01946880|Hormones|hormones|mesh-ancestor
44438872|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438873|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438910|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
44438911|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438912|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438913|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44438914|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44438915|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269351|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269353|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44269354|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269355|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269356|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269357|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
44269358|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44269359|NCT00671424|Furosemide|furosemide|mesh-list
44269360|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269361|NCT00671424|Diuretics|diuretics|mesh-ancestor
44269362|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
44269363|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269364|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44269365|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269366|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438938|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44438939|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44438940|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438941|NCT01946165|Prednisone|prednisone|mesh-list
44438942|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
44438943|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438944|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
44438945|NCT01946165|Hormones|hormones|mesh-ancestor
44438946|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438947|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438948|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44438949|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438950|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44438951|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438952|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438953|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
44438954|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44438955|NCT01946152|Dexamethasone|dexamethasone|mesh-list
44438956|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
44438957|NCT01946152|Pomalidomide|pomalidomide|mesh-list
44438958|NCT01946152|Ichthammol|ichthammol|mesh-list
44438959|NCT01946152|Lenograstim|lenograstim|mesh-list
44438960|NCT01946152|BB 1101|bb 1101|mesh-list
44438961|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438962|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
44438963|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
44438964|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438965|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438966|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438967|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
44438968|NCT01946152|Hormones|hormones|mesh-ancestor
44438969|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439001|NCT01945593|Coagulants|coagulants|mesh-ancestor
44439002|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
44439003|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44439004|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44439005|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44439006|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439007|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439008|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439009|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269367|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44269368|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44269369|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269371|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44269372|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44269373|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269374|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44269375|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269376|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269377|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269378|NCT00671541|Gentamicins|gentamicins|mesh-list
44269379|NCT00671541|Bacitracin|bacitracin|mesh-list
44269380|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269381|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269382|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44269383|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269384|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269385|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44269386|NCT00671593|Phenol|phenol|mesh-list
44269387|NCT00671593|Glycerol|glycerol|mesh-list
44269388|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44269389|NCT00671593|Protective Agents|protective agents|mesh-ancestor
44269390|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269391|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44269392|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269393|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
44269394|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44269395|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44269396|NCT00671632|Triazolam|triazolam|mesh-list
44269397|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43660760|NCT02929212|Acetaminophen|acetaminophen|mesh-list
44439010|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439011|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44439012|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439013|NCT01945281|Amphotericin B|amphotericin b|mesh-list
44439083|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44439084|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44439085|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439086|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439088|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
44439089|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269399|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269400|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269401|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269402|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269403|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
44269405|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269406|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269407|NCT00671645|Bevacizumab|bevacizumab|mesh-list
44269408|NCT00671645|Capecitabine|capecitabine|mesh-list
44269409|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269410|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269411|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44462729|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
44439105|NCT01943435|Ibuprofen|ibuprofen|mesh-list
44439106|NCT01943435|Celecoxib|celecoxib|mesh-list
44439107|NCT01943435|Diclofenac|diclofenac|mesh-list
44439108|NCT01943435|Gabapentin|gabapentin|mesh-list
44439109|NCT01943435|Tramadol|tramadol|mesh-list
44439110|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44439111|NCT01943435|Analgesics|analgesics|mesh-list
44439112|NCT01943435|Mirtazapine|mirtazapine|mesh-list
44439113|NCT01943435|Trazodone|trazodone|mesh-list
44439114|NCT01943435|Sertraline|sertraline|mesh-list
44439115|NCT01943435|Nortriptyline|nortriptyline|mesh-list
44439116|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
44439117|NCT01943435|Misoprostol|misoprostol|mesh-list
44439118|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439119|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
44439120|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439121|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439122|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
44439123|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44439124|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44439125|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439126|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44439127|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439128|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439129|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44439130|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44439131|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
44439132|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44439133|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44439134|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439135|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
44439136|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
44439137|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44439138|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439139|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439140|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439141|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44439142|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44439143|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439144|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
44439145|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44439146|NCT01943435|Narcotics|narcotics|mesh-ancestor
44439147|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44439148|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439149|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439150|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
44269413|NCT00671645|Growth Substances|growth substances|mesh-ancestor
44269414|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269415|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
44269416|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269417|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
44269418|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269419|NCT00671697|Decitabine|decitabine|mesh-list
44269420|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
44269421|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269422|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
44269423|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269424|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269425|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269426|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44269427|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44269428|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269429|NCT00671801|Irinotecan|irinotecan|mesh-list
44269430|NCT00671801|Lenalidomide|lenalidomide|mesh-list
44269431|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44269432|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269433|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439160|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44439162|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44439163|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44439164|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44439165|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44439166|NCT01942993|Vemurafenib|vemurafenib|mesh-list
44439167|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439168|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44439169|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439170|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439171|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
44439172|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
44439173|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439174|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439175|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439176|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439177|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
44439178|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
44439179|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
44439180|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439181|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439182|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439183|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439184|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
44439185|NCT01942590|Clenbuterol|clenbuterol|mesh-list
44439186|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44439187|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44439188|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
44439189|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439190|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439191|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439192|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44269435|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269436|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
44269437|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269438|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269439|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269440|NCT00671801|Growth Substances|growth substances|mesh-ancestor
44269441|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
44269442|NCT00671814|Linezolid|linezolid|mesh-list
44269443|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269444|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269445|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44269446|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660799|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
44439193|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
44439194|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439195|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44439196|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
44439197|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
44439198|NCT01942161|Aripiprazole|aripiprazole|mesh-list
44439199|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
44439200|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439201|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44439202|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439203|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439204|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439205|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439206|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
44439207|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166971|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439208|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439209|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44439210|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44439211|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
44439212|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44439213|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44439214|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44439243|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
44439244|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44439245|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439246|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44439247|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
44439248|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439249|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439250|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44439251|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439252|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44439253|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439254|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
44439255|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439256|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44439257|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
44439258|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44439259|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44439260|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439261|NCT01941095|Amebicides|amebicides|mesh-ancestor
44439262|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44439289|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44439290|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269447|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269449|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269450|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269451|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44269452|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44269453|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
44269454|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269455|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44269456|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269457|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269458|NCT00672113|Nifedipine|nifedipine|mesh-list
44269459|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44269460|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269461|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269462|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660810|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439291|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44439292|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
44439293|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44439294|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439295|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44439296|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44439297|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44439298|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439299|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44439300|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
44439301|NCT01940484|Hematinics|hematinics|mesh-ancestor
44439302|NCT01939977|Calcifediol|calcifediol|mesh-list
44439303|NCT01939977|Vitamins|vitamins|mesh-ancestor
44439304|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
44439305|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439306|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44439307|NCT01939899|Ixazomib|ixazomib|mesh-list
44439308|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439309|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439310|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439311|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439312|NCT01939496|Canagliflozin|canagliflozin|mesh-list
44439313|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43962664|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
44439349|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44439350|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44439380|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439381|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44439382|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44439383|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44439384|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439385|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44439386|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44439387|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439388|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44439389|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44439390|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841621|NCT04602221|BI 409306|bi 409306|mesh-list
44269463|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269464|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
44269465|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
44269466|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269467|NCT00672165|Antibodies|antibodies|mesh-list
44269468|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44269469|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
44269470|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269471|NCT00672282|Bicalutamide|bicalutamide|mesh-list
44269472|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
44269473|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44269474|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269475|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269476|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269477|NCT00672295|Paclitaxel|paclitaxel|mesh-list
44269478|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44269479|NCT00672295|Carboplatin|carboplatin|mesh-list
44269480|NCT00672295|Dasatinib|dasatinib|mesh-list
44269481|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44269482|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269483|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
44269484|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
44269485|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
44269486|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269487|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44269488|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269489|NCT00672347|Clonidine|clonidine|mesh-list
44269490|NCT00672347|Morphine|morphine|mesh-list
44269491|NCT00672347|Bupivacaine|bupivacaine|mesh-list
44269492|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44269493|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
44269494|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269495|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269496|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
44269497|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269505|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44269506|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44269507|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44269508|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269509|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269511|NCT00672360|Hematinics|hematinics|mesh-ancestor
44269512|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
44269513|NCT00672360|Vitamins|vitamins|mesh-ancestor
44269514|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
44269515|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269516|NCT00672399|Exenatide|exenatide|mesh-list
44269517|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
44269518|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439391|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439392|NCT01938716|Gemcitabine|gemcitabine|mesh-list
44439393|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44439394|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
44439395|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439432|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
44439433|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439434|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439435|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44439436|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
44439437|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
44439471|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439473|NCT01937559|Coagulants|coagulants|mesh-ancestor
44439474|NCT01937390|Bromides|bromides|mesh-list
44439475|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
44439511|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44439512|NCT01937299|Travoprost|travoprost|mesh-list
44439513|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44439548|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44439549|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439550|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439551|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439552|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439623|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439624|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439625|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44439626|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439627|NCT01934556|Ranibizumab|ranibizumab|mesh-list
44439628|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439629|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439630|NCT01934556|Growth Substances|growth substances|mesh-ancestor
44439631|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439632|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439660|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439662|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439663|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
44439664|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44439665|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44439666|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44439667|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44439668|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44439669|NCT01933880|Methylphenidate|methylphenidate|mesh-list
44439670|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44439671|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269519|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269520|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44269521|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269522|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269523|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269524|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269525|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269526|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269527|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44269528|NCT00672399|Incretins|incretins|mesh-ancestor
44269529|NCT00672399|Hormones|hormones|mesh-ancestor
44269530|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269531|NCT00672464|Metformin|metformin|mesh-list
44269532|NCT00672464|Olanzapine|olanzapine|mesh-list
44269533|NCT00672464|Simvastatin|simvastatin|mesh-list
44269534|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660856|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
44439672|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44439673|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439674|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439675|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439676|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
44439703|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439704|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44439705|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439706|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439707|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439709|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439710|NCT01933048|Vaccines|vaccines|mesh-list
44439711|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
44439712|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439713|NCT01932996|Nicotine|nicotine|mesh-list
44439714|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44439715|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
44439716|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439717|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439718|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44439719|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44439720|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439721|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439722|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439746|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44439747|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439748|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439749|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439750|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439751|NCT01931839|Ivacaftor|ivacaftor|mesh-list
44439752|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44439753|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439754|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439755|NCT01931566|Pioglitazone|pioglitazone|mesh-list
44439756|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439757|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439758|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44439759|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43841622|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
44269535|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269536|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44269537|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44269538|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
44269539|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269540|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44269541|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44269542|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269543|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
44269544|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
44269545|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269546|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269547|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44269548|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269549|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269550|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269551|NCT00672464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44269552|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44269553|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439760|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439761|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439762|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439763|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439764|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439766|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
44439767|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439768|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
44439769|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439770|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
44439771|NCT01931202|Citalopram|citalopram|mesh-list
44439772|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44439773|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44439800|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439801|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439802|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44439803|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
44439804|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
44439805|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44439806|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439807|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44439808|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
44439809|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439810|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439811|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439812|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439813|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44439814|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439815|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439816|NCT01930188|Incretins|incretins|mesh-ancestor
44439817|NCT01930188|Hormones|hormones|mesh-ancestor
43795811|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44269554|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269555|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
44462730|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462731|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
44462732|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462733|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923932|NCT05247151|Oxytocin|oxytocin|mesh-list
44462734|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462735|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
44269556|NCT00672568|Capsaicin|capsaicin|mesh-list
44269557|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
44269558|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269559|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
44269560|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269561|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269562|NCT00672659|Dexetimide|dexetimide|mesh-list
44269563|NCT00672659|Pipamperone|pipamperone|mesh-list
44439818|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439819|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44439820|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439856|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439857|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
44439858|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439888|NCT01929044|Scopolamine|scopolamine|mesh-list
44439889|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44439890|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44439891|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
44439892|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
44439893|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439894|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439895|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439896|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
44439897|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44439898|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439899|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439900|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439901|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44439902|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
44439932|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44439933|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44439934|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44439935|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
44439936|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439937|NCT01928940|Trametinib|trametinib|mesh-list
44439938|NCT01928940|Dabrafenib|dabrafenib|mesh-list
44439939|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439940|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44439941|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439942|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439943|NCT01928927|Telmisartan|telmisartan|mesh-list
44439944|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44439945|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44439946|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44439947|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439974|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439975|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
44439976|NCT01928433|Finafloxacin|finafloxacin|mesh-list
44439977|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
44439978|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269565|NCT00672659|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44269566|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44269567|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269568|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269569|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269570|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
44269571|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269572|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44269573|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
44269574|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269575|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44269576|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44269577|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
44269578|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
44269579|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269580|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44269581|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44269582|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44269583|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44269584|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44269585|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269586|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269587|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
44269588|NCT00672763|Vitamin D|vitamin d|mesh-list
44269589|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
44269590|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
44269591|NCT00672763|Vitamins|vitamins|mesh-list
44269592|NCT00672763|Calcium|calcium|mesh-list
44439979|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439980|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44439981|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44439982|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439983|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439984|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439985|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44439986|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44439987|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44439988|NCT01928433|Renal Agents|renal agents|mesh-ancestor
44439989|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44439991|NCT01928394|Ipilimumab|ipilimumab|mesh-list
44439992|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44439993|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439994|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44440018|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
44269593|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
44269594|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269595|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44269596|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44269597|NCT00672776|Paroxetine|paroxetine|mesh-list
44269598|NCT00672776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44269599|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44269600|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269601|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269602|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269603|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
44269604|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269605|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44269606|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
44269607|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269608|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44269609|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44269610|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269611|NCT00672867|Adefovir|adefovir|mesh-list
44269612|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44269613|NCT00672867|Clevudine|clevudine|mesh-list
44269614|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
44269615|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269616|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44269617|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44269618|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269619|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269620|NCT00672919|Pioglitazone|pioglitazone|mesh-list
44269621|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269622|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269623|NCT00672971|Permethrin|permethrin|mesh-list
44440019|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440020|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44440021|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44440022|NCT01928082|Estradiol|estradiol|mesh-list
44440023|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44440024|NCT01928082|Estrogens|estrogens|mesh-ancestor
44440025|NCT01928082|Hormones|hormones|mesh-ancestor
44440026|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440027|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440028|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44269625|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269626|NCT00673088|Ropinirole|ropinirole|mesh-list
44269627|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44269628|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44269629|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
44269630|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
44269631|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269632|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269633|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269634|NCT00673205|Bicalutamide|bicalutamide|mesh-list
44269635|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
44269636|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
44269637|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269638|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269639|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269640|NCT00673218|Omalizumab|omalizumab|mesh-list
44269641|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44269642|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269643|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269644|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
44269645|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44269646|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44440029|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
44440030|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44440031|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44440032|NCT01927757|Etanercept|etanercept|mesh-list
44440033|NCT01927757|Methotrexate|methotrexate|mesh-list
44440034|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44440035|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
44440036|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44440037|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440038|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44440039|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
44440040|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440041|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440042|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440043|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440074|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44440075|NCT01927055|Diuretics|diuretics|mesh-ancestor
44440076|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
44440077|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440078|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44440079|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44440080|NCT01926886|Trastuzumab|trastuzumab|mesh-list
44440081|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440082|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440083|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44440084|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
44440085|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269648|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
44269649|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269650|NCT00673296|Bevacizumab|bevacizumab|mesh-list
44269651|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269652|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269653|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269654|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269655|NCT00673296|Growth Substances|growth substances|mesh-ancestor
44269656|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269657|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44269658|NCT00673426|Enoxaparin|enoxaparin|mesh-list
44269659|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
44269660|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44269661|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44269662|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269663|NCT00673504|Gemcitabine|gemcitabine|mesh-list
44440086|NCT01926626|Moclobemide|moclobemide|mesh-list
44440119|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44440120|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44440121|NCT01925768|Analgesics|analgesics|mesh-ancestor
44440122|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
44440123|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440124|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440125|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440126|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44440127|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44440128|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44440157|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440158|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44440159|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44440160|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44440161|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44440162|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44440163|NCT01925274|Irinotecan|irinotecan|mesh-list
44440164|NCT01925274|Cetuximab|cetuximab|mesh-list
44440165|NCT01925274|Gedatolisib|gedatolisib|mesh-list
44440166|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44440167|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44440168|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440169|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440170|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440171|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440172|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44440173|NCT01925183|Interferons|interferons|mesh-list
44440174|NCT01925183|Ribavirin|ribavirin|mesh-list
44440175|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
44440176|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
44440177|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44440178|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440212|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440239|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44440240|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44440241|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440242|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440243|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440244|NCT01923363|Tazobactam|tazobactam|mesh-list
44269664|NCT00673504|Sunitinib|sunitinib|mesh-list
44269665|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269666|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
44269667|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269668|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269669|NCT00673504|Antiviral Agents|antiviral agents|mesh-ancestor
44269670|NCT00673504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269671|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269672|NCT00673504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269673|NCT00673504|Immunologic Factors|immunologic factors|mesh-ancestor
44269674|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269675|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269676|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269677|NCT00673504|Growth Substances|growth substances|mesh-ancestor
44269678|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44269679|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44269680|NCT00673556|Alefacept|alefacept|mesh-list
44269681|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269682|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
44269683|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269684|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44269685|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269686|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44269687|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269688|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269689|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44269690|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44269691|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44269692|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
44269693|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269694|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44269695|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44269696|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269697|NCT00673608|Deferasirox|deferasirox|mesh-list
44269698|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44440245|NCT01923363|Piperacillin|piperacillin|mesh-list
44440246|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44440247|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44440248|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269700|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
44269701|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269702|NCT00673621|Albuterol|albuterol|mesh-list
44269703|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
44269704|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269705|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44269706|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
44269707|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269708|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269709|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269710|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
44269711|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269712|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44269713|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44269714|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44269715|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
44269716|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440249|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44440250|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440251|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440252|NCT01923311|Elvitegravir|elvitegravir|mesh-list
44440253|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44440254|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44440255|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
44440256|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440257|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44440258|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440259|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440288|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
44440289|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440290|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440291|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440292|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440293|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
44440294|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44440295|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440296|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440297|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440298|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
44440299|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44440300|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44440301|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44440302|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44440303|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440304|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44440305|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44440306|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
44440340|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
44440341|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
44440343|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
44440344|NCT01921387|Carmustine|carmustine|mesh-list
44440345|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44440346|NCT01921387|Antibodies|antibodies|mesh-list
44440347|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44440348|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
44440349|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269717|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269719|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44269720|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44269721|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44269722|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44269723|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
44269724|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44269725|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269726|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269727|NCT00673829|Interleukin-2|interleukin-2|mesh-list
44269728|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269729|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44269730|NCT00673829|Analgesics|analgesics|mesh-ancestor
44269731|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
44269732|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269733|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269734|NCT00674011|Bevacizumab|bevacizumab|mesh-list
44440378|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440380|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
44440381|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44440382|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44440383|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440384|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440385|NCT01921140|Olaparib|olaparib|mesh-list
44440386|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44440387|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440388|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440389|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440390|NCT01920932|Prednisone|prednisone|mesh-list
44440391|NCT01920932|Prednisolone|prednisolone|mesh-list
44440425|NCT01920711|Valsartan|valsartan|mesh-list
44440426|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44440427|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44098504|NCT00049439|Lomustine|lomustine|mesh-list
44440428|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44440429|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44440430|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440431|NCT01920568|Vitamin D|vitamin d|mesh-list
44440463|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440465|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44440466|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
44440467|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440468|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
44440469|NCT01920152|Protective Agents|protective agents|mesh-ancestor
44440470|NCT01920061|Cisplatin|cisplatin|mesh-list
44440471|NCT01920061|Docetaxel|docetaxel|mesh-list
44440472|NCT01920061|Gedatolisib|gedatolisib|mesh-list
44440473|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440474|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
44440475|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
44440476|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
44440477|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440507|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440508|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269736|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269737|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269738|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269739|NCT00674011|Growth Substances|growth substances|mesh-ancestor
44269740|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269741|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
44269742|NCT00674050|Fluticasone|fluticasone|mesh-list
44269743|NCT00674050|Albuterol|albuterol|mesh-list
44269744|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167749|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269745|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269746|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44269747|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
44269748|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269749|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269750|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269751|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440509|NCT01919489|Incretins|incretins|mesh-ancestor
44440510|NCT01919489|Hormones|hormones|mesh-ancestor
44440511|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440512|NCT01919411|Amoxicillin|amoxicillin|mesh-list
44440513|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
44440514|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
44440515|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44440516|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44440517|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440518|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44440519|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440551|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44440552|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
44440553|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440554|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44440555|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44440556|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440557|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44440558|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44440559|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44440560|NCT01918306|Cisplatin|cisplatin|mesh-list
44440591|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44440592|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440593|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440594|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440595|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440596|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44440597|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44440598|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
44440599|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
44440600|NCT01916967|Desloratadine|desloratadine|mesh-list
44440601|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44440602|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440635|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44440636|NCT01916824|Analgesics|analgesics|mesh-ancestor
44440637|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
44440638|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44440639|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
44269754|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44269755|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44269756|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44269757|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44269758|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
44269759|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269760|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269761|NCT00674063|Alefacept|alefacept|mesh-list
44269762|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269763|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
44440640|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
44440641|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44440642|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440643|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440664|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44440665|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
44440666|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440667|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
44440668|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440669|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440670|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440671|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
44440672|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440673|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440675|NCT01915940|Bimatoprost|bimatoprost|mesh-list
44440676|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44440677|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44440678|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44440679|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440680|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440681|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440682|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440683|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440684|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44440685|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44440686|NCT01915914|Fluticasone|fluticasone|mesh-list
44440687|NCT01915914|Xhance|xhance|mesh-list
44440688|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440689|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44440690|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
44440691|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440692|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440693|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440694|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440695|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440696|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44440697|NCT01915849|Licogliflozin|licogliflozin|mesh-list
44440729|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44440730|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44440731|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440732|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440733|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440734|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440735|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44440736|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440737|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44440738|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
44269764|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269765|NCT00674089|Vitamin A|vitamin a|mesh-list
44269766|NCT00674089|Vitamins|vitamins|mesh-ancestor
44269767|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
44269768|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269769|NCT00674102|Vadimezan|vadimezan|mesh-list
44269770|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269771|NCT00674141|Dexamethasone|dexamethasone|mesh-list
44269772|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269773|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
44269774|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
44269775|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167866|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269776|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269777|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269778|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
44269779|NCT00674141|Hormones|hormones|mesh-ancestor
44269780|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269781|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44269782|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269783|NCT00674167|Cisplatin|cisplatin|mesh-list
44269784|NCT00674167|Docetaxel|docetaxel|mesh-list
44269785|NCT00674167|Capecitabine|capecitabine|mesh-list
44269786|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269787|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44269788|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44269789|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44269790|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269791|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269792|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
44269813|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269814|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269816|NCT00674414|Everolimus|everolimus|mesh-list
44269817|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44269818|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269819|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44269820|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
44269821|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269822|NCT00674557|Exemestane|exemestane|mesh-list
44269823|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44269824|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269825|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44269826|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44269827|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269828|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269829|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44269830|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44440772|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
44440773|NCT01913639|Leucovorin|leucovorin|mesh-list
44440774|NCT01913639|Fluorouracil|fluorouracil|mesh-list
44440775|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
44440776|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
44440815|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440816|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440843|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
44440844|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440845|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440846|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440847|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440848|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
44440850|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440851|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44440852|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44440853|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44440854|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440855|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440856|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440857|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44440858|NCT01912807|Ondansetron|ondansetron|mesh-list
44440859|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
44440860|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
44440861|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440862|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440863|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44440891|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44440892|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44440893|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
44440894|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440895|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44440896|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440897|NCT01912222|Ixazomib|ixazomib|mesh-list
44440898|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440899|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
44440900|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440901|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269831|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269832|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269833|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
44269834|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
44269835|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44269836|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44269837|NCT00674557|Growth Substances|growth substances|mesh-ancestor
44269838|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462736|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462737|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44462738|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44462739|NCT01524978|Cetuximab|cetuximab|mesh-list
44462740|NCT01524978|Vemurafenib|vemurafenib|mesh-list
44462741|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44462742|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462743|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462744|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440902|NCT01911845|Ribavirin|ribavirin|mesh-list
44440903|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
44440904|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440905|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
44440906|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440907|NCT01911780|Amlodipine|amlodipine|mesh-list
44440908|NCT01911780|Telmisartan|telmisartan|mesh-list
44440909|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44440941|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440942|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440943|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44440944|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440945|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
44440946|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44440947|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44440948|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
44440983|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440984|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440985|NCT01910402|Ritonavir|ritonavir|mesh-list
44440986|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44440987|NCT01910402|Tenofovir|tenofovir|mesh-list
44440988|NCT01910402|Lamivudine|lamivudine|mesh-list
44441015|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441016|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44441017|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441018|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441019|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44441020|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44441021|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441022|NCT01909804|Ribavirin|ribavirin|mesh-list
44441023|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
44441024|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441025|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
44441026|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441027|NCT01909791|Aflibercept|aflibercept|mesh-list
44441028|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44441029|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44441030|NCT01909791|Growth Substances|growth substances|mesh-ancestor
44441031|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441032|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
44167925|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44462745|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462746|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
44462747|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44462748|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
44462749|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462750|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
44462751|NCT01524913|Protective Agents|protective agents|mesh-ancestor
44462752|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
44462753|NCT01524887|Antibodies|antibodies|mesh-list
44462754|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
44269839|NCT00674596|Ramipril|ramipril|mesh-list
44269840|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44269841|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
44269842|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269843|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269844|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269845|NCT00674674|Topotecan|topotecan|mesh-list
44269846|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44269847|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269848|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269849|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269850|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269851|NCT00674687|Gabapentin|gabapentin|mesh-list
44269852|NCT00674687|Analgesics|analgesics|mesh-ancestor
44269853|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
44269854|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269855|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167995|NCT00270010|Hematinics|hematinics|mesh-ancestor
44167997|NCT00270023|Hematinics|hematinics|mesh-ancestor
44167998|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
44167999|NCT00270036|Hematinics|hematinics|mesh-ancestor
44168000|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
44168001|NCT00270049|Hematinics|hematinics|mesh-ancestor
44168002|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
44168003|NCT00270062|Hematinics|hematinics|mesh-ancestor
44168004|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
44168005|NCT00270075|Hematinics|hematinics|mesh-ancestor
44168006|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
44168007|NCT00270088|Hematinics|hematinics|mesh-ancestor
44168008|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
44168009|NCT00270101|Hematinics|hematinics|mesh-ancestor
44168010|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
44168011|NCT00270114|Hematinics|hematinics|mesh-ancestor
44168012|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
44168013|NCT00270127|Hematinics|hematinics|mesh-ancestor
44168014|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
44168015|NCT00270140|Hematinics|hematinics|mesh-ancestor
44168016|NCT00270153|Enalapril|enalapril|mesh-list
44168017|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44168018|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
44168019|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269856|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
43660980|NCT02927379|Analgesics|analgesics|mesh-ancestor
44441033|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441034|NCT01909466|Aripiprazole|aripiprazole|mesh-list
44441035|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
44441036|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441069|NCT01908816|Growth Substances|growth substances|mesh-ancestor
44441070|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441071|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
44441072|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441073|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
44441074|NCT01908803|Dexamethasone|dexamethasone|mesh-list
44441075|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441076|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
44441077|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
44441105|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441106|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441107|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44441108|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44441109|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44269858|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269859|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269860|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269861|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44269862|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44269863|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269864|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269865|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
44269866|NCT00674713|Ondansetron|ondansetron|mesh-list
44269867|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44269868|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
44269869|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
44441110|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44441111|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44441112|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44441113|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44441114|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44441115|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
44441116|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44441117|NCT01908205|Oxytocin|oxytocin|mesh-list
44441118|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
44441119|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44441120|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441121|NCT01908140|Fluticasone|fluticasone|mesh-list
44441122|NCT01908140|Bromides|bromides|mesh-list
44441148|NCT01907854|Liraglutide|liraglutide|mesh-list
44441149|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44441150|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441151|NCT01907854|Incretins|incretins|mesh-ancestor
44441152|NCT01907854|Hormones|hormones|mesh-ancestor
44441153|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441154|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44441155|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441156|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441157|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441158|NCT01907815|Trametinib|trametinib|mesh-list
44441159|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441160|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44441161|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441162|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441163|NCT01907217|Methohexital|methohexital|mesh-list
44441164|NCT01907217|Succinylcholine|succinylcholine|mesh-list
44441165|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44441166|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44441167|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44441168|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441169|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441196|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
44441197|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441198|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44441199|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44441200|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44441201|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441202|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441204|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441205|NCT01906008|Minocycline|minocycline|mesh-list
44441206|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44441207|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441208|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
44269870|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269871|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269872|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44269874|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
44269875|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44269876|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
44269877|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269878|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269879|NCT00674713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44269880|NCT00674713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269881|NCT00674713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269882|NCT00674713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44269883|NCT00674713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44269884|NCT00674752|Gabapentin|gabapentin|mesh-list
44269885|NCT00674752|Analgesics|analgesics|mesh-ancestor
44269886|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
44269887|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269888|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269889|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
44269890|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44269891|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44269892|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441209|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44441210|NCT01905943|Chlorambucil|chlorambucil|mesh-list
44441211|NCT01905943|Fludarabine|fludarabine|mesh-list
44441212|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
44441213|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441214|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
44441215|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441216|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168084|NCT00270491|Paclitaxel|paclitaxel|mesh-list
44441244|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44441245|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441246|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441247|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441249|NCT01904903|Pertuzumab|pertuzumab|mesh-list
44441250|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44441251|NCT01904903|Maytansine|maytansine|mesh-list
44441252|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44441253|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441254|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44441255|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
44441256|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441257|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
44441258|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099475|NCT00052403|Antibodies|antibodies|mesh-list
44441259|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
44441291|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441292|NCT01904032|Vitamin D|vitamin d|mesh-list
44441293|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
44441294|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
44441295|NCT01904032|Vitamins|vitamins|mesh-list
44269894|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44269895|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44269896|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269897|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269898|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
44269899|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44269900|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44269901|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269902|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44269903|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44269904|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269905|NCT00674921|Renal Agents|renal agents|mesh-ancestor
44269906|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269907|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
44269908|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44269909|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44269910|NCT00674999|Bacitracin|bacitracin|mesh-list
44269911|NCT00674999|Nystatin|nystatin|mesh-list
44269912|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44269913|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44269914|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44269915|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
44269916|NCT00674999|Ionophores|ionophores|mesh-ancestor
44269917|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44269918|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269919|NCT00675012|Capecitabine|capecitabine|mesh-list
44269920|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
44269921|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269922|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
44269923|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269924|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269925|NCT00675181|Melatonin|melatonin|mesh-list
44441296|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
44441297|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441298|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44441299|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44441300|NCT01903993|Docetaxel|docetaxel|mesh-list
44441301|NCT01903993|Atezolizumab|atezolizumab|mesh-list
44441327|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
44269926|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
44269927|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269928|NCT00675181|Protective Agents|protective agents|mesh-ancestor
44269929|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269930|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44269931|NCT00675194|Cisplatin|cisplatin|mesh-list
44269932|NCT00675194|Capecitabine|capecitabine|mesh-list
44269933|NCT00675194|Irinotecan|irinotecan|mesh-list
44269934|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269935|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44269936|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
44269937|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269938|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44269939|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44269940|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269941|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44269942|NCT00675207|Dorzolamide|dorzolamide|mesh-list
44269943|NCT00675207|Brinzolamide|brinzolamide|mesh-list
44269944|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44269945|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44269946|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44269947|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44269948|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
44269949|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44269950|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269951|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269952|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44269953|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269954|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
44269955|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269956|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269957|NCT00675246|Betamethasone|betamethasone|mesh-list
44269958|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
44269959|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269960|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
44269961|NCT00675246|Hormones|hormones|mesh-ancestor
43661018|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269962|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168201|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
44269963|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269964|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269965|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269966|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44269967|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
44269968|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44269969|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
44269970|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44269971|NCT00675285|Montelukast|montelukast|mesh-list
44269972|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44269973|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
44269974|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44269975|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
44269976|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44269977|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269978|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44269979|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44269980|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269981|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
44269982|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44441329|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
44441330|NCT01903811|Ichthammol|ichthammol|mesh-list
44441331|NCT01903811|BB 1101|bb 1101|mesh-list
44441332|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441333|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
44441334|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
44441335|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441336|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441337|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441338|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
44441339|NCT01903811|Hormones|hormones|mesh-ancestor
44441340|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441341|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441342|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441343|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441344|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441345|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441346|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44441347|NCT01903720|Dexamethasone|dexamethasone|mesh-list
44441348|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441349|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
44441350|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
44441351|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441385|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44441386|NCT01903031|Tenofovir|tenofovir|mesh-list
44441387|NCT01903031|Efavirenz|efavirenz|mesh-list
44441388|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44441389|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44441390|NCT01903031|Etonogestrel|etonogestrel|mesh-list
44441391|NCT01903031|NuvaRing|nuvaring|mesh-list
44441392|NCT01903031|Estradiol|estradiol|mesh-list
44269984|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44269985|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44269986|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44269987|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
44269988|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
44269989|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44269990|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44269991|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44269992|NCT00675545|Carboplatin|carboplatin|mesh-list
44269993|NCT00675545|Docetaxel|docetaxel|mesh-list
44269994|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44269995|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
44269996|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441393|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44441417|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44441418|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44441420|NCT01902966|Propranolol|propranolol|mesh-list
44441421|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44441422|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44441423|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
44441424|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441425|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441426|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441427|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44441428|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44441429|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
44441430|NCT01902290|Brodalumab|brodalumab|mesh-list
44441431|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
44441432|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44441433|NCT01902134|Tramadol|tramadol|mesh-list
44441434|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44441435|NCT01902134|Narcotics|narcotics|mesh-ancestor
44441436|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441437|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441438|NCT01902134|Analgesics|analgesics|mesh-ancestor
44441439|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
44441469|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
44441470|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
44441471|NCT01901393|Ibuprofen|ibuprofen|mesh-list
44441472|NCT01901393|Ketorolac|ketorolac|mesh-list
44441473|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44441474|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441475|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441476|NCT01901393|Analgesics|analgesics|mesh-ancestor
44441477|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
44441478|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441479|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441480|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441481|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441482|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44441511|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441512|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441514|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441515|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441516|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
44441517|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44441518|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441519|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441520|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44269997|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
44269998|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270000|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44270001|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270002|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270003|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
44270004|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270005|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44270006|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
44270007|NCT00675688|Estrogens|estrogens|mesh-list
44270008|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44270009|NCT00675688|Hormones|hormones|mesh-ancestor
44270010|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270011|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270012|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44270013|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270014|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44270015|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44270016|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44270017|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
44270018|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270019|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168354|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168355|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168356|NCT00271466|Analgesics|analgesics|mesh-ancestor
44168357|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
44168358|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168359|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44168360|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44168361|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
44168362|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
44168363|NCT00271492|Atrasentan|atrasentan|mesh-list
44168364|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168365|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44168366|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44168367|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168368|NCT00271518|Hormones|hormones|mesh-list
44168369|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168370|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168371|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44168372|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168373|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168374|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
44270020|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44270021|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44270022|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270023|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270024|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270025|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44270026|NCT00675714|Itraconazole|itraconazole|mesh-list
44270027|NCT00675714|Fluconazole|fluconazole|mesh-list
44270028|NCT00675714|Ketoconazole|ketoconazole|mesh-list
44270029|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
44270030|NCT00675714|Propranolol|propranolol|mesh-list
44270031|NCT00675714|Metoprolol|metoprolol|mesh-list
44270032|NCT00675714|Hormones|hormones|mesh-list
44270036|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44270037|NCT00675714|Oxandrolone|oxandrolone|mesh-list
44270038|NCT00675714|Nandrolone|nandrolone|mesh-list
44270039|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44270040|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270041|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270042|NCT00675714|Androgens|androgens|mesh-ancestor
44270043|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44270044|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270045|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
44270046|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
44270047|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270048|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44270049|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270050|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270051|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270052|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44270053|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270054|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44270055|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44270056|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44270057|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270058|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661091|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
44441521|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441522|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44441523|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441524|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441525|NCT01900444|Vaccines|vaccines|mesh-list
44441526|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
44441527|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441528|NCT01900431|Leucovorin|leucovorin|mesh-list
44441560|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44441561|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
44441562|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44441563|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
44441564|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441565|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441566|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44441567|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
44441568|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
44441569|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44441570|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441571|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441572|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441608|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441609|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441639|NCT01897714|Dexamethasone|dexamethasone|mesh-list
44270059|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44270060|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270061|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
43924333|NCT04482244|Cannabidiol|cannabidiol|mesh-list
44270062|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
44270063|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
44270064|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270065|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44270066|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44270067|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44270068|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44270069|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
44270070|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270071|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270072|NCT00675779|Atorvastatin|atorvastatin|mesh-list
44270073|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
44270074|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
44270075|NCT00675779|Dacuronium|dacuronium|mesh-list
44270076|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270077|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270078|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
44270079|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270080|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270081|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44270082|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270083|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44270084|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270085|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44270086|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44270087|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44270088|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44270089|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270090|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44270091|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
44270092|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270096|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270097|NCT00675961|Naltrexone|naltrexone|mesh-list
44270098|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44270099|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44270100|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270101|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
44270102|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270103|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44270104|NCT00676039|Citalopram|citalopram|mesh-list
44270105|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44270106|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44270107|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44270108|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270109|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270110|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270111|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44270112|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
44270113|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270114|NCT00676039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44270115|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
44270116|NCT00676117|Loxoprofen|loxoprofen|mesh-list
44270117|NCT00676117|Esomeprazole|esomeprazole|mesh-list
44270118|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44270119|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270120|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44270121|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270122|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270123|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44270124|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44270125|NCT00676117|Analgesics|analgesics|mesh-ancestor
44270131|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
44270140|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44270141|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270142|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44270143|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
44270144|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270145|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270146|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270147|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270148|NCT00676260|Pioglitazone|pioglitazone|mesh-list
44270149|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270150|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270151|NCT00676286|Choline|choline|mesh-list
44270152|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
44270153|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270154|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
44270155|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270156|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270157|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270158|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
44270159|NCT00676377|Neostigmine|neostigmine|mesh-list
44270160|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44270161|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441640|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441641|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
44441642|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
44441643|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441644|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441645|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441646|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
44441647|NCT01897714|Hormones|hormones|mesh-ancestor
44441648|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441649|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441650|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441651|NCT01897532|Linagliptin|linagliptin|mesh-list
44441652|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44441653|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441654|NCT01897532|Incretins|incretins|mesh-ancestor
44441655|NCT01897532|Hormones|hormones|mesh-ancestor
43962665|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441685|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
44441686|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441687|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
44441688|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44441689|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44441690|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44441691|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44441692|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441693|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441694|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795812|NCT00783354|Loratadine|loratadine|mesh-list
44270162|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270163|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44270164|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270165|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270166|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44270167|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
44270168|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270169|NCT00676416|Propofol|propofol|mesh-list
44270170|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44270171|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270172|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270173|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44270174|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
44270175|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
44270176|NCT00676429|Ziprasidone|ziprasidone|mesh-list
44270177|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44270178|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
44270179|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270180|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270181|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270182|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44270183|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44270184|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270185|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270186|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44270187|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
44270188|NCT00676468|Montelukast|montelukast|mesh-list
44270189|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44270190|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
44270191|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44462762|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462763|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462764|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
44462765|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44270198|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
44270199|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270200|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270201|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44270202|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44270203|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270204|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270205|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270206|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44270207|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270208|NCT00676559|Ranibizumab|ranibizumab|mesh-list
44270209|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44270210|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44270211|NCT00676559|Growth Substances|growth substances|mesh-ancestor
44270212|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441695|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441696|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441730|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44441731|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44441732|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44441733|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44441734|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44441735|NCT01896700|Methylphenidate|methylphenidate|mesh-list
44441759|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441760|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44441761|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
44441762|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
44441763|NCT01896531|Leucovorin|leucovorin|mesh-list
44441764|NCT01896531|Fluorouracil|fluorouracil|mesh-list
44441765|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
44441766|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
44441767|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441768|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44441769|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441770|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441771|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
44441772|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441773|NCT01896531|Antidotes|antidotes|mesh-ancestor
44441774|NCT01896531|Protective Agents|protective agents|mesh-ancestor
44441775|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
44441776|NCT01896531|Vitamins|vitamins|mesh-ancestor
44441777|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
44441778|NCT01896297|Dabigatran|dabigatran|mesh-list
44441779|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
44441780|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44441781|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441782|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441783|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441785|NCT01896232|Cinacalcet|cinacalcet|mesh-list
44441786|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44441818|NCT01895777|Dabigatran|dabigatran|mesh-list
44270213|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
44270214|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270215|NCT00676637|Timolol|timolol|mesh-list
44270216|NCT00676637|Travoprost|travoprost|mesh-list
44270217|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44270218|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44270219|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44270220|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44270221|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270222|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270223|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270224|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441819|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
44441820|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44441821|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441822|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441823|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441824|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
44441825|NCT01895335|Teriflunomide|teriflunomide|mesh-list
44441826|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441850|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441851|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441853|NCT01895270|Isradipine|isradipine|mesh-list
44441854|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44441855|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44441856|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441857|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441858|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44441859|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441860|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
44441861|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
44441862|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44441863|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44441864|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441865|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
44441866|NCT01895101|Coagulants|coagulants|mesh-ancestor
44441867|NCT01894984|Risperidone|risperidone|mesh-list
44441868|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
44441869|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44441870|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
44441871|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441872|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441873|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441874|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44441875|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441908|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
44441909|NCT01894477|Treosulfan|treosulfan|mesh-list
44441910|NCT01894477|Busulfan|busulfan|mesh-list
44441911|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441912|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44441913|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
44441914|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441915|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441916|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
44441917|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441918|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44441919|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
44441920|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44441948|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44441949|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441950|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270225|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44270226|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270227|NCT00676702|Vitamin K|vitamin k|mesh-list
44270228|NCT00676702|Pancrelipase|pancrelipase|mesh-list
44270229|NCT00676702|Pancreatin|pancreatin|mesh-list
44270230|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270231|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44270232|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44270233|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270234|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
44270235|NCT00676702|Coagulants|coagulants|mesh-ancestor
44270236|NCT00676702|Vitamins|vitamins|mesh-ancestor
44168651|NCT00272753|Budesonide|budesonide|mesh-list
44270237|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
44270238|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270239|NCT00676741|Insulin|insulin|mesh-list
44270240|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44270241|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
44270242|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
44270243|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44270244|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
44270283|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44270284|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270285|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270287|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44270288|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
44270289|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270290|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270291|NCT00677118|Cisplatin|cisplatin|mesh-list
44270292|NCT00677118|Fluorouracil|fluorouracil|mesh-list
44270293|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270294|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
44270295|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270296|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44270297|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270298|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
44270299|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270300|NCT00677144|Capecitabine|capecitabine|mesh-list
44270301|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
43661147|NCT02925299|Insulin|insulin|mesh-list
44441951|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441952|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441953|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441954|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44441955|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441956|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
44441957|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44441958|NCT01893281|Testosterone|testosterone|mesh-list
44441959|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
44441960|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
44441961|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44441962|NCT01893281|Androgens|androgens|mesh-ancestor
44441964|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441965|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441966|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441967|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441968|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
44441999|NCT01892163|Hormones|hormones|mesh-ancestor
44442000|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442001|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442002|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442003|NCT01892020|Insulin|insulin|mesh-list
44442004|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44442005|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
44442006|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
44442007|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442008|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442009|NCT01891890|Lamotrigine|lamotrigine|mesh-list
44442010|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
44442011|NCT01891890|Levetiracetam|levetiracetam|mesh-list
44442012|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
44442013|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
44442038|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442039|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
44442040|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795813|NCT00783354|Desloratadine|desloratadine|mesh-list
44270302|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44270304|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270305|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270306|NCT00677170|Pevonedistat|pevonedistat|mesh-list
44270307|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270308|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270309|NCT00677248|Ezetimibe|ezetimibe|mesh-list
44270310|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270311|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270312|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
44270313|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270314|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270315|NCT00677261|Anesthetics|anesthetics|mesh-list
44270316|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
44270317|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270318|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270319|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
44442042|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442043|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442044|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442045|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442046|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442047|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
44442048|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44442049|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
44442050|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442051|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
44442052|NCT01891396|Protective Agents|protective agents|mesh-ancestor
44442053|NCT01891357|Paclitaxel|paclitaxel|mesh-list
44442054|NCT01891357|Trastuzumab|trastuzumab|mesh-list
44442055|NCT01891357|Lapatinib|lapatinib|mesh-list
44442056|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44442057|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442058|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442059|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442060|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442061|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442062|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442093|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442094|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
44442095|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442096|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442097|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
44442098|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442099|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44442100|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44442101|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44442102|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442103|NCT01890707|Anesthetics|anesthetics|mesh-list
44442104|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442105|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442106|NCT01890473|Abatacept|abatacept|mesh-list
44442139|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442140|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44270323|NCT00677300|Tenofovir|tenofovir|mesh-list
44270324|NCT00677300|Emtricitabine|emtricitabine|mesh-list
44270325|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
44270326|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44270327|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44270328|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44270329|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270330|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270331|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44270332|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44270333|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
44270334|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442141|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442142|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442143|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442144|NCT01890109|Erenumab|erenumab|mesh-list
44442145|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44442146|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442147|NCT01890109|Analgesics|analgesics|mesh-ancestor
44442148|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
44442176|NCT01889069|Rituximab|rituximab|mesh-list
44442177|NCT01889069|Doxorubicin|doxorubicin|mesh-list
44442178|NCT01889069|Vincristine|vincristine|mesh-list
44442179|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442180|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
44442181|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442182|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442183|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44442184|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
44442185|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442186|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442187|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44442188|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442189|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44442190|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44442191|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44442192|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442193|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442194|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
44442195|NCT01889069|Hormones|hormones|mesh-ancestor
44442196|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442197|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442235|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
44442236|NCT01888432|Everolimus|everolimus|mesh-list
44442237|NCT01888432|Tacrolimus|tacrolimus|mesh-list
44442238|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442269|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442270|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442272|NCT01887288|Digoxin|digoxin|mesh-list
44442273|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442274|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
44442275|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442276|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442277|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44442278|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44270335|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44270336|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270337|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44270338|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44270339|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44270340|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44270341|NCT00677339|Vitamin D|vitamin d|mesh-list
44270342|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
44270343|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
44270344|NCT00677339|Vitamins|vitamins|mesh-list
44270345|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
44270346|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270347|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44270348|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44270349|NCT00677391|Sibutramine|sibutramine|mesh-list
44270350|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
44270351|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270352|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
44270353|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44270354|NCT00677443|Capecitabine|capecitabine|mesh-list
44270355|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
44270356|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44270357|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
44270358|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270387|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270388|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270389|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44270390|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
44270391|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
44270392|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44270393|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44270394|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44270395|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44270396|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270397|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270398|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270400|NCT00677755|Mifepristone|mifepristone|mesh-list
44270401|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44270402|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
44270403|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44270404|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270405|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44270406|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270407|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
44270408|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44270409|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44270410|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44270411|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44270436|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44270437|NCT00678145|Epinephrine|epinephrine|mesh-list
44270438|NCT00678145|Morphine|morphine|mesh-list
44270439|NCT00678145|Naloxone|naloxone|mesh-list
44270440|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270441|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44270442|NCT00678145|Narcotics|narcotics|mesh-ancestor
44270443|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270444|NCT00678145|Analgesics|analgesics|mesh-ancestor
44270445|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
44270446|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270447|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44270448|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44270449|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270450|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270451|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270452|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44270453|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44270454|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
44270455|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44442279|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442280|NCT01887288|Protective Agents|protective agents|mesh-ancestor
44442281|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962666|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44442351|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
44442352|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442353|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442354|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442355|NCT01884675|Ambrisentan|ambrisentan|mesh-list
44442356|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442357|NCT01884597|Ranibizumab|ranibizumab|mesh-list
44442358|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44442359|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44442360|NCT01884597|Growth Substances|growth substances|mesh-ancestor
44442361|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442394|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44442395|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
44442396|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44442397|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442398|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442399|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442400|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
44442401|NCT01884337|Apixaban|apixaban|mesh-list
44442402|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44442403|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
44442404|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44442405|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442420|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442421|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442423|NCT01882985|Protective Agents|protective agents|mesh-ancestor
44442424|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270456|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44270457|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
44270458|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
44270459|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44270460|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44270461|NCT00678184|Atorvastatin|atorvastatin|mesh-list
44270462|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270463|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270464|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
44270465|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270466|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270467|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44270468|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270469|NCT00678236|Gentamicins|gentamicins|mesh-list
44270470|NCT00678236|Cimetidine|cimetidine|mesh-list
44270471|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44270472|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270473|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44270474|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
44270501|NCT00678327|Etoposide|etoposide|mesh-list
44270512|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270513|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270514|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44270515|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44270516|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44270517|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44270518|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270519|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44270520|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
44270521|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
44270522|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
44270523|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270524|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
44270525|NCT00678327|Hormones|hormones|mesh-ancestor
44270526|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270527|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462766|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462767|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462768|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44462769|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44462770|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44462771|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44462772|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44462773|NCT01524783|Everolimus|everolimus|mesh-list
44462774|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462775|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462776|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
44462795|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462796|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462798|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44462799|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44462800|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
44462801|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462802|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44462803|NCT01524198|Budesonide|budesonide|mesh-list
44462804|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462805|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462806|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
44462807|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462808|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462809|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462810|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462811|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
44462812|NCT01524198|Hormones|hormones|mesh-ancestor
44462813|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462814|NCT01524133|Sertraline|sertraline|mesh-list
44270528|NCT00678431|Resveratrol|resveratrol|mesh-list
44270529|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
44270530|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270531|NCT00678431|Protective Agents|protective agents|mesh-ancestor
44270532|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270533|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270534|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44270535|NCT00678457|Ondansetron|ondansetron|mesh-list
44270536|NCT00678457|Olanzapine|olanzapine|mesh-list
44270537|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
44270538|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
44270539|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270551|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270552|NCT00678457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44270553|NCT00678457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44270554|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44270555|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44270556|NCT00678483|Rimonabant|rimonabant|mesh-list
44270557|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44270558|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44270559|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44270560|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270561|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270562|NCT00678483|Hormones|hormones|mesh-ancestor
44270563|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270564|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270565|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44270566|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44270567|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
44270568|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270569|NCT00678522|Atorvastatin|atorvastatin|mesh-list
44270570|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270571|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270572|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
44270573|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270574|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270575|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44270576|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270577|NCT00678613|Norfloxacin|norfloxacin|mesh-list
44270578|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270579|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270580|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44270581|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44270582|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270583|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270584|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270589|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44270590|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44270591|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44270592|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270593|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44270594|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
44270595|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44270596|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44270597|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270598|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270599|NCT00678704|Urological Agents|urological agents|mesh-ancestor
44270600|NCT00678743|Simvastatin|simvastatin|mesh-list
44270601|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270602|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270603|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
44270604|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270605|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270606|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44270607|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270608|NCT00678756|Ketoconazole|ketoconazole|mesh-list
44270609|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
44270610|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270611|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44270612|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270637|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44270638|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44270639|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270640|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270641|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
44270642|NCT00678964|Carboplatin|carboplatin|mesh-list
44270643|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44270644|NCT00678964|Vinorelbine|vinorelbine|mesh-list
44270645|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270646|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44270647|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270648|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270649|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44270650|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44270651|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44270652|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44270653|NCT00678977|Gemcitabine|gemcitabine|mesh-list
44270654|NCT00678977|Cisplatin|cisplatin|mesh-list
44270695|NCT00679224|Ambrisentan|ambrisentan|mesh-list
44270696|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270697|NCT00679237|Metformin|metformin|mesh-list
44270698|NCT00679237|Glimepiride|glimepiride|mesh-list
44270699|NCT00679237|Ezetimibe|ezetimibe|mesh-list
44270700|NCT00679237|Diuretics|diuretics|mesh-list
44270701|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270702|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270703|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44270704|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44270705|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
44270706|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270707|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44270708|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44270709|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442425|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44442426|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44442427|NCT01882907|Pioglitazone|pioglitazone|mesh-list
44442428|NCT01882907|Vildagliptin|vildagliptin|mesh-list
44442429|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442430|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442431|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44442432|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442433|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442434|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442435|NCT01882829|Quinidine|quinidine|mesh-list
44442436|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
44442437|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
44442438|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
44442439|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44442440|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44442441|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442442|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442443|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442444|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44442445|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44442446|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44442447|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44442448|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
44442449|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44442450|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44442451|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442452|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442453|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44442454|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44442455|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
44442456|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44442457|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44442458|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442459|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44442460|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44442461|NCT01882439|Tofacitinib|tofacitinib|mesh-list
44442462|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442463|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442489|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44442490|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44442491|NCT01881789|Growth Substances|growth substances|mesh-ancestor
44270710|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
44270711|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
44270712|NCT00679250|Cetirizine|cetirizine|mesh-list
44270713|NCT00679250|Levocetirizine|levocetirizine|mesh-list
44270714|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44270715|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44270716|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
44270717|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
44270718|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270719|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270720|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270721|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44270722|NCT00679315|Alfuzosin|alfuzosin|mesh-list
44270723|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44270724|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44270725|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44270726|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270727|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270728|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270729|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270730|NCT00679315|Urological Agents|urological agents|mesh-ancestor
44270731|NCT00679458|Buprenorphine|buprenorphine|mesh-list
44270732|NCT00679458|Naloxone|naloxone|mesh-list
44270762|NCT00679536|Busulfan|busulfan|mesh-list
44270763|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
44270764|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270765|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270766|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44270767|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
44270768|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270769|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
44270770|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44270771|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44270772|NCT00679601|Tavaborole|tavaborole|mesh-list
44270773|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
44270774|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270775|NCT00679614|Acetaminophen|acetaminophen|mesh-list
44270776|NCT00679614|Tramadol|tramadol|mesh-list
44270777|NCT00679614|Naloxone|naloxone|mesh-list
44270778|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44270779|NCT00679614|Analgesics|analgesics|mesh-ancestor
44270780|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
44270781|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270782|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270783|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
44270784|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44442492|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44442493|NCT01881230|Gemcitabine|gemcitabine|mesh-list
44442494|NCT01881230|Paclitaxel|paclitaxel|mesh-list
44442495|NCT01881230|Carboplatin|carboplatin|mesh-list
44442496|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44442497|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442498|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442499|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442500|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442501|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169247|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43609622|NCT03187015|Entinostat|entinostat|mesh-list
44442502|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442503|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
44442504|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
44442505|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442506|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442507|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442508|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
44442509|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442510|NCT01881126|Timolol|timolol|mesh-list
44442511|NCT01881126|Bimatoprost|bimatoprost|mesh-list
44442512|NCT01881126|Travoprost|travoprost|mesh-list
44442546|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442547|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442548|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44442549|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44442550|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
44442551|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
44442552|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442567|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442568|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44270786|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270787|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44270788|NCT00679640|Candesartan|candesartan|mesh-list
44270789|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270790|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44270791|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44270792|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270793|NCT00679653|Sibutramine|sibutramine|mesh-list
44270794|NCT00679653|Metoprolol|metoprolol|mesh-list
44270795|NCT00679653|Verapamil|verapamil|mesh-list
44270796|NCT00679653|Felodipine|felodipine|mesh-list
44270797|NCT00679653|Ramipril|ramipril|mesh-list
44270798|NCT00679653|Trandolapril|trandolapril|mesh-list
44270799|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44270800|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270801|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
44270802|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
44270803|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270804|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270805|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44270806|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44270807|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661307|NCT02924285|Amiodarone|amiodarone|mesh-list
44442569|NCT01880528|Protective Agents|protective agents|mesh-ancestor
44442570|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442571|NCT01880515|Tetracycline|tetracycline|mesh-list
44442572|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44442573|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442574|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44442575|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442576|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442577|NCT01880437|Cytarabine|cytarabine|mesh-list
44442578|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442579|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
44442580|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442581|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442582|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
44442583|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442584|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442585|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
44442586|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442587|NCT01880424|Linaclotide|linaclotide|mesh-list
44442588|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44442589|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
44442590|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169248|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44442591|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442592|NCT01880086|Clomiphene|clomiphene|mesh-list
44442593|NCT01880086|Enclomiphene|enclomiphene|mesh-list
44442594|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
44442595|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44442596|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270809|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270810|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270811|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44270812|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
44270813|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270814|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44270815|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44270816|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44270817|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
44270818|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
44270819|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44270820|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
44442597|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442598|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442599|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44442600|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
44442601|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44442602|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44442603|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44442604|NCT01879618|Dalteparin|dalteparin|mesh-list
44442605|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
44442606|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44442607|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44442608|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442609|NCT01879579|Insulin|insulin|mesh-list
44442610|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442611|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442612|NCT01878890|Efavirenz|efavirenz|mesh-list
44442613|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44442648|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442679|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
44442681|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
44442682|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44442683|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
44442684|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442685|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44442686|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44442687|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44442688|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442689|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
44442690|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
44442720|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442721|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442722|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442723|NCT01876082|Methotrexate|methotrexate|mesh-list
44442724|NCT01876082|Vinblastine|vinblastine|mesh-list
44442725|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44442726|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
44442727|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44442728|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169304|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
44442729|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442730|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
44442731|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442767|NCT01875445|Inositol|inositol|mesh-list
44442768|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
44442769|NCT01875445|Vitamins|vitamins|mesh-ancestor
44442770|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
44442771|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270821|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44270822|NCT00679666|Riboflavin|riboflavin|mesh-list
43925084|NCT00395603|Atorvastatin|atorvastatin|mesh-list
44270823|NCT00679666|Vitamins|vitamins|mesh-ancestor
44270824|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
44270825|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270826|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
44270827|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44270828|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
44270829|NCT00679679|Metformin|metformin|mesh-list
44270830|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270831|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270832|NCT00679705|Atosiban|atosiban|mesh-list
44270833|NCT00679705|Ritodrine|ritodrine|mesh-list
44270834|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270835|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270836|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442809|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442810|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
44442811|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
44442827|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442828|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442830|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44442831|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442832|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44442833|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442834|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442835|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
44442836|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
44442837|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44442838|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
44442839|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442840|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442841|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442842|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44442843|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44442844|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44442845|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
44442846|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442847|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442848|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442849|NCT01873950|Quinidine|quinidine|mesh-list
44442850|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
44442851|NCT01873950|Verapamil|verapamil|mesh-list
44442852|NCT01873950|Dofetilide|dofetilide|mesh-list
44442853|NCT01873950|Ranolazine|ranolazine|mesh-list
44442854|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44442855|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44442856|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442857|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442858|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44442859|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442860|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
44442861|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44442862|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44442863|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44442864|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
44442865|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442866|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
44442867|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44270837|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
44270838|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44270839|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
44270840|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
44270841|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270842|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44270843|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44270844|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44270845|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270846|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270847|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270848|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44270849|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44270850|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
44270851|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
44270852|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44270853|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44270854|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270855|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44270856|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270857|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270858|NCT00679770|Tavaborole|tavaborole|mesh-list
44270859|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
44270860|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270861|NCT00679835|Daptomycin|daptomycin|mesh-list
44270862|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44270863|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270864|NCT00679900|SR 46349B|sr 46349b|mesh-list
44270865|NCT00679900|Lormetazepam|lormetazepam|mesh-list
44270866|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44270867|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44270868|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270869|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44270870|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44270871|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
44270872|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270873|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270875|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270876|NCT00679965|Tavaborole|tavaborole|mesh-list
44270877|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
44270878|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270879|NCT00680095|Tavaborole|tavaborole|mesh-list
44270880|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
44270881|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270882|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44270883|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44270884|NCT00680134|Tavaborole|tavaborole|mesh-list
44270885|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
44270886|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270887|NCT00680160|Tavaborole|tavaborole|mesh-list
44270888|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
44270889|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44270890|NCT00680173|Interferons|interferons|mesh-list
44270891|NCT00680173|Ribavirin|ribavirin|mesh-list
44270892|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
44270893|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
44270894|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44270895|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270896|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
44270897|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661355|NCT02923934|Nivolumab|nivolumab|mesh-list
44442868|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44442869|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442888|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44442889|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442890|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44442891|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442892|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442893|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44442894|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44442895|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442896|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
44442897|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442898|NCT01872910|Celecoxib|celecoxib|mesh-list
44442899|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442900|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442901|NCT01872910|Analgesics|analgesics|mesh-ancestor
44442902|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
44442903|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442904|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442905|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442906|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442907|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44442908|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44442909|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442910|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442911|NCT01872715|Doxycycline|doxycycline|mesh-list
44442912|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44442913|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442914|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
44442915|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44442916|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44270898|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
44270899|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270900|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
44270901|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270903|NCT00680212|Carotenoids|carotenoids|mesh-list
44270904|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
44270905|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270906|NCT00680212|Protective Agents|protective agents|mesh-ancestor
44270907|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270908|NCT00680212|Provitamins|provitamins|mesh-ancestor
44270909|NCT00680212|Vitamins|vitamins|mesh-ancestor
44270910|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
44270911|NCT00680277|Carotenoids|carotenoids|mesh-list
44270912|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
44270913|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270914|NCT00680277|Protective Agents|protective agents|mesh-ancestor
44270915|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270916|NCT00680329|Timolol|timolol|mesh-list
44270917|NCT00680329|Travoprost|travoprost|mesh-list
44270918|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44270919|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44270920|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44270921|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661378|NCT02923999|Antibodies|antibodies|mesh-list
44442917|NCT01872689|Pirfenidone|pirfenidone|mesh-list
44442918|NCT01872689|Analgesics|analgesics|mesh-ancestor
44169493|NCT00274859|Gemcitabine|gemcitabine|mesh-list
44442919|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
44442920|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442921|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442922|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442923|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442924|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442925|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442954|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442955|NCT01871558|Metformin|metformin|mesh-list
44442956|NCT01871558|Vildagliptin|vildagliptin|mesh-list
44442957|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442958|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442959|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44442960|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442961|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442962|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442963|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44442964|NCT01871532|Hormones|hormones|mesh-ancestor
44442965|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442966|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442967|NCT01871285|Morphine|morphine|mesh-list
44442968|NCT01871285|Oxycodone|oxycodone|mesh-list
44442969|NCT01871285|Buprenorphine|buprenorphine|mesh-list
44442970|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44442971|NCT01871285|Narcotics|narcotics|mesh-ancestor
44270922|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44270923|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270924|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270925|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270926|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44270927|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44270929|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
44270930|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270931|NCT00680355|Protective Agents|protective agents|mesh-ancestor
44270932|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462815|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
44462816|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44462817|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44462818|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44462819|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442972|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442973|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442990|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44442991|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
44442992|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44442993|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44442994|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44442995|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44442996|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44442997|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44442998|NCT01870973|Analgesics|analgesics|mesh-list
44442999|NCT01870973|Anesthetics|anesthetics|mesh-list
44443000|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443001|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443002|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443003|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
44443004|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
44443005|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443006|NCT01870921|Ticagrelor|ticagrelor|mesh-list
44443007|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44443008|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44443009|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44443010|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44443011|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
44443012|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443013|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443014|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443015|NCT01870843|Citalopram|citalopram|mesh-list
44443016|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44443017|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44443018|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44443019|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443020|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443021|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
44443022|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443023|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44443024|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
44443025|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44443026|NCT01870739|Amlodipine|amlodipine|mesh-list
44462820|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462822|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
44462823|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925202|NCT00092833|Ezetimibe|ezetimibe|mesh-list
44270933|NCT00680394|Misoprostol|misoprostol|mesh-list
44270934|NCT00680394|Mifepristone|mifepristone|mesh-list
44270935|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44270936|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
44270937|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44270938|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270939|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44270940|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44270941|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
44270942|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44270943|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44270944|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44270945|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44270946|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
44270947|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44270948|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44443027|NCT01870739|Valsartan|valsartan|mesh-list
44443028|NCT01870739|Olmesartan|olmesartan|mesh-list
44443029|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44443030|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44443065|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44443067|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443068|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443069|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44443070|NCT01869725|Hormones|hormones|mesh-ancestor
44443089|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443090|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443091|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44443092|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443093|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443094|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443095|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443096|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
44443097|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44443098|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443099|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443100|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443101|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
44443102|NCT01868893|Chlorambucil|chlorambucil|mesh-list
44443103|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44443104|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443105|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44443106|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
44443107|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443108|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
44443109|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44270949|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
44169600|NCT00277498|Latanoprost|latanoprost|mesh-list
44270950|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270951|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
44270952|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44270953|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44270955|NCT00680433|Analgesics|analgesics|mesh-ancestor
44270956|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
44270957|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270958|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270959|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44270960|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44270961|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
44270962|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
44270963|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44270964|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44270965|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44270966|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44270967|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270968|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
44270969|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44443110|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443111|NCT01868503|Lapatinib|lapatinib|mesh-list
44443112|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443113|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44443114|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443115|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443116|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
44443117|NCT01868477|Deferasirox|deferasirox|mesh-list
44443118|NCT01868477|Hematinics|hematinics|mesh-ancestor
44443119|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44443120|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
44443121|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
44443122|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443123|NCT01868243|Warfarin|warfarin|mesh-list
44443124|NCT01868243|Dabigatran|dabigatran|mesh-list
44443125|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
44443126|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
44443127|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44443128|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443143|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443145|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44443146|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44443147|NCT01867710|Dexamethasone|dexamethasone|mesh-list
44443148|NCT01867710|Prednisone|prednisone|mesh-list
44443149|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
44443150|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443151|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
44443152|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
44443153|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443154|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443155|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443156|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
44443157|NCT01867710|Hormones|hormones|mesh-ancestor
44106616|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270970|NCT00680446|Antibodies|antibodies|mesh-list
44270971|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
44270972|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
44270973|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270974|NCT00680485|Ketoconazole|ketoconazole|mesh-list
44270975|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
44270976|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846674|NCT04182984|Tacrolimus|tacrolimus|mesh-list
44443158|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443159|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44443160|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443161|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44443162|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443163|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443164|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
44443165|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44443166|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
44443167|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443168|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
44443169|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44443170|NCT01867606|Antibodies|antibodies|mesh-list
44443171|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
44443172|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443173|NCT01867307|Empagliflozin|empagliflozin|mesh-list
44443174|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44443175|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443176|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443177|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443178|NCT01867294|Doxycycline|doxycycline|mesh-list
44443179|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
44443180|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44443181|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44443182|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44443183|NCT01867294|Spironolactone|spironolactone|mesh-list
44443184|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
44443185|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443186|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443187|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443188|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
44443189|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44443190|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44443215|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
44443216|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443217|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443218|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
44443219|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443220|NCT01866826|Rifaximin|rifaximin|mesh-list
44443221|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443222|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443223|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443224|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44443225|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
44443226|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
44443227|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443228|NCT01866657|Phenylephrine|phenylephrine|mesh-list
44443229|NCT01866657|Dopamine|dopamine|mesh-list
44443230|NCT01866657|Ephedrine|ephedrine|mesh-list
44443231|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44443232|NCT01866657|Propofol|propofol|mesh-list
44443233|NCT01866657|Sevoflurane|sevoflurane|mesh-list
44443234|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
44443235|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443236|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443237|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44443238|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44443239|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
44443240|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44443241|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44443261|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270977|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44270978|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44270979|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44270980|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44270981|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44270982|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
44270983|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44270984|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270985|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44270986|NCT00680498|Ranibizumab|ranibizumab|mesh-list
44270987|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44270988|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44270989|NCT00680498|Growth Substances|growth substances|mesh-ancestor
44270990|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270991|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
44270992|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44270993|NCT00680511|Methamphetamine|methamphetamine|mesh-list
44169737|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
44270994|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44270995|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44270996|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
44270997|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
44270998|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44270999|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
44271000|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271001|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271002|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271003|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43846678|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
44443262|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44443263|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443264|NCT01866098|Naltrexone|naltrexone|mesh-list
44443265|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44443266|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44443267|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443268|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
44443269|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443270|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44443271|NCT01865812|Cathartics|cathartics|mesh-ancestor
44443272|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443273|NCT01865747|Everolimus|everolimus|mesh-list
44443274|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443275|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443276|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
44271004|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44271006|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44271007|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
44271008|NCT00680563|Hematinics|hematinics|mesh-ancestor
44271009|NCT00680602|Sertraline|sertraline|mesh-list
44271010|NCT00680602|Fluoxetine|fluoxetine|mesh-list
44271011|NCT00680602|Paroxetine|paroxetine|mesh-list
44271012|NCT00680602|Citalopram|citalopram|mesh-list
44271013|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
44271014|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271015|NCT00680602|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44271016|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44271017|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44271018|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271019|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271020|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
44443277|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443278|NCT01865552|Etanercept|etanercept|mesh-list
44443279|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44443280|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44443281|NCT01865552|Analgesics|analgesics|mesh-ancestor
44443282|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
44443283|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443284|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443285|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443286|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443287|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443288|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443289|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
44443290|NCT01865084|Tadalafil|tadalafil|mesh-list
44443291|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
44443292|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44443293|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44443294|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443295|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443296|NCT01865084|Urological Agents|urological agents|mesh-ancestor
44443297|NCT01864174|Metformin|metformin|mesh-list
44443298|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443299|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443323|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443324|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44443325|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443326|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
44443327|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
44443328|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443329|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443330|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
44443331|NCT01864018|Hormones|hormones|mesh-ancestor
44101537|NCT00058201|Vitamins|vitamins|mesh-ancestor
44443332|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443334|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443335|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443336|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443337|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
44443338|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443339|NCT01864005|Clopidogrel|clopidogrel|mesh-list
44443340|NCT01864005|Ticagrelor|ticagrelor|mesh-list
44443341|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44443342|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44271021|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271022|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44271023|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44271024|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44271025|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271026|NCT00680641|Simvastatin|simvastatin|mesh-list
44271027|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44271028|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44271029|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
44271030|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271031|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44271032|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44271033|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443343|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44443344|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44443345|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
44443346|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443347|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443348|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443349|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44443350|NCT01863953|Bimatoprost|bimatoprost|mesh-list
44443351|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44443352|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44443353|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44443354|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44443379|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44443380|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
44443381|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44443382|NCT01862991|Digoxin|digoxin|mesh-list
44443383|NCT01862991|Misoprostol|misoprostol|mesh-list
44443384|NCT01862991|Mifepristone|mifepristone|mesh-list
44443385|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44443386|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
44443387|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44443388|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443389|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44443390|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443391|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
44443392|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44443393|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44443394|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443395|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443396|NCT01862991|Protective Agents|protective agents|mesh-ancestor
44443397|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44443398|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44443399|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44443400|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44443401|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
44443402|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44443403|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44443427|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443428|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443429|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443430|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443431|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
44443432|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
44443433|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443434|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443435|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271034|NCT00680654|Riociguat|riociguat|mesh-list
44271035|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
44271036|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271037|NCT00680680|Dutasteride|dutasteride|mesh-list
44271038|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44271039|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44271040|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271041|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271042|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44271043|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271044|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271045|NCT00680732|Folic Acid|folic acid|mesh-list
44271046|NCT00680732|Micronutrients|micronutrients|mesh-list
44271047|NCT00680732|Trace Elements|trace elements|mesh-list
44271048|NCT00680732|Chloroquine|chloroquine|mesh-list
44443436|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
44443437|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443438|NCT01862250|Clonidine|clonidine|mesh-list
44443439|NCT01862250|Analgesics|analgesics|mesh-ancestor
44443440|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
44443441|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443442|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443443|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44443444|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
44443445|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
44443446|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44443447|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44443448|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443449|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443450|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443451|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443452|NCT01861717|Lanreotide|lanreotide|mesh-list
44443453|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443454|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
44443455|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44443456|NCT01860976|Abatacept|abatacept|mesh-list
44443482|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443483|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
44443484|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443485|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443486|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443487|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
44443488|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443489|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44443490|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44443491|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44443492|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443493|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443494|NCT01859793|Incretins|incretins|mesh-ancestor
44443495|NCT01859793|Hormones|hormones|mesh-ancestor
44443496|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443497|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44443498|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443499|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443500|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443501|NCT01859741|Cisplatin|cisplatin|mesh-list
44443502|NCT01859741|Carboplatin|carboplatin|mesh-list
44443503|NCT01859741|Etoposide|etoposide|mesh-list
44443504|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795957|NCT00552097|Simvastatin|simvastatin|mesh-list
44271050|NCT00680732|Hematinics|hematinics|mesh-ancestor
44271051|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
44271052|NCT00680732|Vitamins|vitamins|mesh-ancestor
44271053|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271054|NCT00680732|Amebicides|amebicides|mesh-ancestor
44271055|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44271056|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44271057|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271058|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
44271059|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271060|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44271061|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271062|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271063|NCT00680758|Paclitaxel|paclitaxel|mesh-list
44271064|NCT00680758|Cisplatin|cisplatin|mesh-list
44271065|NCT00680758|Everolimus|everolimus|mesh-list
44271066|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271067|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271068|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271069|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271070|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271071|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271072|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443505|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44443506|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443527|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443528|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443529|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44443530|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44443531|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44443532|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44443533|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
44443534|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443535|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
44443536|NCT01859702|Dexamethasone|dexamethasone|mesh-list
44443537|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44443538|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443539|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
44443540|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
44443541|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443542|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443543|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443544|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
44443545|NCT01859702|Hormones|hormones|mesh-ancestor
44443546|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443547|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44443548|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443549|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44443550|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443551|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443552|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443553|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271074|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271075|NCT00680940|Paclitaxel|paclitaxel|mesh-list
44271076|NCT00680940|Cisplatin|cisplatin|mesh-list
43925370|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
44271077|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271078|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271079|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271080|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271081|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271082|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271083|NCT00681005|Rabeprazole|rabeprazole|mesh-list
44271084|NCT00681005|Pantoprazole|pantoprazole|mesh-list
44271085|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44271086|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271087|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44271088|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271089|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271090|NCT00681135|Olaflur|olaflur|mesh-list
44271091|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
44271092|NCT00681135|Protective Agents|protective agents|mesh-ancestor
43661412|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443554|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443555|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443556|NCT01859390|Antioxidants|antioxidants|mesh-list
44443557|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443558|NCT01859390|Protective Agents|protective agents|mesh-ancestor
44443559|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443560|NCT01858766|Ribavirin|ribavirin|mesh-list
44443561|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
44443562|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443563|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
44443583|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443584|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
44443586|NCT01857583|Edoxaban|edoxaban|mesh-list
44443587|NCT01857583|Fondaparinux|fondaparinux|mesh-list
44443588|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44443589|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
44443590|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44443591|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443592|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443593|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443594|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
44443595|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44443596|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44443597|NCT01857531|Nicotine|nicotine|mesh-list
44443598|NCT01857531|Ganaxolone|ganaxolone|mesh-list
44443599|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44443600|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
44443601|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443602|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443603|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44443604|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44443605|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
44443606|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271093|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271094|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44271096|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271097|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271098|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44271099|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44271100|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271101|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44271102|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271103|NCT00681174|Acetaminophen|acetaminophen|mesh-list
44271104|NCT00681174|Morphine|morphine|mesh-list
44443607|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443608|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
44443609|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
44443610|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
44443611|NCT01857323|Albuterol|albuterol|mesh-list
44443612|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44443613|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
44443614|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443615|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101776|NCT00058994|Anecortave|anecortave|mesh-list
44443616|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44443617|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443618|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
44443632|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44443633|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443634|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44443635|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443636|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443637|NCT01857206|Vaccines|vaccines|mesh-list
44443638|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
44443639|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443640|NCT01857063|Montelukast|montelukast|mesh-list
44443641|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44443642|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443643|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44443644|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44443645|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443646|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443647|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44443648|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44443649|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443650|NCT01856907|Metformin|metformin|mesh-list
44443651|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44443652|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443653|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443654|NCT01856907|Incretins|incretins|mesh-ancestor
44443655|NCT01856907|Hormones|hormones|mesh-ancestor
44443656|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443657|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44443658|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443659|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443660|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443661|NCT01856790|Liraglutide|liraglutide|mesh-list
44443662|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443663|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443664|NCT01856790|Incretins|incretins|mesh-ancestor
44443665|NCT01856790|Hormones|hormones|mesh-ancestor
44443666|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271105|NCT00681174|Remifentanil|remifentanil|mesh-list
44271106|NCT00681174|Oxycodone|oxycodone|mesh-list
44271107|NCT00681174|Propofol|propofol|mesh-list
44271108|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44271109|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271110|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271111|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44271112|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
44271113|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
44271114|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44271115|NCT00681174|Narcotics|narcotics|mesh-ancestor
44271116|NCT00681174|Analgesics|analgesics|mesh-ancestor
44271117|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
44271118|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271119|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44271120|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
44271121|NCT00681213|Sirolimus|sirolimus|mesh-list
44271122|NCT00681213|Tacrolimus|tacrolimus|mesh-list
44271123|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271124|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
44271125|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271126|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44271127|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271128|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271129|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44271130|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271131|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44271132|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271133|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
44271134|NCT00681226|Ramipril|ramipril|mesh-list
44271135|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43661441|NCT02923336|Propranolol|propranolol|mesh-list
44443667|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
44443668|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443669|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443670|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44443671|NCT01856322|Sulindac|sulindac|mesh-list
44443672|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44443673|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44443674|NCT01856322|Analgesics|analgesics|mesh-ancestor
44443675|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
44443676|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443677|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443678|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443679|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443708|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
44271136|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
44271137|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271138|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271139|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44271140|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
44271141|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
44271142|NCT00681343|Daclizumab|daclizumab|mesh-list
44271143|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
44271144|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271145|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271146|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271147|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271148|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44271149|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44271150|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44271151|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
44271152|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925429|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44271153|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44271154|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44271155|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271157|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44271160|NCT00681525|Ezetimibe|ezetimibe|mesh-list
44271188|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271189|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44271190|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271191|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271192|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44271193|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44271194|NCT00681733|Protective Agents|protective agents|mesh-ancestor
44271195|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
44271196|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44271197|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
44271198|NCT00681746|Flumazenil|flumazenil|mesh-list
44271199|NCT00681746|Antidotes|antidotes|mesh-ancestor
44271200|NCT00681746|Protective Agents|protective agents|mesh-ancestor
44271201|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271202|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
44271203|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
44271204|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271205|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271206|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44271207|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
44443709|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443710|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443711|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
44443713|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443714|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44443715|NCT01856257|Protective Agents|protective agents|mesh-ancestor
44443716|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44443717|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443718|NCT01856114|Fentanyl|fentanyl|mesh-list
44443719|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44443720|NCT01856114|Narcotics|narcotics|mesh-ancestor
44443721|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443722|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443723|NCT01856114|Analgesics|analgesics|mesh-ancestor
44443724|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
44443725|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443726|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44443727|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44443728|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
44443763|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443764|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44443765|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44443767|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443768|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443769|NCT01855789|Methotrexate|methotrexate|mesh-list
44443801|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443802|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443803|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443804|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443805|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
44443806|NCT01855750|Hormones|hormones|mesh-ancestor
44443807|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443808|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44443809|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271209|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44271210|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271211|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271212|NCT00681772|Urological Agents|urological agents|mesh-ancestor
44271213|NCT00681785|Dalteparin|dalteparin|mesh-list
44271214|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44271215|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
44271216|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44271217|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44271218|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271219|NCT00681876|Bevacizumab|bevacizumab|mesh-list
44271220|NCT00681876|Cetuximab|cetuximab|mesh-list
44271221|NCT00681876|Irinotecan|irinotecan|mesh-list
44271222|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271223|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271224|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44271225|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44271226|NCT00681876|Growth Substances|growth substances|mesh-ancestor
44443810|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443811|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443842|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
44443843|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44443844|NCT01854827|Antibodies|antibodies|mesh-list
44443845|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
44443846|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44443847|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
44443848|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443849|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
44443850|NCT01854710|Loxapine|loxapine|mesh-list
44443851|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443852|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443853|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443854|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443855|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443856|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443857|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443892|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44443893|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44443894|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44443895|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
44443896|NCT01854645|Bromides|bromides|mesh-list
44443897|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
44443929|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443930|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443931|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443933|NCT01853982|Piperacillin|piperacillin|mesh-list
44443934|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44443935|NCT01853982|Ceftolozane|ceftolozane|mesh-list
44443936|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44443937|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443938|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443939|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44443940|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444005|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
44271227|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271228|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
44271229|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43925507|NCT00592124|Tenofovir|tenofovir|mesh-list
44271230|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271231|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271232|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271234|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
44271235|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
44271236|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271237|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271238|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
44271239|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271240|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44271241|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44271242|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44271243|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44271244|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271245|NCT00681928|Letrozole|letrozole|mesh-list
44271246|NCT00681928|Anastrozole|anastrozole|mesh-list
44271247|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271248|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44271249|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44271250|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271251|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271252|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44271253|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
44271254|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271255|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271256|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44271257|NCT00681941|Sevelamer|sevelamer|mesh-list
44444006|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444007|NCT01853072|Prednisolone|prednisolone|mesh-list
44444008|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44444009|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
44444010|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44444011|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
44444012|NCT01853072|Nepafenac|nepafenac|mesh-list
44444013|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44444014|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
44444015|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271258|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
44271259|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
44271260|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271261|NCT00681967|Gefitinib|gefitinib|mesh-list
44271262|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271263|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44271264|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271265|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271266|NCT00681980|Valproic Acid|valproic acid|mesh-list
44271267|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
44271268|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271269|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271270|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
44271271|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271272|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271273|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
44271274|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44271275|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271276|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271277|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
44271278|NCT00681993|Carboplatin|carboplatin|mesh-list
44271279|NCT00681993|Docetaxel|docetaxel|mesh-list
44271280|NCT00681993|Trastuzumab|trastuzumab|mesh-list
44271281|NCT00681993|Doxorubicin|doxorubicin|mesh-list
44271282|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44271283|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444016|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
44444017|NCT01853072|Hormones|hormones|mesh-ancestor
44444018|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444019|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444020|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44444021|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444022|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
44444023|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
44444024|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444057|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
44444058|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444059|NCT01852214|Ticagrelor|ticagrelor|mesh-list
44444060|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44444061|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44102234|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44444090|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44444091|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444092|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444093|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
44444094|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444095|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444096|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44444097|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271284|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
44271285|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271286|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271287|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44271288|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
44271289|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271290|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271291|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44271292|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271293|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271294|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271295|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271296|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44271297|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44271298|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271299|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271300|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
44271301|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44271302|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44271303|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271304|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
44271305|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271306|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44271307|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
44271308|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44271309|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44271310|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271311|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271312|NCT00682019|Urological Agents|urological agents|mesh-ancestor
44271314|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
44271315|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
44271316|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271317|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271325|NCT00682149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271326|NCT00682149|Protective Agents|protective agents|mesh-ancestor
44462825|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44462826|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44462827|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44462828|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462829|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462830|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44462831|NCT01523587|Afatinib|afatinib|mesh-list
44462832|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462833|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462834|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462835|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462836|NCT01523457|Folfirinox|folfirinox|mesh-list
44462837|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462838|NCT01523392|Clopidogrel|clopidogrel|mesh-list
44462839|NCT01523392|Ticagrelor|ticagrelor|mesh-list
44462840|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44462841|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44462842|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44462843|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44462844|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
44462845|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462846|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462847|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462848|NCT01523366|Clopidogrel|clopidogrel|mesh-list
44462849|NCT01523366|Ticagrelor|ticagrelor|mesh-list
44462850|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44462851|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44462852|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44462853|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44444098|NCT01851863|Flupenthixol|flupenthixol|mesh-list
44444099|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
44444101|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44444102|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444103|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44444131|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444132|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
43795958|NCT00552097|Ezetimibe|ezetimibe|mesh-list
44462854|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
44462855|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462856|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462857|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462858|NCT01523301|Rotigotine|rotigotine|mesh-list
44462859|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
44462860|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
44462861|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462862|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462863|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462864|NCT01523275|Mitomycins|mitomycins|mesh-list
44462865|NCT01523275|Mitomycin|mitomycin|mesh-list
44462866|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44462867|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462868|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
44462869|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462870|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462871|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462872|NCT01522950|Atenolol|atenolol|mesh-list
44462873|NCT01522950|Nebivolol|nebivolol|mesh-list
44462874|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44462875|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44271327|NCT00682214|Vitamin D|vitamin d|mesh-list
44271328|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
44271329|NCT00682214|Vitamins|vitamins|mesh-ancestor
44271330|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
44271331|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271332|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44271333|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44271334|NCT00682279|Topotecan|topotecan|mesh-list
44271335|NCT00682279|Lapatinib|lapatinib|mesh-list
44271336|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44271337|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271338|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444133|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44444134|NCT01851330|Ledipasvir|ledipasvir|mesh-list
44444135|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
44444136|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444137|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
44444138|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444139|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444140|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44444141|NCT01850615|Insulin|insulin|mesh-list
44271339|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271340|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271341|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44271342|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
44271343|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44271344|NCT00682292|Daclizumab|daclizumab|mesh-list
44271345|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
44271346|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271347|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271348|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
44271349|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
44271350|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
44271351|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271352|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271353|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
44271354|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271355|NCT00682383|Cisplatin|cisplatin|mesh-list
44271356|NCT00682383|Docetaxel|docetaxel|mesh-list
44271357|NCT00682383|Etoposide|etoposide|mesh-list
44271358|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271359|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271360|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271361|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271362|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271363|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271364|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44271365|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271366|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271367|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
44271368|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44271369|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44444142|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44444143|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
44444144|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444145|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444146|NCT01850602|Sevelamer|sevelamer|mesh-list
44444147|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
44444148|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
44444149|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444150|NCT01850524|Dexamethasone|dexamethasone|mesh-list
44444151|NCT01850524|Lenalidomide|lenalidomide|mesh-list
44444152|NCT01850524|Ixazomib|ixazomib|mesh-list
44444153|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444154|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
44444216|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44271370|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44271372|NCT00682500|Calfactant|calfactant|mesh-list
44271373|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44271374|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271375|NCT00682578|Artesunate|artesunate|mesh-list
44271376|NCT00682578|Chloroquine|chloroquine|mesh-list
44271377|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
44271378|NCT00682578|Piperaquine|piperaquine|mesh-list
44271379|NCT00682578|Artenimol|artenimol|mesh-list
44271380|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
44271381|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44271382|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44271383|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271384|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271385|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
44271386|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
44271387|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44271388|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
44271389|NCT00682578|Amebicides|amebicides|mesh-ancestor
44271390|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271391|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44271392|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271393|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271394|NCT00682630|Artesunate|artesunate|mesh-list
44271395|NCT00682630|Pyronaridine|pyronaridine|mesh-list
44271396|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
44271397|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44271398|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44271399|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271422|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271423|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44271424|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271425|NCT00682825|Anesthetics|anesthetics|mesh-list
44271426|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
44271427|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271428|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271429|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
44271430|NCT00682955|Zinc|zinc|mesh-list
44271431|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
44271432|NCT00682955|Trace Elements|trace elements|mesh-ancestor
44271433|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
44271434|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271435|NCT00682955|Astringents|astringents|mesh-ancestor
44271436|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271437|NCT00683059|Paclitaxel|paclitaxel|mesh-list
43661570|NCT02922283|Interleukin-2|interleukin-2|mesh-list
44444217|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44444218|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444219|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44444220|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
44444221|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444222|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444223|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44444224|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44444225|NCT01849783|Growth Substances|growth substances|mesh-ancestor
44444226|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
44444227|NCT01849588|Sorafenib|sorafenib|mesh-list
44444228|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444229|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44444230|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444231|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444232|NCT01849562|Ribavirin|ribavirin|mesh-list
44444233|NCT01849562|Odalasvir|odalasvir|mesh-list
44444234|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
44444235|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444236|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
44444237|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444238|NCT01849497|Evolocumab|evolocumab|mesh-list
44444239|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44444240|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44444241|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44444242|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
44444274|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44444275|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444276|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444277|NCT01848990|Insulin|insulin|mesh-list
44444278|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44444279|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
44444280|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
44444281|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
44444282|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444283|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444284|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
44444285|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44444286|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444353|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44444354|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795996|NCT00370890|Gemcitabine|gemcitabine|mesh-list
44271438|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271440|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271441|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271442|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271443|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271444|NCT00683111|Esomeprazole|esomeprazole|mesh-list
44271445|NCT00683111|Famotidine|famotidine|mesh-list
44271446|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44271447|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271448|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44271449|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271450|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271451|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44271452|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
44271453|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
44271454|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271455|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271456|NCT00683124|Losartan|losartan|mesh-list
44271457|NCT00683124|Nebivolol|nebivolol|mesh-list
44271458|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44271459|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44271460|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44271461|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44271462|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444355|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44444356|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44444357|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44444358|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444359|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444360|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44444361|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
44444362|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
44444363|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44444364|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44444365|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444366|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
44444367|NCT01846507|Coagulants|coagulants|mesh-ancestor
44444368|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44444369|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44444370|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
44444371|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444372|NCT01846416|Atezolizumab|atezolizumab|mesh-list
44444406|NCT01846104|Vaccines|vaccines|mesh-list
44444407|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
44444408|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444409|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
44444410|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44271463|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
44271464|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44271465|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271466|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271467|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271468|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271469|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271471|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44271472|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44271473|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271474|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271475|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44271476|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44271477|NCT00683137|Analgesics|analgesics|mesh-ancestor
44271478|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
44271479|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271480|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271481|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271482|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271483|NCT00683176|Choline|choline|mesh-list
44271484|NCT00683176|Fenofibrate|fenofibrate|mesh-list
44271485|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44271486|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
44271487|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271488|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44271489|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
44271490|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271491|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
44271492|NCT00683189|Warfarin|warfarin|mesh-list
44271493|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
44271494|NCT00683202|Aspirin|aspirin|mesh-list
44271495|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44271496|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44271497|NCT00683202|Analgesics|analgesics|mesh-ancestor
44271498|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
43661600|NCT02922348|Progestins|progestins|mesh-list
44444411|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
43795997|NCT00370890|Cisplatin|cisplatin|mesh-list
44271499|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271500|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271501|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271502|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271503|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44271504|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44271505|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271506|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44271507|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44271508|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271509|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
44271511|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
44271512|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271513|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
44444412|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444413|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
44444414|NCT01846039|Protective Agents|protective agents|mesh-ancestor
44444415|NCT01845831|Metformin|metformin|mesh-list
44444416|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
44444417|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44444449|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
44444450|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444451|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444452|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44444453|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44444454|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444455|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44444456|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44444457|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44444458|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44444459|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444485|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44444486|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444487|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444488|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444489|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
44444490|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
44444491|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
44444492|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44444493|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
44444494|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44444495|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
44444496|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44444497|NCT01844830|Protective Agents|protective agents|mesh-ancestor
44444498|NCT01844778|Tobramycin|tobramycin|mesh-list
44444499|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444500|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444501|NCT01844700|Risperidone|risperidone|mesh-list
44444502|NCT01844700|Aripiprazole|aripiprazole|mesh-list
44444503|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44444504|NCT01844700|Ziprasidone|ziprasidone|mesh-list
44444505|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44444506|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
44444507|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444508|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444532|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
44444533|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444534|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444535|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
44444536|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44271515|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271516|NCT00683306|Gefitinib|gefitinib|mesh-list
44271517|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271518|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44271519|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271520|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271521|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
44271522|NCT00683319|Cisplatin|cisplatin|mesh-list
44271523|NCT00683319|Carboplatin|carboplatin|mesh-list
44271524|NCT00683319|Methotrexate|methotrexate|mesh-list
44271525|NCT00683319|Vincristine|vincristine|mesh-list
44271526|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271527|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
44271528|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271529|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271530|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44271531|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
44444537|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44444538|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44444539|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44444540|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44444541|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44444542|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44444544|NCT01844531|Empagliflozin|empagliflozin|mesh-list
44444545|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444546|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444547|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44444548|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444549|NCT01844518|Abatacept|abatacept|mesh-list
44444550|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44444551|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444552|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444553|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444554|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
44444555|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444556|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444557|NCT01844505|Nivolumab|nivolumab|mesh-list
44444558|NCT01844505|Ipilimumab|ipilimumab|mesh-list
44444590|NCT01843660|Acetaminophen|acetaminophen|mesh-list
44444591|NCT01843660|Tramadol|tramadol|mesh-list
44170819|NCT00282165|Naratriptan|naratriptan|mesh-list
44444592|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44444593|NCT01843660|Analgesics|analgesics|mesh-ancestor
44444594|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
44444595|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444596|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444597|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
44444598|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44444599|NCT01843660|Narcotics|narcotics|mesh-ancestor
44444623|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44444624|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444625|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
44444626|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
44444627|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444628|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
44444629|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796057|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
44271532|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271533|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271534|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44271535|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44271536|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
44271537|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271538|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44271539|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
44271540|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271541|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271542|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44271543|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44271544|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271545|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271546|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271547|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271548|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44271549|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271550|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44271551|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44271552|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
44271553|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271554|NCT00683436|Adipiplon|adipiplon|mesh-list
44271555|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271556|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271557|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
44271558|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
44271559|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271560|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271561|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44271562|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44271563|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271574|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
44271575|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271576|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271577|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44271578|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
44271579|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271580|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271581|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44271582|NCT00683735|Metformin|metformin|mesh-list
44271583|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44271584|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44271585|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271586|NCT00683735|Incretins|incretins|mesh-ancestor
44271587|NCT00683735|Hormones|hormones|mesh-ancestor
44271588|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271589|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44271590|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
44271591|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271592|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271593|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
44271594|NCT00683865|Ofloxacin|ofloxacin|mesh-list
44271595|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44271596|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44271597|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271598|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44271599|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44271600|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444630|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444631|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444632|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44444633|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44444634|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444635|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44444636|NCT01843023|Naltrexone|naltrexone|mesh-list
44444637|NCT01843023|Buprenorphine|buprenorphine|mesh-list
44444638|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44444639|NCT01843023|Narcotics|narcotics|mesh-ancestor
44444640|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444641|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444642|NCT01843023|Analgesics|analgesics|mesh-ancestor
44444643|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
44444644|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444645|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44444646|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44444647|NCT01842633|Acetaminophen|acetaminophen|mesh-list
44444648|NCT01842633|Ibuprofen|ibuprofen|mesh-list
44444649|NCT01842633|Caffeine|caffeine|mesh-list
44271601|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271602|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271603|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44271604|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
44271605|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271606|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271607|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44271608|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44271609|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44271610|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44271612|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44271613|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44271614|NCT00683891|Clozapine|clozapine|mesh-list
44271615|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44444650|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44444651|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44444652|NCT01842633|Analgesics|analgesics|mesh-ancestor
44444653|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
44444685|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444687|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
44444688|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44444689|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44444690|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
44444691|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444692|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444693|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44444694|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444695|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
44444728|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
44444729|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444730|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44444731|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44444732|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444733|NCT01841359|Pramlintide|pramlintide|mesh-list
44444734|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444735|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444771|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44444772|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44444773|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44444774|NCT01840410|Ranibizumab|ranibizumab|mesh-list
44444775|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44444776|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44444777|NCT01840410|Growth Substances|growth substances|mesh-ancestor
44444797|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
44444798|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
44444799|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444800|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444801|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444802|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
44444803|NCT01839487|Hormones|hormones|mesh-ancestor
44444804|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444805|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44444806|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444807|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
44444808|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
44271616|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
44271617|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271618|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271619|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271620|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44271621|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44271622|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271623|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271624|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
44271625|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
44271626|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
44271627|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44271628|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271629|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271630|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271631|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
44271632|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44271633|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271634|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444809|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444810|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444811|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444812|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
44444813|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
44444814|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44444815|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44444816|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
44444817|NCT01839279|Tizanidine|tizanidine|mesh-list
44444818|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444819|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444820|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44444821|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44444822|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444823|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444824|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444825|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444826|NCT01839279|Analgesics|analgesics|mesh-ancestor
44444827|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
44444828|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444829|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
44444830|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44444831|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44444832|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
44444833|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
44444834|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44444869|NCT01838616|Tapentadol|tapentadol|mesh-list
44444870|NCT01838616|Naloxone|naloxone|mesh-list
44444871|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44444872|NCT01838616|Narcotics|narcotics|mesh-ancestor
44444873|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444874|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444875|NCT01838616|Analgesics|analgesics|mesh-ancestor
44444904|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171008|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44444905|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44444906|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44271636|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
44271637|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271638|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271639|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44271640|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44271641|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
44271642|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
44271643|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44271644|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271645|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44271646|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
44271647|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44271648|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271649|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271650|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271651|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
44271652|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44271653|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271654|NCT00683995|Fentanyl|fentanyl|mesh-list
44271655|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44271656|NCT00683995|Narcotics|narcotics|mesh-ancestor
44444907|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44444908|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444909|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44444910|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44444911|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44444912|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444913|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444914|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44444915|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44444916|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444917|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44444918|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44444919|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44444920|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
44444921|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444948|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444949|NCT01836549|Imetelstat|imetelstat|mesh-list
44444950|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
44444951|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444952|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444953|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44444954|NCT01836523|Liraglutide|liraglutide|mesh-list
44444955|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444956|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444957|NCT01836523|Incretins|incretins|mesh-ancestor
44444958|NCT01836523|Hormones|hormones|mesh-ancestor
44444959|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444960|NCT01836471|Fluticasone|fluticasone|mesh-list
44444961|NCT01836471|Xhance|xhance|mesh-list
44444962|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
44444963|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444964|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271657|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271658|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271659|NCT00683995|Analgesics|analgesics|mesh-ancestor
44271660|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
44271661|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271662|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44271663|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44271664|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
44271665|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
44271666|NCT00684099|Docetaxel|docetaxel|mesh-list
44271667|NCT00684099|Pemetrexed|pemetrexed|mesh-list
44271668|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271669|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44271670|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44271671|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44271672|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271673|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271674|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44271675|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44271676|NCT00684112|Gabapentin|gabapentin|mesh-list
44271677|NCT00684112|Analgesics|analgesics|mesh-ancestor
44271678|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
44271679|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271680|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271681|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
44271682|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44271683|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44271685|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44271706|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462876|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
44271707|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271708|NCT00684216|Tamoxifen|tamoxifen|mesh-list
44271709|NCT00684216|Capecitabine|capecitabine|mesh-list
44271710|NCT00684216|Letrozole|letrozole|mesh-list
44271711|NCT00684216|Anastrozole|anastrozole|mesh-list
44271712|NCT00684216|Exemestane|exemestane|mesh-list
44271713|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44271714|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
44271715|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271716|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271717|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44271718|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44271719|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271720|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44271721|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
44444965|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
44444966|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444967|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444968|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44444969|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
44444970|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444997|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44444998|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
44444999|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44445000|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44445001|NCT01835587|Cc-486|cc-486|mesh-list
44445002|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445003|NCT01835470|Abatacept|abatacept|mesh-list
44445004|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44445005|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445006|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445007|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445008|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
44445009|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445010|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445011|NCT01835431|Insulin|insulin|mesh-list
44445012|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44445013|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
44445014|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
44445015|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44445016|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
44445017|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445028|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445030|NCT01835145|Dacarbazine|dacarbazine|mesh-list
44445031|NCT01835145|Imidazole|imidazole|mesh-list
44445032|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44445033|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
44171175|NCT00284193|Thrombin|thrombin|mesh-list
44103156|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445034|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445035|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445036|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445037|NCT01834729|Alfuzosin|alfuzosin|mesh-list
44445038|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44445039|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44445040|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44445041|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271722|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271723|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271724|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44271725|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44271726|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44271727|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44462877|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
44462878|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462879|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462880|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44462881|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44462882|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44462883|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
44462884|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462885|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462886|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
44445042|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445043|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445044|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445045|NCT01834729|Urological Agents|urological agents|mesh-ancestor
44445047|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445048|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445049|NCT01834274|Metformin|metformin|mesh-list
44445050|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44445051|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445052|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445053|NCT01834274|Incretins|incretins|mesh-ancestor
44445054|NCT01834274|Hormones|hormones|mesh-ancestor
44445055|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445056|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44445057|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
44445058|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445059|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445060|NCT01833897|Cycloserine|cycloserine|mesh-list
44445061|NCT01833897|Ketamine|ketamine|mesh-list
44445062|NCT01833897|Olanzapine|olanzapine|mesh-list
44445063|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44445064|NCT01833897|Fluoxetine|fluoxetine|mesh-list
44445065|NCT01833897|Analgesics|analgesics|mesh-ancestor
44445066|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
44445067|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445068|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445069|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44445070|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44445071|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
44445072|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
44445073|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445074|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44445075|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44445076|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445077|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445078|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
44445079|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
44462887|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44462889|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44462890|NCT01522651|Dronedarone|dronedarone|mesh-list
44462891|NCT01522651|Ranolazine|ranolazine|mesh-list
44462892|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44462893|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462894|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462895|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44462896|NCT01522456|Tretinoin|tretinoin|mesh-list
44462897|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
44462898|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462899|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
44462900|NCT01522443|Prednisone|prednisone|mesh-list
44462901|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
44462902|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462903|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
44462904|NCT01522443|Hormones|hormones|mesh-ancestor
44462905|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462906|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462907|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462908|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462909|NCT01522443|Analgesics|analgesics|mesh-ancestor
44462910|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
44462911|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462912|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44462913|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44462914|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661726|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445104|NCT01833832|Protective Agents|protective agents|mesh-ancestor
44445105|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445106|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
44445107|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445108|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
44445109|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445110|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445111|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
44445112|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
44445114|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
44445115|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445116|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
44445117|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445118|NCT01833455|Flecainide|flecainide|mesh-list
44445119|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44445120|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445121|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44462915|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462916|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44462917|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44462918|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44462919|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462920|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462922|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462923|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462924|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44462925|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
44462926|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44462927|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
44462928|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271728|NCT00684229|Anesthetics|anesthetics|mesh-list
44271729|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271730|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271731|NCT00684268|Silybin|silybin|mesh-list
44271732|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44271733|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445122|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445123|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445124|NCT01833143|Acyclovir|acyclovir|mesh-list
44445125|NCT01833143|Bortezomib|bortezomib|mesh-list
44171289|NCT00284687|Artesunate|artesunate|mesh-list
44445126|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445127|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
44445128|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445129|NCT01832766|Dronabinol|dronabinol|mesh-list
44445130|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
44445147|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445148|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445149|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44445150|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
44445151|NCT01832727|Hormones|hormones|mesh-ancestor
44445152|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445153|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44445154|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445155|NCT01832532|Liraglutide|liraglutide|mesh-list
44445156|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445157|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445158|NCT01832532|Incretins|incretins|mesh-ancestor
44445159|NCT01832532|Hormones|hormones|mesh-ancestor
44445160|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445161|NCT01832038|Lacosamide|lacosamide|mesh-list
44445162|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
44445163|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445164|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445165|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445166|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445167|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
44445168|NCT01831817|Listerine|listerine|mesh-list
44445169|NCT01831817|Calcium|calcium|mesh-list
44271735|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271736|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44271737|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44271738|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271739|NCT00684372|Leflunomide|leflunomide|mesh-list
44271740|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271741|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271742|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44271743|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
44271744|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271746|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661755|NCT02920567|Octreotide|octreotide|mesh-list
44445170|NCT01831817|Fluorides|fluorides|mesh-list
44445171|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
44445172|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
44445173|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44445174|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445175|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44445176|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
44445177|NCT01831817|Protective Agents|protective agents|mesh-ancestor
44445178|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44445179|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445180|NCT01831791|Dutasteride|dutasteride|mesh-list
44445181|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44445182|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44445183|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445184|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445185|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44445186|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445211|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44445212|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44445213|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44445214|NCT01831089|Growth Substances|growth substances|mesh-ancestor
44445215|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445216|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
44445217|NCT01830881|Ibuprofen|ibuprofen|mesh-list
44445218|NCT01830881|Lidocaine|lidocaine|mesh-list
44445219|NCT01830881|Midazolam|midazolam|mesh-list
44445220|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
44445221|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
44445222|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445223|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445224|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
44445225|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445226|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44445227|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445228|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445229|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445230|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445231|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44445232|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44445233|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44445234|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44445235|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44445273|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271747|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44271748|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271749|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271751|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
44271752|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271753|NCT00684450|Coagulants|coagulants|mesh-ancestor
44271754|NCT00684463|Palonosetron|palonosetron|mesh-list
44271755|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
44271756|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
44271757|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271758|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271759|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271760|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44271761|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44271762|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
44271763|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271764|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271765|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
44271766|NCT00684489|Coal Tar|coal tar|mesh-list
44271767|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
44445274|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44445275|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44445276|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445297|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44445298|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445299|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445300|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171401|NCT00285155|Bupropion|bupropion|mesh-list
44445301|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
44445302|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44445303|NCT01829425|Oxybutynin|oxybutynin|mesh-list
44445304|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44445305|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44445306|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
44445307|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445308|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445309|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445310|NCT01829425|Urological Agents|urological agents|mesh-ancestor
44445311|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
44445312|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
44445313|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445314|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
44445315|NCT01829295|Prednisone|prednisone|mesh-list
44445316|NCT01829295|Methotrexate|methotrexate|mesh-list
44445317|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445318|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
44445319|NCT01829295|Hormones|hormones|mesh-ancestor
44445320|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445321|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445322|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44445323|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445324|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44445325|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
44271768|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271770|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44271771|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271772|NCT00684606|Oxytocin|oxytocin|mesh-list
44271773|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
44271774|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271775|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271776|NCT00684632|Fentanyl|fentanyl|mesh-list
44271777|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44271778|NCT00684632|Narcotics|narcotics|mesh-ancestor
44271779|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271780|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271781|NCT00684632|Analgesics|analgesics|mesh-ancestor
44271782|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
44271783|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271784|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44271785|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44271786|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
44271787|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
44271788|NCT00684827|Albuterol|albuterol|mesh-list
44271789|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271790|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
44271791|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271792|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271793|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271794|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271795|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
44271796|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44445326|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44445327|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445328|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
44445329|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445330|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445331|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445332|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44445365|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445366|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
44445367|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44445368|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44445369|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
44445370|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445371|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44445398|NCT01827839|Vaccines|vaccines|mesh-list
44445399|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
44445400|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445401|NCT01827670|Fluorides|fluorides|mesh-list
44445402|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
44445403|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
44271797|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271798|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271800|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926139|NCT00606489|Ibuprofen|ibuprofen|mesh-list
44271801|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271802|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271803|NCT00684853|Bevacizumab|bevacizumab|mesh-list
44271804|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44271805|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271806|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44271807|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44271808|NCT00684853|Growth Substances|growth substances|mesh-ancestor
44271809|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271810|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
44271811|NCT00684866|Albuterol|albuterol|mesh-list
44271812|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271813|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
44271814|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271815|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271816|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271817|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271818|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
44445404|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
44445405|NCT01827670|Protective Agents|protective agents|mesh-ancestor
44445406|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445407|NCT01827384|Carboplatin|carboplatin|mesh-list
44445408|NCT01827384|Everolimus|everolimus|mesh-list
44445409|NCT01827384|Temozolomide|temozolomide|mesh-list
44445410|NCT01827384|Trametinib|trametinib|mesh-list
44445411|NCT01827384|Veliparib|veliparib|mesh-list
44445412|NCT01827384|Adavosertib|adavosertib|mesh-list
44445413|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445414|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445415|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
44445416|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445417|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44445418|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
44445419|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445420|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445421|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445451|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445452|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445453|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445454|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445455|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44445456|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445457|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445458|NCT01827111|Paclitaxel|paclitaxel|mesh-list
44445459|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44445460|NCT01827111|Ipilimumab|ipilimumab|mesh-list
44271819|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271820|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271821|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271822|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271823|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271824|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271825|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271826|NCT00684905|Leuprolide|leuprolide|mesh-list
44271827|NCT00684905|Bicalutamide|bicalutamide|mesh-list
44271828|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44271829|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
44271830|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271831|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271832|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44271833|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271834|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
44271835|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
44271836|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271837|NCT00684957|Hormones|hormones|mesh-list
44271838|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445461|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445462|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445463|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445464|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445465|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445466|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445467|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44445494|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44445495|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44445496|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445497|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445498|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44445499|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
44445500|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
44445501|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445502|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
44445503|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
44445504|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44445505|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44445506|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
44445507|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
44103644|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44445508|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445509|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445510|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44445511|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
44445512|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445513|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44445514|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44445537|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44445538|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796132|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
44271839|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271840|NCT00685009|Hormones|hormones|mesh-list
44271841|NCT00685009|Progesterone|progesterone|mesh-list
44271842|NCT00685009|Estrogens|estrogens|mesh-list
44271843|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271844|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271845|NCT00685009|Progestins|progestins|mesh-ancestor
44271846|NCT00685022|Albuterol|albuterol|mesh-list
44271847|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271848|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
44271849|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271850|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271851|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271852|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271853|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
44271854|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271855|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271856|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271857|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271858|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271859|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271860|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271861|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
44271862|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
44271863|NCT00685061|Daclizumab|daclizumab|mesh-list
44271864|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
44271889|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271890|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271891|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
44271892|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44271893|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44271894|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
44271895|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44271896|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44271897|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44271898|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271899|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271901|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
44271902|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271903|NCT00685269|Eszopiclone|eszopiclone|mesh-list
44271904|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44271905|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44271906|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271907|NCT00685347|Albuterol|albuterol|mesh-list
44271908|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271909|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
44271910|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271911|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271912|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271913|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271914|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
44271915|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661836|NCT02920047|Amlodipine|amlodipine|mesh-list
44445539|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445541|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445542|NCT01824875|Capecitabine|capecitabine|mesh-list
44445543|NCT01824875|Temozolomide|temozolomide|mesh-list
44445544|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445545|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
44445546|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445547|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445548|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44445549|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
44445550|NCT01824823|Afatinib|afatinib|mesh-list
44445551|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445552|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445553|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445554|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445555|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
44445556|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
44445557|NCT01824693|Melphalan|melphalan|mesh-list
44445558|NCT01824693|Busulfan|busulfan|mesh-list
44271916|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271917|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271918|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271919|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271920|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271921|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271922|NCT00685425|Albuterol|albuterol|mesh-list
44271923|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271924|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
44171643|NCT00286143|Fentanyl|fentanyl|mesh-list
44271925|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44271926|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271927|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271928|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271929|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
44271930|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44271931|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271932|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271933|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271934|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271935|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271936|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271937|NCT00685464|Abciximab|abciximab|mesh-list
44271938|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
44271939|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44271940|NCT00685503|Ranibizumab|ranibizumab|mesh-list
44271941|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44271942|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44271943|NCT00685503|Growth Substances|growth substances|mesh-ancestor
44445559|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
44445560|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44445561|NCT01824693|Fludarabine|fludarabine|mesh-list
44445562|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
44445563|NCT01824693|Tacrolimus|tacrolimus|mesh-list
44445564|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445565|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
44445566|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445590|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445592|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
44445593|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44445594|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44445595|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445596|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445597|NCT01824290|Urological Agents|urological agents|mesh-ancestor
44445598|NCT01823835|Palbociclib|palbociclib|mesh-list
44445599|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445600|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445601|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271944|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271945|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44271946|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271947|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
44271948|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44271949|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
44271950|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171723|NCT00286403|Fenoldopam|fenoldopam|mesh-list
44171761|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
44271951|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271952|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44271953|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44271954|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44271955|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44271956|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44271957|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44271958|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44271959|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271960|NCT00685542|Diacetylrhein|diacetylrhein|mesh-list
44271961|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271962|NCT00685568|Celecoxib|celecoxib|mesh-list
44271963|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44271964|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44271965|NCT00685568|Analgesics|analgesics|mesh-ancestor
44271966|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
44271967|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445602|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445603|NCT01823679|Capecitabine|capecitabine|mesh-list
44445604|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445605|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
44445606|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445607|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445608|NCT01823328|Ketamine|ketamine|mesh-list
44445609|NCT01823328|Etomidate|etomidate|mesh-list
44445610|NCT01823328|Analgesics|analgesics|mesh-ancestor
44445611|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
44445612|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445613|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445646|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445647|NCT01822899|Fluticasone|fluticasone|mesh-list
44445649|NCT01822899|Bromides|bromides|mesh-list
44445650|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44445651|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445652|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44445653|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
44445688|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
44445689|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445690|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44445691|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
44445692|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445693|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445722|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796133|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
44271969|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44271970|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44271971|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44271972|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44271973|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44271974|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271975|NCT00685594|Vitamin D|vitamin d|mesh-list
44271976|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
44271977|NCT00685594|Vitamins|vitamins|mesh-ancestor
44271978|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
44271979|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271980|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44271981|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44271982|NCT00685607|Simethicone|simethicone|mesh-list
44271983|NCT00685607|Loperamide|loperamide|mesh-list
44271984|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
44271985|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44271986|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
44271987|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44271988|NCT00685607|Emollients|emollients|mesh-ancestor
44271989|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
44271990|NCT00685633|Bicalutamide|bicalutamide|mesh-list
44271991|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
44271992|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
44445723|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445724|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445725|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44445726|NCT01822561|Diuretics|diuretics|mesh-ancestor
44445727|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
44445728|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44445729|NCT01822535|Midodrine|midodrine|mesh-list
44445730|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
44445731|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
44445732|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445733|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445734|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44445735|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44445736|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44445773|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445774|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
44445775|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445776|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
44445777|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445778|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
44445808|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44445809|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44445810|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44445811|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44271993|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44271994|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44271995|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44271996|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
44271997|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
44271998|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44271999|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272000|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44272001|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272002|NCT00685672|Epinephrine|epinephrine|mesh-list
44272003|NCT00685672|Racepinephrine|racepinephrine|mesh-list
44272004|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
44272005|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44272006|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44272007|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272008|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272009|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272010|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445813|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44445814|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
44445815|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445816|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445817|NCT01821560|Baclofen|baclofen|mesh-list
44445818|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44445819|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445820|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44445821|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445822|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44445823|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
44445824|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
44445825|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445826|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445851|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445852|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445853|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
44445854|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445855|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445856|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445857|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44445858|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445859|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44445860|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
44445861|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445862|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445863|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445864|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445865|NCT01819129|Insulin|insulin|mesh-list
44445866|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44445867|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
44445868|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
44445869|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
44445870|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44445871|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272013|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
44272014|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272015|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272016|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272017|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
44272018|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
44272019|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44272020|NCT00685776|Anacetrapib|anacetrapib|mesh-list
44272021|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272022|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272023|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
44272024|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272025|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272026|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
44272027|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272028|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44272029|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445872|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445873|NCT01818752|Prednisone|prednisone|mesh-list
44445874|NCT01818752|Bortezomib|bortezomib|mesh-list
44445875|NCT01818752|Melphalan|melphalan|mesh-list
44445876|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445877|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
44445913|NCT01818284|Plerixafor|plerixafor|mesh-list
44445946|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445947|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44445948|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
44445949|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445950|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445951|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44445952|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44445953|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445954|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44445955|NCT01817777|Metformin|metformin|mesh-list
44445956|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445957|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445958|NCT01817764|Fluticasone|fluticasone|mesh-list
44445959|NCT01817764|Xhance|xhance|mesh-list
44445991|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44445992|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44445993|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44445994|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44445996|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
44445997|NCT01817530|Estradiol|estradiol|mesh-list
44445998|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44445999|NCT01817530|Estrogens|estrogens|mesh-ancestor
44446000|NCT01817530|Hormones|hormones|mesh-ancestor
44446001|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446002|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446030|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
44446031|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
44446032|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
44446033|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446034|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44446035|NCT01816477|Ropivacaine|ropivacaine|mesh-list
44272030|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272031|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44272033|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44272034|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44272035|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
44272036|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272037|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272038|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272039|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272040|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44272041|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44272042|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44272043|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272044|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272045|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272046|NCT00685854|Ranibizumab|ranibizumab|mesh-list
44272047|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44272048|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44272049|NCT00685854|Growth Substances|growth substances|mesh-ancestor
44272050|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272051|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
44272052|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272053|NCT00685906|Ticagrelor|ticagrelor|mesh-list
44272054|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
44272055|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44272056|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44272057|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44272073|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44272074|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
44272075|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272076|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272077|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44272078|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44171925|NCT00287352|Amantadine|amantadine|mesh-list
44272079|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44272080|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43661882|NCT02919501|Vortioxetine|vortioxetine|mesh-list
44446036|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
44446037|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
44446038|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446039|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446040|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
44446041|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446042|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
44446043|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44446044|NCT01816295|Testosterone|testosterone|mesh-list
44446045|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
44446046|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
44446047|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44446048|NCT01816295|Androgens|androgens|mesh-ancestor
44446049|NCT01816295|Hormones|hormones|mesh-ancestor
44446050|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446075|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
44446076|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446077|NCT01816048|Listerine|listerine|mesh-list
44446078|NCT01816048|Fluorides|fluorides|mesh-list
44446079|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
44446080|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
44446081|NCT01816048|Protective Agents|protective agents|mesh-ancestor
44446082|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446083|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44446084|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446085|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
44446086|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446087|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44446088|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
44446089|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446090|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44446091|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44446092|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44446093|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44446094|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44446095|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44446096|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446127|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446128|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
44446129|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44446130|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44446131|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44446132|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446133|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446134|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
44446135|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446136|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272082|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
44272083|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44272084|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44272085|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272086|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
44272087|NCT00685971|Vitamin D|vitamin d|mesh-list
44272088|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44272089|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272090|NCT00685971|Vitamins|vitamins|mesh-ancestor
44272091|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
44272092|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44446137|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44172002|NCT00287560|Propofol|propofol|mesh-list
44446138|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446139|NCT01814553|Afatinib|afatinib|mesh-list
44446140|NCT01814553|Loperamide|loperamide|mesh-list
44446141|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
44446142|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446175|NCT01814046|Fludarabine|fludarabine|mesh-list
44446176|NCT01814046|Interleukin-2|interleukin-2|mesh-list
44446177|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446178|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
44446179|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446180|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446181|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44446182|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
44446183|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446198|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446199|NCT01813890|Analgesics|analgesics|mesh-ancestor
44446200|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
44446201|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446202|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44446203|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446204|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446205|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446206|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44446207|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446208|NCT01813474|Olaparib|olaparib|mesh-list
44446209|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44446210|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446211|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446212|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446213|NCT01813435|Aspirin|aspirin|mesh-list
44446214|NCT01813435|Clopidogrel|clopidogrel|mesh-list
44446215|NCT01813435|Ticagrelor|ticagrelor|mesh-list
44446216|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44446217|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446218|NCT01813435|Analgesics|analgesics|mesh-ancestor
44446219|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
44446220|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446221|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446222|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446223|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446224|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44446225|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44446226|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446227|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44446228|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44446229|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446230|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
44446231|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44446232|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44446233|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44446234|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
44272093|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
44272094|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272095|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272096|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
44272097|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272098|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272099|NCT00686114|Paclitaxel|paclitaxel|mesh-list
44272100|NCT00686114|Cisplatin|cisplatin|mesh-list
44272101|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44272102|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44272103|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272104|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272105|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272106|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272107|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272108|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44272109|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272110|NCT00686140|Celecoxib|celecoxib|mesh-list
44272111|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272112|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272113|NCT00686140|Analgesics|analgesics|mesh-ancestor
44272114|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
44272115|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272116|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446235|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446236|NCT01813422|Evolocumab|evolocumab|mesh-list
44446237|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44446238|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44446239|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
44446240|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446241|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44446242|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44446243|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44446244|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44446271|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
44446272|NCT01812707|Atorvastatin|atorvastatin|mesh-list
44446273|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44446274|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44446275|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44446276|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
44446277|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446278|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44446279|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44446280|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446281|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
44446282|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446283|NCT01812057|Dexamethasone|dexamethasone|mesh-list
44446284|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446285|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
44446286|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
44446287|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272118|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272119|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44272120|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44272121|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272122|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272123|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
44272124|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272125|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272126|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272127|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272128|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272129|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272130|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272131|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
44272132|NCT00686192|Calcium|calcium|mesh-list
44272133|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44272134|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272135|NCT00686192|Antacids|antacids|mesh-ancestor
44272136|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272137|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446288|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446289|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446290|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
44446291|NCT01812057|Hormones|hormones|mesh-ancestor
44446292|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446293|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44446323|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446325|NCT01811186|Naloxone|naloxone|mesh-list
44446326|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446327|NCT01811186|Narcotics|narcotics|mesh-ancestor
44446328|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446329|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446330|NCT01811186|Analgesics|analgesics|mesh-ancestor
44446331|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
44446332|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446333|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44446334|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
44446335|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
44446336|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446337|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446338|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446339|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
44446369|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44446370|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44446371|NCT01810042|Growth Substances|growth substances|mesh-ancestor
44446372|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446373|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
44446374|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446375|NCT01809327|Metformin|metformin|mesh-list
44446376|NCT01809327|Canagliflozin|canagliflozin|mesh-list
44446377|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272138|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
44272139|NCT00686218|Panobinostat|panobinostat|mesh-list
44272140|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44272141|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272142|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44272143|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272144|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462929|NCT01521923|Methotrexate|methotrexate|mesh-list
44462930|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
44462931|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44462932|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
44462933|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44462934|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462935|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462936|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
44462937|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462938|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462939|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44462940|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462941|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44462942|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462943|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
44462944|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462945|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462946|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44462947|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
44462948|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462949|NCT01521559|Aflibercept|aflibercept|mesh-list
44462950|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44462951|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44462952|NCT01521559|Growth Substances|growth substances|mesh-ancestor
44462953|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462954|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462955|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272148|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44272150|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272151|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272152|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272153|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272154|NCT00686361|Choline|choline|mesh-list
44272155|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
44272156|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272157|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
44272158|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446378|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446379|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44446380|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446381|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
44446382|NCT01809314|Hematinics|hematinics|mesh-ancestor
44446383|NCT01809210|Gemcitabine|gemcitabine|mesh-list
44446384|NCT01809210|Cisplatin|cisplatin|mesh-list
44446415|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446416|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446417|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
44446418|NCT01809132|Hormones|hormones|mesh-ancestor
44446419|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446420|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44446421|NCT01809132|Protective Agents|protective agents|mesh-ancestor
44446422|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44446423|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446424|NCT01809132|Trace Elements|trace elements|mesh-ancestor
44446425|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
44446426|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446427|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44446428|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446429|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446458|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446460|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
44446461|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446462|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44446463|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446464|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446465|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44446466|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446467|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446468|NCT01808573|Capecitabine|capecitabine|mesh-list
44446469|NCT01808573|Lapatinib|lapatinib|mesh-list
44446470|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44446471|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
43962667|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44446494|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446495|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
44446496|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
44446497|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446498|NCT01808196|Losartan|losartan|mesh-list
44446499|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
44446500|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44446501|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44446502|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446503|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44446504|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446505|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44446507|NCT01808144|Lesinurad|lesinurad|mesh-list
44446508|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
44446509|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272160|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272161|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
44272162|NCT00686439|Adalimumab|adalimumab|mesh-list
44272163|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272164|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272165|NCT00686478|Interferons|interferons|mesh-list
44272166|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
44272167|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
44272168|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272169|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
44272170|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272171|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
44272172|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272173|NCT00686556|Cyclosporine|cyclosporine|mesh-list
44272174|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
44272175|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
44272176|NCT00686556|Fludarabine|fludarabine|mesh-list
44272177|NCT00686556|Cyclosporins|cyclosporins|mesh-list
44272178|NCT00686556|Lenograstim|lenograstim|mesh-list
44272179|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272180|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
44272181|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272182|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272183|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44446510|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
44446511|NCT01808144|Renal Agents|renal agents|mesh-ancestor
44446512|NCT01808118|Adalimumab|adalimumab|mesh-list
44446513|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446514|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446515|NCT01808092|Meropenem|meropenem|mesh-list
44446516|NCT01808092|Ceftazidime|ceftazidime|mesh-list
44446517|NCT01808092|Avibactam|avibactam|mesh-list
44446518|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44446519|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446520|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446521|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44446522|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446523|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446524|NCT01807949|Ivacaftor|ivacaftor|mesh-list
44446525|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44446526|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446561|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
44446562|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446596|NCT01806779|Nicotine|nicotine|mesh-list
44446597|NCT01806779|Varenicline|varenicline|mesh-list
44446598|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44446599|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
44446600|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446601|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446602|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44446603|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44446604|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
44446605|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272184|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
44272185|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272186|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272187|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44272188|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272189|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
44272190|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272191|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44272192|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44272193|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44272194|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44272195|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
44272196|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272197|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44272198|NCT00686621|Posaconazole|posaconazole|mesh-list
44272199|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
44272200|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272201|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44272202|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44272203|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44272204|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44272205|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446638|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446674|NCT01804673|Analgesics|analgesics|mesh-ancestor
44446675|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
44446676|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446677|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44446678|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44446679|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
44446680|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
44446710|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44446711|NCT01803282|Growth Substances|growth substances|mesh-ancestor
44446712|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446713|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
44446714|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44446715|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
44446716|NCT01803282|Antiviral Agents|antiviral agents|mesh-ancestor
44446717|NCT01803282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446718|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446719|NCT01803282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446720|NCT01803282|Immunologic Factors|immunologic factors|mesh-ancestor
44446721|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44446722|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44446723|NCT01803282|Antidotes|antidotes|mesh-ancestor
44446724|NCT01803282|Protective Agents|protective agents|mesh-ancestor
44446725|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
44446726|NCT01803282|Vitamins|vitamins|mesh-ancestor
44446727|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
44446756|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446758|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44446759|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446760|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
44446761|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43796200|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
44272206|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272207|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272208|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44272209|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
44272210|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272211|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272212|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
44272213|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272214|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272215|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
44272216|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272217|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272218|NCT00686868|Ofatumumab|ofatumumab|mesh-list
44272219|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926571|NCT00614445|Pyridoxine|pyridoxine|mesh-list
44272220|NCT00686985|Carboplatin|carboplatin|mesh-list
44272221|NCT00686985|Docetaxel|docetaxel|mesh-list
44272222|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272223|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272224|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272225|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272226|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272227|NCT00687011|Dexamethasone|dexamethasone|mesh-list
44446762|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44446763|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44446764|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
44446765|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446766|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44446767|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
44446768|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44446769|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44446770|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
44446771|NCT01802632|Osimertinib|osimertinib|mesh-list
44446772|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446800|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446801|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446802|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44105021|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
44446803|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446804|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446806|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446807|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446808|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44446809|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446810|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446811|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446812|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446813|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
43962669|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
43962670|NCT01516424|Risperidone|risperidone|mesh-list
44446863|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446864|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
44272229|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272230|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
44272231|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
44272232|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272233|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272234|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44272235|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
44272236|NCT00687011|Hormones|hormones|mesh-ancestor
44272237|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272238|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44272239|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272240|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44272241|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44272242|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
44272243|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272244|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272245|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
44446865|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446866|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44446867|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
44446868|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446869|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446870|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44446871|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44446872|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446873|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446874|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44446875|NCT01801436|Bortezomib|bortezomib|mesh-list
44446876|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105097|NCT00071240|Hormones|hormones|mesh-list
44446877|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
44446878|NCT01801280|Pantoprazole|pantoprazole|mesh-list
44446879|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44446880|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446881|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44446882|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
44446883|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446884|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446885|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446886|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446887|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44446888|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446889|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44446890|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44446891|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446892|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446893|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446894|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446895|NCT01800968|Liraglutide|liraglutide|mesh-list
44446896|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446897|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446898|NCT01800968|Incretins|incretins|mesh-ancestor
44446899|NCT01800968|Hormones|hormones|mesh-ancestor
44446900|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272246|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44272247|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272248|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
44272249|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272250|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272252|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272253|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44272254|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44272255|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272256|NCT00687245|Esomeprazole|esomeprazole|mesh-list
44272257|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44272258|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172470|NCT00289250|Renal Agents|renal agents|mesh-ancestor
44272259|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44272260|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272261|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272262|NCT00687258|Vitamin E|vitamin e|mesh-list
44272263|NCT00687258|Vitamins|vitamins|mesh-ancestor
44272264|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
44272265|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272266|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
44272267|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446901|NCT01799993|Amikacin|amikacin|mesh-list
44446902|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446903|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446904|NCT01799941|Quinidine|quinidine|mesh-list
44446905|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
44446906|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
44446907|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
44446908|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44446909|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44446910|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446911|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446943|NCT01798992|Carvedilol|carvedilol|mesh-list
44446944|NCT01798992|Doxazosin|doxazosin|mesh-list
44446945|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44446946|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446947|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
44446948|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
44446949|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446950|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446951|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44446952|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44446953|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44446954|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
44446976|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446977|NCT01797965|Daclizumab|daclizumab|mesh-list
44446978|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446979|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
44446980|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446981|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44272268|NCT00687258|Protective Agents|protective agents|mesh-ancestor
44272270|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272271|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272272|NCT00687388|Celecoxib|celecoxib|mesh-list
44272273|NCT00687388|Doxazosin|doxazosin|mesh-list
44272274|NCT00687388|Prazosin|prazosin|mesh-list
44272275|NCT00687388|Tamsulosin|tamsulosin|mesh-list
44272276|NCT00687388|Alfuzosin|alfuzosin|mesh-list
44272277|NCT00687388|Terazosin|terazosin|mesh-list
44272278|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44272279|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272280|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272281|NCT00687388|Analgesics|analgesics|mesh-ancestor
44272282|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
44272283|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272284|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272285|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272286|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272287|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44272288|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44272289|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272324|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44272325|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272326|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
44272327|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
44272328|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272329|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44272330|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44272331|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272332|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
44272333|NCT00687648|Hormones|hormones|mesh-ancestor
44272334|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662028|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
44446982|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44446983|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44446984|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
44446985|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105218|NCT00071968|Sirolimus|sirolimus|mesh-list
44446987|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44446988|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44446989|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44446990|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446991|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
44446992|NCT01797432|Hormones|hormones|mesh-ancestor
44446993|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446994|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446995|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446996|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
44446997|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446998|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446999|NCT01797302|Vitamin D|vitamin d|mesh-list
44447000|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
44447001|NCT01797302|Vitamins|vitamins|mesh-ancestor
44447002|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
44447003|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447004|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44447005|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44447006|NCT01797120|Everolimus|everolimus|mesh-list
44447007|NCT01797120|Fulvestrant|fulvestrant|mesh-list
44447008|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447033|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447035|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447036|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447037|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44447038|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447039|NCT01796964|Aflibercept|aflibercept|mesh-list
44447040|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44447041|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44447042|NCT01796964|Growth Substances|growth substances|mesh-ancestor
44447043|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447044|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
44447045|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447046|NCT01796470|Idelalisib|idelalisib|mesh-list
44447047|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447048|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447049|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447050|NCT01796197|Paclitaxel|paclitaxel|mesh-list
44447051|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
44447052|NCT01796197|Doxorubicin|doxorubicin|mesh-list
44447053|NCT01796197|Trastuzumab|trastuzumab|mesh-list
44447054|NCT01796197|Pertuzumab|pertuzumab|mesh-list
44447055|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44447088|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447089|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272335|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44272336|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44272337|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44272338|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44272339|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
44272340|NCT00687661|Diphosphonates|diphosphonates|mesh-list
44272341|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44272342|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272343|NCT00687700|Propranolol|propranolol|mesh-list
44272344|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44272345|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44272346|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272347|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172601|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272348|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272349|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272350|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44272351|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272352|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
44272353|NCT00687817|Paclitaxel|paclitaxel|mesh-list
44272354|NCT00687817|Carboplatin|carboplatin|mesh-list
44272355|NCT00687817|Bavituximab|bavituximab|mesh-list
44272356|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44447090|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447091|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44447093|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44447094|NCT01795898|Narcotics|narcotics|mesh-ancestor
44447129|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447130|NCT01795495|Analgesics|analgesics|mesh-ancestor
44447131|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
44447132|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105371|NCT00072228|Gemcitabine|gemcitabine|mesh-list
44447133|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
44447134|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44447150|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447151|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44447153|NCT01794780|Budesonide|budesonide|mesh-list
44447154|NCT01794780|Theophylline|theophylline|mesh-list
44447155|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
44447156|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
44447157|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44447158|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447159|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44447160|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
44447161|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447162|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447163|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44447164|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447165|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
44447166|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44447167|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
44447168|NCT01794780|Hormones|hormones|mesh-ancestor
44447169|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447170|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44272358|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272359|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272360|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272361|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272362|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44272363|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
44272364|NCT00687843|Tegafur|tegafur|mesh-list
44272365|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272366|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
44272367|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272368|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272369|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44272370|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
44272371|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272372|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44272373|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
44272374|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272375|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
44272376|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44272377|NCT00687843|Protective Agents|protective agents|mesh-ancestor
44272378|NCT00687999|Interferons|interferons|mesh-list
44272379|NCT00687999|Ribavirin|ribavirin|mesh-list
44447171|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44447172|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44447173|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
44447174|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447175|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447176|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
44447177|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44447178|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
44447179|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44447180|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447181|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
44447182|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44447183|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44447184|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
44447185|NCT01794689|Morphine|morphine|mesh-list
44447186|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44447187|NCT01794689|Narcotics|narcotics|mesh-ancestor
44447188|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447189|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447190|NCT01794689|Analgesics|analgesics|mesh-ancestor
44447191|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
44447192|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447193|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44447218|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44447219|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447221|NCT01793051|Minocycline|minocycline|mesh-list
44447222|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44447223|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447224|NCT01792830|Metformin|metformin|mesh-list
44272380|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
44272381|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272382|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
44272383|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272384|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
44272385|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272386|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
44272387|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272388|NCT00688077|Calcitonin|calcitonin|mesh-list
44272389|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
44272390|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44272391|NCT00688077|Katacalcin|katacalcin|mesh-list
44272392|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44272393|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272394|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44272395|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
44272396|NCT00688194|Letrozole|letrozole|mesh-list
44272397|NCT00688194|Fulvestrant|fulvestrant|mesh-list
44272398|NCT00688194|Lapatinib|lapatinib|mesh-list
44272399|NCT00688194|Anastrozole|anastrozole|mesh-list
44272400|NCT00688194|Exemestane|exemestane|mesh-list
44447225|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
44447226|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447227|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447228|NCT01792518|Linagliptin|linagliptin|mesh-list
44447229|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447230|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447231|NCT01792518|Incretins|incretins|mesh-ancestor
44447232|NCT01792518|Hormones|hormones|mesh-ancestor
44447233|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447234|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44447235|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
44447236|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447237|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447238|NCT01792284|Insulin|insulin|mesh-list
44447239|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44447240|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
44447241|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447259|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447261|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447262|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447263|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172737|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
44447264|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447265|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
44447266|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447267|NCT01791803|Nicotine|nicotine|mesh-list
44447268|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44447269|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
44447270|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447271|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447272|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44447273|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44447274|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
44447275|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447276|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272401|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272402|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44272403|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44272404|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272405|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272406|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44272407|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
44272408|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272409|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272410|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44272411|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44272412|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44272413|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
44272414|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272415|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272416|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
44272417|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272418|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272419|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272420|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272426|NCT00688298|Imidacloprid|imidacloprid|mesh-list
44272453|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
44272454|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272455|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272456|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272458|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44272459|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44272460|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272461|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44272462|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44272463|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272464|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
44272465|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44272466|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44272467|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44272468|NCT00688480|Allopurinol|allopurinol|mesh-list
44272469|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
44447277|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44447278|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44447279|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
44447280|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44447281|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44447282|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44447283|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
44447284|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447285|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447286|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44447287|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44447288|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44447289|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447290|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447291|NCT01791153|Prednisone|prednisone|mesh-list
44447292|NCT01791153|Methotrexate|methotrexate|mesh-list
44447293|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447294|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
44447295|NCT01791153|Hormones|hormones|mesh-ancestor
44447296|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447297|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447298|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447299|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447336|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447337|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44447338|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
44447339|NCT01790594|Hormones|hormones|mesh-ancestor
44447369|NCT01790503|Temozolomide|temozolomide|mesh-list
44447370|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44447371|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
44447372|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447373|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447374|NCT01790438|Insulin|insulin|mesh-list
44447375|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44447376|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
44447377|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
44447378|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
44447379|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44447380|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447381|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44272470|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272472|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
44272473|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272474|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44272475|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
44272476|NCT00688480|Protective Agents|protective agents|mesh-ancestor
44272477|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272478|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
44272479|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
44272480|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44272481|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272482|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272483|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272484|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272485|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272486|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272487|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272488|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44272489|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
44272490|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447382|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447414|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44447415|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44447416|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447417|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
44447418|NCT01789320|Hormones|hormones|mesh-ancestor
44447419|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447420|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447421|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447422|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
44447423|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447424|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447455|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447456|NCT01789047|Analgesics|analgesics|mesh-ancestor
44447457|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
44447458|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447459|NCT01788566|Gemcitabine|gemcitabine|mesh-list
44447460|NCT01788566|Cisplatin|cisplatin|mesh-list
44447461|NCT01788566|Necitumumab|necitumumab|mesh-list
44447462|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447463|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447464|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
44447465|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447466|NCT01788566|Antiviral Agents|antiviral agents|mesh-ancestor
44447467|NCT01788566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447468|NCT01788566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447469|NCT01788566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447470|NCT01788566|Immunologic Factors|immunologic factors|mesh-ancestor
44447484|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
44447485|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
44172874|NCT00290823|Hormones|hormones|mesh-ancestor
44447486|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44272491|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272492|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44272493|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44272494|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44272495|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44272496|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272497|NCT00688558|Simvastatin|simvastatin|mesh-list
44272498|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
44272499|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272500|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272501|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
44272502|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272503|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43662108|NCT02918110|Misoprostol|misoprostol|mesh-list
44447487|NCT01788228|Vaccines|vaccines|mesh-list
44447488|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
44447489|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447490|NCT01788215|Doxycycline|doxycycline|mesh-list
44447491|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44447492|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447493|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
44447494|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44447495|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44447496|NCT01787331|Itraconazole|itraconazole|mesh-list
44447497|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
44447498|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447499|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44447500|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447501|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447502|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447503|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447504|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447505|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105702|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
44447506|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447507|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44447508|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44447509|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
44447510|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447511|NCT01787188|Meloxicam|meloxicam|mesh-list
44447512|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44447513|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447514|NCT01787188|Analgesics|analgesics|mesh-ancestor
44447515|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
44447516|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447517|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447518|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447519|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447520|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44447521|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44447522|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447523|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447524|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
44447525|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44447526|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44447527|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
44447553|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447555|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44447556|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796455|NCT05067517|Nintedanib|nintedanib|mesh-list
44272504|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44272506|NCT00688805|Propranolol|propranolol|mesh-list
44272507|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44272508|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44172939|NCT00290940|Metformin|metformin|mesh-list
44272509|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272510|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272511|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272512|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272513|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44272514|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272515|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44447557|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447558|NCT01786603|Rasagiline|rasagiline|mesh-list
44447559|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44447560|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447561|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447562|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44447563|NCT01786603|Protective Agents|protective agents|mesh-ancestor
44447564|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447565|NCT01786551|Eplerenone|eplerenone|mesh-list
44447566|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44447567|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447568|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447569|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447570|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44447571|NCT01786551|Diuretics|diuretics|mesh-ancestor
44447603|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44447604|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44447605|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44447606|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44447607|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44447608|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447609|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
44447610|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44447627|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
44447628|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447630|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
44447631|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44447632|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44447633|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447634|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447635|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447636|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447637|NCT01784419|Ivacaftor|ivacaftor|mesh-list
44447638|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44447639|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447640|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447641|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
44447642|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447643|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447644|NCT01784029|Vitamin D|vitamin d|mesh-list
44447645|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
44447646|NCT01784029|Vitamins|vitamins|mesh-ancestor
44447647|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
44447648|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447649|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44447650|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44447651|NCT01783938|Nivolumab|nivolumab|mesh-list
44447652|NCT01783938|Ipilimumab|ipilimumab|mesh-list
44272516|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44272517|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
44272518|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44272519|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44272520|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44447653|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44447654|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447655|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44447656|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447657|NCT01783886|Aflibercept|aflibercept|mesh-list
44447658|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44447659|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44447660|NCT01783886|Growth Substances|growth substances|mesh-ancestor
44447661|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447662|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
44447663|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447665|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
44447666|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447667|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44447668|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
44447669|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447703|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44447704|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447705|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447706|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44447707|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447708|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447726|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447727|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
44447728|NCT01782872|Ropivacaine|ropivacaine|mesh-list
44447729|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
44447730|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
44447731|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447732|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447733|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
44447734|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447735|NCT01782859|Prednisone|prednisone|mesh-list
44447736|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
44447737|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44447738|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44447739|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44447740|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447741|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
44447742|NCT01782859|Hormones|hormones|mesh-ancestor
44447743|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447744|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447745|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447746|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447747|NCT01782742|Bexarotene|bexarotene|mesh-list
44447748|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447749|NCT01782690|Gemcitabine|gemcitabine|mesh-list
44447750|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44447751|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447752|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
44447753|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447754|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447755|NCT01782690|Antiviral Agents|antiviral agents|mesh-ancestor
44447756|NCT01782690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447757|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447758|NCT01782690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447759|NCT01782690|Immunologic Factors|immunologic factors|mesh-ancestor
44447760|NCT01782690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447761|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44447762|NCT01782495|Ritonavir|ritonavir|mesh-list
44447763|NCT01782495|Ribavirin|ribavirin|mesh-list
44447764|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44447765|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44447766|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
44447767|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272521|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44272522|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272524|NCT00688857|Choline|choline|mesh-list
44272525|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
44272526|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272527|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
44272528|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272529|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44272530|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272531|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
44272532|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272533|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
44272534|NCT00688883|Fludarabine|fludarabine|mesh-list
44272535|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
44272536|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272537|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272538|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
44272539|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447768|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447803|NCT01781611|Aspirin|aspirin|mesh-list
44447804|NCT01781611|Dipyridamole|dipyridamole|mesh-list
44447828|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447829|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447830|NCT01780987|Heparin|heparin|mesh-list
44447831|NCT01780987|Calcium heparin|calcium heparin|mesh-list
44447832|NCT01780987|Warfarin|warfarin|mesh-list
44447833|NCT01780987|Apixaban|apixaban|mesh-list
44447834|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
44447835|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44447836|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44447837|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447838|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44447839|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
44447840|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44447841|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
44447842|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447843|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
44447844|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
44447845|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447846|NCT01780974|Protective Agents|protective agents|mesh-ancestor
44447847|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447848|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
44447849|NCT01780974|Vitamins|vitamins|mesh-ancestor
44447850|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
44447851|NCT01780935|Ranibizumab|ranibizumab|mesh-list
44447852|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44447853|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44447854|NCT01780935|Growth Substances|growth substances|mesh-ancestor
44447855|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447856|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
44447889|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447890|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44447892|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44447893|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
44447894|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447895|NCT01780389|Milnacipran|milnacipran|mesh-list
44447898|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44447899|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447932|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447933|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447934|NCT01778049|Incretins|incretins|mesh-ancestor
44447935|NCT01778049|Hormones|hormones|mesh-ancestor
44447936|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447972|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44447973|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44447974|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447975|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448007|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448008|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448009|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44448010|NCT01777581|Analgesics|analgesics|mesh-ancestor
44448011|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
44448012|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448042|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448043|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448044|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448045|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448046|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448047|NCT01777269|Tamsulosin|tamsulosin|mesh-list
44448048|NCT01777269|Dutasteride|dutasteride|mesh-list
44448049|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44448050|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44448051|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44448052|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448053|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448054|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448055|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448056|NCT01777269|Urological Agents|urological agents|mesh-ancestor
44448091|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448092|NCT01777139|Ezogabine|ezogabine|mesh-list
44448093|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
44448094|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448095|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448164|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44448165|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44448188|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44448189|NCT01775124|Ranibizumab|ranibizumab|mesh-list
44448190|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44448191|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44448192|NCT01775124|Growth Substances|growth substances|mesh-ancestor
44448193|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448194|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
44448195|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448197|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448198|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448199|NCT01774929|Fentanyl|fentanyl|mesh-list
44448200|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44448201|NCT01774929|Narcotics|narcotics|mesh-ancestor
44448202|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448203|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448204|NCT01774929|Analgesics|analgesics|mesh-ancestor
44448205|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
44448206|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448207|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44448208|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44448209|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
44448210|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
44448211|NCT01774903|Fentanyl|fentanyl|mesh-list
44448212|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44448213|NCT01774903|Narcotics|narcotics|mesh-ancestor
44448214|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448215|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448216|NCT01774903|Analgesics|analgesics|mesh-ancestor
44448217|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
44448218|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272541|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
44272542|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272543|NCT00688896|Pravastatin|pravastatin|mesh-list
44272544|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
44272545|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272546|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272547|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
44272548|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272549|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272550|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44448219|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44448253|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448255|NCT01773993|Analgesics|analgesics|mesh-ancestor
44448256|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
44448257|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448258|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448294|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448295|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44448296|NCT01773070|Ritonavir|ritonavir|mesh-list
44448297|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44448298|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44448330|NCT01772537|Propofol|propofol|mesh-list
44448331|NCT01772537|Isoflurane|isoflurane|mesh-list
44448332|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44448333|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448334|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448335|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44448336|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
44448337|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
44448338|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44448339|NCT01772368|Fluticasone|fluticasone|mesh-list
44448373|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448374|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448375|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448377|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44448378|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44448379|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44448380|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44448381|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448417|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448419|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448420|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
44448454|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44448455|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
44448456|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448457|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448458|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448459|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44448476|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448477|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
44448478|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448479|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448480|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448481|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44448482|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44448483|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448484|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448485|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448486|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
44272551|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272552|NCT00688922|Pravastatin|pravastatin|mesh-list
44272553|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272554|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272555|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
44272556|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272557|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272558|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44272559|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272560|NCT00688948|Alfuzosin|alfuzosin|mesh-list
44272561|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44272562|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44272563|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44272564|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
44272565|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272566|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662130|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44448487|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448488|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44448489|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44448490|NCT01769456|Tenofovir|tenofovir|mesh-list
44448491|NCT01769456|Emtricitabine|emtricitabine|mesh-list
44448492|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44448493|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
44448494|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448495|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44448496|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448497|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448498|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448499|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44448500|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44448501|NCT01769443|Bortezomib|bortezomib|mesh-list
44448502|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448503|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
44448504|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448505|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448506|NCT01769391|Paclitaxel|paclitaxel|mesh-list
44448507|NCT01769391|Carboplatin|carboplatin|mesh-list
44448508|NCT01769391|Necitumumab|necitumumab|mesh-list
44448509|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44448510|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448511|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
44448512|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
44448513|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
44448514|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448515|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448516|NCT01769378|Glimepiride|glimepiride|mesh-list
44448517|NCT01769378|Dulaglutide|dulaglutide|mesh-list
44448518|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44448519|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448532|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44448533|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
44448534|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448535|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448536|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44448537|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44272567|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272568|NCT00688948|Urological Agents|urological agents|mesh-ancestor
44272569|NCT00688961|Aspirin|aspirin|mesh-list
44272570|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272571|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272572|NCT00688961|Analgesics|analgesics|mesh-ancestor
44272573|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
44272574|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272575|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272576|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272577|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272578|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44272579|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44272580|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272581|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44272582|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44272583|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272584|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
44272585|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
44272586|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272587|NCT00689000|Tosedostat|tosedostat|mesh-list
44272588|NCT00689000|Glycine|glycine|mesh-list
44272589|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448539|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448540|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448541|NCT01768637|Aspirin|aspirin|mesh-list
44448542|NCT01768637|Clopidogrel|clopidogrel|mesh-list
44448543|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44448544|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44448545|NCT01768637|Analgesics|analgesics|mesh-ancestor
44448546|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
44448547|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448548|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448549|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448550|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448551|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44448552|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44448553|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448554|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44448555|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44448556|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448557|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
44448558|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44448559|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44448560|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44448561|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
44448562|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448563|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
44448564|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
44448565|NCT01768572|Methotrexate|methotrexate|mesh-list
44448566|NCT01768572|Leflunomide|leflunomide|mesh-list
44448567|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44448568|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
44272590|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272591|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
44272592|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272593|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272594|NCT00689143|Sargramostim|sargramostim|mesh-list
44272595|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
43926918|NCT00621049|Docetaxel|docetaxel|mesh-list
44272596|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272597|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
44272598|NCT00689156|Docetaxel|docetaxel|mesh-list
44272599|NCT00689156|Epirubicin|epirubicin|mesh-list
44272600|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272601|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
44272602|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272603|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272604|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44272605|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
44272606|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272607|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272608|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44272609|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272610|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272611|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272612|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44272613|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272614|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272615|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272616|NCT00689169|Cytarabine|cytarabine|mesh-list
44272617|NCT00689169|Rituximab|rituximab|mesh-list
44272618|NCT00689169|Etoposide|etoposide|mesh-list
44272619|NCT00689169|Melphalan|melphalan|mesh-list
43662155|NCT02917525|Vitamin K|vitamin k|mesh-list
44448569|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44448570|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448571|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448572|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
44448573|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448574|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448575|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448576|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448577|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44448578|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448579|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
44448580|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448616|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44272620|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44272621|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272622|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
44272623|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272624|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272625|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44272626|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272627|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272628|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272629|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272630|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44272631|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
44272632|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44272633|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272634|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272635|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
44272636|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
44272637|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272638|NCT00689195|Curcumin|curcumin|mesh-list
44272639|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272640|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44272641|NCT00689195|Analgesics|analgesics|mesh-ancestor
44272642|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
44272643|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272644|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272645|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272646|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448617|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44448618|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448619|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448620|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
44448621|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448650|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
44448651|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448652|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
44448653|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448654|NCT01766778|Metformin|metformin|mesh-list
44448655|NCT01766778|Vildagliptin|vildagliptin|mesh-list
44448656|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448657|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448658|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44448659|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
44448660|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448661|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448662|NCT01766336|Inositol|inositol|mesh-list
44448663|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
44272647|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272648|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272649|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272650|NCT00689208|Atropine|atropine|mesh-list
44272651|NCT00689208|Physostigmine|physostigmine|mesh-list
44272652|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44272653|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44272654|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44272655|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
44272656|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272657|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272658|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272659|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272660|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
44272661|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
44272662|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44272663|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44272664|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
44272665|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272666|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448664|NCT01766336|Vitamins|vitamins|mesh-ancestor
44448665|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
44448666|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448667|NCT01766310|Folic Acid|folic acid|mesh-list
44448668|NCT01766310|Hematinics|hematinics|mesh-ancestor
44448669|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
44448670|NCT01766310|Vitamins|vitamins|mesh-ancestor
44448700|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448701|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44448702|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44448703|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44448704|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44448705|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
44448706|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
44448707|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448708|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44448709|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44448710|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44448711|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448712|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448713|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
44448714|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448715|NCT01765764|Bimatoprost|bimatoprost|mesh-list
44448716|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44448717|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44448718|NCT01765582|Leucovorin|leucovorin|mesh-list
44448749|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44448750|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44448751|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448752|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448753|NCT01765569|Protective Agents|protective agents|mesh-ancestor
44448754|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448755|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448756|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448759|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43796513|NCT05065658|Posaconazole|posaconazole|mesh-list
44272667|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44272668|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272670|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44272671|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272672|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272673|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
44272674|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272675|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272676|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44272677|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272678|NCT00689442|Atorvastatin|atorvastatin|mesh-list
44272679|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
44272680|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272681|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272682|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
44272683|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272684|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44272685|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44272686|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272687|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
44272688|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44272689|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
44272690|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44272691|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662205|NCT02917057|Incretins|incretins|mesh-ancestor
44448760|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
44448761|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44448762|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448763|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
44448764|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448765|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448766|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448767|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44448795|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
44448796|NCT01765179|Testosterone|testosterone|mesh-list
44448797|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
44448798|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
44448799|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44448800|NCT01765179|Androgens|androgens|mesh-ancestor
44448801|NCT01765179|Hormones|hormones|mesh-ancestor
44448802|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448803|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448804|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44448805|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448806|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
44448807|NCT01764997|Adalimumab|adalimumab|mesh-list
44448808|NCT01764997|Etanercept|etanercept|mesh-list
44272693|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44272694|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44272695|NCT00689520|Vitamin K|vitamin k|mesh-list
44272696|NCT00689520|Tinzaparin|tinzaparin|mesh-list
44272697|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44272698|NCT00689520|Dalteparin|dalteparin|mesh-list
44272699|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
44272700|NCT00689520|Vitamins|vitamins|mesh-ancestor
44272701|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
44272702|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272703|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44272704|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44272705|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448809|NCT01764997|Methotrexate|methotrexate|mesh-list
44448836|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448837|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448838|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448839|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448840|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44448841|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44448843|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44448844|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44448845|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
44448846|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448847|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44448848|NCT01764464|Gabapentin|gabapentin|mesh-list
44448849|NCT01764464|Analgesics|analgesics|mesh-ancestor
44448850|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
44448851|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448852|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448853|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
44448854|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44448855|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44448891|NCT01763164|Dacarbazine|dacarbazine|mesh-list
44448892|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44448893|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
44448894|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448930|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44448931|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44448932|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448933|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
44448934|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
44448935|NCT01762800|Hormones|hormones|mesh-ancestor
44448968|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448969|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448970|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
44448971|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44448972|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44448973|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
44448974|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448975|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44449014|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44449044|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449045|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449046|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44449047|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
44449048|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
44449049|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796514|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
44272708|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
44272709|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44272710|NCT00689559|Aripiprazole|aripiprazole|mesh-list
44272711|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
44272712|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44272713|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44272714|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44272715|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44272716|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272717|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
44272718|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
44272719|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272720|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272721|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44272722|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44272723|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
44272724|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44272725|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44272726|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44272727|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44449050|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449051|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44449052|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44449053|NCT01756833|Doxycycline|doxycycline|mesh-list
44449054|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449085|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449086|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449087|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44449088|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449089|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449090|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
44449091|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44449092|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44449093|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44449094|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44449095|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
44449096|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449097|NCT01755637|Albendazole|albendazole|mesh-list
44449098|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
44449163|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44449164|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449165|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449166|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449167|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449168|NCT01754493|Analgesics|analgesics|mesh-ancestor
44449169|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
44449170|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272729|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
44272730|NCT00689598|Spironolactone|spironolactone|mesh-list
44272731|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44272732|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
44272733|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44272734|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272735|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44272736|NCT00689598|Diuretics|diuretics|mesh-ancestor
44272737|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
44272738|NCT00689624|Leucovorin|leucovorin|mesh-list
44272739|NCT00689624|Fluorouracil|fluorouracil|mesh-list
44272740|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
44449171|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
44449172|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44449173|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
44449174|NCT01754402|Dexamethasone|dexamethasone|mesh-list
44449205|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44449206|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44449207|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
44449208|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449209|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449210|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449211|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449213|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44449214|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449215|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449216|NCT01753856|Vitamin D|vitamin d|mesh-list
44449217|NCT01753856|Denosumab|denosumab|mesh-list
44449218|NCT01753856|Teriparatide|teriparatide|mesh-list
44449244|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449245|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449246|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449247|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
44449248|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44449249|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44449250|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44449251|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449252|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449253|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
44449254|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449255|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449256|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44449257|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449258|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
44449259|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44449260|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44449261|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44449262|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449263|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449264|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44449265|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449266|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449267|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44449292|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449293|NCT01752842|Fenofibrate|fenofibrate|mesh-list
44449294|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44449295|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
44449296|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449297|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44449298|NCT01752023|Gemcitabine|gemcitabine|mesh-list
44449299|NCT01752023|Itraconazole|itraconazole|mesh-list
44449300|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
44272741|NCT00689624|Irinotecan|irinotecan|mesh-list
44272742|NCT00689624|Cetuximab|cetuximab|mesh-list
44272743|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
44272744|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272745|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272746|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272747|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272748|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
44272749|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272750|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44272751|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272752|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272753|NCT00689624|Antidotes|antidotes|mesh-ancestor
44272754|NCT00689624|Protective Agents|protective agents|mesh-ancestor
43662255|NCT02916602|Losartan|losartan|mesh-list
44449301|NCT01752023|Cisplatin|cisplatin|mesh-list
44449302|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449303|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44449304|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
44449305|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449306|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
44449307|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449308|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449309|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449310|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
44449311|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449312|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
44449313|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44449314|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44449315|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44449349|NCT01751646|Vitamins|vitamins|mesh-list
44449350|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
44449351|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449352|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44449353|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44449354|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
44449383|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44449384|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449385|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
44449386|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44449387|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
44449388|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44449389|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
44449390|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449391|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449392|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44449393|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44449394|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44449395|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449396|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
44449397|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
44449398|NCT01751113|Hormones|hormones|mesh-ancestor
44449399|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449400|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
44449401|NCT01751087|Vitamins|vitamins|mesh-list
44449402|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
44449403|NCT01751087|Misoprostol|misoprostol|mesh-list
44449432|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44449433|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449434|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449435|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
44272757|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
44272758|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44272759|NCT00689637|Warfarin|warfarin|mesh-list
44272760|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
44272761|NCT00689702|Capecitabine|capecitabine|mesh-list
44272762|NCT00689702|Cetuximab|cetuximab|mesh-list
44272763|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272764|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
44272765|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272766|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272767|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44272768|NCT00689715|Ethanol|ethanol|mesh-list
44272769|NCT00689715|Paclitaxel|paclitaxel|mesh-list
44272770|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44272771|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44272772|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272773|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272774|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272775|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449436|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449437|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44449438|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449439|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449440|NCT01750840|Cimetidine|cimetidine|mesh-list
44449441|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44449442|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449443|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44449444|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
44449445|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
44449446|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449447|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449448|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449449|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44449486|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449487|NCT01748994|Pioglitazone|pioglitazone|mesh-list
44449488|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44449521|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
44449522|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44449523|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449524|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449525|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44449526|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44449527|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44449528|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449529|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44449530|NCT01747629|Albuterol|albuterol|mesh-list
44449562|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44449563|NCT01747551|Growth Substances|growth substances|mesh-ancestor
44449564|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
44449565|NCT01747499|Azacitidine|azacitidine|mesh-list
44449566|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272776|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449567|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
44449568|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449569|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449570|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449572|NCT01746901|Oxycodone|oxycodone|mesh-list
44449573|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449574|NCT01746901|Narcotics|narcotics|mesh-ancestor
44449575|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449602|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44449603|NCT01746225|Paclitaxel|paclitaxel|mesh-list
44449604|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44449605|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449606|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44449607|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44449608|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449609|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449610|NCT01745380|Phenylephrine|phenylephrine|mesh-list
44449611|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
44449612|NCT01745380|Tetracaine|tetracaine|mesh-list
44449613|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
44449614|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
44449615|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449616|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449617|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
44449618|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449619|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44449620|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44449621|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449622|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449638|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449639|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449640|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
44449641|NCT01745094|Mirabegron|mirabegron|mesh-list
44449642|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44449643|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44449644|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
44449645|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449646|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449647|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449648|NCT01745094|Urological Agents|urological agents|mesh-ancestor
44449649|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44449650|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44449651|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44449652|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449653|NCT01744782|Cysteamine|cysteamine|mesh-list
44449654|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44449655|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449656|NCT01744496|Rotigotine|rotigotine|mesh-list
44449657|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
44449658|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
44449659|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449660|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449661|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449662|NCT01744197|Lidocaine|lidocaine|mesh-list
44449663|NCT01744197|Tetracaine|tetracaine|mesh-list
44449664|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
44449665|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
44449666|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449667|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449668|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
44449669|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449670|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44449671|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44449672|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44449673|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449674|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449675|NCT01744093|Doxycycline|doxycycline|mesh-list
44449676|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449677|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449678|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
44272777|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44272778|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449679|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44449680|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44449681|NCT01743560|Everolimus|everolimus|mesh-list
44449682|NCT01743560|Exemestane|exemestane|mesh-list
44449714|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44449715|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449716|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44449718|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449719|NCT01742897|Narcotics|narcotics|mesh-ancestor
44449720|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449738|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449739|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
44449740|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449741|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
44449742|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449743|NCT01741532|Deferiprone|deferiprone|mesh-list
44449744|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44449745|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
44449746|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
44449747|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449748|NCT01741259|Meperidine|meperidine|mesh-list
44449749|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449750|NCT01741259|Narcotics|narcotics|mesh-ancestor
44449751|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449752|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449753|NCT01741259|Analgesics|analgesics|mesh-ancestor
44449754|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
44449755|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449756|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44449757|NCT01740791|Velpatasvir|velpatasvir|mesh-list
44449758|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
44449759|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449760|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
44449761|NCT01740401|Ipilimumab|ipilimumab|mesh-list
44449762|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449763|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
44449764|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449765|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449766|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44449767|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
44449768|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449769|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449770|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44449771|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44449772|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44449773|NCT01740388|Besifloxacin|besifloxacin|mesh-list
44449774|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449775|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449776|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44449777|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44449778|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173955|NCT00294944|Idazoxan|idazoxan|mesh-list
44449779|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449792|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449793|NCT01740154|Sunitinib|sunitinib|mesh-list
44449794|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449795|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44449796|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44449797|NCT01740154|Growth Substances|growth substances|mesh-ancestor
44449798|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449799|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44449800|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449801|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449802|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449803|NCT01740089|Ribavirin|ribavirin|mesh-list
44449804|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44449805|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
44449806|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449807|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
44449808|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449809|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
44272779|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44272780|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272781|NCT00689780|Midazolam|midazolam|mesh-list
44272782|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44272783|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44272784|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44272785|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272786|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44272787|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44272788|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44272789|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44272790|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
44272791|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
44272792|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
44272793|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
44272794|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44272795|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272796|NCT00689806|Lovastatin|lovastatin|mesh-list
44272797|NCT00689806|L 647318|l 647318|mesh-list
44272798|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
44272799|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44272800|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44272837|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
44272838|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272839|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272840|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44272841|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
44272842|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272843|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272844|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44272845|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44272846|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44272847|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272848|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272849|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272850|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272851|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
44272852|NCT00689845|Hormones|hormones|mesh-ancestor
44272853|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662292|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
44449810|NCT01739933|Propofol|propofol|mesh-list
44449811|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44449812|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449813|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449814|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44449815|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
44449816|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
44449817|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449818|NCT01739933|Analgesics|analgesics|mesh-ancestor
44449819|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
44449820|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449821|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44449822|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44449823|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44449824|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449825|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449826|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449827|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
44449828|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44449829|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
44449830|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449831|NCT01739790|Expectorants|expectorants|mesh-ancestor
44449832|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449833|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44449834|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
44449835|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449837|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449838|NCT01739790|Antidotes|antidotes|mesh-ancestor
44449839|NCT01739764|Vemurafenib|vemurafenib|mesh-list
44449840|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449841|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449842|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449863|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
44449864|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449865|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272854|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44272855|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44272856|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
44272857|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44272858|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44272859|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
44272860|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
44272861|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44272862|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44272863|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44272864|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
44272865|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272866|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272867|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272868|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272870|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44272871|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
44272872|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272873|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272874|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272875|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272876|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44272877|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43662308|NCT02916121|Folic Acid|folic acid|mesh-list
44449866|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44449867|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44449868|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44449869|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
44449870|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44449871|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44449872|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44449873|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449874|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
44449875|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44449876|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44449877|NCT01738971|Progestins|progestins|mesh-list
44449878|NCT01738971|Hormones|hormones|mesh-ancestor
44449879|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449880|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449881|NCT01738646|Bevacizumab|bevacizumab|mesh-list
44449882|NCT01738646|Vorinostat|vorinostat|mesh-list
44449883|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44449884|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449885|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44449886|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44449887|NCT01738646|Growth Substances|growth substances|mesh-ancestor
44449888|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272878|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272879|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44272880|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
44272881|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44272882|NCT00689858|Protective Agents|protective agents|mesh-ancestor
44272883|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44272884|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44272885|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272886|NCT00689949|Folic Acid|folic acid|mesh-list
44272887|NCT00689949|Hematinics|hematinics|mesh-ancestor
44272888|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
44272889|NCT00689949|Vitamins|vitamins|mesh-ancestor
44272890|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
44272891|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272892|NCT00690014|Probenecid|probenecid|mesh-list
44272893|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
44272894|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
44272895|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272896|NCT00690014|Renal Agents|renal agents|mesh-ancestor
44272897|NCT00690105|Fluticasone|fluticasone|mesh-list
44272898|NCT00690105|Tacrolimus|tacrolimus|mesh-list
44272899|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449889|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
44449890|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44449891|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449892|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449909|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449911|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449912|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449913|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
44449914|NCT01737931|Promethazine|promethazine|mesh-list
44449915|NCT01737931|Dexamethasone|dexamethasone|mesh-list
44449916|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44449917|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
44449918|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449919|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
44449920|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
44449921|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449922|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449923|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449924|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
44449925|NCT01737931|Hormones|hormones|mesh-ancestor
44449926|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449927|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449928|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449929|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44449930|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44449931|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449932|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
44449933|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
44449934|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
44449935|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
44449936|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449937|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449938|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44449939|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
44272900|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
44272901|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272902|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44272903|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272904|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272905|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44272906|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44272907|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
44272908|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44272909|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44272910|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44272911|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
44272912|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44462979|NCT01520922|Ofatumumab|ofatumumab|mesh-list
44462980|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44462981|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
44462982|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462983|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462984|NCT01520402|Warfarin|warfarin|mesh-list
44462985|NCT01520402|Anticoagulants|anticoagulants|mesh-list
44462986|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
44462987|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
44462988|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462989|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44462990|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44462991|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462992|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462993|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927289|NCT00628628|Rasburicase|rasburicase|mesh-list
44449940|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
44449941|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
44449942|NCT01737879|Hematinics|hematinics|mesh-ancestor
44449943|NCT01737840|Pantoprazole|pantoprazole|mesh-list
44449944|NCT01737840|Ranitidine|ranitidine|mesh-list
44449945|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44449946|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44449947|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449948|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44449949|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449950|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449966|NCT01736917|Dexamethasone|dexamethasone|mesh-list
44449967|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
44449968|NCT01736917|Aprepitant|aprepitant|mesh-list
44449969|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449970|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
44449971|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
44449972|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449973|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449974|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449975|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
44449976|NCT01736917|Hormones|hormones|mesh-ancestor
44449977|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449978|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449979|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449980|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44108337|NCT00081575|Levofloxacin|levofloxacin|mesh-list
44449981|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449982|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449983|NCT01736696|Tofacitinib|tofacitinib|mesh-list
44449984|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449985|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449986|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449987|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
44449988|NCT01736579|Antibodies|antibodies|mesh-list
44449989|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
44449990|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44449991|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44449992|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
44449993|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449994|NCT01736475|Factor VIII|factor viii|mesh-list
44272940|NCT00690300|Docetaxel|docetaxel|mesh-list
44272941|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
44449995|NCT01736475|BAX 855|bax 855|mesh-list
44449996|NCT01736475|Coagulants|coagulants|mesh-ancestor
44449997|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
44449998|NCT01736254|Evacetrapib|evacetrapib|mesh-list
44449999|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44450000|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
44450001|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450002|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44450003|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44450004|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44450005|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450006|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44450007|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
44450008|NCT01736215|Hematinics|hematinics|mesh-ancestor
44450009|NCT01736189|Adalimumab|adalimumab|mesh-list
44450010|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450011|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450042|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
44450043|NCT01734902|Scopolamine|scopolamine|mesh-list
44450044|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44450045|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44450046|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
44450047|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
44450048|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450049|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450050|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450051|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
44450052|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44450053|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
44450054|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450085|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
44450086|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450087|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450088|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450090|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44450091|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450092|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450093|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
44450094|NCT01734395|Galantamine|galantamine|mesh-list
44450095|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44450109|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450110|NCT01733758|Incretins|incretins|mesh-ancestor
44450111|NCT01733758|Hormones|hormones|mesh-ancestor
44450112|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450113|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44450114|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
44450115|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44450116|NCT01733680|Amiloride|amiloride|mesh-list
44450117|NCT01733680|Diuretics|diuretics|mesh-ancestor
44450118|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
44450119|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450120|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44450121|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44450122|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450123|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450124|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44450125|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44450126|NCT01733329|Folic Acid|folic acid|mesh-list
44450127|NCT01733329|Misoprostol|misoprostol|mesh-list
44450128|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44450129|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
44450130|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44450131|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450132|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44450133|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450134|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
44450135|NCT01733329|Hematinics|hematinics|mesh-ancestor
44450136|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
44450137|NCT01733329|Vitamins|vitamins|mesh-ancestor
44450138|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
44450139|NCT01733316|Cysteamine|cysteamine|mesh-list
44450140|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44450141|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450142|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
44272942|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272943|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
44272944|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
44272945|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
44272946|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272947|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
44272948|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44272949|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44272950|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44272951|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44272952|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44272953|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44272954|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272955|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44272956|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44272957|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
44272958|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662325|NCT02915731|Vitamin A|vitamin a|mesh-list
44450143|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44450144|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450145|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174338|NCT00296010|Doxorubicin|doxorubicin|mesh-list
44450146|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450147|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44450148|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450149|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450150|NCT01732926|Rituximab|rituximab|mesh-list
44450151|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44450152|NCT01732926|Idelalisib|idelalisib|mesh-list
44450153|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450154|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450155|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
44450156|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450157|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450175|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44450176|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44450177|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
44450178|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450179|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450180|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450182|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
44450183|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450184|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
44450185|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450186|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
44450187|NCT01732770|Denosumab|denosumab|mesh-list
44450188|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44450189|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450190|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44450191|NCT01732757|Dextrans|dextrans|mesh-list
44450192|NCT01732757|Alcaftadine|alcaftadine|mesh-list
44450193|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
44450194|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
44450195|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
44450196|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44272959|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272960|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44272961|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44272962|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44272964|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
44272965|NCT00690417|Vitamins|vitamins|mesh-ancestor
44272966|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
44272967|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272968|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44272969|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44272970|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44272971|NCT00690521|Metolazone|metolazone|mesh-list
44272972|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272973|NCT00690521|Diuretics|diuretics|mesh-ancestor
44272974|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
44272975|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272976|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44272977|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44272978|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272979|NCT00690534|Insulin|insulin|mesh-list
44272980|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44272981|NCT00690534|Nitroprusside|nitroprusside|mesh-list
44272982|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44272983|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272984|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44272985|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
44272986|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44272987|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272988|NCT00690560|Prednisone|prednisone|mesh-list
44450197|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44450198|NCT01732757|Analgesics|analgesics|mesh-ancestor
44450199|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
44450200|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450201|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450202|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450203|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450204|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44450205|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44108523|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
44450206|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44450207|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
44450208|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
44450209|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450210|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44272990|NCT00690560|Rituximab|rituximab|mesh-list
44272991|NCT00690560|Doxorubicin|doxorubicin|mesh-list
44272992|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44272993|NCT00690560|Vincristine|vincristine|mesh-list
44272994|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44272995|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
44272996|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44272997|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44272998|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44272999|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
44273000|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273001|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273002|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44273003|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44273004|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273005|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44273006|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44273007|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273008|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273009|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
44273010|NCT00690560|Hormones|hormones|mesh-ancestor
44273011|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273012|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927363|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
44273013|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43662363|NCT02915354|Analgesics|analgesics|mesh-ancestor
44450211|NCT01732640|Paclitaxel|paclitaxel|mesh-list
44450212|NCT01732640|Cisplatin|cisplatin|mesh-list
44450213|NCT01732640|Carboplatin|carboplatin|mesh-list
44450251|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44450290|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44450291|NCT01730729|Cabergoline|cabergoline|mesh-list
44450324|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44450325|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44450326|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450327|NCT01730040|Atorvastatin|atorvastatin|mesh-list
44450328|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44450329|NCT01730040|Ezetimibe|ezetimibe|mesh-list
44450330|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44450331|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44450332|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
44450355|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44450356|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44174441|NCT00296218|Irbesartan|irbesartan|mesh-list
44450357|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
44450358|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450359|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450360|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273014|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273015|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273016|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273017|NCT00690677|Panobinostat|panobinostat|mesh-list
44273018|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273019|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44273020|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273021|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273022|NCT00690768|Bevacizumab|bevacizumab|mesh-list
44273023|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44273024|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273025|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44273026|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43662374|NCT02915172|Capecitabine|capecitabine|mesh-list
44450361|NCT01729819|Urological Agents|urological agents|mesh-ancestor
44450362|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
44450363|NCT01729819|Coagulants|coagulants|mesh-ancestor
44450364|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44450365|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
44450366|NCT01729728|Tapentadol|tapentadol|mesh-list
44450367|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44450368|NCT01729728|Narcotics|narcotics|mesh-ancestor
44450369|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450370|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450371|NCT01729728|Analgesics|analgesics|mesh-ancestor
44450372|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
44450373|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450374|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44450375|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450376|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450377|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450378|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
44450379|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450380|NCT01729559|Heparin|heparin|mesh-list
44450381|NCT01729559|Enoxaparin|enoxaparin|mesh-list
44450382|NCT01729559|Calcium heparin|calcium heparin|mesh-list
44450383|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
44450384|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
44450385|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44450386|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44450400|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450402|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450403|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44450404|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450405|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450406|NCT01728584|Bromides|bromides|mesh-list
44450407|NCT01728584|Rocuronium|rocuronium|mesh-list
44450408|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
44450409|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44450410|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44450411|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44450412|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450413|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450414|NCT01728376|Daptomycin|daptomycin|mesh-list
44450415|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44450416|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450417|NCT01728324|Ribavirin|ribavirin|mesh-list
44450418|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
44450419|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450420|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
44450421|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450422|NCT01728246|Acetaminophen|acetaminophen|mesh-list
44450423|NCT01728246|Tramadol|tramadol|mesh-list
44273027|NCT00690768|Growth Substances|growth substances|mesh-ancestor
44273028|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273029|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
44273030|NCT00690781|Caseins|caseins|mesh-list
44273031|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
44273032|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
44273033|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273034|NCT00690846|Adalimumab|adalimumab|mesh-list
44273035|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273036|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273037|NCT00690872|Gemcitabine|gemcitabine|mesh-list
44273038|NCT00690872|Carboplatin|carboplatin|mesh-list
44273039|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273040|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44273041|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
44273042|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273043|NCT00690872|Antiviral Agents|antiviral agents|mesh-ancestor
43662385|NCT02915055|Oxycodone|oxycodone|mesh-list
44450424|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44450425|NCT01728246|Analgesics|analgesics|mesh-ancestor
44450426|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
44450427|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450428|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450429|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
44450430|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44450431|NCT01728246|Narcotics|narcotics|mesh-ancestor
44450432|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450433|NCT01728194|Citalopram|citalopram|mesh-list
44450434|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44450435|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450436|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450437|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450438|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450439|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
44450440|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108827|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450441|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44450442|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450443|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450444|NCT01728077|Brivaracetam|brivaracetam|mesh-list
44450445|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
44450446|NCT01727713|Aripiprazole|aripiprazole|mesh-list
44450447|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450478|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44450479|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44450480|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44450481|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44450482|NCT01727258|Fluorides|fluorides|mesh-list
44450483|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
44450484|NCT01727258|Protective Agents|protective agents|mesh-ancestor
44450485|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450486|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
44450487|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44450488|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44450489|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44450508|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450509|NCT01726335|Risperidone|risperidone|mesh-list
44450510|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44450511|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
44273044|NCT00690872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273045|NCT00690872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273046|NCT00690872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273047|NCT00690872|Immunologic Factors|immunologic factors|mesh-ancestor
44273048|NCT00690872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273049|NCT00690885|Interferons|interferons|mesh-list
44273050|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
44273051|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
44273052|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44273053|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273054|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
44273055|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273056|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
44273057|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450512|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450513|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450514|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450515|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450516|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450517|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450518|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450519|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44450520|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
44450521|NCT01726270|Tamsulosin|tamsulosin|mesh-list
44450522|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44450523|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44450524|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44450525|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
44450526|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450527|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450528|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450529|NCT01726270|Urological Agents|urological agents|mesh-ancestor
44450530|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
44450531|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
44450532|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44450533|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44450534|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450535|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450536|NCT01726049|Urological Agents|urological agents|mesh-ancestor
44450537|NCT01726023|Metronidazole|metronidazole|mesh-list
44450538|NCT01726023|Meropenem|meropenem|mesh-list
44450539|NCT01726023|Ceftazidime|ceftazidime|mesh-list
44450540|NCT01726023|Avibactam|avibactam|mesh-list
44450541|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44450542|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450543|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44450571|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450572|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450573|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450574|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44450575|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450576|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450577|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450578|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450579|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450580|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450582|NCT01725126|Liraglutide|liraglutide|mesh-list
44450583|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450584|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450585|NCT01725126|Incretins|incretins|mesh-ancestor
44450586|NCT01725126|Hormones|hormones|mesh-ancestor
44106617|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44273059|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273060|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273061|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44273062|NCT00690937|Sevelamer|sevelamer|mesh-list
44273063|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
44273064|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
44273065|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273066|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44273067|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44273068|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
44273069|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44273070|NCT00690950|Dutasteride|dutasteride|mesh-list
44273071|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44273072|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44273073|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273074|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273075|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
44273076|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273077|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273078|NCT00691067|Mifepristone|mifepristone|mesh-list
44273079|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44273080|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
44273081|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44273082|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273083|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44273084|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44450587|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450588|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
44450589|NCT01724866|Docetaxel|docetaxel|mesh-list
44450590|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450591|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
44450621|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450622|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44450623|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44450624|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
44450625|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450626|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450627|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44450628|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44450629|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
44450630|NCT01724177|Lenalidomide|lenalidomide|mesh-list
44450631|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
44450632|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450633|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44273086|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
44273087|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44273088|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44273089|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
44273090|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273091|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
44273092|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44273093|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44273094|NCT00691145|Tacrolimus|tacrolimus|mesh-list
44273095|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273096|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
44273097|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273098|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44273099|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273100|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273101|NCT00691184|Terbinafine|terbinafine|mesh-list
44273102|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
44273103|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273104|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273105|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273106|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
44273107|NCT00691236|Doxorubicin|doxorubicin|mesh-list
44273108|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273109|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273110|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44273111|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44273112|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273113|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273114|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44273115|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273116|NCT00691262|Tacrolimus|tacrolimus|mesh-list
44273117|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273118|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
44174760|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
44450634|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44450653|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
44450654|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450655|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273119|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273120|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44273121|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273122|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273123|NCT00691275|Ondansetron|ondansetron|mesh-list
44273124|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
44273125|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
44273126|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273127|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273128|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273129|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
44273130|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
44273131|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44273132|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
44273133|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273134|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273135|NCT00691275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44273136|NCT00691275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450656|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450657|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
44450658|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450659|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450660|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44450661|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450662|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450663|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
44450664|NCT01724021|Hormones|hormones|mesh-ancestor
44450665|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450666|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44450667|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44450668|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450669|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450670|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450671|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
44450672|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
44450673|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450674|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450675|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44450676|NCT01724021|Protective Agents|protective agents|mesh-ancestor
44450677|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44450678|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44450679|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44450680|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450681|NCT01723904|Rotigotine|rotigotine|mesh-list
44450682|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
44450683|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
44450684|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450685|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450686|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450687|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
44450688|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
44450689|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450690|NCT01723228|Rasagiline|rasagiline|mesh-list
44450691|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44450692|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796637|NCT05062681|Protective Agents|protective agents|mesh-ancestor
44273137|NCT00691275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273138|NCT00691275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273139|NCT00691275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44273140|NCT00691379|Paclitaxel|paclitaxel|mesh-list
44273141|NCT00691379|Bevacizumab|bevacizumab|mesh-list
44273142|NCT00691379|Carboplatin|carboplatin|mesh-list
44273143|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273144|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273145|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273146|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273147|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273148|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273149|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44273150|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44273151|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44273152|NCT00691379|Growth Substances|growth substances|mesh-ancestor
44273153|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273154|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44273155|NCT00691392|Linezolid|linezolid|mesh-list
44273156|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273157|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273158|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44273159|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273160|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273161|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44273162|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
44273163|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44273164|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
44273165|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273166|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273167|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44273168|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273170|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44273178|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273180|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
44273181|NCT00691548|Cetuximab|cetuximab|mesh-list
44273182|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44273183|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273184|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
44273185|NCT00691613|Hematinics|hematinics|mesh-ancestor
44273186|NCT00691795|Clonidine|clonidine|mesh-list
44273187|NCT00691795|Fentanyl|fentanyl|mesh-list
44273188|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44273189|NCT00691795|Narcotics|narcotics|mesh-ancestor
44273190|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273191|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273192|NCT00691795|Analgesics|analgesics|mesh-ancestor
44273193|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
44273194|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273195|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44273196|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44273197|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
44273198|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
44273199|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44273200|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
44273201|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
44273202|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44273203|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44273204|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44273205|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273206|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273207|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273208|NCT00691873|Omalizumab|omalizumab|mesh-list
44273209|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44273210|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44273211|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273212|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
44273213|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44450693|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450727|NCT01722097|Rocuronium|rocuronium|mesh-list
44450728|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44450729|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44450730|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44450731|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273215|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273216|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44273217|NCT00691886|Analgesics|analgesics|mesh-ancestor
44273218|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
44273219|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273220|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44273221|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44273222|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44273223|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273224|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273225|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273226|NCT00691912|Paclitaxel|paclitaxel|mesh-list
44273227|NCT00691912|Doxorubicin|doxorubicin|mesh-list
44273228|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44273229|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273230|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273231|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273232|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273233|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273234|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273235|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273236|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44273237|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44273238|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273239|NCT00691951|Budesonide|budesonide|mesh-list
44273240|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
44273241|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273242|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44273243|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
44273244|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273245|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273246|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44273247|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273248|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
44273249|NCT00691951|Hormones|hormones|mesh-ancestor
44273250|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273251|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44273252|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44273253|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44273254|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273255|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273256|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273258|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44273259|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44273260|NCT00692016|Analgesics|analgesics|mesh-ancestor
44273261|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
44273262|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450732|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450733|NCT01722071|Oxytocin|oxytocin|mesh-list
44450734|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
44450802|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450804|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
44450805|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450806|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450807|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44450808|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44450809|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44450810|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
44450811|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450812|NCT01721070|Ketoconazole|ketoconazole|mesh-list
44450849|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
44450850|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44450864|NCT01720602|Vorinostat|vorinostat|mesh-list
44450865|NCT01720602|Exemestane|exemestane|mesh-list
44450866|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44450867|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450868|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44450869|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44450870|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450871|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450872|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44450873|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
44450874|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450875|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450876|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44450877|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44450878|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44450879|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
44450880|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44450881|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44450882|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44450883|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450884|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450885|NCT01720524|Urological Agents|urological agents|mesh-ancestor
44450886|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44450887|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450888|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450889|NCT01720264|Incretins|incretins|mesh-ancestor
44450890|NCT01720264|Hormones|hormones|mesh-ancestor
44450891|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450892|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44450893|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
44273263|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273264|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273265|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273266|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
44273267|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44273268|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273269|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273270|NCT00692055|Naproxen|naproxen|mesh-list
44273271|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44273272|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44273273|NCT00692055|Analgesics|analgesics|mesh-ancestor
44273274|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
44273275|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273276|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273277|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273278|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273279|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
44273280|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44273281|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273282|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273283|NCT00692120|Vitamin D|vitamin d|mesh-list
44273284|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
44273294|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273295|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44273296|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44273297|NCT00692172|Alefacept|alefacept|mesh-list
44273298|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44273299|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
44273300|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273301|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44273302|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44273303|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44273304|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
44273305|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273306|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44273307|NCT00692263|Tramadol|tramadol|mesh-list
44273308|NCT00692263|Citalopram|citalopram|mesh-list
44273309|NCT00692263|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44273310|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174961|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273311|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273312|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273313|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450894|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450895|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450896|NCT01720225|Azacitidine|azacitidine|mesh-list
44450897|NCT01720225|Decitabine|decitabine|mesh-list
44450898|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44450899|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
44450900|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450901|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450902|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450903|NCT01720043|Bortezomib|bortezomib|mesh-list
44450904|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450905|NCT01719861|Desipramine|desipramine|mesh-list
44450906|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44450907|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450908|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450909|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450927|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
44450928|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450929|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44450930|NCT01719380|Cetuximab|cetuximab|mesh-list
44450931|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450932|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450933|NCT01719237|Ropivacaine|ropivacaine|mesh-list
44450934|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
44450935|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
44450936|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
44450937|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450938|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450939|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
44450940|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450941|NCT01719172|Hemostatics|hemostatics|mesh-list
44273314|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
44273315|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273316|NCT00692263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44273317|NCT00692263|Antidepressive Agents|antidepressive agents|mesh-ancestor
44273318|NCT00692263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273319|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273320|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44273321|NCT00692263|Narcotics|narcotics|mesh-ancestor
44273322|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273323|NCT00692263|Analgesics|analgesics|mesh-ancestor
44273324|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
44273325|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
44273326|NCT00692315|Vitamins|vitamins|mesh-ancestor
44450942|NCT01719172|Coagulants|coagulants|mesh-ancestor
44450944|NCT01719003|Empagliflozin|empagliflozin|mesh-list
44450945|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450946|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450947|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44450948|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450949|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44450950|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44450951|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450952|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44450953|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450954|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450955|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450956|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
44450957|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450958|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44450959|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44450960|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450961|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44450962|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450963|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450964|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450965|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
44450988|NCT01717456|Loperamide|loperamide|mesh-list
44450989|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
44450990|NCT01717456|Laxatives|laxatives|mesh-list
44450991|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450992|NCT01717326|Ribavirin|ribavirin|mesh-list
44450993|NCT01717326|Grazoprevir|grazoprevir|mesh-list
44450994|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
44450995|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450996|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
44450997|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450998|NCT01717313|Metformin|metformin|mesh-list
44450999|NCT01717313|Glimepiride|glimepiride|mesh-list
44451000|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451001|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451002|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44451003|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451004|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
44451005|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
44451006|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44451007|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44451008|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
44451009|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451010|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44451011|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44451012|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451013|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273327|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
44273328|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273329|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
44273330|NCT00692328|Levodopa|levodopa|mesh-list
44273331|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44273332|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44273333|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
44273334|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273335|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273336|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273337|NCT00692354|Tosedostat|tosedostat|mesh-list
44273338|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273339|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273340|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
44273341|NCT00692510|Midazolam|midazolam|mesh-list
44273342|NCT00692510|Caffeine|caffeine|mesh-list
44273343|NCT00692510|Bupropion|bupropion|mesh-list
44273344|NCT00692510|Omeprazole|omeprazole|mesh-list
44273345|NCT00692510|Bilirubin|bilirubin|mesh-list
44273346|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44273347|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44273348|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273349|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273350|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44273351|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44451014|NCT01717040|Pioglitazone|pioglitazone|mesh-list
44451015|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451016|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451018|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44451019|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451020|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451021|NCT01716715|Paclitaxel|paclitaxel|mesh-list
44451054|NCT01716052|Ibuprofen|ibuprofen|mesh-list
44451055|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44451056|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44451057|NCT01716052|Analgesics|analgesics|mesh-ancestor
44451058|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
44451059|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451060|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451061|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451078|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44451079|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44451080|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451081|NCT01715415|Ribavirin|ribavirin|mesh-list
44451082|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
44451083|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451084|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
44451085|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451086|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
44451087|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44451088|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44451089|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44273352|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273353|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44273354|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
44273356|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
44273357|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
44273358|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273359|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273360|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44273361|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273362|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44273363|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273364|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44273365|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44273366|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44273367|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44273368|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
44273369|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44273370|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
44273371|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44273372|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44273373|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273374|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
44273375|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44451090|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451091|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451092|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451093|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451094|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44451095|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
44451096|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44451097|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
44451098|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451099|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451100|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44451101|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44451102|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451103|NCT01714609|Sorafenib|sorafenib|mesh-list
44451104|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451105|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44451106|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451107|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451108|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
44451109|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
44451110|NCT01714544|Hormones|hormones|mesh-ancestor
44451111|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451112|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273376|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44273377|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44273378|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
44273379|NCT00692510|Protective Agents|protective agents|mesh-ancestor
44273380|NCT00692601|Capsaicin|capsaicin|mesh-list
44273381|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
44273382|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
44273383|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
44273384|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273385|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273386|NCT00692614|Triamcinolone|triamcinolone|mesh-list
44273387|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44273388|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44273389|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44273390|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273391|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
44273392|NCT00692614|Hormones|hormones|mesh-ancestor
43662495|NCT02914028|Analgesics|analgesics|mesh-ancestor
44451113|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44451114|NCT01714310|Fluoxetine|fluoxetine|mesh-list
44451115|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44451116|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44451117|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451118|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451119|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451135|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
44451136|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451137|NCT01713530|Insulin|insulin|mesh-list
44451138|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44451139|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
44451140|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
44451141|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44451142|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451143|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451144|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
44451145|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
44451146|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451147|NCT01712984|Fluconazole|fluconazole|mesh-list
44451148|NCT01712984|Vaccines|vaccines|mesh-list
44451149|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
44451150|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451151|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
44451152|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451153|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44451154|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44451155|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451156|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451157|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44451158|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
44451159|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451160|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44451161|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44451162|NCT01712854|Budesonide|budesonide|mesh-list
44109495|NCT04542278|Prednisone|prednisone|mesh-list
44451163|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44451164|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451165|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451166|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
44273393|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273394|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273395|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273396|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
44273397|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273398|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273399|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44273400|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273401|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44273402|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273403|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273404|NCT00692731|Caffeine|caffeine|mesh-list
44273405|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44273406|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273407|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44273408|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273409|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825847|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
44451167|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451168|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451169|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451170|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451171|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
44451172|NCT01712854|Hormones|hormones|mesh-ancestor
44451173|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451174|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
44451175|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44451176|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44451188|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451189|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44451190|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44451191|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451192|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451193|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44451194|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
44451195|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451196|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451197|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451198|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451199|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451200|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
44451201|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451203|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
44451204|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451205|NCT01712178|Adalimumab|adalimumab|mesh-list
44451206|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451207|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451208|NCT01712009|Loratadine|loratadine|mesh-list
44451209|NCT01712009|Naproxen|naproxen|mesh-list
44451210|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44451211|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44451212|NCT01712009|Analgesics|analgesics|mesh-ancestor
44451213|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
44451214|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273410|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44273411|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44273412|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
44273413|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273414|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
44273415|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44273416|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273417|NCT00692900|Docetaxel|docetaxel|mesh-list
44273418|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
44273419|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273420|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273421|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273422|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273423|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273424|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44273425|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
44273426|NCT00692952|Nonoxynol|nonoxynol|mesh-list
44273427|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44273428|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273429|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44273430|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273431|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44273432|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44273433|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44273434|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44273435|NCT00693004|Donepezil|donepezil|mesh-list
44273436|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44273457|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273458|NCT00693043|Lidocaine|lidocaine|mesh-list
44273459|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
44273460|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
44273461|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273462|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273463|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
44273464|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273465|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44273466|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44273467|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44273468|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273469|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273470|NCT00693056|beta-Lactams|beta-lactams|mesh-list
44273471|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273472|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273473|NCT00693069|Clopidogrel|clopidogrel|mesh-list
44451215|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451216|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451217|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451218|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
44451219|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44451220|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451221|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451222|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
44451223|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451224|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44451225|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44451226|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44451227|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
44451228|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
44451229|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451230|NCT01711879|Aflibercept|aflibercept|mesh-list
44451231|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44451232|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44451233|NCT01711879|Growth Substances|growth substances|mesh-ancestor
44451234|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451235|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
44451236|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451237|NCT01711866|Rotigotine|rotigotine|mesh-list
44451238|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
44451239|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
44451240|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451241|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451261|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451262|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451263|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451264|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
44451265|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451266|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451267|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451268|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451269|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44451270|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451271|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
44451272|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796773|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
44273474|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44273475|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44273476|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44273477|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44273478|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
44273479|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273480|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273481|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273482|NCT00693108|Testosterone|testosterone|mesh-list
44273483|NCT00693108|Androgens|androgens|mesh-ancestor
44273484|NCT00693108|Hormones|hormones|mesh-ancestor
44273485|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273486|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273487|NCT00693121|Amantadine|amantadine|mesh-list
44273488|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44273489|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44273490|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
44273491|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273492|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
44273493|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273494|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273495|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273496|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44273497|NCT00693121|Analgesics|analgesics|mesh-ancestor
44273498|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
44273499|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273500|NCT00693199|Amlodipine|amlodipine|mesh-list
44273501|NCT00693199|Prazosin|prazosin|mesh-list
44451273|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44451274|NCT01711359|Hematinics|hematinics|mesh-ancestor
44451275|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
44451276|NCT01711359|Vitamins|vitamins|mesh-ancestor
44451277|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
44451278|NCT01710800|Esomeprazole|esomeprazole|mesh-list
44451279|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44451280|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451281|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44451282|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451283|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451284|NCT01710709|Aripiprazole|aripiprazole|mesh-list
44451285|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
44451286|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44451287|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44451288|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44451289|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44451290|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451291|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
44273502|NCT00693199|Terazosin|terazosin|mesh-list
44273503|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44273504|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44273505|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273506|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273507|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44273508|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273509|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
44273510|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44273511|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44463018|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927839|NCT00641797|Promethazine|promethazine|mesh-list
44273512|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44273513|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273514|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273515|NCT00693199|Urological Agents|urological agents|mesh-ancestor
44273516|NCT00693212|Methylphenidate|methylphenidate|mesh-list
44273517|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44273518|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273519|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44273520|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44273521|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662527|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451292|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
44451293|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451294|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451295|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44451296|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44451297|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
44451325|NCT01710358|Methotrexate|methotrexate|mesh-list
44451326|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44451327|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
44451328|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451329|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451330|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451331|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
44451332|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451333|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451334|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451335|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451336|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44451337|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451338|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
44451339|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451340|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44451341|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451342|NCT01710345|Sufentanil|sufentanil|mesh-list
44451344|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44451345|NCT01710345|Narcotics|narcotics|mesh-ancestor
44273523|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
44273524|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273525|NCT00693251|Sirolimus|sirolimus|mesh-list
44273526|NCT00693251|Paclitaxel|paclitaxel|mesh-list
44273527|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44273528|NCT00693251|Everolimus|everolimus|mesh-list
44273529|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273530|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273531|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273532|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273533|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273534|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451379|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451380|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44451381|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44451382|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44451383|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44451384|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
44451385|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451402|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451403|NCT01709838|Deferasirox|deferasirox|mesh-list
44451404|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44451405|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
44451406|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
44451407|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451408|NCT01709721|Hydromorphone|hydromorphone|mesh-list
44451409|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44451410|NCT01709721|Narcotics|narcotics|mesh-ancestor
44451411|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44451412|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451413|NCT01709721|Analgesics|analgesics|mesh-ancestor
44451414|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
44451415|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451416|NCT01709708|Bupivacaine|bupivacaine|mesh-list
44451417|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
44451418|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
44451419|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44451420|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451421|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
44451422|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451423|NCT01709695|Guanfacine|guanfacine|mesh-list
44451424|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44451425|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44451426|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44451427|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44451428|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
44451429|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451430|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451431|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451432|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
44451433|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
44451434|NCT01709578|Methotrexate|methotrexate|mesh-list
44451435|NCT01709578|Leflunomide|leflunomide|mesh-list
44451436|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44451437|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
44451438|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451439|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451440|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451441|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
44106618|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273535|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273536|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
44273537|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273538|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273539|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273540|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273541|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
44273542|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44273543|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
44273544|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273546|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
44273547|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
44273548|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273549|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273550|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273551|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
44273552|NCT00693381|Prednisone|prednisone|mesh-list
44273553|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
44273554|NCT00693381|Tacrolimus|tacrolimus|mesh-list
44273555|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273556|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
44273557|NCT00693381|Hormones|hormones|mesh-ancestor
43662553|NCT02913469|Morphine|morphine|mesh-list
44451442|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451466|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
44451467|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451468|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44451469|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44451470|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451471|NCT01709500|Atorvastatin|atorvastatin|mesh-list
44451472|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44451473|NCT01709500|Simvastatin|simvastatin|mesh-list
44451474|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44451475|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44451476|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
44451477|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451478|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44451479|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44451480|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451481|NCT01709409|Poractant alfa|poractant alfa|mesh-list
44451482|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44451483|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44109819|NCT03352427|Everolimus|everolimus|mesh-list
44451484|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44451485|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44451486|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44451487|NCT01709318|Etonogestrel|etonogestrel|mesh-list
44451488|NCT01709318|Estradiol|estradiol|mesh-list
44451489|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44451490|NCT01709318|Estrogens|estrogens|mesh-ancestor
44451491|NCT01709318|Hormones|hormones|mesh-ancestor
44451492|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273559|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273560|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44273561|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273562|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273563|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
44273564|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44273565|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273566|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273567|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44451493|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451511|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451512|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451513|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451514|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451515|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44451516|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175580|NCT00300313|Citalopram|citalopram|mesh-list
44451517|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
44451518|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44451520|NCT01709227|Diuretics|diuretics|mesh-ancestor
44451521|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
44451522|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451523|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44451524|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451525|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451526|NCT01709162|Ipilimumab|ipilimumab|mesh-list
44451527|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451528|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451529|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44451530|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451531|NCT01709149|Riluzole|riluzole|mesh-list
44451532|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
44451533|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44451534|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44451535|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451536|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451537|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451538|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44451539|NCT01709149|Protective Agents|protective agents|mesh-ancestor
44451540|NCT01709110|Vitamin D|vitamin d|mesh-list
44451541|NCT01709110|Teriparatide|teriparatide|mesh-list
44451542|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
44451543|NCT01709110|Calcium|calcium|mesh-list
44451544|NCT01709110|Vitamins|vitamins|mesh-ancestor
44451545|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
44451546|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451547|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44451548|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44451549|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44451550|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451581|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451582|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451583|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44451584|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451585|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
44451586|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451587|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
44451588|NCT01708915|Capsaicin|capsaicin|mesh-list
44451589|NCT01708915|Nonivamide|nonivamide|mesh-list
44273568|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44273569|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
44273570|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273571|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273573|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
44273574|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273575|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273576|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44273577|NCT00693381|Protective Agents|protective agents|mesh-ancestor
44273578|NCT00693407|Capsaicin|capsaicin|mesh-list
44273579|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
44273580|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44273581|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
44273582|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273583|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273584|NCT00693433|Sirolimus|sirolimus|mesh-list
44273585|NCT00693433|Dexamethasone|dexamethasone|mesh-list
44273586|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273587|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
44273588|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
44451590|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
44451591|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175646|NCT00300560|Colistin|colistin|mesh-list
44451592|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451612|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451613|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451614|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451615|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451617|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44451618|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451619|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451620|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451621|NCT01707667|Prucalopride|prucalopride|mesh-list
44451622|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44451623|NCT01707667|Laxatives|laxatives|mesh-ancestor
44451624|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451625|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44451626|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44451627|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
44451628|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451629|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451630|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451631|NCT01707290|Ivacaftor|ivacaftor|mesh-list
44451632|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44451633|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451634|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451635|NCT01707147|Linagliptin|linagliptin|mesh-list
44451636|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451637|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451638|NCT01707147|Incretins|incretins|mesh-ancestor
44451639|NCT01707147|Hormones|hormones|mesh-ancestor
44451640|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451641|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451642|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44273590|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273591|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273592|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
44273593|NCT00693433|Hormones|hormones|mesh-ancestor
44273594|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273595|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44273596|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273597|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273598|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273599|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273600|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
44273601|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273602|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
44273603|NCT00693446|Sirolimus|sirolimus|mesh-list
44451643|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451644|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451645|NCT01707004|Vidarabine|vidarabine|mesh-list
44451646|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
44451647|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
44451648|NCT01707004|Busulfan|busulfan|mesh-list
44451674|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44451676|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451677|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
44451678|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44451679|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451680|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
44451681|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451682|NCT01706575|Interferons|interferons|mesh-list
44451683|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451684|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
44451685|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451686|NCT01706328|Fluticasone|fluticasone|mesh-list
44451687|NCT01706328|Xhance|xhance|mesh-list
44451688|NCT01706328|Albuterol|albuterol|mesh-list
44451689|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44451690|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451691|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451692|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
44451693|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451694|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451695|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451696|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451697|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451698|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44451699|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44451700|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44451736|NCT01706146|Apixaban|apixaban|mesh-list
44451737|NCT01706146|Dabigatran|dabigatran|mesh-list
44451738|NCT01706146|Anticoagulants|anticoagulants|mesh-list
44451739|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44451740|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
44451770|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
44451771|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451772|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44451773|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44451775|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44451776|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451777|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451778|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44106619|NCT00076544|Ziconotide|ziconotide|mesh-list
44273605|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273606|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
44273607|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273608|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44273609|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273610|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273611|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273612|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273613|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273614|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273615|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
44273616|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
44273617|NCT00693524|Prednisone|prednisone|mesh-list
44273618|NCT00693524|Tacrolimus|tacrolimus|mesh-list
44273619|NCT00693524|Daclizumab|daclizumab|mesh-list
44273620|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273621|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
44273622|NCT00693524|Hormones|hormones|mesh-ancestor
44273623|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273624|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273625|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44273626|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273628|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
44273657|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44273658|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273659|NCT00693589|Hematinics|hematinics|mesh-ancestor
44273660|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
44273661|NCT00693602|Asparaginase|asparaginase|mesh-list
44273662|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273663|NCT00693615|Vaccines|vaccines|mesh-list
44273664|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
44273665|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273666|NCT00693680|Imipramine|imipramine|mesh-list
44273667|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44273668|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
44273669|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273670|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44273671|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44273672|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273673|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273674|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
44273675|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273676|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273677|NCT00693732|Citalopram|citalopram|mesh-list
44273678|NCT00693732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44273679|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44273680|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662606|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44451779|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44451780|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451817|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451818|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451819|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44451821|NCT01704261|Metformin|metformin|mesh-list
44451822|NCT01704261|Glimepiride|glimepiride|mesh-list
44451823|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451847|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
44451848|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44451849|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451850|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451851|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451852|NCT01703741|Testosterone|testosterone|mesh-list
44451853|NCT01703741|Androgens|androgens|mesh-ancestor
44451855|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451856|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451857|NCT01703286|Glimepiride|glimepiride|mesh-list
44451858|NCT01703286|Linagliptin|linagliptin|mesh-list
44110191|NCT00084370|Celecoxib|celecoxib|mesh-list
44451860|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451861|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451862|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451863|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
44451864|NCT01703286|Incretins|incretins|mesh-ancestor
44451865|NCT01703286|Hormones|hormones|mesh-ancestor
44451866|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451867|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451868|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451869|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451870|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451871|NCT01703260|Pioglitazone|pioglitazone|mesh-list
44451872|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451873|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451874|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44451901|NCT01702987|Atorvastatin|atorvastatin|mesh-list
44451902|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44451903|NCT01702987|Simvastatin|simvastatin|mesh-list
44451904|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44451905|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44451906|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
44451907|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451908|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44451909|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44451910|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451911|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
44451912|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451913|NCT01702987|Vitamins|vitamins|mesh-ancestor
44451914|NCT01702961|Cytarabine|cytarabine|mesh-list
44451915|NCT01702961|Etoposide|etoposide|mesh-list
44451916|NCT01702961|Rituximab|rituximab|mesh-list
44451917|NCT01702961|Melphalan|melphalan|mesh-list
44451918|NCT01702961|Carmustine|carmustine|mesh-list
44451919|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451920|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451921|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44451922|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44451943|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451944|NCT01702558|Capecitabine|capecitabine|mesh-list
43633966|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451945|NCT01702558|Trastuzumab|trastuzumab|mesh-list
44451946|NCT01702558|Maytansine|maytansine|mesh-list
44451947|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44451948|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451949|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
44451950|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451951|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451952|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451953|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451954|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451955|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451956|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451957|NCT01702532|Nicotine|nicotine|mesh-list
44451958|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44451959|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
44451960|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451961|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451962|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44451963|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44451964|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451965|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451966|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451967|NCT01702519|Nicotine|nicotine|mesh-list
44451968|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44451969|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
44451970|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451971|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451972|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44451973|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44451974|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451975|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962671|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44452005|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44452006|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44273681|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273683|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
44273684|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273685|NCT00693732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44273686|NCT00693732|Antidepressive Agents|antidepressive agents|mesh-ancestor
44273687|NCT00693732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273688|NCT00693758|Adenosine|adenosine|mesh-list
44273689|NCT00693758|Analgesics|analgesics|mesh-ancestor
44273690|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
44273691|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273692|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273693|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43662616|NCT02912793|Betadex|betadex|mesh-list
44452007|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452008|NCT01702025|Aminophylline|aminophylline|mesh-list
44452009|NCT01702025|Methazolamide|methazolamide|mesh-list
44452010|NCT01702025|Theophylline|theophylline|mesh-list
44452011|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452012|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
44110355|NCT00084695|Hormones|hormones|mesh-ancestor
44452013|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452014|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452016|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452017|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44452018|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452050|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
44452051|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452052|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452053|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44452054|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452055|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44452056|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452057|NCT01701674|Analgesics|analgesics|mesh-ancestor
44452058|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
44452059|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452060|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43962672|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
44452082|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44452083|NCT01701258|Amisulpride|amisulpride|mesh-list
44452084|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44452085|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44452086|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452087|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452088|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44452089|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44452090|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
44452091|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452092|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452093|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44452094|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
44452095|NCT01701063|Ribavirin|ribavirin|mesh-list
44452096|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44452097|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
44452098|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452099|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
44452100|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452101|NCT01700959|Melatonin|melatonin|mesh-list
44452102|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
44452103|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273694|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
44273695|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44273696|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
44273697|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
44273698|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273699|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273700|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
44273701|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44273702|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273703|NCT00693849|Citalopram|citalopram|mesh-list
44273704|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43635090|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
43635091|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635092|NCT05389995|Expectorants|expectorants|mesh-ancestor
44273705|NCT00693849|Sertraline|sertraline|mesh-list
44273706|NCT00693849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44273707|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44273708|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273709|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273710|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273711|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
44273712|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273713|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44273714|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44273715|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273716|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44273717|NCT00693862|Levodopa|levodopa|mesh-list
44273718|NCT00693862|Carbidopa|carbidopa|mesh-list
44273719|NCT00693862|Entacapone|entacapone|mesh-list
44273720|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44273732|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
44273733|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273734|NCT00693979|Paclitaxel|paclitaxel|mesh-list
44452104|NCT01700959|Protective Agents|protective agents|mesh-ancestor
44452105|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452106|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452107|NCT01700946|Cytarabine|cytarabine|mesh-list
44452108|NCT01700946|Aldesleukin|aldesleukin|mesh-list
44452109|NCT01700946|Dexamethasone|dexamethasone|mesh-list
44452110|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
44452111|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44452112|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44452113|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44452114|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
44452149|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452150|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
44452151|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452152|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452153|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44452154|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44452155|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44452156|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44452157|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44452196|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44452197|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
44452231|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452232|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
44452233|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
44452234|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44452235|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452236|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452237|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44452238|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
44452266|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452267|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452268|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452270|NCT01699178|Testosterone|testosterone|mesh-list
44452271|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
44452272|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
44452273|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44452274|NCT01699178|Androgens|androgens|mesh-ancestor
44452275|NCT01699178|Hormones|hormones|mesh-ancestor
44452276|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452277|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452278|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452279|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452280|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
44452281|NCT01699022|CycloProvera|cycloprovera|mesh-list
44452282|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44452283|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44452284|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44452285|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
44452302|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452303|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452304|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452305|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452306|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
44452307|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44452308|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44452309|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452310|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452311|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44452312|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
44452313|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
44452314|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452315|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452316|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44452317|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44452318|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44452319|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452320|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44273736|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273737|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273738|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273739|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273740|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273741|NCT00694005|Sirolimus|sirolimus|mesh-list
44273742|NCT00694005|Paclitaxel|paclitaxel|mesh-list
44273743|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44273744|NCT00694005|Everolimus|everolimus|mesh-list
44273745|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44273746|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273747|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44273748|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44273749|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273750|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273751|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273752|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
44273753|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273754|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273755|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273756|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273757|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
44452321|NCT01698814|Analgesics|analgesics|mesh-ancestor
44452322|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
44452323|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452324|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452325|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452326|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452327|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44452328|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44452329|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44452330|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
44452332|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452333|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452334|NCT01698801|Dexamethasone|dexamethasone|mesh-list
44452335|NCT01698801|Lenalidomide|lenalidomide|mesh-list
44452336|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452337|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
44452338|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
44452339|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452340|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452341|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452342|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
44452343|NCT01698801|Hormones|hormones|mesh-ancestor
44452344|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452345|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452361|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452362|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452364|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
44273759|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44273760|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44273761|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44273762|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273763|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273764|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273765|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44273766|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44273767|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273768|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452365|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
44452366|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44452367|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44452368|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44452369|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44452370|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
44452371|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452372|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452373|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44452374|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44452375|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44452376|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452377|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452378|NCT01697969|Analgesics|analgesics|mesh-ancestor
44452379|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
44452380|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452381|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452382|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452383|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452384|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44452385|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44452386|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44452387|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
44452388|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
44452389|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452390|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452391|NCT01697956|Beclomethasone|beclomethasone|mesh-list
44452392|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452393|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
44452394|NCT01697956|Hormones|hormones|mesh-ancestor
44452395|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452396|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452397|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44110791|NCT00086086|Hematinics|hematinics|mesh-ancestor
44452398|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452399|NCT01697800|Tadalafil|tadalafil|mesh-list
44452400|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
44452401|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44452402|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44452403|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452423|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
44452424|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452425|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44452426|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
44452427|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452428|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452429|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44452430|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44452431|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452432|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44273769|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44273770|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273771|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273772|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44273773|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44273774|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44273775|NCT00694187|Zaleplon|zaleplon|mesh-list
44273776|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
44273777|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44273778|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273779|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273780|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
44273781|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
44273828|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
44273829|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273830|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
44273831|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
44273832|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273833|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273834|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273835|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
44273836|NCT00694408|Hormones|hormones|mesh-ancestor
44273837|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273838|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44273839|NCT00694408|Protective Agents|protective agents|mesh-ancestor
44273840|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44273841|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273842|NCT00694460|Vaccines|vaccines|mesh-list
44273843|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
44273844|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273845|NCT00694590|Plerixafor|plerixafor|mesh-list
44273846|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44273847|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44273848|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
44273849|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273850|NCT00694629|Rifampin|rifampin|mesh-list
44273851|NCT00694629|Rifapentine|rifapentine|mesh-list
44273852|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44273853|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
44273856|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
44273877|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
44273878|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
44273879|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44273880|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
44273882|NCT00694759|Pioglitazone|pioglitazone|mesh-list
44273883|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44273884|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273885|NCT00694837|Nelfinavir|nelfinavir|mesh-list
44273886|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44273887|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44273888|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
44273889|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273890|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273891|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44273892|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44273893|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
44273894|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273895|NCT00694863|Cosyntropin|cosyntropin|mesh-list
44273896|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
44273897|NCT00694863|Hormones|hormones|mesh-ancestor
44452433|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44452434|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44452435|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44452436|NCT01697345|Testosterone|testosterone|mesh-list
44452437|NCT01697345|Androgens|androgens|mesh-ancestor
44452438|NCT01697345|Hormones|hormones|mesh-ancestor
44452439|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452440|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452441|NCT01697267|Rituximab|rituximab|mesh-list
44452442|NCT01697267|Azathioprine|azathioprine|mesh-list
44452443|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452444|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452445|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
44452446|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452447|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452448|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
44452449|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452450|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452451|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452452|NCT01696955|Cetuximab|cetuximab|mesh-list
44452453|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452454|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452455|NCT01696942|Mesalamine|mesalamine|mesh-list
44452456|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452457|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452458|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452459|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452468|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
44452469|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452470|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452471|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452472|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
44452473|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452474|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452475|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44452476|NCT01696695|Capecitabine|capecitabine|mesh-list
44273898|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273899|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273901|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44273902|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
44273903|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273904|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44273905|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44273906|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44273907|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
44273908|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273909|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273910|NCT00694967|Progestins|progestins|mesh-ancestor
44273911|NCT00694967|Hormones|hormones|mesh-ancestor
44273912|NCT00694980|Etrolizumab|etrolizumab|mesh-list
44273913|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273914|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
44273915|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273916|NCT00695032|Cisplatin|cisplatin|mesh-list
44273917|NCT00695032|Ifosfamide|ifosfamide|mesh-list
44452477|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452478|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
44452479|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452480|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452481|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
44452482|NCT01696279|Calcium|calcium|mesh-list
44452483|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44452484|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452485|NCT01696279|Antacids|antacids|mesh-ancestor
44452486|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452487|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452488|NCT01696214|Fluticasone|fluticasone|mesh-list
44452489|NCT01696214|Xhance|xhance|mesh-list
44452490|NCT01696214|Theophylline|theophylline|mesh-list
44452491|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44452492|NCT01696214|Ipratropium|ipratropium|mesh-list
44452493|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44452494|NCT01696214|Montelukast|montelukast|mesh-list
44452495|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452496|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452497|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
44452498|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452499|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452500|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452501|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452502|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452503|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44452504|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44452505|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44452506|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44452507|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44452508|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452509|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452510|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44273918|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273919|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44273920|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
44273921|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273922|NCT00695045|Morphine|morphine|mesh-list
44273923|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44273924|NCT00695045|Narcotics|narcotics|mesh-ancestor
44273925|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273926|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273927|NCT00695045|Analgesics|analgesics|mesh-ancestor
44273928|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
44273929|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273930|NCT00695071|Itraconazole|itraconazole|mesh-list
44273931|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
44273932|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273933|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44452511|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
44452512|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452513|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44452514|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44452515|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452516|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452517|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44452518|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452519|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
44452520|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44452521|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44452522|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
44452523|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
44452524|NCT01696214|Hormones|hormones|mesh-ancestor
44452525|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
44452526|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
44452527|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452543|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452544|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452545|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452546|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
44110936|NCT00086606|Omalizumab|omalizumab|mesh-list
44452547|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452548|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452549|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452550|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452551|NCT01696045|Ipilimumab|ipilimumab|mesh-list
44452552|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452553|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452554|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44452555|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452556|NCT01696032|Gemcitabine|gemcitabine|mesh-list
44452557|NCT01696032|Paclitaxel|paclitaxel|mesh-list
44452558|NCT01696032|Carboplatin|carboplatin|mesh-list
43641404|NCT00389610|Pancrelipase|pancrelipase|mesh-list
43641405|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452559|NCT01696032|Doxorubicin|doxorubicin|mesh-list
44452560|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44452561|NCT01696032|Topotecan|topotecan|mesh-list
44452562|NCT01696032|Guadecitabine|guadecitabine|mesh-list
44452563|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44452564|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452565|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44452566|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44452567|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44273934|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44273935|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273936|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273937|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44273938|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
44273939|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44273940|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452568|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452569|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452570|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
44452571|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
44452572|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452573|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452574|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452575|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
44452576|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452577|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44452578|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44452579|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44452580|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44452581|NCT01695954|Ritonavir|ritonavir|mesh-list
44452582|NCT01695954|Darunavir|darunavir|mesh-list
44452583|NCT01695954|Efavirenz|efavirenz|mesh-list
44452584|NCT01695954|Pitavastatin|pitavastatin|mesh-list
44452585|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44452586|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44452587|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452589|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452591|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452592|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
44452593|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452594|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44452595|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44452596|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44452597|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44452598|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44452599|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44452600|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44452601|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44452602|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44452603|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44452604|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44452605|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44452606|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
44452607|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44452608|NCT01695772|Bevacizumab|bevacizumab|mesh-list
44452609|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452610|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452611|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44452612|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44452613|NCT01695772|Growth Substances|growth substances|mesh-ancestor
44452614|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452615|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
44452616|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
44452617|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
44452618|NCT01695317|Vitamins|vitamins|mesh-ancestor
44452619|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
44452620|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452621|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
44452622|NCT01695239|Adalimumab|adalimumab|mesh-list
44452623|NCT01695239|Ixekizumab|ixekizumab|mesh-list
44452624|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452625|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452626|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452627|NCT01695135|Prednisone|prednisone|mesh-list
44273941|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44273942|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
44273943|NCT00695201|Irinotecan|irinotecan|mesh-list
44273944|NCT00695201|Floxuridine|floxuridine|mesh-list
44273945|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273946|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44273947|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44273948|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273949|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273950|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44273951|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
44273953|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
44273954|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
44273955|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44273956|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273957|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
44452628|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
44452629|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452630|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
44452631|NCT01695135|Hormones|hormones|mesh-ancestor
44452632|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452633|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452634|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452635|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452636|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44452637|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452638|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452639|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
44452640|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44452641|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
44452642|NCT01694771|Olodaterol|olodaterol|mesh-list
44452643|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452644|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
44452645|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452646|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452647|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452648|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452649|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
44452650|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452651|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452652|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452653|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452654|NCT01694706|Omeprazole|omeprazole|mesh-list
44452655|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44452656|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452657|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44452658|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452659|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452677|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452678|NCT01693562|Durvalumab|durvalumab|mesh-list
44452679|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452680|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452681|NCT01693523|Minocycline|minocycline|mesh-list
44452682|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44452683|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452684|NCT01693185|Midazolam|midazolam|mesh-list
44452685|NCT01693185|Meperidine|meperidine|mesh-list
44452686|NCT01693185|Remifentanil|remifentanil|mesh-list
44452687|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44273958|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273959|NCT00695331|Misoprostol|misoprostol|mesh-list
44273960|NCT00695331|Oxytocin|oxytocin|mesh-list
44273961|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
44273962|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44273963|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273964|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44273965|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
44273966|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44273967|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44273968|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
44273969|NCT00695344|Everolimus|everolimus|mesh-list
44273970|NCT00695344|Azathioprine|azathioprine|mesh-list
44273971|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44273972|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44273973|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
44273974|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44273975|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44273976|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44273977|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
44452688|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44452689|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452690|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452691|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44452692|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44452693|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44452694|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44452695|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
44452696|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
44111087|NCT00087035|Docetaxel|docetaxel|mesh-list
44452697|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
44452698|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
44452699|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452700|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452701|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44452702|NCT01693185|Narcotics|narcotics|mesh-ancestor
44452703|NCT01693185|Analgesics|analgesics|mesh-ancestor
44452704|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
44452705|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452706|NCT01693068|Dacarbazine|dacarbazine|mesh-list
44452707|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452708|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
44452709|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452710|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452711|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
44452712|NCT01693029|Hematinics|hematinics|mesh-ancestor
44452713|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
44452714|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452715|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452716|NCT01692626|Analgesics|analgesics|mesh-ancestor
44452730|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44452731|NCT01692301|Olmesartan|olmesartan|mesh-list
44452732|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44452733|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44452734|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44452735|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44452736|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44273978|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44273979|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44273980|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44273981|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44273982|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
44273983|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44273984|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44273985|NCT00695604|Fluticasone|fluticasone|mesh-list
44273986|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44273987|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43850266|NCT05698771|Niacin|niacin|mesh-list
44273988|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
44273989|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44273990|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274029|NCT00695994|Docetaxel|docetaxel|mesh-list
44274030|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274031|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44274032|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
44274033|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274034|NCT00695994|Antiviral Agents|antiviral agents|mesh-ancestor
44274035|NCT00695994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452737|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452738|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44452739|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452740|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44452741|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44452742|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44452743|NCT01692301|Diuretics|diuretics|mesh-ancestor
44452744|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
44452745|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44452746|NCT01692197|Cytarabine|cytarabine|mesh-list
44452747|NCT01692197|Dexamethasone|dexamethasone|mesh-list
44452748|NCT01692197|Idarubicin|idarubicin|mesh-list
44452749|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452750|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
44452751|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
44452752|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452753|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452754|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452755|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
44452756|NCT01692197|Hormones|hormones|mesh-ancestor
44452757|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452758|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452759|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452760|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452761|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
44452762|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452763|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
44452764|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452765|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452766|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
44452767|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44452768|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44452769|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44452770|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452771|NCT01691898|Rituximab|rituximab|mesh-list
44452772|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
44452773|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452774|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452775|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
44452776|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452803|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44452805|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452806|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452807|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44452808|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44452809|NCT01691781|Protective Agents|protective agents|mesh-ancestor
44452810|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452811|NCT01691768|Tenofovir|tenofovir|mesh-list
44452812|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
44452813|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452814|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44452815|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44452816|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452817|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452818|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44452819|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452820|NCT01691508|Prednisone|prednisone|mesh-list
44452821|NCT01691508|Prednisolone|prednisolone|mesh-list
44274036|NCT00695994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274037|NCT00695994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274038|NCT00695994|Immunologic Factors|immunologic factors|mesh-ancestor
44274039|NCT00695994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274040|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44274041|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44274042|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44274043|NCT00696007|Gemcitabine|gemcitabine|mesh-list
44274045|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274046|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44274047|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
44274048|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274049|NCT00696007|Antiviral Agents|antiviral agents|mesh-ancestor
43662730|NCT02912182|Betamethasone|betamethasone|mesh-list
44452822|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452823|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
44452824|NCT01691508|Hormones|hormones|mesh-ancestor
44452825|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452826|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452856|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44452857|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
44452858|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
44452859|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452860|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44452861|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44452862|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452863|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452864|NCT01690988|Ketamine|ketamine|mesh-list
44452865|NCT01690988|Analgesics|analgesics|mesh-ancestor
44452866|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
44452867|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452868|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452869|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44452870|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44452871|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
44452907|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452908|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452909|NCT01690299|Analgesics|analgesics|mesh-ancestor
44452910|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
44452911|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452935|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452936|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452937|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44452938|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44452939|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452940|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452941|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452942|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44452943|NCT01689974|Ipilimumab|ipilimumab|mesh-list
44452944|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452945|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452946|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44452947|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452948|NCT01689649|Topiramate|topiramate|mesh-list
44452949|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
44452950|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452951|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452952|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44452953|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
44274050|NCT00696007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274051|NCT00696007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851546|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274052|NCT00696007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274053|NCT00696007|Immunologic Factors|immunologic factors|mesh-ancestor
44274054|NCT00696007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274055|NCT00696033|Diazepam|diazepam|mesh-list
44274056|NCT00696033|Lorazepam|lorazepam|mesh-list
44274057|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
44274058|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
44274059|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
44274060|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274061|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452954|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452955|NCT01689519|Vemurafenib|vemurafenib|mesh-list
44452956|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452957|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44452958|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452959|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452960|NCT01689363|Histamine|histamine|mesh-list
44452961|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
44452962|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
44452990|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452992|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
44452993|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452994|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452995|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44452996|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44452997|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
44452998|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452999|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453000|NCT01688466|Pomalidomide|pomalidomide|mesh-list
44453001|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
44453002|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453003|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44453004|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44453005|NCT01688466|Growth Substances|growth substances|mesh-ancestor
44453006|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
44453007|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453059|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453060|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453061|NCT01687413|Cisplatin|cisplatin|mesh-list
44453062|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453063|NCT01687296|Fluticasone|fluticasone|mesh-list
44453064|NCT01687296|Xhance|xhance|mesh-list
44453065|NCT01687296|Prednisone|prednisone|mesh-list
44453066|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44453067|NCT01687296|Albuterol|albuterol|mesh-list
44453068|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453069|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
44453070|NCT01687296|Hormones|hormones|mesh-ancestor
44453071|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453072|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453073|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453074|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453075|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44453076|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
44453077|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453078|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44453079|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453080|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453081|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44453082|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
44453083|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44453084|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44453085|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44274062|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274063|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44274064|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274065|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43851615|NCT03413995|Rucaparib|rucaparib|mesh-list
43851672|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851717|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43851753|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44274066|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44274067|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44274068|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
44274069|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
44274070|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274071|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274072|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44274073|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44274074|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44274075|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44274076|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
44274077|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
44274078|NCT00696059|Adalimumab|adalimumab|mesh-list
44274079|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274080|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274081|NCT00696098|Butyric Acid|butyric acid|mesh-list
44274082|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
44274083|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
44274084|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274085|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274113|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44274114|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274115|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274116|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44274117|NCT00696215|Protective Agents|protective agents|mesh-ancestor
44274118|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274120|NCT00696475|Choline|choline|mesh-list
44274121|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
44274122|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44274123|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
44274124|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274125|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274126|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44274127|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
44274128|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274129|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
44274130|NCT00696514|Vitamin D|vitamin d|mesh-list
44274131|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
43825894|NCT04528004|Vitamins|vitamins|mesh-ancestor
44453086|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44111486|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
44453087|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453088|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453089|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453090|NCT01687283|Fluticasone|fluticasone|mesh-list
44453091|NCT01687283|Xhance|xhance|mesh-list
44453092|NCT01687283|Budesonide|budesonide|mesh-list
44453093|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453094|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44453095|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
44453096|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453097|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453098|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44453135|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43851983|NCT00923013|Rituximab|rituximab|mesh-list
43851984|NCT00923013|Cladribine|cladribine|mesh-list
44453136|NCT01686932|Vildagliptin|vildagliptin|mesh-list
44453137|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453153|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453155|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453156|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453157|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453158|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44453159|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453160|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453161|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111562|NCT00088686|Capsaicin|capsaicin|mesh-list
44453162|NCT01686828|Androgens|androgens|mesh-ancestor
44453163|NCT01686828|Hormones|hormones|mesh-ancestor
44453164|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453165|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
44453166|NCT01686633|Fluticasone|fluticasone|mesh-list
44453167|NCT01686633|Xhance|xhance|mesh-list
44453168|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453169|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44453170|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
44453171|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453172|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274132|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
44274133|NCT00696514|Vitamins|vitamins|mesh-list
44274134|NCT00696514|Folic Acid|folic acid|mesh-list
44274135|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
44274136|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
44274137|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
44453173|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44453174|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453175|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453176|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44453177|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
44453178|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44453179|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44453180|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44453181|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453182|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453183|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
44453184|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453185|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453186|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44453187|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453188|NCT01686152|Imiquimod|imiquimod|mesh-list
44453189|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44453190|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
44453191|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453192|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453193|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
44453194|NCT01685983|Prednisolone|prednisolone|mesh-list
44453195|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
44453196|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453230|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44453232|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
44453233|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962673|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453249|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
44453250|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
44453251|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
44453252|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453253|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44453254|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
44453255|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
44453256|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453257|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453258|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453259|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
44453260|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453261|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44453262|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44453263|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453264|NCT01684722|Vitamin D|vitamin d|mesh-list
44453265|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
44453266|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
44453267|NCT01684722|Vitamins|vitamins|mesh-list
44453268|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
44453269|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453270|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44453271|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44453272|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
44453273|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44453274|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
44453275|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44453276|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
44453277|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453278|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453279|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
44453280|NCT01684215|Letrozole|letrozole|mesh-list
44453281|NCT01684215|Palbociclib|palbociclib|mesh-list
44453282|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453283|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44453284|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453285|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106620|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44274138|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274139|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44274140|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44274141|NCT00696514|Hematinics|hematinics|mesh-ancestor
44274142|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
44274143|NCT00696540|Albuterol|albuterol|mesh-list
44274144|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44274145|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
44274146|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274147|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274148|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44274149|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44274150|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
44274151|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44274152|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44274153|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44274154|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44274155|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274156|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274157|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274158|NCT00696566|Rifampin|rifampin|mesh-list
44274159|NCT00696566|Clopidogrel|clopidogrel|mesh-list
44274160|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274161|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44274162|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44274163|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44274164|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
44274165|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274166|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463041|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43928494|NCT00660075|Hormones|hormones|mesh-ancestor
44274167|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662769|NCT02912026|Olorofim|olorofim|mesh-list
44453286|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453287|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44453288|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453289|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453290|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453291|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453292|NCT01684202|Tolvaptan|tolvaptan|mesh-list
44274168|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44274169|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
44274170|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274171|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274172|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
44274173|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44274174|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274175|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44274176|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44274177|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44274178|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44274179|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44274180|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44274181|NCT00696579|Gemcitabine|gemcitabine|mesh-list
44274182|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44453322|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453323|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453324|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
44453325|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453326|NCT01683058|Aripiprazole|aripiprazole|mesh-list
44453327|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
44453328|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453329|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44453330|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453331|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453332|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453333|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
44453358|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
44453359|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
44453360|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453361|NCT01682837|Diuretics|diuretics|mesh-ancestor
44453362|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
44453363|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453364|NCT01682837|Expectorants|expectorants|mesh-ancestor
44453365|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453366|NCT01682837|Cathartics|cathartics|mesh-ancestor
44453367|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453368|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44453369|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44453370|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453371|NCT01682759|Metformin|metformin|mesh-list
44453372|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
44453373|NCT01682759|Glimepiride|glimepiride|mesh-list
44453374|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453375|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453376|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44453377|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453378|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
44453379|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
44453380|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
44453381|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453382|NCT01682681|Topiramate|topiramate|mesh-list
44453383|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
44453384|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453385|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453418|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453419|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453420|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44453421|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274183|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
44274184|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274185|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274186|NCT00696579|Antiviral Agents|antiviral agents|mesh-ancestor
44274187|NCT00696579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274188|NCT00696579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274189|NCT00696579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274190|NCT00696579|Immunologic Factors|immunologic factors|mesh-ancestor
44274191|NCT00696579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274192|NCT00696592|Bevacizumab|bevacizumab|mesh-list
44274193|NCT00696592|Verteporfin|verteporfin|mesh-list
44274194|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43662793|NCT02911662|Cephalexin|cephalexin|mesh-list
44453422|NCT01682044|Rituximab|rituximab|mesh-list
44453423|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453424|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453425|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
44453443|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453444|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453445|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453446|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
44453447|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453448|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44453449|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44453450|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453451|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44453452|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453453|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453454|NCT01681576|Valsartan|valsartan|mesh-list
44453455|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44453456|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44453457|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44453458|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44453459|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453460|NCT01681472|Leucovorin|leucovorin|mesh-list
44453461|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
44453462|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
44453463|NCT01681472|Antidotes|antidotes|mesh-ancestor
44453464|NCT01681472|Protective Agents|protective agents|mesh-ancestor
44453465|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453466|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
44453467|NCT01681472|Vitamins|vitamins|mesh-ancestor
44453468|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
44453469|NCT01681433|Prednisone|prednisone|mesh-list
44453470|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
44453471|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453472|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
44453473|NCT01681433|Hormones|hormones|mesh-ancestor
44453474|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453475|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453476|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453477|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453478|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453479|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453480|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453481|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453482|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453483|NCT01681212|Ipilimumab|ipilimumab|mesh-list
44453520|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453521|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453552|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274195|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274196|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44274197|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44274198|NCT00696592|Growth Substances|growth substances|mesh-ancestor
44274199|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274200|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
44274201|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44274202|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
44274203|NCT00696631|Dronedarone|dronedarone|mesh-list
44274204|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44274205|NCT00696644|Teriparatide|teriparatide|mesh-list
44274206|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44274207|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274208|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44274209|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44274210|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44274211|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44274212|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
44274213|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274214|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453554|NCT01679613|Nintedanib|nintedanib|mesh-list
44453555|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
44453556|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453557|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44453558|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453559|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453560|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453561|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453562|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453563|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453593|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
44453594|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453595|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453596|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
44453597|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44453598|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453599|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453600|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453601|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44453602|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44453603|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453604|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453605|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
44453606|NCT01678820|Metformin|metformin|mesh-list
44453607|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44453633|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453634|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453635|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453636|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44453637|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44453638|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44453639|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274216|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44274217|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
44274218|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274219|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
44274220|NCT00696748|Testosterone|testosterone|mesh-list
44274221|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
44274222|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
44274223|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44274224|NCT00696748|Androgens|androgens|mesh-ancestor
44274225|NCT00696748|Hormones|hormones|mesh-ancestor
44274226|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274227|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274228|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44274229|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274230|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
44274231|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44274232|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274233|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274234|NCT00696826|Incretins|incretins|mesh-ancestor
44274272|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274273|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44274275|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274276|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274277|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
44274278|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
44274279|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44274280|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274281|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274282|NCT00697021|Aspirin|aspirin|mesh-list
44274283|NCT00697021|Clopidogrel|clopidogrel|mesh-list
44274284|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274285|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274286|NCT00697021|Analgesics|analgesics|mesh-ancestor
44274287|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
44274288|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274289|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274290|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274291|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274292|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44274293|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44274294|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274295|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274296|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44453640|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453641|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44453642|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44453643|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44453644|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44453645|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453646|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453647|NCT01678209|Methylphenidate|methylphenidate|mesh-list
44453648|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44453649|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44453650|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453651|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44453652|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44453653|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453654|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453679|NCT01677858|Hormones|hormones|mesh-ancestor
44274297|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274298|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
44274299|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44274300|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44274301|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44274302|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
44274303|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274304|NCT00697034|Capsaicin|capsaicin|mesh-list
44274305|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
44274306|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44274307|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
44274308|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274309|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274310|NCT00697060|Docetaxel|docetaxel|mesh-list
44274311|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274312|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44274313|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44274314|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44274315|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274316|NCT00697086|Dronedarone|dronedarone|mesh-list
44274317|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44274318|NCT00697125|Vaccines|vaccines|mesh-list
44453680|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453681|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453682|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453683|NCT01677741|Dabrafenib|dabrafenib|mesh-list
44453684|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453685|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453686|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453687|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453688|NCT01677507|Timolol|timolol|mesh-list
44453689|NCT01677507|Latanoprost|latanoprost|mesh-list
44453690|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44453691|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44453692|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453693|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453694|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453695|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453696|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44453697|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44453698|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44453699|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44453700|NCT01677377|Risperidone|risperidone|mesh-list
44453701|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44453702|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
44453703|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453704|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453705|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453706|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44453740|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453741|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453742|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44453743|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44274320|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274321|NCT00697138|Amphetamine|amphetamine|mesh-list
44274322|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
44274323|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44274324|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44274325|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44274326|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44274327|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274328|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274329|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274330|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274331|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44274332|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
44274333|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
44274334|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274335|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
44453744|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
44453745|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453746|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453747|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44453748|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453749|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44453750|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44453751|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
44453781|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44453782|NCT01675167|Buprenorphine|buprenorphine|mesh-list
44453783|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44453784|NCT01675167|Narcotics|narcotics|mesh-ancestor
44453785|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453786|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453787|NCT01675167|Analgesics|analgesics|mesh-ancestor
44453788|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
44453789|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453790|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44453791|NCT01675154|Orlistat|orlistat|mesh-list
44453792|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453793|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453794|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44453795|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44453796|NCT01675141|Lenalidomide|lenalidomide|mesh-list
44453797|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
44453798|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453799|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44453800|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44453837|NCT01674647|Vitamin K|vitamin k|mesh-list
44453838|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
44453839|NCT01674647|Vitamins|vitamins|mesh-ancestor
44453876|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44453877|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175771|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
44175772|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44175773|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44175774|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175775|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44175776|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175777|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274337|NCT00697151|Aspirin|aspirin|mesh-list
44274338|NCT00697151|Warfarin|warfarin|mesh-list
44274339|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274340|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274341|NCT00697151|Analgesics|analgesics|mesh-ancestor
44274342|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
44274343|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274344|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274345|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274346|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274347|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44274348|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44274349|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274350|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274351|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44274352|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274353|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
44274354|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
44274355|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
44274356|NCT00697164|Hematinics|hematinics|mesh-ancestor
44274357|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
44175778|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44175779|NCT00301054|Renal Agents|renal agents|mesh-ancestor
44175780|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
44175781|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175782|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44175783|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175784|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175815|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175817|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
44175818|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175819|NCT00301223|Pregabalin|pregabalin|mesh-list
44175820|NCT00301223|Analgesics|analgesics|mesh-ancestor
44175821|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
44175822|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175823|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175824|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
44175825|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44175826|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175827|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175828|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44175855|NCT00301301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175856|NCT00301301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175857|NCT00301392|Pitavastatin|pitavastatin|mesh-list
44175858|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44175859|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44175860|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44175861|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
44175862|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175863|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175864|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44274359|NCT00697281|Growth Substances|growth substances|mesh-ancestor
44274360|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274362|NCT00697372|Everolimus|everolimus|mesh-list
44274363|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274364|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274365|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
44274366|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274367|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274368|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274369|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44274370|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
44274371|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
44274372|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44274373|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43662883|NCT02910518|Calcium heparin|calcium heparin|mesh-list
44175865|NCT00301405|Thalidomide|thalidomide|mesh-list
44175866|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175867|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
44175868|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175869|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
44175870|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175871|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175872|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44175873|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44175874|NCT00301405|Growth Substances|growth substances|mesh-ancestor
44175875|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44175876|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175907|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
44175908|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44175909|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44175910|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175911|NCT00301535|Chrysarobin|chrysarobin|mesh-list
44175912|NCT00301535|HBOC 201|hboc 201|mesh-list
44175913|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175914|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175915|NCT00301535|Analgesics|analgesics|mesh-ancestor
44175916|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
44175917|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175918|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175919|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175952|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44175953|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44175954|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175955|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175956|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44175957|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44175958|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175959|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175960|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175961|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44175962|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
44175996|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175997|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175998|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
44175999|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44106626|NCT00076544|Protective Agents|protective agents|mesh-ancestor
44274374|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274375|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
44274376|NCT00697385|Coagulants|coagulants|mesh-ancestor
44176034|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176035|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44176036|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44176037|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44176038|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44176039|NCT00301795|Rituximab|rituximab|mesh-list
44176040|NCT00301795|Oblimersen|oblimersen|mesh-list
44176041|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176079|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
44176118|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176119|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176181|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176182|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44176183|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44176184|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176185|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176186|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44176187|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
44176188|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176189|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176190|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44176191|NCT00302289|Caffeine|caffeine|mesh-list
44176192|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176193|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176194|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44176195|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176196|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176197|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44176198|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44176199|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
43541670|NCT04907227|Hormones|hormones|mesh-ancestor
43549918|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
43550285|NCT03624322|Olanzapine|olanzapine|mesh-list
43550350|NCT03624010|Simendan|simendan|mesh-list
43551099|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
43551177|NCT03616405|Amoxicillin|amoxicillin|mesh-list
43551251|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43551467|NCT03613428|Prednisone|prednisone|mesh-list
43551540|NCT03612557|Penicillin G|penicillin g|mesh-list
44176200|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176201|NCT00302341|Trimethoprim|trimethoprim|mesh-list
44176233|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176234|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176236|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176237|NCT00302393|Methylphenidate|methylphenidate|mesh-list
44176238|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176239|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176240|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44176273|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176275|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176276|NCT00302536|Tacrolimus|tacrolimus|mesh-list
44176277|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176278|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
44176279|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176307|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176308|NCT00302653|Rasburicase|rasburicase|mesh-list
44176309|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
44176310|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176311|NCT00302666|Dienogest|dienogest|mesh-list
44176312|NCT00302666|Nandrolone|nandrolone|mesh-list
44176313|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44176314|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
44176315|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44176316|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176317|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44176318|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44176319|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44176320|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44176321|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
44176322|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176323|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44176324|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176325|NCT00302666|Androgens|androgens|mesh-ancestor
44176326|NCT00302666|Hormones|hormones|mesh-ancestor
44176327|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
44274377|NCT00697437|Ketoconazole|ketoconazole|mesh-list
44274378|NCT00697437|Docetaxel|docetaxel|mesh-list
44274379|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274380|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
44274381|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
44274382|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
44274383|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274384|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
44274385|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274386|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44274387|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44274388|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274389|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43928704|NCT00662545|Entecavir|entecavir|mesh-list
44274390|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
44274391|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274392|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274393|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44274394|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
44274395|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274396|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274397|NCT00697476|Topotecan|topotecan|mesh-list
44274398|NCT00697476|Vorinostat|vorinostat|mesh-list
44274399|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44274400|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176328|NCT00302692|Metoprolol|metoprolol|mesh-list
44176329|NCT00302692|Esmolol|esmolol|mesh-list
44176356|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44176357|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453905|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453906|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453907|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112795|NCT00093522|Fludarabine|fludarabine|mesh-list
44453908|NCT01673646|Pasireotide|pasireotide|mesh-list
44176358|NCT00302822|Tenofovir|tenofovir|mesh-list
44176359|NCT00302822|Emtricitabine|emtricitabine|mesh-list
44176360|NCT00302822|Efavirenz|efavirenz|mesh-list
44176361|NCT00302822|Lopinavir|lopinavir|mesh-list
44176362|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
44176363|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
44176364|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176365|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44176366|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176367|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176368|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176369|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176370|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176371|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44176404|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44176405|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44274402|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274403|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274404|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44274405|NCT00697502|Capecitabine|capecitabine|mesh-list
44274406|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44274407|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
44274408|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274409|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274410|NCT00697554|Vaccines|vaccines|mesh-list
44274411|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
44274412|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463043|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
44463044|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
44463045|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44463046|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44463047|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
44463048|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44463049|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
44463050|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463051|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463052|NCT01519674|Incretins|incretins|mesh-ancestor
44463053|NCT01519674|Hormones|hormones|mesh-ancestor
44463054|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463055|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44463056|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463057|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176407|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44176438|NCT00303160|Antioxidants|antioxidants|mesh-ancestor
44176439|NCT00303160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176440|NCT00303160|Protective Agents|protective agents|mesh-ancestor
44176441|NCT00303264|Esomeprazole|esomeprazole|mesh-list
44176442|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44176443|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44176444|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44176445|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176446|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176447|NCT00303277|Simvastatin|simvastatin|mesh-list
44176448|NCT00303277|Pravastatin|pravastatin|mesh-list
44176484|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44176485|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176486|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44176487|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44176512|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176513|NCT00303576|Dapivirine|dapivirine|mesh-list
44463058|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463059|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44463060|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44463061|NCT01519635|Diuretics|diuretics|mesh-ancestor
44463062|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
44463063|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463064|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44463065|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463066|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463067|NCT01519518|Heparin|heparin|mesh-list
44463068|NCT01519518|Calcium heparin|calcium heparin|mesh-list
44463069|NCT01519518|Bivalirudin|bivalirudin|mesh-list
44463070|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
44463071|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44463072|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463073|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463074|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
44463075|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44463076|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463077|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463078|NCT01519323|Vemurafenib|vemurafenib|mesh-list
44463079|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463080|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463081|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463082|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463083|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
44274427|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44274428|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44274429|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
44274430|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
44274431|NCT00697671|Etoposide|etoposide|mesh-list
44274432|NCT00697671|Interleukin-2|interleukin-2|mesh-list
44274433|NCT00697671|Clofarabine|clofarabine|mesh-list
44274434|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274435|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
44274436|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274437|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176514|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176515|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176516|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
44176517|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176518|NCT00303589|Lactams|lactams|mesh-list
44176519|NCT00303589|beta-Lactams|beta-lactams|mesh-list
44176520|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44176521|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176522|NCT00303615|Anastrozole|anastrozole|mesh-list
44176523|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
44176524|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44176525|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176526|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44176527|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44176528|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176529|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176530|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44176531|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
44176532|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176533|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176534|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
44176535|NCT00303615|Hormones|hormones|mesh-ancestor
44176536|NCT00303732|Everolimus|everolimus|mesh-list
44176537|NCT00303732|Vatalanib|vatalanib|mesh-list
44176538|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176570|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44176572|NCT00303758|Protective Agents|protective agents|mesh-ancestor
44176573|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
44176574|NCT00303758|Vitamins|vitamins|mesh-ancestor
44176575|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
44176576|NCT00303771|Leucovorin|leucovorin|mesh-list
44176577|NCT00303771|Fluorouracil|fluorouracil|mesh-list
44176578|NCT00303771|Irinotecan|irinotecan|mesh-list
44176579|NCT00303771|Calcium|calcium|mesh-list
44112970|NCT00093886|Clevidipine|clevidipine|mesh-list
44176580|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
44176581|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44176582|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176583|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
44176619|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
44176620|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176621|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
44176622|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176623|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176624|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176625|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
44176626|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176627|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176628|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176684|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176685|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
44106627|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274438|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44274439|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
44274440|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274441|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274442|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44274443|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44274444|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44274445|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44274446|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274447|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274448|NCT00697671|Analgesics|analgesics|mesh-ancestor
44274449|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
44274450|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274451|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44274452|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
44176686|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176687|NCT00303992|Trastuzumab|trastuzumab|mesh-list
44176688|NCT00303992|Irinotecan|irinotecan|mesh-list
44176689|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176690|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176691|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44176692|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176693|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176694|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176695|NCT00304018|Prednisone|prednisone|mesh-list
44176696|NCT00304018|Fludarabine|fludarabine|mesh-list
44176697|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
44176698|NCT00304018|Etoposide|etoposide|mesh-list
44176699|NCT00304018|Busulfan|busulfan|mesh-list
44176700|NCT00304018|Tacrolimus|tacrolimus|mesh-list
44176701|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44176702|NCT00304018|Sargramostim|sargramostim|mesh-list
44176703|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44176704|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
44176705|NCT00304018|Hormones|hormones|mesh-ancestor
44176706|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176707|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176708|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44176709|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176710|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176711|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
44176712|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176713|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176714|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
44176715|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44176716|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44176717|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176718|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176719|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176720|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
44176721|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176722|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176723|NCT00304135|Gemcitabine|gemcitabine|mesh-list
44176759|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176760|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44176761|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274454|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
44274455|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274456|NCT00697814|Clomiphene|clomiphene|mesh-list
44274457|NCT00697814|Enclomiphene|enclomiphene|mesh-list
44274458|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
44274459|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44274460|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
44274461|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274462|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274463|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44274464|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
44274465|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44274466|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44274467|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44274468|NCT00697866|Vaccines|vaccines|mesh-list
44274469|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
44274470|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274471|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44274472|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274473|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274474|NCT00697892|Ritonavir|ritonavir|mesh-list
44274475|NCT00697892|Lopinavir|lopinavir|mesh-list
44274476|NCT00697892|Efavirenz|efavirenz|mesh-list
44274477|NCT00697892|Lumefantrine|lumefantrine|mesh-list
43669088|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43669093|NCT02907749|Diuretics|diuretics|mesh-ancestor
44274478|NCT00697892|Artemether|artemether|mesh-list
44274480|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44274504|NCT00697905|Fluorouracil|fluorouracil|mesh-list
44274505|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274506|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44274507|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
44274508|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274509|NCT00697905|Antiviral Agents|antiviral agents|mesh-ancestor
44274510|NCT00697905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274511|NCT00697905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274512|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274513|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
44274514|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274515|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44274516|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
44274517|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274518|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44274519|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44274520|NCT00697996|Rituximab|rituximab|mesh-list
44274521|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44274522|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274523|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
44274524|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274525|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274526|NCT00698126|Insulin|insulin|mesh-list
44274527|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44274528|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
44274529|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
44274530|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274554|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44274555|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44274556|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44274557|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44274558|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44274560|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
44274561|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
44274562|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44274563|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
44274564|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
44274565|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274566|NCT00698464|Pasireotide|pasireotide|mesh-list
44274567|NCT00698464|Hormones|hormones|mesh-ancestor
44274568|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274569|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274570|NCT00698607|Sirolimus|sirolimus|mesh-list
44274571|NCT00698607|Everolimus|everolimus|mesh-list
44274572|NCT00698607|Clopidogrel|clopidogrel|mesh-list
44176762|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
44176763|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44176798|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44176799|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176800|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176802|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176839|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44176840|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44176841|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44176842|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176873|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
44176874|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176875|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176876|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176877|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44176878|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44176879|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669148|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43669149|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43669150|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
43669151|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669152|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669153|NCT02907437|Minocycline|minocycline|mesh-list
43669155|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669156|NCT02907307|Clotrimazole|clotrimazole|mesh-list
43669157|NCT02907307|Miconazole|miconazole|mesh-list
43669158|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43669159|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176880|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44176881|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44176882|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
44176883|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
44176884|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
44176885|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176886|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44176887|NCT00304616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44113272|NCT00095082|Insulin|insulin|mesh-list
44176888|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176917|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44176918|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176919|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
44176920|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
44176921|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274574|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274576|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274577|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274578|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44274579|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44274580|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44274581|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
44274582|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274583|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274584|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274585|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274586|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44274587|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
44274588|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
44274589|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44274590|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
43662944|NCT02909972|Cytarabine|cytarabine|mesh-list
44176922|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176923|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44176924|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44176925|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
44176926|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44176927|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44176928|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44176929|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44176930|NCT00304668|Dapivirine|dapivirine|mesh-list
44176931|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176932|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176933|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
44176934|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453909|NCT01673646|Hormones|hormones|mesh-ancestor
44176976|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176977|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176978|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176979|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44176980|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44177014|NCT00304980|Renal Agents|renal agents|mesh-ancestor
44177016|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
44177017|NCT00304993|Fenofibrate|fenofibrate|mesh-list
44177044|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177045|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44177046|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44177047|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44177048|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177049|NCT00305331|Domperidone|domperidone|mesh-list
44177050|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
44177051|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
44177052|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177053|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177054|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274591|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44274593|NCT00698724|Bromfenac|bromfenac|mesh-list
44274594|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44274595|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
44274596|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274597|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
44274598|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
44274599|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274600|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274601|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274602|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
44274603|NCT00698724|Hormones|hormones|mesh-ancestor
44274604|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274605|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44274606|NCT00698724|Protective Agents|protective agents|mesh-ancestor
44274607|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44274608|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274650|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
44274651|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274652|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44274653|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44274654|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274655|NCT00699036|Metformin|metformin|mesh-list
44274656|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
44274657|NCT00699036|Losartan|losartan|mesh-list
44274658|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274659|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274660|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44274661|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274662|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44274663|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44274664|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274665|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
44274666|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44274667|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43825902|NCT04465383|Propofol|propofol|mesh-list
44177055|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177056|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
44177057|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177058|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177059|NCT00305370|Aripiprazole|aripiprazole|mesh-list
44177060|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
44177061|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177062|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44177063|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177064|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177065|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177102|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177103|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177104|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44177105|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177139|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177140|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177141|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
44177142|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177143|NCT00305500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44177144|NCT00305500|Antidepressive Agents|antidepressive agents|mesh-ancestor
44177145|NCT00305500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177146|NCT00305513|Caffeine|caffeine|mesh-list
44177182|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177183|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
44177215|NCT00305734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177216|NCT00305734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177217|NCT00305734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177218|NCT00305734|Immunologic Factors|immunologic factors|mesh-ancestor
44177219|NCT00305734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274669|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
44274670|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274671|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274672|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274673|NCT00699049|Urological Agents|urological agents|mesh-ancestor
44274674|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44274675|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274676|NCT00699062|Montelukast|montelukast|mesh-list
44274677|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44274678|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
44274679|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44274680|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
44274681|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274682|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274683|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44274684|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44274685|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274686|NCT00699114|Acetaminophen|acetaminophen|mesh-list
44274687|NCT00699114|Ibuprofen|ibuprofen|mesh-list
44274688|NCT00699114|Codeine|codeine|mesh-list
44274689|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274690|NCT00699114|Analgesics|analgesics|mesh-ancestor
44274691|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
44274692|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177220|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44177221|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44177222|NCT00305747|Protective Agents|protective agents|mesh-ancestor
44177223|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177224|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177225|NCT00305786|Gemcitabine|gemcitabine|mesh-list
44177226|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
44177258|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177259|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44177260|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177261|NCT00305825|Bevacizumab|bevacizumab|mesh-list
44177262|NCT00305825|Letrozole|letrozole|mesh-list
44177263|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44177264|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177265|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177266|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177267|NCT00305825|Growth Substances|growth substances|mesh-ancestor
44177268|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177269|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177270|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44177271|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44274694|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
44274695|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274696|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274697|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274698|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44274699|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274700|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274701|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44274702|NCT00699114|Narcotics|narcotics|mesh-ancestor
44274703|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274704|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
44274705|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
44274706|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
44274707|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
44274708|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44274709|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274710|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177302|NCT00306020|Morphine|morphine|mesh-list
44177303|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44177304|NCT00306020|Narcotics|narcotics|mesh-ancestor
44113680|NCT00096187|Pemetrexed|pemetrexed|mesh-list
44177305|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177306|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177308|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
44177309|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177310|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44177311|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
44177333|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177334|NCT00306150|Aprotinin|aprotinin|mesh-list
44177335|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
44177336|NCT00306150|Coagulants|coagulants|mesh-ancestor
44177337|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44177338|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44177339|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44177340|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177341|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177342|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
44177343|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177344|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177345|NCT00306254|Enoxaparin|enoxaparin|mesh-list
44177346|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
44177347|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
44177348|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44177349|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44177350|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177351|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44177352|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
44177353|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44177354|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
44177355|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177356|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
44177357|NCT00306267|Hematinics|hematinics|mesh-ancestor
44177358|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
43929015|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
44274711|NCT00699244|Anesthetics|anesthetics|mesh-list
44274712|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274713|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274714|NCT00699296|Panobinostat|panobinostat|mesh-list
44274715|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274716|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44274717|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274718|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274719|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44274720|NCT00699322|Glimepiride|glimepiride|mesh-list
44274721|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274722|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274723|NCT00699322|Incretins|incretins|mesh-ancestor
44274725|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274726|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44274727|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44274728|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669324|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669325|NCT02905305|Dexamethasone|dexamethasone|mesh-list
43669326|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274729|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274730|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44274731|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274732|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
44274733|NCT00699361|Pantoprazole|pantoprazole|mesh-list
44274734|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44274735|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274736|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44274737|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274738|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274739|NCT00699387|Benzonidazole|benzonidazole|mesh-list
44274740|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44274741|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
43662969|NCT02909933|Metformin|metformin|mesh-list
44177359|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177360|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177361|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44177362|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44177363|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177364|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177365|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177366|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
44453941|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44274742|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274743|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44274744|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44274745|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44274746|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274747|NCT00699426|Esomeprazole|esomeprazole|mesh-list
44274748|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44274749|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274750|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44274751|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274752|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274753|NCT00699452|Candesartan|candesartan|mesh-list
44274754|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274755|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44274756|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44274757|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463094|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463095|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463096|NCT01519167|Analgesics|analgesics|mesh-ancestor
44463097|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
44463098|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463099|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44463100|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44463101|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44463102|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463103|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463104|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463105|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44463106|NCT01519167|Narcotics|narcotics|mesh-ancestor
44463107|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44463108|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44463109|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
44463110|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
44463119|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463120|NCT01518972|Prazosin|prazosin|mesh-list
44463121|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274758|NCT00699465|Enoxaparin|enoxaparin|mesh-list
44274759|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
44274760|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
44274761|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44274762|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44274763|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274764|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
44274765|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
44274766|NCT00699478|Vitamins|vitamins|mesh-ancestor
44274767|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
44274768|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274769|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
44274770|NCT00699504|Cangrelor|cangrelor|mesh-list
44274771|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44274772|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274773|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44274774|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44274775|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274776|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274777|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274778|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274779|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663003|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
44453942|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453943|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453944|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453945|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453946|NCT01673490|Urological Agents|urological agents|mesh-ancestor
44453947|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44453948|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453949|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453950|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453951|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453952|NCT01673386|Sunitinib|sunitinib|mesh-list
44453953|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453954|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44453955|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44453956|NCT01673386|Growth Substances|growth substances|mesh-ancestor
44453957|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453958|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
44453959|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453960|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453961|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453962|NCT01673282|Lacosamide|lacosamide|mesh-list
44453963|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
44106628|NCT00076544|Analgesics|analgesics|mesh-ancestor
44274780|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44274781|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44274782|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44274783|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
44274784|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274785|NCT00699530|Cabergoline|cabergoline|mesh-list
44274786|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44274787|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44274788|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
44274789|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
44274790|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274791|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274792|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274793|NCT00699634|Nabilone|nabilone|mesh-list
44274794|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
44274795|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
44274796|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274797|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274798|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274799|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44453964|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44453965|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44453966|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453967|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453968|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
44453969|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453970|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453971|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113820|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
44177417|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44177418|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
44177419|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177420|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44177456|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177457|NCT00306735|Palonosetron|palonosetron|mesh-list
44177458|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
44177459|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
44177481|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44177482|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44177483|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44177484|NCT00306813|Lenalidomide|lenalidomide|mesh-list
44177485|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
44177486|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177487|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177488|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177489|NCT00306813|Growth Substances|growth substances|mesh-ancestor
44177490|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177491|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177493|NCT00306826|Simvastatin|simvastatin|mesh-list
44177494|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44177495|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44177496|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
44177497|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177498|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44106629|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
44274801|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274802|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44274803|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
44274804|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
44274805|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274806|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274807|NCT00699764|Vaccines|vaccines|mesh-list
44274808|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
44274809|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274810|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
44274811|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
44274812|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44274813|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44274814|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274815|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44274816|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274817|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44274818|NCT00699881|Cetuximab|cetuximab|mesh-list
44274819|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44274820|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177499|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44177500|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177501|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177502|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846803|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
44177503|NCT00306878|Abatacept|abatacept|mesh-list
44177504|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44177505|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177506|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177507|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177508|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
44177509|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177510|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44177511|NCT00306969|Bexarotene|bexarotene|mesh-list
44177512|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177548|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44177549|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44177550|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177575|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
44177576|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177577|NCT00307411|Hormones|hormones|mesh-list
44177578|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177579|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177580|NCT00307450|Levetiracetam|levetiracetam|mesh-list
44177581|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
44177582|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
44177583|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
44177584|NCT00307502|Ritonavir|ritonavir|mesh-list
44177585|NCT00307502|Lopinavir|lopinavir|mesh-list
44177586|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44177587|NCT00307502|Darunavir|darunavir|mesh-list
44177588|NCT00307502|Nelfinavir|nelfinavir|mesh-list
44177589|NCT00307502|Indinavir|indinavir|mesh-list
44274822|NCT00699894|Aprepitant|aprepitant|mesh-list
44274823|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
44274824|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
44274825|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274826|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274827|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274828|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
44274829|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
44274830|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44274831|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
44274832|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274833|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274834|NCT00699894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44274835|NCT00699894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44274836|NCT00699894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274837|NCT00699894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44274838|NCT00699894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44274839|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44274840|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44274841|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
44274842|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44177590|NCT00307502|Saquinavir|saquinavir|mesh-list
44177591|NCT00307502|Amprenavir|amprenavir|mesh-list
44177592|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
44177593|NCT00307502|Nevirapine|nevirapine|mesh-list
44177594|NCT00307502|Tipranavir|tipranavir|mesh-list
44177595|NCT00307502|Efavirenz|efavirenz|mesh-list
44177596|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44177597|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44177598|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
44177599|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177600|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177601|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44177602|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44177603|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
44177604|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177605|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44177628|NCT00307593|Infliximab|infliximab|mesh-list
44177629|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44177630|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177631|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
44177632|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177633|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44177634|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
44177635|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177636|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
44177637|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44177638|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44177639|NCT00307606|Prednisolone|prednisolone|mesh-list
44114045|NCT00097383|Epirubicin|epirubicin|mesh-list
44177640|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
44177641|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44177642|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
44177643|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274843|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44274844|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274845|NCT00699946|Olanzapine|olanzapine|mesh-list
44274846|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
44274847|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
44274848|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274849|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274850|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44274851|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44274852|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44274853|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44274854|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44274855|NCT00699946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44274856|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44274857|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44274904|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
44274905|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
44274906|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274907|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44274908|NCT00700362|Insulin|insulin|mesh-list
44274909|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274910|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274911|NCT00700466|Metoprolol|metoprolol|mesh-list
44274912|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44274913|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44274914|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274915|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
44274916|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
44274917|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274918|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274919|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44274920|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44274921|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
43663074|NCT02909413|Desflurane|desflurane|mesh-list
44177644|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
44177645|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
44177646|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177647|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177648|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177649|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
44177650|NCT00307606|Hormones|hormones|mesh-ancestor
44177651|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177652|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44177653|NCT00307606|Protective Agents|protective agents|mesh-ancestor
44177654|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177670|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44177671|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44177672|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
44177673|NCT00307645|Prednisone|prednisone|mesh-list
44177674|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
44177675|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
44177676|NCT00307645|Azathioprine|azathioprine|mesh-list
44177677|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177678|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
43669468|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
44177679|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177680|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44177681|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44177682|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
44177683|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177684|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177685|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44177686|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177687|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
44177688|NCT00307645|Hormones|hormones|mesh-ancestor
44177689|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177690|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177691|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44177692|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44177693|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
44177694|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177695|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44274922|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274923|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274924|NCT00700492|Progesterone|progesterone|mesh-list
44274925|NCT00700492|Progestins|progestins|mesh-ancestor
44274926|NCT00700492|Hormones|hormones|mesh-ancestor
44274927|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274928|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274929|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
44274930|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
44274931|NCT00700544|Norethandrolone|norethandrolone|mesh-list
44274932|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
44274933|NCT00700544|Hormones|hormones|mesh-ancestor
44274934|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44274935|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274936|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44274937|NCT00700583|Terazosin|terazosin|mesh-list
44274938|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44274939|NCT00700583|Diuretics|diuretics|mesh-ancestor
44274940|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
44274941|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274942|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44274943|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44274944|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274945|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44274946|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44274947|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44274948|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274949|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274950|NCT00700583|Urological Agents|urological agents|mesh-ancestor
44274951|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
44274952|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663082|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
44177696|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177697|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
44177698|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
44177699|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177700|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177701|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44177702|NCT00307645|Protective Agents|protective agents|mesh-ancestor
44177703|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
44177704|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177705|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
44274953|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274954|NCT00700687|Aspirin|aspirin|mesh-list
44274955|NCT00700687|Celecoxib|celecoxib|mesh-list
44274956|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44274957|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44274958|NCT00700687|Analgesics|analgesics|mesh-ancestor
44274959|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
44274960|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44274961|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274962|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44274963|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44274964|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44274965|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44274966|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274967|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44274968|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44274969|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274970|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
44274971|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44274972|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
44274973|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274974|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274975|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
44274976|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274977|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274978|NCT00700856|Pioglitazone|pioglitazone|mesh-list
44274979|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44274980|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44274981|NCT00700895|Warfarin|warfarin|mesh-list
44274982|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
44274983|NCT00700921|Lovastatin|lovastatin|mesh-list
44274984|NCT00700921|L 647318|l 647318|mesh-list
43929309|NCT00674609|Nabiximols|nabiximols|mesh-list
44274985|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
44274986|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44274987|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44177706|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44177707|NCT00307658|Antibodies|antibodies|mesh-list
44177708|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
44177709|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
44177710|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44177711|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
44274989|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274990|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44274991|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44274992|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44274993|NCT00700947|Metoprolol|metoprolol|mesh-list
44274994|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44274995|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44274996|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44274997|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44274998|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44274999|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275000|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44275001|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275002|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
44275003|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
44275004|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275005|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44275006|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
44177712|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177713|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
44177714|NCT00307671|Prednisone|prednisone|mesh-list
44177715|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
44177729|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44177731|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177732|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177733|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44177734|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177735|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
44177736|NCT00307671|Hormones|hormones|mesh-ancestor
44177737|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177738|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43669605|NCT02903017|Coagulants|coagulants|mesh-ancestor
44177739|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44177740|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
44177741|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44177742|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177743|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
44177744|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
44177745|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177746|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44177747|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44177748|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44177749|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44177750|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
44177751|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177752|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177753|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
44177754|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
44177755|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177756|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177757|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44177758|NCT00307671|Protective Agents|protective agents|mesh-ancestor
44177759|NCT00307723|Gemcitabine|gemcitabine|mesh-list
44275007|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275008|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275009|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
44275010|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275011|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275012|NCT00701220|Atorvastatin|atorvastatin|mesh-list
44275013|NCT00701220|Calcium|calcium|mesh-list
44275014|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44275015|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275016|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44275017|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275018|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
44275019|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275020|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275021|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44177760|NCT00307723|Bevacizumab|bevacizumab|mesh-list
44177761|NCT00307723|Fluorouracil|fluorouracil|mesh-list
44177762|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
44177763|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44177764|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177765|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177766|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177767|NCT00307723|Growth Substances|growth substances|mesh-ancestor
44177768|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177769|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177770|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177771|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
44177772|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177773|NCT00307723|Antiviral Agents|antiviral agents|mesh-ancestor
44177774|NCT00307723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177775|NCT00307723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177776|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177777|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
44177792|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177793|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177794|NCT00307996|Ubiquinone|ubiquinone|mesh-list
44177796|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
44177797|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177798|NCT00307996|Vitamins|vitamins|mesh-ancestor
44177799|NCT00308048|Interferons|interferons|mesh-list
44177800|NCT00308048|Ribavirin|ribavirin|mesh-list
44177801|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
44177802|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
44177803|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44177804|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177805|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
44177806|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177807|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
44177808|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177809|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
44177810|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177811|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44177812|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
44177813|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
44177814|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44177815|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
44177816|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
44177817|NCT00308165|Topotecan|topotecan|mesh-list
44177818|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44177819|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275022|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275023|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
44275024|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44275025|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44275026|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275027|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44275028|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275029|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275030|NCT00701246|Folic Acid|folic acid|mesh-list
44275031|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
44275032|NCT00701246|Hematinics|hematinics|mesh-ancestor
44275033|NCT00701246|Vitamins|vitamins|mesh-ancestor
44275034|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
44275035|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275036|NCT00701259|Lansoprazole|lansoprazole|mesh-list
44275037|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
44275038|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44275039|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275040|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44275041|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275042|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275043|NCT00701285|Pravastatin|pravastatin|mesh-list
44275044|NCT00701285|Pitavastatin|pitavastatin|mesh-list
44275045|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44275046|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275047|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
44275048|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275049|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275071|NCT00701337|Estrogens|estrogens|mesh-ancestor
43669670|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
43826860|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826861|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275073|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275074|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275075|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44275076|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
44275077|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44275078|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44275079|NCT00701428|Losartan|losartan|mesh-list
44275080|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44275081|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44177820|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177821|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177822|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177823|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44177824|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177825|NCT00308191|Bromides|bromides|mesh-list
44177826|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
44177827|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
44177828|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44177829|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
44177830|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177831|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177832|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44177833|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
44177834|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44177835|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44177836|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44177837|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
44177838|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177839|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177840|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
44177841|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44453983|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
44453984|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453985|NCT01672801|Nimodipine|nimodipine|mesh-list
44453986|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44453987|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44453988|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453989|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453990|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669721|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669723|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44453991|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453992|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
44453993|NCT01672788|Metformin|metformin|mesh-list
44453994|NCT01672788|Empagliflozin|empagliflozin|mesh-list
44453995|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453996|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114206|NCT00098423|Cytarabine|cytarabine|mesh-list
44177844|NCT00308269|Folic Acid|folic acid|mesh-list
44177845|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
44177846|NCT00308269|Hematinics|hematinics|mesh-ancestor
44177847|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
44177848|NCT00308269|Vitamins|vitamins|mesh-ancestor
44177849|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
44177850|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177851|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177852|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
44177853|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
44177854|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
44177855|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275082|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44275083|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44275084|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275085|NCT00701493|Topiramate|topiramate|mesh-list
44275086|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
44275087|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275088|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275089|NCT00701532|Modafinil|modafinil|mesh-list
44275090|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44275091|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177856|NCT00308321|Prednisolone|prednisolone|mesh-list
44177857|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44177858|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
44177859|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44177860|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
44177861|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44177862|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
44177863|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177864|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
44177865|NCT00308321|Hormones|hormones|mesh-ancestor
44177866|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177867|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177868|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177869|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177870|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
44177871|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
44177872|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177873|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177874|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44177875|NCT00308321|Protective Agents|protective agents|mesh-ancestor
44177876|NCT00308334|Domperidone|domperidone|mesh-list
44177877|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
44177910|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44177911|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177912|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44177913|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
44177914|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177915|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177916|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177917|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177918|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44177919|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44177920|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44177921|NCT00308438|Teduglutide|teduglutide|mesh-list
44177955|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177956|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44177957|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177958|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
44177959|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177960|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177961|NCT00308529|Bevacizumab|bevacizumab|mesh-list
44177962|NCT00308529|Carboplatin|carboplatin|mesh-list
44177963|NCT00308529|Irinotecan|irinotecan|mesh-list
44177964|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44177965|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178018|NCT00308763|Nicotine|nicotine|mesh-list
44178019|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44178020|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
44178021|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178022|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178023|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44178024|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44178025|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
44178026|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275092|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44275093|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44275094|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44275095|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463122|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44463123|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44463124|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44463125|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463126|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463127|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463128|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463129|NCT01518946|Midodrine|midodrine|mesh-list
44463130|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
44463131|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
44463132|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463133|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463134|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44463135|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44275110|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275111|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275112|NCT00701857|Cisplatin|cisplatin|mesh-list
44275113|NCT00701857|Pemetrexed|pemetrexed|mesh-list
44275114|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275115|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275116|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275117|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44275118|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44275119|NCT00701909|Ketamine|ketamine|mesh-list
44275120|NCT00701909|Morphine|morphine|mesh-list
44275121|NCT00701909|Analgesics|analgesics|mesh-ancestor
44275122|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
44275123|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275124|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275125|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44275126|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44275127|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
44275128|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
44178027|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178028|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44178029|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
44178030|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44178031|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44178032|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44178033|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178034|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
44178035|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44178036|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44178037|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178038|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
44178039|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44178040|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178041|NCT00308841|Lidocaine|lidocaine|mesh-list
44178042|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
44178043|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
44178044|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178045|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178046|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
44178047|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178048|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44178049|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44178050|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44178051|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178052|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178053|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
44178054|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44178055|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44178056|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178057|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
44178058|NCT00308880|Coagulants|coagulants|mesh-ancestor
44178095|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178097|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44178098|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44275129|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275130|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44275131|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44275132|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275133|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275134|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44275135|NCT00701909|Narcotics|narcotics|mesh-ancestor
44275136|NCT00701961|Artesunate|artesunate|mesh-list
44275137|NCT00701961|Mefloquine|mefloquine|mesh-list
44275138|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
44275139|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44275140|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44275141|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275142|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275143|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
44275144|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
44275145|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44275146|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
44275147|NCT00702091|Ramipril|ramipril|mesh-list
44275148|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44275149|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44275150|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275151|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275152|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275153|NCT00702117|Flecainide|flecainide|mesh-list
44275154|NCT00702117|Procainamide|procainamide|mesh-list
44275155|NCT00702117|Ajmaline|ajmaline|mesh-list
44275156|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44275157|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44275158|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44275159|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44275160|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275161|NCT00702130|Pravastatin|pravastatin|mesh-list
44275162|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44275163|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275164|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
44275165|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178099|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44275166|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275167|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44275168|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275169|NCT00702156|Bisoprolol|bisoprolol|mesh-list
44275170|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275171|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
44275172|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
44275173|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275174|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275175|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44275176|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44275177|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44275178|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
44275179|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275180|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275181|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44275183|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275184|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44275185|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275186|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275187|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275188|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275189|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275190|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275191|NCT00702260|Ramipril|ramipril|mesh-list
44275192|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44275193|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
44275194|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178113|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178114|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
44178115|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44178116|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44178117|NCT00309218|Prednisolone|prednisolone|mesh-list
44178118|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
44178119|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44178120|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
44178121|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178122|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
44178123|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
44178124|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178125|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178126|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178127|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
44178128|NCT00309218|Hormones|hormones|mesh-ancestor
44106630|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275195|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275196|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275197|NCT00702416|Acetaminophen|acetaminophen|mesh-list
44275198|NCT00702416|Fentanyl|fentanyl|mesh-list
44275199|NCT00702416|Morphine|morphine|mesh-list
44275200|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
44275201|NCT00702416|Narcotics|narcotics|mesh-list
44275202|NCT00702416|Analgesics|analgesics|mesh-list
44275203|NCT00702416|Anesthetics|anesthetics|mesh-list
44275204|NCT00702416|Ropivacaine|ropivacaine|mesh-list
44275205|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
44275206|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275207|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275208|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
44275209|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275210|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44275211|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44275212|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
44275213|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44275214|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
44275215|NCT00702442|Droperidol|droperidol|mesh-list
44275216|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44275217|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
44275218|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
44275219|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275220|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178129|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178130|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44178131|NCT00309218|Protective Agents|protective agents|mesh-ancestor
44178132|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178133|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178134|NCT00309257|Valsartan|valsartan|mesh-list
44178135|NCT00309257|Benazepril|benazepril|mesh-list
44178136|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178137|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44178138|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44178139|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178140|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44178141|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
44178142|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178143|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
44178144|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178145|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178146|NCT00309283|Somatostatin|somatostatin|mesh-list
44178147|NCT00309283|Hormones|hormones|mesh-ancestor
44178148|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178149|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178150|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
44178151|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44178152|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178153|NCT00309322|Phentolamine|phentolamine|mesh-list
44275222|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44275223|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44275224|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275225|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275226|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44275227|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44275228|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
44275229|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275230|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275231|NCT00702481|Cisplatin|cisplatin|mesh-list
44275232|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
44275233|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275234|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275235|NCT00702572|Paclitaxel|paclitaxel|mesh-list
44275236|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44275237|NCT00702572|Bevacizumab|bevacizumab|mesh-list
44275238|NCT00702572|Carboplatin|carboplatin|mesh-list
44275239|NCT00702572|Vorinostat|vorinostat|mesh-list
44275240|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275274|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275275|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44275277|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44275278|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44275279|NCT00702793|Varenicline|varenicline|mesh-list
44275280|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44275281|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44275282|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
44275283|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275284|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275285|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275286|NCT00702819|Bevacizumab|bevacizumab|mesh-list
44275287|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275288|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275289|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275290|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44178154|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44178155|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178156|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178157|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178158|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178159|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178160|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178197|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178198|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
44178199|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178200|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178227|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44178228|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44178229|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44178230|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43826936|NCT05493267|Analgesics|analgesics|mesh-ancestor
43669907|NCT02900742|Gemcitabine|gemcitabine|mesh-list
43669908|NCT02900742|Docetaxel|docetaxel|mesh-list
43669909|NCT02900742|Pemetrexed|pemetrexed|mesh-list
43669910|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669911|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
43669912|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669913|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669914|NCT02900742|Antiviral Agents|antiviral agents|mesh-ancestor
43669915|NCT02900742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178231|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178232|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178234|NCT00309517|Edrecolomab|edrecolomab|mesh-list
44178235|NCT00309517|Antidotes|antidotes|mesh-ancestor
44178236|NCT00309517|Protective Agents|protective agents|mesh-ancestor
44178237|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178238|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
44178239|NCT00309517|Vitamins|vitamins|mesh-ancestor
44178240|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
44178241|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44178242|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
44178243|NCT00309530|Interferons|interferons|mesh-list
44178244|NCT00309530|Fluorouracil|fluorouracil|mesh-list
44178245|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
44178280|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44178281|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178282|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178283|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178284|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
44178285|NCT00309569|Fluorouracil|fluorouracil|mesh-list
44178286|NCT00309569|Methotrexate|methotrexate|mesh-list
44178287|NCT00309569|Epirubicin|epirubicin|mesh-list
44178288|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178306|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44275291|NCT00702819|Growth Substances|growth substances|mesh-ancestor
44275292|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275293|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275294|NCT00702871|Ranitidine|ranitidine|mesh-list
44275295|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44275296|NCT00702871|Sucralfate|sucralfate|mesh-list
44275297|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44275298|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275299|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44275300|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
44275301|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
44275302|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275303|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275304|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275305|NCT00702936|Telmisartan|telmisartan|mesh-list
44275306|NCT00702936|Ramipril|ramipril|mesh-list
44275307|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275308|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44275309|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44275310|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275311|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44275312|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
44275313|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275314|NCT00702975|Paclitaxel|paclitaxel|mesh-list
44275315|NCT00702975|Bevacizumab|bevacizumab|mesh-list
44275316|NCT00702975|Carboplatin|carboplatin|mesh-list
44275317|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44275318|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275319|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275320|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275321|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275322|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275323|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663193|NCT05259631|Propofol|propofol|mesh-list
44178307|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178308|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178310|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178311|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44178312|NCT00309634|Vaccines|vaccines|mesh-list
44178313|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
44178314|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275324|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275325|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275326|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275327|NCT00702975|Growth Substances|growth substances|mesh-ancestor
44275328|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275329|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275330|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44275331|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275333|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
44275334|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275335|NCT00703079|Octreotide|octreotide|mesh-list
44275336|NCT00703079|Lanreotide|lanreotide|mesh-list
44275337|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275338|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44275339|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275340|NCT00703144|Tazobactam|tazobactam|mesh-list
44275341|NCT00703144|Piperacillin|piperacillin|mesh-list
44275342|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44275343|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275344|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275345|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44275346|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275347|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275348|NCT00703170|Sirolimus|sirolimus|mesh-list
44275349|NCT00703170|Doxorubicin|doxorubicin|mesh-list
44178315|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
44178316|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44178317|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178318|NCT00309673|Lidocaine|lidocaine|mesh-list
44178319|NCT00309673|Prilocaine|prilocaine|mesh-list
44178320|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44178321|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
44178322|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
44178323|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178324|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178325|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
44178326|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178327|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44178328|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44178329|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44178330|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178331|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178332|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44178333|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44178334|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44178335|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44178336|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178337|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275350|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44275351|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44275352|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275353|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44275354|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275355|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275356|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275357|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275358|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275359|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
44275360|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275361|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
44275362|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275363|NCT00703196|Folic Acid|folic acid|mesh-list
44275364|NCT00703196|Hematinics|hematinics|mesh-ancestor
44275365|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
44275366|NCT00703196|Vitamins|vitamins|mesh-ancestor
44275367|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
44275368|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275369|NCT00703235|Bevacizumab|bevacizumab|mesh-list
44275370|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275371|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275372|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275373|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275374|NCT00703235|Growth Substances|growth substances|mesh-ancestor
44275375|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275376|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275377|NCT00703300|Bortezomib|bortezomib|mesh-list
44275378|NCT00703300|Decitabine|decitabine|mesh-list
44275379|NCT00703300|Azacitidine|azacitidine|mesh-list
44275380|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275381|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275382|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
43663226|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
44178338|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44178339|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44178340|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44178341|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
44178342|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178343|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178344|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44178360|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44275383|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275384|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275385|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
44275386|NCT00703313|Levofloxacin|levofloxacin|mesh-list
44275387|NCT00703313|Ofloxacin|ofloxacin|mesh-list
44275388|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
44275389|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44275390|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44275391|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44275392|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275393|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275394|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44275395|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275396|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275397|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275398|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275399|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44275400|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
44275401|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44275402|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275403|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44275404|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44275405|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44275406|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44275407|NCT00703313|Renal Agents|renal agents|mesh-ancestor
43825948|NCT04265950|Vaccines|vaccines|mesh-list
44178361|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44178362|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
43670044|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670045|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670046|NCT02898792|Remifentanil|remifentanil|mesh-list
44178363|NCT00309712|Simvastatin|simvastatin|mesh-list
44178364|NCT00309712|Fenofibrate|fenofibrate|mesh-list
44178365|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44178366|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44178367|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
44178368|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178369|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44178370|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44178371|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178372|NCT00309725|Galantamine|galantamine|mesh-list
44178373|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44178374|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178375|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178376|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
44178377|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178378|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178379|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44178380|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
44178381|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178382|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
44275408|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44275409|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44275410|NCT00703352|Eplerenone|eplerenone|mesh-list
44275411|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44275412|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
44275413|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275414|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275415|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44275416|NCT00703352|Diuretics|diuretics|mesh-ancestor
44275417|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
44275418|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275419|NCT00703365|Gemcitabine|gemcitabine|mesh-list
44275420|NCT00703365|Sorafenib|sorafenib|mesh-list
44275421|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275422|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
43670047|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43670048|NCT02898792|Narcotics|narcotics|mesh-ancestor
44275423|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275424|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275425|NCT00703365|Antiviral Agents|antiviral agents|mesh-ancestor
44275426|NCT00703365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275427|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275428|NCT00703365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275429|NCT00703365|Immunologic Factors|immunologic factors|mesh-ancestor
44275430|NCT00703365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275431|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44275432|NCT00703378|Docetaxel|docetaxel|mesh-list
44275433|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275434|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275435|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275436|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275437|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275438|NCT00703430|Memantine|memantine|mesh-list
44275439|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44275440|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44178383|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
44178384|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44178385|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44178386|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44178387|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178388|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178389|NCT00309790|Urological Agents|urological agents|mesh-ancestor
44178390|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
44275442|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275443|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275444|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275445|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44275446|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44275447|NCT00703469|Nivolumab|nivolumab|mesh-list
44275448|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275449|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275450|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44275451|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275452|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
44275453|NCT00703482|Ubiquinone|ubiquinone|mesh-list
44275454|NCT00703482|Fenofibrate|fenofibrate|mesh-list
44275455|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275456|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
44275457|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275458|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275459|NCT00703482|Vitamins|vitamins|mesh-ancestor
44275460|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
44275461|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178391|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
44178392|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44178393|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44178394|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178395|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178396|NCT00309816|Urological Agents|urological agents|mesh-ancestor
44178397|NCT00309855|Anastrozole|anastrozole|mesh-list
44178398|NCT00309855|Testosterone|testosterone|mesh-list
44178399|NCT00309855|Dutasteride|dutasteride|mesh-list
44178400|NCT00309855|Androgens|androgens|mesh-ancestor
44178401|NCT00309855|Hormones|hormones|mesh-ancestor
44178402|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178425|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178426|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178427|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178428|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178429|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44178430|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178431|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178432|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178433|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178434|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
44178436|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178437|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178438|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44178439|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178440|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178441|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44453997|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44106631|NCT00076609|Capecitabine|capecitabine|mesh-list
44275462|NCT00703586|Maraviroc|maraviroc|mesh-list
44275463|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44275464|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44275465|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275466|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44275467|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44275468|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
44275469|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275470|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44275471|NCT00703625|Sirolimus|sirolimus|mesh-list
44275472|NCT00703625|Docetaxel|docetaxel|mesh-list
44275473|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275474|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275475|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275476|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275477|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275478|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275479|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275480|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44275481|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
44275482|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275483|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
44275484|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275485|NCT00703638|Cisplatin|cisplatin|mesh-list
44275486|NCT00703638|Pemetrexed|pemetrexed|mesh-list
44275487|NCT00703638|Sorafenib|sorafenib|mesh-list
44275488|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275489|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846720|NCT04177082|Riboflavin|riboflavin|mesh-list
44453998|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453999|NCT01672736|Dexamethasone|dexamethasone|mesh-list
44178442|NCT00309894|Ketoconazole|ketoconazole|mesh-list
44178443|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
44178444|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44178445|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44178446|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44178447|NCT00309894|Sargramostim|sargramostim|mesh-list
44178448|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178449|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
44178450|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178451|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
44178465|NCT00309920|Fluorouracil|fluorouracil|mesh-list
44178466|NCT00309920|Epirubicin|epirubicin|mesh-list
44178467|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
44178468|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178469|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
44178470|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178471|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178472|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44275490|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275491|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44275492|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44275493|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44275494|NCT00703651|Vaccines|vaccines|mesh-list
44275495|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
44275496|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275497|NCT00703690|Fenofibrate|fenofibrate|mesh-list
44275498|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275499|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
44275538|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275539|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275540|NCT00703872|Interferons|interferons|mesh-list
44275541|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275542|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
44275543|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275544|NCT00703898|Nevirapine|nevirapine|mesh-list
44275545|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44178473|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
44178474|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178475|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178476|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178477|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178478|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178479|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178480|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44178481|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178482|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178483|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178484|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
44178485|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178486|NCT00309920|Hematinics|hematinics|mesh-ancestor
44178487|NCT00309998|Bevacizumab|bevacizumab|mesh-list
44178488|NCT00309998|Vinorelbine|vinorelbine|mesh-list
44178489|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178490|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178491|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44178492|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44178493|NCT00309998|Growth Substances|growth substances|mesh-ancestor
44178494|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178495|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44178496|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44178497|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178498|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178499|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178500|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178501|NCT00310011|Gemcitabine|gemcitabine|mesh-list
44178502|NCT00310011|Paclitaxel|paclitaxel|mesh-list
44178503|NCT00310011|Cisplatin|cisplatin|mesh-list
44178504|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44178505|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178506|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178507|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178508|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178509|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178510|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178511|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
44178512|NCT00310011|Antiviral Agents|antiviral agents|mesh-ancestor
44178551|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
44178570|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
44178571|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178572|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178573|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
44178575|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178576|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44178577|NCT00310128|Protective Agents|protective agents|mesh-ancestor
44178578|NCT00310141|Nicotine|nicotine|mesh-list
44178579|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44178580|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
44178581|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178582|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178583|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44178584|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44178585|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
44178586|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178587|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178588|NCT00310154|Docetaxel|docetaxel|mesh-list
44275546|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44275547|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275548|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275549|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
44275550|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275551|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44275552|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44275553|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44275554|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44275555|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
44275556|NCT00703989|Benphothiamine|benphothiamine|mesh-list
44275557|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
44275558|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275559|NCT00703989|Protective Agents|protective agents|mesh-ancestor
44275560|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275561|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
44275562|NCT00703989|Vitamins|vitamins|mesh-ancestor
44275563|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
44275564|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44275565|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
44275566|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
44275567|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
44275568|NCT00704080|Temozolomide|temozolomide|mesh-list
44178589|NCT00310154|Gefitinib|gefitinib|mesh-list
44178590|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178591|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178592|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178593|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178594|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178595|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44178596|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178598|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
44178599|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178600|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
44178601|NCT00310232|Hematinics|hematinics|mesh-ancestor
44178602|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
44178603|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670228|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670229|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670230|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670231|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
44178604|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178605|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
44178606|NCT00310323|Caffeine|caffeine|mesh-list
44178607|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44178608|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178640|NCT00310505|Amphotericin B|amphotericin b|mesh-list
44178641|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44178642|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44178643|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
44178644|NCT00310505|Amebicides|amebicides|mesh-ancestor
44178645|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44178646|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44178647|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178648|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44178649|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
44178650|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44178651|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275569|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44275570|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
44275571|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275572|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275574|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275575|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275576|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275577|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275578|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275579|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275580|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
44275581|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
44275582|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275583|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275584|NCT00704249|Nevirapine|nevirapine|mesh-list
43663253|NCT05124067|Hormones|hormones|mesh-ancestor
44178669|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44178670|NCT00310583|Pregabalin|pregabalin|mesh-list
44178671|NCT00310583|Analgesics|analgesics|mesh-ancestor
44178672|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
44178673|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178674|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178675|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
44178676|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44178677|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178678|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178679|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44178680|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44178681|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44178682|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178683|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44178684|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
44178685|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44178686|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44178687|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178688|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178689|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178690|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178691|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178692|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178693|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44178694|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
44178695|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44178696|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178697|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44178698|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44178699|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44178700|NCT00310765|Pregabalin|pregabalin|mesh-list
44178701|NCT00310765|Gabapentin|gabapentin|mesh-list
44178702|NCT00310765|Analgesics|analgesics|mesh-ancestor
44178703|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
44178704|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178705|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178706|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
44178727|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44275586|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44275587|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275588|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275589|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
44275590|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275591|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44275592|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44275593|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44275594|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44275595|NCT00704275|Cyclosporine|cyclosporine|mesh-list
44275596|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44275597|NCT00704275|Cyclosporins|cyclosporins|mesh-list
44275598|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275599|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275600|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178728|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
44178729|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178730|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44178731|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
44178732|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
44178733|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178734|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178735|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44178736|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44178737|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178738|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178739|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178741|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44178742|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44178743|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178744|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178745|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
44178746|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178747|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44178748|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44178749|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44178750|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44178752|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
44178753|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178754|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178755|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44178756|NCT00310908|Tramadol|tramadol|mesh-list
44178757|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44178758|NCT00310908|Narcotics|narcotics|mesh-ancestor
44178792|NCT00311051|Ramatroban|ramatroban|mesh-list
44178793|NCT00311051|Montelukast|montelukast|mesh-list
44178794|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44178795|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
44178796|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44178797|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178798|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178799|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178814|NCT00311129|Rituximab|rituximab|mesh-list
44178815|NCT00311129|Fludarabine|fludarabine|mesh-list
44115058|NCT00101179|Azacitidine|azacitidine|mesh-list
44178816|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
44275602|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275603|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
44275604|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275605|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275606|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275607|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44275608|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44275609|NCT00704301|Rivastigmine|rivastigmine|mesh-list
44275610|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44275611|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275612|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275613|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
44275614|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275615|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275616|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44275617|NCT00704301|Protective Agents|protective agents|mesh-ancestor
44275618|NCT00704314|Simvastatin|simvastatin|mesh-list
44275619|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44275620|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275621|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
44275622|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275623|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275624|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44275625|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178817|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178818|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178819|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
44178820|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178821|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178822|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178823|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
44178824|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178825|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178826|NCT00311259|Melatonin|melatonin|mesh-list
44178827|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
44178828|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178829|NCT00311259|Protective Agents|protective agents|mesh-ancestor
44178830|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178831|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178832|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
44178833|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178834|NCT00311337|Bortezomib|bortezomib|mesh-list
44178835|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178836|NCT00311389|Timolol|timolol|mesh-list
44178837|NCT00311389|Travoprost|travoprost|mesh-list
44178838|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44178839|NCT00311389|Latanoprost|latanoprost|mesh-list
44178840|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44275626|NCT00704366|Saracatinib|saracatinib|mesh-list
44275627|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275628|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275629|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275630|NCT00704392|XL647|xl647|mesh-list
44275631|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275632|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44275633|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275634|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275635|NCT00704431|Darapladib|darapladib|mesh-list
44275636|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44275637|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275638|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670344|NCT02896101|Tacrolimus|tacrolimus|mesh-list
44275639|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44275640|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
44275641|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44275642|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44275643|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44275644|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275645|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275646|NCT00704548|Simvastatin|simvastatin|mesh-list
44275647|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44275648|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44275649|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
44275650|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275651|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44275652|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44275653|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275654|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
44275655|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44275656|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275657|NCT00704600|Nelfinavir|nelfinavir|mesh-list
44275658|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44275659|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44178841|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44178842|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178843|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178844|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106632|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275661|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275662|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275663|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44275664|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44275665|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
44275666|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275668|NCT00704639|Cetuximab|cetuximab|mesh-list
44275669|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275670|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275671|NCT00704665|Methocarbamol|methocarbamol|mesh-list
44275672|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44275673|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275674|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44275675|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275676|NCT00704678|Sevelamer|sevelamer|mesh-list
43930041|NCT00693992|Sunitinib|sunitinib|mesh-list
44275677|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
44275678|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
44275679|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275680|NCT00704691|Lenalidomide|lenalidomide|mesh-list
44178845|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178846|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178847|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44178848|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178849|NCT00311467|Interferons|interferons|mesh-list
44178850|NCT00311467|Capecitabine|capecitabine|mesh-list
44178851|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178852|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
44178853|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178854|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178855|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
44178856|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178857|NCT00311545|Siltuximab|siltuximab|mesh-list
44178858|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178859|NCT00311558|Interferons|interferons|mesh-list
44178890|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178891|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178892|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178893|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
44178894|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178895|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44178896|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178897|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178898|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178899|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
44178900|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178901|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44178902|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
44178903|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44178904|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275681|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
44275682|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275683|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275684|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275685|NCT00704691|Growth Substances|growth substances|mesh-ancestor
44275686|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275687|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275688|NCT00704704|Thalidomide|thalidomide|mesh-list
44275689|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275690|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
44275691|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275692|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
44275693|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275694|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275695|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275696|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275697|NCT00704704|Growth Substances|growth substances|mesh-ancestor
44275698|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275699|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275700|NCT00704743|Calpastatin|calpastatin|mesh-list
44275701|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44275734|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275736|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44275737|NCT00704925|Amifampridine|amifampridine|mesh-list
44275738|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44275739|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275740|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275741|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44275742|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44275743|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275744|NCT00704951|Posaconazole|posaconazole|mesh-list
44275745|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
44275746|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275747|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44275748|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44275749|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44275750|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44275751|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44178905|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44178906|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44454011|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454013|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454014|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454015|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454016|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454017|NCT01672723|Naltrexone|naltrexone|mesh-list
44454018|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44454019|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44454020|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454021|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
44454022|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454023|NCT01672710|Niacin|niacin|mesh-list
44454024|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44454025|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
44454026|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454027|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44454028|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
44454029|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
44454030|NCT01672710|Vitamins|vitamins|mesh-ancestor
44454031|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
44454032|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115206|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
44178912|NCT00311688|Interleukin-2|interleukin-2|mesh-list
44178913|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178914|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44178915|NCT00311688|Analgesics|analgesics|mesh-ancestor
44178916|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
44178917|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178918|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178919|NCT00311740|Valsartan|valsartan|mesh-list
44178920|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44178921|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178922|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44178923|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44275754|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44275755|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
44275756|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275757|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275758|NCT00704990|Vitamins|vitamins|mesh-list
44275759|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
44275760|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
44275761|NCT00704990|Pyridoxal|pyridoxal|mesh-list
44275762|NCT00704990|Pyridoxine|pyridoxine|mesh-list
44275763|NCT00704990|Zinc|zinc|mesh-list
44275764|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
44275765|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
44178924|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178925|NCT00311740|Diuretics|diuretics|mesh-ancestor
44178926|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
44178927|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178928|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44178929|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178930|NCT00311753|Heparin|heparin|mesh-list
44178931|NCT00311753|Certoparin|certoparin|mesh-list
44178932|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
44178933|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44178934|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44178961|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
44178962|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44178963|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44178964|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178965|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178966|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178967|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178968|NCT00311896|Bemiparin|bemiparin|mesh-list
44178969|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
44178970|NCT00311961|Prednisolone|prednisolone|mesh-list
44178971|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44178972|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
44178973|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44178974|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
44178975|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44178976|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
44178977|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178978|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
44178979|NCT00311961|Hormones|hormones|mesh-ancestor
44178980|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179010|NCT00312039|Lamivudine|lamivudine|mesh-list
44179011|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
44179012|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44179013|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44179014|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179015|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179016|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
44179017|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179018|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44179019|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44179020|NCT00312104|Insulin|insulin|mesh-list
44179021|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44179022|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
44179023|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
44179024|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
44179025|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44106633|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
44275766|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275767|NCT00704990|Trace Elements|trace elements|mesh-ancestor
44275768|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
44275769|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275770|NCT00704990|Protective Agents|protective agents|mesh-ancestor
44275771|NCT00705042|Etanercept|etanercept|mesh-list
44275772|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44275773|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44275774|NCT00705042|Analgesics|analgesics|mesh-ancestor
44275775|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
44275776|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44275777|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275778|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44275779|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275780|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275781|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275782|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
44275783|NCT00705120|Cyclosporine|cyclosporine|mesh-list
44275784|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
44179057|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179058|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44179059|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43670494|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43670495|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
43670496|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670497|NCT02894593|Ethanol|ethanol|mesh-list
43670498|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
43670499|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43670500|NCT02894593|Listerine|listerine|mesh-list
43670501|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
43670502|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43670503|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670504|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670505|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670506|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
43670507|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670508|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
43670526|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179060|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
44179061|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179062|NCT00312260|Gabapentin|gabapentin|mesh-list
44179063|NCT00312260|Amitriptyline|amitriptyline|mesh-list
44179065|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
44179066|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179067|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179068|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
44179069|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44179070|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179091|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
44179093|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44179094|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179095|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179096|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44179097|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44179098|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
44179099|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179100|NCT00312273|Protective Agents|protective agents|mesh-ancestor
44179101|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44179102|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179103|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44179104|NCT00312299|Protective Agents|protective agents|mesh-ancestor
44179105|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179106|NCT00312325|Prednisolone|prednisolone|mesh-list
44179107|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44179108|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
44179109|NCT00312325|Hormones|hormones|mesh-ancestor
44179110|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179111|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179112|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44179113|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179114|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44179115|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275787|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275788|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
44275789|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275790|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275791|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44275792|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
44275793|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275794|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275795|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44275796|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275797|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
44275798|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275799|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275800|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44275801|NCT00705198|Temozolomide|temozolomide|mesh-list
44275802|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44275803|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
44275804|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275805|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275806|NCT00705315|Bevacizumab|bevacizumab|mesh-list
44275807|NCT00705315|Docetaxel|docetaxel|mesh-list
44275808|NCT00705315|Epirubicin|epirubicin|mesh-list
44275809|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44275810|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275811|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275812|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275813|NCT00705315|Growth Substances|growth substances|mesh-ancestor
44275814|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275815|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275816|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275817|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179116|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44179117|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44179118|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44179119|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179120|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179144|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
44179145|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44179146|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
44275818|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275819|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275820|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44275821|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44275822|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275823|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275824|NCT00705354|Bacitracin|bacitracin|mesh-list
44275825|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44275826|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275827|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44275828|NCT00705419|Tenofovir|tenofovir|mesh-list
44275829|NCT00705419|Emtricitabine|emtricitabine|mesh-list
44275830|NCT00705419|Maleic acid|maleic acid|mesh-list
44275831|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
44275832|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275833|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44275834|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44275835|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275836|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275837|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44275838|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44179147|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
44179148|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179149|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179150|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44179151|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
44179153|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179154|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44179155|NCT00312520|Protective Agents|protective agents|mesh-ancestor
44179156|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44179157|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179158|NCT00312533|Hylan|hylan|mesh-list
44179159|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
44179160|NCT00312533|Protective Agents|protective agents|mesh-ancestor
43670578|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
44179161|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179162|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
44179163|NCT00312546|Valproic Acid|valproic acid|mesh-list
44179164|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
44179165|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179166|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179167|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
44179168|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179169|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179170|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
44179171|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179172|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179187|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
44179188|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
44179189|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179190|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179191|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44179192|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44179193|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
44275839|NCT00705445|Zinc|zinc|mesh-list
44275840|NCT00705445|Trace Elements|trace elements|mesh-list
44275841|NCT00705445|Micronutrients|micronutrients|mesh-list
44275842|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275843|NCT00705471|Infliximab|infliximab|mesh-list
44275844|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275845|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275846|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275847|NCT00705510|Cyclosporine|cyclosporine|mesh-list
44275848|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44275849|NCT00705510|Cyclosporins|cyclosporins|mesh-list
44275850|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275851|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275852|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275853|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
44275854|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275855|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
44275856|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275857|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275858|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275859|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44275860|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44275861|NCT00705549|Gemcitabine|gemcitabine|mesh-list
44275862|NCT00705549|Cisplatin|cisplatin|mesh-list
44275863|NCT00705549|Docetaxel|docetaxel|mesh-list
44275864|NCT00705549|Vinorelbine|vinorelbine|mesh-list
44275865|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275866|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275867|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
44275868|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275869|NCT00705549|Antiviral Agents|antiviral agents|mesh-ancestor
44275870|NCT00705549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275871|NCT00705549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275872|NCT00705549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44275873|NCT00705549|Immunologic Factors|immunologic factors|mesh-ancestor
44275879|NCT00705562|Caseins|caseins|mesh-list
44275882|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275883|NCT00705588|Tadalafil|tadalafil|mesh-list
44275884|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44275885|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
44275886|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44275887|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44275888|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44275889|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275890|NCT00705588|Urological Agents|urological agents|mesh-ancestor
44275891|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
44275892|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44275893|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
44275894|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275895|NCT00705692|Levamisole|levamisole|mesh-list
44275896|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44275897|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
43670664|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43670665|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44275898|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275899|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
44275900|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
44275901|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44275902|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275903|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44275904|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
44179194|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44179195|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44179196|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44179197|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44179198|NCT00312650|Gemcitabine|gemcitabine|mesh-list
44179199|NCT00312650|Doxorubicin|doxorubicin|mesh-list
44179200|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44179201|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44179202|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
44179203|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179204|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179205|NCT00312650|Antiviral Agents|antiviral agents|mesh-ancestor
44179206|NCT00312650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179207|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179208|NCT00312650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179209|NCT00312650|Immunologic Factors|immunologic factors|mesh-ancestor
44179210|NCT00312650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179211|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44179212|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44179213|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179214|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44179215|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44179216|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44179217|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
44179218|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179219|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179220|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44179221|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44179222|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
44275906|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44275907|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44275908|NCT00705770|Growth Substances|growth substances|mesh-ancestor
44275909|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275910|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
44275911|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275912|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44275914|NCT00705796|Testosterone|testosterone|mesh-list
44275915|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
44275916|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
44275917|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44275918|NCT00705796|Androgens|androgens|mesh-ancestor
44275919|NCT00705796|Hormones|hormones|mesh-ancestor
44275920|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275921|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275922|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44275923|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275924|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
44275925|NCT00705822|Prednisone|prednisone|mesh-list
44275926|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
44275927|NCT00705822|Docetaxel|docetaxel|mesh-list
44179223|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179224|NCT00312806|Pantoprazole|pantoprazole|mesh-list
44179225|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44179226|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44179227|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44179228|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179229|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179230|NCT00312819|Disulfiram|disulfiram|mesh-list
44179231|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44179232|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44179248|NCT00312988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179250|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179251|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
44179252|NCT00313001|Exenatide|exenatide|mesh-list
44179253|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
44179254|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179255|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179256|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44179257|NCT00313001|Incretins|incretins|mesh-ancestor
44179258|NCT00313001|Hormones|hormones|mesh-ancestor
44179259|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179260|NCT00313053|Vincristine|vincristine|mesh-list
44179261|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44179262|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179263|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179264|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179265|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179266|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179267|NCT00313079|Vincristine|vincristine|mesh-list
44179268|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275928|NCT00705822|Estramustine|estramustine|mesh-list
44275929|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275930|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275931|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275932|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275933|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275934|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44275935|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
44275936|NCT00705822|Hormones|hormones|mesh-ancestor
44275937|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44275938|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275939|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44275940|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44275941|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
44275942|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44275943|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44275944|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
44275945|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179269|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179270|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179271|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179272|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179273|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179274|NCT00313105|Lobeline|lobeline|mesh-list
44179275|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44179276|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
44179277|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179278|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179279|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44179280|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44179281|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
44179282|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179283|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179284|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44179285|NCT00313131|Metronidazole|metronidazole|mesh-list
44179286|NCT00313131|Fluconazole|fluconazole|mesh-list
44179287|NCT00313131|Clotrimazole|clotrimazole|mesh-list
44179288|NCT00313131|Miconazole|miconazole|mesh-list
44179289|NCT00313131|Tinidazole|tinidazole|mesh-list
44179290|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179291|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179292|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44179293|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44179324|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179325|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
44179326|NCT00313157|Protective Agents|protective agents|mesh-ancestor
44179327|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44179328|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44179329|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44179330|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179331|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44179332|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44179333|NCT00313183|Pramlintide|pramlintide|mesh-list
44179334|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454040|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454041|NCT01671332|Suramin|suramin|mesh-list
44275946|NCT00705835|Antacids|antacids|mesh-ancestor
44275947|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275948|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44275949|NCT00705900|Calcipotriene|calcipotriene|mesh-list
44275950|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
44275951|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44275952|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
44275953|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44275954|NCT00705978|Pancreatin|pancreatin|mesh-list
44275955|NCT00705978|Pancrelipase|pancrelipase|mesh-list
44275956|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44463172|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44463173|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44463174|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463175|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463176|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
44463177|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463178|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463179|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44463180|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463181|NCT01518244|Timolol|timolol|mesh-list
44463182|NCT01518244|Brinzolamide|brinzolamide|mesh-list
44463183|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44463184|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44463185|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463186|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463187|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463188|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463189|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44463190|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44275962|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44275963|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
44275964|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44275965|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44275966|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44275967|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44275968|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44275969|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44275970|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
44275971|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44275972|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
44275973|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44275974|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44275975|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
44275976|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
44275977|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275978|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275979|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
44275980|NCT00706225|Estrogens|estrogens|mesh-list
44275981|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44275982|NCT00706225|Hormones|hormones|mesh-ancestor
44275983|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670793|NCT05424692|Fluorouracil|fluorouracil|mesh-list
43670808|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
44275984|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275985|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44275986|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44275987|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44275988|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44275989|NCT00706277|Fentanyl|fentanyl|mesh-list
44275990|NCT00706277|Remifentanil|remifentanil|mesh-list
44275991|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
44275992|NCT00706277|Propofol|propofol|mesh-list
44179356|NCT00313391|Risperidone|risperidone|mesh-list
44179357|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44179358|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
44179359|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179360|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179361|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179362|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44179363|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179364|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179365|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179366|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44179367|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
44179368|NCT00313456|Satraplatin|satraplatin|mesh-list
44275993|NCT00706277|Sevoflurane|sevoflurane|mesh-list
44275994|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44275995|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44275996|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44275997|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44275998|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
44275999|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
44276000|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276001|NCT00706277|Narcotics|narcotics|mesh-ancestor
44276002|NCT00706277|Analgesics|analgesics|mesh-ancestor
44276003|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
44276004|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276005|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44276006|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44276007|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44276008|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276009|NCT00706576|Mitogens|mitogens|mesh-list
44276010|NCT00706576|Enkephalins|enkephalins|mesh-list
44276011|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276012|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276013|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276014|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276015|NCT00706680|Cyclosporine|cyclosporine|mesh-list
44276016|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
44276017|NCT00706680|Prednisone|prednisone|mesh-list
44276018|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44276019|NCT00706680|Cyclosporins|cyclosporins|mesh-list
44276020|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
44276021|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276022|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
44276023|NCT00706680|Hormones|hormones|mesh-ancestor
44276024|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276025|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276026|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44276027|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663411|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
44179369|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179370|NCT00313482|Prednisone|prednisone|mesh-list
44179371|NCT00313482|Docetaxel|docetaxel|mesh-list
44179372|NCT00313482|Sargramostim|sargramostim|mesh-list
44179373|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276028|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276029|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276030|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276031|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
44276032|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
43930380|NCT00702884|Sunitinib|sunitinib|mesh-list
44276033|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276034|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276035|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276036|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44276037|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276038|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44276039|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
44276040|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276041|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44276042|NCT00706680|Protective Agents|protective agents|mesh-ancestor
44179374|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179375|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179395|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
44179396|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179398|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44179399|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
44179400|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179401|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179402|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44179403|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179404|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
44179405|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179406|NCT00313534|Masoprocol|masoprocol|mesh-list
44179407|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
44179408|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179409|NCT00313534|Protective Agents|protective agents|mesh-ancestor
44179410|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179411|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44179412|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179413|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44179414|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44179415|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44179416|NCT00313534|Analgesics|analgesics|mesh-ancestor
44179417|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
44179418|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179419|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44179420|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44179421|NCT00313547|Amlodipine|amlodipine|mesh-list
44179422|NCT00313547|Quinapril|quinapril|mesh-list
44179423|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179424|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44179425|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44179426|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179427|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44179428|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179458|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44179459|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179460|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
44179461|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44179462|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44179463|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44179464|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44276044|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
44276045|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276046|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276047|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
44276048|NCT00706888|Pyridoxal|pyridoxal|mesh-list
44276049|NCT00706888|Pyridoxine|pyridoxine|mesh-list
44276050|NCT00706888|Vitamins|vitamins|mesh-ancestor
44276051|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
44276052|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276053|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276054|NCT00706927|Timolol|timolol|mesh-list
44276055|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44276056|NCT00706927|Latanoprost|latanoprost|mesh-list
44276057|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44276058|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44276059|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
44276060|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276061|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276062|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276063|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44276064|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44276065|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44276066|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44276067|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44276068|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44276069|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44276070|NCT00706953|Doxorubicin|doxorubicin|mesh-list
44179465|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
44179466|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44179467|NCT00313690|Cisplatin|cisplatin|mesh-list
44179468|NCT00313690|Docetaxel|docetaxel|mesh-list
44179469|NCT00313690|Bortezomib|bortezomib|mesh-list
44179470|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179471|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179472|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179473|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179474|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179475|NCT00313742|Insulin|insulin|mesh-list
44179496|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
44179497|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179498|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44179499|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44179500|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179501|NCT00313885|SR 46349B|sr 46349b|mesh-list
44179502|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44179503|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44179504|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115746|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
44179505|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44179506|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44179507|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
44276071|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44276073|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276074|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276075|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44276076|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44276077|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276078|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276079|NCT00707070|Acitretin|acitretin|mesh-list
44276080|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44276081|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
44276082|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276083|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
44276084|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276085|NCT00707083|Dexamethasone|dexamethasone|mesh-list
44276086|NCT00707083|Methotrexate|methotrexate|mesh-list
44276087|NCT00707083|Vincristine|vincristine|mesh-list
44276088|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
44276089|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276090|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
44276091|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
44276092|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276093|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276094|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44179508|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179509|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179510|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
44179511|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179512|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44179513|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44179514|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179515|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179516|NCT00313898|Urological Agents|urological agents|mesh-ancestor
44179517|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44179518|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44179519|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44179520|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
44179521|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179522|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179523|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179524|NCT00313924|Urological Agents|urological agents|mesh-ancestor
44179525|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
44179526|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179527|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179528|NCT00313950|Vaccines|vaccines|mesh-list
44179529|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
44179598|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44179599|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179600|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179601|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179603|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179604|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276097|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276098|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44276099|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276100|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44276101|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
44276102|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44276103|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44276104|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
44276105|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276106|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276107|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276108|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44276109|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276110|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
44276111|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276112|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44276113|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44276114|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179605|NCT00314379|Vitamin E|vitamin e|mesh-list
44179606|NCT00314379|Vitamins|vitamins|mesh-ancestor
44179607|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
44179608|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179609|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
44179645|NCT00314548|Urological Agents|urological agents|mesh-ancestor
44179646|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179647|NCT00314561|Pioglitazone|pioglitazone|mesh-list
44179648|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
44179677|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44179678|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44179679|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44179681|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44179682|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179683|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44179684|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44179685|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44179686|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179687|NCT00314652|Buprenorphine|buprenorphine|mesh-list
44179688|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44179689|NCT00314652|Narcotics|narcotics|mesh-ancestor
44179690|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179724|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179725|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179726|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179727|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179728|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
44179729|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
44179730|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179731|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44276115|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44276116|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276118|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276119|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276120|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276121|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276122|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
44276123|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276124|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
44276125|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276126|NCT00707187|Tadalafil|tadalafil|mesh-list
44276127|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276128|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44276129|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44276130|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179732|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44179733|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
44179751|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44179752|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
44179753|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179754|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179755|NCT00314743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44179756|NCT00314743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179757|NCT00314743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179758|NCT00314743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179759|NCT00314743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44179760|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44179761|NCT00314756|Imiquimod|imiquimod|mesh-list
44179762|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44179763|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
44179764|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179765|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179766|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
44179767|NCT00314782|Docetaxel|docetaxel|mesh-list
44179768|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179769|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179770|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179771|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179772|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179773|NCT00314821|Ropinirole|ropinirole|mesh-list
44179774|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44179775|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44179776|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
44179777|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
44179778|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179779|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179780|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179781|NCT00314860|Ropinirole|ropinirole|mesh-list
44179782|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44179783|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44179784|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
44179785|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
44179786|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179787|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179788|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179789|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
44179790|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179791|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44179792|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276132|NCT00707187|Urological Agents|urological agents|mesh-ancestor
44276133|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44276134|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276135|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44276136|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276137|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276138|NCT00707278|Capecitabine|capecitabine|mesh-list
44276139|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
44276140|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44276141|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
44276142|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276143|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276144|NCT00707330|Clarithromycin|clarithromycin|mesh-list
44276145|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276146|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276147|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44276148|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276149|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276150|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44276151|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44276152|NCT00707369|Amoxicillin|amoxicillin|mesh-list
44276153|NCT00707369|Metronidazole|metronidazole|mesh-list
44276154|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276155|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276156|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44276157|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44276158|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
44276159|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276160|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44276161|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276162|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826025|NCT03699956|Cisplatin|cisplatin|mesh-list
44179826|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
44179828|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
44179829|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179830|NCT00315003|Azithromycin|azithromycin|mesh-list
44179831|NCT00315003|Telithromycin|telithromycin|mesh-list
44179832|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276163|NCT00707421|Fluorometholone|fluorometholone|mesh-list
44276165|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44276166|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276167|NCT00707421|Analgesics|analgesics|mesh-ancestor
44276168|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
44276169|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276170|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276171|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276172|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276173|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44179833|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179834|NCT00315016|Eplerenone|eplerenone|mesh-list
44179835|NCT00315016|Fosinopril|fosinopril|mesh-list
44179836|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44179850|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179851|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179853|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44179854|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44179855|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
44179856|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179857|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179858|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
44179859|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
44179860|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179861|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454043|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454044|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44454045|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44454046|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44454047|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454048|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
44454049|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
44454050|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44454051|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454052|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44454053|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44454054|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
44454055|NCT01671319|Docetaxel|docetaxel|mesh-list
44454056|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454057|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
44454058|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454059|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454060|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44454061|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
44454062|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454063|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454064|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44116060|NCT00104741|Flutamide|flutamide|mesh-list
44179862|NCT00315185|Cetuximab|cetuximab|mesh-list
44179863|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44179864|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179865|NCT00315211|Docetaxel|docetaxel|mesh-list
44179866|NCT00315211|Topotecan|topotecan|mesh-list
44179867|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179868|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179869|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179870|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179871|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179872|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44179873|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179898|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
44179899|NCT00315484|Hematinics|hematinics|mesh-ancestor
44179900|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44276174|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276175|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276176|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
44276177|NCT00707421|Hormones|hormones|mesh-ancestor
44276178|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276179|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44276180|NCT00707473|Cisplatin|cisplatin|mesh-list
44276181|NCT00707473|Carboplatin|carboplatin|mesh-list
44276182|NCT00707473|Docetaxel|docetaxel|mesh-list
44276183|NCT00707473|Fluorouracil|fluorouracil|mesh-list
44276184|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276185|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44276186|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44276187|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276188|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276189|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
44276190|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44276191|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276192|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
44276193|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276194|NCT00707512|Natalizumab|natalizumab|mesh-list
43663461|NCT04660760|Trifluridine|trifluridine|mesh-list
44179901|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44179902|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44179903|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
44179904|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179905|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44179906|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44179907|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179908|NCT00315523|Levocetirizine|levocetirizine|mesh-list
44179909|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44179910|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44179911|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
44179912|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
44179913|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179914|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179915|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179916|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
44179917|NCT00315536|Remifentanil|remifentanil|mesh-list
44179918|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44179919|NCT00315536|Narcotics|narcotics|mesh-ancestor
44179920|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179921|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179922|NCT00315536|Analgesics|analgesics|mesh-ancestor
44179923|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
44179935|NCT00315601|Azithromycin|azithromycin|mesh-list
44179936|NCT00315601|Telithromycin|telithromycin|mesh-list
44179937|NCT00315601|Dimercaprol|dimercaprol|mesh-list
44179938|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179939|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179940|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
44179941|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
44179942|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179943|NCT00315666|Memantine|memantine|mesh-list
44276195|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
44276196|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276197|NCT00707551|Ketoconazole|ketoconazole|mesh-list
44276199|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
44276200|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276201|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44276202|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44276203|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276204|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663466|NCT04660760|Antibodies|antibodies|mesh-list
44179944|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44179945|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44179946|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
44179947|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179948|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179949|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179950|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44179951|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44179952|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
44179953|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44179954|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179955|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179956|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44179957|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44179958|NCT00315679|Protective Agents|protective agents|mesh-ancestor
44179959|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179960|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179961|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44179962|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
44179963|NCT00315744|Fluticasone|fluticasone|mesh-list
44179965|NCT00315744|Albuterol|albuterol|mesh-list
44179966|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44179967|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44179968|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44179969|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
44179970|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179971|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179972|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44179973|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
44179974|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44179975|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44179976|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44179977|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44179978|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44179979|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179980|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179981|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179982|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
44179983|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44179984|NCT00315835|Buprenorphine|buprenorphine|mesh-list
44179985|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44179986|NCT00315835|Narcotics|narcotics|mesh-ancestor
44179987|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180021|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44180022|NCT00315887|Narcotics|narcotics|mesh-ancestor
44180023|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180024|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180025|NCT00315887|Analgesics|analgesics|mesh-ancestor
44180026|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
44180027|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180028|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44180029|NCT00315900|Valproic Acid|valproic acid|mesh-list
44276206|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
44276207|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276208|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276209|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44276210|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44276211|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44276212|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276213|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44276214|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276215|NCT00707642|Vaccines|vaccines|mesh-list
44276216|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
44276217|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276218|NCT00707707|Paclitaxel|paclitaxel|mesh-list
44276219|NCT00707707|Olaparib|olaparib|mesh-list
44276220|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44276221|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276222|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44276223|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180064|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180065|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44180066|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
44180067|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44180068|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
44180094|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180095|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44180096|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44180097|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180098|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180099|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
44180100|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180101|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180102|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44180103|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44180104|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180105|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44180106|NCT00316212|INS 50589|ins 50589|mesh-list
44180107|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44180108|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44180109|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
44180110|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180111|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180112|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180113|NCT00316238|Olanzapine|olanzapine|mesh-list
44180114|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
44180115|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
44180148|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180149|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44180151|NCT00316420|Gemcitabine|gemcitabine|mesh-list
44180152|NCT00316420|Capecitabine|capecitabine|mesh-list
44180153|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180154|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
44276224|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276225|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276226|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44276227|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276229|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44276230|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
44276231|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
44276232|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276233|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
44276234|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276235|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
44276236|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276237|NCT00707785|Vitamin A|vitamin a|mesh-list
44276238|NCT00707785|Vitamins|vitamins|mesh-ancestor
44276239|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
44276240|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276241|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44276242|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
44276243|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276244|NCT00707824|Nalbuphine|nalbuphine|mesh-list
44276245|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276246|NCT00707824|Narcotics|narcotics|mesh-ancestor
44276247|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180155|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180156|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180157|NCT00316420|Antiviral Agents|antiviral agents|mesh-ancestor
44180158|NCT00316420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180189|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44180191|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180192|NCT00316563|Dronabinol|dronabinol|mesh-list
44180193|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
44180194|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644794|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43644795|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180195|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180196|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180197|NCT00316563|Analgesics|analgesics|mesh-ancestor
44180198|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
44180199|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180200|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44180236|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180237|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180238|NCT00316849|Sirolimus|sirolimus|mesh-list
44180239|NCT00316849|Temozolomide|temozolomide|mesh-list
44180240|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44180267|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180268|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
44180269|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
44180270|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180271|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180272|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276248|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276249|NCT00707824|Analgesics|analgesics|mesh-ancestor
44276250|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
44276251|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276252|NCT00707850|Ribavirin|ribavirin|mesh-list
44276253|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44276254|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
44276255|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
44276256|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276257|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
44276258|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276259|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
44276260|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276261|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44276262|NCT00707876|Hematinics|hematinics|mesh-ancestor
44276263|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44276264|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44276265|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
44276266|NCT00707902|Lidocaine|lidocaine|mesh-list
44276267|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
44276268|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
44276269|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276270|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276271|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
44276272|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180273|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
44180274|NCT00316927|Hormones|hormones|mesh-ancestor
44180275|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180276|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44180277|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180278|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180279|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180280|NCT00316927|Analgesics|analgesics|mesh-ancestor
44180281|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
44180282|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180283|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44180284|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44180285|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180286|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44180287|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44180288|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180306|NCT00317031|Acamprosate|acamprosate|mesh-list
44180307|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44180308|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44180309|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180310|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
44180311|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180312|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44180313|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44180314|NCT00317070|Protective Agents|protective agents|mesh-ancestor
44276273|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44276274|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44276275|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44276276|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276277|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276278|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44276279|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276280|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
44276281|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
44276282|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276283|NCT00707941|Oseltamivir|oseltamivir|mesh-list
44276284|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
44276285|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276286|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276287|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276288|NCT00708149|Lansoprazole|lansoprazole|mesh-list
44276289|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
44276290|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44276291|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276292|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44276293|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276294|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276295|NCT00708240|Citalopram|citalopram|mesh-list
44276296|NCT00708240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44276297|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44276298|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276299|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276300|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276301|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
43663512|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
44180315|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180316|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44180317|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
44180318|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180319|NCT00317096|Rituximab|rituximab|mesh-list
44180320|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44180321|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180322|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
44180323|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180324|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180325|NCT00317135|Vaccines|vaccines|mesh-list
44180326|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
43796774|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
44276303|NCT00708240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44276304|NCT00708240|Antidepressive Agents|antidepressive agents|mesh-ancestor
44276305|NCT00708240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44276306|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44276307|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44276308|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44276309|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44276310|NCT00708318|Fentanyl|fentanyl|mesh-list
44276311|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276312|NCT00708318|Narcotics|narcotics|mesh-ancestor
44276313|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276314|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276315|NCT00708318|Analgesics|analgesics|mesh-ancestor
44276316|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
44276317|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276318|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44276319|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44180327|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180328|NCT00317187|Vaccines|vaccines|mesh-list
44180344|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44180345|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44180346|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
44180347|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180348|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180349|NCT00317330|Rifampin|rifampin|mesh-list
44180350|NCT00317330|Isoniazid|isoniazid|mesh-list
44180351|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
44180352|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44180353|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
44180354|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180355|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180356|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
44180357|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44180358|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180359|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180360|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44180361|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44180362|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44180363|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44180364|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44180365|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44180366|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44180367|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44180368|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
44180369|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44180370|NCT00317343|Anticoagulants|anticoagulants|mesh-list
44180371|NCT00317343|Bivalirudin|bivalirudin|mesh-list
44180372|NCT00317343|Thrombin|thrombin|mesh-list
44180373|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
44180374|NCT00317343|Coagulants|coagulants|mesh-ancestor
44180375|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
44180376|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44180377|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
44180378|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276320|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
44276321|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
44276322|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44276323|NCT00708344|Irbesartan|irbesartan|mesh-list
44276324|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44276325|NCT00708344|Diuretics|diuretics|mesh-ancestor
44276326|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
44276327|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276328|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44276329|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276330|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276331|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44276332|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43930693|NCT00707863|Citalopram|citalopram|mesh-list
44276333|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44276334|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276335|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463201|NCT01518153|Methotrexate|methotrexate|mesh-list
44463202|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
44463203|NCT01518153|Fludarabine|fludarabine|mesh-list
44463204|NCT01518153|Melphalan|melphalan|mesh-list
44463205|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
44463206|NCT01518153|Tacrolimus|tacrolimus|mesh-list
44463207|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44463208|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
44463209|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44463210|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463211|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44463212|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
44463214|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463231|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44463232|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44463233|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44463234|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463235|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
44463236|NCT01517984|Hormones|hormones|mesh-ancestor
44463237|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463238|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463239|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44463240|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463241|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
44463242|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463243|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463244|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44463245|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44463246|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
44463247|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463248|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463249|NCT01517893|Simvastatin|simvastatin|mesh-list
44463250|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44463251|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44463252|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
44463253|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463254|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44463255|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44463256|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463257|NCT01517802|Prednisone|prednisone|mesh-list
44463258|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
44463259|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463260|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
44463261|NCT01517802|Hormones|hormones|mesh-ancestor
44463262|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180379|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116599|NCT00107419|Pemetrexed|pemetrexed|mesh-list
44180380|NCT00317408|Leucovorin|leucovorin|mesh-list
44180381|NCT00317408|Cytarabine|cytarabine|mesh-list
44463263|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463264|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44463266|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44463267|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463268|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463269|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
44463270|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463271|NCT01517412|Metformin|metformin|mesh-list
44463272|NCT01517412|Lixisenatide|lixisenatide|mesh-list
44276337|NCT00708396|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44276338|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44276339|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276340|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276341|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276342|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
44276343|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276344|NCT00708396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44276345|NCT00708396|Antidepressive Agents|antidepressive agents|mesh-ancestor
44276346|NCT00708396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44276347|NCT00708539|Progesterone|progesterone|mesh-list
44276348|NCT00708539|Progestins|progestins|mesh-ancestor
44276349|NCT00708539|Hormones|hormones|mesh-ancestor
44276350|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276351|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276352|NCT00708565|Iloprost|iloprost|mesh-list
44276353|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44276354|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276355|NCT00708578|Metformin|metformin|mesh-list
44276356|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
44276357|NCT00708578|Glimepiride|glimepiride|mesh-list
44276358|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44276359|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180382|NCT00317408|Cyclosporine|cyclosporine|mesh-list
44180383|NCT00317408|Dexamethasone|dexamethasone|mesh-list
44180384|NCT00317408|Prednisolone|prednisolone|mesh-list
44180385|NCT00317408|Carboplatin|carboplatin|mesh-list
44180386|NCT00317408|Methotrexate|methotrexate|mesh-list
44180387|NCT00317408|Etoposide|etoposide|mesh-list
44180388|NCT00317408|Melphalan|melphalan|mesh-list
44180408|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
44180409|NCT00317408|Hormones|hormones|mesh-ancestor
44276360|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44276361|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276362|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
44276363|NCT00708591|Sirolimus|sirolimus|mesh-list
44276364|NCT00708591|Ketoconazole|ketoconazole|mesh-list
44276365|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276366|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276367|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276368|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276369|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
44276370|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276371|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
44276372|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276373|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44276374|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44276375|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276376|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276377|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44276378|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
44276379|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276380|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44276381|NCT00708656|Mesalamine|mesalamine|mesh-list
44276382|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44276383|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276384|NCT00708656|Analgesics|analgesics|mesh-ancestor
43663529|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
44180410|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180411|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44180412|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180413|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44180414|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
44180415|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44180416|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180417|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
44180418|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180419|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
44180420|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180421|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44180422|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180423|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
44180424|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180425|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44180426|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44180427|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44180428|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180429|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
44276385|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
44276386|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276387|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276388|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276389|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276390|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
44276391|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44276392|NCT00708747|Antibodies|antibodies|mesh-list
44276393|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
44276394|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276395|NCT00708773|Irinotecan|irinotecan|mesh-list
44276396|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44276397|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44276398|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276399|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276400|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276401|NCT00708799|Azithromycin|azithromycin|mesh-list
44276402|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276403|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276404|NCT00708812|Paclitaxel|paclitaxel|mesh-list
44276405|NCT00708812|Carboplatin|carboplatin|mesh-list
44276406|NCT00708812|Endostar protein|endostar protein|mesh-list
44276407|NCT00708812|Endostatins|endostatins|mesh-list
44276438|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44276439|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
44276440|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276441|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276442|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44276443|NCT00709137|Diuretics|diuretics|mesh-ancestor
44276444|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
44276445|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44276446|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44276447|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276448|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276449|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44276450|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44276451|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
44276452|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276454|NCT00709189|Norgestimate|norgestimate|mesh-list
44276455|NCT00709189|Estradiol|estradiol|mesh-list
44276456|NCT00709189|Estrogens|estrogens|mesh-ancestor
44276457|NCT00709189|Hormones|hormones|mesh-ancestor
44276458|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276459|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276460|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44276461|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
44276462|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44276463|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44276464|NCT00709189|Hematinics|hematinics|mesh-ancestor
44276465|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276466|NCT00709189|Vitamins|vitamins|mesh-ancestor
44276482|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276484|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
43930831|NCT00713817|Nabiximols|nabiximols|mesh-list
44276485|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276486|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44276487|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44276488|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
44276489|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
44276490|NCT00709267|Folic Acid|folic acid|mesh-list
44276491|NCT00709267|Hematinics|hematinics|mesh-ancestor
44276492|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276493|NCT00709267|Vitamins|vitamins|mesh-ancestor
44276494|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
44276495|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276496|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44276497|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
44276498|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276499|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276500|NCT00709332|Folic Acid|folic acid|mesh-list
44276501|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44276502|NCT00709332|Norgestimate|norgestimate|mesh-list
44276503|NCT00709332|Estradiol|estradiol|mesh-list
44276504|NCT00709332|Estrogens|estrogens|mesh-ancestor
44276505|NCT00709332|Hormones|hormones|mesh-ancestor
44276506|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276507|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276508|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44276509|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
44276512|NCT00709332|Hematinics|hematinics|mesh-ancestor
44276531|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
44276532|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
44276533|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276534|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44276535|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44276536|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276537|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276539|NCT00709449|Moxaverine|moxaverine|mesh-list
44276540|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
44276541|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
44276542|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276543|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276544|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44276545|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276546|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276547|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276548|NCT00709449|Urological Agents|urological agents|mesh-ancestor
44276549|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
44276550|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44276551|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276552|NCT00709488|Talaporfin|talaporfin|mesh-list
44276553|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276554|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43663602|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
44180430|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180431|NCT00317408|Antidotes|antidotes|mesh-ancestor
44180432|NCT00317408|Protective Agents|protective agents|mesh-ancestor
44180433|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
44180434|NCT00317408|Vitamins|vitamins|mesh-ancestor
44180435|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
44180436|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
44180437|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44180438|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44180439|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
44180440|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44180441|NCT00317408|Analgesics|analgesics|mesh-ancestor
44180442|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
44180443|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44180444|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180445|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180446|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44180447|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
44180448|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180449|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180450|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44180465|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44180466|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180467|NCT00317499|Etanercept|etanercept|mesh-list
44180468|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180469|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276555|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276556|NCT00709553|Midazolam|midazolam|mesh-list
44276557|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44276558|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44276559|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276560|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276561|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44276562|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44276563|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44276564|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44276565|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
44276566|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
44276567|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
44276568|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
44276569|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276570|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276571|NCT00709644|Folic Acid|folic acid|mesh-list
44276572|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44180470|NCT00317499|Analgesics|analgesics|mesh-ancestor
44180471|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
44180472|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180473|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180474|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180475|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180476|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180477|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180478|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
44180479|NCT00317512|Chrysarobin|chrysarobin|mesh-list
44180480|NCT00317512|HBOC 201|hboc 201|mesh-list
44180481|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180482|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180483|NCT00317512|Analgesics|analgesics|mesh-ancestor
44180484|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
44180485|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180486|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180487|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180488|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180489|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
44180490|NCT00317538|Etanercept|etanercept|mesh-list
44180491|NCT00317538|Infliximab|infliximab|mesh-list
44180492|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44180493|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180494|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180495|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180496|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180497|NCT00317538|Analgesics|analgesics|mesh-ancestor
44180498|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
44180499|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180500|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180501|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180502|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180503|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
44180504|NCT00317577|Timolol|timolol|mesh-list
44180505|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44180506|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44180507|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44180508|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
44180509|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180510|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276574|NCT00709644|Estradiol|estradiol|mesh-list
44276575|NCT00709644|Estrogens|estrogens|mesh-ancestor
44276576|NCT00709644|Hormones|hormones|mesh-ancestor
44276577|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276578|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276579|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44276580|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
44276581|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44276582|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44276583|NCT00709644|Hematinics|hematinics|mesh-ancestor
44276584|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276585|NCT00709644|Vitamins|vitamins|mesh-ancestor
44276586|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
44276587|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44276588|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44276589|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44276590|NCT00709657|Bevacizumab|bevacizumab|mesh-list
44276591|NCT00709657|Ranibizumab|ranibizumab|mesh-list
44276592|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44276593|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276594|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44276595|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44276596|NCT00709657|Growth Substances|growth substances|mesh-ancestor
44276597|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276598|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44276599|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
44180511|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180526|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
44180527|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180528|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180529|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44180530|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180531|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
44180532|NCT00317629|Protective Agents|protective agents|mesh-ancestor
44180533|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44180534|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44180535|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180536|NCT00317655|Ibuprofen|ibuprofen|mesh-list
44180537|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180538|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180539|NCT00317655|Analgesics|analgesics|mesh-ancestor
44180540|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
44180541|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180542|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180543|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180544|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180545|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44180546|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276600|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
44276601|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44276602|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44276603|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276605|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276606|NCT00709917|Repaglinide|repaglinide|mesh-list
44276607|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44276608|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276609|NCT00709969|Lumefantrine|lumefantrine|mesh-list
44276610|NCT00709969|Artemether|artemether|mesh-list
44276611|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44276612|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
44180547|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180548|NCT00317681|Tacrolimus|tacrolimus|mesh-list
44180549|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180550|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
44180551|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180552|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44180553|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180554|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180555|NCT00317733|Ketoprofen|ketoprofen|mesh-list
44180556|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44180557|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180558|NCT00317733|Analgesics|analgesics|mesh-ancestor
44180559|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
44180560|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180561|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180562|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180563|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180564|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44180565|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180566|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180567|NCT00317746|Citalopram|citalopram|mesh-list
44180568|NCT00317746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44180569|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44180570|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180579|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
44180580|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180581|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180582|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
44180583|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180584|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180585|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
44180586|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180587|NCT00317785|Cyclosporine|cyclosporine|mesh-list
44180588|NCT00317785|Sirolimus|sirolimus|mesh-list
44180589|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
44180590|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
44180591|NCT00317785|Methotrexate|methotrexate|mesh-list
44180592|NCT00317785|Tacrolimus|tacrolimus|mesh-list
44180593|NCT00317785|Cyclosporins|cyclosporins|mesh-list
44180594|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180595|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
44180596|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180597|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180598|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44180599|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
44180600|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180601|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180602|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44276613|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44276614|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44276615|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276617|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44276618|NCT00709982|Norgestimate|norgestimate|mesh-list
44276619|NCT00709982|Estradiol|estradiol|mesh-list
44276620|NCT00709982|Estrogens|estrogens|mesh-ancestor
44276621|NCT00709982|Hormones|hormones|mesh-ancestor
44276622|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276623|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276624|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44276625|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
44276626|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44276627|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44276628|NCT00709982|Hematinics|hematinics|mesh-ancestor
44276629|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
44180603|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44180604|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
44180605|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44180606|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116797|NCT00108251|Diuretics|diuretics|mesh-ancestor
44180607|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
44180608|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44180609|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180610|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44180611|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44180612|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44180613|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
44180614|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180615|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44180616|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44180617|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
44180618|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180619|NCT00317798|Sirolimus|sirolimus|mesh-list
44180620|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44180621|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180622|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180623|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44180624|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180625|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
44180626|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180627|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
44180628|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180629|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
44180630|NCT00317811|Bortezomib|bortezomib|mesh-list
44180631|NCT00317811|Melphalan|melphalan|mesh-list
44180632|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180633|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44180634|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
44180635|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180644|NCT00317850|Gabapentin|gabapentin|mesh-list
44180645|NCT00317850|Analgesics|analgesics|mesh-ancestor
44180646|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
44180647|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180648|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180649|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
44180650|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44180651|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44180652|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276630|NCT00709982|Vitamins|vitamins|mesh-ancestor
44276631|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
44276632|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44276633|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44276634|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44276635|NCT00710086|Remifentanil|remifentanil|mesh-list
44276636|NCT00710086|Hydromorphone|hydromorphone|mesh-list
44276637|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44276638|NCT00710086|Narcotics|narcotics|mesh-ancestor
44276639|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276640|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276641|NCT00710086|Analgesics|analgesics|mesh-ancestor
44276642|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
44276643|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276644|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
44276645|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276646|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44276647|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44276648|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276649|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276650|NCT00710099|Urological Agents|urological agents|mesh-ancestor
44276651|NCT00710125|Doxorubicin|doxorubicin|mesh-list
44276652|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276653|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276654|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44180653|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180654|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44180655|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44180656|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180657|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180658|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
44180659|NCT00317876|Cyclosporine|cyclosporine|mesh-list
44180660|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
44180661|NCT00317876|Methotrexate|methotrexate|mesh-list
44180662|NCT00317876|Cyclosporins|cyclosporins|mesh-list
44180663|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180664|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
44180665|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180666|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180667|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44180668|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
44180669|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180670|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180671|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44180672|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44180673|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
44180674|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44180675|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180676|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
44180677|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276655|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44276656|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276657|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276658|NCT00710138|Vitamins|vitamins|mesh-list
44276659|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
44276660|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
44276661|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
44276662|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
44276663|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276664|NCT00710138|Hematinics|hematinics|mesh-ancestor
44276665|NCT00710216|Lamivudine|lamivudine|mesh-list
44276666|NCT00710216|Telbivudine|telbivudine|mesh-list
44276667|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44276668|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44276669|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276670|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276671|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
44276672|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276673|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44276674|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44276675|NCT00710229|Bevacizumab|bevacizumab|mesh-list
44276676|NCT00710229|Ranibizumab|ranibizumab|mesh-list
44180678|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180679|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44180680|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44180681|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
44180682|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180683|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44180684|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
44180685|NCT00317902|Hematinics|hematinics|mesh-ancestor
44180686|NCT00317915|Irbesartan|irbesartan|mesh-list
44180687|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180688|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44180689|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44180690|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180691|NCT00317928|Metformin|metformin|mesh-list
44180692|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180693|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180694|NCT00317954|Spironolactone|spironolactone|mesh-list
44180695|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44180696|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
44180697|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180698|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180699|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44180700|NCT00317954|Diuretics|diuretics|mesh-ancestor
44180701|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
44180702|NCT00317967|Atorvastatin|atorvastatin|mesh-list
44180703|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44180725|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180726|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44180727|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180728|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180730|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44180731|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44276677|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44276678|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276679|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44276680|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44276681|NCT00710229|Growth Substances|growth substances|mesh-ancestor
44276682|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276683|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44276684|NCT00710268|Bevacizumab|bevacizumab|mesh-list
44276685|NCT00710268|Olaparib|olaparib|mesh-list
44276686|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44276687|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276688|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44276689|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44180732|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180733|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
44180734|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180735|NCT00318175|Bosentan|bosentan|mesh-list
44180736|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180737|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44180738|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180739|NCT00318201|Erythromycin|erythromycin|mesh-list
44180740|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
44180741|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44180742|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
44180743|NCT00318201|Diltiazem|diltiazem|mesh-list
44180744|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180745|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44180746|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180747|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180748|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44180749|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180750|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180751|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180752|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180753|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180754|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44180755|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180767|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180768|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180769|NCT00318422|Incretins|incretins|mesh-ancestor
44180770|NCT00318422|Hormones|hormones|mesh-ancestor
44180771|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180772|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44180773|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180774|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
44180775|NCT00318448|Zolpidem|zolpidem|mesh-list
44180776|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44180777|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44180778|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180779|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180780|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44180781|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
44180782|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
44180783|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180784|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180785|NCT00318513|Bevacizumab|bevacizumab|mesh-list
44180786|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44180787|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180788|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44180789|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44276690|NCT00710268|Growth Substances|growth substances|mesh-ancestor
44276691|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276692|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
44276693|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44276694|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276695|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276696|NCT00710320|Anesthetics|anesthetics|mesh-list
44276697|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276698|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463273|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463274|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463275|NCT01517373|Glimepiride|glimepiride|mesh-list
44463276|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44463277|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463278|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463279|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44463280|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
44463281|NCT01517295|Hydrocodone|hydrocodone|mesh-list
44463282|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44463283|NCT01517295|Narcotics|narcotics|mesh-ancestor
44463284|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44463285|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463286|NCT01517295|Analgesics|analgesics|mesh-ancestor
44463287|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
44463288|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180790|NCT00318513|Growth Substances|growth substances|mesh-ancestor
44180791|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180792|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
44180793|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44180794|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180795|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180796|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44180797|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44180798|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180799|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180800|NCT00318552|Meropenem|meropenem|mesh-list
44180801|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180802|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180803|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
44180804|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180805|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180806|NCT00318669|Paroxetine|paroxetine|mesh-list
44180807|NCT00318669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44180808|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44180809|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180810|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180811|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180812|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
44463290|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
44463291|NCT01516970|Ritonavir|ritonavir|mesh-list
44276699|NCT00710359|Vitamins|vitamins|mesh-list
44276700|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
44276701|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
44276702|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
44276703|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
44276704|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276705|NCT00710359|Hematinics|hematinics|mesh-ancestor
44276706|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
44276707|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44276708|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276709|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276710|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44276711|NCT00710437|Analgesics|analgesics|mesh-ancestor
44276712|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
44276713|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276714|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44276715|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44276716|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44276717|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44276718|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826030|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44180813|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180814|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44180815|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180816|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180817|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44180818|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44180819|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454088|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180820|NCT00318760|Clonidine|clonidine|mesh-list
44180821|NCT00318760|Analgesics|analgesics|mesh-ancestor
44180822|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
44180823|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180824|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180825|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180826|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
44180827|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
44180828|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44180829|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44180830|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44180831|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44180832|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180833|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180834|NCT00318773|Sertraline|sertraline|mesh-list
44180835|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180836|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180837|NCT00318773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44180838|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44276719|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276720|NCT00710528|Idelalisib|idelalisib|mesh-list
44276721|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276722|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276723|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276724|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44276725|NCT00710619|Coagulants|coagulants|mesh-ancestor
44276726|NCT00710736|Fluorouracil|fluorouracil|mesh-list
44276727|NCT00710736|Capecitabine|capecitabine|mesh-list
44276728|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
44276729|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276730|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44276731|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276732|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276733|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
44276734|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276735|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
44276736|NCT00710788|Calcium|calcium|mesh-list
44276737|NCT00710788|Sevelamer|sevelamer|mesh-list
44180839|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180840|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180841|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180842|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
44180843|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180844|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
44180845|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
44180846|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180847|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180848|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
44180849|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44180850|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
44180851|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
44180852|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180853|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180854|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180855|NCT00318825|Analgesics|analgesics|mesh-ancestor
44180856|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
44180857|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180858|NCT00318838|Azimilide|azimilide|mesh-list
44180859|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44180860|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44180861|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180862|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180863|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44180864|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180865|NCT00318890|Cisplatin|cisplatin|mesh-list
44180866|NCT00318890|Docetaxel|docetaxel|mesh-list
44180867|NCT00318890|Amifostine|amifostine|mesh-list
44180868|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180869|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180877|NCT00318903|Irinotecan|irinotecan|mesh-list
44180878|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180879|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180880|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180881|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
44180882|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276738|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44276739|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276741|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276742|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276743|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
44276744|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
44276745|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
44276746|NCT00710827|Androgens|androgens|mesh-ancestor
44276747|NCT00710827|Hormones|hormones|mesh-ancestor
44276748|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44276749|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276750|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44276751|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44180883|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44180884|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180885|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180886|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
44180887|NCT00318955|Propofol|propofol|mesh-list
44180888|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44180889|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180890|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180891|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44180892|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
44180893|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
44180894|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180895|NCT00318955|Analgesics|analgesics|mesh-ancestor
44180896|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
44180897|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180898|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44180899|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44180900|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44180901|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
44180902|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180903|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180904|NCT00318968|Esomeprazole|esomeprazole|mesh-list
44180905|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44180906|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180907|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44180908|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180909|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180910|NCT00318981|Methylphenidate|methylphenidate|mesh-list
44180911|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44180912|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180913|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44180914|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44180915|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180916|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180917|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
44180918|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180919|NCT00318994|Meropenem|meropenem|mesh-list
44180920|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180921|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180922|NCT00319007|Sulindac|sulindac|mesh-list
44180923|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44276752|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276753|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44276754|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44276755|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
44276756|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276757|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
44276758|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276759|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276760|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44276761|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44276762|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44276763|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44276764|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44276766|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44276767|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276768|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276769|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44276770|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276771|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276772|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
44276773|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
44276774|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44276775|NCT00711256|Protective Agents|protective agents|mesh-ancestor
44276805|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276806|NCT00711698|Analgesics|analgesics|mesh-ancestor
44276807|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
44276808|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276809|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
44276810|NCT00711789|Giapreza|giapreza|mesh-list
44276811|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
44276812|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44276813|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44276814|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
44276815|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276816|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276817|NCT00711841|Dexamethasone|dexamethasone|mesh-list
44276818|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
44276819|NCT00711841|BB 1101|bb 1101|mesh-list
44276820|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44276821|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
44276822|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
44276823|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276824|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276825|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44276826|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
44276827|NCT00711841|Hormones|hormones|mesh-ancestor
44276828|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180924|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180925|NCT00319007|Analgesics|analgesics|mesh-ancestor
44180926|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
44180927|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180928|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180929|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180930|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44180931|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180932|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44180933|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180934|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180935|NCT00319033|Bosentan|bosentan|mesh-list
44180936|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180949|NCT00319163|Estradiol|estradiol|mesh-list
44180950|NCT00319163|Estrogens|estrogens|mesh-ancestor
44180951|NCT00319163|Hormones|hormones|mesh-ancestor
44180952|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180953|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180954|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44180955|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
44180956|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44180957|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44180958|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44276830|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276831|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
44276832|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276833|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276834|NCT00711854|Rifampin|rifampin|mesh-list
44276835|NCT00711854|Linezolid|linezolid|mesh-list
44276836|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44276837|NCT00711854|Trimethoprim|trimethoprim|mesh-list
44276838|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
44276839|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44276840|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
44276841|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276842|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276843|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
44276844|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44276845|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276846|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276847|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44276848|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44276849|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44180959|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44180960|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44180961|NCT00319189|Nateglinide|nateglinide|mesh-list
44180962|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180963|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180964|NCT00319202|Candesartan|candesartan|mesh-list
44180965|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180966|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44180967|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44117126|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
43644803|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180968|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180969|NCT00319215|Zopiclone|zopiclone|mesh-list
44180970|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44180971|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180972|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180973|NCT00319267|Bosentan|bosentan|mesh-list
44180974|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180975|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44180976|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180977|NCT00319293|Metformin|metformin|mesh-list
44180978|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180979|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180980|NCT00319306|Budesonide|budesonide|mesh-list
44180981|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
44180982|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44180983|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180984|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44180985|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
44276850|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44276851|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44276852|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44276853|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44276854|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44276855|NCT00711854|Renal Agents|renal agents|mesh-ancestor
44276856|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
44276857|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44276858|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44276859|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44276860|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44276861|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44276862|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44276863|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
44276864|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
44276865|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44276866|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44276867|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
44276868|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44276869|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44276870|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276871|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44276872|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276873|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276874|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44276875|NCT00711906|Renal Agents|renal agents|mesh-ancestor
44276876|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276877|NCT00711919|Pitavastatin|pitavastatin|mesh-list
44276878|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44276894|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44276895|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276896|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
44276897|NCT00712049|Vitamins|vitamins|mesh-ancestor
44276898|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
44276899|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276900|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
44276901|NCT00712062|Pemetrexed|pemetrexed|mesh-list
44276902|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276903|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276904|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276905|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44276906|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44276907|NCT00712101|Abciximab|abciximab|mesh-list
44276908|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
44276909|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44276910|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44276911|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44276912|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
44276913|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276914|NCT00712140|Trastuzumab|trastuzumab|mesh-list
44276915|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44276916|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276917|NCT00712205|Calcitriol|calcitriol|mesh-list
44180986|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180987|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180988|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44180989|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
44180990|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
44180991|NCT00319306|Hormones|hormones|mesh-ancestor
44180992|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180993|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44180994|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44180995|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181008|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181009|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181010|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
44181011|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181012|NCT00319345|Mannitol|mannitol|mesh-list
44181013|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44181014|NCT00319345|Diuretics|diuretics|mesh-ancestor
44181015|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
44181016|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181017|NCT00319358|Antioxidants|antioxidants|mesh-list
44181018|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181019|NCT00319358|Protective Agents|protective agents|mesh-ancestor
44181020|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181021|NCT00319488|Budesonide|budesonide|mesh-list
44276918|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44276919|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276921|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44276922|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276923|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44276924|NCT00712205|Vitamins|vitamins|mesh-ancestor
44276925|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
44276926|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44276927|NCT00712257|Heparin|heparin|mesh-list
44276928|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
44276929|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44276930|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44276931|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276932|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
44276933|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
44276934|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44276935|NCT00712374|Amodiaquine|amodiaquine|mesh-list
44276936|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
44181022|NCT00319488|Albuterol|albuterol|mesh-list
44181023|NCT00319488|Montelukast|montelukast|mesh-list
44181024|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
44181025|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181026|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44181027|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
44181028|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181029|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181030|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44181031|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
44181032|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
44181033|NCT00319488|Hormones|hormones|mesh-ancestor
44181034|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181035|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
44181036|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44181037|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44181038|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181039|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
44181040|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44181041|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44181042|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44181043|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181044|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181045|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181046|NCT00319514|Docetaxel|docetaxel|mesh-list
44181047|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181048|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181049|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181050|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181051|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181052|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44181053|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
44181054|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44181055|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44181056|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44276937|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44276938|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44276939|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276940|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44276941|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44276942|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276943|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44276944|NCT00712374|Renal Agents|renal agents|mesh-ancestor
44276945|NCT00712400|Latanoprost|latanoprost|mesh-list
44276946|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44276947|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44276948|NCT00712439|Gabapentin|gabapentin|mesh-list
44276949|NCT00712439|Analgesics|analgesics|mesh-ancestor
44276950|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
44276951|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44276952|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276953|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
44276954|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44276955|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44276956|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44276957|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44276958|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44276959|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44276960|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44276961|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276962|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
44463292|NCT01516970|Lopinavir|lopinavir|mesh-list
44463293|NCT01516970|Darunavir|darunavir|mesh-list
44463294|NCT01516970|Zidovudine|zidovudine|mesh-list
44463295|NCT01516970|Efavirenz|efavirenz|mesh-list
44463296|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44463297|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44463298|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463309|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44463310|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44463311|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44463312|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44463313|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44463314|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44463315|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
44463316|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44463317|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44463318|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44463319|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463320|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463321|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
44463322|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463323|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463324|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44463325|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463326|NCT01516879|Atorvastatin|atorvastatin|mesh-list
44463327|NCT01516879|Ezetimibe|ezetimibe|mesh-list
44463328|NCT01516879|Evolocumab|evolocumab|mesh-list
44276963|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
44276964|NCT00712452|Vinblastine|vinblastine|mesh-list
44276965|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276966|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
44276967|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276968|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44276969|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44276970|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
44276971|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276972|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276973|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44276974|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181076|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181077|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181078|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181079|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181080|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181081|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44181082|NCT00319670|Laxatives|laxatives|mesh-ancestor
44276976|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44276977|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276978|NCT00712465|Digoxin|digoxin|mesh-list
44276979|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44276980|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44276981|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644805|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44276982|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276983|NCT00712465|Protective Agents|protective agents|mesh-ancestor
44276984|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276985|NCT00712478|Insulin|insulin|mesh-list
44276986|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44276987|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276988|NCT00712491|Sirolimus|sirolimus|mesh-list
44276989|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44276990|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44276991|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44276992|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44276993|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
43663752|NCT03732820|Olaparib|olaparib|mesh-list
44181083|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181084|NCT00319683|Eniluracil|eniluracil|mesh-list
44181085|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181086|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181087|NCT00319709|Amibegron|amibegron|mesh-list
44181088|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44181089|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181090|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181091|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181092|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181093|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181094|NCT00319761|Calcitriol|calcitriol|mesh-list
44181095|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44181096|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181097|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44181098|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181099|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181100|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44181101|NCT00319761|Vitamins|vitamins|mesh-ancestor
44181102|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
44181103|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44181104|NCT00319787|Gefitinib|gefitinib|mesh-list
44181105|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181106|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181107|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181108|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181109|NCT00319800|Irinotecan|irinotecan|mesh-list
44181110|NCT00319800|Gefitinib|gefitinib|mesh-list
44181111|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181167|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181168|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
44181169|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181170|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181171|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181172|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44276994|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44276995|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
44276996|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44276997|NCT00712504|Docetaxel|docetaxel|mesh-list
44276998|NCT00712504|Sunitinib|sunitinib|mesh-list
44276999|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277000|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
44277001|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277002|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
44277003|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277004|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44277005|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44277006|NCT00712504|Growth Substances|growth substances|mesh-ancestor
44277007|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277008|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44277009|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44277010|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277011|NCT00712517|Propofol|propofol|mesh-list
44277012|NCT00712517|Sevoflurane|sevoflurane|mesh-list
44277013|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44277014|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277015|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277016|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44277017|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
44277018|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
44277019|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44277020|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44277021|NCT00712556|Fluorides|fluorides|mesh-list
44277022|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
44277023|NCT00712556|Protective Agents|protective agents|mesh-ancestor
44277024|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277025|NCT00712595|Mifepristone|mifepristone|mesh-list
44277026|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44277027|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
44277028|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277034|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44277035|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44277036|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
43931453|NCT00728910|Niacin|niacin|mesh-list
44463329|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44277037|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277038|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
44277039|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44277040|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44277041|NCT00712647|Beta Carotene|beta carotene|mesh-list
44277043|NCT00712647|Carotenoids|carotenoids|mesh-list
44277044|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
44277045|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277046|NCT00712647|Protective Agents|protective agents|mesh-ancestor
44277047|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277048|NCT00712647|Provitamins|provitamins|mesh-ancestor
44277049|NCT00712647|Vitamins|vitamins|mesh-ancestor
44277050|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
44277051|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
44277052|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44277053|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277054|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277055|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44277056|NCT00712686|Olanzapine|olanzapine|mesh-list
44277057|NCT00712686|Aripiprazole|aripiprazole|mesh-list
44277058|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
44277059|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
44277060|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277062|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277078|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44277079|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44277080|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44277081|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44277082|NCT00712738|Nifedipine|nifedipine|mesh-list
44277083|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277084|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277085|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277086|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277087|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277088|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277089|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
44277090|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277091|NCT00712764|Adenosine|adenosine|mesh-list
44277092|NCT00712764|Analgesics|analgesics|mesh-ancestor
44277093|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
44277094|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277095|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277096|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44277097|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277098|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44277099|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
44277100|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
44277101|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277102|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277103|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44277104|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44277105|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44277106|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44277120|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44277121|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277122|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277123|NCT00712894|Verapamil|verapamil|mesh-list
44277124|NCT00712894|Diltiazem|diltiazem|mesh-list
44277125|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
44277126|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277127|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44277128|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277129|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277130|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277131|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277132|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277133|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44277134|NCT00712907|Ascorbic Acid|ascorbic acid|mesh-list
44277135|NCT00712907|Vitamins|vitamins|mesh-ancestor
44277136|NCT00712907|Micronutrients|micronutrients|mesh-ancestor
44277137|NCT00712907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277138|NCT00712907|Antioxidants|antioxidants|mesh-ancestor
44277139|NCT00712907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277140|NCT00712907|Protective Agents|protective agents|mesh-ancestor
44277141|NCT00713011|Nifedipine|nifedipine|mesh-list
44277142|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44181173|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
44181174|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
44181175|NCT00320021|Vitamins|vitamins|mesh-ancestor
44181176|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
44181177|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181178|NCT00320034|Albuterol|albuterol|mesh-list
44181179|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44181180|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
44181181|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181182|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181183|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44181184|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
44181185|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
44181186|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44181187|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44181188|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44181189|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181190|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181191|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181192|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181193|NCT00320047|Baclofen|baclofen|mesh-list
44181194|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44181195|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181196|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44181197|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181198|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44181199|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
44181200|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
44181201|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277143|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277144|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277145|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277146|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277147|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277148|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
44277149|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277150|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
44277151|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44277152|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277153|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
44277154|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277155|NCT00713167|Protective Agents|protective agents|mesh-ancestor
44277156|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277157|NCT00713193|Cyclosporine|cyclosporine|mesh-list
44277158|NCT00713193|Prednisone|prednisone|mesh-list
44277159|NCT00713193|Cyclosporins|cyclosporins|mesh-list
44277160|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277161|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
44277162|NCT00713193|Hormones|hormones|mesh-ancestor
44277163|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277164|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277165|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44277166|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277167|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277168|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277169|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277170|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
44277171|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
44277172|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277173|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44277174|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44277175|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44277176|NCT00713271|AZD-3199|azd-3199|mesh-list
44277177|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44277178|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44277180|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44277181|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277182|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277183|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277184|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
44277185|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44277186|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277187|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277188|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44277189|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277190|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277191|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277192|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277193|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44277194|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
44277195|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277196|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277197|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44277198|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44277199|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44277200|NCT00713440|Acetaminophen|acetaminophen|mesh-list
44277201|NCT00713440|Prednisolone|prednisolone|mesh-list
44277202|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43663859|NCT05467436|Analgesics|analgesics|mesh-list
44181202|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181203|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
44181204|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
44181205|NCT00320060|Vitamins|vitamins|mesh-ancestor
44181241|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181242|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181243|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181244|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181269|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181270|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181271|NCT00320476|Bortezomib|bortezomib|mesh-list
44181272|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454089|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454090|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
44454091|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454092|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44454093|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454094|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454095|NCT01670721|Antidotes|antidotes|mesh-ancestor
44454096|NCT01670721|Protective Agents|protective agents|mesh-ancestor
44454097|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
44454098|NCT01670721|Vitamins|vitamins|mesh-ancestor
44277204|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44277205|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
44277206|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44277207|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
44277208|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277209|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
44277210|NCT00713440|Hormones|hormones|mesh-ancestor
44277211|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277212|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277213|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44277214|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277215|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
44277216|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
44277217|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277218|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277219|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44277220|NCT00713440|Protective Agents|protective agents|mesh-ancestor
44277221|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44277222|NCT00713440|Analgesics|analgesics|mesh-ancestor
44277223|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
44277224|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
44277225|NCT00713557|Tirofiban|tirofiban|mesh-list
44277226|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44277227|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44277228|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277229|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44277230|NCT00713622|Zonisamide|zonisamide|mesh-list
44277231|NCT00713622|Valproic Acid|valproic acid|mesh-list
44277232|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
44454099|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
44454100|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44454101|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44454102|NCT01670721|Growth Substances|growth substances|mesh-ancestor
44454103|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
44454104|NCT01670539|Triamcinolone|triamcinolone|mesh-list
44454105|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454106|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
44454107|NCT01670539|Hormones|hormones|mesh-ancestor
44454108|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454109|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454110|NCT01670526|Rivastigmine|rivastigmine|mesh-list
44454111|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
44454145|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
44454146|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
44454147|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44277234|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277235|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
44277236|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277237|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277238|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
44277239|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44277240|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277241|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44277242|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277243|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277244|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277245|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44277246|NCT00713674|Mupirocin|mupirocin|mesh-list
44277247|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277248|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44277249|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277250|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277251|NCT00713687|Gemcitabine|gemcitabine|mesh-list
44277252|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
44277253|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44277254|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
44277255|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277256|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277257|NCT00713687|Antiviral Agents|antiviral agents|mesh-ancestor
44277258|NCT00713687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277259|NCT00713687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277260|NCT00713687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277261|NCT00713687|Immunologic Factors|immunologic factors|mesh-ancestor
44277262|NCT00713687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277263|NCT00713726|Fentanyl|fentanyl|mesh-list
44277264|NCT00713726|Tramadol|tramadol|mesh-list
44277265|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44277266|NCT00713726|Narcotics|narcotics|mesh-ancestor
44277267|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277268|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454148|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44277269|NCT00713726|Analgesics|analgesics|mesh-ancestor
44277270|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
44277271|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277272|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44277273|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44277274|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
44277275|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
44277277|NCT00713739|Doxazosin|doxazosin|mesh-list
44277278|NCT00713739|Nifedipine|nifedipine|mesh-list
44277279|NCT00713739|Alfuzosin|alfuzosin|mesh-list
44277280|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277281|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277282|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277283|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277284|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277285|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277286|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
44277287|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277288|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44277289|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44277290|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44277291|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44277292|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
44277293|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277294|NCT00713739|Urological Agents|urological agents|mesh-ancestor
44277295|NCT00713765|Donepezil|donepezil|mesh-list
44277296|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44277297|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277298|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277314|NCT00713947|Pantoprazole|pantoprazole|mesh-list
44277315|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277316|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277317|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44277318|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44277319|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44277320|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277321|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277322|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44277323|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44277324|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44277325|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277326|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44277327|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
44277328|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
44277329|NCT00713986|Protective Agents|protective agents|mesh-ancestor
44277330|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277331|NCT00713999|Praziquantel|praziquantel|mesh-list
44277332|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
44277333|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44277334|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277335|NCT00714025|Everolimus|everolimus|mesh-list
44277336|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277337|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277338|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
44277339|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277340|NCT00714064|Edetic Acid|edetic acid|mesh-list
44277341|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44277342|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
44277343|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
44277344|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277345|NCT00714064|Antidotes|antidotes|mesh-ancestor
44277346|NCT00714064|Protective Agents|protective agents|mesh-ancestor
44277347|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
44277355|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44277356|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277357|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277358|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277359|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277360|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44277361|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
44277363|NCT00714103|Adenosine|adenosine|mesh-list
44277364|NCT00714103|Analgesics|analgesics|mesh-ancestor
44277365|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
44277366|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277367|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277368|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44277369|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277370|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44277371|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
44277372|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
44277373|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277374|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277375|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
44277376|NCT00714181|Temozolomide|temozolomide|mesh-list
44277377|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44277378|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
44277379|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277380|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277381|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
44277382|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44277383|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44277384|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663967|NCT05466019|Leucovorin|leucovorin|mesh-list
44454149|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44454150|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181300|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
44181301|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44181302|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44181303|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181401|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44181402|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44277385|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277386|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463330|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44463331|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
44463332|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463333|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44463334|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44463335|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463336|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44463337|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463338|NCT01516216|Vitamin D|vitamin d|mesh-list
44463339|NCT01516216|Leucovorin|leucovorin|mesh-list
44463340|NCT01516216|Bevacizumab|bevacizumab|mesh-list
44463341|NCT01516216|Fluorouracil|fluorouracil|mesh-list
44463342|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
44463343|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44463344|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463345|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44277422|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
44277423|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44277424|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44277425|NCT00714584|Naltrexone|naltrexone|mesh-list
44277426|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44277427|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44277428|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277429|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
44277430|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277431|NCT00714623|Sirolimus|sirolimus|mesh-list
44277432|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277433|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277434|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277435|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277436|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
44277437|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277438|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
44277439|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277440|NCT00714649|Cetuximab|cetuximab|mesh-list
44277441|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44277442|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277443|NCT00714740|Acetazolamide|acetazolamide|mesh-list
44277444|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
44277445|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44277446|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277447|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181403|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44181404|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181405|NCT00320892|Atropine|atropine|mesh-list
44181406|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44181407|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44181408|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44181409|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44181410|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
44181411|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181412|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181413|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44181414|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
44181415|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
44181416|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
44181417|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44181418|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44181419|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181420|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181491|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181492|NCT00321347|Lidocaine|lidocaine|mesh-list
44181493|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
44181494|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
44181495|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181496|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277448|NCT00714740|Diuretics|diuretics|mesh-ancestor
44277449|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
44277450|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277451|NCT00714779|Fluoxetine|fluoxetine|mesh-list
44277452|NCT00714779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44277453|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44277454|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277455|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277456|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277457|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
44277458|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277459|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44277460|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44277461|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44277462|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44277463|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44277464|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277465|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
44277466|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44277467|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277468|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277469|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44277470|NCT00714857|Analgesics|analgesics|mesh-ancestor
44277471|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
44277472|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277473|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44277474|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44277475|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44277479|NCT00714883|Sirolimus|sirolimus|mesh-list
44277490|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44277491|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44277492|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44277493|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
44277494|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277495|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277496|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277497|NCT00715013|Epothilone B|epothilone b|mesh-list
44277498|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277499|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
44277500|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277501|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
44277502|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277503|NCT00715039|Lorazepam|lorazepam|mesh-list
44277504|NCT00715039|Paroxetine|paroxetine|mesh-list
44277505|NCT00715039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44277506|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44277507|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277508|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277509|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277510|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
44277511|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277512|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44277513|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
44277514|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44277518|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
44277536|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277537|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44277538|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44277539|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277540|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277542|NCT00715273|Niacinamide|niacinamide|mesh-list
44277543|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
44277544|NCT00715273|Atorvastatin|atorvastatin|mesh-list
44277545|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44277546|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44277547|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44277548|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
44277549|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277550|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44277551|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44277552|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277553|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
44277554|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
44277555|NCT00715273|Vitamins|vitamins|mesh-ancestor
44277556|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
44277557|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277558|NCT00715351|Insulin|insulin|mesh-list
44277559|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44277560|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
44277561|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
44277562|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
44277563|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
44277585|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44277586|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44277587|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277588|NCT00715637|Cytarabine|cytarabine|mesh-list
44277589|NCT00715637|Amonafide|amonafide|mesh-list
44277590|NCT00715637|Daunorubicin|daunorubicin|mesh-list
44277591|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44277592|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
44277593|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277594|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277595|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
44277596|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277597|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277598|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
44277599|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277600|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277601|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44277602|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277603|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277604|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
44277605|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
44277606|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44277607|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44277608|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277609|NCT00715689|Hormones|hormones|mesh-list
44277610|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277611|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463353|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
44277613|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44277626|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277627|NCT00715780|Insulin|insulin|mesh-list
44277628|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44277629|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
44277630|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
44277631|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44277632|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
44277633|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
44277634|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
44277635|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
44277636|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
44277637|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44277638|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277639|NCT00715858|Doxycycline|doxycycline|mesh-list
44277640|NCT00715858|Rifampin|rifampin|mesh-list
44277641|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277642|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277643|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
44277644|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44277645|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44277646|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44277647|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
44277648|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
44277649|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44277650|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277651|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277652|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44277653|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44277654|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44277655|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44277656|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44277657|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44277667|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277668|NCT00715975|Clobetasol|clobetasol|mesh-list
44277669|NCT00715975|Halobetasol|halobetasol|mesh-list
44277670|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277671|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
44277672|NCT00715975|Hormones|hormones|mesh-ancestor
44277673|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277674|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277675|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44277676|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
44277677|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44277678|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
44277679|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277680|NCT00716001|Expectorants|expectorants|mesh-ancestor
44277681|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
44277682|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44277683|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
44277684|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277685|NCT00716001|Protective Agents|protective agents|mesh-ancestor
44277686|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277687|NCT00716001|Antidotes|antidotes|mesh-ancestor
44463354|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463355|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44463356|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44463357|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
44463358|NCT01516216|Antidotes|antidotes|mesh-ancestor
44463381|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44463382|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44463383|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44463384|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463385|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463386|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463387|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44463388|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44463389|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44463390|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44463391|NCT01515189|Ipilimumab|ipilimumab|mesh-list
44463392|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44463393|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463394|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44463395|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463396|NCT01514864|Dasatinib|dasatinib|mesh-list
44463397|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463398|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463399|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463400|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463401|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44463402|NCT01514448|Everolimus|everolimus|mesh-list
44463403|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463404|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44463405|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
44463406|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463407|NCT01514422|Minocycline|minocycline|mesh-list
44463408|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463409|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463410|NCT01514370|Interferons|interferons|mesh-list
44463411|NCT01514370|Interferon-beta|interferon-beta|mesh-list
44463412|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
44463413|NCT01514370|Curcumin|curcumin|mesh-list
44463414|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463415|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
44463416|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463418|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463419|NCT01514370|Analgesics|analgesics|mesh-ancestor
44463420|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
44463421|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463422|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463423|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463424|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463425|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277689|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44277690|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44277691|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277692|NCT00716170|Hormones|hormones|mesh-ancestor
44277693|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277694|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277695|NCT00716170|Incretins|incretins|mesh-ancestor
44277696|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44277697|NCT00716183|Amoxicillin|amoxicillin|mesh-list
44277698|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
44277699|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
44277700|NCT00716183|Lactams|lactams|mesh-list
44277701|NCT00716183|beta-Lactams|beta-lactams|mesh-list
44277702|NCT00716183|Cloxacillin|cloxacillin|mesh-list
44277703|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277704|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277705|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277706|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44277707|NCT00716248|Bucillamine|bucillamine|mesh-list
44277708|NCT00716248|Methotrexate|methotrexate|mesh-list
44277709|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44277710|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
44277711|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277724|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44277725|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44277726|NCT00716248|Analgesics|analgesics|mesh-ancestor
44277727|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
44277728|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277729|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277730|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
44277731|NCT00716248|Protective Agents|protective agents|mesh-ancestor
44277732|NCT00716391|Cisplatin|cisplatin|mesh-list
44277733|NCT00716391|Cetuximab|cetuximab|mesh-list
44277734|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277735|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44277736|NCT00716469|Talaporfin|talaporfin|mesh-list
44277737|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277738|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44277739|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
44277740|NCT00716521|Zolpidem|zolpidem|mesh-list
44277741|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44277742|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44277743|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44277744|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277745|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44277746|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
44277747|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
44277748|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826128|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181497|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
44181498|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181499|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44181530|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181531|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181532|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181534|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
44181535|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181536|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
44181537|NCT00321516|Aripiprazole|aripiprazole|mesh-list
44181538|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181539|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181569|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181571|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181572|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
44181573|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44181574|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181575|NCT00321750|Analgesics|analgesics|mesh-ancestor
44181576|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
44181577|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181578|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181579|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181580|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44277749|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277751|NCT00716547|Ketoprofen|ketoprofen|mesh-list
44277752|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44277753|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44277754|NCT00716547|Analgesics|analgesics|mesh-ancestor
44277755|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
44277756|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277757|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277758|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277759|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646260|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
43646261|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646262|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646263|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
44277760|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44277761|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44277762|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277763|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277764|NCT00716573|Everolimus|everolimus|mesh-list
44277765|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277766|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277767|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
43826149|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181612|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
44181613|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44181614|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
44181615|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181616|NCT00322062|Protective Agents|protective agents|mesh-ancestor
44181617|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181618|NCT00322062|Vitamins|vitamins|mesh-ancestor
44181619|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
44181636|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44181637|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
44181638|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181639|NCT00322166|Calcium|calcium|mesh-list
44181640|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44181641|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117873|NCT00111891|Niacin|niacin|mesh-list
44181642|NCT00322296|Bexarotene|bexarotene|mesh-list
44181643|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181644|NCT00322400|Paclitaxel|paclitaxel|mesh-list
44181645|NCT00322400|Docetaxel|docetaxel|mesh-list
44181646|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
44181647|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181648|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181649|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181650|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181651|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181652|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181653|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181654|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181655|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
44181656|NCT00322413|Hematinics|hematinics|mesh-ancestor
44181657|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
44181658|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44181659|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181660|NCT00322543|Analgesics|analgesics|mesh-ancestor
44181661|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
44277768|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277769|NCT00716612|Ubiquinone|ubiquinone|mesh-list
44277770|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
44277771|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
44277772|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277773|NCT00716612|Vitamins|vitamins|mesh-ancestor
44277774|NCT00716846|Atorvastatin|atorvastatin|mesh-list
44277775|NCT00716846|Simvastatin|simvastatin|mesh-list
44277776|NCT00716846|Pitavastatin|pitavastatin|mesh-list
44277777|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44277778|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44277779|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
44277780|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277781|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44181662|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181663|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181664|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181665|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181666|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
44181667|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181668|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
44181669|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43646264|NCT03292861|Sirolimus|sirolimus|mesh-list
43647466|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44181670|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181671|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181672|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
44181673|NCT00322569|Paclitaxel|paclitaxel|mesh-list
44181674|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44181675|NCT00322569|Tacrolimus|tacrolimus|mesh-list
44181676|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181677|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181678|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181679|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181680|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181710|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44181711|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44181712|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181713|NCT00322660|Epinephrine|epinephrine|mesh-list
44181714|NCT00322660|Racepinephrine|racepinephrine|mesh-list
44181715|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
44181716|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44181717|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181718|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181719|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181720|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181721|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181722|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44454178|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454179|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454180|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44454181|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
44454182|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454183|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454184|NCT01669122|Nicotine|nicotine|mesh-list
44454185|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44454186|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
44454187|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454188|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454189|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44454190|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44454191|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454192|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454193|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277783|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277784|NCT00716911|Ganciclovir|ganciclovir|mesh-list
44277785|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44277786|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
44277787|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277788|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44277789|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277790|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277791|NCT00716924|Clopidogrel|clopidogrel|mesh-list
44277792|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44277793|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44277794|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44277795|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44277796|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
44454194|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
44454195|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
44454196|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454197|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181734|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181735|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
44181736|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44181738|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181739|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181740|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181741|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181742|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181743|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
44181744|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
44181745|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44181746|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44181747|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181748|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181749|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181750|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44181751|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
44181752|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
44181753|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181754|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181755|NCT00322907|Mefloquine|mefloquine|mesh-list
44181756|NCT00322907|Quinine|quinine|mesh-list
44181757|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
44181784|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
44181785|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181786|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181787|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44181788|NCT00322985|Growth Substances|growth substances|mesh-ancestor
44181789|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181790|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181791|NCT00323011|Leucovorin|leucovorin|mesh-list
44181792|NCT00323011|Folic Acid|folic acid|mesh-list
44181793|NCT00323011|Bevacizumab|bevacizumab|mesh-list
44181794|NCT00323011|Fluorouracil|fluorouracil|mesh-list
44181795|NCT00323011|Irinotecan|irinotecan|mesh-list
44181796|NCT00323011|Dalteparin|dalteparin|mesh-list
44181797|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
44181798|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44277798|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277800|NCT00716950|Losartan|losartan|mesh-list
44277801|NCT00716950|Valsartan|valsartan|mesh-list
44277802|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44277803|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44277804|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44277805|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277806|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44277807|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
44277808|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
44277809|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277810|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277811|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664254|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181799|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181800|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181801|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44181802|NCT00323011|Growth Substances|growth substances|mesh-ancestor
44181803|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181804|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181805|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
44118047|NCT00112554|Cytarabine|cytarabine|mesh-list
44181806|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181807|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44181844|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181845|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181846|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44181847|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181848|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181876|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181877|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181878|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44181879|NCT00323375|Chloroquine|chloroquine|mesh-list
44181880|NCT00323375|Amebicides|amebicides|mesh-ancestor
44181881|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44181882|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44181883|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181885|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181886|NCT00323505|Interferons|interferons|mesh-list
44181887|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
44181888|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
44181889|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181890|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
44181891|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181892|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
44181893|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181894|NCT00323544|Tenofovir|tenofovir|mesh-list
44181895|NCT00323544|Lamivudine|lamivudine|mesh-list
44181896|NCT00323544|Zidovudine|zidovudine|mesh-list
44181897|NCT00323544|Emtricitabine|emtricitabine|mesh-list
44181934|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44181960|NCT00323804|Ribavirin|ribavirin|mesh-list
44181961|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44181962|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
44181963|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277812|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277813|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277814|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44277816|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44277817|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
44277818|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277819|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277820|NCT00717340|Paclitaxel|paclitaxel|mesh-list
44277821|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181964|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
44181965|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181966|NCT00323817|Z 338|z 338|mesh-list
44181967|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44181968|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181969|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181970|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181971|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181972|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181973|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181974|NCT00323830|Cisplatin|cisplatin|mesh-list
44181975|NCT00323830|Capecitabine|capecitabine|mesh-list
44181976|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181977|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44181978|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
44181979|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181980|NCT00323843|Isoproterenol|isoproterenol|mesh-list
44181981|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44181982|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44181983|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181984|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182018|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182019|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182020|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182021|NCT00323986|Azithromycin|azithromycin|mesh-list
44182049|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
44182050|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
44182051|NCT00324077|Dasatinib|dasatinib|mesh-list
44182052|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182053|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44182054|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182055|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182056|NCT00324129|Mocetinostat|mocetinostat|mesh-list
44182057|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44182058|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182059|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182060|NCT00324142|Tinidazole|tinidazole|mesh-list
44182061|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
44182062|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182063|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182064|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182065|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44182066|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44182067|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44182068|NCT00324194|Mocetinostat|mocetinostat|mesh-list
44182069|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44182099|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44182100|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182101|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44182102|NCT00324363|Incretins|incretins|mesh-ancestor
44182103|NCT00324363|Hormones|hormones|mesh-ancestor
44182104|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182105|NCT00324376|Sevelamer|sevelamer|mesh-list
44277823|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
44277824|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
44277825|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
44277826|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277827|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
44277828|NCT00717379|Prednisone|prednisone|mesh-list
44277829|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
44277830|NCT00717379|Tacrolimus|tacrolimus|mesh-list
44277831|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277832|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
44277833|NCT00717379|Hormones|hormones|mesh-ancestor
44277834|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277835|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277836|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44277837|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277838|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277839|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
44277840|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44277841|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277842|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277843|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277844|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44277845|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
44277846|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277847|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277848|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
44182106|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
44182107|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
44182108|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182109|NCT00324389|Interferons|interferons|mesh-list
44182110|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
44182111|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182112|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
44182148|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824429|NCT05512481|Apatinib|apatinib|mesh-list
44182149|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182150|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
44182151|NCT00324467|Hormones|hormones|mesh-ancestor
44182152|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182153|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44182154|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44182155|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182156|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182157|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182158|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182185|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44277850|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277851|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277852|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44277853|NCT00717379|Protective Agents|protective agents|mesh-ancestor
44277854|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
44277855|NCT00717470|Prednisone|prednisone|mesh-list
44277856|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
44277857|NCT00717470|Tacrolimus|tacrolimus|mesh-list
44277858|NCT00717470|Basiliximab|basiliximab|mesh-list
44277859|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277860|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
44277861|NCT00717470|Hormones|hormones|mesh-ancestor
44277862|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44277863|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277864|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44277865|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277866|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277867|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
44277868|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44277869|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182186|NCT00324480|Vorinostat|vorinostat|mesh-list
44182187|NCT00324480|Alvocidib|alvocidib|mesh-list
44182188|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182189|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44182190|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182191|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182192|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
44182193|NCT00324480|Growth Substances|growth substances|mesh-ancestor
44182194|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182195|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44182196|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
44182197|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182198|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182199|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44182200|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
44182201|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182202|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182203|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182204|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182205|NCT00324519|Misoprostol|misoprostol|mesh-list
44182206|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44182207|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
44182208|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44182209|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454251|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182233|NCT00324597|Immunologic Factors|immunologic factors|mesh-ancestor
44182234|NCT00324597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182235|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44182236|NCT00324610|Capecitabine|capecitabine|mesh-list
44182237|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44182238|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
44182268|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277871|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277872|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44277873|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
44277874|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277875|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277876|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
44277877|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
44277878|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44277879|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44277880|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44277881|NCT00717470|Protective Agents|protective agents|mesh-ancestor
44277882|NCT00717561|Amoxicillin|amoxicillin|mesh-list
44182270|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44182271|NCT00324727|Melphalan|melphalan|mesh-list
44182272|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44182273|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
44182274|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182275|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182276|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44182277|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182278|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
44182279|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182298|NCT00324818|Azithromycin|azithromycin|mesh-list
44182299|NCT00324818|Metronidazole|metronidazole|mesh-list
44182300|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182301|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182302|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44182303|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44182305|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
44182306|NCT00324831|Rituximab|rituximab|mesh-list
44182307|NCT00324831|Doxorubicin|doxorubicin|mesh-list
44182308|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44182309|NCT00324831|Vincristine|vincristine|mesh-list
44182310|NCT00324831|Vaccines|vaccines|mesh-list
44182311|NCT00324831|Antibodies|antibodies|mesh-list
44182312|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
44182313|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44182314|NCT00324831|Sargramostim|sargramostim|mesh-list
44182315|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44182316|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
44182317|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182318|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182319|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182320|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44182321|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
44182322|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182323|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182324|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44182325|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44182326|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182327|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182328|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182329|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182330|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182331|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
44182332|NCT00324831|Hormones|hormones|mesh-ancestor
44182333|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182334|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44182335|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44182336|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653440|NCT02984345|Caseins|caseins|mesh-list
43655185|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
43797047|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
44277884|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
44277885|NCT00717561|Clarithromycin|clarithromycin|mesh-list
44277886|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
44277887|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
44277888|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
44277889|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44277890|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44277891|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277892|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277893|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44277894|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277895|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277896|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277897|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277898|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44277899|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
44277900|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44277901|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277902|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44277903|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44277904|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44277905|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44277906|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44182405|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182407|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44182408|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44182409|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
44182410|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182411|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182412|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44182413|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
44182447|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44182448|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182449|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182450|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182451|NCT00325351|Carboplatin|carboplatin|mesh-list
44182452|NCT00325351|Sagopilone|sagopilone|mesh-list
44182453|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182454|NCT00325390|Clopidogrel|clopidogrel|mesh-list
44182455|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44182470|NCT00325455|Anacetrapib|anacetrapib|mesh-list
44182471|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44182472|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44182473|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
44182474|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182475|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44277907|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44277908|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44277909|NCT00717587|Sunitinib|sunitinib|mesh-list
44277910|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
44277911|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277912|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44277913|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44277914|NCT00717587|Growth Substances|growth substances|mesh-ancestor
44277915|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277916|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
44277917|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44277918|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277919|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277920|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44277921|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44277922|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
44277923|NCT00717678|Tacrolimus|tacrolimus|mesh-list
44277924|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44277925|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
44277926|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277927|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44277928|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277929|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182477|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44182478|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44182479|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44182480|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182481|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182482|NCT00325546|Hormones|hormones|mesh-ancestor
44182483|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182484|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182485|NCT00325637|Losartan|losartan|mesh-list
44182486|NCT00325637|Cilnidipine|cilnidipine|mesh-list
44182487|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44182488|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182489|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44182490|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44182491|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182492|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44182493|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182494|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182495|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182496|NCT00325676|Pantoprazole|pantoprazole|mesh-list
44182497|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182498|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182499|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44182500|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182501|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277930|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277931|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277932|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44277933|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
44277934|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44277935|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277937|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277938|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44277939|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277940|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277941|NCT00717730|Vitamins|vitamins|mesh-list
44277942|NCT00717730|Folic Acid|folic acid|mesh-list
44277943|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
44277944|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
44182502|NCT00325689|Risperidone|risperidone|mesh-list
44182503|NCT00325689|Aripiprazole|aripiprazole|mesh-list
44182504|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44182505|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44182506|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
44182507|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182508|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182509|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182510|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44182511|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43656675|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656790|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43656791|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656792|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
43656793|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
43656794|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44182527|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182529|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44182530|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
44182531|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182532|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182533|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44182534|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
44182535|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
44182536|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44182537|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44182538|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44182539|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44182540|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182541|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182542|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182543|NCT00325793|Nicardipine|nicardipine|mesh-list
44182544|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182545|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44182546|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182547|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182548|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182549|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182550|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182551|NCT00325806|Ramipril|ramipril|mesh-list
44182552|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44182553|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44182554|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182555|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182556|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182558|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
44182559|NCT00325845|Protective Agents|protective agents|mesh-ancestor
44182560|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182561|NCT00325858|Tramadol|tramadol|mesh-list
44182562|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44182563|NCT00325858|Narcotics|narcotics|mesh-ancestor
44277946|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
44277947|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277948|NCT00717730|Hematinics|hematinics|mesh-ancestor
44277949|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
44277950|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44277951|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277952|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277953|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
44277954|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277955|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277956|NCT00717808|Tranilast|tranilast|mesh-list
44277957|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
44277958|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44277959|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44182564|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182565|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182566|NCT00325858|Analgesics|analgesics|mesh-ancestor
44182567|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
44182568|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182569|NCT00325910|Metformin|metformin|mesh-list
44182570|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44182597|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44182598|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43656795|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
43656871|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656966|NCT02957877|Calcium heparin|calcium heparin|mesh-list
43656967|NCT02957877|Nadroparin|nadroparin|mesh-list
44182599|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182600|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182601|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182602|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182603|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182604|NCT00326027|Pantoprazole|pantoprazole|mesh-list
44182605|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182606|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182607|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44182608|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182609|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182610|NCT00326053|Budesonide|budesonide|mesh-list
44182611|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
44182612|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182613|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44182614|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
44182615|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182644|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182645|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182646|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182647|NCT00326131|Taxane|taxane|mesh-list
44182648|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182649|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44182650|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
44182651|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182652|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44182653|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182654|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182655|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182656|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44182657|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
44182658|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182659|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44182660|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44277961|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
44277962|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656968|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
43657020|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
44277963|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44277964|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44277965|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44277966|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44277967|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44277968|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277969|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44277970|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44277971|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
44277972|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
44277973|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44277974|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44277975|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44277976|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
44277977|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
44277978|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
44277979|NCT00717821|Hematinics|hematinics|mesh-ancestor
44277980|NCT00717834|Formaldehyde|formaldehyde|mesh-list
43664369|NCT04942730|Busulfan|busulfan|mesh-list
44182688|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182689|NCT00326352|Remifentanil|remifentanil|mesh-list
44182690|NCT00326352|Propofol|propofol|mesh-list
44182691|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44182692|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182693|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182694|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44182695|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
44182696|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
44182697|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44182698|NCT00326352|Narcotics|narcotics|mesh-ancestor
44182699|NCT00326352|Analgesics|analgesics|mesh-ancestor
44182700|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
44182701|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182702|NCT00326378|Cisplatin|cisplatin|mesh-list
44182703|NCT00326378|Docetaxel|docetaxel|mesh-list
44182704|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182705|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44182706|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182735|NCT00326404|Progestins|progestins|mesh-ancestor
44454269|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44454270|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454271|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454272|NCT01667900|Dulaglutide|dulaglutide|mesh-list
44454273|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454274|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454275|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
44454276|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
44454277|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454278|NCT01667679|Sumatriptan|sumatriptan|mesh-list
44454279|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44454280|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44277981|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
44277982|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44277983|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44277984|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44277985|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277986|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44277987|NCT00717938|Carboplatin|carboplatin|mesh-list
44277989|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
44277991|NCT00717938|Enoxaparin|enoxaparin|mesh-list
44277992|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
44277993|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44277994|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44277995|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44277996|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44277997|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44277998|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44277999|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
43657457|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43657458|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43657459|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
43657460|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43657461|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43825417|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825418|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454281|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44454282|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
44454283|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454284|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454298|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454299|NCT01667107|Posaconazole|posaconazole|mesh-list
44454300|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
44454301|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454302|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44454303|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44454304|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44454305|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44454306|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44454307|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454308|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454309|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44454310|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
44454311|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454312|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454313|NCT01667081|Grazoprevir|grazoprevir|mesh-list
44454314|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
44454315|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454316|NCT01666951|Tacrolimus|tacrolimus|mesh-list
44454317|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454318|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
44454319|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454320|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44454321|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454322|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454323|NCT01666782|Vaccines|vaccines|mesh-list
44454324|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
44454325|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454326|NCT01666730|Leucovorin|leucovorin|mesh-list
44454327|NCT01666730|Metformin|metformin|mesh-list
44454328|NCT01666730|Fluorouracil|fluorouracil|mesh-list
44454329|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
43657812|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43657813|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
43657814|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657815|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657816|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
43657817|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
43657818|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43657819|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43657820|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657821|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657854|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657855|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44454330|NCT01666730|Calcium|calcium|mesh-list
44454331|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
44454332|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454333|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278000|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44278001|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44278002|NCT00717951|Cisplatin|cisplatin|mesh-list
44278003|NCT00717951|Capecitabine|capecitabine|mesh-list
44278004|NCT00717951|Docetaxel|docetaxel|mesh-list
44278005|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278006|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278007|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
44278008|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278009|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278010|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278011|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
44463426|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454334|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44454335|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
44454336|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454337|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454338|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182737|NCT00326456|Carboplatin|carboplatin|mesh-list
44182738|NCT00326456|Doxorubicin|doxorubicin|mesh-list
44182739|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44182740|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44182741|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182742|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44182743|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182744|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182768|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44182769|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182770|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44182771|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44182772|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182773|NCT00326768|Diuretics|diuretics|mesh-ancestor
44182774|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
44182775|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182776|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44182777|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182778|NCT00326807|Naltrexone|naltrexone|mesh-list
44182779|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44182780|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44182781|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182782|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
44182783|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182784|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
44182785|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
44182786|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44182787|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182788|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
44182789|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
44182790|NCT00326833|Vitamins|vitamins|mesh-ancestor
44182791|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
44182792|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182793|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
44182794|NCT00326833|Hematinics|hematinics|mesh-ancestor
44182795|NCT00326859|Remifentanil|remifentanil|mesh-list
44182821|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44182822|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182823|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
44182824|NCT00327106|Coagulants|coagulants|mesh-ancestor
44182825|NCT00327119|Panitumumab|panitumumab|mesh-list
44182826|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44182827|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182828|NCT00327132|Amoxicillin|amoxicillin|mesh-list
44463427|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
44463428|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44463429|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44463430|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
44463431|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463432|NCT01514240|Mesalamine|mesalamine|mesh-list
44463433|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463434|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463435|NCT01514240|Analgesics|analgesics|mesh-ancestor
44463436|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
44463437|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463438|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463439|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463440|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463441|NCT01514201|Temozolomide|temozolomide|mesh-list
44463442|NCT01514201|Veliparib|veliparib|mesh-list
44463443|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463444|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
44463445|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463446|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463447|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44463448|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278012|NCT00717990|Bevacizumab|bevacizumab|mesh-list
44278013|NCT00717990|Capecitabine|capecitabine|mesh-list
44278014|NCT00717990|Irinotecan|irinotecan|mesh-list
44278015|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44278016|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278017|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44278018|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44278019|NCT00717990|Growth Substances|growth substances|mesh-ancestor
44278020|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278021|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44278022|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278023|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
44278025|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44278030|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278031|NCT00718172|Ribavirin|ribavirin|mesh-list
44278032|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
44278033|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278034|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
44278035|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278036|NCT00718276|Vitamin D|vitamin d|mesh-list
44278037|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
44278038|NCT00718276|Vitamins|vitamins|mesh-ancestor
44278039|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
44278040|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278041|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44278042|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44278043|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
44278044|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44278045|NCT00718354|Cisplatin|cisplatin|mesh-list
44278046|NCT00718354|Carboplatin|carboplatin|mesh-list
44278047|NCT00718354|Fluorouracil|fluorouracil|mesh-list
44278048|NCT00718354|Capecitabine|capecitabine|mesh-list
44278049|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
44278050|NCT00718354|Epirubicin|epirubicin|mesh-list
44278051|NCT00718354|Enoxaparin|enoxaparin|mesh-list
44278052|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278053|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
44278054|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278081|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44278082|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
44278083|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278084|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278085|NCT00718471|Heparin|heparin|mesh-list
43932517|NCT00759187|Triclosan|triclosan|mesh-list
44278086|NCT00718471|Enoxaparin|enoxaparin|mesh-list
44278087|NCT00718471|Calcium heparin|calcium heparin|mesh-list
44278088|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
44278089|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44278090|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44278091|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278092|NCT00718484|Doxorubicin|doxorubicin|mesh-list
44278093|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44278094|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
44278095|NCT00718484|Ifosfamide|ifosfamide|mesh-list
44278096|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278097|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278098|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278099|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278100|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278101|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278102|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44278103|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
44278104|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
44278105|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278106|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44278107|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
44278108|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278109|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44278110|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44278111|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278112|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278113|NCT00718601|Imetelstat|imetelstat|mesh-list
44278114|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
44278115|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278120|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278122|NCT00718757|Irinotecan|irinotecan|mesh-list
44278123|NCT00718757|Vincristine|vincristine|mesh-list
44278124|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278125|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
44278126|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
44278127|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278128|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278129|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44278130|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
44278131|NCT00718757|Hormones|hormones|mesh-ancestor
44278132|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278133|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44278134|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278135|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44278136|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278137|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278138|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278139|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44278140|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278141|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278142|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44278143|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
44278144|NCT00718796|Ubiquinone|ubiquinone|mesh-list
44278145|NCT00718796|Atorvastatin|atorvastatin|mesh-list
44278146|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44278147|NCT00718796|Simvastatin|simvastatin|mesh-list
44278148|NCT00718796|Pravastatin|pravastatin|mesh-list
44278149|NCT00718796|Lovastatin|lovastatin|mesh-list
44278150|NCT00718796|L 647318|l 647318|mesh-list
44278151|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
44278152|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
44278153|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44278154|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
44278155|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278156|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44182829|NCT00327132|Clarithromycin|clarithromycin|mesh-list
44182830|NCT00327132|Omeprazole|omeprazole|mesh-list
44182831|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182832|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278157|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44278158|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278159|NCT00718796|Vitamins|vitamins|mesh-ancestor
44278160|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
44278161|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278162|NCT00718913|Cisplatin|cisplatin|mesh-list
44278163|NCT00718913|Docetaxel|docetaxel|mesh-list
44278164|NCT00718913|Capecitabine|capecitabine|mesh-list
44278165|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278166|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278167|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278169|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182833|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182834|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182835|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44182836|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182837|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182838|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44182839|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44182840|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44182841|NCT00327145|Amlodipine|amlodipine|mesh-list
44182842|NCT00327145|Valsartan|valsartan|mesh-list
44182843|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44182844|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182845|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44182859|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44182860|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182862|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182863|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
44182864|NCT00327197|Hormones|hormones|mesh-ancestor
44182865|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182866|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182867|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44182868|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182869|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
44182870|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182871|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44182872|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182873|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182874|NCT00327288|Docetaxel|docetaxel|mesh-list
44182875|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182876|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
44182877|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182878|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182879|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182880|NCT00327327|Gemcitabine|gemcitabine|mesh-list
44182881|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44182882|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
44182883|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182884|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182885|NCT00327327|Antiviral Agents|antiviral agents|mesh-ancestor
44182886|NCT00327327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182888|NCT00327327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182889|NCT00327327|Immunologic Factors|immunologic factors|mesh-ancestor
44182890|NCT00327327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182891|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
44182892|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44182893|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44182894|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
44182895|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182896|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182897|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44278170|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278171|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
44278172|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44278173|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
44278174|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44278175|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44278176|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278177|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278178|NCT00718952|Urological Agents|urological agents|mesh-ancestor
44278179|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
44278180|NCT00719056|Lactams|lactams|mesh-list
44278181|NCT00719056|Cephalosporins|cephalosporins|mesh-list
44278182|NCT00719056|Teicoplanin|teicoplanin|mesh-list
44278183|NCT00719056|beta-Lactams|beta-lactams|mesh-list
44182898|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44182899|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44182900|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44182901|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44182902|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182903|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182904|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182935|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182936|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182937|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182938|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
44182939|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182940|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
44182941|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182942|NCT05458180|Prednisone|prednisone|mesh-list
44182943|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
44182944|NCT05458180|Etoposide|etoposide|mesh-list
44182945|NCT05458180|Vincristine|vincristine|mesh-list
43661828|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661830|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44182946|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
44182947|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182948|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
44182978|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182979|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182980|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44182981|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44182982|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
44182983|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182984|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44182985|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44454339|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454340|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
44454341|NCT01666730|Antidotes|antidotes|mesh-ancestor
44454342|NCT01666730|Protective Agents|protective agents|mesh-ancestor
44454343|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
44454344|NCT01666730|Vitamins|vitamins|mesh-ancestor
44454345|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
44182999|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44183000|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183001|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183002|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183003|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44183004|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183005|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183006|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183007|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183008|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183009|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
44183010|NCT05457751|Rocuronium|rocuronium|mesh-list
43797048|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
44278185|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278186|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278187|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278188|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278189|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278190|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278191|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44278192|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278193|NCT00719095|Naltrexone|naltrexone|mesh-list
44183011|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44183012|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44183013|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44183014|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183015|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183016|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44183017|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
44183018|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183019|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44183020|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44183021|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183022|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183023|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44183024|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44183025|NCT05457465|Cannabidiol|cannabidiol|mesh-list
44183026|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
44183027|NCT05457361|Azacitidine|azacitidine|mesh-list
44183028|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
44183029|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183030|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
44183031|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183052|NCT05453045|Albendazole|albendazole|mesh-list
44183053|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
44183054|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44183055|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183056|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
44183057|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44183058|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44183059|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183060|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183061|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183062|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183063|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183064|NCT05420402|Propofol|propofol|mesh-list
44183065|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44183066|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183067|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183068|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44183069|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
44183070|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
44183071|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
44183072|NCT05373303|Hematinics|hematinics|mesh-ancestor
44183073|NCT05371964|Imetelstat|imetelstat|mesh-list
44183074|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
44183075|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183076|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183077|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183078|NCT05360264|Decitabine|decitabine|mesh-list
44183079|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183080|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
44183081|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183082|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183083|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278195|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44278196|NCT00719095|Narcotics|narcotics|mesh-ancestor
44278197|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278198|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278199|NCT00719095|Analgesics|analgesics|mesh-ancestor
44278200|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
44278201|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278202|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44278203|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44278204|NCT00719108|Insulin|insulin|mesh-list
44278205|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44278206|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44183084|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
44183085|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
44183086|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44183116|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44183117|NCT05238831|Bevacizumab|bevacizumab|mesh-list
44183118|NCT05238831|Carboplatin|carboplatin|mesh-list
44183119|NCT05238831|Capecitabine|capecitabine|mesh-list
44183120|NCT05238831|Trastuzumab|trastuzumab|mesh-list
44183121|NCT05238831|Irinotecan|irinotecan|mesh-list
44183122|NCT05238831|Atezolizumab|atezolizumab|mesh-list
44183123|NCT05238831|Letrozole|letrozole|mesh-list
44183124|NCT05238831|Olaparib|olaparib|mesh-list
44183125|NCT05238831|Fulvestrant|fulvestrant|mesh-list
44183126|NCT05238831|Palbociclib|palbociclib|mesh-list
44183127|NCT05238831|Anastrozole|anastrozole|mesh-list
44183128|NCT05238831|Pertuzumab|pertuzumab|mesh-list
44183129|NCT05238831|Niraparib|niraparib|mesh-list
44183130|NCT05238831|Vemurafenib|vemurafenib|mesh-list
44183131|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44183132|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
44183133|NCT05238831|Antibodies|antibodies|mesh-list
44183134|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
44183135|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44183136|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44183137|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
44183138|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
44183139|NCT05238831|Entrectinib|entrectinib|mesh-list
44183171|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44183172|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44183173|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44183174|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183175|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
44183176|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
44183177|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183178|NCT05198960|Aspirin|aspirin|mesh-list
44183179|NCT05198960|Anticoagulants|anticoagulants|mesh-list
44183214|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44183215|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183216|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44183217|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183218|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44454419|NCT01664624|Alogliptin|alogliptin|mesh-list
44454420|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454421|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454422|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44454423|NCT01664624|Incretins|incretins|mesh-ancestor
44454456|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183223|NCT05008224|Prednisone|prednisone|mesh-list
44183224|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
44183225|NCT05008224|Dacarbazine|dacarbazine|mesh-list
44183226|NCT05008224|Doxorubicin|doxorubicin|mesh-list
44183227|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
44183228|NCT05008224|Etoposide|etoposide|mesh-list
44183229|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
44183230|NCT05008224|Vincristine|vincristine|mesh-list
44183249|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
44278207|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278208|NCT00719121|Adapalene|adapalene|mesh-list
44278209|NCT00719121|R 115866|r 115866|mesh-list
44278210|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44278211|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278212|NCT00719121|Analgesics|analgesics|mesh-ancestor
44278213|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
44278214|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278215|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278216|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278217|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278218|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
44278219|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278220|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278221|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278222|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
44278223|NCT00719173|Aprepitant|aprepitant|mesh-list
44278224|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278225|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
44278226|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278227|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278228|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44278229|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
44278230|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278231|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183251|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183252|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183253|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183254|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183255|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183256|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183257|NCT04998669|Rituximab|rituximab|mesh-list
44183258|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44183259|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183260|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183261|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
44183262|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183263|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183264|NCT04982796|Psilocybin|psilocybin|mesh-list
44183265|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
44183266|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183267|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183268|NCT04960930|Minocycline|minocycline|mesh-list
44183269|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183270|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183271|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
44183272|NCT04942340|Caffeine|caffeine|mesh-list
44183273|NCT04942340|Atipamezole|atipamezole|mesh-list
44183274|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44278232|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44278233|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
44278234|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
44278235|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278236|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44278237|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44278238|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278239|NCT00719199|Cetuximab|cetuximab|mesh-list
44278240|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44278241|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278242|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
44278243|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44278244|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
44183275|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183276|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183277|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183278|NCT04942340|Analgesics|analgesics|mesh-ancestor
44183279|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
44183280|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183281|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44183282|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44183283|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44183284|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44183285|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183286|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183316|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
44183317|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183318|NCT04635280|Pancrelipase|pancrelipase|mesh-list
44183319|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183320|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
44183321|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183322|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183323|NCT04575233|Ropivacaine|ropivacaine|mesh-list
43664089|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43664090|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43664091|NCT05308030|Analgesics|analgesics|mesh-ancestor
43664092|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
43664093|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664094|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664095|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664096|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664097|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43664098|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43664179|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183324|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
44183325|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
44183326|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183327|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183328|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
44183329|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183330|NCT04520217|Imipramine|imipramine|mesh-list
44183331|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44183332|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
44183358|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183359|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
44183360|NCT04478019|Povidone|povidone|mesh-list
44183361|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
44183362|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
44183363|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44183364|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183365|NCT04432012|Dexamethasone|dexamethasone|mesh-list
44183366|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
44183367|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44183368|NCT04432012|BB 1101|bb 1101|mesh-list
44183369|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183370|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
44183371|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
44183372|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183373|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183374|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119711|NCT00118690|Xhance|xhance|mesh-list
44183375|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
44183376|NCT04432012|Hormones|hormones|mesh-ancestor
44183377|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278245|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278246|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
44278247|NCT00719290|Protective Agents|protective agents|mesh-ancestor
44278248|NCT00719381|Pioglitazone|pioglitazone|mesh-list
44278249|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278250|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278251|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
44278252|NCT00719407|Hematinics|hematinics|mesh-ancestor
44278253|NCT00719420|Amoxicillin|amoxicillin|mesh-list
44278254|NCT00719420|Metronidazole|metronidazole|mesh-list
44278255|NCT00719420|Clarithromycin|clarithromycin|mesh-list
44278257|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278258|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278259|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44278260|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44278261|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44278262|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44278263|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44278264|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183378|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183379|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183413|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44183414|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183415|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
44183416|NCT04231773|Protective Agents|protective agents|mesh-ancestor
44183417|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
44183418|NCT04109482|Fludarabine|fludarabine|mesh-list
44183419|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183436|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183437|NCT03975439|Analgesics|analgesics|mesh-ancestor
44183438|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
44183439|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183440|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183441|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183442|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454458|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44454459|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
44454460|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44454461|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454462|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454463|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183443|NCT03897868|Losartan|losartan|mesh-list
44183444|NCT03897868|Amlodipine|amlodipine|mesh-list
44183445|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44183446|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44183447|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183448|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183449|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44183450|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183451|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183452|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44183453|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44183454|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44183455|NCT03878524|Vitamins|vitamins|mesh-list
44183456|NCT03878524|Leucovorin|leucovorin|mesh-list
44183457|NCT03878524|Vitamin A|vitamin a|mesh-list
44183458|NCT03878524|Sirolimus|sirolimus|mesh-list
44183459|NCT03878524|Celecoxib|celecoxib|mesh-list
44183460|NCT03878524|Paclitaxel|paclitaxel|mesh-list
44183461|NCT03878524|Maytansine|maytansine|mesh-list
44278265|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278266|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44278267|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44278268|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278269|NCT00719433|Armin|armin|mesh-list
44278270|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44278271|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278272|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278273|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
44278274|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278275|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278276|NCT00719459|Iron|iron|mesh-list
44278277|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43664473|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278278|NCT00719459|Trace Elements|trace elements|mesh-ancestor
44278279|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
44278280|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183462|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44183463|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44183464|NCT03878524|Bevacizumab|bevacizumab|mesh-list
44183465|NCT03878524|Carboplatin|carboplatin|mesh-list
44183466|NCT03878524|Doxorubicin|doxorubicin|mesh-list
44183467|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44183468|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
44183469|NCT03878524|Fluorouracil|fluorouracil|mesh-list
44183470|NCT03878524|Capecitabine|capecitabine|mesh-list
44183471|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
44183472|NCT03878524|Nivolumab|nivolumab|mesh-list
44183473|NCT03878524|Trastuzumab|trastuzumab|mesh-list
44183474|NCT03878524|Everolimus|everolimus|mesh-list
44183497|NCT03878524|Idelalisib|idelalisib|mesh-list
44183498|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44183499|NCT03878524|Losartan|losartan|mesh-list
44183500|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
44183501|NCT03878524|Antibodies|antibodies|mesh-list
44183502|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
44183503|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44183504|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44183505|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
44183506|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
44183507|NCT03878524|Entrectinib|entrectinib|mesh-list
44183508|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
44183509|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183510|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183511|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183512|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183513|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183514|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183515|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44183516|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44183517|NCT03878524|Growth Substances|growth substances|mesh-ancestor
44183518|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183519|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44183520|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
44183521|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
44183522|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44183523|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44183524|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183525|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183526|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
44183527|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183528|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278281|NCT00719459|Hematinics|hematinics|mesh-ancestor
44278282|NCT00719602|Ritonavir|ritonavir|mesh-list
44278283|NCT00719602|Lopinavir|lopinavir|mesh-list
44278284|NCT00719602|Lamivudine|lamivudine|mesh-list
44278285|NCT00719602|Zidovudine|zidovudine|mesh-list
44278286|NCT00719602|Nevirapine|nevirapine|mesh-list
44278287|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44278288|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44278289|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
44278290|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278291|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278292|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278293|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44278294|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
44278295|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278296|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44278297|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278298|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44278299|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44278300|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
43665135|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665136|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44278301|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44278302|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44278303|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
44278304|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44278305|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
44278306|NCT00719693|Fenofibrate|fenofibrate|mesh-list
44278307|NCT00719693|Calcium|calcium|mesh-list
44278308|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44278309|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278310|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44278311|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44278312|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44278313|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
44278314|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183529|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44183530|NCT03878524|Antidotes|antidotes|mesh-ancestor
44183531|NCT03878524|Protective Agents|protective agents|mesh-ancestor
44183532|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
44183533|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183534|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183535|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183536|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
44278316|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44278318|NCT00719745|Tacrolimus|tacrolimus|mesh-list
44278319|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278320|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
44278321|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278322|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44278323|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278324|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278325|NCT00719758|Beraprost|beraprost|mesh-list
44278326|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44278327|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
44278328|NCT00719797|Leucovorin|leucovorin|mesh-list
44278329|NCT00719797|Bevacizumab|bevacizumab|mesh-list
44278330|NCT00719797|Fluorouracil|fluorouracil|mesh-list
44278331|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
44278332|NCT00719797|Irinotecan|irinotecan|mesh-list
44278333|NCT00719797|Calcium|calcium|mesh-list
44278334|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
44278335|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44278336|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278337|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44278338|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44278339|NCT00719797|Growth Substances|growth substances|mesh-ancestor
44278340|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664603|NCT04449198|Resveratrol|resveratrol|mesh-list
44183537|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183538|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183539|NCT03878524|Analgesics|analgesics|mesh-ancestor
44183560|NCT03852992|Minoxidil|minoxidil|mesh-list
44183561|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44183562|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183563|NCT03754140|Polidocanol|polidocanol|mesh-list
44183564|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44183565|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44183566|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
44183567|NCT03715972|Acetazolamide|acetazolamide|mesh-list
43665582|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665583|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665584|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
43665585|NCT05468450|Polidocanol|polidocanol|mesh-list
43665586|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
43665587|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43665588|NCT05468372|Amphotericin B|amphotericin b|mesh-list
43665589|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43665590|NCT05468372|Posaconazole|posaconazole|mesh-list
44183568|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183569|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
44183570|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183571|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183572|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44183573|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
44183574|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44183575|NCT03715972|Diuretics|diuretics|mesh-ancestor
44183576|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
44183577|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183578|NCT03690544|Apremilast|apremilast|mesh-list
44278342|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44278343|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
44278344|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278345|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278346|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278347|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
44278348|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44278349|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278350|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278351|NCT00719797|Antidotes|antidotes|mesh-ancestor
44278352|NCT00719797|Protective Agents|protective agents|mesh-ancestor
44278353|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
44278354|NCT00719797|Vitamins|vitamins|mesh-ancestor
44278355|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
44278356|NCT00719823|Maraviroc|maraviroc|mesh-list
44278357|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44278358|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44278359|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278360|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278361|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44278362|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
44278363|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278364|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44278365|NCT00719875|Vorinostat|vorinostat|mesh-list
44278366|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44278367|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278368|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278369|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463449|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44463450|NCT01513759|Plasminogen|plasminogen|mesh-list
44463451|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43664639|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
44183579|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183580|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183581|NCT03690544|Analgesics|analgesics|mesh-ancestor
44183582|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
44183583|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183584|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183585|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183586|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183587|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44463454|NCT01513590|Insulin|insulin|mesh-list
44463455|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
44463456|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463457|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463458|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44463459|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
44463460|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463461|NCT01513473|Insulin|insulin|mesh-list
44463462|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44463463|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
44463464|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
44463465|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463466|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463467|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
44463468|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
44463469|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44463470|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
44463471|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463472|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463473|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44463474|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
43664664|NCT04261218|Paclitaxel|paclitaxel|mesh-list
44183588|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44183589|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183590|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183623|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183624|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183625|NCT03031483|Clarithromycin|clarithromycin|mesh-list
44183626|NCT03031483|Lenalidomide|lenalidomide|mesh-list
44183627|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
44183628|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183629|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44183661|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
44183662|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44183663|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183664|NCT02645149|Trametinib|trametinib|mesh-list
44183665|NCT02645149|Ceritinib|ceritinib|mesh-list
44183666|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183667|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183668|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183669|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183725|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183726|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
44183727|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
44183728|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183729|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183730|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
44183731|NCT02244125|Hormones|hormones|mesh-ancestor
44463475|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
44278371|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44278372|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44278373|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44278374|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
44278375|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278376|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278377|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278378|NCT00720135|Rituximab|rituximab|mesh-list
44278379|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44278380|NCT00720135|Interleukin-2|interleukin-2|mesh-list
44278381|NCT00720135|Antibodies|antibodies|mesh-list
44278382|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
44278383|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44278384|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
44278385|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664681|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
43826418|NCT05498064|Ensartinib|ensartinib|mesh-list
43831667|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831668|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43831669|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
44183732|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183733|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183734|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44183735|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44183736|NCT02244125|Growth Substances|growth substances|mesh-ancestor
44183737|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44183738|NCT01820910|Doxycycline|doxycycline|mesh-list
44183739|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183740|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183741|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
44183742|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44183743|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44183744|NCT01808599|Rituximab|rituximab|mesh-list
44183745|NCT01808599|Chlorambucil|chlorambucil|mesh-list
44183746|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183747|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183748|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
44183749|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183750|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183751|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183752|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
44183753|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183754|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
44183755|NCT01785459|Bupivacaine|bupivacaine|mesh-list
44183756|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
44183757|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
44183758|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183759|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183760|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
44183761|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183762|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
44183763|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
44183764|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183765|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44183766|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44183767|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183768|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44183769|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
44183770|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183771|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278388|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278389|NCT00720135|Analgesics|analgesics|mesh-ancestor
44278390|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
44278391|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278392|NCT00720148|Bortezomib|bortezomib|mesh-list
44278393|NCT00720148|Sunitinib|sunitinib|mesh-list
44278394|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278395|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43664693|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
44183773|NCT01691833|Vitamins|vitamins|mesh-ancestor
44183774|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
44183775|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183776|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44183777|NCT01600079|Vaccines|vaccines|mesh-list
44183778|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
44183816|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44183852|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44183853|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183854|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183885|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831673|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
44183886|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183887|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44183888|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183889|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44183890|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44183891|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183892|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
44183893|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
44183894|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183895|NCT00327756|Ubiquinone|ubiquinone|mesh-list
44183896|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
44183897|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
44183925|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44183926|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44183927|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183928|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183929|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44183930|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183931|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183932|NCT00327847|Vitamin D|vitamin d|mesh-list
44183933|NCT00327847|Vitamins|vitamins|mesh-ancestor
44183934|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
44183935|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183936|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44454464|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
44454465|NCT01663857|Gemcitabine|gemcitabine|mesh-list
44454466|NCT01663857|Carboplatin|carboplatin|mesh-list
44454467|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454468|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183958|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183959|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183960|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44183961|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44183962|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
44183963|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183964|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183965|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
44183966|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183967|NCT00328302|Candesartan|candesartan|mesh-list
44183968|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44183969|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44278397|NCT00720148|Growth Substances|growth substances|mesh-ancestor
44278398|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278399|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
44278400|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44278401|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278402|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278403|NCT00720161|Metformin|metformin|mesh-list
44278404|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278405|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278406|NCT00720174|Doxorubicin|doxorubicin|mesh-list
44278407|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44278408|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44278409|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278410|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278411|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278412|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183970|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44183971|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183972|NCT00328367|Aripiprazole|aripiprazole|mesh-list
44183973|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
44183974|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183975|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44183976|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44183977|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183978|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183979|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
44183980|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
44183981|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183982|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183983|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44183984|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44183985|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
44183986|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44183987|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44183988|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44183989|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44184063|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44184064|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44184098|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44184099|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184100|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44184101|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
44184102|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184103|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184104|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44184140|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184141|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184142|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184174|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184175|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184176|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184177|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
44184178|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278413|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278414|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278415|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
44278416|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278417|NCT00720265|Tacrolimus|tacrolimus|mesh-list
44278418|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278419|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
44278420|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278421|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44278422|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278423|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278424|NCT00720291|Metronidazole|metronidazole|mesh-list
44278425|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278426|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278427|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44278428|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44278429|NCT00720304|Docetaxel|docetaxel|mesh-list
44278430|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44278431|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278432|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278433|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278434|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
44278435|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278436|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44278437|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278438|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
44278439|NCT00720408|Tacrolimus|tacrolimus|mesh-list
43664724|NCT04153032|Diltiazem|diltiazem|mesh-list
44184179|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44184180|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184181|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184182|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44184183|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44184184|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184185|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44184186|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44184256|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
44184257|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184258|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
44184259|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184260|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184290|NCT00329446|Citalopram|citalopram|mesh-list
44184291|NCT00329446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44184292|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184293|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184294|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278441|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
44278442|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278443|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44278444|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278445|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278446|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278447|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278448|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44278449|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
44278450|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278451|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184295|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184296|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
44184297|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184298|NCT00329446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44184299|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184300|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184301|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184302|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184303|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184304|NCT00329459|Naproxen|naproxen|mesh-list
44184305|NCT00329459|Sumatriptan|sumatriptan|mesh-list
44184306|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184307|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184308|NCT00329459|Analgesics|analgesics|mesh-ancestor
44184335|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
44184336|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
44184337|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184338|NCT00329498|Protective Agents|protective agents|mesh-ancestor
44184339|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184341|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
44184342|NCT00329511|Clonidine|clonidine|mesh-list
44184343|NCT00329511|Methyldopa|methyldopa|mesh-list
44184344|NCT00329511|Analgesics|analgesics|mesh-ancestor
44184345|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
44184346|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184347|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184348|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44184349|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
44184350|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
44184351|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44184352|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44184353|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44184354|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44184355|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184356|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184357|NCT00329537|Sargramostim|sargramostim|mesh-list
44184404|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184405|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184406|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44184407|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184408|NCT00329810|Aripiprazole|aripiprazole|mesh-list
44184409|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184410|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184442|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184443|NCT00329940|Letrozole|letrozole|mesh-list
44184444|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184445|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44184446|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44184447|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278453|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
44278454|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
44278455|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
44278456|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278457|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278458|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44278459|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44278460|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278461|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44278462|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44278463|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44278464|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
44278465|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
44278466|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278467|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278468|NCT00720447|Cytarabine|cytarabine|mesh-list
44278469|NCT00720447|Etoposide|etoposide|mesh-list
44278470|NCT00720447|Melphalan|melphalan|mesh-list
44278471|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
44278472|NCT00720447|Carmustine|carmustine|mesh-list
44278473|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44278474|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278475|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278476|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278477|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278478|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278479|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43712218|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
43712325|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712326|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278480|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
44278481|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
44278482|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278483|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278484|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
44278485|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278486|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44184448|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184449|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44184450|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184451|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184483|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278487|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
44278488|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44278489|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44278490|NCT00720512|Leucovorin|leucovorin|mesh-list
44278491|NCT00720512|Bevacizumab|bevacizumab|mesh-list
44278492|NCT00720512|Fluorouracil|fluorouracil|mesh-list
44278493|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
44278494|NCT00720512|Irinotecan|irinotecan|mesh-list
44278495|NCT00720512|Calcium|calcium|mesh-list
44278496|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
44278497|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44278498|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278499|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44278500|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44278501|NCT00720512|Growth Substances|growth substances|mesh-ancestor
44278502|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278503|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
44278504|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44278505|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
44278506|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278507|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44278508|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184484|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44184485|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184486|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184487|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44184488|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44184489|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184490|NCT00330252|Rituximab|rituximab|mesh-list
44184491|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
44184492|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44184493|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184494|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
44184495|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184496|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184521|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44184522|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184523|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184524|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184525|NCT00330395|Caspofungin|caspofungin|mesh-list
44184526|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
44184527|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184528|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184529|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712396|NCT02684123|Apremilast|apremilast|mesh-list
43712397|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712398|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712399|NCT02684123|Analgesics|analgesics|mesh-ancestor
43712400|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
43712401|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712402|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712403|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712404|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712421|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712422|NCT02683759|Curcumin|curcumin|mesh-list
43712423|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184530|NCT00330486|Acamprosate|acamprosate|mesh-list
44184531|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44184532|NCT00330499|Cisplatin|cisplatin|mesh-list
44184533|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184534|NCT00330525|Sibutramine|sibutramine|mesh-list
44184535|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184536|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184537|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
44184538|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44184539|NCT00330577|Timolol|timolol|mesh-list
44278509|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
44278510|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44278511|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278512|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278513|NCT00720512|Antidotes|antidotes|mesh-ancestor
44278514|NCT00720512|Protective Agents|protective agents|mesh-ancestor
44278515|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
44278516|NCT00720512|Vitamins|vitamins|mesh-ancestor
44278517|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
44278518|NCT00720538|Thalidomide|thalidomide|mesh-list
44278519|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278520|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
44278521|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278522|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
44278523|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278524|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278525|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44278526|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44278527|NCT00720538|Growth Substances|growth substances|mesh-ancestor
44278528|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
44278529|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278530|NCT00720564|Temozolomide|temozolomide|mesh-list
44278531|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
44278532|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44278533|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
44278534|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278536|NCT00720577|Pioglitazone|pioglitazone|mesh-list
44278559|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278560|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278561|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43712425|NCT02683759|Analgesics|analgesics|mesh-ancestor
43712435|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44278562|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
44278563|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278564|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44278565|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278566|NCT00720603|Plerixafor|plerixafor|mesh-list
44278567|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44278568|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44278569|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
44278570|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278571|NCT00720616|Insulin|insulin|mesh-list
44278572|NCT00720616|Hormones|hormones|mesh-list
44278573|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278574|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278575|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278576|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
44278577|NCT00720772|Antidotes|antidotes|mesh-ancestor
44278578|NCT00720772|Protective Agents|protective agents|mesh-ancestor
44278579|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278580|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
44278581|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278582|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
44278583|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278584|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278585|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
44278586|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
44278587|NCT00720811|Acetaminophen|acetaminophen|mesh-list
44278588|NCT00720811|Amoxicillin|amoxicillin|mesh-list
44278589|NCT00720811|Lumefantrine|lumefantrine|mesh-list
44278590|NCT00720811|Artemether|artemether|mesh-list
44278591|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44278592|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278600|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
44278601|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44278602|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44278604|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44278605|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
44278606|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278607|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278608|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
44278609|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278610|NCT00720850|Lenalidomide|lenalidomide|mesh-list
44278611|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
44278612|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278613|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44278614|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44278615|NCT00720850|Growth Substances|growth substances|mesh-ancestor
44278616|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
44278617|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278618|NCT00720915|Anticoagulants|anticoagulants|mesh-list
44278619|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
44278620|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44278621|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44278622|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278623|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
44278624|NCT00720915|Coagulants|coagulants|mesh-ancestor
44278625|NCT00721032|Amiodarone|amiodarone|mesh-list
44278626|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44278627|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
44278628|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44278629|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44278630|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278631|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44278632|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43664808|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44184540|NCT00330577|Latanoprost|latanoprost|mesh-list
44184541|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
44184542|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44184543|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44184544|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
44184545|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278635|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44278636|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44278637|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44278638|NCT00721201|Mifepristone|mifepristone|mesh-list
44278639|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44278640|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
44278641|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44278642|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278643|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44278644|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44278645|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44278646|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
44278647|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44278648|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44278649|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
44278650|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278651|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
44278652|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43664846|NCT03809442|Analgesics|analgesics|mesh-ancestor
44184546|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184547|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184548|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184579|NCT00330746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184580|NCT00330746|Immunologic Factors|immunologic factors|mesh-ancestor
44184581|NCT00330746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184582|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44184583|NCT00330772|Aspirin|aspirin|mesh-list
44184584|NCT00330772|Clopidogrel|clopidogrel|mesh-list
44184585|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184586|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184587|NCT00330772|Analgesics|analgesics|mesh-ancestor
44184588|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
44184589|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184590|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184591|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184592|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184593|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44184618|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44184619|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184621|NCT00330798|Ketorolac|ketorolac|mesh-list
44184622|NCT00330798|Nepafenac|nepafenac|mesh-list
44184623|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184624|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184625|NCT00330798|Analgesics|analgesics|mesh-ancestor
44184626|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
44184627|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278653|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44278654|NCT00721240|Montelukast|montelukast|mesh-list
44278655|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44278656|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
44278657|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44278658|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
44278659|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278660|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278661|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43831842|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44278662|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44278663|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278664|NCT00721305|Lovastatin|lovastatin|mesh-list
44278665|NCT00721305|L 647318|l 647318|mesh-list
44278666|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
44278667|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44278668|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44278669|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
44278670|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278671|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44278672|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44278673|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278674|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
44278675|NCT00721331|Loratadine|loratadine|mesh-list
44278676|NCT00721331|Nortriptyline|nortriptyline|mesh-list
44278677|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278678|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
43664868|NCT03809442|Narcotics|narcotics|mesh-ancestor
44184628|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184629|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184630|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184631|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184632|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184633|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184634|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44184635|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
44184636|NCT00330824|Dexamethasone|dexamethasone|mesh-list
44184637|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
44184638|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44184639|NCT00330824|BB 1101|bb 1101|mesh-list
44184640|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184670|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184671|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184672|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184673|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
44184674|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
44184675|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44184676|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
43841888|NCT04580472|Clindamycin|clindamycin|mesh-list
44278679|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44278680|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
44278681|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44278682|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44278683|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
44278684|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
44278685|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278686|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278687|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278688|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44278689|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
44278690|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44278691|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44278692|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44278693|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44278694|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
44278695|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
44278696|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44278697|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278698|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278699|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278700|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278701|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712627|NCT02682134|Lidocaine|lidocaine|mesh-list
44278702|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278703|NCT00721448|Ticagrelor|ticagrelor|mesh-list
44278704|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664888|NCT03737981|Venetoclax|venetoclax|mesh-list
44184677|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44184678|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184679|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184680|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44184681|NCT00330902|Renal Agents|renal agents|mesh-ancestor
44184682|NCT00330941|Lidocaine|lidocaine|mesh-list
44184683|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44184684|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
44184717|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44184718|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44184719|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184720|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184721|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
44184722|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44184748|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
44184749|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
44184750|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184751|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184752|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44278705|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44278706|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44278707|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44278709|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278710|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278711|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278712|NCT00721487|Fluconazole|fluconazole|mesh-list
44278713|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
44278714|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278715|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44278716|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278717|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278718|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278719|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44278720|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
44278721|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278722|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278723|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44278724|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44278725|NCT00721526|Disulfiram|disulfiram|mesh-list
44278726|NCT00721526|Lorazepam|lorazepam|mesh-list
44278727|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
44278728|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
44278729|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
44278730|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278731|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278732|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664917|NCT03580148|Cortisone|cortisone|mesh-list
44184753|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
44184754|NCT00331084|Hormones|hormones|mesh-ancestor
44184755|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184756|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44184757|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712850|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712851|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
44184758|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44184759|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184760|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184761|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184762|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44184763|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44184764|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44278733|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44278734|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278735|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44278736|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44278737|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44278738|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
44278740|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278741|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278742|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44278743|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44278744|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933131|NCT00770133|Ketotifen|ketotifen|mesh-list
44278745|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44278747|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44278748|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
44278749|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44278750|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
44278751|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44278752|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
44278753|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278754|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
44278755|NCT00721552|Hormones|hormones|mesh-ancestor
44278756|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44278757|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278758|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44278759|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278760|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
44278761|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
44278762|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278763|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184765|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
44184766|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44184767|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44184768|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44184769|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44184770|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
44184771|NCT00331097|Docetaxel|docetaxel|mesh-list
44184772|NCT00331097|Fluorouracil|fluorouracil|mesh-list
44184773|NCT00331097|Methotrexate|methotrexate|mesh-list
44184803|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
44184804|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
44184805|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184806|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278766|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278767|NCT00721552|Incretins|incretins|mesh-ancestor
44278768|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44278769|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44278770|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278771|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278772|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44278773|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
44278774|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
44278775|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
44278776|NCT00721747|Docetaxel|docetaxel|mesh-list
44278777|NCT00721747|Doxorubicin|doxorubicin|mesh-list
44278778|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44278779|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278780|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
44278781|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712852|NCT02680717|Hormones|hormones|mesh-ancestor
44184807|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184809|NCT00331188|Analgesics|analgesics|mesh-ancestor
44184810|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
44184811|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184812|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184813|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184814|NCT00331214|Testosterone|testosterone|mesh-list
44184815|NCT00331214|Androgens|androgens|mesh-ancestor
44184816|NCT00331214|Hormones|hormones|mesh-ancestor
44184847|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44184848|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184849|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44184850|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44184851|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44184852|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184853|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184854|NCT00331500|Analgesics|analgesics|mesh-ancestor
44184855|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
44184856|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184857|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184858|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184891|NCT00331643|Epothilone B|epothilone b|mesh-list
44184892|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
44184893|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
44184894|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
44184949|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
44184950|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44184951|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
44184952|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44184953|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
44184954|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184955|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44184956|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
44184957|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
44184958|NCT00331786|Protective Agents|protective agents|mesh-ancestor
44184959|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44184960|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44184962|NCT00331825|Risperidone|risperidone|mesh-list
44184963|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44278782|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278783|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44278784|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
44278785|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278786|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278787|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44278788|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278789|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278790|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
44278791|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278792|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278793|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278794|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278795|NCT00721773|Valsartan|valsartan|mesh-list
44278796|NCT00721773|Benazepril|benazepril|mesh-list
44278797|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44278798|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44278799|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44278800|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278801|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44278802|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
44278803|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278804|NCT00721877|Resveratrol|resveratrol|mesh-list
44278805|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
44278806|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278807|NCT00721877|Protective Agents|protective agents|mesh-ancestor
43713114|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713115|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278808|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278809|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278810|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44278811|NCT00721916|Leucovorin|leucovorin|mesh-list
44278812|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
44278813|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278814|NCT00721916|Antidotes|antidotes|mesh-ancestor
44278815|NCT00721916|Protective Agents|protective agents|mesh-ancestor
44278818|NCT00721916|Vitamins|vitamins|mesh-ancestor
44278821|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44278822|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278824|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
44278825|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278826|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278827|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278828|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278829|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
44278830|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
44278831|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44278832|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44278833|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278834|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278835|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
44278836|NCT00722098|Vaccines|vaccines|mesh-list
44278837|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
44278838|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278839|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278840|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278841|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44278842|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
44278843|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278844|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278845|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44278846|NCT00722150|Artesunate|artesunate|mesh-list
44278847|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
44278848|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44278849|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44278850|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44278851|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278852|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
44278853|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
44278862|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44278863|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44278864|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278865|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44278866|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44278867|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
44278869|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
44278870|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44278871|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44278872|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278873|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44278874|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278875|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
44278876|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
44278877|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44278878|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44278879|NCT00722293|Doxorubicin|doxorubicin|mesh-list
44278880|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44278881|NCT00722293|Epirubicin|epirubicin|mesh-list
44278882|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44278883|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184964|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
44184965|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184966|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184967|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184968|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184969|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184970|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184971|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184972|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44184973|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
43713222|NCT02678234|Micronutrients|micronutrients|mesh-ancestor
43713223|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713224|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713255|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43713256|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43713257|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713258|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43713259|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
43713260|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43713261|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
43713262|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713263|NCT02678182|Capecitabine|capecitabine|mesh-list
43713264|NCT02678182|Trastuzumab|trastuzumab|mesh-list
43713265|NCT02678182|Durvalumab|durvalumab|mesh-list
43713266|NCT02678182|Ramucirumab|ramucirumab|mesh-list
43713267|NCT02678182|Rucaparib|rucaparib|mesh-list
43713268|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43713269|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
43713296|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43713297|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43713298|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
43713299|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713300|NCT02677571|Morphine|morphine|mesh-list
43648421|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43648422|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184974|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
44184975|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
44184976|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184977|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184978|NCT00331825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44184979|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184980|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184981|NCT00331838|Enoxaparin|enoxaparin|mesh-list
44184982|NCT00331838|Semuloparin|semuloparin|mesh-list
44184983|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44184984|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
44184985|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
44184986|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44184987|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44184988|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184989|NCT00331851|Metformin|metformin|mesh-list
44184990|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
44184991|NCT00331851|Liraglutide|liraglutide|mesh-list
44184992|NCT00331851|Glimepiride|glimepiride|mesh-list
44185025|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185026|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44278884|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44278885|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44278886|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278887|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278888|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
44278889|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44278890|NCT00722475|Antibodies|antibodies|mesh-list
44278891|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
44278892|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44278893|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
44278894|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278895|NCT00722488|Pevonedistat|pevonedistat|mesh-list
44278896|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278897|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278899|NCT00722579|Chromium|chromium|mesh-list
44278900|NCT00722579|Trace Elements|trace elements|mesh-ancestor
44278901|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
44278902|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278903|NCT00722631|Pioglitazone|pioglitazone|mesh-list
44278904|NCT00722631|Glimepiride|glimepiride|mesh-list
44278905|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44278906|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278907|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44278908|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44278909|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
44278910|NCT00722709|Ropivacaine|ropivacaine|mesh-list
44278911|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
44278912|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
44278913|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278914|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278915|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
44278917|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
44278927|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44278928|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44278929|NCT00722735|Renal Agents|renal agents|mesh-ancestor
44278930|NCT00722839|Vaccines|vaccines|mesh-list
44278931|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
44278932|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278933|NCT00722852|Ketoprofen|ketoprofen|mesh-list
44278934|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44278935|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44278936|NCT00722852|Analgesics|analgesics|mesh-ancestor
44278937|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
44278938|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44278939|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278940|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44278941|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44278942|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44278943|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278944|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278945|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44278946|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
44278947|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278948|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44278949|NCT00722956|Atorvastatin|atorvastatin|mesh-list
44278950|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44278951|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44278952|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
44278953|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278954|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44278955|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44278956|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278966|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44278967|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278968|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44278969|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
44278970|NCT00723047|Coagulants|coagulants|mesh-ancestor
44278971|NCT00723060|Citalopram|citalopram|mesh-list
44278972|NCT00723060|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44278973|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44278974|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44278975|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278976|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44278977|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
44278978|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278979|NCT00723060|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44278980|NCT00723060|Antidepressive Agents|antidepressive agents|mesh-ancestor
44278981|NCT00723060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44278982|NCT00723086|Docetaxel|docetaxel|mesh-list
44278983|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44278984|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44278985|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44278986|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44278987|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44278988|NCT00723164|Fentanyl|fentanyl|mesh-list
44278989|NCT00723164|Midazolam|midazolam|mesh-list
44278990|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44278991|NCT00723164|Narcotics|narcotics|mesh-ancestor
44278992|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44278993|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44278994|NCT00723164|Analgesics|analgesics|mesh-ancestor
44279013|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279015|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
44279016|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279017|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
43713507|NCT02675868|Coagulants|coagulants|mesh-ancestor
44279018|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279019|NCT00723268|Prednisolone|prednisolone|mesh-list
44279020|NCT00723268|Colchicine|colchicine|mesh-list
44279021|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279022|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
44279023|NCT00723268|Hormones|hormones|mesh-ancestor
44279024|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279025|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279026|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279027|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279028|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
44279029|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279030|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44279031|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665154|NCT02496585|Hormones|hormones|mesh-ancestor
44185027|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
44185028|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185029|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185030|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44185031|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44185032|NCT00331994|Metronidazole|metronidazole|mesh-list
44185033|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185139|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44185140|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185141|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44185142|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44185143|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44185155|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44185156|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44185157|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44185158|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44185159|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44185160|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44185161|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44185162|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
44185164|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
44185165|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
44185166|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185167|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185168|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185169|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44185170|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185171|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185172|NCT00332345|Timolol|timolol|mesh-list
44185173|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44279032|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44279033|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279034|NCT00723307|Metformin|metformin|mesh-list
44279035|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279036|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279037|NCT00723320|Atorvastatin|atorvastatin|mesh-list
44279038|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44279039|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279040|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
44279041|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279042|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44279043|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44279044|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279045|NCT00723346|Asparaginase|asparaginase|mesh-list
44185174|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185175|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185176|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185177|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121424|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713595|NCT02675387|Lidocaine|lidocaine|mesh-list
44185178|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185179|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185180|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185181|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185182|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44185183|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44185184|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185185|NCT00332384|Timolol|timolol|mesh-list
44185186|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44185187|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185188|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185189|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185190|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185191|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185192|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185193|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185194|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185195|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44185196|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44185197|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185198|NCT00332397|Sirolimus|sirolimus|mesh-list
44185199|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44185200|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185201|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44185202|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185203|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
44185204|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185205|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
44185241|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44185270|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185271|NCT00332631|Antidotes|antidotes|mesh-ancestor
44185272|NCT00332735|Bupivacaine|bupivacaine|mesh-list
44185273|NCT00332735|Carticaine|carticaine|mesh-list
44185274|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
44185275|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
44185276|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185277|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185278|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
44185279|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185280|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44279046|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279048|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
44279049|NCT00723385|Vitamins|vitamins|mesh-ancestor
44279050|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
44279051|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279052|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44279053|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44279054|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
44279055|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44279056|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
44279057|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279058|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44279059|NCT00723424|Digoxin|digoxin|mesh-list
44279060|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44279061|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44279062|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713776|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713777|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43713778|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713779|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279063|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279064|NCT00723424|Protective Agents|protective agents|mesh-ancestor
44279065|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279066|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44279067|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44185281|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44185282|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44185283|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
44185284|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185285|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44185286|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185287|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44185303|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185304|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185305|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185306|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44185307|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185308|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185309|NCT00332787|Fluoxetine|fluoxetine|mesh-list
44185310|NCT00332787|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44185311|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44185312|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44185313|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185314|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185315|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
44185316|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185317|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44185318|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44185319|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185320|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44185321|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44185322|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279068|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279069|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
44279070|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279071|NCT00723437|Acitretin|acitretin|mesh-list
44279072|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
44279073|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279074|NCT00723502|Amoxicillin|amoxicillin|mesh-list
44279075|NCT00723502|Finafloxacin|finafloxacin|mesh-list
44279076|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
44279077|NCT00723502|Esomeprazole|esomeprazole|mesh-list
44279078|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44279079|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279080|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44279081|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279082|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44279083|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279084|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279085|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44279086|NCT00723502|Renal Agents|renal agents|mesh-ancestor
44279087|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44279088|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44279089|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279090|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43713833|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
44279091|NCT00723515|Listerine|listerine|mesh-list
44279092|NCT00723515|Calcium|calcium|mesh-list
44279093|NCT00723515|Fluorides|fluorides|mesh-list
44279094|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
44279095|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44279096|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279097|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
44279098|NCT00723515|Protective Agents|protective agents|mesh-ancestor
44279099|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44279100|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279101|NCT00723658|Cytarabine|cytarabine|mesh-list
44279102|NCT00723658|Thalidomide|thalidomide|mesh-list
44279103|NCT00723658|Dexamethasone|dexamethasone|mesh-list
44279104|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
44279112|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279113|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
44279114|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279115|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279116|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44279117|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
43933504|NCT00778869|Infliximab|infliximab|mesh-list
44279118|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279119|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279120|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44279121|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279122|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279124|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
44279125|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279126|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279127|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
44279128|NCT00723658|Hormones|hormones|mesh-ancestor
44279129|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279130|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279131|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44279132|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44279133|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44279134|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279135|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44279136|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44279137|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
44279138|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
44185323|NCT00332826|Insulin|insulin|mesh-list
44185324|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185325|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185327|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185328|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44185329|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44185330|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185331|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185332|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44185333|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185334|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185335|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185336|NCT00332891|Amibegron|amibegron|mesh-list
44185337|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44185338|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185339|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185340|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185341|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279140|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
44279141|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44279142|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44279143|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44279144|NCT00723658|Growth Substances|growth substances|mesh-ancestor
44279145|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279146|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43832008|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43832009|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832010|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279147|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44279148|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44279149|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279150|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279151|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44279152|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279153|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279154|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
44279155|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279156|NCT00723879|Ribavirin|ribavirin|mesh-list
44279157|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44279158|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
44279159|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279160|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
44279161|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279162|NCT00723918|Methadone|methadone|mesh-list
44279163|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44279164|NCT00723918|Narcotics|narcotics|mesh-ancestor
44279165|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279166|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279167|NCT00723918|Analgesics|analgesics|mesh-ancestor
44279168|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
44279169|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185342|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185343|NCT00332904|Propranolol|propranolol|mesh-list
44185344|NCT00332904|Spironolactone|spironolactone|mesh-list
44185379|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
44185380|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185381|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185382|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44185383|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
44185384|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185385|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185386|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44279171|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
44279172|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44279173|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
44279174|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44279175|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44279176|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44279177|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279178|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279179|NCT00723983|Sumatriptan|sumatriptan|mesh-list
44279180|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44279181|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44279182|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44279183|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
44279184|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279185|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279186|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279187|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
44279188|NCT00724022|Prednisolone|prednisolone|mesh-list
44185398|NCT00333021|Fondaparinux|fondaparinux|mesh-list
44121633|NCT00124696|Cocaethylene|cocaethylene|mesh-list
44185399|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44185400|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
44185401|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44185402|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
44185403|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185404|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713906|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713907|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43713908|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
43713909|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713910|NCT02672566|Enoxaparin|enoxaparin|mesh-list
43713911|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
43713912|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713913|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44185405|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
44185406|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44185407|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44185408|NCT00333034|Etanercept|etanercept|mesh-list
44185409|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185410|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185411|NCT00333034|Analgesics|analgesics|mesh-ancestor
44185412|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
44185413|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185414|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185415|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185416|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185417|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185418|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185419|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
44185420|NCT00333047|Letrozole|letrozole|mesh-list
44185421|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185422|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44185423|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44185424|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185425|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185426|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44185427|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185428|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185429|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185430|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44185431|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44185432|NCT00333086|Letrozole|letrozole|mesh-list
44279190|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
44279191|NCT00724022|Basiliximab|basiliximab|mesh-list
44279192|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279193|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
44279194|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279195|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44279196|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279197|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279198|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279199|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
44279200|NCT00724022|Hormones|hormones|mesh-ancestor
44279201|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279202|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279203|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279204|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44185433|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185434|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44185435|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44185436|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185437|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185438|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44185439|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185440|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185441|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185442|NCT00333112|Tamsulosin|tamsulosin|mesh-list
44185443|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
44185444|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44185445|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44185446|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185447|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185448|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185477|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185479|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44185481|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185482|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185483|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44185484|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
44185485|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44185486|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44185487|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185488|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44185489|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
44185490|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44185491|NCT00333164|Protective Agents|protective agents|mesh-ancestor
44185492|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44185493|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44185494|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185530|NCT00333307|Methocarbamol|methocarbamol|mesh-list
44185531|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44185532|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185541|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
44185542|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185543|NCT00333372|Z 338|z 338|mesh-list
44185544|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44279205|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44279206|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
44279207|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44279208|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279209|NCT00724035|Fentanyl|fentanyl|mesh-list
44279210|NCT00724035|Midazolam|midazolam|mesh-list
44279211|NCT00724035|Analgesics|analgesics|mesh-list
44279212|NCT00724035|Anesthetics|anesthetics|mesh-list
44279213|NCT00724035|Ropivacaine|ropivacaine|mesh-list
44279214|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
44279215|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279216|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279217|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
44279218|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279219|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44279220|NCT00724035|Narcotics|narcotics|mesh-ancestor
44279221|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44279222|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44279223|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
44279224|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44279225|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44279226|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44279227|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44279228|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
44279229|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
44279230|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279231|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185545|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185546|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185547|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
44185548|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185549|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185550|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185551|NCT00333385|Ceftazidime|ceftazidime|mesh-list
44185552|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44185553|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185554|NCT00333398|Vaccines|vaccines|mesh-list
44185555|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
44185556|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185557|NCT00333424|Vaccines|vaccines|mesh-list
44185558|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
44185559|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185560|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44185561|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
44185562|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185563|NCT00333476|Squalamine|squalamine|mesh-list
44185564|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44185565|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185566|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44185567|NCT00333476|Protective Agents|protective agents|mesh-ancestor
44279232|NCT00724074|Bupivacaine|bupivacaine|mesh-list
44279233|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
44279234|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
44279235|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279236|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279237|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
44279238|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463476|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44463477|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
44463478|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463479|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463480|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44463481|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44463482|NCT01513317|Siltuximab|siltuximab|mesh-list
44463483|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463484|NCT01512979|Metformin|metformin|mesh-list
44463485|NCT01512979|Linagliptin|linagliptin|mesh-list
44463486|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463487|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463488|NCT01512979|Incretins|incretins|mesh-ancestor
44463489|NCT01512979|Hormones|hormones|mesh-ancestor
44185568|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185569|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185570|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44185571|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44185572|NCT00333476|Growth Substances|growth substances|mesh-ancestor
44185573|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
44185574|NCT00333489|Valsartan|valsartan|mesh-list
44185610|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185611|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185612|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185647|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44185648|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44185649|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44185650|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185651|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44185652|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44185653|NCT00333944|Pralidoxime|pralidoxime|mesh-list
44185654|NCT00333944|Antidotes|antidotes|mesh-ancestor
44185655|NCT00333944|Protective Agents|protective agents|mesh-ancestor
44185686|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185687|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185688|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185689|NCT00334048|Ropinirole|ropinirole|mesh-list
44185690|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44185691|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44185692|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
44185693|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
44185694|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185695|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185696|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185697|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44185723|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185724|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463490|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463491|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44463492|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463493|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463494|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463495|NCT01512745|Apatinib|apatinib|mesh-list
44463496|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463497|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463498|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463499|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463500|NCT01512160|Ibuprofen|ibuprofen|mesh-list
44463501|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463502|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463503|NCT01512160|Analgesics|analgesics|mesh-ancestor
44463504|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
44463505|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463506|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463507|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463508|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933642|NCT00782756|Temozolomide|temozolomide|mesh-list
44279239|NCT00724113|Lidocaine|lidocaine|mesh-list
44279240|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
44279241|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
44279242|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279243|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279244|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
44279245|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279246|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44279247|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44279248|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44279249|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665332|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
44185726|NCT00334256|Emtricitabine|emtricitabine|mesh-list
44185727|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
44185728|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185729|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44185730|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44185731|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185732|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279250|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279252|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
44279253|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
44279254|NCT00724178|Calcium|calcium|mesh-list
44279255|NCT00724178|Vitamins|vitamins|mesh-ancestor
44279256|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
44279257|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279258|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44279259|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44279260|NCT00724178|Antacids|antacids|mesh-ancestor
44279261|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279262|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279263|NCT00724230|Ribavirin|ribavirin|mesh-list
44279264|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44279265|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
44279266|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
44279267|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279268|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
44279269|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279270|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
44279271|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279272|NCT00724256|Ceftibuten|ceftibuten|mesh-list
44279273|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44279274|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279275|NCT00724295|Ribavirin|ribavirin|mesh-list
44279276|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44279277|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
44279278|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279279|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
44279280|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279281|NCT00724321|Iloprost|iloprost|mesh-list
44279282|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44279283|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
44279284|NCT00724360|Trastuzumab|trastuzumab|mesh-list
44279285|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279291|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
44279292|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
44279293|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
44279294|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279295|NCT00724529|Infliximab|infliximab|mesh-list
44279296|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279297|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279298|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279299|NCT00724542|Voglibose|voglibose|mesh-list
44279300|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279301|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279302|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44279303|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279304|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279305|NCT00724581|Amiodarone|amiodarone|mesh-list
44279306|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44279307|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
44279308|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44279309|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279310|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279311|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44279312|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44279313|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44279314|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279315|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44279316|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44279317|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44279318|NCT00724620|Ribavirin|ribavirin|mesh-list
44185733|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44185734|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44185735|NCT00334308|Caseins|caseins|mesh-list
44185736|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
44185737|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
44185738|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185739|NCT00334321|Paclitaxel|paclitaxel|mesh-list
44185740|NCT00334321|Carboplatin|carboplatin|mesh-list
44185741|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44185742|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185743|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
44185744|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
44185745|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
44185777|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
44185778|NCT00334386|Torsemide|torsemide|mesh-list
44185779|NCT00334386|Diuretics|diuretics|mesh-list
44185780|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44279319|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44279320|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
44279321|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279322|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
44279323|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279324|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
44279325|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44279326|NCT00724672|Adalimumab|adalimumab|mesh-list
44279327|NCT00724672|Etanercept|etanercept|mesh-list
44279328|NCT00724672|Infliximab|infliximab|mesh-list
44279329|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279330|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279331|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279332|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279333|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44279334|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44279335|NCT00724672|Analgesics|analgesics|mesh-ancestor
44279336|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
44279337|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279338|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279339|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279340|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
44279341|NCT00724685|Ropivacaine|ropivacaine|mesh-list
44279342|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
44279343|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
44279344|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665403|NCT05470595|Atezolizumab|atezolizumab|mesh-list
44185781|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
44185782|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185783|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44185784|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185785|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185786|NCT00334399|Miglitol|miglitol|mesh-list
44185787|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185825|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44185887|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185888|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185889|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44185890|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
44185891|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185892|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185893|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44185894|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185895|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
44185896|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
44185897|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185898|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185899|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
44185900|NCT00334672|Hormones|hormones|mesh-ancestor
43841889|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
44279345|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279346|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
44279347|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279348|NCT00724724|Aspirin|aspirin|mesh-list
44279349|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44279350|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44279351|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44279352|NCT00724724|Analgesics|analgesics|mesh-ancestor
44279353|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
44279354|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279355|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279356|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279357|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279358|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44279359|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43714225|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714300|NCT02669706|Pentamidine|pentamidine|mesh-list
44279360|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279361|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44279362|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44279363|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279364|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
44279365|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44279366|NCT00724724|Protective Agents|protective agents|mesh-ancestor
44279367|NCT00724802|Triacetin|triacetin|mesh-list
44279368|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
44279369|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279370|NCT00724880|Clopidogrel|clopidogrel|mesh-list
44279371|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44279379|NCT00725036|Insulin|insulin|mesh-list
44279392|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
44279393|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279394|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44279395|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279396|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279397|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
44279398|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44279399|NCT00725218|Analgesics|analgesics|mesh-ancestor
44279400|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
44279401|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279402|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279403|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44279404|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44279405|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279406|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279407|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44279408|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279409|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279410|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
44279411|NCT00725231|Doxorubicin|doxorubicin|mesh-list
44279412|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44279413|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279414|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279415|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43665470|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185901|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185902|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44185903|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44185904|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
44185905|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44185906|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44185907|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
44185908|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
43714348|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43714349|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714350|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44185909|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185910|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44185926|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185927|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185928|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
44185929|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44185930|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44185931|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185932|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44185933|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44185934|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185935|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185936|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44279417|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44279418|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279419|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279420|NCT00725348|R 115866|r 115866|mesh-list
44279421|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44279422|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279423|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279424|NCT00725400|Cetuximab|cetuximab|mesh-list
44279425|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279426|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279427|NCT00725439|R 115866|r 115866|mesh-list
44279428|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44279429|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279430|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279431|NCT00725478|Piribedil|piribedil|mesh-list
44185937|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44185938|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44185939|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44185940|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185941|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185942|NCT00334698|Cetirizine|cetirizine|mesh-list
44185943|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
44185944|NCT00334698|Ephedrine|ephedrine|mesh-list
44185945|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44185946|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44185947|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44185948|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
44185949|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
44185950|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185951|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185952|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185953|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44185954|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
44185955|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185956|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44185957|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
44185958|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
44185959|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44185960|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44185961|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
44185962|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185963|NCT00334763|Paclitaxel|paclitaxel|mesh-list
44185964|NCT00334763|Bevacizumab|bevacizumab|mesh-list
44185965|NCT00334763|Carboplatin|carboplatin|mesh-list
44185966|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44185967|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185968|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44185969|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44185990|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185991|NCT00334854|Doxorubicin|doxorubicin|mesh-list
44185992|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44185993|NCT00334854|Ifosfamide|ifosfamide|mesh-list
44185994|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44185995|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185996|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44185997|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44185998|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279432|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44279433|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44279434|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
44279435|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
44279436|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279437|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279438|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279439|NCT00725517|Icodextrin|icodextrin|mesh-list
44279440|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
44279441|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44279442|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44279443|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44279444|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279445|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44279446|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185999|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186000|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186001|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
44186002|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
44186003|NCT00334867|Ifosfamide|ifosfamide|mesh-list
44186004|NCT00334867|Doxorubicin|doxorubicin|mesh-list
44186005|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44186006|NCT00334867|Etoposide|etoposide|mesh-list
44186007|NCT00334867|Vincristine|vincristine|mesh-list
44186008|NCT00334867|Topotecan|topotecan|mesh-list
44186009|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
44186010|NCT00334867|Razoxane|razoxane|mesh-list
44186011|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186012|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
44186013|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186014|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186015|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186016|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
44186017|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186018|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186019|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44186020|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44186021|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44186022|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186023|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186024|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44186025|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44186046|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186047|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44186048|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44186049|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44186050|NCT00334932|Doxorubicin|doxorubicin|mesh-list
44186051|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44186053|NCT00334932|Melphalan|melphalan|mesh-list
44186054|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44186055|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186056|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44186057|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186058|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186059|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186060|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186061|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
44186062|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44186063|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186064|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
44279447|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279449|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279450|NCT00725777|Lumefantrine|lumefantrine|mesh-list
44279451|NCT00725777|Artemether|artemether|mesh-list
44279452|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44279453|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
44279454|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44279455|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44279456|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279457|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44279458|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44279459|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44279460|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44279461|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279462|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279463|NCT00725790|Urological Agents|urological agents|mesh-ancestor
44279464|NCT00725829|Simvastatin|simvastatin|mesh-list
44279465|NCT00725829|Ezetimibe|ezetimibe|mesh-list
44279466|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44279467|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279468|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
44279469|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279470|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44279471|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43665517|NCT05469204|Analgesics|analgesics|mesh-ancestor
44186065|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186066|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
44186067|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
44454544|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454545|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44454546|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454547|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454548|NCT01662986|Bromides|bromides|mesh-list
44454549|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
44454550|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44454551|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
44454552|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454553|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832074|NCT05281471|Doxorubicin|doxorubicin|mesh-list
43832075|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43832077|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832078|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832079|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832080|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44454577|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454578|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454579|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44454580|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44454581|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
44454582|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
44454583|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44454584|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44279472|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279473|NCT00725946|Iodine|iodine|mesh-list
44279474|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
44279475|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44279476|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279477|NCT00725946|Trace Elements|trace elements|mesh-ancestor
44279478|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
44279479|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279480|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
44279481|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
44279482|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
44279483|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279484|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279485|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
44279486|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279487|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44279488|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279489|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463509|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463510|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463511|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463512|NCT01512108|Liraglutide|liraglutide|mesh-list
44463513|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44463514|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463515|NCT01512108|Incretins|incretins|mesh-ancestor
44463516|NCT01512108|Hormones|hormones|mesh-ancestor
44463517|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463518|NCT01511939|Diclofenac|diclofenac|mesh-list
44454585|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44454586|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454587|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454588|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454589|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454590|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454591|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44454592|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186068|NCT00335075|Temozolomide|temozolomide|mesh-list
44186069|NCT00335075|Semustine|semustine|mesh-list
44186070|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186071|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
44186072|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186073|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186074|NCT00335088|Iodine|iodine|mesh-list
44186075|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
44186076|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
44186077|NCT00335088|Povidone|povidone|mesh-list
44463519|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44463521|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463522|NCT01511939|Analgesics|analgesics|mesh-ancestor
44463523|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
44463524|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463525|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463526|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714602|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
43714604|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463527|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463528|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463529|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463530|NCT01511536|Prednisone|prednisone|mesh-list
44463531|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
44463532|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463533|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
44463534|NCT01511536|Hormones|hormones|mesh-ancestor
44463535|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463536|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463537|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44463538|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463539|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44463540|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463541|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463542|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
44463543|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463544|NCT01511445|Silicon|silicon|mesh-list
44463545|NCT01511445|Trace Elements|trace elements|mesh-ancestor
44279497|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
44279498|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
44279499|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279500|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44279501|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44279502|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279503|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279504|NCT00726466|Ranibizumab|ranibizumab|mesh-list
44279505|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44279506|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44279507|NCT00726466|Growth Substances|growth substances|mesh-ancestor
44279508|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279509|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279510|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279511|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
44279512|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44279513|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279514|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665606|NCT05468294|Nivolumab|nivolumab|mesh-list
44186078|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186079|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186117|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186128|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186129|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43714695|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714696|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
43714697|NCT02666209|Hormones|hormones|mesh-ancestor
43714698|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714699|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714700|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714701|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
43714702|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43714703|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44186130|NCT00335205|Ropinirole|ropinirole|mesh-list
44186131|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44186132|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44186133|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
44186134|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
44186135|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186136|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186137|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186138|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
44186139|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122438|NCT00127504|Azithromycin|azithromycin|mesh-list
44186140|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186141|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44186142|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44186143|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44454593|NCT01662336|Ritonavir|ritonavir|mesh-list
44186144|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186145|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186146|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186147|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186148|NCT00335270|Ritonavir|ritonavir|mesh-list
44186149|NCT00335270|Amprenavir|amprenavir|mesh-list
44186150|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
44186151|NCT00335270|Lamivudine|lamivudine|mesh-list
44186152|NCT00335270|Abacavir|abacavir|mesh-list
44186153|NCT00335270|Calcium|calcium|mesh-list
44186154|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44186155|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186156|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44186157|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44186158|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
44186159|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279516|NCT00726570|Heparin|heparin|mesh-list
44279517|NCT00726570|Calcium heparin|calcium heparin|mesh-list
44279518|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44279519|NCT00726570|Tinzaparin|tinzaparin|mesh-list
44279520|NCT00726570|Dalteparin|dalteparin|mesh-list
44279521|NCT00726570|Anticoagulants|anticoagulants|mesh-list
44279522|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44279523|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44279524|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279525|NCT00726687|Capecitabine|capecitabine|mesh-list
44279526|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44279527|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
44279528|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665613|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44186160|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186161|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186162|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44186163|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
44186164|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186165|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44186166|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44186167|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186168|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43714704|NCT02666209|Growth Substances|growth substances|mesh-ancestor
43714705|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
43714706|NCT02666365|Cefazolin|cefazolin|mesh-list
43714707|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43714708|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714709|NCT02666443|Dexamethasone|dexamethasone|mesh-list
43714710|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
43714711|NCT02666443|BB 1101|bb 1101|mesh-list
43714712|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714713|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
44186169|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44186170|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
44186171|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186172|NCT00335309|Amoxicillin|amoxicillin|mesh-list
44186173|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
44186174|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
44186175|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186176|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186177|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44186178|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186179|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186180|NCT00335348|Dexamethasone|dexamethasone|mesh-list
44186181|NCT00335348|Bortezomib|bortezomib|mesh-list
44186193|NCT00335400|Anesthetics|anesthetics|mesh-list
44186194|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186195|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186196|NCT00335413|Spironolactone|spironolactone|mesh-list
44186197|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44186198|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
44186199|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186200|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186201|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44186202|NCT00335413|Diuretics|diuretics|mesh-ancestor
44186203|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
44186204|NCT00335439|Ketorolac|ketorolac|mesh-list
44186205|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44186206|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44186207|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44186208|NCT00335439|Analgesics|analgesics|mesh-ancestor
44186209|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
44186210|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186211|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186212|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186213|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186214|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44279529|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279531|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
44279532|NCT00726700|Rituximab|rituximab|mesh-list
44279533|NCT00726700|Doxorubicin|doxorubicin|mesh-list
44279534|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44279535|NCT00726700|Vincristine|vincristine|mesh-list
44279536|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279537|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
44279538|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279539|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279540|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44279541|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
43714714|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
43714715|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279542|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279543|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279544|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44279545|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279546|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44279547|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44279548|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44279549|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279550|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279551|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
44279552|NCT00726700|Hormones|hormones|mesh-ancestor
44279553|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279554|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279555|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44279556|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44279557|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44279558|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44279559|NCT00726726|Vitamin K|vitamin k|mesh-list
44279560|NCT00726726|Midazolam|midazolam|mesh-list
44279561|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
44279562|NCT00726726|Caffeine|caffeine|mesh-list
44279563|NCT00726726|Omeprazole|omeprazole|mesh-list
44279564|NCT00726726|Warfarin|warfarin|mesh-list
44279565|NCT00726726|Vitamins|vitamins|mesh-ancestor
44279566|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
43665627|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
44279567|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279568|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44279569|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44279570|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279571|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44279572|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44279573|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44279574|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44279575|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
44279576|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
44279577|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
44279578|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
44279579|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279580|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279581|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
44279582|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44279583|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279584|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44279585|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279586|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44279587|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44279588|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44279589|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44279590|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
44279591|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44279592|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44279593|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
44279594|NCT00726726|Coagulants|coagulants|mesh-ancestor
44279595|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
44279596|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
44279597|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44279598|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44279599|NCT05373680|Metformin|metformin|mesh-list
44279609|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279610|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
44279611|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279612|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44279613|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44279614|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279615|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44279616|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44279617|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44279618|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44279619|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
44279620|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279621|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279622|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44279623|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44279624|NCT05373264|Diuretics|diuretics|mesh-ancestor
44279625|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
44279626|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279627|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44279628|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279629|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279630|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
44279631|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44279632|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279633|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279653|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279654|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44279655|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
44279656|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44279657|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
44279658|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279659|NCT05366621|Denosumab|denosumab|mesh-list
44279660|NCT05366621|Diphosphonates|diphosphonates|mesh-list
44279661|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279662|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44279663|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
44279664|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
44279665|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279666|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
44279667|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279668|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279669|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44279670|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
44279671|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279672|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279673|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44279674|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279675|NCT05292001|Dextrans|dextrans|mesh-list
43665659|NCT05466305|Cobalt|cobalt|mesh-list
44186215|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186216|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186217|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
44122492|NCT00127777|Amantadine|amantadine|mesh-list
44186218|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44186219|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186220|NCT00335543|Gemcitabine|gemcitabine|mesh-list
44186221|NCT00335543|Cisplatin|cisplatin|mesh-list
44186222|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186223|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186224|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
44186225|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186226|NCT00335543|Antiviral Agents|antiviral agents|mesh-ancestor
44186227|NCT00335543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186228|NCT00335543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186229|NCT00335543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186230|NCT00335543|Immunologic Factors|immunologic factors|mesh-ancestor
44186231|NCT00335543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186232|NCT00335582|Clonidine|clonidine|mesh-list
44186233|NCT00335582|Analgesics|analgesics|mesh-ancestor
44186234|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
44186235|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186236|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186237|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44186238|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
44186239|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
44186240|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44186241|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44279676|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
44279677|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
44279678|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
44279679|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
44279680|NCT05292001|Hematinics|hematinics|mesh-ancestor
44279681|NCT05206877|Insulin|insulin|mesh-list
44279682|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44279683|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44279684|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463557|NCT01510912|Diclofenac|diclofenac|mesh-list
44463558|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44186242|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44186243|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
44186275|NCT00335686|Lopinavir|lopinavir|mesh-list
44186276|NCT00335686|Nevirapine|nevirapine|mesh-list
44186277|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44186278|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44186279|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
44186280|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186281|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186282|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186283|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44186284|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
44186310|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186312|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186313|NCT00335933|Gabapentin|gabapentin|mesh-list
44186314|NCT00335933|Analgesics|analgesics|mesh-ancestor
44186315|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
44186316|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186317|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186318|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
44186319|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44186320|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44186321|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186322|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186323|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44186324|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44186325|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186326|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186327|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
44186328|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
44186329|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44186330|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
44186346|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186348|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44186349|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
44186350|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186351|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44186352|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
44186353|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186354|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186355|NCT00336219|Pantoprazole|pantoprazole|mesh-list
44186356|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44186357|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44186358|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44186359|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186360|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186361|NCT00336245|Copper|copper|mesh-list
44186362|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
44186363|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44186364|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186365|NCT00336245|Trace Elements|trace elements|mesh-ancestor
44122647|NCT00127998|Renal Agents|renal agents|mesh-ancestor
44186366|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
44186367|NCT00336310|Repaglinide|repaglinide|mesh-list
44186368|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463560|NCT01510912|Analgesics|analgesics|mesh-ancestor
44463561|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
44463562|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463563|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463564|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463565|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463566|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463567|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463568|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463569|NCT01510769|Febuxostat|febuxostat|mesh-list
44463570|NCT01510769|Lesinurad|lesinurad|mesh-list
44463571|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
44463572|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463573|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
44463574|NCT01510769|Renal Agents|renal agents|mesh-ancestor
44463575|NCT01510756|Sorafenib|sorafenib|mesh-list
44463576|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463577|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463578|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463579|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463580|NCT01510158|Allopurinol|allopurinol|mesh-list
44186369|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186370|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44186371|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44186372|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44186373|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
44186374|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186375|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44186376|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44186377|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186378|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
44186379|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44186380|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44186381|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44186382|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44186383|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186384|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
44186385|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186386|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186387|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44186422|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186423|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44186424|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186425|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
44186426|NCT00336414|Hormones|hormones|mesh-ancestor
44186427|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186428|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44186458|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186459|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44186460|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44463581|NCT01510158|Lesinurad|lesinurad|mesh-list
44463582|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
44463583|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463584|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463585|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
44463586|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715177|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
44463587|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43934135|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44279685|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
44279686|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44279687|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279688|NCT05145296|Daratumumab|daratumumab|mesh-list
44279689|NCT05145296|Abatacept|abatacept|mesh-list
44279690|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279691|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44279692|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279693|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665716|NCT05525078|Nicotine|nicotine|mesh-list
44186461|NCT00336648|Growth Substances|growth substances|mesh-ancestor
44186462|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186463|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
44186464|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186465|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
44186466|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186467|NCT00336648|Antiviral Agents|antiviral agents|mesh-ancestor
44186468|NCT00336648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186469|NCT00336648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186470|NCT00336648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186471|NCT00336648|Immunologic Factors|immunologic factors|mesh-ancestor
44186472|NCT00336674|Insulin|insulin|mesh-list
44186473|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44186492|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44186493|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186495|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44186496|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44186497|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186498|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186499|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
44186500|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186501|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186502|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186503|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
44186504|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44186505|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44186506|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44186507|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186508|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186509|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
44186510|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454594|NCT01662336|Lopinavir|lopinavir|mesh-list
44454595|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44454596|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44454597|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454598|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186511|NCT00336882|Midazolam|midazolam|mesh-list
44186512|NCT00336882|Propofol|propofol|mesh-list
44186513|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44186514|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279694|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
43715660|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44279695|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279696|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279697|NCT05124275|Pilocarpine|pilocarpine|mesh-list
44279698|NCT05124275|Miotics|miotics|mesh-ancestor
44279699|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
44279700|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279701|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279702|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44279703|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44279704|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
44279705|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279706|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279707|NCT05092828|Morphine|morphine|mesh-list
44279708|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44279709|NCT05092828|Narcotics|narcotics|mesh-ancestor
44279710|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279711|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279712|NCT05092828|Analgesics|analgesics|mesh-ancestor
44279713|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
44279714|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279715|NCT05036408|Coal Tar|coal tar|mesh-list
44279716|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
44279717|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279718|NCT04984811|Atezolizumab|atezolizumab|mesh-list
44279719|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279720|NCT04961528|Terlipressin|terlipressin|mesh-list
44279721|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
44279722|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44279723|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44279724|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279725|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
44279726|NCT04961528|Coagulants|coagulants|mesh-ancestor
44279729|NCT04956627|Itraconazole|itraconazole|mesh-list
44279737|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279738|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44279739|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
44279740|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279741|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279742|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44279743|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
44279744|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44279745|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44279746|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44279747|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44279748|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44279749|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279750|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
44279751|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44279752|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44186515|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186516|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44186517|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
44186518|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
44186519|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44186520|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44186521|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44186522|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186523|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
44186524|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
44186525|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186526|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186552|NCT00336960|Analgesics|analgesics|mesh-ancestor
43715744|NCT02658773|Prilocaine|prilocaine|mesh-list
43715869|NCT02658396|Bortezomib|bortezomib|mesh-list
44186553|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
44186554|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186555|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186556|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186557|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44186558|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44186559|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186561|NCT00337051|Sevoflurane|sevoflurane|mesh-list
44186562|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44186563|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186564|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186565|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44186566|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
44186567|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
44186568|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44186569|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44186570|NCT00337090|Mirabegron|mirabegron|mesh-list
44186571|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44186572|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44186573|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44186574|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
44186611|NCT00337259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186643|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
44186644|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186645|NCT00337389|Leucovorin|leucovorin|mesh-list
44279753|NCT04921371|Listerine|listerine|mesh-list
44279754|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44279755|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279756|NCT04800224|Propolis|propolis|mesh-list
44279757|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279758|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
44279759|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279760|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
44279761|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279762|NCT04620304|UB-421|ub-421|mesh-list
44279763|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279764|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
44279765|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279766|NCT04620291|UB-421|ub-421|mesh-list
44279767|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279768|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
44279769|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279770|NCT04577404|Edaravone|edaravone|mesh-list
44279771|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44279772|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
44279773|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279774|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44279775|NCT04577404|Protective Agents|protective agents|mesh-ancestor
44279776|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279777|NCT04541407|Temozolomide|temozolomide|mesh-list
44279778|NCT04541407|Osimertinib|osimertinib|mesh-list
44279779|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44279780|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
44279781|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279782|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279783|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44279784|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279785|NCT04480463|Aflibercept|aflibercept|mesh-list
44279786|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826438|NCT05497804|Dexamethasone|dexamethasone|mesh-list
44186646|NCT00337389|Bevacizumab|bevacizumab|mesh-list
44186647|NCT00337389|Fluorouracil|fluorouracil|mesh-list
44186648|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186649|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186650|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44186651|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44186652|NCT00337389|Growth Substances|growth substances|mesh-ancestor
44186653|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186654|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279788|NCT04480463|Growth Substances|growth substances|mesh-ancestor
44279789|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279790|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279791|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279792|NCT04426240|Cyclosporine|cyclosporine|mesh-list
44279793|NCT04426240|Cyclosporins|cyclosporins|mesh-list
44279794|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279795|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279796|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279797|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
44279798|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279799|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
44279800|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279801|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279802|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186726|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186727|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186728|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44186729|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44186730|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44186731|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186733|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44186734|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44186757|NCT00337792|Midazolam|midazolam|mesh-list
44186758|NCT00337792|Oxycodone|oxycodone|mesh-list
44186759|NCT00337792|Lorazepam|lorazepam|mesh-list
44186760|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44186761|NCT00337792|Narcotics|narcotics|mesh-ancestor
44186762|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186763|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186764|NCT00337792|Analgesics|analgesics|mesh-ancestor
44186765|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
44186766|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186767|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44186768|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44186769|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
44186770|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
44186771|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44186772|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44186773|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44186774|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186775|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
44186776|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
44186777|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186778|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186779|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
44186780|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
44186781|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
44186782|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44186783|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44186784|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
44186785|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
44186786|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44186787|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186788|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43715934|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44186789|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186822|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44186823|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44279804|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44279806|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
44279807|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279808|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
44279809|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44279810|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44279811|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279812|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
44279813|NCT04390217|Coagulants|coagulants|mesh-ancestor
44279814|NCT04318210|Tenofovir|tenofovir|mesh-list
44279815|NCT04318210|Emtricitabine|emtricitabine|mesh-list
44279816|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
44279817|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279818|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44279819|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44279820|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279821|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279822|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44279823|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279824|NCT04286867|Ethanol|ethanol|mesh-list
44279825|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44279826|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279827|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44279828|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279829|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
44279830|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
44279831|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279832|NCT04254627|Etanercept|etanercept|mesh-list
44279833|NCT04254627|Mifepristone|mifepristone|mesh-list
44186824|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44186825|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44186826|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186827|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43715935|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186828|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44186829|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186830|NCT00338117|Galantamine|galantamine|mesh-list
44186831|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44186832|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186868|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186897|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44186898|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700572|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279834|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934288|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279835|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44279837|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
44279838|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279839|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279840|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279841|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279842|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44279843|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279844|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
44279845|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44279846|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
44279847|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44279848|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44279849|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44186899|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186900|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44186901|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186902|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
44186903|NCT00338390|Lamivudine|lamivudine|mesh-list
44186904|NCT00338390|Abacavir|abacavir|mesh-list
44186905|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
44186906|NCT00338390|Didanosine|didanosine|mesh-list
44186907|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186908|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186909|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186910|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186911|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
44186912|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186913|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186914|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44186933|NCT00338507|Erdosteine|erdosteine|mesh-list
44186934|NCT00338507|Expectorants|expectorants|mesh-ancestor
44186935|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44186936|NCT00338546|Cocaine|cocaine|mesh-list
44186937|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
44186938|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44186939|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186940|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186941|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44186942|NCT00338546|Analgesics|analgesics|mesh-ancestor
44186943|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
44186944|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186945|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44186946|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44186947|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44186948|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44186949|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186950|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186951|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
44186952|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
44186953|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44186954|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44186955|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44279850|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44279851|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
44279852|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44279853|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44279854|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
44279855|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279856|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
44279857|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44279858|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44279859|NCT04250883|Iodine|iodine|mesh-list
44279860|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44279861|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279862|NCT04250883|Trace Elements|trace elements|mesh-ancestor
44279863|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
44279864|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279865|NCT04237103|Methotrexate|methotrexate|mesh-list
44279866|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44279867|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
44279868|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44279869|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279870|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44279871|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
44279872|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665800|NCT05328908|Nivolumab|nivolumab|mesh-list
44186956|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44186957|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
44186958|NCT00338624|Oxybutynin|oxybutynin|mesh-list
44186959|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
44186960|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
44186961|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186962|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186963|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44186964|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44186965|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44186966|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186967|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186968|NCT00338624|Urological Agents|urological agents|mesh-ancestor
44186969|NCT00338650|Adalimumab|adalimumab|mesh-list
44186970|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186971|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454599|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454600|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44454625|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454627|NCT01661972|Aflibercept|aflibercept|mesh-list
44454628|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454629|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
44454630|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454631|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279873|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279874|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
44279875|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279876|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44279877|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44279878|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
44279879|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279880|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44279882|NCT04213794|Cisplatin|cisplatin|mesh-list
44279883|NCT04213794|Doxorubicin|doxorubicin|mesh-list
44279884|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44279885|NCT04213794|Daunorubicin|daunorubicin|mesh-list
44279886|NCT04213794|Antidotes|antidotes|mesh-list
44279887|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279888|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44279889|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44279890|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44279891|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454632|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44454633|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44454634|NCT01661972|Growth Substances|growth substances|mesh-ancestor
44454635|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454636|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
44454637|NCT01661790|Bevacizumab|bevacizumab|mesh-list
44454638|NCT01661790|Cisplatin|cisplatin|mesh-list
44454639|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454640|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454641|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44454642|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44454643|NCT01661790|Growth Substances|growth substances|mesh-ancestor
44454644|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454645|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44454646|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
44454647|NCT01661595|Tadalafil|tadalafil|mesh-list
44454648|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
44186981|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44186982|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44186983|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186984|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186985|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
44186986|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186987|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44186988|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
44186989|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186990|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44186991|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44186992|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186994|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186995|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186996|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186997|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186998|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
44186999|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187000|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44187001|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279892|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279894|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279895|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
44279896|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
44279897|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44279898|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279899|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
44279900|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
44279901|NCT04209543|Progesterone|progesterone|mesh-list
44279902|NCT04209543|Progestins|progestins|mesh-ancestor
44279903|NCT04209543|Hormones|hormones|mesh-ancestor
44279904|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279905|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279906|NCT04144465|Phenylephrine|phenylephrine|mesh-list
44187021|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187023|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187024|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187025|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187026|NCT00338936|Valsartan|valsartan|mesh-list
44187027|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44187028|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44187029|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44187030|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44187031|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187032|NCT00338936|Diuretics|diuretics|mesh-ancestor
44187033|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
44187034|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187035|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44187036|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187037|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
44187038|NCT00339001|Hematinics|hematinics|mesh-ancestor
44187039|NCT00339014|Zonisamide|zonisamide|mesh-list
44187040|NCT00339014|Bupropion|bupropion|mesh-list
44187041|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44187042|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
44187043|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187044|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44187045|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44187046|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187047|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187048|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
44187049|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187050|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187051|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44187052|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44187053|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187054|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
44187055|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44187085|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187086|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44187087|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44187088|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187089|NCT00339196|Azacitidine|azacitidine|mesh-list
44187090|NCT00339196|Tretinoin|tretinoin|mesh-list
44187091|NCT00339196|Valproic Acid|valproic acid|mesh-list
44187092|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187093|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
44279907|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
44279908|NCT04144465|Norepinephrine|norepinephrine|mesh-list
44279909|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44279910|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
44279911|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
44279912|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279913|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279914|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
44279915|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44279916|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
44279917|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44279918|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44279919|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44279920|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44279921|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44279922|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44279923|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279924|NCT04144465|Protective Agents|protective agents|mesh-ancestor
44463589|NCT01510158|Protective Agents|protective agents|mesh-ancestor
44187094|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187095|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187096|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187097|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
44187098|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
44187122|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44187123|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187124|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187125|NCT00339768|Amoxicillin|amoxicillin|mesh-list
44187126|NCT00339768|Omeprazole|omeprazole|mesh-list
44187127|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187128|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187129|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44187130|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43716471|NCT02653638|Indomethacin|indomethacin|mesh-list
44187131|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44187132|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187133|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187134|NCT00340080|Abacavir|abacavir|mesh-list
44187135|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44187136|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187137|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187138|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187139|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
44187140|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187141|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44187142|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44187143|NCT00340184|Paclitaxel|paclitaxel|mesh-list
44187144|NCT00340184|Carboplatin|carboplatin|mesh-list
44187145|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44187146|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187147|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187148|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187149|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187150|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187151|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44463590|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463591|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
44463592|NCT01510158|Renal Agents|renal agents|mesh-ancestor
44463593|NCT01510145|Travoprost|travoprost|mesh-list
44463594|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44463595|NCT01509846|Vaccines|vaccines|mesh-list
44463596|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
44463597|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463598|NCT01509547|Varenicline|varenicline|mesh-list
44463599|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44463600|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44463601|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
44463602|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463603|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463604|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463605|NCT01509079|Vitamin D|vitamin d|mesh-list
44463606|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
44463607|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
44463608|NCT01509079|Vitamins|vitamins|mesh-list
44463609|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
44463610|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454692|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
44454693|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454694|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454695|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454696|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454697|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
44454698|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454699|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44454700|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454701|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454702|NCT01660711|Antidotes|antidotes|mesh-ancestor
44454703|NCT01660711|Protective Agents|protective agents|mesh-ancestor
44454704|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
44454705|NCT01660711|Vitamins|vitamins|mesh-ancestor
44454706|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
44454707|NCT01660334|Voriconazole|voriconazole|mesh-list
44454708|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
44454709|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454710|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44187152|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44187153|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44187154|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
44187155|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187156|NCT00340574|Antacids|antacids|mesh-ancestor
44187157|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187158|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187159|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
44187160|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44187184|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
44187185|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187186|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454711|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44454712|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454713|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454714|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44463613|NCT01509053|Aripiprazole|aripiprazole|mesh-list
44463614|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
44463615|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463616|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44463617|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44463618|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44463619|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463620|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
44463621|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
44463622|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463623|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463624|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44454715|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
44454716|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454717|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454718|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44454719|NCT01660256|Rebamipide|rebamipide|mesh-list
44454720|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44454721|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44454722|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
44454723|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454724|NCT01660256|Protective Agents|protective agents|mesh-ancestor
44454725|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454726|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454727|NCT01660022|Piperaquine|piperaquine|mesh-list
44454728|NCT01660022|Artefenomel|artefenomel|mesh-list
44454729|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
44454730|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44454731|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44454732|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454733|NCT01659853|Azelaic acid|azelaic acid|mesh-list
44454734|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44454735|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44454736|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44187204|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187206|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44187207|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
44187208|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187209|NCT00343005|Antacids|antacids|mesh-ancestor
44187210|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187211|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187212|NCT00343070|Citalopram|citalopram|mesh-list
44187213|NCT00343070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44187214|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44187244|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187245|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44187246|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717238|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187247|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187248|NCT00343161|Esomeprazole|esomeprazole|mesh-list
44187249|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44187250|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
44187251|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44187252|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187253|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44187254|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463625|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44463626|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
44463627|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44463628|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44463629|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44463630|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44463631|NCT01508936|Reslizumab|reslizumab|mesh-list
44463632|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44463633|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
44463634|NCT01508702|Lesinurad|lesinurad|mesh-list
44463635|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
44463636|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463637|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
44463638|NCT01508702|Renal Agents|renal agents|mesh-ancestor
44463639|NCT01508676|Diclofenac|diclofenac|mesh-list
44463640|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44463641|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44463642|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463643|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463644|NCT01508676|Analgesics|analgesics|mesh-ancestor
44463645|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
44463646|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463647|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934443|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43826469|NCT05497700|Norepinephrine|norepinephrine|mesh-list
44187255|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187256|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44187257|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
44187258|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717239|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
44187259|NCT00343161|Antacids|antacids|mesh-ancestor
44187276|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187278|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44187279|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44187280|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187281|NCT00343200|Urological Agents|urological agents|mesh-ancestor
44187282|NCT00343226|Basiliximab|basiliximab|mesh-list
44187283|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187284|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
44187285|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187286|NCT00343239|Cisplatin|cisplatin|mesh-list
44187287|NCT00343239|Docetaxel|docetaxel|mesh-list
44187288|NCT00343239|Fluorouracil|fluorouracil|mesh-list
44187289|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187290|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187291|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187292|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187293|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187294|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
44187295|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187296|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187297|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
44463648|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463649|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463650|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279926|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
44279927|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279928|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44279929|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44279930|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44279931|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279932|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279933|NCT04126317|Aflibercept|aflibercept|mesh-list
44279934|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187298|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187299|NCT00343265|Progesterone|progesterone|mesh-list
44187300|NCT00343265|Progestins|progestins|mesh-ancestor
44187302|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187303|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187304|NCT00343278|Valacyclovir|valacyclovir|mesh-list
44187305|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
44187306|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187307|NCT00343317|Cefoxitin|cefoxitin|mesh-list
44187308|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187309|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187310|NCT00343369|Cytarabine|cytarabine|mesh-list
44187311|NCT00343369|Dexamethasone|dexamethasone|mesh-list
44187312|NCT00343369|Prednisolone|prednisolone|mesh-list
44187313|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
44187314|NCT00343369|Doxorubicin|doxorubicin|mesh-list
44187315|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44187316|NCT00343369|Methotrexate|methotrexate|mesh-list
44187317|NCT00343369|Vincristine|vincristine|mesh-list
44187318|NCT00343369|Daunorubicin|daunorubicin|mesh-list
44187319|NCT00343369|Asparaginase|asparaginase|mesh-list
44187320|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
44187321|NCT00343369|Pegaspargase|pegaspargase|mesh-list
44187322|NCT00343369|Thioguanine|thioguanine|mesh-list
44187353|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187355|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187356|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44187357|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187358|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187359|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187360|NCT00343408|Leucovorin|leucovorin|mesh-list
44187361|NCT00343408|Gemcitabine|gemcitabine|mesh-list
44187362|NCT00343408|Cisplatin|cisplatin|mesh-list
44187363|NCT00343408|Fluorouracil|fluorouracil|mesh-list
44187364|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
44187365|NCT00343408|Cediranib|cediranib|mesh-list
44187366|NCT00343408|Calcium|calcium|mesh-list
44187397|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187399|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44187400|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187401|NCT00343486|Solabegron|solabegron|mesh-list
44187402|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44187403|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44187404|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44187405|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
44187406|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187407|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187408|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187409|NCT00343499|Valsartan|valsartan|mesh-list
44187410|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44187428|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187429|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187430|NCT00343655|Atorvastatin|atorvastatin|mesh-list
44187431|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187432|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279935|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44279936|NCT04126317|Growth Substances|growth substances|mesh-ancestor
44279937|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279938|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279939|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279940|NCT04120636|Celecoxib|celecoxib|mesh-list
44279941|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44279942|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44279943|NCT04120636|Analgesics|analgesics|mesh-ancestor
43826501|NCT05497674|Renal Agents|renal agents|mesh-ancestor
44187433|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
44187434|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187435|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44187436|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44187437|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187439|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44187440|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44187441|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187442|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187443|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187444|NCT00343707|Paroxetine|paroxetine|mesh-list
44187445|NCT00343707|Vestipitant|vestipitant|mesh-list
44187446|NCT00343707|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44187447|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44187448|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187449|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187450|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187451|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
44187452|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187453|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44187454|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44187455|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187456|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44187457|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44187458|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187459|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44187460|NCT00343720|Bortezomib|bortezomib|mesh-list
44187461|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187462|NCT00343733|Fentanyl|fentanyl|mesh-list
44187463|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44187464|NCT00343733|Narcotics|narcotics|mesh-ancestor
44454760|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454761|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44187479|NCT00343798|Cyclosporine|cyclosporine|mesh-list
44187480|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
44187481|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
44187482|NCT00343798|Fludarabine|fludarabine|mesh-list
44187483|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
44187484|NCT00343798|Cyclosporins|cyclosporins|mesh-list
44187485|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187486|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
44187487|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187488|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187489|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44187490|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
44187491|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187492|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187493|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44187494|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187495|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
44187496|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187497|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
44187498|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187499|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
43841890|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
44279945|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44279946|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279947|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44279948|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44279949|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44279950|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44187500|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44187501|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44187502|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44187503|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
44187504|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187505|NCT00343811|Modafinil|modafinil|mesh-list
44187506|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44187507|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187537|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
44187538|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44187539|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44187540|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44187541|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
44187542|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187543|NCT00343980|Insulin|insulin|mesh-list
44187544|NCT00343980|Glimepiride|glimepiride|mesh-list
44187545|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
44187546|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44187547|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44187548|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187549|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44187550|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187579|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
44187580|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187581|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44187582|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
44187583|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44187584|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187585|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187586|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44187587|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
44187588|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44187589|NCT00344123|Ritonavir|ritonavir|mesh-list
44187590|NCT00344123|Tipranavir|tipranavir|mesh-list
44187591|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44187592|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44187593|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44187594|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
44187595|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187596|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187597|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44187598|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44187599|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
44187600|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187601|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44187627|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44187628|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
44187629|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44187630|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187631|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187632|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
44187633|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187634|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187635|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
44187636|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187637|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44187638|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187639|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
44279952|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279953|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44279954|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44279955|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44279956|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
44279957|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279958|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44279959|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44279960|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279961|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
44279962|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
43665887|NCT05119439|Misoprostol|misoprostol|mesh-list
44187640|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187641|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187642|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
44187643|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187644|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44187645|NCT00344383|Norgestimate|norgestimate|mesh-list
44187646|NCT00344383|Estradiol|estradiol|mesh-list
44187647|NCT00344383|Estrogens|estrogens|mesh-ancestor
44187648|NCT00344383|Hormones|hormones|mesh-ancestor
44187649|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187650|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187651|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44187652|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
44187681|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44187682|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44187683|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44187684|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187685|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187686|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187688|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44187689|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44187690|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44187691|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
44187692|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187693|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187694|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187695|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43832447|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832448|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43832449|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718361|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
43718362|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43718363|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718364|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718365|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718366|NCT02643017|Analgesics|analgesics|mesh-ancestor
43718367|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
44187696|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
44124005|NCT00131261|Dexamethasone|dexamethasone|mesh-list
44187697|NCT00344513|Protective Agents|protective agents|mesh-ancestor
44187729|NCT00344539|Antacids|antacids|mesh-ancestor
44187730|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187731|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187732|NCT00344552|Paclitaxel|paclitaxel|mesh-list
44187733|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44187734|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187735|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187736|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187737|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187738|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187739|NCT00344565|Modafinil|modafinil|mesh-list
44187740|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44187757|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187758|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
44187759|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44187760|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187761|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187762|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44279963|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279964|NCT04042935|Protective Agents|protective agents|mesh-ancestor
44279965|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279966|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
44279967|NCT04042935|Vitamins|vitamins|mesh-ancestor
44279968|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
44279969|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44279970|NCT03900793|Sunitinib|sunitinib|mesh-list
44279971|NCT03900793|Losartan|losartan|mesh-list
44279972|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44279973|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44279974|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44279975|NCT03900793|Growth Substances|growth substances|mesh-ancestor
44279976|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279977|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
44279978|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44279979|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44279980|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44279981|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44187763|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718375|NCT02643173|Anesthetics|anesthetics|mesh-list
44187764|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187765|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187766|NCT00344695|Bupropion|bupropion|mesh-list
44187767|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44187768|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
44187769|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187770|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44187771|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44187772|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187773|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187774|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
44187775|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187776|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124076|NCT00131430|Hormones|hormones|mesh-ancestor
44187777|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44187778|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44187779|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187780|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44187781|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187782|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187784|NCT00344760|Lamivudine|lamivudine|mesh-list
44187785|NCT00344760|Efavirenz|efavirenz|mesh-list
44187786|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
44187787|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
44187788|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187789|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44187790|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187791|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187792|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187793|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44187794|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44187795|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44187796|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44187815|NCT00344825|Fludarabine|fludarabine|mesh-list
44279983|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44279984|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44279985|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
44279986|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
44279987|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279988|NCT03743376|UB-421|ub-421|mesh-list
44279989|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44279990|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
44279991|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44279992|NCT03734653|Testosterone|testosterone|mesh-list
44279993|NCT03734653|Androgens|androgens|mesh-ancestor
44279994|NCT03734653|Hormones|hormones|mesh-ancestor
44279995|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44279996|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44279997|NCT03728478|Etanercept|etanercept|mesh-list
44279998|NCT03728478|Methotrexate|methotrexate|mesh-list
44279999|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44280000|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
44280001|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44280002|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187816|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
44187817|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
44187818|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187819|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718479|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
43718480|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718481|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718482|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44187820|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
44187821|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187822|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187823|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
44187824|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187825|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187826|NCT00344851|Metformin|metformin|mesh-list
44187827|NCT00344851|Exenatide|exenatide|mesh-list
44187828|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44187829|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187830|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44187831|NCT00344851|Incretins|incretins|mesh-ancestor
44187832|NCT00344851|Hormones|hormones|mesh-ancestor
44187833|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187834|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44187835|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187836|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187837|NCT00344942|Triamcinolone|triamcinolone|mesh-list
44187838|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44187839|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44187840|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44187841|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187842|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
44187843|NCT00344942|Hormones|hormones|mesh-ancestor
44187844|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187845|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187846|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280003|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280005|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280006|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280007|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44280008|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280009|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44280010|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280011|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
44280012|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280013|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44280014|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280015|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280016|NCT03728478|Analgesics|analgesics|mesh-ancestor
44280017|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
44280018|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280019|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280020|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280021|NCT03702283|Penicillins|penicillins|mesh-list
44280022|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280023|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280024|NCT03655821|Pemetrexed|pemetrexed|mesh-list
44280025|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280026|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280027|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280028|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44280029|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44280030|NCT03635164|Durvalumab|durvalumab|mesh-list
44280031|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280032|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280033|NCT03613116|Vitamin D|vitamin d|mesh-list
44187847|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
44187848|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187849|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187850|NCT00344955|Atorvastatin|atorvastatin|mesh-list
44187851|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187883|NCT00345059|Vinorelbine|vinorelbine|mesh-list
44187884|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187885|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
44187886|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187887|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187888|NCT00345059|Antiviral Agents|antiviral agents|mesh-ancestor
44280034|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
44280035|NCT03613116|Vitamins|vitamins|mesh-ancestor
44280036|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
44280037|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280038|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44280039|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44280040|NCT03583957|Caffeine|caffeine|mesh-list
44280041|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44280042|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280043|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44280044|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280045|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280046|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44280047|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44280048|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
44280049|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187889|NCT00345059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187890|NCT00345059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187891|NCT00345059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187892|NCT00345059|Immunologic Factors|immunologic factors|mesh-ancestor
44187893|NCT00345059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187894|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187895|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187928|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187929|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44187930|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44187931|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187932|NCT00345306|Progesterone|progesterone|mesh-list
44187933|NCT00345306|Progestins|progestins|mesh-ancestor
44187934|NCT00345306|Hormones|hormones|mesh-ancestor
44187935|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454778|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454779|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44454780|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
44454781|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454782|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454783|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44454784|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44454785|NCT01659151|Analgesics|analgesics|mesh-ancestor
44454786|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
44454787|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454788|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44454789|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44454790|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
44454791|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454792|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454793|NCT01659021|Ofatumumab|ofatumumab|mesh-list
44454794|NCT01659021|Idelalisib|idelalisib|mesh-list
44454795|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454796|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454797|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454799|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
44454800|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
44454801|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454802|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454803|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454804|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454805|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
44454806|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454807|NCT01658904|Melphalan|melphalan|mesh-list
44454808|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
44454809|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454810|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44454811|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
44454812|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454813|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187953|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
44187954|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187955|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44187956|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
44187957|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
44187959|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
44187960|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187961|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187962|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44187963|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187964|NCT00345696|Bevacizumab|bevacizumab|mesh-list
44187965|NCT00345696|Capecitabine|capecitabine|mesh-list
44187966|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
44187967|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187968|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187969|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187970|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44187971|NCT00345696|Growth Substances|growth substances|mesh-ancestor
44187972|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187973|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
44187974|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187975|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
44187976|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187977|NCT00345735|Fentanyl|fentanyl|mesh-list
44187978|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44187979|NCT00345735|Narcotics|narcotics|mesh-ancestor
44187980|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187981|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187982|NCT00345735|Analgesics|analgesics|mesh-ancestor
44187983|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
44187984|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187985|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44187986|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44187987|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
44188016|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188017|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188018|NCT00345826|Dasatinib|dasatinib|mesh-list
44188019|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188020|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44188021|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188022|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188023|NCT00345982|Sertindole|sertindole|mesh-list
44188024|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44188025|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44188026|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188027|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188028|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44280076|NCT03491540|Ornidazole|ornidazole|mesh-list
44280077|NCT03491540|Sennosides|sennosides|mesh-list
44280078|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665958|NCT04983238|Trastuzumab|trastuzumab|mesh-list
44188029|NCT00346047|Buprenorphine|buprenorphine|mesh-list
44188030|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188031|NCT00346047|Narcotics|narcotics|mesh-ancestor
44188032|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718652|NCT02641899|Atorvastatin|atorvastatin|mesh-list
43718653|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43718654|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44188033|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188034|NCT00346047|Analgesics|analgesics|mesh-ancestor
44188035|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
44188069|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188070|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188071|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188072|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188073|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188074|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188099|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44188101|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44188102|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188103|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188104|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44188105|NCT00346463|Allopurinol|allopurinol|mesh-list
44188106|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
44188107|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188108|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188109|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
44188110|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188111|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44188112|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
44188113|NCT00346463|Protective Agents|protective agents|mesh-ancestor
44188114|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188115|NCT00346489|Fluorouracil|fluorouracil|mesh-list
44188116|NCT00346489|Mitomycins|mitomycins|mesh-list
44188117|NCT00346489|Mitomycin|mitomycin|mesh-list
44188118|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
44188119|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188120|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188121|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188122|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188123|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
44188124|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188139|NCT00346502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44188140|NCT00346502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44188141|NCT00346502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188142|NCT00346502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44188143|NCT00346502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188144|NCT00346502|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44188145|NCT00346502|Hormone Antagonists|hormone antagonists|mesh-ancestor
44188146|NCT00346502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44188147|NCT00346502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44188148|NCT00346502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188149|NCT00346502|Antiviral Agents|antiviral agents|mesh-ancestor
44188150|NCT00346567|Tenofovir|tenofovir|mesh-list
44188151|NCT00346567|Lamivudine|lamivudine|mesh-list
44188152|NCT00346567|Zidovudine|zidovudine|mesh-list
44188153|NCT00346567|Emtricitabine|emtricitabine|mesh-list
44188154|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44188155|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44188156|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
44188157|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188158|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44280079|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280080|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44280081|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280082|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280083|NCT03491540|Laxatives|laxatives|mesh-ancestor
44280084|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280085|NCT03491540|Amebicides|amebicides|mesh-ancestor
44280086|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44280087|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44280088|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44280089|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44280090|NCT03479268|Pevonedistat|pevonedistat|mesh-list
44280091|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280092|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
43665969|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
43718690|NCT02641652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43718691|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43718692|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718693|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188159|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44188160|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188161|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188162|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44188163|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188164|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
44124480|NCT00133198|Pramipexole|pramipexole|mesh-list
44188165|NCT00346580|Nelfinavir|nelfinavir|mesh-list
44188166|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44188167|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44188168|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
44188169|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188170|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188171|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44188172|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188173|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
44188174|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188175|NCT00346619|Nelfinavir|nelfinavir|mesh-list
44188176|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44188177|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44188178|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
44188179|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188180|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188181|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44188182|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188183|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
44188184|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188210|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188212|NCT00346801|Cisplatin|cisplatin|mesh-list
44188213|NCT00346801|Irinotecan|irinotecan|mesh-list
44188214|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188215|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44188216|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44188217|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188218|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188219|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188220|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188221|NCT00346801|Analgesics|analgesics|mesh-ancestor
44188222|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
44188223|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188224|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188225|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188226|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188227|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44188228|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44280094|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280095|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44280096|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280097|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44280098|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44280099|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280100|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280101|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
44280102|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280103|NCT03164447|UB-421|ub-421|mesh-list
44280104|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188229|NCT00346827|Apomorphine|apomorphine|mesh-list
44188230|NCT00346827|Emetics|emetics|mesh-ancestor
44188231|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188232|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
44188233|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188234|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188235|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
44188259|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188260|NCT00346879|PENTA|penta|mesh-list
44188261|NCT00346879|Fondaparinux|fondaparinux|mesh-list
44188262|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44188263|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
44188264|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44188265|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
44188266|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188267|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188268|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
44188269|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44188270|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44188271|NCT00346918|Sirolimus|sirolimus|mesh-list
44188272|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44188273|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188274|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44188275|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188276|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
44188277|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188278|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
44188279|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188280|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
44188281|NCT00346957|Anecortave|anecortave|mesh-list
44188282|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188283|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188284|NCT00346957|Growth Substances|growth substances|mesh-ancestor
44188285|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188286|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188287|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188288|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188314|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188315|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188316|NCT00347048|Tacrolimus|tacrolimus|mesh-list
44188317|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124627|NCT00133419|Zinc|zinc|mesh-list
44188318|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
44188319|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188320|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44188321|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188322|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188323|NCT00347087|Irbesartan|irbesartan|mesh-list
44188324|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188325|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44188326|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43841891|NCT04580472|Cephalexin|cephalexin|mesh-list
44280105|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
44280106|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280107|NCT03149211|UB-421|ub-421|mesh-list
44280108|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44280109|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
44280110|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280111|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
44188327|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188328|NCT00347100|Metformin|metformin|mesh-list
44188329|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
44188330|NCT00347100|Glyburide|glyburide|mesh-list
44188331|NCT00347100|Glipizide|glipizide|mesh-list
44188332|NCT00347100|Gliclazide|gliclazide|mesh-list
43718746|NCT02641340|Fentanyl|fentanyl|mesh-list
44188333|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188334|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188335|NCT00347113|Albendazole|albendazole|mesh-list
44188336|NCT00347113|Praziquantel|praziquantel|mesh-list
44188337|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
44188338|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44188339|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188340|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
44188371|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44188372|NCT00347165|Bevacizumab|bevacizumab|mesh-list
44188373|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188374|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188375|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188376|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188377|NCT00347165|Growth Substances|growth substances|mesh-ancestor
44188378|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188379|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188380|NCT00347204|Ketorolac|ketorolac|mesh-list
44188381|NCT00347204|Nepafenac|nepafenac|mesh-list
44188382|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188383|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44454834|NCT01658150|Isradipine|isradipine|mesh-list
44454835|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44454836|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44454853|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
44454854|NCT01657903|Protective Agents|protective agents|mesh-ancestor
44454855|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454856|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44454857|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454858|NCT01657877|Calcium|calcium|mesh-list
44454859|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44454860|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454861|NCT01657799|Veliparib|veliparib|mesh-list
44454862|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44454863|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454864|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454865|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454866|NCT01657760|Citalopram|citalopram|mesh-list
44454867|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44454868|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44454869|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454870|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454871|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454872|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
44454873|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454874|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44454875|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
44454876|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454877|NCT01657500|Gentamicins|gentamicins|mesh-list
44454878|NCT01657500|Dextrans|dextrans|mesh-list
44454879|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44454880|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44454881|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188408|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
44188409|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188410|NCT00347386|Astringents|astringents|mesh-ancestor
44188411|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188412|NCT00347399|Bevacizumab|bevacizumab|mesh-list
44188413|NCT00347399|Verteporfin|verteporfin|mesh-list
44280112|NCT02916862|Calcium|calcium|mesh-list
44280113|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44280114|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718899|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43718900|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
44280115|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44280116|NCT02704156|Gemcitabine|gemcitabine|mesh-list
44280117|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
44280118|NCT02704156|Trametinib|trametinib|mesh-list
44280119|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280120|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
44280121|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280122|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280123|NCT02704156|Antiviral Agents|antiviral agents|mesh-ancestor
44280124|NCT02704156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280125|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280126|NCT02704156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280127|NCT02704156|Immunologic Factors|immunologic factors|mesh-ancestor
44280128|NCT02704156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280129|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188414|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188415|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188416|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188417|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188418|NCT00347399|Growth Substances|growth substances|mesh-ancestor
44188419|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188435|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188436|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44188437|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44188438|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
44188439|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
44188440|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
44188441|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188442|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188443|NCT00347425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44188444|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44188445|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44188446|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
44188447|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
44188448|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44188449|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44188450|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44188451|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44188452|NCT00347490|Enoxaparin|enoxaparin|mesh-list
44188453|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
44188454|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44188455|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43718953|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
43718954|NCT02639741|Vitamins|vitamins|mesh-list
43718955|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
43718956|NCT02639741|Melatonin|melatonin|mesh-list
44188456|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188457|NCT00347503|Ketorolac|ketorolac|mesh-list
44188458|NCT00347503|Bromfenac|bromfenac|mesh-list
44188459|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188460|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188461|NCT00347503|Analgesics|analgesics|mesh-ancestor
44188462|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
44188463|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188464|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188465|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188466|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280130|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280131|NCT02227927|Domperidone|domperidone|mesh-list
44280132|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
44280133|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
44280134|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666011|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188467|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188468|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188469|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188470|NCT00347542|Vitamin D|vitamin d|mesh-list
44188471|NCT00347542|Vitamins|vitamins|mesh-ancestor
44188472|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
44188473|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188474|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44188475|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
44188476|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44188477|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
44188478|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188479|NCT00347555|Antacids|antacids|mesh-ancestor
44188480|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188496|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
44188497|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44188498|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44188499|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188500|NCT00347685|Tramadol|tramadol|mesh-list
44188501|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188502|NCT00347685|Narcotics|narcotics|mesh-ancestor
44188503|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188504|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188505|NCT00347685|Analgesics|analgesics|mesh-ancestor
44188506|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
44188507|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188508|NCT00347698|Bevacizumab|bevacizumab|mesh-list
44188509|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188510|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188511|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188512|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188513|NCT00347698|Growth Substances|growth substances|mesh-ancestor
44188514|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188515|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188516|NCT00347724|Tramadol|tramadol|mesh-list
44188517|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188518|NCT00347724|Narcotics|narcotics|mesh-ancestor
44188519|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188520|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188521|NCT00347724|Analgesics|analgesics|mesh-ancestor
44188522|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
44188523|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188524|NCT00347737|Teriparatide|teriparatide|mesh-list
44188525|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44188526|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188527|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44188528|NCT00347750|Lopinavir|lopinavir|mesh-list
44188529|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44188530|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44188531|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
44188532|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188533|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188534|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44188535|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44188536|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
44188537|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188538|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44188539|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44188540|NCT00347763|Permethrin|permethrin|mesh-list
44188572|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44188573|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
44188574|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188575|NCT00347854|Laxatives|laxatives|mesh-ancestor
44188576|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280135|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280136|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280137|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44280138|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
44280139|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280140|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280141|NCT01951274|Serlopitant|serlopitant|mesh-list
44280142|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44280143|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280144|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280145|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280146|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44280147|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934654|NCT00802685|Analgesics|analgesics|mesh-ancestor
44280148|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280149|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280150|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280152|NCT00732212|Coagulants|coagulants|mesh-ancestor
44280153|NCT00522145|XL647|xl647|mesh-list
44280154|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280155|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280156|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280157|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280158|NCT00364780|XL647|xl647|mesh-list
44280159|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463651|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463652|NCT01508325|Metoprolol|metoprolol|mesh-list
44463653|NCT01508325|Bisoprolol|bisoprolol|mesh-list
43719025|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43719026|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43719027|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43719028|NCT02638922|Trisequens|trisequens|mesh-list
43719029|NCT02638922|Norethindrone|norethindrone|mesh-list
43719030|NCT02638922|Estradiol|estradiol|mesh-list
44463654|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44463655|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44463656|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
44463657|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
44463658|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463659|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463660|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44463661|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44463662|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44463663|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463664|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826511|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
44188577|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
44188578|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
44188579|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44188580|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44188581|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188582|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188583|NCT00347867|Urological Agents|urological agents|mesh-ancestor
44188585|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188586|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188612|NCT00348062|Bimatoprost|bimatoprost|mesh-list
44188613|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188614|NCT00348101|Enoximone|enoximone|mesh-list
44188615|NCT00348101|Esmolol|esmolol|mesh-list
44188616|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44188617|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44188618|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44188619|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188620|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188621|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188622|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188623|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44188624|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
44188625|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44188626|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44188627|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188628|NCT00348101|Protective Agents|protective agents|mesh-ancestor
44188629|NCT00348153|Adalimumab|adalimumab|mesh-list
44188630|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188631|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125018|NCT00134654|Hormones|hormones|mesh-ancestor
44188632|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
44188633|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
44188634|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
44188635|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188636|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188673|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44188674|NCT00348244|Protective Agents|protective agents|mesh-ancestor
44188675|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188712|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44188713|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
44188714|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44463665|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463666|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44463667|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
44463668|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463669|NCT01507246|Morphine|morphine|mesh-list
44463670|NCT01507246|Bupivacaine|bupivacaine|mesh-list
44463671|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
44463672|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
44463673|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719031|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44463674|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463675|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
44463676|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463677|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44463678|NCT01507246|Narcotics|narcotics|mesh-ancestor
44463679|NCT01507246|Analgesics|analgesics|mesh-ancestor
44463680|NCT01507051|Vitamin K|vitamin k|mesh-list
44463681|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
44463682|NCT01507051|Warfarin|warfarin|mesh-list
44463683|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
44463684|NCT01507051|Vitamins|vitamins|mesh-ancestor
44463685|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
44463686|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463687|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
44463688|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44188715|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44188788|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188789|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188790|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188792|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188820|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44188821|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44188822|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188823|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188824|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44188825|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44188826|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
44188827|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188828|NCT00348517|Laxatives|laxatives|mesh-ancestor
44188829|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188830|NCT00348530|Verapamil|verapamil|mesh-list
44188831|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44188832|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44188833|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44188834|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188835|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44188836|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188837|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
44188838|NCT00348582|Ketorolac|ketorolac|mesh-list
44188868|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
44188869|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188870|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44188871|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
44188872|NCT00348738|Hematinics|hematinics|mesh-ancestor
44188873|NCT00348764|Polidocanol|polidocanol|mesh-list
44463689|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
44463690|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44463691|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463692|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463693|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280185|NCT00726960|Aprepitant|aprepitant|mesh-list
44188874|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44188875|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44454882|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44454883|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454884|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454885|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
44454886|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
44454887|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
44454888|NCT01657461|Plasminogen|plasminogen|mesh-list
44454889|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43719090|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719091|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719092|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
43719093|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43719094|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
43719095|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43719096|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719097|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719098|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719099|NCT02638545|Analgesics|analgesics|mesh-ancestor
43719100|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
43719101|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719102|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44454890|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44454891|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44454923|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44454924|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454925|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454926|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454927|NCT01656395|Montelukast|montelukast|mesh-list
44454928|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44454929|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
44454930|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44454931|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
44188891|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
44188892|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188893|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
44188894|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188895|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188896|NCT00348985|Bortezomib|bortezomib|mesh-list
44188897|NCT00348985|Belinostat|belinostat|mesh-list
44188898|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188899|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44188900|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188901|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188902|NCT00348998|Bevacizumab|bevacizumab|mesh-list
44188903|NCT00348998|Goserelin|goserelin|mesh-list
44188904|NCT00348998|Bicalutamide|bicalutamide|mesh-list
44188905|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188906|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188907|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188908|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188909|NCT00348998|Growth Substances|growth substances|mesh-ancestor
44188910|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188911|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188912|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44188913|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
44188914|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
44188915|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44188931|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188932|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
44188933|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188934|NCT00349089|Cisplatin|cisplatin|mesh-list
44188935|NCT00349089|Pemetrexed|pemetrexed|mesh-list
43719114|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
43719115|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719116|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719117|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719118|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719119|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43719120|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719121|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188936|NCT00349089|Vinorelbine|vinorelbine|mesh-list
44188937|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188938|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188939|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188940|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44188941|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44188942|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44188943|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44188944|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44188945|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44188946|NCT00349115|Thalidomide|thalidomide|mesh-list
44188947|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280186|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44280187|NCT00726960|Narcotics|narcotics|mesh-ancestor
44280188|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280189|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280190|NCT00726960|Analgesics|analgesics|mesh-ancestor
44280191|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
44280192|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280193|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44280194|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
44280195|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
44280196|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280197|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44188948|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
44188949|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188950|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
44188951|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44188952|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188953|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188954|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188955|NCT00349115|Growth Substances|growth substances|mesh-ancestor
44188956|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188957|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719122|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
43719123|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
43719124|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719125|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43719126|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188959|NCT00349128|Fenofibrate|fenofibrate|mesh-list
44188960|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188961|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188962|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44188963|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
44188964|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188965|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44188966|NCT00349180|Enoxaparin|enoxaparin|mesh-list
44188967|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
44188968|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
44188969|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44188970|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44188971|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188972|NCT00349206|Sirolimus|sirolimus|mesh-list
44188973|NCT00349206|Sorafenib|sorafenib|mesh-list
44188974|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188975|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44188976|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188977|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188978|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44189012|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189013|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189014|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44189015|NCT00349245|Narcotics|narcotics|mesh-ancestor
44189016|NCT00349258|Leuprolide|leuprolide|mesh-list
44189017|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44189018|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
44189019|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44189044|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189045|NCT00349375|Simvastatin|simvastatin|mesh-list
44189046|NCT00349375|Fenofibrate|fenofibrate|mesh-list
44189047|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44189048|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189049|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
44189050|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189051|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189052|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44189053|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189054|NCT00349401|Ketorolac|ketorolac|mesh-list
44189055|NCT00349401|Morphine|morphine|mesh-list
44189056|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44189057|NCT00349401|Narcotics|narcotics|mesh-ancestor
44280198|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280199|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280200|NCT00726973|Ranibizumab|ranibizumab|mesh-list
44280201|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44280202|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280203|NCT00726973|Growth Substances|growth substances|mesh-ancestor
44280204|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280205|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280206|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280207|NCT00727038|Ranibizumab|ranibizumab|mesh-list
44280208|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44280209|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280210|NCT00727038|Growth Substances|growth substances|mesh-ancestor
44280211|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280212|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280213|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189058|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189059|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189060|NCT00349401|Analgesics|analgesics|mesh-ancestor
44189061|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
44189062|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189063|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189064|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189065|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189066|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189067|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44189068|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189069|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189070|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
44189088|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
44189089|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
44189090|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189091|NCT00349453|Siderophores|siderophores|mesh-ancestor
44189092|NCT00349492|Cisplatin|cisplatin|mesh-list
44189093|NCT00349492|Irinotecan|irinotecan|mesh-list
44189094|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189095|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44189096|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189097|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189098|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189099|NCT00349518|Dasatinib|dasatinib|mesh-list
44189100|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189101|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189102|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189103|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189104|NCT00349531|Pramipexole|pramipexole|mesh-list
44189105|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
44189106|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189107|NCT00349531|Protective Agents|protective agents|mesh-ancestor
44189108|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189109|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44189110|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44189111|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
44189112|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
44189113|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189114|NCT00349557|Bevacizumab|bevacizumab|mesh-list
44189115|NCT00349557|Goserelin|goserelin|mesh-list
44189116|NCT00349557|Bicalutamide|bicalutamide|mesh-list
43797423|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44280215|NCT00727077|Ribavirin|ribavirin|mesh-list
44280216|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
44280217|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
44280218|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280219|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
44280220|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280221|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
44280222|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280223|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
44280224|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280225|NCT00727103|Varenicline|varenicline|mesh-list
44280226|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44280227|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44280228|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
44280229|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280230|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280231|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280232|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44189117|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44189118|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189119|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44189120|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43719279|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44189121|NCT00349557|Growth Substances|growth substances|mesh-ancestor
44189122|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189123|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
44189124|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44189125|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
44189126|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44189127|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189128|NCT00349583|Cyclosporine|cyclosporine|mesh-list
44189129|NCT00349583|Cyclosporins|cyclosporins|mesh-list
44189153|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189154|NCT00349674|Methotrexate|methotrexate|mesh-list
44189155|NCT00349674|Azathioprine|azathioprine|mesh-list
44189156|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44189157|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
44189158|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44189159|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189160|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189161|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
44189162|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189163|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189164|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189165|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189166|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44189167|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189168|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
44189169|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189170|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44189171|NCT00349726|Inositol|inositol|mesh-list
44189172|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
44189173|NCT00349726|Vitamins|vitamins|mesh-ancestor
44189174|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
44189175|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189176|NCT00349739|Anecortave|anecortave|mesh-list
44280233|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44280234|NCT00727129|Estradiol|estradiol|mesh-list
44280235|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44280236|NCT00727129|Estrogens|estrogens|mesh-ancestor
44280237|NCT00727129|Hormones|hormones|mesh-ancestor
44280238|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280239|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280240|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44280241|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
44280242|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44280243|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44280244|NCT00727207|Everolimus|everolimus|mesh-list
44280245|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280246|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280247|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
44280248|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280249|NCT00727233|Sorafenib|sorafenib|mesh-list
44189177|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44189178|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44189179|NCT00349739|Growth Substances|growth substances|mesh-ancestor
44189180|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189181|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
44189205|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189206|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189207|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44189208|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189209|NCT00350077|Vitamins|vitamins|mesh-list
44189210|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
44189211|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
44189212|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189213|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
44189214|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189215|NCT00350077|Protective Agents|protective agents|mesh-ancestor
44189216|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
44189217|NCT00350090|Hematinics|hematinics|mesh-ancestor
44189218|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
44189219|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
44189220|NCT00350116|Vitamins|vitamins|mesh-ancestor
44189221|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
44189222|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189223|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
44189224|NCT00350116|Hematinics|hematinics|mesh-ancestor
44189225|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
44189226|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44189227|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44189228|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189229|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189230|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189231|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189232|NCT00350155|Analgesics|analgesics|mesh-ancestor
44189233|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
44189234|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189235|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189262|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189263|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44189264|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44189265|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44189266|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44280250|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280251|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280252|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280253|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280254|NCT00727493|Alendronate|alendronate|mesh-list
44280255|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44280256|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280257|NCT00727545|Chelating Agents|chelating agents|mesh-list
44280258|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
43934807|NCT00806078|Quinine|quinine|mesh-list
44280259|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189267|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189268|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44189269|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44189270|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
44189271|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44189272|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189273|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
44189274|NCT00350311|Nicotine|nicotine|mesh-list
44189275|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44189276|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
44189277|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189278|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189279|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44189280|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44189281|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44189282|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189283|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189300|NCT00350454|Sirolimus|sirolimus|mesh-list
44189301|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719300|NCT02637284|BPC 157|bpc 157|mesh-list
43719353|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719354|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
43719355|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
43719356|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43719357|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
43719358|NCT02636816|Carbetocin|carbetocin|mesh-list
43719359|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
43719360|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719361|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719362|NCT02636803|Albendazole|albendazole|mesh-list
44189302|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189303|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44189304|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189305|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
44189306|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189307|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
44189308|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189309|NCT00350467|Olanzapine|olanzapine|mesh-list
44189310|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44189311|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
44189312|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
44189313|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189314|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189315|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44189316|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189317|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189318|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189319|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189320|NCT00350467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44189321|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44189322|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189323|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189324|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189325|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
44189326|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43719363|NCT02636803|Oxfendazole|oxfendazole|mesh-list
43719364|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
43719365|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43719366|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719367|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
43719368|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44189327|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44189328|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44189329|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44125724|NCT00136526|Docetaxel|docetaxel|mesh-list
44189331|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44189332|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
44189333|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44189334|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44280261|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44280262|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44280263|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
44280264|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
44280265|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280266|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280267|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280268|NCT00727753|Bevacizumab|bevacizumab|mesh-list
44280269|NCT00727753|Ranibizumab|ranibizumab|mesh-list
44280270|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280271|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280272|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44280273|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280274|NCT00727753|Growth Substances|growth substances|mesh-ancestor
44280275|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280276|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280277|NCT00727766|Clofarabine|clofarabine|mesh-list
44280278|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280279|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
44280280|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280281|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189335|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
44189336|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44189337|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189338|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44189339|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44189340|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44454972|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44454974|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454975|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454976|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
44454996|NCT01654536|Ciclesonide|ciclesonide|mesh-list
44454997|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
43719369|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43719422|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
43719423|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719424|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43719425|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44454999|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455000|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189342|NCT00350597|Molgramostim|molgramostim|mesh-list
44189343|NCT00350597|Sargramostim|sargramostim|mesh-list
44189344|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
44189345|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189346|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189347|NCT00350662|Deferiprone|deferiprone|mesh-list
44189348|NCT00350662|Deferoxamine|deferoxamine|mesh-list
44189349|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44189350|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
44189351|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
44189352|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189353|NCT00350662|Siderophores|siderophores|mesh-ancestor
44189354|NCT00350753|Bevacizumab|bevacizumab|mesh-list
44189355|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44189356|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280283|NCT00727831|Methotrexate|methotrexate|mesh-list
44280284|NCT00727831|Calcium|calcium|mesh-list
44280285|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
44280286|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44280287|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280288|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44280289|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
44280290|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44280291|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280292|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
44280293|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280294|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280295|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189357|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189358|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44189359|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44189360|NCT00350753|Growth Substances|growth substances|mesh-ancestor
44189361|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189362|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
44189363|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189364|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189365|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189366|NCT00350818|Azacitidine|azacitidine|mesh-list
44189367|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189368|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
44189369|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189370|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189371|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189372|NCT00350857|Carbamazepine|carbamazepine|mesh-list
44189393|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189394|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189395|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189396|NCT00350961|Gemcitabine|gemcitabine|mesh-list
44189397|NCT00350961|Capecitabine|capecitabine|mesh-list
44189398|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
44189399|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189400|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
44189401|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189402|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189403|NCT00350961|Antiviral Agents|antiviral agents|mesh-ancestor
44189404|NCT00350961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189405|NCT00350961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189406|NCT00350961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189407|NCT00350961|Immunologic Factors|immunologic factors|mesh-ancestor
44189408|NCT00350961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189409|NCT00351026|Methadone|methadone|mesh-list
44189410|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44189411|NCT00351026|Narcotics|narcotics|mesh-ancestor
43719492|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43719493|NCT02635607|Ganirelix|ganirelix|mesh-list
43719494|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
44189412|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189413|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189414|NCT00351026|Analgesics|analgesics|mesh-ancestor
44189415|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
44189416|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189417|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
44189418|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189420|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189421|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189422|NCT00351052|Analgesics|analgesics|mesh-ancestor
44189423|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
44280296|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280297|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44280298|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280299|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
44280300|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280301|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44280302|NCT00727831|Antidotes|antidotes|mesh-ancestor
44280303|NCT00727831|Protective Agents|protective agents|mesh-ancestor
44280304|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
44280305|NCT00727831|Vitamins|vitamins|mesh-ancestor
44280306|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
44280307|NCT00727870|Glycerol|glycerol|mesh-list
44280308|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44280309|NCT00727870|Protective Agents|protective agents|mesh-ancestor
44280310|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280311|NCT00727935|Lidocaine|lidocaine|mesh-list
44280312|NCT00727935|Ropivacaine|ropivacaine|mesh-list
44280313|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
44280314|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
44280315|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280316|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280317|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
44189424|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189425|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189426|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189448|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189449|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189450|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44189451|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189452|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189453|NCT00351130|Amlodipine|amlodipine|mesh-list
44189454|NCT00351130|Valsartan|valsartan|mesh-list
44189455|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44189456|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44189457|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189458|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189459|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44189460|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189461|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
44189462|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44189463|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44189464|NCT00351143|Fluticasone|fluticasone|mesh-list
44189465|NCT00351143|Xhance|xhance|mesh-list
44189466|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44189467|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189468|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44189469|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
44189470|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189471|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189472|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43832724|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43832725|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832726|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832727|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832728|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832729|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832730|NCT05253053|Paclitaxel|paclitaxel|mesh-list
44189473|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189474|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189475|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44189476|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44280318|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280319|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44280320|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44280321|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44280322|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44280323|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280324|NCT00727948|Aspirin|aspirin|mesh-list
44280325|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280326|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280327|NCT00727948|Analgesics|analgesics|mesh-ancestor
44280328|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
44280329|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280330|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280331|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280332|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280333|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44280334|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44280335|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280336|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44280337|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44280338|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280339|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
44189492|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189494|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189495|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189496|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189497|NCT00351182|Doxycycline|doxycycline|mesh-list
44189498|NCT00351182|Telithromycin|telithromycin|mesh-list
44189499|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44189500|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189501|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
44189502|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44189503|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44189504|NCT00351195|Capecitabine|capecitabine|mesh-list
44189505|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
44189506|NCT00351195|Etoposide|etoposide|mesh-list
44189507|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189508|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
44189509|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189510|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189511|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44189512|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44189513|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189514|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189515|NCT00351286|Simvastatin|simvastatin|mesh-list
44189516|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44189517|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189518|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
44189519|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189520|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44280341|NCT00727987|Methotrexate|methotrexate|mesh-list
44280342|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44280343|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
44280344|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43832731|NCT05253053|Atezolizumab|atezolizumab|mesh-list
44280345|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280346|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280347|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
44280348|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280349|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280350|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44280351|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280352|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44280353|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280354|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
44280355|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280356|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44189521|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44189522|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189523|NCT00351364|Montelukast|montelukast|mesh-list
44189524|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44189525|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189526|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44189527|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
44189528|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189529|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189530|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44189531|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44189550|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
44189551|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189552|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189553|NCT00351585|Vildagliptin|vildagliptin|mesh-list
44189554|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189555|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189556|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44189557|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
44189558|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189559|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189560|NCT00351637|Methadone|methadone|mesh-list
44189561|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44189562|NCT00351637|Narcotics|narcotics|mesh-ancestor
44189563|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189564|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189565|NCT00351637|Analgesics|analgesics|mesh-ancestor
44189566|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
44189567|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189568|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
44189569|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189570|NCT00351663|Enoxaparin|enoxaparin|mesh-list
44189571|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
44189572|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44189573|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44189574|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189575|NCT00351702|Isoniazid|isoniazid|mesh-list
44189576|NCT00351702|Ethambutol|ethambutol|mesh-list
44189577|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
44280357|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44280358|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280360|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
44280361|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44280362|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280363|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
44280364|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280365|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280366|NCT00728000|Antiviral Agents|antiviral agents|mesh-ancestor
44280367|NCT00728000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280368|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720961|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43720962|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44280369|NCT00728000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280370|NCT00728000|Immunologic Factors|immunologic factors|mesh-ancestor
44280371|NCT00728000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280372|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280373|NCT00728013|Atorvastatin|atorvastatin|mesh-list
44280374|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44280375|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44280376|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
44280377|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280378|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44280379|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44280380|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280381|NCT00728078|Thalidomide|thalidomide|mesh-list
44280382|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280383|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
43666192|NCT04255160|Estrogens|estrogens|mesh-ancestor
44189578|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44189579|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189580|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44189581|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189582|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
44189583|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189584|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189585|NCT00351715|Methadone|methadone|mesh-list
44189586|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44189587|NCT00351715|Narcotics|narcotics|mesh-ancestor
44189610|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189611|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44189612|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
44189613|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189614|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189615|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44189616|NCT00351910|Amitriptyline|amitriptyline|mesh-list
44189617|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44280385|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
44280386|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280387|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280388|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44280389|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280390|NCT00728078|Growth Substances|growth substances|mesh-ancestor
44280391|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280392|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280393|NCT00728156|Clopidogrel|clopidogrel|mesh-list
44280394|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44280395|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44280396|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44280397|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44280398|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
44280399|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189618|NCT00351910|Citalopram|citalopram|mesh-list
44189619|NCT00351910|Bupropion|bupropion|mesh-list
44189620|NCT00351910|Fluoxetine|fluoxetine|mesh-list
44189621|NCT00351910|Paroxetine|paroxetine|mesh-list
44189622|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44189623|NCT00351910|Sertraline|sertraline|mesh-list
44189624|NCT00351910|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44189625|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44189626|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189627|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189628|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189629|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
44189630|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189631|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44189632|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189633|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720963|NCT02626234|Protective Agents|protective agents|mesh-ancestor
43720964|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189634|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189635|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44189636|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
44189637|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44189638|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44189666|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189667|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
44189668|NCT00352092|Sirolimus|sirolimus|mesh-list
44189669|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44189670|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44189671|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189672|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44189673|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
44189674|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44189675|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189676|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189677|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189678|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
44189679|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189680|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
44189681|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189682|NCT00352144|Eszopiclone|eszopiclone|mesh-list
44189683|NCT00352144|Zopiclone|zopiclone|mesh-list
44189684|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44189685|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280400|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280401|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280402|NCT00728195|Olanzapine|olanzapine|mesh-list
44280403|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
44280404|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
44280405|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
44280406|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280407|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280408|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280409|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44280410|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44280411|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280412|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44280413|NCT00728195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44280414|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44280415|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44280416|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280417|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280419|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44280420|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44280421|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
44280422|NCT00728273|Micronutrients|micronutrients|mesh-list
43648423|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648424|NCT03439293|Dexamethasone|dexamethasone|mesh-list
43648425|NCT03439293|Daratumumab|daratumumab|mesh-list
43648426|NCT03439293|Ixazomib|ixazomib|mesh-list
43648427|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648428|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
43648429|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
43648430|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648431|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648432|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280423|NCT00728273|Trace Elements|trace elements|mesh-list
43666233|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
44189686|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189699|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189700|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
44189701|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189702|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189703|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44189704|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189705|NCT00352196|Risperidone|risperidone|mesh-list
44189706|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44189707|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
44189708|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189709|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189710|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189711|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189712|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189713|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189714|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189715|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44189716|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
44189718|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44189719|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
44189720|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280424|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280425|NCT00728312|Aripiprazole|aripiprazole|mesh-list
44280426|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
44280427|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44280428|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44280429|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44280430|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280431|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280432|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
44280433|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
44280434|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280435|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280436|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44280437|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44280438|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
44280439|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44280440|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44280441|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44280442|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44280443|NCT00728520|Azacitidine|azacitidine|mesh-list
44280444|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280445|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
44280446|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280447|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189721|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189722|NCT00352261|Esomeprazole|esomeprazole|mesh-list
44189723|NCT00352261|Lansoprazole|lansoprazole|mesh-list
44189724|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
44189725|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44189726|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44189727|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44189728|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189729|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189730|NCT00352287|Pioglitazone|pioglitazone|mesh-list
44189731|NCT00352287|Hormones|hormones|mesh-list
44189732|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189733|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189734|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189735|NCT00352300|Paclitaxel|paclitaxel|mesh-list
44189736|NCT00352300|Carboplatin|carboplatin|mesh-list
44189737|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44189738|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189739|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
44189740|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
44189741|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
44189742|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189743|NCT00352313|Carboplatin|carboplatin|mesh-list
44189744|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455001|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44280448|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280449|NCT00728546|Isoniazid|isoniazid|mesh-list
44280450|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
44280451|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280452|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280453|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44280454|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44280455|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
44280456|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280457|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44280458|NCT00728559|Bupivacaine|bupivacaine|mesh-list
44280459|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
44280460|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
44455002|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
44455003|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455004|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455005|NCT01654302|Lidocaine|lidocaine|mesh-list
44455006|NCT01654302|Tetracaine|tetracaine|mesh-list
44455007|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
44455008|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
44455032|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455033|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
44455034|NCT01653847|Everolimus|everolimus|mesh-list
44455035|NCT01653847|Tacrolimus|tacrolimus|mesh-list
44455036|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455037|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
44455038|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455039|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44455040|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455041|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455042|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721614|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455043|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44126206|NCT00137813|Docetaxel|docetaxel|mesh-list
44455044|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44189745|NCT00352339|Aripiprazole|aripiprazole|mesh-list
44189746|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189747|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189748|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189749|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189750|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189751|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189752|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
44189753|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
44189754|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189755|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189756|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44189757|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44189758|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
44189783|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189784|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
44189785|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
44189786|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44189787|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
44189788|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189789|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189790|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44189791|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189792|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44189793|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
44189794|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189795|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189796|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44189797|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
44280461|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280462|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280463|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
44280464|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280465|NCT00728585|Mitogens|mitogens|mesh-list
44280466|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44280467|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280468|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
44280469|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44280470|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
44280471|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280472|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
44280473|NCT00728611|Protective Agents|protective agents|mesh-ancestor
44280474|NCT00728663|Docetaxel|docetaxel|mesh-list
44280475|NCT00728663|Cetuximab|cetuximab|mesh-list
44280476|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280477|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
44280478|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
44280479|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
44280480|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280481|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280483|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
44280484|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280485|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44280486|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
44280487|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280488|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280489|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44280490|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44280491|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
44280492|NCT00728715|Hormones|hormones|mesh-ancestor
44280493|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280494|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44280495|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44280496|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44463694|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44463695|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463696|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
44463697|NCT01507051|Coagulants|coagulants|mesh-ancestor
44463698|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
44463699|NCT01506947|Hematinics|hematinics|mesh-ancestor
44463700|NCT01506908|Nicotine|nicotine|mesh-list
44463701|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44463702|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
44463703|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463704|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189798|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
44189799|NCT00352430|Protective Agents|protective agents|mesh-ancestor
44189800|NCT00352443|Everolimus|everolimus|mesh-list
44189801|NCT00352443|Lapatinib|lapatinib|mesh-list
44189802|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189803|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189804|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
44189805|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189806|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189807|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189808|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189809|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44189844|NCT00352599|Lovastatin|lovastatin|mesh-list
44189845|NCT00352599|L 647318|l 647318|mesh-list
44189846|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
44189847|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44189848|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189878|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189879|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189880|NCT00352677|Bafetinib|bafetinib|mesh-list
44189881|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189882|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189883|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189884|NCT00352742|Bortezomib|bortezomib|mesh-list
44189885|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44189886|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189887|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
44189888|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
44189889|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189890|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189916|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44189917|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44189918|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44189919|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
44189920|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189921|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189922|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189923|NCT00352833|Catumaxomab|catumaxomab|mesh-list
44189924|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44189925|NCT00352859|Gemcitabine|gemcitabine|mesh-list
44189926|NCT00352859|Interferons|interferons|mesh-list
44189927|NCT00352859|Sorafenib|sorafenib|mesh-list
44189928|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189929|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
44189930|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189931|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189932|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
44189933|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189934|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189935|NCT00352859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700573|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44463705|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44463706|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44463707|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
44463708|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463709|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463710|NCT01506882|Levetiracetam|levetiracetam|mesh-list
44463711|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
44463712|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
44463713|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
44463714|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44463715|NCT01506726|Salicylates|salicylates|mesh-list
44463716|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463717|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463718|NCT01506726|Analgesics|analgesics|mesh-ancestor
44189954|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189956|NCT00353015|Irinotecan|irinotecan|mesh-list
44189957|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189958|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44189959|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189960|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189961|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189962|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
44189963|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189964|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189965|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44189966|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189967|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189968|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189969|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189970|NCT00353028|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44189971|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44189972|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722124|NCT02618876|Analgesics|analgesics|mesh-ancestor
43722125|NCT02618824|Tryptophan|tryptophan|mesh-list
43722126|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43722127|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
43722128|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722129|NCT02618668|Ketamine|ketamine|mesh-list
43722130|NCT02618668|Propofol|propofol|mesh-list
43722131|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43722132|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722133|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722134|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44189973|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189974|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
44189975|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44189976|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189977|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44189978|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44189979|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44189980|NCT00353041|Lidocaine|lidocaine|mesh-list
44189981|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
44189982|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
44189983|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189984|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189985|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
44189986|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189987|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44189988|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44190009|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44190010|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190011|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190012|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44190013|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190014|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44190015|NCT00353145|Gemcitabine|gemcitabine|mesh-list
44190016|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
44190017|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190018|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
43700574|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463720|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463721|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463722|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463723|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463724|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463725|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463726|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190019|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190020|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190022|NCT00353145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190023|NCT00353145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190024|NCT00353145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190025|NCT00353145|Immunologic Factors|immunologic factors|mesh-ancestor
44190026|NCT00353145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190027|NCT00353184|Montelukast|montelukast|mesh-list
44190028|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44190029|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190030|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44190031|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
44190032|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722136|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
44190033|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190034|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44190035|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44455045|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
44190070|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44190071|NCT00353665|Riluzole|riluzole|mesh-list
44190072|NCT00353665|Memantine|memantine|mesh-list
44190073|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44190103|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190104|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44190105|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44190106|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190107|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190108|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44190109|NCT00353743|Metronidazole|metronidazole|mesh-list
44190110|NCT00353743|Doxycycline|doxycycline|mesh-list
44190111|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190112|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190113|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44190114|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190115|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
44190116|NCT00353808|Reboxetine|reboxetine|mesh-list
44190117|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
44190118|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44190119|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44190120|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44190157|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190158|NCT00354081|Hematinics|hematinics|mesh-ancestor
44190159|NCT00354094|Reboxetine|reboxetine|mesh-list
44190173|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44190174|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190175|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190176|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44190177|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
44190178|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44190179|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190180|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190181|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44190182|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44190183|NCT00354198|Protective Agents|protective agents|mesh-ancestor
44190184|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463727|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463728|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
44463729|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
44463730|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44463732|NCT01506609|Carboplatin|carboplatin|mesh-list
44463733|NCT01506609|Temozolomide|temozolomide|mesh-list
44463734|NCT01506609|Veliparib|veliparib|mesh-list
44463735|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44463736|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463737|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
44463738|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
44463739|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
44463740|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463741|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463742|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
44463743|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44463744|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463745|NCT01506453|Gabapentin|gabapentin|mesh-list
44463746|NCT01506453|Analgesics|analgesics|mesh-ancestor
44463747|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
44463748|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463749|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190185|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
44190186|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43833032|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190187|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
44190188|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190189|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
44190190|NCT00354198|Hormones|hormones|mesh-ancestor
44190191|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190192|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44190193|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44190194|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190195|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44190196|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455046|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455047|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455048|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44455049|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44455050|NCT01653743|Hormones|hormones|mesh-ancestor
44455051|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455052|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455053|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44455054|NCT01653327|Ketamine|ketamine|mesh-list
44455055|NCT01653327|Analgesics|analgesics|mesh-ancestor
44455056|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
44455057|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455058|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455059|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44455060|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44455061|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
44455062|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
43700575|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280500|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44280501|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44280502|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44280504|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280505|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44280506|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44280507|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280508|NCT00728832|Morphine|morphine|mesh-list
44455063|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455064|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44455065|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44455066|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455088|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455090|NCT01652716|Exenatide|exenatide|mesh-list
44455091|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455092|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455093|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44455094|NCT01652716|Incretins|incretins|mesh-ancestor
44455095|NCT01652716|Hormones|hormones|mesh-ancestor
44455096|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455097|NCT01652703|Evolocumab|evolocumab|mesh-list
44455098|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44455099|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44455100|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
44455101|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455102|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44455103|NCT01652690|Denosumab|denosumab|mesh-list
44455104|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44455105|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126669|NCT00139256|Hormones|hormones|mesh-ancestor
44455106|NCT01652664|Timolol|timolol|mesh-list
44455107|NCT01652664|Travoprost|travoprost|mesh-list
44455108|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44190198|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190199|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
43722615|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43722616|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722617|NCT02615782|Tadalafil|tadalafil|mesh-list
43722618|NCT02615782|Tamsulosin|tamsulosin|mesh-list
43722619|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
43722620|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44190200|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190201|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190202|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
44190203|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190204|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190205|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
44190206|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190207|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
44190208|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
44190209|NCT00354302|Alendronate|alendronate|mesh-list
44190240|NCT00354380|Amodiaquine|amodiaquine|mesh-list
44190241|NCT00354380|Methylene Blue|methylene blue|mesh-list
44190242|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
44190243|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44190244|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190245|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190246|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190247|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
44190248|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
44190249|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44190250|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
44190251|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190252|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190253|NCT00354393|Cisplatin|cisplatin|mesh-list
44190254|NCT00354393|Methotrexate|methotrexate|mesh-list
44190255|NCT00354393|Vinorelbine|vinorelbine|mesh-list
44190288|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190289|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797470|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
44280509|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44280510|NCT00728832|Narcotics|narcotics|mesh-ancestor
44280511|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280512|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280513|NCT00728832|Analgesics|analgesics|mesh-ancestor
44280514|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
44190290|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44190291|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
44190292|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190293|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190294|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44190295|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44190296|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190297|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
44190298|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190299|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
44190300|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44190335|NCT00354549|Antiviral Agents|antiviral agents|mesh-ancestor
44190336|NCT00354549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190337|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190338|NCT00354549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190339|NCT00354549|Immunologic Factors|immunologic factors|mesh-ancestor
44190340|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44190377|NCT00354757|Rabeprazole|rabeprazole|mesh-list
44190378|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44190379|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190413|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44190414|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190415|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722621|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43722650|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
43722651|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722652|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43722653|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44190416|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190417|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
44190418|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44190419|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190437|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190439|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44190440|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44190441|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190442|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44190443|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44190444|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190445|NCT00354991|Diuretics|diuretics|mesh-ancestor
44190446|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
44190447|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190448|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44190449|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190450|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
44190451|NCT00355043|Astringents|astringents|mesh-ancestor
44190452|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190453|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
44190454|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
44190455|NCT00355095|Hematinics|hematinics|mesh-ancestor
44190456|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
44190457|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44190458|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44190459|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190460|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
44190461|NCT00355108|Coagulants|coagulants|mesh-ancestor
44190462|NCT00355251|Atorvastatin|atorvastatin|mesh-list
44190463|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44190464|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44190465|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
44190466|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190467|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44190468|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44190469|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190470|NCT00355277|Amitriptyline|amitriptyline|mesh-list
44190471|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44190472|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
44280515|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280516|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44280517|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
44280518|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280519|NCT00729118|Lenalidomide|lenalidomide|mesh-list
44280520|NCT00729118|Vorinostat|vorinostat|mesh-list
44280521|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
44280522|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280523|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44280524|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280525|NCT00729118|Growth Substances|growth substances|mesh-ancestor
44280526|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280527|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280528|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44190473|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44190474|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44190475|NCT00355277|Analgesics|analgesics|mesh-ancestor
44190534|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190535|NCT00355576|Minocycline|minocycline|mesh-list
43722654|NCT02615574|Analgesics|analgesics|mesh-ancestor
43722655|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
43722867|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648433|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
43648435|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648436|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648437|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190537|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44190538|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44190539|NCT00355576|Analgesics|analgesics|mesh-ancestor
44190540|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
44190541|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190542|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190543|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190544|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190545|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44190546|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44190547|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190548|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190549|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190550|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190551|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44190552|NCT00355589|Ramipril|ramipril|mesh-list
44190553|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190554|NCT00355589|Diuretics|diuretics|mesh-ancestor
44190555|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
44190556|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190557|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44190558|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190559|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190560|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44190561|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190562|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190563|NCT00355602|Metronidazole|metronidazole|mesh-list
44190564|NCT00355602|Vancomycin|vancomycin|mesh-list
44190565|NCT00355602|Clarithromycin|clarithromycin|mesh-list
44190566|NCT00355602|Doxycycline|doxycycline|mesh-list
44190567|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
44190581|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190582|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
44190583|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44190584|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44190585|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190586|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44190587|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190588|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44190589|NCT00355602|Renal Agents|renal agents|mesh-ancestor
44190590|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44280529|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280530|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280531|NCT00729131|Etanercept|etanercept|mesh-list
44280532|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280533|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280534|NCT00729131|Analgesics|analgesics|mesh-ancestor
44280535|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
44280536|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280537|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280538|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280539|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834342|NCT05148000|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43648438|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
43648439|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648440|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280540|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648441|NCT03320018|Minocycline|minocycline|mesh-list
43648442|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43666355|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44190591|NCT00355628|Fentanyl|fentanyl|mesh-list
44190592|NCT00355628|Citric Acid|citric acid|mesh-list
44190593|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
44190594|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44190595|NCT00355628|Narcotics|narcotics|mesh-ancestor
44190596|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44190597|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190598|NCT00355628|Analgesics|analgesics|mesh-ancestor
44190599|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
44190600|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190601|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44190602|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44190603|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
44190604|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
44190605|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
44190606|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44190607|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
44190608|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
44190609|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190610|NCT00355641|Ropinirole|ropinirole|mesh-list
44190611|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44190612|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44190613|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
44190614|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
44190615|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190616|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190617|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190618|NCT00355667|Furosemide|furosemide|mesh-list
44190619|NCT00355667|Azosemide|azosemide|mesh-list
44190620|NCT00355667|Diuretics|diuretics|mesh-ancestor
44190621|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
44190622|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190623|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44190624|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190625|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190626|NCT00355693|Propofol|propofol|mesh-list
44190627|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44190653|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44190654|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
44190655|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
44190656|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190657|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190658|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190659|NCT00355862|Cyclosporine|cyclosporine|mesh-list
44190660|NCT00355862|Sirolimus|sirolimus|mesh-list
44190661|NCT00355862|Prednisolone|prednisolone|mesh-list
44190662|NCT00355862|Azathioprine|azathioprine|mesh-list
44190663|NCT00355862|Tacrolimus|tacrolimus|mesh-list
44190664|NCT00355862|Cyclosporins|cyclosporins|mesh-list
44190665|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280541|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280542|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
44280543|NCT00729170|Calcium|calcium|mesh-list
44280544|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44280545|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280546|NCT00729222|Rolofylline|rolofylline|mesh-list
44190666|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
44190667|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190668|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44190669|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190670|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190671|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
44190672|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190673|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
44190674|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190701|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190702|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190703|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
44190704|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44190705|NCT00355953|Estrogens|estrogens|mesh-ancestor
44190707|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190708|NCT00355966|Misoprostol|misoprostol|mesh-list
44190709|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44190710|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
44190711|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44190712|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190713|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44190714|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190715|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
44190716|NCT00356005|Azithromycin|azithromycin|mesh-list
44190717|NCT00356005|Artesunate|artesunate|mesh-list
44190718|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190719|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190720|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
44190721|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44127166|NCT00140712|Ropinirole|ropinirole|mesh-list
44190722|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190737|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44190739|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44190740|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190741|NCT00356083|Analgesics|analgesics|mesh-ancestor
44190742|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
44190743|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190744|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
44190745|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190746|NCT00356096|Pramipexole|pramipexole|mesh-list
44190747|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
44190748|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190749|NCT00356096|Protective Agents|protective agents|mesh-ancestor
44190750|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190751|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44190752|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44190753|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
44190754|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
44190755|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190756|NCT00356226|Clonidine|clonidine|mesh-list
44190757|NCT00356226|Analgesics|analgesics|mesh-ancestor
44190758|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
44190759|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190760|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190761|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190762|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
44190792|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190793|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44190794|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190795|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190796|NCT00356447|Estradiol|estradiol|mesh-list
44190797|NCT00356447|Estrogens|estrogens|mesh-ancestor
44190798|NCT00356447|Hormones|hormones|mesh-ancestor
44280547|NCT00729222|Diuretics|diuretics|mesh-ancestor
44280548|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
44280549|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280550|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44280551|NCT00729287|Selenium|selenium|mesh-list
44280552|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
44280553|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280554|NCT00729287|Protective Agents|protective agents|mesh-ancestor
44280555|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280556|NCT00729287|Trace Elements|trace elements|mesh-ancestor
44280557|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
44280558|NCT00729300|Disulfiram|disulfiram|mesh-list
44280559|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43666381|NCT03998735|Lobeline|lobeline|mesh-list
44190799|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190800|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190801|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44190803|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
44190804|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44190805|NCT00356460|Mitogens|mitogens|mesh-list
44190806|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
44190807|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190825|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190826|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
44190827|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190828|NCT00356616|Tenofovir|tenofovir|mesh-list
44190829|NCT00356616|Abacavir|abacavir|mesh-list
44190830|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
44190831|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190832|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44190833|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190834|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190835|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190836|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190837|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44190838|NCT00356720|Azithromycin|azithromycin|mesh-list
44190839|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190840|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190841|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
44190842|NCT00356733|Hematinics|hematinics|mesh-ancestor
44190843|NCT00356772|Azithromycin|azithromycin|mesh-list
44190844|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190845|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190846|NCT00356824|Artesunate|artesunate|mesh-list
44190847|NCT00356824|Amodiaquine|amodiaquine|mesh-list
44190848|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
44190849|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44190850|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190851|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190852|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190853|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
44190854|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
44190855|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44190856|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
44190857|NCT00356850|Azithromycin|azithromycin|mesh-list
44190858|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190859|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190860|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
44190861|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190862|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
44190863|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190864|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190865|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44190866|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
44190901|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44280560|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44280561|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280562|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280563|NCT00729313|Lanreotide|lanreotide|mesh-list
44280564|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280565|NCT00729339|Mosapride|mosapride|mesh-list
44190902|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190903|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190904|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190920|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44190922|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190923|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
44190924|NCT00357084|Hormones|hormones|mesh-ancestor
44190925|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190926|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190927|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44190928|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190929|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44190930|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
44190931|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44190932|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190933|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
44190934|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190935|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
44190936|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190937|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44190938|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190939|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
44190940|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190941|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190942|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
44190943|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
44190944|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190945|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190946|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44190947|NCT00357084|Protective Agents|protective agents|mesh-ancestor
44190948|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44190949|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44190950|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44190951|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
44190952|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190953|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44190954|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44190955|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190956|NCT00357149|Cisplatin|cisplatin|mesh-list
44190957|NCT00357149|Docetaxel|docetaxel|mesh-list
44190958|NCT00357149|Fluorouracil|fluorouracil|mesh-list
44190959|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190960|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44190961|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44190962|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190963|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190988|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44190989|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44190991|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44190992|NCT00357240|Omeprazole|omeprazole|mesh-list
44190993|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44190994|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44190995|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190996|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190997|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190998|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190999|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44191000|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
44191001|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191002|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43797770|NCT05037253|Vitamins|vitamins|mesh-ancestor
44280567|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44280568|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
44280569|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280570|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280571|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280572|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44280573|NCT00729404|Gestodene|gestodene|mesh-list
44280574|NCT00729404|Femovan|femovan|mesh-list
44463751|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44191003|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44191004|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44191005|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191006|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44191007|NCT00357253|Capecitabine|capecitabine|mesh-list
44191008|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191009|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
44191010|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191030|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
44191031|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191032|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44191033|NCT00357318|Bevacizumab|bevacizumab|mesh-list
44191034|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44191036|NCT00357318|Antibodies|antibodies|mesh-list
44191037|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
44191038|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44191039|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191040|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191041|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191042|NCT00357318|Growth Substances|growth substances|mesh-ancestor
44191043|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191044|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
44191045|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
44191046|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44191047|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191048|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191049|NCT00357383|Azithromycin|azithromycin|mesh-list
44191050|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191051|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191052|NCT00357422|Ethanol|ethanol|mesh-list
43723415|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723416|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723417|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723418|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723419|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43723420|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723421|NCT02609997|Dexamethasone|dexamethasone|mesh-list
43723422|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
43723423|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723424|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
43723425|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
43723426|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723427|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723428|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43723429|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
43723430|NCT02609997|Hormones|hormones|mesh-ancestor
44191053|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44191054|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191055|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191056|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191057|NCT00357448|Interleukin-2|interleukin-2|mesh-list
44191058|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
44191059|NCT00357448|Immunotoxins|immunotoxins|mesh-list
44191060|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191061|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191062|NCT00357448|Analgesics|analgesics|mesh-ancestor
44191063|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
44191064|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191065|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191066|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
44191067|NCT00357461|Ipilimumab|ipilimumab|mesh-list
44191068|NCT00357461|Vaccines|vaccines|mesh-list
44191069|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
44191103|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
44191104|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191105|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44191106|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44191107|NCT00357604|Estrogens|estrogens|mesh-ancestor
44191108|NCT00357604|Hormones|hormones|mesh-ancestor
44191109|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191128|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280575|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44280576|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44191129|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191130|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191131|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191132|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44191133|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44191134|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191135|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191137|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191138|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
44191139|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191140|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191141|NCT00357630|Antiviral Agents|antiviral agents|mesh-ancestor
44191142|NCT00357630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191143|NCT00357630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191144|NCT00357630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191145|NCT00357630|Immunologic Factors|immunologic factors|mesh-ancestor
44191146|NCT00357630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191147|NCT00357643|Vitamin D|vitamin d|mesh-list
44191148|NCT00357643|Calcium|calcium|mesh-list
44191149|NCT00357643|Vitamins|vitamins|mesh-ancestor
44191150|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
44191151|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191152|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44191153|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44191154|NCT00357669|Brivaracetam|brivaracetam|mesh-list
44191155|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
44191156|NCT00357682|Aspirin|aspirin|mesh-list
44191157|NCT00357682|Esomeprazole|esomeprazole|mesh-list
44191158|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44191159|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191160|NCT00357682|Analgesics|analgesics|mesh-ancestor
44191161|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
44191162|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191163|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191164|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191183|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191184|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44191185|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43723637|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723638|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723639|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191186|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44191187|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44191188|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
44191189|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191190|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191191|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44191192|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44191193|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
44191194|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191195|NCT00357747|Docetaxel|docetaxel|mesh-list
44191196|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191197|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
44191198|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
44191199|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
44191200|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191201|NCT00357773|Azithromycin|azithromycin|mesh-list
44191202|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191203|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191204|NCT00357825|Reboxetine|reboxetine|mesh-list
44191205|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
44191206|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44191207|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44191208|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44191209|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191210|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191211|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191212|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191213|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191214|NCT00357851|Aprotinin|aprotinin|mesh-list
44191215|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
44191216|NCT00357851|Coagulants|coagulants|mesh-ancestor
44191217|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44191218|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44280577|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44280578|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
44280579|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44280580|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280581|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44280582|NCT00729404|Estrogens|estrogens|mesh-ancestor
44280583|NCT00729404|Hormones|hormones|mesh-ancestor
44280584|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280585|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44191219|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
44191220|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191221|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191236|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
44191237|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191238|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191240|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44191241|NCT00357942|Narcotics|narcotics|mesh-ancestor
44191242|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191243|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191244|NCT00357942|Analgesics|analgesics|mesh-ancestor
44191245|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
44191246|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191247|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
44191248|NCT00357981|Ortho Evra|ortho evra|mesh-list
44191249|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191250|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191251|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44455118|NCT01652573|Calcitonin|calcitonin|mesh-list
44455119|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
44455120|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44191252|NCT00358020|Thalidomide|thalidomide|mesh-list
44191253|NCT00358020|Bortezomib|bortezomib|mesh-list
43723713|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723714|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
43723715|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723716|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191254|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191255|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191256|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
44191257|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191258|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
44191259|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191260|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191261|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191262|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191263|NCT00358020|Growth Substances|growth substances|mesh-ancestor
44191264|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
44191265|NCT00358124|Metformin|metformin|mesh-list
44191266|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
44191267|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
44191268|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191269|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191270|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
44191271|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44191272|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191273|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191274|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44191275|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191276|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44191277|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
44191278|NCT00358202|Cefepime|cefepime|mesh-list
44191279|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191280|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191281|NCT00358228|Rimonabant|rimonabant|mesh-list
44191300|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
44191301|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191302|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191303|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
44191304|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44280587|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44280588|NCT00729495|Celecoxib|celecoxib|mesh-list
44280589|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280590|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280591|NCT00729495|Analgesics|analgesics|mesh-ancestor
44280592|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
44280593|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191305|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44191306|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
44191307|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
44191308|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44191309|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44191310|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44191311|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191312|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191313|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191314|NCT00358319|Valproic Acid|valproic acid|mesh-list
44191315|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
44191316|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191317|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191318|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
43723889|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
43723890|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723891|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
43723892|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723893|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723894|NCT02607423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723895|NCT02607423|Immunologic Factors|immunologic factors|mesh-ancestor
44191319|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191320|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191321|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
44191322|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44191323|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191324|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44191325|NCT00358358|Fluticasone|fluticasone|mesh-list
44191326|NCT00358358|Xhance|xhance|mesh-list
44191327|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44191328|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44191329|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191330|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44191331|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
44191332|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191333|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191334|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44191335|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
44191336|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191355|NCT00358384|Calcipotriene|calcipotriene|mesh-list
44191356|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44191357|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191358|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
44191359|NCT00358384|Hormones|hormones|mesh-ancestor
44191360|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191361|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191362|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44191363|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44191364|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191365|NCT00358410|Casopitant|casopitant|mesh-list
44191366|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
44191367|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
44191368|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191369|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191370|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191371|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44191372|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191373|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191374|NCT00358488|Albuterol|albuterol|mesh-list
44191375|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44191376|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44191377|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
44191378|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191379|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191380|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44280594|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280595|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280596|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191381|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
44191382|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44191383|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44191384|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44191385|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191386|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191387|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191388|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
44191389|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191390|NCT00358553|Insulin|insulin|mesh-list
44191391|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191422|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723989|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43723990|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43723991|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191424|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44191425|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
44191426|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191427|NCT00358813|Casopitant|casopitant|mesh-list
44191428|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
44191429|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
44191430|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191431|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191432|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191433|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44191434|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191435|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191471|NCT00359151|Celecoxib|celecoxib|mesh-list
44191496|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
44191497|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
44191498|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191499|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191500|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191501|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44191502|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191503|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191504|NCT00359190|Lapatinib|lapatinib|mesh-list
44191505|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191506|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44191507|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191508|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191509|NCT00359229|Zolpidem|zolpidem|mesh-list
44191510|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44191511|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44191512|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191513|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191514|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44191515|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
44191516|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
44191517|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191518|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191519|NCT00359333|Gemcitabine|gemcitabine|mesh-list
44191520|NCT00359333|Docetaxel|docetaxel|mesh-list
44191521|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191522|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
44191555|NCT00359658|Cyclosporine|cyclosporine|mesh-list
44191556|NCT00359658|Prednisolone|prednisolone|mesh-list
44191557|NCT00359658|Cyclosporins|cyclosporins|mesh-list
44191558|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191559|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191560|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191561|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
44191562|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191563|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
44191564|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191594|NCT00359814|Cyclosporine|cyclosporine|mesh-list
44191595|NCT00359814|Cyclosporins|cyclosporins|mesh-list
44191596|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830498|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44280597|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44280598|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44280599|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723993|NCT02606994|Lidocaine|lidocaine|mesh-list
44280600|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280601|NCT00729573|Tenofovir|tenofovir|mesh-list
44280602|NCT00729573|Emtricitabine|emtricitabine|mesh-list
44280603|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44280604|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
44280605|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280606|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44191597|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191598|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191599|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
44191600|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191601|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
44191602|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191603|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191604|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191605|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44191606|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
44191607|NCT00359840|Hematinics|hematinics|mesh-ancestor
44191608|NCT00359853|Norfloxacin|norfloxacin|mesh-list
44191609|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455133|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44455134|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455135|NCT01651936|Methotrexate|methotrexate|mesh-list
44455136|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44455137|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
44455138|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44455139|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455140|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44455141|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
44455142|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455143|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455144|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
44455170|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44455171|NCT01651039|Dexamethasone|dexamethasone|mesh-list
44455172|NCT01651039|Lenalidomide|lenalidomide|mesh-list
44455173|NCT01651039|Panobinostat|panobinostat|mesh-list
44455174|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455175|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
44455176|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
44455177|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455178|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455179|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455180|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
44455181|NCT01651039|Hormones|hormones|mesh-ancestor
44455182|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455183|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44455184|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455185|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
44455186|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44455187|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44455188|NCT01651039|Growth Substances|growth substances|mesh-ancestor
44455189|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455190|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44455191|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455192|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724268|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724269|NCT02604992|Dronabinol|dronabinol|mesh-list
43724270|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
44455193|NCT01651000|Calcifediol|calcifediol|mesh-list
44191628|NCT00359905|Tamsulosin|tamsulosin|mesh-list
44191629|NCT00359905|Silodosin|silodosin|mesh-list
44191654|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44191656|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44191657|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44280608|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724271|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724272|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43724273|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280609|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280610|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44280611|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44280612|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
44280613|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44280614|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280615|NCT00729638|Lenalidomide|lenalidomide|mesh-list
44280616|NCT00729638|Everolimus|everolimus|mesh-list
44280617|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
44280618|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280619|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191658|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191659|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191660|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44191661|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191662|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44191663|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44191664|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44191665|NCT00360178|Diuretics|diuretics|mesh-ancestor
44191666|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
44191667|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44191668|NCT00360191|Buspirone|buspirone|mesh-list
44191669|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44191670|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44191671|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191672|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191673|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44191674|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44191675|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
44191676|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191677|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191678|NCT00360295|Azithromycin|azithromycin|mesh-list
44191701|NCT00360607|Sulbactam|sulbactam|mesh-list
44191702|NCT00360607|Cefoperazone|cefoperazone|mesh-list
44191703|NCT00360607|Sulperazone|sulperazone|mesh-list
44191704|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191705|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191706|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44191707|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44191708|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44191709|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191710|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191711|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44191712|NCT00360607|Renal Agents|renal agents|mesh-ancestor
44191713|NCT00360737|Antitoxins|antitoxins|mesh-list
44191714|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
44191715|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
44191716|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191717|NCT00360750|Cytarabine|cytarabine|mesh-list
44191718|NCT00360750|Carboplatin|carboplatin|mesh-list
44191719|NCT00360750|Etoposide|etoposide|mesh-list
44191720|NCT00360750|Vincristine|vincristine|mesh-list
44191721|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191722|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44191723|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44191724|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191725|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191726|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191727|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44280620|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44280621|NCT00729638|Growth Substances|growth substances|mesh-ancestor
44280622|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
44280623|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280624|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280625|NCT00729664|Atezolizumab|atezolizumab|mesh-list
44280626|NCT00729664|BMS-936559|bms-936559|mesh-list
44280627|NCT00729664|Antibodies|antibodies|mesh-list
44280628|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
44280629|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44280630|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
44280631|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280632|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280633|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44280634|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44280635|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280636|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280637|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666448|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
44191728|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
44191729|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
44191730|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191731|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191732|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
44191733|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191755|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191756|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44191758|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191759|NCT00360984|Insulin|insulin|mesh-list
44191760|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44191761|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
44191762|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191763|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191764|NCT00361010|Levetiracetam|levetiracetam|mesh-list
44191765|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
44191766|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
44191767|NCT00361023|Losartan|losartan|mesh-list
44191768|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44191769|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44191770|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44191771|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44191772|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191773|NCT00361075|Estradiol|estradiol|mesh-list
44191774|NCT00361075|Estrogens|estrogens|mesh-list
44191775|NCT00361075|Progesterone|progesterone|mesh-list
44191776|NCT00361075|Hormones|hormones|mesh-ancestor
44191777|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128333|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191778|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191779|NCT00361075|Progestins|progestins|mesh-ancestor
44191780|NCT00361088|Bortezomib|bortezomib|mesh-list
44191781|NCT00361088|Tipifarnib|tipifarnib|mesh-list
44191782|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191783|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
44191784|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
44191785|NCT00361114|Dapsone|dapsone|mesh-list
44191786|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43724385|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724386|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43724387|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43724388|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43724389|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724391|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44191787|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
44191808|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44280639|NCT00729768|Cyclosporine|cyclosporine|mesh-list
44280640|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
44280641|NCT00729768|Cyclosporins|cyclosporins|mesh-list
44280642|NCT00729768|Basiliximab|basiliximab|mesh-list
44280643|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280644|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280645|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191809|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44191810|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191811|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191812|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44191813|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44191814|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44191815|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
44191816|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191817|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191818|NCT00361244|Irinotecan|irinotecan|mesh-list
44191819|NCT00361244|Cetuximab|cetuximab|mesh-list
44191820|NCT00361244|Sunitinib|sunitinib|mesh-list
44191821|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44191822|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191823|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191824|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191825|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191826|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44191827|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191828|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191829|NCT00361244|Growth Substances|growth substances|mesh-ancestor
44191830|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191831|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
44191832|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44191833|NCT00361309|Sunitinib|sunitinib|mesh-list
44191834|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191835|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191836|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191837|NCT00361309|Growth Substances|growth substances|mesh-ancestor
44191838|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191839|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
44191840|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44191841|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191872|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191873|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44191874|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44191875|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191876|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191877|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
44191878|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191879|NCT00361413|Alefacept|alefacept|mesh-list
44191880|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191881|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
44191882|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191883|NCT00361452|Epinephrine|epinephrine|mesh-list
44191884|NCT00361452|Albuterol|albuterol|mesh-list
44191885|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44191922|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44191948|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44191949|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
44191950|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
44191951|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
44191952|NCT00361686|Tramadol|tramadol|mesh-list
43724452|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43724453|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43724454|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724455|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
43724456|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724457|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724458|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
43724459|NCT02604134|Fluorides|fluorides|mesh-list
43724460|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
44191953|NCT00361686|Remifentanil|remifentanil|mesh-list
44191954|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44191955|NCT00361686|Narcotics|narcotics|mesh-ancestor
44191956|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280647|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280648|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
43935231|NCT00816751|Lidocaine|lidocaine|mesh-list
44280649|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280650|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
44280651|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280652|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44280653|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44280654|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280655|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44191957|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191958|NCT00361686|Analgesics|analgesics|mesh-ancestor
44191959|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
44191960|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191961|NCT00361751|Fenofibrate|fenofibrate|mesh-list
44191962|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44191963|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
44191964|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191965|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44191966|NCT00361790|Aripiprazole|aripiprazole|mesh-list
44191967|NCT00361790|Citalopram|citalopram|mesh-list
44191968|NCT00361790|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44191969|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44191970|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191971|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191972|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191994|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455194|NCT01651000|Vitamins|vitamins|mesh-ancestor
44455195|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
44455196|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455197|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44455198|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
44455199|NCT01650805|Ponatinib|ponatinib|mesh-list
44455200|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455201|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44455202|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455203|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455204|NCT01650558|Chloroquine|chloroquine|mesh-list
44191996|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
44191997|NCT00361868|Fenofibrate|fenofibrate|mesh-list
44191998|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191999|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192000|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192001|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
44192002|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192003|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192004|NCT00361881|Acyclovir|acyclovir|mesh-list
44192005|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
44192006|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
44192007|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192008|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192009|NCT00361894|Enoxaparin|enoxaparin|mesh-list
44192010|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
44192011|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44192012|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
44192013|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44192014|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192015|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192032|NCT00361933|Valganciclovir|valganciclovir|mesh-list
44192033|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
44192034|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192035|NCT00361959|Fluticasone|fluticasone|mesh-list
44192037|NCT00361959|Bromides|bromides|mesh-list
44192038|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
44280656|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
44280657|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280659|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
44280660|NCT00729794|Vasopressins|vasopressins|mesh-list
44280661|NCT00729794|Arginine Vasopressin|arginine vasopressin|mesh-list
44280662|NCT00729794|Epinephrine|epinephrine|mesh-list
44280663|NCT00729794|Racepinephrine|racepinephrine|mesh-list
44280664|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
44280665|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280666|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
44280667|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
44192039|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44192040|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192041|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44192042|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
44192043|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192044|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192045|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44192046|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44192047|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192048|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44192049|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
44192050|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44192051|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
44192052|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192053|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192054|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44192055|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44192056|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44192057|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44192058|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
44192059|NCT00361985|Esomeprazole|esomeprazole|mesh-list
44192060|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192061|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192062|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44192063|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192064|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192065|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
44192066|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44192067|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192068|NCT00361998|Renal Agents|renal agents|mesh-ancestor
44192069|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192070|NCT00362037|Irbesartan|irbesartan|mesh-list
44192071|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44192072|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44192073|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44192074|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192090|NCT00362089|Hormones|hormones|mesh-ancestor
44192091|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192092|NCT00362102|Cetuximab|cetuximab|mesh-list
44192093|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44192094|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192095|NCT00362141|Levetiracetam|levetiracetam|mesh-list
44192096|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
44192097|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
44192098|NCT00362206|Simvastatin|simvastatin|mesh-list
44192099|NCT00362206|Pravastatin|pravastatin|mesh-list
44192100|NCT00362206|Fenofibrate|fenofibrate|mesh-list
44192101|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44192102|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192103|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
44192104|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724531|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
43724567|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
43724568|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724569|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724570|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648443|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648444|NCT03317899|Lenograstim|lenograstim|mesh-list
43648445|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43648446|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
44192105|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192106|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192107|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192108|NCT00362245|Amikacin|amikacin|mesh-list
44280668|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280669|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280670|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280671|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
44280672|NCT00729794|Hormones|hormones|mesh-ancestor
44280673|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280674|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44280675|NCT00729794|Protective Agents|protective agents|mesh-ancestor
44280676|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44280677|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44280678|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280679|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192109|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192110|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192111|NCT00362258|Irbesartan|irbesartan|mesh-list
44192112|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44192113|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44192114|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44192115|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192116|NCT00362271|Aripiprazole|aripiprazole|mesh-list
44192117|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44192118|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
44192119|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43724571|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724572|NCT02603445|Idelalisib|idelalisib|mesh-list
44192120|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192121|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192122|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192123|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192124|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
44192125|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
44192126|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192127|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192128|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44192129|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44192130|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
44192131|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44192132|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44192161|NCT00362531|Tacrolimus|tacrolimus|mesh-list
44192162|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192163|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
44192164|NCT00362531|Hormones|hormones|mesh-ancestor
44192165|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192166|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192167|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44192168|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192169|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192170|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
44192171|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44192172|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192173|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192174|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44192175|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
44192176|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192177|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44192178|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44192211|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192213|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192214|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44192215|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44192216|NCT00362700|Clevudine|clevudine|mesh-list
44192217|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
44192218|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280680|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280681|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44280682|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44280683|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44280684|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
44280686|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
44280687|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44280688|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
44280689|NCT00729794|Coagulants|coagulants|mesh-ancestor
44280690|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44192219|NCT00362713|Ipilimumab|ipilimumab|mesh-list
44192245|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44192246|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192247|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192248|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192249|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44192250|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44192251|NCT00362765|Metformin|metformin|mesh-list
44192252|NCT00362765|Fenofibrate|fenofibrate|mesh-list
44192253|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192254|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192255|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192256|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
44192257|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192258|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43724710|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44192259|NCT00362778|Insulin|insulin|mesh-list
44192260|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192261|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192262|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
44192263|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44192264|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192265|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44192266|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192267|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44192282|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44192283|NCT00362895|Tobramycin|tobramycin|mesh-list
44192284|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44192285|NCT00362895|Dexamethasone|dexamethasone|mesh-list
44192286|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
44192287|NCT00362895|BB 1101|bb 1101|mesh-list
44192288|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192289|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
44192290|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
44192291|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192292|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192293|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192294|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
44192295|NCT00362895|Hormones|hormones|mesh-ancestor
44128782|NCT05593939|Niacin|niacin|mesh-list
44192296|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192297|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44192298|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192299|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192300|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192301|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192302|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192303|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192304|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44192305|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44192306|NCT00362921|Carmustine|carmustine|mesh-list
44192307|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44192308|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44192309|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
44280691|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
44280692|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
44280693|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
44280694|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44280695|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44280696|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280697|NCT00729911|Amiodarone|amiodarone|mesh-list
44280698|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44280699|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
44280700|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44280701|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44280702|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280703|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44280704|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44280705|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44280706|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280707|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43724875|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724876|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
43724877|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724878|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
43724879|NCT02601898|Progesterone|progesterone|mesh-list
43724880|NCT02601898|Progestins|progestins|mesh-ancestor
43724881|NCT02601898|Hormones|hormones|mesh-ancestor
43724883|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280708|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44192310|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192311|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192312|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192313|NCT00362934|Atorvastatin|atorvastatin|mesh-list
44192314|NCT00362934|Simvastatin|simvastatin|mesh-list
44192315|NCT00362934|Fenofibrate|fenofibrate|mesh-list
44192316|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44192317|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192318|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
44192319|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192320|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192321|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192322|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192323|NCT00362947|Parnaparin|parnaparin|mesh-list
44192324|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
44192325|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44192326|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44192327|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192345|NCT00363025|Idarubicin|idarubicin|mesh-list
44192346|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44192347|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192348|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192349|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44192350|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192351|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192352|NCT00363090|Prednisone|prednisone|mesh-list
44192353|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
44192354|NCT00363090|Doxorubicin|doxorubicin|mesh-list
44192355|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44192356|NCT00363090|Vincristine|vincristine|mesh-list
44192357|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
44192358|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192359|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
44192360|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192361|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192362|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44280709|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44280711|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44192363|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
44192364|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192365|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192366|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44192367|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44192368|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192369|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43724943|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43724944|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43724945|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43724946|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724947|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
43724948|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724973|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43724974|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
43724975|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724977|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
43724978|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192370|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192371|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192372|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
44192373|NCT00363090|Hormones|hormones|mesh-ancestor
44192374|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192375|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44192376|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44192377|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44192378|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
44192379|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
44192380|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44192381|NCT00363116|Daclizumab|daclizumab|mesh-list
44192382|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192383|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
44192384|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192421|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44192422|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44192455|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192457|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192458|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
44192459|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44192460|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192461|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192462|NCT00363519|Incretins|incretins|mesh-ancestor
44192463|NCT00363519|Hormones|hormones|mesh-ancestor
44192489|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192491|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192492|NCT00363688|Penicillins|penicillins|mesh-list
44192493|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192494|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192495|NCT00363701|Esomeprazole|esomeprazole|mesh-list
44192496|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192497|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192498|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44192499|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192500|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455205|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44455206|NCT01650558|Amebicides|amebicides|mesh-ancestor
44455207|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44455208|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44455209|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455210|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
44455211|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455212|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44455213|NCT01650558|Renal Agents|renal agents|mesh-ancestor
44192522|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44192523|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44192524|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192526|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44192527|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44192528|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44192529|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
44192530|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192531|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
44192532|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
44192533|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
44192554|NCT00363909|Citalopram|citalopram|mesh-list
44192555|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44192556|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192557|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44280713|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44280714|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280715|NCT00729963|Sibutramine|sibutramine|mesh-list
44280716|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
44280717|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44280718|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
44280719|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44280720|NCT00729976|Ibuprofen|ibuprofen|mesh-list
44280721|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280722|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280723|NCT00729976|Analgesics|analgesics|mesh-ancestor
44280724|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
43826546|NCT05497323|Adapalene|adapalene|mesh-list
44192558|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192559|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192560|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
44192561|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192562|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44192563|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
44192564|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192565|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44192566|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44192567|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
44192568|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
44192569|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192570|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44192571|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44192572|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
44192573|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
44192574|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44455224|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192575|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192576|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192577|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192579|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
44192580|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192581|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44192582|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44192583|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44192584|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
44192585|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192606|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44192607|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192609|NCT00364052|Ganciclovir|ganciclovir|mesh-list
44192610|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44192611|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
44192612|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192613|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192614|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725083|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725084|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43725085|NCT02600741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43725086|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43725087|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725088|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
43725089|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
43725150|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192615|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192616|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44192617|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44192618|NCT00364143|Irinotecan|irinotecan|mesh-list
44192619|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44192620|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44192621|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192622|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192623|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280727|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280728|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280729|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44280730|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280731|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280732|NCT00730054|Clonidine|clonidine|mesh-list
44280733|NCT00730054|Remifentanil|remifentanil|mesh-list
44280734|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44280735|NCT00730054|Narcotics|narcotics|mesh-ancestor
44280736|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280737|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280738|NCT00730054|Analgesics|analgesics|mesh-ancestor
44280739|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
44192624|NCT00364195|Tesmilifene|tesmilifene|mesh-list
44192625|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
44192626|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
44192627|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192628|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192629|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192630|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44192631|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
44192632|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192633|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192634|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
44192635|NCT00364260|Hematinics|hematinics|mesh-ancestor
44192636|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44192637|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44192665|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192666|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192667|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44192668|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44192669|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
44192670|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
44192671|NCT00364442|Fluticasone|fluticasone|mesh-list
44192672|NCT00364442|Xhance|xhance|mesh-list
44192673|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44192674|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192675|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44192676|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
43725154|NCT02600247|Narcotics|narcotics|mesh-ancestor
43725199|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
43725200|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
43725201|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725202|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725203|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43725204|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43725205|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43725206|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
43725207|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725208|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725209|NCT02599792|Ivacaftor|ivacaftor|mesh-list
44192677|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192678|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192679|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44192680|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44192681|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192682|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44192683|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44192684|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44192685|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44192686|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44192722|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44192744|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192746|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192747|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192748|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192750|NCT00364871|Bupropion|bupropion|mesh-list
44192751|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44192752|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44280740|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280741|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44280743|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
44280744|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44280745|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44280746|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44192753|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192754|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
44192755|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192756|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44192757|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
44192758|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192759|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44192760|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192761|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44192762|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192763|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
44192764|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192765|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44192766|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44192767|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192768|NCT00364988|Pioglitazone|pioglitazone|mesh-list
44192769|NCT00364988|Losartan|losartan|mesh-list
44192770|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192771|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192772|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44192773|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44192798|NCT00365040|Mitomycins|mitomycins|mesh-list
44192799|NCT00365040|Mitomycin|mitomycin|mesh-list
44192800|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44192801|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192802|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
44192803|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192804|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192805|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192806|NCT00365170|Insulin|insulin|mesh-list
44192807|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44192808|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
44192809|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192810|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192811|NCT00365183|Pemetrexed|pemetrexed|mesh-list
44192812|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
44192813|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192814|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192815|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192816|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44192817|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192818|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44192850|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
44192851|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192852|NCT00365313|Celecoxib|celecoxib|mesh-list
44192853|NCT00365313|Esomeprazole|esomeprazole|mesh-list
44192854|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44192855|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192856|NCT00365313|Analgesics|analgesics|mesh-ancestor
44192857|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
44192858|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192859|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192860|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192861|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192862|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44192883|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44192884|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43830499|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
44280747|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280748|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280749|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280750|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
44280751|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
44280752|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44280753|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44280754|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280755|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280756|NCT00730067|Urological Agents|urological agents|mesh-ancestor
44280757|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
44280758|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
44280759|NCT00730093|Vitamins|vitamins|mesh-ancestor
44280760|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
44280761|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280762|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
44280763|NCT00730093|Hematinics|hematinics|mesh-ancestor
44280764|NCT00730197|Albuterol|albuterol|mesh-list
44280765|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44280766|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
44280767|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192885|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44192886|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192887|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44192888|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192889|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192890|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192891|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192892|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192893|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
44192894|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
44192895|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192896|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44192897|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44192898|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
44192899|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44192900|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44192901|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44192902|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44192903|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192904|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192905|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44192906|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
44192907|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
44192908|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
44192909|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44192910|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
44192911|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192912|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192913|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44192914|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
44192915|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
44192916|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44192917|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
44280768|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280769|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44280770|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
44280772|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44280773|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44280774|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44280775|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44280776|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280777|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280778|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280779|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
44280780|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44280781|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280782|NCT00730223|Efavirenz|efavirenz|mesh-list
44280783|NCT00730223|Nevirapine|nevirapine|mesh-list
44280784|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44455225|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44455226|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455227|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455229|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
44455230|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455231|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
44455232|NCT01650246|Renal Agents|renal agents|mesh-ancestor
44455269|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455270|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
44455271|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455290|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44455291|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44455292|NCT01648699|Hydromorphone|hydromorphone|mesh-list
44455293|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44455294|NCT01648699|Narcotics|narcotics|mesh-ancestor
44192949|NCT00365638|Simvastatin|simvastatin|mesh-list
44192950|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44192951|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192952|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
44192953|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192954|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192955|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192956|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192957|NCT00365742|Simvastatin|simvastatin|mesh-list
44192958|NCT00365742|Red yeast rice|red yeast rice|mesh-list
44192959|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44192960|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192961|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
44192962|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192963|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192964|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192965|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192966|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
44192967|NCT00365755|Melphalan|melphalan|mesh-list
44192968|NCT00365755|Cisplatin|cisplatin|mesh-list
44192969|NCT00365755|Carboplatin|carboplatin|mesh-list
44192970|NCT00365755|Etoposide|etoposide|mesh-list
44192971|NCT00365755|Vincristine|vincristine|mesh-list
44192972|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192973|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
44280785|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44280786|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280787|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280788|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
44280789|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280790|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44280791|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44280792|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44280793|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44280794|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44280795|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44280796|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44280797|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44280798|NCT00730249|Methylphenidate|methylphenidate|mesh-list
44280799|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43666529|NCT03757585|Vitamins|vitamins|mesh-ancestor
44192974|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192975|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192976|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44192977|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
44192978|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192979|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192980|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44193009|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193010|NCT00365950|Warfarin|warfarin|mesh-list
44193011|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
44193012|NCT00366002|Darifenacin|darifenacin|mesh-list
44193013|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44193014|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44193015|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
44193016|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193017|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193018|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193019|NCT00366002|Urological Agents|urological agents|mesh-ancestor
44193020|NCT00366067|Phenytoin|phenytoin|mesh-list
44193021|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
44193022|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44193023|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44129461|NCT04599894|Pregabalin|pregabalin|mesh-list
44193024|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193025|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193049|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193050|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193051|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
44193052|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44193053|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193054|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193055|NCT00366418|Rituximab|rituximab|mesh-list
44193056|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193057|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193058|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
44193059|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193060|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193061|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
44193062|NCT00366470|Vitamin D|vitamin d|mesh-list
44280800|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280801|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44280802|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44280803|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44280804|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280806|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280808|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
44280809|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280810|NCT00730366|Chloroquine|chloroquine|mesh-list
44193063|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193064|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193065|NCT00366470|Vitamins|vitamins|mesh-ancestor
44193066|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
44193067|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44193068|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44193069|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44193070|NCT00366652|Desipramine|desipramine|mesh-list
44193071|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44193072|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44193073|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193074|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193075|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193076|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193109|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193110|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193111|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
44193112|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193113|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44193114|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
44193115|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193116|NCT00366834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43725513|NCT02597231|Melatonin|melatonin|mesh-list
43725592|NCT02596880|Ribavirin|ribavirin|mesh-list
43725593|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
43725594|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
43725595|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725596|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
44193117|NCT00366834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193118|NCT00366834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193119|NCT00366834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193120|NCT00366834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44193121|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44193122|NCT00366873|Calcium|calcium|mesh-list
44193123|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193157|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193159|NCT00367081|Renal Agents|renal agents|mesh-ancestor
44193160|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193161|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
44193194|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193195|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193196|NCT00367185|Growth Substances|growth substances|mesh-ancestor
44193197|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193198|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193200|NCT00367211|Omeprazole|omeprazole|mesh-list
44193201|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44193202|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193203|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44193234|NCT00367302|Buprenorphine|buprenorphine|mesh-list
44193235|NCT00367302|Methadone|methadone|mesh-list
44193236|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44193237|NCT00367302|Narcotics|narcotics|mesh-ancestor
44193238|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193239|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193240|NCT00367302|Analgesics|analgesics|mesh-ancestor
44193241|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
44193242|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193243|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44280812|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
44280813|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43725597|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725598|NCT02596828|Sirolimus|sirolimus|mesh-list
43725599|NCT02596828|Irinotecan|irinotecan|mesh-list
43725600|NCT02596828|Temozolomide|temozolomide|mesh-list
43725601|NCT02596828|Dasatinib|dasatinib|mesh-list
43725602|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43725603|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725604|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725605|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725606|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725607|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43725608|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
43725609|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280814|NCT00730366|Amebicides|amebicides|mesh-ancestor
43725735|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
43725736|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44280815|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44280816|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44280817|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280818|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
44280819|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666544|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193244|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
44193245|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
44129633|NCT04033276|Rituximab|rituximab|mesh-list
44193265|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193266|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193267|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193268|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193269|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193270|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
44193271|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44193272|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193273|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455295|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455296|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455297|NCT01648699|Analgesics|analgesics|mesh-ancestor
44455298|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
44455299|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455300|NCT01648582|Metformin|metformin|mesh-list
44455301|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
44455302|NCT01648582|Dulaglutide|dulaglutide|mesh-list
44455303|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455304|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455305|NCT01648348|Bevacizumab|bevacizumab|mesh-list
44455306|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44455307|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
43725737|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43725738|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725739|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725740|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725741|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833333|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833334|NCT05216055|Dexamethasone|dexamethasone|mesh-list
43833335|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
43833336|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
43833337|NCT05216055|Bupivacaine|bupivacaine|mesh-list
43833338|NCT05216055|Ropivacaine|ropivacaine|mesh-list
43833339|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43833340|NCT05216055|BB 1101|bb 1101|mesh-list
43833341|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833355|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
43833356|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43833357|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44455308|NCT01648348|Antibodies|antibodies|mesh-list
44455309|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
44455310|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455311|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
44455312|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455313|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44455314|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44455315|NCT01648348|Growth Substances|growth substances|mesh-ancestor
44455316|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455317|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455318|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
44455319|NCT01648283|Methadone|methadone|mesh-list
44455320|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44455321|NCT01648283|Narcotics|narcotics|mesh-ancestor
44193283|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193285|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44193286|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
44193287|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193288|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193290|NCT00367471|Carboplatin|carboplatin|mesh-list
44193291|NCT00367471|Trastuzumab|trastuzumab|mesh-list
44193292|NCT00367471|Lapatinib|lapatinib|mesh-list
44193293|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44193294|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193295|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44193313|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44193314|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193315|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193316|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44193317|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
44193318|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
44193319|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797771|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
44280820|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44280821|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280822|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280823|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44280824|NCT00730366|Renal Agents|renal agents|mesh-ancestor
44280825|NCT00730392|Etanercept|etanercept|mesh-list
44280826|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280827|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280828|NCT00730392|Analgesics|analgesics|mesh-ancestor
44280829|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
44280830|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280831|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193320|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193321|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193322|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
44193323|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
44193324|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193325|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193326|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
44193327|NCT00367497|Hormones|hormones|mesh-ancestor
44193328|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193329|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44193330|NCT00367497|Protective Agents|protective agents|mesh-ancestor
44193331|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
44193332|NCT00367536|Estrogens|estrogens|mesh-list
44193333|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44193334|NCT00367536|Hormones|hormones|mesh-ancestor
44193335|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193336|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193337|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44193338|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44193339|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
44193340|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44193341|NCT00367562|Valsartan|valsartan|mesh-list
44193342|NCT00367562|Enalapril|enalapril|mesh-list
44193343|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193344|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44193345|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44193346|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193347|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44193348|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193349|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193350|NCT00367614|Pantoprazole|pantoprazole|mesh-list
44193351|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44193374|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44193375|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44193376|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
44193377|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193378|NCT00367718|Bortezomib|bortezomib|mesh-list
44193379|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193380|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44193381|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
44193382|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193383|NCT00367822|Ropinirole|ropinirole|mesh-list
44193384|NCT00367822|Lisuride|lisuride|mesh-list
44193385|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44193386|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44193387|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
44193388|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
44193389|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193390|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193391|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280832|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280833|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280834|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280835|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280836|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
44193392|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44193393|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
44193394|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
44193395|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193396|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44193397|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193398|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193400|NCT00367874|Valproic Acid|valproic acid|mesh-list
44193401|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44193402|NCT00367874|Narcotics|narcotics|mesh-ancestor
44193403|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193404|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193405|NCT00367874|Analgesics|analgesics|mesh-ancestor
44193406|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
44193432|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44193433|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
44193434|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
44193435|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44193436|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44193437|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44193438|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44193439|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44193440|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44193441|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44193442|NCT00367939|Amlodipine|amlodipine|mesh-list
44193443|NCT00367939|Valsartan|valsartan|mesh-list
44193444|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193445|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43725859|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43725860|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44193446|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193447|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193448|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193449|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193450|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
44193451|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44193452|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44193475|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193476|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193477|NCT00368056|Eszopiclone|eszopiclone|mesh-list
44193478|NCT00368056|Zopiclone|zopiclone|mesh-list
44193479|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44193480|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193481|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193482|NCT00368121|Dexamethasone|dexamethasone|mesh-list
44193483|NCT00368121|Cetuximab|cetuximab|mesh-list
44193484|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193485|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
44193486|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
44193487|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193488|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193489|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193490|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
44193491|NCT00368121|Hormones|hormones|mesh-ancestor
44193492|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193493|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44193494|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193495|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193496|NCT00368134|Vildagliptin|vildagliptin|mesh-list
44193497|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193498|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455344|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
44193499|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44193500|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
44280837|NCT00730418|Doxazosin|doxazosin|mesh-list
44280838|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44280839|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44280840|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44280841|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43666564|NCT03657160|Vedolizumab|vedolizumab|mesh-list
44193501|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193502|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193503|NCT00368160|Eszopiclone|eszopiclone|mesh-list
44193504|NCT00368160|Zopiclone|zopiclone|mesh-list
44193537|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44193538|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44193539|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193540|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193541|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193542|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
44193543|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193544|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44193545|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
44193546|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193565|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
44193566|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44193567|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
44193568|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193569|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193570|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44193571|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193572|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455345|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
44193573|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44193574|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44193575|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193576|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
44193577|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193578|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
44193579|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193580|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193581|NCT00368498|Teicoplanin|teicoplanin|mesh-list
44193582|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193583|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193584|NCT00368589|Atorvastatin|atorvastatin|mesh-list
44193585|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44193586|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44193587|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
44193588|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193589|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44193590|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44193591|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193593|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44193594|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44193595|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
44193596|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193597|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193598|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193599|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44193600|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193601|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
44193602|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44193603|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44193621|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193622|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193623|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193624|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
44193625|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193626|NCT00368862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44193627|NCT00368862|Antidepressive Agents|antidepressive agents|mesh-ancestor
44280842|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44280843|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280844|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280845|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280846|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44280847|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280848|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280849|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280850|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44280851|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
44280852|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
44280854|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
44280855|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280856|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
44280857|NCT00730509|Hematinics|hematinics|mesh-ancestor
44280858|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44280859|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43666575|NCT03534284|Trazodone|trazodone|mesh-list
44193628|NCT00368862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193629|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43726053|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726054|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
43726055|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
43726056|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726057|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193630|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44193631|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
44193632|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44193633|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44193634|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
44193635|NCT00368901|Hematinics|hematinics|mesh-ancestor
44193637|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193638|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193639|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44193640|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193641|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
44193642|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193643|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
44193644|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193645|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44193646|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44193647|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44193648|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193649|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
44193650|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44193651|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
44193652|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193653|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44193654|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193655|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
44193656|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193657|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
44193658|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44193659|NCT00369031|Protective Agents|protective agents|mesh-ancestor
44193660|NCT00369044|Prednisone|prednisone|mesh-list
44193690|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193692|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44193693|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44193694|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
44193695|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455346|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44455347|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280861|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
44280862|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280863|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280864|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280865|NCT00730535|Urological Agents|urological agents|mesh-ancestor
44280867|NCT00730574|Folic Acid|folic acid|mesh-list
44280868|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
44280869|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
44280870|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
43726059|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
44280871|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
44280872|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280873|NCT00730574|Hematinics|hematinics|mesh-ancestor
44280874|NCT00730769|Valganciclovir|valganciclovir|mesh-list
44280875|NCT00730769|Ganciclovir|ganciclovir|mesh-list
44455348|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
44455349|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455350|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
44455351|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455352|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
44455353|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455354|NCT01648101|Ezogabine|ezogabine|mesh-list
44455355|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
44455372|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193696|NCT00369356|Prednisone|prednisone|mesh-list
44193697|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193698|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
44193699|NCT00369356|Hormones|hormones|mesh-ancestor
44193700|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193701|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193702|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44193703|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193704|NCT00369395|Volociximab|volociximab|mesh-list
44193705|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193706|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193707|NCT00369395|Growth Substances|growth substances|mesh-ancestor
44193708|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193709|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193710|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193711|NCT00369408|Naltrexone|naltrexone|mesh-list
44193712|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44193713|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44193714|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193715|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
44193716|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193717|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44193718|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44193719|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44193720|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193721|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193722|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193723|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193724|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
44193725|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193726|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
44193727|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193728|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193729|NCT00369538|Losartan|losartan|mesh-list
44280876|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44280877|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
44280878|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44280879|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726184|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726185|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43726186|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
43726187|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43726188|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726189|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726190|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43726191|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43726192|NCT02592863|Protective Agents|protective agents|mesh-ancestor
43726193|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726194|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
44280880|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280881|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463752|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193730|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44193731|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44193732|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193733|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44193734|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44193748|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44193750|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44193751|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44193752|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44193753|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193754|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193755|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193756|NCT00369551|Growth Substances|growth substances|mesh-ancestor
44193757|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193758|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193759|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
44193760|NCT00369603|Donepezil|donepezil|mesh-list
44193761|NCT00369603|Galantamine|galantamine|mesh-list
44193762|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44193763|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193764|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193765|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
44193766|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193767|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193768|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
44193769|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44193770|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
44193771|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193772|NCT00369694|Terlipressin|terlipressin|mesh-list
44193773|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193774|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44193775|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
44193776|NCT00369733|Hematinics|hematinics|mesh-ancestor
44193777|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
44193778|NCT00369772|Hematinics|hematinics|mesh-ancestor
44193779|NCT00369798|Rolipram|rolipram|mesh-list
44193780|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
44193781|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193782|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44193783|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44193784|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193785|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193786|NCT00369811|Fentanyl|fentanyl|mesh-list
44193787|NCT00369811|Oxycodone|oxycodone|mesh-list
44193788|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44193789|NCT00369811|Narcotics|narcotics|mesh-ancestor
44193790|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193791|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193792|NCT00369811|Analgesics|analgesics|mesh-ancestor
44193793|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
44193794|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193795|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44193796|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44193827|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44193829|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193830|NCT00369954|Gemcitabine|gemcitabine|mesh-list
44193831|NCT00369954|Carboplatin|carboplatin|mesh-list
44193832|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193833|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44193834|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
44463754|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463755|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44463756|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44463757|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463758|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463759|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
44463760|NCT01506271|Imipenem|imipenem|mesh-list
44463761|NCT01506271|Relebactam|relebactam|mesh-list
44463762|NCT01506271|Cilastatin|cilastatin|mesh-list
44463763|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463764|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463765|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463766|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463767|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463768|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44463769|NCT01506193|Vaccines|vaccines|mesh-list
44463770|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
44463771|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463772|NCT01505881|Warfarin|warfarin|mesh-list
44463773|NCT01505881|Dabigatran|dabigatran|mesh-list
44463774|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
44463775|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
44463776|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44193835|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193836|NCT00369954|Antiviral Agents|antiviral agents|mesh-ancestor
44193837|NCT00369954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193860|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44193861|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
44193862|NCT00370019|Estradiol|estradiol|mesh-list
44193863|NCT00370019|Estrogens|estrogens|mesh-ancestor
44193864|NCT00370019|Hormones|hormones|mesh-ancestor
44193865|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193866|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193867|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44193868|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
43726389|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726390|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193869|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44193870|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44193871|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44193872|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44193873|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44193874|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44193875|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44193876|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193877|NCT00370045|Bivalirudin|bivalirudin|mesh-list
44193878|NCT00370045|Eptifibatide|eptifibatide|mesh-list
44193879|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
44193880|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44193881|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193882|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463778|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463779|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463780|NCT01505868|Carboplatin|carboplatin|mesh-list
44463781|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463782|NCT01505647|Vaccines|vaccines|mesh-list
44463783|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
44463784|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463785|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
44463786|NCT01505634|Imipenem|imipenem|mesh-list
44463787|NCT01505634|Relebactam|relebactam|mesh-list
44463788|NCT01505634|Cilastatin|cilastatin|mesh-list
44463789|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44463790|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463791|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44463792|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44463793|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463794|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463795|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463796|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44463797|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463798|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
44463799|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44463800|NCT01505608|Irinotecan|irinotecan|mesh-list
44463801|NCT01505608|Temozolomide|temozolomide|mesh-list
44193883|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193884|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
44193885|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44193886|NCT00370097|Fluticasone|fluticasone|mesh-list
44193887|NCT00370097|Xhance|xhance|mesh-list
44193888|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193889|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44193890|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
44193921|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44193922|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
43726466|NCT02591004|Nifedipine|nifedipine|mesh-list
44193923|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193924|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193925|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193926|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
44193927|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
44193928|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193930|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193931|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
44193933|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193934|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193935|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
44193936|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193967|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463802|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44463803|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44463804|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463805|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463806|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463807|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463808|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
44463809|NCT01505491|Adalimumab|adalimumab|mesh-list
44463810|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463811|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193969|NCT00370422|Bevacizumab|bevacizumab|mesh-list
44193970|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193971|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193972|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193973|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193974|NCT00370422|Growth Substances|growth substances|mesh-ancestor
44193975|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193976|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193977|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193978|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
44193979|NCT00370422|Hormones|hormones|mesh-ancestor
44193980|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193997|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193999|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194000|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194001|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194002|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
44194003|NCT00370539|Hormones|hormones|mesh-ancestor
44194004|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194005|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194006|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
44194007|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194008|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194009|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44194010|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194011|NCT00370565|Insulin|insulin|mesh-list
44194012|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44194013|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194014|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194015|NCT00370591|Fluticasone|fluticasone|mesh-list
44194016|NCT00370591|Xhance|xhance|mesh-list
44194017|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44194018|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194019|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44194020|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
44194021|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194022|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194023|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44194024|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194025|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194026|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44194027|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44194028|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44194029|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44194030|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
44194031|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194032|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194033|NCT00370617|Metformin|metformin|mesh-list
44194034|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194035|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194036|NCT00370630|Triamcinolone|triamcinolone|mesh-list
44194037|NCT00370630|Bevacizumab|bevacizumab|mesh-list
44194038|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194039|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463812|NCT01505114|Tenofovir|tenofovir|mesh-list
44463813|NCT01505114|Emtricitabine|emtricitabine|mesh-list
44463814|NCT01505114|Maraviroc|maraviroc|mesh-list
44463815|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
44463816|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463817|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44463818|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44463819|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463820|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280882|NCT00730821|Nintedanib|nintedanib|mesh-list
44280883|NCT00730821|Afatinib|afatinib|mesh-list
44194071|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194072|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
44194073|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
44194074|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44194075|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194076|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44194077|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
44194078|NCT00370669|Triamcinolone|triamcinolone|mesh-list
44194079|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44194100|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194101|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194102|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194103|NCT00370721|Growth Substances|growth substances|mesh-ancestor
44194104|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194105|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194106|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
44194107|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44194108|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44194109|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44194110|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194111|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194112|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194113|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194114|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194115|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44194116|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194117|NCT00370747|Ecabet|ecabet|mesh-list
44194118|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194119|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44194120|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194121|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
44194122|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194123|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194124|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44194125|NCT00370747|Protective Agents|protective agents|mesh-ancestor
44194126|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194127|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194128|NCT00370760|Dexamethasone|dexamethasone|mesh-list
44194129|NCT00370760|Colchicine|colchicine|mesh-list
44194130|NCT00370760|Heparin|heparin|mesh-list
44194131|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44194132|NCT00370760|Tinzaparin|tinzaparin|mesh-list
44194133|NCT00370760|Dalteparin|dalteparin|mesh-list
44194159|NCT00370786|Growth Substances|growth substances|mesh-ancestor
44194160|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194161|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194162|NCT00370799|Betamethasone|betamethasone|mesh-list
44194163|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
44194164|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44194165|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
44194166|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44194167|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44194168|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194169|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
44194171|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280884|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280885|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44280886|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280887|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280889|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
44280890|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44280891|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194172|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194173|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44194174|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194175|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44194176|NCT00370825|Miltefosine|miltefosine|mesh-list
44194177|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
44194178|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194179|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194180|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194181|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194215|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194216|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194217|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
44194218|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44194219|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194220|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194221|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44194222|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44194223|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44194258|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
44194259|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
44194260|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44194261|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44194262|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194263|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455403|NCT01646320|Saxagliptin|saxagliptin|mesh-list
44194265|NCT00371306|Metformin|metformin|mesh-list
44194266|NCT00371306|Glyburide|glyburide|mesh-list
44194267|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194268|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194269|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
44194270|NCT00371319|Tacrolimus|tacrolimus|mesh-list
44194271|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194272|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
44194273|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194274|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44194302|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194303|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194304|NCT00371501|Aspirin|aspirin|mesh-list
44194305|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44194306|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44194307|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194308|NCT00371501|Analgesics|analgesics|mesh-ancestor
44194309|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
44194310|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194311|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194312|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194313|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194314|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44194315|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44194316|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194317|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44194318|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44194319|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194320|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
44194353|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44194354|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194355|NCT00371592|Acyclovir|acyclovir|mesh-list
44280893|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44280894|NCT00730977|Diuretics|diuretics|mesh-ancestor
44280895|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
44280896|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280897|NCT00731003|Tryptophan|tryptophan|mesh-list
44280898|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44280899|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44280900|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
44280901|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44280902|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
44280903|NCT00731016|Pravastatin|pravastatin|mesh-list
44194356|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
44194357|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194358|NCT00371696|Acetaminophen|acetaminophen|mesh-list
44194359|NCT00371696|Diclofenac|diclofenac|mesh-list
44194395|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194396|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194397|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194398|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44194399|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
44194400|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194472|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44194473|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194474|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194475|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194508|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194509|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194510|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194511|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194512|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44194513|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
44194514|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
44194552|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194581|NCT00372801|Ibuprofen|ibuprofen|mesh-list
44194582|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44194583|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194584|NCT00372801|Analgesics|analgesics|mesh-ancestor
43726688|NCT02588755|Tegafur|tegafur|mesh-list
43726689|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43726690|NCT02588755|Estrogens|estrogens|mesh-ancestor
43726691|NCT02588755|Hormones|hormones|mesh-ancestor
43726692|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726693|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726694|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726695|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726696|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44194585|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
44194586|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194587|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194588|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194589|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194590|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44194591|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194592|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194593|NCT00372827|Travoprost|travoprost|mesh-list
44194594|NCT00372827|Brinzolamide|brinzolamide|mesh-list
44194595|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44194596|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44194597|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194612|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194614|NCT00372879|Vitamins|vitamins|mesh-ancestor
44194615|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
44194616|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194617|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
44194618|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194619|NCT00372879|Protective Agents|protective agents|mesh-ancestor
44194620|NCT00372892|Rituximab|rituximab|mesh-list
44194621|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194622|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194623|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
44194624|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280904|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44280905|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280906|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44280907|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44280909|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280910|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44280911|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44280912|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280913|NCT00731068|Mitogens|mitogens|mesh-list
44280914|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44280915|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726744|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726745|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726746|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
43726747|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
43726748|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726749|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
43726750|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43726751|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726752|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280916|NCT00731146|Anesthetics|anesthetics|mesh-list
44280917|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44280918|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194625|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194626|NCT00373048|Mefloquine|mefloquine|mesh-list
44194627|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
44194628|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194629|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194630|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455404|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455405|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455406|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44455407|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455408|NCT01646320|Incretins|incretins|mesh-ancestor
44455409|NCT01646320|Hormones|hormones|mesh-ancestor
44455410|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131035|NCT00147511|Linezolid|linezolid|mesh-list
44194631|NCT00373061|Omalizumab|omalizumab|mesh-list
44194632|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44194633|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44194634|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194635|NCT00373087|Entacapone|entacapone|mesh-list
44194636|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44194637|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44194638|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194639|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44194640|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194641|NCT00373126|Nicotine|nicotine|mesh-list
44194642|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44194643|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
44194644|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194645|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194646|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44194647|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44194648|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194649|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194675|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194676|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
44194677|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726753|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
43726778|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
43726779|NCT02588196|BB 1101|bb 1101|mesh-list
43726780|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726781|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
43726782|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
43726787|NCT02588196|Hormones|hormones|mesh-ancestor
43726789|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44194678|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194679|NCT00373373|Sorafenib|sorafenib|mesh-list
44194680|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194681|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194682|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194683|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194684|NCT00373412|Vaccines|vaccines|mesh-list
44280920|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
44280921|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44280922|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
44280923|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280924|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280925|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280926|NCT00731224|Rivastigmine|rivastigmine|mesh-list
44280927|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44194685|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
44194686|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194687|NCT00373451|Heparin|heparin|mesh-list
44194688|NCT00373451|Calcium heparin|calcium heparin|mesh-list
44194689|NCT00373451|Bivalirudin|bivalirudin|mesh-list
44194690|NCT00373451|Abciximab|abciximab|mesh-list
44194691|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
44194692|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44194693|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44194694|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194695|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
44194696|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44194697|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726790|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726791|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726792|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726793|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726794|NCT02588131|Durvalumab|durvalumab|mesh-list
43726795|NCT02588131|Tremelimumab|tremelimumab|mesh-list
43726796|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726797|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726798|NCT02588118|Propofol|propofol|mesh-list
43726799|NCT02588118|Cisatracurium|cisatracurium|mesh-list
43726800|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43726801|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726802|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726803|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726817|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
43726818|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726819|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726820|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
43726828|NCT02587533|Dopamine|dopamine|mesh-list
43726829|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43726830|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
43726831|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
43726832|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726833|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726834|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
43726835|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726836|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194698|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194729|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44194730|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44194731|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44194732|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44194733|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
44194734|NCT00373542|Ropinirole|ropinirole|mesh-list
44194735|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44194736|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44194737|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
44194738|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
44194739|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194740|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194761|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
44194762|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194763|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
44194764|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194766|NCT00373594|Rituximab|rituximab|mesh-list
44194767|NCT00373594|Fludarabine|fludarabine|mesh-list
44194768|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194769|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194770|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
44194771|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194772|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194773|NCT00373607|Artesunate|artesunate|mesh-list
44194774|NCT00373607|Piperaquine|piperaquine|mesh-list
44194775|NCT00373607|Mefloquine|mefloquine|mesh-list
44194776|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
44194777|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194778|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194779|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194780|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194781|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
44194782|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
44194783|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44194784|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
44194785|NCT00373620|Paclitaxel|paclitaxel|mesh-list
44194786|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44194787|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194788|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
44194789|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
44194790|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
44194791|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194792|NCT00373646|Thalidomide|thalidomide|mesh-list
44194793|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194794|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
44194795|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280928|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280929|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280930|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
44280931|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280932|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280933|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44280934|NCT00731224|Protective Agents|protective agents|mesh-ancestor
44280935|NCT00731276|Irinotecan|irinotecan|mesh-list
44194796|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
44194833|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44194856|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
44194857|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194859|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
44194860|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
44194861|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194862|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194863|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
44194864|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194865|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44194866|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44194867|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44194868|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194869|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194870|NCT00373906|Bortezomib|bortezomib|mesh-list
44194871|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194872|NCT00373919|Erythromycin|erythromycin|mesh-list
44194873|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
44194874|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44194875|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
44194876|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194877|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194878|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194879|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44194880|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194881|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726857|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726858|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726859|NCT02587273|Analgesics|analgesics|mesh-ancestor
43726860|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
43726861|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726862|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43726965|NCT02586649|Bromides|bromides|mesh-list
44194882|NCT00374023|Vitamin A|vitamin a|mesh-list
44194883|NCT00374023|Vitamins|vitamins|mesh-ancestor
44194884|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
44194885|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194886|NCT00374075|Valproic Acid|valproic acid|mesh-list
44194887|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
44194919|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
44194920|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44194921|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
44194923|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44194924|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194925|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44194926|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44194927|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194928|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194929|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
44194930|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
44194931|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194932|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194965|NCT00374465|Protective Agents|protective agents|mesh-ancestor
44194966|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44194967|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194968|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44194969|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
44194970|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44194971|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44194972|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44194997|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194998|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
44194999|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44195000|NCT00374621|Diuretics|diuretics|mesh-ancestor
44195001|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
44280936|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44280937|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44280938|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280939|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280940|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280941|NCT00731289|Triamcinolone|triamcinolone|mesh-list
44280942|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44280943|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44280944|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
44280945|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44280946|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44280947|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
44280948|NCT00731289|Hormones|hormones|mesh-ancestor
44280949|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44280950|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280951|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280952|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
44280953|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280954|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280955|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44195002|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195003|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44195004|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195005|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
44195006|NCT00374647|Sirolimus|sirolimus|mesh-list
44131415|NCT00148460|Tenecteplase|tenecteplase|mesh-list
44195007|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195008|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195009|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44195010|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
44195011|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195012|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833523|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
43833524|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833525|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833526|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43833527|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43727086|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727087|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195013|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195014|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195015|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
44195016|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195017|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
44195018|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195019|NCT00374686|Valganciclovir|valganciclovir|mesh-list
44195020|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
44195021|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195022|NCT00374699|Bortezomib|bortezomib|mesh-list
44195023|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195024|NCT00374764|Risperidone|risperidone|mesh-list
44195025|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44195050|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195051|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
44455411|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44455412|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
44455413|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455415|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
44455416|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
44455417|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455418|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280956|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
44280957|NCT00731289|Protective Agents|protective agents|mesh-ancestor
44280959|NCT00731302|Meloxicam|meloxicam|mesh-list
44280960|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44280961|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44280962|NCT00731302|Analgesics|analgesics|mesh-ancestor
44280963|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
44280964|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44280965|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666681|NCT03220022|Antibodies|antibodies|mesh-list
44455419|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455420|NCT01646255|Levodopa|levodopa|mesh-list
44455421|NCT01646255|Rotigotine|rotigotine|mesh-list
44455422|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44455423|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44455424|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
44455425|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455426|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455427|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455428|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
44455429|NCT01646177|Etanercept|etanercept|mesh-list
44455430|NCT01646177|Ixekizumab|ixekizumab|mesh-list
44455431|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44455432|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44455433|NCT01646177|Analgesics|analgesics|mesh-ancestor
44455434|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
44455435|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195075|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44195076|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
44195077|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
44195078|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44195079|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44195080|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44195081|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
44195082|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195083|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195084|NCT00374881|Protective Agents|protective agents|mesh-ancestor
44195085|NCT00374881|Cathartics|cathartics|mesh-ancestor
44195086|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195088|NCT00374894|Antidotes|antidotes|mesh-ancestor
44195089|NCT00374894|Protective Agents|protective agents|mesh-ancestor
44195123|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195125|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44195126|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44455444|NCT01646125|Pemetrexed|pemetrexed|mesh-list
44195127|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195151|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
44195152|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195153|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
44195154|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195155|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44195156|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44195157|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195158|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195159|NCT00375297|Urological Agents|urological agents|mesh-ancestor
44195160|NCT00375310|Gemcitabine|gemcitabine|mesh-list
44195161|NCT00375310|Sorafenib|sorafenib|mesh-list
44195162|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195163|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
44195164|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195165|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195166|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
44195167|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195168|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280967|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44280968|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44280969|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44280970|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280971|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44280972|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44280973|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44280974|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
44280975|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44280976|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44195169|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195170|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
44195171|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195172|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44195173|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
44195174|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195175|NCT00375375|Lactulose|lactulose|mesh-list
44195176|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195177|NCT00375388|Metformin|metformin|mesh-list
44195178|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44195179|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195180|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
44195201|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455445|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131576|NCT00148824|Vaccines|vaccines|mesh-list
44195202|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195203|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
44195204|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195205|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
44195206|NCT00375583|Albendazole|albendazole|mesh-list
44195207|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
44195208|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44195209|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195210|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
44195211|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44195212|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44195213|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195214|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195215|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195216|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195217|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195218|NCT00375596|Ketotifen|ketotifen|mesh-list
44195219|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44195220|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
44195221|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
43833597|NCT05202080|Narcotics|narcotics|mesh-ancestor
43833598|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833599|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833600|NCT05202080|Analgesics|analgesics|mesh-ancestor
44195222|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44195223|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
44195224|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
44195225|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195226|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195227|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195228|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44195229|NCT00375622|Tamoxifen|tamoxifen|mesh-list
44195230|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44195231|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
44195232|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195233|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195254|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
44195255|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44195256|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
44195257|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44195258|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280978|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44280979|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44280980|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44280981|NCT00731393|Vaccines|vaccines|mesh-list
44280982|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
44280983|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280984|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44280985|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44280986|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280987|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44280988|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
44280989|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280990|NCT00731562|Varenicline|varenicline|mesh-list
44280991|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44280992|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44280993|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
44195259|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44195260|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44195261|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195262|NCT00375765|Dutasteride|dutasteride|mesh-list
44195263|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44195264|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44195265|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195266|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195267|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
44195268|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195269|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195271|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44195272|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44195273|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
44195274|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195275|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195276|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195277|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44195278|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44195279|NCT00375843|Citalopram|citalopram|mesh-list
44195280|NCT00375843|Sertraline|sertraline|mesh-list
44195281|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44195282|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44195283|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44195284|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195313|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
44195314|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44195315|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195316|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195317|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44195318|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44195319|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44195320|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44195321|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44195322|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44195323|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44280994|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44280995|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44280996|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44280997|NCT00731575|Prednisolone|prednisolone|mesh-list
44280998|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44280999|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
44195324|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44195325|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
44195326|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44195327|NCT00376025|Antioxidants|antioxidants|mesh-list
44195328|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195329|NCT00376025|Protective Agents|protective agents|mesh-ancestor
44195330|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195331|NCT00376038|Metformin|metformin|mesh-list
44195353|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
44195354|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195355|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195356|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195357|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
44195358|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44195359|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43727649|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43727650|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43727651|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43727652|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
43727653|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
43727654|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43727655|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727656|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727657|NCT02582736|Analgesics|analgesics|mesh-ancestor
43727658|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
43727659|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43727660|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43727661|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43727662|NCT02582372|Fentanyl|fentanyl|mesh-list
43648447|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195360|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
44195361|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44195362|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44195363|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
44195364|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
44195365|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195366|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195367|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195368|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
44195369|NCT00376077|Hormones|hormones|mesh-ancestor
44195370|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195371|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44195372|NCT00376077|Protective Agents|protective agents|mesh-ancestor
44195373|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44195374|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195375|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
44195376|NCT00376103|Temozolomide|temozolomide|mesh-list
44195377|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44195378|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
44195379|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195380|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195381|NCT00376129|Alefacept|alefacept|mesh-list
44195382|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195407|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44195408|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195409|NCT00376285|Fenofibrate|fenofibrate|mesh-list
44195410|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44195411|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
44195412|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195413|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44195415|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
44195416|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44195417|NCT00376311|Katacalcin|katacalcin|mesh-list
43824250|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
43824251|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824252|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44195418|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44195419|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195420|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44195421|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195422|NCT00376324|Tigecycline|tigecycline|mesh-list
44195423|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195424|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195425|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44195426|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195427|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195428|NCT00376337|Micafungin|micafungin|mesh-list
44195429|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
44195430|NCT00376337|Clotrimazole|clotrimazole|mesh-list
44281000|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44281001|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
44281002|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44281003|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
44281004|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281005|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
44281006|NCT00731575|Hormones|hormones|mesh-ancestor
44281007|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195431|NCT00376337|Miconazole|miconazole|mesh-list
44195432|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195467|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195468|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
44195495|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195496|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195497|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44195498|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44195499|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
44455446|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455447|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455448|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455449|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455450|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455451|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44455452|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455453|NCT01646073|Adalimumab|adalimumab|mesh-list
44455454|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455455|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727885|NCT02581124|Lapatinib|lapatinib|mesh-list
43824253|NCT05514080|Insulin|insulin|mesh-list
43824254|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824255|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824256|NCT05514041|Varenicline|varenicline|mesh-list
43824257|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43824258|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43824259|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
44455456|NCT01646021|Sirolimus|sirolimus|mesh-list
44455457|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455458|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455459|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44455460|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455461|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
44455462|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598456|NCT03299426|Vaccines|vaccines|mesh-list
44455476|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455477|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44455478|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455479|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
44455480|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44455481|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44455482|NCT01645930|Growth Substances|growth substances|mesh-ancestor
44455483|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455484|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44455485|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455486|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455487|NCT01645735|Vancomycin|vancomycin|mesh-list
44455488|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
44455489|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44455490|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455491|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455492|NCT01645280|Methotrexate|methotrexate|mesh-list
44455493|NCT01645280|Ustekinumab|ustekinumab|mesh-list
44455494|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44455495|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
44455496|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44455497|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455498|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44455499|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
44455500|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455501|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455502|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44455503|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455504|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44455505|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455506|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
44455507|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281008|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281009|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44281010|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281011|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
44281012|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
44281013|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281014|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281015|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44455508|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455509|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
44455510|NCT01645176|Atorvastatin|atorvastatin|mesh-list
44455511|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44455512|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44455513|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
44455514|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455515|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44455516|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44455517|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455518|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
44195500|NCT00376519|Cyclosporine|cyclosporine|mesh-list
44195501|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
44195502|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
44195503|NCT00376519|Fludarabine|fludarabine|mesh-list
44195504|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
44195505|NCT00376519|Cyclosporins|cyclosporins|mesh-list
44195506|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195507|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
43598494|NCT03298958|Sirolimus|sirolimus|mesh-list
44195535|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195536|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
44195537|NCT00376662|Hormones|hormones|mesh-list
44195538|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195539|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195540|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44195541|NCT00376701|Bevacizumab|bevacizumab|mesh-list
44195542|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195543|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195544|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44195545|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44195546|NCT00376701|Growth Substances|growth substances|mesh-ancestor
44195547|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195548|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
44195549|NCT00376727|Cetuximab|cetuximab|mesh-list
44195550|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195551|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195552|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
44195553|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43598550|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44195572|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195573|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195574|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44195575|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44195576|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
44195577|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
44195578|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195579|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44195580|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44195581|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195582|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195583|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44195584|NCT00376831|Narcotics|narcotics|mesh-ancestor
44195585|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44195586|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44195587|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44195588|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44195589|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195590|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
44281016|NCT00731575|Protective Agents|protective agents|mesh-ancestor
44281017|NCT00731601|Pantoprazole|pantoprazole|mesh-list
44281018|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44281019|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281020|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44281021|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281022|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195591|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
44195592|NCT00376870|Pioglitazone|pioglitazone|mesh-list
44195593|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44195594|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195595|NCT00376883|Pamidronate|pamidronate|mesh-list
44195596|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44195597|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195599|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195600|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
44195601|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44195602|NCT00376987|Protective Agents|protective agents|mesh-ancestor
43648449|NCT03162731|Ipilimumab|ipilimumab|mesh-list
43648450|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195603|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195604|NCT00377000|Clindamycin|clindamycin|mesh-list
44195605|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
44195606|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
44195607|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44195608|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195609|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195610|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44195611|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195612|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648451|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648452|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43648453|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648454|NCT03090880|Tinzaparin|tinzaparin|mesh-list
43648455|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43648456|NCT03090880|Dalteparin|dalteparin|mesh-list
43648457|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
43648458|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43648459|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43648460|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648461|NCT03076203|Niraparib|niraparib|mesh-list
43648462|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43648463|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43648464|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648465|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648466|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648467|NCT03063450|Nivolumab|nivolumab|mesh-list
43648468|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648469|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195613|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195629|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
44195630|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195631|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44195632|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44195633|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195634|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195636|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195637|NCT00377091|PENTA|penta|mesh-list
44195638|NCT00377091|Fondaparinux|fondaparinux|mesh-list
44195639|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44195640|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
44195641|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44195642|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44195643|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195644|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195645|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
44195646|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44195647|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195648|NCT00377104|Alvocidib|alvocidib|mesh-list
44195649|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195650|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
44195651|NCT00377104|Growth Substances|growth substances|mesh-ancestor
44195652|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195653|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44195654|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195655|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195656|NCT00377143|Warfarin|warfarin|mesh-list
44195657|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
44195658|NCT00377273|Fluorouracil|fluorouracil|mesh-list
44195659|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
44195660|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195661|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195662|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195663|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195664|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
44195665|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195666|NCT00377325|Cyclosporine|cyclosporine|mesh-list
44195667|NCT00377325|Cyclosporins|cyclosporins|mesh-list
44195668|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195669|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281023|NCT00731627|Simvastatin|simvastatin|mesh-list
44281024|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44281025|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44195670|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195671|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
44195672|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195673|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
44195674|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195704|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
44195705|NCT00377481|Hematinics|hematinics|mesh-ancestor
44195706|NCT00377494|Vaccines|vaccines|mesh-list
44195707|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
44195708|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195709|NCT00377546|Ketorolac|ketorolac|mesh-list
44195710|NCT00377546|Nepafenac|nepafenac|mesh-list
44195711|NCT00377546|Bromfenac|bromfenac|mesh-list
44195712|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44195713|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44195714|NCT00377546|Analgesics|analgesics|mesh-ancestor
44195715|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
44195716|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195717|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195718|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44195719|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44195744|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195745|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195747|NCT00377780|Doxorubicin|doxorubicin|mesh-list
44195748|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44195749|NCT00377780|Trastuzumab|trastuzumab|mesh-list
44195750|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195751|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195752|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195753|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195754|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195755|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195756|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44195757|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44195758|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195759|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195760|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44195761|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195762|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44195763|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44195764|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195765|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648470|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43648471|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648472|NCT02943057|Ganciclovir|ganciclovir|mesh-list
43648473|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43648474|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
43648475|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195766|NCT00377793|Urological Agents|urological agents|mesh-ancestor
44195791|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195793|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44195794|NCT00377923|Progesterone|progesterone|mesh-list
44195795|NCT00377923|Progestins|progestins|mesh-ancestor
44195796|NCT00377923|Hormones|hormones|mesh-ancestor
44195797|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195798|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195799|NCT00377936|Gemcitabine|gemcitabine|mesh-list
44195800|NCT00377936|Paclitaxel|paclitaxel|mesh-list
44132211|NCT00150709|Levetiracetam|levetiracetam|mesh-list
44195801|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195802|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
44195803|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195804|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195805|NCT00377936|Antiviral Agents|antiviral agents|mesh-ancestor
44195806|NCT00377936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195807|NCT00377936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195808|NCT00377936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195809|NCT00377936|Immunologic Factors|immunologic factors|mesh-ancestor
44195810|NCT00377936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195811|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44195812|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195813|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195834|NCT00377988|Norgestimate|norgestimate|mesh-list
44195835|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
43648476|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648477|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648478|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648479|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43648481|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
44195836|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44195837|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281026|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
44281027|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281028|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44281029|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44281030|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281031|NCT00731861|Paclitaxel|paclitaxel|mesh-list
44281032|NCT00731861|Vatalanib|vatalanib|mesh-list
44281033|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44195838|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44195839|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44195840|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44195842|NCT00378027|Fondaparinux|fondaparinux|mesh-list
44195843|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44195844|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
44195845|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44195846|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728340|NCT02577497|Beclomethasone|beclomethasone|mesh-list
43728341|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728342|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44195847|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195848|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195849|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
44195850|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44195851|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195852|NCT00378066|Bevacizumab|bevacizumab|mesh-list
44195853|NCT00378066|Capecitabine|capecitabine|mesh-list
44195854|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
44195855|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44195856|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195857|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44195858|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44195859|NCT00378066|Growth Substances|growth substances|mesh-ancestor
44195860|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195861|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
44195862|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195863|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
44195864|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195865|NCT00378092|Risperidone|risperidone|mesh-list
44195866|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44195867|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
44195868|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195869|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195895|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
44195896|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44195897|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44195898|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
44195899|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
44195900|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195901|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195902|NCT00378183|Risperidone|risperidone|mesh-list
44195903|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44195904|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
44195905|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195906|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195907|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195908|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44195909|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44195910|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728466|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728467|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43728468|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195911|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195912|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44195913|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
44195914|NCT00378196|Ranibizumab|ranibizumab|mesh-list
44195915|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44195916|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44195917|NCT00378196|Growth Substances|growth substances|mesh-ancestor
44195918|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195919|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
44195920|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598888|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
44281034|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281035|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281036|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281037|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281038|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281039|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281040|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281041|NCT00731926|Vitamins|vitamins|mesh-list
44281042|NCT00731926|Ascorbic Acid|ascorbic acid|mesh-list
44281043|NCT00731926|Vitamin E|vitamin e|mesh-list
44281044|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
44281045|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281046|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
44281047|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281048|NCT00731926|Protective Agents|protective agents|mesh-ancestor
44281049|NCT00731952|Bortezomib|bortezomib|mesh-list
44455546|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455547|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455548|NCT01644643|Metronidazole|metronidazole|mesh-list
44455549|NCT01644643|Ceftazidime|ceftazidime|mesh-list
44195921|NCT00378287|Rabeprazole|rabeprazole|mesh-list
44195922|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44195923|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195924|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44195925|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195926|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195927|NCT00378313|Gemcitabine|gemcitabine|mesh-list
44195928|NCT00378313|Paclitaxel|paclitaxel|mesh-list
44195929|NCT00378313|Epirubicin|epirubicin|mesh-list
44195930|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44195931|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195932|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195933|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195934|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195935|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195952|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195953|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195954|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195956|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
44195957|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195958|NCT00378443|Prednisone|prednisone|mesh-list
44195959|NCT00378443|Losartan|losartan|mesh-list
44195960|NCT00378443|Cilazapril|cilazapril|mesh-list
44195961|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44195962|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
44195963|NCT00378443|Hormones|hormones|mesh-ancestor
44195964|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195965|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195966|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44195967|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195968|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43728703|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728734|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
43728735|NCT02575677|Oxycodone|oxycodone|mesh-list
43648482|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195969|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44195970|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44195971|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44195972|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195973|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44195974|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44195975|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195976|NCT00378456|Vitamins|vitamins|mesh-list
44195977|NCT00378456|Leucovorin|leucovorin|mesh-list
44281051|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281052|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44281053|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281054|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281055|NCT00732082|Gemcitabine|gemcitabine|mesh-list
44281056|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281057|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
44281058|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281059|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281060|NCT00732082|Antiviral Agents|antiviral agents|mesh-ancestor
44281061|NCT00732082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281062|NCT00732082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666764|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
44195978|NCT00378456|Folic Acid|folic acid|mesh-list
44195979|NCT00378456|Vitamin A|vitamin a|mesh-list
44195980|NCT00378456|Zinc|zinc|mesh-list
44195981|NCT00378456|Selenium|selenium|mesh-list
44195982|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
44195983|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
44195984|NCT00378456|Antioxidants|antioxidants|mesh-list
44195985|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
44195986|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195987|NCT00378456|Trace Elements|trace elements|mesh-ancestor
44195988|NCT00378456|Antidotes|antidotes|mesh-ancestor
44195989|NCT00378456|Protective Agents|protective agents|mesh-ancestor
44195990|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
44195991|NCT00378456|Hematinics|hematinics|mesh-ancestor
44195992|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195993|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44195994|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195995|NCT00378495|Miltefosine|miltefosine|mesh-list
44195996|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
44132439|NCT00151242|Cytarabine|cytarabine|mesh-list
44196022|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
44196023|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
44196024|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
44196025|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44196026|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196027|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44196028|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196029|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43728895|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
44196030|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196031|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196032|NCT00378612|Sirolimus|sirolimus|mesh-list
44196033|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196034|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196035|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44196036|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196037|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
44196038|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196039|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
44196040|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728896|NCT02574975|Hormones|hormones|mesh-ancestor
43728897|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728898|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43648484|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43648485|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43648486|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
43648487|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648488|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44196041|NCT00378625|Artesunate|artesunate|mesh-list
44196042|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
44196043|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44196044|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44196045|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196046|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196047|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
44196048|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
44196074|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44196075|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196076|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44281063|NCT00732082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281064|NCT00732082|Immunologic Factors|immunologic factors|mesh-ancestor
44281065|NCT00732082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281066|NCT00732108|Topiramate|topiramate|mesh-list
44281067|NCT00732108|Lactulose|lactulose|mesh-list
44281068|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
44281069|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281070|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281071|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281072|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44281073|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281074|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281075|NCT00732121|Incretins|incretins|mesh-ancestor
44281076|NCT00732121|Hormones|hormones|mesh-ancestor
44281077|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666777|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196077|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196078|NCT00378716|Leucovorin|leucovorin|mesh-list
44196079|NCT00378716|Fluorouracil|fluorouracil|mesh-list
44196080|NCT00378716|Tegafur|tegafur|mesh-list
44196081|NCT00378716|Calcium|calcium|mesh-list
44196082|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
44196083|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44196084|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196085|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
44196086|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196087|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44196088|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196089|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196090|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
44196091|NCT00378716|Antidotes|antidotes|mesh-ancestor
44196092|NCT00378716|Protective Agents|protective agents|mesh-ancestor
44196093|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
44196094|NCT00378716|Vitamins|vitamins|mesh-ancestor
44196095|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
44196096|NCT00378729|Metformin|metformin|mesh-list
44196097|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43599095|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
44196115|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
44196116|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196117|NCT00378833|Niacin|niacin|mesh-list
44196118|NCT00378833|Niacinamide|niacinamide|mesh-list
44196119|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
44196120|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44196121|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
44196122|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648489|NCT02783547|Azacitidine|azacitidine|mesh-list
43648490|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43648491|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
43648492|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729159|NCT02573727|Terlipressin|terlipressin|mesh-list
43729160|NCT02573727|Epinephrine|epinephrine|mesh-list
43729161|NCT02573727|Racepinephrine|racepinephrine|mesh-list
43729162|NCT02573727|Norepinephrine|norepinephrine|mesh-list
44196123|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44196124|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196125|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
44196126|NCT00378833|Vitamins|vitamins|mesh-ancestor
44196127|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
44196128|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196129|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
44196130|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44196131|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44196132|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196133|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
44196134|NCT00378872|Coagulants|coagulants|mesh-ancestor
44196135|NCT00378911|Sunitinib|sunitinib|mesh-list
44196136|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196137|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44196138|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44281078|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44281080|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281081|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281082|NCT00732147|Pramlintide|pramlintide|mesh-list
44281083|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281084|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281085|NCT00732186|Ipilimumab|ipilimumab|mesh-list
44281086|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281087|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281088|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44281089|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281090|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
44196139|NCT00378911|Growth Substances|growth substances|mesh-ancestor
44196140|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196141|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44196142|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44196143|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196144|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196145|NCT00378937|Acetaminophen|acetaminophen|mesh-list
44196146|NCT00378937|Morphine|morphine|mesh-list
44196147|NCT00378937|Oxycodone|oxycodone|mesh-list
44196148|NCT00378937|Codeine|codeine|mesh-list
44196149|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
44196150|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
44196151|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44132587|NCT00151541|Analgesics|analgesics|mesh-ancestor
44196152|NCT00378937|Narcotics|narcotics|mesh-ancestor
43729163|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
43729164|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43729165|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729166|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729167|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196153|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196154|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196155|NCT00378937|Analgesics|analgesics|mesh-ancestor
44196156|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
44196157|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599154|NCT03293368|Hormones|hormones|mesh-ancestor
44196176|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196177|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44196178|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44196179|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44196180|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44196181|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44196182|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44196183|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44196184|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44196185|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196186|NCT00379028|Fluticasone|fluticasone|mesh-list
44196187|NCT00379028|Budesonide|budesonide|mesh-list
44196188|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
44196189|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44196190|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196191|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44196192|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
44196193|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196194|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196195|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44196196|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196197|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
44196198|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44196199|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
44196200|NCT00379028|Hormones|hormones|mesh-ancestor
44196201|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196202|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44196203|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44281091|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44281092|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44281093|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44281094|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281096|NCT00732290|Clopidogrel|clopidogrel|mesh-list
44196204|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44196205|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196206|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196207|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196208|NCT00379041|Prednisone|prednisone|mesh-list
44196209|NCT00379041|Doxorubicin|doxorubicin|mesh-list
44196210|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44196211|NCT00379041|Bleomycin|bleomycin|mesh-list
44196212|NCT00379041|Vincristine|vincristine|mesh-list
44196213|NCT00379041|Vinblastine|vinblastine|mesh-list
44196214|NCT00379041|Procarbazine|procarbazine|mesh-list
44196215|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
44196216|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43729334|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648493|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648494|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196217|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196249|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
44196250|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196251|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44196252|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44196253|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196254|NCT00379262|Fluorouracil|fluorouracil|mesh-list
44196255|NCT00379262|Capecitabine|capecitabine|mesh-list
44196256|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
44196257|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196258|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43599265|NCT03292172|Atezolizumab|atezolizumab|mesh-list
44196295|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196296|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196297|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44196298|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44196299|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44196330|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196331|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
44196332|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44196333|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196334|NCT00379626|Hormones|hormones|mesh-list
44196335|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196336|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196337|NCT00379665|Cisplatin|cisplatin|mesh-list
44196338|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196339|NCT00379691|Phenylephrine|phenylephrine|mesh-list
44196340|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
44196341|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44196342|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
44196343|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
43599350|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
44196377|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196378|NCT00379756|Urological Agents|urological agents|mesh-ancestor
44196379|NCT00379847|Conivaptan|conivaptan|mesh-list
44196380|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44196381|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196382|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
44455554|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44455555|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44455556|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455557|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455558|NCT01644500|Glimepiride|glimepiride|mesh-list
43729390|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43729391|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729392|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
43729393|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729395|NCT02571842|Rituximab|rituximab|mesh-list
43729396|NCT02571842|Enalapril|enalapril|mesh-list
43729397|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43729398|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729399|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
43729400|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455559|NCT01644500|Dulaglutide|dulaglutide|mesh-list
44455560|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44455561|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455562|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455563|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455564|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
44455565|NCT01644474|Ezetimibe|ezetimibe|mesh-list
44281097|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281098|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44281099|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44281100|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44281101|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
44281102|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281103|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281104|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281105|NCT00732290|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44463821|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43935715|NCT04634071|Bupropion|bupropion|mesh-list
44281106|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44281107|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281108|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
44281109|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44281110|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
44281111|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281112|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44281113|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44281114|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281115|NCT00732407|Losartan|losartan|mesh-list
44455566|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455567|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44455568|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44455569|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
44455570|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455571|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44455572|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
44196410|NCT00380133|Prednisolone|prednisolone|mesh-list
44196411|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196412|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
44196413|NCT00380133|Hormones|hormones|mesh-ancestor
44196414|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196415|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196416|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196417|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196418|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
44196419|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
44196420|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44196421|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
44196422|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44196423|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44196424|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196448|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196450|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196451|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196452|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43729417|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729418|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729419|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43648496|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
44196453|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43648497|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196454|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196455|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281116|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44281117|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44281118|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44281119|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44281120|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281122|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43666815|NCT02884206|Valsartan|valsartan|mesh-list
44196456|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196457|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196458|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44196459|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44196460|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44196461|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196462|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196463|NCT00380380|Vildagliptin|vildagliptin|mesh-list
44196464|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44196465|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196466|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44196467|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
44196468|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648498|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43648499|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44196469|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196496|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44196497|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
44196498|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44196499|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44196500|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196501|NCT00380575|Conivaptan|conivaptan|mesh-list
44196502|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44196503|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196504|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
44196505|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196506|NCT00380614|Lamivudine|lamivudine|mesh-list
44196507|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44196508|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44196509|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196510|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196511|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
44196512|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196513|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43599570|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
44196544|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196545|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44196547|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196548|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44196549|NCT00380887|Estrogens|estrogens|mesh-ancestor
44196550|NCT00380887|Hormones|hormones|mesh-ancestor
44196551|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196552|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196554|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
44196555|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
44196556|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599632|NCT03288896|Ethanol|ethanol|mesh-list
44196582|NCT00381017|Interferons|interferons|mesh-list
44196583|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
44196584|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
44196585|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44196586|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729559|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729560|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729561|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43729562|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729563|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
43729564|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
43729565|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729566|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43729567|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44196587|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
44196588|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196589|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
44196590|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281123|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44281124|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281125|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281126|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281127|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
44281128|NCT00732446|Dexamethasone|dexamethasone|mesh-list
44281129|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
43666817|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44196592|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44196593|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44196594|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196595|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196596|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196597|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196598|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44196599|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
44196600|NCT00381030|Protective Agents|protective agents|mesh-ancestor
44196601|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44196602|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196603|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44196604|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196605|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44196627|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44196628|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44196629|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
44196630|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196631|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
44196632|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196633|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196634|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44196635|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
44196636|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196637|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196638|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44196639|NCT00381199|Amitriptyline|amitriptyline|mesh-list
44196640|NCT00381199|Nabilone|nabilone|mesh-list
44196641|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44196642|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
43729652|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43648500|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648501|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648502|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648504|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648505|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
43648506|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648507|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196643|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196644|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196645|NCT00381199|Analgesics|analgesics|mesh-ancestor
44196646|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
44196647|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196648|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196649|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44196650|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44196651|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196652|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196653|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196654|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196677|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44196678|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196679|NCT00381342|Exenatide|exenatide|mesh-list
44196680|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44196681|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196682|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44196683|NCT00381342|Incretins|incretins|mesh-ancestor
44196684|NCT00381342|Hormones|hormones|mesh-ancestor
44196685|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196686|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
44196687|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44196688|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196689|NCT00381472|Ropinirole|ropinirole|mesh-list
44196690|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44196691|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44281130|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44281132|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281133|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
44281134|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
44281135|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281136|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281137|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281138|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
44281139|NCT00732446|Hormones|hormones|mesh-ancestor
44281140|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281141|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196692|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
44196693|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
44196694|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196695|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196696|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196697|NCT00381511|Heparin|heparin|mesh-list
44196698|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44196699|NCT00381511|Tinzaparin|tinzaparin|mesh-list
44196700|NCT00381511|Dalteparin|dalteparin|mesh-list
44196701|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
44196702|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44196703|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44196704|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196705|NCT00381537|Carbamazepine|carbamazepine|mesh-list
44196706|NCT00381537|Phenobarbital|phenobarbital|mesh-list
44196707|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
44196708|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
44196736|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44196737|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196738|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44196739|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
44196740|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196741|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196742|NCT00381654|MP 412|mp 412|mesh-list
44196743|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196744|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44196745|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196746|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729854|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729856|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729857|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43729858|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729859|NCT02568995|Analgesics|analgesics|mesh-ancestor
43729871|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
44196747|NCT00381732|Tadalafil|tadalafil|mesh-list
44196748|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196749|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44196750|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44196751|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196752|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196753|NCT00381732|Urological Agents|urological agents|mesh-ancestor
43599812|NCT03286959|Calcium|calcium|mesh-list
44455644|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44455645|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455646|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455647|NCT01642589|Vaccines|vaccines|mesh-list
44455648|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
44455649|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455650|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
44455651|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
44455652|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44455653|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44455654|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455655|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455656|NCT01642407|Urological Agents|urological agents|mesh-ancestor
44196797|NCT00382057|Testosterone|testosterone|mesh-list
44281142|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281143|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
44281144|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281145|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281146|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281147|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281148|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44281149|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666831|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
44196798|NCT00382057|Androgens|androgens|mesh-ancestor
44196799|NCT00382057|Hormones|hormones|mesh-ancestor
44196800|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196801|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196802|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196803|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196804|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44196805|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44196806|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196807|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196808|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44196809|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
44196810|NCT00382083|Acetaminophen|acetaminophen|mesh-list
44196811|NCT00382083|Ibuprofen|ibuprofen|mesh-list
43729944|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729945|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
43729946|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
43729947|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
43729948|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
43729949|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729950|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196812|NCT00382083|Lidocaine|lidocaine|mesh-list
44196813|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
44196847|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196848|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44196849|NCT00382239|Incretins|incretins|mesh-ancestor
43599985|NCT03284294|Vitamins|vitamins|mesh-ancestor
43600003|NCT03283800|Copper|copper|mesh-list
44196883|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44196884|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44196885|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196886|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196887|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44196888|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196889|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
43600026|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196900|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44196901|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196902|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
44196903|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
44196904|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
44196905|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44196906|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44196907|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44196908|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196909|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196910|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44196911|NCT00382499|Lidocaine|lidocaine|mesh-list
44196912|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
44196913|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
44196914|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196915|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196916|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
44196917|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196918|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44196919|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44196920|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44196921|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196922|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196923|NCT00382538|Mifepristone|mifepristone|mesh-list
44196924|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44196925|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
44196926|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281150|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43729951|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43729952|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
43729953|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43729954|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43729955|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43729962|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
43729963|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729964|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729965|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43729966|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
43729967|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43729968|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43729969|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729970|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729971|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729972|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730133|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281151|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
44281152|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281153|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44281154|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44281155|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44281157|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44281158|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
44281159|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281160|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44281161|NCT00732511|Metoprolol|metoprolol|mesh-list
44281162|NCT00732511|Carvedilol|carvedilol|mesh-list
44281163|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44281164|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44281165|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
44281166|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
44281167|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281168|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281169|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44281170|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44196927|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196928|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44196929|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44196930|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44196931|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
44196932|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44196933|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44196934|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
44196935|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196936|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
44196937|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44196938|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44196939|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
44196940|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
44196941|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196942|NCT00382629|Protective Agents|protective agents|mesh-ancestor
44196943|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196944|NCT00382642|Ondansetron|ondansetron|mesh-list
44196945|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
44196946|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
44196947|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196948|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196949|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196950|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
44196951|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
44196952|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44196976|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196977|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196979|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196980|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
44196981|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281171|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44281172|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
44281173|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281174|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281175|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
44281176|NCT00732511|Protective Agents|protective agents|mesh-ancestor
44281177|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44281178|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281179|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44281180|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44281181|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44281182|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44281183|NCT00732524|Glipizide|glipizide|mesh-list
44281184|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281185|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281186|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
44281187|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44281188|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
43666876|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
44196982|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44196983|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44196984|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44196985|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196986|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196987|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196988|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196989|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
44196990|NCT00382889|Hormones|hormones|mesh-ancestor
44196991|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196992|NCT00382954|Bortezomib|bortezomib|mesh-list
44196993|NCT00382954|Idarubicin|idarubicin|mesh-list
44196994|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196995|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44196996|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44196997|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44196998|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196999|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197000|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44197001|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44197002|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
44197003|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197037|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44197039|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44197040|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197041|NCT00383214|Epratuzumab|epratuzumab|mesh-list
44197042|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197043|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197080|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44197081|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44197082|NCT00383487|Analgesics|analgesics|mesh-ancestor
44197083|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
44197108|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197109|NCT00383656|Hormones|hormones|mesh-list
44197110|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730255|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730256|NCT02566720|Analgesics|analgesics|mesh-ancestor
43730257|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
43730258|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730259|NCT02566733|Remifentanil|remifentanil|mesh-list
43730260|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730261|NCT02566733|Narcotics|narcotics|mesh-ancestor
43730262|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281189|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730263|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730264|NCT02566733|Analgesics|analgesics|mesh-ancestor
43730265|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
43730266|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833907|NCT05176821|Esomeprazole|esomeprazole|mesh-list
44281190|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281191|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44281192|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281193|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44281194|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
44281195|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281196|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281197|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44281198|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
44281199|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
44281200|NCT00732537|Protective Agents|protective agents|mesh-ancestor
44281201|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44281202|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44281203|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281204|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
44281206|NCT00732576|Vitamin MK 7|vitamin mk 7|mesh-list
44281207|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44281208|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44281209|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281210|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
44197111|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197112|NCT00383682|Mexiletine|mexiletine|mesh-list
44197113|NCT00383682|Morphine|morphine|mesh-list
44197114|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44197115|NCT00383682|Narcotics|narcotics|mesh-ancestor
44197116|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197117|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197118|NCT00383682|Analgesics|analgesics|mesh-ancestor
44197119|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
44197120|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197121|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44197122|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44197123|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44197124|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197125|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197126|NCT00383695|Capecitabine|capecitabine|mesh-list
44197127|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
44197128|NCT00383695|Cetuximab|cetuximab|mesh-list
44197129|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43833908|NCT05176821|Bismuth|bismuth|mesh-list
43833909|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197130|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
44197131|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197132|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600261|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44197153|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197155|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197156|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197157|NCT00383851|Temozolomide|temozolomide|mesh-list
44197158|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44197159|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44197160|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
44281211|NCT00732576|Coagulants|coagulants|mesh-ancestor
44281212|NCT00732576|Vitamins|vitamins|mesh-ancestor
44281213|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
44281214|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281215|NCT00732589|Lidocaine|lidocaine|mesh-list
44281216|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
44281217|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
44281218|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281219|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281220|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
44281221|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281222|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44281223|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44281224|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44281225|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281226|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281227|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44281228|NCT00732693|Norethindrone|norethindrone|mesh-list
44281229|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
44281230|NCT00732693|Estradiol|estradiol|mesh-list
44281231|NCT00732693|Progesterone|progesterone|mesh-list
44281232|NCT00732693|Estrogens|estrogens|mesh-ancestor
44281233|NCT00732693|Hormones|hormones|mesh-ancestor
44281234|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281235|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730278|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43730279|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
43730280|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
43730281|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730282|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43730283|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43730284|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43730285|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730286|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730287|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730288|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43730289|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
43730365|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730366|NCT02565680|Prednisone|prednisone|mesh-list
43730367|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43730368|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
43730369|NCT02565680|Hormones|hormones|mesh-ancestor
43730370|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43730371|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730372|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43730373|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730374|NCT02565862|Metformin|metformin|mesh-list
44281236|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44281237|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
44281238|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281239|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44281240|NCT00732693|Progestins|progestins|mesh-ancestor
43666918|NCT02529852|Hormones|hormones|mesh-ancestor
44197161|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197162|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197163|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
44197164|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
44197165|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197166|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197167|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197168|NCT00383851|Growth Substances|growth substances|mesh-ancestor
44197169|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197170|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197171|NCT00383864|Interferons|interferons|mesh-list
44197172|NCT00383864|Ribavirin|ribavirin|mesh-list
44197173|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197174|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
44281241|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44281242|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44281243|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44463822|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44463823|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44463824|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44463825|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44463827|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44463828|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44463829|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44463830|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463831|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281245|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
44281246|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281247|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281248|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281249|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
43730375|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43730376|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730377|NCT02565836|Thrombin|thrombin|mesh-list
43730378|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
43730379|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
44197175|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197176|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
44197177|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197178|NCT00383877|Insulin|insulin|mesh-list
44197179|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44197180|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
44197181|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
44197182|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
44197198|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197199|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455672|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44455673|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44455674|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455675|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455676|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44455677|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
44455678|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
44455679|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455680|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455681|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455682|NCT01642212|Budesonide|budesonide|mesh-list
44455683|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455684|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44455685|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
44455686|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455687|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455688|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44455689|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455690|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
44455691|NCT01642212|Hormones|hormones|mesh-ancestor
44455692|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455693|NCT01641952|Rituximab|rituximab|mesh-list
44455694|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455695|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455696|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
44455697|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455698|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197200|NCT00383916|Pantoprazole|pantoprazole|mesh-list
44281250|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281251|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
44281252|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
44281253|NCT00732784|Calcium|calcium|mesh-list
44281254|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44281255|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281256|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281257|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281258|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281259|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281260|NCT00732784|Antacids|antacids|mesh-ancestor
44281261|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281262|NCT00732810|Capecitabine|capecitabine|mesh-list
44281263|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44281264|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281265|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
44281266|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281267|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281268|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281269|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281270|NCT00732836|Paclitaxel|paclitaxel|mesh-list
44281271|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43730491|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730493|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43730494|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
43730495|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730496|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730497|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43730498|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43730499|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44281272|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281273|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281274|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281275|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281276|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281277|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281278|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
44281279|NCT00732888|Calcium|calcium|mesh-list
44197201|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44197202|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197203|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44197204|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197205|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197206|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44197207|NCT00383929|Candesartan|candesartan|mesh-list
44197208|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
44197209|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44197210|NCT00383929|Diuretics|diuretics|mesh-ancestor
44197211|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
44197212|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197213|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43600363|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
44281280|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44281281|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281282|NCT00732888|Antacids|antacids|mesh-ancestor
44281283|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281284|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281285|NCT00732914|Sorafenib|sorafenib|mesh-list
44197246|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44197247|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44197248|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197249|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197250|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600423|NCT03274596|Protective Agents|protective agents|mesh-ancestor
44197271|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197272|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
44197273|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44197274|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197275|NCT00384280|Rifampin|rifampin|mesh-list
44197276|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44197277|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
44197278|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44197279|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197280|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
44197281|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197282|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197283|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197284|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44197285|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44197286|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44197287|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44197288|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44197289|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44197290|NCT00384306|Prednisolone|prednisolone|mesh-list
44197291|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44197292|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
44197293|NCT00384306|Hormones|hormones|mesh-ancestor
44197294|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197295|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197296|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44197297|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197298|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
44197299|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44197300|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44197301|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44197302|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197303|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197336|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197337|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44197338|NCT00384527|Vancomycin|vancomycin|mesh-list
44197339|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
44197340|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44197341|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197342|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44197343|NCT00384540|Dobutamine|dobutamine|mesh-list
44197344|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44197345|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
44197380|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44197381|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
44197382|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44197383|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44197412|NCT00384618|Protective Agents|protective agents|mesh-ancestor
44197413|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44197414|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44197415|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
44197416|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44197417|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44197418|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281286|NCT00732914|Sunitinib|sunitinib|mesh-list
44281287|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281288|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281289|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281290|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281291|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44281292|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44281293|NCT00732914|Growth Substances|growth substances|mesh-ancestor
44281294|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197420|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197421|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197422|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197423|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197445|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197446|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
44197447|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197448|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
44197449|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44197450|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197451|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197452|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197453|NCT00384800|Growth Substances|growth substances|mesh-ancestor
43730505|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
44197454|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197455|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197456|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197457|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
44197458|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197459|NCT00384826|Paclitaxel|paclitaxel|mesh-list
44197460|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44197461|NCT00384826|Carboplatin|carboplatin|mesh-list
44197462|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44197463|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197464|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44197465|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44197466|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44197467|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197468|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197469|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197470|NCT00384878|Leucovorin|leucovorin|mesh-list
44197471|NCT00384878|Cisplatin|cisplatin|mesh-list
44197472|NCT00384878|Fluorouracil|fluorouracil|mesh-list
44197473|NCT00384878|Cetuximab|cetuximab|mesh-list
44197474|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197475|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
44197476|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197477|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197478|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197479|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
43600649|NCT04239040|Nivolumab|nivolumab|mesh-list
44197494|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44197495|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197497|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197498|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44197499|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197500|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197501|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197502|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44197503|NCT00384969|Sorafenib|sorafenib|mesh-list
44197504|NCT00384969|Everolimus|everolimus|mesh-list
44197505|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197506|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197507|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197508|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197509|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281295|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
44281297|NCT00732927|Parnaparin|parnaparin|mesh-list
43730679|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730680|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43730681|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730682|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43834344|NCT05144854|Capecitabine|capecitabine|mesh-list
44281298|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44281299|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44281300|NCT00732927|Analgesics|analgesics|mesh-ancestor
44281301|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
44281302|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281303|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281304|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281305|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281306|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44281307|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43666975|NCT02188745|Hormones|hormones|mesh-ancestor
44197510|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
44197511|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197512|NCT00385021|Leucovorin|leucovorin|mesh-list
44197513|NCT00385021|Fluorouracil|fluorouracil|mesh-list
44197514|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
44197515|NCT00385021|Bevacizumab|bevacizumab|mesh-list
44197516|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
44197517|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197518|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197519|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197520|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197521|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
44197522|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197523|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197524|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197525|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197526|NCT00385021|Growth Substances|growth substances|mesh-ancestor
44197527|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197528|NCT00385021|Antidotes|antidotes|mesh-ancestor
44197529|NCT00385021|Protective Agents|protective agents|mesh-ancestor
44197530|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
44197531|NCT00385021|Vitamins|vitamins|mesh-ancestor
44197532|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
44197533|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44197534|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44197535|NCT00385125|Rituximab|rituximab|mesh-list
44197536|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44197537|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197538|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197539|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
44197540|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197560|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44197561|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44197562|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44197563|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44197564|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197565|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197566|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197567|NCT00385385|KRM 1648|krm 1648|mesh-list
44197568|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44197569|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
44197570|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44197571|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197572|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
44197573|NCT00385398|Temozolomide|temozolomide|mesh-list
44197574|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44197575|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44197576|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
43700715|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
44281308|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281309|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281310|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44281311|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281312|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
44281313|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
44281314|NCT00732953|Paclitaxel|paclitaxel|mesh-list
44281315|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281316|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281317|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281318|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281319|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281320|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281321|NCT00732966|Losartan|losartan|mesh-list
44281322|NCT00732966|Valsartan|valsartan|mesh-list
44281323|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44281324|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44281325|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43666985|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44197577|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197578|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197579|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197580|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197581|NCT00385411|Valproic Acid|valproic acid|mesh-list
44197582|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
44197583|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197584|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197585|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
44197586|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730855|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43730871|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
43730872|NCT02561923|Coagulants|coagulants|mesh-ancestor
43730873|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43730874|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
43730875|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43730876|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
43730877|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730878|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
43730879|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43730880|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43730881|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43730882|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43730883|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
43730884|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730885|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44197587|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197588|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
44197589|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44197590|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197591|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44197592|NCT00385437|Mirtazapine|mirtazapine|mesh-list
44197593|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
44197594|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43600765|NCT03271866|Metformin|metformin|mesh-list
44197628|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197629|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197630|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44197631|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43600819|NCT03270033|Dexamethasone|dexamethasone|mesh-list
44197658|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197659|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
44197660|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197661|NCT00385606|Antiviral Agents|antiviral agents|mesh-ancestor
44197662|NCT00385606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197663|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197664|NCT00385606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197665|NCT00385606|Immunologic Factors|immunologic factors|mesh-ancestor
44197666|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197667|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44197668|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44281326|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281328|NCT00733031|Gemcitabine|gemcitabine|mesh-list
44281329|NCT00733031|Pemetrexed|pemetrexed|mesh-list
44281330|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281331|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
44281332|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281333|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281334|NCT00733031|Antiviral Agents|antiviral agents|mesh-ancestor
44281335|NCT00733031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281336|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281337|NCT00733031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281338|NCT00733031|Immunologic Factors|immunologic factors|mesh-ancestor
44281339|NCT00733031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281340|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44281341|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44281342|NCT00733057|Minocycline|minocycline|mesh-list
43730886|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44281343|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281344|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197669|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44197670|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44197672|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
44197673|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197674|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44197675|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197676|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44197677|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
44197678|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197679|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44197708|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197709|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
44197710|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197711|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197712|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
44197713|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44197714|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197715|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44455699|NCT01641939|Trastuzumab|trastuzumab|mesh-list
44197716|NCT00385853|Temozolomide|temozolomide|mesh-list
44197717|NCT00385853|Vatalanib|vatalanib|mesh-list
44197718|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44197719|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
44197720|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197721|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197722|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197723|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197724|NCT00385931|Valsartan|valsartan|mesh-list
44197725|NCT00385931|Simvastatin|simvastatin|mesh-list
43600908|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
44197739|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197740|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197741|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
44197742|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197743|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44197744|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197745|NCT00385970|Leucovorin|leucovorin|mesh-list
44281346|NCT00733083|Morphine|morphine|mesh-list
44281347|NCT00733083|Oxycodone|oxycodone|mesh-list
44281348|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281349|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
44281350|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
44281351|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281352|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281353|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281354|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
44281355|NCT00733083|Hormones|hormones|mesh-ancestor
44281356|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281357|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44281358|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281359|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44281360|NCT00733083|Narcotics|narcotics|mesh-ancestor
44197746|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
44197747|NCT00385970|Tegafur|tegafur|mesh-list
43730887|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730888|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730889|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43730891|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44197748|NCT00385970|Calcium|calcium|mesh-list
44197749|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
44197750|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44197751|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197752|NCT00385970|Antidotes|antidotes|mesh-ancestor
44197753|NCT00385970|Protective Agents|protective agents|mesh-ancestor
44197754|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
44197755|NCT00385970|Vitamins|vitamins|mesh-ancestor
44197756|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
44197757|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197758|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
44197759|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197760|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197761|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44197762|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
44197763|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44197764|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
44197765|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197766|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
44197767|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44197768|NCT00386061|Rimonabant|rimonabant|mesh-list
44197769|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44197770|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44197771|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44197772|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197773|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197774|NCT00386061|Hormones|hormones|mesh-ancestor
44197775|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197776|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197777|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44197778|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44197779|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
44197780|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
44197781|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197782|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44197783|NCT00386126|Hematinics|hematinics|mesh-ancestor
44197784|NCT00386178|Vitamin E|vitamin e|mesh-list
44197785|NCT00386178|Tocopherols|tocopherols|mesh-list
44197786|NCT00386178|Tocotrienols|tocotrienols|mesh-list
44197823|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
44197825|NCT00386282|Mifepristone|mifepristone|mesh-list
44197826|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44197856|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197857|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281361|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281363|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
44281364|NCT00733148|Insulin|insulin|mesh-list
44281365|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281366|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281367|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
44281368|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281369|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197858|NCT00386412|Valganciclovir|valganciclovir|mesh-list
44197859|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
44197860|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197861|NCT00386503|Artesunate|artesunate|mesh-list
44197862|NCT00386503|Amodiaquine|amodiaquine|mesh-list
44197863|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
44197864|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44197865|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43853231|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
44197866|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197867|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197868|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
44197869|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
44197901|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44197902|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44197903|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197904|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197905|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197906|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44197907|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44197908|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44197909|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197910|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197911|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197912|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197943|NCT00386672|Vitamin D|vitamin d|mesh-list
44197944|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
44197945|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
44197946|NCT00386672|Vitamins|vitamins|mesh-list
44197947|NCT00386672|Calcium|calcium|mesh-list
44197948|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
44197949|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197950|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44197951|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44197952|NCT00386685|Trastuzumab|trastuzumab|mesh-list
44197953|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197954|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197955|NCT00386750|Lumefantrine|lumefantrine|mesh-list
44197956|NCT00386750|Artemether|artemether|mesh-list
44197957|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44197980|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197981|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197982|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44197983|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44197985|NCT00386815|Pemetrexed|pemetrexed|mesh-list
44197986|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197987|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197988|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197989|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44197990|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197991|NCT00386828|Bevacizumab|bevacizumab|mesh-list
44197992|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197993|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197994|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197995|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197996|NCT00386828|Growth Substances|growth substances|mesh-ancestor
44197997|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281370|NCT00733239|Cycloserine|cycloserine|mesh-list
44281371|NCT00733239|Verapamil|verapamil|mesh-list
44281372|NCT00733239|Diltiazem|diltiazem|mesh-list
44281373|NCT00733239|Isradipine|isradipine|mesh-list
44281374|NCT00733239|Nifedipine|nifedipine|mesh-list
44197998|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197999|NCT00386841|Citalopram|citalopram|mesh-list
44198000|NCT00386841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44198001|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44198002|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44198003|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198004|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198005|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
44198006|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198007|NCT00386841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43601182|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
44198034|NCT00386997|Amebicides|amebicides|mesh-ancestor
44198035|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44198036|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44198037|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198038|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198039|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
44198040|NCT00387114|Ascorbic Acid|ascorbic acid|mesh-list
44198041|NCT00387114|Vitamins|vitamins|mesh-ancestor
44198042|NCT00387114|Micronutrients|micronutrients|mesh-ancestor
44198043|NCT00387114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198044|NCT00387114|Antioxidants|antioxidants|mesh-ancestor
44198045|NCT00387114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731565|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
43731566|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731567|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731568|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43731569|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
43731571|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731572|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43731573|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731574|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
43731575|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43731576|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731577|NCT02556905|Growth Substances|growth substances|mesh-ancestor
43648517|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43648518|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
43648519|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198046|NCT00387114|Protective Agents|protective agents|mesh-ancestor
44198047|NCT00387179|Melatonin|melatonin|mesh-list
44198048|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
44198049|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198050|NCT00387179|Protective Agents|protective agents|mesh-ancestor
44198051|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198052|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198053|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
44198054|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44198055|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198056|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
44198057|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198058|NCT00387322|Pemetrexed|pemetrexed|mesh-list
44198084|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
44198086|NCT00387400|Temozolomide|temozolomide|mesh-list
44198087|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198088|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198089|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
44198090|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198091|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198092|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
44198093|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198095|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44198096|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44198097|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44198098|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44198099|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198100|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198101|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198102|NCT00387413|Analgesics|analgesics|mesh-ancestor
44198103|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
44198104|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198105|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
44198106|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44198133|NCT00387556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44198134|NCT00387556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43731695|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731696|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731697|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198135|NCT00387556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198136|NCT00387556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44198137|NCT00387556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44198138|NCT00387569|Vaccines|vaccines|mesh-list
44198139|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
44198140|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455700|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44455701|NCT01641939|Maytansine|maytansine|mesh-list
44281377|NCT00733239|Analgesics|analgesics|mesh-ancestor
44281378|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
44281379|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281380|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281381|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
44281382|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44281383|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44281384|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281385|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44455702|NCT01641939|Taxane|taxane|mesh-list
44455703|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455704|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455705|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44455706|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455707|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455708|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455709|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455710|NCT01641926|Interferons|interferons|mesh-list
44455711|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
44455712|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
44455713|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44455714|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44455715|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455716|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
44455717|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455718|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
44198163|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198164|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44198165|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198166|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198167|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198169|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
44198170|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
44198171|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648521|NCT02555007|Vinorelbine|vinorelbine|mesh-list
43648522|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43648523|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648524|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
43648525|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648526|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648527|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198172|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198173|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198174|NCT00387777|Buprenorphine|buprenorphine|mesh-list
44198175|NCT00387777|Analgesics|analgesics|mesh-list
44198176|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198177|NCT00387777|Narcotics|narcotics|mesh-ancestor
44198178|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198179|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198180|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
44198181|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198216|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
44198217|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198218|NCT00388076|Paclitaxel|paclitaxel|mesh-list
44198219|NCT00388076|Carboplatin|carboplatin|mesh-list
44198220|NCT00388076|Lapatinib|lapatinib|mesh-list
43601423|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
44198251|NCT00388193|Rituximab|rituximab|mesh-list
44198252|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198253|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198254|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
44198255|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198256|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198257|NCT00388219|Buprenorphine|buprenorphine|mesh-list
44198258|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198259|NCT00388219|Narcotics|narcotics|mesh-ancestor
44198260|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198261|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198262|NCT00388219|Analgesics|analgesics|mesh-ancestor
43601467|NCT03263689|Morphine|morphine|mesh-list
44281386|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44281387|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44281388|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281389|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281390|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
44281391|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44281392|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44281393|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281394|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44281395|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
44281396|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
44281397|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43731870|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43731872|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43731873|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43731874|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731875|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731876|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
43731877|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281398|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43731878|NCT02555046|Anesthetics|anesthetics|mesh-list
44281399|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281400|NCT00733239|Renal Agents|renal agents|mesh-ancestor
44281401|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44281402|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
44281403|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281404|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
44198290|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44198292|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198293|NCT00388427|Cetuximab|cetuximab|mesh-list
44198294|NCT00388427|Dasatinib|dasatinib|mesh-list
44198295|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198296|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198297|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198298|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198299|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198300|NCT00388479|Alvimopan|alvimopan|mesh-list
44198301|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198302|NCT00388557|Ketoconazole|ketoconazole|mesh-list
44198303|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
44198304|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198305|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44198306|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44198307|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601502|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
44198343|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601557|NCT03262857|Analgesics|analgesics|mesh-ancestor
44198367|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198370|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198371|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44198372|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44198373|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198374|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
44198375|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44198376|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44198377|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44198378|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44198379|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731879|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731880|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731881|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
43731882|NCT02554942|Hematinics|hematinics|mesh-ancestor
44198380|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198381|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198382|NCT00388778|Doxycycline|doxycycline|mesh-list
44198383|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281406|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44281408|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281409|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44281410|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44281411|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44281412|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
44281413|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198384|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198385|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
44198386|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44198387|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44198388|NCT00388856|Ascorbic Acid|ascorbic acid|mesh-list
44198389|NCT00388856|Vitamins|vitamins|mesh-ancestor
44198390|NCT00388856|Micronutrients|micronutrients|mesh-ancestor
44198391|NCT00388856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198392|NCT00388856|Antioxidants|antioxidants|mesh-ancestor
44198393|NCT00388856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198394|NCT00388856|Protective Agents|protective agents|mesh-ancestor
44198395|NCT00388882|Bromides|bromides|mesh-list
44198396|NCT00388882|Albuterol|albuterol|mesh-list
44198414|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44198415|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44198416|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44198418|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198419|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198420|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198421|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198422|NCT00388986|Glyburide|glyburide|mesh-list
44198423|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198424|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198425|NCT00388999|Lectins|lectins|mesh-list
43731891|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731892|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731893|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731894|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
43731895|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731896|NCT02554864|Lidocaine|lidocaine|mesh-list
43731897|NCT02554864|Ropivacaine|ropivacaine|mesh-list
43834346|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
43731997|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731998|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732000|NCT02553226|Oxytocin|oxytocin|mesh-list
43732001|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
43732002|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732003|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834152|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834347|NCT05144854|Nivolumab|nivolumab|mesh-list
43648529|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
43648530|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648531|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648532|NCT02381535|Cisplatin|cisplatin|mesh-list
43648533|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198426|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
44198427|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
44198428|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198429|NCT00388999|Coagulants|coagulants|mesh-ancestor
44198430|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44198431|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44198432|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198433|NCT00389025|Analgesics|analgesics|mesh-ancestor
44198434|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
44198435|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198436|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198437|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198438|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198439|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44198440|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44198441|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44198442|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
44198443|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
44198444|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198445|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198446|NCT00389038|Amitriptyline|amitriptyline|mesh-list
44198447|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44198448|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
44198449|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44198450|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198451|NCT00389038|Analgesics|analgesics|mesh-ancestor
44198452|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
44198453|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198481|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198482|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44198483|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43648534|NCT01597414|Trastuzumab|trastuzumab|mesh-list
43648535|NCT01597414|Pertuzumab|pertuzumab|mesh-list
43700716|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281414|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281415|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281416|NCT00733317|Budesonide|budesonide|mesh-list
44281417|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281418|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44281419|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
44281420|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281421|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281422|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44281423|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198484|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198485|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44198486|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44198487|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198488|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
44198489|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
44198490|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44198491|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
44198492|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198493|NCT00389233|Protective Agents|protective agents|mesh-ancestor
44198494|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198495|NCT00389233|Vitamins|vitamins|mesh-ancestor
44198496|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
44198497|NCT00389233|Laxatives|laxatives|mesh-ancestor
44198533|NCT00389402|Saquinavir|saquinavir|mesh-list
44198534|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44198535|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44198536|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
44198537|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198560|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198561|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
44198562|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198563|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44198564|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44198565|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198566|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455725|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455726|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455727|NCT01641809|Tenofovir|tenofovir|mesh-list
44455728|NCT01641809|Lamivudine|lamivudine|mesh-list
44455729|NCT01641809|Emtricitabine|emtricitabine|mesh-list
44455730|NCT01641809|Efavirenz|efavirenz|mesh-list
44455731|NCT01641809|Abacavir|abacavir|mesh-list
44455732|NCT01641809|Rilpivirine|rilpivirine|mesh-list
44455733|NCT01641809|Cabotegravir|cabotegravir|mesh-list
44455734|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
44455735|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455736|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44455737|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43732084|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732086|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
43732087|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732088|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455738|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455739|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455740|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44455741|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44455742|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44455743|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44455744|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44455745|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44455746|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44198601|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198602|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44198603|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198604|NCT00389701|Dexamethasone|dexamethasone|mesh-list
44198605|NCT00389701|Bortezomib|bortezomib|mesh-list
44198606|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198607|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
44281424|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
44281425|NCT00733317|Hormones|hormones|mesh-ancestor
44281426|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281427|NCT00733434|Alprostadil|alprostadil|mesh-list
44281428|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281429|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
44281430|NCT00733434|Urological Agents|urological agents|mesh-ancestor
43732089|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732090|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
43732091|NCT02552342|Hormones|hormones|mesh-ancestor
43732092|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732093|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43732094|NCT02552342|Protective Agents|protective agents|mesh-ancestor
43732095|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43732096|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732097|NCT02552537|Mannitol|mannitol|mesh-list
43732098|NCT02552537|Omeprazole|omeprazole|mesh-list
43732099|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43834348|NCT05144854|Ipilimumab|ipilimumab|mesh-list
44281431|NCT00733473|Budesonide|budesonide|mesh-list
44281432|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281433|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44281434|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
44281435|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281436|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281437|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43667020|NCT01666080|Busulfan|busulfan|mesh-list
44198608|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
44198628|NCT00389909|Doxapram|doxapram|mesh-list
44198629|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44198630|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198631|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198632|NCT00389922|Vinorelbine|vinorelbine|mesh-list
44198633|NCT00389922|Lapatinib|lapatinib|mesh-list
44198634|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198635|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198636|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44198637|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44198638|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732100|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732101|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43732102|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732103|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732104|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43732105|NCT02552537|Diuretics|diuretics|mesh-ancestor
43732106|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
43732107|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732108|NCT02552589|Fluorides|fluorides|mesh-list
43732109|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
43732110|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
43732111|NCT02552589|Protective Agents|protective agents|mesh-ancestor
43732112|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732113|NCT02551861|Ribavirin|ribavirin|mesh-list
43732114|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
43732115|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
43732116|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732117|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
43732118|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732119|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
43732120|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43732121|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43648536|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648537|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648538|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
43648539|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
43648540|NCT01384513|Busulfan|busulfan|mesh-list
43648541|NCT01384513|Fludarabine|fludarabine|mesh-list
43648542|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
44198639|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198640|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198641|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198642|NCT00389935|Thalidomide|thalidomide|mesh-list
44198643|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198644|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
44198645|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198646|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
44198647|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198648|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198649|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198650|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198651|NCT00389935|Growth Substances|growth substances|mesh-ancestor
44198652|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198653|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198654|NCT00389987|Tazobactam|tazobactam|mesh-list
44198655|NCT00389987|Piperacillin|piperacillin|mesh-list
44198656|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198657|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198658|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198659|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44198660|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198661|NCT00390000|Pemetrexed|pemetrexed|mesh-list
44198662|NCT00390000|Vatalanib|vatalanib|mesh-list
43601867|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
44198683|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198684|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198686|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
44198687|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198688|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
44198689|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44198690|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
44198691|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198692|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198693|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44281438|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281440|NCT00733473|Hormones|hormones|mesh-ancestor
44281441|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281442|NCT00733525|Fluoxetine|fluoxetine|mesh-list
44281443|NCT00733525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44281444|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44281445|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281446|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281447|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281448|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
44281449|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281450|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44281451|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
44281452|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281453|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43667034|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
44198694|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198695|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44198696|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
44198697|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198698|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198699|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44198700|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44198701|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
44198702|NCT00390065|Protective Agents|protective agents|mesh-ancestor
44198703|NCT00390091|Abetimus|abetimus|mesh-list
44198704|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198705|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
44198706|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732214|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732215|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732216|NCT02551367|Letrozole|letrozole|mesh-list
43732217|NCT02551367|Clomiphene|clomiphene|mesh-list
43732218|NCT02551367|Enclomiphene|enclomiphene|mesh-list
43732219|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
43732220|NCT02551367|Hormones|hormones|mesh-list
43732221|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732252|NCT02550977|Progestins|progestins|mesh-ancestor
44198707|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44198708|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
44198709|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198710|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
44198711|NCT00390156|Bevacizumab|bevacizumab|mesh-list
44198712|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
44198713|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198714|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
44198715|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601929|NCT03259529|Rituximab|rituximab|mesh-list
44198745|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198747|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198748|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198749|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198750|NCT00390208|Growth Substances|growth substances|mesh-ancestor
44198751|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198752|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44198753|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44198754|NCT00390247|Thalidomide|thalidomide|mesh-list
44198755|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198756|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
44198757|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198758|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
44198759|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198760|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281454|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44281455|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281456|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
44281457|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44281458|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281459|NCT00733564|Lidocaine|lidocaine|mesh-list
44281460|NCT00733564|Propofol|propofol|mesh-list
44281461|NCT00733564|Sevoflurane|sevoflurane|mesh-list
44281462|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
44281463|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
44281464|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281465|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281466|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
44281467|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198797|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198798|NCT00390390|Lansoprazole|lansoprazole|mesh-list
44198799|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
44198800|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44198812|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198813|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198814|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732253|NCT02550977|Hormones|hormones|mesh-ancestor
43732255|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
44198815|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198816|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44198817|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
44198818|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198819|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44198820|NCT00390403|Protective Agents|protective agents|mesh-ancestor
44198821|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44198822|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
44198823|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44198824|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198825|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44198826|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44198827|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44198828|NCT00390520|Vildagliptin|vildagliptin|mesh-list
44198829|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198830|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198831|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44198832|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
44198833|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198834|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198835|NCT00390598|Sennosides|sennosides|mesh-list
44198836|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44198837|NCT00390598|Laxatives|laxatives|mesh-ancestor
44198838|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198839|NCT00390624|Mannitol|mannitol|mesh-list
44198840|NCT00390624|Ularitide|ularitide|mesh-list
44198841|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44198842|NCT00390624|Diuretics|diuretics|mesh-ancestor
44198843|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
44198844|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198845|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44198846|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
44198847|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198848|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732383|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
43732384|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732385|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732386|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732430|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
43732431|NCT02550418|Budesonide|budesonide|mesh-list
43732432|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732433|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43732434|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
43732435|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732436|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732437|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732438|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732439|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
43732440|NCT02550418|Hormones|hormones|mesh-ancestor
43732441|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732442|NCT02550080|Dapsone|dapsone|mesh-list
44198849|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198850|NCT00390676|Carboplatin|carboplatin|mesh-list
44198851|NCT00390676|Docetaxel|docetaxel|mesh-list
44198852|NCT00390676|Capecitabine|capecitabine|mesh-list
44198853|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198854|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44198855|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44198856|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281468|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44281469|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44281470|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44281471|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281472|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281473|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44281474|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44281475|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
44281476|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281477|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44281478|NCT00733616|Docetaxel|docetaxel|mesh-list
44281479|NCT00733616|Capecitabine|capecitabine|mesh-list
44281480|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
44281481|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281482|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281483|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281484|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281485|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281486|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281487|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
44281488|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44281489|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
44281490|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281491|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44281492|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44281493|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281494|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281495|NCT00733720|Naltrexone|naltrexone|mesh-list
44281496|NCT00733720|Buprenorphine|buprenorphine|mesh-list
44281498|NCT00733720|Naloxone|naloxone|mesh-list
44281513|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44281514|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
44281515|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
44281516|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281517|NCT00733811|Siderophores|siderophores|mesh-ancestor
44281518|NCT00733850|Gemcitabine|gemcitabine|mesh-list
44281519|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281520|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
44281521|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281522|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281523|NCT00733850|Antiviral Agents|antiviral agents|mesh-ancestor
44281524|NCT00733850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281525|NCT00733850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281526|NCT00733850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281527|NCT00733850|Immunologic Factors|immunologic factors|mesh-ancestor
44281528|NCT00733850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281529|NCT00733889|Cisplatin|cisplatin|mesh-list
44281530|NCT00733889|Docetaxel|docetaxel|mesh-list
44281531|NCT00733889|Fluorouracil|fluorouracil|mesh-list
44281532|NCT00733889|Cetuximab|cetuximab|mesh-list
44281533|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281534|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281535|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281536|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281537|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281538|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
44281539|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281544|NCT00733967|Varenicline|varenicline|mesh-list
44281563|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281564|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281565|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281566|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281567|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44281568|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667081|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
43667082|NCT01125761|BB 1101|bb 1101|mesh-list
43667083|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667084|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
44281569|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281570|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44281571|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44281572|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281573|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
44281574|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44281575|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44281576|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
44281577|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44281578|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44281579|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44281580|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44281609|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44281610|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281611|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44198857|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198858|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44198859|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
44198860|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
44198861|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198862|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198863|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
44198864|NCT00390832|Hematinics|hematinics|mesh-ancestor
44198865|NCT00390871|Fentanyl|fentanyl|mesh-list
44198866|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
44198867|NCT00390871|Propofol|propofol|mesh-list
44198888|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198889|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
44198890|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198891|NCT00390923|Selegiline|selegiline|mesh-list
44198892|NCT00390923|Nicotine|nicotine|mesh-list
44198893|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44198894|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
44198895|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198896|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198897|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44198898|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44198899|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
43732682|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198900|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198901|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198902|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
44198903|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44198904|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44198905|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44198906|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44198907|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198908|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44198909|NCT00390923|Protective Agents|protective agents|mesh-ancestor
44198910|NCT00390975|Tegaserod|tegaserod|mesh-list
44198911|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44198912|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
44198913|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198914|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198915|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198916|NCT00391014|Amphotericin B|amphotericin b|mesh-list
44198917|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44198918|NCT00391014|Amebicides|amebicides|mesh-ancestor
44198919|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44198920|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44198921|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732683|NCT02548832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732684|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732685|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
43644786|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
43648543|NCT01384513|Tacrolimus|tacrolimus|mesh-list
43648544|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648545|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
43648546|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648547|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648548|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648549|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
43648550|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648551|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648552|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43648553|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44198922|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198923|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
44198924|NCT00391105|Remifentanil|remifentanil|mesh-list
44198952|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43732770|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43732771|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43732772|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
44198953|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
44198954|NCT00391157|Hormones|hormones|mesh-ancestor
44198955|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198956|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198957|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732773|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732774|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732775|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
43732776|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
43732777|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43732778|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43732779|NCT02548494|Insulin|insulin|mesh-list
43732780|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
44198958|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44198959|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198960|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198961|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198962|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198963|NCT00391261|Metformin|metformin|mesh-list
44198964|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198965|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198966|NCT00391313|Chloroquine|chloroquine|mesh-list
44198967|NCT00391313|Amebicides|amebicides|mesh-ancestor
44198968|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44198969|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44198970|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198971|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
44198972|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198973|NCT00391404|Alendronate|alendronate|mesh-list
44198988|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44281612|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44281613|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44281614|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
44281615|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281616|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281617|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281618|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44281619|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44281620|NCT00734383|Propofol|propofol|mesh-list
44281621|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44281622|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732781|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43732782|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732783|NCT02548403|Simethicone|simethicone|mesh-list
43732784|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
43834349|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43732826|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732827|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
43732828|NCT02548052|Hormones|hormones|mesh-ancestor
43732829|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732830|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732831|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732832|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732833|NCT02547597|Atenolol|atenolol|mesh-list
43732834|NCT02547597|Carvedilol|carvedilol|mesh-list
44281623|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281624|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44455747|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44455749|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44455750|NCT01641692|Albuterol|albuterol|mesh-list
44455751|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44455752|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
44455753|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455754|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455755|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44455756|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455757|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
44455758|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44455759|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44455760|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44455761|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44455762|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44455763|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455764|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455765|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
44455766|NCT01641640|Ribavirin|ribavirin|mesh-list
44455767|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
44455768|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455769|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
44455770|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455771|NCT01641367|Tenofovir|tenofovir|mesh-list
44455772|NCT01641367|Emtricitabine|emtricitabine|mesh-list
44455773|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
44455774|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44455775|NCT01641367|Darunavir|darunavir|mesh-list
44455776|NCT01641367|Etravirine|etravirine|mesh-list
44455777|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44455778|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
44455779|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
44455780|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455781|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44455782|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198989|NCT00391638|Interferons|interferons|mesh-list
44198990|NCT00391638|Tenofovir|tenofovir|mesh-list
44198991|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44198992|NCT00391638|Emtricitabine|emtricitabine|mesh-list
44198993|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44198994|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198995|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
43602223|NCT03257423|Ofloxacin|ofloxacin|mesh-list
44199007|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199008|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
44199009|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44199010|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732835|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43732845|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732870|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732871|NCT02547896|Analgesics|analgesics|mesh-ancestor
43732872|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
43732873|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732874|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732875|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732876|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732877|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43732878|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732879|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732880|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44199011|NCT00391885|Anesthetics|anesthetics|mesh-list
44199012|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281625|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
44281626|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
44281627|NCT00734448|Inositol|inositol|mesh-list
44281628|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
44281629|NCT00734448|Vitamins|vitamins|mesh-ancestor
44281630|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
44199013|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199014|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
44199015|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44199016|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
44199017|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199018|NCT00391911|Expectorants|expectorants|mesh-ancestor
44199019|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
44199020|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44199021|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
44199022|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199023|NCT00391911|Protective Agents|protective agents|mesh-ancestor
44199024|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199025|NCT00391911|Antidotes|antidotes|mesh-ancestor
44199026|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44199027|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44199028|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
44199029|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199030|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
44199031|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44199032|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199033|NCT00392002|Esomeprazole|esomeprazole|mesh-list
44199034|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44199035|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44199036|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44199037|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199038|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199039|NCT00392028|Ertapenem|ertapenem|mesh-list
44199040|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199041|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199042|NCT00392067|Calcipotriene|calcipotriene|mesh-list
44199043|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732881|NCT02547896|Narcotics|narcotics|mesh-ancestor
43732882|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732885|NCT02547844|Tenofovir|tenofovir|mesh-list
43732891|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43732892|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732893|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732894|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43732895|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43732896|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43732929|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732930|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732931|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732932|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43732934|NCT02547025|Clarithromycin|clarithromycin|mesh-list
43732935|NCT02547025|Levofloxacin|levofloxacin|mesh-list
43732936|NCT02547025|Ofloxacin|ofloxacin|mesh-list
43732937|NCT02547025|Tetracycline|tetracycline|mesh-list
44199044|NCT00392080|Naproxen|naproxen|mesh-list
44199045|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44199046|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44199047|NCT00392080|Analgesics|analgesics|mesh-ancestor
44199048|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
44199049|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199050|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199051|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199052|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199053|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
44199054|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44199055|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199056|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199057|NCT00392093|Estrogens|estrogens|mesh-list
44199058|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44199059|NCT00392093|Hormones|hormones|mesh-ancestor
44199074|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199075|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44199076|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44199077|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44199078|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44199079|NCT00392158|Anesthetics|anesthetics|mesh-list
44199080|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199081|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199082|NCT00392262|Amlodipine|amlodipine|mesh-list
44199083|NCT00392262|Valsartan|valsartan|mesh-list
44199084|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44199085|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44199086|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199087|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199088|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44199089|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199090|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44281631|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281632|NCT00734526|Temozolomide|temozolomide|mesh-list
44281633|NCT00734526|Sorafenib|sorafenib|mesh-list
43732938|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44281634|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44281635|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
44281636|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281637|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281638|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281639|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281640|NCT00734669|Glyburide|glyburide|mesh-list
44281641|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281642|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281643|NCT00734682|Irinotecan|irinotecan|mesh-list
44281644|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44281645|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44281646|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281647|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199091|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44199092|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44199093|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
44199094|NCT00392275|Levofloxacin|levofloxacin|mesh-list
44199095|NCT00392275|Ofloxacin|ofloxacin|mesh-list
44199096|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199097|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199098|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44199099|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44199100|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199101|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199102|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199103|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44199104|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199105|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44199106|NCT00392275|Renal Agents|renal agents|mesh-ancestor
44199107|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
44199108|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
44199109|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199110|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
44199111|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199112|NCT00392340|Doxorubicin|doxorubicin|mesh-list
44199113|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44199114|NCT00392340|Vincristine|vincristine|mesh-list
44199115|NCT00392340|Topotecan|topotecan|mesh-list
44199116|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44199117|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199150|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199151|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733001|NCT02546791|Dasatinib|dasatinib|mesh-list
43733085|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733086|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43733087|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
43733088|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
43733089|NCT02546297|Hormones|hormones|mesh-ancestor
43733090|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199152|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199153|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44199183|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44199184|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44199185|NCT00392652|Protective Agents|protective agents|mesh-ancestor
44199186|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199187|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199188|NCT00392691|Rituximab|rituximab|mesh-list
44199189|NCT00392691|Melphalan|melphalan|mesh-list
44199190|NCT00392691|Vinorelbine|vinorelbine|mesh-list
44199191|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281648|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281649|NCT00734695|Vitamins|vitamins|mesh-list
44281650|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
44281651|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
44281652|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281653|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
44281654|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281655|NCT00734695|Protective Agents|protective agents|mesh-ancestor
44463832|NCT01504867|Aspirin|aspirin|mesh-list
44463833|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463834|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463835|NCT01504867|Analgesics|analgesics|mesh-ancestor
44463836|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
44463837|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463838|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463839|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463840|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463841|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44463842|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463843|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463844|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44463845|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44199192|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199193|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
44199194|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199195|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199196|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44199197|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
44199198|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199199|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43602450|NCT03254186|Propranolol|propranolol|mesh-list
44199226|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
44199227|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199228|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199229|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43733103|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199230|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43733104|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
43733105|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648554|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
43648555|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648556|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43648557|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648558|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648559|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43648560|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
43648561|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648563|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648564|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199231|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
44199232|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44199233|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199234|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
44199235|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
44199236|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199237|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44199238|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44199239|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44199240|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44199241|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44199242|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199243|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199244|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199245|NCT00392899|Tegafur|tegafur|mesh-list
44463846|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463847|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
44463848|NCT01504841|Etravirine|etravirine|mesh-list
44463849|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44463850|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44463851|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463852|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463853|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
44463854|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463855|NCT01504412|Pregabalin|pregabalin|mesh-list
44463856|NCT01504412|Analgesics|analgesics|mesh-ancestor
44199246|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199247|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
44199248|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199249|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199281|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199282|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44199283|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
44199284|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199285|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199286|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44199287|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199290|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44199291|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
44199292|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44199322|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44199323|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199325|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44199326|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648567|NCT01013649|Capecitabine|capecitabine|mesh-list
43648568|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43648569|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199327|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199328|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199329|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199330|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199331|NCT00393328|Ritonavir|ritonavir|mesh-list
44199332|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44199333|NCT00393328|Aripiprazole|aripiprazole|mesh-list
44199334|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44199335|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44199336|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602596|NCT03252496|Narcotics|narcotics|mesh-ancestor
44199400|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
44199401|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199402|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44199403|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44199404|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44199405|NCT00393614|Levetiracetam|levetiracetam|mesh-list
44199406|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
44199407|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
44455783|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455784|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455785|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44455786|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44455787|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44455788|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44455789|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44455790|NCT01641237|Listerine|listerine|mesh-list
44455791|NCT01641237|Fluorides|fluorides|mesh-list
44455792|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
44455793|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
44455794|NCT01641237|Protective Agents|protective agents|mesh-ancestor
44455795|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455796|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44455797|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199430|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199431|NCT00393731|Misoprostol|misoprostol|mesh-list
44463857|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
44463858|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463859|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463860|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
44463861|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44463862|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463863|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463864|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44463865|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44463866|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44463867|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44463868|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44463869|NCT01504204|Adapalene|adapalene|mesh-list
44463870|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44463871|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43667161|NCT00717652|Triamcinolone|triamcinolone|mesh-list
44199432|NCT00393731|Oxytocin|oxytocin|mesh-list
44199433|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
44199434|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44199435|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199436|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44199437|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
44199438|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44199439|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44199473|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199474|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199475|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199476|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199477|NCT00394303|Insulin|insulin|mesh-list
44199478|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199479|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199480|NCT00394368|Fluticasone|fluticasone|mesh-list
44199513|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44199514|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44199515|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199516|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44199517|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44199518|NCT00394407|Insulin|insulin|mesh-list
44199519|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44199520|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199521|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199522|NCT00394459|Anesthetics|anesthetics|mesh-list
44199523|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199549|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44199550|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199551|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199552|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199553|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199554|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44199556|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
44199557|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199558|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44199559|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44199560|NCT00394628|Temozolomide|temozolomide|mesh-list
44199561|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463872|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
44281657|NCT00734773|Rituximab|rituximab|mesh-list
44199562|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
44199563|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199564|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199565|NCT00394693|Interferons|interferons|mesh-list
44199566|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
44199567|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199568|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
44199569|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199570|NCT00394745|Valsartan|valsartan|mesh-list
44199571|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602845|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199603|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199604|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199605|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44199606|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199607|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199608|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199609|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44199610|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
44199611|NCT00395070|Temozolomide|temozolomide|mesh-list
44199612|NCT00395070|Dacarbazine|dacarbazine|mesh-list
44199639|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199640|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44199641|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
44199642|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199643|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199644|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44199645|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
44199646|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
44199648|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199649|NCT00395252|Gemcitabine|gemcitabine|mesh-list
44199650|NCT00395252|Cetuximab|cetuximab|mesh-list
44199651|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199652|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
44199653|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199654|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199655|NCT00395252|Antiviral Agents|antiviral agents|mesh-ancestor
44199656|NCT00395252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199657|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199658|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199659|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
44199660|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602934|NCT03249311|Analgesics|analgesics|mesh-ancestor
44199695|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199696|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199697|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199698|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199699|NCT00395499|Risperidone|risperidone|mesh-list
44199700|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44199701|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
44199714|NCT00395551|Growth Substances|growth substances|mesh-ancestor
44199715|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199716|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
44199717|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199718|NCT00395655|Hydralazine|hydralazine|mesh-list
44199719|NCT00395655|Valproic Acid|valproic acid|mesh-list
44199720|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
44199721|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199722|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199723|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
44199724|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199725|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199726|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
44199727|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199728|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199729|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199730|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44199731|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
44199732|NCT00395681|Propofol|propofol|mesh-list
44199733|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44199734|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281658|NCT00734773|Methotrexate|methotrexate|mesh-list
44281659|NCT00734773|Vincristine|vincristine|mesh-list
44281660|NCT00734773|Procarbazine|procarbazine|mesh-list
44281661|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
44281662|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281663|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281664|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
44281665|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199735|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199736|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44199737|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
44199738|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
44199739|NCT00395707|Ranibizumab|ranibizumab|mesh-list
44199740|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44199741|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199742|NCT00395707|Growth Substances|growth substances|mesh-ancestor
44199743|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199744|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44199745|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199746|NCT00395720|Vaccines|vaccines|mesh-list
44199747|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
44199748|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199749|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
44199750|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44199751|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44199752|NCT00395772|Vitamin K|vitamin k|mesh-list
44199753|NCT00395772|Heparin|heparin|mesh-list
44199754|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
44199755|NCT00395772|Vitamins|vitamins|mesh-ancestor
44199756|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
44199757|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199758|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
44199759|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44199760|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44199761|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199762|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44199763|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
44199764|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44199765|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
43603028|NCT03249038|Chrysarobin|chrysarobin|mesh-list
44455818|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44455820|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44199776|NCT00395915|Aripiprazole|aripiprazole|mesh-list
44199777|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
44199778|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199779|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44199780|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199781|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199782|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199783|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
44199784|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
44199785|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199786|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199787|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44199788|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44199789|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
44199790|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44199791|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44199792|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44199793|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44199794|NCT00395941|Pioglitazone|pioglitazone|mesh-list
44199795|NCT00395941|Acitretin|acitretin|mesh-list
44199796|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199797|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199798|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
44199799|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44199800|NCT00396045|Lenalidomide|lenalidomide|mesh-list
44199801|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
44199802|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199803|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44281666|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281667|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44281668|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
43733811|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281669|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281670|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281671|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
44199804|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199805|NCT00396045|Growth Substances|growth substances|mesh-ancestor
44199806|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
44199807|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199808|NCT00396058|Methylphenidate|methylphenidate|mesh-list
44199809|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44199841|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44199842|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44199843|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44199844|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
44199845|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199846|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44199847|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44199848|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199849|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
43603154|NCT03248401|Aspirin|aspirin|mesh-list
44199871|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199872|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199873|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199874|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
44199875|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199876|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44199877|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44199878|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199880|NCT00396500|Albendazole|albendazole|mesh-list
44199881|NCT00396500|Vitamins|vitamins|mesh-ancestor
44199882|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
44199883|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199884|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199885|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199886|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
44199887|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44199888|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199889|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
44199890|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44199891|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44199892|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199893|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199894|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199895|NCT00396513|Metformin|metformin|mesh-list
44199896|NCT00396513|Simvastatin|simvastatin|mesh-list
44199897|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199898|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199899|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44199900|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44199901|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
44199902|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199903|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44199904|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43733812|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733814|NCT03955861|Etanercept|etanercept|mesh-list
43733815|NCT03955861|Golimumab|golimumab|mesh-list
43734003|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734004|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
43734005|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43734006|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43734007|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43734008|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734009|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
43734010|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734011|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734012|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43734013|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
43734014|NCT02542137|Thymalfasin|thymalfasin|mesh-list
44455821|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199926|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44199927|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
44199928|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199929|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44199930|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44199931|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199932|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199933|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
44199934|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199935|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199936|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44281672|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281673|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
44281674|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199937|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199938|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199939|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
44199940|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199941|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
44199942|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199943|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199944|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44199945|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
44199946|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199947|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199948|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44199949|NCT00396721|Sirolimus|sirolimus|mesh-list
44199950|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44199951|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44199952|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199953|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199954|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43603243|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
43734015|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43734016|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
43734017|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734119|NCT02541552|Ropivacaine|ropivacaine|mesh-list
43734120|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
43734121|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
44199981|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
44199982|NCT00396747|Methotrexate|methotrexate|mesh-list
44199983|NCT00396747|Infliximab|infliximab|mesh-list
44199984|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44199985|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
44199986|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44199987|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
43734335|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43734336|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43734337|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
43734338|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734339|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734340|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734341|NCT02540707|Urological Agents|urological agents|mesh-ancestor
43734342|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43734343|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43734344|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43734345|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199988|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44199989|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199990|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199991|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
44199992|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199993|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199994|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
44199995|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199996|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44199997|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199998|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
44199999|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200000|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200001|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44200002|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
44200031|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
44200032|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44200033|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200034|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
44200036|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44200037|NCT00396799|Hormones|hormones|mesh-ancestor
44200038|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200039|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200040|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44200041|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44200042|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200043|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43644787|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
43734347|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
43734348|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43734349|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200044|NCT00396851|Metformin|metformin|mesh-list
44200045|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200046|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200047|NCT00396929|Paclitaxel|paclitaxel|mesh-list
44200048|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44200049|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200050|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200051|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200079|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44200080|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44200081|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44200082|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44200083|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200084|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200085|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200086|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
44200087|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200089|NCT00397241|Dorzolamide|dorzolamide|mesh-list
44200090|NCT00397241|Latanoprost|latanoprost|mesh-list
43734350|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43734351|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734352|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734353|NCT02540512|Acetaminophen|acetaminophen|mesh-list
43734354|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43734355|NCT02540512|Hydrocodone|hydrocodone|mesh-list
43734356|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734357|NCT02540512|Analgesics|analgesics|mesh-ancestor
43734358|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
43734359|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734360|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734361|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
43734362|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43648570|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
43648571|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648572|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200091|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
44200092|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44200093|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44200094|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
44200095|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200096|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200113|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44200114|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44200115|NCT00397384|Cetuximab|cetuximab|mesh-list
44200116|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44200117|NCT00397384|Antibodies|antibodies|mesh-list
44200118|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
44200119|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44200120|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
44200121|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200122|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200123|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200124|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200125|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200126|NCT00397423|Lenograstim|lenograstim|mesh-list
44200127|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44200128|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
44200129|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200130|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
44200131|NCT00397475|Vitamin D|vitamin d|mesh-list
44200132|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44200133|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200134|NCT00397475|Vitamins|vitamins|mesh-ancestor
44200135|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
44200136|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44200137|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
44200138|NCT00397501|Carboplatin|carboplatin|mesh-list
44200139|NCT00397501|Methotrexate|methotrexate|mesh-list
44200140|NCT00397501|Trastuzumab|trastuzumab|mesh-list
44200141|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200142|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44200143|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
44200144|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44200145|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200146|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200147|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
43855327|NCT03580317|Carbamazepine|carbamazepine|mesh-list
44200148|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200149|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
44200150|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200151|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44200152|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200153|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
44200154|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200155|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200181|NCT00397657|Ezetimibe|ezetimibe|mesh-list
44200182|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44200183|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44200184|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
44200185|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200186|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44200187|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
44200188|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
44200189|NCT00397657|Vitamins|vitamins|mesh-ancestor
44200190|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
44200191|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200192|NCT00397709|Rifampin|rifampin|mesh-list
44200193|NCT00397709|Isoniazid|isoniazid|mesh-list
43734521|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734522|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734523|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734524|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
44200194|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44200195|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
44200196|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200197|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200198|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
44200199|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200200|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700717|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281675|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44281676|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281677|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200201|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200202|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44200203|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44200204|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44200205|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44200206|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44200232|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44200233|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
44200234|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200235|NCT00397735|Protective Agents|protective agents|mesh-ancestor
44200236|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200237|NCT00397735|Antidotes|antidotes|mesh-ancestor
44200238|NCT00397761|Paclitaxel|paclitaxel|mesh-list
44200239|NCT00397761|Capecitabine|capecitabine|mesh-list
44200240|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44200241|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44200242|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200243|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200244|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200245|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200246|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200247|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200248|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
44200249|NCT00397787|Sunitinib|sunitinib|mesh-list
44200250|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200251|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44200252|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200253|NCT00397787|Growth Substances|growth substances|mesh-ancestor
44200254|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200281|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44200283|NCT00397917|Folic Acid|folic acid|mesh-list
44200284|NCT00397917|Hematinics|hematinics|mesh-ancestor
44200285|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
44200286|NCT00397917|Vitamins|vitamins|mesh-ancestor
44200287|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
44200288|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455822|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455823|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455824|NCT01640964|Terlipressin|terlipressin|mesh-list
44455825|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44455826|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44455827|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455828|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
44455829|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455830|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
44455831|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44455832|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44200290|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200291|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200322|NCT00398372|Rituximab|rituximab|mesh-list
44200323|NCT00398372|Epratuzumab|epratuzumab|mesh-list
44200324|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200325|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200326|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
44200327|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200328|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200329|NCT00398385|Gemcitabine|gemcitabine|mesh-list
44200330|NCT00398385|Cisplatin|cisplatin|mesh-list
44200331|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200332|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200333|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
44200334|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200335|NCT00398385|Antiviral Agents|antiviral agents|mesh-ancestor
44200364|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44200365|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44200366|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
44200367|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281678|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
44281679|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200368|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44200369|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200371|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200372|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
44200373|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44200374|NCT00398463|Protective Agents|protective agents|mesh-ancestor
44200375|NCT00398489|Tamoxifen|tamoxifen|mesh-list
44200376|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
44200377|NCT00398489|Docetaxel|docetaxel|mesh-list
44200378|NCT00398489|Trastuzumab|trastuzumab|mesh-list
44200379|NCT00398489|Epirubicin|epirubicin|mesh-list
44200380|NCT00398489|Anastrozole|anastrozole|mesh-list
44200381|NCT00398489|Goserelin|goserelin|mesh-list
44200382|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200383|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
44200384|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200411|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200412|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44200413|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200415|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
44200416|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200417|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200418|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200419|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44200420|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
44200421|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200422|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
44200423|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
44200424|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44200425|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
44200426|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200427|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200428|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200429|NCT00398554|Prednisone|prednisone|mesh-list
43603733|NCT03243344|Coagulants|coagulants|mesh-ancestor
44200454|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44200455|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200456|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200457|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200458|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
44200459|NCT00398580|Testosterone|testosterone|mesh-list
44200460|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
44200461|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
44200462|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44200463|NCT00398580|Dutasteride|dutasteride|mesh-list
44200464|NCT00398580|Androgens|androgens|mesh-ancestor
44200466|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200467|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200468|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200469|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200470|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
44200471|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44200472|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44200473|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200474|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200475|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200476|NCT00398658|Clindamycin|clindamycin|mesh-list
44200477|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
44200478|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
44200497|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200499|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200500|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200501|NCT00398697|Antiviral Agents|antiviral agents|mesh-ancestor
44200502|NCT00398697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200503|NCT00398697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200504|NCT00398697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200505|NCT00398697|Immunologic Factors|immunologic factors|mesh-ancestor
44200506|NCT00398697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200507|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
44200508|NCT00398749|Hematinics|hematinics|mesh-ancestor
44200509|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44200510|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200511|NCT00398788|Hydromorphone|hydromorphone|mesh-list
44200512|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44281680|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281681|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281682|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281683|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281684|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44281685|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
44281686|NCT00734890|Bevacizumab|bevacizumab|mesh-list
44281687|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281688|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281689|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44281690|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200513|NCT00398788|Narcotics|narcotics|mesh-ancestor
44200514|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200515|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200516|NCT00398788|Analgesics|analgesics|mesh-ancestor
44200517|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
44200518|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200519|NCT00398814|Sorafenib|sorafenib|mesh-list
44200520|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200521|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200522|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200523|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200524|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
44200525|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44200526|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200527|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200528|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735165|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200529|NCT00398827|Analgesics|analgesics|mesh-ancestor
44200530|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
44200531|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200532|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43603839|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200550|NCT00398892|Protective Agents|protective agents|mesh-ancestor
44200551|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200552|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
44200554|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
44200555|NCT00398905|Enoxaparin|enoxaparin|mesh-list
44200556|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
44200557|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44200558|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
44200559|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44200560|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
44200561|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200562|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200563|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
44200564|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44200565|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200566|NCT00398957|Naltrexone|naltrexone|mesh-list
44200567|NCT00398957|Hydromorphone|hydromorphone|mesh-list
44200568|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
44200569|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44200570|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200571|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
44200572|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200573|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44200574|NCT00398957|Narcotics|narcotics|mesh-ancestor
44200575|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200576|NCT00398957|Analgesics|analgesics|mesh-ancestor
44200577|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44200578|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44200579|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44200580|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44200581|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281691|NCT00734890|Growth Substances|growth substances|mesh-ancestor
44281692|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281693|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
44281694|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44281695|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44281696|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43667211|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44200582|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200583|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200584|NCT00399022|Analgesics|analgesics|mesh-ancestor
44200585|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
44200586|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200587|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
44200588|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200589|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
44200590|NCT00399048|Hydromorphone|hydromorphone|mesh-list
44200627|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735303|NCT05068232|Durvalumab|durvalumab|mesh-list
43735600|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735601|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43735619|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
43735620|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43735621|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43735622|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43735623|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
43735624|NCT02256865|Testosterone|testosterone|mesh-list
43735625|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
43735626|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
43735627|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43735628|NCT02256865|Androgens|androgens|mesh-ancestor
43735629|NCT02256865|Hormones|hormones|mesh-ancestor
44200628|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200629|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200630|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44200631|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
44200632|NCT00399087|Hormones|hormones|mesh-ancestor
43603951|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
44200652|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200654|NCT00399165|Testosterone|testosterone|mesh-list
44200655|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
44200656|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
44200657|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44200658|NCT00399165|Dutasteride|dutasteride|mesh-list
44200659|NCT00399165|Androgens|androgens|mesh-ancestor
44200660|NCT00399165|Hormones|hormones|mesh-ancestor
44200661|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200662|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200663|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200664|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200665|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
43855782|NCT03528902|Tamoxifen|tamoxifen|mesh-list
44200666|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44200667|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44200668|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200669|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200670|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200671|NCT00399204|Metformin|metformin|mesh-list
44200672|NCT00399204|Pioglitazone|pioglitazone|mesh-list
44200673|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200674|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200675|NCT00399243|Sumatriptan|sumatriptan|mesh-list
44200676|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44200677|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44200678|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44200679|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
44200680|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200681|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200682|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200683|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
43603988|NCT03241407|Triclosan|triclosan|mesh-list
44200713|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200715|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
44200716|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44200717|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200718|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200719|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200720|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
44200721|NCT00399399|Azathioprine|azathioprine|mesh-list
44200722|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200723|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
44200724|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200725|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281697|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44281698|NCT00735020|Vaccines|vaccines|mesh-list
44281699|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
44281700|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281701|NCT00735124|Gabapentin|gabapentin|mesh-list
43735635|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735636|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
43735637|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735638|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43648573|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
43648574|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648576|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648577|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
43648578|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648579|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43648580|NCT00670358|Prednisone|prednisone|mesh-list
43648581|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
43648582|NCT00670358|Rituximab|rituximab|mesh-list
43648583|NCT00670358|Doxorubicin|doxorubicin|mesh-list
43648584|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43648585|NCT00670358|Vincristine|vincristine|mesh-list
43648586|NCT00670358|Lenalidomide|lenalidomide|mesh-list
43648587|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648588|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
43648589|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648590|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648591|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648592|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
43648593|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648594|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648595|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43735668|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43735669|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735670|NCT00859781|Ketoconazole|ketoconazole|mesh-list
43735671|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
43735672|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281702|NCT00735124|Analgesics|analgesics|mesh-ancestor
43735673|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
44200726|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44200727|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
44200728|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200729|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200730|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44200731|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
44200770|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44200803|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44200804|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44200805|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200806|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44200807|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44200808|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200835|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200836|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44200838|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200839|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200840|NCT00399750|Bevacizumab|bevacizumab|mesh-list
44200841|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
44200842|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735674|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735675|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43735676|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43735677|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735678|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735679|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43735680|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
43735681|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735701|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648604|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648606|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43648607|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200843|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200844|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44200845|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200846|NCT00399750|Growth Substances|growth substances|mesh-ancestor
44200847|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200848|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455833|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455834|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
44455835|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44455836|NCT01640301|Aldesleukin|aldesleukin|mesh-list
44455837|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
44455838|NCT01640301|Fludarabine|fludarabine|mesh-list
44455839|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
44455840|NCT01640301|Interleukin-2|interleukin-2|mesh-list
43604164|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
44455869|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44455870|NCT01639729|Narcotics|narcotics|mesh-ancestor
44455871|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455872|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455873|NCT01639729|Analgesics|analgesics|mesh-ancestor
44455874|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
44455875|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455876|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44455877|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44455878|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
44455879|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
44200849|NCT00399867|Simvastatin|simvastatin|mesh-list
44200850|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44200851|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44200852|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
44200853|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200854|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44200855|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44200856|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200857|NCT00399945|Tobramycin|tobramycin|mesh-list
44200858|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200859|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200889|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
44200890|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44200891|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44200892|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44200894|NCT00400114|Irinotecan|irinotecan|mesh-list
44200895|NCT00400114|Sunitinib|sunitinib|mesh-list
44200896|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281703|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
44281704|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281705|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200897|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44200898|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44200899|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200900|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200901|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44200902|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200928|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200929|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200930|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
44200931|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44200932|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44200933|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200934|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200935|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200936|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44200937|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200938|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200939|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200940|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200941|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200942|NCT00400374|Celecoxib|celecoxib|mesh-list
44200943|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44200944|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200945|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200946|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200947|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200948|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44200949|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44200950|NCT00400374|Analgesics|analgesics|mesh-ancestor
44200951|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
44200972|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200973|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
44200974|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44200975|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200976|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200978|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
44200979|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44200980|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44200981|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
44200982|NCT00400387|Protective Agents|protective agents|mesh-ancestor
44200983|NCT00400387|Hematinics|hematinics|mesh-ancestor
44200984|NCT00400478|Rituximab|rituximab|mesh-list
44200985|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200986|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200987|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
44200988|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200989|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200990|NCT00400491|Vitamin D|vitamin d|mesh-list
44200991|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
44200992|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
44200993|NCT00400491|Vitamins|vitamins|mesh-list
44200994|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
44200995|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200996|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44200997|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44200998|NCT00400530|Alendronate|alendronate|mesh-list
44200999|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201000|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44201001|NCT00400556|Lenograstim|lenograstim|mesh-list
44201002|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44201003|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
44201004|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201005|NCT00400582|Candesartan|candesartan|mesh-list
44201006|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44201007|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44201008|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44201009|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201010|NCT00400595|Mupirocin|mupirocin|mesh-list
44281706|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
44281707|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44281708|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44281709|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281710|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281711|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44281712|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44281713|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736138|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43736139|NCT04928391|Narcotics|narcotics|mesh-ancestor
44281714|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281715|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
44281716|NCT00735228|Pancrelipase|pancrelipase|mesh-list
44281717|NCT00735228|Pancreatin|pancreatin|mesh-list
44281718|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281719|NCT00735241|Leucovorin|leucovorin|mesh-list
44281720|NCT00735241|Folic Acid|folic acid|mesh-list
44281721|NCT00735241|Bevacizumab|bevacizumab|mesh-list
44201011|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201012|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736140|NCT04928352|Bupivacaine|bupivacaine|mesh-list
43736141|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
43736142|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
43736143|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201035|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201036|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201037|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44201038|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
44201039|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201040|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201041|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201042|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201043|NCT00400725|Clobetasol|clobetasol|mesh-list
44201044|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201045|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
44201046|NCT00400725|Hormones|hormones|mesh-ancestor
44201047|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201048|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201049|NCT00400738|Ritonavir|ritonavir|mesh-list
44201050|NCT00400738|Lopinavir|lopinavir|mesh-list
44201051|NCT00400738|Saquinavir|saquinavir|mesh-list
44201052|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44201053|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44201054|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
44201055|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201056|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201057|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44201058|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44201059|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
44201060|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201061|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44201062|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44201063|NCT00400777|Amlodipine|amlodipine|mesh-list
44201064|NCT00400777|Valsartan|valsartan|mesh-list
44201091|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201094|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201095|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44201096|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
44201097|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201098|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201099|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201100|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201101|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201102|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44201103|NCT00400998|Fluticasone|fluticasone|mesh-list
44201104|NCT00400998|Xhance|xhance|mesh-list
44201105|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281723|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
44281724|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
44281725|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281726|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281727|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44281728|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44281729|NCT00735241|Growth Substances|growth substances|mesh-ancestor
44281730|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736185|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736186|NCT04767256|Dexamethasone|dexamethasone|mesh-list
43736187|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
44281731|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
44281732|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
44281733|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281734|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281735|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281737|NCT00735241|Antidotes|antidotes|mesh-ancestor
44281738|NCT00735241|Protective Agents|protective agents|mesh-ancestor
44281739|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
44281740|NCT00735241|Vitamins|vitamins|mesh-ancestor
44281741|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
44281742|NCT00735241|Hematinics|hematinics|mesh-ancestor
44281743|NCT00735280|Heparin|heparin|mesh-list
44281744|NCT00735280|Calcium heparin|calcium heparin|mesh-list
44281745|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
44281746|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44201106|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44201107|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
44201108|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201109|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201110|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201111|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201138|NCT00401128|Immunologic Factors|immunologic factors|mesh-ancestor
44201139|NCT00401128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201140|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44201141|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44201142|NCT00401167|Memantine|memantine|mesh-list
44201143|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44201144|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44201145|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
44201146|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201147|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201148|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736188|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736189|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
43736190|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
43736191|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736192|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736193|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736194|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
43736195|NCT04767256|Hormones|hormones|mesh-ancestor
43736196|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736197|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43736198|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736199|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736200|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736269|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
43856283|NCT03470805|Olaparib|olaparib|mesh-list
44201149|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44201150|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44201151|NCT00401180|Docetaxel|docetaxel|mesh-list
44201152|NCT00401180|Temozolomide|temozolomide|mesh-list
44201153|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201154|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201155|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201156|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201157|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201158|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44281747|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44281748|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281749|NCT00735345|Cisplatin|cisplatin|mesh-list
44281750|NCT00735345|Docetaxel|docetaxel|mesh-list
44281751|NCT00735345|Cetuximab|cetuximab|mesh-list
44281752|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281753|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201159|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
44201193|NCT00401362|Naltrexone|naltrexone|mesh-list
44201194|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
44201195|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44201196|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201197|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
44201198|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201199|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44201200|NCT00401427|Trastuzumab|trastuzumab|mesh-list
44201233|NCT00401492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201234|NCT00401492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201235|NCT00401492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201236|NCT00401492|Immunologic Factors|immunologic factors|mesh-ancestor
44201237|NCT00401492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201238|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44201239|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201240|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455906|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455907|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
44455908|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455909|NCT01639001|Cisplatin|cisplatin|mesh-list
44455910|NCT01639001|Carboplatin|carboplatin|mesh-list
44455911|NCT01639001|Pemetrexed|pemetrexed|mesh-list
44455912|NCT01639001|Crizotinib|crizotinib|mesh-list
44455913|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455914|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455915|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455916|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44455917|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455918|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44455919|NCT01638546|Temozolomide|temozolomide|mesh-list
44455920|NCT01638546|Veliparib|veliparib|mesh-list
44455921|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44455922|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
44455923|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455924|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455925|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44455926|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455927|NCT01638429|Rifaximin|rifaximin|mesh-list
44201253|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
44201254|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201255|NCT00401609|Antiviral Agents|antiviral agents|mesh-ancestor
44201256|NCT00401609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201257|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201258|NCT00401609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201259|NCT00401609|Immunologic Factors|immunologic factors|mesh-ancestor
44201260|NCT00401609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201261|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44201262|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44201263|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44201264|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201265|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201266|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201267|NCT00401635|Carboplatin|carboplatin|mesh-list
44201268|NCT00401635|Doxorubicin|doxorubicin|mesh-list
44201269|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44201270|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736414|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
43736415|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
43736416|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736417|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43736418|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44201271|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201272|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44201273|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44201274|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201275|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201276|NCT00401648|Brivaracetam|brivaracetam|mesh-list
44281755|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281756|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281757|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281758|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
44281759|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44281760|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281761|NCT00735527|Lorazepam|lorazepam|mesh-list
44281762|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
44281763|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
44281764|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
44281765|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281766|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281767|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201277|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
44201278|NCT00401661|Alfuzosin|alfuzosin|mesh-list
44201279|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44201280|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44201281|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44201282|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201283|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201305|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201306|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
44201307|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
44201308|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201309|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201310|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201311|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
44201312|NCT00401804|Hormones|hormones|mesh-ancestor
44201313|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201314|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201315|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856474|NCT03447379|Aspirin|aspirin|mesh-list
44201316|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201317|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44201318|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44201319|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201320|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201321|NCT00401856|Eplerenone|eplerenone|mesh-list
44201322|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44201323|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
44201324|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201325|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201326|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44201327|NCT00401856|Diuretics|diuretics|mesh-ancestor
44201328|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
44201329|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44201330|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
44201331|NCT00401869|Hematinics|hematinics|mesh-ancestor
44201332|NCT00401921|Minocycline|minocycline|mesh-list
44201333|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736645|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736646|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43736647|NCT05359341|Empagliflozin|empagliflozin|mesh-list
44201334|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201335|NCT00402012|Pioglitazone|pioglitazone|mesh-list
44201336|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43604755|NCT03234842|Paclitaxel|paclitaxel|mesh-list
44201366|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
44201367|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201368|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201369|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201370|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
44201371|NCT00402181|Hormones|hormones|mesh-ancestor
44281769|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281770|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44281771|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44281772|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281773|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
44281774|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
44281775|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281776|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281777|NCT00735761|Acyclovir|acyclovir|mesh-list
44281778|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
44281779|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
44281780|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281781|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281782|NCT00735813|Heparin|heparin|mesh-list
44281783|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
44281784|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44281785|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44201372|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201373|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201374|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201375|NCT00402207|Fluticasone|fluticasone|mesh-list
44201376|NCT00402207|Beclomethasone|beclomethasone|mesh-list
44201377|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201378|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44201379|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
44201380|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201381|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201382|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201383|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201420|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201421|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201422|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44201423|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
44201424|NCT00402376|Protective Agents|protective agents|mesh-ancestor
44201439|NCT00402415|Sirolimus|sirolimus|mesh-list
44201440|NCT00402415|Sunitinib|sunitinib|mesh-list
44201441|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201442|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201443|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201444|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201445|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
44201446|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201447|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
44201448|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201449|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201450|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201451|NCT00402415|Growth Substances|growth substances|mesh-ancestor
44201452|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201453|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44201454|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201455|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201456|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
44201457|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44201458|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201459|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281786|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281787|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44281788|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
44201460|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44201461|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201462|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44201463|NCT00402454|Rifampin|rifampin|mesh-list
44201464|NCT00402454|Isoniazid|isoniazid|mesh-list
44201465|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
44201466|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44201467|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
44201468|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43856609|NCT03434678|Fentanyl|fentanyl|mesh-list
44201469|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201470|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
44201471|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44201472|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201473|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201474|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44201475|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44201476|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44201477|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44201478|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44201479|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44201480|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44201516|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44201517|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44201518|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44201519|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44201520|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44201536|NCT00402545|Docetaxel|docetaxel|mesh-list
44201537|NCT00402545|Fluorouracil|fluorouracil|mesh-list
44201538|NCT00402545|Cetuximab|cetuximab|mesh-list
44201539|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201540|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201541|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201542|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201543|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201544|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
44201546|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201547|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
44201548|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201549|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44201550|NCT00402558|Aldesleukin|aldesleukin|mesh-list
44201551|NCT00402558|Methotrexate|methotrexate|mesh-list
44201552|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
44201553|NCT00402558|Fludarabine|fludarabine|mesh-list
44201554|NCT00402558|Busulfan|busulfan|mesh-list
44201555|NCT00402558|Interleukin-2|interleukin-2|mesh-list
44201556|NCT00402558|Tacrolimus|tacrolimus|mesh-list
44201557|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
44201558|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44201559|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44201560|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
44201561|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44201562|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201563|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201564|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
44201565|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201566|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201567|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201568|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201569|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44201570|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201571|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
44201572|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201573|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44201574|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
44201575|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201576|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44201577|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
44201578|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44281789|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44281790|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
44281791|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44281792|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201579|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44201580|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201581|NCT00402558|Analgesics|analgesics|mesh-ancestor
44201582|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
44201583|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201584|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44201585|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44201586|NCT00402571|Acetaminophen|acetaminophen|mesh-list
44201611|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44201612|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44201613|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44201614|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44201615|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44201616|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44201617|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
44201618|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44201619|NCT00402623|Quercetin|quercetin|mesh-list
44201620|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
44201621|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201623|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201624|NCT00402636|Sirolimus|sirolimus|mesh-list
44201625|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201626|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201627|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43644814|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834666|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43834667|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43834668|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43834669|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201628|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201629|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
44201630|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201631|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
44201632|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201633|NCT00402662|Everolimus|everolimus|mesh-list
44201634|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
44201635|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201636|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201637|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
44201638|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605041|NCT03232307|Hormones|hormones|mesh-ancestor
44201675|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
44201676|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201693|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201695|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44201696|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201697|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201698|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201699|NCT00403026|Growth Substances|growth substances|mesh-ancestor
44201700|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201701|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201702|NCT00403039|Ranibizumab|ranibizumab|mesh-list
44201703|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201704|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201705|NCT00403039|Growth Substances|growth substances|mesh-ancestor
44201706|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201707|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201708|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201709|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
44201710|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44201711|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
44201712|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201713|NCT00403065|Dexamethasone|dexamethasone|mesh-list
44201714|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201715|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
44201716|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
44201717|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201718|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201719|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201720|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
44201721|NCT00403065|Hormones|hormones|mesh-ancestor
44201722|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44281793|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44281794|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44281795|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281796|NCT00735930|Lenalidomide|lenalidomide|mesh-list
44281797|NCT00735930|Alvocidib|alvocidib|mesh-list
44281798|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
44281799|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281800|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44281801|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44281802|NCT00735930|Growth Substances|growth substances|mesh-ancestor
44281803|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44281804|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281805|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44281806|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281807|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736994|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43736995|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736996|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736997|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
43736998|NCT05283408|Esketamine|esketamine|mesh-list
43736999|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43737000|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201723|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201724|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201725|NCT00403156|Ranibizumab|ranibizumab|mesh-list
44201726|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
44201727|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201728|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201729|NCT00403156|Growth Substances|growth substances|mesh-ancestor
44201730|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201731|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201732|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201757|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44201758|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201759|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44201760|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
44201761|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201762|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201763|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201764|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201765|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201766|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44201767|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43856872|NCT03396588|Clonidine|clonidine|mesh-list
44201768|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44201769|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44201770|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201771|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201772|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201773|NCT00403312|Nicotine|nicotine|mesh-list
44201774|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44201775|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
44201776|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201777|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201778|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44201779|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44201780|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
44201781|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201782|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201783|NCT00403325|Ranibizumab|ranibizumab|mesh-list
44201819|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
44201820|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201821|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201822|NCT00403442|Bevacizumab|bevacizumab|mesh-list
44201823|NCT00403442|Verteporfin|verteporfin|mesh-list
44201842|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
44281808|NCT00736021|Citalopram|citalopram|mesh-list
44281809|NCT00736021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44281810|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44281811|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201843|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44201844|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201845|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
44201846|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201847|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
44201848|NCT00402974|Vitamin K|vitamin k|mesh-list
44201849|NCT00402974|Vitamin MK 7|vitamin mk 7|mesh-list
44201850|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44201851|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44201852|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737001|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201853|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
44201854|NCT00402974|Coagulants|coagulants|mesh-ancestor
44201855|NCT00402974|Vitamins|vitamins|mesh-ancestor
44201856|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
44201857|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201858|NCT00403637|Maleic acid|maleic acid|mesh-list
44201859|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201860|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201861|NCT00403650|Iloprost|iloprost|mesh-list
44201862|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44201863|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
44201864|NCT00403663|Fentanyl|fentanyl|mesh-list
44201865|NCT00403663|Morphine|morphine|mesh-list
44201866|NCT00403663|Bupivacaine|bupivacaine|mesh-list
44201867|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
44201868|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
44201869|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201870|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201871|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
44201872|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201873|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43605289|NCT03229694|Bosentan|bosentan|mesh-list
44201885|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201886|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
44201887|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201888|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
44201889|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201890|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201891|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201892|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44201894|NCT00403780|Analgesics|analgesics|mesh-ancestor
44201895|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
44201896|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201897|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201898|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
44201899|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44201900|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201901|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201902|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44201903|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44201904|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44201905|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201906|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44201907|NCT00403806|Dexamethasone|dexamethasone|mesh-list
44201908|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
44201909|NCT00403806|BB 1101|bb 1101|mesh-list
44201910|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201911|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
44201912|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
44201913|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737287|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737288|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737289|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43737291|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737292|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
43737293|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43737294|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43737295|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44201914|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201915|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201916|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
44201917|NCT00403806|Hormones|hormones|mesh-ancestor
43857011|NCT03384537|Listerine|listerine|mesh-list
44201918|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201919|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201920|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201921|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
44281812|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281813|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201922|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201923|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201924|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44201925|NCT00403819|Laxatives|laxatives|mesh-ancestor
44201926|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201928|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44201929|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201930|NCT00403858|Laxatives|laxatives|mesh-ancestor
44201931|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44201932|NCT00403897|Laxatives|laxatives|mesh-ancestor
44201933|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201934|NCT00403910|Canrenone|canrenone|mesh-list
44201935|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44201936|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
44201937|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605326|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44201956|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201957|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44201958|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44201959|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44201960|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
44201961|NCT00403988|Vinorelbine|vinorelbine|mesh-list
44201962|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201963|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44201964|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201965|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201966|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201967|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201968|NCT00404040|Lactulose|lactulose|mesh-list
44201969|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44201970|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201971|NCT00404040|Laxatives|laxatives|mesh-ancestor
44201972|NCT00404053|Clopidogrel|clopidogrel|mesh-list
44201973|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44201974|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44201975|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44201976|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44201977|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
43648608|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648609|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648610|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648612|NCT00670358|Growth Substances|growth substances|mesh-ancestor
44201978|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201979|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201980|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201981|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44201982|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44201983|NCT00404157|Rituximab|rituximab|mesh-list
44201984|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44201985|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201986|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
44201987|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201988|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201989|NCT00404183|Acetaminophen|acetaminophen|mesh-list
44201990|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44201991|NCT00404183|Hydrocodone|hydrocodone|mesh-list
44201992|NCT00404183|Oxycodone|oxycodone|mesh-list
44202009|NCT00404222|Acetaminophen|acetaminophen|mesh-list
44202010|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44202011|NCT00404222|Hydrocodone|hydrocodone|mesh-list
44202012|NCT00404222|Oxycodone|oxycodone|mesh-list
44202013|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202014|NCT00404222|Analgesics|analgesics|mesh-ancestor
44202015|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
44202016|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202017|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202018|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
44202019|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44202020|NCT00404222|Narcotics|narcotics|mesh-ancestor
44202021|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202022|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
44202023|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202024|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44281815|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281816|NCT00736021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44281817|NCT00736021|Antidepressive Agents|antidepressive agents|mesh-ancestor
44202025|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202027|NCT00404261|Fluticasone|fluticasone|mesh-list
44202028|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44202029|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44202030|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202031|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202032|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
44202033|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202034|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202035|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202036|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202037|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202038|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44202039|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44202040|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44202041|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44202042|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44202043|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202044|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202045|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
44202046|NCT00404261|Hormones|hormones|mesh-ancestor
44202047|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202048|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
44202049|NCT00404274|Casopitant|casopitant|mesh-list
44202050|NCT00404274|Warfarin|warfarin|mesh-list
44202051|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
44202052|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
43737299|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
43737451|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737452|NCT04851301|Naloxone|naloxone|mesh-list
43737453|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43737454|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202077|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202078|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44202079|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44202080|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202081|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202082|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44202083|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
44202084|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202085|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202086|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44202088|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
44202089|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202090|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202091|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44202092|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202093|NCT00404391|Acetaminophen|acetaminophen|mesh-list
44202094|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44202095|NCT00404391|Hydrocodone|hydrocodone|mesh-list
44202096|NCT00404391|Oxycodone|oxycodone|mesh-list
44202097|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202098|NCT00404391|Analgesics|analgesics|mesh-ancestor
44202099|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
44202100|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202101|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202102|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
44202103|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44202126|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
44202127|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44202128|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44202129|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44202130|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44202131|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202132|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
44202133|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202134|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202135|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44202136|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202137|NCT00404456|Melatonin|melatonin|mesh-list
44202138|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
44281818|NCT00736021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281819|NCT00736164|Selenium|selenium|mesh-list
44281820|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
43667287|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44202139|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202140|NCT00404456|Protective Agents|protective agents|mesh-ancestor
44202141|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202142|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202143|NCT00404482|Cyclosporine|cyclosporine|mesh-list
44202144|NCT00404482|Cyclosporins|cyclosporins|mesh-list
44202145|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202146|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202147|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737455|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
43834743|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834744|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43834745|NCT05102552|Protective Agents|protective agents|mesh-ancestor
43834746|NCT05098457|Lidocaine|lidocaine|mesh-list
43834747|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
43834748|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
43834749|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834750|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847677|NCT04083183|Vidarabine|vidarabine|mesh-list
43847678|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
43847679|NCT04083183|Fludarabine|fludarabine|mesh-list
44202148|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
44202149|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202150|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
44202151|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202152|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202153|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202154|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44202189|NCT00404586|Xhance|xhance|mesh-list
44202190|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202191|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202192|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
44202193|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202194|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202195|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43605603|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
44202216|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202218|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202219|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
44202220|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202221|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202222|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202223|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202224|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44202225|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44202226|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202227|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44202228|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44202229|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44202230|NCT00404716|Protective Agents|protective agents|mesh-ancestor
44202231|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44202232|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44202233|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202234|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44202235|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
44202236|NCT00404781|Aspirin|aspirin|mesh-list
44202237|NCT00404781|Cilostazol|cilostazol|mesh-list
44202238|NCT00404781|Clopidogrel|clopidogrel|mesh-list
44202239|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202240|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202241|NCT00404781|Analgesics|analgesics|mesh-ancestor
44202242|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
43847680|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
44202243|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202244|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202245|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202246|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202247|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44202248|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43605649|NCT03226340|Niacin|niacin|mesh-list
44202271|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
44202272|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44202273|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
44202275|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44202276|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
43737621|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43737622|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43737623|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737624|NCT04644627|Gentamicins|gentamicins|mesh-list
43737625|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43737626|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737627|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43737628|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737629|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737630|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43737631|NCT04635774|Insulin|insulin|mesh-list
43737667|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737668|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43737669|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737670|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43737703|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202277|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44202278|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
44202279|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202280|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44202281|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202282|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281821|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281822|NCT00736164|Protective Agents|protective agents|mesh-ancestor
44281823|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281824|NCT00736164|Trace Elements|trace elements|mesh-ancestor
44202283|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44202284|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202285|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44202286|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
44202287|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202288|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202289|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202290|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
44202291|NCT00404794|Hormones|hormones|mesh-ancestor
44455944|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44202292|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202293|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44202294|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
44202295|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
44202296|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202297|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202298|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44202320|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202321|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202322|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44202323|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
44202324|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
44202325|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202326|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202327|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44202328|NCT00404833|Protective Agents|protective agents|mesh-ancestor
44202329|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44202330|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
44202331|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44202332|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44202333|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202334|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202335|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
44202337|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202338|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202339|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44202340|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44202341|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
44202342|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44202343|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202344|NCT00405080|Rifampin|rifampin|mesh-list
44202345|NCT00405080|Casopitant|casopitant|mesh-list
44202346|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44202347|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
44202348|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202349|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202350|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
44202351|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44202352|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202384|NCT00405158|Floxacillin|floxacillin|mesh-list
44202385|NCT00405158|Cefadroxil|cefadroxil|mesh-list
44202386|NCT00405158|Oxytocin|oxytocin|mesh-list
44202387|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
44202388|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44202389|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202390|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202391|NCT00405158|Analgesics|analgesics|mesh-ancestor
44202392|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
44202393|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202394|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202413|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202414|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44202415|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202416|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
44202417|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202418|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
44281825|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
44281827|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44281828|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44202419|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202420|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202421|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202422|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202423|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
44202424|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44202425|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
44202426|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202427|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202428|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
44202429|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44202430|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44202431|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202432|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202433|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
44202434|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202435|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44202436|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43834803|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834805|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43834806|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43834807|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834808|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834809|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834810|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
43834811|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
43834812|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43834813|NCT05096663|Vitamins|vitamins|mesh-list
43834814|NCT05096663|Folic Acid|folic acid|mesh-list
43737817|NCT04378621|Adalimumab|adalimumab|mesh-list
44455946|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455947|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455948|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455949|NCT01638000|Urological Agents|urological agents|mesh-ancestor
44202437|NCT00405262|Ketorolac|ketorolac|mesh-list
44202438|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44202439|NCT00405262|Bupivacaine|bupivacaine|mesh-list
44202440|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
44202441|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
44202442|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202443|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202444|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
44202445|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605830|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
44202465|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202466|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202467|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44202468|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44202469|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44202470|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44202471|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44202472|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44202474|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202475|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202476|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
44202477|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202478|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202479|NCT00405366|Sorafenib|sorafenib|mesh-list
44202480|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202481|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44202482|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202483|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202484|NCT00405405|Bevacizumab|bevacizumab|mesh-list
44202485|NCT00405405|Cisplatin|cisplatin|mesh-list
44202486|NCT00405405|Docetaxel|docetaxel|mesh-list
44202487|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44202488|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202489|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202490|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202491|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202492|NCT00405405|Growth Substances|growth substances|mesh-ancestor
44202493|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202494|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202495|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
44202496|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202497|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
44202498|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281830|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281831|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44202499|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44202518|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44202519|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44202520|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
44202521|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
44202522|NCT00405496|Difluprednate|difluprednate|mesh-list
44202523|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
44202524|NCT00405496|Hormones|hormones|mesh-ancestor
44202525|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202526|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202527|NCT00405535|Glycine|glycine|mesh-list
44202528|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
44202529|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202530|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202531|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202532|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44202533|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
44202534|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
44202535|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202536|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202537|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202538|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202539|NCT00405574|Growth Substances|growth substances|mesh-ancestor
44202540|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202541|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202542|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202543|NCT00405717|Atorvastatin|atorvastatin|mesh-list
44202544|NCT00405717|Pravastatin|pravastatin|mesh-list
44202545|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44202546|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44202547|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
44202548|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202549|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44202550|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44202551|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202552|NCT00405730|Ketorolac|ketorolac|mesh-list
44202553|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44202554|NCT00405730|Nepafenac|nepafenac|mesh-list
44202555|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44202556|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44202557|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202558|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202577|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44202578|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44202579|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44202580|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202581|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202582|NCT00405808|Hormones|hormones|mesh-ancestor
44202583|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202584|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202585|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
44202586|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44202587|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202588|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202589|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202590|NCT00405847|Analgesics|analgesics|mesh-ancestor
44202591|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
44202592|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202593|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44202594|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44202595|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43737830|NCT04378621|Analgesics|analgesics|mesh-ancestor
44202596|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44202597|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202598|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202599|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
44202600|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44202601|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281832|NCT00736320|Vincristine|vincristine|mesh-list
44281833|NCT00736320|Doxorubicin|doxorubicin|mesh-list
44281834|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44281835|NCT00736320|Dacarbazine|dacarbazine|mesh-list
44281836|NCT00736320|Bleomycin|bleomycin|mesh-list
44202602|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44202603|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
44202604|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202605|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202606|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202607|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202608|NCT00405925|Lamivudine|lamivudine|mesh-list
44202609|NCT00405925|Zidovudine|zidovudine|mesh-list
44202610|NCT00405925|Abacavir|abacavir|mesh-list
44202611|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43605977|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202634|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44202635|NCT00406003|Paroxetine|paroxetine|mesh-list
44202636|NCT00406003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44202637|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44202638|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44202639|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202640|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202641|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
44202642|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202643|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44202644|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
44202645|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202646|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43738042|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
43738043|NCT04179864|Hormones|hormones|mesh-ancestor
43738044|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738045|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738046|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738047|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738048|NCT04168710|Bupivacaine|bupivacaine|mesh-list
43738092|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43738093|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
43738095|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738096|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738097|NCT04059484|Tamoxifen|tamoxifen|mesh-list
43738098|NCT04059484|Letrozole|letrozole|mesh-list
43738099|NCT04059484|Fulvestrant|fulvestrant|mesh-list
43738100|NCT04059484|Anastrozole|anastrozole|mesh-list
43738101|NCT04059484|Exemestane|exemestane|mesh-list
44202647|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44202648|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202649|NCT00406042|Prednisolone|prednisolone|mesh-list
44202650|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44202651|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
44202652|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44202653|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
44202654|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44202655|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
44202656|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202657|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
44202658|NCT00406042|Hormones|hormones|mesh-ancestor
44202659|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202660|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606042|NCT03222089|Analgesics|analgesics|mesh-ancestor
44202675|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202676|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44202677|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44202678|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202679|NCT00406146|Artesunate|artesunate|mesh-list
44202680|NCT00406146|Lumefantrine|lumefantrine|mesh-list
44202681|NCT00406146|Artemether|artemether|mesh-list
44202682|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44202683|NCT00406146|Amodiaquine|amodiaquine|mesh-list
44202684|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
44202685|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44202686|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44202687|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202688|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202689|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
44202690|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
44202691|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44202692|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
44202693|NCT00406172|Bevacizumab|bevacizumab|mesh-list
44202694|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202695|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202696|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202697|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202698|NCT00406172|Growth Substances|growth substances|mesh-ancestor
44202699|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202700|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202701|NCT00406237|Tigecycline|tigecycline|mesh-list
44202702|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281837|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281839|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281840|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202703|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202704|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44202705|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202706|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202707|NCT00406250|Bevacizumab|bevacizumab|mesh-list
44202708|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202709|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202710|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202711|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202712|NCT00406250|Growth Substances|growth substances|mesh-ancestor
44202713|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202714|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202715|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44202716|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43738196|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43738197|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738198|NCT03905928|Nicotine|nicotine|mesh-list
43738199|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43738200|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
43540460|NCT05224999|Nivolumab|nivolumab|mesh-list
43738285|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202717|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202718|NCT00406302|Docetaxel|docetaxel|mesh-list
44202719|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
44202720|NCT00406302|Cetuximab|cetuximab|mesh-list
43606089|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
44202748|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44202749|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
44202750|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202751|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44202752|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44202753|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202754|NCT00406471|Ranibizumab|ranibizumab|mesh-list
44202755|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202756|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202757|NCT00406471|Growth Substances|growth substances|mesh-ancestor
44202758|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202759|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202760|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202761|NCT00406497|Difluprednate|difluprednate|mesh-list
44202762|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
44202763|NCT00406497|Hormones|hormones|mesh-ancestor
44202782|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202783|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
44202784|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44202785|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202786|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202787|NCT00406744|Bevacizumab|bevacizumab|mesh-list
44202788|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202789|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202790|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202791|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202792|NCT00406744|Growth Substances|growth substances|mesh-ancestor
44202793|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202794|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202795|NCT00406796|Ranibizumab|ranibizumab|mesh-list
44202796|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202797|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202798|NCT00406796|Growth Substances|growth substances|mesh-ancestor
44202799|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202800|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202801|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202802|NCT00406861|Montelukast|montelukast|mesh-list
44202803|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202804|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202805|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44202806|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
43857829|NCT03284463|Glyburide|glyburide|mesh-list
44202807|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202808|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202809|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44202810|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44202811|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281841|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
43738286|NCT03762915|Minocycline|minocycline|mesh-list
43738287|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281842|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281843|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44281844|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44202812|NCT00406874|Folic Acid|folic acid|mesh-list
44202813|NCT00406874|Hematinics|hematinics|mesh-ancestor
44202814|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
44202815|NCT00406874|Vitamins|vitamins|mesh-ancestor
44202816|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
43606193|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
44202836|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202837|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
44202838|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202839|NCT00406978|Thalidomide|thalidomide|mesh-list
44202840|NCT00406978|Prednisone|prednisone|mesh-list
44202841|NCT00406978|Melphalan|melphalan|mesh-list
44202842|NCT00406978|Defibrotide|defibrotide|mesh-list
44202843|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202844|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
44202845|NCT00406978|Hormones|hormones|mesh-ancestor
44202846|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202847|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202848|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44202849|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202850|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44202851|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
44202852|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202853|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44202854|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44202855|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
44202856|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
44202857|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202858|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202859|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202860|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202861|NCT00406978|Growth Substances|growth substances|mesh-ancestor
44202862|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202863|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44202864|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44202865|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44202866|NCT00406991|Aspirin|aspirin|mesh-list
44202867|NCT00406991|Clopidogrel|clopidogrel|mesh-list
44202868|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202869|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202870|NCT00406991|Analgesics|analgesics|mesh-ancestor
44202899|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202900|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202901|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202902|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202903|NCT00407017|Analgesics|analgesics|mesh-ancestor
44202904|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
44202905|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202906|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202907|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738305|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
43738474|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43738475|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43738476|NCT03440892|Analgesics|analgesics|mesh-ancestor
43738477|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
43738478|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738479|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738480|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202908|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44202909|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44202910|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44202911|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44202912|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44202913|NCT00407056|Difluprednate|difluprednate|mesh-list
44202914|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
44202915|NCT00407056|Hormones|hormones|mesh-ancestor
43606300|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44202925|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202926|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202927|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202928|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202929|NCT00407121|Growth Substances|growth substances|mesh-ancestor
44202930|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202931|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455950|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44455951|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44281845|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44281846|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281847|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44281848|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
44281849|NCT00736346|Paroxetine|paroxetine|mesh-list
44455952|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44455953|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
44455954|NCT01637623|Allopurinol|allopurinol|mesh-list
44455955|NCT01637623|Losartan|losartan|mesh-list
44455956|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44455957|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44455958|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44455959|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44455960|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455961|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
44455962|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455963|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
44455964|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455965|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44455966|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
44455967|NCT01637623|Protective Agents|protective agents|mesh-ancestor
44455968|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455969|NCT01637584|Prazosin|prazosin|mesh-list
44455970|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44455971|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44455972|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44455973|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44202932|NCT00405457|Cyclosporine|cyclosporine|mesh-list
44202933|NCT00405457|Cyclosporins|cyclosporins|mesh-list
44202934|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202935|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202936|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44202937|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
44202938|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202939|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
44202940|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738577|NCT03002389|Xhance|xhance|mesh-list
43738578|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202941|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202942|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202943|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44202944|NCT00407186|Cisplatin|cisplatin|mesh-list
44202945|NCT00407186|Capecitabine|capecitabine|mesh-list
44202946|NCT00407186|Epirubicin|epirubicin|mesh-list
44202947|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202948|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44202949|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
44202950|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202951|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43738579|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202952|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44202953|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44202954|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202955|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44202956|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
44202972|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44202973|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202974|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44202975|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202976|NCT00407264|Fluticasone|fluticasone|mesh-list
44202978|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202979|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202980|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
44202981|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202982|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202983|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202984|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202985|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202986|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44202987|NCT00407277|Nicotine|nicotine|mesh-list
44202988|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44202989|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
44202990|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202991|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281850|NCT00736346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44281851|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44281852|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44281853|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281854|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281856|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281857|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44281858|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
44281859|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281860|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44202992|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44202993|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44202994|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
44202995|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738580|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
43738581|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644815|NCT04361825|Durvalumab|durvalumab|mesh-list
43738688|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738689|NCT02557945|Gabapentin|gabapentin|mesh-list
43738690|NCT02557945|Analgesics|analgesics|mesh-ancestor
43738691|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
43738699|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43738923|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
43738924|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738925|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738927|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43738928|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
43738929|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738930|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738931|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43738932|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738933|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
43738934|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43738935|NCT01682941|Estrogens|estrogens|mesh-ancestor
44202996|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202997|NCT00407290|Neostigmine|neostigmine|mesh-list
44202998|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44202999|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203000|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203001|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203002|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203003|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203004|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44203005|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
44203006|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203007|NCT00407342|Alefacept|alefacept|mesh-list
44203008|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203009|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
44203010|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203011|NCT00407394|Amoxicillin|amoxicillin|mesh-list
44203012|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203013|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203014|NCT00407407|Carboplatin|carboplatin|mesh-list
44203015|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44203016|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203038|NCT00407459|Pemetrexed|pemetrexed|mesh-list
44203039|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203040|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203041|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44203042|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44203043|NCT00407459|Growth Substances|growth substances|mesh-ancestor
44203044|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203045|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44203046|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203047|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203048|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44203049|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44203050|NCT00407589|Besifloxacin|besifloxacin|mesh-list
44203051|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203052|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203053|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44203054|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44203055|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203056|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738943|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738944|NCT01608451|Vitamins|vitamins|mesh-ancestor
43738945|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
43738946|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43738947|NCT01608451|Progestins|progestins|mesh-ancestor
44203057|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203058|NCT00407641|Heparin|heparin|mesh-list
44203059|NCT00407641|Tinzaparin|tinzaparin|mesh-list
44203060|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44203061|NCT00407641|Dalteparin|dalteparin|mesh-list
44203062|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
44281861|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44281862|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281863|NCT00736463|Atorvastatin|atorvastatin|mesh-list
44281864|NCT00736463|Simvastatin|simvastatin|mesh-list
44281865|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44281866|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44281867|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
44281868|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203063|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44203064|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44203065|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203066|NCT00407680|Valsartan|valsartan|mesh-list
43738948|NCT01608451|Hormones|hormones|mesh-ancestor
43738949|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738950|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43738951|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738952|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738953|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738954|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43738985|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203067|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203068|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44203069|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43606470|NCT03216070|Dasatinib|dasatinib|mesh-list
44203083|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44203085|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44203086|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
44203087|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203088|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203089|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44203090|NCT00407784|Diuretics|diuretics|mesh-ancestor
44203091|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
44203092|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203093|NCT00407849|Triamcinolone|triamcinolone|mesh-list
44203094|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44203095|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44203096|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44203097|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203098|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
44203099|NCT00407849|Hormones|hormones|mesh-ancestor
44203100|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203101|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203102|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203103|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
44203104|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203105|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203106|NCT00407862|Losartan|losartan|mesh-list
44203107|NCT00407862|Telmisartan|telmisartan|mesh-list
44203108|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44203109|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203110|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44203111|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44203112|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203113|NCT00407927|Epinastine|epinastine|mesh-list
44203114|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44203115|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
44203116|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
44203117|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203118|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203119|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203120|NCT00408031|Cycloserine|cycloserine|mesh-list
44203121|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44203122|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203123|NCT00408031|Renal Agents|renal agents|mesh-ancestor
44203124|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44203125|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
44203126|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203127|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
43606524|NCT03213639|Esomeprazole|esomeprazole|mesh-list
44203141|NCT00408174|Balsalazide|balsalazide|mesh-list
44203142|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44203143|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44203144|NCT00408174|Analgesics|analgesics|mesh-ancestor
44203145|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
44281870|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44281871|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281872|NCT00736515|Insulin|insulin|mesh-list
44281873|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44281874|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
44281875|NCT00736515|Gliclazide|gliclazide|mesh-list
44281876|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44203146|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203147|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203148|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203149|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203150|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203151|NCT00408187|Cyclosporine|cyclosporine|mesh-list
44203152|NCT00408187|Cyclosporins|cyclosporins|mesh-list
44203153|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203154|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203155|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203156|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
44203157|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203158|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
44203159|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203160|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203161|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203162|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44203163|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
44203164|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44203165|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203166|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44203167|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
44203168|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203169|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203170|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203171|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203172|NCT00408226|Pemetrexed|pemetrexed|mesh-list
44203173|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203174|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203175|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203176|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44203177|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44203178|NCT00408239|Enoxaparin|enoxaparin|mesh-list
44203179|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
44203180|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44203181|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44203182|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203183|NCT00408252|Sunitinib|sunitinib|mesh-list
44203184|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203185|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44203186|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44203199|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44203200|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44203201|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203202|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203203|NCT00408330|Azelaic acid|azelaic acid|mesh-list
44203204|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203205|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203206|NCT00408369|Pafuramidine|pafuramidine|mesh-list
44203207|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44203208|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44203209|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44203210|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203211|NCT00408382|Atorvastatin|atorvastatin|mesh-list
44203212|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44203213|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44203214|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
43739476|NCT00819546|Midostaurin|midostaurin|mesh-list
44203215|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281877|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281879|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44281880|NCT00736541|Cystatins|cystatins|mesh-list
44281881|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
44281882|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739629|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739630|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
43739677|NCT02534623|Sevoflurane|sevoflurane|mesh-list
44281883|NCT00736541|Expectorants|expectorants|mesh-ancestor
44281884|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281885|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44281886|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
44281887|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281888|NCT00736541|Protective Agents|protective agents|mesh-ancestor
44281889|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281890|NCT00736541|Antidotes|antidotes|mesh-ancestor
44203216|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44203217|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44203218|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203219|NCT00408525|Donepezil|donepezil|mesh-list
44203220|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44203221|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203222|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203223|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203224|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203225|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203226|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
44203227|NCT00408538|UC-781|uc-781|mesh-list
44203228|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
44203229|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44203230|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
44203231|NCT00408551|Leucovorin|leucovorin|mesh-list
44203232|NCT00408551|Fluorouracil|fluorouracil|mesh-list
44203233|NCT00408551|Floxuridine|floxuridine|mesh-list
44203234|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
44203235|NCT00408551|Irinotecan|irinotecan|mesh-list
44203236|NCT00408551|Calcium|calcium|mesh-list
44203237|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
44203238|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203239|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203240|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
44203241|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203242|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203243|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203244|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203245|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
44203246|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44203247|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44203248|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203249|NCT00408551|Antidotes|antidotes|mesh-ancestor
44203250|NCT00408551|Protective Agents|protective agents|mesh-ancestor
44203267|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203269|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203270|NCT00408772|Bevacizumab|bevacizumab|mesh-list
44203271|NCT00408772|Capecitabine|capecitabine|mesh-list
44203272|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
44203273|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203274|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203275|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44203276|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44203277|NCT00408772|Growth Substances|growth substances|mesh-ancestor
44203278|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203279|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
44203280|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203281|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
43842049|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44281891|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44281892|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
44281893|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281894|NCT00736606|Simvastatin|simvastatin|mesh-list
44281895|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44281896|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44281897|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
44281898|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281899|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44203282|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203283|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
44203284|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44203285|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44203286|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44203287|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203288|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203289|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203290|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203291|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203292|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44203293|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203294|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
44203295|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44203296|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44203297|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44203298|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203299|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203300|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203301|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203302|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203303|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44203304|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203305|NCT00408850|Pioglitazone|pioglitazone|mesh-list
44203306|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44203307|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203308|NCT00408915|Lisuride|lisuride|mesh-list
44203309|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44203336|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203337|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203338|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44203339|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44455974|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44455975|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455976|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455977|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455979|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
44455980|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455981|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
44455982|NCT01637402|Hormones|hormones|mesh-ancestor
44455983|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455984|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455985|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44455986|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455987|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44455988|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455989|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455990|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
44455991|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44203345|NCT00409201|Reboxetine|reboxetine|mesh-list
44203346|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
44203347|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43739918|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739919|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739920|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
43739949|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44203348|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44203349|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44281900|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44281901|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281902|NCT00736619|Paclitaxel|paclitaxel|mesh-list
44203350|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203351|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203352|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203353|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203354|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203355|NCT00409214|Talaporfin|talaporfin|mesh-list
44203356|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203357|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44203358|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203359|NCT00409227|Alfuzosin|alfuzosin|mesh-list
44203360|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44203361|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44203375|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203376|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203377|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44203378|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
44203379|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203380|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44203381|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44203382|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44203383|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203384|NCT00409305|Betahistine|betahistine|mesh-list
44203385|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203386|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
44203387|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
44203388|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203389|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203390|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203391|NCT00409318|Etanercept|etanercept|mesh-list
44203392|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44203393|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44203394|NCT00409318|Analgesics|analgesics|mesh-ancestor
44203395|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
44203396|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203397|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203398|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203399|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203400|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203401|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203402|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
44203403|NCT00409357|Alfuzosin|alfuzosin|mesh-list
44203404|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44203405|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44203406|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44203407|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203408|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203409|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203410|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203411|NCT00409357|Urological Agents|urological agents|mesh-ancestor
44203412|NCT00409383|Paclitaxel|paclitaxel|mesh-list
44203413|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44203415|NCT00409383|Oblimersen|oblimersen|mesh-list
44203416|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44203417|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203418|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44203419|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44203420|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44203421|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606832|NCT03208257|Esmolol|esmolol|mesh-list
44203444|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44203445|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44203446|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44203447|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203448|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203449|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44203450|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44203451|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
44203452|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281903|NCT00736619|Cetuximab|cetuximab|mesh-list
44281904|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44281905|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44281906|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203453|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44203454|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44203455|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
44203456|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44203457|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44203458|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44203459|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44203460|NCT00409630|Fluticasone|fluticasone|mesh-list
44203461|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203462|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44203463|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
44203464|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203465|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740423|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44203466|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44203467|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
44203468|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203469|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44203470|NCT00409643|Amlodipine|amlodipine|mesh-list
44203471|NCT00409643|Valsartan|valsartan|mesh-list
44203472|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203473|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44203474|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203475|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606885|NCT03207308|Vitamins|vitamins|mesh-ancestor
44203487|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
44203488|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203489|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203491|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44203492|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44203493|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
44203494|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203495|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203496|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203497|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44203498|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44203499|NCT00409760|Amlodipine|amlodipine|mesh-list
44203500|NCT00409760|Valsartan|valsartan|mesh-list
44203501|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203502|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44203503|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203504|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203505|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203506|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203507|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203508|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44203509|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44203510|NCT00409851|Amlodipine|amlodipine|mesh-list
44203511|NCT00409851|Valsartan|valsartan|mesh-list
44203512|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203513|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44203514|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203515|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203516|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203517|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203518|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203519|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44203520|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44203521|NCT00409890|Scopolamine|scopolamine|mesh-list
44203522|NCT00409890|Bromides|bromides|mesh-list
44203523|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44203524|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
44203525|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44203526|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
44203527|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
44203528|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740717|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740774|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740775|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
44281907|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281908|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281909|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667309|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
44203529|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203530|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203531|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
44203532|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44203533|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203534|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203535|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203536|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44203561|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203562|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44203563|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203564|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
44203565|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203566|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
44203567|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203569|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44203570|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
44203571|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
44203572|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
44203573|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
44203574|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44203575|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203577|NCT00410215|Cathartics|cathartics|mesh-ancestor
44203578|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203579|NCT00410215|Laxatives|laxatives|mesh-ancestor
44203580|NCT00410254|Midazolam|midazolam|mesh-list
44203581|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44203582|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44203583|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203584|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203585|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44203586|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44203616|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44203617|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44203618|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
44203619|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203620|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
44203621|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44203622|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44203623|NCT00410371|Lamotrigine|lamotrigine|mesh-list
43740984|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740985|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740987|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43740988|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
43740989|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43740990|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740991|NCT02526979|Mirabegron|mirabegron|mesh-list
43740992|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43740993|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43740994|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43740995|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203624|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
44203625|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44203626|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203627|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203628|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203629|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203630|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44203664|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203665|NCT00410553|Gemcitabine|gemcitabine|mesh-list
44203666|NCT00410553|Halichondrin B|halichondrin b|mesh-list
44203667|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203668|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
44203669|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203670|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203671|NCT00410553|Antiviral Agents|antiviral agents|mesh-ancestor
44203672|NCT00410553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203673|NCT00410553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203674|NCT00410553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607119|NCT03205176|Olaparib|olaparib|mesh-list
44203706|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203707|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44203708|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
44203709|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203710|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203711|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44203712|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44281910|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281911|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203713|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44203714|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44203715|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203716|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44203717|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
43740996|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741030|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43741031|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43741032|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43741102|NCT02526030|Ziprasidone|ziprasidone|mesh-list
44203718|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
44203719|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
44203720|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44203721|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203722|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44203723|NCT00410644|Hydromorphone|hydromorphone|mesh-list
43607142|NCT03204760|Dexamethasone|dexamethasone|mesh-list
44203744|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203745|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44203746|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203747|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
44203748|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
44203749|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203750|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203751|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44203752|NCT00410657|Protective Agents|protective agents|mesh-ancestor
44203753|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203754|NCT00410696|Lenograstim|lenograstim|mesh-list
44203755|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44203756|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
44203757|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203758|NCT00410735|Pranlukast|pranlukast|mesh-list
44203759|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44203760|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
44203761|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44203762|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
44203763|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203764|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203765|NCT00410748|Hydromorphone|hydromorphone|mesh-list
44203766|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203767|NCT00410748|Narcotics|narcotics|mesh-ancestor
44203768|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203769|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203770|NCT00410748|Analgesics|analgesics|mesh-ancestor
44203771|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
44203772|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203773|NCT00410774|Gemcitabine|gemcitabine|mesh-list
44203774|NCT00410774|Bevacizumab|bevacizumab|mesh-list
44203775|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203776|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203777|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44203778|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43607204|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
44203805|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203806|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203807|NCT00410878|Analgesics|analgesics|mesh-ancestor
44203808|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
44203809|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741105|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43741220|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43741221|NCT02525302|Growth Substances|growth substances|mesh-ancestor
43741267|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456017|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
44456018|NCT01636947|Metoclopramide|metoclopramide|mesh-list
44456019|NCT01636947|Granisetron|granisetron|mesh-list
44456020|NCT01636947|Tropisetron|tropisetron|mesh-list
44456021|NCT01636947|Dolasetron|dolasetron|mesh-list
44456022|NCT01636947|Alizapride|alizapride|mesh-list
44456023|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44456024|NCT01636947|BB 1101|bb 1101|mesh-list
44456025|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456026|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
44456027|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
44456028|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456029|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456030|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44456031|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
44456032|NCT01636947|Hormones|hormones|mesh-ancestor
44456033|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456034|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44456035|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281912|NCT00736697|Moxidectin|moxidectin|mesh-list
44281913|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
44281914|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44281915|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281916|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
44281917|NCT00736801|Fluticasone|fluticasone|mesh-list
44281918|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44281919|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281920|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44281921|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
44281922|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281923|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667314|NCT05288907|Lidocaine|lidocaine|mesh-list
44456069|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44456070|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
44456071|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456072|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456073|NCT01635764|Adalimumab|adalimumab|mesh-list
44456074|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456075|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203845|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203846|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
44203847|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43607340|NCT03203668|Choline|choline|mesh-list
44203876|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203877|NCT00411164|Narcotics|narcotics|mesh-ancestor
44203878|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203879|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203880|NCT00411164|Analgesics|analgesics|mesh-ancestor
44203881|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
44203882|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203883|NCT00411190|Acetaminophen|acetaminophen|mesh-list
44203884|NCT00411190|Ibuprofen|ibuprofen|mesh-list
44203885|NCT00411190|Atorvastatin|atorvastatin|mesh-list
44456076|NCT01635218|Fluoxetine|fluoxetine|mesh-list
44203886|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44203887|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44203888|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
44203889|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203890|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44203891|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44203892|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607376|NCT03203408|Hylan|hylan|mesh-list
44203926|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203927|NCT00411281|Cytarabine|cytarabine|mesh-list
44203928|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203929|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
44203930|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203931|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203959|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44203960|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44203961|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203962|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
44203964|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203965|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203966|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203967|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
44203968|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203969|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203970|NCT00411372|Fluticasone|fluticasone|mesh-list
44203971|NCT00411372|Xhance|xhance|mesh-list
44203972|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44203973|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44203974|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44281924|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44281925|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
44203975|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44203976|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
44203977|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203978|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203979|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43607456|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44204005|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
44204006|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204007|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204008|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44204009|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
44204010|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44204011|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204012|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204013|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204014|NCT00411541|Dexamethasone|dexamethasone|mesh-list
44204015|NCT00411541|Vincristine|vincristine|mesh-list
44204016|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204017|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
44204018|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
44204019|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204020|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204021|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204022|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
44204024|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204025|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204026|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204027|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44204049|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204050|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204051|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44204052|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
44204053|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741523|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741524|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43741526|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741528|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44204054|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204055|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44204056|NCT00411879|Vasopressins|vasopressins|mesh-list
44204057|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
44204058|NCT00411879|Epinephrine|epinephrine|mesh-list
44204059|NCT00411879|Racepinephrine|racepinephrine|mesh-list
44204060|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
44204061|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44204062|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44204063|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
44204064|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204065|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204066|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204067|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44204068|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44204069|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
44204070|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204071|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44204072|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
44204073|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
44204074|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
44204075|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44204076|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
44204077|NCT00411879|Coagulants|coagulants|mesh-ancestor
44204078|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44204079|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
44204080|NCT00411905|Bortezomib|bortezomib|mesh-list
44204081|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204108|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44204109|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204110|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44204111|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44204112|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204113|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204114|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44204115|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44281926|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44281927|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44281928|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43667326|NCT05255367|Phenol|phenol|mesh-list
44204116|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204117|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204118|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204119|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44204120|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44204121|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44204122|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
44204123|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44204124|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
44204125|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204126|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44204127|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
44204128|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44204129|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43607613|NCT03201601|Inositol|inositol|mesh-list
44204161|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44204162|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204163|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204164|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43741750|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43741752|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835363|NCT05059223|Reboxetine|reboxetine|mesh-list
44204165|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204166|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44204167|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44204168|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204169|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44204170|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44204171|NCT00412204|Bromides|bromides|mesh-list
44204172|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
44204173|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44204207|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204208|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44204209|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44204210|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204211|NCT00412555|Oseltamivir|oseltamivir|mesh-list
44204212|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
44204213|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607708|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
44204230|NCT00412646|Etravirine|etravirine|mesh-list
44204231|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44204232|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44204233|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204234|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204235|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
44204236|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204237|NCT00412698|Rimonabant|rimonabant|mesh-list
44204238|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44204239|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44204240|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44204241|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204242|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204243|NCT00412698|Hormones|hormones|mesh-ancestor
44204244|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204245|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204246|NCT00412763|Silymarin|silymarin|mesh-list
44204247|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
44204248|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204249|NCT00412763|Protective Agents|protective agents|mesh-ancestor
44204250|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204251|NCT00412789|Epothilone B|epothilone b|mesh-list
44204252|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204253|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204254|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204255|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204256|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204257|NCT00412802|Enoxaparin|enoxaparin|mesh-list
44204258|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
44204259|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
44281929|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44204260|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44204261|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44204262|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204263|NCT00412919|Azacitidine|azacitidine|mesh-list
44204264|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204265|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
44204266|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204267|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204268|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204269|NCT00412997|Panobinostat|panobinostat|mesh-list
44204270|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456077|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44456078|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44456079|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456080|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741946|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
43741947|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741948|NCT05547243|Vaccines|vaccines|mesh-list
43741949|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
43741950|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741951|NCT05517642|Vaccines|vaccines|mesh-list
43741961|NCT05494866|Cobicistat|cobicistat|mesh-list
44456081|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456082|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
44456083|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456084|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44456085|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
44456086|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456087|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44456088|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44456089|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456090|NCT01635153|Micronutrients|micronutrients|mesh-list
44456091|NCT01635153|Trace Elements|trace elements|mesh-list
44456092|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456093|NCT01634854|Misoprostol|misoprostol|mesh-list
44456094|NCT01634854|Oxytocin|oxytocin|mesh-list
44456095|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
44456096|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44456097|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456098|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44456099|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
44456100|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44456101|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44456102|NCT01634555|Leucovorin|leucovorin|mesh-list
44456103|NCT01634555|Folic Acid|folic acid|mesh-list
44456104|NCT01634555|Fluorouracil|fluorouracil|mesh-list
44456105|NCT01634555|Irinotecan|irinotecan|mesh-list
44456106|NCT01634555|Ramucirumab|ramucirumab|mesh-list
44456107|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
44456108|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
44456109|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456110|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44456111|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456112|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204316|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44204318|NCT00413257|Nefopam|nefopam|mesh-list
44204319|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44204320|NCT00413257|Analgesics|analgesics|mesh-ancestor
44204321|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
44204322|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204323|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204352|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204353|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204355|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
44204356|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
44204357|NCT00413387|Hormones|hormones|mesh-ancestor
44204358|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204359|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44204360|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44204361|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44204362|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
44204363|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204364|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204365|NCT00413426|Darifenacin|darifenacin|mesh-list
44204366|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44204367|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44204368|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
43842100|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44281931|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
44281932|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742086|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
43742203|NCT05359211|Fludarabine|fludarabine|mesh-list
44281933|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281934|NCT00736814|Gemcitabine|gemcitabine|mesh-list
44281935|NCT00736814|Carboplatin|carboplatin|mesh-list
44281936|NCT00736814|Docetaxel|docetaxel|mesh-list
44281937|NCT00736814|Vinorelbine|vinorelbine|mesh-list
44281938|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281939|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44281940|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
44281941|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281942|NCT00736814|Antiviral Agents|antiviral agents|mesh-ancestor
44281943|NCT00736814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204369|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204370|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204403|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44204404|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
44204405|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204406|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204407|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204408|NCT00413686|Gemcitabine|gemcitabine|mesh-list
44204409|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204410|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
44204411|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204412|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607942|NCT03199482|Hormones|hormones|mesh-ancestor
44204443|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44204444|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44204445|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204446|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204447|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204448|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44204449|NCT00413790|Darifenacin|darifenacin|mesh-list
44204450|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44204451|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44204452|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
44204453|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204454|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607989|NCT03199105|Tetracaine|tetracaine|mesh-list
44204465|NCT00413946|Hematinics|hematinics|mesh-ancestor
44204466|NCT00414024|Tegaserod|tegaserod|mesh-list
44204467|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44204468|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
44204469|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204470|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204471|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204472|NCT00414037|Eszopiclone|eszopiclone|mesh-list
44204473|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44204474|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204475|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204476|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44204477|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
43742349|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43742350|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
43742351|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742422|NCT05211323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204478|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204479|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
44204480|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
44204481|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204482|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
44204483|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204484|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44204485|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44204486|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
44281944|NCT00736814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281945|NCT00736814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44281946|NCT00736814|Immunologic Factors|immunologic factors|mesh-ancestor
44281947|NCT00736814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281948|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
44281949|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
44281950|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
44281951|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44463873|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44463874|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44463875|NCT01504204|Analgesics|analgesics|mesh-ancestor
44463876|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
44463877|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463878|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204487|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204488|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204489|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44204490|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204491|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44204492|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
44204493|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44204494|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204495|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204496|NCT00414180|Bupropion|bupropion|mesh-list
44204497|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44204498|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
44204499|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44204500|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44204501|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44204502|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204503|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204504|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
44204505|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204506|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204507|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44204508|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44204509|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204510|NCT00414245|Metformin|metformin|mesh-list
44204511|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44204512|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742609|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742610|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742611|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43742612|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43742613|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43742614|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44204513|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44204514|NCT00414323|Citalopram|citalopram|mesh-list
44204515|NCT00414323|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44204516|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44204517|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608027|NCT03198403|Epinephrine|epinephrine|mesh-list
44204552|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
44204553|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204554|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43608091|NCT03197961|Emtricitabine|emtricitabine|mesh-list
44204580|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
44204581|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204582|NCT00414921|Analgesics|analgesics|mesh-ancestor
44204583|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
44204584|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204585|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44204586|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
44204587|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
44204588|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44463879|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463880|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463881|NCT01503229|Prednisone|prednisone|mesh-list
44281953|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44281954|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
43667355|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
44204589|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44204590|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44204591|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
44204592|NCT00414947|Vildagliptin|vildagliptin|mesh-list
44204593|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44204594|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204595|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44204596|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
44204597|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204598|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204599|NCT00415064|Dexamethasone|dexamethasone|mesh-list
44204600|NCT00415064|Lenalidomide|lenalidomide|mesh-list
44204601|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204602|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
44204603|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
44204628|NCT00415103|Aprepitant|aprepitant|mesh-list
44204629|NCT00415103|Palonosetron|palonosetron|mesh-list
44204630|NCT00415103|Granisetron|granisetron|mesh-list
44204631|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
44204632|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
44204633|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204634|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204635|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204636|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44204637|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204638|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204639|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43835574|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742765|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742766|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204640|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44204641|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
44204642|NCT00415116|Carboplatin|carboplatin|mesh-list
44204643|NCT00415116|Docetaxel|docetaxel|mesh-list
44204644|NCT00415116|Lenalidomide|lenalidomide|mesh-list
44204645|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204646|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204647|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204648|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204649|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204650|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
44204651|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204652|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204678|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
44204679|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204680|NCT00415311|Coagulants|coagulants|mesh-ancestor
44204681|NCT00415324|Cisplatin|cisplatin|mesh-list
44204682|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204683|NCT00415350|Azithromycin|azithromycin|mesh-list
44204684|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44204685|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204686|NCT00415376|Levetiracetam|levetiracetam|mesh-list
44204687|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
44204688|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
44204689|NCT00415402|Vitamin D|vitamin d|mesh-list
44204690|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
44204691|NCT00415402|Vitamins|vitamins|mesh-ancestor
44204722|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204723|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204724|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204725|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44204726|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204727|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44204728|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44204729|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
44204730|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
44204731|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44204732|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204734|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43798733|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
44281955|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281956|NCT00736866|Expectorants|expectorants|mesh-ancestor
44281957|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44281958|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44281959|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
44281960|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281961|NCT00736866|Protective Agents|protective agents|mesh-ancestor
44281962|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281963|NCT00736866|Antidotes|antidotes|mesh-ancestor
44281964|NCT00736905|Rilpivirine|rilpivirine|mesh-list
44281965|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44204735|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204736|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
44204761|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44204762|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
44204763|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
44204765|NCT00415844|Carbidopa|carbidopa|mesh-list
44204766|NCT00415844|Entacapone|entacapone|mesh-list
44204767|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44204768|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44204769|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44204770|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
44204771|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204772|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204773|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204774|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44204775|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743027|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743060|NCT04792320|Protective Agents|protective agents|mesh-ancestor
43743061|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743062|NCT04788914|Charcoal|charcoal|mesh-list
43743063|NCT04788914|Antidotes|antidotes|mesh-ancestor
44204776|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43743064|NCT04788914|Protective Agents|protective agents|mesh-ancestor
43743065|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743066|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43743067|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
44204777|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44204778|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
44204779|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
44204780|NCT00415883|Valsartan|valsartan|mesh-list
44204781|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44204782|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44204783|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44204784|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204808|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204809|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204810|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44204811|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204812|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44204813|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204814|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
44204815|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44204816|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44204817|NCT00415961|Paclitaxel|paclitaxel|mesh-list
44204818|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44204819|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204820|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204821|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204822|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204823|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204824|NCT00416039|Midazolam|midazolam|mesh-list
44204825|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44204826|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44204827|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204828|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204829|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44204830|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43743068|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743069|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743071|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
43835594|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44204831|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43743151|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44204832|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44204833|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
44204834|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
44281966|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44281967|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44281968|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44281969|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
44281970|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44281971|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44281972|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44281973|NCT00736931|Levetiracetam|levetiracetam|mesh-list
44281974|NCT00736931|Lorazepam|lorazepam|mesh-list
44281975|NCT00736931|Brivaracetam|brivaracetam|mesh-list
44281976|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
44281977|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
44204835|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
44204864|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204865|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
44204866|NCT00416221|Citalopram|citalopram|mesh-list
44204867|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44204868|NCT00416221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44204869|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44204870|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204871|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204872|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204873|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
44204874|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204875|NCT00416221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44204876|NCT00416273|Bortezomib|bortezomib|mesh-list
44204877|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204878|NCT00416325|Lycopene|lycopene|mesh-list
44204879|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204880|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
44204916|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
44204917|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204918|NCT00416390|Protective Agents|protective agents|mesh-ancestor
44204919|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204920|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44204921|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43608461|NCT03196401|Durvalumab|durvalumab|mesh-list
44204950|NCT00416507|Gemcitabine|gemcitabine|mesh-list
44204951|NCT00416507|Cisplatin|cisplatin|mesh-list
44204952|NCT00416507|Fluorouracil|fluorouracil|mesh-list
44204953|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204954|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204955|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
44204956|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204958|NCT00416507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204959|NCT00416507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204960|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204961|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
44204962|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204963|NCT00416533|Prednisone|prednisone|mesh-list
44204964|NCT00416533|Docetaxel|docetaxel|mesh-list
44204965|NCT00416533|Doxorubicin|doxorubicin|mesh-list
44204966|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44204967|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204968|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204969|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204993|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204994|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44204995|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204996|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204997|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
44204998|NCT00416676|Cisplatin|cisplatin|mesh-list
44204999|NCT00416676|Carboplatin|carboplatin|mesh-list
44205000|NCT00416676|Etoposide|etoposide|mesh-list
44205001|NCT00416676|Vincristine|vincristine|mesh-list
44205002|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205003|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
44281978|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
44281979|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
44281980|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44281981|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44281982|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44281983|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44281984|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44281985|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44281986|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44281987|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44281988|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
44281989|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
44281990|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44281991|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205004|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205005|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205006|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205007|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
44205008|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205009|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205010|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44205011|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205012|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44205013|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205014|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205015|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205016|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205017|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44205018|NCT00416728|Valsartan|valsartan|mesh-list
44205019|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44205046|NCT00416819|Rituximab|rituximab|mesh-list
44205047|NCT00416819|Methotrexate|methotrexate|mesh-list
44205048|NCT00416819|Etoposide|etoposide|mesh-list
44205049|NCT00416819|Temozolomide|temozolomide|mesh-list
44205050|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
44205051|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
44205052|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44205053|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205054|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
44205055|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205056|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205057|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44205058|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
44205059|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44205060|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44205061|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
44205062|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205063|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44205064|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205065|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44205066|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205067|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44205068|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205069|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43608582|NCT03195491|Nivolumab|nivolumab|mesh-list
43860068|NCT03008278|Olaparib|olaparib|mesh-list
43743934|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44456154|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43744061|NCT04068103|Antidotes|antidotes|mesh-ancestor
44456155|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456156|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456157|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456158|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
44281993|NCT00736970|Trastuzumab|trastuzumab|mesh-list
44281994|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44281995|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44281996|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44281997|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456159|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456160|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
44456161|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456162|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456163|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456164|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456165|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
44456166|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44456167|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456168|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456169|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456170|NCT01634113|Bromides|bromides|mesh-list
44205113|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205114|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
44205115|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205116|NCT00416858|Cisplatin|cisplatin|mesh-list
44205117|NCT00416858|Fluorouracil|fluorouracil|mesh-list
44205118|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205119|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
44205120|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205121|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44205152|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205153|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205154|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205155|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
44205156|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205157|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205158|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44205159|NCT00416910|Analgesics|analgesics|mesh-ancestor
44205160|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
44205161|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43744062|NCT04068103|Protective Agents|protective agents|mesh-ancestor
43744217|NCT03907488|Vinblastine|vinblastine|mesh-list
43744218|NCT03907488|Antibodies|antibodies|mesh-list
44205162|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44205163|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205164|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205165|NCT00416923|Rituximab|rituximab|mesh-list
44205166|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44205167|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205168|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
44205193|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205194|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205195|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205197|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205198|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205199|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205200|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
44205201|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205202|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205203|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
44205204|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
44205205|NCT00417053|Melphalan|melphalan|mesh-list
44205206|NCT00417053|Busulfan|busulfan|mesh-list
44205207|NCT00417053|Carboplatin|carboplatin|mesh-list
44205208|NCT00417053|Doxorubicin|doxorubicin|mesh-list
44205209|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44205210|NCT00417053|Etoposide|etoposide|mesh-list
44205211|NCT00417053|Vincristine|vincristine|mesh-list
44205212|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
44205213|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205214|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
44205215|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205216|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205217|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205218|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
44281998|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44281999|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
44282000|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282001|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
44282002|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282003|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
44282004|NCT00736983|Adalimumab|adalimumab|mesh-list
44282005|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282006|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282007|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667402|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44205219|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205220|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205221|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44205245|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44205246|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
44205247|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44205248|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205249|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44205250|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205251|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205252|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205253|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744219|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
44205254|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44205256|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205257|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205258|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205259|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44205260|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44205261|NCT00417183|Ganirelix|ganirelix|mesh-list
44205262|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
44205263|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44205264|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
44205265|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44205266|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205267|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44205268|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205269|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205270|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205287|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205288|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
44205289|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205290|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205291|NCT00417404|Vitamins|vitamins|mesh-list
44205292|NCT00417404|Vitamin A|vitamin a|mesh-list
44205293|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
44205294|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
44205295|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205296|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
44205297|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205298|NCT00417404|Protective Agents|protective agents|mesh-ancestor
44205299|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44205300|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205301|NCT00417430|Fulvestrant|fulvestrant|mesh-list
44205302|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205303|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205304|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44205305|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44205306|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205307|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205308|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205309|NCT00417443|Clonidine|clonidine|mesh-list
44205310|NCT00417443|Analgesics|analgesics|mesh-ancestor
44282008|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282009|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44282010|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44282011|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282012|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667413|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
44205311|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
44205312|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205313|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744717|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744776|NCT03031730|Ichthammol|ichthammol|mesh-list
43744777|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43744778|NCT03031730|BB 1101|bb 1101|mesh-list
43744779|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43744780|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
43744781|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
43744840|NCT02978625|Nivolumab|nivolumab|mesh-list
43744841|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44205314|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44205315|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
44205316|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
44205317|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44205318|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44205319|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44205320|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44205321|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205322|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205323|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44205324|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
44205325|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205326|NCT00417677|Sirolimus|sirolimus|mesh-list
44205327|NCT00417677|Sunitinib|sunitinib|mesh-list
44205328|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205360|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205361|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205362|NCT00417768|Plasminogen|plasminogen|mesh-list
44205363|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44205364|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44205365|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44205366|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205367|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44205368|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44205369|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205406|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44205434|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205435|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
44205436|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205437|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205438|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205439|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44205440|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
44205441|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205442|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
44205443|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205444|NCT00418080|Bicalutamide|bicalutamide|mesh-list
44205445|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
44205446|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205447|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205448|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205449|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205450|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
44205451|NCT00418119|Hematinics|hematinics|mesh-ancestor
44205452|NCT00418132|Thalidomide|thalidomide|mesh-list
44205453|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205454|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
44205455|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744842|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744863|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744864|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744865|NCT02932410|Macitentan|macitentan|mesh-list
43744866|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44205456|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
44205457|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205458|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205478|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205479|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205480|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
44205481|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44205482|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44205483|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
44205484|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44282013|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282014|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44282015|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282016|NCT00737113|Hormones|hormones|mesh-list
44282017|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282018|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282019|NCT00737126|Folic Acid|folic acid|mesh-list
44282020|NCT00737126|Hematinics|hematinics|mesh-ancestor
44282021|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
44282022|NCT00737126|Vitamins|vitamins|mesh-ancestor
44282023|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
44282024|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282025|NCT00737139|Epinephrine|epinephrine|mesh-list
44205485|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44205486|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
44205487|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205488|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205489|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44205490|NCT00418249|Protective Agents|protective agents|mesh-ancestor
44205491|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44205492|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44205493|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205494|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205496|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205497|NCT00418275|Plasminogen|plasminogen|mesh-list
44205498|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44205499|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44205500|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205501|NCT00418288|Glucagon|glucagon|mesh-list
44205502|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44205503|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205504|NCT00418288|Hormones|hormones|mesh-ancestor
44205505|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205506|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205507|NCT00418288|Incretins|incretins|mesh-ancestor
44205508|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44205509|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205510|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205511|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205512|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205513|NCT00418353|Dexamethasone|dexamethasone|mesh-list
44205530|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205531|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44205532|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44205533|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44205535|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205536|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205537|NCT00418366|Incretins|incretins|mesh-ancestor
44205538|NCT00418366|Hormones|hormones|mesh-ancestor
44205539|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205540|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44205541|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205542|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205543|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205544|NCT00418392|Minocycline|minocycline|mesh-list
44205545|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205546|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205547|NCT00418431|Bevacizumab|bevacizumab|mesh-list
44205548|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44205549|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205550|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282026|NCT00737139|Bupivacaine|bupivacaine|mesh-list
44282027|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44282028|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44282029|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282030|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282031|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282032|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282033|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44205551|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205552|NCT00418431|Growth Substances|growth substances|mesh-ancestor
44205553|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205554|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205555|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44205556|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44205557|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205558|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
44205559|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
44205560|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44205561|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44205562|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205563|NCT00418496|Aldesleukin|aldesleukin|mesh-list
44205564|NCT00418496|Sorafenib|sorafenib|mesh-list
44205565|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205566|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205567|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205568|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205569|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44205570|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44205589|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44205590|NCT00418535|Cisplatin|cisplatin|mesh-list
43835740|NCT05025787|Analgesics|analgesics|mesh-ancestor
43745620|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
43745621|NCT02186834|Hormones|hormones|mesh-ancestor
43745622|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43745623|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745624|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745625|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745626|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745628|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205591|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205592|NCT00418548|Etanercept|etanercept|mesh-list
44205593|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205594|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205595|NCT00418548|Analgesics|analgesics|mesh-ancestor
44205596|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
44205597|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205598|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205599|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205600|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205601|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205602|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205603|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
44456199|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44456200|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44456201|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44456202|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44456203|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44456204|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
44456205|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
44456206|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456207|NCT01634100|Renal Agents|renal agents|mesh-ancestor
44456208|NCT01633944|Buprenorphine|buprenorphine|mesh-list
44456209|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44456210|NCT01633944|Narcotics|narcotics|mesh-ancestor
44456211|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456212|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456213|NCT01633944|Analgesics|analgesics|mesh-ancestor
44456214|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
44456215|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456216|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44456217|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
44456218|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44456219|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
44456220|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44456221|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282034|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44282035|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
44205618|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44205620|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44205621|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205622|NCT00418678|Nabilone|nabilone|mesh-list
44205623|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
44205624|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
44205625|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205626|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205627|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205628|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44205629|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44205630|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44205631|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205632|NCT00418704|Docetaxel|docetaxel|mesh-list
44205633|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44205634|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205635|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205636|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205637|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745802|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43745803|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43745804|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
43745805|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43745806|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
43745807|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
43745899|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
44205638|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205639|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205640|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205641|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44205642|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205643|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205644|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205645|NCT00418782|Naproxen|naproxen|mesh-list
44205646|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205647|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205648|NCT00418782|Analgesics|analgesics|mesh-ancestor
44205649|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
44205650|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205651|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205652|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205653|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205665|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44205666|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205667|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205668|NCT00418860|Aspirin|aspirin|mesh-list
44205669|NCT00418860|Clopidogrel|clopidogrel|mesh-list
44205670|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205671|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205672|NCT00418860|Analgesics|analgesics|mesh-ancestor
44205673|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
44205674|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205675|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205676|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205677|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205678|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43860752|NCT02933697|Apixaban|apixaban|mesh-list
44205679|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44205680|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205681|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44205682|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44205684|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
44205685|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44205686|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44205687|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44205688|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
44205689|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205690|NCT00418873|Risperidone|risperidone|mesh-list
44205691|NCT00418873|Zotepine|zotepine|mesh-list
44205692|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44205693|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
44205694|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205695|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205696|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205697|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44205698|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44205699|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44205700|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282036|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282037|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44282038|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44282039|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
43746200|NCT00602459|Fludarabine|fludarabine|mesh-list
43746201|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
44205701|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44205702|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
44205703|NCT00418925|Dronabinol|dronabinol|mesh-list
44205704|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
44205705|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205706|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205707|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205708|NCT00418925|Analgesics|analgesics|mesh-ancestor
44205709|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
44205710|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205711|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44205712|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44205713|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205714|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205715|NCT00418925|Hormones|hormones|mesh-ancestor
44205716|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205752|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44205754|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205755|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205756|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
44205757|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44205787|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205788|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
44205789|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205790|NCT00419471|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44205791|NCT00419471|Antidepressive Agents|antidepressive agents|mesh-ancestor
44205792|NCT00419471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205793|NCT00419484|Pioglitazone|pioglitazone|mesh-list
44205794|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205795|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205796|NCT00419536|Panobinostat|panobinostat|mesh-list
44205797|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205798|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44205799|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205800|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205870|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44205871|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
44205872|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205873|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44205874|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205875|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609463|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
44205898|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44205899|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
44205900|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44205901|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44205902|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205903|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205904|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205905|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205906|NCT00419796|Analgesics|analgesics|mesh-ancestor
44205907|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
44205908|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205909|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205910|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205911|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205912|NCT00419835|Losartan|losartan|mesh-list
44205913|NCT00419835|Enalapril|enalapril|mesh-list
44205914|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44205915|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44205916|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44205917|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44205918|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205919|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44282040|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
44282041|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44282042|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
43746454|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43746455|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746456|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43746457|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44282043|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
44282044|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282045|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
44282046|NCT00737191|Olanzapine|olanzapine|mesh-list
44205920|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205921|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205922|NCT00419848|Azithromycin|azithromycin|mesh-list
44205923|NCT00419848|Doxycycline|doxycycline|mesh-list
44205960|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
44205961|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205990|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205991|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44205992|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44205993|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205994|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44205995|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205996|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
44205997|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205998|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456229|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456230|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44456231|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44456232|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
43609577|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456256|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44456257|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
44456258|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456259|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44456260|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44456261|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44456262|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44456263|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44456264|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44456265|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44456266|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44456267|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44456268|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44456270|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
44456271|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44456272|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44456273|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44456274|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44456275|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44456276|NCT01632579|Celecoxib|celecoxib|mesh-list
44206000|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206001|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206002|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
44206003|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206004|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206005|NCT00420537|Cyclosporine|cyclosporine|mesh-list
44206006|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
44206007|NCT00420537|Everolimus|everolimus|mesh-list
44206030|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44206031|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
44206032|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206033|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206034|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44206035|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43747050|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43835863|NCT05019703|Atezolizumab|atezolizumab|mesh-list
43835864|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43835865|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747187|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648621|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648622|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648623|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43648624|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44206036|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44206037|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44206038|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
44206039|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44206040|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44282047|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
44282048|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
44282049|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282050|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282051|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282052|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44206041|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44206042|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44206043|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44206044|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44206045|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44206046|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206047|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206048|NCT00420589|Hormones|hormones|mesh-ancestor
44206049|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206050|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206051|NCT00420615|Epothilone B|epothilone b|mesh-list
44206052|NCT00420615|Epothilones|epothilones|mesh-list
44206053|NCT00420615|Omeprazole|omeprazole|mesh-list
44206054|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44206055|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44206056|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44206057|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206092|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44206093|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206094|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
44206095|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206096|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44206097|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44206098|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206099|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206129|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206130|NCT00421083|Tadalafil|tadalafil|mesh-list
44206131|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206132|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44206133|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44206134|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206135|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206136|NCT00421083|Urological Agents|urological agents|mesh-ancestor
44206137|NCT00421096|Gemcitabine|gemcitabine|mesh-list
44206138|NCT00421096|Cisplatin|cisplatin|mesh-list
44206139|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206140|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206162|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44206163|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
44206164|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206165|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206166|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44206167|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206168|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
44206169|NCT00421122|Hormones|hormones|mesh-ancestor
44206170|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206171|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44206172|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43747436|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747438|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747439|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43747440|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206173|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44206174|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206175|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206176|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206177|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
44206178|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
44206179|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44206180|NCT00421187|Amphotericin B|amphotericin b|mesh-list
44206181|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44206182|NCT00421187|Amebicides|amebicides|mesh-ancestor
44206183|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44282054|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282055|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282056|NCT00737191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44282057|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44282058|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282059|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282060|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282061|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
44282062|NCT00737256|Aripiprazole|aripiprazole|mesh-list
44282063|NCT00737256|Perphenazine|perphenazine|mesh-list
44282064|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
44282065|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282066|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44206184|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44206185|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206186|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44206187|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
44206188|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44206189|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44206190|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
44206191|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
44206219|NCT00421395|Epratuzumab|epratuzumab|mesh-list
44206220|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206221|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206222|NCT00421421|Dutasteride|dutasteride|mesh-list
44206223|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44206224|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44206225|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206226|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206227|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206228|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206229|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206230|NCT00421434|Ribavirin|ribavirin|mesh-list
44206231|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44206232|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
44206233|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
44206234|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
44206235|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206236|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
44206237|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206267|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206268|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
44206269|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43747441|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747442|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
43747443|NCT05584631|Antibodies|antibodies|mesh-list
44206270|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44206271|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206272|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206273|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
44206274|NCT00421512|Bevacizumab|bevacizumab|mesh-list
44206275|NCT00421512|Sunitinib|sunitinib|mesh-list
44206276|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206277|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206278|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206279|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206280|NCT00421512|Growth Substances|growth substances|mesh-ancestor
44206281|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609909|NCT03184805|Analgesics|analgesics|mesh-ancestor
44206304|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206305|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44206306|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282067|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44282068|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282069|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282070|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
44282071|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
44282072|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282073|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282074|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44282075|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44282076|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
44282077|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44282078|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44206308|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206309|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206311|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
44206312|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206313|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206314|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206315|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206316|NCT00421720|Sufentanil|sufentanil|mesh-list
44206317|NCT00421720|Remifentanil|remifentanil|mesh-list
44206318|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44206319|NCT00421720|Narcotics|narcotics|mesh-ancestor
44206320|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206321|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206322|NCT00421720|Analgesics|analgesics|mesh-ancestor
44206323|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
44206324|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206325|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44206326|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44206327|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
44206328|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
44206329|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
44206330|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44206331|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
44206332|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206333|NCT00421785|Expectorants|expectorants|mesh-ancestor
44206334|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206347|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206348|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
44206349|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206350|NCT00421824|Capecitabine|capecitabine|mesh-list
44206351|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
44206352|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206353|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
44206354|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206355|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206356|NCT00421863|Amlodipine|amlodipine|mesh-list
44206357|NCT00421863|Telmisartan|telmisartan|mesh-list
44206358|NCT00421863|Clonidine|clonidine|mesh-list
44206359|NCT00421863|Ramipril|ramipril|mesh-list
44206360|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44206361|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44206362|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44206363|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206364|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44206365|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206366|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206367|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44206368|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44206369|NCT00421863|Analgesics|analgesics|mesh-ancestor
44282079|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44282080|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44282081|NCT00737373|Leucovorin|leucovorin|mesh-list
44282082|NCT00737373|Folic Acid|folic acid|mesh-list
44282083|NCT00737373|Docetaxel|docetaxel|mesh-list
44282084|NCT00737373|Fluorouracil|fluorouracil|mesh-list
44282085|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
44282086|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
44282087|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282088|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
44282089|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
44282090|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667488|NCT05080530|Vitamin D|vitamin d|mesh-list
44206370|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
44206371|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206372|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
44206373|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
44206374|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44206375|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44206376|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44206377|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206378|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206379|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44206380|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
44206381|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206382|NCT00421915|Etanercept|etanercept|mesh-list
44206383|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44206384|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44206385|NCT00421915|Analgesics|analgesics|mesh-ancestor
44206386|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
44206387|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206388|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206389|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206390|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206391|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44206392|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206393|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
44206394|NCT00421967|Ketorolac|ketorolac|mesh-list
44206395|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44206396|NCT00421967|Epinephrine|epinephrine|mesh-list
44206397|NCT00421967|Racepinephrine|racepinephrine|mesh-list
44206431|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206432|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206433|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206434|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206435|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44206436|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206437|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
44206438|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43861489|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
44206458|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43847627|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43648625|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
43648626|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648627|NCT00669734|Protective Agents|protective agents|mesh-ancestor
43648628|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
43648629|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648630|NCT00669734|Growth Substances|growth substances|mesh-ancestor
43648631|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44206459|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206460|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206461|NCT00422240|Adapalene|adapalene|mesh-list
44206462|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44206463|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44206464|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
44206465|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44206466|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44206467|NCT00422240|Analgesics|analgesics|mesh-ancestor
44206468|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
44206469|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206470|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206471|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206472|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456277|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44282091|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282093|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282094|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282095|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
44282096|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282097|NCT00737373|Antidotes|antidotes|mesh-ancestor
44282098|NCT00737373|Protective Agents|protective agents|mesh-ancestor
44456278|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456279|NCT01632579|Analgesics|analgesics|mesh-ancestor
44456280|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
44456281|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456282|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456283|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456284|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456285|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44456286|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44456287|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456288|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456289|NCT01632566|Celecoxib|celecoxib|mesh-list
44456290|NCT01632566|Simvastatin|simvastatin|mesh-list
44456291|NCT01632566|LY3031207|ly3031207|mesh-list
44456292|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44456293|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44456294|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
44456295|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456296|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44206474|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
44206475|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
44206476|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206477|NCT00422318|Renal Agents|renal agents|mesh-ancestor
44206478|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
44206479|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
44206480|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206481|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206482|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206483|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
44206484|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44206485|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206486|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206487|NCT00422344|Sunitinib|sunitinib|mesh-list
44206488|NCT00422344|Everolimus|everolimus|mesh-list
44206489|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748011|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748013|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43748014|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748015|NCT04294264|Trifluridine|trifluridine|mesh-list
43748016|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
44206490|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206491|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206492|NCT00422344|Growth Substances|growth substances|mesh-ancestor
44206493|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206494|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206495|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206496|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206497|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206498|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206499|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
44206500|NCT00422396|Fenofibrate|fenofibrate|mesh-list
44206501|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44206502|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
44206503|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610164|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206537|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44206538|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44206539|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44206540|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206541|NCT00422617|Alefacept|alefacept|mesh-list
44206542|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44206543|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
44206559|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206560|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44282099|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
44282101|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
43648632|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648633|NCT00467987|Testosterone|testosterone|mesh-list
43648634|NCT00467987|Androgens|androgens|mesh-ancestor
43648636|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648637|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648638|NCT00433589|Tamoxifen|tamoxifen|mesh-list
43648639|NCT00433589|Docetaxel|docetaxel|mesh-list
43648640|NCT00433589|Capecitabine|capecitabine|mesh-list
43648641|NCT00433589|Letrozole|letrozole|mesh-list
43648642|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648643|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
43648644|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648645|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648646|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648647|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43748138|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
43748139|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748140|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748141|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43748142|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282102|NCT00737373|Hematinics|hematinics|mesh-ancestor
43748143|NCT03863184|Growth Substances|growth substances|mesh-ancestor
43748144|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282103|NCT00737542|Lidocaine|lidocaine|mesh-list
44282104|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44282105|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
44282106|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282107|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282108|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
44206561|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206562|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206563|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206564|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
44206565|NCT00422682|Antiviral Agents|antiviral agents|mesh-ancestor
44206566|NCT00422682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206567|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206568|NCT00422682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206569|NCT00422682|Immunologic Factors|immunologic factors|mesh-ancestor
44206570|NCT00422682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206571|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44206572|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
44206573|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44206574|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44206575|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44206576|NCT00422708|Anesthetics|anesthetics|mesh-list
44206577|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206578|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206579|NCT00422773|Cetuximab|cetuximab|mesh-list
44206580|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206581|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206582|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
44206583|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206584|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206585|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206586|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206587|NCT00422864|Leucovorin|leucovorin|mesh-list
44206588|NCT00422864|Fluorouracil|fluorouracil|mesh-list
44206589|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
44206590|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
44206591|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206592|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206593|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748145|NCT03860038|Dexamethasone|dexamethasone|mesh-list
43748146|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748147|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
43748148|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
43748149|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206594|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206595|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
44206596|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206597|NCT00422864|Antidotes|antidotes|mesh-ancestor
44206598|NCT00422864|Protective Agents|protective agents|mesh-ancestor
44206599|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
44206600|NCT00422864|Vitamins|vitamins|mesh-ancestor
44206601|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
44206602|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
44206603|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206604|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206605|NCT00422994|Ropinirole|ropinirole|mesh-list
44206606|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44206635|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206636|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44206637|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44206638|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206639|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206640|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44206641|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206642|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206643|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282109|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282110|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44282111|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44282112|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44282113|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282114|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282115|NCT00737555|Tosedostat|tosedostat|mesh-list
44282116|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282117|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282118|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
44282119|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44282120|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667513|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
44206644|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44206645|NCT00423202|Ambrisentan|ambrisentan|mesh-list
44206646|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44206647|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
44206648|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206649|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206650|NCT00423228|Donepezil|donepezil|mesh-list
44206651|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44206652|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206653|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206682|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206683|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44206684|NCT00423501|Incretins|incretins|mesh-ancestor
44206686|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206687|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206688|NCT00423527|Levetiracetam|levetiracetam|mesh-list
44206689|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
44206690|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
44206691|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
44206692|NCT00423540|Analgesics|analgesics|mesh-ancestor
44206693|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
44206694|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206695|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206696|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
44206697|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206698|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44206699|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
44206700|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44206701|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44206721|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
44206722|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206723|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206724|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206725|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
44206726|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44206727|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44206728|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206729|NCT00423696|Antidotes|antidotes|mesh-ancestor
44206730|NCT00423696|Protective Agents|protective agents|mesh-ancestor
44206731|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
44206732|NCT00423696|Vitamins|vitamins|mesh-ancestor
44206733|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
44206734|NCT00423709|Fludarabine|fludarabine|mesh-list
44206735|NCT00423709|Melphalan|melphalan|mesh-list
44206736|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206737|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206738|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206739|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
44282121|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44282122|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
44282123|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282124|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282125|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282126|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282127|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
44206740|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206741|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44206742|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
44206743|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44206744|NCT00423748|Ambrisentan|ambrisentan|mesh-list
44206745|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44206746|NCT00423761|Midazolam|midazolam|mesh-list
44206747|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44206748|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44206749|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206750|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206751|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44206752|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44206753|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206754|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44206755|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
44206756|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
44206757|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
44206758|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
44206759|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610395|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44206793|NCT00423969|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44206794|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44206795|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43748314|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
43836019|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836020|NCT05007613|Atezolizumab|atezolizumab|mesh-list
44206796|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206797|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206798|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
44206799|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206800|NCT00423969|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44206801|NCT00423969|Antidepressive Agents|antidepressive agents|mesh-ancestor
44206802|NCT00423969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206803|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
43610452|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206838|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206839|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206841|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206842|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206843|NCT00424164|Tamoxifen|tamoxifen|mesh-list
44206867|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206868|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44206869|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44206870|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44206871|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44206872|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206873|NCT00424229|Lenalidomide|lenalidomide|mesh-list
44206874|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
44206875|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206876|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206877|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206878|NCT00424229|Growth Substances|growth substances|mesh-ancestor
44206879|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206880|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206881|NCT00424242|Pemetrexed|pemetrexed|mesh-list
44206882|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206883|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206884|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206885|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44206886|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44206887|NCT00424281|PENTA|penta|mesh-list
44206888|NCT00424281|Fondaparinux|fondaparinux|mesh-list
44206889|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44282128|NCT00737685|Fludarabine|fludarabine|mesh-list
44282129|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
44282130|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282131|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
44282132|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282133|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282134|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44282135|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
44282136|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667531|NCT05063734|Aflibercept|aflibercept|mesh-list
44206890|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
44206891|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44206892|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456326|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44456327|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44456328|NCT01632306|Leucovorin|leucovorin|mesh-list
44456329|NCT01632306|Gemcitabine|gemcitabine|mesh-list
44456330|NCT01632306|Paclitaxel|paclitaxel|mesh-list
44456331|NCT01632306|Fluorouracil|fluorouracil|mesh-list
44456332|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
44456333|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44456334|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456335|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
44456336|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
44456337|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206906|NCT00424437|Insulin|insulin|mesh-list
44206907|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44206908|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206909|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206910|NCT00424580|Montelukast|montelukast|mesh-list
44206911|NCT00424580|Desloratadine|desloratadine|mesh-list
44206912|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44206913|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206914|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44206915|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206916|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206917|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206918|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44206919|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44206920|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206921|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44206922|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
44206954|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206956|NCT00424801|Valsartan|valsartan|mesh-list
44206957|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44206958|NCT00424801|Doxazosin|doxazosin|mesh-list
44206959|NCT00424801|Lercanidipine|lercanidipine|mesh-list
44206960|NCT00424801|Pindolol|pindolol|mesh-list
44206961|NCT00424801|Moxonidine|moxonidine|mesh-list
44206962|NCT00424801|Amiloride|amiloride|mesh-list
44206963|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44206964|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44206965|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44206966|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206989|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44206990|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
44206992|NCT00424814|Lopinavir|lopinavir|mesh-list
44206993|NCT00424814|Lamivudine|lamivudine|mesh-list
44206994|NCT00424814|Zidovudine|zidovudine|mesh-list
44206995|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44206996|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44206997|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44206998|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44206999|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207000|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207001|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44207002|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44207003|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
44207004|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207005|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44207006|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44207007|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44207008|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44207009|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
44207011|NCT00424853|Cisplatin|cisplatin|mesh-list
44207012|NCT00424853|Docetaxel|docetaxel|mesh-list
44207013|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207014|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207015|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
44207016|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207017|NCT00424853|Antiviral Agents|antiviral agents|mesh-ancestor
44207018|NCT00424853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610672|NCT03178084|Efavirenz|efavirenz|mesh-list
44207031|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207032|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207033|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44207034|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44207035|NCT00424931|Modafinil|modafinil|mesh-list
44207036|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44207037|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207038|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44207039|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44207040|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43748643|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748644|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836042|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44207041|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207042|NCT00424944|Vaccines|vaccines|mesh-list
44207043|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
44207044|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207045|NCT00424970|Acetazolamide|acetazolamide|mesh-list
44207046|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
44207047|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44207048|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207049|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207050|NCT00424970|Diuretics|diuretics|mesh-ancestor
44207051|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
44207052|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207053|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
44207054|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44207055|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207057|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44207058|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207059|NCT00425035|Panitumumab|panitumumab|mesh-list
44207060|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207061|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207062|NCT00425074|Aspirin|aspirin|mesh-list
44207063|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
44207064|NCT00425074|Salicylates|salicylates|mesh-list
44207065|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207066|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
44207067|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
44207068|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207069|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207070|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207071|NCT00425074|Analgesics|analgesics|mesh-ancestor
44207072|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
44207073|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207074|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207075|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207076|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207077|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207078|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207079|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207109|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207110|NCT00425191|Gemcitabine|gemcitabine|mesh-list
44207111|NCT00425191|Cisplatin|cisplatin|mesh-list
44207112|NCT00425191|Docetaxel|docetaxel|mesh-list
44207113|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207114|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207115|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
44207116|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207117|NCT00425191|Antiviral Agents|antiviral agents|mesh-ancestor
44207118|NCT00425191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282137|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282138|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44282139|NCT00737724|Efavirenz|efavirenz|mesh-list
44282140|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44282141|NCT00737724|Isoniazid|isoniazid|mesh-list
44282142|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44282143|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44207119|NCT00425191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207120|NCT00425191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207121|NCT00425191|Immunologic Factors|immunologic factors|mesh-ancestor
44207122|NCT00425191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207123|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207124|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207125|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207126|NCT00425204|Panitumumab|panitumumab|mesh-list
44207127|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207128|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207129|NCT00425217|Rituximab|rituximab|mesh-list
44207130|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748772|NCT02515604|Misoprostol|misoprostol|mesh-list
44207155|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
44207156|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207157|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207158|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207159|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
44207160|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207161|NCT00425425|Fluorouracil|fluorouracil|mesh-list
44207162|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
44207163|NCT00425425|Cetuximab|cetuximab|mesh-list
44207164|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
44207165|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207166|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207167|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207168|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207169|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
44207170|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207171|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207172|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
44207173|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44207174|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
44207175|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44207176|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207177|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
44207178|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207179|NCT00425451|Analgesics|analgesics|mesh-ancestor
44207180|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
44207181|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207182|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207208|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44207210|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207211|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207212|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44207213|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207214|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207215|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207216|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
44207217|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207218|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44207219|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44207220|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44207221|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648648|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
43648649|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43648650|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43648651|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648652|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43648653|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
43648654|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207222|NCT00425568|Testosterone|testosterone|mesh-list
44207223|NCT00425568|Androgens|androgens|mesh-ancestor
44207224|NCT00425568|Hormones|hormones|mesh-ancestor
44207225|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207226|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207227|NCT00425594|Bisacodyl|bisacodyl|mesh-list
44207228|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43700718|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44282144|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826646|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207265|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207266|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207267|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
44207268|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
44207269|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207306|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207307|NCT00425997|Amlodipine|amlodipine|mesh-list
44207308|NCT00425997|Valsartan|valsartan|mesh-list
44207309|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44207334|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44207335|NCT00426023|Cyclosporins|cyclosporins|mesh-list
44207336|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207337|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207338|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207339|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
44207340|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207341|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
44207342|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207343|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207344|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207345|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44207346|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44207347|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
44207348|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44207349|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
43749014|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
43749015|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749016|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749017|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43749018|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
43749019|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749020|NCT02514200|Riboflavin|riboflavin|mesh-list
43749021|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
43749022|NCT02514200|Vitamins|vitamins|mesh-ancestor
43749023|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
43749024|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749025|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43749026|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
43749027|NCT02514018|Vaccines|vaccines|mesh-list
43749028|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
43749029|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749030|NCT02513875|Vitamin D|vitamin d|mesh-list
43648655|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648656|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648657|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44207350|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
44207351|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207352|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44207353|NCT00426049|Everolimus|everolimus|mesh-list
44207354|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207355|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207356|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
44207357|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207372|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207373|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44207374|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44207375|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44207376|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207377|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207378|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207379|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
44207380|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
44207381|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207382|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207383|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207384|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44207385|NCT00426140|Epothilone B|epothilone b|mesh-list
44207386|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207387|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207388|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207389|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207390|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207391|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
44207392|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207393|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44207394|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207395|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207396|NCT00426192|Mannitol|mannitol|mesh-list
44207397|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44207398|NCT00426192|Diuretics|diuretics|mesh-ancestor
44207399|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
44207400|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207401|NCT00426296|Ritonavir|ritonavir|mesh-list
44207402|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44207403|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44207404|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44207405|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
44207406|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207407|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207408|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44207409|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44207410|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
44282145|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282146|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
44282147|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207411|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552433|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749132|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43749133|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43749134|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
43749135|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
43749136|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749137|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207412|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44207413|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44207414|NCT00426348|Valsartan|valsartan|mesh-list
44207415|NCT00426348|Probucol|probucol|mesh-list
44207416|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44207417|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44207418|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44207419|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207443|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207445|NCT00426478|Valsartan|valsartan|mesh-list
44207446|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44207447|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44207448|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44207449|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207450|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207451|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44207452|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207453|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
43611121|NCT03174171|Everolimus|everolimus|mesh-list
44207465|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207466|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
44207467|NCT00426530|Everolimus|everolimus|mesh-list
44207468|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207469|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207470|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
44207471|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207472|NCT00426543|Rituximab|rituximab|mesh-list
44207473|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207474|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207475|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
44207476|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207477|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207478|NCT00426582|Epothilone B|epothilone b|mesh-list
44207479|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207480|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207481|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207482|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207483|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207484|NCT00426595|Omeprazole|omeprazole|mesh-list
44207485|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44207486|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207487|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44207488|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207489|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207490|NCT00426608|Alprazolam|alprazolam|mesh-list
44207491|NCT00426608|Metyrapone|metyrapone|mesh-list
44207492|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44207493|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207494|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207495|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44207496|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44207497|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44207498|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
44207499|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
44207500|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207501|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207502|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
44207503|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207504|NCT00426621|Diclofenac|diclofenac|mesh-list
44207505|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207506|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207507|NCT00426621|Analgesics|analgesics|mesh-ancestor
44207508|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
44207509|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207510|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207511|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207512|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282148|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44282149|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282150|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44282151|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44282152|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44282153|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44282154|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282155|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282156|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
44207513|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207514|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207515|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207516|NCT00426647|Buprenorphine|buprenorphine|mesh-list
44207517|NCT00426647|Tramadol|tramadol|mesh-list
44207539|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44207540|NCT00426829|Bevacizumab|bevacizumab|mesh-list
44207541|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207542|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207543|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43749140|NCT02513342|Docetaxel|docetaxel|mesh-list
43749463|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
44207544|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44207545|NCT00426829|Growth Substances|growth substances|mesh-ancestor
44207546|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207547|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
44207549|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44207550|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207551|NCT00426933|Vancomycin|vancomycin|mesh-list
44207552|NCT00426933|Daptomycin|daptomycin|mesh-list
44207553|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207554|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207555|NCT00426946|Reboxetine|reboxetine|mesh-list
44207556|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
44207557|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44207558|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44207559|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44207560|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207561|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207562|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44207563|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207564|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207565|NCT00426972|Estradiol|estradiol|mesh-list
44207566|NCT00426972|Estrogens|estrogens|mesh-ancestor
44207567|NCT00426972|Hormones|hormones|mesh-ancestor
44207568|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207569|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207570|NCT00426985|Ketoprofen|ketoprofen|mesh-list
44207598|NCT00427076|Renal Agents|renal agents|mesh-ancestor
44207599|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
44207600|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44207601|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44207602|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
44207603|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44207604|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
44207605|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207606|NCT00427089|Protective Agents|protective agents|mesh-ancestor
44207607|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207608|NCT00427089|Vitamins|vitamins|mesh-ancestor
44207609|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
44207610|NCT00427089|Laxatives|laxatives|mesh-ancestor
44207611|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207612|NCT00427102|Cisplatin|cisplatin|mesh-list
44207613|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207614|NCT00427128|Fluoxetine|fluoxetine|mesh-list
44207615|NCT00427128|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44207616|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43611279|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282158|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44282159|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44282160|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
44282161|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44282162|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
44282163|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
44282164|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44282165|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282166|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282167|NCT00737789|Mesalamine|mesalamine|mesh-list
44282168|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44282169|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749469|NCT02510586|Sevoflurane|sevoflurane|mesh-list
44282170|NCT00737789|Analgesics|analgesics|mesh-ancestor
44282171|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
44282172|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207650|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
44207651|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207652|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207653|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44207654|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
44207655|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207683|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
44207684|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207685|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
44207686|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44207687|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44207688|NCT00427362|Adalimumab|adalimumab|mesh-list
44207689|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207690|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207691|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
44207692|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44207693|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44207694|NCT00427388|Prednisolone|prednisolone|mesh-list
44207695|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
44207696|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44207697|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
44207698|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207699|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
44207700|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
44207701|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207702|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207703|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207731|NCT00427505|Deferasirox|deferasirox|mesh-list
44207732|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44207733|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
44207734|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
44207735|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207736|NCT00427570|Fluorouracil|fluorouracil|mesh-list
44207737|NCT00427570|Vincristine|vincristine|mesh-list
44207738|NCT00427570|Semustine|semustine|mesh-list
44207739|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
44207740|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
44207741|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207742|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207743|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207744|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282173|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282174|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282175|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207745|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
44207746|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207747|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43611410|NCT03171974|Hormones|hormones|mesh-ancestor
44207778|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44207779|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44207780|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44207781|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207782|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749483|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
43749664|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749665|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43749666|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749667|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
43749668|NCT02509286|Leucovorin|leucovorin|mesh-list
43749669|NCT02509286|Paclitaxel|paclitaxel|mesh-list
43749670|NCT02509286|Docetaxel|docetaxel|mesh-list
44207783|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207784|NCT00427882|Urological Agents|urological agents|mesh-ancestor
44207786|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44207787|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
44207788|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207789|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207826|NCT00428142|Rituximab|rituximab|mesh-list
44207827|NCT00428142|Vincristine|vincristine|mesh-list
44207828|NCT00428142|Bortezomib|bortezomib|mesh-list
44207829|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611500|NCT03171740|Midazolam|midazolam|mesh-list
44207865|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611541|NCT03171610|Fentanyl|fentanyl|mesh-list
44207884|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207885|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44207886|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
44207887|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44207888|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44207889|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44207890|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44207891|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
44207892|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44207893|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207894|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44207895|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44207896|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
44207897|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44207898|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44207899|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44207900|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207901|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207902|NCT00428428|Isoproterenol|isoproterenol|mesh-list
44207903|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44207904|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44207937|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44207938|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207939|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44207940|NCT00428519|Aprepitant|aprepitant|mesh-list
44207941|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
44207942|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
44207943|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
44207944|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207945|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208008|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749671|NCT02509286|Carboplatin|carboplatin|mesh-list
44208009|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208011|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44208012|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44208013|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44208014|NCT00428818|Renal Agents|renal agents|mesh-ancestor
44208015|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44208016|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208017|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208018|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44208019|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44208020|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44208021|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
44208022|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44208023|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
44208024|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208025|NCT00428883|Expectorants|expectorants|mesh-ancestor
44282176|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
44282177|NCT00737815|Cathartics|cathartics|mesh-ancestor
44282178|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282179|NCT00737867|Gemcitabine|gemcitabine|mesh-list
44282180|NCT00737867|Carboplatin|carboplatin|mesh-list
44208026|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
44208027|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44208054|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208055|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208056|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44208057|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44208058|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44208059|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44208060|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208061|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44208062|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208063|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208064|NCT00429208|Nicotine|nicotine|mesh-list
44208065|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44208066|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
44208067|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208068|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208069|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44208070|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44208071|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
44208072|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208073|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208074|NCT00429234|Gemcitabine|gemcitabine|mesh-list
44208102|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44208103|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44208104|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208105|NCT00429468|Acetaminophen|acetaminophen|mesh-list
44208106|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44208107|NCT00429468|Hydrocodone|hydrocodone|mesh-list
44208108|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44208109|NCT00429468|Analgesics|analgesics|mesh-ancestor
44208110|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
44208111|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208112|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208113|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
44208114|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44208115|NCT00429468|Narcotics|narcotics|mesh-ancestor
44208116|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208117|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
44208118|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
43611803|NCT03169738|Antidotes|antidotes|mesh-ancestor
44208147|NCT00429559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208148|NCT00429559|Immunologic Factors|immunologic factors|mesh-ancestor
43749904|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749905|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749906|NCT02507583|Insulin|insulin|mesh-list
43749907|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43749908|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749909|NCT02507648|Oseltamivir|oseltamivir|mesh-list
43749910|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
43749911|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208149|NCT00429559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208150|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44208151|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208152|NCT00429624|Acetaminophen|acetaminophen|mesh-list
44208153|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44208154|NCT00429624|Analgesics|analgesics|mesh-ancestor
44208155|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
44208156|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208157|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208158|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
44208159|NCT00429676|Haloperidol|haloperidol|mesh-list
44208160|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
44208161|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
44208162|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
44208163|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208164|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208165|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208166|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44208187|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208188|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
44208189|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208190|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
44208191|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282182|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282183|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282184|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
44282185|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282186|NCT00737867|Antiviral Agents|antiviral agents|mesh-ancestor
44282187|NCT00737867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282188|NCT00737867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282189|NCT00737867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282190|NCT00737867|Immunologic Factors|immunologic factors|mesh-ancestor
44282191|NCT00737867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282192|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44282193|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
44282194|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44282195|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44282196|NCT00737880|Pancrelipase|pancrelipase|mesh-list
44282197|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282198|NCT00737971|Triamcinolone|triamcinolone|mesh-list
44208192|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44208193|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208194|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
44208195|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208196|NCT00429832|Promethazine|promethazine|mesh-list
44208197|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
44208198|NCT00429832|Ondansetron|ondansetron|mesh-list
44208199|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
44208200|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
44208201|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208202|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208203|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208204|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
44208205|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44208206|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44208207|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
44208208|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208209|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208210|NCT00429832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44208211|NCT00429832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208212|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208213|NCT00429832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208214|NCT00429832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44208215|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44208216|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
44208217|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
44208218|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44208219|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44208220|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44208221|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
44208248|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
44208249|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44208250|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44208251|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44208252|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208253|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44208254|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44208255|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44282199|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43750221|NCT02506140|Analgesics|analgesics|mesh-ancestor
43750222|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
43750223|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750224|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750225|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750226|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43750227|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43750228|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43750298|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750299|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282200|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44282201|NCT00737971|Bevacizumab|bevacizumab|mesh-list
44282202|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44282203|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282204|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208256|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44208257|NCT00429936|Fenretinide|fenretinide|mesh-list
44208258|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208259|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44208260|NCT00429936|Protective Agents|protective agents|mesh-ancestor
44208261|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208262|NCT00429962|Ranibizumab|ranibizumab|mesh-list
44208263|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44208264|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44208265|NCT00429962|Growth Substances|growth substances|mesh-ancestor
44208266|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208267|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
44208268|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208269|NCT00429975|Levofloxacin|levofloxacin|mesh-list
44208270|NCT00429975|Ofloxacin|ofloxacin|mesh-list
44208301|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208303|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
44208304|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208305|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
44208306|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208307|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208308|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44208309|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
44208310|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208311|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611989|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
44208334|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208335|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208336|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44208337|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208338|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
44208339|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
44208340|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208341|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208342|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
44208343|NCT00430118|Hormones|hormones|mesh-ancestor
44208344|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208345|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44208346|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208347|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43750363|NCT02505477|Antidotes|antidotes|mesh-ancestor
44208348|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208349|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208350|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44208351|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
44208352|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44208353|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208354|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
44208355|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
44208356|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44208357|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44208358|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208359|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
44208360|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208361|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208362|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208363|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208388|NCT00430196|Tizanidine|tizanidine|mesh-list
44208389|NCT00430196|Analgesics|analgesics|mesh-ancestor
44208390|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
44208391|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208392|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208393|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
44282205|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282206|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282207|NCT00737971|Growth Substances|growth substances|mesh-ancestor
44208394|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44208395|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44208396|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
44208397|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
44208398|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44208399|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44208400|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44208401|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
44208402|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208403|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208404|NCT00430235|Sorafenib|sorafenib|mesh-list
44208405|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208406|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44208407|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612080|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
44208427|NCT00430443|Annamycin|annamycin|mesh-list
44208428|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208429|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208430|NCT00430469|Lactoferrin|lactoferrin|mesh-list
44208431|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208432|NCT00430547|Carbimazole|carbimazole|mesh-list
44208433|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
44208434|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
44208435|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208436|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208437|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44208438|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44208439|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
44208440|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44208441|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44208442|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208443|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208444|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44208445|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750594|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
43750595|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
43750596|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750598|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43750599|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750600|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43750601|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750602|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
44208446|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208447|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
44208448|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208449|NCT00430651|Carboplatin|carboplatin|mesh-list
44208450|NCT00430651|Docetaxel|docetaxel|mesh-list
44208451|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208452|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208453|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208454|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208455|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208456|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
44208457|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44208458|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208459|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
43612131|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
44208485|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44208486|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44208487|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208488|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44208489|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208490|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208491|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
44208492|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44208493|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
44208494|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44208495|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
44208496|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208497|NCT00430898|Basiliximab|basiliximab|mesh-list
44208498|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208499|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
44208500|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208502|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44282208|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282209|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282210|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282211|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
43750603|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750604|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
43750699|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750700|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43750701|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43750702|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43750703|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750704|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750705|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750706|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43750707|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44282213|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282214|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282215|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
44282216|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282217|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750708|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282218|NCT00737997|Morphine|morphine|mesh-list
44282219|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44282220|NCT00737997|Narcotics|narcotics|mesh-ancestor
44282221|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282222|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282223|NCT00737997|Analgesics|analgesics|mesh-ancestor
44282224|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
44282225|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282226|NCT00738088|Gliclazide|gliclazide|mesh-list
44282227|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282228|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282229|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
44282230|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282231|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282232|NCT00738192|Fentanyl|fentanyl|mesh-list
44282233|NCT00738192|Sufentanil|sufentanil|mesh-list
44282234|NCT00738192|Dsuvia|dsuvia|mesh-list
44282235|NCT00738192|Butorphanol|butorphanol|mesh-list
44282236|NCT00738192|Citric Acid|citric acid|mesh-list
44282237|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
44208503|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
44208504|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208535|NCT00431054|Docetaxel|docetaxel|mesh-list
44208536|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208537|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208538|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208539|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208540|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208541|NCT00431080|Paclitaxel|paclitaxel|mesh-list
44208542|NCT00431080|Docetaxel|docetaxel|mesh-list
44208543|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
44208544|NCT00431080|Epirubicin|epirubicin|mesh-list
44208545|NCT00431080|Fluorouracil|fluorouracil|mesh-list
44208571|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208573|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836311|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836312|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836313|NCT04982367|Sirolimus|sirolimus|mesh-list
43836314|NCT04982367|Paclitaxel|paclitaxel|mesh-list
43836315|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43750806|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750807|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43750808|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43750809|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
43750810|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750811|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750812|NCT02502799|Methylphenidate|methylphenidate|mesh-list
43750813|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43750814|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208574|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208575|NCT00431106|Antiviral Agents|antiviral agents|mesh-ancestor
44208576|NCT00431106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208577|NCT00431106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282238|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44282239|NCT00738192|Narcotics|narcotics|mesh-ancestor
44282240|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282241|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282242|NCT00738192|Analgesics|analgesics|mesh-ancestor
44208578|NCT00431106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208579|NCT00431106|Immunologic Factors|immunologic factors|mesh-ancestor
44208580|NCT00431106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208581|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208582|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208583|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208584|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208585|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
44208586|NCT00431119|Azathioprine|azathioprine|mesh-list
44208587|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208588|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208589|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44208590|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
44208591|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44208592|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208593|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208594|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208629|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208631|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
44208632|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208633|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612331|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
44208648|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208650|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208651|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
43750815|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43750816|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43750817|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43750818|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750819|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
44208652|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44208653|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44208654|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
44208655|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208656|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208657|NCT00431236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44208658|NCT00431236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208659|NCT00431236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208660|NCT00431236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208661|NCT00431236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44208662|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44208663|NCT00431249|Cilostazol|cilostazol|mesh-list
44208664|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44208665|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
44208666|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208667|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208668|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44208669|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
44208670|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44208671|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44208672|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208673|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44208674|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208675|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44208676|NCT00431249|Protective Agents|protective agents|mesh-ancestor
44208677|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44208678|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44208679|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208680|NCT00431262|Disulfiram|disulfiram|mesh-list
44208681|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44208682|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44208683|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750820|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750822|NCT02502877|Propofol|propofol|mesh-list
43750823|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750824|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750825|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750826|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750827|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
43750828|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
43644817|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644818|NCT04350463|Nivolumab|nivolumab|mesh-list
43750870|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
43750871|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750872|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
43750873|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43750874|NCT02502032|Cisatracurium|cisatracurium|mesh-list
43750875|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43750876|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43750877|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750878|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750879|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
43750880|NCT02502708|Temozolomide|temozolomide|mesh-list
43750881|NCT02502708|Etoposide|etoposide|mesh-list
44208684|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208685|NCT00431275|Tremelimumab|tremelimumab|mesh-list
44208687|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208688|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208689|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43798734|NCT05018182|Hematinics|hematinics|mesh-ancestor
44282243|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
44282244|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282245|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750882|NCT02502708|Tryptophan|tryptophan|mesh-list
43750883|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208690|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208691|NCT00431340|Belinostat|belinostat|mesh-list
44208692|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208693|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44208694|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612370|NCT03165890|Diuretics|diuretics|mesh-ancestor
44208721|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
44208722|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44208723|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44208724|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44208725|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
44208726|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208727|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208728|NCT00431392|Protective Agents|protective agents|mesh-ancestor
44208729|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44208730|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44208731|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44208732|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44208733|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
44208734|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44208735|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44208736|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
44208737|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44208738|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44208739|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44208740|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208741|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208742|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
44208743|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
43612434|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
43750884|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
43751038|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751039|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751040|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
43751041|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43751042|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
43751043|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751044|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751045|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43751046|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44208770|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208771|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208772|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
44208773|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208774|NCT00431613|Antiviral Agents|antiviral agents|mesh-ancestor
44208775|NCT00431613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208776|NCT00431613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208777|NCT00431613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208778|NCT00431613|Immunologic Factors|immunologic factors|mesh-ancestor
44208779|NCT00431613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208780|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208781|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208782|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208783|NCT00431665|Heparin|heparin|mesh-list
44208784|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44208785|NCT00431665|Somatostatin|somatostatin|mesh-list
44208786|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44208787|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208788|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
44208789|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44208790|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43751047|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43751048|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43751049|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43751050|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
43751051|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208791|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208817|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44208819|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44208820|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44208821|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
44208822|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208823|NCT00431704|Carboplatin|carboplatin|mesh-list
44208824|NCT00431704|Trastuzumab|trastuzumab|mesh-list
44208825|NCT00431704|Vinorelbine|vinorelbine|mesh-list
44208826|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208827|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208828|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208829|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208830|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
43751052|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751053|NCT02500940|Leucovorin|leucovorin|mesh-list
43751054|NCT02500940|Cisplatin|cisplatin|mesh-list
43751055|NCT02500940|Fluorouracil|fluorouracil|mesh-list
43751056|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751057|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751058|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
43751059|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751060|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43751061|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751062|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
43648658|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43648659|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43648660|NCT00268385|Temozolomide|temozolomide|mesh-list
43648661|NCT00268385|Vorinostat|vorinostat|mesh-list
43648662|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648663|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
43648664|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648668|NCT00265798|Sorafenib|sorafenib|mesh-list
43751063|NCT02500940|Antidotes|antidotes|mesh-ancestor
43751153|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751154|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43751155|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
44208831|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
44456363|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
43863751|NCT02444429|Hormones|hormones|mesh-ancestor
44282246|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44282247|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
44282248|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
44282249|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
44282250|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44282251|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
44282252|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
44282253|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282254|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
44282255|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
44282256|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44282257|NCT00738257|Pamidronate|pamidronate|mesh-list
44282258|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282259|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282260|NCT00738296|Simvastatin|simvastatin|mesh-list
44282261|NCT00738296|Ezetimibe|ezetimibe|mesh-list
44282262|NCT00738296|Pravastatin|pravastatin|mesh-list
43667562|NCT04977232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208832|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208834|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208835|NCT00431795|Doxorubicin|doxorubicin|mesh-list
44208836|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44208837|NCT00431795|Epirubicin|epirubicin|mesh-list
44208838|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44456383|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456384|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456385|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44456386|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44456387|NCT01632150|Growth Substances|growth substances|mesh-ancestor
44456388|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456389|NCT01632020|Metformin|metformin|mesh-list
44456390|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456391|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456392|NCT01631864|Amlodipine|amlodipine|mesh-list
44456393|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44456394|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44456395|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44456396|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751156|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751312|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751313|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44456397|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456398|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44456399|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456400|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
44456401|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43863801|NCT02427620|Rituximab|rituximab|mesh-list
44208844|NCT00431990|Dexamethasone|dexamethasone|mesh-list
44208845|NCT00431990|Bortezomib|bortezomib|mesh-list
44208846|NCT00431990|Romidepsin|romidepsin|mesh-list
44208847|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208870|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44208871|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44208872|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44208873|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44208874|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208875|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
44208876|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208877|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208878|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44208879|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208880|NCT00432068|Octreotide|octreotide|mesh-list
44282263|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44282264|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44282265|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
44282266|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282267|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44282268|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44282269|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282270|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44282271|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282272|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44282273|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282274|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282275|NCT00738413|Deferasirox|deferasirox|mesh-list
44282276|NCT00738413|Deferoxamine|deferoxamine|mesh-list
44282277|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44282278|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
44282279|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
44282280|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282281|NCT00738413|Siderophores|siderophores|mesh-ancestor
44282282|NCT00738452|Antibodies|antibodies|mesh-list
44282283|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44282284|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
44282285|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282286|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
44282287|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44282288|NCT00738517|Antibodies|antibodies|mesh-list
44282289|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
44282290|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282291|NCT00738556|Sirolimus|sirolimus|mesh-list
44282292|NCT00738556|Paclitaxel|paclitaxel|mesh-list
44282293|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208881|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208882|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44208883|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208884|NCT00432081|Indomethacin|indomethacin|mesh-list
44208885|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44208886|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44208887|NCT00432081|Analgesics|analgesics|mesh-ancestor
44208888|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
44208889|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751490|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751491|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
43751492|NCT02497638|Metformin|metformin|mesh-list
43751493|NCT02497638|Biguanides|biguanides|mesh-list
43751494|NCT02497638|Atorvastatin|atorvastatin|mesh-list
43751495|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43751496|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751497|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43751498|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43751499|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
43751500|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751501|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43751502|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43751503|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836368|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44208890|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208891|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208892|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208893|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
44282294|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282295|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44282296|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44282297|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44282298|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282299|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282300|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208894|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
44208895|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44208896|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44208897|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208898|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208925|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208926|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208927|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208928|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208929|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208930|NCT00432354|Atorvastatin|atorvastatin|mesh-list
44208931|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44208932|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44208933|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
44208934|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208935|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44208936|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44208937|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208938|NCT00432367|Artesunate|artesunate|mesh-list
44208939|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
44208940|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
44208941|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44208942|NCT00432367|Amodiaquine|amodiaquine|mesh-list
44208943|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
44208944|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43836370|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836371|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43836372|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836373|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836374|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43836375|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208945|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44208946|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208947|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208948|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
44208976|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44208977|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44208979|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
44208980|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208981|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208982|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208983|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208984|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
44208985|NCT00432432|Infliximab|infliximab|mesh-list
44208986|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
44208987|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208988|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208989|NCT00432510|Complement C1s|complement c1s|mesh-list
44208990|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44208991|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44208992|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
44208993|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208994|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43612743|NCT03163238|Analgesics|analgesics|mesh-ancestor
44209024|NCT00432614|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44209025|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44209026|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209027|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836376|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836377|NCT04978298|Phenelzine|phenelzine|mesh-list
43836378|NCT04978298|Ozanimod|ozanimod|mesh-list
43836379|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43836380|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836381|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836382|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
43836383|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836384|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
43836385|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43836386|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43836387|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836388|NCT04978051|Icatibant|icatibant|mesh-list
43836389|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43836390|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209028|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836391|NCT04978051|Analgesics|analgesics|mesh-ancestor
43836392|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
43836393|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836394|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836395|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836396|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836397|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43836398|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44209029|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
44209030|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209031|NCT00432614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44209032|NCT00432614|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209033|NCT00432614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282301|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44282302|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
44282303|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282304|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
44282305|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282306|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
44282307|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44209034|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44209035|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44209036|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44209037|NCT00432627|Deferasirox|deferasirox|mesh-list
44209038|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43612777|NCT03163381|Apatinib|apatinib|mesh-list
44209063|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44209064|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209065|NCT00432861|Pancrelipase|pancrelipase|mesh-list
44209067|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209068|NCT00432887|Caffeine|caffeine|mesh-list
44209069|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43864027|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209070|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209071|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44209072|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209073|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209074|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44209075|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44209076|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
44209077|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209079|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44209080|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44209081|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209082|NCT00433043|Metoprolol|metoprolol|mesh-list
44209083|NCT00433043|Carvedilol|carvedilol|mesh-list
44209084|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44209085|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44209086|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44209087|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
44209088|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
44209089|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209122|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209123|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209124|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209125|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209126|NCT00433121|Olanzapine|olanzapine|mesh-list
44209127|NCT00433121|Risperidone|risperidone|mesh-list
44209128|NCT00433121|Citalopram|citalopram|mesh-list
44209129|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44209130|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
43612874|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
44209163|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
44209164|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
44209165|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43751736|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751737|NCT02496299|Dexamethasone|dexamethasone|mesh-list
43751738|NCT02496299|Bupivacaine|bupivacaine|mesh-list
43751739|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751740|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
43751741|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
43751742|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209166|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209167|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44209168|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
44209169|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209170|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209207|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44209208|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209242|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44209243|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44209244|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209245|NCT00433459|Prednisone|prednisone|mesh-list
44209246|NCT00433459|Prednisolone|prednisolone|mesh-list
44209247|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
44209248|NCT00433459|Dacarbazine|dacarbazine|mesh-list
44209249|NCT00433459|Vincristine|vincristine|mesh-list
44209250|NCT00433459|Procarbazine|procarbazine|mesh-list
44209275|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209276|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
44282308|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282309|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
44282310|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282311|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43667617|NCT04899778|Estrogens|estrogens|mesh-ancestor
44209277|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209278|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
44209279|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209281|NCT00433498|Carboplatin|carboplatin|mesh-list
44209282|NCT00433498|Etoposide|etoposide|mesh-list
44209283|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
44209284|NCT00433498|Pravastatin|pravastatin|mesh-list
44209285|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209286|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209287|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44209288|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209289|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209290|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209291|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44209292|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44209293|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
44209294|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44209295|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44209297|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
44209298|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209299|NCT00433576|Protective Agents|protective agents|mesh-ancestor
43613054|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
44209329|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209330|NCT00433732|Analgesics|analgesics|mesh-ancestor
44209331|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
44209332|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209333|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209334|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209335|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751847|NCT02496052|Hormones|hormones|mesh-ancestor
43751848|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751849|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751850|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43751851|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
43751852|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43751853|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43648669|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648670|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43648671|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209336|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
44209337|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44209338|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209339|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209340|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44209341|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44209342|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44209349|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44209350|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
44209351|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209352|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209353|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209354|NCT00433823|Atorvastatin|atorvastatin|mesh-list
44209355|NCT00433823|Ezetimibe|ezetimibe|mesh-list
44209356|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44209357|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44209358|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
44209359|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209360|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44209361|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44209362|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209363|NCT00433927|Leucovorin|leucovorin|mesh-list
44209364|NCT00433927|Folic Acid|folic acid|mesh-list
44209365|NCT00433927|Bevacizumab|bevacizumab|mesh-list
43751945|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751946|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44209395|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44209396|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209397|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44209398|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
44209399|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209400|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209401|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209402|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209403|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44209404|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
44209405|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209406|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
44209407|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44209409|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209410|NCT00434005|Expectorants|expectorants|mesh-ancestor
44209411|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
44209412|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44209413|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
44209451|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
44209452|NCT00434083|Naproxen|naproxen|mesh-list
44209484|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209486|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209487|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209488|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209489|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209490|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
44209491|NCT00434135|Antiviral Agents|antiviral agents|mesh-ancestor
44209492|NCT00434135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613292|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
44209519|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209521|NCT00434382|Sufentanil|sufentanil|mesh-list
44209522|NCT00434382|Remifentanil|remifentanil|mesh-list
44209523|NCT00434382|Alfentanil|alfentanil|mesh-list
44209524|NCT00434382|Propofol|propofol|mesh-list
44209525|NCT00434382|Sevoflurane|sevoflurane|mesh-list
44209526|NCT00434382|Desflurane|desflurane|mesh-list
44209527|NCT00434382|Isoflurane|isoflurane|mesh-list
44209528|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44209529|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44209530|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209531|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44209532|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
44209533|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
44209534|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44209535|NCT00434382|Narcotics|narcotics|mesh-ancestor
44209536|NCT00434382|Analgesics|analgesics|mesh-ancestor
44209537|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
44209538|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209539|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43752042|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752043|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43752044|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43752045|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209540|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44209541|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44209542|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
44209578|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209579|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209580|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209581|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
44209582|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
44209583|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44209609|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44209610|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44209611|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44209612|NCT00435175|Estradiol|estradiol|mesh-list
44209613|NCT00435175|Estrogens|estrogens|mesh-ancestor
44209614|NCT00435175|Hormones|hormones|mesh-ancestor
44209615|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209616|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209617|NCT00435279|Eszopiclone|eszopiclone|mesh-list
44209618|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44209619|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44209620|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44209621|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209622|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209623|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209624|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209625|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44209626|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209627|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209628|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44209629|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44209661|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44209662|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209663|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44209664|NCT00435435|Disulfiram|disulfiram|mesh-list
44209665|NCT00435435|Acamprosate|acamprosate|mesh-list
44209666|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44209667|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44209668|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282312|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44282313|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282314|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282315|NCT00738595|Nicotine|nicotine|mesh-list
44282316|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44282317|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
43667623|NCT04891302|Clevudine|clevudine|mesh-list
44209669|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209670|NCT00435448|Lonidamine|lonidamine|mesh-list
44209671|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209672|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44209673|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613465|NCT05549154|Vitamin D|vitamin d|mesh-list
44456441|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456442|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456443|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
44456444|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752128|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
43752129|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752130|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752131|NCT02493179|Analgesics|analgesics|mesh-ancestor
43752132|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
43752133|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752134|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752135|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752136|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752137|NCT02493192|Meperidine|meperidine|mesh-list
44456445|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456446|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456447|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456448|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456449|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44456450|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44456451|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
44456452|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456453|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44456454|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44456455|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209717|NCT00435799|Vitamins|vitamins|mesh-ancestor
44209718|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
44209719|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209720|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44209721|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44209722|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
44209723|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
44209724|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
44209725|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43752138|NCT02493192|Haloperidol|haloperidol|mesh-list
43752139|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
43752140|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
43752141|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
44209726|NCT00435851|Hormones|hormones|mesh-list
43613561|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
44209749|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209751|NCT00436033|Analgesics|analgesics|mesh-ancestor
44209752|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
44209753|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209754|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209755|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209756|NCT00436059|Bortezomib|bortezomib|mesh-list
44209757|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752142|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752143|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648672|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648674|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43648675|NCT03035578|Narcotics|narcotics|mesh-ancestor
43648676|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648677|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648678|NCT03035578|Analgesics|analgesics|mesh-ancestor
43648679|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
43648680|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648681|NCT03035617|Bupivacaine|bupivacaine|mesh-list
44209758|NCT00436072|Irinotecan|irinotecan|mesh-list
44209759|NCT00436072|Cetuximab|cetuximab|mesh-list
44209760|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44209761|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209762|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209763|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209764|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209765|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209766|NCT00436124|Oseltamivir|oseltamivir|mesh-list
44209767|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
44209768|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209769|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209770|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209771|NCT00436241|Capecitabine|capecitabine|mesh-list
44209772|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
44209773|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209774|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
43613611|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209801|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44209802|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
44209803|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209804|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209805|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44282318|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282319|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282320|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44282321|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44282322|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
44282323|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282324|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209806|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209807|NCT00436423|Gemcitabine|gemcitabine|mesh-list
44209808|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209809|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
44209810|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209811|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209812|NCT00436423|Antiviral Agents|antiviral agents|mesh-ancestor
44209813|NCT00436423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209814|NCT00436423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209815|NCT00436423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209816|NCT00436423|Immunologic Factors|immunologic factors|mesh-ancestor
44209817|NCT00436423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209818|NCT00436579|Sorafenib|sorafenib|mesh-list
44209819|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209820|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44209821|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209853|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
44209854|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44209855|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
44209856|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209857|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209858|NCT00436761|Cyclosporine|cyclosporine|mesh-list
44209859|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
44209860|NCT00436761|Melphalan|melphalan|mesh-list
44209861|NCT00436761|Busulfan|busulfan|mesh-list
44209862|NCT00436761|Cyclosporins|cyclosporins|mesh-list
43752155|NCT02493192|Narcotics|narcotics|mesh-ancestor
44209863|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44209864|NCT00436761|Sargramostim|sargramostim|mesh-list
44209865|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613707|NCT05149131|Leuprolide|leuprolide|mesh-list
44209896|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209898|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44209899|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44209900|NCT00436800|Gemcitabine|gemcitabine|mesh-list
44209901|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
44209902|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209903|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
44209904|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209905|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209906|NCT00436800|Antiviral Agents|antiviral agents|mesh-ancestor
44209907|NCT00436800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209908|NCT00436800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209909|NCT00436800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613759|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
44209937|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44209938|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
44209939|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209940|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209941|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44209942|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44209943|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44209944|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209945|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209946|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44209947|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209948|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209949|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44209950|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44209951|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209952|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
44209953|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44282325|NCT00738621|Dexamethasone|dexamethasone|mesh-list
44282326|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
44209954|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44209955|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209956|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
44209957|NCT00436995|Hematinics|hematinics|mesh-ancestor
44209958|NCT00437008|Benphothiamine|benphothiamine|mesh-list
43613804|NCT04927780|Antidotes|antidotes|mesh-ancestor
44209994|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209995|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209996|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209997|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
44209998|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209999|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210000|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
44210001|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210002|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44210028|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44210029|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43752351|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752352|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752353|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752354|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210030|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210031|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44210032|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
44210033|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210034|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210035|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44210036|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44210037|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44210039|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210040|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44210041|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44210042|NCT00437372|Growth Substances|growth substances|mesh-ancestor
44210043|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210044|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44210045|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44210046|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210047|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210048|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
44210049|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
44210050|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210076|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210077|NCT00437554|Glimepiride|glimepiride|mesh-list
44210078|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44210079|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210080|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210081|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210082|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
44210083|NCT00437606|Ethanol|ethanol|mesh-list
44210084|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44210085|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210086|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210087|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210088|NCT00437619|Calcipotriene|calcipotriene|mesh-list
44210089|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210090|NCT00437632|Caffeine|caffeine|mesh-list
44210091|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44210092|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210093|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44210094|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210095|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210096|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44210097|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44210098|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
44210099|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456480|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456481|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
44456482|NCT01628965|Rotigotine|rotigotine|mesh-list
44456483|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
44456484|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
44456485|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456486|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456487|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456488|NCT01628926|Ropinirole|ropinirole|mesh-list
44282327|NCT00738621|Ondansetron|ondansetron|mesh-list
44282328|NCT00738621|Aprepitant|aprepitant|mesh-list
44282329|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
44282330|NCT00738621|BB 1101|bb 1101|mesh-list
44456489|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43752492|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
43752493|NCT02490592|Protective Agents|protective agents|mesh-ancestor
43752494|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752495|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
43752527|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456490|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44456491|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
44456492|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
44456493|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456494|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456495|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210100|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
44210101|NCT00437671|Antibodies|antibodies|mesh-list
44210102|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
44210103|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44210104|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44210105|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
44210106|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210107|NCT00437684|Ribavirin|ribavirin|mesh-list
44210108|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44210109|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
44210110|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210111|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
43613995|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210142|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210143|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44210144|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44210145|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210146|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210147|NCT00437853|Anastrozole|anastrozole|mesh-list
44210148|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210149|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210150|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44210151|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44210152|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210153|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210154|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44210155|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
44210166|NCT00437918|Acarbose|acarbose|mesh-list
44210167|NCT00437918|Nateglinide|nateglinide|mesh-list
44210168|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44210169|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210170|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210171|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210172|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210173|NCT00437957|Temozolomide|temozolomide|mesh-list
44210174|NCT00437957|Valproic Acid|valproic acid|mesh-list
44210175|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44210176|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
44210177|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210178|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210179|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
44210180|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210181|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
44210182|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210183|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210184|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
44210185|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210186|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210187|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210188|NCT00437970|Metformin|metformin|mesh-list
44210189|NCT00437970|Pioglitazone|pioglitazone|mesh-list
43752528|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752618|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43752619|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43752620|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752621|NCT02489786|Digoxin|digoxin|mesh-list
43752622|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43752623|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43752624|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752625|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752626|NCT02489786|Protective Agents|protective agents|mesh-ancestor
43752627|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752628|NCT02489760|Adalimumab|adalimumab|mesh-list
43752629|NCT02489760|Etanercept|etanercept|mesh-list
43752630|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210190|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210191|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210192|NCT00437996|Clonidine|clonidine|mesh-list
44210193|NCT00437996|Sufentanil|sufentanil|mesh-list
44210194|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
44210195|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44210196|NCT00437996|Narcotics|narcotics|mesh-ancestor
44210197|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210198|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210199|NCT00437996|Analgesics|analgesics|mesh-ancestor
44210200|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
44210201|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282331|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282332|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
44282333|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
44282334|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282335|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282336|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44282338|NCT00738621|Hormones|hormones|mesh-ancestor
44282339|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282340|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44282341|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282342|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44282343|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282344|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282345|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
44282346|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44282347|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44282348|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
44282349|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282350|NCT00738621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44282351|NCT00738621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210202|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44210203|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44210204|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
44210205|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
44210206|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44210207|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
44210208|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
44210209|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44210210|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44210211|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44210212|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44210213|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210214|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752631|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752632|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752663|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752664|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
43752665|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752666|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43752667|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43752668|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43752669|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43752670|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43752671|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43752672|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43752673|NCT02489487|Ritonavir|ritonavir|mesh-list
43752674|NCT02489487|Darunavir|darunavir|mesh-list
43752675|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
43752676|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43752677|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43752850|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752851|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43752852|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43752854|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43752855|NCT02488616|Hormones|hormones|mesh-list
43752856|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752857|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210215|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
44210216|NCT00438048|Pilocarpine|pilocarpine|mesh-list
44210217|NCT00438048|Miotics|miotics|mesh-ancestor
44210218|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
44210219|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614101|NCT04400539|Nivolumab|nivolumab|mesh-list
44210246|NCT00438113|Atenolol|atenolol|mesh-list
44210247|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44210248|NCT00438113|Terazosin|terazosin|mesh-list
44210249|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44210250|NCT00438113|Diuretics|diuretics|mesh-ancestor
44210251|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
44456496|NCT01628913|Everolimus|everolimus|mesh-list
44210252|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210253|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44210254|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210255|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210256|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44210257|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
44210258|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
44210259|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210260|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44210261|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44210262|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44210264|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210265|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43614175|NCT04360941|Palbociclib|palbociclib|mesh-list
43752858|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836527|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43836528|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43836529|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
43836530|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836531|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836532|NCT04966702|Ivermectin|ivermectin|mesh-list
43836533|NCT04966702|Albendazole|albendazole|mesh-list
43836534|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43836535|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836536|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
43836537|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
43836538|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43836539|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752894|NCT02488057|Hormones|hormones|mesh-ancestor
43752895|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752896|NCT02488291|Sufentanil|sufentanil|mesh-list
43752898|NCT02488291|Ropivacaine|ropivacaine|mesh-list
43752899|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
43752900|NCT02488291|Anesthetics|anesthetics|mesh-list
43752901|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210294|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44210295|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44210297|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210298|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210299|NCT00438217|Leuprolide|leuprolide|mesh-list
44210300|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44210301|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44210302|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44210303|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
44210304|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44210305|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210306|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210307|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210308|NCT00438217|Hormones|hormones|mesh-ancestor
44210309|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210310|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
44210332|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210333|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210334|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44210335|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44210336|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44210337|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44210338|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210339|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210340|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210341|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44210342|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44210343|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44210344|NCT00438321|Anastrozole|anastrozole|mesh-list
44210345|NCT00438321|Goserelin|goserelin|mesh-list
44210346|NCT00438321|Testosterone|testosterone|mesh-list
44210347|NCT00438321|Androgens|androgens|mesh-ancestor
44210348|NCT00438321|Hormones|hormones|mesh-ancestor
43752902|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752903|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
43752904|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752936|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752938|NCT02487680|Picolinic acid|picolinic acid|mesh-list
44210349|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210350|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210351|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210352|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210353|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44210354|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44210355|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210356|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210357|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44210358|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44210359|NCT00438386|Aripiprazole|aripiprazole|mesh-list
44210360|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
44210361|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210362|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44210363|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210364|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210365|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210366|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
44210399|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
44210400|NCT00438737|Calcium|calcium|mesh-list
44210401|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
44210402|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44210403|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210434|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210436|NCT00438789|Eculizumab|eculizumab|mesh-list
44210437|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44210438|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210439|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
44210440|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210441|NCT00438828|Dexamethasone|dexamethasone|mesh-list
44210442|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210443|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
44210444|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
44210445|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798735|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44282352|NCT00738621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282353|NCT00738621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282354|NCT00738621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44282355|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44282356|NCT00738660|Telmisartan|telmisartan|mesh-list
44282357|NCT00738660|Ramipril|ramipril|mesh-list
44282358|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44282359|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43667662|NCT04824911|Analgesics|analgesics|mesh-ancestor
44210446|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210472|NCT00438841|Hormones|hormones|mesh-ancestor
44210473|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210474|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210475|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
44210476|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210477|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210478|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44210479|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44210480|NCT00438841|Growth Substances|growth substances|mesh-ancestor
44210481|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
44210482|NCT00438906|Secretin|secretin|mesh-list
44210483|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210484|NCT00438906|Hormones|hormones|mesh-ancestor
44210485|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210486|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210487|NCT00438945|Eprosartan|eprosartan|mesh-list
44210488|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44210489|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44210490|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44210491|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210492|NCT00438958|Lenograstim|lenograstim|mesh-list
44210493|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44210494|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
44210495|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210521|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44210522|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210523|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
44210524|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210525|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44210526|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44210527|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44210528|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44210529|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210530|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
44210531|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
44210532|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
44210533|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210534|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
44210535|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44210536|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44210537|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210538|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44210539|NCT00439062|Roxithromycin|roxithromycin|mesh-list
44210540|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210541|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210542|NCT00439166|Doxycycline|doxycycline|mesh-list
44210543|NCT00439166|Rifampin|rifampin|mesh-list
44210544|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210545|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210546|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
44210547|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44210575|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44210577|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210578|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282360|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43753345|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43753346|NCT02485340|Diuretics|diuretics|mesh-ancestor
44282361|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282362|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44282363|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
44282364|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463882|NCT01503229|Cortisone|cortisone|mesh-list
44463883|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
44463884|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463885|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
44463886|NCT01503229|Hormones|hormones|mesh-ancestor
44463887|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44463888|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463889|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44463890|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463891|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44463892|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463893|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463894|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44463895|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44463896|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44463897|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44463898|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463899|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463900|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44463901|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44463902|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210579|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210580|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210581|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44210582|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210583|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
44210584|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753347|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
43753348|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753349|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43753350|NCT02485327|Insulin|insulin|mesh-list
43753351|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43753352|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43753353|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753354|NCT02485249|Dexamethasone|dexamethasone|mesh-list
43753355|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
43836615|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
43836616|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836617|NCT04964128|Insulin|insulin|mesh-list
43836618|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43836619|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836620|NCT04964063|Listerine|listerine|mesh-list
43836621|NCT04964063|Fluorides|fluorides|mesh-list
43836622|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
44210585|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44210586|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210587|NCT00439361|Carboplatin|carboplatin|mesh-list
44210588|NCT00439361|Etoposide|etoposide|mesh-list
44210589|NCT00439361|Bortezomib|bortezomib|mesh-list
44210590|NCT00439361|Ifosfamide|ifosfamide|mesh-list
44210591|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456504|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
44456505|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
44456506|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456507|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456508|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
43799096|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
44463904|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463905|NCT01502644|Morphine|morphine|mesh-list
44463906|NCT01502644|Oxycodone|oxycodone|mesh-list
44463907|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44463908|NCT01502644|Narcotics|narcotics|mesh-ancestor
44463909|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44463910|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463911|NCT01502644|Analgesics|analgesics|mesh-ancestor
43667692|NCT04805541|Tropicamide|tropicamide|mesh-list
44456509|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456510|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44210611|NCT00439504|Lobeline|lobeline|mesh-list
44210612|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44210613|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
44210614|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210615|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210616|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44210617|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44210618|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
44210619|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836623|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
43836624|NCT04964063|Protective Agents|protective agents|mesh-ancestor
43836625|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836626|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43836627|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753484|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753485|NCT02484573|Propranolol|propranolol|mesh-list
43753486|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43753487|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43753488|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
43753489|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753495|NCT02484755|Gefitinib|gefitinib|mesh-list
43753496|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210620|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210621|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
44210622|NCT00439530|Oseltamivir|oseltamivir|mesh-list
44210623|NCT00439530|Probenecid|probenecid|mesh-list
44210624|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
44210625|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614530|NCT03607890|Nivolumab|nivolumab|mesh-list
44210648|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
44210649|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210650|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210651|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210652|NCT00439751|Goserelin|goserelin|mesh-list
44210653|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210654|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210655|NCT00439829|Cetrorelix|cetrorelix|mesh-list
44210656|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44210657|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
44210658|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44210659|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210660|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44210661|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210662|NCT00439855|Heparin|heparin|mesh-list
44210663|NCT00439855|Enoxaparin|enoxaparin|mesh-list
44210664|NCT00439855|Calcium heparin|calcium heparin|mesh-list
44210665|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
44210666|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44210667|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44210668|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210669|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
44210670|NCT00439972|Ortho Evra|ortho evra|mesh-list
44210671|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44210672|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44210673|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
44210674|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44210675|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210676|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210677|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210704|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44210705|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44210707|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210708|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44210709|NCT00440128|Docetaxel|docetaxel|mesh-list
44210710|NCT00440128|Casopitant|casopitant|mesh-list
44210711|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210712|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44210713|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
44463912|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
44463913|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463914|NCT01502423|Adalimumab|adalimumab|mesh-list
44463915|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463916|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463917|NCT01502410|Sorafenib|sorafenib|mesh-list
44463918|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753645|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
43753646|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43753647|NCT02483624|Protective Agents|protective agents|mesh-ancestor
43753648|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753649|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753650|NCT02483325|Fludarabine|fludarabine|mesh-list
43753651|NCT02483325|Busulfan|busulfan|mesh-list
43753652|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
43753653|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753654|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753655|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753656|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
43753657|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753658|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
43753659|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44463919|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44463920|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463921|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463922|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
44463923|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282365|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44282366|NCT00738751|Panobinostat|panobinostat|mesh-list
44282367|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44282368|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282369|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44282370|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282371|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282372|NCT00738777|Tamoxifen|tamoxifen|mesh-list
44282373|NCT00738777|Fulvestrant|fulvestrant|mesh-list
44282374|NCT00738777|Anastrozole|anastrozole|mesh-list
44282375|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44282376|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
44282377|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282378|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282379|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44282380|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282381|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44282382|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44282383|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282384|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44282385|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44282386|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44282387|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282389|NCT00738829|Rituximab|rituximab|mesh-list
44282391|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
43753660|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43753661|NCT02483299|Metformin|metformin|mesh-list
43753662|NCT02483299|Liraglutide|liraglutide|mesh-list
43753663|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43753664|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753714|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753715|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753716|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43753717|NCT02483169|Protective Agents|protective agents|mesh-ancestor
43753718|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43753719|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43753729|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
43753730|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753731|NCT02483221|Morphine|morphine|mesh-list
43753732|NCT02483221|Hydromorphone|hydromorphone|mesh-list
43753754|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753755|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753756|NCT02483195|Urological Agents|urological agents|mesh-ancestor
43836638|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282392|NCT00738829|Lenalidomide|lenalidomide|mesh-list
44282393|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282394|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282395|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
44282396|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282397|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282398|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282399|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
44282400|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282401|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210714|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44210715|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210716|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
44210717|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
44210718|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210719|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210720|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210721|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44210722|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210723|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44210724|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44210725|NCT00440141|Latanoprost|latanoprost|mesh-list
44210726|NCT00440141|Brinzolamide|brinzolamide|mesh-list
44210727|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44210749|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210750|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210752|NCT00440167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210753|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210754|NCT00440167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210755|NCT00440167|Immunologic Factors|immunologic factors|mesh-ancestor
43836639|NCT04959331|Fosfomycin|fosfomycin|mesh-list
43836640|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
43836641|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
43836642|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836643|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836644|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43836645|NCT04959331|Renal Agents|renal agents|mesh-ancestor
43836646|NCT04959266|Itraconazole|itraconazole|mesh-list
43836647|NCT04959266|Rifampin|rifampin|mesh-list
43836648|NCT04959266|Omeprazole|omeprazole|mesh-list
43836649|NCT04959266|Adavosertib|adavosertib|mesh-list
43836650|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43753809|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753842|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753844|NCT02482272|Adefovir|adefovir|mesh-list
43753845|NCT02482272|Entecavir|entecavir|mesh-list
43753846|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43753847|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43753897|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43753898|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210756|NCT00440167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210757|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44210758|NCT00440219|Prednisone|prednisone|mesh-list
44210759|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210760|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
44210761|NCT00440219|Hormones|hormones|mesh-ancestor
44210762|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210763|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210764|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210765|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210766|NCT00440245|Albuterol|albuterol|mesh-list
44210767|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44210768|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
44210769|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210770|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210771|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44210772|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
44210773|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
44210774|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44210775|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44210776|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44210777|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44210778|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
43614691|NCT03323476|Prednisone|prednisone|mesh-list
44210804|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44210805|NCT00440349|Tamoxifen|tamoxifen|mesh-list
44210806|NCT00440349|Prednisone|prednisone|mesh-list
44210807|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210808|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
44210809|NCT00440349|Hormones|hormones|mesh-ancestor
44210810|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44282402|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282403|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282404|NCT00738829|Growth Substances|growth substances|mesh-ancestor
44282405|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282406|NCT00738842|Ticagrelor|ticagrelor|mesh-list
44282407|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44282408|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44210811|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210812|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210813|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210814|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44210815|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
44210816|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44210817|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44210818|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44210819|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
44210820|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210821|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210822|NCT00440414|Pemetrexed|pemetrexed|mesh-list
43753907|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753908|NCT02481960|Irinotecan|irinotecan|mesh-list
43753909|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43753910|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43753934|NCT02481609|Expectorants|expectorants|mesh-ancestor
43753935|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753936|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43753937|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
43753938|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753939|NCT02481609|Protective Agents|protective agents|mesh-ancestor
43753940|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210823|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44210824|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210825|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210826|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210827|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44210858|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210860|NCT00440622|Antiviral Agents|antiviral agents|mesh-ancestor
44210861|NCT00440622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210862|NCT00440622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210863|NCT00440622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210864|NCT00440622|Immunologic Factors|immunologic factors|mesh-ancestor
44210865|NCT00440622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210866|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44210867|NCT00440635|Bortezomib|bortezomib|mesh-list
44210868|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210869|NCT00440648|Sevelamer|sevelamer|mesh-list
44210904|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44210905|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
44210906|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44210907|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43614830|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
44210932|NCT00440804|Ibuprofen|ibuprofen|mesh-list
44210933|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44210934|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210935|NCT00440804|Analgesics|analgesics|mesh-ancestor
44210936|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
44210937|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210938|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210939|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210940|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210941|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753941|NCT02481609|Antidotes|antidotes|mesh-ancestor
43753942|NCT02481453|Sirolimus|sirolimus|mesh-list
43753943|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43753944|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753945|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43753946|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753947|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
43753948|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753949|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
43753950|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847859|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847860|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847861|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847862|NCT04072822|Prednisone|prednisone|mesh-list
44210942|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210943|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210944|NCT00440843|Olanzapine|olanzapine|mesh-list
44210945|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
44210946|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
44210947|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210948|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210949|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210950|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44210951|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210952|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210953|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210954|NCT00440843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44210955|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44210956|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210957|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799097|NCT05013164|Antidotes|antidotes|mesh-ancestor
44210992|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210993|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44210994|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44210996|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44210997|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44210998|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210999|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211000|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
44211002|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211003|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44211037|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211038|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211039|NCT00441181|Travoprost|travoprost|mesh-list
44211040|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211041|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
44211042|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
44211043|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211044|NCT00441207|Protective Agents|protective agents|mesh-ancestor
44211045|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211046|NCT00441207|Vitamins|vitamins|mesh-ancestor
44211068|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44211069|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
44211070|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44211072|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
44211073|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211074|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44211075|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44211076|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211077|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211078|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44211079|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43754224|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754225|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754226|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
43754227|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754228|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754229|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43754230|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456511|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44456512|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44456513|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456514|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456515|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44456516|NCT01628692|Ribavirin|ribavirin|mesh-list
44456517|NCT01628692|Simeprevir|simeprevir|mesh-list
44456518|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
44456519|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456520|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
44456521|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456522|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456523|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456524|NCT01628549|Sarecycline|sarecycline|mesh-list
44456525|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456526|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456527|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456528|NCT01628393|Ozanimod|ozanimod|mesh-list
44456529|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44456530|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615021|NCT01979367|Analgesics|analgesics|mesh-list
44456557|NCT01627327|Xhance|xhance|mesh-list
44456558|NCT01627327|Bromides|bromides|mesh-list
44456559|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
44456560|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456561|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456562|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
44456563|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456564|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456565|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456566|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456567|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456568|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44211080|NCT00441415|Adapalene|adapalene|mesh-list
44211081|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211082|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211083|NCT00441415|Analgesics|analgesics|mesh-ancestor
44211084|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
44211085|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211086|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211087|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282409|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44282411|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
44282412|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282413|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282414|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282415|NCT00738868|Cetuximab|cetuximab|mesh-list
44282416|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282417|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211088|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211089|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
44211090|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
44211091|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44211092|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44211116|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211117|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
44211118|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43754358|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
43754359|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754360|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754361|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754362|NCT02479217|Docetaxel|docetaxel|mesh-list
43754363|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754364|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
43754365|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754366|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754367|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754368|NCT02479529|Norepinephrine|norepinephrine|mesh-list
43754369|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43754392|NCT02479074|Prednisolone|prednisolone|mesh-list
43754393|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43754394|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
43754395|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43754396|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
44211119|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211120|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211121|NCT00441532|Lidocaine|lidocaine|mesh-list
44211122|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
44211123|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
44211124|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211125|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211126|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
44211127|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211128|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44211129|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44211130|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44211131|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211132|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211133|NCT00441597|Atorvastatin|atorvastatin|mesh-list
44211134|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211135|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211136|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
44211137|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211138|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44211139|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211140|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211174|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211175|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211176|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
44211177|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211178|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44211179|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211180|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211216|NCT00442026|Docetaxel|docetaxel|mesh-list
44211217|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44211218|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
44211219|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211220|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211221|NCT00442026|Antiviral Agents|antiviral agents|mesh-ancestor
44211222|NCT00442026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211223|NCT00442026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211253|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211254|NCT00442221|Naproxen|naproxen|mesh-list
44211255|NCT00442221|Sumatriptan|sumatriptan|mesh-list
43754397|NCT02479074|Montelukast|montelukast|mesh-list
44211256|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211257|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211258|NCT00442221|Analgesics|analgesics|mesh-ancestor
44211259|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
44211260|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211261|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282418|NCT00738985|Simvastatin|simvastatin|mesh-list
44282420|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44282421|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44282422|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44282423|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
44282424|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667725|NCT04766853|Hormones|hormones|mesh-ancestor
44211262|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211263|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211264|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
44211265|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211266|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211267|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615240|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
44211293|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211295|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211296|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211297|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
44211298|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211299|NCT00442403|Chloroquine|chloroquine|mesh-list
44211300|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44211301|NCT00442403|Amebicides|amebicides|mesh-ancestor
44211302|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44211303|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44211304|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211305|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
44211306|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211307|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211308|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44211309|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
44211310|NCT00442455|Cisplatin|cisplatin|mesh-list
44211311|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44211312|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211313|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43615284|NCT03155477|Vitamin D|vitamin d|mesh-list
44211336|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211337|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211338|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211339|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211340|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211342|NCT00442637|Capecitabine|capecitabine|mesh-list
44211343|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211344|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211345|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211346|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211347|NCT00442637|Growth Substances|growth substances|mesh-ancestor
44211348|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211349|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
44211350|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43754702|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754703|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211351|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
44211352|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211353|NCT00442676|Celecoxib|celecoxib|mesh-list
44211354|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211355|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211356|NCT00442676|Analgesics|analgesics|mesh-ancestor
44211357|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
44211358|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211359|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211360|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211361|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211362|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44211382|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
44211383|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211384|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211385|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211386|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
44282425|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44282426|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44282427|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282429|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
44282430|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282431|NCT00739193|Amiodarone|amiodarone|mesh-list
44282432|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44282433|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282434|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44282435|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282436|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282437|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44282438|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44282439|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282440|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282441|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44282442|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44282443|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44282444|NCT00739388|Azacitidine|azacitidine|mesh-list
44282445|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282446|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
44282447|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282448|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282449|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667736|NCT04743934|Androgens|androgens|mesh-list
44211387|NCT00442793|Hematinics|hematinics|mesh-ancestor
44211388|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44211389|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
44211390|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44211391|NCT00442819|Protective Agents|protective agents|mesh-ancestor
44211392|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211393|NCT00442832|Vancomycin|vancomycin|mesh-list
44211394|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44211395|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211396|NCT00442845|Atorvastatin|atorvastatin|mesh-list
43754931|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754932|NCT02476123|Nivolumab|nivolumab|mesh-list
43754933|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
44211397|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211398|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211399|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
44211400|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211401|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44211402|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211403|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211404|NCT00443105|Tacrolimus|tacrolimus|mesh-list
44211405|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211406|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
44282450|NCT00739414|Panobinostat|panobinostat|mesh-list
44282451|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282452|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44282453|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282454|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282455|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44282456|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282457|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44282458|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282459|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211407|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211408|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44211409|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211410|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211412|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211413|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211414|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
44211415|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
44211445|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211446|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211447|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211448|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211449|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211450|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211451|NCT00443222|Infliximab|infliximab|mesh-list
44211452|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44211453|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211454|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211455|NCT00443235|Thalidomide|thalidomide|mesh-list
43755062|NCT02475499|Vildagliptin|vildagliptin|mesh-list
44211456|NCT00443235|Prednisone|prednisone|mesh-list
44211457|NCT00443235|Melphalan|melphalan|mesh-list
44211458|NCT00443235|Bortezomib|bortezomib|mesh-list
44211459|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211460|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
44211461|NCT00443235|Hormones|hormones|mesh-ancestor
44211462|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211463|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456571|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456572|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456573|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456575|NCT01627249|Bevacizumab|bevacizumab|mesh-list
44456576|NCT01627249|Ranibizumab|ranibizumab|mesh-list
44456577|NCT01627249|Aflibercept|aflibercept|mesh-list
44456578|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44456579|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456580|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44456581|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44456582|NCT01627249|Growth Substances|growth substances|mesh-ancestor
44456583|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456584|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456585|NCT01627067|Metformin|metformin|mesh-list
44456586|NCT01627067|Everolimus|everolimus|mesh-list
44456587|NCT01627067|Exemestane|exemestane|mesh-list
44456588|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456589|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755063|NCT02475499|Saxagliptin|saxagliptin|mesh-list
43755064|NCT02475499|Acarbose|acarbose|mesh-list
43755065|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43755066|NCT02475499|Repaglinide|repaglinide|mesh-list
43755067|NCT02475499|Gliclazide|gliclazide|mesh-list
43755068|NCT02475499|Glipizide|glipizide|mesh-list
43755069|NCT02475499|Biguanides|biguanides|mesh-list
43755070|NCT02475499|Voglibose|voglibose|mesh-list
43755071|NCT02475499|Tolbutamide|tolbutamide|mesh-list
43755072|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43755073|NCT02475499|Nateglinide|nateglinide|mesh-list
43755074|NCT02475499|Miglitol|miglitol|mesh-list
43755075|NCT02475499|Troglitazone|troglitazone|mesh-list
43755076|NCT02475499|Meglitinide|meglitinide|mesh-list
43755077|NCT02475499|Acetohexamide|acetohexamide|mesh-list
43755078|NCT02475499|Phenformin|phenformin|mesh-list
43755079|NCT02475499|Buformin|buformin|mesh-list
43755080|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
43755081|NCT02475499|Gliquidone|gliquidone|mesh-list
43755082|NCT02475499|Carbutamide|carbutamide|mesh-list
43755083|NCT02475499|Tolazamide|tolazamide|mesh-list
43755148|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755149|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755150|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43755151|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43755152|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43755153|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43755156|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755157|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43755158|NCT02475161|Rabeprazole|rabeprazole|mesh-list
43755159|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43755189|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755190|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456590|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456591|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456592|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
44456593|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44456594|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44456595|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456596|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456597|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44282460|NCT00739466|Alendronate|alendronate|mesh-list
44282461|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282462|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282463|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
44282464|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
44282465|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282466|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
44282467|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44282468|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
44282469|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456598|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
44456599|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456600|NCT01626872|Risperidone|risperidone|mesh-list
44456601|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44456602|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
44456603|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456604|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456605|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456606|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44456607|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44456608|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615482|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
44211491|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211492|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211493|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755192|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43836760|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755193|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755194|NCT02474654|Ketorolac|ketorolac|mesh-list
43755195|NCT02474654|Epinephrine|epinephrine|mesh-list
43755196|NCT02474654|Racepinephrine|racepinephrine|mesh-list
43755197|NCT02474654|Fentanyl|fentanyl|mesh-list
43755264|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755265|NCT02474433|Misoprostol|misoprostol|mesh-list
43755266|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43755267|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
43755268|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43755269|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211494|NCT00443508|Everolimus|everolimus|mesh-list
44211495|NCT00443508|Tacrolimus|tacrolimus|mesh-list
44211496|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211497|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
44211498|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211499|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44211500|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211501|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211502|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211503|NCT00443521|Triamcinolone|triamcinolone|mesh-list
44211504|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44211505|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44211506|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44211507|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211508|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
44211509|NCT00443521|Hormones|hormones|mesh-ancestor
44211510|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211511|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211512|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211513|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
44211514|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211515|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211516|NCT00443573|Protein C|protein c|mesh-list
44211517|NCT00443573|Anticoagulants|anticoagulants|mesh-list
44211518|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44211519|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211520|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211521|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44211522|NCT00443612|Irbesartan|irbesartan|mesh-list
43755300|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755301|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
43755302|NCT02474446|Vitamin D|vitamin d|mesh-list
43755303|NCT02474446|Vitamins|vitamins|mesh-ancestor
43755304|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
43755305|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648704|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
44211523|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211524|NCT00443612|Diuretics|diuretics|mesh-ancestor
44211525|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
44211546|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211547|NCT00443794|Analgesics|analgesics|mesh-ancestor
44211548|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
44211549|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211550|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211551|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211552|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211553|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44282470|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648705|NCT03035214|BB 1101|bb 1101|mesh-list
43648706|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282471|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44282472|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
44282473|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44282475|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282476|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667779|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44211554|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43755306|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43755307|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43755308|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
43755309|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755310|NCT02474420|Amlodipine|amlodipine|mesh-list
43648707|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
43648708|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
43648709|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648710|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648711|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648713|NCT03035214|Hormones|hormones|mesh-ancestor
43648714|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648715|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648716|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648717|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
43648718|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648719|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648723|NCT03035084|Vitamin D|vitamin d|mesh-list
44211555|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211556|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44211557|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211558|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211559|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
44211560|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211561|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211562|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
44211563|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43755311|NCT02474420|Deferasirox|deferasirox|mesh-list
43836773|NCT04950465|Fluorides|fluorides|mesh-list
43836774|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
43836775|NCT04950465|Protective Agents|protective agents|mesh-ancestor
43836776|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836777|NCT04949867|Glucagon|glucagon|mesh-list
43836778|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836779|NCT04949867|Hormones|hormones|mesh-ancestor
43836780|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648724|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
43648725|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
43648727|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
43836781|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836782|NCT04949425|Adavosertib|adavosertib|mesh-list
44211564|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211565|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44211566|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
44211567|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211568|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44211569|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
44211570|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
44211571|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44211572|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44211573|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43836783|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836784|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836785|NCT04948489|Norethindrone|norethindrone|mesh-list
43836786|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
43836787|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43836788|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43836789|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43648728|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211574|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211575|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211576|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211577|NCT00443794|Diuretics|diuretics|mesh-ancestor
44211578|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
44211638|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44211639|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44211640|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
44211641|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836790|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
43836791|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43836792|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836793|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43836794|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43836795|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
43836796|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43836797|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43648729|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43648730|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43648731|NCT03034941|Metformin|metformin|mesh-list
43648732|NCT03034941|Liraglutide|liraglutide|mesh-list
43648733|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43648734|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648735|NCT03034941|Incretins|incretins|mesh-ancestor
43648736|NCT03034941|Hormones|hormones|mesh-ancestor
43648737|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648738|NCT03034850|Doxorubicin|doxorubicin|mesh-list
43648739|NCT03034850|Fluorouracil|fluorouracil|mesh-list
44211642|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211643|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211645|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44211646|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44211647|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211648|NCT00444184|Timolol|timolol|mesh-list
44211649|NCT00444184|Travoprost|travoprost|mesh-list
44211650|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43755382|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648740|NCT03034850|Ifosfamide|ifosfamide|mesh-list
43648741|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648742|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648743|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648744|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648745|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648746|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648747|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
43648748|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43648749|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648750|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
43648751|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648752|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648753|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
43648754|NCT03034759|Insulin|insulin|mesh-list
43648755|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43648756|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648757|NCT03035058|Vedolizumab|vedolizumab|mesh-list
43648758|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648759|NCT03035045|Acetaminophen|acetaminophen|mesh-list
43648760|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43648774|NCT03034733|Hormones|hormones|mesh-ancestor
44211651|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44211652|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211653|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211654|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211655|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211656|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44211657|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211658|NCT00444223|Fluorides|fluorides|mesh-list
43755383|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43755384|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43755386|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755387|NCT02473627|Pioglitazone|pioglitazone|mesh-list
43755388|NCT02473627|Tolbutamide|tolbutamide|mesh-list
43755389|NCT02473627|DS-1971a|ds-1971a|mesh-list
43755390|NCT02473627|Midazolam|midazolam|mesh-list
43824264|NCT05514015|Rituximab|rituximab|mesh-list
43644789|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824265|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824266|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
43824267|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824268|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824269|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44211659|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
44211660|NCT00444223|Protective Agents|protective agents|mesh-ancestor
44211661|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211662|NCT00444236|Esomeprazole|esomeprazole|mesh-list
44211663|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44211664|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211665|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211666|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615676|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211690|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755418|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755419|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755420|NCT02473328|Ritonavir|ritonavir|mesh-list
43755421|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43755422|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43755423|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43755424|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
43824270|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
43824271|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211691|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211692|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282477|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44282478|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282479|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
44282480|NCT00739531|Protective Agents|protective agents|mesh-ancestor
44282481|NCT00739609|Tryptophan|tryptophan|mesh-list
44282482|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44282483|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
44282484|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44282485|NCT00739622|Rilpivirine|rilpivirine|mesh-list
44282486|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44282487|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282488|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282489|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755425|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755426|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755427|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43755428|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43755429|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
44282490|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
44282491|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282492|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282493|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282494|NCT00739830|Sirolimus|sirolimus|mesh-list
44282495|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44282496|NCT00739830|Megestrol|megestrol|mesh-list
44282497|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
44282498|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
44282499|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44282500|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44282501|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43755430|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755431|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43755432|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755433|NCT02473302|Tocopherols|tocopherols|mesh-list
43755434|NCT02473302|Vitamin E|vitamin e|mesh-list
43755435|NCT02473302|Tocotrienols|tocotrienols|mesh-list
43824272|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824273|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44282502|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
44282503|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44282504|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282524|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282525|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44282526|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282527|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44282529|NCT00740064|Lamivudine|lamivudine|mesh-list
44282596|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282597|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282598|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
44282599|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282663|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
44282664|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282665|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44282666|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44282667|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44282668|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44282669|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
44282670|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282671|NCT00740493|Warfarin|warfarin|mesh-list
44282672|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
44282673|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
44282674|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44282675|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755436|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
43755437|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
43755438|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755471|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43755472|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755473|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755474|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43755476|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
43755477|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43755478|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
43755479|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755480|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755511|NCT02473198|Analgesics|analgesics|mesh-ancestor
44282676|NCT00740545|Enoxaparin|enoxaparin|mesh-list
44282677|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
44282678|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44282679|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44282680|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463924|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
44463925|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44463926|NCT01502293|Interleukin-12|interleukin-12|mesh-list
44463927|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44463928|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
44463929|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463930|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44463931|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44463932|NCT01502293|Growth Substances|growth substances|mesh-ancestor
44463933|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
44463934|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463935|NCT01502228|Sunitinib|sunitinib|mesh-list
44463936|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755522|NCT02472873|Ethanol|ethanol|mesh-list
43755523|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43755524|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755525|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648781|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
43648782|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648783|NCT03034408|Mannitol|mannitol|mesh-list
43648784|NCT03034408|Baclofen|baclofen|mesh-list
43648786|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44463937|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44463945|NCT01502072|Ribavirin|ribavirin|mesh-list
44463951|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44463952|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
44463953|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44463954|NCT01501110|Expectorants|expectorants|mesh-ancestor
44463955|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44463956|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44463957|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
43648787|NCT03034408|Diuretics|diuretics|mesh-ancestor
43648788|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
43648789|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648790|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43648791|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43648792|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648793|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44463958|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463959|NCT01501110|Protective Agents|protective agents|mesh-ancestor
44463960|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463961|NCT01501110|Antidotes|antidotes|mesh-ancestor
44463962|NCT01500720|Topotecan|topotecan|mesh-list
44463963|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44463964|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44463965|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463966|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463967|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44463968|NCT01500694|Guanfacine|guanfacine|mesh-list
44463969|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44463970|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44211693|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211694|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211695|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
44211696|NCT00444379|Ritonavir|ritonavir|mesh-list
44211697|NCT00444379|Lopinavir|lopinavir|mesh-list
44211698|NCT00444379|Tenofovir|tenofovir|mesh-list
44211699|NCT00444379|Emtricitabine|emtricitabine|mesh-list
43648794|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
43648795|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
43648796|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648797|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648798|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43648799|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
43648800|NCT03034382|Lidocaine|lidocaine|mesh-list
43648801|NCT03034382|Epinephrine|epinephrine|mesh-list
43648802|NCT03034382|Morphine|morphine|mesh-list
43648803|NCT03034382|Nalbuphine|nalbuphine|mesh-list
43648804|NCT03034382|Bupivacaine|bupivacaine|mesh-list
43648805|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
43648806|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
43648807|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648808|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648809|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
43648810|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211700|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44211701|NCT00444379|Efavirenz|efavirenz|mesh-list
44211702|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44211703|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44211704|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
44211705|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211706|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648811|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43648812|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43648815|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648816|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44211707|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44211708|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44211709|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
44211710|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211711|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44211712|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44211713|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44211714|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44211715|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43615729|NCT03146689|Ibuprofen|ibuprofen|mesh-list
44211745|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
44211746|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211747|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44211748|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44211749|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211750|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211751|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211752|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211753|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648817|NCT03034382|Narcotics|narcotics|mesh-ancestor
43648818|NCT03034382|Analgesics|analgesics|mesh-ancestor
44211754|NCT00444561|Pramlintide|pramlintide|mesh-list
44211755|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44463971|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44463972|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44463973|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
44463974|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44463975|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755624|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43755625|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
43755626|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755627|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43755628|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43755629|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
43847628|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43648819|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43648820|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43648821|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
43648822|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648823|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43648824|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43648825|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
43648826|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43755630|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463976|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282682|NCT00740571|Amitriptyline|amitriptyline|mesh-list
44282683|NCT00740571|Analgesics|analgesics|mesh-ancestor
44282684|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
44282685|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282686|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282687|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
44282688|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44282689|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282690|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282691|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282692|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44282693|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44282694|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282695|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43755631|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755632|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43755633|NCT02472054|Cyclosporine|cyclosporine|mesh-list
43755634|NCT02472054|Prednisolone|prednisolone|mesh-list
43755635|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43755636|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
43755637|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43755638|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
43755639|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
43755640|NCT02472054|Cyclosporins|cyclosporins|mesh-list
43755641|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43755642|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
43755643|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755644|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755645|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648827|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
43648828|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
43648829|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
43648830|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43648831|NCT03034005|Budesonide|budesonide|mesh-list
43755646|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
44282696|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44282697|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44282698|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44282699|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44282700|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44282701|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282702|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44282703|NCT00740883|Warfarin|warfarin|mesh-list
44282704|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
44282705|NCT00740922|Becaplermin|becaplermin|mesh-list
43755647|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755648|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
43755649|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755650|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
43755651|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43755652|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43755653|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755654|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
43755655|NCT02472054|Hormones|hormones|mesh-ancestor
43648833|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43648834|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
43648835|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648836|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648837|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43648838|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
43648839|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
44282706|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
43755656|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755657|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43755658|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43755659|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
43755660|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
43755661|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755662|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755663|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43755664|NCT02472054|Protective Agents|protective agents|mesh-ancestor
43755665|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282707|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44282708|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282709|NCT00740922|Growth Substances|growth substances|mesh-ancestor
43667810|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211756|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211757|NCT00444574|Methylphenidate|methylphenidate|mesh-list
44211758|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44282710|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282712|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282713|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282714|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
44282715|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282716|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44282717|NCT00741052|Azithromycin|azithromycin|mesh-list
44282718|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
44282719|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282720|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282721|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44282722|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44282723|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282724|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282725|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282726|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44282727|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282728|NCT00741078|Amlodipine|amlodipine|mesh-list
44282729|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44282730|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44282731|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282732|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282733|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282734|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282735|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282736|NCT00741117|Bilirubin|bilirubin|mesh-list
43755666|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
43836816|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836817|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44282737|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
44282738|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836862|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44282739|NCT00741117|Protective Agents|protective agents|mesh-ancestor
44282740|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282741|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
44282742|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44282743|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
44282744|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
44282746|NCT00741169|Rifampin|rifampin|mesh-list
44282748|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44282749|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
44282750|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44282751|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282752|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
44282753|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282754|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282755|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282756|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44282757|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44282758|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44282759|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44282760|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44282761|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44282762|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
43667831|NCT04641247|Niraparib|niraparib|mesh-list
44211759|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211760|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44211761|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44211786|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211787|NCT00444717|Pitavastatin|pitavastatin|mesh-list
44211788|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44211789|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211790|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211791|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
44211792|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211793|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211794|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44211795|NCT00444756|Lidocaine|lidocaine|mesh-list
43648840|NCT03034005|Hormones|hormones|mesh-ancestor
43648841|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648842|NCT03033589|Bupivacaine|bupivacaine|mesh-list
43648843|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43648844|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
43648845|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
44211796|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
44211797|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
44211798|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211799|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211800|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
44211801|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211802|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44211803|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44211804|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44211805|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211806|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211807|NCT00444808|Calcitonin|calcitonin|mesh-list
44211808|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
44211809|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43648846|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648847|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648849|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211810|NCT00444808|Katacalcin|katacalcin|mesh-list
44211811|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44211837|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211838|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211839|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44211840|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211841|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211842|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44211843|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648850|NCT03033537|Verapamil|verapamil|mesh-list
43648851|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
43648852|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43648853|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648854|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43648855|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648856|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648857|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
43648858|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
43648875|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
43648876|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
43648877|NCT03033472|Clindamycin|clindamycin|mesh-list
43648878|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
43648882|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43648884|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211844|NCT00445016|Anesthetics|anesthetics|mesh-list
44211845|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282763|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
44282764|NCT00741182|Teriparatide|teriparatide|mesh-list
44282765|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282766|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282767|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44282768|NCT00741195|Bevacizumab|bevacizumab|mesh-list
44282769|NCT00741195|Docetaxel|docetaxel|mesh-list
43755872|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43755874|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755875|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43755876|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44282770|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282771|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282772|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282773|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282774|NCT00741195|Growth Substances|growth substances|mesh-ancestor
44282775|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282776|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282777|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
44282778|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
44282779|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
43847629|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43648885|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43648886|NCT03033836|Dolutegravir|dolutegravir|mesh-list
44282780|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282781|NCT00741221|Bevacizumab|bevacizumab|mesh-list
44282782|NCT00741221|Pemetrexed|pemetrexed|mesh-list
44282783|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44282784|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44282785|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44282786|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44282787|NCT00741221|Growth Substances|growth substances|mesh-ancestor
44282788|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282789|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
44282790|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282791|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282792|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44282793|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44282794|NCT00741234|Azacitidine|azacitidine|mesh-list
44282795|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44282796|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
44282803|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
44282804|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282805|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44282806|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44282807|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
44282808|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44282809|NCT00741351|Fentanyl|fentanyl|mesh-list
44282810|NCT00741351|Remifentanil|remifentanil|mesh-list
44282811|NCT00741351|Propofol|propofol|mesh-list
44282812|NCT00741351|Sevoflurane|sevoflurane|mesh-list
44282813|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44282814|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44282815|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282816|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44282817|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
44282818|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
44282819|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44282820|NCT00741351|Narcotics|narcotics|mesh-ancestor
44282821|NCT00741351|Analgesics|analgesics|mesh-ancestor
44282822|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
44282823|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44282824|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44282825|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44282826|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44282827|NCT00741364|Vitamin D|vitamin d|mesh-list
44282828|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
44282829|NCT00741364|Vitamins|vitamins|mesh-ancestor
44282858|NCT00741585|Irbesartan|irbesartan|mesh-list
44282859|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
44282860|NCT00741585|Quinapril|quinapril|mesh-list
44282861|NCT00741585|Lercanidipine|lercanidipine|mesh-list
44282862|NCT00741585|Manidipine|manidipine|mesh-list
44282863|NCT00741585|Doxazosin|doxazosin|mesh-list
44282864|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44282865|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44282866|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755879|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43755917|NCT02470065|Afatinib|afatinib|mesh-list
43756070|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43756071|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756072|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756073|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
44282867|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44282868|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44282869|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
44282870|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44282918|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44282919|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
44282920|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
44282921|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44282990|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44282991|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282992|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44282993|NCT00742066|Felodipine|felodipine|mesh-list
44282994|NCT00742066|Irbesartan|irbesartan|mesh-list
44282995|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44282996|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44282997|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44282998|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44282999|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283000|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44283004|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
43756074|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756075|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756076|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756077|NCT02468375|Urological Agents|urological agents|mesh-ancestor
43836899|NCT04942626|Capecitabine|capecitabine|mesh-list
43836900|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43836901|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43836902|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
43836903|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836904|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836905|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648887|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43648888|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648889|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648890|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648891|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
43648892|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648893|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283049|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283050|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283051|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44283052|NCT00742339|Octreotide|octreotide|mesh-list
44283053|NCT00742339|Terlipressin|terlipressin|mesh-list
44283054|NCT00742339|Midodrine|midodrine|mesh-list
44283055|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44463977|NCT01500434|Aspirin|aspirin|mesh-list
44283056|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283057|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283058|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
44283059|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
43836906|NCT04942470|Propolis|propolis|mesh-list
43836907|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836908|NCT04941196|Ticagrelor|ticagrelor|mesh-list
43836909|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43836910|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43836911|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43836912|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43836913|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
43836914|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836915|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836916|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836917|NCT04939987|Acetaminophen|acetaminophen|mesh-list
43836918|NCT04939987|Ketorolac|ketorolac|mesh-list
43836919|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43836920|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43836921|NCT04939987|Ketamine|ketamine|mesh-list
43836922|NCT04939987|Oxycodone|oxycodone|mesh-list
43836923|NCT04939987|Gabapentin|gabapentin|mesh-list
43836924|NCT04939987|Tramadol|tramadol|mesh-list
43836925|NCT04939987|Hydrocodone|hydrocodone|mesh-list
44283060|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283061|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283062|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44283063|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44283064|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44283065|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44283066|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283067|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283068|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283069|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283070|NCT00742404|Dexamethasone|dexamethasone|mesh-list
44283071|NCT00742404|Doxorubicin|doxorubicin|mesh-list
44283072|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44283073|NCT00742404|Bortezomib|bortezomib|mesh-list
44283074|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283075|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
44283076|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
43836926|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
43836927|NCT04939987|Analgesics|analgesics|mesh-ancestor
43836928|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
44463983|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
44463984|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44463985|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44463986|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44463987|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44463988|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44463989|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44463990|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44463991|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44463992|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44463993|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44463994|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
44463995|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44463996|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44463997|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44463998|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
44463999|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464000|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44464001|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44464002|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44464003|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44464004|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464005|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44283105|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44283160|NCT00742911|Copper|copper|mesh-list
44283182|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283183|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44283184|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44283186|NCT00743327|Pioglitazone|pioglitazone|mesh-list
43836948|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43836955|NCT04939883|Carvedilol|carvedilol|mesh-list
44283252|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283253|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
44283327|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44283328|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
44283329|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44283330|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283334|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
44283372|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283373|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44283374|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44283375|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283376|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283377|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44283378|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
44283379|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44283380|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44283381|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
44283382|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
44283383|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283384|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283385|NCT00744406|Sertraline|sertraline|mesh-list
44283386|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44283387|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
44283388|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44283389|NCT00744406|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44283390|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44283428|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44283429|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44283430|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
44283431|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283432|NCT00744549|Protective Agents|protective agents|mesh-ancestor
44283433|NCT00744549|Trace Elements|trace elements|mesh-ancestor
44283434|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283435|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44283436|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44283437|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283438|NCT00744640|Gemcitabine|gemcitabine|mesh-list
44283439|NCT00744640|Capecitabine|capecitabine|mesh-list
44283440|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
44283441|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44283442|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
44283443|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283444|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283445|NCT00744640|Antiviral Agents|antiviral agents|mesh-ancestor
44283446|NCT00744640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44283447|NCT00744640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283448|NCT00744640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44283449|NCT00744640|Immunologic Factors|immunologic factors|mesh-ancestor
44283450|NCT00744640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283451|NCT00744666|Prednisolone|prednisolone|mesh-list
44283452|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44283453|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283454|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
44283455|NCT00744666|Hormones|hormones|mesh-ancestor
44283456|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283457|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283458|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44283459|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283460|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44283461|NCT00744679|Natalizumab|natalizumab|mesh-list
44283462|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
44283463|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211846|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211847|NCT00445042|Sorafenib|sorafenib|mesh-list
44211848|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283464|NCT00744718|Bevacizumab|bevacizumab|mesh-list
44283465|NCT00744718|Carboplatin|carboplatin|mesh-list
44283466|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44283467|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283468|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44283469|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44283470|NCT00744718|Growth Substances|growth substances|mesh-ancestor
44283531|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
44283532|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
44283533|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283534|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283602|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44283603|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283605|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44283606|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44283607|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44283608|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44283609|NCT00745511|Growth Substances|growth substances|mesh-ancestor
44283663|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44283664|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283665|NCT00746447|Analgesics|analgesics|mesh-ancestor
44283666|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
44283667|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283668|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283669|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283670|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283671|NCT00746486|Budesonide|budesonide|mesh-list
44283672|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283673|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44283674|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
44283675|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283676|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283677|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44283678|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
44283679|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
44283680|NCT00746486|Hormones|hormones|mesh-ancestor
44283681|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283682|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
44283683|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44283684|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44283685|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
44283715|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283716|NCT00746720|Analgesics|analgesics|mesh-ancestor
44283717|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
44283718|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283719|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283720|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44283721|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44283722|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44283723|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44283776|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44283777|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44283778|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44283847|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
44283848|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283849|NCT00747604|Mecasermin|mecasermin|mesh-list
44283850|NCT00747604|Growth Substances|growth substances|mesh-ancestor
44283851|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283852|NCT00747669|Lidocaine|lidocaine|mesh-list
44283853|NCT00747669|Tetracaine|tetracaine|mesh-list
43836961|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836962|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836963|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
44283854|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
44283855|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
44283856|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44283857|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283858|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
44283859|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44283860|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44283861|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44283862|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44283863|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283864|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44283865|NCT00747695|Rabeprazole|rabeprazole|mesh-list
44283866|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44283867|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283868|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44283871|NCT00747708|Lenograstim|lenograstim|mesh-list
44283898|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283899|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44283973|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44283974|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44283975|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
44283977|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44283978|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44283979|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44283980|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
44283981|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44283982|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44283983|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44283984|NCT00748059|Urological Agents|urological agents|mesh-ancestor
44283985|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44283986|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44283987|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44283988|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44283989|NCT00748059|Antidotes|antidotes|mesh-ancestor
44283990|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44283991|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44283992|NCT00748150|Vaccines|vaccines|mesh-list
44283993|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
44283994|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44283995|NCT00748163|Paclitaxel|paclitaxel|mesh-list
44283996|NCT00748163|Sunitinib|sunitinib|mesh-list
44283997|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44283998|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44283999|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284000|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
44284001|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
44284002|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44284003|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284004|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44284005|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211849|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44211850|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211851|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211852|NCT00445055|Droperidol|droperidol|mesh-list
44211853|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44211854|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
44211855|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
43756922|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
43756923|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756924|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
44211856|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211857|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284006|NCT00748163|Growth Substances|growth substances|mesh-ancestor
44284007|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284008|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284056|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284057|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44284058|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
44284059|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44284060|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
44284061|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284062|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284063|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44284064|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284065|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
44284066|NCT00748423|Protective Agents|protective agents|mesh-ancestor
44284067|NCT00748436|Betahistine|betahistine|mesh-list
44284068|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284069|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
44284070|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
44284071|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284072|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284073|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284074|NCT00748527|Carboplatin|carboplatin|mesh-list
44284075|NCT00748527|Decitabine|decitabine|mesh-list
44284076|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284077|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284078|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
44284079|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284080|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284081|NCT00748644|Rituximab|rituximab|mesh-list
44284082|NCT00748644|Azathioprine|azathioprine|mesh-list
44284083|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44284084|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284085|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
44284086|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284087|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938742|NCT00887575|Paclitaxel|paclitaxel|mesh-list
44284088|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
44284098|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284099|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284106|NCT00749021|Ranibizumab|ranibizumab|mesh-list
44284166|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
44284167|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757041|NCT02462369|Incretins|incretins|mesh-ancestor
44284168|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284169|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284170|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284171|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
44284172|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44284173|NCT00749450|Fluorouracil|fluorouracil|mesh-list
44284174|NCT00749450|Capecitabine|capecitabine|mesh-list
44284175|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
44284176|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
44284177|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284178|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284179|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284180|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284181|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
44284182|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284183|NCT00749502|Niraparib|niraparib|mesh-list
44284184|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44284185|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284186|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284187|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284188|NCT00749567|Bevacizumab|bevacizumab|mesh-list
43826677|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
44211858|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615876|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
44211880|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211881|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
44211882|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
44211883|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211884|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
44211885|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211886|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44211887|NCT00445094|Vancomycin|vancomycin|mesh-list
44211888|NCT00445094|Imipenem|imipenem|mesh-list
44211889|NCT00445094|Amikacin|amikacin|mesh-list
44211890|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44211891|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44211892|NCT00445094|Cilastatin|cilastatin|mesh-list
44211893|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44211894|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211895|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211896|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44211897|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211898|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44456617|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456618|NCT01626118|Indomethacin|indomethacin|mesh-list
44456619|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44456620|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456621|NCT01626118|Analgesics|analgesics|mesh-ancestor
44456622|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
44456623|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284189|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44284190|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43757328|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43757329|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837088|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837089|NCT04934748|Protective Agents|protective agents|mesh-ancestor
43837090|NCT04934683|Propofol|propofol|mesh-list
44284191|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284192|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44284193|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44284194|NCT00749567|Growth Substances|growth substances|mesh-ancestor
44284195|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284196|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456624|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456625|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456626|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456627|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
44456628|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
44456629|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44211913|NCT00445406|Growth Substances|growth substances|mesh-ancestor
44211914|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211915|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
44211916|NCT00445497|Amoxicillin|amoxicillin|mesh-list
44211917|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
44211918|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
44211919|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
44211920|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44211921|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44211922|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211923|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44211924|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44211925|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211926|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211927|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211928|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44211929|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44211930|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44211931|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44211932|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44211933|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44211934|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211959|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
44211960|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
44211961|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44211962|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
44211964|NCT00445861|Docetaxel|docetaxel|mesh-list
44211965|NCT00445861|Cetuximab|cetuximab|mesh-list
44211966|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211967|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211968|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211969|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
44211970|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211971|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211972|NCT00445874|Ketotifen|ketotifen|mesh-list
44211973|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
44211975|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44211976|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
44211977|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
44211978|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211979|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211980|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211981|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44211982|NCT00445900|Thalidomide|thalidomide|mesh-list
44211983|NCT00445900|Prednisone|prednisone|mesh-list
44211984|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
44211985|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211986|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
43837091|NCT04934683|Etomidate|etomidate|mesh-list
44211987|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212024|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616075|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
44284197|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284198|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284199|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212047|NCT00446043|Analgesics|analgesics|mesh-ancestor
44212048|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
44212049|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212050|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212051|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212052|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212054|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44212055|NCT00446069|Narcotics|narcotics|mesh-ancestor
44212056|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212057|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212058|NCT00446069|Analgesics|analgesics|mesh-ancestor
44212059|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
44212060|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212061|NCT00446082|Pasireotide|pasireotide|mesh-list
44212062|NCT00446082|Hormones|hormones|mesh-ancestor
44212063|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212064|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212065|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
44212066|NCT00446173|Busulfan|busulfan|mesh-list
44212067|NCT00446173|Sargramostim|sargramostim|mesh-list
44212068|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212069|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
44212070|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212071|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212072|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44212073|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
44212074|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212075|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212076|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44212077|NCT00446212|Propofol|propofol|mesh-list
44212078|NCT00446212|Desflurane|desflurane|mesh-list
44212113|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44212114|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212115|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212116|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44212117|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
44212118|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
43616180|NCT04688203|Labetalol|labetalol|mesh-list
44212148|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44212149|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44212150|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44212151|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212152|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212153|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212154|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44212155|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44212156|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44212157|NCT00446537|Methylphenidate|methylphenidate|mesh-list
44212158|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44212159|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212160|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44212161|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44212162|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44212163|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212196|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
44212197|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212198|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212199|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757394|NCT02460393|Antibodies|antibodies|mesh-list
44212200|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212201|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44212202|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212203|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
44212204|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212205|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44212206|NCT00446810|Benphothiamine|benphothiamine|mesh-list
44212207|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44284201|NCT00749619|Heparin|heparin|mesh-list
44284202|NCT00749619|Calcium heparin|calcium heparin|mesh-list
44284203|NCT00749619|Citric Acid|citric acid|mesh-list
44284204|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
44284205|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44284206|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
44284207|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44284208|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
44284209|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
44284210|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284211|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44284212|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44284213|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284214|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44284215|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284216|NCT00749710|Clopidogrel|clopidogrel|mesh-list
44284217|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43826692|NCT05495568|Adalimumab|adalimumab|mesh-list
44212208|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
44212209|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212245|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44212246|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212247|NCT00446953|Betamethasone|betamethasone|mesh-list
44212283|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212285|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44212286|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44212287|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456661|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456662|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
44456663|NCT01625377|Everolimus|everolimus|mesh-list
44456664|NCT01625377|Tacrolimus|tacrolimus|mesh-list
44456665|NCT01625377|Basiliximab|basiliximab|mesh-list
44456666|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456667|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
44456668|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456669|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44456670|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456671|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456672|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456673|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44456674|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44456675|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
44456676|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456677|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456678|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
44456679|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
44456680|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456681|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44456682|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43616373|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212315|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
44212336|NCT00447473|Ketoconazole|ketoconazole|mesh-list
44212337|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
44212338|NCT00447473|Analgesics|analgesics|mesh-ancestor
44212339|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
44212340|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212341|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212342|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284218|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43757590|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44284219|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44284220|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44284221|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
44284222|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757591|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44284223|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284224|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284225|NCT00749723|Carboplatin|carboplatin|mesh-list
44284226|NCT00749723|Etoposide|etoposide|mesh-list
44284227|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
44284228|NCT00749723|Temozolomide|temozolomide|mesh-list
44284229|NCT00749723|Thiotepa|thiotepa|mesh-list
44284230|NCT00749723|Trofosfamide|trofosfamide|mesh-list
44284231|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
44284232|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284233|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44284234|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44284235|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44284236|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284237|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284238|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44212343|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44212344|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212345|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212346|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212347|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
44212348|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212349|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44212350|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44212351|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44212352|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
44212353|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212354|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44212355|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44212356|NCT00447577|Tobramycin|tobramycin|mesh-list
44212357|NCT00447577|Dexamethasone|dexamethasone|mesh-list
44212358|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212359|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
44212360|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
44212361|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212362|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212363|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44212364|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
44212365|NCT00447577|Hormones|hormones|mesh-ancestor
44212366|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212367|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44212368|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867380|NCT01415752|Rituximab|rituximab|mesh-list
44212397|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212398|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212399|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44284239|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
44284240|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44284241|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284242|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
44284243|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284244|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284245|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
44284246|NCT00749736|Vitamin D|vitamin d|mesh-list
44284247|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44284248|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284249|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284250|NCT00749736|Vitamins|vitamins|mesh-ancestor
44284251|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
44284252|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44284253|NCT00749814|Melatonin|melatonin|mesh-list
44284254|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
44284255|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284256|NCT00749814|Protective Agents|protective agents|mesh-ancestor
44284257|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212400|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
44212401|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44212402|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44212403|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44212404|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44212405|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44212407|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
44212408|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
44212409|NCT00447915|Calcium|calcium|mesh-list
44212410|NCT00447915|Vitamins|vitamins|mesh-ancestor
44212411|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
44212412|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212413|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212414|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44212415|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
44212416|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
44212417|NCT00447967|Leucovorin|leucovorin|mesh-list
44212418|NCT00447967|Fluorouracil|fluorouracil|mesh-list
44212419|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
44212420|NCT00447967|Irinotecan|irinotecan|mesh-list
44212421|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
44212455|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212456|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212458|NCT00448149|Sorafenib|sorafenib|mesh-list
44212459|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212460|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212461|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
44212462|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212463|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212498|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212499|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212500|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212501|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616595|NCT01826838|Dasatinib|dasatinib|mesh-list
44212521|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
44212522|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44212523|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
44212524|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212526|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
44212527|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284258|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284260|NCT00749853|Hormones|hormones|mesh-list
44284261|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44284262|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284263|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284264|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44284265|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
44284266|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284267|NCT00749866|Gentamicins|gentamicins|mesh-list
44284268|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212528|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
44212529|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212530|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212531|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44212532|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
44212533|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212534|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44212535|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44212536|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212537|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212538|NCT00448643|Cisplatin|cisplatin|mesh-list
44212539|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212540|NCT00448734|Docetaxel|docetaxel|mesh-list
44212541|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212542|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212543|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212544|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212545|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212546|NCT00448786|Niacinamide|niacinamide|mesh-list
44212547|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
44212548|NCT00448786|Imetelstat|imetelstat|mesh-list
44212549|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212550|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212551|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212552|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
44212553|NCT00448786|Vitamins|vitamins|mesh-ancestor
44212554|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
44212555|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212556|NCT00448825|Topiramate|topiramate|mesh-list
44212557|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
44212558|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44212559|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212560|NCT00448838|Gemcitabine|gemcitabine|mesh-list
44212594|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212596|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
44456699|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44456700|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44456701|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212597|NCT00449137|Leucovorin|leucovorin|mesh-list
44212598|NCT00449137|Fluorouracil|fluorouracil|mesh-list
44212599|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
44212600|NCT00449137|Calcium|calcium|mesh-list
44212601|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
44212602|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212634|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212636|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212637|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44212638|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
44212639|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212640|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
44212641|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212642|NCT00449319|Daunorubicin|daunorubicin|mesh-list
44212643|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44212644|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284270|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44284271|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284272|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284273|NCT00749918|Vitamin D|vitamin d|mesh-list
44212645|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44212646|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212647|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212679|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44212680|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44212681|NCT00449449|Lidocaine|lidocaine|mesh-list
44212682|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
44212683|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
44212684|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212685|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212686|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
44212710|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
44212711|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212712|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212714|NCT00449514|Clomiphene|clomiphene|mesh-list
44212715|NCT00449514|Enclomiphene|enclomiphene|mesh-list
44212716|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
44212717|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44212718|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
44212719|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212720|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212721|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44212722|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212723|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44212724|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44212725|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44212726|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44212727|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
44212728|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44212729|NCT00449527|Budesonide|budesonide|mesh-list
44212730|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
44212731|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212732|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44212733|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
44212734|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212735|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212755|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
44212756|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212757|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212758|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212759|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212760|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44212761|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44212762|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212763|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44212764|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44212765|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212767|NCT00449657|Gemcitabine|gemcitabine|mesh-list
44212768|NCT00449657|Paclitaxel|paclitaxel|mesh-list
44212769|NCT00449657|Carboplatin|carboplatin|mesh-list
44212770|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44212771|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212772|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212773|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212774|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212775|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212776|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212777|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
44212778|NCT00449657|Antiviral Agents|antiviral agents|mesh-ancestor
44212779|NCT00449657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212780|NCT00449657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212781|NCT00449657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212782|NCT00449657|Immunologic Factors|immunologic factors|mesh-ancestor
44212783|NCT00449657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284274|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
44284275|NCT00749918|Vitamins|vitamins|mesh-ancestor
44284276|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
44284277|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284278|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44212784|NCT00449683|Terazosin|terazosin|mesh-list
44212785|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44212786|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44212787|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44212788|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
44212819|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44212820|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44212821|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212822|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212823|NCT00449839|Insulin|insulin|mesh-list
44212824|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44212825|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
44212826|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
44212827|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44212828|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44212829|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212830|NCT00450008|Thalidomide|thalidomide|mesh-list
44212831|NCT00450008|Docetaxel|docetaxel|mesh-list
44212857|NCT00450086|Hormones|hormones|mesh-ancestor
44212858|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212859|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212860|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212861|NCT00450086|Analgesics|analgesics|mesh-ancestor
44212862|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
44212863|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212864|NCT00450099|Bupivacaine|bupivacaine|mesh-list
44212865|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
44212866|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
44212867|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212868|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212869|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
44212870|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212871|NCT00450138|Cisplatin|cisplatin|mesh-list
44212872|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212873|NCT00450164|Nadolol|nadolol|mesh-list
44212874|NCT00450164|Prazosin|prazosin|mesh-list
44212875|NCT00450164|Isosorbide|isosorbide|mesh-list
44212876|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44212877|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44212878|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44212879|NCT00450164|Diuretics|diuretics|mesh-ancestor
44212880|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
44212881|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212882|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
44212917|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44212918|NCT00450229|Protective Agents|protective agents|mesh-ancestor
44212919|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212920|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212921|NCT00450281|Antibodies|antibodies|mesh-list
44212922|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
44212923|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212952|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212953|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212954|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44212955|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44212956|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212957|NCT00450645|Heparin|heparin|mesh-list
44212958|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44212959|NCT00450645|Tinzaparin|tinzaparin|mesh-list
44212960|NCT00450645|Dalteparin|dalteparin|mesh-list
44212961|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
44212962|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44212963|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44212964|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212965|NCT00450736|Celecoxib|celecoxib|mesh-list
44212966|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284279|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284280|NCT00750048|Acetaminophen|acetaminophen|mesh-list
44284281|NCT00750048|Naloxone|naloxone|mesh-list
44284282|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284283|NCT00750048|Analgesics|analgesics|mesh-ancestor
44284284|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
43759220|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
43759221|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759222|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43759223|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43759224|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759225|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759226|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43759227|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
44284285|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284286|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284287|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
44284288|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44284289|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44212967|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212968|NCT00450736|Analgesics|analgesics|mesh-ancestor
44212969|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
44212970|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212971|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212991|NCT00450827|Antibodies|antibodies|mesh-list
44212992|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44212993|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44212994|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212995|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212996|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212997|NCT00450827|Growth Substances|growth substances|mesh-ancestor
44212998|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212999|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
44213000|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
44213001|NCT00450840|Simvastatin|simvastatin|mesh-list
44213002|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213003|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213004|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
44213005|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213006|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213007|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213008|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213009|NCT00450853|Granisetron|granisetron|mesh-list
44213010|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
44213011|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
44213012|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213013|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213014|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213015|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44213016|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
44213017|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213018|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213019|NCT00450892|Docetaxel|docetaxel|mesh-list
44213020|NCT00450892|Trastuzumab|trastuzumab|mesh-list
44213021|NCT00450892|Lapatinib|lapatinib|mesh-list
44213022|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213023|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213024|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213025|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213026|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617116|NCT03142360|Beraprost|beraprost|mesh-list
44213052|NCT00451074|Gentamicins|gentamicins|mesh-list
44213053|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213054|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213055|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44213056|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213057|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213058|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
44213059|NCT00451100|Neostigmine|neostigmine|mesh-list
44213060|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44213061|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617159|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
44213097|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44213098|NCT00451139|Analgesics|analgesics|mesh-ancestor
44284290|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284291|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284293|NCT00750113|Nifedipine|nifedipine|mesh-list
44284294|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44284295|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44284296|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44284297|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284298|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44284299|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44284300|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284301|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284302|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284303|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
44284304|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464073|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213099|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
44213100|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213125|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
44213126|NCT00451386|Ertapenem|ertapenem|mesh-list
44213127|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213128|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213129|NCT00451399|Metformin|metformin|mesh-list
44213130|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213131|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213132|NCT00451412|Heparin|heparin|mesh-list
44213133|NCT00451412|Calcium heparin|calcium heparin|mesh-list
44213134|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44213135|NCT00451412|Tinzaparin|tinzaparin|mesh-list
44213136|NCT00451412|Dalteparin|dalteparin|mesh-list
44213137|NCT00451412|Certoparin|certoparin|mesh-list
44213138|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
44213139|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44213140|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44213141|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213142|NCT00451490|S 20098|s 20098|mesh-list
44213143|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44213144|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213145|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213146|NCT00451568|Metformin|metformin|mesh-list
44213147|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213148|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213149|NCT00451594|Dexamethasone|dexamethasone|mesh-list
44213150|NCT00451594|Prednisolone|prednisolone|mesh-list
44213151|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213152|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
44213177|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213178|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213179|NCT00451711|Amphotericin B|amphotericin b|mesh-list
44213180|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44213181|NCT00451711|Amebicides|amebicides|mesh-ancestor
44213182|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44213183|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44213184|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213185|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213186|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
44213187|NCT00451724|Ketamine|ketamine|mesh-list
44213188|NCT00451724|Analgesics|analgesics|mesh-ancestor
44213189|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
44213190|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464074|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
44464075|NCT01500213|Hormones|hormones|mesh-ancestor
44464076|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464077|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464078|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284305|NCT00750126|Fludarabine|fludarabine|mesh-list
44284306|NCT00750126|Busulfan|busulfan|mesh-list
44284307|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
44284308|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284309|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284310|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284311|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
44213191|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868152|NCT00869232|Melphalan|melphalan|mesh-list
44213192|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44213193|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44213194|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
44213196|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213197|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44213198|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44213199|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213200|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213201|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
44213226|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213227|NCT00451828|Simvastatin|simvastatin|mesh-list
44213228|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213229|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213230|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
44213231|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213232|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213233|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213234|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213235|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
44213236|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44213237|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213238|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44213239|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
44213240|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213241|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213242|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213243|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213244|NCT00451880|Famotidine|famotidine|mesh-list
44213245|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44213246|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213247|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44213248|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
44213274|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213275|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
44213276|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213277|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213278|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213279|NCT00452062|Dexamethasone|dexamethasone|mesh-list
44213280|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213281|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
44213282|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
44213283|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213284|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213285|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213286|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
44213287|NCT00452062|Hormones|hormones|mesh-ancestor
44213288|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213289|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44284312|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284313|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
44284314|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44284315|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44284316|NCT00750178|Vorinostat|vorinostat|mesh-list
44284317|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667994|NCT04326673|Testosterone|testosterone|mesh-list
44213290|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213291|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44213292|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213293|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213294|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213295|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213296|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
44213317|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213319|NCT00452244|Simvastatin|simvastatin|mesh-list
44213320|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213321|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213322|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
44213323|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213324|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213325|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213326|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213327|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213328|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213329|NCT00452270|Xylometazoline|xylometazoline|mesh-list
44213330|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
44213331|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44213332|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
44213333|NCT00452296|Insulin|insulin|mesh-list
44213334|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213335|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213336|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
44213337|NCT00452322|Testosterone|testosterone|mesh-list
44213338|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
44213339|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
44213340|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44213341|NCT00452322|Androgens|androgens|mesh-ancestor
44213342|NCT00452322|Hormones|hormones|mesh-ancestor
44213343|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213344|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759711|NCT02447666|Azacitidine|azacitidine|mesh-list
44213345|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44213346|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213347|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
44213348|NCT00452556|Docetaxel|docetaxel|mesh-list
44213349|NCT00452556|Leuprolide|leuprolide|mesh-list
44213350|NCT00452556|Androgens|androgens|mesh-list
44213374|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44213375|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213376|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213377|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
44213378|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
44213379|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213380|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213381|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44213382|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44213383|NCT00452569|Growth Substances|growth substances|mesh-ancestor
44213384|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44213385|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
44213386|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
44213387|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44213388|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44213389|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213390|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213391|NCT00452582|Urological Agents|urological agents|mesh-ancestor
44213392|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44213393|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44213394|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44284318|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44284319|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213395|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44213396|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213397|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213398|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213399|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
44456711|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456712|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44456713|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44456714|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456716|NCT01624662|Xhance|xhance|mesh-list
44456717|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456718|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456719|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
44456743|NCT01624090|Plicamycin|plicamycin|mesh-list
44456744|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44456745|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456746|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44456747|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456748|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44456749|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456750|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456751|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44456752|NCT01623752|Etanercept|etanercept|mesh-list
44456753|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44456754|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456755|NCT01623752|Analgesics|analgesics|mesh-ancestor
44456756|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
44456757|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456758|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456759|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456760|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456761|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44456762|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456763|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
44456764|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44456765|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44456766|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213430|NCT00452829|Folic Acid|folic acid|mesh-list
44213431|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
44213432|NCT00452829|Inositol|inositol|mesh-list
44213433|NCT00452829|Hematinics|hematinics|mesh-ancestor
44213434|NCT00452829|Vitamins|vitamins|mesh-ancestor
44213435|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
43617589|NCT03138356|Metformin|metformin|mesh-list
44213472|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
44213473|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
44213474|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44213475|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
43617645|NCT03137134|Crizotinib|crizotinib|mesh-list
44213506|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44213507|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
44213508|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213509|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213510|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
44213511|NCT00453076|Paclitaxel|paclitaxel|mesh-list
44213512|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44213513|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213514|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213515|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213516|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213517|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213518|NCT00453115|Gemcitabine|gemcitabine|mesh-list
44213519|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
44213520|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43617679|NCT03137186|Metformin|metformin|mesh-list
44213550|NCT00453167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213551|NCT00453167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213552|NCT00453167|Immunologic Factors|immunologic factors|mesh-ancestor
44213553|NCT00453167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213554|NCT00453232|Cisplatin|cisplatin|mesh-list
44213555|NCT00453232|Etoposide|etoposide|mesh-list
44213556|NCT00453232|Bleomycin|bleomycin|mesh-list
44284320|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284321|NCT00750217|Buprenorphine|buprenorphine|mesh-list
44284322|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44284323|NCT00750217|Narcotics|narcotics|mesh-ancestor
44284324|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284325|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284326|NCT00750217|Analgesics|analgesics|mesh-ancestor
44213557|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213558|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44213559|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44213560|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44213561|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213562|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213563|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44213564|NCT00453323|Paclitaxel|paclitaxel|mesh-list
44213565|NCT00453323|Capecitabine|capecitabine|mesh-list
43617737|NCT03136705|Niacinamide|niacinamide|mesh-list
44213627|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44213628|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44213629|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44213630|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
44213631|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213632|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213633|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44213634|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44213635|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213636|NCT00453778|Fluticasone|fluticasone|mesh-list
44213637|NCT00453778|Xhance|xhance|mesh-list
44213638|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213639|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44213640|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
44213641|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213642|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213643|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44213644|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
44213645|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
44213646|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44213677|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44213678|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44213679|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
44213680|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44213681|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213682|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44213683|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44213684|NCT00454168|Sargramostim|sargramostim|mesh-list
44213685|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
44213686|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213687|NCT00454233|Metformin|metformin|mesh-list
44213688|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213689|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213690|NCT00454259|Fentanyl|fentanyl|mesh-list
44213691|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44213692|NCT00454259|Narcotics|narcotics|mesh-ancestor
44213728|NCT00454480|Fludarabine|fludarabine|mesh-list
44213729|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
44213730|NCT00454480|Azacitidine|azacitidine|mesh-list
44213731|NCT00454480|Melphalan|melphalan|mesh-list
44213732|NCT00454480|Busulfan|busulfan|mesh-list
44213733|NCT00454480|Daunorubicin|daunorubicin|mesh-list
44213759|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213760|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44213761|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
44213762|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213763|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44213764|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213766|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213767|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213768|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
44284327|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
44284328|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284329|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44284331|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213769|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213770|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213771|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213772|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213773|NCT00454558|Riociguat|riociguat|mesh-list
44213774|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
44213775|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456767|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456768|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
44456769|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456770|NCT01623310|Fluticasone|fluticasone|mesh-list
44456771|NCT01623310|Xhance|xhance|mesh-list
44456772|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456773|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456774|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
44456775|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456801|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868803|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
44213778|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44213779|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44213780|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44213781|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44213782|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213783|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44213784|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213785|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
44213786|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44213787|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44213788|NCT00454701|Alefacept|alefacept|mesh-list
44213789|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44213790|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
44213791|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213792|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
44213793|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
44213794|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44213795|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44213796|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213797|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213820|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213821|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213822|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213823|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44213824|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44213825|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213826|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44213827|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44213828|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
44213829|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
44213830|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44213831|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44213832|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
44213833|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213834|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213835|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213836|NCT00454896|Urological Agents|urological agents|mesh-ancestor
44213837|NCT00454961|Lumefantrine|lumefantrine|mesh-list
44213838|NCT00454961|Artemether|artemether|mesh-list
44213839|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44213840|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
44213841|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44213842|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44213843|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213844|NCT00455026|Remifentanil|remifentanil|mesh-list
44284332|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
44284333|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284334|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284335|NCT00750347|Acetaminophen|acetaminophen|mesh-list
44284336|NCT00750347|Rimonabant|rimonabant|mesh-list
44284337|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284338|NCT00750347|Analgesics|analgesics|mesh-ancestor
44284339|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
44284340|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284341|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284342|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
44284343|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44213845|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44213846|NCT00455026|Narcotics|narcotics|mesh-ancestor
44213847|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213848|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213849|NCT00455026|Analgesics|analgesics|mesh-ancestor
44213850|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
43618035|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44213885|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213886|NCT00455234|Promethazine|promethazine|mesh-list
44213887|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
44213888|NCT00455234|Haloperidol|haloperidol|mesh-list
44213889|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
44213890|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
44213891|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
44213929|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
43671594|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43671631|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
43671632|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43671662|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43671663|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671664|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43671665|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43671666|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43671667|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671703|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
43671704|NCT04090775|Nivolumab|nivolumab|mesh-list
43671705|NCT04090775|Ipilimumab|ipilimumab|mesh-list
43671706|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671707|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
43671733|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43671734|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213956|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213958|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
44213959|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213960|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44213961|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44213962|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213963|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213964|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44213965|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
44213966|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213967|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213968|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44213969|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
44213970|NCT00455416|Selenium|selenium|mesh-list
44213971|NCT00455416|Allicin|allicin|mesh-list
44213972|NCT00455416|Resveratrol|resveratrol|mesh-list
44213973|NCT00455416|Quercetin|quercetin|mesh-list
44213974|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
44213975|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214007|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44214008|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
44214009|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214010|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214011|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214012|NCT00455572|Cisplatin|cisplatin|mesh-list
44214013|NCT00455572|Vinorelbine|vinorelbine|mesh-list
44214014|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214015|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44214016|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
44214036|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214037|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214039|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44214040|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44214041|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44214042|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43799098|NCT05013164|Protective Agents|protective agents|mesh-ancestor
44284344|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44284345|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44284346|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284347|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214043|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214044|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44214045|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214046|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214047|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44214048|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214049|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
44214050|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
44214051|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43644819|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
43671735|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43671736|NCT03993132|Hormones|hormones|mesh-ancestor
43671738|NCT03993132|Incretins|incretins|mesh-ancestor
44214052|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44214053|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214054|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214055|NCT00455715|Urological Agents|urological agents|mesh-ancestor
44214056|NCT00455754|Esomeprazole|esomeprazole|mesh-list
44214057|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44214058|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214059|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44214060|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214061|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214062|NCT00455806|Amoxicillin|amoxicillin|mesh-list
44214063|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
44214064|NCT00455806|Esomeprazole|esomeprazole|mesh-list
44214065|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214066|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214067|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44214068|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44214069|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214070|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618264|NCT03132493|Nivolumab|nivolumab|mesh-list
44214098|NCT00455897|Rituximab|rituximab|mesh-list
44214099|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214100|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214101|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
44214102|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214103|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44214104|NCT00455910|Thalidomide|thalidomide|mesh-list
44214105|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214106|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
44214107|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214108|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
44214109|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214110|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214111|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214112|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214113|NCT00455910|Growth Substances|growth substances|mesh-ancestor
44214114|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214115|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214116|NCT00455936|Gefitinib|gefitinib|mesh-list
44214117|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618365|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
44214182|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214183|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44214184|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214185|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44214186|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214187|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214188|NCT00456430|Citalopram|citalopram|mesh-list
44214189|NCT00456430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44214190|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214191|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214192|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671840|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671841|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43671843|NCT03635333|Nicotine|nicotine|mesh-list
44214193|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214194|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
44214195|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284349|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284350|NCT00750386|Paclitaxel|paclitaxel|mesh-list
44284351|NCT00750386|Carboplatin|carboplatin|mesh-list
44284352|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44214196|NCT00456430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214197|NCT00456430|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214198|NCT00456430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456802|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618401|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44456822|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44456823|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
44456824|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
44456825|NCT01622673|Protective Agents|protective agents|mesh-ancestor
44456826|NCT01622660|Gemcitabine|gemcitabine|mesh-list
44214199|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44214200|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214201|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
44214202|NCT00456482|Hormones|hormones|mesh-ancestor
44214203|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214204|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214205|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
44214206|NCT00456560|Paroxetine|paroxetine|mesh-list
44214207|NCT00456560|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44214208|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214209|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214210|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214211|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214212|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
44214213|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214214|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214215|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214216|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214217|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44214218|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44214219|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214220|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44214221|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214222|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214223|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44214224|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44214225|NCT00456586|Istradefylline|istradefylline|mesh-list
44214226|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44214257|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214258|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44214259|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214260|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214261|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214262|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
44214263|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214264|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214265|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44214266|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44214267|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214300|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214301|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214302|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44214303|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44214304|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214332|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44214333|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
44214334|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214335|NCT00456976|Selegiline|selegiline|mesh-list
44214336|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214337|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214338|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44214339|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43799312|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44284353|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284354|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
44284355|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
44284356|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
44284357|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284358|NCT00750399|Ranibizumab|ranibizumab|mesh-list
44284359|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44284360|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44284361|NCT00750399|Growth Substances|growth substances|mesh-ancestor
44284362|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284363|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284364|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284366|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284367|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284368|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214340|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43869310|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214341|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214342|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214343|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44214344|NCT00456976|Protective Agents|protective agents|mesh-ancestor
44214345|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214346|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
44214347|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214369|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214370|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214371|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214373|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214374|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214375|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214376|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44214377|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
44214378|NCT00457106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44214379|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214380|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214381|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214382|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214383|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44214384|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44214385|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672292|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672293|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
43672315|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672317|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672318|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44214386|NCT00457119|Everolimus|everolimus|mesh-list
44214387|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214388|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214389|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
44214390|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214391|NCT00457145|Ranibizumab|ranibizumab|mesh-list
44214392|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214393|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214394|NCT00457145|Growth Substances|growth substances|mesh-ancestor
44214395|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214396|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214397|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214398|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44214399|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
44214400|NCT00457223|Coagulants|coagulants|mesh-ancestor
44214426|NCT00457483|Diuretics|diuretics|mesh-ancestor
44214427|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
44284369|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214428|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214429|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44214430|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214431|NCT00457509|Vaccines|vaccines|mesh-list
44214432|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
44214433|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214434|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44214435|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44214436|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44214437|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
44214438|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214439|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44214440|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44214441|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214442|NCT00457678|Dexamethasone|dexamethasone|mesh-list
44214443|NCT00457678|Ranibizumab|ranibizumab|mesh-list
44214444|NCT00457678|Verteporfin|verteporfin|mesh-list
44214445|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214446|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
44214447|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
43618694|NCT03130270|Apatinib|apatinib|mesh-list
44214465|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44214467|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214468|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214469|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44214470|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
44214471|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
44214472|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
44214473|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44214474|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44214475|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
44214476|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214477|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214478|NCT00457769|Donepezil|donepezil|mesh-list
43672319|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214479|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44214480|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214481|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214482|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
44214483|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214484|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214485|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
44214486|NCT00457808|Sirolimus|sirolimus|mesh-list
44214487|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214488|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214489|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44214490|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214491|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
44214492|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214493|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
44214494|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672333|NCT02372578|Pregabalin|pregabalin|mesh-list
43672334|NCT02372578|Analgesics|analgesics|mesh-ancestor
43672335|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
43672336|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672337|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672338|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
44214495|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
44214496|NCT00457860|Immunotoxins|immunotoxins|mesh-list
44214497|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
43672339|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44214498|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214499|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214500|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44214501|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214502|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214503|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44214504|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214529|NCT00458081|Rimonabant|rimonabant|mesh-list
44214530|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44214531|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44214532|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44214533|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214534|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214535|NCT00458081|Hormones|hormones|mesh-ancestor
44214536|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214537|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214538|NCT00458185|Etanercept|etanercept|mesh-list
44214539|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284371|NCT00750451|Enoxaparin|enoxaparin|mesh-list
44284372|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44284373|NCT00750451|Tinzaparin|tinzaparin|mesh-list
44284374|NCT00750451|Dalteparin|dalteparin|mesh-list
44214540|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44214541|NCT00458185|Analgesics|analgesics|mesh-ancestor
44214542|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
44214543|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214544|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214545|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214546|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44214547|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214548|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214549|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
44456827|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44456828|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
44456829|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456830|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456831|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
43618812|NCT03128346|Aspirin|aspirin|mesh-list
44214609|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214610|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214611|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214612|NCT00458367|Risperidone|risperidone|mesh-list
44214613|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44214614|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
44214615|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618885|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
44214644|NCT00458510|Fentanyl|fentanyl|mesh-list
44214645|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44214646|NCT00458510|Narcotics|narcotics|mesh-ancestor
44214647|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214648|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214649|NCT00458510|Analgesics|analgesics|mesh-ancestor
44214650|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
44214651|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214652|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44214653|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44214654|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
44214655|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
44214656|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
44214657|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214658|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214659|NCT00458614|Lansoprazole|lansoprazole|mesh-list
44214660|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
44214661|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44214662|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214663|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44214710|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214712|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44214713|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
44214714|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214715|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
44214716|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
44214717|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44214718|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44214719|NCT00459004|Rimonabant|rimonabant|mesh-list
44214720|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44214721|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44214722|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44214723|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214724|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214725|NCT00459004|Hormones|hormones|mesh-ancestor
44214726|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214727|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214728|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
44214729|NCT00459173|Rimonabant|rimonabant|mesh-list
44214730|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44214731|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44214732|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44214733|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214734|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284375|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
44284376|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
44284377|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44284378|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44214735|NCT00459173|Hormones|hormones|mesh-ancestor
44214736|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214737|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214738|NCT00459264|Folic Acid|folic acid|mesh-list
44214739|NCT00459264|Hematinics|hematinics|mesh-ancestor
44214740|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
44214741|NCT00459264|Vitamins|vitamins|mesh-ancestor
44214742|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
44214743|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214744|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44214745|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
44214746|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214747|NCT00459407|Protective Agents|protective agents|mesh-ancestor
44214748|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214749|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44214750|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44214751|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214752|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44214773|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869714|NCT04776226|Citalopram|citalopram|mesh-list
44214774|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44214775|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44214776|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44214777|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214778|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214779|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44214780|NCT00459615|Artesunate|artesunate|mesh-list
44214781|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
44214782|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44214783|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44214784|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214785|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214786|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
44214787|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
44214788|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44214789|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
44214790|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44214791|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214792|NCT00459719|Tacrolimus|tacrolimus|mesh-list
44214793|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214794|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
44214795|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214796|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44214797|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214798|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214799|NCT00459771|Candesartan|candesartan|mesh-list
44214800|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44214801|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44214802|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44214803|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214804|NCT00459836|Gemcitabine|gemcitabine|mesh-list
44214805|NCT00459836|Docetaxel|docetaxel|mesh-list
44214806|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44214807|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
43619052|NCT03126461|Ipilimumab|ipilimumab|mesh-list
44214820|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44214821|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44214822|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
43673091|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673092|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
44214823|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214824|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214825|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44214826|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214827|NCT00459940|Pioglitazone|pioglitazone|mesh-list
44214828|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44214829|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214830|NCT00459992|Betahistine|betahistine|mesh-list
44214831|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44214832|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
44284379|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284380|NCT00750529|Donepezil|donepezil|mesh-list
44284381|NCT00750529|Galantamine|galantamine|mesh-list
44214833|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
44214834|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214835|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214836|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214837|NCT00460057|Alendronate|alendronate|mesh-list
44214838|NCT00460057|Diphosphonates|diphosphonates|mesh-list
44214839|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44214840|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214841|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
44214842|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44214843|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44214844|NCT00460083|Analgesics|analgesics|mesh-ancestor
44214845|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
44214846|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214847|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214848|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214849|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44214850|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
43673093|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
44214851|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214852|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
44214853|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44214854|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214855|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214856|NCT00460148|Ropinirole|ropinirole|mesh-list
44214857|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44214858|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44214859|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
44214860|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
44214861|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214862|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214863|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214864|NCT00460174|Gemcitabine|gemcitabine|mesh-list
44214865|NCT00460174|Bevacizumab|bevacizumab|mesh-list
44214866|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214867|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214868|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214869|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214870|NCT00460174|Growth Substances|growth substances|mesh-ancestor
44214897|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44456842|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456843|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456844|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456845|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456847|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44456848|NCT01622231|Fluticasone|fluticasone|mesh-list
44456849|NCT01622231|Xhance|xhance|mesh-list
44456850|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456851|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456852|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
44456853|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456854|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456855|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456856|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456857|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456858|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44456859|NCT01622088|Pramipexole|pramipexole|mesh-list
44214903|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214905|NCT00460369|Lumefantrine|lumefantrine|mesh-list
44214906|NCT00460369|Artemether|artemether|mesh-list
44214907|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
44214908|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
44214909|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44214910|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44214911|NCT00460369|Amodiaquine|amodiaquine|mesh-list
44214912|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
44214913|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44214914|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44214915|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214916|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214917|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
44284382|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44284383|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214918|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
44214919|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44214920|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
44214921|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44214922|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214923|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214924|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44214925|NCT00460369|Renal Agents|renal agents|mesh-ancestor
44214926|NCT00460382|Ritonavir|ritonavir|mesh-list
44214927|NCT00460382|Darunavir|darunavir|mesh-list
44214928|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
44214929|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
44214930|NCT00460382|Etravirine|etravirine|mesh-list
44214931|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44214932|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44214933|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
44214934|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214935|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214936|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44214937|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44214938|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
44214939|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214940|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44214941|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44214942|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44214943|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44214944|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44214945|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44214946|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44214947|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44214948|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
44214949|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214950|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214951|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
44214952|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44214953|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214954|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214969|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44214970|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214971|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44214972|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44214973|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214974|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214975|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214976|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214977|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44214978|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44214979|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
44214980|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214981|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214982|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44214983|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44214984|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
44214985|NCT00460616|Cabergoline|cabergoline|mesh-list
44214986|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44214987|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44214988|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
44214989|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
44214990|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214991|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214992|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214993|NCT00460642|Cetrorelix|cetrorelix|mesh-list
44214994|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44214995|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
44214996|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44214997|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214998|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
44214999|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215000|NCT00460681|Thymopentin|thymopentin|mesh-list
44215001|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44284384|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284385|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
44284386|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668058|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
44215002|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
44215003|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215004|NCT00460707|Ketoconazole|ketoconazole|mesh-list
44215005|NCT00460707|Casopitant|casopitant|mesh-list
44215006|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
44215007|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215008|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44215009|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44215010|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215011|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215012|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44215013|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619279|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215030|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44215031|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44215032|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44215033|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215034|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215035|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
44215036|NCT00460759|Rifapentine|rifapentine|mesh-list
44215037|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215038|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215039|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44215040|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215041|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215042|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215043|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215044|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44215045|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
44215046|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
44215047|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
43869947|NCT04771026|Hormones|hormones|mesh-ancestor
44215048|NCT00460785|Narcotics|narcotics|mesh-ancestor
44215049|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215050|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215051|NCT00460785|Analgesics|analgesics|mesh-ancestor
44215052|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
44215053|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215054|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
44215055|NCT00460837|Cathartics|cathartics|mesh-ancestor
44215056|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215057|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44215058|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
44215059|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215060|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
44215061|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44215062|NCT00460876|Topotecan|topotecan|mesh-list
44215063|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44215064|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215065|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215066|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215067|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215068|NCT00460915|Amlodipine|amlodipine|mesh-list
44215069|NCT00460915|Lacidipine|lacidipine|mesh-list
44215070|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44215071|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43619336|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
44215080|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44215081|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44215082|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
44215083|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215085|NCT00460954|Carbidopa|carbidopa|mesh-list
44215086|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44215087|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44215088|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44215089|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
44215090|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284387|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284388|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
44284389|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44284390|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
44215091|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215092|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215093|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44215094|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215095|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44215096|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
44215097|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
44215098|NCT00461084|Clarithromycin|clarithromycin|mesh-list
44215099|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215100|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215101|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44215102|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215103|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215104|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44215105|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44215106|NCT00461149|Octreotide|octreotide|mesh-list
44215107|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215108|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44215109|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215110|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44215111|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
44215112|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
44215113|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215114|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43674263|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
43674264|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215115|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44215116|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674510|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43674511|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43674515|NCT02893371|Analgesics|analgesics|mesh-ancestor
44215117|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44215118|NCT00461344|Docetaxel|docetaxel|mesh-list
44215119|NCT00461344|Doxorubicin|doxorubicin|mesh-list
44215120|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215121|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
44215122|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870030|NCT05606107|Hormones|hormones|mesh-ancestor
44215123|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215124|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215125|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44215126|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44215127|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215128|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215129|NCT00461396|Interferons|interferons|mesh-list
44215130|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
44215131|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215132|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
44215133|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215134|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44215135|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
44215136|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215159|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44215160|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
44215161|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44215162|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215163|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215164|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
44215165|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215166|NCT00461617|Mitiglinide|mitiglinide|mesh-list
44215167|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215168|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215169|NCT00461643|Metformin|metformin|mesh-list
44215170|NCT00461643|Citric Acid|citric acid|mesh-list
44215171|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
44215172|NCT00461643|Clomiphene|clomiphene|mesh-list
44215173|NCT00461643|Enclomiphene|enclomiphene|mesh-list
44215174|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
44215175|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215176|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215177|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
44215178|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44215179|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
44215180|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
44284391|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284392|NCT00750581|Indomethacin|indomethacin|mesh-list
44215181|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215182|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44215183|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
44215184|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215185|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44215186|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
44215187|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215188|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44215189|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44215190|NCT00461747|Thalidomide|thalidomide|mesh-list
44215191|NCT00461747|Dexamethasone|dexamethasone|mesh-list
44215202|NCT00461747|Hormones|hormones|mesh-ancestor
44215203|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215204|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44215205|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215206|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
44215207|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215208|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215209|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215210|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
44215211|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
44215212|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215213|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43675187|NCT02886195|Cisplatin|cisplatin|mesh-list
43675188|NCT02886195|Pemetrexed|pemetrexed|mesh-list
43675189|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43675190|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215214|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44215215|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44215216|NCT00461747|Growth Substances|growth substances|mesh-ancestor
44215217|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44215218|NCT00461799|Orlistat|orlistat|mesh-list
44215219|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215220|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215221|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44215222|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44215223|NCT00461825|Cyclosporine|cyclosporine|mesh-list
44215224|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
44215225|NCT00461825|Azathioprine|azathioprine|mesh-list
44215226|NCT00461825|Cyclosporins|cyclosporins|mesh-list
44215227|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215228|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215229|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215230|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
44215231|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215232|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
44215233|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215234|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
44215235|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44215236|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44215237|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44215238|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215239|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44215240|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
44215241|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215242|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
44215243|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215244|NCT00461890|Naltrexone|naltrexone|mesh-list
44215245|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44215246|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44215247|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215248|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
44215249|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215250|NCT00461903|Perindopril|perindopril|mesh-list
44215251|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44215252|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44215253|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215254|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215255|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44215256|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44215257|NCT00461916|Buserelin|buserelin|mesh-list
44215258|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
44215273|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215274|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44284393|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284394|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284395|NCT00750581|Analgesics|analgesics|mesh-ancestor
44215275|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44215276|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215277|NCT00462111|Indomethacin|indomethacin|mesh-list
44215278|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44215279|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44215280|NCT00462111|Analgesics|analgesics|mesh-ancestor
44215281|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
44215282|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215283|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215284|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215285|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44215286|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
44215287|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
44215288|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215289|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44215290|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215291|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456867|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
44456868|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456869|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
44456870|NCT01621880|Bevacizumab|bevacizumab|mesh-list
44456871|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44456872|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456873|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44456874|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44456875|NCT01621880|Growth Substances|growth substances|mesh-ancestor
44456876|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456877|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456878|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456879|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
44456880|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
44456881|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456882|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44456883|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
43675297|NCT02885454|Odalasvir|odalasvir|mesh-list
43675359|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456885|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456886|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44456887|NCT01621880|Protective Agents|protective agents|mesh-ancestor
44456888|NCT01621568|Sunitinib|sunitinib|mesh-list
44456889|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456890|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44456891|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44456892|NCT01621568|Growth Substances|growth substances|mesh-ancestor
44456893|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456894|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
43619579|NCT03121573|Analgesics|analgesics|mesh-ancestor
44456909|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456910|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456911|NCT01621191|Analgesics|analgesics|mesh-ancestor
44456912|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
44456913|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456914|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
44456915|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456916|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
44456918|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44456919|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
44456920|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
44456921|NCT01621178|Dulaglutide|dulaglutide|mesh-list
44456922|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456923|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215292|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
44215293|NCT00462189|Immunotoxins|immunotoxins|mesh-list
44215294|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
44215295|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215296|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215297|NCT00462215|Vaccines|vaccines|mesh-list
44215298|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
44215299|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215300|NCT00462358|Filanesib|filanesib|mesh-list
44215301|NCT00462358|Lenograstim|lenograstim|mesh-list
44215302|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44284396|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
44284397|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675360|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44284398|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284399|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284400|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44215303|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
44215304|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215305|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215306|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215307|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215308|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215309|NCT00462371|Insulin|insulin|mesh-list
44215310|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215311|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827593|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827594|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675591|NCT02883023|Bleomycin|bleomycin|mesh-list
43675592|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44215312|NCT00462397|Paclitaxel|paclitaxel|mesh-list
44215313|NCT00462397|Cisplatin|cisplatin|mesh-list
44215314|NCT00462397|Carboplatin|carboplatin|mesh-list
44215315|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44215316|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215317|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
43675593|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215318|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215319|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215320|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215321|NCT00462475|Hormones|hormones|mesh-list
44215337|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215338|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215339|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215340|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
43675594|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43675595|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44215341|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
44215342|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215343|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44215344|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
44215345|NCT00462553|Gemcitabine|gemcitabine|mesh-list
44215346|NCT00462553|Sunitinib|sunitinib|mesh-list
44215347|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215348|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
44215349|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215350|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215351|NCT00462553|Antiviral Agents|antiviral agents|mesh-ancestor
44215352|NCT00462553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215353|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215354|NCT00462553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215355|NCT00462553|Immunologic Factors|immunologic factors|mesh-ancestor
44215356|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215357|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44215358|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44215359|NCT00462553|Growth Substances|growth substances|mesh-ancestor
44215360|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
44215361|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44215362|NCT00462592|Budesonide|budesonide|mesh-list
44215363|NCT00462592|Montelukast|montelukast|mesh-list
44215364|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215365|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44215366|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
44215367|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215368|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215369|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44215370|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
44215371|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
44215372|NCT00462592|Hormones|hormones|mesh-ancestor
44215373|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215374|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44215375|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
44215376|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44215377|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44215378|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215379|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44215380|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
44215397|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284401|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
44284402|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
44215399|NCT00462696|Epirubicin|epirubicin|mesh-list
44215400|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215401|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44215402|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215403|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215404|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215405|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44215406|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44215407|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215408|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215409|NCT00462787|Dexamethasone|dexamethasone|mesh-list
44215410|NCT00462787|Topotecan|topotecan|mesh-list
44215411|NCT00462787|Vinorelbine|vinorelbine|mesh-list
44215412|NCT00462787|Thiotepa|thiotepa|mesh-list
44215413|NCT00462787|Clofarabine|clofarabine|mesh-list
44215414|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215415|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
44215416|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
44215417|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215418|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215419|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215420|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
44215421|NCT00462787|Hormones|hormones|mesh-ancestor
44215422|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215423|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44215424|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215425|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
44215426|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44215427|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215428|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215429|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215430|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44215431|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44215432|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215433|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215434|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44215435|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
44215436|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44215437|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215438|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215439|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
44215458|NCT00462852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215460|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44215461|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44215462|NCT00462878|Vancomycin|vancomycin|mesh-list
44215463|NCT00462878|Meropenem|meropenem|mesh-list
44215464|NCT00462878|Teicoplanin|teicoplanin|mesh-list
44215465|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215466|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215467|NCT00462956|Lapatinib|lapatinib|mesh-list
44215468|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215469|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44215470|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215471|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215472|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44215473|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215474|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44215475|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215476|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676012|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
43676013|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676014|NCT02879292|Anesthetics|anesthetics|mesh-list
44215477|NCT00463008|Methotrexate|methotrexate|mesh-list
44215478|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44215479|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
44215480|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215481|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215482|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215483|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
44215484|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215485|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215486|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44215487|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284403|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284404|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44284405|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284406|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215488|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44215489|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215490|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
44215491|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44215492|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44215493|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44215495|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
44215496|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215527|NCT00463203|Irinotecan|irinotecan|mesh-list
44215528|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44215529|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215530|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44215531|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44215532|NCT00463203|Growth Substances|growth substances|mesh-ancestor
44215533|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215534|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44215535|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44215536|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215537|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215538|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215539|NCT00463268|Vitamin D|vitamin d|mesh-list
44215540|NCT00463268|Alendronate|alendronate|mesh-list
44215541|NCT00463268|Calcium|calcium|mesh-list
44215542|NCT00463268|Vitamins|vitamins|mesh-ancestor
44215543|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
44215566|NCT00463515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215567|NCT00463515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215568|NCT00463515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215569|NCT00463515|Immunologic Factors|immunologic factors|mesh-ancestor
44215570|NCT00463515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215571|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
44215572|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44215573|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44215574|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
44215575|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215576|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215577|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676015|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676293|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
43676294|NCT02877173|Urological Agents|urological agents|mesh-ancestor
44215578|NCT00463541|Urological Agents|urological agents|mesh-ancestor
44215579|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
44215580|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44215581|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
44215582|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215583|NCT00463671|Expectorants|expectorants|mesh-ancestor
44215584|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
44215585|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44215586|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
44215587|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215588|NCT00463671|Protective Agents|protective agents|mesh-ancestor
43676295|NCT02877277|Ascorbic Acid|ascorbic acid|mesh-list
44215589|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215590|NCT00463671|Antidotes|antidotes|mesh-ancestor
44215591|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
44215592|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44215593|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
44215594|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215595|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215596|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
44215597|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215609|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44215610|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215611|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215612|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44215613|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
44215614|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215615|NCT00463762|Sulbactam|sulbactam|mesh-list
44215616|NCT00463762|Cefoperazone|cefoperazone|mesh-list
44215617|NCT00463762|Sulperazone|sulperazone|mesh-list
44284407|NCT00750620|Mirabegron|mirabegron|mesh-list
44284408|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44215618|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215619|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215620|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44215621|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215622|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215623|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44215624|NCT00463762|Renal Agents|renal agents|mesh-ancestor
44215625|NCT00463775|Topiramate|topiramate|mesh-list
44215626|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
44215627|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215628|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215629|NCT00463827|Atorvastatin|atorvastatin|mesh-list
44215630|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44215631|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44215632|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
44215633|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215634|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44215635|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44215636|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215637|NCT00463879|Galantamine|galantamine|mesh-list
44215638|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44215639|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215640|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215641|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
44215642|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215643|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676296|NCT02877277|Vitamins|vitamins|mesh-ancestor
43676297|NCT02877277|Micronutrients|micronutrients|mesh-ancestor
44215644|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44215645|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
44215646|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215647|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
44215648|NCT00463918|Varenicline|varenicline|mesh-list
44215649|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44215650|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44215651|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
44215652|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215653|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215654|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215655|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
44215656|NCT00463957|Tadalafil|tadalafil|mesh-list
44215657|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
44215658|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44215659|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44215660|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619956|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44215668|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44215669|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215671|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44215672|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44215673|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44215674|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215675|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215676|NCT00464165|Hormones|hormones|mesh-ancestor
44215677|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215678|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456924|NCT01620489|Liraglutide|liraglutide|mesh-list
44456925|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456926|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456927|NCT01620489|Incretins|incretins|mesh-ancestor
44456928|NCT01620489|Hormones|hormones|mesh-ancestor
44456929|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456930|NCT01620177|Ethanol|ethanol|mesh-list
44456931|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44456932|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456933|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456934|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456935|NCT01620138|Cabergoline|cabergoline|mesh-list
44456936|NCT01620138|Pasireotide|pasireotide|mesh-list
44456937|NCT01620138|Hormones|hormones|mesh-ancestor
44456938|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284409|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44284410|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43668081|NCT04082650|Vitamin D|vitamin d|mesh-list
44456939|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456940|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44456941|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44456942|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
44456943|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
44456944|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456945|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456946|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44456947|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44456948|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43676416|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456949|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456950|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456951|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456952|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44456953|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44456954|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44456955|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
44456956|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456957|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456958|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44456959|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44456960|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
44456961|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44456962|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44456963|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
44456964|NCT01619878|Lumefantrine|lumefantrine|mesh-list
43676632|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456965|NCT01619878|Artemether|artemether|mesh-list
44456966|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44456967|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
44456968|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44456969|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44456970|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456971|NCT01619865|Edotreotide|edotreotide|mesh-list
44456988|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
44456989|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44215679|NCT00464191|Citalopram|citalopram|mesh-list
44215680|NCT00464191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44215681|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44215682|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215683|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215684|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215685|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
44215686|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215687|NCT00464191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44215688|NCT00464191|Antidepressive Agents|antidepressive agents|mesh-ancestor
44215689|NCT00464191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44215690|NCT00464217|Idarubicin|idarubicin|mesh-list
44215691|NCT00464217|Molgramostim|molgramostim|mesh-list
44215692|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44215693|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215694|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44215695|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215696|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215697|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215698|NCT00464256|Rimonabant|rimonabant|mesh-list
44215699|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44215700|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44215701|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43827704|NCT05486481|Daratumumab|daratumumab|mesh-list
43676890|NCT02872389|Desflurane|desflurane|mesh-list
43676891|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44215702|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215703|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215704|NCT00464256|Hormones|hormones|mesh-ancestor
44215705|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215706|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215707|NCT00464295|Capecitabine|capecitabine|mesh-list
44215708|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215709|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
44215710|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215711|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284411|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
44284412|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284413|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215712|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44215713|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
44215714|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215715|NCT00464347|Triamcinolone|triamcinolone|mesh-list
44215727|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215728|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
44215729|NCT00464347|Hormones|hormones|mesh-ancestor
44215730|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215731|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215732|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
44215733|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215734|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215735|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
44215736|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44215737|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44215738|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44215739|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215740|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215741|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
43676892|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44215742|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215743|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215744|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44215745|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43676893|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
43676894|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
43676895|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676896|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827720|NCT05486104|Hemay005|hemay005|mesh-list
44215746|NCT00464399|Everolimus|everolimus|mesh-list
44215747|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215748|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215749|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
44215750|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215751|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
44215752|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
44215753|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44215754|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215755|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215756|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44215757|NCT00464451|Analgesics|analgesics|mesh-ancestor
44215758|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
44215759|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215760|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44215761|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44215762|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44215763|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215764|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215765|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215766|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44215767|NCT00464503|Pravastatin|pravastatin|mesh-list
44215768|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44215769|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44215770|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
44215771|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215772|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44215773|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44215774|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215775|NCT00464594|Metformin|metformin|mesh-list
44215776|NCT00464594|Acarbose|acarbose|mesh-list
44215777|NCT00464594|Gliclazide|gliclazide|mesh-list
44215778|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215797|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
44215798|NCT00464789|Estrogens|estrogens|mesh-list
44215799|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44215800|NCT00464789|Hormones|hormones|mesh-ancestor
44215801|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215802|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215803|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44215804|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44215805|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
44215806|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44215807|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
44215808|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44284414|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284415|NCT00750620|Urological Agents|urological agents|mesh-ancestor
44284416|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
44284417|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44215809|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215810|NCT00464893|Catumaxomab|catumaxomab|mesh-list
44215811|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44215812|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215813|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
44215814|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215815|NCT00464919|Sorafenib|sorafenib|mesh-list
44215816|NCT00464919|Tegafur|tegafur|mesh-list
44215817|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215818|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44215819|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215820|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215821|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215822|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
44215823|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44215824|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215825|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
44215826|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44215827|NCT00464932|Protective Agents|protective agents|mesh-ancestor
44215828|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215829|NCT00464958|Tizanidine|tizanidine|mesh-list
44215830|NCT00464958|Analgesics|analgesics|mesh-ancestor
44215831|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
44215832|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215863|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44215864|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44215865|NCT00465192|Estradiol|estradiol|mesh-list
44215866|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44215867|NCT00465192|Estrogens|estrogens|mesh-ancestor
44215868|NCT00465192|Hormones|hormones|mesh-ancestor
43677044|NCT02871193|Hormones|hormones|mesh-ancestor
43677328|NCT02868827|Vitamin D|vitamin d|mesh-list
43677349|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
43677350|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
43677351|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43677352|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677353|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
43677354|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43677355|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
43677356|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677357|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
43677358|NCT02868437|Protective Agents|protective agents|mesh-ancestor
43677359|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
43677360|NCT02868151|Vitamins|vitamins|mesh-ancestor
44215869|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215870|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215871|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44215872|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
44215873|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215874|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44215875|NCT00465205|Valacyclovir|valacyclovir|mesh-list
44215900|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215901|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44215902|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215904|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44215905|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44215906|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
44215907|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
44215908|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215909|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215911|NCT00465257|Amodiaquine|amodiaquine|mesh-list
44215912|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
44215913|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44215914|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44215915|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215916|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215917|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
44215918|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
44215919|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44215920|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
44215921|NCT00465283|Donepezil|donepezil|mesh-list
44215922|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44215923|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215924|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215925|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
44215926|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215927|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215928|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
44215929|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
44215930|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43620315|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
44215961|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44215963|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
44284418|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
44284419|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677361|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
43677362|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677363|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
43677366|NCT02868073|Vaccines|vaccines|mesh-list
44215964|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215965|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215966|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
44215967|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215968|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215969|NCT00465452|Protective Agents|protective agents|mesh-ancestor
44215970|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
43677368|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677369|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43677371|NCT02867956|Etoposide|etoposide|mesh-list
44215971|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44215972|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44215973|NCT00465543|Analgesics|analgesics|mesh-ancestor
44215974|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
43620365|NCT04677049|Vitamins|vitamins|mesh-ancestor
44216004|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216005|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216006|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216007|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44216008|NCT00465751|Cathartics|cathartics|mesh-ancestor
44216009|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216010|NCT00465907|Paclitaxel|paclitaxel|mesh-list
44216011|NCT00465907|Carboplatin|carboplatin|mesh-list
44216012|NCT00465907|Irinotecan|irinotecan|mesh-list
44216013|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44216014|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216015|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44216016|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44216017|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44216018|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216019|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44457021|NCT01618708|Protective Agents|protective agents|mesh-ancestor
44457022|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457023|NCT01618669|Regadenoson|regadenoson|mesh-list
44216022|NCT00466063|Deferasirox|deferasirox|mesh-list
44216023|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44216024|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
44216025|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
44216026|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216027|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
44216028|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
44216043|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216044|NCT00466128|Indomethacin|indomethacin|mesh-list
44216045|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216046|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216047|NCT00466128|Analgesics|analgesics|mesh-ancestor
44216048|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
44216049|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216050|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216051|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216052|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216053|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
44216054|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
44216055|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44216056|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44216057|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216058|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216059|NCT00466154|Aspirin|aspirin|mesh-list
44216060|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216061|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216062|NCT00466154|Analgesics|analgesics|mesh-ancestor
44216063|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
44216064|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216065|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216066|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216067|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216068|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44216069|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44216070|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216071|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44216072|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44216073|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216074|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
44216075|NCT00466180|Nevirapine|nevirapine|mesh-list
44284420|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
44284421|NCT00750724|Protective Agents|protective agents|mesh-ancestor
44284422|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
44284423|NCT00750763|Cathartics|cathartics|mesh-ancestor
44284424|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284425|NCT00750802|Lorazepam|lorazepam|mesh-list
44284426|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
44284427|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
44216076|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44216077|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44216078|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216079|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216080|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
44216081|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216082|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44216083|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44216084|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44216085|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44216086|NCT00466219|Interferons|interferons|mesh-list
44216087|NCT00466219|Ribavirin|ribavirin|mesh-list
44216088|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
44216110|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216111|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44216112|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216113|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216114|NCT00466388|Cevimeline|cevimeline|mesh-list
44216115|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44216116|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
44216117|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216118|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216119|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44216120|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44216121|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216122|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216123|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216124|NCT00466401|Simvastatin|simvastatin|mesh-list
44216125|NCT00466401|Ezetimibe|ezetimibe|mesh-list
44216126|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44216127|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44216128|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
44216129|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216130|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44216131|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44216132|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216133|NCT00466466|Everolimus|everolimus|mesh-list
44216134|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216135|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216136|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
44216137|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216138|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44216139|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216140|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44216141|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44216142|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44216205|NCT00466791|Methylphenidate|methylphenidate|mesh-list
44216206|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44216207|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216208|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44216209|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44216210|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44216211|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216212|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
44216213|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216214|NCT00466843|Prednisone|prednisone|mesh-list
44216215|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44216216|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216217|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
44216218|NCT00466843|Hormones|hormones|mesh-ancestor
43700719|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44284429|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284430|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284431|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284432|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44284433|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284434|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44284435|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44284436|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44284437|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
44284438|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
44284439|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284440|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284441|NCT00750997|Dextrans|dextrans|mesh-list
44284442|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
44284443|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
44284444|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
44216219|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216220|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216221|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44216222|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216223|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
44216224|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216244|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44216245|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216246|NCT00466999|Misoprostol|misoprostol|mesh-list
44216247|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44216248|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
44216249|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44216250|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216251|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44216252|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216253|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
44216255|NCT00467012|Bevacizumab|bevacizumab|mesh-list
44216256|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44216257|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216258|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44216259|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44216260|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44216261|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216262|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216263|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216264|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216265|NCT00467012|Growth Substances|growth substances|mesh-ancestor
44216266|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216267|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216268|NCT00467116|Gemcitabine|gemcitabine|mesh-list
44216269|NCT00467116|Cetuximab|cetuximab|mesh-list
44216270|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216271|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
44216272|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216273|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216274|NCT00467116|Antiviral Agents|antiviral agents|mesh-ancestor
44216275|NCT00467116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216276|NCT00467116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216277|NCT00467116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216278|NCT00467116|Immunologic Factors|immunologic factors|mesh-ancestor
44284445|NCT00751049|Timolol|timolol|mesh-list
44284446|NCT00751049|Latanoprost|latanoprost|mesh-list
44284447|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44284448|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44284449|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678007|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216279|NCT00467116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620710|NCT03511625|Hormones|hormones|mesh-ancestor
44216299|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216300|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44216301|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
44216302|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216303|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
44216304|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
44216305|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44216306|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44216307|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44216308|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44216309|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216310|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216311|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216312|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216313|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44216314|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216315|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
44216316|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216317|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216318|NCT00467376|Insulin|insulin|mesh-list
44216319|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44216320|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
44216321|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
44216322|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216323|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216324|NCT00467454|Naltrexone|naltrexone|mesh-list
44216325|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43678161|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44216326|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43846953|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846954|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846955|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43846956|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846957|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846958|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
43846959|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
43846960|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216327|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216328|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
44216329|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216330|NCT00467467|Alfuzosin|alfuzosin|mesh-list
44216331|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44216332|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44216333|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43846961|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
43846962|NCT04157036|Hormones|hormones|mesh-ancestor
43846963|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846964|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43846965|NCT04157036|Protective Agents|protective agents|mesh-ancestor
44216334|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620767|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
44216359|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216361|NCT00467571|Clarithromycin|clarithromycin|mesh-list
44216362|NCT00467571|Lansoprazole|lansoprazole|mesh-list
44216363|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
44216364|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216365|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216366|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44216367|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216368|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216369|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44216370|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44216371|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44216372|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216373|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44216374|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
44216375|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216376|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216377|NCT00467662|Acyclovir|acyclovir|mesh-list
44216378|NCT00467662|Docosanol|docosanol|mesh-list
44216379|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
44216380|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216381|NCT00467766|Donepezil|donepezil|mesh-list
44216382|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44457030|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457031|NCT01618305|Lamivudine|lamivudine|mesh-list
44457032|NCT01618305|Zidovudine|zidovudine|mesh-list
44457033|NCT01618305|Efavirenz|efavirenz|mesh-list
44284450|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668119|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457034|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44457035|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
44457036|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44457037|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44457038|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457060|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
44457062|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679024|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679025|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457063|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457064|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457065|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
44457066|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
44457067|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44457068|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457069|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457070|NCT01618162|Liraglutide|liraglutide|mesh-list
44457071|NCT01618162|Xultophy|xultophy|mesh-list
44457072|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457073|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457074|NCT01618162|Incretins|incretins|mesh-ancestor
44457075|NCT01618162|Hormones|hormones|mesh-ancestor
44457076|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457077|NCT01617681|Valsartan|valsartan|mesh-list
44457078|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44457079|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44457080|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44457081|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457082|NCT01617668|Paclitaxel|paclitaxel|mesh-list
44457083|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44216410|NCT00468091|Atropine|atropine|mesh-list
44216411|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44216412|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44216413|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44216414|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
44216415|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216435|NCT00468234|Nicotine|nicotine|mesh-list
44216436|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44216437|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
44216438|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216439|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216440|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44216441|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44216442|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216443|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216444|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216445|NCT00468260|Epothilone B|epothilone b|mesh-list
44216446|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216447|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
44216448|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
44216449|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
44216450|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216451|NCT00468351|Triamcinolone|triamcinolone|mesh-list
44216452|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44216453|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44216454|NCT00468351|Bevacizumab|bevacizumab|mesh-list
44216455|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44216456|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216457|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216458|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216459|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216460|NCT00468351|Growth Substances|growth substances|mesh-ancestor
44216461|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216462|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216463|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216464|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
44216465|NCT00468351|Hormones|hormones|mesh-ancestor
44216466|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216467|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216468|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
44216469|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679229|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
44284451|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284452|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284453|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44284454|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44284455|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44284456|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44216470|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216471|NCT00468364|Insulin|insulin|mesh-list
44216490|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216491|NCT00468533|Aripiprazole|aripiprazole|mesh-list
44216492|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
44216493|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44216494|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44216495|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44216496|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216497|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216498|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
44216499|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
44216500|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216501|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216502|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44216503|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44216504|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
44216505|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44216506|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44216507|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44216508|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44216509|NCT00468689|Ketoconazole|ketoconazole|mesh-list
44216510|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
44216511|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216512|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44216513|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44216514|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216515|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216516|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44216517|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
44216518|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216519|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216520|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44216521|NCT00468754|Insulin|insulin|mesh-list
44216522|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216523|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216524|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44216525|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44216526|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216527|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
44216528|NCT00468871|Hormones|hormones|mesh-ancestor
43621008|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216546|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216547|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44216548|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
44216549|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43846995|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846996|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
44216550|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216551|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216552|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216554|NCT00468988|Latanoprost|latanoprost|mesh-list
44216555|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44216556|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44216557|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216558|NCT00469053|Buprenorphine|buprenorphine|mesh-list
44216559|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44216560|NCT00469053|Narcotics|narcotics|mesh-ancestor
44216561|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216562|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216563|NCT00469053|Analgesics|analgesics|mesh-ancestor
44216564|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
43700720|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
44216565|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216566|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44216567|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
44216568|NCT00469131|Tacrolimus|tacrolimus|mesh-list
44216569|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216570|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
44216571|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216572|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44216573|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216574|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216575|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44216576|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216577|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44216578|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
44216579|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216580|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216581|NCT00469261|Doxycycline|doxycycline|mesh-list
44216582|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216583|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216604|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216605|NCT00469404|Buprenorphine|buprenorphine|mesh-list
44216606|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44216607|NCT00469404|Narcotics|narcotics|mesh-ancestor
44216608|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216609|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216610|NCT00469404|Analgesics|analgesics|mesh-ancestor
44216611|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
44216612|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216613|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44216614|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44216615|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44216616|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44216617|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44216618|NCT00469430|Metronidazole|metronidazole|mesh-list
44216619|NCT00469430|Cefotaxime|cefotaxime|mesh-list
44216620|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216621|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216622|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44216623|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44216624|NCT00469443|Leucovorin|leucovorin|mesh-list
44216625|NCT00469443|Bevacizumab|bevacizumab|mesh-list
44216626|NCT00469443|Fluorouracil|fluorouracil|mesh-list
44216627|NCT00469443|Capecitabine|capecitabine|mesh-list
44216628|NCT00469443|Irinotecan|irinotecan|mesh-list
44216629|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216630|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216631|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216632|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216633|NCT00469443|Growth Substances|growth substances|mesh-ancestor
44216634|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216635|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216636|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
44216637|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216638|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216639|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216640|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
44216659|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216660|NCT00469547|Ethanol|ethanol|mesh-list
44216661|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
44216662|NCT00469547|Emollients|emollients|mesh-list
44216663|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44216664|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216665|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216666|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
44216667|NCT00469560|Deferasirox|deferasirox|mesh-list
44216668|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44216669|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
44216670|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
44216671|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216672|NCT00469586|Insulin|insulin|mesh-list
44216673|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44216674|NCT00469586|Metformin|metformin|mesh-list
44216675|NCT00469586|Glimepiride|glimepiride|mesh-list
44216676|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216677|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216678|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799415|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
44284458|NCT00751062|Latanoprost|latanoprost|mesh-list
44284459|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44284460|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44284461|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44216679|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216680|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
44216681|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
44216682|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44216683|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44216684|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216685|NCT00469599|Vitamins|vitamins|mesh-ancestor
44216686|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
44216687|NCT00469651|Vaccines|vaccines|mesh-list
44216688|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
44216689|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216690|NCT00469664|Guanfacine|guanfacine|mesh-list
43679786|NCT05381558|Triamcinolone|triamcinolone|mesh-list
44216691|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216692|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44216693|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44216694|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44216695|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44216696|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216697|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216698|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216699|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44216700|NCT00469690|Bromfenac|bromfenac|mesh-list
44216713|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216714|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
44216715|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216716|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
44216717|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216718|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216719|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216720|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216721|NCT00469703|Growth Substances|growth substances|mesh-ancestor
44216722|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216723|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216724|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44216725|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
44216726|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
44216728|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44216729|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44216730|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
44216731|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216732|NCT00469781|Bromfenac|bromfenac|mesh-list
44216733|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
44216734|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44216735|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
44216736|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44216737|NCT00469781|Prednisolone|prednisolone|mesh-list
44216738|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44216739|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
44216740|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216741|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216742|NCT00469781|Analgesics|analgesics|mesh-ancestor
44216743|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
44216744|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216745|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216746|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216747|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216748|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
44216749|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
44216750|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216751|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
44216752|NCT00469781|Hormones|hormones|mesh-ancestor
44216753|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216754|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44216755|NCT00469781|Protective Agents|protective agents|mesh-ancestor
44216756|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44216757|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216758|NCT00469846|Ascorbic Acid|ascorbic acid|mesh-list
44216759|NCT00469846|Vitamins|vitamins|mesh-ancestor
44284462|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284463|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216760|NCT00469846|Micronutrients|micronutrients|mesh-ancestor
44216761|NCT00469846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216762|NCT00469846|Antioxidants|antioxidants|mesh-ancestor
43621229|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216779|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216780|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216781|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44216782|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44216783|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
44216784|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457084|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457085|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44457086|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44457087|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
44457088|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216785|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
44216786|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
44216787|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44216788|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216789|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216790|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
44216791|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44216792|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216793|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216794|NCT00469976|Gemcitabine|gemcitabine|mesh-list
44216795|NCT00469976|Bevacizumab|bevacizumab|mesh-list
44216796|NCT00469976|Carboplatin|carboplatin|mesh-list
44216797|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216798|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216799|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216800|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216801|NCT00469976|Growth Substances|growth substances|mesh-ancestor
44216802|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216803|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216804|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216805|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
44216806|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216807|NCT00469976|Antiviral Agents|antiviral agents|mesh-ancestor
44216808|NCT00469976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216809|NCT00469976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216810|NCT00469976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216811|NCT00469976|Immunologic Factors|immunologic factors|mesh-ancestor
44216812|NCT00470015|Aldesleukin|aldesleukin|mesh-list
44216813|NCT00470015|Interleukin-2|interleukin-2|mesh-list
44216814|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216832|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44216833|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44216834|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
44216836|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
44216837|NCT00470197|Alvocidib|alvocidib|mesh-list
44216838|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216839|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
44216840|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216841|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216842|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
44216843|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216844|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216845|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
44216846|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216847|NCT00470197|Analgesics|analgesics|mesh-ancestor
44216848|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
44216849|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216850|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44216851|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216852|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216853|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216854|NCT00470197|Growth Substances|growth substances|mesh-ancestor
44216855|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44216856|NCT00470210|Ribavirin|ribavirin|mesh-list
44216857|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44216858|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
44284464|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284465|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43536623|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
44216859|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216860|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
44216861|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216862|NCT00470249|Gemcitabine|gemcitabine|mesh-list
44216863|NCT00470249|Carboplatin|carboplatin|mesh-list
44216864|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216865|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216866|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
44216867|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216868|NCT00470249|Antiviral Agents|antiviral agents|mesh-ancestor
44216869|NCT00470249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216870|NCT00470249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216871|NCT00470249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216872|NCT00470249|Immunologic Factors|immunologic factors|mesh-ancestor
44216873|NCT00470249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216889|NCT00470340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216890|NCT00470340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216891|NCT00470340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216892|NCT00470340|Immunologic Factors|immunologic factors|mesh-ancestor
44216893|NCT00470340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216894|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
44216895|NCT00470353|Vitamin D|vitamin d|mesh-list
44216896|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
44216897|NCT00470353|Calcium|calcium|mesh-list
44216898|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44216899|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216900|NCT00470353|Vitamins|vitamins|mesh-ancestor
44216901|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
44216902|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44216903|NCT00470353|Antacids|antacids|mesh-ancestor
44216904|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216905|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216906|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
44216907|NCT00470405|Pemetrexed|pemetrexed|mesh-list
44216908|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216909|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216910|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216911|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44216912|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44216913|NCT00470483|Paroxetine|paroxetine|mesh-list
44216914|NCT00470483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44216915|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44216916|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44216917|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216918|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216919|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
44216920|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216921|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44216922|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
44216923|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44216924|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44216925|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44216926|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216927|NCT00470509|Adalimumab|adalimumab|mesh-list
44216928|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216929|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216930|NCT00470522|Folic Acid|folic acid|mesh-list
44216931|NCT00470522|Methotrexate|methotrexate|mesh-list
44216932|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44216933|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
44216966|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
44216967|NCT00470665|Sirolimus|sirolimus|mesh-list
44216968|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216969|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216970|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44216971|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216972|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
44216973|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681403|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
43681659|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681660|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681661|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681662|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43681663|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44216974|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
44216975|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284466|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44284467|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44284468|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44284469|NCT00751127|Timolol|timolol|mesh-list
44284470|NCT00751127|Latanoprost|latanoprost|mesh-list
44284471|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44284472|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44284473|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
44284474|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284475|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284476|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284477|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44284478|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217024|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44217026|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217027|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
44217028|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217029|NCT00470990|Acyline|acyline|mesh-list
44217030|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217031|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217032|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217033|NCT00471003|Telmisartan|telmisartan|mesh-list
44217034|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217035|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44217036|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44217037|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217038|NCT00471029|Esomeprazole|esomeprazole|mesh-list
44217039|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217040|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217041|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44217042|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217043|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217044|NCT00471042|Buprenorphine|buprenorphine|mesh-list
44217045|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44217046|NCT00471042|Narcotics|narcotics|mesh-ancestor
44217047|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217048|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217049|NCT00471042|Analgesics|analgesics|mesh-ancestor
44217050|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
44217051|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217052|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44217053|NCT00471055|Capsaicin|capsaicin|mesh-list
44217054|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
44217055|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217056|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
44217057|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217058|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217059|NCT00471094|Lansoprazole|lansoprazole|mesh-list
44217060|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
44217061|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217062|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217063|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43681747|NCT02962063|Paclitaxel|paclitaxel|mesh-list
44217064|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217065|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217066|NCT00471159|Docetaxel|docetaxel|mesh-list
44217067|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217092|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44217093|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217095|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217096|NCT00471393|Diclofenac|diclofenac|mesh-list
44217097|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44284479|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44284480|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44284481|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
44284482|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44284483|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44284484|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44284485|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
44284486|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284487|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44284488|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44217098|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682234|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44217099|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217101|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
44217102|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217103|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217104|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217105|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217106|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217107|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217108|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217109|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44217110|NCT00471393|Protective Agents|protective agents|mesh-ancestor
44217111|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44217112|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
44217113|NCT00471406|Verteporfin|verteporfin|mesh-list
44217114|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44217115|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217141|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217142|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217143|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
44217144|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44217145|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217146|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
44217147|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217148|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
44217149|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217150|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44217151|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
44217152|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217153|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217154|NCT00471523|Metformin|metformin|mesh-list
44217155|NCT00471523|Clomiphene|clomiphene|mesh-list
44217156|NCT00471523|Enclomiphene|enclomiphene|mesh-list
44217157|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
44217158|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44217159|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217160|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44217161|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
44457089|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44217162|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217163|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44217164|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
44217165|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621640|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44217197|NCT00471627|Pancrelipase|pancrelipase|mesh-list
44217198|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217199|NCT00471640|Dexamethasone|dexamethasone|mesh-list
44217200|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217201|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
44217202|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
44217203|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217204|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217205|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217206|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
44217207|NCT00471640|Hormones|hormones|mesh-ancestor
43621692|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44284489|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284490|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217234|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217235|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
44217236|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217237|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217239|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217240|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
44217241|NCT00471809|Hormones|hormones|mesh-ancestor
44217242|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217243|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44217244|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217245|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44217246|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44217247|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44217248|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
44217249|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217250|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217251|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44217252|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217253|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44217254|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44457090|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
44457091|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457092|NCT01617460|Aripiprazole|aripiprazole|mesh-list
44457120|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457121|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44457122|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44457123|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
44457124|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44457125|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44457126|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44457127|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44457128|NCT01617434|Liraglutide|liraglutide|mesh-list
44457129|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457130|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457131|NCT01617434|Incretins|incretins|mesh-ancestor
44457132|NCT01617434|Hormones|hormones|mesh-ancestor
44457133|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457134|NCT01617187|Olanzapine|olanzapine|mesh-list
44457135|NCT01617187|Asenapine|asenapine|mesh-list
44457136|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
44457137|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
44457138|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217277|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682854|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217278|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44217279|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44217280|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217281|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217283|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44217284|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217285|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
44217286|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217287|NCT00471965|Antidotes|antidotes|mesh-ancestor
44217288|NCT00471965|Protective Agents|protective agents|mesh-ancestor
44217289|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
44217290|NCT00471965|Vitamins|vitamins|mesh-ancestor
44217291|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
44217292|NCT00471991|Dienogest|dienogest|mesh-list
43621832|NCT03112564|Narcotics|narcotics|mesh-ancestor
44217320|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44217322|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44217323|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44217324|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217325|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44217326|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44217327|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217328|NCT00472134|Bupivacaine|bupivacaine|mesh-list
44217329|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
44217330|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
44217331|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217332|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284491|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44284492|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44284493|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284494|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
44284495|NCT00751205|Prednisone|prednisone|mesh-list
44284496|NCT00751205|Prednisolone|prednisolone|mesh-list
44284497|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44284498|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
44217333|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
44217334|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217335|NCT00472173|Calcium|calcium|mesh-list
44217336|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44217337|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217338|NCT00472225|Rituximab|rituximab|mesh-list
44217339|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44217361|NCT00472381|Insulin|insulin|mesh-list
44217362|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44217363|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217364|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
44217365|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44217366|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217367|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44217368|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44217369|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217370|NCT00472472|Paclitaxel|paclitaxel|mesh-list
44217371|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44217372|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217373|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44217374|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44217375|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217376|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217377|NCT00472550|Esomeprazole|esomeprazole|mesh-list
44217378|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217379|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217380|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44217381|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217382|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217383|NCT00472758|Sifalimumab|sifalimumab|mesh-list
44217384|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
44217385|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217386|NCT00472810|Mitomycins|mitomycins|mesh-list
44217387|NCT00472810|Mitomycin|mitomycin|mesh-list
44217388|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44217389|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217390|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
44217391|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217392|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44217393|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217421|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217422|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217423|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217424|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
44217425|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217426|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44217427|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217428|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44217429|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217430|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
44217431|NCT00473070|Hormones|hormones|mesh-ancestor
44217432|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217433|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217434|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44217435|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44217436|NCT00473174|Ramipril|ramipril|mesh-list
44217437|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44217438|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
44217439|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700722|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284499|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44284500|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
44284501|NCT00751205|Sagopilone|sagopilone|mesh-list
44284502|NCT00751205|Epothilones|epothilones|mesh-list
44284503|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44217440|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217441|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217442|NCT00473213|Interferons|interferons|mesh-list
44217443|NCT00473213|Interferon-beta|interferon-beta|mesh-list
44217474|NCT00473486|Sorafenib|sorafenib|mesh-list
44217475|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217476|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217477|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217478|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44217479|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44217480|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44217481|NCT00473551|Sirolimus|sirolimus|mesh-list
44217482|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
44217484|NCT00473551|Fludarabine|fludarabine|mesh-list
44217485|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
44217486|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217487|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
44217488|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217506|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217507|NCT00473616|Irinotecan|irinotecan|mesh-list
44217508|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44217509|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44217510|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217511|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683480|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217512|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217513|NCT00473707|Oxytocin|oxytocin|mesh-list
44217514|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
44217515|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217516|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217517|NCT00473720|Paclitaxel|paclitaxel|mesh-list
44217518|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44217519|NCT00473720|Satraplatin|satraplatin|mesh-list
44217520|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44217521|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217522|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
44217523|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
44217524|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217525|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457146|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44457147|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457148|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457149|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457150|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
44457152|NCT01616693|Vaccines|vaccines|mesh-list
44457153|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
44457154|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457155|NCT01616693|Trace Elements|trace elements|mesh-ancestor
44457156|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
44457157|NCT01616654|Tazarotene|tazarotene|mesh-list
44457158|NCT01616654|Trifarotene|trifarotene|mesh-list
44457159|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
44457160|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
44457161|NCT01616459|Vaccines|vaccines|mesh-list
44457162|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44457163|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
44457164|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457165|NCT01616173|Dexamethasone|dexamethasone|mesh-list
44457166|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
44217540|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217541|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217542|NCT00473980|Analgesics|analgesics|mesh-ancestor
44217543|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
44217544|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217545|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217546|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217547|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284504|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
44284505|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284506|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
44284507|NCT00751205|Hormones|hormones|mesh-ancestor
44284508|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217548|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44217549|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217550|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217551|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217552|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217553|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217554|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44217555|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
44217556|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
44217557|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217558|NCT00474006|Daunorubicin|daunorubicin|mesh-list
44217559|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44217560|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217561|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44217562|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44217563|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217564|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217565|NCT00474019|Esomeprazole|esomeprazole|mesh-list
43872416|NCT04753112|Valsartan|valsartan|mesh-list
44217599|NCT00474136|Analgesics|analgesics|mesh-ancestor
44217600|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
44217601|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217602|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217603|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217604|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217605|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217633|NCT00474591|Fondaparinux|fondaparinux|mesh-list
44217634|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44217635|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
44217636|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44217637|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44217638|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217639|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217640|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
44217641|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44217642|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44217643|NCT00474669|Docetaxel|docetaxel|mesh-list
44217644|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217645|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44217646|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44217647|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217648|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217649|NCT00474695|Ranibizumab|ranibizumab|mesh-list
44217650|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44217651|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44217652|NCT00474695|Growth Substances|growth substances|mesh-ancestor
44217687|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217688|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217689|NCT00474838|Metformin|metformin|mesh-list
44217690|NCT00474838|Glimepiride|glimepiride|mesh-list
44217691|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44217692|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217693|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44217723|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217724|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217725|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44217726|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44217727|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217728|NCT00475072|Ribavirin|ribavirin|mesh-list
44217729|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44217730|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
44217731|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217732|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
44217733|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217734|NCT00475098|Tinzaparin|tinzaparin|mesh-list
44217735|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44217736|NCT00475098|Dalteparin|dalteparin|mesh-list
44217737|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
44217738|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44217739|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44217765|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44217766|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44217768|NCT00475189|Hormones|hormones|mesh-ancestor
44217769|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217770|NCT00475293|Panitumumab|panitumumab|mesh-list
44217771|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217772|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44217773|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44217774|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44217775|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44217776|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44217777|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217778|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217779|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217780|NCT00475358|Analgesics|analgesics|mesh-ancestor
44217781|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
44217782|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217809|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44217810|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44217812|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684344|NCT02844270|Sirolimus|sirolimus|mesh-list
44217813|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217814|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217815|NCT00475514|Frovatriptan|frovatriptan|mesh-list
44217816|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44217817|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
44217818|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217819|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872581|NCT04750603|Xhance|xhance|mesh-list
44217820|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217821|NCT00475527|Amoxicillin|amoxicillin|mesh-list
44217822|NCT00475527|Metronidazole|metronidazole|mesh-list
44217823|NCT00475527|Clarithromycin|clarithromycin|mesh-list
44217824|NCT00475527|Omeprazole|omeprazole|mesh-list
44217825|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44217826|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217827|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44217828|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44217829|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217859|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217860|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
44217861|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217863|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
44217864|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
44217865|NCT00475618|Protective Agents|protective agents|mesh-ancestor
44217866|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217867|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44217868|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44217869|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44217870|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44217871|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217872|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217873|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217898|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
44217899|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217900|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217901|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44217902|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217903|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217904|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44217905|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44217906|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44217907|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44217908|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
44217909|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217910|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217911|NCT00475826|Ezetimibe|ezetimibe|mesh-list
44284509|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284510|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44284511|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217912|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44217913|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44217914|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
44217915|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217916|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44217917|NCT00475917|Gemcitabine|gemcitabine|mesh-list
44217918|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44217919|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
44217920|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217921|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217922|NCT00475917|Antiviral Agents|antiviral agents|mesh-ancestor
44217923|NCT00475917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217924|NCT00475917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217925|NCT00475917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217926|NCT00475917|Immunologic Factors|immunologic factors|mesh-ancestor
44217940|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44217941|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44217942|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44217943|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44217944|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217945|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217946|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217947|NCT00475969|Analgesics|analgesics|mesh-ancestor
44217948|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
44217949|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217950|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
44217951|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217952|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
43684491|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684492|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44457179|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457180|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457181|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457182|NCT01615939|Bupivacaine|bupivacaine|mesh-list
44457183|NCT01615939|Ropivacaine|ropivacaine|mesh-list
44457184|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
44457185|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
44457186|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457187|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457188|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
44457189|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457190|NCT01615822|Artefenomel|artefenomel|mesh-list
44457191|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
44457192|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44457193|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44457194|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457195|NCT01615198|Olmesartan|olmesartan|mesh-list
44217953|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
44217954|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44217955|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217956|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217957|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217958|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217959|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217960|NCT00476034|Analgesics|analgesics|mesh-ancestor
44217961|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
44217962|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217963|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217964|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217965|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217966|NCT00476073|Fluticasone|fluticasone|mesh-list
44217967|NCT00476073|Xhance|xhance|mesh-list
44217968|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
44217969|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217970|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217971|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
44217985|NCT00476099|Beclomethasone|beclomethasone|mesh-list
44217986|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
44217987|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284514|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284515|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284516|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44217988|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217989|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
44217990|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217991|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217992|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44217993|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217994|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
44217995|NCT00476099|Hormones|hormones|mesh-ancestor
44217996|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217997|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44217998|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44217999|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44218000|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218001|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218002|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218003|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44218004|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
44218005|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218006|NCT00476138|Protective Agents|protective agents|mesh-ancestor
44218007|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218008|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44218009|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44218010|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218011|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44218012|NCT00476164|Rituximab|rituximab|mesh-list
44218013|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218014|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218015|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
44218016|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218017|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218018|NCT00476216|Fondaparinux|fondaparinux|mesh-list
44218019|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44218020|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
44218021|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44218022|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44218023|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218024|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218025|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
44218026|NCT00476268|Beclomethasone|beclomethasone|mesh-list
44218027|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
44218028|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44218029|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
44218030|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218031|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622599|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
44218043|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218045|NCT00476346|Calcium|calcium|mesh-list
44218046|NCT00476346|Vitamins|vitamins|mesh-ancestor
44218047|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
44218048|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218049|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44218050|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44218051|NCT00476359|Lopinavir|lopinavir|mesh-list
44218052|NCT00476359|Saquinavir|saquinavir|mesh-list
44218053|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44218054|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44218055|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
44218056|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218057|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218058|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218059|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218060|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
43684970|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
43684971|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218061|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218062|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44218063|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218064|NCT00476424|Efavirenz|efavirenz|mesh-list
43799416|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
44284517|NCT00751205|Protective Agents|protective agents|mesh-ancestor
44284518|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
44218065|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44218066|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44218067|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218068|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218069|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
44218070|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218071|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44218072|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218073|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44218074|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44218075|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44218076|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44218077|NCT00476437|Insulin|insulin|mesh-list
44218078|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44218079|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
44218080|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
44218081|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44218082|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218083|NCT00476463|Emtricitabine|emtricitabine|mesh-list
44218084|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
44218085|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218086|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44218087|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44218088|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218089|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218090|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218091|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218092|NCT00476515|Rituximab|rituximab|mesh-list
44218093|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218126|NCT00476918|Hormones|hormones|mesh-ancestor
44218127|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218128|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218129|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218130|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
44218131|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218132|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218133|NCT00476983|Ritonavir|ritonavir|mesh-list
44218134|NCT00476983|Saquinavir|saquinavir|mesh-list
44218135|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44218148|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44218149|NCT00477035|Gemcitabine|gemcitabine|mesh-list
44218150|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
44218151|NCT00477035|Melphalan|melphalan|mesh-list
44218152|NCT00477035|Carmustine|carmustine|mesh-list
44218153|NCT00477035|Etoposide|etoposide|mesh-list
44218154|NCT00477035|Vinorelbine|vinorelbine|mesh-list
44218155|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218156|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
44218157|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218158|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218159|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44218160|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
44218161|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218162|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218163|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44218164|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218165|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
44218166|NCT00477035|Antiviral Agents|antiviral agents|mesh-ancestor
44218167|NCT00477035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218168|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218169|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44218170|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44218171|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44218172|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44218173|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44218174|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218175|NCT00477048|Saquinavir|saquinavir|mesh-list
43872891|NCT04744753|Calcium|calcium|mesh-list
44218176|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44218177|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44218178|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284519|NCT00751205|Vitamins|vitamins|mesh-ancestor
44284520|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
44284521|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
44218179|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218180|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218181|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218182|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218183|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
44218184|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218185|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44218186|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218187|NCT00477061|Morphine|morphine|mesh-list
44218188|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44218189|NCT00477061|Narcotics|narcotics|mesh-ancestor
44218190|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218191|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218192|NCT00477061|Analgesics|analgesics|mesh-ancestor
44218193|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
44218194|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218195|NCT00477074|Dimercaprol|dimercaprol|mesh-list
44218196|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
43622767|NCT03106389|Misoprostol|misoprostol|mesh-list
44218212|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44218213|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218214|NCT00477282|Topotecan|topotecan|mesh-list
44218215|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44218216|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44218217|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218218|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218219|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218220|NCT00477373|Valproic Acid|valproic acid|mesh-list
43685196|NCT02837614|BB 1101|bb 1101|mesh-list
43685286|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
43685287|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218221|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
44218222|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218223|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218224|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
44218225|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218226|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218227|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
44218228|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44218229|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218230|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218231|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
44218232|NCT00477503|Gallium citrate|gallium citrate|mesh-list
44218233|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
44218234|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
44218235|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218236|NCT00477503|Antidotes|antidotes|mesh-ancestor
44218237|NCT00477503|Protective Agents|protective agents|mesh-ancestor
44218238|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218239|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44218240|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44218241|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
44218242|NCT00477516|Calcium|calcium|mesh-list
44218243|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44218244|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218245|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43685288|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685289|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218246|NCT00477542|Clofarabine|clofarabine|mesh-list
44218247|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218248|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
44218249|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218250|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218251|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44218252|NCT00477581|Exenatide|exenatide|mesh-list
44218253|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44218254|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218255|NCT00477581|Incretins|incretins|mesh-ancestor
44218287|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218288|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
44218289|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218290|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
44218291|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218292|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44218293|NCT00477776|Metoclopramide|metoclopramide|mesh-list
44218294|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
44218295|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
44284522|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
44284523|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
44284524|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218296|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218297|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218298|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218315|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44218316|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44218317|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44218318|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44218319|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218320|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
44218321|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218322|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218323|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44218324|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218325|NCT00477815|Rituximab|rituximab|mesh-list
44218326|NCT00477815|Melphalan|melphalan|mesh-list
44218327|NCT00477815|Sargramostim|sargramostim|mesh-list
44218328|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44218329|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218330|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218331|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
44218332|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218333|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218334|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44218335|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
44218336|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218337|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44218338|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218339|NCT00477854|Chromium|chromium|mesh-list
44218340|NCT00477854|Picolinic acid|picolinic acid|mesh-list
44218341|NCT00477854|Trace Elements|trace elements|mesh-ancestor
44218342|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
44218343|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218344|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44218345|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
44218346|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
44218347|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218348|NCT00477880|Cetuximab|cetuximab|mesh-list
44218349|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218350|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218351|NCT00477893|Adalimumab|adalimumab|mesh-list
44218352|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218353|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457196|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44457197|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44457198|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44457211|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44457212|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44457213|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457214|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44457215|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457216|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
44457217|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457218|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
44457219|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457220|NCT01614769|Glimepiride|glimepiride|mesh-list
44457221|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44457222|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44457223|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457224|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457225|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
44457226|NCT01614470|Ivacaftor|ivacaftor|mesh-list
44457227|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44457228|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457229|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457230|NCT01614457|Ivacaftor|ivacaftor|mesh-list
44457231|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44457232|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457233|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284525|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668179|NCT03818685|Capecitabine|capecitabine|mesh-list
44457234|NCT01614093|Oxytocin|oxytocin|mesh-list
44457235|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
44457236|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44457237|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457238|NCT01614067|Ganirelix|ganirelix|mesh-list
44457239|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
44457240|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457241|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457242|NCT01613716|Dexamethasone|dexamethasone|mesh-list
44218354|NCT00477945|Clofarabine|clofarabine|mesh-list
44218355|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218356|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
44218357|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218358|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218359|NCT00477984|Ethanol|ethanol|mesh-list
44218360|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44218361|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218362|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218363|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218364|NCT00477997|Hormones|hormones|mesh-list
44218365|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218366|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685566|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
44218367|NCT00478049|Docetaxel|docetaxel|mesh-list
44218368|NCT00478049|Gefitinib|gefitinib|mesh-list
44218369|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218370|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44218388|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218389|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218390|NCT00478101|Analgesics|analgesics|mesh-ancestor
44218391|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
44218392|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218393|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44218394|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44218395|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
44218396|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
44218397|NCT00478114|Sorafenib|sorafenib|mesh-list
44218398|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218399|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218400|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218401|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218402|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
44218403|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44218404|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218405|NCT00478374|Doxorubicin|doxorubicin|mesh-list
44218406|NCT00478374|Sorafenib|sorafenib|mesh-list
44218407|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44218408|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218409|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44218410|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44218411|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218412|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218413|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218414|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
44218415|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218416|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
44218417|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218418|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218419|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44218420|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
44218421|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218422|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218423|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44218424|NCT00478504|Letrozole|letrozole|mesh-list
44218425|NCT00478504|Clomiphene|clomiphene|mesh-list
44218426|NCT00478504|Enclomiphene|enclomiphene|mesh-list
44218427|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
44218428|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218429|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218437|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44284527|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43685711|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43685712|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43685713|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43685714|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
44284528|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
44218438|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
44218439|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44218440|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44218441|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44218442|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
44218443|NCT00478517|Hematinics|hematinics|mesh-ancestor
44218444|NCT00478543|Furosemide|furosemide|mesh-list
44218445|NCT00478543|Diuretics|diuretics|mesh-ancestor
44218446|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
44218447|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218448|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44218449|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44218450|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218451|NCT00478621|Vaccines|vaccines|mesh-list
44218452|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
44218453|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218454|NCT00478634|Irinotecan|irinotecan|mesh-list
44218455|NCT00478634|Cetuximab|cetuximab|mesh-list
44218456|NCT00478634|Everolimus|everolimus|mesh-list
44218457|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44218458|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44218459|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218460|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218461|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218462|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218463|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218464|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
44218465|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218466|NCT00478660|Adalimumab|adalimumab|mesh-list
44218467|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218468|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218469|NCT00478699|Gemcitabine|gemcitabine|mesh-list
44218470|NCT00478699|Cisplatin|cisplatin|mesh-list
44218471|NCT00478699|Docetaxel|docetaxel|mesh-list
44218472|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218473|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218474|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
44218475|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218476|NCT00478699|Antiviral Agents|antiviral agents|mesh-ancestor
44218477|NCT00478699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218478|NCT00478699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218479|NCT00478699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218480|NCT00478699|Immunologic Factors|immunologic factors|mesh-ancestor
44218481|NCT00478699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218482|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44218483|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44218484|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218485|NCT00478764|Triamcinolone|triamcinolone|mesh-list
44218486|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218487|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
44218488|NCT00478764|Hormones|hormones|mesh-ancestor
44218489|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218490|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218491|NCT00478816|Vaccines|vaccines|mesh-list
44218492|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
44218493|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218494|NCT00478855|Piperacillin|piperacillin|mesh-list
44218495|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43685791|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
44218496|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44218497|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218525|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
44218527|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
44218528|NCT00478959|Lenalidomide|lenalidomide|mesh-list
44218529|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
44218530|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218531|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44218532|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44218533|NCT00478959|Growth Substances|growth substances|mesh-ancestor
44218534|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
44218535|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218536|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
44218537|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218538|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284530|NCT00751257|Expectorants|expectorants|mesh-ancestor
44284531|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44284532|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44284533|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
44464079|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44284534|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218539|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218540|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218541|NCT00478998|Tamsulosin|tamsulosin|mesh-list
44218542|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44218543|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44218544|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44218545|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218546|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218547|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218585|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44218586|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218587|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44218588|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44218622|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44218623|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44218624|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44218625|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44218626|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218627|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218628|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218629|NCT00479726|Analgesics|analgesics|mesh-ancestor
44218630|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
43623290|NCT04727138|Midazolam|midazolam|mesh-list
44218666|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218668|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44218669|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43623351|NCT04644016|Cyclosporine|cyclosporine|mesh-list
44457250|NCT01613716|Hormones|hormones|mesh-ancestor
44457251|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457273|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457274|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
44457275|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44218699|NCT00480064|Cytarabine|cytarabine|mesh-list
44218700|NCT00480064|Lomustine|lomustine|mesh-list
44218701|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685938|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43685939|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218702|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
44218703|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218704|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218705|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
44218706|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218707|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218708|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
44218709|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218710|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44218711|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
44218712|NCT00480090|Cytarabine|cytarabine|mesh-list
44218713|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218714|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
44218715|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218716|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218717|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
44218718|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218719|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218720|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
44218721|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218722|NCT00480103|Mineral Oil|mineral oil|mesh-list
44218723|NCT00480103|Emollients|emollients|mesh-ancestor
44284535|NCT00751257|Protective Agents|protective agents|mesh-ancestor
44218724|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
44218725|NCT00480116|Vaccines|vaccines|mesh-list
44218726|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
44218727|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218728|NCT00480142|Oxycodone|oxycodone|mesh-list
44218729|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44218763|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
44218764|NCT00480207|Hematinics|hematinics|mesh-ancestor
44218765|NCT00480207|Vitamins|vitamins|mesh-ancestor
44218766|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
44218767|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218768|NCT00480246|Perphenazine|perphenazine|mesh-list
44218769|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44218770|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44218771|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218772|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218773|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218799|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218800|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218801|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
44218802|NCT00480298|Hormones|hormones|mesh-ancestor
44218803|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218804|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44218805|NCT00480298|Protective Agents|protective agents|mesh-ancestor
44218806|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44218807|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218808|NCT00480363|Dexamethasone|dexamethasone|mesh-list
44218809|NCT00480363|Lenalidomide|lenalidomide|mesh-list
44218810|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686082|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686083|NCT02831101|Sufentanil|sufentanil|mesh-list
44218811|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
44218812|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
44218813|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218814|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218815|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218816|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
44218817|NCT00480363|Hormones|hormones|mesh-ancestor
44218818|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218819|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44218820|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218821|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
44218822|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44218823|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44218824|NCT00480363|Growth Substances|growth substances|mesh-ancestor
44218825|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
44218860|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218861|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218862|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44218863|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44218864|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218895|NCT00480597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218896|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44218897|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44218898|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44218899|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218900|NCT00480610|Tacrolimus|tacrolimus|mesh-list
44218901|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218902|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
44218903|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218904|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44218905|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218906|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218907|NCT00480623|Satraplatin|satraplatin|mesh-list
44218908|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218909|NCT00480649|Fluticasone|fluticasone|mesh-list
44218911|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43623598|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218945|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
44218946|NCT00480675|Hormones|hormones|mesh-ancestor
44218947|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218948|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44218949|NCT00480675|Protective Agents|protective agents|mesh-ancestor
44218950|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44218951|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218952|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
44284536|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284537|NCT00751257|Antidotes|antidotes|mesh-ancestor
44218985|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218986|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44218987|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44218988|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218990|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686492|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43686493|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43686494|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
44218991|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
44218992|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218993|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44218994|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218995|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219027|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219028|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44219030|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
44219031|NCT00481182|Methadone|methadone|mesh-list
44219032|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44219033|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44219034|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
44219035|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219036|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219049|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219050|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
44219051|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219053|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44219054|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
44219055|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219056|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219057|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219058|NCT00481312|Midazolam|midazolam|mesh-list
44219059|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
44219060|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44219061|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219062|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219063|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219064|NCT00481312|Analgesics|analgesics|mesh-ancestor
44219065|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
44219066|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219067|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44219068|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44219069|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44219070|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44219071|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219072|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219073|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44219074|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44219075|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44219076|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44219077|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44219078|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
44219079|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
44219080|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
44219081|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
44219082|NCT00481364|Atorvastatin|atorvastatin|mesh-list
44219083|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44219084|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44219085|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
44219086|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219087|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44219088|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44219089|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219090|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
44219091|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219092|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219093|NCT00481442|Phenylephrine|phenylephrine|mesh-list
44219094|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
44219095|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44219096|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
44219097|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
44219098|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623768|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
44219131|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219133|NCT00481572|Vasopressins|vasopressins|mesh-list
44284539|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
44219134|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
44219135|NCT00481572|Norepinephrine|norepinephrine|mesh-list
44219136|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44219137|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44219138|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44219139|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219140|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219171|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219172|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219173|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44219174|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219175|NCT00481702|Metronidazole|metronidazole|mesh-list
44219176|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
44219177|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219178|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219179|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44219180|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44219181|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44219182|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44219183|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44219184|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
44219185|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623871|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457302|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457303|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457304|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
44457305|NCT01612702|Hormones|hormones|mesh-ancestor
44457306|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457307|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457308|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457309|NCT01612156|Lidocaine|lidocaine|mesh-list
44457310|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
44457311|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
44457312|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457313|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457314|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
43623919|NCT02536794|Durvalumab|durvalumab|mesh-list
44219219|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219220|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44219221|NCT00481819|Protective Agents|protective agents|mesh-ancestor
44219222|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44219223|NCT00481884|Petrolatum|petrolatum|mesh-list
44219224|NCT00481884|Emollients|emollients|mesh-ancestor
44219225|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44219226|NCT00481923|Rimonabant|rimonabant|mesh-list
44219227|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44219228|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44219229|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44219230|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219231|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219232|NCT00481923|Hormones|hormones|mesh-ancestor
43623960|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
44219254|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44219255|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219256|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219257|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219258|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
44219259|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219260|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219261|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44219262|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219263|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219264|NCT00482079|Incretins|incretins|mesh-ancestor
44219265|NCT00482079|Hormones|hormones|mesh-ancestor
44219266|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219267|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44219268|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
44219269|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686593|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
43686594|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43686595|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43686615|NCT02826343|Xenon|xenon|mesh-list
44219270|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219271|NCT00482183|Pioglitazone|pioglitazone|mesh-list
44219272|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44284540|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284541|NCT00751374|Gentamicins|gentamicins|mesh-list
44284542|NCT00751374|Mupirocin|mupirocin|mesh-list
44284543|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284544|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284545|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44284546|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219273|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219274|NCT00482209|Misoprostol|misoprostol|mesh-list
44219275|NCT00482209|Mifepristone|mifepristone|mesh-list
44219276|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44219277|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
44219278|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44219279|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219280|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44219281|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219282|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
44219311|NCT00482222|Protective Agents|protective agents|mesh-ancestor
44219312|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
44219313|NCT00482222|Vitamins|vitamins|mesh-ancestor
44219314|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
44219315|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44219316|NCT00482248|Omalizumab|omalizumab|mesh-list
44219317|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44219318|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44219319|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219320|NCT00482261|Aspirin|aspirin|mesh-list
44219321|NCT00482261|Dexamethasone|dexamethasone|mesh-list
44219322|NCT00482261|Lenalidomide|lenalidomide|mesh-list
44219323|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219324|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
44219325|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
44219326|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219327|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219328|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219329|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
44219330|NCT00482261|Hormones|hormones|mesh-ancestor
44219350|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44219351|NCT00482313|Methylphenidate|methylphenidate|mesh-list
44219352|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44219353|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219354|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44219355|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44219356|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219357|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219358|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
44219359|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219360|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
44219361|NCT00482378|Pamidronate|pamidronate|mesh-list
44219362|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44219363|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219364|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
44219365|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44219366|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
44219367|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
44219368|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219369|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219370|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219371|NCT00482456|Analgesics|analgesics|mesh-ancestor
44219372|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
44219373|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219374|NCT00482495|Bevacizumab|bevacizumab|mesh-list
44219375|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44219376|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219377|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219378|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219379|NCT00482495|Growth Substances|growth substances|mesh-ancestor
44219380|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219381|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284548|NCT00751478|Naltrexone|naltrexone|mesh-list
44284549|NCT00751478|Morphine|morphine|mesh-list
44284550|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44284551|NCT00751478|Narcotics|narcotics|mesh-ancestor
44284552|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284553|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284554|NCT00751478|Analgesics|analgesics|mesh-ancestor
44284555|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
44219382|NCT00482508|Omalizumab|omalizumab|mesh-list
44219383|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44219403|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219404|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44219405|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44219406|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
44219407|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219408|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44219409|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219410|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
44219411|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
44219412|NCT00482690|Nicotine|nicotine|mesh-list
44219413|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44219414|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
43873991|NCT04403516|Hormones|hormones|mesh-ancestor
44219415|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219416|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219417|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44219418|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44219419|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
44219420|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219421|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219422|NCT00482716|Iron|iron|mesh-list
44219423|NCT00482716|Dextrans|dextrans|mesh-list
44219424|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
44219425|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44219426|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
44219427|NCT00482716|Trace Elements|trace elements|mesh-ancestor
44219428|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
44219429|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219430|NCT00482716|Hematinics|hematinics|mesh-ancestor
44219431|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
44219432|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
44219433|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
44219434|NCT00482755|Sunitinib|sunitinib|mesh-list
44219435|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219436|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219437|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219438|NCT00482755|Growth Substances|growth substances|mesh-ancestor
44219439|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219440|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
43686680|NCT02825576|Neostigmine|neostigmine|mesh-list
44219465|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219466|NCT00482963|Efavirenz|efavirenz|mesh-list
44219467|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
44219468|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44219469|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44219470|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219471|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219472|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
44219473|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219474|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44219475|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219476|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44219477|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44219478|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44219479|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44284556|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284557|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44284558|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44284559|NCT00751491|Clopidogrel|clopidogrel|mesh-list
44219480|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44219481|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
44219482|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44219483|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219484|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44219485|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44219486|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44219487|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
44219522|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219523|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219525|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219526|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624265|NCT05137262|Doxorubicin|doxorubicin|mesh-list
44219562|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219563|NCT00483210|Fenofibrate|fenofibrate|mesh-list
44219599|NCT00483366|Antiviral Agents|antiviral agents|mesh-ancestor
44219600|NCT00483366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219601|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219602|NCT00483366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219603|NCT00483366|Immunologic Factors|immunologic factors|mesh-ancestor
43624352|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
44219628|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44457317|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44457318|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44457319|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457320|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457321|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
44457322|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
44457323|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
44457324|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457325|NCT01611974|Maribavir|maribavir|mesh-list
44457326|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
44457327|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219629|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
44219630|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
44219631|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44219632|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44219633|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219634|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219635|NCT00483626|Urological Agents|urological agents|mesh-ancestor
44219636|NCT00483730|Actovegin|actovegin|mesh-list
43687374|NCT02820558|Substance P|substance p|mesh-list
43687408|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
43687409|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687410|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43687411|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44219637|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44219638|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219639|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44219640|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219641|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
44219642|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219643|NCT00483730|Protective Agents|protective agents|mesh-ancestor
44219644|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44219645|NCT00483743|Budesonide|budesonide|mesh-list
44219716|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219717|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624472|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
44219727|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
44219728|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44219729|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
44219730|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
44219731|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219732|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219733|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
44219734|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219735|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44219736|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
44219737|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219738|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219739|NCT00484003|Analgesics|analgesics|mesh-ancestor
44219740|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
44284560|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44284561|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44284562|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44284563|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44219741|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219742|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219743|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219744|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219745|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
44219746|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219747|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
44219748|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44219749|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219750|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219751|NCT00484055|Gentamicins|gentamicins|mesh-list
44219752|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219753|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219754|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44219755|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219756|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219757|NCT00484068|Enalapril|enalapril|mesh-list
44219758|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44219759|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
44219760|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219761|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219762|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44219763|NCT00484107|Estrogens|estrogens|mesh-list
44219764|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44219765|NCT00484107|Hormones|hormones|mesh-ancestor
44219766|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219767|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219768|NCT00484120|Diclofenac|diclofenac|mesh-list
44219769|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219770|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219771|NCT00484120|Analgesics|analgesics|mesh-ancestor
44219772|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
44219773|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219774|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219775|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219776|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219777|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44219778|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219779|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219815|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
44219816|NCT00484250|Metronidazole|metronidazole|mesh-list
44219817|NCT00484250|Doxycycline|doxycycline|mesh-list
44219818|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219819|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219820|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44219821|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44219822|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
44219845|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219846|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219847|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44219848|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44219849|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
44219850|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
44219851|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219852|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44219853|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44219854|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219855|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219856|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
44219857|NCT00484510|Vitamins|vitamins|mesh-ancestor
44219858|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
44219859|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219860|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
44219861|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284564|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
44284565|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284566|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826698|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
44219862|NCT00484510|Protective Agents|protective agents|mesh-ancestor
44219863|NCT00484575|Propofol|propofol|mesh-list
44219864|NCT00484575|Sevoflurane|sevoflurane|mesh-list
44219865|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44219866|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219867|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219868|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44219869|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
44219870|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
44219871|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44219872|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44219873|NCT00484601|Doxorubicin|doxorubicin|mesh-list
44219874|NCT00484601|Ifosfamide|ifosfamide|mesh-list
44219875|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219892|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219894|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219895|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219896|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44219897|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219898|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219899|NCT00484731|Bupivacaine|bupivacaine|mesh-list
44219900|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
44219901|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
44219902|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219903|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219904|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
44219905|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219906|NCT00484744|Acetaminophen|acetaminophen|mesh-list
44219907|NCT00484744|Ibuprofen|ibuprofen|mesh-list
44219908|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219909|NCT00484744|Analgesics|analgesics|mesh-ancestor
44219910|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
44219911|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219912|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219913|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
44219914|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219915|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219916|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219917|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44219918|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219919|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219920|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44219921|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
44219922|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219923|NCT00484809|Etanercept|etanercept|mesh-list
44219924|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219925|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219926|NCT00484809|Analgesics|analgesics|mesh-ancestor
44219927|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
44219928|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219929|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219930|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219931|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219964|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44219965|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44219966|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
44219967|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219968|NCT00484991|Verapamil|verapamil|mesh-list
44219969|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44219970|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44219971|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219972|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624722|NCT02936843|Analgesics|analgesics|mesh-ancestor
44220005|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220006|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44220007|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284567|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284568|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43538447|NCT04786873|Clonidine|clonidine|mesh-list
44220008|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220009|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44220010|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220012|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
44220013|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220014|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44220015|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220035|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44220036|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220037|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220038|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
44220039|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
44220040|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44220041|NCT00485238|Acetazolamide|acetazolamide|mesh-list
44220042|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
44220043|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44220044|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220045|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220046|NCT00485238|Diuretics|diuretics|mesh-ancestor
44220047|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
44220048|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457328|NCT01611935|Vasopressins|vasopressins|mesh-list
44457329|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
44457330|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
44457331|NCT01611935|Coagulants|coagulants|mesh-ancestor
44457332|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44457333|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44457334|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
44457335|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457336|NCT01611883|Ezetimibe|ezetimibe|mesh-list
44457337|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44457338|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44457339|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
44457340|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457341|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44457342|NCT01611857|Leucovorin|leucovorin|mesh-list
44457343|NCT01611857|Fluorouracil|fluorouracil|mesh-list
44457344|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
44457345|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
44457346|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
44457347|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457348|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44457349|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457350|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624813|NCT02581748|Trastuzumab|trastuzumab|mesh-list
44220070|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220071|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220072|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220073|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220074|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220075|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220076|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220077|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220078|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220079|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220080|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220081|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220082|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220083|NCT00485498|Olanzapine|olanzapine|mesh-list
44220084|NCT00485498|Risperidone|risperidone|mesh-list
44220085|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44220086|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
44220087|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220088|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220089|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220114|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220115|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220116|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284569|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
44284570|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44284571|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220117|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
44220118|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220119|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43874681|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44220120|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220121|NCT00485576|Eculizumab|eculizumab|mesh-list
44220122|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44220123|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220124|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
44220125|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220126|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220127|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43688347|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688496|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44220128|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220129|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220130|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220131|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220132|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220133|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220134|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
44220135|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220136|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220158|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
44220159|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220160|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220161|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
44220162|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
44220163|NCT00485706|Calcium|calcium|mesh-list
44220164|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220165|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220166|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44220167|NCT00485771|Lamotrigine|lamotrigine|mesh-list
44220168|NCT00485771|Olanzapine|olanzapine|mesh-list
44220169|NCT00485771|Fluoxetine|fluoxetine|mesh-list
44220170|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
44220171|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
44220172|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220173|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220174|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220175|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220176|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220177|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220178|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220179|NCT00485771|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220180|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220181|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220182|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220183|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220184|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
44220185|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44220186|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220187|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43624963|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44220217|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220219|NCT00485823|Olanzapine|olanzapine|mesh-list
44220220|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
44220221|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
44220222|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220223|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220224|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220225|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220226|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220227|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220245|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220246|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220247|NCT00485862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220248|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220249|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220250|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284572|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44284573|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538607|NCT04584112|Carboplatin|carboplatin|mesh-list
44220251|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220252|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
44220253|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220254|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220255|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220256|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220257|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220258|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220259|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220260|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220261|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220262|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874807|NCT04732247|Oxytocin|oxytocin|mesh-list
44220263|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220264|NCT00485888|Citalopram|citalopram|mesh-list
44220265|NCT00485888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220266|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220267|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220268|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220269|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220270|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
44220271|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220272|NCT00485888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44220273|NCT00485888|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220274|NCT00485888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220275|NCT00485901|Haloperidol|haloperidol|mesh-list
44220276|NCT00485901|Olanzapine|olanzapine|mesh-list
44220277|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
44220278|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
44220279|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
43625054|NCT00432094|Paclitaxel|paclitaxel|mesh-list
44220300|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44220301|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
44220302|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220303|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220304|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220305|NCT00485979|Docetaxel|docetaxel|mesh-list
44220306|NCT00485979|Trastuzumab|trastuzumab|mesh-list
44220307|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220308|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44220309|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44220310|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44220311|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220312|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44220313|NCT00486005|Olanzapine|olanzapine|mesh-list
44220314|NCT00486005|Nizatidine|nizatidine|mesh-list
44220315|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
44220316|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
44220317|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220318|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220319|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220320|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220321|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220322|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220323|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220324|NCT00486005|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220325|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220326|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220327|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220328|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220329|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
44220330|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44220331|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44220332|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
44220365|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
44220366|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220367|NCT00486317|Calcitonin|calcitonin|mesh-list
44220368|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
44220369|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44284574|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284575|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
44284576|NCT00751517|Methotrexate|methotrexate|mesh-list
44284577|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44284578|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
44284579|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220370|NCT00486317|Katacalcin|katacalcin|mesh-list
44220371|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220372|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220373|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44220408|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
44220409|NCT00486421|Prednisone|prednisone|mesh-list
44220410|NCT00486421|Rituximab|rituximab|mesh-list
44457357|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
44220411|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43625215|NCT03103555|Bortezomib|bortezomib|mesh-list
43847133|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
43847134|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847135|NCT04138394|Protective Agents|protective agents|mesh-ancestor
43847136|NCT04138212|Paclitaxel|paclitaxel|mesh-list
44220447|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220448|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220449|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220450|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220475|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44220476|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44220477|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44220478|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44220479|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220480|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44220481|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44220482|NCT00486694|Artesunate|artesunate|mesh-list
44220483|NCT00486694|Chloroquine|chloroquine|mesh-list
44220484|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
43874981|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220485|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
44457358|NCT01611558|Ipilimumab|ipilimumab|mesh-list
44220486|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44220487|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
44220488|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44220489|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44220490|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220491|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220492|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
44220493|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
44220494|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44220495|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
44220496|NCT00486694|Amebicides|amebicides|mesh-ancestor
44220497|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220498|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44220499|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220500|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220501|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44220502|NCT00486694|Renal Agents|renal agents|mesh-ancestor
44220529|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220530|NCT00486980|Peramivir|peramivir|mesh-list
44220531|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
44220532|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220533|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220534|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220535|NCT00487032|Fluticasone|fluticasone|mesh-list
44220537|NCT00487032|Prazosin|prazosin|mesh-list
44220538|NCT00487032|Phenylephrine|phenylephrine|mesh-list
44220539|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
44220540|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220541|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44220542|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
44220543|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220544|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220545|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44220546|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
44220547|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
44220548|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44220549|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44220550|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44284580|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668201|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220551|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44220552|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44457377|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44457378|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44457379|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44457380|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457381|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457382|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457383|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457384|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44457385|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
44457386|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457388|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44457389|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457390|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220582|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44220583|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44220584|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44220585|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44220586|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220587|NCT00487123|Diuretics|diuretics|mesh-ancestor
44220588|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
44220589|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220590|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44220591|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220593|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44220594|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
44220595|NCT00487136|Fenofibrate|fenofibrate|mesh-list
44220596|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44220597|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44220598|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
43625458|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
44220686|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
44220687|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220688|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44220689|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44220690|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
44220691|NCT00487773|Hormones|hormones|mesh-ancestor
44220692|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220693|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44220694|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44220695|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44220696|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44220697|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220698|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
44220699|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44220700|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44220701|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44220702|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44220703|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220704|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220705|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220706|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44220707|NCT00487786|Docetaxel|docetaxel|mesh-list
44220708|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220709|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
44220710|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
44220711|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690119|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690180|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
43690181|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220712|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220713|NCT00487799|Ularitide|ularitide|mesh-list
44220714|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44220715|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
43625545|NCT03100877|Lenalidomide|lenalidomide|mesh-list
44220776|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220777|NCT00488189|Tazobactam|tazobactam|mesh-list
44220778|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44220779|NCT00488189|Piperacillin|piperacillin|mesh-list
44220780|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284581|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44284582|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
43538836|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
44220781|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220782|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44220783|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220784|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220785|NCT00488215|Prucalopride|prucalopride|mesh-list
44220786|NCT00488215|Laxatives|laxatives|mesh-ancestor
44220787|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457428|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220788|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44220810|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220812|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
44220813|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220814|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
44220815|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220816|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
44220817|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220818|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44220819|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
44220820|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44220821|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220822|NCT00488540|Acetaminophen|acetaminophen|mesh-list
44220823|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220824|NCT00488540|Analgesics|analgesics|mesh-ancestor
44220825|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
44220826|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220827|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220828|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
44220829|NCT00488566|Lamotrigine|lamotrigine|mesh-list
44220830|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
44220831|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44220832|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220833|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220834|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220835|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220836|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220837|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220838|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220839|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220840|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44220912|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
44220913|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220914|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220969|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220971|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220972|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220973|NCT00489151|Lamivudine|lamivudine|mesh-list
44220974|NCT00489151|Adefovir|adefovir|mesh-list
44220975|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44220976|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44220977|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44220978|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220979|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847163|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43847165|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220980|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
44220981|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220982|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44220983|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44220984|NCT00489164|Sirolimus|sirolimus|mesh-list
44221096|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44221097|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221098|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457440|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
44221099|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221100|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221101|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221102|NCT00489775|Analgesics|analgesics|mesh-ancestor
44221103|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
44221104|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284583|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221105|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
43625901|NCT03097445|Nicotine|nicotine|mesh-list
44221137|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221138|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44221139|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44221140|NCT00489944|Growth Substances|growth substances|mesh-ancestor
44221141|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221142|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
44221143|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221144|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221145|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44221146|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
44221173|NCT00489996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221175|NCT00489996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221176|NCT00489996|Immunologic Factors|immunologic factors|mesh-ancestor
44221177|NCT00489996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221178|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
44221179|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44221180|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
44221181|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44221182|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221183|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44221184|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44221185|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44221186|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
44221187|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
44221189|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
44221190|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221191|NCT00490178|Metformin|metformin|mesh-list
44221192|NCT00490178|Fenofibrate|fenofibrate|mesh-list
44221193|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221194|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221251|NCT00490360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221252|NCT00490360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221253|NCT00490360|Immunologic Factors|immunologic factors|mesh-ancestor
44221254|NCT00490360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221255|NCT00490373|Pemetrexed|pemetrexed|mesh-list
44221256|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221257|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221258|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221259|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44221260|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44221261|NCT00490399|Gemcitabine|gemcitabine|mesh-list
44221262|NCT00490399|Cisplatin|cisplatin|mesh-list
44221263|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221264|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221265|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
44221266|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221267|NCT00490399|Antiviral Agents|antiviral agents|mesh-ancestor
44221268|NCT00490399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221269|NCT00490399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221306|NCT00490659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221307|NCT00490685|Sorafenib|sorafenib|mesh-list
44221308|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221373|NCT00490880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221374|NCT00490880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221375|NCT00490880|Immunologic Factors|immunologic factors|mesh-ancestor
44221376|NCT00490880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221377|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
44221378|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221379|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457441|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44457442|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
44457443|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457444|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457445|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44457446|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
44457447|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
44457448|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44457449|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457450|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457451|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457453|NCT01609933|Ritonavir|ritonavir|mesh-list
44284584|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284585|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44284586|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44284587|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
44284588|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284589|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284590|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
44284591|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
44284592|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284593|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44284594|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44284595|NCT00751556|Naproxen|naproxen|mesh-list
43668206|NCT03789916|Analgesics|analgesics|mesh-ancestor
44457454|NCT01609933|Ribavirin|ribavirin|mesh-list
44457455|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
44457456|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
44457457|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43626132|NCT03095209|Carboplatin|carboplatin|mesh-list
44221403|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221405|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
44221406|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
43691198|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44221407|NCT00490997|Analgesics|analgesics|mesh-ancestor
44221408|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
44221409|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221410|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44221411|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44221412|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44221413|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221414|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221415|NCT00491049|Levofloxacin|levofloxacin|mesh-list
44221416|NCT00491049|Ofloxacin|ofloxacin|mesh-list
44221417|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44221418|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44221419|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44221420|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221421|NCT00491049|Renal Agents|renal agents|mesh-ancestor
44221422|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221423|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44221424|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44221425|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626156|NCT03095378|Citric Acid|citric acid|mesh-list
44221457|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221458|NCT00491127|Antiviral Agents|antiviral agents|mesh-ancestor
44221459|NCT00491127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221460|NCT00491127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221461|NCT00491127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221462|NCT00491127|Immunologic Factors|immunologic factors|mesh-ancestor
44221463|NCT00491166|Bromfenac|bromfenac|mesh-list
44221464|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44221465|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44221466|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44221467|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44221567|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
44221568|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221569|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221570|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44221571|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44221572|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221573|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
44221574|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221575|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44221576|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44284596|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284597|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44221577|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221610|NCT00491920|Vitamins|vitamins|mesh-ancestor
44221611|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
44221612|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221613|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221614|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44221615|NCT00491946|Dactinomycin|dactinomycin|mesh-list
44221616|NCT00491946|Vincristine|vincristine|mesh-list
44221617|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44221618|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221619|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44221620|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44221621|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44221649|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221650|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44221651|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44221652|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221653|NCT00492128|Losartan|losartan|mesh-list
44221654|NCT00492128|Amlodipine|amlodipine|mesh-list
44221655|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44221656|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44221657|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44221658|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221659|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221660|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44221661|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221662|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221663|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44221697|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221698|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44221699|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221700|NCT00492258|Sorafenib|sorafenib|mesh-list
44221701|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221702|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221703|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221769|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221770|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44221771|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44221772|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43691516|NCT02786823|Folic Acid|folic acid|mesh-list
43691726|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43691732|NCT02785146|Leucovorin|leucovorin|mesh-list
44221773|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221774|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
44221775|NCT00492518|Theophylline|theophylline|mesh-list
44221776|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44221777|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
44221778|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221816|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221850|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44221851|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
44221852|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221854|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221855|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457461|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44457462|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44457490|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457491|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44457492|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44457493|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44457494|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457495|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44457496|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457497|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44457498|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457499|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457501|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457502|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44457503|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44457504|NCT01609231|Irinotecan|irinotecan|mesh-list
44284598|NCT00751556|Analgesics|analgesics|mesh-ancestor
44284599|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
44284600|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284601|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284602|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284603|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457505|NCT01609231|Cetuximab|cetuximab|mesh-list
44221856|NCT00492934|Menotropins|menotropins|mesh-list
44221857|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44221858|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
44221859|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44221860|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221862|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221884|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
44221885|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221886|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221887|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221888|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
44221889|NCT00493116|Hormones|hormones|mesh-ancestor
44221890|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221891|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44221892|NCT00493116|Protective Agents|protective agents|mesh-ancestor
44221893|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
44221894|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44221895|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
44221896|NCT00493129|Interleukin-2|interleukin-2|mesh-list
44221897|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221898|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44221899|NCT00493129|Analgesics|analgesics|mesh-ancestor
44221900|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
44221901|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221902|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221903|NCT00493194|Cyclosporine|cyclosporine|mesh-list
44221904|NCT00493194|Sirolimus|sirolimus|mesh-list
44221905|NCT00493194|Cyclosporins|cyclosporins|mesh-list
44221906|NCT00493194|Daclizumab|daclizumab|mesh-list
43691965|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221907|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221908|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221909|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221910|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
44221911|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221912|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
44221913|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221914|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
44221915|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44221916|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44221917|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221918|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44221919|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221984|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221985|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221986|NCT00493480|Propranolol|propranolol|mesh-list
44221987|NCT00493480|Carvedilol|carvedilol|mesh-list
44221988|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44221989|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44221990|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
44221991|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221992|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221993|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221994|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43692037|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221995|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44221996|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221997|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
44221998|NCT00493480|Protective Agents|protective agents|mesh-ancestor
44221999|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44222000|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222001|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44222002|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44222003|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44284604|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
44284605|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44284606|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222027|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44222028|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
44222029|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222030|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
44222031|NCT00493662|Protective Agents|protective agents|mesh-ancestor
44222032|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
44222033|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44222034|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
44222035|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222036|NCT00493727|Expectorants|expectorants|mesh-ancestor
44222037|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
44222038|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44222039|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
44222040|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222041|NCT00493727|Protective Agents|protective agents|mesh-ancestor
44222042|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222043|NCT00493727|Antidotes|antidotes|mesh-ancestor
44222044|NCT00493766|Panobinostat|panobinostat|mesh-list
44222045|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222046|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44222047|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222048|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222049|NCT00493831|Nicotine|nicotine|mesh-list
44222050|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44222051|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
44222052|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222053|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222054|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43626688|NCT03088072|Aspirin|aspirin|mesh-list
44222119|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
44222120|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222121|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222122|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222123|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222124|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44222125|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44222126|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222127|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44222128|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43626776|NCT03084783|Hormones|hormones|mesh-ancestor
44222193|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
44222194|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44222195|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
44222196|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222197|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222198|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44222199|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44222200|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222201|NCT00494598|Sufentanil|sufentanil|mesh-list
44222202|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44222203|NCT00494598|Narcotics|narcotics|mesh-ancestor
44222204|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222205|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222206|NCT00494598|Analgesics|analgesics|mesh-ancestor
44222207|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
44222208|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222209|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44222210|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44222211|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
44222244|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222245|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
44222246|NCT00494741|Azathioprine|azathioprine|mesh-list
44222247|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44222248|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222249|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43626858|NCT03079453|Hormones|hormones|mesh-ancestor
44457529|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457530|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
44457531|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457532|NCT01608724|Saxagliptin|saxagliptin|mesh-list
44284607|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284609|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44457533|NCT01608724|Incretins|incretins|mesh-ancestor
44457534|NCT01608724|Hormones|hormones|mesh-ancestor
43626906|NCT03079219|Hormones|hormones|mesh-ancestor
44222273|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222274|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222275|NCT00494884|Vildagliptin|vildagliptin|mesh-list
44222276|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829488|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
43829489|NCT05422027|Lenalidomide|lenalidomide|mesh-list
43829490|NCT05422027|Bortezomib|bortezomib|mesh-list
43829491|NCT05422027|BB 1101|bb 1101|mesh-list
43829492|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829493|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
44222277|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222278|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44222279|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
44222280|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626933|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222315|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44222317|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44222318|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222319|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43626976|NCT03079141|Diuretics|diuretics|mesh-ancestor
44222389|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222390|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222391|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
44222392|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222393|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222394|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
44222395|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222396|NCT00495313|Metronidazole|metronidazole|mesh-list
44222430|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44222431|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
44222432|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44222433|NCT00495339|Levofloxacin|levofloxacin|mesh-list
44222434|NCT00495339|Ofloxacin|ofloxacin|mesh-list
44222435|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43627053|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
44222458|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44222460|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
44222461|NCT00495365|Hematinics|hematinics|mesh-ancestor
44222462|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
44222463|NCT00495378|Hematinics|hematinics|mesh-ancestor
44222464|NCT00495547|Azacitidine|azacitidine|mesh-list
44222465|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
44222466|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222467|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
44222468|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222469|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222470|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222471|NCT00495547|Hematinics|hematinics|mesh-ancestor
44222472|NCT00495560|Misoprostol|misoprostol|mesh-list
44222473|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44222474|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
44222475|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44222476|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222477|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44222478|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44222479|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
44222480|NCT00495573|Acyclovir|acyclovir|mesh-list
44222481|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
44222482|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222483|NCT00495651|Isoniazid|isoniazid|mesh-list
44222484|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44222485|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
44222486|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222537|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222538|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44222539|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222540|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
43829494|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
43829497|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44222541|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222542|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
44222543|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222544|NCT00496002|Adefovir|adefovir|mesh-list
44222545|NCT00496002|Clevudine|clevudine|mesh-list
44222546|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
44222547|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222548|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44222549|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44284610|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284611|NCT00751699|Analgesics|analgesics|mesh-ancestor
44284612|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
44284613|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539476|NCT02926690|OTS167|ots167|mesh-list
44222550|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627125|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222615|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222616|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
44222617|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222618|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222619|NCT00496301|Antiviral Agents|antiviral agents|mesh-ancestor
44222620|NCT00496301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222621|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222654|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
44222655|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222656|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222657|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
44222658|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44222659|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222660|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222661|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
44222662|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222663|NCT00496600|Everolimus|everolimus|mesh-list
44222664|NCT00496600|Epothilone B|epothilone b|mesh-list
44222665|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222696|NCT00496704|Gemcitabine|gemcitabine|mesh-list
44222697|NCT00496704|Capecitabine|capecitabine|mesh-list
44222698|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
44222699|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222700|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
44222701|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222702|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222703|NCT00496704|Antiviral Agents|antiviral agents|mesh-ancestor
44222704|NCT00496704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222705|NCT00496704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222706|NCT00496704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222707|NCT00496704|Immunologic Factors|immunologic factors|mesh-ancestor
44222708|NCT00496704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222724|NCT00497003|Protective Agents|protective agents|mesh-ancestor
44222725|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44222726|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222727|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44222728|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
44222729|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44222730|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44222731|NCT00497016|Atorvastatin|atorvastatin|mesh-list
44222732|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44222733|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44222734|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
44222735|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222736|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44222737|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44222738|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222739|NCT00497029|Fluorides|fluorides|mesh-list
44222740|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
44222741|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
44222742|NCT00497029|Protective Agents|protective agents|mesh-ancestor
44222743|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222744|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
44222745|NCT00497107|Leucovorin|leucovorin|mesh-list
44222746|NCT00497107|Calcium|calcium|mesh-list
43693133|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547784|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
44222747|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
44222748|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44222749|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222750|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44222751|NCT00497107|Antidotes|antidotes|mesh-ancestor
44222752|NCT00497107|Protective Agents|protective agents|mesh-ancestor
44222753|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
44222754|NCT00497107|Vitamins|vitamins|mesh-ancestor
44222755|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
44222756|NCT00497120|Acetazolamide|acetazolamide|mesh-list
44222757|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
44284614|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222758|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44222759|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627258|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222780|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
44222781|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44222782|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222783|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44222784|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
44222785|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222786|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222787|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44222788|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
44222789|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
44222790|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44222791|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44222792|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44222793|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44222794|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222795|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222796|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222797|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
44222798|NCT00497237|Hormones|hormones|mesh-ancestor
44222799|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222800|NCT00497250|Gefitinib|gefitinib|mesh-list
44222801|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222802|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44222803|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222804|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222805|NCT00497315|Cisplatin|cisplatin|mesh-list
44222806|NCT00497315|Pemetrexed|pemetrexed|mesh-list
44222807|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222808|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222809|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222810|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44222811|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44222812|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
43627312|NCT03074773|Hormones|hormones|mesh-ancestor
44222850|NCT00497497|Bevacizumab|bevacizumab|mesh-list
44222851|NCT00497497|Cetuximab|cetuximab|mesh-list
44222852|NCT00497497|Irinotecan|irinotecan|mesh-list
44222883|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222885|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44222886|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
44222887|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
43693452|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
43693453|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
43693454|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693455|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693456|NCT02773979|Chloroquine|chloroquine|mesh-list
43693457|NCT02773979|Amebicides|amebicides|mesh-ancestor
43693458|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43693487|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
43693488|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44222888|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44222889|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222890|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222891|NCT00497562|Tramadol|tramadol|mesh-list
44222892|NCT00497562|Amitriptyline|amitriptyline|mesh-list
44222893|NCT00497562|Fluoxetine|fluoxetine|mesh-list
44222894|NCT00497562|Hormones|hormones|mesh-list
44222924|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44222925|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222926|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222927|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
44222928|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44222929|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44222930|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44222931|NCT00497614|Adalimumab|adalimumab|mesh-list
44222932|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222933|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222934|NCT00497744|Cefepime|cefepime|mesh-list
44222935|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222936|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222937|NCT00497809|Lenograstim|lenograstim|mesh-list
44222970|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44222971|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
44222972|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
44222973|NCT00498108|Rotigotine|rotigotine|mesh-list
44222974|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
44222975|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
44222976|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222977|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284615|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284616|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222978|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222979|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
44223015|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44223016|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760835|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44223054|NCT00498342|Expectorants|expectorants|mesh-ancestor
44223055|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
44223056|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44223066|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223067|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44223068|NCT00498537|Diuretics|diuretics|mesh-ancestor
44223104|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44223105|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
44223135|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877450|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
44223136|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223137|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
44223138|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223139|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693489|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44223140|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
44223141|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223142|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223143|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223144|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44223145|NCT00498979|Interferons|interferons|mesh-list
44223146|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
44223147|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
44223148|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44223149|NCT00498979|Cisplatin|cisplatin|mesh-list
44223150|NCT00498979|Dacarbazine|dacarbazine|mesh-list
44223151|NCT00498979|Vinblastine|vinblastine|mesh-list
44223152|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223183|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223184|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
44223185|NCT00498992|Protective Agents|protective agents|mesh-ancestor
44223186|NCT00499005|Carbetocin|carbetocin|mesh-list
44223187|NCT00499005|Oxytocin|oxytocin|mesh-list
44223188|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
44223189|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223190|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223191|NCT00499018|Cytarabine|cytarabine|mesh-list
44223192|NCT00499018|Prednisone|prednisone|mesh-list
44223193|NCT00499018|Rituximab|rituximab|mesh-list
44223194|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
44223195|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
44223196|NCT00499018|Vincristine|vincristine|mesh-list
44223197|NCT00499018|Doxorubicin|doxorubicin|mesh-list
44223198|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44223199|NCT00499018|Lenograstim|lenograstim|mesh-list
44223233|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223234|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44223235|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44223236|NCT00499135|Growth Substances|growth substances|mesh-ancestor
44223237|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223238|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
44223239|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223271|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
44223272|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223273|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223274|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223275|NCT00499577|Vaccines|vaccines|mesh-list
44223276|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44223277|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
44223278|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223279|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
44223280|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44223281|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761020|NCT02441894|Ranitidine|ranitidine|mesh-list
44223316|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223317|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223318|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223319|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
44223320|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223348|NCT00499850|Vitamins|vitamins|mesh-ancestor
44223349|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
44284617|NCT00751738|Azimilide|azimilide|mesh-list
44284618|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44284619|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44284620|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43539655|NCT01445509|Dasatinib|dasatinib|mesh-list
44223350|NCT00499876|Mefloquine|mefloquine|mesh-list
44223351|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
44223352|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44223353|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44223354|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223355|NCT00499993|Lanreotide|lanreotide|mesh-list
44223356|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223357|NCT00500006|Dasatinib|dasatinib|mesh-list
44223358|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223359|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223360|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223361|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223362|NCT00500058|Rituximab|rituximab|mesh-list
44223363|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223364|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223365|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
44223366|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223367|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223368|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44223369|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
44223404|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223406|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
44223407|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223408|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223441|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44223442|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44223443|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44457583|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44457584|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44457585|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457586|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457587|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43761126|NCT02441816|Aflibercept|aflibercept|mesh-list
44457623|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44457624|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44457625|NCT01606319|Analgesics|analgesics|mesh-ancestor
44457626|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
44457627|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457628|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457629|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
44223455|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223485|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
44223486|NCT00500864|Analgesics|analgesics|mesh-ancestor
44223487|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
44223488|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223489|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223490|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
44223491|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44223492|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44223493|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
44223494|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44223495|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44223496|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761234|NCT02440347|Anesthetics|anesthetics|mesh-list
44223530|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223531|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
44223532|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44223533|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223534|NCT00501241|ATI 7505|ati 7505|mesh-list
44223535|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44223536|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44223537|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
44223538|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223612|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
44223643|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
44284621|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284622|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44223644|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223645|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44223646|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44223647|NCT00501579|Protective Agents|protective agents|mesh-ancestor
44223648|NCT00501605|Cediranib|cediranib|mesh-list
44223649|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223650|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223651|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223652|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223653|NCT00501618|Clozapine|clozapine|mesh-list
44223654|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44223655|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
44223688|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223689|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
44223690|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223691|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223692|NCT00501787|Metformin|metformin|mesh-list
44223693|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223694|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223695|NCT00501839|Clomiphene|clomiphene|mesh-list
44223730|NCT00501982|Poractant alfa|poractant alfa|mesh-list
44223731|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44223732|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
44223733|NCT00502034|Interferons|interferons|mesh-list
44223734|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
44223735|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
44223736|NCT00502034|Interleukin-2|interleukin-2|mesh-list
44223737|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223770|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223771|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
44223772|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223773|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
44223774|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223775|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
44223776|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223777|NCT00502112|Lenalidomide|lenalidomide|mesh-list
44223778|NCT00502112|Lintuzumab|lintuzumab|mesh-list
44223779|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
44223780|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223781|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44223782|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44223840|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223841|NCT00502437|Granisetron|granisetron|mesh-list
44223842|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
44223843|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
44223844|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223845|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223846|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44223847|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44223848|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
44223849|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223850|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223851|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
44223852|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44223853|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223854|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
44223855|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44223856|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44223857|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44223858|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223859|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44223860|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223861|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
44223863|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223864|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223865|NCT00502567|Leucovorin|leucovorin|mesh-list
44223866|NCT00502567|Docetaxel|docetaxel|mesh-list
44223867|NCT00502567|Fluorouracil|fluorouracil|mesh-list
44223902|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
44223903|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223904|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284623|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284624|NCT00751751|Losartan|losartan|mesh-list
43693840|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
44284625|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44284626|NCT00751751|Olmesartan|olmesartan|mesh-list
44284627|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44284628|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44223905|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223906|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44223907|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44223908|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
44223909|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44223910|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223911|NCT00502684|Analgesics|analgesics|mesh-ancestor
44223978|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44223979|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44223980|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223981|NCT00503204|Cediranib|cediranib|mesh-list
44223982|NCT00503204|Lomustine|lomustine|mesh-list
44223983|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223984|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223985|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224050|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224051|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224052|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224053|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224054|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44224055|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44224056|NCT00503503|Etanercept|etanercept|mesh-list
44224057|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224058|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224059|NCT00503503|Analgesics|analgesics|mesh-ancestor
44224060|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
44224061|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224062|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224063|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224064|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224065|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224093|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224094|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
44224095|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44224096|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44224097|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44224098|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
44224099|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224100|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224101|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44224102|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44224103|NCT00503568|Vaccines|vaccines|mesh-list
44224104|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
44224105|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224106|NCT00503594|Cytarabine|cytarabine|mesh-list
44224107|NCT00503594|Methotrexate|methotrexate|mesh-list
44224108|NCT00503594|Vincristine|vincristine|mesh-list
44224109|NCT00503594|Temozolomide|temozolomide|mesh-list
44224110|NCT00503594|Procarbazine|procarbazine|mesh-list
44224111|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44224112|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
44224113|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224129|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
44224130|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
44224131|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
44224132|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44224133|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
44224134|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44224135|NCT00503607|Laxatives|laxatives|mesh-ancestor
44224136|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224137|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
44224138|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44224139|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44224140|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44284629|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44284630|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44284631|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44284632|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284633|NCT00751751|Diuretics|diuretics|mesh-ancestor
44284634|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
44284635|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224141|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224142|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224143|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
44224144|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224145|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224146|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44224147|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224148|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
44224149|NCT00503659|Miotics|miotics|mesh-ancestor
44224150|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
44224151|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224152|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224153|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44224154|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44224155|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224156|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44224157|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44224158|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44224159|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224160|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224161|NCT00503763|Simvastatin|simvastatin|mesh-list
44224162|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44224163|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224164|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
44224165|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224166|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224167|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44224168|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224169|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44224170|NCT00503815|Laxatives|laxatives|mesh-ancestor
43761753|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
44457658|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44457659|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44457661|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457662|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457663|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44457664|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44457665|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
44457666|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44457667|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44457668|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457704|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44224241|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224242|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44224243|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224245|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224246|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
44224247|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224248|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
44224249|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224285|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
44224286|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224287|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224288|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224289|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224290|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284636|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44284637|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44284638|NCT00751764|Moxidectin|moxidectin|mesh-list
44284639|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
44284640|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44224326|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224328|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44224366|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224367|NCT00504673|Insulin|insulin|mesh-list
44224400|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224401|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224402|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224403|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
44224404|NCT00504946|Vitamin D|vitamin d|mesh-list
44224405|NCT00504946|Prednisone|prednisone|mesh-list
44224406|NCT00504946|Budesonide|budesonide|mesh-list
44224407|NCT00504946|Montelukast|montelukast|mesh-list
43762027|NCT02433808|Neostigmine|neostigmine|mesh-list
44224443|NCT00505102|Everolimus|everolimus|mesh-list
44224474|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44224475|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224476|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224478|NCT00505336|Atorvastatin|atorvastatin|mesh-list
44224479|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44224480|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224481|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
44224482|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224483|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224484|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44224485|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224486|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44224522|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
44224523|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224524|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44224525|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44224526|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
44224543|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224544|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
44224545|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224546|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224547|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
44224548|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224549|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44224550|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44224551|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224552|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224553|NCT00505739|Mifepristone|mifepristone|mesh-list
44224554|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44224555|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
44224556|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224557|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224558|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44224559|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44224560|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44224561|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
44224562|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44224563|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44224564|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44224565|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224566|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
44224567|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44224568|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44224569|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44224570|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
44224571|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224572|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
44224573|NCT00505804|Haloperidol|haloperidol|mesh-list
44224574|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
44224575|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44224576|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284641|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284642|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
44284643|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44284644|NCT00751829|Olmesartan|olmesartan|mesh-list
44284645|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43540019|NCT00725374|Hormones|hormones|mesh-ancestor
44224577|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224578|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224579|NCT00505804|Analgesics|analgesics|mesh-ancestor
44224580|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
44224581|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224582|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44224583|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44224584|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44224585|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44224619|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224620|NCT00505947|Infliximab|infliximab|mesh-list
44224621|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224622|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224623|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457724|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
44457725|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
44457726|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457727|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224626|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224627|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224628|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44224629|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44224630|NCT00506168|Capecitabine|capecitabine|mesh-list
44224631|NCT00506168|Irinotecan|irinotecan|mesh-list
44224632|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224633|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
44224634|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644886|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
44224635|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644887|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224636|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224637|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224638|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224639|NCT00506194|Gliclazide|gliclazide|mesh-list
44224640|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44224641|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224642|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
44224643|NCT00506207|Irinotecan|irinotecan|mesh-list
44224644|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224645|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224646|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224647|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224648|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224649|NCT00506246|Propofol|propofol|mesh-list
44224650|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44224651|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224652|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224653|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44224654|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
44224655|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
44224656|NCT00506259|Melatonin|melatonin|mesh-list
44224657|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
44224658|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224733|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224838|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224839|NCT00507195|Midazolam|midazolam|mesh-list
44224840|NCT00507195|Propofol|propofol|mesh-list
44224841|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44224842|NCT00507195|Sevoflurane|sevoflurane|mesh-list
44224879|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44224917|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
44224918|NCT00507585|Vitamins|vitamins|mesh-ancestor
44224919|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
44224920|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
44224921|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44224922|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44224959|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44224960|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284646|NCT00751829|Nitrendipine|nitrendipine|mesh-list
44284647|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44284648|NCT00751829|Diuretics|diuretics|mesh-ancestor
44284649|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
43540096|NCT00598208|Hormones|hormones|mesh-ancestor
44457762|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44457763|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
44457764|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
44457765|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44457766|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
43762539|NCT02431221|Perhexiline|perhexiline|mesh-list
44225013|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44225014|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44225015|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44225016|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
43762575|NCT02431013|Cilostazol|cilostazol|mesh-list
44225051|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225052|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225053|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225054|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847901|NCT04069156|Aspirin|aspirin|mesh-list
44225121|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225122|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225123|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
44225124|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44225125|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225126|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
44225127|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225128|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44225129|NCT00508690|Metronidazole|metronidazole|mesh-list
44225130|NCT00508690|Kanamycin|kanamycin|mesh-list
44225131|NCT00508690|Cefmetazole|cefmetazole|mesh-list
44225132|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225133|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225134|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225135|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225136|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44225171|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
44225172|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
44225173|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44225174|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695145|NCT02763761|Prednisone|prednisone|mesh-list
44225208|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44225209|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
44225210|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44225211|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225212|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225213|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44225214|NCT00509015|Renal Agents|renal agents|mesh-ancestor
44225215|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44225216|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44225217|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44225241|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225242|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225243|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225244|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225245|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43695423|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225246|NCT00509379|Rituximab|rituximab|mesh-list
44225247|NCT00509379|Bortezomib|bortezomib|mesh-list
44225248|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44225249|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225250|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
44225251|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225252|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225253|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
44225254|NCT00509405|Diuretics|diuretics|mesh-ancestor
44225255|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
44225256|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225257|NCT00509405|Expectorants|expectorants|mesh-ancestor
44225258|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
44225259|NCT00509431|Sirolimus|sirolimus|mesh-list
44225260|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44225261|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225262|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284650|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284651|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44284652|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668258|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225263|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225264|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225265|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225266|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225267|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225268|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
44225269|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225270|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
43762719|NCT02429960|Narcotics|narcotics|mesh-ancestor
44225300|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225301|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225302|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225303|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225304|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
44225305|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225306|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
44225307|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225308|NCT00509639|Metronidazole|metronidazole|mesh-list
44225309|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225310|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225311|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225312|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225313|NCT00509678|Rituximab|rituximab|mesh-list
44225314|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44225397|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
44225398|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225399|NCT00510159|Artesunate|artesunate|mesh-list
44225400|NCT00510159|Sulfalene|sulfalene|mesh-list
44225401|NCT00510159|Praziquantel|praziquantel|mesh-list
44225402|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
44225403|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225404|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225405|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225406|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225407|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
44225434|NCT00510250|Cisplatin|cisplatin|mesh-list
44225435|NCT00510250|Sorafenib|sorafenib|mesh-list
44225436|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225437|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225438|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225439|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225440|NCT00510263|Valacyclovir|valacyclovir|mesh-list
44225441|NCT00510263|Prednisolone|prednisolone|mesh-list
44225442|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44225443|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
44225444|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44225445|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
44225446|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44225447|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
44225448|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225449|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
44225450|NCT00510263|Hormones|hormones|mesh-ancestor
44225451|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225452|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225453|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225454|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225455|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
44225456|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
44225457|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225478|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225480|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44225481|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225482|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44225483|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225484|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225485|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
44225486|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284653|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284654|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44225487|NCT00510393|Everolimus|everolimus|mesh-list
44225488|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225489|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225490|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
44225491|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225492|NCT00510406|Tamsulosin|tamsulosin|mesh-list
44225493|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
44225494|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44225495|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44225496|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44225497|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
44225498|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225499|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225500|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225501|NCT00510406|Urological Agents|urological agents|mesh-ancestor
44225502|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44225503|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44225504|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
44225505|NCT00510419|Sumatriptan|sumatriptan|mesh-list
44225506|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44225507|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44225508|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44225509|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
44225510|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837547|NCT04903509|Incretins|incretins|mesh-ancestor
44225539|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44225540|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225541|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225542|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
44225543|NCT00510627|Irinotecan|irinotecan|mesh-list
44225544|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225545|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44225546|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225547|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225548|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225549|NCT00510640|Sunitinib|sunitinib|mesh-list
44225550|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225551|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44225552|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44225553|NCT00510640|Growth Substances|growth substances|mesh-ancestor
44225554|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225555|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44225556|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43762983|NCT02428777|Diclofenac|diclofenac|mesh-list
44225571|NCT00510705|Metformin|metformin|mesh-list
44225572|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225573|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225574|NCT00510913|Tacrolimus|tacrolimus|mesh-list
44225575|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225576|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
44225577|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225578|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44225579|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225580|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225581|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
44225582|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225583|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225584|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225585|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225586|NCT00510939|Bortezomib|bortezomib|mesh-list
44225587|NCT00510939|Tipifarnib|tipifarnib|mesh-list
44225588|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225589|NCT00510965|Ranibizumab|ranibizumab|mesh-list
44225590|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44225591|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44225592|NCT00510965|Growth Substances|growth substances|mesh-ancestor
44225593|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225594|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
44225595|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225596|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44225597|NCT00511017|Vitamins|vitamins|mesh-ancestor
44284655|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44284656|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44225598|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
44225599|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225600|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44225601|NCT00511069|Bortezomib|bortezomib|mesh-list
44225602|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225603|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44225604|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
44225605|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225606|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225607|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225608|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225609|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
44225610|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225611|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
44225612|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44225613|NCT00511212|Antibodies|antibodies|mesh-list
44225614|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
44225615|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44225616|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
44225617|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225618|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
44225619|NCT00511225|Vitamin D|vitamin d|mesh-list
44225653|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225654|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225655|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44225656|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
44225657|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
44225797|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225798|NCT00512265|Antidotes|antidotes|mesh-ancestor
44225799|NCT00512291|Olanzapine|olanzapine|mesh-list
44225800|NCT00512291|Fluoxetine|fluoxetine|mesh-list
44225801|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
44225802|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
44225834|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
44225835|NCT00512408|Testosterone|testosterone|mesh-list
44225836|NCT00512408|Androgens|androgens|mesh-ancestor
44225837|NCT00512408|Hormones|hormones|mesh-ancestor
44225838|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225839|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225840|NCT00512473|Hormones|hormones|mesh-list
44225841|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225842|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763222|NCT02427334|Dienogest|dienogest|mesh-list
44225866|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225867|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225868|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
44225869|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225870|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
44225871|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
44225872|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
44225873|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225874|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
44225875|NCT00512681|Irinotecan|irinotecan|mesh-list
44225876|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225877|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44225878|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225879|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225880|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225881|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
44225882|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225883|NCT00512811|Furosemide|furosemide|mesh-list
44225884|NCT00512811|Diuretics|diuretics|mesh-ancestor
44225885|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
44225886|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225887|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44225888|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225889|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225890|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
44225891|NCT00512824|Calcium|calcium|mesh-list
44225892|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44225893|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225894|NCT00512824|Antacids|antacids|mesh-ancestor
44284657|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284658|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284659|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
44284660|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225895|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225896|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225957|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225958|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225959|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225960|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225961|NCT00513110|Caffeine|caffeine|mesh-list
44225962|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44225963|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225964|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44225965|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225966|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644970|NCT04319614|Coagulants|coagulants|mesh-ancestor
43644971|NCT04315701|Cemiplimab|cemiplimab|mesh-list
44225967|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44225968|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44225969|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
44225970|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225971|NCT00513149|Clopidogrel|clopidogrel|mesh-list
44225972|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44225973|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44225974|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44225975|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44225976|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
44225977|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225978|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226045|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226046|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226047|NCT00513253|Lapatinib|lapatinib|mesh-list
44226048|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226049|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44226050|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226051|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226052|NCT00513266|Leucovorin|leucovorin|mesh-list
44226053|NCT00513266|Bevacizumab|bevacizumab|mesh-list
44226054|NCT00513266|Cetuximab|cetuximab|mesh-list
44226055|NCT00513266|Fluorouracil|fluorouracil|mesh-list
44226056|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
44226057|NCT00513266|Irinotecan|irinotecan|mesh-list
44226095|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457801|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457802|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457803|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457804|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457805|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457806|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44457807|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457808|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
43644972|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457809|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44457810|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44457811|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44457812|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457813|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457814|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457815|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457816|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457817|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44226145|NCT00513552|Clarithromycin|clarithromycin|mesh-list
44226146|NCT00513552|Rifabutin|rifabutin|mesh-list
44226147|NCT00513552|Clofazimine|clofazimine|mesh-list
44226148|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226149|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226150|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44226151|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226152|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226153|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44226154|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284661|NCT00751907|Atorvastatin|atorvastatin|mesh-list
44284662|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44284663|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44284664|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
44284665|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226155|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44226156|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
44226157|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226158|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
44226159|NCT00513578|Sargramostim|sargramostim|mesh-list
44226160|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
44226161|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
44226226|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226227|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
44226228|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226229|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226230|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226231|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
44226232|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226233|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226234|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44226235|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44226236|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226237|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226238|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226239|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226240|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226241|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226242|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226243|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226244|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
44226245|NCT00513955|Hormones|hormones|mesh-ancestor
44226246|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226247|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44226248|NCT00513968|Adefovir|adefovir|mesh-list
44226249|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
43763559|NCT02425709|Diclofenac|diclofenac|mesh-list
44226359|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226360|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226361|NCT00514527|Oritavancin|oritavancin|mesh-list
44226362|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226363|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226364|NCT00514605|Antibodies|antibodies|mesh-list
44226396|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226397|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44226398|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44226399|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226400|NCT00514891|Vitamin A|vitamin a|mesh-list
44226401|NCT00514891|Vitamins|vitamins|mesh-ancestor
44226402|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
44226403|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226404|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
44226405|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226406|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44226407|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226446|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226514|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
44226515|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226516|NCT00515489|Risperidone|risperidone|mesh-list
44226517|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44226518|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
44226519|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226520|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457846|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457847|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457848|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457884|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44457886|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
44226561|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226562|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
44284666|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44284667|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44284668|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284669|NCT00751959|Poractant alfa|poractant alfa|mesh-list
44284670|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44226563|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226564|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226565|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
44226566|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226567|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226568|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
44226569|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763848|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
44226603|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
44226604|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44226605|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44226606|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
44226607|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44226608|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44226609|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44226610|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226611|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226612|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44226643|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226644|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226645|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
44226646|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226647|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44226648|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
44226649|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44226650|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44226651|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44226652|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226653|NCT00516152|Methotrexate|methotrexate|mesh-list
44226654|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
44226655|NCT00516152|Fludarabine|fludarabine|mesh-list
44226692|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226693|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44226724|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226725|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
44226726|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226727|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
44226728|NCT00516425|Doxorubicin|doxorubicin|mesh-list
44226729|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44226730|NCT00516425|Epirubicin|epirubicin|mesh-list
44226731|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226732|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
44226733|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226734|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226735|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226736|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
44226737|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226738|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226739|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44226775|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
44226776|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226777|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226806|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226807|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226808|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226809|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226810|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44226811|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
44226812|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226813|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226814|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226815|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
44284671|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
44284672|NCT00752011|Carboplatin|carboplatin|mesh-list
44284673|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284674|NCT00752024|Hemostatics|hemostatics|mesh-list
44226816|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226817|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44226818|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226819|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
44226820|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226821|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226822|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226823|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226851|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
44226852|NCT00516854|Clidinium|clidinium|mesh-list
44226853|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44226854|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44226855|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226856|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226857|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44226858|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44226859|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44226860|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
44226861|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
44226862|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226863|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226864|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
44226865|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
44226866|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226867|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
44226868|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226869|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226870|NCT00516945|Lamivudine|lamivudine|mesh-list
43764063|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
44226899|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226900|NCT00517062|Hormones|hormones|mesh-list
44226901|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226902|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226903|NCT00517114|Rabeprazole|rabeprazole|mesh-list
44226904|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44226905|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226906|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44226907|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226908|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226909|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44226910|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
44226911|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44226912|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44226913|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226914|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226950|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43697355|NCT04723004|Growth Substances|growth substances|mesh-ancestor
44457888|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457889|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226959|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
44226960|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44226961|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226962|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226963|NCT00517426|Diuretics|diuretics|mesh-ancestor
44226964|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
44226965|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226966|NCT00517491|Lanreotide|lanreotide|mesh-list
44226967|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226968|NCT00517504|Methylphenidate|methylphenidate|mesh-list
44226989|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226990|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44226991|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44226992|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226993|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44226994|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226995|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
44226996|NCT00517621|Paclitaxel|paclitaxel|mesh-list
44284676|NCT00752037|Ritonavir|ritonavir|mesh-list
44284677|NCT00752037|Lopinavir|lopinavir|mesh-list
44284678|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
44284679|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44226997|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226998|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226999|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
44227000|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
44227001|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
44227002|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227003|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
44227004|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227005|NCT00517725|Carvedilol|carvedilol|mesh-list
44227006|NCT00517725|Nebivolol|nebivolol|mesh-list
44227007|NCT00517725|Bisoprolol|bisoprolol|mesh-list
44227008|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44227009|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44227010|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
44227011|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227012|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227013|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227014|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44227015|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
44227016|NCT00517725|Protective Agents|protective agents|mesh-ancestor
44227017|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44227018|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227019|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227020|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
44227035|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227036|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
44227037|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227038|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44227039|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227040|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227041|NCT00517803|Micronutrients|micronutrients|mesh-list
44227042|NCT00517803|Trace Elements|trace elements|mesh-list
44227043|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227044|NCT00517946|Cetirizine|cetirizine|mesh-list
44227045|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
44227046|NCT00517946|Ephedrine|ephedrine|mesh-list
44227047|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44227048|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44227049|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44227050|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
44227051|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
44227052|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227053|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227054|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227055|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44227056|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
44227057|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227058|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44227059|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44227060|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
44227061|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44227062|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44227063|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
44227064|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
44227065|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44227066|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44227067|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227068|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227069|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227070|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227071|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227072|NCT00517985|Analgesics|analgesics|mesh-ancestor
44227073|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
44227074|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227075|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227076|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44284680|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44284681|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284682|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284683|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227077|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
44227078|NCT00518102|Becaplermin|becaplermin|mesh-list
44227079|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
44227113|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227114|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227115|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227117|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227118|NCT00518245|Enoxaparin|enoxaparin|mesh-list
44227119|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
44227132|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227133|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44227134|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227135|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
44227136|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
44227137|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44227138|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44227139|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44227140|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
44227141|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227142|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44227143|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44227144|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227145|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227146|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44227147|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44227148|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
44227149|NCT00518375|Cyclosporine|cyclosporine|mesh-list
44227150|NCT00518375|Sirolimus|sirolimus|mesh-list
44227151|NCT00518375|Cyclosporins|cyclosporins|mesh-list
44227152|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227153|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227154|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227155|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
44227156|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227157|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
44227158|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227159|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
44227160|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227161|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44227162|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227163|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44227164|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227165|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
44227166|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227167|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227168|NCT00518466|Topiramate|topiramate|mesh-list
44227169|NCT00518466|Phentermine|phentermine|mesh-list
44227170|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
44227171|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697716|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
43697925|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
43697926|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697927|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43697929|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43697930|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44227172|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227173|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43881200|NCT04645303|Hormones|hormones|mesh-ancestor
44227174|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
44227175|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44227176|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
44227177|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
44227178|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227179|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
44227180|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227181|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227182|NCT00518479|Amlodipine|amlodipine|mesh-list
44227217|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227218|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44227220|NCT00518895|Oblimersen|oblimersen|mesh-list
44227221|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44227222|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
44227257|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284685|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44227258|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44457918|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457919|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457920|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457921|NCT01601873|Heparin|heparin|mesh-list
44457922|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
43764360|NCT02420652|Analgesics|analgesics|mesh-ancestor
44227300|NCT00519207|Lidocaine|lidocaine|mesh-list
44227301|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
44227329|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44227330|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
44227331|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227332|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227333|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
44227334|NCT00519298|Donepezil|donepezil|mesh-list
44227335|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44227336|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227337|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227338|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44227339|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227340|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227341|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
44227342|NCT00519324|Everolimus|everolimus|mesh-list
44227343|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227344|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227345|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
43764431|NCT02419729|Estrogens|estrogens|mesh-list
44227410|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227411|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227412|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44227413|NCT00519753|Timolol|timolol|mesh-list
44227414|NCT00519753|Travoprost|travoprost|mesh-list
44227415|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44227416|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44227417|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44227418|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44227419|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44227420|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227421|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227422|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227423|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227424|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44227425|NCT00519805|Dalteparin|dalteparin|mesh-list
44227426|NCT00519805|Tinzaparin|tinzaparin|mesh-list
44227427|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44227428|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
44227429|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44227430|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44227431|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227432|NCT00519870|Losartan|losartan|mesh-list
44227433|NCT00519870|Nifedipine|nifedipine|mesh-list
44227434|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227458|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227459|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44227460|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44227461|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227462|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227463|NCT00520000|Carboplatin|carboplatin|mesh-list
44227464|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44227465|NCT00520000|Paclitaxel|paclitaxel|mesh-list
44227466|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227467|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44227468|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
44227469|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
44227470|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
44227471|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227472|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
44227473|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227474|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227475|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227476|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284686|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
44284687|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284688|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44227477|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
44227478|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44227479|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227480|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227481|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
43764517|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44227553|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227554|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227615|NCT00520585|Atorvastatin|atorvastatin|mesh-list
44227616|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44227617|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44227618|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
44227619|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227620|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44227621|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44227622|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227623|NCT00520650|Aripiprazole|aripiprazole|mesh-list
44227624|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227625|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227626|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44227627|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44227628|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227629|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227630|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
44227631|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
44227632|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227633|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227634|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44227635|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44227636|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
44227637|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44227638|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44227669|NCT00520949|Furazolidone|furazolidone|mesh-list
44227670|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44227671|NCT00520949|Esomeprazole|esomeprazole|mesh-list
44227672|NCT00520949|Bismuth|bismuth|mesh-list
44227673|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227674|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227675|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44227676|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227677|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44227678|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227679|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457971|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44457972|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
44457973|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44457975|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44457976|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44457977|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44457978|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44457979|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44457980|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44457981|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44457982|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44457983|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764672|NCT02417506|Ibuprofen|ibuprofen|mesh-list
44227712|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227713|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227739|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
44227740|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227741|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44227742|NCT00521261|Antibodies|antibodies|mesh-list
44227743|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44227744|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
44227745|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227746|NCT00521274|Docetaxel|docetaxel|mesh-list
44227747|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284689|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284690|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44284691|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44227748|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44227749|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44227750|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44227751|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227752|NCT00521300|Octreotide|octreotide|mesh-list
44227753|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227754|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44227755|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227756|NCT00521430|Cyclosporine|cyclosporine|mesh-list
44227757|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
44227758|NCT00521430|Methotrexate|methotrexate|mesh-list
44227759|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
44227760|NCT00521430|Fludarabine|fludarabine|mesh-list
44227761|NCT00521430|Busulfan|busulfan|mesh-list
44227762|NCT00521430|Cyclosporins|cyclosporins|mesh-list
44227763|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43881735|NCT04634058|Antibodies|antibodies|mesh-list
43764743|NCT02417298|Ketamine|ketamine|mesh-list
44227797|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44227798|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
44227799|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227800|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227801|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227802|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
43764794|NCT02416752|Remifentanil|remifentanil|mesh-list
44227839|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764835|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44227875|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227877|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227878|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227879|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
44227916|NCT00522184|Etanercept|etanercept|mesh-list
44227917|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227918|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227919|NCT00522184|Analgesics|analgesics|mesh-ancestor
44227954|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227956|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227957|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227958|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
44227959|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44227960|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227997|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227998|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458021|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44458022|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44458023|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44458024|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
44458025|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458026|NCT01600885|Guanfacine|guanfacine|mesh-list
44458027|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44458028|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44458029|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44458030|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44458031|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
44458032|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228005|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228006|NCT00522782|Budesonide|budesonide|mesh-list
44228007|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
44228008|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228009|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44228010|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
44228011|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228012|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228013|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44228014|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
44228015|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
44228016|NCT00522782|Hormones|hormones|mesh-ancestor
44228017|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284692|NCT00752063|Capecitabine|capecitabine|mesh-list
44284693|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
44284694|NCT00752063|Sorafenib|sorafenib|mesh-list
44284695|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228018|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44228019|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
44228020|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228021|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228022|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44228023|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
44228060|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228096|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44228097|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44228098|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
44228099|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
44228128|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228129|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228130|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228131|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228132|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228134|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44228135|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44228136|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228137|NCT00523406|Triamcinolone|triamcinolone|mesh-list
44228138|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228139|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
44228140|NCT00523406|Hormones|hormones|mesh-ancestor
44228141|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228142|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228143|NCT00523432|Sirolimus|sirolimus|mesh-list
44228144|NCT00523432|Topotecan|topotecan|mesh-list
44228145|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44228146|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43765117|NCT02415270|Menthol|menthol|mesh-list
44228181|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43765184|NCT02414880|Rocuronium|rocuronium|mesh-list
44228212|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
44228213|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228214|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228215|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228216|NCT00523757|Spironolactone|spironolactone|mesh-list
44228217|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44228218|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
44228219|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228220|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228221|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44228222|NCT00523757|Diuretics|diuretics|mesh-ancestor
44228223|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
44228224|NCT00523887|Fentanyl|fentanyl|mesh-list
44228225|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44228226|NCT00523887|Narcotics|narcotics|mesh-ancestor
44228260|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228261|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
44228262|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228263|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44228264|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228265|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
44228266|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
44228267|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228268|NCT00524069|Gemcitabine|gemcitabine|mesh-list
44228269|NCT00524069|Bevacizumab|bevacizumab|mesh-list
44228270|NCT00524069|Capecitabine|capecitabine|mesh-list
44228304|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228306|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
44228307|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228308|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44228309|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44228310|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
44228341|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228342|NCT00524251|Esomeprazole|esomeprazole|mesh-list
44228343|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44228344|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284696|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
44284697|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284698|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228345|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44228346|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228347|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228349|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228350|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228351|NCT00524381|Analgesics|analgesics|mesh-ancestor
44228352|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
44228353|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228354|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228355|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228356|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228357|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228358|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228359|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
44228385|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228386|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
44228387|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228389|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228390|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
44228391|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43699492|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
44228392|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228393|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458058|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44458059|NCT01599806|Trimethoprim|trimethoprim|mesh-list
44458060|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
44458061|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458062|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458063|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44458064|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44458065|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458066|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458067|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458068|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44458069|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44458070|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44458071|NCT01599806|Renal Agents|renal agents|mesh-ancestor
43837798|NCT04885907|Vaccines|vaccines|mesh-list
44228453|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
44228454|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228455|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228456|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
44228457|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44228458|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
44228459|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
44228460|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228461|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228462|NCT00524966|Hemostatics|hemostatics|mesh-list
44228489|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
44228490|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228491|NCT00525200|Docetaxel|docetaxel|mesh-list
44228492|NCT00525200|Cisplatin|cisplatin|mesh-list
44228493|NCT00525200|Fluorouracil|fluorouracil|mesh-list
44228494|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228495|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228496|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228497|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228498|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228499|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
44228500|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228501|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228502|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
44228503|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228504|NCT00525239|Ritonavir|ritonavir|mesh-list
44228505|NCT00525239|Lopinavir|lopinavir|mesh-list
44228506|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44228507|NCT00525239|Efavirenz|efavirenz|mesh-list
44228508|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44228509|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44284699|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44284700|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284702|NCT00752115|Carboplatin|carboplatin|mesh-list
44284703|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
44228510|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
44228511|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228540|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
44228541|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458080|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882562|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44228542|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228543|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228544|NCT00525382|Levocetirizine|levocetirizine|mesh-list
44228545|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44228546|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44228547|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
44228548|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
44228549|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228550|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228583|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228584|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
44228585|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228586|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228587|NCT00525486|Nifedipine|nifedipine|mesh-list
44228588|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44228589|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699955|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699956|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228590|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228591|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765543|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
44228624|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
44228625|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228626|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44228627|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
44228628|NCT00525577|Protective Agents|protective agents|mesh-ancestor
44228629|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228630|NCT00525616|Rituximab|rituximab|mesh-list
44228631|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228632|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228633|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
43765574|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228669|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228670|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
44228671|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228672|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44228673|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228674|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228711|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228712|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
44228713|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228714|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228715|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228742|NCT00525967|Methadone|methadone|mesh-list
44228743|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228744|NCT00525967|Analgesics|analgesics|mesh-ancestor
44228745|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
44228746|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228747|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228748|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
43699957|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44228749|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44228750|NCT00525967|Narcotics|narcotics|mesh-ancestor
44228751|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228752|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
44228753|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
44228754|NCT00525993|Etoricoxib|etoricoxib|mesh-list
44228755|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228756|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228757|NCT00525993|Analgesics|analgesics|mesh-ancestor
44228758|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
44228759|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799806|NCT05001412|Carboplatin|carboplatin|mesh-list
44284704|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44284705|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284706|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
43699958|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
44284707|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
44284708|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
43541310|NCT05563155|Dexamethasone|dexamethasone|mesh-list
44228760|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228761|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228762|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228763|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44228764|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44228792|NCT00526175|Hormones|hormones|mesh-ancestor
44228793|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228794|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44228795|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44228796|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
44228797|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44228798|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228799|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
44228800|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228801|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228802|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44228803|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228804|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44228805|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228806|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228807|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228808|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
44228809|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228810|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228811|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228812|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228813|NCT00526214|Celecoxib|celecoxib|mesh-list
44228848|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228849|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228850|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
44228851|NCT00526305|Hormones|hormones|mesh-ancestor
44228852|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228853|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44228892|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228893|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228928|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228930|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228931|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44228932|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
44228933|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44228934|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43700360|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700361|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700362|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43700363|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43700364|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700365|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700367|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43700368|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700369|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
44228935|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
44458090|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458091|NCT01599325|Azacitidine|azacitidine|mesh-list
44458092|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229009|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44229010|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44229011|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229012|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229013|NCT00526877|Risperidone|risperidone|mesh-list
44229014|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44229015|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
44229016|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229017|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837850|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44229049|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44229051|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229052|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229053|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44229054|NCT00527059|Diuretics|diuretics|mesh-ancestor
44284709|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229055|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
44229056|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44229085|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229086|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229087|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
44229088|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229089|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229090|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44229091|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229092|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
44229094|NCT00527228|Deflazacort|deflazacort|mesh-list
44229095|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229096|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229097|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
44229098|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229099|NCT00527267|Cinacalcet|cinacalcet|mesh-list
44229100|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44229101|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229138|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44229139|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
44229140|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765977|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
44229179|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44229208|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
44229210|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44229211|NCT00528060|Tenofovir|tenofovir|mesh-list
44229212|NCT00528060|Emtricitabine|emtricitabine|mesh-list
44229213|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44229214|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44229215|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44229216|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229217|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229218|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229219|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229220|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
44229221|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229222|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44229223|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44229224|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44229225|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44229226|NCT00528073|Rifaximin|rifaximin|mesh-list
43766054|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44229256|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229257|NCT00528255|Misoprostol|misoprostol|mesh-list
44229258|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44229259|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
44229260|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44229261|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229262|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44229264|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
44229265|NCT00528281|Pemetrexed|pemetrexed|mesh-list
44229266|NCT00528281|Lapatinib|lapatinib|mesh-list
44229267|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229268|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229269|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229270|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44229271|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44229272|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44229273|NCT00528359|Olanzapine|olanzapine|mesh-list
44229274|NCT00528359|Risperidone|risperidone|mesh-list
44229307|NCT00528385|Diuretics|diuretics|mesh-ancestor
44229308|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
44458114|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830534|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830535|NCT05357417|Bevacizumab|bevacizumab|mesh-list
44458115|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44458116|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458117|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458118|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
44229318|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44229319|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229320|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229321|NCT00528515|Propofol|propofol|mesh-list
44284710|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284711|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44284712|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44284713|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284714|NCT00752115|Urological Agents|urological agents|mesh-ancestor
44229322|NCT00528515|Desflurane|desflurane|mesh-list
44229323|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44229324|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229325|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229326|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44229327|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
44229358|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229359|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229360|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
44229361|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
44229362|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
44229363|NCT00528723|Albuterol|albuterol|mesh-list
44229364|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44229365|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
44229366|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229367|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229368|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44229369|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
44229370|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
44229371|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44229372|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44229373|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43837901|NCT04881682|Antibodies|antibodies|mesh-list
44229397|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229398|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229399|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
44229400|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44229401|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229402|NCT00528983|Azacitidine|azacitidine|mesh-list
44229404|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229405|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
44229406|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229407|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229408|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229409|NCT00529022|Carboplatin|carboplatin|mesh-list
44229410|NCT00529022|Azacitidine|azacitidine|mesh-list
44229411|NCT00529022|Valproic Acid|valproic acid|mesh-list
44229412|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229413|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229414|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
44229415|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229416|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229417|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
44229418|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
44229419|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229420|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229421|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
44229422|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44229423|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43571192|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
44229459|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229460|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229461|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229496|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44229497|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
44229498|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
44229499|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229500|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229501|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44229537|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
44229538|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229539|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
43766308|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
44229576|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44284715|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
44229577|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229578|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229579|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44229580|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44229581|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229616|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44229617|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229618|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44458142|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44458143|NCT01598896|Hormones|hormones|mesh-ancestor
43766384|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458175|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458176|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
44458177|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458178|NCT01597973|Meropenem|meropenem|mesh-list
44458179|NCT01597973|Colistin|colistin|mesh-list
44458180|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458181|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458182|NCT01597908|Trametinib|trametinib|mesh-list
44458183|NCT01597908|Vemurafenib|vemurafenib|mesh-list
44458184|NCT01597908|Dabrafenib|dabrafenib|mesh-list
44458185|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458186|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44458187|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458188|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229624|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229625|NCT00530868|Growth Substances|growth substances|mesh-ancestor
44229626|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229627|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229628|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44229629|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44229630|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229631|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229632|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44229633|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
44229634|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229635|NCT00530907|Bevacizumab|bevacizumab|mesh-list
44229636|NCT00530907|Valproic Acid|valproic acid|mesh-list
44229637|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229638|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229639|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43701609|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
43701610|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
43701646|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701648|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229640|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229641|NCT00530907|Growth Substances|growth substances|mesh-ancestor
44229642|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229643|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229644|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
44229645|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229679|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
43702063|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44229681|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229682|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229683|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
44229684|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229685|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229686|NCT00531115|Cetuximab|cetuximab|mesh-list
44229719|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
44229720|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44229721|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229722|NCT00531310|Fludarabine|fludarabine|mesh-list
44229723|NCT00531310|Busulfan|busulfan|mesh-list
44229724|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229725|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229751|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229752|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44229753|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44229754|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
44229755|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44229756|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44229758|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229759|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229760|NCT00531362|Analgesics|analgesics|mesh-ancestor
44229761|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
44284717|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
44284718|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
44284719|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668311|NCT03684590|Analgesics|analgesics|mesh-ancestor
44229762|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229763|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229764|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229765|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229766|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44229767|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44229768|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229769|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44229770|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44229771|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229772|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
44229773|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
44229796|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229798|NCT00531557|Darunavir|darunavir|mesh-list
44229799|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44229800|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44229801|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
44229802|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229803|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229804|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229805|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229806|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
44229807|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229808|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44229809|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44229810|NCT00531596|Selegiline|selegiline|mesh-list
44229811|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
44229812|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229813|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44229814|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44229815|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44229816|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229817|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229818|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44229819|NCT00531596|Protective Agents|protective agents|mesh-ancestor
44229820|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229821|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
44229822|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44229823|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229824|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44229863|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
44229898|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44229899|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44229922|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44229923|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44229924|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44229926|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44229927|NCT05319912|Choline|choline|mesh-list
44229928|NCT05319912|Omeprazole|omeprazole|mesh-list
44229929|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44229930|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44229931|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44229932|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229933|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229934|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
44229935|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44229936|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
44229937|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44229938|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
44229939|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
44229940|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
44229941|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229942|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229943|NCT05319912|Growth Substances|growth substances|mesh-ancestor
44229944|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229945|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284720|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284721|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44284722|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44284723|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
44284724|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668314|NCT03672292|Voriconazole|voriconazole|mesh-list
44229946|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229947|NCT05319912|Trace Elements|trace elements|mesh-ancestor
44229948|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
44229949|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44229950|NCT05319899|Choline|choline|mesh-list
44229951|NCT05319899|Omeprazole|omeprazole|mesh-list
44229952|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44229953|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44229988|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44229989|NCT05319756|Narcotics|narcotics|mesh-ancestor
44229990|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229991|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229992|NCT05319756|Analgesics|analgesics|mesh-ancestor
44229993|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
44229994|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458225|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458226|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44458227|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458228|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458229|NCT01597245|Etanercept|etanercept|mesh-list
44458230|NCT01597245|Ixekizumab|ixekizumab|mesh-list
44458231|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44458232|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44458233|NCT01597245|Analgesics|analgesics|mesh-ancestor
44458234|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
44458235|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458236|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458265|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458266|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
44458267|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44458268|NCT01596335|Antibodies|antibodies|mesh-list
44230012|NCT05318794|Doxorubicin|doxorubicin|mesh-list
44230013|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230014|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44230015|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44230016|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44230017|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230018|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230019|NCT05318248|Clonidine|clonidine|mesh-list
44230020|NCT05318248|Analgesics|analgesics|mesh-ancestor
44230021|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
44230022|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230023|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230024|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44230025|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
44230026|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
44230027|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44230059|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
44230060|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230061|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
44230062|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
44230063|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230064|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
44230065|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
44230066|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44230067|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
44230068|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230069|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230107|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230108|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
44230109|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
44230110|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
44230147|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230149|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44284725|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284726|NCT00752141|Urological Agents|urological agents|mesh-ancestor
44458269|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
44458270|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458271|NCT01596127|Rituximab|rituximab|mesh-list
44458272|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44458273|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458274|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
44458275|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458276|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458277|NCT01596062|Cyclosporine|cyclosporine|mesh-list
44458278|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
44458279|NCT01596062|Everolimus|everolimus|mesh-list
44458280|NCT01596062|Cyclosporins|cyclosporins|mesh-list
44458281|NCT01596062|Basiliximab|basiliximab|mesh-list
44458282|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458283|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458284|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458285|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
44458286|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458287|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
44458288|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458289|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458290|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458291|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44458292|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458293|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44458294|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44458295|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
44458296|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458297|NCT01595646|Insulin|insulin|mesh-list
44458298|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44230231|NCT05013892|Memantine|memantine|mesh-list
44230232|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44230233|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44230234|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
44230235|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230236|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645171|NCT04183062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230237|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230238|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44230239|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44230240|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
44230241|NCT04998240|Paraproteins|paraproteins|mesh-list
44230242|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
44230243|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230244|NCT04988685|Sirolimus|sirolimus|mesh-list
44230245|NCT04988685|Paclitaxel|paclitaxel|mesh-list
44230246|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44230247|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230248|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
44230249|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
44230285|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44230286|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44230287|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44230288|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44230289|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767065|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44230325|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
44230326|NCT04630886|Coagulants|coagulants|mesh-ancestor
44230327|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44230328|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44230329|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44230330|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230368|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458304|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
44458305|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
44458306|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44458307|NCT01595581|Androgens|androgens|mesh-ancestor
44458308|NCT01595581|Hormones|hormones|mesh-ancestor
44458309|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458310|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458311|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44284727|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44284728|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284729|NCT00752141|Renal Agents|renal agents|mesh-ancestor
44284730|NCT00752154|Curcumin|curcumin|mesh-list
44458312|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458313|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
44458314|NCT01595529|Trimethoprim|trimethoprim|mesh-list
44458315|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
44458316|NCT01595529|Cephalexin|cephalexin|mesh-list
44458317|NCT01595529|Cefixime|cefixime|mesh-list
44458318|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44458319|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458320|NCT01595529|Renal Agents|renal agents|mesh-ancestor
44458321|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
44458322|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458323|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458324|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458325|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458326|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458327|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458328|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44458329|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44458330|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458331|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
44458332|NCT01595438|Ceftazidime|ceftazidime|mesh-list
44458333|NCT01595438|Avibactam|avibactam|mesh-list
44458334|NCT01595438|Doripenem|doripenem|mesh-list
44458335|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44458336|NCT01595438|Trimethoprim|trimethoprim|mesh-list
44230413|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
44230414|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44230415|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44230416|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230417|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230418|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230419|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230437|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
44230438|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230439|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
44230440|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230441|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44230442|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230443|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44230444|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
44230445|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230446|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230448|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
44230449|NCT04067726|Denosumab|denosumab|mesh-list
44230450|NCT04067726|Calcium|calcium|mesh-list
44230451|NCT04067726|Vitamins|vitamins|mesh-ancestor
44230452|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
44230453|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230454|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230455|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230456|NCT04049084|Adenosine|adenosine|mesh-list
44230457|NCT04049084|Analgesics|analgesics|mesh-ancestor
44230458|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
44230459|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230460|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230461|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44230462|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
44230463|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44230464|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
44230465|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
44230466|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230467|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230468|NCT04033419|Memantine|memantine|mesh-list
44230469|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44230470|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44230471|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
44230472|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230473|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230474|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284731|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284732|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284733|NCT00752154|Analgesics|analgesics|mesh-ancestor
44284734|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
44284735|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284736|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284737|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230475|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44230476|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44230509|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44230510|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44230511|NCT03741530|Glyburide|glyburide|mesh-list
44230512|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44230513|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230514|NCT03673787|Atezolizumab|atezolizumab|mesh-list
44230515|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230516|NCT03571802|Simvastatin|simvastatin|mesh-list
44230517|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44230543|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230544|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230545|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230547|NCT03532022|Hormones|hormones|mesh-ancestor
44230548|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230549|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230550|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230551|NCT03403569|Triptolide|triptolide|mesh-list
44230552|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44230553|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230554|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44230555|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
44230556|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44230557|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230558|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
44230559|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230560|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
44230561|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230562|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703403|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43703404|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43703405|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703535|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43703536|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703537|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
43703538|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
43703539|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
43703540|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230563|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
44230564|NCT03315897|Hematinics|hematinics|mesh-ancestor
43767325|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44458373|NCT01594827|Rifampin|rifampin|mesh-list
44458374|NCT01594827|Trimethoprim|trimethoprim|mesh-list
44458375|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
44458376|NCT01594827|Mupirocin|mupirocin|mesh-list
44458377|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44458378|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458379|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
44458380|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458381|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458382|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
44458383|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458384|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458385|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44458386|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
44458387|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
44458388|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44458389|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458390|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458391|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44458392|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44458393|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44458394|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44458395|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44230565|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
43767374|NCT02402543|Hormones|hormones|mesh-ancestor
44230597|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44230598|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44284738|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284739|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284740|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230599|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230600|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230601|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230602|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44230603|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43645206|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
43703717|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230604|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
43703718|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43703719|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44230605|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230606|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44230607|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
44230608|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
44230609|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
44230610|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44230611|NCT02978391|Coagulants|coagulants|mesh-ancestor
44230612|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
44230613|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230614|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884573|NCT04594343|Disulfiram|disulfiram|mesh-list
44230641|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230642|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44230644|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230645|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44230646|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230647|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230648|NCT02550470|Sevoflurane|sevoflurane|mesh-list
44230649|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44230650|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44230651|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
44230652|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
44230653|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230654|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230655|NCT02503839|Etoricoxib|etoricoxib|mesh-list
44230656|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44230657|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230658|NCT02503839|Analgesics|analgesics|mesh-ancestor
44230659|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
44230660|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230661|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230686|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230688|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44230689|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44230690|NCT02042287|Metronidazole|metronidazole|mesh-list
44230691|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230692|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230693|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44230694|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44230695|NCT01840566|Cytarabine|cytarabine|mesh-list
44230696|NCT01840566|Etoposide|etoposide|mesh-list
44230697|NCT01840566|Melphalan|melphalan|mesh-list
44230698|NCT01840566|Carmustine|carmustine|mesh-list
44230699|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44230700|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704055|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704056|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704057|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
43704058|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704059|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704060|NCT02707250|Narcotics|narcotics|mesh-ancestor
43704061|NCT02707250|Analgesics|analgesics|mesh-ancestor
43704062|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43704063|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
43704099|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704100|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
44230701|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44230702|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44230703|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230704|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230705|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44230706|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
44230707|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
44230708|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230709|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230710|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
44230711|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230712|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230743|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44230744|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230745|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230746|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230747|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44230748|NCT01614171|Hormones|hormones|mesh-list
43668334|NCT03642132|Growth Substances|growth substances|mesh-ancestor
44230749|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230750|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230751|NCT01582776|Lenalidomide|lenalidomide|mesh-list
44230752|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
44230753|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
44230754|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230755|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44230756|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44230757|NCT01582776|Growth Substances|growth substances|mesh-ancestor
44230758|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767567|NCT02400645|Ketorolac|ketorolac|mesh-list
44230788|NCT00532168|Ritonavir|ritonavir|mesh-list
43704101|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704102|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43645207|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645209|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
43645211|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645212|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230789|NCT00532168|Lopinavir|lopinavir|mesh-list
44230790|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44230791|NCT00532168|Tenofovir|tenofovir|mesh-list
44230792|NCT00532168|Emtricitabine|emtricitabine|mesh-list
44230793|NCT00532168|Efavirenz|efavirenz|mesh-list
44230794|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44230795|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44230796|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
44230797|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230798|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230799|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44230800|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44230801|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
44230802|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230803|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43767610|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44230829|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44230830|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43704258|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
43704259|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230831|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230832|NCT00532272|Letrozole|letrozole|mesh-list
44230833|NCT00532272|Goserelin|goserelin|mesh-list
44230834|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230835|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44230836|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44230837|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230838|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230839|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44230840|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230841|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230842|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230843|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230844|NCT00532285|Gemcitabine|gemcitabine|mesh-list
44230845|NCT00532285|Paclitaxel|paclitaxel|mesh-list
43767659|NCT02400281|Cytarabine|cytarabine|mesh-list
44230882|NCT00532389|Panobinostat|panobinostat|mesh-list
44230915|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44230917|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230918|NCT00532519|Citalopram|citalopram|mesh-list
44230940|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
44230941|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458396|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44458397|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44458398|NCT01594827|Renal Agents|renal agents|mesh-ancestor
44458399|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458400|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458401|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44458402|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44458403|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44458404|NCT01594762|Pexiganan|pexiganan|mesh-list
44458405|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458406|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458407|NCT01594749|Dexamethasone|dexamethasone|mesh-list
44458408|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
44458409|NCT01594749|Ondansetron|ondansetron|mesh-list
44458410|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
44458411|NCT01594749|Aprepitant|aprepitant|mesh-list
44458412|NCT01594749|BB 1101|bb 1101|mesh-list
44458413|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458414|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
44458415|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
44458416|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458417|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458418|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44458419|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
44284741|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464081|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458420|NCT01594749|Hormones|hormones|mesh-ancestor
44458421|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458422|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44458423|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458451|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44458452|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
44458453|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458454|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458455|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458456|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458457|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458458|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458459|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
44458460|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458461|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44458462|NCT01594281|Ranibizumab|ranibizumab|mesh-list
44458463|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458464|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44458465|NCT01594281|Growth Substances|growth substances|mesh-ancestor
44230942|NCT00532584|Beclomethasone|beclomethasone|mesh-list
44230943|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230944|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
44230945|NCT00532584|Hormones|hormones|mesh-ancestor
43838023|NCT04876027|Dulaglutide|dulaglutide|mesh-list
44230975|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230976|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44230977|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44230978|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230979|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230980|NCT00532675|Lenalidomide|lenalidomide|mesh-list
44230981|NCT00532675|Panobinostat|panobinostat|mesh-list
44230982|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
44230983|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230984|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44230985|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44230986|NCT00532675|Growth Substances|growth substances|mesh-ancestor
44230987|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
44230988|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231022|NCT00532727|Carboplatin|carboplatin|mesh-list
44231024|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231025|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231026|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231027|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231028|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231066|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231067|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767899|NCT02398448|Allopurinol|allopurinol|mesh-list
44231140|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767939|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
44231171|NCT00533390|Efavirenz|efavirenz|mesh-list
44231172|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44231173|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44231174|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231175|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231176|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
44231177|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231178|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44231179|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44231180|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44231181|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44231182|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44231183|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44231184|NCT00533416|ON 01910|on 01910|mesh-list
44231218|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44231219|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231220|NCT00533585|Paclitaxel|paclitaxel|mesh-list
44231221|NCT00533585|Bevacizumab|bevacizumab|mesh-list
44464082|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464083|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44231222|NCT00533585|Carboplatin|carboplatin|mesh-list
44231223|NCT00533585|Sorafenib|sorafenib|mesh-list
44231224|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231225|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231244|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231245|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
44231247|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
44231248|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
44231249|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44231250|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231251|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44231252|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
44231253|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231254|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231255|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231256|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231257|NCT00533637|Cetirizine|cetirizine|mesh-list
44231258|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44231259|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44231260|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44231261|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
44231262|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
44231263|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231264|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231265|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231266|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
44231267|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44231268|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44231269|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
44231270|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231271|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231272|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231273|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
44231274|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
44231275|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231276|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
44231277|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44231278|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44231279|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44231280|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44231281|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
44231312|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
44231313|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231314|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
44231315|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44458467|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231316|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231318|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
44231320|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44231321|NCT00533936|Fluorouracil|fluorouracil|mesh-list
44231322|NCT00533936|Trastuzumab|trastuzumab|mesh-list
44231323|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231324|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231349|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231350|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
44231351|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44231352|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
44231353|NCT00534014|Vitamins|vitamins|mesh-ancestor
44231354|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
44231355|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231356|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
44231357|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231358|NCT00534014|Protective Agents|protective agents|mesh-ancestor
44231359|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44231360|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
44231361|NCT00534144|Hematinics|hematinics|mesh-ancestor
44231362|NCT00534183|Haloperidol|haloperidol|mesh-list
44231363|NCT00534183|Olanzapine|olanzapine|mesh-list
44231364|NCT00534183|Risperidone|risperidone|mesh-list
44231365|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
44231366|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44231367|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
44464084|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44464085|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44231368|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231369|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231370|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231371|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44231372|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231373|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231374|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231375|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44231410|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44458469|NCT01594125|Nintedanib|nintedanib|mesh-list
44458470|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768147|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
44458503|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
44458504|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
44458505|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
44458506|NCT01592864|Protective Agents|protective agents|mesh-ancestor
44458507|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458508|NCT01592786|Memantine|memantine|mesh-list
44458509|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44458510|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458511|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
44231434|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231435|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44231436|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231437|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231438|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44231439|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
44231440|NCT00534456|Hematinics|hematinics|mesh-ancestor
44231441|NCT00534508|Tacrolimus|tacrolimus|mesh-list
44231459|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44231460|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
44231461|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44231462|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231463|NCT00534586|Ketamine|ketamine|mesh-list
44231464|NCT00534586|Remifentanil|remifentanil|mesh-list
44231465|NCT00534586|Propofol|propofol|mesh-list
44231466|NCT00534586|Sevoflurane|sevoflurane|mesh-list
44231467|NCT00534586|Esketamine|esketamine|mesh-list
44231468|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44231469|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231470|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231471|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44231472|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
44231473|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
44231474|NCT00534586|Analgesics|analgesics|mesh-ancestor
44231475|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
44231476|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231477|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44231478|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44231479|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44231480|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231481|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231482|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44231483|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44231484|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44231485|NCT00534586|Narcotics|narcotics|mesh-ancestor
44231486|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
44231487|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231488|NCT00534625|Zileuton|zileuton|mesh-list
44231489|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
44231490|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44231491|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44231492|NCT00534625|Analgesics|analgesics|mesh-ancestor
44231493|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
44231494|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231495|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231496|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44231497|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231498|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44231499|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231532|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44231533|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44464086|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
44464087|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464088|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231534|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44231535|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44231536|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44231537|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43768260|NCT02396043|Cytarabine|cytarabine|mesh-list
44231569|NCT00535158|Vitamin D|vitamin d|mesh-list
44231570|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
44231571|NCT00535158|Vitamins|vitamins|mesh-ancestor
44231572|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
44231573|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231574|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231575|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231576|NCT00535340|Amibegron|amibegron|mesh-list
44231577|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44231578|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44231579|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44231580|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231581|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231582|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231583|NCT00535353|Irinotecan|irinotecan|mesh-list
44231609|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231611|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
44231612|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
44231613|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231614|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44231615|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231616|NCT00535509|Cisplatin|cisplatin|mesh-list
44231617|NCT00535509|Docetaxel|docetaxel|mesh-list
44231618|NCT00535509|Trastuzumab|trastuzumab|mesh-list
44231619|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231620|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231621|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231622|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231623|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231624|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231625|NCT00535574|Bexarotene|bexarotene|mesh-list
44231626|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231627|NCT00535665|Vaccines|vaccines|mesh-list
44231628|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
44231629|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231630|NCT00535691|Tacrolimus|tacrolimus|mesh-list
44231658|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231660|NCT00536003|Progestins|progestins|mesh-ancestor
44231661|NCT00536003|Hormones|hormones|mesh-ancestor
44231662|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231663|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231664|NCT00536042|Minocycline|minocycline|mesh-list
44231665|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231666|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231667|NCT00536068|Acetaminophen|acetaminophen|mesh-list
44231668|NCT00536068|Aspirin|aspirin|mesh-list
44231669|NCT00536068|Diclofenac|diclofenac|mesh-list
44231670|NCT00536068|Naproxen|naproxen|mesh-list
44231671|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44231672|NCT00536068|Analgesics|analgesics|mesh-ancestor
44231673|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
44231674|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231675|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231676|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
44458534|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44458535|NCT01592708|Erythromycin|erythromycin|mesh-list
44458536|NCT01592708|Ibuprofen|ibuprofen|mesh-list
44458537|NCT01592708|Ketorolac|ketorolac|mesh-list
44458538|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44458539|NCT01592708|Fentanyl|fentanyl|mesh-list
44458540|NCT01592708|Scopolamine|scopolamine|mesh-list
44458541|NCT01592708|Droperidol|droperidol|mesh-list
44458542|NCT01592708|Remifentanil|remifentanil|mesh-list
43885565|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458543|NCT01592708|Hydrocodone|hydrocodone|mesh-list
44458544|NCT01592708|Ondansetron|ondansetron|mesh-list
44464089|NCT01499940|Vitamin D|vitamin d|mesh-list
44464090|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
44464091|NCT01499940|Vitamins|vitamins|mesh-ancestor
44464092|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
43939413|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
43542455|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
44231690|NCT00536237|Niacin|niacin|mesh-list
43705610|NCT04177693|Protective Agents|protective agents|mesh-ancestor
44231691|NCT00536237|Niacinamide|niacinamide|mesh-list
44231692|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
44231693|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231694|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231695|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44231696|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
44231697|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44231698|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231699|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
44231700|NCT00536237|Vitamins|vitamins|mesh-ancestor
44231701|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
44231702|NCT00536276|Vitamin D|vitamin d|mesh-list
44231703|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
44231704|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
44231705|NCT00536276|Vitamins|vitamins|mesh-list
44231736|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231737|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231738|NCT00536640|Growth Substances|growth substances|mesh-ancestor
44231739|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231740|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231741|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231742|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
44231743|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231744|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
44231745|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231746|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768419|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
44231815|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231816|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231817|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231818|NCT00536848|Metronidazole|metronidazole|mesh-list
44231819|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231820|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231821|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44231822|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44231823|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44231824|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231825|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231826|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231849|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
44231850|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44231851|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231852|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231853|NCT00537121|Antidotes|antidotes|mesh-ancestor
44231854|NCT00537121|Protective Agents|protective agents|mesh-ancestor
44231855|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
44231856|NCT00537121|Vitamins|vitamins|mesh-ancestor
44231857|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
44231858|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44231859|NCT00537173|Paclitaxel|paclitaxel|mesh-list
44231860|NCT00537173|Bevacizumab|bevacizumab|mesh-list
44231861|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231862|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231863|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231864|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231865|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231866|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231867|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231868|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231869|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231870|NCT00537173|Growth Substances|growth substances|mesh-ancestor
44231871|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231872|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231873|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
44231874|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44231875|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231876|NCT00537355|Histamine|histamine|mesh-list
44464093|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464094|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44284742|NCT00752180|Insulin|insulin|mesh-list
44284743|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44284744|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44284745|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284746|NCT00752310|Darunavir|darunavir|mesh-list
44231877|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
44231878|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
44231901|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231902|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231903|NCT00537550|Methotrexate|methotrexate|mesh-list
44231904|NCT00537550|Vincristine|vincristine|mesh-list
44231905|NCT00537550|Asparaginase|asparaginase|mesh-list
44231906|NCT00537550|Daunorubicin|daunorubicin|mesh-list
44231907|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44231908|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
44231909|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44231910|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231911|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231912|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
44231913|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231914|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231915|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44231916|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231917|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44231918|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231919|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
44231920|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231921|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44231922|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231923|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231924|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231925|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231926|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44231927|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44231928|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231929|NCT00537563|Telithromycin|telithromycin|mesh-list
44231930|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838100|NCT04871958|Insulin|insulin|mesh-list
44231961|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231962|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231963|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231964|NCT00537888|Fluconazole|fluconazole|mesh-list
44231965|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
44231966|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231967|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44231968|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44231969|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231970|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231971|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44231972|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231973|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231974|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232006|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232007|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232008|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44232009|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44232010|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
44232011|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232012|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44232013|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44232014|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44232015|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44232016|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44232017|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44232018|NCT00538005|Bevacizumab|bevacizumab|mesh-list
44284747|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44284748|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44284749|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284750|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645281|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
44284751|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232019|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
44232020|NCT00538005|Sorafenib|sorafenib|mesh-list
44232021|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44232022|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232046|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232048|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232049|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
44232050|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232051|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232052|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232053|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232054|NCT00538148|Telithromycin|telithromycin|mesh-list
44232055|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232056|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232057|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
44232058|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44232059|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232060|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232061|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232062|NCT00538187|Bortezomib|bortezomib|mesh-list
44232063|NCT00538187|Obatoclax|obatoclax|mesh-list
44232064|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232065|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232066|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232067|NCT00538239|Sirolimus|sirolimus|mesh-list
44232068|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232069|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232070|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44232071|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232102|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232103|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44232104|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44232105|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44232107|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
44232108|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44232109|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44232110|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232111|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232112|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
44232113|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
44232147|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232148|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232149|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44232150|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44232151|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232152|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232153|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232154|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
44232155|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43768634|NCT02393482|Vitamins|vitamins|mesh-ancestor
44232180|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44232181|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232182|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232184|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44232185|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44232186|NCT00538538|Growth Substances|growth substances|mesh-ancestor
44232187|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232188|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
44232189|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232190|NCT00538564|Tadalafil|tadalafil|mesh-list
44232191|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
44232192|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44232193|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43645292|NCT04150640|Irinotecan|irinotecan|mesh-list
44284752|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43707033|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
44284753|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44284754|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
44284755|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284756|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44284757|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44284758|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44284759|NCT00752375|Trimethoprim|trimethoprim|mesh-list
44232194|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232195|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232196|NCT00538564|Urological Agents|urological agents|mesh-ancestor
44232197|NCT00538603|Paclitaxel|paclitaxel|mesh-list
44232198|NCT00538603|Carboplatin|carboplatin|mesh-list
44232199|NCT00538603|Doxorubicin|doxorubicin|mesh-list
44232200|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44232201|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44232202|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232203|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232204|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232205|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232206|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232207|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43768673|NCT02393430|Rebamipide|rebamipide|mesh-list
44232245|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44232246|NCT00538811|Analgesics|analgesics|mesh-ancestor
44232265|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44232266|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
44232267|NCT00538954|Antacids|antacids|mesh-ancestor
44232268|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232269|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44232270|NCT00538967|Doxycycline|doxycycline|mesh-list
44232271|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232272|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232273|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
44232274|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44232275|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44232276|NCT00539071|Risperidone|risperidone|mesh-list
44232277|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44232278|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
44232279|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232280|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232281|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232282|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44232283|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44232284|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232285|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44232286|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44232287|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
44232288|NCT00539123|Buprenorphine|buprenorphine|mesh-list
44232289|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44232290|NCT00539123|Narcotics|narcotics|mesh-ancestor
43886088|NCT04572867|Diuretics|diuretics|mesh-list
44232291|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232292|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232293|NCT00539123|Analgesics|analgesics|mesh-ancestor
44232294|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
44232295|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232296|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44232298|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232299|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232300|NCT00539331|Paclitaxel|paclitaxel|mesh-list
44232301|NCT00539331|Carboplatin|carboplatin|mesh-list
44232302|NCT00539331|Cediranib|cediranib|mesh-list
44232333|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232335|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232336|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232337|NCT00539630|Docetaxel|docetaxel|mesh-list
44232338|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232339|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232340|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232341|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
44284760|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44284761|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
44284762|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44284763|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284764|NCT00752375|Renal Agents|renal agents|mesh-ancestor
44284765|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
44232342|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232343|NCT00539669|Docetaxel|docetaxel|mesh-list
44232344|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232345|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232346|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232347|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232348|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232349|NCT00539773|Interferons|interferons|mesh-list
44232378|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232380|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232381|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232382|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232383|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232384|NCT00540072|Daptomycin|daptomycin|mesh-list
44232385|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232386|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232387|NCT00540085|Rocuronium|rocuronium|mesh-list
44232388|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44232389|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44232390|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44232391|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232392|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232393|NCT00540098|Paroxetine|paroxetine|mesh-list
44232394|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44232395|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43768842|NCT02391844|Oxycodone|oxycodone|mesh-list
44232427|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44232429|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
44232430|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44232431|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44232432|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232433|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44232434|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232435|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44232470|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
44232471|NCT00540384|Hematinics|hematinics|mesh-ancestor
44232472|NCT00540410|Artesunate|artesunate|mesh-list
44232473|NCT00540410|Lumefantrine|lumefantrine|mesh-list
44232474|NCT00540410|Amodiaquine|amodiaquine|mesh-list
44232475|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44232476|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
44232508|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232509|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232511|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
44232512|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44232513|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232514|NCT00540787|Quinidine|quinidine|mesh-list
44232515|NCT00540787|Amiodarone|amiodarone|mesh-list
44232516|NCT00540787|Sotalol|sotalol|mesh-list
44232517|NCT00540787|Flecainide|flecainide|mesh-list
44232518|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44232519|NCT00540787|Propafenone|propafenone|mesh-list
44232520|NCT00540787|Dofetilide|dofetilide|mesh-list
43886294|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44232521|NCT00540787|Cifenline|cifenline|mesh-list
44232522|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
44232553|NCT00540800|Capecitabine|capecitabine|mesh-list
44232555|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232556|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232557|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232558|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232559|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232560|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232561|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
44232562|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44284766|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44284767|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44284768|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44284769|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284770|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232563|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43769001|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
44232585|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44232586|NCT00540930|Growth Substances|growth substances|mesh-ancestor
44232587|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232588|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
44232589|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232590|NCT00540943|Irinotecan|irinotecan|mesh-list
44232591|NCT00540943|Cetuximab|cetuximab|mesh-list
44232592|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44232593|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232594|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232595|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232596|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156883|NCT00232648|Budesonide|budesonide|mesh-list
44232597|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44232598|NCT00540956|Cytarabine|cytarabine|mesh-list
44232599|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232600|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
44232601|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232602|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232603|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
44232604|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232605|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232606|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
44232607|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232608|NCT00541008|Sunitinib|sunitinib|mesh-list
44232609|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232610|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44232611|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44232612|NCT00541008|Growth Substances|growth substances|mesh-ancestor
43769004|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232648|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
44232649|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232650|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232651|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232652|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232653|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44232684|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232685|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232686|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232687|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232688|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
44232689|NCT00541112|Antidotes|antidotes|mesh-ancestor
44232690|NCT00541112|Protective Agents|protective agents|mesh-ancestor
44232691|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
44232692|NCT00541112|Vitamins|vitamins|mesh-ancestor
44232693|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
44232694|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44232695|NCT00541125|Leucovorin|leucovorin|mesh-list
44232696|NCT00541125|Bevacizumab|bevacizumab|mesh-list
44232697|NCT00541125|Fluorouracil|fluorouracil|mesh-list
44232698|NCT00541125|Irinotecan|irinotecan|mesh-list
44232699|NCT00541125|Calcium|calcium|mesh-list
44232700|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
44232701|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44232726|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232727|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44232728|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232730|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44232731|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
44232732|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232733|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232734|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707496|NCT02700217|Bupivacaine|bupivacaine|mesh-list
43707497|NCT02700217|Propofol|propofol|mesh-list
43707498|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707499|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
43707500|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707501|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707502|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
43707503|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707504|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707505|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43707529|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
43707530|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707531|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799807|NCT05001412|Etoposide|etoposide|mesh-list
44284771|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44284772|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44284773|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284774|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284775|NCT00752401|Vitamin D|vitamin d|mesh-list
44232735|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44232736|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44232737|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44232738|NCT00541164|Ubiquinone|ubiquinone|mesh-list
44232739|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
44232740|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
44232741|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232742|NCT00541164|Vitamins|vitamins|mesh-ancestor
44232743|NCT00541177|Atropine|atropine|mesh-list
44232744|NCT00541177|Tropicamide|tropicamide|mesh-list
44232745|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44232746|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44232747|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44232748|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
44232749|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232750|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232751|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44232752|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
44232784|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44232785|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
44232786|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
44232787|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44232788|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
44232789|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44232790|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
44232791|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232792|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232829|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232830|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44232831|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44232832|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44232863|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
44232864|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
44232865|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232866|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232867|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44232868|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44232869|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
43707554|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707584|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43707586|NCT02699645|Diuretics|diuretics|mesh-ancestor
43707587|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
44232870|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44232871|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44232872|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44232873|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44232874|NCT00541567|Ibipinabant|ibipinabant|mesh-list
44232875|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44232876|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44232900|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232901|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232903|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232904|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
44232905|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44232906|NCT00541814|Cyclosporine|cyclosporine|mesh-list
44232907|NCT00541814|Cyclosporins|cyclosporins|mesh-list
44232908|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232909|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232910|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232911|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
44232912|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232913|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
44232914|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232915|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
44232916|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44232917|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44284776|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
44284778|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
44284779|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284780|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44284781|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284782|NCT00752414|Levofloxacin|levofloxacin|mesh-list
44284783|NCT00752414|Ofloxacin|ofloxacin|mesh-list
44284784|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44284785|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232918|NCT00541840|Sorafenib|sorafenib|mesh-list
44232919|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232920|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232921|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232922|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232923|NCT00541853|Candesartan|candesartan|mesh-list
44232924|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
44232954|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44232955|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44232956|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
44232957|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232958|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232959|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232960|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
44232961|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
44232962|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232963|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
44232964|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44232965|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
44232966|NCT00542074|Ethanol|ethanol|mesh-list
44458551|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44458552|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
44458553|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44458554|NCT01592708|Narcotics|narcotics|mesh-ancestor
44458555|NCT01592708|Analgesics|analgesics|mesh-ancestor
44458556|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
44458557|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458558|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44458559|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44458560|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44458561|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458562|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707943|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
43707944|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823955|NCT05517239|Antiviral Agents|antiviral agents|mesh-ancestor
43707946|NCT02698228|Narcotics|narcotics|mesh-ancestor
44458563|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44458564|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458565|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458566|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
44458567|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44458568|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
44458569|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458570|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44458571|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
44458572|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458573|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44458574|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44458575|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458576|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44458577|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
44458578|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
44458579|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458580|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458581|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44458582|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
44458583|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44458584|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
44458585|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44458586|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
44232988|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44284786|NCT00752414|Renal Agents|renal agents|mesh-ancestor
44284787|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284788|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44284789|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44284790|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284791|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232989|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44232992|NCT00542152|Cyclosporins|cyclosporins|mesh-list
44232993|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232994|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232995|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232996|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
44232997|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232998|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
44232999|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233026|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233027|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233028|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
44233030|NCT00542347|Omeprazole|omeprazole|mesh-list
44233031|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44233032|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44233033|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44233034|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233035|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233036|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
44233037|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233038|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233039|NCT00542412|Riluzole|riluzole|mesh-list
44233040|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
44233041|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44233042|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44233043|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233044|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233045|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233074|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44233075|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233076|NCT00542711|Analgesics|analgesics|mesh-ancestor
44233077|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
44233078|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233079|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233080|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233081|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233082|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233083|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233084|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233085|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
44233086|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233087|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233088|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44233089|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
44233090|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769387|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
44233108|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44233109|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233110|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44233111|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44233112|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
44233113|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233114|NCT00542893|Dacarbazine|dacarbazine|mesh-list
44233115|NCT00542893|Oblimersen|oblimersen|mesh-list
44233116|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233117|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
44233118|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233119|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233120|NCT00542984|Teriparatide|teriparatide|mesh-list
44284792|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284793|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44284794|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284795|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44284796|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44284797|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44284798|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284799|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543097|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
44233121|NCT00542984|Calcitonin|calcitonin|mesh-list
44233122|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
44233123|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44233124|NCT00542984|Katacalcin|katacalcin|mesh-list
44233125|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233126|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233127|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233128|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
44233129|NCT00543023|Teriparatide|teriparatide|mesh-list
44233130|NCT00543023|Calcitonin|calcitonin|mesh-list
43886787|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44233131|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
44233132|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44233133|NCT00543023|Katacalcin|katacalcin|mesh-list
44233134|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233135|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233136|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233137|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
44233138|NCT00543049|Sunitinib|sunitinib|mesh-list
44233139|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233140|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233141|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233142|NCT00543049|Growth Substances|growth substances|mesh-ancestor
44233143|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233144|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233145|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233146|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233147|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233167|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233168|NCT00543205|Oblimersen|oblimersen|mesh-list
44233169|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233170|NCT00543218|Teriparatide|teriparatide|mesh-list
44233171|NCT00543218|Calcitonin|calcitonin|mesh-list
44233172|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
44233173|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44233174|NCT00543218|Katacalcin|katacalcin|mesh-list
44233175|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233176|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233177|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233178|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
44233179|NCT00543231|Oblimersen|oblimersen|mesh-list
44233180|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233181|NCT00543244|Interferons|interferons|mesh-list
44233182|NCT00543244|Ribavirin|ribavirin|mesh-list
44233183|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
44233184|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44233185|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233186|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
44233187|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233188|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
44233189|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233190|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
44233191|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233192|NCT00543335|Sorafenib|sorafenib|mesh-list
44233193|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233194|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233195|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700723|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44284800|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44284801|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44284802|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44284803|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
44284804|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284805|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284806|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44284807|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44284808|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
44284809|NCT00752466|Topiramate|topiramate|mesh-list
44284810|NCT00752466|Flunarizine|flunarizine|mesh-list
44233196|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233197|NCT00543361|Metformin|metformin|mesh-list
44233198|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233199|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233200|NCT00543413|Enalapril|enalapril|mesh-list
44233201|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44233202|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
44233203|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233204|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233205|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44233206|NCT00543504|Bevacizumab|bevacizumab|mesh-list
44233239|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233240|NCT00543634|Estrogens|estrogens|mesh-ancestor
44233241|NCT00543634|Hormones|hormones|mesh-ancestor
44233242|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233243|NCT00543647|Fenofibrate|fenofibrate|mesh-list
44233244|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44233245|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
44233246|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233247|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44233248|NCT00543686|Fluticasone|fluticasone|mesh-list
44233249|NCT00543686|Montelukast|montelukast|mesh-list
44233278|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44233279|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44233280|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233281|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233282|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44233283|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44233284|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44233285|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233287|NCT00543842|Capecitabine|capecitabine|mesh-list
44233288|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44233289|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233290|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233291|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233292|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233293|NCT00543842|Growth Substances|growth substances|mesh-ancestor
44233314|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
44233315|NCT00543933|Protective Agents|protective agents|mesh-ancestor
44233316|NCT00543959|Pioglitazone|pioglitazone|mesh-list
44233317|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233318|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233319|NCT00544011|Bevacizumab|bevacizumab|mesh-list
44233320|NCT00544011|Fluorouracil|fluorouracil|mesh-list
44233321|NCT00544011|Capecitabine|capecitabine|mesh-list
44233322|NCT00544011|Irinotecan|irinotecan|mesh-list
44233323|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233324|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233325|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233326|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233327|NCT00544011|Growth Substances|growth substances|mesh-ancestor
44233328|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233329|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
44284811|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
44284812|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44284813|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284814|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44284815|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44284816|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284817|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233330|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
44233331|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233332|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233333|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233334|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
44233335|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44233336|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233337|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233338|NCT00544037|Interferons|interferons|mesh-list
44233339|NCT00544037|Interferon-beta|interferon-beta|mesh-list
44233340|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
44233341|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233342|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
44233343|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233344|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
44233345|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233346|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43769583|NCT02386150|Vaccines|vaccines|mesh-list
44233373|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44233374|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44233375|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44233376|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
44233377|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233378|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
44233379|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233380|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233381|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
44233382|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44233383|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44233384|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233385|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233386|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233387|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233388|NCT00544193|Gemcitabine|gemcitabine|mesh-list
44233389|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233390|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
44233391|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233392|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233393|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
43769632|NCT02386072|Mirabegron|mirabegron|mesh-list
44233459|NCT00544232|Hematinics|hematinics|mesh-ancestor
44233460|NCT00544284|Temozolomide|temozolomide|mesh-list
44233461|NCT00544284|Bortezomib|bortezomib|mesh-list
44233462|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233463|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
44233464|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233465|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233503|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233504|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233505|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
44233539|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233540|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233541|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233542|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
44233543|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233544|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233545|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44233546|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44284818|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44284819|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
44284820|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
44284821|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284822|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
44284824|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
44284825|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
44284826|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44284827|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44233547|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233548|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233585|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44233586|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44233587|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
44233588|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233614|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233616|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44233617|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233618|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44233619|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44233620|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233621|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233622|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44233623|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
44233624|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233625|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233626|NCT00544999|Cytarabine|cytarabine|mesh-list
44233627|NCT00544999|Everolimus|everolimus|mesh-list
44233628|NCT00544999|Daunorubicin|daunorubicin|mesh-list
44233629|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233630|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
44233631|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233632|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233633|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
43769820|NCT02385136|Temozolomide|temozolomide|mesh-list
44233661|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44233662|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
44233663|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44233664|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44233665|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44233666|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44233667|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
44233668|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233669|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
44233670|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
44233671|NCT00545194|Dinoprostone|dinoprostone|mesh-list
44233672|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
44233673|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44233674|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233675|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
44233676|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233677|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233679|NCT00545246|Aflibercept|aflibercept|mesh-list
44233680|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233681|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44233716|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233717|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233718|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44233719|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43769892|NCT02384746|Fulvestrant|fulvestrant|mesh-list
44233739|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
44233740|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233741|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233742|NCT00545558|Tenofovir|tenofovir|mesh-list
44233743|NCT00545558|Emtricitabine|emtricitabine|mesh-list
44233744|NCT00545558|Efavirenz|efavirenz|mesh-list
43799808|NCT05001412|Apatinib|apatinib|mesh-list
44284828|NCT00752479|Prednisolone|prednisolone|mesh-list
44284829|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
44284830|NCT00752479|Cyclosporins|cyclosporins|mesh-list
44284831|NCT00752479|Basiliximab|basiliximab|mesh-list
44233745|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44233746|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
44233747|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233748|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44233749|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44233750|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233751|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233752|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44233753|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44233754|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44233755|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44233756|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44233757|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44233758|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44233759|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44233760|NCT00545675|Valproic Acid|valproic acid|mesh-list
44233761|NCT00545675|Aripiprazole|aripiprazole|mesh-list
44233762|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
44233763|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233764|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44233765|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44233766|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233767|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233768|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
44233769|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
44233770|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233771|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233772|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44233773|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44233805|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44233806|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44233807|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233808|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233809|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
44233810|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
44233811|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44233812|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
44233813|NCT00545961|Amoxicillin|amoxicillin|mesh-list
44233814|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
44233815|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
44233816|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44233817|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44233818|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233819|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43769919|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
44233840|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233841|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
44233842|NCT00546130|Cisplatin|cisplatin|mesh-list
44233843|NCT00546130|Irinotecan|irinotecan|mesh-list
44233844|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233845|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44233846|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233847|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233848|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233849|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44233850|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
44233851|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233852|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233853|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
44233854|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233855|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
44233856|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44233857|NCT00546130|Protective Agents|protective agents|mesh-ancestor
44233858|NCT00546143|Omalizumab|omalizumab|mesh-list
44233859|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44233860|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44233861|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44284838|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
44284839|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284840|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
44284841|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284842|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
44284843|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284844|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44284845|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44284846|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831496|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44284847|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44284848|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
44233862|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
44233863|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
44233864|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233865|NCT00546169|Thrombin|thrombin|mesh-list
44233866|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
44233867|NCT00546169|Coagulants|coagulants|mesh-ancestor
44458613|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
44458614|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458615|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44458616|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44458617|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44458618|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
44458619|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44458620|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870081|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43870082|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
43870083|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
43870084|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870085|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
43870086|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870087|NCT05605158|Pioglitazone|pioglitazone|mesh-list
43870088|NCT05605158|Empagliflozin|empagliflozin|mesh-list
43870089|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870090|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870091|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43870092|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870093|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43870094|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
43870130|NCT05423210|Atezolizumab|atezolizumab|mesh-list
43870131|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870132|NCT05417087|Vortioxetine|vortioxetine|mesh-list
43870133|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870134|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44160401|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
43870135|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44284849|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284850|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284852|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
44284853|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284854|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44284855|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
44284856|NCT00752479|Hormones|hormones|mesh-ancestor
44284857|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284858|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44284859|NCT00752479|Protective Agents|protective agents|mesh-ancestor
44284860|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43870136|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870137|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870138|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870139|NCT05417087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43870140|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870141|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838263|NCT04857203|Vitamin D|vitamin d|mesh-list
43870177|NCT05358704|Capecitabine|capecitabine|mesh-list
43870178|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
43870213|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43870214|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870215|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870216|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601060|NCT03268226|Hormones|hormones|mesh-ancestor
44161122|NCT00244283|Sevoflurane|sevoflurane|mesh-list
44161197|NCT00244452|Cetrorelix|cetrorelix|mesh-list
44134843|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
44134844|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134872|NCT00159484|Analgesics|analgesics|mesh-ancestor
44134873|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
44134874|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134875|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134876|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44134877|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134878|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44134879|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44134880|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134881|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134882|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134883|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
44134884|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
44134885|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
43870226|NCT05286619|Cisplatin|cisplatin|mesh-list
43870227|NCT05286619|Carboplatin|carboplatin|mesh-list
43870228|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
43870229|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870230|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870231|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
43870265|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
43870266|NCT05087381|Bromhexine|bromhexine|mesh-list
43870267|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870268|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870269|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43870270|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870271|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870301|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870302|NCT05003037|Cisplatin|cisplatin|mesh-list
43870303|NCT05003037|Carboplatin|carboplatin|mesh-list
43870304|NCT05003037|Pemetrexed|pemetrexed|mesh-list
43870305|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870306|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870307|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284861|NCT00752518|Bortezomib|bortezomib|mesh-list
44284862|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284863|NCT00752544|Simeprevir|simeprevir|mesh-list
44284864|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
44284865|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284866|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284867|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284868|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284869|NCT00752596|Azimilide|azimilide|mesh-list
43870308|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43870309|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43870310|NCT04937881|Tenofovir|tenofovir|mesh-list
43870311|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
43870312|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870313|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43870314|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43870315|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770225|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870346|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870347|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43870348|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43870349|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43870351|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
43870352|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
43870353|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870354|NCT04714541|Ketamine|ketamine|mesh-list
43870355|NCT04714541|Analgesics|analgesics|mesh-ancestor
43870356|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
43870357|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870358|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164840|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164999|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
43870375|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870376|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870377|NCT04656301|Psilocybin|psilocybin|mesh-list
43870378|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
43870379|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870380|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870381|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
43870382|NCT04645719|Analgesics|analgesics|mesh-ancestor
43870383|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
43870384|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870385|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870386|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
43870387|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870388|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43870389|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
43870390|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43870391|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870392|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870393|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43870394|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
43870395|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43870396|NCT04643327|Levetiracetam|levetiracetam|mesh-list
43870397|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
43870398|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
43870399|NCT04639843|Doxorubicin|doxorubicin|mesh-list
43870400|NCT04639843|Romidepsin|romidepsin|mesh-list
43870401|NCT04639843|Azacitidine|azacitidine|mesh-list
43870402|NCT04639843|Cc-486|cc-486|mesh-list
43870403|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43870404|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870405|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43870406|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43870407|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870408|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870409|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44284870|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44284871|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44284872|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44284873|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284874|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44284875|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284877|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
44284878|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44284879|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44284880|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44284881|NCT00752635|Norgestimate|norgestimate|mesh-list
44284882|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44284883|NCT00752635|Estradiol|estradiol|mesh-list
44284884|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44284885|NCT00752635|Cyproterone|cyproterone|mesh-list
44284886|NCT00752635|Estrogens|estrogens|mesh-ancestor
44284887|NCT00752635|Hormones|hormones|mesh-ancestor
44284888|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284889|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939559|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
44284890|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43870410|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
43870411|NCT04638517|Danazol|danazol|mesh-list
43870412|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44134914|NCT00159627|Diuretics|diuretics|mesh-ancestor
44134915|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
44134916|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134917|NCT00159653|Timolol|timolol|mesh-list
44134918|NCT00159653|Latanoprost|latanoprost|mesh-list
44134919|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44134920|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44134921|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134922|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155719|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870416|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
43870417|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870418|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
43870419|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43870420|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43870421|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870422|NCT04565925|Urological Agents|urological agents|mesh-ancestor
43870423|NCT04531176|Liraglutide|liraglutide|mesh-list
43870452|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43870453|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43870454|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
43870455|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
43870456|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
43870457|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43870459|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870460|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870461|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44284891|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
44284892|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284893|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44284894|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44284895|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44284896|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
44284897|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
44284898|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284899|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44284900|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44284901|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284902|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284903|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44284904|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44284905|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284906|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284907|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44284909|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
44166221|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44166375|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
43870462|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870464|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
43870465|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
43870493|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870494|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
43870495|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870496|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43870497|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870498|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870499|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43870500|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43870501|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44166451|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
44166552|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
43870502|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870503|NCT04480450|Rituximab|rituximab|mesh-list
43770395|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870566|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870567|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870568|NCT04118556|Sirolimus|sirolimus|mesh-list
43870569|NCT04118556|Etanercept|etanercept|mesh-list
43870570|NCT04118556|Everolimus|everolimus|mesh-list
43870571|NCT04118556|Infliximab|infliximab|mesh-list
43870572|NCT04118556|Vedolizumab|vedolizumab|mesh-list
43870573|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870574|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870575|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
43870576|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870577|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870578|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870579|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43870580|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
43870581|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
43870582|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870583|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44284910|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284911|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
44284912|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284913|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284915|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43870584|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43870585|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43870586|NCT04118556|Analgesics|analgesics|mesh-ancestor
43870587|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
43870588|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770481|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
43870612|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
43870613|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870614|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
43870616|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43870617|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870618|NCT04083144|Varenicline|varenicline|mesh-list
43870619|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43870620|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43870621|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
43870622|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870623|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870624|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870625|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43870626|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43870627|NCT04079218|Estradiol|estradiol|mesh-list
43870628|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43870629|NCT04079218|Estrogens|estrogens|mesh-ancestor
43870630|NCT04079218|Hormones|hormones|mesh-ancestor
43870631|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870632|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870633|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43870634|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
43870635|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43838327|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
43870660|NCT04062656|Hematinics|hematinics|mesh-ancestor
43870661|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
43870662|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43870663|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43870664|NCT04051203|Prednisolone|prednisolone|mesh-list
43870665|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
43870666|NCT04051203|Lidocaine|lidocaine|mesh-list
43870667|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43870668|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
43870669|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
44168728|NCT00272948|Defibrotide|defibrotide|mesh-list
44168805|NCT00273338|Calcitriol|calcitriol|mesh-list
43870670|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
43870671|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870672|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870673|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
43870674|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870675|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43870676|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43870677|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43870678|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870679|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870680|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43870681|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
43870682|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
43870683|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870684|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
43870685|NCT04051203|Hormones|hormones|mesh-ancestor
43770502|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43870725|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
43870726|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43870727|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134932|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799976|NCT04999137|Ascorbic Acid|ascorbic acid|mesh-list
44284916|NCT00752661|Narcotics|narcotics|mesh-ancestor
44284917|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44284918|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284919|NCT00752661|Analgesics|analgesics|mesh-ancestor
44284920|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
44284921|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284923|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
44284924|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284925|NCT00752739|Protective Agents|protective agents|mesh-ancestor
44284926|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284927|NCT00752739|Trace Elements|trace elements|mesh-ancestor
44284928|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
44284929|NCT00752843|Mifepristone|mifepristone|mesh-list
44284930|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44284931|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
44284932|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44284933|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284934|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44284935|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44284936|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44284937|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
44284938|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44134933|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134934|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
44134935|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134936|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134937|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134938|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43770597|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
43870752|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870753|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870754|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870755|NCT03824847|Clarithromycin|clarithromycin|mesh-list
43870756|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870757|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870758|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43870759|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870760|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870761|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43870762|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870763|NCT03818607|Eculizumab|eculizumab|mesh-list
43870764|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43870765|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870766|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
43870803|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43870804|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
43870805|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870806|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44284940|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
44284941|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284942|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
44284943|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44284944|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44284945|NCT00752869|Dutasteride|dutasteride|mesh-list
44284946|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44284947|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44284948|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668510|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
43870807|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
43870808|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43870833|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870834|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870835|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870836|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870837|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
43870838|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171799|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
44172184|NCT00288002|Docetaxel|docetaxel|mesh-list
44172266|NCT00288236|Rimonabant|rimonabant|mesh-list
43870839|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43870840|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870841|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870842|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43870843|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43870844|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
43870845|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
43870846|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870847|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43870848|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43870849|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
43870850|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43870851|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43870852|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43870853|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44172479|NCT00289354|Biotin|biotin|mesh-list
43870873|NCT03531918|Lenograstim|lenograstim|mesh-list
43870874|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870875|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
43870876|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870877|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870878|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
43870879|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870880|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870881|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
43870882|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870883|NCT03531918|Analgesics|analgesics|mesh-ancestor
43870884|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
43870885|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870886|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43870887|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43870888|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870889|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43870890|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870891|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43870892|NCT03520686|Paclitaxel|paclitaxel|mesh-list
43870893|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43870894|NCT03520686|Cisplatin|cisplatin|mesh-list
43870895|NCT03520686|Carboplatin|carboplatin|mesh-list
43870896|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
43870897|NCT03520686|Pemetrexed|pemetrexed|mesh-list
44284949|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284950|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
44284951|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44284952|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284953|NCT00752882|Ceftazidime|ceftazidime|mesh-list
44284954|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284955|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284956|NCT00752921|Etoricoxib|etoricoxib|mesh-list
44284957|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44284958|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44284959|NCT00752921|Analgesics|analgesics|mesh-ancestor
44284960|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
44284961|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284962|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44284963|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44284964|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43870898|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43870899|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870900|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870901|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870902|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
43870903|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870904|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870905|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870906|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43870934|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870935|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870936|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870938|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870939|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43870940|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870941|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870942|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43870943|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870944|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870945|NCT03438487|Vaccines|vaccines|mesh-list
43870946|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
43870947|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870948|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43870949|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43870983|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870984|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870985|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
43870986|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43870987|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
43870988|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43770756|NCT02377180|Anesthetics|anesthetics|mesh-list
43871011|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871012|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43871013|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43871014|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871015|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871016|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
43871018|NCT03145558|Tirapazamine|tirapazamine|mesh-list
43871019|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44284967|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284968|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284969|NCT00752934|Baclofen|baclofen|mesh-list
44284970|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44284971|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668537|NCT03013218|Ramucirumab|ramucirumab|mesh-list
43871020|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871021|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43871022|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43871023|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871024|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871025|NCT03117660|Vitamin A|vitamin a|mesh-list
43871026|NCT03117660|Vitamins|vitamins|mesh-ancestor
43871027|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
43871028|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871029|NCT03022773|Carotenoids|carotenoids|mesh-list
43871030|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
43871031|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871032|NCT03022773|Protective Agents|protective agents|mesh-ancestor
43871033|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871034|NCT03019666|Niacinamide|niacinamide|mesh-list
43871035|NCT03019666|Niacin|niacin|mesh-list
43871036|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
43871037|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
43871038|NCT03019666|Vitamins|vitamins|mesh-ancestor
43645380|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43871039|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
43871040|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871041|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43871042|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
43871043|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871044|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43871045|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
43871112|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
43871113|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871114|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43871115|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871116|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
43871117|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43871118|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871119|NCT02740179|Eplerenone|eplerenone|mesh-list
43887450|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43887451|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887452|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887453|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887485|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
43887486|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887487|NCT04551755|Doxycycline|doxycycline|mesh-list
43887488|NCT04551755|Ivermectin|ivermectin|mesh-list
43887489|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887490|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887491|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
43887492|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43887493|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43887494|NCT04551703|Epinephrine|epinephrine|mesh-list
43887495|NCT04551703|Racepinephrine|racepinephrine|mesh-list
43887530|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887531|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
43887532|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43887533|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887534|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887535|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43887570|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
43887571|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887572|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284972|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44284973|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44284974|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44284975|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
44284976|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
44284977|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44284978|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284979|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
43616814|NCT03144115|Oxytocin|oxytocin|mesh-list
43770986|NCT02375464|Octreotide|octreotide|mesh-list
43887603|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43887604|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
43887605|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887606|NCT04549935|Prednisolone|prednisolone|mesh-list
43887607|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887608|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
43887609|NCT04549935|Hormones|hormones|mesh-ancestor
43644509|NCT04582669|Hormones|hormones|mesh-ancestor
43887610|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887611|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887612|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887613|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887614|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
43887615|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
43887616|NCT04550078|Calcium|calcium|mesh-list
43887617|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887618|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887619|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43887620|NCT04550078|Antacids|antacids|mesh-ancestor
43887621|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887638|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43887639|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43887640|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887641|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
43887679|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43887735|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887736|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43887737|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
43887738|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
43887739|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43887740|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43887741|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43887742|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887743|NCT04547348|Denosumab|denosumab|mesh-list
43887744|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43887745|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887746|NCT04547426|Nicotine|nicotine|mesh-list
43887747|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43887748|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
43887749|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887750|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887751|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43887752|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43887753|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
43887754|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887755|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887756|NCT04547452|Antibodies|antibodies|mesh-list
43887757|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
43887758|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887759|NCT04547335|Voriconazole|voriconazole|mesh-list
43887760|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
43887761|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887762|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43887763|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43887764|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771139|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
44136440|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
44136441|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284980|NCT00752947|Metronidazole|metronidazole|mesh-list
44284981|NCT00752947|Levofloxacin|levofloxacin|mesh-list
44284982|NCT00752947|Ofloxacin|ofloxacin|mesh-list
44284983|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44284984|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44284985|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44284986|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136442|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44136443|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44136444|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44136445|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44136446|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
44136447|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44136448|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44136449|NCT00164749|Curcumin|curcumin|mesh-list
44136450|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44136451|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44136476|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136477|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136478|NCT00164801|Diltiazem|diltiazem|mesh-list
44136479|NCT00164801|Baclofen|baclofen|mesh-list
44136480|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44136481|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136482|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44136483|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136484|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44136485|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
44136486|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
44136487|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136488|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136489|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44136490|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44136491|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44136492|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44136493|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
44136494|NCT00164840|Esomeprazole|esomeprazole|mesh-list
44136495|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44136496|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136497|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43887782|NCT04547088|Apatinib|apatinib|mesh-list
43887783|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887803|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
43887804|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887805|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887806|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43887807|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
43887808|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887809|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887810|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43887811|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43887812|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
43887813|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
43887814|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887815|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887816|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
43887817|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887818|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43887819|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43887820|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43887821|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
43887822|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887823|NCT04546373|Niraparib|niraparib|mesh-list
43887824|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43887825|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887826|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887827|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887828|NCT04546282|Osimertinib|osimertinib|mesh-list
43887829|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284987|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44284988|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44284989|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44284990|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44284991|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44284992|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44284993|NCT00752947|Renal Agents|renal agents|mesh-ancestor
43887830|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887831|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887832|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887833|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43887834|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
43887835|NCT04546334|Analgesics|analgesics|mesh-ancestor
43887836|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
43887837|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887838|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887839|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
43887902|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
43887903|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887904|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43887905|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
43887906|NCT04545879|Protective Agents|protective agents|mesh-ancestor
43887907|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887908|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887943|NCT04545463|Psyllium|psyllium|mesh-list
43887944|NCT04545463|Cathartics|cathartics|mesh-ancestor
43887945|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887946|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
43887947|NCT04545450|Testosterone|testosterone|mesh-list
43887948|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
43887949|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
43887950|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43887951|NCT04545450|Dutasteride|dutasteride|mesh-list
43887952|NCT04545450|Androgens|androgens|mesh-ancestor
43887988|NCT04544969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887989|NCT04544969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887990|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136503|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44136504|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136505|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136537|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136538|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136539|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136540|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136541|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136542|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136543|NCT00165048|Rofecoxib|rofecoxib|mesh-list
44136544|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44136545|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44136546|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136547|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136548|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43771408|NCT02373462|Olmesartan|olmesartan|mesh-list
43888038|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888040|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888041|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888042|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
43888043|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888044|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43888045|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43888046|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43888047|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888048|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888049|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43888050|NCT04544163|Narcotics|narcotics|mesh-ancestor
43888051|NCT04544163|Analgesics|analgesics|mesh-ancestor
44284994|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44284995|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44284997|NCT00753038|Carboplatin|carboplatin|mesh-list
44284998|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44284999|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285000|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285001|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285002|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285003|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285004|NCT00753051|Haloperidol|haloperidol|mesh-list
44285005|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
44285006|NCT00753051|Clozapine|clozapine|mesh-list
44285007|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
44285008|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
44285009|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285010|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285011|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285012|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44285013|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44285014|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285015|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888052|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43888053|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888054|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
43888055|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
43888056|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43888057|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43771424|NCT02373254|Hydrocodone|hydrocodone|mesh-list
43888088|NCT04543370|Deflazacort|deflazacort|mesh-list
43888090|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43888091|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888092|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888093|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888094|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43888095|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43888096|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888097|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888098|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
43888100|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
43888102|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888103|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888125|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
43888126|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888127|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888129|NCT04542759|Besifloxacin|besifloxacin|mesh-list
43888130|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43888131|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43888132|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43888133|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888134|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888135|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888136|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285017|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
44285018|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285019|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285020|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44285021|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44285022|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
44285023|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
44285024|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
44285025|NCT00753064|Prazosin|prazosin|mesh-list
44285026|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285027|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44285028|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44285029|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44285030|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285031|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826734|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888137|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888138|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888139|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43888140|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43888141|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888142|NCT04542226|Bromides|bromides|mesh-list
43888143|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
43888144|NCT04542213|Insulin|insulin|mesh-list
43888145|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43888146|NCT04542213|Linagliptin|linagliptin|mesh-list
43888147|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43888148|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888149|NCT04542213|Incretins|incretins|mesh-ancestor
43888150|NCT04542213|Hormones|hormones|mesh-ancestor
43888151|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888152|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43888153|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
43888154|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888155|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888156|NCT04542369|Cisplatin|cisplatin|mesh-list
43888170|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888171|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
43888172|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888173|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888174|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888175|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43888177|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43888178|NCT04541719|Narcotics|narcotics|mesh-ancestor
43888179|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888180|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888181|NCT04541719|Analgesics|analgesics|mesh-ancestor
43888182|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
43888183|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888184|NCT04541732|Anesthetics|anesthetics|mesh-list
43888185|NCT04541732|Propofol|propofol|mesh-list
43888186|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888187|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888188|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888189|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888190|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
43888191|NCT04541823|Propofol|propofol|mesh-list
44285032|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285033|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285034|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
44285035|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
44285036|NCT00753103|Prednisolone|prednisolone|mesh-list
43888192|NCT04541823|Desflurane|desflurane|mesh-list
43888193|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888194|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888195|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888196|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888197|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
43888198|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
43888199|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43888200|NCT04542005|Albuterol|albuterol|mesh-list
43888201|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43888202|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
43888203|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888204|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888205|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43888206|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
43888207|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
43888208|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43888209|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43888210|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43888211|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43888212|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888213|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888214|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888215|NCT04541147|Dexamethasone|dexamethasone|mesh-list
43888216|NCT04541147|Analgesics|analgesics|mesh-list
43888217|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888240|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43888241|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
43888242|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888243|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888244|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
43888245|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888246|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888247|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
43888248|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888249|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888318|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888319|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888351|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888352|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43888353|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43888354|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888355|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888356|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43888357|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43888358|NCT04539106|Ranibizumab|ranibizumab|mesh-list
43888359|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43888360|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43888361|NCT04539106|Growth Substances|growth substances|mesh-ancestor
43888362|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888391|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888392|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43888393|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888394|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888395|NCT04539418|Vitamin K|vitamin k|mesh-list
43888396|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
43888397|NCT04539418|Vitamins|vitamins|mesh-ancestor
43888398|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
43888399|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888400|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43888401|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888402|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888403|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
43888404|NCT04539418|Coagulants|coagulants|mesh-ancestor
44285037|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
44285039|NCT00753103|Infliximab|infliximab|mesh-list
43939676|NCT00915538|Budesonide|budesonide|mesh-list
44285040|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285041|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
44285042|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285043|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285044|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44285045|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
44285046|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285047|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285048|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44285049|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44285050|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44285051|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
43668563|NCT02881242|Trametinib|trametinib|mesh-list
44136572|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136573|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157227|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157228|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157229|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157230|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
44157231|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157232|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
44157233|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888428|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43888459|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43888460|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43888461|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43888462|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888463|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888464|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888465|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888466|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
43888467|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43771766|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
43888501|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888502|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43888503|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
43888505|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888532|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888533|NCT04536558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43888534|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43888535|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888536|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888537|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888538|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
43888539|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43888540|NCT04536662|Dexamethasone|dexamethasone|mesh-list
43888541|NCT04536662|Prednisone|prednisone|mesh-list
43888542|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
43888543|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888544|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
43888545|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
43888546|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888547|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888548|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285053|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285054|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285055|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285056|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
44285057|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
44285058|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285059|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285060|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
44285061|NCT00753103|Hormones|hormones|mesh-ancestor
44285062|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285063|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44285064|NCT00753103|Protective Agents|protective agents|mesh-ancestor
43888549|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
43888551|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888552|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888553|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888555|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
43888556|NCT04536363|Alprostadil|alprostadil|mesh-list
44136609|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
44136610|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44136611|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
44136612|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
44136613|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136614|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136615|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136647|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
43888560|NCT04536532|Entecavir|entecavir|mesh-list
43888561|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
43888562|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888563|NCT04536415|Oseltamivir|oseltamivir|mesh-list
43888564|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
43888565|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888566|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888567|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888568|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
43888569|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888602|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
43888603|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43888604|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
43888605|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
43888606|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
43888607|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43888608|NCT04535960|Liraglutide|liraglutide|mesh-list
43888609|NCT04535960|Empagliflozin|empagliflozin|mesh-list
43888610|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43888611|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888612|NCT04535960|Incretins|incretins|mesh-ancestor
43888647|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43771928|NCT02369939|Fluorouracil|fluorouracil|mesh-list
43888669|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43888670|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888671|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
43888672|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
43888673|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888674|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888675|NCT04535700|Pioglitazone|pioglitazone|mesh-list
43888676|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43888677|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888678|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
43888679|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43888680|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
43888681|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888682|NCT04534725|Interferons|interferons|mesh-list
43888683|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
44285065|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285066|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888684|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888685|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
43888686|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888687|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
43888688|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888689|NCT04534478|Prednisone|prednisone|mesh-list
43888690|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888691|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
43888692|NCT04534478|Hormones|hormones|mesh-ancestor
43888693|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888694|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888695|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888696|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888697|NCT04534465|Mannitol|mannitol|mesh-list
43888698|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43888699|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43888700|NCT04534465|Diuretics|diuretics|mesh-ancestor
43888701|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
43888702|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888703|NCT04534465|Laxatives|laxatives|mesh-ancestor
43888736|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
43888737|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
43888738|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888739|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888740|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888741|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
43888742|NCT04534322|Hormones|hormones|mesh-ancestor
43888743|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888744|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888745|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888746|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43888779|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
43888780|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888781|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888782|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43888783|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43888784|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888785|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888786|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44136665|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
44136666|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136667|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136668|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44136669|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44136670|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136671|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44136672|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
44136673|NCT00165204|Hormones|hormones|mesh-ancestor
44136674|NCT00165217|Thalidomide|thalidomide|mesh-list
44136675|NCT00165217|Capecitabine|capecitabine|mesh-list
44136676|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44136677|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
44136678|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136679|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136680|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136681|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
44136682|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136683|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136684|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136685|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136686|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136687|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136688|NCT00165217|Growth Substances|growth substances|mesh-ancestor
44136689|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136690|NCT00165230|Thalidomide|thalidomide|mesh-list
44136691|NCT00165230|Temozolomide|temozolomide|mesh-list
44136692|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136693|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
44136694|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136695|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136696|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44285067|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
44285068|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44285069|NCT00753168|Timolol|timolol|mesh-list
44285070|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44285071|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44285072|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44285073|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44285074|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285075|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285076|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285077|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285078|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44285079|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285080|NCT00753207|Epirubicin|epirubicin|mesh-list
44285081|NCT00753207|Lapatinib|lapatinib|mesh-list
44285082|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136697|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136698|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136699|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136700|NCT00165230|Growth Substances|growth substances|mesh-ancestor
44136701|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136702|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136703|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44136704|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
44136705|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888797|NCT04533243|Analgesics|analgesics|mesh-ancestor
43888798|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
43888799|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888800|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43888801|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888802|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
43888803|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
43888804|NCT04533321|Afatinib|afatinib|mesh-list
43888805|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888806|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43888807|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888808|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888809|NCT04532931|Acetaminophen|acetaminophen|mesh-list
43888810|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
43888811|NCT04532931|Artesunate|artesunate|mesh-list
43888812|NCT04532931|Favipiravir|favipiravir|mesh-list
43888813|NCT04532931|Amodiaquine|amodiaquine|mesh-list
43888814|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
43888815|NCT04532931|Pyronaridine|pyronaridine|mesh-list
43888816|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43888817|NCT04532931|Analgesics|analgesics|mesh-ancestor
43888818|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
43888819|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888820|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888821|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
43888822|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
43888849|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
43888850|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43888851|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43888852|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43888853|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43888854|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43888855|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43888856|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43888857|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
44285083|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285084|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44285085|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285086|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285087|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285088|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44285089|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
44285090|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285091|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285092|NCT00753311|Rizatriptan|rizatriptan|mesh-list
44285093|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44285094|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
44285095|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285096|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285097|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285098|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44285099|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
44285100|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285101|NCT00753389|Anesthetics|anesthetics|mesh-list
44285102|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285103|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285104|NCT00753402|Epinephrine|epinephrine|mesh-list
44285105|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44285106|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44285107|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285108|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668594|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
43888858|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
43888859|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43888860|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
43888861|NCT04532918|Protective Agents|protective agents|mesh-ancestor
43888862|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
43888863|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43888864|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43888865|NCT04532775|Prednisolone|prednisolone|mesh-list
43888866|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
43888868|NCT04532775|Bupivacaine|bupivacaine|mesh-list
43888869|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43888870|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
43888871|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888872|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
43888873|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772117|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43888902|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888903|NCT04532684|Pregabalin|pregabalin|mesh-list
43888904|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43888905|NCT04532684|Analgesics|analgesics|mesh-ancestor
43888906|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
44285109|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285110|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285111|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44285112|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44285113|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
44285114|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285115|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44285116|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
44285118|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
43888907|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888908|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888909|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
43888910|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43888911|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888912|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888913|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43888914|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43888915|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43888916|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888917|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772168|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888952|NCT04532606|Anesthetics|anesthetics|mesh-list
43888953|NCT04532606|Propofol|propofol|mesh-list
43888954|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888955|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888990|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888991|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888992|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43888993|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43888994|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
43888995|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43888996|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889028|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889029|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889030|NCT04531423|Golimumab|golimumab|mesh-list
43889031|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43889032|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889033|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136725|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44136726|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136727|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136728|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136729|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136730|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136731|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136732|NCT00165347|Vatalanib|vatalanib|mesh-list
44136733|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44136734|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136735|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136736|NCT00165360|Temozolomide|temozolomide|mesh-list
44136737|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44136738|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
44136739|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838569|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889078|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43889079|NCT04531072|Lumefantrine|lumefantrine|mesh-list
43889080|NCT04531072|Artemether|artemether|mesh-list
43889081|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43889082|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43889083|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43889084|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
44285120|NCT00753467|Interferons|interferons|mesh-list
44285121|NCT00753467|Adefovir|adefovir|mesh-list
44285122|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44285123|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
44285124|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285125|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
44285126|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285127|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44285128|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44285129|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668622|NCT02607748|Fluorides|fluorides|mesh-list
43889085|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889086|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889087|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43889088|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43889089|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
43889090|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889091|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43889092|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43889093|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
43889094|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889095|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889096|NCT04530864|Dexamethasone|dexamethasone|mesh-list
43889097|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
43889098|NCT04530864|BB 1101|bb 1101|mesh-list
43889099|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889100|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
43889131|NCT04530474|Ivermectin|ivermectin|mesh-list
43889132|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889133|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889134|NCT04530500|Androgens|androgens|mesh-list
43889135|NCT04530500|Hormones|hormones|mesh-ancestor
43889136|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889137|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889138|NCT04530578|Heparin|heparin|mesh-list
43889139|NCT04530578|Calcium heparin|calcium heparin|mesh-list
43889140|NCT04530578|Enoxaparin|enoxaparin|mesh-list
43889141|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43889142|NCT04530578|Tinzaparin|tinzaparin|mesh-list
43889143|NCT04530578|Dalteparin|dalteparin|mesh-list
43889144|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
43889178|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889179|NCT04530045|Piperacillin|piperacillin|mesh-list
43889180|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889181|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889182|NCT04530188|Propofol|propofol|mesh-list
43889183|NCT04530188|Sevoflurane|sevoflurane|mesh-list
43889184|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43889185|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889186|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889187|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889188|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
43889222|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889223|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
43889224|NCT04529512|Hormones|hormones|mesh-ancestor
43889225|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889226|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889227|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889228|NCT04529356|Acetaminophen|acetaminophen|mesh-list
43889229|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889230|NCT04529356|Analgesics|analgesics|mesh-ancestor
43889231|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
43889232|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889233|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889234|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
43799977|NCT04999137|Thiamine|thiamine|mesh-list
44285130|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285131|NCT00753493|Topiramate|topiramate|mesh-list
44285132|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
44285133|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44285134|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285135|NCT00753558|Gentamicins|gentamicins|mesh-list
44285136|NCT00753558|Polymyxins|polymyxins|mesh-list
44285137|NCT00753558|Colistin|colistin|mesh-list
44285138|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44285139|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285140|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44285141|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285142|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285143|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
44285144|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44285145|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44285146|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285147|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889273|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889302|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43889303|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43889304|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
43889305|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43889306|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43889307|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
43889308|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43889309|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43889310|NCT04528797|Prednisolone|prednisolone|mesh-list
43889311|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
43889312|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43889313|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
43889314|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889315|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
43889316|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
43889317|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889318|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889319|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889320|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
43889321|NCT04528797|Hormones|hormones|mesh-ancestor
44136748|NCT00165399|Docetaxel|docetaxel|mesh-list
44136749|NCT00165399|Goserelin|goserelin|mesh-list
44136750|NCT00165399|Bicalutamide|bicalutamide|mesh-list
44136751|NCT00165399|Estramustine|estramustine|mesh-list
44136752|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136753|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136754|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772558|NCT02365623|Bedaquiline|bedaquiline|mesh-list
43889378|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889379|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889380|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889381|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43889382|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43889383|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889384|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889385|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
43889386|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
43889387|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43889388|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
43799978|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
44285148|NCT00753571|Protective Agents|protective agents|mesh-ancestor
44285149|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285150|NCT00753597|Rituximab|rituximab|mesh-list
44285151|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285152|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285153|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
44285154|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285155|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889389|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43889390|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
43889391|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
43889392|NCT04528056|Ambrisentan|ambrisentan|mesh-list
43889393|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889394|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43889395|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889396|NCT04528056|Analgesics|analgesics|mesh-ancestor
43889397|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
43889398|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889399|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889433|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889434|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43889435|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43889436|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
43889437|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889438|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889440|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889441|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889491|NCT05126121|Amoxicillin|amoxicillin|mesh-list
43889492|NCT05126121|Clarithromycin|clarithromycin|mesh-list
43889493|NCT05126121|Levofloxacin|levofloxacin|mesh-list
43889494|NCT05126121|Ofloxacin|ofloxacin|mesh-list
43889495|NCT05126121|Tetracycline|tetracycline|mesh-list
43889496|NCT05126121|Tinidazole|tinidazole|mesh-list
43889497|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43889498|NCT05126121|Furazolidone|furazolidone|mesh-list
43889499|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889500|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
43889536|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43889551|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
43889552|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889553|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889554|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43889555|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889556|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
43889557|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889558|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43889559|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43889560|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889562|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889563|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
43889564|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43889565|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
43889566|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889567|NCT04312594|Expectorants|expectorants|mesh-ancestor
43889568|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
43889569|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43889570|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
43889571|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889572|NCT04312594|Protective Agents|protective agents|mesh-ancestor
43889573|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889574|NCT04312594|Antidotes|antidotes|mesh-ancestor
43889575|NCT03921866|Palbociclib|palbociclib|mesh-list
43889576|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889577|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43889578|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889579|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889580|NCT03772158|Cetirizine|cetirizine|mesh-list
44285156|NCT00753727|Sunitinib|sunitinib|mesh-list
44285157|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285158|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44285159|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285160|NCT00753727|Growth Substances|growth substances|mesh-ancestor
44285161|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889581|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43889582|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43889583|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43889584|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
43889585|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
43889586|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889587|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889588|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889589|NCT03558854|Aspirin|aspirin|mesh-list
43889590|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43889591|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889592|NCT03558854|Analgesics|analgesics|mesh-ancestor
43889593|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
43889594|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889595|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889596|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889597|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889598|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43889599|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43889610|NCT03366272|Nivolumab|nivolumab|mesh-list
43889611|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
43889612|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43889613|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889614|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
43889615|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889616|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889617|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43889618|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
43889619|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889620|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
43889621|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889622|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889623|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889624|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43889625|NCT03113955|Epirubicin|epirubicin|mesh-list
43889626|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43889627|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889628|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43889629|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43889630|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889631|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889632|NCT03016338|Niraparib|niraparib|mesh-list
43889633|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43889634|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889635|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889636|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889637|NCT02995694|Estradiol|estradiol|mesh-list
43889638|NCT02995694|Estrogens|estrogens|mesh-ancestor
43889639|NCT02995694|Hormones|hormones|mesh-ancestor
43889640|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889641|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889642|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
43889643|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43889644|NCT01870193|Glycine|glycine|mesh-list
43889645|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
43889646|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889647|NCT01870193|Expectorants|expectorants|mesh-ancestor
43889648|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
43889649|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43889650|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
43889651|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889652|NCT01870193|Protective Agents|protective agents|mesh-ancestor
43800123|NCT04997291|Protective Agents|protective agents|mesh-ancestor
44285162|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285163|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44285164|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285165|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889653|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889654|NCT01870193|Antidotes|antidotes|mesh-ancestor
43889655|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
43889656|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889657|NCT01805284|Linezolid|linezolid|mesh-list
43889658|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889659|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889660|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43889661|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889662|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889663|NCT01134601|Capecitabine|capecitabine|mesh-list
43889664|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43889665|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
44136793|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136794|NCT00165451|Growth Substances|growth substances|mesh-ancestor
44136795|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136796|NCT00165464|Cisplatin|cisplatin|mesh-list
44136797|NCT00165464|Irinotecan|irinotecan|mesh-list
44136798|NCT00165464|Docetaxel|docetaxel|mesh-list
44136799|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136800|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44136801|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136802|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136803|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136804|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136805|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136806|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136807|NCT00165477|Lenalidomide|lenalidomide|mesh-list
44136808|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
44136809|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136810|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136811|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136812|NCT00165477|Growth Substances|growth substances|mesh-ancestor
44136813|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136814|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136816|NCT00165490|Irinotecan|irinotecan|mesh-list
44136817|NCT00165490|Cetuximab|cetuximab|mesh-list
44136818|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136819|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44136820|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136821|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889668|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43889669|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43889670|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889691|NCT04455776|Propofol|propofol|mesh-list
43889692|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43889693|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889694|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889695|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889696|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
43889697|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
43889698|NCT04446793|Bevacizumab|bevacizumab|mesh-list
43889699|NCT04446793|Onvansertib|onvansertib|mesh-list
43889700|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43889701|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889702|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43889711|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
43889712|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889713|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43889714|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
43889715|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889716|NCT04407572|Vitamin D|vitamin d|mesh-list
43889717|NCT04407572|Vitamins|vitamins|mesh-list
43889718|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
43889719|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
43889720|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
43889721|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889722|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43889723|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
44285166|NCT00753740|Camptothecin|camptothecin|mesh-list
44285167|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285168|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285169|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44285170|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285171|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889724|NCT04407572|Hematinics|hematinics|mesh-ancestor
43889725|NCT04405284|Disinfectants|disinfectants|mesh-list
43889726|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889758|NCT04377295|Ranibizumab|ranibizumab|mesh-list
43889759|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43889760|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43889761|NCT04377295|Growth Substances|growth substances|mesh-ancestor
43889762|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889763|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
43889764|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889765|NCT04374123|Antibodies|antibodies|mesh-list
43889766|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
43889767|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
43889768|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889769|NCT04367688|Tenofovir|tenofovir|mesh-list
43889770|NCT04367688|Emtricitabine|emtricitabine|mesh-list
43889771|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
43889772|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889773|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43889774|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43889775|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889776|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889777|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43889778|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43889779|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
43889780|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889781|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
43889782|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889783|NCT04365725|Remdesivir|remdesivir|mesh-list
43889784|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
43889785|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889787|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889788|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43889789|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
43889790|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889812|NCT04314336|Coal Tar|coal tar|mesh-list
43889813|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
43889814|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889815|NCT04312555|Alprostadil|alprostadil|mesh-list
43889816|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43889817|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
43889671|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
43889672|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
43889673|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889674|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889675|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889676|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889677|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889729|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43889730|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43889731|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43889732|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889734|NCT04396587|Oxycodone|oxycodone|mesh-list
43889735|NCT04396587|Hydromorphone|hydromorphone|mesh-list
43889736|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43889737|NCT04396587|Narcotics|narcotics|mesh-ancestor
43889738|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889739|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889740|NCT04396587|Analgesics|analgesics|mesh-ancestor
43889741|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
43889742|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889743|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43889744|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889745|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
43889746|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
44285172|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285173|NCT00753779|Simvastatin|simvastatin|mesh-list
44285174|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44285175|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285176|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285177|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
44285178|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285179|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44285180|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44285181|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285182|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
44285183|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44285184|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44285185|NCT00753792|Prednisolone|prednisolone|mesh-list
44285186|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
44285187|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43889747|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43889748|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43889749|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889750|NCT04389294|Antibodies|antibodies|mesh-list
43889751|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
43889752|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889753|NCT04381091|Idebenone|idebenone|mesh-list
43889754|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
43889755|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889756|NCT04381091|Protective Agents|protective agents|mesh-ancestor
43889757|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889791|NCT04334837|Copper|copper|mesh-list
43889792|NCT04334837|Trace Elements|trace elements|mesh-ancestor
43889793|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
43889794|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889795|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
43889796|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43889797|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889798|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889799|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889800|NCT04321733|Amoxicillin|amoxicillin|mesh-list
43889801|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
43889802|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
43889803|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43889804|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889805|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889806|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43889807|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889808|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889809|NCT04319341|Autoantibodies|autoantibodies|mesh-list
43889810|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
43889811|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889818|NCT04312555|Urological Agents|urological agents|mesh-ancestor
43889819|NCT04310631|Ranibizumab|ranibizumab|mesh-list
43889820|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43889821|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136826|NCT00165516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136827|NCT00165516|Antidotes|antidotes|mesh-ancestor
44136828|NCT00165516|Protective Agents|protective agents|mesh-ancestor
44136829|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136830|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
44136831|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285188|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
44285189|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285190|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
44285191|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
44285192|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285193|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285194|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285195|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
44285196|NCT00753792|Hormones|hormones|mesh-ancestor
44285197|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285198|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44285199|NCT00753792|Protective Agents|protective agents|mesh-ancestor
44285200|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285201|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285202|NCT00753883|Simvastatin|simvastatin|mesh-list
44285203|NCT00753883|Ezetimibe|ezetimibe|mesh-list
44285204|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285205|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285206|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
44285207|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285208|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44285209|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44285210|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285211|NCT00753909|Paclitaxel|paclitaxel|mesh-list
44136832|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136833|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136834|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136835|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
44136836|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
44136837|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
44136838|NCT00165555|Cisplatin|cisplatin|mesh-list
44136839|NCT00165555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136840|NCT00165555|Antidotes|antidotes|mesh-ancestor
44136841|NCT00165555|Protective Agents|protective agents|mesh-ancestor
44136842|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136843|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
44136844|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136845|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136846|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136847|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136848|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
44136849|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
44136850|NCT00165568|Bevacizumab|bevacizumab|mesh-list
44136851|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44136852|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136853|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136854|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136855|NCT00165568|Growth Substances|growth substances|mesh-ancestor
44136856|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136857|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136858|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44285213|NCT00753909|Carboplatin|carboplatin|mesh-list
44285214|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285215|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285216|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285217|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285218|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285219|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285220|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285221|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136859|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136860|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43889840|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43889842|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136887|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44136888|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136889|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136890|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
44136891|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136892|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136893|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
44136894|NCT00165750|Donepezil|donepezil|mesh-list
44136895|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44136896|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136915|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136916|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136917|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
44136918|NCT00165828|Zonisamide|zonisamide|mesh-list
44136919|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
44136920|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44136921|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44136922|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136923|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44136924|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136925|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44136926|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136927|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44136928|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136929|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136930|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44136931|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136932|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44136933|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136934|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136935|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44136936|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136937|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44136939|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136940|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44136941|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
44136942|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136943|NCT00166127|Simendan|simendan|mesh-list
44136944|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44136945|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
44136946|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44136947|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43889843|NCT04267601|Anagliptin|anagliptin|mesh-list
43889858|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889859|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889860|NCT04256265|Risdiplam|risdiplam|mesh-list
44285222|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285223|NCT00753909|Growth Substances|growth substances|mesh-ancestor
44285224|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285225|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285226|NCT00754039|Fenofibrate|fenofibrate|mesh-list
44285227|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44285228|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285229|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
44285230|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889861|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43889862|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889863|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889864|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43889865|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
43889866|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889867|NCT04240509|Tenofovir|tenofovir|mesh-list
43889868|NCT04240509|Emtricitabine|emtricitabine|mesh-list
43889869|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
43889870|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889871|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43889872|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43889873|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889874|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889875|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43889876|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43889877|NCT04238741|Anesthetics|anesthetics|mesh-list
43889878|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889879|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889880|NCT04230707|Melatonin|melatonin|mesh-list
43889881|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
43889882|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889883|NCT04230707|Protective Agents|protective agents|mesh-ancestor
43889884|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889885|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889886|NCT04221568|Fentanyl|fentanyl|mesh-list
43889887|NCT04221568|Bupivacaine|bupivacaine|mesh-list
43889888|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
43889889|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
43889890|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
43889891|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889892|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889893|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
43889894|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889895|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43889896|NCT04221568|Narcotics|narcotics|mesh-ancestor
43889897|NCT04221568|Analgesics|analgesics|mesh-ancestor
43889898|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43889899|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889900|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
43889901|NCT04220203|Capecitabine|capecitabine|mesh-list
43889902|NCT04220203|Trastuzumab|trastuzumab|mesh-list
43889903|NCT04220203|Tucatinib|tucatinib|mesh-list
43889904|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43889905|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
43889912|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43889913|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889914|NCT04216303|Analgesics|analgesics|mesh-ancestor
43889915|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
43889916|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889917|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889918|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889919|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889920|NCT04204928|Pralsetinib|pralsetinib|mesh-list
43889921|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889922|NCT04195009|Anesthetics|anesthetics|mesh-list
43889923|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889924|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285231|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44285232|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285233|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44285234|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285235|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44285236|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285237|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889933|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889934|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
43889935|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
43889936|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889937|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43889938|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43889939|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889940|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889941|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43889942|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889943|NCT04163224|Imidacloprid|imidacloprid|mesh-list
43889944|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
43889945|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889946|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889947|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136948|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136949|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136950|NCT00166127|Protective Agents|protective agents|mesh-ancestor
44136951|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136952|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
44136953|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136954|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136955|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44136956|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136957|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136958|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136959|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136960|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136961|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
44136962|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136963|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773161|NCT02361190|Hormones|hormones|mesh-ancestor
44136982|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136984|NCT00166413|Lenalidomide|lenalidomide|mesh-list
44136985|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136986|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
44136987|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136988|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136989|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136990|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136991|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43889949|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43889950|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889951|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889952|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889953|NCT04138641|Cangrelor|cangrelor|mesh-list
43889954|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43889955|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43889956|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43889957|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43889958|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
43889959|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889960|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889961|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889962|NCT04135092|Aldesleukin|aldesleukin|mesh-list
43889963|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
43889964|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
43889965|NCT04135092|Fludarabine|fludarabine|mesh-list
44285238|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44285239|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
44285240|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464095|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44464097|NCT01499849|Granisetron|granisetron|mesh-list
44464098|NCT01499849|Rolapitant|rolapitant|mesh-list
44464099|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464100|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
44464101|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
44464102|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464103|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889966|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889967|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
43889968|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889969|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889970|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43889971|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
43889972|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889973|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889974|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43889983|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889984|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
43889985|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889986|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
43889987|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889988|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889989|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
43889990|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
43889991|NCT04130776|Kallikreins|kallikreins|mesh-list
43889992|NCT04130776|Coagulants|coagulants|mesh-ancestor
43889993|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
43889994|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
43889995|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43889996|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889997|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
43889998|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43889999|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
43890000|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
43890001|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890002|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890003|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890004|NCT04124562|Analgesics|analgesics|mesh-ancestor
43890005|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
43890006|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890007|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
43890008|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43890009|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
43890010|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890011|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
43890012|NCT04124133|Protective Agents|protective agents|mesh-ancestor
43890013|NCT04114500|Estradiol|estradiol|mesh-list
43890014|NCT04114500|Progesterone|progesterone|mesh-list
43890015|NCT04114500|Estrogens|estrogens|mesh-ancestor
43890016|NCT04114500|Hormones|hormones|mesh-ancestor
43890017|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890018|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890019|NCT04114500|Progestins|progestins|mesh-ancestor
43890040|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43890041|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43890042|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43890043|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890020|NCT04112277|Morphine|morphine|mesh-list
43890021|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43890022|NCT04112277|Narcotics|narcotics|mesh-ancestor
44464104|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464106|NCT01499849|Hormones|hormones|mesh-ancestor
44464107|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464108|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464109|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464110|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464111|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
44464112|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464113|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668756|NCT01497392|Gemcitabine|gemcitabine|mesh-list
43890023|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890024|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890025|NCT04112277|Analgesics|analgesics|mesh-ancestor
43890026|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
43890027|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890028|NCT04102319|Hepcidins|hepcidins|mesh-list
43890029|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890030|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
43890031|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43890032|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
43890033|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
43890034|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890035|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890036|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890037|NCT04095494|Analgesics|analgesics|mesh-ancestor
43890038|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
43890039|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136992|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136993|NCT00166413|Growth Substances|growth substances|mesh-ancestor
44136994|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
44136995|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136996|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
44136997|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136998|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44136999|NCT00166426|Protective Agents|protective agents|mesh-ancestor
44137000|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137001|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44137002|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137003|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137004|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44137005|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44137006|NCT00166426|Analgesics|analgesics|mesh-ancestor
44137007|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
44137008|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137009|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137010|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137011|NCT00166465|Leucovorin|leucovorin|mesh-list
44137012|NCT00166465|Fluorouracil|fluorouracil|mesh-list
44137013|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
44137014|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
44137015|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137016|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44137017|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137018|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137019|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
44137020|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137021|NCT00166465|Antidotes|antidotes|mesh-ancestor
44137022|NCT00166465|Protective Agents|protective agents|mesh-ancestor
44137023|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
44137024|NCT00166465|Vitamins|vitamins|mesh-ancestor
44137025|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
44137026|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
44464114|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44464115|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43545420|NCT03671941|Ticagrelor|ticagrelor|mesh-list
44137027|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137028|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44137029|NCT00166478|Protective Agents|protective agents|mesh-ancestor
43890061|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
43890081|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890082|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890083|NCT03977142|Chrysarobin|chrysarobin|mesh-list
43890084|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890085|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890086|NCT03977142|Analgesics|analgesics|mesh-ancestor
43890087|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
43890088|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890089|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890090|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890091|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890092|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
43890093|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
43890094|NCT03974464|Coagulants|coagulants|mesh-ancestor
43890095|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43890096|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43890097|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
43890098|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890099|NCT03970265|Meropenem|meropenem|mesh-list
43890100|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43890101|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890102|NCT03967483|Indomethacin|indomethacin|mesh-list
43890103|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890104|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890105|NCT03967483|Analgesics|analgesics|mesh-ancestor
43890106|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
43890107|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890108|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890109|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890110|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890111|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
43890112|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
43890113|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43890114|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43890115|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890116|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890135|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890136|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43890137|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43890138|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890139|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890140|NCT03930017|Vaccines|vaccines|mesh-list
43890141|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
43890142|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137030|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137031|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44137032|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137033|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137034|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44137035|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44137036|NCT00166478|Analgesics|analgesics|mesh-ancestor
44137037|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
44137038|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137039|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137040|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137041|NCT00166491|Insulin|insulin|mesh-list
44137042|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44137043|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137044|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
44137045|NCT00166556|Tacrolimus|tacrolimus|mesh-list
44137046|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137047|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
44137048|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137049|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44464117|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285242|NCT00754351|Bevacizumab|bevacizumab|mesh-list
44285243|NCT00754351|Docetaxel|docetaxel|mesh-list
44285244|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285245|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285246|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44285247|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285248|NCT00754351|Growth Substances|growth substances|mesh-ancestor
44285249|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285250|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285251|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44285252|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
44285253|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285254|NCT00754351|Antiviral Agents|antiviral agents|mesh-ancestor
44285255|NCT00754351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285256|NCT00754351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285257|NCT00754351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285258|NCT00754351|Immunologic Factors|immunologic factors|mesh-ancestor
44285259|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137050|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137051|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137052|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137053|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137054|NCT00166595|Risperidone|risperidone|mesh-list
44137055|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137056|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
44137075|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137077|NCT00166686|Analgesics|analgesics|mesh-ancestor
44137078|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
44137079|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137080|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137081|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137082|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
44137083|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
44137084|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44137085|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44137086|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44137087|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137088|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137089|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137090|NCT00166725|Octreotide|octreotide|mesh-list
44137091|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137092|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44137093|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157250|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157251|NCT00233896|Beclomethasone|beclomethasone|mesh-list
43890143|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43890144|NCT03920566|Dalteparin|dalteparin|mesh-list
43890145|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
43890146|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44285260|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285261|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
43890147|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890148|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890149|NCT03914170|Cetuximab|cetuximab|mesh-list
43890150|NCT03914170|Folfirinox|folfirinox|mesh-list
43890151|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890152|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890153|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
43890154|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43890155|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
43890156|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890157|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890158|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43890182|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
43890183|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890184|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890185|NCT03897192|Bevacizumab|bevacizumab|mesh-list
43890186|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890187|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890188|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43890189|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43890190|NCT03897192|Growth Substances|growth substances|mesh-ancestor
43890191|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890192|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
43890193|NCT03896815|INCB054329|incb054329|mesh-list
43890194|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890195|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
43890196|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890197|NCT03881917|Cystatins|cystatins|mesh-list
43890198|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43890199|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
43890200|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890201|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890202|NCT03851965|Plasminogen|plasminogen|mesh-list
43890203|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43890204|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890205|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890277|NCT05277038|Zopiclone|zopiclone|mesh-list
43890278|NCT05277038|Analgesics|analgesics|mesh-ancestor
43890279|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
43890280|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890212|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
43890213|NCT05278897|Protective Agents|protective agents|mesh-ancestor
43890214|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
43890215|NCT05278793|Trace Elements|trace elements|mesh-ancestor
43890216|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
43890217|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890220|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43890221|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890222|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890223|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890224|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890225|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890226|NCT05278637|Aspirin|aspirin|mesh-list
43890227|NCT05278637|Ticagrelor|ticagrelor|mesh-list
43890228|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890229|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890230|NCT05278637|Analgesics|analgesics|mesh-ancestor
43890231|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
43890232|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890233|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890234|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890235|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890236|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43890237|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890238|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890239|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43890240|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43890241|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890242|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
43890243|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44285271|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285272|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44285273|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285274|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
44285275|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43890244|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43890245|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43890246|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
43890247|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890248|NCT05277974|Dexamethasone|dexamethasone|mesh-list
43890249|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890250|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
43890251|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
43890252|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890253|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890254|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890255|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
43890256|NCT05277974|Hormones|hormones|mesh-ancestor
43890257|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890258|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890275|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890289|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890290|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890291|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43890292|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890293|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
43890294|NCT05276960|Vitamin D|vitamin d|mesh-list
43890295|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43890296|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890297|NCT05276960|Vitamins|vitamins|mesh-ancestor
43890298|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
43890299|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43890300|NCT05257213|Heparin|heparin|mesh-list
43890301|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
43890302|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43890303|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890304|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890313|NCT05173493|Amoxicillin|amoxicillin|mesh-list
43890314|NCT05173493|Levofloxacin|levofloxacin|mesh-list
43890315|NCT05173493|Ofloxacin|ofloxacin|mesh-list
43890316|NCT05173493|Tetracycline|tetracycline|mesh-list
43890317|NCT05173493|Furazolidone|furazolidone|mesh-list
43890318|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43890319|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285276|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44285277|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44285278|NCT00754507|Atorvastatin|atorvastatin|mesh-list
44285279|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44285280|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285281|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285282|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
44285283|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285284|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43668768|NCT01367002|Paclitaxel|paclitaxel|mesh-list
43890320|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43890321|NCT05173493|Renal Agents|renal agents|mesh-ancestor
43890322|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43890323|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890324|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890325|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890326|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890327|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43890328|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43890329|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43890330|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43773584|NCT02358304|Katacalcin|katacalcin|mesh-list
43890344|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890345|NCT05326269|Terbutaline|terbutaline|mesh-list
43890346|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43890347|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
43890348|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890349|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890350|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43890351|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
43890352|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
43890353|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
43890354|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43890355|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43890356|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43890357|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43890358|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890359|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890360|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890361|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
43890362|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43890363|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43890364|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890365|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
43890366|NCT05326139|Coagulants|coagulants|mesh-ancestor
43890367|NCT05326087|Cetrorelix|cetrorelix|mesh-list
43890368|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43890369|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
43890370|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43890371|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890372|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
43890373|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890374|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43890375|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890376|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890377|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
43890378|NCT05325528|Tegafur|tegafur|mesh-list
43890379|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890380|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43890381|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
43890382|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890383|NCT05325515|Alendronate|alendronate|mesh-list
43890384|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44285285|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44285287|NCT00754689|Metformin|metformin|mesh-list
44285288|NCT00754689|Rimonabant|rimonabant|mesh-list
44285289|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44285290|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890385|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890386|NCT05325346|Argatroban|argatroban|mesh-list
43890387|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
43890388|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43890389|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
43890390|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890391|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137113|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137114|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
44137115|NCT00166829|Sirolimus|sirolimus|mesh-list
44137116|NCT00166829|Tacrolimus|tacrolimus|mesh-list
44137117|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137118|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
44137119|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137120|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44137121|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137122|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137123|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137124|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137125|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44137126|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
44137127|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137128|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137129|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
44137130|NCT00166842|Cyclosporine|cyclosporine|mesh-list
44137131|NCT00166842|Sirolimus|sirolimus|mesh-list
44137132|NCT00166842|Tacrolimus|tacrolimus|mesh-list
44137133|NCT00166842|Cyclosporins|cyclosporins|mesh-list
44137134|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137135|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
44137136|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137137|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44137138|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137139|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137140|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
44137141|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137142|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
43890394|NCT05325190|Granisetron|granisetron|mesh-list
43890395|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
43890396|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
43890397|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890398|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890415|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890416|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
43890417|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890418|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890419|NCT05324904|Vitamin D|vitamin d|mesh-list
43890420|NCT05324904|Acyclovir|acyclovir|mesh-list
43890421|NCT05324904|Vitamins|vitamins|mesh-ancestor
43890422|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
43890423|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890424|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43890425|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
43890426|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890427|NCT05324891|Fentanyl|fentanyl|mesh-list
43890428|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
43890429|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43890430|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890431|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890432|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890433|NCT05324891|Analgesics|analgesics|mesh-ancestor
43890434|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
43890435|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890436|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44285291|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44285292|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44285293|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44285294|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285295|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285296|NCT00754689|Hormones|hormones|mesh-ancestor
43890437|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43890438|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43890439|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890440|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890441|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890442|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43890443|NCT05324891|Narcotics|narcotics|mesh-ancestor
43890444|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43890445|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43890446|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
43890447|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
43890448|NCT05323058|Benzydamine|benzydamine|mesh-list
43890449|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890450|NCT05317403|Cytarabine|cytarabine|mesh-list
43890451|NCT05317403|Fludarabine|fludarabine|mesh-list
43890452|NCT05317403|Venetoclax|venetoclax|mesh-list
43890453|NCT05317403|Vorinostat|vorinostat|mesh-list
43890454|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890455|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43890456|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
43890457|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890458|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890459|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
43890460|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890461|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
43890462|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890496|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890497|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43890498|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890499|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
43890500|NCT05014646|Leflunomide|leflunomide|mesh-list
43890501|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890502|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890503|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890533|NCT04498923|Dexamethasone|dexamethasone|mesh-list
43890534|NCT04498923|Epinephrine|epinephrine|mesh-list
43890535|NCT04498923|Bupivacaine|bupivacaine|mesh-list
43890536|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890537|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
43890538|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
43890539|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890540|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890541|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890542|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
43890543|NCT04498923|Hormones|hormones|mesh-ancestor
43890544|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890545|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890546|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890547|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43890548|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
43890549|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890550|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
43890583|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43890584|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890585|NCT04469556|Antidotes|antidotes|mesh-ancestor
43890586|NCT04469556|Protective Agents|protective agents|mesh-ancestor
43890587|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
43890588|NCT04469556|Vitamins|vitamins|mesh-ancestor
43890589|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
43890590|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
43890591|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
43890592|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43890593|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43890594|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890595|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285298|NCT00754702|Vinorelbine|vinorelbine|mesh-list
44285299|NCT00754702|Lapatinib|lapatinib|mesh-list
44285300|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285301|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285302|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285303|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285304|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285305|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285306|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43773759|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43890624|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890626|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
43890627|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890628|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
43890629|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890630|NCT04277858|Cisplatin|cisplatin|mesh-list
43890631|NCT04277858|Docetaxel|docetaxel|mesh-list
43890632|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890633|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
43890634|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
43890635|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
43890636|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890637|NCT04232657|Denosumab|denosumab|mesh-list
43890638|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43890639|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890640|NCT04216043|Caseins|caseins|mesh-list
44137172|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137173|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137174|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137175|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137176|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137177|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44137178|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
44137179|NCT00167232|Naltrexone|naltrexone|mesh-list
44137180|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44137181|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43890648|NCT04184622|Hormones|hormones|mesh-ancestor
43890649|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890650|NCT04170738|Amphetamine|amphetamine|mesh-list
43890651|NCT04170738|Adderall|adderall|mesh-list
43890652|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
43890653|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43890654|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890655|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
43890656|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
43890657|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890658|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
43890659|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890660|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890661|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890662|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43890663|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43890664|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43890665|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43890666|NCT04155424|Eculizumab|eculizumab|mesh-list
43890667|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43890668|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890669|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
43890670|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890671|NCT04099849|Zinc|zinc|mesh-list
43890672|NCT04099849|Trace Elements|trace elements|mesh-ancestor
43890673|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
43890674|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285307|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285308|NCT00754780|Pirfenidone|pirfenidone|mesh-list
44285309|NCT00754780|Analgesics|analgesics|mesh-ancestor
44285310|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
44285311|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890675|NCT04095442|Benzocaine|benzocaine|mesh-list
43890676|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
43890677|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
43890678|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890679|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890711|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890712|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43890713|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
43890714|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43890715|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890716|NCT03860428|Acetaminophen|acetaminophen|mesh-list
43890717|NCT03860428|Ibuprofen|ibuprofen|mesh-list
43890718|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
43890719|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890720|NCT03860428|Analgesics|analgesics|mesh-ancestor
43890721|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
43890722|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890723|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890724|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
43890725|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890758|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43890759|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43890760|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890762|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890763|NCT03235739|Naloxegol|naloxegol|mesh-list
43890764|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43890765|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890766|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
43890791|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890793|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
43890794|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890795|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890796|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
43890797|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
43890798|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43890799|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
43890800|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890801|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890802|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43890803|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43890804|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43890805|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43890806|NCT02845271|Acetaminophen|acetaminophen|mesh-list
43890807|NCT02845271|Tramadol|tramadol|mesh-list
43890808|NCT02845271|Codeine|codeine|mesh-list
43890809|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890810|NCT02845271|Analgesics|analgesics|mesh-ancestor
43890811|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
43890812|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890813|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890814|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
43890815|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43890816|NCT02845271|Narcotics|narcotics|mesh-ancestor
43890849|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43890850|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
43890851|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43890852|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890853|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43890854|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890855|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
43890856|NCT02022592|Midazolam|midazolam|mesh-list
43890888|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43890889|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890890|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890891|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285312|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285313|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285314|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285315|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285316|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285317|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285318|NCT00754819|Colchicine|colchicine|mesh-list
44285319|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
44285320|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285321|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285322|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285323|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285324|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285325|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285326|NCT00754858|Cisplatin|cisplatin|mesh-list
44285327|NCT00754858|Belotecan|belotecan|mesh-list
44285328|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285329|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44285330|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285331|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668799|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43890892|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43890893|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
43890894|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
43890895|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
43890896|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43890897|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
43890898|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
43890899|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
43890900|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43890901|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890902|NCT01813227|Dexamethasone|dexamethasone|mesh-list
43890903|NCT01813227|Rituximab|rituximab|mesh-list
43890904|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43773985|NCT02355639|Betamethasone|betamethasone|mesh-list
43890931|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890932|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43890933|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
43890934|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43890935|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890936|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
43890937|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890938|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43890939|NCT01505569|Protective Agents|protective agents|mesh-ancestor
44137200|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137201|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
44137202|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137203|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137204|NCT00167479|Risperidone|risperidone|mesh-list
44137205|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137206|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
43890940|NCT01196936|Tamoxifen|tamoxifen|mesh-list
43890941|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43890942|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
43890943|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285332|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285333|NCT00754871|Dienogest|dienogest|mesh-list
44285334|NCT00754871|Nandrolone|nandrolone|mesh-list
44285335|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44285336|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
44285337|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44285338|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285339|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44285340|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44285341|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44285342|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44285343|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
44285344|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285345|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285346|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285347|NCT00754871|Androgens|androgens|mesh-ancestor
43890944|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890945|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890946|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890947|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43890948|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43890983|NCT00268476|Hormones|hormones|mesh-ancestor
43890984|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890985|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890986|NCT00268476|Estrogens|estrogens|mesh-ancestor
43890987|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890988|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890989|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890990|NCT00268476|Analgesics|analgesics|mesh-ancestor
43890991|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
43891018|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891019|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43891020|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891021|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891022|NCT05049980|Mifepristone|mifepristone|mesh-list
43891023|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43891024|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
43891025|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43891026|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891027|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43891028|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43891029|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43891030|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
43891031|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43891032|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43891033|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
43891034|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891035|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
43891036|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43891037|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43891038|NCT05003258|Dexamethasone|dexamethasone|mesh-list
43891039|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891040|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
43891066|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43800382|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
44285349|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
44285350|NCT00754884|Calcitonin|calcitonin|mesh-list
44285351|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
44285352|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44285353|NCT00754884|Glycerol|glycerol|mesh-list
43891067|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43891068|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43891069|NCT04844762|Menthol|menthol|mesh-list
43891070|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
43891071|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
43891072|NCT04829903|Liraglutide|liraglutide|mesh-list
43891073|NCT04829903|Dulaglutide|dulaglutide|mesh-list
43891074|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43891075|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891076|NCT04829903|Incretins|incretins|mesh-ancestor
43891077|NCT04829903|Hormones|hormones|mesh-ancestor
43891078|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891079|NCT04813822|Miconazole|miconazole|mesh-list
43891080|NCT04813822|Clotrimazole|clotrimazole|mesh-list
43891081|NCT04813822|Bromides|bromides|mesh-list
43891082|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
43891083|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
43891084|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891085|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43891086|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43891087|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891088|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891089|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43891090|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774168|NCT02354261|Itraconazole|itraconazole|mesh-list
43891125|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891126|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43891128|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43891129|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
43838690|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137217|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137218|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137219|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44137220|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
44137221|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891150|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891151|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43891152|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891153|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891154|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43891155|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
43891156|NCT04151017|Coagulants|coagulants|mesh-ancestor
43891157|NCT04116398|Dexamethasone|dexamethasone|mesh-list
43891158|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891189|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891190|NCT04080427|Analgesics|analgesics|mesh-ancestor
43891191|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
43891192|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891193|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43891194|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43891195|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891196|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891197|NCT04080427|Hormones|hormones|mesh-ancestor
43891198|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891199|NCT04070157|Lofexidine|lofexidine|mesh-list
43891200|NCT04070157|Clonidine|clonidine|mesh-list
43891201|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43891202|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43891203|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891238|NCT03955211|Analgesics|analgesics|mesh-ancestor
43891239|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
43891240|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891241|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891242|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
43891243|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285354|NCT00754884|Katacalcin|katacalcin|mesh-list
44285355|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44285356|NCT00754884|Protective Agents|protective agents|mesh-ancestor
44285357|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285358|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43668840|NCT02467361|Ipilimumab|ipilimumab|mesh-list
43891244|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774275|NCT02353325|Vitamins|vitamins|mesh-ancestor
43891269|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891270|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43891271|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
43891272|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891273|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891274|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43891275|NCT03874897|Antibodies|antibodies|mesh-list
43891276|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43891277|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
43891278|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891279|NCT03853330|Bupivacaine|bupivacaine|mesh-list
43891280|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
43891281|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
43891282|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891283|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891284|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
43891285|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891286|NCT03850691|Aldesleukin|aldesleukin|mesh-list
43891287|NCT03850691|Nivolumab|nivolumab|mesh-list
43891288|NCT03850691|Ipilimumab|ipilimumab|mesh-list
43891289|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891290|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891291|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43891292|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891293|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43891294|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43891328|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
43891329|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
43891330|NCT03647566|Protective Agents|protective agents|mesh-ancestor
43891331|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891332|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43891333|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891334|NCT03576313|Ivermectin|ivermectin|mesh-list
43891335|NCT03576313|Piperaquine|piperaquine|mesh-list
43891366|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891367|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891368|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891369|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
43891370|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891371|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43891372|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43891373|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
43891374|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891375|NCT03435003|Analgesics|analgesics|mesh-ancestor
43891376|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
43891377|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43891378|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43891379|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43891380|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891381|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891382|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891383|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43891384|NCT03435003|Narcotics|narcotics|mesh-ancestor
43891385|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43891386|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43891387|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43891417|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891419|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43891420|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891421|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285359|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44285360|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
44285361|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44285362|NCT00754910|Trioxsalen|trioxsalen|mesh-list
44285363|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891422|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
43891423|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891424|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
43891425|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
43891426|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891427|NCT03161028|Protective Agents|protective agents|mesh-ancestor
43891428|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891429|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
43891430|NCT03161028|Vitamins|vitamins|mesh-ancestor
43891431|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
43891432|NCT03134131|TIC10 compound|tic10 compound|mesh-list
43891433|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891434|NCT03088826|Acetaminophen|acetaminophen|mesh-list
43891435|NCT03088826|Morphine|morphine|mesh-list
43891436|NCT03088826|Oxycodone|oxycodone|mesh-list
43891437|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43891462|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891463|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43891464|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43891465|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891466|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43891467|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
43891468|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
43891469|NCT02596997|Brincidofovir|brincidofovir|mesh-list
43891470|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
43891471|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891472|NCT02555254|Methamphetamine|methamphetamine|mesh-list
43891473|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43891474|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891475|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
43891476|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
43891477|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891478|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
43891479|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891480|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891481|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891482|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43891483|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43891484|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43891514|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
43891515|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43891516|NCT02381353|Bupivacaine|bupivacaine|mesh-list
43891517|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
43891518|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
43891519|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891520|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891521|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
43891522|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891523|NCT02296918|Rituximab|rituximab|mesh-list
43891524|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
43891525|NCT02296918|Venetoclax|venetoclax|mesh-list
43891526|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
43891527|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891528|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891529|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
43891530|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891606|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
43891607|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891634|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891635|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
43891636|NCT05281419|Hormones|hormones|mesh-ancestor
43891637|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891638|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891639|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891640|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
43891641|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285364|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44285365|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44285366|NCT00754962|Protriptyline|protriptyline|mesh-list
44285367|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44285368|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
44285369|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285370|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43546283|NCT03664037|Hormones|hormones|mesh-ancestor
43891642|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891643|NCT05281276|Celecoxib|celecoxib|mesh-list
43891644|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43891645|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891646|NCT05281276|Analgesics|analgesics|mesh-ancestor
43891647|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
43891648|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891649|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891650|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891651|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891652|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43891653|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43891654|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891655|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137228|NCT00167518|Hormones|hormones|mesh-ancestor
43891677|NCT05281003|Paclitaxel|paclitaxel|mesh-list
43891678|NCT05281003|Cisplatin|cisplatin|mesh-list
43891679|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
43891680|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43891681|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891682|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
43891683|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
43891684|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
43891685|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891686|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891687|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
43891688|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43891689|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43891690|NCT05280873|Prednisolone|prednisolone|mesh-list
43891691|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
43891692|NCT05280873|Pirfenidone|pirfenidone|mesh-list
43891693|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43891694|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
43891695|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891696|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
43891697|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
43891698|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891699|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891700|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891701|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
43891702|NCT05280873|Hormones|hormones|mesh-ancestor
43891703|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891704|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43891705|NCT05280873|Protective Agents|protective agents|mesh-ancestor
43891735|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43891736|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43891737|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891738|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891739|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891740|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
43891742|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891743|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891744|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
43891745|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
43891746|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891747|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891748|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43891749|NCT05280626|Protective Agents|protective agents|mesh-ancestor
43891750|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285371|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44285372|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285373|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285374|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285375|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285376|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891751|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
43774688|NCT02350725|Furosemide|furosemide|mesh-list
43891786|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891787|NCT05280054|Probenecid|probenecid|mesh-list
43891788|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
43891789|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
43891790|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891791|NCT05280054|Renal Agents|renal agents|mesh-ancestor
43891822|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891823|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43891824|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43891825|NCT05279690|Colchicine|colchicine|mesh-list
43891826|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
43891827|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891828|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
43891829|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
43891830|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
43891831|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891832|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891833|NCT05279586|Colistin|colistin|mesh-list
43891834|NCT05279586|Lactulose|lactulose|mesh-list
43891835|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891836|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891837|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891838|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
43891839|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43891840|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43891841|NCT05279482|Prednisolone|prednisolone|mesh-list
43891842|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
43891869|NCT05279391|Dalteparin|dalteparin|mesh-list
43891870|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891871|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
43891872|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
43891873|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891874|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891875|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891876|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
43891877|NCT05279391|Hormones|hormones|mesh-ancestor
43891878|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891879|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891880|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891881|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
43891882|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43891883|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43891884|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891885|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891886|NCT05279235|Favipiravir|favipiravir|mesh-list
43891887|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
43891888|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891890|NCT05279040|Elexacaftor|elexacaftor|mesh-list
43891891|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43891892|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774816|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
43891921|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
43891922|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
43891923|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891924|NCT05249634|Testosterone|testosterone|mesh-list
43891925|NCT05249634|Androgens|androgens|mesh-ancestor
43891926|NCT05249634|Hormones|hormones|mesh-ancestor
43891927|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891928|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285377|NCT00755014|Ethanol|ethanol|mesh-list
44285378|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44285379|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285380|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285381|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285382|NCT00755027|Rasagiline|rasagiline|mesh-list
43891929|NCT05239637|Heparin|heparin|mesh-list
43891930|NCT05239637|Calcium heparin|calcium heparin|mesh-list
43891931|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
43891932|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43891933|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43891934|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891935|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
43891936|NCT05232357|Methylene Blue|methylene blue|mesh-list
43891937|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891938|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891939|NCT05232357|Antidotes|antidotes|mesh-ancestor
43891976|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891977|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43774893|NCT02349763|Dexamethasone|dexamethasone|mesh-list
43892006|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43892007|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43892009|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892010|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43892011|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892012|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892013|NCT05187715|Simvastatin|simvastatin|mesh-list
43892014|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43892015|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43892016|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
43892017|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892018|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43892019|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43892020|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892022|NCT05177731|Decitabine|decitabine|mesh-list
43892023|NCT05177731|Venetoclax|venetoclax|mesh-list
43892024|NCT05177731|Idarubicin|idarubicin|mesh-list
43892025|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892057|NCT05137587|Propofol|propofol|mesh-list
43892058|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892059|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892060|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892061|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892062|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
43892063|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
43892064|NCT05137587|Analgesics|analgesics|mesh-ancestor
43892065|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
43892066|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892067|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43892068|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43892069|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43892102|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
43892103|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892104|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43892105|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892106|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892107|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43892108|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
43892109|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
43892110|NCT05125224|Calcium|calcium|mesh-list
43892135|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892136|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892137|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892138|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43892139|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892140|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892141|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
44285383|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44285384|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285385|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285386|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44285387|NCT00755027|Protective Agents|protective agents|mesh-ancestor
44285388|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285389|NCT00755053|Clotrimazole|clotrimazole|mesh-list
43940058|NCT00927888|Bupivacaine|bupivacaine|mesh-list
44285391|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44285392|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285393|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
44285394|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44285395|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43892142|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
43892143|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892144|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43892145|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43892146|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
43892147|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892148|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
43892149|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43892150|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43892151|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892152|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
43892153|NCT05075200|Coagulants|coagulants|mesh-ancestor
43892154|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
43892155|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892156|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892157|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892158|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892192|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892193|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892194|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
43892195|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
43892196|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43892197|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892198|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892199|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892200|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892201|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43892202|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892203|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
43892204|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892241|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892242|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892243|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892244|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
43892245|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
43892246|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892247|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137254|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44137255|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44137256|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44137257|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
43892255|NCT04912492|Ethanol|ethanol|mesh-list
43892256|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43892257|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892258|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892259|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892260|NCT04910711|Dolutegravir|dolutegravir|mesh-list
43892261|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44285396|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285397|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285398|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44285399|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
44285400|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285401|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285402|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44285403|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44285404|NCT00755066|Fluticasone|fluticasone|mesh-list
44285405|NCT00755066|Xhance|xhance|mesh-list
44285406|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285407|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44285408|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
44285409|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285410|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285411|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44285412|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
44285413|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
44285414|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44285415|NCT00755118|Leucovorin|leucovorin|mesh-list
44285416|NCT00755118|Bevacizumab|bevacizumab|mesh-list
44285417|NCT00755118|Cetuximab|cetuximab|mesh-list
43892295|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43892296|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43892297|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892298|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892299|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43892300|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
43892301|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892335|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892336|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892337|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43892338|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
43892339|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892340|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892341|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892342|NCT04846348|Analgesics|analgesics|mesh-ancestor
43892343|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775184|NCT02347501|Incretins|incretins|mesh-ancestor
43892371|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
43892372|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892373|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892374|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892375|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
43892376|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892377|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892378|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892379|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892380|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43892381|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285418|NCT00755118|Fluorouracil|fluorouracil|mesh-list
44285419|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
44285420|NCT00755118|Irinotecan|irinotecan|mesh-list
44285421|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285422|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285423|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43892382|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
43892383|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892384|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43892385|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892386|NCT04792801|Choline|choline|mesh-list
43892387|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
43892389|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
43892390|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892391|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892392|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43892414|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892415|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892416|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43892417|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43892418|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892419|NCT04753879|Gemcitabine|gemcitabine|mesh-list
43892420|NCT04753879|Paclitaxel|paclitaxel|mesh-list
43892421|NCT04753879|Cisplatin|cisplatin|mesh-list
43892422|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
43892423|NCT04753879|Capecitabine|capecitabine|mesh-list
43892424|NCT04753879|Irinotecan|irinotecan|mesh-list
43892425|NCT04753879|Olaparib|olaparib|mesh-list
43892426|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892427|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892428|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892429|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892430|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892431|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892432|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892433|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
43892434|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
43892435|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892436|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892437|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892438|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
43892439|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892440|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892441|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43892442|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43892443|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43892444|NCT04752540|Olorofim|olorofim|mesh-list
43892445|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
43892446|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892479|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892480|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
43892481|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775305|NCT02346110|Dexamethasone|dexamethasone|mesh-list
44137271|NCT00167674|Zidovudine|zidovudine|mesh-list
44137272|NCT00167674|Nevirapine|nevirapine|mesh-list
44137273|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
43775345|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43892506|NCT04642430|Apixaban|apixaban|mesh-list
43892507|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43892508|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
43892509|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43892510|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
43892511|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892585|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43892586|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43892587|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892588|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892589|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892590|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892626|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700724|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44285424|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285425|NCT00755118|Growth Substances|growth substances|mesh-ancestor
44285426|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285427|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285428|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
44285429|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285430|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44285431|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285432|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
44285433|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44285434|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285435|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285436|NCT00755118|Antidotes|antidotes|mesh-ancestor
44285437|NCT00755118|Protective Agents|protective agents|mesh-ancestor
44285438|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
44285440|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
44285441|NCT00755157|Bevacizumab|bevacizumab|mesh-list
44285442|NCT00755157|Docetaxel|docetaxel|mesh-list
43668891|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43892627|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892628|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43892629|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43775488|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
43892666|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892667|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892669|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
43892670|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892699|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892701|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892702|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892703|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892704|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892705|NCT04471402|Analgesics|analgesics|mesh-ancestor
43892706|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
43892707|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892708|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892709|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892710|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892711|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892712|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892713|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892714|NCT04459234|Ketamine|ketamine|mesh-list
43892715|NCT04459234|Analgesics|analgesics|mesh-ancestor
43892716|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
43892717|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892745|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892746|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
43892747|NCT04367233|Anesthetics|anesthetics|mesh-list
43892748|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892749|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892750|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
43892751|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43892752|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43892753|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44285443|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285444|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546696|NCT03658850|Diuretics|diuretics|mesh-ancestor
43892754|NCT04359147|Yohimbine|yohimbine|mesh-list
43892755|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892756|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
43892757|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
43892758|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892759|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892760|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43892761|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43892762|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43892763|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892786|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
43892787|NCT04332367|Paclitaxel|paclitaxel|mesh-list
43892788|NCT04332367|Carboplatin|carboplatin|mesh-list
43892789|NCT04332367|Ramucirumab|ramucirumab|mesh-list
43892790|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892791|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892793|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892794|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892795|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892796|NCT04322357|Prednisone|prednisone|mesh-list
43892797|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
43892798|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892799|NCT04322357|Hormones|hormones|mesh-ancestor
43892800|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892801|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892802|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43892803|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137306|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
44137307|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44137308|NCT00167739|Quinine|quinine|mesh-list
44137309|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
44137310|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44137311|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137312|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892805|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
43892806|NCT04300985|Anesthetics|anesthetics|mesh-list
43892807|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892808|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892809|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892810|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892811|NCT04300985|Analgesics|analgesics|mesh-ancestor
43892831|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892833|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
43892834|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892835|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892836|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892837|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892838|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892839|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892840|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892841|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
43892842|NCT04276792|Narcotics|narcotics|mesh-ancestor
43892843|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892844|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892845|NCT04276792|Analgesics|analgesics|mesh-ancestor
43892846|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
43892847|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892848|NCT04275531|Anesthetics|anesthetics|mesh-list
43892849|NCT04275531|Propofol|propofol|mesh-list
43892850|NCT04275531|Sevoflurane|sevoflurane|mesh-list
43892851|NCT04275531|Isoflurane|isoflurane|mesh-list
43892852|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892853|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892854|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892855|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892856|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
43892857|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43892858|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43892859|NCT04263064|Clonidine|clonidine|mesh-list
43892860|NCT04263064|Analgesics|analgesics|mesh-ancestor
43800884|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
44285445|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44285446|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285447|NCT00755157|Growth Substances|growth substances|mesh-ancestor
44285448|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285449|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285450|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892861|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
43892862|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892863|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892864|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43892880|NCT04240054|Dexamethasone|dexamethasone|mesh-list
43892881|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
43892882|NCT04240054|Bortezomib|bortezomib|mesh-list
43892883|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892884|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
43892885|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892886|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892887|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43892888|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
43892889|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892890|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892891|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43892892|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892893|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
43892894|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
43892895|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892896|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892897|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
43892898|NCT04240054|Hormones|hormones|mesh-ancestor
43892899|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892900|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43892901|NCT04239716|Anesthetics|anesthetics|mesh-list
43892902|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892903|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892904|NCT04235634|Alprostadil|alprostadil|mesh-list
43892905|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43892906|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
43892907|NCT04235634|Urological Agents|urological agents|mesh-ancestor
43892908|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
43892909|NCT04234906|Amiodarone|amiodarone|mesh-list
43892910|NCT04234906|Procainamide|procainamide|mesh-list
43892911|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
43892912|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892913|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892914|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892915|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892916|NCT04234906|Analgesics|analgesics|mesh-ancestor
43892917|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
43892918|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892919|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892920|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892921|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892922|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892923|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775702|NCT02344095|Cisplatin|cisplatin|mesh-list
43892950|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892951|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892952|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
43892953|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892954|NCT04195958|Omalizumab|omalizumab|mesh-list
43892955|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43892956|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892957|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892958|NCT04188860|Paclitaxel|paclitaxel|mesh-list
43892959|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43892960|NCT04188860|Antibodies|antibodies|mesh-list
43892961|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892962|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892963|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892964|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285451|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285452|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285453|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892965|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892966|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892967|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
43892968|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892969|NCT04188847|Apatinib|apatinib|mesh-list
43892989|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892990|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892991|NCT04121468|Metformin|metformin|mesh-list
43892992|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43892993|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892994|NCT04117932|Ustekinumab|ustekinumab|mesh-list
43892995|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892996|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
43892997|NCT04098393|Fludarabine|fludarabine|mesh-list
43892998|NCT04098393|Melphalan|melphalan|mesh-list
43892999|NCT04098393|Busulfan|busulfan|mesh-list
43893000|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43893001|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893002|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893003|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893004|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
43893005|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893006|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43893007|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
43893008|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43893009|NCT04088513|Aspirin|aspirin|mesh-list
43893010|NCT04088513|Clopidogrel|clopidogrel|mesh-list
43893011|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43893012|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43893013|NCT04088513|Analgesics|analgesics|mesh-ancestor
43893014|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
43893015|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893016|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893017|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893018|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43893019|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43893020|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43893021|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893022|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43893023|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43893056|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893057|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893058|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
43893059|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43893060|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
43893061|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893062|NCT03976973|Expectorants|expectorants|mesh-ancestor
43893063|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
43893064|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44137333|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137334|NCT00167817|Aripiprazole|aripiprazole|mesh-list
44137335|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
44137336|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137337|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137338|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137339|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137340|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137341|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
44137342|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
44137343|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137344|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893070|NCT03873311|Cytarabine|cytarabine|mesh-list
43893071|NCT03873311|Azacitidine|azacitidine|mesh-list
43893072|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893073|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
43893074|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893075|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893076|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
43893077|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285455|NCT00755170|Vinorelbine|vinorelbine|mesh-list
44285456|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285457|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285458|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44285459|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285460|NCT00755170|Growth Substances|growth substances|mesh-ancestor
44285461|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285462|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940131|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285463|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285464|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285465|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285466|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285467|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285468|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
44285469|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44285470|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44285471|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285472|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
44285473|NCT00755209|Coagulants|coagulants|mesh-ancestor
44285474|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
44285475|NCT00755313|Carboplatin|carboplatin|mesh-list
44285476|NCT00755313|Docetaxel|docetaxel|mesh-list
44285477|NCT00755313|Doxorubicin|doxorubicin|mesh-list
44285478|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44285479|NCT00755313|Trastuzumab|trastuzumab|mesh-list
44285480|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44285481|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44285482|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893078|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893079|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
43893080|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893081|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893082|NCT03841292|Varenicline|varenicline|mesh-list
43893083|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43893104|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893105|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893106|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43893107|NCT03817515|Sirolimus|sirolimus|mesh-list
43893108|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893109|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623305|NCT04720326|Tacrolimus|tacrolimus|mesh-list
43893111|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893112|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
43893113|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285483|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
44285484|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285485|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285486|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44285487|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
44285488|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285489|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285490|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44285491|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285492|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893114|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
43893115|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893116|NCT03786796|Olaparib|olaparib|mesh-list
43893117|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43893118|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893119|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893120|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893121|NCT03779074|Amoxicillin|amoxicillin|mesh-list
43893122|NCT03779074|Metronidazole|metronidazole|mesh-list
43893123|NCT03779074|Clarithromycin|clarithromycin|mesh-list
43893124|NCT03779074|Tetracycline|tetracycline|mesh-list
43893125|NCT03779074|Rabeprazole|rabeprazole|mesh-list
43893126|NCT03779074|Bismuth|bismuth|mesh-list
43893127|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893128|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893129|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43893130|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43893131|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43893132|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893133|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893134|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43893135|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43893136|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43893137|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893138|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43893139|NCT03779074|Antacids|antacids|mesh-ancestor
43893140|NCT03756961|Lidocaine|lidocaine|mesh-list
43893157|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893158|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43893159|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43893160|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
43893161|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43893162|NCT03756961|Analgesics|analgesics|mesh-ancestor
43893163|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43893164|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43893165|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43893166|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
43893167|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893168|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43893169|NCT03756961|Narcotics|narcotics|mesh-ancestor
43893170|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43893171|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
43893172|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893173|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
43893174|NCT03735537|Teriparatide|teriparatide|mesh-list
43893175|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43893176|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43893177|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893178|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43893179|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
43893180|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893181|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893182|NCT03723967|Paclitaxel|paclitaxel|mesh-list
43893183|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43893184|NCT03723967|Carboplatin|carboplatin|mesh-list
44285493|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285494|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44285495|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44285496|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285497|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285498|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285499|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43668960|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893185|NCT03723967|Durvalumab|durvalumab|mesh-list
43893186|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43893187|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43893188|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893189|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893190|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893191|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893192|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893193|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893194|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
43893195|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893197|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893198|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43893199|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43893200|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893201|NCT03659461|Incretins|incretins|mesh-ancestor
43893202|NCT03659461|Hormones|hormones|mesh-ancestor
43893219|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893220|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
44157253|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
43893221|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893223|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893224|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893225|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893226|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893227|NCT03535727|Gemcitabine|gemcitabine|mesh-list
43893228|NCT03535727|Paclitaxel|paclitaxel|mesh-list
43893229|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43893230|NCT03535727|Cisplatin|cisplatin|mesh-list
43893231|NCT03535727|Capecitabine|capecitabine|mesh-list
43893232|NCT03535727|Irinotecan|irinotecan|mesh-list
43893233|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43893234|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893235|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893236|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893237|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893238|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893239|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893240|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
43893241|NCT03535727|Antiviral Agents|antiviral agents|mesh-ancestor
43893242|NCT03535727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893243|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893244|NCT03535727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893245|NCT03535727|Immunologic Factors|immunologic factors|mesh-ancestor
43893246|NCT03535727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893247|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43893248|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43893249|NCT03526874|Lidocaine|lidocaine|mesh-list
43893250|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
43893251|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
43893252|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893253|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893254|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
43893255|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893256|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43893257|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43893258|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43893277|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645564|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645565|NCT03932136|Sulforaphane|sulforaphane|mesh-list
43645566|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43893278|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285500|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44285501|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44285502|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668968|NCT02909049|Analgesics|analgesics|mesh-ancestor
43893279|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
43893280|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43893281|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43893282|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893283|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893284|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893285|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43893286|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
43893287|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893288|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137345|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44137346|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44137347|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
44137348|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44137349|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137350|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43893289|NCT03448783|Apixaban|apixaban|mesh-list
43893290|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43893291|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
43893292|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43893293|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893294|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893295|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893296|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
43893297|NCT03435458|Misoprostol|misoprostol|mesh-list
43893298|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43893299|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
43893300|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43893301|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893302|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43893303|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893304|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
43893305|NCT03434444|Propranolol|propranolol|mesh-list
43893306|NCT03434444|Oxytocin|oxytocin|mesh-list
43893307|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
43893308|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43893344|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893345|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
43893346|NCT03376672|Hormones|hormones|mesh-ancestor
43893347|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893348|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893385|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893386|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
43893387|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43893388|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893412|NCT03158090|Lanreotide|lanreotide|mesh-list
43893413|NCT03158090|Octreotide|octreotide|mesh-list
43893414|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893415|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893416|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893417|NCT03155100|Dexamethasone|dexamethasone|mesh-list
43893418|NCT03155100|Elotuzumab|elotuzumab|mesh-list
43893419|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43893420|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893421|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
43893422|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
43893423|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893424|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893425|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893426|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
43893427|NCT03155100|Hormones|hormones|mesh-ancestor
43893428|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893429|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893430|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893431|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893432|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893433|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893434|NCT03104283|Apatinib|apatinib|mesh-list
43893435|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285503|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285504|NCT00755352|Pravastatin|pravastatin|mesh-list
44285505|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44285506|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285507|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285508|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
44285509|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285510|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44285511|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44285512|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285513|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44285514|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44285515|NCT00755495|Doxepin|doxepin|mesh-list
44285516|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44285517|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44285518|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285519|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285520|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44285521|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
44285522|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285523|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
44285524|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
44285525|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668975|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
43893436|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893437|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893438|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893439|NCT02967640|Ketamine|ketamine|mesh-list
43893471|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893472|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43893473|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43893474|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43893475|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
43893476|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43893477|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43893478|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
43893479|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893481|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43893505|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893507|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43893508|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
43893509|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893510|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893511|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893512|NCT02656797|Amphotericin B|amphotericin b|mesh-list
43893513|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43644837|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
43893514|NCT02656797|Amebicides|amebicides|mesh-ancestor
44285526|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285527|NCT00755508|Gabapentin|gabapentin|mesh-list
44285528|NCT00755508|Analgesics|analgesics|mesh-ancestor
44285529|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
43893515|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43893516|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43893517|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893518|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893519|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
43893520|NCT02625441|Trastuzumab|trastuzumab|mesh-list
43893521|NCT02625441|Pertuzumab|pertuzumab|mesh-list
43893522|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893523|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893524|NCT02617407|Listerine|listerine|mesh-list
43893525|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
43893526|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
43893527|NCT02617407|Protective Agents|protective agents|mesh-ancestor
43893528|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893529|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43893530|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893531|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
43893532|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776268|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
43893558|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43893559|NCT02542657|Growth Substances|growth substances|mesh-ancestor
43893560|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
43893561|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893562|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
43893563|NCT02400567|Letrozole|letrozole|mesh-list
43893564|NCT02400567|Epirubicin|epirubicin|mesh-list
43893565|NCT02400567|Palbociclib|palbociclib|mesh-list
43893566|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893567|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
43893568|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893569|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43893570|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43893571|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
43893572|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893573|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893574|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43893575|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43893576|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43893577|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893578|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43893579|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
43893580|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893581|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43893611|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893612|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893613|NCT02361801|Protective Agents|protective agents|mesh-ancestor
44137353|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
44137354|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44137355|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
44137356|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44137357|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137358|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137359|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44137360|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137384|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44137386|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137387|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44137388|NCT00167921|Estrogens|estrogens|mesh-ancestor
44137389|NCT00167921|Hormones|hormones|mesh-ancestor
44137390|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137391|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137392|NCT00167947|Cyclosporine|cyclosporine|mesh-list
44137393|NCT00167947|Sirolimus|sirolimus|mesh-list
44137394|NCT00167947|Cyclosporins|cyclosporins|mesh-list
44137395|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137396|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137397|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137398|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
44285530|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285531|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285532|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
44285533|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44285534|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44285535|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285536|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285537|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44285538|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44285539|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285540|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285542|NCT00755521|Etoricoxib|etoricoxib|mesh-list
44285543|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285544|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285545|NCT00755521|Analgesics|analgesics|mesh-ancestor
44285546|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
44285547|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285548|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285549|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285550|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285551|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44285552|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44137399|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893614|NCT02356705|Lidocaine|lidocaine|mesh-list
43893615|NCT02356705|Midazolam|midazolam|mesh-list
43893616|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43893617|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43893618|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893619|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893620|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43893621|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43893622|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893653|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893743|NCT01061840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893745|NCT00107250|Carboplatin|carboplatin|mesh-list
43893774|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
43893775|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893776|NCT05285293|Vitamin A|vitamin a|mesh-list
43893777|NCT05285293|Vitamins|vitamins|mesh-ancestor
43893778|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
43893779|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893780|NCT05285228|Fluorides|fluorides|mesh-list
43893781|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
43893782|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
43893783|NCT05285228|Protective Agents|protective agents|mesh-ancestor
43893784|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893785|NCT05285085|Atorvastatin|atorvastatin|mesh-list
43893786|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43893787|NCT05285085|Simvastatin|simvastatin|mesh-list
43893788|NCT05285085|Pravastatin|pravastatin|mesh-list
43893789|NCT05285085|Pitavastatin|pitavastatin|mesh-list
43893790|NCT05285085|Lovastatin|lovastatin|mesh-list
43893791|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285554|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285555|NCT00755534|Capecitabine|capecitabine|mesh-list
44285556|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
44285557|NCT00755534|Irinotecan|irinotecan|mesh-list
44285558|NCT00755534|Cetuximab|cetuximab|mesh-list
44285559|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44285560|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
43669021|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893792|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43893793|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
43893794|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776506|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
44137404|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44137405|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137406|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137407|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137408|NCT00167960|Tazobactam|tazobactam|mesh-list
44137409|NCT00167960|Piperacillin|piperacillin|mesh-list
43776549|NCT02338323|Renal Agents|renal agents|mesh-ancestor
43893844|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893845|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893846|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893848|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
43893849|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
43893850|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
43893851|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893852|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893853|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893854|NCT05283980|Bupivacaine|bupivacaine|mesh-list
43893855|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
43893856|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
43893857|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893858|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893859|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
43893860|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893862|NCT05283954|Ivermectin|ivermectin|mesh-list
43893863|NCT05283954|Albendazole|albendazole|mesh-list
43893864|NCT05283954|Prednisolone|prednisolone|mesh-list
43893865|NCT05283954|Fluoxetine|fluoxetine|mesh-list
43893866|NCT05283954|Vitamins|vitamins|mesh-ancestor
43893867|NCT05283954|Micronutrients|micronutrients|mesh-ancestor
43645210|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
43893900|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43893901|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893902|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43893903|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43893904|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
43893905|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893906|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43838876|NCT04812912|Hormones|hormones|mesh-list
43893933|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893934|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43893935|NCT05252884|Vitamins|vitamins|mesh-ancestor
43893936|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
43893937|NCT05233163|Empagliflozin|empagliflozin|mesh-list
43893938|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43893939|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893940|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43893941|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893942|NCT05216744|Doxycycline|doxycycline|mesh-list
43893943|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
43893944|NCT05216744|Cefixime|cefixime|mesh-list
43893945|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893946|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893947|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
43893948|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43893949|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43893950|NCT05183178|Ticagrelor|ticagrelor|mesh-list
44285561|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285562|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285563|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44285564|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44285565|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285566|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893951|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43893952|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43893953|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43893954|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43893986|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
43893987|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893988|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893989|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43893990|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43893991|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43893992|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893993|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894012|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
43894013|NCT05137496|Hormones|hormones|mesh-ancestor
43894014|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894015|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43894016|NCT05137496|Protective Agents|protective agents|mesh-ancestor
43894017|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43894018|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894019|NCT05061563|Esomeprazole|esomeprazole|mesh-list
43894020|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43894021|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894022|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43894023|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894024|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894025|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43894026|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43894027|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894028|NCT04987892|Tamsulosin|tamsulosin|mesh-list
43894029|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43894030|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43894031|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43894032|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
43894033|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894034|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894035|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894036|NCT04987892|Urological Agents|urological agents|mesh-ancestor
43894037|NCT04977167|Antibodies|antibodies|mesh-list
43894038|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
43894039|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894040|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
43894041|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894042|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894043|NCT04933721|Berotralstat|berotralstat|mesh-list
43894044|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894045|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157254|NCT00233896|Hormones|hormones|mesh-ancestor
43894046|NCT04849325|Sirolimus|sirolimus|mesh-list
43894047|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894048|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894075|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43894076|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43894077|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43894078|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894079|NCT04707430|Progesterone|progesterone|mesh-list
43894080|NCT04707430|Progestins|progestins|mesh-ancestor
43894081|NCT04707430|Hormones|hormones|mesh-ancestor
43871135|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
43894082|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894083|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894085|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44285567|NCT00755560|Albendazole|albendazole|mesh-list
44285568|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
44285569|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44285570|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285571|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
44285572|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44285573|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44285574|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285575|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285576|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
43547401|NCT03652571|Nortriptyline|nortriptyline|mesh-list
43894086|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43894087|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894088|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894089|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43894090|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43894091|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43894092|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43894093|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
43894094|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
43894095|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
43894096|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
43776781|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645388|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
43894122|NCT04394117|Olmesartan|olmesartan|mesh-list
43894123|NCT04394117|Irbesartan|irbesartan|mesh-list
43894124|NCT04394117|Eprosartan|eprosartan|mesh-list
43894125|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43894126|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43894127|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43894128|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894129|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894130|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
43894131|NCT04393753|Avelumab|avelumab|mesh-list
43894132|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894133|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894134|NCT04335890|Vaccines|vaccines|mesh-list
43894135|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
43894136|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137417|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137418|NCT00167986|Vancomycin|vancomycin|mesh-list
44137419|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137420|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137421|NCT00167999|Tazobactam|tazobactam|mesh-list
44137422|NCT00167999|Piperacillin|piperacillin|mesh-list
44137423|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44137424|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137425|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137426|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44137427|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137428|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137448|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
44137449|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137450|NCT00168181|Pilocarpine|pilocarpine|mesh-list
44137451|NCT00168181|Miotics|miotics|mesh-ancestor
44137452|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
44137453|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137454|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137455|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44137456|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44137457|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
44137458|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137459|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137460|NCT00168350|Memantine|memantine|mesh-list
44137461|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44137462|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44137463|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
44285578|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285580|NCT00755573|Analgesics|analgesics|mesh-ancestor
44285581|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
44285582|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285583|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285584|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
44285585|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44285586|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285587|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137464|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137465|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137466|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137467|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44137468|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44157255|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157256|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157257|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44157258|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
44157259|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
44157260|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44157261|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157262|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44157263|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
44158386|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
43894137|NCT04203290|Bupivacaine|bupivacaine|mesh-list
43894138|NCT04203290|Sevoflurane|sevoflurane|mesh-list
43894139|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894140|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
43894141|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894142|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894143|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
43894144|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894163|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894164|NCT03954782|Nintedanib|nintedanib|mesh-list
43894165|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894166|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43894167|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894168|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894169|NCT03899428|Sorafenib|sorafenib|mesh-list
43894170|NCT03899428|Durvalumab|durvalumab|mesh-list
43894171|NCT03899428|Lenvatinib|lenvatinib|mesh-list
43894173|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43894174|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894175|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894176|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894177|NCT03885713|Adalimumab|adalimumab|mesh-list
43894178|NCT03885713|Golimumab|golimumab|mesh-list
43894179|NCT03885713|Infliximab|infliximab|mesh-list
43894180|NCT03885713|Ustekinumab|ustekinumab|mesh-list
43894181|NCT03885713|Vedolizumab|vedolizumab|mesh-list
43894182|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894183|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894184|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894185|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894186|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43894187|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894188|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
43894189|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285588|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44285590|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44285591|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285592|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285593|NCT00755664|Vitamins|vitamins|mesh-list
44285594|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
44285595|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
44285596|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285597|NCT00755781|Cyclosporine|cyclosporine|mesh-list
44285598|NCT00755781|Cyclosporins|cyclosporins|mesh-list
44285599|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285600|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894190|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
43894191|NCT03862170|Cefazolin|cefazolin|mesh-list
43894192|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894193|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894194|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43894195|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43894196|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894197|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894198|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894199|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43894200|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43894201|NCT03825302|Mannitol|mannitol|mesh-list
43894202|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
43894203|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43894233|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894234|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43894235|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43894236|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894237|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43894238|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
43894239|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894240|NCT03418779|Prednisolone|prednisolone|mesh-list
43894241|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
43894242|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43894243|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
43894244|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894245|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894246|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894247|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
43894248|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894249|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894250|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894280|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894281|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
43894282|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894283|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894284|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43894285|NCT03101722|Protective Agents|protective agents|mesh-ancestor
43894287|NCT03088852|Cathartics|cathartics|mesh-ancestor
43894288|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894289|NCT03067610|Paclitaxel|paclitaxel|mesh-list
43894290|NCT03067610|Cisplatin|cisplatin|mesh-list
43894291|NCT03067610|Carboplatin|carboplatin|mesh-list
43894292|NCT03067610|Cetuximab|cetuximab|mesh-list
43894293|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43894294|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894295|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43894296|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44285601|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285602|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
44285603|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285604|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
44285605|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285606|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894297|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43894328|NCT03000374|Antidotes|antidotes|mesh-ancestor
43894329|NCT03000374|Protective Agents|protective agents|mesh-ancestor
43894330|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
43894331|NCT03000374|Vitamins|vitamins|mesh-ancestor
43894332|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
43894333|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894334|NCT02994836|Adalimumab|adalimumab|mesh-list
43894335|NCT02994836|Infliximab|infliximab|mesh-list
43894336|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43894337|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894338|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894339|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894352|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
43894353|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
43894354|NCT01904136|Melphalan|melphalan|mesh-list
43894355|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
43894356|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43894357|NCT01904136|Fludarabine|fludarabine|mesh-list
43894358|NCT01904136|Tacrolimus|tacrolimus|mesh-list
43777033|NCT02334462|Antacids|antacids|mesh-ancestor
43894385|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894386|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43894387|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43894388|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
43894389|NCT01310010|Dasatinib|dasatinib|mesh-list
43894390|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894391|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43894392|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894393|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894394|NCT00503035|Celecoxib|celecoxib|mesh-list
43894395|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43894396|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894397|NCT00503035|Analgesics|analgesics|mesh-ancestor
43894398|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
43894399|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894400|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894401|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894402|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894403|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43894404|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43894405|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777059|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43894424|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
43894425|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894426|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894427|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
43894428|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894429|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43894430|NCT00303849|Diuretics|diuretics|mesh-ancestor
43894431|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
43894432|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
43894433|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894434|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
43894435|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
43894436|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
43894437|NCT00303849|Protective Agents|protective agents|mesh-ancestor
43894438|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
43894439|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
43894440|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894441|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894442|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
43894443|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
43894444|NCT00161044|Galantamine|galantamine|mesh-list
43894445|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43894446|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894447|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285607|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285608|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44285609|NCT00755820|Cycloserine|cycloserine|mesh-list
44285610|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44285611|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285612|NCT00755820|Renal Agents|renal agents|mesh-ancestor
44285613|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43894448|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
43894449|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894450|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894452|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
43894453|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894454|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
43894455|NCT03833323|Treprostinil|treprostinil|mesh-list
43894456|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43894457|NCT03829579|Esketamine|esketamine|mesh-list
43894458|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
43894459|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43894460|NCT03828162|Anticoagulants|anticoagulants|mesh-list
44137492|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44137493|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137494|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894467|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
43894468|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894469|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43894470|NCT03815422|Anesthetics|anesthetics|mesh-list
43894471|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894503|NCT03793400|Growth Substances|growth substances|mesh-ancestor
43894504|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894505|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
43894506|NCT03792334|Anesthetics|anesthetics|mesh-list
43894507|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894508|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894509|NCT03789968|Tenofovir|tenofovir|mesh-list
43894510|NCT03789968|Emtricitabine|emtricitabine|mesh-list
43894511|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43894512|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
43894513|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894514|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43894515|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43894516|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894540|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894541|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894542|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43894543|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894544|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894546|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894547|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894555|NCT05141968|Vitamins|vitamins|mesh-ancestor
43894556|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
43894557|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894558|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43894559|NCT05141864|Lidocaine|lidocaine|mesh-list
43894560|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894561|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
43894573|NCT05141474|Fludarabine|fludarabine|mesh-list
43894574|NCT05141474|Interleukin-2|interleukin-2|mesh-list
43894575|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894576|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
43894577|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894578|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894579|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894580|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
43894581|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894582|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894583|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894584|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894585|NCT05141474|Analgesics|analgesics|mesh-ancestor
43894586|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
44285614|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
44285615|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44285616|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
44285617|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285618|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
44285619|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
44285620|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44285621|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285622|NCT00755859|Prednisone|prednisone|mesh-list
44285623|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44285624|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43894587|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894588|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43894589|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43894590|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
43894591|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894592|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
43894593|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894594|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
43894595|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894596|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894597|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
43894598|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894600|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43894601|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894602|NCT05089175|Analgesics|analgesics|mesh-ancestor
43894603|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
43894604|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894605|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894606|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894607|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894608|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43894609|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43894610|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137523|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
43894611|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43894612|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43894613|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894614|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
43894615|NCT05064449|Itraconazole|itraconazole|mesh-list
43894616|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
43894617|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
43894618|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894619|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43894620|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43894621|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894622|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894652|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
43894653|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894654|NCT05033639|Protective Agents|protective agents|mesh-ancestor
43894655|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894656|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137524|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137525|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137526|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44137527|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137528|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
44137529|NCT00168493|Serotonin|serotonin|mesh-list
44137530|NCT00168493|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43777311|NCT02332603|Hormones|hormones|mesh-ancestor
43894667|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43894668|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43894669|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
44285642|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285643|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285644|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44285645|NCT00755859|Protective Agents|protective agents|mesh-ancestor
44285646|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
44285647|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
44285648|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285649|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285650|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
44285651|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
44285652|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44285653|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285654|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285655|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44285656|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285657|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44285658|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
44285659|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285660|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44285661|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285662|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285663|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
44285664|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285665|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285666|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44285667|NCT00755898|Amantadine|amantadine|mesh-list
44285668|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44285669|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44285670|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
44285671|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285672|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
43710565|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44109493|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
44109494|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109496|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109497|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
44109498|NCT04542278|Hormones|hormones|mesh-ancestor
44109499|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285673|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285674|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285675|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285676|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285677|NCT00755898|Analgesics|analgesics|mesh-ancestor
44285678|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
44285679|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285680|NCT00755924|Acetic Acid|acetic acid|mesh-list
44285681|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44285682|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285683|NCT00755950|Silymarin|silymarin|mesh-list
44285684|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
44285685|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940338|NCT00932438|Leucovorin|leucovorin|mesh-list
44285686|NCT00755950|Protective Agents|protective agents|mesh-ancestor
44285687|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285688|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44285689|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44285690|NCT00755963|Estradiol|estradiol|mesh-list
44285691|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44285692|NCT00755963|Progesterone|progesterone|mesh-list
44285693|NCT00755963|Estrogens|estrogens|mesh-ancestor
44285694|NCT00755963|Hormones|hormones|mesh-ancestor
44285695|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285696|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285697|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44285698|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
44285699|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44285700|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44285701|NCT00755963|Progestins|progestins|mesh-ancestor
44285702|NCT00755976|Sulindac|sulindac|mesh-list
44285703|NCT00755976|Epirubicin|epirubicin|mesh-list
44285714|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285715|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285716|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285717|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285718|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44285719|NCT00755989|Morphine|morphine|mesh-list
44285720|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44285721|NCT00755989|Narcotics|narcotics|mesh-ancestor
44285722|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285723|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285724|NCT00755989|Analgesics|analgesics|mesh-ancestor
44285725|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
44285726|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285727|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44285728|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
44285729|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285730|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44285731|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285732|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285733|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
44109500|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109501|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109502|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109503|NCT04538378|Durvalumab|durvalumab|mesh-list
44109531|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44109532|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
44109533|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
44109534|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44109535|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44109536|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
44109537|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
44109538|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109539|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109541|NCT04328285|Lopinavir|lopinavir|mesh-list
44109542|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
44109543|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44109544|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44109545|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109546|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109547|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109548|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44109549|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44109560|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109561|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44109562|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109563|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
44109564|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109565|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
44109566|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109569|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109570|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44109571|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109572|NCT04125927|Cysteamine|cysteamine|mesh-list
44109573|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44285734|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285735|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44285737|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285738|NCT00756301|Lidocaine|lidocaine|mesh-list
44285739|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
44285740|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
44285741|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285742|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285743|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
44109574|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109575|NCT04081389|Interferons|interferons|mesh-list
44109576|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
44109577|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
44109578|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44109579|NCT04081389|Celecoxib|celecoxib|mesh-list
44109580|NCT04081389|Paclitaxel|paclitaxel|mesh-list
44109581|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
44109582|NCT04081389|Doxorubicin|doxorubicin|mesh-list
44109583|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44109584|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44109585|NCT04081389|Daunorubicin|daunorubicin|mesh-list
44109586|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
44109587|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109588|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109589|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109590|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109591|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109592|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645694|NCT03820830|Palbociclib|palbociclib|mesh-list
44109593|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109594|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
44109595|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109596|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109597|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44109598|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
44109599|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44109600|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44109601|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44109602|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109603|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109604|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
44109605|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109606|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44109607|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44109608|NCT04081389|Analgesics|analgesics|mesh-ancestor
44109609|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
44109610|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109611|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109612|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44109613|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44109614|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44109615|NCT04030026|Nalbuphine|nalbuphine|mesh-list
44109616|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44109620|NCT04030026|Analgesics|analgesics|mesh-ancestor
44109621|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
44109622|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109623|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
44109624|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109625|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109626|NCT03977194|Paclitaxel|paclitaxel|mesh-list
44109627|NCT03977194|Carboplatin|carboplatin|mesh-list
44109628|NCT03977194|Atezolizumab|atezolizumab|mesh-list
44109629|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109630|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109631|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109632|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109633|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285744|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285745|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44285746|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44285747|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44285748|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285749|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464118|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464119|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
44109634|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109635|NCT03972488|Octreotide|octreotide|mesh-list
44109636|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
44109637|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109638|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109639|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109640|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44109641|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109642|NCT03937830|Bevacizumab|bevacizumab|mesh-list
44109643|NCT03937830|Durvalumab|durvalumab|mesh-list
44109644|NCT03937830|Doxorubicin|doxorubicin|mesh-list
44109645|NCT03937830|Tremelimumab|tremelimumab|mesh-list
44109646|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109647|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109648|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44109649|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44109650|NCT03937830|Growth Substances|growth substances|mesh-ancestor
44109651|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109652|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109653|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44109654|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44109655|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109656|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109657|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109658|NCT03913832|Sirolimus|sirolimus|mesh-list
44109659|NCT03913832|Paclitaxel|paclitaxel|mesh-list
44109660|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109661|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109662|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109663|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109664|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109665|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109666|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44109667|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109668|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44109669|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
44109670|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109671|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
44109672|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109673|NCT03883919|Vitamin D|vitamin d|mesh-list
44109674|NCT03883919|Leucovorin|leucovorin|mesh-list
44109675|NCT03883919|Fluorouracil|fluorouracil|mesh-list
44109676|NCT03883919|Irinotecan|irinotecan|mesh-list
44109677|NCT03883919|Vitamins|vitamins|mesh-ancestor
44109678|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
44109679|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109680|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44109681|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
44109682|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109683|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44109684|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109685|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109686|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
44109687|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44109688|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109689|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109728|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44464120|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464121|NCT01499576|Acetic Acid|acetic acid|mesh-list
44464122|NCT01499576|Retinol acetate|retinol acetate|mesh-list
44464123|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464124|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464125|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43940414|NCT00934934|Anidulafungin|anidulafungin|mesh-list
44464126|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
44464127|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285751|NCT00756340|Everolimus|everolimus|mesh-list
44285752|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44285753|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285754|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43710640|NCT02696148|Incretins|incretins|mesh-ancestor
44109730|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109739|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109740|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44109741|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
44109742|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109743|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109744|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44109745|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109746|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
44109747|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
44109748|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109749|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109750|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
44109752|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109753|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109754|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44109755|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44109756|NCT03731832|Growth Substances|growth substances|mesh-ancestor
44109757|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109758|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109759|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109760|NCT03709550|Decitabine|decitabine|mesh-list
44109761|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44109762|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
44109763|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109764|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109765|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109766|NCT03646175|Choline|choline|mesh-list
44109767|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
44109768|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44109769|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
44109770|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109771|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109772|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44109773|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
44109774|NCT03611595|Tretinoin|tretinoin|mesh-list
44109775|NCT03611595|Isotretinoin|isotretinoin|mesh-list
44109776|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109777|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
44109778|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
44109779|NCT03551964|Ticagrelor|ticagrelor|mesh-list
44109780|NCT03551964|Cangrelor|cangrelor|mesh-list
44109781|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44109782|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44109783|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44109784|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44109785|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
44109786|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285755|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44285756|NCT00756340|Growth Substances|growth substances|mesh-ancestor
44285757|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285758|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
44285759|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285760|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
44285761|NCT00756405|Antioxidants|antioxidants|mesh-list
44285762|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285763|NCT00756405|Protective Agents|protective agents|mesh-ancestor
44285764|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285765|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44285766|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44285767|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285768|NCT00756847|Paclitaxel|paclitaxel|mesh-list
44285769|NCT00756847|Carboplatin|carboplatin|mesh-list
44285770|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44285771|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285772|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44285773|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109787|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109788|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109789|NCT03538938|Nicotine|nicotine|mesh-list
44109790|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44109791|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
44109792|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109793|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109794|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44109795|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44109796|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
44109797|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109798|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153693|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153694|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153696|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153697|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153698|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44153699|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153700|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153701|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153702|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
44153703|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
44153704|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153705|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153706|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44153707|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44153708|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
44153709|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44153710|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44153711|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44153712|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44153713|NCT00221429|Valproic Acid|valproic acid|mesh-list
44153714|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153715|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701831|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44285774|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44285775|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285776|NCT00756860|Sevelamer|sevelamer|mesh-list
44285777|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
44285778|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
44285779|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285780|NCT00756873|Etoricoxib|etoricoxib|mesh-list
44285781|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44285782|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285783|NCT00756873|Analgesics|analgesics|mesh-ancestor
44285784|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
44285785|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285786|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285787|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285788|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44285789|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44285790|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44285791|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285792|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285793|NCT00756990|Naltrexone|naltrexone|mesh-list
44285826|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
44285827|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285828|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44285829|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
44285830|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44285831|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285832|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
44285834|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
44285835|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
44285836|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44285837|NCT00757185|Ganirelix|ganirelix|mesh-list
44285838|NCT00757185|Androgens|androgens|mesh-ancestor
44285839|NCT00757185|Hormones|hormones|mesh-ancestor
44285840|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285841|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285842|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44285843|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285844|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
44285845|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
44285846|NCT00757198|Remifentanil|remifentanil|mesh-list
44285847|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44285848|NCT00757198|Narcotics|narcotics|mesh-ancestor
44285849|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44285850|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285851|NCT00757198|Analgesics|analgesics|mesh-ancestor
44285852|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
44285853|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285874|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44285875|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
44285876|NCT00757393|Vitamin D|vitamin d|mesh-list
44285877|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
44285878|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
44285879|NCT00757393|Vitamins|vitamins|mesh-list
44285880|NCT00757393|Calcium|calcium|mesh-list
44285881|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
44285882|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285883|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44285884|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44285885|NCT00757419|Lesogaberan|lesogaberan|mesh-list
44285886|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44285887|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44285888|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
44285889|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
44285934|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285935|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285936|NCT00757679|Analgesics|analgesics|mesh-ancestor
44285937|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
44285938|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285939|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
44285940|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285941|NCT00757692|Bicalutamide|bicalutamide|mesh-list
44285942|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
44285943|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
44285944|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285945|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285946|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44285947|NCT00757731|Milnacipran|milnacipran|mesh-list
44285948|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
44153716|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153717|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
44153718|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153719|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153720|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153721|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
44153722|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
44153723|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153724|NCT00221442|Zonisamide|zonisamide|mesh-list
44153725|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
44153726|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44153727|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153728|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153729|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44153730|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153731|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44153732|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153733|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153734|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44153735|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153736|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153737|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153742|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153743|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153744|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153746|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153747|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153748|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153749|NCT00221481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44153750|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44153751|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109811|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
44109812|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109813|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109814|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44109815|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
44109816|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44109817|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109818|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
44109820|NCT03352427|Dasatinib|dasatinib|mesh-list
44109821|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109822|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109823|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
44109824|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285950|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44285951|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44285952|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285953|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285954|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285955|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44285956|NCT00757731|Analgesics|analgesics|mesh-ancestor
44285957|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
44285958|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44285959|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
44285960|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44285961|NCT00757835|Timolol|timolol|mesh-list
44285962|NCT00757835|Latanoprost|latanoprost|mesh-list
44109825|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44109826|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109827|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109828|NCT03319901|Venetoclax|venetoclax|mesh-list
44109829|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109830|NCT03272477|Tamoxifen|tamoxifen|mesh-list
44109831|NCT03272477|Paclitaxel|paclitaxel|mesh-list
44109832|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44109833|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
44109834|NCT03272477|Trastuzumab|trastuzumab|mesh-list
44109835|NCT03272477|Letrozole|letrozole|mesh-list
44109836|NCT03272477|Epirubicin|epirubicin|mesh-list
44109837|NCT03272477|Anastrozole|anastrozole|mesh-list
44109838|NCT03272477|Pertuzumab|pertuzumab|mesh-list
44109839|NCT03272477|Exemestane|exemestane|mesh-list
44109840|NCT03272477|Goserelin|goserelin|mesh-list
44109841|NCT03272477|Leuprolide|leuprolide|mesh-list
44109842|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109843|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109844|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109845|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109846|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109847|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109848|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109849|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
44109850|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109851|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109852|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44109853|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
44109854|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44109855|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109856|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44109857|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44109858|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109859|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44109860|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
44109861|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109862|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44109863|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44109864|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109865|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109866|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44109867|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44109868|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44285964|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44285965|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
44285966|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285967|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285968|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285969|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44285970|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44285971|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44285972|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44285973|NCT00757874|Clobetasol|clobetasol|mesh-list
44109869|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44109870|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
44109879|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44109880|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44109881|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109882|NCT03238365|Urological Agents|urological agents|mesh-ancestor
43823443|NCT05523401|Psilocybin|psilocybin|mesh-list
44109884|NCT02966665|Vitamin E|vitamin e|mesh-list
44109885|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
44109888|NCT02966665|Nitroprusside|nitroprusside|mesh-list
44109889|NCT02966665|Phentolamine|phentolamine|mesh-list
44109890|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44109891|NCT02966665|Norepinephrine|norepinephrine|mesh-list
44109892|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
44109893|NCT02966665|Giapreza|giapreza|mesh-list
44109894|NCT02966665|Acetylcholine|acetylcholine|mesh-list
44109895|NCT02966665|Ranitidine|ranitidine|mesh-list
44109896|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
44109897|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
44109898|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109899|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44109900|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44109901|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44109902|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109903|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
44109904|NCT02966665|Protective Agents|protective agents|mesh-ancestor
44109905|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44109906|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44109907|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
44109908|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109909|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
44109910|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
44109911|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109912|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44109913|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
44109914|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44109915|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44109916|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44109917|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
44109918|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
44109919|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44109920|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109921|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44109922|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
44109923|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44109924|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44109925|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109926|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109927|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44109928|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
44109929|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44109930|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44109931|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44109932|NCT02922894|Trazodone|trazodone|mesh-list
44109933|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44285974|NCT00757874|Tacrolimus|tacrolimus|mesh-list
44285975|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44285976|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
44285977|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285978|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44285979|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44285980|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285981|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44285982|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
44285983|NCT00757874|Hormones|hormones|mesh-ancestor
44285984|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44285985|NCT00757978|Memantine|memantine|mesh-list
44285986|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44285987|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44285988|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
44285989|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44285990|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285991|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44285992|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44285993|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44285994|NCT00758004|Atorvastatin|atorvastatin|mesh-list
44285995|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44285996|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44285997|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
44285998|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44285999|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44286000|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44109934|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44109935|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109936|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109937|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44109938|NCT02922894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44109939|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43636759|NCT04772222|Narcotics|narcotics|mesh-ancestor
44109942|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109943|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
44109944|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44109945|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
44109947|NCT02832544|Warfarin|warfarin|mesh-list
44109948|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
44109949|NCT02832544|Vitamins|vitamins|mesh-ancestor
44109950|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
44109951|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109952|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
44109953|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44109954|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
44286001|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286002|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44286003|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44286004|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44286005|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286006|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286007|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44286008|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44286009|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44286010|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
44286011|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286012|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286013|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44286014|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44286015|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
44286016|NCT00758134|Trastuzumab|trastuzumab|mesh-list
44286017|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286018|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464128|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44464129|NCT01499576|Protective Agents|protective agents|mesh-ancestor
44109955|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44109956|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109957|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109958|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109959|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44109960|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44109961|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
44109962|NCT02832544|Coagulants|coagulants|mesh-ancestor
44109964|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44109965|NCT02571725|Olaparib|olaparib|mesh-list
44109966|NCT02571725|Tremelimumab|tremelimumab|mesh-list
44109967|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44109968|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109969|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109970|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109971|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
44109972|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
44109973|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44109974|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109975|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109976|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
44109977|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44109978|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109979|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109980|NCT02470299|Ketorolac|ketorolac|mesh-list
44109981|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44109982|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44109983|NCT02470299|Analgesics|analgesics|mesh-ancestor
44109984|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
44109985|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109986|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109987|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109988|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109989|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44464130|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464131|NCT01499368|Omeprazole|omeprazole|mesh-list
44464132|NCT01499368|Famotidine|famotidine|mesh-list
44464133|NCT01499368|Lafutidine|lafutidine|mesh-list
44464134|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44464135|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464136|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44464137|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464138|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645829|NCT03742986|Trastuzumab|trastuzumab|mesh-list
43645830|NCT03742986|Pertuzumab|pertuzumab|mesh-list
43645831|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43645832|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464139|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44464140|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
44464141|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
44464142|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464143|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464144|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
44464145|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44464146|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464147|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44464148|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
44464149|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464150|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464151|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464152|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464153|NCT01499290|Metronidazole|metronidazole|mesh-list
44464154|NCT01499290|Meropenem|meropenem|mesh-list
44464155|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464156|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44286019|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
44286020|NCT00758199|Prednisolone|prednisolone|mesh-list
44286021|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44286022|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
44109990|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109991|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109992|NCT02395705|Paclitaxel|paclitaxel|mesh-list
44109993|NCT02395705|Cisplatin|cisplatin|mesh-list
44109994|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109995|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109996|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109997|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109998|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109999|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110000|NCT01821833|Paclitaxel|paclitaxel|mesh-list
44110001|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44110002|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110003|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110004|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286023|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44286024|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
44286025|NCT00758199|Bromfenac|bromfenac|mesh-list
44412290|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110005|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110006|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110007|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44110008|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
44110009|NCT00083824|Estrogens|estrogens|mesh-list
44110010|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44110011|NCT00083824|Hormones|hormones|mesh-ancestor
44110012|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110016|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44110017|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
44110018|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44110019|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44110020|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44110021|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44110022|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44110023|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110024|NCT00083876|Thalidomide|thalidomide|mesh-list
44110025|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110026|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
44110027|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110028|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
44110029|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645833|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110030|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110031|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44110032|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44110033|NCT00083876|Growth Substances|growth substances|mesh-ancestor
44110034|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
44110035|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110037|NCT00083902|Dexamethasone|dexamethasone|mesh-list
44110038|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110039|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
44110040|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
44110041|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110042|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110043|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44110044|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
44110046|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110047|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44110048|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110049|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110050|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
44110051|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
44110052|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110053|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110054|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44110055|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44110056|NCT00083902|Growth Substances|growth substances|mesh-ancestor
44110057|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
44110058|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44110059|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
44110060|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110061|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110062|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110063|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110064|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110065|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44110066|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44110067|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44110068|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110069|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110070|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110071|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110072|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44110073|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
44286026|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44286027|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44286028|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
44286029|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286030|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
44286031|NCT00758199|Hormones|hormones|mesh-ancestor
44286032|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286033|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286034|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44286035|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286036|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
44286037|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
44286038|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286039|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286040|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44286041|NCT00758199|Protective Agents|protective agents|mesh-ancestor
44110074|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110075|NCT00083993|Sirolimus|sirolimus|mesh-list
44110076|NCT00083993|Letrozole|letrozole|mesh-list
44110077|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110078|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44110079|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44110080|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110081|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110082|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43637010|NCT04708470|Entinostat|entinostat|mesh-list
44110087|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110088|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110089|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
44110090|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110091|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
44110092|NCT00084019|Ritonavir|ritonavir|mesh-list
44110093|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44110094|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44110095|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44110096|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
44110097|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110098|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110099|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110100|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110101|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
44110102|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110103|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44110104|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44110105|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44110106|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
44110107|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110108|NCT00084058|Ritonavir|ritonavir|mesh-list
44110109|NCT00084058|Lopinavir|lopinavir|mesh-list
44110110|NCT00084058|Saquinavir|saquinavir|mesh-list
44110111|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44110112|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44110113|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44110114|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110115|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110116|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110117|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110118|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
44110119|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286043|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286044|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44286045|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44286046|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286047|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286048|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44286049|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
44286050|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44286051|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44286052|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44110120|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44110121|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44110122|NCT00084097|Omalizumab|omalizumab|mesh-list
44110123|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44110124|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44110125|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44110126|NCT00084201|Amoxicillin|amoxicillin|mesh-list
44110127|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110128|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110129|NCT00084214|Paclitaxel|paclitaxel|mesh-list
44110130|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44110131|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110132|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110133|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110134|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110135|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110136|NCT00084227|Azithromycin|azithromycin|mesh-list
44110137|NCT00084227|Chloroquine|chloroquine|mesh-list
44110138|NCT00084227|Atovaquone|atovaquone|mesh-list
44110139|NCT00084227|Proguanil|proguanil|mesh-list
44110140|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44110141|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110142|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110143|NCT00084227|Amebicides|amebicides|mesh-ancestor
44110144|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44110145|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44110146|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
44110147|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110148|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110149|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110150|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
44110151|NCT00084240|Azithromycin|azithromycin|mesh-list
44110152|NCT00084240|Chloroquine|chloroquine|mesh-list
44110153|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44110154|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
44110155|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
44110163|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110164|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110165|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110166|NCT00084240|Analgesics|analgesics|mesh-ancestor
44110167|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
44110168|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110169|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110170|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110171|NCT00084240|Filaricides|filaricides|mesh-ancestor
44110172|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
44110173|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
44110174|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44110175|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110176|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110177|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44110178|NCT00084240|Renal Agents|renal agents|mesh-ancestor
44110179|NCT00084279|Interferons|interferons|mesh-list
44110180|NCT00084279|Ribavirin|ribavirin|mesh-list
44286053|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44286054|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286056|NCT00758199|Analgesics|analgesics|mesh-ancestor
44286057|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
44286058|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286059|NCT00758212|Vaccines|vaccines|mesh-list
44286060|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
44286061|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286062|NCT00758225|Idebenone|idebenone|mesh-list
44286063|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
44286064|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286065|NCT00758225|Protective Agents|protective agents|mesh-ancestor
44286066|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286067|NCT00758277|Levetiracetam|levetiracetam|mesh-list
44286068|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
44286069|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
44286070|NCT00758368|Apomorphine|apomorphine|mesh-list
44286071|NCT00758368|Emetics|emetics|mesh-ancestor
44286072|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286073|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
43710779|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110181|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
44110182|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
44110183|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
44110184|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110185|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
44110186|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110187|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
44110188|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110189|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
43641669|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
44110190|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110192|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110193|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110194|NCT00084370|Analgesics|analgesics|mesh-ancestor
44110195|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
44110196|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110197|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110198|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110199|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110200|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44110201|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110202|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110203|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110204|NCT00084396|Letrozole|letrozole|mesh-list
44110205|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110206|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44110207|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44110208|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110209|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110210|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44110211|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
44110212|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286074|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286075|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286076|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
44286077|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
44286078|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286079|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286080|NCT00758381|Sorafenib|sorafenib|mesh-list
44286081|NCT00758381|Cisplatin|cisplatin|mesh-list
44286082|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286083|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44286084|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286085|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286086|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44286087|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44110213|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110214|NCT00084435|Cisplatin|cisplatin|mesh-list
44110215|NCT00084435|Docetaxel|docetaxel|mesh-list
44110216|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110217|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110218|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110219|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110220|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110221|NCT00084448|Celecoxib|celecoxib|mesh-list
44110222|NCT00084448|Paclitaxel|paclitaxel|mesh-list
44110223|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637188|NCT04664361|Niacin|niacin|mesh-list
44110257|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110258|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110259|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44110260|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44110261|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110262|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44110263|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
43641737|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110270|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
44110271|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110272|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110273|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110274|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110275|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44110276|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110277|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110278|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110279|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44110280|NCT00084591|Capecitabine|capecitabine|mesh-list
44110281|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110282|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
44110283|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110284|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110285|NCT00084604|Bevacizumab|bevacizumab|mesh-list
44110286|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44110287|NCT00084604|Cisplatin|cisplatin|mesh-list
44110288|NCT00084604|Irinotecan|irinotecan|mesh-list
44110289|NCT00084604|Antibodies|antibodies|mesh-list
44110290|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
44110291|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44110292|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110293|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44110294|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44110295|NCT00084604|Growth Substances|growth substances|mesh-ancestor
44110296|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110297|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
44286088|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286090|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44286091|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
44286092|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286093|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
43940767|NCT00943800|Vidarabine|vidarabine|mesh-list
44286094|NCT05436002|Protective Agents|protective agents|mesh-ancestor
44286096|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44286097|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44286098|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44286099|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286100|NCT05435729|Levodopa|levodopa|mesh-list
44286101|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44286102|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44286103|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
44286104|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286105|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110298|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
44110299|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44110300|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44110301|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110302|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110303|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
44110304|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110305|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110306|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110307|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110308|NCT00084643|Capecitabine|capecitabine|mesh-list
44110309|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
44110310|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110311|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
44110312|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110313|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110314|NCT00084669|Zolpidem|zolpidem|mesh-list
44110315|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44110316|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44110317|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44110318|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110319|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110320|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110321|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110322|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44110323|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
44110324|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110325|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44110326|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44110327|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110328|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44110329|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
44110330|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
44110331|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
44110336|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
44286106|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286107|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
44286108|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44286109|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286110|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286111|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286112|NCT05435560|Analgesics|analgesics|mesh-ancestor
44286113|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
44286114|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286115|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44286116|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44286117|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286118|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286119|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286120|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286121|NCT05435378|Vitamins|vitamins|mesh-list
44286122|NCT05435378|Folic Acid|folic acid|mesh-list
44286123|NCT05435378|Niacinamide|niacinamide|mesh-list
44286124|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
44286125|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
44286126|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286127|NCT05435378|Hematinics|hematinics|mesh-ancestor
44286128|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
44286129|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286130|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
44286131|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
44286132|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44286133|NCT05434546|Pregnanolone|pregnanolone|mesh-list
44286134|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
44286136|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286153|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286154|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
44286155|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286156|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286157|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286158|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44286159|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286160|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286161|NCT05428293|Acetaminophen|acetaminophen|mesh-list
44286163|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286164|NCT05428293|Analgesics|analgesics|mesh-ancestor
44286165|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
44286166|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286167|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286168|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
44286169|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286170|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286171|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286172|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44286173|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286174|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286176|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286177|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286178|NCT05427266|Bupivacaine|bupivacaine|mesh-list
44286179|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286180|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
44286181|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286182|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286183|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
44286184|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286185|NCT05424796|Hemostatics|hemostatics|mesh-list
44286186|NCT05424796|Coagulants|coagulants|mesh-ancestor
44286187|NCT05414305|Lidocaine|lidocaine|mesh-list
44286188|NCT05414305|Heparin|heparin|mesh-list
44286189|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286192|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286194|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286195|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286196|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44286197|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44110337|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44110338|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110339|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
44110340|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110341|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110342|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44110343|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
44110344|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110345|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110346|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44110347|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110349|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110350|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
44110351|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
44110352|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110353|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44110354|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
44110356|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110357|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44110358|NCT00084695|Protective Agents|protective agents|mesh-ancestor
44110359|NCT00084708|Calcitriol|calcitriol|mesh-list
44110360|NCT00084708|Dexamethasone|dexamethasone|mesh-list
44110361|NCT00084708|Gefitinib|gefitinib|mesh-list
44110362|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110363|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
44110364|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
44110365|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110366|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110367|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44110368|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
44110369|NCT00084708|Hormones|hormones|mesh-ancestor
44110370|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110371|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44110372|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110373|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110374|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110375|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110376|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44110377|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44110378|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110379|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44110380|NCT00084708|Vitamins|vitamins|mesh-ancestor
44110381|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
44110382|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44110383|NCT00084721|Celecoxib|celecoxib|mesh-list
44110384|NCT00084721|Irinotecan|irinotecan|mesh-list
44110385|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44110386|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44110387|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110388|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110389|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110390|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110391|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110392|NCT00084721|Analgesics|analgesics|mesh-ancestor
44110393|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
44110394|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110395|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110396|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110397|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286198|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286199|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286200|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
44286201|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44286202|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44286203|NCT05396898|Tacrolimus|tacrolimus|mesh-list
44286204|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286205|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
44286206|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286207|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44286208|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286209|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464157|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44464158|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44464159|NCT01499277|Vancomycin|vancomycin|mesh-list
44464160|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
44464161|NCT01499277|Aztreonam|aztreonam|mesh-list
44464162|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464163|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464164|NCT01499199|Dolutegravir|dolutegravir|mesh-list
44110398|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44110399|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110400|NCT00084734|Cisplatin|cisplatin|mesh-list
44110401|NCT00084734|Docetaxel|docetaxel|mesh-list
44110402|NCT00084734|Capecitabine|capecitabine|mesh-list
44110403|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110404|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110405|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110406|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110411|NCT00084773|Cetuximab|cetuximab|mesh-list
44110413|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110414|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110415|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110416|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110417|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
44110418|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110419|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110420|NCT00084786|Docetaxel|docetaxel|mesh-list
44110421|NCT00084786|Gefitinib|gefitinib|mesh-list
44110422|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110423|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110424|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110425|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110426|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110427|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110428|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110429|NCT00084812|Cisplatin|cisplatin|mesh-list
44110430|NCT00084812|Safingol|safingol|mesh-list
44110431|NCT00084812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110432|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110433|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110434|NCT00084825|Docetaxel|docetaxel|mesh-list
44110435|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
44110436|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110437|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110438|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110439|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44464165|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44464166|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44464167|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464168|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464169|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44464170|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44464171|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
44464172|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110440|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110441|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110442|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110443|NCT00084877|Irinotecan|irinotecan|mesh-list
44110444|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44110445|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44110446|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110447|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110448|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110449|NCT00084890|Carboplatin|carboplatin|mesh-list
44110450|NCT00084890|Docetaxel|docetaxel|mesh-list
44110451|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110452|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110453|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110454|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110455|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110456|NCT00084916|Sirolimus|sirolimus|mesh-list
44110457|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110458|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110459|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110460|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110461|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
44110462|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110463|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
44110464|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110465|NCT00084942|Gemcitabine|gemcitabine|mesh-list
44110466|NCT00084942|Capecitabine|capecitabine|mesh-list
44110467|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110468|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
44110469|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110470|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110471|NCT00084942|Antiviral Agents|antiviral agents|mesh-ancestor
44110472|NCT00084942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110473|NCT00084942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110474|NCT00084942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110475|NCT00084942|Immunologic Factors|immunologic factors|mesh-ancestor
44110476|NCT00084942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153752|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153753|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153759|NCT00221494|Pindolol|pindolol|mesh-list
44153760|NCT00221494|Citalopram|citalopram|mesh-list
44153761|NCT00221494|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43553728|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
44153762|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44153763|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153764|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110477|NCT00084981|Decitabine|decitabine|mesh-list
44110478|NCT00084981|Azacitidine|azacitidine|mesh-list
44110479|NCT00084981|Valproic Acid|valproic acid|mesh-list
44110480|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110481|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
44110482|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110483|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110484|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110485|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
44110486|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
44110487|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110488|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110489|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
44464174|NCT01499160|Letrozole|letrozole|mesh-list
44464175|NCT01499160|Lapatinib|lapatinib|mesh-list
44464176|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464177|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464178|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
44464179|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464180|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44464181|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44464182|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464183|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464184|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44464185|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
44464186|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464187|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464188|NCT01499134|Metoprolol|metoprolol|mesh-list
44464189|NCT01499134|Nebivolol|nebivolol|mesh-list
44464190|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44464191|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44464192|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
44286211|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43710846|NCT02694458|Vancomycin|vancomycin|mesh-list
44110490|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110491|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110492|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110493|NCT00085020|Trastuzumab|trastuzumab|mesh-list
44110494|NCT00085020|Lapatinib|lapatinib|mesh-list
44110495|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110496|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110497|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110498|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110499|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110500|NCT00085111|Bevacizumab|bevacizumab|mesh-list
44110501|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44110502|NCT00085111|Antibodies|antibodies|mesh-list
44110503|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
44110504|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44110505|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110506|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44110507|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44110508|NCT00085111|Growth Substances|growth substances|mesh-ancestor
44110509|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110510|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
44110511|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
44110512|NCT00085124|Cytarabine|cytarabine|mesh-list
44110513|NCT00085124|Daunorubicin|daunorubicin|mesh-list
44110514|NCT00085124|Oblimersen|oblimersen|mesh-list
44110515|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110516|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
44110517|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110518|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110519|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
44110520|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110521|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110522|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
44286212|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286213|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
44286214|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
44286215|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286216|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286217|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286218|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
44286219|NCT05343156|Hormones|hormones|mesh-ancestor
44286220|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286221|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44286222|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286223|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44286224|NCT05291364|Ethanol|ethanol|mesh-list
44286225|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
44286226|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43710849|NCT02694289|Metformin|metformin|mesh-list
44110523|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110524|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110525|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44110526|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44110527|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110528|NCT00085150|Immunotoxins|immunotoxins|mesh-list
44110529|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
44110530|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110531|NCT00085163|Leucovorin|leucovorin|mesh-list
44110532|NCT00085163|Celecoxib|celecoxib|mesh-list
44110533|NCT00085163|Fluorouracil|fluorouracil|mesh-list
44110534|NCT00085163|Calcium|calcium|mesh-list
44110535|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
44110536|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44110537|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110538|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
44110540|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110541|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110542|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110543|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
44110544|NCT00085163|Antidotes|antidotes|mesh-ancestor
44110545|NCT00085163|Protective Agents|protective agents|mesh-ancestor
44110546|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
44110547|NCT00085163|Vitamins|vitamins|mesh-ancestor
44110548|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
44110549|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110550|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110551|NCT00085163|Analgesics|analgesics|mesh-ancestor
44110552|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
44110553|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110554|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110555|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110556|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44110557|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110558|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110559|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44110560|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
44110561|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44110562|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
44110563|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110564|NCT00085228|Docetaxel|docetaxel|mesh-list
44110565|NCT00085228|Oblimersen|oblimersen|mesh-list
44110566|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110567|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110568|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110569|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
44286227|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286228|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286229|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286230|NCT05291364|Analgesics|analgesics|mesh-ancestor
44286231|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
44286232|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286233|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44286234|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44286235|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286236|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286237|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286238|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286239|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44286240|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286241|NCT05291221|Lidocaine|lidocaine|mesh-list
43645915|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286242|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
44286243|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286244|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
44286245|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286246|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286247|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
44286248|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286249|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286250|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44110570|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110571|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44110572|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110573|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110574|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110575|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110576|NCT00085306|Interferons|interferons|mesh-list
44110577|NCT00085306|Interferon-beta|interferon-beta|mesh-list
44110578|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110579|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
44110580|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110581|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
44110582|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110583|NCT00085332|Docetaxel|docetaxel|mesh-list
44110584|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110585|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110586|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110587|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110588|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110589|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
44110590|NCT00085345|Melphalan|melphalan|mesh-list
44110591|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
44110592|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44110593|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
44110594|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286251|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44286252|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286253|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286254|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44286255|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286256|NCT05291221|Analgesics|analgesics|mesh-ancestor
44286257|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44286258|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44286259|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286260|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286261|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286262|NCT05289193|Nivolumab|nivolumab|mesh-list
44286263|NCT05289193|Ipilimumab|ipilimumab|mesh-list
44286264|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286265|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286266|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44286267|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286268|NCT05271071|Lidocaine|lidocaine|mesh-list
44286269|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286270|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
44286271|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286272|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286273|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
44286274|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110595|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110596|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44110597|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110598|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
44110599|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110600|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
44110601|NCT00085345|Protective Agents|protective agents|mesh-ancestor
44110602|NCT00085345|Vitamins|vitamins|mesh-ancestor
44110603|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
44110604|NCT00085358|Paclitaxel|paclitaxel|mesh-list
44110605|NCT00085358|Docetaxel|docetaxel|mesh-list
44110606|NCT00085358|Bevacizumab|bevacizumab|mesh-list
44110607|NCT00085358|Carboplatin|carboplatin|mesh-list
44110608|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44110609|NCT00085358|Antibodies|antibodies|mesh-list
44110610|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
44110611|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44110612|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44110613|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110614|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110633|NCT00085449|Cyclosporine|cyclosporine|mesh-list
44110634|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
44110635|NCT00085449|Fludarabine|fludarabine|mesh-list
44110636|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
44110637|NCT00085449|Melphalan|melphalan|mesh-list
44110638|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
44110639|NCT00085449|Cyclosporins|cyclosporins|mesh-list
44110640|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286275|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286276|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44286277|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44286278|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286279|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286280|NCT05230901|Dihydralazine|dihydralazine|mesh-list
44286281|NCT05230901|Spironolactone|spironolactone|mesh-list
44286282|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44286283|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44286284|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286285|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286286|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44286287|NCT05230901|Diuretics|diuretics|mesh-ancestor
44286288|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
44286289|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286290|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44286291|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286292|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286293|NCT05170009|Oseltamivir|oseltamivir|mesh-list
44286294|NCT05170009|Baloxavir|baloxavir|mesh-list
44286295|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
44286296|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286297|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286298|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286299|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44286300|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44286301|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44286302|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44286303|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286318|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
44286319|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286320|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286321|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44286322|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286323|NCT05122221|Analgesics|analgesics|mesh-ancestor
44286324|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
44286325|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286326|NCT05011760|Amphetamine|amphetamine|mesh-list
44286327|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
44286328|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44286329|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286330|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
44286331|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
44286332|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286333|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
44286334|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286335|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286336|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286337|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44286372|NCT04767061|Metoprolol|metoprolol|mesh-list
44286373|NCT04767061|Atenolol|atenolol|mesh-list
44286374|NCT04767061|Sotalol|sotalol|mesh-list
44286375|NCT04767061|Nadolol|nadolol|mesh-list
44286376|NCT04767061|Acebutolol|acebutolol|mesh-list
44286377|NCT04767061|Carvedilol|carvedilol|mesh-list
44286378|NCT04767061|Nebivolol|nebivolol|mesh-list
44286379|NCT04767061|Bisoprolol|bisoprolol|mesh-list
44286380|NCT04767061|Labetalol|labetalol|mesh-list
44286381|NCT04767061|Pindolol|pindolol|mesh-list
44286382|NCT04767061|Betaxolol|betaxolol|mesh-list
44286383|NCT04767061|Penbutolol|penbutolol|mesh-list
44286384|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44286385|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44286386|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286387|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645933|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44286388|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286389|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286390|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286391|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286392|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
44286393|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
44286394|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
44286395|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286396|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44286397|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
44110641|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110642|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
44110643|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110644|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110645|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
44110646|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110647|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110648|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
44110649|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110650|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
44110651|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110652|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44110653|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110654|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44110655|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
44110656|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110657|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44110658|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
44110659|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44110660|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110661|NCT00085462|Aldesleukin|aldesleukin|mesh-list
44110662|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
44110663|NCT00085462|Fludarabine|fludarabine|mesh-list
44110664|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
44110665|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110666|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
44110667|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110668|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701832|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286400|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286401|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44286402|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44286403|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44286404|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44286405|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44286406|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286407|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
44286408|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44286409|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
44286410|NCT04757584|Propranolol|propranolol|mesh-list
44286411|NCT04757584|Metoprolol|metoprolol|mesh-list
44110669|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44110670|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
44110671|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110672|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110673|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43637735|NCT04447716|Lenalidomide|lenalidomide|mesh-list
44110700|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110701|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110702|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110703|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110704|NCT00085579|Aldesleukin|aldesleukin|mesh-list
44110706|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
44110707|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110708|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110709|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110710|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110711|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
44110712|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110713|NCT00085696|Rituximab|rituximab|mesh-list
44110714|NCT00085696|Bortezomib|bortezomib|mesh-list
44110715|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110716|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110717|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
44110718|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110719|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110720|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44110721|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110722|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110723|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110724|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110731|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44110732|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44110733|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
44110734|NCT00085761|Capsaicin|capsaicin|mesh-list
44110735|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
44110736|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
44110737|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
44110738|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110739|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110740|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
44110741|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110742|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44110743|NCT00085826|Protective Agents|protective agents|mesh-ancestor
44110744|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110745|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110746|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286413|NCT04757584|Sotalol|sotalol|mesh-list
44286414|NCT04757584|Nadolol|nadolol|mesh-list
44286415|NCT04757584|Acebutolol|acebutolol|mesh-list
44286416|NCT04757584|Carvedilol|carvedilol|mesh-list
44286417|NCT04757584|Nebivolol|nebivolol|mesh-list
44110747|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110748|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110749|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110750|NCT00085826|Analgesics|analgesics|mesh-ancestor
44110751|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
44110752|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110753|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110754|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110755|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44110756|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
44110757|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110758|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110759|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110760|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110761|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110762|NCT00085943|Ritonavir|ritonavir|mesh-list
44110763|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
44110764|NCT00085943|Lamivudine|lamivudine|mesh-list
44110765|NCT00085943|Abacavir|abacavir|mesh-list
44110766|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44110767|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44110768|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
44110769|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110770|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110771|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110772|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110773|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
44110774|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110775|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44110776|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44110777|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44110778|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44110779|NCT00085969|Exenatide|exenatide|mesh-list
44110781|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110782|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44110783|NCT00085969|Incretins|incretins|mesh-ancestor
44110784|NCT00085969|Hormones|hormones|mesh-ancestor
44153765|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110785|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110786|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
44110787|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110788|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44110789|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44110790|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
44110792|NCT00086099|Amifostine|amifostine|mesh-list
44110793|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43637847|NCT04406259|Verapamil|verapamil|mesh-list
44110800|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110801|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110802|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110803|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110804|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110805|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110806|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44110807|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
44110808|NCT00086125|Sirolimus|sirolimus|mesh-list
44110809|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110810|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110811|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110812|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110813|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
44110814|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110815|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
44110816|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110817|NCT00086177|Progesterone|progesterone|mesh-list
44110818|NCT00086177|Progestins|progestins|mesh-ancestor
44110819|NCT00086177|Hormones|hormones|mesh-ancestor
43701833|NCT02722369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286418|NCT04757584|Bisoprolol|bisoprolol|mesh-list
44286419|NCT04757584|Labetalol|labetalol|mesh-list
44286420|NCT04757584|Pindolol|pindolol|mesh-list
44286421|NCT04757584|Betaxolol|betaxolol|mesh-list
44286422|NCT04757584|Penbutolol|penbutolol|mesh-list
44286423|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44110820|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110821|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110822|NCT00086203|Rituximab|rituximab|mesh-list
44110823|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110824|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110825|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
44110826|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110827|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110828|NCT00086255|Tiagabine|tiagabine|mesh-list
44110829|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
44110830|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44110831|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44110832|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110833|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110834|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
44110835|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110836|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110837|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
44110838|NCT00086268|Carboplatin|carboplatin|mesh-list
44110839|NCT00086268|Docetaxel|docetaxel|mesh-list
44110840|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110841|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110842|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110843|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110844|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110845|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44110846|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110847|NCT00086294|Levodopa|levodopa|mesh-list
44110848|NCT00086294|Pimavanserin|pimavanserin|mesh-list
44110849|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44110850|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44110851|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
44110852|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110853|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110854|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110855|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110856|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110857|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110858|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110859|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44110860|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44110861|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
44110862|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43637941|NCT04363801|Leucovorin|leucovorin|mesh-list
44110864|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110865|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110866|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110867|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110868|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44110869|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44110870|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
44110871|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110872|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110873|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44110874|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44110875|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
44110876|NCT00086333|Docetaxel|docetaxel|mesh-list
44110877|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110878|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110879|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110880|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110881|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110882|NCT00086359|Ritonavir|ritonavir|mesh-list
44110883|NCT00086359|Lopinavir|lopinavir|mesh-list
44110884|NCT00086359|Lamivudine|lamivudine|mesh-list
44110885|NCT00086359|Zidovudine|zidovudine|mesh-list
44286424|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44286425|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286426|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286427|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286428|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286429|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286430|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286431|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
44286432|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
44286433|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
44286434|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286435|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44286436|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
44286437|NCT04757584|Protective Agents|protective agents|mesh-ancestor
44464193|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
44110886|NCT00086359|Abacavir|abacavir|mesh-list
44110887|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44110888|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44110889|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44110890|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
44110891|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110892|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110893|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110894|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110895|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
44110896|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110897|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44110898|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44110899|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44110900|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44110901|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
44110902|NCT00086463|Iloprost|iloprost|mesh-list
44110903|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44110904|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
44110905|NCT00086489|Tremelimumab|tremelimumab|mesh-list
44110906|NCT00086489|Ipilimumab|ipilimumab|mesh-list
44110907|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110908|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110909|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44110910|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110911|NCT00086528|XL647|xl647|mesh-list
44110912|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110913|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110914|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110915|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110916|NCT00086541|Interferons|interferons|mesh-list
44110917|NCT00086541|Ribavirin|ribavirin|mesh-list
44110918|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
44110919|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110920|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
44110921|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110922|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
44110923|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110924|NCT00086593|Lamotrigine|lamotrigine|mesh-list
44110925|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
44110926|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44110927|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110928|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701834|NCT02722369|Immunologic Factors|immunologic factors|mesh-ancestor
44286438|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44286439|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286440|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44286441|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44286442|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44286443|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44286444|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44286445|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286446|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
44286447|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44286448|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
44286449|NCT04741438|Nivolumab|nivolumab|mesh-list
44286450|NCT04741438|Ipilimumab|ipilimumab|mesh-list
44286451|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286452|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286453|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44286454|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286455|NCT04627246|Vaccines|vaccines|mesh-list
44286456|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
44286457|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286458|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
43710983|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
44110929|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44110930|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110931|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110932|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44110933|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110934|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110935|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44110937|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44110944|NCT00086645|Citalopram|citalopram|mesh-list
44110945|NCT00086645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44110946|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44110947|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44110948|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110949|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110950|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
44110951|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110952|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44110953|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44110954|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110955|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44110956|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44110957|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
44110958|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
44110959|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110960|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44110961|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44110962|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
44110963|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
44110964|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44286459|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286460|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286461|NCT04507906|Nivolumab|nivolumab|mesh-list
44286462|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286463|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286464|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44286465|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464194|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464195|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464196|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44464197|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44464198|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44464199|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44464200|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464201|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464202|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
44464203|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44464204|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44464205|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44464206|NCT01498952|Sorafenib|sorafenib|mesh-list
44464207|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464208|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464209|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464234|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44464235|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
44464236|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941217|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
44286466|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44286467|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44286468|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286469|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
44286470|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44286471|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44286472|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286473|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
44286474|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44286475|NCT04249427|Erenumab|erenumab|mesh-list
44286476|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44286477|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286478|NCT04249427|Analgesics|analgesics|mesh-ancestor
44286479|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
44286480|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286481|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286482|NCT04007809|Glucagon|glucagon|mesh-list
44286483|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286484|NCT04007809|Hormones|hormones|mesh-ancestor
44286485|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286486|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286487|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
44286488|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44286489|NCT03916419|Paclitaxel|paclitaxel|mesh-list
44286490|NCT03916419|Carboplatin|carboplatin|mesh-list
44286491|NCT03916419|Durvalumab|durvalumab|mesh-list
44286492|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44286493|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286494|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
44286495|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286496|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110965|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44110966|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110967|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110968|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44286497|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286498|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286500|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
44286501|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44286502|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44286503|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286504|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286505|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
44286506|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286507|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286508|NCT03802305|Anesthetics|anesthetics|mesh-list
44286509|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44110969|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
44110970|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110971|NCT00086736|Eflornithine|eflornithine|mesh-list
44110972|NCT00086736|Bicalutamide|bicalutamide|mesh-list
44110973|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
44110974|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
44110975|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110976|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110977|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110978|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44110979|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44110980|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44110981|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110982|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44110983|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110984|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110985|NCT00086775|Rituximab|rituximab|mesh-list
44110986|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
44110987|NCT00086775|Fludarabine|fludarabine|mesh-list
44110988|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
44110989|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110990|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110991|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
44110992|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110993|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110994|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110995|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
44110996|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110997|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44110998|NCT00086801|Gemcitabine|gemcitabine|mesh-list
44110999|NCT00086801|Doxorubicin|doxorubicin|mesh-list
44111000|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44111001|NCT00086801|Vinblastine|vinblastine|mesh-list
44111002|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44111003|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111004|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
44111005|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638222|NCT04235101|Niraparib|niraparib|mesh-list
44111011|NCT00086801|Immunologic Factors|immunologic factors|mesh-ancestor
44111012|NCT00086801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111013|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111014|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44111015|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44111016|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44111017|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111018|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111019|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286510|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286511|NCT03734198|Daratumumab|daratumumab|mesh-list
44286512|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44286513|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286514|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
44286515|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286516|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44286517|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44286518|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
44111020|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111021|NCT00086827|Romidepsin|romidepsin|mesh-list
44111022|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111023|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111024|NCT00086840|Sirolimus|sirolimus|mesh-list
44111025|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111026|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111027|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111028|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111029|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
44111030|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111031|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
44111032|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111033|NCT00086879|Temozolomide|temozolomide|mesh-list
44111034|NCT00086879|Carmustine|carmustine|mesh-list
44111035|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44111036|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111037|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
44111038|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111039|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111040|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111041|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111042|NCT00086892|Carboplatin|carboplatin|mesh-list
44111043|NCT00086892|Cetuximab|cetuximab|mesh-list
44111044|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111045|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111046|NCT00086931|Capecitabine|capecitabine|mesh-list
44111047|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
44111048|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111049|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
44111050|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111051|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111052|NCT00086944|Rituximab|rituximab|mesh-list
44111053|NCT00086944|Carboplatin|carboplatin|mesh-list
44111054|NCT00086944|Etoposide|etoposide|mesh-list
44111055|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
44111056|NCT00086944|Ifosfamide|ifosfamide|mesh-list
44111057|NCT00086944|Oblimersen|oblimersen|mesh-list
44111058|NCT00086944|Lenograstim|lenograstim|mesh-list
44111059|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111060|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111061|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
44111062|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111063|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111064|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111065|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44111066|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44111067|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111068|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111069|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111070|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111071|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
44111072|NCT00086970|Ifosfamide|ifosfamide|mesh-list
44111073|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44111074|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111075|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
44111076|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111077|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286519|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286520|NCT03719131|Rituximab|rituximab|mesh-list
44286521|NCT03719131|Nivolumab|nivolumab|mesh-list
44286522|NCT03719131|Ipilimumab|ipilimumab|mesh-list
44286523|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286524|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286525|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
44286526|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286527|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286528|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44286529|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286530|NCT03680352|Cefepime|cefepime|mesh-list
44286531|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
44286532|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44286533|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286534|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44286535|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286536|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286537|NCT03617458|Metformin|metformin|mesh-list
44111078|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111079|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
44111083|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111085|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111086|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111088|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44111089|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111090|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111091|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111092|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111093|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111094|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111095|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111097|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44111098|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44111099|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111100|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111101|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111102|NCT00087074|Sirolimus|sirolimus|mesh-list
44111103|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111104|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111105|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111106|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111107|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
44111108|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111109|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
44111110|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153766|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
44153767|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153768|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44153769|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153770|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153771|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44153772|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44153773|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
44153774|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153775|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44286538|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43941289|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44464237|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44286539|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286540|NCT03492463|Nicotine|nicotine|mesh-list
44286541|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44286542|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
44286543|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286544|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286545|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44286546|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44286547|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
44286548|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286549|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286550|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
44286551|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711055|NCT02691910|Chloroquine|chloroquine|mesh-list
44153776|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
44153777|NCT00221520|Midazolam|midazolam|mesh-list
44153778|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44153779|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44153780|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153781|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153782|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44153783|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153784|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153785|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44153786|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
44153787|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
44153788|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
44153789|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
44153790|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153791|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153792|NCT00221611|Baclofen|baclofen|mesh-list
44153793|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44153794|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153795|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44153796|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153797|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44153798|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
44153799|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
44153800|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153801|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153802|NCT00221624|Ribavirin|ribavirin|mesh-list
44153803|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44153804|NCT00221624|Amantadine|amantadine|mesh-list
44153805|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
44153806|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153810|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44153812|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153813|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642506|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
44153814|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153815|NCT00221624|Analgesics|analgesics|mesh-ancestor
44111111|NCT00087087|Pemetrexed|pemetrexed|mesh-list
44111112|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111113|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111114|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111115|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44286552|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286553|NCT03417687|Xenon|xenon|mesh-list
44286554|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44286555|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
44286556|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
44286557|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286558|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286559|NCT03205137|Amlodipine|amlodipine|mesh-list
44286560|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44286561|NCT03205137|Telmisartan|telmisartan|mesh-list
44286562|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43711066|NCT02691910|Analgesics|analgesics|mesh-ancestor
44111116|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111117|NCT00087100|Pemetrexed|pemetrexed|mesh-list
44111118|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111119|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111120|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111121|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44111122|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111123|NCT00087113|Pemetrexed|pemetrexed|mesh-list
44111124|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111125|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111126|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111127|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44111128|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111129|NCT00087165|Prednisone|prednisone|mesh-list
44111130|NCT00087165|Docetaxel|docetaxel|mesh-list
44111131|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111132|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111133|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111134|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111135|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111136|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111137|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
44111138|NCT00087165|Hormones|hormones|mesh-ancestor
44111139|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111140|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111141|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111142|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
44111143|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44111144|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111145|NCT00087217|Paclitaxel|paclitaxel|mesh-list
44111146|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111147|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111148|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111149|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111150|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111151|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111152|NCT00087256|Celecoxib|celecoxib|mesh-list
44111153|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44111154|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44111155|NCT00087256|Analgesics|analgesics|mesh-ancestor
44111156|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
44111157|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111158|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111159|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111160|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111161|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44111162|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44111163|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111164|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111165|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44111166|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286563|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44286564|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286565|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44286566|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286567|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286568|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44286569|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286570|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
44286571|NCT03205137|Diuretics|diuretics|mesh-ancestor
44286572|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
44286573|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44111167|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111168|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111169|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111170|NCT00087282|Irinotecan|irinotecan|mesh-list
44111171|NCT00087282|Alvocidib|alvocidib|mesh-list
44111173|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44111174|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111175|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111176|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111177|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
44111178|NCT00087282|Growth Substances|growth substances|mesh-ancestor
44111179|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111180|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111181|NCT00087295|Romidepsin|romidepsin|mesh-list
44111182|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111183|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111184|NCT00087334|Capecitabine|capecitabine|mesh-list
44111185|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
44111186|NCT00087334|Gefitinib|gefitinib|mesh-list
44111187|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111188|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
44111189|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111190|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111191|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111192|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111193|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44111194|NCT00087347|Hematinics|hematinics|mesh-ancestor
44111195|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44111196|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44111197|NCT00087373|Metronidazole|metronidazole|mesh-list
44111198|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111199|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111200|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44111201|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44111202|NCT00087399|Gabapentin|gabapentin|mesh-list
44111203|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
44111204|NCT00087399|Analgesics|analgesics|mesh-ancestor
44111205|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
44111206|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111207|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111208|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
44111209|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44111210|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111211|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111212|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111213|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44111214|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44111215|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111216|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111217|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
44111218|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44286574|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44286575|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44286577|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286578|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286579|NCT03168256|Analgesics|analgesics|mesh-ancestor
44286580|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
44286581|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286582|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286583|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286584|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286585|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44286586|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44286587|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286588|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286589|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
44286590|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286591|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111219|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111220|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111221|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111222|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111223|NCT00087425|Rituximab|rituximab|mesh-list
44111224|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
44111225|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111226|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111227|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
44111228|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111229|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111230|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111231|NCT00087451|Sirolimus|sirolimus|mesh-list
44111232|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111233|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111234|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111235|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111236|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
44111237|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111238|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
44111239|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111240|NCT00087464|Tenofovir|tenofovir|mesh-list
44111241|NCT00087464|Emtricitabine|emtricitabine|mesh-list
44111242|NCT00087464|Nevirapine|nevirapine|mesh-list
44111243|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
44111244|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111245|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44111246|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111258|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111259|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111260|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111261|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44111262|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44111263|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
44111264|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111265|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111266|NCT00087581|Cyclosporine|cyclosporine|mesh-list
44286592|NCT03078010|Tazobactam|tazobactam|mesh-list
44286593|NCT03078010|Piperacillin|piperacillin|mesh-list
44286594|NCT03078010|Cefepime|cefepime|mesh-list
44286595|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44286596|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44286597|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286598|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44286599|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286600|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286601|NCT02981979|Prednisone|prednisone|mesh-list
44286602|NCT02981979|Leflunomide|leflunomide|mesh-list
44286603|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286604|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
44286605|NCT02981979|Hormones|hormones|mesh-ancestor
44286606|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44286607|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286608|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44286609|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286610|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286611|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286612|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286613|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
44286614|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
44286615|NCT02915224|Chlorambucil|chlorambucil|mesh-list
44286616|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286617|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286618|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44286619|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
44286620|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286621|NCT02912572|Avelumab|avelumab|mesh-list
44286622|NCT02912572|Axitinib|axitinib|mesh-list
44286623|NCT02912572|Talazoparib|talazoparib|mesh-list
44286624|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286625|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286626|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44286631|NCT02870920|Tremelimumab|tremelimumab|mesh-list
44286632|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286633|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286634|NCT02813824|Aspirin|aspirin|mesh-list
44286635|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44286636|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286637|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286638|NCT02813824|Analgesics|analgesics|mesh-ancestor
44286639|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
44286640|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286641|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286642|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111267|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
44111268|NCT00087581|Tacrolimus|tacrolimus|mesh-list
44111269|NCT00087581|Cyclosporins|cyclosporins|mesh-list
44111270|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111271|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
44111272|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111273|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44111274|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111275|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111276|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
44111277|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111278|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111279|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111280|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111281|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111282|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44111283|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
44111284|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111285|NCT00087620|Capecitabine|capecitabine|mesh-list
44111286|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111287|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
44111288|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111289|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111290|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
44111291|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44111292|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111293|NCT00087711|Gemcitabine|gemcitabine|mesh-list
44111294|NCT00087711|Cisplatin|cisplatin|mesh-list
44111295|NCT00087711|Pemetrexed|pemetrexed|mesh-list
44111296|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111297|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111298|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
44111299|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111300|NCT00087711|Antiviral Agents|antiviral agents|mesh-ancestor
44111301|NCT00087711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111302|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111303|NCT00087711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111304|NCT00087711|Immunologic Factors|immunologic factors|mesh-ancestor
44111305|NCT00087711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111306|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44111307|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111308|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44111309|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44111317|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111318|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44111319|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111320|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111321|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111322|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111323|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286643|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286644|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44286645|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44286646|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286647|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44286648|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44286649|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286650|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
44111324|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111325|NCT00087802|Gemcitabine|gemcitabine|mesh-list
44111327|NCT00087802|Carboplatin|carboplatin|mesh-list
44111328|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
44111329|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111330|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111331|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111332|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111333|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111334|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111335|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111336|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
44111337|NCT00087802|Antiviral Agents|antiviral agents|mesh-ancestor
44111338|NCT00087802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111339|NCT00087802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111340|NCT00087802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111341|NCT00087802|Immunologic Factors|immunologic factors|mesh-ancestor
44111342|NCT00087802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111343|NCT00087815|Dexamethasone|dexamethasone|mesh-list
44111344|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111345|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
44111346|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
44111347|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111348|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111349|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111350|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
44111351|NCT00087815|Hormones|hormones|mesh-ancestor
44111352|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111353|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111354|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111355|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44111356|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111357|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111358|NCT00087854|Amonafide|amonafide|mesh-list
44111359|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111360|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
44111361|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111362|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111363|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111364|NCT00087867|Bortezomib|bortezomib|mesh-list
44111365|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111366|NCT00087880|Bupropion|bupropion|mesh-list
44111367|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44111368|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111369|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111370|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44111371|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111372|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111373|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111374|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
43638706|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
44111375|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111376|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111377|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44111378|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44111380|NCT00087945|Lamivudine|lamivudine|mesh-list
44111381|NCT00087945|Zidovudine|zidovudine|mesh-list
44111382|NCT00087945|Abacavir|abacavir|mesh-list
44111383|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
44286652|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
44286653|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286654|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286655|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286656|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111384|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44111385|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111386|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111387|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111388|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
44111389|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111390|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44111391|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44111392|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
44111393|NCT00088036|Olanzapine|olanzapine|mesh-list
44111394|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
44111395|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
44111396|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111397|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111398|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111399|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111400|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111401|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111402|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111403|NCT00088036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111404|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111405|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111406|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111407|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111408|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
44111409|NCT00088049|Olanzapine|olanzapine|mesh-list
44111411|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
44111412|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
44111413|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111414|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111415|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111416|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111417|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111418|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111419|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111420|NCT00088049|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111421|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111422|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111423|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111424|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111425|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
44111426|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111427|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
44111428|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
44111429|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44111430|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44111431|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44111432|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44111433|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44111434|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44111435|NCT00088075|Risperidone|risperidone|mesh-list
44111436|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44111437|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
44111438|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111439|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111440|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111441|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111442|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111443|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111444|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111445|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44286658|NCT02726997|Carboplatin|carboplatin|mesh-list
44286659|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44286660|NCT02726997|Durvalumab|durvalumab|mesh-list
44286661|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
44286662|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44286663|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
44286664|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44286665|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286666|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44286667|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286668|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
43711130|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
44111446|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
44111447|NCT00088088|Paclitaxel|paclitaxel|mesh-list
44111448|NCT00088088|Carboplatin|carboplatin|mesh-list
44111449|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111452|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111453|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111454|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111455|NCT00088114|Paclitaxel|paclitaxel|mesh-list
44111456|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111457|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111458|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111459|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111460|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111461|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111462|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
44111463|NCT00088231|Vatalanib|vatalanib|mesh-list
44111464|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111465|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111466|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111467|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111468|NCT00088270|Leucovorin|leucovorin|mesh-list
44111469|NCT00088270|Fluorouracil|fluorouracil|mesh-list
44111470|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
44111471|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111472|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111473|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111474|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111475|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
44111476|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111478|NCT00088270|Protective Agents|protective agents|mesh-ancestor
44111479|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
44111480|NCT00088270|Vitamins|vitamins|mesh-ancestor
44111481|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
44111482|NCT00088387|Valproic Acid|valproic acid|mesh-list
44111483|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111484|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111485|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111487|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111488|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111489|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111490|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
44111491|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
44111492|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111493|NCT00088478|Olanzapine|olanzapine|mesh-list
44111494|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
44111495|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
44111496|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111497|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111498|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111499|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111500|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111501|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286669|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286670|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286671|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
44286672|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286673|NCT02677545|Aspirin|aspirin|mesh-list
44286674|NCT02677545|Clopidogrel|clopidogrel|mesh-list
44286675|NCT02677545|Ticagrelor|ticagrelor|mesh-list
44286676|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286677|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286678|NCT02677545|Analgesics|analgesics|mesh-ancestor
44286679|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
44286680|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286681|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286682|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286683|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286684|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44286685|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44111502|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111503|NCT00088478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111504|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111505|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111506|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111507|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111508|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
44111509|NCT00088491|Olanzapine|olanzapine|mesh-list
44111510|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
44111511|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
44111512|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111513|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111514|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111515|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111516|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111517|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111518|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111519|NCT00088491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111520|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111521|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111522|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111523|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111524|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
44111525|NCT00088504|Interferons|interferons|mesh-list
44111527|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
44111528|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
44111529|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44111530|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111531|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
44111532|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111533|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
44111534|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111535|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
44111536|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111537|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
44111538|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44111539|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
44111540|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111541|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111542|NCT00088556|Paclitaxel|paclitaxel|mesh-list
44286686|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286687|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44286688|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44286689|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286691|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44286692|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44286693|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44286694|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
44286695|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286696|NCT02476279|Indomethacin|indomethacin|mesh-list
44286697|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44286698|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44286699|NCT02476279|Analgesics|analgesics|mesh-ancestor
44286700|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
44286701|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286702|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286703|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286704|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286705|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
44111543|NCT00088556|Carboplatin|carboplatin|mesh-list
44111544|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44111545|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111546|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111547|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111548|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111549|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111550|NCT00088582|Octreotide|octreotide|mesh-list
44111551|NCT00088582|Pasireotide|pasireotide|mesh-list
44111552|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111553|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111554|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111556|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111557|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111558|NCT00088608|Pasireotide|pasireotide|mesh-list
44111559|NCT00088608|Hormones|hormones|mesh-ancestor
44111560|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111561|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111563|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
44111564|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111565|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
44111566|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111567|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111568|NCT00088816|Cisplatin|cisplatin|mesh-list
44111569|NCT00088816|Tegafur|tegafur|mesh-list
44111570|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111571|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111572|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
44111573|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111574|NCT00088855|Doxorubicin|doxorubicin|mesh-list
44111575|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44111576|NCT00088855|Bortezomib|bortezomib|mesh-list
44111577|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111578|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286707|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44286708|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44286709|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286710|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286711|NCT02471833|Telmisartan|telmisartan|mesh-list
44286712|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286713|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44286714|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44286715|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286716|NCT02369458|Mitomycins|mitomycins|mesh-list
44286717|NCT02369458|Mitomycin|mitomycin|mesh-list
44286718|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44286719|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286720|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
44286721|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286722|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44286723|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286724|NCT02312245|Gemcitabine|gemcitabine|mesh-list
44286725|NCT02312245|Paclitaxel|paclitaxel|mesh-list
44286726|NCT02312245|Bevacizumab|bevacizumab|mesh-list
44286727|NCT02312245|Doxorubicin|doxorubicin|mesh-list
44286728|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44286729|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44286730|NCT02312245|Topotecan|topotecan|mesh-list
44111579|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44111580|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44111581|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111582|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111583|NCT00088894|Gemcitabine|gemcitabine|mesh-list
44111584|NCT00088894|Bevacizumab|bevacizumab|mesh-list
44111585|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44111586|NCT00088894|Antibodies|antibodies|mesh-list
44111587|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
44111588|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44111589|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111590|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44111591|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44111592|NCT00088894|Growth Substances|growth substances|mesh-ancestor
44111593|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111594|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44111595|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
44111596|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111597|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
44111598|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111599|NCT00088894|Antiviral Agents|antiviral agents|mesh-ancestor
44111600|NCT00088894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111601|NCT00088894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638943|NCT03678025|Bicalutamide|bicalutamide|mesh-list
44111603|NCT00088933|Metronidazole|metronidazole|mesh-list
44286731|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44286732|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
44286733|NCT02312245|Antibodies|antibodies|mesh-list
44286734|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
44286735|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44286736|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
44286737|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44286738|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711193|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
44111604|NCT00088933|Docetaxel|docetaxel|mesh-list
44111605|NCT00088933|Vaccines|vaccines|mesh-list
44111606|NCT00088933|Sargramostim|sargramostim|mesh-list
44111607|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
44111608|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111609|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111610|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111611|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111612|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111613|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111614|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111615|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111616|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44111617|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44111618|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44111619|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111620|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111621|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111622|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642946|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43642947|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43642948|NCT05235256|Dexamethasone|dexamethasone|mesh-list
43642949|NCT05235256|Lidocaine|lidocaine|mesh-list
43642950|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642951|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
43642952|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
43642953|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642954|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642955|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642956|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
44111623|NCT00088959|Celecoxib|celecoxib|mesh-list
44111624|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44111625|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111626|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111627|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111628|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111629|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44111630|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44111632|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
44111633|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111634|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111635|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111636|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111637|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44111638|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44111639|NCT00088998|Bevacizumab|bevacizumab|mesh-list
44111640|NCT00088998|Docetaxel|docetaxel|mesh-list
44111641|NCT00088998|Capecitabine|capecitabine|mesh-list
44111642|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111643|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111644|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44111645|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44111646|NCT00088998|Growth Substances|growth substances|mesh-ancestor
44111647|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111648|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44111649|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111650|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111651|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
44286739|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
44286740|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286741|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
44286742|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286743|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44286744|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44286745|NCT02312245|Growth Substances|growth substances|mesh-ancestor
44286746|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286747|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
44286748|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
44111652|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111653|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111654|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
44111656|NCT00089037|Methotrexate|methotrexate|mesh-list
44111657|NCT00089037|Tacrolimus|tacrolimus|mesh-list
44111658|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44111659|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
44111660|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44111661|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111662|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111663|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
44111664|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111665|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639018|NCT03635983|Nivolumab|nivolumab|mesh-list
44111666|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111667|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111668|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44111669|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111670|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
44111671|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111672|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111673|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44111674|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111675|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111676|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44111677|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
44111678|NCT00089050|Cyclosporine|cyclosporine|mesh-list
44111680|NCT00089050|Cyclosporins|cyclosporins|mesh-list
44111681|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111682|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111683|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111684|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
44111685|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111686|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
44111687|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111688|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111689|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643029|NCT05219799|Propranolol|propranolol|mesh-list
43643030|NCT05219799|Nitroprusside|nitroprusside|mesh-list
43643031|NCT05219799|Isoproterenol|isoproterenol|mesh-list
43643032|NCT05219799|Norepinephrine|norepinephrine|mesh-list
43643033|NCT05219799|Acetylcholine|acetylcholine|mesh-list
43643034|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43643035|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43643036|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643037|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643038|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111691|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111692|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111693|NCT00089063|Sargramostim|sargramostim|mesh-list
44111694|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44111695|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
44111696|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
44111697|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286749|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44286750|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
44286751|NCT02312245|Antiviral Agents|antiviral agents|mesh-ancestor
44286752|NCT02312245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286753|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286754|NCT02312245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43550102|NCT03625739|Streptomycin|streptomycin|mesh-list
44111698|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111699|NCT00089089|Decitabine|decitabine|mesh-list
44111700|NCT00089089|Azacitidine|azacitidine|mesh-list
44111701|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111702|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
44111703|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111704|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111705|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153816|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
44153817|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153818|NCT00221637|Valproic Acid|valproic acid|mesh-list
44153819|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
44153820|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153821|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153822|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
44153823|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153824|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153825|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
44153826|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153827|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153828|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153829|NCT00221650|Ribavirin|ribavirin|mesh-list
44153830|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44153831|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
44153832|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153833|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
44153834|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153835|NCT00221689|Baclofen|baclofen|mesh-list
44153836|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44153837|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153838|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44153839|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153840|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44153841|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
44153842|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
44153843|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153850|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44153851|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
44153852|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153853|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44153854|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44153855|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153856|NCT00221845|Telmisartan|telmisartan|mesh-list
44153857|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153858|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44153859|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44153860|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153861|NCT00221871|Ketamine|ketamine|mesh-list
44153862|NCT00221871|Analgesics|analgesics|mesh-ancestor
44153863|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
44153864|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153865|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153866|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44153867|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44153868|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
44153869|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
44153870|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153871|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44153872|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44111706|NCT00089115|Rituximab|rituximab|mesh-list
44111707|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
44111708|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44286755|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44286756|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44286757|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44286758|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44286759|NCT02303028|Topotecan|topotecan|mesh-list
44286760|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44286761|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44286762|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286763|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286764|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286766|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
44286767|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286768|NCT01737502|Sirolimus|sirolimus|mesh-list
44286769|NCT01737502|Auranofin|auranofin|mesh-list
44286770|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44286771|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286772|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44286773|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286774|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
44286775|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286776|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
44286777|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286778|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464238|NCT01498445|Decitabine|decitabine|mesh-list
44464239|NCT01498445|Dasatinib|dasatinib|mesh-list
44464240|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44464241|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
44464242|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111709|NCT00089115|Antibodies|antibodies|mesh-list
44111710|NCT00089115|Sargramostim|sargramostim|mesh-list
44111711|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44111712|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111713|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111714|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
44111715|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111716|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111717|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44111718|NCT00089154|Antibodies|antibodies|mesh-list
44111719|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
44111720|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44111721|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
44111722|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111723|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111724|NCT00089167|Thalidomide|thalidomide|mesh-list
44111725|NCT00089167|Dexamethasone|dexamethasone|mesh-list
44111726|NCT00089167|Melphalan|melphalan|mesh-list
44111727|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111728|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
44111729|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
44464243|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464244|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464245|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464246|NCT01498289|Leucovorin|leucovorin|mesh-list
44464247|NCT01498289|Docetaxel|docetaxel|mesh-list
44464248|NCT01498289|Fluorouracil|fluorouracil|mesh-list
44464249|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
44464250|NCT01498289|Irinotecan|irinotecan|mesh-list
44464251|NCT01498289|Calcium|calcium|mesh-list
44464252|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
44464253|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464254|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
44464255|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
44464256|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
44464257|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464258|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44464259|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464260|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
44464261|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44464262|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111730|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111731|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111732|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111733|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
44111734|NCT00089167|Hormones|hormones|mesh-ancestor
44111735|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111736|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111737|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111738|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
44111739|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111740|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
44111741|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111742|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44111743|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111744|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
44111745|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111752|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
44111753|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
44111754|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111755|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111757|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
44111758|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
44111759|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111760|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111761|NCT00089219|Sargramostim|sargramostim|mesh-list
44111762|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
44111763|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
44111764|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111765|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44111766|NCT00089258|Isotretinoin|isotretinoin|mesh-list
44111767|NCT00089258|Antibodies|antibodies|mesh-list
44111768|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44111769|NCT00089258|Sargramostim|sargramostim|mesh-list
44111770|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
44111771|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111772|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111773|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44464264|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44464265|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44464266|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464267|NCT01498289|Antidotes|antidotes|mesh-ancestor
44464268|NCT01498289|Protective Agents|protective agents|mesh-ancestor
44464269|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
44464270|NCT01498289|Vitamins|vitamins|mesh-ancestor
44464271|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
44464272|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
44464273|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44464274|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464275|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44464276|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111774|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
44111775|NCT00089349|Methotrexate|methotrexate|mesh-list
44111776|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
44111777|NCT00089349|Antibodies|antibodies|mesh-list
44111778|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
44111779|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44111780|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
44111781|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111782|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111783|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44111784|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
44111785|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44111786|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111787|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
44111788|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111789|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111790|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111791|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44111792|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111793|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111794|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44111795|NCT00089401|Melphalan|melphalan|mesh-list
44111796|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111797|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
44111798|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111799|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111800|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44111801|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111802|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
44111803|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111804|NCT00089427|Temozolomide|temozolomide|mesh-list
44111805|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111806|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
44111807|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111808|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111809|NCT00089440|Aripiprazole|aripiprazole|mesh-list
44111810|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111811|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111812|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111813|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111814|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111815|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111819|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111820|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44111821|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44111822|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
44464278|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
44464279|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
44464280|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464281|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464282|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464283|NCT01498068|Interferons|interferons|mesh-list
44464284|NCT01498068|Ribavirin|ribavirin|mesh-list
44464285|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
44464286|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
44464287|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44464288|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464289|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
44464290|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464291|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
44464292|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464293|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
44464294|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941580|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44464295|NCT01497938|Insulin|insulin|mesh-list
44464296|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44111823|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44111824|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44111825|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44111826|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44111827|NCT00089453|Dexamethasone|dexamethasone|mesh-list
44111828|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
44111829|NCT00089453|Melphalan|melphalan|mesh-list
44111830|NCT00089453|Fludarabine|fludarabine|mesh-list
44111831|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111832|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
44111833|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111834|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111835|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111836|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
44111837|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111838|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111839|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44111840|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111841|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
44111842|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
44111843|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111844|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111845|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
44111846|NCT00089453|Hormones|hormones|mesh-ancestor
44111847|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111848|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111849|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
44111850|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44111851|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44111852|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111853|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44111854|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44111855|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
44111856|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643232|NCT05163405|Bortezomib|bortezomib|mesh-list
44464297|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286779|NCT00485693|Epinephrine|epinephrine|mesh-list
44286780|NCT00485693|Bupivacaine|bupivacaine|mesh-list
44286781|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
44286782|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
44111858|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44111859|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44111860|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44111861|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111862|NCT00089557|Capsaicin|capsaicin|mesh-list
44111863|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
44111864|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44111865|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
44111866|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111867|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111868|NCT00089570|Terlipressin|terlipressin|mesh-list
44111869|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44111870|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44111871|NCT00089622|Levodopa|levodopa|mesh-list
44111872|NCT00089622|Lisuride|lisuride|mesh-list
44111873|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44111874|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44111875|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
44111876|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111877|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111878|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111879|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44111880|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
44111881|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
44111882|NCT00089687|Vanoxerine|vanoxerine|mesh-list
44111883|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44111884|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111885|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111886|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111887|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
44111891|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44111892|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44111893|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
44111894|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111895|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
44111896|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111897|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
44111898|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111899|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44111900|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44111901|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
44111902|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111903|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111904|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44111905|NCT00089765|Ranibizumab|ranibizumab|mesh-list
44111906|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44111907|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44111908|NCT00089765|Growth Substances|growth substances|mesh-ancestor
44111909|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111910|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
44111911|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111912|NCT00089804|Abetimus|abetimus|mesh-list
44111913|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111914|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
44111915|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111916|NCT00089830|Squalamine|squalamine|mesh-list
44111917|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44111918|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111919|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44111920|NCT00089830|Protective Agents|protective agents|mesh-ancestor
44111921|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111922|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111923|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44111924|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44111925|NCT00089830|Growth Substances|growth substances|mesh-ancestor
44111926|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44286783|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286784|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286785|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
44286786|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286787|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44286788|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44286789|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286790|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286791|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286792|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44286793|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44286794|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
44286795|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44286796|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44286797|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
44286798|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
44286799|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44286800|NCT00758407|Methylphenidate|methylphenidate|mesh-list
44286801|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44286802|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111927|NCT00089856|Prednisone|prednisone|mesh-list
44111928|NCT00089856|Docetaxel|docetaxel|mesh-list
44111929|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44111930|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
44111931|NCT00089856|Hormones|hormones|mesh-ancestor
43643308|NCT05099471|Dexamethasone|dexamethasone|mesh-list
44111932|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44111933|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111934|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44111935|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111936|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111937|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
44111938|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
44111939|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111940|NCT00089869|Olanzapine|olanzapine|mesh-list
44111941|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44111942|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
44111943|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
44111944|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111945|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111946|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111947|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111948|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111949|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111950|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111951|NCT00089869|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111952|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111953|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111954|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111955|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111956|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
44111957|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44111958|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286803|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44286804|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286805|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286806|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286807|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
44286808|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286810|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
44286811|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
44286812|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
44286813|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286814|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286815|NCT00758693|Rituximab|rituximab|mesh-list
44286816|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44286817|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44286818|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111959|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
44111967|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111968|NCT00090012|Olanzapine|olanzapine|mesh-list
44111969|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44111970|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
44111971|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
44111972|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44111973|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111974|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44111975|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111976|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111977|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44111978|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44111979|NCT00090012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44111980|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111981|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111982|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111983|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111984|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
44111985|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111986|NCT00090025|Leucovorin|leucovorin|mesh-list
44111987|NCT00090025|Fluorouracil|fluorouracil|mesh-list
44111988|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
44111989|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111990|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44111991|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111992|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111993|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
44111994|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111995|NCT00090025|Antidotes|antidotes|mesh-ancestor
44111996|NCT00090025|Protective Agents|protective agents|mesh-ancestor
44111997|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
44111998|NCT00090025|Vitamins|vitamins|mesh-ancestor
44111999|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
44112000|NCT00090038|Rituximab|rituximab|mesh-list
44112001|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112002|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112003|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
44112004|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112005|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112006|NCT00090090|Elsamicin A|elsamicin a|mesh-list
43643366|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
44286819|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
44286820|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286821|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44286822|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44286823|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
44286824|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286825|NCT00758732|Carboplatin|carboplatin|mesh-list
44286826|NCT00758732|Docetaxel|docetaxel|mesh-list
44286827|NCT00758732|Doxorubicin|doxorubicin|mesh-list
44286828|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44286829|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286830|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
44286831|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
44286832|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
44286833|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286834|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44286835|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44286836|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44286837|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286838|NCT00758914|Vitamin E|vitamin e|mesh-list
44112007|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112008|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112009|NCT00090155|Ondansetron|ondansetron|mesh-list
44112011|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
44112012|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
44112013|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112014|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112015|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112016|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
44112017|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112018|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44112019|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
44112020|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112021|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112022|NCT00090155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112023|NCT00090155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112024|NCT00090155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112025|NCT00090155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112026|NCT00090155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44112027|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43639478|NCT03244020|Analgesics|analgesics|mesh-ancestor
44112035|NCT00090207|Ondansetron|ondansetron|mesh-list
44112036|NCT00090207|Aprepitant|aprepitant|mesh-list
44112037|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
44112038|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
44112039|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112040|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112041|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112042|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
44112043|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112044|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44112045|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
44112046|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112047|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112048|NCT00090207|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112049|NCT00090207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44286839|NCT00758914|Vitamins|vitamins|mesh-ancestor
44286840|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
44286841|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286842|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
44286843|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286844|NCT00758914|Protective Agents|protective agents|mesh-ancestor
44286845|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
44286846|NCT00759005|Propranolol|propranolol|mesh-list
44286847|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44286848|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44286849|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286850|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286851|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711320|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
44112050|NCT00090207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112051|NCT00090207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112052|NCT00090207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44112053|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44112054|NCT00090246|Ondansetron|ondansetron|mesh-list
44112055|NCT00090246|Aprepitant|aprepitant|mesh-list
44112056|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
44112057|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
44112058|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112059|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112060|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112061|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
44112062|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112063|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44112064|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
44112065|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112066|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112067|NCT00090246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112068|NCT00090246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112069|NCT00090246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112070|NCT00090246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112071|NCT00090246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44112072|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44112073|NCT00090272|Ertapenem|ertapenem|mesh-list
44112074|NCT00090272|Cefotetan|cefotetan|mesh-list
44112075|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112076|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112077|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44112078|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
44112079|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112080|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112081|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112082|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112083|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112084|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44112085|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
44112086|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112087|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112088|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112089|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112090|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112091|NCT00090428|Caseins|caseins|mesh-list
44112092|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
44112093|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
44112094|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112095|NCT00090480|Vaccines|vaccines|mesh-list
44112096|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
44112097|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286852|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286853|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286854|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286855|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
44286856|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286857|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
44286858|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44286859|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
44286860|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286861|NCT00759070|Ritonavir|ritonavir|mesh-list
44286862|NCT00759070|Lopinavir|lopinavir|mesh-list
44286863|NCT00759070|Tenofovir|tenofovir|mesh-list
44286864|NCT00759070|Emtricitabine|emtricitabine|mesh-list
44286865|NCT00759070|Efavirenz|efavirenz|mesh-list
44286866|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44286867|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44286868|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44112098|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
44112100|NCT00090623|Ranibizumab|ranibizumab|mesh-list
44112101|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44112102|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44112103|NCT00090623|Growth Substances|growth substances|mesh-ancestor
44112104|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112105|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
44112106|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112108|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112109|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112110|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112111|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112112|NCT00090727|AQ4N|aq4n|mesh-list
44112113|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112114|NCT00090896|Ipilimumab|ipilimumab|mesh-list
44112115|NCT00090896|Antibodies|antibodies|mesh-list
44112116|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44112117|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
44112118|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112119|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112120|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112121|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44112122|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112123|NCT00090909|Gemcitabine|gemcitabine|mesh-list
44112124|NCT00090909|Dexamethasone|dexamethasone|mesh-list
44112125|NCT00090909|Cisplatin|cisplatin|mesh-list
44112126|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112127|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
44112128|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
44112129|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112130|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112131|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112132|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
44112133|NCT00090909|Hormones|hormones|mesh-ancestor
44112134|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44112135|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44112136|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112137|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112138|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
44112139|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112140|NCT00090909|Antiviral Agents|antiviral agents|mesh-ancestor
44112141|NCT00090909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112142|NCT00090909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112143|NCT00090909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286869|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286870|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286871|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44286872|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44286873|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
44286874|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286875|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44286876|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44286877|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44286878|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44286879|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44286880|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44286881|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43711346|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
44112144|NCT00090909|Immunologic Factors|immunologic factors|mesh-ancestor
44112145|NCT00091039|Metronidazole|metronidazole|mesh-list
44112146|NCT00091039|Paclitaxel|paclitaxel|mesh-list
44112147|NCT00091039|Carboplatin|carboplatin|mesh-list
44112148|NCT00091039|Vaccines|vaccines|mesh-list
44112149|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
44112150|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112151|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44112152|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112153|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
44112154|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
44112155|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
44112156|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112157|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112158|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112159|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43643520|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
44112160|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44112162|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
44112163|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112164|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
44112165|NCT00091078|Oblimersen|oblimersen|mesh-list
44112166|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112167|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112168|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112169|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112170|NCT00091104|Aldesleukin|aldesleukin|mesh-list
44112171|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
44112172|NCT00091104|Fludarabine|fludarabine|mesh-list
44112173|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
44112174|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
44112178|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112179|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112180|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
44112181|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112182|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112183|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44112184|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112185|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
44112186|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44112187|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44112188|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44112189|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
44112190|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112192|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112193|NCT00091130|Vaccines|vaccines|mesh-list
44286882|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44286883|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44286884|NCT00759083|Bivalirudin|bivalirudin|mesh-list
44286885|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
44286886|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44286887|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
44286888|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286889|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286890|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
44286891|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44286892|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44286893|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286894|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286895|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286896|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286897|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286898|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44286899|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
44112194|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
44112195|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112196|NCT00091143|Fludarabine|fludarabine|mesh-list
44112197|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
44112198|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
44112199|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44112200|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112201|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112202|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
44112203|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112204|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112205|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
44112206|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112207|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44112208|NCT00091156|Gefitinib|gefitinib|mesh-list
44112209|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112210|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112211|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112212|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112213|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
44112214|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112215|NCT00091195|Romidepsin|romidepsin|mesh-list
44112216|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112217|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112218|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
44112219|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112220|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112221|NCT00091247|Tetracycline|tetracycline|mesh-list
44112222|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112223|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112224|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44112225|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112226|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112227|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44112228|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44286900|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44286901|NCT00759200|Interferons|interferons|mesh-list
44286902|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
44286903|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
44286904|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286905|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
44286906|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286907|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
44286908|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286910|NCT00759226|Folic Acid|folic acid|mesh-list
44286911|NCT00759226|Gemcitabine|gemcitabine|mesh-list
44286912|NCT00759226|Cisplatin|cisplatin|mesh-list
44112229|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
44112230|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112231|NCT00091299|Warfarin|warfarin|mesh-list
44112232|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
44112233|NCT00091312|Leucovorin|leucovorin|mesh-list
44112234|NCT00091312|Fluorouracil|fluorouracil|mesh-list
44112235|NCT00091312|Irinotecan|irinotecan|mesh-list
44112236|NCT00091312|Calcium|calcium|mesh-list
43643642|NCT04943848|Iodine|iodine|mesh-list
44112237|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
44112238|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112239|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112241|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112242|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112243|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112244|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112245|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
44112246|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44112247|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112260|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44112261|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112262|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44112263|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
44112264|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44112265|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
44112266|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112267|NCT00091377|Paclitaxel|paclitaxel|mesh-list
44112268|NCT00091377|Cisplatin|cisplatin|mesh-list
44112269|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44112270|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112271|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44112272|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44112273|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44112274|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153874|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158139|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44158140|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158141|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158142|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44158143|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158144|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158145|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158146|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
44158147|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158148|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158149|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44158150|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158151|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158435|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158436|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44158437|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44286913|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
44286914|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44286915|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44286916|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
44286917|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286918|NCT00759226|Antiviral Agents|antiviral agents|mesh-ancestor
44286919|NCT00759226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44286920|NCT00759226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286921|NCT00759226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44286922|NCT00759226|Immunologic Factors|immunologic factors|mesh-ancestor
44286923|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286924|NCT00759226|Antidotes|antidotes|mesh-ancestor
44286925|NCT00759226|Protective Agents|protective agents|mesh-ancestor
44286926|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
44286927|NCT00759226|Vitamins|vitamins|mesh-ancestor
44286928|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
44158438|NCT00236730|Topiramate|topiramate|mesh-list
44158439|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
44158440|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158441|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158442|NCT00236743|Topiramate|topiramate|mesh-list
44158443|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
44158444|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158445|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158446|NCT00236756|Topiramate|topiramate|mesh-list
44158447|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
44158448|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158449|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158450|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44158451|NCT00236769|Norelgestromin|norelgestromin|mesh-list
44158452|NCT00236769|Estradiol|estradiol|mesh-list
44158453|NCT00236769|Estrogens|estrogens|mesh-ancestor
44158454|NCT00236769|Hormones|hormones|mesh-ancestor
44158455|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158456|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643664|NCT04939935|Metformin|metformin|mesh-list
44112279|NCT00091468|Nicotine|nicotine|mesh-list
44112280|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44112281|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
44112282|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112283|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112284|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44112285|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44112286|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
44112287|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112288|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112289|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44112290|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
44112291|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112292|NCT00091559|Vorinostat|vorinostat|mesh-list
44112293|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112294|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44112295|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112296|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112297|NCT00091598|Ambrisentan|ambrisentan|mesh-list
44112298|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44112299|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
44112300|NCT00091611|Fludarabine|fludarabine|mesh-list
44112301|NCT00091611|Interleukin-2|interleukin-2|mesh-list
44112302|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112303|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
44112304|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941737|NCT00971633|Ondansetron|ondansetron|mesh-list
44286929|NCT00759226|Hematinics|hematinics|mesh-ancestor
44286930|NCT00759239|Timolol|timolol|mesh-list
44286931|NCT00759239|Travoprost|travoprost|mesh-list
44286932|NCT00759239|Maleic acid|maleic acid|mesh-list
44286933|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44286934|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44286935|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
44286936|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286937|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286938|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286939|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44286940|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286941|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44286942|NCT00759291|Acipimox|acipimox|mesh-list
44286943|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44286944|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
44286945|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286946|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44112305|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112306|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112307|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
44112308|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112309|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112310|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44112311|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112312|NCT00091611|Analgesics|analgesics|mesh-ancestor
44112313|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
44112314|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112315|NCT00091624|Lenalidomide|lenalidomide|mesh-list
44112316|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
44112317|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112318|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44112319|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44112320|NCT00091624|Growth Substances|growth substances|mesh-ancestor
44112321|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
44112322|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112323|NCT00091650|Olanzapine|olanzapine|mesh-list
44112324|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
44112325|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
44112326|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112327|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112328|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112329|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112330|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112331|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112332|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112333|NCT00091650|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44112334|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44112335|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112336|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112337|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112338|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
44112339|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44112340|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112341|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44286947|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44286948|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44286949|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286950|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286951|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286952|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286953|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286954|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44286955|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
44286956|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44286957|NCT00759421|Olanzapine|olanzapine|mesh-list
44286958|NCT00759421|Sertindole|sertindole|mesh-list
44286959|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
44286960|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
44286961|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44286962|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44286963|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44286964|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44286965|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44286966|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44286967|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44286968|NCT00759421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44286969|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44286970|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44286971|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286972|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44286973|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
44286974|NCT00759460|Olanzapine|olanzapine|mesh-list
44286991|NCT00759551|Olmesartan|olmesartan|mesh-list
44286992|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44286993|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44286994|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44286995|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44286996|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44286997|NCT00759720|Glyburide|glyburide|mesh-list
44286998|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44286999|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287000|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44287001|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
44287002|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941815|NCT00972439|Norinyl|norinyl|mesh-list
44287003|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
44287004|NCT00759824|Doxorubicin|doxorubicin|mesh-list
44287005|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44112342|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112343|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112344|NCT00091702|Vaccines|vaccines|mesh-list
44112350|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112351|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44112352|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
44112353|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
44112354|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
44112355|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44112356|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44112357|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112358|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44112359|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44112360|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44112361|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44112362|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44112363|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44112364|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112365|NCT00091741|Etanercept|etanercept|mesh-list
44112366|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112367|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112368|NCT00091741|Analgesics|analgesics|mesh-ancestor
44112369|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
44112370|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112371|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112372|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112373|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112374|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112375|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112376|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
44112377|NCT00091806|Panitumumab|panitumumab|mesh-list
44112378|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112379|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112380|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
44112381|NCT00091858|Hematinics|hematinics|mesh-ancestor
44112382|NCT00091897|Rituximab|rituximab|mesh-list
44112383|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112384|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112385|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
44112386|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112387|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287006|NCT00759824|Vindesine|vindesine|mesh-list
44287007|NCT00759824|Valproic Acid|valproic acid|mesh-list
44287008|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287009|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
44287010|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287011|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287012|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44287013|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
44287014|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287015|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287016|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44287017|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44287018|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44287019|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287020|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287021|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
44287022|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
44287023|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287024|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
44287025|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44287026|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287027|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287028|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44287029|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287030|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287031|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287032|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44287033|NCT00759928|Sorafenib|sorafenib|mesh-list
44287034|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287038|NCT00759993|Chromium|chromium|mesh-list
44287051|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44287052|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44287053|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
44287054|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44287055|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44287056|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
44287057|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287058|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
44287059|NCT00760045|Protective Agents|protective agents|mesh-ancestor
44287060|NCT00760149|Rifampin|rifampin|mesh-list
44287061|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44287062|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
44287063|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287064|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287065|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
44287066|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44287067|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287068|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287069|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44112388|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
44112389|NCT00091910|Hematinics|hematinics|mesh-ancestor
44112390|NCT00091936|Lamivudine|lamivudine|mesh-list
44112391|NCT00091936|Efavirenz|efavirenz|mesh-list
44112392|NCT00091936|Didanosine|didanosine|mesh-list
44112393|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44112394|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44112395|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112396|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112397|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
44112398|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112399|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44112400|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44112401|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44112402|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44112403|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44112404|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44112405|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44112406|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44112407|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
44112408|NCT00092001|Sunitinib|sunitinib|mesh-list
44112409|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112410|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44112411|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44112412|NCT00092001|Growth Substances|growth substances|mesh-ancestor
44112416|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643806|NCT04892069|Insulin|insulin|mesh-list
43643807|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
43643808|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43643809|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643816|NCT04891809|Dexamethasone|dexamethasone|mesh-list
43643817|NCT04891809|Lenalidomide|lenalidomide|mesh-list
43643818|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112417|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112418|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
44112419|NCT00092079|Vitamin D|vitamin d|mesh-list
44112420|NCT00092079|Alendronate|alendronate|mesh-list
44287070|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44287071|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44287072|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44287073|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44287074|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44287076|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
44287077|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287078|NCT00760279|Azithromycin|azithromycin|mesh-list
44287079|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287080|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287081|NCT00760318|Levetiracetam|levetiracetam|mesh-list
44287082|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
44287083|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
44287084|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
44287085|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44287086|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287087|NCT00760448|Insulin|insulin|mesh-list
44287088|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44287089|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
44287090|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
44287091|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
44287092|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
44287093|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287094|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412291|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112421|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112422|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112423|NCT00092079|Vitamins|vitamins|mesh-ancestor
44112424|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
44112425|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44112426|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
44112427|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
44112428|NCT00092170|Ertapenem|ertapenem|mesh-list
44112429|NCT00092170|Ticarcillin|ticarcillin|mesh-list
44112430|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44112431|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112432|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112433|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112434|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112435|NCT00092183|Ondansetron|ondansetron|mesh-list
44112436|NCT00092183|Aprepitant|aprepitant|mesh-list
44112437|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
44112438|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
44112439|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112440|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112441|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112442|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
44112443|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112444|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44112445|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
44464298|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44464299|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44464300|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44464301|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
44464302|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464303|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
44464304|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
44464305|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464306|NCT01497275|Rituximab|rituximab|mesh-list
44464307|NCT01497275|Bortezomib|bortezomib|mesh-list
44464308|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711483|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
44112446|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112447|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112448|NCT00092183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44112449|NCT00092183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44112450|NCT00092183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112451|NCT00092183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112452|NCT00092183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44112453|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44112454|NCT00092196|Aprepitant|aprepitant|mesh-list
44112455|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
44112456|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
44112457|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112458|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112459|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112460|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44112461|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112462|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112463|NCT00092274|Ofatumumab|ofatumumab|mesh-list
44112464|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112465|NCT00092287|Lanreotide|lanreotide|mesh-list
44112466|NCT00092287|Octreotide|octreotide|mesh-list
44112467|NCT00092287|Somatostatin|somatostatin|mesh-list
44112468|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112469|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112470|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44112471|NCT00092287|Hormones|hormones|mesh-ancestor
44112472|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44112473|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112474|NCT00092300|Valdecoxib|valdecoxib|mesh-list
44112475|NCT00092300|Rofecoxib|rofecoxib|mesh-list
44112476|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112477|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112478|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112479|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112482|NCT00092300|Analgesics|analgesics|mesh-ancestor
44112483|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
44112484|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112485|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112486|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112487|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112488|NCT00092313|Acetaminophen|acetaminophen|mesh-list
44112489|NCT00092313|Rofecoxib|rofecoxib|mesh-list
44112490|NCT00092313|Oxycodone|oxycodone|mesh-list
44112491|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112492|NCT00092313|Analgesics|analgesics|mesh-ancestor
44112493|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
44112494|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112495|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112496|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
44112497|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44112498|NCT00092313|Narcotics|narcotics|mesh-ancestor
44112499|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464309|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464310|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
44464311|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464312|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464313|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44464314|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44464315|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464316|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464317|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
44464318|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464319|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44464320|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464321|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112500|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112501|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112502|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112503|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112504|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112505|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112506|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112507|NCT00092326|Acetaminophen|acetaminophen|mesh-list
44112508|NCT00092326|Rofecoxib|rofecoxib|mesh-list
44112509|NCT00092326|Oxycodone|oxycodone|mesh-list
44112510|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112511|NCT00092326|Analgesics|analgesics|mesh-ancestor
44112512|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
44112513|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112514|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112515|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
44112516|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44112517|NCT00092326|Narcotics|narcotics|mesh-ancestor
44112518|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44112519|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112520|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112521|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112522|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112523|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112524|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112525|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112526|NCT00092339|Valdecoxib|valdecoxib|mesh-list
44112527|NCT00092339|Rofecoxib|rofecoxib|mesh-list
44112528|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112529|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112530|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112531|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112532|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112533|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112534|NCT00092339|Analgesics|analgesics|mesh-ancestor
44112535|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
44112536|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112537|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112538|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112539|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112540|NCT00092352|Celecoxib|celecoxib|mesh-list
44112541|NCT00092352|Rofecoxib|rofecoxib|mesh-list
44112542|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112543|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112544|NCT00092352|Analgesics|analgesics|mesh-ancestor
44112545|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
44112546|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464322|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
44464323|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44464324|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44464325|NCT01496976|Prednisolone|prednisolone|mesh-list
44464326|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
44464327|NCT01496976|Lenalidomide|lenalidomide|mesh-list
44464329|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44464330|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
44464331|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
44464332|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464333|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44464334|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44464335|NCT01496976|Growth Substances|growth substances|mesh-ancestor
44464336|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
44464337|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464338|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464339|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
44464340|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
44464341|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464342|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464343|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
44464344|NCT01496976|Hormones|hormones|mesh-ancestor
44412292|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44112547|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112548|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112549|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112550|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112551|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112552|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112565|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112566|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112567|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112569|NCT00092378|Rofecoxib|rofecoxib|mesh-list
44112570|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112571|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112572|NCT00092378|Analgesics|analgesics|mesh-ancestor
44112573|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
44112574|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112575|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112576|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112577|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112578|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112579|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112580|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112581|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112582|NCT00092391|Vaccines|vaccines|mesh-list
44112583|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
44112584|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112585|NCT00092404|Vaccines|vaccines|mesh-list
44112586|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
44112587|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112588|NCT00092508|Mesalamine|mesalamine|mesh-list
44464345|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464346|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44464347|NCT01496976|Protective Agents|protective agents|mesh-ancestor
44464348|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464349|NCT01496846|Lidocaine|lidocaine|mesh-list
44464350|NCT01496846|Carticaine|carticaine|mesh-list
44464351|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
44464352|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
44464353|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464354|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464355|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
43941888|NCT00974051|Insulin|insulin|mesh-list
44464356|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287095|NCT00760695|Dronabinol|dronabinol|mesh-list
44287096|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
44287097|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287098|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287099|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287100|NCT00760695|Analgesics|analgesics|mesh-ancestor
44287101|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
44287102|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287103|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44287104|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44287105|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287106|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287107|NCT00760695|Hormones|hormones|mesh-ancestor
44287108|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287109|NCT00760864|Methotrexate|methotrexate|mesh-list
44287110|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44287111|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
44287112|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44287113|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287114|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287115|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
44287120|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44287121|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287122|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
44287123|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287124|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44287125|NCT00760916|Treprostinil|treprostinil|mesh-list
44287126|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44287127|NCT00760968|Methotrexate|methotrexate|mesh-list
44287128|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44287129|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
44287130|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44287131|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287132|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287133|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
44287134|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287135|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287136|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287137|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287138|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44287139|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287140|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
44287141|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287142|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44287143|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
44287144|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287145|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44287146|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287147|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287148|NCT00761020|Mefloquine|mefloquine|mesh-list
44287149|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
44287150|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44287154|NCT00761228|Emetics|emetics|mesh-ancestor
44287163|NCT00761241|Gemcitabine|gemcitabine|mesh-list
44287164|NCT00761241|Interferons|interferons|mesh-list
44287165|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
44287166|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44287167|NCT00761241|Docetaxel|docetaxel|mesh-list
44287168|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
44287169|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941972|NCT00975637|Brodalumab|brodalumab|mesh-list
44287170|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
44287171|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287172|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287173|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
44287174|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287175|NCT00761241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287176|NCT00761241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287177|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
44287178|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287179|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287180|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287181|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287182|NCT00761254|Domperidone|domperidone|mesh-list
44287183|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
44112589|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112590|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112591|NCT00092508|Analgesics|analgesics|mesh-ancestor
44112592|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
44112593|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112594|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112595|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112596|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112597|NCT00092846|Lovastatin|lovastatin|mesh-list
44112598|NCT00092846|L 647318|l 647318|mesh-list
44112599|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
44112600|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44112601|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44112602|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
44112603|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112604|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44112605|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44112606|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112607|NCT00092924|Mapatumumab|mapatumumab|mesh-list
44112608|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112609|NCT00092937|Busulfan|busulfan|mesh-list
44112610|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
44112611|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112612|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112613|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
44112614|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112618|NCT00092976|Factor VIII|factor viii|mesh-list
44112619|NCT00092976|Coagulants|coagulants|mesh-ancestor
44112620|NCT00093002|Fulvestrant|fulvestrant|mesh-list
44112621|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44112622|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112623|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44112624|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44112625|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701835|NCT02722369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287185|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287186|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287187|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287188|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44287189|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
44287190|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287191|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287192|NCT00761332|Teriparatide|teriparatide|mesh-list
44287193|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44287194|NCT00761332|Diphosphonates|diphosphonates|mesh-list
44287195|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44287196|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287197|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44287198|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44287199|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
44412320|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44112626|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44112627|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112628|NCT00093028|Bortezomib|bortezomib|mesh-list
44112629|NCT00093028|Lenalidomide|lenalidomide|mesh-list
44112630|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112631|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
44112632|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112633|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44112634|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44112635|NCT00093028|Growth Substances|growth substances|mesh-ancestor
44112636|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
44112637|NCT00093067|Daptomycin|daptomycin|mesh-list
44112639|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112640|NCT00093093|Interferons|interferons|mesh-list
44112641|NCT00093093|Ribavirin|ribavirin|mesh-list
44112642|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
44112643|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
44112644|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44112645|NCT00093093|Taribavirin|taribavirin|mesh-list
44112646|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112647|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
44112648|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112649|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
44112650|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112651|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
44112652|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112653|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44112654|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112655|NCT00093158|Anticoagulants|anticoagulants|mesh-list
44112656|NCT00093158|Bivalirudin|bivalirudin|mesh-list
44112657|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
44112658|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44112659|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
44112660|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112661|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112662|NCT00093184|Anticoagulants|anticoagulants|mesh-list
44112663|NCT00093184|Bivalirudin|bivalirudin|mesh-list
44112664|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
44112665|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44112666|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
44112667|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646209|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646210|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287200|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287201|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44287202|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44287203|NCT00761358|Z 338|z 338|mesh-list
44287204|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44287205|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287206|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287207|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
44287208|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287209|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287210|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287211|NCT00761449|Lenalidomide|lenalidomide|mesh-list
44287212|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
44287213|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287214|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44287215|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44287216|NCT00761449|Growth Substances|growth substances|mesh-ancestor
44287217|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44112668|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112669|NCT00093223|Paclitaxel|paclitaxel|mesh-list
44112670|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44112671|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44112672|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112673|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44112674|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44112675|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44112676|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112677|NCT00093249|Clevidipine|clevidipine|mesh-list
44112678|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44112679|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112680|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112681|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112682|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112683|NCT00093262|Clevidipine|clevidipine|mesh-list
44112684|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44112685|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112686|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112687|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112693|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44112694|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44112695|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112696|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112697|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
44112698|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112699|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112700|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44112701|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44112702|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112703|NCT00093301|Simendan|simendan|mesh-list
44112704|NCT00093301|Dobutamine|dobutamine|mesh-list
44112705|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44112706|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
44287218|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287219|NCT00761501|Naproxen|naproxen|mesh-list
44287220|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287221|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287222|NCT00761501|Analgesics|analgesics|mesh-ancestor
44287223|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
44287224|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287225|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287226|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287227|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287228|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
44287229|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44287230|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287231|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287232|NCT00761540|Liraglutide|liraglutide|mesh-list
44287233|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287234|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287235|NCT00761540|Incretins|incretins|mesh-ancestor
44287236|NCT00761540|Hormones|hormones|mesh-ancestor
44287237|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287238|NCT00761644|Sirolimus|sirolimus|mesh-list
44112707|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44112708|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44112709|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112710|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112712|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112713|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
44112714|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
44112715|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112716|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44112717|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44112718|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44112719|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
44112720|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112721|NCT00093314|Ofatumumab|ofatumumab|mesh-list
44112722|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112723|NCT00093353|Cefixime|cefixime|mesh-list
44112724|NCT00093353|Irinotecan|irinotecan|mesh-list
44112725|NCT00093353|Temozolomide|temozolomide|mesh-list
44112726|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44112727|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112728|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112729|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112730|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112731|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112732|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
44112733|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112734|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112735|NCT00093366|Etanercept|etanercept|mesh-list
44112736|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
44112737|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112738|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112739|NCT00093366|Analgesics|analgesics|mesh-ancestor
44112740|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
44287240|NCT00761644|Doxorubicin|doxorubicin|mesh-list
44287241|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44287242|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44287243|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287244|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44287245|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44287246|NCT00761644|Growth Substances|growth substances|mesh-ancestor
44287247|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287248|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44287249|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44287250|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44287251|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287252|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112741|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112742|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112743|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112744|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112745|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44112746|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112747|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
44112748|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112749|NCT00093418|Tipifarnib|tipifarnib|mesh-list
44112750|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112751|NCT00093444|Doxorubicin|doxorubicin|mesh-list
44112752|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44112753|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112754|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112755|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44112756|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112757|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640295|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44112772|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112773|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112774|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
44112775|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112776|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112777|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44112778|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112779|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112780|NCT00093509|Doxorubicin|doxorubicin|mesh-list
44112781|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44112783|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
44112784|NCT00093509|Mesna|mesna|mesh-list
44112785|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112786|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112787|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44112788|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112789|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112790|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112791|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112792|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
44112793|NCT00093509|Protective Agents|protective agents|mesh-ancestor
44112794|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112796|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
44112797|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44112798|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112799|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112800|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
44112801|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112802|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287253|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287254|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287255|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287256|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
44287257|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287258|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
44287259|NCT00761670|Risperidone|risperidone|mesh-list
44287260|NCT00761670|Amisulpride|amisulpride|mesh-list
44287261|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44287262|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
44287263|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287264|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287265|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287266|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44287267|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44287268|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287269|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287270|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44287271|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
44112803|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
44112804|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112805|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44112807|NCT00093548|Sargramostim|sargramostim|mesh-list
44112808|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
44112809|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112810|NCT00093561|Lycopene|lycopene|mesh-list
44112811|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112812|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
44112813|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112814|NCT00093561|Protective Agents|protective agents|mesh-ancestor
44112815|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112816|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44112817|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44112818|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112819|NCT00093587|Cyclosporine|cyclosporine|mesh-list
44112823|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44112824|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112825|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
44112826|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112827|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112828|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112829|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
44112830|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112831|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112832|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44112833|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112834|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
44112835|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112836|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112837|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44112839|NCT00093600|Daunorubicin|daunorubicin|mesh-list
44112840|NCT00093600|Midostaurin|midostaurin|mesh-list
44112841|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112842|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
44112843|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112844|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287272|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44287273|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
44287274|NCT00761722|Azacitidine|azacitidine|mesh-list
44287275|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287276|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
44287277|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287278|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287279|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287280|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
44287281|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287282|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287283|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44287284|NCT00761904|Simvastatin|simvastatin|mesh-list
44287285|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44287286|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44287287|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
44287288|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287289|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44287290|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44287291|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287292|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44287293|NCT00761904|Diuretics|diuretics|mesh-ancestor
44287294|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
44287295|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711605|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
44112845|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
44112846|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112847|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112848|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
44112849|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112850|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112851|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44112852|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112853|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112854|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112855|NCT00093613|Sorafenib|sorafenib|mesh-list
44112856|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112857|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112858|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112859|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112860|NCT00093626|Sorafenib|sorafenib|mesh-list
44112861|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112862|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112864|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112865|NCT00093639|Everolimus|everolimus|mesh-list
44112866|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
44112867|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112868|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287296|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44287297|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287298|NCT00762060|Anesthetics|anesthetics|mesh-list
44287299|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
44287300|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287301|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287302|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
44287303|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287304|NCT00762099|Pregabalin|pregabalin|mesh-list
44287305|NCT00762099|Analgesics|analgesics|mesh-ancestor
44287306|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
44287307|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287308|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287309|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
44287310|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44287311|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287312|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287313|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44287314|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44287315|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44287316|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287317|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112869|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
43644163|NCT04728230|Carboplatin|carboplatin|mesh-list
44112870|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112871|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112872|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112873|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112875|NCT00093652|Gefitinib|gefitinib|mesh-list
44112876|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112877|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112878|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112879|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112880|NCT00093665|Cisplatin|cisplatin|mesh-list
44112881|NCT00093665|Fluorouracil|fluorouracil|mesh-list
44112882|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112883|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
44112884|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112885|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112886|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112887|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
44112888|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153876|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153877|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153878|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44153879|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43640439|NCT02352948|Antiviral Agents|antiviral agents|mesh-ancestor
44153899|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153900|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153901|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287318|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44287319|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287320|NCT00762190|Insulin|insulin|mesh-list
44287321|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44287322|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287323|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287324|NCT00762255|Bevacizumab|bevacizumab|mesh-list
44287325|NCT00762255|Irinotecan|irinotecan|mesh-list
44287326|NCT00762255|Vorinostat|vorinostat|mesh-list
44287327|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44287328|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287329|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44287330|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44287331|NCT00762255|Growth Substances|growth substances|mesh-ancestor
44287332|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287333|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
44287334|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44287335|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287336|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287337|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287338|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44153903|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44153904|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153905|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44153906|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44153907|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44153908|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
44153909|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153910|NCT00222053|Thalidomide|thalidomide|mesh-list
44153911|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153912|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
44153913|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153914|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
44153915|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44153916|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153917|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44153918|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44153919|NCT00222053|Growth Substances|growth substances|mesh-ancestor
44153920|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
44153921|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153922|NCT00222079|Esomeprazole|esomeprazole|mesh-list
44153923|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44153925|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44153926|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153927|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153928|NCT00222144|Docetaxel|docetaxel|mesh-list
44153929|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
44153930|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112889|NCT00093678|Celecoxib|celecoxib|mesh-list
44112890|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112891|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112892|NCT00093678|Analgesics|analgesics|mesh-ancestor
44112901|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112902|NCT00093704|Ganciclovir|ganciclovir|mesh-list
44287339|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
44287340|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44287341|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287342|NCT00762398|Chrysarobin|chrysarobin|mesh-list
44287343|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287344|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287345|NCT00762398|Analgesics|analgesics|mesh-ancestor
44287346|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
44287347|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287348|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287349|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287350|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287351|NCT00762567|Phenylephrine|phenylephrine|mesh-list
44287352|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
44287353|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
44287354|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44287355|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
44287356|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
44287357|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287358|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287359|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
44287360|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44287361|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
44287362|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44287363|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44287364|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44287365|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44287366|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287367|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287368|NCT00762567|Protective Agents|protective agents|mesh-ancestor
44287369|NCT00762632|Everolimus|everolimus|mesh-list
44287370|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287371|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287372|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
44287373|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287374|NCT00762658|Betamethasone|betamethasone|mesh-list
44287375|NCT00762658|Tacrolimus|tacrolimus|mesh-list
43831746|NCT05299476|Bevacizumab|bevacizumab|mesh-list
44287376|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44287377|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287378|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
44287379|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287380|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44287381|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287382|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287383|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287384|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
44287385|NCT00762658|Hormones|hormones|mesh-ancestor
44287386|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287387|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44287388|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
44287389|NCT00762671|Ebselen|ebselen|mesh-list
44287390|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287391|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287392|NCT00762671|Analgesics|analgesics|mesh-ancestor
44287393|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
44287394|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287395|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287396|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287398|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44287427|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
44287428|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
44287429|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287430|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287431|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44287432|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
44287433|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287434|NCT00762775|Vitamin D|vitamin d|mesh-list
44287435|NCT00762775|Calcium|calcium|mesh-list
44287436|NCT00762775|Vitamins|vitamins|mesh-ancestor
44287437|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
44287438|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287439|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44287440|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44287441|NCT00762918|Vitamin D|vitamin d|mesh-list
44287442|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
44287443|NCT00762918|Vitamins|vitamins|mesh-ancestor
44287444|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
44287445|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112903|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44112904|NCT00093704|Bortezomib|bortezomib|mesh-list
44112905|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112906|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
44112907|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112908|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44112909|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112910|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112911|NCT00093743|Cyclosporine|cyclosporine|mesh-list
44112912|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
44112913|NCT00093743|Fludarabine|fludarabine|mesh-list
44112914|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
44112915|NCT00093743|Cyclosporins|cyclosporins|mesh-list
44112916|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112917|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112918|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
44112919|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112920|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112921|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
44112922|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112923|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112924|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
44112925|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44112926|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
44112927|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112928|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44112929|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112930|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44112931|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
44112932|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44112933|NCT00093769|Rituximab|rituximab|mesh-list
44112934|NCT00093769|Bortezomib|bortezomib|mesh-list
44112935|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44112936|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112937|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
44112938|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112939|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112940|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
44112941|NCT00093834|Doxorubicin|doxorubicin|mesh-list
44112942|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44112943|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287446|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44287447|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44287448|NCT00762944|Cimetidine|cimetidine|mesh-list
44287449|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44287450|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287451|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44287452|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
44287453|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
44287454|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287455|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287456|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287457|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44287458|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44112944|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
44112945|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112946|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112947|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112948|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
44112949|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112950|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112951|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44112952|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44112953|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44112954|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44112955|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112956|NCT00093860|Propranolol|propranolol|mesh-list
44112958|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44112959|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
44112960|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44112963|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44112964|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44112965|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
44112966|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
44112967|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112968|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112969|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112971|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
44112972|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
44112973|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44112974|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112975|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112976|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112977|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112978|NCT00093912|Nitroprusside|nitroprusside|mesh-list
44112979|NCT00093912|Clevidipine|clevidipine|mesh-list
44112980|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44112981|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
44112982|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44112983|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112984|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44112985|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112986|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112987|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112988|NCT00093925|Nicardipine|nicardipine|mesh-list
44112989|NCT00093925|Clevidipine|clevidipine|mesh-list
44112990|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44112991|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44112992|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287459|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287460|NCT00762957|Metformin|metformin|mesh-list
44287461|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287462|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287463|NCT00762983|Loratadine|loratadine|mesh-list
44287464|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
44287465|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287466|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44287467|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44287468|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44287469|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
44287470|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
44287471|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287472|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287473|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464357|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44464358|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44464359|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44464360|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464361|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464362|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44112993|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112994|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44112995|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112996|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
44112997|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
44112998|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44112999|NCT00093951|Protective Agents|protective agents|mesh-ancestor
44113000|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113001|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
44113002|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
44113003|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113004|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113005|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
44113006|NCT00093977|Hematinics|hematinics|mesh-ancestor
44113007|NCT00093990|Tipifarnib|tipifarnib|mesh-list
44113008|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113009|NCT00094003|Poly I-C|poly i-c|mesh-list
44113010|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
44113011|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113012|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
44113013|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
44113014|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113015|NCT00094029|Sunitinib|sunitinib|mesh-list
44113016|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113017|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113018|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113019|NCT00094029|Growth Substances|growth substances|mesh-ancestor
44113020|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113021|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113022|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113023|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464364|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464365|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464366|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44464367|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464368|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
44464369|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464370|NCT01496612|Buspirone|buspirone|mesh-list
44464371|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44464372|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464373|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464374|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464375|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464376|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44464377|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
44464378|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464379|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464380|NCT01496469|Febuxostat|febuxostat|mesh-list
44464381|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
44464382|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464383|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44464384|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44464385|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44113024|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113025|NCT00094081|Cisplatin|cisplatin|mesh-list
44113026|NCT00094081|Tirapazamine|tirapazamine|mesh-list
44113027|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113028|NCT00094120|Squalamine|squalamine|mesh-list
44113029|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113030|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113031|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44113032|NCT00094120|Protective Agents|protective agents|mesh-ancestor
44113040|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113041|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44113042|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113043|NCT00094289|Disulfiram|disulfiram|mesh-list
44113044|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44113045|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44113046|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113047|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113048|NCT00094315|Cocaine|cocaine|mesh-list
44113049|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
44113050|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
44113051|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113052|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113053|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
44113054|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113055|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44113056|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44113057|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44113058|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464387|NCT01496365|Pregabalin|pregabalin|mesh-list
44464388|NCT01496365|Analgesics|analgesics|mesh-ancestor
44464389|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
44464390|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464391|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464392|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
44464393|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44464394|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464395|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464396|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44464397|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44464398|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464399|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464400|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113059|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113060|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
44113061|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113062|NCT00094341|Etanercept|etanercept|mesh-list
44113063|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44113064|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44113065|NCT00094341|Analgesics|analgesics|mesh-ancestor
44113066|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
44113067|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113068|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113069|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44113070|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113071|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113072|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113073|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
44113074|NCT00094367|Lamivudine|lamivudine|mesh-list
44113075|NCT00094367|Abacavir|abacavir|mesh-list
44113076|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44113077|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44113078|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113079|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113080|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
44113081|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113082|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44113083|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44113084|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
44113085|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113086|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
44113087|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113088|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113089|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44113090|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
44113091|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113092|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113093|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44113094|NCT00094406|Dimercaprol|dimercaprol|mesh-list
44113095|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
44113096|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
44113097|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
44113098|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113099|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
44113103|NCT00094432|Aripiprazole|aripiprazole|mesh-list
44464401|NCT01496183|Olanzapine|olanzapine|mesh-list
44464402|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
44464403|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
44464404|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464405|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464406|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464407|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44464408|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44464409|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464410|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44464411|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44464412|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44464413|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464414|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464415|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464416|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
44464417|NCT01495793|Rotigotine|rotigotine|mesh-list
44464418|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
44464419|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
44464420|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711789|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113104|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113105|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113106|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113107|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113108|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113109|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113110|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113111|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
44113112|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113113|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113114|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113115|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113116|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
44113117|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113118|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113119|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113120|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113121|NCT00094484|Cinacalcet|cinacalcet|mesh-list
44113122|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44113123|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113124|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44113125|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
44113126|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44113127|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
44113128|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44113129|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44113130|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
44113131|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113132|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113133|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44113134|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44113135|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
44464421|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464422|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942344|NCT00986401|Metformin|metformin|mesh-list
44287475|NCT00763165|Fluorides|fluorides|mesh-list
44287476|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
44287477|NCT00763165|Protective Agents|protective agents|mesh-ancestor
44287478|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287479|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44287480|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287481|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44287482|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44287483|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
44287484|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287485|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44287486|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44287487|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44287488|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44287489|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287490|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287491|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287492|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287493|NCT00763178|Analgesics|analgesics|mesh-ancestor
44287494|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
44287495|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287496|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113136|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113137|NCT00094549|Valproic Acid|valproic acid|mesh-list
44113138|NCT00094549|Olanzapine|olanzapine|mesh-list
44113139|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
44113140|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
44113141|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113142|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113143|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113144|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113145|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113146|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113147|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43646428|NCT03098485|Ofloxacin|ofloxacin|mesh-list
44113148|NCT00094549|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44113149|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44113150|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44113151|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113152|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113153|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
44113154|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
44113155|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113156|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
44287497|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287498|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
44287499|NCT00763204|Betamethasone|betamethasone|mesh-list
44287500|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44287501|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287502|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
44287503|NCT00763204|Hormones|hormones|mesh-ancestor
44287504|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287505|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287506|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44287507|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44287508|NCT00763347|Alogliptin|alogliptin|mesh-list
44287509|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287510|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287511|NCT00763347|Incretins|incretins|mesh-ancestor
44287512|NCT00763347|Hormones|hormones|mesh-ancestor
44287513|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287514|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44287515|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
44287516|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287517|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287518|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44287519|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44287520|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711845|NCT02687100|Hormones|hormones|mesh-ancestor
44113157|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
44113158|NCT00094614|Atropine|atropine|mesh-list
44113159|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44113160|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44113161|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44113162|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
44113163|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113164|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113165|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44113166|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
44113167|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
44113168|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
44113169|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44113170|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44113171|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
44113176|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
44113177|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113178|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113179|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
44113180|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
44113181|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
44113182|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113183|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113184|NCT00094640|Olanzapine|olanzapine|mesh-list
44113185|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
44287521|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
44287522|NCT00763438|Sertindole|sertindole|mesh-list
44287523|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44287524|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44287525|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287526|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287527|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44287528|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44287529|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
44287530|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
44287531|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287532|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44287533|NCT00763620|Dimercaprol|dimercaprol|mesh-list
44287534|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
44287535|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
44287536|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287537|NCT00763633|Vitamins|vitamins|mesh-list
44287538|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
44287539|NCT00763633|Pyridoxal|pyridoxal|mesh-list
44287540|NCT00763633|Pyridoxine|pyridoxine|mesh-list
44287541|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
44113186|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
44113187|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113188|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113189|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113190|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113191|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113192|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113193|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113194|NCT00094640|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44113195|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44113196|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44113197|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113198|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113199|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
44113200|NCT00094666|Gaboxadol|gaboxadol|mesh-list
44113201|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113202|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113203|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113204|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113205|NCT00094666|Analgesics|analgesics|mesh-ancestor
44113206|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
44113207|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
44113208|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
44113209|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
44113210|NCT00094692|Atropine|atropine|mesh-list
44113211|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44113212|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44113213|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44113214|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
44113215|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113216|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113217|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44113218|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
44113219|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
44113220|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
44113221|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44287542|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
44287543|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287545|NCT00763646|Docetaxel|docetaxel|mesh-list
44287546|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287547|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287548|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287549|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287550|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287551|NCT00763685|Etoricoxib|etoricoxib|mesh-list
44287552|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287553|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287554|NCT00763685|Analgesics|analgesics|mesh-ancestor
44287555|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
44287556|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287557|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287558|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287559|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287560|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44287561|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44287562|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287563|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287564|NCT00763763|Interferons|interferons|mesh-list
44287565|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44287566|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
44287567|NCT00763763|Dexamethasone|dexamethasone|mesh-list
44287568|NCT00763763|Vincristine|vincristine|mesh-list
44287569|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
44287570|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287571|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
44287572|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
44287573|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113222|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44113223|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
44113224|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113225|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113226|NCT00094848|Mapatumumab|mapatumumab|mesh-list
44113227|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113228|NCT00094926|Risperidone|risperidone|mesh-list
44113229|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113230|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
44113231|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113232|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113233|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287574|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287575|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287576|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
44287577|NCT00763763|Hormones|hormones|mesh-ancestor
44287578|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287579|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44287580|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287581|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
44287582|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287583|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44287584|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287585|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287586|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287587|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287588|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44287589|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287590|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
44287591|NCT00763789|Remifentanil|remifentanil|mesh-list
44287592|NCT00763789|Anesthetics|anesthetics|mesh-list
44287593|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287594|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287625|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
44287626|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
44287627|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287628|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44287629|NCT00763997|Acetaminophen|acetaminophen|mesh-list
44287630|NCT00763997|Dipyrone|dipyrone|mesh-list
44287631|NCT00763997|Ibuprofen|ibuprofen|mesh-list
44287632|NCT00763997|Parecoxib|parecoxib|mesh-list
44287633|NCT00763997|Valdecoxib|valdecoxib|mesh-list
44287634|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287635|NCT00763997|Analgesics|analgesics|mesh-ancestor
44287636|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
44287637|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287638|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287639|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
44287640|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44287641|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287642|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113234|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113235|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113236|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113237|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113238|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113239|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
44113240|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
44113241|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113242|NCT00094978|Alvocidib|alvocidib|mesh-list
44113243|NCT00094978|Romidepsin|romidepsin|mesh-list
44113251|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113252|NCT00095043|Gaboxadol|gaboxadol|mesh-list
44113253|NCT00095043|Analgesics|analgesics|mesh-ancestor
44113254|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
44113255|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113256|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113257|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
44113258|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
44113259|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
44113260|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113261|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113262|NCT00095069|Gaboxadol|gaboxadol|mesh-list
44113263|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113264|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113265|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113266|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113267|NCT00095069|Analgesics|analgesics|mesh-ancestor
44113268|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
44113269|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
43646537|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44113270|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
44113271|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
44113273|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44113274|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
44113275|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
44113276|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
44113277|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113278|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113279|NCT00095134|Risperidone|risperidone|mesh-list
44113280|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113281|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
44113282|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113283|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113284|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113285|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44287643|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44287644|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287645|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287646|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44287647|NCT00764036|Artesunate|artesunate|mesh-list
44287648|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
44287649|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44287650|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44287651|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287652|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287653|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
44287654|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
44287655|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44287656|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
44287657|NCT00764062|Amoxicillin|amoxicillin|mesh-list
44287658|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287659|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287660|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44287661|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287662|NCT00764140|Mitogens|mitogens|mesh-list
44287663|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287664|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287665|NCT00764166|Docetaxel|docetaxel|mesh-list
44287666|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44287667|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287668|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287669|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287670|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287671|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287672|NCT00764166|Hormones|hormones|mesh-ancestor
44287673|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287674|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287675|NCT00764244|Triamcinolone|triamcinolone|mesh-list
44113286|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113287|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113288|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113289|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113290|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
44113291|NCT00095186|Lactoferrin|lactoferrin|mesh-list
44113292|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113293|NCT00095225|Bevacizumab|bevacizumab|mesh-list
44113294|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44287676|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44287677|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44287678|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44287679|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287681|NCT00764244|Hormones|hormones|mesh-ancestor
44287682|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287683|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287684|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287685|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
44287686|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287687|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287688|NCT00764374|Z 338|z 338|mesh-list
44287689|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44287690|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287691|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287692|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
44287693|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287694|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287695|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287696|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
44287697|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44287698|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43942521|NCT00991081|Bupropion|bupropion|mesh-list
44287699|NCT00764413|Prednisolone|prednisolone|mesh-list
44287700|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
44287701|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44287702|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
43711967|NCT02686151|Hormones|hormones|mesh-ancestor
44113295|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113296|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113297|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113298|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113299|NCT00095225|Growth Substances|growth substances|mesh-ancestor
44113300|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113301|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113302|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113303|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113304|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113305|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
44113306|NCT00095251|Lorazepam|lorazepam|mesh-list
44113307|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44113308|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113309|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113310|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44287703|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44287705|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
44287706|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287707|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287708|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44287709|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
44287710|NCT00764413|Hormones|hormones|mesh-ancestor
44287711|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44287712|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44287713|NCT00764413|Protective Agents|protective agents|mesh-ancestor
44287714|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44287715|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287716|NCT00764426|Ethanol|ethanol|mesh-list
44287717|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44287718|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287719|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287720|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287721|NCT00764439|Nicotine|nicotine|mesh-list
44287722|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44287723|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
44287724|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287725|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287726|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44287727|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44287728|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44287729|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44287730|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287731|NCT00764556|Insulin|insulin|mesh-list
44287732|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287733|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287734|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
44287735|NCT00764582|Levofloxacin|levofloxacin|mesh-list
44287736|NCT00764582|Ofloxacin|ofloxacin|mesh-list
44287737|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44287738|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44287739|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44287744|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287745|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287746|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44287747|NCT00764582|Renal Agents|renal agents|mesh-ancestor
44287748|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44287749|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44287750|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
44287751|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287752|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44287753|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287754|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287755|NCT00764712|Insulin|insulin|mesh-list
44287756|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44287757|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287758|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
44287759|NCT00764725|Methotrexate|methotrexate|mesh-list
44287760|NCT00764725|Infliximab|infliximab|mesh-list
44287761|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44287762|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
44287763|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44287764|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287765|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287766|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
44287767|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287768|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287769|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287770|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287771|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44287772|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287786|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
44287787|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287788|NCT00764855|Propofol|propofol|mesh-list
44287789|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44287790|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287791|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287792|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44287793|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
44287794|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
44287795|NCT00764907|Leucovorin|leucovorin|mesh-list
44287796|NCT00764907|Cytarabine|cytarabine|mesh-list
44287797|NCT00764907|Dexamethasone|dexamethasone|mesh-list
44287798|NCT00764907|Prednisone|prednisone|mesh-list
44287799|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
44287800|NCT00764907|Ifosfamide|ifosfamide|mesh-list
44287801|NCT00764907|Doxorubicin|doxorubicin|mesh-list
44287802|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44287803|NCT00764907|Methotrexate|methotrexate|mesh-list
44287804|NCT00764907|Etoposide|etoposide|mesh-list
44287805|NCT00764907|Vincristine|vincristine|mesh-list
44287806|NCT00764907|Daunorubicin|daunorubicin|mesh-list
44287807|NCT00764907|Asparaginase|asparaginase|mesh-list
44287808|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
44287809|NCT00764907|Thioguanine|thioguanine|mesh-list
44287810|NCT00764907|Vindesine|vindesine|mesh-list
44287811|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
44287812|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44287813|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
44287814|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287815|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44287816|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44287817|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
44287818|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287819|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287822|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
44287832|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287833|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287834|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44287835|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
44287836|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44287837|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287838|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
44287839|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
44287840|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44287841|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44287842|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44287843|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
44287844|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44287845|NCT00764907|Antidotes|antidotes|mesh-ancestor
44287846|NCT00764907|Protective Agents|protective agents|mesh-ancestor
44287847|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
44287848|NCT00764907|Vitamins|vitamins|mesh-ancestor
44287849|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
44287850|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287851|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44287852|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44287853|NCT00764972|Sorafenib|sorafenib|mesh-list
44287854|NCT00764972|Vinorelbine|vinorelbine|mesh-list
44287855|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287856|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44287857|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287858|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287859|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44287860|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
44287863|NCT00765011|Cetuximab|cetuximab|mesh-list
44287878|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287879|NCT00765154|Ritonavir|ritonavir|mesh-list
44287880|NCT00765154|Darunavir|darunavir|mesh-list
44287881|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44287882|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44287883|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44287884|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287885|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287886|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44287887|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44287946|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
44287948|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44287949|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44287950|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
44287951|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44287952|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44287953|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44287954|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44287955|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44287956|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287957|NCT00765973|Topotecan|topotecan|mesh-list
44287958|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44287959|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44287960|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44287961|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287962|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287963|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44287964|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44287965|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44287966|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287967|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44287968|NCT00766025|Calcium|calcium|mesh-list
44287994|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44287995|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
44287996|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44287997|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44287998|NCT00766181|Lidocaine|lidocaine|mesh-list
44287999|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
44288000|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
44288001|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288002|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288003|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
44288004|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288005|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44288006|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44288007|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44288008|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288009|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288010|NCT00766220|Irinotecan|irinotecan|mesh-list
44288011|NCT00766220|Cetuximab|cetuximab|mesh-list
44288012|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44288013|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44288014|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288015|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288016|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288017|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44288018|NCT00766246|Bevacizumab|bevacizumab|mesh-list
44288019|NCT00766246|Carboplatin|carboplatin|mesh-list
44288020|NCT00766246|Docetaxel|docetaxel|mesh-list
44288021|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44288022|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288038|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288039|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44288040|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288041|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
44288042|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288043|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
44288044|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288045|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288046|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288047|NCT00766337|Growth Substances|growth substances|mesh-ancestor
44288048|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288049|NCT00766350|Amitriptyline|amitriptyline|mesh-list
44288050|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44288051|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
44288052|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288053|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44288054|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288055|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288056|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288057|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44288058|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44288059|NCT00766350|Analgesics|analgesics|mesh-ancestor
44288060|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
44288061|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288062|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44288063|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288064|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288065|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288066|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288067|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288068|NCT00766402|Acetaminophen|acetaminophen|mesh-list
44288069|NCT00766402|Diclofenac|diclofenac|mesh-list
44288070|NCT00766402|Tramadol|tramadol|mesh-list
44288071|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44288072|NCT00766402|Analgesics|analgesics|mesh-ancestor
44288073|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
44288075|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288076|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
44288077|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44288078|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44288079|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288080|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44288081|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288082|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288083|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44288084|NCT00766402|Narcotics|narcotics|mesh-ancestor
44288085|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288086|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44288087|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288088|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288089|NCT00766441|Incretins|incretins|mesh-ancestor
44288091|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288092|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44288093|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288094|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288095|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288126|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44288127|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44288128|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288129|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44288130|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288131|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288132|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44288133|NCT00766662|Renal Agents|renal agents|mesh-ancestor
44288134|NCT00766805|Propranolol|propranolol|mesh-list
44288135|NCT00766805|Isosorbide|isosorbide|mesh-list
44288136|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44288137|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44288138|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44288139|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44288140|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288141|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288184|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44288185|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44288186|NCT00766896|Analgesics|analgesics|mesh-ancestor
44288187|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
44288188|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288189|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288190|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44288191|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288192|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44288193|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44288194|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288195|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44288196|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44288197|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288198|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
44288199|NCT00766909|Cyclosporine|cyclosporine|mesh-list
44288228|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288229|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44288230|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44288231|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
44288232|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288233|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44288234|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288235|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44288236|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44288237|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
44288239|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44288240|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288241|NCT00767221|Budesonide|budesonide|mesh-list
44288242|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44288243|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44288244|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
44288245|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288246|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288247|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44288248|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
44288249|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
44288250|NCT00767221|Hormones|hormones|mesh-ancestor
44288251|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288252|NCT00767260|Insulin|insulin|mesh-list
44288253|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288276|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288278|NCT00767494|Brinzolamide|brinzolamide|mesh-list
44288279|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44288280|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44288281|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288282|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288283|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
44288284|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44288285|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288286|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288287|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
44288288|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288289|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288291|NCT00767559|Warfarin|warfarin|mesh-list
44288292|NCT00767559|Fondaparinux|fondaparinux|mesh-list
44288293|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
44288294|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44288295|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
44288296|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44288297|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288298|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288299|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288300|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44288301|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44288302|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
44288303|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44288304|NCT00767598|Udenafil|udenafil|mesh-list
44288305|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
44288306|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288307|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44288308|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288310|NCT00767598|Urological Agents|urological agents|mesh-ancestor
44288317|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
44288318|NCT00767689|Pyridoxal|pyridoxal|mesh-list
44288319|NCT00767689|Pyridoxine|pyridoxine|mesh-list
44288320|NCT00767689|Vitamins|vitamins|mesh-ancestor
44288321|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
44288322|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288323|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
44288324|NCT00767715|Haloperidol|haloperidol|mesh-list
44288325|NCT00767715|Olanzapine|olanzapine|mesh-list
44288326|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
44288327|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
44288328|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
44288329|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288330|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288331|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44288332|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44288333|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288334|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288335|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288336|NCT00767715|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44288337|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288338|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288339|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288340|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288341|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
44288342|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44288343|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
44288344|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44288365|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44288366|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288367|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288368|NCT00767871|Citalopram|citalopram|mesh-list
44288369|NCT00767871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44288370|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288371|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288372|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288373|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288374|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
44288375|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288376|NCT00767871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44288377|NCT00767871|Antidepressive Agents|antidepressive agents|mesh-ancestor
44288378|NCT00767871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288379|NCT00767975|Rifampin|rifampin|mesh-list
44288380|NCT00767975|Isoniazid|isoniazid|mesh-list
44288381|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44288382|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
44288383|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288384|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288417|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44288418|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44288420|NCT00768183|Morphine|morphine|mesh-list
44288421|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44288422|NCT00768183|Narcotics|narcotics|mesh-ancestor
44288423|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288424|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288425|NCT00768183|Analgesics|analgesics|mesh-ancestor
44288426|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
44288427|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288428|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44288429|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288430|NCT00768209|Topiramate|topiramate|mesh-list
44288431|NCT00768209|Phentermine|phentermine|mesh-list
44288432|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
44288433|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288434|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288435|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44288436|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
43943220|NCT01005355|Ramucirumab|ramucirumab|mesh-list
44288437|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44288438|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
44288439|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
44288440|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288441|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44288442|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288467|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44288468|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288469|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
44288470|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288471|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
44288472|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
44288473|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44288474|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
44288475|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44288476|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44288477|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
44288478|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288479|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288480|NCT00768508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44288481|NCT00768508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288482|NCT00768508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288483|NCT00768508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288484|NCT00768508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44288485|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
44288486|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
44288487|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44288488|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44288489|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288490|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288491|NCT00768573|Urological Agents|urological agents|mesh-ancestor
44288492|NCT00768612|Risperidone|risperidone|mesh-list
44288493|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44288494|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
44288513|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
44288514|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288515|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288516|NCT00768690|Ketoconazole|ketoconazole|mesh-list
44288517|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
44288518|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288519|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44288520|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288521|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288522|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288523|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44288524|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288525|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288526|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288527|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44288528|NCT00768729|Sirolimus|sirolimus|mesh-list
44288529|NCT00768729|Azathioprine|azathioprine|mesh-list
44288530|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288531|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288532|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44288533|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288534|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
44288535|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288536|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
44288537|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288538|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
44288539|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288540|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44288541|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44288542|NCT00768768|Terbinafine|terbinafine|mesh-list
44288543|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
44288544|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288545|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288546|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288550|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44288551|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288552|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44288553|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44288554|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44288555|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288556|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464437|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
44464438|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44464439|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464440|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464441|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44464442|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
44464443|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44464444|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44464445|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464446|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
44464447|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44464448|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44464449|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
44464450|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464451|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464452|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44464453|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
44464454|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
44464455|NCT01494610|Hormones|hormones|mesh-ancestor
44464456|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464457|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
44464458|NCT01494584|Ezogabine|ezogabine|mesh-list
44464459|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
44464460|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464461|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464462|NCT01494532|Ropinirole|ropinirole|mesh-list
44464463|NCT01494532|Levodopa|levodopa|mesh-list
44464464|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44288559|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
44288560|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288561|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288562|NCT00768937|Sorafenib|sorafenib|mesh-list
44288563|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288564|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44288565|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288566|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288567|NCT00768963|Ranibizumab|ranibizumab|mesh-list
44288568|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288569|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288570|NCT00768963|Growth Substances|growth substances|mesh-ancestor
44288571|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288572|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288573|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288574|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
44288575|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288576|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288577|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44288578|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44288579|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288580|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288581|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288582|NCT00769054|Ropivacaine|ropivacaine|mesh-list
44288583|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44288584|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
44288608|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288609|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
44288610|NCT00769171|Metronidazole|metronidazole|mesh-list
44288611|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
44288612|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44288613|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288614|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288615|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44288616|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44288617|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288618|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288619|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288620|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44288621|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
44288622|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44288623|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288624|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44288625|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44288646|NCT00769405|Leucovorin|leucovorin|mesh-list
44288661|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
44288662|NCT00769405|Vitamins|vitamins|mesh-ancestor
44288663|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
44288664|NCT00769470|Carboplatin|carboplatin|mesh-list
44288665|NCT00769470|Docetaxel|docetaxel|mesh-list
44288666|NCT00769470|Trastuzumab|trastuzumab|mesh-list
44288667|NCT00769470|Lapatinib|lapatinib|mesh-list
44288668|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288669|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44288670|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44288671|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44288672|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288673|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44288674|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44288725|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288726|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288727|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
44288728|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44288729|NCT00769990|Estrogens|estrogens|mesh-ancestor
44288730|NCT00769990|Hormones|hormones|mesh-ancestor
44288731|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288732|NCT00770042|Ritonavir|ritonavir|mesh-list
44288733|NCT00770042|Ketoconazole|ketoconazole|mesh-list
44288734|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44288735|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44288736|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288737|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288738|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288739|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44288740|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44288741|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
44288742|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288743|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44288744|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44288745|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
44288746|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44288747|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44288748|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
44288749|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288750|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288751|NCT00770107|Thiamine|thiamine|mesh-list
44288752|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
44288753|NCT00770107|Vitamins|vitamins|mesh-ancestor
44288754|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
44288755|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288756|NCT00770172|Lenograstim|lenograstim|mesh-list
44288757|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44288758|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
44288759|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288760|NCT00770263|Sirolimus|sirolimus|mesh-list
44288764|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288765|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288766|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288767|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288768|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44288769|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
44288770|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288771|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
44288772|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288773|NCT00770302|Saxagliptin|saxagliptin|mesh-list
44288774|NCT00770302|Incretins|incretins|mesh-ancestor
44288775|NCT00770302|Hormones|hormones|mesh-ancestor
44288776|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44288777|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288778|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43943600|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
44288779|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288780|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464466|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288814|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288815|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288816|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44288817|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288818|NCT00770497|Pioglitazone|pioglitazone|mesh-list
44288820|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288821|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288822|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44288823|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
44288824|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288825|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288826|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44288827|NCT00770536|Doxorubicin|doxorubicin|mesh-list
44288828|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44288829|NCT00770536|Topotecan|topotecan|mesh-list
44288830|NCT00770536|Trebananib|trebananib|mesh-list
44288831|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44288832|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288833|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44288834|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44288835|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288836|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288837|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44288838|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44288839|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44288840|NCT00770536|Growth Substances|growth substances|mesh-ancestor
44288841|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288842|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
44288843|NCT00770575|Pioglitazone|pioglitazone|mesh-list
44288844|NCT00770575|Atorvastatin|atorvastatin|mesh-list
44288845|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44288846|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44288847|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
44288848|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113311|NCT00095251|Analgesics|analgesics|mesh-ancestor
44113312|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
44113316|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44288849|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44288850|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44288851|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288852|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288853|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943673|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
44288855|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44288856|NCT00770640|Pioglitazone|pioglitazone|mesh-list
44288857|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288858|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288859|NCT00770666|Bupropion|bupropion|mesh-list
44288860|NCT00770666|Nicotine|nicotine|mesh-list
44288861|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44288862|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
44288863|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288864|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288865|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44288866|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44288867|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44288868|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44288869|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288870|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44288871|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
44288872|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288873|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44288874|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44288875|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44288876|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
44288877|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44288879|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288894|NCT00770731|Topotecan|topotecan|mesh-list
44288895|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44288896|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44288897|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44288898|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288899|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288900|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288901|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288902|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44288903|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
44288904|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288905|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
44288906|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288907|NCT00770744|Olanzapine|olanzapine|mesh-list
44288908|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
44288909|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
44288910|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288911|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288912|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44288913|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44288914|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44288915|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288916|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44288922|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
44288942|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288943|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44288944|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44288945|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464467|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464468|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464469|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44464470|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44464471|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
44464472|NCT01494506|Leucovorin|leucovorin|mesh-list
44464473|NCT01494506|Fluorouracil|fluorouracil|mesh-list
44464474|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
44464475|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464476|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44464477|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464478|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464479|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
44464480|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464481|NCT01494506|Antidotes|antidotes|mesh-ancestor
44464482|NCT01494506|Protective Agents|protective agents|mesh-ancestor
44464483|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
44464484|NCT01494506|Vitamins|vitamins|mesh-ancestor
44464485|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
44464486|NCT01494467|Azelaic acid|azelaic acid|mesh-list
44464487|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464488|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44464513|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44464514|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
44464515|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464516|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464517|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
44464518|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44464519|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464520|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44464521|NCT01493531|Allopurinol|allopurinol|mesh-list
44464522|NCT01493531|Lesinurad|lesinurad|mesh-list
44464523|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
44464524|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464525|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44288946|NCT00770952|Pioglitazone|pioglitazone|mesh-list
44288947|NCT00770952|Glimepiride|glimepiride|mesh-list
44288948|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288949|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288950|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44288951|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288952|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
44288953|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
44288954|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44288955|NCT00770978|Cephalosporins|cephalosporins|mesh-list
44288956|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44288957|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44288958|NCT00771004|Pioglitazone|pioglitazone|mesh-list
44288959|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44288961|NCT00771017|Leuprolide|leuprolide|mesh-list
44288980|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44288981|NCT00771199|Fentanyl|fentanyl|mesh-list
44288982|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44288983|NCT00771199|Narcotics|narcotics|mesh-ancestor
44288984|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44288985|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288986|NCT00771199|Analgesics|analgesics|mesh-ancestor
44288987|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
44288988|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44288989|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44288990|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44288991|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
44288992|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
44288993|NCT00771251|Golimumab|golimumab|mesh-list
44288994|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44288995|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44288996|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44288997|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
44288998|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44288999|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
44289000|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44289001|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44289002|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289003|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
44289004|NCT00771303|Coagulants|coagulants|mesh-ancestor
44289005|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
44289006|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44289028|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
44289029|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289030|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289031|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44289032|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289033|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
44289034|NCT00771368|Protective Agents|protective agents|mesh-ancestor
44289035|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44289036|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44289037|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289038|NCT00771394|Tamsulosin|tamsulosin|mesh-list
44289039|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
44289040|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44289041|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44289042|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289043|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289044|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289045|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289046|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289047|NCT00771394|Urological Agents|urological agents|mesh-ancestor
44289048|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44289049|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44289050|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289051|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
44289052|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44289053|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289054|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
44289055|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289056|NCT00771433|Lenograstim|lenograstim|mesh-list
44289057|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44289067|NCT00771498|Lopinavir|lopinavir|mesh-list
44289069|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44289070|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
44289071|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289072|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289073|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289074|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289075|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
44289076|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289077|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289078|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289079|NCT00771511|Capsaicin|capsaicin|mesh-list
44289080|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
44289081|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
44289082|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
44289083|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289084|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289085|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
44289086|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44289087|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289088|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289089|NCT00771563|Cisplatin|cisplatin|mesh-list
44289090|NCT00771563|Docetaxel|docetaxel|mesh-list
44289091|NCT00771563|Enoxaparin|enoxaparin|mesh-list
44289092|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289093|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289094|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289095|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44464526|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
43943922|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289096|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289113|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289115|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289116|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289117|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
44289118|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44289119|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289120|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289121|NCT00771823|Maraviroc|maraviroc|mesh-list
44289122|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44289123|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44289124|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289125|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289126|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289127|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
44289128|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289129|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44289130|NCT00771888|Lanreotide|lanreotide|mesh-list
44289131|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289132|NCT00771979|Saracatinib|saracatinib|mesh-list
44289133|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289134|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289135|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289136|NCT00772057|Propranolol|propranolol|mesh-list
44289137|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44289138|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44289159|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289160|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
44289161|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289162|NCT00772174|Metformin|metformin|mesh-list
44289163|NCT00772174|Pioglitazone|pioglitazone|mesh-list
44289164|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44289165|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289166|NCT00772187|Fentanyl|fentanyl|mesh-list
44289167|NCT00772187|Morphine|morphine|mesh-list
44289168|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
44289169|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289170|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289171|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44289172|NCT00772187|Narcotics|narcotics|mesh-ancestor
44289173|NCT00772187|Analgesics|analgesics|mesh-ancestor
44289174|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
44289175|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289176|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44289177|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44289178|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
44289179|NCT00772265|Insulin|insulin|mesh-list
44289180|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
44289181|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44289182|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289183|NCT00772291|Pregabalin|pregabalin|mesh-list
44289184|NCT00772291|Analgesics|analgesics|mesh-ancestor
44289185|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
44289186|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289187|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289188|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
44289189|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289190|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289191|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289192|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289200|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289201|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
44289202|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289203|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289204|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289205|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289206|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289207|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44289208|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
44289209|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44289210|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
44289211|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289212|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289213|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289214|NCT00772499|Atenolol|atenolol|mesh-list
44289215|NCT00772499|Amlodipine|amlodipine|mesh-list
44289216|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44289217|NCT00772499|Olmesartan|olmesartan|mesh-list
44289218|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44289219|NCT00772499|Hydralazine|hydralazine|mesh-list
44289220|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289221|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289222|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44289223|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289224|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44289225|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289226|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289227|NCT00772499|Diuretics|diuretics|mesh-ancestor
44289228|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
44289229|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44289230|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44289240|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289241|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
44289242|NCT00772551|Ezetimibe|ezetimibe|mesh-list
44289243|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44289244|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44289245|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
44289246|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289247|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44289248|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289249|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289250|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
44289251|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289252|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44289253|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289254|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289255|NCT00772564|Atorvastatin|atorvastatin|mesh-list
44289256|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44289257|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44289258|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
44289259|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289260|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44289261|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44289262|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289263|NCT00772616|Sufentanil|sufentanil|mesh-list
44289264|NCT00772616|Remifentanil|remifentanil|mesh-list
44289265|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44289266|NCT00772616|Narcotics|narcotics|mesh-ancestor
44289267|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289268|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289269|NCT00772616|Analgesics|analgesics|mesh-ancestor
44289270|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
44289271|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289272|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44289273|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44289274|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
44289275|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
44113317|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44113318|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289276|NCT00772655|Rituximab|rituximab|mesh-list
44289277|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289278|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289279|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
44289280|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289281|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289282|NCT00772681|Cisplatin|cisplatin|mesh-list
44289283|NCT00772681|Docetaxel|docetaxel|mesh-list
44289284|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289285|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289286|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289287|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44289288|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289289|NCT00772694|Sorafenib|sorafenib|mesh-list
44289290|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289291|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44289292|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289293|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289294|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
44289295|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289296|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289297|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
44289298|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289299|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44289300|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289301|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289302|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289303|NCT00772759|AZD-3199|azd-3199|mesh-list
44289304|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44289305|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44289306|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44289307|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44289308|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289309|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113319|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113320|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
44113321|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
44113322|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
44113323|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113324|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44289310|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289311|NCT00772798|Paclitaxel|paclitaxel|mesh-list
44289312|NCT00772798|Carboplatin|carboplatin|mesh-list
44289313|NCT00772798|Vorinostat|vorinostat|mesh-list
44289314|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44289315|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289316|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44289317|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44289318|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944072|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289319|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289320|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44289321|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289322|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44289323|NCT00772837|Amoxicillin|amoxicillin|mesh-list
44289324|NCT00772837|Clarithromycin|clarithromycin|mesh-list
44289325|NCT00772837|Omeprazole|omeprazole|mesh-list
44289326|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289327|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44289328|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44289329|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44289330|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289331|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289332|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289333|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289334|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289335|NCT00772863|Cisplatin|cisplatin|mesh-list
44289336|NCT00772863|Docetaxel|docetaxel|mesh-list
44464532|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
44464533|NCT01493531|Renal Agents|renal agents|mesh-ancestor
44464534|NCT01493427|Travoprost|travoprost|mesh-list
44464535|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44464536|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44464537|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44464538|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464539|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464540|NCT01492686|Edaravone|edaravone|mesh-list
44464541|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44464542|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
44464543|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464544|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44464545|NCT01492686|Protective Agents|protective agents|mesh-ancestor
44464546|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464547|NCT01492426|Ribavirin|ribavirin|mesh-list
44464548|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44464549|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
44464550|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464551|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
44464552|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464553|NCT01492400|Dexamethasone|dexamethasone|mesh-list
44464554|NCT01492400|Ranibizumab|ranibizumab|mesh-list
44464555|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464556|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
44464557|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
44464558|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464559|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464560|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464561|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
44464562|NCT01492400|Hormones|hormones|mesh-ancestor
44464563|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464564|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464565|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464566|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44289351|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
44289352|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
44289354|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289355|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289356|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289357|NCT00773084|Lisinopril|lisinopril|mesh-list
44289358|NCT00773084|Spironolactone|spironolactone|mesh-list
44289359|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44289360|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44289361|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289362|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289363|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44289364|NCT00773084|Diuretics|diuretics|mesh-ancestor
44289365|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
44289366|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44289367|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44289368|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289369|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289370|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289405|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44289406|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
44289407|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
44289408|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289409|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
44289410|NCT00773331|Hematinics|hematinics|mesh-ancestor
44289411|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
44289412|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44289413|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44289414|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
44289415|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289416|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289417|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289418|NCT00773552|Urological Agents|urological agents|mesh-ancestor
44289419|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
44289420|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44289421|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
44289422|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289423|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289424|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289425|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289426|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44289427|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
44289428|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289429|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289430|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44289431|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289432|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
44289433|NCT00773578|Protective Agents|protective agents|mesh-ancestor
44289434|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44289449|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289450|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289451|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289452|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44289453|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44289454|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289455|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44289456|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
44289457|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44289458|NCT00773630|Protective Agents|protective agents|mesh-ancestor
44289459|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44289460|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44289461|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289462|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
44289463|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289464|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289465|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
44289466|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289467|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43646632|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
44289468|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289469|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289470|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289472|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289498|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44289499|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289500|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
44289501|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44289502|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289503|NCT00774072|Tobramycin|tobramycin|mesh-list
44289504|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289505|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289506|NCT00774111|Dolutegravir|dolutegravir|mesh-list
44289507|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44289508|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289509|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289510|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289511|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289512|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289513|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
44289514|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289515|NCT00774189|Clarithromycin|clarithromycin|mesh-list
44289516|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289517|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289518|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289552|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289553|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44289554|NCT00774358|Analgesics|analgesics|mesh-ancestor
44289555|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
44289556|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44289557|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289558|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289559|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289560|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
44289561|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289562|NCT00774423|Riluzole|riluzole|mesh-list
44289563|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
44289564|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44289565|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44289566|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289567|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289568|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289569|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44289570|NCT00774423|Protective Agents|protective agents|mesh-ancestor
44289571|NCT00774462|Rituximab|rituximab|mesh-list
44289572|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44289573|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289574|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
44289575|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289576|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289577|NCT00774475|Clopidogrel|clopidogrel|mesh-list
44289578|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44289579|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44289580|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44289581|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44289582|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
44289583|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44289584|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289588|NCT00774488|Incretins|incretins|mesh-ancestor
44289590|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289591|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289592|NCT00774501|Anesthetics|anesthetics|mesh-list
44289593|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44289594|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289595|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
44289596|NCT00774527|Fludarabine|fludarabine|mesh-list
44289597|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44289598|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289599|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
44289600|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289601|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44289602|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44289603|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
44289646|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289647|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44289649|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289650|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289651|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289652|NCT00774722|Metronidazole|metronidazole|mesh-list
44289653|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289654|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44289655|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44289656|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44289657|NCT00774735|Dolutegravir|dolutegravir|mesh-list
44289658|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44289659|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44289660|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289661|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289662|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44289663|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44289664|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
44289665|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464570|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44464571|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44464572|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44464573|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
44464574|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464575|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44464576|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44464596|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
44464597|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464598|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464599|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44464600|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
44464601|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464602|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44464603|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44464604|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464605|NCT01491737|Trastuzumab|trastuzumab|mesh-list
44464606|NCT01491737|Pertuzumab|pertuzumab|mesh-list
44464607|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44464608|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44464609|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464610|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44464611|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464612|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289698|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289699|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44289700|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44289701|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44289702|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
44289703|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289704|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44289705|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44289706|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44289708|NCT00775034|Coagulants|coagulants|mesh-ancestor
44289709|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44289710|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
44289711|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44289712|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
44289757|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289758|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44289759|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44289760|NCT00775151|Amlodipine|amlodipine|mesh-list
44289761|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289762|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44289825|NCT00775489|Hormones|hormones|mesh-ancestor
44289826|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44289827|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289828|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44289829|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44289830|NCT00775541|Ascorbic Acid|ascorbic acid|mesh-list
44289831|NCT00775541|Vitamins|vitamins|mesh-ancestor
44289832|NCT00775541|Micronutrients|micronutrients|mesh-ancestor
44289833|NCT00775541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44289834|NCT00775541|Antioxidants|antioxidants|mesh-ancestor
44289835|NCT00775541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289836|NCT00775541|Protective Agents|protective agents|mesh-ancestor
44289837|NCT00775580|Atenolol|atenolol|mesh-list
44289838|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44289839|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289884|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44289885|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
44289886|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44289887|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44464617|NCT01491672|Everolimus|everolimus|mesh-list
44289889|NCT00775697|Montelukast|montelukast|mesh-list
44289949|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44289950|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44289951|NCT00775827|Fenofibrate|fenofibrate|mesh-list
44289952|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44289953|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
44289954|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44289955|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44289956|NCT00775840|Candesartan|candesartan|mesh-list
44289957|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44289958|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43944747|NCT01025830|Lamivudine|lamivudine|mesh-list
44289959|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44289962|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44290010|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44290011|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44290012|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44290013|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290014|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290015|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290016|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290017|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
44290018|NCT00776113|Protective Agents|protective agents|mesh-ancestor
44290019|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44290020|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290021|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44290022|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
44290025|NCT00776139|Cetirizine|cetirizine|mesh-list
44290067|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290068|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290069|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
44290070|NCT00776360|Oxytocin|oxytocin|mesh-list
44290071|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
44290072|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44290073|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290074|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
44290075|NCT00776425|Hematinics|hematinics|mesh-ancestor
44290076|NCT00776438|Vaccines|vaccines|mesh-list
44290077|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
44290078|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290079|NCT00776477|Aspirin|aspirin|mesh-list
44290080|NCT00776477|Clopidogrel|clopidogrel|mesh-list
44290081|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44290082|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290126|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44290127|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44290128|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44290129|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44290131|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
44290132|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290133|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290134|NCT00776516|Urological Agents|urological agents|mesh-ancestor
44290135|NCT00776542|Minocycline|minocycline|mesh-list
44290149|NCT00776633|Clopidogrel|clopidogrel|mesh-list
44290150|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44290151|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290152|NCT00776633|Analgesics|analgesics|mesh-ancestor
44290153|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
44290154|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290155|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290156|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290157|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290158|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44290159|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44290160|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290210|NCT00776763|Bevacizumab|bevacizumab|mesh-list
44290211|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44290212|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290213|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290214|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290215|NCT00776763|Growth Substances|growth substances|mesh-ancestor
44290216|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290217|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290218|NCT00776802|Dexamethasone|dexamethasone|mesh-list
44290219|NCT00776802|Etoposide|etoposide|mesh-list
44290220|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290221|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
44290222|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
44290223|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290224|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290225|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290226|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
44290227|NCT00776802|Hormones|hormones|mesh-ancestor
44290228|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44290229|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44290230|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290231|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44290262|NCT00777218|Topiramate|topiramate|mesh-list
44290263|NCT00777218|Propranolol|propranolol|mesh-list
44290264|NCT00777218|Zonisamide|zonisamide|mesh-list
44290265|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44290266|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44290267|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
44290268|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290269|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290270|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290271|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44290272|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290273|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
44290274|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
44290275|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44290325|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
44290326|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290327|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44290328|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44290329|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290331|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44290332|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290391|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44290392|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290393|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44290394|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290395|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44290396|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290397|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290398|NCT00777738|Bortezomib|bortezomib|mesh-list
44290399|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290400|NCT00777933|Cyclosporine|cyclosporine|mesh-list
44290401|NCT00777933|Tacrolimus|tacrolimus|mesh-list
44290402|NCT00777933|Cyclosporins|cyclosporins|mesh-list
44290403|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44290404|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
44290405|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290406|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44290407|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290408|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290409|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
44290410|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290411|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290413|NCT00777959|Sirolimus|sirolimus|mesh-list
44290444|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290445|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290446|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44290447|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44290448|NCT00777998|Growth Substances|growth substances|mesh-ancestor
44290449|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44290450|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290451|NCT00777998|Trace Elements|trace elements|mesh-ancestor
44290452|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
44290453|NCT00778011|Ondansetron|ondansetron|mesh-list
44290454|NCT00778011|Metoclopramide|metoclopramide|mesh-list
44290455|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
44290456|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
44290457|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290458|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290459|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44290460|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
44290461|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
44290462|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44290463|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
44290464|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290465|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290466|NCT00778011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44290467|NCT00778011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290468|NCT00778011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290493|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290495|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290496|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290497|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290498|NCT00778050|Amoxicillin|amoxicillin|mesh-list
44290499|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290500|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290501|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
44290502|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44290503|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290504|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290505|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290506|NCT00778063|Analgesics|analgesics|mesh-ancestor
44290507|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
44290508|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290552|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44290553|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290554|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290555|NCT00778193|Aspirin|aspirin|mesh-list
44290556|NCT00778193|Celecoxib|celecoxib|mesh-list
44290557|NCT00778193|Naproxen|naproxen|mesh-list
44290558|NCT00778193|Clopidogrel|clopidogrel|mesh-list
44290559|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44290560|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44290561|NCT00778193|Analgesics|analgesics|mesh-ancestor
44290562|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
44290563|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290564|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290565|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290566|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290567|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44290568|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44290609|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44290610|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44290611|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290612|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290613|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
44290614|NCT00778284|Amoxicillin|amoxicillin|mesh-list
44290615|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290616|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290617|NCT00778297|Vaccines|vaccines|mesh-list
44290618|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
44290661|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44290662|NCT00778505|Narcotics|narcotics|mesh-ancestor
44290663|NCT00778505|Analgesics|analgesics|mesh-ancestor
44290664|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
44290665|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290666|NCT00778544|Amoxicillin|amoxicillin|mesh-list
44290667|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
44290668|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
44290669|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44290670|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290671|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290672|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290673|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290674|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44290675|NCT00778557|Cefprozil|cefprozil|mesh-list
44290676|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290677|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290678|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
44290679|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44290680|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290681|NCT00778583|Renal Agents|renal agents|mesh-ancestor
44290682|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290683|NCT00778596|Prednisolone|prednisolone|mesh-list
44290684|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44290685|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
44290686|NCT00778596|Hormones|hormones|mesh-ancestor
44290687|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44290688|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290689|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44290690|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290691|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44290692|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44290693|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44290694|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
44290695|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44290699|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44290700|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44290701|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44290702|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44290703|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44290704|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44290705|NCT00778661|Amoxicillin|amoxicillin|mesh-list
44290706|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44290707|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44290708|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44290709|NCT00778674|Benazepril|benazepril|mesh-list
44290710|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44290711|NCT00778674|Diuretics|diuretics|mesh-ancestor
44290712|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
44290713|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290714|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44290715|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44290754|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290755|NCT00778765|Gabapentin|gabapentin|mesh-list
44290756|NCT00778765|Analgesics|analgesics|mesh-ancestor
44290757|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
44290758|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44290759|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290760|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
44290761|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44290762|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44290763|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290764|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44290765|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44290766|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44290767|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290769|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
44290814|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290815|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44290816|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44290817|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
44290818|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290882|NCT00779389|Dasatinib|dasatinib|mesh-list
44290883|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44290884|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44290885|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44290886|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44290887|NCT00779441|Zolpidem|zolpidem|mesh-list
44290888|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44290889|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44290890|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44290891|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290892|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44290893|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
44290894|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
44290895|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44290944|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
44290945|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44290946|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44290947|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
44290948|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44290949|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44290950|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44290951|NCT00779792|Triamcinolone|triamcinolone|mesh-list
44291010|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44291011|NCT00779922|Growth Substances|growth substances|mesh-ancestor
44291012|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
44291013|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291014|NCT00779935|Infliximab|infliximab|mesh-list
44291015|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
44291016|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44291017|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291018|NCT00780013|Metformin|metformin|mesh-list
44291019|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44291020|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291021|NCT00780039|Carboplatin|carboplatin|mesh-list
44291022|NCT00780039|Doxorubicin|doxorubicin|mesh-list
44291023|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44291024|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291025|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44291026|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44291027|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44291028|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291029|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291030|NCT00780104|Cytarabine|cytarabine|mesh-list
44291031|NCT00780104|Sirolimus|sirolimus|mesh-list
44291032|NCT00780104|Etoposide|etoposide|mesh-list
44291033|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
44291034|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44291035|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291036|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44291060|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291062|NCT00780325|Naproxen|naproxen|mesh-list
44291063|NCT00780325|Acetazolamide|acetazolamide|mesh-list
44291064|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44291065|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44291066|NCT00780325|Analgesics|analgesics|mesh-ancestor
44291067|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
44291068|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291069|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291070|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291071|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291072|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44291073|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44291074|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291075|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291076|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
44113325|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113326|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113327|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
44113328|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
44113329|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
44113330|NCT00095264|Hematinics|hematinics|mesh-ancestor
44113331|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
44113332|NCT00095277|Hematinics|hematinics|mesh-ancestor
44113333|NCT00095316|Caspofungin|caspofungin|mesh-list
44113334|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
44113335|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113336|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113337|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113338|NCT00095329|Sirolimus|sirolimus|mesh-list
44113339|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113340|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113341|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113342|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113343|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
44113344|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113345|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
44113346|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113348|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113349|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113350|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113351|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
44113352|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113353|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113354|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113355|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
44113356|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
44113357|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113358|NCT00095368|Amoxicillin|amoxicillin|mesh-list
44113359|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113360|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113361|NCT00095433|Ranibizumab|ranibizumab|mesh-list
44113362|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113363|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113364|NCT00095433|Growth Substances|growth substances|mesh-ancestor
44113365|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113366|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113367|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113368|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
44291077|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
44291078|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44291079|NCT00780325|Diuretics|diuretics|mesh-ancestor
44291080|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
44291081|NCT00780377|Bradykinin|bradykinin|mesh-list
44291082|NCT00780377|Kininogens|kininogens|mesh-list
44291083|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291084|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44291085|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
44291086|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291087|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464671|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
44464672|NCT01490866|Antidotes|antidotes|mesh-ancestor
44464673|NCT01490866|Protective Agents|protective agents|mesh-ancestor
44464674|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
44464675|NCT01490866|Vitamins|vitamins|mesh-ancestor
44464676|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
44464677|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464678|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464679|NCT01490697|Cycloserine|cycloserine|mesh-list
44464680|NCT01490697|Mifepristone|mifepristone|mesh-list
44464681|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44464682|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
44464683|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464684|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464685|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44464686|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44464687|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44291088|NCT00780598|Tosedostat|tosedostat|mesh-list
44291089|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291090|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291105|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291106|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
44291107|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291108|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44291109|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44291110|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714927|NCT02665208|Nicotine|nicotine|mesh-list
44113369|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113370|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113371|NCT00095459|Bevacizumab|bevacizumab|mesh-list
44113372|NCT00095459|Sorafenib|sorafenib|mesh-list
44113373|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113374|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113375|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113376|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113377|NCT00095459|Growth Substances|growth substances|mesh-ancestor
44113378|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113379|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113380|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113381|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113382|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113383|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44113384|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113385|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113386|NCT00095511|Aripiprazole|aripiprazole|mesh-list
44113388|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113389|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113390|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113391|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113392|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113393|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113394|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
44113395|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113396|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113397|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113398|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113399|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
44113400|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113401|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113402|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113403|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113404|NCT00095524|Aripiprazole|aripiprazole|mesh-list
44113405|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113406|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113407|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113408|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113409|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113410|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113411|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113412|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
44113413|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113414|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113415|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113416|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113418|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113419|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113420|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113421|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113422|NCT00095641|Capecitabine|capecitabine|mesh-list
44113423|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113424|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
44113425|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113426|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113427|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
44113429|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113430|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291111|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291113|NCT00780754|Dutasteride|dutasteride|mesh-list
44291114|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44291115|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44291116|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291117|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291118|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291119|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291120|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291121|NCT00780780|Triamcinolone|triamcinolone|mesh-list
44291122|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44291123|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44291124|NCT00780780|Nepafenac|nepafenac|mesh-list
44291125|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44291126|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291127|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
44291128|NCT00780780|Hormones|hormones|mesh-ancestor
44291129|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291130|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291131|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291132|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
44291133|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291134|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291135|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44291136|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44291137|NCT00780780|Analgesics|analgesics|mesh-ancestor
44291138|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
43714937|NCT02665039|Gemcitabine|gemcitabine|mesh-list
44113431|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44113432|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
44113433|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113434|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113435|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44113436|NCT00095667|Lapatinib|lapatinib|mesh-list
44113437|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113438|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113439|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113440|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113441|NCT00095680|Bortezomib|bortezomib|mesh-list
44113442|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153931|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
44291139|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291140|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291141|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44291142|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291143|NCT00780832|Caffeine|caffeine|mesh-list
44291144|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44291145|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44291146|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291147|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44291148|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291149|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291150|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44291151|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44291152|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
44291153|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291154|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
44291155|NCT00780858|Ganirelix|ganirelix|mesh-list
44291156|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291157|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291158|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291159|NCT00781105|Telbivudine|telbivudine|mesh-list
44291160|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
44291161|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153932|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
44153933|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
44153934|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153935|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44153936|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153937|NCT00222170|Rabeprazole|rabeprazole|mesh-list
44153938|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44153939|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153940|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44153941|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153942|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153943|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
44153944|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44153945|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153946|NCT00222183|Analgesics|analgesics|mesh-ancestor
44153947|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
44153951|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153952|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153953|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153954|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
44153955|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44153956|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153957|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153958|NCT00222235|Cycloserine|cycloserine|mesh-list
44153959|NCT00222235|Glycine|glycine|mesh-list
44153960|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44153961|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291162|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44291163|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291164|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291165|NCT00781131|Pregabalin|pregabalin|mesh-list
44291166|NCT00781131|Analgesics|analgesics|mesh-ancestor
44291167|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
44291168|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291169|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291170|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
44291171|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44291172|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44291173|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291174|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44291175|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44291176|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291177|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291178|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291179|NCT00781157|Phenylephrine|phenylephrine|mesh-list
44291180|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
44291181|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44291182|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
44291183|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
44291184|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291185|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291186|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
44291187|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44291188|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
44291189|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291190|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44291191|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44291192|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44291193|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291194|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291195|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291196|NCT00781157|Protective Agents|protective agents|mesh-ancestor
44291197|NCT00781196|Folic Acid|folic acid|mesh-list
44291199|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
44291201|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
44291202|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291203|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
44291204|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291205|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291206|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
44291207|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44153962|NCT00222235|Renal Agents|renal agents|mesh-ancestor
44153963|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44153964|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
44153965|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44153966|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
44153967|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153968|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
44153969|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153970|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153971|NCT00222261|Aspirin|aspirin|mesh-list
44153972|NCT00222261|Clopidogrel|clopidogrel|mesh-list
44153973|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44153974|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153975|NCT00222261|Analgesics|analgesics|mesh-ancestor
44153976|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
44113443|NCT00095693|Sorafenib|sorafenib|mesh-list
44113444|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44113445|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113446|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113447|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113448|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113449|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44113450|NCT00095706|Bevacizumab|bevacizumab|mesh-list
44113451|NCT00095706|Trastuzumab|trastuzumab|mesh-list
44113452|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113453|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113454|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113455|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113456|NCT00095706|Growth Substances|growth substances|mesh-ancestor
44113457|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113458|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113459|NCT00095719|Aripiprazole|aripiprazole|mesh-list
44113460|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113461|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113462|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113463|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113464|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113465|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113466|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113467|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
44113468|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113469|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113470|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113471|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113472|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
44113473|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113474|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113475|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113476|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113477|NCT00095745|Aripiprazole|aripiprazole|mesh-list
44113478|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
44113479|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113480|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113481|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113482|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113483|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113484|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113485|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
44291208|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44291209|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
44291210|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291211|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44291212|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44291213|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291214|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291215|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44291216|NCT00781300|Dexamethasone|dexamethasone|mesh-list
44291217|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291218|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
44291219|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
44291220|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291221|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291222|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44291223|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
44291224|NCT00781300|Hormones|hormones|mesh-ancestor
44291225|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291226|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44291227|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291228|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44291229|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
44291230|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44291231|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
44291232|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
44291233|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945964|NCT03753919|Durvalumab|durvalumab|mesh-list
44291234|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291235|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44291236|NCT00781352|Analgesics|analgesics|mesh-ancestor
43714968|NCT02664493|Prednisolone|prednisolone|mesh-list
44113492|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113493|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113494|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113495|NCT00095758|Aripiprazole|aripiprazole|mesh-list
44113496|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
44113497|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113498|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113499|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113500|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113501|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113502|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113503|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
44113504|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113505|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291237|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
44291238|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291239|NCT00781378|Plasminogen|plasminogen|mesh-list
44291240|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44291241|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44291242|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44291243|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291244|NCT00781404|Adenosine|adenosine|mesh-list
44291245|NCT00781404|Analgesics|analgesics|mesh-ancestor
44291246|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
44291247|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291248|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291249|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44291250|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291251|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44291252|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
44291253|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
44291254|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291255|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291256|NCT00781417|Vitamin D|vitamin d|mesh-list
44291257|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
44291258|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
44291259|NCT00781417|Vitamins|vitamins|mesh-list
44291260|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
44291261|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291262|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291263|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44291264|NCT00781482|Zolpidem|zolpidem|mesh-list
44291265|NCT00781482|Eszopiclone|eszopiclone|mesh-list
44291266|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44291267|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44113506|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113507|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113508|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
44113509|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113510|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113511|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113512|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113513|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
44113514|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113515|NCT00095810|Aripiprazole|aripiprazole|mesh-list
44113516|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113517|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113518|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44291268|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291269|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291270|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44291271|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
44291272|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
44291273|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291274|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291275|NCT00781521|Ofloxacin|ofloxacin|mesh-list
44291276|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44291277|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113519|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113520|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113521|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113522|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113523|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
44113524|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113525|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113526|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113527|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113528|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
44113529|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113530|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113531|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113532|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113533|NCT00095823|Aripiprazole|aripiprazole|mesh-list
44113534|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
44113535|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113536|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113537|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113538|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113539|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113540|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113541|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
44113542|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113543|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113544|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113545|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113546|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
44113547|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113548|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113549|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44113550|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113551|NCT00095862|Interferons|interferons|mesh-list
44113556|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113558|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646707|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
44113559|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
44113560|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113561|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113562|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44113563|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
44113564|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113565|NCT00095888|Gemcitabine|gemcitabine|mesh-list
44113566|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113567|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
44113568|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113569|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113570|NCT00095888|Antiviral Agents|antiviral agents|mesh-ancestor
44113571|NCT00095888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113572|NCT00095888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113573|NCT00095888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113574|NCT00095888|Immunologic Factors|immunologic factors|mesh-ancestor
44113575|NCT00095888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291278|NCT00781521|Renal Agents|renal agents|mesh-ancestor
44291279|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291280|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44291281|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44291282|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291283|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291284|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291285|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44291286|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44291287|NCT00781547|Hormones|hormones|mesh-list
44291288|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291289|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291290|NCT00781573|Clopidogrel|clopidogrel|mesh-list
44291291|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44291292|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44291293|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44291294|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44291295|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
44291296|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291297|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291298|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291299|NCT00781586|Caffeine|caffeine|mesh-list
44291300|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291301|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44291302|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44291303|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291304|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291305|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44291306|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44291307|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
44291308|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291309|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
44291310|NCT00781625|Methenamine|methenamine|mesh-list
44291315|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291317|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44291318|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44291319|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
44291320|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291321|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291322|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113576|NCT00095901|Capecitabine|capecitabine|mesh-list
44113577|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113578|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
44113579|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113580|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113581|NCT00095914|Paclitaxel|paclitaxel|mesh-list
44113582|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44113583|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113584|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113585|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113586|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113587|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44113588|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113589|NCT00095927|Paclitaxel|paclitaxel|mesh-list
44113590|NCT00095927|Carboplatin|carboplatin|mesh-list
44113591|NCT00095927|Amifostine|amifostine|mesh-list
44113592|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113593|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113594|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113595|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113596|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
44113597|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113598|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44113599|NCT00095927|Protective Agents|protective agents|mesh-ancestor
44113600|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113601|NCT00095966|Gemcitabine|gemcitabine|mesh-list
44113602|NCT00095966|Sorafenib|sorafenib|mesh-list
44113603|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113604|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
44113605|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113606|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113607|NCT00095966|Antiviral Agents|antiviral agents|mesh-ancestor
44113608|NCT00095966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113609|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113610|NCT00095966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113611|NCT00095966|Immunologic Factors|immunologic factors|mesh-ancestor
44113612|NCT00095966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113613|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113614|NCT00096005|Bortezomib|bortezomib|mesh-list
44113615|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113616|NCT00096057|Antibodies|antibodies|mesh-list
44113617|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44113618|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
44113619|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113620|NCT00096070|Gemcitabine|gemcitabine|mesh-list
44113621|NCT00096070|Fluorouracil|fluorouracil|mesh-list
44113622|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
44113627|NCT00096070|Antiviral Agents|antiviral agents|mesh-ancestor
44113628|NCT00096070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113629|NCT00096070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113630|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113631|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
44113632|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113634|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44113635|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
44113636|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113637|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113638|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44113639|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291323|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
44291324|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291325|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291326|NCT00781820|Bifonazole|bifonazole|mesh-list
44291327|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
44291328|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291329|NCT00781846|Sirolimus|sirolimus|mesh-list
44291330|NCT00781846|Bevacizumab|bevacizumab|mesh-list
44291331|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291332|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291333|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44291334|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44291335|NCT00781846|Growth Substances|growth substances|mesh-ancestor
44291336|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715068|NCT02663713|Ticagrelor|ticagrelor|mesh-list
44113640|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
44113641|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113642|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
44113643|NCT00096096|Tacrolimus|tacrolimus|mesh-list
44113644|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113645|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
44113646|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113647|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44113648|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113649|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113650|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113651|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113652|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44113653|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
44113654|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113655|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113656|NCT00096148|Cytarabine|cytarabine|mesh-list
44113657|NCT00096148|Bevacizumab|bevacizumab|mesh-list
44113658|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44113659|NCT00096148|Idarubicin|idarubicin|mesh-list
44113660|NCT00096148|Antibodies|antibodies|mesh-list
44113661|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
44113663|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113664|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113665|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113666|NCT00096148|Growth Substances|growth substances|mesh-ancestor
44113667|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113668|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113669|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
44113670|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113671|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
44113672|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113673|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
44113674|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113675|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113676|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113677|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44113678|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44113679|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113681|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113682|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113683|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113684|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44113685|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44113686|NCT00096291|Paclitaxel|paclitaxel|mesh-list
44113687|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44291338|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291339|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291340|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44291341|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
44291342|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291343|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
44291344|NCT00782041|Leucovorin|leucovorin|mesh-list
44291345|NCT00782041|Folic Acid|folic acid|mesh-list
44291346|NCT00782041|Fluorouracil|fluorouracil|mesh-list
44291347|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
44291348|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
44291349|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
44291350|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291351|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44291352|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113688|NCT00096291|Doxorubicin|doxorubicin|mesh-list
44113689|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44113690|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113691|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113692|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113693|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113694|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44113698|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44113699|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113700|NCT00096304|Docetaxel|docetaxel|mesh-list
44113701|NCT00096304|Epirubicin|epirubicin|mesh-list
44113702|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113703|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113704|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113705|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
44113706|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113707|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113708|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44113709|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44113710|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113711|NCT00096317|Ketoconazole|ketoconazole|mesh-list
44113712|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
44113713|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113714|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44113715|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44113716|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113717|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113718|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44113719|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
44113720|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44113721|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113722|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44113723|NCT00096330|Folic Acid|folic acid|mesh-list
44113724|NCT00096330|Hematinics|hematinics|mesh-ancestor
44113725|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
44113726|NCT00096330|Vitamins|vitamins|mesh-ancestor
44113727|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
44113728|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113729|NCT00096343|Paclitaxel|paclitaxel|mesh-list
44113730|NCT00096343|Carboplatin|carboplatin|mesh-list
44113731|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113732|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113733|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113734|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113735|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
44291353|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291354|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
44291355|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291356|NCT00782041|Antidotes|antidotes|mesh-ancestor
44291357|NCT00782041|Protective Agents|protective agents|mesh-ancestor
44291358|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
44291359|NCT00782041|Vitamins|vitamins|mesh-ancestor
44291360|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
44291361|NCT00782041|Hematinics|hematinics|mesh-ancestor
44291362|NCT00782093|Volociximab|volociximab|mesh-list
44291363|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44291364|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44291365|NCT00782093|Growth Substances|growth substances|mesh-ancestor
44291366|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291367|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44291368|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291369|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
44291370|NCT00782106|Antibodies|antibodies|mesh-list
44291371|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
44291372|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44291373|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44291374|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
44291375|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
44291376|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291377|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
44291378|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44291379|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
44291380|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291381|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
43557275|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113736|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113737|NCT00096369|Tamoxifen|tamoxifen|mesh-list
44113738|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44113739|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
44113740|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44113741|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113742|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44113743|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113744|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44113745|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44113746|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44113747|NCT00096395|Gemcitabine|gemcitabine|mesh-list
44113748|NCT00096395|Sorafenib|sorafenib|mesh-list
44113749|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113750|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
44113751|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113752|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113753|NCT00096395|Antiviral Agents|antiviral agents|mesh-ancestor
44291382|NCT00782197|Protective Agents|protective agents|mesh-ancestor
44464688|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
44464689|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44464690|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44464691|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291383|NCT00782301|Maraviroc|maraviroc|mesh-list
44291384|NCT00782301|Etravirine|etravirine|mesh-list
44291385|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44113754|NCT00096395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113755|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113756|NCT00096395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113757|NCT00096395|Immunologic Factors|immunologic factors|mesh-ancestor
44113758|NCT00096395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113759|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113760|NCT00096434|Sorafenib|sorafenib|mesh-list
44113761|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113762|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113763|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113771|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113772|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
44113773|NCT00096512|Sorafenib|sorafenib|mesh-list
44113774|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113775|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113776|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113777|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113778|NCT00096525|Lenalidomide|lenalidomide|mesh-list
44113779|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
44113780|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113781|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113782|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113783|NCT00096525|Growth Substances|growth substances|mesh-ancestor
44113784|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113785|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113786|NCT00096551|Metronidazole|metronidazole|mesh-list
44113787|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113788|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113789|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44113790|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44113791|NCT00096616|Albuterol|albuterol|mesh-list
44113792|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44113793|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
44113794|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113795|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113796|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44113797|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
44113798|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
44113799|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44113800|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44113801|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44113802|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44113803|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44113804|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113805|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113806|NCT00096629|Vaccines|vaccines|mesh-list
44113807|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
44113808|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113809|NCT00096655|Infliximab|infliximab|mesh-list
44113810|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44113811|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113812|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113813|NCT00096668|Paclitaxel|paclitaxel|mesh-list
44113814|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113815|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113816|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113817|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113818|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
44113819|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113821|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44113822|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
44291387|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291388|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44291389|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44291390|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
44291391|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291392|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44291393|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44291394|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44113823|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44113824|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113825|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44113826|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44113827|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44113828|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
44113829|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
44113830|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113831|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
44113836|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44113837|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
44113838|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113839|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113840|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113841|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
44113842|NCT00096720|Protective Agents|protective agents|mesh-ancestor
44113843|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113844|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44113845|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44113846|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44113847|NCT00096811|Entecavir|entecavir|mesh-list
44113848|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
44113849|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113850|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
44113851|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113852|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44113853|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44113854|NCT00096850|Ritonavir|ritonavir|mesh-list
44113855|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44113856|NCT00096850|Rifampin|rifampin|mesh-list
44113857|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44113858|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44113859|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44113860|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113861|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113862|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44113863|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44113864|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
44113865|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113866|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44113867|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44113868|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44113869|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
44113870|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44113871|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
44113872|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44113873|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44113874|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44113875|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44113876|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44113877|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44113878|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44113879|NCT00096863|Haloperidol|haloperidol|mesh-list
44113880|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
44113881|NCT00096863|Ziprasidone|ziprasidone|mesh-list
44291396|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44291397|NCT00782405|Mirtazapine|mirtazapine|mesh-list
44291398|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
44291399|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291400|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44291401|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291402|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291403|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291404|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44291405|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
44291406|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
44291407|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113882|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
44113883|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
44113884|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113885|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113886|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113887|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113888|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113889|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113890|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113891|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113892|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
44113893|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113894|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113895|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44113896|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113897|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
44113898|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
44113899|NCT00096915|Hematinics|hematinics|mesh-ancestor
44113900|NCT00096967|Bevacizumab|bevacizumab|mesh-list
44113901|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113902|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113903|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113909|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113910|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113911|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113912|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113913|NCT00097019|Growth Substances|growth substances|mesh-ancestor
44113914|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113915|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113916|NCT00097032|Risperidone|risperidone|mesh-list
44113917|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44113918|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44113919|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
44113920|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113921|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113922|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113923|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113924|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113925|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113926|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113927|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44113928|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
44113929|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113930|NCT00097045|Interferons|interferons|mesh-list
44113931|NCT00097045|Ribavirin|ribavirin|mesh-list
44113932|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
44113933|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113934|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
44113935|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113936|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
44291408|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291410|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44291411|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44291412|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44291413|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291414|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44291415|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44291416|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
44291417|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44291418|NCT00782470|Factor VIII|factor viii|mesh-list
44291419|NCT00782470|Coagulants|coagulants|mesh-ancestor
44291420|NCT00782548|Morphine|morphine|mesh-list
44291421|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44291422|NCT00782548|Narcotics|narcotics|mesh-ancestor
44291423|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291424|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291425|NCT00782548|Analgesics|analgesics|mesh-ancestor
44291426|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
44291427|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291428|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
44291429|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44291430|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
44291431|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291432|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291433|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44291434|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291435|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44291436|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
44113937|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113938|NCT00097071|Insulin|insulin|mesh-list
44113939|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44113940|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
44113941|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
44113942|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113943|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113944|NCT00097084|Insulin|insulin|mesh-list
44113945|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44113946|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
44113947|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
44113948|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
44113949|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44113950|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113951|NCT00097110|Ascorbic Acid|ascorbic acid|mesh-list
44113952|NCT00097110|Vitamins|vitamins|mesh-ancestor
44113953|NCT00097110|Micronutrients|micronutrients|mesh-ancestor
44291437|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291438|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291439|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44291440|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291442|NCT00782652|Protective Agents|protective agents|mesh-ancestor
44291443|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
44291444|NCT00782847|Cyproterone|cyproterone|mesh-list
44291445|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
44113954|NCT00097110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113955|NCT00097110|Antioxidants|antioxidants|mesh-ancestor
44113956|NCT00097110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113957|NCT00097110|Protective Agents|protective agents|mesh-ancestor
44113958|NCT00097123|Misoprostol|misoprostol|mesh-list
44113959|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44113960|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
44113961|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44113962|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113963|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44113964|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44113965|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
44113966|NCT00097188|Rituximab|rituximab|mesh-list
44113967|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113968|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113969|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
44113970|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113971|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113972|NCT00097214|Carboplatin|carboplatin|mesh-list
44113973|NCT00097214|Cetuximab|cetuximab|mesh-list
44113974|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113975|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113976|NCT00097227|Paclitaxel|paclitaxel|mesh-list
44113984|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113985|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44113986|NCT00097266|Haloperidol|haloperidol|mesh-list
44113987|NCT00097266|Aripiprazole|aripiprazole|mesh-list
44113988|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
44113989|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113990|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44113991|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44113992|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44113993|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44113994|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113995|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
44113996|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
44113997|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113998|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113999|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44114000|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44114001|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
44114002|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44114003|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44114004|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44114005|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44114006|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
44114007|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
44114008|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114009|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44114010|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44114011|NCT00097279|Metformin|metformin|mesh-list
44114012|NCT00097279|Pioglitazone|pioglitazone|mesh-list
44114013|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
44114014|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
44114015|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114016|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114017|NCT00097318|Interferons|interferons|mesh-list
44114018|NCT00097318|Interferon-beta|interferon-beta|mesh-list
44291446|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291447|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291448|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291449|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291450|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44114019|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
44114020|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114021|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
44114022|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114023|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
44114024|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114025|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44114026|NCT00097344|Toremifene|toremifene|mesh-list
44114027|NCT00097344|Letrozole|letrozole|mesh-list
44114028|NCT00097344|Hormones|hormones|mesh-list
44114029|NCT00097344|Atamestane|atamestane|mesh-list
44114030|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
44114031|NCT00097344|Estrogens|estrogens|mesh-list
44114032|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
44114033|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
44114034|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114035|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114036|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114037|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44114038|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44114039|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114040|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114041|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114042|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44114043|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44114044|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114046|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114049|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44114050|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114051|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114053|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
44114054|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114055|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
44114056|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153977|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153978|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153979|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44153980|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153981|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44153982|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44153983|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153984|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44153985|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44153986|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153987|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
44153988|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44153989|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44153990|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44153991|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
44153992|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153993|NCT00222443|Irinotecan|irinotecan|mesh-list
44153994|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44153995|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153996|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153997|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153998|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153999|NCT00222469|Gemcitabine|gemcitabine|mesh-list
44154000|NCT00222469|Bevacizumab|bevacizumab|mesh-list
44154001|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
44154002|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44154003|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154004|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44291451|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
44291452|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44291453|NCT00782951|Morphine|morphine|mesh-list
44291454|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44291455|NCT00782951|Narcotics|narcotics|mesh-ancestor
44291456|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291457|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291458|NCT00782951|Analgesics|analgesics|mesh-ancestor
44291459|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
44291460|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291461|NCT00783016|Morphine|morphine|mesh-list
44154005|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44154006|NCT00222469|Growth Substances|growth substances|mesh-ancestor
44154007|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154008|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
44154009|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44154010|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
44154011|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154012|NCT00222469|Antiviral Agents|antiviral agents|mesh-ancestor
44154013|NCT00222469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154014|NCT00222469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154015|NCT00222469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154016|NCT00222469|Immunologic Factors|immunologic factors|mesh-ancestor
44154017|NCT00222482|Valproic Acid|valproic acid|mesh-list
44154018|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
44154019|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154020|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154021|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
44154022|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154023|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154024|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
44154025|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154026|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154027|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154028|NCT00222495|Olanzapine|olanzapine|mesh-list
44154029|NCT00222495|Risperidone|risperidone|mesh-list
44154030|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44154031|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44154032|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
44154033|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154034|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154035|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154037|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44114057|NCT00097734|Ertapenem|ertapenem|mesh-list
44114058|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114063|NCT00097799|Ritonavir|ritonavir|mesh-list
44114064|NCT00097799|Tipranavir|tipranavir|mesh-list
44114065|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44114066|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44114067|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114068|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114069|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114070|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114071|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114072|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
44114073|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114074|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44114075|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114076|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
44114077|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114078|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114079|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
44114080|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114081|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114082|NCT00097877|Insulin|insulin|mesh-list
44114083|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44291462|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44291463|NCT00783016|Narcotics|narcotics|mesh-ancestor
44291464|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291465|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291466|NCT00783016|Analgesics|analgesics|mesh-ancestor
44291467|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
44291468|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291469|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44291470|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44291471|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44291472|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
44291473|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291474|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44291475|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44291476|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291477|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
44291478|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44291479|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44291480|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
44291481|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291482|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291483|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291484|NCT00783081|Cilostazol|cilostazol|mesh-list
44291485|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44291486|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
44291487|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291488|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291489|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44291490|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291491|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44291504|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291505|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291506|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
44291507|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291508|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
44291509|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291510|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
44291511|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291512|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44291513|NCT00783172|Gemcitabine|gemcitabine|mesh-list
44291514|NCT00783172|Mitogens|mitogens|mesh-list
44291515|NCT00783172|Enkephalins|enkephalins|mesh-list
44291516|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44291517|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
44291518|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291519|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291520|NCT00783172|Antiviral Agents|antiviral agents|mesh-ancestor
44291521|NCT00783172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291522|NCT00783172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291523|NCT00783172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291524|NCT00783172|Immunologic Factors|immunologic factors|mesh-ancestor
44291525|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114084|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
44114085|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
44114086|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
44114087|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114088|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114089|NCT00097903|Camptothecin|camptothecin|mesh-list
44114090|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44114091|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114092|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44114093|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44114094|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114095|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114096|NCT00097916|Memantine|memantine|mesh-list
44114097|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44114098|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44114099|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
44114100|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114101|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114102|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114103|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44114104|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44114105|NCT00097929|Vorinostat|vorinostat|mesh-list
44114106|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114107|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44114108|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114109|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114110|NCT00097942|Memantine|memantine|mesh-list
44114111|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44114112|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44114113|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
44114114|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291527|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291528|NCT00783250|Albuterol|albuterol|mesh-list
44291529|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
44291530|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44291531|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
44291532|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291533|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291534|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44291535|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291536|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
44291537|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44291538|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
44291539|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291540|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114115|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114116|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114117|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44114118|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44114119|NCT00097968|Everolimus|everolimus|mesh-list
44114120|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114121|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114122|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
44114123|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114124|NCT00098007|Everolimus|everolimus|mesh-list
44114125|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114126|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114127|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
44114128|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114133|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114134|NCT00098046|Famciclovir|famciclovir|mesh-list
44114135|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
44114136|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114137|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114138|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114139|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114140|NCT00098111|Azathioprine|azathioprine|mesh-list
44114141|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
44114142|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114143|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114144|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114145|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114146|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
44114147|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114148|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114149|NCT00098124|Milnacipran|milnacipran|mesh-list
44114150|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
44114151|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44114152|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44114153|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114154|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114155|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114156|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114157|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114158|NCT00098124|Analgesics|analgesics|mesh-ancestor
44114159|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
44114160|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291541|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
44291542|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44291543|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44291544|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44291545|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44291546|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291547|NCT00783380|Vaccines|vaccines|mesh-list
44291548|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
44291549|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291550|NCT00783393|Temozolomide|temozolomide|mesh-list
44291551|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44291552|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
44291553|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291554|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291555|NCT00783471|Docetaxel|docetaxel|mesh-list
44291556|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44291557|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291558|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44291559|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44291560|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44291561|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291562|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291563|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291564|NCT00783484|Maraviroc|maraviroc|mesh-list
44291565|NCT00783484|Darunavir|darunavir|mesh-list
44291566|NCT00783484|Midazolam|midazolam|mesh-list
44291567|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44291568|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44291569|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291570|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291571|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44291572|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291573|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291574|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44291575|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
44291576|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
44291580|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291582|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44291583|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44291584|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44291585|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
44291586|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291587|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44291588|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44291589|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44291590|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
44291591|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291592|NCT00783523|Doxycycline|doxycycline|mesh-list
44291593|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291594|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291595|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
44291596|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44291597|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44291598|NCT00783601|Montelukast|montelukast|mesh-list
44291599|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44291600|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291601|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44291602|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291603|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291604|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291605|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44291606|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43715256|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
44114161|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
44114162|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44114163|NCT00098137|Olmesartan|olmesartan|mesh-list
44114164|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44114165|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44114166|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44114167|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114168|NCT00098241|Everolimus|everolimus|mesh-list
44114169|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114170|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114171|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
44114172|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114173|NCT00098280|Eculizumab|eculizumab|mesh-list
44114174|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44114175|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114176|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
44114177|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114178|NCT00098319|Folic Acid|folic acid|mesh-list
44291607|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291608|NCT00783653|Sunitinib|sunitinib|mesh-list
44291609|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291610|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44291611|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44291612|NCT00783653|Growth Substances|growth substances|mesh-ancestor
44291613|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715284|NCT02662348|Aldesleukin|aldesleukin|mesh-list
44114179|NCT00098319|Hematinics|hematinics|mesh-ancestor
44114180|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
44114181|NCT00098319|Vitamins|vitamins|mesh-ancestor
44114182|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
44114183|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114184|NCT00098358|Zileuton|zileuton|mesh-list
44114185|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44114186|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114187|NCT00098358|Analgesics|analgesics|mesh-ancestor
44114188|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
44114189|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114190|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114191|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44114192|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114193|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44114194|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114195|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114196|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44114200|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114201|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114202|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44114204|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114205|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114207|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114208|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
44114209|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114210|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114211|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
44114212|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114213|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114214|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
44114215|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114216|NCT00098436|Temozolomide|temozolomide|mesh-list
44114217|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44114218|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
44114219|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114220|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114221|NCT00098462|Sirolimus|sirolimus|mesh-list
44114222|NCT00098462|Gefitinib|gefitinib|mesh-list
44114223|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114224|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114225|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114226|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114227|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
44114228|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114229|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
44114230|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114231|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114232|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114233|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114234|NCT00098488|Rituximab|rituximab|mesh-list
44114235|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44114236|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114237|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
44114238|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114239|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114240|NCT00098501|Sirolimus|sirolimus|mesh-list
44114241|NCT00098501|EKB 569|ekb 569|mesh-list
44114242|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291614|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
44291615|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291616|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291617|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291619|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44291620|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44291621|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291622|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291623|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44291624|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291625|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291626|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44291627|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
44291628|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
44291629|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
44291630|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
44291631|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291632|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291633|NCT00783744|Insulin|insulin|mesh-list
44291634|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44291635|NCT00783744|Metformin|metformin|mesh-list
44291636|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
44291637|NCT00783744|Glimepiride|glimepiride|mesh-list
44291638|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
44291639|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
44291640|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
44291641|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44291642|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291643|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44291644|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291645|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
44291646|NCT00783900|Metoprolol|metoprolol|mesh-list
44291647|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44291648|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44291649|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
44291650|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
44291654|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44291655|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44291657|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291658|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291659|NCT00783926|Vaccines|vaccines|mesh-list
44291660|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
44291661|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
44291662|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291663|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
44291664|NCT00784017|Asparaginase|asparaginase|mesh-list
44291665|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291666|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
44291667|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291668|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
44291669|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291670|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291671|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44291672|NCT00784186|Misoprostol|misoprostol|mesh-list
44291673|NCT00784186|Mifepristone|mifepristone|mesh-list
44291674|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44291675|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
44291676|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44291677|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291678|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44291679|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44291680|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
44291681|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44291682|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44291683|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44291684|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44291685|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
44291686|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44464693|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
44464694|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44464695|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44464696|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44464697|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464699|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44464700|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
44464701|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464702|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
44464703|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464704|NCT01490580|Atropine|atropine|mesh-list
44464705|NCT01490580|Sufentanil|sufentanil|mesh-list
44464706|NCT01490580|Propofol|propofol|mesh-list
44464707|NCT01490580|Atracurium|atracurium|mesh-list
44464708|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44464709|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44464710|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464711|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44464712|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
44464713|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
44464714|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44464715|NCT01490580|Narcotics|narcotics|mesh-ancestor
44464716|NCT01490580|Analgesics|analgesics|mesh-ancestor
44464717|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
44464718|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114243|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114244|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114245|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114246|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
44114247|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114248|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
44114249|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114250|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114251|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114252|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114253|NCT00098527|Romidepsin|romidepsin|mesh-list
44114254|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114255|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114256|NCT00098540|Sorafenib|sorafenib|mesh-list
44114257|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114258|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114259|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114260|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114261|NCT00098553|Everolimus|everolimus|mesh-list
44114262|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114263|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114264|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
44114265|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464719|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44464720|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44464721|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44464722|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
44464723|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44464724|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
44464726|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
44464727|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44464728|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44464729|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
44464730|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114266|NCT00098579|Doxorubicin|doxorubicin|mesh-list
44114267|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44114268|NCT00098579|Alvocidib|alvocidib|mesh-list
44114269|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114270|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114271|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44114272|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44114273|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114274|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114275|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
44114276|NCT00098579|Growth Substances|growth substances|mesh-ancestor
44114277|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114278|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114279|NCT00098605|Lapatinib|lapatinib|mesh-list
44114280|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114281|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114282|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114283|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114284|NCT00098618|Interferons|interferons|mesh-list
44114285|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
44114286|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
44114287|NCT00098618|Sorafenib|sorafenib|mesh-list
44114288|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114289|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
44114290|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114291|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114292|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114293|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114294|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
44114295|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114296|NCT00098631|Lapatinib|lapatinib|mesh-list
44114297|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114298|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114299|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114300|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114301|NCT00098683|Amifostine|amifostine|mesh-list
44114302|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44114303|NCT00098683|Protective Agents|protective agents|mesh-ancestor
44114304|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114305|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44114306|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44114307|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114308|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114309|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
44114310|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114311|NCT00098800|Fenretinide|fenretinide|mesh-list
44114312|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114313|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44114314|NCT00098800|Protective Agents|protective agents|mesh-ancestor
44114315|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114316|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
44464731|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464732|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44464733|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44464734|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44464735|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44464737|NCT01490190|Etonogestrel|etonogestrel|mesh-list
44464738|NCT01490190|NuvaRing|nuvaring|mesh-list
44464739|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44464740|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44114317|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114318|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114319|NCT00098878|Carboplatin|carboplatin|mesh-list
44114320|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114321|NCT00098891|Entinostat|entinostat|mesh-list
44114322|NCT00098891|Isotretinoin|isotretinoin|mesh-list
44114323|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44114324|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
44114325|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114326|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114327|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114328|NCT00098917|Vaccines|vaccines|mesh-list
44114329|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
44114330|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114331|NCT00098969|Resveratrol|resveratrol|mesh-list
44114332|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
44114333|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114334|NCT00098969|Protective Agents|protective agents|mesh-ancestor
44114335|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114336|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114337|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44114338|NCT00098982|Leucovorin|leucovorin|mesh-list
44114339|NCT00098982|Fluorouracil|fluorouracil|mesh-list
44114340|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
44114341|NCT00098982|Bortezomib|bortezomib|mesh-list
44114342|NCT00098982|Calcium|calcium|mesh-list
44114343|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
44114344|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44114345|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114346|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
44114347|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114348|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114350|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114351|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
44114352|NCT00098982|Antidotes|antidotes|mesh-ancestor
44114353|NCT00098982|Protective Agents|protective agents|mesh-ancestor
44114354|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
44114355|NCT00098982|Vitamins|vitamins|mesh-ancestor
44114356|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
44114357|NCT00098995|Cisplatin|cisplatin|mesh-list
44114358|NCT00098995|Tirapazamine|tirapazamine|mesh-list
44114359|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114361|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44114362|NCT00099008|Protective Agents|protective agents|mesh-ancestor
44114363|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114364|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114365|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114366|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114367|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114368|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
44114369|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44114370|NCT00099008|Estrogens|estrogens|mesh-ancestor
44114371|NCT00099008|Hormones|hormones|mesh-ancestor
44114372|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114373|NCT00099060|Lapatinib|lapatinib|mesh-list
44114374|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114375|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464741|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44464743|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44464744|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464745|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44464746|NCT01490190|Estrogens|estrogens|mesh-ancestor
44464747|NCT01490190|Hormones|hormones|mesh-ancestor
44464748|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464749|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
44464750|NCT01490125|Albuterol|albuterol|mesh-list
44464751|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
44464752|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44464753|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
44464754|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464755|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464756|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44114376|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114377|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114378|NCT00099125|Irinotecan|irinotecan|mesh-list
44114379|NCT00099125|Temozolomide|temozolomide|mesh-list
44114380|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44114381|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44114382|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114383|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114384|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114385|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44114386|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
44114387|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44114388|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44114389|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44114390|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114391|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114392|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114393|NCT00099164|Progestins|progestins|mesh-ancestor
44114394|NCT00099164|Hormones|hormones|mesh-ancestor
44114395|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
44114396|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
44114397|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114398|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114399|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
44114400|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114401|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44114402|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114403|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114404|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114405|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
44114406|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
44114407|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
44114408|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114409|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114410|NCT00099216|Rivastigmine|rivastigmine|mesh-list
44114411|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44114412|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114413|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114414|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
44114415|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114416|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464758|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
44291694|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291695|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291696|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291697|NCT00784316|Metoprolol|metoprolol|mesh-list
44291698|NCT00784316|Amiodarone|amiodarone|mesh-list
44291699|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44291700|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44291701|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
44291702|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
44291703|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291704|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291705|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44291706|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44291707|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44291708|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
44291709|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291710|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291711|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
44291712|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44291713|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114417|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44114418|NCT00099216|Protective Agents|protective agents|mesh-ancestor
44114419|NCT00099242|Rivastigmine|rivastigmine|mesh-list
44114420|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44114421|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114422|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114423|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
44114424|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114425|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114426|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44114427|NCT00099242|Protective Agents|protective agents|mesh-ancestor
44114429|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114430|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114431|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44114432|NCT00099320|Incretins|incretins|mesh-ancestor
44114433|NCT00099320|Hormones|hormones|mesh-ancestor
44114434|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114435|NCT00099333|Exenatide|exenatide|mesh-list
44114436|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114437|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114438|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44114439|NCT00099333|Incretins|incretins|mesh-ancestor
44114440|NCT00099333|Hormones|hormones|mesh-ancestor
44114441|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114442|NCT00099450|INS 50589|ins 50589|mesh-list
44114443|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44114444|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44114445|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
44114446|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291714|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44291715|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44291716|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44291717|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291718|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44291719|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44291720|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44291721|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44291722|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44291723|NCT00784394|Protective Agents|protective agents|mesh-ancestor
44291724|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291725|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291726|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
44291727|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114447|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114448|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154038|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154039|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154040|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44154041|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
44154042|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
44154043|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
44154044|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154045|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44154046|NCT00222495|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44154047|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154048|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154049|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154050|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
44154051|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154052|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154053|NCT00222534|Acetazolamide|acetazolamide|mesh-list
44154054|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
44154055|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44154056|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154057|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154058|NCT00222534|Diuretics|diuretics|mesh-ancestor
44154059|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
44154060|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154061|NCT00222547|Vitamin A|vitamin a|mesh-list
44154062|NCT00222547|Albendazole|albendazole|mesh-list
44154063|NCT00222547|Vitamins|vitamins|mesh-ancestor
44154064|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
44154065|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154066|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154067|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154068|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
44154069|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44154070|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154071|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
44154072|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44154073|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44154074|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
44154075|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
44154076|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
44154077|NCT00222573|Metoprolol|metoprolol|mesh-list
44154078|NCT00222573|Clopidogrel|clopidogrel|mesh-list
44154079|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44154080|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44291728|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44291729|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
44291730|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291731|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44291732|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44291733|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291734|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291735|NCT00784446|Bevacizumab|bevacizumab|mesh-list
44291736|NCT00784446|Capecitabine|capecitabine|mesh-list
44291737|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
44291738|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
44291739|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291740|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154081|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44154082|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44154083|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
44154084|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154085|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154086|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114469|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114470|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
44114471|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114472|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114474|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44114475|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114477|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
44114478|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114479|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114480|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44114481|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114482|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44114483|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114484|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
44114485|NCT00099606|Dasatinib|dasatinib|mesh-list
44114486|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114487|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114491|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44114493|NCT00099619|Exenatide|exenatide|mesh-list
44114494|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114495|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114496|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44114497|NCT00099619|Incretins|incretins|mesh-ancestor
44114498|NCT00099619|Hormones|hormones|mesh-ancestor
44114499|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114500|NCT00099645|Mifepristone|mifepristone|mesh-list
44114501|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44114502|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
44114503|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44114504|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114505|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44114506|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44114507|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44114508|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
44114509|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44114510|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44114511|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114512|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114513|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
44114514|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44114515|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44114516|NCT00099684|Ezetimibe|ezetimibe|mesh-list
44291742|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44291743|NCT00784446|Growth Substances|growth substances|mesh-ancestor
44291744|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291745|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44291746|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44291747|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
43715430|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
44114517|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44114518|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44114519|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
43558172|NCT03535519|Methotrexate|methotrexate|mesh-list
44114520|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114522|NCT00099710|Curcumin|curcumin|mesh-list
44114523|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44114524|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114525|NCT00099710|Analgesics|analgesics|mesh-ancestor
44114526|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
44114527|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114528|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114529|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44114530|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114531|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114532|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114533|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114534|NCT00099736|Cyclosporine|cyclosporine|mesh-list
44114535|NCT00099736|Cyclosporins|cyclosporins|mesh-list
44114536|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44114537|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
44114538|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114539|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44114540|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114541|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114542|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114543|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
44114544|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114545|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114546|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44114547|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44114548|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44114549|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44114550|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114551|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114552|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
44114553|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114554|NCT00099775|Caspofungin|caspofungin|mesh-list
44114555|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
44114556|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114557|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114572|NCT00099866|Vildagliptin|vildagliptin|mesh-list
44114573|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114574|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114575|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114576|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114577|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114578|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114579|NCT00099892|Vildagliptin|vildagliptin|mesh-list
44114580|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114581|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114582|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114583|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114584|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114585|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114586|NCT00099905|Vildagliptin|vildagliptin|mesh-list
44114587|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44291748|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291749|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291750|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291751|NCT00784472|Morphine|morphine|mesh-list
44291752|NCT00784472|Oxycodone|oxycodone|mesh-list
44291753|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44291754|NCT00784472|Narcotics|narcotics|mesh-ancestor
44291755|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291756|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291757|NCT00784472|Analgesics|analgesics|mesh-ancestor
44291758|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
44291759|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291760|NCT00784485|Omalizumab|omalizumab|mesh-list
44291761|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44291762|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44291763|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44291764|NCT00784498|Midazolam|midazolam|mesh-list
44291765|NCT00784498|Ketamine|ketamine|mesh-list
44291766|NCT00784498|Propofol|propofol|mesh-list
44291767|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44291768|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291769|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291770|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44291771|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
44291772|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
44291773|NCT00784498|Analgesics|analgesics|mesh-ancestor
44291774|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
44291775|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291776|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44291777|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44291778|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44291779|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44291780|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291781|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44291782|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44291783|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291788|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
44291789|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
44291790|NCT00784511|Vitamins|vitamins|mesh-list
44291791|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
44291792|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291793|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291794|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44291795|NCT00784589|Rituximab|rituximab|mesh-list
44114588|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114589|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114590|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114591|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114592|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114593|NCT00099918|Vildagliptin|vildagliptin|mesh-list
44114594|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114595|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114596|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114597|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114598|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114599|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114600|NCT00099931|Vildagliptin|vildagliptin|mesh-list
44114601|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114602|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114603|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114604|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114605|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114606|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114607|NCT00099944|Glimepiride|glimepiride|mesh-list
44114608|NCT00099944|Vildagliptin|vildagliptin|mesh-list
44114609|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44114610|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114611|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114612|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114613|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
44114618|NCT00099957|Vildagliptin|vildagliptin|mesh-list
44114619|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44114620|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114621|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114622|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114623|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114624|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114625|NCT00099970|Dacarbazine|dacarbazine|mesh-list
44114626|NCT00099970|Volociximab|volociximab|mesh-list
44114627|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44114628|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
44114629|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114630|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114631|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44114632|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44114633|NCT00099970|Growth Substances|growth substances|mesh-ancestor
44114634|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114635|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
44114636|NCT00099996|Ezetimibe|ezetimibe|mesh-list
44114637|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44114638|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44114639|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
44114640|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114641|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44114642|NCT00100009|Triamcinolone|triamcinolone|mesh-list
44114643|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44114644|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44114645|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44114646|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44114647|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
44114648|NCT00100009|Hormones|hormones|mesh-ancestor
43701836|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44291796|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291797|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291798|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
44291799|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291800|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291801|NCT00784667|Cetuximab|cetuximab|mesh-list
44291802|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44291803|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291804|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291805|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44291806|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291807|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291808|NCT00784680|Tamoxifen|tamoxifen|mesh-list
44291809|NCT00784680|Anastrozole|anastrozole|mesh-list
44291810|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44291811|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291812|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291813|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291814|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44291815|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291816|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44291817|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43646799|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43646801|NCT02784171|Cisplatin|cisplatin|mesh-list
44291818|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291819|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44291820|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44291821|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291822|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291823|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
44291824|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291825|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
44291826|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44291827|NCT00784745|Dexamethasone|dexamethasone|mesh-list
44291828|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291829|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
44114649|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114650|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114651|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291830|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
44291831|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291832|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291833|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44291834|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
44291835|NCT00784745|Hormones|hormones|mesh-ancestor
44291836|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291837|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44291838|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291839|NCT00784797|Oxytocin|oxytocin|mesh-list
44291840|NCT00784797|Mifepristone|mifepristone|mesh-list
44291841|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
44291842|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44291843|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291844|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44291845|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
44291846|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44291847|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44291848|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44291849|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
44291850|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44291851|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44291852|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291853|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291854|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
44291855|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44291875|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291876|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44291877|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291878|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291879|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291880|NCT00784914|Sirolimus|sirolimus|mesh-list
44291881|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44291882|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291883|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44291884|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291885|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
44291886|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291887|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
44291888|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291889|NCT00784940|Tamoxifen|tamoxifen|mesh-list
44291890|NCT00784940|Anastrozole|anastrozole|mesh-list
44291891|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44291892|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
43715524|NCT02660502|Insulin|insulin|mesh-list
44114652|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
44114653|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114654|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114655|NCT00100074|Lobeline|lobeline|mesh-list
44114656|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44114657|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
44114658|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114659|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114660|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44114661|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44114662|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
44114663|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114664|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114665|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
44114667|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44114668|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154096|NCT00222651|Tenecteplase|tenecteplase|mesh-list
44114669|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44114670|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44114671|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44114672|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114673|NCT00100113|Vanoxerine|vanoxerine|mesh-list
44114674|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44114675|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44114676|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114677|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114678|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
44114679|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114680|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114688|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44114689|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44114690|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44114691|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114692|NCT00100243|Abarelix|abarelix|mesh-list
44114693|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
44291893|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44291894|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291895|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44291896|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291897|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44291898|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44291899|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44291900|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44291901|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44291902|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291903|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291904|NCT00784966|Etanercept|etanercept|mesh-list
44291905|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44291906|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44291907|NCT00784966|Analgesics|analgesics|mesh-ancestor
44291908|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
44291909|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291910|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291911|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44291912|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114694|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114695|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114696|NCT00100269|Antioxidants|antioxidants|mesh-list
44114697|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114698|NCT00100269|Protective Agents|protective agents|mesh-ancestor
44114699|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114700|NCT00100308|Heparin|heparin|mesh-list
44114701|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
44114702|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44114703|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44114704|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114705|NCT00100412|Phenylephrine|phenylephrine|mesh-list
44114706|NCT00100412|Dobutamine|dobutamine|mesh-list
44114707|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
44114708|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44114709|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
44114710|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
44114711|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114712|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114713|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
44114714|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44114715|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
44114716|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
44114717|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44114718|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44114719|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44114720|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44114721|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114722|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114723|NCT00100412|Protective Agents|protective agents|mesh-ancestor
44291914|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291915|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
44291916|NCT00785018|Complement C1s|complement c1s|mesh-list
44291917|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44291918|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44291919|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
44291920|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291921|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44291922|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291923|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44291924|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44291925|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291926|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291927|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
44114724|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44114725|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44114727|NCT00100464|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44114728|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44114729|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114730|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114731|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114732|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
44114733|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114734|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44114735|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
44114736|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44114737|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44114738|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114739|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114740|NCT00100477|Etoposide|etoposide|mesh-list
44114741|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
44114742|NCT00100477|Topotecan|topotecan|mesh-list
44114743|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44114744|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114745|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44114746|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44114747|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114753|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114754|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
44114755|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114756|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114757|NCT00100568|Lamivudine|lamivudine|mesh-list
44114758|NCT00100568|Zidovudine|zidovudine|mesh-list
44114759|NCT00100568|Efavirenz|efavirenz|mesh-list
44114760|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44114761|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44114762|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114763|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114764|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114765|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
44114766|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114767|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114768|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114769|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
44291928|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291929|NCT00785109|Vitamin K|vitamin k|mesh-list
44291930|NCT00785109|Vitamins|vitamins|mesh-ancestor
44291931|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
44291932|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291933|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44291934|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44291935|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291936|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
44291937|NCT00785109|Coagulants|coagulants|mesh-ancestor
44291938|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
44291939|NCT00785122|Molgramostim|molgramostim|mesh-list
44291940|NCT00785122|Imiquimod|imiquimod|mesh-list
44291941|NCT00785122|Sargramostim|sargramostim|mesh-list
44291942|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44291943|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
44291944|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291945|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291946|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44291947|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
44291948|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291949|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291950|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44291951|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44291952|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
44291953|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
44291954|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44291955|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291956|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
44291957|NCT00785330|Rituximab|rituximab|mesh-list
44291958|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44291959|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291960|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
44291961|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291962|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44291963|NCT00785382|Pregabalin|pregabalin|mesh-list
44114770|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44114771|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114772|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44114773|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44291964|NCT00785382|Analgesics|analgesics|mesh-ancestor
44291965|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
44291966|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44291967|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291968|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
44291969|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44291970|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44291971|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291972|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44291973|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44291974|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44291975|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44291976|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44291977|NCT00785395|Oxytocin|oxytocin|mesh-list
44291978|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
44291979|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44291980|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44291981|NCT00785421|Leucovorin|leucovorin|mesh-list
44291982|NCT00785421|Folic Acid|folic acid|mesh-list
44291983|NCT00785421|Gemcitabine|gemcitabine|mesh-list
44291984|NCT00785421|Cisplatin|cisplatin|mesh-list
44291985|NCT00785421|Enoxaparin|enoxaparin|mesh-list
44291986|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
44291987|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
44291988|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44291989|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44291990|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
44291991|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44291992|NCT00785421|Antiviral Agents|antiviral agents|mesh-ancestor
44291993|NCT00785421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44291994|NCT00785421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44291998|NCT00785421|Antidotes|antidotes|mesh-ancestor
44292010|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292011|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292012|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292013|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
44292014|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292015|NCT00785434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44292016|NCT00785434|Antidepressive Agents|antidepressive agents|mesh-ancestor
44292017|NCT00785434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292018|NCT00785460|Benphothiamine|benphothiamine|mesh-list
44292019|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44292020|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
44292021|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292022|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
44292023|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
44292024|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292025|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
44292026|NCT00785473|Vitamin D|vitamin d|mesh-list
44292027|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
44292028|NCT00785473|Calcium|calcium|mesh-list
44292029|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44292030|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292031|NCT00785473|Vitamins|vitamins|mesh-ancestor
44292032|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
44292033|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44292034|NCT00785473|Antacids|antacids|mesh-ancestor
44292035|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292036|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44292057|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292058|NCT00785603|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44292059|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44292060|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292061|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292062|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292064|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44292065|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
44292066|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292067|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44292068|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44292069|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292070|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
44292071|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44292072|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44292073|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292074|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292075|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292076|NCT00785863|Ketorolac|ketorolac|mesh-list
44292077|NCT00785863|Parecoxib|parecoxib|mesh-list
44292078|NCT00785863|Remifentanil|remifentanil|mesh-list
44292079|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44292080|NCT00785863|Narcotics|narcotics|mesh-ancestor
44292081|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292082|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292083|NCT00785863|Analgesics|analgesics|mesh-ancestor
44292084|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
44292085|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292098|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
44292099|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292100|NCT00786058|Fluorouracil|fluorouracil|mesh-list
44292101|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
44292102|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292103|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44292104|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292105|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292106|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
44292107|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292108|NCT00786110|Paclitaxel|paclitaxel|mesh-list
44292109|NCT00786110|Sorafenib|sorafenib|mesh-list
44292110|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44292111|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292112|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44292113|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44292114|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44292115|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292130|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292131|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292132|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292133|NCT00786240|Fesoterodine|fesoterodine|mesh-list
44292134|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44292135|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44292136|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
44292137|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292138|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292139|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292140|NCT00786240|Urological Agents|urological agents|mesh-ancestor
44292141|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44292142|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44292143|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44292144|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44292145|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292146|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292147|NCT00786253|Urological Agents|urological agents|mesh-ancestor
44292148|NCT00786279|Ethanol|ethanol|mesh-list
44292183|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
44292184|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44292185|NCT00786370|Analgesics|analgesics|mesh-ancestor
44292186|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
44292187|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292188|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44292189|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44292190|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44292191|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
44292192|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292193|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292194|NCT00786383|Ramucirumab|ramucirumab|mesh-list
44292195|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292196|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44292197|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
44292198|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292199|NCT00786448|Darifenacin|darifenacin|mesh-list
44292200|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44292201|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44292202|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
44292203|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292204|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292205|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292206|NCT00786448|Urological Agents|urological agents|mesh-ancestor
44292207|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
44292208|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44292209|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292210|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
44292211|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44292212|NCT00786552|Paclitaxel|paclitaxel|mesh-list
44292213|NCT00786552|Pemetrexed|pemetrexed|mesh-list
44292214|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44292216|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
44292227|NCT00786669|Vincristine|vincristine|mesh-list
44292228|NCT00786669|Temozolomide|temozolomide|mesh-list
44292229|NCT00786669|Camptothecin|camptothecin|mesh-list
44292230|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44292231|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292232|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292233|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292234|NCT00786669|Growth Substances|growth substances|mesh-ancestor
44292235|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292236|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292237|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44292238|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44292239|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292240|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292241|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44292242|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44292243|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44292249|NCT00786695|Esomeprazole|esomeprazole|mesh-list
44292282|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292283|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292284|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
44292285|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292286|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44292287|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
44292288|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292289|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44292290|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44292291|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292292|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44292293|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
44292343|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44292345|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292346|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292347|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292348|NCT00787501|Citalopram|citalopram|mesh-list
44292349|NCT00787501|Fluoxetine|fluoxetine|mesh-list
44292350|NCT00787501|Sertraline|sertraline|mesh-list
44292351|NCT00787501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44292352|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44292353|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292354|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292355|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292356|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
44292357|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292358|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44292359|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
44292360|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292361|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44292362|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44292363|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292364|NCT00787553|Cefazolin|cefazolin|mesh-list
44292365|NCT00787553|Tinidazole|tinidazole|mesh-list
44292366|NCT00787553|Imidazole|imidazole|mesh-list
44292367|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292368|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292369|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292370|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292371|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
44292372|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44292373|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44292374|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44292375|NCT00787657|Interferons|interferons|mesh-list
44292384|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
44292385|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44292386|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44292387|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
44292388|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292389|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44292390|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44292391|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292392|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292393|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
44292394|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44292395|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
44292396|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292397|NCT00787813|Expectorants|expectorants|mesh-ancestor
44292398|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292399|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44292400|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
44292401|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292402|NCT00787813|Protective Agents|protective agents|mesh-ancestor
44292403|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292404|NCT00787813|Antidotes|antidotes|mesh-ancestor
44292405|NCT00787826|Vaccines|vaccines|mesh-list
44292406|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
44292407|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292408|NCT00787969|Sirolimus|sirolimus|mesh-list
44292409|NCT00787969|Rituximab|rituximab|mesh-list
44292410|NCT00787969|Cladribine|cladribine|mesh-list
44292411|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44292412|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292413|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
44292414|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292415|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292416|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292417|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292418|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292419|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
44292420|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292421|NCT00788034|Vortioxetine|vortioxetine|mesh-list
43832234|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
44292422|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
44292423|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292424|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44292425|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292426|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292427|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292428|NCT00788034|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44292429|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44292430|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292431|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292432|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292433|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
44292434|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44292435|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44292436|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44292437|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44292438|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
44292439|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
44292440|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292441|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44292442|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44292443|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292445|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292470|NCT00788099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292471|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292472|NCT00788112|Vorinostat|vorinostat|mesh-list
44292473|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292474|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44292475|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292476|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292477|NCT00788138|Vitamin D|vitamin d|mesh-list
44292478|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
44292479|NCT00788138|Vitamins|vitamins|mesh-ancestor
44292480|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
44292481|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292482|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44292483|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44464781|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44464782|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464783|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44464784|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44464785|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
44464786|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44464787|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464788|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44464789|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44292511|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
44292512|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292513|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292514|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44292515|NCT00788424|Protective Agents|protective agents|mesh-ancestor
44292516|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44292517|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44292518|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292519|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292520|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
44292521|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292522|NCT00788463|Beclomethasone|beclomethasone|mesh-list
44292523|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292524|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
44292525|NCT00788463|Hormones|hormones|mesh-ancestor
44292526|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292527|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292567|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292568|NCT00788749|Fluticasone|fluticasone|mesh-list
44292569|NCT00788749|Xhance|xhance|mesh-list
44292570|NCT00788749|Prednisolone|prednisolone|mesh-list
44292571|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292572|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44292573|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
44292574|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292575|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292576|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44292577|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
44292578|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44292579|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44292580|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
44292581|NCT00788749|Hormones|hormones|mesh-ancestor
44292582|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292583|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44292584|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292585|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
44292586|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
44292587|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
44292588|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44292589|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292590|NCT00788918|Interferons|interferons|mesh-list
44292591|NCT00788918|Ribavirin|ribavirin|mesh-list
44292592|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292593|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
44292594|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292595|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
44292615|NCT00789165|Quinidine|quinidine|mesh-list
44292616|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44292617|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44292618|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
44292619|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292620|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292621|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292622|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44292623|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
44292624|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44292625|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44292626|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292627|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292628|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44292629|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44292630|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
43947310|NCT01068964|Timolol|timolol|mesh-list
44292631|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44292632|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44292633|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292634|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44292635|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44292637|NCT00789308|Sirolimus|sirolimus|mesh-list
44292638|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
44292639|NCT00789308|Etanercept|etanercept|mesh-list
44292640|NCT00789308|Heparin|heparin|mesh-list
44292641|NCT00789308|Dextrans|dextrans|mesh-list
44292642|NCT00789308|Tacrolimus|tacrolimus|mesh-list
44292643|NCT00789308|Cyclosporins|cyclosporins|mesh-list
44114774|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44114775|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44114776|NCT00100581|Interferons|interferons|mesh-list
44114777|NCT00100581|Ritonavir|ritonavir|mesh-list
44114778|NCT00100581|Tenofovir|tenofovir|mesh-list
44114779|NCT00100581|Ribavirin|ribavirin|mesh-list
44114780|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
44114781|NCT00100581|Lamivudine|lamivudine|mesh-list
44114782|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
44114783|NCT00100581|Efavirenz|efavirenz|mesh-list
44114784|NCT00100581|Lopinavir|lopinavir|mesh-list
44114785|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44114786|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114787|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
44114788|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114789|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44114790|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44114791|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114792|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114793|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114794|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44292648|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
44292649|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292650|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44292651|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292652|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292653|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
44292654|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292655|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
44292656|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292657|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292658|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292659|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44292660|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
44292661|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292662|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
44292663|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44292664|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44292665|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44292666|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44292667|NCT00789308|Analgesics|analgesics|mesh-ancestor
44292668|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
44292669|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292670|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292671|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44292672|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
43716127|NCT02655965|Clonidine|clonidine|mesh-list
44114795|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114796|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44114797|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114798|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44114799|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114800|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
44114801|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
44114802|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114803|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44114804|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44114805|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44292681|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292682|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292683|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44292684|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
44292685|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
44292686|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
44292687|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
44292688|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292689|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292690|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44292691|NCT00789386|Narcotics|narcotics|mesh-ancestor
44292692|NCT00789386|Analgesics|analgesics|mesh-ancestor
44292693|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
44292694|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114811|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44114813|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114814|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114815|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114816|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
44114817|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114818|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114819|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114820|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
44114821|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44114822|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114823|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44114824|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44114825|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44114826|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44114827|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
44114828|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44114829|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114831|NCT00100646|Lopinavir|lopinavir|mesh-list
44114832|NCT00100646|Lamivudine|lamivudine|mesh-list
44114833|NCT00100646|Stavudine|stavudine|mesh-list
44114834|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44114835|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44292695|NCT00789464|Trimethoprim|trimethoprim|mesh-list
44292696|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
44292697|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44292698|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292699|NCT00789464|Renal Agents|renal agents|mesh-ancestor
44292700|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
44292701|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44292702|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44292703|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44292704|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292705|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292706|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43947384|NCT01072643|Analgesics|analgesics|mesh-ancestor
44292707|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44292708|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44292709|NCT00789503|Vitamin D|vitamin d|mesh-list
44292710|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
44292711|NCT00789503|Calcium|calcium|mesh-list
44292712|NCT00789503|Vitamins|vitamins|mesh-ancestor
44292713|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
44292714|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292715|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44292716|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44292746|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
44292747|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
44292748|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292749|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292750|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
44292751|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292752|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44292753|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44292754|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44292755|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114836|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114837|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114838|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114839|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114840|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114841|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
44114842|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114843|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44114844|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44114845|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44114846|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44114847|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
44114848|NCT00100685|Volociximab|volociximab|mesh-list
44114849|NCT00100685|Antibodies|antibodies|mesh-list
44114850|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44114851|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
44114852|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114853|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44114854|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44114855|NCT00100685|Growth Substances|growth substances|mesh-ancestor
44114856|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
44114857|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114858|NCT00100737|Rituximab|rituximab|mesh-list
44114859|NCT00100737|Interleukin-2|interleukin-2|mesh-list
44114860|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44114861|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114862|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
44114863|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114864|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114865|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114866|NCT00100737|Analgesics|analgesics|mesh-ancestor
44114867|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
44114868|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114869|NCT00100750|Gemcitabine|gemcitabine|mesh-list
44114870|NCT00100750|Tipifarnib|tipifarnib|mesh-list
44114871|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114872|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
44114873|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114874|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114876|NCT00100750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114883|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
44114884|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114885|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114886|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44114887|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44114888|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44114889|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44114890|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44114891|NCT00100776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44114892|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44114893|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44292756|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292757|NCT00789711|Insulin|insulin|mesh-list
44292758|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44292759|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
44292760|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
44292761|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
44292762|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44292763|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44292764|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292765|NCT00789763|Gemcitabine|gemcitabine|mesh-list
44292766|NCT00789763|Sorafenib|sorafenib|mesh-list
44292767|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44292768|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
44292769|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292770|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292771|NCT00789763|Antiviral Agents|antiviral agents|mesh-ancestor
44292772|NCT00789763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292773|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292774|NCT00789763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292775|NCT00789763|Immunologic Factors|immunologic factors|mesh-ancestor
44292776|NCT00789763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292777|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292778|NCT00789945|Insulin|insulin|mesh-list
44292779|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44292780|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44292781|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292782|NCT00789971|Triamcinolone|triamcinolone|mesh-list
44464790|NCT01490060|Dexamethasone|dexamethasone|mesh-list
44292783|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44292784|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44292785|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44292786|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44292787|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
44292789|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292796|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44292797|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
44292798|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292799|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292800|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292801|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44292802|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292803|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292804|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292805|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44292806|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
44292807|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
44292808|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44292809|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44292810|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114894|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114895|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44114896|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
44114897|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44114898|NCT00100854|Fulvestrant|fulvestrant|mesh-list
44114899|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114900|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114901|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114902|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114903|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44114904|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44114905|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44114906|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114907|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114908|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114909|NCT00100880|Lenalidomide|lenalidomide|mesh-list
44114910|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
44114911|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114912|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44114913|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44114914|NCT00100880|Growth Substances|growth substances|mesh-ancestor
44114915|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
44114916|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114917|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
44114918|NCT00100893|Procyanidin|procyanidin|mesh-list
44114919|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
44114920|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114921|NCT00100893|Protective Agents|protective agents|mesh-ancestor
44114922|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114923|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44114924|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44114925|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114926|NCT00100906|Aldesleukin|aldesleukin|mesh-list
44114927|NCT00100906|Interleukin-2|interleukin-2|mesh-list
44114928|NCT00100906|Tretinoin|tretinoin|mesh-list
44114929|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114930|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114931|NCT00100906|Analgesics|analgesics|mesh-ancestor
44114932|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
44114933|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114934|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114935|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44114936|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114937|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
44292812|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44292813|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292814|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44292815|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44292816|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
44292817|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44292818|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44292819|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44292820|NCT00790114|Midazolam|midazolam|mesh-list
44292821|NCT00790114|Caffeine|caffeine|mesh-list
44292822|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44292823|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44292824|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292825|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292826|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44292827|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292828|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292829|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44292830|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
44292831|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
44292832|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
44292833|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
44292834|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292835|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292836|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44292837|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44292838|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292839|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44292840|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44114938|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114939|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
44114940|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44114941|NCT00100945|Gefitinib|gefitinib|mesh-list
44114942|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114943|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114944|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114945|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114946|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
44114957|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292841|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
44292842|NCT00790153|Insulin|insulin|mesh-list
44292843|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44292844|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464791|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
44464792|NCT01490060|Doxorubicin|doxorubicin|mesh-list
44464793|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44464794|NCT01490060|Vincristine|vincristine|mesh-list
44464795|NCT01490060|Ifosfamide|ifosfamide|mesh-list
44464796|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
44464797|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
44464798|NCT01490060|Aprepitant|aprepitant|mesh-list
44464799|NCT01490060|BB 1101|bb 1101|mesh-list
43716257|NCT02655146|Progesterone|progesterone|mesh-list
44114959|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44114960|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
44114961|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114962|NCT00101062|Celecoxib|celecoxib|mesh-list
44114963|NCT00101062|Letrozole|letrozole|mesh-list
44114964|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114965|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44114966|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44114967|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114968|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114969|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44114970|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114971|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114972|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114973|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44114974|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44114975|NCT00101062|Analgesics|analgesics|mesh-ancestor
44114976|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
44114977|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114978|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44114979|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44114980|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44114981|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154098|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154099|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154100|NCT00222677|Aspirin|aspirin|mesh-list
44154101|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154102|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154103|NCT00222677|Analgesics|analgesics|mesh-ancestor
44154104|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
44154105|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154106|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154107|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154108|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154109|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44154110|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154111|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154112|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44154113|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154114|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154115|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
44154116|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44154117|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44154118|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154119|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154120|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154121|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44154122|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154123|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464800|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464802|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
44464803|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292845|NCT00790179|Ropivacaine|ropivacaine|mesh-list
44292846|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44292847|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
44292848|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292849|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292850|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
44292851|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44292852|NCT00790244|Doxorubicin|doxorubicin|mesh-list
44292853|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44292854|NCT00790244|Ifosfamide|ifosfamide|mesh-list
44292855|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
44292856|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292857|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292858|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44292859|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44292860|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292861|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292898|NCT00790439|Daclizumab|daclizumab|mesh-list
44292899|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44292900|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
44292901|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292902|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44292903|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292904|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292905|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
44292906|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292907|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44292908|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44292909|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44292910|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292911|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44292912|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
44292913|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44292914|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
44292915|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44292916|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44292917|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
44292918|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
43947617|NCT01080248|Gemcitabine|gemcitabine|mesh-list
44292919|NCT00790595|Sunitinib|sunitinib|mesh-list
44292920|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292921|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44292922|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44292923|NCT00790595|Growth Substances|growth substances|mesh-ancestor
44292924|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292925|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44292926|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292927|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292928|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292929|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
44292930|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44292931|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
44292934|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44292936|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44292937|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
44292938|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292939|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292940|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44292941|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
44292942|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
44292943|NCT00790608|Protective Agents|protective agents|mesh-ancestor
44292944|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44292945|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44292946|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44292947|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44292948|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44292949|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44292950|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44292951|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44292952|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
44292953|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44292954|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292955|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44292956|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44292957|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
44292958|NCT00790816|Lapatinib|lapatinib|mesh-list
43646894|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
44292959|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
44292960|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44292961|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44292962|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292963|NCT00790881|Lumefantrine|lumefantrine|mesh-list
44292964|NCT00790881|Artemether|artemether|mesh-list
44154124|NCT00222820|Citalopram|citalopram|mesh-list
44154128|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154129|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154130|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
44154131|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154132|NCT00222820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44154133|NCT00222820|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154134|NCT00222820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154135|NCT00222833|Aripiprazole|aripiprazole|mesh-list
44154137|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154138|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154139|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154140|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154141|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154142|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
44154143|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
44292965|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44292966|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
44292967|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44292968|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44292969|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44292970|NCT00790894|Epothilones|epothilones|mesh-list
44292971|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
44292972|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
44292973|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
44292974|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292975|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44292976|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44292977|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44292978|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44292979|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292980|NCT00790946|Valsartan|valsartan|mesh-list
44292981|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43646895|NCT02697383|Hormones|hormones|mesh-ancestor
44292982|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44292983|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44292984|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44292985|NCT00790985|Naproxen|naproxen|mesh-list
44292988|NCT00790985|Analgesics|analgesics|mesh-ancestor
44293016|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293017|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
44293018|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293019|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44293020|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44293021|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44293022|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293023|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293024|NCT00791141|Cetuximab|cetuximab|mesh-list
44293025|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293026|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293027|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293028|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293029|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293030|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293031|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293032|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43646896|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644721|NCT04446039|Analgesics|analgesics|mesh-ancestor
44293033|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293034|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293035|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
44293036|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293037|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293064|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293065|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293066|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293067|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293068|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
44293069|NCT00791271|Interferons|interferons|mesh-list
44293070|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
44293071|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
44293072|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44293073|NCT00791271|Decitabine|decitabine|mesh-list
44293074|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293075|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
44293076|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293077|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
44293078|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293079|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293080|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
44293081|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293082|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293083|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293084|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293085|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293086|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293087|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293088|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293113|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293114|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293115|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293116|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
44293117|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293118|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293119|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293120|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293121|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293122|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293123|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293124|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293125|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
44293126|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293127|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293128|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293129|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293130|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
44293131|NCT00791427|Ranibizumab|ranibizumab|mesh-list
44293132|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44293133|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44293134|NCT00791427|Growth Substances|growth substances|mesh-ancestor
44293135|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293136|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
44293137|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293138|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
44293139|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44293140|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
44293141|NCT00791505|Trimethoprim|trimethoprim|mesh-list
44293142|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
44293143|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44293151|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44293152|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44293153|NCT00791505|Renal Agents|renal agents|mesh-ancestor
44293154|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
44293155|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44293156|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44293157|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44293158|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44293159|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44293160|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44293161|NCT00791531|Methotrexate|methotrexate|mesh-list
44293162|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44293163|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
44293164|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44293165|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293166|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293167|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
44293168|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293169|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293170|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293171|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293172|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44293173|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293174|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
44293175|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293176|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44293177|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44293178|NCT00791544|Sorafenib|sorafenib|mesh-list
44293179|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293180|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293181|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293182|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293183|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293184|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293185|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43716522|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44293186|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293187|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293188|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293189|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293190|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293191|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
44293192|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293193|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293194|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293195|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293196|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
44293197|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44293198|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293199|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293200|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293201|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293202|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293203|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44293204|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293205|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
44293206|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293207|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293208|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44293209|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293210|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
44293211|NCT00791739|Pregabalin|pregabalin|mesh-list
44293212|NCT00791739|Trazodone|trazodone|mesh-list
44293213|NCT00791739|Analgesics|analgesics|mesh-ancestor
44293214|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
44293215|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293216|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293218|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44293219|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293220|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293224|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293225|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293226|NCT00791739|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44293227|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44293228|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293229|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
44293230|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44293231|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
44293232|NCT00791804|Fentanyl|fentanyl|mesh-list
44293233|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44293234|NCT00791804|Narcotics|narcotics|mesh-ancestor
44293235|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293236|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293237|NCT00791804|Analgesics|analgesics|mesh-ancestor
44293238|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
44293239|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293240|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44293241|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44293242|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
44293243|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
44293244|NCT00791830|Irbesartan|irbesartan|mesh-list
44293245|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44293246|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44293247|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44293274|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
44293275|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293276|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293277|NCT00792012|Temozolomide|temozolomide|mesh-list
44293278|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293279|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
44293280|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293281|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293282|NCT00792025|Sunitinib|sunitinib|mesh-list
44293283|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293284|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44293285|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44293286|NCT00792025|Growth Substances|growth substances|mesh-ancestor
44293287|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293288|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
44293289|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293290|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293291|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293292|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44293293|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44293294|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44293295|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293296|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293321|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44293323|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293324|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44293325|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
44293326|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293327|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293328|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44464804|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464805|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44464806|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
44464807|NCT01490060|Hormones|hormones|mesh-ancestor
44464808|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464809|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44464810|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464811|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44464812|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464813|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464814|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44464815|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44464816|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44464817|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44464818|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44464819|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44464820|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44464831|NCT01489891|Lidocaine|lidocaine|mesh-list
44293334|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293335|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
44293336|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293337|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44293338|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44293339|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44293340|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44293341|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44293342|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44293343|NCT00792337|Simvastatin|simvastatin|mesh-list
44293344|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44293345|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44293346|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
44293347|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293348|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44293349|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44293350|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293351|NCT00792350|Sorafenib|sorafenib|mesh-list
44293352|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293353|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293354|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293355|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293356|NCT00792363|Irinotecan|irinotecan|mesh-list
44293357|NCT00792363|Panitumumab|panitumumab|mesh-list
44293358|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44293359|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293360|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293361|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293362|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293363|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293364|NCT00792376|Diclofenac|diclofenac|mesh-list
44293365|NCT00792376|Etoricoxib|etoricoxib|mesh-list
44293370|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293371|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293372|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293373|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293374|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44293375|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293376|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293377|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44293378|NCT00792584|Efavirenz|efavirenz|mesh-list
44293379|NCT00792584|Etravirine|etravirine|mesh-list
44293380|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44293381|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44293382|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293383|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293384|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
44293385|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293386|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44293387|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44293388|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44293389|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44293390|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44293391|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44293392|NCT00792662|Methylphenidate|methylphenidate|mesh-list
44293393|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44293394|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293395|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44293396|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44293397|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44293398|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293399|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
44293400|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293408|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293409|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293410|NCT00792766|Everolimus|everolimus|mesh-list
44293411|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293412|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293413|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
44293414|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293415|NCT00792779|Propofol|propofol|mesh-list
44293416|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44293417|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293418|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293419|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44293420|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
44293421|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
44293422|NCT00792818|Ibuprofen|ibuprofen|mesh-list
44293423|NCT00792818|Curcumin|curcumin|mesh-list
44293424|NCT00792818|Turmeric extract|turmeric extract|mesh-list
44293425|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44293426|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44293427|NCT00792818|Analgesics|analgesics|mesh-ancestor
44293428|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
44293429|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293430|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293431|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293459|NCT00793052|Analgesics|analgesics|mesh-ancestor
44293460|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
44293461|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293462|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44293463|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44293464|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293465|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293466|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44293467|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44293468|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44293469|NCT00793195|SMOFlipid|smoflipid|mesh-list
44293470|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44293471|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44293472|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44293473|NCT00793221|Sirolimus|sirolimus|mesh-list
44293474|NCT00793221|Everolimus|everolimus|mesh-list
44293475|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293476|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293477|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
44293478|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293479|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114982|NCT00101075|Capecitabine|capecitabine|mesh-list
44114983|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
44114984|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114985|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
44114986|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114987|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114988|NCT00101088|Sirolimus|sirolimus|mesh-list
44114989|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
44114990|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114991|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44114992|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114993|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114994|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114995|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114996|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44114997|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
44114998|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114999|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
44115000|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115001|NCT00101114|Interferons|interferons|mesh-list
44115002|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
44115003|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
44115004|NCT00101114|Sorafenib|sorafenib|mesh-list
44115005|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115006|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
44115007|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115008|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115009|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115010|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115011|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
44115012|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115013|NCT00101127|Gemcitabine|gemcitabine|mesh-list
44115014|NCT00101127|Docetaxel|docetaxel|mesh-list
44115015|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293480|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293481|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44293482|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
44293483|NCT00793234|Enoxaparin|enoxaparin|mesh-list
44293484|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
44293485|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44293486|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44293487|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293488|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
44293489|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44293490|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293491|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
44293492|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
44293493|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44293494|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44293495|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293496|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293497|NCT00793338|Urological Agents|urological agents|mesh-ancestor
44293498|NCT00793377|Tamoxifen|tamoxifen|mesh-list
44293499|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
44293500|NCT00793377|Docetaxel|docetaxel|mesh-list
44293501|NCT00793377|Doxorubicin|doxorubicin|mesh-list
44293502|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44293503|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293504|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
44115016|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
44115017|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115018|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115019|NCT00101127|Antiviral Agents|antiviral agents|mesh-ancestor
44115020|NCT00101127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115021|NCT00101127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115022|NCT00101127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115023|NCT00101127|Immunologic Factors|immunologic factors|mesh-ancestor
44115024|NCT00101127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115025|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44115026|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44115027|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44115028|NCT00101140|Fludarabine|fludarabine|mesh-list
44115029|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
44115030|NCT00101140|Thiotepa|thiotepa|mesh-list
44115031|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44115032|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115033|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115034|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
44115035|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115039|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44115041|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44115042|NCT00101153|Cytarabine|cytarabine|mesh-list
44115043|NCT00101153|Daunorubicin|daunorubicin|mesh-list
44115044|NCT00101153|Tipifarnib|tipifarnib|mesh-list
44115045|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115046|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
44293505|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293506|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293507|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293508|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
44293509|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293510|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293511|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44293512|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44293513|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293514|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44293515|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44293516|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44293517|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293518|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293519|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44293520|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44115047|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115048|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115049|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
44115050|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115051|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115052|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
44115053|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115054|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44115055|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44115056|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115057|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115060|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44115061|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115062|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
44115063|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115064|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115065|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115066|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
44115067|NCT00101205|Etoposide|etoposide|mesh-list
44115068|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
44115069|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115070|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44115071|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44115072|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115073|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115074|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115075|NCT00101231|Alvocidib|alvocidib|mesh-list
44115076|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115077|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
44115078|NCT00101231|Growth Substances|growth substances|mesh-ancestor
44115079|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115080|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115081|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115082|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115083|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
44115084|NCT00101270|Irinotecan|irinotecan|mesh-list
44115085|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115086|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44115087|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115088|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293521|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293523|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44293524|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44293525|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44293526|NCT00793429|Prucalopride|prucalopride|mesh-list
44293527|NCT00793429|Laxatives|laxatives|mesh-ancestor
44293528|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293529|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44293530|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44293531|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
44293532|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293533|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293534|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293535|NCT00793468|Nicotine|nicotine|mesh-list
44293536|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44293537|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
44293538|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293539|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293540|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44293541|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44293542|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
44293543|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293544|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293545|NCT00793559|Terlipressin|terlipressin|mesh-list
44115089|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115090|NCT00101296|Tipifarnib|tipifarnib|mesh-list
44115091|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115092|NCT00101309|Aldesleukin|aldesleukin|mesh-list
44115093|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115094|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115095|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115096|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
44115097|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115098|NCT00101335|Celecoxib|celecoxib|mesh-list
44115099|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44115100|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44115101|NCT00101335|Analgesics|analgesics|mesh-ancestor
44115102|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
44115103|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115104|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115105|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115106|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115107|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44115128|NCT00101374|Leflunomide|leflunomide|mesh-list
44115129|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293546|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44293547|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44293549|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
44293550|NCT00793663|Ondansetron|ondansetron|mesh-list
44293551|NCT00793663|Sevoflurane|sevoflurane|mesh-list
44293552|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293553|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
44293554|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
44293555|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293556|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293557|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293558|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
44293559|NCT00793663|Hormones|hormones|mesh-ancestor
44293560|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293561|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293562|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293563|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44293564|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44293565|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
44293566|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
44293567|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293568|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
44293569|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293570|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293571|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
44293572|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293573|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293574|NCT00793663|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293575|NCT00793663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293576|NCT00793663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293577|NCT00793663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44293578|NCT00793741|Somatostatin|somatostatin|mesh-list
44293579|NCT00793741|Hormones|hormones|mesh-ancestor
43716906|NCT02651350|Hormones|hormones|mesh-ancestor
43716912|NCT02651324|Ketamine|ketamine|mesh-list
44115130|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115131|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115132|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
44115133|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115134|NCT00101426|Ranirestat|ranirestat|mesh-list
44293580|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293582|NCT00793754|Aspirin|aspirin|mesh-list
44293583|NCT00793754|Atorvastatin|atorvastatin|mesh-list
44293584|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44293585|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44293586|NCT00793754|Analgesics|analgesics|mesh-ancestor
44293587|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
44293588|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293589|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293590|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293591|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293592|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44293593|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44293594|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293595|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44293596|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44293597|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293598|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
44293599|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44293600|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44115135|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115136|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115137|NCT00101569|Aripiprazole|aripiprazole|mesh-list
44115138|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
44115139|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115140|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115141|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115142|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115143|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115144|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
44115145|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
44115146|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115147|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115148|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44115149|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44115150|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
44115151|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44115152|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44115153|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44115154|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115155|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44115156|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115157|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115158|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115193|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
44115194|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115195|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115196|NCT00101764|Triamcinolone|triamcinolone|mesh-list
44115198|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44115199|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44293601|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
44293602|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44293603|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44293604|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
44293605|NCT00793767|Hematinics|hematinics|mesh-ancestor
44293606|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
44293607|NCT00793845|Melphalan|melphalan|mesh-list
44293608|NCT00793845|Thiotepa|thiotepa|mesh-list
44293609|NCT00793845|Carboplatin|carboplatin|mesh-list
44293610|NCT00793845|Etoposide|etoposide|mesh-list
44293611|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293612|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
44293613|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293614|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716962|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44115200|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115201|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
44115202|NCT00101764|Hormones|hormones|mesh-ancestor
44115203|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115204|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115205|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115207|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115208|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115209|NCT00101790|Pamidronate|pamidronate|mesh-list
44115210|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44115211|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115212|NCT00101803|Vildagliptin|vildagliptin|mesh-list
44115213|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115214|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115215|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44115216|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115217|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115218|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115219|NCT00101829|Rituximab|rituximab|mesh-list
44115220|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115221|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115222|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
44115223|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646989|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646990|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115224|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115225|NCT00101842|Gemcitabine|gemcitabine|mesh-list
44115226|NCT00101842|Pemetrexed|pemetrexed|mesh-list
44115227|NCT00101842|Cisplatin|cisplatin|mesh-list
44115228|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115229|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
44115230|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115231|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115232|NCT00101842|Antiviral Agents|antiviral agents|mesh-ancestor
44115233|NCT00101842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115234|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115235|NCT00101842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115236|NCT00101842|Immunologic Factors|immunologic factors|mesh-ancestor
44115237|NCT00101842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115238|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44115239|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44115240|NCT00101894|Panitumumab|panitumumab|mesh-list
44115241|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
44115242|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115243|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115244|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115245|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115246|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293615|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293616|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
44293617|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293618|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293619|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44293620|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44293621|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44293622|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293623|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293624|NCT00793858|Ciclesonide|ciclesonide|mesh-list
44293625|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
43948264|NCT01100606|Pancrelipase|pancrelipase|mesh-list
44293627|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293628|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293629|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44115247|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
44115248|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115249|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115250|NCT00102115|Talaporfin|talaporfin|mesh-list
44115251|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115252|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44115253|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44115254|NCT00102141|Drospirenone|drospirenone|mesh-list
44115255|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44115256|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44115257|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44115258|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44115259|NCT00102141|Estradiol|estradiol|mesh-list
44115260|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44115261|NCT00102141|Estrogens|estrogens|mesh-ancestor
44115262|NCT00102141|Hormones|hormones|mesh-ancestor
44115263|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115264|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115265|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44115266|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
44115267|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44115268|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44115269|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44115270|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
44115279|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115280|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115281|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
44115282|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
44115283|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
44115284|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115285|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115287|NCT00102167|Analgesics|analgesics|mesh-ancestor
44115288|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
44115289|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115290|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115291|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
44115292|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
44115293|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
44115294|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115295|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115296|NCT00102206|Ritonavir|ritonavir|mesh-list
44115297|NCT00102206|Lopinavir|lopinavir|mesh-list
44115298|NCT00102206|Saquinavir|saquinavir|mesh-list
44115299|NCT00102206|Tenofovir|tenofovir|mesh-list
44293630|NCT00793897|Paclitaxel|paclitaxel|mesh-list
44293631|NCT00793897|Carboplatin|carboplatin|mesh-list
44293632|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44293633|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293634|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44293635|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293636|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44115300|NCT00102206|Lamivudine|lamivudine|mesh-list
44115301|NCT00102206|Zidovudine|zidovudine|mesh-list
44115302|NCT00102206|Emtricitabine|emtricitabine|mesh-list
44115303|NCT00102206|Abacavir|abacavir|mesh-list
44115304|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44115305|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44115306|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115307|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115308|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115309|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115310|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115311|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
44115312|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115313|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44115314|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44115315|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44115316|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44115317|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
44115318|NCT00102219|Doxorubicin|doxorubicin|mesh-list
44115319|NCT00102219|Pemetrexed|pemetrexed|mesh-list
44115320|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44115321|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115322|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44115323|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115324|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115325|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115326|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44115327|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44115328|NCT00102258|Hormones|hormones|mesh-list
44115329|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115330|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115331|NCT00102271|Oxypurinol|oxypurinol|mesh-list
44115332|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115333|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115334|NCT00102284|Levodopa|levodopa|mesh-list
44115335|NCT00102284|Modafinil|modafinil|mesh-list
44115336|NCT00102284|Rivastigmine|rivastigmine|mesh-list
44115337|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44115338|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44115339|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
44115340|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115341|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115348|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115349|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
44115350|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44115351|NCT00102284|Protective Agents|protective agents|mesh-ancestor
44115353|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44115354|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115355|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115356|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44115357|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115358|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115359|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115360|NCT00102375|Topotecan|topotecan|mesh-list
44115361|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44115362|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43647001|NCT02630121|Protective Agents|protective agents|mesh-ancestor
43647002|NCT02620072|Insulin|insulin|mesh-list
44115363|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115364|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115365|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115366|NCT00102388|Vildagliptin|vildagliptin|mesh-list
44115367|NCT00102388|Gliclazide|gliclazide|mesh-list
44115368|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44293637|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293639|NCT00793923|Ranibizumab|ranibizumab|mesh-list
44293640|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293641|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
44293642|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
44293643|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293644|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293645|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293646|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
44293647|NCT00793923|Hormones|hormones|mesh-ancestor
44293648|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293649|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293650|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293651|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44293652|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44293653|NCT00793923|Growth Substances|growth substances|mesh-ancestor
44293654|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44293655|NCT00793975|Ramucirumab|ramucirumab|mesh-list
44293656|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293657|NCT00793988|Anesthetics|anesthetics|mesh-list
44293658|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293659|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293660|NCT00794209|Fentanyl|fentanyl|mesh-list
44293661|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44115369|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115370|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44115371|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115372|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115373|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115374|NCT00102414|Gemcitabine|gemcitabine|mesh-list
44115375|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115376|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
44115377|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115378|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115379|NCT00102414|Antiviral Agents|antiviral agents|mesh-ancestor
44115380|NCT00102414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115381|NCT00102414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115382|NCT00102414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115383|NCT00102414|Immunologic Factors|immunologic factors|mesh-ancestor
44115384|NCT00102414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115385|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
44115386|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44115387|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115388|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115389|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44115390|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44115391|NCT00102453|Protective Agents|protective agents|mesh-ancestor
44293663|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293664|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293665|NCT00794209|Analgesics|analgesics|mesh-ancestor
44293666|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
44293667|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293668|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44293669|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44293670|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
44293671|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
44464836|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
44464837|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464838|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44464839|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44464840|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44115392|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115393|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
44115394|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44115395|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
44115396|NCT00102479|Aripiprazole|aripiprazole|mesh-list
44115397|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
44115398|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115399|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115400|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115401|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115402|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115403|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
44115404|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
44115405|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115406|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115407|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44115408|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44115413|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115414|NCT00102492|Casopitant|casopitant|mesh-list
44115415|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
44115416|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
44115417|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115418|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115419|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115420|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44115421|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115422|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115423|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
44115424|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115425|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44115426|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
44115427|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
44115428|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
44115429|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44115430|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44115431|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115432|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115433|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115434|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115435|NCT00102583|Cyclosporine|cyclosporine|mesh-list
44115436|NCT00102583|Cyclosporins|cyclosporins|mesh-list
44115437|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115438|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115439|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464841|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464842|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464843|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
44464844|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
44464845|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44464846|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
44464847|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464848|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464849|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44464850|NCT01489189|Ranibizumab|ranibizumab|mesh-list
44464851|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44464852|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44464853|NCT01489189|Growth Substances|growth substances|mesh-ancestor
44464854|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464855|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44464856|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464857|NCT01489020|Vaccines|vaccines|mesh-list
44464858|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
44464859|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464860|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44464861|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44464862|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44464863|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
44464864|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293673|NCT00794235|Dacarbazine|dacarbazine|mesh-list
44293674|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293675|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293676|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293677|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293678|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44293679|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
44293680|NCT00794261|Lenograstim|lenograstim|mesh-list
44293681|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44293682|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
43717031|NCT02650427|Hormones|hormones|mesh-ancestor
44115440|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
44115441|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115442|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
44115443|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115444|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293683|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293684|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
44293685|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44293686|NCT00794443|Diphosphonates|diphosphonates|mesh-list
44293687|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44293688|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293689|NCT00794625|Valproic Acid|valproic acid|mesh-list
44293690|NCT00794625|Risperidone|risperidone|mesh-list
44293691|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
44293692|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44293693|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
44293694|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293695|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293696|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293697|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44293698|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44293699|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293700|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44293701|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44293738|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293739|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44293740|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44293741|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293742|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
44293743|NCT00794755|Coagulants|coagulants|mesh-ancestor
44293744|NCT00794807|Alefacept|alefacept|mesh-list
44293745|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293746|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
44293747|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293748|NCT00794859|Sorafenib|sorafenib|mesh-list
44293749|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293750|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293751|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293752|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115445|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115446|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44115447|NCT00102609|Dexamethasone|dexamethasone|mesh-list
44115448|NCT00102609|Doxorubicin|doxorubicin|mesh-list
44115449|NCT00102609|Trabectedin|trabectedin|mesh-list
44115450|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115451|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
44115452|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
44115453|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115454|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115455|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115456|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
44115458|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115459|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44115460|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115461|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44115462|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44115463|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115464|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115465|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115466|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44115467|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
44115468|NCT00102622|Paclitaxel|paclitaxel|mesh-list
44115469|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44115470|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115471|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
44115472|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44115473|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44115474|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115475|NCT00102635|Fenretinide|fenretinide|mesh-list
44115476|NCT00102635|Lonafarnib|lonafarnib|mesh-list
44115477|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115478|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44115479|NCT00102635|Protective Agents|protective agents|mesh-ancestor
44115480|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115484|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115485|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115486|NCT00102674|Cangrelor|cangrelor|mesh-list
44115487|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44115488|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44115489|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44115490|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44115491|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
44115492|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293755|NCT00794885|Enalapril|enalapril|mesh-list
44293756|NCT00794885|Enalaprilat|enalaprilat|mesh-list
44293757|NCT00794885|Maleic acid|maleic acid|mesh-list
44293758|NCT00794885|Hematinics|hematinics|mesh-ancestor
44293759|NCT00794885|Vitamins|vitamins|mesh-ancestor
44293760|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
44293761|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293762|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293763|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293764|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44293765|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
44293766|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44293767|NCT00794898|Infliximab|infliximab|mesh-list
44293768|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293769|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293770|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293771|NCT00794976|Dexamethasone|dexamethasone|mesh-list
44293772|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
44293773|NCT00794976|BB 1101|bb 1101|mesh-list
44293774|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44293775|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
44293776|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
44293777|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293778|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293779|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293780|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
44293781|NCT00794976|Hormones|hormones|mesh-ancestor
44293782|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717121|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
44115493|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115494|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115495|NCT00102700|Gemcitabine|gemcitabine|mesh-list
44115496|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
44115497|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43647029|NCT02542696|Apomorphine|apomorphine|mesh-list
44115498|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
44115499|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115500|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115501|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
44115502|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115503|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115504|NCT00102700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647030|NCT02542696|Emetics|emetics|mesh-ancestor
44115505|NCT00102700|Immunologic Factors|immunologic factors|mesh-ancestor
44115506|NCT00102700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115507|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44293783|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44293784|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293785|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
44293786|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293787|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293788|NCT00795015|Insulin|insulin|mesh-list
44293789|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44293790|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44293791|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293792|NCT00795106|Capsaicin|capsaicin|mesh-list
44293793|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
44293794|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293795|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
44293796|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293797|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293798|NCT00795171|Docetaxel|docetaxel|mesh-list
44293799|NCT00795171|Sunitinib|sunitinib|mesh-list
44293800|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293801|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
44293802|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293803|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
44293804|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293805|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44293806|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44293807|NCT00795171|Growth Substances|growth substances|mesh-ancestor
44293808|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293809|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
44115508|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44115509|NCT00102713|Valproic Acid|valproic acid|mesh-list
44115510|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
44115511|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115512|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115513|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
44115514|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115515|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115516|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
44115517|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115518|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115519|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115520|NCT00102752|Gemcitabine|gemcitabine|mesh-list
44115521|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115522|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
44115523|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115524|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115525|NCT00102752|Antiviral Agents|antiviral agents|mesh-ancestor
44115526|NCT00102752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115527|NCT00102752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115528|NCT00102752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293811|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293812|NCT00795223|Morphine|morphine|mesh-list
44293813|NCT00795223|Bupivacaine|bupivacaine|mesh-list
44293814|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
44293815|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
44293816|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293817|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293818|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
44293819|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293820|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948506|NCT01106859|Zolpidem|zolpidem|mesh-list
44293821|NCT00795223|Narcotics|narcotics|mesh-ancestor
44293822|NCT00795223|Analgesics|analgesics|mesh-ancestor
44293823|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
44293824|NCT00795262|Quinapril|quinapril|mesh-list
44293825|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
44293826|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293827|NCT00795262|Protective Agents|protective agents|mesh-ancestor
44293828|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293829|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
44293830|NCT00795262|Vitamins|vitamins|mesh-ancestor
44293831|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
43717172|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115529|NCT00102752|Immunologic Factors|immunologic factors|mesh-ancestor
44115530|NCT00102752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115531|NCT00102765|Fluticasone|fluticasone|mesh-list
44115532|NCT00102765|Xhance|xhance|mesh-list
44115533|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44115534|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44115535|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115536|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44115537|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
44115538|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115539|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115540|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44115541|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44115542|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44115543|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44115544|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44115545|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44115546|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44115547|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
44115548|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115549|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115550|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
44115551|NCT00102765|Hormones|hormones|mesh-ancestor
44115552|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115554|NCT00102778|Ritonavir|ritonavir|mesh-list
44115555|NCT00102778|Lopinavir|lopinavir|mesh-list
44115556|NCT00102778|Aplaviroc|aplaviroc|mesh-list
44115557|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44115558|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44115559|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115560|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293832|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44293833|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
44293834|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293835|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44293836|NCT00795301|Capecitabine|capecitabine|mesh-list
44293837|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
44293838|NCT00795301|Cetuximab|cetuximab|mesh-list
44293839|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293840|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
44293841|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293842|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293843|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293844|NCT00795314|Fentanyl|fentanyl|mesh-list
44293845|NCT00795314|Butorphanol|butorphanol|mesh-list
44293846|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44293847|NCT00795314|Narcotics|narcotics|mesh-ancestor
44293848|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44293849|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293850|NCT00795314|Analgesics|analgesics|mesh-ancestor
44293851|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
44293852|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44293853|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44293854|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44293855|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
44293856|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
44293857|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
44293858|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
44293859|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44293860|NCT00795353|Alefacept|alefacept|mesh-list
44293861|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293862|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
44293863|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293864|NCT00795444|Maraviroc|maraviroc|mesh-list
44293865|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44293866|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43717189|NCT02649478|Fluticasone|fluticasone|mesh-list
44115561|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115562|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115563|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115564|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
44115565|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293867|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293868|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44293869|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44293870|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
44293871|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293872|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44293873|NCT00795457|Poly I-C|poly i-c|mesh-list
44293874|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44293875|NCT00795457|Vaccines|vaccines|mesh-list
44293876|NCT00795457|Poly ICLC|poly iclc|mesh-list
44293877|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
44293878|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293879|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
44293880|NCT00795457|Laxatives|laxatives|mesh-ancestor
44293881|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44293882|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
44293883|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293884|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
44293885|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44293886|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
44293887|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44293888|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293889|NCT00795496|Histamine|histamine|mesh-list
44293890|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
44293891|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
44293892|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44293893|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293894|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293895|NCT00795548|Azacitidine|azacitidine|mesh-list
44293896|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293897|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
44293898|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293899|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293900|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293901|NCT00795574|Infliximab|infliximab|mesh-list
44293902|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293908|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
44293909|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293911|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44293912|NCT00795613|Vincristine|vincristine|mesh-list
44293913|NCT00795613|Procarbazine|procarbazine|mesh-list
44293914|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44293915|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293916|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44293917|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293918|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293919|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293920|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44293921|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
44293922|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293923|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
44293924|NCT00795678|Gemcitabine|gemcitabine|mesh-list
44293925|NCT00795678|Paclitaxel|paclitaxel|mesh-list
44293926|NCT00795678|Vinorelbine|vinorelbine|mesh-list
44293927|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44293928|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
44293929|NCT00795678|Doxorubicin|doxorubicin|mesh-list
44293930|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44293931|NCT00795678|Capecitabine|capecitabine|mesh-list
44293932|NCT00795678|Trastuzumab|trastuzumab|mesh-list
44293933|NCT00795678|Lapatinib|lapatinib|mesh-list
44293934|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44293935|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293936|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44293937|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44293938|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44293939|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293948|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
44293952|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44293953|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44293954|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44293955|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44293956|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44293958|NCT00795756|Methotrexate|methotrexate|mesh-list
44293959|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44293960|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
44293961|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44293962|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293963|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44293964|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
44293965|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293966|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44293967|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44293968|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44293969|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44293970|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44293971|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
44293972|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44293973|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44293974|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
44293975|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44293976|NCT00795808|Metformin|metformin|mesh-list
43948644|NCT01111318|Empagliflozin|empagliflozin|mesh-list
44293977|NCT00795808|Clomiphene|clomiphene|mesh-list
44293978|NCT00795808|Enclomiphene|enclomiphene|mesh-list
44293979|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
44293980|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44293981|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293982|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44293983|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
44115566|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44115567|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44115568|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44115569|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44115570|NCT00102830|Trebananib|trebananib|mesh-list
44115571|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44115572|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44115573|NCT00102830|Growth Substances|growth substances|mesh-ancestor
44115574|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44293984|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44293985|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44293987|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44293988|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44293989|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44293991|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44293992|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44293993|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44293994|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44293995|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44293996|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44293997|NCT00795847|Diuretics|diuretics|mesh-ancestor
44293998|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
43717278|NCT02649101|Thalidomide|thalidomide|mesh-list
44115575|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44115576|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115577|NCT00102843|Folic Acid|folic acid|mesh-list
44115578|NCT00102843|Betaine|betaine|mesh-list
44115579|NCT00102843|Hematinics|hematinics|mesh-ancestor
44115580|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
44115581|NCT00102843|Vitamins|vitamins|mesh-ancestor
44115582|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
44115583|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115584|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115585|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
44115586|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44115587|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
44115588|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115589|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44154144|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154145|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154146|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44154147|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44154148|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
44154149|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44154150|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44154151|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44154152|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44154153|NCT00222872|Hormones|hormones|mesh-list
44154154|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
44154155|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44154156|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154157|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154158|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154159|NCT00222976|Naproxen|naproxen|mesh-list
44154160|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154161|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154162|NCT00222976|Analgesics|analgesics|mesh-ancestor
44154163|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
44154164|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154165|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154166|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154167|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154168|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
44154169|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44293999|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294000|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44294001|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44294002|NCT00795899|Paclitaxel|paclitaxel|mesh-list
44294003|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
44294004|NCT00795899|Trastuzumab|trastuzumab|mesh-list
44294005|NCT00795899|Epirubicin|epirubicin|mesh-list
44294006|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294007|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294008|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294009|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294010|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294011|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294012|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294013|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
44294014|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294015|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294016|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294017|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
44294018|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294019|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294020|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294021|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294022|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44294023|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294024|NCT00795912|Atorvastatin|atorvastatin|mesh-list
44294025|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44294026|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44154170|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154171|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154172|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
44154173|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44154174|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154175|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
44154176|NCT00223015|Tacrolimus|tacrolimus|mesh-list
44154177|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154178|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
44154179|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154185|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154186|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44154187|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154188|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
44154189|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154190|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
44154191|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154192|NCT00223054|Cyclosporine|cyclosporine|mesh-list
44154193|NCT00223054|Sirolimus|sirolimus|mesh-list
44294027|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
44294028|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294029|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44294030|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44294031|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294032|NCT00795925|Propiverine|propiverine|mesh-list
44294033|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
44294034|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
44294035|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294036|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294037|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44294038|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44294039|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
44294040|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154194|NCT00223054|Everolimus|everolimus|mesh-list
44154195|NCT00223054|Tacrolimus|tacrolimus|mesh-list
44154196|NCT00223054|Cyclosporins|cyclosporins|mesh-list
44154197|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154198|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
44154199|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154200|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44154201|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154202|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154203|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
44154204|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154205|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44154206|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154207|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154208|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44115591|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115592|NCT00102856|Pramipexole|pramipexole|mesh-list
44115593|NCT00102856|Rivastigmine|rivastigmine|mesh-list
44115594|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
44115595|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115596|NCT00102856|Protective Agents|protective agents|mesh-ancestor
44115597|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115598|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44115599|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44115600|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
44115601|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
44115602|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115603|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44115604|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115605|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
44115606|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44115607|NCT00102869|Levodopa|levodopa|mesh-list
44115608|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44115609|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44115610|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
44115611|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115612|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115613|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115614|NCT00102882|Fluticasone|fluticasone|mesh-list
44115615|NCT00102882|Xhance|xhance|mesh-list
44115616|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44115617|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44115618|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115619|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44115620|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
44115621|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115622|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294041|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294042|NCT00795925|Urological Agents|urological agents|mesh-ancestor
44294043|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
44294044|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
44294045|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44294046|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44294047|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294048|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294049|NCT00795938|Urological Agents|urological agents|mesh-ancestor
44294050|NCT00795977|Picibanil|picibanil|mesh-list
44294051|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294052|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294053|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294054|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294055|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294056|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294057|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294058|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294059|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294060|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
44294061|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294062|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294063|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294064|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294065|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
44294066|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294067|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294068|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294069|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294070|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294071|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294072|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43717342|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
44115623|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44115624|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
44115625|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
44115626|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44115627|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44115628|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44115629|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44294073|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294075|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294076|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294077|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294078|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294079|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
44294080|NCT00796159|Olmesartan|olmesartan|mesh-list
44294081|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44294082|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44294083|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44294084|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44294085|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294086|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294087|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294088|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294089|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294090|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294091|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294092|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294093|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294094|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
44294095|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294096|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115630|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44115631|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115632|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115636|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
44115637|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
44115638|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44115639|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115641|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44115642|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44115643|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115644|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115645|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115646|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
44115647|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115648|NCT00102947|Daptomycin|daptomycin|mesh-list
44115649|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44115650|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115651|NCT00102973|Carboplatin|carboplatin|mesh-list
44115652|NCT00102973|Doxorubicin|doxorubicin|mesh-list
44115653|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44115654|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115655|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43559444|NCT03738618|Hormones|hormones|mesh-ancestor
44115656|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294098|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294099|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
44294100|NCT00796198|Latanoprost|latanoprost|mesh-list
44294101|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44294102|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44294103|NCT00796211|Nortriptyline|nortriptyline|mesh-list
44294104|NCT00796211|Calcipotriene|calcipotriene|mesh-list
44294105|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294106|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44294107|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
44294108|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294109|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44294110|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44294111|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44294112|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294113|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294114|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294115|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294116|NCT00796250|Prednisolone|prednisolone|mesh-list
44294117|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44294118|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
44294119|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44294120|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
44294121|NCT00796250|Azathioprine|azathioprine|mesh-list
44294122|NCT00796250|Infliximab|infliximab|mesh-list
44294123|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44294124|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
44294125|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294126|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
44294127|NCT00796250|Hormones|hormones|mesh-ancestor
44294128|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294129|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294130|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44115657|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44115658|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115659|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115660|NCT00102986|Ritonavir|ritonavir|mesh-list
44115661|NCT00102986|Lopinavir|lopinavir|mesh-list
44115662|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44294132|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
44294133|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
44294134|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294135|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294136|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44294137|NCT00796250|Protective Agents|protective agents|mesh-ancestor
44294138|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294139|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294140|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
44294141|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294142|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294143|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294144|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
44294145|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44115663|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44115664|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115665|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115666|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115667|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115668|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115669|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
44115670|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115671|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44115672|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44115673|NCT00103051|Gemcitabine|gemcitabine|mesh-list
44115674|NCT00103051|Cisplatin|cisplatin|mesh-list
44115675|NCT00103051|Gefitinib|gefitinib|mesh-list
44115676|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115677|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115678|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
44115679|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115680|NCT00103051|Antiviral Agents|antiviral agents|mesh-ancestor
44115681|NCT00103051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115682|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115683|NCT00103051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115684|NCT00103051|Immunologic Factors|immunologic factors|mesh-ancestor
44115685|NCT00103051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115686|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115687|NCT00103103|Leucovorin|leucovorin|mesh-list
44115688|NCT00103103|Fluorouracil|fluorouracil|mesh-list
44115689|NCT00103103|Bortezomib|bortezomib|mesh-list
44115690|NCT00103103|Calcium|calcium|mesh-list
44115691|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
44115692|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44115693|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115694|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
44115695|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115696|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115697|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115698|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115699|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
44115700|NCT00103103|Antidotes|antidotes|mesh-ancestor
44115701|NCT00103103|Protective Agents|protective agents|mesh-ancestor
44115702|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
44115703|NCT00103103|Vitamins|vitamins|mesh-ancestor
44115704|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
44115709|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115710|NCT00103233|Trastuzumab|trastuzumab|mesh-list
44115711|NCT00103233|Vinorelbine|vinorelbine|mesh-list
44294146|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294147|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294148|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294149|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294150|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294151|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294152|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294153|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
44294154|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294155|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294156|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294157|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115712|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115713|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115714|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44115715|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
44115716|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
44115717|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
44115718|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115720|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
44115721|NCT00103246|Trace Elements|trace elements|mesh-ancestor
44115722|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
44115723|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115724|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
44115725|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44115726|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44115727|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115728|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
44115729|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44115730|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44115731|NCT00103272|Bortezomib|bortezomib|mesh-list
44115732|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115733|NCT00103298|Leucovorin|leucovorin|mesh-list
44115734|NCT00103298|Fluorouracil|fluorouracil|mesh-list
44115735|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
44115736|NCT00103298|Melphalan|melphalan|mesh-list
44115737|NCT00103298|Calcium|calcium|mesh-list
44115738|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
44115739|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44115740|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115741|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
44115742|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115743|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44115744|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115745|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115747|NCT00103298|Antidotes|antidotes|mesh-ancestor
44115748|NCT00103298|Protective Agents|protective agents|mesh-ancestor
44115749|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
44115750|NCT00103298|Vitamins|vitamins|mesh-ancestor
44115751|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
44115752|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44115753|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
44115754|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44115755|NCT00103324|Lapatinib|lapatinib|mesh-list
44115756|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115757|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115758|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115759|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115760|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
44115761|NCT00103519|Hormones|hormones|mesh-ancestor
44115762|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115763|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115764|NCT00103545|Abagovomab|abagovomab|mesh-list
44294158|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
44294159|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294160|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294161|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294162|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294163|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294164|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294165|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294166|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294167|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
44294168|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294169|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294170|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294171|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294172|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
44464865|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464866|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464867|NCT01488578|Urological Agents|urological agents|mesh-ancestor
44464868|NCT01488487|Everolimus|everolimus|mesh-list
44464869|NCT01488487|Pasireotide|pasireotide|mesh-list
44464870|NCT01488487|Somatostatin|somatostatin|mesh-list
44464871|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464872|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464873|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
44464874|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464875|NCT01488487|Hormones|hormones|mesh-ancestor
44464876|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464877|NCT01488071|Vortioxetine|vortioxetine|mesh-list
44464878|NCT01488071|S 20098|s 20098|mesh-list
44464879|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
44464880|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294174|NCT00796458|Hormones|hormones|mesh-list
44294175|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294176|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294177|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294178|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294179|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294180|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294181|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294182|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294183|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294184|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294185|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294186|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294187|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294188|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294189|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294190|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
44294191|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294192|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294193|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294194|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294195|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
44294196|NCT00796497|Ondansetron|ondansetron|mesh-list
44294197|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
44294198|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
44294220|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294221|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
44294222|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294223|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294224|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294225|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294226|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
44294227|NCT00796692|Heparin|heparin|mesh-list
44294228|NCT00796692|Calcium heparin|calcium heparin|mesh-list
44294229|NCT00796692|Nadroparin|nadroparin|mesh-list
44294230|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
44294231|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44294232|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44294233|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294234|NCT00796796|Sirolimus|sirolimus|mesh-list
44294235|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44294236|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294237|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294238|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115765|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115766|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115767|NCT00103571|Olanzapine|olanzapine|mesh-list
44115768|NCT00103571|Aripiprazole|aripiprazole|mesh-list
44115769|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
44115770|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
44115771|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115772|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115773|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115774|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115775|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115776|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115777|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115778|NCT00103571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44115784|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
44115785|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
44115786|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
44115787|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44115788|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44115789|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44115790|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44115791|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44115792|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115793|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
44115794|NCT00103597|Domperidone|domperidone|mesh-list
44115795|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
44115796|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
44115797|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115798|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115799|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115800|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115801|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
44115802|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115803|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115804|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115805|NCT00103623|Abarelix|abarelix|mesh-list
44115806|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44115807|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294239|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
44294240|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294241|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
44294242|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294243|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44294244|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44294245|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294246|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294247|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294248|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294249|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294250|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294251|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
44294252|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294253|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294254|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44294255|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44294256|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
44294257|NCT00796887|Niacin|niacin|mesh-list
44294258|NCT00796887|Niacinamide|niacinamide|mesh-list
44294259|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
44294260|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44294261|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
44294262|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294263|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44294264|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
44294265|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
44294266|NCT00796887|Vitamins|vitamins|mesh-ancestor
44294267|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
44294268|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294269|NCT00796900|Dantrolene|dantrolene|mesh-list
44294270|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44294271|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115808|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115809|NCT00103649|Xaliproden|xaliproden|mesh-list
44115810|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44115811|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44115812|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
44115813|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115814|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115815|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115816|NCT00103701|Dasatinib|dasatinib|mesh-list
44294273|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294274|NCT00797017|Fentanyl|fentanyl|mesh-list
44294275|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44294276|NCT00797017|Narcotics|narcotics|mesh-ancestor
44294277|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294278|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294279|NCT00797017|Analgesics|analgesics|mesh-ancestor
44294280|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
44294281|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294282|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44294283|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44294284|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
44294285|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
44294286|NCT00797030|Cyclosporine|cyclosporine|mesh-list
44294287|NCT00797030|Cyclosporins|cyclosporins|mesh-list
44294288|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294289|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717471|NCT02647424|Letrozole|letrozole|mesh-list
44115817|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115818|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115819|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115820|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115822|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44115823|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
44115824|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115825|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115826|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115827|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115828|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115829|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115830|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115831|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115832|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
44115833|NCT00103753|Deferiprone|deferiprone|mesh-list
44115834|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44115835|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
44115836|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
44115837|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115838|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44115839|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44115840|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44115841|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115842|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
44115843|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44115844|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115845|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
44115846|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
44115861|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115862|NCT00103805|Levodopa|levodopa|mesh-list
44115863|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44115864|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44115865|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
44115866|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115867|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115868|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115869|NCT00103818|Gaboxadol|gaboxadol|mesh-list
44294291|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
44294292|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294293|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
44294294|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294295|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294296|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294297|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44294298|NCT00797056|Aspirin|aspirin|mesh-list
44294299|NCT00797056|Clopidogrel|clopidogrel|mesh-list
44294300|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44294301|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294302|NCT00797056|Analgesics|analgesics|mesh-ancestor
44294303|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
44294304|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294305|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294306|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294307|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115870|NCT00103818|Analgesics|analgesics|mesh-ancestor
44115871|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
44115872|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115873|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115874|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
44115875|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
44115876|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
44115877|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115878|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115879|NCT00103922|Cilomilast|cilomilast|mesh-list
44115880|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44115881|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44115882|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115883|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115884|NCT00103935|Exenatide|exenatide|mesh-list
44115885|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115886|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115887|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44115888|NCT00103935|Incretins|incretins|mesh-ancestor
44115889|NCT00103935|Hormones|hormones|mesh-ancestor
44115890|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115891|NCT00103948|Donepezil|donepezil|mesh-list
44115892|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44115893|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115894|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115895|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
44115896|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115897|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115898|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
44115899|NCT00104013|Xaliproden|xaliproden|mesh-list
44115900|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44115901|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44115902|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
44115903|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115904|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115905|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115911|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115913|NCT00104169|Hematinics|hematinics|mesh-ancestor
44115914|NCT00104182|Insulin|insulin|mesh-list
44294308|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44294309|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44294310|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294311|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44294312|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44294313|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294314|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
44294315|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44294316|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44294317|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44294318|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
44294319|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294320|NCT00797160|Propofol|propofol|mesh-list
44294321|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44294322|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294323|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294324|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44294325|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
44294326|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
44294327|NCT00797264|Ketamine|ketamine|mesh-list
44294328|NCT00797264|Morphine|morphine|mesh-list
44294329|NCT00797264|Analgesics|analgesics|mesh-ancestor
44294330|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
44294331|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294332|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294357|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44294358|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44294359|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294360|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294361|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44294362|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
44294363|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294364|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294365|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44294366|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44294367|NCT00797472|Bleomycin|bleomycin|mesh-list
44294368|NCT00797472|Dacarbazine|dacarbazine|mesh-list
44294369|NCT00797472|Vinblastine|vinblastine|mesh-list
44294370|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294371|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294372|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294373|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294374|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
44294375|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294376|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294377|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294378|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294379|NCT00797485|Leucovorin|leucovorin|mesh-list
44294380|NCT00797485|Bevacizumab|bevacizumab|mesh-list
44294381|NCT00797485|Fluorouracil|fluorouracil|mesh-list
44294382|NCT00797485|Capecitabine|capecitabine|mesh-list
44294383|NCT00797485|Irinotecan|irinotecan|mesh-list
44294384|NCT00797485|Calcium|calcium|mesh-list
44294385|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
44294386|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294387|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294388|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44294389|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44294390|NCT00797485|Growth Substances|growth substances|mesh-ancestor
44294391|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294394|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
44294395|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294396|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294397|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294398|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
44294399|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44294400|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44294401|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294402|NCT00797485|Antidotes|antidotes|mesh-ancestor
44294403|NCT00797485|Protective Agents|protective agents|mesh-ancestor
44294404|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
44294405|NCT00797485|Vitamins|vitamins|mesh-ancestor
44294406|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
44294407|NCT00797693|Misoprostol|misoprostol|mesh-list
44115915|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44115916|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
44115917|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
44115918|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
44115919|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
44115920|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115921|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115922|NCT00104260|Verapamil|verapamil|mesh-list
44115923|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44115924|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44115925|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44115926|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115927|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44115928|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115929|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
44115930|NCT00104273|Rasagiline|rasagiline|mesh-list
44115931|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44115932|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115933|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115934|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44115935|NCT00104273|Protective Agents|protective agents|mesh-ancestor
44115936|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115937|NCT00104286|Troxacitabine|troxacitabine|mesh-list
44115938|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115939|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115940|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115941|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
44115942|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115943|NCT00104403|Dexamethasone|dexamethasone|mesh-list
44115944|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
44115945|NCT00104403|Ondansetron|ondansetron|mesh-list
44115946|NCT00104403|Casopitant|casopitant|mesh-list
44115947|NCT00104403|BB 1101|bb 1101|mesh-list
44115948|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44115949|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
44115950|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
44115951|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44115952|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115953|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44115954|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
44115955|NCT00104403|Hormones|hormones|mesh-ancestor
44115956|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115957|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44115958|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115959|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115960|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115961|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115962|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
44115963|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44294408|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44294409|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
44294410|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44294411|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294412|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44294413|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294415|NCT00797745|Ritonavir|ritonavir|mesh-list
44294416|NCT00797745|Ribavirin|ribavirin|mesh-list
44294417|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44294418|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44294419|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44294420|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
44294421|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294422|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294423|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44294424|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44294425|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
44294426|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294427|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44294428|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44294429|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
44294430|NCT00797771|Insulin|insulin|mesh-list
44294431|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44294432|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294433|NCT00797784|Etanercept|etanercept|mesh-list
44294434|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44294435|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294436|NCT00797784|Analgesics|analgesics|mesh-ancestor
44294437|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
44294438|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294439|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294440|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294441|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294442|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294443|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294444|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
44115964|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294446|NCT00797810|Dexamethasone|dexamethasone|mesh-list
44294447|NCT00797810|Prednisone|prednisone|mesh-list
44294448|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
44294449|NCT00797810|Ifosfamide|ifosfamide|mesh-list
44294450|NCT00797810|Rituximab|rituximab|mesh-list
44294451|NCT00797810|Vincristine|vincristine|mesh-list
44294452|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294453|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
44294454|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294455|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294456|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294457|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
44294458|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294459|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294460|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294461|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294462|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294463|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
44294464|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
44294465|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294466|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294467|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
44294468|NCT00797810|Hormones|hormones|mesh-ancestor
44294469|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294470|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44294471|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294472|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
44294473|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
43949151|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
44294474|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115965|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
44115966|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115967|NCT00104403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44115968|NCT00104403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44115969|NCT00104403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44115970|NCT00104403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115971|NCT00104403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44115972|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44115973|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44115974|NCT00104429|Aplaviroc|aplaviroc|mesh-list
44115975|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44115978|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115980|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294475|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294477|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294478|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294479|NCT00797836|Interferons|interferons|mesh-list
44294480|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294481|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
44294482|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294483|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44294484|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
44294485|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
44294486|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294487|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294488|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294489|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294490|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
44294491|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
44294492|NCT00798070|Fluorouracil|fluorouracil|mesh-list
44294493|NCT00798070|Docetaxel|docetaxel|mesh-list
44294494|NCT00798070|Epirubicin|epirubicin|mesh-list
44294495|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294496|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
44294497|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115981|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115982|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115983|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44115984|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44115985|NCT00104442|Rivastigmine|rivastigmine|mesh-list
44115986|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44115987|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115988|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115989|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
44115990|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115991|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115992|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44115993|NCT00104442|Protective Agents|protective agents|mesh-ancestor
44115994|NCT00104468|Troxacitabine|troxacitabine|mesh-list
44115995|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115996|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44115997|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44115998|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
44115999|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116000|NCT00104546|Vitamin K|vitamin k|mesh-list
44116001|NCT00104546|Vitamins|vitamins|mesh-ancestor
44116002|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
44116003|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116004|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44116005|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44116006|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116007|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
44116008|NCT00104546|Coagulants|coagulants|mesh-ancestor
44116009|NCT00104598|Bupropion|bupropion|mesh-list
44116010|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44116011|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116012|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294498|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294499|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294500|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
44294501|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294502|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294503|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294504|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
44294505|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294506|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294507|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294508|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294509|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294510|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294511|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44294512|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294513|NCT00798083|Lidocaine|lidocaine|mesh-list
44294514|NCT00798083|Ketamine|ketamine|mesh-list
44294515|NCT00798083|Amitriptyline|amitriptyline|mesh-list
44294516|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
44294517|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
44294518|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294519|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294520|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
44294521|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294522|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44294523|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44294524|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44294525|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717622|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
44116013|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44116014|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116015|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116016|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116017|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
44116018|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116019|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116020|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44116021|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44116022|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116023|NCT00104624|Docetaxel|docetaxel|mesh-list
44116024|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116025|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116026|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44116027|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294526|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294527|NCT00798083|Analgesics|analgesics|mesh-ancestor
44294528|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44294529|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44294530|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
44294531|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44294532|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44294533|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294534|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44294535|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
44294536|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294537|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294538|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44294539|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44294540|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294541|NCT00798148|Carboplatin|carboplatin|mesh-list
44294542|NCT00798148|Etoposide|etoposide|mesh-list
44294543|NCT00798148|Melphalan|melphalan|mesh-list
44294544|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294545|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294546|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294547|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44294548|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294549|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294550|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294551|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
44294552|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294553|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294554|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
44294555|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294556|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
44294557|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294558|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294559|NCT00798252|Paclitaxel|paclitaxel|mesh-list
44294560|NCT00798252|Docetaxel|docetaxel|mesh-list
44294561|NCT00798252|Doxorubicin|doxorubicin|mesh-list
44294562|NCT00798252|Capecitabine|capecitabine|mesh-list
44294563|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294564|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294565|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294566|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294567|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294568|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294569|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294570|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44294571|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44294572|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294573|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294574|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
44464892|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44464893|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44464894|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44464895|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44464896|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
44464897|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464898|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44464899|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464900|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464901|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
44464902|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464903|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464904|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44464905|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
44464906|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44464907|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464908|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44464909|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
44464910|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44464911|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464912|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464913|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464915|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44464916|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44464917|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464918|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464919|NCT01487200|Triamcinolone|triamcinolone|mesh-list
44464920|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44464921|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44464922|NCT01487200|FX006|fx006|mesh-list
44464923|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44464924|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464925|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
44464926|NCT01487200|Hormones|hormones|mesh-ancestor
44464927|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44464928|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44464929|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44464930|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
44464931|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464932|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464933|NCT01487161|Triamcinolone|triamcinolone|mesh-list
44464934|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44464935|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44464936|NCT01487161|FX006|fx006|mesh-list
44464937|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44464938|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44464939|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
44464940|NCT01487161|Hormones|hormones|mesh-ancestor
44464941|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116028|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116029|NCT00104663|Quinacrine|quinacrine|mesh-list
44116030|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
44116031|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44116032|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
44116033|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44116034|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116035|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
44116036|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44116037|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
44116038|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116039|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116040|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116041|NCT00104689|Capecitabine|capecitabine|mesh-list
44116042|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
44116043|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116044|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
44116045|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116046|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116047|NCT00104715|Docetaxel|docetaxel|mesh-list
44464942|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294575|NCT00798343|Vaccines|vaccines|mesh-list
44294576|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
44294577|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294578|NCT00798395|Zopiclone|zopiclone|mesh-list
44294579|NCT00798395|Mirtazapine|mirtazapine|mesh-list
44294580|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44294581|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294582|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294583|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
44294584|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294585|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44294586|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
44294587|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
44294588|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294589|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294590|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44294591|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294592|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44294593|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44294594|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44294595|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294596|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44294597|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44294598|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
44294599|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44294600|NCT00798460|Lamivudine|lamivudine|mesh-list
44294601|NCT00798460|Adefovir|adefovir|mesh-list
44294602|NCT00798460|Clevudine|clevudine|mesh-list
44294603|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44294604|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44116053|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44116054|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116055|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44116056|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116057|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116058|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154209|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44154210|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44154211|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154212|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154213|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43647077|NCT02490904|Eplerenone|eplerenone|mesh-list
44294605|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294606|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294607|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
44294608|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294609|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44294610|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44294611|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
44294612|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44294613|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294615|NCT00798525|Argatroban|argatroban|mesh-list
44294616|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
44294617|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44294618|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
44294619|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294620|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294621|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
44294622|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44294623|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44294624|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44294625|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
44294626|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44294627|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44294628|NCT00798616|Prednisolone|prednisolone|mesh-list
44294629|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
44294630|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44294631|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
44294632|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294633|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
44294634|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
44294635|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294636|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294637|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44294648|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294649|NCT00798772|Protective Agents|protective agents|mesh-ancestor
44294650|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294651|NCT00798785|Rituximab|rituximab|mesh-list
44294652|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44294653|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294654|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
44294655|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294656|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294657|NCT00798876|Vitamin E|vitamin e|mesh-list
44294658|NCT00798876|Vitamins|vitamins|mesh-ancestor
44294659|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
44294660|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294661|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
44294662|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294663|NCT00798876|Protective Agents|protective agents|mesh-ancestor
44294664|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44294665|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44154214|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154215|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154216|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154217|NCT00223223|Levetiracetam|levetiracetam|mesh-list
44154218|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
44154219|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
44154220|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44154221|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154222|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154223|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154224|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154225|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154226|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154227|NCT00223275|Naltrexone|naltrexone|mesh-list
44154228|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44154229|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44154230|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154231|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
44154232|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154233|NCT00223288|Citalopram|citalopram|mesh-list
44154234|NCT00223288|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44154235|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154236|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154237|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154238|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154239|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
44154240|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154241|NCT00223288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44154242|NCT00223288|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154243|NCT00223288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154244|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
44154245|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44154246|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154247|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44154248|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
44154249|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44154250|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154251|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294666|NCT00798915|Incretins|incretins|mesh-ancestor
44294668|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294669|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294670|NCT00798954|Sirolimus|sirolimus|mesh-list
44294671|NCT00798954|Paclitaxel|paclitaxel|mesh-list
44294672|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294673|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294674|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294675|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294676|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
43717791|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44154252|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158152|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44158153|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44158154|NCT00236301|Estradiol|estradiol|mesh-list
44158155|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44158156|NCT00236301|Estrogens|estrogens|mesh-ancestor
44158158|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158159|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158160|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44158161|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
44158162|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44158163|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44158164|NCT00236327|Fentanyl|fentanyl|mesh-list
44116059|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44116061|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
44116074|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44116075|NCT00104767|Analgesics|analgesics|mesh-ancestor
44116076|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
44116077|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116078|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116079|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116080|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116081|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44116082|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44116083|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116084|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116085|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
44116086|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44116087|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
44116088|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116089|NCT00104793|Carboplatin|carboplatin|mesh-list
44116090|NCT00104793|Irinotecan|irinotecan|mesh-list
44116091|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116092|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44116093|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116094|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116095|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116096|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
44116097|NCT00104806|Vitamin D|vitamin d|mesh-list
44116098|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
44116099|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44116100|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116101|NCT00104806|Vitamins|vitamins|mesh-ancestor
44116102|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
44116103|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44116104|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116105|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
44116106|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44116107|NCT00104819|Antibodies|antibodies|mesh-list
44116108|NCT00104819|Sargramostim|sargramostim|mesh-list
44116109|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44116110|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
44294677|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294678|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44294679|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294680|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44294681|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
44294682|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294683|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
44294684|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294686|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44294687|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
44294688|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44294689|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294690|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44294691|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44294692|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44294693|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
44116111|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116112|NCT00104845|Vaccines|vaccines|mesh-list
44116113|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
44116114|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116115|NCT00104910|Cisplatin|cisplatin|mesh-list
44116116|NCT00104910|Cetuximab|cetuximab|mesh-list
44116117|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116118|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44116119|NCT00104923|Fenretinide|fenretinide|mesh-list
44116120|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116121|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44116122|NCT00104923|Protective Agents|protective agents|mesh-ancestor
44116123|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116129|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116130|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44116131|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44116132|NCT00104962|Growth Substances|growth substances|mesh-ancestor
44116133|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
44116134|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116135|NCT00104975|Fludarabine|fludarabine|mesh-list
44116136|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
44116137|NCT00104975|Melphalan|melphalan|mesh-list
44116138|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
44116139|NCT00104975|Thiotepa|thiotepa|mesh-list
44116140|NCT00104975|Tacrolimus|tacrolimus|mesh-list
44116141|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116142|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116143|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
44116144|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116145|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116146|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
44116147|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116148|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44116149|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116150|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44116151|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
44116152|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44116153|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44116154|NCT00104988|Thalidomide|thalidomide|mesh-list
44116155|NCT00104988|Temozolomide|temozolomide|mesh-list
44294695|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44294696|NCT00798993|Calcifediol|calcifediol|mesh-list
44294697|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44294698|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294699|NCT00798993|Vitamins|vitamins|mesh-ancestor
44294700|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
44294701|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44294702|NCT00799045|Clopidogrel|clopidogrel|mesh-list
44294703|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44294704|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44294705|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44294706|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44294707|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
44294708|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116156|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44116157|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
44116158|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116159|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116160|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116161|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
44116162|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116163|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
44116164|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44116165|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116166|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44116167|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44116168|NCT00104988|Growth Substances|growth substances|mesh-ancestor
44116169|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44116170|NCT00105040|Levetiracetam|levetiracetam|mesh-list
44116171|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
44116172|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
44116173|NCT00105105|Mifepristone|mifepristone|mesh-list
44116174|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44116175|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
44116176|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44116177|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116178|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44116179|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44116180|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44116181|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
44116182|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44116183|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44116184|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116185|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116186|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
44116187|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44116188|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44116189|NCT00105144|Caspofungin|caspofungin|mesh-list
44116190|NCT00105144|Micafungin|micafungin|mesh-list
44116191|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
44116192|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116193|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116197|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44116198|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44116199|NCT00105209|Analgesics|analgesics|mesh-ancestor
44116200|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
44116201|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116202|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294709|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294710|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294712|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
44294713|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44294714|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44294715|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44294716|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44294717|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44294718|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44294719|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294720|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647098|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
43717835|NCT02645981|Sorafenib|sorafenib|mesh-list
44116203|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116204|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116205|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44116206|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44116207|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116208|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44116209|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44116210|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116211|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
44116212|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44116213|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44116214|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44116215|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
44116216|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116217|NCT00105287|Fentanyl|fentanyl|mesh-list
44116218|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44116219|NCT00105287|Narcotics|narcotics|mesh-ancestor
44116220|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116221|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116222|NCT00105287|Analgesics|analgesics|mesh-ancestor
44116223|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
44116224|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116225|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44116226|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44116227|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
44116228|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
44116229|NCT00105300|Adalimumab|adalimumab|mesh-list
44116230|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116231|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116232|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44116233|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44116234|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116235|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116236|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116237|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116238|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44116239|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44116240|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
44116241|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116242|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116243|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44116244|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44116245|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
44116246|NCT00105352|Glucagon|glucagon|mesh-list
44116247|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116248|NCT00105352|Hormones|hormones|mesh-ancestor
44116249|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294721|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44294723|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294724|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294726|NCT00799136|Vincristine|vincristine|mesh-list
44294727|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294728|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
44294729|NCT00799136|Hormones|hormones|mesh-ancestor
44294730|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116250|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116251|NCT00105404|Triamcinolone|triamcinolone|mesh-list
44116252|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44116253|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44116254|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44116255|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116256|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
44116257|NCT00105404|Hormones|hormones|mesh-ancestor
44116258|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116259|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116260|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116261|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
44116262|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647100|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44116263|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116264|NCT00105495|Deferiprone|deferiprone|mesh-list
44116265|NCT00105495|Deferoxamine|deferoxamine|mesh-list
44116269|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116270|NCT00105495|Siderophores|siderophores|mesh-ancestor
44116271|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
44116272|NCT00105547|Analgesics|analgesics|mesh-ancestor
44116273|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
44116274|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116275|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116276|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44116277|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44116278|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116279|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116280|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44116281|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116282|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116283|NCT00105937|Fentanyl|fentanyl|mesh-list
44116284|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44116285|NCT00105937|Narcotics|narcotics|mesh-ancestor
44116286|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116287|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116288|NCT00105937|Analgesics|analgesics|mesh-ancestor
44116289|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
44116290|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116291|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44116292|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44116293|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
44116294|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
44116295|NCT00105950|Lapatinib|lapatinib|mesh-list
44116296|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116297|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44116298|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116299|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116300|NCT00106054|Leucovorin|leucovorin|mesh-list
44116301|NCT00106054|Bevacizumab|bevacizumab|mesh-list
44116302|NCT00106054|Irinotecan|irinotecan|mesh-list
44116303|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44116304|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116305|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44116306|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44116307|NCT00106054|Growth Substances|growth substances|mesh-ancestor
44294731|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294732|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44294733|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116308|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116309|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
44116310|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44116311|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116312|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116313|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116314|NCT00106054|Antidotes|antidotes|mesh-ancestor
44116315|NCT00106054|Protective Agents|protective agents|mesh-ancestor
44116316|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
44116317|NCT00106054|Vitamins|vitamins|mesh-ancestor
44116318|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
44116319|NCT00106132|Triamcinolone|triamcinolone|mesh-list
44116320|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44116321|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44116322|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44116323|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116324|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
44116325|NCT00106132|Hormones|hormones|mesh-ancestor
44116326|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116327|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116328|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116329|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
44116330|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116331|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116332|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44116333|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
44116334|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116335|NCT00106197|Bupropion|bupropion|mesh-list
44116336|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44116337|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116338|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116341|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116342|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116344|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116345|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116346|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44116347|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44116348|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116349|NCT00106262|Irinotecan|irinotecan|mesh-list
44116350|NCT00106262|Bortezomib|bortezomib|mesh-list
44116351|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44116352|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116353|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116354|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116355|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116356|NCT00106288|Amphotericin B|amphotericin b|mesh-list
44116357|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44116358|NCT00106288|Micafungin|micafungin|mesh-list
44116359|NCT00106288|Amebicides|amebicides|mesh-ancestor
44116360|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44116361|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44116362|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116363|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44116364|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
44116366|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44116367|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116368|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44116369|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44116370|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
44116371|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116372|NCT00106366|Insulin|insulin|mesh-list
44116373|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44116374|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
44116375|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
44116376|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
44116377|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44116378|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116379|NCT00106379|Tenofovir|tenofovir|mesh-list
44294734|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44294735|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
44294736|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
44294737|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
44294738|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294739|NCT00799149|Etoricoxib|etoricoxib|mesh-list
44294740|NCT00799149|Gabapentin|gabapentin|mesh-list
44294741|NCT00799149|Analgesics|analgesics|mesh-ancestor
44294742|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
44294743|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294744|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294745|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
44294746|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44294747|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44294748|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294749|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44294750|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44294751|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44294752|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294753|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294754|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
44294755|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44294756|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44294757|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294758|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44294759|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44294760|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44294761|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294762|NCT00799175|Ketorolac|ketorolac|mesh-list
44294763|NCT00799175|Epinephrine|epinephrine|mesh-list
44294764|NCT00799175|Ropivacaine|ropivacaine|mesh-list
44116380|NCT00106379|Emtricitabine|emtricitabine|mesh-list
44116381|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44116382|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
44116383|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116384|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44116385|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44116386|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116387|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116388|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44116389|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44116390|NCT00106405|Memantine|memantine|mesh-list
44116391|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44294765|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
44294766|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
44294767|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44294768|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294769|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
44294770|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294771|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44294772|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44294791|NCT00799188|Everolimus|everolimus|mesh-list
44294833|NCT00799539|Bortezomib|bortezomib|mesh-list
44294834|NCT00799539|Melphalan|melphalan|mesh-list
44294835|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44294836|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
44294837|NCT00799539|Hormones|hormones|mesh-ancestor
44294838|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44294839|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294840|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44294841|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294842|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294843|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
44294844|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294845|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294846|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294847|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
44294851|NCT00799682|Travoprost|travoprost|mesh-list
44294890|NCT00800137|Calcium heparin|calcium heparin|mesh-list
44294891|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44294892|NCT00800137|Tinzaparin|tinzaparin|mesh-list
44294893|NCT00800137|Dalteparin|dalteparin|mesh-list
44294894|NCT00800137|Warfarin|warfarin|mesh-list
44294895|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
44294896|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44294897|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44294898|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294899|NCT00800150|Fludarabine|fludarabine|mesh-list
44294900|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
44294901|NCT00800150|Melphalan|melphalan|mesh-list
44294902|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44294903|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44294904|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
44294905|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294906|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44294907|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
44294908|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294909|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44294910|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
44294911|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44294912|NCT00800215|Lacosamide|lacosamide|mesh-list
44294913|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
44294914|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44294915|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44294916|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464964|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44464965|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44464966|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44464967|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464968|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44464969|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44464970|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44464971|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44464972|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44464973|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949586|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
44294918|NCT00800267|Timolol|timolol|mesh-list
44294919|NCT00800267|Latanoprost|latanoprost|mesh-list
44294920|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44294921|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44294922|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294923|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294924|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294925|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294926|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44294927|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44294928|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44294929|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44294955|NCT00800306|Dobutamine|dobutamine|mesh-list
44294956|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44294957|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
44294958|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44294959|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44294960|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44294961|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294962|NCT00800306|Protective Agents|protective agents|mesh-ancestor
44294963|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294964|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
44294965|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
43718034|NCT02644915|Protective Agents|protective agents|mesh-ancestor
44116392|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44116393|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
44116394|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116395|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116396|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116397|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44116398|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44116399|NCT00106418|Romidepsin|romidepsin|mesh-list
44116400|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44116401|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116402|NCT00106496|Tacrolimus|tacrolimus|mesh-list
44116403|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116404|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
44116405|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116406|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44116407|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116408|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116409|NCT00106522|Methotrexate|methotrexate|mesh-list
44116410|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44116411|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
44116421|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116422|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
44116423|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116424|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44154253|NCT00223418|Aripiprazole|aripiprazole|mesh-list
44154254|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154255|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154256|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154257|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154258|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154259|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154260|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
44154261|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
44154262|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116425|NCT00106548|Methotrexate|methotrexate|mesh-list
44116426|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44116427|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
44116428|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44116429|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116430|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116431|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
44116432|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116433|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116434|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
44116435|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116436|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44116437|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116438|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
44116439|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116440|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44294966|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294967|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44294968|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44294969|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44294970|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44294971|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294972|NCT00800319|ALKS-33|alks-33|mesh-list
44294973|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44294974|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294975|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
44294976|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44294977|NCT00800358|Calcitriol|calcitriol|mesh-list
44294978|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44294979|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294980|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44294981|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44294982|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294983|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44294984|NCT00800358|Vitamins|vitamins|mesh-ancestor
44294985|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
44294986|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44294987|NCT00800423|Timolol|timolol|mesh-list
44294988|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44294989|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44294990|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44294991|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
43949663|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44294992|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44294993|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44294994|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44294995|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44294996|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43718046|NCT02644616|Diuretics|diuretics|mesh-ancestor
44116442|NCT00106561|Spironolactone|spironolactone|mesh-list
44116443|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44116444|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116445|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116446|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116447|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44294997|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44294998|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44294999|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44295000|NCT00800462|Bromides|bromides|mesh-list
44295001|NCT00800462|Oxybutynin|oxybutynin|mesh-list
44295002|NCT00800462|Darifenacin|darifenacin|mesh-list
44295003|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
44295004|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
44295005|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
44295006|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295007|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295008|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44295009|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44295010|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295011|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295012|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295013|NCT00800462|Urological Agents|urological agents|mesh-ancestor
44295014|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
44295015|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44295016|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
44295017|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295018|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44295019|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44295020|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44295021|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295022|NCT00800527|Diclofenac|diclofenac|mesh-list
44295023|NCT00800527|Gabapentin|gabapentin|mesh-list
44295024|NCT00800527|Analgesics|analgesics|mesh-ancestor
44295025|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
44295026|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295041|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295042|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295043|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295044|NCT00800553|Donepezil|donepezil|mesh-list
44295045|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44295046|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295047|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295048|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295049|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295050|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295051|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
44295052|NCT00800566|Clofarabine|clofarabine|mesh-list
44295053|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44295054|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
44295055|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295056|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295057|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
44295058|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
44295059|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44295060|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44295061|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295062|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295063|NCT00800592|Urological Agents|urological agents|mesh-ancestor
44295064|NCT00800709|Memantine|memantine|mesh-list
43949741|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295065|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44295066|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44295067|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
44295068|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295069|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295070|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718090|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116448|NCT00106561|Diuretics|diuretics|mesh-ancestor
44116449|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
44116450|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44116451|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44116452|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44116453|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116454|NCT00106587|Paclitaxel|paclitaxel|mesh-list
44116455|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295071|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44295072|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44295073|NCT00800722|Sirolimus|sirolimus|mesh-list
44295074|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295075|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295076|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295077|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295078|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
44295079|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295080|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
44295081|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295082|NCT00800748|Ribavirin|ribavirin|mesh-list
44295083|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44295084|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
44295085|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295086|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
44295087|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295088|NCT00800761|Deferiprone|deferiprone|mesh-list
44295089|NCT00800761|Deferoxamine|deferoxamine|mesh-list
44295090|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44295091|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
44295092|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
44295093|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295094|NCT00800761|Siderophores|siderophores|mesh-ancestor
44295095|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
43718094|NCT02644395|Amlodipine|amlodipine|mesh-list
44116456|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116457|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116458|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44116459|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44116460|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116461|NCT00106600|Pixantrone|pixantrone|mesh-list
44116462|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44116463|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116464|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116465|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116471|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44116472|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116473|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44116474|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44116475|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116476|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116477|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116478|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44116479|NCT00106821|Bromides|bromides|mesh-list
44116480|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
44116481|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44116482|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
44116483|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295096|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
44295097|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295098|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44295099|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44295100|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44295101|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
44295102|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295103|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44295104|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44295105|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295106|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
44295107|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44295108|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295109|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295110|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295111|NCT00800826|Analgesics|analgesics|mesh-ancestor
44116484|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116485|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44116486|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
44116487|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
44116488|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44116489|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
44116490|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116491|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116492|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
44116493|NCT00106834|Infliximab|infliximab|mesh-list
44116494|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44116495|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116496|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116497|NCT00106847|Infliximab|infliximab|mesh-list
44116498|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44116499|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116500|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116501|NCT00106886|Folic Acid|folic acid|mesh-list
44116502|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
44116503|NCT00106886|Pyridoxal|pyridoxal|mesh-list
44116504|NCT00106886|Pyridoxine|pyridoxine|mesh-list
44116505|NCT00106886|Vitamins|vitamins|mesh-ancestor
44116506|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
44116507|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116508|NCT00106886|Hematinics|hematinics|mesh-ancestor
44116509|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
44116510|NCT00107003|Lapatinib|lapatinib|mesh-list
44116511|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116512|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44116513|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116514|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116515|NCT00107016|Letrozole|letrozole|mesh-list
44116516|NCT00107016|Everolimus|everolimus|mesh-list
44116517|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116518|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44116519|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44116520|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116521|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116522|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44116523|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116524|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116525|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116526|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295112|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
44295113|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295114|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44295115|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44295116|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44295117|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44295118|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295119|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295120|NCT00800917|Sirolimus|sirolimus|mesh-list
44295121|NCT00800917|Bevacizumab|bevacizumab|mesh-list
44295122|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295123|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295124|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44295125|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44295126|NCT00800917|Growth Substances|growth substances|mesh-ancestor
44295127|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295128|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44295129|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295130|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295131|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295132|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
44295133|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295134|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
44295135|NCT00800930|Butyric Acid|butyric acid|mesh-list
44295136|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
44116527|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
44116528|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44116529|NCT00107081|Amoxicillin|amoxicillin|mesh-list
44116530|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
44116531|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116532|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44116533|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116534|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116535|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116536|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116537|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44116543|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116544|NCT00107237|Everolimus|everolimus|mesh-list
44116545|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116546|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116547|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
44116548|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116549|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
44116550|NCT00107263|Letrozole|letrozole|mesh-list
44116551|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116552|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44116553|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44116554|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116555|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949742|NCT03418805|Ibuprofen|ibuprofen|mesh-list
44295137|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
44295138|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295139|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295140|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295142|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295143|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295144|NCT00801034|Calcium|calcium|mesh-list
44295145|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44295146|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295147|NCT00801047|Remifentanil|remifentanil|mesh-list
44295148|NCT00801047|Bupivacaine|bupivacaine|mesh-list
44295149|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295150|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
44295151|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295152|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295153|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
44295154|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295155|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295156|NCT00801047|Narcotics|narcotics|mesh-ancestor
44295157|NCT00801047|Analgesics|analgesics|mesh-ancestor
44295158|NCT00801086|Ethanol|ethanol|mesh-list
44295160|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44295161|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295162|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116556|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44116557|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116558|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116559|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116560|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44116561|NCT00107341|Paclitaxel|paclitaxel|mesh-list
44116562|NCT00107341|Carboplatin|carboplatin|mesh-list
44116563|NCT00107341|Bortezomib|bortezomib|mesh-list
44116564|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44116565|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116566|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116567|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44116568|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44116569|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116570|NCT00107354|Cytarabine|cytarabine|mesh-list
44116571|NCT00107354|Aldesleukin|aldesleukin|mesh-list
44116572|NCT00107354|Etoposide|etoposide|mesh-list
44116573|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
44116574|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44116575|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116576|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44116577|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116578|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116579|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295163|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295164|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
44295165|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295166|NCT00801086|Protective Agents|protective agents|mesh-ancestor
44295167|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44295168|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295169|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44295170|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44295171|NCT00801125|Natalizumab|natalizumab|mesh-list
44295172|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
44295173|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295174|NCT00801151|Vinorelbine|vinorelbine|mesh-list
44295175|NCT00801151|Vorinostat|vorinostat|mesh-list
44295176|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295177|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295178|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116580|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116581|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
44116582|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
44116583|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116584|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116585|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
44116586|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116587|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44116588|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44116589|NCT00107354|Analgesics|analgesics|mesh-ancestor
44116590|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
44116591|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116592|NCT00107393|Capecitabine|capecitabine|mesh-list
44116593|NCT00107393|Trastuzumab|trastuzumab|mesh-list
44116594|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116595|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
44116596|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116597|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116598|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44116600|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116601|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116602|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116603|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44116604|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44116605|NCT00107432|Sorafenib|sorafenib|mesh-list
44116606|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116607|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44116608|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116613|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116615|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116616|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116617|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
44116618|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116619|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116620|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116621|NCT00107471|Topotecan|topotecan|mesh-list
44116622|NCT00107471|Lenograstim|lenograstim|mesh-list
44116623|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44116624|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
44116625|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116626|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44116627|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44295179|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
44295180|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
44295181|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295182|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44295183|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295184|NCT00801177|Necitumumab|necitumumab|mesh-list
44295185|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44295186|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295187|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295188|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
44295189|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295190|NCT00801255|Lactams|lactams|mesh-list
44295191|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295192|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295193|NCT00801268|Emodin|emodin|mesh-list
44295194|NCT00801268|Cathartics|cathartics|mesh-ancestor
44295195|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295196|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44295197|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295198|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295199|NCT00801281|Prednisone|prednisone|mesh-list
44295200|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
44295201|NCT00801281|Rituximab|rituximab|mesh-list
44295202|NCT00801281|Doxorubicin|doxorubicin|mesh-list
44295203|NCT00801281|Vincristine|vincristine|mesh-list
44295204|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295205|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
44295206|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295207|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116628|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116629|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116630|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116631|NCT00107510|Carboplatin|carboplatin|mesh-list
44116632|NCT00107510|Docetaxel|docetaxel|mesh-list
44116633|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116634|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116635|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
44116636|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
44116637|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116638|NCT00107523|Cytarabine|cytarabine|mesh-list
44116639|NCT00107523|Idarubicin|idarubicin|mesh-list
44116640|NCT00107523|Pravastatin|pravastatin|mesh-list
44116641|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116642|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
44116643|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116644|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116645|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
44116646|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295208|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44295209|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
44295210|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295211|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295212|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44295213|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949819|NCT02930044|Insulin|insulin|mesh-list
44295214|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295215|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43555679|NCT03560440|Vancomycin|vancomycin|mesh-list
44116647|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44116648|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
44116649|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116650|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44116651|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44116652|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44116653|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116654|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44116655|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44116656|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44116657|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44116658|NCT00107601|Insulin|insulin|mesh-list
44116659|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44116660|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116661|NCT00107731|Valproic Acid|valproic acid|mesh-list
44116662|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44116663|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116664|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116665|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44116666|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116667|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116668|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116669|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116670|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116671|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
44116672|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
44116673|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
44116674|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116675|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44116676|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116677|NCT00107796|Modafinil|modafinil|mesh-list
44116678|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44116679|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116683|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116684|NCT00107809|Modafinil|modafinil|mesh-list
44116685|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44116686|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116687|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44116688|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44116689|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44116690|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116691|NCT00107822|Lidocaine|lidocaine|mesh-list
44116692|NCT00107822|Tetracaine|tetracaine|mesh-list
44116693|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
44116694|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
44116695|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116696|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116697|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
44116698|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116699|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44116700|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44116701|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44116702|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44295217|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295218|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295219|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
44295220|NCT00801281|Hormones|hormones|mesh-ancestor
44295221|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295222|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44295223|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295224|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44295225|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44295226|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44295227|NCT00801294|Nintedanib|nintedanib|mesh-list
44295228|NCT00801294|Afatinib|afatinib|mesh-list
44295229|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116703|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116704|NCT00107835|Lidocaine|lidocaine|mesh-list
44116705|NCT00107835|Tetracaine|tetracaine|mesh-list
44116706|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
44116707|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
44116708|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116709|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116710|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
44116711|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116712|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44116713|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44116714|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44116715|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647215|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647216|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
44116716|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116718|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44116719|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116720|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44116721|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44116722|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44116723|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116724|NCT00107874|Misoprostol|misoprostol|mesh-list
44116725|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44116726|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
44116727|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44116728|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116729|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44116730|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116731|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
44116732|NCT00108004|Pramlintide|pramlintide|mesh-list
44116733|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44116734|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116735|NCT00108017|Timolol|timolol|mesh-list
44116736|NCT00108017|Dorzolamide|dorzolamide|mesh-list
44116737|NCT00108017|Maleic acid|maleic acid|mesh-list
44116738|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44116739|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44116740|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44116741|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116742|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116743|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116744|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44116745|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44116746|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116747|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44295230|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44295231|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295232|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295233|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44295234|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44295235|NCT00801385|Sorafenib|sorafenib|mesh-list
44295236|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295237|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44295238|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718248|NCT02643563|Epinephrine|epinephrine|mesh-list
44116748|NCT00108095|Ondansetron|ondansetron|mesh-list
44116749|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
44116755|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44116756|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44116757|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
44116758|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116759|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116760|NCT00108095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44116761|NCT00108095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116762|NCT00108095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116763|NCT00108095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116764|NCT00108095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44116766|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44116767|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44116768|NCT00108186|Analgesics|analgesics|mesh-ancestor
44116769|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
44116770|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116771|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116772|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44116773|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44116774|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44116775|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44116776|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116777|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647217|NCT02283996|Hormones|hormones|mesh-ancestor
44116778|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44116779|NCT00108238|Estradiol|estradiol|mesh-list
44116780|NCT00108238|Progesterone|progesterone|mesh-list
44116781|NCT00108238|Estrogens|estrogens|mesh-ancestor
44116782|NCT00108238|Hormones|hormones|mesh-ancestor
44116783|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116784|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116785|NCT00108238|Progestins|progestins|mesh-ancestor
44116786|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44116787|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116788|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44116789|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44116790|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44116791|NCT00108251|Eplerenone|eplerenone|mesh-list
44116792|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44116793|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116794|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116795|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116796|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44116798|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
44116799|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44116800|NCT00108316|Fluoxetine|fluoxetine|mesh-list
44116801|NCT00108316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44116802|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116803|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116804|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116805|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116806|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
44116807|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295239|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295240|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
44295241|NCT00801411|Docetaxel|docetaxel|mesh-list
44295242|NCT00801411|Doxorubicin|doxorubicin|mesh-list
44295243|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44295244|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295245|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
44295246|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295247|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295248|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44295249|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
44295250|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295251|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295252|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44295253|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
44295254|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
44295255|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
44295256|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295257|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44295258|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44295259|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295260|NCT00801450|Triamcinolone|triamcinolone|mesh-list
44295261|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44295262|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44295263|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44295264|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295265|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
44295266|NCT00801450|Hormones|hormones|mesh-ancestor
44295267|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295268|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295269|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295270|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
44295271|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295272|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295273|NCT00801515|Maraviroc|maraviroc|mesh-list
44116808|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44116809|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116810|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44295274|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44295275|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44295276|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295277|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44295278|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44295279|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
44295280|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295281|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44295282|NCT00801528|Diclofenac|diclofenac|mesh-list
44295283|NCT00801528|Ropivacaine|ropivacaine|mesh-list
44295284|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295285|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
44295286|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295287|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295288|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
44295289|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295290|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295291|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295293|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295294|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295295|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295296|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295297|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295298|NCT00801580|Doxorubicin|doxorubicin|mesh-list
44295299|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44295300|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295301|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295302|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44295303|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44295304|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295305|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295306|NCT00801606|Zinc|zinc|mesh-list
44116811|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44116812|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44116813|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116814|NCT00108368|Olanzapine|olanzapine|mesh-list
44116815|NCT00108368|Risperidone|risperidone|mesh-list
44116816|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44116817|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
44116818|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116821|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44295307|NCT00801606|Trace Elements|trace elements|mesh-list
44295308|NCT00801606|Micronutrients|micronutrients|mesh-list
44295309|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295310|NCT00801697|Vaccines|vaccines|mesh-list
44295311|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
44295312|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295313|NCT00801736|Paclitaxel|paclitaxel|mesh-list
44295314|NCT00801736|Cisplatin|cisplatin|mesh-list
44295315|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44295316|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295317|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
44295318|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44295319|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
44295320|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295321|NCT00801788|Oxycodone|oxycodone|mesh-list
44295322|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295323|NCT00801788|Narcotics|narcotics|mesh-ancestor
44295324|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295325|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295326|NCT00801788|Analgesics|analgesics|mesh-ancestor
44295327|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
44295328|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44464992|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44464993|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44464994|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
44295343|NCT00801879|Mupirocin|mupirocin|mesh-list
44295344|NCT00801879|Calcium|calcium|mesh-list
44295345|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44295346|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295347|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295348|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295349|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44295350|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295352|NCT00801905|Nepafenac|nepafenac|mesh-list
44295403|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295404|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
44295405|NCT00802009|Dexamethasone|dexamethasone|mesh-list
44295406|NCT00802009|Mepivacaine|mepivacaine|mesh-list
44295407|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295408|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
44295409|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
44295410|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295411|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295412|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295413|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
44295414|NCT00802009|Hormones|hormones|mesh-ancestor
44295415|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295416|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44295417|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295418|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295419|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
44295420|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295421|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
44295422|NCT00802035|Baclofen|baclofen|mesh-list
44295423|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44295424|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295425|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44295426|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295427|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44295428|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
44295429|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
44295430|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295431|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295432|NCT00802048|Ropivacaine|ropivacaine|mesh-list
44295433|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
44295434|NCT00802048|Anesthetics|anesthetics|mesh-list
44295435|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295436|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295437|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
44295438|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295442|NCT00802087|Analgesics|analgesics|mesh-ancestor
44295443|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
44295444|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295445|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295446|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
44295447|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295448|NCT00802087|Narcotics|narcotics|mesh-ancestor
44295449|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295450|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
44295451|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
44295452|NCT00802139|Iron|iron|mesh-list
44295453|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44295454|NCT00802139|Trace Elements|trace elements|mesh-ancestor
44295455|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
44295456|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295457|NCT00802139|Hematinics|hematinics|mesh-ancestor
44295458|NCT00802217|Capsaicin|capsaicin|mesh-list
44295459|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
44295460|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
44295461|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
44295462|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295463|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295464|NCT00802230|Terbutaline|terbutaline|mesh-list
44295465|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44295466|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
44295467|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295468|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295469|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44295470|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
44295471|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
44295472|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
44295473|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44295474|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44295475|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44295476|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44295477|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
44295478|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295480|NCT00802243|Leflunomide|leflunomide|mesh-list
44295481|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295482|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295483|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295484|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
44295485|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295486|NCT00802282|Psilocybin|psilocybin|mesh-list
44295487|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
44295488|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295489|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44295490|NCT00802308|Morphine|morphine|mesh-list
44295491|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295492|NCT00802308|Narcotics|narcotics|mesh-ancestor
44295493|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295494|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295542|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44295543|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
44295544|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295545|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295546|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
44295547|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295548|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
44295549|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44295550|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44295551|NCT00802581|Anesthetics|anesthetics|mesh-list
44295552|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
44295605|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
44295606|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295607|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
44295608|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44295609|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44295610|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44295611|NCT00802815|Etanercept|etanercept|mesh-list
44295612|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295613|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295614|NCT00802815|Analgesics|analgesics|mesh-ancestor
44295615|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
44295669|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
44295670|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295671|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295672|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44295673|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
44295674|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
44295675|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44295676|NCT00803309|Interferons|interferons|mesh-list
44295710|NCT00803465|Xhance|xhance|mesh-list
44295737|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
44295738|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295739|NCT00803699|Protective Agents|protective agents|mesh-ancestor
44295740|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295741|NCT00803699|Trace Elements|trace elements|mesh-ancestor
44295742|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
44295743|NCT00803725|Fentanyl|fentanyl|mesh-list
44295744|NCT00803725|Mepivacaine|mepivacaine|mesh-list
44295745|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44295746|NCT00803725|Narcotics|narcotics|mesh-ancestor
44295747|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44295748|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295749|NCT00803725|Analgesics|analgesics|mesh-ancestor
44295750|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
44295751|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295752|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44295753|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44295754|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
44295755|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
44295756|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
44295757|NCT00803764|Naproxen|naproxen|mesh-list
44295758|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295759|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295760|NCT00803764|Analgesics|analgesics|mesh-ancestor
44295761|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
44295762|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295764|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295785|NCT00803829|Sulfalene|sulfalene|mesh-list
44295786|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44295787|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44295788|NCT00803829|Renal Agents|renal agents|mesh-ancestor
44295789|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
44295790|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44295791|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44295792|NCT00803842|Doxycycline|doxycycline|mesh-list
44295793|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44295795|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
44465037|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
44465038|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44465039|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44465040|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465041|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465042|NCT01484951|Timolol|timolol|mesh-list
44465043|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44465044|NCT01484951|Brinzolamide|brinzolamide|mesh-list
44465045|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44465046|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44465047|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44465048|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
44465049|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465050|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465051|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465052|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44465053|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44158393|NCT00236652|Renal Agents|renal agents|mesh-ancestor
44295848|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44295849|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44295850|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44295851|NCT00804115|Miotics|miotics|mesh-ancestor
44295852|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
44295853|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295854|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44295855|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44295856|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
44295857|NCT00804206|Bevacizumab|bevacizumab|mesh-list
44295858|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44295859|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295860|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44295861|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44295862|NCT00804206|Growth Substances|growth substances|mesh-ancestor
44295863|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295864|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
44295865|NCT00804245|Choline|choline|mesh-list
44295866|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
44295867|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44295868|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
44295869|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295870|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295871|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44295872|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
44295873|NCT00804271|Memantine|memantine|mesh-list
44295874|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44295875|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44295876|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
44295877|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44295878|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295879|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295880|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44295890|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295893|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295894|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44295895|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
44295896|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295897|NCT00804336|Hormones|hormones|mesh-ancestor
44295898|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44295899|NCT00804388|Vitamin E|vitamin e|mesh-list
44295900|NCT00804388|Vitamins|vitamins|mesh-ancestor
44295901|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
44295902|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295903|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
44295904|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295905|NCT00804388|Protective Agents|protective agents|mesh-ancestor
44295906|NCT00804401|Naproxen|naproxen|mesh-list
44295907|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295908|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295909|NCT00804401|Analgesics|analgesics|mesh-ancestor
44295910|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
44295911|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295912|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295913|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295914|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44295915|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
44295916|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295917|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295918|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295919|NCT00804440|Ibuprofen|ibuprofen|mesh-list
44295920|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44295921|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44295922|NCT00804440|Analgesics|analgesics|mesh-ancestor
44295923|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
44295924|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295925|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295928|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44295929|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295930|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295931|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44295932|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
44295933|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44295934|NCT00804531|Prednisolone|prednisolone|mesh-list
44295935|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
44295936|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44295937|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
44295938|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44295939|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
44295940|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
44295941|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44295942|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295943|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44295944|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
44295945|NCT00804531|Hormones|hormones|mesh-ancestor
44295947|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44295984|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44295986|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44295987|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44295988|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44295989|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44295990|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44295991|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44295992|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295993|NCT00804856|Cytarabine|cytarabine|mesh-list
44295994|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44295995|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
44295996|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44295997|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44295998|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
44295999|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296000|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296001|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
44296002|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296003|NCT00804895|Cortivazol|cortivazol|mesh-list
44296004|NCT00804895|Verapamil|verapamil|mesh-list
44296005|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44296006|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44296007|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296032|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296034|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
44296035|NCT00804934|Ranibizumab|ranibizumab|mesh-list
44296036|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296037|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296038|NCT00804934|Growth Substances|growth substances|mesh-ancestor
44296039|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296040|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296041|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296042|NCT00804947|Melphalan|melphalan|mesh-list
44296043|NCT00804947|Busulfan|busulfan|mesh-list
44296044|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44296045|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
44296046|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296047|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296048|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44296049|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296050|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
44296051|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296052|NCT00804960|Letrozole|letrozole|mesh-list
44296053|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296054|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44296055|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44296056|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296057|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296058|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44296059|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
44296060|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296061|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296062|NCT00805012|Docetaxel|docetaxel|mesh-list
44296063|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296064|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44296065|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44296066|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44296068|NCT00805064|Triamcinolone|triamcinolone|mesh-list
44296070|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296071|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296072|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296073|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296074|NCT00805064|Growth Substances|growth substances|mesh-ancestor
44296075|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296076|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296077|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296078|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
44296079|NCT00805064|Hormones|hormones|mesh-ancestor
44296080|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296081|NCT00805090|Itraconazole|itraconazole|mesh-list
44296082|NCT00805090|Diclofenac|diclofenac|mesh-list
44296083|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296084|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296085|NCT00805090|Analgesics|analgesics|mesh-ancestor
44296086|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
44296087|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296088|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296089|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296090|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296091|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44296092|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296093|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296094|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
44296117|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296118|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296119|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296120|NCT00805233|Analgesics|analgesics|mesh-ancestor
44296121|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
44296122|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296123|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296124|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296125|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
44296126|NCT00805298|Epinephrine|epinephrine|mesh-list
44296182|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44296183|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44296185|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44296186|NCT00805519|Prednisolone|prednisolone|mesh-list
44296187|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44296188|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
44296189|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44296250|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296251|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296252|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
44296253|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
44296254|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296255|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647271|NCT02126553|Lenalidomide|lenalidomide|mesh-list
43647272|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
43647273|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647274|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296256|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
44296257|NCT00805649|Hormones|hormones|mesh-ancestor
44296258|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296259|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296260|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44296263|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44465087|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465088|NCT01484431|Urological Agents|urological agents|mesh-ancestor
44465090|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465091|NCT01484197|Maleic acid|maleic acid|mesh-list
44465092|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465093|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465094|NCT01483690|Dexamethasone|dexamethasone|mesh-list
44296326|NCT00806611|Ethanol|ethanol|mesh-list
44296327|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44296328|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296329|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296330|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296331|NCT00806663|Sunitinib|sunitinib|mesh-list
44296332|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296333|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296334|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296335|NCT00806663|Growth Substances|growth substances|mesh-ancestor
44296336|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296337|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296338|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44296339|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296340|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296341|NCT00806741|Phenylephrine|phenylephrine|mesh-list
44296342|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
44296343|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44296344|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44296345|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
44296346|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
44296347|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296348|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296349|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
44296350|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44296351|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
44296352|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
44296353|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44296354|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44296355|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44296356|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
44296357|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296358|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296368|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44296369|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
44296370|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296371|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44296372|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44296373|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44296374|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296375|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296376|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44296377|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44296378|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
44296379|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
44296380|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296381|NCT00806767|Fludarabine|fludarabine|mesh-list
44296382|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
44296383|NCT00806767|Busulfan|busulfan|mesh-list
44296384|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
44296385|NCT00806767|Antibodies|antibodies|mesh-list
44296386|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
44296387|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44296388|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44296423|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44296424|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296425|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
44296426|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296427|NCT00806923|Gemcitabine|gemcitabine|mesh-list
44296428|NCT00806923|Bevacizumab|bevacizumab|mesh-list
44296429|NCT00806923|Cisplatin|cisplatin|mesh-list
44296430|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296431|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296432|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296433|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296434|NCT00806923|Growth Substances|growth substances|mesh-ancestor
44296435|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296436|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44296483|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296484|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296485|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44296486|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
44296487|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296488|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296489|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44296490|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44296491|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44296492|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44296493|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296494|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44296495|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44296496|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296498|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
44296541|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296542|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296543|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296544|NCT00807534|Bromides|bromides|mesh-list
44465131|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44465132|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44465133|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44465134|NCT01483690|Analgesics|analgesics|mesh-ancestor
44465135|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
44465136|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44465137|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44465138|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44465139|NCT01483651|Insulin|insulin|mesh-list
44465140|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44465141|NCT01483651|Glucagon|glucagon|mesh-list
44465142|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465143|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296610|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
44296611|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44296612|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296613|NCT00808002|Tenofovir|tenofovir|mesh-list
44296614|NCT00808002|Emtricitabine|emtricitabine|mesh-list
44296615|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
44296616|NCT00808002|Maraviroc|maraviroc|mesh-list
44296617|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
44296618|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296619|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44296620|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44296621|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296622|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296623|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44296630|NCT00808054|Lidocaine|lidocaine|mesh-list
44296670|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296671|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296672|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44296673|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
43647287|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
44296674|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296675|NCT00808171|Analgesics|analgesics|mesh-ancestor
44296676|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44296677|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
44296678|NCT00808184|Midazolam|midazolam|mesh-list
44296679|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44296680|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44296681|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296682|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296683|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44296684|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44296685|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44296686|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44296687|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
44296688|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
44296689|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
44296690|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
44296691|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296692|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296693|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44296694|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296700|NCT00808223|Alefacept|alefacept|mesh-list
44296719|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
44296720|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296721|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296722|NCT00808327|Fentanyl|fentanyl|mesh-list
44296723|NCT00808327|Bupivacaine|bupivacaine|mesh-list
44296724|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
44296725|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
44296726|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44296727|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296728|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
44296729|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296730|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44296731|NCT00808327|Narcotics|narcotics|mesh-ancestor
44296732|NCT00808327|Analgesics|analgesics|mesh-ancestor
44296733|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44296734|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44296735|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
44296736|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
44296737|NCT00808366|Clotrimazole|clotrimazole|mesh-list
44296738|NCT00808366|Miconazole|miconazole|mesh-list
44296739|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
44296740|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296741|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44296742|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44296743|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44296744|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296745|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296746|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44296747|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
44296748|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296764|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44296765|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
44296766|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296767|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44296768|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44296769|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296770|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
44296771|NCT00808704|Hematinics|hematinics|mesh-ancestor
44296772|NCT00808717|Atorvastatin|atorvastatin|mesh-list
44296773|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44296774|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44116822|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116823|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116824|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116825|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44116827|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
44116828|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
44116829|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116830|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116831|NCT00108368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44116832|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116833|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154263|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154264|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44154265|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44154266|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
44154267|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44154268|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44154269|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44154270|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44154271|NCT00223509|Lamotrigine|lamotrigine|mesh-list
44154272|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
44154273|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44154274|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154275|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154276|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154277|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154278|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154279|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154280|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154281|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154282|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44154283|NCT00223548|Mesna|mesna|mesh-list
44154284|NCT00223548|Protective Agents|protective agents|mesh-ancestor
44154285|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154286|NCT00223561|Methylphenidate|methylphenidate|mesh-list
44154287|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44154288|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154289|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44154290|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154291|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154292|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154293|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
44154294|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154295|NCT00223613|Insulin|insulin|mesh-list
44116834|NCT00108394|Pamidronate|pamidronate|mesh-list
44116835|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44116836|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116837|NCT00108420|Prazosin|prazosin|mesh-list
44296775|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
44296776|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296777|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44296778|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44296779|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296780|NCT00808743|Celecoxib|celecoxib|mesh-list
44296781|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44296782|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296783|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296784|NCT00808743|Analgesics|analgesics|mesh-ancestor
44296785|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
44296786|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296787|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296788|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296789|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296790|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44296791|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44296792|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296793|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296794|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44296795|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296796|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
43719547|NCT02635230|Aspirin|aspirin|mesh-list
44116838|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44116839|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44116840|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44116841|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44116842|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
44116843|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116844|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116845|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116846|NCT00108446|Lidocaine|lidocaine|mesh-list
44116847|NCT00108446|Fentanyl|fentanyl|mesh-list
44116848|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
44116849|NCT00108446|Naloxone|naloxone|mesh-list
44116850|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
44116851|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
44116852|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116853|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116854|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
44116862|NCT00108446|Narcotics|narcotics|mesh-ancestor
44116863|NCT00108446|Analgesics|analgesics|mesh-ancestor
44116864|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44116865|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44116866|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
44116867|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44116868|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
44116869|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
44116870|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44116871|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44296797|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44296798|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
44296799|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296800|NCT00808795|Expectorants|expectorants|mesh-ancestor
44296801|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
44296802|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44296803|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
44296804|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296805|NCT00808795|Protective Agents|protective agents|mesh-ancestor
44296806|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296807|NCT00808795|Antidotes|antidotes|mesh-ancestor
44116872|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116873|NCT00108498|Mirtazapine|mirtazapine|mesh-list
44116874|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116875|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116876|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44116877|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
44116878|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
44116879|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116880|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116881|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116882|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44116883|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116884|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116885|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44116886|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44116887|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44116888|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
44116889|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44116890|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44116891|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
44116892|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44116893|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
44116894|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44116895|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
44116896|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116897|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44116898|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44116899|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44116900|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116901|NCT00108537|Bupropion|bupropion|mesh-list
44116902|NCT00108537|Nicotine|nicotine|mesh-list
44116903|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44116904|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
44116905|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116906|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116907|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44116908|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44116909|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
44116910|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116911|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116912|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44116913|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116914|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116915|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44116916|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116917|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116918|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
44116921|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116922|NCT00108563|Citalopram|citalopram|mesh-list
44116923|NCT00108563|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44116924|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116925|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44296808|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
44296809|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
44296810|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44296811|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44296812|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296813|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296814|NCT00808912|Urological Agents|urological agents|mesh-ancestor
44296815|NCT00808951|Artesunate|artesunate|mesh-list
44296816|NCT00808951|Lumefantrine|lumefantrine|mesh-list
44296817|NCT00808951|Artemether|artemether|mesh-list
44296818|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44296819|NCT00808951|Amodiaquine|amodiaquine|mesh-list
44296820|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
44296821|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44296822|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44296823|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44116926|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116927|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116928|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
44116929|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116930|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44116931|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
44116932|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116933|NCT00108576|Valproic Acid|valproic acid|mesh-list
44116934|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
44116935|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116936|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116937|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
44116938|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116939|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116940|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
44116941|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44116942|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116943|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44116944|NCT00108602|Acetazolamide|acetazolamide|mesh-list
44116945|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
44116946|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44116947|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116948|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116949|NCT00108602|Diuretics|diuretics|mesh-ancestor
44116950|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
44116951|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116952|NCT00108615|Metformin|metformin|mesh-list
44116953|NCT00108615|Pioglitazone|pioglitazone|mesh-list
44116954|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44116955|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116956|NCT00108667|Levodopa|levodopa|mesh-list
44116957|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44116958|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44116959|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
44116960|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116961|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116962|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116963|NCT00108706|Candesartan|candesartan|mesh-list
44116964|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44116965|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44116966|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44116967|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116968|NCT00108771|Fentanyl|fentanyl|mesh-list
44116969|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44296824|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296825|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
44296826|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
44296827|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44296828|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
44296829|NCT00808977|Mesalamine|mesalamine|mesh-list
44296830|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44296831|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44296832|NCT00808977|Analgesics|analgesics|mesh-ancestor
44296833|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
44296834|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44296835|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296836|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44296837|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647356|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43647357|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
44296838|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44296839|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43719591|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
44116970|NCT00108771|Narcotics|narcotics|mesh-ancestor
44116971|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44116972|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116973|NCT00108771|Analgesics|analgesics|mesh-ancestor
44116974|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
44116975|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116977|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44116978|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
44116979|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
44116980|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44116981|NCT00108797|Coagulants|coagulants|mesh-ancestor
44116982|NCT00108849|Estradiol|estradiol|mesh-list
44116983|NCT00108849|Estrogens|estrogens|mesh-ancestor
44116984|NCT00108849|Hormones|hormones|mesh-ancestor
44116985|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116986|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116987|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
44116988|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44116989|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
44116990|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116991|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116995|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116996|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116997|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44116999|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117000|NCT00108979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44117001|NCT00108979|Antidepressive Agents|antidepressive agents|mesh-ancestor
44117002|NCT00108979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117003|NCT00108992|Diclofenac|diclofenac|mesh-list
44117004|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117005|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117006|NCT00108992|Analgesics|analgesics|mesh-ancestor
44117007|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
44117008|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117009|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117010|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117011|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117012|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44117013|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117014|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117015|NCT00109044|Citalopram|citalopram|mesh-list
44296840|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296841|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44296842|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296843|NCT00809029|Incretins|incretins|mesh-ancestor
44296844|NCT00809029|Hormones|hormones|mesh-ancestor
44296845|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296846|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296847|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
44296848|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296849|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
44296850|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296851|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296852|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44296853|NCT00809068|Tibolone|tibolone|mesh-list
44296854|NCT00809068|Fenofibrate|fenofibrate|mesh-list
44296855|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44296856|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
44296857|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296858|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44296859|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
44296860|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
44296861|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296862|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296863|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44296864|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44296865|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296866|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44117016|NCT00109044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44117017|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44117018|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117019|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117020|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117021|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
44117022|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117023|NCT00109044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44117024|NCT00109044|Antidepressive Agents|antidepressive agents|mesh-ancestor
44117025|NCT00109044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117026|NCT00109057|Bevacizumab|bevacizumab|mesh-list
44117027|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117028|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117029|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44117030|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44296867|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
44296868|NCT00809068|Hormones|hormones|mesh-ancestor
44296869|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44296870|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44296871|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296872|NCT00809172|Cyclosporine|cyclosporine|mesh-list
44296873|NCT00809172|Methotrexate|methotrexate|mesh-list
44296874|NCT00809172|Cyclosporins|cyclosporins|mesh-list
44296875|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43719637|NCT02634489|Tamsulosin|tamsulosin|mesh-list
44117031|NCT00109057|Growth Substances|growth substances|mesh-ancestor
44117032|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117033|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
44117034|NCT00109070|Bevacizumab|bevacizumab|mesh-list
44117035|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117036|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117037|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44117038|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44117039|NCT00109070|Growth Substances|growth substances|mesh-ancestor
44117040|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117041|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
44117042|NCT00109096|Pemetrexed|pemetrexed|mesh-list
44117043|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117044|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117045|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117046|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44117047|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117049|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117050|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44117051|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117052|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154296|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117053|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44117054|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44117055|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44117056|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117057|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117061|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44117063|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44117064|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117065|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117066|NCT00109148|Hormones|hormones|mesh-ancestor
44117067|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117068|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117069|NCT00109161|Antibodies|antibodies|mesh-list
44117070|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44117071|NCT00109161|Daclizumab|daclizumab|mesh-list
44117072|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
44117073|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117074|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117075|NCT00109187|Omalizumab|omalizumab|mesh-list
44117076|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44117077|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44117078|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
44117079|NCT00109200|Omalizumab|omalizumab|mesh-list
44117080|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44117081|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44117082|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44117083|NCT00109226|Bevacizumab|bevacizumab|mesh-list
44117084|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117085|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117086|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44296877|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44296878|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296879|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44296880|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
44296881|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296882|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296883|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44296884|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296885|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44296886|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296887|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
44296888|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296889|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44296890|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
44296891|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117087|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44117088|NCT00109226|Growth Substances|growth substances|mesh-ancestor
44117089|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117090|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
44117091|NCT00109239|Bevacizumab|bevacizumab|mesh-list
44117092|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117093|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117094|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44117095|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44117096|NCT00109239|Growth Substances|growth substances|mesh-ancestor
44117097|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117098|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44117099|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44117100|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117101|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44117102|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117103|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117104|NCT00109278|Vaccines|vaccines|mesh-list
44117105|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
44117106|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117108|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117109|NCT00109382|Aspirin|aspirin|mesh-list
44117110|NCT00109382|Clopidogrel|clopidogrel|mesh-list
44117111|NCT00109382|Simvastatin|simvastatin|mesh-list
44117112|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117113|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117114|NCT00109382|Analgesics|analgesics|mesh-ancestor
44117115|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
44117117|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117118|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117119|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117120|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44117121|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44117122|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158165|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44117123|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44117124|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44117125|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117131|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117132|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44117134|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
44296892|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44296893|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44296894|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
44296895|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44296896|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
44296897|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296898|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
44296899|NCT00809198|Protective Agents|protective agents|mesh-ancestor
44296901|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44296902|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
44296903|NCT00809237|Gefitinib|gefitinib|mesh-list
44296904|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
44296905|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44296906|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44296907|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296908|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296909|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296910|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44296911|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296912|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44296913|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
44117135|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44117136|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44117137|NCT00109395|Midazolam|midazolam|mesh-list
44117138|NCT00109395|Lorazepam|lorazepam|mesh-list
44117139|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44117140|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44117141|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117142|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117143|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44117144|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44117145|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117146|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44117147|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
44117148|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
44117149|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
44117150|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
44117151|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117152|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117153|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
44117154|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
44117155|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
44117156|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117157|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117158|NCT00109408|Methotrexate|methotrexate|mesh-list
44117159|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44117160|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
44117161|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44117162|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117163|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117164|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
44117165|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117166|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296914|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44296915|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296916|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44296917|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44296918|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296919|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296920|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296921|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
44296922|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44296923|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44296924|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296925|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
44117167|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117168|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117169|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44117170|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117171|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
44117172|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647409|NCT01590277|Ethanol|ethanol|mesh-list
44117173|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117174|NCT00109551|Folic Acid|folic acid|mesh-list
44117175|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
44117176|NCT00109551|Hematinics|hematinics|mesh-ancestor
44117177|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
44117178|NCT00109551|Vitamins|vitamins|mesh-ancestor
44117179|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
44117180|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117181|NCT00109551|Astringents|astringents|mesh-ancestor
44117182|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117183|NCT00109564|Acetylcholine|acetylcholine|mesh-list
44117184|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
44117185|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
44117186|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44117187|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
44117188|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117189|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117190|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117192|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
44117193|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117194|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44117195|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117196|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117197|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117198|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117204|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117205|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
44117206|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117207|NCT00109746|Chromium|chromium|mesh-list
44117208|NCT00109746|Picolinic acid|picolinic acid|mesh-list
44117209|NCT00109746|Trace Elements|trace elements|mesh-ancestor
44117210|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
44117211|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117212|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44117213|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
44117214|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
44117215|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117216|NCT00109785|Idoxuridine|idoxuridine|mesh-list
44117217|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44117218|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44117219|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117220|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
44117221|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117222|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117223|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117224|NCT00109798|Temozolomide|temozolomide|mesh-list
44296926|NCT00809393|Coagulants|coagulants|mesh-ancestor
44296927|NCT00809536|Metformin|metformin|mesh-list
44296928|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44296929|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296930|NCT00809549|Lenograstim|lenograstim|mesh-list
44296931|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44296932|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
44296933|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296934|NCT00809627|Caffeine|caffeine|mesh-list
44296935|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44296936|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44296937|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44296938|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117225|NCT00109798|Topotecan|topotecan|mesh-list
44117226|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44117227|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
44117228|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117229|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117230|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44117231|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44117232|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117233|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
44117234|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44117235|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
44117236|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117237|NCT00109824|Decitabine|decitabine|mesh-list
44117238|NCT00109824|Azacitidine|azacitidine|mesh-list
44117239|NCT00109824|Valproic Acid|valproic acid|mesh-list
44117240|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117241|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
44117242|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117243|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117244|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117245|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
44117246|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
44117247|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117248|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117249|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
44117250|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44117251|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117252|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117253|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
44117254|NCT00109941|Mitogens|mitogens|mesh-list
44117255|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
44117256|NCT00109941|Narcotics|narcotics|mesh-ancestor
44117257|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117258|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117259|NCT00109941|Analgesics|analgesics|mesh-ancestor
44117260|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
44117261|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117262|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117263|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117264|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117265|NCT00109954|Cisplatin|cisplatin|mesh-list
44117266|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117268|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44117269|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44117270|NCT00109993|Prednisolone|prednisolone|mesh-list
44117271|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
44117276|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117277|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
44117278|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117279|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44117280|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296939|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296940|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44296941|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44296943|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296944|NCT00809692|Histamine|histamine|mesh-list
44296945|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
44296946|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
44296947|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
44296948|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44296949|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296950|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117281|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117282|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117283|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
44117284|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
44117285|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117286|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117287|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
44117288|NCT00109993|Hormones|hormones|mesh-ancestor
44117289|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117290|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44117291|NCT00109993|Protective Agents|protective agents|mesh-ancestor
44117292|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117293|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117294|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117295|NCT00110006|Prednisone|prednisone|mesh-list
44117296|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
44117297|NCT00110006|Rituximab|rituximab|mesh-list
44117298|NCT00110006|Doxorubicin|doxorubicin|mesh-list
44117299|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44117300|NCT00110006|Vincristine|vincristine|mesh-list
44117301|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44117302|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117303|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
44117304|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117305|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117306|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44117307|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
44117308|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117309|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117310|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44117311|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117312|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44117313|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44117314|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44117315|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117316|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117317|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
44117318|NCT00110006|Hormones|hormones|mesh-ancestor
44117319|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117320|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117321|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44117322|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
44117323|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
44117324|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117325|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44117326|NCT00110032|Etanidazole|etanidazole|mesh-list
44117327|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117328|NCT00110045|Caspofungin|caspofungin|mesh-list
44117329|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
44117330|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296951|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44296952|NCT00809705|Incretins|incretins|mesh-ancestor
44296953|NCT00809705|Hormones|hormones|mesh-ancestor
44296954|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44296955|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465177|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465178|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465179|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44465180|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44465181|NCT01482962|Gemcitabine|gemcitabine|mesh-list
44465182|NCT01482962|Romidepsin|romidepsin|mesh-list
44465183|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465184|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
44465185|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465186|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465187|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
44465188|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465189|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465190|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44296956|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
44296957|NCT00809718|Rifapentine|rifapentine|mesh-list
44117331|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117332|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117333|NCT00110058|Interferons|interferons|mesh-list
44117334|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
44117335|NCT00110058|Cyclosporine|cyclosporine|mesh-list
44117336|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
44117337|NCT00110058|Fludarabine|fludarabine|mesh-list
44117338|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
44117339|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
44117340|NCT00110058|Cyclosporins|cyclosporins|mesh-list
44117341|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117342|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117344|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117345|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117352|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117353|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117354|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44117355|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44117356|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44117357|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
44117358|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117359|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44117360|NCT00110071|Iodine|iodine|mesh-list
44117361|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
44117362|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44117363|NCT00110071|Fludarabine|fludarabine|mesh-list
44117364|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
44117365|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
44117366|NCT00110071|Antibodies|antibodies|mesh-list
44117367|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
44117368|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44117369|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
44117370|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117371|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44296958|NCT00809718|Rifampin|rifampin|mesh-list
44296959|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44296960|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44296961|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
44296962|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296963|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44117372|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117373|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
44117374|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117375|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117376|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44117377|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117378|NCT00110071|Trace Elements|trace elements|mesh-ancestor
44117379|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
44117380|NCT00110123|Fotemustine|fotemustine|mesh-list
44117381|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117382|NCT00110162|Hormones|hormones|mesh-list
44117383|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
44117384|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117385|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117386|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
44117387|NCT00110188|Sirolimus|sirolimus|mesh-list
44117388|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117389|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117390|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44117391|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117392|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
44117393|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117394|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
44117395|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117396|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44117397|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
44117398|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117399|NCT00110240|Vildagliptin|vildagliptin|mesh-list
44117400|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117401|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117402|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44117403|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
44117404|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117405|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117406|NCT00110253|Lidocaine|lidocaine|mesh-list
44117407|NCT00110253|Tetracaine|tetracaine|mesh-list
44117408|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
44117409|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
44117410|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117411|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117412|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
44117413|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117414|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44117415|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44154300|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154301|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154302|NCT00223639|Topiramate|topiramate|mesh-list
44154303|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
44154304|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154305|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117419|NCT00110344|Sorafenib|sorafenib|mesh-list
44117420|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117421|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44117422|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117423|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117424|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
44117425|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117426|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117427|NCT00110448|Aspirin|aspirin|mesh-list
44117428|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117429|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117430|NCT00110448|Analgesics|analgesics|mesh-ancestor
44117431|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
44296964|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44296965|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44296966|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296967|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44296968|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
44296969|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44296970|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
44296971|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44296972|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44296973|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44296974|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44296975|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44296976|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44296977|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44296978|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
44296979|NCT00809744|Vitamin D|vitamin d|mesh-list
44296980|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44117432|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117433|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117434|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117435|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117436|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44117437|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44117438|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117439|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44117440|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44117441|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117442|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
44117443|NCT00110474|Acetaminophen|acetaminophen|mesh-list
44117444|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117445|NCT00110474|Analgesics|analgesics|mesh-ancestor
44117446|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
44117447|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117448|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117449|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
44117450|NCT00110578|Aldesleukin|aldesleukin|mesh-list
44117451|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117452|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117453|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117454|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
44117455|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117456|NCT00110591|Leronlimab|leronlimab|mesh-list
44117457|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44117458|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44117459|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117460|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117461|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117462|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
44117463|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117464|NCT00110604|Folic Acid|folic acid|mesh-list
44117465|NCT00110604|Hematinics|hematinics|mesh-ancestor
44117466|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
44117467|NCT00110604|Vitamins|vitamins|mesh-ancestor
44117468|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
44117469|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117470|NCT00110630|Nicotine|nicotine|mesh-list
44296982|NCT00809744|Vitamins|vitamins|mesh-ancestor
44296983|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
44296984|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44296985|NCT00809796|Pentamidine|pentamidine|mesh-list
44296986|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
44296987|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296988|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44296989|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44296990|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44296991|NCT00809874|Caseins|caseins|mesh-list
43556581|NCT03551210|Ofloxacin|ofloxacin|mesh-list
44117471|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44117472|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
44117473|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117474|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117475|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44117476|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44117481|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117482|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
44117483|NCT00110669|Hormones|hormones|mesh-ancestor
44117484|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117485|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117486|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117487|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117488|NCT00110682|Imiquimod|imiquimod|mesh-list
44117489|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44117490|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
44117491|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117492|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117493|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
44117494|NCT00110695|Paclitaxel|paclitaxel|mesh-list
44117495|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44117496|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44117497|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117498|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44117499|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44117500|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117501|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117502|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
44117503|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44117504|NCT00110708|Antibodies|antibodies|mesh-list
44117505|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
44117506|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117507|NCT00110721|Fluorouracil|fluorouracil|mesh-list
44117508|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
44117509|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117510|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117511|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117512|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117513|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
44117514|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117515|NCT00110734|Lidocaine|lidocaine|mesh-list
44117516|NCT00110734|Tetracaine|tetracaine|mesh-list
44117517|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
44117518|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
44117519|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117520|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117521|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
44117522|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117523|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44117524|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44117525|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44117526|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117527|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296992|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
44296993|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
44296994|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44296995|NCT00809887|Micafungin|micafungin|mesh-list
44296996|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
44296997|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44296998|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
44296999|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297000|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297001|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44297002|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44297003|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297004|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297005|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297006|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43719766|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
44117528|NCT00110747|Lidocaine|lidocaine|mesh-list
44117529|NCT00110747|Tetracaine|tetracaine|mesh-list
44117530|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
44117531|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
44117532|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117533|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117534|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
44117535|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117536|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44117537|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44117538|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44117539|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117540|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117541|NCT00110760|Lidocaine|lidocaine|mesh-list
44117542|NCT00110760|Tetracaine|tetracaine|mesh-list
44117543|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
44117544|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
44117545|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117546|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117551|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44117552|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117553|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117554|NCT00110773|Lidocaine|lidocaine|mesh-list
44117555|NCT00110773|Tetracaine|tetracaine|mesh-list
44117556|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
44117557|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
44117558|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117559|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117560|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
44117561|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117562|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44117563|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44117564|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44117565|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117566|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117567|NCT00110851|Metformin|metformin|mesh-list
44117568|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
44117569|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117570|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117571|NCT00110864|Insulin|insulin|mesh-list
44117572|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117573|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297007|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44297008|NCT00809939|Progesterone|progesterone|mesh-list
44297009|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44297010|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44297011|NCT00809939|Progestins|progestins|mesh-ancestor
44297012|NCT00809939|Hormones|hormones|mesh-ancestor
44297013|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297014|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297015|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44297016|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297017|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44297018|NCT00810030|Hematinics|hematinics|mesh-ancestor
44117574|NCT00110877|Darunavir|darunavir|mesh-list
44117575|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44117576|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44117577|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
44117578|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117579|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117580|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117581|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117582|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
44117583|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117584|NCT00110903|Etanercept|etanercept|mesh-list
44117585|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117586|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117587|NCT00110903|Analgesics|analgesics|mesh-ancestor
44117588|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
44117589|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117590|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117591|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117592|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117593|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117594|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117595|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
44117596|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44117597|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117598|NCT00110929|Cinacalcet|cinacalcet|mesh-list
44117599|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44117600|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117601|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44117602|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
44117603|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117604|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
44117605|NCT00110955|Hematinics|hematinics|mesh-ancestor
44117606|NCT00110981|Etanercept|etanercept|mesh-list
44117607|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117608|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117609|NCT00110981|Analgesics|analgesics|mesh-ancestor
44117610|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
44117611|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117612|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117613|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117614|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117615|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117616|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117632|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117633|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44117634|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117635|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117636|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44117638|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117639|NCT00111072|Dexamethasone|dexamethasone|mesh-list
44297020|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297021|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297022|NCT00810121|Analgesics|analgesics|mesh-ancestor
44297023|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
44297024|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297025|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297026|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297027|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297028|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44297029|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297030|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297032|NCT00810316|Alprazolam|alprazolam|mesh-list
44297033|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44297034|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297035|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297036|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44297037|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44297038|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44297039|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
44297040|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
43719785|NCT02633930|Clarithromycin|clarithromycin|mesh-list
44117640|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117641|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
44117642|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
44117643|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154306|NCT00223691|Acarbose|acarbose|mesh-list
44117644|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117645|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117646|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
44117647|NCT00111072|Hormones|hormones|mesh-ancestor
44117648|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117649|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117650|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117651|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
44117652|NCT00111098|Hematinics|hematinics|mesh-ancestor
44117653|NCT00111111|Etanercept|etanercept|mesh-list
44117654|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117655|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117656|NCT00111111|Analgesics|analgesics|mesh-ancestor
44117657|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
44117658|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117659|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117660|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117661|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117662|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117663|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117664|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
44117665|NCT00111124|Etanercept|etanercept|mesh-list
44117666|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117667|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117668|NCT00111124|Analgesics|analgesics|mesh-ancestor
44117669|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
44297042|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297043|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
44297044|NCT00810381|Nitroprusside|nitroprusside|mesh-list
44297045|NCT00810381|Isosorbide|isosorbide|mesh-list
44297046|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44297047|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44297048|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
44297049|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
44297050|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44297051|NCT00810381|Diuretics|diuretics|mesh-ancestor
44297052|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297053|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297054|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44297055|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297056|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44297057|NCT00810446|Rifabutin|rifabutin|mesh-list
44297058|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297059|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719803|NCT02633878|Progesterone|progesterone|mesh-list
44117670|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117671|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117672|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117673|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117674|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117675|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117708|NCT00111163|Renal Agents|renal agents|mesh-ancestor
44117709|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
44117710|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117711|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44117712|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44117713|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44117714|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117715|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117716|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117717|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44117718|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44117719|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
44117720|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117729|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117730|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
44117731|NCT00111215|Coagulants|coagulants|mesh-ancestor
44117732|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44117733|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
44117734|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117735|NCT00111267|Vitamins|vitamins|mesh-list
44117736|NCT00111267|Folic Acid|folic acid|mesh-list
44117737|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
44117738|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
44117739|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
44117740|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
44117741|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117742|NCT00111267|Hematinics|hematinics|mesh-ancestor
44117743|NCT00111280|Etravirine|etravirine|mesh-list
44117744|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44117745|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117746|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297060|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44297061|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
44297063|NCT00810524|Adefovir|adefovir|mesh-list
44297064|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44297065|NCT00810524|Telbivudine|telbivudine|mesh-list
44297066|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44297067|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44297068|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297069|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297070|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
44297071|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297072|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44297073|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44297074|NCT00810563|Bupivacaine|bupivacaine|mesh-list
44297075|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
44297076|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
44297077|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297078|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297079|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
44117747|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117748|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
44117749|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117750|NCT00111306|Epratuzumab|epratuzumab|mesh-list
44117751|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44117752|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117753|NCT00111319|Bortezomib|bortezomib|mesh-list
44117754|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117755|NCT00111345|Daunorubicin|daunorubicin|mesh-list
44117756|NCT00111345|Idarubicin|idarubicin|mesh-list
44117757|NCT00111345|Cladribine|cladribine|mesh-list
44117758|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44117759|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117760|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44117761|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44117762|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117763|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117764|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117765|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
44117766|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117767|NCT00111371|Levodopa|levodopa|mesh-list
44117768|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44117769|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44117770|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
44117771|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117772|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117773|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117774|NCT00111397|Interferons|interferons|mesh-list
44117775|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
44117776|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117777|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
44117778|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117779|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44117780|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117781|NCT00111436|Etanercept|etanercept|mesh-list
44117782|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297080|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297082|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44297083|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
44297084|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
44297085|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297086|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297087|NCT00810680|Valproic Acid|valproic acid|mesh-list
44297088|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
44297089|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297090|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297091|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
44297092|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297093|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297094|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
44297095|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44297096|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297097|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44297098|NCT00810706|Exemestane|exemestane|mesh-list
44297099|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297100|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44297101|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44297102|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297103|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297104|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44297105|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297106|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117783|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117784|NCT00111436|Analgesics|analgesics|mesh-ancestor
44117785|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
44117786|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117787|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849540|NCT03917303|Adalimumab|adalimumab|mesh-list
44117790|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117791|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117792|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
44117794|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117795|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117796|NCT00111449|Analgesics|analgesics|mesh-ancestor
44117797|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
44117798|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117799|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117800|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117801|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117802|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117803|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117804|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
44117805|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
44297107|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297108|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44297109|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297110|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297111|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
44297112|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297113|NCT00810849|Prednisolone|prednisolone|mesh-list
44297114|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297115|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
44297116|NCT00810849|Hormones|hormones|mesh-ancestor
44297117|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297118|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297119|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297120|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297121|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
44297122|NCT00810862|Lactitol|lactitol|mesh-list
44297123|NCT00810862|Cathartics|cathartics|mesh-ancestor
44297124|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556893|NCT03548948|Iron|iron|mesh-list
44117806|NCT00111462|Hematinics|hematinics|mesh-ancestor
44117807|NCT00111540|Exenatide|exenatide|mesh-list
44117808|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117809|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117810|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44117811|NCT00111540|Incretins|incretins|mesh-ancestor
44117812|NCT00111540|Hormones|hormones|mesh-ancestor
44117813|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117814|NCT00111566|Eptifibatide|eptifibatide|mesh-list
44117815|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44117816|NCT00111618|Vadimezan|vadimezan|mesh-list
44117817|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117818|NCT00111631|Metformin|metformin|mesh-list
44117819|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44117820|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117821|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117822|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
44117823|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117824|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117825|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
44117826|NCT00111644|Lactams|lactams|mesh-list
44117827|NCT00111644|beta-Lactams|beta-lactams|mesh-list
44117828|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117829|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117830|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44117831|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
44117832|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117833|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117834|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117835|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117836|NCT00111748|Thalidomide|thalidomide|mesh-list
44117837|NCT00111748|Dexamethasone|dexamethasone|mesh-list
44117838|NCT00111748|Bortezomib|bortezomib|mesh-list
44117839|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117840|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
44117841|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
44117842|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117843|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117844|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117845|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
44297125|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297126|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297128|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
44297129|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297130|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297131|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297132|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297133|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297134|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297135|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
44297136|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44297137|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297138|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297139|NCT00810914|Bupivacaine|bupivacaine|mesh-list
44297140|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
44297141|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
44297142|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297143|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297144|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
44297145|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297146|NCT00810940|Mannitol|mannitol|mesh-list
44297147|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43832659|NCT05255003|Enoxaparin|enoxaparin|mesh-list
44117846|NCT00111748|Hormones|hormones|mesh-ancestor
44117847|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117848|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117849|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117850|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117851|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
44117852|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
44117853|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117854|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117855|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44117856|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44117857|NCT00111748|Growth Substances|growth substances|mesh-ancestor
44117858|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
44117859|NCT00111787|Paclitaxel|paclitaxel|mesh-list
44117860|NCT00111787|Lapatinib|lapatinib|mesh-list
44117861|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44117862|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117869|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44117870|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44117871|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44117872|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117874|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44117875|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
44117876|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117877|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44297148|NCT00810940|Diuretics|diuretics|mesh-ancestor
44297149|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297150|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297151|NCT00810953|Pentamidine|pentamidine|mesh-list
44297152|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
44297153|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297154|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44297155|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44297156|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44117878|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
44117879|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
44117880|NCT00111891|Vitamins|vitamins|mesh-ancestor
44117881|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
44117882|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154307|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
44154308|NCT00223691|Promethazine|promethazine|mesh-list
44154309|NCT00223691|Ibuprofen|ibuprofen|mesh-list
44154310|NCT00223691|Celecoxib|celecoxib|mesh-list
44154311|NCT00223691|Indomethacin|indomethacin|mesh-list
44154312|NCT00223691|Octreotide|octreotide|mesh-list
44154313|NCT00223691|Phenylephrine|phenylephrine|mesh-list
44154314|NCT00223691|Acetazolamide|acetazolamide|mesh-list
44154315|NCT00223691|Midodrine|midodrine|mesh-list
44154316|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
44154317|NCT00223691|Ephedrine|ephedrine|mesh-list
44154318|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
44154319|NCT00223691|Ergotamine|ergotamine|mesh-list
44154320|NCT00223691|Bromides|bromides|mesh-list
44154321|NCT00223691|Levodopa|levodopa|mesh-list
44154322|NCT00223691|Carbidopa|carbidopa|mesh-list
43647583|NCT00530517|Sumatriptan|sumatriptan|mesh-list
44154323|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44154324|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
44154325|NCT00223691|Methylphenidate|methylphenidate|mesh-list
44154326|NCT00223691|Caffeine|caffeine|mesh-list
44154327|NCT00223691|Modafinil|modafinil|mesh-list
44154328|NCT00223691|Rivastigmine|rivastigmine|mesh-list
44154329|NCT00223691|Ranitidine|ranitidine|mesh-list
44154330|NCT00223691|Yohimbine|yohimbine|mesh-list
44154331|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44154332|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44154333|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154334|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154335|NCT00223691|Analgesics|analgesics|mesh-ancestor
44154336|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
44154337|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154338|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154339|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154340|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154341|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154342|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154343|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154344|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44154345|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44154346|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44154347|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154348|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154349|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
44154350|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154351|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44154352|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44154353|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44154354|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
44154355|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
44154356|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44154357|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44154358|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44154359|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44154364|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44154365|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44154366|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154367|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
44154368|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
44297157|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
44297158|NCT00811005|Methoxsalen|methoxsalen|mesh-list
44297159|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44297160|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297161|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297162|NCT00811031|Prednisone|prednisone|mesh-list
44297163|NCT00811031|Docetaxel|docetaxel|mesh-list
44297164|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297165|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297166|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44297167|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297168|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297169|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297170|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
44297171|NCT00811031|Hormones|hormones|mesh-ancestor
44297172|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297173|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297174|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297175|NCT00811083|Succimer|succimer|mesh-list
44297176|NCT00811083|Antidotes|antidotes|mesh-ancestor
44154369|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
44154370|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
44154371|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44154372|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
44154373|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
44154374|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44154375|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
44154376|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117884|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44117885|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117886|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44117887|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44117888|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117889|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117890|NCT00111943|Tenofovir|tenofovir|mesh-list
44117891|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
44117892|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117893|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44117894|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117895|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117896|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117897|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117898|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117899|NCT00111956|Etanercept|etanercept|mesh-list
44117900|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117901|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117902|NCT00111956|Analgesics|analgesics|mesh-ancestor
44117903|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
44117904|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117905|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117906|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117907|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117908|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117909|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117910|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
44117911|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
44117912|NCT00111995|Hematinics|hematinics|mesh-ancestor
44297177|NCT00811083|Protective Agents|protective agents|mesh-ancestor
44297178|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297179|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
44297180|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
44297181|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951888|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
44297182|NCT00811096|Chloroquine|chloroquine|mesh-list
44297183|NCT00811096|Tinidazole|tinidazole|mesh-list
44297184|NCT00811096|Amebicides|amebicides|mesh-ancestor
44297185|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44297186|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44297187|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297188|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
44297189|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297190|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
44297191|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297192|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44117913|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
44117914|NCT00112008|Hematinics|hematinics|mesh-ancestor
44117915|NCT00112021|Pramlintide|pramlintide|mesh-list
44117916|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44117917|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44117918|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117919|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
44117920|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44117921|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44117922|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117923|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
44117924|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44117925|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44117926|NCT00112034|Prednisolone|prednisolone|mesh-list
44117927|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
44117928|NCT00112034|Methotrexate|methotrexate|mesh-list
44117929|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44117930|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
44117931|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44117932|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
44117933|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44117934|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117935|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117936|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
44117937|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117943|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
44117944|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117945|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117946|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117947|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
44117948|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
44117949|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117950|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44117951|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
44117952|NCT00112034|Hormones|hormones|mesh-ancestor
44117953|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117954|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44117955|NCT00112034|Protective Agents|protective agents|mesh-ancestor
44117956|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44117957|NCT00112086|Paclitaxel|paclitaxel|mesh-list
44117958|NCT00112086|Carboplatin|carboplatin|mesh-list
44117959|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44297193|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44297194|NCT00811122|Corticosterone|corticosterone|mesh-list
44297195|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297196|NCT00811200|Triamcinolone|triamcinolone|mesh-list
44297197|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44297198|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44297199|NCT00811200|Ranibizumab|ranibizumab|mesh-list
44297200|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44297201|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297202|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297203|NCT00811200|Growth Substances|growth substances|mesh-ancestor
44297204|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297205|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297206|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297207|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297208|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
44297209|NCT00811200|Hormones|hormones|mesh-ancestor
44297210|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297211|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117960|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117961|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44117962|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44117963|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117964|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117965|NCT00112138|Gabapentin|gabapentin|mesh-list
44117966|NCT00112138|Analgesics|analgesics|mesh-ancestor
44117967|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
44117968|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117969|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117970|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
44117971|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44117972|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44117973|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44117974|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44117975|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44117976|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44117977|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117978|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117979|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
44117980|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44117981|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117982|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44117983|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44117984|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
44117985|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117986|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44117987|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117988|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117989|NCT00112346|Gemcitabine|gemcitabine|mesh-list
44117990|NCT00112346|Cetuximab|cetuximab|mesh-list
44117991|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44117992|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
44117993|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117994|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117995|NCT00112346|Antiviral Agents|antiviral agents|mesh-ancestor
44117996|NCT00112346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297212|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
44297213|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297214|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297215|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44297217|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44297218|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44297219|NCT00811226|Diuretics|diuretics|mesh-ancestor
44297220|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297221|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297222|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44297223|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44297224|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297225|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44297226|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44297227|NCT00811239|Antivenins|antivenins|mesh-list
44297228|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
44297229|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297230|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
44117997|NCT00112346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117998|NCT00112346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44117999|NCT00112346|Immunologic Factors|immunologic factors|mesh-ancestor
44118000|NCT00112346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118001|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118002|NCT00112372|Sirolimus|sirolimus|mesh-list
44118003|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44118004|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118005|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44118006|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118007|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
44118017|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
44118018|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118019|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
44118020|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118021|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44118022|NCT00112515|Modafinil|modafinil|mesh-list
44118023|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44118024|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118025|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44118026|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44118027|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44118028|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118030|NCT00112528|Bevacizumab|bevacizumab|mesh-list
44118031|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
44118032|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118033|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118034|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118035|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118036|NCT00112528|Growth Substances|growth substances|mesh-ancestor
44118037|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118038|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118039|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118040|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
44297231|NCT00811291|Folic Acid|folic acid|mesh-list
44297232|NCT00811291|Calcium|calcium|mesh-list
44297233|NCT00811291|Vitamins|vitamins|mesh-ancestor
44297234|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
44297235|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297236|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44297237|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44297238|NCT00811291|Hematinics|hematinics|mesh-ancestor
44297239|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
44297240|NCT00811330|Atorvastatin|atorvastatin|mesh-list
44297241|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44297242|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44297243|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
44118041|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118042|NCT00112528|Antiviral Agents|antiviral agents|mesh-ancestor
44118043|NCT00112528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118044|NCT00112528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118045|NCT00112528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118046|NCT00112528|Immunologic Factors|immunologic factors|mesh-ancestor
44118048|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118049|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
44118050|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118051|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118052|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
44118053|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118054|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118055|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
44118056|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118057|NCT00112567|Fludarabine|fludarabine|mesh-list
44118058|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
44118059|NCT00112567|Thiotepa|thiotepa|mesh-list
44118060|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118061|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118062|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
44118063|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118064|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118065|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
44118066|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118067|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44118068|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
44118069|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44118070|NCT00112619|Topotecan|topotecan|mesh-list
44118071|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44118072|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118073|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118077|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118078|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44118079|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118080|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118081|NCT00112645|Cyclosporine|cyclosporine|mesh-list
44118082|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
44118083|NCT00112645|Methotrexate|methotrexate|mesh-list
44118085|NCT00112645|Busulfan|busulfan|mesh-list
44118086|NCT00112645|Cyclosporins|cyclosporins|mesh-list
44118087|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44118088|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44118089|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
44118090|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44118091|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118092|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118093|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
44118094|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118095|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562086|NCT01535508|Vitamin D|vitamin d|mesh-list
44297244|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297245|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43719892|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
44118096|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118097|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118098|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44118099|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118100|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
44118101|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118102|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44118103|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
44118104|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118105|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44118106|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118108|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
44118109|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118110|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118111|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
44118112|NCT00112645|Hormones|hormones|mesh-ancestor
44118113|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118114|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44118115|NCT00112645|Protective Agents|protective agents|mesh-ancestor
44118116|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44118117|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
44118118|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44118119|NCT00112658|Leucovorin|leucovorin|mesh-list
44118120|NCT00112658|Gemcitabine|gemcitabine|mesh-list
44118121|NCT00112658|Fluorouracil|fluorouracil|mesh-list
44118122|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
44118123|NCT00112658|Irinotecan|irinotecan|mesh-list
44118124|NCT00112658|Calcium|calcium|mesh-list
44118125|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
44118126|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118127|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
43824123|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118128|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118129|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118130|NCT00112658|Antiviral Agents|antiviral agents|mesh-ancestor
44118131|NCT00112658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118132|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118133|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118134|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
44118135|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118136|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44118137|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44118138|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118139|NCT00112658|Antidotes|antidotes|mesh-ancestor
44118140|NCT00112658|Protective Agents|protective agents|mesh-ancestor
44118141|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
44118142|NCT00112658|Vitamins|vitamins|mesh-ancestor
44118143|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
44118144|NCT00112684|Alvocidib|alvocidib|mesh-list
44118145|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118146|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118147|NCT00112684|Growth Substances|growth substances|mesh-ancestor
44118151|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118152|NCT00112697|Cisplatin|cisplatin|mesh-list
44118153|NCT00112697|Docetaxel|docetaxel|mesh-list
44118154|NCT00112697|Fluorouracil|fluorouracil|mesh-list
44118155|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118156|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118157|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118158|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118159|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118160|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
44118161|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118162|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118163|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
44118164|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118165|NCT00112710|Gemcitabine|gemcitabine|mesh-list
44118166|NCT00112710|Cisplatin|cisplatin|mesh-list
44118167|NCT00112710|Carboplatin|carboplatin|mesh-list
44118168|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118169|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118170|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
43701837|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44297246|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44297247|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297249|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44297250|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44297251|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44297252|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
44297253|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297254|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44297255|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44297256|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118171|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118172|NCT00112710|Antiviral Agents|antiviral agents|mesh-ancestor
43562187|NCT01516086|Xhance|xhance|mesh-list
44118173|NCT00112710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118174|NCT00112710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118175|NCT00112710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118176|NCT00112710|Immunologic Factors|immunologic factors|mesh-ancestor
44118177|NCT00112710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118178|NCT00112749|Infliximab|infliximab|mesh-list
44118179|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118180|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118181|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118182|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
44118183|NCT00112775|Dasatinib|dasatinib|mesh-list
44118184|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118185|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44118186|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118187|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118188|NCT00112853|Etoposide|etoposide|mesh-list
44118189|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
44118190|NCT00112853|Tipifarnib|tipifarnib|mesh-list
44118191|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44118192|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118193|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44118194|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118195|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118196|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118197|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
44118198|NCT00112879|Thalidomide|thalidomide|mesh-list
44118199|NCT00112879|Dexamethasone|dexamethasone|mesh-list
44118200|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
44118201|NCT00112879|Mitogens|mitogens|mesh-list
44118202|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118203|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
44118204|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
44118205|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118206|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118207|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118208|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
44118209|NCT00112879|Hormones|hormones|mesh-ancestor
44118210|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118211|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44118212|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118213|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118214|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118215|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118216|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
44118217|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
44118218|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44118219|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118220|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118227|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
44118228|NCT00112892|Selenium|selenium|mesh-list
44297257|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297258|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297259|NCT00811369|Fulvestrant|fulvestrant|mesh-list
44297260|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297261|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297262|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44297263|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44297264|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297265|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297266|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297267|NCT00811408|Cidofovir|cidofovir|mesh-list
44297268|NCT00811408|Carboplatin|carboplatin|mesh-list
44297269|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118229|NCT00112892|Irinotecan|irinotecan|mesh-list
44118230|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44118231|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118232|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118233|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118234|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118235|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
44118236|NCT00112892|Protective Agents|protective agents|mesh-ancestor
44118237|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118238|NCT00112892|Trace Elements|trace elements|mesh-ancestor
44118239|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
44118240|NCT00112931|Rituximab|rituximab|mesh-list
44118241|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118242|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118243|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
44118244|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118245|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118246|NCT00112983|Eculizumab|eculizumab|mesh-list
44118247|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44118248|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118249|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
44118250|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118251|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
44118252|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
44118253|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118254|NCT00112996|Protective Agents|protective agents|mesh-ancestor
44118255|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118256|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
44118257|NCT00112996|Vitamins|vitamins|mesh-ancestor
44118258|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
44118259|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
44118260|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118261|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118262|NCT00113074|Nicotine|nicotine|mesh-list
44118263|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44118264|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
44118265|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118266|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118267|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44118268|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44118269|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
44118270|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118271|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118272|NCT00113100|Ethanol|ethanol|mesh-list
44118273|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44118274|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44118275|NCT00113100|Estradiol|estradiol|mesh-list
44118276|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44118277|NCT00113100|Estrogens|estrogens|mesh-ancestor
44118278|NCT00113100|Hormones|hormones|mesh-ancestor
44297270|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
44297271|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297272|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297273|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297274|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
44297275|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
44297276|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44297277|NCT00811421|Mefloquine|mefloquine|mesh-list
44118279|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118280|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118281|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44118282|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
44118283|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44118284|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44118285|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44118286|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118287|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118288|NCT00113113|Rubitecan|rubitecan|mesh-list
44118289|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118290|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44118291|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118292|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118296|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44118297|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118298|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118299|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44118300|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118301|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44118302|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44118303|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118304|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118305|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44118306|NCT00113256|Rubitecan|rubitecan|mesh-list
44118307|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118308|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44118309|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118310|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118311|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118312|NCT00113282|Interleukin-2|interleukin-2|mesh-list
44118313|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118314|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44118315|NCT00113282|Analgesics|analgesics|mesh-ancestor
44118316|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
44118317|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118318|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118319|NCT00113347|Docetaxel|docetaxel|mesh-list
44118320|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44118321|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118322|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118323|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118324|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118325|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118326|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44118327|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118328|NCT00113503|Azathioprine|azathioprine|mesh-list
44118329|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
44118330|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118331|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118332|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118333|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118334|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
44118335|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118336|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118337|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44118338|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
44297278|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
44297279|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44297280|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44297281|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297282|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44297283|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297284|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297285|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44297287|NCT00811447|Cisplatin|cisplatin|mesh-list
44297288|NCT00811447|Docetaxel|docetaxel|mesh-list
44297289|NCT00811447|Fluorouracil|fluorouracil|mesh-list
44297290|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297291|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297292|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118339|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
44118340|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118341|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118342|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118343|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118344|NCT00113542|Growth Substances|growth substances|mesh-ancestor
44118345|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118346|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118347|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118348|NCT00113594|Olanzapine|olanzapine|mesh-list
44118349|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
44118350|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
44118351|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118352|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118353|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118354|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44118355|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44118356|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118357|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118358|NCT00113594|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44118359|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44118360|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118361|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118362|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118369|NCT00113698|Enalapril|enalapril|mesh-list
44118370|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44118371|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
44118372|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118373|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118374|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44118375|NCT00113737|Fluoxetine|fluoxetine|mesh-list
44118376|NCT00113737|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44118377|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44118378|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118379|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118380|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118381|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
44118382|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118383|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44118384|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118385|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118386|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44118387|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44118388|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297293|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297294|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297295|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
44297296|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297297|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297298|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
44297299|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297300|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44297301|NCT00811460|Incretins|incretins|mesh-ancestor
44297302|NCT00811460|Hormones|hormones|mesh-ancestor
44297303|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297304|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297305|NCT00811486|Spironolactone|spironolactone|mesh-list
44297306|NCT00811486|Conivaptan|conivaptan|mesh-list
44297307|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44297308|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297309|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297310|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297311|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44297312|NCT00811486|Diuretics|diuretics|mesh-ancestor
44297313|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297314|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44297315|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297316|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44297317|NCT00811603|Cefazolin|cefazolin|mesh-list
44118389|NCT00113802|Epratuzumab|epratuzumab|mesh-list
44118390|NCT00113802|Antibodies|antibodies|mesh-list
44118391|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
44118392|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118393|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118394|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118395|NCT00113815|Topiramate|topiramate|mesh-list
44118396|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
44118397|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44118398|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118399|NCT00113828|Cyclosporine|cyclosporine|mesh-list
44118400|NCT00113828|Cyclosporins|cyclosporins|mesh-list
44118401|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118402|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118403|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118404|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
44118405|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118406|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
44118407|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118408|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118409|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118410|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44297318|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297319|NCT00811681|Pioglitazone|pioglitazone|mesh-list
44297320|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297321|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297322|NCT00811746|Eszopiclone|eszopiclone|mesh-list
44297323|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44297324|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297325|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297326|NCT00811759|Temozolomide|temozolomide|mesh-list
44297327|NCT00811759|Sorafenib|sorafenib|mesh-list
44297328|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44297329|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
44297330|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297331|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297332|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44297333|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297334|NCT00811785|Copper|copper|mesh-list
44297335|NCT00811785|Trace Elements|trace elements|mesh-ancestor
44297336|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
44297337|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297338|NCT00811837|Midazolam|midazolam|mesh-list
44297339|NCT00811837|Remifentanil|remifentanil|mesh-list
44118411|NCT00113854|Mannitol|mannitol|mesh-list
44118412|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44118413|NCT00113854|Diuretics|diuretics|mesh-ancestor
44118414|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
44118415|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118416|NCT00113906|Melatonin|melatonin|mesh-list
44118417|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
44118418|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118419|NCT00113906|Protective Agents|protective agents|mesh-ancestor
44118420|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118421|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118422|NCT00113945|Cinacalcet|cinacalcet|mesh-list
44118423|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44118424|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118425|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44118426|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
44118427|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118428|NCT00113958|Cinacalcet|cinacalcet|mesh-list
44118429|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44118430|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118431|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44118432|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
44118437|NCT00113984|Metronidazole|metronidazole|mesh-list
44118438|NCT00113984|Ipilimumab|ipilimumab|mesh-list
44118439|NCT00113984|Sargramostim|sargramostim|mesh-list
44118440|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
44118441|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118442|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118443|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118444|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44118445|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118446|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297340|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44297341|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44297342|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44297343|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297344|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44297345|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44297346|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44297347|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44297348|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
44297349|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
44297350|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
44297351|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
44118447|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44118448|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44118449|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44154377|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44154378|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44154379|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44154380|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
44154381|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
44154382|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44154383|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44154384|NCT00223691|Diuretics|diuretics|mesh-ancestor
44154385|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
44154386|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44154387|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154388|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44154389|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
44154390|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44154391|NCT00223691|Protective Agents|protective agents|mesh-ancestor
44154392|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
44154393|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44154394|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44154395|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44154396|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44154397|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44154398|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
44154399|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
44154400|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44154401|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44154402|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44154403|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
44154404|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44154405|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
44154406|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44154407|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44154408|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44154409|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44154410|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44154411|NCT00223691|Urological Agents|urological agents|mesh-ancestor
44154412|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154413|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118450|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44118451|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44118452|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
44118453|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118455|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118456|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118457|NCT00114023|Imiquimod|imiquimod|mesh-list
44118458|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44118459|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
44118460|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118461|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297352|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297353|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297354|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44297355|NCT00811837|Narcotics|narcotics|mesh-ancestor
44297356|NCT00811837|Analgesics|analgesics|mesh-ancestor
44297357|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
44297358|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465191|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
44465192|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465193|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44465194|NCT01482910|Aflibercept|aflibercept|mesh-list
44465195|NCT01482910|Verteporfin|verteporfin|mesh-list
44465196|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465197|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465198|NCT01482910|Growth Substances|growth substances|mesh-ancestor
44465199|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465200|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465201|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465202|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44465203|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465204|NCT01482767|Interferons|interferons|mesh-list
44465205|NCT01482767|Ribavirin|ribavirin|mesh-list
44465206|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
44465207|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
44465208|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44465209|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465210|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
43719986|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
44118462|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
44118463|NCT00114153|Carboplatin|carboplatin|mesh-list
44118464|NCT00114153|Capecitabine|capecitabine|mesh-list
44118465|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118475|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44118476|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118477|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118478|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118479|NCT00114179|Growth Substances|growth substances|mesh-ancestor
44118480|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118481|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118482|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
44118483|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118484|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
44118485|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118486|NCT00114179|Antiviral Agents|antiviral agents|mesh-ancestor
44118487|NCT00114179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118488|NCT00114179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118489|NCT00114179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118490|NCT00114192|Thalidomide|thalidomide|mesh-list
44118491|NCT00114192|Docetaxel|docetaxel|mesh-list
44118492|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465211|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465212|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
44465213|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465214|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
44465215|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465216|NCT01482169|Adenosine|adenosine|mesh-list
44465217|NCT01482169|Regadenoson|regadenoson|mesh-list
44465218|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44465219|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44465220|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
44465221|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
44465222|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465223|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465224|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118493|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118494|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118495|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118496|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118497|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118498|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
44118499|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118500|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
44118501|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44118502|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118503|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118504|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118505|NCT00114192|Growth Substances|growth substances|mesh-ancestor
44118506|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118507|NCT00114205|Docetaxel|docetaxel|mesh-list
44118509|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118510|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118511|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118512|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118513|NCT00114257|Decitabine|decitabine|mesh-list
44118514|NCT00114257|Romidepsin|romidepsin|mesh-list
44118515|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118516|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
44118517|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118518|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118519|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118520|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44118521|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
44118522|NCT00114270|Letrozole|letrozole|mesh-list
44118523|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118524|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44118525|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44118526|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118527|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118528|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44118529|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
44118530|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118531|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118532|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44118533|NCT00114283|Lapatinib|lapatinib|mesh-list
44118537|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118539|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44118540|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
44118541|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118542|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
44465225|NCT01482169|Analgesics|analgesics|mesh-ancestor
44465226|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
44465227|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465228|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44465229|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
44465230|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
44465231|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465232|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465233|NCT01481116|Glimepiride|glimepiride|mesh-list
44465234|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44465235|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465236|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465237|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465238|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
44465239|NCT01480674|Trastuzumab|trastuzumab|mesh-list
44465240|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465241|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952110|NCT01189370|Sorafenib|sorafenib|mesh-list
44465242|NCT01480596|Belimumab|belimumab|mesh-list
44465243|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297360|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44297361|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
44297362|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44297363|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297364|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297365|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297366|NCT00811915|Sirolimus|sirolimus|mesh-list
44297367|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297368|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118543|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118544|NCT00114374|Citalopram|citalopram|mesh-list
44118545|NCT00114374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44118546|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44118547|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118548|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118549|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118550|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
44118551|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118552|NCT00114374|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44118553|NCT00114374|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118554|NCT00114374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118555|NCT00114387|Tocopherols|tocopherols|mesh-list
44118556|NCT00114387|Vitamin E|vitamin e|mesh-list
44118557|NCT00114387|Tocotrienols|tocotrienols|mesh-list
44118558|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
44118559|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
44118560|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297369|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44297371|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
44297372|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297373|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
44297374|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297375|NCT00811967|Ribavirin|ribavirin|mesh-list
44297376|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44297377|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
44297378|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
44297379|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297380|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
44297381|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297382|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
44297383|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297384|NCT00811980|Vancomycin|vancomycin|mesh-list
44297385|NCT00811980|Linezolid|linezolid|mesh-list
43720050|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118561|NCT00114387|Protective Agents|protective agents|mesh-ancestor
44118562|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118563|NCT00114387|Vitamins|vitamins|mesh-ancestor
44118564|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
44118565|NCT00114400|Vitamins|vitamins|mesh-list
44118566|NCT00114400|Folic Acid|folic acid|mesh-list
44118567|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
44118568|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
44118569|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
44118570|NCT00114400|Pyridoxal|pyridoxal|mesh-list
44118571|NCT00114400|Pyridoxine|pyridoxine|mesh-list
44118572|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
44118573|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
44118574|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118575|NCT00114400|Hematinics|hematinics|mesh-ancestor
44118576|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
44118577|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118578|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118579|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118580|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118581|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
44118582|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44118583|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118584|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118585|NCT00114478|Epinephrine|epinephrine|mesh-list
44118586|NCT00114478|Albuterol|albuterol|mesh-list
44118587|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44118588|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44118589|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
44118590|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118591|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118592|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118593|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44118594|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44118595|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
44118596|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118597|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44118598|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44118599|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
44118600|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
44118601|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44118602|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
44118603|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44297386|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297387|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297388|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44297389|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297390|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297391|NCT00811993|Gemcitabine|gemcitabine|mesh-list
44297392|NCT00811993|Etoposide|etoposide|mesh-list
44297393|NCT00811993|Docetaxel|docetaxel|mesh-list
44297394|NCT00811993|Bevacizumab|bevacizumab|mesh-list
44297395|NCT00811993|Carboplatin|carboplatin|mesh-list
44297396|NCT00811993|Capecitabine|capecitabine|mesh-list
44297397|NCT00811993|Trastuzumab|trastuzumab|mesh-list
44118604|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44118605|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44118606|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44118610|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44118611|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44118612|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118613|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
44118614|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44118615|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118617|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
44118618|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
44118619|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
44118620|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118621|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118622|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118623|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44118624|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118625|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44118626|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44118627|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118628|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
44118629|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
44118630|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118631|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118632|NCT00114686|Valproic Acid|valproic acid|mesh-list
44118633|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44118634|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118635|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118636|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44118637|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44118638|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118639|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118640|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118641|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118642|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
44118643|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
44118644|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
44118645|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118646|NCT00114764|Lenograstim|lenograstim|mesh-list
44118647|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44118648|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
44118649|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118650|NCT00114803|Calcitonin|calcitonin|mesh-list
44118651|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
44118652|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44118653|NCT00114803|Katacalcin|katacalcin|mesh-list
44118654|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44118655|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118656|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44118657|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
44118658|NCT00114816|Docetaxel|docetaxel|mesh-list
44118660|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118661|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118662|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44297399|NCT00811993|Cetuximab|cetuximab|mesh-list
44297400|NCT00811993|Temozolomide|temozolomide|mesh-list
44297401|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44297402|NCT00811993|Sorafenib|sorafenib|mesh-list
44297403|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44297404|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297405|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297406|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44297407|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118663|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118664|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118665|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118666|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
44118667|NCT00114868|Vitamins|vitamins|mesh-list
44118668|NCT00114868|Vitamin A|vitamin a|mesh-list
44118669|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
44118670|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
44118671|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118672|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
44118673|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118674|NCT00114868|Protective Agents|protective agents|mesh-ancestor
44118675|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44118676|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118677|NCT00114933|Ritonavir|ritonavir|mesh-list
44118678|NCT00114933|Lopinavir|lopinavir|mesh-list
44118679|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44118680|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44118687|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118688|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44118689|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44118690|NCT00114946|Bevacizumab|bevacizumab|mesh-list
44118691|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118692|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118693|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44118694|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118695|NCT00114946|Growth Substances|growth substances|mesh-ancestor
44118696|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118697|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118699|NCT00115011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44118700|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44118701|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118702|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118703|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118704|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
44118705|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118706|NCT00115011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44118707|NCT00115011|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118708|NCT00115011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118709|NCT00115024|Estradiol|estradiol|mesh-list
44118710|NCT00115024|Estrogens|estrogens|mesh-ancestor
44118711|NCT00115024|Hormones|hormones|mesh-ancestor
44118712|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118713|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118714|NCT00115089|Beclomethasone|beclomethasone|mesh-list
44118715|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118716|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
44118717|NCT00115089|Hormones|hormones|mesh-ancestor
44118718|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118719|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118720|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44118721|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44118722|NCT00115102|Fentanyl|fentanyl|mesh-list
44118723|NCT00115102|Ketamine|ketamine|mesh-list
44118724|NCT00115102|Esketamine|esketamine|mesh-list
44118725|NCT00115102|Analgesics|analgesics|mesh-ancestor
44118726|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
44297408|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297409|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44297410|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297411|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297413|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297414|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297415|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297416|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
44297417|NCT00811993|Antiviral Agents|antiviral agents|mesh-ancestor
44297418|NCT00811993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297419|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297420|NCT00811993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297421|NCT00811993|Immunologic Factors|immunologic factors|mesh-ancestor
44297422|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44297423|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44297424|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44297425|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44297426|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
44297427|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44297428|NCT00812019|Vaccines|vaccines|mesh-list
44297429|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44297430|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
44118727|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118728|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118729|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44118730|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44118731|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
44118732|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
44118733|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118734|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44118735|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44118736|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118737|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118738|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44118740|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44118741|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118742|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118743|NCT00115115|Dopamine|dopamine|mesh-list
44118744|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44118745|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
44118746|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
44118747|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118748|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118749|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
44118754|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44118755|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
44118756|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118757|NCT00115154|Imiquimod|imiquimod|mesh-list
44118758|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44297432|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44297433|NCT00812123|Cyclosporine|cyclosporine|mesh-list
44297434|NCT00812123|Sirolimus|sirolimus|mesh-list
44297435|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
44297436|NCT00812123|Prednisone|prednisone|mesh-list
44297437|NCT00812123|Cyclosporins|cyclosporins|mesh-list
44297438|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297439|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
44297440|NCT00812123|Hormones|hormones|mesh-ancestor
44297441|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297442|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297443|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297444|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297445|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297446|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297447|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297448|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
44297449|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
44297450|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720107|NCT02632032|Insulin|insulin|mesh-list
44118759|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
44118760|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118761|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118762|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
44118763|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
44118764|NCT00115167|Hematinics|hematinics|mesh-ancestor
44118765|NCT00115219|Etanercept|etanercept|mesh-list
44118766|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44118767|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44118768|NCT00115219|Analgesics|analgesics|mesh-ancestor
44118769|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
44118770|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118771|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118772|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118773|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118774|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44118775|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118776|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
44118777|NCT00115245|Adefovir|adefovir|mesh-list
44118778|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44118779|NCT00115245|Telbivudine|telbivudine|mesh-list
44118780|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
44118781|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118782|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44118783|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44118784|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118785|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118786|NCT00115310|Capsaicin|capsaicin|mesh-list
44118787|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
44118788|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118789|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
44118790|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118791|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118792|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44297452|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297453|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44297454|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44297455|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44297456|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
44297457|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297459|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297460|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44297461|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297462|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297463|NCT00812214|Eszopiclone|eszopiclone|mesh-list
44297464|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44297465|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118793|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44118794|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44118795|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118796|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118797|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118798|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118799|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44118800|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
44118801|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44118802|NCT00115375|Clopidogrel|clopidogrel|mesh-list
44118803|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44118804|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44118805|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44118806|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44118807|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
44118808|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118809|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118810|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118811|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
44118812|NCT00115414|Docetaxel|docetaxel|mesh-list
44118813|NCT00115414|Doxorubicin|doxorubicin|mesh-list
44118814|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118815|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
44118816|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118817|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118818|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44118823|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118824|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118825|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118826|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44118827|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44118828|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44118829|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118830|NCT00115479|Insulin|insulin|mesh-list
44118831|NCT00115479|Benzocaine|benzocaine|mesh-list
44118832|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44118833|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118834|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
44118835|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
44118836|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44118837|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
44118838|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297468|NCT00812266|Carboplatin|carboplatin|mesh-list
44297469|NCT00812266|Etoposide|etoposide|mesh-list
44297470|NCT00812266|Topotecan|topotecan|mesh-list
44297471|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297472|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44297473|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44297474|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44297475|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297476|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297477|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44297478|NCT00812292|Rilpivirine|rilpivirine|mesh-list
44297479|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44297480|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44297481|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118839|NCT00115492|Fluticasone|fluticasone|mesh-list
44118841|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44118842|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44118843|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118844|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44118845|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
44118846|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118847|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118848|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44118849|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
44118850|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118851|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44118852|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44118853|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44118854|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44118855|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
44118856|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118857|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118858|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
44118859|NCT00115492|Hormones|hormones|mesh-ancestor
44118860|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118861|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
44118862|NCT00115518|Cetuximab|cetuximab|mesh-list
44118863|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118864|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118865|NCT00115531|Vaccines|vaccines|mesh-list
44118866|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
44118867|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118868|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44118869|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118870|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118871|NCT00115570|Insulin|insulin|mesh-list
44118872|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44118873|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
44118874|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
44118875|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
44118876|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
44118877|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
44118878|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
44118879|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44118880|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118881|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
44297482|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297484|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297485|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44297486|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44297487|NCT00812318|Cabotegravir|cabotegravir|mesh-list
44297488|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44297489|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44297490|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118882|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44118883|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44118884|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118885|NCT00115609|Tenofovir|tenofovir|mesh-list
44118886|NCT00115609|Emtricitabine|emtricitabine|mesh-list
44118887|NCT00115609|Efavirenz|efavirenz|mesh-list
44118888|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
44118889|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118890|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44118896|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44118897|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44118898|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44118899|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44118900|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44118901|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44118903|NCT00115622|Xhance|xhance|mesh-list
44118904|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118905|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44118906|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
44118907|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118908|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118909|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44118910|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
44118911|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44118912|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44154414|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44154415|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44154416|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154417|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
44154418|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44154419|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
44154420|NCT00223717|Aspirin|aspirin|mesh-list
44154421|NCT00223717|Losartan|losartan|mesh-list
44154422|NCT00223717|Metoprolol|metoprolol|mesh-list
44154423|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44154424|NCT00223717|Clonidine|clonidine|mesh-list
44154425|NCT00223717|Eplerenone|eplerenone|mesh-list
44154426|NCT00223717|Nebivolol|nebivolol|mesh-list
44154427|NCT00223717|Bosentan|bosentan|mesh-list
44154428|NCT00223717|Diltiazem|diltiazem|mesh-list
44154429|NCT00223717|Guanfacine|guanfacine|mesh-list
44154430|NCT00223717|Prazosin|prazosin|mesh-list
44154431|NCT00223717|Hydralazine|hydralazine|mesh-list
44154432|NCT00223717|Captopril|captopril|mesh-list
44154433|NCT00223717|Nifedipine|nifedipine|mesh-list
44154434|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44154435|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
44154436|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
44154437|NCT00223717|Dipyridamole|dipyridamole|mesh-list
44154438|NCT00223717|Carbidopa|carbidopa|mesh-list
44154439|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44154440|NCT00223717|Tamsulosin|tamsulosin|mesh-list
44154441|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154442|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154443|NCT00223717|Analgesics|analgesics|mesh-ancestor
44154444|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
44154445|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154446|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154447|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154448|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297492|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44297493|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44297494|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
44297495|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297496|NCT00812344|Ketoconazole|ketoconazole|mesh-list
44297497|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
44297498|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297499|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44297500|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44297501|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297502|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154449|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44154450|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154451|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154452|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44154453|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154454|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154455|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
44154456|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
44154457|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44154458|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44154459|NCT00223717|Urological Agents|urological agents|mesh-ancestor
44154460|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44154461|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44154462|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44154463|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44154469|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
44154470|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44154471|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44154472|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44154473|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
44154474|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154475|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44154476|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44154477|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44154478|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44154479|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44154480|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44154481|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44118913|NCT00115635|Gemcitabine|gemcitabine|mesh-list
44118914|NCT00115635|Docetaxel|docetaxel|mesh-list
44118915|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44118916|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
44118917|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118918|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118919|NCT00115635|Antiviral Agents|antiviral agents|mesh-ancestor
44118920|NCT00115635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118921|NCT00115635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118922|NCT00115635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118923|NCT00115635|Immunologic Factors|immunologic factors|mesh-ancestor
44118924|NCT00115635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118925|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
44118926|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
44118927|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44118928|NCT00115648|Zidovudine|zidovudine|mesh-list
44118929|NCT00115648|Nevirapine|nevirapine|mesh-list
44118930|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
44118931|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118932|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44297503|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44297504|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297505|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297506|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297507|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44297508|NCT00812370|Bivalirudin|bivalirudin|mesh-list
44297509|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
44297510|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44297511|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44297512|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297513|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297514|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
44297515|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
44297516|NCT00812396|Testosterone|testosterone|mesh-list
44297517|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
44297518|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
44297519|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44297520|NCT00812396|Androgens|androgens|mesh-ancestor
44297521|NCT00812396|Hormones|hormones|mesh-ancestor
44297522|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297523|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297524|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297525|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297526|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
44297527|NCT00812422|Ibuprofen|ibuprofen|mesh-list
44297528|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297529|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297530|NCT00812422|Analgesics|analgesics|mesh-ancestor
44118933|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44118934|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118935|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
44118936|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118937|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44118938|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44118939|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44118940|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44118941|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
44118942|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44118943|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118944|NCT00115687|Nicotine|nicotine|mesh-list
44118945|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44118946|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
44118947|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118948|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118949|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44297532|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297533|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297534|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297535|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297536|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44297537|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297538|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297539|NCT00812435|Eptifibatide|eptifibatide|mesh-list
44297540|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44297541|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44297542|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
44297543|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297544|NCT00812448|Protective Agents|protective agents|mesh-ancestor
44118950|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44118951|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
44118952|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118953|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118955|NCT00115726|Diuretics|diuretics|mesh-ancestor
44118956|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
44118957|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118958|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44118959|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44118960|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118961|NCT00115752|Valdecoxib|valdecoxib|mesh-list
44118962|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
44118963|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44118964|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118972|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44118973|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44118974|NCT00115817|Atorvastatin|atorvastatin|mesh-list
44118975|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44118976|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44118977|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
44118978|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118979|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44118980|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44118981|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118982|NCT00115830|Atorvastatin|atorvastatin|mesh-list
44118983|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44118984|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44118985|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44118986|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
44154482|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
44118987|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118988|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44118989|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44118990|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118992|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44118993|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
44118994|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118995|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
44118996|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118997|NCT00115921|Antimalarials|antimalarials|mesh-list
44118998|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44118999|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44297545|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297547|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44297548|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297549|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44297550|NCT00812513|Becaplermin|becaplermin|mesh-list
44297551|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
44297552|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44297553|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297554|NCT00812513|Growth Substances|growth substances|mesh-ancestor
44297555|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297556|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
44297557|NCT00812578|Vitamin D|vitamin d|mesh-list
44297558|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44297559|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297560|NCT00812578|Vitamins|vitamins|mesh-ancestor
44297561|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
44297562|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44297563|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
44297564|NCT00812669|Rituximab|rituximab|mesh-list
44297565|NCT00812669|Fludarabine|fludarabine|mesh-list
44297566|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
44297567|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297568|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
44297569|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297570|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297571|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44297572|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
44297573|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297574|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297589|NCT00812786|Cyclosporine|cyclosporine|mesh-list
44297590|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
44297591|NCT00812786|Everolimus|everolimus|mesh-list
44297592|NCT00812786|Tacrolimus|tacrolimus|mesh-list
44297593|NCT00812786|Cyclosporins|cyclosporins|mesh-list
44297594|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44297595|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
44297596|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297597|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44297598|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297599|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297600|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
44297601|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297602|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
43832738|NCT05252598|Psilocybin|psilocybin|mesh-list
44119000|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119001|NCT00115947|Terlipressin|terlipressin|mesh-list
44119002|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44119003|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44119004|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
44119005|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119006|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119007|NCT00116064|Lorazepam|lorazepam|mesh-list
44119008|NCT00116064|Paraldehyde|paraldehyde|mesh-list
44119009|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
44119010|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
44119011|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
44119012|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119013|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119014|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119015|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44119016|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44119017|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44119018|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44119019|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119020|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
44119021|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
44119022|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119023|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119024|NCT00116103|Tacrolimus|tacrolimus|mesh-list
44119025|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119026|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
44119027|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119028|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44119029|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119030|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119040|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119041|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119042|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
44119043|NCT00116259|Aripiprazole|aripiprazole|mesh-list
44119044|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44119045|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119046|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44119047|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44119048|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44119049|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119050|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
44119051|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
44119052|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119053|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647752|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
44119054|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44119055|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44119056|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
44297603|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297604|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297605|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44297606|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44297607|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
44297608|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44297609|NCT00812825|Prednisolone|prednisolone|mesh-list
44297610|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297611|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
44297612|NCT00812825|Hormones|hormones|mesh-ancestor
44297613|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297614|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297615|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297616|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297617|NCT00812851|Dronabinol|dronabinol|mesh-list
44297618|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
44297619|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297620|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44297621|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297622|NCT00812851|Analgesics|analgesics|mesh-ancestor
44297623|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
44297624|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297625|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44297626|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44297627|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297628|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297629|NCT00812851|Hormones|hormones|mesh-ancestor
44297630|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297636|NCT00812994|Citalopram|citalopram|mesh-list
44297646|NCT00812994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44297647|NCT00813059|Bevacizumab|bevacizumab|mesh-list
44297648|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44297649|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297650|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297651|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297652|NCT00813059|Growth Substances|growth substances|mesh-ancestor
44297653|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297654|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297655|NCT00813072|Docetaxel|docetaxel|mesh-list
44297656|NCT00813072|Irinotecan|irinotecan|mesh-list
44297657|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297658|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297659|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
43952366|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
44297660|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297661|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297662|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44297663|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44297664|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297665|NCT00813137|Endostar protein|endostar protein|mesh-list
44297666|NCT00813137|Endostatins|endostatins|mesh-list
44297667|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297668|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297669|NCT00813137|Growth Substances|growth substances|mesh-ancestor
44297670|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297671|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297672|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297673|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44297674|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297675|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297676|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44297677|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297678|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297679|NCT00813228|Incretins|incretins|mesh-ancestor
44297680|NCT00813228|Hormones|hormones|mesh-ancestor
44297685|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297686|NCT00813241|Celecoxib|celecoxib|mesh-list
44297687|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297688|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297689|NCT00813241|Analgesics|analgesics|mesh-ancestor
44297690|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
44297691|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297692|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297693|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297694|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297695|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44297696|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44297697|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297698|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297699|NCT00813332|Docetaxel|docetaxel|mesh-list
44297700|NCT00813332|Endostar protein|endostar protein|mesh-list
44297701|NCT00813332|Endostatins|endostatins|mesh-list
44297702|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297703|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297704|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44297705|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297706|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297707|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297708|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297709|NCT00813332|Growth Substances|growth substances|mesh-ancestor
44297710|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297711|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297712|NCT00813410|Insulin|insulin|mesh-list
44297713|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119057|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44119058|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44119059|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44119060|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44119061|NCT00116324|Montelukast|montelukast|mesh-list
44119062|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119063|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119064|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44119065|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
44119066|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119067|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119068|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44297714|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297715|NCT00813436|Oxytocin|oxytocin|mesh-list
44297716|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
44297717|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44297718|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297719|NCT00813449|Dacarbazine|dacarbazine|mesh-list
44297720|NCT00813449|Endostar protein|endostar protein|mesh-list
44297721|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44297722|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
44297723|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297724|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297725|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297726|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297727|NCT00813449|Growth Substances|growth substances|mesh-ancestor
44297728|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297729|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297730|NCT00813475|Insulin|insulin|mesh-list
44297731|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44297732|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297733|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952447|NCT01199744|Zanamivir|zanamivir|mesh-list
44297734|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44297735|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
44297736|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297737|NCT00813527|Fenofibrate|fenofibrate|mesh-list
44297738|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44297739|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
44297740|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297741|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44297742|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44297743|NCT00813631|Laxatives|laxatives|mesh-ancestor
44297745|NCT00813696|Gemcitabine|gemcitabine|mesh-list
44297756|NCT00813696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297757|NCT00813722|Losartan|losartan|mesh-list
44297758|NCT00813722|Atenolol|atenolol|mesh-list
44297759|NCT00813722|Amlodipine|amlodipine|mesh-list
44297760|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44297761|NCT00813722|Calcium|calcium|mesh-list
44297762|NCT00813722|Diuretics|diuretics|mesh-list
44297763|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44297764|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44297765|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297766|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44297767|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44297768|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44297769|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297770|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
44297771|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44297772|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44297773|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44297774|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
44297775|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44297776|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44297777|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
44297778|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297779|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
44297780|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
44297781|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297782|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44297783|NCT00813735|Dexetimide|dexetimide|mesh-list
44297784|NCT00813735|Eszopiclone|eszopiclone|mesh-list
44297785|NCT00813735|Citalopram|citalopram|mesh-list
44297786|NCT00813735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44297787|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44297788|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44297797|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44297798|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
44297799|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
44297800|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297801|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44297802|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44297803|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
44297804|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44297805|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465244|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
43952511|NCT01202162|Sevoflurane|sevoflurane|mesh-list
44465245|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297806|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
44297807|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44297808|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
44297809|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297810|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297811|NCT00813891|Ranibizumab|ranibizumab|mesh-list
44297812|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297813|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44297814|NCT00813891|Growth Substances|growth substances|mesh-ancestor
44297815|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297816|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297817|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297818|NCT00814008|Insulin|insulin|mesh-list
44297819|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44297820|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297821|NCT00814021|Sunitinib|sunitinib|mesh-list
44297822|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297823|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44297824|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119069|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44119070|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119071|NCT00116350|Misoprostol|misoprostol|mesh-list
44119072|NCT00116350|Oxytocin|oxytocin|mesh-list
44119073|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
44119074|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119075|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119076|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44119077|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
44119078|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44119079|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119080|NCT00116389|Gemcitabine|gemcitabine|mesh-list
44297825|NCT00814021|Growth Substances|growth substances|mesh-ancestor
44297826|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297827|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44297828|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44297829|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297830|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297831|NCT00814047|Yohimbine|yohimbine|mesh-list
44297832|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
44297833|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
44297834|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297835|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297836|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44297837|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44297838|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44297839|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
44297840|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297841|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297842|NCT00814047|Urological Agents|urological agents|mesh-ancestor
44297843|NCT00814086|Paclitaxel|paclitaxel|mesh-list
44297844|NCT00814086|Cisplatin|cisplatin|mesh-list
44297845|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44297846|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297847|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44297848|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44297849|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44297850|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297851|NCT00814125|Tamoxifen|tamoxifen|mesh-list
44297852|NCT00814125|Anastrozole|anastrozole|mesh-list
44297853|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44119081|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119082|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
44119083|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119084|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119085|NCT00116389|Antiviral Agents|antiviral agents|mesh-ancestor
44119086|NCT00116389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119087|NCT00116389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119088|NCT00116389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119089|NCT00116389|Immunologic Factors|immunologic factors|mesh-ancestor
44119090|NCT00116389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119091|NCT00116402|Fluticasone|fluticasone|mesh-list
44119092|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44119093|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119094|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44119095|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
44119101|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44297854|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297855|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297856|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297857|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297858|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297859|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44297860|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44297861|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44297862|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44297863|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44297864|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297865|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297866|NCT00814216|Fluticasone|fluticasone|mesh-list
44297868|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297869|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44297870|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
44297871|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297872|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297873|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44297874|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
44297875|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44297876|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44297877|NCT00814229|Vaccines|vaccines|mesh-list
44297878|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
44297879|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
44297880|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297881|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44297882|NCT00814268|Aspirin|aspirin|mesh-list
44297883|NCT00814268|Clopidogrel|clopidogrel|mesh-list
44297884|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44297885|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44297886|NCT00814268|Analgesics|analgesics|mesh-ancestor
44297887|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
44297888|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297892|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44297893|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44297894|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297895|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44297896|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44297897|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297898|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
44297899|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44297900|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44297901|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44297902|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
44297903|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44297904|NCT00814281|Montelukast|montelukast|mesh-list
44297905|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44297906|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
44297907|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44297908|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
44297909|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297910|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297911|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44297912|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44297913|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297914|NCT00814359|Benzydamine|benzydamine|mesh-list
44297915|NCT00814359|Sucralfate|sucralfate|mesh-list
44297916|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297917|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44297918|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44297919|NCT00814515|Cyclosporine|cyclosporine|mesh-list
44297920|NCT00814515|Cyclosporins|cyclosporins|mesh-list
44297921|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297931|NCT00814528|Imiquimod|imiquimod|mesh-list
44297934|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297935|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297936|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
44297937|NCT00814541|Dexamethasone|dexamethasone|mesh-list
44297938|NCT00814541|Doxorubicin|doxorubicin|mesh-list
44297939|NCT00814541|Bortezomib|bortezomib|mesh-list
44297940|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297941|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
44297942|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
44297943|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44297944|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297945|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44297946|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
44297947|NCT00814541|Hormones|hormones|mesh-ancestor
44297948|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44297949|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44297950|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297951|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44297952|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44297953|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44297954|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297955|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297956|NCT00814593|Carmustine|carmustine|mesh-list
44297957|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44297958|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
44297959|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297960|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297961|NCT00814606|Ribavirin|ribavirin|mesh-list
44297962|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44297963|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
44297964|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297965|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
44297966|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44297967|NCT00814619|Capecitabine|capecitabine|mesh-list
44297968|NCT00814619|Panitumumab|panitumumab|mesh-list
44297969|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44297972|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44297973|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44297974|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44297975|NCT00814723|Ezetimibe|ezetimibe|mesh-list
44297976|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44297977|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44297978|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
44297979|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297980|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44297981|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
44297982|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
44297983|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44297984|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44297985|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44297986|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44297987|NCT00814736|Urological Agents|urological agents|mesh-ancestor
44297988|NCT00814762|Vaccines|vaccines|mesh-list
44297989|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
44119102|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44119103|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44119104|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44119105|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44119106|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119107|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119108|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
44119109|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119110|NCT00116467|Vaccines|vaccines|mesh-list
44119111|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
44119112|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119113|NCT00116480|Misoprostol|misoprostol|mesh-list
44119114|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44119115|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
44119116|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119117|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119118|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44119119|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119120|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
44119121|NCT00116493|Folic Acid|folic acid|mesh-list
44119122|NCT00116493|Mebendazole|mebendazole|mesh-list
44119123|NCT00116493|Piperazine|piperazine|mesh-list
44119124|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
44119125|NCT00116493|DMP 777|dmp 777|mesh-list
44119126|NCT00116493|Hematinics|hematinics|mesh-ancestor
44119127|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
44119128|NCT00116493|Vitamins|vitamins|mesh-ancestor
44119129|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
44119130|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119131|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
44119132|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
44119133|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119134|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119135|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44119136|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44119137|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44158166|NCT00236327|Narcotics|narcotics|mesh-ancestor
44297990|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44297992|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44297993|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44297994|NCT00814905|Clindamycin|clindamycin|mesh-list
44297995|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
44297996|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
44297997|NCT00814905|Gentamicins|gentamicins|mesh-list
44297998|NCT00814905|Ampicillin|ampicillin|mesh-list
44297999|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298000|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298001|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44298002|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298003|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298004|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44298005|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44298006|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
44298007|NCT00814944|Sirolimus|sirolimus|mesh-list
44298008|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298009|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298010|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298011|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298012|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
44298013|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298014|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
44298015|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298016|NCT00815022|Fentanyl|fentanyl|mesh-list
44298017|NCT00815022|Morphine|morphine|mesh-list
44298042|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44298043|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44298045|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
44298046|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44298047|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44298048|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
44298049|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44298050|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
44298051|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
44298052|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
44298053|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44298054|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44298055|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
44298056|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298057|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298058|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44298059|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44298060|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44298061|NCT00815204|Dexamethasone|dexamethasone|mesh-list
44298062|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44298063|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
44298064|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
44298065|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298066|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298067|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298068|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
44298069|NCT00815204|Hormones|hormones|mesh-ancestor
44298070|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44298071|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44298072|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298073|NCT00815256|Riboflavin|riboflavin|mesh-list
44298074|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
44298075|NCT00815256|Vitamins|vitamins|mesh-ancestor
44298076|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
44298085|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44298086|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44298087|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
44298088|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
44298089|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298090|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298091|NCT00815282|Vaccines|vaccines|mesh-list
44298092|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
44298093|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298094|NCT00815373|Timolol|timolol|mesh-list
44298095|NCT00815373|Dorzolamide|dorzolamide|mesh-list
44298096|NCT00815373|Latanoprost|latanoprost|mesh-list
44298097|NCT00815373|Maleic acid|maleic acid|mesh-list
44298098|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44298099|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44298100|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298101|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298102|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298103|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298104|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44298105|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44298106|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298107|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44298108|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44298109|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44298110|NCT00815399|Metformin|metformin|mesh-list
44298111|NCT00815399|Pioglitazone|pioglitazone|mesh-list
44298112|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44298113|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298114|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
43720369|NCT02630485|Inositol|inositol|mesh-list
44119138|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119139|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119140|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119141|NCT00116506|Bevacizumab|bevacizumab|mesh-list
44119142|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44119143|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44119144|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119145|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44119146|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119147|NCT00116506|Growth Substances|growth substances|mesh-ancestor
44119148|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119149|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
44119150|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44298117|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
44298118|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
44298119|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298120|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298121|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
44298122|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298123|NCT00815542|Dinoprostone|dinoprostone|mesh-list
44298124|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
44298125|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44298126|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298127|NCT00815568|Fludarabine|fludarabine|mesh-list
44298128|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
44298129|NCT00815568|Busulfan|busulfan|mesh-list
44298130|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298131|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298132|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
44298133|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298134|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298135|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
44298136|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298137|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
44298138|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44298139|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44298140|NCT00815594|Bevacizumab|bevacizumab|mesh-list
44298141|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720389|NCT02630303|Coal Tar|coal tar|mesh-list
44119151|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119152|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119153|NCT00116532|Citalopram|citalopram|mesh-list
44119154|NCT00116532|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44119155|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44119156|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44119157|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119158|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119159|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
44119160|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119161|NCT00116532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44119162|NCT00116532|Antidepressive Agents|antidepressive agents|mesh-ancestor
44119163|NCT00116532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119164|NCT00116545|Troglitazone|troglitazone|mesh-list
44119172|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119173|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
44119174|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44119175|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44119176|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
44298142|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298143|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44298144|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44298145|NCT00815594|Growth Substances|growth substances|mesh-ancestor
44298146|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298147|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44298148|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
44298149|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298150|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44298151|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44298152|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298153|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298154|NCT00815646|Urological Agents|urological agents|mesh-ancestor
44465246|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44465247|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
44465248|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465249|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
44465250|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44465251|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465252|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465254|NCT01479868|Ribavirin|ribavirin|mesh-list
44465255|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
44465256|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
44465257|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44465258|NCT01479868|Simeprevir|simeprevir|mesh-list
44465259|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465260|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
44465261|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465262|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
44119177|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44119178|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44119179|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119180|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44119181|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
44119182|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119183|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44119184|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44119185|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119186|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119187|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
44119188|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44119189|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465263|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465265|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465266|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465267|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465268|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
44465269|NCT01479764|Neostigmine|neostigmine|mesh-list
44465270|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44465271|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465272|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465273|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
44465274|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465275|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465276|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43952861|NCT01213199|Adapalene|adapalene|mesh-list
44298155|NCT00815841|Methylphenidate|methylphenidate|mesh-list
44298156|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44298157|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298158|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44298159|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298160|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298161|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298162|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
44298163|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298164|NCT00815854|Folic Acid|folic acid|mesh-list
44298165|NCT00815854|Hematinics|hematinics|mesh-ancestor
44119190|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119191|NCT00116701|Hematinics|hematinics|mesh-ancestor
44119192|NCT00116727|Etanercept|etanercept|mesh-list
44119193|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44119194|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44119195|NCT00116727|Analgesics|analgesics|mesh-ancestor
44119196|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
44119197|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119198|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119199|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119200|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119201|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119202|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119203|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
44119204|NCT00116870|Lovastatin|lovastatin|mesh-list
44119205|NCT00116870|L 647318|l 647318|mesh-list
44119206|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
44119207|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44119208|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44119209|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
44119210|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298166|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
44298167|NCT00815854|Vitamins|vitamins|mesh-ancestor
44298168|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
44298169|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298170|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
44298171|NCT00815867|Hematinics|hematinics|mesh-ancestor
44298172|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
44298173|NCT00815893|Propofol|propofol|mesh-list
44298174|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44298175|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298176|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298177|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44298178|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
44298179|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
44298180|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44298181|NCT00815893|Analgesics|analgesics|mesh-ancestor
44298182|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
44298183|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298184|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44298185|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44298186|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44298187|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298188|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298189|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298190|NCT00815945|Carboplatin|carboplatin|mesh-list
44298191|NCT00815945|Doxorubicin|doxorubicin|mesh-list
44298192|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298193|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298194|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44298195|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44298196|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298197|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298198|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
44298208|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44298210|NCT00816127|Coagulants|coagulants|mesh-ancestor
44298211|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44298212|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
44298213|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298214|NCT00816140|Clarithromycin|clarithromycin|mesh-list
44298215|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298216|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298217|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44298218|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298219|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298220|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44298221|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298222|NCT00816205|Nifedipine|nifedipine|mesh-list
44298223|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298224|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298225|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298226|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44298227|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298228|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298229|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
44298230|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44298231|NCT00816218|Pioglitazone|pioglitazone|mesh-list
44298232|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44298233|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298234|NCT00816244|Atorvastatin|atorvastatin|mesh-list
44298235|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44298236|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44298237|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
44298238|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298239|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44298248|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44298249|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44298250|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44298251|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298252|NCT00816413|Cyclosporine|cyclosporine|mesh-list
44298253|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
44298254|NCT00816413|Pentostatin|pentostatin|mesh-list
44298255|NCT00816413|Cyclosporins|cyclosporins|mesh-list
44298256|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298257|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298258|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298259|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
44298260|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298261|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
44298262|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298263|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
44298264|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298265|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44298266|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298267|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298268|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44298269|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
44298270|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298271|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44298272|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
44298273|NCT00816426|Rifampin|rifampin|mesh-list
44298274|NCT00816426|Isoniazid|isoniazid|mesh-list
44298275|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
44298276|NCT00816426|Kanamycin|kanamycin|mesh-list
44298277|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298278|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298279|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44298280|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44298281|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298282|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119211|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44119212|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44119213|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119214|NCT00116896|Cisplatin|cisplatin|mesh-list
44119215|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119216|NCT00116922|Metformin|metformin|mesh-list
44298283|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298284|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44298285|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
44298286|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
44298287|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44298288|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44298289|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44298290|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44298291|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44298292|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44298293|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44298294|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44298295|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44298296|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
44298297|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44298298|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44298299|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
44298300|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44298301|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44298302|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44298303|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298304|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298305|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
44298306|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298307|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298308|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44298309|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298311|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
44298312|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298313|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298314|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298315|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298316|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298318|NCT00816634|Cisplatin|cisplatin|mesh-list
44298320|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44298321|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298322|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298323|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298324|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298325|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298326|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298327|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
44298328|NCT00816660|Factor VIII|factor viii|mesh-list
44298329|NCT00816660|Coagulants|coagulants|mesh-ancestor
44298330|NCT00816673|Melatonin|melatonin|mesh-list
44298331|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
44298332|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298333|NCT00816673|Protective Agents|protective agents|mesh-ancestor
44298334|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298335|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298336|NCT00816699|Anesthetics|anesthetics|mesh-list
44298337|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298338|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298339|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
44298340|NCT00816712|Testosterone|testosterone|mesh-list
44298341|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
44298342|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
44298343|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44298344|NCT00816712|Androgens|androgens|mesh-ancestor
44119217|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
44119218|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119219|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119220|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
44119221|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119222|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119223|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119224|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119225|NCT00116948|Cimetidine|cimetidine|mesh-list
44119226|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44119227|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119228|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44119229|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
44119230|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
44119231|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119232|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119239|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119240|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
44119241|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
44119242|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119243|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119244|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119245|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
44119246|NCT00116961|Hormones|hormones|mesh-ancestor
44119247|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44298346|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44298347|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298348|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44298349|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298350|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
44298351|NCT00816790|Tazobactam|tazobactam|mesh-list
44298352|NCT00816790|Piperacillin|piperacillin|mesh-list
44298353|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44298354|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298355|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298356|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44298357|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298358|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298359|NCT00816816|Cisplatin|cisplatin|mesh-list
44298360|NCT00816816|Docetaxel|docetaxel|mesh-list
44298361|NCT00816816|Fluorouracil|fluorouracil|mesh-list
44298362|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298363|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298364|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298365|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298366|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298367|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
44298368|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298369|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298370|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
44119248|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44119249|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119250|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
44119251|NCT00117000|Testosterone|testosterone|mesh-list
44119252|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
44119253|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
44119254|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44119255|NCT00117000|Androgens|androgens|mesh-ancestor
44119256|NCT00117000|Hormones|hormones|mesh-ancestor
44119257|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119258|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119259|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44119260|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119261|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
44119262|NCT00117013|Topotecan|topotecan|mesh-list
44119263|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44119265|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119266|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119267|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119268|NCT00117026|Benphothiamine|benphothiamine|mesh-list
44119269|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44119270|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
44298371|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298372|NCT00816855|Cisplatin|cisplatin|mesh-list
44298373|NCT00816855|Docetaxel|docetaxel|mesh-list
44298374|NCT00816855|Fluorouracil|fluorouracil|mesh-list
44298375|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298376|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298377|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298378|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298379|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298380|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
44298381|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298382|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298383|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
44298384|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298385|NCT00816868|Capecitabine|capecitabine|mesh-list
44298386|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44298387|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298388|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
44298389|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298390|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298391|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44298392|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298393|NCT00816894|Olanzapine|olanzapine|mesh-list
44298394|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
44298395|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
44298396|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298397|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298398|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298399|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44298400|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44298401|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298402|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119271|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119272|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
44119273|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
44119274|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119275|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119276|NCT00117039|Hematinics|hematinics|mesh-ancestor
44119277|NCT00117052|Cinacalcet|cinacalcet|mesh-list
44119278|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44119279|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119280|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44119281|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
44298403|NCT00816894|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44298404|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298405|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298406|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298407|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298408|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
44298409|NCT00816959|Bleomycin|bleomycin|mesh-list
44298410|NCT00816959|Dacarbazine|dacarbazine|mesh-list
44298411|NCT00816959|Vinblastine|vinblastine|mesh-list
44298412|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298413|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298414|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298415|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44298416|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
44298417|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44298418|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298419|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298420|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298421|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44298422|NCT00817011|Mirtazapine|mirtazapine|mesh-list
44298423|NCT00817011|Trazodone|trazodone|mesh-list
44298424|NCT00817011|Bupropion|bupropion|mesh-list
44298425|NCT00817011|Fluoxetine|fluoxetine|mesh-list
44298426|NCT00817011|Paroxetine|paroxetine|mesh-list
44298427|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44298428|NCT00817011|Citalopram|citalopram|mesh-list
44119282|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119283|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119284|NCT00117065|Hematinics|hematinics|mesh-ancestor
44119285|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119286|NCT00117078|Hematinics|hematinics|mesh-ancestor
44119287|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44119288|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119290|NCT00117104|Hematinics|hematinics|mesh-ancestor
44119291|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119292|NCT00117117|Hematinics|hematinics|mesh-ancestor
44119293|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119294|NCT00117130|Hematinics|hematinics|mesh-ancestor
44119295|NCT00117182|Budesonide|budesonide|mesh-list
44119296|NCT00117182|Mannitol|mannitol|mesh-list
43647834|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44119297|NCT00117182|Bromides|bromides|mesh-list
44119298|NCT00117182|Albuterol|albuterol|mesh-list
44119299|NCT00117182|Ipratropium|ipratropium|mesh-list
44119300|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119301|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44119302|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
44119303|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119304|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119305|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119309|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119311|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
44119312|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44298430|NCT00817011|Nortriptyline|nortriptyline|mesh-list
44298431|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44298432|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
44298433|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298434|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44298435|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298436|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298437|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298438|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
44298439|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298440|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298441|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44298442|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298443|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298444|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44298445|NCT00817011|Analgesics|analgesics|mesh-ancestor
44298446|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
44298447|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298448|NCT00817011|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44298449|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
44298450|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44298451|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
44298452|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
44298453|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44298454|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43953165|NCT01217411|R04929097|r04929097|mesh-list
44298455|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298456|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44298457|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44298458|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44298459|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298465|NCT00817037|Nifedipine|nifedipine|mesh-list
44298467|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298468|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298469|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298470|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44298471|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298472|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298473|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
44298474|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44298475|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44298476|NCT00817245|Amoxicillin|amoxicillin|mesh-list
44298477|NCT00817245|Metronidazole|metronidazole|mesh-list
44298478|NCT00817245|Omeprazole|omeprazole|mesh-list
44298479|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298480|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298481|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44298482|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44298483|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44298484|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298485|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44298486|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298487|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298488|NCT00817258|Cisplatin|cisplatin|mesh-list
44298489|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298490|NCT00817271|Glucagon|glucagon|mesh-list
44298491|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298492|NCT00817271|Hormones|hormones|mesh-ancestor
44298493|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119313|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44119314|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44119315|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44119316|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44119317|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119318|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119319|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44119320|NCT00117182|Diuretics|diuretics|mesh-ancestor
44119321|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
44119322|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44119323|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
44119324|NCT00117208|Mannitol|mannitol|mesh-list
44119325|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44119326|NCT00117208|Diuretics|diuretics|mesh-ancestor
44119327|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
44119328|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119329|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119330|NCT00117234|Hematinics|hematinics|mesh-ancestor
44119331|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119332|NCT00117247|Hematinics|hematinics|mesh-ancestor
44119333|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
44119334|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44298494|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298495|NCT00817284|Bevacizumab|bevacizumab|mesh-list
44298497|NCT00817284|Temozolomide|temozolomide|mesh-list
44298498|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44298499|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298500|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44298501|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44298502|NCT00817284|Growth Substances|growth substances|mesh-ancestor
44298503|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298504|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44298505|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44298506|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44298507|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298508|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298509|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44298510|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
44298511|NCT00817375|Milnacipran|milnacipran|mesh-list
44298512|NCT00817375|Mirtazapine|mirtazapine|mesh-list
44298513|NCT00817375|Sertraline|sertraline|mesh-list
44298514|NCT00817375|Fluoxetine|fluoxetine|mesh-list
44298515|NCT00817375|Paroxetine|paroxetine|mesh-list
44298516|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44298517|NCT00817375|Nortriptyline|nortriptyline|mesh-list
44298518|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
44298519|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298520|NCT00817375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44298521|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298522|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298523|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298524|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298525|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
44298526|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298527|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44298528|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44298532|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44298533|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
44298534|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
44298535|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44298536|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44298537|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298538|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44298539|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44298540|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44298541|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298542|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44298543|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44298544|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44298545|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44298547|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
44298548|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298549|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44298550|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44465277|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
44465278|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465279|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44465280|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44465281|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44465282|NCT01479621|Fluticasone|fluticasone|mesh-list
44465283|NCT01479621|Xhance|xhance|mesh-list
44465284|NCT01479621|Albuterol|albuterol|mesh-list
44465285|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
44465286|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465287|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44465288|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
44465289|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465301|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465303|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44465304|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465305|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465306|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44465307|NCT01479530|Protective Agents|protective agents|mesh-ancestor
44465308|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465309|NCT01479465|Leucovorin|leucovorin|mesh-list
44465310|NCT01479465|Fluorouracil|fluorouracil|mesh-list
44465311|NCT01479465|Irinotecan|irinotecan|mesh-list
44465312|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
44465313|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465314|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465315|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465316|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465317|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
44465318|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465319|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44465320|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44465321|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465322|NCT01479465|Antidotes|antidotes|mesh-ancestor
44465323|NCT01479465|Protective Agents|protective agents|mesh-ancestor
44465324|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
44465325|NCT01479465|Vitamins|vitamins|mesh-ancestor
44465326|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
44465327|NCT01479439|Losartan|losartan|mesh-list
44465328|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44465329|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44298551|NCT00817466|Epinephrine|epinephrine|mesh-list
44298552|NCT00817466|Racepinephrine|racepinephrine|mesh-list
43720607|NCT02628951|Paclitaxel|paclitaxel|mesh-list
44119335|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44119336|NCT00117260|Estradiol|estradiol|mesh-list
44119337|NCT00117260|Estrogens|estrogens|mesh-ancestor
44119338|NCT00117260|Hormones|hormones|mesh-ancestor
44119339|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119340|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563402|NCT01255709|Epinephrine|epinephrine|mesh-list
44119341|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44119342|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
44119343|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119344|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44119345|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44119346|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44298554|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44298555|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44298556|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298557|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298558|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298559|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298560|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44298561|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44298562|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
44298563|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298564|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44298565|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44298566|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
44298567|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
44298568|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44298569|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44298570|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44298571|NCT00817583|Cisplatin|cisplatin|mesh-list
44298572|NCT00817583|Docetaxel|docetaxel|mesh-list
44298573|NCT00817583|Fluorouracil|fluorouracil|mesh-list
44298574|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298575|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298576|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298608|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298609|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
44298610|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298611|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298612|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44298613|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
44298614|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298615|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298616|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298617|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298618|NCT00817713|Ivermectin|ivermectin|mesh-list
44298619|NCT00817713|Albendazole|albendazole|mesh-list
44298620|NCT00817713|Praziquantel|praziquantel|mesh-list
44298621|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44298622|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298623|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
44298624|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
44298625|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44298626|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44298627|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298628|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298629|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298630|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298631|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298632|NCT00817739|Leuprolide|leuprolide|mesh-list
44119347|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44119348|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44119349|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
44119350|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44119351|NCT00117273|Estradiol|estradiol|mesh-list
44119352|NCT00117273|Estrogens|estrogens|mesh-ancestor
44119353|NCT00117273|Hormones|hormones|mesh-ancestor
44119354|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119355|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119356|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44119357|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
44119358|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119359|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44119360|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44119361|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44119362|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44119363|NCT00117299|Vatalanib|vatalanib|mesh-list
44119364|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119365|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119366|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119367|NCT00117351|Bortezomib|bortezomib|mesh-list
44298635|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
44298636|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44298637|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298638|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44298639|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298640|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
44298641|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44298642|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44298643|NCT00817765|Ritonavir|ritonavir|mesh-list
44298644|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
44298645|NCT00817765|Posaconazole|posaconazole|mesh-list
44298646|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44298647|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44298648|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
44298649|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298650|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298651|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44298652|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44298653|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
44298654|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298655|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44298656|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298657|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
44298658|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44298659|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44298660|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44298661|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44298662|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44298663|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
44298664|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44298665|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298666|NCT00817895|Cisplatin|cisplatin|mesh-list
44298667|NCT00817895|Fluorouracil|fluorouracil|mesh-list
44119368|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154483|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44154484|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298669|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
44298670|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298671|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298672|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298673|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
44298674|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298675|NCT00817934|Bisacodyl|bisacodyl|mesh-list
44298676|NCT00817934|Cathartics|cathartics|mesh-ancestor
44298677|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298678|NCT00817934|Laxatives|laxatives|mesh-ancestor
44298679|NCT00817960|Methylphenidate|methylphenidate|mesh-list
44298680|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44298681|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298682|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44298683|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298684|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298685|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298686|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
44298687|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298688|NCT00817973|Caseins|caseins|mesh-list
44298689|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
44298690|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
44298691|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298692|NCT00818038|Natalizumab|natalizumab|mesh-list
44298693|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
44298694|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298695|NCT00818090|Paclitaxel|paclitaxel|mesh-list
44298696|NCT00818090|Cisplatin|cisplatin|mesh-list
44298697|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44298698|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298699|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298700|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298701|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
43953433|NCT01224145|Bupivacaine|bupivacaine|mesh-list
44298707|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298708|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44298709|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44298710|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
44298711|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298712|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44298713|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44298714|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298715|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44298716|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44298717|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298718|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298719|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298720|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298721|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298722|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
44298723|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298724|NCT00818194|Cyclosporine|cyclosporine|mesh-list
44298725|NCT00818194|Tacrolimus|tacrolimus|mesh-list
44298726|NCT00818194|Cyclosporins|cyclosporins|mesh-list
44298727|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298728|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
44298729|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298730|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44298731|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298732|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298733|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
44298734|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154485|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154486|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
44154487|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44154488|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44154489|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
44154497|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44154498|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44154499|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
44154500|NCT00223743|Zonisamide|zonisamide|mesh-list
44154501|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
44154502|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44154503|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154504|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154505|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44298735|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
44298736|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298737|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
44298738|NCT00818298|Ziprasidone|ziprasidone|mesh-list
44298739|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44298740|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
44298741|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298742|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298743|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298744|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44298745|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44298746|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298747|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298748|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44298749|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
44298750|NCT00818350|Sunitinib|sunitinib|mesh-list
44298751|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298752|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44298753|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44298754|NCT00818350|Growth Substances|growth substances|mesh-ancestor
44298755|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298756|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44298757|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44298758|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298759|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298760|NCT00818415|Naproxen|naproxen|mesh-list
44298761|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44298762|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44298763|NCT00818415|Analgesics|analgesics|mesh-ancestor
44298764|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
44298765|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298766|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298767|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44298777|NCT00818610|Clarithromycin|clarithromycin|mesh-list
44298778|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44298780|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
44298781|NCT00818610|Lactams|lactams|mesh-list
44298782|NCT00818610|beta-Lactams|beta-lactams|mesh-list
44298783|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298784|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298785|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44298786|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298787|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298788|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44298789|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298790|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44298791|NCT00818675|Sirolimus|sirolimus|mesh-list
44298792|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44298793|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298794|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44298795|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298796|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
44298797|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298798|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
44154506|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154507|NCT00223769|Oxandrolone|oxandrolone|mesh-list
44154508|NCT00223769|Androgens|androgens|mesh-ancestor
44154509|NCT00223769|Hormones|hormones|mesh-ancestor
44154510|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154511|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154512|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
44154513|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44154514|NCT00223860|Hormones|hormones|mesh-list
44154515|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44154516|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154517|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154518|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44154519|NCT00223925|Maribavir|maribavir|mesh-list
44154520|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
44154521|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154522|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
44154523|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
44154524|NCT00223938|Hematinics|hematinics|mesh-ancestor
44154525|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
44154526|NCT00223964|Hematinics|hematinics|mesh-ancestor
44154527|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
44154529|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
44154530|NCT00224081|Hematinics|hematinics|mesh-ancestor
44154531|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44154532|NCT00224094|Estrogens|estrogens|mesh-ancestor
44154533|NCT00224094|Hormones|hormones|mesh-ancestor
44154534|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154535|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154536|NCT00224146|Oxybutynin|oxybutynin|mesh-list
44154537|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
44154538|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
44298799|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298800|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44298801|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
44298802|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298803|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44298804|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44298805|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298806|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298807|NCT00818701|Urological Agents|urological agents|mesh-ancestor
44298808|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
44298809|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298810|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44298811|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44298812|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44298813|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298814|NCT00818870|Omeprazole|omeprazole|mesh-list
44298815|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44298816|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298817|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44298818|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298819|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298820|NCT00819000|Interferon-beta|interferon-beta|mesh-list
44298821|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
44298822|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
44298823|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
44298824|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44298825|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
44298826|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298827|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298828|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298829|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298843|NCT00819078|Bupropion|bupropion|mesh-list
44298844|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44298845|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
44298846|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44298847|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44298848|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44298849|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298850|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298851|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
44298852|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298853|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298854|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44298855|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44298856|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298857|NCT00819104|Metoprolol|metoprolol|mesh-list
44298858|NCT00819104|Amlodipine|amlodipine|mesh-list
44298859|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44298860|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298861|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298862|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298863|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44298864|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298865|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298866|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44298867|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
44298868|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
44298869|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298870|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43720701|NCT02628197|Vitamins|vitamins|mesh-ancestor
44154539|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154540|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154541|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44154542|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44154543|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
44154544|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154545|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154546|NCT00224146|Urological Agents|urological agents|mesh-ancestor
44154547|NCT00224185|Dimercaprol|dimercaprol|mesh-list
44154548|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
44154549|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
44298871|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44298872|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44298874|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298875|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
44298876|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
44298877|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44298878|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
44298879|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298880|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298881|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298882|NCT00819325|Pioglitazone|pioglitazone|mesh-list
44298883|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44298884|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298885|NCT00819351|Asparaginase|asparaginase|mesh-list
44298886|NCT00819351|Pegaspargase|pegaspargase|mesh-list
44298887|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298888|NCT00819377|Milrinone|milrinone|mesh-list
44298889|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44298890|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44298891|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298892|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44298893|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44298894|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298895|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298896|NCT00819377|Protective Agents|protective agents|mesh-ancestor
44298897|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465330|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44465331|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44465332|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465333|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44465334|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44465335|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44465336|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44465337|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44465338|NCT01479374|Analgesics|analgesics|mesh-ancestor
44154550|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465339|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
44465340|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465341|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465342|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465343|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44465344|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44465345|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44465346|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44465347|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
44465348|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
44465349|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465350|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465351|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
44465352|NCT01478971|Hematinics|hematinics|mesh-ancestor
44465353|NCT01478828|Lovastatin|lovastatin|mesh-list
44465354|NCT01478828|L 647318|l 647318|mesh-list
44465355|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
44465356|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44465357|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44465358|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
44298898|NCT00819468|Teduglutide|teduglutide|mesh-list
44298899|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44298900|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44298901|NCT00819468|Protective Agents|protective agents|mesh-ancestor
44298902|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298904|NCT00819520|Malathion|malathion|mesh-list
44298905|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44298906|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44298907|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44298908|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720748|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
44119369|NCT00117364|Sacchachitin|sacchachitin|mesh-list
44119370|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
44119371|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119372|NCT00117364|Protective Agents|protective agents|mesh-ancestor
44119373|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119374|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
44119378|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
44119379|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119380|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119381|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119382|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119383|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
44119384|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119385|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
44119386|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44298909|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298910|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
44298911|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298912|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298913|NCT00819572|Antibodies|antibodies|mesh-list
44298914|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
44298915|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
44298916|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298917|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
44298918|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44298919|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
44298920|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298921|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298922|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44298923|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44298924|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44298925|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
44298926|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298927|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298928|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44298929|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298930|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
44298931|NCT00819676|Protective Agents|protective agents|mesh-ancestor
44298932|NCT00819728|Docetaxel|docetaxel|mesh-list
44298933|NCT00819728|Irinotecan|irinotecan|mesh-list
44298934|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298935|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
44298936|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
44298937|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
44298938|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298939|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44119387|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119388|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119389|NCT00117403|Vitamins|vitamins|mesh-list
44119390|NCT00117403|Vitamin E|vitamin e|mesh-list
44119391|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
44119392|NCT00117403|Ubiquinone|ubiquinone|mesh-list
44119393|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
44119394|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119395|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
44119396|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119397|NCT00117403|Protective Agents|protective agents|mesh-ancestor
44119398|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
44119399|NCT00117442|Paclitaxel|paclitaxel|mesh-list
44298940|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44298941|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298943|NCT00819754|Capecitabine|capecitabine|mesh-list
44298944|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
44298945|NCT00819754|Irinotecan|irinotecan|mesh-list
44298946|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44298947|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298948|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44298949|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44298950|NCT00819754|Growth Substances|growth substances|mesh-ancestor
44298951|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298952|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
44298953|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44298954|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
44298955|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298956|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44298957|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44298958|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298959|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
44298960|NCT00819806|Vaccines|vaccines|mesh-list
44298961|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
44298962|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298963|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44298964|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44298965|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44298966|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
44298967|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298968|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44298969|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44298970|NCT00819845|Carvedilol|carvedilol|mesh-list
44298971|NCT00819845|Ramipril|ramipril|mesh-list
44119400|NCT00117442|Carboplatin|carboplatin|mesh-list
44119401|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44119402|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119403|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44119404|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44119405|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119406|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119407|NCT00117455|Lenograstim|lenograstim|mesh-list
44119408|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44119409|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
44119410|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298972|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43953746|NCT01231399|Leucovorin|leucovorin|mesh-list
44298973|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44298974|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44298975|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
44298976|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44298977|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44298978|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298979|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44298980|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
44298981|NCT00819845|Protective Agents|protective agents|mesh-ancestor
44298982|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44298983|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44298984|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44298985|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44298986|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44298987|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44298988|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44298989|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44298990|NCT00819962|Bupivacaine|bupivacaine|mesh-list
44298991|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
44298992|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
44298993|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44298994|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44298995|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
44298996|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44298997|NCT00819975|Caseins|caseins|mesh-list
44298998|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
44298999|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
44299001|NCT00819988|Pregabalin|pregabalin|mesh-list
44299014|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299015|NCT00820053|Epirubicin|epirubicin|mesh-list
44299016|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
44299017|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299018|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299019|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299020|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299021|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299022|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299023|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44299024|NCT00820092|Hormones|hormones|mesh-ancestor
44299025|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299026|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299027|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44299028|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44299029|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44299030|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44299031|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299032|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299033|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
44299034|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299035|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44299036|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44299037|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44299038|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44299061|NCT00820417|Gefitinib|gefitinib|mesh-list
44299062|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299063|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299064|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44299065|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299066|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299067|NCT00820469|Rituximab|rituximab|mesh-list
44299068|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299069|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299070|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
44299071|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299072|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299073|NCT00820482|Menotropins|menotropins|mesh-list
44299074|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44299075|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
44299076|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44299077|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299078|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
44299079|NCT00820547|Bevacizumab|bevacizumab|mesh-list
44299080|NCT00820547|Docetaxel|docetaxel|mesh-list
44299081|NCT00820547|Fluorouracil|fluorouracil|mesh-list
44299082|NCT00820547|Epirubicin|epirubicin|mesh-list
44299083|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299084|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
44299085|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299086|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299087|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299088|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
44299089|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299090|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299091|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44299092|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299093|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44299094|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119411|NCT00117468|Progesterone|progesterone|mesh-list
44119412|NCT00117468|Progestins|progestins|mesh-ancestor
44119413|NCT00117468|Hormones|hormones|mesh-ancestor
43701838|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299095|NCT00820547|Growth Substances|growth substances|mesh-ancestor
44299096|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
44299097|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299098|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299099|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299100|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
44299101|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44299102|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299103|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299104|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299105|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299107|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
44299108|NCT00820690|Doxorubicin|doxorubicin|mesh-list
44299109|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44299110|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299111|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299112|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299113|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299114|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299115|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299116|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
44299117|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299118|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299119|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299120|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
44299121|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44299122|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299123|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720878|NCT02627248|Epirubicin|epirubicin|mesh-list
44119414|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119415|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119416|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44119417|NCT00117494|Pravastatin|pravastatin|mesh-list
44119418|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44119419|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44119420|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
44119421|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119422|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44119423|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44119424|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119426|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44119427|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701839|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
44299124|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299125|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299126|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44299127|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299128|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
44299129|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
44299130|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299131|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299132|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299133|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
44299134|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299135|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299136|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299137|NCT00820885|Teduglutide|teduglutide|mesh-list
44299138|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299139|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44299140|NCT00820885|Protective Agents|protective agents|mesh-ancestor
44299141|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299142|NCT00820911|Cyclosporine|cyclosporine|mesh-list
44299143|NCT00820911|Everolimus|everolimus|mesh-list
44299144|NCT00820911|Cyclosporins|cyclosporins|mesh-list
44299145|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299146|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299147|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299148|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
44299149|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299150|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
44299151|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299152|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
44299153|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299154|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44299155|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299156|NCT00820963|Temozolomide|temozolomide|mesh-list
44299157|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299158|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
44299161|NCT00821028|Paclitaxel|paclitaxel|mesh-list
44299163|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299164|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299165|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299166|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299167|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299168|NCT00821054|Lapatinib|lapatinib|mesh-list
44299169|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299170|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44299171|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299172|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299173|NCT00821080|Sirolimus|sirolimus|mesh-list
44299174|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299175|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299176|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299177|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299178|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
44299179|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299180|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
44299181|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299182|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44299183|NCT00821158|Antioxidants|antioxidants|mesh-list
44299184|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299185|NCT00821158|Protective Agents|protective agents|mesh-ancestor
44299186|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299187|NCT00821262|Propofol|propofol|mesh-list
44299188|NCT00821262|Sevoflurane|sevoflurane|mesh-list
44299189|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44299190|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299191|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299192|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44465367|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465368|NCT01478594|Growth Substances|growth substances|mesh-ancestor
44465369|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465370|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465371|NCT01478321|Bevacizumab|bevacizumab|mesh-list
44465372|NCT01478321|Temozolomide|temozolomide|mesh-list
44465373|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465374|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465375|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465376|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465377|NCT01478321|Growth Substances|growth substances|mesh-ancestor
44465378|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465379|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465380|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44465381|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
44465382|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465383|NCT01478113|Amphetamine|amphetamine|mesh-list
44465384|NCT01478113|Adderall|adderall|mesh-list
44465385|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
44465386|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44465387|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465388|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
44465389|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
44465390|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465391|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
44465392|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465393|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465394|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
44465395|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44465396|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44465397|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465398|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44465399|NCT01478048|Dexamethasone|dexamethasone|mesh-list
44465408|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465409|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465410|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
44465411|NCT01478048|Hormones|hormones|mesh-ancestor
44465412|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465413|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44465414|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465415|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465416|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465417|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465418|NCT01477892|Remifentanil|remifentanil|mesh-list
44465419|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44465420|NCT01477892|Narcotics|narcotics|mesh-ancestor
44465421|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465422|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465423|NCT01477892|Analgesics|analgesics|mesh-ancestor
44465424|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
44465425|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465426|NCT01477853|Metformin|metformin|mesh-list
44465427|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44465428|NCT01477853|Glimepiride|glimepiride|mesh-list
44465429|NCT01477853|Atorvastatin|atorvastatin|mesh-list
44465430|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465431|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465432|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44299197|NCT00821301|Fluphenazine|fluphenazine|mesh-list
44299198|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
44299199|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44299200|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44299201|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299202|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299203|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299204|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299205|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44299206|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
44299207|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299210|NCT00821392|Febuxostat|febuxostat|mesh-list
44299212|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299213|NCT00821444|Ziprasidone|ziprasidone|mesh-list
44299214|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44299215|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
44299216|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299217|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299218|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299219|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44299220|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299221|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299222|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299223|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44299224|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
44299225|NCT00821457|Mitogens|mitogens|mesh-list
44299226|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299227|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299228|NCT00821483|Frovatriptan|frovatriptan|mesh-list
44299229|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44299230|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
44299231|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299232|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299233|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299234|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44299235|NCT00821496|Norethindrone|norethindrone|mesh-list
44299236|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
44299237|NCT00821496|Norinyl|norinyl|mesh-list
44299238|NCT00821496|Estradiol|estradiol|mesh-list
44299239|NCT00821496|Estrogens|estrogens|mesh-ancestor
44299240|NCT00821496|Hormones|hormones|mesh-ancestor
44299241|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299242|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299243|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44299244|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
44299245|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44299250|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44299251|NCT00821535|Maraviroc|maraviroc|mesh-list
44299252|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44299253|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44299254|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299255|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44299256|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44299257|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
44299258|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299259|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44299260|NCT00821574|Valsartan|valsartan|mesh-list
44299261|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44299262|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299263|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44299264|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44299265|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299266|NCT00821574|Diuretics|diuretics|mesh-ancestor
44299267|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
44299268|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299269|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44299270|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299271|NCT00821600|Risperidone|risperidone|mesh-list
44299272|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44299273|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
44299274|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299275|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299276|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299277|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44299278|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299279|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299280|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299281|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44119428|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44119429|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119430|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119431|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44119432|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44119433|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
44119434|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299282|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
44299283|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44299284|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
44299285|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44299286|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
44299287|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299288|NCT00821782|Azithromycin|azithromycin|mesh-list
44299289|NCT00821782|Levofloxacin|levofloxacin|mesh-list
44299290|NCT00821782|Ofloxacin|ofloxacin|mesh-list
44299291|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299292|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299293|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44299294|NCT00821782|Renal Agents|renal agents|mesh-ancestor
44299295|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299296|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299297|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299298|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299299|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299300|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44299301|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299302|NCT00821834|Ticlopidine|ticlopidine|mesh-list
44299303|NCT00821834|Clopidogrel|clopidogrel|mesh-list
44299304|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299305|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44299306|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44299307|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44299308|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
44299309|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299310|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299311|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299312|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44299313|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44299316|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299323|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299324|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44299325|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
44299327|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44299328|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299329|NCT00822055|Timolol|timolol|mesh-list
44299330|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44299331|NCT00822055|Dorzolamide|dorzolamide|mesh-list
44299332|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
44299333|NCT00822055|Maleic acid|maleic acid|mesh-list
44299334|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44299335|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44299336|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44299337|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299338|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299339|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299340|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299341|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299342|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299343|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44299344|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44299345|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44299346|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44299347|NCT00822081|Timolol|timolol|mesh-list
44299348|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44299349|NCT00822081|Dorzolamide|dorzolamide|mesh-list
44299351|NCT00822081|Maleic acid|maleic acid|mesh-list
44299368|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
44299369|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299370|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299371|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
44299372|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299373|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299374|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44299375|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44299376|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299377|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299378|NCT00822133|Analgesics|analgesics|mesh-ancestor
44299379|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44299380|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44299381|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
44299382|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44299383|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44299384|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299385|NCT00822211|Vildagliptin|vildagliptin|mesh-list
44299386|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44299387|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299388|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44299389|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44299390|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299391|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299392|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
44299393|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44299394|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
44299395|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299396|NCT00822263|Expectorants|expectorants|mesh-ancestor
44299397|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
44299398|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44299399|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
44299400|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299401|NCT00822263|Protective Agents|protective agents|mesh-ancestor
44299402|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119435|NCT00117533|Ribavirin|ribavirin|mesh-list
44119436|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
44119437|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
44299404|NCT00822315|Efavirenz|efavirenz|mesh-list
44299405|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
44299406|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44299407|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44299408|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299409|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299410|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
44299411|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299412|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44299413|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299414|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44299415|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44299416|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44299417|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44299418|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44299419|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44299420|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44299421|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44299422|NCT00822380|Iron|iron|mesh-list
44299423|NCT00822380|Trace Elements|trace elements|mesh-list
44299424|NCT00822380|Folic Acid|folic acid|mesh-list
44299425|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
44299426|NCT00822380|Micronutrients|micronutrients|mesh-list
44299427|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299428|NCT00822380|Hematinics|hematinics|mesh-ancestor
44299429|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
44299430|NCT00822380|Vitamins|vitamins|mesh-ancestor
44299431|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
44299432|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299433|NCT00822380|Protective Agents|protective agents|mesh-ancestor
44299434|NCT00822393|Busulfan|busulfan|mesh-list
44299435|NCT00822393|Treosulfan|treosulfan|mesh-list
44299436|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
44299446|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
44299447|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
44299448|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299449|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299450|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
44299451|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299452|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299453|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44299454|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44299455|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299456|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299457|NCT00822419|Analgesics|analgesics|mesh-ancestor
44299458|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44299459|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44299460|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
44299461|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44299462|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44299463|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299464|NCT00822536|Aspirin|aspirin|mesh-list
44299465|NCT00822536|Clopidogrel|clopidogrel|mesh-list
44299466|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44299467|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44299468|NCT00822536|Analgesics|analgesics|mesh-ancestor
44299469|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
44299470|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299471|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299472|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44299473|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299474|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44299475|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44299476|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558979|NCT04521335|Copper|copper|mesh-list
44299485|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299486|NCT00822549|Morphine|morphine|mesh-list
44299487|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44299488|NCT00822549|Narcotics|narcotics|mesh-ancestor
44299489|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299490|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299491|NCT00822549|Analgesics|analgesics|mesh-ancestor
44299492|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
44299493|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954339|NCT01247363|Globalagliatin|globalagliatin|mesh-list
44299494|NCT00822614|Fentanyl|fentanyl|mesh-list
44299496|NCT00822614|Oxycodone|oxycodone|mesh-list
44299497|NCT00822614|Hydromorphone|hydromorphone|mesh-list
44299498|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44299499|NCT00822614|Narcotics|narcotics|mesh-ancestor
44299500|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299501|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299502|NCT00822614|Analgesics|analgesics|mesh-ancestor
44299503|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
44299504|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299505|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44299506|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44299507|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
44299508|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
44299509|NCT00822666|Clopidogrel|clopidogrel|mesh-list
44299510|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299511|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44299512|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44299513|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44299514|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
44299515|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299516|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299517|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299518|NCT00822744|Citalopram|citalopram|mesh-list
44299519|NCT00822744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44299524|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
44299525|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299526|NCT00822744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44299527|NCT00822744|Antidepressive Agents|antidepressive agents|mesh-ancestor
44299528|NCT00822744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299529|NCT00822783|Omalizumab|omalizumab|mesh-list
44299530|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44299531|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44299532|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
44299533|NCT00822809|Prednisolone|prednisolone|mesh-list
44299534|NCT00822809|Catumaxomab|catumaxomab|mesh-list
44299535|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44299536|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
44299537|NCT00822809|Hormones|hormones|mesh-ancestor
44299538|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299539|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299540|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44299541|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299542|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299543|NCT00822848|Sorafenib|sorafenib|mesh-list
44299544|NCT00822848|Epirubicin|epirubicin|mesh-list
44299545|NCT00822848|Ifosfamide|ifosfamide|mesh-list
44299546|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299547|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44299548|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299549|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299550|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299551|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299552|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299553|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299554|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
44299555|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44299556|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44299557|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44299558|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299561|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299562|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299563|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
44299564|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299566|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
44299567|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
44299568|NCT00823004|Buserelin|buserelin|mesh-list
44299569|NCT00823004|Ganirelix|ganirelix|mesh-list
44299570|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299571|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44299572|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44299573|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299574|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299575|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44299576|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44299577|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299578|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299579|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44299580|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44299581|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44299582|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
44465433|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44465434|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
44465435|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465436|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44465437|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44465438|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465439|NCT01477853|Incretins|incretins|mesh-ancestor
44465440|NCT01477853|Hormones|hormones|mesh-ancestor
44465443|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465453|NCT01476475|Metformin|metformin|mesh-list
44465454|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
44465455|NCT01476475|Lixisenatide|lixisenatide|mesh-list
44465456|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465457|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465458|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44465459|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
44465460|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465461|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44465462|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44465463|NCT01475825|Mipomersen|mipomersen|mesh-list
44465464|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44465465|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44465466|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
44465467|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465468|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44465469|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
44465470|NCT01475734|Incretins|incretins|mesh-ancestor
44465471|NCT01475734|Hormones|hormones|mesh-ancestor
44465472|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465473|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465474|NCT01475721|Fluticasone|fluticasone|mesh-list
44465475|NCT01475721|Xhance|xhance|mesh-list
44465476|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44465477|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44465478|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
44465479|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465480|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465481|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465482|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465483|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
44119438|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119439|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
44119440|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119441|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119442|NCT00117546|Methyldopa|methyldopa|mesh-list
44119443|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44119444|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
44119445|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
44119446|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119447|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119452|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701840|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44465484|NCT01475721|Hormones|hormones|mesh-ancestor
44465485|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465486|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
44465487|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465488|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465489|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44465490|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44465491|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465492|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465493|NCT01475461|Incretins|incretins|mesh-ancestor
44299583|NCT00823030|Lidocaine|lidocaine|mesh-list
44299584|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
44299585|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
44299586|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299587|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299588|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
44299589|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299590|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299591|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44299592|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44299593|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299594|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299595|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44299596|NCT00823121|Buserelin|buserelin|mesh-list
44299597|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44299598|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299599|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44299600|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
44299601|NCT00823186|Paclitaxel|paclitaxel|mesh-list
44299602|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44299603|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299604|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299605|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299606|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299633|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299634|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299635|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299636|NCT00823433|Penicillins|penicillins|mesh-list
44299637|NCT00823433|Penicillin V|penicillin v|mesh-list
44299638|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299639|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299640|NCT00823550|Lamivudine|lamivudine|mesh-list
44299641|NCT00823550|Entecavir|entecavir|mesh-list
44299642|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44299643|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44299644|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832866|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119453|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119454|NCT00117611|Omalizumab|omalizumab|mesh-list
44119455|NCT00117611|Antibodies|antibodies|mesh-list
44119456|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
44119457|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119458|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44119459|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119460|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119461|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
44299645|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299646|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
44299647|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299648|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44299649|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44299650|NCT00823602|Buserelin|buserelin|mesh-list
44299651|NCT00823602|Ganirelix|ganirelix|mesh-list
44299652|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
44299653|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299654|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299655|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44299656|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
44299657|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44299658|NCT00823641|Infliximab|infliximab|mesh-list
44299659|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
44299660|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299661|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299662|NCT00823849|Cilostazol|cilostazol|mesh-list
44299663|NCT00823849|Probucol|probucol|mesh-list
44299664|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44299665|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
44299666|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299667|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299668|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44299669|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
44299670|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44299671|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44299672|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299673|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299674|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
44299675|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44299676|NCT00823849|Protective Agents|protective agents|mesh-ancestor
44299677|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44299678|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44299679|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299680|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44299684|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
44299685|NCT00823862|Ribavirin|ribavirin|mesh-list
44299686|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
44299687|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299688|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
44299689|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299690|NCT00823875|Cilostazol|cilostazol|mesh-list
44299691|NCT00823875|Probucol|probucol|mesh-list
44299692|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44299693|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
44299694|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299695|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299696|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44299697|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44299698|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44299699|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44299700|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299701|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44299702|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
44299703|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44299704|NCT00823875|Protective Agents|protective agents|mesh-ancestor
44299705|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44299706|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44299707|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299708|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44299709|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44299710|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
44299711|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44299712|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
44299713|NCT00823940|Glucagon|glucagon|mesh-list
44299714|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44299715|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299716|NCT00823940|Hormones|hormones|mesh-ancestor
44119462|NCT00117624|Hematinics|hematinics|mesh-ancestor
44119463|NCT00117663|Hormones|hormones|mesh-list
44119464|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119465|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119466|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
44119467|NCT00117689|Tacrolimus|tacrolimus|mesh-list
44119468|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
44119469|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44119470|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119471|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
44119472|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299717|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299718|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299719|NCT00823940|Incretins|incretins|mesh-ancestor
44299720|NCT00824057|Midazolam|midazolam|mesh-list
44299721|NCT00824057|Caffeine|caffeine|mesh-list
44299722|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44299723|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44299724|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299725|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299726|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44299727|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299728|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299729|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44299730|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
44299731|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
44299732|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
44299733|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
44299734|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299735|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299736|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44299737|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44299738|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299739|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44299740|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44299741|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
44299742|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
44299743|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44299744|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
44299746|NCT00824135|Melphalan|melphalan|mesh-list
44299747|NCT00824135|Thiotepa|thiotepa|mesh-list
44299748|NCT00824135|Clofarabine|clofarabine|mesh-list
44299749|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
44299750|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299751|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299752|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
44299753|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299754|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299756|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44299757|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
44299758|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44299759|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299760|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299761|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299762|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299763|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
44299764|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44299765|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299766|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44299767|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
44299768|NCT00824200|Tamsulosin|tamsulosin|mesh-list
44299769|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
44299770|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
44299771|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44299772|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44299773|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299774|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299775|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299776|NCT00824200|Urological Agents|urological agents|mesh-ancestor
44299777|NCT00824239|Fentanyl|fentanyl|mesh-list
44299778|NCT00824239|Midazolam|midazolam|mesh-list
44299779|NCT00824239|Propofol|propofol|mesh-list
44299780|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44299781|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299782|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299783|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44299784|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
44299785|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
44299786|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44299787|NCT00824239|Narcotics|narcotics|mesh-ancestor
44299788|NCT00824239|Analgesics|analgesics|mesh-ancestor
44299789|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
44299790|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299791|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44299792|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44299794|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299795|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
44299796|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
44299797|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299798|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299799|NCT00824317|Methylphenidate|methylphenidate|mesh-list
44299800|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44299801|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299802|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44299803|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44299804|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299805|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299806|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
44299807|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299808|NCT00824668|Insulin|insulin|mesh-list
44299809|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44299810|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
44299811|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
44299813|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44299814|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
44299815|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44299816|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299817|NCT00824707|Entecavir|entecavir|mesh-list
44299818|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
44299819|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299820|NCT00824785|Capecitabine|capecitabine|mesh-list
44299821|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
44299822|NCT00824785|Epirubicin|epirubicin|mesh-list
44299823|NCT00824785|Panitumumab|panitumumab|mesh-list
44299824|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44299825|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
43721287|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44119473|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44119474|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119475|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119476|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44119477|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119478|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44119479|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
44119480|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44119481|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299826|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299827|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299828|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299829|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44299830|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44299831|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299832|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299833|NCT00824811|Fluorometholone|fluorometholone|mesh-list
44299834|NCT00824811|Cyclosporine|cyclosporine|mesh-list
44299835|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44299836|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
44299837|NCT00824811|Cyclosporins|cyclosporins|mesh-list
44299838|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299839|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299840|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299841|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
44299842|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299843|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
44299844|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299845|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44299846|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299847|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44299848|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44299849|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44299850|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
44299851|NCT00824811|Hormones|hormones|mesh-ancestor
44119482|NCT00117702|Everolimus|everolimus|mesh-list
44119483|NCT00117702|Tacrolimus|tacrolimus|mesh-list
44119484|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119485|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
44119486|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119487|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44119488|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119489|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119490|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119491|NCT00117728|Nevirapine|nevirapine|mesh-list
44119492|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44119493|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44119494|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119495|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119496|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
44119497|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119498|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44119499|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44119500|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44119501|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44119502|NCT00117754|Terbinafine|terbinafine|mesh-list
44119503|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
44119504|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119505|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299852|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299853|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44299854|NCT00824863|Ketoconazole|ketoconazole|mesh-list
44299855|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
44299856|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44299857|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44299858|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299859|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299860|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299861|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44299862|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
44299863|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299864|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299865|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44465494|NCT01475461|Hormones|hormones|mesh-ancestor
44465495|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465496|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44465497|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
44465498|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465499|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465500|NCT01475331|Ethanol|ethanol|mesh-list
44465501|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44465502|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465503|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465504|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465505|NCT01475253|Lidocaine|lidocaine|mesh-list
44465506|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
44465507|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
44465508|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465509|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465510|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
44465512|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299870|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299871|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299872|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299873|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
44299874|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648004|NCT04975152|Cemiplimab|cemiplimab|mesh-list
44299875|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44299876|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
44299877|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299878|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44299879|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299880|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299881|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44299882|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44299883|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
44299884|NCT00825045|Risperidone|risperidone|mesh-list
44299885|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44299886|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
44299887|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299888|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299889|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299890|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44299891|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44299892|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44299893|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299894|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44299895|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
44119506|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119507|NCT00117767|Terbinafine|terbinafine|mesh-list
44119508|NCT00117767|Griseofulvin|griseofulvin|mesh-list
44119509|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
44119510|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119511|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119512|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119513|NCT00117780|Insulin|insulin|mesh-list
44119514|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44119515|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
44119516|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
44119517|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119518|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119519|NCT00117832|Azelastine|azelastine|mesh-list
44119524|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119525|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119526|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44119527|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119528|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119529|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44299897|NCT00825058|Amibegron|amibegron|mesh-list
44299898|NCT00825058|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44299899|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44299900|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299901|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299902|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299903|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
44299904|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299905|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44299906|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
44299907|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44299908|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44299909|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44299910|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44299911|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44299912|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44299913|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44299914|NCT00825071|Dexamethasone|dexamethasone|mesh-list
44299915|NCT00825071|Ondansetron|ondansetron|mesh-list
44299916|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44299917|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
44299918|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
44299919|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299920|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299921|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44299922|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
44299923|NCT00825071|Hormones|hormones|mesh-ancestor
44299925|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44299941|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299942|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
44299943|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299944|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299946|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44299947|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299948|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
44299949|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
44299950|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44299951|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299952|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44299953|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44299954|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44299955|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
44299956|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44299957|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299958|NCT00825149|Prednisone|prednisone|mesh-list
44299959|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
44299960|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44299961|NCT00825149|Doxorubicin|doxorubicin|mesh-list
44299962|NCT00825149|Fludarabine|fludarabine|mesh-list
44299963|NCT00825149|Vincristine|vincristine|mesh-list
44299964|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
44299965|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44299966|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
44299967|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299968|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44299969|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44299970|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
44299971|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299972|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44299973|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44299974|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44299981|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44299982|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44299983|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44299984|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44299985|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44299986|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44299987|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44299989|NCT00825188|Eplerenone|eplerenone|mesh-list
44299990|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44299991|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44299992|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44299993|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44299994|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44299995|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44299996|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
44299997|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44299998|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
44299999|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300000|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44300001|NCT00825188|Diuretics|diuretics|mesh-ancestor
44300002|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
44300003|NCT00825201|Paclitaxel|paclitaxel|mesh-list
44300004|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44300005|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44300006|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300007|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
44300011|NCT00825253|Insulin|insulin|mesh-list
44300024|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300025|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
44300026|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300027|NCT00825552|Risperidone|risperidone|mesh-list
44300028|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44300029|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
44300030|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300031|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300032|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300033|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44300034|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300035|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300036|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300037|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44300038|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
44300039|NCT00825591|Melatonin|melatonin|mesh-list
44300040|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
44300041|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300042|NCT00825591|Protective Agents|protective agents|mesh-ancestor
44300043|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300044|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300045|NCT00825617|Hormones|hormones|mesh-list
44300046|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300047|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300048|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
44300049|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44300050|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300051|NCT00825656|Capsaicin|capsaicin|mesh-list
44300052|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
44119530|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44119531|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44119532|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
44119533|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
44119534|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119535|NCT00117897|Lenograstim|lenograstim|mesh-list
44119536|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44119537|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
44119538|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119539|NCT00117936|Mitogens|mitogens|mesh-list
44119540|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119541|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119542|NCT00117975|Galiximab|galiximab|mesh-list
44119543|NCT00117975|Rituximab|rituximab|mesh-list
44119544|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44119545|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300053|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300054|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
44300055|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300056|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300057|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44300058|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44300060|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44300061|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
44300062|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300063|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300064|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44300065|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44300066|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
44300067|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300068|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300069|NCT00825864|Dexamethasone|dexamethasone|mesh-list
44300070|NCT00825864|Diclofenac|diclofenac|mesh-list
44300071|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
44300072|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44300073|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44300074|NCT00825864|BB 1101|bb 1101|mesh-list
44300075|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300076|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
44300077|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
44300078|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300079|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300080|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44300081|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
44300082|NCT00825864|Hormones|hormones|mesh-ancestor
44300083|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300084|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44119546|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
44119547|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119548|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119549|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119550|NCT00118014|Sertraline|sertraline|mesh-list
44119551|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
44119552|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119553|NCT00118014|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44119554|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44119555|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701841|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44300085|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300086|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44300087|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44300088|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300090|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
44300091|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300092|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44300093|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300094|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300095|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
44300096|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44300097|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44300098|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
44300099|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300100|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
44300101|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300102|NCT00826163|Budesonide|budesonide|mesh-list
44300103|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300104|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300105|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
44300106|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300107|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300108|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300109|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300110|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
44119556|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119557|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119558|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
44119559|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119560|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
44119561|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
44119562|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44119563|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
44119564|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119565|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119566|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119567|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44119568|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119569|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119570|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44119571|NCT00118027|Renal Agents|renal agents|mesh-ancestor
44119572|NCT00118066|Calcitriol|calcitriol|mesh-list
44119573|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44119574|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119575|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44119576|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44119577|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119578|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44119579|NCT00118066|Vitamins|vitamins|mesh-ancestor
44300111|NCT00826163|Hormones|hormones|mesh-ancestor
44300112|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300113|NCT00826254|Vitamins|vitamins|mesh-list
44300114|NCT00826254|Vitamin K|vitamin k|mesh-list
44300115|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
44300116|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300117|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44300118|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44300119|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300120|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
44300121|NCT00826254|Coagulants|coagulants|mesh-ancestor
44300122|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
44300123|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44300124|NCT00826306|Protective Agents|protective agents|mesh-ancestor
44300125|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300126|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300127|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44300128|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44300129|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44300130|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
44300131|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300132|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44300133|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44300134|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300135|NCT00826371|Ranibizumab|ranibizumab|mesh-list
44300136|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44300137|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44300138|NCT00826371|Growth Substances|growth substances|mesh-ancestor
44300139|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300140|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44300156|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300157|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300158|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44300160|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
44300161|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300162|NCT00826553|Analgesics|analgesics|mesh-ancestor
44300163|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
44300164|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300165|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44300166|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44300167|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44300168|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
44300169|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300170|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300171|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44300172|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44300173|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300174|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300175|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
44300176|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
44300177|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
44300178|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
44300179|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
44300180|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44300181|NCT00826566|Caffeine|caffeine|mesh-list
44300182|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44300183|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300203|NCT00826657|Vitamins|vitamins|mesh-ancestor
44300204|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
44300205|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300206|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
44300207|NCT00826657|Hematinics|hematinics|mesh-ancestor
44300208|NCT00826722|Levetiracetam|levetiracetam|mesh-list
44300209|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
44300210|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
44300211|NCT00826787|Levetiracetam|levetiracetam|mesh-list
44300212|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
44300213|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
44300214|NCT00826826|Amiodarone|amiodarone|mesh-list
44300215|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44300216|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
44300217|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44300218|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44300219|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300220|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44300221|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44300222|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44300223|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300224|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44300225|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44300226|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44300227|NCT00826839|Leuprolide|leuprolide|mesh-list
44300228|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
44300229|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
44300230|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44300231|NCT00826839|Ganirelix|ganirelix|mesh-list
44300232|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300233|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832892|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
44119580|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
44119581|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44119582|NCT00118105|Bevacizumab|bevacizumab|mesh-list
44119583|NCT00118105|Capecitabine|capecitabine|mesh-list
44119584|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
44119585|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44119586|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119587|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44119588|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119589|NCT00118105|Growth Substances|growth substances|mesh-ancestor
44119593|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
44119594|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300234|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44300235|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
44300236|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44300237|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300238|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44300239|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
44300240|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300242|NCT00826852|Docetaxel|docetaxel|mesh-list
44300243|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300244|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
44300245|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
44300246|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
44300247|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300248|NCT00826865|Levetiracetam|levetiracetam|mesh-list
44300249|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
44300250|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
44300251|NCT00826891|Cisplatin|cisplatin|mesh-list
44300252|NCT00826891|Topotecan|topotecan|mesh-list
44300253|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300254|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44300255|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44300256|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300257|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300258|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
44300259|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
44300260|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300261|NCT00826930|Protective Agents|protective agents|mesh-ancestor
44300262|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300263|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44300264|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300265|NCT00826969|Ciclesonide|ciclesonide|mesh-list
44300266|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
44300267|NCT00826969|Hormones|hormones|mesh-ancestor
44119596|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119597|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119598|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119599|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119600|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44119601|NCT00118183|Cetuximab|cetuximab|mesh-list
44119602|NCT00118183|Docetaxel|docetaxel|mesh-list
44119603|NCT00118183|Bortezomib|bortezomib|mesh-list
44300268|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300269|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300270|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44300271|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
44300273|NCT00827034|Warfarin|warfarin|mesh-list
44300274|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
44300275|NCT00827138|Rebastinib|rebastinib|mesh-list
44300276|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300277|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300278|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300279|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300280|NCT00827151|Estrogens|estrogens|mesh-list
44300281|NCT00827151|Hormones|hormones|mesh-ancestor
44300282|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300283|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300284|NCT00827177|Sorafenib|sorafenib|mesh-list
44300285|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300286|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300287|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300288|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300289|NCT00827216|Erythromycin|erythromycin|mesh-list
44300290|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
44300291|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44300292|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
44300293|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300294|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300295|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44300296|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44300297|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300298|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300299|NCT00827281|Cycloserine|cycloserine|mesh-list
44300300|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44300301|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300302|NCT00827281|Renal Agents|renal agents|mesh-ancestor
43847501|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
44119604|NCT00118183|Antibodies|antibodies|mesh-list
44119605|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
44119606|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44300303|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44300304|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
44300305|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300306|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
44300307|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300308|NCT00827307|Tamoxifen|tamoxifen|mesh-list
44300309|NCT00827307|Goserelin|goserelin|mesh-list
44300310|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44300311|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
44300312|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300313|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300314|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44300315|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300316|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44300317|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44300318|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44300319|NCT00827320|Levetiracetam|levetiracetam|mesh-list
44300320|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
44300321|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
44300322|NCT00827346|Clopidogrel|clopidogrel|mesh-list
44300323|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44300324|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44300325|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44300326|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44300327|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
44300328|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300329|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300330|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300346|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44300347|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300349|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44300350|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44300351|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44300352|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
44300353|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300354|NCT00827450|Caffeine|caffeine|mesh-list
44300355|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44300356|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300357|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44300358|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300359|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300360|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44300361|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44300362|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
44300363|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300364|NCT00827554|Nadroparin|nadroparin|mesh-list
44300365|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
44300366|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44300367|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44300368|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300369|NCT00827580|Eniluracil|eniluracil|mesh-list
44300370|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300371|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300372|NCT00827671|Cetuximab|cetuximab|mesh-list
44300373|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44300374|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300390|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44300391|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44300392|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300393|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300394|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
44300395|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300396|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300397|NCT00827840|Risperidone|risperidone|mesh-list
44300398|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44300399|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44300400|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
44300401|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300402|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300403|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300404|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44300405|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300406|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300407|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300408|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44300409|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
44300410|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44300411|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44300412|NCT00827892|Pioglitazone|pioglitazone|mesh-list
44300413|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44300414|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300415|NCT00827996|Adalimumab|adalimumab|mesh-list
44300416|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300417|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300418|NCT00828087|Cobalt|cobalt|mesh-list
44300419|NCT00828087|Chromium|chromium|mesh-list
44300434|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300435|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
44300436|NCT00828230|Hormones|hormones|mesh-ancestor
44300437|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300438|NCT00828282|Simvastatin|simvastatin|mesh-list
44300439|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44300440|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44300441|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
44300442|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300443|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44300444|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44300445|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300446|NCT00828373|Lidocaine|lidocaine|mesh-list
44300447|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
44300448|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
44300449|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300450|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300451|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
44300452|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300453|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44300454|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44300455|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44300456|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44300457|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300458|NCT00828477|Nepafenac|nepafenac|mesh-list
44300459|NCT00828477|Bromfenac|bromfenac|mesh-list
44300460|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44300461|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300462|NCT00828477|Analgesics|analgesics|mesh-ancestor
44300463|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
44300464|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955274|NCT01280409|Metformin|metformin|mesh-list
44300465|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300466|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300467|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300468|NCT00828503|Valganciclovir|valganciclovir|mesh-list
44300470|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300471|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44300472|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
44300473|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300474|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
44300475|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300476|NCT00828529|Bedaquiline|bedaquiline|mesh-list
44300477|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
44300478|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300479|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300480|NCT00828594|Sorafenib|sorafenib|mesh-list
44300481|NCT00828594|Everolimus|everolimus|mesh-list
44300482|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300483|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300484|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300485|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300486|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44300487|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
44300488|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465513|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44465514|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44465515|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465516|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465517|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44465518|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44465519|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44465520|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465521|NCT01474993|Sulforaphane|sulforaphane|mesh-list
44465522|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44465523|NCT01474993|Protective Agents|protective agents|mesh-ancestor
44465524|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465525|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465526|NCT01474772|Pregabalin|pregabalin|mesh-list
44465527|NCT01474772|Analgesics|analgesics|mesh-ancestor
44465528|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
44465529|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119607|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
44119608|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465530|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465531|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
44465532|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44465533|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465534|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465535|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44465536|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44465537|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44465538|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465539|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465540|NCT01474746|Sertraline|sertraline|mesh-list
44465541|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
44465542|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465543|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44465544|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44465545|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465546|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465547|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465548|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
44465549|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465550|NCT01474551|Vemurafenib|vemurafenib|mesh-list
44465551|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465552|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465553|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465554|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465555|NCT01474538|Insulin|insulin|mesh-list
44465556|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44465557|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
43955341|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44465558|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
44465559|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465560|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300496|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
44300497|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300498|NCT00828776|Heparin|heparin|mesh-list
44300499|NCT00828776|Calcium heparin|calcium heparin|mesh-list
44300500|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
44300501|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44300502|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44300503|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300504|NCT00828789|Tenofovir|tenofovir|mesh-list
44300505|NCT00828789|Efavirenz|efavirenz|mesh-list
44300506|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
44300507|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300508|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44300509|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44300510|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300511|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300512|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44300513|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44300514|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44300515|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44300516|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44300517|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44300518|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44300519|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44300520|NCT00828802|Lenalidomide|lenalidomide|mesh-list
44300521|NCT00828802|Decitabine|decitabine|mesh-list
44300522|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
44300523|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300524|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44300541|NCT00828919|Crizotinib|crizotinib|mesh-list
44300542|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300543|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300544|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300545|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300546|NCT00828958|Risperidone|risperidone|mesh-list
44300547|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44300548|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
44300549|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300550|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300551|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300552|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44300553|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300554|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300555|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300556|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44300557|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
44300558|NCT00828971|Amoxicillin|amoxicillin|mesh-list
44300559|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
44300560|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44300561|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300562|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955355|NCT01284296|Lidocaine|lidocaine|mesh-list
44300563|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44300564|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44300565|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300566|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300567|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300568|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44300569|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
44300570|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300571|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300572|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44300573|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44119609|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300576|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
44300577|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300579|NCT00829023|Chlorhexidine|chlorhexidine|mesh-list
44300580|NCT00829023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44300581|NCT00829023|Povidone-Iodine|povidone-iodine|mesh-list
44300582|NCT00829023|Povidone|povidone|mesh-list
44300583|NCT00829023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44300584|NCT00829023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300585|NCT00829023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300586|NCT00829023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300587|NCT00829023|Disinfectants|disinfectants|mesh-ancestor
44300588|NCT00829023|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300589|NCT00829023|Plasma Substitutes|plasma substitutes|mesh-ancestor
44300590|NCT00829023|Blood Substitutes|blood substitutes|mesh-ancestor
44300591|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44300592|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44300593|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44300594|NCT00829114|Estradiol|estradiol|mesh-list
44300595|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44300596|NCT00829114|Estrogens|estrogens|mesh-ancestor
44300597|NCT00829114|Hormones|hormones|mesh-ancestor
44300598|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300599|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300600|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44300601|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
44300602|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300603|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44300604|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44119610|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
44119611|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
44119612|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119613|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119614|NCT00118196|Azacitidine|azacitidine|mesh-list
44119615|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
44119616|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119617|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
44119618|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119619|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119620|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119621|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44119622|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44119623|NCT00118222|Ether|ether|mesh-list
44119624|NCT00118222|Trioxsalen|trioxsalen|mesh-list
44119625|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119626|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44119627|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44119628|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44300605|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44300606|NCT00829192|Afamelanotide|afamelanotide|mesh-list
44300607|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300608|NCT00829205|Rituximab|rituximab|mesh-list
44300609|NCT00829205|Carboplatin|carboplatin|mesh-list
44300610|NCT00829205|Etoposide|etoposide|mesh-list
44300611|NCT00829205|Ifosfamide|ifosfamide|mesh-list
44300612|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
44300613|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44300614|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300615|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
44300616|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300617|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44300618|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44300619|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44300620|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44300621|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300622|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300623|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44300624|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
44300625|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44300626|NCT00829205|Protective Agents|protective agents|mesh-ancestor
44300627|NCT00829231|Sorafenib|sorafenib|mesh-list
44300628|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300629|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300630|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300631|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300632|NCT00829257|Fluticasone|fluticasone|mesh-list
44300633|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44300634|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300635|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300636|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
43955430|NCT01286259|Disulfiram|disulfiram|mesh-list
44300637|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300638|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300639|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300644|NCT00829257|Hormones|hormones|mesh-ancestor
44300645|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300646|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
44300647|NCT00829322|Modafinil|modafinil|mesh-list
44300648|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44300649|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300650|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44300651|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44300652|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44300653|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300654|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44300655|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
44300656|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300657|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44300658|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44300659|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44300660|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44300661|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44300662|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
44300663|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119629|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
44119630|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
44119631|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44119632|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119633|NCT00118235|Bevacizumab|bevacizumab|mesh-list
44119634|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44119635|NCT00118235|Cisplatin|cisplatin|mesh-list
44119636|NCT00118235|Irinotecan|irinotecan|mesh-list
44119637|NCT00118235|Antibodies|antibodies|mesh-list
44119638|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
44119639|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44119640|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119641|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44119642|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119643|NCT00118235|Growth Substances|growth substances|mesh-ancestor
44119644|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119645|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44119646|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
44119647|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44119648|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44119649|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119650|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119651|NCT00118261|Leucovorin|leucovorin|mesh-list
44119652|NCT00118261|Bevacizumab|bevacizumab|mesh-list
44119653|NCT00118261|Fluorouracil|fluorouracil|mesh-list
44119654|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
44119655|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44119656|NCT00118261|Calcium|calcium|mesh-list
44119657|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
44119658|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44119659|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300664|NCT00829608|Vaccines|vaccines|mesh-list
44300665|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
44300666|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300667|NCT00829634|Methamphetamine|methamphetamine|mesh-list
44300668|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44300669|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300670|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
44300671|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
44300672|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300673|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
44300674|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300675|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300676|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44300677|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44300678|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44300679|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44300680|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44300681|NCT00829647|Lenalidomide|lenalidomide|mesh-list
44300682|NCT00829647|Dasatinib|dasatinib|mesh-list
44300683|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
44300684|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300685|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44300686|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44300687|NCT00829647|Growth Substances|growth substances|mesh-ancestor
44300688|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
44300689|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300690|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300691|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300692|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300693|NCT00829660|Acarbose|acarbose|mesh-list
44300703|NCT00829777|Naloxone|naloxone|mesh-list
44300706|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300708|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955508|NCT01288521|Tacrolimus|tacrolimus|mesh-list
44300709|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44300710|NCT00829881|Betahistine|betahistine|mesh-list
44300711|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
44300712|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
44300713|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
44300714|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300715|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300716|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300717|NCT00829894|Risperidone|risperidone|mesh-list
44300718|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44300719|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
44300720|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300721|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300722|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300723|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44300724|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300725|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300726|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300727|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44300728|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
44300729|NCT00830050|Naproxen|naproxen|mesh-list
44300730|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44300731|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300732|NCT00830050|Analgesics|analgesics|mesh-ancestor
44300733|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
44300734|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300736|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44300748|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300749|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
44300750|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44300751|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
44300752|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300753|NCT00830193|Expectorants|expectorants|mesh-ancestor
44300754|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300755|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44300756|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
44300757|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300758|NCT00830193|Protective Agents|protective agents|mesh-ancestor
44300759|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300760|NCT00830193|Antidotes|antidotes|mesh-ancestor
44300761|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44300762|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300763|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44300764|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300765|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300766|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
44300767|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
44300768|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
44300769|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
44300770|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44300771|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721780|NCT02620800|Vitamins|vitamins|mesh-ancestor
44119660|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44119661|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119662|NCT00118261|Growth Substances|growth substances|mesh-ancestor
44119663|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119669|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119670|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
44119671|NCT00118261|Antidotes|antidotes|mesh-ancestor
44119672|NCT00118261|Protective Agents|protective agents|mesh-ancestor
44119673|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
44119674|NCT00118261|Vitamins|vitamins|mesh-ancestor
44119675|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
44119676|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119677|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119678|NCT00118300|Capecitabine|capecitabine|mesh-list
44119679|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119680|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
44119681|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119682|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119683|NCT00118313|Imiquimod|imiquimod|mesh-list
44119684|NCT00118313|Sargramostim|sargramostim|mesh-list
44119685|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
44119686|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44119687|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
44119688|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119689|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119690|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44119691|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
44300772|NCT00830323|Oseltamivir|oseltamivir|mesh-list
44300773|NCT00830323|Amantadine|amantadine|mesh-list
44300774|NCT00830323|Zanamivir|zanamivir|mesh-list
44300775|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
44300776|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300777|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300778|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300779|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44300780|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44300781|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
44300782|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300783|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300784|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44300785|NCT00830323|Analgesics|analgesics|mesh-ancestor
44300786|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
44300787|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300788|NCT00830349|Risperidone|risperidone|mesh-list
44300789|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44300790|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
44300791|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300792|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300793|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300794|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44300795|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44300796|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300797|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44300798|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44300799|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
44300800|NCT00830401|Doxycycline|doxycycline|mesh-list
44300801|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300802|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300803|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
44300804|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44300805|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44300806|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44300807|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
44300808|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43721787|NCT02620839|Cisplatin|cisplatin|mesh-list
44300810|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44300811|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
44300812|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300813|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300814|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44300815|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44300816|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44300817|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44300818|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300819|NCT00830466|Sirolimus|sirolimus|mesh-list
44300820|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44300821|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300822|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44300823|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300824|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
44300825|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44300826|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
44300827|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300828|NCT00830492|Clomiphene|clomiphene|mesh-list
44300829|NCT00830492|Enclomiphene|enclomiphene|mesh-list
44300830|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
44300831|NCT00830492|Buserelin|buserelin|mesh-list
44300832|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44300833|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
44300834|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300835|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300836|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44300837|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
44300838|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300839|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44300840|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44300841|NCT00830505|Fluticasone|fluticasone|mesh-list
44300852|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
44300853|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44300854|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44300855|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44300856|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44300857|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44300858|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300859|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300861|NCT00830505|Hormones|hormones|mesh-ancestor
44300862|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44300863|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
44300864|NCT00830531|Bumetanide|bumetanide|mesh-list
44300865|NCT00830531|Diuretics|diuretics|mesh-ancestor
44300866|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
44300867|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300868|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44300869|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44300870|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300871|NCT00830570|Warfarin|warfarin|mesh-list
44300872|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
44300873|NCT00830609|Ribavirin|ribavirin|mesh-list
44300874|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44300875|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
44300876|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
44300877|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300878|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
44300879|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300880|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
44300881|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465563|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
44465564|NCT01474486|Thiamine|thiamine|mesh-list
44465576|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465577|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465578|NCT01474239|Growth Substances|growth substances|mesh-ancestor
44465579|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465580|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465581|NCT01474018|Bromocriptine|bromocriptine|mesh-list
44465582|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44465583|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44465584|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
44465585|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465586|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465587|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
44465588|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
44465589|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465590|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465591|NCT01473953|Liraglutide|liraglutide|mesh-list
44465592|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44465593|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465594|NCT01473953|Incretins|incretins|mesh-ancestor
44465596|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465597|NCT01473940|Gemcitabine|gemcitabine|mesh-list
44465598|NCT01473940|Ipilimumab|ipilimumab|mesh-list
44465599|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44465600|NCT01473940|Antibodies|antibodies|mesh-list
44465601|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
44465602|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44465603|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
44465604|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465605|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465606|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
44465607|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465608|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465609|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
44465610|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465611|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119692|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44119693|NCT00118313|Protective Agents|protective agents|mesh-ancestor
44465612|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465613|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44465614|NCT01473836|Metronidazole|metronidazole|mesh-list
43955723|NCT01294163|Propofol|propofol|mesh-list
44465615|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
44465616|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300882|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
44300883|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44300884|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
44300885|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300886|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
44300887|NCT00830830|Protective Agents|protective agents|mesh-ancestor
44300888|NCT00830843|Propofol|propofol|mesh-list
44300889|NCT00830843|Isoflurane|isoflurane|mesh-list
44300890|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44300891|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44300892|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300893|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44300894|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
44300895|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
44300896|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44300897|NCT00830856|Lamivudine|lamivudine|mesh-list
44300898|NCT00830856|Nevirapine|nevirapine|mesh-list
44300899|NCT00830856|Stavudine|stavudine|mesh-list
44300900|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
44300901|NCT00830856|Fluconazole|fluconazole|mesh-list
44300902|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44300903|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44300904|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300905|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300906|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
44300907|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300908|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44300919|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44300920|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44300921|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
44300922|NCT00830882|Albuterol|albuterol|mesh-list
44300923|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300924|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
44300925|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300926|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300927|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300928|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300929|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
44300930|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300931|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44300932|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44300933|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44300934|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44300935|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300936|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300937|NCT00831103|Valacyclovir|valacyclovir|mesh-list
44300938|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
44300939|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44300940|NCT00831155|Nicotine|nicotine|mesh-list
44300941|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44300942|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
44300943|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300944|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300945|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44300946|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44300947|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44300948|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300949|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300950|NCT00831350|Ranibizumab|ranibizumab|mesh-list
44300951|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43721906|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119694|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44119695|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
44119696|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119697|NCT00118326|Lenograstim|lenograstim|mesh-list
44119698|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44119699|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
44300952|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44300953|NCT00831350|Growth Substances|growth substances|mesh-ancestor
44300954|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300955|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
44300956|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300957|NCT00831376|Albuterol|albuterol|mesh-list
44300958|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44300959|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
44300960|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44300961|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300962|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44300963|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
44300964|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
44300965|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44300966|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44300967|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44300968|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44300969|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44300970|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44300971|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300972|NCT00831506|Digoxin|digoxin|mesh-list
44300973|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44300974|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44300975|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44300976|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300977|NCT00831506|Protective Agents|protective agents|mesh-ancestor
44300978|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44300979|NCT00831545|Temozolomide|temozolomide|mesh-list
44300980|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44300981|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
44300982|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300992|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
44300993|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300994|NCT00831636|Cytarabine|cytarabine|mesh-list
44300995|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44300996|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
44300997|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44300998|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44300999|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
44301000|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301001|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301002|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
44301003|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301004|NCT00831649|Natalizumab|natalizumab|mesh-list
44301005|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
44301006|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301007|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
44301008|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44301009|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
44301010|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44301011|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301012|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301013|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301014|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
44301015|NCT00831857|Bevacizumab|bevacizumab|mesh-list
44301016|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44301017|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44301018|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301019|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44301020|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44301021|NCT00831857|Growth Substances|growth substances|mesh-ancestor
44301022|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301023|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
44301024|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43721943|NCT02619786|Colistin|colistin|mesh-list
44119700|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119701|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
44119702|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44119703|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44119704|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119705|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301025|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301027|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44301028|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301029|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301030|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44301031|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
44301032|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
44301033|NCT00832039|Selenious Acid|selenious acid|mesh-list
44301034|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
44301035|NCT00832039|Trace Elements|trace elements|mesh-ancestor
44301036|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
44301037|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301038|NCT00832182|Insulin|insulin|mesh-list
44301039|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44301040|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
44301041|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
44301042|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
44301043|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
44301044|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44301045|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301046|NCT00832208|Amphotericin B|amphotericin b|mesh-list
44301047|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44301048|NCT00832208|Amebicides|amebicides|mesh-ancestor
44301049|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44301050|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44301051|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301052|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44301053|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
44301054|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44301055|NCT00832221|Raclopride|raclopride|mesh-list
44301056|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301057|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301058|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301059|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301060|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301061|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301062|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44119706|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119707|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44301063|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
44301064|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301065|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301066|NCT00832234|Dexamethasone|dexamethasone|mesh-list
44301067|NCT00832234|Rituximab|rituximab|mesh-list
44301068|NCT00832234|Bortezomib|bortezomib|mesh-list
44301069|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44301070|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301071|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
44301072|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301073|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301074|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301075|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
44301076|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
44301077|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301078|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301079|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
44301080|NCT00832234|Hormones|hormones|mesh-ancestor
44301081|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301082|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44301083|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
44301084|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44301085|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301086|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44301087|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44301088|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301089|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301090|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301091|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44301109|NCT00832442|Carvedilol|carvedilol|mesh-list
44301110|NCT00832442|Nebivolol|nebivolol|mesh-list
44301111|NCT00832442|Bisoprolol|bisoprolol|mesh-list
44301112|NCT00832442|Bucindolol|bucindolol|mesh-list
44301113|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44301114|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44301115|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44301116|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
44301117|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
44301118|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301119|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301120|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44301121|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44301122|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44301123|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301124|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301125|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
44301126|NCT00832442|Protective Agents|protective agents|mesh-ancestor
44301127|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44301128|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301129|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301130|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
44301131|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44301132|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44301133|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44301134|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44301135|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44301136|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
44301137|NCT00832481|Metformin|metformin|mesh-list
44301138|NCT00832481|Repaglinide|repaglinide|mesh-list
44301139|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44301140|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301141|NCT00832494|Paclitaxel|paclitaxel|mesh-list
44301142|NCT00832494|Carboplatin|carboplatin|mesh-list
44301143|NCT00832494|Vadimezan|vadimezan|mesh-list
44301144|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44301145|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301148|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301149|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301150|NCT00832689|Gemcitabine|gemcitabine|mesh-list
44301151|NCT00832689|Irinotecan|irinotecan|mesh-list
44301152|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44301153|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
44301154|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301155|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301156|NCT00832689|Antiviral Agents|antiviral agents|mesh-ancestor
44301157|NCT00832689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301158|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301159|NCT00832689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301160|NCT00832689|Immunologic Factors|immunologic factors|mesh-ancestor
44301161|NCT00832689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301162|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44301163|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44301164|NCT00832806|Varenicline|varenicline|mesh-list
44301165|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44301166|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44301167|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
44301168|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301169|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301170|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465617|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44465618|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44301181|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44301183|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301184|NCT00833157|Ibuprofen|ibuprofen|mesh-list
44301185|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44301186|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301187|NCT00833157|Analgesics|analgesics|mesh-ancestor
44301188|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
44301189|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301190|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301191|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301192|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301193|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44301194|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301195|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301196|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
44301197|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44301198|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44301199|NCT00833300|Haloperidol|haloperidol|mesh-list
44301200|NCT00833300|Olanzapine|olanzapine|mesh-list
44301201|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
44301202|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
44301203|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
44301204|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301205|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301206|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301207|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301208|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301209|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301210|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301211|NCT00833300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301212|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301213|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301214|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119708|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119709|NCT00118638|Hematinics|hematinics|mesh-ancestor
44119710|NCT00118690|Fluticasone|fluticasone|mesh-list
44119712|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44119713|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301215|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301216|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
44301217|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44301218|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
44301219|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44301220|NCT00833326|Docetaxel|docetaxel|mesh-list
44301221|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
44301222|NCT00833326|Mitogens|mitogens|mesh-list
44301223|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301224|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44301225|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301226|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301227|NCT00833339|Mifepristone|mifepristone|mesh-list
44301228|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44301229|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
44301230|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44301231|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301232|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44301233|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44301234|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44301235|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
44301236|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44301237|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44301238|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
44301239|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301240|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
44301241|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44301242|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44301243|NCT00833378|Ritonavir|ritonavir|mesh-list
44301244|NCT00833378|Lopinavir|lopinavir|mesh-list
44301245|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44301246|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44301247|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301248|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832950|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
44119714|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44119715|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
44119716|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119717|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119718|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44301249|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301250|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44301251|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44301252|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
44301253|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301254|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44301255|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44301256|NCT00833404|Nicotine|nicotine|mesh-list
44301257|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44301258|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
44301259|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301260|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301261|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44301262|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44301263|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
44301264|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301265|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301266|NCT00833534|Rituximab|rituximab|mesh-list
44301267|NCT00833534|Lenalidomide|lenalidomide|mesh-list
44301268|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44301269|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301270|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
44301271|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301272|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301273|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44301274|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44119719|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119720|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44119721|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44119722|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44119723|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44119725|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
44119726|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119727|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119728|NCT00118768|Interferons|interferons|mesh-list
44119729|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
44119730|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119731|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
44119732|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119733|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
44119734|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119735|NCT00118794|Lumefantrine|lumefantrine|mesh-list
44119741|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119742|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119743|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119744|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44119745|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701842|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301275|NCT00833534|Growth Substances|growth substances|mesh-ancestor
44301276|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
44301277|NCT00833729|Etanercept|etanercept|mesh-list
44301278|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44301279|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301280|NCT00833729|Analgesics|analgesics|mesh-ancestor
44301281|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
44301282|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301283|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301284|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301285|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301286|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301287|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301288|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
44301289|NCT00833768|Sevelamer|sevelamer|mesh-list
44301290|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
44301291|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
44301292|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301293|NCT00833807|Paclitaxel|paclitaxel|mesh-list
44301294|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44301295|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44301296|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301297|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44301298|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44301299|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301300|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301301|NCT00833963|Trastuzumab|trastuzumab|mesh-list
44301302|NCT00833963|Pertuzumab|pertuzumab|mesh-list
44301303|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44301304|NCT00833963|Maytansine|maytansine|mesh-list
44301305|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44301306|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832982|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
44119746|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119747|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
44119748|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44119749|NCT00118807|Artesunate|artesunate|mesh-list
44119750|NCT00118807|Chloroquine|chloroquine|mesh-list
44119751|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
44119752|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
44119753|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44119754|NCT00118807|Amodiaquine|amodiaquine|mesh-list
44119755|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
44301307|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44301308|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44301309|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44301310|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301311|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301312|NCT00834184|Nikkomycin|nikkomycin|mesh-list
44301313|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
44301314|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301315|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301316|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301317|NCT00834262|Insulin|insulin|mesh-list
44301318|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44301319|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
44301320|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
43648164|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44301321|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44301322|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
44301323|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44301324|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44301325|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301326|NCT00834379|Pravastatin|pravastatin|mesh-list
44301327|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44301328|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44301329|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
44301330|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301331|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44301332|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44301333|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301334|NCT00834457|Ritonavir|ritonavir|mesh-list
44301335|NCT00834457|Lopinavir|lopinavir|mesh-list
44301336|NCT00834457|Zidovudine|zidovudine|mesh-list
44301337|NCT00834457|Lamivudine|lamivudine|mesh-list
44119756|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119757|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119758|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119759|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119760|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
44119761|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
44119762|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44119763|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
44119764|NCT00118807|Amebicides|amebicides|mesh-ancestor
44119765|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119766|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44119767|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701843|NCT02722356|Oxytocin|oxytocin|mesh-list
44301338|NCT00834457|Abacavir|abacavir|mesh-list
44301339|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
44301340|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44301341|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44301342|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301343|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301344|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301345|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44301346|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44301347|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
44301348|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301349|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44301350|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44301351|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
44301352|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44301353|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44301354|NCT00834470|Atropine|atropine|mesh-list
44301355|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44301356|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44301357|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44301358|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
44301359|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301360|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301361|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44301362|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
44301363|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
44301364|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
44301365|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44301366|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44301367|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
44301368|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301369|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301370|NCT00834600|Amlodipine|amlodipine|mesh-list
44301371|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44301377|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301378|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301379|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301380|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
44301382|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
44301383|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44301384|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44301385|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44301386|NCT00834665|Molgramostim|molgramostim|mesh-list
44301387|NCT00834665|Sargramostim|sargramostim|mesh-list
44301388|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
44301389|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301390|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301391|NCT00834730|Ketamine|ketamine|mesh-list
44301392|NCT00834730|Analgesics|analgesics|mesh-ancestor
44301393|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
44301394|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301395|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301396|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44301397|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44301398|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
44301399|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
44301400|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301401|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44301402|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44301403|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301404|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301405|NCT00834847|Pravastatin|pravastatin|mesh-list
44301406|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44301407|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44301408|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
44301409|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301415|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
44301416|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301417|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
44301418|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301419|NCT00834925|Diltiazem|diltiazem|mesh-list
44301420|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44301421|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44301422|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301423|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301424|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301425|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301426|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
44301427|NCT00835029|Clotrimazole|clotrimazole|mesh-list
44301428|NCT00835029|Miconazole|miconazole|mesh-list
44301429|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44301430|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301431|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
44301432|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44301433|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44301434|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301435|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301436|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44301437|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
44301438|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301439|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301440|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44301441|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44301442|NCT00835107|Ziprasidone|ziprasidone|mesh-list
44301443|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44301456|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301457|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44301458|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301459|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301460|NCT00835471|Docetaxel|docetaxel|mesh-list
44301461|NCT00835471|Pemetrexed|pemetrexed|mesh-list
44301462|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44301463|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301464|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44301465|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44301466|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301467|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301468|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301469|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44301470|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44301471|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465631|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44465632|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
44465633|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44465634|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465670|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465671|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465672|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
44465673|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465674|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44465675|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44465676|NCT01473381|Dexetimide|dexetimide|mesh-list
44465677|NCT01473381|Citalopram|citalopram|mesh-list
44465678|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44465679|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44465680|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44465681|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465682|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465683|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465684|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
44465685|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465686|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44465687|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
44465688|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465689|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44465690|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44465691|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
44465692|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
44465693|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465694|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44465695|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44465696|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44301484|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
44301485|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44301486|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44301487|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301488|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301489|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44301490|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
44301491|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44301492|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44301493|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44301494|NCT00835848|Exenatide|exenatide|mesh-list
44301495|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44301496|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301497|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44301498|NCT00835848|Incretins|incretins|mesh-ancestor
44301499|NCT00835848|Hormones|hormones|mesh-ancestor
44301500|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301501|NCT00835939|Lidocaine|lidocaine|mesh-list
44301502|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
44301503|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
44301504|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301505|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301506|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
44301507|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301508|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44301509|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44301510|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44301511|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301512|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301513|NCT00835965|Dexamethasone|dexamethasone|mesh-list
44301514|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
44301515|NCT00835965|Aprepitant|aprepitant|mesh-list
44301516|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
44301517|NCT00835965|BB 1101|bb 1101|mesh-list
44301522|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301523|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301524|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
44301525|NCT00835965|Hormones|hormones|mesh-ancestor
44301526|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301527|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44301528|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301529|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301530|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301531|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301532|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44301533|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301534|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
44301535|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44301536|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301537|NCT00836134|Bupivacaine|bupivacaine|mesh-list
44301538|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
44301539|NCT00836134|Anesthetics|anesthetics|mesh-list
44301540|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301541|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301542|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
44301543|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301544|NCT00836199|Vaccines|vaccines|mesh-list
44301545|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
44301546|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301547|NCT00836212|Efavirenz|efavirenz|mesh-list
44301569|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
44301570|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301571|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301572|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
44301573|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301574|NCT00836368|Vitamin E|vitamin e|mesh-list
44301575|NCT00836368|Tocopherols|tocopherols|mesh-list
44301576|NCT00836368|Tocotrienols|tocotrienols|mesh-list
44301577|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
44301578|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
44301579|NCT00836368|Vitamins|vitamins|mesh-ancestor
44301580|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
44301581|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301582|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
44301583|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301584|NCT00836368|Protective Agents|protective agents|mesh-ancestor
44301585|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44301586|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44301587|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44301588|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44301589|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301590|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301591|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301592|NCT00836381|Urological Agents|urological agents|mesh-ancestor
44301593|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44301594|NCT00836485|Ketotifen|ketotifen|mesh-list
44301595|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
44301596|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44301597|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44301598|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44301599|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301611|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301612|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301613|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
44301614|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301615|NCT00836537|Benazepril|benazepril|mesh-list
44301616|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44301617|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301618|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301619|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301620|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44301621|NCT00836576|Benazepril|benazepril|mesh-list
44301622|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44301623|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301624|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301625|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301626|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44301628|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
44301629|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301630|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301631|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
44301632|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301633|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44301634|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301635|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44301636|NCT00836654|Catumaxomab|catumaxomab|mesh-list
44301637|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301638|NCT00836667|Sertraline|sertraline|mesh-list
44301639|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301640|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301648|NCT00836823|Alfuzosin|alfuzosin|mesh-list
44301654|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301655|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301656|NCT00836823|Urological Agents|urological agents|mesh-ancestor
44301658|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301659|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301660|NCT00836849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301661|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301662|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301663|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301664|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301665|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
44301666|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301667|NCT00836914|Idelalisib|idelalisib|mesh-list
44301668|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301669|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301670|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301671|NCT00837044|Naproxen|naproxen|mesh-list
44301672|NCT00837044|Sumatriptan|sumatriptan|mesh-list
44301673|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44301674|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301675|NCT00837044|Analgesics|analgesics|mesh-ancestor
44301676|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
44301677|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301678|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301679|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301680|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44301688|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
44301698|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301699|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
44301700|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44301701|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301702|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301703|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44301704|NCT00837187|Analgesics|analgesics|mesh-ancestor
44301705|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
44301706|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301707|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44301708|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44301709|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44301710|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
44301711|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301712|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301713|NCT00837239|Gemcitabine|gemcitabine|mesh-list
44301714|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44301715|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
44301716|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301717|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301718|NCT00837239|Antiviral Agents|antiviral agents|mesh-ancestor
44301719|NCT00837239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301720|NCT00837239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301721|NCT00837239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301722|NCT00837239|Immunologic Factors|immunologic factors|mesh-ancestor
44301723|NCT00837239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301724|NCT00837317|Phenol|phenol|mesh-list
44301725|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44301726|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301727|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
44301728|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44301729|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44301730|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44301731|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301736|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301737|NCT00837369|Regadenoson|regadenoson|mesh-list
44301738|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44301739|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44301740|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
44301741|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
44301742|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301743|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301744|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301746|NCT00837564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44301747|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301748|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301749|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301750|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301751|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
44301752|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301753|NCT00837564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44301754|NCT00837564|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301755|NCT00837564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301756|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
44301757|NCT00837655|Calcium|calcium|mesh-list
44301758|NCT00837655|Sevelamer|sevelamer|mesh-list
44301759|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301760|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301761|NCT00837655|Antacids|antacids|mesh-ancestor
44301762|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301766|NCT00837707|Aripiprazole|aripiprazole|mesh-list
44301777|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44301778|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44301779|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
44301780|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44301781|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44301782|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44301783|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44301784|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
44301785|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44301786|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301787|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301788|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301789|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301790|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44301791|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44301792|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301793|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301794|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
44301795|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301796|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
44301797|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
44301798|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301799|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44301800|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
44301801|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
44301802|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301803|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301804|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301805|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44119768|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119769|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44119770|NCT00118807|Renal Agents|renal agents|mesh-ancestor
44119771|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44119772|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119773|NCT00118937|Metformin|metformin|mesh-list
44119774|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119775|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119776|NCT00118950|Metformin|metformin|mesh-list
44119777|NCT00118950|Repaglinide|repaglinide|mesh-list
44119778|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119779|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119780|NCT00118963|Metformin|metformin|mesh-list
44119781|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
44301806|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44301807|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
44301808|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44301809|NCT00837850|Protective Agents|protective agents|mesh-ancestor
44301810|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301812|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
44301813|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301814|NCT00837915|Loratadine|loratadine|mesh-list
44301815|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
44301816|NCT00837915|Ephedrine|ephedrine|mesh-list
44301817|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
44301818|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301819|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44301820|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44301821|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44301822|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
44301823|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
44301824|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301825|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301826|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301827|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44301828|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
44301829|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301830|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44301831|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
44301832|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
44301833|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44301834|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44301835|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
44301836|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
44301837|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44301838|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44301839|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
44301841|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301847|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
44301848|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301849|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301850|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
44301851|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44301852|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44301853|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301854|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44301855|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44301856|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301857|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301858|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301859|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44301860|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44301861|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301862|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301863|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
44301864|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44301865|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44301866|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44301867|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
44301868|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
44301869|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
44301870|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301871|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44301872|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
44301873|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
44301874|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44301875|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
44301876|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
44301877|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
44301878|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
44301879|NCT00837954|Coagulants|coagulants|mesh-ancestor
44301880|NCT00838032|Haloperidol|haloperidol|mesh-list
43722403|NCT02617017|Buspirone|buspirone|mesh-list
44119782|NCT00118963|Repaglinide|repaglinide|mesh-list
44119783|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119784|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119785|NCT00118976|Lisinopril|lisinopril|mesh-list
44119786|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44301881|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44301882|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
44301883|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
44301884|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44301885|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44301886|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44301887|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44301888|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301890|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
44301891|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301892|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44301893|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44301894|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
44301895|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301896|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301897|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44301898|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
44301899|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44301900|NCT00838071|Antibodies|antibodies|mesh-list
44301901|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
44301902|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301903|NCT00838214|Prednisone|prednisone|mesh-list
44301904|NCT00838214|Budesonide|budesonide|mesh-list
44301905|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44301906|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
44301907|NCT00838214|Hormones|hormones|mesh-ancestor
44301908|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44301909|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301910|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44301911|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301912|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44301913|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
44301914|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301915|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44301916|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
44301917|NCT00838227|Modafinil|modafinil|mesh-list
44119787|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
44301918|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44301919|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301920|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44301921|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44301922|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44301923|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301925|NCT00838240|Clofarabine|clofarabine|mesh-list
44301926|NCT00838240|Idarubicin|idarubicin|mesh-list
44301927|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44301928|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
44301929|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301930|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301931|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
44301932|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301933|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301934|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
44301935|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301936|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44301937|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44301938|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44301939|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301940|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
44301941|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44301942|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301943|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
44301944|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301945|NCT00838266|Protective Agents|protective agents|mesh-ancestor
44301946|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301947|NCT00838305|Citalopram|citalopram|mesh-list
44301958|NCT00838357|Plerixafor|plerixafor|mesh-list
44301959|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44301960|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44301961|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
44301962|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301963|NCT00838370|Fluorouracil|fluorouracil|mesh-list
44301964|NCT00838370|Capecitabine|capecitabine|mesh-list
44301965|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
44301966|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301967|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44301968|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301969|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44301970|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
44301971|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301972|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
44301973|NCT00838396|Baclofen|baclofen|mesh-list
44301974|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44301975|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44301976|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44301977|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44301978|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44301979|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
44301980|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
44301981|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44301982|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301983|NCT00838656|Gemcitabine|gemcitabine|mesh-list
44301984|NCT00838656|Paclitaxel|paclitaxel|mesh-list
44301985|NCT00838656|Carboplatin|carboplatin|mesh-list
44301986|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44301987|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44301988|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
44301989|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
44301990|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
44301991|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44301992|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44301994|NCT00838656|Antiviral Agents|antiviral agents|mesh-ancestor
44301995|NCT00838656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44301996|NCT00838656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44301998|NCT00838656|Immunologic Factors|immunologic factors|mesh-ancestor
44301999|NCT00838656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302000|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44302001|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44302002|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44302003|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302004|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302005|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44302006|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44302007|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44302008|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
44302009|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302010|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302011|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44302012|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44302013|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
44302015|NCT00838760|TMC-310911|tmc-310911|mesh-list
44302016|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44302017|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44302018|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44302019|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302020|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302021|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44302022|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44302023|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
44302024|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302025|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
44302026|NCT00838838|Testosterone|testosterone|mesh-list
44302027|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
44302028|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
44302029|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44302041|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302042|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302043|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44302044|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302045|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
44302046|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302047|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
44302048|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302049|NCT00838968|Interferons|interferons|mesh-list
44302050|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
44302051|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302052|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
44302053|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302054|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
44302055|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302056|NCT00839059|Lenalidomide|lenalidomide|mesh-list
44302057|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
44302058|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302059|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302060|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302061|NCT00839059|Growth Substances|growth substances|mesh-ancestor
44302062|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302063|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302064|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
44302065|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
44302066|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
44302067|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302069|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302070|NCT00839085|Vitamins|vitamins|mesh-ancestor
44302071|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
44302072|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44302073|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302074|NCT00839111|Irinotecan|irinotecan|mesh-list
44302075|NCT00839111|Sorafenib|sorafenib|mesh-list
44302076|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44302077|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302081|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44302082|NCT00839163|Vitamin K|vitamin k|mesh-list
44302083|NCT00839163|Enoxaparin|enoxaparin|mesh-list
44302084|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
44302085|NCT00839163|Vitamins|vitamins|mesh-ancestor
44302086|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
44302087|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302088|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44302089|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
44302090|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44302091|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
44302092|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302093|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302094|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
44302095|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44302096|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44302097|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44302098|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
44302099|NCT00839163|Coagulants|coagulants|mesh-ancestor
44302100|NCT00839228|Perhexiline|perhexiline|mesh-list
44302101|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44119788|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119789|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119790|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44119791|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44119792|NCT00118976|Protective Agents|protective agents|mesh-ancestor
44119793|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119794|NCT00119002|Dexamethasone|dexamethasone|mesh-list
44119795|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119796|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
44119797|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
44119798|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119799|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119800|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44119801|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
44119802|NCT00119002|Hormones|hormones|mesh-ancestor
44119803|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119804|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44119805|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119806|NCT00119119|Tocopherols|tocopherols|mesh-list
44119807|NCT00119119|Vitamin E|vitamin e|mesh-list
44119808|NCT00119119|Tocotrienols|tocotrienols|mesh-list
44119809|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
44119810|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
44119815|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
44119816|NCT00119132|Artesunate|artesunate|mesh-list
44119817|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
44119818|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
44119819|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44119820|NCT00119132|Amodiaquine|amodiaquine|mesh-list
44119821|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
44119822|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119823|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119824|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119825|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119826|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
44119827|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
44119828|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44119829|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
43701844|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
44302102|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302103|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302104|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44302105|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302106|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
44302107|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
44302108|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
44302109|NCT00839280|Vitamins|vitamins|mesh-ancestor
44302110|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
44302111|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302112|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
44302113|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44302114|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44302115|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
44302116|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302117|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44302118|NCT00839345|Clopidogrel|clopidogrel|mesh-list
44302119|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44302120|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44302121|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44302122|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44119830|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44119831|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119832|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119833|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44119834|NCT00119132|Renal Agents|renal agents|mesh-ancestor
44119835|NCT00119145|Artesunate|artesunate|mesh-list
44119836|NCT00119145|Amodiaquine|amodiaquine|mesh-list
44119837|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44119838|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
44119839|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44119840|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44119841|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119842|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119843|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
44119844|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
44119845|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44119846|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
44119847|NCT00119171|Capecitabine|capecitabine|mesh-list
44119848|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119849|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
44119850|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119851|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119852|NCT00119184|Anesthetics|anesthetics|mesh-list
44119853|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44119854|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119855|NCT00119210|Bupropion|bupropion|mesh-list
44119856|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44119857|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44119858|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119859|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44119860|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44302123|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
44302124|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302125|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302126|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302128|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
44302129|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
44302130|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302131|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302132|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44302133|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44302134|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44302135|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44302136|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44302137|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302138|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302139|NCT00839371|Midazolam|midazolam|mesh-list
44302140|NCT00839371|Propofol|propofol|mesh-list
44302141|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44302142|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302143|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302144|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44302145|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
44302146|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
44302147|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44302148|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44302149|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44302150|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44302151|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
44302152|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
44302153|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302154|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302156|NCT00839397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44302157|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44119861|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44119862|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119863|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
44119864|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302158|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302159|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302160|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302161|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
44302162|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302163|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44302164|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
44302165|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44302166|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44302167|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44302168|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302169|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44302170|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44302171|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44302172|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
44302173|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
44302174|NCT00839462|Vitamins|vitamins|mesh-ancestor
44302175|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
44302176|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302177|NCT00839488|Pantoprazole|pantoprazole|mesh-list
44302178|NCT00839488|Famotidine|famotidine|mesh-list
44302179|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44302180|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302181|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44302182|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302183|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302184|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44302185|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
44302186|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
44465708|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465709|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465711|NCT01472835|Midazolam|midazolam|mesh-list
44465712|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44465713|NCT01472835|Narcotics|narcotics|mesh-ancestor
44465714|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465715|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465716|NCT01472835|Analgesics|analgesics|mesh-ancestor
44465717|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
44465718|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465719|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44465720|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44465721|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
43957058|NCT01332461|Xhance|xhance|mesh-list
44302200|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
43648239|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302201|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44302202|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302203|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302204|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302205|NCT00839605|Analgesics|analgesics|mesh-ancestor
44302206|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
44302207|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302208|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44302209|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44302210|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44302211|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44302212|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302213|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302214|NCT00839657|Warfarin|warfarin|mesh-list
44302215|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
44302216|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
44302217|NCT00839683|Valsartan|valsartan|mesh-list
44302218|NCT00839683|Simvastatin|simvastatin|mesh-list
44302219|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44302220|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44302224|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44302225|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302226|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44302227|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44302228|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44302229|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44302230|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302231|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302232|NCT00839761|Iron|iron|mesh-list
44302233|NCT00839761|Trace Elements|trace elements|mesh-ancestor
44302234|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
44302235|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302236|NCT00839787|Morphine|morphine|mesh-list
44302237|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44302238|NCT00839787|Narcotics|narcotics|mesh-ancestor
44302239|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302240|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302241|NCT00839787|Analgesics|analgesics|mesh-ancestor
44302242|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
44302243|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302244|NCT00839826|Enoxaparin|enoxaparin|mesh-list
44302245|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
44302246|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44302247|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
44302248|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44302249|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44302250|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302273|NCT00840229|Triamcinolone|triamcinolone|mesh-list
44302274|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44302275|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44302276|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44302277|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302278|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
44302280|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302281|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302282|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302283|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
44302284|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302285|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302286|NCT00840242|Nicotine|nicotine|mesh-list
44302287|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44302288|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
44302289|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302290|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302291|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44302292|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44302293|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
44302294|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302295|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302296|NCT00840333|Levofloxacin|levofloxacin|mesh-list
44302322|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
44302323|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302324|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
44302325|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302326|NCT00840398|Buspirone|buspirone|mesh-list
44302327|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44302328|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44302329|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302330|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302331|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44302332|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44302333|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
44302334|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302335|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302336|NCT00840489|Ribavirin|ribavirin|mesh-list
44302337|NCT00840489|Colchicine|colchicine|mesh-list
44302338|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
44302339|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302340|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
44302341|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302342|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
44302343|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302344|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44302345|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44302346|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44302347|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302348|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
44302349|NCT00840580|Levofloxacin|levofloxacin|mesh-list
44302350|NCT00840580|Ofloxacin|ofloxacin|mesh-list
43957204|NCT01334957|Ibuprofen|ibuprofen|mesh-list
44302351|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44302352|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44302358|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302364|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302365|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44302366|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44302367|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44302368|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44302369|NCT00840580|Renal Agents|renal agents|mesh-ancestor
44302370|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44302371|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44302373|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44302374|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44302375|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302376|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302377|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44302378|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44302379|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
44302380|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302381|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302382|NCT00840645|Mirabegron|mirabegron|mesh-list
44302383|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44302384|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44302385|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44302386|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44302387|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302388|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302389|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302390|NCT00840645|Urological Agents|urological agents|mesh-ancestor
44302391|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
44302392|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44302393|NCT00840671|Protective Agents|protective agents|mesh-ancestor
44302394|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302395|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
44302396|NCT00840684|Cytarabine|cytarabine|mesh-list
44302397|NCT00840684|Melphalan|melphalan|mesh-list
44302398|NCT00840684|Busulfan|busulfan|mesh-list
44302405|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302406|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
44302407|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302408|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302409|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
44302410|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302411|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44302412|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
44302413|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44302414|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44302415|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302416|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302417|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302418|NCT00840684|Analgesics|analgesics|mesh-ancestor
44302419|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
44302420|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302421|NCT00840801|Vaccines|vaccines|mesh-list
44302422|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
44302423|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302424|NCT00840918|Lidocaine|lidocaine|mesh-list
44302425|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
44302426|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
44302427|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44302428|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302429|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
44302430|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302431|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44302432|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44302433|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44302434|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302435|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302436|NCT00840931|Lenalidomide|lenalidomide|mesh-list
44302444|NCT00840957|Infliximab|infliximab|mesh-list
44302446|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302447|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302448|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
44302449|NCT00841061|Trace Elements|trace elements|mesh-ancestor
44302450|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
44302451|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302452|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
44302453|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44302454|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44302455|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302456|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
44302457|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44302458|NCT00841113|Goserelin|goserelin|mesh-list
44302459|NCT00841113|Bicalutamide|bicalutamide|mesh-list
44302460|NCT00841113|Abarelix|abarelix|mesh-list
44302461|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302462|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302463|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
44302464|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
44302465|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302466|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302467|NCT00841126|Iron|iron|mesh-list
44302468|NCT00841126|Trace Elements|trace elements|mesh-ancestor
44302469|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
44302470|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302471|NCT00841139|Perhexiline|perhexiline|mesh-list
44302472|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44302473|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302494|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302495|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302496|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302497|NCT00841386|Riboflavin|riboflavin|mesh-list
44302498|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
44302499|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
44302500|NCT00841386|Vitamins|vitamins|mesh-ancestor
43957348|NCT01339091|Linezolid|linezolid|mesh-list
44302501|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
44302502|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302503|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44302504|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
44302506|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
44302507|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44465722|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
44465723|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44465724|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44465725|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44465726|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465727|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
44465728|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
44465729|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465730|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465731|NCT01472380|Efavirenz|efavirenz|mesh-list
44465732|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
44465733|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44465734|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44465735|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465737|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
44465756|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465757|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465758|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44465759|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465760|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465761|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465762|NCT01472081|Growth Substances|growth substances|mesh-ancestor
44465763|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465764|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465765|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465766|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465767|NCT01471782|Blinatumomab|blinatumomab|mesh-list
44465768|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465769|NCT01471691|Ranibizumab|ranibizumab|mesh-list
44465770|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465771|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465772|NCT01471691|Growth Substances|growth substances|mesh-ancestor
44465773|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465774|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465775|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465776|NCT01471574|Interferons|interferons|mesh-list
44465777|NCT01471574|Ribavirin|ribavirin|mesh-list
44465778|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
44465779|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
44465780|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44465781|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465782|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
44465783|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465784|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
44465785|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465786|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
44465787|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465788|NCT01471379|Milnacipran|milnacipran|mesh-list
44465789|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
44302513|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302514|NCT00841581|Growth Substances|growth substances|mesh-ancestor
44302515|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302516|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302517|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302518|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
44302519|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44302520|NCT00841633|Norepinephrine|norepinephrine|mesh-list
44302521|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44302522|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44302523|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
44302524|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302525|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302526|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302527|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
44302528|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
44302529|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302530|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44302531|NCT00841724|Fludarabine|fludarabine|mesh-list
44302532|NCT00841724|Busulfan|busulfan|mesh-list
44302533|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
44302534|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302535|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302536|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302537|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
44302538|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302539|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
44302540|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44302541|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44302542|NCT00841789|Etanercept|etanercept|mesh-list
44302543|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44302544|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302545|NCT00841789|Analgesics|analgesics|mesh-ancestor
44302546|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
43722798|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44119865|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119866|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44119867|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44119868|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302547|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302548|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302549|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302550|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302551|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302552|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302553|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
44302554|NCT00841802|Prednisone|prednisone|mesh-list
44302555|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
44302556|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302557|NCT00841802|Hormones|hormones|mesh-ancestor
44302558|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302559|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302560|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302561|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302562|NCT00841841|Acetaminophen|acetaminophen|mesh-list
44302563|NCT00841841|Dipyrone|dipyrone|mesh-list
44302564|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302565|NCT00841841|Analgesics|analgesics|mesh-ancestor
44302566|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
44302567|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302568|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302569|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
44302570|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44302571|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302572|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302573|NCT00841854|Metronidazole|metronidazole|mesh-list
44302574|NCT00841854|Tetracycline|tetracycline|mesh-list
44302575|NCT00841854|Pantoprazole|pantoprazole|mesh-list
44302576|NCT00841854|Bismuth|bismuth|mesh-list
44302577|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302578|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302579|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44302580|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44302581|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44302582|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302583|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44302584|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119869|NCT00119236|Irinotecan|irinotecan|mesh-list
44302585|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302586|NCT00841854|Antacids|antacids|mesh-ancestor
44302587|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44302588|NCT00841880|Felodipine|felodipine|mesh-list
44302589|NCT00841880|Ramipril|ramipril|mesh-list
44302590|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44302591|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
44302592|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302593|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302594|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44302595|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44302596|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44302597|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302598|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44302599|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302600|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
44302601|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
44302602|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
44302603|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302604|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44302605|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302606|NCT00841919|Insulin|insulin|mesh-list
44302607|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44302608|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
44302609|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
44302610|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
44302611|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
44302612|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
44302613|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302630|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
44302631|NCT00841945|Hormones|hormones|mesh-ancestor
44302632|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302633|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302634|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44302635|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44302636|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44302637|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44302638|NCT00842114|Interferons|interferons|mesh-list
44302639|NCT00842114|Prednisone|prednisone|mesh-list
44302640|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
44302641|NCT00842114|Vincristine|vincristine|mesh-list
44302642|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302643|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
44302644|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302645|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302646|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44302647|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
44302648|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302649|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302650|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44302651|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302652|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
44302653|NCT00842114|Hormones|hormones|mesh-ancestor
44302654|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302655|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302656|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
44302657|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302658|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44302659|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
44302661|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
44302662|NCT00842127|Methylphenidate|methylphenidate|mesh-list
44302663|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44302664|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302666|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44302667|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44302668|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302669|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
44302670|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302671|NCT00842140|Metformin|metformin|mesh-list
44302672|NCT00842140|Spironolactone|spironolactone|mesh-list
44302673|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
44302674|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
44302675|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302676|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302677|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44302678|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44302679|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
44302680|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302681|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44302682|NCT00842140|Diuretics|diuretics|mesh-ancestor
44302683|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
44302684|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44302685|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
44302686|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302687|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302688|NCT00842205|Interferons|interferons|mesh-list
44302689|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302690|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
44302691|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302692|NCT00842400|Metformin|metformin|mesh-list
44302693|NCT00842400|Probenecid|probenecid|mesh-list
44302694|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302695|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302696|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
44302710|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302711|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
44302712|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302713|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302714|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302715|NCT00842491|Growth Substances|growth substances|mesh-ancestor
44302716|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302717|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302718|NCT00842504|Micafungin|micafungin|mesh-list
44302719|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
44302720|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302721|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44302722|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
44302723|NCT00842556|Glimepiride|glimepiride|mesh-list
44302724|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302725|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302726|NCT00842556|Incretins|incretins|mesh-ancestor
44302727|NCT00842556|Hormones|hormones|mesh-ancestor
44302728|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302729|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44302730|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
44302731|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302732|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302733|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44302734|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44302735|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302736|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
44302737|NCT00842582|Azacitidine|azacitidine|mesh-list
44302738|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302739|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
44302740|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302741|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302742|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302744|NCT00842595|Rituximab|rituximab|mesh-list
44302750|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
44302751|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302752|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302753|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302754|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
44302755|NCT00842595|Hormones|hormones|mesh-ancestor
44302756|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302757|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44302758|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44302759|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
44302760|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
44302761|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
44302762|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302763|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44302764|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
44302765|NCT00842595|Analgesics|analgesics|mesh-ancestor
44302766|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
44302767|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302768|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302769|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302770|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302771|NCT00842660|Gemcitabine|gemcitabine|mesh-list
44302772|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44302773|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
44302774|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302775|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302796|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
44302797|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
44302798|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
44302799|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44302800|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44302801|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302802|NCT00842907|Tretinoin|tretinoin|mesh-list
44302803|NCT00842907|Isotretinoin|isotretinoin|mesh-list
44302804|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302805|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
44302806|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
44302807|NCT00842920|Simvastatin|simvastatin|mesh-list
43957682|NCT01351740|Ritonavir|ritonavir|mesh-list
44302808|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44302809|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44302810|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
44302811|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302812|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44302813|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44302814|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302815|NCT00842933|Prednisone|prednisone|mesh-list
44302816|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
44302817|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
44302818|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44302819|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44302820|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44302821|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302822|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
44302823|NCT00842933|Hormones|hormones|mesh-ancestor
44302824|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44302825|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302838|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44302839|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302840|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302842|NCT00843063|Famotidine|famotidine|mesh-list
44302843|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44302844|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302845|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44302846|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302847|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302848|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44302849|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
44302850|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
44302851|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302852|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302853|NCT00843154|Candesartan|candesartan|mesh-list
44302854|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44302855|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44302856|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44302857|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302858|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44302859|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44302860|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44302861|NCT00843362|Dinoprostone|dinoprostone|mesh-list
44302862|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
44302863|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44302864|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465792|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465793|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465794|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465795|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465796|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44465797|NCT01471379|Analgesics|analgesics|mesh-ancestor
44465798|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
44465799|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119870|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44465801|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465802|NCT01471353|Capecitabine|capecitabine|mesh-list
44465803|NCT01471353|Sorafenib|sorafenib|mesh-list
44465804|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465805|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
44465806|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465807|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465808|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465809|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957757|NCT01354444|Carvedilol|carvedilol|mesh-list
44302865|NCT00843440|Bevacizumab|bevacizumab|mesh-list
44302866|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44302867|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302868|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44302869|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44302870|NCT00843440|Growth Substances|growth substances|mesh-ancestor
44302871|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302872|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
44302873|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
44302874|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
44302875|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
44302876|NCT00843453|Vitamins|vitamins|mesh-ancestor
44302877|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
44302878|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302879|NCT00843453|Hematinics|hematinics|mesh-ancestor
44302880|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44302881|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44302882|NCT00843570|Nafarelin|nafarelin|mesh-list
44302903|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302904|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44302905|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44302906|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302911|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44302912|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
44302913|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302914|NCT00843908|Imidacloprid|imidacloprid|mesh-list
44302915|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
44302916|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44302917|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302918|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302919|NCT00843934|Cisplatin|cisplatin|mesh-list
44302920|NCT00843934|Epirubicin|epirubicin|mesh-list
44302921|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302922|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44302923|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44302924|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44302925|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302926|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302927|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44302928|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44302929|NCT00844012|Estradiol|estradiol|mesh-list
44302930|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44302931|NCT00844012|Estrogens|estrogens|mesh-ancestor
44302932|NCT00844012|Hormones|hormones|mesh-ancestor
44302934|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302948|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302949|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302950|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302951|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44302952|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302953|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
44302954|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302955|NCT00844155|Oseltamivir|oseltamivir|mesh-list
44302956|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
44302957|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302958|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302959|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302960|NCT00844168|Sorafenib|sorafenib|mesh-list
44302961|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302962|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44302963|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44302964|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302965|NCT00844207|Azithromycin|azithromycin|mesh-list
44302966|NCT00844207|Chloroquine|chloroquine|mesh-list
44302967|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44302968|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44302969|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44302970|NCT00844207|Amebicides|amebicides|mesh-ancestor
44302971|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44302972|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44302973|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
44302974|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302975|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44302976|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44302977|NCT00844207|Analgesics|analgesics|mesh-ancestor
44302978|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
44302979|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44302980|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302981|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44302989|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44302990|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44302991|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
44302992|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44302993|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
44302994|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302995|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44302996|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44302997|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44302998|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44302999|NCT00844324|Candesartan|candesartan|mesh-list
44303000|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
44303001|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44303002|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44303003|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44303004|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303005|NCT00844337|Amoxicillin|amoxicillin|mesh-list
44303006|NCT00844337|Gentamicins|gentamicins|mesh-list
44303007|NCT00844337|Penicillins|penicillins|mesh-list
44303008|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303009|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303010|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44303011|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303012|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303014|NCT00844350|Oxytocin|oxytocin|mesh-list
44303015|NCT00844350|Clomiphene|clomiphene|mesh-list
44119871|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44119872|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119873|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119874|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119875|NCT00119249|Sorafenib|sorafenib|mesh-list
44119876|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119877|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119879|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119880|NCT00119301|Leucovorin|leucovorin|mesh-list
44119881|NCT00119301|Trimetrexate|trimetrexate|mesh-list
44119882|NCT00119301|Methotrexate|methotrexate|mesh-list
44119883|NCT00119301|Calcium|calcium|mesh-list
44119887|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44119888|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
44119889|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44119890|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119891|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
44119892|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119893|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119894|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
44303016|NCT00844350|Enclomiphene|enclomiphene|mesh-list
44303017|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
44303018|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303019|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
44303020|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44303021|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303022|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303023|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44303024|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44303025|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303026|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44303027|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
44303028|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303029|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44303030|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
44303031|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44303032|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44303033|NCT00844402|Atorvastatin|atorvastatin|mesh-list
44303034|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44303035|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44303036|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
44303037|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303038|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44303039|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44303040|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303041|NCT00844454|Ethanol|ethanol|mesh-list
44303042|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44303043|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303044|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303045|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303046|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
44303047|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303048|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
44303054|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303055|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44303056|NCT00844662|Sevelamer|sevelamer|mesh-list
44303057|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
44303058|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
44303059|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303060|NCT00844675|Rabeprazole|rabeprazole|mesh-list
44303061|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44303062|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44303063|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44303064|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303065|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303066|NCT00844688|Gemcitabine|gemcitabine|mesh-list
44303067|NCT00844688|Sorafenib|sorafenib|mesh-list
44303068|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303069|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
44303070|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303071|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303072|NCT00844688|Antiviral Agents|antiviral agents|mesh-ancestor
44303073|NCT00844688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303074|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303075|NCT00844688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303076|NCT00844688|Immunologic Factors|immunologic factors|mesh-ancestor
44303077|NCT00844688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303078|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303079|NCT00844727|Rofecoxib|rofecoxib|mesh-list
44303080|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44303081|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44303082|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303086|NCT00844727|Analgesics|analgesics|mesh-ancestor
44303098|NCT00844792|Vitamin D|vitamin d|mesh-list
44303099|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
44303100|NCT00844792|Vitamins|vitamins|mesh-list
44303101|NCT00844792|Vitamin E|vitamin e|mesh-list
44303102|NCT00844792|Selenium|selenium|mesh-list
44303103|NCT00844792|Lycopene|lycopene|mesh-list
44303104|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
44303105|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303106|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44303107|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44303108|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
44303109|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303110|NCT00844792|Protective Agents|protective agents|mesh-ancestor
44303111|NCT00844792|Trace Elements|trace elements|mesh-ancestor
44303112|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303113|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44303114|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44303115|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303116|NCT00845104|Bevacizumab|bevacizumab|mesh-list
44303117|NCT00845104|Rituximab|rituximab|mesh-list
44303118|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44303119|NCT00845104|Fludarabine|fludarabine|mesh-list
44303120|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
44303121|NCT00845104|Antibodies|antibodies|mesh-list
44303122|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
44303123|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44303124|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303133|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
44303149|NCT00845338|Darifenacin|darifenacin|mesh-list
44303150|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44303151|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44303152|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
44303153|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303154|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303155|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303156|NCT00845338|Urological Agents|urological agents|mesh-ancestor
44303157|NCT00845351|Bexarotene|bexarotene|mesh-list
44303158|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303159|NCT00845364|Perhexiline|perhexiline|mesh-list
44303160|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44303161|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303162|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303163|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44303164|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303165|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
44465810|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
44465811|NCT01471340|Prednisone|prednisone|mesh-list
44465812|NCT01471340|Prednisolone|prednisolone|mesh-list
44303166|NCT00845533|Piperaquine|piperaquine|mesh-list
44303167|NCT00845533|Artenimol|artenimol|mesh-list
44303168|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
44303169|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44303170|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44303171|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303172|NCT00845546|Loratadine|loratadine|mesh-list
44303173|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
44303174|NCT00845546|Ephedrine|ephedrine|mesh-list
44303175|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
43723257|NCT02611518|Metformin|metformin|mesh-list
44303192|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44303193|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
44303194|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303195|NCT00845559|Exenatide|exenatide|mesh-list
44303196|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44303197|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303198|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44303199|NCT00845559|Incretins|incretins|mesh-ancestor
44303200|NCT00845559|Hormones|hormones|mesh-ancestor
44303201|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303202|NCT00845572|Risperidone|risperidone|mesh-list
44303203|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44303204|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
44303205|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303206|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303207|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303208|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44303209|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44303210|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303211|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44303212|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44303213|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
44303214|NCT00845598|Fluticasone|fluticasone|mesh-list
44303215|NCT00845598|Xhance|xhance|mesh-list
44303216|NCT00845598|Azelastine|azelastine|mesh-list
44303217|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303218|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44303219|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
44303220|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303221|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303238|NCT00845689|Adenosine|adenosine|mesh-list
44303239|NCT00845689|Analgesics|analgesics|mesh-ancestor
44303240|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
44303241|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303242|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303243|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303244|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
44303245|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44303246|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
44303247|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
44303248|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303249|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303250|NCT00845754|Ketorolac|ketorolac|mesh-list
44303251|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44303252|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303253|NCT00845754|Analgesics|analgesics|mesh-ancestor
44303254|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
44303255|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303256|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303257|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303258|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303259|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44303260|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303261|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303262|NCT00845780|Amiodarone|amiodarone|mesh-list
44303263|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303264|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
44303265|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44303266|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303268|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44303282|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44303283|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303284|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
44303285|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44303286|NCT00845819|Trace Elements|trace elements|mesh-ancestor
44303287|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
44303288|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303289|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
44303290|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
44303291|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303292|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
44303293|NCT00845819|Ionophores|ionophores|mesh-ancestor
44303294|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303295|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303296|NCT00845884|Bevacizumab|bevacizumab|mesh-list
44303297|NCT00845884|Cisplatin|cisplatin|mesh-list
44303298|NCT00845884|Docetaxel|docetaxel|mesh-list
44303299|NCT00845884|Capecitabine|capecitabine|mesh-list
44303300|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303301|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303302|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44303303|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44303304|NCT00845884|Growth Substances|growth substances|mesh-ancestor
44303305|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303306|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
44303307|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44303308|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44303309|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44303310|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303311|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303312|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
44303313|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44303314|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
44303315|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44303316|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
44303321|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44303322|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303323|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44303324|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
44303325|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303326|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303327|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44303328|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44303329|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
44303330|NCT00848302|Protective Agents|protective agents|mesh-ancestor
44303331|NCT00848432|Risperidone|risperidone|mesh-list
44303332|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44303333|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
44303334|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303335|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303336|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303337|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44303338|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44303339|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303340|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44303341|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44303342|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
44303343|NCT00848458|Azelaic acid|azelaic acid|mesh-list
44303344|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303345|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44303346|NCT00848523|Panobinostat|panobinostat|mesh-list
44303347|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303348|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44303349|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303350|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303351|NCT00848562|Nicorandil|nicorandil|mesh-list
44303352|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303353|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44303354|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44303362|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303363|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303364|NCT00848679|Lidocaine|lidocaine|mesh-list
44303365|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
44303366|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
44303367|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303368|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303369|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
44303370|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303371|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44303372|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44303373|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44303374|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303375|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303376|NCT00848692|Rituximab|rituximab|mesh-list
44303377|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303378|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303379|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
44303380|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303381|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303382|NCT00848770|Norepinephrine|norepinephrine|mesh-list
44303383|NCT00848770|Esmolol|esmolol|mesh-list
44303384|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44303385|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44303386|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303387|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303388|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303389|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303390|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
44303391|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
44303392|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958275|NCT01366196|Pregabalin|pregabalin|mesh-list
44303393|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44303394|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44303395|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44303399|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
44303400|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44303401|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44303402|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303403|NCT00848809|Vancomycin|vancomycin|mesh-list
44303404|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303405|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303406|NCT00848848|Vaccines|vaccines|mesh-list
44303407|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
44303408|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303409|NCT00848861|Midazolam|midazolam|mesh-list
44303410|NCT00848861|Meperidine|meperidine|mesh-list
44303411|NCT00848861|Propofol|propofol|mesh-list
44303412|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44303413|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303414|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303415|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44303416|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
44303417|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
44303418|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44303419|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44303420|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44303421|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44303422|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
44303423|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
44303424|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303425|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303426|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44303427|NCT00848861|Narcotics|narcotics|mesh-ancestor
44303428|NCT00848861|Analgesics|analgesics|mesh-ancestor
44303429|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
44119895|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119896|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44119897|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119898|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
44119899|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119900|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44119901|NCT00119301|Antidotes|antidotes|mesh-ancestor
44119902|NCT00119301|Protective Agents|protective agents|mesh-ancestor
44119903|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
44119904|NCT00119301|Vitamins|vitamins|mesh-ancestor
44119905|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
44119906|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
44119907|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119908|NCT00119314|Gemcitabine|gemcitabine|mesh-list
44119909|NCT00119314|Capecitabine|capecitabine|mesh-list
44303430|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303431|NCT00848939|Treprostinil|treprostinil|mesh-list
44303432|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44303433|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
44303434|NCT00848991|Propofol|propofol|mesh-list
44303435|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44303436|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303437|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303438|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44303439|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
44303440|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
44303441|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303442|NCT00848991|Analgesics|analgesics|mesh-ancestor
44303443|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
44303444|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303445|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44303446|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44303447|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44303448|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303449|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303450|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303451|NCT00849030|Tamoxifen|tamoxifen|mesh-list
44303452|NCT00849030|Anastrozole|anastrozole|mesh-list
44303453|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44303454|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
44303455|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303456|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303457|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44303458|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303459|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44303460|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44303461|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44303462|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44303463|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44303466|NCT00849082|Goserelin|goserelin|mesh-list
44303467|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
44303468|NCT00849082|Cyproterone|cyproterone|mesh-list
44303469|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44303470|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303471|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
44303472|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
44303473|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303474|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303475|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44303476|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
44303477|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44303478|NCT00849095|Budesonide|budesonide|mesh-list
44303479|NCT00849095|Terbutaline|terbutaline|mesh-list
44303480|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
44303481|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44303482|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303483|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44303484|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
44303485|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303486|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303487|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44303488|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303489|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
44303490|NCT00849095|Hormones|hormones|mesh-ancestor
44303491|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303492|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44303493|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44303494|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44303495|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303496|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303497|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303498|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
44303499|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
44303506|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303507|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44303508|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44303509|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
44303510|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303511|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
44303512|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44303513|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303514|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44303515|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
44303516|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303517|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303518|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303519|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303520|NCT00849264|Fluorouracil|fluorouracil|mesh-list
44303521|NCT00849264|Endostar protein|endostar protein|mesh-list
44303522|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
44303523|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303524|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303525|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303526|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303527|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
44303528|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303529|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44303530|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44303531|NCT00849264|Growth Substances|growth substances|mesh-ancestor
44303532|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
44303533|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
44303534|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44303535|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303536|NCT00849329|Lapatinib|lapatinib|mesh-list
44303537|NCT00849329|Esomeprazole|esomeprazole|mesh-list
44303538|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44303539|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44303540|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44303541|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303544|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303545|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
44303546|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44303547|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303548|NCT00849355|Rituximab|rituximab|mesh-list
44303549|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303550|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303551|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
44303552|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303553|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303554|NCT00849368|Azathioprine|azathioprine|mesh-list
44303555|NCT00849368|Allopurinol|allopurinol|mesh-list
44303556|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
44303557|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303558|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303559|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
44303560|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303561|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44303562|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
44303563|NCT00849368|Protective Agents|protective agents|mesh-ancestor
44303600|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
44303601|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303602|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
44303603|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303604|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303605|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
44465813|NCT01471340|Albuterol|albuterol|mesh-list
44465814|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
44465815|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
44465816|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465817|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
44465818|NCT01471340|Hormones|hormones|mesh-ancestor
44465819|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465820|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465821|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44465822|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465823|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
44465824|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303607|NCT00849602|Amebicides|amebicides|mesh-ancestor
44303608|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44303609|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44303610|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303611|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
44303612|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303613|NCT00849615|Leucovorin|leucovorin|mesh-list
44303614|NCT00849615|Folic Acid|folic acid|mesh-list
44303615|NCT00849615|Docetaxel|docetaxel|mesh-list
44303616|NCT00849615|Fluorouracil|fluorouracil|mesh-list
44303617|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
44303618|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
44303636|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44303637|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303638|NCT00849966|Celecoxib|celecoxib|mesh-list
44303639|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44303640|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303641|NCT00849966|Analgesics|analgesics|mesh-ancestor
44303642|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
44303643|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303644|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303645|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303646|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303647|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44303648|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44303649|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303650|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303651|NCT00849992|Imiquimod|imiquimod|mesh-list
44303652|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44303653|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
44303654|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303655|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303656|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
44303657|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
44303658|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44303659|NCT00850005|Antibodies|antibodies|mesh-list
44303660|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
44303661|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44303687|NCT00850382|Daunorubicin|daunorubicin|mesh-list
44303689|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303690|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
44303691|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303692|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303693|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
44303694|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303695|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303696|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
44303697|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303698|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44303699|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44303700|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44303701|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303702|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44303703|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
44303704|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
44303705|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303706|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
44303707|NCT00850746|Z 338|z 338|mesh-list
44303708|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303709|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303710|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44303711|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44303712|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303713|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303714|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303715|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303716|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44303717|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
44303718|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303719|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44303727|NCT00850850|Miotics|miotics|mesh-ancestor
44303728|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
44303729|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303730|NCT00851175|Caffeine|caffeine|mesh-list
44303731|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44303732|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44303733|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44303734|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
44303735|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303736|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44303737|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44303738|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303739|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44303740|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303741|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44303742|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44303743|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44303744|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
44303745|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303746|NCT00851227|Conivaptan|conivaptan|mesh-list
44303747|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44303748|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303749|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
44303750|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303751|NCT00851344|Cetirizine|cetirizine|mesh-list
44303752|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44303753|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44303754|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44303755|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
44303756|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
44303757|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958638|NCT01379664|Sevoflurane|sevoflurane|mesh-list
44303758|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303759|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303760|NCT00851370|Omalizumab|omalizumab|mesh-list
44303761|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44119910|NCT00119314|Docetaxel|docetaxel|mesh-list
44303763|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303765|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44303766|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303767|NCT00851487|Amoxicillin|amoxicillin|mesh-list
44303768|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303769|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465825|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44465826|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44465827|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
44465828|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44465829|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44465830|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44465831|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44465832|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465833|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465834|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
44465835|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44465836|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465837|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44465838|NCT01471197|Pemetrexed|pemetrexed|mesh-list
44465839|NCT01471197|Ipilimumab|ipilimumab|mesh-list
44465840|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465841|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465842|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465843|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44465844|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44465845|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465846|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44465847|NCT01471171|Bromides|bromides|mesh-list
44465848|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
44465849|NCT01471093|Rebamipide|rebamipide|mesh-list
44465850|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44465851|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44465859|NCT01471054|Dexamethasone|dexamethasone|mesh-list
44465860|NCT01471054|Bevacizumab|bevacizumab|mesh-list
44465861|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44465862|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465863|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44465864|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44465865|NCT01471054|Growth Substances|growth substances|mesh-ancestor
44465866|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465867|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
44465868|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465869|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
44465870|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
44465871|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465872|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44465873|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
44465874|NCT01471054|Hormones|hormones|mesh-ancestor
44465875|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44465876|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44465877|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
44465878|NCT01471015|Hematinics|hematinics|mesh-ancestor
44465879|NCT01470989|Triamcinolone|triamcinolone|mesh-list
44465880|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44465881|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44465882|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44465883|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465884|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
44465885|NCT01470989|Hormones|hormones|mesh-ancestor
44465886|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303787|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44303788|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303789|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
44303790|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44303791|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
44303792|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303793|NCT00851708|Expectorants|expectorants|mesh-ancestor
44303794|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303795|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44303796|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
44303797|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303798|NCT00851708|Protective Agents|protective agents|mesh-ancestor
44303799|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303800|NCT00851708|Antidotes|antidotes|mesh-ancestor
44303801|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44303802|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44303803|NCT00851864|Tinzaparin|tinzaparin|mesh-list
44303804|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44303805|NCT00851864|Dalteparin|dalteparin|mesh-list
44303806|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
44303807|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44303808|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44303809|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303810|NCT00851929|Ambrisentan|ambrisentan|mesh-list
44303811|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44303812|NCT00851942|Cosyntropin|cosyntropin|mesh-list
44303813|NCT00851942|Hormones|hormones|mesh-ancestor
44303814|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44303815|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303816|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
44303817|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44303818|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303830|NCT00852059|Methylphenidate|methylphenidate|mesh-list
44303831|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44303832|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303833|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44303834|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44303835|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303836|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303837|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
44303838|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303839|NCT00852163|Busulfan|busulfan|mesh-list
44303840|NCT00852163|Clofarabine|clofarabine|mesh-list
44303841|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
44303842|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303843|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303844|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
44303845|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303846|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44303847|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44303848|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44303849|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44303850|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
44303851|NCT00852189|Folic Acid|folic acid|mesh-list
44303852|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
44303853|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
44303854|NCT00852189|Hematinics|hematinics|mesh-ancestor
44303855|NCT00852189|Vitamins|vitamins|mesh-ancestor
44303878|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303879|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44303880|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44303882|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
44303883|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303884|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303885|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303886|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44303887|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303888|NCT00852345|Clofazimine|clofazimine|mesh-list
44303889|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44303890|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
44303891|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44303892|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303893|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
44303894|NCT00852371|Piperaquine|piperaquine|mesh-list
44303895|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
44303896|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44303897|NCT00852371|Amodiaquine|amodiaquine|mesh-list
44303898|NCT00852371|Artenimol|artenimol|mesh-list
44303899|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
44303900|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44303901|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44303902|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44303903|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44303904|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44303905|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303906|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44303907|NCT00852371|Renal Agents|renal agents|mesh-ancestor
44303908|NCT00852410|Lidocaine|lidocaine|mesh-list
44303909|NCT00852410|Epinephrine|epinephrine|mesh-list
44303921|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303922|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303923|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44303924|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44303925|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
44303926|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44303927|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44303928|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44303929|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
44303930|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44303931|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44303932|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
44303933|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
44303934|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44303936|NCT00852423|Lumefantrine|lumefantrine|mesh-list
44303937|NCT00852423|Artemether|artemether|mesh-list
44303938|NCT00852423|Piperaquine|piperaquine|mesh-list
44303939|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44303940|NCT00852423|Amodiaquine|amodiaquine|mesh-list
44303941|NCT00852423|Artenimol|artenimol|mesh-list
44303942|NCT00852423|Mefloquine|mefloquine|mesh-list
44303943|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
44303977|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303978|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303979|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
44303980|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303981|NCT00852683|Pregabalin|pregabalin|mesh-list
44303982|NCT00852683|Analgesics|analgesics|mesh-ancestor
44303983|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
44303984|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44303985|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44303986|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
44303987|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44303988|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44303989|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44303990|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44303991|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44303992|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44303993|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44303994|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44303995|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
44303996|NCT00852709|Clofarabine|clofarabine|mesh-list
44303997|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44303998|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
44303999|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304000|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304001|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44304002|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
44304003|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304004|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304005|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44304006|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304007|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
44304008|NCT00852787|Digoxin|digoxin|mesh-list
44304009|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44304010|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44304015|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44304016|NCT00852956|Betahistine|betahistine|mesh-list
44304017|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
44304018|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
44304019|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
44304020|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304021|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304022|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304023|NCT00853008|Cytarabine|cytarabine|mesh-list
44304024|NCT00853008|Dexamethasone|dexamethasone|mesh-list
44304025|NCT00853008|Prednisone|prednisone|mesh-list
44304026|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
44304027|NCT00853008|Methotrexate|methotrexate|mesh-list
44304028|NCT00853008|Vincristine|vincristine|mesh-list
44304029|NCT00853008|Daunorubicin|daunorubicin|mesh-list
44304030|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
44304031|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
44304032|NCT00853008|Teniposide|teniposide|mesh-list
44304033|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304034|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
44304035|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
44304036|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304037|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304038|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304039|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
44304040|NCT00853008|Hormones|hormones|mesh-ancestor
44304041|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304042|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44304043|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304044|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44304045|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
44304046|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44304047|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304048|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
44304058|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304059|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44304060|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44304061|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44304062|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44304063|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44304064|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44304065|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44304066|NCT00853008|Analgesics|analgesics|mesh-ancestor
44304067|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
44304068|NCT00853177|Lidocaine|lidocaine|mesh-list
44304069|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
44304070|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
44304071|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304072|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465890|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304073|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
44304074|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304075|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44304076|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44304077|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44304078|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44304079|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304080|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
44304081|NCT00853190|Hydrocodone|hydrocodone|mesh-list
44304082|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304083|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304084|NCT00853190|Narcotics|narcotics|mesh-ancestor
44304085|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304086|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304087|NCT00853190|Analgesics|analgesics|mesh-ancestor
44304088|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
44304089|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304096|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
44304097|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304098|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44304099|NCT00853216|Oxycodone|oxycodone|mesh-list
44304100|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304101|NCT00853216|Narcotics|narcotics|mesh-ancestor
44304102|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304103|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304104|NCT00853216|Analgesics|analgesics|mesh-ancestor
44304105|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
44304106|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304107|NCT00853268|Oxycodone|oxycodone|mesh-list
44304108|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304109|NCT00853268|Narcotics|narcotics|mesh-ancestor
44304110|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304111|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304112|NCT00853268|Analgesics|analgesics|mesh-ancestor
44304113|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
44304114|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304115|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
44304116|NCT00853294|Hydrocodone|hydrocodone|mesh-list
44304117|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304118|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304119|NCT00853294|Narcotics|narcotics|mesh-ancestor
44304120|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304121|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304122|NCT00853294|Analgesics|analgesics|mesh-ancestor
44304123|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
44304124|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304125|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
44304126|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44304141|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465891|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304142|NCT00853411|Prednisone|prednisone|mesh-list
44304143|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304144|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
44304145|NCT00853411|Hormones|hormones|mesh-ancestor
44304146|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304147|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304148|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44304149|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304150|NCT00853450|Clopidogrel|clopidogrel|mesh-list
44304151|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44304152|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44304153|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44304154|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44304155|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
44304156|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304157|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304158|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304159|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
44304160|NCT00853502|Testosterone|testosterone|mesh-list
44304161|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
44304162|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
44304163|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44304164|NCT00853502|Androgens|androgens|mesh-ancestor
44304165|NCT00853502|Hormones|hormones|mesh-ancestor
44304170|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
44304185|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304186|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44304187|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44304188|NCT00853684|Growth Substances|growth substances|mesh-ancestor
44304189|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304190|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44304191|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
44304192|NCT00853697|Testosterone|testosterone|mesh-list
44304193|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
44304194|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
44304195|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44304196|NCT00853697|Dutasteride|dutasteride|mesh-list
44304197|NCT00853697|Androgens|androgens|mesh-ancestor
44304198|NCT00853697|Hormones|hormones|mesh-ancestor
44304199|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304200|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304201|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44304202|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304203|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
44304204|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44304205|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44304206|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304239|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304240|NCT00853892|Narcotics|narcotics|mesh-ancestor
44304241|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304242|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304243|NCT00853892|Analgesics|analgesics|mesh-ancestor
44304244|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
44304245|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304246|NCT00853931|Panitumumab|panitumumab|mesh-list
44304247|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44304248|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304249|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44304250|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44304251|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304252|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304253|NCT00853944|Incretins|incretins|mesh-ancestor
44304254|NCT00853944|Hormones|hormones|mesh-ancestor
44304255|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304256|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44304257|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304258|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304259|NCT00853983|Saracatinib|saracatinib|mesh-list
44304260|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304261|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304262|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304263|NCT00854009|BLI-489|bli-489|mesh-list
44304264|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44304265|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304266|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304267|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304283|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304284|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
44304285|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304286|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304287|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44304288|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
44304289|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304290|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304291|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44304292|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304293|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
44304294|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304295|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
44304296|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44304297|NCT00854178|Anesthetics|anesthetics|mesh-list
44304298|NCT00854178|Isoflurane|isoflurane|mesh-list
44304299|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304300|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304301|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
44304302|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44304303|NCT00854204|Darunavir|darunavir|mesh-list
44304304|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44304305|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44304306|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
44304307|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304308|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304309|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44304310|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44304311|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
44304312|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304313|NCT00854230|Naltrexone|naltrexone|mesh-list
44304314|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44304324|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304325|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44304326|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304327|NCT00854321|Rituximab|rituximab|mesh-list
44304328|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44304329|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304330|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
44304331|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304332|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304333|NCT00854425|Asparaginase|asparaginase|mesh-list
44304334|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304335|NCT00854451|Amoxicillin|amoxicillin|mesh-list
44304336|NCT00854451|Omeprazole|omeprazole|mesh-list
44304337|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304338|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304339|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44304340|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44304341|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44304342|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304343|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304344|NCT00854477|Capecitabine|capecitabine|mesh-list
44304345|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44304346|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
44304347|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304348|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304374|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304375|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
44304376|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44304377|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
44304378|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304379|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304380|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44304381|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
44304382|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44304383|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
44304384|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304385|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304386|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44304387|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
44304388|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
44304389|NCT00854711|Protective Agents|protective agents|mesh-ancestor
44304390|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44304391|NCT00854750|Hormones|hormones|mesh-ancestor
44304392|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304393|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304424|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304425|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44304426|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
44304427|NCT00854841|Dasatinib|dasatinib|mesh-list
44304428|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304429|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44304430|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304431|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304432|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
44304433|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44304434|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304435|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304436|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44304437|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44304438|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304439|NCT00855049|Acetaminophen|acetaminophen|mesh-list
44304440|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44304441|NCT00855049|Analgesics|analgesics|mesh-ancestor
44304442|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
44304443|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304444|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304445|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
44304447|NCT00855088|Darunavir|darunavir|mesh-list
44304448|NCT00855088|Etravirine|etravirine|mesh-list
44304449|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44304450|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44304451|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
44304452|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304453|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304454|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44304455|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44304456|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
44304457|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304458|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44304459|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44304460|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43724112|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44304461|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44304462|NCT00855101|Voriconazole|voriconazole|mesh-list
44304463|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
44304464|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304465|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44304466|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44304467|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304468|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304469|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44304470|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
44304471|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304472|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304473|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44304474|NCT00855114|Everolimus|everolimus|mesh-list
44304475|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304476|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304477|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
44304478|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304479|NCT00855153|Cycloserine|cycloserine|mesh-list
44304480|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44304481|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304482|NCT00855153|Renal Agents|renal agents|mesh-ancestor
44304483|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44304484|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
44304485|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304486|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
44304487|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304488|NCT00855205|Rituximab|rituximab|mesh-list
44304489|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44304490|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304491|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
44304492|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304493|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44465892|NCT01470612|Tofacitinib|tofacitinib|mesh-list
44465893|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465895|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465896|NCT01470599|Tofacitinib|tofacitinib|mesh-list
44465897|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465898|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465899|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465900|NCT01470469|Guanfacine|guanfacine|mesh-list
44465901|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44465902|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44465903|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44465904|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44465905|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
44465906|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465907|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465908|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465909|NCT01470417|Gemcitabine|gemcitabine|mesh-list
44465910|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44465911|NCT01470417|Paclitaxel|paclitaxel|mesh-list
44465912|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44465913|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
44465914|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304494|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
44304495|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304496|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
44304497|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44304498|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44304499|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44304500|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
44304501|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304502|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304503|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304516|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44304517|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44304518|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
44304519|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304520|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304521|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304522|NCT00855608|Adalimumab|adalimumab|mesh-list
44304523|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304524|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304525|NCT00855660|Riociguat|riociguat|mesh-list
44304526|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
44304527|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304528|NCT00855686|Memantine|memantine|mesh-list
44304529|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44304530|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44304531|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
44304532|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304533|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304534|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304535|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44304536|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44304537|NCT00855699|Acamprosate|acamprosate|mesh-list
44304538|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44304539|NCT00855777|Ibuprofen|ibuprofen|mesh-list
44304565|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44304566|NCT00856037|Topotecan|topotecan|mesh-list
44304567|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44304568|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304569|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44304571|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304572|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304573|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44304574|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44304575|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44304576|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44304577|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44304578|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304579|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44304580|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304581|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304582|NCT00856089|Retapamulin|retapamulin|mesh-list
44304583|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304584|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304585|NCT00856271|Losartan|losartan|mesh-list
44304586|NCT00856271|Olmesartan|olmesartan|mesh-list
44304587|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44304588|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44304589|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44304590|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44304591|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44304592|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304593|NCT00856310|Fasinumab|fasinumab|mesh-list
44304611|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
44304612|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
44304613|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304614|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304615|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
44304616|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44304617|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304618|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
44304619|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
44304620|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304621|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44304622|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
44304624|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304625|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304626|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
44304627|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304628|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44304629|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44304630|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
44304631|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44304632|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304633|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304634|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304635|NCT00856570|Warfarin|warfarin|mesh-list
44304636|NCT00856570|Mirabegron|mirabegron|mesh-list
44304637|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
44304638|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44304639|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44304657|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304659|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44304660|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44304661|NCT00856687|Montelukast|montelukast|mesh-list
44304662|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44304663|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44304664|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44304665|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
44304666|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304667|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304668|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44304669|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44304670|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304671|NCT00856700|Incretins|incretins|mesh-list
44304672|NCT00856700|Hormones|hormones|mesh-ancestor
44304713|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304714|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44304715|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304716|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304717|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44304720|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
44304721|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44304722|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44304723|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
44304724|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44304725|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44304726|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44304727|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44304728|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44304729|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304730|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304731|NCT00857142|Oxymorphone|oxymorphone|mesh-list
44304732|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304733|NCT00857142|Narcotics|narcotics|mesh-ancestor
44304734|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304735|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304736|NCT00857142|Analgesics|analgesics|mesh-ancestor
44304737|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
44304738|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304739|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44304740|NCT00857155|Clopidogrel|clopidogrel|mesh-list
44304749|NCT00857168|Testosterone|testosterone|mesh-list
44304760|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
44304761|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304762|NCT00857376|Protective Agents|protective agents|mesh-ancestor
44304763|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304764|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
44304765|NCT00857376|Vitamins|vitamins|mesh-ancestor
44304766|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
44304767|NCT00857428|Oxymorphone|oxymorphone|mesh-list
44304768|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304769|NCT00857428|Narcotics|narcotics|mesh-ancestor
44304770|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304771|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304772|NCT00857428|Analgesics|analgesics|mesh-ancestor
44304773|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
44304805|NCT00857753|Fentanyl|fentanyl|mesh-list
44304806|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44304807|NCT00857753|Narcotics|narcotics|mesh-ancestor
44304808|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304809|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304810|NCT00857753|Analgesics|analgesics|mesh-ancestor
44304811|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
44304812|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304813|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44304814|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44304815|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
44304816|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
44304817|NCT00857831|Vitamin D|vitamin d|mesh-list
44304818|NCT00857831|Calcium|calcium|mesh-list
44304819|NCT00857831|Vitamins|vitamins|mesh-ancestor
44304820|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
44304821|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304822|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44304823|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44304824|NCT00857870|Metformin|metformin|mesh-list
44304825|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
44304826|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304827|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304828|NCT00857909|Amiloride|amiloride|mesh-list
44304829|NCT00857909|Spironolactone|spironolactone|mesh-list
44304830|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44304831|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
44304832|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304852|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
44304853|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304854|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304855|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304856|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304857|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
44304858|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
44304859|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44304860|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44304861|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304916|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
44304917|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44304918|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44304919|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44304920|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44304921|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304922|NCT00858663|Cisplatin|cisplatin|mesh-list
44304923|NCT00858663|Everolimus|everolimus|mesh-list
44304924|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304925|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44304926|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
44304927|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304928|NCT00858676|Acarbose|acarbose|mesh-list
44304929|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44304930|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304931|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304932|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304933|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304934|NCT00858715|Aspirin|aspirin|mesh-list
44304935|NCT00858715|Clopidogrel|clopidogrel|mesh-list
44304936|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44304937|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44304938|NCT00858715|Analgesics|analgesics|mesh-ancestor
44304939|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
44304940|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304941|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304942|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44304943|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44304944|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44304960|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44304961|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
44304962|NCT00858767|Vitamin K|vitamin k|mesh-list
44304963|NCT00858767|Vitamin MK 7|vitamin mk 7|mesh-list
44304964|NCT00858767|Caseins|caseins|mesh-list
44304965|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
44304966|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
44304967|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304968|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44304969|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44304970|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
44304971|NCT00858767|Coagulants|coagulants|mesh-ancestor
44304972|NCT00858767|Vitamins|vitamins|mesh-ancestor
44304973|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
44304974|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304975|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
44304976|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44304977|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44304978|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44304979|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44304980|NCT00858897|Insulin|insulin|mesh-list
44304981|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44304982|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304983|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304984|NCT00859079|Insulin|insulin|mesh-list
44304985|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44304986|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44304987|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44304988|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44304989|NCT00859079|Incretins|incretins|mesh-ancestor
44304990|NCT00859079|Hormones|hormones|mesh-ancestor
44304991|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44304992|NCT00859105|Imiquimod|imiquimod|mesh-list
44304993|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44304994|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
44304998|NCT00859118|Axitinib|axitinib|mesh-list
44305002|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305003|NCT00859183|Sirolimus|sirolimus|mesh-list
44305004|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305005|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305006|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44305007|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305008|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
44305009|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305010|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
44305011|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305012|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
44305013|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44305014|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44305015|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305016|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
44305017|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44305018|NCT00859274|Budesonide|budesonide|mesh-list
44305019|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305020|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44305021|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
44305022|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305023|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305024|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44305025|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
44305026|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
44305027|NCT00859274|Hormones|hormones|mesh-ancestor
44305028|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305029|NCT00859352|Midazolam|midazolam|mesh-list
44305030|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44305031|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44305032|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305033|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305034|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44305035|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305036|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44119911|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119912|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
44119913|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119914|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305037|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44305038|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
44305039|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
44305040|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
44305041|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
44305042|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305043|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305044|NCT00859534|Afamelanotide|afamelanotide|mesh-list
44305045|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465932|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44465933|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
44465934|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44465935|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44465936|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
44465937|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44465938|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465939|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465940|NCT01470001|Urological Agents|urological agents|mesh-ancestor
44465941|NCT01469819|Lubiprostone|lubiprostone|mesh-list
44465942|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44465943|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44465944|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465945|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
44465946|NCT01469637|Mesalamine|mesalamine|mesh-list
44465947|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465948|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44465949|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44465950|NCT01469637|Analgesics|analgesics|mesh-ancestor
44465951|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
44465952|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44465953|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465954|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44465955|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119915|NCT00119314|Antiviral Agents|antiviral agents|mesh-ancestor
44119916|NCT00119314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119917|NCT00119314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119918|NCT00119314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119919|NCT00119314|Immunologic Factors|immunologic factors|mesh-ancestor
44119920|NCT00119314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119921|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
44119922|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
44465956|NCT01469546|Axitinib|axitinib|mesh-list
44465957|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465958|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44465959|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465960|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465961|NCT01469377|Cariprazine|cariprazine|mesh-list
44465962|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44465963|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305046|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
44305047|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44305048|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305049|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305050|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44305051|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305052|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44305053|NCT00859807|Amodiaquine|amodiaquine|mesh-list
44305054|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
44305055|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44305056|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44305057|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305058|NCT00859872|Haloperidol|haloperidol|mesh-list
44305059|NCT00859872|Risperidone|risperidone|mesh-list
44305060|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
44305061|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44305062|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
44305063|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305064|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305065|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305066|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44305067|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305068|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305080|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44305081|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44305082|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44305083|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44305084|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
44305085|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305086|NCT00859911|Micronutrients|micronutrients|mesh-list
44305087|NCT00859911|Trace Elements|trace elements|mesh-list
44305088|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305089|NCT00860119|Alprazolam|alprazolam|mesh-list
44305090|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44305091|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305092|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305093|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43648480|NCT02929927|Eusol|eusol|mesh-list
44305094|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305095|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305096|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
44305097|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
44305098|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305099|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305100|NCT00860223|Digoxin|digoxin|mesh-list
44305101|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305102|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44305103|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305104|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305105|NCT00860223|Protective Agents|protective agents|mesh-ancestor
44305106|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305123|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44305124|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
44305125|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305126|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305127|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44305129|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
44305130|NCT00860366|Uric Acid|uric acid|mesh-list
44305131|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
44305132|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305133|NCT00860366|Protective Agents|protective agents|mesh-ancestor
44305134|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305135|NCT00860496|Cyclosporine|cyclosporine|mesh-list
44305136|NCT00860496|Tacrolimus|tacrolimus|mesh-list
44305137|NCT00860496|Cyclosporins|cyclosporins|mesh-list
44305138|NCT00860496|Tofacitinib|tofacitinib|mesh-list
44305139|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305140|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
44305141|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305142|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44305143|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305144|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305145|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
44305146|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305147|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
44305148|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44305149|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44305150|NCT00860626|Interferons|interferons|mesh-list
44305151|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305152|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
44305153|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305154|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
44305155|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44305156|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305157|NCT00860899|Clonidine|clonidine|mesh-list
44305158|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
44305159|NCT00860899|Analgesics|analgesics|mesh-ancestor
44305162|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305164|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
44305165|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
44305166|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44305167|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44305168|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44305169|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305170|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305171|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305172|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
44305173|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
44305174|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305175|NCT00860925|Clonidine|clonidine|mesh-list
44305176|NCT00860925|Analgesics|analgesics|mesh-ancestor
44305177|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
44305178|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305179|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305180|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305181|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
44305182|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
44305183|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44305184|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44305185|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44305186|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305187|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305188|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119923|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
44119924|NCT00119340|Cyclosporine|cyclosporine|mesh-list
44119925|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
44119926|NCT00119340|Fludarabine|fludarabine|mesh-list
44119927|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
44119928|NCT00119340|Cyclosporins|cyclosporins|mesh-list
44119929|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119930|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119931|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
44119932|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119933|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119934|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
44119935|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119936|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119937|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
44119938|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44119939|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
44119940|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119941|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44119942|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44305189|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44305190|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44305191|NCT00860964|Estradiol|estradiol|mesh-list
44305192|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44305193|NCT00860964|Estrogens|estrogens|mesh-ancestor
44305194|NCT00860964|Hormones|hormones|mesh-ancestor
44305195|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305196|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305197|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44305198|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
44305199|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305200|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44305201|NCT00860977|Valacyclovir|valacyclovir|mesh-list
44305202|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
44305203|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305204|NCT00861016|Metoprolol|metoprolol|mesh-list
44305205|NCT00861016|Felodipine|felodipine|mesh-list
44305206|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305207|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305208|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
44305209|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
44305210|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305211|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305212|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44305213|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44305214|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44305215|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305216|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305217|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305218|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44305232|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
44305233|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305234|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305235|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44305236|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44305237|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44305238|NCT00861042|Lacosamide|lacosamide|mesh-list
44305239|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
44305240|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44305241|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44305242|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305243|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305244|NCT00861068|Lacosamide|lacosamide|mesh-list
44305245|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
44305246|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44305247|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44305248|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305249|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305250|NCT00861094|Leucovorin|leucovorin|mesh-list
44305251|NCT00861094|Folic Acid|folic acid|mesh-list
44305252|NCT00861094|Fluorouracil|fluorouracil|mesh-list
44305253|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
44305254|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
44305255|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305256|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
44305257|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305258|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44305259|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305260|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
44305261|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305276|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44305277|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44305278|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305279|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305280|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44305281|NCT00861250|Dexamethasone|dexamethasone|mesh-list
44305282|NCT00861250|Bortezomib|bortezomib|mesh-list
44305283|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305284|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
44305285|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
44305286|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305287|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305288|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305289|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
44305290|NCT00861250|Hormones|hormones|mesh-ancestor
44305291|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305292|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44305293|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305294|NCT00861276|Nicotine|nicotine|mesh-list
44305295|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44305296|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
44305297|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305298|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305299|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44305300|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44305301|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
44305302|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305303|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305304|NCT00861315|Amikacin|amikacin|mesh-list
44305305|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305306|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305307|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
44305308|NCT00861328|Irinotecan|irinotecan|mesh-list
44305309|NCT00861328|Camptothecin|camptothecin|mesh-list
44305310|NCT00861328|ON 01910|on 01910|mesh-list
44305311|NCT00861328|Glycine|glycine|mesh-list
44305316|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305317|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44305318|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44305319|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
44305320|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305321|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305322|NCT00861367|Aspirin|aspirin|mesh-list
44305323|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44305324|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44305325|NCT00861367|Analgesics|analgesics|mesh-ancestor
44305326|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
44305327|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305328|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305329|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305330|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44305331|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44305332|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44305333|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305334|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44305335|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44305336|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305337|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
44305338|NCT00861406|Interferons|interferons|mesh-list
44305339|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
44305340|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
44305341|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44305342|NCT00861406|Vaccines|vaccines|mesh-list
43960201|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
44305343|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
44305344|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305345|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305346|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
44305347|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305348|NCT00861419|Niacinamide|niacinamide|mesh-list
44305349|NCT00861419|Bevacizumab|bevacizumab|mesh-list
44305350|NCT00861419|Sunitinib|sunitinib|mesh-list
44305351|NCT00861419|Trebananib|trebananib|mesh-list
44305352|NCT00861419|Sorafenib|sorafenib|mesh-list
44119943|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44305353|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
44305355|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44305356|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305357|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44305358|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44305359|NCT00861419|Growth Substances|growth substances|mesh-ancestor
44305360|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305361|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
44305362|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44305363|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305364|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305365|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
44305366|NCT00861419|Vitamins|vitamins|mesh-ancestor
44305367|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
44465964|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44465965|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44465966|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44465967|NCT01469364|Aztreonam|aztreonam|mesh-list
44465968|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44465969|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44465970|NCT01469221|Apaziquone|apaziquone|mesh-list
44465971|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44465972|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
44465973|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44465974|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465975|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44465994|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
44465995|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44465996|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44465997|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44465998|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
44465999|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466000|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44466002|NCT01469000|Gefitinib|gefitinib|mesh-list
44466003|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466004|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466005|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466006|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44466007|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44466008|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466009|NCT01468987|Insulin|insulin|mesh-list
44466010|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44466011|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
44466012|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
44466013|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44466014|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305402|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
44305403|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305404|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
44305405|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
44305406|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305407|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305408|NCT00861627|Paclitaxel|paclitaxel|mesh-list
44305409|NCT00861627|Carboplatin|carboplatin|mesh-list
44305410|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44305411|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305412|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44305413|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44305414|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44305415|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305416|NCT00861640|Omeprazole|omeprazole|mesh-list
44305417|NCT00861640|Rabeprazole|rabeprazole|mesh-list
44305418|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44305419|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305420|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44305421|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305422|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305423|NCT00861731|Simvastatin|simvastatin|mesh-list
44305424|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44305425|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44305426|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
44305427|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305428|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44305429|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44305430|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305431|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
44305432|NCT00861783|Irinotecan|irinotecan|mesh-list
44305433|NCT00861783|Camptothecin|camptothecin|mesh-list
44305434|NCT00861783|ON 01910|on 01910|mesh-list
44305435|NCT00861783|Glycine|glycine|mesh-list
44305436|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305437|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44305438|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44305439|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305441|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44305442|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44305443|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
44305444|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305445|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305446|NCT00861861|Atorvastatin|atorvastatin|mesh-list
44305447|NCT00861861|Pitavastatin|pitavastatin|mesh-list
44305448|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44305449|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44305450|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
44305451|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305452|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44305453|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44305454|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305455|NCT00861874|Sirolimus|sirolimus|mesh-list
44305456|NCT00861874|Decitabine|decitabine|mesh-list
44305457|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44305458|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
44305459|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305460|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305461|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305462|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305463|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305469|NCT00861887|Vancomycin|vancomycin|mesh-list
44305492|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305494|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44305495|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
44305496|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305497|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44305498|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305499|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305500|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305501|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
44305502|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305503|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305504|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44305505|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44305506|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305507|NCT00861952|Mineral Oil|mineral oil|mesh-list
44305508|NCT00861952|Emollients|emollients|mesh-ancestor
44305509|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
44305510|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
44305511|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305512|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
44305513|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44305514|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44305540|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305541|NCT00862108|Methylphenidate|methylphenidate|mesh-list
44305542|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44305543|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305544|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44305545|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305546|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305547|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305548|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
44305549|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305550|NCT00862264|Beclomethasone|beclomethasone|mesh-list
44305551|NCT00862264|Norflurane|norflurane|mesh-list
44305552|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
44305553|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44305554|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
44305555|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305556|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305567|NCT00862264|Hormones|hormones|mesh-ancestor
44305595|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44305596|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305597|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305598|NCT00862420|Ticlopidine|ticlopidine|mesh-list
44305599|NCT00862420|Clopidogrel|clopidogrel|mesh-list
44305600|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44305601|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44305602|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44305603|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44305604|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
44305605|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305606|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305607|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305608|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44305609|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44305610|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44305611|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44305612|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305613|NCT00862472|Timolol|timolol|mesh-list
44305614|NCT00862472|Cloprostenol|cloprostenol|mesh-list
44305615|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
44305616|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44305617|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
44305618|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305619|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305620|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44305621|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44305622|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44305623|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
44119944|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
44119945|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44119946|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44119947|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44119948|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44119949|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
44119950|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154551|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44154552|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44154553|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154554|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305624|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305625|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305626|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305627|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305628|NCT00862628|Rebamipide|rebamipide|mesh-list
44305629|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44305630|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305631|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
44305632|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305633|NCT00862628|Protective Agents|protective agents|mesh-ancestor
44305634|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305635|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305636|NCT00862693|Calcitriol|calcitriol|mesh-list
44305637|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44305638|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305639|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44305640|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305641|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305642|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44305643|NCT00862693|Vitamins|vitamins|mesh-ancestor
44305644|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
44305645|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44305646|NCT00862706|Telbivudine|telbivudine|mesh-list
44305647|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
44305648|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305649|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44305650|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305651|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305652|NCT00862875|Insulin|insulin|mesh-list
44305653|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44305654|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
44305666|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
44305667|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305668|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44305669|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44305671|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
44305672|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305673|NCT00863148|Busulfan|busulfan|mesh-list
44305674|NCT00863148|Clofarabine|clofarabine|mesh-list
44305675|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
44305676|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305677|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305678|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
44305679|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305680|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44305681|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305682|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44305683|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44305684|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
44305685|NCT00863161|Lesogaberan|lesogaberan|mesh-list
44305686|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305687|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44305688|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
44305689|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
44305690|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305691|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305692|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305693|NCT00863187|Rituximab|rituximab|mesh-list
44305694|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44305695|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305696|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
44305701|NCT00863239|Ribavirin|ribavirin|mesh-list
44305711|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305712|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
44305713|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44305714|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305715|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44305716|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
44305717|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44305718|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305719|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305720|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466016|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44466017|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44466018|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466019|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
44466020|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
44466021|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
44466022|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466023|NCT01468844|Minocycline|minocycline|mesh-list
44466024|NCT01468844|Bevacizumab|bevacizumab|mesh-list
44466025|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466026|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466027|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44466028|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44466029|NCT01468844|Growth Substances|growth substances|mesh-ancestor
44466030|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466031|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
44466032|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466033|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466034|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
44305734|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305735|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
44305736|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305737|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305738|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44305739|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44305740|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305741|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305742|NCT00863460|Cytarabine|cytarabine|mesh-list
44305743|NCT00863460|Prednisone|prednisone|mesh-list
44305744|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
44305745|NCT00863460|Busulfan|busulfan|mesh-list
44305746|NCT00863460|Thiotepa|thiotepa|mesh-list
44305747|NCT00863460|Carmustine|carmustine|mesh-list
44305748|NCT00863460|Methotrexate|methotrexate|mesh-list
44305749|NCT00863460|Etoposide|etoposide|mesh-list
44305750|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44305751|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
44305752|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305753|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44305754|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44305755|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
44305756|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305757|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305758|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44305759|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305760|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
44305761|NCT00863460|Hormones|hormones|mesh-ancestor
44305762|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305763|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44305764|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44305765|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
44305766|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44305774|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44305775|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44305776|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
44305777|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305778|NCT00863499|Methylphenidate|methylphenidate|mesh-list
44305779|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44305780|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305781|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44305782|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305783|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305784|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305785|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
44305786|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305787|NCT00863577|Bemiparin|bemiparin|mesh-list
44305788|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
44305789|NCT00863629|Insulin|insulin|mesh-list
44305790|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44305791|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305792|NCT00863668|Tenofovir|tenofovir|mesh-list
44305793|NCT00863668|Emtricitabine|emtricitabine|mesh-list
44305794|NCT00863668|Efavirenz|efavirenz|mesh-list
44305795|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
44466037|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
44305798|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
44305825|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
44305826|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305827|NCT00863785|Protective Agents|protective agents|mesh-ancestor
44305828|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305829|NCT00863785|Antidotes|antidotes|mesh-ancestor
44305830|NCT00863837|Terlipressin|terlipressin|mesh-list
44305831|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44305832|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44305833|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44305834|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305835|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305836|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44305837|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44305838|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
44305839|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305840|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305841|NCT00863863|Griseofulvin|griseofulvin|mesh-list
44305842|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
44305843|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305844|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44305845|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
44305846|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44305847|NCT00863889|Prednisolone|prednisolone|mesh-list
44305848|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
44305849|NCT00863889|Lidocaine|lidocaine|mesh-list
44305850|NCT00863889|Bupivacaine|bupivacaine|mesh-list
44305851|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44305852|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
44305853|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44305854|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
44305855|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305856|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305857|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
44305858|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305859|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44305860|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43725227|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44154557|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305861|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44305862|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305863|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305864|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44305865|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
44305866|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
44305867|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305868|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
44305869|NCT00863889|Hormones|hormones|mesh-ancestor
44305870|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44305871|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44305872|NCT00863889|Protective Agents|protective agents|mesh-ancestor
44305873|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44305874|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44305875|NCT00863902|Cetirizine|cetirizine|mesh-list
44305876|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44305877|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44305878|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44305879|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
44305880|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
44305881|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305913|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44305914|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305915|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
44305916|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305917|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305918|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
44305919|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305920|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305921|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305922|NCT00864019|Sertraline|sertraline|mesh-list
44305923|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
44305924|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305925|NCT00864019|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44305926|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305927|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305928|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305929|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305930|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
44305931|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305932|NCT00864045|Olanzapine|olanzapine|mesh-list
44305933|NCT00864045|Sertindole|sertindole|mesh-list
44305934|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
44305935|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
44305936|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305937|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305938|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44305939|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44305940|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305941|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305942|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305944|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44305945|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44305946|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305947|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305948|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
44154559|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
44305950|NCT00864058|Analgesics|analgesics|mesh-ancestor
44305951|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
44305952|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44305953|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44305954|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
44305955|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44305956|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44305957|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44305958|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44305959|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44305960|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44305961|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44305962|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44305963|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
44305964|NCT00864071|Griseofulvin|griseofulvin|mesh-list
44305965|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
44305966|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44305967|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
44305968|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44305969|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44305970|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306001|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306002|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306003|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306004|NCT00864188|Beta Carotene|beta carotene|mesh-list
44306005|NCT00864188|Carotenoids|carotenoids|mesh-list
44306006|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
44306007|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306008|NCT00864188|Protective Agents|protective agents|mesh-ancestor
44306009|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306010|NCT00864188|Provitamins|provitamins|mesh-ancestor
44306011|NCT00864188|Vitamins|vitamins|mesh-ancestor
44306012|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
44306013|NCT00864201|Bosentan|bosentan|mesh-list
44306014|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306015|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43960895|NCT01462279|Thiamine|thiamine|mesh-list
44306016|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306017|NCT00864214|Hormones|hormones|mesh-list
44306018|NCT00864214|Estradiol|estradiol|mesh-list
44306019|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306020|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306021|NCT00864214|Estrogens|estrogens|mesh-ancestor
44306022|NCT00864240|Clobetasol|clobetasol|mesh-list
44306023|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306024|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
44306025|NCT00864240|Hormones|hormones|mesh-ancestor
44306027|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306049|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306050|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306051|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
44306052|NCT00864318|Paclitaxel|paclitaxel|mesh-list
44306053|NCT00864318|Etoposide|etoposide|mesh-list
44306054|NCT00864318|Ifosfamide|ifosfamide|mesh-list
44306055|NCT00864318|Carboplatin|carboplatin|mesh-list
44306056|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44306057|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306058|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44306059|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44306060|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44306061|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306062|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44306063|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44306064|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306065|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44306066|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
44306067|NCT00864344|Sertraline|sertraline|mesh-list
44306068|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306069|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306070|NCT00864344|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44306071|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306072|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306099|NCT00864409|Ropivacaine|ropivacaine|mesh-list
44306100|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
44306101|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
44306102|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306103|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306104|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
44306105|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306106|NCT00864435|Carvedilol|carvedilol|mesh-list
44306107|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44306108|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306109|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306110|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306111|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306112|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306113|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306114|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
44306115|NCT00864435|Protective Agents|protective agents|mesh-ancestor
44306116|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44306117|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306118|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44306119|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306120|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44306122|NCT00864448|Ramipril|ramipril|mesh-list
44306149|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306150|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306151|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306152|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306153|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44306154|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306155|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306156|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44306157|NCT00864526|Narcotics|narcotics|mesh-ancestor
44306158|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306159|NCT00864552|Factor VIII|factor viii|mesh-list
44306160|NCT00864552|Coagulants|coagulants|mesh-ancestor
44306161|NCT00864565|Fentanyl|fentanyl|mesh-list
44306162|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44306163|NCT00864565|Narcotics|narcotics|mesh-ancestor
44306164|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306165|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306166|NCT00864565|Analgesics|analgesics|mesh-ancestor
44306167|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
44306168|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306169|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44306170|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44306171|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
44306172|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
44306173|NCT00864591|Adenosine|adenosine|mesh-list
44306174|NCT00864591|Analgesics|analgesics|mesh-ancestor
44306175|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
44306197|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306199|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44306200|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306201|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306202|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44306203|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306204|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306205|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
44306206|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44306207|NCT00864643|Atorvastatin|atorvastatin|mesh-list
44306208|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44306209|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44306210|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
44306211|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306212|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44306213|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44306214|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306215|NCT00864669|Metformin|metformin|mesh-list
44306216|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306217|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306218|NCT00864734|Metformin|metformin|mesh-list
44306219|NCT00864734|Glyburide|glyburide|mesh-list
44306220|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306221|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306222|NCT00864747|Propranolol|propranolol|mesh-list
44306223|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44306224|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306225|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306226|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306227|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961112|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
44306239|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306240|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306241|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306242|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306243|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306244|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306245|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306246|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
44306247|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
44306248|NCT00864773|Growth Substances|growth substances|mesh-ancestor
44306249|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306250|NCT00864799|Misoprostol|misoprostol|mesh-list
44306251|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44306252|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
44306253|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44306254|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306255|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44306256|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44306257|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
44306258|NCT00864812|Fluticasone|fluticasone|mesh-list
44306259|NCT00864812|Xhance|xhance|mesh-list
44306260|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
44306261|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44306262|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44306263|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306264|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44306265|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
44306266|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306267|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306283|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306284|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
44306285|NCT00864825|Allopurinol|allopurinol|mesh-list
44306286|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
44306287|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306288|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306289|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
44306290|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306291|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44306292|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
44306293|NCT00864825|Protective Agents|protective agents|mesh-ancestor
44306294|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306295|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44306296|NCT00864838|Acetazolamide|acetazolamide|mesh-list
44306297|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306298|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44306299|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44306300|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44306301|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306302|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306304|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306335|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
44306336|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306337|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44306338|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44306339|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
44306340|NCT00864942|Lenalidomide|lenalidomide|mesh-list
44306341|NCT00864942|Rituximab|rituximab|mesh-list
44306342|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44306343|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
44306344|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306345|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44306346|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44306347|NCT00864942|Growth Substances|growth substances|mesh-ancestor
44306348|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
44306349|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306350|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44306351|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306352|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44306353|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
44306354|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306355|NCT00864968|Nabumetone|nabumetone|mesh-list
44306356|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44306357|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44306358|NCT00864968|Analgesics|analgesics|mesh-ancestor
44306359|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
44306360|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306361|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306362|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44306363|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306364|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44306365|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44306366|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306367|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306368|NCT00864981|Bupropion|bupropion|mesh-list
44306369|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43725618|NCT02596776|Propranolol|propranolol|mesh-list
44306371|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306372|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44306373|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306374|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306375|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306376|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
44306377|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306378|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306379|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44306380|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306381|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466038|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466039|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466040|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961237|NCT01474122|Macitentan|macitentan|mesh-list
44306383|NCT00865007|Lopinavir|lopinavir|mesh-list
44306384|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44306385|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44306386|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44306387|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306388|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306389|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44306390|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44306391|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
44306392|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306393|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44306394|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306395|NCT00865033|Metformin|metformin|mesh-list
44306396|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306397|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306398|NCT00865059|Gabapentin|gabapentin|mesh-list
44306399|NCT00865059|Analgesics|analgesics|mesh-ancestor
44306400|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
44306401|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306406|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306407|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306408|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306409|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306410|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306411|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306412|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
44306413|NCT00865072|Metformin|metformin|mesh-list
44306414|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306415|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306416|NCT00865085|Dexetimide|dexetimide|mesh-list
44306417|NCT00865085|Citalopram|citalopram|mesh-list
44306418|NCT00865085|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44306419|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306420|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306421|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306422|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306423|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
44306424|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306425|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306426|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306427|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306428|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44306429|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306430|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
44306431|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
44306432|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306433|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44306434|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44306435|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
44306436|NCT00865111|Bupropion|bupropion|mesh-list
44306437|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306438|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306439|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725689|NCT02596269|Nefopam|nefopam|mesh-list
44154560|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154561|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154562|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154563|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
44154564|NCT00224315|Risperidone|risperidone|mesh-list
44306440|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44306441|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306442|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306443|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306444|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
44306445|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306446|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306447|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44306502|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306503|NCT00865384|Mirtazapine|mirtazapine|mesh-list
44306504|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306505|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306506|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44306507|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
44306508|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
44306509|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306510|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306511|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306512|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306513|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306514|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306515|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44306516|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44306517|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306518|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306519|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44306520|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44306521|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
44306522|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44306523|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
44306524|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306525|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306526|NCT00865410|Bupropion|bupropion|mesh-list
44306527|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306528|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306529|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306530|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44306531|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306532|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306533|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306534|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
44306535|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306536|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306537|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44306538|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306539|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306540|NCT00865423|Gabapentin|gabapentin|mesh-list
44306541|NCT00865423|Analgesics|analgesics|mesh-ancestor
44306542|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
44306543|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306544|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306545|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
44306546|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306547|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306548|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306549|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306550|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306551|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306552|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306553|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306554|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
44306555|NCT00865436|Metformin|metformin|mesh-list
44306556|NCT00865436|Glyburide|glyburide|mesh-list
44306557|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306558|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306559|NCT00865449|Spironolactone|spironolactone|mesh-list
44306560|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44306561|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306562|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306563|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306564|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44306565|NCT00865449|Diuretics|diuretics|mesh-ancestor
44306566|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
44306567|NCT00865462|Bupropion|bupropion|mesh-list
44306568|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306569|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
44306576|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306577|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306578|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44306579|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306580|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306581|NCT00865501|Spironolactone|spironolactone|mesh-list
44306582|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44306583|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306584|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306585|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306586|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44306587|NCT00865501|Diuretics|diuretics|mesh-ancestor
44306588|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
44306589|NCT00865540|Prednisolone|prednisolone|mesh-list
44306590|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44306634|NCT00865618|Diuretics|diuretics|mesh-ancestor
44306635|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
44306636|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306637|NCT00865631|Gabapentin|gabapentin|mesh-list
44306638|NCT00865631|Analgesics|analgesics|mesh-ancestor
44306639|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
44306640|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306641|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306642|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
44306643|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306644|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306645|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306646|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306647|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306648|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306649|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306650|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306651|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
44306652|NCT00865644|Imiquimod|imiquimod|mesh-list
44306653|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44306654|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
44306655|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306656|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306657|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
44306658|NCT00865657|Alprazolam|alprazolam|mesh-list
44306659|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44306660|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306661|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306681|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306682|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306683|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306684|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44306685|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44306686|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306687|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306688|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44306689|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44306690|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
44306691|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44306692|NCT00865748|Metformin|metformin|mesh-list
44306693|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306694|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306695|NCT00865761|Alprazolam|alprazolam|mesh-list
44306696|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44306697|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306698|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306699|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44306700|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306701|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306702|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
44306703|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
44306704|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306705|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306706|NCT00865839|Metformin|metformin|mesh-list
44306707|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44306708|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306709|NCT00865852|Metformin|metformin|mesh-list
44306726|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44306727|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44306728|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
44306729|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
44306730|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306731|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306732|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44306733|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44306734|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
44306735|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306736|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306737|NCT00865943|Dexetimide|dexetimide|mesh-list
44306738|NCT00865943|Citalopram|citalopram|mesh-list
44306739|NCT00865943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44306740|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44306741|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44306743|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306782|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44306783|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
44306784|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306785|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306786|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44306787|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44306788|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
44306789|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306790|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44306791|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44306792|NCT00866060|Memantine|memantine|mesh-list
44306793|NCT00866060|Donepezil|donepezil|mesh-list
44306794|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44306795|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306796|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306797|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
44306798|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306799|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306800|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
44306801|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44306802|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306803|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
44306804|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44306805|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44306806|NCT00866073|Decitabine|decitabine|mesh-list
44306807|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44306808|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
44306809|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306810|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306811|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306812|NCT00866216|Azithromycin|azithromycin|mesh-list
44306813|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44306814|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306822|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44306823|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961692|NCT01488188|Vaccines|vaccines|mesh-list
44306824|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44306825|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44306826|NCT00866437|Estropipate|estropipate|mesh-list
44306827|NCT00866437|Estradiol|estradiol|mesh-list
44306828|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44306829|NCT00866437|Estrone|estrone|mesh-list
44306830|NCT00866437|Progesterone|progesterone|mesh-list
44306831|NCT00866437|Estrogens|estrogens|mesh-ancestor
44306832|NCT00866437|Hormones|hormones|mesh-ancestor
44306833|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306834|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306835|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44306836|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
44306837|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44306838|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44306839|NCT00866437|Progestins|progestins|mesh-ancestor
44306840|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
44306841|NCT00866450|Calcium|calcium|mesh-list
44306842|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44306843|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306844|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44306845|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
44306846|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306847|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44306848|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44306849|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306850|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306851|NCT00866463|Urological Agents|urological agents|mesh-ancestor
44306852|NCT00866515|Ketoconazole|ketoconazole|mesh-list
44306853|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
44306854|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306855|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44306860|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306861|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306862|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306863|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44306864|NCT00866528|Paclitaxel|paclitaxel|mesh-list
44306865|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44306866|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306867|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
44306868|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
44306869|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
44306870|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306871|NCT00866554|Tamoxifen|tamoxifen|mesh-list
44306872|NCT00866554|Bicalutamide|bicalutamide|mesh-list
44306873|NCT00866554|Dutasteride|dutasteride|mesh-list
44306874|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44306875|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
44306876|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44306877|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306878|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44306879|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306880|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44306881|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44306883|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
44306909|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
44306910|NCT00866645|Sulpiride|sulpiride|mesh-list
44306911|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44306912|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
44306913|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
44306914|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44306915|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306916|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44306917|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44306918|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44306919|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44306920|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44306921|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44306922|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
44306923|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44306924|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306925|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44306926|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44306927|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44466042|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466045|NCT01468311|Daclizumab|daclizumab|mesh-list
44466075|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466076|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
44466077|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44466078|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44466079|NCT01467505|Interferons|interferons|mesh-list
44466080|NCT01467505|Ribavirin|ribavirin|mesh-list
44466081|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
44466082|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
44466083|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44466084|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44466085|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466086|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
44466087|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466088|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
44306928|NCT00866684|Cyclosporine|cyclosporine|mesh-list
44306929|NCT00866684|Sirolimus|sirolimus|mesh-list
44306930|NCT00866684|Azathioprine|azathioprine|mesh-list
44306931|NCT00866684|Tacrolimus|tacrolimus|mesh-list
44306932|NCT00866684|Cyclosporins|cyclosporins|mesh-list
44306933|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44306934|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
44306935|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306936|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44306937|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306938|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306939|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
44306940|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306941|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
44306942|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44306943|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44306944|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306945|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44306946|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
44306947|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44306948|NCT00866736|Dasatinib|dasatinib|mesh-list
44306949|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306950|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44306951|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306954|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44306955|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306956|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306957|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306958|NCT00866853|Simeprevir|simeprevir|mesh-list
44306959|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
44306960|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306961|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44306962|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306963|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306964|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
44306965|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44306966|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
44306967|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44306968|NCT00866866|Expectorants|expectorants|mesh-ancestor
44306969|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
44306970|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44306971|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
44306972|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306973|NCT00866866|Protective Agents|protective agents|mesh-ancestor
44306974|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306975|NCT00866866|Antidotes|antidotes|mesh-ancestor
44306976|NCT00866944|Leucovorin|leucovorin|mesh-list
44306977|NCT00866944|Fluorouracil|fluorouracil|mesh-list
44306978|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
44306979|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44306980|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
44306981|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306982|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44306983|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44306984|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44306985|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
44306986|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44306987|NCT00866944|Antidotes|antidotes|mesh-ancestor
44306988|NCT00866944|Protective Agents|protective agents|mesh-ancestor
44306989|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
44306990|NCT00866944|Vitamins|vitamins|mesh-ancestor
44306991|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
44306992|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
44306993|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
44306994|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44306995|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44306996|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44306997|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44306998|NCT00866983|Urological Agents|urological agents|mesh-ancestor
44306999|NCT00866996|Methylphenidate|methylphenidate|mesh-list
44307000|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44307001|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44307002|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307003|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44307004|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44307005|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307006|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307007|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
44307008|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307009|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44307010|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307012|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307013|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307014|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307015|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307016|NCT00867126|Pioglitazone|pioglitazone|mesh-list
44307017|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44307018|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307019|NCT00867152|Ritonavir|ritonavir|mesh-list
44307020|NCT00867152|Lopinavir|lopinavir|mesh-list
44307021|NCT00867152|Darunavir|darunavir|mesh-list
44307022|NCT00867152|Dolutegravir|dolutegravir|mesh-list
44307023|NCT00867152|Etravirine|etravirine|mesh-list
44307024|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44307025|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44307026|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307027|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726113|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44154565|NCT00224315|Ziprasidone|ziprasidone|mesh-list
44307028|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307029|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44307030|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44307031|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
44307032|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307033|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44307034|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44307035|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44307036|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44307037|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44307038|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44307040|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307041|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307042|NCT00867672|Decitabine|decitabine|mesh-list
44307043|NCT00867672|Tretinoin|tretinoin|mesh-list
44307044|NCT00867672|Valproic Acid|valproic acid|mesh-list
44307045|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307046|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
44307047|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307048|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307049|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307079|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44307080|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44307081|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307082|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307083|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307084|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
44307085|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
44307086|NCT00867867|Trace Elements|trace elements|mesh-ancestor
44307087|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
44307088|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307089|NCT00868010|Donepezil|donepezil|mesh-list
44307090|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44307091|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307092|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307140|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307141|NCT00868426|Budesonide|budesonide|mesh-list
44307142|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
44307143|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44307144|NCT00868426|Charcoal|charcoal|mesh-list
44307145|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307146|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44307147|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
44307148|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307149|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307150|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44307151|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
44307152|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
44307153|NCT00868426|Hormones|hormones|mesh-ancestor
44307154|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307155|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44307156|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44307157|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44307158|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
44307159|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307160|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307162|NCT00868426|Protective Agents|protective agents|mesh-ancestor
44307163|NCT00868465|Lumefantrine|lumefantrine|mesh-list
44307164|NCT00868465|Artemether|artemether|mesh-list
44307165|NCT00868465|Piperaquine|piperaquine|mesh-list
44307166|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44307167|NCT00868465|Artenimol|artenimol|mesh-list
44307168|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
44307169|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44307170|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44307171|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307172|NCT00868491|Cisplatin|cisplatin|mesh-list
44307173|NCT00868491|Docetaxel|docetaxel|mesh-list
44307174|NCT00868491|Fluorouracil|fluorouracil|mesh-list
44307175|NCT00868491|Cetuximab|cetuximab|mesh-list
44307176|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307177|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307181|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
44307182|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307183|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307184|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
44307185|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307186|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307187|NCT00868569|Leucovorin|leucovorin|mesh-list
44307188|NCT00868569|Fluorouracil|fluorouracil|mesh-list
44307189|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
44307190|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
44307191|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307192|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307193|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307194|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307195|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
44307196|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307197|NCT00868569|Antidotes|antidotes|mesh-ancestor
44307198|NCT00868569|Protective Agents|protective agents|mesh-ancestor
44307199|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
44307200|NCT00868569|Vitamins|vitamins|mesh-ancestor
44307201|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
44307202|NCT00868634|Bevacizumab|bevacizumab|mesh-list
44307203|NCT00868634|Capecitabine|capecitabine|mesh-list
44307204|NCT00868634|Vinorelbine|vinorelbine|mesh-list
44307205|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307206|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307207|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44307208|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44307209|NCT00868634|Growth Substances|growth substances|mesh-ancestor
44307210|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307211|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
44307213|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
44307226|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
44307227|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307228|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307229|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307230|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44307231|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
44307232|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307233|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466089|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466090|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
44466091|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466092|NCT01467492|Interferons|interferons|mesh-list
44466093|NCT01467492|Ribavirin|ribavirin|mesh-list
44466094|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
44466095|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
44466096|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44466097|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466098|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
44466099|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466100|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
44466101|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466102|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
44466103|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466104|NCT01467479|Interferons|interferons|mesh-list
44466105|NCT01467479|Ribavirin|ribavirin|mesh-list
44466106|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
44466130|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44466131|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
44466132|NCT01467076|Urological Agents|urological agents|mesh-ancestor
44466133|NCT01466790|Ribavirin|ribavirin|mesh-list
44466134|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
44466135|NCT01466790|Simeprevir|simeprevir|mesh-list
44466136|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
44466137|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466138|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
44466139|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466140|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466141|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466142|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
44466143|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44466144|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44466145|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44466146|NCT01466673|Desogestrel|desogestrel|mesh-list
44466147|NCT01466673|Norgestimate|norgestimate|mesh-list
44466148|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44466149|NCT01466673|Estradiol|estradiol|mesh-list
44466150|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44466151|NCT01466673|Estrogens|estrogens|mesh-ancestor
44466152|NCT01466673|Hormones|hormones|mesh-ancestor
44466153|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466154|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466155|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44466156|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
44466157|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44466158|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44466159|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44466160|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44466161|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44466162|NCT01466673|Progestins|progestins|mesh-ancestor
44466163|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466164|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307234|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
44307240|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44307242|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
44307243|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307244|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
44307245|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307246|NCT00868829|Trace Elements|trace elements|mesh-ancestor
44307247|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
44307248|NCT00868855|Bradykinin|bradykinin|mesh-list
44307249|NCT00868855|Kininogens|kininogens|mesh-list
44307250|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
44307251|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44307252|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307253|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307254|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307255|NCT00868894|Latanoprost|latanoprost|mesh-list
44307256|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44307257|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44307258|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
44307259|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
44307260|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44307261|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307262|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307263|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44307264|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307265|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44307266|NCT00868946|Ribavirin|ribavirin|mesh-list
44307267|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
44307272|NCT00868985|Laxatives|laxatives|mesh-ancestor
44307286|NCT00869180|Diclofenac|diclofenac|mesh-list
44307287|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44307288|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44307289|NCT00869180|Analgesics|analgesics|mesh-ancestor
44307290|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
44307291|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307292|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307293|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307294|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307295|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44307296|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307297|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307298|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
44307299|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44307300|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307301|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
44307302|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307303|NCT00869193|Protective Agents|protective agents|mesh-ancestor
44307343|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44307344|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307345|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307346|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307347|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307348|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44307349|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307350|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44307351|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44307352|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
44307353|NCT00869427|Ascorbic Acid|ascorbic acid|mesh-list
44307354|NCT00869427|Vitamins|vitamins|mesh-ancestor
44307355|NCT00869427|Micronutrients|micronutrients|mesh-ancestor
44307357|NCT00869427|Antioxidants|antioxidants|mesh-ancestor
44307405|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44307406|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44307407|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307408|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307409|NCT00869765|Cycloserine|cycloserine|mesh-list
44307410|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44307411|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307412|NCT00869765|Renal Agents|renal agents|mesh-ancestor
44307413|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44307414|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
44307415|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307416|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
44307418|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
44307466|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44307467|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307468|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
44307469|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44307470|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44307471|NCT00870220|Estradiol|estradiol|mesh-list
44307472|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44307473|NCT00870220|Estrogens|estrogens|mesh-ancestor
44307474|NCT00870220|Hormones|hormones|mesh-ancestor
44307475|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307476|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307477|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44307478|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
44307479|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44307480|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44307481|NCT00870272|Misoprostol|misoprostol|mesh-list
44307482|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44307483|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
44307484|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44307485|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307486|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44307487|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307488|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
44307489|NCT00870298|Trimethoprim|trimethoprim|mesh-list
44307490|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
44307515|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307516|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44307517|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
44307518|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307519|NCT00870402|Spironolactone|spironolactone|mesh-list
44307520|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44307521|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
44307522|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307523|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307524|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44307525|NCT00870402|Diuretics|diuretics|mesh-ancestor
44307526|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
44307527|NCT00870441|Valacyclovir|valacyclovir|mesh-list
44307528|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
44307529|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307530|NCT00870480|Finasteride|finasteride|mesh-list
44307531|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44307532|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44307533|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307534|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307535|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44307536|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307537|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307538|NCT00870480|Urological Agents|urological agents|mesh-ancestor
44307539|NCT00870532|Sorafenib|sorafenib|mesh-list
44307540|NCT00870532|Vinorelbine|vinorelbine|mesh-list
44307551|NCT00870571|Amlodipine|amlodipine|mesh-list
44307560|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307562|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44307563|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44307564|NCT00870636|Growth Substances|growth substances|mesh-ancestor
44307565|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307566|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
44466165|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44466166|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466167|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466168|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466169|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466170|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44466171|NCT01466660|Gefitinib|gefitinib|mesh-list
44466172|NCT01466660|Afatinib|afatinib|mesh-list
44466173|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466174|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466175|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466176|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466177|NCT01466595|Rifaximin|rifaximin|mesh-list
44466178|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466179|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466180|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44466181|NCT01466491|Lidocaine|lidocaine|mesh-list
44466182|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
44466206|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466207|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466208|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44307567|NCT00870714|Ketoconazole|ketoconazole|mesh-list
44307569|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307570|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
44307571|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
44307572|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
44307573|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307574|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
44307575|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307576|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44307577|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44307578|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307579|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44307624|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307625|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307626|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
44307627|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
44307628|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307629|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307630|NCT00871052|Vitamin D|vitamin d|mesh-list
44307631|NCT00871052|Calcipotriene|calcipotriene|mesh-list
44307632|NCT00871052|Vitamins|vitamins|mesh-ancestor
44307633|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
44307634|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307635|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44307636|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307637|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
44307638|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307639|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
44307640|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43962527|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
44307641|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44307642|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307643|NCT00871065|Urological Agents|urological agents|mesh-ancestor
44307644|NCT00871104|Vancomycin|vancomycin|mesh-list
44307645|NCT00871104|Imipenem|imipenem|mesh-list
44307646|NCT00871104|Fosfomycin|fosfomycin|mesh-list
44307647|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307648|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307649|NCT00871156|Chloroquine|chloroquine|mesh-list
44307650|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44307651|NCT00871156|Tafenoquine|tafenoquine|mesh-list
44307652|NCT00871156|Amebicides|amebicides|mesh-ancestor
44307653|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44307654|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44307655|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307656|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
44307657|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44307658|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44307660|NCT00871156|Analgesics|analgesics|mesh-ancestor
44307665|NCT00871156|Filaricides|filaricides|mesh-ancestor
44307666|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
44307667|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
44307668|NCT00871208|Retapamulin|retapamulin|mesh-list
44307669|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
44307670|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44307671|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44307672|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44307673|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44307674|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307675|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307676|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44307677|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307678|NCT00871247|Finasteride|finasteride|mesh-list
44307679|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44307680|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44307681|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307682|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307683|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
44307684|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44307685|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307686|NCT00871247|Urological Agents|urological agents|mesh-ancestor
44307687|NCT00871273|Capecitabine|capecitabine|mesh-list
44307688|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44307689|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
44307690|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307691|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307692|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44307693|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44307694|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44307695|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833481|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154566|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44154567|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
44154568|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154569|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154570|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154571|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154572|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307696|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307697|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307698|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307699|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44307700|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
44307701|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307703|NCT00871442|Bupivacaine|bupivacaine|mesh-list
44307704|NCT00871442|Anesthetics|anesthetics|mesh-list
44307705|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
44307706|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307707|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307708|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
44307709|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307710|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44307711|NCT00871442|Narcotics|narcotics|mesh-ancestor
44307712|NCT00871442|Analgesics|analgesics|mesh-ancestor
44307713|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44307714|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44307715|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
44307716|NCT00871455|Baclofen|baclofen|mesh-list
44307717|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44307718|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307719|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44307720|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307721|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44307722|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
44307723|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
44307724|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307725|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307726|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44307727|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44307728|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307729|NCT00871507|Incretins|incretins|mesh-ancestor
44307730|NCT00871507|Hormones|hormones|mesh-ancestor
44307732|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44307734|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307735|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307737|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
44307738|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44307739|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44307740|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
44307741|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307742|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
44307743|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307744|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307745|NCT00871546|Bortezomib|bortezomib|mesh-list
44307746|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
44307747|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307748|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307749|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44307750|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
44307751|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307752|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44307753|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44307754|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307755|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44307756|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44307757|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
44307758|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307759|NCT00871910|Dexamethasone|dexamethasone|mesh-list
44307760|NCT00871910|Ondansetron|ondansetron|mesh-list
44307761|NCT00871910|Aprepitant|aprepitant|mesh-list
44307762|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44307763|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
44307764|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
44307765|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307766|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307767|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307772|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307773|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
44307774|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
44307775|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44307776|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
44307777|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307778|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307779|NCT00871910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44307780|NCT00871910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307781|NCT00871910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307782|NCT00871910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307783|NCT00871910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44307784|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44307786|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44307787|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44307788|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307789|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307790|NCT00872131|Sertraline|sertraline|mesh-list
44307791|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
44307792|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307793|NCT00872131|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44307794|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44307795|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307796|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307797|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307798|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
44307799|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307801|NCT00872144|Analgesics|analgesics|mesh-ancestor
44307802|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
44307803|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307814|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44307815|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44307816|NCT00872235|Quinapril|quinapril|mesh-list
44307817|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307818|NCT00872235|Diuretics|diuretics|mesh-ancestor
44307819|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
44307820|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307821|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44307822|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307823|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307824|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44307825|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
44307826|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307827|NCT00872248|Anesthetics|anesthetics|mesh-list
44307828|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307829|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307830|NCT00872274|Sumatriptan|sumatriptan|mesh-list
44307831|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44307832|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44307833|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44307834|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
44307835|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307836|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307841|NCT00872378|Exenatide|exenatide|mesh-list
44307863|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
44307864|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307865|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307866|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44307867|NCT00872586|Olmesartan|olmesartan|mesh-list
44307868|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44307869|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307870|NCT00872586|Diuretics|diuretics|mesh-ancestor
44307871|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
44307872|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307873|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44307874|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44307876|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44466216|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466217|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466218|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466219|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
44466220|NCT01466192|Ribavirin|ribavirin|mesh-list
44466221|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44466222|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
44466223|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466224|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
44466225|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466226|NCT01466179|Blinatumomab|blinatumomab|mesh-list
44466227|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466228|NCT01466153|Rituximab|rituximab|mesh-list
44466229|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44466230|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466231|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466232|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
44307918|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44307919|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
44307920|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44307921|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44307922|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44307923|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44307924|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307925|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44307927|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44307928|NCT00872781|Diuretics|diuretics|mesh-ancestor
44307949|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44307950|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307951|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307952|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307953|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307954|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44307955|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
44307956|NCT00873002|Sorafenib|sorafenib|mesh-list
44307957|NCT00873002|Panobinostat|panobinostat|mesh-list
44307958|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307959|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44307960|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44307961|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307962|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44307963|NCT00873197|Granisetron|granisetron|mesh-list
44307964|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
44307965|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
44307966|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44307967|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44307968|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44307969|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44307970|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
44307971|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44307972|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44307973|NCT00873210|Sunitinib|sunitinib|mesh-list
44307974|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307975|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44307976|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44307977|NCT00873210|Growth Substances|growth substances|mesh-ancestor
44307983|NCT00873223|Liraglutide|liraglutide|mesh-list
44307993|NCT00873236|Bevacizumab|bevacizumab|mesh-list
44307994|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44307995|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44307996|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44307997|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44307998|NCT00873236|Growth Substances|growth substances|mesh-ancestor
44307999|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308000|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308001|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
44308002|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308003|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
44308004|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44308005|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44308006|NCT00873262|Estropipate|estropipate|mesh-list
44308008|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44308009|NCT00873262|Estrone|estrone|mesh-list
44308010|NCT00873262|Progesterone|progesterone|mesh-list
44308011|NCT00873262|Estrogens|estrogens|mesh-ancestor
44308012|NCT00873262|Hormones|hormones|mesh-ancestor
44308013|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44308014|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308015|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44308016|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
44308017|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308018|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44308019|NCT00873262|Progestins|progestins|mesh-ancestor
44308020|NCT00873340|Interferons|interferons|mesh-list
44308021|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
44308022|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308023|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
44308024|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308025|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44308026|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
44308027|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308036|NCT00873379|Melatonin|melatonin|mesh-list
44308037|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
44308038|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308039|NCT00873379|Protective Agents|protective agents|mesh-ancestor
44308040|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308041|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308042|NCT00873392|Nicotine|nicotine|mesh-list
44308043|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44308044|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
44308045|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308046|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308047|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44308048|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44308049|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
44308050|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308051|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308052|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44308053|NCT00873483|Gestodene|gestodene|mesh-list
44308054|NCT00873483|Femovan|femovan|mesh-list
44308055|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44308056|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44308057|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44308058|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
44308059|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308060|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308061|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44308062|NCT00873483|Estrogens|estrogens|mesh-ancestor
44308063|NCT00873483|Hormones|hormones|mesh-ancestor
44308064|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44308065|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44308076|NCT00873509|Buspirone|buspirone|mesh-list
44308079|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308080|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308081|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308082|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44308083|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
44308084|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308085|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308087|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44308088|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44308089|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
44308090|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308091|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308092|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308093|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
44308094|NCT00873626|Levofloxacin|levofloxacin|mesh-list
44308095|NCT00873626|Ofloxacin|ofloxacin|mesh-list
44308096|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
44308097|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308098|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308099|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44308100|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308101|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308102|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308103|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308104|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44308105|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44308106|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44308107|NCT00873626|Renal Agents|renal agents|mesh-ancestor
44308123|NCT00873756|Growth Substances|growth substances|mesh-ancestor
44308124|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308125|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308126|NCT00873769|Loxapine|loxapine|mesh-list
44308127|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44308128|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308129|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308130|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308131|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308132|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44308133|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
44308134|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308135|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308136|NCT00873795|Aripiprazole|aripiprazole|mesh-list
44308137|NCT00873795|Sertraline|sertraline|mesh-list
44308138|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
44308139|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308140|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44308141|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308142|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308143|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308144|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
44308145|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
44308146|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308147|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308148|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44308149|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44308150|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
44308151|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44308152|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44308153|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44308154|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44308155|NCT00873795|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44308156|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44308157|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44308158|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
44308160|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
44308161|NCT00873808|Tetracycline|tetracycline|mesh-list
44308162|NCT00873808|Demeclocycline|demeclocycline|mesh-list
44308163|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44308164|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308165|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308166|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308167|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44308168|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308169|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308171|NCT00873834|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44308172|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44308173|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44308174|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308175|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308216|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
44308217|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44308218|NCT00874042|Gemcitabine|gemcitabine|mesh-list
44308219|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308220|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
44308221|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308222|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308223|NCT00874042|Antiviral Agents|antiviral agents|mesh-ancestor
44308224|NCT00874042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308225|NCT00874042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308226|NCT00874042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308227|NCT00874042|Immunologic Factors|immunologic factors|mesh-ancestor
44308228|NCT00874042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308229|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
44308230|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308231|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308232|NCT00874107|Paclitaxel|paclitaxel|mesh-list
44308233|NCT00874107|Bevacizumab|bevacizumab|mesh-list
44308234|NCT00874107|Carboplatin|carboplatin|mesh-list
44308235|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44308236|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308237|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44308238|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44308239|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44308240|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308241|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308242|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308243|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308244|NCT00874107|Growth Substances|growth substances|mesh-ancestor
44308245|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308246|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308247|NCT00874133|Domperidone|domperidone|mesh-list
44308248|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
44308249|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
44308250|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308251|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308254|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
44308255|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308256|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308257|NCT00874172|Analgesics|analgesics|mesh-list
44308258|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
44308259|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308260|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308261|NCT00874315|Cyclosporine|cyclosporine|mesh-list
44308262|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
44308263|NCT00874315|Fludarabine|fludarabine|mesh-list
44308264|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
44308265|NCT00874315|Busulfan|busulfan|mesh-list
44308266|NCT00874315|Tacrolimus|tacrolimus|mesh-list
44308267|NCT00874315|Cyclosporins|cyclosporins|mesh-list
44308268|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
44308269|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44308270|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308271|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308272|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
44308273|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308274|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308275|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
44308276|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308277|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44308278|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308279|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
44308280|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308281|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
44308282|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308283|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44308284|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44308285|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
44308286|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308287|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
44308289|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44308296|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466233|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466234|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466235|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44466236|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
44466237|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466238|NCT01466062|Palivizumab|palivizumab|mesh-list
44466239|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
44466240|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466241|NCT01465997|Lacosamide|lacosamide|mesh-list
44466242|NCT01465997|Carbamazepine|carbamazepine|mesh-list
44466243|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
44466244|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44466245|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44466246|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466247|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466248|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
44466249|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466250|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466251|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466252|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466253|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466254|NCT01465997|Analgesics|analgesics|mesh-ancestor
44466255|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
44466256|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466257|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44466258|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44466259|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44466260|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
44466261|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44466262|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
44466263|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
44466264|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466265|NCT01465802|Doxycycline|doxycycline|mesh-list
43726988|NCT02586311|Amlodipine|amlodipine|mesh-list
44154573|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154574|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154575|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44466267|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466268|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466269|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
44466270|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44466271|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44466272|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466273|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
44466274|NCT01465802|Hormones|hormones|mesh-ancestor
44466275|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466276|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466277|NCT01465763|Tofacitinib|tofacitinib|mesh-list
44466278|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466279|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466280|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466281|NCT01465659|Temozolomide|temozolomide|mesh-list
44466282|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44466283|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
44466284|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466285|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466286|NCT01465464|Orantinib|orantinib|mesh-list
44466287|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466288|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466289|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466290|NCT01465386|Bortezomib|bortezomib|mesh-list
44466291|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466292|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
44466293|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
44466294|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466295|NCT01465347|Protective Agents|protective agents|mesh-ancestor
44466296|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466297|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44154576|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
44154577|NCT00224354|Interleukin-2|interleukin-2|mesh-list
44154578|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
44154579|NCT00224354|Immunotoxins|immunotoxins|mesh-list
44119951|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
44119952|NCT00119483|Testosterone|testosterone|mesh-list
44119953|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
44119954|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
44119955|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44308301|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
44308302|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
44308303|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308304|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308305|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
44308306|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308307|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308308|NCT00874393|Protective Agents|protective agents|mesh-ancestor
44308309|NCT00874406|Leucovorin|leucovorin|mesh-list
44308310|NCT00874406|Fluorouracil|fluorouracil|mesh-list
44308311|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
44308312|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
44308313|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308314|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308315|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308316|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308317|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
43727023|NCT02586454|Morphine|morphine|mesh-list
44119956|NCT00119483|Androgens|androgens|mesh-ancestor
44119957|NCT00119483|Hormones|hormones|mesh-ancestor
44119958|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119959|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119960|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44119961|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119962|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
44119963|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
44119964|NCT00119496|Beclomethasone|beclomethasone|mesh-list
44119965|NCT00119496|Theophylline|theophylline|mesh-list
44119966|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119967|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119968|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119969|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119970|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119971|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
44119972|NCT00119496|Hormones|hormones|mesh-ancestor
44119973|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44119974|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119975|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119976|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44119977|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
44119978|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308318|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308320|NCT00874406|Protective Agents|protective agents|mesh-ancestor
44308321|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
44308322|NCT00874406|Vitamins|vitamins|mesh-ancestor
44308323|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
44308324|NCT00874419|Gemcitabine|gemcitabine|mesh-list
44308325|NCT00874419|Carboplatin|carboplatin|mesh-list
44308326|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44308327|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308328|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308329|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
44308330|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308331|NCT00874419|Antiviral Agents|antiviral agents|mesh-ancestor
44308332|NCT00874419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308333|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308334|NCT00874419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308335|NCT00874419|Immunologic Factors|immunologic factors|mesh-ancestor
44308336|NCT00874419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308337|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44308338|NCT00874484|Enoxaparin|enoxaparin|mesh-list
44308339|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
44308340|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44308341|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44308342|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308343|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
44308344|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44308345|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44308346|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44308347|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
44308348|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308349|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44308350|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44308351|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119979|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44119980|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44119981|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44119982|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44119983|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
44119984|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44119985|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119986|NCT00119587|Hematinics|hematinics|mesh-ancestor
44119987|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
44119988|NCT00119613|Hematinics|hematinics|mesh-ancestor
44308352|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308353|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44308354|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44308355|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
44308357|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308358|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308359|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44308360|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308361|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
44308362|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308363|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
44308364|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308365|NCT00874575|Vitamin D|vitamin d|mesh-list
44308366|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
44308367|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
44308368|NCT00874575|Vitamins|vitamins|mesh-list
44308369|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
44308370|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308371|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44308372|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44308373|NCT00874601|Valsartan|valsartan|mesh-list
44308374|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44308375|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44308376|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44308377|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308378|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
44308379|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44308380|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
44119989|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
44119991|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119992|NCT00119626|Protective Agents|protective agents|mesh-ancestor
44119993|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119994|NCT00119639|Sorafenib|sorafenib|mesh-list
44119995|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44119996|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44119997|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119998|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120006|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120007|NCT00119652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44120008|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44120009|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120010|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308381|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308382|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308383|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44308384|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44308385|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44308386|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44308387|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
44308388|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44308389|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44308390|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308391|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308392|NCT00874679|Urological Agents|urological agents|mesh-ancestor
44308393|NCT00874744|Triamcinolone|triamcinolone|mesh-list
44308394|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44308395|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44308396|NCT00874744|Bevacizumab|bevacizumab|mesh-list
44308397|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44308398|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308437|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
44308438|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44308439|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44308440|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308441|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308442|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
44308443|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
44308444|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44308445|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
44308446|NCT00875069|Ethanol|ethanol|mesh-list
44308447|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44308448|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308449|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308450|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308451|NCT00875082|Montelukast|montelukast|mesh-list
44308452|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44308453|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
44308454|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44308455|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
44308456|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44308457|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308458|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44308459|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44308460|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308461|NCT00875147|Bevacizumab|bevacizumab|mesh-list
44308462|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308463|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308464|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44120011|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120012|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
44120013|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44120014|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44120015|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120016|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120017|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44120018|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
44120019|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120020|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
44120021|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44120022|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44120023|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44120024|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120025|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308465|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308466|NCT00875147|Growth Substances|growth substances|mesh-ancestor
44308467|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308468|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308469|NCT00875173|Selenium|selenium|mesh-list
44308470|NCT00875173|Antioxidants|antioxidants|mesh-list
44308471|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308472|NCT00875173|Protective Agents|protective agents|mesh-ancestor
44308473|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308474|NCT00875173|Trace Elements|trace elements|mesh-ancestor
44308475|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
44308476|NCT00875238|Doxorubicin|doxorubicin|mesh-list
44308477|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44308478|NCT00875238|Trastuzumab|trastuzumab|mesh-list
44308479|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44308480|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308481|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44308482|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308483|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308484|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308485|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308486|NCT00875355|Temozolomide|temozolomide|mesh-list
44308487|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44308488|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
44308489|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308490|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308491|NCT00875368|Maraviroc|maraviroc|mesh-list
44308492|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44308493|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44308494|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308495|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44308505|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308506|NCT00875537|Capsaicin|capsaicin|mesh-list
44308507|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
44308508|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
44308509|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
44308510|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308511|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308512|NCT00875745|Sorafenib|sorafenib|mesh-list
44308513|NCT00875745|Vorinostat|vorinostat|mesh-list
44308514|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308515|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44308516|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308517|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308518|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44308519|NCT00875771|Bevacizumab|bevacizumab|mesh-list
44308520|NCT00875771|Capecitabine|capecitabine|mesh-list
44308521|NCT00875771|Irinotecan|irinotecan|mesh-list
44308522|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308523|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308524|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308525|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308526|NCT00875771|Growth Substances|growth substances|mesh-ancestor
44308527|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308528|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308529|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308531|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308532|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44308533|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308534|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308535|NCT00875784|Sumatriptan|sumatriptan|mesh-list
44308536|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44308537|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44308538|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44308539|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
43727144|NCT02585531|Hormones|hormones|mesh-ancestor
44120026|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120027|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120028|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120029|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44308540|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308541|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308542|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308543|NCT00875849|Cisplatin|cisplatin|mesh-list
44308544|NCT00875849|Cetuximab|cetuximab|mesh-list
44308545|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308546|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308547|NCT00875875|Rifaximin|rifaximin|mesh-list
44308548|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308549|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308550|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44308552|NCT00875927|Propolis|propolis|mesh-list
44308553|NCT00875927|Trace Elements|trace elements|mesh-ancestor
44308554|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
44308555|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308556|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308557|NCT00875966|Azithromycin|azithromycin|mesh-list
44308558|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308559|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308560|NCT00876044|Aflibercept|aflibercept|mesh-list
44308561|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44308562|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44308563|NCT00876044|Growth Substances|growth substances|mesh-ancestor
44308564|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308565|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
44308566|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308567|NCT00876135|Albuterol|albuterol|mesh-list
44308568|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44308569|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
44308589|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308590|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44308591|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
44308592|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43963510|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
44308593|NCT00876317|Etoricoxib|etoricoxib|mesh-list
44308594|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44308595|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44308596|NCT00876317|Analgesics|analgesics|mesh-ancestor
44308597|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
44308598|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308599|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308600|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44308601|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308602|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44308603|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44308604|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308605|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308606|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
44308607|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44308608|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44308609|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44308610|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
44308611|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308612|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308613|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308614|NCT00876421|Urological Agents|urological agents|mesh-ancestor
44308620|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
44308621|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308622|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
44308623|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308624|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
44308625|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44308626|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308627|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308628|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44308629|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308630|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308631|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308632|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308633|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44308634|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
44308635|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308636|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308637|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44308638|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44308639|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44308640|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
44308641|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
44308642|NCT00876616|Tacrolimus|tacrolimus|mesh-list
44308643|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44308644|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
44308645|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308646|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308647|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44308648|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
44308649|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308650|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308651|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44308652|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44308653|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308654|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44120030|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120031|NCT00119730|Rituximab|rituximab|mesh-list
44308655|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44308656|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
44308657|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308658|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308659|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
44308660|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308661|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308662|NCT00876772|Olanzapine|olanzapine|mesh-list
44308663|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
44308664|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
44308665|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308666|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308667|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44308668|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44308669|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308670|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308671|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308672|NCT00876772|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44308673|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44308674|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44308675|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308676|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308678|NCT00876824|Amphotericin B|amphotericin b|mesh-list
44308679|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44308680|NCT00876824|Amebicides|amebicides|mesh-ancestor
44308681|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44308682|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44308683|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308684|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308685|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
44308686|NCT00876850|Linezolid|linezolid|mesh-list
44308687|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44308688|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308689|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44308690|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308692|NCT00876889|Riluzole|riluzole|mesh-list
44308695|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44308696|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308697|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308698|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308699|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44308700|NCT00876889|Protective Agents|protective agents|mesh-ancestor
44308701|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
44308702|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44308703|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
44308704|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308705|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44308706|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308707|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
44308708|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308709|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
44308710|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44308711|NCT00876902|Protective Agents|protective agents|mesh-ancestor
44308712|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
44308713|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
44308714|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
44308715|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
44308716|NCT00877097|Trisequens|trisequens|mesh-list
44308717|NCT00877097|Norethindrone|norethindrone|mesh-list
44308718|NCT00877097|Estradiol|estradiol|mesh-list
44308719|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44308720|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308721|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44308722|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44308723|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44308724|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
44308725|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44308726|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44308727|NCT00877097|Estrogens|estrogens|mesh-ancestor
44308728|NCT00877097|Hormones|hormones|mesh-ancestor
44308729|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44308735|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
44308736|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308737|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308738|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44308739|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
44308740|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308741|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308742|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44308743|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44308744|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44308745|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44308746|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44308747|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44308748|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308749|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308751|NCT00877123|Vitamins|vitamins|mesh-ancestor
44308752|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
44308753|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308754|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44308755|NCT00877149|Telbivudine|telbivudine|mesh-list
44308756|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
44308757|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308758|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44308759|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308760|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308761|NCT00877175|Phenylephrine|phenylephrine|mesh-list
44308762|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
44308763|NCT00877175|Tropicamide|tropicamide|mesh-list
44308764|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44308765|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
44308766|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
44308767|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308768|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308769|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
44308770|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44308771|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
44308775|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44308776|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44308777|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308778|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308779|NCT00877175|Protective Agents|protective agents|mesh-ancestor
44308780|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44308781|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44308782|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
44308783|NCT00877227|Leucovorin|leucovorin|mesh-list
44308784|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44308785|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
44308786|NCT00877227|Antidotes|antidotes|mesh-ancestor
44308787|NCT00877227|Protective Agents|protective agents|mesh-ancestor
44308788|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308789|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
44308790|NCT00877227|Vitamins|vitamins|mesh-ancestor
44308791|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
44308792|NCT00877253|Carboplatin|carboplatin|mesh-list
44308793|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308794|NCT00877266|Mepivacaine|mepivacaine|mesh-list
44308795|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
44308796|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
44308797|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308798|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308799|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
44308800|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308801|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44308802|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44308803|NCT00877422|Vitamin D|vitamin d|mesh-list
44308804|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
44308805|NCT00877422|Vitamins|vitamins|mesh-ancestor
44308806|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
44308807|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308808|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43727269|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120032|NCT00119730|Fludarabine|fludarabine|mesh-list
44120033|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
44120034|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44120035|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120036|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
44120037|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120038|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44308809|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44308811|NCT00877539|Xhance|xhance|mesh-list
44308812|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44308813|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44308814|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
44308815|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308816|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308817|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44308818|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
44308819|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44308820|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44308821|NCT00877591|Ritonavir|ritonavir|mesh-list
44308822|NCT00877591|Darunavir|darunavir|mesh-list
44308823|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
44308824|NCT00877591|Rifampin|rifampin|mesh-list
44308825|NCT00877591|Rifabutin|rifabutin|mesh-list
44308826|NCT00877591|Buprenorphine|buprenorphine|mesh-list
44308827|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44308828|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44308829|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44308830|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308831|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308832|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44308833|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44308834|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
44308835|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308836|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44308837|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44308838|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44308839|NCT00877591|Narcotics|narcotics|mesh-ancestor
44308840|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308841|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308842|NCT00877591|Analgesics|analgesics|mesh-ancestor
44308843|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
44308844|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308851|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44308852|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44308853|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44308854|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44308855|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44308856|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44308858|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44308859|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308860|NCT00877734|Baclofen|baclofen|mesh-list
44308861|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44308862|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308863|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44308864|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308865|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44308866|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
44308867|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
44308868|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308869|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308870|NCT00877760|Interferons|interferons|mesh-list
44308871|NCT00877760|Entecavir|entecavir|mesh-list
44308872|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308873|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
44308874|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44308875|NCT00877812|Glycine|glycine|mesh-list
44308876|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
44308877|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308878|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120039|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120040|NCT00119730|Analgesics|analgesics|mesh-ancestor
44120041|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
44120042|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120043|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44120044|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44120045|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120046|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44120047|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44120048|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120049|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120050|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120051|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120052|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44120053|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44120054|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
44120055|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308883|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308884|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44308885|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308886|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308888|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
44308889|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308890|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308891|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
44308892|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44308893|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308894|NCT00878124|Ubiquinone|ubiquinone|mesh-list
44308895|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
44308896|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
44308897|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308898|NCT00878124|Vitamins|vitamins|mesh-ancestor
44308899|NCT00878306|Ritonavir|ritonavir|mesh-list
44308900|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44308901|NCT00878306|Efavirenz|efavirenz|mesh-list
44308902|NCT00878306|Disulfiram|disulfiram|mesh-list
44308903|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44308920|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44308921|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44308922|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44308923|NCT00878345|Pentobarbital|pentobarbital|mesh-list
44308924|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
44308925|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44308926|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308927|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308928|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44308929|NCT00878345|Analgesics|analgesics|mesh-ancestor
44308930|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
44308931|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308932|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44308933|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44308934|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44308935|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44308936|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308937|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308938|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44308939|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
44308940|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
44308941|NCT00878371|Morphine|morphine|mesh-list
44308942|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44308943|NCT00878371|Narcotics|narcotics|mesh-ancestor
44308944|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727359|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44120056|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120057|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44120058|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44120059|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
44120060|NCT00119769|Hormones|hormones|mesh-list
43564208|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120061|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44120063|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
44120064|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44120071|NCT00119990|Icodextrin|icodextrin|mesh-list
44120072|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44120073|NCT00120003|Candesartan|candesartan|mesh-list
44120074|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
44120075|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44120076|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44120077|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44120078|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120079|NCT00120055|Atorvastatin|atorvastatin|mesh-list
44120080|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44120081|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44120082|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
44308945|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308946|NCT00878371|Analgesics|analgesics|mesh-ancestor
44308947|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
44308948|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44308950|NCT00878449|Etoposide|etoposide|mesh-list
44308951|NCT00878449|Navitoclax|navitoclax|mesh-list
44308952|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308953|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44308954|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44308955|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44308956|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44308957|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308958|NCT00878514|Alprazolam|alprazolam|mesh-list
44308959|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44308960|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44308961|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308962|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44308963|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44308964|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308965|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
44308966|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
44308967|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308968|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308969|NCT00878540|Mirtazapine|mirtazapine|mesh-list
44308970|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
44308971|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44308972|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44308973|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
44308974|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
44308975|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44308976|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308977|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44308986|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44308987|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
44308988|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44308989|NCT00878631|Dextrans|dextrans|mesh-list
44308990|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
44308991|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
44308992|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
44308993|NCT00878657|Gemcitabine|gemcitabine|mesh-list
44308994|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44308995|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
44308996|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44308997|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44308998|NCT00878657|Antiviral Agents|antiviral agents|mesh-ancestor
44308999|NCT00878657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309000|NCT00878657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309001|NCT00878657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309002|NCT00878657|Immunologic Factors|immunologic factors|mesh-ancestor
44309003|NCT00878657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309004|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
44309005|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44309006|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309007|NCT00878670|Analgesics|analgesics|mesh-ancestor
44309008|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
44309009|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309010|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309011|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309012|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309013|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44309014|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
44309027|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309028|NCT00878865|Alprazolam|alprazolam|mesh-list
44309029|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44309030|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309031|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309032|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44309033|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309034|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309035|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
44309036|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
44309037|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309038|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309039|NCT00878904|Epirubicin|epirubicin|mesh-list
44309040|NCT00878904|Panobinostat|panobinostat|mesh-list
44309041|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44309042|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309043|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44309044|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44309045|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309046|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309047|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44309048|NCT00878917|Dorzolamide|dorzolamide|mesh-list
44309049|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44309050|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44309051|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309052|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44309053|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309054|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309055|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
44309057|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
44309070|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309071|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44309072|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
44309073|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44309074|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309075|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44309076|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44309077|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44309079|NCT00879021|Analgesics|analgesics|mesh-ancestor
44309080|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
44309081|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309082|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309083|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
44309084|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44309085|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309086|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309087|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44309088|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44309089|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309090|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309091|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309092|NCT00879047|Ethanol|ethanol|mesh-list
44309093|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44309094|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309095|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309096|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309097|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44309098|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309099|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
44309100|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309101|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309109|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309110|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309111|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44309112|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309113|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309114|NCT00879099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44309115|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44309116|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309117|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
44309118|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44309119|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
44309120|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309121|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44309122|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44309123|NCT00879164|Bupivacaine|bupivacaine|mesh-list
44309124|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
44309125|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
44309126|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309127|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309128|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
44309129|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309130|NCT00879177|Varenicline|varenicline|mesh-list
44309131|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44309132|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44309133|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
44309134|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309135|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309136|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309137|NCT00879242|Deferasirox|deferasirox|mesh-list
44309138|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44309150|NCT00879372|Tianeptine|tianeptine|mesh-list
44309151|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44309152|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
44309153|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309154|NCT00879385|Decitabine|decitabine|mesh-list
44309155|NCT00879385|Panitumumab|panitumumab|mesh-list
44309156|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309157|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
44309158|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309159|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309160|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309161|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44309162|NCT00879424|Vitamin D|vitamin d|mesh-list
44309163|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
44309164|NCT00879424|Vitamins|vitamins|mesh-ancestor
44309165|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
44309166|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309167|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44309168|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44309169|NCT00879476|Ramipril|ramipril|mesh-list
44309170|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44309171|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309172|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309173|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309174|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309175|NCT00879541|Factor VIII|factor viii|mesh-list
44309176|NCT00879541|Coagulants|coagulants|mesh-ancestor
44309177|NCT00879723|Vitamins|vitamins|mesh-list
44309178|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
44309179|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309180|NCT00879788|Ramipril|ramipril|mesh-list
44309181|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44466331|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44466332|NCT01465191|Narcotics|narcotics|mesh-ancestor
44466333|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466334|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466335|NCT01465191|Analgesics|analgesics|mesh-ancestor
44466336|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
44466337|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466338|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
44466339|NCT01465178|Vitamin D|vitamin d|mesh-list
43648813|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43648814|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466340|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44466341|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466342|NCT01465178|Vitamins|vitamins|mesh-ancestor
44466343|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
44120083|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120084|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44120085|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44120086|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120087|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44120088|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44120089|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
44120090|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120091|NCT00120081|Antacids|antacids|mesh-ancestor
44120092|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120093|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120094|NCT00120120|Lenalidomide|lenalidomide|mesh-list
44120095|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
44120096|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466344|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44466345|NCT01465022|Estrogens|estrogens|mesh-list
44466346|NCT01465022|Progestins|progestins|mesh-list
44466347|NCT01465022|Hormones|hormones|mesh-ancestor
44466348|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466349|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466350|NCT01464931|Denosumab|denosumab|mesh-list
44466351|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44466352|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466353|NCT01464879|Testosterone|testosterone|mesh-list
44466354|NCT01464879|Androgens|androgens|mesh-ancestor
44466355|NCT01464879|Hormones|hormones|mesh-ancestor
44466356|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466357|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466358|NCT01464827|Ritonavir|ritonavir|mesh-list
44466359|NCT01464827|Ribavirin|ribavirin|mesh-list
44466360|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44466361|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44466362|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466363|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466364|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466365|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44466366|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44466367|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
44466368|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466369|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44466370|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44466371|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
44466372|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44466373|NCT01464788|Argatroban|argatroban|mesh-list
44466374|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44466375|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44466376|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309195|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309196|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309198|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44309199|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
44309200|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309201|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309202|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44309203|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44309204|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
44309205|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309206|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309207|NCT00879957|Heparin|heparin|mesh-list
44309208|NCT00879957|Calcium heparin|calcium heparin|mesh-list
44309209|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
44309210|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309211|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309212|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309213|NCT00879983|Azithromycin|azithromycin|mesh-list
44309214|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309215|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309216|NCT00880178|Niacin|niacin|mesh-list
44309217|NCT00880178|Niacinamide|niacinamide|mesh-list
44309218|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
44309219|NCT00880178|Simvastatin|simvastatin|mesh-list
44309220|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44309221|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44309222|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
44309224|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44309243|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309244|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309246|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
44309247|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309248|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309249|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
44309250|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309251|NCT00880243|Analgesics|analgesics|mesh-ancestor
44309252|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
44309253|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309254|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44309255|NCT00880282|Sirolimus|sirolimus|mesh-list
44309256|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44309257|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309258|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309259|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44309260|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309261|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
44309262|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309263|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
44309264|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309265|NCT00880321|Dabrafenib|dabrafenib|mesh-list
44309266|NCT00880321|Midazolam|midazolam|mesh-list
44309267|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44309268|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44309269|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309270|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309271|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44309272|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309273|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309274|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44120097|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44120098|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44120099|NCT00120120|Growth Substances|growth substances|mesh-ancestor
44120100|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
44120101|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120102|NCT00120133|Atorvastatin|atorvastatin|mesh-list
44120103|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44120104|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44120105|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
44120106|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120107|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44309275|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
44309276|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
44309277|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
44309278|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
44309279|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309280|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309281|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309282|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44309283|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309284|NCT00880373|Ibuprofen|ibuprofen|mesh-list
44309285|NCT00880373|Morphine|morphine|mesh-list
44309286|NCT00880373|Heroin|heroin|mesh-list
44309287|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44309288|NCT00880373|Narcotics|narcotics|mesh-ancestor
44309289|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309290|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309291|NCT00880373|Analgesics|analgesics|mesh-ancestor
44309292|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
44309293|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309294|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44309295|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309296|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309297|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309298|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44309299|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309300|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309301|NCT00880386|Losartan|losartan|mesh-list
44309302|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44309303|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309304|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44309305|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44309306|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309307|NCT00880412|Etazolate|etazolate|mesh-list
44309308|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44309309|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309310|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309314|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309316|NCT00880477|Edetic Acid|edetic acid|mesh-list
44309317|NCT00880477|Vaccines|vaccines|mesh-list
44309318|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
44309319|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
44309320|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309321|NCT00880477|Antidotes|antidotes|mesh-ancestor
44309322|NCT00880477|Protective Agents|protective agents|mesh-ancestor
44309323|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
44309324|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
44309325|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309326|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44309327|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
44309328|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44309329|NCT00880529|Morphine|morphine|mesh-list
44309330|NCT00880529|Bupivacaine|bupivacaine|mesh-list
44309331|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
44309332|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
44309333|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309334|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309335|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
44309336|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309337|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44309338|NCT00880529|Narcotics|narcotics|mesh-ancestor
44309339|NCT00880529|Analgesics|analgesics|mesh-ancestor
44309340|NCT00880672|Dutasteride|dutasteride|mesh-list
44309341|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43727568|NCT02583243|Analgesics|analgesics|mesh-ancestor
44120108|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44120109|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120110|NCT00120172|Bevacizumab|bevacizumab|mesh-list
44120111|NCT00120172|Capecitabine|capecitabine|mesh-list
44120112|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
44120113|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44120114|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120115|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44120116|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44120117|NCT00120172|Growth Substances|growth substances|mesh-ancestor
44120118|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120119|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44120120|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44120121|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
44120122|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120123|NCT00120185|Interleukin-2|interleukin-2|mesh-list
44120124|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309342|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44309343|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309344|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309345|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
44309346|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309347|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309349|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44309350|NCT00880815|Methotrexate|methotrexate|mesh-list
44309351|NCT00880815|Fludarabine|fludarabine|mesh-list
44309352|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44309353|NCT00880815|Antibodies|antibodies|mesh-list
44309354|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
44309355|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44309356|NCT00880815|Tacrolimus|tacrolimus|mesh-list
44309357|NCT00880815|Lenograstim|lenograstim|mesh-list
44309358|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
44309359|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44309360|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
44309361|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309362|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309363|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309364|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44309365|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
44309366|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44309367|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309368|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
44309369|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309370|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44309371|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309372|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44309373|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309374|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44309375|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44309376|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44309377|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309378|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
44309380|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309381|NCT00880828|Analgesics|analgesics|mesh-ancestor
44309382|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
44309383|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309384|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309385|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
44309386|NCT00880841|Buprenorphine|buprenorphine|mesh-list
44309387|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44309388|NCT00880841|Naloxone|naloxone|mesh-list
44309389|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44309390|NCT00880841|Narcotics|narcotics|mesh-ancestor
44309391|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309392|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309393|NCT00880841|Analgesics|analgesics|mesh-ancestor
44309394|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
44309395|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309396|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44309397|NCT00880854|Tremelimumab|tremelimumab|mesh-list
44309398|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309399|NCT00880867|Poly ICLC|poly iclc|mesh-list
44309400|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
44309401|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
44309402|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309403|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
44309404|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309405|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44309406|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309407|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309408|NCT00881088|PENTA|penta|mesh-list
44309409|NCT00881088|Nadroparin|nadroparin|mesh-list
44309410|NCT00881088|Fondaparinux|fondaparinux|mesh-list
44309412|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
44309426|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309427|NCT00881114|Cisplatin|cisplatin|mesh-list
44309428|NCT00881114|Cetuximab|cetuximab|mesh-list
44309429|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309430|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44309431|NCT00881127|Cetirizine|cetirizine|mesh-list
44309432|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
44309433|NCT00881127|Ephedrine|ephedrine|mesh-list
44309434|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44309435|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44309436|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44309437|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
44309438|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
44309439|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309440|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309441|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309442|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44309443|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
44309444|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309445|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44309446|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
44309447|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
44309448|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44309449|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44309450|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
44309451|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
44309452|NCT00881140|Mifepristone|mifepristone|mesh-list
44309453|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44309454|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
44309455|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44309456|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309457|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44309458|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44309459|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44309460|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
44309461|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44120125|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309462|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44309463|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
44309464|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309465|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
44309466|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44309467|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44309468|NCT00881153|Cefprozil|cefprozil|mesh-list
44309469|NCT00881153|Cephalosporins|cephalosporins|mesh-list
44309470|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309471|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309472|NCT00881166|Paclitaxel|paclitaxel|mesh-list
44309473|NCT00881166|Etoposide|etoposide|mesh-list
44309474|NCT00881166|Docetaxel|docetaxel|mesh-list
44309475|NCT00881166|Carboplatin|carboplatin|mesh-list
44309476|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44309477|NCT00881166|Topotecan|topotecan|mesh-list
44309478|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309479|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309480|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44309481|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44309482|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44309483|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309484|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44309485|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44309486|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309487|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44309488|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44309489|NCT00881179|Clarithromycin|clarithromycin|mesh-list
44309490|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309491|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120126|NCT00120185|Analgesics|analgesics|mesh-ancestor
44120127|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
44120128|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120129|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120130|NCT00120198|Rituximab|rituximab|mesh-list
44120131|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44120138|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
44120139|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44120140|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120141|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44120142|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120143|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
44120144|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
44120145|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120146|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120147|NCT00120302|Analgesics|analgesics|mesh-ancestor
44309492|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44309493|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309494|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309495|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44309496|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44309497|NCT00881218|Regadenoson|regadenoson|mesh-list
44309498|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44309499|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44309500|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
44309501|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
44309502|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309503|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648879|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
43648880|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648881|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648883|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309504|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309505|NCT00881231|Cilostazol|cilostazol|mesh-list
44309506|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44309507|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
44309508|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309509|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727695|NCT02582307|Analgesics|analgesics|mesh-list
44120148|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
44120149|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120150|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120151|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120152|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120153|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120154|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120155|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
44120156|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44120157|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120158|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120159|NCT00120315|Esomeprazole|esomeprazole|mesh-list
44120160|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44120161|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120162|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44120163|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120164|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120165|NCT00120341|Analgesics|analgesics|mesh-list
44120166|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
44120167|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120168|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120169|NCT00120354|Lamivudine|lamivudine|mesh-list
44120170|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120171|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120172|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120173|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120174|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
44120175|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120176|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120177|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120179|NCT00120367|Emtricitabine|emtricitabine|mesh-list
44120180|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
44120181|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
44120182|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309510|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44309511|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
44309512|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309513|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309514|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309515|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44309516|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
44309517|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44309518|NCT00881231|Protective Agents|protective agents|mesh-ancestor
44309519|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44309520|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44309521|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309522|NCT00881296|Gemcitabine|gemcitabine|mesh-list
44309523|NCT00881296|Carboplatin|carboplatin|mesh-list
44309524|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309525|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309526|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
44309527|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309528|NCT00881296|Antiviral Agents|antiviral agents|mesh-ancestor
44309529|NCT00881296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309530|NCT00881296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309531|NCT00881296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309532|NCT00881296|Immunologic Factors|immunologic factors|mesh-ancestor
44309533|NCT00881296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309534|NCT00881387|Gemcitabine|gemcitabine|mesh-list
44309535|NCT00881387|Rituximab|rituximab|mesh-list
44309536|NCT00881387|Vinorelbine|vinorelbine|mesh-list
44309537|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44309538|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309539|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
44309540|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309541|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309551|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44309552|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44309553|NCT00881400|Cefprozil|cefprozil|mesh-list
44309554|NCT00881400|Cephalosporins|cephalosporins|mesh-list
44309555|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309556|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309557|NCT00881413|Esomeprazole|esomeprazole|mesh-list
44309558|NCT00881413|Pantoprazole|pantoprazole|mesh-list
44309559|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44309560|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44309561|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44309562|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309563|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309564|NCT00881426|Cefprozil|cefprozil|mesh-list
44309565|NCT00881426|Cephalosporins|cephalosporins|mesh-list
44309566|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309567|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309568|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44309569|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44309570|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309571|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
44309572|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
44309573|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
44309574|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309575|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44309576|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44309577|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44309578|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309579|NCT00881543|Incretins|incretins|mesh-ancestor
44309580|NCT00881543|Hormones|hormones|mesh-ancestor
44309581|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309582|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309583|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309584|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309585|NCT00881556|Fludarabine|fludarabine|mesh-list
44309586|NCT00881556|Busulfan|busulfan|mesh-list
44309587|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
44309591|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309592|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309593|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
44309594|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309595|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44309596|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309597|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
44309598|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309599|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44309600|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44309601|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
44309602|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
44309603|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
44309604|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309605|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44309606|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44309607|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309608|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44309609|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44309610|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309611|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
44309612|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
44309613|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309614|NCT00881582|Interferons|interferons|mesh-list
44309615|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
44309616|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
44309617|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44309618|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309619|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
44309637|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309639|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44309640|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
44309641|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309642|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44309643|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
44309644|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
44309645|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44309646|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44309647|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
44309648|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
44309649|NCT00881673|Dexamethasone|dexamethasone|mesh-list
44309650|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44309651|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44309652|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309653|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
44309654|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
44309655|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309656|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309657|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44309658|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
44309659|NCT00881673|Hormones|hormones|mesh-ancestor
44309660|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309661|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44309662|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309663|NCT00881686|Adenosine|adenosine|mesh-list
44309664|NCT00881686|Analgesics|analgesics|mesh-ancestor
44309665|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
44309666|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309667|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309668|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44309669|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
44309670|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44309671|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
44120183|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44309672|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
44309673|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309674|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309676|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44309677|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309678|NCT00881738|Clarithromycin|clarithromycin|mesh-list
44309679|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309680|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309681|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44309682|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309683|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309684|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44309685|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44309686|NCT00881764|Anesthetics|anesthetics|mesh-list
44309687|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309688|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309689|NCT00881790|Fluorides|fluorides|mesh-list
44309690|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
44309691|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
44309692|NCT00881790|Protective Agents|protective agents|mesh-ancestor
44309693|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309694|NCT00881816|Paclitaxel|paclitaxel|mesh-list
44309695|NCT00881816|Capecitabine|capecitabine|mesh-list
44309696|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309697|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309698|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
44309699|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
44309700|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
44309701|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309702|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309703|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
44466384|NCT01464424|Travoprost|travoprost|mesh-list
44466393|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466394|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466395|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466396|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466398|NCT01463982|Irinotecan|irinotecan|mesh-list
44466399|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44466400|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
44466401|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964607|NCT01581710|Montelukast|montelukast|mesh-list
44466402|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309704|NCT00881855|Cefprozil|cefprozil|mesh-list
44309705|NCT00881855|Cephalosporins|cephalosporins|mesh-list
44309706|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309707|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309708|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44309709|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44309710|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309711|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
44309712|NCT00882024|Tranilast|tranilast|mesh-list
44309713|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44309714|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309715|NCT00882024|Analgesics|analgesics|mesh-ancestor
44309716|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
44309717|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309718|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309719|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309720|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309721|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44309722|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309723|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309724|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44309725|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44309726|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
44309727|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
44120184|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120185|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701845|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44309728|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309729|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44309730|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44309731|NCT00882076|Etoposide|etoposide|mesh-list
44309732|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
44309733|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
44309734|NCT00882076|Clofarabine|clofarabine|mesh-list
44309735|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44309736|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309737|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44309738|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44309739|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309740|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309741|NCT00882076|Analgesics|analgesics|mesh-ancestor
44309742|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
44309743|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309744|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309745|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44309746|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
44309747|NCT00882154|Cefdinir|cefdinir|mesh-list
44309748|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309749|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309750|NCT00882193|Ribavirin|ribavirin|mesh-list
44309751|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44309752|NCT00882193|Betaine|betaine|mesh-list
44309753|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
44309754|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309755|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
44309756|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309757|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44309758|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
44309759|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44309760|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44309761|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
44309770|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44309771|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
44309772|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309773|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309774|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309775|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
44309776|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309777|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309778|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44309779|NCT00882375|Nicotine|nicotine|mesh-list
44309780|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44309781|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
44309782|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309783|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309784|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44309785|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44309786|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
44309787|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309788|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309789|NCT00882388|Aspirin|aspirin|mesh-list
44309790|NCT00882388|Celecoxib|celecoxib|mesh-list
44309791|NCT00882388|Clopidogrel|clopidogrel|mesh-list
44309792|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44309793|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44309794|NCT00882388|Analgesics|analgesics|mesh-ancestor
44309795|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
44309796|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120186|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120187|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120188|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120189|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44120190|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44120191|NCT00120380|Iloprost|iloprost|mesh-list
44120192|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44120193|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
44120194|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
44120195|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44120196|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120197|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44120198|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
44120199|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44120200|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120201|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120202|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120208|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
44120209|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309797|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309798|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309799|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44309800|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309801|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309802|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309803|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44309804|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44309805|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309806|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
44309807|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44309808|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44309809|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44309810|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
44309811|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309812|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44309813|NCT00882401|Vitamin D|vitamin d|mesh-list
44309814|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
44309815|NCT00882401|Vitamins|vitamins|mesh-ancestor
44309816|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
44309817|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309818|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44309819|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44309820|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
44309821|NCT00882414|Hematinics|hematinics|mesh-ancestor
44309822|NCT00882453|Interferons|interferons|mesh-list
44309823|NCT00882453|Interferon-beta|interferon-beta|mesh-list
44309824|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
44309825|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309826|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
44309827|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309828|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
44309829|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309830|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44309831|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
44120210|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120212|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44120213|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
44120214|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120215|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44309832|NCT00882466|Hematinics|hematinics|mesh-ancestor
44309833|NCT00882531|Isotretinoin|isotretinoin|mesh-list
44309834|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44309835|NCT00882570|Cefdinir|cefdinir|mesh-list
44309836|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309837|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309838|NCT00882609|Fluorides|fluorides|mesh-list
44309839|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
44309840|NCT00882609|Protective Agents|protective agents|mesh-ancestor
44309841|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309842|NCT00882635|Heparin|heparin|mesh-list
44309843|NCT00882635|Enoxaparin|enoxaparin|mesh-list
44309844|NCT00882635|Calcium heparin|calcium heparin|mesh-list
44309845|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
44309846|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44309847|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44309848|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309849|NCT00882700|Cefdinir|cefdinir|mesh-list
44309850|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309851|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309852|NCT00882739|Clopidogrel|clopidogrel|mesh-list
44309853|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44309854|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43964740|NCT01586962|Ephedrine|ephedrine|mesh-list
44309855|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44309856|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44309858|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309859|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309860|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309861|NCT00882765|Genistein|genistein|mesh-list
44309862|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44309878|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309879|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309880|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44309881|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44309882|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44309883|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
44309884|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309885|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309886|NCT00882869|Sorafenib|sorafenib|mesh-list
44309887|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309888|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44309889|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309890|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309891|NCT00882882|Metformin|metformin|mesh-list
44309892|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44309893|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309894|NCT00882947|Iloprost|iloprost|mesh-list
44309895|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44309896|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
44309897|NCT00882960|Fentanyl|fentanyl|mesh-list
44309898|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44309899|NCT00882960|Narcotics|narcotics|mesh-ancestor
44309900|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309901|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309902|NCT00882960|Analgesics|analgesics|mesh-ancestor
44309903|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
44309904|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309905|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44309906|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44309907|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
44309908|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
44309909|NCT00883064|Lisinopril|lisinopril|mesh-list
44309920|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
44309921|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44309922|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44309923|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44309924|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44309925|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309926|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
44309927|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44309928|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309929|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44309930|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44309931|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309932|NCT00883194|Ropivacaine|ropivacaine|mesh-list
44309933|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
44309934|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
44309935|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44309936|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309937|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
44309938|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309939|NCT00883259|Metformin|metformin|mesh-list
44309940|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44309941|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309942|NCT00883298|Bevacizumab|bevacizumab|mesh-list
44309943|NCT00883298|Temozolomide|temozolomide|mesh-list
44309944|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44309945|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44309946|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44309947|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44309948|NCT00883298|Growth Substances|growth substances|mesh-ancestor
44309949|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309950|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
44120216|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44120217|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44120218|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
44120219|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120220|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120221|NCT00120432|Protective Agents|protective agents|mesh-ancestor
44120222|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44120223|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44120224|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120225|NCT00120471|Tenofovir|tenofovir|mesh-list
44120226|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
44309951|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44309953|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309954|NCT00883506|Lisinopril|lisinopril|mesh-list
44309955|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44309956|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
44309957|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44309958|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44309959|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44309960|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44309961|NCT00883506|Protective Agents|protective agents|mesh-ancestor
44309962|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309963|NCT00883532|Budesonide|budesonide|mesh-list
44309964|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44309965|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44309966|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44309967|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
44309968|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44309969|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44309970|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44309971|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
44309972|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
44309973|NCT00883532|Hormones|hormones|mesh-ancestor
44309974|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44309975|NCT00883623|Lenalidomide|lenalidomide|mesh-list
44309976|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
44309977|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648911|NCT03033264|Dinoprostone|dinoprostone|mesh-list
44309978|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44309979|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44309980|NCT00883623|Growth Substances|growth substances|mesh-ancestor
44309983|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
44466404|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466405|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466406|NCT01463306|Pregabalin|pregabalin|mesh-list
44466407|NCT01463306|Analgesics|analgesics|mesh-ancestor
44466408|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
44466409|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466410|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466411|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
44466412|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44466413|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466414|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466415|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44309991|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
44309992|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44309993|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44309994|NCT00883818|Azithromycin|azithromycin|mesh-list
44309995|NCT00883818|Doxycycline|doxycycline|mesh-list
44309996|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44309997|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44309998|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
44309999|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44310000|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44310001|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
44310002|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44310003|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44310005|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310006|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310007|NCT00883909|Dutasteride|dutasteride|mesh-list
44310008|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44310009|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44310010|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310015|NCT00883935|Ritonavir|ritonavir|mesh-list
44310025|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
44310026|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310027|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44310028|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44310029|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44310030|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44310031|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
44310032|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44310033|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44310034|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
44310035|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310036|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310037|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310038|NCT00884104|Urological Agents|urological agents|mesh-ancestor
44310039|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
44310040|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44310041|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
44310042|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44310043|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310044|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44310045|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44310046|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44310047|NCT00884299|Antioxidants|antioxidants|mesh-list
44310048|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310049|NCT00884299|Protective Agents|protective agents|mesh-ancestor
44310050|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310070|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310071|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
44310072|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310073|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310074|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44310075|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310076|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310077|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310078|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310079|NCT00884546|Dexamethasone|dexamethasone|mesh-list
44310080|NCT00884546|Lenalidomide|lenalidomide|mesh-list
44310081|NCT00884546|Bortezomib|bortezomib|mesh-list
44310082|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310083|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
44310084|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
44310085|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310086|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310087|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310088|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
44310089|NCT00884546|Hormones|hormones|mesh-ancestor
44310090|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310091|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310092|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310093|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
44310094|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310095|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310096|NCT00884546|Growth Substances|growth substances|mesh-ancestor
44310097|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310098|NCT00884663|Propranolol|propranolol|mesh-list
44310099|NCT00884663|Candesartan|candesartan|mesh-list
44310100|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44310101|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44310102|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310103|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310104|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310105|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310107|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44310108|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310109|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44310110|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44310111|NCT00884676|Sunitinib|sunitinib|mesh-list
44310112|NCT00884676|Epothilone B|epothilone b|mesh-list
44310113|NCT00884676|Epothilones|epothilones|mesh-list
44310114|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310115|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310116|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310117|NCT00884676|Growth Substances|growth substances|mesh-ancestor
44310118|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310119|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310120|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310121|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310122|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310123|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44310124|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44310125|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44310126|NCT00884767|Leucovorin|leucovorin|mesh-list
44310127|NCT00884767|Fluorouracil|fluorouracil|mesh-list
44310128|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
44310129|NCT00884767|Calcium|calcium|mesh-list
44310130|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
44310131|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44310132|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310133|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
44310134|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310135|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44310136|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310137|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310138|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
44310139|NCT00884767|Antidotes|antidotes|mesh-ancestor
44310150|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310151|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310152|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310153|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310154|NCT00884858|Maraviroc|maraviroc|mesh-list
44310155|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44310156|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44310157|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310158|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44310159|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44310160|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
44310161|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310162|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44310163|NCT00884884|Topiramate|topiramate|mesh-list
44310164|NCT00884884|Aripiprazole|aripiprazole|mesh-list
44310165|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
44310166|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310167|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44310168|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310169|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310170|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310171|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
44310172|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
44310173|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310174|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310175|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44310176|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44310177|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
44310178|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44310194|NCT00885066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310195|NCT00885066|Immunologic Factors|immunologic factors|mesh-ancestor
44310196|NCT00885066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310197|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310198|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
44310199|NCT00885274|Citric Acid|citric acid|mesh-list
44310200|NCT00885274|Antacids|antacids|mesh-ancestor
44310201|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310202|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310203|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
44310204|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44310205|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
44310206|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
44310207|NCT00885287|Lumefantrine|lumefantrine|mesh-list
44310208|NCT00885287|Artemether|artemether|mesh-list
44310209|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44310210|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
44310211|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44310212|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44310213|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310214|NCT00885300|Cloxacillin|cloxacillin|mesh-list
44310215|NCT00885300|Heparin|heparin|mesh-list
44310216|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
44310217|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44310218|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44310219|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310220|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310221|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310244|NCT00885443|Sevoflurane|sevoflurane|mesh-list
44310245|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44310246|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310247|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310248|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44310249|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
44310250|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
44310251|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44310252|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44310253|NCT00885508|Lenalidomide|lenalidomide|mesh-list
44310254|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
44310255|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310256|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310257|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310258|NCT00885508|Growth Substances|growth substances|mesh-ancestor
44310259|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310260|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310261|NCT00885586|Gabapentin|gabapentin|mesh-list
44310262|NCT00885586|Analgesics|analgesics|mesh-ancestor
44310263|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
44310264|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310265|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310266|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
44310267|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44310268|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310269|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310270|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120227|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120228|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120229|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120230|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120231|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120232|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120233|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120234|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
44120235|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
44120236|NCT00120484|Vitamins|vitamins|mesh-ancestor
44120237|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
44120238|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120239|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
44120240|NCT00120484|Hematinics|hematinics|mesh-ancestor
44120241|NCT00120497|Hormones|hormones|mesh-list
44120242|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44120243|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120244|NCT00120510|Lamivudine|lamivudine|mesh-list
44120245|NCT00120510|Zidovudine|zidovudine|mesh-list
44120246|NCT00120510|Efavirenz|efavirenz|mesh-list
44120247|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44120248|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44310272|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44310273|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310274|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310275|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
44466416|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44466417|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466418|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466419|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466420|NCT01463111|Lamotrigine|lamotrigine|mesh-list
44466421|NCT01463111|Valproic Acid|valproic acid|mesh-list
44466422|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466423|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466424|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466425|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
44466426|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466427|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466428|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466429|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
44466430|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44466431|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466432|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44310276|NCT00885599|Listerine|listerine|mesh-list
44310277|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44310278|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310279|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44310280|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
44310281|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310282|NCT00885690|Olanzapine|olanzapine|mesh-list
44310283|NCT00885690|Sertindole|sertindole|mesh-list
44120249|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120250|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120251|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120252|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
44120253|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120254|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120255|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120256|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
44120257|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44120258|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120259|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44310285|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
44310286|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310287|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310288|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310289|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44310290|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310291|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310292|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310293|NCT00885690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44310294|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44310295|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44310296|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310297|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310298|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
44310299|NCT00885781|SMOFlipid|smoflipid|mesh-list
44310300|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44310301|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44310302|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44310303|NCT00885794|Ranibizumab|ranibizumab|mesh-list
44310304|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310305|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310306|NCT00885794|Growth Substances|growth substances|mesh-ancestor
44310307|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310308|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310309|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310310|NCT00885820|Prednisone|prednisone|mesh-list
44310311|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
44120260|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44120261|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44120262|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44120263|NCT00120536|Vildagliptin|vildagliptin|mesh-list
44120264|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44120265|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120266|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44120267|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120268|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120269|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120270|NCT00120601|Naltrexone|naltrexone|mesh-list
44120271|NCT00120601|Acamprosate|acamprosate|mesh-list
44120272|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44120273|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44120274|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120279|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44120280|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701846|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310314|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
44310315|NCT00885820|Hormones|hormones|mesh-ancestor
44310316|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310317|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310318|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310319|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310320|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310321|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
44310322|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44310323|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310324|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310325|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
44310326|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
44310327|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310328|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310329|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44310330|NCT00885820|Protective Agents|protective agents|mesh-ancestor
44310331|NCT00885833|Fludarabine|fludarabine|mesh-list
44310332|NCT00885833|Busulfan|busulfan|mesh-list
44310333|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
44310334|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310335|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310336|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310337|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
44310338|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849178|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310339|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
44310340|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44310341|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44310342|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44310343|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44310344|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44310345|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
44120281|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44120282|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120284|NCT00120640|Hormones|hormones|mesh-ancestor
44120285|NCT00120653|Metoclopramide|metoclopramide|mesh-list
44120286|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
44310346|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310347|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44310348|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44310349|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310351|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44310352|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310353|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44310354|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
44310355|NCT00885924|Coagulants|coagulants|mesh-ancestor
44310356|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44310357|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
44310358|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310360|NCT00886002|Buprenorphine|buprenorphine|mesh-list
44310361|NCT00886002|Naloxone|naloxone|mesh-list
44310362|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44310363|NCT00886002|Narcotics|narcotics|mesh-ancestor
44310364|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310365|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310366|NCT00886002|Analgesics|analgesics|mesh-ancestor
44310367|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
44310368|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310369|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44310370|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44310371|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
44310372|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
44310398|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310399|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44310400|NCT00886106|Narcotics|narcotics|mesh-ancestor
44310401|NCT00886106|Analgesics|analgesics|mesh-ancestor
44310402|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
44310403|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310404|NCT00886132|Sunitinib|sunitinib|mesh-list
44310405|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310406|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310407|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310408|NCT00886132|Growth Substances|growth substances|mesh-ancestor
44310409|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310410|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310411|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310412|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310413|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310414|NCT00886275|Midazolam|midazolam|mesh-list
44310415|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
44310416|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44310417|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310418|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599011|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
43599012|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
43599013|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43599014|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43599015|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599016|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43599017|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44310419|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44310420|NCT00886275|Analgesics|analgesics|mesh-ancestor
44310421|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
44310422|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310423|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44310424|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44310425|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44310426|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310427|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310428|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310429|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44310430|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44310431|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310432|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310436|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
44310437|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
44310438|NCT00886314|Midazolam|midazolam|mesh-list
44310439|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44310440|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44310441|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310442|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310443|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44310444|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310445|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310446|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44310447|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
44310448|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
44310449|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
44310450|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
44310451|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310452|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310453|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
44310454|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310455|NCT00886457|Interferons|interferons|mesh-list
44310456|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
44310457|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
44310458|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44310459|NCT00886457|Decitabine|decitabine|mesh-list
44310460|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310461|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
44310462|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310463|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
44310464|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310465|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44310466|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
44310467|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310468|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310469|NCT00886496|Lectins|lectins|mesh-list
44310470|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
44310471|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
43648897|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
43648898|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43648899|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43648900|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43648948|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43648949|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648951|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
44120287|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
44120288|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120289|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120290|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120291|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44120292|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44310472|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310474|NCT00886509|Lenograstim|lenograstim|mesh-list
44310475|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44310476|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
44310477|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310478|NCT00886574|Aspirin|aspirin|mesh-list
44310479|NCT00886574|Cilostazol|cilostazol|mesh-list
44310480|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44310481|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44310482|NCT00886574|Analgesics|analgesics|mesh-ancestor
44310483|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
44310484|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310485|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310486|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310487|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44310488|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44310489|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44310490|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310491|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44310492|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44310493|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310494|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
44310495|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44310496|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
44310497|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44310498|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
44310499|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310500|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43965333|NCT05564442|Benzocaine|benzocaine|mesh-list
44310516|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44310517|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44310518|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310519|NCT00886860|Misoprostol|misoprostol|mesh-list
44310520|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44310521|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
44310522|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44310523|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310524|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44310525|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310526|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
44310527|NCT00886873|Mifepristone|mifepristone|mesh-list
44310528|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44310529|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
44310530|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44310531|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310532|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44310533|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44310534|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44310535|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
44310536|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44310537|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44310538|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
44310539|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310540|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
44310541|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44310542|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44310543|NCT00886886|Reboxetine|reboxetine|mesh-list
44310559|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44310560|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44310561|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
44310562|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310563|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44310564|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44310565|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
44310566|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44310567|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44310568|NCT00887003|Prednisolone|prednisolone|mesh-list
44310569|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
44310570|NCT00887003|Bupivacaine|bupivacaine|mesh-list
44310571|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44310572|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
44310573|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
44310574|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
44310575|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310576|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310577|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
44466433|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44310578|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310579|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310580|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
44310581|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
44310582|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310583|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
44310584|NCT00887003|Hormones|hormones|mesh-ancestor
44310585|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310586|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44310587|NCT00887003|Protective Agents|protective agents|mesh-ancestor
44310588|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310589|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310590|NCT00887029|Timolol|timolol|mesh-list
44310591|NCT00887029|Travoprost|travoprost|mesh-list
44310592|NCT00887029|Latanoprost|latanoprost|mesh-list
44310593|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44310594|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44310595|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44310597|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310598|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310599|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310600|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44310601|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44310602|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44310603|NCT00887042|Fludarabine|fludarabine|mesh-list
44310604|NCT00887042|Busulfan|busulfan|mesh-list
44310605|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
44310606|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310607|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310608|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310609|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
44310610|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310611|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
44310612|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44310613|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44310614|NCT00887081|Ribavirin|ribavirin|mesh-list
44310615|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
44310616|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
44310617|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44310618|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44310619|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44310620|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
44310621|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310622|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
44310623|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310624|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
44310625|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310626|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310627|NCT00887107|Sorafenib|sorafenib|mesh-list
44310628|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310629|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310630|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728143|NCT02578602|Edetic Acid|edetic acid|mesh-list
44120293|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
44120294|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120295|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648901|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648902|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648903|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44310631|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310632|NCT00887120|Ritonavir|ritonavir|mesh-list
44310633|NCT00887120|Lopinavir|lopinavir|mesh-list
44310634|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44310635|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44310636|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44310637|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310638|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310639|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44310640|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44310641|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
44310642|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310643|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44310644|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44310645|NCT00887211|Sirolimus|sirolimus|mesh-list
44310646|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310647|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310648|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44310649|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310650|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
44310651|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310652|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
44310653|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310654|NCT00887263|Budesonide|budesonide|mesh-list
44310655|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310656|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44310657|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
44310658|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310659|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310660|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44120296|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
44120297|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
44120298|NCT00120679|Hematinics|hematinics|mesh-ancestor
44120299|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
44120300|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
44120301|NCT00120692|Hematinics|hematinics|mesh-ancestor
44120302|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
44120303|NCT00120705|Hematinics|hematinics|mesh-ancestor
44120304|NCT00120718|Fasudil|fasudil|mesh-list
44120305|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44120306|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120307|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120308|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44120309|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120310|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310661|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
44310662|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
44310663|NCT00887263|Hormones|hormones|mesh-ancestor
44310664|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310665|NCT00887276|Amoxicillin|amoxicillin|mesh-list
44310666|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
44310667|NCT00887276|Ampicillin|ampicillin|mesh-list
44310668|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310669|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310670|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44310671|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310672|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310673|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310674|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310675|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44310676|NCT00887328|Plasminogen|plasminogen|mesh-list
44310677|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44310678|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44310679|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310680|NCT00887367|Ethanol|ethanol|mesh-list
44310681|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44310682|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599375|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310683|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310684|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310685|NCT00887601|Donepezil|donepezil|mesh-list
44310686|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44310687|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310688|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310689|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
44310690|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310691|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310692|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
44466438|NCT01463098|Lemborexant|lemborexant|mesh-list
44466439|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44466440|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44466441|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466442|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466443|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44466444|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
44466445|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
44466446|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466447|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466448|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44466449|NCT01463033|Levetiracetam|levetiracetam|mesh-list
44466450|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
44466451|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
44466452|NCT01462942|Bromides|bromides|mesh-list
44466453|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
44466454|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44466455|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
44466456|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466457|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466458|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44466459|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
44466460|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44466461|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44466462|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44466463|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
44466464|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310698|NCT00887757|Gemcitabine|gemcitabine|mesh-list
44310700|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728192|NCT02578537|Ticagrelor|ticagrelor|mesh-list
44120311|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44120312|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120313|NCT00120731|Acetazolamide|acetazolamide|mesh-list
44120314|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
44120315|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120316|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
44120317|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44120318|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120319|NCT00120731|Diuretics|diuretics|mesh-ancestor
44120320|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
44120321|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120322|NCT00120731|Expectorants|expectorants|mesh-ancestor
44120323|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120325|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
44120326|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
44120327|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310701|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
44310702|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310703|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310704|NCT00887757|Antiviral Agents|antiviral agents|mesh-ancestor
44310705|NCT00887757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310706|NCT00887757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310707|NCT00887757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310708|NCT00887757|Immunologic Factors|immunologic factors|mesh-ancestor
44310709|NCT00887757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310710|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
44310711|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
44310712|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310713|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310714|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44310715|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310716|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310717|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310718|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310719|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44310720|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44310721|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44310722|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
44310723|NCT00888043|Bevacizumab|bevacizumab|mesh-list
44310724|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44120328|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120329|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120330|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
44120331|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120332|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44120333|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
44120334|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120335|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120336|NCT00120744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44120337|NCT00120744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120338|NCT00120744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120339|NCT00120744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120340|NCT00120744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44120341|NCT00120757|Alendronate|alendronate|mesh-list
44120342|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44120343|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120344|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
44120345|NCT00120783|Ritonavir|ritonavir|mesh-list
44120346|NCT00120783|Indinavir|indinavir|mesh-list
44120347|NCT00120783|Lamivudine|lamivudine|mesh-list
44120354|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120355|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
44120356|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310726|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44310727|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44310728|NCT00888043|Growth Substances|growth substances|mesh-ancestor
44310729|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310730|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
44310731|NCT00888082|Goserelin|goserelin|mesh-list
44310732|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310733|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310734|NCT00888108|Docetaxel|docetaxel|mesh-list
44310735|NCT00888108|Navitoclax|navitoclax|mesh-list
44310736|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310737|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
44310738|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
44310739|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
44310740|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310741|NCT00888186|Levodopa|levodopa|mesh-list
44310742|NCT00888186|Carbidopa|carbidopa|mesh-list
44310743|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44310744|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44310745|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
44310746|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310747|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310748|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310749|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44310750|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310751|NCT00888303|Dexamethasone|dexamethasone|mesh-list
44310752|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310753|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
44310754|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
44310755|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310756|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310757|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120357|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120358|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120359|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120360|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120362|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120363|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120364|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599729|NCT03288038|Ezetimibe|ezetimibe|mesh-list
43701847|NCT02722343|Tenofovir|tenofovir|mesh-list
44310758|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
44310759|NCT00888303|Hormones|hormones|mesh-ancestor
44310760|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310761|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44310762|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310763|NCT00888342|Ethanol|ethanol|mesh-list
44310764|NCT00888342|Zopiclone|zopiclone|mesh-list
44310765|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44310766|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310767|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310768|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310769|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44310770|NCT00888394|Imidacloprid|imidacloprid|mesh-list
44310771|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
44310772|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310773|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310774|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310776|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
44310777|NCT00888602|Cathartics|cathartics|mesh-ancestor
44310778|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44310779|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
44310780|NCT00888732|Insulin|insulin|mesh-list
44310781|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44310782|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
44310783|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
44310784|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44310785|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44310786|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310787|NCT00888758|Sirolimus|sirolimus|mesh-list
44120365|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120366|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
44120367|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120368|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120369|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120370|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
44120371|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
44120372|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44120373|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
44120374|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44120375|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44120376|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120377|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44120378|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120379|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120380|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44120381|NCT00120809|Renal Agents|renal agents|mesh-ancestor
44310788|NCT00888758|Umirolimus|umirolimus|mesh-list
44310789|NCT00888758|Everolimus|everolimus|mesh-list
44310790|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310791|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310792|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
44310793|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310794|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310795|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44310796|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44310797|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44310798|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
44310799|NCT00888784|Propranolol|propranolol|mesh-list
44310800|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44310801|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44310802|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310803|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310804|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310805|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310806|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44310807|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44310808|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310809|NCT00888797|Etodolac|etodolac|mesh-list
44310810|NCT00888797|Propranolol|propranolol|mesh-list
44310811|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44310812|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44310813|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310814|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599841|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44310815|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310816|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310817|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44310818|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44310819|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310830|NCT00888810|Topotecan|topotecan|mesh-list
44310831|NCT00888810|Lapatinib|lapatinib|mesh-list
44310832|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44310833|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310834|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310835|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310836|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310837|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310838|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44310839|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310840|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44310841|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44310842|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44310843|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44310844|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310845|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310846|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310848|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310849|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44310850|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
44310851|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44310852|NCT00888901|Prednisolone|prednisolone|mesh-list
44310853|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
44310854|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44310855|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
44310856|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310857|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
44310876|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
44310877|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310878|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310879|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310880|NCT00889057|Sorafenib|sorafenib|mesh-list
44310881|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310882|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44310883|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310884|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310885|NCT00889096|Propranolol|propranolol|mesh-list
44310886|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44310887|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44310888|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44310889|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310890|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310891|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310892|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44310893|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44310894|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
44310895|NCT00889135|Droxidopa|droxidopa|mesh-list
44310896|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44310897|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44310898|NCT00889148|Gabapentin|gabapentin|mesh-list
44310899|NCT00889148|Analgesics|analgesics|mesh-ancestor
44310900|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
44310901|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310902|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310903|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
44310904|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44310905|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44310906|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44310907|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310908|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44310915|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44310916|NCT00889161|Analgesics|analgesics|mesh-ancestor
44310917|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
44310918|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310919|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310920|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44310921|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44310922|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310923|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310924|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310925|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44310926|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
44310927|NCT00889213|Coagulants|coagulants|mesh-ancestor
44310928|NCT00889343|Leucovorin|leucovorin|mesh-list
44310929|NCT00889343|Fluorouracil|fluorouracil|mesh-list
44310930|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
44310931|NCT00889343|Irinotecan|irinotecan|mesh-list
44310932|NCT00889343|Sorafenib|sorafenib|mesh-list
44310933|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
44310934|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310935|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44310936|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44310937|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44310938|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
44310939|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310940|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44310941|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44310942|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44310943|NCT00889343|Antidotes|antidotes|mesh-ancestor
44310944|NCT00889343|Protective Agents|protective agents|mesh-ancestor
44310945|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
44310946|NCT00889343|Vitamins|vitamins|mesh-ancestor
44310960|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310961|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
44310962|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44310963|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44310964|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44310965|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
44310966|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44310967|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310968|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44310969|NCT00889356|Amebicides|amebicides|mesh-ancestor
44310970|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44310971|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44310972|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44310973|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44310974|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44310975|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44310976|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310977|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44310978|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310979|NCT00889369|Analgesics|analgesics|mesh-ancestor
44310980|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
44310981|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310982|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
44310983|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44310984|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
44310985|NCT00889434|Tocotrienols|tocotrienols|mesh-list
44310987|NCT00889434|Tocopherols|tocopherols|mesh-list
44310988|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
44310989|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44310990|NCT00889434|Protective Agents|protective agents|mesh-ancestor
44310991|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310992|NCT00889434|Vitamins|vitamins|mesh-ancestor
44310993|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
44310994|NCT00889499|Tropisetron|tropisetron|mesh-list
44310995|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
44120382|NCT00120822|Folic Acid|folic acid|mesh-list
44310996|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
44310997|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44310998|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44310999|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311000|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44311001|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311002|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
44311003|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311004|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311006|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44311007|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44311008|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
44311009|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
44311010|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311011|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311012|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466465|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466466|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
44466467|NCT01462929|Bromides|bromides|mesh-list
44466468|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
44466469|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44466470|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
44466471|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466472|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466473|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44466474|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
44466475|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
44466476|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44466477|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466478|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466479|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466480|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
44466481|NCT01462695|Sunitinib|sunitinib|mesh-list
44466482|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466483|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44466486|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466487|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44466488|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466489|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466490|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466491|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44466492|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44466493|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466494|NCT01462435|Celecoxib|celecoxib|mesh-list
44466495|NCT01462435|Diclofenac|diclofenac|mesh-list
44466496|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44466497|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466498|NCT01462435|Analgesics|analgesics|mesh-ancestor
44466499|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
44466500|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466501|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466502|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466503|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466504|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44466505|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44466506|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466507|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466508|NCT01462370|Acetaminophen|acetaminophen|mesh-list
44466509|NCT01462370|Ibuprofen|ibuprofen|mesh-list
44466510|NCT01462370|Etoricoxib|etoricoxib|mesh-list
44466511|NCT01462370|Caffeine|caffeine|mesh-list
44466512|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466513|NCT01462370|Analgesics|analgesics|mesh-ancestor
44466514|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
44466515|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466516|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466517|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
44466518|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44466519|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311017|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44311018|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
44311019|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311021|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311022|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311023|NCT00889629|Vitamin D|vitamin d|mesh-list
44311024|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
44311025|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44311026|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
44311027|NCT00889629|Vitamins|vitamins|mesh-ancestor
44311028|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
44311029|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311030|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311031|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311032|NCT00889642|Lidocaine|lidocaine|mesh-list
44311033|NCT00889642|Epinephrine|epinephrine|mesh-list
44311034|NCT00889642|Racepinephrine|racepinephrine|mesh-list
44311035|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
44311036|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
44311037|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
44311038|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311039|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311040|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
44311041|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311042|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44311043|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44311044|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44311045|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311046|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311047|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44311048|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44311049|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
44311050|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311051|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44311052|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44311053|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
43833729|NCT05190445|Paclitaxel|paclitaxel|mesh-list
44311054|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44311055|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
44311056|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
44311057|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
44311058|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44311059|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44311060|NCT00889655|Laxatives|laxatives|mesh-ancestor
44311061|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311062|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
44311063|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311064|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44311065|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44311066|NCT00889694|Analgesics|analgesics|mesh-ancestor
44311067|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
44311068|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311069|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311070|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311071|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311072|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311073|NCT00889733|Cisplatin|cisplatin|mesh-list
44311074|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311075|NCT00889837|Loxapine|loxapine|mesh-list
44311076|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311077|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311078|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311079|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311080|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311081|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311082|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
44311083|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311084|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311085|NCT00889850|Esomeprazole|esomeprazole|mesh-list
44311086|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44311087|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311088|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44311089|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311091|NCT00889876|Metformin|metformin|mesh-list
44311093|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311094|NCT00890110|Sunitinib|sunitinib|mesh-list
44311095|NCT00890110|Vaccines|vaccines|mesh-list
44311096|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
44311097|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311098|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311099|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311100|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311101|NCT00890110|Growth Substances|growth substances|mesh-ancestor
44311102|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311103|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43600484|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
44311104|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311105|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311106|NCT00890175|Loxapine|loxapine|mesh-list
44311107|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311108|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311109|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311110|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311111|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311112|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311113|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
44311114|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311115|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311116|NCT00890188|Thalidomide|thalidomide|mesh-list
44311117|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311118|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
44311119|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311120|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
44311121|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311122|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311123|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311137|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44311138|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311139|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
44311140|NCT00890253|Prednisone|prednisone|mesh-list
44311141|NCT00890253|Prednisolone|prednisolone|mesh-list
44311142|NCT00890253|Everolimus|everolimus|mesh-list
44311143|NCT00890253|Basiliximab|basiliximab|mesh-list
44311144|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311145|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
44311146|NCT00890253|Hormones|hormones|mesh-ancestor
44311147|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311148|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311149|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311150|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311151|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311152|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
44311153|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44311154|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44311155|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
44311156|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311157|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311158|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311159|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311160|NCT00890279|Imidapril|imidapril|mesh-list
44311161|NCT00890279|Cilnidipine|cilnidipine|mesh-list
44311162|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44311163|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311164|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311165|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311166|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311180|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311181|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311182|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44311183|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44311184|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
44311185|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
44311186|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
44311187|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44311188|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
44311189|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311190|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
44311191|NCT00890487|Protective Agents|protective agents|mesh-ancestor
44311192|NCT00890500|Sirolimus|sirolimus|mesh-list
44311193|NCT00890500|Fludarabine|fludarabine|mesh-list
44311194|NCT00890500|Melphalan|melphalan|mesh-list
44311195|NCT00890500|Tacrolimus|tacrolimus|mesh-list
44311196|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44311197|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311198|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311199|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311200|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
44311201|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311202|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44311203|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311204|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311205|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311206|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44311207|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
44311208|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44311209|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
44311210|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44311211|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
44311212|NCT00890539|Miotics|miotics|mesh-ancestor
44311213|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
44311221|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
44311222|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311223|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311224|NCT00890565|Granisetron|granisetron|mesh-list
44311225|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
44311226|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
44311227|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311228|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311229|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311230|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311231|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
44311232|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311233|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311234|NCT00890604|Acetaminophen|acetaminophen|mesh-list
44311235|NCT00890604|Ibuprofen|ibuprofen|mesh-list
44311236|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44311237|NCT00890604|Analgesics|analgesics|mesh-ancestor
44311238|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
44311239|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311240|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311241|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
44311242|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44311243|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311244|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311245|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44311246|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311247|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311248|NCT00890630|Oxytocin|oxytocin|mesh-list
44311249|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
44311250|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44311264|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44311265|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44311266|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311267|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311268|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44311269|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
44311270|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311271|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311272|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44311273|NCT00890747|Sunitinib|sunitinib|mesh-list
44311274|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311275|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311276|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311277|NCT00890747|Growth Substances|growth substances|mesh-ancestor
44311278|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311279|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311280|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311281|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311282|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311283|NCT00890786|Bevacizumab|bevacizumab|mesh-list
44311284|NCT00890786|Irinotecan|irinotecan|mesh-list
44311285|NCT00890786|Temozolomide|temozolomide|mesh-list
44311286|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44311287|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311288|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311289|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311290|NCT00890786|Growth Substances|growth substances|mesh-ancestor
44311291|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311292|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311293|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44311304|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
44311305|NCT00890955|Amrubicin|amrubicin|mesh-list
44311306|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311307|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
44311308|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311309|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311310|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44311311|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
43966147|NCT05106153|Suvorexant|suvorexant|mesh-list
44311312|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311313|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311314|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44311315|NCT00891033|Bortezomib|bortezomib|mesh-list
44311316|NCT00891033|Panobinostat|panobinostat|mesh-list
44311317|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311318|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44311319|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311320|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311321|NCT00891072|Acetic Acid|acetic acid|mesh-list
44311322|NCT00891072|Paclitaxel|paclitaxel|mesh-list
44311323|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
44311324|NCT00891072|Carboplatin|carboplatin|mesh-list
44311325|NCT00891072|Retinol acetate|retinol acetate|mesh-list
44311326|NCT00891072|Gossypol|gossypol|mesh-list
44311327|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44311328|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311329|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
44311330|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
44311331|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
44311332|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311333|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311334|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311348|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44311349|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311350|NCT00891163|Lidocaine|lidocaine|mesh-list
44311351|NCT00891163|Tetracaine|tetracaine|mesh-list
44311352|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
44311353|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
44311354|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311355|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311356|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
44311357|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311358|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44311359|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44311360|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44311361|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311362|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311363|NCT00891267|Amlodipine|amlodipine|mesh-list
44311364|NCT00891267|Olmesartan|olmesartan|mesh-list
44311365|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44311366|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311367|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44311368|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311369|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311370|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311371|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311372|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311373|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44311374|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44311375|NCT00891306|Cyclosporine|cyclosporine|mesh-list
44311376|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
44311377|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
44311378|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44311379|NCT00891306|Cyclosporins|cyclosporins|mesh-list
44311380|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311381|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311382|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120383|NCT00120822|Hematinics|hematinics|mesh-ancestor
44120384|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
44120385|NCT00120822|Vitamins|vitamins|mesh-ancestor
44311383|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
44311384|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311385|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
44311386|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311387|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44311388|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311389|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44311390|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44311391|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311392|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44311393|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
44311394|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311395|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311397|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
44311398|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311399|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311400|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
44311401|NCT00891306|Hormones|hormones|mesh-ancestor
44311402|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311403|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44311404|NCT00891306|Protective Agents|protective agents|mesh-ancestor
44311405|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311406|NCT00891332|Leucovorin|leucovorin|mesh-list
44311407|NCT00891332|Antidotes|antidotes|mesh-ancestor
44311408|NCT00891332|Protective Agents|protective agents|mesh-ancestor
44311409|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311410|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
44311411|NCT00891332|Vitamins|vitamins|mesh-ancestor
44311412|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
44311413|NCT00891384|Lenalidomide|lenalidomide|mesh-list
44311414|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
44311415|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311416|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311417|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311418|NCT00891384|Growth Substances|growth substances|mesh-ancestor
44311421|NCT00891397|Pregabalin|pregabalin|mesh-list
44311424|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311425|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311426|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
44311427|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44311428|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311429|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311430|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311431|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44311432|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311433|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311434|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311435|NCT00891423|Meropenem|meropenem|mesh-list
44311436|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311437|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466522|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466523|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466524|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44466525|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44466526|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44466527|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44466528|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
44466529|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466530|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44466531|NCT01462344|Fluticasone|fluticasone|mesh-list
44466532|NCT01462344|Xhance|xhance|mesh-list
44466533|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44466534|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44466535|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
44466536|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466537|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466538|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44466539|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44466540|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
44466541|NCT01462344|Hormones|hormones|mesh-ancestor
44466545|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
44311438|NCT00891475|Interferons|interferons|mesh-list
44311439|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
43600985|NCT03268902|Niacin|niacin|mesh-list
44311440|NCT00891475|Sunitinib|sunitinib|mesh-list
44311441|NCT00891475|Maleic acid|maleic acid|mesh-list
44311442|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311443|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
44311444|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311445|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
44311446|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311447|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311448|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311449|NCT00891475|Growth Substances|growth substances|mesh-ancestor
44311450|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311451|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311452|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311453|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311454|NCT00891540|Ropivacaine|ropivacaine|mesh-list
44311455|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
44311456|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
44311457|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311458|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311459|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
44311460|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311461|NCT00891579|Pemetrexed|pemetrexed|mesh-list
44311462|NCT00891579|Gefitinib|gefitinib|mesh-list
44311463|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311464|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311465|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311466|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43728743|NCT02575443|Rocuronium|rocuronium|mesh-list
44120386|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
44120387|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120388|NCT00120835|Interferons|interferons|mesh-list
44120389|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120390|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
44120391|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120392|NCT00120861|Interferons|interferons|mesh-list
44120393|NCT00120861|Ribavirin|ribavirin|mesh-list
44120394|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120395|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
44120396|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120397|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
44120398|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120399|NCT00120887|Atorvastatin|atorvastatin|mesh-list
44120400|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44311467|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44311468|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311469|NCT00891605|Paclitaxel|paclitaxel|mesh-list
44311470|NCT00891605|Navitoclax|navitoclax|mesh-list
44311471|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44311472|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311473|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
44311474|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
44311475|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
44311476|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311477|NCT00891670|Aspirin|aspirin|mesh-list
44311478|NCT00891670|Cilostazol|cilostazol|mesh-list
44311479|NCT00891670|Clopidogrel|clopidogrel|mesh-list
44311480|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44311481|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44311482|NCT00891670|Analgesics|analgesics|mesh-ancestor
44311483|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
44311484|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311485|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311486|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311487|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311488|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44311489|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44311490|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311491|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43601012|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
44311492|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43728756|NCT02575521|Propofol|propofol|mesh-list
44120401|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44120402|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
44120403|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120404|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44120405|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44120406|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120407|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
44120408|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44120409|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44120410|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
44120411|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44120412|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154580|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154581|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154582|NCT00224354|Analgesics|analgesics|mesh-ancestor
44154583|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
44154584|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154589|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154590|NCT00224393|Analgesics|analgesics|mesh-ancestor
44154591|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
44311493|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311494|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
44311495|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44311496|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44311497|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44311498|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
44311499|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311500|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44311501|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
44311502|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44311503|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
44311504|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311505|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44311506|NCT00891670|Protective Agents|protective agents|mesh-ancestor
44311507|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44311508|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44311509|NCT00891696|Sirolimus|sirolimus|mesh-list
44311510|NCT00891696|Nitroprusside|nitroprusside|mesh-list
44311511|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311512|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311513|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44311514|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311515|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
44311516|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311517|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
44311518|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311519|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311520|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311521|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44311540|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311541|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311542|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
44311543|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
44311544|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311545|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
44311546|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311547|NCT00891761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311548|NCT00891761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311549|NCT00891761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311550|NCT00891761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311551|NCT00891761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44311552|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44311553|NCT00892073|Metformin|metformin|mesh-list
44311554|NCT00892073|Diazoxide|diazoxide|mesh-list
44311555|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44311556|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311557|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311558|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311559|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
44311560|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
44311561|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44311562|NCT00892112|Antibodies|antibodies|mesh-list
44311563|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
44311564|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44311565|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
44311566|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311567|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
44311568|NCT00892125|Carbamazepine|carbamazepine|mesh-list
43728790|NCT02575664|Buprenorphine|buprenorphine|mesh-list
44154592|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154593|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154594|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154595|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154596|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44154597|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154598|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
44154599|NCT00224419|Nicotine|nicotine|mesh-list
44154600|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44154601|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
43564553|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
44154602|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154603|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154605|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44154606|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
44154607|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311569|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44311570|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311571|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311572|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311573|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311574|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311575|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44311576|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311577|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
44311578|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311579|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311580|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44311581|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311582|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
44311583|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
44311584|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
44311585|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44311586|NCT00892125|Analgesics|analgesics|mesh-ancestor
44311587|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
44311588|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311589|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44311590|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311591|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44311592|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44311593|NCT00892190|Dasatinib|dasatinib|mesh-list
44311594|NCT00892190|Tretinoin|tretinoin|mesh-list
44311595|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311596|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311597|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311598|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311599|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
44311600|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44311601|NCT00892229|Misoprostol|misoprostol|mesh-list
44311602|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44154608|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154609|NCT00224445|Ritonavir|ritonavir|mesh-list
44154610|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44154611|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44154612|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44311603|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
44311604|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44311605|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311606|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44311607|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311608|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
44311609|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
44311610|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311611|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311613|NCT00892307|Analgesics|analgesics|mesh-ancestor
44311614|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
44311615|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311616|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311617|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44311618|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311619|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44311620|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
44311621|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
44311622|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311623|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833740|NCT05190094|Letrozole|letrozole|mesh-list
44154613|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44154614|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
44154615|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154616|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154617|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44154618|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44154619|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
44154620|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154621|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44154622|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44154623|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44154624|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44154625|NCT00224458|Efavirenz|efavirenz|mesh-list
44154626|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44154627|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44154628|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44154629|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154630|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154631|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
44154632|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154633|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44154634|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44154635|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44154636|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44154637|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44154638|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44120413|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
44120414|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311624|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44311625|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311626|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311627|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311628|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311629|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311630|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44311631|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311632|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
44311633|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311634|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311635|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44311636|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311637|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
44311638|NCT00892346|Thalidomide|thalidomide|mesh-list
44311639|NCT00892346|Melphalan|melphalan|mesh-list
44311640|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44311641|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
44311642|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311643|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311644|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44311645|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44311646|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
44311647|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311648|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
44311649|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311650|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311651|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44311652|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311653|NCT00892346|Growth Substances|growth substances|mesh-ancestor
44311654|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311655|NCT00892359|Anidulafungin|anidulafungin|mesh-list
44311656|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
44311657|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120415|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44120416|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120417|NCT00120978|Fluticasone|fluticasone|mesh-list
44120418|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44120419|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
44120420|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311659|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44311660|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
44311661|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311662|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311663|NCT00892398|Ranibizumab|ranibizumab|mesh-list
44311664|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44466546|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44311665|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44311666|NCT00892398|Growth Substances|growth substances|mesh-ancestor
44311667|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311668|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
44311669|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311670|NCT00892424|Sorafenib|sorafenib|mesh-list
44311671|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311672|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311673|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311674|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311675|NCT00892450|Oxybutynin|oxybutynin|mesh-list
44311676|NCT00892450|Darifenacin|darifenacin|mesh-list
44311677|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
44311678|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
44311679|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311680|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311681|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44311682|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44311683|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
44311684|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311685|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120421|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120422|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44120423|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120424|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120425|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120426|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44120431|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44120432|NCT00121017|Efavirenz|efavirenz|mesh-list
44120433|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120434|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120435|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120436|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120437|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120438|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120439|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44311686|NCT00892450|Urological Agents|urological agents|mesh-ancestor
44311687|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44311688|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
44311689|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311690|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311691|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311692|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311693|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311694|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
44311695|NCT00892476|Calcium|calcium|mesh-list
44311696|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311697|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311698|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43601686|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
44311699|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44311700|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311701|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311702|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311703|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311704|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311705|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44311706|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311707|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
44311708|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311709|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833779|NCT05189535|Protective Agents|protective agents|mesh-ancestor
44120440|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
44120441|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120442|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120443|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120444|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120445|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43564623|NCT01009242|Methotrexate|methotrexate|mesh-list
44120446|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44120447|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44120448|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44120449|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44120450|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44120452|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
44120453|NCT00121030|Hematinics|hematinics|mesh-ancestor
44120454|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44120455|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120456|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44120457|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120458|NCT00121069|Citalopram|citalopram|mesh-list
44120459|NCT00121069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44120460|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44311710|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44311711|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311712|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
44311713|NCT00892502|Bismuth|bismuth|mesh-list
44311714|NCT00892502|Antacids|antacids|mesh-ancestor
44311715|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311716|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44311717|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44311718|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311719|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311720|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311721|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311722|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311723|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44311724|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311725|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
44311726|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311727|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311728|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43648906|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43648907|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648909|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648910|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598280|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43598281|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43598282|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311729|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311730|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
44311731|NCT00892658|Sorafenib|sorafenib|mesh-list
44311732|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311733|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311734|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311735|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311736|NCT00892736|Veliparib|veliparib|mesh-list
44311737|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44311738|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311739|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311740|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311753|NCT00892892|Rilmenidine|rilmenidine|mesh-list
44311754|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311755|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44311756|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311757|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311758|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311759|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311760|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311761|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
44311762|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
44311763|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311764|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44311765|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44311766|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44311767|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44311768|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311769|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
44311770|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
44311771|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44311772|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44311773|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311774|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311775|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44311776|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44311777|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311778|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311779|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311780|NCT00892996|Dexamethasone|dexamethasone|mesh-list
44311781|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
44311782|NCT00892996|BB 1101|bb 1101|mesh-list
44311783|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311784|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
44311785|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
44311786|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311787|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311792|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311793|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311795|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311796|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311797|NCT00893009|Theophylline|theophylline|mesh-list
44311798|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44311799|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
44311800|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311801|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311802|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44311803|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44311804|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44311805|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311806|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311807|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311808|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44311809|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44311810|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
44311811|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311812|NCT00893048|Prednisone|prednisone|mesh-list
44311813|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311814|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
44311815|NCT00893048|Hormones|hormones|mesh-ancestor
44311816|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311817|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311818|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311819|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311820|NCT00893061|Tamoxifen|tamoxifen|mesh-list
44311821|NCT00893061|Letrozole|letrozole|mesh-list
44311822|NCT00893061|Anastrozole|anastrozole|mesh-list
44311823|NCT00893061|Exemestane|exemestane|mesh-list
44311824|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311825|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311826|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44311827|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44311829|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44311830|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
44311831|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311832|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311833|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44311834|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44311835|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44311836|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311837|NCT00893100|Diltiazem|diltiazem|mesh-list
44311838|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311839|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44311840|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311841|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311842|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311843|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311844|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
44311845|NCT00893217|Interferons|interferons|mesh-list
44311846|NCT00893217|Interferon-beta|interferon-beta|mesh-list
44311847|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
44311848|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311849|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
44311850|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311851|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
44311852|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311853|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44120461|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120462|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120463|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120464|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
44120465|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120466|NCT00121069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44120467|NCT00121069|Antidepressive Agents|antidepressive agents|mesh-ancestor
44120468|NCT00121069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120469|NCT00121095|Docetaxel|docetaxel|mesh-list
44120470|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44120471|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120472|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44120473|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44120474|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44120475|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120476|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120477|NCT00121095|Analgesics|analgesics|mesh-ancestor
44120478|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
44120479|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120480|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120481|NCT00121147|Travoprost|travoprost|mesh-list
44311854|NCT00893256|Risperidone|risperidone|mesh-list
44311855|NCT00893256|Citalopram|citalopram|mesh-list
44311856|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44311857|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
44311858|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311859|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311860|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311861|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311862|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311863|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311864|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311865|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44311866|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
44311867|NCT00893256|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44311868|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44311869|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44311870|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44311871|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
44311872|NCT00893269|Zolpidem|zolpidem|mesh-list
44311873|NCT00893269|Eszopiclone|eszopiclone|mesh-list
44311874|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44311875|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44311876|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311877|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311878|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44311879|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
44311880|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
44311881|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311882|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466547|NCT01462318|Vitamin K|vitamin k|mesh-list
44466548|NCT01462318|Midazolam|midazolam|mesh-list
44466549|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
44466550|NCT01462318|Caffeine|caffeine|mesh-list
44311892|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44311893|NCT00893412|Narcotics|narcotics|mesh-ancestor
44311894|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311895|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311896|NCT00893412|Analgesics|analgesics|mesh-ancestor
44311897|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
44311898|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311899|NCT00893425|Ramipril|ramipril|mesh-list
44311900|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44311901|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
44311902|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311903|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311904|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44311905|NCT00893451|Vitamin D|vitamin d|mesh-list
44311906|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
44311907|NCT00893451|Vitamins|vitamins|mesh-ancestor
44311908|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
44311909|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311910|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311911|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44311912|NCT00893477|Rituximab|rituximab|mesh-list
44311913|NCT00893477|Sargramostim|sargramostim|mesh-list
44311914|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44311915|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311916|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
44311917|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311918|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311919|NCT00893490|Mitomycins|mitomycins|mesh-list
44311920|NCT00893490|Mitomycin|mitomycin|mesh-list
44311921|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44311922|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44311923|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
44311924|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311925|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44311926|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311927|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
44311928|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44120482|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44311930|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44311931|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
44311932|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44311933|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311934|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311935|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311936|NCT00893555|Voriconazole|voriconazole|mesh-list
44311937|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
44311938|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44311939|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44311940|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44311941|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311942|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311943|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44311944|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
44311945|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44311946|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311947|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44311948|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44311949|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
44311950|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44311951|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44311952|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44311953|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44311954|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311955|NCT00893594|Naproxen|naproxen|mesh-list
44311956|NCT00893594|Sumatriptan|sumatriptan|mesh-list
44311957|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44311958|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44120483|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44120484|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44120485|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44120486|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44120487|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44120488|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120489|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120490|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120491|NCT00121264|Sorafenib|sorafenib|mesh-list
44311960|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
44311961|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311962|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311963|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311964|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44311965|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44311966|NCT00893594|Analgesics|analgesics|mesh-ancestor
44311967|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
44311968|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311969|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44311970|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44311971|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
44311972|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44311973|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44311974|NCT00893607|Methoxamine|methoxamine|mesh-list
44311975|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
44311976|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
44311977|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44311978|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311979|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44311980|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44311981|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44311982|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44311983|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
44311984|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44311985|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44311987|NCT00893711|Vitamins|vitamins|mesh-ancestor
44311988|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
44311989|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44311990|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44311991|NCT00893724|Tocopherols|tocopherols|mesh-list
44311992|NCT00893724|Vitamin E|vitamin e|mesh-list
44311993|NCT00893724|Tocotrienols|tocotrienols|mesh-list
44311994|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
44311995|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
44120492|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120493|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44311996|NCT00893724|Niacinamide|niacinamide|mesh-list
44311998|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
44311999|NCT00893724|Ubiquinone|ubiquinone|mesh-list
44312000|NCT00893724|Minocycline|minocycline|mesh-list
44312001|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
44312002|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44312003|NCT00893724|Vitamins|vitamins|mesh-ancestor
44312004|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
44312005|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312006|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
44312007|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312008|NCT00893724|Protective Agents|protective agents|mesh-ancestor
44312009|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312010|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312011|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
44312012|NCT00893724|Expectorants|expectorants|mesh-ancestor
44312013|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
44312014|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44312015|NCT00893724|Antidotes|antidotes|mesh-ancestor
44312016|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
44312017|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44312018|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
44312019|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44312020|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44312021|NCT00893841|Pramipexole|pramipexole|mesh-list
44312022|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44312023|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
44312024|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44312025|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44312026|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120494|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120495|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120500|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120502|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44120503|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120504|NCT00121303|Cytarabine|cytarabine|mesh-list
44120505|NCT00121303|Daunorubicin|daunorubicin|mesh-list
44120506|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
44120507|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44120508|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
44120509|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120510|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120511|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
44120512|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120513|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120514|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
44120515|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120516|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312027|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312028|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312029|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
44312030|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312031|NCT00893841|Protective Agents|protective agents|mesh-ancestor
44312032|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44312033|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44312034|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
44312035|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
44312036|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312037|NCT00893854|Triamcinolone|triamcinolone|mesh-list
44312038|NCT00893854|Diclofenac|diclofenac|mesh-list
44312039|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312040|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
44312041|NCT00893854|Hormones|hormones|mesh-ancestor
44312042|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312043|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312044|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312045|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312046|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312047|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312048|NCT00893854|Analgesics|analgesics|mesh-ancestor
44312049|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
44312050|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312051|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312052|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44312053|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
44312054|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44312055|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
44312056|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312057|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729025|NCT02574338|Alprostadil|alprostadil|mesh-list
44120517|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44120518|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44120519|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120520|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44120521|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
44120522|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120523|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120524|NCT00121316|Analgesics|analgesics|mesh-ancestor
44120525|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
44312058|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44312059|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
44312060|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44312062|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312063|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312064|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44312065|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
44312066|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
44312067|NCT00893880|Protective Agents|protective agents|mesh-ancestor
44312068|NCT00893906|Vaccines|vaccines|mesh-list
44312069|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
44312070|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312071|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
44312072|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312073|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312074|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44312075|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
44312076|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312077|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312078|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312079|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312080|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
44312081|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312082|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312083|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44312084|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
44312104|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312105|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44312106|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44312107|NCT00894023|Abciximab|abciximab|mesh-list
44312108|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
44466552|NCT01462318|Warfarin|warfarin|mesh-list
44312109|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44312110|NCT00894062|Everolimus|everolimus|mesh-list
44312111|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312112|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312113|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
44312114|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312115|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
44312116|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312117|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312118|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44312119|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
44312120|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312121|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312122|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312123|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312124|NCT00894231|Levocetirizine|levocetirizine|mesh-list
44312125|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44312126|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44312127|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
44312128|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
44312129|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312130|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312131|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312132|NCT00894283|Enoxaparin|enoxaparin|mesh-list
44312133|NCT00894283|PENTA|penta|mesh-list
44312147|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44312148|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312149|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312150|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
44312151|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
44312152|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44312153|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
44312155|NCT00894439|BLI-489|bli-489|mesh-list
44312156|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312157|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312158|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44312159|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312160|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312161|NCT00894569|Paclitaxel|paclitaxel|mesh-list
44312162|NCT00894569|Carboplatin|carboplatin|mesh-list
44312163|NCT00894569|Cetuximab|cetuximab|mesh-list
44312164|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312165|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312166|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312167|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312168|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312169|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312170|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312171|NCT00894608|Letrozole|letrozole|mesh-list
44312172|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312173|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44312174|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44312175|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312176|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312177|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44312178|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
44312179|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312180|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312181|NCT00894621|Norepinephrine|norepinephrine|mesh-list
44312182|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44312183|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44312184|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
44312186|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312187|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312188|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
44312189|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
44312190|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312191|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44312192|NCT00894634|Brompheniramine|brompheniramine|mesh-list
44312193|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312194|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44312195|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
44312196|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
44312197|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312198|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312199|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44312200|NCT00894660|Amodiaquine|amodiaquine|mesh-list
44312201|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
44312202|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44312203|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44312204|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312205|NCT00894673|Heparin|heparin|mesh-list
44312206|NCT00894673|Calcium heparin|calcium heparin|mesh-list
44312207|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
44312208|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312209|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312210|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312211|NCT00894712|Sulforaphane|sulforaphane|mesh-list
44312212|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44312213|NCT00894712|Protective Agents|protective agents|mesh-ancestor
44312214|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312215|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312229|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44312230|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44312231|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44312232|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312233|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312234|NCT00894829|Heparin|heparin|mesh-list
44312235|NCT00894829|Calcium heparin|calcium heparin|mesh-list
44312236|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
44312237|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312238|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312239|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312240|NCT00894920|Biotin|biotin|mesh-list
44312241|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
44312242|NCT00894920|Vitamins|vitamins|mesh-ancestor
44312243|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
44312244|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312245|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
44312246|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312247|NCT00894959|Heparin|heparin|mesh-list
44312248|NCT00894959|Calcium heparin|calcium heparin|mesh-list
44312249|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
44312250|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312251|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312252|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312253|NCT00894985|Heparin|heparin|mesh-list
44312254|NCT00894985|Calcium heparin|calcium heparin|mesh-list
44312255|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
44312256|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312276|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312277|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312278|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44312279|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
44312280|NCT00895076|Hormones|hormones|mesh-ancestor
44312281|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312282|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312283|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312284|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
44312285|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
44312286|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44312287|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44312288|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312289|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44312290|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44312291|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312292|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312293|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312294|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44312295|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
44312296|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44312297|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312298|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44312299|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44312300|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44312301|NCT00895115|Vitamin E|vitamin e|mesh-list
44312302|NCT00895115|Vitamins|vitamins|mesh-ancestor
44312303|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
44312304|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312305|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
44312306|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312307|NCT00895115|Protective Agents|protective agents|mesh-ancestor
44312308|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44312309|NCT00895128|Dasatinib|dasatinib|mesh-list
44312314|NCT00895167|Curcumin|curcumin|mesh-list
44312315|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312316|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312317|NCT00895167|Analgesics|analgesics|mesh-ancestor
44312318|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
44312319|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312320|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312321|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312322|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312323|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312324|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312325|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312326|NCT00895297|Dasatinib|dasatinib|mesh-list
44312327|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312328|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312329|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312330|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312331|NCT00895323|Antibodies|antibodies|mesh-list
44312332|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44312333|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44312334|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
44312335|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312336|NCT00895362|Cetuximab|cetuximab|mesh-list
44312337|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44312338|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312339|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312340|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312341|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312342|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312343|NCT00895505|Warfarin|warfarin|mesh-list
44312344|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
44312345|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
44312346|NCT00895544|Vaccines|vaccines|mesh-list
44312357|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44312358|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312359|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44312360|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44312361|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44312362|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312363|NCT00895609|Neostigmine|neostigmine|mesh-list
44312364|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44312365|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312366|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312367|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
44312368|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312369|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312370|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44312371|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
44312372|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312373|NCT00895648|Cisplatin|cisplatin|mesh-list
44312374|NCT00895648|Pemetrexed|pemetrexed|mesh-list
44312375|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312376|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312377|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312378|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44312379|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44312380|NCT00895674|Sorafenib|sorafenib|mesh-list
44312381|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312382|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312383|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312384|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312385|NCT00895687|Bortezomib|bortezomib|mesh-list
44312386|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44120526|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120527|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120528|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120529|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120530|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120531|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120532|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
44120533|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44120534|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312387|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312388|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312389|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312390|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312391|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
44312392|NCT00895713|Antibodies|antibodies|mesh-list
44312393|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
44312394|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44312395|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44312396|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
44312397|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312398|NCT00895739|Cyclosporine|cyclosporine|mesh-list
44312399|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
44312400|NCT00895739|Cyclosporins|cyclosporins|mesh-list
44312401|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312402|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312403|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312404|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
44312405|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312406|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
44312407|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312409|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312410|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44312411|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312412|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312413|NCT00895778|Rocuronium|rocuronium|mesh-list
44312414|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44312415|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44312416|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44312419|NCT00895804|Pindolol|pindolol|mesh-list
44312433|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
44312434|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312435|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
44312436|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312437|NCT00895960|Temozolomide|temozolomide|mesh-list
44312438|NCT00895960|Dasatinib|dasatinib|mesh-list
44312439|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312440|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
44312441|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312442|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312443|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312444|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312445|NCT00896077|Lisofylline|lisofylline|mesh-list
44312446|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44312447|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
44312448|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312449|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312450|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312451|NCT00896077|Analgesics|analgesics|mesh-ancestor
44312452|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
44312453|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312454|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312455|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312456|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312457|NCT00896155|Tamoxifen|tamoxifen|mesh-list
44312458|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44312459|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
44312460|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312461|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312462|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312463|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312464|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44312465|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44312466|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44312468|NCT00896285|Analgesics|analgesics|mesh-list
44312471|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312472|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312473|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312474|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312475|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312476|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44312477|NCT00896285|Narcotics|narcotics|mesh-ancestor
44312478|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312479|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
44312480|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44312481|NCT00896376|Trastuzumab|trastuzumab|mesh-list
44312482|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312483|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312484|NCT00896402|Iodine|iodine|mesh-list
44312485|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
44312486|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44312487|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
44312488|NCT00896402|Povidone|povidone|mesh-list
44312489|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44312490|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312491|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
44312492|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
44312493|NCT00896402|Trace Elements|trace elements|mesh-ancestor
44312494|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
44312495|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312496|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
44312497|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
44312498|NCT00896428|Gallopamil|gallopamil|mesh-list
44312499|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44312500|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44312501|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312504|NCT00896519|Prednisone|prednisone|mesh-list
44312517|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312518|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312519|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44312520|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44312521|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312522|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44312523|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44312524|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312525|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312526|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
44312528|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312529|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312530|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312531|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312532|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312533|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312534|NCT00896558|Midazolam|midazolam|mesh-list
44312535|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44312536|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44312537|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312538|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312539|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44312540|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44312541|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44312542|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44312563|NCT00896727|Antibodies|antibodies|mesh-list
44312564|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
44312565|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312566|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
44312567|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44312568|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44312569|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312570|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312571|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312572|NCT00896948|Antibodies|antibodies|mesh-list
44312573|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
44312574|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466556|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466557|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44466558|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44466559|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466560|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44466561|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466562|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466563|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44466564|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
44466565|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
44466566|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
44466567|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
44466568|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466569|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466570|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
44466571|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44466572|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44466573|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44466574|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466575|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44466576|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44466577|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44466578|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44466582|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
44466583|NCT01462318|Coagulants|coagulants|mesh-ancestor
44466584|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
44466585|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
44466586|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44466587|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44466588|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44466589|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
44466590|NCT01462266|Metformin|metformin|mesh-list
44466591|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
44466592|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44466593|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44466594|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466595|NCT01462266|Incretins|incretins|mesh-ancestor
44466596|NCT01462266|Hormones|hormones|mesh-ancestor
43603274|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44466597|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466598|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44466599|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466600|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466601|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466602|NCT01462227|Naltrexone|naltrexone|mesh-list
44466603|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44466604|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44466605|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466606|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
44466607|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466608|NCT01461928|Rituximab|rituximab|mesh-list
44466609|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466610|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466611|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
44466612|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466613|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967414|NCT05094804|Docetaxel|docetaxel|mesh-list
44312575|NCT00896987|Lamotrigine|lamotrigine|mesh-list
44312576|NCT00896987|Carbamazepine|carbamazepine|mesh-list
44312577|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
44312578|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44312581|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44312582|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312583|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44312584|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44312585|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312586|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44312587|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44312588|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
44312589|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312591|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
44312592|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312593|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44312594|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44312595|NCT00897026|Paclitaxel|paclitaxel|mesh-list
44312596|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
44312597|NCT00897026|Doxorubicin|doxorubicin|mesh-list
44312598|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44312599|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312600|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312601|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312602|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312603|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312604|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312605|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312606|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
44312607|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312608|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312609|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312610|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
44312624|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312625|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44312626|NCT00897221|Deferiprone|deferiprone|mesh-list
44312627|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44312628|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
44312629|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
44312630|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312631|NCT00897312|Interferons|interferons|mesh-list
44312632|NCT00897312|Ribavirin|ribavirin|mesh-list
44312633|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
44312634|NCT00897312|Tremelimumab|tremelimumab|mesh-list
44312635|NCT00897312|Infliximab|infliximab|mesh-list
44312636|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312637|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
44312638|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312639|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
44312640|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312641|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
44312642|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312643|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44312644|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44312645|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312646|NCT00897377|Temozolomide|temozolomide|mesh-list
44312647|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44312648|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
44312649|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312650|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312651|NCT00897520|Interferons|interferons|mesh-list
44312652|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
44312653|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312654|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
44312655|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312670|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44312671|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312672|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44312673|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44312674|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312675|NCT00897884|Metformin|metformin|mesh-list
44312676|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44312677|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312678|NCT00897975|Red yeast rice|red yeast rice|mesh-list
44312679|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44312680|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44312681|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44312682|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
44312683|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312684|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312685|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44312686|NCT00898287|Gemcitabine|gemcitabine|mesh-list
44312687|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44312688|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
44312689|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312690|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312691|NCT00898287|Antiviral Agents|antiviral agents|mesh-ancestor
44312721|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312722|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312723|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312724|NCT00898573|Lapatinib|lapatinib|mesh-list
44312725|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312726|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44312727|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312728|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466614|NCT01461551|Propofol|propofol|mesh-list
44466615|NCT01461551|Sevoflurane|sevoflurane|mesh-list
44466616|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44466617|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466618|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466619|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44466620|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
44466621|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
44466622|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44466623|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44466624|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44466625|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44466626|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466627|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466628|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
44466629|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466630|NCT01461369|Diclofenac|diclofenac|mesh-list
44466631|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44466632|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466633|NCT01461369|Analgesics|analgesics|mesh-ancestor
44466634|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
44466635|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466636|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466637|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466638|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466647|NCT01461057|Trastuzumab|trastuzumab|mesh-list
44466648|NCT01461057|Pertuzumab|pertuzumab|mesh-list
44466649|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466650|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44466651|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
44466652|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466653|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44466654|NCT01460719|Vaccines|vaccines|mesh-list
44466655|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
44466656|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466657|NCT01460628|Modafinil|modafinil|mesh-list
44466658|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44466659|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466660|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44466661|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44466662|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44466663|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466664|NCT01460407|Clarithromycin|clarithromycin|mesh-list
44466665|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466666|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466667|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44466668|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466669|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466670|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44466671|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44466672|NCT01460381|Quinidine|quinidine|mesh-list
44466673|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
44312729|NCT00898794|Bevacizumab|bevacizumab|mesh-list
44312734|NCT00898794|Growth Substances|growth substances|mesh-ancestor
44312735|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312736|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44312738|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44312739|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
44312740|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312741|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312742|NCT00898950|Aspirin|aspirin|mesh-list
44312743|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
44312744|NCT00898950|Salicylates|salicylates|mesh-list
44312745|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312746|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312747|NCT00898950|Analgesics|analgesics|mesh-ancestor
44312748|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
44312749|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312750|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312751|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312752|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312753|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44312754|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44312755|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312756|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44312757|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44312758|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312759|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
44312760|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312761|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
44312762|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
44312779|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
44312780|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312781|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312782|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44312783|NCT00899821|Aldesleukin|aldesleukin|mesh-list
44312784|NCT00899821|Interleukin-12|interleukin-12|mesh-list
44312785|NCT00899821|Sargramostim|sargramostim|mesh-list
44312786|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
44312787|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312788|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312789|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44312790|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44312791|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
44312792|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312793|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44312794|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44312795|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44312796|NCT00899821|Growth Substances|growth substances|mesh-ancestor
44312797|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44312798|NCT00899951|Fentanyl|fentanyl|mesh-list
44312799|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44312800|NCT00899951|Narcotics|narcotics|mesh-ancestor
44312801|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312802|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312803|NCT00899951|Analgesics|analgesics|mesh-ancestor
44312804|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
44312805|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312806|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44312807|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44312809|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
44312826|NCT00900445|Prednisolone|prednisolone|mesh-list
44312827|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44312828|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
44312829|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44312830|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
44312831|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
44312832|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44312833|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44312834|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44312836|NCT00900445|Vincristine|vincristine|mesh-list
44312837|NCT00900445|Daunorubicin|daunorubicin|mesh-list
44312838|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44312839|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
44312840|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312841|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
44312842|NCT00900445|Hormones|hormones|mesh-ancestor
44312843|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312844|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312845|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312846|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312847|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44312848|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44312849|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44312850|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44312851|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312852|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
44312853|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
44312854|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312855|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44312856|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44312857|NCT00900445|Protective Agents|protective agents|mesh-ancestor
44312858|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44312859|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44312860|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44312862|NCT00900510|Trimethoprim|trimethoprim|mesh-list
44312865|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44312866|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44312867|NCT00900510|Renal Agents|renal agents|mesh-ancestor
44312868|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
44312869|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44312870|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44312871|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44312872|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312873|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312874|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44312875|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44312876|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43967701|NCT03762850|Irbesartan|irbesartan|mesh-list
44312877|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466686|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44466687|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44312878|NCT00900744|Tamoxifen|tamoxifen|mesh-list
44312879|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44312880|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44312881|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312882|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312883|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44312884|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312885|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44312886|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44312887|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44312888|NCT00900874|Albuterol|albuterol|mesh-list
44312889|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
44312890|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44312891|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
44312903|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44312905|NCT00900887|Nepafenac|nepafenac|mesh-list
44312906|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44312907|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44312908|NCT00900887|Analgesics|analgesics|mesh-ancestor
44312909|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
44312910|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312911|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312912|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44312913|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44312914|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44312915|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312916|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312917|NCT00900913|Ropivacaine|ropivacaine|mesh-list
44312918|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
44312919|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
44312920|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312921|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312922|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
44312923|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312924|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44312925|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
44312926|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312927|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
44312928|NCT00901069|Rituximab|rituximab|mesh-list
44312929|NCT00901069|Vincristine|vincristine|mesh-list
44312930|NCT00901069|Azacitidine|azacitidine|mesh-list
44312931|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44312947|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312948|NCT00901147|Bortezomib|bortezomib|mesh-list
44312949|NCT00901147|Panobinostat|panobinostat|mesh-list
44312950|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44312951|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44312952|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312953|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312954|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
44312955|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
44312956|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44312957|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312958|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44312959|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44312960|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44312962|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44312963|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312964|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44312965|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
44312966|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
44312967|NCT00901368|Hormones|hormones|mesh-ancestor
44312968|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44312969|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
44312970|NCT00901381|Lenograstim|lenograstim|mesh-list
44312971|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44312972|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
44312973|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312974|NCT00901407|Lamotrigine|lamotrigine|mesh-list
44312975|NCT00901407|Paroxetine|paroxetine|mesh-list
44312976|NCT00901407|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44312977|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44312978|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44312979|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44312980|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44312981|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
44312982|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44312983|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44312984|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
44312985|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44312986|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44312987|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44312988|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44312989|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
44312990|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44312991|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44312992|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44312993|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44312994|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44312995|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44312996|NCT00901511|Molgramostim|molgramostim|mesh-list
44312997|NCT00901511|Sargramostim|sargramostim|mesh-list
44312998|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
44312999|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313000|NCT00901511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313001|NCT00901524|Interferons|interferons|mesh-list
44313002|NCT00901524|Ribavirin|ribavirin|mesh-list
44313003|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
44313004|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
44313005|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44313006|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313007|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
44313008|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313009|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
44313010|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313011|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
44313012|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313013|NCT00901537|Cisplatin|cisplatin|mesh-list
44313014|NCT00901537|Azacitidine|azacitidine|mesh-list
44313015|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313016|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313017|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
43729654|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44120535|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120536|NCT00121329|Lidocaine|lidocaine|mesh-list
44120537|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
44120538|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
44120539|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120540|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313018|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313019|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313020|NCT00901550|Methotrexate|methotrexate|mesh-list
44313021|NCT00901550|Infliximab|infliximab|mesh-list
44313022|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44313023|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
44313024|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44313025|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313026|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313028|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313029|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313030|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313031|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313032|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44313033|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313034|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
44313035|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313036|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313037|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313038|NCT00901615|Lenalidomide|lenalidomide|mesh-list
44313039|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
44313040|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313041|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44313042|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44313043|NCT00901615|Growth Substances|growth substances|mesh-ancestor
44313044|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44313045|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313046|NCT00901654|Vaccines|vaccines|mesh-list
44313047|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
44313048|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313049|NCT00901719|Nitroprusside|nitroprusside|mesh-list
44313050|NCT00901719|Acetylcholine|acetylcholine|mesh-list
44120541|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
44120542|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120543|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44120544|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44120545|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44120546|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120547|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120548|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
44120549|NCT00121381|Tacrolimus|tacrolimus|mesh-list
43701848|NCT02722343|Emtricitabine|emtricitabine|mesh-list
44313051|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313052|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313053|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44313054|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313055|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44313056|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313057|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313058|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313059|NCT00901732|Calcium|calcium|mesh-list
44313060|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44313061|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313062|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
44313063|NCT00901745|Giapreza|giapreza|mesh-list
44313064|NCT00901745|Norepinephrine|norepinephrine|mesh-list
44313065|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
44313066|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44313067|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44313068|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
44313069|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313070|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313071|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44313072|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44313073|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
44313074|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313075|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313076|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
44313081|NCT00901784|Topiramate|topiramate|mesh-list
44313100|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44313101|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313102|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
44313103|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313104|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
44313105|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313106|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313107|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313108|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313110|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44313112|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44313113|NCT00901875|Narcotics|narcotics|mesh-ancestor
44313114|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313115|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313116|NCT00901875|Analgesics|analgesics|mesh-ancestor
43598346|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598348|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598374|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43598375|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598376|NCT03300609|Antidotes|antidotes|mesh-ancestor
44313117|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
44313118|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313119|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44313120|NCT00901888|Nitroprusside|nitroprusside|mesh-list
44313121|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313122|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313123|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44313124|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313125|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44313126|NCT00902031|Sennosides|sennosides|mesh-list
44120550|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120551|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120552|NCT00121381|Analgesics|analgesics|mesh-ancestor
44120553|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
44120554|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120555|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120556|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120557|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120558|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120559|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120560|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
44120561|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44120562|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120563|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120564|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
44120565|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44120569|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44120570|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44120571|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
44120572|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120573|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44120574|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313127|NCT00902031|Senna Extract|senna extract|mesh-list
44313128|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
44313129|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313130|NCT00902031|Laxatives|laxatives|mesh-ancestor
44313131|NCT00902031|Cathartics|cathartics|mesh-ancestor
44313132|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44313133|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
44313134|NCT00902057|Coagulants|coagulants|mesh-ancestor
44313135|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44313136|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
44313137|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313139|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44313140|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44313141|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44313142|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313143|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313144|NCT00902135|Interferons|interferons|mesh-list
44313145|NCT00902135|Interferon-beta|interferon-beta|mesh-list
44313146|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
44313147|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313148|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
44313149|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313150|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
44313151|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313152|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44313153|NCT00902187|Fesoterodine|fesoterodine|mesh-list
44313178|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313179|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44313180|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44313181|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
44313182|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
43648923|NCT03033199|Hormones|hormones|mesh-ancestor
44313183|NCT00902421|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44313184|NCT00902421|Serotonin|serotonin|mesh-list
44313185|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
44313186|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44313187|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313188|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313189|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313190|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
44313191|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313192|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44313193|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313194|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466688|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466689|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44466690|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44466691|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466692|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44466693|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44466694|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
44466695|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466696|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466697|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44466698|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466699|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466700|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466701|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466702|NCT01460342|Tadalafil|tadalafil|mesh-list
44466703|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
44466706|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466710|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44466711|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466712|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466713|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466714|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466715|NCT01459913|Interferons|interferons|mesh-list
44466716|NCT01459913|Ribavirin|ribavirin|mesh-list
44466717|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
44466718|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
44466719|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44466720|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466721|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
44466722|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466723|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
44466724|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466725|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
44466726|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466727|NCT01459796|Rilonacept|rilonacept|mesh-list
44466728|NCT01459796|Allopurinol|allopurinol|mesh-list
44466729|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
44466730|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466731|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466732|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
44466733|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44466734|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44466735|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
44466736|NCT01459796|Protective Agents|protective agents|mesh-ancestor
44466737|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466738|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466739|NCT01459718|Deferasirox|deferasirox|mesh-list
44466740|NCT01459718|Deferoxamine|deferoxamine|mesh-list
44466741|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44466742|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
44466743|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
43648930|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648931|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598383|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44466744|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120575|NCT00121446|Enoxaparin|enoxaparin|mesh-list
44120576|NCT00121446|Tenecteplase|tenecteplase|mesh-list
44120577|NCT00121446|Clopidogrel|clopidogrel|mesh-list
44120578|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44120579|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44120580|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44120581|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44466745|NCT01459718|Siderophores|siderophores|mesh-ancestor
44466746|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44313196|NCT00902460|Tofacitinib|tofacitinib|mesh-list
44313197|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44313198|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44313199|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313200|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313201|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313202|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44313203|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44313204|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44313205|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
44313206|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
44313207|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
44313208|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
44313209|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313210|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313211|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313212|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313213|NCT00902473|Topiramate|topiramate|mesh-list
44313214|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
44313215|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44313216|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120582|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
44120583|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120584|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120585|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120586|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
44120587|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44120588|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44120589|NCT00121459|Psyllium|psyllium|mesh-list
44120590|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
44120591|NCT00121459|Cathartics|cathartics|mesh-ancestor
44120592|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120593|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
44120594|NCT00121498|Lidocaine|lidocaine|mesh-list
44120595|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
44120596|NCT00121498|Anesthetics|anesthetics|mesh-list
44120597|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120598|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120599|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
44120600|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120601|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44120602|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44120603|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44120604|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120605|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120606|NCT00121511|Fluorouracil|fluorouracil|mesh-list
44120607|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
43598390|NCT03300440|Vitamins|vitamins|mesh-list
44120608|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120609|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44120610|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120611|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313218|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313219|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44313220|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44313221|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313222|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313223|NCT00902512|Urological Agents|urological agents|mesh-ancestor
44313224|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44313225|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
44313226|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313227|NCT00902603|Iloprost|iloprost|mesh-list
44313228|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44313229|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313230|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44313231|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
44313232|NCT00902655|Coagulants|coagulants|mesh-ancestor
44313233|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44313234|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
43729728|NCT02569905|Parecoxib|parecoxib|mesh-list
44120612|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
44120613|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120614|NCT00121524|Atropine|atropine|mesh-list
44120615|NCT00121524|Amiodarone|amiodarone|mesh-list
44120616|NCT00121524|Epinephrine|epinephrine|mesh-list
44120617|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44120618|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44120619|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
44120620|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120621|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120622|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120623|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44120624|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44120625|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
44120626|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120627|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44120628|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120629|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
44120630|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
44120631|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44120632|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44120633|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44120634|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
44120635|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44120636|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44120637|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120638|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44120649|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44120650|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120651|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44120652|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120653|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120654|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120655|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120656|NCT00121563|Thalidomide|thalidomide|mesh-list
44120657|NCT00121563|Ibuprofen|ibuprofen|mesh-list
44120658|NCT00121563|Diazepam|diazepam|mesh-list
44120659|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313235|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313236|NCT00902681|Fesoterodine|fesoterodine|mesh-list
44313237|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44313238|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313239|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313240|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313241|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313242|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313243|NCT00902681|Urological Agents|urological agents|mesh-ancestor
44313244|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
44313245|NCT00902707|Guaifenesin|guaifenesin|mesh-list
44313246|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44313247|NCT00902707|Expectorants|expectorants|mesh-ancestor
44313248|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
44313249|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44313250|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44313251|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
44313252|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313253|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313254|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313255|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
44313256|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44313257|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
44313258|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
44313259|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313260|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
44313261|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44313262|NCT00902772|Lorazepam|lorazepam|mesh-list
44313263|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
44313264|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
44313265|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
44120660|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120661|NCT00121563|Analgesics|analgesics|mesh-ancestor
44120662|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
44120663|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120664|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120665|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120666|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120667|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44120668|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120669|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120670|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120671|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
44313266|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313267|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313268|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313269|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43968097|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
44313270|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313271|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313272|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44313273|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44313274|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
44313275|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
44313276|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313277|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313279|NCT00902811|Amodiaquine|amodiaquine|mesh-list
44313280|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
44313281|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44313282|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44313283|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313284|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313285|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
44313286|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
43604681|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
44313287|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44313288|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
44313289|NCT00902837|Oxycodone|oxycodone|mesh-list
44313290|NCT00902837|Naloxone|naloxone|mesh-list
44313291|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44313292|NCT00902837|Narcotics|narcotics|mesh-ancestor
44313293|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313294|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313295|NCT00902837|Analgesics|analgesics|mesh-ancestor
44313296|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
44313297|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120672|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
44120673|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44120674|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120675|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44120676|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44120677|NCT00121563|Growth Substances|growth substances|mesh-ancestor
44120678|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
44120679|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120680|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44120681|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
44120682|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
44120683|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
44313298|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44313300|NCT00902915|Lenalidomide|lenalidomide|mesh-list
44313301|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313302|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
44313303|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
44313304|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313305|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313306|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313307|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
44313308|NCT00902915|Hormones|hormones|mesh-ancestor
44313309|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44313310|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44313311|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313312|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
44313313|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44313314|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44313315|NCT00902915|Growth Substances|growth substances|mesh-ancestor
44313316|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
44313317|NCT00902941|Rasagiline|rasagiline|mesh-list
44313318|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44313319|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313320|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313321|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44313322|NCT00902941|Protective Agents|protective agents|mesh-ancestor
44313323|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313324|NCT00902954|Letrozole|letrozole|mesh-list
44313325|NCT00902954|Anastrozole|anastrozole|mesh-list
44313326|NCT00902954|Exemestane|exemestane|mesh-list
44313327|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313328|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44313329|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44313330|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313340|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
44313341|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313342|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44313343|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44313344|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313346|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
44313347|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
44313348|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313349|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313350|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44313351|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313352|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313353|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313354|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313355|NCT00903045|Urological Agents|urological agents|mesh-ancestor
44313356|NCT00903084|Tenofovir|tenofovir|mesh-list
44313357|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
44313358|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313359|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44313360|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313361|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313362|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313363|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44313364|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44313365|NCT00903188|Cyclosporine|cyclosporine|mesh-list
44313366|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
44313367|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
44313368|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44313369|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44313370|NCT00903188|Prednisolone|prednisolone|mesh-list
44313371|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
44313372|NCT00903188|Everolimus|everolimus|mesh-list
44313373|NCT00903188|Cyclosporins|cyclosporins|mesh-list
44120684|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120685|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44120686|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120687|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44120688|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44120689|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313374|NCT00903188|Basiliximab|basiliximab|mesh-list
44313375|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44313376|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
44313377|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313378|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313379|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313380|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
44313381|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313382|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
44313383|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313384|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313385|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313386|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44313387|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313388|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313389|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
44313390|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
44313391|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313392|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313393|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
44313394|NCT00903188|Hormones|hormones|mesh-ancestor
44313395|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44313396|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44313397|NCT00903188|Protective Agents|protective agents|mesh-ancestor
44313398|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44313401|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
44313422|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44313423|NCT00903279|Retapamulin|retapamulin|mesh-list
44313424|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313425|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313426|NCT00903292|Pemetrexed|pemetrexed|mesh-list
44313427|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44313428|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313429|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313430|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313431|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44313432|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313433|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313434|NCT00903656|Lapatinib|lapatinib|mesh-list
44313435|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313436|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313437|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313438|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313439|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44313440|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313441|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313442|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313443|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313444|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
44313445|NCT00903747|Prucalopride|prucalopride|mesh-list
44313446|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313447|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313448|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44313449|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44313450|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313451|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313452|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313453|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313454|NCT00903747|Laxatives|laxatives|mesh-ancestor
44313455|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313456|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44313457|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44313458|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
44313459|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313460|NCT00903825|Lidocaine|lidocaine|mesh-list
44313461|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
44313462|NCT00903825|Anesthetics|anesthetics|mesh-list
44313463|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313464|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313465|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
44313466|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313467|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313468|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313469|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313470|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313471|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313472|NCT00903838|Pramipexole|pramipexole|mesh-list
44313473|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
44313474|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313475|NCT00903838|Protective Agents|protective agents|mesh-ancestor
44313476|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313477|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44313478|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44313479|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
44313480|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
44313481|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313482|NCT00903851|Lidocaine|lidocaine|mesh-list
44313483|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313484|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
44313485|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313502|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313503|NCT00903994|Ketoprofen|ketoprofen|mesh-list
44313504|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313505|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44313506|NCT00903994|Analgesics|analgesics|mesh-ancestor
44313507|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
44313508|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313509|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313510|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313511|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313512|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44313513|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313514|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313515|NCT00904020|Lidocaine|lidocaine|mesh-list
44313516|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313517|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
44313518|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313519|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313520|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
44313521|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313522|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313553|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313554|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313555|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313556|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313557|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313558|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
44313559|NCT00904176|Digoxin|digoxin|mesh-list
44313560|NCT00904176|Warfarin|warfarin|mesh-list
44313561|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
44313562|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44313563|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313564|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44313565|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706576|NCT02705872|Dsuvia|dsuvia|mesh-list
44313566|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313567|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44313568|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313569|NCT00904176|Protective Agents|protective agents|mesh-ancestor
44313571|NCT00904202|Gabapentin|gabapentin|mesh-list
44313572|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313573|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
44313574|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313575|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313576|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
44120690|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120691|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120692|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44120693|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
44120694|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
44120695|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
44120696|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
44120697|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120698|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
44120699|NCT00121602|Hematinics|hematinics|mesh-ancestor
44120700|NCT00121615|Etanercept|etanercept|mesh-list
44120701|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120710|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120711|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
44120712|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
44120713|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44120714|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120715|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120716|NCT00121680|Lenvatinib|lenvatinib|mesh-list
44120717|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120718|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44120719|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120720|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120721|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
44313577|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313578|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313579|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313580|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313581|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313582|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313583|NCT00904202|Analgesics|analgesics|mesh-ancestor
44313584|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
44313585|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313586|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44313587|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44313588|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44313589|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44313590|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313591|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
44313592|NCT00904280|Oxymorphone|oxymorphone|mesh-list
44313593|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44313594|NCT00904280|Narcotics|narcotics|mesh-ancestor
44313595|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313596|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313597|NCT00904280|Analgesics|analgesics|mesh-ancestor
44313598|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
44313599|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313600|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44313601|NCT00904293|Warfarin|warfarin|mesh-list
44313602|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
43598517|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43598518|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44313603|NCT00904306|Chromium|chromium|mesh-list
44313604|NCT00904306|Picolinic acid|picolinic acid|mesh-list
44313605|NCT00904306|Trace Elements|trace elements|mesh-ancestor
44313606|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
44313607|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466756|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466757|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
44466758|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
44466759|NCT01459614|Gemcitabine|gemcitabine|mesh-list
44466760|NCT01459614|Cisplatin|cisplatin|mesh-list
44466761|NCT01459614|Docetaxel|docetaxel|mesh-list
44466762|NCT01459614|Capecitabine|capecitabine|mesh-list
44466763|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466764|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44466765|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
44466766|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466767|NCT01459614|Antiviral Agents|antiviral agents|mesh-ancestor
44466768|NCT01459614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466769|NCT01459614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466770|NCT01459614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44466771|NCT01459614|Immunologic Factors|immunologic factors|mesh-ancestor
44466772|NCT01459614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466773|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
44466774|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
44466775|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
44466776|NCT01458951|Tofacitinib|tofacitinib|mesh-list
44466777|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43730014|NCT02567981|Vitamin A|vitamin a|mesh-list
44120722|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44120723|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120724|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44120725|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
44120726|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44120727|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120728|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120729|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120730|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44120731|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120732|NCT00121875|Hormones|hormones|mesh-list
44120733|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44120734|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120735|NCT00121888|Paroxetine|paroxetine|mesh-list
44120736|NCT00121888|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44120737|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44120738|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120739|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120740|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120741|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
44120742|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120743|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44120744|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
44120745|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120746|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44120747|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120748|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120749|NCT00121914|Ethanol|ethanol|mesh-list
44120750|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44120751|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466778|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313612|NCT00904397|Celecoxib|celecoxib|mesh-list
44313613|NCT00904397|Lidocaine|lidocaine|mesh-list
44313614|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313615|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
44313616|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313617|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313618|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
44313619|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313620|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313621|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313622|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313623|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313624|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313625|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313626|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730019|NCT02568033|Paclitaxel|paclitaxel|mesh-list
44120752|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120753|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120754|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
44120755|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44120756|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120757|NCT00121966|Insulin|insulin|mesh-list
44120758|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44120759|NCT00121966|Metformin|metformin|mesh-list
44120760|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
44120761|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
44120762|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
44120763|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
44120764|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
44120765|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44120766|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120770|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120771|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120772|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
44120773|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120774|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
44120775|NCT00122018|Fenoldopam|fenoldopam|mesh-list
44120776|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44120777|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
44120778|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120779|NCT00122018|Expectorants|expectorants|mesh-ancestor
44120780|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120781|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44120782|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
44120783|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120784|NCT00122018|Protective Agents|protective agents|mesh-ancestor
44120785|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120786|NCT00122018|Antidotes|antidotes|mesh-ancestor
44120787|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44120788|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
44120789|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
44120790|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
44120791|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120792|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
44120793|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44120794|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44120795|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44120796|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313627|NCT00904397|Analgesics|analgesics|mesh-ancestor
44313628|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313629|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313630|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44313631|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44313632|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313633|NCT00904436|Ipratropium|ipratropium|mesh-list
44313634|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44313635|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
44313636|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313637|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313638|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44313639|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
44313640|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44313641|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
44313642|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313643|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313644|NCT00904449|Oxymorphone|oxymorphone|mesh-list
44313645|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44313646|NCT00904449|Narcotics|narcotics|mesh-ancestor
44313647|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313648|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313649|NCT00904449|Analgesics|analgesics|mesh-ancestor
44313650|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
44313651|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313652|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44313653|NCT00904462|Lidocaine|lidocaine|mesh-list
44313654|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313655|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
44313656|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313657|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313658|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
44313659|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313660|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313661|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313665|NCT00904475|Lidocaine|lidocaine|mesh-list
44313666|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313667|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
44313668|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313669|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313670|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
44313671|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313672|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313673|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313674|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313675|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313676|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313677|NCT00904540|Lidocaine|lidocaine|mesh-list
44313678|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
44313679|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
44313680|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313681|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313682|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
44313683|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968551|NCT01619774|Trametinib|trametinib|mesh-list
44313684|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313685|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44313686|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44313687|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313688|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313690|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313691|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44313692|NCT00904605|Analgesics|analgesics|mesh-ancestor
44313693|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
44313694|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313695|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313696|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313697|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313702|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
44313703|NCT00904631|Salicylates|salicylates|mesh-list
44313704|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313705|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
44313706|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
44313707|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313708|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313709|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44313710|NCT00904631|Analgesics|analgesics|mesh-ancestor
44313711|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
44313712|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313713|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313714|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313715|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313716|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44313717|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313718|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313719|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
44313720|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44313721|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44313722|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
44313723|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313724|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44313725|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44313726|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313727|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313728|NCT00904657|Sunitinib|sunitinib|mesh-list
44313729|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313730|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44313731|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44120797|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120798|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120799|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120800|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120801|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44120802|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120803|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44120804|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
44120805|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120806|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44120807|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120808|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120809|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120810|NCT00122096|Valdecoxib|valdecoxib|mesh-list
44313732|NCT00904657|Growth Substances|growth substances|mesh-ancestor
44313733|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313734|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44313735|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313736|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313737|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313738|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
44313739|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44313740|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44313741|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313742|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
44313743|NCT00904709|Coagulants|coagulants|mesh-ancestor
44313744|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
44313745|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
44313746|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313747|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44313748|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313749|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313750|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
44313751|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313752|NCT00904852|Bevacizumab|bevacizumab|mesh-list
44313753|NCT00904852|Temozolomide|temozolomide|mesh-list
44313754|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44313755|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968607|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730095|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44120811|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44120812|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44120813|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120814|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120815|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120816|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120817|NCT00122096|Analgesics|analgesics|mesh-ancestor
44120818|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
44120819|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120820|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120821|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120822|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120824|NCT00122226|Lopinavir|lopinavir|mesh-list
44120825|NCT00122226|Lamivudine|lamivudine|mesh-list
44120826|NCT00122226|Zidovudine|zidovudine|mesh-list
44120827|NCT00122226|Nevirapine|nevirapine|mesh-list
44120828|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120829|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120830|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120831|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120832|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313756|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44313757|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44313759|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313760|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
44313761|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44313762|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
44313763|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313764|NCT00904904|Ketorolac|ketorolac|mesh-list
44313765|NCT00904904|Indomethacin|indomethacin|mesh-list
44313766|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44313767|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44313768|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44313769|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44313770|NCT00904904|Analgesics|analgesics|mesh-ancestor
44313771|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
44313772|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313773|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313774|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313775|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313776|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44313777|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313778|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313780|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
44313806|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313807|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313808|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313809|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313810|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44313811|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313812|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
44313813|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44313814|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313815|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
44313816|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313817|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44313818|NCT00905190|Ondansetron|ondansetron|mesh-list
44313819|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
44313820|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
44313821|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44313822|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313823|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44313824|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
44313825|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44313826|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44313827|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
44313828|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313829|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313830|NCT00905190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44313831|NCT00905190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43968702|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
44313832|NCT00905190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44313834|NCT00905190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44313835|NCT00905216|Heparin|heparin|mesh-list
44313836|NCT00905216|Calcium heparin|calcium heparin|mesh-list
44313837|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
44313838|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44313839|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44313840|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313841|NCT00905229|Vitamins|vitamins|mesh-list
44313846|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44313847|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44313848|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313850|NCT00905229|Coagulants|coagulants|mesh-ancestor
44313851|NCT00905333|Felodipine|felodipine|mesh-list
44313852|NCT00905333|Candesartan|candesartan|mesh-list
44313853|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
44313854|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313855|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44313856|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44313857|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313858|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313859|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44313860|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44313861|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44313862|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313863|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313864|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44313865|NCT00905528|Telmisartan|telmisartan|mesh-list
44313866|NCT00905528|Ramipril|ramipril|mesh-list
44313867|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313868|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44313869|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44313870|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313871|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44313872|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44313873|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313874|NCT00905541|Simvastatin|simvastatin|mesh-list
44313875|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44120833|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120834|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120835|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
44120836|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120837|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120838|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120839|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120842|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44120843|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44120844|NCT00122291|Capecitabine|capecitabine|mesh-list
44120845|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313876|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44313877|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
44313878|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313879|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44313880|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44313881|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313882|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44313883|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44313884|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313885|NCT00905723|Estradiol|estradiol|mesh-list
44313886|NCT00905723|Estrogens|estrogens|mesh-ancestor
44313887|NCT00905723|Hormones|hormones|mesh-ancestor
44313888|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44313889|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313890|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
44313891|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
44313892|NCT00905762|Besifloxacin|besifloxacin|mesh-list
44313893|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313894|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313895|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44313896|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44313897|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313898|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313899|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313900|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44313923|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44313924|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44313925|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
44313926|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313927|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44313928|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44313929|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313930|NCT00905918|Vitamin E|vitamin e|mesh-list
44313931|NCT00905918|Vitamins|vitamins|mesh-ancestor
44313932|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
44313933|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313934|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
44313935|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313936|NCT00905918|Protective Agents|protective agents|mesh-ancestor
44313937|NCT00905931|Lycopene|lycopene|mesh-list
44313938|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44313939|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
44313940|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313941|NCT00905931|Protective Agents|protective agents|mesh-ancestor
44313942|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313943|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44313944|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44313945|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313946|NCT00905983|Gemcitabine|gemcitabine|mesh-list
44313947|NCT00905983|Docetaxel|docetaxel|mesh-list
44313948|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313949|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
44313950|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313951|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313952|NCT00905983|Antiviral Agents|antiviral agents|mesh-ancestor
44313953|NCT00905983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313954|NCT00905983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313955|NCT00905983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44313956|NCT00905983|Immunologic Factors|immunologic factors|mesh-ancestor
44313961|NCT00905996|Propranolol|propranolol|mesh-list
44313964|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44313965|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44313966|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313967|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313968|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44313969|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44313970|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
44313971|NCT00906048|Levofloxacin|levofloxacin|mesh-list
44313972|NCT00906048|Ofloxacin|ofloxacin|mesh-list
44313973|NCT00906048|Rifampin|rifampin|mesh-list
44313974|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44313975|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44313976|NCT00906048|Renal Agents|renal agents|mesh-ancestor
44313977|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44313978|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44313979|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44313980|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44313981|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44313982|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44313983|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44120846|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
44120847|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120848|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120849|NCT00122304|Eculizumab|eculizumab|mesh-list
44120850|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44120851|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120852|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
44120853|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120854|NCT00122330|Eculizumab|eculizumab|mesh-list
44120855|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44120856|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120857|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
44154639|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120858|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120859|NCT00122343|Sirolimus|sirolimus|mesh-list
44120860|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44120861|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120862|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44120863|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120864|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
44120865|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44120866|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
44120867|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120868|NCT00122356|Alendronate|alendronate|mesh-list
44120869|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44120870|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120871|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
44120872|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44120873|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
44120874|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120875|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44313984|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44313985|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44313986|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
44313987|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
44313988|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44313989|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44313990|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44313991|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44313992|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44313993|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44313994|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44313995|NCT00906061|Gemcitabine|gemcitabine|mesh-list
44313996|NCT00906061|Docetaxel|docetaxel|mesh-list
44313997|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44313998|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
44313999|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314000|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314001|NCT00906061|Antiviral Agents|antiviral agents|mesh-ancestor
44314002|NCT00906061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314003|NCT00906061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314004|NCT00906061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314005|NCT00906061|Immunologic Factors|immunologic factors|mesh-ancestor
44314006|NCT00906061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120876|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44120877|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44120878|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
44120879|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44120880|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120881|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120882|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120883|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
44120884|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120885|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44120886|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43565061|NCT00948142|Linezolid|linezolid|mesh-list
44120887|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120888|NCT00122486|Tenofovir|tenofovir|mesh-list
44120889|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
44120890|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120891|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120892|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120893|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120894|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120895|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120896|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120897|NCT00122499|Tadalafil|tadalafil|mesh-list
44120898|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44120899|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43701894|NCT02721511|Diuretics|diuretics|mesh-ancestor
44314007|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
44314008|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
44314009|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
44314011|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44314012|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
44314013|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314014|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314015|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44314016|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314017|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
44314018|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314019|NCT00906126|Misoprostol|misoprostol|mesh-list
44314020|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44314021|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
44314022|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44314023|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314024|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44314025|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314026|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
44314027|NCT00906139|Fentanyl|fentanyl|mesh-list
44314028|NCT00906139|Midazolam|midazolam|mesh-list
44314029|NCT00906139|Propofol|propofol|mesh-list
44314030|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44314031|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314032|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314033|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44314034|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
44314035|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
44314036|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44314037|NCT00906139|Narcotics|narcotics|mesh-ancestor
44314038|NCT00906139|Analgesics|analgesics|mesh-ancestor
44314039|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
44314040|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314050|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
44314051|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44314052|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44314053|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314054|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314056|NCT00906295|Chrysarobin|chrysarobin|mesh-list
44314057|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314058|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314059|NCT00906295|Analgesics|analgesics|mesh-ancestor
44314060|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
44314061|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314062|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314063|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314064|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314065|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44314066|NCT00906360|Cetuximab|cetuximab|mesh-list
44314067|NCT00906360|Sunitinib|sunitinib|mesh-list
44314068|NCT00906360|Antibodies|antibodies|mesh-list
44314069|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
44314070|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44314071|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
44314072|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314073|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314074|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314075|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314076|NCT00906360|Growth Substances|growth substances|mesh-ancestor
44314077|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314078|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44314079|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314080|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314081|NCT00906386|Varenicline|varenicline|mesh-list
44314082|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44314083|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44314084|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
44314085|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314086|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730220|NCT02566928|Bacitracin|bacitracin|mesh-list
44314087|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466779|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466780|NCT01458639|Xenon|xenon|mesh-list
44466781|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44466782|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
44466783|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
44466784|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466785|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466786|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44466787|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44466788|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44466789|NCT01458574|Tofacitinib|tofacitinib|mesh-list
44466790|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44466791|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466792|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466793|NCT01458535|Ritonavir|ritonavir|mesh-list
44466794|NCT01458535|Ribavirin|ribavirin|mesh-list
44466795|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44466796|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44466797|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466798|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466799|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466800|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44466801|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44466802|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
44466803|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466804|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44466805|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44466806|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
44466807|NCT01458522|Lacosamide|lacosamide|mesh-list
44314091|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
44314092|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314093|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44314094|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44314095|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314097|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314098|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314099|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314100|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314101|NCT00906516|Growth Substances|growth substances|mesh-ancestor
44314102|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314103|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314104|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
44314105|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
44314106|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314107|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314108|NCT00906594|Latanoprost|latanoprost|mesh-list
44314109|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44314110|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43598533|NCT03298698|Hormones|hormones|mesh-ancestor
44314111|NCT00906685|Bevacizumab|bevacizumab|mesh-list
44314112|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314113|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314114|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314115|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314116|NCT00906685|Growth Substances|growth substances|mesh-ancestor
44314117|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120900|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44120901|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120902|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120903|NCT00122499|Urological Agents|urological agents|mesh-ancestor
44120904|NCT00122512|Tenofovir|tenofovir|mesh-list
44120905|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
44120906|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120907|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120908|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120909|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120913|NCT00122538|Lamivudine|lamivudine|mesh-list
44120914|NCT00122538|Efavirenz|efavirenz|mesh-list
44120915|NCT00122538|Didanosine|didanosine|mesh-list
44120916|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120917|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120918|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120919|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120920|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
44120921|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314118|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314120|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314121|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314122|NCT00906828|Levodopa|levodopa|mesh-list
44314123|NCT00906828|Carbidopa|carbidopa|mesh-list
44314124|NCT00906828|Entacapone|entacapone|mesh-list
44314125|NCT00906828|Tolcapone|tolcapone|mesh-list
44314126|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44314127|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44314128|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
44314129|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314130|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314131|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314132|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44314133|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314134|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44314135|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
44314136|NCT00906867|Miotics|miotics|mesh-ancestor
44314137|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
44314138|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314139|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314140|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44314141|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44314142|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
44314143|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44314144|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44314145|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
44314146|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314147|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314148|NCT00906880|Eflornithine|eflornithine|mesh-list
44314149|NCT00906880|Nifurtimox|nifurtimox|mesh-list
44314164|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314165|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314166|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
44314167|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314168|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314169|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
44314170|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314171|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314172|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
44314173|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314174|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
44314175|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314176|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44314177|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44314178|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
44314179|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44314180|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314182|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44314183|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314184|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314185|NCT00907114|Analgesics|analgesics|mesh-ancestor
44314186|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
44314187|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314188|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314189|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314190|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314191|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44314192|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314193|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314194|NCT00907166|Gemcitabine|gemcitabine|mesh-list
44314195|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314196|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
44314203|NCT00907166|Immunologic Factors|immunologic factors|mesh-ancestor
44314204|NCT00907166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314205|NCT00907179|Pemetrexed|pemetrexed|mesh-list
44314206|NCT00907179|Panobinostat|panobinostat|mesh-list
44314207|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314208|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314209|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314210|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44314211|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44314212|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44314213|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
44314214|NCT00907270|Vitamin D|vitamin d|mesh-list
44314215|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44314216|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314217|NCT00907270|Vitamins|vitamins|mesh-ancestor
44314218|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
44314219|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44314220|NCT00907400|Naproxen|naproxen|mesh-list
44314221|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314222|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314223|NCT00907400|Analgesics|analgesics|mesh-ancestor
44314224|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
44314225|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314226|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314227|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314228|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314229|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
44314252|NCT00907452|Growth Substances|growth substances|mesh-ancestor
44314253|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314254|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44314255|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
44314256|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314257|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44314258|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314259|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
44314260|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314261|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314262|NCT00907504|Gemcitabine|gemcitabine|mesh-list
44314263|NCT00907504|Cisplatin|cisplatin|mesh-list
44314264|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314265|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969169|NCT01640340|Hormones|hormones|mesh-ancestor
44314313|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314314|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44314315|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44314316|NCT00907985|Lamotrigine|lamotrigine|mesh-list
44314317|NCT00907985|Vofopitant|vofopitant|mesh-list
44314318|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
44314319|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44314320|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44314321|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314322|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44314323|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314324|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44314325|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44314326|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314327|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44314328|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44314329|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
44314330|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
44314331|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314332|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314333|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44314334|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314335|NCT00908024|Cetuximab|cetuximab|mesh-list
44314336|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314337|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314338|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
44314339|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44314340|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44314341|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44314342|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44314343|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314344|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
44314347|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44314350|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
44314351|NCT00908089|Prednisolone|prednisolone|mesh-list
44314352|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44314353|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
44314354|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44314355|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
44314356|NCT00908089|Infliximab|infliximab|mesh-list
44314357|NCT00908089|Naltrexone|naltrexone|mesh-list
44314358|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44314359|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
44314360|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314361|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
44314362|NCT00908089|Hormones|hormones|mesh-ancestor
44314363|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314364|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314365|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314366|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314367|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
44314368|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
44314369|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314370|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314371|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44314372|NCT00908089|Protective Agents|protective agents|mesh-ancestor
44314373|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
44314374|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314375|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314376|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314377|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314378|NCT00908089|Analgesics|analgesics|mesh-ancestor
44314379|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
44314397|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
44314398|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314399|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44314400|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314401|NCT00908180|Cytarabine|cytarabine|mesh-list
44314402|NCT00908180|Cyclosporine|cyclosporine|mesh-list
44314403|NCT00908180|Etoposide|etoposide|mesh-list
44314404|NCT00908180|Melphalan|melphalan|mesh-list
44314405|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
44314406|NCT00908180|Carmustine|carmustine|mesh-list
44314407|NCT00908180|Cyclosporins|cyclosporins|mesh-list
44314408|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44314409|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314410|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44314411|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44314412|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314413|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314414|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314415|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
44314416|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
44314417|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314418|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314419|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
44314420|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314421|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
44314422|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
44314423|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314424|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44314425|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44314426|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
44314427|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44466823|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466832|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44466834|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
44466835|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44466836|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44466837|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466838|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466839|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466840|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44466841|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44466842|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466843|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466844|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466845|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44466846|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
44466847|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44466848|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44466849|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44466850|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44466851|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
44466852|NCT01458171|Antibodies|antibodies|mesh-list
44466853|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
44314429|NCT00908219|Bevacizumab|bevacizumab|mesh-list
44314430|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314431|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314432|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314456|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314458|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314459|NCT00908362|Fluticasone|fluticasone|mesh-list
44314460|NCT00908362|Xhance|xhance|mesh-list
44314461|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44314462|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44314463|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314464|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44314465|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
44314466|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314467|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314468|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44314469|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
44314470|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
44314471|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44314472|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44314473|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44314474|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44314475|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
44314476|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314477|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314478|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
44314479|NCT00908362|Hormones|hormones|mesh-ancestor
44314480|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314481|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
44314482|NCT00908414|TMC-310911|tmc-310911|mesh-list
44314483|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314484|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314485|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314486|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
44314487|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
44314488|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44314489|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120922|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120923|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120924|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44314490|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314491|NCT00908531|Letrozole|letrozole|mesh-list
44314492|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314493|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44314494|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44314495|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314496|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314497|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44314498|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44314499|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314500|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314501|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
44314502|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
43969342|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
44314503|NCT00908661|Coagulants|coagulants|mesh-ancestor
44314504|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
44314505|NCT00908674|Cyproterone|cyproterone|mesh-list
44314506|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
44314507|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
44314508|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314509|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314512|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
44314542|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44314543|NCT00908817|Triamcinolone|triamcinolone|mesh-list
44314544|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44314545|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44314546|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44314547|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44314548|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314549|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
44314550|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
44314551|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314552|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
44314553|NCT00908817|Hormones|hormones|mesh-ancestor
44314554|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314555|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314556|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314557|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
44314558|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314559|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314560|NCT00908869|Interferons|interferons|mesh-list
44314561|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
44314562|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
44314563|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
44314564|NCT00908869|Vinorelbine|vinorelbine|mesh-list
44314565|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314566|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
44314567|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314568|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314569|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44314587|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314588|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314590|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314591|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314592|NCT00909051|Acarbose|acarbose|mesh-list
44314593|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44314594|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314595|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314596|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314597|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314598|NCT00909077|Dexamethasone|dexamethasone|mesh-list
44314599|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
44314600|NCT00909077|Rituximab|rituximab|mesh-list
44314601|NCT00909077|BB 1101|bb 1101|mesh-list
44314602|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314603|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314604|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
44314605|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314606|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314607|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314608|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
44314609|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
44314610|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314611|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314612|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
44314613|NCT00909077|Hormones|hormones|mesh-ancestor
44314614|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314634|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314635|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314636|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44314637|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
44314638|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44314639|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44314640|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314641|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314642|NCT00909233|Urological Agents|urological agents|mesh-ancestor
44314644|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44314645|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44314646|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314647|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314648|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314649|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44314650|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44314651|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
44314652|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314653|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43969489|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
44314654|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44314656|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730582|NCT02563704|Artesunate|artesunate|mesh-list
44120925|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120926|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44120927|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44120928|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44120929|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44120930|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
44120932|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
44120933|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120934|NCT00122577|Ritonavir|ritonavir|mesh-list
44120935|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44120936|NCT00122577|Tenofovir|tenofovir|mesh-list
44120937|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120938|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120939|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120940|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120941|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120942|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120943|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120944|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
44120945|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120946|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120947|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120948|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44120949|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44314657|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44314658|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314659|NCT00909402|Cisplatin|cisplatin|mesh-list
44314660|NCT00909402|Capecitabine|capecitabine|mesh-list
44314661|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314662|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314663|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
44314664|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314665|NCT00909454|Vitamin D|vitamin d|mesh-list
44314666|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
44314667|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
44314668|NCT00909454|Vitamins|vitamins|mesh-list
44314669|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
44314670|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314671|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44314672|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44314673|NCT00909506|Metformin|metformin|mesh-list
44314674|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314675|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314676|NCT00909519|Naproxen|naproxen|mesh-list
44314677|NCT00909519|Furosemide|furosemide|mesh-list
44314678|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44314679|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314680|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314681|NCT00909519|Analgesics|analgesics|mesh-ancestor
44314682|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
44314685|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314705|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314706|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314707|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314708|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314709|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
44314710|NCT00909831|Sirolimus|sirolimus|mesh-list
44314711|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
44314712|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44314713|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44314714|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314715|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314716|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314717|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314718|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314719|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44314720|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314721|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
44314722|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314723|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
44314724|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314725|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
44314726|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44314727|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43969567|NCT01655563|Tacrolimus|tacrolimus|mesh-list
44314728|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314729|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
44314730|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730624|NCT02563405|Doxazosin|doxazosin|mesh-list
44120950|NCT00122590|Ritonavir|ritonavir|mesh-list
44120951|NCT00122590|Lopinavir|lopinavir|mesh-list
44120952|NCT00122590|Nelfinavir|nelfinavir|mesh-list
44120953|NCT00122590|Indinavir|indinavir|mesh-list
44120954|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120955|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120956|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120957|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120958|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120959|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120960|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120961|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
44120962|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120963|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120964|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120965|NCT00122603|Saquinavir|saquinavir|mesh-list
44120966|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
44120967|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120968|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120969|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314731|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314732|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
44314733|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44314734|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314735|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314736|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314737|NCT00909935|Analgesics|analgesics|mesh-ancestor
44314738|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
44314739|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314740|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44314741|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44314742|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44314743|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
44314744|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314745|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314746|NCT00909948|Fludarabine|fludarabine|mesh-list
44314747|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314748|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
44314749|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44314750|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314751|NCT00909974|Micronutrients|micronutrients|mesh-list
44120970|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120971|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120972|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120973|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44120974|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
44120975|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120976|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120977|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44154640|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44154641|NCT00224471|Vaccines|vaccines|mesh-list
44154642|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
44154643|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154649|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154650|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154651|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154652|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154653|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154654|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154655|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44154656|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
44154657|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154658|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44154659|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44154660|NCT00224549|Amlodipine|amlodipine|mesh-list
44154661|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44154662|NCT00224549|Irbesartan|irbesartan|mesh-list
44154663|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44154664|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44154665|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154666|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701895|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
44314753|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314754|NCT00909987|Bevacizumab|bevacizumab|mesh-list
44314755|NCT00909987|Capecitabine|capecitabine|mesh-list
44314756|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
44314757|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314758|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314759|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314760|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314761|NCT00909987|Growth Substances|growth substances|mesh-ancestor
44314762|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314763|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314764|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314765|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
44314766|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314767|NCT00910013|Ropivacaine|ropivacaine|mesh-list
44314768|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
44314769|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
44314770|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314771|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314772|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
44314773|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314774|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44314775|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
44314776|NCT00910052|Coagulants|coagulants|mesh-ancestor
44154667|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44120979|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44120980|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44120981|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
44120982|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120983|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
44120984|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120985|NCT00122629|Interferons|interferons|mesh-list
44120986|NCT00122629|Ribavirin|ribavirin|mesh-list
44120987|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
44120988|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
44120989|NCT00122629|Amantadine|amantadine|mesh-list
44120990|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44120991|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120992|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
44120993|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44120994|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
44120995|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120996|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
44120997|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120998|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44120999|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44121000|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
44121001|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121002|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44121003|NCT00122629|Analgesics|analgesics|mesh-ancestor
44314777|NCT00910065|Aspirin|aspirin|mesh-list
44314778|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
44314779|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44314780|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314781|NCT00910065|Analgesics|analgesics|mesh-ancestor
44314782|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
44314783|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314784|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314785|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314786|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314787|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44314788|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44314789|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314790|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44314791|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44314792|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314793|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
44314794|NCT00910117|Cisplatin|cisplatin|mesh-list
44314795|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
44314796|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314797|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44314798|NCT00910195|Acetaminophen|acetaminophen|mesh-list
44314799|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44314800|NCT00910195|Analgesics|analgesics|mesh-ancestor
44314801|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
44314802|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314803|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314804|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
44466865|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466866|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
44466867|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466868|NCT01457846|Paclitaxel|paclitaxel|mesh-list
44466869|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44466870|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466871|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
44466872|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
44466873|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
44466874|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466875|NCT01457703|Letrozole|letrozole|mesh-list
44466876|NCT01457703|Cetrorelix|cetrorelix|mesh-list
44466877|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44466878|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466879|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44466880|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44466881|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466882|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466883|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44466884|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44466885|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466886|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466887|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44466888|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
44466889|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44466890|NCT01457703|Hormones|hormones|mesh-ancestor
44466891|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44466892|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44466893|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466894|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44466895|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44466905|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466906|NCT01457053|Torsemide|torsemide|mesh-list
44466907|NCT01457053|Furosemide|furosemide|mesh-list
44466908|NCT01457053|Bumetanide|bumetanide|mesh-list
44466909|NCT01457053|Diuretics|diuretics|mesh-list
44466910|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44466911|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
44466912|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466913|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466914|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466915|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44466916|NCT01456936|Bupropion|bupropion|mesh-list
44466917|NCT01456936|Nicotine|nicotine|mesh-list
44466918|NCT01456936|Varenicline|varenicline|mesh-list
44314814|NCT00910234|Hematinics|hematinics|mesh-ancestor
44314815|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
44314816|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314817|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314818|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44314819|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44314820|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314821|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314822|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314823|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44314824|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44314825|NCT00910390|Ethylene|ethylene|mesh-list
44314826|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44314849|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44314850|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44314851|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
44314852|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314853|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314854|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
44314855|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44314856|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
44314857|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314858|NCT00910442|Expectorants|expectorants|mesh-ancestor
44314859|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44314860|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44314861|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
44314862|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314863|NCT00910442|Protective Agents|protective agents|mesh-ancestor
44314864|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314865|NCT00910442|Antidotes|antidotes|mesh-ancestor
44314866|NCT00910455|SRX246|srx246|mesh-list
44314867|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44314868|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314869|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
44314870|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314871|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
44314872|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314873|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314874|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
44314875|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
44314876|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44314877|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
44314878|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314879|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314880|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44314892|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314893|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44314894|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314895|NCT00910741|Gemcitabine|gemcitabine|mesh-list
44314896|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44314897|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
44314898|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314899|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314900|NCT00910741|Antiviral Agents|antiviral agents|mesh-ancestor
44314901|NCT00910741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314902|NCT00910741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314903|NCT00910741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314904|NCT00910741|Immunologic Factors|immunologic factors|mesh-ancestor
44314905|NCT00910741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314906|NCT00910754|Prednisone|prednisone|mesh-list
44314907|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
44314908|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314909|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
44314910|NCT00910754|Hormones|hormones|mesh-ancestor
44314911|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314912|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314913|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314914|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314915|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44314916|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314917|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314918|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
44314919|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44314920|NCT00910767|Insulin|insulin|mesh-list
44314921|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44314922|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121004|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
44121005|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121006|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44121007|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44121008|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
43565204|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121009|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121010|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314924|NCT00910780|Aripiprazole|aripiprazole|mesh-list
44314925|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
44314926|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44314927|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44314928|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44314929|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44314930|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314931|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
44314932|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
44314933|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44314934|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314935|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44314936|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44314937|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
44314938|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44314939|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44314940|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44314941|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44314942|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
44314943|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
44314944|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314945|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314946|NCT00910780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44314947|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44314948|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44314949|NCT00910806|Nevirapine|nevirapine|mesh-list
44314950|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44314951|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121011|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121012|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
44121013|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121014|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44121015|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44121016|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44121017|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44121018|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44121019|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
44121020|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121021|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121022|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121023|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
44121029|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
44314952|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314953|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314954|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
44314955|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314956|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44314957|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44314958|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44314959|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44314960|NCT00910897|Thalidomide|thalidomide|mesh-list
44314961|NCT00910897|Dexamethasone|dexamethasone|mesh-list
44314962|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
44314964|NCT00910897|BB 1101|bb 1101|mesh-list
44314965|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44314966|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
44314967|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
44314968|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44314969|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44314970|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44314971|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
44314972|NCT00910897|Hormones|hormones|mesh-ancestor
44314973|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44314974|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44314975|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314976|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
44314977|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44314978|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730748|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
44121030|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121031|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
44121032|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121033|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121034|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
44121035|NCT00122720|Hematinics|hematinics|mesh-ancestor
44121036|NCT00122733|Loxapine|loxapine|mesh-list
44121037|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44121038|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44121039|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121040|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121041|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121042|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44121043|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
44121044|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121045|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121046|NCT00122746|Cisplatin|cisplatin|mesh-list
44121047|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121048|NCT00122759|Ketamine|ketamine|mesh-list
44121049|NCT00122759|Analgesics|analgesics|mesh-ancestor
44121050|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
44314979|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44314980|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
44314981|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
44314982|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44314983|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314984|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44314985|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44314986|NCT00910897|Growth Substances|growth substances|mesh-ancestor
44314987|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
44314988|NCT00910975|Interferons|interferons|mesh-list
44314989|NCT00910975|Ribavirin|ribavirin|mesh-list
44314990|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
44314991|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
44314992|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44314993|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44314994|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
44314995|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44314996|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
44314997|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44314998|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
44314999|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315000|NCT00911066|Azacitidine|azacitidine|mesh-list
44315001|NCT00911066|Pevonedistat|pevonedistat|mesh-list
44315002|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44315003|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
44315004|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315005|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315006|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315007|NCT00911092|Cisplatin|cisplatin|mesh-list
44315008|NCT00911092|Fluorouracil|fluorouracil|mesh-list
44315009|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315010|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
44315012|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44315022|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315023|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315024|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44315025|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
44315026|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315027|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315028|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44315029|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44315030|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44315031|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44315032|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
44315033|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43969871|NCT01663935|Levodopa|levodopa|mesh-list
44315034|NCT00911235|Urological Agents|urological agents|mesh-ancestor
44315035|NCT00911261|Oxymorphone|oxymorphone|mesh-list
44315036|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44315037|NCT00911261|Narcotics|narcotics|mesh-ancestor
44315038|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315039|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315040|NCT00911261|Analgesics|analgesics|mesh-ancestor
44315041|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
44315042|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315043|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44315044|NCT00911287|Oxymorphone|oxymorphone|mesh-list
44315045|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44315046|NCT00911287|Narcotics|narcotics|mesh-ancestor
44315047|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315048|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315066|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44315067|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44315068|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
44315069|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315070|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44315071|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44315072|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315073|NCT00911573|Vancomycin|vancomycin|mesh-list
44315074|NCT00911573|Clindamycin|clindamycin|mesh-list
44315075|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
44315076|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
44315077|NCT00911573|Tigecycline|tigecycline|mesh-list
44315078|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44315079|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315080|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44315081|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730810|NCT02562287|Olanzapine|olanzapine|mesh-list
44121051|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121052|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121053|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44121054|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44121056|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
44121057|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121058|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44121059|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44121060|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121061|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121062|NCT00122772|Cisplatin|cisplatin|mesh-list
44121063|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121064|NCT00122785|Dexamethasone|dexamethasone|mesh-list
44121065|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44121066|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
44121067|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
44121068|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121069|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121070|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121071|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
44121072|NCT00122785|Hormones|hormones|mesh-ancestor
44121073|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121074|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44121075|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121076|NCT00122811|Perindopril|perindopril|mesh-list
44121077|NCT00122811|Indapamide|indapamide|mesh-list
44121078|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44121079|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
44121080|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121081|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121082|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44121083|NCT00122811|Diuretics|diuretics|mesh-ancestor
44121084|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
44121085|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121086|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44121087|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121088|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44121089|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44121090|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121091|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315082|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315084|NCT00911651|Albuterol|albuterol|mesh-list
44315085|NCT00911651|Ipratropium|ipratropium|mesh-list
44315086|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
44315087|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315088|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
44315089|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315090|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315091|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315092|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315093|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
44315094|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44315095|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44315096|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44315097|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315098|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315099|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315100|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315101|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44315102|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
44315103|NCT00911664|Vitamin D|vitamin d|mesh-list
44315104|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
44315105|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
44315106|NCT00911664|Vitamins|vitamins|mesh-list
44315107|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
44315108|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315109|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44315110|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44315111|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
44315112|NCT00911716|Bevacizumab|bevacizumab|mesh-list
44315113|NCT00911716|Docetaxel|docetaxel|mesh-list
44315114|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315115|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
44315116|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315117|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315118|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44315119|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
44315120|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315121|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315122|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44315123|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44315124|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44315125|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44315126|NCT00911716|Growth Substances|growth substances|mesh-ancestor
44315127|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
44315128|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315129|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44315130|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44315131|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
44315132|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44315133|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315135|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
44315179|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44315180|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315181|NCT00912327|Cetuximab|cetuximab|mesh-list
44315182|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44315183|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466919|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44466920|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
44466921|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315184|NCT00912379|Chrysarobin|chrysarobin|mesh-list
44315185|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44315186|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44315187|NCT00912379|Analgesics|analgesics|mesh-ancestor
44315188|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
44315189|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315190|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315191|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315192|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315193|NCT00912392|Carboplatin|carboplatin|mesh-list
44315194|NCT00912392|Etoposide|etoposide|mesh-list
44315195|NCT00912392|Endostar protein|endostar protein|mesh-list
44315196|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315197|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44315198|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44315199|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44315200|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315201|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315202|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44315203|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44315204|NCT00912392|Growth Substances|growth substances|mesh-ancestor
44315205|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315206|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
44315219|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44315220|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315221|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
44315222|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
44315223|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44315224|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44315225|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44315226|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315227|NCT00912457|Donepezil|donepezil|mesh-list
44315228|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44315229|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315230|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315231|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
44315232|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315233|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315234|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
44315235|NCT00912483|Heparin|heparin|mesh-list
44315236|NCT00912483|Calcium heparin|calcium heparin|mesh-list
44315237|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
44315238|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44315239|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315240|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315241|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44315242|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315243|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315244|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44315245|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315246|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315247|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315248|NCT00912548|Tamoxifen|tamoxifen|mesh-list
44315249|NCT00912548|Goserelin|goserelin|mesh-list
44315250|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44315251|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
44315252|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315253|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315254|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44315256|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44315257|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44315258|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44315259|NCT00912574|Molgramostim|molgramostim|mesh-list
44315260|NCT00912574|Sargramostim|sargramostim|mesh-list
44315261|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44315262|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
44315263|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
44315264|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315265|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315266|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44315268|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44315269|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315270|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
44315271|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
44315272|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
44315273|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315274|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
44315275|NCT00912678|Tacrolimus|tacrolimus|mesh-list
44315276|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315277|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
44315278|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315279|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44315280|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315281|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315282|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44315283|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315284|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44315285|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
44315286|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44315287|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315288|NCT00912756|Cilostazol|cilostazol|mesh-list
44315289|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315296|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315297|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315298|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44315299|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
44315300|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44315301|NCT00912756|Protective Agents|protective agents|mesh-ancestor
44315302|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44315303|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44315304|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315305|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
44315306|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44315307|NCT00912860|Interferons|interferons|mesh-list
44315308|NCT00912860|Interferon-beta|interferon-beta|mesh-list
44315309|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
44315310|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315311|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
44315312|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315313|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
44315314|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315315|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44315316|NCT00912899|Noscapine|noscapine|mesh-list
44315317|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
44315318|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315319|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
44315320|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44315321|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315322|NCT00913029|Timolol|timolol|mesh-list
44315323|NCT00913029|Latanoprost|latanoprost|mesh-list
44315324|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44315325|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44315326|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315327|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315328|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315329|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315330|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598623|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43598624|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44315331|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44315332|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44315333|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44315334|NCT00913055|Octreotide|octreotide|mesh-list
44315335|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44315336|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44315337|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315338|NCT00913107|Lamotrigine|lamotrigine|mesh-list
44315339|NCT00913107|Carbamazepine|carbamazepine|mesh-list
44315340|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
44315341|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44315342|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315343|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315344|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44315345|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315346|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44315347|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315348|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315349|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315350|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44315351|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
44315352|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44315353|NCT00913107|Analgesics|analgesics|mesh-ancestor
44315354|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
44315355|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315356|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44315357|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44315358|NCT00913120|Enoxaparin|enoxaparin|mesh-list
44315359|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
44315360|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44315361|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315362|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315363|NCT00913224|Diclofenac|diclofenac|mesh-list
44315364|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44121092|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121093|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121097|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121098|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121099|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121100|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
44121101|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44121102|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43701896|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315365|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44315366|NCT00913224|Analgesics|analgesics|mesh-ancestor
44315367|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
44315368|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315369|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315370|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315371|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315372|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44315373|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315374|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315375|NCT00913237|Desipramine|desipramine|mesh-list
44315376|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315377|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315378|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315379|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315380|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315381|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44315382|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315383|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315384|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315385|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315386|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315387|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
44315388|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44315389|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
44315390|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315391|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315392|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
44315393|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315394|NCT00913276|Propofol|propofol|mesh-list
44315395|NCT00913276|Sevoflurane|sevoflurane|mesh-list
44315396|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44315397|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315398|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315399|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44315400|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
44315401|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
44315402|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44315403|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44315404|NCT00913315|Tamsulosin|tamsulosin|mesh-list
44315405|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44315406|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44315407|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44315408|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44315409|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315410|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315411|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315412|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315413|NCT00913315|Urological Agents|urological agents|mesh-ancestor
44315414|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44315415|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44315416|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44315417|NCT00913328|Montelukast|montelukast|mesh-list
44315418|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315419|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315420|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44315421|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
44315422|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315423|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315424|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44315425|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44315426|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315447|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
44315448|NCT00913419|Amitriptyline|amitriptyline|mesh-list
44315449|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
44315450|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315451|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315452|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315453|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44315454|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315455|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44315456|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315457|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315458|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315459|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44315460|NCT00913419|Analgesics|analgesics|mesh-ancestor
44315461|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
44315462|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44315463|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315464|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315465|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315466|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315467|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315468|NCT00913484|Disulfiram|disulfiram|mesh-list
44315469|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44315470|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44315471|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315472|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315473|NCT00913497|Insulin|insulin|mesh-list
44315474|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44315475|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
44315476|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
44315490|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44315491|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44315492|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
44315493|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315494|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44315495|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44315496|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315498|NCT00913588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44315499|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315500|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315501|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315502|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315503|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
44315504|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315505|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44315506|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315507|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315508|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44315509|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44315510|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315511|NCT00913614|SR 46349B|sr 46349b|mesh-list
44315512|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44315513|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315514|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315515|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44315516|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44315517|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
44315518|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315519|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315520|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44315521|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43731073|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
44121103|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44121104|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121105|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315522|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315523|NCT00913666|Interferons|interferons|mesh-list
44315524|NCT00913666|Interferon-beta|interferon-beta|mesh-list
44315525|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
44315526|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315527|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
44315528|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315529|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
44315530|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315531|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44315532|NCT00913718|Fluoxetine|fluoxetine|mesh-list
44315533|NCT00913718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44315534|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315535|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315536|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315537|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315538|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
44315539|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315540|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44315541|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315542|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315543|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44315544|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44315545|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315546|NCT00913783|Clomipramine|clomipramine|mesh-list
44315547|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315548|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315549|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315550|NCT00913783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44315551|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315552|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315553|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315554|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315555|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
44315556|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315557|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
44315558|NCT00913796|Diuretics|diuretics|mesh-ancestor
44315559|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
44315560|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315561|NCT00913796|Expectorants|expectorants|mesh-ancestor
44315562|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315563|NCT00913809|Desipramine|desipramine|mesh-list
44315564|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315565|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315566|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315567|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315568|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315569|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44315570|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315571|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315572|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315573|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315574|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315575|NCT00913822|Desipramine|desipramine|mesh-list
44315576|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315577|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315578|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315579|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315580|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315581|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44315582|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315606|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44315607|NCT00913861|Narcotics|narcotics|mesh-ancestor
44315608|NCT00913861|Analgesics|analgesics|mesh-ancestor
44315609|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
44315610|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315611|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44315612|NCT00913874|Valproic Acid|valproic acid|mesh-list
44315613|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
44315614|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315615|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315616|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
44315617|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315618|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315619|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
44315620|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315621|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315622|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315623|NCT00913887|Diclofenac|diclofenac|mesh-list
44315624|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44315625|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44315626|NCT00913887|Analgesics|analgesics|mesh-ancestor
44315627|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
44315628|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970468|NCT01689779|Vitamin D|vitamin d|mesh-list
44315629|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315630|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315631|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315632|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44315633|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121106|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121107|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121108|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121109|NCT00122837|Analgesics|analgesics|mesh-ancestor
44121110|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
44121111|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121112|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121113|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121114|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
44121115|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44121116|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44121117|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44121118|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44121119|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121120|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315635|NCT00913952|Clomipramine|clomipramine|mesh-list
44315636|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315637|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315638|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315639|NCT00913952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44315640|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315641|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315642|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315643|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315644|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
44315645|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315646|NCT00913965|Atenolol|atenolol|mesh-list
44315647|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44315648|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44315649|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
44315650|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
44121121|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121122|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121123|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121124|NCT00122850|Analgesics|analgesics|mesh-ancestor
44121125|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
44121126|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121127|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121128|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121129|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
44121130|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44121131|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44121132|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44121133|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121134|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121135|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121136|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121137|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121138|NCT00122863|Analgesics|analgesics|mesh-ancestor
44121139|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
44121140|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121141|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121142|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121143|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
44121144|NCT00122876|Talaporfin|talaporfin|mesh-list
44121145|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121146|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44121147|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121148|NCT00122889|Allicin|allicin|mesh-list
44121149|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
44121150|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
44121151|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121152|NCT00122889|Protective Agents|protective agents|mesh-ancestor
44121153|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121154|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44121155|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121156|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44315651|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315652|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315653|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44315654|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44315655|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44315656|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315657|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315658|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315659|NCT00914004|Desipramine|desipramine|mesh-list
44315660|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44315661|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315662|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315663|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315664|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315665|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44315666|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121157|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121158|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121159|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44121160|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
44121161|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44121172|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44121173|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44121174|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44121175|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
44121176|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44121177|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121178|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44121179|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44121180|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44121181|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44121182|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121183|NCT00123175|Hormones|hormones|mesh-ancestor
44121184|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121185|NCT00123201|Dronabinol|dronabinol|mesh-list
44121186|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
44121187|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121188|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121189|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44121190|NCT00123201|Analgesics|analgesics|mesh-ancestor
44121191|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
44121192|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121193|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44121194|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44121195|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121196|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121197|NCT00123201|Hormones|hormones|mesh-ancestor
44121198|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121199|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
44121200|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44121201|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121202|NCT00123253|Tesamorelin|tesamorelin|mesh-list
44121203|NCT00123253|Growth Substances|growth substances|mesh-ancestor
44121204|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315669|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315670|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315671|NCT00914017|Atorvastatin|atorvastatin|mesh-list
44315672|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44315673|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44315674|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
44315675|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315676|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44315677|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44315678|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315679|NCT00914056|Lactulose|lactulose|mesh-list
44315680|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44315681|NCT00914095|Methylphenidate|methylphenidate|mesh-list
44315682|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44315683|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315684|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44315685|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44315686|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315687|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315688|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
44315689|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466922|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121205|NCT00123266|Plasminogen|plasminogen|mesh-list
44121206|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44121207|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44121208|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121209|NCT00123279|Plasminogen|plasminogen|mesh-list
44121210|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44121211|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44121212|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121213|NCT00123292|Plasminogen|plasminogen|mesh-list
44121214|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
44121215|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44121216|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44121217|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121218|NCT00123305|Plasminogen|plasminogen|mesh-list
44121219|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
44121220|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44121221|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44121222|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121223|NCT00123318|Cisplatin|cisplatin|mesh-list
44121224|NCT00123318|Fluorouracil|fluorouracil|mesh-list
44121225|NCT00123318|Epirubicin|epirubicin|mesh-list
44121226|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121227|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
44466923|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44466924|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44466925|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
44466926|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44466927|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466928|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44466929|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
44466930|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466931|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44315690|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
44315691|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44315692|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315693|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44315694|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44315695|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315696|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315697|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315698|NCT00914134|Levodopa|levodopa|mesh-list
44315699|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44315700|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44315701|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
44315702|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315703|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315704|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315705|NCT00914160|Diclofenac|diclofenac|mesh-list
44315706|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44315707|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44121228|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121233|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121234|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121235|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121236|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121238|NCT00123331|Sirolimus|sirolimus|mesh-list
44121239|NCT00123331|Cyclosporins|cyclosporins|mesh-list
44121240|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121241|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121242|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121243|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
44121244|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121245|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
44121246|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121247|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121248|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44121249|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44121250|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44315708|NCT00914160|Analgesics|analgesics|mesh-ancestor
44315709|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
44315710|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315711|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315712|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315713|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44315714|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44315715|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315716|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315717|NCT00914212|Sibutramine|sibutramine|mesh-list
44315718|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315719|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315720|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
44315721|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44315722|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
44315723|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
44315724|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44315725|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44315726|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315727|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315728|NCT00914277|Urological Agents|urological agents|mesh-ancestor
44315729|NCT00914368|Clopidogrel|clopidogrel|mesh-list
44315730|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44315731|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44315732|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44315733|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44315734|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
44315735|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315736|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315737|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315738|NCT00914394|Phenylephrine|phenylephrine|mesh-list
44315739|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
44315740|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44121251|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121252|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121253|NCT00123370|Modafinil|modafinil|mesh-list
44121254|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44121255|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121256|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44315741|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44315742|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
44315743|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
44315744|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315745|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315746|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
44315747|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44315748|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
44315749|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315750|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44315751|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44315752|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315753|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315754|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315755|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315756|NCT00914394|Protective Agents|protective agents|mesh-ancestor
44315757|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315758|NCT00914420|Trapidil|trapidil|mesh-list
44315759|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44315760|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315761|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315762|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44315763|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
44315765|NCT00914472|Calcium heparin|calcium heparin|mesh-list
44315766|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
44315767|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44315768|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44315769|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315770|NCT00914498|Lidocaine|lidocaine|mesh-list
44315771|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
44121257|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44121258|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44121259|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121260|NCT00123383|Modafinil|modafinil|mesh-list
44121261|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44121262|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121263|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44121264|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44121265|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44121266|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121267|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44121268|NCT00123461|Vitamins|vitamins|mesh-ancestor
44121269|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
44315773|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315774|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315775|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
44315776|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315777|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44315778|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44315779|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44315780|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44315781|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315782|NCT00914524|Olmesartan|olmesartan|mesh-list
44315783|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44315784|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44315785|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44315786|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44315787|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315788|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
44315789|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
44315790|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44315791|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315792|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315793|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
44315794|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315795|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315796|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121270|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121271|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44121272|NCT00123539|Estrogens|estrogens|mesh-list
44121273|NCT00123539|Hormones|hormones|mesh-ancestor
44121274|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121275|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121276|NCT00123552|Artesunate|artesunate|mesh-list
44121277|NCT00123552|Lumefantrine|lumefantrine|mesh-list
44121278|NCT00123552|Artemether|artemether|mesh-list
44121279|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
44121280|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
44121281|NCT00123552|Amodiaquine|amodiaquine|mesh-list
44121282|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44121283|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
44121284|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44121285|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44121286|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121287|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121288|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
44121289|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
44121290|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44315798|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
44315799|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315800|NCT00914641|Apixaban|apixaban|mesh-list
44315801|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44315802|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
44315803|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44315804|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
44315805|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315806|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315807|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
44315808|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
44315809|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315810|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
44315811|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315812|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315813|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43834019|NCT05169957|Nivolumab|nivolumab|mesh-list
44121291|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
44121292|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44121293|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121294|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121295|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44121296|NCT00123552|Renal Agents|renal agents|mesh-ancestor
44121297|NCT00123578|Pentobarbital|pentobarbital|mesh-list
44121298|NCT00123578|Lorazepam|lorazepam|mesh-list
44121318|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44121319|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
44121320|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121321|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121322|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44121323|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
44121324|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121325|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44121326|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44121327|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121328|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44121329|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121330|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121331|NCT00123669|Progesterone|progesterone|mesh-list
44121332|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44121333|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44121334|NCT00123669|Progestins|progestins|mesh-ancestor
44121336|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121337|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121338|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44121339|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
44121340|NCT00123825|Gemcitabine|gemcitabine|mesh-list
44121341|NCT00123825|Cisplatin|cisplatin|mesh-list
44121342|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121343|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121344|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
44121345|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121346|NCT00123825|Antiviral Agents|antiviral agents|mesh-ancestor
44121347|NCT00123825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121348|NCT00123825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121349|NCT00123825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121350|NCT00123825|Immunologic Factors|immunologic factors|mesh-ancestor
44315814|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315815|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44315816|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44315817|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315818|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315819|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315820|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315821|NCT00914667|Warfarin|warfarin|mesh-list
44315822|NCT00914667|Fesoterodine|fesoterodine|mesh-list
44315823|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
44315824|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44315825|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44315826|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
44315827|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315828|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315829|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315830|NCT00914667|Urological Agents|urological agents|mesh-ancestor
44315831|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44315832|NCT00914693|Gestodene|gestodene|mesh-list
44315833|NCT00914693|Femovan|femovan|mesh-list
44315834|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44315835|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44315836|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44315837|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
44315838|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44315839|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315840|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44315842|NCT00914693|Hormones|hormones|mesh-ancestor
44315843|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315844|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44315845|NCT00914693|Progestins|progestins|mesh-ancestor
44121351|NCT00123825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121352|NCT00123851|Capecitabine|capecitabine|mesh-list
44121353|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
44121354|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44121357|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121359|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44121360|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121361|NCT00123877|Esorubicin|esorubicin|mesh-list
44121362|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121363|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121364|NCT00123890|Aplaviroc|aplaviroc|mesh-list
44121365|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44315847|NCT00914771|Vaccines|vaccines|mesh-list
44315848|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
44315849|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315850|NCT00914797|Terbutaline|terbutaline|mesh-list
44315851|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315852|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
44315853|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315854|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315855|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315856|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315857|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
44315858|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
44315859|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44315860|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44315861|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44315862|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315863|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315864|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315865|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315866|NCT00914836|Betamethasone|betamethasone|mesh-list
44315867|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
44315868|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44315869|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
44315870|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43731220|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44121366|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44121367|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121368|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44121369|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44121370|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
44121371|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121372|NCT00123903|Metoprolol|metoprolol|mesh-list
44121373|NCT00123903|Carvedilol|carvedilol|mesh-list
44121374|NCT00123903|Lisinopril|lisinopril|mesh-list
44121375|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44121376|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44121377|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
44121378|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
44121379|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121380|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121381|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44121382|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44121383|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44121384|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
44121385|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315871|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44315872|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315873|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
44315874|NCT00914836|Hormones|hormones|mesh-ancestor
44315875|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315876|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315877|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315878|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315879|NCT00914888|Metronidazole|metronidazole|mesh-list
44315880|NCT00914888|Clarithromycin|clarithromycin|mesh-list
44315881|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
44315882|NCT00914888|Tigecycline|tigecycline|mesh-list
44315883|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315884|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44315885|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44315886|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44315887|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44315888|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315889|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315890|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44315891|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44315892|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44315893|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44315894|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
44315895|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315896|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315897|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44315898|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315899|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44315900|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44315901|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44315902|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
44315903|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44315904|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121386|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121388|NCT00123903|Protective Agents|protective agents|mesh-ancestor
44121389|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44315905|NCT00914953|Oxytocin|oxytocin|mesh-list
44315906|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
44315907|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44315908|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609179|NCT03191981|Growth Substances|growth substances|mesh-ancestor
44315909|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
43970756|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
44315910|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44315911|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44315912|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315913|NCT00915083|Amrubicin|amrubicin|mesh-list
44315914|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315915|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
44315916|NCT00915200|Silybin|silybin|mesh-list
44315917|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44315918|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
44315919|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315920|NCT00915200|Expectorants|expectorants|mesh-ancestor
44315921|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44315922|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44315923|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
44315924|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315925|NCT00915200|Protective Agents|protective agents|mesh-ancestor
44121390|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121391|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44121392|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
44121393|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44121394|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44121395|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44121396|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44121397|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121398|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44121399|NCT00123916|Benzonidazole|benzonidazole|mesh-list
44121400|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121401|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
44121402|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121403|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44121404|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44121405|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44121406|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121407|NCT00123929|Docetaxel|docetaxel|mesh-list
44121408|NCT00123929|Doxorubicin|doxorubicin|mesh-list
44121409|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121410|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
44121411|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
44121412|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44121413|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121414|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121415|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121416|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121417|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121418|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44121419|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121420|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121421|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44121422|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315926|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315927|NCT00915200|Antidotes|antidotes|mesh-ancestor
44315928|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44315929|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315930|NCT00915239|Pantoprazole|pantoprazole|mesh-list
44315931|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44315932|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44315933|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44315934|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315935|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315936|NCT00915252|Cytarabine|cytarabine|mesh-list
44315937|NCT00915252|Azacitidine|azacitidine|mesh-list
44315938|NCT00915252|Daunorubicin|daunorubicin|mesh-list
44315939|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44315940|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
44315941|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44315942|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315943|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
44315944|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315945|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44315946|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
44315947|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315948|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44315949|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44315950|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44315951|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44315952|NCT00915369|Paclitaxel|paclitaxel|mesh-list
44315953|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44315959|NCT00915382|Cisplatin|cisplatin|mesh-list
44315973|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44315974|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
44315975|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
44315976|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44315977|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44315978|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
44315979|NCT00915408|Hormones|hormones|mesh-ancestor
44315980|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44315981|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44315982|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44315983|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44315984|NCT00915408|Growth Substances|growth substances|mesh-ancestor
44315985|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44315986|NCT00915460|Interferons|interferons|mesh-list
44315987|NCT00915460|Interferon-beta|interferon-beta|mesh-list
44315988|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
44315989|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44315990|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
44315991|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44315992|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
44315993|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44315994|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44315995|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44315996|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44315997|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44315998|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44315999|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316000|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316001|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44121423|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121425|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
44121426|NCT00124098|Hematinics|hematinics|mesh-ancestor
44121427|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
44121428|NCT00124111|Fluorouracil|fluorouracil|mesh-list
44121432|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121433|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44121434|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44121435|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
44121436|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121437|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121438|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44121439|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
44121440|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316003|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
44316004|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316005|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316006|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44316007|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44316008|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
44316009|NCT00915564|Simeprevir|simeprevir|mesh-list
44316010|NCT00915564|Methadone|methadone|mesh-list
44316011|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44316012|NCT00915564|Narcotics|narcotics|mesh-ancestor
44316013|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316014|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316015|NCT00915564|Analgesics|analgesics|mesh-ancestor
44316016|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
44316017|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316018|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
44316019|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
44316020|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
44316021|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316022|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316023|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316024|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121441|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44121442|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
44121443|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44121444|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121445|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121446|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44121447|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121448|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44121449|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44121450|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
44121451|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121452|NCT00124137|Diuretics|diuretics|mesh-list
44121453|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
43565667|NCT00875459|Insulin|insulin|mesh-list
44121454|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121455|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
44121456|NCT00124150|Analgesics|analgesics|mesh-ancestor
44121457|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
44121458|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121459|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121460|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
44121461|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121462|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44121463|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
44121464|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44121465|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121466|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121467|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44316025|NCT00915577|Interferons|interferons|mesh-list
44316026|NCT00915577|Interferon-beta|interferon-beta|mesh-list
44316027|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
44316028|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316029|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
44316030|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316031|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
44316032|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316033|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44316034|NCT00915616|Melatonin|melatonin|mesh-list
44316035|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
44316036|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316037|NCT00915616|Protective Agents|protective agents|mesh-ancestor
44316038|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316039|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316040|NCT00915694|Nelfinavir|nelfinavir|mesh-list
44316041|NCT00915694|Temozolomide|temozolomide|mesh-list
44316042|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316043|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
44316044|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316045|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316046|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44316047|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44316048|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316049|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316050|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316051|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316052|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
44316053|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316054|NCT00915733|Aspirin|aspirin|mesh-list
44316055|NCT00915733|Cilostazol|cilostazol|mesh-list
44316071|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
44316072|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44316073|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44316074|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44316075|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
44316076|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316077|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44316078|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
44316079|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44316080|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
44316081|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
44316082|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44316083|NCT00915733|Protective Agents|protective agents|mesh-ancestor
44316084|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44316085|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44316086|NCT00915746|Ketoconazole|ketoconazole|mesh-list
44316087|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
44316088|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316089|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44316090|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44316091|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121468|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
44121469|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44154668|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154669|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
44154670|NCT00224549|Diuretics|diuretics|mesh-ancestor
44154671|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
44154672|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44154673|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44154674|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44154675|NCT00224588|Ketamine|ketamine|mesh-list
44154676|NCT00224588|Analgesics|analgesics|mesh-ancestor
44154677|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
44154678|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154679|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154680|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44154681|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44154682|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
44154683|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
44154684|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154685|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44154686|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44154687|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154688|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154689|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
44154690|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
44154691|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
44154692|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154693|NCT00224679|Aspirin|aspirin|mesh-list
44121470|NCT00124241|Lamivudine|lamivudine|mesh-list
44121471|NCT00124241|Telbivudine|telbivudine|mesh-list
44121472|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44121478|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316092|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316093|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44316094|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
44316095|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316096|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316097|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44316098|NCT00915785|Azacitidine|azacitidine|mesh-list
44316099|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316100|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
44316101|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316102|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316103|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316104|NCT00915811|Fludarabine|fludarabine|mesh-list
44316105|NCT00915811|Busulfan|busulfan|mesh-list
44316106|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
44316107|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44316108|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316109|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316110|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316111|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
44316112|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316113|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
44316114|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316115|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44316116|NCT00915837|Triamcinolone|triamcinolone|mesh-list
44316117|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44316118|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44316119|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44316137|NCT00915915|Gestodene|gestodene|mesh-list
44316138|NCT00915915|Femovan|femovan|mesh-list
44316139|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44316140|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44316141|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44316142|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
44316143|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316144|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316145|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44316146|NCT00915915|Estrogens|estrogens|mesh-ancestor
44316147|NCT00915915|Hormones|hormones|mesh-ancestor
44316148|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316149|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44316150|NCT00915915|Progestins|progestins|mesh-ancestor
44316151|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44466932|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44466933|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466934|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
44466935|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44466936|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44466937|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466938|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44466939|NCT01456780|Tobramycin|tobramycin|mesh-list
44466940|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
44466941|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44466942|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44466943|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44466944|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44466945|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44466946|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
44466947|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44121479|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44121480|NCT00124267|Quinine|quinine|mesh-list
44121481|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
44121482|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44121483|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44121484|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121485|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44121486|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121487|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44121488|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121489|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44466948|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44466949|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44466950|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466951|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44466952|NCT01456169|Diuretics|diuretics|mesh-ancestor
44466953|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
44466954|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466955|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44466956|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466957|NCT01456130|Alogliptin|alogliptin|mesh-list
44466958|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
44466959|NCT01456130|Secretagogues|secretagogues|mesh-list
44466960|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44466961|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466962|NCT01456130|Incretins|incretins|mesh-ancestor
44466963|NCT01456130|Hormones|hormones|mesh-ancestor
44466964|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44466965|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44466966|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
44466967|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44466968|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466969|NCT01456039|Romidepsin|romidepsin|mesh-list
44466970|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44466971|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44466972|NCT01455428|Pregabalin|pregabalin|mesh-list
44466973|NCT01455428|Analgesics|analgesics|mesh-ancestor
44466974|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
43731367|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
44121490|NCT00124267|Analgesics|analgesics|mesh-ancestor
44121491|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
44121492|NCT00124280|Everolimus|everolimus|mesh-list
44121493|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121494|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121495|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
44121496|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121497|NCT00124306|Amitriptyline|amitriptyline|mesh-list
44121498|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44121499|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121500|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121501|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44121502|NCT00124306|Analgesics|analgesics|mesh-ancestor
44121504|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121505|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121506|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44121507|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121508|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466975|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466976|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44466978|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44466979|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44466980|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466981|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44466982|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44466983|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466984|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466985|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44466986|NCT01455415|Pregabalin|pregabalin|mesh-list
44466987|NCT01455415|Analgesics|analgesics|mesh-ancestor
44466988|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
44316152|NCT00916045|Vidarabine|vidarabine|mesh-list
44316153|NCT00916045|Cyclosporine|cyclosporine|mesh-list
44316154|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
44316155|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
44316156|NCT00916045|Melphalan|melphalan|mesh-list
44316157|NCT00916045|Busulfan|busulfan|mesh-list
44316158|NCT00916045|Thiotepa|thiotepa|mesh-list
44316159|NCT00916045|Fludarabine|fludarabine|mesh-list
44316160|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
44316161|NCT00916045|Cyclosporins|cyclosporins|mesh-list
44316162|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
44316163|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44316164|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316165|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
44316166|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316167|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316168|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43731377|NCT02557984|Naltrexone|naltrexone|mesh-list
44121509|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121510|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44121511|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121512|NCT00124332|Rimonabant|rimonabant|mesh-list
44121513|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44121514|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44121515|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44121516|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121517|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121518|NCT00124332|Hormones|hormones|mesh-ancestor
44121519|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121520|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121521|NCT00124358|Buprenorphine|buprenorphine|mesh-list
44316169|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
44316170|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316171|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316172|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44316173|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316174|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
44316175|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
44316176|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316177|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316178|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
44316179|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316180|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44316181|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44316182|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44316183|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
44316184|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44316185|NCT00916097|Docetaxel|docetaxel|mesh-list
44316186|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316187|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316188|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316189|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316190|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316191|NCT00916123|Prednisone|prednisone|mesh-list
44316192|NCT00916123|Docetaxel|docetaxel|mesh-list
44316193|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316194|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316195|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316196|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316197|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316198|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316215|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
44316216|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316217|NCT00916409|Temozolomide|temozolomide|mesh-list
44316218|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316219|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
44316220|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316221|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316222|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44316223|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44316224|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44316225|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316226|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316227|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316228|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316229|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316230|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
44316231|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316232|NCT00916461|Minocycline|minocycline|mesh-list
44316233|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44316234|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316235|NCT00916500|Cisplatin|cisplatin|mesh-list
44316236|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316237|NCT00916526|Mannitol|mannitol|mesh-list
44316238|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44316239|NCT00916526|Diuretics|diuretics|mesh-ancestor
44316240|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
44316241|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316242|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
44316243|NCT00916552|Hematinics|hematinics|mesh-ancestor
44316244|NCT00916630|Pemetrexed|pemetrexed|mesh-list
44316245|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316246|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316247|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731430|NCT02557789|Lefamulin|lefamulin|mesh-list
44121522|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44121523|NCT00124358|Narcotics|narcotics|mesh-ancestor
44121524|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121525|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121526|NCT00124358|Analgesics|analgesics|mesh-ancestor
44121527|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
44121528|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316248|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44316249|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44316250|NCT00916669|Cisplatin|cisplatin|mesh-list
44316251|NCT00916669|Etoposide|etoposide|mesh-list
44316252|NCT00916669|Enoxaparin|enoxaparin|mesh-list
44316253|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
44316254|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316255|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44316256|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44316257|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44316258|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316259|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316260|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
44316261|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44316262|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44316263|NCT00916695|Everolimus|everolimus|mesh-list
44316264|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316265|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316266|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
44316267|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316268|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44316269|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44316270|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
44316271|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316272|NCT00916760|Antacids|antacids|mesh-ancestor
44316273|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316274|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316275|NCT00916890|Fentanyl|fentanyl|mesh-list
44316276|NCT00916890|Morphine|morphine|mesh-list
44316277|NCT00916890|Oxycodone|oxycodone|mesh-list
44316278|NCT00916890|Buprenorphine|buprenorphine|mesh-list
44316279|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44316280|NCT00916890|Narcotics|narcotics|mesh-ancestor
44316281|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598642|NCT03297931|Iproplatin|iproplatin|mesh-list
44316282|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316283|NCT00916890|Analgesics|analgesics|mesh-ancestor
44316284|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
44121529|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44121530|NCT00124384|Modafinil|modafinil|mesh-list
44121531|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44316285|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316286|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44316287|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44316289|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
44316290|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44316291|NCT00916942|Lidocaine|lidocaine|mesh-list
44316292|NCT00916942|Prilocaine|prilocaine|mesh-list
44316293|NCT00916942|Capsaicin|capsaicin|mesh-list
44316294|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
44316295|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
44316296|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316297|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316298|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
44316299|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316300|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44316301|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44316302|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44316303|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316304|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316305|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
44316306|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316307|NCT00917059|Citalopram|citalopram|mesh-list
44316308|NCT00917059|Bupropion|bupropion|mesh-list
44316309|NCT00917059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44316310|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44316311|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316312|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316313|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121532|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121533|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44121534|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44121535|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44121536|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121537|NCT00124397|Atorvastatin|atorvastatin|mesh-list
44121538|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44121539|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44121540|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
44121541|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121551|NCT00124527|Capecitabine|capecitabine|mesh-list
44121552|NCT00124527|Irofulven|irofulven|mesh-list
44121553|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121554|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
44121555|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316314|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
44316315|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316316|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44316317|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44316318|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316319|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44316320|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
44316321|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44316322|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44316323|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316324|NCT00917163|Sirolimus|sirolimus|mesh-list
44316325|NCT00917163|Everolimus|everolimus|mesh-list
44316326|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316327|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316328|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
44316329|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316330|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44316331|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316332|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44316333|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
44316334|NCT00917241|Dexamethasone|dexamethasone|mesh-list
43561644|NCT02602353|Loxoprofen|loxoprofen|mesh-list
44121556|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598644|NCT03297879|Metformin|metformin|mesh-list
44121557|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44121558|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
44121559|NCT00124540|Misoprostol|misoprostol|mesh-list
44121560|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44121561|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
44121562|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44121563|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121564|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44121565|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121566|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
44121567|NCT00124566|Prednisone|prednisone|mesh-list
44121568|NCT00124566|Capecitabine|capecitabine|mesh-list
44121569|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
44121570|NCT00124566|Irofulven|irofulven|mesh-list
44121571|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44121572|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
44121573|NCT00124566|Hormones|hormones|mesh-ancestor
44121574|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121575|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121576|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44121578|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121579|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
44121580|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121581|NCT00124566|Analgesics|analgesics|mesh-ancestor
44121582|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
44121583|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121584|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121585|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121586|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121587|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316336|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316337|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
44316338|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
44316339|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316340|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316341|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316342|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
44316343|NCT00917241|Hormones|hormones|mesh-ancestor
44316344|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316345|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316346|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316347|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
44316348|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
44316349|NCT00917254|Enoxaparin|enoxaparin|mesh-list
44316350|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
44316351|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44316352|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44316353|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316354|NCT00917345|Captopril|captopril|mesh-list
44316355|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44316356|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316357|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316358|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316359|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44316360|NCT00917358|Interferons|interferons|mesh-list
44316361|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
44121588|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
44121589|NCT00124605|Pamidronate|pamidronate|mesh-list
44121590|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
44121591|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121592|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44121593|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121594|NCT00124644|Cytarabine|cytarabine|mesh-list
44121595|NCT00124644|Etoposide|etoposide|mesh-list
44121596|NCT00124644|Daunorubicin|daunorubicin|mesh-list
44121597|NCT00124644|Tipifarnib|tipifarnib|mesh-list
44121598|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44121599|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44121600|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121601|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121602|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121603|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121604|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121605|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
44121606|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
44121607|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121610|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316362|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
44316363|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44316364|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316365|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
44316366|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316367|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
44316368|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316369|NCT00917397|Sertraline|sertraline|mesh-list
44316370|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
44316371|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316372|NCT00917397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44316373|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44316374|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316375|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316376|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316377|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
44316378|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316379|NCT00917527|Atorvastatin|atorvastatin|mesh-list
44316380|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44316381|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44316382|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
44316383|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316384|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44316385|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44316386|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316387|NCT00917592|Amoxicillin|amoxicillin|mesh-list
44316388|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
44316389|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
44316390|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44316391|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316392|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316393|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316394|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44466989|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44466994|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44466995|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44466996|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44466997|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44466998|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44466999|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44467001|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
44467002|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467003|NCT01455194|Ciclesonide|ciclesonide|mesh-list
44467004|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
44467005|NCT01455194|Hormones|hormones|mesh-ancestor
44467006|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467007|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467008|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467009|NCT01455012|Rotigotine|rotigotine|mesh-list
44467010|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
44467011|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
44467012|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467013|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467014|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467015|NCT01454934|Gemcitabine|gemcitabine|mesh-list
44467016|NCT01454934|Docetaxel|docetaxel|mesh-list
44467017|NCT01454934|Pemetrexed|pemetrexed|mesh-list
44467018|NCT01454934|Vinorelbine|vinorelbine|mesh-list
44467019|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467020|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
44467021|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467022|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467023|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
44467024|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467025|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467026|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467027|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
44467028|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467029|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467032|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467033|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467034|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467035|NCT01454778|Paclitaxel|paclitaxel|mesh-list
44467036|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467037|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467038|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467039|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467040|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467041|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467042|NCT01454739|Factor VIII|factor viii|mesh-list
44467043|NCT01454739|Coagulants|coagulants|mesh-ancestor
44467044|NCT01454596|Aldesleukin|aldesleukin|mesh-list
44467045|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
44467046|NCT01454596|Fludarabine|fludarabine|mesh-list
44467047|NCT01454596|Mitogens|mitogens|mesh-list
44467048|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467049|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
44467050|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467051|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316395|NCT00917748|Docetaxel|docetaxel|mesh-list
44316396|NCT00917748|Modafinil|modafinil|mesh-list
44316397|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316398|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316399|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316400|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316401|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316402|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44316403|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316404|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44316405|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44316406|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44316407|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44316408|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
44316409|NCT00917761|Entecavir|entecavir|mesh-list
44316410|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
44316414|NCT00917839|Lamotrigine|lamotrigine|mesh-list
44316415|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
44316416|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44316417|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316418|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316419|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44316420|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316421|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44316422|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316423|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316424|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316425|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44316427|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44316428|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316429|NCT00917891|Dapivirine|dapivirine|mesh-list
44316430|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316431|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316432|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
44316433|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316434|NCT00917904|Dapivirine|dapivirine|mesh-list
44316435|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316436|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316437|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
44316438|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316439|NCT00918021|Olanzapine|olanzapine|mesh-list
44316440|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
44316441|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
44316442|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316443|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316444|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316445|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44316446|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316447|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316448|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316449|NCT00918021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44316450|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44316451|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316452|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316453|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316455|NCT00918034|Talaporfin|talaporfin|mesh-list
44316456|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316457|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44316458|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316459|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
44316460|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
44316461|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44316462|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44316463|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316464|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316465|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44316466|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44316467|NCT00918086|Vitamin D|vitamin d|mesh-list
44316468|NCT00918086|Vitamins|vitamins|mesh-ancestor
44316469|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
44316470|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316471|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44316472|NCT00918177|Levodopa|levodopa|mesh-list
44316473|NCT00918177|Carbidopa|carbidopa|mesh-list
44316474|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44316475|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44316476|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44316477|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
44316478|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316479|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316480|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316481|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44316482|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316483|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44316484|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
44316485|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
44121611|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121612|NCT00124683|Bupropion|bupropion|mesh-list
44121613|NCT00124683|Nicotine|nicotine|mesh-list
44316486|NCT00918190|Dexamethasone|dexamethasone|mesh-list
44316487|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
44316488|NCT00918190|Midazolam|midazolam|mesh-list
44316489|NCT00918190|Ondansetron|ondansetron|mesh-list
44316490|NCT00918190|BB 1101|bb 1101|mesh-list
44316491|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316492|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
44316493|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
44316494|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316495|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316496|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316497|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
44316498|NCT00918190|Hormones|hormones|mesh-ancestor
44316499|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316500|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316501|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316502|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
44316503|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316504|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316505|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44316506|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44316507|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316508|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44316509|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316510|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316511|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44316512|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
44316513|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
44316514|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
44316515|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
44316516|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316517|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
44316531|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316533|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316534|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316535|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44316536|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44316537|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316538|NCT00918411|Ramosetron|ramosetron|mesh-list
44316539|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
44316540|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
44316541|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316542|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316543|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316544|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44316545|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
44316546|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467052|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316547|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316548|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
44316549|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
44316550|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44316551|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44316552|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316553|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316554|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44316555|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44316556|NCT00918450|Navitoclax|navitoclax|mesh-list
44316557|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316558|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
44316559|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
44316572|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
44316573|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316574|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44316575|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316576|NCT00918554|Methotrexate|methotrexate|mesh-list
44316577|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44316578|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
44316579|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316580|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316581|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316582|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
44316583|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316584|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316585|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316586|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316587|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44316588|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316589|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
44316590|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316591|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44316592|NCT00918593|Bleomycin|bleomycin|mesh-list
44316593|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44316594|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316595|NCT00918632|Axitinib|axitinib|mesh-list
44316596|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316597|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44316598|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316599|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316600|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44316601|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
44316602|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316603|NCT00918853|Pancrelipase|pancrelipase|mesh-list
44316604|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316605|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
44316612|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44316613|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
44316614|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316615|NCT00919178|Vaccines|vaccines|mesh-list
44316616|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
44316617|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316618|NCT00919204|Axitinib|axitinib|mesh-list
44316619|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316620|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44316621|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316622|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316624|NCT00919243|Allopurinol|allopurinol|mesh-list
44316625|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316626|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
44316627|NCT00919243|Hormones|hormones|mesh-ancestor
44316628|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316629|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316630|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316631|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316632|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
44316633|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121614|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44121615|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
44121616|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121617|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121618|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44121619|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44121620|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
44121621|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121622|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121623|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44121624|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121625|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121626|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44121627|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121628|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121629|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
44121630|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44121631|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44121632|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121634|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44121635|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121636|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121637|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121638|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
44121639|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121640|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121641|NCT00124722|Bromides|bromides|mesh-list
44121642|NCT00124722|Rocuronium|rocuronium|mesh-list
44121643|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
44121644|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44316634|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316635|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
44316636|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316637|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44316638|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
44316639|NCT00919243|Protective Agents|protective agents|mesh-ancestor
44316640|NCT00919282|Leucovorin|leucovorin|mesh-list
44316641|NCT00919282|Folic Acid|folic acid|mesh-list
44316642|NCT00919282|Gemcitabine|gemcitabine|mesh-list
44316643|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
44316644|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316645|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
44316646|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316647|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316648|NCT00919282|Antiviral Agents|antiviral agents|mesh-ancestor
44316649|NCT00919282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316650|NCT00919282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316651|NCT00919282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316652|NCT00919282|Immunologic Factors|immunologic factors|mesh-ancestor
44316653|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316654|NCT00919282|Antidotes|antidotes|mesh-ancestor
44316655|NCT00919282|Protective Agents|protective agents|mesh-ancestor
44316656|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
44316657|NCT00919282|Vitamins|vitamins|mesh-ancestor
44316658|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
44316659|NCT00919282|Hematinics|hematinics|mesh-ancestor
44316660|NCT00919295|Mirtazapine|mirtazapine|mesh-list
44316661|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
44316662|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316663|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44316664|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
44316665|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
44316681|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
44316682|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316683|NCT00919399|Tamoxifen|tamoxifen|mesh-list
44316684|NCT00919399|Exemestane|exemestane|mesh-list
44316685|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44316686|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44316687|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316688|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316689|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316690|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316691|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44316692|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43971657|NCT01730872|Hormones|hormones|mesh-ancestor
44316693|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44316694|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44316695|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44316696|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316697|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316699|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
44316700|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316701|NCT00919451|Cyclosporine|cyclosporine|mesh-list
44316702|NCT00919451|Cyclosporins|cyclosporins|mesh-list
44316703|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316704|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316705|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316706|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
44316707|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316708|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
44316709|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316710|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316711|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316712|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44316713|NCT00919542|Cyclosporine|cyclosporine|mesh-list
44316714|NCT00919542|Prednisolone|prednisolone|mesh-list
44121645|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44121646|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44121647|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121648|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121650|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
44316715|NCT00919542|Cyclosporins|cyclosporins|mesh-list
44316716|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316717|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316718|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316719|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
44316720|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316721|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
44316722|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316723|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316724|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316725|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44316726|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316727|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
44316728|NCT00919542|Hormones|hormones|mesh-ancestor
44316729|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316730|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316731|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316732|NCT00919555|Pioglitazone|pioglitazone|mesh-list
44316733|NCT00919555|Tretinoin|tretinoin|mesh-list
44316734|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44121651|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
44121652|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121653|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121654|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121655|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44121656|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
44121657|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
44121658|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121659|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121660|NCT00124813|Thalidomide|thalidomide|mesh-list
44121661|NCT00124813|Idarubicin|idarubicin|mesh-list
44121662|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121663|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
44121664|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121665|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
44121666|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44121667|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121668|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44121669|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44121670|NCT00124813|Growth Substances|growth substances|mesh-ancestor
44121671|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44121672|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121673|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121674|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121675|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121676|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121677|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121678|NCT00124826|Insulin|insulin|mesh-list
44121679|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44121680|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121681|NCT00124839|Naltrexone|naltrexone|mesh-list
44121685|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
44121686|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121687|NCT00124930|Olanzapine|olanzapine|mesh-list
44121688|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
44121689|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
44316736|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316737|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
44316738|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467053|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
44467054|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467055|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467056|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44467057|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467058|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44467059|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44467060|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
44467061|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467063|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44467064|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467065|NCT01454102|Gemcitabine|gemcitabine|mesh-list
44467066|NCT01454102|Paclitaxel|paclitaxel|mesh-list
44467067|NCT01454102|Bevacizumab|bevacizumab|mesh-list
44467068|NCT01454102|Cisplatin|cisplatin|mesh-list
44467069|NCT01454102|Carboplatin|carboplatin|mesh-list
44467070|NCT01454102|Nivolumab|nivolumab|mesh-list
44467071|NCT01454102|Pemetrexed|pemetrexed|mesh-list
44467072|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44467073|NCT01454102|Ipilimumab|ipilimumab|mesh-list
44467074|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467075|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467076|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467077|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467078|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467079|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121690|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121691|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121692|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121693|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44121694|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44121695|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121696|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121697|NCT00124930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44121698|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121699|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121700|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121701|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121702|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
44121703|NCT00124956|Doxorubicin|doxorubicin|mesh-list
44467080|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467081|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44467082|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44467083|NCT01454102|Growth Substances|growth substances|mesh-ancestor
44467084|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467085|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44316739|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44316740|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
43598668|NCT03297463|Ipilimumab|ipilimumab|mesh-list
44316741|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44316742|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44316743|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44316744|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44316745|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316746|NCT00919776|Cyclosporine|cyclosporine|mesh-list
44316747|NCT00919776|Prednisolone|prednisolone|mesh-list
44316748|NCT00919776|Cyclosporins|cyclosporins|mesh-list
44316749|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316750|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121704|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44121705|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121706|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44121707|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44121708|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121709|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121710|NCT00124969|Amlodipine|amlodipine|mesh-list
44121711|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44121712|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44121713|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121714|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121715|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44121716|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121717|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
44121718|NCT00124995|Terbutaline|terbutaline|mesh-list
44121719|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44121720|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
44121721|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121722|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121723|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44121724|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
44121726|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
44121727|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44121728|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44121729|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44121730|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44121731|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
44121732|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121733|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121734|NCT00125008|Vaccines|vaccines|mesh-list
44121735|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
44121736|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121737|NCT00125021|Capecitabine|capecitabine|mesh-list
44121738|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44121739|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121740|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
44121741|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316751|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316752|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
44316753|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316754|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
44316755|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316756|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316757|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316758|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44316759|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316760|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
44316761|NCT00919776|Hormones|hormones|mesh-ancestor
44316762|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316763|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316764|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316765|NCT00919815|Cyclosporine|cyclosporine|mesh-list
44316766|NCT00919815|Prednisolone|prednisolone|mesh-list
44316767|NCT00919815|Cyclosporins|cyclosporins|mesh-list
44316768|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316769|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316770|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316771|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
44316772|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316773|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
44316774|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316775|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44316776|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316777|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44316778|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316779|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
44316780|NCT00919815|Hormones|hormones|mesh-ancestor
44316781|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316782|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316783|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316784|NCT00919880|Paclitaxel|paclitaxel|mesh-list
44121742|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121743|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44121744|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121745|NCT00125047|Vaccines|vaccines|mesh-list
44121746|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
44121747|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121748|NCT00125060|Simvastatin|simvastatin|mesh-list
44316785|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44316786|NCT00919880|Carboplatin|carboplatin|mesh-list
44316787|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44316788|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316789|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316790|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316791|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316792|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316793|NCT00919919|Progesterone|progesterone|mesh-list
44316794|NCT00919919|Progestins|progestins|mesh-ancestor
44316795|NCT00919919|Hormones|hormones|mesh-ancestor
44316796|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316797|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316798|NCT00919984|Paclitaxel|paclitaxel|mesh-list
44316799|NCT00919984|Carboplatin|carboplatin|mesh-list
44316800|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44316801|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316802|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316803|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316804|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316805|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316806|NCT00920088|Ritonavir|ritonavir|mesh-list
44316807|NCT00920088|Lopinavir|lopinavir|mesh-list
44316808|NCT00920088|Darunavir|darunavir|mesh-list
44316838|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44316839|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44316840|NCT00920088|Analgesics|analgesics|mesh-ancestor
44316841|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
44316842|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316843|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44316844|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44316845|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316846|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316847|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44316848|NCT00920101|Atorvastatin|atorvastatin|mesh-list
44316849|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44316850|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44316851|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
44316852|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316853|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44316854|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44316855|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316856|NCT00920153|Gemcitabine|gemcitabine|mesh-list
44316857|NCT00920153|Cytarabine|cytarabine|mesh-list
44316858|NCT00920153|Dexamethasone|dexamethasone|mesh-list
44316859|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
44316860|NCT00920153|Doxorubicin|doxorubicin|mesh-list
44316861|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44316862|NCT00920153|Etoposide|etoposide|mesh-list
44316863|NCT00920153|Vincristine|vincristine|mesh-list
44316864|NCT00920153|Melphalan|melphalan|mesh-list
44316865|NCT00920153|Vinorelbine|vinorelbine|mesh-list
44316866|NCT00920153|Ifosfamide|ifosfamide|mesh-list
44316867|NCT00920153|Dacarbazine|dacarbazine|mesh-list
44316868|NCT00920153|Carmustine|carmustine|mesh-list
44316869|NCT00920153|Bleomycin|bleomycin|mesh-list
44121749|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44121750|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44121751|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
44121752|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121755|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121756|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44121757|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44121758|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121759|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
44121760|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121761|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44121762|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
44121763|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44121764|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44316870|NCT00920153|Vindesine|vindesine|mesh-list
44316871|NCT00920153|Mitoguazone|mitoguazone|mesh-list
44316872|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44316873|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
44316874|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
44316875|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316876|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316877|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316878|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
44316879|NCT00920153|Hormones|hormones|mesh-ancestor
44316880|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316881|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44316882|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44316883|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44316884|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
44316885|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316886|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
44316887|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316888|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316889|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44316890|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
44316891|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43971797|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316892|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44316893|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44316894|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44316895|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
44316896|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
44316897|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
44316898|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44316899|NCT00920153|Protective Agents|protective agents|mesh-ancestor
44316900|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44316901|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
44316902|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44316904|NCT00920244|Amiodarone|amiodarone|mesh-list
44121765|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44121766|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121767|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121768|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
44316905|NCT00920244|Epinephrine|epinephrine|mesh-list
44316906|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44316907|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44316908|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
44316909|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44316910|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316911|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316912|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44316913|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44316914|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
44316915|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44316916|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44316917|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
44316918|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
43598677|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598678|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598679|NCT03297359|Dalteparin|dalteparin|mesh-list
44316919|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
44316920|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44121769|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121770|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121771|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44121772|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121773|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44121774|NCT00125229|Mannitol|mannitol|mesh-list
44121775|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44121776|NCT00125229|Diuretics|diuretics|mesh-ancestor
44121777|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
44121778|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121779|NCT00125255|Lidocaine|lidocaine|mesh-list
44121780|NCT00125255|Tetracaine|tetracaine|mesh-list
44121781|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
44121782|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
44121783|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121784|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121785|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
44121786|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121787|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44121788|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44121789|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44121790|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121791|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121792|NCT00125294|Methadone|methadone|mesh-list
44121793|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44121794|NCT00125294|Narcotics|narcotics|mesh-ancestor
44121795|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121796|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121797|NCT00125294|Analgesics|analgesics|mesh-ancestor
44121798|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
44121799|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121800|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
44121801|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
44121802|NCT00125307|Tacrolimus|tacrolimus|mesh-list
44121803|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121804|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
44121805|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121806|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44121807|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121808|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121809|NCT00125346|Tobramycin|tobramycin|mesh-list
44316921|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44316922|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44316923|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
44316924|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44316925|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44316926|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
44316927|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
44316928|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44316929|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44316930|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44316931|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44316932|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44316933|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316934|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44316935|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44316936|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44316937|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44316938|NCT00920270|Colistin|colistin|mesh-list
44121810|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44121811|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121812|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44121813|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
44121814|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121815|NCT00125398|Fospropofol|fospropofol|mesh-list
44121816|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44121817|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121818|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121819|NCT00125411|Docetaxel|docetaxel|mesh-list
44121820|NCT00125411|Satraplatin|satraplatin|mesh-list
44121821|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121822|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
44121823|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
44121824|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
44121826|NCT00125424|Midazolam|midazolam|mesh-list
44121827|NCT00125424|Fospropofol|fospropofol|mesh-list
44121828|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44121829|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44121830|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121831|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121832|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44121833|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44121834|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121835|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44121836|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
44121837|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
44121838|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
44121839|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
44121840|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121841|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121842|NCT00125437|Spironolactone|spironolactone|mesh-list
44121843|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44121844|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
44121845|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44121846|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121847|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44121848|NCT00125437|Diuretics|diuretics|mesh-ancestor
44316939|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316941|NCT00920283|Trace Elements|trace elements|mesh-ancestor
44316942|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
44316943|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316944|NCT00920296|Cabotegravir|cabotegravir|mesh-list
44316945|NCT00920296|Etravirine|etravirine|mesh-list
44316946|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44316947|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44316948|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44316949|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316950|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44316951|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44316952|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
44316953|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44316954|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44316955|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121849|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
44121850|NCT00125463|Candesartan|candesartan|mesh-list
44121851|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
44121852|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44121853|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44121854|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44121855|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121856|NCT00125489|Chloroquine|chloroquine|mesh-list
44121857|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44121858|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
44121859|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
44121860|NCT00125489|Amebicides|amebicides|mesh-ancestor
44121861|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44121862|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44121863|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121864|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
44121865|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44121866|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44121867|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44121868|NCT00125489|Analgesics|analgesics|mesh-ancestor
44121869|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
44121870|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121871|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121872|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44121873|NCT00125489|Filaricides|filaricides|mesh-ancestor
44121874|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
44121875|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
44121876|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44121877|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121878|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121879|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44121880|NCT00125489|Renal Agents|renal agents|mesh-ancestor
44121881|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44121882|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44121883|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121884|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
44121885|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121886|NCT00125554|Metyrapone|metyrapone|mesh-list
44121887|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
44121888|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121889|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121890|NCT00125567|Levodopa|levodopa|mesh-list
44121891|NCT00125567|Carbidopa|carbidopa|mesh-list
44316956|NCT00920413|Ascorbic Acid|ascorbic acid|mesh-list
44316957|NCT00920413|Vitamins|vitamins|mesh-ancestor
44316958|NCT00920413|Micronutrients|micronutrients|mesh-ancestor
44316959|NCT00920413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316960|NCT00920413|Antioxidants|antioxidants|mesh-ancestor
44316961|NCT00920413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44316962|NCT00920413|Protective Agents|protective agents|mesh-ancestor
44143552|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
44316963|NCT00920465|Misoprostol|misoprostol|mesh-list
44316964|NCT00920465|Mifepristone|mifepristone|mesh-list
44316965|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44316966|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
44316967|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44316968|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44316969|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44316970|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44316971|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
44316972|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44316973|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44316974|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44316975|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44316976|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
44316977|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44316978|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44316979|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44316980|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44316981|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
44316982|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44316983|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44316984|NCT00920608|Methotrexate|methotrexate|mesh-list
44316985|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44316997|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
44316998|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44316999|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317000|NCT00920660|Prednisolone|prednisolone|mesh-list
44317001|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317002|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
44317003|NCT00920660|Hormones|hormones|mesh-ancestor
44317004|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317005|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317006|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44317007|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317008|NCT00920725|Insulin|insulin|mesh-list
44317009|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44317010|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
44317011|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44317012|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317013|NCT05674721|Ibuprofen|ibuprofen|mesh-list
44317014|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44317015|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44317016|NCT05674721|Analgesics|analgesics|mesh-ancestor
44317017|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
44317018|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317019|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317020|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317021|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317022|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44317023|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317024|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317025|NCT05674695|Omalizumab|omalizumab|mesh-list
44317026|NCT05674695|Cyclosporine|cyclosporine|mesh-list
44317027|NCT05674695|Methotrexate|methotrexate|mesh-list
44317028|NCT05674695|Upadacitinib|upadacitinib|mesh-list
44317029|NCT05674695|Cyclosporins|cyclosporins|mesh-list
44317030|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44317031|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
44317032|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317036|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317037|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317038|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
44317039|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317040|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44317041|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317042|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
44317043|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317044|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317045|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
44317046|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317047|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44317048|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44317049|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44317050|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
44317051|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44317052|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317053|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44317054|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
44317055|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317056|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317057|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44317058|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
44317059|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317060|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317061|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44317063|NCT05674656|Rilpivirine|rilpivirine|mesh-list
44317064|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
44317065|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44317066|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44317067|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317068|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317069|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44317070|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44317071|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
44121892|NCT00125567|Entacapone|entacapone|mesh-list
44317072|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317073|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44317074|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317075|NCT05674643|Acetaminophen|acetaminophen|mesh-list
44317076|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44317077|NCT05674643|Analgesics|analgesics|mesh-ancestor
44317078|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
44317079|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317080|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317081|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
44317082|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
44317083|NCT05674565|Analgesics|analgesics|mesh-ancestor
44317084|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
44317085|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317086|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317087|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
44317088|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317089|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44317090|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
44317091|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44317092|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317093|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317094|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44317095|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
44317096|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317097|NCT05674539|Vidarabine|vidarabine|mesh-list
44317098|NCT05674539|Fludarabine|fludarabine|mesh-list
44317099|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
44317100|NCT05674539|Melphalan|melphalan|mesh-list
44317101|NCT05674539|Busulfan|busulfan|mesh-list
44317102|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317103|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317104|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
44317105|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317112|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
44317113|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44317114|NCT05674526|Cetuximab|cetuximab|mesh-list
44317115|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317116|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317118|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44317119|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
44317120|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317121|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317122|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44317123|NCT05674487|Misoprostol|misoprostol|mesh-list
44317124|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44317125|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
44317126|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317127|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317128|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44317129|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317130|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
44467086|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467087|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
44467088|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
44467089|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467090|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467091|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467092|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
44467093|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44467094|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467095|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467096|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44467097|NCT01454076|Clarithromycin|clarithromycin|mesh-list
44467098|NCT01454076|Rifampin|rifampin|mesh-list
44467099|NCT01454076|Ketoconazole|ketoconazole|mesh-list
44467100|NCT01454076|Ixazomib|ixazomib|mesh-list
44467101|NCT01454076|Glycine|glycine|mesh-list
44467102|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467110|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
44467111|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
44467112|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467113|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44467114|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44467115|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44467116|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44467117|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44467118|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44467119|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
44467120|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44467121|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44467122|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467123|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467124|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467125|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467126|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467127|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
44467128|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467129|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44467130|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
44467131|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467133|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44467134|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44467135|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44467136|NCT01453725|Golimumab|golimumab|mesh-list
44467137|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44467138|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467139|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467140|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
44317137|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44317138|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
44317139|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
44317140|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44317141|NCT05674201|Analgesics|analgesics|mesh-ancestor
44317142|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
44317143|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317144|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44317145|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44317146|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44317147|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44317148|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317149|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317150|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44317151|NCT05674201|Narcotics|narcotics|mesh-ancestor
44317152|NCT05673980|Vitamin D|vitamin d|mesh-list
44317153|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
44317154|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
44317155|NCT05673980|Vitamins|vitamins|mesh-ancestor
44317156|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
44317157|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317158|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44317159|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44317160|NCT05673928|Trastuzumab|trastuzumab|mesh-list
44317189|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
44317190|NCT05673811|Antiviral Agents|antiviral agents|mesh-ancestor
44317191|NCT05673811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317192|NCT05673811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317193|NCT05673811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317194|NCT05673811|Immunologic Factors|immunologic factors|mesh-ancestor
44317195|NCT05673811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317196|NCT05673785|Prednisone|prednisone|mesh-list
44317197|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
44317198|NCT05673785|Doxorubicin|doxorubicin|mesh-list
44317199|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44317200|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317201|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
44317202|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317203|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317204|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44317205|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
44317206|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317207|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317208|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44317209|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44317210|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44317211|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317212|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317213|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317214|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
44317215|NCT05673785|Hormones|hormones|mesh-ancestor
44317216|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317217|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44317218|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317219|NCT05673590|Docetaxel|docetaxel|mesh-list
44317220|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317221|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317222|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317223|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731898|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
44121893|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44121894|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44121895|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
44317224|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317225|NCT05673577|Cetuximab|cetuximab|mesh-list
44317226|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317227|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317228|NCT05673200|Paclitaxel|paclitaxel|mesh-list
44317229|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
43598706|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
43598709|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44317230|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44317231|NCT05673200|Decitabine|decitabine|mesh-list
44317232|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44317233|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317234|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317235|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317236|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44317237|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317238|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317239|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317240|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
44317241|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317242|NCT05673187|Adagrasib|adagrasib|mesh-list
44317243|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317244|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
44317245|NCT05659290|Bevacizumab|bevacizumab|mesh-list
44317246|NCT05659290|Capecitabine|capecitabine|mesh-list
44317247|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317248|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317249|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44317257|NCT05657444|Tenecteplase|tenecteplase|mesh-list
44317272|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317273|NCT05643573|Apixaban|apixaban|mesh-list
44317274|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44317275|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
44317276|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44317277|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
44317278|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317279|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317280|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
44317281|NCT05630209|Doxorubicin|doxorubicin|mesh-list
44317282|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44317283|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317284|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44317285|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317286|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317287|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467146|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44467147|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467148|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
44467149|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467150|NCT01453348|Vaccines|vaccines|mesh-list
44467151|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
44467152|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467153|NCT01453205|Rituximab|rituximab|mesh-list
44467154|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467155|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467156|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
44467157|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317302|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317303|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317304|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44317306|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
44317307|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44317308|NCT05591092|Iodine|iodine|mesh-list
44317309|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
44317310|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44317311|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317312|NCT05591092|Trace Elements|trace elements|mesh-ancestor
44317313|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
44317314|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317315|NCT05581004|Atezolizumab|atezolizumab|mesh-list
44317316|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317317|NCT05580016|Plasminogen|plasminogen|mesh-list
44317318|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44317319|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44317320|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317321|NCT05575440|Fluorides|fluorides|mesh-list
44317322|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
44317323|NCT05575440|Protective Agents|protective agents|mesh-ancestor
44317324|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317325|NCT05567406|Belumosudil|belumosudil|mesh-list
44317326|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317327|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317328|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317329|NCT05562973|Psilocybin|psilocybin|mesh-list
44317330|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
44317331|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317332|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317333|NCT05560009|Levodopa|levodopa|mesh-list
44317334|NCT05560009|Fluorides|fluorides|mesh-list
44317335|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
44317336|NCT05560009|Protective Agents|protective agents|mesh-ancestor
44317345|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317346|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44317347|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44317348|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317349|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317350|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44317351|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
44317352|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317353|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317354|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44317355|NCT05549661|Onvansertib|onvansertib|mesh-list
44317356|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317357|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317358|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317359|NCT05542264|Olanzapine|olanzapine|mesh-list
44317360|NCT05542264|Risperidone|risperidone|mesh-list
44317361|NCT05542264|Aripiprazole|aripiprazole|mesh-list
44317362|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44317363|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
44317364|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44317365|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
44317366|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317367|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317368|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317369|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44317370|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317371|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121896|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121897|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121898|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121906|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121908|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
44121909|NCT00125684|Morphine|morphine|mesh-list
44121910|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44121911|NCT00125684|Narcotics|narcotics|mesh-ancestor
44121912|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121913|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121914|NCT00125684|Analgesics|analgesics|mesh-ancestor
44121915|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
44121916|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317372|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44317374|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
44317375|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
44317376|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317377|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317378|NCT05542264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44317379|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44317380|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317381|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
44317382|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
44317383|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44317384|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44317385|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44317386|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44317387|NCT05541016|Cisplatin|cisplatin|mesh-list
44317388|NCT05541016|Docetaxel|docetaxel|mesh-list
44317389|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317390|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317391|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317392|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44317393|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317394|NCT05535764|Interferons|interferons|mesh-list
44317395|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
44317396|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
44317397|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44317398|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649976|NCT03017248|Ketamine|ketamine|mesh-list
44317399|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
44317400|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317401|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
44317402|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317403|NCT05526417|Coal Tar|coal tar|mesh-list
44317404|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
44317405|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44317414|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
44317415|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317416|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44317417|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44317418|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317419|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317420|NCT05512767|Capecitabine|capecitabine|mesh-list
44317421|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317422|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
44317423|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317424|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317425|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
44317426|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44317427|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317428|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44317429|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44317430|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317431|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317432|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317433|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
44317434|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
44317435|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317436|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317464|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317465|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44317466|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44317467|NCT05450978|Lamotrigine|lamotrigine|mesh-list
44317468|NCT05450978|Levetiracetam|levetiracetam|mesh-list
44317469|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
44317470|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
44317471|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44317472|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317473|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317474|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44317475|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317476|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44317477|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44317478|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317479|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317480|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44317481|NCT05447910|Letrozole|letrozole|mesh-list
44317482|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317483|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44317484|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44317485|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317486|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317487|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44317488|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
44317489|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317490|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317491|NCT05445921|Mepivacaine|mepivacaine|mesh-list
44317509|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
44317510|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317511|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317512|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
44317513|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317515|NCT05429970|Propofol|propofol|mesh-list
44317516|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44317517|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317518|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317519|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44317520|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
44317521|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
44317522|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44317523|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44317524|NCT05429970|Analgesics|analgesics|mesh-ancestor
43612858|NCT03162185|Citalopram|citalopram|mesh-list
44317525|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
44317533|NCT05426174|Vaccines|vaccines|mesh-list
44467191|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467193|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467194|NCT01453049|Glimepiride|glimepiride|mesh-list
44467195|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
44467196|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44467197|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44467198|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467199|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467200|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
44467201|NCT01453023|Fluticasone|fluticasone|mesh-list
44467202|NCT01453023|Xhance|xhance|mesh-list
44467203|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467204|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44467205|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
44467206|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467207|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467208|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44467209|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44467210|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
44317536|NCT05425940|Atezolizumab|atezolizumab|mesh-list
44317537|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732131|NCT02551549|Rezafungin|rezafungin|mesh-list
44121918|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44121919|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121920|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44121921|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121922|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121923|NCT00125801|Hydromorphone|hydromorphone|mesh-list
44121924|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44121925|NCT00125801|Narcotics|narcotics|mesh-ancestor
44121926|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121927|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121928|NCT00125801|Analgesics|analgesics|mesh-ancestor
44121929|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
44121930|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121931|NCT00125814|Interferons|interferons|mesh-list
44121932|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
44121933|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
44121934|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121935|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
44121936|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121937|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
44121938|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121939|NCT00125827|Clofarabine|clofarabine|mesh-list
44121940|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121941|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
44121942|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121943|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121944|NCT00125840|Clofarabine|clofarabine|mesh-list
44121945|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121946|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
44121947|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121948|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317538|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
44317539|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317540|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
44317541|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317542|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317543|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44317544|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
44317545|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317546|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317547|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44317548|NCT05403580|Olanzapine|olanzapine|mesh-list
44317549|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
44317550|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
44317551|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317552|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317553|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317554|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44317555|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44317556|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317557|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317558|NCT05403580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44317559|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44317560|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317561|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317562|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317563|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
44317564|NCT05393713|Antibodies|antibodies|mesh-list
44317565|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317566|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
44317582|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317583|NCT05392946|Dexamethasone|dexamethasone|mesh-list
44317584|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
44317585|NCT05392946|Bortezomib|bortezomib|mesh-list
44317586|NCT05392946|Daratumumab|daratumumab|mesh-list
44317587|NCT05392946|Ichthammol|ichthammol|mesh-list
44317588|NCT05392946|BB 1101|bb 1101|mesh-list
44317589|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317590|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
44317591|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
44317592|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317593|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317594|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317595|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
44317596|NCT05392946|Hormones|hormones|mesh-ancestor
44317597|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317598|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44317599|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317600|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
44317601|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317602|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317603|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44317604|NCT05388877|Dabrafenib|dabrafenib|mesh-list
44317605|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317606|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317607|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317608|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317609|NCT05388058|Cannabidiol|cannabidiol|mesh-list
44317610|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
44317629|NCT05354674|Growth Substances|growth substances|mesh-ancestor
44317630|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317631|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
44317632|NCT05340205|Misoprostol|misoprostol|mesh-list
44317633|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
44317634|NCT05340205|Oxytocin|oxytocin|mesh-list
44317635|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
44317636|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317637|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317638|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44317639|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44317640|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317641|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
44317642|NCT05340205|Coagulants|coagulants|mesh-ancestor
44317643|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44317644|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
44317645|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44317646|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317647|NCT05322577|Nivolumab|nivolumab|mesh-list
44317648|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
44317649|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317650|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317651|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44317652|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317653|NCT05282550|Trazodone|trazodone|mesh-list
44317679|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
44317680|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317681|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317682|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44317683|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317684|NCT05267470|Paclitaxel|paclitaxel|mesh-list
44317685|NCT05267470|Docetaxel|docetaxel|mesh-list
44317686|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44317687|NCT05267470|Carboplatin|carboplatin|mesh-list
44317688|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
44317689|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
44317690|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44317691|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317692|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44317693|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44317694|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44317695|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317696|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317697|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
44317698|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317699|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317704|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
44317705|NCT05232851|Vaccines|vaccines|mesh-list
44317706|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
44317707|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317708|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317709|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317710|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44317711|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
44317712|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317714|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
44317724|NCT05141721|Atezolizumab|atezolizumab|mesh-list
44317725|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317726|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317727|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44317728|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44317729|NCT05141721|Growth Substances|growth substances|mesh-ancestor
44317730|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317731|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
44317732|NCT05141721|Antidotes|antidotes|mesh-ancestor
44317733|NCT05141721|Protective Agents|protective agents|mesh-ancestor
44317734|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
44317735|NCT05141721|Vitamins|vitamins|mesh-ancestor
44317736|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
44317737|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44317738|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317739|NCT05118477|Caffeine|caffeine|mesh-list
44317740|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44317741|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317742|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44317743|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317744|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317745|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44317746|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44317747|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
44317748|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317749|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44317750|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44317772|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44317773|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44317774|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44317775|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
44317776|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317777|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317778|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317779|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
44317780|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317781|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317782|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
44317783|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317784|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44317785|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317786|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
44317787|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317788|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317789|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44317790|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44317791|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
44317792|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44317793|NCT04951492|Olaparib|olaparib|mesh-list
44317794|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44317795|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317796|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317797|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317798|NCT04940013|Misoprostol|misoprostol|mesh-list
44317799|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44317800|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
44317801|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44317803|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44467218|NCT01452789|Analgesics|analgesics|mesh-ancestor
44467219|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
44467220|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467221|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44467222|NCT01452529|Hydrocodone|hydrocodone|mesh-list
44467223|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44467224|NCT01452529|Narcotics|narcotics|mesh-ancestor
44467225|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467226|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467227|NCT01452529|Analgesics|analgesics|mesh-ancestor
44467228|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
44467229|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467230|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
44467231|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44467232|NCT01452347|Warfarin|warfarin|mesh-list
44467233|NCT01452347|Dabigatran|dabigatran|mesh-list
44467234|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
44467235|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
44467236|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44467237|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467238|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467239|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467240|NCT01452152|Clopidogrel|clopidogrel|mesh-list
44467241|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44467242|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44467243|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44467244|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44467245|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44467246|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
44317807|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44317808|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317809|NCT04895930|Aflutinib|aflutinib|mesh-list
44317823|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317824|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
44317825|NCT04892446|Hormones|hormones|mesh-ancestor
44317826|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44317827|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44317828|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317829|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
44317830|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44317831|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44317832|NCT04892446|Growth Substances|growth substances|mesh-ancestor
44317833|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
44317834|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317835|NCT04892017|Trametinib|trametinib|mesh-list
44317836|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317837|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317838|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317839|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317840|NCT04844866|Gemcitabine|gemcitabine|mesh-list
44317841|NCT04844866|Rituximab|rituximab|mesh-list
44317842|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
44317843|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44317844|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317845|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
44317846|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317847|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317848|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
44317849|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317850|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317851|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44317852|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
44317853|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317854|NCT04844866|Antiviral Agents|antiviral agents|mesh-ancestor
44317855|NCT04844866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317856|NCT04844866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317857|NCT04844866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317862|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317863|NCT04837716|Bevacizumab|bevacizumab|mesh-list
44317864|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44317865|NCT04837716|Carboplatin|carboplatin|mesh-list
44317866|NCT04837716|Pemetrexed|pemetrexed|mesh-list
44317867|NCT04837716|Ensartinib|ensartinib|mesh-list
44317868|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
44317869|NCT04837716|Antibodies|antibodies|mesh-list
44317870|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
44317871|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44317872|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
44317873|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317874|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44317875|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44317876|NCT04837716|Growth Substances|growth substances|mesh-ancestor
44317877|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317878|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
44317879|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
44317880|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317881|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317882|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44317883|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44317884|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317886|NCT04802759|Pertuzumab|pertuzumab|mesh-list
44317887|NCT04802759|Everolimus|everolimus|mesh-list
44317888|NCT04802759|Atezolizumab|atezolizumab|mesh-list
44317889|NCT04802759|Palbociclib|palbociclib|mesh-list
44317890|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44317891|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44317892|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44317893|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
44317894|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317895|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317896|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317897|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317898|NCT04775329|Rifaximin|rifaximin|mesh-list
44317899|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44121949|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44121950|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44317900|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317901|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44317902|NCT04766229|Gabapentin|gabapentin|mesh-list
44317903|NCT04766229|Citalopram|citalopram|mesh-list
44317904|NCT04766229|Analgesics|analgesics|mesh-ancestor
44317905|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
44317906|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317907|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317908|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
44317909|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44317910|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44317911|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317912|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44317913|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44317914|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44317915|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317916|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317917|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
44317918|NCT04766229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44317919|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44317920|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317921|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
44317922|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44317951|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
44317952|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44317953|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44317954|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44317955|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43972878|NCT02382575|Rituximab|rituximab|mesh-list
44317956|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44317957|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44317958|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44317959|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44317960|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44317961|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44317962|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44317963|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
44317964|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44317965|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44317966|NCT04703257|Dipyrone|dipyrone|mesh-list
44317967|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44317968|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44317969|NCT04703257|Analgesics|analgesics|mesh-ancestor
44317970|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
44317971|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317972|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317973|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44317974|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44317975|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
44317976|NCT04680975|Belumosudil|belumosudil|mesh-list
44317977|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44317978|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44317979|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317980|NCT04666610|Brivaracetam|brivaracetam|mesh-list
44317981|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
44317982|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
44317983|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43732457|NCT02550028|Levetiracetam|levetiracetam|mesh-list
44121951|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44121952|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121953|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121954|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44317985|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317986|NCT04648891|Lidocaine|lidocaine|mesh-list
44317987|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
44317988|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
44317989|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44317990|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44317991|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
44317992|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44317993|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44317994|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44317995|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44317996|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44317997|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44317998|NCT04648033|Atovaquone|atovaquone|mesh-list
44317999|NCT04648033|Cisplatin|cisplatin|mesh-list
44318000|NCT04648033|Vinorelbine|vinorelbine|mesh-list
44318001|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318002|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44318003|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318004|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318005|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318006|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318007|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318008|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
44318009|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44121955|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121957|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
44121958|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121959|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121960|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121961|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
44121962|NCT00125905|Bupropion|bupropion|mesh-list
44121963|NCT00125905|Nicotine|nicotine|mesh-list
44121964|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44121965|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
44121968|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44121969|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44121970|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44121971|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121972|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121973|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44121974|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121975|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121976|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44121977|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44318010|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44318011|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318012|NCT04625907|Dactinomycin|dactinomycin|mesh-list
44318013|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
44318014|NCT04625907|Temozolomide|temozolomide|mesh-list
44318015|NCT04625907|Ifosfamide|ifosfamide|mesh-list
44318016|NCT04625907|Doxorubicin|doxorubicin|mesh-list
44318017|NCT04625907|Irinotecan|irinotecan|mesh-list
44318018|NCT04625907|Vincristine|vincristine|mesh-list
44318019|NCT04625907|Vinorelbine|vinorelbine|mesh-list
44318020|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318021|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
44318022|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318023|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318024|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318025|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
44318026|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318027|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318028|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318029|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318030|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44318031|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44318032|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318033|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44318034|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44318035|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318036|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318037|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318038|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44318039|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318040|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44318041|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44318043|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44318044|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
44318045|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318052|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44318053|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
44318055|NCT04606264|Lidocaine|lidocaine|mesh-list
44318056|NCT04606264|Ketamine|ketamine|mesh-list
44318057|NCT04606264|Morphine|morphine|mesh-list
44318058|NCT04606264|Hydromorphone|hydromorphone|mesh-list
44318059|NCT04606264|Ondansetron|ondansetron|mesh-list
44318060|NCT04606264|Aprepitant|aprepitant|mesh-list
44318061|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
44318062|NCT04606264|Anesthetics|anesthetics|mesh-list
44318063|NCT04606264|Perphenazine|perphenazine|mesh-list
44318064|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318065|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
44318066|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
44318067|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318068|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318069|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44318070|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
44318071|NCT04606264|Hormones|hormones|mesh-ancestor
44318072|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318073|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44318074|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318075|NCT04606264|Anesthetics, Local|anesthetics, local|mesh-ancestor
44318076|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318077|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
44318078|NCT04606264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44318079|NCT04606264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44318080|NCT04606264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44318081|NCT04606264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44318082|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318083|NCT04606264|Analgesics|analgesics|mesh-ancestor
44318084|NCT04606264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44318085|NCT04606264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44318086|NCT04606264|Anesthetics, General|anesthetics, general|mesh-ancestor
44318087|NCT04606264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44318091|NCT04606264|Narcotics|narcotics|mesh-ancestor
44318093|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44318094|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44318095|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
44318096|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44318097|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44318098|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44318099|NCT04606264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44318100|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44318101|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44318102|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
44318103|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44318104|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
44318105|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
44318106|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
44318107|NCT04581382|Nivolumab|nivolumab|mesh-list
44318108|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318109|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318110|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318111|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318113|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44318114|NCT04546009|Letrozole|letrozole|mesh-list
44318115|NCT04546009|Palbociclib|palbociclib|mesh-list
44318116|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318117|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44121978|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44121979|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
44121980|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44121981|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44121982|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154694|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154695|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154696|NCT00224679|Analgesics|analgesics|mesh-ancestor
44154697|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
44154698|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121984|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
44121985|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44121986|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44121987|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121988|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121989|NCT00125918|Urological Agents|urological agents|mesh-ancestor
44121990|NCT00125983|Ritonavir|ritonavir|mesh-list
44121991|NCT00125983|Lopinavir|lopinavir|mesh-list
44121992|NCT00125983|Norinyl|norinyl|mesh-list
44121993|NCT00125983|Ortho Evra|ortho evra|mesh-list
44121994|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44121995|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44121996|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
44121997|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121998|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121999|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44122000|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44122001|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
44318118|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44318119|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318120|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318121|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44318122|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318123|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318124|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318125|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318126|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
44318127|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
44318128|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318129|NCT04544007|Poly ICLC|poly iclc|mesh-list
44318130|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
44318131|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
44318132|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318133|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
44318134|NCT04491617|Narcotics|narcotics|mesh-ancestor
44318135|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44318136|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318137|NCT04491617|Analgesics|analgesics|mesh-ancestor
44318138|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
44318139|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318140|NCT04472000|Ascorbic Acid|ascorbic acid|mesh-list
44318141|NCT04472000|Vitamins|vitamins|mesh-ancestor
44318142|NCT04472000|Micronutrients|micronutrients|mesh-ancestor
44318143|NCT04472000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318144|NCT04472000|Antioxidants|antioxidants|mesh-ancestor
44318145|NCT04472000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318146|NCT04472000|Protective Agents|protective agents|mesh-ancestor
44318147|NCT04430738|Leucovorin|leucovorin|mesh-list
44318148|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
44318149|NCT04430738|Trastuzumab|trastuzumab|mesh-list
44318150|NCT04430738|Fluorouracil|fluorouracil|mesh-list
44318151|NCT04430738|Capecitabine|capecitabine|mesh-list
44318152|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
44122002|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122003|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44122004|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122005|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44122006|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44122007|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44318153|NCT04430738|Tucatinib|tucatinib|mesh-list
44318154|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318155|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318156|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
44318157|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318158|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318159|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318160|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
44318161|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318162|NCT04430738|Antidotes|antidotes|mesh-ancestor
44318163|NCT04430738|Protective Agents|protective agents|mesh-ancestor
44318164|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44318165|NCT04430738|Vitamins|vitamins|mesh-ancestor
44318166|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
44318167|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318168|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467247|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467248|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467249|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467250|NCT01451827|Tolvaptan|tolvaptan|mesh-list
44467251|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44467252|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467253|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
44467254|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467255|NCT01451814|Nicotine|nicotine|mesh-list
44467256|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44467257|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
44467258|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467259|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467260|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44467261|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44467262|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
44318176|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318177|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
44318178|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318179|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318180|NCT04398368|Gemcitabine|gemcitabine|mesh-list
44318181|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318182|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
44318183|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318184|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318185|NCT04398368|Antiviral Agents|antiviral agents|mesh-ancestor
44318186|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318187|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318188|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318189|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
44318190|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318191|NCT04396535|Docetaxel|docetaxel|mesh-list
44318192|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318193|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
43614248|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318194|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318195|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318196|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318197|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
44318198|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
44318199|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44318200|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44318201|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318202|NCT04375384|Cetuximab|cetuximab|mesh-list
44318203|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318204|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318205|NCT04368559|Fluconazole|fluconazole|mesh-list
44318206|NCT04368559|Posaconazole|posaconazole|mesh-list
44318207|NCT04368559|Rezafungin|rezafungin|mesh-list
44318208|NCT04368559|Trimethoprim|trimethoprim|mesh-list
44318209|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
44318210|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44318216|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318217|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44318218|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318219|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318220|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318221|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44318222|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44318223|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44318225|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
44318226|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44318227|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44318228|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44318229|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44318230|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44318231|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44318232|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44318233|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
44318234|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318235|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318236|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
44318237|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318238|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318239|NCT04337580|Omeprazole|omeprazole|mesh-list
44318240|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44318241|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44318242|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44318263|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318265|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318266|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318267|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44318268|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44318269|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318270|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318271|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
44318272|NCT04323956|Hormones|hormones|mesh-ancestor
44318273|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318274|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44318275|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44318276|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44318277|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318278|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318279|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318280|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
44318281|NCT04322643|Nivolumab|nivolumab|mesh-list
44318282|NCT04322643|Durvalumab|durvalumab|mesh-list
44318283|NCT04322643|Avelumab|avelumab|mesh-list
44318284|NCT04322643|Atezolizumab|atezolizumab|mesh-list
44318285|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318286|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318287|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318288|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318289|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44318290|NCT04285671|Trastuzumab|trastuzumab|mesh-list
44318291|NCT04285671|Necitumumab|necitumumab|mesh-list
44318292|NCT04285671|Osimertinib|osimertinib|mesh-list
44318293|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44318294|NCT04285671|Antibodies|antibodies|mesh-list
44318295|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
44318296|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318297|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
44318303|NCT04263922|Valsartan|valsartan|mesh-list
44318304|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44318305|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44318306|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44318307|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318308|NCT04249622|Rifaximin|rifaximin|mesh-list
44318309|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44318310|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318311|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44318312|NCT04249167|Paclitaxel|paclitaxel|mesh-list
44318313|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44318314|NCT04249167|Atezolizumab|atezolizumab|mesh-list
44318315|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318316|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44318317|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318318|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318319|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318320|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318321|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318322|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
44318323|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318324|NCT04233216|Islatravir|islatravir|mesh-list
44318325|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
44318326|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318327|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318328|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318329|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44318332|NCT04230304|Daratumumab|daratumumab|mesh-list
44318350|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318351|NCT04227184|Urological Agents|urological agents|mesh-ancestor
44318352|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
44318353|NCT04171843|Fludarabine|fludarabine|mesh-list
44318354|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318355|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
44318356|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318357|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318358|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318359|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
44318360|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318361|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318362|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318363|NCT04164212|Vaccines|vaccines|mesh-list
44318364|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
44318365|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318366|NCT04144023|Molgramostim|molgramostim|mesh-list
44318367|NCT04144023|Vaccines|vaccines|mesh-list
44318368|NCT04144023|Sargramostim|sargramostim|mesh-list
44318369|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
44318370|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318371|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318372|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
44318373|NCT04119024|Fludarabine|fludarabine|mesh-list
44318374|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
44318375|NCT04119024|Interleukin-2|interleukin-2|mesh-list
44318376|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318377|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
44318398|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44467264|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467265|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
44467266|NCT01451762|Promethazine|promethazine|mesh-list
44467267|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44467268|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44467269|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467270|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467271|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
44467272|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
44467273|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
44467274|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467275|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
44467276|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
44467277|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467278|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44467279|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
44467280|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
44467281|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467282|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467283|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467284|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
44467285|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467286|NCT01451749|Donepezil|donepezil|mesh-list
44467287|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44467288|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467289|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467290|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
44467291|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467292|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467293|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
44467294|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44467295|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
44467296|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467301|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467302|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44467303|NCT01451645|Colchicine|colchicine|mesh-list
44467304|NCT01451645|Allopurinol|allopurinol|mesh-list
44467305|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
44467306|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467307|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467308|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467309|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467310|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467311|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467312|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
44467313|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467314|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44467315|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
44467316|NCT01451645|Protective Agents|protective agents|mesh-ancestor
44467317|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467318|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44467319|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44467320|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44467321|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467322|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467323|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467324|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467325|NCT01451606|Analgesics|analgesics|mesh-ancestor
44467326|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
44467327|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467328|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
44467329|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44467330|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
44467331|NCT01451541|Ciclesonide|ciclesonide|mesh-list
44467332|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
44467333|NCT01451541|Hormones|hormones|mesh-ancestor
44467334|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318399|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
44318400|NCT04093752|Tirzepatide|tirzepatide|mesh-list
44318401|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44318403|NCT04093752|Incretins|incretins|mesh-ancestor
44318404|NCT04093752|Hormones|hormones|mesh-ancestor
44318405|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318406|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44318407|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
44318408|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318409|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44318410|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
44318411|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318412|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318413|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44318414|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44318415|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44318416|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44318417|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44318418|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
44318419|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
44318420|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318421|NCT04028063|Doxorubicin|doxorubicin|mesh-list
44318422|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318423|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318424|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44318425|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44318426|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318427|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318428|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
44318429|NCT04019379|Calcium|calcium|mesh-list
44318433|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
44318447|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44318448|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318450|NCT04005339|Protective Agents|protective agents|mesh-ancestor
44318451|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
44318452|NCT04005339|Vitamins|vitamins|mesh-ancestor
44318453|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
44318454|NCT03963375|Cladribine|cladribine|mesh-list
44318455|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318456|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318457|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
44318458|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318459|NCT03936777|Fenfluramine|fenfluramine|mesh-list
44318460|NCT03936777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44318461|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44318462|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44318463|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318464|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318465|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
44318466|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318467|NCT03906136|Adalimumab|adalimumab|mesh-list
44318468|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318503|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318504|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44318505|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318506|NCT03798314|Growth Substances|growth substances|mesh-ancestor
44318507|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
44318508|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
44318509|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44318510|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
44318511|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318512|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318513|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44318514|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
44318515|NCT03778294|Temozolomide|temozolomide|mesh-list
44318516|NCT03778294|Levodopa|levodopa|mesh-list
44318517|NCT03778294|Fluorides|fluorides|mesh-list
44318518|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318519|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
44318520|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318521|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318522|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
44318523|NCT03778294|Protective Agents|protective agents|mesh-ancestor
44318524|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318525|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
44318526|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318527|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44318528|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44318529|NCT03743662|Bevacizumab|bevacizumab|mesh-list
44318530|NCT03743662|Nivolumab|nivolumab|mesh-list
44318531|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122008|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
44122009|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44122010|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122011|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44122012|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44122013|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44122014|NCT00125996|Hematinics|hematinics|mesh-ancestor
44122015|NCT00126009|Amisulpride|amisulpride|mesh-list
44122016|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44122017|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44122018|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122019|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122020|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44122021|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44318532|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318533|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44318534|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318535|NCT03743662|Growth Substances|growth substances|mesh-ancestor
44318536|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318537|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44318538|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318539|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318540|NCT03726671|Choline|choline|mesh-list
44318541|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
44318542|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44318543|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
44318544|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318545|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44318546|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44318547|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
43973449|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44318548|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
44318550|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318551|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
44318552|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318553|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318554|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318555|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
44318556|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318557|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318558|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318559|NCT03718767|Nivolumab|nivolumab|mesh-list
44318560|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467349|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
44467350|NCT01451515|Clofarabine|clofarabine|mesh-list
44467351|NCT01451515|Pegaspargase|pegaspargase|mesh-list
44467352|NCT01451515|Thioguanine|thioguanine|mesh-list
44467353|NCT01451515|Antimetabolites|antimetabolites|mesh-list
44467354|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467355|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
44467356|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467357|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467358|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44467359|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
44467360|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467361|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467362|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44467363|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467364|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
44467365|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
44467366|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467367|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467368|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
44467369|NCT01451515|Hormones|hormones|mesh-ancestor
44467370|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467371|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467372|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467373|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44467374|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44467375|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467396|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44318565|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
44318566|NCT03713294|Pomalidomide|pomalidomide|mesh-list
44318567|NCT03713294|Elotuzumab|elotuzumab|mesh-list
44318568|NCT03713294|Ichthammol|ichthammol|mesh-list
44318569|NCT03713294|BB 1101|bb 1101|mesh-list
44318570|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318571|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
44318572|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
44318573|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318574|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318575|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44318576|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
44318577|NCT03713294|Hormones|hormones|mesh-ancestor
44318578|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318579|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44318580|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318581|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44318582|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318583|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318584|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
44318585|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44318586|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318587|NCT03713294|Growth Substances|growth substances|mesh-ancestor
44318616|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44318617|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44318618|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318619|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318620|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44318621|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318622|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318623|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318624|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44318625|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44318626|NCT03627468|Bromides|bromides|mesh-list
44318627|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
44318628|NCT03620643|Fulvestrant|fulvestrant|mesh-list
44318629|NCT03620643|Crizotinib|crizotinib|mesh-list
44318630|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44318631|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318632|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44318633|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44318634|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318635|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318636|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318637|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318638|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318639|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318640|NCT03617913|Cisplatin|cisplatin|mesh-list
44318641|NCT03617913|Fluorouracil|fluorouracil|mesh-list
44318642|NCT03617913|Mitomycins|mitomycins|mesh-list
44318643|NCT03617913|Mitomycin|mitomycin|mesh-list
44318644|NCT03617913|Avelumab|avelumab|mesh-list
44318645|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44318646|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318647|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
43732902|NCT02547519|Insulin|insulin|mesh-list
44318655|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44318656|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318657|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318659|NCT03616587|Palbociclib|palbociclib|mesh-list
44318660|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318661|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318662|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
44318663|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318664|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318665|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318666|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318667|NCT03601637|Ivacaftor|ivacaftor|mesh-list
44318668|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44318669|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44318670|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318671|NCT03592576|Venetoclax|venetoclax|mesh-list
44318672|NCT03592576|Navitoclax|navitoclax|mesh-list
44318673|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318674|NCT03590821|Aspirin|aspirin|mesh-list
44318675|NCT03590821|Celecoxib|celecoxib|mesh-list
44318676|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44318677|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44318678|NCT03590821|Analgesics|analgesics|mesh-ancestor
44318679|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
44318680|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44318681|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318682|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318683|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318684|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44318685|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44318686|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318687|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44318688|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44318689|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318690|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
44122022|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
44318691|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44318692|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
44318693|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
44318694|NCT03570827|Androgens|androgens|mesh-list
44318695|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44318696|NCT03570827|Hormones|hormones|mesh-ancestor
44318697|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318698|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318699|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
44318700|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318701|NCT03570827|Protective Agents|protective agents|mesh-ancestor
44318702|NCT03570827|Vitamins|vitamins|mesh-ancestor
44318703|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
44318704|NCT03570827|Estrogens|estrogens|mesh-ancestor
44318705|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44318706|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318707|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
44318708|NCT03560531|Palbociclib|palbociclib|mesh-list
44318709|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318710|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318711|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318712|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318713|NCT03557619|Venetoclax|venetoclax|mesh-list
44318714|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
44318715|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44318716|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44318717|NCT03557619|Estradiol|estradiol|mesh-list
44318718|NCT03557619|Estrogens|estrogens|mesh-ancestor
44318739|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318740|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318741|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318742|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
44318743|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318744|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318745|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318746|NCT03477539|Lenalidomide|lenalidomide|mesh-list
44318747|NCT03477539|Daratumumab|daratumumab|mesh-list
44318748|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
44318749|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318750|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44318751|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44318752|NCT03477539|Growth Substances|growth substances|mesh-ancestor
44318753|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
44318754|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318755|NCT03472365|Capecitabine|capecitabine|mesh-list
44318756|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
44318757|NCT03472365|Apatinib|apatinib|mesh-list
44318758|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318759|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
44318760|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318761|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318762|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318763|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318791|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
44318792|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973752|NCT01752712|Oxytocin|oxytocin|mesh-list
44318793|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318794|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318795|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318796|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
44318797|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318798|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
44318799|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318800|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318801|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318802|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318803|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44318804|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318805|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44318806|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
44318807|NCT03417154|Nivolumab|nivolumab|mesh-list
44318808|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318809|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
44318810|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318811|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318812|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318813|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
44318814|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318815|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318816|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318817|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318818|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44318836|NCT03240211|Decitabine|decitabine|mesh-list
44318837|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318838|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318839|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318840|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
44318841|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318842|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318843|NCT03188432|Carboplatin|carboplatin|mesh-list
44318844|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318845|NCT03110094|Adalimumab|adalimumab|mesh-list
44318846|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44318847|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318850|NCT02989662|Mifepristone|mifepristone|mesh-list
44318851|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44318852|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
44318853|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44318854|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318855|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44318856|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44318857|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44318858|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
44318859|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44318860|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44318861|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
44318862|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44318863|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
44318864|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44318865|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43973827|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
44318866|NCT02970448|Temozolomide|temozolomide|mesh-list
44318873|NCT02807636|Carboplatin|carboplatin|mesh-list
44318874|NCT02807636|Atezolizumab|atezolizumab|mesh-list
44318875|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318876|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318877|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
44318878|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318879|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
44318880|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318881|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318882|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318883|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
44318884|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318885|NCT02626715|Vidarabine|vidarabine|mesh-list
44318886|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
44318887|NCT02626715|Fludarabine|fludarabine|mesh-list
44318888|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
44318889|NCT02626715|Thiotepa|thiotepa|mesh-list
44318890|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318891|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
44318892|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318893|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318894|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318895|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
44318910|NCT02537509|Vitamin D|vitamin d|mesh-list
44318927|NCT02393248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318928|NCT02393248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318929|NCT02393248|Immunologic Factors|immunologic factors|mesh-ancestor
44318930|NCT02393248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318931|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
44318932|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
44318933|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
44318934|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318935|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
44318936|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44318937|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318938|NCT01835041|Leucovorin|leucovorin|mesh-list
44318939|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
44318940|NCT01835041|Fluorouracil|fluorouracil|mesh-list
44318941|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
44318942|NCT01835041|Irinotecan|irinotecan|mesh-list
44318943|NCT01835041|Calcium|calcium|mesh-list
44318944|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
44318945|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44318946|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318947|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
44318948|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318949|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318950|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318951|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318952|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
44318953|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44318954|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44318955|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318956|NCT01835041|Antidotes|antidotes|mesh-ancestor
44318957|NCT01835041|Protective Agents|protective agents|mesh-ancestor
44318958|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
44318959|NCT01835041|Vitamins|vitamins|mesh-ancestor
44318960|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
44318961|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
44318962|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
44318963|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
44318964|NCT01760655|Busulfan|busulfan|mesh-list
44318965|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
44122023|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44318966|NCT01760655|Fludarabine|fludarabine|mesh-list
44318967|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
44318968|NCT01760655|Tacrolimus|tacrolimus|mesh-list
44318969|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44318970|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
44318971|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44318972|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44318973|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44318974|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
44318975|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318976|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318977|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44318978|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44318979|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
44318980|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44318981|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44318982|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318983|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44318984|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44318985|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
44318986|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44318987|NCT01748149|Vemurafenib|vemurafenib|mesh-list
44318988|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44318989|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44318990|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44318991|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44318992|NCT01712620|Spironolactone|spironolactone|mesh-list
44467409|NCT01450813|Bromides|bromides|mesh-list
44467410|NCT01450813|Rocuronium|rocuronium|mesh-list
44467411|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
44467412|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44467413|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44467414|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44467415|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467416|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319000|NCT01631617|Doxycycline|doxycycline|mesh-list
44319001|NCT01631617|Cephalexin|cephalexin|mesh-list
44319002|NCT01631617|Trimethoprim|trimethoprim|mesh-list
44319003|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
44319004|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44319005|NCT01631617|Eusol|eusol|mesh-list
44319006|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319007|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319008|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
44319009|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44319010|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44319011|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44319012|NCT01631617|Renal Agents|renal agents|mesh-ancestor
44319013|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44319014|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319015|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319016|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44319017|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44319018|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44319019|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
44319020|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
44319021|NCT01593254|Dasatinib|dasatinib|mesh-list
44319022|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319023|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44319024|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319025|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319036|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
44319037|NCT01005914|Asparaginase|asparaginase|mesh-list
44319038|NCT01005914|Pegaspargase|pegaspargase|mesh-list
44319039|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319040|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
44319041|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319042|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319043|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44319044|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
44319045|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319046|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319047|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44319048|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319049|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
44319050|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
44319051|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319052|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44319053|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
44319054|NCT01005914|Hormones|hormones|mesh-ancestor
44319055|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44319056|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44319057|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44319058|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44319059|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44319060|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319061|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44319062|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
44319063|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44319064|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319065|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
44319066|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
44319067|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44319068|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44319069|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
44319075|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44319076|NCT01005914|Protective Agents|protective agents|mesh-ancestor
44319077|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44319078|NCT00312728|Bevacizumab|bevacizumab|mesh-list
44319079|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319080|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319081|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319082|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319083|NCT00312728|Growth Substances|growth substances|mesh-ancestor
44319084|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319085|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319086|NCT00920803|Resveratrol|resveratrol|mesh-list
44319087|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
44319088|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319089|NCT00920803|Protective Agents|protective agents|mesh-ancestor
44319090|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319091|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319092|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44319093|NCT00920868|Bevacizumab|bevacizumab|mesh-list
44319094|NCT00920868|Capecitabine|capecitabine|mesh-list
44319095|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
44319096|NCT00920868|Dasatinib|dasatinib|mesh-list
44319097|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319098|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319099|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319100|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319101|NCT00920868|Growth Substances|growth substances|mesh-ancestor
44319102|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319103|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319104|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319105|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
44319106|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319107|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44319108|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319109|NCT00920933|Prednisolone|prednisolone|mesh-list
43733190|NCT02545530|Clonidine|clonidine|mesh-list
44122024|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319110|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319111|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
44319112|NCT00920933|Hormones|hormones|mesh-ancestor
44319113|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44319114|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319115|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44319116|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319117|NCT00920998|Z 338|z 338|mesh-list
44319118|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44319119|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319120|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319121|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319122|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319123|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319124|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44319125|NCT00921063|Alprazolam|alprazolam|mesh-list
44319126|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44319127|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319128|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319129|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44319130|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44319131|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44319132|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
44319133|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
44319134|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319135|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319136|NCT00921102|Atropine|atropine|mesh-list
44122025|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44122026|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
44122027|NCT00126022|Tedisamil|tedisamil|mesh-list
44122028|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44122029|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44122030|NCT00126022|Protective Agents|protective agents|mesh-ancestor
44122031|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122032|NCT00126048|Atorvastatin|atorvastatin|mesh-list
44122038|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44122039|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122040|NCT00126061|Tedisamil|tedisamil|mesh-list
44122041|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44122042|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44122043|NCT00126061|Protective Agents|protective agents|mesh-ancestor
44122044|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122045|NCT00126074|Tedisamil|tedisamil|mesh-list
44122046|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44122047|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44122048|NCT00126074|Protective Agents|protective agents|mesh-ancestor
44122049|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122050|NCT00126087|Dopamine|dopamine|mesh-list
44319140|NCT00921102|Anesthetics|anesthetics|mesh-list
44319141|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319142|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319143|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
44319144|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319145|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319146|NCT00921102|Narcotics|narcotics|mesh-ancestor
44319147|NCT00921102|Analgesics|analgesics|mesh-ancestor
44319148|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44319149|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319150|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44319151|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
44319152|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44319153|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
44319154|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
44319155|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
44319156|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44319157|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44319158|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319159|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319160|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319161|NCT00921128|Muscimol|muscimol|mesh-list
44319162|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44319163|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
44122051|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44122052|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
44122053|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
44122054|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122055|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122056|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
44122057|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122058|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122059|NCT00126087|Protective Agents|protective agents|mesh-ancestor
44122060|NCT00126100|Lenograstim|lenograstim|mesh-list
44122061|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44122062|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
44122063|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122064|NCT00126139|Abciximab|abciximab|mesh-list
44122065|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
44122066|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44122067|NCT00126204|Doxycycline|doxycycline|mesh-list
44122068|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122069|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122070|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
44122071|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122072|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122073|NCT00126230|Docetaxel|docetaxel|mesh-list
44319164|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
44319165|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319166|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319167|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319168|NCT00921154|Ivermectin|ivermectin|mesh-list
44319169|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44319170|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319171|NCT00921167|Bevacizumab|bevacizumab|mesh-list
44319172|NCT00921167|Irinotecan|irinotecan|mesh-list
44319173|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319174|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319175|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319176|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319177|NCT00921167|Growth Substances|growth substances|mesh-ancestor
44319178|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319179|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319180|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44319181|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44319182|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319183|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319184|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44319185|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
44319186|NCT00921180|Entecavir|entecavir|mesh-list
44319187|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
44319188|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319189|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
44319190|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319191|NCT00921219|Ivermectin|ivermectin|mesh-list
44319192|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44319193|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319194|NCT00921245|Darifenacin|darifenacin|mesh-list
44319195|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44319196|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44319197|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319198|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319199|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319200|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319202|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
44319203|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44319204|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319205|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319206|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319207|NCT00921284|Analgesics|analgesics|mesh-ancestor
44319208|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
43615858|NCT03145610|Fluorides|fluorides|mesh-list
44319209|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319210|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44319211|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44319212|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44319213|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319214|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319215|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319216|NCT00921349|Nadolol|nadolol|mesh-list
44319217|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44319218|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44319219|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319220|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319221|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319222|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319223|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319224|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319225|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
44319226|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
44319227|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319229|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44319230|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44319231|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319246|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319247|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319249|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44319250|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319251|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319252|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44319253|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319254|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319255|NCT00921531|Thalidomide|thalidomide|mesh-list
44319256|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319257|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
44319258|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319259|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
44319260|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319261|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319262|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319263|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319264|NCT00921531|Growth Substances|growth substances|mesh-ancestor
44319265|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319266|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319267|NCT00921570|Amlodipine|amlodipine|mesh-list
44319268|NCT00921570|Valsartan|valsartan|mesh-list
44319269|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319270|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44319271|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319272|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319273|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44319274|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319275|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
44319278|NCT00921622|Vitamin D|vitamin d|mesh-list
44319289|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319290|NCT00921661|Growth Substances|growth substances|mesh-ancestor
44319291|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319292|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319293|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319295|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44319296|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319297|NCT00921700|Acetaminophen|acetaminophen|mesh-list
44319298|NCT00921700|Ibuprofen|ibuprofen|mesh-list
44319299|NCT00921700|Codeine|codeine|mesh-list
44319300|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319301|NCT00921700|Analgesics|analgesics|mesh-ancestor
44319302|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
44319303|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319304|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319306|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44319307|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319308|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319309|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44319310|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319311|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319312|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319313|NCT00921700|Narcotics|narcotics|mesh-ancestor
44319314|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319315|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
44319316|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44319317|NCT00921726|Oseltamivir|oseltamivir|mesh-list
44319318|NCT00921726|Zanamivir|zanamivir|mesh-list
44319319|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
44319320|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319321|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319322|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319323|NCT00921765|Ketamine|ketamine|mesh-list
44319324|NCT00921765|Naloxone|naloxone|mesh-list
44319325|NCT00921765|Analgesics|analgesics|mesh-ancestor
44319326|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
44319327|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319328|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319329|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44319330|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44319331|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
44319332|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
44319333|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319334|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44319335|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44319336|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319337|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319338|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44319339|NCT00921804|Risperidone|risperidone|mesh-list
44319340|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44319341|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
44319342|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319343|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319344|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319345|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44319346|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44319347|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319348|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44319349|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44319350|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
44319351|NCT00921830|Ibuprofen|ibuprofen|mesh-list
44319352|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44319353|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319354|NCT00921830|Analgesics|analgesics|mesh-ancestor
44319355|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
44319356|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319357|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319358|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319359|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319360|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44319361|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319362|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319363|NCT00921973|Vaccines|vaccines|mesh-list
44319365|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319366|NCT00922129|Cyclosporine|cyclosporine|mesh-list
44319367|NCT00922129|Sirolimus|sirolimus|mesh-list
44319368|NCT00922129|Tacrolimus|tacrolimus|mesh-list
44319369|NCT00922129|Cyclosporins|cyclosporins|mesh-list
44319370|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319371|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
44319372|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319373|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44319374|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319375|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319376|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
44319377|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319378|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44319379|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319380|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319381|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44319382|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467417|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
44467418|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44467419|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467420|NCT01450800|Renal Agents|renal agents|mesh-ancestor
44122074|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122075|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44122076|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44122077|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44122078|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122079|NCT00126243|Rituximab|rituximab|mesh-list
44122080|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122081|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122082|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
44122083|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122084|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122085|NCT00126256|Leucovorin|leucovorin|mesh-list
44122086|NCT00126256|Fluorouracil|fluorouracil|mesh-list
44122087|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
44122088|NCT00126256|Irinotecan|irinotecan|mesh-list
44122090|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122091|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44122092|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122093|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122094|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
44122095|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122096|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44122097|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44122098|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122099|NCT00126256|Antidotes|antidotes|mesh-ancestor
44122100|NCT00126256|Protective Agents|protective agents|mesh-ancestor
44122101|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
44122102|NCT00126256|Vitamins|vitamins|mesh-ancestor
44122103|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
44122104|NCT00126269|Gemcitabine|gemcitabine|mesh-list
44122105|NCT00126269|Cisplatin|cisplatin|mesh-list
44122111|NCT00126269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122112|NCT00126269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122113|NCT00126269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467421|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467422|NCT01450761|Cisplatin|cisplatin|mesh-list
44467423|NCT01450761|Carboplatin|carboplatin|mesh-list
44467424|NCT01450761|Etoposide|etoposide|mesh-list
44467425|NCT01450761|Ipilimumab|ipilimumab|mesh-list
44467426|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467427|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467428|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44467429|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44467430|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467431|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467432|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467433|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44467434|NCT01450696|Cisplatin|cisplatin|mesh-list
44467435|NCT01450696|Capecitabine|capecitabine|mesh-list
44467436|NCT01450696|Trastuzumab|trastuzumab|mesh-list
44467437|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467438|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467439|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
44467440|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467441|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467442|NCT01450683|Itraconazole|itraconazole|mesh-list
44467443|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
44467444|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467445|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44467446|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44467447|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467448|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467449|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44467450|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467451|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467452|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467453|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44122114|NCT00126269|Immunologic Factors|immunologic factors|mesh-ancestor
44122115|NCT00126269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122117|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44122118|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122119|NCT00126282|Renal Agents|renal agents|mesh-ancestor
44467454|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
44467455|NCT01450137|Hormones|hormones|mesh-ancestor
44467456|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467457|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467458|NCT01450098|Evacetrapib|evacetrapib|mesh-list
44467459|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
44467460|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44467461|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44467462|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
44467463|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467464|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44467465|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
44467466|NCT01450098|Protective Agents|protective agents|mesh-ancestor
44467467|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467468|NCT01450007|Dexamethasone|dexamethasone|mesh-list
44467469|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
44467470|NCT01450007|Ropivacaine|ropivacaine|mesh-list
44467471|NCT01450007|BB 1101|bb 1101|mesh-list
44467472|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467473|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
44467474|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
44467475|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467476|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467477|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467478|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
44467479|NCT01450007|Hormones|hormones|mesh-ancestor
44467480|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467481|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467482|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467483|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467484|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467485|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319387|NCT00922402|Insulin|insulin|mesh-list
44319392|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44319393|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44319394|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319395|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319396|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319397|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319398|NCT00922506|Doxazosin|doxazosin|mesh-list
44319399|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44319400|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44319401|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44319402|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319403|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319404|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319405|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319406|NCT00922506|Urological Agents|urological agents|mesh-ancestor
44319407|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319408|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44319409|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44122120|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44122121|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
44122122|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122123|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
44122124|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122125|NCT00126308|Mannitol|mannitol|mesh-list
44122126|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44122127|NCT00126308|Diuretics|diuretics|mesh-ancestor
44122128|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
44122129|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122130|NCT00126321|Cladribine|cladribine|mesh-list
44122131|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122132|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122133|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
44122134|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122135|NCT00126347|Folic Acid|folic acid|mesh-list
44122136|NCT00126347|Betaine|betaine|mesh-list
44122137|NCT00126347|Hematinics|hematinics|mesh-ancestor
44122138|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
44122139|NCT00126347|Vitamins|vitamins|mesh-ancestor
44122140|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
44122141|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122142|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122143|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
44122144|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44122145|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
44122146|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122147|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44122148|NCT00126360|Anastrozole|anastrozole|mesh-list
44122149|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122150|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122151|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44122152|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44122153|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122154|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122155|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44122156|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701991|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44319410|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44319411|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319413|NCT00922519|Fluorides|fluorides|mesh-list
44319414|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
44319415|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
44319416|NCT00922519|Protective Agents|protective agents|mesh-ancestor
44319417|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319418|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44319419|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319420|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
44319421|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44319422|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
44319423|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319424|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319425|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44319426|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
44319427|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44319428|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
44319429|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319430|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319431|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44319432|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44319433|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
44319434|NCT00922532|Protective Agents|protective agents|mesh-ancestor
44319435|NCT00922584|Sorafenib|sorafenib|mesh-list
44319436|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319437|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44319438|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319444|NCT00922649|Insulin|insulin|mesh-list
44319458|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319459|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319461|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319462|NCT00922896|Antiviral Agents|antiviral agents|mesh-ancestor
44319463|NCT00922896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319464|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319465|NCT00922896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319466|NCT00922896|Immunologic Factors|immunologic factors|mesh-ancestor
44319467|NCT00922896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319468|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44319469|NCT00923000|Morphine|morphine|mesh-list
44319470|NCT00923000|Nalbuphine|nalbuphine|mesh-list
44319471|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319472|NCT00923000|Narcotics|narcotics|mesh-ancestor
44319473|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319474|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319475|NCT00923000|Analgesics|analgesics|mesh-ancestor
44319476|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
44319477|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319478|NCT00923169|Mitogens|mitogens|mesh-list
44319479|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
44319480|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319481|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
44319482|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319483|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319484|NCT00923234|Lenalidomide|lenalidomide|mesh-list
44319485|NCT00923234|Azacitidine|azacitidine|mesh-list
44319486|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
44319487|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319488|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319489|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319494|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
44319501|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44319502|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319504|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
44319505|NCT00923390|Fludarabine|fludarabine|mesh-list
44319506|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319507|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
44319508|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319509|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319510|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44319511|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
44319512|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319513|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319514|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44319515|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44319516|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44319517|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
44319518|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319519|NCT00923494|Ropivacaine|ropivacaine|mesh-list
44319520|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
44319521|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
44319522|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319523|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319524|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
44319525|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319526|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44122157|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122158|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122159|NCT00126373|Bupropion|bupropion|mesh-list
44122160|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44122161|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
44122162|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44122163|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43566417|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
44122164|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44122165|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44122166|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122167|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
44122168|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122169|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122170|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44122171|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122172|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122173|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
44122180|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122181|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122182|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44319527|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319528|NCT00923533|Diuretics|diuretics|mesh-ancestor
44319529|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
44319530|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319531|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44319532|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319533|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319534|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44319535|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44319536|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319537|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
44319538|NCT00923637|Pemetrexed|pemetrexed|mesh-list
44319539|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319540|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319541|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319542|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44319543|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44319544|NCT00923663|Lenalidomide|lenalidomide|mesh-list
44319545|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
44319546|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319547|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319548|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44319549|NCT00923663|Growth Substances|growth substances|mesh-ancestor
44319550|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44319551|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319552|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44319574|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44319575|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319577|NCT00923962|Analgesics|analgesics|mesh-ancestor
44319578|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
44319579|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319580|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319581|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
44319582|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44319583|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
44319584|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
44319585|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319586|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319587|NCT00924014|Furosemide|furosemide|mesh-list
44319588|NCT00924014|Conivaptan|conivaptan|mesh-list
44319589|NCT00924014|Diuretics|diuretics|mesh-ancestor
44319590|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
44319591|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319592|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44319593|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319594|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319595|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44319596|NCT00924079|Nalbuphine|nalbuphine|mesh-list
44319597|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319598|NCT00924079|Narcotics|narcotics|mesh-ancestor
44319599|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319600|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319601|NCT00924079|Analgesics|analgesics|mesh-ancestor
44467493|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467495|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
44467496|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467497|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
44467498|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467499|NCT01449929|Ritonavir|ritonavir|mesh-list
44467500|NCT01449929|Darunavir|darunavir|mesh-list
44467501|NCT01449929|Dolutegravir|dolutegravir|mesh-list
44467502|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44467503|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44467504|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467505|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467506|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467507|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44467508|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44467509|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
44467510|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467511|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44467512|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44467513|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44467514|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44467515|NCT01449682|Dexamethasone|dexamethasone|mesh-list
44467516|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
44467517|NCT01449682|BB 1101|bb 1101|mesh-list
44467518|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467519|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
44467520|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
44467521|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467522|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467523|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467524|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
44467525|NCT01449682|Hormones|hormones|mesh-ancestor
44467536|NCT01449630|Analgesics|analgesics|mesh-ancestor
44467537|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
44467538|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467539|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467540|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467541|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467542|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44467543|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44467544|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467545|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467546|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44467547|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467548|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467549|NCT01449370|Serabelisib|serabelisib|mesh-list
44467550|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467551|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467552|NCT01449279|Ipilimumab|ipilimumab|mesh-list
44467553|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467554|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467555|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43974696|NCT01787916|Liraglutide|liraglutide|mesh-list
44467556|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319615|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44319616|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44319617|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
44319618|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319619|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44319620|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44319621|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319622|NCT00924573|Metformin|metformin|mesh-list
44319623|NCT00924573|Glimepiride|glimepiride|mesh-list
44319624|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319625|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319631|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44319632|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319633|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319634|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319635|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319636|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44319638|NCT00924742|Piperacillin|piperacillin|mesh-list
44319639|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319640|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319641|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44319642|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319643|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319644|NCT00924755|Caffeine|caffeine|mesh-list
44319645|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44319646|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319647|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44319648|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319649|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319650|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44319651|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44319652|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
44319653|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319654|NCT00924963|Lidocaine|lidocaine|mesh-list
44319655|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
44319656|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
44319657|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319658|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319659|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
44319666|NCT00925028|Warfarin|warfarin|mesh-list
44319674|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319675|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319676|NCT00925106|Celecoxib|celecoxib|mesh-list
44319677|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44319678|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319679|NCT00925106|Analgesics|analgesics|mesh-ancestor
44319680|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
44319681|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319682|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319683|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44319684|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44319685|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44319686|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43974774|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
44319687|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319688|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319689|NCT00925327|Riboflavin|riboflavin|mesh-list
44319690|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
44319691|NCT00925327|Vitamins|vitamins|mesh-ancestor
44319692|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
44319693|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319694|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44319695|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
44319696|NCT00925392|Doripenem|doripenem|mesh-list
44319697|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319698|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319722|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
44319723|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44319724|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319725|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319726|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
44319727|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
44319728|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44319729|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319730|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319731|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
44319732|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44319733|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319734|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319735|NCT00925873|Vidarabine|vidarabine|mesh-list
44319736|NCT00925873|Fludarabine|fludarabine|mesh-list
44319737|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
44319738|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319739|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319740|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
44319741|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319742|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319743|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
44319744|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319745|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
44319746|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319747|NCT00925912|Bupivacaine|bupivacaine|mesh-list
44319748|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
44319749|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
44319750|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319751|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319752|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
44319753|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319754|NCT00925951|Acetaminophen|acetaminophen|mesh-list
44319755|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319756|NCT00925951|Analgesics|analgesics|mesh-ancestor
44319757|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
44122183|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122184|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319758|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319759|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319760|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
44319762|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44319763|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
44319764|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
44319765|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
44319766|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
44319767|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
44319768|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319769|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319771|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319772|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319773|NCT00926055|Simvastatin|simvastatin|mesh-list
44319774|NCT00926055|Ezetimibe|ezetimibe|mesh-list
44319775|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44319776|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44319777|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44319778|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
44319779|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319780|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44319781|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44319782|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319783|NCT00926107|Sirolimus|sirolimus|mesh-list
44319784|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319785|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319808|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319809|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319810|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44319811|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44319812|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617332|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
44319813|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44319814|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44319815|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
44319816|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319817|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319818|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44319819|NCT00926354|Protective Agents|protective agents|mesh-ancestor
44319820|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44319821|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44319822|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319823|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319824|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
44319825|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467557|NCT01449006|Maraviroc|maraviroc|mesh-list
44467558|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44467559|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44467560|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467561|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44467562|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44467563|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
44467564|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467565|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44467566|NCT01448824|Ketoconazole|ketoconazole|mesh-list
44467567|NCT01448824|Evacetrapib|evacetrapib|mesh-list
44467568|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
44319826|NCT00926419|Vaccines|vaccines|mesh-list
44319827|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
44319828|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319829|NCT00926614|Pioglitazone|pioglitazone|mesh-list
44122185|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122186|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44319830|NCT00926614|Atorvastatin|atorvastatin|mesh-list
44319831|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44319832|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44319833|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
44319834|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319835|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44319836|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44319837|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319838|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44319839|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319840|NCT00926627|Bosentan|bosentan|mesh-list
44319841|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44319842|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44319843|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319844|NCT00926640|Cisplatin|cisplatin|mesh-list
44319845|NCT00926640|Etoposide|etoposide|mesh-list
44319846|NCT00926640|Belinostat|belinostat|mesh-list
44319847|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319848|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44319849|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44319850|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44319851|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319852|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319853|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44319854|NCT00926653|Citalopram|citalopram|mesh-list
44319855|NCT00926653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44319856|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44319857|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319858|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319859|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319860|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
44319861|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319862|NCT00926653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44319863|NCT00926653|Antidepressive Agents|antidepressive agents|mesh-ancestor
43733682|NCT04633148|Fludarabine|fludarabine|mesh-list
44122188|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319864|NCT00926653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44319865|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
44319866|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
44319867|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
44319868|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319869|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319870|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
44319871|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319872|NCT00926705|Fentanyl|fentanyl|mesh-list
44319873|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
44319874|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44319875|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319876|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319877|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44319878|NCT00926705|Analgesics|analgesics|mesh-ancestor
44319879|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
44319880|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319881|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44319882|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44319883|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44319884|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319885|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319886|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319887|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319888|NCT00926705|Narcotics|narcotics|mesh-ancestor
44319889|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44319890|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44319891|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
44319892|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
44319893|NCT00926718|Remifentanil|remifentanil|mesh-list
44319894|NCT00926718|Rocuronium|rocuronium|mesh-list
44319895|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44319896|NCT00926718|Narcotics|narcotics|mesh-ancestor
43733701|NCT04627753|Growth Substances|growth substances|mesh-ancestor
44122189|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44122190|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122191|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122192|NCT00126464|Tamoxifen|tamoxifen|mesh-list
44122193|NCT00126464|Fulvestrant|fulvestrant|mesh-list
44122194|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44122195|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
44122196|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44319897|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319898|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319899|NCT00926718|Analgesics|analgesics|mesh-ancestor
44319900|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
44319901|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319902|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44319903|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44319904|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44319905|NCT00926731|Cytarabine|cytarabine|mesh-list
44319906|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44319907|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
44319908|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319909|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44319910|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
44319911|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319912|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44319913|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
44319914|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319915|NCT00926757|Entecavir|entecavir|mesh-list
44319916|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
44319917|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319918|NCT00926809|Amoxicillin|amoxicillin|mesh-list
44319919|NCT00926809|Clarithromycin|clarithromycin|mesh-list
44319920|NCT00926809|Lansoprazole|lansoprazole|mesh-list
44319921|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
44319922|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44319923|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319924|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319925|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44319926|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319927|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319928|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44319941|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44319942|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44319943|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319944|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44319945|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
44319946|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44319947|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44319948|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
44319949|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44319950|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44319951|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44319952|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
44319953|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
44319954|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44319955|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44319956|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44319957|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
44319958|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44319959|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
44319960|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44319961|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44319962|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44319963|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44122197|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122198|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122199|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122200|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44122201|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44122202|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44122203|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44122204|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
44122205|NCT00126516|Giapreza|giapreza|mesh-list
44122206|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44122207|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
44122208|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44122209|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44122210|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122211|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44122212|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44122213|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
44122214|NCT00126542|Bevacizumab|bevacizumab|mesh-list
44122215|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44122216|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44122217|NCT00126542|Antibodies|antibodies|mesh-list
44122218|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
44122219|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44122220|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122221|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44319964|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44319965|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44319966|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
44319967|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44319968|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44319969|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44319970|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44319971|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44319972|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44319973|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44319974|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
43974999|NCT01799213|Analgesics|analgesics|mesh-ancestor
44319975|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44319976|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44319977|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44319978|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44319979|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
44319980|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
44319981|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44319982|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44319983|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44319984|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44319985|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
44319986|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44319987|NCT00926900|Cycloserine|cycloserine|mesh-list
44319988|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44319989|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44319990|NCT00926900|Renal Agents|renal agents|mesh-ancestor
44319991|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44319992|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
44319993|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44319994|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
44319995|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44319996|NCT00926926|Oxybutynin|oxybutynin|mesh-list
44319997|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
44319999|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320000|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320001|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44320002|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44320003|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
44320004|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320005|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320006|NCT00926926|Urological Agents|urological agents|mesh-ancestor
44320007|NCT00926965|Olanzapine|olanzapine|mesh-list
44320008|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
44320009|NCT00926965|Amisulpride|amisulpride|mesh-list
44320010|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
44320011|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
44320012|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320013|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320014|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320015|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320016|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320017|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320018|NCT00926965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44320019|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44320020|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320021|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320022|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320023|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
44320024|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44320025|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
44320026|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44320028|NCT00927004|Etoricoxib|etoricoxib|mesh-list
44320042|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
44320043|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320044|NCT00927030|Protective Agents|protective agents|mesh-ancestor
44320045|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320046|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320048|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320049|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320050|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44320051|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44320052|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
44320053|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320054|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320055|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44320056|NCT00927212|Protective Agents|protective agents|mesh-ancestor
44320057|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44320058|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44320059|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320060|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320061|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
44320062|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320063|NCT00927225|Ropivacaine|ropivacaine|mesh-list
44320064|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
44320065|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
44320066|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320067|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320068|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
43733794|NCT04012138|Insulin|insulin|mesh-list
44122222|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44122223|NCT00126542|Growth Substances|growth substances|mesh-ancestor
44122224|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122225|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
44122226|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
44122227|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44122228|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122229|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122230|NCT00126607|Trastuzumab|trastuzumab|mesh-list
44122231|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122232|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122233|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44122234|NCT00126620|Sorafenib|sorafenib|mesh-list
44122235|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122236|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44122237|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320070|NCT00927290|Pioglitazone|pioglitazone|mesh-list
44320071|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44320072|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320074|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44320075|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320076|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320077|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
44320078|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320079|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320080|NCT00927498|Cytarabine|cytarabine|mesh-list
44320081|NCT00927498|Daunorubicin|daunorubicin|mesh-list
44320082|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
44320083|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44320084|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320085|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44320086|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320087|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320088|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320089|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320090|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320091|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
44320092|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
44320093|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320094|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320095|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
44320096|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320097|NCT00927511|Fulvestrant|fulvestrant|mesh-list
44320098|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122238|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122239|NCT00126633|Gemcitabine|gemcitabine|mesh-list
44122240|NCT00126633|Bevacizumab|bevacizumab|mesh-list
44122241|NCT00126633|Cisplatin|cisplatin|mesh-list
44122242|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122249|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44122250|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
44122251|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122252|NCT00126633|Antiviral Agents|antiviral agents|mesh-ancestor
44122253|NCT00126633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122254|NCT00126633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122255|NCT00126633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122256|NCT00126633|Immunologic Factors|immunologic factors|mesh-ancestor
44122258|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
44122259|NCT00126646|Immunotoxins|immunotoxins|mesh-list
44122260|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
44320099|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320100|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44320101|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44320102|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
44320103|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320104|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320105|NCT00927524|Insulin|insulin|mesh-list
44320106|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44320107|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
44320108|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44320109|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320110|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44320111|NCT00927537|Telmisartan|telmisartan|mesh-list
44320112|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44320113|NCT00927537|Diuretics|diuretics|mesh-ancestor
44320114|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
44320115|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618216|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320116|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44320117|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320118|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320119|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44320120|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44320121|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
44320122|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
44320123|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320124|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320125|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320126|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
44320145|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44320146|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
44320147|NCT00927693|Calcium|calcium|mesh-list
44320148|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44320149|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320150|NCT00927732|Quinidine|quinidine|mesh-list
44320151|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
44320152|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44320153|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
44320154|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
44320155|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320156|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320157|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44320158|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44320159|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
44320160|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320161|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320162|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
44320163|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122261|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122262|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
44122263|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44122264|NCT00126698|Trimethoprim|trimethoprim|mesh-list
44122265|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
44122266|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122267|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122268|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44122269|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44122270|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122271|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122272|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122273|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44122274|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122275|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44122276|NCT00126698|Renal Agents|renal agents|mesh-ancestor
44122277|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
44122278|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122279|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122280|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44122281|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44122282|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44122283|NCT00126763|Fentanyl|fentanyl|mesh-list
44122284|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44122285|NCT00126763|Narcotics|narcotics|mesh-ancestor
44122286|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122287|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122288|NCT00126763|Analgesics|analgesics|mesh-ancestor
44122289|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
44122290|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122291|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44122292|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44122293|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
44122294|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
44122295|NCT00126789|Fentanyl|fentanyl|mesh-list
44320164|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44320165|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320166|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320167|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44320168|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44320169|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
44320170|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44320171|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44320172|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320173|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44320174|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44320175|NCT00927771|Azelaic acid|azelaic acid|mesh-list
44320176|NCT00927771|Hydroquinone|hydroquinone|mesh-list
44320177|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320178|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
44320179|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
44320180|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320181|NCT00927771|Protective Agents|protective agents|mesh-ancestor
44320182|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320183|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44320184|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
44320185|NCT00927797|Rituximab|rituximab|mesh-list
44320186|NCT00927797|Pentostatin|pentostatin|mesh-list
44320187|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320188|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
44320189|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320190|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320191|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44320192|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
44320193|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320194|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320195|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44320206|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44320207|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44320208|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320209|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320210|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320211|NCT00927966|Everolimus|everolimus|mesh-list
44320212|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320213|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320214|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
44320215|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320216|NCT00927979|Ropivacaine|ropivacaine|mesh-list
44320217|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
44320218|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
44320219|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320220|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320221|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
44320222|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320223|NCT00928148|Amphetamine|amphetamine|mesh-list
44320224|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44320225|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122296|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44122297|NCT00126789|Narcotics|narcotics|mesh-ancestor
44122298|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122299|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122300|NCT00126789|Analgesics|analgesics|mesh-ancestor
44122301|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
44122302|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122303|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44122304|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44122305|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
44122306|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
44122307|NCT00126880|Lamivudine|lamivudine|mesh-list
44122308|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44122309|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122310|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122311|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122319|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122320|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122321|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122322|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44122323|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122324|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122325|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44122326|NCT00126906|Renal Agents|renal agents|mesh-ancestor
44122328|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
44122329|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122330|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
43648934|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43648935|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44122331|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122332|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122333|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44122334|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122335|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122336|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
44320226|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
44320227|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
44320228|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320229|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
44320230|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320231|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320232|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44320233|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44320234|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44320235|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320236|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44320237|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
44320238|NCT00928161|Lansoprazole|lansoprazole|mesh-list
44320239|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44320240|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320241|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44320242|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320243|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320245|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44320246|NCT00928213|Tinzaparin|tinzaparin|mesh-list
44320247|NCT00928213|Dalteparin|dalteparin|mesh-list
44320248|NCT00928213|Progesterone|progesterone|mesh-list
44320249|NCT00928213|Hormones|hormones|mesh-ancestor
44320250|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320251|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320252|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
44320253|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44320254|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44320255|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320256|NCT00928213|Progestins|progestins|mesh-ancestor
44320257|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44467569|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467570|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44467571|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44467572|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975303|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
44320267|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
44320268|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320269|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44320270|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320271|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320272|NCT00928655|Acetazolamide|acetazolamide|mesh-list
44320273|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
44320274|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44320275|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320276|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320277|NCT00928655|Diuretics|diuretics|mesh-ancestor
44320278|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
44320279|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320280|NCT00928798|Sirolimus|sirolimus|mesh-list
44320281|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122337|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122338|NCT00127010|Vaccines|vaccines|mesh-list
44122339|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
44122340|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122341|NCT00127023|Vaccines|vaccines|mesh-list
44122342|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
44122343|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122344|NCT00127049|Gemcitabine|gemcitabine|mesh-list
44122345|NCT00127049|Cisplatin|cisplatin|mesh-list
44122346|NCT00127049|Ifosfamide|ifosfamide|mesh-list
44122347|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122348|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44122349|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
44122350|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122351|NCT00127049|Antiviral Agents|antiviral agents|mesh-ancestor
44122352|NCT00127049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122353|NCT00127049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122354|NCT00127049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122355|NCT00127049|Immunologic Factors|immunologic factors|mesh-ancestor
44122356|NCT00127049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122357|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44122358|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
44122359|NCT00127075|Estradiol|estradiol|mesh-list
44122360|NCT00127075|Estrogens|estrogens|mesh-ancestor
44122361|NCT00127075|Hormones|hormones|mesh-ancestor
44122362|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122363|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122364|NCT00127088|Docetaxel|docetaxel|mesh-list
44122365|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122366|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44122367|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44122368|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44122369|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122370|NCT00127114|Amantadine|amantadine|mesh-list
44122371|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44320282|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320283|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44320284|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320285|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
44320286|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320287|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
44320288|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320289|NCT00928811|Basiliximab|basiliximab|mesh-list
44320290|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320291|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
44320292|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320293|NCT00928837|Naproxen|naproxen|mesh-list
44320294|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320295|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122372|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44122373|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
44122374|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122375|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
44122376|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122377|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122378|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122379|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122380|NCT00127114|Analgesics|analgesics|mesh-ancestor
44122381|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
44122382|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122387|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122388|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44122389|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
44122390|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122392|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44122393|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
44122394|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
44122395|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
44122396|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122397|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122398|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122399|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44122400|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122401|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44122402|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44122403|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44122404|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44122405|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44122406|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44122407|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
44122408|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
44122409|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
44122410|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
44122411|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122412|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122413|NCT00127270|Darifenacin|darifenacin|mesh-list
44122414|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44122415|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44122416|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
44122417|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122418|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122419|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122420|NCT00127270|Urological Agents|urological agents|mesh-ancestor
44122421|NCT00127387|Etanercept|etanercept|mesh-list
44122422|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320298|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320299|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320300|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320301|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320302|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
44320303|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320304|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320305|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320306|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44320307|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320308|NCT00928915|Thrombin|thrombin|mesh-list
44320309|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
44320310|NCT00928915|Coagulants|coagulants|mesh-ancestor
44320311|NCT00928967|Interferons|interferons|mesh-list
44320312|NCT00928967|Interferon-beta|interferon-beta|mesh-list
44320313|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
44320314|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320315|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
44320316|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320317|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
44320318|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320319|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44320320|NCT00929045|Hormones|hormones|mesh-list
44320321|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122423|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122424|NCT00127387|Analgesics|analgesics|mesh-ancestor
44122425|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
44122426|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122427|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122428|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122429|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122430|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122431|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122432|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
44122433|NCT00127478|Atrasentan|atrasentan|mesh-list
44122434|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122435|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44122436|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44122437|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122439|NCT00127504|Rifampin|rifampin|mesh-list
44122440|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122441|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122442|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44122443|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
44122444|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
44122445|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122446|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320322|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320323|NCT00929058|Bevacizumab|bevacizumab|mesh-list
44320324|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320325|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320326|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320327|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320328|NCT00929058|Growth Substances|growth substances|mesh-ancestor
44320329|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320330|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320331|NCT00929279|Abciximab|abciximab|mesh-list
44320332|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
44320333|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44320334|NCT00929370|Glycine|glycine|mesh-list
44320335|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
44320336|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320337|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320338|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320339|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44320340|NCT00929591|Tamoxifen|tamoxifen|mesh-list
44320341|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
44320342|NCT00929591|Doxorubicin|doxorubicin|mesh-list
44320343|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44320344|NCT00929591|Fluorouracil|fluorouracil|mesh-list
44320345|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320346|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
44320347|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122447|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122448|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44122449|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44122450|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44122451|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44122452|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44122453|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44122458|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122459|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122460|NCT00127595|Gemcitabine|gemcitabine|mesh-list
44122461|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
44122462|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44122463|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
44122464|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122465|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122466|NCT00127595|Antiviral Agents|antiviral agents|mesh-ancestor
44122467|NCT00127595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122468|NCT00127595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122469|NCT00127595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122470|NCT00127595|Immunologic Factors|immunologic factors|mesh-ancestor
44122471|NCT00127595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122472|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
44122473|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
44320348|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320349|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44320350|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
44320351|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320352|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320353|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44320354|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44320355|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44320356|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320357|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320358|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
44320359|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320360|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44320361|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
44320362|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320363|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44320364|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44320365|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44320366|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44320367|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44320368|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
44320369|NCT00929630|Coagulants|coagulants|mesh-ancestor
44320370|NCT00929799|Hormones|hormones|mesh-list
44320371|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320372|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320373|NCT00929812|Glucagon|glucagon|mesh-list
44320374|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320375|NCT00929812|Hormones|hormones|mesh-ancestor
44320376|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320378|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
44320389|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320390|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320391|NCT00929877|Ketoprofen|ketoprofen|mesh-list
44320392|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320393|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320394|NCT00929877|Analgesics|analgesics|mesh-ancestor
44320395|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
44320396|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320397|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320398|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320399|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320400|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320401|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320402|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320403|NCT00929955|Ondansetron|ondansetron|mesh-list
44320404|NCT00929955|Simvastatin|simvastatin|mesh-list
44320405|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44320406|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44320407|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
44320408|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320409|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44320410|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44320411|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320412|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
44320413|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
44320414|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975401|NCT01817855|AZD7624|azd7624|mesh-list
44320415|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320416|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320417|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
44320418|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
44122474|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
44122475|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44122476|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44122477|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122478|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122479|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122480|NCT00127764|Dexamethasone|dexamethasone|mesh-list
44122481|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122482|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
44122483|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
44122484|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320419|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44320420|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
44320421|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320422|NCT00929955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44320423|NCT00929955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320424|NCT00929955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320425|NCT00929955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320426|NCT00929955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44320428|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44320429|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320430|NCT00930033|Sunitinib|sunitinib|mesh-list
44320431|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320432|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320433|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320434|NCT00930033|Growth Substances|growth substances|mesh-ancestor
44320435|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320436|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320437|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44320438|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320439|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320440|NCT00930072|Clonidine|clonidine|mesh-list
44320441|NCT00930072|Bupivacaine|bupivacaine|mesh-list
44320443|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
44320471|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320472|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
44320474|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320475|NCT00930202|Conivaptan|conivaptan|mesh-list
44320476|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44320477|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320478|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
44320479|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320480|NCT00930241|Tacrolimus|tacrolimus|mesh-list
44320481|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320482|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
44320483|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320484|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44320485|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320486|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320487|NCT00930306|Tolbutamide|tolbutamide|mesh-list
44320488|NCT00930306|Midazolam|midazolam|mesh-list
44320489|NCT00930306|Caffeine|caffeine|mesh-list
44122485|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122486|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122487|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
44122488|NCT00127764|Hormones|hormones|mesh-ancestor
44122489|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122490|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122491|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154699|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154700|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154701|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154702|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44154703|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154704|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154705|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44154706|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154707|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154708|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
44154709|NCT00224692|Ketamine|ketamine|mesh-list
44154710|NCT00224692|Analgesics|analgesics|mesh-ancestor
44154711|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
44154712|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154713|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154714|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44154715|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44154716|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
44154717|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
44122493|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44122494|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44122495|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
44122496|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122497|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
44122498|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122499|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122500|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122501|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122502|NCT00127777|Analgesics|analgesics|mesh-ancestor
44320492|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44320493|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320494|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320495|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44320496|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320497|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320498|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44320499|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
44320500|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
44320501|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
44320502|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
44320503|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320504|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320505|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44320506|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320507|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44320508|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320509|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44320510|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44320511|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44320512|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44320513|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
44320514|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44320515|NCT00930332|Methadone|methadone|mesh-list
44320516|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44320517|NCT00930332|Narcotics|narcotics|mesh-ancestor
44320518|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320519|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320520|NCT00930332|Analgesics|analgesics|mesh-ancestor
44320521|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
44320522|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320523|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
44320524|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
44320525|NCT00930345|Sunitinib|sunitinib|mesh-list
44320526|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320527|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320529|NCT00930345|Growth Substances|growth substances|mesh-ancestor
44320530|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320531|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320532|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44320533|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320534|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320535|NCT00930358|Anesthetics|anesthetics|mesh-list
44320536|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320537|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320538|NCT00930475|Carboplatin|carboplatin|mesh-list
44320539|NCT00930475|Everolimus|everolimus|mesh-list
44320540|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320541|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320542|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
44320543|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467573|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467574|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44467575|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467576|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467577|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467578|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44467579|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44467580|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44467581|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
44467582|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44467583|NCT01448707|Ritonavir|ritonavir|mesh-list
44467584|NCT01448707|Darunavir|darunavir|mesh-list
44122503|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
44122504|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122505|NCT00127829|Gefitinib|gefitinib|mesh-list
44122506|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122515|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
44122516|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122517|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44122518|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122519|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122520|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122522|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
44122523|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122524|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122525|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44122526|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
44122527|NCT00127868|Protective Agents|protective agents|mesh-ancestor
44122528|NCT00127868|Trace Elements|trace elements|mesh-ancestor
44122529|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
44467585|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44467586|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44467587|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44467588|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467589|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467590|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44467591|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44467592|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
44467593|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320544|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
44320545|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44320546|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44320547|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320548|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44320549|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320550|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320551|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320552|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320553|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44320554|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
44320555|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44320556|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320557|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44320558|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44320559|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44320560|NCT00930514|Rituximab|rituximab|mesh-list
44320561|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320562|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320563|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
44320564|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320565|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320566|NCT00930566|Methoxsalen|methoxsalen|mesh-list
44320567|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44320568|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
44320569|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
44320574|NCT00930670|Pantoprazole|pantoprazole|mesh-list
44320575|NCT00930670|Ranitidine|ranitidine|mesh-list
44320576|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44320577|NCT00930670|Atorvastatin|atorvastatin|mesh-list
44320578|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44320579|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44320580|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44320581|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
44320582|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320583|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44320584|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44320585|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320586|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44320587|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320588|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44320589|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44320590|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
44320591|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
44320592|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320593|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320594|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44320595|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
44320596|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122530|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44122531|NCT00127881|Zanolimumab|zanolimumab|mesh-list
44122532|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122533|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122534|NCT00127907|Vasopressins|vasopressins|mesh-list
44122535|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
44122536|NCT00127907|Epinephrine|epinephrine|mesh-list
44122537|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44122538|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44122539|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
44122540|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122541|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122542|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122543|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44122544|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44122545|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
44122546|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122547|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44122548|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
44122549|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
44122550|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
44122551|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44122552|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
44122553|NCT00127907|Coagulants|coagulants|mesh-ancestor
44122554|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44122555|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
44122556|NCT00127920|Bevacizumab|bevacizumab|mesh-list
44122557|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320597|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
44320598|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44320599|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44320600|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44320601|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320602|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320603|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
44320604|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320605|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320606|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44320607|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320608|NCT00930839|Aspirin|aspirin|mesh-list
44320610|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
44320611|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320612|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320613|NCT00930839|Analgesics|analgesics|mesh-ancestor
44320614|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
44122558|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122559|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44122560|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44122561|NCT00127920|Growth Substances|growth substances|mesh-ancestor
44122562|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122563|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44122564|NCT00127959|Tenofovir|tenofovir|mesh-list
44122565|NCT00127959|Zidovudine|zidovudine|mesh-list
44122566|NCT00127959|Emtricitabine|emtricitabine|mesh-list
44122567|NCT00127959|Efavirenz|efavirenz|mesh-list
44122568|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
44122569|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122570|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44122571|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122572|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122573|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122574|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44122575|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44122576|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
44122578|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122579|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44122580|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44122581|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44122582|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44122583|NCT00127972|Lamivudine|lamivudine|mesh-list
44122584|NCT00127972|Efavirenz|efavirenz|mesh-list
44122585|NCT00127972|Nevirapine|nevirapine|mesh-list
44122586|NCT00127972|Stavudine|stavudine|mesh-list
44122587|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44122588|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122589|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122590|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122591|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
44122592|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122593|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44122594|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44122595|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44122596|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122597|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44122598|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44320615|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320616|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320617|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320618|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320619|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44320620|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44320621|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320622|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44320623|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320624|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320625|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
44320626|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44320627|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
44320628|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44320629|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
44320630|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
44320631|NCT00930839|Vitamins|vitamins|mesh-ancestor
44320632|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
44320633|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
44320634|NCT00930865|Bumetanide|bumetanide|mesh-list
44320635|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44320636|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320637|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44320638|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320639|NCT00930865|Diuretics|diuretics|mesh-ancestor
44320640|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
44320641|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44320642|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320643|NCT00930891|Bevacizumab|bevacizumab|mesh-list
44320644|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44320645|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320646|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320647|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43619631|NCT03121339|Vaccines|vaccines|mesh-list
44320648|NCT00930891|Growth Substances|growth substances|mesh-ancestor
43734163|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122599|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44122600|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44122601|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
44320649|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320650|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320651|NCT00930943|Oxymorphone|oxymorphone|mesh-list
44320652|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44320653|NCT00930943|Narcotics|narcotics|mesh-ancestor
44320654|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320655|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320656|NCT00930943|Analgesics|analgesics|mesh-ancestor
44320657|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
44320658|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320659|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44320660|NCT00930995|Candesartan|candesartan|mesh-list
44320661|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44320662|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44320663|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44320664|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320665|NCT00931008|Docetaxel|docetaxel|mesh-list
44320666|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320667|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44320668|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44122602|NCT00127985|Prednisolone|prednisolone|mesh-list
44122603|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44122604|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
44122605|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44122606|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
44122607|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44122608|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
44122609|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122610|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
44122611|NCT00127985|Hormones|hormones|mesh-ancestor
44122612|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122613|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122614|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122615|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122616|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
44122617|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
44122618|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122619|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122620|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44122621|NCT00127985|Protective Agents|protective agents|mesh-ancestor
44122622|NCT00127998|Artesunate|artesunate|mesh-list
44122623|NCT00127998|Chloroquine|chloroquine|mesh-list
44122624|NCT00127998|Lumefantrine|lumefantrine|mesh-list
44122625|NCT00127998|Artemether|artemether|mesh-list
44122626|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
44122627|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
44122628|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44122629|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44122630|NCT00127998|Amodiaquine|amodiaquine|mesh-list
44122631|NCT00127998|Mefloquine|mefloquine|mesh-list
44122632|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
44122633|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122634|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122635|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122636|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122637|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
44122638|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
44320670|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320672|NCT00931021|Varenicline|varenicline|mesh-list
44320673|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44320674|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
44320675|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320676|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320677|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44320678|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44320679|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
44320680|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320681|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320682|NCT00931073|Ketoconazole|ketoconazole|mesh-list
44320683|NCT00931073|Omeprazole|omeprazole|mesh-list
44320684|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44320685|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320686|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44320687|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320688|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320689|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
44320690|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122639|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44122640|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
44122641|NCT00127998|Amebicides|amebicides|mesh-ancestor
44122642|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122643|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44122644|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122645|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122646|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44122648|NCT00128037|Cisplatin|cisplatin|mesh-list
44122649|NCT00128037|Mitomycins|mitomycins|mesh-list
44122650|NCT00128037|Mitomycin|mitomycin|mesh-list
44122651|NCT00128037|Vindesine|vindesine|mesh-list
44122652|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122657|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122658|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44122659|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44122660|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44122661|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44122662|NCT00128154|Chromium|chromium|mesh-list
44122663|NCT00128154|Picolinic acid|picolinic acid|mesh-list
44122664|NCT00128154|Trace Elements|trace elements|mesh-ancestor
44122665|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
44122666|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122667|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44122668|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
44122669|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
44122670|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122671|NCT00128232|Octreotide|octreotide|mesh-list
44122672|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122673|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122674|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320691|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44320692|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44320694|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
44320695|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320696|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320697|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44320698|NCT00931086|Belimumab|belimumab|mesh-list
44320699|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320700|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
44320701|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320702|NCT00931125|Ranibizumab|ranibizumab|mesh-list
44320703|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320704|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320705|NCT00931125|Growth Substances|growth substances|mesh-ancestor
44320706|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320707|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320708|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320709|NCT00931138|Cytarabine|cytarabine|mesh-list
44320710|NCT00931138|Daunorubicin|daunorubicin|mesh-list
44320711|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44320712|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320713|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44320714|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44320715|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320716|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320717|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320718|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
44320719|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
44320720|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320733|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44320734|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44320735|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320736|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320737|NCT00931229|Entecavir|entecavir|mesh-list
44320738|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
44320739|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320740|NCT00931281|Ritonavir|ritonavir|mesh-list
44320741|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44320742|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44320743|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44320744|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320745|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320746|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44320747|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44320748|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
44320749|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44320750|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44320751|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44320752|NCT00931372|Lixisenatide|lixisenatide|mesh-list
44320753|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44320754|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320755|NCT00931398|Methylphenidate|methylphenidate|mesh-list
44320756|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44320757|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320758|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44320759|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44320760|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320761|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122676|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44122677|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122678|NCT00128245|Analgesics|analgesics|mesh-ancestor
44122679|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
44122680|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122681|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122682|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122683|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122684|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
44122685|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122686|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
44122687|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44122688|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320762|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
44320763|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320764|NCT00931437|Vitamin K|vitamin k|mesh-list
44320765|NCT00931437|Vitamins|vitamins|mesh-ancestor
44320766|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
44320767|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320768|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44320769|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43734280|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122689|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122690|NCT00128271|Bavituximab|bavituximab|mesh-list
44122691|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122692|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122693|NCT05562518|Estrogens|estrogens|mesh-list
44122694|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44122695|NCT05562518|Hormones|hormones|mesh-ancestor
44122696|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122697|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122698|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44122699|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
44122700|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
44122701|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44122702|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
44122703|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122704|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
44122705|NCT05561972|Protective Agents|protective agents|mesh-ancestor
44122706|NCT05561751|Propranolol|propranolol|mesh-list
44122707|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44122708|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44122709|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44122710|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122711|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122712|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122713|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44122714|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44122715|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
44122716|NCT05561725|Dexamethasone|dexamethasone|mesh-list
44122717|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122718|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
44122719|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
44122720|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122721|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122722|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122723|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
44122724|NCT05561725|Hormones|hormones|mesh-ancestor
44122728|NCT05561543|Peppermint oil|peppermint oil|mesh-list
44122729|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
44122730|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
44122731|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122732|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122733|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122734|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
44122735|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
44122736|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
44122737|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
44122738|NCT05561049|Thalidomide|thalidomide|mesh-list
44122739|NCT05561049|Dexamethasone|dexamethasone|mesh-list
44122740|NCT05561049|Bortezomib|bortezomib|mesh-list
44122741|NCT05561049|Daratumumab|daratumumab|mesh-list
44122742|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122743|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
44122744|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
44122745|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122746|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122747|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122749|NCT05561049|Hormones|hormones|mesh-ancestor
44122750|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122751|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122752|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320770|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320772|NCT00931437|Coagulants|coagulants|mesh-ancestor
44320773|NCT00931450|Sunitinib|sunitinib|mesh-list
44320774|NCT00931450|Exemestane|exemestane|mesh-list
44320775|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320776|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44320777|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44320778|NCT00931450|Growth Substances|growth substances|mesh-ancestor
44320779|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320780|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44320781|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44320782|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320783|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320784|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44320785|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44320786|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44320787|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
44320788|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320789|NCT00931580|Vitamin D|vitamin d|mesh-list
44320790|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
44320791|NCT00931580|Vitamins|vitamins|mesh-ancestor
44320792|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
44320793|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320794|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44320795|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44320796|NCT00931645|Cytarabine|cytarabine|mesh-list
44122753|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44122754|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
44122755|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
44122756|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122757|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122758|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44122759|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44122760|NCT05561049|Growth Substances|growth substances|mesh-ancestor
44122761|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44122762|NCT05561036|Doxorubicin|doxorubicin|mesh-list
44122763|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44122764|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122765|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44122766|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44122767|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122768|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122769|NCT05561010|Bupivacaine|bupivacaine|mesh-list
44122770|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619999|NCT05463601|Tamoxifen|tamoxifen|mesh-list
44122771|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
44122772|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320798|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
44320799|NCT00931645|Cisplatin|cisplatin|mesh-list
44320800|NCT00931645|Fludarabine|fludarabine|mesh-list
44320801|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320802|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
44320803|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320804|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320805|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44320806|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
44320807|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320808|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320809|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44320810|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320811|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
44320812|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
44320813|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320814|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320815|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
44320816|NCT00931645|Hormones|hormones|mesh-ancestor
44320817|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320818|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44320819|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320820|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
44320847|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44320848|NCT00931775|Pindolol|pindolol|mesh-list
44320849|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44320850|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44320851|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44320852|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320853|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320854|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320855|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44320856|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44320857|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
44320858|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
44320859|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
44320860|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
44320861|NCT00931827|Etonogestrel|etonogestrel|mesh-list
44320862|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44320863|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
44320864|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44320865|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320866|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44320867|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44320868|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44320869|NCT00931840|Irinotecan|irinotecan|mesh-list
44320870|NCT00931840|Cetuximab|cetuximab|mesh-list
44320871|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44320896|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44320897|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
44320898|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320899|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44320900|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
44320901|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320902|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44320903|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44320904|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
44320905|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44320906|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44320907|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44320908|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
44320909|NCT00931957|Hormones|hormones|mesh-ancestor
44320910|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44320911|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44320912|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320913|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320914|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44320915|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320916|NCT00931957|Analgesics|analgesics|mesh-ancestor
44320917|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
44320918|NCT00932048|Atorvastatin|atorvastatin|mesh-list
44320919|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44320920|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44320921|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
44320922|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320923|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44320924|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44320925|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44320926|NCT00932100|Heparin|heparin|mesh-list
44320927|NCT00932100|Calcium heparin|calcium heparin|mesh-list
44122773|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122774|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
44122775|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122776|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44122777|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44122778|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44122779|NCT05560919|Protective Agents|protective agents|mesh-ancestor
44122780|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320928|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44320929|NCT00932100|Tinzaparin|tinzaparin|mesh-list
44320930|NCT00932100|Dalteparin|dalteparin|mesh-list
44320931|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
44320932|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44320933|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44320934|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320935|NCT00932217|Lenograstim|lenograstim|mesh-list
44320936|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44320937|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
44320938|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320939|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
44320940|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44320941|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320942|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320943|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44320944|NCT00932386|Analgesics|analgesics|mesh-ancestor
44320945|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
44320946|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320947|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44320948|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44320949|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44320950|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44320951|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44320952|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467594|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44467595|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44467596|NCT01448616|Tenofovir|tenofovir|mesh-list
44467614|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
44467615|NCT01448213|Hormones|hormones|mesh-ancestor
44467616|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467617|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467618|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467619|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467620|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
44467621|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
44467622|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467623|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467624|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44467625|NCT01448213|Protective Agents|protective agents|mesh-ancestor
44467626|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467627|NCT01448057|Acetaminophen|acetaminophen|mesh-list
44467628|NCT01448057|Dimethindene|dimethindene|mesh-list
44467629|NCT01448057|Phenylephrine|phenylephrine|mesh-list
44467630|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
44467631|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44467632|NCT01448057|Analgesics|analgesics|mesh-ancestor
43975961|NCT01840345|Expectorants|expectorants|mesh-ancestor
44320953|NCT00932529|Olanzapine|olanzapine|mesh-list
44320954|NCT00932529|Risperidone|risperidone|mesh-list
44320955|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44320956|NCT00932529|Ziprasidone|ziprasidone|mesh-list
44320957|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44320958|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
44320959|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122781|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44122782|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
44122783|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122784|NCT05560919|Vitamins|vitamins|mesh-ancestor
44122785|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
44122786|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44154718|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154719|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44154720|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44154721|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154722|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154723|NCT00224809|Aspirin|aspirin|mesh-list
44154724|NCT00224809|Spironolactone|spironolactone|mesh-list
44154725|NCT00224809|Clopidogrel|clopidogrel|mesh-list
44154726|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44122787|NCT05556356|Acetaminophen|acetaminophen|mesh-list
44122788|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122795|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44122796|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122797|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122798|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122799|NCT05553392|Petrolatum|petrolatum|mesh-list
44122800|NCT05553392|Emollients|emollients|mesh-ancestor
44122801|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
44122802|NCT05552144|Listerine|listerine|mesh-list
44320960|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320961|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320962|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44320963|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320964|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320965|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320966|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44320967|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
44320968|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
44320969|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
44320970|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320971|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44320972|NCT00932529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44320973|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44320974|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320975|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
44320976|NCT00932542|Lidocaine|lidocaine|mesh-list
44122803|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
44122804|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
44122805|NCT05552144|Protective Agents|protective agents|mesh-ancestor
44122806|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122807|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44122808|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122809|NCT05549895|Dexamethasone|dexamethasone|mesh-list
44122810|NCT05549895|Bupivacaine|bupivacaine|mesh-list
44122811|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122812|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
44122813|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
44122814|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122815|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122816|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122817|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
44122818|NCT05549895|Hormones|hormones|mesh-ancestor
44122819|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122820|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122821|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122822|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
44122823|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
44122824|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122825|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
44122826|NCT05544110|Paroxetine|paroxetine|mesh-list
44122827|NCT05544110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44122828|NCT05544110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44122829|NCT05544110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44122830|NCT05544110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122831|NCT05544110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122832|NCT05544110|Serotonin Agents|serotonin agents|mesh-ancestor
44122833|NCT05544110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122834|NCT05544110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44122835|NCT05544110|Antidepressive Agents|antidepressive agents|mesh-ancestor
44122836|NCT05544110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44122837|NCT05544110|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44122838|NCT05544110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44122839|NCT05544110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122840|NCT05543109|Fentanyl|fentanyl|mesh-list
44122841|NCT05543109|Narcotics|narcotics|mesh-list
44122842|NCT05543109|Propofol|propofol|mesh-list
44320977|NCT00932542|Prilocaine|prilocaine|mesh-list
44320978|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44320979|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
44320980|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320981|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320982|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
44320983|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44320984|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44320985|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44320986|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44320987|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44320988|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44320989|NCT00932555|Factor VIII|factor viii|mesh-list
44320990|NCT00932555|Coagulants|coagulants|mesh-ancestor
44320991|NCT00932685|Midazolam|midazolam|mesh-list
44320992|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44320993|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44320994|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44320995|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44320996|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44320997|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44320998|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44320999|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44321000|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
44321001|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
44321002|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
44321003|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
44321004|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321005|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321006|NCT00932763|Amlodipine|amlodipine|mesh-list
44321007|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44321008|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44321009|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321010|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321016|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321017|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321018|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44321019|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44321020|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321021|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321022|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321023|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44321024|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
44321025|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44321026|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321027|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44321028|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44321029|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44321030|NCT00932867|Telmisartan|telmisartan|mesh-list
44321031|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44321032|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44321033|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44321034|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321035|NCT00932880|Amlodipine|amlodipine|mesh-list
44321036|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44321037|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44321038|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321039|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321040|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44321041|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321042|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
44321043|NCT00932971|Tenofovir|tenofovir|mesh-list
44321058|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321059|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
44321060|NCT00933023|Betamethasone|betamethasone|mesh-list
44321061|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321062|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
44321064|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321065|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321066|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44321067|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321068|NCT00933049|Amoxicillin|amoxicillin|mesh-list
44321069|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44321070|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321071|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122843|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44122844|NCT05543109|Ropivacaine|ropivacaine|mesh-list
44122845|NCT05543109|Anesthetics|anesthetics|mesh-list
44122846|NCT05543109|Sevoflurane|sevoflurane|mesh-list
44122847|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
44122848|NCT05543109|Rocuronium|rocuronium|mesh-list
44122849|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44122850|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122851|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122852|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
44122853|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
44122854|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122855|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44122856|NCT05543109|Analgesics|analgesics|mesh-ancestor
44122857|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44122858|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44122859|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44122877|NCT05516628|Atezolizumab|atezolizumab|mesh-list
44122878|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122879|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122880|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44122881|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44122882|NCT05516628|Growth Substances|growth substances|mesh-ancestor
44122883|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122884|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
44122885|NCT05497336|Cetuximab|cetuximab|mesh-list
44122886|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122887|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122888|NCT05473520|Doxycycline|doxycycline|mesh-list
44122889|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122890|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122892|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44122893|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44122894|NCT05417425|Lidocaine|lidocaine|mesh-list
44122895|NCT05417425|Protective Agents|protective agents|mesh-list
44122896|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
44122897|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
44122898|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122899|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122900|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
44122901|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122902|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44122903|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44122904|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44122905|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44122906|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122907|NCT05413161|Omalizumab|omalizumab|mesh-list
44321073|NCT00933049|Renal Agents|renal agents|mesh-ancestor
44321074|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
44321075|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44321076|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44321077|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
44321078|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44321079|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44321080|NCT00933179|Gestodene|gestodene|mesh-list
44321081|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44321082|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
44321083|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44321084|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321085|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44321086|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44321087|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44321088|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43650461|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321089|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43734538|NCT02538926|Etoposide|etoposide|mesh-list
44122908|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44122909|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44122910|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44122911|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44122912|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
44122913|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122914|NCT05393817|Caffeine|caffeine|mesh-list
44122915|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
44122916|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122917|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44122918|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122919|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44122923|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
44122924|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44122926|NCT05361824|Ketorolac|ketorolac|mesh-list
44122927|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44122928|NCT05361824|Analgesics|analgesics|mesh-ancestor
44122929|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
44122930|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122931|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122932|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
44122933|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44122934|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122935|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122936|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44122937|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122938|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122939|NCT05323435|Vaccines|vaccines|mesh-list
44122940|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
44122941|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122942|NCT05305885|Pemetrexed|pemetrexed|mesh-list
44122943|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122944|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122945|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122946|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44321090|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44321091|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44321092|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44321093|NCT00933179|Progestins|progestins|mesh-ancestor
44321094|NCT00933179|Hormones|hormones|mesh-ancestor
44321095|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321096|NCT00933205|Tipranavir|tipranavir|mesh-list
44321097|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321098|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44321099|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
44321100|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321101|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
44321102|NCT00933231|Prednisone|prednisone|mesh-list
44321103|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
44321104|NCT00933231|Ramipril|ramipril|mesh-list
44321105|NCT00933231|Irbesartan|irbesartan|mesh-list
44321106|NCT00933231|Tacrolimus|tacrolimus|mesh-list
44321107|NCT00933231|Basiliximab|basiliximab|mesh-list
44321108|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122947|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122948|NCT05289908|Folic Acid|folic acid|mesh-list
44122949|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
44122950|NCT05289908|Hydroxocobalamin|hydroxocobalamin|mesh-list
44122951|NCT05289908|Dexamethasone|dexamethasone|mesh-list
44122952|NCT05289908|Pemetrexed|pemetrexed|mesh-list
44122953|NCT05289908|Vitamins|vitamins|mesh-ancestor
44122954|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
44122955|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122956|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122957|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
44122958|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
44122959|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122960|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122961|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
44122962|NCT05289908|Hormones|hormones|mesh-ancestor
44122963|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122964|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43567208|NCT00765804|Hormones|hormones|mesh-ancestor
44122965|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122966|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122967|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122968|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44122969|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122970|NCT05289908|Hematinics|hematinics|mesh-ancestor
44122971|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
44122972|NCT05285813|Acetaminophen|acetaminophen|mesh-list
44122973|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
44122974|NCT05285813|Promethazine|promethazine|mesh-list
44122975|NCT05285813|Dexamethasone|dexamethasone|mesh-list
44122976|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44122977|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
44122978|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
44122979|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122980|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122981|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44122982|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
44122983|NCT05285813|Hormones|hormones|mesh-ancestor
44122984|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122985|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122986|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122987|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321109|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
44321110|NCT00933231|Hormones|hormones|mesh-ancestor
44321111|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321112|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321113|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321114|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321115|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321116|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
44321117|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44321118|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321119|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321120|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
44321121|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
44321122|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321123|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321124|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44321125|NCT00933231|Protective Agents|protective agents|mesh-ancestor
44321126|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44321127|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44321128|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
44321129|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321130|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321131|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44321132|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321133|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44321134|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44321156|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44321157|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321158|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321159|NCT00933374|Paclitaxel|paclitaxel|mesh-list
44321160|NCT00933374|Everolimus|everolimus|mesh-list
44321161|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321162|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321163|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321164|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321165|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321166|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321167|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321168|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
44321169|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321170|NCT00933387|Paclitaxel|paclitaxel|mesh-list
44321171|NCT00933387|Cisplatin|cisplatin|mesh-list
44321172|NCT00933387|Cetuximab|cetuximab|mesh-list
44321173|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321174|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321175|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321176|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321177|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321178|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321179|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44321181|NCT00933426|Lenalidomide|lenalidomide|mesh-list
44321182|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321183|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321184|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321185|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321186|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321187|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321188|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
44321189|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321192|NCT00933426|Growth Substances|growth substances|mesh-ancestor
44321196|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44321197|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321198|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321199|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321200|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321202|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
44321203|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321204|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
44321205|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321206|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
44321207|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44321208|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44321209|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44321210|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321211|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321212|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321213|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321214|NCT00933452|Analgesics|analgesics|mesh-ancestor
44321215|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
44321216|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321217|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
44321218|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44122988|NCT05285813|Analgesics|analgesics|mesh-ancestor
44122989|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
44122990|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
44122991|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44123005|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44123006|NCT05284552|Dalteparin|dalteparin|mesh-list
44123007|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
44123008|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44123009|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44123010|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123017|NCT05234112|Acetic Acid|acetic acid|mesh-list
44123018|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44123019|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123020|NCT05232084|Fentanyl|fentanyl|mesh-list
44123021|NCT05232084|Bupivacaine|bupivacaine|mesh-list
44123022|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
44123023|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
44123024|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123025|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123026|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
44123027|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123028|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44123029|NCT05232084|Narcotics|narcotics|mesh-ancestor
44123030|NCT05232084|Analgesics|analgesics|mesh-ancestor
44123031|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44123032|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44321219|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
44321220|NCT00933465|Loperamide|loperamide|mesh-list
44321221|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
44321222|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321223|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
44321224|NCT00933517|Docetaxel|docetaxel|mesh-list
44321225|NCT00933517|Panitumumab|panitumumab|mesh-list
44321226|NCT00933517|Epirubicin|epirubicin|mesh-list
44321227|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321228|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
44321229|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321230|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321231|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44321232|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
44321233|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321234|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321235|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44321236|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321237|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321238|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321239|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44321240|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44321241|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44321242|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44321243|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321244|NCT00933582|Naproxen|naproxen|mesh-list
44321245|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44321246|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321247|NCT00933582|Analgesics|analgesics|mesh-ancestor
44321248|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
44321249|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321250|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321251|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321252|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321253|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
44321254|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44321255|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321257|NCT00933634|Propafenone|propafenone|mesh-list
44321258|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44321259|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44321260|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44321261|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321262|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321263|NCT00933777|Everolimus|everolimus|mesh-list
44321264|NCT00933777|Sorafenib|sorafenib|mesh-list
44321265|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321266|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321267|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
44321268|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321269|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44321270|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321271|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321272|NCT00933790|Rifampin|rifampin|mesh-list
44321273|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
44321274|NCT00933790|Ethambutol|ethambutol|mesh-list
44321275|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44321276|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
44321277|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321278|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321279|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
44321280|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44321307|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
44321308|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321309|NCT00933894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44321310|NCT00933894|Antidepressive Agents|antidepressive agents|mesh-ancestor
44321311|NCT00933894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321312|NCT00933985|Doxorubicin|doxorubicin|mesh-list
44321313|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44321314|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
44321315|NCT00933985|Vincristine|vincristine|mesh-list
44321316|NCT00933985|Razoxane|razoxane|mesh-list
44321317|NCT00933985|Obatoclax|obatoclax|mesh-list
44321318|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44321319|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321320|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44321321|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44321322|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321323|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321324|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321325|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321326|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321327|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321328|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44321329|NCT00933985|Protective Agents|protective agents|mesh-ancestor
44321330|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321331|NCT00933998|Pyridoxal|pyridoxal|mesh-list
44321332|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
44321333|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44321334|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
44321335|NCT00933998|Vitamins|vitamins|mesh-ancestor
44467646|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44467647|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44467648|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
44467649|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467650|NCT01448057|Protective Agents|protective agents|mesh-ancestor
44467651|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
44467652|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467653|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44467654|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
44467655|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
44467656|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467657|NCT01448044|Interferons|interferons|mesh-list
44467658|NCT01448044|Ribavirin|ribavirin|mesh-list
44467659|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
44467660|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
44467661|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44467662|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467663|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
44467664|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467665|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
44467666|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467667|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
44467668|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467669|NCT01447927|Metformin|metformin|mesh-list
44467670|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44467671|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123033|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
44123034|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
44123035|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44123036|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44123037|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44123038|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123039|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123040|NCT05201144|Urological Agents|urological agents|mesh-ancestor
44123041|NCT05161468|Triamcinolone|triamcinolone|mesh-list
44123042|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44123043|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44123044|NCT05161468|Lidocaine|lidocaine|mesh-list
44123045|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
44123046|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
44123047|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44123048|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
44123049|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
44123050|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123051|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123052|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
44123053|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123054|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44123055|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44123056|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44123057|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467672|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
44467673|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44467674|NCT01447446|Ribavirin|ribavirin|mesh-list
44467675|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
44467676|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
44467677|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44467678|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44467679|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44467680|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
44467681|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467682|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
44467683|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467684|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
44467685|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467686|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467687|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
44467688|NCT01447433|Calcium|calcium|mesh-list
44467689|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44467690|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467691|NCT01447433|Antacids|antacids|mesh-ancestor
44467692|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321342|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44321343|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321344|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44321345|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321346|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321347|NCT00934154|Thalidomide|thalidomide|mesh-list
44321348|NCT00934154|Prednisolone|prednisolone|mesh-list
44321349|NCT00934154|Melphalan|melphalan|mesh-list
44321350|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44321351|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
44321352|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123058|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123059|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
44123060|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123061|NCT05161468|Hormones|hormones|mesh-ancestor
44123064|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
44123065|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123066|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44123068|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44123069|NCT05084989|Vaccines|vaccines|mesh-list
44123070|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
44123071|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321353|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321354|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44321355|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321356|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
44154727|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44154728|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44154729|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154730|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154731|NCT00224809|Analgesics|analgesics|mesh-ancestor
44154732|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
44154733|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154734|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154735|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154736|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154737|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44154738|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154739|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154740|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44154741|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154742|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
44154743|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44154744|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44154745|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44123072|NCT05070260|Glenzocimab|glenzocimab|mesh-list
44123073|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
44123074|NCT05055128|Lansoprazole|lansoprazole|mesh-list
44123075|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
44123076|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44123077|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123078|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44123079|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123080|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123081|NCT05049057|Erenumab|erenumab|mesh-list
44123082|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44123083|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123084|NCT05049057|Analgesics|analgesics|mesh-ancestor
44123085|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
44123086|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123087|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123088|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44123089|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44123090|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123091|NCT05001828|Azacitidine|azacitidine|mesh-list
44123092|NCT05001828|Venetoclax|venetoclax|mesh-list
44123093|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123094|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
44123095|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123096|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123098|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44123099|NCT04995263|Caffeine|caffeine|mesh-list
44123100|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44123101|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123102|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44123103|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123104|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123105|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44123106|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44123107|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
44123108|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123109|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123110|NCT04955366|Abatacept|abatacept|mesh-list
44123111|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44123112|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123136|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44123137|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123139|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
44123140|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321357|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321358|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321359|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
44321360|NCT00934154|Hormones|hormones|mesh-ancestor
44321361|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321362|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321363|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
44321364|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321365|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321366|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44321367|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44321368|NCT00934154|Growth Substances|growth substances|mesh-ancestor
44321369|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44321370|NCT00934167|Heparin|heparin|mesh-list
44321371|NCT00934167|Calcium heparin|calcium heparin|mesh-list
43734712|NCT02537860|Fentanyl|fentanyl|mesh-list
44123141|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44123142|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44123143|NCT04635683|Growth Substances|growth substances|mesh-ancestor
44123144|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
44123145|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123146|NCT04621149|Lactoferrin|lactoferrin|mesh-list
44123147|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
44123148|NCT04621149|Famotidine|famotidine|mesh-list
44123149|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44123150|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123151|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44123152|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
44123153|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
44123154|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123155|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123156|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123157|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123158|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
44123159|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
44123160|NCT04587830|Temozolomide|temozolomide|mesh-list
44123161|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44123162|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
44123167|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
44123168|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123169|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44123170|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44123172|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
44123173|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123174|NCT04539236|Hematinics|hematinics|mesh-ancestor
44123175|NCT04484363|Azacitidine|azacitidine|mesh-list
44123176|NCT04484363|Pevonedistat|pevonedistat|mesh-list
44123177|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123178|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
44123179|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123180|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123181|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123182|NCT04457557|Ropivacaine|ropivacaine|mesh-list
44123183|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
44123184|NCT04457557|Anesthetics|anesthetics|mesh-list
44123185|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123186|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123187|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
44123188|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123189|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
44321372|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
44321373|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44321374|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44321375|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321376|NCT00934193|Gabapentin|gabapentin|mesh-list
44321377|NCT00934193|Analgesics|analgesics|mesh-ancestor
44321378|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
44321379|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321380|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321381|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
44321382|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44321383|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44321384|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44321385|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321386|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44321387|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44321388|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321389|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321390|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
44321391|NCT00934232|Busulfan|busulfan|mesh-list
44321392|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
44123190|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
44123191|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
44123192|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123193|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123194|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
44123195|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123196|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44123197|NCT04409873|Listerine|listerine|mesh-list
44123198|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
44123199|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
44123200|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44123201|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123202|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
44123203|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
44123204|NCT04396730|Cannabidiol|cannabidiol|mesh-list
44123205|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
44123206|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
44123207|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44123208|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44123209|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123210|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
44123211|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44154746|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
44154747|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154748|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44154749|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44154750|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154751|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44154752|NCT00224809|Diuretics|diuretics|mesh-ancestor
44154753|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
44154754|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
44154755|NCT00224822|Aripiprazole|aripiprazole|mesh-list
44123212|NCT04352166|Buprenorphine|buprenorphine|mesh-list
44321393|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321394|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321396|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321397|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44321398|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321399|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44321400|NCT00934245|Vaccines|vaccines|mesh-list
44321401|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
44321402|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321403|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44321404|NCT00934258|Fenofibrate|fenofibrate|mesh-list
44321405|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44321406|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44321407|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
44321408|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321409|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44321410|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44321411|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321412|NCT00934323|Metformin|metformin|mesh-list
44321413|NCT00934323|Glimepiride|glimepiride|mesh-list
44321414|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321415|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321416|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44321417|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321418|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
44321419|NCT00934414|Insulin|insulin|mesh-list
44321420|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321421|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321422|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
44321423|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
44321424|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
43734737|NCT02537925|Celecoxib|celecoxib|mesh-list
44123213|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44123214|NCT04352166|Narcotics|narcotics|mesh-ancestor
44123215|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123216|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123217|NCT04352166|Analgesics|analgesics|mesh-ancestor
44123218|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
44123219|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123220|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44123221|NCT04333914|Avdoralimab|avdoralimab|mesh-list
44123222|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321425|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
44321426|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321427|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44321428|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44321429|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321430|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321431|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321432|NCT00934479|Lubiprostone|lubiprostone|mesh-list
44321433|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44321434|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321435|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734751|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123223|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
44123224|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123225|NCT04321408|Ziconotide|ziconotide|mesh-list
44123226|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44123233|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123234|NCT04321408|Analgesics|analgesics|mesh-ancestor
44123235|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
44123236|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123237|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
44123238|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44123239|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44123240|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123241|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
44123242|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
44123243|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123244|NCT04272242|Pyridoxine|pyridoxine|mesh-list
44123245|NCT04272242|Pyridoxal|pyridoxal|mesh-list
44123246|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
44123247|NCT04272242|Isoniazid|isoniazid|mesh-list
44123248|NCT04272242|Rifapentine|rifapentine|mesh-list
44123249|NCT04272242|Dolutegravir|dolutegravir|mesh-list
44123250|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44123251|NCT04272242|Vitamins|vitamins|mesh-ancestor
44123252|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
44123253|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123254|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
43621423|NCT03116269|Aspirin|aspirin|mesh-list
44123255|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
44123256|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44123257|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123258|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44123259|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44123260|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
44123261|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123262|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44123263|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44123264|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44123265|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123266|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44123267|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
44123268|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44123269|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
44123270|NCT04263298|Capecitabine|capecitabine|mesh-list
44123271|NCT04263298|Fulvestrant|fulvestrant|mesh-list
44123272|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123273|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
44123274|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123275|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123276|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123277|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44123278|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44123279|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321436|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44321437|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44321438|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321440|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321441|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
44321442|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44321443|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44321444|NCT00934518|Cetuximab|cetuximab|mesh-list
44321445|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44321446|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321447|NCT00934531|Donepezil|donepezil|mesh-list
44321448|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44321449|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321450|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321451|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
44321452|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321453|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321454|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
44321455|NCT00934570|Metformin|metformin|mesh-list
44321456|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321457|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321458|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
44321459|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44321460|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44321461|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44321462|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321463|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321464|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
44123280|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123281|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123282|NCT04244552|Doxorubicin|doxorubicin|mesh-list
44123283|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44123284|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
44123285|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44123286|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123287|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123288|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123289|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123290|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123291|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123292|NCT04244058|Amantadine|amantadine|mesh-list
44123293|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44123294|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44123295|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
44321465|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321466|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321467|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44321468|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321469|NCT00934713|Montelukast|montelukast|mesh-list
44321470|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44321471|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321472|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44321473|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321474|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321475|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321476|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44321477|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321478|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321479|NCT00934739|Thalidomide|thalidomide|mesh-list
44321480|NCT00934739|Dexamethasone|dexamethasone|mesh-list
44321481|NCT00934739|Celecoxib|celecoxib|mesh-list
43734804|NCT02537561|Cisplatin|cisplatin|mesh-list
44123299|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123301|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123302|NCT04244058|Analgesics|analgesics|mesh-ancestor
44123303|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
44123304|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123305|NCT04162210|Dexamethasone|dexamethasone|mesh-list
44123306|NCT04162210|Pomalidomide|pomalidomide|mesh-list
44123307|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123308|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
44123309|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
44123310|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123311|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123312|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123313|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
44123314|NCT04162210|Hormones|hormones|mesh-ancestor
44123315|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123316|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123317|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123318|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
44123319|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44123320|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44123321|NCT04162210|Growth Substances|growth substances|mesh-ancestor
44123322|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
44123323|NCT04153565|Cisplatin|cisplatin|mesh-list
44123324|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
44123325|NCT04153565|Pemetrexed|pemetrexed|mesh-list
44123326|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123327|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123328|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123329|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123330|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44123331|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44123332|NCT04128683|Bromocriptine|bromocriptine|mesh-list
44123333|NCT04128683|Amisulpride|amisulpride|mesh-list
44123334|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44123335|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44123336|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123337|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321482|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
44321483|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321484|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
44321485|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321486|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321487|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44321488|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
44467693|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43976561|NCT01865708|Ethanol|ethanol|mesh-list
44321489|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321490|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321491|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44321492|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321493|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
44321494|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
44321495|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321496|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321497|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
44321498|NCT00934739|Hormones|hormones|mesh-ancestor
44321499|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321500|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321501|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
44123338|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44123339|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44123340|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
44123341|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123342|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123343|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44123344|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
44123345|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44123346|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44123347|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123348|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123349|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
44123350|NCT04065451|Epinephrine|epinephrine|mesh-list
44123351|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44123352|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44123353|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
44123354|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123355|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123356|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123357|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44123358|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44123359|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
44123360|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123361|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44123362|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
44123363|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
44123364|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
44123365|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44123366|NCT04063163|Carboplatin|carboplatin|mesh-list
44123376|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321502|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321503|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321504|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44321505|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44321506|NCT00934739|Growth Substances|growth substances|mesh-ancestor
44321507|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
44321508|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44321509|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321511|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
44321512|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44321513|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44321514|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321515|NCT00934752|Paclitaxel|paclitaxel|mesh-list
44321516|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321517|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321518|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321519|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321520|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734827|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
44123377|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44123378|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123380|NCT03990467|Piperacillin|piperacillin|mesh-list
44123381|NCT03990467|Amikacin|amikacin|mesh-list
44123382|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44123383|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123384|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44123385|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123386|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123387|NCT03983954|Durvalumab|durvalumab|mesh-list
44123388|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
44123389|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44123390|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
44123391|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123392|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123393|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
44123394|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123395|NCT03981146|Nivolumab|nivolumab|mesh-list
44123396|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123397|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123398|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44123399|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123400|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44123401|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
44123402|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
44123403|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123404|NCT03948568|Tamoxifen|tamoxifen|mesh-list
44123405|NCT03948568|Letrozole|letrozole|mesh-list
44123406|NCT03948568|Anastrozole|anastrozole|mesh-list
44123407|NCT03948568|Exemestane|exemestane|mesh-list
44123408|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123409|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44123410|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44123411|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123412|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321521|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321523|NCT00934817|Glimepiride|glimepiride|mesh-list
44321524|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321525|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321526|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44321527|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321528|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
44321529|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44321530|NCT00934830|Amoxicillin|amoxicillin|mesh-list
44321531|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321532|NCT00934895|Paclitaxel|paclitaxel|mesh-list
44321533|NCT00934895|Everolimus|everolimus|mesh-list
44321534|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44321535|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321536|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321537|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321538|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321539|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321540|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321541|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321542|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
44321543|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321574|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321575|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321576|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
44321577|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321578|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44321579|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
44321580|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321581|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44321582|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44321583|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
44321584|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
44321585|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321586|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44321587|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44321588|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
44321589|NCT00935298|Tacrolimus|tacrolimus|mesh-list
44321590|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321591|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
44321592|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321593|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44321594|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734857|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44123413|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44123414|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123415|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123416|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598802|NCT03296189|BB 1101|bb 1101|mesh-list
44123417|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123418|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44123419|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44123420|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44123421|NCT03929718|Spironolactone|spironolactone|mesh-list
44123422|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44123423|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123424|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123425|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123426|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44123427|NCT03929718|Diuretics|diuretics|mesh-ancestor
44123428|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
44123429|NCT03928366|Remifentanil|remifentanil|mesh-list
44123436|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
44123437|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44123438|NCT03928366|Narcotics|narcotics|mesh-ancestor
44123439|NCT03928366|Analgesics|analgesics|mesh-ancestor
44123440|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
44123441|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123442|NCT03809429|Cetrorelix|cetrorelix|mesh-list
44123443|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44123444|NCT03809429|Hormones|hormones|mesh-ancestor
44123445|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321595|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321597|NCT00935363|Rifampin|rifampin|mesh-list
44321598|NCT00935363|Fluconazole|fluconazole|mesh-list
44321599|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44321600|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
44321601|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44321602|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321603|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
44321604|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44321605|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321606|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321607|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44321608|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321609|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44321610|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43734890|NCT02537080|Nimodipine|nimodipine|mesh-list
44123446|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123447|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44123448|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
44123449|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44123450|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123451|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
44123452|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123453|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123454|NCT03739411|Temozolomide|temozolomide|mesh-list
44123455|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44123456|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
44123457|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123458|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123459|NCT03712826|Ustekinumab|ustekinumab|mesh-list
44123461|NCT03705507|Dexamethasone|dexamethasone|mesh-list
44123462|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123463|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
44123464|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
44123465|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123466|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123467|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123468|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
44123469|NCT03705507|Hormones|hormones|mesh-ancestor
44123470|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123471|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123472|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123473|NCT03622775|Daratumumab|daratumumab|mesh-list
44123474|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123475|NCT03560752|Vaccines|vaccines|mesh-list
44123476|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
44123477|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123478|NCT03546686|Nivolumab|nivolumab|mesh-list
44123479|NCT03546686|Ipilimumab|ipilimumab|mesh-list
44123480|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123481|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123482|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44123483|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123484|NCT03501498|Loperamide|loperamide|mesh-list
44123485|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
44123486|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123487|NCT03448107|Fluorides|fluorides|mesh-list
44321612|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44321613|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
44321614|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44321615|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44321616|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44321617|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321618|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321619|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321620|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44321621|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44321622|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321623|NCT00935415|Montelukast|montelukast|mesh-list
44321624|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44321625|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321626|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44321627|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321628|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321629|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321630|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44321631|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321632|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321633|NCT00935467|Saxagliptin|saxagliptin|mesh-list
44321634|NCT00935467|Incretins|incretins|mesh-ancestor
44321635|NCT00935467|Hormones|hormones|mesh-ancestor
43976645|NCT01869686|Denosumab|denosumab|mesh-list
44321636|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321637|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123488|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
44123489|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
44123490|NCT03448107|Protective Agents|protective agents|mesh-ancestor
44123491|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123492|NCT03442309|Fluorides|fluorides|mesh-list
44123493|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
44123494|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
44123495|NCT03442309|Protective Agents|protective agents|mesh-ancestor
44123496|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123497|NCT03399838|Midazolam|midazolam|mesh-list
44123498|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
44123499|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44123500|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123504|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
44321638|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44321639|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321640|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321641|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321642|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321643|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
44321644|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321645|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44321646|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
44321647|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321648|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44321649|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44321650|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321651|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321652|NCT00935506|Aspirin|aspirin|mesh-list
44321653|NCT00935506|Clopidogrel|clopidogrel|mesh-list
44321654|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44321655|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321656|NCT00935506|Analgesics|analgesics|mesh-ancestor
44321657|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
44321658|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321659|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321660|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321661|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321662|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44321663|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44321664|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321665|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44321666|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44321667|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321668|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
44123505|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123506|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44123507|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44123508|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44123509|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
44123510|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123511|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123512|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44123513|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44123514|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44123515|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44123516|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44321669|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44321670|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44321671|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44321672|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
44321673|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321674|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44321675|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44321676|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
44321677|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321678|NCT00935558|Interleukin-2|interleukin-2|mesh-list
44321679|NCT00935558|Exemestane|exemestane|mesh-list
44321680|NCT00935558|Anastrozole|anastrozole|mesh-list
44321681|NCT00935558|Letrozole|letrozole|mesh-list
44321682|NCT00935558|Lactitol|lactitol|mesh-list
44321683|NCT00935558|Vaccines|vaccines|mesh-list
44321684|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44321685|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
44321686|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321687|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321688|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44321689|NCT00935558|Analgesics|analgesics|mesh-ancestor
43734905|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
44123517|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
44123518|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
44123519|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
44123520|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
44154756|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154757|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154758|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44154759|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44154760|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154761|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154762|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
44154763|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
44154764|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154765|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154766|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44154767|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44154768|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
44154769|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44154770|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44154771|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44154772|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44154773|NCT00224978|Chloroquine|chloroquine|mesh-list
44154774|NCT00224978|Amebicides|amebicides|mesh-ancestor
44154775|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44154776|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44154777|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154778|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
44154779|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154780|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
44154781|NCT00225043|Phenylephrine|phenylephrine|mesh-list
44154782|NCT00225043|Epinephrine|epinephrine|mesh-list
44154783|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
44154784|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44154785|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44154786|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44321690|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
44321691|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321692|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44321694|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321695|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44321696|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321697|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321698|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321699|NCT00935558|Cathartics|cathartics|mesh-ancestor
44321700|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321701|NCT00935571|Remifentanil|remifentanil|mesh-list
44321702|NCT00935571|Propofol|propofol|mesh-list
44321703|NCT00935571|Sevoflurane|sevoflurane|mesh-list
44321704|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44321705|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44321706|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321707|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44321708|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
44321709|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
44321710|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44321711|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44321712|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44321714|NCT00935571|Analgesics|analgesics|mesh-ancestor
44321715|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
44321716|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321717|NCT00935610|Caseins|caseins|mesh-list
44321718|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
44321719|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
44154787|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154788|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154789|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154790|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44154791|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44154792|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
44154793|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154794|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44154795|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
44154796|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
44154797|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
44154798|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44154799|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44154800|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
44154801|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44154802|NCT00225043|Protective Agents|protective agents|mesh-ancestor
44321720|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321721|NCT00935675|Citalopram|citalopram|mesh-list
44321722|NCT00935675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44321723|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44321724|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321725|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321726|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321727|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
44321728|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321729|NCT00935675|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44321730|NCT00935675|Antidepressive Agents|antidepressive agents|mesh-ancestor
44321731|NCT00935675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44321732|NCT00935805|Insulin|insulin|mesh-list
44321733|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44321734|NCT00935805|Metformin|metformin|mesh-list
44321735|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
44321736|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
44321737|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
44321738|NCT00935805|Glyburide|glyburide|mesh-list
44321739|NCT00935805|Propranolol|propranolol|mesh-list
44321740|NCT00935805|Amlodipine|amlodipine|mesh-list
44321741|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44321742|NCT00935805|Captopril|captopril|mesh-list
44321743|NCT00935805|Diuretics|diuretics|mesh-list
44321744|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44321745|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321746|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44321747|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44321748|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321749|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158168|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158169|NCT00236327|Analgesics|analgesics|mesh-ancestor
44158170|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
44158171|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158172|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44158173|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158180|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158182|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158183|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158184|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158185|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158186|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158187|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
44158188|NCT00236366|Fentanyl|fentanyl|mesh-list
44158189|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44321750|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44321751|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44321752|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44321753|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44321754|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44321755|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44321756|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44321757|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321758|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44321759|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44321760|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321761|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467694|NCT01447420|Ribavirin|ribavirin|mesh-list
44467695|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44467696|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
44467697|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467698|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
44467699|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467700|NCT01447407|Vaccines|vaccines|mesh-list
44467701|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
44467702|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
44467703|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467704|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44467705|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
44467706|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44467707|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467708|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
44467709|NCT01446809|Doxorubicin|doxorubicin|mesh-list
44467710|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44467711|NCT01446809|Ifosfamide|ifosfamide|mesh-list
44467712|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
44467713|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467714|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123521|NCT02962414|Everolimus|everolimus|mesh-list
44123522|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123523|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123524|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
44123525|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123526|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
44123527|NCT02952092|Hematinics|hematinics|mesh-ancestor
44123528|NCT02839915|Leucovorin|leucovorin|mesh-list
44123529|NCT02839915|Folic Acid|folic acid|mesh-list
44123530|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
44123531|NCT02839915|Antidotes|antidotes|mesh-ancestor
44123532|NCT02839915|Protective Agents|protective agents|mesh-ancestor
44467715|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44467716|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44467717|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467718|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321763|NCT00935961|Docetaxel|docetaxel|mesh-list
44321764|NCT00935961|Everolimus|everolimus|mesh-list
44321765|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321766|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44321767|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44321768|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44321769|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321770|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321771|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
44321772|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321773|NCT00936013|Oseltamivir|oseltamivir|mesh-list
44321774|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
44123533|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123534|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
44123535|NCT02839915|Vitamins|vitamins|mesh-ancestor
44123536|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
44123537|NCT02839915|Hematinics|hematinics|mesh-ancestor
44123538|NCT02824523|Aspirin|aspirin|mesh-list
44123539|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44123540|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123541|NCT02824523|Analgesics|analgesics|mesh-ancestor
44123542|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
44123543|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123544|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123545|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123546|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123547|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44123548|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44123549|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123550|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44123551|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44123552|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123553|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
44123554|NCT02823366|Fenofibrate|fenofibrate|mesh-list
44123555|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44123556|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
44123557|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123558|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44123559|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
44123561|NCT02778685|Fulvestrant|fulvestrant|mesh-list
44123562|NCT02778685|Palbociclib|palbociclib|mesh-list
44123563|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123564|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123565|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44123566|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44123567|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123568|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123569|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44123570|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123571|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123572|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123573|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321775|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321776|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321777|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321778|NCT00936091|Vitamin A|vitamin a|mesh-list
44321779|NCT00936091|Vitamins|vitamins|mesh-ancestor
44321780|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
44321781|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321782|NCT00936143|Infliximab|infliximab|mesh-list
44321783|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44321784|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321785|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321786|NCT00936156|Carboplatin|carboplatin|mesh-list
44321787|NCT00936156|Etoposide|etoposide|mesh-list
44321788|NCT00936156|Thiotepa|thiotepa|mesh-list
44321789|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321790|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44321791|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43598849|NCT03295968|Ibuprofen|ibuprofen|mesh-list
44321792|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44321793|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321794|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321795|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44321796|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
44321797|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44321798|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44321799|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
44321800|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321801|NCT00936182|Fluconazole|fluconazole|mesh-list
44321802|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
44321803|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321804|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44321805|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44321806|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321807|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321808|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44321809|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
43734985|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44123574|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44123575|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44321810|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321811|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321812|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44321813|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44321814|NCT00936195|Ritonavir|ritonavir|mesh-list
44321815|NCT00936195|Lopinavir|lopinavir|mesh-list
44321816|NCT00936195|Tenofovir|tenofovir|mesh-list
44321817|NCT00936195|Lamivudine|lamivudine|mesh-list
44321818|NCT00936195|Zidovudine|zidovudine|mesh-list
44321819|NCT00936195|Emtricitabine|emtricitabine|mesh-list
44321820|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44321821|NCT00936195|Efavirenz|efavirenz|mesh-list
44321822|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44321823|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44321824|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
44321825|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321826|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321827|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321828|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44321829|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
44321830|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321831|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44321832|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44321833|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44321834|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44321835|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
44321836|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44321849|NCT00936260|Alendronate|alendronate|mesh-list
44321855|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321857|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321858|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44321859|NCT00936442|Anastrozole|anastrozole|mesh-list
44321860|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321861|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321862|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44321863|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44321864|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321865|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321866|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44321867|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321868|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321869|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321870|NCT00936520|Lifitegrast|lifitegrast|mesh-list
44321871|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44321872|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44321873|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44321874|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44321875|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
44321876|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44321877|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321878|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321879|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
44321880|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44321881|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321882|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44321883|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44321884|NCT00936546|Rituximab|rituximab|mesh-list
44321885|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44321886|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123576|NCT02736422|Xenon|xenon|mesh-list
44123589|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44123590|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44123591|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44123592|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123593|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123594|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44123595|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321887|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
44321888|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321889|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44321890|NCT00936624|Montelukast|montelukast|mesh-list
44321891|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44321892|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321893|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44321894|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
44321895|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321896|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321897|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44321898|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44321899|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321901|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44321902|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321903|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44321904|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
43735055|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44154803|NCT00225056|Docetaxel|docetaxel|mesh-list
44123596|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123597|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
44123598|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123599|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
44123600|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123601|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123602|NCT02415309|Melatonin|melatonin|mesh-list
44123603|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
44123604|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123605|NCT02415309|Protective Agents|protective agents|mesh-ancestor
44123606|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123607|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123608|NCT02086175|Rituximab|rituximab|mesh-list
44123609|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123610|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123611|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
44123612|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123613|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123614|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
44123615|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123616|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
44123617|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123618|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123619|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44123620|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
44123621|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123622|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123623|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44123624|NCT01990911|Diuretics|diuretics|mesh-list
44123625|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
44123626|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123627|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
44123629|NCT01803594|Niacinamide|niacinamide|mesh-list
44321905|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321906|NCT00936676|Rasagiline|rasagiline|mesh-list
44321907|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44321908|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321909|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321910|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44321911|NCT00936676|Protective Agents|protective agents|mesh-ancestor
44321912|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321913|NCT00936689|Doxorubicin|doxorubicin|mesh-list
44321914|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
44321915|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44321916|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44321917|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44321918|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44321919|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44321920|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321921|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44321922|NCT00936689|Estrogens|estrogens|mesh-ancestor
44321923|NCT00936689|Hormones|hormones|mesh-ancestor
44321924|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321925|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321926|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44321927|NCT00936767|Artesunate|artesunate|mesh-list
44321928|NCT00936767|Mefloquine|mefloquine|mesh-list
44321929|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
44321930|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44321938|NCT00936780|Paclitaxel|paclitaxel|mesh-list
44321952|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321953|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44321954|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44321955|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
44321956|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44321957|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44321958|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44321959|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44321960|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
44321961|NCT00936793|Hormones|hormones|mesh-ancestor
44321962|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44321963|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321964|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44321965|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
44321966|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
44321967|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44321968|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44321969|NCT00936923|Furosemide|furosemide|mesh-list
44321970|NCT00936923|Diuretics|diuretics|mesh-list
44321971|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
44321972|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321973|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44321974|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44321975|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44321976|NCT00936962|Vaccines|vaccines|mesh-list
44321977|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
44321978|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44321998|NCT00937092|Diuretics|diuretics|mesh-ancestor
44321999|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
44322000|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322001|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44322002|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322003|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322004|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44322005|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
44322006|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
44322007|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322008|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
44322009|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322010|NCT00937092|Protective Agents|protective agents|mesh-ancestor
44322011|NCT00937131|Rituximab|rituximab|mesh-list
44322012|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44322013|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322014|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
44322015|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322016|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322017|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
44322018|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322019|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44322020|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44322021|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322022|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322023|NCT00937144|Urological Agents|urological agents|mesh-ancestor
44322024|NCT00937183|Vaccines|vaccines|mesh-list
44322025|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
44322026|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322027|NCT00937261|Risperidone|risperidone|mesh-list
44123630|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
44123631|NCT01803594|Vitamins|vitamins|mesh-ancestor
44123632|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
44123633|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123634|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44123635|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
44123636|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123637|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44123643|NCT01731236|Neomycin|neomycin|mesh-list
44123644|NCT01731236|Choline|choline|mesh-list
44123645|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44123646|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123647|NCT01731236|Analgesics|analgesics|mesh-ancestor
44322028|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44322029|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44322030|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
44322031|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322032|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322033|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322034|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44322035|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322036|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322037|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322038|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44322039|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
44322040|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44322041|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44322042|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
44322043|NCT00937300|Fludarabine|fludarabine|mesh-list
44322044|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
44322045|NCT00937300|Interleukin-2|interleukin-2|mesh-list
44322046|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322047|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
44322048|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322049|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322050|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322051|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
44322052|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322056|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
44322077|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322078|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322080|NCT00937625|Fludarabine|fludarabine|mesh-list
44322081|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
44322082|NCT00937625|Interleukin-2|interleukin-2|mesh-list
44322083|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322084|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
44322085|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322086|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322087|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322088|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
44322089|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322090|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322091|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44322092|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322093|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
44322094|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322095|NCT00937625|Analgesics|analgesics|mesh-ancestor
44322096|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
44322097|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322098|NCT00937664|Gemcitabine|gemcitabine|mesh-list
44322099|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322100|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
44123648|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
44123649|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123650|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123651|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123652|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123653|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44123654|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44123655|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123656|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44123657|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44123658|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123659|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
44123660|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123661|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123662|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123663|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123664|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44123665|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44123666|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
44123667|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44123668|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
44123669|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123670|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44123671|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
44123672|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44322101|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322102|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322103|NCT00937664|Antiviral Agents|antiviral agents|mesh-ancestor
44322104|NCT00937664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322105|NCT00937664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322106|NCT00937664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322107|NCT00937664|Immunologic Factors|immunologic factors|mesh-ancestor
44322108|NCT00937664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322109|NCT00937677|Natalizumab|natalizumab|mesh-list
44322110|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
44322111|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322112|NCT00937807|Sevoflurane|sevoflurane|mesh-list
44322113|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44322114|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44322115|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
44322116|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
44322117|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322118|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322119|NCT00937820|Darexaban|darexaban|mesh-list
44322120|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44322121|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
44322122|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44322123|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
44322124|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322125|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322126|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
44467719|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44467720|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
44467721|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44467722|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322139|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322140|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322141|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
44322142|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
44322143|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
44322144|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322145|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
44322146|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
44322147|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44322148|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44322149|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
44322150|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
44322151|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322152|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322153|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44322154|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
44322155|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322156|NCT00938132|Warfarin|warfarin|mesh-list
44322157|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
44322158|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
44322159|NCT00938158|Incretins|incretins|mesh-ancestor
44322160|NCT00938158|Hormones|hormones|mesh-ancestor
44322161|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322162|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322163|NCT00938171|Anesthetics|anesthetics|mesh-list
44322164|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322165|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322166|NCT00938184|Paroxetine|paroxetine|mesh-list
44322167|NCT00938184|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44322168|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44322169|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322170|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322171|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322180|NCT00938197|Amlodipine|amlodipine|mesh-list
44322181|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44322182|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44322183|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322184|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322185|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322186|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322187|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322188|NCT00938236|Cyclosporine|cyclosporine|mesh-list
44322189|NCT00938236|Cyclosporins|cyclosporins|mesh-list
44322190|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322191|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322192|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322193|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
44322194|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322195|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
44123673|NCT01726452|Leucovorin|leucovorin|mesh-list
44123674|NCT01726452|Paclitaxel|paclitaxel|mesh-list
44123675|NCT01726452|Docetaxel|docetaxel|mesh-list
44123676|NCT01726452|Cisplatin|cisplatin|mesh-list
44123677|NCT01726452|Carboplatin|carboplatin|mesh-list
44123678|NCT01726452|Fluorouracil|fluorouracil|mesh-list
44123679|NCT01726452|Capecitabine|capecitabine|mesh-list
44123680|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
44123681|NCT01726452|Epirubicin|epirubicin|mesh-list
44123682|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123683|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123684|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123685|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123686|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123687|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123688|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
44123689|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123690|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123691|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
44123692|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123693|NCT01726452|Antidotes|antidotes|mesh-ancestor
44123694|NCT01726452|Protective Agents|protective agents|mesh-ancestor
44123695|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
44123696|NCT01726452|Vitamins|vitamins|mesh-ancestor
44123697|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
44123698|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44123699|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123700|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123701|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123702|NCT01409161|Vitamins|vitamins|mesh-list
44123703|NCT01409161|Vitamin A|vitamin a|mesh-list
44123704|NCT01409161|Tretinoin|tretinoin|mesh-list
44123705|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
44123706|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
44123707|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
44123708|NCT01409161|Calicheamicins|calicheamicins|mesh-list
44123709|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
44123710|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123711|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123712|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
44123713|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123714|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
44123729|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
44123730|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322196|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322198|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322199|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44322200|NCT00938262|Rifampin|rifampin|mesh-list
44322201|NCT00938262|Ketoconazole|ketoconazole|mesh-list
44322202|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44322203|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
44322204|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44322205|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322206|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
44322207|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44322208|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322209|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322210|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44322211|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44322212|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44322213|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44322214|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44322215|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44322216|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
44322217|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44322218|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44322219|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44322220|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
44322221|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322222|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322223|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44322224|NCT00938353|Beclomethasone|beclomethasone|mesh-list
44123731|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44123732|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44123733|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123734|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
44123735|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44123736|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123737|NCT00130507|Capecitabine|capecitabine|mesh-list
44123738|NCT00130507|Trastuzumab|trastuzumab|mesh-list
44123739|NCT00130507|Vinorelbine|vinorelbine|mesh-list
44123740|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123741|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
44123742|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322225|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322226|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
44322227|NCT00938353|Hormones|hormones|mesh-ancestor
44322228|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322229|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322230|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44322231|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44322232|NCT00938379|Insect Repellents|insect repellents|mesh-list
44322233|NCT00938379|Protective Agents|protective agents|mesh-ancestor
44322234|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322235|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44322236|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44322237|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44322238|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
44322239|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322240|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44322241|NCT00938509|Ibuprofen|ibuprofen|mesh-list
44322242|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44322243|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322244|NCT00938509|Analgesics|analgesics|mesh-ancestor
44322245|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
44322246|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322247|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322248|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322249|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322250|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44322251|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322252|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322253|NCT00938522|Cilostazol|cilostazol|mesh-list
44322254|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44322255|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
44322256|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123743|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123744|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123745|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123746|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123747|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123748|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123749|NCT00130546|Sirolimus|sirolimus|mesh-list
44123750|NCT00130546|Paclitaxel|paclitaxel|mesh-list
44154804|NCT00225056|Capecitabine|capecitabine|mesh-list
44322257|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322258|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44322259|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
44322260|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44322261|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44322262|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322263|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44322264|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322265|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44322266|NCT00938522|Protective Agents|protective agents|mesh-ancestor
44322267|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44322268|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44322269|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322270|NCT00938600|Vitamin D|vitamin d|mesh-list
44322271|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
44322272|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
44322273|NCT00938600|Vitamins|vitamins|mesh-list
44322274|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
44322275|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322276|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44322277|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322278|NCT00938613|Budesonide|budesonide|mesh-list
44123751|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123752|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123753|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123754|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123755|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123756|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123757|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44123758|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123759|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44123760|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
44123761|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123762|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
44123763|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123764|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
44123765|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44123766|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123767|NCT00130572|Analgesics|analgesics|mesh-ancestor
44123768|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
44123769|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123770|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123771|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123772|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123773|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123784|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123786|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44123787|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
44123788|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44123789|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123790|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44322280|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44322281|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
44322282|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322283|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322284|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44322285|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
44322286|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
44322287|NCT00938613|Hormones|hormones|mesh-ancestor
44322288|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322289|NCT00938626|Antibodies|antibodies|mesh-list
44322290|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44322291|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
44322292|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322293|NCT00938730|Warfarin|warfarin|mesh-list
44322294|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
44322295|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44322296|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44322297|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44322298|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322299|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322300|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322301|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322302|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322303|NCT00938821|Morphine|morphine|mesh-list
44322304|NCT00938821|Bupivacaine|bupivacaine|mesh-list
44322305|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
44322306|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
44322307|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322308|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322309|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
44322310|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322311|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44322312|NCT00938821|Narcotics|narcotics|mesh-ancestor
44322313|NCT00938821|Analgesics|analgesics|mesh-ancestor
44123791|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44123792|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44123793|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
44123794|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44322314|NCT00938899|Simeprevir|simeprevir|mesh-list
44322315|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
44322316|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322317|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
44322318|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322319|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322320|NCT00938990|Midazolam|midazolam|mesh-list
44322321|NCT00938990|Etomidate|etomidate|mesh-list
44322322|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44322323|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44322324|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322325|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322326|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44322327|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322328|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322329|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44322330|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
44322331|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
44322332|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
44322333|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
44322334|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322335|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322336|NCT00939068|Telbivudine|telbivudine|mesh-list
44322337|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
44322338|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322339|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44322340|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322341|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123795|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44123796|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123797|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123798|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
44123799|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44123800|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44123801|NCT00130702|Gefitinib|gefitinib|mesh-list
44123802|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123803|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44123804|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123805|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123806|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
44123807|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
44123808|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123809|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123810|NCT00130767|Finasteride|finasteride|mesh-list
44123811|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44123812|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44123813|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322342|NCT00939133|Tretinoin|tretinoin|mesh-list
44322343|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322344|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
44322345|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322346|NCT00939328|Rituximab|rituximab|mesh-list
44322347|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44322348|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44144164|NCT00191438|Docetaxel|docetaxel|mesh-list
44322349|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322350|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
44322351|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322352|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322353|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322354|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
44322355|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322356|NCT00939458|Lamotrigine|lamotrigine|mesh-list
44322357|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
44322358|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44322359|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322360|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322361|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322362|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123814|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123815|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
44123816|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123817|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123818|NCT00130767|Urological Agents|urological agents|mesh-ancestor
44123819|NCT00130819|Buprenorphine|buprenorphine|mesh-list
44123820|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44123821|NCT00130819|Narcotics|narcotics|mesh-ancestor
44123822|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123823|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123824|NCT00130819|Analgesics|analgesics|mesh-ancestor
44123825|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
44123826|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123827|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44123828|NCT00130845|Octreotide|octreotide|mesh-list
44123829|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123830|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123831|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123832|NCT00130858|Carboplatin|carboplatin|mesh-list
44123833|NCT00130858|Topotecan|topotecan|mesh-list
44123834|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123835|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44123836|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123837|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123840|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44123841|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44123842|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44123843|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44123844|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123845|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322363|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44322364|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322365|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322366|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322367|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44322368|NCT00939497|Risperidone|risperidone|mesh-list
44322369|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44322370|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
44322371|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322372|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322373|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322374|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44322375|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322376|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322377|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322378|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44322379|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
44322380|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
44322381|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
44322382|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
44123846|NCT00130871|Protective Agents|protective agents|mesh-ancestor
44123847|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123848|NCT00130884|Simendan|simendan|mesh-list
44123849|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44123850|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
44123851|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44123852|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44123853|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123854|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123855|NCT00130884|Protective Agents|protective agents|mesh-ancestor
44123856|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123857|NCT00130897|Sunitinib|sunitinib|mesh-list
44123858|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123859|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44123860|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44123861|NCT00130897|Growth Substances|growth substances|mesh-ancestor
44123862|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123863|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
44123864|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44123865|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123866|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123867|NCT00130910|Albendazole|albendazole|mesh-list
44123868|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
44123869|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44123870|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123871|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
44123872|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44123873|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44123874|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123875|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123876|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123877|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123878|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123879|NCT00130936|Carboplatin|carboplatin|mesh-list
44123880|NCT00130936|Capecitabine|capecitabine|mesh-list
44123881|NCT00130936|Epirubicin|epirubicin|mesh-list
44322384|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
44322385|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322386|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322387|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322388|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
44322389|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322390|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322391|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44322392|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44322394|NCT00939588|Telmisartan|telmisartan|mesh-list
44322395|NCT00939588|Ramipril|ramipril|mesh-list
44322396|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44322397|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44322398|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44322399|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123882|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123883|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123884|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
44123885|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123886|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44123887|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123888|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123889|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123890|NCT00130975|Candesartan|candesartan|mesh-list
44123891|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44123892|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44123893|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44123894|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123895|NCT00131027|Cytarabine|cytarabine|mesh-list
44123896|NCT00131027|Dexamethasone|dexamethasone|mesh-list
44123897|NCT00131027|Prednisolone|prednisolone|mesh-list
44123898|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
44123899|NCT00131027|Doxorubicin|doxorubicin|mesh-list
44123900|NCT00131027|Methotrexate|methotrexate|mesh-list
44123901|NCT00131027|Etoposide|etoposide|mesh-list
44123902|NCT00131027|Vincristine|vincristine|mesh-list
44123903|NCT00131027|Daunorubicin|daunorubicin|mesh-list
44123904|NCT00131027|Asparaginase|asparaginase|mesh-list
44123905|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
44123906|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123907|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
44123908|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123909|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123910|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44123918|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123919|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123920|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
44123921|NCT00131027|Hormones|hormones|mesh-ancestor
44123922|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123923|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123925|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123926|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123927|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322400|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44322401|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
44322402|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322403|NCT00939614|Lamotrigine|lamotrigine|mesh-list
44322404|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
44322405|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44322406|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322407|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322408|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322409|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322410|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44322411|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322412|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322413|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322414|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44123928|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44123929|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
44123930|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44123931|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123932|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
44123933|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123934|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44123935|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44123936|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123937|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
44123938|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123939|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123940|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123941|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123942|NCT00131040|Aprotinin|aprotinin|mesh-list
44123943|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
44123944|NCT00131040|Coagulants|coagulants|mesh-ancestor
44123945|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44123946|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44123947|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44123948|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123949|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123950|NCT00131053|Cytarabine|cytarabine|mesh-list
44123951|NCT00131053|Dexamethasone|dexamethasone|mesh-list
44123952|NCT00131053|Prednisolone|prednisolone|mesh-list
44123953|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
44123954|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
44123955|NCT00131053|Methotrexate|methotrexate|mesh-list
44123956|NCT00131053|Vincristine|vincristine|mesh-list
44123957|NCT00131053|Asparaginase|asparaginase|mesh-list
44123958|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
44123959|NCT00131053|Pirarubicin|pirarubicin|mesh-list
44123960|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123961|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
44123962|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123963|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123964|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44123965|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
44123966|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123967|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123968|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44123969|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123970|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
44123971|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
44123972|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322415|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
44322416|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
44322417|NCT00939718|Vitamins|vitamins|mesh-ancestor
44322418|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
44322419|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322420|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
44322421|NCT00939718|Hematinics|hematinics|mesh-ancestor
44322422|NCT00939757|Mirabegron|mirabegron|mesh-list
44322423|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44322424|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44322425|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44322426|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322427|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322428|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322429|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322430|NCT00939757|Urological Agents|urological agents|mesh-ancestor
44322431|NCT00939835|Dexetimide|dexetimide|mesh-list
44322432|NCT00939835|Citalopram|citalopram|mesh-list
44322433|NCT00939835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44322434|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44322435|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322436|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322437|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322438|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
44322439|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322440|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44322441|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
44322442|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322443|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44322444|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44322445|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
44123973|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123974|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
44123975|NCT00131053|Hormones|hormones|mesh-ancestor
44123976|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123977|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123978|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44123979|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
44123980|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44123986|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44123988|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123989|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123990|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44322446|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
44322447|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322448|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44322449|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44322450|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
44322451|NCT00939848|Gemcitabine|gemcitabine|mesh-list
44322452|NCT00939848|Cisplatin|cisplatin|mesh-list
44322453|NCT00939848|Cediranib|cediranib|mesh-list
44322454|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322455|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322456|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
44322457|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322458|NCT00939848|Antiviral Agents|antiviral agents|mesh-ancestor
44322459|NCT00939848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322460|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322461|NCT00939848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322462|NCT00939848|Immunologic Factors|immunologic factors|mesh-ancestor
44322463|NCT00939848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322464|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44322465|NCT00939926|Risperidone|risperidone|mesh-list
44322466|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44322467|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
44322468|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322469|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322470|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322471|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44322472|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44322473|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44322474|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322475|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44322476|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
44467726|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467727|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44467728|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467729|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467730|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123991|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467732|NCT01446042|Testosterone|testosterone|mesh-list
44467733|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
44467734|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
44467735|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44467736|NCT01446042|Androgens|androgens|mesh-ancestor
44467737|NCT01446042|Hormones|hormones|mesh-ancestor
44467738|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467739|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467740|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467741|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467742|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
44467743|NCT01445951|Insulin|insulin|mesh-list
44467744|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44467745|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
44467746|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43977361|NCT03867500|Vitamins|vitamins|mesh-ancestor
44322477|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44322478|NCT00939939|Glimepiride|glimepiride|mesh-list
44322479|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322480|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322481|NCT00939939|Incretins|incretins|mesh-ancestor
44322482|NCT00939939|Hormones|hormones|mesh-ancestor
44322483|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322484|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44322485|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
44322486|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322487|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322488|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44123992|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123993|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
44123994|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44123995|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123996|NCT00131144|Octreotide|octreotide|mesh-list
44123997|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44123998|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44123999|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124001|NCT00131183|Androgens|androgens|mesh-ancestor
44124002|NCT00131183|Hormones|hormones|mesh-ancestor
44124003|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124004|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154805|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154806|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
44154807|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
44154808|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
44154809|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322489|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322490|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
44322491|NCT00939965|Isotretinoin|isotretinoin|mesh-list
44322492|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322493|NCT00940069|Pemetrexed|pemetrexed|mesh-list
44322494|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322495|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322496|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322497|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44322498|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44322499|NCT00940121|Mirabegron|mirabegron|mesh-list
44322500|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44322501|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44322502|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44322503|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322504|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322505|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322506|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322507|NCT00940121|Urological Agents|urological agents|mesh-ancestor
44322508|NCT00940238|Dexetimide|dexetimide|mesh-list
44322509|NCT00940238|Citalopram|citalopram|mesh-list
44322510|NCT00940238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44322511|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44322512|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154810|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44154811|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
44154812|NCT00225108|Tinzaparin|tinzaparin|mesh-list
44154813|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44154814|NCT00225108|Dalteparin|dalteparin|mesh-list
44154815|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
44154816|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44154817|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44154818|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154819|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
44154820|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
44154821|NCT00225160|Vitamins|vitamins|mesh-ancestor
44154822|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
44154823|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154824|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
44154825|NCT00225173|Gemcitabine|gemcitabine|mesh-list
44154826|NCT00225173|Prednisone|prednisone|mesh-list
44154827|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
44154828|NCT00225173|Doxorubicin|doxorubicin|mesh-list
44154829|NCT00225173|Etoposide|etoposide|mesh-list
44154830|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
44154831|NCT00225173|Vincristine|vincristine|mesh-list
44154832|NCT00225173|Vinorelbine|vinorelbine|mesh-list
44154833|NCT00225173|Bleomycin|bleomycin|mesh-list
44154834|NCT00225173|Vinblastine|vinblastine|mesh-list
44154835|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154836|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
44154837|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154838|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154839|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322513|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322514|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322515|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
44322516|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322517|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44322518|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
44322519|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322520|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44322521|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44322522|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
44322523|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
44322524|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322525|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44322526|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44322527|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
44322575|NCT00940524|Asparaginase|asparaginase|mesh-list
44322576|NCT00940524|Dasatinib|dasatinib|mesh-list
44322577|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
44322578|NCT00940524|Pegaspargase|pegaspargase|mesh-list
44322579|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322580|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
44322581|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322582|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322583|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322584|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
44322585|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322586|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322587|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44322588|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44322589|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
44322590|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44322591|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322592|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
44322593|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44322594|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322595|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44322596|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44322597|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44322598|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44322599|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44322603|NCT00940524|Analgesics|analgesics|mesh-ancestor
44322623|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
43624094|NCT05404516|Sorafenib|sorafenib|mesh-list
44322624|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
44322625|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322626|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44322627|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322628|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322629|NCT00940628|Orlistat|orlistat|mesh-list
44322630|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322631|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322632|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44322633|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44322634|NCT00940654|Acetaminophen|acetaminophen|mesh-list
44322635|NCT00940654|Antipyretics|antipyretics|mesh-list
44322636|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44322637|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322638|NCT00940654|Analgesics|analgesics|mesh-ancestor
44322639|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
44322640|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322641|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322642|NCT00940667|Losartan|losartan|mesh-list
44322643|NCT00940667|Amlodipine|amlodipine|mesh-list
44322644|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44322645|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44322646|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322647|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322648|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322650|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
44322668|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44322669|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44322670|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322671|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322672|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322673|NCT00940693|Analgesics|analgesics|mesh-ancestor
44322674|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
44322675|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322676|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
44322677|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322678|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
44322679|NCT00940719|Vitamin D|vitamin d|mesh-list
44322680|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
44322681|NCT00940719|Vitamins|vitamins|mesh-ancestor
44322682|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
44322683|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322684|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44322685|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322686|NCT00940784|Aspirin|aspirin|mesh-list
44322687|NCT00940784|Clopidogrel|clopidogrel|mesh-list
44322688|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44322689|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322690|NCT00940784|Analgesics|analgesics|mesh-ancestor
44322691|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
44322692|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322693|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322694|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322695|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44322696|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43832076|NCT05281471|Taxane|taxane|mesh-list
44322711|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44322712|NCT00940836|Analgesics|analgesics|mesh-ancestor
44322713|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
44322714|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322715|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322716|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
44322717|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44322718|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
44322719|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
44322720|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
44322721|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44322722|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
44322723|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
44322724|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44322725|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44322726|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44322727|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322728|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322729|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322730|NCT00940836|Protective Agents|protective agents|mesh-ancestor
44322765|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
44322766|NCT00941057|Dienogest|dienogest|mesh-list
44322767|NCT00941057|Calcium|calcium|mesh-list
44322768|NCT00941057|Nandrolone|nandrolone|mesh-list
44322769|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322770|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322771|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44322772|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44322773|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
44322774|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44322775|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44322776|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44322777|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44322778|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44322779|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
44322780|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322781|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44322782|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322783|NCT00941057|Androgens|androgens|mesh-ancestor
44322784|NCT00941057|Hormones|hormones|mesh-ancestor
44322785|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
44322786|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
44322787|NCT00941057|Vitamins|vitamins|mesh-ancestor
44322788|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
44322789|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
44322790|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44322791|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44322792|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
44154840|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
44154841|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154842|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154843|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44154844|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44154845|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
44154846|NCT00225173|Antiviral Agents|antiviral agents|mesh-ancestor
44154847|NCT00225173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154848|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154849|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44154850|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44154851|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44154852|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154853|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
44124009|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
44124010|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124011|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124012|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124013|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
44124014|NCT00131261|Hormones|hormones|mesh-ancestor
44322793|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322794|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44322795|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44322796|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322797|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322798|NCT00941096|Timolol|timolol|mesh-list
44322799|NCT00941096|Bimatoprost|bimatoprost|mesh-list
44322800|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44322801|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44322802|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322803|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322804|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322805|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322806|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44322807|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44322808|NCT00941109|Decitabine|decitabine|mesh-list
44322809|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322810|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
43735758|NCT05300477|Hematinics|hematinics|mesh-ancestor
44124015|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124016|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44124017|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624253|NCT05256056|Bupivacaine|bupivacaine|mesh-list
44124018|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44124019|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124020|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124021|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
44124022|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124023|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44124024|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124025|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124026|NCT00131300|Hylan|hylan|mesh-list
44124027|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
44124028|NCT00131300|Protective Agents|protective agents|mesh-ancestor
44124029|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124030|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
44124031|NCT00131313|Rituximab|rituximab|mesh-list
44124032|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124033|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
44124034|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124035|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124036|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44124037|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
44124038|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124039|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124040|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44124041|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44124042|NCT00131326|Hylan|hylan|mesh-list
44124043|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
44124044|NCT00131326|Protective Agents|protective agents|mesh-ancestor
44124045|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124046|NCT00131339|Cycloserine|cycloserine|mesh-list
44124047|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124048|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124049|NCT00131339|Renal Agents|renal agents|mesh-ancestor
44124050|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44124051|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
44322811|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322812|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322813|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322814|NCT00941135|Cisplatin|cisplatin|mesh-list
44322815|NCT00941135|Docetaxel|docetaxel|mesh-list
44322816|NCT00941135|Cetuximab|cetuximab|mesh-list
44322817|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322818|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
44322819|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
44322820|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
44322821|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322822|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44322823|NCT00941148|Insulin|insulin|mesh-list
44322824|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44322825|NCT00941148|Metformin|metformin|mesh-list
44322826|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
44322827|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
44322828|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
44322829|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
44322830|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322831|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124052|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124053|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
44124054|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124055|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44124056|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44124057|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44124058|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124059|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124060|NCT00131391|Hormones|hormones|mesh-ancestor
44124061|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124062|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124063|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
43849169|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
44124064|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44124065|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44124066|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124067|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124068|NCT00131404|Hormones|hormones|mesh-ancestor
44124069|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124071|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44124073|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44124075|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124077|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124078|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124079|NCT00131443|Topiramate|topiramate|mesh-list
44124080|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
44124081|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322833|NCT00941161|Glimepiride|glimepiride|mesh-list
44322834|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322835|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322836|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44322837|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322838|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
44322839|NCT00941174|Leucovorin|leucovorin|mesh-list
44322840|NCT00941174|Calcium|calcium|mesh-list
44322841|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
44322842|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44322843|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322844|NCT00941174|Antidotes|antidotes|mesh-ancestor
44322845|NCT00941174|Protective Agents|protective agents|mesh-ancestor
44322846|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
44322847|NCT00941174|Vitamins|vitamins|mesh-ancestor
44322848|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
44322849|NCT00941239|Metformin|metformin|mesh-list
44322850|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322851|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322852|NCT00941252|Imiquimod|imiquimod|mesh-list
44322853|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44322854|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
44322855|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322856|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322857|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
44322858|NCT00941265|Levodopa|levodopa|mesh-list
44322859|NCT00941265|Benserazide|benserazide|mesh-list
44322860|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44322861|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44322862|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
44322863|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124082|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124083|NCT00131482|Thrombin|thrombin|mesh-list
44124084|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
44124085|NCT00131482|Coagulants|coagulants|mesh-ancestor
44124086|NCT00131495|Testosterone|testosterone|mesh-list
44124087|NCT00131495|Androgens|androgens|mesh-ancestor
44124088|NCT00131495|Hormones|hormones|mesh-ancestor
44124089|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124090|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124091|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
44124092|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
44124093|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124094|NCT00131521|Expectorants|expectorants|mesh-ancestor
44124095|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44124096|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44124097|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
44322864|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322865|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322866|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322867|NCT00941343|Alfuzosin|alfuzosin|mesh-list
44322868|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44322869|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44322870|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44322871|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
44322872|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44322873|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322874|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322875|NCT00941343|Urological Agents|urological agents|mesh-ancestor
44322876|NCT00941369|Insulin|insulin|mesh-list
44322877|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
44322878|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
44322879|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
44322880|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
44322881|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322882|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322883|NCT00941382|Metformin|metformin|mesh-list
44322884|NCT00941382|Sibutramine|sibutramine|mesh-list
44322885|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44322886|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322887|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
44322888|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44322889|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
44322890|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44322891|NCT00941460|Temozolomide|temozolomide|mesh-list
44124098|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124099|NCT00131521|Protective Agents|protective agents|mesh-ancestor
44124100|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124101|NCT00131703|Chloroquine|chloroquine|mesh-list
44124102|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
44124103|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
44124104|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44124105|NCT00131703|Amodiaquine|amodiaquine|mesh-list
44124106|NCT00131703|Amebicides|amebicides|mesh-ancestor
44124107|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44124108|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124109|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124110|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
44124111|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124112|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124113|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124114|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124115|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124116|NCT00131703|Renal Agents|renal agents|mesh-ancestor
44124117|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
44322892|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44322893|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
44322894|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322895|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322896|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44322897|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44322898|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
44322899|NCT00941473|Hormones|hormones|mesh-ancestor
44322900|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44322901|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322902|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322903|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
44322904|NCT00941499|Leucovorin|leucovorin|mesh-list
44322905|NCT00941499|Bevacizumab|bevacizumab|mesh-list
44322906|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44322907|NCT00941499|Cetuximab|cetuximab|mesh-list
44322908|NCT00941499|Fluorouracil|fluorouracil|mesh-list
44322909|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
44322910|NCT00941499|Antibodies|antibodies|mesh-list
44322911|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
44322912|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44322913|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322914|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44322915|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44322927|NCT00941499|Vitamins|vitamins|mesh-ancestor
44322942|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322943|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322944|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
44322945|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
44322946|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44322947|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322948|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44322949|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
44322950|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44322951|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322952|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322953|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322955|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
44322956|NCT00941967|Sorafenib|sorafenib|mesh-list
44322957|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44322958|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
44322959|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322960|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44322961|NCT00941967|Antiviral Agents|antiviral agents|mesh-ancestor
44322962|NCT00941967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322963|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322964|NCT00941967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44322965|NCT00941967|Immunologic Factors|immunologic factors|mesh-ancestor
44322966|NCT00941967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322967|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44322968|NCT00942006|Doxycycline|doxycycline|mesh-list
44322969|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
44322970|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44322971|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322972|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
44322973|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44322974|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43847642|NCT04085276|Paclitaxel|paclitaxel|mesh-list
44124118|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
44124119|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44124120|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
44124121|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44124122|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124123|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124124|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124125|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124126|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322975|NCT00942136|Dolutegravir|dolutegravir|mesh-list
44322976|NCT00942136|Omeprazole|omeprazole|mesh-list
44322977|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44322978|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44322979|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44322980|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322981|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44322982|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44322983|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44322984|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44322985|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44322986|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
44322987|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44322988|NCT00942201|Dexamethasone|dexamethasone|mesh-list
44322989|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
44322990|NCT00942201|BB 1101|bb 1101|mesh-list
44322991|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124127|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124128|NCT00131716|Renal Agents|renal agents|mesh-ancestor
44124129|NCT00131742|Lamivudine|lamivudine|mesh-list
44124130|NCT00131742|Telbivudine|telbivudine|mesh-list
44124131|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44124132|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44124133|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124134|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124135|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
44124136|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124137|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44124138|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44124139|NCT00131755|Diazoxide|diazoxide|mesh-list
44124140|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124141|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124142|NCT00131768|Hylan|hylan|mesh-list
44124149|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124150|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124151|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124152|NCT00131963|Paclitaxel|paclitaxel|mesh-list
44124153|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
44124154|NCT00131963|Doxorubicin|doxorubicin|mesh-list
44124155|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44124156|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124157|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124158|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124159|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124160|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124161|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124162|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
44124163|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124164|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124165|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44124166|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
44124167|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44124168|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124169|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44124170|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44124171|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124172|NCT00131989|Sorafenib|sorafenib|mesh-list
44124173|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124174|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44124175|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44322992|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
44322993|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
44322994|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44322995|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44322996|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44322997|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
44322998|NCT00942201|Hormones|hormones|mesh-ancestor
44322999|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323000|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44323001|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323002|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323003|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323004|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323005|NCT00942214|Natalizumab|natalizumab|mesh-list
44323006|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
44323007|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323008|NCT00942253|Dopamine|dopamine|mesh-list
44323009|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
44323010|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44323011|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
44323012|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
44323013|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323014|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323015|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
44323016|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323017|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323018|NCT00942253|Protective Agents|protective agents|mesh-ancestor
44323019|NCT00942318|Insulin|insulin|mesh-list
44323020|NCT00942318|Metformin|metformin|mesh-list
44323021|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
44323022|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323036|NCT00942435|Darexaban|darexaban|mesh-list
44323037|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44323038|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
44323039|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44323040|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323041|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323042|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323043|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
44323044|NCT00942487|Nebivolol|nebivolol|mesh-list
44323045|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323046|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44323047|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44323048|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44323049|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44323050|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
44323051|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323052|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323053|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323054|NCT00942526|Nystatin|nystatin|mesh-list
44323055|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44323056|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323057|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
44323058|NCT00942526|Ionophores|ionophores|mesh-ancestor
44323059|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323060|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323061|NCT00942539|Midazolam|midazolam|mesh-list
44323062|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44323063|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44323077|NCT00942565|Tramadol|tramadol|mesh-list
44323083|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
44323084|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44323085|NCT00942565|Narcotics|narcotics|mesh-ancestor
44323086|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323087|NCT00942591|Interferons|interferons|mesh-list
44323088|NCT00942591|Interferon-beta|interferon-beta|mesh-list
44323089|NCT00942591|Atorvastatin|atorvastatin|mesh-list
44323090|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
44323091|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323092|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
44323093|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323094|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44323095|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44323096|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
44323097|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323098|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323099|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44323100|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323101|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
44323102|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323103|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44323104|NCT00942617|Aspirin|aspirin|mesh-list
44323105|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44323106|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323107|NCT00942617|Analgesics|analgesics|mesh-ancestor
44323108|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
44323109|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323110|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323111|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323112|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323113|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44323114|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44323115|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323116|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44323117|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44323118|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323119|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
44323121|NCT00942682|Everolimus|everolimus|mesh-list
44323122|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323123|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44323124|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323125|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323126|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323127|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
44323128|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323129|NCT00942747|Sirolimus|sirolimus|mesh-list
44323130|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44323131|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323132|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44323133|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323134|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
44323135|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323136|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
44323137|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323138|NCT00942773|Voriconazole|voriconazole|mesh-list
44323139|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
44323140|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323141|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44323142|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323143|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323144|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323145|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44323146|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
44323166|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323167|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44323168|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323169|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323170|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
44323171|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323172|NCT00943176|Modafinil|modafinil|mesh-list
44323173|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44323174|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323175|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44323176|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43651018|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
44323177|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44323178|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323179|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
44323180|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44323181|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323182|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44323183|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
44323184|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44323185|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323186|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323187|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323188|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44323189|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323190|NCT00943293|Fludarabine|fludarabine|mesh-list
44323191|NCT00943293|Melphalan|melphalan|mesh-list
44323192|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
44323193|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323194|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323195|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323196|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
44124176|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124177|NCT00132054|Irinotecan|irinotecan|mesh-list
44124178|NCT00132054|Amrubicin|amrubicin|mesh-list
44124179|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44124180|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44124181|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124182|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124183|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124184|NCT00132067|Vorinostat|vorinostat|mesh-list
44323197|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323198|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44323199|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
44323200|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44323201|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44323203|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44323204|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323205|NCT00943345|Analgesics|analgesics|mesh-ancestor
44323206|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
44323207|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323208|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323209|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323210|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323211|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
44323212|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
44323213|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44323214|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44323215|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323216|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323217|NCT00943358|Vaccines|vaccines|mesh-list
44323218|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
44323219|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323220|NCT00943410|Trastuzumab|trastuzumab|mesh-list
44323221|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44323222|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323223|NCT00943449|Sorafenib|sorafenib|mesh-list
44323224|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323225|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44323226|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323227|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323228|NCT00943462|Temozolomide|temozolomide|mesh-list
44323238|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323240|NCT00943540|Emtricitabine|emtricitabine|mesh-list
44323241|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
44323242|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44323243|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44323244|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44323245|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323246|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323247|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
44323248|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323249|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323250|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323251|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44323252|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44323253|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44323254|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44323255|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323256|NCT00943553|Decitabine|decitabine|mesh-list
44323257|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44323258|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
44323259|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323260|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323261|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323262|NCT00943566|Sufentanil|sufentanil|mesh-list
44323263|NCT00943566|Morphine|morphine|mesh-list
44323264|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44323265|NCT00943566|Narcotics|narcotics|mesh-ancestor
44323266|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323267|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323268|NCT00943566|Analgesics|analgesics|mesh-ancestor
44323269|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
44323270|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323273|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
44467754|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467755|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467756|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44467757|NCT01445886|Vitamins|vitamins|mesh-ancestor
44467758|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
44467759|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44467760|NCT01445847|Lidocaine|lidocaine|mesh-list
44467761|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
44467762|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
44467763|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467764|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467765|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
44467766|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467767|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44467768|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44467769|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44467770|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467771|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467772|NCT01445678|Metronidazole|metronidazole|mesh-list
44467773|NCT01445678|Meropenem|meropenem|mesh-list
44467774|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467775|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467776|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44467777|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44467778|NCT01445548|Sirolimus|sirolimus|mesh-list
44467779|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44467780|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467781|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467782|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467783|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
44467785|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
44323288|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44323289|NCT00943839|Growth Substances|growth substances|mesh-ancestor
44323290|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323291|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44323292|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44323293|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323294|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323295|NCT00943930|Dronabinol|dronabinol|mesh-list
44323296|NCT00943930|Amphetamine|amphetamine|mesh-list
44323297|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
44323298|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44323299|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323300|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
44323301|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
44323302|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323303|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
44323304|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323305|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323306|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
44323307|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44323308|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323309|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323310|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44323311|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
44323312|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323313|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323314|NCT00943930|Analgesics|analgesics|mesh-ancestor
44323315|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
44323316|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44323317|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44323318|NCT00943930|Hormones|hormones|mesh-ancestor
43736043|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
44124185|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124186|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44124187|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124188|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124189|NCT00132093|Eplerenone|eplerenone|mesh-list
44124190|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44124191|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
44124192|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323319|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323321|NCT00943943|Sorafenib|sorafenib|mesh-list
44323322|NCT00943943|Lenograstim|lenograstim|mesh-list
44323323|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323324|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44323325|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323326|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323327|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44323328|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
44323329|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323330|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323331|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323332|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
44323333|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323334|NCT00943956|Everolimus|everolimus|mesh-list
44323335|NCT00943956|Leuprolide|leuprolide|mesh-list
44323336|NCT00943956|Bicalutamide|bicalutamide|mesh-list
44323337|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625704|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
44323338|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323339|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
44323340|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323341|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44323342|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
44323343|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44323344|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44323345|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
44323346|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
44323347|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323348|NCT00943982|Interferons|interferons|mesh-list
44323349|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
44323350|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323351|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
44323352|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323353|NCT00944177|Metformin|metformin|mesh-list
44323354|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736062|NCT04979377|Insulin|insulin|mesh-list
44124193|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124194|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44124195|NCT00132093|Diuretics|diuretics|mesh-ancestor
44323355|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323356|NCT00944242|Sertraline|sertraline|mesh-list
44323357|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323358|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323359|NCT00944242|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44323360|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323361|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323362|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323363|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323364|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
44323365|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323366|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
44323367|NCT00944307|Antacids|antacids|mesh-list
44323368|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
44323369|NCT00944307|TEMPO|tempo|mesh-list
44323370|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323371|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323372|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
44323373|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323374|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44323375|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44323376|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323377|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323378|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323379|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
44323380|NCT00944307|Protective Agents|protective agents|mesh-ancestor
44323381|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323382|NCT00944333|Clopidogrel|clopidogrel|mesh-list
44323383|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44323384|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44323386|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44323397|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323398|NCT00944385|Urinastatin|urinastatin|mesh-list
44323399|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44323400|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44323401|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323402|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323403|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323404|NCT00944398|Vitamins|vitamins|mesh-list
44323405|NCT00944398|Zinc|zinc|mesh-list
44323406|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
44323407|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
44323408|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
44323409|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323410|NCT00944398|Trace Elements|trace elements|mesh-ancestor
44323411|NCT00944398|Astringents|astringents|mesh-ancestor
44323412|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323413|NCT00944424|Vitamin D|vitamin d|mesh-list
44323414|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
44323415|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
44323416|NCT00944424|Vitamins|vitamins|mesh-list
44323417|NCT00944424|Docetaxel|docetaxel|mesh-list
44323418|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
44323419|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323420|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323421|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
44323422|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
44323423|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44323424|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323425|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44323426|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43978222|NCT01904526|Guanfacine|guanfacine|mesh-list
44323427|NCT00944463|Gemcitabine|gemcitabine|mesh-list
44323428|NCT00944463|Simvastatin|simvastatin|mesh-list
44323442|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44323443|NCT00944502|Dexamethasone|dexamethasone|mesh-list
44323444|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323445|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
44323446|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
44323447|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323448|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323449|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323450|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
44323451|NCT00944502|Hormones|hormones|mesh-ancestor
44323452|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323453|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44323454|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323455|NCT00944515|Azithromycin|azithromycin|mesh-list
44323456|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44323457|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323458|NCT00944541|Maraviroc|maraviroc|mesh-list
44323459|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44323460|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44323461|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323462|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323463|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323464|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
44323465|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124196|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
44124197|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124198|NCT00132106|Phentolamine|phentolamine|mesh-list
44124199|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44124200|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44124201|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44124202|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124203|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124204|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124205|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124206|NCT00132119|Nalmefene|nalmefene|mesh-list
44124207|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44124208|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124209|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
44124210|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124215|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124216|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124217|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124218|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44124219|NCT00132184|Vitamin D|vitamin d|mesh-list
44124220|NCT00132184|Vitamins|vitamins|mesh-ancestor
44124221|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
43651065|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
44124222|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124223|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44124224|NCT00132210|Interferons|interferons|mesh-list
44124225|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323466|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44323467|NCT00944606|Vitamin D|vitamin d|mesh-list
44323468|NCT00944606|Vitamins|vitamins|mesh-ancestor
44323469|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
44323470|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323471|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44323472|NCT00944619|Insulin|insulin|mesh-list
44323473|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323474|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323475|NCT00944684|Ribavirin|ribavirin|mesh-list
44323476|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
44323477|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323478|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
44323479|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323480|NCT00944723|Vitamins|vitamins|mesh-list
44323482|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
44323483|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
44323484|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
44323485|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323486|NCT00944723|Trace Elements|trace elements|mesh-ancestor
44323487|NCT00944723|Astringents|astringents|mesh-ancestor
44323488|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323489|NCT00944801|Doxorubicin|doxorubicin|mesh-list
44124226|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
44124227|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124229|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44124230|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
44124231|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124232|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124233|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44124234|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44124235|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
44124236|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124237|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124238|NCT00132275|Amoxicillin|amoxicillin|mesh-list
44124239|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
44124240|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
44124241|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124242|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124243|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44124244|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124245|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124246|NCT00132379|Docetaxel|docetaxel|mesh-list
44124247|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124249|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124250|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124251|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124252|NCT00132418|Etanercept|etanercept|mesh-list
44124253|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44124254|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44124255|NCT00132418|Analgesics|analgesics|mesh-ancestor
44124256|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
44124257|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124258|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124259|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323490|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44323491|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44323492|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323493|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44323494|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44323495|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651091|NCT03009500|Bupivacaine|bupivacaine|mesh-list
44323496|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323498|NCT00944814|Trace Elements|trace elements|mesh-ancestor
44323499|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
44323500|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323501|NCT00944840|Amodiaquine|amodiaquine|mesh-list
44323502|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
44323503|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44323504|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44323505|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323507|NCT00944853|Trace Elements|trace elements|mesh-ancestor
44323508|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
44323509|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323510|NCT00944918|Fulvestrant|fulvestrant|mesh-list
44323511|NCT00944918|Anastrozole|anastrozole|mesh-list
44323512|NCT00944918|Exemestane|exemestane|mesh-list
44323513|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44323514|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323515|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44323516|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44323517|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
44323518|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323519|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323520|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44323521|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44323522|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323523|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323524|NCT00944957|Efavirenz|efavirenz|mesh-list
44323525|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
44323530|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
44323531|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323532|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44323533|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323534|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44323535|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44323536|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44323537|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44323538|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323539|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323540|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44323541|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44323542|NCT00944996|Citalopram|citalopram|mesh-list
44323543|NCT00944996|Fluoxetine|fluoxetine|mesh-list
44323544|NCT00944996|Paroxetine|paroxetine|mesh-list
44323545|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44323546|NCT00944996|Sertraline|sertraline|mesh-list
44323547|NCT00944996|Clomipramine|clomipramine|mesh-list
44323548|NCT00944996|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44323549|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323550|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323551|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323552|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323553|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
44323554|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323555|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44323556|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323557|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323558|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44323573|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323574|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323575|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
44323576|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43978382|NCT01909141|Metformin|metformin|mesh-list
44323577|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323578|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323580|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44323581|NCT00945347|Miglustat|miglustat|mesh-list
44323582|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323583|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323584|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323585|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323586|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
44323587|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323588|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44323589|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323590|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323591|NCT00945360|Letrozole|letrozole|mesh-list
44323592|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44323593|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323594|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44323595|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323596|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323597|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44323598|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
44323620|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323621|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44323622|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
44323623|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
44323624|NCT00945529|Protective Agents|protective agents|mesh-ancestor
44323625|NCT00945542|Hemostatics|hemostatics|mesh-list
44323626|NCT00945542|Coagulants|coagulants|mesh-ancestor
44467786|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467787|NCT01445535|Prednisone|prednisone|mesh-list
44467788|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
44467789|NCT01445535|Rituximab|rituximab|mesh-list
44467790|NCT01445535|Doxorubicin|doxorubicin|mesh-list
44467791|NCT01445535|Etoposide|etoposide|mesh-list
44467792|NCT01445535|Vincristine|vincristine|mesh-list
44467793|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467794|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
44467795|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467796|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467797|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44467798|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
44467799|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467800|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467801|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44467802|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44467803|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44467804|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44467805|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44467806|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467807|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467808|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
44467809|NCT01445535|Hormones|hormones|mesh-ancestor
44467810|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44323627|NCT00945620|Ropivacaine|ropivacaine|mesh-list
44323628|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44323629|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
44323630|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323635|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
44323636|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44323637|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
44323638|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323639|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323640|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44323641|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
44323642|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44323643|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
44323644|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323645|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323646|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44323647|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
44323648|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
44323649|NCT00945789|Protective Agents|protective agents|mesh-ancestor
44323650|NCT00945789|Hematinics|hematinics|mesh-ancestor
44323651|NCT00945919|Oxymorphone|oxymorphone|mesh-list
44323652|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44323653|NCT00945919|Narcotics|narcotics|mesh-ancestor
44323654|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323655|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323656|NCT00945919|Analgesics|analgesics|mesh-ancestor
44323657|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
44323658|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323659|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44323660|NCT00945997|Misoprostol|misoprostol|mesh-list
44323661|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44323662|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
44323663|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44323664|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323665|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44323666|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323667|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
44323668|NCT00946036|Sertraline|sertraline|mesh-list
44323676|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
44323677|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323678|NCT00946166|Simvastatin|simvastatin|mesh-list
44323679|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44323680|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44323681|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
44323682|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323683|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323684|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44323685|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323686|NCT00946179|Vaccines|vaccines|mesh-list
44323687|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
44323688|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323689|NCT00946335|Temozolomide|temozolomide|mesh-list
44323690|NCT00946335|Veliparib|veliparib|mesh-list
44323691|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44323692|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
44323693|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323694|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323695|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44323696|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323697|NCT00946374|Cyclosporine|cyclosporine|mesh-list
44323698|NCT00946374|Doxorubicin|doxorubicin|mesh-list
44323699|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44323700|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323701|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44323703|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323713|NCT00946387|Ondansetron|ondansetron|mesh-list
44323724|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323725|NCT00946387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44323726|NCT00946387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44323727|NCT00946387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323728|NCT00946387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323729|NCT00946387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44323730|NCT00946465|Ramipril|ramipril|mesh-list
44323731|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44323732|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
44323733|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323734|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323735|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44323736|NCT00946491|Haloperidol|haloperidol|mesh-list
44323737|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
44323738|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
44323739|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
44323740|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323741|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323742|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323743|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44323744|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44323745|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323746|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323747|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44323748|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
44323749|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323750|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323751|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44323752|NCT00946504|Glipizide|glipizide|mesh-list
44323753|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323754|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323767|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44323768|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44323769|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
44323770|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323771|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44323772|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323773|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44323774|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44323775|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44323776|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44323777|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44323778|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44323779|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44323780|NCT00946608|Loratadine|loratadine|mesh-list
44323781|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
44323782|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323783|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44323784|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44323785|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44323786|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
44323787|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
44323788|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323789|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323790|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323813|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323814|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323815|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44323816|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44323817|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44323818|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
44323819|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323820|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323821|NCT00946751|Levetiracetam|levetiracetam|mesh-list
44323822|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
44323823|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
44323824|NCT00946764|Imipramine|imipramine|mesh-list
44323825|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44323826|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323827|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323828|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44323829|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44323830|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44323843|NCT00946829|Telmisartan|telmisartan|mesh-list
44323866|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
44323867|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323868|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44323869|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323870|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44323871|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
44323872|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323873|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44323874|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44323875|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44323876|NCT00946946|Analgesics|analgesics|mesh-ancestor
44323877|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
44323878|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323879|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44323880|NCT00947024|Glipizide|glipizide|mesh-list
44323881|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44323882|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323883|NCT00947063|Promethazine|promethazine|mesh-list
44323884|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
44323885|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
44323886|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323887|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44323888|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
44323889|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
44323890|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323891|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323892|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323893|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44323894|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44323898|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
44323911|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323912|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44323913|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
44323914|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323915|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44323916|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323917|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323919|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
44323920|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
44323921|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323922|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323923|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323924|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
44323925|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
44323926|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44323927|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
44323928|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44323929|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323930|NCT00947128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44323931|NCT00947128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44323932|NCT00947128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323933|NCT00947128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323934|NCT00947128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44323936|NCT00947141|Ganciclovir|ganciclovir|mesh-list
44323937|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44323938|NCT00947141|Foscarnet|foscarnet|mesh-list
44323939|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44323940|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
44323941|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323942|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44323943|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323944|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323945|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44323946|NCT00947323|Simvastatin|simvastatin|mesh-list
44323948|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44323951|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44323952|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44323953|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323954|NCT00947336|Norfloxacin|norfloxacin|mesh-list
44323955|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44323956|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44323957|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44323958|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44323959|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44323960|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323961|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44323962|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44323963|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44323964|NCT00947375|Lamotrigine|lamotrigine|mesh-list
44323965|NCT00947375|Haloperidol|haloperidol|mesh-list
44323966|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
44323967|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
44323968|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
44323969|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44323970|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44323971|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44323972|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44323973|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44323974|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44323975|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44323976|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44323977|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
44323987|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
44323997|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44323998|NCT00947453|Montelukast|montelukast|mesh-list
44323999|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44324000|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
44324001|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44324002|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324003|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324004|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324005|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44324006|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44324007|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324008|NCT00947466|Buprenorphine|buprenorphine|mesh-list
44324009|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44324010|NCT00947466|Narcotics|narcotics|mesh-ancestor
44324011|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324012|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324013|NCT00947466|Analgesics|analgesics|mesh-ancestor
44324014|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
44324015|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324016|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44467811|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44467812|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467813|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467814|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467815|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467816|NCT01445080|Sorafenib|sorafenib|mesh-list
44467817|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467818|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44467819|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467820|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467831|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467833|NCT01444742|Clofarabine|clofarabine|mesh-list
44467834|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467835|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
44467836|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467837|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467838|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
44467839|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467840|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467841|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
44467842|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467843|NCT01444651|Tadalafil|tadalafil|mesh-list
44467844|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
44467845|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44467846|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44467847|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467848|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467849|NCT01444651|Urological Agents|urological agents|mesh-ancestor
44467850|NCT01444430|Budesonide|budesonide|mesh-list
44467851|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44467852|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467853|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44467854|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
44467855|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467856|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467857|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44467858|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
43627350|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44467859|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
44467860|NCT01444430|Hormones|hormones|mesh-ancestor
44467861|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44467862|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
44124260|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124261|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124262|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124263|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
44124264|NCT00132431|Cinacalcet|cinacalcet|mesh-list
44124265|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44124266|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124267|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44124268|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
44467863|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44467864|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44467865|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324017|NCT00947596|Atropine|atropine|mesh-list
44324018|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44324019|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44324020|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44324021|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
44324022|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324023|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324024|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44324025|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44324026|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
44324027|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
44324028|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44324029|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44324030|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
44324031|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324032|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324033|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44324034|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324035|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324036|NCT00947739|Camptothecin|camptothecin|mesh-list
44324037|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44324038|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324039|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44324040|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44324041|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324042|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324043|NCT00947843|Aspirin|aspirin|mesh-list
44324056|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44324057|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44324058|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324059|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
44324060|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44324061|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44324062|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44324063|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
44324064|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324065|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
44324066|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44324067|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44324068|NCT00947895|Prednisolone|prednisolone|mesh-list
44324069|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
44324070|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44324071|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
44324072|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44324073|NCT00947895|Hormones|hormones|mesh-ancestor
43761003|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761004|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43761005|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
43761006|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
43761007|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761008|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44324074|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324075|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324076|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324077|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
44324078|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
44324079|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324080|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324081|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
44324082|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44324083|NCT00947895|Protective Agents|protective agents|mesh-ancestor
44324102|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324103|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44324104|NCT00948168|Incretins|incretins|mesh-ancestor
44324105|NCT00948168|Hormones|hormones|mesh-ancestor
44324106|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324107|NCT00948220|Ribavirin|ribavirin|mesh-list
44324108|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44324109|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
44324110|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324111|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
44324112|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324113|NCT00948272|Vaccines|vaccines|mesh-list
44324114|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
44324115|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324116|NCT00948402|Metformin|metformin|mesh-list
44324117|NCT00948402|Biguanides|biguanides|mesh-list
44324118|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
44324119|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
44324120|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324121|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324122|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324123|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44324124|NCT00948480|Sargramostim|sargramostim|mesh-list
44324125|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
44324126|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324127|NCT00948493|Insulin|insulin|mesh-list
44324128|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44324129|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324130|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324131|NCT00948584|Insulin|insulin|mesh-list
44324132|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44324148|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324149|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324150|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44324151|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324152|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324153|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324154|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44324155|NCT00948727|Cyclosporine|cyclosporine|mesh-list
44324156|NCT00948727|Cyclosporins|cyclosporins|mesh-list
44324157|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324158|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324159|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324160|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
44324161|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324162|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
44324163|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324164|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
44324165|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324166|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44324167|NCT00948740|Vitamin D|vitamin d|mesh-list
44324168|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
44324169|NCT00948740|Vitamins|vitamins|mesh-ancestor
44324170|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
44324171|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324172|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44324173|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324174|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43651252|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44324175|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44324176|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324177|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
44324178|NCT00948805|Goserelin|goserelin|mesh-list
44324179|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44324180|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324181|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324182|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324184|NCT00948987|Aspirin|aspirin|mesh-list
44324185|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324186|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324187|NCT00948987|Analgesics|analgesics|mesh-ancestor
44324188|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
44324189|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324190|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324191|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324192|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324193|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44324194|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44324195|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324196|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44324197|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44324198|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324199|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
44324200|NCT00949026|Sirolimus|sirolimus|mesh-list
44324201|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324202|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324203|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44324204|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324205|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
44324206|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324207|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
43834602|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124269|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124271|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44124272|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
44124273|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124274|NCT00132535|Chloroquine|chloroquine|mesh-list
44124275|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
44124276|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
44124277|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44124278|NCT00132535|Amebicides|amebicides|mesh-ancestor
44124279|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44124280|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124281|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124282|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
44124283|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124284|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124285|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124294|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
44124295|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44124296|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124297|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124298|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124299|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
44124300|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
44124301|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44124302|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
44124303|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124304|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324208|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324209|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
44324210|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44324211|NCT00949065|Antibodies|antibodies|mesh-list
44324212|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
44324213|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44324214|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
44324215|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324216|NCT00949130|Linezolid|linezolid|mesh-list
44324217|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324218|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324219|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44324220|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324221|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324222|NCT00949182|Doxorubicin|doxorubicin|mesh-list
44324223|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44324224|NCT00949182|Mitomycins|mitomycins|mesh-list
44324225|NCT00949182|Mitomycin|mitomycin|mesh-list
44324226|NCT00949182|Sorafenib|sorafenib|mesh-list
44324227|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44324228|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324229|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44324230|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44324231|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324232|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324233|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324234|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
44324235|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44324236|NCT00949247|Bevacizumab|bevacizumab|mesh-list
44324237|NCT00949247|Trastuzumab|trastuzumab|mesh-list
44324238|NCT00949247|Carboplatin|carboplatin|mesh-list
44324239|NCT00949247|Docetaxel|docetaxel|mesh-list
44324240|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324241|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324242|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44324243|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44324249|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
44324250|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324251|NCT00949299|Buprenorphine|buprenorphine|mesh-list
44324252|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44324253|NCT00949299|Narcotics|narcotics|mesh-ancestor
44324254|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324255|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324256|NCT00949299|Analgesics|analgesics|mesh-ancestor
44324257|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
44324258|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324259|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44324260|NCT00949364|Pomalidomide|pomalidomide|mesh-list
44324261|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
44324262|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324263|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44324264|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44324265|NCT00949364|Growth Substances|growth substances|mesh-ancestor
44324266|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
44324267|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467866|NCT01443923|Interferons|interferons|mesh-list
44467867|NCT01443923|Ribavirin|ribavirin|mesh-list
44467868|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
44467869|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
44467870|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44467871|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467872|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
44467873|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467874|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
44467875|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467876|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
44467877|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467878|NCT01443858|Meclizine|meclizine|mesh-list
44467879|NCT01443858|Nicotine|nicotine|mesh-list
44467880|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44467881|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
44124305|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124306|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124308|NCT00132561|Artesunate|artesunate|mesh-list
44124309|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
44124310|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
44124311|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
44124312|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44467882|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467883|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467884|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44467885|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44467886|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
44467887|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44467888|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467889|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
44467890|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467891|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44467892|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
44467893|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
44467894|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44467895|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
44467896|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44467897|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
44467898|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467899|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467900|NCT01443130|Chloroquine|chloroquine|mesh-list
44467901|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
44467902|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
44467903|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44467904|NCT01443130|Amebicides|amebicides|mesh-ancestor
44467905|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44467906|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44467907|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467908|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
44467909|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467910|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467911|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467912|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467913|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44467914|NCT01443130|Renal Agents|renal agents|mesh-ancestor
44467915|NCT01443078|Gemcitabine|gemcitabine|mesh-list
44324272|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324273|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
44324274|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324275|NCT00949442|Insulin|insulin|mesh-list
44324276|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44324277|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
44324278|NCT00949442|Glimepiride|glimepiride|mesh-list
44324279|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324280|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324281|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44324282|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324283|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
44324284|NCT00949455|Lapatinib|lapatinib|mesh-list
44324285|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324286|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324287|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324288|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324289|NCT00949494|Hylan|hylan|mesh-list
44324290|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
44324291|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
44324292|NCT00949494|Protective Agents|protective agents|mesh-ancestor
44324293|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324294|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44324295|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
44324296|NCT00949546|Etanercept|etanercept|mesh-list
44324323|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324324|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324325|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44324326|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44324327|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44324328|NCT00949624|Docetaxel|docetaxel|mesh-list
44324329|NCT00949624|Axitinib|axitinib|mesh-list
44324330|NCT00949624|Crenolanib|crenolanib|mesh-list
44324331|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324332|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
44324333|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
44324334|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
44324335|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324336|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324337|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324338|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44324339|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324340|NCT00949663|Incretins|incretins|mesh-ancestor
44324341|NCT00949663|Hormones|hormones|mesh-ancestor
44324342|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324343|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324344|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44324345|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
44324346|NCT00949728|Coagulants|coagulants|mesh-ancestor
44324347|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
44324348|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44324349|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324350|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324351|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
44324353|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
44324354|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
44324355|NCT00949832|Vitamins|vitamins|mesh-list
44324367|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324369|NCT00949949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324370|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324371|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324372|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
44324373|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324374|NCT00949962|Leuprolide|leuprolide|mesh-list
44324375|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
44324376|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44324377|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
44324378|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324379|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324380|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324381|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324382|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324383|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324384|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
44324385|NCT00950027|Povidone|povidone|mesh-list
44324386|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
44324387|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
44324388|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44324389|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324390|NCT00950066|Amlodipine|amlodipine|mesh-list
44324391|NCT00950066|Irbesartan|irbesartan|mesh-list
44324392|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44324393|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44324394|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324395|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324396|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324397|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324409|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324410|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324411|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
44324412|NCT00950196|Amantadine|amantadine|mesh-list
44324413|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44324414|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44324415|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
44324416|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324417|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
44324418|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324419|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324420|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324421|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324422|NCT00950196|Analgesics|analgesics|mesh-ancestor
44324423|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
44324424|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324425|NCT00950209|Heparin|heparin|mesh-list
44324426|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
44324427|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44324428|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44324429|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324430|NCT00950222|Imipenem|imipenem|mesh-list
44324431|NCT00950222|Amikacin|amikacin|mesh-list
44324432|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324461|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324462|NCT00950404|Urological Agents|urological agents|mesh-ancestor
44324463|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
44324464|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324465|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324466|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
44324467|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44324468|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324469|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
44324470|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
44324471|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44324472|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44324473|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44324474|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324475|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324476|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324478|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
44324479|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
44324480|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324481|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324482|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
44324483|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324484|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44324485|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44324486|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44324487|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324488|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324489|NCT00950677|Exenatide|exenatide|mesh-list
44324490|NCT00950677|Pramlintide|pramlintide|mesh-list
44324501|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324502|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324503|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44324504|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
44324505|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44324506|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44324507|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44324508|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44324509|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324510|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324511|NCT00950820|Capecitabine|capecitabine|mesh-list
44324512|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
44324513|NCT00950820|Panitumumab|panitumumab|mesh-list
44324514|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324515|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
44324516|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324517|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324518|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44324519|NCT00950898|Caffeine|caffeine|mesh-list
44324520|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44324521|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324522|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44324523|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324524|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324525|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44324526|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44324527|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
44324528|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324529|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
44324544|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44324545|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324546|NCT00951223|Interferons|interferons|mesh-list
44324547|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
44324548|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324549|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
44324550|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467921|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467922|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44467923|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
44467924|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467925|NCT01443078|Antiviral Agents|antiviral agents|mesh-ancestor
44467926|NCT01443078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467927|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44467928|NCT01443078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762059|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44467929|NCT01443078|Immunologic Factors|immunologic factors|mesh-ancestor
44467930|NCT01443078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467931|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44467932|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44467933|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44467934|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44467935|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44467936|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44467937|NCT01443026|Lycopene|lycopene|mesh-list
44467938|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324573|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324574|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324575|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
44324576|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44324577|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44324578|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324579|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
44324580|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
44324581|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44324582|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44324583|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324584|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324585|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44324586|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44324587|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44324588|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
44324589|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324590|NCT00951834|Protective Agents|protective agents|mesh-ancestor
44324591|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324592|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44324593|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44324594|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324595|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44324596|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
44324597|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
44324598|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44324599|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44324600|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324601|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324602|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44324603|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44324604|NCT00952003|Bevacizumab|bevacizumab|mesh-list
44324611|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44324612|NCT00952003|Growth Substances|growth substances|mesh-ancestor
44324613|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324614|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
44324615|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
44324616|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
44324617|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
44324618|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324619|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44324620|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44324621|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324622|NCT00952016|Methotrexate|methotrexate|mesh-list
44324623|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44324624|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
44324625|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324626|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324627|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324628|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
44324629|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324630|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324631|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
44324632|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324638|NCT00952029|Leucovorin|leucovorin|mesh-list
44324662|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
44324663|NCT00952029|Vitamins|vitamins|mesh-ancestor
44324664|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
44324665|NCT00952094|Cinacalcet|cinacalcet|mesh-list
44324666|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324667|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324668|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44324669|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44324670|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324671|NCT00952159|Tramadol|tramadol|mesh-list
44324672|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
44324673|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44324674|NCT00952159|Narcotics|narcotics|mesh-ancestor
44324675|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324676|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324677|NCT00952159|Analgesics|analgesics|mesh-ancestor
44324678|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
44324679|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324680|NCT00952185|Antibodies|antibodies|mesh-list
44324681|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
44324682|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324683|NCT00952302|Iron|iron|mesh-list
44324684|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44324685|NCT00952302|Trace Elements|trace elements|mesh-ancestor
44324686|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
44324687|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324688|NCT00952302|Hematinics|hematinics|mesh-ancestor
44324689|NCT00952432|Carbamazepine|carbamazepine|mesh-list
44324711|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
44324713|NCT00952562|Vitamins|vitamins|mesh-ancestor
44324714|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
44324715|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324716|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44324717|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44324718|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
44324719|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44324720|NCT00952575|Antibodies|antibodies|mesh-list
44324721|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44324722|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
44324723|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
44324724|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324725|NCT00952627|Pycnogenols|pycnogenols|mesh-list
44324726|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44324727|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
44324728|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324729|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
44324730|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324731|NCT00952627|Protective Agents|protective agents|mesh-ancestor
44324732|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44324733|NCT00952640|Vitamin A|vitamin a|mesh-list
44324734|NCT00952640|Vitamins|vitamins|mesh-ancestor
44324735|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
44324736|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324737|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
44324738|NCT00952796|Ampicillin|ampicillin|mesh-list
44324739|NCT00952796|Sulbactam|sulbactam|mesh-list
44324740|NCT00952796|Sultamicillin|sultamicillin|mesh-list
44324741|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44324742|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324743|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44324757|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324758|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324759|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44324760|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324761|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324763|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324764|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324765|NCT00952952|Analgesics|analgesics|mesh-ancestor
44324766|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
44324767|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324768|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324769|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324770|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324771|NCT00952978|Omeprazole|omeprazole|mesh-list
44324772|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324773|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324774|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44324775|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324776|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324777|NCT00952991|Vildagliptin|vildagliptin|mesh-list
44324778|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324779|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324780|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44324781|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44324782|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324783|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324784|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44324785|NCT00953108|Citalopram|citalopram|mesh-list
44324786|NCT00953108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44324787|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44324788|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44324790|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324796|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44324797|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44324798|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44324799|NCT00953134|Folic Acid|folic acid|mesh-list
44324800|NCT00953134|Micronutrients|micronutrients|mesh-list
44324801|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
44324802|NCT00953134|Trace Elements|trace elements|mesh-list
44324803|NCT00953134|Hematinics|hematinics|mesh-ancestor
44324804|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
44324805|NCT00953134|Vitamins|vitamins|mesh-ancestor
44324806|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467939|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
44467940|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44467941|NCT01443026|Protective Agents|protective agents|mesh-ancestor
44467942|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467943|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44467944|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44467945|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467946|NCT01442779|Interferons|interferons|mesh-list
44467947|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
44467948|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44467949|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
44467950|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44467951|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
44467952|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467953|NCT01442714|Lenalidomide|lenalidomide|mesh-list
44467954|NCT01442714|Azacitidine|azacitidine|mesh-list
44467955|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
44467956|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467957|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44467959|NCT01442714|Growth Substances|growth substances|mesh-ancestor
44467975|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467976|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44467977|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44467979|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44467980|NCT01442493|Narcotics|narcotics|mesh-ancestor
44467981|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44467982|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467983|NCT01442493|Analgesics|analgesics|mesh-ancestor
44467984|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
44467985|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467986|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
44324808|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
44324809|NCT00953303|Prednisone|prednisone|mesh-list
44324810|NCT00953303|Torsemide|torsemide|mesh-list
44324811|NCT00953303|Dobutamine|dobutamine|mesh-list
44324812|NCT00953303|Dopamine|dopamine|mesh-list
44324813|NCT00953303|Furosemide|furosemide|mesh-list
44324814|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
44324815|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
44324816|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44324817|NCT00953303|BB 1101|bb 1101|mesh-list
44324818|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847927|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324819|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
44324820|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
44324821|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324822|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324823|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324824|NCT00953303|Hormones|hormones|mesh-ancestor
44324825|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44324826|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324827|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324828|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
44324829|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324831|NCT00953303|Diuretics|diuretics|mesh-ancestor
44324839|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44324840|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44324841|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44324842|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324843|NCT00953303|Protective Agents|protective agents|mesh-ancestor
44324845|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44324846|NCT00953355|Metformin|metformin|mesh-list
44324847|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44324848|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324849|NCT00953381|Omeprazole|omeprazole|mesh-list
44324850|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324851|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324852|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44324853|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324854|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324855|NCT00953394|Octreotide|octreotide|mesh-list
44324856|NCT00953394|Fluorouracil|fluorouracil|mesh-list
44324857|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324858|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44324859|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324860|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
44324861|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324862|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324863|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324864|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
44324865|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324866|NCT00953459|Sunitinib|sunitinib|mesh-list
44324886|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324887|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
44324888|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324889|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324891|NCT00953550|Succinylcholine|succinylcholine|mesh-list
44324892|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44324893|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44324894|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44324895|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324896|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324897|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44324898|NCT00953589|Ribavirin|ribavirin|mesh-list
44324899|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
44324900|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324901|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
44324902|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324903|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44324904|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324905|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324906|NCT00953641|Misoprostol|misoprostol|mesh-list
44324907|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44324908|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
44324909|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324910|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324911|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44324912|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324934|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44324935|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
44324936|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324937|NCT00954005|Antiviral Agents|antiviral agents|mesh-ancestor
44324938|NCT00954005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44324939|NCT00954005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324940|NCT00954005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324941|NCT00954096|Nicotine|nicotine|mesh-list
44324942|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44324943|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
44324944|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324945|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324946|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44324947|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44324948|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
44324949|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44324950|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324951|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
44324952|NCT00954135|Sorafenib|sorafenib|mesh-list
44324953|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44324954|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
44324955|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324956|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324957|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44324958|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
44324959|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324960|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324961|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44324962|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324963|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324964|NCT00954200|Ibuprofen|ibuprofen|mesh-list
44324976|NCT00954252|Flurbiprofen|flurbiprofen|mesh-list
44324977|NCT00954252|Analgesics|analgesics|mesh-ancestor
44324978|NCT00954252|Sensory System Agents|sensory system agents|mesh-ancestor
44324979|NCT00954252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44324980|NCT00954252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324981|NCT00954252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44324982|NCT00954252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44324983|NCT00954252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44324984|NCT00954252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44324985|NCT00954252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44324986|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324987|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324988|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44324989|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44324990|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44324991|NCT00954278|Sorafenib|sorafenib|mesh-list
44324992|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44324993|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44324994|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44324995|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44324996|NCT00954304|Loperamide|loperamide|mesh-list
44324997|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
44324998|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44324999|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
44325000|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
44325001|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44325002|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44325003|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325004|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
44325005|NCT00954395|Coagulants|coagulants|mesh-ancestor
44325006|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
44325007|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
44325018|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325019|NCT00954525|Antiviral Agents|antiviral agents|mesh-ancestor
44325020|NCT00954525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325021|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325022|NCT00954525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325023|NCT00954525|Immunologic Factors|immunologic factors|mesh-ancestor
44325024|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325025|NCT00954525|Antioxidants|antioxidants|mesh-ancestor
44325026|NCT00954525|Protective Agents|protective agents|mesh-ancestor
44325027|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44325028|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44325029|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325030|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325031|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44325032|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
44325033|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325034|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325036|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44325037|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
44325038|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
44325039|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325040|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44325041|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325042|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325043|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325044|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
44325045|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
44325046|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325047|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325048|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44325049|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
44325050|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325051|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325053|NCT00954642|Paclitaxel|paclitaxel|mesh-list
44325059|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325060|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325061|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325062|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325063|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44325064|NCT00954642|Growth Substances|growth substances|mesh-ancestor
44325065|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325066|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325067|NCT00954785|Diclofenac|diclofenac|mesh-list
44325068|NCT00954785|Etoricoxib|etoricoxib|mesh-list
44325069|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44325070|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44325071|NCT00954785|Analgesics|analgesics|mesh-ancestor
44325072|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
44325073|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325074|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325075|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325076|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44325077|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44325078|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325079|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325080|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44325081|NCT00954798|Vaccines|vaccines|mesh-list
44325082|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
44325083|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325084|NCT00954811|Progesterone|progesterone|mesh-list
44325085|NCT00954811|Progestins|progestins|mesh-ancestor
44325086|NCT00954811|Hormones|hormones|mesh-ancestor
44325087|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325088|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325101|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325102|NCT00955045|Istradefylline|istradefylline|mesh-list
44325103|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44325104|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44325105|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44325107|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325108|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325109|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467987|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
44467988|NCT01442376|Ondansetron|ondansetron|mesh-list
44467989|NCT01442376|Palonosetron|palonosetron|mesh-list
44467990|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
44467991|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
44467992|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44467993|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44467994|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44467995|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
44467996|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
44467997|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44467998|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
44467999|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468000|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468001|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44468002|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44468003|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468004|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468005|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44468006|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44468007|NCT01442155|Capecitabine|capecitabine|mesh-list
44468008|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
44468009|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44468010|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
44468011|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468012|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468013|NCT01442064|Ranibizumab|ranibizumab|mesh-list
44468017|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468018|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
44468019|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468020|NCT01442038|Ranolazine|ranolazine|mesh-list
44468021|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44468022|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468023|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468024|NCT01441973|Elotuzumab|elotuzumab|mesh-list
44468025|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468026|NCT01441960|Rocuronium|rocuronium|mesh-list
44468027|NCT01441960|Succinylcholine|succinylcholine|mesh-list
44468028|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44468029|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44468030|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44468031|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468032|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468033|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
44468034|NCT01441765|Pidilizumab|pidilizumab|mesh-list
44468035|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44468036|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468037|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44468038|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44468039|NCT01441635|Norethindrone|norethindrone|mesh-list
44468040|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
44468041|NCT01441635|Estradiol|estradiol|mesh-list
44468042|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44468043|NCT01441635|Progesterone|progesterone|mesh-list
44468044|NCT01441635|Estrogens|estrogens|mesh-ancestor
44468045|NCT01441635|Hormones|hormones|mesh-ancestor
44468046|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468047|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468048|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44468049|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
44468050|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44468051|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44468052|NCT01441635|Progestins|progestins|mesh-ancestor
44468056|NCT01441596|Vinorelbine|vinorelbine|mesh-list
44468057|NCT01441596|Afatinib|afatinib|mesh-list
44325110|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44325111|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325112|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325113|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325114|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325116|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44325117|NCT00955162|Naloxone|naloxone|mesh-list
44325118|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44325119|NCT00955162|Narcotics|narcotics|mesh-ancestor
44325120|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325121|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325122|NCT00955162|Analgesics|analgesics|mesh-ancestor
44325123|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
44325124|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325125|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44325126|NCT00955214|Paclitaxel|paclitaxel|mesh-list
44325127|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325128|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325129|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325130|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325131|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325132|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325133|NCT00955227|Ezetimibe|ezetimibe|mesh-list
44325134|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44325135|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44325136|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
44325137|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325138|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44325154|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325156|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
44325157|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
44325158|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325159|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325160|NCT00955526|Istradefylline|istradefylline|mesh-list
44325161|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44325162|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44325163|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44325164|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
44325165|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325166|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325167|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325168|NCT00955604|Rasagiline|rasagiline|mesh-list
44325169|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
44325170|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325171|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44325172|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325173|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325174|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44325175|NCT00955604|Protective Agents|protective agents|mesh-ancestor
44325176|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325177|NCT00955630|Ranibizumab|ranibizumab|mesh-list
44325178|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325179|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44325180|NCT00955630|Growth Substances|growth substances|mesh-ancestor
44325181|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325182|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325183|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325184|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44325185|NCT00955695|Gefitinib|gefitinib|mesh-list
44325190|NCT00955773|Everolimus|everolimus|mesh-list
44325194|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
44325195|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325196|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325197|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325198|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325199|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
44325200|NCT00955890|Razoxane|razoxane|mesh-list
44325201|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325202|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44325203|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44325204|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44325205|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325206|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325207|NCT00955890|Protective Agents|protective agents|mesh-ancestor
44325208|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325209|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325210|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325211|NCT00956007|Cetuximab|cetuximab|mesh-list
44325212|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325213|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325214|NCT00956046|Vaccines|vaccines|mesh-list
44325215|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
44325216|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325217|NCT00956059|Prednisone|prednisone|mesh-list
44325218|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325219|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
44325220|NCT00956059|Hormones|hormones|mesh-ancestor
44325221|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325222|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325223|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44325224|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325225|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
44325235|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
44325236|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44325237|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44325238|NCT00956098|Protective Agents|protective agents|mesh-ancestor
44325239|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325240|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325241|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44325242|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44325243|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325244|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325245|NCT00956111|Vaccines|vaccines|mesh-list
44325246|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
44325247|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325248|NCT00956150|Rifaximin|rifaximin|mesh-list
44325249|NCT00956150|Lactulose|lactulose|mesh-list
44325250|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44325251|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325252|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325253|NCT00956163|Diphosphonates|diphosphonates|mesh-list
44325254|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
44325255|NCT00956163|Listerine|listerine|mesh-list
44325256|NCT00956163|Fluorides|fluorides|mesh-list
44325257|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
44325258|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
44325259|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
44325260|NCT00956163|Protective Agents|protective agents|mesh-ancestor
44325261|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325262|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44325263|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325264|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44325265|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325266|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44325268|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
44325269|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325270|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325271|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325272|NCT00956189|Aripiprazole|aripiprazole|mesh-list
44325273|NCT00956189|Amisulpride|amisulpride|mesh-list
44325275|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325276|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44325277|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325278|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325279|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325280|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
44325281|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
44325282|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325283|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325284|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44325285|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44325286|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
44325287|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44325288|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44325289|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44325290|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44325291|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44325293|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
44325294|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325295|NCT00956215|Aprepitant|aprepitant|mesh-list
44325296|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
44325297|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
44325298|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
44325299|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325300|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325301|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325302|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44325303|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325304|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325316|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44325317|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44325318|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325319|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325320|NCT00956319|Estazolam|estazolam|mesh-list
44325321|NCT00956319|Zolpidem|zolpidem|mesh-list
44325322|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44325323|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44325324|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325325|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325326|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44325327|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
44325328|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
44325329|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325330|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325331|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
44325332|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44325333|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325334|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325335|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
44325337|NCT00956397|Lactulose|lactulose|mesh-list
44325338|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44325339|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325340|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325341|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44325342|NCT00956436|Sorafenib|sorafenib|mesh-list
44325343|NCT00956436|Liver Extracts|liver extracts|mesh-list
44325344|NCT00956436|Antibodies|antibodies|mesh-list
44325345|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
44325346|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44325347|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
44325348|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325349|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325351|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325360|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325361|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325362|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325363|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
44325364|NCT00956462|Hormones|hormones|mesh-ancestor
44325365|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325366|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44325367|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325368|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44325369|NCT00956462|Analgesics|analgesics|mesh-ancestor
44325370|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
44325371|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44325372|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44325373|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325374|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325375|NCT00956644|Amlodipine|amlodipine|mesh-list
44325376|NCT00956644|Irbesartan|irbesartan|mesh-list
44325377|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44325378|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44325379|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325380|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325381|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325382|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325383|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44325384|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44325385|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44325386|NCT00956696|Topiramate|topiramate|mesh-list
44325387|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
44325402|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44325403|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325404|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325405|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325406|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
44325407|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325408|NCT00956748|Expectorants|expectorants|mesh-ancestor
44325409|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44325410|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44325411|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
44325412|NCT00956748|Protective Agents|protective agents|mesh-ancestor
44325413|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44325414|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44325415|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44325416|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44325417|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44325418|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
44325419|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325420|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468058|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44468059|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468060|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
44468061|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44468062|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44468063|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468085|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
44468086|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468087|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
44468088|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
44468089|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468090|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44468091|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44468092|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468093|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468094|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468095|NCT01441063|Zidovudine|zidovudine|mesh-list
44468096|NCT01441063|Valganciclovir|valganciclovir|mesh-list
44468097|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
44468098|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468099|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44468100|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44468101|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468102|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
44468103|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468104|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44468105|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44468106|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44468107|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
44468108|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468109|NCT01440816|Interleukin-12|interleukin-12|mesh-list
44468110|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44468111|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
44468112|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468113|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44468114|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44468115|NCT01440816|Growth Substances|growth substances|mesh-ancestor
44468116|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
44468117|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468118|NCT01440803|Teriparatide|teriparatide|mesh-list
44325426|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325427|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
44325428|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325429|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
44325430|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325431|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
44325432|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325433|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44325434|NCT00957060|Glimepiride|glimepiride|mesh-list
44325435|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44325436|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325437|NCT00957060|Incretins|incretins|mesh-ancestor
44325438|NCT00957060|Hormones|hormones|mesh-ancestor
44325439|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325440|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44325441|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44325442|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325443|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325444|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44325445|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325446|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
44325447|NCT00957125|Bevacizumab|bevacizumab|mesh-list
44325448|NCT00957125|Docetaxel|docetaxel|mesh-list
44325449|NCT00957125|Epirubicin|epirubicin|mesh-list
44325450|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325451|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325475|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44325476|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325477|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325478|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325479|NCT00957190|Timolol|timolol|mesh-list
44325480|NCT00957190|Dorzolamide|dorzolamide|mesh-list
44325481|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44325482|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44325483|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44325484|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325485|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325486|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325487|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44325488|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44325489|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44325490|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325491|NCT00957203|Istradefylline|istradefylline|mesh-list
44325492|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44325493|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44325494|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44325495|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
44325496|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325497|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325498|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325499|NCT00957216|Ubiquinone|ubiquinone|mesh-list
44325522|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325523|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
44325524|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44325525|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44325526|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44325527|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44325528|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
44325529|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44325530|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44325531|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
44325532|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325533|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
44325534|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44325535|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44325536|NCT00957385|Lenalidomide|lenalidomide|mesh-list
44325537|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
44325538|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325539|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325540|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43837608|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43837609|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
44325541|NCT00957385|Growth Substances|growth substances|mesh-ancestor
44325542|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325543|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325544|NCT00957411|Cisplatin|cisplatin|mesh-list
44325545|NCT00957411|Cetuximab|cetuximab|mesh-list
44325546|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325547|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325548|NCT00957554|Amlodipine|amlodipine|mesh-list
44325549|NCT00957554|Irbesartan|irbesartan|mesh-list
44325550|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44325551|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44325552|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325560|NCT00957866|Ribavirin|ribavirin|mesh-list
44325564|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
44325565|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325566|NCT00957879|Calcitriol|calcitriol|mesh-list
44325567|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
44325568|NCT00957879|Vitamin D|vitamin d|mesh-list
44325569|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325570|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325571|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44325572|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325573|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325574|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44325575|NCT00957879|Vitamins|vitamins|mesh-ancestor
44325576|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
44325577|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44325578|NCT00958022|Carboplatin|carboplatin|mesh-list
44325579|NCT00958022|Etoposide|etoposide|mesh-list
44325580|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
44325581|NCT00958022|Panobinostat|panobinostat|mesh-list
44325582|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
44325583|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325584|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325585|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44325586|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44325587|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325588|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325589|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44325590|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
44325591|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
44325592|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325593|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325594|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325595|NCT00958100|Tenofovir|tenofovir|mesh-list
44325596|NCT00958100|Lamivudine|lamivudine|mesh-list
44325597|NCT00958100|Emtricitabine|emtricitabine|mesh-list
44325598|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
44325599|NCT00958100|Abacavir|abacavir|mesh-list
44325605|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325606|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325607|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44325608|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44325609|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44325610|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44325611|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
44325612|NCT00958139|Permethrin|permethrin|mesh-list
43598973|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325613|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325614|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325615|NCT00958204|Fluoxetine|fluoxetine|mesh-list
44325616|NCT00958204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44325617|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44325618|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325619|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325620|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325621|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
44325622|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325623|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44325624|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44325625|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44325626|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44325627|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44325628|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325629|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44325630|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44325631|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325632|NCT00958269|Incretins|incretins|mesh-ancestor
44325633|NCT00958269|Hormones|hormones|mesh-ancestor
44325634|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44325635|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44325636|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44325644|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44325645|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43980605|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
44325646|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325647|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325648|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325649|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325650|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
44325651|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44325652|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
44325653|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325654|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
44325655|NCT00958425|Protective Agents|protective agents|mesh-ancestor
44325657|NCT00958451|Vitamin D|vitamin d|mesh-list
44325703|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44325704|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44325706|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44325707|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44325708|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
44468119|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468120|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468121|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44468122|NCT01440595|Ribavirin|ribavirin|mesh-list
44468123|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44468124|NCT01440595|Grazoprevir|grazoprevir|mesh-list
44468125|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
44468126|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598974|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
43598975|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598976|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598977|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598978|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
43598979|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468127|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
44468128|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468129|NCT01440569|Darunavir|darunavir|mesh-list
44468130|NCT01440569|Cobicistat|cobicistat|mesh-list
44325709|NCT05351606|Bupropion|bupropion|mesh-list
44325710|NCT05351606|Nicotine|nicotine|mesh-list
44325711|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44325712|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
44325713|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325714|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325715|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44325716|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44325717|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
44325718|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325719|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325736|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
44325737|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44325738|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
44325739|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325740|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325741|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44325742|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
44325743|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
44325744|NCT05351502|Protective Agents|protective agents|mesh-ancestor
44325745|NCT05351385|Dimercaprol|dimercaprol|mesh-list
44325746|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
44325747|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
44325748|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325749|NCT05351021|Metformin|metformin|mesh-list
44325750|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44325751|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325752|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
44325753|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44325754|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44325755|NCT05350384|Prednisolone|prednisolone|mesh-list
44325756|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
44325757|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44325758|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
44325759|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44325760|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
44325761|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
44325762|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325763|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325764|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44325765|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
44325766|NCT05350384|Hormones|hormones|mesh-ancestor
44325768|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44325779|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44325780|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325781|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44325782|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325783|NCT05254106|Paclitaxel|paclitaxel|mesh-list
44325784|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325785|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325786|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325787|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325788|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325789|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325790|NCT05212012|Methadone|methadone|mesh-list
44325791|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44325792|NCT05212012|Narcotics|narcotics|mesh-ancestor
44325793|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325794|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325795|NCT05212012|Analgesics|analgesics|mesh-ancestor
44325796|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
44325797|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325798|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
44325799|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
44325800|NCT05194969|Petrolatum|petrolatum|mesh-list
44325801|NCT05194969|Emollients|emollients|mesh-ancestor
44325802|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44325803|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
44325804|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
44325810|NCT05100654|Doxycycline|doxycycline|mesh-list
44325826|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44325827|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44468131|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44468132|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44468133|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
44468134|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468135|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468136|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44468137|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44468138|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
44468139|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468140|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44468141|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44468142|NCT01440101|Natalizumab|natalizumab|mesh-list
44468143|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
44468144|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468145|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
44468146|NCT01439945|Antacids|antacids|mesh-ancestor
44468147|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468148|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44468149|NCT01439880|Evolocumab|evolocumab|mesh-list
44468150|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44468151|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44468152|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
44468153|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468154|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44468155|NCT01439867|Cinacalcet|cinacalcet|mesh-list
44468156|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468157|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468158|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44468159|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
44325829|NCT05014061|Adenosine|adenosine|mesh-list
44325830|NCT05014061|Analgesics|analgesics|mesh-ancestor
44325831|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
44325832|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44325833|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325834|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44325835|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
44325836|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44325837|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
44325838|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
44325839|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325840|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325842|NCT05003245|Antibodies|antibodies|mesh-list
44325843|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44325844|NCT05003245|Mitogens|mitogens|mesh-list
44325845|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
44325846|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
44325847|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325848|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325849|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325850|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325851|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44325852|NCT05003245|Growth Substances|growth substances|mesh-ancestor
44325853|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325854|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325855|NCT04966663|Gemcitabine|gemcitabine|mesh-list
43764260|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44325856|NCT04966663|Cisplatin|cisplatin|mesh-list
44325857|NCT04966663|Carboplatin|carboplatin|mesh-list
44325858|NCT04966663|Nivolumab|nivolumab|mesh-list
44325859|NCT04966663|Pemetrexed|pemetrexed|mesh-list
44325860|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325861|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44325862|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
44325863|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325864|NCT04966663|Antiviral Agents|antiviral agents|mesh-ancestor
44325865|NCT04966663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325879|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44325880|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
44325881|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325882|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325883|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
44325884|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
44325885|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
44325886|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
44325887|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325888|NCT04919369|Protective Agents|protective agents|mesh-ancestor
44325889|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44325890|NCT04913805|Niacinamide|niacinamide|mesh-list
44325891|NCT04913805|Niacin|niacin|mesh-list
44325892|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
44325893|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
44325894|NCT04913805|Vitamins|vitamins|mesh-ancestor
44325895|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
44325896|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325897|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44325898|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
44325899|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325900|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44325901|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44325902|NCT04770493|Lamotrigine|lamotrigine|mesh-list
44325903|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
43980892|NCT02005601|Analgesics|analgesics|mesh-ancestor
44325904|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44325905|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44325906|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325907|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44325908|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325909|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44325910|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44325911|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325914|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
44325919|NCT04722718|Carboplatin|carboplatin|mesh-list
44325920|NCT04722718|Apatinib|apatinib|mesh-list
44325921|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44325922|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325923|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325924|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325925|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325926|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325927|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44325928|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325929|NCT04720547|Zolpidem|zolpidem|mesh-list
44325930|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44325931|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44325932|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44325933|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325934|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44325935|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
44325936|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
44325937|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44325938|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651736|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651739|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44325939|NCT04718285|Favipiravir|favipiravir|mesh-list
44325940|NCT04718285|Montelukast|montelukast|mesh-list
44325941|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44325942|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
44325943|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44325944|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
44325950|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
44325966|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44325967|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325968|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325969|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44325970|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44325971|NCT04588948|Aflibercept|aflibercept|mesh-list
44325972|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44325973|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44325974|NCT04588948|Growth Substances|growth substances|mesh-ancestor
44325975|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325976|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
44325977|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325978|NCT04577014|Gemcitabine|gemcitabine|mesh-list
44325980|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44325981|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
44325982|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44325983|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44325984|NCT04577014|Antiviral Agents|antiviral agents|mesh-ancestor
44325985|NCT04577014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44325986|NCT04577014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44325987|NCT04577014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44325988|NCT04577014|Immunologic Factors|immunologic factors|mesh-ancestor
44325989|NCT04577014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44325990|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
44325991|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
44325992|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
44325993|NCT04534023|Idebenone|idebenone|mesh-list
44326013|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44326014|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
44326015|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44326016|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326017|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326018|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326019|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
44326020|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
44326021|NCT04370509|Axitinib|axitinib|mesh-list
44326022|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326023|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326024|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44326025|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326026|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326027|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
44326028|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
44326029|NCT04355130|Vitamins|vitamins|mesh-ancestor
44326030|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
44326031|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326032|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
44326033|NCT04355130|Hematinics|hematinics|mesh-ancestor
44326034|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44326035|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326036|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
44326037|NCT04340505|Hormones|hormones|mesh-ancestor
44326038|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326039|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326040|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44326041|NCT04291105|Cemiplimab|cemiplimab|mesh-list
44326042|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326043|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468160|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468161|NCT01439711|Letrozole|letrozole|mesh-list
44468170|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326044|NCT04237012|Dexamethasone|dexamethasone|mesh-list
44326045|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
44326046|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326047|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
44326048|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
44326049|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326050|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326051|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326052|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
44326053|NCT04237012|Hormones|hormones|mesh-ancestor
44326054|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326055|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44326056|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326057|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44326058|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44326059|NCT04206163|Edotreotide|edotreotide|mesh-list
44326060|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44326061|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326062|NCT04170153|Niraparib|niraparib|mesh-list
44326063|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44326064|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326065|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326066|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326067|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44326068|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
44326069|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326070|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44326071|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44326072|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326074|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44326084|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326085|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
44326086|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
44326087|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326088|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326089|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326090|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
44326091|NCT03973177|Hormones|hormones|mesh-ancestor
44326092|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326093|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44326094|NCT03973177|Protective Agents|protective agents|mesh-ancestor
44326095|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44326096|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326097|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44326098|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326099|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
44326100|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44326101|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44326102|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
44326103|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326104|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326105|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
44326106|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44326107|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326108|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
44326134|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44326135|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44326136|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326137|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44326138|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326139|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326140|NCT03559192|Aticaprant|aticaprant|mesh-list
44326141|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44326142|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326143|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
44326144|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326145|NCT03549715|Durvalumab|durvalumab|mesh-list
44326146|NCT03549715|Tremelimumab|tremelimumab|mesh-list
44326147|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326148|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326149|NCT03387761|Nivolumab|nivolumab|mesh-list
44326150|NCT03387761|Ipilimumab|ipilimumab|mesh-list
44326151|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326152|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326153|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44326154|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326155|NCT03284502|Cetuximab|cetuximab|mesh-list
44326156|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326157|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326158|NCT03282799|Etonogestrel|etonogestrel|mesh-list
44326159|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44326160|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
44326161|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44326162|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326163|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44326164|NCT03047070|Lidocaine|lidocaine|mesh-list
44326165|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
44326166|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
44326174|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44326175|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326177|NCT03040778|Tocopherols|tocopherols|mesh-list
44326178|NCT03040778|Tocotrienols|tocotrienols|mesh-list
44326179|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
44326180|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
44326181|NCT03040778|Vitamins|vitamins|mesh-ancestor
44326182|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
44326183|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326184|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
44326185|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326186|NCT03040778|Protective Agents|protective agents|mesh-ancestor
44326187|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44326188|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326189|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44326190|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44326191|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
44326192|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44326193|NCT03024684|Atorvastatin|atorvastatin|mesh-list
44326194|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44326195|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44326196|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
44326197|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326198|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44326199|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44326200|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326201|NCT02968108|Ustekinumab|ustekinumab|mesh-list
44326202|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
44326203|NCT02897778|Entinostat|entinostat|mesh-list
44326204|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326205|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44326219|NCT02879409|Hormones|hormones|mesh-ancestor
44326220|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326221|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44326222|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326223|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326224|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326225|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44326226|NCT02815592|Cisplatin|cisplatin|mesh-list
44326227|NCT02815592|Carboplatin|carboplatin|mesh-list
44326228|NCT02815592|Etoposide|etoposide|mesh-list
44326229|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326230|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44326231|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44326232|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44326233|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326234|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326235|NCT02748707|Celecoxib|celecoxib|mesh-list
44326236|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44326237|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326238|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44326239|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326240|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326241|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326242|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326243|NCT02748707|Analgesics|analgesics|mesh-ancestor
44326244|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
44326245|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326246|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326247|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326248|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326249|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44326250|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326251|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44326252|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44468173|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468174|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44468175|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44468176|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44468177|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468178|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468179|NCT01439555|Simvastatin|simvastatin|mesh-list
44468180|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44468181|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44468182|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
44468183|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468184|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44468185|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44468186|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326254|NCT02573324|Temozolomide|temozolomide|mesh-list
44326255|NCT02573324|Immunoconjugates|immunoconjugates|mesh-list
44326256|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326257|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
44326258|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326259|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326260|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
44326261|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326262|NCT02465138|Ketorolac|ketorolac|mesh-list
44326263|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326264|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326265|NCT02465138|Analgesics|analgesics|mesh-ancestor
44326266|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
44326267|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326268|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326269|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326270|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326271|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326272|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326273|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326277|NCT02139397|Eflornithine|eflornithine|mesh-list
44326278|NCT02139397|Bortezomib|bortezomib|mesh-list
44326279|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326280|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44326281|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44326282|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44326283|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326284|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44326285|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326286|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326287|NCT01095003|Capecitabine|capecitabine|mesh-list
44326288|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326289|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
44326290|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326291|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326292|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
44326293|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44326294|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326295|NCT00958633|Citalopram|citalopram|mesh-list
44326296|NCT00958633|Bupropion|bupropion|mesh-list
44326297|NCT00958633|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44326298|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44326299|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44326300|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326301|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326302|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
44326303|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326304|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44326305|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
44326306|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44326307|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44326308|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
44326316|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
44326317|NCT00958854|Fludarabine|fludarabine|mesh-list
44326318|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
44326319|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44326320|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
44326321|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326322|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326323|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326324|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
44326325|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326326|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326327|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44326328|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326329|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
44326330|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
44326331|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44326332|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326333|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44326334|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44326335|NCT00958854|Growth Substances|growth substances|mesh-ancestor
44326336|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
44326337|NCT00958906|Infliximab|infliximab|mesh-list
44326338|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44326339|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326341|NCT00959062|Clonidine|clonidine|mesh-list
44326368|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326369|NCT00959218|Analgesics|analgesics|mesh-ancestor
44326370|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
44326371|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326372|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44326373|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44326374|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326375|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326376|NCT00959218|Hormones|hormones|mesh-ancestor
44326377|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326378|NCT00959231|Cyclosporine|cyclosporine|mesh-list
44326379|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
44326380|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
44326381|NCT00959231|Fludarabine|fludarabine|mesh-list
44326382|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
44326383|NCT00959231|Cyclosporins|cyclosporins|mesh-list
44326384|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44326385|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
44326386|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326387|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326388|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326389|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
44326390|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326391|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326392|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44326393|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43981401|NCT02030574|Cisplatin|cisplatin|mesh-list
44326414|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44326415|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44326416|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44326417|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326418|NCT00959400|Fentanyl|fentanyl|mesh-list
44326419|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44326420|NCT00959400|Narcotics|narcotics|mesh-ancestor
44326421|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326422|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326423|NCT00959400|Analgesics|analgesics|mesh-ancestor
44326424|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
44326425|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326426|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44326427|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44326428|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
44326429|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
44326430|NCT00959439|Naproxen|naproxen|mesh-list
44326431|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326432|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326433|NCT00959439|Analgesics|analgesics|mesh-ancestor
44326434|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
44326435|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326436|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326437|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326438|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326439|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
44326440|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326441|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326442|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326443|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
44326444|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
44326445|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326446|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
44326447|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326448|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326454|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44326455|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
44326456|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44326457|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44326458|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326459|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326460|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
44326461|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
44326462|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44326463|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
44326465|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326466|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44326467|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326468|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326469|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44326470|NCT00959517|Renal Agents|renal agents|mesh-ancestor
44326471|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44326472|NCT00959569|Esmolol|esmolol|mesh-list
44326473|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44326474|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
44326475|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326476|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326477|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326478|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44326479|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44326480|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44326481|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326482|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44326497|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326498|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326499|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44326500|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44326501|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326502|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44326503|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326504|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326505|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
44468187|NCT01439373|Interferons|interferons|mesh-list
44468188|NCT01439373|Ribavirin|ribavirin|mesh-list
44468189|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
44468190|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
44468191|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44468192|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468193|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
44468194|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468195|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
44468196|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468197|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
44468198|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468199|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44468200|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
44468201|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468202|NCT01439347|Vincristine|vincristine|mesh-list
44468203|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44468204|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468225|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468226|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468227|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44468228|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
44468229|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
44468230|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44468231|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44468232|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468233|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468234|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326506|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44326507|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326508|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
44326509|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326510|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326511|NCT00959725|Infliximab|infliximab|mesh-list
44326512|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44326513|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326514|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326515|NCT00959777|Lenograstim|lenograstim|mesh-list
44326516|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44326517|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
44326518|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326519|NCT00959881|Donepezil|donepezil|mesh-list
44326520|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44326521|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326522|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326523|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
44326524|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326525|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326526|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
44326527|NCT00959933|Ribavirin|ribavirin|mesh-list
44326528|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
44326530|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
44326537|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44326538|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
44326539|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326540|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326541|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44326542|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44326543|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44326544|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326545|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326546|NCT00960037|Vitamin D|vitamin d|mesh-list
44326547|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
44326548|NCT00960037|Vitamins|vitamins|mesh-ancestor
44326549|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
44326550|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326551|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326552|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44326553|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
44326554|NCT00960232|Vitamin D|vitamin d|mesh-list
44326555|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44326556|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326557|NCT00960232|Vitamins|vitamins|mesh-ancestor
44326558|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
44326559|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44326560|NCT00960245|Nadolol|nadolol|mesh-list
44326561|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44326562|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44326563|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
44326564|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326565|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326582|NCT00960284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326583|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326584|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44326585|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
44326586|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326587|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44326588|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44326589|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44326590|NCT00960310|Bicalutamide|bicalutamide|mesh-list
44326591|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
44326592|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
44326593|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326594|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326595|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326596|NCT00960336|Doxorubicin|doxorubicin|mesh-list
44326597|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44326598|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44326599|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326600|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44326601|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44326602|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326603|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326604|NCT00960349|Cisplatin|cisplatin|mesh-list
44326605|NCT00960349|Capecitabine|capecitabine|mesh-list
44326606|NCT00960349|Cediranib|cediranib|mesh-list
44326607|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326608|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326609|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
44326610|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326611|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44326612|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326613|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44326623|NCT00960479|Ribavirin|ribavirin|mesh-list
44326624|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
44326625|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326626|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
44326627|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326628|NCT00960492|Temozolomide|temozolomide|mesh-list
44326629|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326630|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
44326631|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326632|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326633|NCT00960518|Adefovir|adefovir|mesh-list
44326634|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
44326635|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326636|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44326637|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44326638|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326639|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326640|NCT00960544|Capecitabine|capecitabine|mesh-list
44326641|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326642|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
44326643|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326644|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326645|NCT00960557|Combretastatin|combretastatin|mesh-list
44326646|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44326647|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326648|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
44326649|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
44326650|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
44326651|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326652|NCT00960635|Vitamin D|vitamin d|mesh-list
44326653|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
44326654|NCT00960635|Calcitriol|calcitriol|mesh-list
44326664|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44326665|NCT00960713|Rituximab|rituximab|mesh-list
44326666|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326667|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326668|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
44326669|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326670|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326671|NCT00960739|Topotecan|topotecan|mesh-list
44326672|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44326673|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44326674|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44326675|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326676|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326677|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326678|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44326679|NCT00960817|Aspirin|aspirin|mesh-list
44326680|NCT00960817|Dipyridamole|dipyridamole|mesh-list
44326681|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326682|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326683|NCT00960817|Analgesics|analgesics|mesh-ancestor
44326684|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
44326685|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326686|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326687|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326688|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326689|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44326690|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44326712|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44326713|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
44326714|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44326715|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44326716|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
44326717|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44326718|NCT00960921|Iron|iron|mesh-list
44326719|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44326720|NCT00960921|Trace Elements|trace elements|mesh-ancestor
44326721|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
44326722|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326723|NCT00960921|Hematinics|hematinics|mesh-ancestor
44326724|NCT00960960|Paclitaxel|paclitaxel|mesh-list
44326725|NCT00960960|Bevacizumab|bevacizumab|mesh-list
44326726|NCT00960960|Trastuzumab|trastuzumab|mesh-list
44326727|NCT00960960|Letrozole|letrozole|mesh-list
44326728|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44326729|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326730|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44326732|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44326733|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326734|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326735|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44326736|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44326737|NCT00960960|Growth Substances|growth substances|mesh-ancestor
44326738|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326739|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
44326740|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44326741|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44326742|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326743|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44326744|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
44326745|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326746|NCT00960973|Menatetrenone|menatetrenone|mesh-list
44326747|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
44326748|NCT00960973|Coagulants|coagulants|mesh-ancestor
44326749|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
43738510|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
44326751|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326752|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44326753|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44326754|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326755|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326756|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326757|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44326758|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44326759|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
44326760|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326761|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
44326762|NCT00961155|Montelukast|montelukast|mesh-list
44326763|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44326764|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
44326765|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326766|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326767|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44326768|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
44326769|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44326770|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44326771|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44326772|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
44326773|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326774|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326775|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44326776|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
44326777|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326778|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44326779|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44326780|NCT00961194|Ketamine|ketamine|mesh-list
44326781|NCT00961194|Analgesics|analgesics|mesh-ancestor
44326782|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
44326783|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326789|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44326790|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44326791|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44326792|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44326793|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326794|NCT00961324|Insulin|insulin|mesh-list
44326795|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44326796|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
44326797|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326798|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326799|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44326800|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326801|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326802|NCT00961363|Incretins|incretins|mesh-ancestor
44326803|NCT00961363|Hormones|hormones|mesh-ancestor
44326804|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326805|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44326806|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326807|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326808|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326809|NCT00961467|Thalidomide|thalidomide|mesh-list
44326810|NCT00961467|Prednisone|prednisone|mesh-list
44326811|NCT00961467|Melphalan|melphalan|mesh-list
44326812|NCT00961467|Lenalidomide|lenalidomide|mesh-list
44326813|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326814|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
44326815|NCT00961467|Hormones|hormones|mesh-ancestor
44326816|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326817|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326818|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44326819|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326820|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326821|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
44326822|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326823|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44326825|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
44326826|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44326827|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44326828|NCT00961467|Growth Substances|growth substances|mesh-ancestor
44326829|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
44326830|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
44326831|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44326832|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326834|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44326835|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326836|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326837|NCT00961480|Incretins|incretins|mesh-ancestor
44326838|NCT00961480|Hormones|hormones|mesh-ancestor
44326839|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326840|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44326841|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326842|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326843|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326844|NCT00961753|Ibuprofen|ibuprofen|mesh-list
44326845|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44326846|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44326847|NCT00961753|Analgesics|analgesics|mesh-ancestor
44326848|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
44326849|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44326850|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326851|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326852|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326853|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326854|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468248|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468249|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
44468250|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44468251|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44468252|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468253|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44468254|NCT01438957|Analgesics|analgesics|mesh-ancestor
44468255|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
44326856|NCT00961844|Temozolomide|temozolomide|mesh-list
44326857|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44326858|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
44326859|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326860|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326862|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44326863|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326864|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326865|NCT00961857|Incretins|incretins|mesh-ancestor
44326866|NCT00961857|Hormones|hormones|mesh-ancestor
44326867|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326868|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44326869|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
44326870|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326871|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326872|NCT00961909|Metformin|metformin|mesh-list
44326873|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44326874|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326875|NCT00962026|Rilonacept|rilonacept|mesh-list
44326876|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326877|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44326878|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
44326879|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
44326880|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
44326881|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326882|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44326883|NCT00962234|Protective Agents|protective agents|mesh-ancestor
44124313|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124314|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326884|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326885|NCT00962286|Furosemide|furosemide|mesh-list
44326886|NCT00962286|Diuretics|diuretics|mesh-ancestor
44326887|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
44326888|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326889|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44326890|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44326891|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326892|NCT00962299|Beclomethasone|beclomethasone|mesh-list
44326893|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326894|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
44326895|NCT00962299|Hormones|hormones|mesh-ancestor
44326896|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326897|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326898|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44326899|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
44326900|NCT00962312|Capecitabine|capecitabine|mesh-list
44326901|NCT00962312|Lapatinib|lapatinib|mesh-list
44326902|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44326903|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
44326904|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326905|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326906|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44326907|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326908|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
44326909|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44326910|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
44326911|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326912|NCT00962442|Expectorants|expectorants|mesh-ancestor
44326913|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44326914|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44326915|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
44326916|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326917|NCT00962442|Protective Agents|protective agents|mesh-ancestor
44326924|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
44326925|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326926|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44326927|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326928|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326930|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
44326931|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326932|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44326933|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326934|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326935|NCT00962624|Vaccines|vaccines|mesh-list
44326936|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
44326937|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326938|NCT00962637|Citric Acid|citric acid|mesh-list
44326939|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
44326940|NCT00962637|Enclomiphene|enclomiphene|mesh-list
44326941|NCT00962637|Clomiphene|clomiphene|mesh-list
44326942|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
44326943|NCT00962637|Testosterone|testosterone|mesh-list
44326944|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
44326945|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44326946|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
44326947|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
44326948|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326949|NCT00962637|Androgens|androgens|mesh-ancestor
44326950|NCT00962637|Hormones|hormones|mesh-ancestor
44326951|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44326952|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326953|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44326954|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
44326967|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44326968|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44326969|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44326970|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326971|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326972|NCT00962715|Interferons|interferons|mesh-list
44326973|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
44326974|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
44326975|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44326976|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326977|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
44326978|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326979|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
44326980|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44326981|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
44326982|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326983|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326984|NCT00962936|Pidilizumab|pidilizumab|mesh-list
44326985|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44326986|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44326987|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44326988|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
44326989|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44326990|NCT00963001|Treprostinil|treprostinil|mesh-list
44326991|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44326992|NCT00963027|Treprostinil|treprostinil|mesh-list
44326993|NCT00963027|Esomeprazole|esomeprazole|mesh-list
44326994|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44326995|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44326996|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44326997|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44326998|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44326999|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327000|NCT00963040|Oxytocin|oxytocin|mesh-list
44327001|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
44327002|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44327003|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327004|NCT00963131|Antioxidants|antioxidants|mesh-list
44124315|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327005|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327006|NCT00963131|Protective Agents|protective agents|mesh-ancestor
44327007|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327008|NCT00963209|Tamoxifen|tamoxifen|mesh-list
44327009|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44327010|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44327011|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327012|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327013|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44327014|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327015|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44327016|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44327017|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44327018|NCT00963222|Vitamin A|vitamin a|mesh-list
44327019|NCT00963222|Vitamins|vitamins|mesh-ancestor
44327020|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
44327021|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327022|NCT00963274|Bortezomib|bortezomib|mesh-list
44327023|NCT00963274|Romidepsin|romidepsin|mesh-list
44327024|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327025|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327026|NCT00963313|Adalimumab|adalimumab|mesh-list
44327027|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327028|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327029|NCT00963443|Aspirin|aspirin|mesh-list
44327030|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
44327031|NCT00963443|Ephedrine|ephedrine|mesh-list
44327032|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44327033|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327034|NCT00963443|Analgesics|analgesics|mesh-ancestor
44327035|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
44327036|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124316|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
44124317|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
44124318|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44124319|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
44124320|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44124321|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124322|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124323|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124324|NCT00132561|Renal Agents|renal agents|mesh-ancestor
44124326|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124327|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44327037|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327038|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327039|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327040|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44327041|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44327042|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327043|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44327044|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44327045|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327046|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
44327047|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44327048|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
44327049|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44327050|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44327051|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
44327052|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44327053|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44327054|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
44327055|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327056|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327057|NCT00963534|Rituximab|rituximab|mesh-list
44327058|NCT00963534|Lenalidomide|lenalidomide|mesh-list
44327059|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44327060|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327061|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738768|NCT02407509|Everolimus|everolimus|mesh-list
44124328|NCT00132587|Protective Agents|protective agents|mesh-ancestor
44124329|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124330|NCT00132600|Bacitracin|bacitracin|mesh-list
44124331|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44124332|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124333|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124334|NCT00132613|Bleomycin|bleomycin|mesh-list
44124335|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124336|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124337|NCT00132639|Cisplatin|cisplatin|mesh-list
44124338|NCT00132639|Docetaxel|docetaxel|mesh-list
44124339|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124340|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124341|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124342|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124343|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124344|NCT00132652|Lamivudine|lamivudine|mesh-list
44124345|NCT00132652|Telbivudine|telbivudine|mesh-list
44124346|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44124347|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44124348|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124349|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124350|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
44124351|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327062|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
44327063|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327064|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327065|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44327066|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44327067|NCT00963534|Growth Substances|growth substances|mesh-ancestor
44327068|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
44327069|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44327070|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
44327071|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327072|NCT00963573|Loratadine|loratadine|mesh-list
44327073|NCT00963573|Betamethasone|betamethasone|mesh-list
44327074|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327075|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
44327076|NCT00963573|Hormones|hormones|mesh-ancestor
44327077|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327078|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327079|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44327080|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44327081|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
44327082|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
44327083|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44327084|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44327085|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44124352|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44124353|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44124354|NCT00132743|Cilostazol|cilostazol|mesh-list
44124355|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44124356|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
44124357|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124361|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44124362|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44124363|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124364|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44124365|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124366|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44124367|NCT00132743|Protective Agents|protective agents|mesh-ancestor
44124368|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44124369|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44124370|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124371|NCT00132756|Estramustine|estramustine|mesh-list
44124372|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44124373|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
44124374|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124375|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124376|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44124377|NCT00132821|Bupropion|bupropion|mesh-list
44124378|NCT00132821|Nicotine|nicotine|mesh-list
44124379|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44327086|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
44327087|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
44327088|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327089|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327090|NCT00963664|Interferons|interferons|mesh-list
44327091|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
44327092|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
44327093|NCT00963664|Lovastatin|lovastatin|mesh-list
44327094|NCT00963664|L 647318|l 647318|mesh-list
44327095|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
44327096|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327097|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
44327098|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327099|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
44327100|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327101|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44327102|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327103|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
44327104|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327105|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327106|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44327107|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327108|NCT00963690|Hemostatics|hemostatics|mesh-list
44327109|NCT00963690|Coagulants|coagulants|mesh-ancestor
44327110|NCT00963703|Rituximab|rituximab|mesh-list
43738816|NCT02095184|Letrozole|letrozole|mesh-list
44124380|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
44124381|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124382|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124383|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44124384|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44124385|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
44124386|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124387|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124388|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44124389|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
44124390|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44124391|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44124392|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44124393|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124394|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
44124395|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44124396|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44124397|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124398|NCT00132860|Azithromycin|azithromycin|mesh-list
44124400|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44154855|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154856|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44154857|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44154858|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327111|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327112|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327113|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
44327114|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327115|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468256|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468257|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44468258|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44468259|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468260|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468261|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468262|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468263|NCT01438840|Maleic acid|maleic acid|mesh-list
44468264|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468265|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468266|NCT01438814|Metformin|metformin|mesh-list
44468267|NCT01438814|Linagliptin|linagliptin|mesh-list
44154859|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44154860|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44154861|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
44154862|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154863|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154864|NCT00225238|Esomeprazole|esomeprazole|mesh-list
44154865|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44154866|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44154867|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44154868|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154869|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154870|NCT00225264|Pioglitazone|pioglitazone|mesh-list
44154871|NCT00225264|Glimepiride|glimepiride|mesh-list
44154872|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44154873|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154874|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44154875|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154876|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
44154877|NCT00225290|Thalidomide|thalidomide|mesh-list
44154878|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44154879|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
44154880|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154881|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
44154882|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124454|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124455|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44124456|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124457|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124458|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
44124459|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44124460|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124515|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124516|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
44124517|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124518|NCT00133250|Heparin|heparin|mesh-list
44124519|NCT00133250|Calcium heparin|calcium heparin|mesh-list
44124520|NCT00133250|Abciximab|abciximab|mesh-list
44124521|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
44124522|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44124523|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43701992|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44468268|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468269|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468270|NCT01438814|Incretins|incretins|mesh-ancestor
44468271|NCT01438814|Hormones|hormones|mesh-ancestor
44468272|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468273|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44468274|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
44468275|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468276|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468277|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44468278|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
44468279|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468280|NCT01438424|Lamivudine|lamivudine|mesh-list
44468281|NCT01438424|Entecavir|entecavir|mesh-list
44468282|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44468283|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44468284|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468285|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468286|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
44468287|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468288|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44468289|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44468290|NCT01438411|Cholic Acids|cholic acids|mesh-list
44468291|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44468292|NCT01438177|Chloroquine|chloroquine|mesh-list
44468293|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
44124524|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767652|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44124525|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44124526|NCT00133276|Citalopram|citalopram|mesh-list
44124527|NCT00133276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44124528|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44124529|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124530|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124531|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124532|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
44124533|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124534|NCT00133276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44124535|NCT00133276|Antidepressive Agents|antidepressive agents|mesh-ancestor
44124536|NCT00133276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44124537|NCT00133315|Adalimumab|adalimumab|mesh-list
44124538|NCT00133315|Etanercept|etanercept|mesh-list
44124539|NCT00133315|Infliximab|infliximab|mesh-list
44124540|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124574|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124575|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124576|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44124577|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
44124578|NCT00133367|Sirolimus|sirolimus|mesh-list
44468294|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44468295|NCT01438177|Bortezomib|bortezomib|mesh-list
44468296|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44468297|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
44468298|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468299|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327116|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
44327118|NCT00963729|Fluorouracil|fluorouracil|mesh-list
44327119|NCT00963729|Letrozole|letrozole|mesh-list
44327120|NCT00963729|Epirubicin|epirubicin|mesh-list
44327121|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327122|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
44327123|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327124|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327125|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44327126|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
44327127|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327128|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327129|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44327130|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327131|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
44327132|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
44327133|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
44124579|NCT00133367|Fludarabine|fludarabine|mesh-list
44124580|NCT00133367|Melphalan|melphalan|mesh-list
44124581|NCT00133367|Tacrolimus|tacrolimus|mesh-list
44124582|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
44124583|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44124584|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124585|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124586|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124587|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
44124588|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124589|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44124590|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124591|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124592|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124593|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124594|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
44124595|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44124596|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
44124597|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44124598|NCT00133380|Atorvastatin|atorvastatin|mesh-list
44124599|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124600|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124601|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
44124602|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124603|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124604|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44124605|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124606|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
44124607|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44124608|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701993|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44327135|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44327136|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44327137|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327138|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44327139|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
44327140|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327141|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327142|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44327143|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327144|NCT00963768|Canagliflozin|canagliflozin|mesh-list
44327145|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44327146|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327147|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327148|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327149|NCT00963833|Interferons|interferons|mesh-list
44327150|NCT00963833|Interferon-beta|interferon-beta|mesh-list
44327151|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
44327152|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327153|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
44327154|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327155|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
44124609|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124610|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44124611|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44124612|NCT00133393|Protective Agents|protective agents|mesh-ancestor
44124613|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124614|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124615|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44124616|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
44124617|NCT00133406|Vitamin A|vitamin a|mesh-list
44124618|NCT00133406|Glycine|glycine|mesh-list
44124619|NCT00133406|Vitamins|vitamins|mesh-ancestor
44124620|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
44124621|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124622|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124623|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
44124624|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124625|NCT00133419|Vitamins|vitamins|mesh-list
44124626|NCT00133419|Vitamin A|vitamin a|mesh-list
44124628|NCT00133419|Trace Elements|trace elements|mesh-list
44124629|NCT00133419|Micronutrients|micronutrients|mesh-list
44124630|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
44124631|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124632|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
44124633|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124634|NCT00133419|Protective Agents|protective agents|mesh-ancestor
44124635|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44124636|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124637|NCT00133445|Vaccines|vaccines|mesh-list
44124638|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
44327156|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327157|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44327159|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44327160|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327161|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327162|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327163|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327164|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327165|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44327166|NCT00963846|Protective Agents|protective agents|mesh-ancestor
44327167|NCT00963976|Enalapril|enalapril|mesh-list
44327168|NCT00963976|Labetalol|labetalol|mesh-list
44327169|NCT00963976|Hydralazine|hydralazine|mesh-list
44327170|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44327171|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327172|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327173|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327174|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327175|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44327176|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44327177|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327178|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327179|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327180|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
44327181|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
44327182|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327204|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327205|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327206|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
44327207|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327208|NCT00964080|Antidotes|antidotes|mesh-ancestor
44327209|NCT00964080|Protective Agents|protective agents|mesh-ancestor
44327210|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
44327211|NCT00964080|Vitamins|vitamins|mesh-ancestor
44327212|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
44327213|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
44327214|NCT00964106|Rifampin|rifampin|mesh-list
44327215|NCT00964106|Fluconazole|fluconazole|mesh-list
44327216|NCT00964106|Ketoconazole|ketoconazole|mesh-list
44327217|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
44327218|NCT00964106|Midazolam|midazolam|mesh-list
44327219|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
44327220|NCT00964106|Caffeine|caffeine|mesh-list
44327221|NCT00964106|Omeprazole|omeprazole|mesh-list
44327222|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44327223|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44327224|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44327225|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327226|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327227|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44327259|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44327260|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44327261|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44327262|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44327263|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327264|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
44327265|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44327266|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44327267|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44327268|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
44327269|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327270|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44327271|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44327272|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44327273|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
44327274|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44327275|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44327276|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44327277|NCT00964106|Analgesics|analgesics|mesh-ancestor
44327278|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
44327279|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327280|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44327281|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327282|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327283|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327284|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44327286|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44327287|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327299|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327300|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327301|NCT00964262|Exenatide|exenatide|mesh-list
44327302|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327303|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327304|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44327305|NCT00964262|Incretins|incretins|mesh-ancestor
44327306|NCT00964262|Hormones|hormones|mesh-ancestor
44327307|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327308|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44327309|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44327310|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327311|NCT00964288|Lidocaine|lidocaine|mesh-list
44327312|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
44327313|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
44327314|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327315|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327316|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
44327317|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327318|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327319|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44327320|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44327321|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327322|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327323|NCT00964327|Darunavir|darunavir|mesh-list
44327324|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44327325|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44327326|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327327|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327328|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327329|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44327330|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44327331|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
44327332|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327333|NCT00964418|Insulin|insulin|mesh-list
44327334|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43739000|NCT00655993|Simvastatin|simvastatin|mesh-list
44124639|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327335|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
44327336|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327337|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327338|NCT00964457|Cetuximab|cetuximab|mesh-list
44327339|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327340|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327341|NCT00964535|Budesonide|budesonide|mesh-list
44327342|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
44327343|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44327344|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327345|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44327346|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
44327347|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327348|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327349|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44327350|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44327351|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
44327352|NCT00964535|Hormones|hormones|mesh-ancestor
44124640|NCT00133458|Albendazole|albendazole|mesh-list
44124641|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
44124642|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44124643|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124644|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
44124645|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44124646|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44124647|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124725|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44124726|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
44124727|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44124728|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44124729|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44124730|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124731|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124732|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
44124733|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124734|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124735|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44124736|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44124737|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124738|NCT00133770|Pantoprazole|pantoprazole|mesh-list
44124739|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44124740|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124741|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44124742|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124743|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124744|NCT00133796|Trastuzumab|trastuzumab|mesh-list
44124745|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44124746|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124747|NCT00133822|Risperidone|risperidone|mesh-list
44124748|NCT00133822|Sertraline|sertraline|mesh-list
44124749|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44124750|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
44124751|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124752|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124753|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124754|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44327353|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327354|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44327356|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44327357|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327358|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327359|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327360|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44327361|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
44327362|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44327363|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327364|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
44327365|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44327366|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327367|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327368|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327369|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327370|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44327371|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44327372|NCT00964574|Insulin|insulin|mesh-list
44327373|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44327374|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
44327375|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
44327376|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327377|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327378|NCT00964626|Paclitaxel|paclitaxel|mesh-list
44327379|NCT00964626|Cisplatin|cisplatin|mesh-list
44327380|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44327381|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327382|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327395|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
44327396|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327397|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
44327398|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327400|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
44327401|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
44327402|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44327403|NCT00964691|Amebicides|amebicides|mesh-ancestor
44327404|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44327405|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44327406|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327407|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
44327408|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327409|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44327410|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327411|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327412|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44327413|NCT00964691|Renal Agents|renal agents|mesh-ancestor
44327414|NCT00964704|Bevacizumab|bevacizumab|mesh-list
44327415|NCT00964704|Trastuzumab|trastuzumab|mesh-list
44327416|NCT00964704|Docetaxel|docetaxel|mesh-list
44327417|NCT00964704|Capecitabine|capecitabine|mesh-list
44327418|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327419|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327420|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44327421|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44327422|NCT00964704|Growth Substances|growth substances|mesh-ancestor
44327423|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768451|NCT02394418|Analgesics|analgesics|mesh-ancestor
44327424|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
44327425|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327426|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44327427|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
44327428|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327429|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327430|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
44124755|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44124756|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44124757|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44124758|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44327431|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
44327432|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44327433|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327434|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44327435|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327436|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327437|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327438|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327439|NCT00964756|Ganciclovir|ganciclovir|mesh-list
44327440|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44327441|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
44327442|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327443|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327444|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327445|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327446|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44327447|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
44327448|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327449|NCT00964808|Oxycodone|oxycodone|mesh-list
44327450|NCT00964808|Buprenorphine|buprenorphine|mesh-list
44327451|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44327452|NCT00964808|Narcotics|narcotics|mesh-ancestor
44327453|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327454|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327455|NCT00964808|Analgesics|analgesics|mesh-ancestor
44327456|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
44327457|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327458|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44327459|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44327460|NCT00964834|Doxycycline|doxycycline|mesh-list
44327461|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44327462|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327475|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327476|NCT00965107|Thiopental|thiopental|mesh-list
44327477|NCT00965107|Propofol|propofol|mesh-list
44327478|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44327479|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327480|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327481|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44327482|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
44327483|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
44327484|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
44327485|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
44327486|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
44327487|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327488|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327489|NCT00965120|Bradykinin|bradykinin|mesh-list
44327490|NCT00965120|Kininogens|kininogens|mesh-list
44327491|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
44327492|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327493|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44327494|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327495|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327496|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327497|NCT00965172|Calcium|calcium|mesh-list
44327498|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44327499|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327500|NCT00965289|Rituximab|rituximab|mesh-list
44327501|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327502|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327503|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
44327504|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327505|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327506|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44327507|NCT00965315|Fenofibrate|fenofibrate|mesh-list
44124759|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
44124760|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
44124848|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124849|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44124851|NCT00134095|Tegafur|tegafur|mesh-list
44124852|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44124853|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327508|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44327509|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327510|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
44327511|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327512|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327513|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44327514|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327515|NCT00965393|Bradykinin|bradykinin|mesh-list
44327516|NCT00965393|Kininogens|kininogens|mesh-list
44327517|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
44327518|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327519|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44327520|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327521|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327522|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327523|NCT00965406|Insulin|insulin|mesh-list
44327524|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327525|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327526|NCT00965549|Insulin|insulin|mesh-list
44327527|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44327528|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
44327529|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
44327530|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
44327531|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327532|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327533|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
44327534|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43835002|NCT05082025|Fulvestrant|fulvestrant|mesh-list
44124854|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124855|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124856|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124857|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44124858|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
44124859|NCT00134147|Insulin|insulin|mesh-list
44124860|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44124861|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124862|NCT00134160|Amlodipine|amlodipine|mesh-list
44124863|NCT00134160|Olmesartan|olmesartan|mesh-list
44124864|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44124865|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
44124866|NCT00134160|Calcium|calcium|mesh-list
44124867|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44124868|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124869|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124870|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124871|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124872|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124983|NCT00134511|Atorvastatin|atorvastatin|mesh-list
44327535|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327536|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327537|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327538|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327539|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327540|NCT00965653|Folic Acid|folic acid|mesh-list
44327541|NCT00965653|Methotrexate|methotrexate|mesh-list
44327542|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44327543|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
44327544|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44327545|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327546|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327547|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
44327548|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327549|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327550|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44327551|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327552|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44327553|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327554|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
44327555|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327556|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327557|NCT00965653|Hematinics|hematinics|mesh-ancestor
44327558|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
44327559|NCT00965653|Vitamins|vitamins|mesh-ancestor
44327560|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
44468300|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44468301|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
44124984|NCT00134511|Torcetrapib|torcetrapib|mesh-list
44124985|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124986|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124987|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
44124988|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124989|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124990|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44124991|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124992|NCT00134550|Atorvastatin|atorvastatin|mesh-list
44124993|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124994|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124995|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
44124996|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124997|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124998|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44125120|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44468302|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468303|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468304|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44468305|NCT01438177|Amebicides|amebicides|mesh-ancestor
44327561|NCT00965666|Etanercept|etanercept|mesh-list
44327562|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44327563|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327564|NCT00965666|Analgesics|analgesics|mesh-ancestor
44327565|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
44327566|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327567|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327568|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327569|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327570|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44327571|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327572|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
44327573|NCT00965796|Lidocaine|lidocaine|mesh-list
44327574|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
44327575|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
44327576|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327577|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125121|NCT00134953|Protective Agents|protective agents|mesh-ancestor
44125122|NCT00134966|Levodopa|levodopa|mesh-list
44125123|NCT00134966|Carbidopa|carbidopa|mesh-list
44125124|NCT00134966|Entacapone|entacapone|mesh-list
44125125|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44125126|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44125127|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
44125128|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125129|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125130|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125131|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44125132|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125133|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44125134|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
44125135|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44125136|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
44125137|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125138|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125139|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44125140|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44125141|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44125142|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44125143|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44125144|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
44125145|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125146|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125147|NCT00134992|Prednisolone|prednisolone|mesh-list
44125148|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44125149|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
44125150|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44125151|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
44125152|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44327578|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
44327579|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327580|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327581|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44327582|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44327583|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327584|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327586|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
44327587|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327588|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44327589|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327590|NCT00965809|Analgesics|analgesics|mesh-ancestor
44327591|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
44327592|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327593|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44327594|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44327595|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327596|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327597|NCT00965809|Hormones|hormones|mesh-ancestor
44327598|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44327599|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
44327600|NCT00965874|Analgesics|analgesics|mesh-ancestor
44327601|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
44327602|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327603|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327604|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
44327605|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327606|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327607|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
44327608|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44327609|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327610|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327611|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44327614|NCT00965900|Propranolol|propranolol|mesh-list
44327615|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44327616|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44327617|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327618|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327619|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327620|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327621|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327622|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327623|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327624|NCT00965913|Nicotine|nicotine|mesh-list
44327625|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44327626|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
44327627|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327628|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327629|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44327630|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44327631|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327632|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327633|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327635|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44327636|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44327637|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44327638|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327639|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327640|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739267|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125153|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
44125154|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125155|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
44125156|NCT00134992|Hormones|hormones|mesh-ancestor
44125157|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125158|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125159|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125160|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125161|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
44125162|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
44125163|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125164|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125165|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44125166|NCT00134992|Protective Agents|protective agents|mesh-ancestor
44125167|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
44125168|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125169|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44327641|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327643|NCT00965991|Metformin|metformin|mesh-list
44327644|NCT00965991|Glyburide|glyburide|mesh-list
44327645|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44327646|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327647|NCT00966004|Mirabegron|mirabegron|mesh-list
44327648|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44327649|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44327650|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44327651|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44327652|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327653|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327654|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327655|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327656|NCT00966004|Urological Agents|urological agents|mesh-ancestor
44327657|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44327658|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44327659|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327660|NCT00966056|Mitomycins|mitomycins|mesh-list
44327661|NCT00966056|Mitomycin|mitomycin|mesh-list
44327662|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327663|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327664|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
44327665|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327666|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327667|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327668|NCT00966082|Propranolol|propranolol|mesh-list
44327669|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44327670|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44327671|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327672|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125170|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125285|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125286|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44125287|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44125288|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
44125289|NCT00135408|Hormones|hormones|mesh-ancestor
44125290|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125291|NCT00135434|Ritonavir|ritonavir|mesh-list
44125292|NCT00135434|Lopinavir|lopinavir|mesh-list
44125293|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44125294|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44125295|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44125296|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327674|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327675|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327676|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327677|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327678|NCT00966121|Propranolol|propranolol|mesh-list
44327679|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44327680|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44327681|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327682|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327683|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327684|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327685|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327686|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327687|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125297|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125298|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125299|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44125300|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44125301|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
44125302|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125303|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44125304|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125306|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44125307|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44125308|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125309|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125310|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
44125311|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
44125312|NCT00135499|Prednisone|prednisone|mesh-list
44125313|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
44125314|NCT00135499|Rituximab|rituximab|mesh-list
44125315|NCT00135499|Doxorubicin|doxorubicin|mesh-list
44125316|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44125317|NCT00135499|Vincristine|vincristine|mesh-list
44125318|NCT00135499|Bleomycin|bleomycin|mesh-list
44125319|NCT00135499|Vindesine|vindesine|mesh-list
44125320|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125321|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
44125322|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125323|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125324|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44125325|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
44125326|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125327|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125328|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44125329|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125330|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125331|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125332|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125333|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125334|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125335|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
44125336|NCT00135499|Hormones|hormones|mesh-ancestor
44125337|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125338|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44327689|NCT00966160|Lopinavir|lopinavir|mesh-list
44327690|NCT00966160|Lamivudine|lamivudine|mesh-list
44327691|NCT00966160|Zidovudine|zidovudine|mesh-list
44327692|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44327693|NCT00966160|Efavirenz|efavirenz|mesh-list
44327694|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44327695|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44327696|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
44327697|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327698|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327699|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44327700|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44327701|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
44327702|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327703|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44327704|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44327705|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44327706|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43982656|NCT02081014|Hormones|hormones|mesh-ancestor
44327707|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
44327708|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44327709|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44327710|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44327711|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44327712|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43835017|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
44125339|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44125340|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125341|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125342|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125343|NCT00135525|Paroxetine|paroxetine|mesh-list
44125344|NCT00135525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44125345|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44125346|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125347|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125348|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125349|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
44125350|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125351|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44125352|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
44125353|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125354|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44125355|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125356|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125357|NCT00135551|Benidipine|benidipine|mesh-list
44125358|NCT00135551|Diuretics|diuretics|mesh-list
44125359|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44327713|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
44327714|NCT00966251|Pidilizumab|pidilizumab|mesh-list
44327715|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44327716|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327717|NCT00966290|Warfarin|warfarin|mesh-list
44327718|NCT00966290|Anticoagulants|anticoagulants|mesh-list
44327719|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
44327720|NCT00966290|Fluindione|fluindione|mesh-list
44327721|NCT00966290|Phenindione|phenindione|mesh-list
44327722|NCT00966316|Aspirin|aspirin|mesh-list
44327723|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44327724|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44327725|NCT00966316|Analgesics|analgesics|mesh-ancestor
44327726|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
44327727|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327728|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327729|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44327730|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327731|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44327732|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44327733|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327734|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44327735|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44327736|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327737|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
44327738|NCT00966329|Maraviroc|maraviroc|mesh-list
44327739|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44327740|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44327741|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327742|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44327743|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44327744|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
44327745|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327746|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44327747|NCT00966368|Insulin|insulin|mesh-list
44327754|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327755|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44327756|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327757|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327758|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44327759|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327760|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
44327761|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327762|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44327763|NCT00966576|Timolol|timolol|mesh-list
44327764|NCT00966576|Brinzolamide|brinzolamide|mesh-list
44327765|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44327766|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44327767|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
44327768|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327769|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327770|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327771|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44327772|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44327773|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327774|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44327775|NCT00966602|Ivacaftor|ivacaftor|mesh-list
44327776|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44327777|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43739348|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125360|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44125361|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44125362|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
44125363|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125364|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125365|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125366|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44125367|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44125368|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125369|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44125370|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44125371|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125373|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125374|NCT00135603|Amoxicillin|amoxicillin|mesh-list
44125375|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
44125376|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
44125377|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44125378|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125379|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125380|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44125381|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125382|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327779|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
44327780|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44327781|NCT00966680|Anesthetics|anesthetics|mesh-list
43982730|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
44327782|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327783|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327784|NCT00966706|Gemcitabine|gemcitabine|mesh-list
44327785|NCT00966706|Cisplatin|cisplatin|mesh-list
44327786|NCT00966706|Docetaxel|docetaxel|mesh-list
44327787|NCT00966706|Capecitabine|capecitabine|mesh-list
44327788|NCT00966706|Epirubicin|epirubicin|mesh-list
44327789|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327790|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327791|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
44327792|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327793|NCT00966706|Antiviral Agents|antiviral agents|mesh-ancestor
44327794|NCT00966706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327795|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125384|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44125385|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125386|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44125387|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125388|NCT00135681|Nedocromil|nedocromil|mesh-list
44125389|NCT00135681|Budesonide|budesonide|mesh-list
44125390|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125391|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44125392|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
44125393|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125394|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125395|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44125396|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
44125397|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
44125398|NCT00135681|Hormones|hormones|mesh-ancestor
44125399|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125400|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44125401|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
44125402|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44125403|NCT00135720|Etanercept|etanercept|mesh-list
44125404|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44125405|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125406|NCT00135720|Analgesics|analgesics|mesh-ancestor
44125407|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
44125408|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125409|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125410|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125411|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125412|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125413|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125414|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
44125415|NCT00135733|Alefacept|alefacept|mesh-list
44125416|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125417|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
44125418|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125419|NCT00135746|Nicotine|nicotine|mesh-list
44125420|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44125421|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
44125422|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327796|NCT00966706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327797|NCT00966706|Immunologic Factors|immunologic factors|mesh-ancestor
44327798|NCT00966706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327799|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327800|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44327801|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44327802|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327803|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44327804|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327805|NCT00966745|Milrinone|milrinone|mesh-list
44327806|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44327807|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44327808|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
44327809|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44327810|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44327811|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327812|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327813|NCT00966745|Protective Agents|protective agents|mesh-ancestor
44327814|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327815|NCT00966771|Copper|copper|mesh-list
44327816|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
44327817|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44327818|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
44327819|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44327820|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327821|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44327822|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44327823|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44327824|NCT00966771|Trace Elements|trace elements|mesh-ancestor
44327825|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
44327826|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
44327827|NCT00966836|Valganciclovir|valganciclovir|mesh-list
44327828|NCT00966836|Everolimus|everolimus|mesh-list
44327829|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327830|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327831|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
44327832|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125423|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327833|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327834|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44327835|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
44327836|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44327837|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44327838|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327839|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327840|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
44327841|NCT00966901|Nicotine|nicotine|mesh-list
44327842|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44327843|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
44327844|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327845|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327846|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44327847|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44327848|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327849|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327850|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327851|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
44327852|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327853|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
44327854|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327855|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327885|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44327886|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
44327887|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44327888|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44327889|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
44327890|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327891|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44327892|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327893|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44327894|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44327895|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
44327896|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44327897|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327898|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44327899|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44327900|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44327901|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44327902|NCT00967057|Analgesics|analgesics|mesh-ancestor
44327903|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
44327904|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44327905|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44327906|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327907|NCT00967070|Nicotine|nicotine|mesh-list
44327934|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327935|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
44327936|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44327937|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327938|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327939|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44327940|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44327941|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44327942|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44327943|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44327944|NCT00967148|Tinzaparin|tinzaparin|mesh-list
44327945|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44327946|NCT00967148|Dalteparin|dalteparin|mesh-list
44327947|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
44327948|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44327949|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44327950|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327951|NCT00967174|Nicotine|nicotine|mesh-list
44327952|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44327953|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
44327954|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44327955|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327956|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44327957|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44327958|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
44327959|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327960|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327961|NCT00967213|Ranibizumab|ranibizumab|mesh-list
44327962|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44125424|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44125425|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44125426|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
44125427|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125428|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125429|NCT00135759|Naltrexone|naltrexone|mesh-list
44125430|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44125431|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44125432|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125433|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
44125434|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125435|NCT00135785|Bupropion|bupropion|mesh-list
44125436|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44125437|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
44125438|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44327963|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44327964|NCT00967213|Growth Substances|growth substances|mesh-ancestor
44327965|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44327966|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44327967|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327969|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44327970|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44327971|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
44327972|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327973|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44327974|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44327975|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327976|NCT00967291|Ifosfamide|ifosfamide|mesh-list
44327977|NCT00967291|Mitomycins|mitomycins|mesh-list
44327978|NCT00967291|Mitomycin|mitomycin|mesh-list
44327979|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44327980|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
44327981|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327982|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44327983|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44327984|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44327985|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44327986|NCT00967382|Dalteparin|dalteparin|mesh-list
44327987|NCT00967382|Tinzaparin|tinzaparin|mesh-list
44327988|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44327989|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
44327995|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44327996|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44327997|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44327998|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44327999|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
44328000|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328001|NCT00967408|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44328002|NCT00967408|Antidepressive Agents|antidepressive agents|mesh-ancestor
44328003|NCT00967408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328004|NCT00967421|Ethanol|ethanol|mesh-list
44328005|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44328006|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328007|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328008|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328009|NCT00967434|Atorvastatin|atorvastatin|mesh-list
44328010|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44328011|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44328012|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
44328013|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328014|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44328015|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44328016|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328017|NCT00967512|Cytarabine|cytarabine|mesh-list
44328018|NCT00967512|Idarubicin|idarubicin|mesh-list
44328019|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44328020|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
44328021|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328022|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328023|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
44328024|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328036|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
44328037|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328038|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328039|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328040|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328041|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328042|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328043|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
44328044|NCT00967603|Sunitinib|sunitinib|mesh-list
44328045|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328046|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328047|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328048|NCT00967603|Growth Substances|growth substances|mesh-ancestor
44328049|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328050|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328051|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44125439|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44125440|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44125441|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125442|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125444|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125445|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125446|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44125447|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125448|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125449|NCT00135811|Cyclosporine|cyclosporine|mesh-list
44125450|NCT00135811|Dexamethasone|dexamethasone|mesh-list
44125451|NCT00135811|Cyclosporins|cyclosporins|mesh-list
44125454|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
44125455|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125456|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125457|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125458|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
44125460|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125461|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125462|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125463|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125464|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125465|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125466|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
44125467|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
44125468|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125469|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125470|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125471|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44125472|NCT00135824|Povidone|povidone|mesh-list
44125473|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44125474|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44125475|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
44125476|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
44125477|NCT00135837|Verteporfin|verteporfin|mesh-list
44125478|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44125479|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125480|NCT00135863|Tinzaparin|tinzaparin|mesh-list
44125481|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44125482|NCT00135863|Dalteparin|dalteparin|mesh-list
44125483|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
44125484|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44328053|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328054|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
44328055|NCT00967629|Calcium|calcium|mesh-list
44328056|NCT00967629|Sevelamer|sevelamer|mesh-list
44328057|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44328058|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328059|NCT00967629|Antacids|antacids|mesh-ancestor
44328060|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328061|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328062|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
44328063|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
44328064|NCT00967642|Insulin|insulin|mesh-list
44328065|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328066|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328067|NCT00967655|Capecitabine|capecitabine|mesh-list
44328068|NCT00967655|Irinotecan|irinotecan|mesh-list
44328069|NCT00967655|Panitumumab|panitumumab|mesh-list
44328070|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44328071|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
44328072|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328073|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328074|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44328075|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328076|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328077|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328078|NCT00967707|Gabapentin|gabapentin|mesh-list
44328079|NCT00967707|Donepezil|donepezil|mesh-list
44328080|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44328081|NCT00967707|Analgesics|analgesics|mesh-ancestor
44328082|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
44328096|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328097|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328098|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
44328099|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44328100|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44328101|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328102|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44328103|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
44328104|NCT00967772|Naftopidil|naftopidil|mesh-list
44328105|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44328106|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44328107|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
44328108|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328109|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328110|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328111|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44328112|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44328113|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328114|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44328115|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44328116|NCT00967837|Insulin|insulin|mesh-list
44328117|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44328118|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328119|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328120|NCT00967850|Verteporfin|verteporfin|mesh-list
44328121|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44328122|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44328123|NCT00967928|Cisplatin|cisplatin|mesh-list
44328124|NCT00967928|Everolimus|everolimus|mesh-list
44328125|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328126|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328127|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
44328128|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328129|NCT00967954|Hormones|hormones|mesh-list
44328130|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
44125485|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44328134|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
44328135|NCT00967967|Desloratadine|desloratadine|mesh-list
44328136|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328137|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
44328138|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44328139|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44328140|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328141|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468322|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
44328142|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328143|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328144|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44328145|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44328146|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
44328147|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
44328148|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44328149|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328150|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328151|NCT00968006|Incretins|incretins|mesh-ancestor
44328153|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328154|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44328155|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
44328156|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328157|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328158|NCT00968110|Omalizumab|omalizumab|mesh-list
44328159|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44328160|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44328161|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44328162|NCT00968162|Fludarabine|fludarabine|mesh-list
44328163|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328164|NCT00968240|Bevacizumab|bevacizumab|mesh-list
44328165|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328166|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739734|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
44125486|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125487|NCT00135876|Dalteparin|dalteparin|mesh-list
44125488|NCT00135876|Tinzaparin|tinzaparin|mesh-list
44328167|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328168|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328169|NCT00968240|Growth Substances|growth substances|mesh-ancestor
44328170|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328171|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328173|NCT00968331|Lenalidomide|lenalidomide|mesh-list
44328174|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328175|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328176|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
44328177|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328178|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328179|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328180|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328181|NCT00968331|Growth Substances|growth substances|mesh-ancestor
44328182|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328183|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44328184|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44328185|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
44328186|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
44328187|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44328188|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
44328189|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328190|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328191|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328192|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328193|NCT00968396|Melphalan|melphalan|mesh-list
44328194|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328212|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
44328213|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468323|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983179|NCT02100579|Bupivacaine|bupivacaine|mesh-list
44328214|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328215|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44328216|NCT00968461|Protective Agents|protective agents|mesh-ancestor
44328217|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328218|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328219|NCT00968565|Citric Acid|citric acid|mesh-list
44328220|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
44328221|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
44328222|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44328223|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
44328224|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
44328225|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328226|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
44328227|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44328228|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44328229|NCT00968578|Prednisolone|prednisolone|mesh-list
44328230|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
44328231|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44328232|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
44328233|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328234|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
44328235|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
44328236|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328237|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328238|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328257|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328258|NCT00968734|Vitamins|vitamins|mesh-ancestor
44328259|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
44328260|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44328261|NCT00968760|Cytarabine|cytarabine|mesh-list
44328262|NCT00968760|Etoposide|etoposide|mesh-list
44328263|NCT00968760|Melphalan|melphalan|mesh-list
44328264|NCT00968760|Interleukin-2|interleukin-2|mesh-list
44328265|NCT00968760|Carmustine|carmustine|mesh-list
44328266|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328267|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328268|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44328269|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328270|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328271|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328272|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44328273|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
44328274|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
44328275|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328276|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328277|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
44328278|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328279|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328280|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
44328281|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328282|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328283|NCT00968760|Analgesics|analgesics|mesh-ancestor
44328284|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
44328306|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
44328307|NCT00968903|Hormones|hormones|mesh-ancestor
44328308|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328309|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44328310|NCT00968903|Protective Agents|protective agents|mesh-ancestor
44328311|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328312|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328313|NCT00968929|Streptokinase|streptokinase|mesh-list
44328314|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44328315|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44328316|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328317|NCT00968955|Ropivacaine|ropivacaine|mesh-list
44328318|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
44328319|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
44328320|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328321|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328322|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
44328323|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328324|NCT00968994|Petrolatum|petrolatum|mesh-list
44328325|NCT00968994|Emollients|emollients|mesh-ancestor
44328326|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44328327|NCT00969033|Irinotecan|irinotecan|mesh-list
44328328|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44328329|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328330|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328331|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328332|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328333|NCT00969046|Epothilone B|epothilone b|mesh-list
44328334|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328335|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44328336|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44328337|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44328338|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125489|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44125490|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
44125491|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44125492|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44125493|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125494|NCT00135902|Progesterone|progesterone|mesh-list
44125495|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44125496|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44328339|NCT00969072|Dutasteride|dutasteride|mesh-list
44328340|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44328341|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44328342|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328343|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328344|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
44328345|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328346|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328347|NCT00969085|Curcumin|curcumin|mesh-list
44328348|NCT00969085|Turmeric extract|turmeric extract|mesh-list
44328349|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44328350|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328351|NCT00969085|Analgesics|analgesics|mesh-ancestor
44328352|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
44328353|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328354|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328355|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328356|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328357|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328358|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328359|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328360|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
44328361|NCT00969085|Protective Agents|protective agents|mesh-ancestor
44328362|NCT00969137|Nicotine|nicotine|mesh-list
44328363|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44328364|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
44328365|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328366|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328367|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44328383|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
44468324|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468325|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44468326|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44468327|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
44468328|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44468329|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44468330|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44468331|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44468332|NCT01437995|Fluticasone|fluticasone|mesh-list
44468333|NCT01437995|Xhance|xhance|mesh-list
44468334|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44468335|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44468336|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468337|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468338|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
44468339|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468340|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468341|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468342|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468343|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468344|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468345|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44468346|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44468347|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468348|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468349|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468351|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
44468368|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468369|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468370|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468371|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468372|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
44468374|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
44468375|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468376|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
44468377|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468378|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468379|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44328384|NCT00969293|Ecallantide|ecallantide|mesh-list
44328385|NCT00969293|Analgesics|analgesics|mesh-ancestor
44328386|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
44328387|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328388|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328389|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44328390|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125497|NCT00135902|Progestins|progestins|mesh-ancestor
44125498|NCT00135902|Hormones|hormones|mesh-ancestor
44125499|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125500|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125501|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44125502|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
44125503|NCT00135928|Lenograstim|lenograstim|mesh-list
44125504|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44125505|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
44125506|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125507|NCT00135941|Insulin|insulin|mesh-list
44125508|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44125509|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
44125510|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
44125511|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125512|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125513|NCT00135954|Prednisolone|prednisolone|mesh-list
44125514|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
44125515|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125516|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
44125517|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125518|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125519|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44125520|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
44125521|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125522|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125523|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44125524|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125525|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
44125526|NCT00135954|Hormones|hormones|mesh-ancestor
43770431|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44125527|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125528|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125529|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
44125530|NCT00135967|Prednisone|prednisone|mesh-list
44125531|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
44125532|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44125533|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44125534|NCT00135967|Prednisolone|prednisolone|mesh-list
44328391|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328392|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328393|NCT00969306|Chloroquine|chloroquine|mesh-list
44328394|NCT00969306|Amebicides|amebicides|mesh-ancestor
44328395|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44328396|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44328397|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328398|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
44328399|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328400|NCT00969319|Factor VIII|factor viii|mesh-list
44328401|NCT00969319|Coagulants|coagulants|mesh-ancestor
44328402|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44328403|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328404|NCT00969397|Growth Substances|growth substances|mesh-ancestor
44328405|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328406|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328407|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328408|NCT00969449|Naproxen|naproxen|mesh-list
44328409|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44328410|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328411|NCT00969449|Analgesics|analgesics|mesh-ancestor
44328412|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
44328413|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328414|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739989|NCT02532062|Vitamin D|vitamin d|mesh-list
44125535|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
44125536|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44125537|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
44125538|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125539|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
44125540|NCT00135967|Hormones|hormones|mesh-ancestor
44125541|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125542|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125543|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125544|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125545|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125546|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44125547|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
44125548|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125549|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125550|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125551|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125552|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
44125553|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
44125554|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125555|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125556|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44125557|NCT00135967|Protective Agents|protective agents|mesh-ancestor
44125558|NCT00135993|Rotigotine|rotigotine|mesh-list
44125559|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
44125560|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
44125561|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328415|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328416|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328417|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
44328418|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44328419|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328420|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328421|NCT00969462|Doxorubicin|doxorubicin|mesh-list
44328422|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44328423|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328424|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44328425|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328426|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328427|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328428|NCT00969566|Metformin|metformin|mesh-list
44328429|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44328430|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125562|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125563|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154942|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125564|NCT00136045|Rotigotine|rotigotine|mesh-list
44125565|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
44125566|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
44125567|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125568|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125569|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125570|NCT00136058|Alendronate|alendronate|mesh-list
44125571|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
44125572|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44125573|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125574|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44125575|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125576|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125577|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44125578|NCT00136110|Valproic Acid|valproic acid|mesh-list
44125579|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
44125580|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125581|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125582|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
44125583|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125584|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125585|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
44125586|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44125587|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125588|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125589|NCT00136175|Gemcitabine|gemcitabine|mesh-list
44125591|NCT00136175|Carboplatin|carboplatin|mesh-list
44125592|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44125593|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125594|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125595|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125596|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125597|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125598|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44125599|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
44125605|NCT00136175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125606|NCT00136188|Folic Acid|folic acid|mesh-list
44125607|NCT00136188|Hematinics|hematinics|mesh-ancestor
44328431|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328432|NCT00969566|Incretins|incretins|mesh-ancestor
44328433|NCT00969566|Hormones|hormones|mesh-ancestor
44328434|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328435|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44328436|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
44328437|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328438|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328439|NCT00969592|Insulin|insulin|mesh-list
44328440|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44328441|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
44328442|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
44328443|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44328444|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
44328445|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328446|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328447|NCT00969631|Metformin|metformin|mesh-list
44328448|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328449|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328450|NCT00969696|Galantamine|galantamine|mesh-list
44328451|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44328452|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328453|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328454|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328455|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328456|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328457|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44328458|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
44328459|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328460|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
44328461|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
44328462|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
44328463|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
44328464|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125608|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
44125609|NCT00136188|Vitamins|vitamins|mesh-ancestor
44125610|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
44125611|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125612|NCT00136201|Tigecycline|tigecycline|mesh-list
44125613|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125614|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125615|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44328465|NCT00969813|Tofacitinib|tofacitinib|mesh-list
44328466|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44328467|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328468|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328470|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
44328471|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328472|NCT00969852|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44328473|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44328474|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328475|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328476|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328477|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
44328478|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328479|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
44328480|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44328481|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
44328482|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328483|NCT00969904|Expectorants|expectorants|mesh-ancestor
44328484|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
44328485|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44328486|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
44328487|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328488|NCT00969904|Protective Agents|protective agents|mesh-ancestor
44328489|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328490|NCT00969904|Antidotes|antidotes|mesh-ancestor
44328491|NCT00969982|Misoprostol|misoprostol|mesh-list
44328492|NCT00969982|Mifepristone|mifepristone|mesh-list
44328493|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44328494|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
44328495|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44125616|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125617|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125618|NCT00136266|Vitamin D|vitamin d|mesh-list
44125619|NCT00136266|Vitamins|vitamins|mesh-list
44125620|NCT00136266|Vitamin A|vitamin a|mesh-list
44125621|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
44125622|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
44125623|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125624|NCT00136266|Trace Elements|trace elements|mesh-ancestor
44125625|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44125626|NCT00136292|Daptomycin|daptomycin|mesh-list
44125627|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125628|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125629|NCT00136344|Levofloxacin|levofloxacin|mesh-list
44125630|NCT00136344|Ofloxacin|ofloxacin|mesh-list
44328496|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328497|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44328498|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328499|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
44328500|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44328501|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44328502|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44328503|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44328504|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
44328505|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44328506|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44328507|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599083|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328508|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328509|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
44328510|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44328511|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44328512|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
44328513|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44328514|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328515|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
44328516|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328517|NCT00970086|Bupivacaine|bupivacaine|mesh-list
44328518|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
44328519|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
44328520|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
44328521|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328522|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328523|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
44328524|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328525|NCT00970138|Apatinib|apatinib|mesh-list
44328526|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328527|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44328536|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328538|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
44328539|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
44328540|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328541|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44328542|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44328543|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
44328544|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328545|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328546|NCT00970528|Acarbose|acarbose|mesh-list
44328547|NCT00970528|Voglibose|voglibose|mesh-list
44328548|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44328549|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328550|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328551|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328552|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328553|NCT00970567|Insulin|insulin|mesh-list
44328554|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328555|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328556|NCT00970580|Paclitaxel|paclitaxel|mesh-list
44328557|NCT00970580|Carboplatin|carboplatin|mesh-list
44328558|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
44125631|NCT00136344|Cefuroxime|cefuroxime|mesh-list
44125632|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
44125633|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44125634|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125635|NCT00136344|Renal Agents|renal agents|mesh-ancestor
44125636|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125637|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125638|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125639|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125640|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125641|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125642|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44125643|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125644|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
44125645|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44125646|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125647|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
44125648|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44125649|NCT00136383|Paroxetine|paroxetine|mesh-list
44125650|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44125651|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44125652|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125653|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125654|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125655|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125656|NCT00136383|Analgesics|analgesics|mesh-ancestor
44125657|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
44125658|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125659|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
44328559|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328560|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328561|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
44328562|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
44328563|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
44328564|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328565|NCT00970697|Becaplermin|becaplermin|mesh-list
44328566|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
44328567|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44328568|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328569|NCT00970697|Growth Substances|growth substances|mesh-ancestor
44328570|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328571|NCT00970762|Rocuronium|rocuronium|mesh-list
44328572|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
44328573|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44328574|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44328575|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44328576|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328577|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328578|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44328579|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43740124|NCT02531568|Warfarin|warfarin|mesh-list
44125660|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125661|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
44125662|NCT00136383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44125663|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
44125664|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44125665|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44125666|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125667|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125668|NCT00136396|Rituximab|rituximab|mesh-list
44125669|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125670|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125686|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
44125687|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125688|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125689|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
44125690|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125691|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125692|NCT00136448|Analgesics|analgesics|mesh-ancestor
44125693|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
44125694|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125695|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125696|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125697|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125698|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125700|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
44125701|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125702|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
44125703|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125704|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44125705|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
44328580|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328581|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328582|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328583|NCT00970879|Mefloquine|mefloquine|mesh-list
44328584|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44328585|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
44328586|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44328587|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44328588|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328589|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44328590|NCT00970879|Renal Agents|renal agents|mesh-ancestor
44328591|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44328592|NCT00970892|Warfarin|warfarin|mesh-list
44328593|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
44328594|NCT00970905|Ondansetron|ondansetron|mesh-list
44328595|NCT00970905|Aprepitant|aprepitant|mesh-list
44328596|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
44328597|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
44328598|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328599|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771295|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44328600|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328601|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
44125706|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125707|NCT00136474|Amifostine|amifostine|mesh-list
44125708|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44125709|NCT00136474|Protective Agents|protective agents|mesh-ancestor
44125710|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125711|NCT00136487|Celecoxib|celecoxib|mesh-list
44125712|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44125713|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125714|NCT00136487|Analgesics|analgesics|mesh-ancestor
44125715|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
44125716|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125717|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125718|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125719|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125720|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44125721|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44125722|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125723|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125725|NCT00136526|Fosfestrol|fosfestrol|mesh-list
44125726|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
44125727|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125728|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125729|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125730|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125731|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125736|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125737|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125738|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
44125739|NCT00136539|Doxorubicin|doxorubicin|mesh-list
44125740|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44125741|NCT00136539|Trastuzumab|trastuzumab|mesh-list
44125742|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328602|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
44328603|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44328604|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
44328605|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328606|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328607|NCT00970905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44328608|NCT00970905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44328609|NCT00970905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328610|NCT00970905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328612|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44328613|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
44328614|NCT00970931|Amiloride|amiloride|mesh-list
44328615|NCT00970931|Diuretics|diuretics|mesh-list
44328616|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
44328617|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328618|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44328619|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44328620|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328621|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328622|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44328623|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44328624|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44328625|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44328626|NCT00970957|Bevacizumab|bevacizumab|mesh-list
44328627|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328628|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125743|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
44125744|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125745|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125746|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44125747|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
44125748|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125749|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125750|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44125751|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125752|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125753|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125754|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125755|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125756|NCT00136552|Rituximab|rituximab|mesh-list
44125757|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125758|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125759|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
44125760|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125761|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125762|NCT00136565|Prednisone|prednisone|mesh-list
44328629|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328630|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328631|NCT00970957|Growth Substances|growth substances|mesh-ancestor
44328632|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328633|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328634|NCT00970970|Bevacizumab|bevacizumab|mesh-list
44328635|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44328636|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328637|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328638|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328639|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328640|NCT00970970|Growth Substances|growth substances|mesh-ancestor
44328641|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328642|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328643|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44328644|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328645|NCT00970996|Interferons|interferons|mesh-list
44328646|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
44328647|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
44328648|NCT00970996|Paclitaxel|paclitaxel|mesh-list
44125763|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
44125764|NCT00136565|Doxorubicin|doxorubicin|mesh-list
44125765|NCT00136565|Bortezomib|bortezomib|mesh-list
44125766|NCT00136565|Bleomycin|bleomycin|mesh-list
44125767|NCT00136565|Vindesine|vindesine|mesh-list
44125768|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125769|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
44125770|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125771|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125772|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44125773|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
44125774|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125775|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125776|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44125777|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44125778|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44125779|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44125780|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125781|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125782|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
44125783|NCT00136565|Hormones|hormones|mesh-ancestor
44125784|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125785|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125786|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44125787|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125788|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44125789|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
44125790|NCT00136578|Carboplatin|carboplatin|mesh-list
44125791|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125792|NCT00136591|Bortezomib|bortezomib|mesh-list
44125793|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125794|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
44125795|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44125796|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44125797|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125798|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328649|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44328651|NCT00970996|Temozolomide|temozolomide|mesh-list
44328652|NCT00970996|Interleukin-2|interleukin-2|mesh-list
44328653|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328654|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328655|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44328656|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
44328657|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44328658|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328659|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
44328660|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328661|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328662|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
44328663|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
44328664|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328665|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328666|NCT00970996|Analgesics|analgesics|mesh-ancestor
44125799|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44125800|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44125801|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125802|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
44125803|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
44125805|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125806|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44125807|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44125808|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125809|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
44125810|NCT00136734|Methylphenidate|methylphenidate|mesh-list
44125811|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44125812|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125813|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44125814|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44125815|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125816|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125817|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
44125818|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125819|NCT00136747|Memantine|memantine|mesh-list
44125820|NCT00136747|Bupropion|bupropion|mesh-list
44125821|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44125822|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
44125823|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125824|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44125825|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44125826|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125827|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125828|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
44125829|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125830|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125831|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44125832|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125833|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125834|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44125835|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44125836|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44468382|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44468383|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44468384|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
44468385|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468386|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468387|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
44468388|NCT01437267|Vaccines|vaccines|mesh-list
44468389|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44468390|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
44468391|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468392|NCT01437111|Vitamin D|vitamin d|mesh-list
44468393|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
44468394|NCT01437111|Alendronate|alendronate|mesh-list
44468395|NCT01437111|Vitamins|vitamins|mesh-ancestor
44468396|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
44328669|NCT00971074|Hylan|hylan|mesh-list
44328670|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
44328671|NCT00971074|Protective Agents|protective agents|mesh-ancestor
44328672|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771717|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43771800|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43771801|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43771802|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125837|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44125838|NCT00136773|Amlodipine|amlodipine|mesh-list
44125839|NCT00136773|Benazepril|benazepril|mesh-list
44125840|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44125841|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44125842|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125843|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125844|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44125845|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125846|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125847|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44125848|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
44125849|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125850|NCT00136786|Memantine|memantine|mesh-list
44125851|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44125852|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44125853|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
44125854|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125855|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125856|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125857|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44125858|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44125859|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
44125860|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44125861|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
44125862|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328673|NCT00971126|Thalidomide|thalidomide|mesh-list
44328674|NCT00971126|Sorafenib|sorafenib|mesh-list
44328675|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328676|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44328677|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328678|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328679|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328680|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
44328681|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328682|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
44328683|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44328684|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125863|NCT00136825|Expectorants|expectorants|mesh-ancestor
44125864|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
44125865|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44125866|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
44125867|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125868|NCT00136825|Protective Agents|protective agents|mesh-ancestor
44125869|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125870|NCT00136825|Antidotes|antidotes|mesh-ancestor
44125871|NCT00136851|Amlodipine|amlodipine|mesh-list
44125875|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44125876|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125877|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44125878|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125879|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125880|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44125881|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
44125882|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125883|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44125884|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44125885|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125887|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44125888|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44125889|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
44125890|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125891|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44125892|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44125893|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125894|NCT00136968|Voriconazole|voriconazole|mesh-list
44125895|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
44125896|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125897|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44125898|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44125899|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771994|NCT02369081|Bisoprolol|bisoprolol|mesh-list
44125900|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125901|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44125902|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
44125903|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125904|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125905|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44125906|NCT00136981|Atorvastatin|atorvastatin|mesh-list
44125907|NCT00136981|Torcetrapib|torcetrapib|mesh-list
44125908|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44125909|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44125910|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
44125911|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125912|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44125913|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44125914|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328685|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328686|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328687|NCT00971126|Growth Substances|growth substances|mesh-ancestor
44328688|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328689|NCT00971152|Menotropins|menotropins|mesh-list
44328690|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44328691|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
44328692|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44328693|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328694|NCT00971165|Losartan|losartan|mesh-list
44328695|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
44328696|NCT00971165|Amiloride|amiloride|mesh-list
44328697|NCT00971165|Diuretics|diuretics|mesh-list
44328698|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44328699|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44328700|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44328701|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44328702|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328703|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
44328704|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328705|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44328706|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328707|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44328708|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44328709|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44328710|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44328711|NCT00971399|Ondansetron|ondansetron|mesh-list
44328712|NCT00971399|Ramosetron|ramosetron|mesh-list
44328713|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
44328714|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
44328715|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328716|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835133|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
44125915|NCT00136994|Ziprasidone|ziprasidone|mesh-list
44125916|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44125917|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
44125918|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125919|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125920|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125921|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44125922|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44328721|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
44328722|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328723|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328724|NCT00971399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44328725|NCT00971399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44328726|NCT00971399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328727|NCT00971399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328728|NCT00971399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44328729|NCT00971581|Ketoprofen|ketoprofen|mesh-list
44328730|NCT00971581|Omeprazole|omeprazole|mesh-list
44328731|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44328732|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328733|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44328734|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328735|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328736|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44328737|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328738|NCT00971581|Analgesics|analgesics|mesh-ancestor
44328739|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
44328740|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740282|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44125923|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125924|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44125925|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44125926|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
44125927|NCT00137007|Azithromycin|azithromycin|mesh-list
44125929|NCT00137007|Sulbactam|sulbactam|mesh-list
44125930|NCT00137007|Sultamicillin|sultamicillin|mesh-list
44125931|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44125932|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125933|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44125934|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125935|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125936|NCT00137020|Ziprasidone|ziprasidone|mesh-list
44125937|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44125938|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
44125941|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125942|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44125943|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44125944|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125945|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43570399|NCT00411892|Insulin|insulin|mesh-list
44125946|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44328741|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328742|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328743|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328744|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44328745|NCT00971607|Sevoflurane|sevoflurane|mesh-list
44328746|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44328747|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44328748|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
44328749|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
44328750|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328751|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328752|NCT00971659|Insulin|insulin|mesh-list
44328753|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44328754|NCT00971659|Metformin|metformin|mesh-list
44328755|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
44328756|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44328757|NCT00971659|Exenatide|exenatide|mesh-list
44328758|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44328759|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328760|NCT00971659|Incretins|incretins|mesh-ancestor
44328761|NCT00971659|Hormones|hormones|mesh-ancestor
44328762|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125949|NCT00137033|Naproxen|naproxen|mesh-list
44125950|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44125951|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125952|NCT00137033|Analgesics|analgesics|mesh-ancestor
44125953|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
44125954|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125955|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125956|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125957|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125958|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44125959|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44125960|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125961|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125962|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
44125963|NCT00137059|Acetaminophen|acetaminophen|mesh-list
44125964|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44125965|NCT00137059|Analgesics|analgesics|mesh-ancestor
44125966|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
44125967|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125968|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125969|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
44125970|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
44125971|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125972|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
44125973|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44125974|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44125975|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125976|NCT00137072|Urological Agents|urological agents|mesh-ancestor
44125977|NCT00137085|Ketamine|ketamine|mesh-list
44125978|NCT00137085|Analgesics|analgesics|mesh-ancestor
44125979|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
44125980|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328763|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44328764|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
44328765|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328766|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328767|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44328768|NCT00971685|Dexamethasone|dexamethasone|mesh-list
44328769|NCT00971685|Lenalidomide|lenalidomide|mesh-list
44328770|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328771|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
44328772|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
44328773|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328774|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328775|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328776|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
44328777|NCT00971685|Hormones|hormones|mesh-ancestor
44328778|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328779|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328780|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328781|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
44328782|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44328783|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44328784|NCT00971685|Growth Substances|growth substances|mesh-ancestor
44328785|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
44328786|NCT00971724|Prednisolone|prednisolone|mesh-list
44328787|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328788|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
44328789|NCT00971724|Hormones|hormones|mesh-ancestor
44328790|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328791|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328792|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328793|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328806|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328807|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328808|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328809|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43599093|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328810|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
44328811|NCT00971763|Antiviral Agents|antiviral agents|mesh-ancestor
44328812|NCT00971763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328813|NCT00971763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328814|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328815|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44328816|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44328817|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44328818|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328819|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
44468397|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328821|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328822|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328823|NCT00971815|Dexetimide|dexetimide|mesh-list
44328824|NCT00971815|Citalopram|citalopram|mesh-list
44328825|NCT00971815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44125981|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125982|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44125983|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44125984|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
44125985|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
44125986|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125987|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44125988|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44125989|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125990|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125991|NCT00137098|Caffeine|caffeine|mesh-list
44125992|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44125993|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125994|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44125995|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125996|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125997|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44125998|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44125999|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
44126000|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126001|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
44126002|NCT00137202|Promethazine|promethazine|mesh-list
44126003|NCT00137202|Ondansetron|ondansetron|mesh-list
44126004|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
44126005|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
44126006|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126007|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126008|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44126009|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
44126010|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44126011|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43701994|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44328826|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44328827|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44328828|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328829|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328830|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
44328831|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328832|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43652146|NCT03002064|Fluorouracil|fluorouracil|mesh-list
44328833|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
44328834|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44328835|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44328836|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44328837|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
44328838|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
44328839|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328840|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44328841|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44328842|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
44328843|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
44328844|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44328845|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44328846|NCT00971893|Prednisolone|prednisolone|mesh-list
44328847|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
44328848|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44328849|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
44328850|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328851|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
44328852|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
44328853|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328854|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328855|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44328856|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
44328859|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44328867|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328868|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44328869|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
44328870|NCT00972101|Rituximab|rituximab|mesh-list
44328871|NCT00972101|Fludarabine|fludarabine|mesh-list
44328872|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
44328873|NCT00972101|Etoposide|etoposide|mesh-list
44328874|NCT00972101|Melphalan|melphalan|mesh-list
44328875|NCT00972101|Thiotepa|thiotepa|mesh-list
44328876|NCT00972101|Tacrolimus|tacrolimus|mesh-list
44328877|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44328878|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328879|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328880|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
44328881|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328882|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328883|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44328884|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
44328885|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328886|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328887|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328888|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328889|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44328890|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328891|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328892|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44126014|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126015|NCT00137202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44126016|NCT00137202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44126017|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44126018|NCT00137202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126019|NCT00137202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44126020|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44126021|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44126022|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
44126023|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
44126024|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
44126025|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44126026|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
44126027|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
44126028|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44126029|NCT00137254|Insulin|insulin|mesh-list
44126030|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126031|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126032|NCT00137345|Sirolimus|sirolimus|mesh-list
44126033|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126034|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126035|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44126036|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126037|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
44328893|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44328894|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44328895|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
44328896|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44328897|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328898|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
44328899|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328900|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
44328901|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44328902|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
44328903|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44328904|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328905|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44328906|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
44328907|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44328908|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44328909|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44328910|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44328911|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328912|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328913|NCT00972218|Adalimumab|adalimumab|mesh-list
44328914|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328915|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328916|NCT00972257|Timolol|timolol|mesh-list
44328917|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44328918|NCT00972257|Dorzolamide|dorzolamide|mesh-list
44328919|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44126038|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126039|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
44126040|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126041|NCT00137358|Cisplatin|cisplatin|mesh-list
44126042|NCT00137358|Amifostine|amifostine|mesh-list
44126043|NCT00137358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126044|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44126045|NCT00137358|Protective Agents|protective agents|mesh-ancestor
44126046|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126047|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44126048|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44126049|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44126050|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
44126051|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126052|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126053|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126054|NCT00137397|Urological Agents|urological agents|mesh-ancestor
44126055|NCT00137410|Celecoxib|celecoxib|mesh-list
44126056|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44126057|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44328920|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44328921|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
44328922|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328923|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328924|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328925|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44328926|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44328927|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44328928|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44328929|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44328930|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44328931|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328932|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
44328933|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44328934|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44328936|NCT00972387|Prednisolone|prednisolone|mesh-list
44328937|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
44328938|NCT00972387|Doxorubicin|doxorubicin|mesh-list
44328939|NCT00972387|Vincristine|vincristine|mesh-list
44328940|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328941|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
44328942|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126058|NCT00137410|Analgesics|analgesics|mesh-ancestor
44126059|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
44126060|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126061|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126062|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126063|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126064|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44126065|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44126066|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126067|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126068|NCT00137462|Atorvastatin|atorvastatin|mesh-list
44126069|NCT00137462|Torcetrapib|torcetrapib|mesh-list
44126070|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44126071|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44126072|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
44126073|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126074|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44126075|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44126076|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126077|NCT00137501|Nifedipine|nifedipine|mesh-list
44126078|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44126079|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126080|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126081|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44126082|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126083|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
44126084|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
44126089|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44328943|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44328944|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44328945|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
44328946|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328947|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328948|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44328949|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44328950|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44328951|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44328952|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328953|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328954|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
44328955|NCT00972387|Hormones|hormones|mesh-ancestor
44328956|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328957|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328958|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44328959|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44328960|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44328961|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44328962|NCT00972426|Timolol|timolol|mesh-list
44328963|NCT00972426|Carteolol|carteolol|mesh-list
44328964|NCT00972426|Latanoprost|latanoprost|mesh-list
44328965|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44328966|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44328967|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
44328968|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44328969|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328970|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328971|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44328972|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44328973|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44328974|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44328975|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
44328976|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
44328977|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126090|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44126091|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126093|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126094|NCT00137527|Anesthetics|anesthetics|mesh-list
43701995|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
44328978|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
44328979|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44328980|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328981|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44328982|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
44328983|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328984|NCT00972660|Cyclosporine|cyclosporine|mesh-list
44328985|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
44328986|NCT00972660|Prednisone|prednisone|mesh-list
44328987|NCT00972660|Cyclosporins|cyclosporins|mesh-list
44328988|NCT00972660|Tacrolimus|tacrolimus|mesh-list
44328989|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44328990|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
44328991|NCT00972660|Hormones|hormones|mesh-ancestor
44328992|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44328993|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44328994|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44328995|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44328996|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44328997|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44328998|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44328999|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
44329000|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
44329001|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329002|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
44329003|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329004|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44329005|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44329006|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44329007|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
44329008|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44329009|NCT00972712|Bortezomib|bortezomib|mesh-list
44329010|NCT00972712|Tipifarnib|tipifarnib|mesh-list
44329011|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329012|NCT00972790|Bupivacaine|bupivacaine|mesh-list
44329013|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
44329014|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
43702101|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
44329017|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
44329018|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329019|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
44329020|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44329021|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329022|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
44329023|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44329024|NCT00972829|Ezetimibe|ezetimibe|mesh-list
44329025|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329026|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329027|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
44329028|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329029|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329030|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329031|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329032|NCT00972842|Lenalidomide|lenalidomide|mesh-list
44329033|NCT00972842|Vorinostat|vorinostat|mesh-list
44329034|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
44329035|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329036|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329037|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329038|NCT00972842|Growth Substances|growth substances|mesh-ancestor
44329039|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329040|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329041|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44329042|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329043|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329044|NCT00972855|Bicalutamide|bicalutamide|mesh-list
44329045|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
44329046|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
43984002|NCT02141555|Misoprostol|misoprostol|mesh-list
44329047|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329048|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329057|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44329058|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44329060|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44468398|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44468399|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44468400|NCT01436643|Fluoxetine|fluoxetine|mesh-list
44468401|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44468402|NCT01436643|Citalopram|citalopram|mesh-list
44468403|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44468404|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44468405|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468406|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468407|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468408|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468409|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
44468410|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468411|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44468412|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
44468413|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468414|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44468415|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44468416|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468417|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44468418|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44468419|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44468420|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
44468421|NCT01436500|Ifetroban|ifetroban|mesh-list
44468423|NCT01436370|Vaccines|vaccines|mesh-list
44468436|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468437|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468438|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44468439|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44468440|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44468441|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
44468442|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44468443|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44468444|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468445|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
44468446|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
44468447|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468448|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44468449|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
44468451|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44468452|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44468453|NCT01436305|Protective Agents|protective agents|mesh-ancestor
44468454|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44468455|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44468456|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44468457|NCT01436201|Dulaglutide|dulaglutide|mesh-list
44329062|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44329063|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329064|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329065|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44329066|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329067|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
44329084|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44329085|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44329086|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329087|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329088|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
44329089|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329090|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44329091|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44329092|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44329093|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
44329094|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
44329095|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
44329096|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329097|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44329098|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44329099|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329100|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44329101|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44329102|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44329103|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
44329104|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
44329105|NCT00973037|Tamoxifen|tamoxifen|mesh-list
44329106|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44329107|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44329108|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329109|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329110|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44329111|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329115|NCT00973050|Bicalutamide|bicalutamide|mesh-list
44329127|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329128|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329129|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44329130|NCT00973128|Sargramostim|sargramostim|mesh-list
44329131|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
44329132|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984155|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
44329133|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44329134|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44329135|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329136|NCT00973154|Prednisone|prednisone|mesh-list
44329137|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329138|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
44329139|NCT00973154|Hormones|hormones|mesh-ancestor
44329140|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329141|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329142|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44329143|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329144|NCT00973193|Panitumumab|panitumumab|mesh-list
44329145|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329146|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329147|NCT00973219|Interferons|interferons|mesh-list
44329148|NCT00973219|Tenofovir|tenofovir|mesh-list
44329149|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
44329150|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
44329151|NCT00973219|Adefovir|adefovir|mesh-list
44329152|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44329153|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44329154|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329155|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
44329156|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329172|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
44329173|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44329174|NCT00973232|Narcotics|narcotics|mesh-ancestor
44329175|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329176|NCT00973245|Warfarin|warfarin|mesh-list
44329177|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
44329178|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
44329179|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44329180|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
44329181|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44329182|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329183|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329184|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329185|NCT00973271|Atorvastatin|atorvastatin|mesh-list
44329186|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
44329187|NCT00973271|Fenofibrate|fenofibrate|mesh-list
44329188|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329189|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329190|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
44329191|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329192|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329193|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329194|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329195|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44329196|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329197|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44329222|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329223|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329225|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329226|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329227|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
44329228|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329229|NCT00973505|Anastrozole|anastrozole|mesh-list
44329230|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44329231|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329232|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44329233|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329234|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329235|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44329236|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
44329237|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329238|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329239|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44329240|NCT00973583|Vitamin D|vitamin d|mesh-list
44329241|NCT00973583|Vitamins|vitamins|mesh-ancestor
44329242|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
44329243|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329244|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44329245|NCT00973609|Folic Acid|folic acid|mesh-list
44329246|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
44329272|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
44329273|NCT00973687|Hormones|hormones|mesh-ancestor
44329274|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329275|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44329276|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329277|NCT00973713|Everolimus|everolimus|mesh-list
44329278|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329279|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329280|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
44329281|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329282|NCT00973778|Capecitabine|capecitabine|mesh-list
44329283|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329284|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
44329285|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984305|NCT02153489|Bromides|bromides|mesh-list
44329286|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329287|NCT00973804|Sirolimus|sirolimus|mesh-list
44329288|NCT00973804|Tacrolimus|tacrolimus|mesh-list
44329289|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329290|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
44329291|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329292|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44329293|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329294|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329295|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44329296|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329297|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44329298|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329299|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
44329300|NCT00973869|Curcumin|curcumin|mesh-list
44329302|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44329315|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44329316|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44329317|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44329318|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329319|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329320|NCT00973986|Atorvastatin|atorvastatin|mesh-list
44329321|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329322|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329323|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
44329324|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329325|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329326|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329327|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329328|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
44329329|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44329330|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329331|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329332|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
44329333|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329334|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329335|NCT00974012|Valproic Acid|valproic acid|mesh-list
44329336|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
44329337|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329338|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126095|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44126096|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126097|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44126099|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
44126100|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44126101|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
44126102|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44126103|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44126104|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126105|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44126106|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126107|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126108|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44126109|NCT00137553|Renal Agents|renal agents|mesh-ancestor
44126110|NCT00137566|Acetaminophen|acetaminophen|mesh-list
44126111|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44126112|NCT00137566|Analgesics|analgesics|mesh-ancestor
44126113|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
44126114|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126115|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126116|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
44126117|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44329339|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
44329340|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329341|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329342|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
44329343|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44329344|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329345|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44329346|NCT00974025|Ascorbic Acid|ascorbic acid|mesh-list
44329347|NCT00974025|Vitamins|vitamins|mesh-ancestor
44329348|NCT00974025|Micronutrients|micronutrients|mesh-ancestor
44329349|NCT00974025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329350|NCT00974025|Antioxidants|antioxidants|mesh-ancestor
44329351|NCT00974025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329352|NCT00974025|Protective Agents|protective agents|mesh-ancestor
44329353|NCT00974155|Dexetimide|dexetimide|mesh-list
44329354|NCT00974155|Citalopram|citalopram|mesh-list
44329355|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44329356|NCT00974155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44329357|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44329358|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468458|NCT01436201|Digoxin|digoxin|mesh-list
43984381|NCT02155101|Ritonavir|ritonavir|mesh-list
44329359|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126118|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
44126119|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154943|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154944|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154945|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44154946|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154947|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154948|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44154949|NCT00225589|Calcium|calcium|mesh-list
44154950|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154951|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154952|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44154953|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44154954|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
44154955|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154956|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44154957|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44154958|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154959|NCT00225615|Verapamil|verapamil|mesh-list
44154960|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44154961|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44154962|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154963|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154964|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44154965|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154966|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
44154967|NCT00225667|Irbesartan|irbesartan|mesh-list
44154968|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44329362|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329363|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44329364|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
44329365|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44329366|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44329367|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44329368|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
44329369|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
44329370|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329371|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44329372|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44329373|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44329374|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44329375|NCT00974181|Paclitaxel|paclitaxel|mesh-list
44329376|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44329377|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44329378|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329379|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44329380|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44329381|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44329382|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329383|NCT00974272|Exenatide|exenatide|mesh-list
44329384|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329385|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329386|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44329387|NCT00974272|Incretins|incretins|mesh-ancestor
44329388|NCT00974272|Hormones|hormones|mesh-ancestor
44329389|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154969|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44154970|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44154971|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154972|NCT00225706|Ibuprofen|ibuprofen|mesh-list
44154973|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154974|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154975|NCT00225706|Analgesics|analgesics|mesh-ancestor
44126120|NCT00137657|Trimethoprim|trimethoprim|mesh-list
44126121|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44126125|NCT00137657|Renal Agents|renal agents|mesh-ancestor
44126126|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
44126127|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44126128|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44126129|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44329390|NCT00974324|Endostar protein|endostar protein|mesh-list
44329391|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329392|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329393|NCT00974324|Growth Substances|growth substances|mesh-ancestor
44329394|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329395|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329396|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329397|NCT00974389|Bevacizumab|bevacizumab|mesh-list
44329398|NCT00974389|Tegafur|tegafur|mesh-list
44329399|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329400|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329401|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329402|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329403|NCT00974389|Growth Substances|growth substances|mesh-ancestor
44329404|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329405|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329406|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329407|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
44329408|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329409|NCT00974428|Wobenzym|wobenzym|mesh-list
44329410|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44329411|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
44329412|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329413|NCT00974441|Valproic Acid|valproic acid|mesh-list
44329414|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
44329415|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740851|NCT02527668|Vitamins|vitamins|mesh-ancestor
44126130|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126131|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126132|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44126133|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44126134|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43570629|NCT00393952|Xhance|xhance|mesh-list
44126135|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126136|NCT00137709|Lamotrigine|lamotrigine|mesh-list
44126137|NCT00137709|Valproic Acid|valproic acid|mesh-list
44126138|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
44126139|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44126140|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126141|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126142|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44126143|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126144|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44126145|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44126146|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44126147|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126148|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44126149|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329416|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329417|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
44329418|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329419|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329420|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
44329421|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44329422|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329423|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44329424|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
44329425|NCT00974532|Calcium|calcium|mesh-list
44329426|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44329427|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329428|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44329429|NCT00974584|Paclitaxel|paclitaxel|mesh-list
44329430|NCT00974584|Bevacizumab|bevacizumab|mesh-list
44329431|NCT00974584|Cisplatin|cisplatin|mesh-list
44329432|NCT00974584|Carboplatin|carboplatin|mesh-list
44329433|NCT00974584|Pemetrexed|pemetrexed|mesh-list
44329434|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44329435|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329436|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44329437|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44329438|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
44329439|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329440|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329441|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329442|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329443|NCT00974584|Growth Substances|growth substances|mesh-ancestor
44329444|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329445|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329446|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329447|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44126150|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
44126151|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126152|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
44126154|NCT00137735|Analgesics|analgesics|mesh-ancestor
44126155|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
44126156|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126157|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126158|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
44126159|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44126160|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44126161|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329448|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44468459|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44468460|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44468461|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44468462|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468463|NCT01436201|Protective Agents|protective agents|mesh-ancestor
44468464|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468465|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44468466|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44468467|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
44468468|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468469|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44468470|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468471|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44468472|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468473|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468474|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468475|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
44468476|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468477|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44468478|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
44468479|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468480|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44468481|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468482|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44468483|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468484|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468485|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468486|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
44468487|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468488|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44468489|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44468490|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126162|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126163|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44126164|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44468491|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44468492|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468493|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44468494|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468495|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
44468496|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468497|NCT01436110|Fluticasone|fluticasone|mesh-list
44468498|NCT01436110|Xhance|xhance|mesh-list
44468499|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468500|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468501|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
44468502|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468503|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468504|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44468505|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468506|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468507|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468508|NCT01436071|Fluticasone|fluticasone|mesh-list
44468509|NCT01436071|Xhance|xhance|mesh-list
44126165|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126166|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126167|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
44126168|NCT00137761|Docetaxel|docetaxel|mesh-list
44126169|NCT00137761|Gefitinib|gefitinib|mesh-list
44126170|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126171|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126172|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126173|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126174|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126175|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44126176|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126177|NCT00137774|Bevacizumab|bevacizumab|mesh-list
44126178|NCT00137774|Temozolomide|temozolomide|mesh-list
44126179|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44126180|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126181|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44126182|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44126183|NCT00137774|Growth Substances|growth substances|mesh-ancestor
44126184|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126185|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
44126186|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126187|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
44126188|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126189|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
44126190|NCT00137787|Cefepime|cefepime|mesh-list
44126191|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126192|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126193|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652307|NCT03000127|Androgens|androgens|mesh-ancestor
44126196|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126197|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126198|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44126199|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44126200|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44126201|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126202|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44468510|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44468511|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44468512|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
44468513|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44468514|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468515|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44329449|NCT00974740|Atorvastatin|atorvastatin|mesh-list
44329450|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44329451|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44329452|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
44329453|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329454|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44329455|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44329456|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329457|NCT00974753|Ketorolac|ketorolac|mesh-list
44329458|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44329459|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44329460|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44329461|NCT00974753|Analgesics|analgesics|mesh-ancestor
44329462|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
44329463|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329464|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329465|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126203|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126204|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126207|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44126208|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126209|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44126210|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44126211|NCT00137813|Growth Substances|growth substances|mesh-ancestor
44126212|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126213|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44126214|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126215|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126216|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126217|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126218|NCT00137826|Bevacizumab|bevacizumab|mesh-list
44126219|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44126220|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44126221|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126222|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44126223|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44126224|NCT00137826|Growth Substances|growth substances|mesh-ancestor
44126225|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126226|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44126227|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44126228|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126229|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126230|NCT00137852|Celecoxib|celecoxib|mesh-list
44126231|NCT00137852|Cisplatin|cisplatin|mesh-list
44329466|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329467|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44329468|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329469|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329470|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
44329471|NCT00974766|Hormones|hormones|mesh-ancestor
44329472|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329473|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329474|NCT00974792|Leucovorin|leucovorin|mesh-list
44329475|NCT00974792|Cytarabine|cytarabine|mesh-list
44329476|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
44329477|NCT00974792|Ifosfamide|ifosfamide|mesh-list
44329478|NCT00974792|Rituximab|rituximab|mesh-list
44329479|NCT00974792|Doxorubicin|doxorubicin|mesh-list
44329480|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44329481|NCT00974792|Methotrexate|methotrexate|mesh-list
44329482|NCT00974792|Etoposide|etoposide|mesh-list
44329483|NCT00974792|Vincristine|vincristine|mesh-list
44329484|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
44329485|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
44329486|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329487|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
44329488|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329489|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329490|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44329491|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
44329492|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329493|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329494|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44329511|NCT00974792|Antidotes|antidotes|mesh-ancestor
44329514|NCT00974792|Vitamins|vitamins|mesh-ancestor
44329515|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
44329516|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
44329517|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
44329518|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
44329519|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44329520|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44329521|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
44329522|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329523|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329524|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44329525|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
44329526|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
44329528|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329529|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
44329530|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44329531|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44329532|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
44329533|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329534|NCT00974935|Antacids|antacids|mesh-ancestor
44329535|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329536|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44329537|NCT00974961|Bupivacaine|bupivacaine|mesh-list
44329538|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
44329539|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
44329540|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
44329541|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329542|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329543|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
44329544|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329545|NCT00974987|Temozolomide|temozolomide|mesh-list
44329546|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44329555|NCT00975052|Hormones|hormones|mesh-ancestor
44329556|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329557|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44329558|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329559|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329560|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329561|NCT00975065|Metformin|metformin|mesh-list
44329562|NCT00975065|Vildagliptin|vildagliptin|mesh-list
44329563|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329564|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329565|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44329566|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329567|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329568|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329569|NCT00975078|Prednisone|prednisone|mesh-list
44329570|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329571|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
44329572|NCT00975078|Hormones|hormones|mesh-ancestor
44329573|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329574|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329575|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44329576|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329577|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44329578|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
44329579|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329580|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44329581|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329582|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44329583|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329584|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126232|NCT00137852|Irinotecan|irinotecan|mesh-list
44126233|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126234|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44126235|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126236|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126237|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126238|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44126239|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44126240|NCT00137852|Analgesics|analgesics|mesh-ancestor
44126241|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
44126242|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329585|NCT00975299|Bombesin|bombesin|mesh-list
44329586|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329587|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329588|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329589|NCT00975312|Tretinoin|tretinoin|mesh-list
44329590|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329591|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
44329592|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
44329593|NCT00975325|Yohimbine|yohimbine|mesh-list
44329594|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
44329595|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
44329596|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329597|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984638|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44329598|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44329599|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44329600|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44329601|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
44329602|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329603|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329604|NCT00975325|Urological Agents|urological agents|mesh-ancestor
44329605|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
44329606|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329607|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
44329608|NCT00975351|Vitamins|vitamins|mesh-ancestor
44329609|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
44329610|NCT00975390|Caffeine|caffeine|mesh-list
44329611|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44329612|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329629|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329631|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
44329632|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329633|NCT00975663|Tacrolimus|tacrolimus|mesh-list
44329634|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329635|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
44329636|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329637|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44329638|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329639|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329640|NCT00975728|Antioxidants|antioxidants|mesh-list
44329641|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329642|NCT00975728|Protective Agents|protective agents|mesh-ancestor
44329643|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329644|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
44329645|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329646|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
44329647|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44329648|NCT00975754|Budesonide|budesonide|mesh-list
44329649|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44329650|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44329651|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
44329652|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329653|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329654|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44329655|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44329656|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
44329657|NCT00975754|Hormones|hormones|mesh-ancestor
44329658|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329659|NCT00975767|Docetaxel|docetaxel|mesh-list
44329660|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44329661|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329662|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
44329669|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44329670|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329671|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44329672|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329673|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
44329674|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329675|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
44329676|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329677|NCT00975897|Leucovorin|leucovorin|mesh-list
44329678|NCT00975897|Bevacizumab|bevacizumab|mesh-list
44329679|NCT00975897|Cetuximab|cetuximab|mesh-list
44329680|NCT00975897|Fluorouracil|fluorouracil|mesh-list
44329681|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
44329682|NCT00975897|Irinotecan|irinotecan|mesh-list
44329683|NCT00975897|Calcium|calcium|mesh-list
44329684|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
44329685|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44329686|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329687|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329688|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329689|NCT00975897|Growth Substances|growth substances|mesh-ancestor
44329690|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329691|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329692|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44329693|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
44329694|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329695|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329696|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329697|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
44329698|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44329699|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44329700|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329701|NCT00975897|Antidotes|antidotes|mesh-ancestor
44329702|NCT00975897|Protective Agents|protective agents|mesh-ancestor
44329703|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
44329711|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
44329712|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329713|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44329714|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44329715|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44329716|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329717|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329719|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
44329720|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329721|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44329722|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44329723|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329724|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329725|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44329726|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
44329727|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44329728|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329729|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44329730|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44329731|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44329732|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44329733|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329734|NCT00975988|Lapatinib|lapatinib|mesh-list
44329737|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329755|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44329756|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44329757|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
44329758|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329759|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329760|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329761|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
44329762|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44329763|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44329764|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
44329765|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44329766|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
44329767|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329768|NCT00976105|Zolpidem|zolpidem|mesh-list
44329769|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44329770|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44329771|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329772|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329773|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44329774|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
44329775|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
44329776|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329777|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329778|NCT00976170|Sorafenib|sorafenib|mesh-list
44329779|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329780|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44329781|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329782|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329783|NCT00976222|Ranibizumab|ranibizumab|mesh-list
44329799|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329800|NCT00976300|Cyclosporine|cyclosporine|mesh-list
44329801|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
44329802|NCT00976300|Cyclosporins|cyclosporins|mesh-list
44329803|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329804|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
44329805|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329806|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44329807|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44329808|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
44329809|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329810|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329811|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44329812|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329813|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
44329814|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329815|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
44329816|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44329817|NCT00976326|Insulin|insulin|mesh-list
44329818|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44329819|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329820|NCT00976469|Vaccines|vaccines|mesh-list
44329821|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
44329822|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329823|NCT00976651|Menotropins|menotropins|mesh-list
44329824|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44329825|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
44329826|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44329827|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468516|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468517|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
44468518|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44468529|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468530|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468531|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44468532|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44468533|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
44468534|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44468535|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44468536|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
44468537|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
44468538|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
44468539|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
44468540|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44468541|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44468542|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44468543|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44468544|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468545|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44468546|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
44468547|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44468548|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44468549|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44468550|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44468551|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44468554|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
44329848|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329849|NCT00976768|Fluorouracil|fluorouracil|mesh-list
44329850|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
44329851|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
44329852|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329853|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329854|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329855|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44329856|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
44329857|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329858|NCT00976794|Carbamazepine|carbamazepine|mesh-list
44329859|NCT00976794|Valproic Acid|valproic acid|mesh-list
44329860|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
44329861|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
44329862|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44329863|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44329864|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329865|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
44329866|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44329867|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329868|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329869|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
44329870|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
44329871|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329872|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44329873|NCT00976794|Analgesics|analgesics|mesh-ancestor
44329874|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
44329875|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329876|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44329877|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329878|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44329879|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44329880|NCT00976963|Fosfomycin|fosfomycin|mesh-list
44329881|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44329883|NCT00976976|Cisplatin|cisplatin|mesh-list
44329888|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
44329889|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
44329890|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329891|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329892|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
44329894|NCT00977028|Epinephrine|epinephrine|mesh-list
44329895|NCT00977028|Racepinephrine|racepinephrine|mesh-list
44329896|NCT00977028|Anesthetics|anesthetics|mesh-list
44329897|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
44329898|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
44329899|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329900|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329901|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
44329902|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329903|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44329904|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44329905|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43741332|NCT02524210|Omeprazole|omeprazole|mesh-list
44126243|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126244|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126245|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126246|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44126247|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44126248|NCT00137995|Cytarabine|cytarabine|mesh-list
44126249|NCT00137995|Dexamethasone|dexamethasone|mesh-list
44126250|NCT00137995|Rituximab|rituximab|mesh-list
44126251|NCT00137995|Etoposide|etoposide|mesh-list
44126252|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
44126253|NCT00137995|Melphalan|melphalan|mesh-list
44126254|NCT00137995|Ifosfamide|ifosfamide|mesh-list
44126255|NCT00137995|Carboplatin|carboplatin|mesh-list
44126256|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44126257|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126258|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
44126259|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126260|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126261|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126262|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
44126263|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
44126264|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126265|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44126266|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
44126267|NCT00137995|Hormones|hormones|mesh-ancestor
44126270|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44126271|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44126272|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126273|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126274|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126275|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126276|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
44126277|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
44126278|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126279|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126280|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126281|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
44126282|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44126283|NCT00138060|Fluorouracil|fluorouracil|mesh-list
44126284|NCT00138060|Irinotecan|irinotecan|mesh-list
44329906|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44329907|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329908|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44329909|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44329910|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44329911|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329912|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44329913|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44329914|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
44329915|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44329916|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
44329917|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
44329918|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
44329919|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44329920|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43566180|NCT00836472|Glyburide|glyburide|mesh-list
44126285|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
44126286|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126287|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126288|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126289|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126290|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
44126291|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126292|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44126293|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126294|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126295|NCT00138099|Dalteparin|dalteparin|mesh-list
44126296|NCT00138099|Tinzaparin|tinzaparin|mesh-list
44126297|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44126298|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
44126299|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44126300|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44126301|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126302|NCT00138112|Vancomycin|vancomycin|mesh-list
44126303|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126304|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126305|NCT00138138|Methylphenidate|methylphenidate|mesh-list
44126306|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44126307|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126308|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44126309|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44126310|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126311|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126312|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
44126313|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126314|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
44126315|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126316|NCT00138177|Leucovorin|leucovorin|mesh-list
44126317|NCT00138177|Fluorouracil|fluorouracil|mesh-list
44126318|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
44126319|NCT00138177|Vorinostat|vorinostat|mesh-list
44126320|NCT00138177|Calcium|calcium|mesh-list
44126321|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
44126322|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44126323|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126324|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
44126325|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126326|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126327|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329921|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
44329922|NCT00977054|Ribavirin|ribavirin|mesh-list
44329923|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
44329924|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44329925|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
44329926|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329927|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
44329928|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329929|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
44329930|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329931|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329932|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
44329933|NCT00977093|Antidotes|antidotes|mesh-ancestor
44329934|NCT00977093|Protective Agents|protective agents|mesh-ancestor
44329935|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329936|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
44329937|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
44329938|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329939|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44329940|NCT00977132|Lenalidomide|lenalidomide|mesh-list
44329941|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
44126328|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126329|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
44126330|NCT00138177|Antidotes|antidotes|mesh-ancestor
44126331|NCT00138177|Protective Agents|protective agents|mesh-ancestor
44126332|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
44126333|NCT00138177|Vitamins|vitamins|mesh-ancestor
44126334|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
44126335|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44126336|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126337|NCT00138216|Irinotecan|irinotecan|mesh-list
44126338|NCT00138216|Vincristine|vincristine|mesh-list
44126341|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126342|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126343|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126344|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126345|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44126346|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126347|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126348|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126349|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126350|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
44126351|NCT00138229|Aldesleukin|aldesleukin|mesh-list
44126352|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
44126353|NCT00138229|Fludarabine|fludarabine|mesh-list
44126354|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
44126355|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126356|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
44126357|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126358|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126359|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126360|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
44126361|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126362|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126363|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44126364|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44329942|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329943|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44329944|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44329945|NCT00977132|Growth Substances|growth substances|mesh-ancestor
44329946|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44329947|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44329948|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
44329949|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
44329950|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44329952|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
44329953|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
44329954|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
44329955|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329956|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329957|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44329958|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44329959|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329960|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329961|NCT00977249|Varenicline|varenicline|mesh-list
44329962|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44329963|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44329964|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
44329965|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44329966|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44329977|NCT00977301|Ritonavir|ritonavir|mesh-list
44329991|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
44329992|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
44329993|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44329994|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44329995|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44329996|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44329997|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44329998|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44329999|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330000|NCT00977301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44330001|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44330002|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330003|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330004|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
44330005|NCT00977353|Citalopram|citalopram|mesh-list
44330006|NCT00977353|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44330007|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44330008|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330009|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330010|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330011|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
44330012|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330013|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44330014|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
44330015|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330016|NCT00977405|Gentamicins|gentamicins|mesh-list
44330017|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330036|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
44330037|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
44330038|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330039|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330040|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44330041|NCT00977444|Protective Agents|protective agents|mesh-ancestor
44330042|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44330043|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330044|NCT00977756|Ritonavir|ritonavir|mesh-list
44330045|NCT00977756|Lopinavir|lopinavir|mesh-list
44330046|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44330047|NCT00977756|Darunavir|darunavir|mesh-list
44330048|NCT00977756|Tenofovir|tenofovir|mesh-list
44330049|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
44330050|NCT00977756|Maraviroc|maraviroc|mesh-list
44330051|NCT00977756|Etravirine|etravirine|mesh-list
44330052|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44330053|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44330054|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
44330055|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330056|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330057|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44330058|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44330059|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
44330060|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330061|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44330062|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330063|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44330064|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44330065|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44330066|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44330067|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44330068|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44330069|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44330070|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44330078|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
44330079|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44330080|NCT00977964|Caseins|caseins|mesh-list
44330081|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
44330082|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
44330083|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330084|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44330085|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44330086|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330087|NCT00978107|Flucytosine|flucytosine|mesh-list
44330088|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
44330089|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330090|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
44330091|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330092|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
44330093|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330094|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
44330095|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330096|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330097|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44330098|NCT00978159|Esomeprazole|esomeprazole|mesh-list
44330099|NCT00978159|Famotidine|famotidine|mesh-list
44330100|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44330101|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330102|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44330103|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330104|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330105|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44330106|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
44330107|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
44330108|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330109|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330110|NCT00978172|Artesunate|artesunate|mesh-list
44330122|NCT00978211|Somatostatin|somatostatin|mesh-list
44330123|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330124|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44330125|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330126|NCT00978211|Hormones|hormones|mesh-ancestor
44330127|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330128|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330129|NCT00978263|Metformin|metformin|mesh-list
44330130|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44330131|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330132|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
44330133|NCT00978315|Vitamin D|vitamin d|mesh-list
44330134|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330135|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330136|NCT00978315|Vitamins|vitamins|mesh-ancestor
44330137|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
44330138|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44330139|NCT00978328|Oxycodone|oxycodone|mesh-list
44330140|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330141|NCT00978328|Narcotics|narcotics|mesh-ancestor
44330142|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330143|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330144|NCT00978328|Analgesics|analgesics|mesh-ancestor
44330145|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
44330146|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330147|NCT00978354|Furosemide|furosemide|mesh-list
44330148|NCT00978354|Diuretics|diuretics|mesh-ancestor
44330149|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
44330150|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330151|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44330152|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330158|NCT00978393|Hormones|hormones|mesh-ancestor
44330163|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330165|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44330166|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330167|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
44330168|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330169|NCT00978549|Docetaxel|docetaxel|mesh-list
44330170|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330171|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330172|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330173|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330174|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330175|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44330176|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
44330177|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
44330178|NCT00978601|Analgesics|analgesics|mesh-list
44330179|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
44330180|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330181|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985281|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44330182|NCT00978653|Allopurinol|allopurinol|mesh-list
44330183|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
44330184|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330185|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330186|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
44330187|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330188|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44330189|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
44330190|NCT00978653|Protective Agents|protective agents|mesh-ancestor
44330191|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330193|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
44330195|NCT00978718|Protective Agents|protective agents|mesh-ancestor
44330205|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44330206|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
44330207|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330208|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330210|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44330211|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330212|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330213|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330214|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330215|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44330216|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44330217|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330218|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
44330219|NCT00978913|Vaccines|vaccines|mesh-list
44330220|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
44330221|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330222|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330223|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330224|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44330225|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
44330226|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330227|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330228|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44330229|NCT00978978|Fentanyl|fentanyl|mesh-list
44330230|NCT00978978|Midazolam|midazolam|mesh-list
44330231|NCT00978978|Propofol|propofol|mesh-list
44330232|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44330233|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835306|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126365|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
44126366|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44126367|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44126368|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
44126369|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126370|NCT00138242|Carboplatin|carboplatin|mesh-list
44126371|NCT00138242|Docetaxel|docetaxel|mesh-list
44126372|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126373|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126374|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126375|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126376|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126377|NCT00138359|Niclosamide|niclosamide|mesh-list
44126378|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
44330234|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330235|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44330236|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
44330237|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
44330238|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330239|NCT00978978|Narcotics|narcotics|mesh-ancestor
44330240|NCT00978978|Analgesics|analgesics|mesh-ancestor
44330241|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
44330242|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330243|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44330244|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44330245|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44330246|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330247|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
44330248|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
44330249|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330250|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330251|NCT00979056|Rifaximin|rifaximin|mesh-list
44330252|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330253|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330254|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330255|NCT00979160|Dasatinib|dasatinib|mesh-list
44330256|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985355|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
44330257|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330258|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330259|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330260|NCT00979186|Hemostatics|hemostatics|mesh-list
44330261|NCT00979186|Coagulants|coagulants|mesh-ancestor
44330262|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
44330263|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330264|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330265|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44330266|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44330267|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330268|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126379|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44126380|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
44126381|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44126382|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330269|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330270|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
44330271|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44330272|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44330273|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
44330274|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330275|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330276|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330277|NCT00979472|Urological Agents|urological agents|mesh-ancestor
44330278|NCT00979537|Nisoldipine|nisoldipine|mesh-list
44330279|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330280|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44330281|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330282|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330283|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330284|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330285|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
44330286|NCT00979563|Irinotecan|irinotecan|mesh-list
44330287|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44330288|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44330289|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330290|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330291|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330292|NCT00979589|Aspirin|aspirin|mesh-list
44330293|NCT00979589|Clopidogrel|clopidogrel|mesh-list
44330294|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44330295|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44330296|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44330297|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44330298|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
44330299|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330300|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330301|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330302|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44330305|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
44330306|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652662|NCT02989038|Nicotine|nicotine|mesh-list
44330307|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330308|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330309|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44330310|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44330311|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44330312|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330313|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
44330314|NCT00979641|Docetaxel|docetaxel|mesh-list
44330315|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330316|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330317|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330318|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330319|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330320|NCT00979667|Oseltamivir|oseltamivir|mesh-list
44330321|NCT00979667|Zanamivir|zanamivir|mesh-list
44330322|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
44330323|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330324|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330325|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330326|NCT00979706|Cyclosporine|cyclosporine|mesh-list
44330327|NCT00979706|Interleukin-2|interleukin-2|mesh-list
44330328|NCT00979706|Cyclosporins|cyclosporins|mesh-list
44330329|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330330|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330331|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330332|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
44330333|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330334|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
44330335|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330336|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330337|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330338|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44330339|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330340|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44330341|NCT00979706|Analgesics|analgesics|mesh-ancestor
44126383|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
44126384|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
44126385|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330342|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
44330343|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330344|NCT00979758|Atorvastatin|atorvastatin|mesh-list
44330345|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44330346|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44330347|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
44330348|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330349|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44330350|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44330351|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330352|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
44330354|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44330355|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330356|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
44330357|NCT00979836|Coagulants|coagulants|mesh-ancestor
44330358|NCT00979862|Cediranib|cediranib|mesh-list
44330359|NCT00979862|Maleic acid|maleic acid|mesh-list
44330360|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330361|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330362|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330363|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330364|NCT00979966|Sirolimus|sirolimus|mesh-list
44330365|NCT00979966|Sunitinib|sunitinib|mesh-list
44330366|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330367|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44330368|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44330369|NCT00979966|Growth Substances|growth substances|mesh-ancestor
44330370|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330371|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
44330372|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330373|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330374|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330375|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330376|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741576|NCT05669833|Golimumab|golimumab|mesh-list
44126386|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126387|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44126388|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126389|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330377|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44330378|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
44330379|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330380|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
44330381|NCT00980031|Eplerenone|eplerenone|mesh-list
44330382|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44330383|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
44330384|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330385|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330386|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44330387|NCT00980031|Diuretics|diuretics|mesh-ancestor
44330388|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
44330389|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330390|NCT00980109|Oseltamivir|oseltamivir|mesh-list
44330391|NCT00980109|Zanamivir|zanamivir|mesh-list
44330392|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
44330393|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330394|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330395|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330396|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
44330397|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330398|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44330399|NCT00980187|Indapamide|indapamide|mesh-list
44330400|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330401|NCT00980187|Diuretics|diuretics|mesh-ancestor
44330402|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
44330403|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330404|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44330405|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330406|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330407|NCT00980213|Sunitinib|sunitinib|mesh-list
44330408|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330409|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44330410|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44330411|NCT00980213|Growth Substances|growth substances|mesh-ancestor
43741618|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44126390|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126391|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330413|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44330414|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330415|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330416|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330417|NCT00980239|Bevacizumab|bevacizumab|mesh-list
44330418|NCT00980239|Cetuximab|cetuximab|mesh-list
44330419|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
44330420|NCT00980239|Irinotecan|irinotecan|mesh-list
44330421|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44330422|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330423|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44330424|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44330425|NCT00980239|Growth Substances|growth substances|mesh-ancestor
44330426|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330427|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44330428|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44330429|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44330430|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599170|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44330431|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330432|NCT00980304|Rituximab|rituximab|mesh-list
44330433|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44330434|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330435|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
44330436|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330437|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330438|NCT00980356|Vildagliptin|vildagliptin|mesh-list
44330439|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330440|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330441|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44330442|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
44330443|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330444|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330445|NCT00980382|Docetaxel|docetaxel|mesh-list
44330451|NCT00980408|Cycloserine|cycloserine|mesh-list
44330452|NCT00980408|Memantine|memantine|mesh-list
44330453|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44330454|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44330455|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
44330456|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330457|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330458|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330459|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44330460|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44330461|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44330462|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330463|NCT00980408|Renal Agents|renal agents|mesh-ancestor
44330464|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44330465|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
44330466|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330467|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
44330468|NCT00980473|Timolol|timolol|mesh-list
44330469|NCT00980473|Travoprost|travoprost|mesh-list
44330470|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44330471|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44330472|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44330473|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330506|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330507|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44330508|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
44330509|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330510|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330511|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44330512|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
44330513|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330514|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44330515|NCT00980850|Vaccines|vaccines|mesh-list
44330516|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
44330517|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330518|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
44330519|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
44330520|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330521|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330522|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330523|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44330524|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44330525|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330526|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330527|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330528|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44330529|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330530|NCT00981006|Mitogens|mitogens|mesh-list
44330531|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330532|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330533|NCT00981201|Celecoxib|celecoxib|mesh-list
44330534|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44330535|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44330536|NCT00981201|Analgesics|analgesics|mesh-ancestor
44330549|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44330550|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44330552|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330553|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330554|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44330555|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44330556|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
44330557|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330558|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44330559|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330560|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44330561|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44330562|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44330563|NCT00981487|Ondansetron|ondansetron|mesh-list
44330564|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
44330565|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
44330566|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330567|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330568|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330569|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
44330570|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330571|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44330572|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
44330573|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330574|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330575|NCT00981487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44330576|NCT00981487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44330577|NCT00981487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330578|NCT00981487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330579|NCT00981487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44330580|NCT00981513|Vaccines|vaccines|mesh-list
44330581|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
44330591|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330592|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
44330593|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330594|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330595|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44330596|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
44330597|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330598|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330599|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44330600|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330602|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
44330603|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330604|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330605|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
44330606|NCT00981708|Hormones|hormones|mesh-ancestor
44330607|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330608|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44330609|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44330610|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330611|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44330612|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44330613|NCT00981708|Growth Substances|growth substances|mesh-ancestor
44330614|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
44330615|NCT00981721|Cediranib|cediranib|mesh-list
44330616|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330617|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44330618|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330619|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330620|NCT00981773|Maraviroc|maraviroc|mesh-list
44330621|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44330622|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44330623|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330624|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44330625|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44330626|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
43702102|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
44330627|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330628|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44330629|NCT00981786|Timolol|timolol|mesh-list
44330630|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44330631|NCT00981786|Travoprost|travoprost|mesh-list
44330632|NCT00981786|Brinzolamide|brinzolamide|mesh-list
44330633|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44330634|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44330635|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
44330636|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330637|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824732|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
44330638|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330639|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44330640|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330641|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44330642|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44330643|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44330644|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44330645|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330646|NCT00981838|Rituximab|rituximab|mesh-list
44330647|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44330648|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330649|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
44330650|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330651|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330652|NCT00981851|Albuterol|albuterol|mesh-list
44330653|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
44330654|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44330655|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
44330656|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330657|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330670|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
44330671|NCT00981903|Tinzaparin|tinzaparin|mesh-list
44330672|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44330673|NCT00981903|Dalteparin|dalteparin|mesh-list
44330674|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
44330675|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44330676|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44330677|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330678|NCT00981929|Losartan|losartan|mesh-list
44330679|NCT00981929|Tramadol|tramadol|mesh-list
44330680|NCT00981929|Caffeine|caffeine|mesh-list
44330681|NCT00981929|Omeprazole|omeprazole|mesh-list
44330682|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44330683|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330684|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44330685|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44330686|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330687|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44330688|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330689|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44330690|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330691|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44330692|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330693|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44330694|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44330695|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44330696|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
44330697|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330698|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330699|NCT00981929|Narcotics|narcotics|mesh-ancestor
44330700|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330713|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330714|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330715|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44330716|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44330717|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
44330718|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330719|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
44330720|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44330721|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599176|NCT03293108|Denosumab|denosumab|mesh-list
44330722|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44330723|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
44330724|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44330725|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330726|NCT00982202|Pioglitazone|pioglitazone|mesh-list
44330727|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330728|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330729|NCT00982215|Acetaminophen|acetaminophen|mesh-list
44330730|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44330731|NCT00982215|Analgesics|analgesics|mesh-ancestor
44330732|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
44330733|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330734|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330735|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
44330736|NCT00982254|Insulin|insulin|mesh-list
44330737|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44330738|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330739|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330740|NCT00982332|Betamethasone|betamethasone|mesh-list
44330741|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
44330742|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44330743|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
44126392|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44126393|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44126394|NCT00138515|Vildagliptin|vildagliptin|mesh-list
44126395|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126396|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126397|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126398|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126399|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126400|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126401|NCT00138541|Vildagliptin|vildagliptin|mesh-list
44330744|NCT00982332|Hormones|hormones|mesh-ancestor
44330745|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330746|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330747|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44330748|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
44330749|NCT00982358|Valsartan|valsartan|mesh-list
44330750|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330751|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44330752|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44330753|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330754|NCT00982436|Cisplatin|cisplatin|mesh-list
44330755|NCT00982436|Carboplatin|carboplatin|mesh-list
44330756|NCT00982436|Docetaxel|docetaxel|mesh-list
44330757|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330758|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330759|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330760|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330761|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330762|NCT00982449|Fialuridine|fialuridine|mesh-list
44330763|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
44330764|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330765|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44330766|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330767|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330768|NCT00982527|Fenoldopam|fenoldopam|mesh-list
44330769|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44330770|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
44330771|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
44330772|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
44330788|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44330789|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330790|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44330791|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44330792|NCT00982566|Navitoclax|navitoclax|mesh-list
44330793|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330794|NCT00982618|Lidocaine|lidocaine|mesh-list
44330795|NCT00982618|Morphine|morphine|mesh-list
44330796|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
44330797|NCT00982618|Anesthetics|anesthetics|mesh-list
44330798|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330799|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774724|NCT02350712|Cisplatin|cisplatin|mesh-list
44330800|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
44330801|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330802|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44330803|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44330804|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44330805|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44330806|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330807|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330808|NCT00982618|Narcotics|narcotics|mesh-ancestor
44330809|NCT00982618|Analgesics|analgesics|mesh-ancestor
44330810|NCT00982631|Sirolimus|sirolimus|mesh-list
44330811|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330812|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330813|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44330814|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330815|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
44330834|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
44330835|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330836|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330837|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
44330838|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44330839|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44330840|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330841|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330842|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44330843|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44330844|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44330845|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330846|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
44330848|NCT00982891|Hydromorphone|hydromorphone|mesh-list
44330849|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44330850|NCT00982891|Narcotics|narcotics|mesh-ancestor
44330851|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330852|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330853|NCT00982891|Analgesics|analgesics|mesh-ancestor
44330854|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
44330855|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44330857|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44330858|NCT00983021|Liraglutide|liraglutide|mesh-list
44330859|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
44330860|NCT00983021|Xultophy|xultophy|mesh-list
44330861|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44330862|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330863|NCT00983021|Incretins|incretins|mesh-ancestor
44330864|NCT00983021|Hormones|hormones|mesh-ancestor
44330865|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126402|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126403|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126404|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126405|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126406|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126407|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126408|NCT00138554|Pioglitazone|pioglitazone|mesh-list
44126409|NCT00138554|Vildagliptin|vildagliptin|mesh-list
44126410|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126411|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126414|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126415|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330866|NCT00983034|Amoxicillin|amoxicillin|mesh-list
44330867|NCT00983034|Clarithromycin|clarithromycin|mesh-list
44330868|NCT00983034|Lansoprazole|lansoprazole|mesh-list
44330869|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
44330870|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330871|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330872|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44330873|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330874|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330875|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44330876|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44330877|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44330878|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44330879|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44330881|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
44330882|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330883|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330884|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330885|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330886|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330887|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44330888|NCT00983112|Thrombin|thrombin|mesh-list
44330889|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
44330890|NCT00983112|Coagulants|coagulants|mesh-ancestor
44330891|NCT00983125|Clonidine|clonidine|mesh-list
44330892|NCT00983125|Analgesics|analgesics|mesh-ancestor
44330893|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
44330916|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330917|NCT00983164|Protective Agents|protective agents|mesh-ancestor
44330918|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330919|NCT00983177|Colchicine|colchicine|mesh-list
44330920|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
43986052|NCT02219997|Hormones|hormones|mesh-ancestor
44330921|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330922|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44330923|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44330924|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330925|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330926|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330927|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44330928|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
44330929|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44330930|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
44330931|NCT00983255|Tedizolid|tedizolid|mesh-list
44330932|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
44330933|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330934|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330935|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44330936|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330937|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330938|NCT00983268|Capecitabine|capecitabine|mesh-list
44330939|NCT00983268|Vorinostat|vorinostat|mesh-list
44330940|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44330941|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
44330942|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126417|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126418|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126419|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126420|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126421|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126422|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126423|NCT00138580|Vildagliptin|vildagliptin|mesh-list
44126424|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126425|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126426|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126427|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126428|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126429|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126430|NCT00138593|Vildagliptin|vildagliptin|mesh-list
44126431|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126432|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330943|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330944|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44330945|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330946|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44330947|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
44330948|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44330949|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44330950|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44330951|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44330952|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330954|NCT00983398|Carboplatin|carboplatin|mesh-list
44330955|NCT00983398|Melphalan|melphalan|mesh-list
44330956|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
44330957|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44330958|NCT00983398|Mannitol|mannitol|mesh-list
44330959|NCT00983398|Antidotes|antidotes|mesh-list
44330960|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44330961|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44330962|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
44330963|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330964|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44330965|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330966|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
44330967|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330968|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44330969|NCT00983398|Diuretics|diuretics|mesh-ancestor
44330970|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
44330971|NCT00983398|Protective Agents|protective agents|mesh-ancestor
44330972|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
44330973|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
44330974|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44330975|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330976|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
44330977|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
44330978|NCT00983424|Cyclosporine|cyclosporine|mesh-list
44330985|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
44330986|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44330987|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44330988|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44330989|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
44330990|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44330991|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
44330992|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44330993|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
44330994|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44330995|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44330996|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44330997|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44330999|NCT00983450|Hormones|hormones|mesh-ancestor
44331000|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331001|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331002|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331003|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331004|NCT00983554|Anastrozole|anastrozole|mesh-list
44331005|NCT00983554|Testosterone|testosterone|mesh-list
44331006|NCT00983554|Dutasteride|dutasteride|mesh-list
44331007|NCT00983554|Androgens|androgens|mesh-ancestor
44331009|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331010|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331011|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44331012|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331013|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44331014|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44126433|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126434|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126435|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126436|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126437|NCT00138606|Vildagliptin|vildagliptin|mesh-list
44126438|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44126439|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126440|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126441|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126442|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126443|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126444|NCT00138619|Vildagliptin|vildagliptin|mesh-list
44126445|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331015|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331016|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331017|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
44331018|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44331019|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44331020|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44331021|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44331022|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331023|NCT00983736|Tramadol|tramadol|mesh-list
44331024|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44331025|NCT00983736|Narcotics|narcotics|mesh-ancestor
44331026|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331027|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331028|NCT00983736|Analgesics|analgesics|mesh-ancestor
44331029|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
44331030|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331031|NCT00983788|Bezafibrate|bezafibrate|mesh-list
44331032|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44331033|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
44331034|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331035|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44331036|NCT00983944|Prednisone|prednisone|mesh-list
44331037|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
44331038|NCT00983944|Rituximab|rituximab|mesh-list
44331039|NCT00983944|Doxorubicin|doxorubicin|mesh-list
44331040|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44331041|NCT00983944|Etoposide|etoposide|mesh-list
44331042|NCT00983944|Vincristine|vincristine|mesh-list
44331043|NCT00983944|Bleomycin|bleomycin|mesh-list
44331044|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331045|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
44331046|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331061|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331062|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44331063|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44331064|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
44331065|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
44331066|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
44331068|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44331069|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331070|NCT00984152|Efavirenz|efavirenz|mesh-list
44331071|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44331072|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
44331073|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331074|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331075|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331076|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331077|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
44331078|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331079|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44331080|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44331081|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44331082|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44331083|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44331084|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44331085|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44126446|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126447|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126448|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126449|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126450|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126451|NCT00138632|Vatalanib|vatalanib|mesh-list
44126452|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44126453|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126454|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126455|NCT00138710|Letrozole|letrozole|mesh-list
44126456|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126457|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44126458|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44126459|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702103|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331086|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331087|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44331088|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44331089|NCT00984217|Panitumumab|panitumumab|mesh-list
44331090|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331091|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331092|NCT00984230|Lactoferrin|lactoferrin|mesh-list
44331093|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331095|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
44331096|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331097|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331098|NCT00984360|Naltrexone|naltrexone|mesh-list
44331099|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44331100|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44331101|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331102|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
44331103|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331104|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44331105|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44331106|NCT00984386|Estradiol|estradiol|mesh-list
44331107|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44331108|NCT00984386|Estrogens|estrogens|mesh-ancestor
44331109|NCT00984386|Hormones|hormones|mesh-ancestor
44331110|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331111|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331112|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44331113|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
44331114|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331115|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44331116|NCT00984425|Sorafenib|sorafenib|mesh-list
44331117|NCT00984425|Lapatinib|lapatinib|mesh-list
44331118|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331120|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331130|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
44331131|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44331132|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331133|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331134|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331135|NCT00984464|Paclitaxel|paclitaxel|mesh-list
44331136|NCT00984464|Carboplatin|carboplatin|mesh-list
44331137|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44331138|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331139|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
44331140|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
44331141|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
44331142|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331143|NCT00984633|Bromides|bromides|mesh-list
44331144|NCT00984633|Propofol|propofol|mesh-list
44331145|NCT00984633|Sevoflurane|sevoflurane|mesh-list
44331146|NCT00984633|Rocuronium|rocuronium|mesh-list
44331147|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44331148|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331149|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331150|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44331151|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
44331152|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
44331153|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44126460|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126461|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44126462|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
44126463|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126464|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126465|NCT00138736|Lectins|lectins|mesh-list
44126466|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
44126467|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
44126468|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126469|NCT00138736|Coagulants|coagulants|mesh-ancestor
44126470|NCT00138801|Doxycycline|doxycycline|mesh-list
44126471|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
44126472|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126473|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126474|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
44126475|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44126476|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44126477|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
44126478|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44126479|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126480|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126481|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43775605|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
44126498|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44126500|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44126501|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
44126502|NCT00138970|Daclizumab|daclizumab|mesh-list
44126503|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331154|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44331155|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
44331156|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44331157|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44331158|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44331159|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331160|NCT00984724|Nicotine|nicotine|mesh-list
44331161|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44331162|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
44331163|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331164|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331165|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44331166|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44331167|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44331168|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331169|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331170|NCT00984737|Insulin|insulin|mesh-list
44331171|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331172|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331173|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
44331174|NCT00984750|Simvastatin|simvastatin|mesh-list
44331175|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44331176|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44331177|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
44331178|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742118|NCT05418699|Insulin|insulin|mesh-list
44126504|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
44126505|NCT00138970|Hormones|hormones|mesh-ancestor
44126506|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126507|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126508|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44126509|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126511|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
44126512|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126513|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44126514|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44126515|NCT00138970|Protective Agents|protective agents|mesh-ancestor
44126516|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44126517|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44126518|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
44126519|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126520|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126521|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126522|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126523|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
44126524|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
44126525|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126526|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
44331179|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44331180|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44331181|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331182|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
44331183|NCT00984750|Vitamins|vitamins|mesh-ancestor
44331184|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
44331185|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331186|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
44331187|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44331188|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44331189|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
44331190|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331191|NCT00984763|Antacids|antacids|mesh-ancestor
44331192|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331193|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331194|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44331195|NCT00984789|Gestodene|gestodene|mesh-list
44331196|NCT00984789|Norelgestromin|norelgestromin|mesh-list
44331197|NCT00984789|Femovan|femovan|mesh-list
44331198|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44331199|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44331200|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44331201|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
44331202|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331203|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331204|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44331205|NCT00984789|Estrogens|estrogens|mesh-ancestor
44331206|NCT00984789|Hormones|hormones|mesh-ancestor
44331207|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331208|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44126527|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126528|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44126529|NCT00138983|Vitamin D|vitamin d|mesh-list
44126530|NCT00138983|Alendronate|alendronate|mesh-list
44126531|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
44126532|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44126533|NCT00138983|Vitamins|vitamins|mesh-ancestor
44126534|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
44126535|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126536|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44126537|NCT00139009|Cyclosporine|cyclosporine|mesh-list
44126538|NCT00139009|Cyclosporins|cyclosporins|mesh-list
44126539|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126540|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126553|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126554|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
44331209|NCT00984789|Progestins|progestins|mesh-ancestor
44331210|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44331211|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
44331212|NCT00984893|Diphosphonates|diphosphonates|mesh-list
44331213|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44331214|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331215|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44331216|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44331217|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44331218|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
44331219|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331220|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44331221|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44331222|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331223|NCT00984945|Vaccines|vaccines|mesh-list
44331224|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
44331225|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331226|NCT00984971|Tenofovir|tenofovir|mesh-list
44331227|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
44331228|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331229|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331230|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331231|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331232|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331233|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44331234|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331235|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
44331236|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44331237|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44331238|NCT00984984|Prednisolone|prednisolone|mesh-list
44331253|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44331254|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331255|NCT00984997|Cisplatin|cisplatin|mesh-list
44331256|NCT00984997|Etoposide|etoposide|mesh-list
44331257|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331258|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44331259|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44331260|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331261|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331262|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331263|NCT00985244|Azithromycin|azithromycin|mesh-list
44331264|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331265|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331266|NCT00985270|Rifampin|rifampin|mesh-list
44331267|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44331268|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
44331269|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331270|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331271|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
44331272|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331273|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331274|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331275|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44331276|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44331277|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44331278|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44331279|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44331299|NCT00985361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986417|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
44331300|NCT00985361|Protective Agents|protective agents|mesh-ancestor
44331301|NCT00985374|Everolimus|everolimus|mesh-list
44331302|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331303|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331304|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
44331305|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331306|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
44331307|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44331308|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44331309|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
44331310|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331311|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331312|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331313|NCT00985387|Urological Agents|urological agents|mesh-ancestor
44331314|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
44331315|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331316|NCT00985556|Capecitabine|capecitabine|mesh-list
44331317|NCT00985556|Tegafur|tegafur|mesh-list
44331318|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
44331319|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331320|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
44331321|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331322|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331323|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44331324|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44331325|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331326|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
44331327|NCT00985647|Lamivudine|lamivudine|mesh-list
44331328|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331329|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331330|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331331|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331332|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
44331333|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126555|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331334|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44331335|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331336|NCT00985660|Nisoldipine|nisoldipine|mesh-list
44331337|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44331338|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44331339|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331340|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331341|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44331342|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331343|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
44331345|NCT00985777|Tocopherols|tocopherols|mesh-list
44331346|NCT00985777|Tocotrienols|tocotrienols|mesh-list
44331347|NCT00985777|Vitamins|vitamins|mesh-ancestor
44331348|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
44331349|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331350|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
44331351|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331352|NCT00985777|Protective Agents|protective agents|mesh-ancestor
44331353|NCT00985855|Cisplatin|cisplatin|mesh-list
44331354|NCT00985855|Etoposide|etoposide|mesh-list
44331355|NCT00985855|Cetuximab|cetuximab|mesh-list
44331356|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331357|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44331358|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44331359|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331360|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331361|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331362|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331363|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
44331364|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44331365|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44126556|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
44126557|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126558|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44126559|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126560|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44126561|NCT00139061|Atorvastatin|atorvastatin|mesh-list
44126562|NCT00139061|Torcetrapib|torcetrapib|mesh-list
44126563|NCT00139061|Fenofibrate|fenofibrate|mesh-list
44126564|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44126565|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44126566|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
44331366|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331367|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
44331368|NCT00985920|Coagulants|coagulants|mesh-ancestor
44331369|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
44331370|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331371|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331372|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44331373|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
44331374|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331375|NCT00986050|Sirolimus|sirolimus|mesh-list
44331377|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331378|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331379|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44331380|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331381|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
44331382|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331383|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
44331384|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331385|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
44331386|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44331387|NCT00986076|Enoxaparin|enoxaparin|mesh-list
44331388|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
44331389|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44331390|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44331391|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331392|NCT00986115|Memantine|memantine|mesh-list
44331393|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44331394|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44331395|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
44331396|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331397|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331398|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331399|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44331401|NCT00986128|Topiramate|topiramate|mesh-list
44331408|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44331409|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44331410|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331411|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331412|NCT00984828|Bortezomib|bortezomib|mesh-list
44331413|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331414|NCT00986284|Gefitinib|gefitinib|mesh-list
44331415|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331416|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44331417|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331418|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331419|NCT00986336|Topiramate|topiramate|mesh-list
44331420|NCT00986336|Risperidone|risperidone|mesh-list
44331421|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44331422|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
44331423|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331424|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331425|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331426|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44331427|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44331428|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331429|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44331430|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44331431|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
44331432|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
44331433|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331434|NCT00986466|Vitamin D|vitamin d|mesh-list
44331435|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
44331436|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
44331437|NCT00986466|Vitamins|vitamins|mesh-list
44331438|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
44331439|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126567|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126568|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44126569|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44126570|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126571|NCT00139074|Valproic Acid|valproic acid|mesh-list
44126572|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44126573|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
44126574|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126575|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44126576|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44126577|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44126578|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331440|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44331441|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44331442|NCT00986505|Lidocaine|lidocaine|mesh-list
44331443|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
44331444|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
44331445|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331446|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331447|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
44331448|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331449|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44331450|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44331451|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44331452|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331453|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331454|NCT00986557|Ganciclovir|ganciclovir|mesh-list
44331455|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44331456|NCT00986557|Foscarnet|foscarnet|mesh-list
44331457|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44331458|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
44331459|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331460|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331461|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
44331462|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331463|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331464|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331465|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331466|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331467|NCT00986596|Vitamin D|vitamin d|mesh-list
44331468|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
44331469|NCT00986596|Vitamins|vitamins|mesh-ancestor
44331485|NCT00986713|Amphotericin B|amphotericin b|mesh-list
44331486|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44331487|NCT00986713|Amebicides|amebicides|mesh-ancestor
44331488|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44331489|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44331490|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331491|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331492|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
44331493|NCT00986765|Aspirin|aspirin|mesh-list
44331494|NCT00986765|Enoxaparin|enoxaparin|mesh-list
44331495|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44331496|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44331497|NCT00986765|Analgesics|analgesics|mesh-ancestor
44331498|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
44331499|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331500|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331501|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331502|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331503|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44331504|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44331505|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331506|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44331507|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44331508|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331509|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
44331510|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
44331511|NCT00986778|Lamivudine|lamivudine|mesh-list
44331512|NCT00986778|Adefovir|adefovir|mesh-list
44331513|NCT00986778|Entecavir|entecavir|mesh-list
44331514|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331515|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331516|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126579|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
44126580|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126581|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126583|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126584|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
44126585|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
44126586|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44126587|NCT00139152|Omalizumab|omalizumab|mesh-list
44126588|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44126589|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44331517|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331518|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
44331519|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331520|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44331521|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331522|NCT00986804|Decitabine|decitabine|mesh-list
44331523|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331524|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
44331525|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331526|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331527|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331528|NCT00986817|Terlipressin|terlipressin|mesh-list
44331529|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44331530|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44331531|NCT00986843|Irinotecan|irinotecan|mesh-list
44331532|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44331533|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331534|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331535|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331536|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331537|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44331538|NCT00986960|Hormones|hormones|mesh-ancestor
44331539|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331540|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331541|NCT00987038|Midazolam|midazolam|mesh-list
44331542|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44331543|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44331544|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331545|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331546|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44331547|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44331548|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44331549|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44331550|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
44331551|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
44331556|NCT00987103|Tacrolimus|tacrolimus|mesh-list
44331557|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331558|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
44331559|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331560|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44331561|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331562|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331563|NCT00987116|Prednisone|prednisone|mesh-list
44331564|NCT00987116|Azathioprine|azathioprine|mesh-list
44331565|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331566|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
44331567|NCT00987116|Hormones|hormones|mesh-ancestor
44331568|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331569|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331570|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44331571|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331572|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
44331573|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331574|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331575|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331576|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
44331577|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331578|NCT00987168|Octreotide|octreotide|mesh-list
44331579|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331580|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44331581|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126590|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
44154976|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
44154977|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154978|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154979|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44154980|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44154981|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44154982|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154983|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154984|NCT00225797|Oxymorphone|oxymorphone|mesh-list
44154985|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44154986|NCT00225797|Narcotics|narcotics|mesh-ancestor
44154987|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44154988|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154989|NCT00225797|Analgesics|analgesics|mesh-ancestor
44154992|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44154993|NCT00225849|Aspirin|aspirin|mesh-list
43702164|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
44331583|NCT00987207|Cyclosporins|cyclosporins|mesh-list
44331584|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331585|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331586|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331587|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
44331588|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331589|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
44331590|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331591|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
44331592|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331593|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44331594|NCT00987220|Donepezil|donepezil|mesh-list
44331595|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44331596|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331597|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331598|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
44331599|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331600|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331601|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
44331602|NCT00987233|Triamcinolone|triamcinolone|mesh-list
44331603|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44331604|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44331605|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44331606|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331607|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
44331608|NCT00987233|Hormones|hormones|mesh-ancestor
44331609|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331610|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331611|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331612|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
44331613|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154994|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44154995|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154996|NCT00225849|Analgesics|analgesics|mesh-ancestor
44154997|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
44154998|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154999|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155000|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155001|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155002|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44331614|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331615|NCT00987376|Choline|choline|mesh-list
44331616|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
43776339|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
44331617|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44331618|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
44331619|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331620|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331621|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44331622|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
44331623|NCT00987441|Sufentanil|sufentanil|mesh-list
44331624|NCT00987441|Dsuvia|dsuvia|mesh-list
44331625|NCT00987441|Ropivacaine|ropivacaine|mesh-list
44331626|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
44331627|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
44331628|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331629|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331630|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
44331631|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331632|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44331633|NCT00987441|Narcotics|narcotics|mesh-ancestor
44331634|NCT00987441|Analgesics|analgesics|mesh-ancestor
44331635|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44331636|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44331637|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
44331638|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
44331639|NCT00987454|Hematinics|hematinics|mesh-ancestor
44331640|NCT00987493|Rituximab|rituximab|mesh-list
44331641|NCT00987493|Lenalidomide|lenalidomide|mesh-list
44331642|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44331643|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331662|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
44331663|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331664|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44331665|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331666|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44331667|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44331669|NCT00987662|Irbesartan|irbesartan|mesh-list
44331670|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44331671|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44331672|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331673|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331674|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44331675|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331676|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
44331677|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44331678|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44331679|NCT00987766|Gemcitabine|gemcitabine|mesh-list
44331680|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
44331681|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44331682|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331683|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
44331684|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331685|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331686|NCT00987766|Antiviral Agents|antiviral agents|mesh-ancestor
44331687|NCT00987766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331688|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331689|NCT00987766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331690|NCT00987766|Immunologic Factors|immunologic factors|mesh-ancestor
44331691|NCT00987766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155003|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44155004|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155005|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44155006|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44155007|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155008|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
44155009|NCT00225862|Ropinirole|ropinirole|mesh-list
44155010|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44155011|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44155012|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
44155013|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
44155014|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331693|NCT00987779|Gabapentin|gabapentin|mesh-list
44331694|NCT00987779|Analgesics|analgesics|mesh-ancestor
44331695|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
44331696|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331697|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331698|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
44331699|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44331700|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44331701|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44331702|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44331703|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44331704|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44331705|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331706|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331707|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
44331708|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
44331709|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44331710|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44331711|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331712|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44331713|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331714|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331715|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331716|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331717|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44331718|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
44331719|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331720|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331721|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44331722|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44331723|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44155015|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155016|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155017|NCT00225875|Rituximab|rituximab|mesh-list
44155018|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155019|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155020|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
44331725|NCT00987844|Laxatives|laxatives|mesh-ancestor
44331726|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331727|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44331728|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44331729|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
44331730|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331731|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331732|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331733|NCT00987870|Betamethasone|betamethasone|mesh-list
44331734|NCT00987870|Calcipotriene|calcipotriene|mesh-list
44331735|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44331736|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
44331737|NCT00987870|Hormones|hormones|mesh-ancestor
44331738|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44331739|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331740|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44331741|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
44331742|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44331743|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
44331744|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331745|NCT00987974|Atorvastatin|atorvastatin|mesh-list
44331746|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44331747|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44331748|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44331749|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
44331750|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331754|NCT00988026|Minocycline|minocycline|mesh-list
44331771|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44331772|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44331773|NCT00988078|Metformin|metformin|mesh-list
44331774|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331775|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331776|NCT00988195|Doxorubicin|doxorubicin|mesh-list
44331777|NCT00988195|BCT-100|bct-100|mesh-list
44331778|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44331779|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331780|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44331781|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44331782|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331783|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331784|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44331785|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
43776585|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331786|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331788|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331789|NCT00988481|Topiramate|topiramate|mesh-list
44331790|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
44331791|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331792|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331793|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44331794|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44331795|NCT00988507|Artesunate|artesunate|mesh-list
44331796|NCT00988507|Ferroquine|ferroquine|mesh-list
44331797|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
44331798|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44331799|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44331800|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331801|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331802|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
44331803|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
44331804|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44331805|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
44331806|NCT00988520|Bromides|bromides|mesh-list
44331815|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
44331816|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44331817|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44331818|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
44331819|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44331820|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44331821|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44331822|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331823|NCT00988663|Memantine|memantine|mesh-list
44331824|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44331825|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44331826|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
44331827|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331828|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331829|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331831|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44331872|NCT00988780|Maraviroc|maraviroc|mesh-list
44331873|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44331874|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44331875|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331876|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331877|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
44331878|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44331879|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44331880|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44331881|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44331882|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44331883|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44331884|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44331885|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44331886|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44331887|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44331888|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44331889|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44155021|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155022|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155023|NCT00225901|Mitogens|mitogens|mesh-list
44155024|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44155025|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155026|NCT00225914|Paroxetine|paroxetine|mesh-list
44155027|NCT00225914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44155028|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44126591|NCT00139165|Budesonide|budesonide|mesh-list
44126592|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126593|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44126594|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
44126595|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126596|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126597|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44126598|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
44126599|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
44126600|NCT00139165|Hormones|hormones|mesh-ancestor
44126601|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126602|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
44126603|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44126604|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126605|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
44126606|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44126607|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
44126608|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126609|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126610|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44126611|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
44126612|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44126613|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
44126614|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126615|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126616|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44126617|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
44331891|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44331892|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
44331893|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44331894|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44331895|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331896|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331897|NCT00988806|Protective Agents|protective agents|mesh-ancestor
44331898|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331899|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
44331900|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44331901|NCT00988845|Protective Agents|protective agents|mesh-ancestor
44331902|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331903|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331904|NCT00988897|Leucovorin|leucovorin|mesh-list
44331905|NCT00988897|Bevacizumab|bevacizumab|mesh-list
44331906|NCT00988897|Fluorouracil|fluorouracil|mesh-list
44331907|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
44331908|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331909|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331910|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44331911|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44331912|NCT00988897|Growth Substances|growth substances|mesh-ancestor
44331913|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331914|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
44331915|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
44331916|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331917|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44331918|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44331919|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
44331920|NCT00988897|Antidotes|antidotes|mesh-ancestor
44331921|NCT00988897|Protective Agents|protective agents|mesh-ancestor
44126618|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
44126619|NCT00139217|Protective Agents|protective agents|mesh-ancestor
44126621|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
44126622|NCT00139230|Cisplatin|cisplatin|mesh-list
44126623|NCT00139230|Fluorouracil|fluorouracil|mesh-list
44126624|NCT00139230|Docetaxel|docetaxel|mesh-list
44126625|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126630|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
44126631|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126632|NCT00139230|Antidotes|antidotes|mesh-ancestor
44126633|NCT00139230|Protective Agents|protective agents|mesh-ancestor
44331922|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
44331923|NCT00988897|Vitamins|vitamins|mesh-ancestor
44331924|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
44331925|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
44331926|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
44331927|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44331928|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331929|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331930|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44331931|NCT00988949|Spiradoline|spiradoline|mesh-list
44331932|NCT00988949|Analgesics|analgesics|mesh-ancestor
44331933|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
44331934|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331935|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331936|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44331937|NCT00988949|Diuretics|diuretics|mesh-ancestor
44331938|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
44331939|NCT00989027|Oxytocin|oxytocin|mesh-list
44331940|NCT00989027|Carboprost|carboprost|mesh-list
44331941|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
44331942|NCT00989027|Ergonovine|ergonovine|mesh-list
44331943|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
44331944|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331945|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331946|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44331947|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
44331948|NCT00989053|Citalopram|citalopram|mesh-list
44331949|NCT00989053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44331950|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44331951|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331952|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331953|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331954|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
44331955|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331956|NCT00989053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44331957|NCT00989053|Antidepressive Agents|antidepressive agents|mesh-ancestor
44331958|NCT00989053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126634|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
44126635|NCT00139230|Vitamins|vitamins|mesh-ancestor
44331959|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
44331960|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44331961|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331962|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44331963|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331964|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
44331965|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44331966|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44331967|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44331968|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44331969|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331970|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
44331971|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44331972|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331973|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44331974|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44331975|NCT00989274|Vaccines|vaccines|mesh-list
44331976|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
44331977|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331978|NCT00989300|Omeprazole|omeprazole|mesh-list
44331979|NCT00989300|Rabeprazole|rabeprazole|mesh-list
44331980|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44331981|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44331982|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44331983|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44331984|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44331985|NCT00989352|Rituximab|rituximab|mesh-list
44331986|NCT00989352|Methotrexate|methotrexate|mesh-list
44331987|NCT00989352|Lomustine|lomustine|mesh-list
44331988|NCT00989352|Procarbazine|procarbazine|mesh-list
44331989|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44331990|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44331991|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
44331992|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44331993|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44331994|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44331996|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44331997|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43987059|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44331998|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
44331999|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332000|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332001|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332002|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44332003|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332004|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44332005|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332006|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
44332007|NCT00989404|Zanamivir|zanamivir|mesh-list
44332008|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
44332009|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332010|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332011|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332012|NCT00989443|Cidofovir|cidofovir|mesh-list
44332013|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
44332014|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332015|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332016|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332017|NCT00989469|Irinotecan|irinotecan|mesh-list
44332018|NCT00989469|Sorafenib|sorafenib|mesh-list
44332019|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44332020|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44332021|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332022|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332023|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126636|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
44126637|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126638|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126639|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126640|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126641|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126642|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44126643|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126644|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126645|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44126646|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44126647|NCT00139243|Leucovorin|leucovorin|mesh-list
44126648|NCT00139243|Cisplatin|cisplatin|mesh-list
44126649|NCT00139243|Fluorouracil|fluorouracil|mesh-list
44126650|NCT00139243|Docetaxel|docetaxel|mesh-list
44126651|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126652|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
44332024|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44332025|NCT00989508|Perhexiline|perhexiline|mesh-list
44332026|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44332027|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44332028|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332029|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44332030|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332031|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44332032|NCT00989625|Naproxen|naproxen|mesh-list
44332033|NCT00989625|Sumatriptan|sumatriptan|mesh-list
44332034|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44332035|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44332036|NCT00989625|Analgesics|analgesics|mesh-ancestor
44332037|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
44332038|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332039|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332040|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332041|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332042|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
44332043|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44332044|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332045|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332046|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44332047|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44332048|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44332049|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
44332050|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332051|NCT00989651|Paclitaxel|paclitaxel|mesh-list
44332052|NCT00989651|Bevacizumab|bevacizumab|mesh-list
44332053|NCT00989651|Cisplatin|cisplatin|mesh-list
44332054|NCT00989651|Carboplatin|carboplatin|mesh-list
44332056|NCT00989651|Veliparib|veliparib|mesh-list
44332067|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332068|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332069|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44332070|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44332071|NCT00989651|Growth Substances|growth substances|mesh-ancestor
44332072|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332073|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
44332074|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
44332075|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44332076|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332077|NCT00989690|Docetaxel|docetaxel|mesh-list
44332078|NCT00989690|Pemetrexed|pemetrexed|mesh-list
44332079|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44332080|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332081|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332082|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332083|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332084|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332085|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332086|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44332087|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44332088|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44332089|NCT00989703|Methotrexate|methotrexate|mesh-list
44332090|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44332091|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
44332092|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44332093|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332094|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44332095|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
44126653|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126654|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126655|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126656|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
44126657|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126658|NCT00139243|Antidotes|antidotes|mesh-ancestor
44126659|NCT00139243|Protective Agents|protective agents|mesh-ancestor
44126660|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
44126661|NCT00139243|Vitamins|vitamins|mesh-ancestor
44126662|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
44126663|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126664|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126665|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126666|NCT00139256|Betamethasone|betamethasone|mesh-list
44126667|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332096|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332097|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332098|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332099|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332100|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44332101|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332102|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
44332103|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332104|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44332105|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
44332106|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
44332107|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44332108|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
44332109|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44332110|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44332111|NCT00989729|Prednisolone|prednisolone|mesh-list
44332112|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
44332113|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44332114|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
44332115|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332116|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
44332117|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
44332118|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332119|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332120|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44332121|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
44332122|NCT00989729|Hormones|hormones|mesh-ancestor
43742784|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44126668|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
44126670|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126671|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126672|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44126673|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44126674|NCT00139269|Cisplatin|cisplatin|mesh-list
44126675|NCT00139269|Docetaxel|docetaxel|mesh-list
44126676|NCT00139269|Fluorouracil|fluorouracil|mesh-list
44126677|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126678|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126679|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126680|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126681|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126682|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
44126683|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126684|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126685|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
44126686|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126687|NCT00139282|Squalamine|squalamine|mesh-list
44126688|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332123|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44332125|NCT00989729|Protective Agents|protective agents|mesh-ancestor
44332126|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44332127|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332128|NCT00989742|Doxycycline|doxycycline|mesh-list
44332129|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332130|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332131|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
44332132|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44332133|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44332134|NCT00989807|Aztreonam|aztreonam|mesh-list
44332135|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332136|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332137|NCT00989820|Coal Tar|coal tar|mesh-list
44332138|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
44332139|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332140|NCT00989898|Insulin|insulin|mesh-list
44332141|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332142|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332143|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44332144|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332145|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332146|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
44332147|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332148|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44126689|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126690|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44126691|NCT00139282|Protective Agents|protective agents|mesh-ancestor
44126692|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126693|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126694|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44126695|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44126696|NCT00139282|Growth Substances|growth substances|mesh-ancestor
44126697|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
44126698|NCT00139360|Bevacizumab|bevacizumab|mesh-list
44126708|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126709|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126710|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
44126711|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126712|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126713|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
44126714|NCT00139386|Candesartan|candesartan|mesh-list
44126715|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44126716|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44126717|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44126718|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126719|NCT00139516|Nicotine|nicotine|mesh-list
44332149|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44332150|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332151|NCT00990054|Plerixafor|plerixafor|mesh-list
44332152|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44332153|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44332154|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
44332155|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332156|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44332157|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44332158|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44332159|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44332160|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599240|NCT03292315|Incretins|incretins|mesh-ancestor
44332161|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332162|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332163|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332164|NCT00990067|Analgesics|analgesics|mesh-ancestor
44332165|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
44332166|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332168|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44332203|NCT00990275|Ethanol|ethanol|mesh-list
44332204|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44332205|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332206|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332207|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332208|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44332209|NCT00990301|Moexipril|moexipril|mesh-list
44332210|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44332211|NCT00990301|Diuretics|diuretics|mesh-ancestor
44332212|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
44332213|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332214|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44332215|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44332216|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332217|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44332218|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
44332219|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332220|NCT00990392|Polymyxins|polymyxins|mesh-list
44332221|NCT00990392|Bacitracin|bacitracin|mesh-list
44332222|NCT00990392|Polymyxin B|polymyxin b|mesh-list
44332223|NCT00990392|Gramicidin|gramicidin|mesh-list
44332224|NCT00990392|Petrolatum|petrolatum|mesh-list
44332225|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332226|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332227|NCT00990392|Emollients|emollients|mesh-ancestor
44332228|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332229|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44332230|NCT00990405|Amoxicillin|amoxicillin|mesh-list
44332231|NCT00990405|Clarithromycin|clarithromycin|mesh-list
44332232|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332233|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332234|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44332235|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332236|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332237|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44332238|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44332240|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44332242|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332243|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332245|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
44332246|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332247|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44332248|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44332249|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
44332250|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
44332251|NCT00990444|Insulin|insulin|mesh-list
44332252|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44332253|NCT00990444|Dextrans|dextrans|mesh-list
44332254|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332255|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332256|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
44332257|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
44332258|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
44332259|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
44332260|NCT00990496|Fludarabine|fludarabine|mesh-list
44332261|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332262|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
44332263|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332264|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332265|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332266|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
44332267|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332268|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332269|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44332270|NCT00990535|Octreotide|octreotide|mesh-list
44126720|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44126721|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
43777409|NCT02332031|Sorafenib|sorafenib|mesh-list
44126722|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126723|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126724|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44126725|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44126726|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44126727|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126728|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126729|NCT00139555|Amlodipine|amlodipine|mesh-list
44126730|NCT00139555|Benazepril|benazepril|mesh-list
44126731|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44126732|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44126733|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126734|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126735|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44332271|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44332272|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44332273|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332274|NCT00990574|Anesthetics|anesthetics|mesh-list
44332275|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332276|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332277|NCT00990587|Ciclopirox|ciclopirox|mesh-list
44332278|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
44332279|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332280|NCT00990600|Tenofovir|tenofovir|mesh-list
44332281|NCT00990600|Emtricitabine|emtricitabine|mesh-list
44332282|NCT00990600|Efavirenz|efavirenz|mesh-list
44332283|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
44332284|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332285|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44332286|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44332287|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332288|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332289|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44332290|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44332291|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44332292|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44332293|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44332294|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44332295|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44332296|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44332298|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44332299|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44332300|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44332301|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332302|NCT00990678|Vitamin D|vitamin d|mesh-list
44332303|NCT00990678|Calcitriol|calcitriol|mesh-list
44332304|NCT00990678|Calcium|calcium|mesh-list
44332305|NCT00990678|Vitamins|vitamins|mesh-ancestor
44332306|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
44332310|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44332311|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44332312|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332313|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44332315|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44332316|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
44332317|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44332318|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332319|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332320|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44332321|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44332322|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44332323|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332324|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332325|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332326|NCT00990795|Cyclosporine|cyclosporine|mesh-list
44332327|NCT00990795|Cyclosporins|cyclosporins|mesh-list
44332328|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332329|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332330|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332331|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
44332332|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332333|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
44332334|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332335|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332336|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332337|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44332338|NCT00990808|Atorvastatin|atorvastatin|mesh-list
44332339|NCT00990808|Anacetrapib|anacetrapib|mesh-list
44332340|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332341|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332342|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
44332343|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742920|NCT04919629|Bevacizumab|bevacizumab|mesh-list
44126736|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126737|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
44332345|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44332346|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332347|NCT00990834|Simvastatin|simvastatin|mesh-list
44332348|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332349|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332350|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
44332351|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332352|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44332353|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44332354|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332355|NCT00990847|Procaterol|procaterol|mesh-list
44332356|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44332357|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
44332358|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332359|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332360|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44332361|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
44332362|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
44332363|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44332364|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44332365|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44332366|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332367|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332368|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332369|NCT00990860|Doxorubicin|doxorubicin|mesh-list
44332370|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44332371|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332372|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44126738|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44126739|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126740|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126741|NCT00139568|Tegaserod|tegaserod|mesh-list
44126742|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44126743|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
44126744|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126745|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126746|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126747|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
44126748|NCT00139581|Tacrolimus|tacrolimus|mesh-list
44126749|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44126750|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44332373|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44332374|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332375|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332377|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
44332378|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
44332379|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332380|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332381|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44332382|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44332383|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44332384|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332385|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332386|NCT00990886|Urological Agents|urological agents|mesh-ancestor
44332388|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
44332389|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332390|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763498|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
44332391|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44332392|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332393|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332394|NCT00991055|Pioglitazone|pioglitazone|mesh-list
44332395|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332396|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332397|NCT00991133|Clofarabine|clofarabine|mesh-list
44332398|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332399|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332400|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44332401|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
44332402|NCT00991159|Bococizumab|bococizumab|mesh-list
44332403|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332404|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332410|NCT00991211|Doxorubicin|doxorubicin|mesh-list
44332416|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332417|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
44332418|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332419|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332420|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44332421|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44332422|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44332423|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44332424|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332425|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332426|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332427|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332428|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332429|NCT00991250|Temozolomide|temozolomide|mesh-list
44332430|NCT00991250|Dacarbazine|dacarbazine|mesh-list
44332431|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332432|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
44332433|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332434|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332435|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44332436|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44332437|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44332438|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332439|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332440|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332441|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332442|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
43987471|NCT02287779|Volixibat|volixibat|mesh-list
44332443|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332444|NCT00991627|Atropine|atropine|mesh-list
44332445|NCT00991627|Ephedrine|ephedrine|mesh-list
44332459|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44332460|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44332461|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
44332462|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44332463|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44332464|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
44332465|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
44332466|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44332467|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44332468|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
44332469|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332470|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332471|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44332472|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
44332473|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44332474|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44126751|NCT00139581|Analgesics|analgesics|mesh-ancestor
44126752|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
44126753|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126754|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126755|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126756|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126757|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44126758|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126759|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
44126760|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44126761|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126768|NCT00139633|Carboplatin|carboplatin|mesh-list
44126769|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126770|NCT00139646|Diclofenac|diclofenac|mesh-list
44126771|NCT00139646|Parecoxib|parecoxib|mesh-list
44126772|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44126773|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44126774|NCT00139646|Analgesics|analgesics|mesh-ancestor
44126775|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
44126776|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126777|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126778|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126779|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126780|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44126781|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126782|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126783|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44126784|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44126785|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
44126786|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
44126787|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44126788|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126789|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44126790|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44126791|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44126792|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44126793|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126794|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44126795|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44332476|NCT00991705|Atorvastatin|atorvastatin|mesh-list
44332477|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332478|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332479|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
44332480|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332481|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44332482|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44332483|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332484|NCT00991744|Cytarabine|cytarabine|mesh-list
44332485|NCT00991744|Cortisone|cortisone|mesh-list
44332486|NCT00991744|Prednisolone|prednisolone|mesh-list
44332487|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44332488|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
44332489|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44332490|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
44332491|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44332492|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
44332493|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44332494|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
44332495|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332496|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332497|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
44332498|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332499|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332500|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
44332501|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332522|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332523|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332524|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332525|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332526|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332527|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332528|NCT00991822|Timolol|timolol|mesh-list
44332529|NCT00991822|Dorzolamide|dorzolamide|mesh-list
44332530|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44332531|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44332532|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332533|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332534|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332535|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332536|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44332537|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44332538|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44332539|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332540|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44332541|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
43743107|NCT04670081|Niacin|niacin|mesh-list
44126796|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44126797|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44126798|NCT00139698|Olmesartan|olmesartan|mesh-list
44126799|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44126800|NCT00139698|Diuretics|diuretics|mesh-ancestor
44126801|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
44126802|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126803|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44126804|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126805|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126806|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44126807|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44126808|NCT00139711|Docetaxel|docetaxel|mesh-list
44126809|NCT00139711|Irinotecan|irinotecan|mesh-list
44126810|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126811|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126812|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126813|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126814|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126815|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44126816|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126817|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126818|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44126819|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44126820|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44126821|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44126822|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126823|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126824|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126825|NCT00139724|Urological Agents|urological agents|mesh-ancestor
44126826|NCT00139750|Varenicline|varenicline|mesh-list
44332542|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332543|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44332544|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332545|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332546|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332547|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44332548|NCT05408845|Trastuzumab|trastuzumab|mesh-list
44332549|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44332550|NCT05408845|Docetaxel|docetaxel|mesh-list
44332551|NCT05408845|Maytansine|maytansine|mesh-list
44332552|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44332553|NCT05408845|Antibodies|antibodies|mesh-list
44332554|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
44332555|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44332556|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
44332557|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
44332558|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332559|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332560|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332561|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332562|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332563|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332564|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332565|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
44332566|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332567|NCT05408221|Lenvatinib|lenvatinib|mesh-list
44332568|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332569|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44332570|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332572|NCT05408208|Triamcinolone|triamcinolone|mesh-list
44332586|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
44332587|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332588|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44332589|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332590|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
44332591|NCT05408208|Hormones|hormones|mesh-ancestor
44332592|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44332593|NCT05408104|Tolvaptan|tolvaptan|mesh-list
44332594|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44332595|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332596|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
44332597|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332598|NCT05408091|Antibodies|antibodies|mesh-list
44332599|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44332600|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
44332601|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332602|NCT05408065|Triamcinolone|triamcinolone|mesh-list
44332603|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44332604|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44332605|NCT05408065|Cortisone|cortisone|mesh-list
44332606|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
44332607|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44332608|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332609|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
44332610|NCT05408065|Hormones|hormones|mesh-ancestor
44332611|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44332612|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332613|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332614|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
44332615|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332618|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
44332630|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332631|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332632|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44332633|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
44332634|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
44332635|NCT05407636|Aflibercept|aflibercept|mesh-list
44332636|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44332637|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44332638|NCT05407636|Growth Substances|growth substances|mesh-ancestor
44332639|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332640|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
44332641|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332642|NCT05407597|Icatibant|icatibant|mesh-list
44332643|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44332644|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44332645|NCT05407597|Analgesics|analgesics|mesh-ancestor
44332646|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
44332647|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332648|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332649|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332650|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332651|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43743207|NCT04607421|Leucovorin|leucovorin|mesh-list
44126827|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44126838|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44126839|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126840|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44126842|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44126843|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126844|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126845|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44126846|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126847|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
44126848|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126849|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126850|NCT00139854|Alprazolam|alprazolam|mesh-list
44126851|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44126852|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44126853|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126854|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44126855|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44126856|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126857|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
44126858|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
44126859|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126860|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126861|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44126862|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44126863|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
44126864|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332653|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332654|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44332655|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332656|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
44332657|NCT05407467|Curcumin|curcumin|mesh-list
44332658|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44332659|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44332660|NCT05407467|Analgesics|analgesics|mesh-ancestor
44332661|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
44332662|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332663|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332664|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332665|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332666|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332667|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332668|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332669|NCT05407246|Hemay005|hemay005|mesh-list
44332670|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332671|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44332672|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44332673|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332674|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332675|NCT05407233|Insulin|insulin|mesh-list
44332676|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44332677|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332678|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332679|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
44332680|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332681|NCT05407155|Paclitaxel|paclitaxel|mesh-list
44332682|NCT05407155|Bevacizumab|bevacizumab|mesh-list
44332683|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43743232|NCT04607421|Vitamins|vitamins|mesh-ancestor
44126865|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44126866|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44126867|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
44126868|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
44126869|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126870|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332685|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
44332686|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
44332687|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
44332688|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332689|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44332690|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44332691|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44332692|NCT05407155|Growth Substances|growth substances|mesh-ancestor
44332693|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332694|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
44332695|NCT05406934|Infliximab|infliximab|mesh-list
44332696|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332697|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44332698|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332699|NCT05406856|Cisplatin|cisplatin|mesh-list
44332700|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332701|NCT05404490|Bupivacaine|bupivacaine|mesh-list
44332702|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
44332703|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
44332704|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332705|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332706|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
44332707|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332708|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44332709|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44332710|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332711|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332712|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332713|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332714|NCT05591001|Ketamine|ketamine|mesh-list
44332715|NCT05591001|Propofol|propofol|mesh-list
44332716|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44332717|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332718|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332719|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44332722|NCT05591001|Analgesics|analgesics|mesh-ancestor
44332723|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
44332724|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332725|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44332726|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44332727|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44332728|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332729|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332730|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
44332731|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44332732|NCT05590637|Pimavanserin|pimavanserin|mesh-list
44332733|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44332734|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
44332735|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44332736|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44332737|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44332738|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332739|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332740|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44332741|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987705|NCT02298933|Eculizumab|eculizumab|mesh-list
44332742|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44332743|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44332744|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
44332745|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332746|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332747|NCT05590585|Emollients|emollients|mesh-list
44332748|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332749|NCT05590572|Etoposide|etoposide|mesh-list
44332750|NCT05590572|Ifosfamide|ifosfamide|mesh-list
44332751|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44126871|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44126872|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44126873|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
44126874|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126875|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44126876|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44126877|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
44126878|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
44126879|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126880|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126881|NCT00139893|Metoclopramide|metoclopramide|mesh-list
44126882|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
44332752|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332753|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44332754|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44332755|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332756|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332757|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332758|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
44332759|NCT05590559|Morphine|morphine|mesh-list
44332760|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44332761|NCT05590559|Narcotics|narcotics|mesh-ancestor
44332762|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332763|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332764|NCT05590559|Analgesics|analgesics|mesh-ancestor
44332765|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
44332766|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332767|NCT05590455|Adalimumab|adalimumab|mesh-list
44332768|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44332769|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332770|NCT05590416|Adalimumab|adalimumab|mesh-list
44332771|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44126883|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
44126884|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126885|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126886|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44126887|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44126888|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44126889|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
44126890|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126891|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126893|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44126894|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
44126895|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126896|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126897|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44126898|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
44126899|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44126900|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44126901|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44126902|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
44126903|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126904|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126905|NCT00139971|Gemcitabine|gemcitabine|mesh-list
44126906|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126907|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
44126908|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126909|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126910|NCT00139971|Antiviral Agents|antiviral agents|mesh-ancestor
44126911|NCT00139971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126912|NCT00139971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126913|NCT00139971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126914|NCT00139971|Immunologic Factors|immunologic factors|mesh-ancestor
44126915|NCT00139971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126916|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
44126917|NCT00140010|Hematinics|hematinics|mesh-ancestor
44332773|NCT05590325|Dolutegravir|dolutegravir|mesh-list
44332774|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44332775|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44332776|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332777|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332778|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44332779|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44332780|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
44332781|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332782|NCT05590312|Anesthetics|anesthetics|mesh-list
44332783|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332784|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332785|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
44332786|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332788|NCT05590260|Trace Elements|trace elements|mesh-ancestor
44332789|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
44332790|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332791|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
44332792|NCT05590221|Fludarabine|fludarabine|mesh-list
44332793|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332794|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
44332795|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332796|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332797|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126918|NCT00140023|Azithromycin|azithromycin|mesh-list
44126919|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44126920|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126921|NCT00140062|Latanoprost|latanoprost|mesh-list
44126922|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44126923|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44126924|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
44126925|NCT00140075|Epirubicin|epirubicin|mesh-list
44126926|NCT00140075|Taxane|taxane|mesh-list
44126927|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126928|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
44126929|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126930|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126931|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44126932|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
44126933|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126934|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126935|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44126936|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44126937|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44126938|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126939|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126940|NCT00140101|Paclitaxel|paclitaxel|mesh-list
44126941|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44332799|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332800|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332801|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44332802|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
44332803|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44332804|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332805|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332806|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332807|NCT05590117|Leucovorin|leucovorin|mesh-list
44332808|NCT05590117|Fluorouracil|fluorouracil|mesh-list
44332809|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
44332810|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
44332811|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332812|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
44332813|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332814|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44332815|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332816|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332817|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
44332818|NCT05590117|Antidotes|antidotes|mesh-ancestor
44332819|NCT05590117|Protective Agents|protective agents|mesh-ancestor
44332820|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
44126942|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126943|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44126944|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44126945|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
44126946|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126947|NCT00140114|Misoprostol|misoprostol|mesh-list
44126948|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44126949|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
44126950|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44126951|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126952|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44126953|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44126954|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
44126955|NCT00140153|Testosterone|testosterone|mesh-list
44126956|NCT00140153|Androgens|androgens|mesh-ancestor
44126957|NCT00140153|Hormones|hormones|mesh-ancestor
44126958|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126959|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126960|NCT00140166|Pyridoxine|pyridoxine|mesh-list
44126961|NCT00140166|Niacinamide|niacinamide|mesh-list
44126962|NCT00140166|Niacin|niacin|mesh-list
44126963|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
44126964|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
44126965|NCT00140166|Vitamins|vitamins|mesh-ancestor
44126966|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
44126967|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126969|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
44126970|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126971|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44332821|NCT05590117|Vitamins|vitamins|mesh-ancestor
44332822|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
44332823|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44332824|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332825|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44332826|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44332827|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
44332828|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44332829|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
44332830|NCT05589974|Verteporfin|verteporfin|mesh-list
44332831|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44332832|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332833|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
44332834|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
44332835|NCT05589896|Busulfan|busulfan|mesh-list
44332836|NCT05589896|Fludarabine|fludarabine|mesh-list
44332837|NCT05589896|Tacrolimus|tacrolimus|mesh-list
44332838|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332839|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
44332840|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332841|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44332842|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44332843|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
44126972|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
44126973|NCT00140218|Pramipexole|pramipexole|mesh-list
44126974|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
44126975|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126976|NCT00140218|Protective Agents|protective agents|mesh-ancestor
44126977|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126978|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44126979|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44126980|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
44126981|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
44126982|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126983|NCT00140257|Citalopram|citalopram|mesh-list
44126984|NCT00140257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44126985|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44126986|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44126987|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126988|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126989|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
44126990|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126991|NCT00140257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44126992|NCT00140257|Antidepressive Agents|antidepressive agents|mesh-ancestor
44126993|NCT00140257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44126994|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
44126995|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44126996|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126997|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
44126998|NCT00140309|Rifampin|rifampin|mesh-list
44126999|NCT00140309|Isoniazid|isoniazid|mesh-list
44127000|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
44127001|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44127002|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127003|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44332844|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332845|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332846|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44332847|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44332848|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332849|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44332850|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44332851|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
44332852|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332853|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332854|NCT05589597|Nivolumab|nivolumab|mesh-list
44332855|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44332856|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332857|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44332858|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332859|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
44332860|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44332861|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
44332862|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332863|NCT05589584|Expectorants|expectorants|mesh-ancestor
44332864|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44332865|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44332866|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
44127004|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44127005|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127006|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127007|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127008|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44127009|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
44127010|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
44127011|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44127012|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44127013|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44127014|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44127015|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44127016|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44127017|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44127018|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44127019|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44127020|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
43599262|NCT03292185|Incretins|incretins|mesh-ancestor
44127021|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44127022|NCT00140361|Artesunate|artesunate|mesh-list
44127023|NCT00140361|Lumefantrine|lumefantrine|mesh-list
44127024|NCT00140361|Artemether|artemether|mesh-list
44127025|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
44127026|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
44127027|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44127028|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
44127029|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44127030|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44332867|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332868|NCT05589584|Protective Agents|protective agents|mesh-ancestor
44332869|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332870|NCT05589584|Antidotes|antidotes|mesh-ancestor
44332871|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
44332872|NCT05589454|Atorvastatin|atorvastatin|mesh-list
44332874|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44332875|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332876|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44332877|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44332878|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44332879|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
44332880|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332881|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44332882|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44332883|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332884|NCT05589441|Insulin|insulin|mesh-list
44332885|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44332886|NCT05589441|Albuterol|albuterol|mesh-list
44332887|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332888|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332889|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44332890|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
44332891|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332892|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44332893|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
44332894|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
44332895|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44332896|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44332897|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44127031|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127032|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127033|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
44127034|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
44127035|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44127036|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
44127037|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44127038|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127039|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127040|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44127041|NCT00140361|Renal Agents|renal agents|mesh-ancestor
44332898|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44332899|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
44332900|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332901|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332903|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
44332904|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
44332905|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332906|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332907|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
44332908|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332909|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44332910|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44332911|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44332912|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44332913|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332914|NCT05589363|Bupivacaine|bupivacaine|mesh-list
44332915|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
44332916|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
44332917|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44332918|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127046|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
44127047|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44127048|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127049|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44127050|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44127051|NCT00140452|Growth Substances|growth substances|mesh-ancestor
44127052|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
44127053|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127054|NCT00140465|Clopidogrel|clopidogrel|mesh-list
44127055|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44127056|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44127057|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44127058|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44127060|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127061|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127062|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127063|NCT00140478|Mifepristone|mifepristone|mesh-list
44127064|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44127065|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
44127066|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44127067|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127068|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44127069|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44127070|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44127071|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
44127072|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44127073|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44127074|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702165|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332919|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
44332920|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332922|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44332923|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
44332924|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332925|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332926|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44332927|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44332928|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
44332929|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332930|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332931|NCT05589064|Vitamin D|vitamin d|mesh-list
44332932|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
44332933|NCT05589064|Vitamins|vitamins|mesh-ancestor
44332934|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
44332935|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332936|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44332937|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43567104|NCT00774761|Xhance|xhance|mesh-list
44127075|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127076|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
44127077|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44127078|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44127079|NCT00140517|Chloroquine|chloroquine|mesh-list
44127080|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
44127081|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
44127082|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44127083|NCT00140517|Amebicides|amebicides|mesh-ancestor
44127084|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44127085|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44127086|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127087|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
44127088|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127089|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44127090|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127091|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127092|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44127093|NCT00140517|Renal Agents|renal agents|mesh-ancestor
44127094|NCT00140530|Sirolimus|sirolimus|mesh-list
44127095|NCT00140530|Paclitaxel|paclitaxel|mesh-list
44127096|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44127097|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127098|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127099|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
44127100|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
44127101|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127102|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44127103|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127104|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127105|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
44127106|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127107|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
44127108|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127109|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
44127110|NCT00140543|Sirolimus|sirolimus|mesh-list
44332939|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
44332940|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
44332941|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
44332942|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44332943|NCT05589025|Protective Agents|protective agents|mesh-ancestor
44332944|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332945|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332946|NCT05566626|Tropicamide|tropicamide|mesh-list
44332947|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
44332948|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
44332949|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44332950|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332951|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44332952|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44332953|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44332954|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44332955|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332956|NCT05558007|Tadalafil|tadalafil|mesh-list
44332957|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
44332958|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44332959|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44332960|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332961|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332962|NCT05558007|Urological Agents|urological agents|mesh-ancestor
44332963|NCT05503797|Cobicistat|cobicistat|mesh-list
44332964|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44332965|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44332966|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
44332967|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743494|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
44127111|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127112|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127113|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44127116|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127118|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127119|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
44127120|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127121|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
44127122|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127123|NCT00140569|Interferons|interferons|mesh-list
44127124|NCT00140569|Fludarabine|fludarabine|mesh-list
44127125|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127126|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
44127127|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332968|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44332969|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44332971|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332972|NCT05488678|Ceftibuten|ceftibuten|mesh-list
44332973|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332974|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332975|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44332976|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
44332977|NCT05440487|Chelating Agents|chelating agents|mesh-list
44332978|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
44332979|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332980|NCT05426681|Glyburide|glyburide|mesh-list
44332981|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44332982|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332983|NCT05406700|Niraparib|niraparib|mesh-list
44332984|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44332985|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44332986|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778866|NCT05079880|Caffeine|caffeine|mesh-list
44332987|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332988|NCT05406622|Sirolimus|sirolimus|mesh-list
44332989|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44332990|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44332991|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44332992|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44332993|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
44332994|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44332995|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
43743519|NCT04438330|Nickel|nickel|mesh-list
44127128|NCT00140582|Rituximab|rituximab|mesh-list
43571678|NCT00229008|Ceftazidime|ceftazidime|mesh-list
44127129|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127131|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
44127132|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127133|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127134|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
44127135|NCT00140595|Rituximab|rituximab|mesh-list
44127136|NCT00140595|Doxorubicin|doxorubicin|mesh-list
44127137|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127138|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
44127139|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127140|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127141|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44127142|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
44127143|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44332996|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44332998|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44332999|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333000|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
44333001|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
44333002|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333003|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
44333004|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333005|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333006|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333007|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44333008|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44333009|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333010|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44333011|NCT05327296|Propofol|propofol|mesh-list
44333012|NCT05327296|Isoflurane|isoflurane|mesh-list
44333013|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44333014|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333015|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333016|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44333017|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
44333018|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
44333019|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44333020|NCT05295355|Bromides|bromides|mesh-list
44333021|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
44333022|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44127144|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127145|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44127146|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127147|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127148|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44127149|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44127150|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127151|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
44127152|NCT00140647|Ramipril|ramipril|mesh-list
44127153|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44127154|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127155|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44127156|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44127157|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127158|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127159|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44127160|NCT00140660|Rituximab|rituximab|mesh-list
44127161|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333023|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
44333024|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333025|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333026|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44333027|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
44333028|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
44333029|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44333030|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44333031|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333032|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333033|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
44333034|NCT05273359|Benralizumab|benralizumab|mesh-list
44333035|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44333036|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44333037|NCT05265247|Esomeprazole|esomeprazole|mesh-list
44333038|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44333039|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44333040|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44333041|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333042|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333043|NCT05232630|Fenfluramine|fenfluramine|mesh-list
44333044|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44333045|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44333046|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333047|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333048|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333049|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
44333050|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127162|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127163|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
44127164|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127165|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155029|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155030|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155031|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155032|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
44155033|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155034|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44155035|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155036|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155037|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44155038|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44155039|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333052|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44333053|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44333054|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333055|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333056|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
44333057|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44333058|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333059|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333060|NCT05210582|Afamelanotide|afamelanotide|mesh-list
44333061|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44333062|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
44333064|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44333065|NCT05186363|Amodiaquine|amodiaquine|mesh-list
44333066|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
44333067|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44333068|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44333069|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333070|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44333071|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333072|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333073|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44333074|NCT05186363|Renal Agents|renal agents|mesh-ancestor
44333076|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333077|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44333078|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44333079|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333080|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333081|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44333082|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
43824310|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
44333083|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333084|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333085|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44333086|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
44155040|NCT00225979|Octreotide|octreotide|mesh-list
44333087|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333088|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44333089|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
44333090|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333091|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333092|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44333093|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44333094|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333095|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333096|NCT05116891|Leucovorin|leucovorin|mesh-list
44333097|NCT05116891|Gemcitabine|gemcitabine|mesh-list
44333098|NCT05116891|Cisplatin|cisplatin|mesh-list
44333099|NCT05116891|Docetaxel|docetaxel|mesh-list
44333100|NCT05116891|Fluorouracil|fluorouracil|mesh-list
44333101|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
44333102|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333103|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333104|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
44333105|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333106|NCT05116891|Antiviral Agents|antiviral agents|mesh-ancestor
44333107|NCT05116891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333108|NCT05116891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333109|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333110|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
44333111|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333112|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333113|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333114|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333115|NCT05116891|Antidotes|antidotes|mesh-ancestor
44333116|NCT05116891|Protective Agents|protective agents|mesh-ancestor
44333117|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
44333118|NCT05116891|Vitamins|vitamins|mesh-ancestor
44333119|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
44333120|NCT05088356|Plerixafor|plerixafor|mesh-list
44333121|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
44333122|NCT05088356|Melphalan|melphalan|mesh-list
44333123|NCT05088356|Fludarabine|fludarabine|mesh-list
44333124|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
44333129|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
44333130|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333131|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333132|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44333133|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333134|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333135|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44333136|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333137|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
44333138|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
44333139|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333140|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44333141|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333142|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44333143|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333144|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333146|NCT05053503|Naltrexone|naltrexone|mesh-list
44333147|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44333148|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44333149|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333150|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
44333151|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333152|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43835655|NCT05032820|Growth Substances|growth substances|mesh-ancestor
44155041|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155042|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155043|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155044|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
44155045|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155046|NCT00226005|Vatalanib|vatalanib|mesh-list
44155047|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44155048|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155049|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127179|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
44127180|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127181|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
44127182|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127183|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44127184|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44127185|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127186|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127188|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44127189|NCT00140751|Ritonavir|ritonavir|mesh-list
44127190|NCT00140751|Lopinavir|lopinavir|mesh-list
44127191|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44127192|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44127193|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
44127194|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333154|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44333155|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44333156|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333157|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333158|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333159|NCT05046314|Vincristine|vincristine|mesh-list
44333160|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44333161|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333162|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333163|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333164|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333165|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333166|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
44333167|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44333168|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
44333169|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333170|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
44333171|NCT05018481|Protective Agents|protective agents|mesh-ancestor
44333172|NCT05013502|Empagliflozin|empagliflozin|mesh-list
43743590|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
44127195|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127196|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44127197|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44127198|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
44127199|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127200|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44127201|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44127202|NCT00140764|Metronidazole|metronidazole|mesh-list
44127203|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127204|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44127205|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44127206|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44127207|NCT00140790|Valsartan|valsartan|mesh-list
44127208|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44127209|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44127210|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44127211|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127212|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44127213|NCT00140803|Verteporfin|verteporfin|mesh-list
44127214|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127215|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
44127216|NCT00140803|Hormones|hormones|mesh-ancestor
44127217|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127218|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127219|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127220|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
44127221|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44127222|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
44127223|NCT00140868|Phenobarbital|phenobarbital|mesh-list
44127224|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
44127241|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44333173|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44333174|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333175|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333176|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333177|NCT05007392|Febuxostat|febuxostat|mesh-list
44333178|NCT05007392|Dotinurad|dotinurad|mesh-list
43824313|NCT05513729|Pioglitazone|pioglitazone|mesh-list
44333179|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
44333180|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333181|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
44333182|NCT05007392|Renal Agents|renal agents|mesh-ancestor
44333183|NCT04992052|Bone wax|bone wax|mesh-list
44333184|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
44333185|NCT04992052|Coagulants|coagulants|mesh-ancestor
44333186|NCT04928820|Edetic Acid|edetic acid|mesh-list
44333187|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44333188|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
44333189|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
44333190|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333191|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
44333192|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44333193|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44333194|NCT04912063|Azacitidine|azacitidine|mesh-list
44127242|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44127243|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127244|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127245|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127246|NCT00140894|Analgesics|analgesics|mesh-ancestor
44127247|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
44127248|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127249|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127250|NCT00140920|Diclofenac|diclofenac|mesh-list
44127251|NCT00140920|Rofecoxib|rofecoxib|mesh-list
44127252|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127253|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127254|NCT00140920|Analgesics|analgesics|mesh-ancestor
44127255|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
44127256|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127257|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127258|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127259|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127260|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44127261|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127262|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127263|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44127264|NCT00140933|Diclofenac|diclofenac|mesh-list
44127265|NCT00140933|Rofecoxib|rofecoxib|mesh-list
44127266|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127267|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127268|NCT00140933|Analgesics|analgesics|mesh-ancestor
44127269|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
44127270|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127271|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127272|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127273|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127274|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44127275|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333196|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333197|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
44333198|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333199|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333200|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333201|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
44333202|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333203|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333204|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
44333205|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
44333206|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333207|NCT04772300|Sirolimus|sirolimus|mesh-list
44333208|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333209|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333210|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333211|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333212|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
44333213|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333214|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
44333215|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333216|NCT04696575|Lamivudine|lamivudine|mesh-list
44333217|NCT04696575|Carboplatin|carboplatin|mesh-list
44333218|NCT04696575|Etoposide|etoposide|mesh-list
44333219|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
44333220|NCT04696575|Atezolizumab|atezolizumab|mesh-list
44333221|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
44333222|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44333223|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333224|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44333225|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44333226|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44333227|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333228|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333229|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44333230|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44333231|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
44127276|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333233|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333234|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333235|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
44333236|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333237|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
44333238|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
44333239|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333240|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333241|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333242|NCT04694300|Acetaminophen|acetaminophen|mesh-list
44333243|NCT04694300|Naproxen|naproxen|mesh-list
44333244|NCT04694300|Tramadol|tramadol|mesh-list
44333245|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44333246|NCT04694300|Analgesics|analgesics|mesh-ancestor
44333247|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
44333248|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333249|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333250|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
44333251|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44333252|NCT04694300|Narcotics|narcotics|mesh-ancestor
44333253|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333254|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44333255|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333256|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333257|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
44333258|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44333259|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333260|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333261|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
44333262|NCT04683679|Olaparib|olaparib|mesh-list
44333263|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743664|NCT04302025|Atezolizumab|atezolizumab|mesh-list
44127277|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44127278|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44127279|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44127282|NCT00140998|Estrogens|estrogens|mesh-ancestor
44127283|NCT00140998|Hormones|hormones|mesh-ancestor
44127284|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127285|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127286|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44127287|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
44127288|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44333265|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44333266|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333267|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333268|NCT04642820|Methamphetamine|methamphetamine|mesh-list
44333269|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44333270|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333271|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
44333272|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
44333273|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333274|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
44333275|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333276|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333277|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333278|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44333279|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44333280|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333281|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44333283|NCT04601857|Futibatinib|futibatinib|mesh-list
44333284|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333285|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127289|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44127290|NCT00141011|Ancrod|ancrod|mesh-list
44127291|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
44127292|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44127293|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44127294|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127295|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44127296|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44127297|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127298|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44127299|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44127300|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127301|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127302|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
44127303|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127304|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44127305|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44127306|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127307|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44127308|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44127309|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127310|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127311|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
44127312|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333287|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44333288|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44333289|NCT04590417|Estradiol|estradiol|mesh-list
44333290|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44333291|NCT04590417|Cyproterone|cyproterone|mesh-list
44333292|NCT04590417|Estrogens|estrogens|mesh-ancestor
44333293|NCT04590417|Hormones|hormones|mesh-ancestor
44333294|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333295|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333296|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44333297|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
44333298|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44333299|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44333300|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
44333301|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
44333302|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333303|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44333304|NCT04584749|Lidocaine|lidocaine|mesh-list
44333305|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
44333306|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
44333307|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333308|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333309|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
44127313|NCT00141089|Tegaserod|tegaserod|mesh-list
44127314|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44127315|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
44127316|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127317|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127318|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127319|NCT00141141|Atorvastatin|atorvastatin|mesh-list
44127320|NCT00141141|Simvastatin|simvastatin|mesh-list
44127321|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44127322|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44127323|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
44127324|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127325|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44127326|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44127327|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127329|NCT00141154|Loxoprofen|loxoprofen|mesh-list
44127330|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127331|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127332|NCT00141154|Analgesics|analgesics|mesh-ancestor
44127333|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
44127334|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127335|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127336|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127337|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127338|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44127339|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44127340|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333310|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333311|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44333312|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44333313|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44333314|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333315|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333317|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333318|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333319|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
44333320|NCT04509115|Narcotics|narcotics|mesh-ancestor
44333321|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333322|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333323|NCT04509115|Analgesics|analgesics|mesh-ancestor
44333324|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
44333325|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333326|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
44333327|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44333328|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333329|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333330|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333331|NCT04446117|Prednisone|prednisone|mesh-list
44333332|NCT04446117|Atezolizumab|atezolizumab|mesh-list
44333333|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
44333334|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127341|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127342|NCT00141167|Varenicline|varenicline|mesh-list
44127343|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44127344|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44127345|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44127346|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127347|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127348|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127349|NCT00141193|Celecoxib|celecoxib|mesh-list
44127350|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127364|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44127365|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
44127366|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127367|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127368|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127369|NCT00141232|Atorvastatin|atorvastatin|mesh-list
44127370|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44127371|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44127372|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
44127373|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127374|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333335|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
44333336|NCT04446117|Hormones|hormones|mesh-ancestor
44333337|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333338|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333339|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44333340|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333341|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44333342|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333343|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333344|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
44333345|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44333346|NCT04403165|Norepinephrine|norepinephrine|mesh-list
44333347|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44333348|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44333349|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333350|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333351|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333352|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333353|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
44333354|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
44333355|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333356|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44333357|NCT04400994|Rituximab|rituximab|mesh-list
44333358|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333359|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333360|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
44333361|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333362|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333364|NCT04382352|Trastuzumab|trastuzumab|mesh-list
44333379|NCT04272086|Bupivacaine|bupivacaine|mesh-list
44333380|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
44333381|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
44333382|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333383|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333384|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
44333385|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333386|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44333387|NCT04270682|Cathartics|cathartics|mesh-ancestor
44333388|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44333389|NCT04262154|Prednisone|prednisone|mesh-list
44333390|NCT04262154|Atezolizumab|atezolizumab|mesh-list
44333391|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333392|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
44333393|NCT04262154|Hormones|hormones|mesh-ancestor
44333394|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333395|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333396|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44333397|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333398|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
44333399|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333400|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
44333401|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
44333402|NCT04232085|Melphalan|melphalan|mesh-list
44333403|NCT04232085|Fludarabine|fludarabine|mesh-list
44333404|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
44333405|NCT04232085|Tacrolimus|tacrolimus|mesh-list
44333406|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333407|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
44333408|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333409|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743794|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
44127375|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44127376|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127377|NCT00141245|Pregabalin|pregabalin|mesh-list
44127378|NCT00141245|Analgesics|analgesics|mesh-ancestor
44127379|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
44127380|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127381|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127382|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
44127383|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127384|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127385|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333413|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333414|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44333415|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44333416|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333417|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333418|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44333419|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
44333420|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333421|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333422|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333423|NCT04198805|Vitamins|vitamins|mesh-list
44333424|NCT04198805|Vitamin E|vitamin e|mesh-list
44333425|NCT04198805|Tocopherols|tocopherols|mesh-list
44333426|NCT04198805|Tocotrienols|tocotrienols|mesh-list
44333427|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
44333428|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
44333429|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333430|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
44333431|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333432|NCT04198805|Protective Agents|protective agents|mesh-ancestor
44333433|NCT04189445|Futibatinib|futibatinib|mesh-list
44333434|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333435|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
44333436|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333437|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333443|NCT04026230|Atorvastatin|atorvastatin|mesh-list
44333459|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333460|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333461|NCT03862716|Insulin|insulin|mesh-list
44333462|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44333463|NCT03862716|Metformin|metformin|mesh-list
44333464|NCT03862716|Liraglutide|liraglutide|mesh-list
44333465|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
44333466|NCT03862716|Xultophy|xultophy|mesh-list
44333467|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333468|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333469|NCT03862716|Incretins|incretins|mesh-ancestor
44333470|NCT03862716|Hormones|hormones|mesh-ancestor
44333471|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333472|NCT03790670|Sargramostim|sargramostim|mesh-list
44333473|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
44333474|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333475|NCT03785405|Valsartan|valsartan|mesh-list
44333476|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44333477|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44333478|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44333479|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44333480|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333481|NCT03635749|Atorvastatin|atorvastatin|mesh-list
44333482|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44333483|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333484|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333485|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44333486|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44333487|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
43743872|NCT04271475|Macitentan|macitentan|mesh-list
44333488|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333489|NCT03562195|Albuterol|albuterol|mesh-list
44333490|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44333491|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
44333492|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333493|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333494|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44333495|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
44333496|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
44333497|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44333498|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44333499|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44333500|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44333501|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333502|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333503|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333504|NCT03502148|Cisplatin|cisplatin|mesh-list
44333505|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333506|NCT03457701|Iron|iron|mesh-list
44333507|NCT03457701|Trace Elements|trace elements|mesh-ancestor
44333508|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
44333509|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333510|NCT03453840|Lumefantrine|lumefantrine|mesh-list
44333511|NCT03453840|Artemether|artemether|mesh-list
44333512|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44333513|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
44333514|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44333515|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44333516|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333517|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44333518|NCT03439254|Cathartics|cathartics|mesh-ancestor
44333519|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44333520|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
44333532|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333533|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333534|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333535|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333536|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
44333537|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
44333538|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333539|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333540|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333541|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
44333542|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333543|NCT03374800|Pantoprazole|pantoprazole|mesh-list
44333544|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44333545|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44333546|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44333547|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333548|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333549|NCT03339258|Doxazosin|doxazosin|mesh-list
44333550|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44333551|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44333552|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44333553|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44127386|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127388|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127389|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127390|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127391|NCT00141258|Pregabalin|pregabalin|mesh-list
44127392|NCT00141258|Analgesics|analgesics|mesh-ancestor
44127393|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
44127394|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127395|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127396|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
44127397|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127398|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127399|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127400|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127401|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127402|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127403|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127404|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127405|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
44127406|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127407|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
44127408|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44127409|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44127414|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
44127415|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127416|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127417|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
44127418|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44333554|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
44333555|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333556|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333557|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333558|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
44333559|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44333560|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333561|NCT03262935|Capecitabine|capecitabine|mesh-list
44333562|NCT03262935|Trastuzumab|trastuzumab|mesh-list
44333563|NCT03262935|Vinorelbine|vinorelbine|mesh-list
44333565|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333566|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
44333567|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333568|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333569|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333570|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44333571|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
44333572|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
44333573|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333574|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44333575|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333576|NCT03253913|Sirolimus|sirolimus|mesh-list
44333577|NCT03253913|Resveratrol|resveratrol|mesh-list
44333578|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333603|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44333604|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44333605|NCT03186638|Analgesics|analgesics|mesh-ancestor
44333606|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
44333607|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333608|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333609|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333610|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333611|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44333612|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333613|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333614|NCT03041740|Perflubron|perflubron|mesh-list
44333615|NCT03041740|Bromides|bromides|mesh-list
44333616|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
44333617|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44333618|NCT02866682|Tacrolimus|tacrolimus|mesh-list
44333619|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333620|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
44333621|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333622|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44333623|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333624|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127419|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127420|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127421|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127422|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127423|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127424|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127425|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127427|NCT00141362|Analgesics|analgesics|mesh-ancestor
44127428|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
44127429|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127430|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127431|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
44127432|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127433|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127434|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127435|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127436|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127437|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127438|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127439|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127440|NCT00141375|Pregabalin|pregabalin|mesh-list
44127441|NCT00141375|Analgesics|analgesics|mesh-ancestor
44127442|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
44127443|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127444|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127445|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
44127446|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127447|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702166|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333625|NCT02773485|Gemcitabine|gemcitabine|mesh-list
44333626|NCT02773485|Cisplatin|cisplatin|mesh-list
44333627|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333628|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44333629|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
44333630|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333631|NCT02773485|Antiviral Agents|antiviral agents|mesh-ancestor
44333632|NCT02773485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333633|NCT02773485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333634|NCT02773485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333635|NCT02773485|Immunologic Factors|immunologic factors|mesh-ancestor
44333636|NCT02773485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333637|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
44333638|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333639|NCT02293954|Antibodies|antibodies|mesh-list
44333640|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44333641|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
44333642|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333643|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
44333644|NCT02176967|Carboplatin|carboplatin|mesh-list
44333645|NCT02176967|Doxorubicin|doxorubicin|mesh-list
44333646|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44333681|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333682|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44333684|NCT01306045|Lapatinib|lapatinib|mesh-list
44333685|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333686|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44333687|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846410|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
44333688|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333689|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44333690|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44333691|NCT01306045|Growth Substances|growth substances|mesh-ancestor
44333692|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333693|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
44333694|NCT00585247|Imiquimod|imiquimod|mesh-list
44333695|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44333696|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
44333697|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333698|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333699|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
44333700|NCT05268614|Cisplatin|cisplatin|mesh-list
44333701|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333703|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333704|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333705|NCT05219942|Insulin|insulin|mesh-list
44333706|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
44333707|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333730|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333731|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333733|NCT05129358|Diuretics|diuretics|mesh-ancestor
44333734|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
44333735|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333736|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44333737|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44333738|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333739|NCT05123092|Morphine|morphine|mesh-list
44333740|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44333741|NCT05123092|Narcotics|narcotics|mesh-ancestor
44333742|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333743|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333744|NCT05123092|Analgesics|analgesics|mesh-ancestor
44333745|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
44333746|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333747|NCT05072093|Tenofovir|tenofovir|mesh-list
44333748|NCT05072093|Emtricitabine|emtricitabine|mesh-list
44333749|NCT05072093|Cabotegravir|cabotegravir|mesh-list
44333750|NCT05072093|Doxycycline|doxycycline|mesh-list
44333751|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
44333752|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333753|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44333754|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44333755|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847754|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44127448|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127449|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127450|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127451|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127452|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127453|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127454|NCT00141388|Pregabalin|pregabalin|mesh-list
44127455|NCT00141388|Analgesics|analgesics|mesh-ancestor
44127456|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
44127457|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127458|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127459|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
44127460|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127461|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127462|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127463|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127464|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127465|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127466|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127467|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127468|NCT00141401|Pregabalin|pregabalin|mesh-list
44333756|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333757|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333758|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333759|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333760|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
44333761|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44333762|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44333763|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44333764|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44333765|NCT04994561|Niacinamide|niacinamide|mesh-list
44333766|NCT04994561|Metformin|metformin|mesh-list
44333767|NCT04994561|Dasatinib|dasatinib|mesh-list
44333768|NCT04994561|Resveratrol|resveratrol|mesh-list
44333769|NCT04994561|Quercetin|quercetin|mesh-list
44333770|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333771|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333772|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333773|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44333774|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333775|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333776|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
44333777|NCT04994561|Protective Agents|protective agents|mesh-ancestor
44333778|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44333779|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
44333780|NCT04994561|Vitamins|vitamins|mesh-ancestor
44333781|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
44333782|NCT04965818|Futibatinib|futibatinib|mesh-list
44333783|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333784|NCT04946006|Oxytocin|oxytocin|mesh-list
44333785|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
44333786|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44333787|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333788|NCT04941443|Ibuprofen|ibuprofen|mesh-list
44333789|NCT04941443|Methadone|methadone|mesh-list
44333790|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44333791|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44333792|NCT04941443|Analgesics|analgesics|mesh-ancestor
43744131|NCT04013542|Nivolumab|nivolumab|mesh-list
44127469|NCT00141401|Analgesics|analgesics|mesh-ancestor
44127470|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
44127471|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127472|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333793|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
44333794|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333795|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333796|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333797|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333798|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44333799|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333800|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333801|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44333802|NCT04941443|Narcotics|narcotics|mesh-ancestor
44333803|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333804|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
44333805|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
44333806|NCT04893291|Sirolimus|sirolimus|mesh-list
44333807|NCT04893291|Everolimus|everolimus|mesh-list
44333808|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333809|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333810|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
44333811|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333812|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333813|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333814|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333815|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
44333816|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
44333817|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
44333818|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127473|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
44127474|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127475|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127476|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127477|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127478|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127487|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
44127488|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127489|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127490|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127491|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127492|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127493|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127494|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127495|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127497|NCT00141427|Analgesics|analgesics|mesh-ancestor
44127498|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
44127499|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127500|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127501|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
44333819|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
44333820|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44333821|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333822|NCT04867707|Zanamivir|zanamivir|mesh-list
44333823|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
44333824|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333825|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333826|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333827|NCT04857398|Insulin|insulin|mesh-list
44333828|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44333829|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333830|NCT04849455|Morphine|morphine|mesh-list
44333831|NCT04849455|Ropivacaine|ropivacaine|mesh-list
44333832|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
44333833|NCT04849455|Anesthetics|anesthetics|mesh-list
44333834|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44333835|NCT04849455|Narcotics|narcotics|mesh-ancestor
44333836|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44333837|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333838|NCT04849455|Analgesics|analgesics|mesh-ancestor
44333839|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
44333840|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333841|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
44333842|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333843|NCT04761198|Nivolumab|nivolumab|mesh-list
44333844|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333845|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333846|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44333847|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333848|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44333849|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
44333866|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333867|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
44333868|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44333869|NCT04477512|Prednisone|prednisone|mesh-list
44333870|NCT04477512|Nivolumab|nivolumab|mesh-list
44333871|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
44333872|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333873|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
44333874|NCT04477512|Hormones|hormones|mesh-ancestor
44333875|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333876|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333877|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44127502|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127503|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127504|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127505|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127506|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127507|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127508|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127509|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127510|NCT00141492|Testosterone|testosterone|mesh-list
44127511|NCT00141492|Androgens|androgens|mesh-ancestor
44127512|NCT00141492|Hormones|hormones|mesh-ancestor
44127513|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127514|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127515|NCT00141531|Apaziquone|apaziquone|mesh-list
44127516|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127517|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
44127518|NCT00141544|Estrogens|estrogens|mesh-list
44127519|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
44127520|NCT00141544|Estrone|estrone|mesh-list
44127521|NCT00141544|Testosterone|testosterone|mesh-list
44127522|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
44127523|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
44127524|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44127525|NCT00141544|Hormones|hormones|mesh-ancestor
44127526|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127527|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779966|NCT05084079|Insulin|insulin|mesh-list
44127528|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44127529|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127530|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
44127531|NCT00141544|Androgens|androgens|mesh-ancestor
44127532|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
44127533|NCT00141557|Estrogens|estrogens|mesh-list
44127534|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
44127535|NCT00141557|Estrone|estrone|mesh-list
44127536|NCT00141557|Testosterone|testosterone|mesh-list
44127537|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
44127538|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
44127539|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44127540|NCT00141557|Hormones|hormones|mesh-ancestor
44127541|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127542|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127543|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44127544|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127546|NCT00141557|Androgens|androgens|mesh-ancestor
44127549|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
44127550|NCT00141570|Testosterone|testosterone|mesh-list
44127551|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
44127552|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
44127553|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44127555|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702167|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
44333879|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333880|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44333881|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333882|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44333883|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333884|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
44333885|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44333886|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
44333888|NCT04469842|Azathioprine|azathioprine|mesh-list
44333889|NCT04469842|Tacrolimus|tacrolimus|mesh-list
44333890|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44333891|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
44333892|NCT04469842|Hormones|hormones|mesh-ancestor
44333893|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44333894|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44333895|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44333896|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333897|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44333898|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
44333899|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44333900|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333901|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333902|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44333903|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44333904|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
44333905|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333906|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333907|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
44333908|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127556|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127557|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44127558|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127559|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
44127560|NCT00141570|Androgens|androgens|mesh-ancestor
44127561|NCT00141583|Candesartan|candesartan|mesh-list
44127562|NCT00141583|Enalapril|enalapril|mesh-list
44127563|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44127564|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44127565|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44333909|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44333910|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
44333911|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44333912|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44333913|NCT04433780|Tenofovir|tenofovir|mesh-list
44333914|NCT04433780|Lamivudine|lamivudine|mesh-list
44333915|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
44333916|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333917|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44333918|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44333919|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333920|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333921|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333922|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333923|NCT04429152|Tenofovir|tenofovir|mesh-list
44333924|NCT04429152|Lamivudine|lamivudine|mesh-list
44333925|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
44333926|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333927|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44127566|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127567|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44127568|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
44127569|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127570|NCT00141596|Amiloride|amiloride|mesh-list
44127571|NCT00141596|Furosemide|furosemide|mesh-list
44127572|NCT00141596|Diuretics|diuretics|mesh-ancestor
44127573|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
44127574|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127575|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44127576|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127577|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127578|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44127579|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44127580|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44127581|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44127582|NCT00141648|Prednisolone|prednisolone|mesh-list
44127583|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
44127584|NCT00141648|Doxorubicin|doxorubicin|mesh-list
44127585|NCT00141648|Vincristine|vincristine|mesh-list
44127586|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127587|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
44127588|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127589|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127590|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44127591|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
44127592|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127593|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127594|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44127595|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127596|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44127597|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44127598|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127599|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44127600|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127601|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
44127602|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
44333928|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44333929|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333930|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333931|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333932|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333933|NCT04424264|Tenofovir|tenofovir|mesh-list
44333934|NCT04424264|Lamivudine|lamivudine|mesh-list
44333935|NCT04424264|Emtricitabine|emtricitabine|mesh-list
44333936|NCT04424264|Efavirenz|efavirenz|mesh-list
44333937|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44333938|NCT04424264|Rifampin|rifampin|mesh-list
44333939|NCT04424264|Isoniazid|isoniazid|mesh-list
44333940|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
44333941|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44333942|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44333943|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44333944|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44333945|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333946|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44333947|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44333948|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44127603|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127604|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
44127605|NCT00141648|Hormones|hormones|mesh-ancestor
44127606|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127607|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44127609|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127610|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127611|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
44127612|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127613|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127614|NCT00141713|Etanercept|etanercept|mesh-list
44127615|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127616|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127617|NCT00141713|Analgesics|analgesics|mesh-ancestor
44127618|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
44127619|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127632|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127633|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127634|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127635|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127636|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127637|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
44127638|NCT00141804|Sirolimus|sirolimus|mesh-list
44127639|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44127640|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127641|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127642|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127643|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
44127644|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127645|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
44127646|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127647|NCT00141830|Methotrexate|methotrexate|mesh-list
44333949|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44333950|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44333951|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44333952|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44333953|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44333955|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
44333956|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44333957|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
44333958|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44333959|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44333960|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44333961|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44333962|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44333963|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
44333964|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44333965|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44333966|NCT04420299|Bemiparin|bemiparin|mesh-list
44333967|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
44333968|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44333969|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44333970|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333971|NCT04364360|Sulforaphane|sulforaphane|mesh-list
44333972|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44333973|NCT04364360|Protective Agents|protective agents|mesh-ancestor
44333997|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44333999|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44334000|NCT03979352|Empagliflozin|empagliflozin|mesh-list
44334001|NCT03979352|Pancrelipase|pancrelipase|mesh-list
44334002|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44334003|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334004|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334005|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334006|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44334007|NCT03971409|Doxorubicin|doxorubicin|mesh-list
44334008|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44334009|NCT03971409|Avelumab|avelumab|mesh-list
44334010|NCT03971409|Camptothecin|camptothecin|mesh-list
44334011|NCT03971409|Antibodies|antibodies|mesh-list
44334012|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44334013|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
44334014|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
44334015|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
44334016|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334017|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44334018|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334019|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44334020|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44334021|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334022|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127648|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44127649|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
44127650|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44127651|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127652|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127653|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
44127654|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127655|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127656|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
44127657|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127658|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44127659|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127660|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
44127661|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127662|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44127663|NCT00141843|Factor VIII|factor viii|mesh-list
44127664|NCT00141843|Coagulants|coagulants|mesh-ancestor
44127665|NCT00141882|Memantine|memantine|mesh-list
44127666|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44127667|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44127668|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
44334029|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334030|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44334031|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334040|NCT03735979|Eptifibatide|eptifibatide|mesh-list
44334041|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
44334042|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44334043|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
44334044|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334045|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334046|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
44334047|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44334048|NCT03709446|Leflunomide|leflunomide|mesh-list
44334049|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334050|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334051|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334052|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
44334066|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44334067|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334068|NCT03675139|Progestins|progestins|mesh-ancestor
44334070|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334071|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
44334072|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44334073|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44334074|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334075|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
44334076|NCT03646474|Coagulants|coagulants|mesh-ancestor
44334077|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
44334078|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44334079|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44334080|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334081|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
44334082|NCT03606785|Coagulants|coagulants|mesh-ancestor
44334083|NCT03322267|Cisplatin|cisplatin|mesh-list
44127669|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127670|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127671|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127672|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44127673|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44127674|NCT00141895|Misoprostol|misoprostol|mesh-list
44127675|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44127676|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
44127677|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44127678|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599304|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
44127679|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44127680|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127687|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44127688|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127689|NCT00141908|Progestins|progestins|mesh-ancestor
44127690|NCT00141908|Hormones|hormones|mesh-ancestor
44127691|NCT00141908|Cathartics|cathartics|mesh-ancestor
44127692|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127693|NCT00141947|Bexarotene|bexarotene|mesh-list
44127694|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127695|NCT00141960|Famotidine|famotidine|mesh-list
44127696|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44127697|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127698|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44127699|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
44127700|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
44127701|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127702|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127703|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127704|NCT00141986|Vitamin D|vitamin d|mesh-list
44127705|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
44127706|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
44127707|NCT00141986|Vitamins|vitamins|mesh-list
44127708|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
44127709|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127710|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43702168|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334084|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
44334085|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334086|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334087|NCT03275818|Paclitaxel|paclitaxel|mesh-list
44334088|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44334089|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334090|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
44334091|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
44334092|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
44334093|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334094|NCT03274804|Maraviroc|maraviroc|mesh-list
44334095|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
44334096|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334097|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334098|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44334099|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44334100|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334101|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44334102|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44334103|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
44334104|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334105|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44334106|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44334107|NCT03270059|Hematinics|hematinics|mesh-ancestor
44127711|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127712|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
44127713|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
44127714|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44127715|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44127716|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127717|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127718|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44127719|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44127720|NCT00142038|Docetaxel|docetaxel|mesh-list
44127721|NCT00142038|Capecitabine|capecitabine|mesh-list
44127722|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127723|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127724|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
44127725|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
44127726|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127727|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127728|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
44127729|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
44127730|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44127731|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
44127732|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127733|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127734|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44127735|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
44334108|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44334109|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44334110|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
44334111|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
44334112|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44334113|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334114|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334115|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
44334116|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44334117|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334118|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334119|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44334120|NCT03179449|Hematinics|hematinics|mesh-ancestor
44334121|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44334122|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44334123|NCT03084237|Docetaxel|docetaxel|mesh-list
44334124|NCT03084237|Trastuzumab|trastuzumab|mesh-list
44334125|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334126|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127736|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44127737|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
44127738|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127739|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127740|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44127741|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
44127742|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
44127743|NCT00142051|Protective Agents|protective agents|mesh-ancestor
44127744|NCT00142129|Bortezomib|bortezomib|mesh-list
44127745|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127746|NCT00142155|Rituximab|rituximab|mesh-list
44127747|NCT00142155|Antibodies|antibodies|mesh-list
44127748|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44127749|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
44127750|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127751|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127756|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127757|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
44127758|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
44127759|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44127760|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
44127761|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44127762|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44127763|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127764|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44127765|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127766|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127767|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44127768|NCT00142207|Renal Agents|renal agents|mesh-ancestor
44127769|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
44127770|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44127771|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44127772|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127773|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127774|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127775|NCT00142246|Amodiaquine|amodiaquine|mesh-list
44127776|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
44127777|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44334127|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44334128|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44334129|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334130|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334131|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
44334132|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334133|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334134|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
44334135|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334136|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44334137|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334138|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334139|NCT02451553|Capecitabine|capecitabine|mesh-list
44334140|NCT02451553|Afatinib|afatinib|mesh-list
44334141|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334142|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
44334143|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334144|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334145|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44334146|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334147|NCT02379247|Paclitaxel|paclitaxel|mesh-list
44334148|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44334149|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334150|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
43744445|NCT03581292|Veliparib|veliparib|mesh-list
44127778|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44127779|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127780|NCT00142324|Donepezil|donepezil|mesh-list
44127781|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44127782|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127783|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127784|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
44127785|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127786|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127787|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
44127788|NCT00142337|Zidovudine|zidovudine|mesh-list
44127789|NCT00142337|Didanosine|didanosine|mesh-list
44127790|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
44127791|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127792|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44127793|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44127794|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127795|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
44127796|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127797|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44127798|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44127799|NCT00142350|Cisplatin|cisplatin|mesh-list
44127800|NCT00142350|Fluorouracil|fluorouracil|mesh-list
44127801|NCT00142350|Irinotecan|irinotecan|mesh-list
44127802|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334151|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
44334152|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
44334153|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334155|NCT02315326|Methotrexate|methotrexate|mesh-list
44334156|NCT02315326|Procarbazine|procarbazine|mesh-list
44334157|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334158|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334159|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
44334160|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334161|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334162|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44334163|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
44334164|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334165|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334166|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
44334167|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334168|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44334169|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334170|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334171|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334172|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334173|NCT02275286|Trabectedin|trabectedin|mesh-list
44334174|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44334175|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
44334176|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334177|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334178|NCT02044497|Oxycodone|oxycodone|mesh-list
44334179|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334180|NCT02044497|Narcotics|narcotics|mesh-ancestor
44334181|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334182|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334183|NCT02044497|Analgesics|analgesics|mesh-ancestor
44334184|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
44334186|NCT02007655|Apixaban|apixaban|mesh-list
44334189|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44334191|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334192|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334193|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
43989301|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334194|NCT01664182|Bevacizumab|bevacizumab|mesh-list
43780431|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44334195|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44334196|NCT01664182|Sunitinib|sunitinib|mesh-list
44334197|NCT01664182|Trebananib|trebananib|mesh-list
44334198|NCT01664182|Sorafenib|sorafenib|mesh-list
44334199|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
44334200|NCT01664182|Antibodies|antibodies|mesh-list
44334201|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
44334202|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44334203|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
44334204|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334205|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334206|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44334207|NCT01664182|Growth Substances|growth substances|mesh-ancestor
44334208|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334209|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334210|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
44334211|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44334212|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334213|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334214|NCT01646814|Aspirin|aspirin|mesh-list
44334215|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334216|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334217|NCT01646814|Analgesics|analgesics|mesh-ancestor
44334218|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
44334219|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334220|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334221|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334222|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334223|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44127803|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
44127804|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127805|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334225|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334226|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44334227|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44334228|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334229|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
44334230|NCT01416636|Treprostinil|treprostinil|mesh-list
44334231|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334232|NCT00788684|Rituximab|rituximab|mesh-list
44334233|NCT00788684|Navitoclax|navitoclax|mesh-list
44334234|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334235|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334236|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
44334237|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334238|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334239|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44334240|NCT00775684|Exenatide|exenatide|mesh-list
44334241|NCT00775684|Glimepiride|glimepiride|mesh-list
44334242|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334243|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334244|NCT00775684|Incretins|incretins|mesh-ancestor
44334245|NCT00775684|Hormones|hormones|mesh-ancestor
44334246|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334247|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44334248|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
44334249|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334250|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334251|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44334252|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334253|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334254|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
44334255|NCT00991848|Lidocaine|lidocaine|mesh-list
44334256|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
44334257|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
44334258|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334259|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334260|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
44127806|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334261|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334262|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334263|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44334264|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44334265|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334266|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334267|NCT00991926|Orlistat|orlistat|mesh-list
44334268|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334269|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334270|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44334271|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44334272|NCT00991978|Bevacizumab|bevacizumab|mesh-list
44334273|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44334274|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334275|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334276|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334277|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44334278|NCT00991978|Growth Substances|growth substances|mesh-ancestor
44334279|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334280|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334281|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44334282|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334283|NCT00992004|Turmeric extract|turmeric extract|mesh-list
44127807|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
44127808|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127809|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44127810|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44127811|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155053|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44155054|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155055|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155056|NCT00226096|Metoprolol|metoprolol|mesh-list
44155057|NCT00226096|Clonidine|clonidine|mesh-list
44155058|NCT00226096|Nitroprusside|nitroprusside|mesh-list
44155059|NCT00226096|Labetalol|labetalol|mesh-list
44155060|NCT00226096|Hydralazine|hydralazine|mesh-list
44155061|NCT00226096|Nicardipine|nicardipine|mesh-list
44155062|NCT00226096|Phentolamine|phentolamine|mesh-list
44155063|NCT00226096|Urapidil|urapidil|mesh-list
44155064|NCT00226096|Enalaprilat|enalaprilat|mesh-list
44155065|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
44155066|NCT00226096|Esmolol|esmolol|mesh-list
44155072|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155073|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127812|NCT00142402|Modafinil|modafinil|mesh-list
44127813|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44127814|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127815|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44127816|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44127817|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44334285|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334286|NCT00992004|Protective Agents|protective agents|mesh-ancestor
44334287|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334288|NCT00992030|Rituximab|rituximab|mesh-list
44334289|NCT00992030|Doxorubicin|doxorubicin|mesh-list
44334290|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44334291|NCT00992030|Dacarbazine|dacarbazine|mesh-list
44334292|NCT00992030|Bleomycin|bleomycin|mesh-list
44334293|NCT00992030|Vinblastine|vinblastine|mesh-list
44334294|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334295|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334296|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
44334297|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334298|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334299|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44334300|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44334301|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44334302|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334303|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334304|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44334305|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
44334306|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44334307|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44334308|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44334309|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44334310|NCT00992069|Efavirenz|efavirenz|mesh-list
44334311|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44334312|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334313|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334314|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334315|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
44334316|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334317|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43744540|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334321|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44334322|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44334324|NCT00992082|Epinephrine|epinephrine|mesh-list
44334325|NCT00992082|Morphine|morphine|mesh-list
44334326|NCT00992082|Ropivacaine|ropivacaine|mesh-list
44334327|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334328|NCT00992082|Narcotics|narcotics|mesh-ancestor
44334329|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334330|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334331|NCT00992082|Analgesics|analgesics|mesh-ancestor
44334332|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
44334333|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334334|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
44334335|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
44334336|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44334337|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44334338|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
44334339|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127818|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127819|NCT00142428|Cetuximab|cetuximab|mesh-list
44127820|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127821|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127822|NCT00142467|Gemcitabine|gemcitabine|mesh-list
44127823|NCT00142467|Bevacizumab|bevacizumab|mesh-list
44127824|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
44127825|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127827|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44127828|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44127829|NCT00142467|Growth Substances|growth substances|mesh-ancestor
44127830|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127831|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
44127832|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127833|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
44127834|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127835|NCT00142467|Antiviral Agents|antiviral agents|mesh-ancestor
44127836|NCT00142467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127837|NCT00142467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127838|NCT00142467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127839|NCT00142467|Immunologic Factors|immunologic factors|mesh-ancestor
44127840|NCT00142480|Bevacizumab|bevacizumab|mesh-list
44127841|NCT00142480|Capecitabine|capecitabine|mesh-list
44127842|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
44127843|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44127844|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127845|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44127846|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44127847|NCT00142480|Growth Substances|growth substances|mesh-ancestor
44127848|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127849|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
44127850|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127851|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
44127852|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127853|NCT00142493|Midazolam|midazolam|mesh-list
44127854|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
44127855|NCT00142493|Thiopental|thiopental|mesh-list
44127856|NCT00142493|Propofol|propofol|mesh-list
44127857|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599344|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
43599345|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334340|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334341|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44334342|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44334343|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
43989448|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
44334344|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44334345|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
44334346|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
44334347|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
44334348|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44334349|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334350|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334351|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334352|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334353|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44334354|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334355|NCT00992095|Buprenorphine|buprenorphine|mesh-list
44334356|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334357|NCT00992095|Narcotics|narcotics|mesh-ancestor
44334358|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334359|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334360|NCT00992095|Analgesics|analgesics|mesh-ancestor
44334361|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
44334362|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334363|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44334364|NCT00992121|Bevacizumab|bevacizumab|mesh-list
44334365|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334366|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334367|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334368|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44127858|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127859|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127860|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44127861|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
44127862|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
44127863|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127864|NCT00142493|Analgesics|analgesics|mesh-ancestor
44127865|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
44127866|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127867|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44127868|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44127869|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44127870|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44127871|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334369|NCT00992121|Growth Substances|growth substances|mesh-ancestor
44334370|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334371|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334372|NCT00992134|Cytarabine|cytarabine|mesh-list
44334373|NCT00992134|Rituximab|rituximab|mesh-list
44334374|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44334375|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334376|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334377|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
44334378|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334379|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334380|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334381|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
44334382|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334383|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
44334384|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334385|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334386|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44334387|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
44334388|NCT00992160|Vestipitant|vestipitant|mesh-list
44334389|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44334390|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334391|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334392|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334393|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44334394|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334395|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334396|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334414|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44334415|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334416|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44334417|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44334418|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334419|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334420|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334421|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44334422|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44334423|NCT00992355|Tobramycin|tobramycin|mesh-list
44334424|NCT00992355|Dexamethasone|dexamethasone|mesh-list
44334425|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
44334426|NCT00992355|Ketorolac|ketorolac|mesh-list
44334427|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44334428|NCT00992355|BB 1101|bb 1101|mesh-list
44334429|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334430|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
44334431|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
44334432|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334433|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334434|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44334435|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
44334436|NCT00992355|Hormones|hormones|mesh-ancestor
44334437|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334438|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44334451|NCT00992381|Naproxen|naproxen|mesh-list
44334464|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
44334465|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
44334466|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
44334467|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334468|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334469|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44334470|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44334471|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44334472|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334473|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44334474|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44334475|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
44334476|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334477|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334478|NCT00992524|Misoprostol|misoprostol|mesh-list
44334479|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44334480|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
44334481|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334482|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334483|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44334484|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44334485|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
44334486|NCT00992537|Insulin|insulin|mesh-list
44334487|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44334488|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
44334489|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
44334490|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44334491|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334492|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127872|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127873|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44127874|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127875|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127876|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127881|NCT00142545|Emetics|emetics|mesh-ancestor
44127882|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127883|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
44127884|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127885|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127886|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
44127887|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
44127888|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334493|NCT00992576|Hydromorphone|hydromorphone|mesh-list
44334495|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44334496|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334497|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
43599425|NCT03290456|Prednisone|prednisone|mesh-list
44334498|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334499|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334500|NCT00992576|Narcotics|narcotics|mesh-ancestor
44334501|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334502|NCT00992576|Analgesics|analgesics|mesh-ancestor
44334503|NCT00992654|Maraviroc|maraviroc|mesh-list
44334504|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44334505|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44334506|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334507|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44334508|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44334509|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
44334510|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334511|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44334512|NCT00992667|Acetovanillone|acetovanillone|mesh-list
44334513|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334514|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334515|NCT00992667|Analgesics|analgesics|mesh-ancestor
44334516|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
44334517|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334518|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334519|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334520|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334521|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
44334522|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334523|NCT00992667|Protective Agents|protective agents|mesh-ancestor
44334524|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334525|NCT00992693|Ribavirin|ribavirin|mesh-list
44334526|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
44334527|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334534|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44334535|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44334536|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334537|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334538|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
44334539|NCT00992758|Antibodies|antibodies|mesh-list
44334540|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
44334541|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334542|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334543|NCT00992771|Varenicline|varenicline|mesh-list
44334544|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44334545|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44334546|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
44334547|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334548|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334549|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334550|NCT00992797|Vitamin D|vitamin d|mesh-list
44334551|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
44334552|NCT00992797|Vitamins|vitamins|mesh-ancestor
44334553|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
44334554|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334555|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44334556|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44334557|NCT00992823|Iron|iron|mesh-list
44334558|NCT00992823|Trace Elements|trace elements|mesh-ancestor
44334559|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
44334560|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334561|NCT00992849|Bevacizumab|bevacizumab|mesh-list
44334562|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44334563|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334564|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44127889|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127890|NCT00142571|Gemcitabine|gemcitabine|mesh-list
44127891|NCT00142571|Docetaxel|docetaxel|mesh-list
44127892|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44127893|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
44127894|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127895|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127896|NCT00142571|Antiviral Agents|antiviral agents|mesh-ancestor
44127897|NCT00142571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127898|NCT00142571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127899|NCT00142571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127900|NCT00142571|Immunologic Factors|immunologic factors|mesh-ancestor
44127901|NCT00142571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334565|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44334566|NCT00992849|Growth Substances|growth substances|mesh-ancestor
44334567|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334568|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334569|NCT00992862|Moexipril|moexipril|mesh-list
44334570|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44334571|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
44334572|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334573|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334574|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334575|NCT00992914|Lidocaine|lidocaine|mesh-list
44334576|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
44334577|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
44334578|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334579|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334580|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
44334581|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334582|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334587|NCT00993057|Insulin|insulin|mesh-list
44334618|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334619|NCT00993122|Ribavirin|ribavirin|mesh-list
44334620|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
44334621|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334622|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
44334623|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334624|NCT00993135|Methotrexate|methotrexate|mesh-list
44334625|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44334626|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
44334627|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334628|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334629|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334630|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
44334631|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334632|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334633|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44334634|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334635|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334636|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334637|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
44334638|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334639|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334640|NCT00993304|Liraglutide|liraglutide|mesh-list
44334641|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334642|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334643|NCT00993304|Incretins|incretins|mesh-ancestor
44334644|NCT00993304|Hormones|hormones|mesh-ancestor
44334645|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334646|NCT00993343|Cyclosporine|cyclosporine|mesh-list
44334647|NCT00993343|Sirolimus|sirolimus|mesh-list
44334648|NCT00993343|Methotrexate|methotrexate|mesh-list
44127902|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127903|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44127904|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44127905|NCT00142610|Vitamins|vitamins|mesh-list
44127906|NCT00142610|Vitamin E|vitamin e|mesh-list
44127907|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
44127908|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127909|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
44127910|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127911|NCT00142610|Protective Agents|protective agents|mesh-ancestor
44127912|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
44127913|NCT00142727|Methadone|methadone|mesh-list
44127914|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
44127915|NCT00142727|Narcotics|narcotics|mesh-ancestor
44334649|NCT00993343|Tacrolimus|tacrolimus|mesh-list
44334650|NCT00993343|Cyclosporins|cyclosporins|mesh-list
44334651|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44334652|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
44334653|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44334654|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334655|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334656|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
44334657|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334658|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334659|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
44334660|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334661|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334662|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334663|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
44334664|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334665|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334666|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44334667|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
44334668|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334669|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44334670|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44127916|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127917|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127918|NCT00142727|Analgesics|analgesics|mesh-ancestor
44127919|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
44127920|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127921|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
44127922|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
44127923|NCT00142779|Fluoxetine|fluoxetine|mesh-list
44127924|NCT00142779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44127925|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44127926|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127927|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127928|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127929|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
44127930|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127931|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44127932|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44127933|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127934|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44127935|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44127936|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127937|NCT00142844|Naltrexone|naltrexone|mesh-list
44127938|NCT00142844|Disulfiram|disulfiram|mesh-list
44127939|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44127940|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44127941|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127942|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
44127943|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127944|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44334671|NCT00993356|Lanreotide|lanreotide|mesh-list
44334672|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334673|NCT00993408|Selexipag|selexipag|mesh-list
44334674|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334675|NCT00993512|Bleomycin|bleomycin|mesh-list
44334676|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44334677|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334678|NCT00993525|Ranibizumab|ranibizumab|mesh-list
44334679|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334680|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44334681|NCT00993525|Growth Substances|growth substances|mesh-ancestor
44334682|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334683|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334684|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43989757|NCT02393378|Folic Acid|folic acid|mesh-list
44334685|NCT00993642|Panobinostat|panobinostat|mesh-list
44334686|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334687|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44334688|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334689|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334690|NCT00993681|Vaccines|vaccines|mesh-list
44334691|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
44334692|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334693|NCT00993694|Dapsone|dapsone|mesh-list
44334694|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44127945|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127946|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127947|NCT00142870|Bupropion|bupropion|mesh-list
44127948|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44127949|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
44127950|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127951|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44127952|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44127953|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127954|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127955|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
44127956|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127957|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127958|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44127959|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44127960|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127961|NCT00142883|Pregabalin|pregabalin|mesh-list
44127962|NCT00142883|Analgesics|analgesics|mesh-ancestor
44127963|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
44127964|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127965|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127966|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
44127967|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44127968|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127969|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334695|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
44334696|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44334697|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44334698|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334699|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334700|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334701|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
44334702|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44334703|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
44334704|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44334705|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
44334706|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334707|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
44334708|NCT00993707|Protective Agents|protective agents|mesh-ancestor
44334709|NCT00993720|Liraglutide|liraglutide|mesh-list
44334710|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334711|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334712|NCT00993720|Incretins|incretins|mesh-ancestor
44334713|NCT00993720|Hormones|hormones|mesh-ancestor
44334714|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334715|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
44334716|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44334717|NCT00993746|Lidocaine|lidocaine|mesh-list
44334718|NCT00993746|Bupivacaine|bupivacaine|mesh-list
44334719|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
44334720|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
44334721|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334722|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334723|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
44334724|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334725|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334726|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44127970|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44127971|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44127972|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127973|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127974|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127976|NCT00142896|Tramadol|tramadol|mesh-list
44127977|NCT00142896|Naloxone|naloxone|mesh-list
44127978|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44127979|NCT00142896|Narcotics|narcotics|mesh-ancestor
44127980|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127981|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334727|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44334728|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334729|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334730|NCT00993863|Ibuprofen|ibuprofen|mesh-list
44334731|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44334732|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44334733|NCT00993863|Analgesics|analgesics|mesh-ancestor
44334734|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
44334735|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334736|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334737|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44334738|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334739|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44334740|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334741|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334742|NCT00993876|Citalopram|citalopram|mesh-list
44334743|NCT00993876|Reboxetine|reboxetine|mesh-list
44334744|NCT00993876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44334745|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44334746|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334747|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334748|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44334749|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
44334750|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334751|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44334752|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44334753|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44334754|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44334755|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
44334756|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
44334757|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
44334758|NCT00994006|Levulinic acid|levulinic acid|mesh-list
44334759|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334760|NCT00994006|Cathartics|cathartics|mesh-ancestor
44334761|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127982|NCT00142896|Analgesics|analgesics|mesh-ancestor
44334762|NCT00994006|Antacids|antacids|mesh-ancestor
44334763|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334764|NCT00994071|Temozolomide|temozolomide|mesh-list
44334765|NCT00994071|Veliparib|veliparib|mesh-list
44334766|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44334767|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
44334768|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334769|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334770|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44334771|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334772|NCT00994097|Gemcitabine|gemcitabine|mesh-list
44334773|NCT00994097|Cisplatin|cisplatin|mesh-list
44334774|NCT00994097|Pemetrexed|pemetrexed|mesh-list
44334775|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334776|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44334777|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
44334778|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334779|NCT00994097|Antiviral Agents|antiviral agents|mesh-ancestor
44334780|NCT00994097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334781|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334782|NCT00994097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334783|NCT00994097|Immunologic Factors|immunologic factors|mesh-ancestor
44334784|NCT00994097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334785|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44334786|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44334787|NCT00994149|Diazoxide|diazoxide|mesh-list
44334788|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334789|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
44334790|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44127983|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
44127984|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127985|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44127986|NCT00142948|Naltrexone|naltrexone|mesh-list
44127987|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44127988|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44127989|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127990|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
44127991|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127992|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44127993|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44127994|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44127995|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44127996|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127997|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44127998|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127999|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334791|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334792|NCT00994253|Diuretics|diuretics|mesh-ancestor
44334793|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
44334794|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334795|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44334796|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334797|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334798|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
44334799|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44334800|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
44334801|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334802|NCT00994305|Expectorants|expectorants|mesh-ancestor
44334803|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
44334804|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44334805|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
44334806|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334807|NCT00994305|Protective Agents|protective agents|mesh-ancestor
44334808|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334809|NCT00994305|Antidotes|antidotes|mesh-ancestor
44334810|NCT00994344|Ritonavir|ritonavir|mesh-list
44334811|NCT00994344|Lopinavir|lopinavir|mesh-list
44334812|NCT00994344|Darunavir|darunavir|mesh-list
44334813|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44334814|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44334815|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
44334816|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334817|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334818|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44334819|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44334820|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
44334821|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44334822|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44334823|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44334824|NCT00994383|Morphine|morphine|mesh-list
44334825|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334826|NCT00994383|Narcotics|narcotics|mesh-ancestor
44334827|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334828|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334829|NCT00994383|Analgesics|analgesics|mesh-ancestor
44334830|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
44334831|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334833|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
44334834|NCT00994396|Vitamins|vitamins|mesh-ancestor
44334835|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
44334836|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334837|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44334838|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44334839|NCT00994500|Bortezomib|bortezomib|mesh-list
44334840|NCT00994500|Vorinostat|vorinostat|mesh-list
44334841|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334842|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44334843|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334844|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334845|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
44334846|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
44334847|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128000|NCT00142974|Tegaserod|tegaserod|mesh-list
44128001|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44128002|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
44128003|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128004|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128005|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128006|NCT00142987|Tegaserod|tegaserod|mesh-list
44128007|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44128008|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
44128009|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128010|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128011|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128012|NCT00143000|Ribavirin|ribavirin|mesh-list
44128013|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44128014|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
44128015|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128016|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
44128017|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128018|NCT00143026|Levodopa|levodopa|mesh-list
44128019|NCT00143026|Carbidopa|carbidopa|mesh-list
44128020|NCT00143026|Entacapone|entacapone|mesh-list
44128021|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44128022|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44128023|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
44128032|NCT00143065|Fludarabine|fludarabine|mesh-list
44128033|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44128034|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128035|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
44128036|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128037|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44128038|NCT00143091|Sertraline|sertraline|mesh-list
44128039|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
44128040|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128041|NCT00143091|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44128042|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44128043|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334848|NCT00994513|Protective Agents|protective agents|mesh-ancestor
44334849|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334850|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
44334851|NCT00994513|Vitamins|vitamins|mesh-ancestor
44334852|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
44334853|NCT00994526|Vitamin E|vitamin e|mesh-list
44334854|NCT00994526|Calcium|calcium|mesh-list
44334855|NCT00994526|Vitamins|vitamins|mesh-ancestor
44334856|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
44334857|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334858|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44334859|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
44334860|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334861|NCT00994526|Protective Agents|protective agents|mesh-ancestor
44334862|NCT00994539|Morphine|morphine|mesh-list
44334863|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334864|NCT00994539|Narcotics|narcotics|mesh-ancestor
44334865|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334866|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334867|NCT00994539|Analgesics|analgesics|mesh-ancestor
44334868|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
44334869|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334870|NCT00994617|Losartan|losartan|mesh-list
44334871|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44334872|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44334873|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44334874|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44334875|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44334876|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334877|NCT00994617|Diuretics|diuretics|mesh-ancestor
44334878|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
44334879|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128044|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128045|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128046|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
43572665|NCT00004093|Paclitaxel|paclitaxel|mesh-list
44128047|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128049|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44128050|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128051|NCT00143130|Pregabalin|pregabalin|mesh-list
44128052|NCT00143130|Analgesics|analgesics|mesh-ancestor
44128053|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
44128054|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334880|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44334881|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334883|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
44334884|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334885|NCT00994708|Esomeprazole|esomeprazole|mesh-list
44334886|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44334887|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44334888|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44334889|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334890|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334891|NCT00994734|Mifepristone|mifepristone|mesh-list
44334892|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44334893|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
44334894|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43599463|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
44334895|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334896|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44334897|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44334898|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44334899|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
44334900|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44334901|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44334902|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
44334903|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44334904|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
44334905|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44334906|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44334907|NCT00994773|Tenofovir|tenofovir|mesh-list
44334908|NCT00994773|Entecavir|entecavir|mesh-list
44334909|NCT00994773|Simvastatin|simvastatin|mesh-list
44334922|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44334924|NCT00994786|Analgesics|analgesics|mesh-ancestor
44334925|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
44334926|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334927|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334928|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
44334929|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44334930|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334931|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334932|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44334933|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44334934|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44334935|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334936|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44334937|NCT00994799|Ranibizumab|ranibizumab|mesh-list
44334938|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44334939|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44334940|NCT00994799|Growth Substances|growth substances|mesh-ancestor
44334941|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334942|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
44334943|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44334944|NCT00994812|Metformin|metformin|mesh-list
44334945|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44334946|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334947|NCT00994825|Simendan|simendan|mesh-list
44334948|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44334949|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
44334950|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44334951|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44334952|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44334953|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334954|NCT00994825|Protective Agents|protective agents|mesh-ancestor
44334962|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44334964|NCT00994916|Amifampridine|amifampridine|mesh-list
44334965|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44334966|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334967|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334968|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44334969|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44334970|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44334971|NCT00994942|Morphine|morphine|mesh-list
44334972|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44334973|NCT00994942|Narcotics|narcotics|mesh-ancestor
44334974|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44334975|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334976|NCT00994942|Analgesics|analgesics|mesh-ancestor
44334977|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
44334978|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44334979|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
44334980|NCT00994968|Docetaxel|docetaxel|mesh-list
44334981|NCT00994968|Doxorubicin|doxorubicin|mesh-list
44334982|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44334983|NCT00994968|Tegafur|tegafur|mesh-list
44334984|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44334985|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
44334986|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44334987|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44334988|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44334989|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
44334990|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335008|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335009|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44335010|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
44335011|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44335012|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335013|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335014|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335015|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
44335016|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335017|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
44335018|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
44335019|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44335020|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44335021|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335022|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
44335023|NCT00994994|Coagulants|coagulants|mesh-ancestor
44335024|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
44335025|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335026|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44335027|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335028|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44335029|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335030|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335031|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335032|NCT00995033|Varenicline|varenicline|mesh-list
44335033|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44335034|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44335035|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
44335053|NCT00995293|Fluorouracil|fluorouracil|mesh-list
44335054|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335055|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335056|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335057|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335058|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335060|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335061|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335062|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
44335063|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335064|NCT00995306|Capsaicin|capsaicin|mesh-list
44335065|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
44335066|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335067|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
44335068|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335069|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335070|NCT00995332|Cytarabine|cytarabine|mesh-list
44335071|NCT00995332|Tretinoin|tretinoin|mesh-list
44335072|NCT00995332|Valproic Acid|valproic acid|mesh-list
44335073|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335074|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
44335075|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335076|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335077|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
44335078|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335079|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335080|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
44335081|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335082|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
44335083|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335084|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
44335085|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335086|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
44335087|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335088|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
44335089|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335094|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44335095|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
44335096|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
44335097|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335098|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335099|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335100|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
44335101|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335102|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44335103|NCT00995423|Paclitaxel|paclitaxel|mesh-list
44335104|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44335105|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335106|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335107|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335108|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335109|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335110|NCT00995618|Tranilast|tranilast|mesh-list
44335111|NCT00995618|Febuxostat|febuxostat|mesh-list
44335112|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
44335113|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335114|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44335115|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335116|NCT00995618|Analgesics|analgesics|mesh-ancestor
44335117|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
44335118|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335119|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335120|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335121|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44335122|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335123|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335124|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335125|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44335126|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
44335127|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
44335128|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335129|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44335131|NCT00995657|Fluticasone|fluticasone|mesh-list
44335132|NCT00995657|Xhance|xhance|mesh-list
44335133|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335134|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44335135|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
44335136|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335137|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335138|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44335139|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335140|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335141|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44335142|NCT00995800|Fluticasone|fluticasone|mesh-list
44335143|NCT00995800|Xhance|xhance|mesh-list
44335144|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
44335145|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335146|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44335147|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
44335148|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335149|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335150|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44335151|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335152|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335153|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43745304|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128055|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128056|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
44128057|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128058|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128059|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128060|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128061|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44128062|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128063|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128064|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128065|NCT00143143|Pregabalin|pregabalin|mesh-list
44128066|NCT00143143|Analgesics|analgesics|mesh-ancestor
44128067|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
44128068|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128069|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128070|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
44128071|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128072|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128073|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128074|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128075|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44128076|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128077|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128078|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128079|NCT00143156|Pregabalin|pregabalin|mesh-list
44128080|NCT00143156|Analgesics|analgesics|mesh-ancestor
44335154|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44335155|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44335156|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44335157|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44335158|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335159|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335160|NCT00995826|Laninamivir|laninamivir|mesh-list
44335161|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
44335162|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335163|NCT00995839|Terlipressin|terlipressin|mesh-list
44335164|NCT00995839|Vasopressins|vasopressins|mesh-list
44335165|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
44335166|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
44335167|NCT00995839|Coagulants|coagulants|mesh-ancestor
44335168|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44335169|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44335170|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
44335171|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335172|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44335174|NCT00995917|Vitamins|vitamins|mesh-ancestor
44335175|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
44335176|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335177|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44335178|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44335179|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335180|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
44335181|NCT00995917|Coagulants|coagulants|mesh-ancestor
44335182|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
44128081|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
44128082|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128083|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128084|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
44128085|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128086|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128087|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128105|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44128106|NCT00143195|Amlodipine|amlodipine|mesh-list
44128107|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128108|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128109|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128110|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128111|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128112|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128113|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
44128114|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
44128115|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
44335183|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44335184|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335185|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
44335186|NCT00996021|Dolutegravir|dolutegravir|mesh-list
44335187|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44335188|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335189|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335190|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44335191|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44335192|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335193|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335194|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335195|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44335196|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
44335197|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335198|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335199|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44335200|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44335201|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44335202|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44335203|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44335204|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44335205|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44335206|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
44335207|NCT00996060|Hydralazine|hydralazine|mesh-list
44335208|NCT00996060|Valproic Acid|valproic acid|mesh-list
44335209|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
44335210|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335211|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335212|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
44335213|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335214|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335215|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
44335225|NCT00996151|Testosterone|testosterone|mesh-list
44335226|NCT00996151|Androgens|androgens|mesh-ancestor
44335227|NCT00996151|Hormones|hormones|mesh-ancestor
44335228|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335229|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335230|NCT00996177|Fentanyl|fentanyl|mesh-list
44335231|NCT00996177|Morphine|morphine|mesh-list
44335232|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44335233|NCT00996177|Narcotics|narcotics|mesh-ancestor
44335234|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335235|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335236|NCT00996177|Analgesics|analgesics|mesh-ancestor
44335237|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
44335238|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335239|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44335240|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44335241|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
44335242|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
44335243|NCT00996190|Phenylephrine|phenylephrine|mesh-list
44335244|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
44335245|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44335246|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
44335247|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
44335248|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335249|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335250|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
44335251|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44335252|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
44335253|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335254|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44335255|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44335256|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44335257|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44335258|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335259|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335261|NCT00996229|Resveratrol|resveratrol|mesh-list
44335263|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335264|NCT00996229|Protective Agents|protective agents|mesh-ancestor
44335265|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335266|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335267|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44335268|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
44335269|NCT00996385|Bortezomib|bortezomib|mesh-list
44335270|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335271|NCT00996411|Salvinorin A|salvinorin a|mesh-list
44335272|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
44335273|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335274|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335275|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
44335276|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44335277|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
44335278|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335279|NCT00996424|Expectorants|expectorants|mesh-ancestor
44335280|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335281|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44335282|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
44335283|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128116|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44128117|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43572729|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
44128119|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128120|NCT00143221|Urological Agents|urological agents|mesh-ancestor
44128121|NCT00143234|Amlodipine|amlodipine|mesh-list
44128122|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44128123|NCT00143234|Atorvastatin|atorvastatin|mesh-list
44128124|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44128125|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128126|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
44128127|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128128|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128129|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44128130|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128131|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128132|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128133|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128134|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128135|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128136|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
44128137|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
44128138|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128139|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
44128140|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44128141|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44128145|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44128146|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44128147|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128148|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128149|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128150|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335284|NCT00996424|Protective Agents|protective agents|mesh-ancestor
44335285|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335286|NCT00996424|Antidotes|antidotes|mesh-ancestor
44335287|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44335288|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44335289|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44335290|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335291|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
44335292|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44335293|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
44335294|NCT00996515|Azacitidine|azacitidine|mesh-list
44335295|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44335296|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335297|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
44335298|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335299|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335300|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335301|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335302|NCT00996567|Cetuximab|cetuximab|mesh-list
44335303|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335304|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335305|NCT00996684|Plasminogen|plasminogen|mesh-list
44335306|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44335307|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44335308|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335309|NCT00996697|Budesonide|budesonide|mesh-list
44335310|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
44335311|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
44335312|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44335313|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335314|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44335315|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
44335316|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335317|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335324|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44335325|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44335326|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
44335327|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335328|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335329|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
44335330|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44335331|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
44335332|NCT00996723|Dasatinib|dasatinib|mesh-list
44335333|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335334|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335335|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335336|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990389|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
44335337|NCT00996762|Lapatinib|lapatinib|mesh-list
44335338|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335339|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335340|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335341|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335342|NCT00996788|Rebamipide|rebamipide|mesh-list
44335343|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44335344|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44335345|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
44335346|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335347|NCT00996788|Protective Agents|protective agents|mesh-ancestor
44335348|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335349|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335350|NCT00996866|Vitamin D|vitamin d|mesh-list
44335351|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
44335352|NCT00996866|Vitamins|vitamins|mesh-ancestor
44335353|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
44335354|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335355|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44335356|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335357|NCT00996879|Midazolam|midazolam|mesh-list
44335358|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44335359|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43745460|NCT02393859|Ifosfamide|ifosfamide|mesh-list
44335360|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335361|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335362|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44335363|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335364|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335365|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44335366|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
44335367|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
44335368|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
44335369|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
44335370|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335371|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335372|NCT00996983|Ziconotide|ziconotide|mesh-list
44335373|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44335374|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335375|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335376|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335377|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335378|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44335379|NCT00996983|Protective Agents|protective agents|mesh-ancestor
44335380|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335381|NCT00996983|Analgesics|analgesics|mesh-ancestor
44335382|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
44335383|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335384|NCT00997009|Paclitaxel|paclitaxel|mesh-list
44335385|NCT00997009|Carboplatin|carboplatin|mesh-list
44335386|NCT00997009|Cetuximab|cetuximab|mesh-list
44335387|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44335388|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335389|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335390|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335391|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335392|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335393|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335398|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335399|NCT00997061|Topotecan|topotecan|mesh-list
44335400|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44335401|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44335402|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335403|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335404|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335405|NCT00997074|Ibuprofen|ibuprofen|mesh-list
44335406|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44335407|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44335408|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335409|NCT00997074|Analgesics|analgesics|mesh-ancestor
44335410|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
44335411|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335412|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335413|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335414|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44335415|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335416|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335418|NCT00997087|Antidotes|antidotes|mesh-ancestor
44335419|NCT00997087|Protective Agents|protective agents|mesh-ancestor
44335420|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335421|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
44335422|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
43568309|NCT00657501|Hormones|hormones|mesh-ancestor
44128151|NCT00143299|Varenicline|varenicline|mesh-list
44128152|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44128153|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44128154|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128155|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128156|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128157|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128158|NCT00143325|Varenicline|varenicline|mesh-list
44128159|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44128160|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44128161|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128162|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128163|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128164|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128166|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44128167|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128168|NCT00143351|Ziprasidone|ziprasidone|mesh-list
44128169|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44128170|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
44128171|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128172|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128173|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128174|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44335424|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335425|NCT00997191|Triamcinolone|triamcinolone|mesh-list
44335426|NCT00997191|Bevacizumab|bevacizumab|mesh-list
44335427|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335428|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335429|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44335430|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44335431|NCT00997191|Growth Substances|growth substances|mesh-ancestor
44335432|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335433|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
44335434|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335435|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
44335436|NCT00997191|Hormones|hormones|mesh-ancestor
44335437|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335438|NCT00997269|Ubiquinone|ubiquinone|mesh-list
44335439|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
44335440|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
44335441|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335442|NCT00997269|Vitamins|vitamins|mesh-ancestor
44335443|NCT00997347|Misoprostol|misoprostol|mesh-list
44335444|NCT00997347|Mifepristone|mifepristone|mesh-list
44335445|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44335446|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
44335447|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335448|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335449|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44335450|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44335451|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
44335452|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44335453|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44335454|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44335455|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44335456|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
44335457|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43745568|NCT02233829|Dopamine|dopamine|mesh-list
44128175|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128176|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128177|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335458|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44335459|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
44335460|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335461|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
44335462|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44335463|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44335464|NCT00997399|Panobinostat|panobinostat|mesh-list
44335465|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335466|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44335467|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335468|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335469|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
44335470|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335471|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335472|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44335473|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
44335474|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335475|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335476|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335477|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335478|NCT00997477|Budesonide|budesonide|mesh-list
44335479|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
44335480|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335481|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44335482|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
44335483|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335484|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335503|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
44335504|NCT00997542|Protective Agents|protective agents|mesh-ancestor
44335505|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335506|NCT00997581|Apremilast|apremilast|mesh-list
44335507|NCT00997581|Indomethacin|indomethacin|mesh-list
44335508|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44335509|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335510|NCT00997581|Analgesics|analgesics|mesh-ancestor
44335511|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
44335512|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335513|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335514|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335515|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335516|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44335517|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44335518|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335519|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335520|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
44335521|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
44335522|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335523|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44335524|NCT00997607|Vaccines|vaccines|mesh-list
44335525|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
44335526|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335527|NCT00997659|Chromium|chromium|mesh-list
44335528|NCT00997659|Picolinic acid|picolinic acid|mesh-list
44335529|NCT00997659|Trace Elements|trace elements|mesh-ancestor
44335530|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
44128178|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44128179|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
44128180|NCT00143364|Varenicline|varenicline|mesh-list
44128181|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44128182|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44128183|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128184|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128185|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128186|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128187|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44128188|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44128189|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128190|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128192|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128193|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128194|NCT00143377|Urological Agents|urological agents|mesh-ancestor
44128195|NCT00143429|Latanoprost|latanoprost|mesh-list
44128196|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44335531|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335532|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44335533|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
44335534|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
44335535|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335536|NCT00997685|Capecitabine|capecitabine|mesh-list
44335537|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
44335538|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335539|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
44335540|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335541|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335542|NCT00997711|Sirolimus|sirolimus|mesh-list
44335543|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335544|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335545|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335546|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335547|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
44335548|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335549|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
44335550|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335551|NCT00997750|Lornoxicam|lornoxicam|mesh-list
44335552|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44335553|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335554|NCT00997750|Analgesics|analgesics|mesh-ancestor
44335555|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
44335556|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335557|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335558|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335559|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335560|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
44335571|NCT00997828|Everolimus|everolimus|mesh-list
44335574|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
44335575|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335576|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
44335577|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44335578|NCT00997880|Calcium|calcium|mesh-list
44335579|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335580|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335581|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44335582|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44335583|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44335584|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
44335585|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335586|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44335587|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44335588|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335589|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44335590|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
44335591|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335592|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
44335593|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335594|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335595|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44335596|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
44335597|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335598|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335599|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335600|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335601|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
44335602|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44128197|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44128198|NCT00143442|Reboxetine|reboxetine|mesh-list
44128199|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
44128200|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128201|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44128202|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44128203|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128204|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128205|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44128206|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128207|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128208|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44128209|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44335603|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335604|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335605|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44335606|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44335607|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335608|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335609|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335610|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44335611|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
44335612|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335613|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335614|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44335615|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44335616|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44335617|NCT00998036|Sirolimus|sirolimus|mesh-list
44335618|NCT00998036|Cisplatin|cisplatin|mesh-list
44335619|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44335620|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335621|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335622|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128210|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128211|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128212|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128213|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128231|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44128232|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128233|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44128235|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
44128236|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128237|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
44128238|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128239|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
44128240|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128241|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128242|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128243|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
44128244|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44128245|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128246|NCT00143676|Atorvastatin|atorvastatin|mesh-list
44128247|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44128248|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128249|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
44128250|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128251|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128252|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44128253|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128254|NCT00143689|Ritonavir|ritonavir|mesh-list
44128255|NCT00143689|Lopinavir|lopinavir|mesh-list
44128256|NCT00143689|Lamivudine|lamivudine|mesh-list
44128257|NCT00143689|Zidovudine|zidovudine|mesh-list
44128258|NCT00143689|Nevirapine|nevirapine|mesh-list
44128259|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44128260|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44335623|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335624|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335625|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335626|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335627|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
44335628|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335629|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
44335630|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335631|NCT00998075|Esomeprazole|esomeprazole|mesh-list
44335632|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335633|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335634|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44335635|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44335636|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44335637|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
44335638|NCT00998088|Hematinics|hematinics|mesh-ancestor
44335639|NCT00998101|Carboplatin|carboplatin|mesh-list
44335640|NCT00998101|Cetuximab|cetuximab|mesh-list
44335641|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335642|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335643|NCT00998166|Bevacizumab|bevacizumab|mesh-list
44335644|NCT00998166|Cisplatin|cisplatin|mesh-list
44335645|NCT00998166|Pemetrexed|pemetrexed|mesh-list
44335646|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335647|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335648|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44335649|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44335650|NCT00998166|Growth Substances|growth substances|mesh-ancestor
44335651|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335652|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
44335653|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335654|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335655|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44128261|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128262|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128263|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128264|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128265|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128266|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
44128267|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128268|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44335659|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44335660|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335661|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335662|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335663|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335664|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335665|NCT00998218|Ranolazine|ranolazine|mesh-list
44335666|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44335667|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335668|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335669|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44335670|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
44335671|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335672|NCT00998322|Gemcitabine|gemcitabine|mesh-list
44335673|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335674|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
44335675|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335676|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335677|NCT00998322|Antiviral Agents|antiviral agents|mesh-ancestor
44335678|NCT00998322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335679|NCT00998322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335680|NCT00998322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335681|NCT00998322|Immunologic Factors|immunologic factors|mesh-ancestor
44128269|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44128270|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128278|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128279|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128280|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128281|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128282|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
44128283|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128284|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128285|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128286|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
44128288|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
44128289|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128290|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44128291|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
44128292|NCT00143715|Vitamin K|vitamin k|mesh-list
44128293|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
44128294|NCT00143715|Vitamins|vitamins|mesh-ancestor
44128295|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
44335682|NCT00998322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335684|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44335685|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335686|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335687|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335688|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335689|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335690|NCT00998504|Resveratrol|resveratrol|mesh-list
44335691|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
44335692|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335693|NCT00998504|Protective Agents|protective agents|mesh-ancestor
44335694|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335695|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335696|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44335697|NCT00998556|Bromocriptine|bromocriptine|mesh-list
44335737|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335738|NCT00998816|Pregabalin|pregabalin|mesh-list
44335739|NCT00998816|Analgesics|analgesics|mesh-ancestor
44335740|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
44335741|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335742|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335743|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
44335744|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44335745|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335746|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335747|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44335748|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44335749|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44335750|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335751|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44335753|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
44335754|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44335755|NCT00998920|Estrogens|estrogens|mesh-ancestor
44335756|NCT00998920|Hormones|hormones|mesh-ancestor
44335757|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335758|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335759|NCT00998933|Testosterone|testosterone|mesh-list
44335760|NCT00998933|Androgens|androgens|mesh-ancestor
44335761|NCT00998933|Hormones|hormones|mesh-ancestor
44335762|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335763|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335764|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
44335765|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44335766|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
44335767|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335768|NCT00998972|Expectorants|expectorants|mesh-ancestor
44128296|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128297|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44128298|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44128299|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128300|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
44128301|NCT00143715|Coagulants|coagulants|mesh-ancestor
44128302|NCT00143728|Lamivudine|lamivudine|mesh-list
44128303|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128304|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128305|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128306|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335769|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335770|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44335771|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
44335772|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335773|NCT00998972|Protective Agents|protective agents|mesh-ancestor
44335774|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335775|NCT00998972|Antidotes|antidotes|mesh-ancestor
44335776|NCT00999128|Rabeprazole|rabeprazole|mesh-list
44335777|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44335778|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44335779|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44335780|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335781|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335782|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
44335783|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44335784|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44335785|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44335786|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335787|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335788|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
44335789|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335790|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335791|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44335792|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335793|NCT00999206|Vaccines|vaccines|mesh-list
44335794|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
44335795|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335796|NCT00999219|Zolpidem|zolpidem|mesh-list
44335797|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44335813|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44335814|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335815|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335816|NCT00999258|Sirolimus|sirolimus|mesh-list
44335817|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44335818|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335819|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335820|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335821|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
44335822|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335823|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
44335824|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335825|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44335826|NCT00999271|Hormones|hormones|mesh-list
44335827|NCT00999271|Incretins|incretins|mesh-list
44335828|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335829|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335830|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44335831|NCT00999297|Capsaicin|capsaicin|mesh-list
44335832|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
44335833|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
44335834|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
44335835|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335836|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335837|NCT00999336|Betrixaban|betrixaban|mesh-list
44335838|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44335839|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
44335840|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44335841|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44335842|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335843|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335844|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
44335845|NCT00999349|Silymarin|silymarin|mesh-list
44335846|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
44335847|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335848|NCT00999349|Protective Agents|protective agents|mesh-ancestor
43745909|NCT01856192|Prednisone|prednisone|mesh-list
44335850|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
44335851|NCT00999427|Povidone|povidone|mesh-list
44335852|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
44335853|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
44335854|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44335855|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335856|NCT00999440|Methadone|methadone|mesh-list
44335857|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44335858|NCT00999440|Narcotics|narcotics|mesh-ancestor
44335859|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44335860|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335861|NCT00999440|Analgesics|analgesics|mesh-ancestor
44335862|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
44335863|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335864|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
44335865|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335866|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
44335867|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44335868|NCT00999479|Norethindrone|norethindrone|mesh-list
44335869|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
44335870|NCT00999479|Estradiol|estradiol|mesh-list
44335871|NCT00999479|Estrogens|estrogens|mesh-ancestor
44335872|NCT00999479|Hormones|hormones|mesh-ancestor
44335873|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44335874|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335875|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44335876|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
44335877|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44335878|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44335879|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44335880|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44335881|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44335882|NCT00999479|Trace Elements|trace elements|mesh-ancestor
44335883|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
44335884|NCT00999505|Amantadine|amantadine|mesh-list
44335885|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44335886|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44335887|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
43745948|NCT01758328|Melphalan|melphalan|mesh-list
44335888|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335889|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
44335890|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335891|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335892|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335893|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335894|NCT00999505|Analgesics|analgesics|mesh-ancestor
44335895|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
44335896|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335897|NCT00999557|Bimatoprost|bimatoprost|mesh-list
44335898|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44335899|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44335900|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44335901|NCT00999700|Cisplatin|cisplatin|mesh-list
44335902|NCT00999700|Docetaxel|docetaxel|mesh-list
44335903|NCT00999700|Fluorouracil|fluorouracil|mesh-list
44335904|NCT00999700|Cetuximab|cetuximab|mesh-list
44335905|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335906|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44335907|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44335908|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44335909|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335910|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
44335911|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44335912|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335913|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
44128307|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
44128308|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128309|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128310|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128311|NCT00143741|Atorvastatin|atorvastatin|mesh-list
44128312|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44128313|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128314|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
44128315|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128316|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128317|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44128318|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128319|NCT00143780|Vaccines|vaccines|mesh-list
44128320|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
44128321|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128322|NCT00143806|Cyclosporine|cyclosporine|mesh-list
44128323|NCT00143806|Alefacept|alefacept|mesh-list
44128324|NCT00143806|Cyclosporins|cyclosporins|mesh-list
44128325|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128326|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128327|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44128328|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
44128329|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128330|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
44128331|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44335914|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335915|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335916|NCT00999739|Vaccines|vaccines|mesh-list
44335917|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44335918|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
44335919|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335920|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44335921|NCT00999752|Nebivolol|nebivolol|mesh-list
44335922|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44335923|NCT00999752|Diuretics|diuretics|mesh-ancestor
44335924|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
44335925|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335926|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44335927|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335928|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335929|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
44335930|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44335931|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44335932|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44335933|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
44335934|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335935|NCT00999791|Diclofenac|diclofenac|mesh-list
44335936|NCT00999791|Bevacizumab|bevacizumab|mesh-list
44335937|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44335938|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335939|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44335940|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44335941|NCT00999791|Growth Substances|growth substances|mesh-ancestor
44335942|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335943|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
44335944|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44335945|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44335946|NCT00999791|Analgesics|analgesics|mesh-ancestor
44335947|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
44335948|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128332|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44128334|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44128335|NCT00143871|Rituximab|rituximab|mesh-list
44335950|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44335951|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44335952|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335953|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335954|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
44335955|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
44335956|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
44335957|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44335958|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44335959|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335960|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335961|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335962|NCT00999843|Sorafenib|sorafenib|mesh-list
44335963|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335964|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44335965|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335966|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335967|NCT00999869|Triamcinolone|triamcinolone|mesh-list
44335969|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44335970|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
44335971|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44335972|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44128336|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44128337|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128338|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
44128339|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128340|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44128341|NCT00143949|Losartan|losartan|mesh-list
44128359|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128360|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846416|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128361|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
44128362|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128363|NCT00143975|Analgesics|analgesics|mesh-ancestor
44128364|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
44128365|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128366|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44128367|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128368|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128369|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155074|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44155075|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44155076|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44155077|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155078|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155079|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155080|NCT00226096|Analgesics|analgesics|mesh-ancestor
44155081|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
43702169|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335974|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44335975|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44335976|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335977|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
44335978|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44335979|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44335980|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44335981|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
44335982|NCT00999869|Hormones|hormones|mesh-ancestor
44335983|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155082|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44155083|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44155084|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44155085|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
44155086|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44155087|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44155088|NCT00226096|Protective Agents|protective agents|mesh-ancestor
44155089|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
44155090|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44155091|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44155092|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44155093|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155094|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44155095|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44155096|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
44155097|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44155098|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
44155099|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155100|NCT00226109|Spironolactone|spironolactone|mesh-list
44155101|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44128373|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
44128374|NCT00144053|Paclitaxel|paclitaxel|mesh-list
44128375|NCT00144053|Vindesine|vindesine|mesh-list
44128376|NCT00144053|Cisplatin|cisplatin|mesh-list
44128377|NCT00144053|Carboplatin|carboplatin|mesh-list
44128378|NCT00144053|Irinotecan|irinotecan|mesh-list
44128379|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43573038|NCT03530280|Analgesics|analgesics|mesh-ancestor
44128380|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128381|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44128382|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44128383|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44128384|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128385|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44128386|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128387|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128389|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128390|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44128391|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128392|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128393|NCT00144118|Sevoflurane|sevoflurane|mesh-list
44128394|NCT00144118|Isoflurane|isoflurane|mesh-list
44128395|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44128396|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44128397|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
44128398|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
44128399|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128400|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128401|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
44128402|NCT00144131|Hematinics|hematinics|mesh-ancestor
44128403|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
44128404|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
44335984|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335985|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
44335986|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335987|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44335988|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44335989|NCT00999973|Mitomycins|mitomycins|mesh-list
44335990|NCT00999973|Mitomycin|mitomycin|mesh-list
44335991|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44335992|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44335993|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
44335994|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44335995|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43746032|NCT01339910|Vidarabine|vidarabine|mesh-list
44128405|NCT00144144|Giapreza|giapreza|mesh-list
44128406|NCT00144144|Calcium|calcium|mesh-list
44128407|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
44128408|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44128409|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128410|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128411|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44128412|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44128413|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128414|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128415|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128416|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128417|NCT00144157|Zidovudine|zidovudine|mesh-list
44128418|NCT00144157|Nevirapine|nevirapine|mesh-list
44128419|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
44128420|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128421|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128422|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128423|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128424|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
44128425|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128426|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128427|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128428|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128458|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44128459|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44128460|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
44128461|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128462|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128463|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128464|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
44128465|NCT00144209|Protective Agents|protective agents|mesh-ancestor
44128466|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
44128467|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128468|NCT00144222|Telmisartan|telmisartan|mesh-list
44128469|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128470|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44128471|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44128472|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128473|NCT00144248|Nevirapine|nevirapine|mesh-list
44128477|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128478|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
44128479|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128480|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128481|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128482|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128483|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128484|NCT00144261|Nevirapine|nevirapine|mesh-list
43702170|NCT02719405|Caseins|caseins|mesh-list
44335996|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44335997|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
44335998|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44335999|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
44336000|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336001|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336002|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336003|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
44336004|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336005|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336006|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336007|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44336008|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
44336009|NCT01000116|Coagulants|coagulants|mesh-ancestor
44336010|NCT01000220|Omeprazole|omeprazole|mesh-list
44336011|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44336012|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336013|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44336014|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336015|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336016|NCT01000233|Inositol|inositol|mesh-list
44336017|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
44128485|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128486|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128487|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128488|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128489|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
44128490|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128491|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128492|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128493|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128494|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128495|NCT00144274|Ambroxol|ambroxol|mesh-list
44128496|NCT00144274|Expectorants|expectorants|mesh-ancestor
44128497|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
44128498|NCT00144287|Ritonavir|ritonavir|mesh-list
44128499|NCT00144287|Tipranavir|tipranavir|mesh-list
44128500|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44128501|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44128502|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128503|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128504|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128505|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128506|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128507|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
44128508|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128509|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44128510|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44128511|NCT00144326|Bromides|bromides|mesh-list
44128512|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
44128513|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44128514|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
44128515|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128516|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336018|NCT01000233|Vitamins|vitamins|mesh-ancestor
44336019|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
44336020|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336021|NCT01000298|Amoxicillin|amoxicillin|mesh-list
44336022|NCT01000298|Cefdinir|cefdinir|mesh-list
44336023|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44336024|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336025|NCT01000415|Cisplatin|cisplatin|mesh-list
44336026|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336027|NCT01000441|Adalimumab|adalimumab|mesh-list
44336028|NCT01000441|Etanercept|etanercept|mesh-list
44336029|NCT01000441|Rituximab|rituximab|mesh-list
44336030|NCT01000441|Abatacept|abatacept|mesh-list
44336031|NCT01000441|Infliximab|infliximab|mesh-list
44336032|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44336033|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336034|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
44336035|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336036|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336037|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336038|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336039|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336040|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44336041|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43991113|NCT02467504|Vitamins|vitamins|mesh-ancestor
44336042|NCT01000441|Analgesics|analgesics|mesh-ancestor
44336043|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
44336045|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336046|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44336047|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336048|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44336049|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
44336050|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44336051|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
44336052|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336053|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44336054|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43746068|NCT01261728|Gemcitabine|gemcitabine|mesh-list
44128517|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44128518|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
44336055|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44336056|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336057|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336058|NCT01000597|Fluticasone|fluticasone|mesh-list
44336059|NCT01000597|Xhance|xhance|mesh-list
44336060|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336061|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44336062|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
44336063|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336064|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336065|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44336066|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
44336067|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336068|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44336069|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44336070|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44336071|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44336072|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44336073|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336074|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336075|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336076|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44336077|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
44336078|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44336079|NCT01000688|Vildagliptin|vildagliptin|mesh-list
44336080|NCT01000688|Acarbose|acarbose|mesh-list
44336081|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336082|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336083|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44336084|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44336085|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336088|NCT01000779|Propranolol|propranolol|mesh-list
44336094|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336095|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44336096|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44336097|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
44336098|NCT01000792|Cetirizine|cetirizine|mesh-list
44336099|NCT01000792|Levocetirizine|levocetirizine|mesh-list
44336100|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44336101|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44336102|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
44336103|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
44336104|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336105|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336106|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336107|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44336108|NCT01000831|Vaccines|vaccines|mesh-list
44336109|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
44336110|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336111|NCT01000857|Paroxetine|paroxetine|mesh-list
44336112|NCT01000857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44336113|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44336114|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43991194|NCT02471521|Rocuronium|rocuronium|mesh-list
44336115|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336116|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336117|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
44336118|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336119|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44336120|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
44336121|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44336122|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44336123|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44336124|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336125|NCT01000896|Paclitaxel|paclitaxel|mesh-list
44336126|NCT01000896|Carboplatin|carboplatin|mesh-list
44336127|NCT01000896|Saracatinib|saracatinib|mesh-list
44336128|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44336131|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336132|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336133|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336134|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336135|NCT01001013|Pioglitazone|pioglitazone|mesh-list
44336136|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336137|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336138|NCT01001130|Fluticasone|fluticasone|mesh-list
44336139|NCT01001130|Xhance|xhance|mesh-list
44336140|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336141|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44336142|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
44336143|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336144|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336145|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44336146|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
44336147|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336148|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44336149|NCT01001143|Decitabine|decitabine|mesh-list
44336150|NCT01001143|Bexarotene|bexarotene|mesh-list
44336151|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44336152|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
44336153|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336154|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336155|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336156|NCT01001247|Rilpivirine|rilpivirine|mesh-list
44128519|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
44128520|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128521|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128522|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128523|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128524|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
44128525|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
44128526|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
43573191|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
44128527|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44128528|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
44128529|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44128530|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44128531|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128532|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44128533|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128534|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128535|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44128536|NCT00144352|Renal Agents|renal agents|mesh-ancestor
44128537|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44128538|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
44128539|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336159|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336160|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44336161|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336162|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336163|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44336164|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44336165|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
44336166|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336167|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44336168|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44336169|NCT01001260|Aspirin|aspirin|mesh-list
44336170|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44336171|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44336172|NCT01001260|Analgesics|analgesics|mesh-ancestor
44128540|NCT00144378|Irinotecan|irinotecan|mesh-list
44128541|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44128542|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128543|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128556|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128558|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44128559|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
44128560|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
44128561|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128562|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44128563|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128564|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44128565|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44128566|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44128567|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128568|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44128569|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128570|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
44128571|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128572|NCT00144430|Pentostatin|pentostatin|mesh-list
44128573|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128574|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44128575|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128576|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128577|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
44128578|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44128579|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
44128580|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44128581|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128582|NCT00144456|Vitamins|vitamins|mesh-ancestor
44128583|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
44128584|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44128585|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
44128586|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128587|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
44128588|NCT00144482|Hematinics|hematinics|mesh-ancestor
44128589|NCT05595109|Silymarin|silymarin|mesh-list
44128590|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
44128591|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128592|NCT05595109|Protective Agents|protective agents|mesh-ancestor
44128593|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336175|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336176|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336177|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336178|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44336179|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44336180|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336181|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44336182|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44336183|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336184|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
44336185|NCT01001364|Budesonide|budesonide|mesh-list
44336186|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
44336187|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336188|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44336189|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
44336190|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336191|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336192|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44336193|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
44336194|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
44336195|NCT01001364|Hormones|hormones|mesh-ancestor
44336196|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336197|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44336198|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44128594|NCT05595096|Anesthetics|anesthetics|mesh-list
44128595|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128596|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128597|NCT05595044|Vitamin D|vitamin d|mesh-list
44128598|NCT05595044|Vitamins|vitamins|mesh-ancestor
44128599|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
44128600|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128601|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44128602|NCT05594849|Budesonide|budesonide|mesh-list
44128603|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44128604|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44128605|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
44128606|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128623|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44128624|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
44128625|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
44128626|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
44128627|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128628|NCT05594745|Lifitegrast|lifitegrast|mesh-list
44336199|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44336200|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336201|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336202|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336204|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44336205|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44336206|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
44336207|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
44336208|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128629|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44128630|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44128631|NCT05594667|Psilocybin|psilocybin|mesh-list
44128632|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
44128633|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128634|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128635|NCT05594615|Midazolam|midazolam|mesh-list
44128636|NCT05594615|Caffeine|caffeine|mesh-list
44128637|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44128638|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44128639|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44128640|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128641|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128642|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44128643|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128644|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128645|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44128646|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
44128647|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
44128648|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
44128649|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
44128650|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128651|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128652|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44128653|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128654|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
44128655|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128656|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44128657|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128658|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44128659|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44128660|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44128661|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44128662|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
44128663|NCT05594602|Itraconazole|itraconazole|mesh-list
44128664|NCT05594602|Quinidine|quinidine|mesh-list
44128665|NCT05594602|Carbamazepine|carbamazepine|mesh-list
44128666|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
44128674|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128675|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128676|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44128677|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
44128678|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
44128679|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128680|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128681|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128682|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44128683|NCT05594602|Analgesics|analgesics|mesh-ancestor
44128684|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
44128685|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128686|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44128687|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128688|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128689|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128690|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44336209|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336210|NCT01001624|Hydroquinone|hydroquinone|mesh-list
44336211|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
44336212|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336213|NCT01001624|Protective Agents|protective agents|mesh-ancestor
44336214|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128691|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44128692|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
44128693|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128694|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44128695|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
44128696|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44128697|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44128698|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44128699|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128700|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128701|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44128702|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44128703|NCT05594563|Eflornithine|eflornithine|mesh-list
44128704|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128705|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44128706|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44128707|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44128708|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128709|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44128710|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128711|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128713|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128714|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
44128715|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128716|NCT05594433|Lenograstim|lenograstim|mesh-list
44128717|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44128718|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
44128719|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128720|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
44128721|NCT05594381|Tegafur|tegafur|mesh-list
44128722|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128723|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44128724|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
44128725|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128726|NCT05594342|Dobutamine|dobutamine|mesh-list
44128727|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44128728|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
44128729|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
44128741|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
44128742|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
44128743|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44128744|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44128745|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44128746|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128747|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
44128748|NCT05594186|Coagulants|coagulants|mesh-ancestor
44128749|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44128750|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128751|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44128752|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44128753|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44128755|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44128756|NCT05594121|Narcotics|narcotics|mesh-ancestor
44128757|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128758|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128759|NCT05594121|Analgesics|analgesics|mesh-ancestor
44128760|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
44128761|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128762|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44128763|NCT05594082|Trastuzumab|trastuzumab|mesh-list
44128764|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44128765|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155109|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155110|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155111|NCT00226122|Analgesics|analgesics|mesh-ancestor
44155112|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
44155113|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155114|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155115|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155116|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155117|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
44155118|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
44155119|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44155120|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44155121|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336278|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336279|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336280|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44336281|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336282|NCT01002079|Rifampin|rifampin|mesh-list
44336283|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44336284|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
44336285|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44336286|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336287|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
44336288|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44336289|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336290|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336291|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44336292|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44336293|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44336294|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44336295|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44336296|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44336297|NCT01002092|Endostar protein|endostar protein|mesh-list
44336298|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44336299|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44336300|NCT01002092|Growth Substances|growth substances|mesh-ancestor
44155122|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155123|NCT00226135|Lamotrigine|lamotrigine|mesh-list
44155124|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155125|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155126|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155127|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155128|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155129|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
44155130|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44155131|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155132|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44155133|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44155134|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44155148|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155149|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155150|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44155151|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44155152|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
44155153|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44155154|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44155155|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44155156|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44336301|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336302|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44336303|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991370|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
44336304|NCT01002157|Vitamin K|vitamin k|mesh-list
44336305|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
44336306|NCT01002157|Vitamin MK 7|vitamin mk 7|mesh-list
44336307|NCT01002157|Vitamins|vitamins|mesh-ancestor
44336308|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
44336309|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336310|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44336311|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44336312|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336313|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
44336314|NCT01002157|Coagulants|coagulants|mesh-ancestor
44336315|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
44336316|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44336317|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336318|NCT01002300|Oxytocin|oxytocin|mesh-list
44336319|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
44336320|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44336321|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336322|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43599546|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
44336323|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
44336324|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44155157|NCT00226330|Pioglitazone|pioglitazone|mesh-list
44155158|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155159|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155160|NCT00226343|Valproic Acid|valproic acid|mesh-list
44155161|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
44128766|NCT05594017|Scopolamine|scopolamine|mesh-list
44128767|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44128768|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44128769|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
44128770|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
44128771|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128772|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128773|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44128775|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128776|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128777|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128778|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128779|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44128780|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
44128781|NCT05593939|Niacinamide|niacinamide|mesh-list
44128783|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
44128784|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
44128785|NCT05593939|Vitamins|vitamins|mesh-ancestor
44128786|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
44128787|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128788|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44128789|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
44128790|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702171|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
44336325|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44336326|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336327|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336328|NCT01002534|Urological Agents|urological agents|mesh-ancestor
44336329|NCT01002690|Etoricoxib|etoricoxib|mesh-list
44336330|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44336331|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44336332|NCT01002690|Analgesics|analgesics|mesh-ancestor
44336333|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
44336334|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336335|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336336|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336337|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336338|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44336339|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44336340|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336341|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336342|NCT01002703|Prednisone|prednisone|mesh-list
44336343|NCT01002703|Lenalidomide|lenalidomide|mesh-list
44336344|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44336345|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336346|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
44336347|NCT01002703|Hormones|hormones|mesh-ancestor
44336348|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336349|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336350|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44336351|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336352|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
44336353|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44336354|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44336355|NCT01002703|Growth Substances|growth substances|mesh-ancestor
44336356|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44128791|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128792|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
44128793|NCT05591144|Prednisone|prednisone|mesh-list
44128794|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44128795|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
44128796|NCT05591144|Hormones|hormones|mesh-ancestor
44128797|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128798|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336357|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336358|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
43839890|NCT04745949|Hormones|hormones|mesh-ancestor
44336359|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336360|NCT01002729|Oseltamivir|oseltamivir|mesh-list
44336361|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
44336362|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336363|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336364|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336365|NCT01002768|Insulin|insulin|mesh-list
44336366|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44336367|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
44336368|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336369|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336370|NCT01002807|Metformin|metformin|mesh-list
44336371|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
44336372|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336373|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336374|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44336375|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336376|NCT01002898|Ritonavir|ritonavir|mesh-list
44336377|NCT01002898|Lopinavir|lopinavir|mesh-list
44336378|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44336379|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44336380|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
44336381|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336382|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336383|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44336384|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44336385|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
44336386|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336387|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44336388|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44336389|NCT01002911|Cefazolin|cefazolin|mesh-list
44336390|NCT01002911|Cephalexin|cephalexin|mesh-list
44336391|NCT01002911|Bacitracin|bacitracin|mesh-list
44336392|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44128799|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44128800|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128801|NCT05589753|Acetazolamide|acetazolamide|mesh-list
44336393|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336394|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44336396|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44336397|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44336398|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
44336399|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336400|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336401|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336402|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
44336403|NCT01003054|Busulfan|busulfan|mesh-list
44336404|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
44336405|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336406|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
44336407|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336408|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336409|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336410|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
44336411|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746378|NCT00406393|Sirolimus|sirolimus|mesh-list
44128802|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
44128803|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44128816|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128817|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44128818|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44128819|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44128820|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
43599555|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
44128821|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44128822|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44128823|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44128824|NCT05569512|Fludarabine|fludarabine|mesh-list
44128825|NCT05569512|Busulfan|busulfan|mesh-list
44128826|NCT05569512|Clofarabine|clofarabine|mesh-list
44128827|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128828|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44128829|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
44128830|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128831|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44128832|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
44128833|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128834|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
44128835|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44128836|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44128837|NCT05564598|Valganciclovir|valganciclovir|mesh-list
44128838|NCT05564598|Ganciclovir|ganciclovir|mesh-list
44128839|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
44128840|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128841|NCT05553678|Midazolam|midazolam|mesh-list
44128842|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44128843|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44128844|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128845|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128846|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44128847|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128848|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44336412|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336413|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336414|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336415|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336416|NCT01003158|Paclitaxel|paclitaxel|mesh-list
44336417|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44336418|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336419|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336420|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336421|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336422|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336423|NCT01003314|Vaccines|vaccines|mesh-list
44336424|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
44336425|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336426|NCT01003483|Orlistat|orlistat|mesh-list
44336427|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336428|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336429|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44336430|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44128850|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
44128851|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
44128852|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
44128853|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
44128854|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128855|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128856|NCT05536362|Clonidine|clonidine|mesh-list
44128857|NCT05536362|Ketamine|ketamine|mesh-list
44128858|NCT05536362|Propofol|propofol|mesh-list
44128859|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44128860|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128861|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128862|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44128863|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
44128864|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
44128865|NCT05536362|Analgesics|analgesics|mesh-ancestor
44128866|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
44128867|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128868|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44128869|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44128874|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
44128875|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
44128876|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44128877|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44128878|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44128879|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
44128880|NCT05507645|Saruplase|saruplase|mesh-list
44128881|NCT05507645|Anticoagulants|anticoagulants|mesh-list
44128882|NCT05507645|Clopidogrel|clopidogrel|mesh-list
44128883|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128884|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44128885|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44128886|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128887|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44128888|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44128889|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44128890|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44336431|NCT01003522|Anesthetics|anesthetics|mesh-list
44336432|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
44336433|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336434|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336435|NCT01003561|Anesthetics|anesthetics|mesh-list
44336436|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336437|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336438|NCT01003613|Tranilast|tranilast|mesh-list
44336439|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44336440|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44336441|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44336442|NCT01003613|Analgesics|analgesics|mesh-ancestor
44336443|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
44336444|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336445|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336446|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336447|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336448|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44336449|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44336450|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336451|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336452|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44336453|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
44336454|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
44336455|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336456|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44336457|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44336458|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
44336459|NCT01003613|Coagulants|coagulants|mesh-ancestor
44336460|NCT01003678|Clofarabine|clofarabine|mesh-list
44336461|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44336462|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
44336473|NCT01004068|Enclomiphene|enclomiphene|mesh-list
44336474|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
44336475|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44336476|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
44336477|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336478|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336479|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44336480|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
44336481|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44336482|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44336483|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44336484|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44336485|NCT01004224|Infigratinib|infigratinib|mesh-list
44336486|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336487|NCT01004237|Valsartan|valsartan|mesh-list
44336488|NCT01004237|Pravastatin|pravastatin|mesh-list
44336489|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44336490|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44336491|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44336492|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336493|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44336494|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44336495|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
44336496|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44336497|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44336498|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336499|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44336500|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44336501|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44336502|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44336503|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336504|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336505|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336507|NCT01004380|Carboplatin|carboplatin|mesh-list
44336511|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44336512|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336513|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44336514|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44336515|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
44336516|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336517|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336518|NCT01004445|Amikacin|amikacin|mesh-list
44336519|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44336520|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336521|NCT01004497|Cytarabine|cytarabine|mesh-list
44336522|NCT01004497|Dexamethasone|dexamethasone|mesh-list
44336523|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
44336524|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
44336525|NCT01004497|Vincristine|vincristine|mesh-list
44336526|NCT01004497|Daunorubicin|daunorubicin|mesh-list
44336527|NCT01004497|Dasatinib|dasatinib|mesh-list
44336528|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
44336529|NCT01004497|BB 1101|bb 1101|mesh-list
44336530|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336531|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
44336532|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336533|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336534|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336535|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
44336536|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336559|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44336560|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44336561|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336563|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
44336564|NCT01004575|Cobalt|cobalt|mesh-list
44336565|NCT01004575|Chromium|chromium|mesh-list
44336566|NCT01004575|Trace Elements|trace elements|mesh-ancestor
44336567|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
44336568|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336569|NCT01004601|Docetaxel|docetaxel|mesh-list
44336570|NCT01004601|Pemetrexed|pemetrexed|mesh-list
44336571|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336572|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336573|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336574|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336575|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336576|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336577|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44336578|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128891|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
44128892|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128893|NCT05497310|Tretinoin|tretinoin|mesh-list
44128894|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
44128895|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128896|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
44128897|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44128898|NCT05483634|Estrogens|estrogens|mesh-list
44128899|NCT05483634|Hormones|hormones|mesh-ancestor
44128900|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128901|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128902|NCT05468671|Remifentanil|remifentanil|mesh-list
44128903|NCT05468671|Oxycodone|oxycodone|mesh-list
44128904|NCT05468671|Propofol|propofol|mesh-list
44128905|NCT05468671|Rocuronium|rocuronium|mesh-list
44128906|NCT05468671|Flumazenil|flumazenil|mesh-list
44128907|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44128908|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128909|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128910|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44128911|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
44128912|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
44128913|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44128914|NCT05468671|Narcotics|narcotics|mesh-ancestor
44128915|NCT05468671|Analgesics|analgesics|mesh-ancestor
44128916|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
44128917|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128918|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44128919|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44128920|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44128921|NCT05468671|Antidotes|antidotes|mesh-ancestor
44128922|NCT05468671|Protective Agents|protective agents|mesh-ancestor
44128923|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
44128924|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
44128925|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128926|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128927|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
44128929|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44128930|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336579|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
44336580|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336581|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
44336582|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
44336583|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336584|NCT01004731|Gemcitabine|gemcitabine|mesh-list
44336585|NCT01004731|Carboplatin|carboplatin|mesh-list
44336586|NCT01004731|Cetuximab|cetuximab|mesh-list
44336587|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336588|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44336589|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
44336590|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336591|NCT01004731|Antiviral Agents|antiviral agents|mesh-ancestor
44336592|NCT01004731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336593|NCT01004731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336594|NCT01004731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336595|NCT01004731|Immunologic Factors|immunologic factors|mesh-ancestor
44336596|NCT01004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336597|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44336598|NCT01004809|Dutasteride|dutasteride|mesh-list
44336599|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44336600|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44336601|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336602|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336603|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44336604|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336605|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336606|NCT01004900|Timolol|timolol|mesh-list
44336607|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44336608|NCT01004900|Travoprost|travoprost|mesh-list
44336609|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44336610|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44336611|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336612|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128931|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44128932|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128933|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128934|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128935|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
44128936|NCT05461807|Apixaban|apixaban|mesh-list
44128937|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44336613|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336614|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336615|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44336616|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44336617|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43599606|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44336618|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44336619|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44336620|NCT01005095|Vitamin D|vitamin d|mesh-list
44336621|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
44336622|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
44336623|NCT01005095|Vitamins|vitamins|mesh-list
44336624|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
44336625|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336626|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44336627|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336628|NCT01005121|Colchicine|colchicine|mesh-list
44336629|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
44336630|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336631|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336632|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336633|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336634|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336635|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336636|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
44336637|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44336638|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44336639|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336640|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
44336641|NCT01005147|Coagulants|coagulants|mesh-ancestor
44128938|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
44128939|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44128940|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128941|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128942|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128946|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44128947|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44128948|NCT05436678|Analgesics|analgesics|mesh-ancestor
44128949|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
44128950|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128951|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128952|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44128953|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44128954|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44128955|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44128956|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336642|NCT01005160|Metformin|metformin|mesh-list
44336643|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336644|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336645|NCT01005199|Everolimus|everolimus|mesh-list
44336646|NCT01005199|Sorafenib|sorafenib|mesh-list
44336647|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336648|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336649|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
44336650|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336651|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336652|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336653|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336654|NCT01005238|Lamivudine|lamivudine|mesh-list
44336655|NCT01005238|Telbivudine|telbivudine|mesh-list
44336656|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44336657|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44336658|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336659|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336660|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
44336661|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336662|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44336663|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44336664|NCT01005303|Vitamin D|vitamin d|mesh-list
44336665|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
44336666|NCT01005303|Vitamins|vitamins|mesh-ancestor
44336667|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
43746575|NCT02523859|Propofol|propofol|mesh-list
44128957|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128958|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44128959|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128960|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43599612|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128961|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128962|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128963|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44128964|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44128965|NCT05425979|Bupivacaine|bupivacaine|mesh-list
44128966|NCT05425979|Mepivacaine|mepivacaine|mesh-list
44128967|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
44128968|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
44128969|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128970|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128971|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
44128972|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128973|NCT05391893|Diltiazem|diltiazem|mesh-list
44128974|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128975|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44128976|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44128977|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128978|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336668|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336669|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44336670|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336671|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
44336672|NCT01005381|Vitamin D|vitamin d|mesh-list
44336673|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
44336674|NCT01005381|Calcium|calcium|mesh-list
44336675|NCT01005381|Vitamins|vitamins|mesh-ancestor
44336676|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
44336677|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336678|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336679|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44336680|NCT01005381|Antacids|antacids|mesh-ancestor
44336681|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336682|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336683|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
44336684|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44336685|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336686|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336687|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44336688|NCT01005433|Analgesics|analgesics|mesh-ancestor
44336689|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
44336690|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128979|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128980|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
44128981|NCT05378906|Darunavir|darunavir|mesh-list
44128982|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44128983|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44128984|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128985|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128986|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128987|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128988|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128989|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
44128990|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128991|NCT05374525|Cabotegravir|cabotegravir|mesh-list
44128992|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44128993|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44128994|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128995|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128996|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128997|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128998|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
44128999|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155163|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155164|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
44155165|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155166|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155167|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
44155168|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155169|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336691|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44336692|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44336694|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336695|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336696|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155170|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155171|NCT00226356|Betaine|betaine|mesh-list
44155172|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155173|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
44155174|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44155175|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
44155176|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155177|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44155194|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155195|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44155197|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
44155198|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
44155199|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155200|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
44155201|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155202|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
44155203|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155204|NCT00226421|Oxymorphone|oxymorphone|mesh-list
44155205|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44155206|NCT00226421|Narcotics|narcotics|mesh-ancestor
44155207|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155208|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155209|NCT00226421|Analgesics|analgesics|mesh-ancestor
44155210|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
44155211|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155212|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44155213|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44155214|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
44155215|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155216|NCT00226447|Interferons|interferons|mesh-list
44155217|NCT00226447|Lamivudine|lamivudine|mesh-list
44155218|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155219|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
44155220|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155221|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44155222|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44155223|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155224|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155225|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44155226|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44155227|NCT00226473|Cisplatin|cisplatin|mesh-list
44155228|NCT00226473|Dacarbazine|dacarbazine|mesh-list
44155229|NCT00226473|Vindesine|vindesine|mesh-list
44155230|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155231|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44155232|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
44158192|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129000|NCT05367336|Fentanyl|fentanyl|mesh-list
44129001|NCT05367336|Morphine|morphine|mesh-list
44129002|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44129003|NCT05367336|Narcotics|narcotics|mesh-ancestor
44129004|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129030|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129031|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
44129032|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129033|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44129034|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44129035|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44129036|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129037|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129038|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
44336697|NCT01005472|Temozolomide|temozolomide|mesh-list
44336698|NCT01005472|Sunitinib|sunitinib|mesh-list
44336699|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336700|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
44336701|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336702|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336703|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44336704|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44336705|NCT01005472|Growth Substances|growth substances|mesh-ancestor
44336706|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746624|NCT02523300|Hormones|hormones|mesh-ancestor
44129039|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129040|NCT05330871|Vaccines|vaccines|mesh-list
44129041|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
44129042|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129043|NCT05300152|Antibodies|antibodies|mesh-list
44129044|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
44129045|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
44129046|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129047|NCT05288361|Acetylcholine|acetylcholine|mesh-list
44129048|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
44129049|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44129050|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
44129051|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129052|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129053|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129054|NCT05281406|Cisplatin|cisplatin|mesh-list
44129055|NCT05281406|Carboplatin|carboplatin|mesh-list
44129056|NCT05281406|Pemetrexed|pemetrexed|mesh-list
44129078|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
44129079|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44129080|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129081|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129082|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129083|NCT05233605|Analgesics|analgesics|mesh-ancestor
44129084|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
44129085|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129086|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44129087|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44129088|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129089|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129090|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129091|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129092|NCT05228431|Capecitabine|capecitabine|mesh-list
44129093|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129094|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
44129095|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129096|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129097|NCT05227456|Etonogestrel|etonogestrel|mesh-list
44129098|NCT05227456|Desogestrel|desogestrel|mesh-list
44129099|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44129100|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
44129101|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44129102|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129103|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44129104|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44129105|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44129114|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129115|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129116|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44129117|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44129118|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
44129119|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129121|NCT05184101|Calcium heparin|calcium heparin|mesh-list
44336707|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44336708|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336709|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336711|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
44336712|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336713|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
44336714|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336715|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336716|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336717|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
44336718|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336719|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336720|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336721|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44336722|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44336723|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
44336724|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336725|NCT01005550|Ropivacaine|ropivacaine|mesh-list
44336726|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
44336727|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
44336728|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336729|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336730|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
44336731|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336732|NCT01005628|Bortezomib|bortezomib|mesh-list
44336733|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336734|NCT01005641|Lapatinib|lapatinib|mesh-list
44336735|NCT01005641|Exemestane|exemestane|mesh-list
44336736|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336737|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336738|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336739|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336740|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44336741|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44336742|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44336745|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336746|NCT01005758|Cytarabine|cytarabine|mesh-list
44336747|NCT01005758|Dexamethasone|dexamethasone|mesh-list
44336748|NCT01005758|Prednisone|prednisone|mesh-list
44336749|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
44336750|NCT01005758|Prednisolone|prednisolone|mesh-list
44336751|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
44336752|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44336753|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44336754|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44336755|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
44336756|NCT01005758|Doxorubicin|doxorubicin|mesh-list
44336757|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44336758|NCT01005758|Methotrexate|methotrexate|mesh-list
44336759|NCT01005758|Etoposide|etoposide|mesh-list
44336760|NCT01005758|Vincristine|vincristine|mesh-list
44336761|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
44336762|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
44336763|NCT01005758|Pegaspargase|pegaspargase|mesh-list
44336764|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
44336765|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336766|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
44336767|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336768|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746663|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
44129122|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
44129123|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44129124|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44129125|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129126|NCT05183048|Panitumumab|panitumumab|mesh-list
44129127|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129128|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129129|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
44129130|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
44129131|NCT05176470|Fludarabine|fludarabine|mesh-list
44129132|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129133|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
44129134|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129135|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129136|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44129137|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
44129138|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129139|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129140|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44129141|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129142|NCT05175430|Paroxetine|paroxetine|mesh-list
44129143|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
44129144|NCT05175430|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44129145|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44129146|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129147|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129148|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129149|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
44129150|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336769|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336770|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
44336771|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336772|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336773|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44336774|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336775|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
44336776|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
44336777|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991882|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
44336778|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336779|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
44336780|NCT01005758|Hormones|hormones|mesh-ancestor
44336781|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336782|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44336783|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44336784|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44336785|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44336787|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44336788|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
44336789|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44336790|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44336791|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
44336792|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336793|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44336794|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44336795|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44336796|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
44336797|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44336798|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44336799|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44336800|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44336801|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44336802|NCT01005758|Protective Agents|protective agents|mesh-ancestor
44336803|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129151|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44129152|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
44336804|NCT01005784|Cetrorelix|cetrorelix|mesh-list
44336805|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44336806|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
44336807|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44336808|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336809|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
44336810|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336811|NCT01005797|Sorafenib|sorafenib|mesh-list
44336812|NCT01005797|Panobinostat|panobinostat|mesh-list
44336813|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336814|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336815|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336816|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336817|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44336818|NCT01005927|Calcium|calcium|mesh-list
44336819|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44336820|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336821|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
44336822|NCT01005979|Rituximab|rituximab|mesh-list
44336823|NCT01005979|Lenalidomide|lenalidomide|mesh-list
44336824|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44336825|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
44336826|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336827|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44336828|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44336829|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
44336830|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336852|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
44336853|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44336854|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336855|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44336856|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44336857|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44336858|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336859|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336860|NCT01006187|Lidocaine|lidocaine|mesh-list
44336861|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
44336862|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
44336863|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336864|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336865|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
44336866|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336867|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44336868|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44336869|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44129153|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129154|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44129155|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44129156|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129158|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44129159|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44129160|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44129161|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44129162|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129163|NCT05118490|Isoniazid|isoniazid|mesh-list
44129164|NCT05118490|Rifapentine|rifapentine|mesh-list
44129165|NCT05118490|Rifampin|rifampin|mesh-list
44129166|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
44129167|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44129168|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129169|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44129170|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44129171|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
44129188|NCT05065567|Haloperidol|haloperidol|mesh-list
44129189|NCT05065567|Ondansetron|ondansetron|mesh-list
44129190|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
44129191|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
44129192|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
44129193|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129194|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129195|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44129196|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
44129197|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
44129198|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44129199|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
44129200|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129201|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129202|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44129203|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44129204|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336871|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336872|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
44336873|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44336874|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336875|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
44336876|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44336877|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336878|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336879|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44336880|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44336881|NCT01006499|Protective Agents|protective agents|mesh-ancestor
44336882|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336883|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44336884|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44129205|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129206|NCT05065567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44129207|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44129208|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
44129209|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44129210|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44129211|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44129213|NCT05062356|Epinephrine|epinephrine|mesh-list
44129214|NCT05062356|Bupivacaine|bupivacaine|mesh-list
44129215|NCT05062356|Prilocaine|prilocaine|mesh-list
44129216|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44129217|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
44129218|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
44129219|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129220|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129221|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
44129222|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129223|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44129224|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129225|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129226|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129227|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129236|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44129237|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129238|NCT05062356|Analgesics|analgesics|mesh-ancestor
44129239|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129240|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129241|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44129242|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129244|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
44129245|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
44129246|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129247|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129248|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44129249|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44129250|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44129251|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129252|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129253|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129254|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336886|NCT01006525|Zolpidem|zolpidem|mesh-list
44336887|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44336888|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44336889|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336890|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336891|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44336892|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
44336893|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
44336894|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336895|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336896|NCT01006551|Ziprasidone|ziprasidone|mesh-list
44336897|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44129255|NCT05058417|Empagliflozin|empagliflozin|mesh-list
44129256|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44129257|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129258|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129259|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155233|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155234|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44155235|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44155236|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44155237|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44155238|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
44155239|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155240|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155241|NCT00226538|Fluconazole|fluconazole|mesh-list
44155242|NCT00226538|Rifampin|rifampin|mesh-list
44155243|NCT00226538|Diclofenac|diclofenac|mesh-list
44155244|NCT00226538|Phenytoin|phenytoin|mesh-list
44155245|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155246|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155247|NCT00226538|Analgesics|analgesics|mesh-ancestor
44155248|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
44155249|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155250|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155251|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155252|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155253|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44155254|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155255|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155256|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
44155257|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155258|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44155259|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44155260|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44155261|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
44155262|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155263|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44155264|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44155265|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44155266|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
44155267|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155268|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
44129294|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129295|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129296|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
44129297|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599689|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44129298|NCT04958044|Calcium|calcium|mesh-list
44129317|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
44336900|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336901|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336902|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44336903|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44336904|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44336905|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44336906|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44336908|NCT01006668|Propofol|propofol|mesh-list
44336909|NCT01006668|Sevoflurane|sevoflurane|mesh-list
44336910|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44336911|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129318|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
44129319|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44129320|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44129321|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129322|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129323|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129324|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129328|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
44129329|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44129330|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129331|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129332|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129333|NCT04871308|Analgesics|analgesics|mesh-ancestor
44129334|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
44129335|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129336|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44129337|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44129339|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129340|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129341|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129342|NCT04864067|Leucovorin|leucovorin|mesh-list
44129343|NCT04864067|Capecitabine|capecitabine|mesh-list
44129344|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
44129345|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129346|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
44129347|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129348|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129349|NCT04864067|Antidotes|antidotes|mesh-ancestor
44129350|NCT04864067|Protective Agents|protective agents|mesh-ancestor
44129351|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129352|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
44129353|NCT04864067|Vitamins|vitamins|mesh-ancestor
44129354|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
44129355|NCT04861051|Ketamine|ketamine|mesh-list
44129356|NCT04861051|Analgesics|analgesics|mesh-ancestor
44129374|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129375|NCT04844385|Paclitaxel|paclitaxel|mesh-list
44129376|NCT04844385|Capecitabine|capecitabine|mesh-list
44129377|NCT04844385|Nedaplatin|nedaplatin|mesh-list
44129378|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44129379|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648978|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
44129380|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44129381|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44129382|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44129383|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336912|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336913|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44336914|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
44336915|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
44336916|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44336917|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44336918|NCT01006681|Vaccines|vaccines|mesh-list
44336919|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44336920|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
44336921|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336922|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44336923|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
44336924|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44336925|NCT01006720|Neostigmine|neostigmine|mesh-list
44336926|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44336927|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336928|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129384|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129385|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
44129386|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
44129387|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129388|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
44129389|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
44129390|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129391|NCT04799249|Gemcitabine|gemcitabine|mesh-list
44129392|NCT04799249|Carboplatin|carboplatin|mesh-list
44129393|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129394|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129395|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
44129396|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129397|NCT04799249|Antiviral Agents|antiviral agents|mesh-ancestor
44129398|NCT04799249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129399|NCT04799249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129400|NCT04799249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129401|NCT04799249|Immunologic Factors|immunologic factors|mesh-ancestor
44129402|NCT04799249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129403|NCT04760730|Vaccines|vaccines|mesh-list
44129404|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
44129405|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129406|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
44129407|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44129408|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
44129409|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
44129410|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129411|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129412|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129413|NCT04749043|Analgesics|analgesics|mesh-ancestor
44129430|NCT04665765|Ifosfamide|ifosfamide|mesh-list
44129431|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
44129432|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
44129433|NCT04665765|Antibodies|antibodies|mesh-list
44129434|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
44129435|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44129436|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
44129437|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
44129438|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129439|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129440|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129441|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44129442|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44129443|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44336929|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
44336930|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336931|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336932|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44336933|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
44336934|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336935|NCT01006798|Vaccines|vaccines|mesh-list
44336936|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
44336937|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336938|NCT01006863|Phenylephrine|phenylephrine|mesh-list
44336939|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
44336940|NCT01006863|Ephedrine|ephedrine|mesh-list
44336941|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44336942|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
44336943|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
44336944|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336945|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336946|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
44336947|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44336948|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
44336949|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
44336950|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44336951|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44336952|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44336953|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336954|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336955|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336956|NCT01006863|Protective Agents|protective agents|mesh-ancestor
44336957|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44336958|NCT01006876|Warfarin|warfarin|mesh-list
44129444|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129445|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129446|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44129447|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
44129448|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
44129449|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44129450|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
44129451|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
44129452|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
44129453|NCT04620200|Nivolumab|nivolumab|mesh-list
44129454|NCT04620200|Ipilimumab|ipilimumab|mesh-list
44129455|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
44129456|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129457|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129458|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129459|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992107|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336960|NCT01007019|Esomeprazole|esomeprazole|mesh-list
44336961|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44336962|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336963|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44336964|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336965|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336966|NCT01007084|Propranolol|propranolol|mesh-list
44336967|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44336968|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44336969|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
44336970|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44336971|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336972|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336973|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44336974|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44336975|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
44336976|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44336977|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44336978|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44336979|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
44336980|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44336981|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43746807|NCT02522013|Aminophylline|aminophylline|mesh-list
44129460|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155269|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44155270|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44155271|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44155272|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44155273|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44155274|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44155275|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44155276|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
44155277|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44155278|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44155279|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155280|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44155281|NCT00226551|Isoproterenol|isoproterenol|mesh-list
44155286|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155287|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155288|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44155289|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
44155290|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155291|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44129462|NCT04599894|Analgesics|analgesics|mesh-ancestor
44336982|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44336983|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44336984|NCT01007500|Dexamethasone|dexamethasone|mesh-list
44336985|NCT01007500|Ondansetron|ondansetron|mesh-list
44336986|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44336987|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
44336988|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
44336989|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44336990|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44336991|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44336992|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
44336993|NCT01007500|Hormones|hormones|mesh-ancestor
44336994|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44336995|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44336996|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746841|NCT02521662|Nicotine|nicotine|mesh-list
44129463|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
44129464|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129465|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129466|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
44129467|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44129468|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129469|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129470|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44129471|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44129472|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44129473|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129474|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129475|NCT04520490|Exenatide|exenatide|mesh-list
44129476|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129477|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129478|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44129479|NCT04520490|Incretins|incretins|mesh-ancestor
44129480|NCT04520490|Hormones|hormones|mesh-ancestor
44129481|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129482|NCT04505189|Psilocybin|psilocybin|mesh-list
44129483|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
44129484|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129485|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129486|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44129487|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44129488|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129489|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129490|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
44129491|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129492|NCT04457180|Repaglinide|repaglinide|mesh-list
44129493|NCT04457180|Apatinib|apatinib|mesh-list
44129494|NCT04457180|Bupropion|bupropion|mesh-list
44129495|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129496|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129497|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129498|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129499|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44129500|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
44129501|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44129502|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44129503|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44336997|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
44336998|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
44336999|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44337000|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
44337001|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337002|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337003|NCT01007500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44337004|NCT01007500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44337005|NCT01007500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337006|NCT01007500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337007|NCT01007500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44337008|NCT01007539|Choline|choline|mesh-list
44337009|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44337010|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
44337011|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337012|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
44337013|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337014|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337015|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337016|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
44337017|NCT01007565|Anesthetics|anesthetics|mesh-list
44337018|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337019|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337020|NCT01007578|Paclitaxel|paclitaxel|mesh-list
44337021|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44337022|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337023|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
44337024|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
44337025|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
44337026|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337027|NCT01007630|Rasagiline|rasagiline|mesh-list
43746843|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
44129504|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129505|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
44129506|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129507|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129508|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44129509|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44129510|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129511|NCT04427956|Riboflavin|riboflavin|mesh-list
44129512|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
44129513|NCT04427956|Vitamins|vitamins|mesh-ancestor
44129514|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
44337029|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337030|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337031|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44337032|NCT01007630|Protective Agents|protective agents|mesh-ancestor
44337033|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337034|NCT01007695|Valproic Acid|valproic acid|mesh-list
44337035|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
44337036|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337037|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337038|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
44129515|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129516|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44129517|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
44129518|NCT04380740|Abatacept|abatacept|mesh-list
44129519|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129520|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129523|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
44129524|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129525|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129527|NCT04341181|Pertuzumab|pertuzumab|mesh-list
44129528|NCT04341181|Avelumab|avelumab|mesh-list
44129529|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44129530|NCT04341181|Atezolizumab|atezolizumab|mesh-list
44129531|NCT04341181|Niraparib|niraparib|mesh-list
44129532|NCT04341181|Axitinib|axitinib|mesh-list
44129533|NCT04341181|Vemurafenib|vemurafenib|mesh-list
44129534|NCT04341181|Maytansine|maytansine|mesh-list
44129535|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129536|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129537|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129538|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129539|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129540|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44129541|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44129542|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44129543|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44129544|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44129546|NCT04334759|Carboplatin|carboplatin|mesh-list
44129547|NCT04334759|Nivolumab|nivolumab|mesh-list
44129548|NCT04334759|Pemetrexed|pemetrexed|mesh-list
44129549|NCT04334759|Ipilimumab|ipilimumab|mesh-list
44129550|NCT04334759|Durvalumab|durvalumab|mesh-list
44129551|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129552|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129553|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129554|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129555|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129556|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44129557|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44129558|NCT04331730|Aflibercept|aflibercept|mesh-list
44129559|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44129560|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44129561|NCT04331730|Growth Substances|growth substances|mesh-ancestor
44129562|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129563|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
44129564|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129565|NCT04263051|Nivolumab|nivolumab|mesh-list
44129566|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129567|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129568|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129569|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129570|NCT04234048|Fenretinide|fenretinide|mesh-list
44129571|NCT04234048|Retinamide|retinamide|mesh-list
44337040|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337041|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
44337042|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44337043|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337044|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337045|NCT01007773|Fentanyl|fentanyl|mesh-list
44337046|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
44337047|NCT01007773|Propofol|propofol|mesh-list
44337048|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44337049|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337050|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337051|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44129572|NCT04234048|Tretinoin|tretinoin|mesh-list
44129573|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129574|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44129575|NCT04234048|Protective Agents|protective agents|mesh-ancestor
44129576|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129577|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
44129578|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
44129579|NCT04206046|Anesthetics|anesthetics|mesh-list
44129580|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129581|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129582|NCT04186013|Atezolizumab|atezolizumab|mesh-list
44129583|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129584|NCT04168112|Dexamethasone|dexamethasone|mesh-list
44129585|NCT04168112|Prednisolone|prednisolone|mesh-list
44129586|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44129587|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
44129588|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44129589|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
44129590|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44129591|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
44129592|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129593|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
44129594|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
44129595|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129604|NCT04168112|Protective Agents|protective agents|mesh-ancestor
43599697|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
44129605|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44129606|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44129607|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44129608|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129609|NCT04085250|Nivolumab|nivolumab|mesh-list
44129610|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129611|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129612|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129613|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129614|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
43574481|NCT03516188|Antacids|antacids|mesh-list
44129615|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
44129616|NCT04083560|Hematinics|hematinics|mesh-ancestor
44129617|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
44129618|NCT04083560|Vitamins|vitamins|mesh-ancestor
44129619|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
44129620|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129621|NCT04054830|Diclofenac|diclofenac|mesh-list
44129622|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44129623|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129624|NCT04054830|Analgesics|analgesics|mesh-ancestor
44129625|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
44129626|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129627|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129628|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337053|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
44337054|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44337055|NCT01007773|Analgesics|analgesics|mesh-ancestor
44337056|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
44337057|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337058|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44337059|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44337060|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44337061|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337062|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43746877|NCT02521246|Losartan|losartan|mesh-list
44129629|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129630|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44129631|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129632|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155292|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
44155293|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44155294|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
44155295|NCT00226551|Protective Agents|protective agents|mesh-ancestor
44155296|NCT00226564|Alfentanil|alfentanil|mesh-list
44155297|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44155298|NCT00226564|Narcotics|narcotics|mesh-ancestor
44155299|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155300|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155301|NCT00226564|Analgesics|analgesics|mesh-ancestor
44155302|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
44155303|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155304|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44155305|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
44155306|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
44158194|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
44158195|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158196|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44158197|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158198|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
44158199|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
44158200|NCT00236379|Olanzapine|olanzapine|mesh-list
44158201|NCT00236379|Risperidone|risperidone|mesh-list
44158202|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158203|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
44158204|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158205|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158206|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158207|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158218|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158219|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158220|NCT00236392|Rabeprazole|rabeprazole|mesh-list
44158221|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44158222|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158223|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44158224|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158225|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158226|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
44158227|NCT00236405|Hematinics|hematinics|mesh-ancestor
44158228|NCT00236418|Topiramate|topiramate|mesh-list
44158229|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
44158230|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158231|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158232|NCT00236431|Galantamine|galantamine|mesh-list
44158233|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44158234|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129634|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
44129635|NCT04033276|Antibodies|antibodies|mesh-list
44129636|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
44129637|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44337064|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337065|NCT01007773|Narcotics|narcotics|mesh-ancestor
44337066|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44337067|NCT01007799|Vitamin D|vitamin d|mesh-list
44337068|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
44337069|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
44337070|NCT01007799|Vitamins|vitamins|mesh-list
44337071|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
44337072|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337073|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44337074|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337075|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44337076|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
44337077|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44337078|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
44337079|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43746887|NCT02521246|Diuretics|diuretics|mesh-ancestor
44129638|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44129639|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129640|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129641|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
44129642|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129643|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129644|NCT04014790|KRN 7000|krn 7000|mesh-list
44129645|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44129646|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
44129647|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129648|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129649|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
44129650|NCT03999723|Vitamins|vitamins|mesh-ancestor
44129651|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
44129652|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129653|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
44129654|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129655|NCT03999723|Protective Agents|protective agents|mesh-ancestor
44129656|NCT03969823|Osimertinib|osimertinib|mesh-list
44129657|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129658|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129659|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129660|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129661|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44129662|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129663|NCT03890952|Bevacizumab|bevacizumab|mesh-list
44129664|NCT03890952|Nivolumab|nivolumab|mesh-list
44129665|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44129666|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129667|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129668|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44129669|NCT03890952|Growth Substances|growth substances|mesh-ancestor
44129670|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129671|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
43599741|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44129672|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129695|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44129696|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129697|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337081|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44337082|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44337083|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337084|NCT01007864|Pramipexole|pramipexole|mesh-list
44337085|NCT01007864|Ropinirole|ropinirole|mesh-list
44337086|NCT01007864|Piribedil|piribedil|mesh-list
44337087|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
44337088|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337089|NCT01007864|Protective Agents|protective agents|mesh-ancestor
44337090|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337091|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44337092|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44129698|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44129699|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
44129700|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129701|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129702|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44129703|NCT03781063|Fulvestrant|fulvestrant|mesh-list
44129704|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44129705|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129706|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44129707|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44129708|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44129709|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129710|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129712|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44129713|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
44129714|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129715|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129716|NCT03761511|Niacinamide|niacinamide|mesh-list
44129717|NCT03761511|Niacin|niacin|mesh-list
44129718|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
44129719|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
44129720|NCT03761511|Vitamins|vitamins|mesh-ancestor
44129721|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
44129722|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129723|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44129724|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
44129725|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129740|NCT03721497|Androgens|androgens|mesh-ancestor
44129741|NCT03721497|Hormones|hormones|mesh-ancestor
44129742|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129743|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129744|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44129745|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129746|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
44129747|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
44129748|NCT03682029|Vitamins|vitamins|mesh-ancestor
44129749|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
44129750|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129751|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
44129752|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129753|NCT03682029|Protective Agents|protective agents|mesh-ancestor
44129754|NCT03681275|Tofacitinib|tofacitinib|mesh-list
44129755|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129756|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129757|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129758|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
44129759|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
44129760|NCT03670966|Fludarabine|fludarabine|mesh-list
44129761|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
44337094|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
44337095|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337096|NCT01007968|Panobinostat|panobinostat|mesh-list
44337097|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337098|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44337099|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337100|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337101|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44337102|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
44337103|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337104|NCT01008020|Protective Agents|protective agents|mesh-ancestor
44337105|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337106|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43746915|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129762|NCT03670966|Tacrolimus|tacrolimus|mesh-list
44129763|NCT03670966|Antibodies|antibodies|mesh-list
44129764|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44129765|NCT03670966|Lenograstim|lenograstim|mesh-list
44129766|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129767|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
44129768|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129769|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129770|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44129771|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
44129772|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129773|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129774|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44129775|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129776|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
44129777|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129778|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44129779|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129780|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44129781|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44129782|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
44129783|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44129784|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44129785|NCT03648996|Allopurinol|allopurinol|mesh-list
44129786|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
44129794|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129796|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44129797|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
44129798|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
44129799|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129800|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129801|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
44129802|NCT03585452|Propofol|propofol|mesh-list
44129803|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
44129804|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129805|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129806|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44129807|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44129808|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
44129809|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129810|NCT03585452|Analgesics|analgesics|mesh-ancestor
44129811|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
44129812|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129813|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44337107|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44337108|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337109|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44337111|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
44337112|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44337113|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44337114|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337115|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
44337116|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337117|NCT01008046|Expectorants|expectorants|mesh-ancestor
44337118|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337119|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44337120|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
44337121|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337122|NCT01008046|Protective Agents|protective agents|mesh-ancestor
44337123|NCT01008046|Antidotes|antidotes|mesh-ancestor
44337124|NCT01008098|Citalopram|citalopram|mesh-list
44337125|NCT01008098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44337126|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44337127|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44337128|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337129|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337130|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
44337131|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337132|NCT01008098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44337133|NCT01008098|Antidepressive Agents|antidepressive agents|mesh-ancestor
44337134|NCT01008098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337135|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44337136|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44337137|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337138|NCT01008137|Vaccines|vaccines|mesh-list
44337139|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
44129814|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44129815|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129816|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129817|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129818|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129819|NCT03570099|Naloxone|naloxone|mesh-list
44129820|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44129821|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129822|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
44337141|NCT01008293|Lactulose|lactulose|mesh-list
44337142|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337143|NCT01008345|Ezetimibe|ezetimibe|mesh-list
44337144|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44337145|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337146|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
44337147|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337148|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337149|NCT01008358|Tremelimumab|tremelimumab|mesh-list
44337150|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337151|NCT01008384|Vitamin D|vitamin d|mesh-list
44337152|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
44337153|NCT01008384|Vitamins|vitamins|mesh-ancestor
44337154|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
44337155|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337156|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44337157|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337158|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44337159|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337160|NCT01008527|Poly ICLC|poly iclc|mesh-list
44337161|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
44337162|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
44337163|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337164|NCT01008566|Sorafenib|sorafenib|mesh-list
44337165|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44337166|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337167|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337168|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337169|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337170|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
44337171|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337172|NCT01008592|Levocetirizine|levocetirizine|mesh-list
44129823|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129824|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44129825|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44129826|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44129827|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129828|NCT03510078|Insulin|insulin|mesh-list
44129829|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129830|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129831|NCT03500913|Hormones|hormones|mesh-list
44163829|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44337173|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44337174|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44337175|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
44337176|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
44337177|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337178|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337179|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337180|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
44337182|NCT01008631|Protective Agents|protective agents|mesh-ancestor
44337183|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337184|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
44337185|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784687|NCT04482686|Zinc|zinc|mesh-list
44337186|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
44337187|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44337188|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337189|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
44337190|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
44337191|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44337192|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44337193|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
44337194|NCT01008709|Hormones|hormones|mesh-ancestor
44337195|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337196|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337197|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337198|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337199|NCT01008761|Azithromycin|azithromycin|mesh-list
44337200|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44337201|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337202|NCT01008813|Vaccines|vaccines|mesh-list
44337203|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
44337204|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337205|NCT01008917|Sirolimus|sirolimus|mesh-list
44337206|NCT01008917|Sorafenib|sorafenib|mesh-list
44129832|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129833|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129834|NCT03459222|Nivolumab|nivolumab|mesh-list
44129835|NCT03459222|Ipilimumab|ipilimumab|mesh-list
44129836|NCT03459222|Linrodostat|linrodostat|mesh-list
43702172|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
44337212|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337213|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44337214|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
44337215|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337216|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
44337217|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337218|NCT01008982|Belimumab|belimumab|mesh-list
44337219|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337220|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
44337221|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129837|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129838|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129839|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129840|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129841|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129842|NCT03421483|Folic Acid|folic acid|mesh-list
44129843|NCT03421483|Hematinics|hematinics|mesh-ancestor
44129844|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
44129845|NCT03421483|Vitamins|vitamins|mesh-ancestor
44129846|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
44129847|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129848|NCT03363217|Trametinib|trametinib|mesh-list
44129849|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129850|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129851|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129852|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129853|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
44129854|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129866|NCT03228537|Cisplatin|cisplatin|mesh-list
44129867|NCT03228537|Pemetrexed|pemetrexed|mesh-list
44129868|NCT03228537|Atezolizumab|atezolizumab|mesh-list
44129869|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44129870|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129871|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129872|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129873|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44129874|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44129875|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
44129876|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129877|NCT03226821|Tesamorelin|tesamorelin|mesh-list
44129878|NCT03226821|Growth Substances|growth substances|mesh-ancestor
44129879|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129880|NCT03225755|Hormones|hormones|mesh-list
44129881|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129882|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129883|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44129884|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
44129885|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129886|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44337223|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44337224|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44337225|NCT01009021|Analgesics|analgesics|mesh-ancestor
44337226|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
44337227|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337228|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337229|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337230|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337231|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44337232|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337233|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337234|NCT01009073|Irinotecan|irinotecan|mesh-list
44337235|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44337236|NCT01009073|Navitoclax|navitoclax|mesh-list
44337237|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44337238|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44337239|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129887|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44129888|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
44129889|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44129890|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44129891|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
44129892|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129893|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
44129894|NCT03186755|Protective Agents|protective agents|mesh-ancestor
44129895|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44129896|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129897|NCT03186755|Analgesics|analgesics|mesh-ancestor
44129898|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
44129899|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129900|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129901|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129902|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44129903|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44129904|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44129905|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
44129906|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
44129907|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129908|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129909|NCT03186456|Aspirin|aspirin|mesh-list
44129910|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44129911|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129912|NCT03186456|Analgesics|analgesics|mesh-ancestor
44129913|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
44129914|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129915|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129916|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129917|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129918|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44129919|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44129920|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129939|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
44129940|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129941|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129942|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337240|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337241|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337242|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337243|NCT01009177|Bosentan|bosentan|mesh-list
44337244|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337245|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44337246|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337247|NCT01009190|Carboplatin|carboplatin|mesh-list
44337248|NCT01009190|Rucaparib|rucaparib|mesh-list
44337249|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337250|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44337251|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337252|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337253|NCT01009437|Ritonavir|ritonavir|mesh-list
44337254|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44337255|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44337256|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
44337257|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337258|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337259|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44337260|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44337261|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
44337262|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337263|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44337264|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44337265|NCT01009476|Nicergoline|nicergoline|mesh-list
44337266|NCT01009476|Piracetam|piracetam|mesh-list
44337267|NCT01009476|Galantamine|galantamine|mesh-list
44337268|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
44337269|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44337270|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337271|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337272|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
44337276|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
44337278|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44337279|NCT01009476|Protective Agents|protective agents|mesh-ancestor
44337280|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44337281|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44337282|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337283|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337284|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44337285|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44337286|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44337287|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337288|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
44337289|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44337290|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
44337291|NCT01009541|Pregabalin|pregabalin|mesh-list
44337292|NCT01009541|Analgesics|analgesics|mesh-ancestor
44337293|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
44337294|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337295|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337296|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
44337297|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44337298|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44337299|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337300|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337301|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44337302|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44337303|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337304|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337305|NCT01009567|Cabergoline|cabergoline|mesh-list
44337306|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44337307|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44337308|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
44337309|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
44337310|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43747051|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44129943|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44129944|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44129945|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129946|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44129947|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44129948|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337311|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337312|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337313|NCT01009593|Sorafenib|sorafenib|mesh-list
44337314|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337315|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337316|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337317|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337318|NCT01009697|Codeine|codeine|mesh-list
44337319|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337320|NCT01009697|Narcotics|narcotics|mesh-ancestor
44337321|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337322|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337323|NCT01009697|Analgesics|analgesics|mesh-ancestor
44337324|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
44337325|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337326|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
44337327|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337328|NCT01009801|Doxorubicin|doxorubicin|mesh-list
44337329|NCT01009801|Everolimus|everolimus|mesh-list
44337330|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44337331|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337332|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44337333|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44337334|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337335|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337336|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337337|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
44337338|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337339|NCT01009853|Codeine|codeine|mesh-list
44337340|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337341|NCT01009853|Narcotics|narcotics|mesh-ancestor
44129949|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
44129950|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44129951|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44129952|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
44129953|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44129954|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44129955|NCT03158129|Cisplatin|cisplatin|mesh-list
44129956|NCT03158129|Carboplatin|carboplatin|mesh-list
44129957|NCT03158129|Docetaxel|docetaxel|mesh-list
44129958|NCT03158129|Nivolumab|nivolumab|mesh-list
44129959|NCT03158129|Pemetrexed|pemetrexed|mesh-list
44129960|NCT03158129|Ipilimumab|ipilimumab|mesh-list
44129961|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129962|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
44337342|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337343|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337344|NCT01009853|Analgesics|analgesics|mesh-ancestor
44337345|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
44337346|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337347|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
44337348|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337349|NCT01009879|Etanercept|etanercept|mesh-list
44337350|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44337351|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44337352|NCT01009879|Analgesics|analgesics|mesh-ancestor
44337353|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
44337354|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337355|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337356|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337357|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337358|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337359|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337360|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
44337361|NCT01009892|Codeine|codeine|mesh-list
44337362|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337363|NCT01009892|Narcotics|narcotics|mesh-ancestor
43747103|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
44129963|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
44129964|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
44129965|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129966|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129967|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129968|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129969|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44129970|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44129971|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
44129972|NCT03156452|Prednisolone|prednisolone|mesh-list
44129973|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44129974|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129975|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44129976|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
44129980|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129982|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
44129983|NCT03156452|Hormones|hormones|mesh-ancestor
44129984|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129985|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129986|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155307|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44155308|NCT00226668|Hormones|hormones|mesh-ancestor
44155309|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155310|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155311|NCT00226694|Citalopram|citalopram|mesh-list
44155312|NCT00226694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44155313|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44337364|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337365|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337366|NCT01009892|Analgesics|analgesics|mesh-ancestor
44337367|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
44337368|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337369|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
44337370|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337371|NCT01009944|Atenolol|atenolol|mesh-list
44337372|NCT01009944|Lisinopril|lisinopril|mesh-list
44337373|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44337374|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44337375|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337376|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337377|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337378|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44337379|NCT01009944|Protective Agents|protective agents|mesh-ancestor
44337380|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337381|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44337382|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
44337383|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
44337384|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337385|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44337386|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44337387|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44337388|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337389|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155314|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155315|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155316|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155317|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
44155318|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155319|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44155320|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155321|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155322|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
44155323|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155324|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155325|NCT00226707|Analgesics|analgesics|mesh-ancestor
44155326|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
44129987|NCT03122639|Atorvastatin|atorvastatin|mesh-list
44129988|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44129989|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44129990|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
44129991|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129992|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44129993|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44337391|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337392|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337393|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
44337394|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337395|NCT01009970|Prednisone|prednisone|mesh-list
44337396|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
44337397|NCT01009970|Rituximab|rituximab|mesh-list
44337398|NCT01009970|Doxorubicin|doxorubicin|mesh-list
44337399|NCT01009970|Vincristine|vincristine|mesh-list
44337400|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337401|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
44337402|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337403|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337404|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44337405|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
44337406|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337407|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337408|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44337409|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44337410|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44337411|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44337412|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44337413|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337414|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337415|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
44337416|NCT01009970|Hormones|hormones|mesh-ancestor
44337417|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337418|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44337419|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44337420|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44337435|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
44337436|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44337437|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44337438|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44337439|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337440|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337441|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337442|NCT01010048|Urological Agents|urological agents|mesh-ancestor
44337443|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44337444|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44337445|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337446|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337447|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
44337448|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44337449|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44337450|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337451|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44337452|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44337453|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
44337454|NCT01010087|Oseltamivir|oseltamivir|mesh-list
44337455|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
44337456|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337457|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337458|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337460|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44337461|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337462|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337463|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44337464|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337465|NCT01010139|Codeine|codeine|mesh-list
44337466|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337467|NCT01010139|Narcotics|narcotics|mesh-ancestor
44337468|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337470|NCT01010139|Analgesics|analgesics|mesh-ancestor
44337474|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337475|NCT01010152|Codeine|codeine|mesh-list
44337476|NCT01010152|Analgesics|analgesics|mesh-ancestor
44337477|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
44337478|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337479|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337480|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44337481|NCT01010152|Narcotics|narcotics|mesh-ancestor
44337482|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337483|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
44337484|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337485|NCT01010178|Theophylline|theophylline|mesh-list
44337486|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44337487|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
44337488|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337489|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337490|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44337491|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337492|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44337493|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337494|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337495|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337496|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44337497|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44337498|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
44337499|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337500|NCT01010243|Pioglitazone|pioglitazone|mesh-list
44337501|NCT01010243|Dexamethasone|dexamethasone|mesh-list
44337502|NCT01010243|Lenalidomide|lenalidomide|mesh-list
44337503|NCT01010243|Treosulfan|treosulfan|mesh-list
44337504|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337505|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
44337514|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337515|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
43785184|NCT04771689|Narcotics|narcotics|mesh-ancestor
44337516|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44337517|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44337518|NCT01010243|Growth Substances|growth substances|mesh-ancestor
44337519|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
44337520|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44337521|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44337522|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
44337523|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337524|NCT01010295|Doxycycline|doxycycline|mesh-list
44337525|NCT01010295|Tetracycline|tetracycline|mesh-list
44337526|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44337527|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337528|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
44337529|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44337530|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44337531|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44337532|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337533|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337535|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44337536|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44337537|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337538|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337539|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337540|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337541|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44337542|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337543|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
44337544|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
44337545|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337546|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44337547|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44129994|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129995|NCT03117309|Nivolumab|nivolumab|mesh-list
44129996|NCT03117309|Ipilimumab|ipilimumab|mesh-list
44129997|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129998|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337548|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
44337549|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337550|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337551|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44337552|NCT01010373|Protective Agents|protective agents|mesh-ancestor
44337553|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44337554|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44337555|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337556|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337557|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
44337558|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337559|NCT01010425|Hormones|hormones|mesh-list
44337560|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337561|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337562|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
44337563|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44337564|NCT01010451|Calcium|calcium|mesh-list
44337565|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337566|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337567|NCT01010490|Dipivefrin|dipivefrin|mesh-list
44337568|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44337569|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44337570|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337571|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337572|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337573|NCT01010516|Niacin|niacin|mesh-list
44337574|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44337594|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44337595|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
44337596|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337597|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337598|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
44337599|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337600|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44337601|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337602|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
44337603|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337604|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44337605|NCT01010581|Hematinics|hematinics|mesh-ancestor
44337606|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
44337608|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
44337609|NCT01010646|Ribavirin|ribavirin|mesh-list
44337610|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
44337611|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
44337612|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44337613|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
44337614|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337615|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
44337616|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337617|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
44337618|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337619|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337620|NCT01010672|Sirolimus|sirolimus|mesh-list
44337621|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44337622|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337623|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44337624|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337629|NCT01010698|Acyclovir|acyclovir|mesh-list
44337639|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337640|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337641|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44337642|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44337643|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337644|NCT01010789|Modafinil|modafinil|mesh-list
44337645|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44337646|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337647|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44337648|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44337649|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44337650|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337651|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
44337652|NCT01010802|Hematinics|hematinics|mesh-ancestor
44337653|NCT01010893|Vaccines|vaccines|mesh-list
44337654|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
44337655|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337656|NCT01010945|Gemcitabine|gemcitabine|mesh-list
44337657|NCT01010945|Paclitaxel|paclitaxel|mesh-list
44337658|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44337659|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44337660|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337661|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44337662|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44337663|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44337664|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337665|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44337666|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
44337667|NCT01010945|Antiviral Agents|antiviral agents|mesh-ancestor
44337668|NCT01010945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337669|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337674|NCT01010958|Valproic Acid|valproic acid|mesh-list
44337679|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337680|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337681|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
44337682|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44337683|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337684|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337685|NCT01011010|Doxorubicin|doxorubicin|mesh-list
44337686|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44337687|NCT01011010|Mitomycins|mitomycins|mesh-list
44337688|NCT01011010|Mitomycin|mitomycin|mesh-list
44337689|NCT01011010|Sorafenib|sorafenib|mesh-list
44337690|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44337691|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337692|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44337693|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44337694|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337695|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337696|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337697|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
44337698|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44337699|NCT01011036|Clonazepam|clonazepam|mesh-list
44337700|NCT01011036|Clobazam|clobazam|mesh-list
44337701|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44337702|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44337703|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44337704|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
44337705|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337706|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337707|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337708|NCT01011036|Urological Agents|urological agents|mesh-ancestor
44337709|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
44337710|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
44337711|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
44337712|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44337713|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44337721|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44337722|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44337723|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337724|NCT01011114|Cinacalcet|cinacalcet|mesh-list
44337725|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337726|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337727|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44337728|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
44337729|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337730|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44337731|NCT01011127|Pravastatin|pravastatin|mesh-list
44337732|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44337733|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337734|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
44337735|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337736|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337737|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44337738|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337739|NCT01011166|Ribavirin|ribavirin|mesh-list
44337740|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44337741|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
44337742|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337743|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
44337744|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337745|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
44337746|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
44337747|NCT01011205|Tacrolimus|tacrolimus|mesh-list
44337748|NCT01011205|Basiliximab|basiliximab|mesh-list
44337749|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337750|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
44337751|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337752|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44337753|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337754|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337756|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337757|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44337758|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
44337759|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44337760|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337761|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337762|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
44337763|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
44337764|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337765|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337766|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
44337767|NCT01011205|Hormones|hormones|mesh-ancestor
44337768|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337769|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44337770|NCT01011205|Protective Agents|protective agents|mesh-ancestor
44337771|NCT01011257|Clopidogrel|clopidogrel|mesh-list
44337772|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44337773|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44337774|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44337775|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44337776|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
44337777|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337778|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337779|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337780|NCT01011348|Ubiquinone|ubiquinone|mesh-list
44337781|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
44337782|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
44337783|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337806|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44337807|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44337808|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337809|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
44337810|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337811|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337812|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44337813|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337814|NCT01011530|Pevonedistat|pevonedistat|mesh-list
44337815|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337816|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337817|NCT01011543|Dimercaprol|dimercaprol|mesh-list
44337818|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
44337819|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
44129999|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44130000|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130001|NCT03109964|Hemostatics|hemostatics|mesh-list
44130002|NCT03109964|Surgiflo|surgiflo|mesh-list
44130003|NCT03109964|Coagulants|coagulants|mesh-ancestor
44130004|NCT03095274|Durvalumab|durvalumab|mesh-list
44130005|NCT03095274|Tremelimumab|tremelimumab|mesh-list
44130006|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130007|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130008|NCT03058835|Tenofovir|tenofovir|mesh-list
44130009|NCT03058835|Emtricitabine|emtricitabine|mesh-list
44130010|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
44130011|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130012|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44130013|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44130014|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130015|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130016|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44130017|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44130018|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
44130019|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
44130020|NCT03016871|Carboplatin|carboplatin|mesh-list
44130021|NCT03016871|Nivolumab|nivolumab|mesh-list
44130022|NCT03016871|Etoposide|etoposide|mesh-list
44130023|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
44130024|NCT03016871|Ifosfamide|ifosfamide|mesh-list
44130025|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
44130026|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
44130027|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130031|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130032|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130033|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130035|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130036|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
44130037|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
44130038|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
44130039|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130040|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130041|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130042|NCT02993029|Celecoxib|celecoxib|mesh-list
44130043|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44130044|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130045|NCT02993029|Analgesics|analgesics|mesh-ancestor
44130046|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
44130047|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337821|NCT01011621|Prednisolone|prednisolone|mesh-list
44337822|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44337823|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
44337824|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44337825|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
44337826|NCT01011621|Betamethasone|betamethasone|mesh-list
44337827|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
44337828|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44337829|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
44337830|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44337831|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
44337832|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44337833|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44337834|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
44337835|NCT01011621|Hormones|hormones|mesh-ancestor
44337836|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337837|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337838|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44337839|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337840|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
44337841|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
44130048|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130049|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130050|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130051|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44130052|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44130053|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130054|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130055|NCT02825641|Oxytocin|oxytocin|mesh-list
44130056|NCT02825641|Dinoprostone|dinoprostone|mesh-list
44130057|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
44130058|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44130059|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130060|NCT02638519|Xenon|xenon|mesh-list
44130061|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44130062|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
44130063|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
44130064|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44130065|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130066|NCT02599324|Paclitaxel|paclitaxel|mesh-list
44130067|NCT02599324|Docetaxel|docetaxel|mesh-list
44130068|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
44130069|NCT02599324|Cetuximab|cetuximab|mesh-list
44130070|NCT02599324|Everolimus|everolimus|mesh-list
44130071|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130072|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130073|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130074|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130075|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130076|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130077|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44337843|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44337844|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44337845|NCT01011621|Protective Agents|protective agents|mesh-ancestor
44337846|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44337847|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337848|NCT01011660|Amlodipine|amlodipine|mesh-list
44337849|NCT01011660|Telmisartan|telmisartan|mesh-list
44337850|NCT01011660|Amiloride|amiloride|mesh-list
44337851|NCT01011660|Simvastatin|simvastatin|mesh-list
44337852|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337853|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44337854|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44337855|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337856|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337857|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337858|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337859|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44337860|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337861|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
44337862|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337863|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44337864|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130078|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130079|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
44130080|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130081|NCT02460887|Gemcitabine|gemcitabine|mesh-list
44130082|NCT02460887|Cisplatin|cisplatin|mesh-list
44130083|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130084|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130085|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
44130086|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599778|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130087|NCT02460887|Antiviral Agents|antiviral agents|mesh-ancestor
44130088|NCT02460887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130089|NCT02460887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130090|NCT02460887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130091|NCT02460887|Immunologic Factors|immunologic factors|mesh-ancestor
44130092|NCT02460887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130093|NCT02448095|Ponatinib|ponatinib|mesh-list
44130094|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130095|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44130096|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130097|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130113|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130114|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130115|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44130116|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44130117|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44130118|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44337866|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44337867|NCT01011660|Diuretics|diuretics|mesh-ancestor
44337868|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
44337869|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44337870|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44337871|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44337872|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44337873|NCT01011699|Niacinamide|niacinamide|mesh-list
44337874|NCT01011699|Niacin|niacin|mesh-list
44337875|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
44337876|NCT01011699|Sevelamer|sevelamer|mesh-list
44337877|NCT01011699|Cinacalcet|cinacalcet|mesh-list
44337878|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
44337879|NCT01011699|Vitamins|vitamins|mesh-ancestor
44337880|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
44337881|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337882|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44337883|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
44337884|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337885|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44337886|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
44337887|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
44337888|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
44337889|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44337890|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44337891|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
44337892|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337893|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44337894|NCT01011751|Leuprolide|leuprolide|mesh-list
44337895|NCT01011751|Flutamide|flutamide|mesh-list
44337896|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
44337897|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44337898|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
44337899|NCT01011751|Cyproterone|cyproterone|mesh-list
44337900|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44130119|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44130120|NCT02266329|Prazosin|prazosin|mesh-list
44130121|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44337901|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44337902|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44337903|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337904|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337905|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337906|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44337907|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
44337908|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44337909|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44337910|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44337911|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44337912|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
44337913|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44337914|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44337915|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44337916|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44337917|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44337918|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337919|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44337920|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
44337921|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
44337922|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
44337923|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44337924|NCT01011920|Cytarabine|cytarabine|mesh-list
44337925|NCT01011920|Rituximab|rituximab|mesh-list
44337926|NCT01011920|Methotrexate|methotrexate|mesh-list
44337927|NCT01011920|Thiotepa|thiotepa|mesh-list
44337928|NCT01011920|Carmustine|carmustine|mesh-list
44337929|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44337930|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337931|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
44337932|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130122|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44130123|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44130124|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44130125|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130126|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130127|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130128|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337933|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44337934|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44337935|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
44337936|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44337937|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44337938|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
44337939|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337940|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
44337941|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337942|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44337943|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44337944|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44337945|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
44337946|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44337947|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44337948|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
44337949|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44337950|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
44337951|NCT01011998|Valproic Acid|valproic acid|mesh-list
44337952|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337953|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337954|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337955|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337956|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
44337957|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
44337958|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337959|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337960|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
44337961|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44130129|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
44130130|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44130131|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44130132|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130133|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
44130134|NCT02261415|Coagulants|coagulants|mesh-ancestor
44130135|NCT02008292|Physostigmine|physostigmine|mesh-list
44130136|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44130137|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130138|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130139|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
44130140|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130141|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130143|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
44337962|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44337964|NCT01012011|Sorafenib|sorafenib|mesh-list
44337965|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337966|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44337967|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44337968|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337969|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
44337970|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44337971|NCT01012063|Hematinics|hematinics|mesh-ancestor
44337972|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44337973|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
44337974|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44337975|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
44337976|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44337977|NCT01012141|Docetaxel|docetaxel|mesh-list
44337978|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44337979|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44337980|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44337981|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44337982|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337983|NCT01012193|Cilostazol|cilostazol|mesh-list
44337984|NCT01012193|Clopidogrel|clopidogrel|mesh-list
44337985|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44337986|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44337987|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44337988|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44337989|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
44337990|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44337991|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44337992|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130144|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130145|NCT01894308|Testosterone|testosterone|mesh-list
44130146|NCT01894308|Androgens|androgens|mesh-ancestor
44130147|NCT01894308|Hormones|hormones|mesh-ancestor
44130148|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130149|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130150|NCT01809808|Hormones|hormones|mesh-list
44130151|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130152|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130153|NCT01406197|Progesterone|progesterone|mesh-list
44130154|NCT01406197|Progestins|progestins|mesh-ancestor
44130155|NCT01406197|Hormones|hormones|mesh-ancestor
44337993|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44337994|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
44337995|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44337996|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44337997|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
44337998|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44337999|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44338000|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
44338001|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44338002|NCT01012193|Protective Agents|protective agents|mesh-ancestor
44338003|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44338004|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44338005|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338006|NCT01012232|Ropivacaine|ropivacaine|mesh-list
44338007|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
44338008|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
44338009|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338010|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338011|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
44338012|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338013|NCT01012284|Bedaquiline|bedaquiline|mesh-list
44338014|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
44338015|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130156|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130189|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130190|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
44130191|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130192|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44130193|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130194|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130195|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130196|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130197|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130198|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130199|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
44130201|NCT00144703|Tacrolimus|tacrolimus|mesh-list
44130202|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130211|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130212|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
44130213|NCT00144716|Insect Repellents|insect repellents|mesh-list
44130214|NCT00144716|Protective Agents|protective agents|mesh-ancestor
44130215|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130216|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
44130217|NCT00144755|Hematinics|hematinics|mesh-ancestor
44130218|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
44130219|NCT00144807|Rituximab|rituximab|mesh-list
44130220|NCT00144807|Doxorubicin|doxorubicin|mesh-list
44130221|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130222|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
44130223|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130224|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338016|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338018|NCT01012349|Citric Acid|citric acid|mesh-list
44338019|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
44338020|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44338021|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338022|NCT01012349|Analgesics|analgesics|mesh-ancestor
44338023|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
44338024|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338025|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338026|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338027|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338028|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44338029|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44338030|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338031|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44338032|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44338033|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338034|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
44338035|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
44338036|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44338037|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
44338038|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
44338039|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44338040|NCT01012479|Candesartan|candesartan|mesh-list
44338041|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
44338042|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130225|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130226|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
44130227|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130228|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130229|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44130230|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130231|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130232|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130233|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130234|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130235|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
44130236|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44130237|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
44130238|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130239|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
44130240|NCT00144820|Protective Agents|protective agents|mesh-ancestor
44130241|NCT00144833|Ritonavir|ritonavir|mesh-list
44130242|NCT00144833|Lopinavir|lopinavir|mesh-list
44130243|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
44130244|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44130245|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44130246|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338044|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
44338045|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338046|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44338047|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44338048|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338049|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44338050|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44338051|NCT01012544|Clopidogrel|clopidogrel|mesh-list
44338052|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44338053|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44338054|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44338055|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44338056|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
44338057|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338058|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338059|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338060|NCT01012570|Adalimumab|adalimumab|mesh-list
44338061|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338062|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338063|NCT01012687|Perindopril|perindopril|mesh-list
44338064|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44338065|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338066|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338067|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338068|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338069|NCT01012700|Poly ICLC|poly iclc|mesh-list
44338070|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
44338071|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
44338072|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338073|NCT01012830|Huperzine A|huperzine a|mesh-list
44338074|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44338075|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338076|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130247|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163830|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
44338077|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
44338078|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338079|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338080|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44338081|NCT01012830|Protective Agents|protective agents|mesh-ancestor
44338082|NCT01012843|Amoxicillin|amoxicillin|mesh-list
44338083|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
44338084|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
44338085|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44338086|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338087|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338088|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44338089|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338090|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338091|NCT01012869|Everolimus|everolimus|mesh-list
44338092|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338093|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338094|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
44338095|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338096|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
44338097|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338098|NCT01012934|Alendronate|alendronate|mesh-list
44338099|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44338100|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338101|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
44338102|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44338103|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338104|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
44338105|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338106|NCT01013012|Dexamethasone|dexamethasone|mesh-list
44338107|NCT01013012|Ramosetron|ramosetron|mesh-list
44338115|NCT01013012|Hormones|hormones|mesh-ancestor
44338120|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
44338121|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338122|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338123|NCT01013103|Atorvastatin|atorvastatin|mesh-list
44338124|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44338125|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44338126|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
44338127|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338128|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44338129|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44338130|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338131|NCT01013155|Perindopril|perindopril|mesh-list
44338132|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44338133|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338134|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338135|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338136|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338137|NCT01013272|Lamivudine|lamivudine|mesh-list
44338138|NCT01013272|Entecavir|entecavir|mesh-list
44338139|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44338140|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44338141|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338142|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338143|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
44338144|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338145|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44338146|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44338147|NCT01013402|Insulin|insulin|mesh-list
44338148|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44338149|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44338150|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338162|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338163|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44338164|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
44338165|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
44338166|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338167|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338168|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44338169|NCT01013506|Letrozole|letrozole|mesh-list
44338170|NCT01013506|Goserelin|goserelin|mesh-list
44338171|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338172|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44338173|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338174|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338175|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44338176|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44338177|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44338178|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
44338179|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338180|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338181|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338182|NCT01013532|Aspirin|aspirin|mesh-list
44338183|NCT01013532|Cilostazol|cilostazol|mesh-list
44338184|NCT01013532|Probucol|probucol|mesh-list
44338185|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44338186|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338187|NCT01013532|Analgesics|analgesics|mesh-ancestor
44338188|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
44338189|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338191|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338207|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44338208|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44338209|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44338210|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44338211|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
44338212|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44338213|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
44338214|NCT01013558|Remifentanil|remifentanil|mesh-list
44338215|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338216|NCT01013558|Narcotics|narcotics|mesh-ancestor
44338217|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338218|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338219|NCT01013558|Analgesics|analgesics|mesh-ancestor
44338220|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
44338221|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338222|NCT01013571|Insulin|insulin|mesh-list
44338223|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44338224|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
44338225|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
44338226|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44338227|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338228|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
44338229|NCT01013584|Vitamin D|vitamin d|mesh-list
44338230|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44338231|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338232|NCT01013584|Vitamins|vitamins|mesh-ancestor
44338233|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
44338234|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44338235|NCT01013675|Vaccines|vaccines|mesh-list
44338236|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
44338237|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338238|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
44338239|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44338240|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338250|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338251|NCT01013805|Antidotes|antidotes|mesh-ancestor
44338252|NCT01013805|Protective Agents|protective agents|mesh-ancestor
44338253|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
44338254|NCT01013805|Vitamins|vitamins|mesh-ancestor
44338255|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
44338256|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44338257|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338258|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44338259|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338260|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338261|NCT01013909|Terbinafine|terbinafine|mesh-list
44338262|NCT01013909|Bifonazole|bifonazole|mesh-list
44338263|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
44338264|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338265|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338266|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338267|NCT01013987|Ritonavir|ritonavir|mesh-list
44338268|NCT01013987|Darunavir|darunavir|mesh-list
44338269|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
44338270|NCT01013987|Maraviroc|maraviroc|mesh-list
44338271|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44338272|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44338273|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338274|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338275|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338276|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44338277|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44338278|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
44338279|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338280|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44338281|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44338294|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
44338295|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44338296|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44338297|NCT01014104|Prednisolone|prednisolone|mesh-list
44338298|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
44338299|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44338300|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
44338301|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338302|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
44338303|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
44338304|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338305|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338306|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338307|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
44338308|NCT01014104|Hormones|hormones|mesh-ancestor
44338309|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338310|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44338311|NCT01014104|Protective Agents|protective agents|mesh-ancestor
44338312|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338313|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338314|NCT01014156|Epoprostenol|epoprostenol|mesh-list
44338315|NCT01014156|Tezosentan|tezosentan|mesh-list
44338316|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338317|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44338318|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
44338319|NCT01014221|Prednisolone|prednisolone|mesh-list
44338320|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338321|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
44338322|NCT01014221|Hormones|hormones|mesh-ancestor
44338323|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338324|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338325|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338337|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
44338338|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338339|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44338340|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338341|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338342|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338344|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44338345|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338346|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338347|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44338348|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44338349|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338350|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338351|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786248|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
44338352|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44338353|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
44338354|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44338355|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338356|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44338357|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44338358|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44338359|NCT01014260|Doxycycline|doxycycline|mesh-list
44338360|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338361|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338362|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
44338363|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44338364|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44338365|NCT01014338|Fosinopril|fosinopril|mesh-list
44338366|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44338367|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338368|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338369|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338370|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338371|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
44338374|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44338375|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338377|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44338378|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338379|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
44338380|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338381|NCT01014468|Bevacizumab|bevacizumab|mesh-list
44338382|NCT01014468|Ranibizumab|ranibizumab|mesh-list
44338383|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44338384|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338385|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44338386|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44338387|NCT01014468|Growth Substances|growth substances|mesh-ancestor
44338388|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338389|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
44338390|NCT01014481|Tenofovir|tenofovir|mesh-list
44338391|NCT01014481|Lamivudine|lamivudine|mesh-list
44338392|NCT01014481|Efavirenz|efavirenz|mesh-list
44338393|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
44338394|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338395|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44338396|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44338397|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338398|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338399|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44338400|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44338401|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44338402|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44338403|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44338404|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44338405|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44338406|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44338407|NCT01014507|Goserelin|goserelin|mesh-list
44338408|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
44338409|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
44130248|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338410|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44338411|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338412|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338413|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338414|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44338416|NCT01014520|Amitriptyline|amitriptyline|mesh-list
44338417|NCT01014520|Analgesics|analgesics|mesh-ancestor
44338418|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
44338419|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338420|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338421|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
44338422|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44338423|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44338424|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338425|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44338426|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44338427|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44338428|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338429|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338430|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
44338431|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44338432|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
44338433|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338434|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44338435|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44338436|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44338437|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44338438|NCT01014559|Oxycodone|oxycodone|mesh-list
44338439|NCT01014559|Naloxone|naloxone|mesh-list
44338440|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338441|NCT01014559|Narcotics|narcotics|mesh-ancestor
44338442|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338443|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338444|NCT01014559|Analgesics|analgesics|mesh-ancestor
44338445|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
44338447|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44338448|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
44338449|NCT01014637|Clotrimazole|clotrimazole|mesh-list
44338451|NCT01014637|Amorolfine|amorolfine|mesh-list
44338452|NCT01014637|Ciclopirox|ciclopirox|mesh-list
44338453|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
44338454|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338455|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44338456|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44338457|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44338458|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338459|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338460|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44338461|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
44338462|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338463|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338464|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44338465|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44338466|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
44338467|NCT01014650|Glycine|glycine|mesh-list
44338468|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
44338469|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338470|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338471|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338472|NCT01014793|Cabergoline|cabergoline|mesh-list
44338473|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44338474|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44338475|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
44338476|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
44338477|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338478|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338479|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130249|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44130250|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44130251|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
44130252|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130253|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44130254|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44130255|NCT00144846|Albuterol|albuterol|mesh-list
44130256|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44338481|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44338482|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44338483|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338484|NCT01014845|Vaccines|vaccines|mesh-list
44338485|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
44338486|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338487|NCT01014858|Donepezil|donepezil|mesh-list
44338488|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44338489|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338490|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338491|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
43599786|NCT03287180|Naloxone|naloxone|mesh-list
44338492|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338493|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338494|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
44338495|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
44338496|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44338497|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44338498|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
44338499|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338500|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338501|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338502|NCT01015040|Urological Agents|urological agents|mesh-ancestor
44338503|NCT01015053|Ropivacaine|ropivacaine|mesh-list
44338504|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
44338505|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
44338506|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338507|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338508|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
44338509|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130257|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
44130258|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130259|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130260|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44130261|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
44130262|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
44130263|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44130264|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44130265|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44130266|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44130267|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130268|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130279|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338510|NCT01015066|Naltrexone|naltrexone|mesh-list
44338511|NCT01015066|Buprenorphine|buprenorphine|mesh-list
44338512|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44338513|NCT01015066|Naloxone|naloxone|mesh-list
44338514|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338515|NCT01015066|Narcotics|narcotics|mesh-ancestor
44338516|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338517|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338518|NCT01015066|Analgesics|analgesics|mesh-ancestor
44338519|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
44338520|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338521|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44338522|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44338523|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
44338524|NCT01015183|Astringents|astringents|mesh-ancestor
44338525|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338526|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
44338527|NCT01015196|Daunorubicin|daunorubicin|mesh-list
44338528|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338529|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338530|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44338531|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44338532|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338533|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338534|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
44338535|NCT01015209|Chitosan|chitosan|mesh-list
44338536|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44338537|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44338538|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44338539|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
44338540|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338541|NCT01015209|Expectorants|expectorants|mesh-ancestor
44338542|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
44338543|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44338544|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
43747630|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130280|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44130281|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44130283|NCT00144911|Xhance|xhance|mesh-list
44130284|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44130285|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130286|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44130287|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
44338545|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338546|NCT01015209|Protective Agents|protective agents|mesh-ancestor
44338547|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338548|NCT01015209|Antidotes|antidotes|mesh-ancestor
44338549|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44338550|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44338551|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
44338552|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44338553|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
44338554|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
44338555|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
44338556|NCT01015209|Coagulants|coagulants|mesh-ancestor
44338557|NCT01015235|Ketorolac|ketorolac|mesh-list
44338558|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44338559|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44338560|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338561|NCT01015235|Analgesics|analgesics|mesh-ancestor
44338562|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
44338563|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338564|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338565|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338566|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338567|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44338568|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338569|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338570|NCT01015248|Rituximab|rituximab|mesh-list
44338571|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44338572|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44338573|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338574|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
44338575|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338576|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338577|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43747649|NCT05350943|Gemcitabine|gemcitabine|mesh-list
44130288|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130289|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130290|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44130291|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
44130292|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
44130293|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44338579|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338580|NCT01015300|Bevacizumab|bevacizumab|mesh-list
44338581|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44338582|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338583|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44338584|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44338585|NCT01015300|Growth Substances|growth substances|mesh-ancestor
44338586|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338587|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
44338588|NCT01015339|Paclitaxel|paclitaxel|mesh-list
44338589|NCT01015339|Cisplatin|cisplatin|mesh-list
44338590|NCT01015339|Capecitabine|capecitabine|mesh-list
44338591|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44338592|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338593|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
44338594|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
44338595|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
44338596|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338597|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338598|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
44338599|NCT01015352|Azacitidine|azacitidine|mesh-list
44338600|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
44338601|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338602|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
44338603|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338604|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338605|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338606|NCT01015352|Hematinics|hematinics|mesh-ancestor
44338607|NCT01015391|Azathioprine|azathioprine|mesh-list
44338608|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
44338609|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338610|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338611|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338617|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44338618|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
44338619|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
44338620|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338621|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43993746|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
44338622|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44338623|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338624|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338625|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
44338626|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
44338627|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338628|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
44338629|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338630|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338631|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44338632|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
44338633|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338634|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338635|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44338636|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338637|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44338638|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
44338639|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338640|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747706|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
44130294|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44130295|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44130296|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44130297|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130298|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130299|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130300|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44130301|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130302|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44130303|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130304|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130306|NCT00144989|Irinotecan|irinotecan|mesh-list
44130307|NCT00144989|Etoposide|etoposide|mesh-list
44130308|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130309|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44130310|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130311|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130312|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130313|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44338641|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338642|NCT01015482|Midazolam|midazolam|mesh-list
44338643|NCT01015482|Remifentanil|remifentanil|mesh-list
44338644|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44338645|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44338646|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338647|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338648|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44338649|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44338650|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44338651|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44338652|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
44338653|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
44338654|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
44338655|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
44338656|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338657|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338658|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338659|NCT01015482|Narcotics|narcotics|mesh-ancestor
44338660|NCT01015482|Analgesics|analgesics|mesh-ancestor
44338661|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
44338662|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338663|NCT01015495|Ranibizumab|ranibizumab|mesh-list
44338664|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44338665|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44338666|NCT01015495|Growth Substances|growth substances|mesh-ancestor
44338667|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338668|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
44338669|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338670|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
44338671|NCT01015547|Methotrexate|methotrexate|mesh-list
44338672|NCT01015547|Infliximab|infliximab|mesh-list
44338673|NCT01015547|Naltrexone|naltrexone|mesh-list
44338674|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44338675|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
44338683|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338684|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44338685|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338686|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
44338687|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338688|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44338689|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338690|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338691|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44338692|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338694|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
44338695|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338696|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338697|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44338698|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44338699|NCT01015651|Remifentanil|remifentanil|mesh-list
44338700|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338701|NCT01015651|Narcotics|narcotics|mesh-ancestor
44338702|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338703|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338704|NCT01015651|Analgesics|analgesics|mesh-ancestor
44338705|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
44338706|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338707|NCT01015664|Sirolimus|sirolimus|mesh-list
44338708|NCT01015664|Cisplatin|cisplatin|mesh-list
44338709|NCT01015664|Cetuximab|cetuximab|mesh-list
44338710|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338711|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44338712|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338713|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130314|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130315|NCT00145002|Lenograstim|lenograstim|mesh-list
44130316|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44130317|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
44130318|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130319|NCT00145028|Carboplatin|carboplatin|mesh-list
44130320|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130321|NCT00145093|Chromium|chromium|mesh-list
44130322|NCT00145093|Trace Elements|trace elements|mesh-ancestor
44130323|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
44130324|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130325|NCT00145106|Minocycline|minocycline|mesh-list
44130326|NCT00145106|Tazarotene|tazarotene|mesh-list
44130327|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130328|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338714|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338715|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
44338716|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338717|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
44338718|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338719|NCT01015729|Esomeprazole|esomeprazole|mesh-list
44338720|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338721|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338722|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44338723|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338724|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44338725|NCT01015794|Ephedrine|ephedrine|mesh-list
44338726|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
44338727|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44338728|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338729|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
44338730|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
44338731|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338732|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44338733|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44338734|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338735|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338736|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44338737|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44338738|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
44338739|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
44338740|NCT01015937|Losartan|losartan|mesh-list
44338741|NCT01015937|Enalapril|enalapril|mesh-list
44338742|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
44338743|NCT01015937|Giapreza|giapreza|mesh-list
44338744|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44338758|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44338759|NCT01016002|Temoporfin|temoporfin|mesh-list
44338760|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338761|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44338762|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44338763|NCT01016041|Paclitaxel|paclitaxel|mesh-list
44338764|NCT01016041|Everolimus|everolimus|mesh-list
44338765|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44338766|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338767|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44338768|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44338769|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44338770|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338771|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338772|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
44338773|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338774|NCT01016054|Gemcitabine|gemcitabine|mesh-list
44338775|NCT01016054|Carboplatin|carboplatin|mesh-list
44338776|NCT01016054|Doxorubicin|doxorubicin|mesh-list
44338777|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44338778|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338779|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338780|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
44338781|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338782|NCT01016054|Antiviral Agents|antiviral agents|mesh-ancestor
44338783|NCT01016054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130329|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44130330|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
44130331|NCT00145171|Apomorphine|apomorphine|mesh-list
44130332|NCT00145171|Emetics|emetics|mesh-ancestor
44155328|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155330|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155331|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44155332|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155333|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
44155334|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44155335|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155336|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155337|NCT00226746|Gemcitabine|gemcitabine|mesh-list
44155338|NCT00226746|Paclitaxel|paclitaxel|mesh-list
44155339|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44155340|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155341|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
44155342|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
44155343|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
44155344|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155345|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155346|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
44130345|NCT00145210|Atenolol|atenolol|mesh-list
44130346|NCT00145210|Nebivolol|nebivolol|mesh-list
44130347|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44338784|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338785|NCT01016054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44338786|NCT01016054|Immunologic Factors|immunologic factors|mesh-ancestor
44338787|NCT01016054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338788|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338789|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44338790|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44338791|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
44338792|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44338793|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338794|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
44338795|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44338796|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44338797|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338798|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338799|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44338800|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44338801|NCT01016184|Vitamin D|vitamin d|mesh-list
44338802|NCT01016184|Vitamins|vitamins|mesh-ancestor
44338803|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
44338804|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338805|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44338806|NCT01016223|Beclomethasone|beclomethasone|mesh-list
44338807|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338808|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
44338809|NCT01016223|Hormones|hormones|mesh-ancestor
44338810|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338811|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338812|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44338813|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
44338814|NCT01016249|Epinephrine|epinephrine|mesh-list
44338815|NCT01016249|Racepinephrine|racepinephrine|mesh-list
44338816|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
44338817|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44338824|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44338825|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
44338826|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338827|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44338828|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
44338829|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
44338830|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
44338831|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44338832|NCT01016509|Insulin|insulin|mesh-list
44338833|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44338834|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44338835|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338836|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
44338837|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44338838|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338839|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44338840|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
44338841|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44338842|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338843|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338844|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338845|NCT01016639|Capecitabine|capecitabine|mesh-list
44338846|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
44338847|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44338848|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
44338849|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130348|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130349|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
44130350|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
44130351|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130352|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130353|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44130354|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44130355|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44130356|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130357|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130358|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130359|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
44130360|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44130361|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44130362|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44130363|NCT00145236|Nebivolol|nebivolol|mesh-list
44130364|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130365|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
44130366|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44130367|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44130368|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44130369|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
44338850|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338851|NCT01016665|Anastrozole|anastrozole|mesh-list
44338852|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338853|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338854|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44338855|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44338856|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338857|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338858|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44338859|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
44338860|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338861|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338862|NCT01016717|Omeprazole|omeprazole|mesh-list
44338863|NCT01016717|Pantoprazole|pantoprazole|mesh-list
44338864|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44338865|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338866|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44338867|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338868|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338869|NCT01016730|Bortezomib|bortezomib|mesh-list
44338870|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338871|NCT01016795|Lenograstim|lenograstim|mesh-list
44338872|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44338873|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
44338874|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338875|NCT01016821|Oxycodone|oxycodone|mesh-list
44130370|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130371|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130372|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130377|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44130378|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44130379|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130380|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130381|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44130382|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130384|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
44130385|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130386|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130387|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130388|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130389|NCT00145314|Leucovorin|leucovorin|mesh-list
44130390|NCT00145314|Folic Acid|folic acid|mesh-list
44130391|NCT00145314|Fluorouracil|fluorouracil|mesh-list
44130392|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
44130393|NCT00145314|Cetuximab|cetuximab|mesh-list
44130394|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
44130395|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
44130396|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338876|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44338877|NCT01016821|Narcotics|narcotics|mesh-ancestor
44338878|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338879|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338880|NCT01016821|Analgesics|analgesics|mesh-ancestor
44338881|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
44338882|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338883|NCT01016860|Irinotecan|irinotecan|mesh-list
44338884|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44338885|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44338886|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338887|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338888|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338889|NCT01016886|Bisoprolol|bisoprolol|mesh-list
44338890|NCT01016886|Perindopril|perindopril|mesh-list
44338891|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44338892|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
44338893|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
44338894|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338895|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338896|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44338897|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44338898|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44338899|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
44338900|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338901|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338902|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44338903|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
44338904|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338921|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
44338922|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44338923|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44338924|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338925|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338926|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
44338927|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44338928|NCT01017133|Fluorides|fluorides|mesh-list
44338929|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44338930|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338931|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
44338932|NCT01017133|Protective Agents|protective agents|mesh-ancestor
44338933|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338934|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
44338935|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
44338936|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44338937|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
44338938|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44338939|NCT01017159|Antibodies|antibodies|mesh-list
44338940|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
44338941|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338942|NCT01017198|Antacids|antacids|mesh-list
44130397|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130398|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130399|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130400|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
44130401|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130402|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130403|NCT00145314|Antidotes|antidotes|mesh-ancestor
44130404|NCT00145314|Protective Agents|protective agents|mesh-ancestor
44130405|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
44130406|NCT00145314|Vitamins|vitamins|mesh-ancestor
44130407|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
44130408|NCT00145314|Hematinics|hematinics|mesh-ancestor
44130409|NCT00145340|Pioglitazone|pioglitazone|mesh-list
44130410|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44130411|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130412|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
44130413|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44130414|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130415|NCT00145379|Metformin|metformin|mesh-list
44130416|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44130417|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130418|NCT00145405|Octreotide|octreotide|mesh-list
44130419|NCT00145405|Lanreotide|lanreotide|mesh-list
44130420|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44130421|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44130422|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130423|NCT00145444|Olanzapine|olanzapine|mesh-list
44130424|NCT00145444|Ziprasidone|ziprasidone|mesh-list
44130425|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
44130426|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
44130427|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130428|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130429|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338943|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338944|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44338945|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44338946|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44338947|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338949|NCT01017354|Vitamins|vitamins|mesh-ancestor
44338950|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
44338951|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338952|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44338953|NCT01017367|Antibodies|antibodies|mesh-list
44338954|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
44338955|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338956|NCT01017380|Celecoxib|celecoxib|mesh-list
44338957|NCT01017380|Etoricoxib|etoricoxib|mesh-list
44338958|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44338959|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44338960|NCT01017380|Analgesics|analgesics|mesh-ancestor
44338961|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
44338962|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338963|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338964|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44338965|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44338966|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44338967|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44338968|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44338969|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338970|NCT01017393|Ketamine|ketamine|mesh-list
44338971|NCT01017393|Analgesics|analgesics|mesh-ancestor
44338972|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
44338973|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44338974|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338975|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44130430|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44130431|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44130432|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44130433|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44130434|NCT00145444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44130435|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44130436|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44338976|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44338977|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
44338978|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
44338979|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44338980|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44338981|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44338982|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44338983|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44338984|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
44338985|NCT01017458|Testosterone|testosterone|mesh-list
44338986|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
44338987|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
44338988|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44338989|NCT01017458|Androgens|androgens|mesh-ancestor
44338990|NCT01017458|Hormones|hormones|mesh-ancestor
44338991|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44338992|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44338993|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44338994|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44338995|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
44338996|NCT01017640|Mitomycins|mitomycins|mesh-list
44338997|NCT01017640|Mitomycin|mitomycin|mesh-list
44338998|NCT01017640|Veliparib|veliparib|mesh-list
44338999|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44339000|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339001|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
44339014|NCT01017679|Gefitinib|gefitinib|mesh-list
44339021|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339022|NCT01017770|Artesunate|artesunate|mesh-list
44339023|NCT01017770|Lumefantrine|lumefantrine|mesh-list
44339024|NCT01017770|Artemether|artemether|mesh-list
44339025|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44339026|NCT01017770|Amodiaquine|amodiaquine|mesh-list
44339027|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
44339028|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44339029|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44339030|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339031|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339032|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
44339033|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
44339034|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44339035|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
44339036|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
44339037|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
44339038|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44339039|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
44339040|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339041|NCT01017796|Expectorants|expectorants|mesh-ancestor
44339042|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339043|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44339044|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
44339045|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339046|NCT01017796|Protective Agents|protective agents|mesh-ancestor
44339047|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339048|NCT01017796|Antidotes|antidotes|mesh-ancestor
44339049|NCT01017796|Vitamins|vitamins|mesh-ancestor
44339050|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
44339051|NCT01017809|Aprepitant|aprepitant|mesh-list
44339052|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
44339053|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
43747888|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130437|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130438|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130439|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
44130440|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44130441|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44130442|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
44130443|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
44130444|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
44130445|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44130448|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130449|NCT00145483|Urological Agents|urological agents|mesh-ancestor
44130450|NCT00145522|Tibolone|tibolone|mesh-list
44130451|NCT00145522|Estradiol|estradiol|mesh-list
44339054|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339055|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339056|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339057|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44339058|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339059|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339060|NCT01017822|Gemcitabine|gemcitabine|mesh-list
44339061|NCT01017822|Capecitabine|capecitabine|mesh-list
44339062|NCT01017822|Conatumumab|conatumumab|mesh-list
44339063|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44339064|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
44339065|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339066|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339067|NCT01017822|Antiviral Agents|antiviral agents|mesh-ancestor
44339068|NCT01017822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339069|NCT01017822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339070|NCT01017822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339071|NCT01017822|Immunologic Factors|immunologic factors|mesh-ancestor
44339072|NCT01017822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339073|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339074|NCT01017926|Triazolam|triazolam|mesh-list
44339075|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44339076|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44339077|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44339078|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339079|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339080|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339081|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
44339082|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
44339083|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339084|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339085|NCT01017939|Prednisone|prednisone|mesh-list
44339086|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
44339087|NCT01017939|Theophylline|theophylline|mesh-list
44339093|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339094|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44339095|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339096|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44339097|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339098|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339099|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
44339100|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44339101|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
44339102|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339103|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44339104|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44339105|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339106|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44339107|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
44339108|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339109|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44339110|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44339111|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
44339112|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44339113|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44339114|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
44339115|NCT01018160|Rabeprazole|rabeprazole|mesh-list
44339116|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44339117|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339118|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44339119|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747927|NCT04788615|Analgesics|analgesics|mesh-ancestor
44130452|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
44130453|NCT00145522|Estrogens|estrogens|mesh-ancestor
44130454|NCT00145522|Hormones|hormones|mesh-ancestor
44130455|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130456|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130457|NCT00145522|Progestins|progestins|mesh-ancestor
44130458|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
44130459|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599791|NCT03287180|Analgesics|analgesics|mesh-ancestor
44130460|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130461|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44130462|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130463|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44130464|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
44130465|NCT00145561|Ritonavir|ritonavir|mesh-list
44130466|NCT00145561|Saquinavir|saquinavir|mesh-list
44130467|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44130468|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44339120|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339122|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44339123|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44339124|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
44339125|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339126|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339127|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339128|NCT01018225|Urological Agents|urological agents|mesh-ancestor
44339129|NCT01018251|Alovudine|alovudine|mesh-list
44339130|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
44339131|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339132|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
44339133|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44339134|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339135|NCT01018342|Renal Agents|renal agents|mesh-ancestor
44339136|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339137|NCT01018368|Rifampin|rifampin|mesh-list
44339138|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44339139|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
44339140|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339141|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339142|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
44339143|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44339144|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339145|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339146|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44339147|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44339148|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44339149|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44339162|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339163|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
44339164|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339165|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339166|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339167|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44339168|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
44339169|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44339170|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44339171|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44339172|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339173|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339174|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
44339175|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339176|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339177|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44339178|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339179|NCT01018602|Vildagliptin|vildagliptin|mesh-list
44339180|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44339181|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339182|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44339183|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
44339184|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339185|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339186|NCT01018615|Silymarin|silymarin|mesh-list
44339187|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
44339188|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339189|NCT01018615|Protective Agents|protective agents|mesh-ancestor
44339190|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339191|NCT01018758|Palonosetron|palonosetron|mesh-list
44339192|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
44339193|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
44130469|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
44130470|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130471|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130472|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44130473|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44130474|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
44130475|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130476|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44339194|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339195|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339196|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339197|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44339198|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44339199|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
44339200|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339201|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339202|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
44339203|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44339204|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339205|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44339206|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339207|NCT01018836|Riluzole|riluzole|mesh-list
44339208|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
44339209|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44339210|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44339211|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339212|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339213|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339214|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44339215|NCT01018836|Protective Agents|protective agents|mesh-ancestor
44339216|NCT01018849|Vitamin D|vitamin d|mesh-list
44339217|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
44339218|NCT01018849|Vitamins|vitamins|mesh-ancestor
44339219|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
44339220|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339221|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44339222|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339223|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
44339224|NCT01018914|Tacrolimus|tacrolimus|mesh-list
44130477|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44130478|NCT00145613|Antibodies|antibodies|mesh-list
44130479|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
44130480|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130481|NCT00145639|Carboplatin|carboplatin|mesh-list
44130482|NCT00145639|Doxorubicin|doxorubicin|mesh-list
44130483|NCT00145639|Ifosfamide|ifosfamide|mesh-list
44130484|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130485|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130486|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44163831|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339225|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339226|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
44339227|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339228|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44339229|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339230|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339231|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44339232|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339233|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44339234|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
44339235|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339236|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339237|NCT01019070|Asunaprevir|asunaprevir|mesh-list
44339238|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44339239|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339240|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339241|NCT01019083|Zinc|zinc|mesh-list
44339242|NCT01019083|Albendazole|albendazole|mesh-list
44339243|NCT01019083|Secnidazole|secnidazole|mesh-list
44339244|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
44339245|NCT01019083|Trace Elements|trace elements|mesh-ancestor
44339246|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
44339247|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339248|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
44339249|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44339250|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339251|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
43747973|NCT04657640|Iron|iron|mesh-list
44130487|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130488|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130489|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130490|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130491|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
44130492|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44130493|NCT00145652|Hematinics|hematinics|mesh-ancestor
44130494|NCT00145665|Telbivudine|telbivudine|mesh-list
44130495|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
44130496|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130497|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44130498|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130499|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130500|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
44130501|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
44130502|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44130503|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44130504|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130505|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163832|NCT00254020|Citalopram|citalopram|mesh-list
44339252|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44339253|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44339254|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44339255|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44339256|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44339257|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339258|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339259|NCT01019083|Astringents|astringents|mesh-ancestor
44339260|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
44339261|NCT01019109|Cobalt|cobalt|mesh-list
44339262|NCT01019109|Trace Elements|trace elements|mesh-ancestor
44339263|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
44339264|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339265|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
44339266|NCT01019174|Lenalidomide|lenalidomide|mesh-list
44339267|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339268|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
44339269|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339270|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339271|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339272|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
44339273|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339274|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339275|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44339276|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44339277|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44339278|NCT01019174|Growth Substances|growth substances|mesh-ancestor
44339279|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
44339280|NCT01019265|Buprenorphine|buprenorphine|mesh-list
44339281|NCT01019265|Tramadol|tramadol|mesh-list
44339282|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44339283|NCT01019265|Narcotics|narcotics|mesh-ancestor
44339284|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339285|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339286|NCT01019265|Analgesics|analgesics|mesh-ancestor
44339290|NCT01019278|Cisplatin|cisplatin|mesh-list
44339293|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
44339294|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339295|NCT01019382|Gemcitabine|gemcitabine|mesh-list
44339296|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44339297|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
44339298|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339299|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339300|NCT01019382|Antiviral Agents|antiviral agents|mesh-ancestor
44339301|NCT01019382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339302|NCT01019382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339303|NCT01019382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339304|NCT01019382|Immunologic Factors|immunologic factors|mesh-ancestor
44339305|NCT01019382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339306|NCT01019395|Daptomycin|daptomycin|mesh-list
44339307|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339308|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339309|NCT01019408|Chloroquine|chloroquine|mesh-list
44339310|NCT01019408|Amebicides|amebicides|mesh-ancestor
44339311|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44339312|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44339313|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339314|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
44339315|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994419|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
44339316|NCT01019434|Sirolimus|sirolimus|mesh-list
44339317|NCT01019434|Temozolomide|temozolomide|mesh-list
44339318|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339319|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
44339320|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339321|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339322|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339323|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339324|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44339336|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339337|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44339338|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44339339|NCT01019590|Olmesartan|olmesartan|mesh-list
44339340|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44339341|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44339342|NCT01019590|Diuretics|diuretics|mesh-ancestor
44339343|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
44339344|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339345|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44339346|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339347|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339348|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44339349|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44339350|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
44339351|NCT01019603|Tazarotene|tazarotene|mesh-list
44339352|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44339353|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
44339354|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
44339355|NCT01019603|Vitamins|vitamins|mesh-ancestor
44339356|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
44339357|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339358|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
44339359|NCT01019642|Vitamin D|vitamin d|mesh-list
44339360|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339361|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339362|NCT01019642|Vitamins|vitamins|mesh-ancestor
44339363|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
44339364|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44339365|NCT01019655|Nadroparin|nadroparin|mesh-list
44339366|NCT01019655|Calcium|calcium|mesh-list
44339367|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339368|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339369|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
44339370|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44339371|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748041|NCT04189107|BB 1101|bb 1101|mesh-list
44130506|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44339372|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339373|NCT01019668|Verteporfin|verteporfin|mesh-list
44339374|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44339375|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44339376|NCT01019746|Propofol|propofol|mesh-list
44339377|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44339378|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339379|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339380|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44339381|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
44339382|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
44339383|NCT01019772|Vaccines|vaccines|mesh-list
44339384|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
44339385|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339386|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
44339387|NCT01019785|Vitamin D|vitamin d|mesh-list
44339388|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339389|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339390|NCT01019785|Vitamins|vitamins|mesh-ancestor
44339391|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
44339392|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44339393|NCT01019798|Cisplatin|cisplatin|mesh-list
44339394|NCT01019798|Docetaxel|docetaxel|mesh-list
44339395|NCT01019798|Sunitinib|sunitinib|mesh-list
44339396|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339397|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44339398|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44339399|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
44339400|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339401|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44339402|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44339403|NCT01019798|Growth Substances|growth substances|mesh-ancestor
44339404|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339405|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
44339406|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44339407|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339408|NCT01019850|Vorinostat|vorinostat|mesh-list
44339412|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339413|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339414|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44339415|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
44339416|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339417|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
44339418|NCT01019876|Fludarabine|fludarabine|mesh-list
44339419|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339420|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
44339421|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339422|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339423|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339424|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
44339425|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339426|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339427|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44339428|NCT01019941|Docetaxel|docetaxel|mesh-list
44339429|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339430|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44339431|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130507|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44130508|NCT00145730|Ibuprofen|ibuprofen|mesh-list
44130509|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44130510|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130511|NCT00145730|Analgesics|analgesics|mesh-ancestor
44130512|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
44130513|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130514|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130515|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130516|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130517|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44130518|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130533|NCT00145925|Perindopril|perindopril|mesh-list
44130534|NCT00145925|Indapamide|indapamide|mesh-list
44130535|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
44130536|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44130537|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
44130538|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130539|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130540|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130541|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44130542|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130543|NCT00145925|Diuretics|diuretics|mesh-ancestor
44130544|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
44130545|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44130546|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130547|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
44130548|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
44130549|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44130550|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44130551|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130552|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130553|NCT00145938|Urological Agents|urological agents|mesh-ancestor
44130554|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
44339432|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44339433|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339435|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339436|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44339437|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339438|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339439|NCT01020162|Gabapentin|gabapentin|mesh-list
44339440|NCT01020162|Amitriptyline|amitriptyline|mesh-list
44339441|NCT01020162|Analgesics|analgesics|mesh-ancestor
44339442|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
44339443|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339444|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339445|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
44339446|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44339447|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44339448|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339449|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339450|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44339451|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44339452|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339453|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339454|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
44339455|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44339456|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
44339457|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339458|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44339459|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44339475|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
44339476|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44339477|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44339478|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339479|NCT01020253|Vitamins|vitamins|mesh-ancestor
44339480|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
44339481|NCT01020279|Celecoxib|celecoxib|mesh-list
44339482|NCT01020279|Ketoprofen|ketoprofen|mesh-list
44339483|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44339484|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339485|NCT01020279|Analgesics|analgesics|mesh-ancestor
44339486|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
44339487|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339488|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339489|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339490|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339491|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44339492|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44339493|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339494|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339495|NCT01020292|Nelfinavir|nelfinavir|mesh-list
44339496|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44339497|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44339498|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
44339499|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339500|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339501|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44339502|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44339503|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
44339504|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339505|NCT01020331|Memantine|memantine|mesh-list
44339506|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44339507|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44339517|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44339518|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339519|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44339521|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44339522|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44339523|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
44339524|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339525|NCT01020383|Abciximab|abciximab|mesh-list
44339526|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
44339527|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44339528|NCT01020396|Metronidazole|metronidazole|mesh-list
44339529|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339530|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339531|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44339532|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44339533|NCT01020539|Fludarabine|fludarabine|mesh-list
44339534|NCT01020539|Busulfan|busulfan|mesh-list
44339535|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
44339536|NCT01020539|Isotretinoin|isotretinoin|mesh-list
44339537|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
44339538|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44339539|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339540|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339541|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339542|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
44339543|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339566|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
44339567|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44339568|NCT01020708|Mesalamine|mesalamine|mesh-list
44339569|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44339570|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
44339571|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339572|NCT01020708|Expectorants|expectorants|mesh-ancestor
44339573|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339574|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44339575|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
44339576|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339577|NCT01020708|Protective Agents|protective agents|mesh-ancestor
44339578|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339579|NCT01020708|Antidotes|antidotes|mesh-ancestor
44339580|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44339581|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339582|NCT01020708|Analgesics|analgesics|mesh-ancestor
44339583|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
44339584|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339585|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339586|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339587|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
44339588|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339620|NCT01020825|Coagulants|coagulants|mesh-ancestor
44339621|NCT01020864|Carboplatin|carboplatin|mesh-list
44339623|NCT01020864|Vinorelbine|vinorelbine|mesh-list
44339624|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339625|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339626|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44339627|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44339628|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44339629|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44339630|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339631|NCT01020955|Mecasermin|mecasermin|mesh-list
44339632|NCT01020955|Growth Substances|growth substances|mesh-ancestor
44339633|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339634|NCT01020994|Octenidine|octenidine|mesh-list
44339635|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339636|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44339637|NCT01021150|Cisplatin|cisplatin|mesh-list
44339638|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339639|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
44339640|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44339641|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
44339642|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339643|NCT01021163|Expectorants|expectorants|mesh-ancestor
44339644|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339645|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44339646|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
44339670|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
44339671|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339672|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339673|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44339674|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339675|NCT01021436|Amikacin|amikacin|mesh-list
44339676|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339677|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339678|NCT01021475|Domperidone|domperidone|mesh-list
44339679|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
44339680|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
44339681|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339682|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339683|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339684|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44339685|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
44339686|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339687|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339688|NCT01021488|Enoxaparin|enoxaparin|mesh-list
44339689|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44339690|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44339691|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44339692|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
44339720|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339721|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
44339722|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339723|NCT01021579|Metformin|metformin|mesh-list
44339724|NCT01021579|Simvastatin|simvastatin|mesh-list
44339725|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44339726|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339727|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44339728|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44339729|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
44339730|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339731|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44339732|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44339733|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339734|NCT01021592|Bortezomib|bortezomib|mesh-list
44339735|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339736|NCT01021696|Acetaminophen|acetaminophen|mesh-list
44339737|NCT01021696|Pregabalin|pregabalin|mesh-list
44339738|NCT01021696|Morphine|morphine|mesh-list
44339739|NCT01021696|Buprenorphine|buprenorphine|mesh-list
44339740|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44339741|NCT01021696|Narcotics|narcotics|mesh-ancestor
44339742|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339743|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339744|NCT01021696|Analgesics|analgesics|mesh-ancestor
44339745|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
44339746|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339747|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
44339748|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44339749|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339750|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339751|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44339752|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44339764|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339765|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339766|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339767|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44339768|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339770|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
44339771|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339772|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339773|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339774|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
44339775|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
44339776|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44339777|NCT01021787|Protective Agents|protective agents|mesh-ancestor
44339778|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339779|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44339780|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44339781|NCT01021865|Glucagon|glucagon|mesh-list
44339782|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44339783|NCT01021865|Regadenoson|regadenoson|mesh-list
44339784|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339785|NCT01021865|Hormones|hormones|mesh-ancestor
44339786|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339787|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339788|NCT01021865|Incretins|incretins|mesh-ancestor
44339789|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44339790|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44339791|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
44339792|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
44339793|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339794|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339795|NCT01021891|Insulin|insulin|mesh-list
44339796|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44339797|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339798|NCT01021930|Sirolimus|sirolimus|mesh-list
44339799|NCT01021930|Paclitaxel|paclitaxel|mesh-list
44339802|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44339803|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44339804|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
44339805|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339806|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44339807|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339808|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44339809|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
44339810|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44339811|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
44339812|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339814|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44339815|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
44339816|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339817|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339818|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44339819|NCT01021943|Diuretics|diuretics|mesh-ancestor
44339820|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
44339821|NCT01022021|Rituximab|rituximab|mesh-list
44339822|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44339823|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44339824|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339825|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
44339826|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339827|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339828|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44339847|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339849|NCT01022151|Doxapram|doxapram|mesh-list
44339850|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44339851|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
44339852|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339853|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339854|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44339855|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
44339856|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44339857|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44339858|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339859|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339860|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44339861|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44339862|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
44339863|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339864|NCT01022151|Protective Agents|protective agents|mesh-ancestor
44339865|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44339866|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44339867|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
44339868|NCT01022164|Coagulants|coagulants|mesh-ancestor
44339869|NCT01022229|Vitamins|vitamins|mesh-list
44339870|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
44339871|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
44339872|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339873|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
44339874|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44339875|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44339876|NCT01022333|Protective Agents|protective agents|mesh-ancestor
44339877|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339878|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339879|NCT01022463|Atenolol|atenolol|mesh-list
44339880|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44339881|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44339887|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44339888|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44339889|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
44339890|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339891|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339892|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
44339893|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44339894|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44339895|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
44339896|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44339897|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44339898|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44339899|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339900|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339902|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
44339903|NCT01022528|BB 1101|bb 1101|mesh-list
44339904|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44339905|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
44339906|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
44339907|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339908|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339909|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44339910|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
44339911|NCT01022528|Hormones|hormones|mesh-ancestor
44339912|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44339913|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44339914|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339915|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44339916|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339917|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339918|NCT01022541|Bevacizumab|bevacizumab|mesh-list
44339919|NCT01022541|Capecitabine|capecitabine|mesh-list
44339920|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
44130555|NCT00145990|Miotics|miotics|mesh-ancestor
44339927|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
44339928|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44339929|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
44339930|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339931|NCT01022632|Curcumin|curcumin|mesh-list
44339932|NCT01022632|Fluoxetine|fluoxetine|mesh-list
44339933|NCT01022632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44339934|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44339935|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44339936|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339937|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339938|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
44339939|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339940|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44339941|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44339942|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339943|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44339944|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44339945|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339946|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44339947|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44339948|NCT01022632|Analgesics|analgesics|mesh-ancestor
44339949|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
44339950|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339951|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570832|NCT00375193|Amrubicin|amrubicin|mesh-list
44130556|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
44130557|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130558|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130559|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44130560|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44130561|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
44130562|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44130563|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44130564|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
44130565|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130566|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130567|NCT00146016|Amantadine|amantadine|mesh-list
44130568|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44130569|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44130570|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
44130571|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130573|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44339952|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44339953|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339955|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
44339956|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44339957|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
44339958|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44339959|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339960|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44339961|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44339962|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44339963|NCT01022645|Trace Elements|trace elements|mesh-ancestor
44339964|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
44339965|NCT01022658|Insulin|insulin|mesh-list
44339966|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
44339967|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
44339968|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44339969|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339970|NCT01022671|Belotecan|belotecan|mesh-list
44339971|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44339972|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44339973|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44339974|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339975|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44339976|NCT01022736|Gabapentin|gabapentin|mesh-list
44339977|NCT01022736|Analgesics|analgesics|mesh-ancestor
44339978|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
44339979|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339980|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339981|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
44339982|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44339983|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44339984|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44339985|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44339986|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44339987|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44130574|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130575|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130576|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130578|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
44130579|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339989|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44339990|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
44339991|NCT01022749|Vaccines|vaccines|mesh-list
44339992|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
44339993|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44339994|NCT01022840|Ketamine|ketamine|mesh-list
44339995|NCT01022840|Esketamine|esketamine|mesh-list
44339996|NCT01022840|Analgesics|analgesics|mesh-ancestor
44339997|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
44339998|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44339999|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340000|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44340001|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44340002|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
44340003|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
44340004|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340005|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44340006|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44340007|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340008|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340009|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
44340010|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340011|NCT01022918|Bevacizumab|bevacizumab|mesh-list
44340012|NCT01022918|Temozolomide|temozolomide|mesh-list
44340013|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340014|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340015|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340016|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340017|NCT01022918|Growth Substances|growth substances|mesh-ancestor
44340018|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340019|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340020|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44340029|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340030|NCT01022983|Protective Agents|protective agents|mesh-ancestor
44340031|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340032|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44340033|NCT01023087|Colistin|colistin|mesh-list
44340034|NCT01023087|Polymyxins|polymyxins|mesh-list
44340035|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44340036|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340037|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
44340038|NCT01023100|Tofacitinib|tofacitinib|mesh-list
44340039|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44340040|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340041|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340042|NCT01023139|Sibutramine|sibutramine|mesh-list
44340043|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
44340044|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340045|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
44340046|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44340047|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
44340048|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
44340049|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44340050|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340051|NCT01023230|Entecavir|entecavir|mesh-list
44340052|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
44340053|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340054|NCT01023243|Aspirin|aspirin|mesh-list
44340055|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44145644|NCT00195637|Antibodies|antibodies|mesh-list
44340056|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340057|NCT01023243|Analgesics|analgesics|mesh-ancestor
44340058|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
44340059|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340060|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340072|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340073|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340074|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340075|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
44340076|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340077|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44340078|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44340079|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44340080|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340081|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340082|NCT01023347|Paclitaxel|paclitaxel|mesh-list
44340083|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44340084|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340085|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340086|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
44340087|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
44340088|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44340089|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340090|NCT01023360|Esomeprazole|esomeprazole|mesh-list
44340091|NCT01023360|Rabeprazole|rabeprazole|mesh-list
44340092|NCT01023360|Pantoprazole|pantoprazole|mesh-list
44340093|NCT01023360|Clopidogrel|clopidogrel|mesh-list
44340094|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44340095|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44340096|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44340097|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44340098|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44340099|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
44340100|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340101|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340102|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130583|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
44130585|NCT00146042|Trastuzumab|trastuzumab|mesh-list
44130586|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130587|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130588|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130589|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130590|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340103|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44340104|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340105|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340106|NCT01023399|Artesunate|artesunate|mesh-list
44340107|NCT01023399|Amodiaquine|amodiaquine|mesh-list
44340108|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
44340109|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44340110|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44340111|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340112|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340113|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
44340114|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
44340115|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44340116|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
44340117|NCT01023425|Donepezil|donepezil|mesh-list
44340118|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44340119|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340120|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340121|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
44340122|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340123|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130591|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130592|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130593|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130594|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44130595|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44130596|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130597|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
44130598|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44130599|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
44130600|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130601|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130602|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
44130603|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130604|NCT00146120|Etoposide|etoposide|mesh-list
44130605|NCT00146120|Idarubicin|idarubicin|mesh-list
44130606|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130607|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130608|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130609|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130610|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130611|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130612|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130613|NCT00146146|Letrozole|letrozole|mesh-list
44130614|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
44130615|NCT00146146|Dutasteride|dutasteride|mesh-list
44130616|NCT00146146|Testosterone|testosterone|mesh-list
44130617|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
44130618|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
44130619|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44130620|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130621|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44130622|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44130623|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130624|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130625|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44340125|NCT01023464|Emollients|emollients|mesh-list
44340126|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44340127|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44340128|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44340129|NCT01023490|Vitamin D|vitamin d|mesh-list
44340130|NCT01023490|Vitamins|vitamins|mesh-ancestor
44340131|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
44340132|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340133|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44340134|NCT01023542|Everolimus|everolimus|mesh-list
44340135|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340136|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340137|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
44340138|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340139|NCT01023607|Atorvastatin|atorvastatin|mesh-list
44340140|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44340141|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44340142|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44340143|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
44340144|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340145|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44340146|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44340147|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340148|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
44340149|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340150|NCT01023750|Fenofibrate|fenofibrate|mesh-list
44340151|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44340152|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
44340153|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340154|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44340155|NCT01023867|Donepezil|donepezil|mesh-list
44340156|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44340157|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340158|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130626|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
44130627|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130628|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130629|NCT00146146|Androgens|androgens|mesh-ancestor
44130630|NCT00146146|Hormones|hormones|mesh-ancestor
44130631|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44340160|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340161|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340162|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
44340163|NCT01023919|Sirolimus|sirolimus|mesh-list
44340164|NCT01023919|Paclitaxel|paclitaxel|mesh-list
44340165|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340166|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340167|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
44340168|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
44340169|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
44340170|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340171|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340172|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340173|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44340174|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
44340175|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340176|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
44340177|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340178|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
44340179|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44340180|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340181|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44340182|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340183|NCT01024075|Dexamethasone|dexamethasone|mesh-list
44340184|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340185|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
44340186|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
44340187|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340191|NCT01024075|Hormones|hormones|mesh-ancestor
44340202|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340203|NCT01024140|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44340204|NCT01024140|Antidepressive Agents|antidepressive agents|mesh-ancestor
44340205|NCT01024140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340207|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340208|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340209|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44340210|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340211|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
44340212|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340213|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
44340214|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340215|NCT01024192|Zolpidem|zolpidem|mesh-list
44340216|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44340217|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44340218|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340219|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340220|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44340221|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
44340222|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
44340223|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340224|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340225|NCT01024205|Sunitinib|sunitinib|mesh-list
44340226|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340227|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340250|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
44340251|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44340252|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340254|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
44340255|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340256|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340257|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340258|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340259|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44340260|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340261|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340263|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
44340264|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340265|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
44340266|NCT01024322|Hormones|hormones|mesh-ancestor
44340267|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340268|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44340269|NCT01024322|Protective Agents|protective agents|mesh-ancestor
44340270|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44340271|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340272|NCT01024348|Acetaminophen|acetaminophen|mesh-list
44130632|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
44130633|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44130634|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
44130635|NCT00146159|Analgesics|analgesics|mesh-ancestor
44130636|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
44130637|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130638|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130639|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130640|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130641|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130642|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130643|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130644|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44130645|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44130646|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44130647|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
44130648|NCT00146224|Hematinics|hematinics|mesh-ancestor
44130649|NCT00146237|Phenytoin|phenytoin|mesh-list
44130650|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
44130651|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44130674|NCT00146276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130675|NCT00146276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130676|NCT00146276|Immunologic Factors|immunologic factors|mesh-ancestor
44130677|NCT00146276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130678|NCT00146289|Telmisartan|telmisartan|mesh-list
44130679|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130680|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44130681|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44340274|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340275|NCT01024348|Analgesics|analgesics|mesh-ancestor
44340276|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
44340277|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340278|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340279|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
44340280|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44340281|NCT01024348|Narcotics|narcotics|mesh-ancestor
44340282|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340283|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44340284|NCT01024413|Gefitinib|gefitinib|mesh-list
44340285|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340286|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44340287|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340288|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340289|NCT01024491|Paroxetine|paroxetine|mesh-list
44340290|NCT01024491|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44340291|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44340292|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340293|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340294|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340295|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
44340296|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340297|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44130682|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130683|NCT00146341|Telmisartan|telmisartan|mesh-list
44130684|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130685|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44130686|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44130687|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130688|NCT00146380|Lamivudine|lamivudine|mesh-list
44130689|NCT00146380|Zidovudine|zidovudine|mesh-list
44130690|NCT00146380|Nevirapine|nevirapine|mesh-list
44130691|NCT00146380|Nelfinavir|nelfinavir|mesh-list
44130692|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44130693|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44130694|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130695|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130696|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
44130697|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130698|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44130699|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44130700|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
44130701|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44130737|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44130738|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
44340298|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
44340299|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340300|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44340301|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44340302|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340303|NCT01024504|Bevacizumab|bevacizumab|mesh-list
44340304|NCT01024504|Capecitabine|capecitabine|mesh-list
44340305|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
44340306|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340307|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340308|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340309|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340310|NCT01024504|Growth Substances|growth substances|mesh-ancestor
44340311|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340312|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340313|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340314|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
44340315|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340316|NCT01024543|Phenylephrine|phenylephrine|mesh-list
44340317|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
44340318|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
44340319|NCT01024543|Giapreza|giapreza|mesh-list
44340320|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
44340321|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44340322|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
44340323|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
44340324|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340325|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340326|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
44340327|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44340328|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
44340329|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
44340330|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44340331|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44340333|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
44340334|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340336|NCT01024543|Protective Agents|protective agents|mesh-ancestor
44340337|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44340338|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44340339|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340340|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
44340341|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340342|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
44340343|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340344|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340345|NCT01024660|Donepezil|donepezil|mesh-list
44340346|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44340347|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340348|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130739|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130746|NCT00146549|Trastuzumab|trastuzumab|mesh-list
44130747|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130748|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130749|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130750|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130751|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130752|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130753|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130754|NCT00146562|Paclitaxel|paclitaxel|mesh-list
44130755|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
44130756|NCT00146562|Doxorubicin|doxorubicin|mesh-list
44130757|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
44130758|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130759|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130760|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130761|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130762|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130763|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130764|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130765|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
44130766|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130767|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130768|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130769|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
44130770|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44130771|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130772|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130773|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130774|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130775|NCT00146562|Hematinics|hematinics|mesh-ancestor
44130776|NCT00146575|Sirolimus|sirolimus|mesh-list
44130777|NCT00146575|Paclitaxel|paclitaxel|mesh-list
44130778|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130779|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130780|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
44130781|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
44130782|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
44130783|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130784|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130785|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130786|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130787|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
44130788|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130789|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
44130790|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130791|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
44130792|NCT00146588|Capecitabine|capecitabine|mesh-list
44130793|NCT00146588|Epirubicin|epirubicin|mesh-list
44130794|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130795|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
44340349|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
44340350|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340351|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340352|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
44340353|NCT01024712|Paclitaxel|paclitaxel|mesh-list
44340354|NCT01024712|Carboplatin|carboplatin|mesh-list
44340355|NCT01024712|Gefitinib|gefitinib|mesh-list
44340356|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340357|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340358|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
44340359|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
44340360|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
44340361|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340362|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44340363|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340364|NCT01024777|Vitamin D|vitamin d|mesh-list
44340365|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
44340366|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
44340367|NCT01024777|Vitamins|vitamins|mesh-list
44340368|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
44340369|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340370|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44340371|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44340372|NCT01024868|Ropivacaine|ropivacaine|mesh-list
44340373|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340374|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
44340375|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748687|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
44130796|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130797|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130798|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130799|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
44130800|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130801|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130802|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44130803|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130804|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
44130805|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130806|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130807|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130808|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130810|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44130822|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44130823|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130824|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130825|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
44130826|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340376|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340377|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
44340378|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340379|NCT01025102|Sufentanil|sufentanil|mesh-list
44340380|NCT01025102|Ropivacaine|ropivacaine|mesh-list
44340381|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44340382|NCT01025102|Narcotics|narcotics|mesh-ancestor
44340383|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340384|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340385|NCT01025102|Analgesics|analgesics|mesh-ancestor
44340386|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
44340387|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340388|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44340389|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44340390|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
44130827|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130828|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44130829|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130830|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44130831|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130832|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
44130833|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130834|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44130835|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44130836|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130837|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130838|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130839|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
44130840|NCT00146627|Eflornithine|eflornithine|mesh-list
44130841|NCT00146627|Nifurtimox|nifurtimox|mesh-list
44130842|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130843|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44130844|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44130845|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44130846|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130847|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44130848|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130849|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130850|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
44130851|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
44130852|NCT00146718|Amodiaquine|amodiaquine|mesh-list
44130853|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
44130854|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44130855|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44130856|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130857|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44130858|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130859|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130860|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44130861|NCT00146718|Renal Agents|renal agents|mesh-ancestor
44130862|NCT00146731|Artesunate|artesunate|mesh-list
44130863|NCT00146731|Amodiaquine|amodiaquine|mesh-list
44130864|NCT00146731|Dapsone|dapsone|mesh-list
44130865|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
44130866|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
44130867|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44130868|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44130869|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130870|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130872|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
44130873|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44130874|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
44340391|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
44340392|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340393|NCT01025128|Vitamin D|vitamin d|mesh-list
44340394|NCT01025128|Vitamins|vitamins|mesh-ancestor
44340395|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
44340396|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340397|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44340398|NCT01025245|Remifentanil|remifentanil|mesh-list
44340399|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44340400|NCT01025245|Narcotics|narcotics|mesh-ancestor
44340401|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340402|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340403|NCT01025245|Analgesics|analgesics|mesh-ancestor
44340404|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
44340405|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340406|NCT01025349|Bevacizumab|bevacizumab|mesh-list
44340407|NCT01025349|Cisplatin|cisplatin|mesh-list
43995440|NCT02616523|Analgesics|analgesics|mesh-ancestor
44340408|NCT01025349|Docetaxel|docetaxel|mesh-list
44340409|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340410|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340411|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340412|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340413|NCT01025349|Growth Substances|growth substances|mesh-ancestor
44340414|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340415|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340416|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44340417|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44340418|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44340419|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340421|NCT01025466|Rivastigmine|rivastigmine|mesh-list
44340422|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44340423|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44340424|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
44340425|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340433|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44340434|NCT01025466|Protective Agents|protective agents|mesh-ancestor
44340435|NCT01025544|Vaccines|vaccines|mesh-list
44340436|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
44340437|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340438|NCT01025570|Gemcitabine|gemcitabine|mesh-list
44340439|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340440|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
44340441|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340442|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340443|NCT01025570|Antiviral Agents|antiviral agents|mesh-ancestor
44340444|NCT01025570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340445|NCT01025570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340446|NCT01025570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340447|NCT01025570|Immunologic Factors|immunologic factors|mesh-ancestor
44340448|NCT01025570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340449|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44340450|NCT01025700|Nabilone|nabilone|mesh-list
44340451|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
44340452|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
44340453|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340454|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340455|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340456|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44340457|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44340458|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340459|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340460|NCT01025765|Metformin|metformin|mesh-list
44130875|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44130876|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155355|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155356|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155357|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155358|NCT00226785|Analgesics|analgesics|mesh-ancestor
44155359|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
44155360|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155361|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44155362|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44155363|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44155364|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155365|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155366|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155367|NCT00226798|Capecitabine|capecitabine|mesh-list
44155368|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155369|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
44155370|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155371|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340462|NCT01025765|Acarbose|acarbose|mesh-list
44340463|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44340464|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340465|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44340466|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340467|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340468|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
44340469|NCT01025778|Thiotepa|thiotepa|mesh-list
44340470|NCT01025778|Etoposide|etoposide|mesh-list
44340471|NCT01025778|Clofarabine|clofarabine|mesh-list
44340472|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340473|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
44340474|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340475|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340476|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44155372|NCT00226824|Galantamine|galantamine|mesh-list
44155373|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44155374|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155375|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155376|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
44155377|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155378|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155379|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44155380|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
44155381|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155382|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
44155383|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
44155384|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44155385|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
44155386|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
44155387|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155388|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155389|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155390|NCT00226837|Analgesics|analgesics|mesh-ancestor
44155391|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
44155392|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155393|NCT00226889|Bosentan|bosentan|mesh-list
44155394|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44155395|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44155396|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155397|NCT00226902|Chrysarobin|chrysarobin|mesh-list
44155398|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155399|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155400|NCT00226902|Analgesics|analgesics|mesh-ancestor
44155401|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
44155402|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155403|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155404|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155405|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130880|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
44130881|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
44130882|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44130883|NCT00146783|Amodiaquine|amodiaquine|mesh-list
44130884|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
44130885|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44130886|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44130887|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130888|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44130889|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340477|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
44340478|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340479|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340480|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44340481|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340482|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44340483|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44340484|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340485|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340486|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
44340488|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340489|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
44340490|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340491|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340492|NCT01025882|Antiviral Agents|antiviral agents|mesh-ancestor
44340493|NCT01025882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340494|NCT01025882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340495|NCT01025882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340496|NCT01025882|Immunologic Factors|immunologic factors|mesh-ancestor
44340497|NCT01025882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340498|NCT01025921|Colistin|colistin|mesh-list
44340499|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340500|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340501|NCT01025934|Bevacizumab|bevacizumab|mesh-list
44130890|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130891|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44130893|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44130894|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
44130895|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130896|NCT00146900|Citalopram|citalopram|mesh-list
44130897|NCT00146900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44130898|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44130899|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130900|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130901|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130902|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
44130903|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130904|NCT00146900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44130905|NCT00146900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44130906|NCT00146900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44130907|NCT00146913|Interferons|interferons|mesh-list
44130908|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
44130909|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130910|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
44130911|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130912|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44130913|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130914|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340502|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340503|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340504|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340505|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340506|NCT01025934|Growth Substances|growth substances|mesh-ancestor
44340507|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340508|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340510|NCT01026064|Cantharidin|cantharidin|mesh-list
44340511|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340512|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340513|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340514|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340515|NCT01026090|Dronedarone|dronedarone|mesh-list
44340516|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44340517|NCT01026116|Paclitaxel|paclitaxel|mesh-list
44340518|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
44340519|NCT01026116|Epirubicin|epirubicin|mesh-list
44340520|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340521|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340522|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44340523|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44340524|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44340525|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340526|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340527|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
44340528|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340529|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340530|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130915|NCT00146926|Lidocaine|lidocaine|mesh-list
44130916|NCT00146926|Ephedrine|ephedrine|mesh-list
44130917|NCT00146926|Ketamine|ketamine|mesh-list
44130918|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
44130919|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
44130920|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44130921|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130922|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
44130923|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130924|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44130925|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44130926|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44130927|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130928|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130929|NCT00146926|Analgesics|analgesics|mesh-ancestor
44130930|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44340531|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
44340532|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44340533|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44340534|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44340535|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44340536|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340537|NCT01026129|Lidocaine|lidocaine|mesh-list
44340538|NCT01026129|Remifentanil|remifentanil|mesh-list
44340539|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340540|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
44340541|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340542|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340543|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
44340544|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340545|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44340546|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44340547|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44340548|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340549|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340550|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44340551|NCT01026129|Narcotics|narcotics|mesh-ancestor
44130931|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44130932|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
44130933|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44130934|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44130935|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130936|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44130937|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
44130938|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
44130939|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44130940|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44130941|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
44130942|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44130943|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44130944|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44130945|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130954|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130955|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
44130956|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130957|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130958|NCT00147186|Hylan|hylan|mesh-list
44130959|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
44130960|NCT00147186|Protective Agents|protective agents|mesh-ancestor
44130961|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130962|NCT00147264|Telmisartan|telmisartan|mesh-list
44130963|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44130964|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44130965|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44130966|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130967|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
44130968|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44340553|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44340554|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340555|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340556|NCT01026285|Risperidone|risperidone|mesh-list
44340557|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
44340558|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44340559|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
44340560|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340561|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340562|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340563|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44340564|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340565|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340566|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44340567|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
44340568|NCT01026311|Ubiquinone|ubiquinone|mesh-list
44340569|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
44340570|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
44340571|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340572|NCT01026311|Vitamins|vitamins|mesh-ancestor
44340573|NCT01026337|Sunitinib|sunitinib|mesh-list
44340574|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340575|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340576|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340577|NCT01026337|Growth Substances|growth substances|mesh-ancestor
44340578|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340579|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44340580|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44340581|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340582|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340583|NCT01026350|Antibodies|antibodies|mesh-list
44340584|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
44340586|NCT01026363|Vitamin D|vitamin d|mesh-list
44340596|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340597|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340598|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44340599|NCT01026376|Decitabine|decitabine|mesh-list
44340600|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340601|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
44340602|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340603|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340604|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340605|NCT01026415|Rifampin|rifampin|mesh-list
44340606|NCT01026415|Ketoconazole|ketoconazole|mesh-list
44340607|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44340608|NCT01026415|Midazolam|midazolam|mesh-list
44340609|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44340610|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44340611|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44340612|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340613|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340614|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44340615|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44340616|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340617|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44340618|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
44340619|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
44340620|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
44340621|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
44340622|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340623|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340624|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44340625|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
44340626|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340627|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748784|NCT02515526|Ethanol|ethanol|mesh-list
44130969|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44130970|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130971|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44130972|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44130973|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
44130974|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340629|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44340630|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340631|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44340632|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44340633|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44340634|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44340635|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44340636|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44340637|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44340638|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340639|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
44340640|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
44340641|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44340642|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44340643|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44340644|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
44130975|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130976|NCT00147355|Acetaminophen|acetaminophen|mesh-list
44130977|NCT00147355|Ibuprofen|ibuprofen|mesh-list
44130978|NCT00147355|Codeine|codeine|mesh-list
44130979|NCT00147355|Ondansetron|ondansetron|mesh-list
44130980|NCT00147355|Metoclopramide|metoclopramide|mesh-list
44130981|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44130982|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130983|NCT00147355|Analgesics|analgesics|mesh-ancestor
44130984|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
44130985|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130986|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130987|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130988|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130989|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44130990|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130991|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130992|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
44130993|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
44130994|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
44130995|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44130996|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
44130997|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
44130998|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44130999|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
44131000|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131001|NCT00147355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131002|NCT00147355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131003|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131004|NCT00147355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131005|NCT00147355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44131006|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44131007|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44131008|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
44131009|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44131010|NCT00147355|Narcotics|narcotics|mesh-ancestor
44131011|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
44131012|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
44131013|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
44340645|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340646|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44340647|NCT01026428|Levodopa|levodopa|mesh-list
44340648|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44340649|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44340650|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
44340651|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340652|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340653|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340654|NCT01026467|Cisplatin|cisplatin|mesh-list
44340655|NCT01026467|Carboplatin|carboplatin|mesh-list
44340656|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340657|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
44340658|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44340659|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340660|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340661|NCT01026584|Aripiprazole|aripiprazole|mesh-list
44340662|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44340663|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340664|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44340665|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44340666|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340667|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340668|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
44340669|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
44340670|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340671|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599846|NCT03286244|Paclitaxel|paclitaxel|mesh-list
44340672|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44340673|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44340674|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
44340675|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44340676|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44340678|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44340686|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340687|NCT01026701|Bortezomib|bortezomib|mesh-list
44340688|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340689|NCT01026714|Fluconazole|fluconazole|mesh-list
44340690|NCT01026714|Rifampin|rifampin|mesh-list
44340691|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
44340692|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
44340693|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340694|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44340695|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44340696|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340697|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340698|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44340699|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
44340700|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340701|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340702|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44340703|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44340704|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44340705|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
44340706|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340707|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
44340708|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44340709|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44340710|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44340711|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44340712|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44340713|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44340714|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44340716|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
44340719|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340726|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
44340727|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44340728|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340729|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340730|NCT01026961|Acetaminophen|acetaminophen|mesh-list
44340731|NCT01026961|Dimethindene|dimethindene|mesh-list
44340732|NCT01026961|Phenylephrine|phenylephrine|mesh-list
44340733|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
44340734|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340735|NCT01026961|Analgesics|analgesics|mesh-ancestor
44340736|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
44340737|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340738|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340739|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
44340740|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340741|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44340742|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
44340743|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
44340744|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
44340745|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44340746|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
44340747|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
44340748|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44340749|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44340750|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44340780|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340781|NCT01027117|Urological Agents|urological agents|mesh-ancestor
44340782|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
44340783|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44340784|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44340785|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
44340786|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340787|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44340788|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44340789|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340790|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340791|NCT01027377|Factor VIII|factor viii|mesh-list
44340792|NCT01027377|Coagulants|coagulants|mesh-ancestor
44340793|NCT01027429|Amoxicillin|amoxicillin|mesh-list
44340794|NCT01027429|Gentamicins|gentamicins|mesh-list
44340795|NCT01027429|Penicillins|penicillins|mesh-list
44340796|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
44340797|NCT01027429|Penicillin G|penicillin g|mesh-list
44340798|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44340799|NCT01027429|Procaine|procaine|mesh-list
44340800|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340801|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340802|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44340803|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340804|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340805|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
44340806|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
44340807|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340808|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340809|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
44340810|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340811|NCT01027481|Ranibizumab|ranibizumab|mesh-list
44340812|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340822|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
44340823|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340824|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340825|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340826|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
44340827|NCT01027494|Hormones|hormones|mesh-ancestor
44340828|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340829|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44340830|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340831|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340832|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340833|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44340834|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44340835|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340836|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340837|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44340838|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44340839|NCT01027520|Monensin|monensin|mesh-list
44340840|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
44340841|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340842|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44340843|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44340844|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
44340845|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
44340846|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
44340847|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340848|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340849|NCT01027520|Ionophores|ionophores|mesh-ancestor
44340850|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340866|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340867|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44340868|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44340869|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44340870|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340871|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340872|NCT01027689|Alprazolam|alprazolam|mesh-list
44340873|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44340874|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44340875|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340876|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44340877|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44340878|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44340879|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
44340880|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
44340881|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131022|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131024|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44131025|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
44131026|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131027|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131028|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131029|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131030|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131031|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131032|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131033|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44131034|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
44131036|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131037|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131038|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44131039|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131040|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131041|NCT00147524|Quinapril|quinapril|mesh-list
44131042|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44131043|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44131044|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131045|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131046|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131047|NCT00147563|Eplerenone|eplerenone|mesh-list
44131048|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44131049|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131050|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131051|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131052|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44131053|NCT00147563|Diuretics|diuretics|mesh-ancestor
44131054|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
44131055|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131056|NCT00147589|Eplerenone|eplerenone|mesh-list
44131057|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44131058|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131059|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131060|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131061|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44131062|NCT00147589|Diuretics|diuretics|mesh-ancestor
44131063|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
44340882|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340883|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
44340884|NCT01027832|Tazobactam|tazobactam|mesh-list
44340885|NCT01027832|Piperacillin|piperacillin|mesh-list
44340886|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44340887|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44340888|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340889|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44340890|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340891|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340892|NCT01027923|Cytarabine|cytarabine|mesh-list
44340893|NCT01027923|Plerixafor|plerixafor|mesh-list
44340894|NCT01027923|Etoposide|etoposide|mesh-list
44340895|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
44340896|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44340897|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340898|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44340899|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44340900|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340901|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340902|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44340903|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
44340904|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
44340905|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340906|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340907|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
44340908|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340909|NCT01027923|Analgesics|analgesics|mesh-ancestor
44340914|NCT01028079|Aspirin|aspirin|mesh-list
44340928|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44340929|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340930|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
44340931|NCT01028092|Cyclosporine|cyclosporine|mesh-list
44340932|NCT01028092|Everolimus|everolimus|mesh-list
44340933|NCT01028092|Interleukin-2|interleukin-2|mesh-list
44340934|NCT01028092|Cyclosporins|cyclosporins|mesh-list
44340935|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
43788777|NCT04562558|Vitamins|vitamins|mesh-ancestor
44340936|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44340937|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340938|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44340939|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
44340940|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340941|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
44340942|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44340943|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
44340944|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44340945|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44340946|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340947|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44340948|NCT01028092|Analgesics|analgesics|mesh-ancestor
44340949|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
44340950|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340952|NCT01028170|Diuretics|diuretics|mesh-ancestor
44340953|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
44340954|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340955|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44340956|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44340957|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340958|NCT01028248|Ranibizumab|ranibizumab|mesh-list
44340959|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44340960|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44340961|NCT01028248|Growth Substances|growth substances|mesh-ancestor
44340971|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44340972|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44340973|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44340974|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
44340975|NCT01028287|Hormones|hormones|mesh-ancestor
44340976|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340977|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340978|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44340979|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44340980|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
44340981|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44340982|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44340983|NCT01028313|Prednisolone|prednisolone|mesh-list
44340984|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
44340985|NCT01028313|Panobinostat|panobinostat|mesh-list
44340986|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44340987|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
44340988|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44340989|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
44340990|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
44340991|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44340992|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44340993|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44340994|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
44340995|NCT01028313|Hormones|hormones|mesh-ancestor
44340996|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44340997|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44340998|NCT01028313|Protective Agents|protective agents|mesh-ancestor
44340999|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341015|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341016|NCT01028443|Cyclosporine|cyclosporine|mesh-list
44341017|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
44341018|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341019|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44341020|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341021|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341022|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341023|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
43599853|NCT03286101|Ivermectin|ivermectin|mesh-list
44341024|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341025|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341026|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44341028|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341029|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341030|NCT01028482|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341031|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341032|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341033|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341034|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341035|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
44341036|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341037|NCT01028495|Gemcitabine|gemcitabine|mesh-list
44341038|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341039|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
44341063|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341064|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341065|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44341066|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44341067|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341068|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44341069|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341071|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341072|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
44341073|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
44341074|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341075|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341076|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341077|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
44341078|NCT01028547|Hormones|hormones|mesh-ancestor
44341079|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341080|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341081|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341082|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44341083|NCT01028573|Laxatives|laxatives|mesh-ancestor
44341084|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341085|NCT01028638|Bevacizumab|bevacizumab|mesh-list
44341086|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44341087|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341088|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341089|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341090|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341091|NCT01028638|Growth Substances|growth substances|mesh-ancestor
44341092|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341093|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
43996147|NCT05588531|Cefepime|cefepime|mesh-list
44341094|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44341095|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341096|NCT01028729|Gemcitabine|gemcitabine|mesh-list
44341098|NCT01028729|Endostar protein|endostar protein|mesh-list
44341099|NCT01028729|Endostatins|endostatins|mesh-list
44341100|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341101|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341102|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
44341103|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341104|NCT01028729|Antiviral Agents|antiviral agents|mesh-ancestor
44341105|NCT01028729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341106|NCT01028729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341107|NCT01028729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341108|NCT01028729|Immunologic Factors|immunologic factors|mesh-ancestor
44341109|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341110|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341111|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341112|NCT01028729|Growth Substances|growth substances|mesh-ancestor
44341113|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341114|NCT01028768|Teduglutide|teduglutide|mesh-list
44341115|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341116|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44341117|NCT01028768|Protective Agents|protective agents|mesh-ancestor
44341118|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341119|NCT01028781|Thalidomide|thalidomide|mesh-list
44341120|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341121|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
44341122|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341123|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
44341124|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341125|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341126|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341127|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341128|NCT01028781|Growth Substances|growth substances|mesh-ancestor
44341145|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44341146|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341147|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
44341148|NCT01028976|Vitamins|vitamins|mesh-ancestor
44341149|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
44341150|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341151|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
44341152|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341153|NCT01028976|Protective Agents|protective agents|mesh-ancestor
44341154|NCT01029002|Vitamin D|vitamin d|mesh-list
44341155|NCT01029002|Vitamins|vitamins|mesh-ancestor
44341156|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
44341157|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341158|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44341159|NCT01029132|Galantamine|galantamine|mesh-list
44341160|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44341161|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341162|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341163|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
44341164|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341165|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341166|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44341167|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
44341168|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341169|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
44341170|NCT01029223|Metoprolol|metoprolol|mesh-list
44341171|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44341172|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44341174|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
44341175|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341176|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341188|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341190|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341191|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44341192|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341193|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341194|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
44341195|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44341196|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341197|NCT01029522|Atorvastatin|atorvastatin|mesh-list
44341198|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44341199|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44341200|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
44341201|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341202|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341203|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44341204|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341205|NCT01029613|Adalimumab|adalimumab|mesh-list
44341206|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341207|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341208|NCT01029639|Insulin|insulin|mesh-list
44341209|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
44131064|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131065|NCT00147602|Atorvastatin|atorvastatin|mesh-list
44131066|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44131067|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44131068|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
44131069|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131070|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44131071|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44131072|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131073|NCT00147615|Eplerenone|eplerenone|mesh-list
44131074|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44131075|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131076|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131077|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131096|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44131097|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44131098|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44131099|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44131100|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44131101|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131102|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131103|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131104|NCT00147654|Urological Agents|urological agents|mesh-ancestor
44131105|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44131106|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44131107|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131108|NCT00147667|Erythromycin|erythromycin|mesh-list
44131109|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
44131110|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44131111|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
44341211|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44341212|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341213|NCT01029678|Cisplatin|cisplatin|mesh-list
44341214|NCT01029678|Vinorelbine|vinorelbine|mesh-list
44341215|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341216|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44341217|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44341218|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44341219|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44341220|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341221|NCT01029743|Aspirin|aspirin|mesh-list
44341222|NCT01029743|PENTA|penta|mesh-list
44341223|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
44341224|NCT01029743|Fondaparinux|fondaparinux|mesh-list
44341225|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44341226|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44341227|NCT01029743|Analgesics|analgesics|mesh-ancestor
44341228|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
44341229|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341230|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341231|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341232|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341233|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44341234|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341235|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341236|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44341237|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44341238|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341239|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
44341240|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44131112|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131113|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131114|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131115|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44131116|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131117|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131119|NCT00147680|Carboplatin|carboplatin|mesh-list
44131120|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131121|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131122|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131123|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131124|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163833|NCT00254020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341241|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
44341242|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44341243|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
44341244|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
44341245|NCT01029769|Olanzapine|olanzapine|mesh-list
44341246|NCT01029769|Amisulpride|amisulpride|mesh-list
44341247|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
44341248|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
44341249|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341250|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341251|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341252|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44341253|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44341254|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44341255|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341256|NCT01029769|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341257|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341258|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789049|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44341259|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341260|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341261|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
44341262|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44341263|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
44341264|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44341292|NCT01030042|Irinotecan|irinotecan|mesh-list
44341293|NCT01030042|Cetuximab|cetuximab|mesh-list
44341294|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341295|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44341296|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44341297|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341298|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341299|NCT01030042|Antidotes|antidotes|mesh-ancestor
44341300|NCT01030042|Protective Agents|protective agents|mesh-ancestor
44341301|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341302|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
44341303|NCT01030042|Vitamins|vitamins|mesh-ancestor
44341304|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
44341305|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341306|NCT01030081|Amlodipine|amlodipine|mesh-list
44341307|NCT01030081|Nifedipine|nifedipine|mesh-list
44341308|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44341309|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44341310|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341311|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341312|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341313|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341314|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
44341315|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
44341344|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341345|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341346|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341347|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341348|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341349|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341350|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
44341351|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44341352|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
44341353|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44341354|NCT01030302|Bortezomib|bortezomib|mesh-list
44341355|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341356|NCT01030328|Fenofibrate|fenofibrate|mesh-list
44341357|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44341358|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
44341359|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341360|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341361|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44341362|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341363|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341364|NCT01030510|Rocuronium|rocuronium|mesh-list
44341365|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44341366|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44341367|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44341368|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341369|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341370|NCT01030601|Dexamethasone|dexamethasone|mesh-list
44341371|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
44341372|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44341373|NCT01030601|BB 1101|bb 1101|mesh-list
44341374|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341375|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
44341376|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
43749193|NCT02512887|Anesthetics|anesthetics|mesh-list
44131125|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131126|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44131127|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44131128|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44131129|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
43599933|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131130|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131131|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341378|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341379|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341380|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
44341382|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341383|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341384|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341385|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
44341386|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341387|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341388|NCT01030614|Dexamethasone|dexamethasone|mesh-list
44341389|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341390|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
44341391|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
44341392|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341393|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341394|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341395|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
44341396|NCT01030614|Hormones|hormones|mesh-ancestor
44341397|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341398|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44341399|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341400|NCT01030640|Tanezumab|tanezumab|mesh-list
44341401|NCT01030640|Analgesics|analgesics|mesh-ancestor
44341402|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
44341403|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131132|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44131133|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44131134|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44131135|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
44131137|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44131138|NCT00147771|Imiquimod|imiquimod|mesh-list
44131139|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44131140|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
44131141|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131142|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131143|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
44131144|NCT00147784|Interferons|interferons|mesh-list
44131145|NCT00147784|Ribavirin|ribavirin|mesh-list
44131146|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131147|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
44131148|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131149|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
44131150|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131151|NCT00147836|Insulin|insulin|mesh-list
44131152|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44341404|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341405|NCT01030692|Rivastigmine|rivastigmine|mesh-list
44341406|NCT01030692|Huperzine A|huperzine a|mesh-list
44341407|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44341408|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341409|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341410|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
44341411|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341412|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341413|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44341414|NCT01030692|Protective Agents|protective agents|mesh-ancestor
44341415|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
44341416|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44341417|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341418|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341419|NCT01030770|Ranibizumab|ranibizumab|mesh-list
44341420|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341421|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341422|NCT01030770|Growth Substances|growth substances|mesh-ancestor
44341423|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341424|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341425|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341426|NCT01030796|Caffeine|caffeine|mesh-list
44341427|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44341428|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836107|NCT04997239|Vaccines|vaccines|mesh-list
44131153|NCT00147836|Metformin|metformin|mesh-list
44131154|NCT00147836|Gliclazide|gliclazide|mesh-list
44131155|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
44131156|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
44131157|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
44131158|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44131159|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131160|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
44131161|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44131162|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44131163|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131164|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
44131165|NCT00147862|Coagulants|coagulants|mesh-ancestor
44131166|NCT00147875|Gemcitabine|gemcitabine|mesh-list
44131167|NCT00147875|Prednisone|prednisone|mesh-list
44131168|NCT00147875|Doxorubicin|doxorubicin|mesh-list
44131169|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44131170|NCT00147875|Vinblastine|vinblastine|mesh-list
44131171|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131172|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
44131173|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131174|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131175|NCT00147875|Antiviral Agents|antiviral agents|mesh-ancestor
44131176|NCT00147875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131177|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341430|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341431|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341432|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44341433|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44341434|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
44341435|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341436|NCT01030926|Insulin|insulin|mesh-list
44341437|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44341438|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
44341439|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44341440|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341441|NCT01031017|Progesterone|progesterone|mesh-list
44341442|NCT01031017|Progestins|progestins|mesh-ancestor
44341443|NCT01031017|Hormones|hormones|mesh-ancestor
44341444|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341445|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341446|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
44341447|NCT01031030|Fluorouracil|fluorouracil|mesh-list
44341448|NCT01031030|Methotrexate|methotrexate|mesh-list
44341449|NCT01031030|Epirubicin|epirubicin|mesh-list
44341450|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341451|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
44341452|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341453|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341454|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44341455|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
44341456|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341457|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341458|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44341459|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
44341460|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341461|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44341462|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
44341463|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341464|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
44131178|NCT00147875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341465|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341466|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44341467|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44341468|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44341469|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44341470|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44341471|NCT01031212|Acetic Acid|acetic acid|mesh-list
44341472|NCT01031212|Paclitaxel|paclitaxel|mesh-list
44341473|NCT01031212|Carboplatin|carboplatin|mesh-list
44341474|NCT01031212|Cetuximab|cetuximab|mesh-list
44341475|NCT01031212|Vadimezan|vadimezan|mesh-list
44341476|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44341477|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341478|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
44341479|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
44341480|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
44341481|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341482|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341483|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341484|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341485|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
44341486|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
44341487|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44341488|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44341489|NCT01031355|Calcium|calcium|mesh-list
44341490|NCT01031355|Estradiol|estradiol|mesh-list
44341491|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44341492|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341493|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341494|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44341495|NCT01031355|Estrogens|estrogens|mesh-ancestor
44341496|NCT01031355|Hormones|hormones|mesh-ancestor
44341497|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341498|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44341499|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
43836131|NCT04992026|Prednisone|prednisone|mesh-list
44131179|NCT00147875|Immunologic Factors|immunologic factors|mesh-ancestor
44131180|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131181|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44341500|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341501|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44341502|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
44341503|NCT01031355|Vitamins|vitamins|mesh-ancestor
44341504|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
44341505|NCT01031368|Cytarabine|cytarabine|mesh-list
44341506|NCT01031368|Clofarabine|clofarabine|mesh-list
44341507|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341508|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
44341509|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341510|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341511|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
44341512|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341513|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341514|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
44341515|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341517|NCT01031459|Interferon-beta|interferon-beta|mesh-list
44341518|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
44341519|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341520|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
44341521|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341522|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
44341523|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341524|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44341525|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44341526|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44341527|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
44341528|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341529|NCT01031589|Rilpivirine|rilpivirine|mesh-list
44341530|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44341531|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44341532|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341533|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341543|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341544|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44341545|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
44341546|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44341547|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341548|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341549|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44341550|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
44341551|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44341552|NCT01031667|Protective Agents|protective agents|mesh-ancestor
44341553|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44341554|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44341555|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341556|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44341557|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44341558|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
44341559|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341561|NCT01031719|Vaccines|vaccines|mesh-list
44341562|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
44341563|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341564|NCT01031732|Tacrine|tacrine|mesh-list
44341565|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44341566|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341567|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341568|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
44341569|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341570|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341571|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44341572|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
44341573|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341574|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
44341575|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44341576|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44341578|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44341582|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341583|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44341584|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341585|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
44341586|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341587|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
44341588|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341589|NCT01031927|Glycine|glycine|mesh-list
44341590|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
44341591|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341592|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341593|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341594|NCT01031966|Thymalfasin|thymalfasin|mesh-list
44341595|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44341596|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
44341597|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341598|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
44341599|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44341600|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341601|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341602|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
44341603|NCT01031992|Coagulants|coagulants|mesh-ancestor
44341604|NCT01032031|Ascorbic Acid|ascorbic acid|mesh-list
44341605|NCT01032031|Vitamins|vitamins|mesh-ancestor
44341606|NCT01032031|Micronutrients|micronutrients|mesh-ancestor
44341607|NCT01032031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341608|NCT01032031|Antioxidants|antioxidants|mesh-ancestor
44341609|NCT01032031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341628|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341629|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
44341630|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341631|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44341632|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341633|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341634|NCT01032109|Bevacizumab|bevacizumab|mesh-list
44341635|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341636|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341637|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341638|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341639|NCT01032109|Growth Substances|growth substances|mesh-ancestor
44341640|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341641|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341642|NCT01032122|Rituximab|rituximab|mesh-list
44341643|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341644|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341645|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
44341646|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341647|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341648|NCT01032148|Panobinostat|panobinostat|mesh-list
44341649|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341650|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44341651|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341652|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341653|NCT01032187|Amphotericin B|amphotericin b|mesh-list
44341654|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44341655|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44341656|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44341657|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
44341658|NCT01032187|Amebicides|amebicides|mesh-ancestor
44341659|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44341660|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44341668|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
44341669|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341670|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341672|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44341673|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44341674|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
44341675|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44341676|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341677|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341678|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44341679|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
44341680|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341681|NCT01032304|Erdosteine|erdosteine|mesh-list
44341682|NCT01032304|Expectorants|expectorants|mesh-ancestor
44341683|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
44341684|NCT01032434|Sertraline|sertraline|mesh-list
44341685|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341686|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341687|NCT01032434|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341688|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341689|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341690|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341691|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341692|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
44341693|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341694|NCT01032486|Rasagiline|rasagiline|mesh-list
44341695|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44341696|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341697|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341698|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44341699|NCT01032486|Protective Agents|protective agents|mesh-ancestor
44341700|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341707|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44341708|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44341709|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
44341710|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341711|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341712|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341713|NCT01032798|Mepivacaine|mepivacaine|mesh-list
44341714|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
44341715|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
44341716|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44341717|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341718|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
44341719|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341720|NCT01033058|Atorvastatin|atorvastatin|mesh-list
44341721|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44341722|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44341723|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
44341724|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341725|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341726|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44341727|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341728|NCT01033084|Sertraline|sertraline|mesh-list
44341729|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
44341730|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341731|NCT01033084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44341732|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44131182|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44131183|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44131184|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131185|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
44131187|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131188|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44131189|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131190|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131191|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131192|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131193|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
44131194|NCT00147901|Fludarabine|fludarabine|mesh-list
44131195|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
44131196|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131197|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
44131198|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131199|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131200|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44131201|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
44163834|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44341733|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341734|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341735|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341736|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
44341737|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341738|NCT01033097|Betamethasone|betamethasone|mesh-list
44341739|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341740|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
44341742|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44341743|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341744|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44341745|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44341746|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
44341747|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44341748|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
44341749|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341750|NCT01033149|Expectorants|expectorants|mesh-ancestor
44341751|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44341752|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44341753|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
44341754|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341755|NCT01033149|Protective Agents|protective agents|mesh-ancestor
44341756|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341757|NCT01033149|Antidotes|antidotes|mesh-ancestor
44341758|NCT01033279|Warfarin|warfarin|mesh-list
44341759|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
44341760|NCT01033305|Cyclosporine|cyclosporine|mesh-list
44341761|NCT01033305|Cyclosporins|cyclosporins|mesh-list
44341762|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749434|NCT02510781|Docetaxel|docetaxel|mesh-list
44131202|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131203|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131204|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44131205|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131206|NCT00147914|Amoxicillin|amoxicillin|mesh-list
44131207|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
44131208|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
44131209|NCT00147914|Cefdinir|cefdinir|mesh-list
44131210|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44131218|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131219|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
44131220|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131221|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341763|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341764|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341765|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
44341766|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341767|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
44341768|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341769|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
44341770|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341771|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44341773|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44341774|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44341775|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44341776|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44341777|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341778|NCT01033370|Clevidipine|clevidipine|mesh-list
44341779|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44341780|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44341781|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341815|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44341816|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341817|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44341818|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341819|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341820|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44341821|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44341822|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341823|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
44341824|NCT01033656|Methotrexate|methotrexate|mesh-list
44341825|NCT01033656|Azathioprine|azathioprine|mesh-list
44341826|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44341827|NCT01033656|Leflunomide|leflunomide|mesh-list
44341828|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44341829|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
44341830|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341831|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341832|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341833|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
44341834|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341835|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341836|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
44341837|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341838|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44341839|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341840|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
44341841|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44341842|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44341843|NCT01033760|Ritonavir|ritonavir|mesh-list
44341844|NCT01033760|Darunavir|darunavir|mesh-list
44341845|NCT01033760|Tenofovir|tenofovir|mesh-list
44341846|NCT01033760|Emtricitabine|emtricitabine|mesh-list
44341847|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
44341848|NCT01033760|Maraviroc|maraviroc|mesh-list
44341849|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44341850|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44131222|NCT00147979|Heparin|heparin|mesh-list
44131223|NCT00147979|Calcium heparin|calcium heparin|mesh-list
44131224|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
44131225|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44341851|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44341852|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341853|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341854|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44341855|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44341856|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
44341857|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341858|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44341859|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44341860|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44341861|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44341862|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44341863|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44341864|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44341865|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44341866|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44341868|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
44341869|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341870|NCT01033903|Misoprostol|misoprostol|mesh-list
44341871|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44341872|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
44341873|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44341874|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341875|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44341876|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44341877|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
44341878|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44341879|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44341880|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44341881|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
44341882|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341883|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44341884|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44131226|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44131227|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131228|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44341885|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341887|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341888|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341889|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341890|NCT01033981|Growth Substances|growth substances|mesh-ancestor
44341891|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341892|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341893|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44341894|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341895|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341896|NCT01033994|Mitogens|mitogens|mesh-list
44341897|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44341898|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341899|NCT01034020|Nicotine|nicotine|mesh-list
44341900|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44341901|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
44341902|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44341903|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341904|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44341905|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44341906|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
44341907|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341908|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341909|NCT01034124|Vitamin K|vitamin k|mesh-list
44341910|NCT01034124|Midazolam|midazolam|mesh-list
44341911|NCT01034124|Warfarin|warfarin|mesh-list
44341912|NCT01034124|Vitamins|vitamins|mesh-ancestor
44341913|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
44341914|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341915|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44341916|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44341917|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44341918|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44341919|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44341920|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44341921|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44131229|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131230|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341923|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
44341924|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
44341925|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
44341926|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44341927|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341929|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44341930|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44341931|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
44341932|NCT01034124|Coagulants|coagulants|mesh-ancestor
44341933|NCT01034189|Paclitaxel|paclitaxel|mesh-list
44341934|NCT01034189|Cisplatin|cisplatin|mesh-list
44341935|NCT01034189|Cetuximab|cetuximab|mesh-list
44341936|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44341937|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341938|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
44341939|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
44341940|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
44341941|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341942|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44341943|NCT01034345|Sirolimus|sirolimus|mesh-list
44341944|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
44341945|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44341946|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341947|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44341948|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341949|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
44341950|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44341951|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
44341952|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341953|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341954|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341955|NCT01034410|Cytarabine|cytarabine|mesh-list
44341956|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44341957|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
44341959|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341964|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341965|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
44341966|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43789813|NCT04841499|Niacin|niacin|mesh-list
44341967|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341968|NCT01034683|Leucovorin|leucovorin|mesh-list
44341969|NCT01034683|Antidotes|antidotes|mesh-ancestor
44341970|NCT01034683|Protective Agents|protective agents|mesh-ancestor
44341971|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341972|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
44341973|NCT01034683|Vitamins|vitamins|mesh-ancestor
44341974|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
44341975|NCT01034787|Tremelimumab|tremelimumab|mesh-list
44341976|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341977|NCT01034878|Sunitinib|sunitinib|mesh-list
44341978|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44341979|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44341980|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44341981|NCT01034878|Growth Substances|growth substances|mesh-ancestor
44341982|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44341983|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44341984|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44341985|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341986|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341987|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44341988|NCT01034917|Etravirine|etravirine|mesh-list
44341989|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
44341990|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44341991|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44341992|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44341993|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44341994|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44341995|NCT01034956|Calcium|calcium|mesh-list
44342005|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44342006|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44342007|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342008|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342009|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
44342010|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342011|NCT01034995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44342012|NCT01034995|Antidepressive Agents|antidepressive agents|mesh-ancestor
44342013|NCT01034995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44342015|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44342016|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44342017|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44342018|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342019|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342020|NCT01035190|Budesonide|budesonide|mesh-list
44342021|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342022|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44342023|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
44342024|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342025|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342026|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44342027|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44342028|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
44342029|NCT01035190|Hormones|hormones|mesh-ancestor
44342030|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342031|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
44342032|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44342033|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
44342034|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342035|NCT01035281|Nabilone|nabilone|mesh-list
44342036|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
44342037|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
44342038|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342039|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131231|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131232|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342041|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44342042|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44342043|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342044|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44342045|NCT01035320|Simvastatin|simvastatin|mesh-list
44342046|NCT01035320|Ezetimibe|ezetimibe|mesh-list
44342047|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44342048|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44342049|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
44342050|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342051|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44342052|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44342053|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342054|NCT01035450|Sirolimus|sirolimus|mesh-list
44342055|NCT01035450|Everolimus|everolimus|mesh-list
44342056|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342057|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342058|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
44342059|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342060|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342061|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342062|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44342063|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
44342064|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44342065|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44342066|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44342067|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44342068|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
44342069|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342070|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342071|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342072|NCT01035528|Metformin|metformin|mesh-list
44342073|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
44342074|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44342078|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44342079|NCT01035580|Analgesics|analgesics|mesh-ancestor
44342080|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
44342081|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342082|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342083|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342084|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342085|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342086|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342087|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342088|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44342089|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44342090|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342091|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
44342092|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342093|NCT01035619|Moxidectin|moxidectin|mesh-list
44342094|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
44342095|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44342096|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342097|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
44342098|NCT01035671|Vitamin E|vitamin e|mesh-list
44342099|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
44342100|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
44342101|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44342102|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
44342103|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342104|NCT01035671|Protective Agents|protective agents|mesh-ancestor
44342105|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342106|NCT01035671|Vitamins|vitamins|mesh-ancestor
44342107|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
44342108|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
44342109|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44342110|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342111|NCT01035853|Colistin|colistin|mesh-list
44342120|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44342121|NCT01036035|Pilocarpine|pilocarpine|mesh-list
44342122|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44342123|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44342124|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
44342125|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342126|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342127|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342128|NCT01036035|Urological Agents|urological agents|mesh-ancestor
44342129|NCT01036035|Miotics|miotics|mesh-ancestor
44342130|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
44342131|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342132|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44342133|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44342134|NCT01036399|Lenalidomide|lenalidomide|mesh-list
44342135|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
44342136|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342137|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44342149|NCT01036659|Bradykinin|bradykinin|mesh-list
44342179|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342180|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342182|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342183|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44342184|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
44342185|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342186|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342187|NCT01036854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44342188|NCT01036854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44342189|NCT01036854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342190|NCT01036854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44342191|NCT01036854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44342192|NCT01036893|Prucalopride|prucalopride|mesh-list
44342193|NCT01036893|Laxatives|laxatives|mesh-ancestor
44342194|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342195|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44342196|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44342197|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
44342198|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342199|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342200|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342201|NCT01036932|Lenograstim|lenograstim|mesh-list
44342202|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44342203|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
44342204|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342205|NCT01037023|Topotecan|topotecan|mesh-list
44131233|NCT00148018|Dexamethasone|dexamethasone|mesh-list
44131234|NCT00148018|Bortezomib|bortezomib|mesh-list
44131235|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131236|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
44131237|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
44131238|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131239|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131240|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131241|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
44131242|NCT00148018|Hormones|hormones|mesh-ancestor
44131243|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131244|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44131245|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131246|NCT00148031|Interferons|interferons|mesh-list
44131247|NCT00148031|Ribavirin|ribavirin|mesh-list
44131248|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131249|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
44131250|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131251|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
44131252|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131253|NCT00148070|Erythromycin|erythromycin|mesh-list
44342208|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342209|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342210|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342211|NCT01037101|Cycloserine|cycloserine|mesh-list
44342212|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44342213|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342214|NCT01037101|Renal Agents|renal agents|mesh-ancestor
44342215|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44342216|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
44342217|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131254|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
44131255|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44131256|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
44131257|NCT00148070|Docetaxel|docetaxel|mesh-list
44131258|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131260|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131261|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131262|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654234|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
44131263|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131264|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131265|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131266|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44131267|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131268|NCT00148083|Risperidone|risperidone|mesh-list
44131269|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44131270|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
44131271|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131272|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131273|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131274|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131275|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131276|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131277|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131283|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131284|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131285|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
44131286|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131287|NCT00148135|Antiviral Agents|antiviral agents|mesh-ancestor
44131288|NCT00148135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131289|NCT00148135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131290|NCT00148135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131291|NCT00148135|Immunologic Factors|immunologic factors|mesh-ancestor
44131292|NCT00148135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131294|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44131295|NCT00148148|Caspofungin|caspofungin|mesh-list
44131296|NCT00148148|Amebicides|amebicides|mesh-ancestor
44131297|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44131298|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44131299|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131300|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131301|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
44131302|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131303|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131304|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
44131305|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131306|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131307|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131308|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131309|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342218|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
44342219|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342221|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
44342222|NCT01037140|Vitamins|vitamins|mesh-ancestor
44342223|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
44342224|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342225|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44342226|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44342227|NCT01037322|Cannabidiol|cannabidiol|mesh-list
44342228|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
44342229|NCT01037335|Morphine|morphine|mesh-list
44342230|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44342231|NCT01037335|Narcotics|narcotics|mesh-ancestor
44131310|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131311|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131312|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131313|NCT00148265|Triamcinolone|triamcinolone|mesh-list
44131314|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131315|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
44131316|NCT00148265|Hormones|hormones|mesh-ancestor
44131317|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131318|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131319|NCT00148278|Dobutamine|dobutamine|mesh-list
44131320|NCT00148278|Epinephrine|epinephrine|mesh-list
44131321|NCT00148278|Norepinephrine|norepinephrine|mesh-list
44131322|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44131323|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44131324|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44131325|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131326|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131327|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131328|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44131329|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44131330|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
44131331|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131332|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44131333|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44131334|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
44131335|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
44131336|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44131337|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44131338|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44131339|NCT00148278|Protective Agents|protective agents|mesh-ancestor
44131340|NCT00148291|Docetaxel|docetaxel|mesh-list
44131341|NCT00148291|Vinorelbine|vinorelbine|mesh-list
44131342|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131343|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131344|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131345|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131346|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131347|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131348|NCT00148330|Triamcinolone|triamcinolone|mesh-list
44131349|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131351|NCT00148330|Hormones|hormones|mesh-ancestor
44131352|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131353|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131354|NCT00148356|Paclitaxel|paclitaxel|mesh-list
44131355|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131356|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131357|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131358|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131359|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342232|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342233|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342234|NCT01037335|Analgesics|analgesics|mesh-ancestor
44342235|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
44342236|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342237|NCT01037348|Ranibizumab|ranibizumab|mesh-list
44342238|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44342239|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44342240|NCT01037348|Growth Substances|growth substances|mesh-ancestor
44342241|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342242|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44342243|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342244|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
44342245|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
44342246|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342247|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342248|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44342249|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
44342250|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
44342251|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44342252|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
44342253|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342254|NCT01037465|Expectorants|expectorants|mesh-ancestor
44342255|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44342257|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
44342282|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44342283|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
44342284|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342285|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44342286|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342287|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44342288|NCT01037517|Plerixafor|plerixafor|mesh-list
44342289|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44342290|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44342291|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
44342292|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342293|NCT01037530|Ramipril|ramipril|mesh-list
44342294|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44342295|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
44342296|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342297|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342298|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131360|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131361|NCT00148382|Cetilistat|cetilistat|mesh-list
44131362|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131363|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131364|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44131365|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44131366|NCT00148395|Gemcitabine|gemcitabine|mesh-list
44131367|NCT00148395|Cisplatin|cisplatin|mesh-list
44131368|NCT00148395|Carboplatin|carboplatin|mesh-list
44131369|NCT00148395|Ifosfamide|ifosfamide|mesh-list
44131370|NCT00148395|Mitomycins|mitomycins|mesh-list
44131371|NCT00148395|Mitomycin|mitomycin|mesh-list
44131372|NCT00148395|Vinorelbine|vinorelbine|mesh-list
44131373|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131374|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131375|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
44131376|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131377|NCT00148395|Antiviral Agents|antiviral agents|mesh-ancestor
44131378|NCT00148395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131379|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131380|NCT00148395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131381|NCT00148395|Immunologic Factors|immunologic factors|mesh-ancestor
44131382|NCT00148395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131383|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44131384|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
44131385|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131386|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44131387|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131388|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131389|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131390|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131391|NCT00148408|Montelukast|montelukast|mesh-list
44131392|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44131393|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44131394|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44131395|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131396|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131397|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131398|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44131399|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44131400|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342299|NCT01037595|Turmeric extract|turmeric extract|mesh-list
44342301|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342302|NCT01037595|Protective Agents|protective agents|mesh-ancestor
44342303|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342304|NCT01037608|Nabiximols|nabiximols|mesh-list
44342305|NCT01037608|Analgesics|analgesics|mesh-ancestor
44342306|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
44342307|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342308|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342309|NCT01037621|Valacyclovir|valacyclovir|mesh-list
44342310|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
44342311|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342312|NCT01037634|Oseltamivir|oseltamivir|mesh-list
44342313|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
44342314|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342315|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342316|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342317|NCT01037660|Metformin|metformin|mesh-list
44342318|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44342319|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342320|NCT01037699|Hormones|hormones|mesh-list
44342321|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44342322|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790277|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
44342323|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342324|NCT01037712|Valacyclovir|valacyclovir|mesh-list
44342325|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
44342326|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342346|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342347|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44342348|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342349|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342350|NCT01038024|Antioxidants|antioxidants|mesh-list
44342351|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342352|NCT01038024|Protective Agents|protective agents|mesh-ancestor
44342353|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342354|NCT01038037|Carboplatin|carboplatin|mesh-list
44342355|NCT01038037|Vinorelbine|vinorelbine|mesh-list
44342356|NCT01038037|Panitumumab|panitumumab|mesh-list
44342357|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342358|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44342359|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342360|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44342361|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342362|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342363|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44342364|NCT01038063|Lumefantrine|lumefantrine|mesh-list
44342365|NCT01038063|Artemether|artemether|mesh-list
44342366|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44342367|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
44342368|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43749813|NCT02508753|Tazobactam|tazobactam|mesh-list
44131401|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
44131402|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
44131403|NCT00148421|Hematinics|hematinics|mesh-ancestor
44131404|NCT00148447|Citalopram|citalopram|mesh-list
44131405|NCT00148447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44131406|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44131407|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131408|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131410|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
44131411|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131412|NCT00148447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44131413|NCT00148447|Antidepressive Agents|antidepressive agents|mesh-ancestor
44131414|NCT00148447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131416|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44131417|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44131418|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131419|NCT00148473|Misoprostol|misoprostol|mesh-list
44131420|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44131421|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
44131422|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44131423|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131424|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44155410|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155411|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
44155412|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44155413|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342369|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44342370|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342371|NCT01038089|Resveratrol|resveratrol|mesh-list
44342372|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
44342373|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342374|NCT01038089|Protective Agents|protective agents|mesh-ancestor
44342375|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342376|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342377|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44342378|NCT01038154|Pravastatin|pravastatin|mesh-list
44342379|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44342380|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44342381|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
44342382|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342383|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44342384|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44342385|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342386|NCT01038167|Cyclosporine|cyclosporine|mesh-list
44342387|NCT01038167|Tacrolimus|tacrolimus|mesh-list
44342388|NCT01038167|Cyclosporins|cyclosporins|mesh-list
44342389|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342390|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
44342391|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155414|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155415|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
44155416|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44155417|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155419|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155420|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155421|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155422|NCT00226980|Thalidomide|thalidomide|mesh-list
44155423|NCT00226980|Capecitabine|capecitabine|mesh-list
44155424|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155425|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
44155426|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155427|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155428|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155429|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
44155430|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155431|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
44155432|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155433|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155434|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44155435|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44155436|NCT00226980|Growth Substances|growth substances|mesh-ancestor
44155437|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
44155438|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44155439|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155440|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44155441|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155442|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342393|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342394|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342395|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
44342396|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342397|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342398|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342399|NCT01038349|Methotrexate|methotrexate|mesh-list
44342400|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44342401|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
44342402|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44342403|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342404|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44342406|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342407|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342408|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342409|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342410|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44342411|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342412|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
44342413|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342414|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44342415|NCT01038388|Dexamethasone|dexamethasone|mesh-list
44342416|NCT01038388|Lenalidomide|lenalidomide|mesh-list
44342417|NCT01038388|Bortezomib|bortezomib|mesh-list
44342418|NCT01038388|Vorinostat|vorinostat|mesh-list
44342419|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342420|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
44342421|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
44342422|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342423|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342424|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342425|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
44342426|NCT01038388|Hormones|hormones|mesh-ancestor
44342428|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44342432|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44342433|NCT01038388|Growth Substances|growth substances|mesh-ancestor
44342434|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
44342435|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44342436|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342437|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342438|NCT01038453|Vitamin D|vitamin d|mesh-list
44342439|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
44342440|NCT01038453|Vitamins|vitamins|mesh-ancestor
44342441|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
44342442|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342443|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44342444|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44342445|NCT01038505|Sirolimus|sirolimus|mesh-list
44342446|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
44342447|NCT01038505|Tacrolimus|tacrolimus|mesh-list
44342448|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342449|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
44342450|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342451|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44342452|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342453|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342454|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342455|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342456|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44342457|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342458|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
44342459|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43749834|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
44155443|NCT00227084|Hemostatics|hemostatics|mesh-list
44155444|NCT00227084|Coagulants|coagulants|mesh-ancestor
44155445|NCT00227097|Anticoagulants|anticoagulants|mesh-list
44155446|NCT00227110|Pioglitazone|pioglitazone|mesh-list
44155447|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155448|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155449|NCT00227123|Risperidone|risperidone|mesh-list
44155450|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44155451|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44155452|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
44155453|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155454|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155455|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155456|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44155457|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155458|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155459|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155460|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44342460|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
44342461|NCT01038570|Oxytocin|oxytocin|mesh-list
44342462|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
44342463|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44342464|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342465|NCT01038583|Aspirin|aspirin|mesh-list
44342466|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342467|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44342468|NCT01038583|Analgesics|analgesics|mesh-ancestor
44342469|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
44342470|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342471|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342472|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342473|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342474|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44342475|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44342476|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342477|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44342478|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44342479|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342480|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
44342481|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44342482|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44342483|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342484|NCT01038648|Incretins|incretins|mesh-ancestor
44342485|NCT01038648|Hormones|hormones|mesh-ancestor
44342491|NCT01038661|Cisplatin|cisplatin|mesh-list
44342510|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44342511|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
44342512|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
44342513|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
44342514|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
44342515|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342516|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342517|NCT01038895|Ramipril|ramipril|mesh-list
44342518|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44342519|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44342520|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342521|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342522|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44342523|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
44131427|NCT00148499|Benzocaine|benzocaine|mesh-list
44131428|NCT00148499|Ambroxol|ambroxol|mesh-list
44131429|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
44131430|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
44131431|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131432|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131433|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
44131434|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131435|NCT00148499|Expectorants|expectorants|mesh-ancestor
44131436|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44131437|NCT00148551|Triamcinolone|triamcinolone|mesh-list
44131438|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44131439|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44131440|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44131441|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131442|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
44131443|NCT00148551|Hormones|hormones|mesh-ancestor
44131444|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131445|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131446|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131456|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131457|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131458|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131459|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131460|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131461|NCT00148564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44131462|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44131463|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131464|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131465|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131466|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
44131467|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44131468|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44131469|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
44131470|NCT00148590|Memantine|memantine|mesh-list
44131471|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44131472|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44131473|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
44131474|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131475|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131476|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131477|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44342525|NCT01039025|Topotecan|topotecan|mesh-list
44342526|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342527|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
44342528|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342529|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342530|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44342531|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
44342532|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342533|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342534|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44342535|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44342536|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342537|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342538|NCT01039090|Dopamine|dopamine|mesh-list
44342539|NCT01039090|Apomorphine|apomorphine|mesh-list
44342540|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
44342541|NCT01039090|Emetics|emetics|mesh-ancestor
44342542|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342543|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
44342544|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342545|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342546|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
44342547|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342548|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342549|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44342550|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
44342551|NCT01039090|Protective Agents|protective agents|mesh-ancestor
44342552|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
44342553|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44342554|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44342555|NCT01039103|Prednisolone|prednisolone|mesh-list
44342556|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
44342557|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44342567|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342568|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44342569|NCT01039103|Protective Agents|protective agents|mesh-ancestor
44342570|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44342571|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342572|NCT01039142|Acitretin|acitretin|mesh-list
44342573|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
44342574|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342575|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
44342576|NCT01039155|Azacitidine|azacitidine|mesh-list
44342577|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342578|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44342579|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
44342580|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342581|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342582|NCT01039181|Vitamin D|vitamin d|mesh-list
44342583|NCT01039181|Calcitriol|calcitriol|mesh-list
44342584|NCT01039181|Vitamins|vitamins|mesh-ancestor
44342585|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
44342586|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342587|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44342588|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44342589|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44342590|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44342591|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342592|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44342593|NCT01039194|Galantamine|galantamine|mesh-list
44342594|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44342595|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342596|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342597|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
44342598|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131478|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44131479|NCT00148603|Montelukast|montelukast|mesh-list
44131480|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44131481|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
44131482|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44131483|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131484|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131485|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342599|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342600|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44342601|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
44342602|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342603|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
44342604|NCT01039233|Bicalutamide|bicalutamide|mesh-list
44342605|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
44342606|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
44342607|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342608|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342609|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342610|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
44342611|NCT01039350|Hematinics|hematinics|mesh-ancestor
44342612|NCT01039363|Cytarabine|cytarabine|mesh-list
44342613|NCT01039363|Vorinostat|vorinostat|mesh-list
44342614|NCT01039363|Idarubicin|idarubicin|mesh-list
44342615|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
44342616|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44342617|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
44342618|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342619|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342620|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
44342621|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342622|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342623|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
44342624|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342625|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44342626|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342627|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44342628|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44342629|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342630|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44342632|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
44342633|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
43749999|NCT02507284|SRX246|srx246|mesh-list
44131486|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44131487|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44131488|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131489|NCT00148616|Memantine|memantine|mesh-list
44131490|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44131491|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44342634|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342635|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342637|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342638|NCT01039506|Irinotecan|irinotecan|mesh-list
44342639|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44342640|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342641|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342642|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342643|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342644|NCT01039545|Norfloxacin|norfloxacin|mesh-list
44342645|NCT01039545|Diclofenac|diclofenac|mesh-list
44342646|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342647|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44342648|NCT01039545|Analgesics|analgesics|mesh-ancestor
44342649|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
44342650|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342651|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342652|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342653|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342654|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44342655|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750028|NCT02507076|Melphalan|melphalan|mesh-list
44131492|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
44131493|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131494|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131495|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131496|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44131497|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44131498|NCT00148681|Paclitaxel|paclitaxel|mesh-list
44131499|NCT00148681|Vinorelbine|vinorelbine|mesh-list
44131500|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
44131501|NCT00148681|Doxorubicin|doxorubicin|mesh-list
44131502|NCT00148681|Trastuzumab|trastuzumab|mesh-list
44131503|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44131504|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131505|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44131506|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131507|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131508|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131509|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131513|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44131514|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
44131515|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44131516|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131517|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44131518|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44131519|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131520|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131522|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342656|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342657|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342658|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342659|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44342660|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342661|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342662|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44342663|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44342664|NCT01039558|Ecabet|ecabet|mesh-list
44342665|NCT01039558|Lansoprazole|lansoprazole|mesh-list
44342666|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
44342667|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44342668|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342669|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44342670|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342671|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342672|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342673|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44342674|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44342675|NCT01039558|Protective Agents|protective agents|mesh-ancestor
44342676|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342677|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342678|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
44342679|NCT01039610|Linezolid|linezolid|mesh-list
44342680|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342681|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342682|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44342683|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342684|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342700|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44342701|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44342702|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44342703|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43997839|NCT02669615|Melphalan|melphalan|mesh-list
44342704|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44342705|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44342707|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44342708|NCT01039766|Oxytocin|oxytocin|mesh-list
44342709|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
44342710|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44342711|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342712|NCT01039844|Paclitaxel|paclitaxel|mesh-list
44342713|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44342714|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342715|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342716|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
44342717|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342718|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342719|NCT01039883|Albaconazole|albaconazole|mesh-list
44342754|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44342755|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44342756|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44342757|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44342758|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44342759|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44342760|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
44342761|NCT01040195|Methotrexate|methotrexate|mesh-list
44342762|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44342763|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
44342764|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44342765|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342766|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44342767|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
43750097|NCT02506777|Metformin|metformin|mesh-list
44131523|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44131524|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131525|NCT00148720|Capecitabine|capecitabine|mesh-list
44131526|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131527|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
44131528|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131529|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131530|NCT00148746|Cyclosporine|cyclosporine|mesh-list
44131531|NCT00148746|Prednisolone|prednisolone|mesh-list
44131532|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
44131533|NCT00148746|Prednicarbate|prednicarbate|mesh-list
44131534|NCT00148746|Tacrolimus|tacrolimus|mesh-list
44131535|NCT00148746|Cyclosporins|cyclosporins|mesh-list
44131536|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131537|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
43654301|NCT02976727|Vitamin D|vitamin d|mesh-list
44131538|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131539|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44131540|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131541|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131542|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
44131543|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131544|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44131545|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131546|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131547|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
44131548|NCT00148746|Hormones|hormones|mesh-ancestor
44131549|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131550|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44131551|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131552|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131553|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44131554|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131555|NCT00148746|Analgesics|analgesics|mesh-ancestor
44131556|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
44131557|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44131558|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131559|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44131560|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131561|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131562|NCT00148785|Ritonavir|ritonavir|mesh-list
44131563|NCT00148785|Indinavir|indinavir|mesh-list
44131564|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
44342769|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342770|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342771|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342772|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44342773|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342774|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
44342775|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342776|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44342777|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
44342778|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44342779|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44342780|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342781|NCT01040234|Bupivacaine|bupivacaine|mesh-list
44342782|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
44342783|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
44342784|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342785|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342786|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
44342787|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342788|NCT01040273|Bupivacaine|bupivacaine|mesh-list
44342789|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
44342790|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
44342791|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44342792|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342793|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
44131565|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44131566|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44131567|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
44131568|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131569|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131570|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44131571|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44131572|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
44131573|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131574|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44131575|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44131577|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44131578|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
44131579|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131580|NCT00148837|Interferons|interferons|mesh-list
44131582|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
44131584|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44131585|NCT00148837|Prazosin|prazosin|mesh-list
44131586|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131587|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
44342794|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342795|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
44342796|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
44342797|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44342798|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342799|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
44342800|NCT01040286|Analgesics|analgesics|mesh-ancestor
44342801|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
44342802|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342803|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342804|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44342805|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44342806|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342807|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342808|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44342809|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342810|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342811|NCT01040312|Cisplatin|cisplatin|mesh-list
44342812|NCT01040312|Carboplatin|carboplatin|mesh-list
44342813|NCT01040312|Nedaplatin|nedaplatin|mesh-list
44342814|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342815|NCT01040325|Vaccines|vaccines|mesh-list
44342816|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
44342817|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342818|NCT01040338|Nicotine|nicotine|mesh-list
44342819|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44342820|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
44342821|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342822|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342823|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44342824|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44131588|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131589|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
44131590|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131591|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
44131592|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131593|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131594|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44131595|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44131596|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44131597|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
44131598|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131599|NCT00148850|Pioglitazone|pioglitazone|mesh-list
44131600|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44131601|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342826|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342827|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342828|NCT01040429|Clonidine|clonidine|mesh-list
44342829|NCT01040429|Analgesics|analgesics|mesh-ancestor
44342830|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
44342831|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342832|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342833|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44342834|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
44342835|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
44342836|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44342837|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44342838|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44342839|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44342840|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791451|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44342841|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342842|NCT01040455|Lansoprazole|lansoprazole|mesh-list
44342843|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
44342844|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44342845|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342846|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44342847|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342848|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342849|NCT01040559|Idarubicin|idarubicin|mesh-list
44342850|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44342851|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342852|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44342853|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44342854|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131602|NCT00148863|Interferons|interferons|mesh-list
44131603|NCT00148863|Ribavirin|ribavirin|mesh-list
44131604|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
44131605|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
44131606|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
44131607|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44131608|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131609|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
44131610|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131611|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
44131612|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131613|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
44131614|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131615|NCT00148876|Capecitabine|capecitabine|mesh-list
44131616|NCT00148876|Trastuzumab|trastuzumab|mesh-list
44342855|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342856|NCT01040585|Linezolid|linezolid|mesh-list
44342857|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342858|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342859|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44342860|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342861|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342862|NCT01040598|Omalizumab|omalizumab|mesh-list
44342863|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44342864|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44342865|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
44342866|NCT01040702|Methylphenidate|methylphenidate|mesh-list
44342867|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44342868|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342869|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44342870|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44342871|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44342872|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342873|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
44342874|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342875|NCT01040936|Atorvastatin|atorvastatin|mesh-list
44342876|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44342877|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44342878|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
44342879|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342880|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44342881|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44342882|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342883|NCT01041027|Paclitaxel|paclitaxel|mesh-list
44342884|NCT01041027|Carboplatin|carboplatin|mesh-list
43750152|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131617|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131618|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
44131619|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131620|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131621|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131622|NCT00148902|Docetaxel|docetaxel|mesh-list
44131623|NCT00148902|Lapatinib|lapatinib|mesh-list
44131624|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131625|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342885|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44342886|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342887|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342888|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
44342889|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342890|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342891|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
44342892|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44342893|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342894|NCT01041066|Labetalol|labetalol|mesh-list
44342895|NCT01041066|Nicardipine|nicardipine|mesh-list
44342896|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44342897|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44342898|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
44342899|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342900|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342901|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342902|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44342903|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
44342904|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
44342905|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342906|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44342907|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44342908|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44342909|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44342910|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44342911|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
44342912|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44342913|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44342927|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342928|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342929|NCT01041183|Ramosetron|ramosetron|mesh-list
44342930|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
44342931|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
44342932|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342933|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342934|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342935|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44342936|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
44342937|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342938|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342939|NCT01041235|Docetaxel|docetaxel|mesh-list
44342940|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342941|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
44342942|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
44342943|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44342944|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342945|NCT01041313|Memantine|memantine|mesh-list
44342946|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44342947|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44342948|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
44342949|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44342950|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342951|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342952|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44342953|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44342954|NCT01041378|Dexamethasone|dexamethasone|mesh-list
44342955|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44342956|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
44342957|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
44342958|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44342959|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750233|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
44131626|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44131627|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44131628|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840944|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848404|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848405|NCT04022239|Lenograstim|lenograstim|mesh-list
44131629|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44131630|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342960|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44342961|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
44342963|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44342964|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44342965|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342966|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
44342967|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
44342968|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342969|NCT01041482|Sorafenib|sorafenib|mesh-list
44342970|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342971|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44342972|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342973|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342974|NCT01041508|Cyclosporine|cyclosporine|mesh-list
44342975|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
44342976|NCT01041508|Clofarabine|clofarabine|mesh-list
44342977|NCT01041508|Cyclosporins|cyclosporins|mesh-list
44342978|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44342979|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44342980|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44342981|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
44342982|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44342983|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
44342984|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44342985|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44342986|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44342987|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44342988|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44342989|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44342990|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44342991|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
44342992|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44342993|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44342994|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
44342998|NCT01041625|Analgesics|analgesics|mesh-ancestor
44342999|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
44343000|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343001|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343002|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343003|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343004|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44343005|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44343006|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343007|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343008|NCT01041690|Bevacizumab|bevacizumab|mesh-list
44343009|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343010|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343011|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343012|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343013|NCT01041690|Growth Substances|growth substances|mesh-ancestor
44343014|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343015|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343016|NCT01041729|Atorvastatin|atorvastatin|mesh-list
44343017|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44343018|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44343019|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
44343020|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343021|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44343022|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44343023|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343024|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
43791956|NCT02856438|Hormones|hormones|mesh-ancestor
44343025|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44343026|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44343027|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343028|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343029|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343030|NCT01041872|Lidocaine|lidocaine|mesh-list
44343036|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
44343037|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343038|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44343039|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44343040|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44343041|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343042|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343043|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44343044|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44343045|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
44343046|NCT01041963|Losartan|losartan|mesh-list
44343047|NCT01041963|Enalapril|enalapril|mesh-list
44343048|NCT01041963|Enalaprilat|enalaprilat|mesh-list
44343049|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44343050|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44343051|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44343052|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44343053|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343054|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44343055|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
44131631|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
44131632|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44131633|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131634|NCT00149019|Antibodies|antibodies|mesh-list
44131635|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44131636|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
44131637|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131638|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
44131639|NCT00149058|Hematinics|hematinics|mesh-ancestor
44131640|NCT00149084|Amoxicillin|amoxicillin|mesh-list
44131641|NCT00149084|Clarithromycin|clarithromycin|mesh-list
44131642|NCT00149084|Lansoprazole|lansoprazole|mesh-list
44131643|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
44131644|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131645|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131646|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44131647|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131648|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131649|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44131650|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44131651|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44131652|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131653|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44131654|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44131655|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44131656|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44131657|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131685|NCT00149162|Analgesics|analgesics|mesh-ancestor
44131686|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
44131687|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131688|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131689|NCT00149188|Lanreotide|lanreotide|mesh-list
44343057|NCT01042028|Capecitabine|capecitabine|mesh-list
44343058|NCT01042028|Irinotecan|irinotecan|mesh-list
44343059|NCT01042028|Cetuximab|cetuximab|mesh-list
44343060|NCT01042028|Everolimus|everolimus|mesh-list
44343061|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
44343062|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343063|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
44343064|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343065|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343066|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44343067|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44343068|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343069|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343070|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343071|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
44343072|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343073|NCT01042041|Cisplatin|cisplatin|mesh-list
44343074|NCT01042041|Doxorubicin|doxorubicin|mesh-list
44343075|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44343076|NCT01042041|Sorafenib|sorafenib|mesh-list
44343077|NCT01042041|Mitomycins|mitomycins|mesh-list
44343078|NCT01042041|Mitomycin|mitomycin|mesh-list
44343079|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343080|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44343081|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44343082|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44343083|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343084|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343085|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44343086|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
44343087|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44343088|NCT01042314|Donepezil|donepezil|mesh-list
44343100|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
44343101|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343102|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343103|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343104|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343105|NCT01042561|Vitamin D|vitamin d|mesh-list
44343106|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
44343107|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
44343108|NCT01042561|Vitamins|vitamins|mesh-list
44343109|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
44343110|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343111|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44343112|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43998224|NCT02701062|Warfarin|warfarin|mesh-list
44343113|NCT01042574|Clevidipine|clevidipine|mesh-list
44343114|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44343115|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343116|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343117|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44343118|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343119|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
44343120|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44343121|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44343122|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
44343123|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343124|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44343125|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44343126|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343127|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343128|NCT01042665|Latanoprost|latanoprost|mesh-list
44343129|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44343130|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44343131|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
44343132|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343133|NCT01042704|Aspirin|aspirin|mesh-list
44343134|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44343138|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343139|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
44343140|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
44343141|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343142|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343143|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343144|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
44343145|NCT01042704|Hormones|hormones|mesh-ancestor
44343146|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343147|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343148|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343149|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44343150|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44343151|NCT01042704|Analgesics|analgesics|mesh-ancestor
44343152|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
44343153|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841044|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343154|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44343155|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44343156|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343157|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44343158|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44343159|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343160|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
44343161|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
44343162|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343163|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343164|NCT01042704|Growth Substances|growth substances|mesh-ancestor
44343165|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343166|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343167|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44343181|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44343182|NCT01042782|Everolimus|everolimus|mesh-list
44343183|NCT01042782|Mitomycin|mitomycin|mesh-list
44343184|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343185|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343186|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
44343187|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343188|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
44343189|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343190|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44343191|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44343192|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998393|NCT02712047|Xhance|xhance|mesh-list
44343194|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44343195|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
44343196|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
43750436|NCT02505113|Montelukast|montelukast|mesh-list
44131690|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131691|NCT00149201|Fluorouracil|fluorouracil|mesh-list
44131692|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
44131693|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131694|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131695|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131696|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131697|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
44131698|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131699|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
44131700|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44131701|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44131702|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44131703|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131704|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131705|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131719|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44131720|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44131721|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131722|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131724|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
44131725|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
44155461|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
44131726|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131727|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131728|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131729|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131730|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131731|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131732|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131733|NCT00149292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44131734|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44131735|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131736|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131737|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131740|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44131741|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131742|NCT00149539|Buprenorphine|buprenorphine|mesh-list
44131743|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44131744|NCT00149539|Naloxone|naloxone|mesh-list
44131745|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44343197|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343198|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343199|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44343200|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44343201|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44343202|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
44343203|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343204|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343205|NCT01042873|Protective Agents|protective agents|mesh-ancestor
44343206|NCT01042951|Vaccines|vaccines|mesh-list
44343207|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
44343208|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343209|NCT01043172|Gemcitabine|gemcitabine|mesh-list
44343210|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343211|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
44343212|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343213|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343214|NCT01043172|Antiviral Agents|antiviral agents|mesh-ancestor
44343215|NCT01043172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343216|NCT01043172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343217|NCT01043172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343218|NCT01043172|Immunologic Factors|immunologic factors|mesh-ancestor
44343219|NCT01043172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343220|NCT01043211|Lidocaine|lidocaine|mesh-list
44343221|NCT01043211|Epinephrine|epinephrine|mesh-list
44343222|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
44343223|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
44343224|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343225|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343226|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
44343227|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343240|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44343241|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
44343242|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
44343243|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
44343244|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44343245|NCT01043224|Clobetasol|clobetasol|mesh-list
44343246|NCT01043224|Calcipotriene|calcipotriene|mesh-list
44343247|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343248|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
44343249|NCT01043224|Hormones|hormones|mesh-ancestor
44343250|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343251|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343252|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44343253|NCT01043341|Vaccines|vaccines|mesh-list
44343254|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
44343255|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343256|NCT01043380|Atorvastatin|atorvastatin|mesh-list
44343257|NCT01043380|Ezetimibe|ezetimibe|mesh-list
44343258|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44343259|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44343260|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
44343261|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343262|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44343263|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43750495|NCT02504801|Hormones|hormones|mesh-ancestor
44131746|NCT00149539|Narcotics|narcotics|mesh-ancestor
44131747|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131748|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131749|NCT00149539|Analgesics|analgesics|mesh-ancestor
44131750|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
44131751|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131752|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44131753|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
44131754|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131755|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
44131756|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131757|NCT00149578|Leucovorin|leucovorin|mesh-list
44131758|NCT00149578|Gemcitabine|gemcitabine|mesh-list
44131759|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
44131760|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44131761|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
44131762|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131763|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131764|NCT00149578|Antiviral Agents|antiviral agents|mesh-ancestor
44131765|NCT00149578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131766|NCT00149578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131767|NCT00149578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131782|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131783|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44131784|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44343264|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343265|NCT01043419|Xenon|xenon|mesh-list
44343266|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44343267|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
44343268|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
44343269|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343270|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343271|NCT01043445|Glycerol|glycerol|mesh-list
44343272|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44343273|NCT01043445|Protective Agents|protective agents|mesh-ancestor
44343274|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343275|NCT01043484|Bevacizumab|bevacizumab|mesh-list
44343276|NCT01043484|Capecitabine|capecitabine|mesh-list
44343277|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343278|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343279|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343280|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343281|NCT01043484|Growth Substances|growth substances|mesh-ancestor
44343282|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343283|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343284|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343285|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
44343286|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343287|NCT01043510|Insulin|insulin|mesh-list
44343288|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44343289|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
44343290|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343291|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343292|NCT01043536|Temozolomide|temozolomide|mesh-list
44343293|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44343294|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
44343295|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343296|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343297|NCT01043575|Rifampin|rifampin|mesh-list
44343298|NCT01043575|Rifapentine|rifapentine|mesh-list
44343299|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44343303|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
44343304|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44343305|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343306|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343307|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43792740|NCT05097274|Lipotropic Agents|lipotropic agents|mesh-ancestor
44343308|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44343309|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44343310|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44343311|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44343312|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44343313|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
44343314|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44343315|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
44343316|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343317|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343318|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44343319|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
44343320|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44343321|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44343322|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44343323|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
44343324|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343325|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343326|NCT01043666|Mirabegron|mirabegron|mesh-list
44343327|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44343328|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44343329|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44343330|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44343331|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
43998522|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
44343342|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44343343|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44343344|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343345|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343347|NCT01043744|Artemether|artemether|mesh-list
44343348|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44343349|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
44343350|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44343351|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44343352|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343353|NCT01043952|Remifentanil|remifentanil|mesh-list
44343354|NCT01043952|Propofol|propofol|mesh-list
44343355|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44343356|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343357|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343358|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44343359|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
44343360|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
44343361|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44343362|NCT01043952|Narcotics|narcotics|mesh-ancestor
44343363|NCT01043952|Analgesics|analgesics|mesh-ancestor
44343364|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
44343365|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343366|NCT01043965|Metformin|metformin|mesh-list
44343367|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343368|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343369|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
44343370|NCT01043991|Hematinics|hematinics|mesh-ancestor
44343371|NCT01044004|Modafinil|modafinil|mesh-list
44343372|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44343373|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343388|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343389|NCT01044225|Cetuximab|cetuximab|mesh-list
44343390|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343391|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343392|NCT01044238|Methylphenidate|methylphenidate|mesh-list
44343393|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44343394|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343395|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44343396|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44343397|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343398|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343399|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
44343400|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343401|NCT01044251|Frovatriptan|frovatriptan|mesh-list
44343402|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44343403|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
44343404|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343405|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343406|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343407|NCT01044329|Triamcinolone|triamcinolone|mesh-list
44343408|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44343409|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44343410|NCT01044329|Bevacizumab|bevacizumab|mesh-list
44343411|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44343412|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343413|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343421|NCT01044329|Hormones|hormones|mesh-ancestor
44343432|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343433|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343434|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
44343435|NCT01044394|Bisacodyl|bisacodyl|mesh-list
44343436|NCT01044394|Cathartics|cathartics|mesh-ancestor
44343437|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343438|NCT01044394|Laxatives|laxatives|mesh-ancestor
44343439|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
44343440|NCT01044446|Icodextrin|icodextrin|mesh-list
44343441|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44343442|NCT01044485|Docetaxel|docetaxel|mesh-list
44343443|NCT01044485|Lapatinib|lapatinib|mesh-list
44343444|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343445|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
44343446|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
44343447|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
43750657|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44131785|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44131787|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44131788|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131789|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131790|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131791|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131792|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44131793|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
44131794|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131795|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131796|NCT00149656|Selenium|selenium|mesh-list
44131797|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
44131798|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131799|NCT00149656|Protective Agents|protective agents|mesh-ancestor
44131800|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131801|NCT00149656|Trace Elements|trace elements|mesh-ancestor
44131802|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
44131803|NCT00149708|Hormones|hormones|mesh-list
44131804|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131805|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131806|NCT00149851|Tegaserod|tegaserod|mesh-list
44131807|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44131809|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131810|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131811|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131812|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
44131813|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131814|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131815|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131816|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131817|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131818|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131819|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131820|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131821|NCT00149877|Tegaserod|tegaserod|mesh-list
44131822|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44131823|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
44131824|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131825|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131826|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131827|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
44131830|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131832|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343448|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343449|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44343450|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998678|NCT02726789|Interferons|interferons|mesh-list
44343451|NCT01044719|Meropenem|meropenem|mesh-list
44343452|NCT01044719|Tobramycin|tobramycin|mesh-list
44343453|NCT01044719|Ceftazidime|ceftazidime|mesh-list
44343454|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343455|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343456|NCT01044810|Efavirenz|efavirenz|mesh-list
44343457|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44343458|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44343459|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343460|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343461|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
44343462|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343463|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44343464|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44343465|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44343466|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44343467|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44343468|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44343469|NCT01044888|Heparin|heparin|mesh-list
44343470|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
44343495|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343496|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343497|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
44343498|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343499|NCT01045083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44343500|NCT01045083|Antidepressive Agents|antidepressive agents|mesh-ancestor
44343501|NCT01045083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44343502|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44343503|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44343504|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
44343505|NCT01045109|Vitamin D|vitamin d|mesh-list
44343506|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
44343507|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
44343508|NCT01045109|Vitamins|vitamins|mesh-list
44343509|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
44343510|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343511|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44343512|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44343513|NCT01045278|Interferons|interferons|mesh-list
44343514|NCT01045278|Ribavirin|ribavirin|mesh-list
44343515|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
44343516|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
44343517|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44343518|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343519|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
44343520|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343521|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
44343543|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343545|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343546|NCT01045434|Omeprazole|omeprazole|mesh-list
44343547|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44343548|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343549|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44343550|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343551|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343552|NCT01045538|Cisplatin|cisplatin|mesh-list
44343553|NCT01045538|Capecitabine|capecitabine|mesh-list
44343554|NCT01045538|Vorinostat|vorinostat|mesh-list
44343555|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343556|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343557|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
44343558|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343559|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44343560|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343561|NCT01045642|Omeprazole|omeprazole|mesh-list
44343562|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44343563|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343564|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44343565|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343566|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343567|NCT01045681|Dexamethasone|dexamethasone|mesh-list
44343568|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
44343569|NCT01045681|Bortezomib|bortezomib|mesh-list
44343570|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44343571|NCT01045681|BB 1101|bb 1101|mesh-list
44343572|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343573|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
44343574|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
44343575|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343576|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131833|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131834|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131835|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131836|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
44131837|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131838|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343577|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343578|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
44343579|NCT01045681|Hormones|hormones|mesh-ancestor
44343580|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343581|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343582|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343583|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
44343584|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343585|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343586|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44343587|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
44343588|NCT01045772|Rilonacept|rilonacept|mesh-list
44343589|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343590|NCT01045837|Prednisolone|prednisolone|mesh-list
44343591|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343592|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
44343593|NCT01045837|Hormones|hormones|mesh-ancestor
44343594|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343595|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343596|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343597|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343598|NCT01045876|Dexamethasone|dexamethasone|mesh-list
44343599|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343600|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
44343601|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
44343602|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343603|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343604|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343605|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
44343606|NCT01045876|Hormones|hormones|mesh-ancestor
44343607|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846540|NCT04193215|Vaccines|vaccines|mesh-list
44343608|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343609|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343610|NCT01045889|Prednisone|prednisone|mesh-list
44343612|NCT01045889|Melphalan|melphalan|mesh-list
44343617|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
44343618|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343619|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343620|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44343621|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
44343622|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343623|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343624|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44343625|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343626|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343628|NCT01045889|Hormones|hormones|mesh-ancestor
44343629|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343630|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343631|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44343632|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44343633|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44131839|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131840|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131841|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131842|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131843|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131844|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131845|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
44131846|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131847|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131848|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131849|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131850|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131851|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131852|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131853|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131854|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
44131855|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131856|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131857|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131858|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131859|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131860|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131861|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131862|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131863|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
44131864|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131865|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131866|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131867|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131868|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131869|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131870|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131871|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131872|NCT00149981|Everolimus|everolimus|mesh-list
44131873|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131874|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131875|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
44343634|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343635|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
44343636|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
44343637|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
44343638|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
44343639|NCT01045902|Ampicillin|ampicillin|mesh-list
44343640|NCT01045902|Sulbactam|sulbactam|mesh-list
44343641|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44343642|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343643|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343644|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44343645|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44343646|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343647|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343648|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343649|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44343650|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
44343651|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44343652|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131876|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131877|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
44131878|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131879|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131880|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131881|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131882|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131883|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131884|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131885|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131886|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
44131887|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131888|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131889|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44131890|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131891|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131892|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131893|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131894|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131896|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131897|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131898|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
44131912|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44131913|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131914|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131915|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
44131916|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131917|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44131918|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131919|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155462|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155463|NCT00227136|Serotonin|serotonin|mesh-list
44155464|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44155465|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
44155466|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343653|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44343654|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44343655|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44343656|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44343657|NCT01045928|Rituximab|rituximab|mesh-list
44343658|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44343659|NCT01045928|Lenalidomide|lenalidomide|mesh-list
44343660|NCT01045928|Antibodies|antibodies|mesh-list
44343661|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
44343662|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44343663|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
44343664|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343665|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343666|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343667|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343668|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343669|NCT01045928|Growth Substances|growth substances|mesh-ancestor
44343670|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343671|NCT01045941|Gemcitabine|gemcitabine|mesh-list
44343672|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343673|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
43600091|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44343674|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343709|NCT01046006|Hormones|hormones|mesh-ancestor
44343710|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343711|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343712|NCT01046032|Metformin|metformin|mesh-list
44343713|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343714|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343715|NCT01046045|Everolimus|everolimus|mesh-list
44343716|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343717|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343718|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
44343719|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343720|NCT01046058|Simeprevir|simeprevir|mesh-list
44343721|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
44343722|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343723|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44343724|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343725|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343726|NCT01046162|Alprazolam|alprazolam|mesh-list
44343727|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44343728|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343729|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343730|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44343731|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44343732|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44343733|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
44343734|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
44343735|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343737|NCT01046214|Bupropion|bupropion|mesh-list
44343756|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
44343757|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343758|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343759|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343760|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44343761|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44343762|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
44343763|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343764|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343765|NCT01046266|Cetuximab|cetuximab|mesh-list
44343766|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343767|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343768|NCT01046279|Bevacizumab|bevacizumab|mesh-list
44343769|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343770|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343771|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343772|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343773|NCT01046279|Growth Substances|growth substances|mesh-ancestor
44343774|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343775|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343776|NCT01046383|Caseins|caseins|mesh-list
44343777|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
44343778|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
44343779|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343780|NCT01046435|Amoxicillin|amoxicillin|mesh-list
44343781|NCT01046435|Metronidazole|metronidazole|mesh-list
44343782|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44343786|NCT01046461|Dexamethasone|dexamethasone|mesh-list
44343802|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343803|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44343804|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
44343805|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
44343806|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
44343807|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343808|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
44343809|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846561|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846562|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43846563|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
44343810|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343811|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44343812|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
44343813|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343814|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343815|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44343816|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44343817|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343818|NCT01046500|Inositol|inositol|mesh-list
44343819|NCT01046500|Metformin|metformin|mesh-list
44343820|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343821|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343822|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
44343823|NCT01046500|Vitamins|vitamins|mesh-ancestor
44343824|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
44343825|NCT01046539|Buprenorphine|buprenorphine|mesh-list
44343826|NCT01046539|ALKS-33|alks-33|mesh-list
44343827|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44343828|NCT01046539|Narcotics|narcotics|mesh-ancestor
44343829|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343830|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343831|NCT01046539|Analgesics|analgesics|mesh-ancestor
44343832|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
44343833|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343834|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44343835|NCT01046578|Letrozole|letrozole|mesh-list
44343836|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343837|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44343838|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44343839|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343840|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343841|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44343842|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
44343843|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343844|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343846|NCT01046630|Analgesics|analgesics|mesh-ancestor
44343847|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
44343848|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343849|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343850|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44343851|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44343852|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
44343853|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
44343854|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44343855|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44343856|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44343857|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343858|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343860|NCT01046708|Progestins|progestins|mesh-ancestor
44343861|NCT01046708|Hormones|hormones|mesh-ancestor
44343862|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343863|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343864|NCT01046721|Exenatide|exenatide|mesh-list
44343865|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44343866|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343867|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44343868|NCT01046721|Incretins|incretins|mesh-ancestor
44343869|NCT01046721|Hormones|hormones|mesh-ancestor
44343870|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343871|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
44155467|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155468|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155469|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44155470|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
44155471|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155472|NCT00227292|Citalopram|citalopram|mesh-list
44155473|NCT00227292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44155474|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44343872|NCT01046773|Vitamin D|vitamin d|mesh-list
44343873|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44343874|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343875|NCT01046773|Vitamins|vitamins|mesh-ancestor
44343876|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
44343877|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44343878|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
44343879|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44343880|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44343881|NCT01046786|Prednisolone|prednisolone|mesh-list
44343882|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
44343883|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44343884|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
44343885|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343886|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
44343887|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
44343888|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343889|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343890|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44343891|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
44343892|NCT01046786|Hormones|hormones|mesh-ancestor
44343893|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44343894|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44343895|NCT01046786|Protective Agents|protective agents|mesh-ancestor
44343896|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44343897|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343898|NCT01046799|Entecavir|entecavir|mesh-list
44343899|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
44343900|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343901|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
44343902|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
44343903|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44343904|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44155475|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155476|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155477|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155478|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
44155479|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155480|NCT00227292|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44155481|NCT00227292|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155482|NCT00227292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155483|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
44343906|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343907|NCT01046838|Urological Agents|urological agents|mesh-ancestor
44343908|NCT01046864|Leucovorin|leucovorin|mesh-list
44343909|NCT01046864|Fluorouracil|fluorouracil|mesh-list
44343910|NCT01046864|Irinotecan|irinotecan|mesh-list
44343911|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
44343912|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343913|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44343914|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343915|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343916|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
44343917|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343918|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44343919|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44343920|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343921|NCT01046864|Antidotes|antidotes|mesh-ancestor
44343922|NCT01046864|Protective Agents|protective agents|mesh-ancestor
44343923|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
44343924|NCT01046864|Vitamins|vitamins|mesh-ancestor
44343925|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
44343926|NCT01046942|Aspirin|aspirin|mesh-list
44343927|NCT01046942|Clopidogrel|clopidogrel|mesh-list
44343928|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44343929|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44343930|NCT01046942|Analgesics|analgesics|mesh-ancestor
43794166|NCT03841201|Nivolumab|nivolumab|mesh-list
44343931|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
43999146|NCT05442411|Analgesics|analgesics|mesh-ancestor
44343932|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44343933|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343934|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44343935|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343936|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44343937|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44155484|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44155485|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44155486|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44131920|NCT00150085|Cyclosporine|cyclosporine|mesh-list
44131921|NCT00150085|Cyclosporins|cyclosporins|mesh-list
44131922|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131923|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343938|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44343940|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44343941|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343942|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
44343943|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44343944|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44343945|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44343946|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
44343947|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44343948|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
44343949|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
44343950|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44343951|NCT01046955|Daclizumab|daclizumab|mesh-list
44343952|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
44343953|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343954|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343955|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343956|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343957|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44343958|NCT01046981|Metronidazole|metronidazole|mesh-list
44343959|NCT01046981|Cefazolin|cefazolin|mesh-list
44343960|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44343961|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44343962|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
44343963|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44343964|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44343965|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44343966|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750997|NCT02501200|Ezetimibe|ezetimibe|mesh-list
44131924|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43577001|NCT03493048|Leucovorin|leucovorin|mesh-list
44131925|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
44131926|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131927|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
44131928|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131929|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
44131930|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131931|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44131932|NCT00150111|Rituximab|rituximab|mesh-list
44131933|NCT00150111|Methimazole|methimazole|mesh-list
44131940|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131941|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131942|NCT00150124|Methimazole|methimazole|mesh-list
44131943|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
44131944|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44163835|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44343967|NCT01047059|Bevacizumab|bevacizumab|mesh-list
44343968|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44343969|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44343970|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44343971|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44343972|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44343973|NCT01047059|Growth Substances|growth substances|mesh-ancestor
44343974|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343975|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
44343976|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44343977|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44343978|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600098|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43600099|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44343979|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
44343980|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
44343981|NCT01047072|Rituximab|rituximab|mesh-list
44343982|NCT01047072|Fludarabine|fludarabine|mesh-list
44343983|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
44343984|NCT01047072|Tacrolimus|tacrolimus|mesh-list
44343985|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44343986|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
44343987|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44343988|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44343989|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344004|NCT01047098|Iron|iron|mesh-list
44344019|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
44344020|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
44344021|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344022|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344023|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44344024|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44344025|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
44344026|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44344027|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44344028|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44344029|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44344030|NCT01047423|Simvastatin|simvastatin|mesh-list
44344031|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44344032|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44344033|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
44344034|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344035|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44344036|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44344037|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344038|NCT01047488|Pregabalin|pregabalin|mesh-list
44344039|NCT01047488|Imipramine|imipramine|mesh-list
44344040|NCT01047488|Analgesics|analgesics|mesh-ancestor
44344041|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
44344042|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344043|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344044|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
44344045|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44344046|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344047|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344048|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44131945|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131946|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131947|NCT00150137|Methimazole|methimazole|mesh-list
44131948|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
44131949|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
44131950|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131951|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131952|NCT00150215|Olanzapine|olanzapine|mesh-list
44131953|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
44131954|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
44131955|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344049|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44344050|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344051|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344052|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344053|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44344054|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
44344055|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44344056|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44344057|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
44344058|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344059|NCT01047566|Digoxin|digoxin|mesh-list
44344060|NCT01047566|Dronedarone|dronedarone|mesh-list
44344061|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
44344062|NCT01047566|Calcium|calcium|mesh-list
44344063|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44344064|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344065|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344066|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44344067|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44344068|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344069|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344070|NCT01047566|Protective Agents|protective agents|mesh-ancestor
44344071|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44344072|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
44344073|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344074|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344075|NCT01047579|Rivastigmine|rivastigmine|mesh-list
44344076|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44344077|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344078|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344079|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
44344080|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131956|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131957|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131958|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44131959|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44131960|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44131961|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131962|NCT00150215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44131963|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44344081|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344082|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44344083|NCT01047579|Protective Agents|protective agents|mesh-ancestor
44344084|NCT01047657|Orlistat|orlistat|mesh-list
44344085|NCT01047657|Sibutramine|sibutramine|mesh-list
44344086|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344087|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344088|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44344089|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44344090|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
44344091|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344092|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
44344093|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
44344094|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44344095|NCT01047722|Aspirin|aspirin|mesh-list
44344096|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44344097|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344098|NCT01047722|Analgesics|analgesics|mesh-ancestor
44344099|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
44344100|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344101|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795013|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
44344102|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44344103|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344104|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44344105|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44344106|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344107|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44344109|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344128|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44344129|NCT01047956|Narcotics|narcotics|mesh-ancestor
44344130|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344131|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344132|NCT01047956|Analgesics|analgesics|mesh-ancestor
44344133|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
44344134|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344135|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
44344136|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
44344137|NCT01047982|Folic Acid|folic acid|mesh-list
44344138|NCT01047982|Inositol|inositol|mesh-list
44344139|NCT01047982|Hematinics|hematinics|mesh-ancestor
44344140|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
44344141|NCT01047982|Vitamins|vitamins|mesh-ancestor
44344142|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
44344143|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344144|NCT01047995|Ritonavir|ritonavir|mesh-list
44344145|NCT01047995|Darunavir|darunavir|mesh-list
44344146|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
44344147|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44344148|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44344149|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
44344150|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344151|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344152|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44344153|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44344154|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
44344155|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344156|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44344157|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44344158|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44344159|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44344160|NCT01048034|Azacitidine|azacitidine|mesh-list
44344161|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
44344197|NCT01048229|Pramipexole|pramipexole|mesh-list
44344198|NCT01048229|Rasagiline|rasagiline|mesh-list
44344199|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
43751175|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
44131964|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44131965|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131966|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131967|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
44131968|NCT00150228|Varenicline|varenicline|mesh-list
44131969|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44131970|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44131971|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131972|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131973|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131974|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131975|NCT00150241|Varenicline|varenicline|mesh-list
44131976|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44131977|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44131978|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131979|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344200|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344201|NCT01048229|Protective Agents|protective agents|mesh-ancestor
44344202|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344203|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44344204|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44344205|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
44344206|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
44344207|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344208|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44344209|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344210|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44344211|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44344212|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344213|NCT01048268|Incretins|incretins|mesh-ancestor
44344214|NCT01048268|Hormones|hormones|mesh-ancestor
43841603|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44344215|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344216|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344217|NCT01048307|Polihexanide|polihexanide|mesh-list
44344218|NCT01048307|Betaine|betaine|mesh-list
44344219|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44344220|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344221|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
44344222|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44344223|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
44344224|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344225|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44344226|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
44344227|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344228|NCT01048320|Gemcitabine|gemcitabine|mesh-list
44344229|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
44131980|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131981|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131982|NCT00150254|Varenicline|varenicline|mesh-list
44131983|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44131984|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44131985|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
44131986|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131987|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131988|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131989|NCT00150280|Ibuprofen|ibuprofen|mesh-list
44131990|NCT00150280|Celecoxib|celecoxib|mesh-list
44131991|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44131992|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131993|NCT00150280|Analgesics|analgesics|mesh-ancestor
44131994|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
44344231|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344233|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344234|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344235|NCT01048320|Antiviral Agents|antiviral agents|mesh-ancestor
44344236|NCT01048320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344237|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344238|NCT01048320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344239|NCT01048320|Immunologic Factors|immunologic factors|mesh-ancestor
44344240|NCT01048320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344241|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44344242|NCT01048385|Ubiquinone|ubiquinone|mesh-list
44344243|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
44344244|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
44344245|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344246|NCT01048385|Vitamins|vitamins|mesh-ancestor
44344247|NCT01048398|Acetaminophen|acetaminophen|mesh-list
44344248|NCT01048398|Remifentanil|remifentanil|mesh-list
44344249|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344250|NCT01048398|Analgesics|analgesics|mesh-ancestor
44344251|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
44344252|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344253|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344254|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
43999468|NCT05221502|Bedaquiline|bedaquiline|mesh-list
44344255|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44344256|NCT01048398|Narcotics|narcotics|mesh-ancestor
44344257|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344258|NCT01048515|Caffeine|caffeine|mesh-list
44344259|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44344260|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131995|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131996|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131997|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131998|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132000|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132011|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132012|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132014|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132015|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132016|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132017|NCT00150306|Sertraline|sertraline|mesh-list
44344261|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44344262|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344263|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344264|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44344265|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44344266|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
44344267|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344268|NCT01048554|Bevacizumab|bevacizumab|mesh-list
44344269|NCT01048554|Temozolomide|temozolomide|mesh-list
44344270|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44344271|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344272|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44344273|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44344274|NCT01048554|Growth Substances|growth substances|mesh-ancestor
44344275|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344276|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
44344277|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344278|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
44344279|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344280|NCT01048580|Capecitabine|capecitabine|mesh-list
44344281|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344282|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
44344283|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344284|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344285|NCT01048619|ON 01910|on 01910|mesh-list
44344286|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344287|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44344288|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344289|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344290|NCT01048632|Oxandrolone|oxandrolone|mesh-list
44344291|NCT01048632|Androgens|androgens|mesh-ancestor
44344292|NCT01048632|Hormones|hormones|mesh-ancestor
44132018|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
44132019|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132020|NCT00150306|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44132021|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132022|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132023|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132024|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132025|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
44344293|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344294|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344295|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
44344296|NCT01048684|Mannitol|mannitol|mesh-list
44344297|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44344298|NCT01048684|Diuretics|diuretics|mesh-ancestor
44344299|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
44344300|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344301|NCT01048827|Busulfan|busulfan|mesh-list
44344302|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
44344303|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344304|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344305|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
44344306|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344307|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43600111|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
44344308|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344309|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44344310|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
44344311|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344312|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
44344313|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344314|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344315|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344316|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
44344317|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344318|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344319|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44344320|NCT01048983|Minocycline|minocycline|mesh-list
44344321|NCT01048983|Curcumin|curcumin|mesh-list
44344322|NCT01048983|Modafinil|modafinil|mesh-list
44344323|NCT01048983|Bupropion|bupropion|mesh-list
44344337|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344338|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344339|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44344340|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344341|NCT01048983|Analgesics|analgesics|mesh-ancestor
44344342|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
44344343|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344344|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44344345|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344346|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344347|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44344348|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44344349|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44344350|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44344351|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
44344352|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44344353|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344354|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344355|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44344356|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44344357|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344358|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344359|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344360|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44344361|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
44344362|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44344363|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344364|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44344365|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44344366|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44344367|NCT01049048|Vitamin D|vitamin d|mesh-list
44344368|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
44344369|NCT01049048|Vitamins|vitamins|mesh-ancestor
44344373|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344374|NCT01049061|Farletuzumab|farletuzumab|mesh-list
44344375|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344376|NCT01049178|Silymarin|silymarin|mesh-list
44344377|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
44344378|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344379|NCT01049178|Protective Agents|protective agents|mesh-ancestor
44344380|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344381|NCT01049204|Maraviroc|maraviroc|mesh-list
44344382|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44344383|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44344384|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344385|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44344386|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44344387|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
44344388|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344389|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44344390|NCT01049347|Amitriptyline|amitriptyline|mesh-list
44344391|NCT01049347|Paroxetine|paroxetine|mesh-list
44344392|NCT01049347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44344393|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44344394|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344395|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344396|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344397|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
44344398|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344399|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44344400|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
44344401|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344402|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43999570|NCT05023993|Niacin|niacin|mesh-list
44344404|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344414|NCT01049425|Epirubicin|epirubicin|mesh-list
44344415|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344416|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
44344417|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344418|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344419|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44344420|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
44344421|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344422|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344423|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44344424|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
44344425|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
44344426|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
44344427|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44344428|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44344429|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44344430|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344431|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44344432|NCT01049438|Doxycycline|doxycycline|mesh-list
44344433|NCT01049438|Minocycline|minocycline|mesh-list
44344434|NCT01049438|Mupirocin|mupirocin|mesh-list
44344435|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44344436|NCT01049438|Trimethoprim|trimethoprim|mesh-list
44344437|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
44344438|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
44344439|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344440|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
44344441|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344442|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344443|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44344444|NCT01049438|Renal Agents|renal agents|mesh-ancestor
44344445|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44344446|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344447|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751360|NCT02498756|Ipilimumab|ipilimumab|mesh-list
43654451|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
44132026|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132027|NCT00150332|Linezolid|linezolid|mesh-list
44132028|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132029|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132030|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44344448|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44344449|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44344450|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44344451|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44344452|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44344453|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
44344454|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44344455|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44344456|NCT01049451|Prednisolone|prednisolone|mesh-list
44344457|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
44344458|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44344459|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
44344460|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44344461|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
44344462|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
44344463|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344464|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344465|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344466|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
44344467|NCT01049451|Hormones|hormones|mesh-ancestor
44344468|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344469|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44344470|NCT01049451|Protective Agents|protective agents|mesh-ancestor
44344471|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44344472|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344473|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
44344474|NCT01049464|Analgesics|analgesics|mesh-ancestor
44344475|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
43751395|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
44132031|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132032|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132033|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
44132034|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132035|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132036|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44132037|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44132038|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132039|NCT00150358|Urological Agents|urological agents|mesh-ancestor
44132040|NCT00150371|Atorvastatin|atorvastatin|mesh-list
44132041|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132042|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132043|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
44132044|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132045|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43702222|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344476|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344477|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344478|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
44344479|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344480|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44344481|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
44344482|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44344483|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344484|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344485|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344486|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
44344487|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44344488|NCT01049542|Astressin|astressin|mesh-list
44344489|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44344490|NCT01049542|Protective Agents|protective agents|mesh-ancestor
44344491|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344492|NCT01049620|Capecitabine|capecitabine|mesh-list
44344493|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
44344494|NCT01049620|Everolimus|everolimus|mesh-list
44344495|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344496|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
44344497|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344498|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344499|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344500|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
44344501|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132046|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44132047|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132048|NCT00150384|Amlodipine|amlodipine|mesh-list
44132049|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44132050|NCT00150384|Atorvastatin|atorvastatin|mesh-list
44132051|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132052|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132053|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
44132054|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132055|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132056|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44132057|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132058|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132059|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132060|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132069|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
44132070|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132071|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132072|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
44132073|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44344503|NCT01049633|Sirolimus|sirolimus|mesh-list
44344504|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44344505|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
44344506|NCT01049633|Clotrimazole|clotrimazole|mesh-list
44344507|NCT01049633|Miconazole|miconazole|mesh-list
44344508|NCT01049633|Trimethoprim|trimethoprim|mesh-list
44344509|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
44344510|NCT01049633|Valganciclovir|valganciclovir|mesh-list
44344511|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
44344512|NCT01049633|Heparin|heparin|mesh-list
44344513|NCT01049633|Enoxaparin|enoxaparin|mesh-list
44344514|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
44344515|NCT01049633|Tacrolimus|tacrolimus|mesh-list
44344516|NCT01049633|Basiliximab|basiliximab|mesh-list
44344517|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44344518|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344519|NCT01049633|Analgesics|analgesics|mesh-ancestor
44344520|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
44344521|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344522|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344523|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44344524|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44344525|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44344526|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44344527|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344528|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44344529|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44344530|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344531|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
44132074|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132075|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132076|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132077|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132078|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132079|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132080|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132081|NCT00150436|Pregabalin|pregabalin|mesh-list
44132082|NCT00150436|Analgesics|analgesics|mesh-ancestor
44132083|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
44132084|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132085|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132086|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
44132087|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132088|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132089|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132090|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132091|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132092|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344532|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344533|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
44344534|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44344535|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344536|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44344537|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344538|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
44344539|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44344540|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44344541|NCT01049633|Protective Agents|protective agents|mesh-ancestor
44344542|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
44344543|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44344544|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
44344545|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44344546|NCT01049633|Renal Agents|renal agents|mesh-ancestor
44344547|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
44344548|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344549|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344550|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44344551|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44344552|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44344553|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44344561|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
44344585|NCT01049711|Hematinics|hematinics|mesh-ancestor
44344586|NCT01049763|Oseltamivir|oseltamivir|mesh-list
44344587|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
44344588|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344589|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344590|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344591|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
44344593|NCT01049815|Sevelamer|sevelamer|mesh-list
44344594|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344595|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344596|NCT01049815|Antacids|antacids|mesh-ancestor
44344597|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344598|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344599|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
44344600|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
44344601|NCT01049841|Sirolimus|sirolimus|mesh-list
44344602|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344603|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344604|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44344605|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344606|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
44344607|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344608|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
44344609|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344637|NCT01049880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344638|NCT01049880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344639|NCT01049880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344640|NCT01049880|Immunologic Factors|immunologic factors|mesh-ancestor
44344641|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344643|NCT01049880|Protective Agents|protective agents|mesh-ancestor
44344644|NCT01049880|Vitamins|vitamins|mesh-ancestor
44344645|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
44344646|NCT01049932|Rilpivirine|rilpivirine|mesh-list
44344647|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44344648|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44344649|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344650|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344651|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
44344652|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344653|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44344654|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44344655|NCT01050036|Busulfan|busulfan|mesh-list
44344656|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
44344657|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344665|NCT01050114|Oxybutynin|oxybutynin|mesh-list
44344692|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344693|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344694|NCT01050270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44344695|NCT01050270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344696|NCT01050270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344697|NCT01050270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344698|NCT01050270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44344699|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
44344700|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344701|NCT01050270|Expectorants|expectorants|mesh-ancestor
44344702|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
44344703|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44344704|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
44344705|NCT01050270|Protective Agents|protective agents|mesh-ancestor
44344706|NCT01050270|Antidotes|antidotes|mesh-ancestor
44344707|NCT01050322|Gemcitabine|gemcitabine|mesh-list
44344708|NCT01050322|Capecitabine|capecitabine|mesh-list
44344709|NCT01050322|Vinorelbine|vinorelbine|mesh-list
44344710|NCT01050322|Lapatinib|lapatinib|mesh-list
44344711|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344712|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
44344713|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344714|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344715|NCT01050322|Antiviral Agents|antiviral agents|mesh-ancestor
44344716|NCT01050322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344717|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344718|NCT01050322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344719|NCT01050322|Immunologic Factors|immunologic factors|mesh-ancestor
44344720|NCT01050322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344721|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44344722|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
44344723|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
44344724|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
44344725|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44344726|NCT01050348|Atorvastatin|atorvastatin|mesh-list
44344727|NCT01050348|Calcium|calcium|mesh-list
43648995|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648996|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648997|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43648998|NCT03032484|Growth Substances|growth substances|mesh-ancestor
43648999|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841825|NCT04588259|Insulin|insulin|mesh-list
44344728|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44344729|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344730|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44344731|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44344732|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
44344733|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344734|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44344735|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44344736|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344737|NCT01050374|Albendazole|albendazole|mesh-list
44344738|NCT01050374|Praziquantel|praziquantel|mesh-list
44344739|NCT01050374|Mebendazole|mebendazole|mesh-list
44344740|NCT01050374|Piperazine|piperazine|mesh-list
44344741|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
44344742|NCT01050374|DMP 777|dmp 777|mesh-list
44344743|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
44344744|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344745|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344746|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
44344747|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44344748|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344749|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44344750|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44344751|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44344752|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344753|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344754|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
44344755|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344756|NCT01050387|Vitamin D|vitamin d|mesh-list
44344757|NCT01050387|Vitamins|vitamins|mesh-ancestor
44344758|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
44344759|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344760|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44344761|NCT01050426|Leucovorin|leucovorin|mesh-list
44344762|NCT01050426|Cetuximab|cetuximab|mesh-list
44344763|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
44344764|NCT01050426|Antidotes|antidotes|mesh-ancestor
44344765|NCT01050426|Protective Agents|protective agents|mesh-ancestor
44344767|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
44344774|NCT01050452|Mebendazole|mebendazole|mesh-list
44344775|NCT01050452|Piperazine|piperazine|mesh-list
44344776|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
44344777|NCT01050452|DMP 777|dmp 777|mesh-list
44344778|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344779|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344780|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
44344781|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
44344782|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44344783|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344784|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
44344785|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
44344786|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
44344787|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344788|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344789|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
44344790|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344791|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44344792|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44344793|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344794|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344795|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344796|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344797|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44344798|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44344799|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
44344800|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344801|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344802|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44344803|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44132093|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132094|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132095|NCT00150449|Pregabalin|pregabalin|mesh-list
44132096|NCT00150449|Analgesics|analgesics|mesh-ancestor
44132097|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
44132098|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132099|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132100|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
44132101|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132102|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132103|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132104|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132105|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44344804|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
44344805|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
44344806|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44344807|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344808|NCT01050517|Ivermectin|ivermectin|mesh-list
44344809|NCT01050517|Albendazole|albendazole|mesh-list
44344810|NCT01050517|Praziquantel|praziquantel|mesh-list
44344811|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344812|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344813|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
44344814|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
44344815|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44344816|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344817|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44344818|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44344819|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44344820|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344821|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344822|NCT01050556|Folic Acid|folic acid|mesh-list
44344823|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
44344824|NCT01050556|Hematinics|hematinics|mesh-ancestor
44344825|NCT01050556|Vitamins|vitamins|mesh-ancestor
44344826|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
44344827|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344828|NCT01050595|Naltrexone|naltrexone|mesh-list
44344829|NCT01050595|Bromides|bromides|mesh-list
44344830|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
44344831|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
44344832|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44344833|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344834|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
44344835|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344836|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44344837|NCT01050608|Ethanol|ethanol|mesh-list
44344838|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44132106|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132107|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132108|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132109|NCT00150527|Dexamethasone|dexamethasone|mesh-list
44132110|NCT00150527|Citalopram|citalopram|mesh-list
44132111|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44132112|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
44132113|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
44132114|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132115|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344839|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344840|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344841|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344843|NCT01050621|Vitamins|vitamins|mesh-ancestor
44344844|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
44344845|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344846|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
44344847|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344848|NCT01050621|Protective Agents|protective agents|mesh-ancestor
44344849|NCT01050699|Fentanyl|fentanyl|mesh-list
44344850|NCT01050699|Midazolam|midazolam|mesh-list
44344851|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
44344852|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44344853|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344854|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344855|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44344856|NCT01050699|Analgesics|analgesics|mesh-ancestor
44344857|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
44344858|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44344859|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44344860|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44344861|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44344862|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
44344863|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344864|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344865|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44344866|NCT01050699|Narcotics|narcotics|mesh-ancestor
44344867|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44344868|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44344869|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
44344870|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
44344871|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44344881|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344882|NCT01050777|Paromomycin|paromomycin|mesh-list
44344883|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44344884|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344885|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344886|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44344887|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44344888|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44344889|NCT01050842|Bicalutamide|bicalutamide|mesh-list
44344890|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
44344891|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
44344892|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344893|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344894|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344895|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44344896|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44344897|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44344898|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44344899|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
44344900|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
44344901|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344902|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
44344903|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344904|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344905|NCT01050985|Sirolimus|sirolimus|mesh-list
44344906|NCT01050985|Capecitabine|capecitabine|mesh-list
44344907|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344908|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
44344909|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344910|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344911|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44344912|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344922|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344923|NCT01051011|Incretins|incretins|mesh-ancestor
44344924|NCT01051011|Hormones|hormones|mesh-ancestor
44344925|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44344926|NCT01051102|Insulin|insulin|mesh-list
44344927|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44344928|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
44344929|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
44344930|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44344931|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
43654538|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43654539|NCT02975219|Growth Substances|growth substances|mesh-ancestor
43654540|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344932|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44344933|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44344934|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344935|NCT01051115|Dasatinib|dasatinib|mesh-list
44344936|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344937|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44344938|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344939|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344940|NCT01051167|Cetuximab|cetuximab|mesh-list
44344941|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44344942|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344943|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
44344944|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
44344945|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44344946|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44344947|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44344948|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344949|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44344950|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44344951|NCT01051219|Losartan|losartan|mesh-list
44344952|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44344953|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44344954|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44344957|NCT01051271|Midazolam|midazolam|mesh-list
44344959|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44344960|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44344961|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344962|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44344963|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44344964|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44344965|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44344966|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
44344967|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
44344968|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
44344969|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
44344970|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44344971|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344972|NCT01051284|Gemcitabine|gemcitabine|mesh-list
44344973|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44344974|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
44344975|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44344976|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344977|NCT01051284|Antiviral Agents|antiviral agents|mesh-ancestor
44344978|NCT01051284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44344979|NCT01051284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44344980|NCT01051284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44344981|NCT01051284|Immunologic Factors|immunologic factors|mesh-ancestor
44344982|NCT01051284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44344983|NCT01051362|Carboplatin|carboplatin|mesh-list
44344984|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44344985|NCT01051388|Rabeprazole|rabeprazole|mesh-list
44344986|NCT01051388|Gefarnate|gefarnate|mesh-list
44344987|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44344988|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44344989|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44345004|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
44345005|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44345006|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
44345007|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345008|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345009|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44345010|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
44345011|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44345012|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44345013|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345014|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345015|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345016|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345017|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44345018|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44345019|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
44345020|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345021|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345022|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44345023|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44345024|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
44000181|NCT03770130|Analgesics|analgesics|mesh-ancestor
44345025|NCT01051544|Factor VIII|factor viii|mesh-list
44345026|NCT01051544|Coagulants|coagulants|mesh-ancestor
44345027|NCT01051583|Bevacizumab|bevacizumab|mesh-list
44345028|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44345029|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345030|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345031|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345032|NCT01051583|Growth Substances|growth substances|mesh-ancestor
44345033|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345034|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345035|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
44345036|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44345043|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
44345044|NCT01051648|Hormones|hormones|mesh-ancestor
44345045|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345046|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345047|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345048|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
44345049|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345050|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345051|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
44345052|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44345053|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44345054|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44345055|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345056|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345057|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
44345058|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345059|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345060|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44345061|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345063|NCT01051765|Irinotecan|irinotecan|mesh-list
44345064|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345065|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44345066|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44345067|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345068|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345069|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44345070|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
44345071|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44345088|NCT01051947|Nebivolol|nebivolol|mesh-list
44345089|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44345090|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44345091|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
44345092|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
44345093|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345094|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345095|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44345096|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44345097|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44345098|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44345099|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345100|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345101|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
44345102|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44345103|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44345104|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44345105|NCT01052025|Curcumin|curcumin|mesh-list
44345106|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345107|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345108|NCT01052025|Analgesics|analgesics|mesh-ancestor
44345109|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
44345110|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345111|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345112|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345117|NCT01052051|Vitamin D|vitamin d|mesh-list
44345136|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345137|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345138|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
44345139|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44345140|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345141|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345142|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
44345143|NCT01052181|Vitamin D|vitamin d|mesh-list
44345144|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44345145|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345146|NCT01052181|Vitamins|vitamins|mesh-ancestor
44345147|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
44345148|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44345149|NCT01052246|Clindamycin|clindamycin|mesh-list
44345150|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
44345151|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
44345152|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44345153|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345154|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345155|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44345156|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345157|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345158|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
44345159|NCT01052259|Gusperimus|gusperimus|mesh-list
44345160|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44345161|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345162|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345163|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345164|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345165|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
44345166|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44345167|NCT01052259|Protective Agents|protective agents|mesh-ancestor
44345168|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
44345169|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345170|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345171|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44345172|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44345174|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345176|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44345177|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44345178|NCT01052311|Niacin|niacin|mesh-list
44345179|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44345180|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
44345181|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345182|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44345183|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44345184|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
44345185|NCT01052311|Vitamins|vitamins|mesh-ancestor
44345186|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
44345187|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345188|NCT01052324|Remifentanil|remifentanil|mesh-list
44345189|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44345190|NCT01052324|Narcotics|narcotics|mesh-ancestor
44345191|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345192|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345193|NCT01052324|Analgesics|analgesics|mesh-ancestor
44345194|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
44345195|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345196|NCT01052337|Anesthetics|anesthetics|mesh-list
44345197|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345198|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345199|NCT01052363|Bevacizumab|bevacizumab|mesh-list
44345200|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44345201|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345202|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345203|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345204|NCT01052363|Growth Substances|growth substances|mesh-ancestor
44345205|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345206|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345207|NCT01052389|Haloperidol|haloperidol|mesh-list
44345214|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345215|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345216|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44345217|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345218|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345219|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345220|NCT01052389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44345221|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44345222|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345223|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345224|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345225|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
44345226|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44345227|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
44345228|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
44345229|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44345230|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44345231|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44345232|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44345233|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44345234|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44345235|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44345236|NCT01052584|Chloroquine|chloroquine|mesh-list
44345237|NCT01052584|Lumefantrine|lumefantrine|mesh-list
44345238|NCT01052584|Artemether|artemether|mesh-list
44345239|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44345240|NCT01052584|Amebicides|amebicides|mesh-ancestor
44345241|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44345242|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44345243|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345244|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
44345245|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132116|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44132117|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
44132118|NCT00150527|Hormones|hormones|mesh-ancestor
44132119|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132120|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132121|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132122|NCT00150527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44132123|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132124|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345246|NCT01052597|Curcumin|curcumin|mesh-list
44345247|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345248|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345249|NCT01052597|Analgesics|analgesics|mesh-ancestor
44345250|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
44345251|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345252|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345253|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345254|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345255|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345256|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649003|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345257|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345258|NCT01052623|Clonidine|clonidine|mesh-list
44345259|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44345260|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44345261|NCT01052623|Estradiol|estradiol|mesh-list
44345262|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44345263|NCT01052623|Hormones|hormones|mesh-ancestor
44345264|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345265|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345266|NCT01052623|Estrogens|estrogens|mesh-ancestor
44345267|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44345268|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
44345269|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44345270|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44345271|NCT01052623|Analgesics|analgesics|mesh-ancestor
44345293|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44345294|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345295|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345296|NCT01052870|Finasteride|finasteride|mesh-list
44345297|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44345298|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44345299|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345300|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345301|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
44345302|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345303|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345304|NCT01052870|Urological Agents|urological agents|mesh-ancestor
44345305|NCT01052896|Gabapentin|gabapentin|mesh-list
44345306|NCT01052896|Analgesics|analgesics|mesh-ancestor
44345307|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
44345308|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345309|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345310|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
44345311|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44345312|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345313|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345314|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345315|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44345316|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44345317|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345318|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345319|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
44345320|NCT01052909|Glimepiride|glimepiride|mesh-list
44345321|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44345322|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345335|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345336|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
44345337|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345339|NCT01052987|Allopurinol|allopurinol|mesh-list
44345340|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
44345341|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345342|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345343|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
44345344|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345345|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44345346|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
44345347|NCT01052987|Protective Agents|protective agents|mesh-ancestor
44345348|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345349|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345350|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345351|NCT01052987|Analgesics|analgesics|mesh-ancestor
44345352|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
44345353|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798451|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798452|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
44345354|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345355|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44345356|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345357|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44345358|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44345359|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
44345360|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
44345361|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345382|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
44345383|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345384|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44345385|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44345386|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345387|NCT01053169|Thrombin|thrombin|mesh-list
44345388|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
44345389|NCT01053169|Coagulants|coagulants|mesh-ancestor
44345390|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
44345391|NCT01053208|Promethazine|promethazine|mesh-list
44345392|NCT01053208|Ibuprofen|ibuprofen|mesh-list
44345393|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345394|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345395|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345396|NCT01053208|Analgesics|analgesics|mesh-ancestor
44345397|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
44345398|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345399|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132128|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44132129|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
44132131|NCT00150553|Carbamazepine|carbamazepine|mesh-list
44132132|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
44132133|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
44132134|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132135|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132136|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132137|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132138|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132139|NCT00150553|Analgesics|analgesics|mesh-ancestor
44132140|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
44132141|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132142|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44132143|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132144|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132145|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44132146|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44132147|NCT00150579|Amphetamine|amphetamine|mesh-list
44132148|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
44132149|NCT00150579|Adderall|adderall|mesh-list
44132150|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132151|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132152|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
44132153|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
44132154|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132155|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
44132156|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132157|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132158|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132159|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44132160|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132161|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132162|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44132163|NCT00150605|Carbamazepine|carbamazepine|mesh-list
44132164|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
44132165|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
44132166|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345400|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345402|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44345403|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345404|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44345405|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44345406|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345407|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
44345408|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
44345409|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
44345410|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
44345411|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345412|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44345413|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
44345414|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
44345415|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345416|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44345417|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
44345418|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44345419|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44345420|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
44345421|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44345422|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44345423|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345424|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44345425|NCT01053325|Renal Agents|renal agents|mesh-ancestor
44345426|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345427|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
44345428|NCT01053338|Promethazine|promethazine|mesh-list
44345429|NCT01053338|Ibuprofen|ibuprofen|mesh-list
44345430|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345431|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44345432|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345433|NCT01053338|Analgesics|analgesics|mesh-ancestor
44345434|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
44345440|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345441|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44345442|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44345443|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345444|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
44345445|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
44345446|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
44345447|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
44345448|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345449|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44345450|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
44345451|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
44345452|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345453|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44345454|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
44345455|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
44345456|NCT01053377|Oseltamivir|oseltamivir|mesh-list
44345457|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
44345458|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345459|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345460|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345462|NCT01053390|Cisplatin|cisplatin|mesh-list
44345463|NCT01053390|Fluorouracil|fluorouracil|mesh-list
44345464|NCT01053390|Epirubicin|epirubicin|mesh-list
44345465|NCT01053390|Somatostatin|somatostatin|mesh-list
44345466|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345467|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
44345468|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345469|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44345488|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
44345489|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345490|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345491|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44345492|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44345493|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44345494|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
44345495|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
43842094|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842095|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43842096|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
43842097|NCT04553263|Naltrexone|naltrexone|mesh-list
43842098|NCT04553263|Bupropion|bupropion|mesh-list
43842099|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44345496|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44345497|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
44345498|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
44345500|NCT01053481|Vitamin D|vitamin d|mesh-list
44345553|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44345554|NCT01053650|Analgesics|analgesics|mesh-ancestor
44345555|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
44345556|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345557|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345558|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
44345559|NCT01053689|Glimepiride|glimepiride|mesh-list
44345560|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44345561|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345562|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345563|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345564|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
44345565|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
44345566|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345567|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345568|NCT01053806|Lenalidomide|lenalidomide|mesh-list
44345569|NCT01053806|Azacitidine|azacitidine|mesh-list
44345570|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
44345571|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345572|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345573|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345574|NCT01053806|Growth Substances|growth substances|mesh-ancestor
44345575|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345576|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345577|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44345578|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
44345605|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345606|NCT01053910|Ramipril|ramipril|mesh-list
44345607|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44345608|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44345609|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345610|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345611|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44345612|NCT01053949|Thalidomide|thalidomide|mesh-list
44345613|NCT01053949|Pomalidomide|pomalidomide|mesh-list
44345614|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
44345615|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345616|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345617|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345618|NCT01053949|Growth Substances|growth substances|mesh-ancestor
44345619|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345620|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345621|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345622|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
44345623|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345624|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345625|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
44132167|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132168|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132169|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132170|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132171|NCT00150605|Analgesics|analgesics|mesh-ancestor
44132172|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
44132173|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132174|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44132175|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132176|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132177|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44132178|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44132179|NCT00150631|Candesartan|candesartan|mesh-list
44132180|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132181|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44132182|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44132183|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132184|NCT00150657|Gemcitabine|gemcitabine|mesh-list
44132185|NCT00150657|Bevacizumab|bevacizumab|mesh-list
44132186|NCT00150657|Carboplatin|carboplatin|mesh-list
44132187|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44132188|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132189|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44132190|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44132191|NCT00150657|Growth Substances|growth substances|mesh-ancestor
44132192|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132193|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44132202|NCT00150670|Cisplatin|cisplatin|mesh-list
44345627|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44345628|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44345629|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345630|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345631|NCT01054001|Urological Agents|urological agents|mesh-ancestor
44345632|NCT01054027|Phenylephrine|phenylephrine|mesh-list
44345633|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
44345634|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
44345635|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44345636|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
44345637|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
44345638|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345639|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345640|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
44345641|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44345642|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
44345643|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
44345644|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44345645|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44345646|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44345647|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
44345648|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345649|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345650|NCT01054027|Protective Agents|protective agents|mesh-ancestor
44345651|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
44345652|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44345653|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44345654|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
44345671|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345672|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345673|NCT01054313|Sirolimus|sirolimus|mesh-list
44345674|NCT01054313|Prednisone|prednisone|mesh-list
44345675|NCT01054313|Docetaxel|docetaxel|mesh-list
44345676|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345677|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
44345678|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
44345679|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
44345680|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345681|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345682|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
44345683|NCT01054313|Hormones|hormones|mesh-ancestor
44345684|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345685|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345686|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44345687|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345688|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345689|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44345690|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
44345691|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345692|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
44345693|NCT01054469|Ropivacaine|ropivacaine|mesh-list
44345694|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
44345695|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
44345696|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345697|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345700|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
44345718|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345719|NCT01054651|Artesunate|artesunate|mesh-list
44345720|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
44345721|NCT01054651|Sulfalene|sulfalene|mesh-list
44345722|NCT01054651|Praziquantel|praziquantel|mesh-list
44345723|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
44345724|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44345725|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44345726|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345727|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345728|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
44345729|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
44345730|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44345731|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
44345732|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44345733|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345734|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345735|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44345736|NCT01054651|Renal Agents|renal agents|mesh-ancestor
44345737|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44345738|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345739|NCT01054781|Rituximab|rituximab|mesh-list
44345740|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44345741|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345742|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
44345743|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345768|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345769|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
44345770|NCT01055145|Levofloxacin|levofloxacin|mesh-list
44345771|NCT01055145|Ofloxacin|ofloxacin|mesh-list
44345772|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345773|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345774|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44345775|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44345776|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345777|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345778|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345779|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44345780|NCT01055145|Renal Agents|renal agents|mesh-ancestor
44345781|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44345782|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44345783|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
44345784|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
44345785|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
44345786|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44345787|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
44345788|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
44345789|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345790|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345791|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345792|NCT01055249|Ibuprofen|ibuprofen|mesh-list
44345793|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
44345794|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44345795|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44345816|NCT01055301|Bortezomib|bortezomib|mesh-list
44345817|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345818|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
44345819|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345820|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44345821|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44345822|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
44345823|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345824|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345825|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44345826|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345827|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
44345828|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
44345829|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345830|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345831|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
44345832|NCT01055301|Hormones|hormones|mesh-ancestor
44345833|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44345834|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44345835|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44345836|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44345837|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44345838|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345839|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44345840|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44345841|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44345842|NCT01055301|Growth Substances|growth substances|mesh-ancestor
44345843|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
44345844|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
44345845|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345846|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345847|NCT01055327|Lamotrigine|lamotrigine|mesh-list
44345848|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
44345849|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44345855|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345856|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345857|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345858|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44345859|NCT01055379|Rasagiline|rasagiline|mesh-list
44345860|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44345861|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345862|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345863|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44345864|NCT01055379|Protective Agents|protective agents|mesh-ancestor
44345865|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345866|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
44345867|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
44345868|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345869|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345870|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345871|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
44345872|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345873|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345874|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345875|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
44345876|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
44345877|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44345878|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44345879|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345880|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345881|NCT01055405|Urological Agents|urological agents|mesh-ancestor
44345882|NCT01055418|Ascorbic Acid|ascorbic acid|mesh-list
44345883|NCT01055418|Vitamins|vitamins|mesh-ancestor
44345884|NCT01055418|Micronutrients|micronutrients|mesh-ancestor
44345886|NCT01055418|Antioxidants|antioxidants|mesh-ancestor
44345898|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
44345899|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345900|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345901|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44345903|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44345904|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345905|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345906|NCT01055483|Panobinostat|panobinostat|mesh-list
44345907|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345908|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44345909|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345910|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345911|NCT01055522|Interleukin-2|interleukin-2|mesh-list
44345912|NCT01055522|Dacarbazine|dacarbazine|mesh-list
44345913|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345914|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132203|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132204|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
44132205|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132206|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132207|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132208|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132209|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132210|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44132212|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
44132213|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
44132214|NCT00150722|Atorvastatin|atorvastatin|mesh-list
44132215|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132216|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132217|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
44132218|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132219|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132220|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44132221|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132222|NCT00150735|Levetiracetam|levetiracetam|mesh-list
44132223|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
44132224|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
44132225|NCT00150748|Levetiracetam|levetiracetam|mesh-list
44132226|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
44132227|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
44132228|NCT00150761|Levocetirizine|levocetirizine|mesh-list
44132229|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44132230|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44132231|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
44132232|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
44132233|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132234|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132235|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132236|NCT00150774|Levetiracetam|levetiracetam|mesh-list
44132237|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
44132238|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
44132239|NCT00150787|Levetiracetam|levetiracetam|mesh-list
44132240|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
44132241|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
44132242|NCT00150826|Quinapril|quinapril|mesh-list
44345915|NCT01055522|Analgesics|analgesics|mesh-ancestor
44345916|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
44345917|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44345918|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345919|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44345920|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
44345921|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345922|NCT01055535|Plasminogen|plasminogen|mesh-list
44345923|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44345924|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44345925|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345927|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44345928|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345929|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345930|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345931|NCT01055691|Metformin|metformin|mesh-list
44345932|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
44345933|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44345934|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345935|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44345936|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345937|NCT01055743|Fluorouracil|fluorouracil|mesh-list
44345938|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
44345939|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345962|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345963|NCT01055821|Interferons|interferons|mesh-list
44345964|NCT01055821|Ribavirin|ribavirin|mesh-list
44345965|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44345966|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
44345967|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345968|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
44345969|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345970|NCT01055847|Aztreonam|aztreonam|mesh-list
44345971|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44345972|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44345973|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44345974|NCT01055925|Laxatives|laxatives|mesh-ancestor
44345975|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44345976|NCT01055938|Valproic Acid|valproic acid|mesh-list
44345977|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
44345978|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799524|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
44345979|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44345980|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
44345981|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44345982|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345983|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
44345984|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44345985|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44345986|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44345987|NCT01055964|Tacrolimus|tacrolimus|mesh-list
44345988|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44345989|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
44345990|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44345991|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44345992|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44345995|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44346006|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44346007|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44346008|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44346009|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44346010|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44346011|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44346012|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346013|NCT01056042|Progestins|progestins|mesh-ancestor
44346014|NCT01056172|Ribavirin|ribavirin|mesh-list
44346015|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44346016|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
44346017|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
44346018|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346019|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
44346020|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346021|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
44346022|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346023|NCT01056224|Remifentanil|remifentanil|mesh-list
44346024|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44346025|NCT01056224|Narcotics|narcotics|mesh-ancestor
44346026|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346027|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346028|NCT01056224|Analgesics|analgesics|mesh-ancestor
44346031|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
44346057|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
44346058|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346059|NCT01056497|Protective Agents|protective agents|mesh-ancestor
44346060|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346061|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
44346062|NCT01056497|Vitamins|vitamins|mesh-ancestor
44346063|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
44346064|NCT01056549|Exenatide|exenatide|mesh-list
44346065|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44346066|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346067|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44346068|NCT01056549|Incretins|incretins|mesh-ancestor
44346069|NCT01056549|Hormones|hormones|mesh-ancestor
44346070|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346071|NCT01056614|Methotrexate|methotrexate|mesh-list
44346072|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
44346073|NCT01056614|Fludarabine|fludarabine|mesh-list
44346074|NCT01056614|Busulfan|busulfan|mesh-list
44346075|NCT01056614|Tacrolimus|tacrolimus|mesh-list
44346076|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
44346077|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44346078|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
44346079|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44346080|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
44346081|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44346082|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346083|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44346084|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
44346085|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346086|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346087|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44346088|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346089|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43799754|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346090|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799799|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346091|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
44132243|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44132244|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
44132245|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132246|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132247|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132248|NCT00150839|Mirtazapine|mirtazapine|mesh-list
44346093|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44346094|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44346095|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
44346096|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44346097|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44346098|NCT01056627|Valproic Acid|valproic acid|mesh-list
44346099|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
44346100|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346101|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346102|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
44346103|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346104|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346105|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
44346106|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44346107|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346108|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44346109|NCT01056679|Doxorubicin|doxorubicin|mesh-list
44346110|NCT01056679|Lenalidomide|lenalidomide|mesh-list
44346111|NCT01056679|Vinblastine|vinblastine|mesh-list
44346112|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44346113|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346114|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44346115|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44346116|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346117|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346142|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44346143|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44346144|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44346145|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346146|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346147|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
44346148|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346149|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346150|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44346151|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346153|NCT01056874|Digoxin|digoxin|mesh-list
44346154|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44346155|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44346156|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346157|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44346158|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44346159|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
44346160|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346161|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44346162|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44346163|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44346164|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346165|NCT01056874|Protective Agents|protective agents|mesh-ancestor
44346166|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346167|NCT01056926|Nicotine|nicotine|mesh-list
44346168|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44346169|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
44346170|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346186|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
44346187|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
44346188|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346189|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44346190|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346191|NCT01057186|Vitamins|vitamins|mesh-ancestor
44346192|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
44346193|NCT01057212|Bevacizumab|bevacizumab|mesh-list
44346194|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44346195|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346196|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44346197|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44346198|NCT01057212|Growth Substances|growth substances|mesh-ancestor
44346199|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346200|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
44346201|NCT01057264|Gemcitabine|gemcitabine|mesh-list
44346202|NCT01057264|Paclitaxel|paclitaxel|mesh-list
44346203|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44346204|NCT01057264|Bevacizumab|bevacizumab|mesh-list
44346205|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346206|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346207|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346208|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346209|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346210|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346211|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44346212|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44346213|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44346214|NCT01057264|Growth Substances|growth substances|mesh-ancestor
44346215|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346216|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
44346217|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44346218|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
44346219|NCT01057264|Antiviral Agents|antiviral agents|mesh-ancestor
44346220|NCT01057264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132249|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44132250|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44132251|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44346221|NCT01057264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346222|NCT01057264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346223|NCT01057264|Immunologic Factors|immunologic factors|mesh-ancestor
44346224|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44346225|NCT01057329|Olanzapine|olanzapine|mesh-list
44001340|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
44346226|NCT01057329|Aripiprazole|aripiprazole|mesh-list
44346227|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44346228|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
44346229|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
44346230|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346231|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346232|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346233|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44346234|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44346235|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346236|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44346237|NCT01057329|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44346238|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44346239|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346240|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346241|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346242|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
44346243|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
44346244|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
44346245|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
44346246|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44346247|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44346248|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43752713|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
44132252|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132253|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132254|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132255|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132256|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44132257|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
44132258|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132262|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132263|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132264|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132265|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44132266|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44132267|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44346249|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44346250|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44346251|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44346252|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44346253|NCT01057329|Analgesics|analgesics|mesh-ancestor
44346254|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
44346255|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44346256|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44346257|NCT01057342|Paclitaxel|paclitaxel|mesh-list
44346258|NCT01057342|Carboplatin|carboplatin|mesh-list
44346259|NCT01057342|Vadimezan|vadimezan|mesh-list
44346260|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346261|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346262|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346263|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346264|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346265|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346266|NCT01057355|Ethanol|ethanol|mesh-list
44346267|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44346268|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346269|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346270|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346271|NCT01057407|Sevelamer|sevelamer|mesh-list
44346272|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
44346273|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
44346274|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346276|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346277|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346278|NCT01057498|Analgesics|analgesics|mesh-ancestor
44346279|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
44346280|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346281|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346282|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346283|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346284|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44346288|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346289|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346290|NCT01057563|Paclitaxel|paclitaxel|mesh-list
44346291|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44346292|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346293|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346294|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346295|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346296|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346297|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346298|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
44346299|NCT01057615|Vitamins|vitamins|mesh-ancestor
44346300|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
44346301|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346302|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
44346303|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346304|NCT01057615|Protective Agents|protective agents|mesh-ancestor
44346305|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
44346306|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44346307|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346308|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44346309|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346310|NCT01057654|Pravastatin|pravastatin|mesh-list
43800297|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44346311|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44346312|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44346313|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
44346314|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346315|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132268|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132269|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44132270|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44132271|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
44132272|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44132273|NCT00150852|Vancomycin|vancomycin|mesh-list
44132274|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132275|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132276|NCT00150865|Ropivacaine|ropivacaine|mesh-list
44132277|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
44132278|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
44132279|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132280|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132281|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
44132282|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132283|NCT00150891|Cyclosporine|cyclosporine|mesh-list
44346316|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44346318|NCT01057758|Simvastatin|simvastatin|mesh-list
44346319|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44346320|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44346321|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
44346322|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346323|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44346324|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44346325|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346326|NCT01057849|Olanzapine|olanzapine|mesh-list
44346327|NCT01057849|Risperidone|risperidone|mesh-list
44346328|NCT01057849|Aripiprazole|aripiprazole|mesh-list
44346329|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44346330|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
44346331|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346332|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346333|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346334|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44346335|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44346336|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346337|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44346338|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44346339|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
44346340|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
44346341|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
44346342|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346343|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346344|NCT01057849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43752797|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
44132284|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
44132285|NCT00150891|Azathioprine|azathioprine|mesh-list
44132286|NCT00150891|Tacrolimus|tacrolimus|mesh-list
44132287|NCT00150891|Cyclosporins|cyclosporins|mesh-list
44132288|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132289|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
44132290|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132291|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44132292|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132293|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132294|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
44132295|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132296|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132297|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346345|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44346346|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346347|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44346348|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
44346349|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44346350|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44346351|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44346352|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44346353|NCT01057875|Caffeine|caffeine|mesh-list
44346354|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44346355|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346356|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44346357|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346358|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346359|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44346360|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44346361|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
44346362|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346363|NCT01057966|Vitamins|vitamins|mesh-list
44346364|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
44346365|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346366|NCT01058057|Atorvastatin|atorvastatin|mesh-list
44346367|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44346368|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44346369|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
44346371|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44346391|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44346392|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346393|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346394|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44346395|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44346396|NCT01058174|Amebicides|amebicides|mesh-ancestor
44346397|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44346398|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44346399|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346400|NCT01058252|Indomethacin|indomethacin|mesh-list
44346401|NCT01058252|Letrozole|letrozole|mesh-list
44346402|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346403|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44346404|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44346405|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346406|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346407|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44346408|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
44346409|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346410|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346411|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346412|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346413|NCT01058252|Analgesics|analgesics|mesh-ancestor
44346414|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
44346415|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346416|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346417|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346418|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
44346419|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
44346420|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44001544|NCT05139095|Apatinib|apatinib|mesh-list
44132298|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44132299|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132300|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44132301|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
44132302|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132303|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
44132304|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132305|NCT00150982|Alefacept|alefacept|mesh-list
44132306|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132307|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
44132308|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346421|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346423|NCT01058291|Emetics|emetics|mesh-ancestor
44346424|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346425|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
44346426|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346427|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346428|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
44346429|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
44346430|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346431|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346432|NCT01058317|Propranolol|propranolol|mesh-list
44346433|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44346434|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44346435|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
44346436|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346437|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346438|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346439|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44346440|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44346441|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346442|NCT01058382|Progesterone|progesterone|mesh-list
44346443|NCT01058382|Progestins|progestins|mesh-ancestor
44346444|NCT01058382|Hormones|hormones|mesh-ancestor
44346445|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346446|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346447|NCT01058408|Cisplatin|cisplatin|mesh-list
44346448|NCT01058408|Everolimus|everolimus|mesh-list
44346449|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346450|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346451|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
44346452|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346453|NCT01058577|Somatostatin|somatostatin|mesh-list
44346454|NCT01058577|Hormones|hormones|mesh-ancestor
44132309|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44132310|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
44132311|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
44132312|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132313|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132314|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44132315|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44132316|NCT00150995|Growth Substances|growth substances|mesh-ancestor
44132317|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132318|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
44346455|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346456|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346457|NCT01058720|Vitamin D|vitamin d|mesh-list
44346458|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
44346459|NCT01058720|Vitamins|vitamins|mesh-ancestor
44346460|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
44346461|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346462|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44346463|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44346464|NCT01058759|Enoxaparin|enoxaparin|mesh-list
44346465|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
44346466|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
44346467|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44346468|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44346469|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346470|NCT01058824|Lincomycin|lincomycin|mesh-list
44346471|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346472|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346473|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44346474|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346475|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346476|NCT01058850|Rindopepimut|rindopepimut|mesh-list
44346477|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44346478|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346479|NCT01058876|Nicotine|nicotine|mesh-list
44346480|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44346481|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
44346482|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346483|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346484|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44346485|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44346486|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
44346487|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346488|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346489|NCT01058902|Aspirin|aspirin|mesh-list
44346492|NCT01058902|Analgesics|analgesics|mesh-ancestor
44346493|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
44346494|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346495|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346496|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654630|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654632|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
43654633|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346497|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346498|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44346499|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44346500|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346501|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44346502|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346503|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346505|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44346506|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44346507|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44346508|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
44346509|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346510|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44346511|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44346512|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346513|NCT01059058|Fluorides|fluorides|mesh-list
44346514|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
44346515|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
44346516|NCT01059058|Protective Agents|protective agents|mesh-ancestor
44346517|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346518|NCT01059084|Valacyclovir|valacyclovir|mesh-list
44346519|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
44346520|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346521|NCT01059110|Salicylates|salicylates|mesh-list
44346522|NCT01059110|Imiquimod|imiquimod|mesh-list
44346523|NCT01059110|Fluorouracil|fluorouracil|mesh-list
44346524|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44346534|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346535|NCT01059110|Analgesics|analgesics|mesh-ancestor
44346536|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
44346537|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346538|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346539|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346540|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346541|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346542|NCT01059123|Amoxicillin|amoxicillin|mesh-list
44346543|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346544|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346545|NCT01059136|Spironolactone|spironolactone|mesh-list
44346546|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44346547|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
44346548|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346549|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346550|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44346551|NCT01059136|Diuretics|diuretics|mesh-ancestor
44346552|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
44001642|NCT05020821|Analgesics|analgesics|mesh-ancestor
44346553|NCT01059331|Pregabalin|pregabalin|mesh-list
44346554|NCT01059331|Analgesics|analgesics|mesh-ancestor
44346555|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
44346556|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346557|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346558|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
44346559|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44346560|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346561|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346562|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44346563|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44346564|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43600160|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600161|NCT03282006|Renal Agents|renal agents|mesh-ancestor
43600162|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600163|NCT03281941|Capsaicin|capsaicin|mesh-list
43600164|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
43600165|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
43600166|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
43600167|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600168|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346575|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44346576|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44346577|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44346578|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346579|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346580|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346581|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44346582|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44346583|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346584|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
44346585|NCT01059396|Protective Agents|protective agents|mesh-ancestor
44346586|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44346587|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346588|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44346589|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44346590|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44346591|NCT01059422|Lamivudine|lamivudine|mesh-list
44346592|NCT01059422|Abacavir|abacavir|mesh-list
44346593|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
44346594|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44346595|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44346596|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346597|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132319|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132320|NCT00151008|Bexarotene|bexarotene|mesh-list
44132321|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132322|NCT00151034|Gemcitabine|gemcitabine|mesh-list
44132323|NCT00151034|Paclitaxel|paclitaxel|mesh-list
44132324|NCT00151034|Carboplatin|carboplatin|mesh-list
44132325|NCT00151034|Trastuzumab|trastuzumab|mesh-list
44132326|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44132327|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132328|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44132329|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44132330|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44132331|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132335|NCT00151034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132336|NCT00151034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132337|NCT00151034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132338|NCT00151034|Immunologic Factors|immunologic factors|mesh-ancestor
44132339|NCT00151034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132340|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44132341|NCT00151047|Docetaxel|docetaxel|mesh-list
44132342|NCT00151047|Capecitabine|capecitabine|mesh-list
44132343|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132344|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
44132345|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
44132346|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44132347|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132348|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44346598|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
44346599|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346600|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44346601|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44346602|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44346603|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44346604|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
44346605|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44346606|NCT01059461|Protective Agents|protective agents|mesh-ancestor
44346607|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346608|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
44346609|NCT01059552|Vorinostat|vorinostat|mesh-list
44346610|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346611|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44346612|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600169|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
44346613|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346614|NCT01059604|Naproxen|naproxen|mesh-list
44346615|NCT01059604|Sumatriptan|sumatriptan|mesh-list
44346616|NCT01059604|Naratriptan|naratriptan|mesh-list
44346617|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346618|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346619|NCT01059604|Analgesics|analgesics|mesh-ancestor
44346620|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
44346621|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346622|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346623|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346624|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346625|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
44346626|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346627|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346628|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346629|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44346630|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44346631|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44346632|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
44132349|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
44132350|NCT00151060|Paclitaxel|paclitaxel|mesh-list
44132351|NCT00151060|Etoposide|etoposide|mesh-list
44132352|NCT00151060|Estramustine|estramustine|mesh-list
44132353|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346633|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346634|NCT01059890|Metronidazole|metronidazole|mesh-list
44346635|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
44346636|NCT01059890|Cefotaxime|cefotaxime|mesh-list
44346637|NCT01059890|Cefoxitin|cefoxitin|mesh-list
44346638|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346639|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346640|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44346641|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44346642|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44346643|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44346644|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346645|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346646|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346647|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44346648|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44346649|NCT01059955|Dexamethasone|dexamethasone|mesh-list
44346650|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
44346651|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44346652|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44346653|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44346654|NCT01059955|BB 1101|bb 1101|mesh-list
44346655|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346656|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
44346657|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
44346658|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346659|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346660|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346661|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
44346662|NCT01059955|Hormones|hormones|mesh-ancestor
44346663|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346664|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44346665|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346666|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
44346667|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654646|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801127|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801128|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801129|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
44346674|NCT01060137|Analgesics|analgesics|mesh-ancestor
44346675|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
44346676|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346677|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44346678|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44346679|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
44346680|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
44346681|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
44346682|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44346683|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44346684|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346685|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
44346686|NCT01060163|Coagulants|coagulants|mesh-ancestor
44346687|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
44346688|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44346689|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44346690|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346691|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
44346692|NCT01060176|Coagulants|coagulants|mesh-ancestor
44346693|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
44346694|NCT01060189|Urinastatin|urinastatin|mesh-list
44346695|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44346696|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44346697|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346698|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
44346699|NCT01060189|Coagulants|coagulants|mesh-ancestor
44346700|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44346701|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44346702|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
44346703|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346704|NCT01060228|Valproic Acid|valproic acid|mesh-list
44346705|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44346706|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44346717|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44346718|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
44346719|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
44346720|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346722|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
44346723|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44346724|NCT01060267|Erythromycin|erythromycin|mesh-list
44346725|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
44346726|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44346727|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
44346728|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346729|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346730|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44346731|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346732|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346733|NCT01060293|Dopamine|dopamine|mesh-list
44346734|NCT01060293|Furosemide|furosemide|mesh-list
44346735|NCT01060293|Diuretics|diuretics|mesh-ancestor
44346736|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
44346737|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346738|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44346739|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346740|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346741|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44346742|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
44346743|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
44346744|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346745|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
44346746|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346747|NCT01060293|Protective Agents|protective agents|mesh-ancestor
44346748|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
44346749|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346750|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
44132354|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132355|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44132356|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44132357|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44132358|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132359|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44132360|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44132361|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346751|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346752|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346753|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44346754|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
44346755|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346756|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346757|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44346758|NCT01060423|Irinotecan|irinotecan|mesh-list
44346759|NCT01060423|Cetuximab|cetuximab|mesh-list
44346760|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44346761|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44346762|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346763|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346764|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346765|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44346766|NCT01060475|Tacrolimus|tacrolimus|mesh-list
44346767|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346768|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
44346769|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346770|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44346771|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346772|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346773|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44346774|NCT01060488|Hormones|hormones|mesh-ancestor
44346775|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346776|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346777|NCT01060501|Leucovorin|leucovorin|mesh-list
44346778|NCT01060501|Folic Acid|folic acid|mesh-list
44346797|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346798|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346799|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346800|NCT01060566|Ivacaftor|ivacaftor|mesh-list
44346801|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44346802|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44346803|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346804|NCT01060605|Sirolimus|sirolimus|mesh-list
44346805|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346806|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346807|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44346808|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346809|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
44346810|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44346811|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
44346812|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346813|NCT01060618|Maraviroc|maraviroc|mesh-list
44346814|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44346815|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44346816|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346817|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44346818|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44346819|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
44346820|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346821|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44346822|NCT01060631|Propofol|propofol|mesh-list
44346823|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44346824|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44346825|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346826|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44346827|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
44346839|NCT01060696|Scopolamine|scopolamine|mesh-list
44346840|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43801672|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44346841|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44346842|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
44346843|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
44346844|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44346845|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346846|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44346847|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
44346848|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44346849|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44346850|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346851|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346852|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44346853|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
44346854|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44346855|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346856|NCT01060696|Analgesics|analgesics|mesh-ancestor
44346857|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
44346858|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346859|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346860|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346861|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346862|NCT01060735|Vitamin D|vitamin d|mesh-list
44346863|NCT01060735|Vitamins|vitamins|mesh-ancestor
44346864|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
44346865|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346887|NCT01060826|Hormones|hormones|mesh-ancestor
44346888|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44346889|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346890|NCT01060891|Colistin|colistin|mesh-list
44346891|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44346892|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346893|NCT01060904|Doxorubicin|doxorubicin|mesh-list
44346894|NCT01060904|Bleomycin|bleomycin|mesh-list
44346895|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44346896|NCT01060904|Dacarbazine|dacarbazine|mesh-list
44346897|NCT01060904|Vinblastine|vinblastine|mesh-list
44346898|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44346899|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44346900|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44346901|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44346902|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44346903|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346904|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346905|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44346906|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
44346907|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346908|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44346909|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
44346910|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44346911|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44346912|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44346913|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44346916|NCT01060930|Epinephrine|epinephrine|mesh-list
44346934|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346935|NCT01060969|Acetazolamide|acetazolamide|mesh-list
44346936|NCT01060969|Tadalafil|tadalafil|mesh-list
44346937|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346938|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44346939|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44346940|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346941|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346942|NCT01060969|Urological Agents|urological agents|mesh-ancestor
44346943|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
44346944|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44346945|NCT01060969|Diuretics|diuretics|mesh-ancestor
44346946|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
44346947|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002014|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
44346948|NCT01061060|Epoprostenol|epoprostenol|mesh-list
44346949|NCT01061060|Beraprost|beraprost|mesh-list
44346950|NCT01061060|Tezosentan|tezosentan|mesh-list
44346951|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43600179|NCT03281694|Nicotine|nicotine|mesh-list
44346952|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346953|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44346954|NCT01061112|Tolbutamide|tolbutamide|mesh-list
44346955|NCT01061112|Fluconazole|fluconazole|mesh-list
44346956|NCT01061112|Ketoprofen|ketoprofen|mesh-list
44346957|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
44346958|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
44346959|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44346960|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44346961|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44346962|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44346963|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346964|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44346965|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
44346971|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44346975|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44346976|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44346977|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44346978|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44346979|NCT01061190|Propranolol|propranolol|mesh-list
44346980|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44346981|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44346982|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44346983|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44346984|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44346985|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346986|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44346987|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44346988|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
44346990|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44346991|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44346992|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44346993|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44346994|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
44346995|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44346996|NCT01061320|Tocopherols|tocopherols|mesh-list
44346997|NCT01061320|Vitamin E|vitamin e|mesh-list
44346998|NCT01061320|Tocotrienols|tocotrienols|mesh-list
44346999|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
44347000|NCT01061320|Vitamins|vitamins|mesh-ancestor
44347001|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
44347002|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347003|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
44347004|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347005|NCT01061320|Protective Agents|protective agents|mesh-ancestor
44347006|NCT01061372|Pregabalin|pregabalin|mesh-list
44347007|NCT01061372|Analgesics|analgesics|mesh-ancestor
44347008|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
43753301|NCT02485548|Cisplatin|cisplatin|mesh-list
44132362|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132363|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
44132364|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132365|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
44132366|NCT00151073|Docetaxel|docetaxel|mesh-list
44132367|NCT00151073|Estramustine|estramustine|mesh-list
44132369|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
44132370|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
44132371|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
44347009|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347010|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347011|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
44347012|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44347013|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347014|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347015|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44347016|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44347017|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44347018|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347019|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801963|NCT03810742|Irinotecan|irinotecan|mesh-list
43801964|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43801965|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43802202|NCT02633059|Ixazomib|ixazomib|mesh-list
44347020|NCT01061437|Lansoprazole|lansoprazole|mesh-list
44347021|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
44347022|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44347023|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347024|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44347025|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347026|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347027|NCT01061450|Simvastatin|simvastatin|mesh-list
44347028|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44347029|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44347030|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
44347031|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347032|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44347033|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44347034|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347035|NCT01061658|Vaccines|vaccines|mesh-list
44347036|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
44347037|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347038|NCT01061697|Pregabalin|pregabalin|mesh-list
44347039|NCT01061697|Analgesics|analgesics|mesh-ancestor
44347040|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
44347041|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347042|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347043|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
44347044|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44347045|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347046|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347047|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44347049|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44347050|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347051|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44347052|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44347053|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
44347054|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347055|NCT01061788|Everolimus|everolimus|mesh-list
44347056|NCT01061788|Panitumumab|panitumumab|mesh-list
44347057|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347058|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347059|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
44347060|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347061|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44347062|NCT01061814|Mipomersen|mipomersen|mesh-list
44347063|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44347064|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44347065|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
44347066|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347067|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44347068|NCT01061853|Sirolimus|sirolimus|mesh-list
44347069|NCT01061853|Betamethasone|betamethasone|mesh-list
44347070|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347071|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347072|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44347073|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347074|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
44347075|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347076|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
44347077|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347078|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347079|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
44347080|NCT01061853|Hormones|hormones|mesh-ancestor
43702223|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347083|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
44347084|NCT01061996|Basiliximab|basiliximab|mesh-list
44347085|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347086|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
43802277|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
44347087|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347088|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44347089|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44347090|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347091|NCT01062048|Incretins|incretins|mesh-ancestor
44347092|NCT01062048|Hormones|hormones|mesh-ancestor
44347093|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347094|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44347095|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
44347096|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002158|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
44347097|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347099|NCT01062087|Bupivacaine|bupivacaine|mesh-list
44347100|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
44347101|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
44347102|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347103|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347104|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
44347105|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347106|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44347107|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44347108|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44347109|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347110|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347111|NCT01062139|Cetirizine|cetirizine|mesh-list
44347124|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44347125|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44347126|NCT01062152|Growth Substances|growth substances|mesh-ancestor
44347127|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44347128|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347129|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44347130|NCT01062191|Laxatives|laxatives|mesh-ancestor
44347131|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347132|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44347133|NCT01062204|Laxatives|laxatives|mesh-ancestor
44347134|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347135|NCT01062282|Iloprost|iloprost|mesh-list
44347136|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44347137|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347138|NCT01062360|Aspirin|aspirin|mesh-list
44347139|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
44347140|NCT01062360|Ephedrine|ephedrine|mesh-list
44347141|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44347142|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347143|NCT01062360|Analgesics|analgesics|mesh-ancestor
44347144|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
44347145|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347146|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347147|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347148|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44347149|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44347150|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44347151|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347152|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44347153|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44347154|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347155|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
44347156|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44347157|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
44347158|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44347159|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
44347160|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
44347162|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44347164|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347165|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347166|NCT01062477|Vaccines|vaccines|mesh-list
44347167|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
44347168|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347169|NCT01062490|Treosulfan|treosulfan|mesh-list
44347170|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44347171|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
44347172|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347173|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347174|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
44347175|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44347176|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347177|NCT01062516|Esomeprazole|esomeprazole|mesh-list
44347178|NCT01062516|Famotidine|famotidine|mesh-list
44347179|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44347180|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347181|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44347182|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347183|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347184|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44347185|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
44347186|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
44347187|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347188|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347189|NCT01062529|Somatostatin|somatostatin|mesh-list
44347190|NCT01062529|Hormones|hormones|mesh-ancestor
44347191|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347192|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347193|NCT01062633|Erythritol|erythritol|mesh-list
44347194|NCT01062633|Sorbitol|sorbitol|mesh-list
44347195|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347196|NCT01062633|Cathartics|cathartics|mesh-ancestor
44347197|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347198|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44347200|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44347201|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347202|NCT01062776|Furosemide|furosemide|mesh-list
44347203|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44347204|NCT01062776|Diuretics|diuretics|mesh-ancestor
44347205|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
44347206|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347207|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44347208|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347209|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347210|NCT01062802|Atorvastatin|atorvastatin|mesh-list
44347211|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44347212|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44347213|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
44347214|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347215|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44347216|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44347217|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347219|NCT01062906|Fentanyl|fentanyl|mesh-list
44347220|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
44347221|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
44347222|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347223|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347224|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
44347225|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347226|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44347227|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44347228|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44132372|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132373|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44132374|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132375|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132376|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
44132377|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132378|NCT00151086|Vinorelbine|vinorelbine|mesh-list
44132379|NCT00151086|Estramustine|estramustine|mesh-list
44132380|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802835|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132381|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132382|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
44132383|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
44132384|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
44132385|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347229|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347230|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347231|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44347232|NCT01062906|Narcotics|narcotics|mesh-ancestor
44347233|NCT01062906|Analgesics|analgesics|mesh-ancestor
44347234|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44347235|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44347236|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
44347237|NCT01062932|Cycloserine|cycloserine|mesh-list
44347238|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44347239|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347240|NCT01062932|Renal Agents|renal agents|mesh-ancestor
44347241|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44347242|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
44347243|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347244|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
44347245|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347247|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44347248|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44347249|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44347250|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44347251|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347252|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347253|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347254|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347255|NCT01062958|Vitamins|vitamins|mesh-list
44347256|NCT01062958|Folic Acid|folic acid|mesh-list
44347257|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
44347258|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
44347259|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
44347260|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347261|NCT01062958|Hematinics|hematinics|mesh-ancestor
44347262|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
44347263|NCT01063010|Bevacizumab|bevacizumab|mesh-list
44347269|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347271|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
44347272|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44347273|NCT01063023|Asunaprevir|asunaprevir|mesh-list
44347274|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
44347275|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347276|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347277|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44347278|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
44347279|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347280|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347281|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44347282|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44347283|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44347284|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347285|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347286|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44347287|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44347288|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347289|NCT01063101|Fucoidan|fucoidan|mesh-list
44347290|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44347291|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347292|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
44347294|NCT01063127|Insulin|insulin|mesh-list
44347297|NCT01063140|Vaccines|vaccines|mesh-list
44347319|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347320|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44347321|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44347322|NCT01063179|Growth Substances|growth substances|mesh-ancestor
44347323|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
44347324|NCT01063192|Leucovorin|leucovorin|mesh-list
44347325|NCT01063192|Gemcitabine|gemcitabine|mesh-list
44347326|NCT01063192|Fluorouracil|fluorouracil|mesh-list
44347327|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
44347328|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347329|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
44347330|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347331|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347332|NCT01063192|Antiviral Agents|antiviral agents|mesh-ancestor
44347333|NCT01063192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347334|NCT01063192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347335|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347336|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
44347337|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347338|NCT01063192|Antidotes|antidotes|mesh-ancestor
44347339|NCT01063192|Protective Agents|protective agents|mesh-ancestor
44347376|NCT01063439|Etoposide|etoposide|mesh-list
44347377|NCT01063439|Melphalan|melphalan|mesh-list
44347378|NCT01063439|Busulfan|busulfan|mesh-list
44347379|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44347380|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347381|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44347382|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44347383|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347384|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347385|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347386|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
44347387|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
44347388|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347389|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347390|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
44347391|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347392|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44347393|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
44347394|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44347395|NCT01063478|Everolimus|everolimus|mesh-list
44347396|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347397|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132386|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132387|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
44132388|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132389|NCT00151112|Anesthetics|anesthetics|mesh-list
44132390|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132391|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132392|NCT00151125|Oprelvekin|oprelvekin|mesh-list
44132393|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132394|NCT00151138|Atenolol|atenolol|mesh-list
44132395|NCT00151138|Lisinopril|lisinopril|mesh-list
44132396|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44132397|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
44132398|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132399|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132400|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132401|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44132402|NCT00151138|Protective Agents|protective agents|mesh-ancestor
44132403|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132404|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44132409|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44132410|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44132411|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132412|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132414|NCT00151203|Dexamethasone|dexamethasone|mesh-list
44132415|NCT00151203|Lenalidomide|lenalidomide|mesh-list
44132416|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44132417|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
44132418|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
44132419|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132420|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132421|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44132422|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
44347398|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
44347399|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347400|NCT01063504|Teriparatide|teriparatide|mesh-list
44347401|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44347402|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347403|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44347404|NCT01063530|Fluorides|fluorides|mesh-list
44347405|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
44347406|NCT01063530|Protective Agents|protective agents|mesh-ancestor
44347407|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347408|NCT01063556|Donepezil|donepezil|mesh-list
44347409|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44347410|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347411|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347412|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44347413|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347414|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347415|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
44347416|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
44347417|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44347418|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44347419|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44347420|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347421|NCT01063621|Apomorphine|apomorphine|mesh-list
44347422|NCT01063621|Emetics|emetics|mesh-ancestor
44347423|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347424|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
44347425|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347426|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347427|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
44347428|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
44347429|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347430|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347431|NCT01063647|Treosulfan|treosulfan|mesh-list
44347432|NCT01063647|Busulfan|busulfan|mesh-list
44347437|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347438|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
44347439|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347440|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44347441|NCT01063660|Treosulfan|treosulfan|mesh-list
44347442|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44347443|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
44347444|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600292|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
43600293|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
43600294|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43600295|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600296|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600297|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44347445|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347446|NCT01063816|Gemcitabine|gemcitabine|mesh-list
44347447|NCT01063816|Carboplatin|carboplatin|mesh-list
44347449|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347450|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347451|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
44347452|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347453|NCT01063816|Antiviral Agents|antiviral agents|mesh-ancestor
44347454|NCT01063816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347455|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347456|NCT01063816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347457|NCT01063816|Immunologic Factors|immunologic factors|mesh-ancestor
44347458|NCT01063816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347459|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44347460|NCT01063842|Acetaminophen|acetaminophen|mesh-list
44347461|NCT01063842|Tramadol|tramadol|mesh-list
44347462|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347463|NCT01063842|Analgesics|analgesics|mesh-ancestor
44347464|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
44347465|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347466|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347471|NCT01063920|Naproxen|naproxen|mesh-list
44347483|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347485|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
44347486|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347487|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347488|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347489|NCT01064102|Cetirizine|cetirizine|mesh-list
44347490|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44347491|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44347492|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44347493|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
44347494|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
44347495|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347496|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347497|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347498|NCT01064115|Cetirizine|cetirizine|mesh-list
44347499|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44347500|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44347501|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44347502|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
44347503|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
44347504|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347505|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347506|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347507|NCT01064141|Vaccines|vaccines|mesh-list
44347508|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
44347509|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347510|NCT01064154|Carvedilol|carvedilol|mesh-list
44347511|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44347512|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44347513|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347514|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347515|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347516|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347517|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44347520|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44347521|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347522|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44347523|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347524|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44347525|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44347526|NCT01064180|Carvedilol|carvedilol|mesh-list
44347527|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44347528|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44347529|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347530|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347531|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347532|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347533|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44347534|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
44347535|NCT01064180|Protective Agents|protective agents|mesh-ancestor
44347536|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44347537|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347538|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44347539|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
44347540|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44347541|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44347542|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44347543|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347544|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347565|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347566|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44347567|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44347568|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
44347569|NCT01064349|Trastuzumab|trastuzumab|mesh-list
44347570|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44347571|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347572|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44347573|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347574|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347575|NCT01064557|Tretinoin|tretinoin|mesh-list
44347576|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347577|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
44347578|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
44347579|NCT01064570|Tretinoin|tretinoin|mesh-list
44347580|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347581|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
44347582|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
44347583|NCT01064726|Fluticasone|fluticasone|mesh-list
44347584|NCT01064726|Xhance|xhance|mesh-list
44347585|NCT01064726|Ibuprofen|ibuprofen|mesh-list
44347586|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347587|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44347588|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
44347589|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347590|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347591|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44347592|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
44347593|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002668|NCT03338920|Sumatriptan|sumatriptan|mesh-list
44347594|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44347595|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44347596|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347597|NCT01064726|Analgesics|analgesics|mesh-ancestor
44347598|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
44347599|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132423|NCT00151203|Hormones|hormones|mesh-ancestor
44132424|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132425|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132426|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347600|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44347601|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347602|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347604|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347605|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347606|NCT01064921|Cisplatin|cisplatin|mesh-list
44347607|NCT01064921|Vorinostat|vorinostat|mesh-list
44347608|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347609|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44347610|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347611|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347612|NCT01064973|Baclofen|baclofen|mesh-list
44347613|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44347614|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347615|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44347616|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347617|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44347618|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
44347619|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
44347620|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347621|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347622|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
44347623|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44347624|NCT01064986|Epinephrine|epinephrine|mesh-list
44347625|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44347626|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44347627|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347637|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
44347646|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347647|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
44347648|NCT01065038|Anagrelide|anagrelide|mesh-list
44347649|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347650|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
44347651|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347652|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347653|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44347654|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44347655|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44347656|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44347657|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44347658|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
44347659|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44347660|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44347661|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347662|NCT01065129|Plerixafor|plerixafor|mesh-list
44347663|NCT01065129|Azacitidine|azacitidine|mesh-list
44347664|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347665|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
44347666|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347701|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347702|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347703|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44347704|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44347705|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43600299|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347706|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44347707|NCT01065246|Catumaxomab|catumaxomab|mesh-list
44347708|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347709|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44347710|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44347711|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44347712|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347713|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347714|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347715|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347716|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347717|NCT01065272|Dexamethasone|dexamethasone|mesh-list
44347718|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347719|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
44347720|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
44347721|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347722|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347723|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347724|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
44347725|NCT01065272|Hormones|hormones|mesh-ancestor
44347726|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347727|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44347728|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347729|NCT01065285|Vaccines|vaccines|mesh-list
44002897|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
44347755|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347756|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347757|NCT01065610|Oxytocin|oxytocin|mesh-list
44347758|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
44347759|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347760|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347761|NCT01065649|Nortriptyline|nortriptyline|mesh-list
44347762|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44347763|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
44347764|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44347765|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44347766|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44347767|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44347768|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347769|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347770|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347771|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347772|NCT01065662|Sirolimus|sirolimus|mesh-list
44347773|NCT01065662|Cediranib|cediranib|mesh-list
44347774|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44347775|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347780|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
44347781|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347782|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44347783|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347784|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347785|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
44347786|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44347787|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347788|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347789|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347790|NCT01065701|Analgesics|analgesics|mesh-ancestor
44347791|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
44347792|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347793|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44347794|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44347795|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44347796|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347797|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347798|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347799|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
44347800|NCT01065727|Natalizumab|natalizumab|mesh-list
44347801|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
44347802|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44347803|NCT01065727|Analgesics|analgesics|mesh-ancestor
44347804|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
44347805|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347806|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347807|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347808|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44347809|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44347810|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347811|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347812|NCT01065805|Alovudine|alovudine|mesh-list
44347813|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
44347814|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347815|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
44347818|NCT01065857|Citric Acid|citric acid|mesh-list
44347819|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
44347820|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
44347821|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44347822|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
44347823|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
44347824|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347825|NCT01065857|Cathartics|cathartics|mesh-ancestor
44347826|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347827|NCT01065857|Antacids|antacids|mesh-ancestor
44347828|NCT01065870|Gemcitabine|gemcitabine|mesh-list
44347829|NCT01065870|Capecitabine|capecitabine|mesh-list
44347830|NCT01065870|Docetaxel|docetaxel|mesh-list
44347831|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44347832|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
44347833|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347834|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347835|NCT01065870|Antiviral Agents|antiviral agents|mesh-ancestor
44347836|NCT01065870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44347837|NCT01065870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347838|NCT01065870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347839|NCT01065870|Immunologic Factors|immunologic factors|mesh-ancestor
44347840|NCT01065870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347841|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
44347842|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
44347843|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
44347844|NCT01065961|Dexamethasone|dexamethasone|mesh-list
44347845|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
44347846|NCT01065961|BB 1101|bb 1101|mesh-list
44347847|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347848|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
44347849|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
44347850|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347851|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347852|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347853|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
44347859|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347860|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347861|NCT01065987|Tizanidine|tizanidine|mesh-list
44347862|NCT01065987|Analgesics|analgesics|mesh-ancestor
44347863|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
44347864|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347865|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347866|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
44347867|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44347868|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44347869|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
44347870|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
44347871|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44347872|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44347873|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44347874|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
44347875|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347876|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347877|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
44347878|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44347879|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
44347880|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600307|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44347881|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347882|NCT01066169|Lactitol|lactitol|mesh-list
44347883|NCT01066169|Cathartics|cathartics|mesh-ancestor
44347884|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347885|NCT01066195|Pemetrexed|pemetrexed|mesh-list
44347886|NCT01066195|Gefitinib|gefitinib|mesh-list
44132427|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
44132428|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44132429|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44132430|NCT00151203|Growth Substances|growth substances|mesh-ancestor
44132431|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44132432|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132433|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132434|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44132435|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132436|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132437|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44132438|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44132440|NCT00151242|Etoposide|etoposide|mesh-list
44132441|NCT00151242|Idarubicin|idarubicin|mesh-list
44132442|NCT00151242|Tretinoin|tretinoin|mesh-list
44132443|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44132444|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132445|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44132446|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44347887|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347888|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347889|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347890|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44347891|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44347892|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44347893|NCT01066247|Midazolam|midazolam|mesh-list
44347894|NCT01066247|Morphine|morphine|mesh-list
44347895|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44347896|NCT01066247|Narcotics|narcotics|mesh-ancestor
44347897|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44347898|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347899|NCT01066247|Analgesics|analgesics|mesh-ancestor
44347900|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
44347901|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347902|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44347903|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44347904|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44347905|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44347906|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44146600|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
44347907|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44347908|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
44347909|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
44347910|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
44347911|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
44347912|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44347913|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347915|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
44347916|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44347920|NCT01066377|Sulfalene|sulfalene|mesh-list
44347934|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
44347935|NCT01066429|BB 1101|bb 1101|mesh-list
44347936|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347937|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347938|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44347939|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
44347940|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
44347941|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347942|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44347943|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
44347944|NCT01066429|Hormones|hormones|mesh-ancestor
44347945|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44347946|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44347947|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
44347948|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347949|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347950|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
43842891|NCT04503161|Estradiol|estradiol|mesh-list
44347951|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347952|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44347953|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44347954|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44347985|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347986|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44347987|NCT01066650|Everolimus|everolimus|mesh-list
44347988|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44347989|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44347990|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
44347991|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347992|NCT01066676|Ibuprofen|ibuprofen|mesh-list
44347993|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44347994|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44347995|NCT01066676|Analgesics|analgesics|mesh-ancestor
44347996|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
44347997|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44347998|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44347999|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348000|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348001|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44348002|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348003|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348004|NCT01066689|Rituximab|rituximab|mesh-list
44348005|NCT01066689|Citric Acid|citric acid|mesh-list
44348006|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
44348007|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348008|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348009|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
44348010|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132447|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132448|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132449|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132451|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
44132452|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132453|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132454|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
44132455|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132456|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44132457|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
44132458|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132459|NCT00151255|Cytarabine|cytarabine|mesh-list
44132460|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
44132461|NCT00151255|Idarubicin|idarubicin|mesh-list
44132462|NCT00151255|Tretinoin|tretinoin|mesh-list
44132463|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132464|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
44132465|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132466|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132467|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
44132468|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132469|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132470|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
44348011|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348012|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
44348013|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44348014|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
44348015|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
44348016|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348017|NCT01066728|Theophylline|theophylline|mesh-list
44348018|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44348019|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
44348020|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348021|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348022|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44348023|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
44348024|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44348025|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348026|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348027|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348028|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44348029|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44348030|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
44348031|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348032|NCT01066754|Fexofenadine|fexofenadine|mesh-list
43573012|NCT03530436|Analgesics|analgesics|mesh-ancestor
44132471|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132472|NCT00151255|Analgesics|analgesics|mesh-ancestor
44132473|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
44132474|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132475|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44132476|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44132477|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132494|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44132495|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
44132496|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
44132497|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132498|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44132499|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44132500|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
44132502|NCT00151346|Bupivacaine|bupivacaine|mesh-list
44132503|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
44132504|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
44132505|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132506|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132507|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
44132508|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132509|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44132510|NCT00151346|Narcotics|narcotics|mesh-ancestor
44132511|NCT00151346|Analgesics|analgesics|mesh-ancestor
44132512|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44132513|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44132514|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
44132516|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44132517|NCT00151450|Analgesics|analgesics|mesh-ancestor
44348033|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44348034|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44348035|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44348036|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
44348037|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
44348038|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348039|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348040|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348041|NCT01066767|Fexofenadine|fexofenadine|mesh-list
44348042|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44348043|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44348044|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44348045|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
44348046|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
44348047|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348048|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348049|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348050|NCT01066806|Calcium|calcium|mesh-list
44348051|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348052|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348053|NCT01066832|Paclitaxel|paclitaxel|mesh-list
44348054|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44348055|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348056|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348057|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348058|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348059|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348060|NCT01066845|Tadalafil|tadalafil|mesh-list
44348061|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753969|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44132518|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
43577607|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
44132519|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132520|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132521|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
44132522|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132523|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132524|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132525|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132526|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132527|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44348062|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44348063|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44348064|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348065|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348066|NCT01066845|Urological Agents|urological agents|mesh-ancestor
44348067|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44348068|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348069|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348070|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348071|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348072|NCT01066962|Ritonavir|ritonavir|mesh-list
44348073|NCT01066962|Darunavir|darunavir|mesh-list
44348074|NCT01066962|Tenofovir|tenofovir|mesh-list
44348075|NCT01066962|Emtricitabine|emtricitabine|mesh-list
44348076|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
44348077|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44348078|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44348079|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
44348080|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348081|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348082|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44348083|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44348084|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
44348085|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348086|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44348087|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44348088|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44348089|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44348090|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44348091|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44348105|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348106|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348107|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
44348108|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348110|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44348111|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
44348112|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348113|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348114|NCT01067118|Insulin|insulin|mesh-list
44348115|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44348116|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
44348117|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348118|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348119|NCT01067222|Modafinil|modafinil|mesh-list
44348120|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44348121|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348122|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44348123|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44348124|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44348125|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348126|NCT01067235|Modafinil|modafinil|mesh-list
44348127|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44348128|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348129|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44348130|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44348131|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44348132|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348133|NCT01067274|Cytarabine|cytarabine|mesh-list
44348134|NCT01067274|Azacitidine|azacitidine|mesh-list
44348135|NCT01067274|Tretinoin|tretinoin|mesh-list
44132528|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132529|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132530|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44132531|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132532|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132533|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44132534|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
44132543|NCT00151489|Analgesics|analgesics|mesh-ancestor
44132544|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
44348136|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348137|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
44348138|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348139|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348140|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
44348141|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348142|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348143|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
44348144|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348145|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348146|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
44348147|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348148|NCT01067365|Citric Acid|citric acid|mesh-list
44348149|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
44348150|NCT01067365|Enclomiphene|enclomiphene|mesh-list
44348151|NCT01067365|Clomiphene|clomiphene|mesh-list
44348152|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
44348153|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
44348154|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44348155|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
44348156|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
44348157|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348190|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348191|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348192|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44348193|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348194|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348195|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44348196|NCT01067443|Amphotericin B|amphotericin b|mesh-list
44348197|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44348198|NCT01067443|Miltefosine|miltefosine|mesh-list
44348199|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44348200|NCT01067443|Amebicides|amebicides|mesh-ancestor
44348201|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44348202|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44348203|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600310|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600311|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
43649037|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649038|NCT03032042|Azithromycin|azithromycin|mesh-list
44348204|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44348205|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
44348206|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348207|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
44348208|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44348209|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
44348210|NCT01067534|Albuterol|albuterol|mesh-list
44348211|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44348212|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
44348213|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348214|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754024|NCT02480894|Maraviroc|maraviroc|mesh-list
44132545|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132546|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132547|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
44132548|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132549|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132550|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132551|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132552|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132553|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132554|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132555|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132556|NCT00151502|Atorvastatin|atorvastatin|mesh-list
44132557|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132558|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132559|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
44132560|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132561|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132562|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44132563|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132564|NCT00151515|Minoxidil|minoxidil|mesh-list
44132565|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132566|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132567|NCT00151528|Pregabalin|pregabalin|mesh-list
44132568|NCT00151528|Analgesics|analgesics|mesh-ancestor
44348215|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44348216|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44348217|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
44348218|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348219|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44348220|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44348221|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44348222|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348223|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348224|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348225|NCT01067547|Iron|iron|mesh-list
44348226|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44348227|NCT01067547|Trace Elements|trace elements|mesh-ancestor
44348228|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
44348229|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348230|NCT01067547|Hematinics|hematinics|mesh-ancestor
44348231|NCT01067599|Nicotine|nicotine|mesh-list
44348232|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44348233|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
44348234|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348235|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348236|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44348237|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44348238|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
44348239|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348240|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348241|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
44348242|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44348243|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44348261|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348263|NCT01067677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44348264|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348265|NCT01067677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44348266|NCT01067677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44348267|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44348268|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44348269|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
44348270|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
44348271|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
44348272|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44348273|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
44348274|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
44348275|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44348276|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44348277|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44348278|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
44348279|NCT01067690|Indinavir|indinavir|mesh-list
44348280|NCT01067690|Bleomycin|bleomycin|mesh-list
44348281|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44348282|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44348283|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
44348284|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348285|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348286|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44348287|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44348288|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
44348289|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348290|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44348291|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348292|NCT01067898|Vitamin D|vitamin d|mesh-list
44348293|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
44348294|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
44348295|NCT01067898|Vitamins|vitamins|mesh-list
44348301|NCT01067898|Antacids|antacids|mesh-ancestor
44348302|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348303|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348305|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348306|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
44348307|NCT01067989|Pamidronate|pamidronate|mesh-list
44348308|NCT01067989|Celecoxib|celecoxib|mesh-list
44348309|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
44348310|NCT01067989|Capecitabine|capecitabine|mesh-list
44348311|NCT01067989|Methotrexate|methotrexate|mesh-list
44348312|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348313|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
44348314|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348315|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348316|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44348317|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
44348318|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348319|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348320|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44348321|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348322|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
44348323|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44348324|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
44348325|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348326|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348327|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348328|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44348329|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44348330|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44348331|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348332|NCT01067989|Analgesics|analgesics|mesh-ancestor
44348333|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
44348334|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348343|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
44348344|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348345|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44348346|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348347|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348348|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
44348349|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348350|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348351|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348352|NCT01068067|Tacrolimus|tacrolimus|mesh-list
43805007|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
44348353|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348354|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
44348355|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348356|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44348357|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348358|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348359|NCT01068093|Ezetimibe|ezetimibe|mesh-list
44348360|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44348361|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44348362|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
44348363|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348364|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44348365|NCT01068132|Cetuximab|cetuximab|mesh-list
44348366|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348367|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348368|NCT01068223|Cetirizine|cetirizine|mesh-list
44348369|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44348370|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44348371|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44348372|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
44348373|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
44348374|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348375|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132569|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
44132570|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132571|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132572|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
44132573|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132574|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702224|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
44348376|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348377|NCT01068301|Plerixafor|plerixafor|mesh-list
44348378|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44348379|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44348380|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
44348381|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348382|NCT01068327|Leucovorin|leucovorin|mesh-list
44348383|NCT01068327|Gemcitabine|gemcitabine|mesh-list
44348384|NCT01068327|Nelfinavir|nelfinavir|mesh-list
44348385|NCT01068327|Fluorouracil|fluorouracil|mesh-list
44348386|NCT01068327|Calcium|calcium|mesh-list
44348387|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
44348388|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348389|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
44348390|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348391|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348392|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
44348393|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348394|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348395|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348396|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
44348397|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348398|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348399|NCT01068327|Antidotes|antidotes|mesh-ancestor
44348400|NCT01068327|Protective Agents|protective agents|mesh-ancestor
44348401|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
44348402|NCT01068327|Vitamins|vitamins|mesh-ancestor
44348403|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
44348404|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44348405|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44348406|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
44132575|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132576|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132577|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132578|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44132579|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132580|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132581|NCT00151541|Dapsone|dapsone|mesh-list
44132582|NCT00151541|Adapalene|adapalene|mesh-list
44132583|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44132584|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132585|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44132586|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132588|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
44132589|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132590|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132591|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348407|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44348408|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44348409|NCT01068353|Etanercept|etanercept|mesh-list
44348410|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44348411|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348412|NCT01068353|Analgesics|analgesics|mesh-ancestor
44348413|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
44348414|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348415|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348416|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348417|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348418|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348419|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348420|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
44348421|NCT01068392|Prednisolone|prednisolone|mesh-list
44348422|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
44348423|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348424|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348425|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
44348426|NCT01068392|Hormones|hormones|mesh-ancestor
44348427|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44348428|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132592|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132593|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132594|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
44132595|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44132596|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44132597|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44132598|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132599|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132600|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
44132604|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44132605|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44132606|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132607|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132608|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132609|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132610|NCT00151567|Urological Agents|urological agents|mesh-ancestor
44132612|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
44132613|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132614|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
44132615|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155487|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155488|NCT00227331|Amoxicillin|amoxicillin|mesh-list
44155489|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155490|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155491|NCT00227357|Buprenorphine|buprenorphine|mesh-list
44155492|NCT00227357|Methadone|methadone|mesh-list
44155493|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44155494|NCT00227357|Naloxone|naloxone|mesh-list
44155495|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44155496|NCT00227357|Narcotics|narcotics|mesh-ancestor
44155497|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348429|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44348430|NCT01068405|Methotrexate|methotrexate|mesh-list
44348431|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44348432|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
44348433|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348434|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348435|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348436|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
44348437|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348438|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348439|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348440|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348441|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44348442|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348443|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
44348444|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348445|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44348446|NCT01068444|Pioglitazone|pioglitazone|mesh-list
44348447|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348448|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348449|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44348450|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348451|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348452|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348453|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348454|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
44348455|NCT01068756|Rifampin|rifampin|mesh-list
44348456|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44348457|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348458|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348459|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348460|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44348461|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
44348462|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155498|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155499|NCT00227357|Analgesics|analgesics|mesh-ancestor
44155500|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
44348463|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348464|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
44348465|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44348466|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348467|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44348468|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44348469|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44348470|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44348471|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44348472|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44348473|NCT01068795|Enoxaparin|enoxaparin|mesh-list
44348474|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
44348475|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44348476|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44348477|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348478|NCT01068847|Cycloserine|cycloserine|mesh-list
44348479|NCT01068847|Verapamil|verapamil|mesh-list
44348480|NCT01068847|Nifedipine|nifedipine|mesh-list
44348481|NCT01068847|Tizanidine|tizanidine|mesh-list
44348482|NCT01068847|Naloxone|naloxone|mesh-list
44348483|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44348484|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348485|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
44155501|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155502|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44155503|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
44155504|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44155505|NCT00227409|Edetic Acid|edetic acid|mesh-list
44155506|NCT00227409|Calcium|calcium|mesh-list
44155507|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
44155508|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44155509|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155510|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
44155511|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44155512|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
44155513|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
44155514|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155515|NCT00227409|Antidotes|antidotes|mesh-ancestor
44155516|NCT00227409|Protective Agents|protective agents|mesh-ancestor
44155517|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44155518|NCT00227448|Phenylephrine|phenylephrine|mesh-list
44155519|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
44155520|NCT00227448|Midodrine|midodrine|mesh-list
44155521|NCT00227448|Norepinephrine|norepinephrine|mesh-list
44155522|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44155523|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
44155524|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
44155525|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155526|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155527|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
44155528|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44155529|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
44155530|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
44155531|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44348486|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348488|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44348489|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348490|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348491|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348492|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
44348493|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348494|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44348495|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348496|NCT01068847|Renal Agents|renal agents|mesh-ancestor
44348497|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44348498|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
44348499|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44348500|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
44348501|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44348502|NCT01068847|Analgesics|analgesics|mesh-ancestor
44348503|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
44348504|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44348505|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44348506|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
44348507|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
44348508|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44348509|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44348536|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348537|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44348538|NCT01069055|Acetaminophen|acetaminophen|mesh-list
44348539|NCT01069055|Lornoxicam|lornoxicam|mesh-list
44348540|NCT01069055|Piroxicam|piroxicam|mesh-list
44348541|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348542|NCT01069055|Analgesics|analgesics|mesh-ancestor
44348543|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
44348544|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348545|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348546|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
44348547|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44348548|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348549|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44348550|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44348551|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348552|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348553|NCT01069081|Cisplatin|cisplatin|mesh-list
44348554|NCT01069081|Docetaxel|docetaxel|mesh-list
44348555|NCT01069081|Esomeprazole|esomeprazole|mesh-list
44348556|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348557|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348558|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348559|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348560|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348561|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44348562|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348563|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44348584|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44348585|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348586|NCT01069198|Vitamin A|vitamin a|mesh-list
44348587|NCT01069198|Albendazole|albendazole|mesh-list
44348588|NCT01069198|Vitamins|vitamins|mesh-ancestor
44348589|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
44348590|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848692|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44348591|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348592|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348593|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
44348594|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44348595|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348596|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
44348597|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44348598|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44348599|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348600|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348601|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348602|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44348603|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44348604|NCT01069263|Protective Agents|protective agents|mesh-ancestor
44348605|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348606|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44348607|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
44348608|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348609|NCT01069302|Clopidogrel|clopidogrel|mesh-list
44348610|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44348611|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44348612|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44348613|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44132616|NCT00151619|Amlodipine|amlodipine|mesh-list
44132617|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132618|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132619|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132620|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132621|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44132622|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132623|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132624|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
44132625|NCT00151632|Tacrolimus|tacrolimus|mesh-list
44132626|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132627|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
44132628|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132632|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44348615|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348616|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348617|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348618|NCT01069328|Paclitaxel|paclitaxel|mesh-list
44348619|NCT01069328|Bevacizumab|bevacizumab|mesh-list
44348620|NCT01069328|Carboplatin|carboplatin|mesh-list
44348621|NCT01069328|Sorafenib|sorafenib|mesh-list
44348622|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44348623|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348624|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348625|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348626|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348627|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348628|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348629|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348630|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348631|NCT01069328|Growth Substances|growth substances|mesh-ancestor
44348632|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348633|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348634|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348635|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348636|NCT01069536|Metoclopramide|metoclopramide|mesh-list
44348637|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
44348638|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
44348639|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348640|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348641|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348642|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43805711|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805712|NCT04922034|Amoxicillin|amoxicillin|mesh-list
43805713|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805714|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348643|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44348644|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
43836720|NCT04954196|Amlodipine|amlodipine|mesh-list
44132633|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132634|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44132635|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
44132636|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132637|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132639|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132640|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132641|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
44132642|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44132643|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348645|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348646|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348647|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44348648|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348649|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348650|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348651|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348653|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348654|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348655|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348656|NCT01069770|Growth Substances|growth substances|mesh-ancestor
44348657|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348658|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348659|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348660|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348661|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348662|NCT01069796|Paclitaxel|paclitaxel|mesh-list
44348663|NCT01069796|Bevacizumab|bevacizumab|mesh-list
44348664|NCT01069796|Capecitabine|capecitabine|mesh-list
44348665|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44348666|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348667|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348668|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348669|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348670|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348671|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44348672|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348673|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348674|NCT01069796|Growth Substances|growth substances|mesh-ancestor
44348675|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348676|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
43754264|NCT02479581|Scopolamine|scopolamine|mesh-list
44132644|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132645|NCT00151710|Pioglitazone|pioglitazone|mesh-list
44132646|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44132647|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132648|NCT00151736|Etodolac|etodolac|mesh-list
44132649|NCT00151736|Chlorambucil|chlorambucil|mesh-list
44132650|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44348677|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348678|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
44348679|NCT01069822|Midazolam|midazolam|mesh-list
44348680|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44348681|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44348682|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348683|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348684|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44348685|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44348686|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44348687|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44348688|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
44348689|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
44348690|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
44348691|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
44348692|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348693|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348694|NCT01069874|Vitamin D|vitamin d|mesh-list
44348695|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
44348696|NCT01069874|Vitamins|vitamins|mesh-ancestor
44348697|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
44348698|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348699|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44348700|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348701|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44348702|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
44348703|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348704|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
44348705|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348707|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348708|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348709|NCT01070030|Amlodipine|amlodipine|mesh-list
44348720|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44348723|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
44348724|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348725|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348726|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44348727|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44348728|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
44348729|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
44348730|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348731|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44348732|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44348733|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348734|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348735|NCT01070160|Metformin|metformin|mesh-list
44348736|NCT01070160|Progesterone|progesterone|mesh-list
44348737|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44348738|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348739|NCT01070160|Progestins|progestins|mesh-ancestor
44348740|NCT01070160|Hormones|hormones|mesh-ancestor
44348741|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44348742|NCT01070186|Sunitinib|sunitinib|mesh-list
44348743|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348744|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348745|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348746|NCT01070186|Growth Substances|growth substances|mesh-ancestor
44348747|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348748|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348749|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348750|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348752|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
44348763|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348764|NCT01070277|Albendazole|albendazole|mesh-list
44348765|NCT01070277|Tinidazole|tinidazole|mesh-list
44348766|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
44348767|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44348768|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348769|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
44348770|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44348771|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44348772|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44348773|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44348774|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44348775|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348776|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348777|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
44348778|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44348779|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44348780|NCT01070290|Capecitabine|capecitabine|mesh-list
44348781|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
44348782|NCT01070290|Irinotecan|irinotecan|mesh-list
44348783|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44348784|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
44348785|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348817|NCT01070524|Budesonide|budesonide|mesh-list
44348818|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44348819|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348820|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44348821|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
44348822|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348823|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348824|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43806030|NCT04918433|Anesthetics|anesthetics|mesh-list
44348825|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
44348826|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
44348827|NCT01070524|Hormones|hormones|mesh-ancestor
44348828|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44348829|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
44348830|NCT01070615|Prucalopride|prucalopride|mesh-list
44348831|NCT01070615|Laxatives|laxatives|mesh-ancestor
44348832|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348833|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44348834|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44348835|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
44348836|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348837|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348838|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348839|NCT01070628|Levodopa|levodopa|mesh-list
44348840|NCT01070628|Carbidopa|carbidopa|mesh-list
44348841|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44348842|NCT01070628|Entacapone|entacapone|mesh-list
44348843|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44348844|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44348845|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
44348846|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348847|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348850|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348858|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348859|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348860|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348861|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348862|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44348863|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
44348864|NCT01070641|Protective Agents|protective agents|mesh-ancestor
44348865|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44348866|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44348867|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44348868|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
44348869|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44348870|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44348871|NCT01070667|Dronedarone|dronedarone|mesh-list
44348872|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44348873|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
44348874|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44348875|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44348876|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348877|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348878|NCT01070680|Analgesics|analgesics|mesh-ancestor
44348879|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
44348880|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348881|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44348882|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44348883|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44348884|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
44348885|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44348886|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348887|NCT01070706|Gemcitabine|gemcitabine|mesh-list
44348899|NCT01070706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44348900|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348901|NCT01070706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348902|NCT01070706|Immunologic Factors|immunologic factors|mesh-ancestor
44348903|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348904|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44348905|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44348906|NCT01070706|Growth Substances|growth substances|mesh-ancestor
44348907|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
44348908|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44348909|NCT01070732|Acetaminophen|acetaminophen|mesh-list
44348910|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348911|NCT01070732|Analgesics|analgesics|mesh-ancestor
44348912|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
44348913|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348914|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348915|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
44348916|NCT01070745|Ibuprofen|ibuprofen|mesh-list
44348917|NCT01070745|Indomethacin|indomethacin|mesh-list
44348918|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44348919|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44348920|NCT01070745|Analgesics|analgesics|mesh-ancestor
44348921|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
44348922|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348923|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348924|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348925|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132651|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
44132652|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132653|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132654|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44132655|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132656|NCT00151736|Analgesics|analgesics|mesh-ancestor
44132657|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
44132658|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132659|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132660|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44132661|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132662|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44132663|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44132664|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132665|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44132666|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132667|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132668|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
44132669|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132670|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44348926|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44348928|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348929|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
44348930|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
44348931|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348932|NCT01070758|Lanreotide|lanreotide|mesh-list
44348933|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348934|NCT01070823|Natalizumab|natalizumab|mesh-list
44348935|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
44348936|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348937|NCT01070836|Natalizumab|natalizumab|mesh-list
44348938|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
44348939|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348940|NCT01070862|Thalidomide|thalidomide|mesh-list
44348941|NCT01070862|Dexamethasone|dexamethasone|mesh-list
44348942|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
44348943|NCT01070862|Doxorubicin|doxorubicin|mesh-list
44132671|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44132672|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44132673|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44132674|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
43600348|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
43600349|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600350|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132675|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132676|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132677|NCT00151801|Interferons|interferons|mesh-list
44132678|NCT00151801|Interferon-beta|interferon-beta|mesh-list
44132679|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
44132680|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132681|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
44132682|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132683|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
44132684|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132685|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44132686|NCT00151827|Losartan|losartan|mesh-list
44132687|NCT00151827|Olmesartan|olmesartan|mesh-list
44132688|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44132689|NCT00151827|Furosemide|furosemide|mesh-list
44132690|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44132691|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132692|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44132693|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44132694|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132696|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
44132697|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132698|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44132702|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44132703|NCT00151944|Analgesics|analgesics|mesh-ancestor
44132704|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
44132705|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132706|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132707|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44132708|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132709|NCT00151957|Methylphenidate|methylphenidate|mesh-list
44132710|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132711|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132712|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44132713|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44348945|NCT01070862|Melphalan|melphalan|mesh-list
44348946|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
44348947|NCT01070862|Vincristine|vincristine|mesh-list
44348948|NCT01070862|BB 1101|bb 1101|mesh-list
44348949|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44348950|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
44348951|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
44348952|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44348953|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44348954|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44348955|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
44348956|NCT01070862|Hormones|hormones|mesh-ancestor
44348957|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44348958|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44348959|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44348960|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
44348961|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348962|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348963|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44348964|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44348965|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44348966|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44348967|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
44348968|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44348969|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44348970|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
44348971|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
44348983|NCT01070875|Heparin|heparin|mesh-list
44004080|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44348991|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348992|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44348993|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44348994|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44348995|NCT01071005|Leuprolide|leuprolide|mesh-list
44348996|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44348997|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
44348998|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44348999|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349000|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349001|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349002|NCT01071057|Morphine|morphine|mesh-list
44349003|NCT01071057|Naloxone|naloxone|mesh-list
44349004|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44349005|NCT01071057|Narcotics|narcotics|mesh-ancestor
44349006|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349007|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349008|NCT01071057|Analgesics|analgesics|mesh-ancestor
44349009|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
44349010|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349011|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44349012|NCT01071122|Valsartan|valsartan|mesh-list
44349013|NCT01071122|Nifedipine|nifedipine|mesh-list
44349014|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349015|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44349018|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44349038|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
44349039|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349040|NCT01071187|Varenicline|varenicline|mesh-list
44349041|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44349042|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44349043|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349044|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349045|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349046|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349047|NCT01071291|Niacin|niacin|mesh-list
44349048|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
44349049|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349050|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
44349051|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349052|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349053|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349054|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
44349055|NCT01071291|Vitamins|vitamins|mesh-ancestor
44349056|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
44349057|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349058|NCT01071304|Midazolam|midazolam|mesh-list
44349059|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44349060|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44349061|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349062|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349063|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44349088|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349089|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349090|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349091|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
44349092|NCT01071369|Hormones|hormones|mesh-ancestor
44349093|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349094|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44349095|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
44349096|NCT01071499|Morphine|morphine|mesh-list
44349097|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44349098|NCT01071499|Narcotics|narcotics|mesh-ancestor
44349099|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349100|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349101|NCT01071499|Analgesics|analgesics|mesh-ancestor
44349102|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
44349103|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349105|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349106|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
44349107|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349108|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349109|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349110|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
44349111|NCT01071525|Vitamins|vitamins|mesh-ancestor
44349112|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
44349113|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349114|NCT01071564|R04929097|r04929097|mesh-list
44349115|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754618|NCT02477501|Norepinephrine|norepinephrine|mesh-list
44132714|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132715|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132716|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
44132717|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132718|NCT00151970|Methylphenidate|methylphenidate|mesh-list
44132719|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132720|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132721|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44132722|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132723|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132724|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132725|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
44132726|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132727|NCT00151983|Methylphenidate|methylphenidate|mesh-list
44132728|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132729|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132730|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44349116|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349117|NCT01071655|Fluorouracil|fluorouracil|mesh-list
44349118|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
44349119|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349120|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44349121|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349122|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349123|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
44349124|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349125|NCT01071681|Telmisartan|telmisartan|mesh-list
44349126|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349127|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44349128|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44349129|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349130|NCT01071694|Interferons|interferons|mesh-list
44349131|NCT01071694|Interferon-beta|interferon-beta|mesh-list
44349132|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
44349133|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349134|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
44349135|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349136|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
44349137|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349138|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44349139|NCT01071772|Insulin|insulin|mesh-list
44349140|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44349141|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349142|NCT01071889|Flumazenil|flumazenil|mesh-list
44349143|NCT01071889|Antidotes|antidotes|mesh-ancestor
44349144|NCT01071889|Protective Agents|protective agents|mesh-ancestor
44349145|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349146|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
44349147|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
44349148|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349149|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349150|NCT01071928|Docetaxel|docetaxel|mesh-list
43806839|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43806840|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
43806843|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132731|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132732|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132733|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349151|NCT01071928|Vadimezan|vadimezan|mesh-list
44349152|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349153|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44349154|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44349155|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44349156|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349157|NCT01072045|Prednisone|prednisone|mesh-list
44349158|NCT01072045|Propranolol|propranolol|mesh-list
44349159|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349160|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
44349161|NCT01072045|Hormones|hormones|mesh-ancestor
44349162|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349163|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349164|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349165|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349166|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44349167|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44349168|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349169|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349170|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349171|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44349172|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349173|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349174|NCT01072058|Adalimumab|adalimumab|mesh-list
44349175|NCT01072058|Etanercept|etanercept|mesh-list
44349176|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44349177|NCT01072058|Infliximab|infliximab|mesh-list
44349178|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349179|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349180|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
44349181|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44349182|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44349183|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349184|NCT01072058|Analgesics|analgesics|mesh-ancestor
44349185|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
44349186|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132734|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
44349189|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
44349191|NCT01072071|Diuretics|diuretics|mesh-ancestor
44349192|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
44349193|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349194|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44349195|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349196|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349197|NCT01072097|Atorvastatin|atorvastatin|mesh-list
44349198|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44349199|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349200|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
44349201|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349202|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349203|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44349204|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349205|NCT01072240|Rituximab|rituximab|mesh-list
44349206|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349207|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349208|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
44349209|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349210|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349211|NCT01072318|Letrozole|letrozole|mesh-list
44132735|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132736|NCT00152022|Amphetamine|amphetamine|mesh-list
44132737|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
44132738|NCT00152022|Adderall|adderall|mesh-list
44132739|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132740|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132741|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
44132742|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
44132743|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132744|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
44132745|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132746|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132747|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132748|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44132749|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132750|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132751|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44132752|NCT00152035|Amphetamine|amphetamine|mesh-list
44132753|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
44132754|NCT00152035|Adderall|adderall|mesh-list
44132755|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44132756|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132757|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
44132758|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
44132759|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132760|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
44132761|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702379|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
44349212|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349213|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44349214|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44349215|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349216|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349217|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44349218|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
44349219|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349220|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349221|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
44349222|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44349223|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349224|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44349225|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349226|NCT01072604|Aspirin|aspirin|mesh-list
44349227|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44349228|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349229|NCT01072604|Analgesics|analgesics|mesh-ancestor
44349230|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
44349231|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349232|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349233|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349234|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349235|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44349236|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44349237|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349238|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44349256|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349258|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
44349259|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349260|NCT01072812|Phenserine|phenserine|mesh-list
44349261|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44349262|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349263|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349264|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349265|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349266|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349267|NCT01072890|Sirolimus|sirolimus|mesh-list
44349268|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349269|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349270|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44349271|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349272|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
44349273|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349274|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
44349275|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349276|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
44349277|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349278|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349279|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44349280|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44349281|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349282|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349283|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349284|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44349285|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44349286|NCT01072955|Heparin|heparin|mesh-list
44349287|NCT01072955|Calcium heparin|calcium heparin|mesh-list
44349288|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
44349297|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349298|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44349299|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349300|NCT01073059|Ertapenem|ertapenem|mesh-list
44349301|NCT01073059|Valproic Acid|valproic acid|mesh-list
44349302|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
44349303|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349304|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349305|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
44349306|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349307|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349308|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
44349309|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349310|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349311|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349312|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349313|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349314|NCT01073111|Sirolimus|sirolimus|mesh-list
44349315|NCT01073111|Everolimus|everolimus|mesh-list
44349316|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349317|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349318|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
44349319|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349320|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349321|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349322|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44132762|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132763|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44132764|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44132765|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132766|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132767|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44132768|NCT00152048|Eflornithine|eflornithine|mesh-list
44132769|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132770|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44132771|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44132772|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44132773|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132774|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44132775|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132776|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132777|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
44132778|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44132779|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132781|NCT00152126|Busulfan|busulfan|mesh-list
44132782|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132783|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
44132784|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349323|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
44349324|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
44349325|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44349326|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349327|NCT01073189|Fenoldopam|fenoldopam|mesh-list
44349328|NCT01073189|Furosemide|furosemide|mesh-list
44349329|NCT01073189|Diuretics|diuretics|mesh-ancestor
44349330|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
44349331|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349332|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44349333|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349334|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349335|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349336|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349337|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
44349338|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
44349339|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349340|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44349341|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44349342|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44349343|NCT01073319|Rivastigmine|rivastigmine|mesh-list
44349344|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44349345|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349346|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349347|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349348|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349349|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349350|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44349351|NCT01073319|Protective Agents|protective agents|mesh-ancestor
44349352|NCT01073332|Antioxidants|antioxidants|mesh-list
44349353|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004444|NCT02714634|Analgesics|analgesics|mesh-ancestor
44349354|NCT01073332|Protective Agents|protective agents|mesh-ancestor
44349355|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349356|NCT01073371|Prilocaine|prilocaine|mesh-list
44132785|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132786|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44132787|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132788|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
44349358|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
44349359|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349360|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349361|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
44349362|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349363|NCT01073384|Beclomethasone|beclomethasone|mesh-list
44349364|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349365|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
44349366|NCT01073384|Hormones|hormones|mesh-ancestor
44349367|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349368|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349369|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44349370|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44349371|NCT01073501|Pregabalin|pregabalin|mesh-list
44349372|NCT01073501|Analgesics|analgesics|mesh-ancestor
44349373|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
44349374|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349375|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349376|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
44349377|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44349378|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349379|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349380|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44349381|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43754751|NCT02477098|Ropivacaine|ropivacaine|mesh-list
44132789|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132790|NCT00152139|Antibodies|antibodies|mesh-list
44132791|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
44132792|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132793|NCT00152178|Tamoxifen|tamoxifen|mesh-list
44132794|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
44132795|NCT00152178|Fluorouracil|fluorouracil|mesh-list
44132796|NCT00152178|Methotrexate|methotrexate|mesh-list
44132797|NCT00152178|Tegafur|tegafur|mesh-list
44132798|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132799|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
44132800|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132801|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132802|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132803|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
44132804|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132805|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132806|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44132807|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
44132808|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132809|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44349382|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349383|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349384|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349385|NCT01073527|Adenosine|adenosine|mesh-list
44349386|NCT01073527|Albuterol|albuterol|mesh-list
44349387|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44349388|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
44349389|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349390|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349391|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44349392|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44349393|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
44349394|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349395|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44349396|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44349397|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44349398|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349399|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349400|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349401|NCT01073527|Analgesics|analgesics|mesh-ancestor
44349402|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
44349403|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44349404|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349405|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44349406|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
44349407|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
44349408|NCT01073540|Cephalexin|cephalexin|mesh-list
44349409|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349410|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349411|NCT01073553|Cephalexin|cephalexin|mesh-list
44349412|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349413|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349414|NCT01073579|Vigabatrin|vigabatrin|mesh-list
44349415|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
44349416|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349417|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349418|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
43754764|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
44349419|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349420|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349421|NCT01073644|Sunitinib|sunitinib|mesh-list
44349422|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349423|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44349424|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44349425|NCT01073644|Growth Substances|growth substances|mesh-ancestor
44349426|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349427|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44349428|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44349429|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349430|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349432|NCT01073670|Indomethacin|indomethacin|mesh-list
44349433|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349434|NCT01073670|Analgesics|analgesics|mesh-ancestor
44349435|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
44349436|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349437|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349438|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
44349439|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44349440|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349441|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349442|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
44349443|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
44349444|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349445|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44349446|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132810|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
44132811|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44132812|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132813|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132814|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44132815|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44132816|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44132817|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
44132818|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132819|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132820|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44132821|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44132822|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44132823|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
44132824|NCT00152191|Fluorouracil|fluorouracil|mesh-list
44132825|NCT00152191|Methotrexate|methotrexate|mesh-list
44132826|NCT00152191|Tegafur|tegafur|mesh-list
44132827|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132828|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
44132829|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349447|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349449|NCT01073683|Docetaxel|docetaxel|mesh-list
44349450|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349451|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
44349452|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
44349453|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
44349454|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349455|NCT01073696|Granisetron|granisetron|mesh-list
44349456|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
44349457|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
44349458|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349459|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349460|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44349461|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44349462|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
44349463|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349464|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349465|NCT01073709|Acetaminophen|acetaminophen|mesh-list
44349466|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349467|NCT01073709|Analgesics|analgesics|mesh-ancestor
44349468|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
44349469|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349470|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349471|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
44349472|NCT01073748|Acetaminophen|acetaminophen|mesh-list
44349473|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349474|NCT01073748|Analgesics|analgesics|mesh-ancestor
44349475|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
44349476|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349477|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349478|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
44349479|NCT01073761|Ritonavir|ritonavir|mesh-list
44349480|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44349481|NCT01073761|Darunavir|darunavir|mesh-list
44349482|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44132830|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132831|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44132832|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
44132833|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349483|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44349484|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44349485|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349486|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349487|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44349488|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44349489|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
44349490|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349491|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44349492|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44349493|NCT01073800|Atorvastatin|atorvastatin|mesh-list
44349494|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44349495|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349496|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
44349497|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349498|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349499|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44349500|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349501|NCT01073813|Minocycline|minocycline|mesh-list
44349502|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44004578|NCT02740660|Caffeine|caffeine|mesh-list
44349503|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349504|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44349506|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349507|NCT01073826|Incretins|incretins|mesh-ancestor
44349508|NCT01073826|Hormones|hormones|mesh-ancestor
44349509|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349529|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44349530|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349531|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349532|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349533|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349534|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
44349535|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44349536|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44349537|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349538|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44349539|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44349540|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349541|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349542|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349543|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44349544|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
44349545|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349546|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349547|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44349548|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44349549|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44349550|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
44349551|NCT01073904|Norgestrel|norgestrel|mesh-list
44349552|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44004650|NCT02745353|Naloxegol|naloxegol|mesh-list
44349575|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349576|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
44349577|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349578|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349579|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
44349580|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349581|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349582|NCT01074060|Plerixafor|plerixafor|mesh-list
44349583|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
44349584|NCT01074060|Lenograstim|lenograstim|mesh-list
44349585|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349586|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
44349587|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349588|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349589|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44349590|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
44349591|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349592|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349593|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44349594|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44349595|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44349596|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44349597|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
44349598|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349599|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44349600|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44349601|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349602|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349603|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349604|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349605|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44349606|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44349607|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44349608|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349609|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349612|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44349613|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
44349614|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44349615|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44349616|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
44349617|NCT01074086|Everolimus|everolimus|mesh-list
44349618|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349619|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44349620|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
44349621|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349622|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
44349623|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349624|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349625|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
44349626|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44349627|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349628|NCT01074281|Enalapril|enalapril|mesh-list
44349629|NCT01074281|Enalaprilat|enalaprilat|mesh-list
44349630|NCT01074281|Nitrendipine|nitrendipine|mesh-list
44349631|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349632|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349633|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44349634|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
44349635|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349636|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44349665|NCT01074567|Protective Agents|protective agents|mesh-ancestor
44349666|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349667|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44349668|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
44349669|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349670|NCT01074593|Interferons|interferons|mesh-list
44349671|NCT01074593|Interferon-beta|interferon-beta|mesh-list
44349672|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
44349673|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349674|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
44349675|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349676|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
44349677|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349678|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44349679|NCT01074619|Memantine|memantine|mesh-list
44349680|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44349681|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44349682|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
44349683|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349684|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349685|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349686|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44349687|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44349688|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44349689|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44349690|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349691|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349692|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349693|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44349694|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44349695|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44349696|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44349697|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349698|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349701|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44349702|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
44349703|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44349704|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44349705|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
44349706|NCT01074645|Tenofovir|tenofovir|mesh-list
44349707|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
44349708|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349709|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44349710|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44349711|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349712|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349713|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44349714|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44349715|NCT01074697|Dexamethasone|dexamethasone|mesh-list
44349716|NCT01074697|Palonosetron|palonosetron|mesh-list
44349717|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
44349719|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349720|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
44349721|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
44349722|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349723|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349724|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44349725|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
44349726|NCT01074697|Hormones|hormones|mesh-ancestor
44349727|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349728|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349729|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349730|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349731|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44349732|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44349733|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
44349734|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349735|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44349736|NCT01074723|Carotenoids|carotenoids|mesh-list
44349741|NCT01074801|Insulin|insulin|mesh-list
44349742|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44349743|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44349744|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349745|NCT01074853|Propranolol|propranolol|mesh-list
44349746|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44349747|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44349748|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349749|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349750|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349751|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349752|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44349753|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349754|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349755|NCT01074879|Caseins|caseins|mesh-list
44349756|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
44349757|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
44349758|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349759|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44349760|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
44349761|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
44349762|NCT01074892|Progestins|progestins|mesh-list
44349763|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44349764|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
44349765|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44349766|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349767|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44349768|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44349769|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44349770|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44349771|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44349772|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349773|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349782|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44349783|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44349784|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349786|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
44349787|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44349788|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
44349789|NCT01074905|Amebicides|amebicides|mesh-ancestor
44349790|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349791|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44349792|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44349793|NCT01074905|Analgesics|analgesics|mesh-ancestor
44349794|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
44349795|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349796|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349797|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349798|NCT01074905|Filaricides|filaricides|mesh-ancestor
44349799|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
44349800|NCT01074970|Cisplatin|cisplatin|mesh-list
44349801|NCT01074970|Rucaparib|rucaparib|mesh-list
44349802|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349803|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44349804|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349805|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349806|NCT01074996|Leucovorin|leucovorin|mesh-list
44349807|NCT01074996|Antidotes|antidotes|mesh-ancestor
44349808|NCT01074996|Protective Agents|protective agents|mesh-ancestor
44349809|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349810|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
44349811|NCT01074996|Vitamins|vitamins|mesh-ancestor
44349812|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
44349830|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349831|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
44349832|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44349833|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349834|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349835|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
44349837|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349838|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44349839|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349840|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349841|NCT01075425|Bortezomib|bortezomib|mesh-list
44349842|NCT01075425|Belinostat|belinostat|mesh-list
44349843|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349844|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44349845|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349846|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349847|NCT01075438|Vaccines|vaccines|mesh-list
44349848|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44349849|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
44349850|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349851|NCT01075464|Paclitaxel|paclitaxel|mesh-list
44349852|NCT01075464|Bevacizumab|bevacizumab|mesh-list
44349853|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44349854|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349855|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
44349856|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
44349857|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
44349858|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349859|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349860|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44349861|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44349862|NCT01075464|Growth Substances|growth substances|mesh-ancestor
44349863|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755084|NCT02475499|Glibornuride|glibornuride|mesh-list
44132834|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132835|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44132836|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
43702380|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
44349864|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
44349865|NCT01075477|Rituximab|rituximab|mesh-list
44349866|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349867|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349868|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
44349869|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349870|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44349871|NCT01075490|Clonidine|clonidine|mesh-list
44349872|NCT01075490|Analgesics|analgesics|mesh-ancestor
44349873|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
44349874|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349875|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349876|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44349877|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
44349878|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
44349879|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44349880|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44349881|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44349882|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349883|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349884|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349885|NCT01075503|Ropivacaine|ropivacaine|mesh-list
44349886|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
44349887|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
44349888|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349889|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349890|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
44349891|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349892|NCT01075529|Fluoxetine|fluoxetine|mesh-list
44349893|NCT01075529|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44349898|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
44349907|NCT01075555|Pravastatin|pravastatin|mesh-list
44349908|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349909|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44349910|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44349911|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349912|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44349913|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44349914|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
44349915|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44349916|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44349917|NCT01075581|Epinephrine|epinephrine|mesh-list
44349918|NCT01075581|Racepinephrine|racepinephrine|mesh-list
44349919|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
44349920|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44349921|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44349922|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
44349923|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349924|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349925|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349926|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44349927|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44349928|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
44349929|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349930|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44349931|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
44349932|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
44349933|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
44349934|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44349935|NCT01075659|Nicotine|nicotine|mesh-list
44349936|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44349951|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44349952|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
44349953|NCT01075711|Hormones|hormones|mesh-ancestor
44349954|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349955|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349956|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349957|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349958|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44349959|NCT01075776|Acetylcholine|acetylcholine|mesh-list
44349960|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44349961|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44349962|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
44349963|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44349964|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349965|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349966|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
44349967|NCT01075789|Lidocaine|lidocaine|mesh-list
44349968|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
44349969|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
44349970|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44349971|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349972|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
44349973|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44349974|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44349975|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44349976|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44349977|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44349978|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44349979|NCT01075802|Tamoxifen|tamoxifen|mesh-list
44349980|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44349981|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
44132837|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132838|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44132839|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
44132840|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44132841|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132842|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132843|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44132854|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702381|NCT02717871|Levofloxacin|levofloxacin|mesh-list
44349982|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349983|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349984|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44349985|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349986|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44349987|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44349988|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44349989|NCT01075828|Cetuximab|cetuximab|mesh-list
44349990|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349991|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349992|NCT01075841|Cetuximab|cetuximab|mesh-list
44349993|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44349994|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44349995|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44349996|NCT01075854|Hormones|hormones|mesh-ancestor
44349997|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44349998|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44349999|NCT01075880|Interferons|interferons|mesh-list
44350000|NCT01075880|Interferon-beta|interferon-beta|mesh-list
44350001|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
44350002|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350003|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
44350004|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350005|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
44350006|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005036|NCT02771093|Alogliptin|alogliptin|mesh-list
44350007|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350008|NCT01075906|Colchicine|colchicine|mesh-list
44350009|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
44350026|NCT01076062|Oxytocin|oxytocin|mesh-list
44350027|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
44350028|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350029|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350030|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44350031|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
44350032|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44350033|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350034|NCT01076140|Lisinopril|lisinopril|mesh-list
44350035|NCT01076140|Nebivolol|nebivolol|mesh-list
44350036|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44350037|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
44350038|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350039|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350040|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44350041|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44350042|NCT01076140|Protective Agents|protective agents|mesh-ancestor
44350043|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350044|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
44350045|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44350046|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44350047|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44350048|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350049|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350050|NCT01076322|Albuterol|albuterol|mesh-list
44350051|NCT01076322|Procaterol|procaterol|mesh-list
44350052|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44350053|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
44350075|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44350076|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
44350077|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350078|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44350079|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44350080|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350081|NCT01076439|Analgesics|analgesics|mesh-ancestor
44350082|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
44350083|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350084|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44350085|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44350086|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
44350087|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
44350088|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350089|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350091|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44350092|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
44350093|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350094|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350095|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44350096|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
44350097|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44350098|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44350099|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350100|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44350101|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
44350102|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44350103|NCT01076478|Protective Agents|protective agents|mesh-ancestor
44350104|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44350107|NCT01076491|Mannitol|mannitol|mesh-list
44350117|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350118|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44350119|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350120|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
44350121|NCT01076556|Rituximab|rituximab|mesh-list
44350122|NCT01076556|Alvocidib|alvocidib|mesh-list
44350123|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44350124|NCT01076556|Antibodies|antibodies|mesh-list
44350125|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
44350126|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44350127|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350128|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
44350129|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350130|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350131|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44350132|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
44350133|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350134|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350135|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44350136|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
44350137|NCT01076556|Growth Substances|growth substances|mesh-ancestor
44350138|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44350139|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350140|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44350141|NCT01076582|Desogestrel|desogestrel|mesh-list
44350169|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350170|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44350171|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
44350172|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350173|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44350174|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44350175|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44350176|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44350177|NCT01076634|Insulin|insulin|mesh-list
44350178|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44350179|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
44350180|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350181|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350182|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
44350183|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350184|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
44350185|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350186|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
44350187|NCT01076673|Protective Agents|protective agents|mesh-ancestor
44350188|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
44350189|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44350190|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350191|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350192|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350193|NCT01076790|Analgesics|analgesics|mesh-ancestor
44350194|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
44350195|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350196|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44350197|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44350198|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44350199|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350200|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350201|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350202|NCT01076803|Lanreotide|lanreotide|mesh-list
44350203|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350204|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
44350206|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350207|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350208|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350209|NCT01076816|Analgesics|analgesics|mesh-ancestor
44350210|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
44350211|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350212|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44350213|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44350214|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44350215|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350216|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350217|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350218|NCT01076842|Insulin|insulin|mesh-list
44350219|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44350220|NCT01076842|Exenatide|exenatide|mesh-list
44350221|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
44350222|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350223|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350224|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44350225|NCT01076842|Incretins|incretins|mesh-ancestor
44350226|NCT01076842|Hormones|hormones|mesh-ancestor
44350227|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350228|NCT01076894|Anesthetics|anesthetics|mesh-list
44350229|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350230|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350231|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44350232|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
44350233|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44350234|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44350235|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
44350236|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44350238|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44350239|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44350248|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350249|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44350250|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
44350251|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350252|NCT01077427|Antiviral Agents|antiviral agents|mesh-ancestor
44350253|NCT01077427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350254|NCT01077427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350255|NCT01077427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350256|NCT01077427|Immunologic Factors|immunologic factors|mesh-ancestor
44350257|NCT01077427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350259|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350260|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44350261|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44350262|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350263|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350264|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44350265|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
44350266|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350267|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350268|NCT01077466|Natalizumab|natalizumab|mesh-list
44350269|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
44350270|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350271|NCT01077479|Metformin|metformin|mesh-list
43600409|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44350272|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350273|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350294|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350295|NCT01077609|Fluticasone|fluticasone|mesh-list
44350296|NCT01077609|Xhance|xhance|mesh-list
44350297|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350298|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44350299|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
44350300|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350301|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350302|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44350303|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
44350304|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350305|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44350306|NCT01077648|Trastuzumab|trastuzumab|mesh-list
44350307|NCT01077648|Lapatinib|lapatinib|mesh-list
44350308|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350309|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350310|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44350311|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350312|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350313|NCT01077661|Nebivolol|nebivolol|mesh-list
44350314|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44350315|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
44350316|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44350317|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44350318|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44350319|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
44350320|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350321|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350322|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350323|NCT01077726|Capecitabine|capecitabine|mesh-list
44350324|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44350325|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
44350337|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350338|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44350339|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44350340|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44350341|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350342|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350343|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44350344|NCT01077752|Narcotics|narcotics|mesh-ancestor
44350345|NCT01077752|Analgesics|analgesics|mesh-ancestor
44350346|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350347|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
44350348|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
44350349|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350350|NCT01077947|Anesthetics|anesthetics|mesh-list
44350351|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350352|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350353|NCT01077986|Capecitabine|capecitabine|mesh-list
44350354|NCT01077986|Cetuximab|cetuximab|mesh-list
44350355|NCT01077986|Everolimus|everolimus|mesh-list
44350356|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44350357|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
44350358|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350359|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350360|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350361|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350362|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
44350363|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350364|NCT01077999|Paclitaxel|paclitaxel|mesh-list
44350365|NCT01077999|Carboplatin|carboplatin|mesh-list
44350382|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350383|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
44350385|NCT01078142|Rituximab|rituximab|mesh-list
44350386|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44350387|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350388|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350389|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
44350390|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350391|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350392|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44350393|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
43808582|NCT04879030|Meropenem|meropenem|mesh-list
44350394|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350395|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350396|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350397|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350398|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
44350399|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350400|NCT01078428|Petrolatum|petrolatum|mesh-list
44350401|NCT01078428|Emollients|emollients|mesh-ancestor
44350402|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350403|NCT01078519|Anesthetics|anesthetics|mesh-list
44350404|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
44350405|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350406|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350407|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
44350408|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350409|NCT01078610|Adalimumab|adalimumab|mesh-list
44350410|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350411|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350412|NCT01078714|Bumetanide|bumetanide|mesh-list
44350427|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44350428|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350429|NCT01078779|Analgesics|analgesics|mesh-ancestor
44350430|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
44350431|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350432|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350433|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350434|NCT01078779|Filaricides|filaricides|mesh-ancestor
44350435|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
44350436|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
44350437|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
44350438|NCT01078818|Trace Elements|trace elements|mesh-ancestor
44350439|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
44350440|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350441|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44350442|NCT01078870|Citalopram|citalopram|mesh-list
44350443|NCT01078870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44350444|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44350445|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44350446|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350447|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350448|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
44350449|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350450|NCT01078870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44350451|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
44350452|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44350453|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132855|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44132857|NCT00152230|Tegafur|tegafur|mesh-list
44132858|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132859|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
44132860|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132861|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132862|NCT00152243|Tegafur|tegafur|mesh-list
44132863|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132864|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
44132865|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132866|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132867|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44132868|NCT00152282|Estrogens|estrogens|mesh-ancestor
44132869|NCT00152282|Hormones|hormones|mesh-ancestor
44132870|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132871|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132872|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44350454|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44350455|NCT01078870|Analgesics|analgesics|mesh-ancestor
44350456|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
44350457|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
44350458|NCT01078961|Bortezomib|bortezomib|mesh-list
44005537|NCT05273814|Pemetrexed|pemetrexed|mesh-list
44350460|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350461|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44350462|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350463|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350464|NCT01079013|Treosulfan|treosulfan|mesh-list
44350465|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44350466|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
44350467|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350468|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350469|NCT01079052|Famotidine|famotidine|mesh-list
44350470|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44350471|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350472|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44350473|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
44350474|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
44350475|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350476|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350477|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350478|NCT01079065|Famotidine|famotidine|mesh-list
44350479|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44350480|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350481|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44350482|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
44350483|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
44350484|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350485|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350486|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350487|NCT01079078|Acetaminophen|acetaminophen|mesh-list
44350488|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350489|NCT01079078|Analgesics|analgesics|mesh-ancestor
44350492|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350494|NCT01079117|Morphine|morphine|mesh-list
44350495|NCT01079117|Methadone|methadone|mesh-list
44350496|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44350497|NCT01079117|Narcotics|narcotics|mesh-ancestor
44350498|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350499|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350500|NCT01079117|Analgesics|analgesics|mesh-ancestor
44350501|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
44350502|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350503|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
44350504|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44350505|NCT01079286|Sirolimus|sirolimus|mesh-list
44350506|NCT01079286|Nelfinavir|nelfinavir|mesh-list
44350507|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350508|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350509|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350510|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350511|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
44350512|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350513|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
44350514|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132873|NCT00152295|Estrogens|estrogens|mesh-ancestor
44132874|NCT00152295|Hormones|hormones|mesh-ancestor
44132875|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132876|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132877|NCT00152308|Sirolimus|sirolimus|mesh-list
44132878|NCT00152308|Ethanol|ethanol|mesh-list
44132879|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132880|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132881|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44132882|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132883|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
44132884|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132885|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
44132886|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132887|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44132888|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44132889|NCT00152360|Orlistat|orlistat|mesh-list
44132890|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132891|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132892|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44132893|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44132894|NCT00152373|Levetiracetam|levetiracetam|mesh-list
44132895|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
44132896|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
44132897|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
44132898|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132899|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
44132900|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132901|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132902|NCT00152399|Somatostatin|somatostatin|mesh-list
44132903|NCT00152399|Hormones|hormones|mesh-ancestor
44163836|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350515|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44350516|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44350517|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
44350518|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350519|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350520|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44350521|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44350522|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
44350523|NCT01079312|Fentanyl|fentanyl|mesh-list
44350524|NCT01079312|Remifentanil|remifentanil|mesh-list
44350525|NCT01079312|Propofol|propofol|mesh-list
44350526|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44350527|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350528|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350529|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44350530|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
44350575|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
44350576|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
44350577|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350578|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350579|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
44350580|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350581|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350582|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
44350583|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
44350584|NCT01079455|Protective Agents|protective agents|mesh-ancestor
44350585|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350586|NCT01079481|Everolimus|everolimus|mesh-list
44350587|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350588|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350589|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
44350590|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350591|NCT01079559|Tobramycin|tobramycin|mesh-list
44350592|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350593|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350594|NCT01079624|Glucagon|glucagon|mesh-list
44350595|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44350596|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350597|NCT01079624|Hormones|hormones|mesh-ancestor
44350598|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350599|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350600|NCT01079624|Incretins|incretins|mesh-ancestor
44350601|NCT01079676|Lenograstim|lenograstim|mesh-list
44350602|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350603|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
44350604|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350605|NCT01079702|Capecitabine|capecitabine|mesh-list
44350606|NCT01079702|Everolimus|everolimus|mesh-list
44350607|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44350618|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44350619|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350620|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350621|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44350622|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44350623|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
44350624|NCT01079754|Morphine|morphine|mesh-list
44350625|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
44350626|NCT01079754|Narcotics|narcotics|mesh-ancestor
44350627|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350628|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350629|NCT01079754|Analgesics|analgesics|mesh-ancestor
44350630|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
44350631|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350632|NCT01079767|Sirolimus|sirolimus|mesh-list
44350633|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350634|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350635|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350636|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350637|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
44350638|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350639|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
44350640|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350641|NCT01079884|Esomeprazole|esomeprazole|mesh-list
44350642|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44350643|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350644|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44350645|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350646|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350647|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
44350649|NCT01079910|Fluorides|fluorides|mesh-list
44350664|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350665|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
44350666|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350667|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
44350668|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350669|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350670|NCT01080066|Cetuximab|cetuximab|mesh-list
44350671|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350672|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350673|NCT01080079|Terbinafine|terbinafine|mesh-list
44350674|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
44350675|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350676|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350677|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350678|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
44350679|NCT01080352|Vitamins|vitamins|mesh-ancestor
44350680|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
44350681|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350682|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
44350683|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350684|NCT01080352|Protective Agents|protective agents|mesh-ancestor
44350685|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
44350686|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350687|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350688|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44350689|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
44350690|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132904|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132905|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132906|NCT00152412|Levocetirizine|levocetirizine|mesh-list
44132907|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44132915|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132917|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132918|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132919|NCT00152438|Progesterone|progesterone|mesh-list
44132920|NCT00152438|Progestins|progestins|mesh-ancestor
44132921|NCT00152438|Hormones|hormones|mesh-ancestor
44132922|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132923|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132924|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
44132925|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132926|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
44132927|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132928|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44132929|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
44132930|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44350691|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350692|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350693|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350694|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
44350695|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350696|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350697|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44350698|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
44350699|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350700|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350701|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350702|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350703|NCT01080456|Tacrolimus|tacrolimus|mesh-list
44350704|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350705|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
44350706|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350707|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350708|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350709|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350710|NCT01080469|Tacrolimus|tacrolimus|mesh-list
44350711|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350712|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
44350713|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350714|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350715|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350716|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350717|NCT01080482|Tacrolimus|tacrolimus|mesh-list
44350718|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350719|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
44350720|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350721|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350722|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350731|NCT01080547|Capecitabine|capecitabine|mesh-list
44350732|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
44350733|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44350734|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
44350735|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350736|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350737|NCT01080560|Cyclosporine|cyclosporine|mesh-list
44350738|NCT01080560|Cyclosporins|cyclosporins|mesh-list
44350739|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350740|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350741|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350742|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
44350743|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350744|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
44350745|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350746|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350747|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350748|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350749|NCT01080586|Cyclosporine|cyclosporine|mesh-list
44350750|NCT01080586|Cyclosporins|cyclosporins|mesh-list
44350751|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350752|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350753|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44350754|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
44350755|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350756|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
44350757|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350758|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350759|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350760|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44350761|NCT01080612|Pregabalin|pregabalin|mesh-list
44350762|NCT01080612|Analgesics|analgesics|mesh-ancestor
44350763|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
44350764|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350765|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350766|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
44350767|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44350769|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350770|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44350771|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44350772|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44350773|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350774|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44350775|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
44350776|NCT01080638|Abciximab|abciximab|mesh-list
44350777|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
44350778|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44350779|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350780|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
44350781|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350782|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44350783|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132931|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
44132932|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132933|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132934|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44132935|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
44132936|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44132937|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
44132938|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132939|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132940|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44132941|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132942|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
44132943|NCT00152542|Protective Agents|protective agents|mesh-ancestor
44132944|NCT00152581|Interferons|interferons|mesh-list
44132945|NCT00152581|Ribavirin|ribavirin|mesh-list
44132946|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
44132947|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
44132948|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44132949|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132950|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
44132951|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132952|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
44132953|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132954|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
44132955|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132956|NCT00152594|Voriconazole|voriconazole|mesh-list
44132957|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
44132958|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132959|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44132960|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44132961|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132962|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132963|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44132964|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
44132965|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132966|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132967|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44132968|NCT00152620|Dexamethasone|dexamethasone|mesh-list
44132969|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
44132970|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44132971|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44132972|NCT00152620|Prednisolone|prednisolone|mesh-list
44133000|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44350784|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
44350785|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350786|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
44350787|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44350788|NCT01080638|Protective Agents|protective agents|mesh-ancestor
44350789|NCT01080651|Voriconazole|voriconazole|mesh-list
44350790|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
44350791|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350792|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44350793|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44350794|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350795|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350796|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44350797|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
44350798|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350799|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350800|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44350801|NCT01080729|Hormones|hormones|mesh-list
44350802|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44350803|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44350804|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350805|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44350806|NCT01080742|Bisoprolol|bisoprolol|mesh-list
44350807|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44350808|NCT01080742|Diuretics|diuretics|mesh-ancestor
44350809|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
44350810|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350828|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44350829|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
44350830|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350831|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350832|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44350833|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44350834|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
44350835|NCT01080911|Morphine|morphine|mesh-list
44350836|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
44350837|NCT01080911|Narcotics|narcotics|mesh-ancestor
44350838|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350839|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350840|NCT01080911|Analgesics|analgesics|mesh-ancestor
44350841|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
44350842|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350843|NCT01080963|Daptomycin|daptomycin|mesh-list
44350844|NCT01080963|Cefuroxime|cefuroxime|mesh-list
44350845|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
44350846|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350847|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350848|NCT01081002|Lidocaine|lidocaine|mesh-list
44350849|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
44350850|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
44350851|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44350852|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350853|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
44350854|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350855|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44350860|NCT01081158|Ritonavir|ritonavir|mesh-list
44350875|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350876|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44350877|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
44350878|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350879|NCT01081353|Aspirin|aspirin|mesh-list
44350880|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44350881|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44350882|NCT01081353|Analgesics|analgesics|mesh-ancestor
44350883|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
44350884|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44350885|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350886|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44350887|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44350888|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44350889|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44350890|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350891|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44350892|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44350893|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350894|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
44350895|NCT01081431|Lenalidomide|lenalidomide|mesh-list
44350896|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
44350898|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44350926|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
44350927|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350928|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44350929|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44350930|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44350931|NCT01081561|Riboflavin|riboflavin|mesh-list
44350932|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
44350933|NCT01081561|Vitamins|vitamins|mesh-ancestor
44350934|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
44350935|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350936|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44350937|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
44350938|NCT01081600|Trastuzumab|trastuzumab|mesh-list
44350939|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350940|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350941|NCT01081613|Bevacizumab|bevacizumab|mesh-list
44350942|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
44350943|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44350944|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44350945|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44350946|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44350947|NCT01081613|Growth Substances|growth substances|mesh-ancestor
44350948|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350949|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
44350950|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44350951|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44350974|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44350975|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44350976|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350978|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44350979|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
44350980|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44350981|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
44350982|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350983|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44350984|NCT01081847|Diuretics|diuretics|mesh-ancestor
44350985|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
44350986|NCT01081938|Insulin|insulin|mesh-list
44350987|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44350988|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
44350989|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
44350990|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44350991|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44350992|NCT01081964|Levofloxacin|levofloxacin|mesh-list
44350993|NCT01081964|Ofloxacin|ofloxacin|mesh-list
44350994|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
44350995|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44133001|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44133002|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44133003|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
44133004|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133005|NCT00152646|Clopidogrel|clopidogrel|mesh-list
44133006|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44133007|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44133008|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44133009|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44133010|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
44133011|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133012|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133013|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133015|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133016|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133017|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133018|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133026|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133028|NCT00152724|Analgesics|analgesics|mesh-ancestor
44133029|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
44133030|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133031|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133032|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133033|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133034|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44133035|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44133036|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133037|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44133038|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133039|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133040|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
44133041|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44133042|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44350996|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44350997|NCT01081964|Renal Agents|renal agents|mesh-ancestor
44350998|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44350999|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44351000|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44351001|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351002|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351003|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351004|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44351005|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44351006|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44351007|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
44351008|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44351009|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
44351010|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351011|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44351012|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351013|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44351014|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351015|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351016|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351017|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
44351018|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44351019|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351020|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351021|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43755940|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
44133043|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44133044|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
44133045|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133046|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44133047|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
44133048|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133049|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
44133050|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
44133051|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44133052|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133053|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133054|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44133055|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44133056|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44133057|NCT00152750|Clonidine|clonidine|mesh-list
43852004|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
43852005|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43852006|NCT03883828|Mupirocin|mupirocin|mesh-list
43852007|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44351022|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44351023|NCT01082003|Protective Agents|protective agents|mesh-ancestor
44351024|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351025|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
44351026|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44351028|NCT01082029|Lansoprazole|lansoprazole|mesh-list
44351029|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
44351030|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44351031|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351032|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44351033|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351034|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351035|NCT01082120|Pioglitazone|pioglitazone|mesh-list
44351036|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44351037|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351038|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44351039|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351040|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351041|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351042|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351043|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351044|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44351045|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44351046|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44351047|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351048|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351049|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755965|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43852008|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852009|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
43852011|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43852012|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43852013|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852014|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852015|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
43852016|NCT03882177|Pyridoxal|pyridoxal|mesh-list
43852017|NCT03882177|Pyridoxine|pyridoxine|mesh-list
43852018|NCT03882177|Pravastatin|pravastatin|mesh-list
43852019|NCT03882177|Vitamins|vitamins|mesh-ancestor
43852020|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
43852021|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852022|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
43852023|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43852024|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43852025|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
44351050|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351051|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351052|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
44351053|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351054|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351055|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
44351056|NCT01082198|Vaccines|vaccines|mesh-list
44351057|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44351058|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
44351059|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351060|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44351061|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
44351062|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351063|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44351064|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351065|NCT01082237|Citalopram|citalopram|mesh-list
44351066|NCT01082237|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44351067|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44351068|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44351069|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351070|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351071|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
44351072|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351073|NCT01082237|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43852026|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852027|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43852028|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43852029|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852030|NCT03881345|Anticoagulants|anticoagulants|mesh-list
43852031|NCT03879798|Irinotecan|irinotecan|mesh-list
43852032|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43852033|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852034|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852035|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852036|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852037|NCT03879694|Octreotide|octreotide|mesh-list
43852043|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852044|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43852045|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852046|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43852047|NCT03878316|Oxytocin|oxytocin|mesh-list
43852048|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
43852049|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852050|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852051|NCT03878069|Elapegademase|elapegademase|mesh-list
43852052|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43852053|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852054|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852055|NCT03877406|Empagliflozin|empagliflozin|mesh-list
44351074|NCT01082237|Antidepressive Agents|antidepressive agents|mesh-ancestor
44351075|NCT01082237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351076|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44351077|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351078|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351079|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351080|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351081|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351082|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44351083|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44351084|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44351085|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351086|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809873|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
44351087|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351088|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351089|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351091|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351092|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351093|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
44351094|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44351095|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43852056|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43852057|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43852058|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852059|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852060|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43852061|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43852062|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43852063|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
43852064|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852065|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43852066|NCT03876262|Ivermectin|ivermectin|mesh-list
43852067|NCT03876262|Moxidectin|moxidectin|mesh-list
43852068|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43852069|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852070|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
43852071|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
43852072|NCT03875755|Inositol|inositol|mesh-list
43852073|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
43852074|NCT03875755|Vitamins|vitamins|mesh-ancestor
43852075|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
43852076|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852077|NCT03875664|Bupivacaine|bupivacaine|mesh-list
43852078|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
43852079|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
43852080|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852081|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852082|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
43852083|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852084|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
43702382|NCT02717871|Ofloxacin|ofloxacin|mesh-list
44351096|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351097|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351098|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351099|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351100|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44351101|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44351102|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44351103|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351104|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351105|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351106|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351107|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351108|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
44351109|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351110|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43852085|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852086|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852087|NCT03874052|Venetoclax|venetoclax|mesh-list
43852088|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43852089|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852090|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852091|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852092|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852093|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
43852094|NCT03873818|Ipilimumab|ipilimumab|mesh-list
43852095|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852096|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852097|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43852098|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852099|NCT03873480|Epinephrine|epinephrine|mesh-list
43852100|NCT03873480|Bupivacaine|bupivacaine|mesh-list
43852101|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43852102|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43852103|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
43852104|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852105|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852106|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852107|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43852108|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43852114|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
43852115|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43852116|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
43852117|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
43852118|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852119|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
43852120|NCT03873337|Nicotine|nicotine|mesh-list
43852121|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43852122|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
43852123|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852124|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852125|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43852126|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43852127|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
43852128|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852129|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852130|NCT03871348|Cemiplimab|cemiplimab|mesh-list
43852131|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351111|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
44351112|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44351113|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351114|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351115|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351116|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351117|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351118|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44351119|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44351120|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44351121|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351122|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351123|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351124|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351125|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351126|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
44351127|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351128|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351166|NCT01082458|Lidocaine|lidocaine|mesh-list
44351167|NCT01082458|Remifentanil|remifentanil|mesh-list
44351168|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
44351169|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
44351170|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351171|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351172|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
44351173|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351174|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44351175|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44351176|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44351177|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44351178|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351179|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351180|NCT01082458|Narcotics|narcotics|mesh-ancestor
44351181|NCT01082458|Analgesics|analgesics|mesh-ancestor
44351182|NCT01082471|Morphine|morphine|mesh-list
44351183|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351184|NCT01082471|Narcotics|narcotics|mesh-ancestor
44351185|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351222|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
44351223|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44351224|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351225|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351226|NCT01082718|Artesunate|artesunate|mesh-list
44351227|NCT01082718|Mefloquine|mefloquine|mesh-list
44351228|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
44351229|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44351230|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351231|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351232|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351233|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
44351234|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
44351235|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44351236|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
44351237|NCT01082731|Artesunate|artesunate|mesh-list
44351238|NCT01082731|Lumefantrine|lumefantrine|mesh-list
44351239|NCT01082731|Artemether|artemether|mesh-list
44351240|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44351241|NCT01082731|Mefloquine|mefloquine|mesh-list
44351242|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
44351243|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44351244|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351245|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351246|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351247|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
44351248|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
44351249|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44351250|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
44351251|NCT01082744|Sufentanil|sufentanil|mesh-list
44351273|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351274|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
44351275|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44351277|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351278|NCT01082848|Aripiprazole|aripiprazole|mesh-list
44351279|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
44351280|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351281|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351282|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351283|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351284|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351285|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
44351286|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
44351287|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351288|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351289|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44351290|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44351291|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
44351292|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351293|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351294|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351295|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351296|NCT01082926|Aldesleukin|aldesleukin|mesh-list
44351297|NCT01082926|Interleukin-2|interleukin-2|mesh-list
44351298|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351299|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44351300|NCT01082926|Analgesics|analgesics|mesh-ancestor
44351301|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
44351302|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351303|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351304|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44351305|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44351306|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
44351307|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852132|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852133|NCT03870919|Palbociclib|palbociclib|mesh-list
43852134|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852135|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852136|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351309|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
44351311|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
44351312|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351313|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44351314|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44351315|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351316|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
44351317|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351318|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
44351319|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852137|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852138|NCT03869996|Cytarabine|cytarabine|mesh-list
43852139|NCT03869996|Methotrexate|methotrexate|mesh-list
43852140|NCT03869996|Etoposide|etoposide|mesh-list
43852141|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852142|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
43852143|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852144|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852145|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
43852146|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852147|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852148|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
43852149|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852150|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852151|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852152|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852153|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852154|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43852155|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
43852156|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852157|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852158|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852159|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852160|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852162|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
43852163|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
43852164|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
43852165|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852166|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852167|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
43852168|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852169|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43852170|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43852171|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43852172|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43852173|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852174|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43852175|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
43852176|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
43852177|NCT03869450|Protective Agents|protective agents|mesh-ancestor
43852178|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43852182|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43852183|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
43852184|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852185|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852186|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43852187|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351320|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44351321|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44351322|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44351323|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351324|NCT01083251|Vitamin D|vitamin d|mesh-list
44351325|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
44351326|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
44351327|NCT01083251|Vitamins|vitamins|mesh-list
44351328|NCT01083251|Entecavir|entecavir|mesh-list
44351329|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
44351330|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351331|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44351332|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44351333|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
44351334|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351335|NCT01083264|Gestodene|gestodene|mesh-list
44351336|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44351337|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44351338|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44351339|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
44351340|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852188|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
43852189|NCT03866538|Budesonide|budesonide|mesh-list
43852190|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852191|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43852192|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
43852193|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852194|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852195|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43852196|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
43852197|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
43852198|NCT03866538|Hormones|hormones|mesh-ancestor
43852199|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852200|NCT03865992|Curcumin|curcumin|mesh-list
43852201|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43852202|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852203|NCT03865992|Analgesics|analgesics|mesh-ancestor
43852204|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
43852205|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852206|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852207|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852208|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852209|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852210|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852211|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852212|NCT03865212|Interferons|interferons|mesh-list
43852213|NCT03865212|Interferon-beta|interferon-beta|mesh-list
43852214|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852215|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
43852216|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852217|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
43852218|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852219|NCT03864926|Tacrolimus|tacrolimus|mesh-list
43852220|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852221|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
43852222|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351341|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351342|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44351343|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44351344|NCT01083264|Progestins|progestins|mesh-ancestor
44351345|NCT01083264|Hormones|hormones|mesh-ancestor
44351346|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351347|NCT01083290|Spironolactone|spironolactone|mesh-list
44351348|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44351349|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
44351350|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351351|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351352|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44351353|NCT01083290|Diuretics|diuretics|mesh-ancestor
44351354|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
44351355|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
44351357|NCT01083329|Niacinamide|niacinamide|mesh-list
44351358|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
44351359|NCT01083329|Vitamins|vitamins|mesh-ancestor
44351360|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
44351361|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351362|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351363|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
44351364|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351365|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44351366|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
44351367|NCT01083381|Risperidone|risperidone|mesh-list
44351368|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351369|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
44351370|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351371|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351372|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351373|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351374|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351375|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351376|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351377|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351378|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
44351380|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44351381|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44351382|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351383|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
44351384|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351385|NCT01083420|Minocycline|minocycline|mesh-list
44351386|NCT01083420|Dexamethasone|dexamethasone|mesh-list
43600504|NCT05074589|Irinotecan|irinotecan|mesh-list
44351387|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44351388|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
44351389|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
44351390|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351391|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351392|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351393|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
44351394|NCT01083420|Hormones|hormones|mesh-ancestor
44351395|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351396|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44351397|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351398|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44351399|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852223|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43852224|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852225|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852226|NCT03864419|Prednisone|prednisone|mesh-list
43852227|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
43852228|NCT03864419|Rituximab|rituximab|mesh-list
43852229|NCT03864419|Doxorubicin|doxorubicin|mesh-list
43852230|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43852231|NCT03864419|Methotrexate|methotrexate|mesh-list
43852232|NCT03864419|Etoposide|etoposide|mesh-list
43852233|NCT03864419|Vincristine|vincristine|mesh-list
43852234|NCT03864419|Daunorubicin|daunorubicin|mesh-list
43852235|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
43852236|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43852237|NCT03864419|Antibodies|antibodies|mesh-list
43852238|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
43852239|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43852240|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852241|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
43852242|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852243|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852244|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43852245|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
43852246|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852247|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852248|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43852249|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852250|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852251|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852257|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852258|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43852259|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
43852260|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852261|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351402|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351403|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351404|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351405|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351406|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351407|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351408|NCT01083589|Docetaxel|docetaxel|mesh-list
44351409|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
44351410|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351411|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351412|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351413|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351414|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351415|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44351416|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351417|NCT01083784|Valproic Acid|valproic acid|mesh-list
44351418|NCT01083784|Clonazepam|clonazepam|mesh-list
44351419|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
44351420|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351421|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351422|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
44351423|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351424|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351425|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
44351426|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351427|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351428|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756276|NCT02467673|Estradiol|estradiol|mesh-list
43852262|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
43852263|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852264|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852265|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852266|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852267|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852268|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852269|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852270|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
44133058|NCT00152750|Analgesics|analgesics|mesh-ancestor
44133059|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
44133060|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133061|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133062|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133063|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
44133064|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
43702383|NCT02717871|Gentamicins|gentamicins|mesh-list
44351429|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
44351430|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
44351431|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
44351432|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44351433|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351434|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351435|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44351436|NCT01083797|Analgesics|analgesics|mesh-ancestor
44351437|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
44351438|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351439|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44351440|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44351441|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44351442|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351443|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351444|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351445|NCT01083875|Amlexanox|amlexanox|mesh-list
44351446|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44351447|NCT01083953|Sevoflurane|sevoflurane|mesh-list
44351448|NCT01083953|Desflurane|desflurane|mesh-list
44351449|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44351450|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44351451|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
44351452|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
44351453|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351454|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351455|NCT01083992|Vitamin D|vitamin d|mesh-list
44351456|NCT01083992|Vildagliptin|vildagliptin|mesh-list
44351457|NCT01083992|Vitamins|vitamins|mesh-ancestor
44351458|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
44351459|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351460|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44351461|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44351462|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44351463|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
44351469|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351471|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
44351472|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
44351473|NCT01084044|Urinastatin|urinastatin|mesh-list
44351474|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44351475|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44351476|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
44351477|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351478|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351480|NCT01084057|Epothilone B|epothilone b|mesh-list
44351481|NCT01084057|Epothilones|epothilones|mesh-list
44351482|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351483|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44351484|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351485|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351486|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351487|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351488|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351489|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44351490|NCT01084122|Hematinics|hematinics|mesh-ancestor
44351491|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44351492|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
43810877|NCT04852081|Tamoxifen|tamoxifen|mesh-list
44351493|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44351494|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44351495|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351496|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351497|NCT01084187|Urological Agents|urological agents|mesh-ancestor
44351498|NCT01084200|Propofol|propofol|mesh-list
44351499|NCT01084200|Sevoflurane|sevoflurane|mesh-list
44351500|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44351501|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351502|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351503|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44351504|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
44351509|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
44351510|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44351511|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351512|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351513|NCT01084291|Vaccines|vaccines|mesh-list
44351514|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
44351515|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351516|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
44351517|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44351518|NCT01084369|Testosterone|testosterone|mesh-list
44351519|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
44351520|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
44351521|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44351522|NCT01084369|Androgens|androgens|mesh-ancestor
44351523|NCT01084369|Hormones|hormones|mesh-ancestor
44351524|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351525|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351526|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44351527|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351528|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
44351529|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
44351530|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44351531|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44351532|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351533|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351534|NCT01084369|Urological Agents|urological agents|mesh-ancestor
44351535|NCT01084408|Paclitaxel|paclitaxel|mesh-list
44351536|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44351537|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351538|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351539|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351540|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351541|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
43756395|NCT02466503|Xhance|xhance|mesh-list
44351550|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
44351551|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351552|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44351553|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44351554|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44351555|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351556|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351557|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351558|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351561|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44351562|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351563|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44351564|NCT01084577|Laxatives|laxatives|mesh-ancestor
44351565|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351566|NCT01084720|V0034CR|v0034cr|mesh-list
44351567|NCT01084720|Emollients|emollients|mesh-ancestor
44351568|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351569|NCT01084824|Cantharidin|cantharidin|mesh-list
44351570|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351571|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351572|NCT01084837|Bortezomib|bortezomib|mesh-list
44351573|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351574|NCT01084863|Paclitaxel|paclitaxel|mesh-list
44351575|NCT01084863|Trastuzumab|trastuzumab|mesh-list
44351576|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351577|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351578|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351598|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351599|NCT01084980|Tacrolimus|tacrolimus|mesh-list
44351600|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44351601|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
44351602|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351603|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44351604|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351605|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351606|NCT01084993|Heparin|heparin|mesh-list
44351607|NCT01084993|Bivalirudin|bivalirudin|mesh-list
44351608|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
44351609|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44351610|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44351611|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351612|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
44351613|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44351614|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
44351615|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351616|NCT01085032|Nicotine|nicotine|mesh-list
44351617|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44351618|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
44351619|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351620|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351621|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44351622|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44351623|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
44351624|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351625|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351626|NCT01085058|Lenograstim|lenograstim|mesh-list
44006633|NCT04260659|Narcotics|narcotics|mesh-ancestor
44351627|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44351640|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44351641|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44351642|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44351643|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351644|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351645|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
44351646|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
44351647|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351648|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351649|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44351650|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44351651|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
44351652|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44351653|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44351654|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44351655|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44351656|NCT01085422|Temozolomide|temozolomide|mesh-list
44351657|NCT01085422|Veliparib|veliparib|mesh-list
44351658|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44351659|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
44351660|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351661|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351662|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44351663|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351664|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44351665|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
44351666|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44351667|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
44351668|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44351669|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351670|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44351671|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44351679|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
44351680|NCT01085552|Hematinics|hematinics|mesh-ancestor
44351681|NCT01085617|Cytarabine|cytarabine|mesh-list
44351682|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
44351683|NCT01085617|Melphalan|melphalan|mesh-list
44351684|NCT01085617|Rituximab|rituximab|mesh-list
44351685|NCT01085617|Methotrexate|methotrexate|mesh-list
44351686|NCT01085617|Fludarabine|fludarabine|mesh-list
44351687|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
44351688|NCT01085617|Etoposide|etoposide|mesh-list
44351689|NCT01085617|Vincristine|vincristine|mesh-list
44351690|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
44351691|NCT01085617|Daunorubicin|daunorubicin|mesh-list
44351692|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
44351693|NCT01085617|Pegaspargase|pegaspargase|mesh-list
44351694|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44351695|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
44351696|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351697|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44351698|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44351699|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
44351700|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351701|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351702|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44351703|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43756548|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44133065|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44133066|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44133067|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44133068|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
44133069|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133070|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133071|NCT00152802|Vaccines|vaccines|mesh-list
44133072|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
44133073|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133074|NCT00152815|Vitamin E|vitamin e|mesh-list
44133075|NCT00152815|Antioxidants|antioxidants|mesh-list
44133076|NCT00152815|Vitamins|vitamins|mesh-ancestor
44133077|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
44133078|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133079|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133080|NCT00152815|Protective Agents|protective agents|mesh-ancestor
44133081|NCT00152828|Celecoxib|celecoxib|mesh-list
44133082|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133083|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133084|NCT00152828|Analgesics|analgesics|mesh-ancestor
44133085|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
44133086|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133087|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133088|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133089|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133090|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44133091|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44351705|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
44351706|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44351707|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351708|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
44351709|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351710|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351711|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44351712|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44351713|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351714|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44351715|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44351716|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
44351717|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351718|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351719|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351720|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351721|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44351722|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44351723|NCT01085656|Combretastatin|combretastatin|mesh-list
44351724|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351725|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351726|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351727|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351728|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351729|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351730|NCT01085695|Rabeprazole|rabeprazole|mesh-list
44351731|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44351732|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351733|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44351734|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351735|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351736|NCT01085708|Rabeprazole|rabeprazole|mesh-list
44351737|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44351738|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44351739|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43852271|NCT03861988|Ketamine|ketamine|mesh-list
43852272|NCT03861988|Analgesics|analgesics|mesh-ancestor
44351740|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351741|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351742|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
44351743|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
44351744|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
44351745|NCT01085721|Ephedrine|ephedrine|mesh-list
44351746|NCT01085721|Guaifenesin|guaifenesin|mesh-list
44351747|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44351748|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44351749|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44351750|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
44351751|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351752|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351753|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44351754|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44006779|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
44351755|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
44351756|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44351757|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44351758|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
44351759|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44351760|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44351761|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351763|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44351764|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44351765|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
44351766|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44351767|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44351768|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
44351785|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351786|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
44351787|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44351788|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44351789|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44351790|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44351791|NCT01085877|Estradiol|estradiol|mesh-list
44351792|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44351793|NCT01085877|Estrogens|estrogens|mesh-ancestor
44351794|NCT01085877|Hormones|hormones|mesh-ancestor
44351795|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351796|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351797|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44351798|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
44351799|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44351800|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44351801|NCT01085981|Niacin|niacin|mesh-list
44351802|NCT01085981|Niacinamide|niacinamide|mesh-list
44351803|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
44351804|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44351805|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
44351806|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351807|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44351808|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
44351809|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
44351810|NCT01085981|Vitamins|vitamins|mesh-ancestor
44351811|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
44351812|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351813|NCT01086020|Atorvastatin|atorvastatin|mesh-list
44351814|NCT01086020|Ezetimibe|ezetimibe|mesh-list
44351833|NCT01086085|Adefovir|adefovir|mesh-list
44351834|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
44351835|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351836|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
44351837|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351838|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44351839|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44351840|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351841|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351842|NCT01086254|Gemcitabine|gemcitabine|mesh-list
44351844|NCT01086254|Iniparib|iniparib|mesh-list
44351845|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351846|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351847|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
44351848|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351849|NCT01086254|Antiviral Agents|antiviral agents|mesh-ancestor
44351850|NCT01086254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351851|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351852|NCT01086254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44351853|NCT01086254|Immunologic Factors|immunologic factors|mesh-ancestor
44351854|NCT01086254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351855|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44351856|NCT01086332|Gemcitabine|gemcitabine|mesh-list
44351857|NCT01086332|Nelfinavir|nelfinavir|mesh-list
44351858|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351859|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
44351860|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351861|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351862|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
44351863|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351864|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351865|NCT01086332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44351866|NCT01086332|Immunologic Factors|immunologic factors|mesh-ancestor
44351867|NCT01086332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351870|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
44351873|NCT01086345|Bevacizumab|bevacizumab|mesh-list
44351874|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44351875|NCT01086345|Irinotecan|irinotecan|mesh-list
44351876|NCT01086345|Camptothecin|camptothecin|mesh-list
44351877|NCT01086345|Antibodies|antibodies|mesh-list
44351878|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
44351879|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44351880|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351881|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44351882|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44351883|NCT01086345|Growth Substances|growth substances|mesh-ancestor
44351884|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351885|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44351886|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
44351887|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44351888|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44351889|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351890|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351891|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44351892|NCT01086527|Montelukast|montelukast|mesh-list
44351893|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44351894|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44351895|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44351896|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
44351897|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44351898|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351922|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351923|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351924|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
44351925|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351926|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44351927|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44351928|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
44351929|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44351930|NCT01086826|Cisplatin|cisplatin|mesh-list
44351931|NCT01086826|Docetaxel|docetaxel|mesh-list
44351932|NCT01086826|Fluorouracil|fluorouracil|mesh-list
44351933|NCT01086826|Cetuximab|cetuximab|mesh-list
44351934|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351935|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351936|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351937|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351938|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351939|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
44351940|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44351941|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44351942|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
44351943|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351944|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44351945|NCT01086878|Trimethoprim|trimethoprim|mesh-list
44351946|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44351947|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
44351948|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44351949|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351950|NCT01086878|Renal Agents|renal agents|mesh-ancestor
44351951|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
44351952|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44351953|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351954|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44351955|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44351962|NCT01086956|Ropivacaine|ropivacaine|mesh-list
44351963|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
44351964|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
44351965|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44351966|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351967|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
44351968|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44351969|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44351970|NCT01086956|Narcotics|narcotics|mesh-ancestor
44351971|NCT01086956|Analgesics|analgesics|mesh-ancestor
44351972|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44351973|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44351974|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
44351975|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
44351976|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44351977|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351978|NCT01087099|Albendazole|albendazole|mesh-list
44351979|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
44351980|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44351981|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351982|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
44351983|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44351985|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44351986|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44351987|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44351988|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44351989|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44351990|NCT01087138|Calcium|calcium|mesh-list
44351991|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44351992|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44351993|NCT01087190|Isoniazid|isoniazid|mesh-list
44351994|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
44351995|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44351996|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44351997|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44352003|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44352004|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
44352005|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
44352006|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352007|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352008|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44352009|NCT01087229|Analgesics|analgesics|mesh-ancestor
44352010|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
44352011|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352012|NCT01087359|Melatonin|melatonin|mesh-list
44352013|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
44352014|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352015|NCT01087359|Protective Agents|protective agents|mesh-ancestor
44352016|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352017|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352018|NCT01087398|Cyclosporine|cyclosporine|mesh-list
44352019|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
44352020|NCT01087398|Busulfan|busulfan|mesh-list
44352021|NCT01087398|Methotrexate|methotrexate|mesh-list
44352022|NCT01087398|Fludarabine|fludarabine|mesh-list
44352023|NCT01087398|Cyclosporins|cyclosporins|mesh-list
44352024|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
44352025|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352026|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
44352027|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352028|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352029|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44352030|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
44352031|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352032|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352033|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44352034|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44352035|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
44352036|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352037|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352038|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
44352039|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44352041|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44352042|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352043|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
44352044|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352045|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44352047|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352048|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352049|NCT01087476|Doxycycline|doxycycline|mesh-list
44352050|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352051|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352052|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
44352053|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44352054|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44352055|NCT01087554|Sirolimus|sirolimus|mesh-list
44352056|NCT01087554|Everolimus|everolimus|mesh-list
44352057|NCT01087554|Vorinostat|vorinostat|mesh-list
44352058|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352059|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352060|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
44352061|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352062|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352063|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352064|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352065|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
44352066|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44352067|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352068|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352069|NCT01087567|Insulin|insulin|mesh-list
43852273|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
43852274|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852275|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852276|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43852277|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43852278|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
43852279|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
43852280|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852281|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43852282|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43852283|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852284|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852285|NCT03861390|Prednisone|prednisone|mesh-list
43852290|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852291|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852292|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852293|NCT03861299|Anesthetics|anesthetics|mesh-list
43852294|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352070|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44352071|NCT01087567|Metformin|metformin|mesh-list
44352072|NCT01087567|Pioglitazone|pioglitazone|mesh-list
44352073|NCT01087567|Glimepiride|glimepiride|mesh-list
44352074|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352075|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352076|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44352077|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352078|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
44352079|NCT01087580|Prednisone|prednisone|mesh-list
44352080|NCT01087580|Docetaxel|docetaxel|mesh-list
44352081|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352082|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352083|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
44352084|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
44352085|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352086|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352087|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
44352088|NCT01087580|Hormones|hormones|mesh-ancestor
44352089|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352090|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352091|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44352092|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44352093|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44352094|NCT01087593|Estradiol|estradiol|mesh-list
44352095|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44352096|NCT01087593|Estrogens|estrogens|mesh-ancestor
44352097|NCT01087593|Hormones|hormones|mesh-ancestor
44352098|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352099|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352100|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44352101|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
44352102|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352103|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44352104|NCT01087632|Folic Acid|folic acid|mesh-list
44352105|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
44352106|NCT01087632|Policosanol|policosanol|mesh-list
44352110|NCT01087632|Vitamins|vitamins|mesh-ancestor
44352111|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
44352112|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352113|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44352114|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44352115|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
44352116|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352117|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44352118|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44352119|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44352120|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352121|NCT01087658|Calcium|calcium|mesh-list
44352122|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352123|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352124|NCT01087710|Vitamins|vitamins|mesh-list
44352125|NCT01087710|Antioxidants|antioxidants|mesh-list
44352126|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
44352127|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352128|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352129|NCT01087710|Protective Agents|protective agents|mesh-ancestor
44352130|NCT01087749|Losartan|losartan|mesh-list
44352131|NCT01087749|Propranolol|propranolol|mesh-list
44352132|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44352133|NCT01087749|Eprosartan|eprosartan|mesh-list
44352134|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44352135|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44352136|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44352137|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44352155|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44352156|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352157|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352158|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352159|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44352160|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44352161|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44352162|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44352163|NCT01087866|Metformin|metformin|mesh-list
44352164|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352165|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352166|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44352167|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44352168|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44352169|NCT01087879|Etonogestrel|etonogestrel|mesh-list
44352170|NCT01087879|Desogestrel|desogestrel|mesh-list
44352171|NCT01087879|NuvaRing|nuvaring|mesh-list
44352172|NCT01087879|Norelgestromin|norelgestromin|mesh-list
44352173|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
44352174|NCT01087879|Estradiol|estradiol|mesh-list
44352175|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43756932|NCT02462941|Adenosine|adenosine|mesh-list
43852295|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852296|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
43852297|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43852298|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43852299|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852300|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43852301|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852302|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43852303|NCT03858491|Cobicistat|cobicistat|mesh-list
43852304|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43852305|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43852306|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
43852307|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852308|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43852309|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43852310|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852311|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852312|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
43852313|NCT03855007|Prednisone|prednisone|mesh-list
43852314|NCT03855007|Methotrexate|methotrexate|mesh-list
43852315|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852316|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
43852317|NCT03855007|Hormones|hormones|mesh-ancestor
43852318|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852319|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852320|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852321|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852322|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43852323|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
43852324|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852325|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852326|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
43702384|NCT02717871|Cefazolin|cefazolin|mesh-list
44352176|NCT01087879|Estrogens|estrogens|mesh-ancestor
44352177|NCT01087879|Hormones|hormones|mesh-ancestor
44352178|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352179|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352180|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44352181|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352182|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44352183|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44352184|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44352185|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44352186|NCT01087879|Progestins|progestins|mesh-ancestor
44352187|NCT01087983|Metformin|metformin|mesh-list
44352188|NCT01087983|Sirolimus|sirolimus|mesh-list
44352189|NCT01087983|Lapatinib|lapatinib|mesh-list
44352190|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352191|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352192|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352193|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352194|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352195|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352196|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
44352197|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352198|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
44352199|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44352200|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352201|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352202|NCT01088009|Lamivudine|lamivudine|mesh-list
44352203|NCT01088009|Adefovir|adefovir|mesh-list
44352204|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44352205|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352206|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352208|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
44352220|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352221|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352222|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352224|NCT01088022|Hormones|hormones|mesh-ancestor
44352225|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352226|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44352227|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352228|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
44352229|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352230|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812035|NCT04835259|Selenium|selenium|mesh-list
44352231|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44352232|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352233|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44352234|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44352235|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
44352236|NCT01088035|Carboplatin|carboplatin|mesh-list
44352237|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352238|NCT01088165|Adalimumab|adalimumab|mesh-list
44352239|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352240|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352241|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
44352242|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44352243|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
44352244|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352245|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352246|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44352247|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44352248|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44352249|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
44352262|NCT01088256|Etoricoxib|etoricoxib|mesh-list
44352263|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44352264|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44352265|NCT01088256|Analgesics|analgesics|mesh-ancestor
44352266|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
44352267|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352268|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352269|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352270|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352271|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44352272|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44352273|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352274|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352276|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44352277|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
44352278|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352279|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352280|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352281|NCT01088347|Cisplatin|cisplatin|mesh-list
44352282|NCT01088347|Mapatumumab|mapatumumab|mesh-list
44352283|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352284|NCT01088373|Lenalidomide|lenalidomide|mesh-list
44352285|NCT01088373|Azacitidine|azacitidine|mesh-list
44352286|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
44352287|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352288|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44352289|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44352290|NCT01088373|Growth Substances|growth substances|mesh-ancestor
44352291|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
44352292|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352293|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352294|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
44352295|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352296|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352297|NCT01088451|Insulin|insulin|mesh-list
44352298|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43852327|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352299|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352300|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44352301|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44352302|NCT01088477|Estradiol|estradiol|mesh-list
44352303|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44352304|NCT01088477|Estrogens|estrogens|mesh-ancestor
44352305|NCT01088477|Hormones|hormones|mesh-ancestor
44352306|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352307|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352308|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44352309|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
44352310|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352311|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44352312|NCT01088516|Ritonavir|ritonavir|mesh-list
44352313|NCT01088516|Lopinavir|lopinavir|mesh-list
44352314|NCT01088516|Zidovudine|zidovudine|mesh-list
44352315|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44352316|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44352317|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
44352318|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352319|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352320|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44352321|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44352322|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
44352323|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352324|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44352349|NCT01088620|Panitumumab|panitumumab|mesh-list
44352350|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352351|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352352|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352353|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44352354|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352355|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352356|NCT01088659|Tenofovir|tenofovir|mesh-list
44352357|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44352358|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
44352359|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352360|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44352361|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352362|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352363|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352364|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44352365|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44352366|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
44352367|NCT01088724|Rituximab|rituximab|mesh-list
44352368|NCT01088724|Doxorubicin|doxorubicin|mesh-list
44352369|NCT01088724|Fludarabine|fludarabine|mesh-list
44352370|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352371|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
44352372|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352373|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352374|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44352375|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
44352376|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352377|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352378|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44352379|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352380|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352381|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852328|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852329|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852330|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852331|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852332|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
43852333|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702385|NCT02717871|Tobramycin|tobramycin|mesh-list
44352383|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352384|NCT01088737|Imiquimod|imiquimod|mesh-list
44352385|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44352386|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
44352387|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352388|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352389|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
44352390|NCT01088750|Prednisolone|prednisolone|mesh-list
44352391|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
44352392|NCT01088750|Vinblastine|vinblastine|mesh-list
44352393|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352394|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
44352395|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352396|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352397|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44352398|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
44352399|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352400|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352401|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44352402|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352403|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
44352404|NCT01088750|Hormones|hormones|mesh-ancestor
44352405|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352406|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44352407|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44352408|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352409|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44352410|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44352411|NCT01088763|Dexamethasone|dexamethasone|mesh-list
44352412|NCT01088763|R04929097|r04929097|mesh-list
44352413|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352414|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
44352415|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
44352420|NCT01088763|Hormones|hormones|mesh-ancestor
44352423|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352424|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352425|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352428|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44352429|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352430|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352431|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44352432|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44352433|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352434|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352435|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
44352436|NCT01088815|Antiviral Agents|antiviral agents|mesh-ancestor
44352437|NCT01088815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352438|NCT01088815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352439|NCT01088815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352440|NCT01088815|Immunologic Factors|immunologic factors|mesh-ancestor
44352441|NCT01088815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352442|NCT01088893|Everolimus|everolimus|mesh-list
44352443|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352444|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352445|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
43852334|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852335|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
43852336|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43852337|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43852338|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852339|NCT03854799|Capecitabine|capecitabine|mesh-list
43852340|NCT03854799|Avelumab|avelumab|mesh-list
43852341|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852342|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
44133092|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852343|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852344|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852345|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852346|NCT03853707|Paclitaxel|paclitaxel|mesh-list
43852347|NCT03853707|Carboplatin|carboplatin|mesh-list
43852348|NCT03853707|Capecitabine|capecitabine|mesh-list
43852349|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43852350|NCT03853707|Atezolizumab|atezolizumab|mesh-list
43852351|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43852352|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852353|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852354|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852355|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852356|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852357|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852358|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852359|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
43852360|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
43852361|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852362|NCT03852901|Empagliflozin|empagliflozin|mesh-list
44352446|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352448|NCT01088906|Pemetrexed|pemetrexed|mesh-list
44352449|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352450|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352451|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352452|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44352453|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352454|NCT01088919|Pioglitazone|pioglitazone|mesh-list
44352455|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
44352456|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352457|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352458|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43812239|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352459|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352460|NCT01088932|SRX246|srx246|mesh-list
44352461|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44352462|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352463|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
44352464|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352465|NCT01088958|Micronutrients|micronutrients|mesh-list
44352466|NCT01088958|Trace Elements|trace elements|mesh-list
44352467|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352468|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
44352469|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44352470|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44352471|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44352472|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352473|NCT01089088|Gemcitabine|gemcitabine|mesh-list
44352474|NCT01089088|Cisplatin|cisplatin|mesh-list
44352475|NCT01089088|Sunitinib|sunitinib|mesh-list
44352476|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352489|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44352490|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44352492|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44352493|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44352494|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352495|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
44352496|NCT01089140|Coagulants|coagulants|mesh-ancestor
44352497|NCT01089166|Metformin|metformin|mesh-list
44352498|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352499|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007433|NCT02791906|Antioxidants|antioxidants|mesh-ancestor
44352500|NCT01089179|Metformin|metformin|mesh-list
44352501|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352502|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352504|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352505|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352506|NCT01089205|Metformin|metformin|mesh-list
44352507|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44352508|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352509|NCT01089218|Amoxicillin|amoxicillin|mesh-list
44352510|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
44352511|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
44352512|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44352513|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352514|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352515|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44352516|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352517|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352518|NCT01089309|Spironolactone|spironolactone|mesh-list
44352519|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44352520|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
44352521|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44352522|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352524|NCT01089309|Diuretics|diuretics|mesh-ancestor
44352528|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352529|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44352530|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44352531|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
44352532|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44352533|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
44352534|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352535|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352536|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44352537|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
44352538|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44352539|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
44352540|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352541|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352542|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44352543|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352544|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
44352545|NCT01089439|Protective Agents|protective agents|mesh-ancestor
44352547|NCT01089452|Olmesartan|olmesartan|mesh-list
44352548|NCT01089452|Perindopril|perindopril|mesh-list
44352549|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43852363|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43852364|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852365|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43852366|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852369|NCT03847428|Bevacizumab|bevacizumab|mesh-list
43852370|NCT03847428|Durvalumab|durvalumab|mesh-list
43852371|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852372|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852373|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43852374|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43852375|NCT03847428|Growth Substances|growth substances|mesh-ancestor
43852376|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852377|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
43852378|NCT03845894|Bupivacaine|bupivacaine|mesh-list
43852379|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
43852380|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
43852381|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852382|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852383|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
43852384|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852385|NCT03844256|Capecitabine|capecitabine|mesh-list
43852386|NCT03844256|Nivolumab|nivolumab|mesh-list
43852387|NCT03844256|Ipilimumab|ipilimumab|mesh-list
43852388|NCT03844256|Mitomycins|mitomycins|mesh-list
43852389|NCT03844256|Mitomycin|mitomycin|mesh-list
43852390|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852391|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
43852392|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852393|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852394|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352550|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44352551|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352552|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352553|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352554|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352555|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352556|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44352557|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44352558|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44352559|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
44352560|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352561|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
44352562|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44352563|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44352564|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44352565|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352566|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352567|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352568|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352569|NCT01089621|Analgesics|analgesics|mesh-ancestor
44352570|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
44352571|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352572|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
44352573|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44352574|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
44352575|NCT01089660|Vaccines|vaccines|mesh-list
44352576|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
44352577|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352578|NCT01089855|Carbamazepine|carbamazepine|mesh-list
44352579|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
44352580|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
44352581|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44352582|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852395|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43852396|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852397|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
43852398|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352583|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352584|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44352585|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44352586|NCT01089855|Analgesics|analgesics|mesh-ancestor
43812474|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
44352587|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
44352588|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352589|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44352590|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352591|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352592|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44352593|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44352594|NCT01089933|Anesthetics|anesthetics|mesh-list
44352595|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
44352596|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352597|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352598|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
44352599|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352601|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44352602|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44352603|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44352604|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352605|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352606|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44352607|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44352608|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44352609|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44352611|NCT01090037|Epoprostenol|epoprostenol|mesh-list
44352629|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352630|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44352631|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
44352632|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44352633|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352634|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44352635|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44352636|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352638|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352639|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
44352640|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352641|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352642|NCT01090206|Vitamin D|vitamin d|mesh-list
44352643|NCT01090206|Calcium|calcium|mesh-list
44352644|NCT01090206|Vitamins|vitamins|mesh-ancestor
44352645|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
44352646|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352647|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352648|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44352649|NCT01090466|Gemcitabine|gemcitabine|mesh-list
44352650|NCT01090466|Sirolimus|sirolimus|mesh-list
44352651|NCT01090466|Cisplatin|cisplatin|mesh-list
44352652|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352653|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44352654|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
44352655|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352656|NCT01090466|Antiviral Agents|antiviral agents|mesh-ancestor
44352657|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352658|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352659|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352660|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
43852399|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852400|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
43852401|NCT03844061|Rituximab|rituximab|mesh-list
43852402|NCT03844061|Belimumab|belimumab|mesh-list
43852403|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852404|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852405|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
43852406|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852407|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852408|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852409|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43852410|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
44352661|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352662|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44352663|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352664|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
44352665|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
44352666|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352667|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
44352668|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352669|NCT01090596|Naproxen|naproxen|mesh-list
44352670|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44352671|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44352672|NCT01090596|Analgesics|analgesics|mesh-ancestor
44352673|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
44352674|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352675|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352676|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44352677|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352678|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
44352679|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44352680|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352681|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352682|NCT01090648|Etravirine|etravirine|mesh-list
44352683|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44352684|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44352710|NCT01090700|Simeprevir|simeprevir|mesh-list
44352711|NCT01090700|Dexetimide|dexetimide|mesh-list
44352712|NCT01090700|Citalopram|citalopram|mesh-list
44352713|NCT01090700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44352714|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44352715|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352716|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352717|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352718|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
44352719|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352720|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44352721|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
44352722|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44352723|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44352724|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44352725|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
44352726|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
44352727|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352728|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44352729|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44352730|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
44352731|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
44352732|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352733|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
44352734|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352735|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44352736|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44352737|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352742|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
44352755|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
44352756|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
44352757|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352758|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352759|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44352760|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44352761|NCT01090830|Growth Substances|growth substances|mesh-ancestor
44352762|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352763|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44352764|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44352765|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352766|NCT01090882|Bupivacaine|bupivacaine|mesh-list
44352767|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
44352768|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
44352769|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352770|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352771|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
44352772|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352773|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
44352774|NCT01090895|Vitamins|vitamins|mesh-ancestor
44352775|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
44352776|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352777|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
44352778|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352779|NCT01090895|Protective Agents|protective agents|mesh-ancestor
44352802|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352803|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
44352804|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44352805|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
44352806|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352807|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44352808|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
44352809|NCT01091324|Silymarin|silymarin|mesh-list
44352810|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
44352811|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
44352812|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44352813|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44352814|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352815|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352816|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352817|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
44352818|NCT01091324|Protective Agents|protective agents|mesh-ancestor
44352819|NCT01091337|Albuterol|albuterol|mesh-list
44352820|NCT01091337|Procaterol|procaterol|mesh-list
44352821|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44352822|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
44352823|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352824|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352825|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44352826|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
44352827|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
44352828|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44352829|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44352830|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44352847|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44352848|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44352849|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352850|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352851|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352852|NCT01091571|Dipyridamole|dipyridamole|mesh-list
44352853|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44352854|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352855|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352856|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44352857|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352858|NCT01091649|Ritonavir|ritonavir|mesh-list
44352859|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44352860|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43757466|NCT02460302|Hormones|hormones|mesh-ancestor
43852411|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43852412|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852413|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852414|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852415|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852416|NCT03844048|Venetoclax|venetoclax|mesh-list
43852417|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852418|NCT03843528|Azacitidine|azacitidine|mesh-list
43852419|NCT03843528|Vorinostat|vorinostat|mesh-list
43852420|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852421|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
43852422|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852424|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852425|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43852426|NCT03843294|Nivolumab|nivolumab|mesh-list
43852427|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852428|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852429|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43852432|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43812877|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
43852433|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852434|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852435|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852436|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
43852437|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852438|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852439|NCT03840915|Gemcitabine|gemcitabine|mesh-list
43852440|NCT03840915|Paclitaxel|paclitaxel|mesh-list
43852441|NCT03840915|Docetaxel|docetaxel|mesh-list
43852442|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43852443|NCT03840915|Cisplatin|cisplatin|mesh-list
43852444|NCT03840915|Carboplatin|carboplatin|mesh-list
43852445|NCT03840915|Pemetrexed|pemetrexed|mesh-list
43852446|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852447|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852448|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852449|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852450|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852451|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852452|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852453|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
43852454|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
43852455|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352861|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
44352862|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352863|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352864|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44352865|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44352866|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
44352867|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352868|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44352869|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44352870|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
44352871|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44352872|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44352873|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
44352874|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44352875|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44352876|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44352877|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352878|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352879|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
44352880|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352881|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352882|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44352883|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352885|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43852456|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852457|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852458|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
43852459|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852460|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852461|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852462|NCT03840239|Capecitabine|capecitabine|mesh-list
43852463|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
43852464|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852465|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
43852466|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852467|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852468|NCT03838796|Lenvatinib|lenvatinib|mesh-list
43852469|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852470|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852471|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852472|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852473|NCT03838159|Paclitaxel|paclitaxel|mesh-list
43852474|NCT03838159|Carboplatin|carboplatin|mesh-list
43852475|NCT03838159|Nivolumab|nivolumab|mesh-list
43852476|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852477|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852478|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
44352886|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44352887|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44352888|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352889|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44352890|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352891|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352892|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44352894|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352895|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352896|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44352897|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44352898|NCT01091792|Growth Substances|growth substances|mesh-ancestor
44352899|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352900|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
44352901|NCT01091818|Midazolam|midazolam|mesh-list
44352902|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
44352903|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44352904|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352905|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352906|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44352907|NCT01091818|Analgesics|analgesics|mesh-ancestor
44352908|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
44352909|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44352910|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44352911|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44352912|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44352913|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
44352914|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352915|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352929|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44352930|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
44352931|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
44352932|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352933|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44352934|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44352935|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44352936|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352937|NCT01091870|Urological Agents|urological agents|mesh-ancestor
44352938|NCT01091896|Bevacizumab|bevacizumab|mesh-list
44352939|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44352940|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352941|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44352942|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44352943|NCT01091896|Growth Substances|growth substances|mesh-ancestor
44352944|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352945|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
44007899|NCT02844582|Prednisone|prednisone|mesh-list
44352947|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44352948|NCT01092091|BCT-100|bct-100|mesh-list
44352949|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352950|NCT01092130|Vitamin D|vitamin d|mesh-list
44352951|NCT01092130|Vitamins|vitamins|mesh-ancestor
44352952|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
44352953|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352954|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44352955|NCT01092221|Allopurinol|allopurinol|mesh-list
44352956|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
44352957|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352958|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44352974|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44352975|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352976|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
44352977|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352978|NCT01092520|Gabapentin|gabapentin|mesh-list
44352979|NCT01092520|Analgesics|analgesics|mesh-ancestor
44352980|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
44352981|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649051|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352982|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44352983|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
44352984|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44352985|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44352986|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44352987|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44352988|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44352989|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44352990|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44352991|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44352992|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
44352993|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
44352994|NCT01092533|Prednisolone|prednisolone|mesh-list
44352995|NCT01092533|Prednisone|prednisone|mesh-list
44352996|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44352997|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44352998|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44352999|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
44353000|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353001|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353002|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353003|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353016|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44353017|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353018|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
44353019|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44353020|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44353021|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353023|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353024|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353025|NCT01092624|Urological Agents|urological agents|mesh-ancestor
44353026|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
44353027|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353028|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44353029|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353030|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353032|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353033|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
44353034|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353035|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44353036|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353037|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353038|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
44353039|NCT01092858|Testosterone|testosterone|mesh-list
44353040|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
44353041|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
44353042|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44353043|NCT01092858|Androgens|androgens|mesh-ancestor
44353044|NCT01092858|Hormones|hormones|mesh-ancestor
44353045|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353046|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353047|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44353048|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353049|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
44353050|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
44353051|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
44353052|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353053|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
44353054|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353055|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353056|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43649061|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353057|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
44353058|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353059|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353060|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44353061|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44353062|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44353063|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
44353064|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353065|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353066|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353067|NCT01092975|Phenylephrine|phenylephrine|mesh-list
44353068|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
44353069|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44353070|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
44353071|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
44353072|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353073|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353074|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
44353075|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44353076|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
44353077|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44353079|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44353101|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353102|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44353104|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
44353105|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44353106|NCT01093157|Hormones|hormones|mesh-list
44353107|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44353108|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353109|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353110|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
44353111|NCT01093235|Bevacizumab|bevacizumab|mesh-list
44353112|NCT01093235|Docetaxel|docetaxel|mesh-list
44353113|NCT01093235|Fluorouracil|fluorouracil|mesh-list
44353114|NCT01093235|Epirubicin|epirubicin|mesh-list
44353115|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353116|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
44353117|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353118|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353119|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44353120|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
44353121|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353122|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353123|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44353124|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44353144|NCT01093300|Paclitaxel|paclitaxel|mesh-list
44353153|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
44353154|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353155|NCT01093365|Varenicline|varenicline|mesh-list
44353156|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44353157|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44353158|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353159|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353160|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353161|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353162|NCT01093638|Insulin|insulin|mesh-list
44353163|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44353164|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353165|NCT01093768|Vasopressins|vasopressins|mesh-list
44353166|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
44353167|NCT01093768|Oxytocin|oxytocin|mesh-list
44353168|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
44353169|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353170|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353171|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
44353172|NCT01093768|Coagulants|coagulants|mesh-ancestor
44353173|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44353174|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44353175|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
44353176|NCT01093807|Enalapril|enalapril|mesh-list
43852479|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852480|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852481|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852482|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852483|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43852484|NCT03837899|Durvalumab|durvalumab|mesh-list
43852485|NCT03837899|Tremelimumab|tremelimumab|mesh-list
43852486|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43852487|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852488|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852489|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
43852490|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852491|NCT03834948|Paclitaxel|paclitaxel|mesh-list
43852492|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
43852493|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852494|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852495|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852496|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852498|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852499|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852500|NCT03834883|Ibutilide|ibutilide|mesh-list
43852501|NCT03834883|Progesterone|progesterone|mesh-list
43852502|NCT03834883|Progestins|progestins|mesh-ancestor
43852503|NCT03834883|Hormones|hormones|mesh-ancestor
43852504|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133095|NCT00152841|Vitamins|vitamins|mesh-ancestor
44133096|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
44353177|NCT01093807|Enalaprilat|enalaprilat|mesh-list
44353178|NCT01093807|Lercanidipine|lercanidipine|mesh-list
44353179|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44353180|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
44353181|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353182|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353183|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44353184|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44353185|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353186|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44353187|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353188|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
44353189|NCT01093820|Hematinics|hematinics|mesh-ancestor
44353190|NCT01093937|Varenicline|varenicline|mesh-list
44353191|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44353192|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44353193|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353194|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353195|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353196|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353197|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44353198|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44008188|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
44353199|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133097|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133098|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
44133099|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133100|NCT00152841|Protective Agents|protective agents|mesh-ancestor
44133101|NCT00152854|Acetaminophen|acetaminophen|mesh-list
44133102|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133103|NCT00152854|Analgesics|analgesics|mesh-ancestor
44133104|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
44133105|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133106|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133107|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
44133108|NCT00152867|Dexamethasone|dexamethasone|mesh-list
44133109|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133110|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
44133111|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
44133112|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133113|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133114|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133115|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
44133117|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133118|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44133119|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133120|NCT00152893|Chromium|chromium|mesh-list
44133122|NCT00152893|Trace Elements|trace elements|mesh-ancestor
44133123|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
44353200|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44353201|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44353202|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353203|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353205|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353206|NCT01094015|Lidocaine|lidocaine|mesh-list
44353207|NCT01094015|Prilocaine|prilocaine|mesh-list
44353208|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44353209|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
44353210|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
44353211|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353212|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353213|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
44353214|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353215|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44353216|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44353217|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44353218|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353219|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353220|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44353221|NCT01094028|Oxytocin|oxytocin|mesh-list
44353222|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
44353223|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353224|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353225|NCT01094158|Cholic Acids|cholic acids|mesh-list
44353226|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133124|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133125|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44133126|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
44133127|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133128|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44133129|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133130|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133131|NCT00152893|Vitamins|vitamins|mesh-ancestor
44133132|NCT00152919|Meloxicam|meloxicam|mesh-list
44133133|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133134|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133135|NCT00152919|Analgesics|analgesics|mesh-ancestor
44133136|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
44133137|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133138|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133139|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133140|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133141|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44353227|NCT01094210|Fluorides|fluorides|mesh-list
44353228|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
44353229|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
44353230|NCT01094210|Protective Agents|protective agents|mesh-ancestor
44353231|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353232|NCT01094249|Valproic Acid|valproic acid|mesh-list
44353233|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44353234|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44353235|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44353236|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353237|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353238|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44353239|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44353240|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44353241|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
44353242|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353243|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353244|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44353245|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44353246|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
44353247|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
44353248|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353249|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
44353250|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
44353251|NCT01094275|Omeprazole|omeprazole|mesh-list
44353252|NCT01094275|Clopidogrel|clopidogrel|mesh-list
44353253|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44353278|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
44353279|NCT01094444|Vitamins|vitamins|mesh-ancestor
44353280|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
44353281|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353282|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44353283|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44353284|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353285|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
44353286|NCT01094444|Coagulants|coagulants|mesh-ancestor
44353287|NCT01094457|Aspirin|aspirin|mesh-list
44353288|NCT01094457|Cilostazol|cilostazol|mesh-list
44353289|NCT01094457|Clopidogrel|clopidogrel|mesh-list
44353290|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44353291|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44353292|NCT01094457|Analgesics|analgesics|mesh-ancestor
44353293|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
44353294|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353295|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353296|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353297|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353298|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44353299|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44353300|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353301|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44353302|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44353303|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353304|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
44353305|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44353306|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44353307|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44353308|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
44353309|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353310|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44353311|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
44353317|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44353318|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44353319|NCT01094535|Secretin|secretin|mesh-list
44353320|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353321|NCT01094535|Hormones|hormones|mesh-ancestor
44353322|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353323|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353324|NCT01094600|Secretin|secretin|mesh-list
44353325|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353326|NCT01094600|Hormones|hormones|mesh-ancestor
44353327|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353328|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353329|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
44353330|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
44353331|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353332|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353333|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353334|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353335|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
43757862|NCT02457585|Infliximab|infliximab|mesh-list
44133142|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133143|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133144|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133145|NCT00152932|Dorzolamide|dorzolamide|mesh-list
44133146|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133147|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44133148|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133149|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133150|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44133151|NCT00152945|Glycerol|glycerol|mesh-list
44133152|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44133153|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44133154|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44133155|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43852508|NCT03833440|Durvalumab|durvalumab|mesh-list
43852509|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852510|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852511|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852512|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852513|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852517|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852518|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852519|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852520|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852521|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852522|NCT03831425|Ubiquinone|ubiquinone|mesh-list
43852523|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
43852524|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
43852525|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852526|NCT03831425|Vitamins|vitamins|mesh-ancestor
43852527|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43852528|NCT03830723|Hormones|hormones|mesh-ancestor
43852529|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353336|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353337|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44353338|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353339|NCT01094626|Secretin|secretin|mesh-list
44353340|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353341|NCT01094626|Hormones|hormones|mesh-ancestor
44353342|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353343|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353344|NCT01094769|Moxonidine|moxonidine|mesh-list
44353345|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44008338|NCT02887404|Analgesics|analgesics|mesh-list
44353347|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44353348|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44353349|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
44353350|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353351|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353352|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353353|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
44353354|NCT01094912|Narcotics|narcotics|mesh-ancestor
43852530|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852531|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
43852532|NCT03829683|Vitamins|vitamins|mesh-ancestor
43852533|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
43852534|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852535|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
43852536|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852537|NCT03829683|Protective Agents|protective agents|mesh-ancestor
43852538|NCT03829501|Atezolizumab|atezolizumab|mesh-list
43852539|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852540|NCT03829319|Cisplatin|cisplatin|mesh-list
43852541|NCT03829319|Carboplatin|carboplatin|mesh-list
43852542|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
43852543|NCT03829319|Pemetrexed|pemetrexed|mesh-list
43852544|NCT03829319|Lenvatinib|lenvatinib|mesh-list
43852545|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852546|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852547|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852548|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852549|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852550|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852551|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852552|NCT03826992|Cytarabine|cytarabine|mesh-list
43852553|NCT03826992|Daunorubicin|daunorubicin|mesh-list
43852554|NCT03826992|Venetoclax|venetoclax|mesh-list
43852555|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852556|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
43852557|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852558|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852559|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
43852560|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852561|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852562|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
43852563|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852564|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852565|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852566|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44353355|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600638|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649077|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
44353356|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353357|NCT01094912|Analgesics|analgesics|mesh-ancestor
44353358|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
44353359|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353360|NCT01094925|Gabapentin|gabapentin|mesh-list
44353361|NCT01094925|Analgesics|analgesics|mesh-ancestor
44353362|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
44353363|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353364|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353365|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
44353366|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44353367|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44353368|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353369|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44353370|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44353371|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44353372|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353373|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353374|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
44353375|NCT01094964|Interferons|interferons|mesh-list
44353376|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
44353377|NCT01094964|Epirubicin|epirubicin|mesh-list
44353378|NCT01094964|Mitomycins|mitomycins|mesh-list
44353379|NCT01094964|Mitomycin|mitomycin|mesh-list
44353380|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353381|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
44353382|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353383|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
44353384|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353385|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44353386|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44353387|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852567|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852568|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
43852569|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43852570|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
43852571|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
43852572|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852573|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852574|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852575|NCT03826693|Analgesics|analgesics|mesh-ancestor
43852576|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
44353388|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353389|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353390|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
44353391|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44353392|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
44353393|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44353394|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44353395|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353396|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
44353397|NCT01094977|Coagulants|coagulants|mesh-ancestor
44353398|NCT01094990|Dexamethasone|dexamethasone|mesh-list
44353399|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353400|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
44353401|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
44353402|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353403|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353404|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353405|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
44353407|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353408|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44353409|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353410|NCT01095016|Fenoterol|fenoterol|mesh-list
44353411|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44353412|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
44353413|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353414|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353415|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44353416|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
44353417|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
44353418|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
44353419|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353420|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44353430|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44353431|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44353432|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353433|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353434|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44353435|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44353436|NCT01095172|Prednisolone|prednisolone|mesh-list
44353437|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44353438|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
44353439|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44353440|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
44353441|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
44353442|NCT01095172|Rituximab|rituximab|mesh-list
44353443|NCT01095172|Tacrolimus|tacrolimus|mesh-list
44353444|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44353445|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
44353446|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44353447|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353448|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
44353449|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353450|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353451|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353452|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44353453|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353454|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852577|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852578|NCT03826628|Sirolimus|sirolimus|mesh-list
43852579|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43852580|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852581|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852582|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852583|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
43852584|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852585|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
43852586|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852592|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852593|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
43852594|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852595|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852596|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
43852597|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852598|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852599|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852600|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852601|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852602|NCT03825757|Aspirin|aspirin|mesh-list
44353455|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353456|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
44353458|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353459|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44353460|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
44353461|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
44353462|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353463|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353464|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44353465|NCT01095172|Protective Agents|protective agents|mesh-ancestor
44353466|NCT01095185|Simvastatin|simvastatin|mesh-list
44353467|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44353468|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44353469|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
44353470|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353471|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44353472|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44353473|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353474|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
44353475|NCT01095211|Vitamins|vitamins|mesh-ancestor
44353476|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
44353477|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353478|NCT01095302|Cisplatin|cisplatin|mesh-list
44353479|NCT01095302|Docetaxel|docetaxel|mesh-list
44353480|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353481|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44353482|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44353483|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44353484|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353485|NCT01095445|Ribavirin|ribavirin|mesh-list
44353486|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44353487|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
44353497|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353498|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353499|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353501|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44353502|NCT01095575|Narcotics|narcotics|mesh-ancestor
44353503|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353504|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353505|NCT01095575|Analgesics|analgesics|mesh-ancestor
44353506|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
44353507|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353508|NCT01095640|Adapalene|adapalene|mesh-list
44353509|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44353510|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44353511|NCT01095640|Analgesics|analgesics|mesh-ancestor
44353512|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
44353513|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353514|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353515|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353516|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353517|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44353518|NCT01095679|Baclofen|baclofen|mesh-list
44353519|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44353520|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353521|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44353522|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353523|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44353524|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
44353525|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
44353526|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353527|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353541|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353542|NCT01095809|Triamcinolone|triamcinolone|mesh-list
44353543|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44353544|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44353545|NCT01095809|Bevacizumab|bevacizumab|mesh-list
44353546|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44353547|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44353548|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353549|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44353550|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44353551|NCT01095809|Growth Substances|growth substances|mesh-ancestor
44353552|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353553|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
44353554|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43574456|NCT03516630|Trazodone|trazodone|mesh-list
43852603|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
43852604|NCT03825757|Salicylates|salicylates|mesh-list
43852605|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852606|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
43852607|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
43852608|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852609|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43852610|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852611|NCT03825757|Analgesics|analgesics|mesh-ancestor
43852612|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
43852613|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852614|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852615|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852616|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852617|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43852618|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852619|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852620|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43852621|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43852622|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43852623|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
43852624|NCT03825198|Dexamethasone|dexamethasone|mesh-list
43852625|NCT03825198|Ketorolac|ketorolac|mesh-list
43852626|NCT03825198|Sufentanil|sufentanil|mesh-list
43852627|NCT03825198|Morphine|morphine|mesh-list
43852628|NCT03825198|Bromides|bromides|mesh-list
43852629|NCT03825198|Propofol|propofol|mesh-list
43852630|NCT03825198|Sevoflurane|sevoflurane|mesh-list
43852631|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
43852632|NCT03825198|Rocuronium|rocuronium|mesh-list
43852633|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852634|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
43852635|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
43852636|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852637|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852638|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43852639|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
43852640|NCT03825198|Hormones|hormones|mesh-ancestor
43852641|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852642|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852643|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852644|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43852645|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852646|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43852647|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
43852648|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
43852649|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43852650|NCT03825198|Narcotics|narcotics|mesh-ancestor
44353555|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
44353556|NCT01095809|Hormones|hormones|mesh-ancestor
44353557|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353558|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353559|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
44353560|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353561|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353562|NCT01095822|Valsartan|valsartan|mesh-list
44353563|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44353564|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44353565|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44353566|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353567|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44353568|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44353569|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
44353570|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353571|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
44353572|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44353573|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353574|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353575|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353576|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353577|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353578|NCT01095926|Doxorubicin|doxorubicin|mesh-list
44353579|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44353580|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353581|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852651|NCT03825198|Analgesics|analgesics|mesh-ancestor
43852652|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
43852653|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852654|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43852655|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43852656|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43852657|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852658|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43852659|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852660|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852665|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43852667|NCT03824938|Aspirin|aspirin|mesh-list
43852668|NCT03824938|Acetaminophen|acetaminophen|mesh-list
43852669|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43852670|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852671|NCT03824938|Analgesics|analgesics|mesh-ancestor
43852672|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
44353582|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44353583|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649079|NCT03031808|Lidocaine|lidocaine|mesh-list
44353584|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353585|NCT01095939|Benazepril|benazepril|mesh-list
44353586|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44353587|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
44353588|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353589|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353590|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44353591|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44353592|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44353593|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353594|NCT01095991|Incretins|incretins|mesh-ancestor
44353595|NCT01095991|Hormones|hormones|mesh-ancestor
44353596|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353597|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44353598|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
44353599|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353600|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353601|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
44353633|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353634|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44353635|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44353636|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353638|NCT01096277|Hormones|hormones|mesh-ancestor
44353639|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353640|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44353641|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44353642|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353643|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353644|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
44353645|NCT01096329|Testosterone|testosterone|mesh-list
44353646|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
44353647|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
44353648|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44353649|NCT01096329|Androgens|androgens|mesh-ancestor
44353650|NCT01096329|Hormones|hormones|mesh-ancestor
44353651|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44353652|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353653|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44353654|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353655|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
44353656|NCT01096355|R04929097|r04929097|mesh-list
44353657|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353658|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353659|NCT01096420|Topiramate|topiramate|mesh-list
44353660|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
44353661|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44353662|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353663|NCT01096472|Octenidine|octenidine|mesh-list
43852673|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852674|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852675|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852676|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852677|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43852678|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43852679|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852680|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43852681|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43852682|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852683|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
43852684|NCT03824483|Venetoclax|venetoclax|mesh-list
44353665|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44353666|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
44353667|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44353668|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
44353669|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353670|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353671|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44353672|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44353673|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44353674|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
44353675|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43814614|NCT04792749|Metformin|metformin|mesh-list
44353676|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
44353677|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353678|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353679|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43852685|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
43852686|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
43852687|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852688|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852689|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852690|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852691|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852692|NCT03824106|Vitamin D|vitamin d|mesh-list
43852693|NCT03824106|Vitamins|vitamins|mesh-ancestor
43852694|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
43852695|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852696|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43852697|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
43852698|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852699|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852700|NCT03821792|Prednisone|prednisone|mesh-list
43852701|NCT03821792|Cortisone|cortisone|mesh-list
43852702|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
43852703|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852704|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
43852705|NCT03821792|Hormones|hormones|mesh-ancestor
43852706|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852707|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852708|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852709|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852710|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43852711|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852712|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852713|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
43852714|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43852715|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
43852716|NCT03820986|Lenvatinib|lenvatinib|mesh-list
43852717|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852718|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852719|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852720|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852721|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852722|NCT03820726|Nintedanib|nintedanib|mesh-list
43852723|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852724|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44353680|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44353681|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44353682|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
44353683|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44353684|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353685|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353686|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44353687|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44353688|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353689|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353690|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353691|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44353692|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
44353693|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44353694|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353695|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44353696|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44353697|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44353698|NCT01096654|Epinephrine|epinephrine|mesh-list
44353699|NCT01096654|Racepinephrine|racepinephrine|mesh-list
44353700|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
44353701|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44353702|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44353703|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44353704|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353705|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353706|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353707|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44353708|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44353709|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
44353710|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353711|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44353713|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
44353719|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353720|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353721|NCT01096706|Aspirin|aspirin|mesh-list
44353722|NCT01096706|Fluconazole|fluconazole|mesh-list
44353723|NCT01096706|Substance P|substance p|mesh-list
44353724|NCT01096706|Neurokinin A|neurokinin a|mesh-list
44353725|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44353726|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44353727|NCT01096706|Analgesics|analgesics|mesh-ancestor
44353728|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
44353729|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353730|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353731|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353732|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353733|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44353734|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44353735|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353736|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44353737|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44353738|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353740|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
44353741|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353742|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44353743|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44353744|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44353745|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
44353747|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44353766|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
44353767|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353768|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353769|NCT01096927|Amoxicillin|amoxicillin|mesh-list
44353770|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
44353771|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
44353772|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353773|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353774|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353775|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353776|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44353777|NCT01096940|Simvastatin|simvastatin|mesh-list
44353778|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44353779|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44353780|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
44353781|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353782|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44353783|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44353784|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353785|NCT01097148|Atracurium|atracurium|mesh-list
44353786|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44353787|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44353788|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44353789|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353790|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353791|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44353792|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44353811|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44353812|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353813|NCT01097278|Vitamins|vitamins|mesh-ancestor
44353814|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
44353815|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44353816|NCT01097317|Carboplatin|carboplatin|mesh-list
44353817|NCT01097317|Vinorelbine|vinorelbine|mesh-list
44353818|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353819|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44353820|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
44353821|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
44353822|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
44353823|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353824|NCT01097382|Zolpidem|zolpidem|mesh-list
43852725|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852726|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852727|NCT03820141|Trastuzumab|trastuzumab|mesh-list
43852728|NCT03820141|Durvalumab|durvalumab|mesh-list
43852729|NCT03820141|Pertuzumab|pertuzumab|mesh-list
43852730|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852731|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852732|NCT03819530|Micronutrients|micronutrients|mesh-list
43852733|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852735|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43852736|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852737|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43852738|NCT03818191|Acamprosate|acamprosate|mesh-list
43852739|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43852740|NCT03817320|Leucovorin|leucovorin|mesh-list
43852741|NCT03817320|Cytarabine|cytarabine|mesh-list
43852742|NCT03817320|Dexamethasone|dexamethasone|mesh-list
43852743|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
43852744|NCT03817320|Doxorubicin|doxorubicin|mesh-list
43852745|NCT03817320|Methotrexate|methotrexate|mesh-list
43852746|NCT03817320|Vincristine|vincristine|mesh-list
43852747|NCT03817320|Asparaginase|asparaginase|mesh-list
43852748|NCT03817320|Ixazomib|ixazomib|mesh-list
43852749|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852750|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
43852751|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
43852752|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852753|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852754|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43852755|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
43852756|NCT03817320|Hormones|hormones|mesh-ancestor
43852757|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852758|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852759|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852760|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852761|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852762|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852763|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852764|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852765|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43852766|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
43852767|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852768|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852769|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
43852770|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
43852771|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852772|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852773|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
43852774|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353825|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44353826|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44353827|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353828|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353829|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44353830|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
44353831|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
44353832|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353833|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353834|NCT01097512|Gemcitabine|gemcitabine|mesh-list
44353835|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353836|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
44353837|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353838|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353839|NCT01097512|Antiviral Agents|antiviral agents|mesh-ancestor
44353840|NCT01097512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353841|NCT01097512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353842|NCT01097512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353843|NCT01097512|Immunologic Factors|immunologic factors|mesh-ancestor
44353844|NCT01097512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353845|NCT01097551|Phenylephrine|phenylephrine|mesh-list
44353846|NCT01097551|Acetylcholine|acetylcholine|mesh-list
44353847|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
44353848|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
44353849|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44353850|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353851|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353852|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353853|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353854|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44353855|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
44353868|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44353869|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353871|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353872|NCT01097811|Erythromycin|erythromycin|mesh-list
44353873|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
44353874|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44353875|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
44353876|NCT01097811|Neomycin|neomycin|mesh-list
44353877|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44353878|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353879|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353880|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44353881|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353882|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353883|NCT01097902|Ibuprofen|ibuprofen|mesh-list
44353884|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44353885|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44353886|NCT01097902|Analgesics|analgesics|mesh-ancestor
44353887|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
44353888|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353889|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353890|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44353891|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852775|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852776|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
43852777|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852778|NCT03817320|Antidotes|antidotes|mesh-ancestor
43852779|NCT03817320|Protective Agents|protective agents|mesh-ancestor
43852780|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
43852781|NCT03817320|Vitamins|vitamins|mesh-ancestor
43852782|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
43852783|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852784|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852785|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852786|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852787|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
43852788|NCT03814954|Epinephrine|epinephrine|mesh-list
43852789|NCT03814954|Albuterol|albuterol|mesh-list
43852790|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43852791|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43852792|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
43852793|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852794|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852795|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852796|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43852797|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43852798|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
43852799|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852800|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44353892|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44353893|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353894|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353895|NCT01097941|Vaccines|vaccines|mesh-list
44353896|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
44353897|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353898|NCT01097980|Trazodone|trazodone|mesh-list
44353899|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44353900|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44353901|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44353902|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353903|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44353904|NCT01097980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44353905|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44353906|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43852801|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
43852802|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
43852803|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
43852804|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43852805|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
43852806|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43852807|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43852808|NCT03814941|Anesthetics|anesthetics|mesh-list
43852809|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852810|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852811|NCT03814109|Niacin|niacin|mesh-list
43852816|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852817|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43852818|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43852819|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852820|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43852821|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
43852822|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43852823|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
43852824|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
43852825|NCT03814109|Vitamins|vitamins|mesh-ancestor
43852826|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
43852827|NCT03813160|Dronabinol|dronabinol|mesh-list
43852828|NCT03813160|Lenabasum|lenabasum|mesh-list
43852829|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43852830|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43852831|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852832|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852833|NCT03813160|Hormones|hormones|mesh-ancestor
43852834|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852835|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852836|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
43852837|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43852838|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852839|NCT03813160|Analgesics|analgesics|mesh-ancestor
43852840|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
43852841|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852842|NCT03807856|Dabigatran|dabigatran|mesh-list
43852843|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
43852844|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43852845|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
43852846|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852847|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852848|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
44353907|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353908|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353909|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
44353910|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44353911|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
44353912|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
44353913|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44353914|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44353915|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44353916|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44353917|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353918|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353919|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353920|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353921|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44353922|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44353923|NCT01098084|Decitabine|decitabine|mesh-list
44353924|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353925|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
44353926|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353927|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353928|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353929|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
44353930|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44353931|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
44353932|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353933|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44353934|NCT01098344|Gemcitabine|gemcitabine|mesh-list
44353935|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44353936|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
44353937|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353938|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44353939|NCT01098344|Antiviral Agents|antiviral agents|mesh-ancestor
44353946|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
44353947|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44353948|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44353949|NCT01098357|Growth Substances|growth substances|mesh-ancestor
44353950|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353951|NCT01098383|Acetylcholine|acetylcholine|mesh-list
44353952|NCT01098383|Donepezil|donepezil|mesh-list
44353953|NCT01098383|Choline|choline|mesh-list
44353954|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008954|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
44353955|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353956|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353957|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
44353958|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44353959|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44353960|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
44353961|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
44353962|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44353963|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
44353964|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44353965|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44353966|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
44353967|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44009037|NCT02931045|Clopidogrel|clopidogrel|mesh-list
44353968|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44353969|NCT01098448|Amoxicillin|amoxicillin|mesh-list
44353970|NCT01098448|Metronidazole|metronidazole|mesh-list
44353971|NCT01098448|Tetracycline|tetracycline|mesh-list
44353972|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353973|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44353974|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44353991|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44353992|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44353993|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
44353994|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44353995|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44353996|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44353997|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44353998|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44353999|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44354000|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44354001|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44354002|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44354003|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44354004|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44354005|NCT01098656|Lenalidomide|lenalidomide|mesh-list
44354006|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
44354007|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354008|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44354009|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44354010|NCT01098656|Growth Substances|growth substances|mesh-ancestor
44354011|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
44354012|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354013|NCT01098760|Sorafenib|sorafenib|mesh-list
44354014|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354015|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44354016|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354038|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354039|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354040|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
44354041|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354042|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44354043|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44354044|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
44354045|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354046|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354047|NCT01099059|Analgesics|analgesics|mesh-ancestor
44354048|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
44354049|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354050|NCT01099072|Methylphenidate|methylphenidate|mesh-list
44354051|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44354052|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354053|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44354054|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44354055|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354056|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354057|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
44354058|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354059|NCT01099085|Simvastatin|simvastatin|mesh-list
43852849|NCT03807479|Ponatinib|ponatinib|mesh-list
43852850|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852851|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852852|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852853|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852854|NCT03807037|Tocotrienols|tocotrienols|mesh-list
43852855|NCT03807037|Vitamin E|vitamin e|mesh-list
43852856|NCT03807037|Tocopherols|tocopherols|mesh-list
43852857|NCT03807037|Tocovid|tocovid|mesh-list
43852858|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
43852859|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852860|NCT03807037|Protective Agents|protective agents|mesh-ancestor
43852861|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852862|NCT03807037|Vitamins|vitamins|mesh-ancestor
43852863|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
43852864|NCT03806530|Gabapentin|gabapentin|mesh-list
43852865|NCT03806530|Ropinirole|ropinirole|mesh-list
43852866|NCT03806530|Analgesics|analgesics|mesh-ancestor
43852867|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
43852868|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852869|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852870|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
43852871|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43852872|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43852873|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43852874|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43852875|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43852876|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43852877|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852878|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354061|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354062|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
44354063|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354064|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354065|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44354066|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354067|NCT01099137|Vildagliptin|vildagliptin|mesh-list
44354068|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354069|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354070|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44354071|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
43852879|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
43852880|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43852881|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43852882|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
43852883|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
43852884|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
43852885|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43852893|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43852894|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852896|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
43852897|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852898|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852899|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852900|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43852901|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43852902|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852903|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852904|NCT03805399|Sirolimus|sirolimus|mesh-list
43852905|NCT03805399|Paclitaxel|paclitaxel|mesh-list
43852906|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43852907|NCT03805399|Capecitabine|capecitabine|mesh-list
43852908|NCT03805399|Everolimus|everolimus|mesh-list
43852909|NCT03805399|Apatinib|apatinib|mesh-list
43852910|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43852911|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852912|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852913|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
43852914|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
43852915|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
43852916|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852917|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852918|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
43852919|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43852920|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
43852921|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852922|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852923|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43852924|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43852925|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43852926|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852927|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
44133156|NCT00152945|Protective Agents|protective agents|mesh-ancestor
44133157|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133158|NCT00152958|Pramipexole|pramipexole|mesh-list
44133159|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
44133160|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133161|NCT00152958|Protective Agents|protective agents|mesh-ancestor
44133162|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133163|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44354073|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354074|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
44354075|NCT01099150|Procyanidin|procyanidin|mesh-list
44354076|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
44354077|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354078|NCT01099150|Protective Agents|protective agents|mesh-ancestor
44354079|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354080|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44354081|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44354082|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354083|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44354084|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354085|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354086|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354087|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44354088|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
44354089|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
44354090|NCT01099436|Docetaxel|docetaxel|mesh-list
44354091|NCT01099436|Doxorubicin|doxorubicin|mesh-list
44354092|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44354093|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44354094|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
44354095|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354096|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354097|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44354098|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
44354099|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354100|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354101|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44354102|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44354103|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
43758525|NCT02454556|Hormones|hormones|mesh-ancestor
44133164|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44133165|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
44133166|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
44133167|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133168|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
44133169|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44133170|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
44133171|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133172|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354104|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44354105|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44354106|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44354107|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44354108|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354109|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354110|NCT01099462|Ibuprofen|ibuprofen|mesh-list
44354111|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44354112|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354113|NCT01099462|Analgesics|analgesics|mesh-ancestor
44354114|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
44354115|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354116|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354117|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44354118|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354119|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44354120|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354121|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354122|NCT01099527|Capecitabine|capecitabine|mesh-list
44354123|NCT01099527|Everolimus|everolimus|mesh-list
44354124|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44354125|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
43758554|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
44133173|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44133174|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
44133175|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
44133176|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44133177|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44133178|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133179|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133180|NCT00152997|Pramipexole|pramipexole|mesh-list
44133181|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
44133184|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133185|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44133186|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44133187|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
44133188|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
44133189|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133190|NCT00153023|Valsartan|valsartan|mesh-list
44133191|NCT00153023|Telmisartan|telmisartan|mesh-list
44133192|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133193|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133194|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43852928|NCT03805022|Doxorubicin|doxorubicin|mesh-list
43852929|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43852931|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
43852932|NCT03805022|Dacarbazine|dacarbazine|mesh-list
43852933|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43852934|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852935|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43852936|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43852937|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354126|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354127|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354128|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44354129|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
44354130|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354131|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44354132|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44354133|NCT01099592|Citalopram|citalopram|mesh-list
44354134|NCT01099592|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44354135|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44354136|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354137|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354138|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354139|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
44354140|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354141|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44354142|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
44354143|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44354144|NCT01099605|Bupivacaine|bupivacaine|mesh-list
44354145|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
44354146|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
43852938|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852939|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43852940|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
43852941|NCT03802799|Cannabidiol|cannabidiol|mesh-list
43852942|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
43852943|NCT03802604|Atezolizumab|atezolizumab|mesh-list
43852944|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43852945|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852946|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852947|NCT03802591|Capecitabine|capecitabine|mesh-list
43852948|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
43852949|NCT03802591|Antibodies|antibodies|mesh-list
43852950|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43852951|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
43852952|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852953|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852954|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
43852955|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852956|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852957|NCT03802240|Cisplatin|cisplatin|mesh-list
43852958|NCT03802240|Pemetrexed|pemetrexed|mesh-list
43852959|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852960|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852961|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852962|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43852963|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43852964|NCT03801369|Durvalumab|durvalumab|mesh-list
43852965|NCT03801369|Olaparib|olaparib|mesh-list
43852966|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43852967|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
43852968|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44354147|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354148|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354149|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
44354150|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354151|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44354152|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44354153|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
44354155|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44354156|NCT01099748|Narcotics|narcotics|mesh-ancestor
44354157|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354158|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354159|NCT01099748|Analgesics|analgesics|mesh-ancestor
44354160|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
44354161|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354162|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
44354163|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44354164|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
44354165|NCT01099839|Miglitol|miglitol|mesh-list
44354166|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44354167|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354168|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354169|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852969|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
43852970|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852971|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852972|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
43852973|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852974|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852975|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852976|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
43852977|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
43852978|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852979|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
43852980|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43852981|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852982|NCT03798678|Dexamethasone|dexamethasone|mesh-list
43852983|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
43852984|NCT03798678|Ichthammol|ichthammol|mesh-list
43852985|NCT03798678|BB 1101|bb 1101|mesh-list
43852986|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852987|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
43852988|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
43852989|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852993|NCT03798678|Hormones|hormones|mesh-ancestor
43852994|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852995|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43852996|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852997|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
43852998|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354170|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354171|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44354172|NCT01100021|Doxazosin|doxazosin|mesh-list
44354173|NCT01100021|Tamsulosin|tamsulosin|mesh-list
44354174|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44354175|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44354176|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44354177|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
44354178|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354179|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354180|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354181|NCT01100021|Urological Agents|urological agents|mesh-ancestor
44354182|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354183|NCT01100060|Azithromycin|azithromycin|mesh-list
44354184|NCT01100060|Chloroquine|chloroquine|mesh-list
44354185|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44354186|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354187|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354188|NCT01100060|Amebicides|amebicides|mesh-ancestor
44354189|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44354190|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44354191|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
44354192|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354193|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44354194|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354195|NCT01100060|Analgesics|analgesics|mesh-ancestor
44354196|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
44354197|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354198|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354199|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44354200|NCT01100060|Filaricides|filaricides|mesh-ancestor
44354201|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
44354202|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
44354203|NCT01100125|Insulin|insulin|mesh-list
44354204|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44354205|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44354206|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
44354207|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354208|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354209|NCT01100125|Incretins|incretins|mesh-ancestor
44354210|NCT01100125|Hormones|hormones|mesh-ancestor
44354211|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354212|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44354213|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354214|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354215|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354216|NCT01100164|Eszopiclone|eszopiclone|mesh-list
44354217|NCT01100164|Zopiclone|zopiclone|mesh-list
44354218|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44354219|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354220|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354221|NCT01100177|Sunitinib|sunitinib|mesh-list
44354222|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354223|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44354224|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44354225|NCT01100177|Growth Substances|growth substances|mesh-ancestor
44354226|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354227|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44354228|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44354229|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354230|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354231|NCT01100203|Eplerenone|eplerenone|mesh-list
44354232|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44354233|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354234|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354235|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354236|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44354237|NCT01100203|Diuretics|diuretics|mesh-ancestor
44354238|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
44354251|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
44354252|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354253|NCT01100333|Hormones|hormones|mesh-list
44354254|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44354255|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354256|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354257|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44354258|NCT01100346|Hormones|hormones|mesh-ancestor
44354259|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354260|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354261|NCT01100359|Carboplatin|carboplatin|mesh-list
44354262|NCT01100359|Doxorubicin|doxorubicin|mesh-list
44354263|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44354264|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354265|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44354266|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44354267|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44354268|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354269|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354270|NCT01100372|Gemcitabine|gemcitabine|mesh-list
44354271|NCT01100372|Doxorubicin|doxorubicin|mesh-list
44354272|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44354273|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44354274|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
43852999|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853000|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853001|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
43853002|NCT03797326|Lenvatinib|lenvatinib|mesh-list
43853003|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853004|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853005|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43853006|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853007|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853008|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43853009|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853011|NCT03794037|Progesterone|progesterone|mesh-list
43853012|NCT03794037|Progestins|progestins|mesh-ancestor
43853014|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853015|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853016|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43853017|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
43853018|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43853019|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354275|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354276|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354278|NCT01100372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354279|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354280|NCT01100372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44354281|NCT01100372|Immunologic Factors|immunologic factors|mesh-ancestor
44354282|NCT01100372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354283|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44354284|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44354285|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44354286|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
44354287|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354288|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354289|NCT01100736|Bosentan|bosentan|mesh-list
44354290|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
44354291|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354292|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44354293|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354294|NCT01100801|Cisplatin|cisplatin|mesh-list
44354295|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
44354296|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354297|NCT01101009|Amlodipine|amlodipine|mesh-list
44354298|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44354299|NCT01101009|Olmesartan|olmesartan|mesh-list
44354300|NCT01101009|Perindopril|perindopril|mesh-list
44354301|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354302|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44354303|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354304|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009373|NCT02953886|Fluorides|fluorides|mesh-list
44354305|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354306|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354307|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
44354308|NCT01101009|Diuretics|diuretics|mesh-ancestor
44354309|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
44354313|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44354314|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354315|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354316|NCT01101113|Cinacalcet|cinacalcet|mesh-list
44354317|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354318|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354319|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44354320|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354321|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354322|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44354323|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44354324|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44354325|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354326|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354327|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354328|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354329|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
44354330|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44354331|NCT01101204|Metformin|metformin|mesh-list
44354332|NCT01101204|Simvastatin|simvastatin|mesh-list
44354333|NCT01101204|Fenofibrate|fenofibrate|mesh-list
44354334|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354335|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354336|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44354337|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354338|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
44354339|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354340|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354341|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44354342|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354343|NCT01101269|Lisinopril|lisinopril|mesh-list
44354344|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44354345|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354349|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44354350|NCT01101269|Protective Agents|protective agents|mesh-ancestor
44354351|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354352|NCT01101386|Voriconazole|voriconazole|mesh-list
44354353|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
44354354|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354355|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44354356|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44354357|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354358|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354359|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44354360|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354361|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354362|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354363|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44354364|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
44354365|NCT01101412|Ethanol|ethanol|mesh-list
44354366|NCT01101412|Trimethoprim|trimethoprim|mesh-list
44354367|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
44354368|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44354369|NCT01101412|Edetic Acid|edetic acid|mesh-list
44354370|NCT01101412|Calcium|calcium|mesh-list
44354371|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
44354372|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354373|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354374|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354375|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354376|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354377|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354378|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44354379|NCT01101412|Renal Agents|renal agents|mesh-ancestor
44354380|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
44354381|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44354382|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44354383|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43758707|NCT02453503|Hormones|hormones|mesh-ancestor
43853020|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44354384|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354385|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354386|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44354387|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44354388|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44354389|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354390|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
44354391|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44354392|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
44354393|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
44354394|NCT01101412|Antidotes|antidotes|mesh-ancestor
44354395|NCT01101412|Protective Agents|protective agents|mesh-ancestor
44354396|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44354397|NCT01101529|Aprepitant|aprepitant|mesh-list
44354398|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
44354399|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
44354400|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354401|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354402|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43853021|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43853022|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853023|NCT03792763|Denosumab|denosumab|mesh-list
43853024|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43853025|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43853026|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853027|NCT03791736|Octreotide|octreotide|mesh-list
43853028|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43853029|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853030|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853031|NCT03791593|Evolocumab|evolocumab|mesh-list
43853032|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43853033|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43853034|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
43853035|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853036|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43853037|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43853038|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853039|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853040|NCT03790137|Fenfluramine|fenfluramine|mesh-list
43853041|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43853042|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43853043|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43853044|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853045|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853046|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
43853047|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853048|NCT03789214|Suvorexant|suvorexant|mesh-list
43853049|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43853050|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43853051|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853052|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853053|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43853054|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853055|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354403|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44354404|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354405|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354406|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44354407|NCT01101568|Simvastatin|simvastatin|mesh-list
44354408|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44354409|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354410|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
44354411|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354412|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354413|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44354414|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354415|NCT01101581|Epratuzumab|epratuzumab|mesh-list
44354416|NCT01101581|Veltuzumab|veltuzumab|mesh-list
44354417|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44354418|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44354419|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354420|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
44354421|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
44354422|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354423|NCT01101620|Simendan|simendan|mesh-list
44354424|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44354425|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
44354426|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44354427|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44354428|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354429|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354430|NCT01101620|Protective Agents|protective agents|mesh-ancestor
44354431|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354432|NCT01101646|Rabeprazole|rabeprazole|mesh-list
44354443|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44354444|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44354445|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
44354446|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
44354447|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354448|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44009525|NCT02959840|Ondansetron|ondansetron|mesh-list
44354449|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44354450|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354451|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354452|NCT01101685|Citalopram|citalopram|mesh-list
44354453|NCT01101685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44354454|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44354455|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354456|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354457|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354463|NCT01101698|Vitamin D|vitamin d|mesh-list
44354499|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354500|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354501|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354502|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354503|NCT01101815|Naltrexone|naltrexone|mesh-list
44354504|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44354505|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44354506|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354507|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
44354508|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354509|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
44354510|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44354511|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44354512|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
44354513|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354514|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44354515|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44354516|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354517|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354518|NCT01101919|Tofacitinib|tofacitinib|mesh-list
44354519|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44354520|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354521|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009595|NCT02965924|Protective Agents|protective agents|mesh-ancestor
44354522|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44354523|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44354524|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
44354525|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44354526|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
44354527|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354528|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
44354529|NCT01101984|Protective Agents|protective agents|mesh-ancestor
44354541|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44354542|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44354543|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354544|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354546|NCT01102244|Hormones|hormones|mesh-ancestor
44354547|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354548|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354549|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44354550|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44354551|NCT01102335|Telbivudine|telbivudine|mesh-list
44354552|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
44354553|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354554|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44354555|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354556|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354557|NCT01102387|Octenidine|octenidine|mesh-list
44354558|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354559|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354560|NCT01102439|Aspirin|aspirin|mesh-list
44354561|NCT01102439|Clopidogrel|clopidogrel|mesh-list
44354562|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44354563|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354564|NCT01102439|Analgesics|analgesics|mesh-ancestor
44354565|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
44354566|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354567|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354568|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44354569|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354570|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44354571|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44354573|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44354581|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354582|NCT01102465|Losartan|losartan|mesh-list
44354583|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44354584|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44354585|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354586|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44354587|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44354588|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354589|NCT01102465|Diuretics|diuretics|mesh-ancestor
44354590|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
44354591|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354592|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44354593|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354594|NCT01102478|Losartan|losartan|mesh-list
44354595|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44354596|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44354597|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354598|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44354599|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44354600|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354601|NCT01102478|Diuretics|diuretics|mesh-ancestor
44354602|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
44354603|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354604|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44354605|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354625|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354626|NCT01102686|Leucovorin|leucovorin|mesh-list
44354627|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
44354628|NCT01102686|Antidotes|antidotes|mesh-ancestor
44354629|NCT01102686|Protective Agents|protective agents|mesh-ancestor
44354630|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354631|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
44354632|NCT01102686|Vitamins|vitamins|mesh-ancestor
44354633|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
44354634|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
44354635|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44354636|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44354637|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354638|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44354639|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354640|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354641|NCT01102699|Lenograstim|lenograstim|mesh-list
44354642|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44354643|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
44354644|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354645|NCT01102946|Ranibizumab|ranibizumab|mesh-list
44354646|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44354647|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44354648|NCT01102946|Growth Substances|growth substances|mesh-ancestor
44354649|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354650|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
44354651|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354652|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44354653|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
44354654|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354655|NCT01103050|Cetirizine|cetirizine|mesh-list
44354656|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44354657|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44354658|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44354659|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
44354660|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
44354666|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
44354667|NCT01103115|Calcium|calcium|mesh-list
44354668|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354669|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354670|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354671|NCT01103115|Vitamins|vitamins|mesh-ancestor
44354672|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
44354673|NCT01103115|Antacids|antacids|mesh-ancestor
44354674|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354675|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44354676|NCT01103154|Nadolol|nadolol|mesh-list
44354677|NCT01103154|Carvedilol|carvedilol|mesh-list
44354678|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44354679|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44354680|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
44354681|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354682|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354683|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354684|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354685|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
44354686|NCT01103154|Protective Agents|protective agents|mesh-ancestor
44354687|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44354688|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44354689|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354690|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
43853056|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
43853057|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
43853058|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853059|NCT03788759|Protective Agents|protective agents|mesh-ancestor
43853060|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853061|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853063|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
43853064|NCT03787602|Avelumab|avelumab|mesh-list
43853065|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853066|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853067|NCT03786783|Vitamin A|vitamin a|mesh-list
43853068|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
43853069|NCT03786783|Melphalan|melphalan|mesh-list
43853070|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
43853071|NCT03786783|Thiotepa|thiotepa|mesh-list
43853072|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43853073|NCT03786783|Cisplatin|cisplatin|mesh-list
43853074|NCT03786783|Carboplatin|carboplatin|mesh-list
43853075|NCT03786783|Doxorubicin|doxorubicin|mesh-list
43853076|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43853077|NCT03786783|Etoposide|etoposide|mesh-list
43853078|NCT03786783|Vincristine|vincristine|mesh-list
43853079|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
43853080|NCT03786783|Daunorubicin|daunorubicin|mesh-list
43853081|NCT03786783|Topotecan|topotecan|mesh-list
43853082|NCT03786783|Tretinoin|tretinoin|mesh-list
43853083|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
44354691|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44354692|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44354693|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44354695|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
44354696|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354697|NCT01103193|Remifentanil|remifentanil|mesh-list
44354698|NCT01103193|Sevoflurane|sevoflurane|mesh-list
44354699|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44354700|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44354701|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
44354702|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
44354703|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44354704|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354705|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44354706|NCT01103193|Narcotics|narcotics|mesh-ancestor
44354707|NCT01103193|Analgesics|analgesics|mesh-ancestor
43853084|NCT03786783|Dinutuximab|dinutuximab|mesh-list
43853085|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
43853086|NCT03786783|Razoxane|razoxane|mesh-list
43853087|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
43853088|NCT03786783|Isotretinoin|isotretinoin|mesh-list
43853089|NCT03786783|Sargramostim|sargramostim|mesh-list
43853090|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853091|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
43853092|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853093|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853094|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853095|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
43853096|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853097|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853098|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853099|NCT03786783|Vitamins|vitamins|mesh-ancestor
43853100|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
43853101|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853102|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43853103|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853104|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853105|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853106|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853107|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853108|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853109|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43853110|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
43853111|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853112|NCT03786783|Protective Agents|protective agents|mesh-ancestor
43853113|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43853114|NCT03783715|Ketoprofen|ketoprofen|mesh-list
43853115|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43853116|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43853117|NCT03783715|Analgesics|analgesics|mesh-ancestor
43853118|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
43853119|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853120|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853121|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853122|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853123|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43853124|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853125|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354709|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354710|NCT01103206|Cinacalcet|cinacalcet|mesh-list
44354711|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44354712|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354713|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44354714|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354715|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354716|NCT01103336|Nicorandil|nicorandil|mesh-list
44354717|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44354718|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44354719|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
44354720|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
44354721|NCT01103336|Vitamins|vitamins|mesh-ancestor
44354722|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
44354723|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354724|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44354725|NCT01103375|Isotretinoin|isotretinoin|mesh-list
44354726|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354727|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44354728|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354729|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354730|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
44354731|NCT01103388|Rituximab|rituximab|mesh-list
44354732|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44354733|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354734|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
44354735|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354736|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354737|NCT01103401|Tobramycin|tobramycin|mesh-list
44354738|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
44354739|NCT01103401|Dexamethasone|dexamethasone|mesh-list
44354740|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
44354741|NCT01103401|Ketorolac|ketorolac|mesh-list
44354742|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44354743|NCT01103401|BB 1101|bb 1101|mesh-list
44354744|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853126|NCT03782415|Temozolomide|temozolomide|mesh-list
43853127|NCT03782415|Ibudilast|ibudilast|mesh-list
43853128|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44354745|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
44354746|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
44354747|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354748|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354749|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44354750|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
44354751|NCT01103401|Hormones|hormones|mesh-ancestor
44354752|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354753|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44354754|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354755|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354756|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354757|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354758|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44354759|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354760|NCT01103401|Analgesics|analgesics|mesh-ancestor
44354761|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
44354762|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44354763|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44354764|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44354765|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354766|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44354767|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44354768|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
44354769|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44354770|NCT01103518|Estradiol|estradiol|mesh-list
44354771|NCT01103518|Cyproterone|cyproterone|mesh-list
44354772|NCT01103518|Estrogens|estrogens|mesh-ancestor
44354773|NCT01103518|Hormones|hormones|mesh-ancestor
44354774|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354775|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354776|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44354777|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
44354778|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44354779|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44354780|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44354783|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
44354784|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354785|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44354786|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
44354787|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354788|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
44354789|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354790|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354791|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44354792|NCT01103609|Warfarin|warfarin|mesh-list
44354793|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
44354794|NCT01103622|Digoxin|digoxin|mesh-list
44354795|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44354796|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44354797|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354798|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354799|NCT01103622|Protective Agents|protective agents|mesh-ancestor
44354800|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354801|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44354802|NCT01103635|Ipilimumab|ipilimumab|mesh-list
44354803|NCT01103635|Tremelimumab|tremelimumab|mesh-list
44354804|NCT01103635|Antibodies|antibodies|mesh-list
44354805|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
44354806|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44354807|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
44354808|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354809|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354810|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43759133|NCT02450968|Hormones|hormones|mesh-ancestor
43853129|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
43853130|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853131|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853132|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43853133|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
43853134|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853135|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853136|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43853137|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
43853140|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43853141|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
43853142|NCT03781388|Bupivacaine|bupivacaine|mesh-list
43853143|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
43853144|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
43853145|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853146|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853147|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
43853148|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354811|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354812|NCT01103648|Simvastatin|simvastatin|mesh-list
44354813|NCT01103648|Ezetimibe|ezetimibe|mesh-list
44354814|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
44354815|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44354816|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44354817|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
44354818|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354819|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354820|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354821|NCT01103739|Simvastatin|simvastatin|mesh-list
44354822|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44354823|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354824|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
44354825|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354826|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354827|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44354828|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354829|NCT01103791|Docetaxel|docetaxel|mesh-list
44354830|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354831|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
44354832|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44354833|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44009901|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44354834|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354836|NCT01103817|Vitamins|vitamins|mesh-ancestor
44354837|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
44354838|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354839|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354840|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
44354841|NCT01103830|Lumefantrine|lumefantrine|mesh-list
44354842|NCT01103830|Artemether|artemether|mesh-list
44354843|NCT01103830|Piperaquine|piperaquine|mesh-list
44354852|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354853|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354854|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354855|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44354856|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
44354857|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44354858|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354859|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44354860|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44354861|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44354862|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
44354863|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44354864|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44354865|NCT01103843|Clopidogrel|clopidogrel|mesh-list
44354866|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44354867|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44354868|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44354869|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44354870|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44354871|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
44354872|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354873|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354874|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354875|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
44354876|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44354883|NCT01104259|Veliparib|veliparib|mesh-list
44354899|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354901|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
44354902|NCT01104337|Acetaminophen|acetaminophen|mesh-list
44354903|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354904|NCT01104337|Analgesics|analgesics|mesh-ancestor
44354905|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
44354906|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354907|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354908|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
44354909|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44354910|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44354911|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44354912|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354913|NCT01104519|Niacin|niacin|mesh-list
44354914|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
44354915|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44354916|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
44354917|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354918|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44354919|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
44354920|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
44354921|NCT01104519|Vitamins|vitamins|mesh-ancestor
44354922|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
44354923|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354924|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44354925|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
44354926|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44354927|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354928|NCT01104532|Incretins|incretins|mesh-ancestor
44354929|NCT01104532|Hormones|hormones|mesh-ancestor
44354930|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44354931|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43853149|NCT03779854|Vidarabine|vidarabine|mesh-list
43853150|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
43853151|NCT03779854|Busulfan|busulfan|mesh-list
43853152|NCT03779854|Thiotepa|thiotepa|mesh-list
43853153|NCT03779854|Methotrexate|methotrexate|mesh-list
43853154|NCT03779854|Fludarabine|fludarabine|mesh-list
43853155|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
43853156|NCT03779854|Tacrolimus|tacrolimus|mesh-list
44354932|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44354933|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354934|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354935|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44354936|NCT01104571|Trastuzumab|trastuzumab|mesh-list
44354937|NCT01104571|Lapatinib|lapatinib|mesh-list
44354938|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44354939|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354940|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44354941|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354942|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354943|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
44354944|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
44354945|NCT01104649|Riluzole|riluzole|mesh-list
44354946|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
44354947|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44354948|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44354949|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354950|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354951|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354952|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44354953|NCT01104649|Protective Agents|protective agents|mesh-ancestor
44354954|NCT01104844|Acetaminophen|acetaminophen|mesh-list
44354955|NCT01104844|Ibuprofen|ibuprofen|mesh-list
44354956|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44354957|NCT01104844|Analgesics|analgesics|mesh-ancestor
44354958|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
44354959|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354960|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354961|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
44354962|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44354963|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44354973|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354974|NCT01104896|Nicotine|nicotine|mesh-list
44354975|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44354976|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
44354977|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44354978|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354979|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44354980|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44354981|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
44354982|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44354983|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44354984|NCT01104935|Trastuzumab|trastuzumab|mesh-list
44354985|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44354986|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44354987|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44354988|NCT01104987|Alendronate|alendronate|mesh-list
44354989|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44354990|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44354991|NCT01105013|Clotrimazole|clotrimazole|mesh-list
44354992|NCT01105013|Miconazole|miconazole|mesh-list
44354993|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44354994|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44354995|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
44354996|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44354997|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44354998|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44354999|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355000|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44355001|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355002|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355003|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355004|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44355013|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355014|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44355016|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
44355017|NCT01105273|Fludarabine|fludarabine|mesh-list
44355018|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44355019|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355020|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
44355021|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355022|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355023|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44355024|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
44355025|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355026|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355027|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44355028|NCT01105286|Vitamin D|vitamin d|mesh-list
44355029|NCT01105286|Calcipotriene|calcipotriene|mesh-list
44355030|NCT01105286|Vitamins|vitamins|mesh-ancestor
44355031|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
44355032|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355033|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44355034|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
44355035|NCT01105299|Anastrozole|anastrozole|mesh-list
44355036|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44355037|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355038|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44355039|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44355046|NCT01105338|Lycopene|lycopene|mesh-list
44355060|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355061|NCT01105390|Cisplatin|cisplatin|mesh-list
44355062|NCT01105390|Pemetrexed|pemetrexed|mesh-list
44355063|NCT01105390|Rilotumumab|rilotumumab|mesh-list
44355064|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44355065|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355066|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355067|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355068|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44355069|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44355070|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355071|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
44355072|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355073|NCT01105481|Amisulpride|amisulpride|mesh-list
44355074|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44355075|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355076|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355077|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355078|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355079|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44355080|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
44355081|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355082|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355083|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44355084|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
44355085|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
44355086|NCT01105494|Hematinics|hematinics|mesh-ancestor
44355087|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44355088|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355089|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
44355091|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44355102|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355103|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44355104|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44355105|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
44355106|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355107|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44355108|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44355109|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44355110|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44355111|NCT01105793|Danazol|danazol|mesh-list
44355112|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44355113|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355114|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355115|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355116|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
44355117|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44355118|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355119|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
44355120|NCT01105832|Teriparatide|teriparatide|mesh-list
44355121|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44355122|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355123|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44355124|NCT01105871|Naloxone|naloxone|mesh-list
44355134|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
44355152|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
44355153|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44355154|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44355155|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355156|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355157|NCT01106118|Urological Agents|urological agents|mesh-ancestor
44355158|NCT01106131|Pioglitazone|pioglitazone|mesh-list
44355159|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44355160|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355161|NCT01106235|Aldesleukin|aldesleukin|mesh-list
44355162|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
44355163|NCT01106235|Interleukin-2|interleukin-2|mesh-list
44355164|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355165|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
44355166|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355167|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355168|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44355169|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
44355170|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355171|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355172|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44355173|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355174|NCT01106235|Analgesics|analgesics|mesh-ancestor
44355175|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
44355176|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355177|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44355178|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44355179|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
44355180|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355181|NCT01106495|Simvastatin|simvastatin|mesh-list
44355182|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44355195|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
44355196|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355197|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
44355198|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
44355199|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355200|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355201|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44355202|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
44355204|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355205|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44355206|NCT01106547|Protective Agents|protective agents|mesh-ancestor
44355207|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44355208|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355209|NCT01106716|Lidocaine|lidocaine|mesh-list
44355210|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
44355211|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
44355212|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355213|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355214|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
44355215|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355216|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44355217|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44355218|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44355219|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44355220|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355221|NCT01106872|Gemcitabine|gemcitabine|mesh-list
44355222|NCT01106872|Bevacizumab|bevacizumab|mesh-list
44355223|NCT01106872|Docetaxel|docetaxel|mesh-list
44355224|NCT01106872|Valproic Acid|valproic acid|mesh-list
44355225|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355226|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355227|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43853158|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
43853159|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853160|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853161|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853162|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
43853163|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853164|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355228|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44355230|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355231|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44355232|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355233|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
44355234|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355235|NCT01106872|Antiviral Agents|antiviral agents|mesh-ancestor
44355236|NCT01106872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355237|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355238|NCT01106872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355239|NCT01106872|Immunologic Factors|immunologic factors|mesh-ancestor
44355240|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355241|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355242|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44355243|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
44355244|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
44355245|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355246|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
44355247|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355248|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355249|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355250|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
44355251|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355252|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759535|NCT02448784|Donepezil|donepezil|mesh-list
43853165|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853166|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43853167|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
43853168|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43853169|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853170|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
43853171|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853172|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853173|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43853174|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43853175|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43853176|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
43853177|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43853178|NCT03779646|Bisoprolol|bisoprolol|mesh-list
43853179|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43853180|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
43853181|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
43853182|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853183|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853184|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43853185|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43853186|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43853187|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
43853188|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355253|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44355254|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44355255|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355256|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355257|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355259|NCT01107067|Androgens|androgens|mesh-ancestor
44355260|NCT01107067|Hormones|hormones|mesh-ancestor
44355261|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355262|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355263|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
44355264|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44355265|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
44355266|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355267|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355268|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44355269|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
44355270|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44355271|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
44355272|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355273|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355274|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44355275|NCT01107145|Artesunate|artesunate|mesh-list
44355276|NCT01107145|Chloroquine|chloroquine|mesh-list
44355277|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44355278|NCT01107145|Lumefantrine|lumefantrine|mesh-list
44355279|NCT01107145|Artemether|artemether|mesh-list
44355280|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44355281|NCT01107145|Mefloquine|mefloquine|mesh-list
44355282|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
44355283|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44355284|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44355285|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355286|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355287|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
44355288|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
44355289|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44355291|NCT01107145|Amebicides|amebicides|mesh-ancestor
44355292|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355293|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44355294|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355295|NCT01107145|Analgesics|analgesics|mesh-ancestor
44355296|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
44355297|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355298|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355299|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355300|NCT01107145|Filaricides|filaricides|mesh-ancestor
44355301|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
44355302|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44355303|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44355304|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355305|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
44355306|NCT01107431|Chromium|chromium|mesh-list
44355307|NCT01107431|Trace Elements|trace elements|mesh-ancestor
44355308|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
44355309|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355310|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44355311|NCT01107470|Hormones|hormones|mesh-ancestor
44355312|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355313|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355314|NCT01107509|Everolimus|everolimus|mesh-list
44355315|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355316|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355317|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
44355318|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355319|NCT01107522|Temozolomide|temozolomide|mesh-list
44355320|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44355321|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
44355322|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355323|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355324|NCT01107574|Gabapentin|gabapentin|mesh-list
44355325|NCT01107574|Analgesics|analgesics|mesh-ancestor
44355326|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
44355330|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44355331|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355332|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355333|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355334|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44355335|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44355336|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355337|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355338|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
44355340|NCT01107639|Docetaxel|docetaxel|mesh-list
44355341|NCT01107639|Cetuximab|cetuximab|mesh-list
44355342|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355343|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355344|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355345|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
44355346|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355347|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44010540|NCT03035955|Azelaic acid|azelaic acid|mesh-list
44355348|NCT01107756|Lenograstim|lenograstim|mesh-list
44355349|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44355350|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
44355351|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355352|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
44355353|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
44355354|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44355355|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44355356|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355357|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355360|NCT01107808|Vitamin D|vitamin d|mesh-list
44355376|NCT01107951|Dexamethasone|dexamethasone|mesh-list
44355377|NCT01107951|Rituximab|rituximab|mesh-list
44355378|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355379|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355380|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
44355381|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355382|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355383|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355384|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
44355385|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
44355386|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355387|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44355388|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
44355389|NCT01107951|Hormones|hormones|mesh-ancestor
44355390|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600672|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355391|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44355392|NCT01108029|Memantine|memantine|mesh-list
44355393|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44355394|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44355395|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
44355396|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355397|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355398|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355399|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44355400|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44355401|NCT01108042|Cisplatin|cisplatin|mesh-list
44355402|NCT01108042|Docetaxel|docetaxel|mesh-list
44355403|NCT01108042|Fluorouracil|fluorouracil|mesh-list
44355404|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355405|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355406|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355421|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355423|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355424|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
44355425|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
44355426|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355427|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355428|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44355429|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
44355430|NCT01108133|Hormones|hormones|mesh-ancestor
44355431|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355432|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44355433|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355434|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
44355435|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44355436|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44355437|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44355438|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355439|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
44355440|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355441|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
44355442|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44355443|NCT01108289|Oxytocin|oxytocin|mesh-list
44355444|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
44355445|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355446|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355447|NCT01108302|Oxytocin|oxytocin|mesh-list
44355448|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
44355449|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355450|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355451|NCT01108393|S 20098|s 20098|mesh-list
44355452|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44355455|NCT01108562|Lidocaine|lidocaine|mesh-list
44355464|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44355465|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44355466|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355467|NCT01108588|Aspirin|aspirin|mesh-list
44355468|NCT01108588|Clopidogrel|clopidogrel|mesh-list
44355469|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44355470|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355471|NCT01108588|Analgesics|analgesics|mesh-ancestor
44355472|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
44355473|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355474|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355475|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355476|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355477|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44355478|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44355479|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355480|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44355481|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44355482|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355483|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
44355484|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44355485|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44355486|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44355487|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
44355488|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355489|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
44355490|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355491|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355492|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44355493|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853189|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853190|NCT03779048|Phentermine|phentermine|mesh-list
43853191|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43853192|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853193|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
43853194|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43853195|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
43853196|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
43853197|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853198|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
43853199|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853200|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355495|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355496|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355497|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44355498|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44355499|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
44355500|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44355501|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
44355502|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355503|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355504|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44355505|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44355506|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44355507|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44355508|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44355509|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44355510|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355511|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355512|NCT01108744|Mannitol|mannitol|mesh-list
44355513|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44355514|NCT01108744|Diuretics|diuretics|mesh-ancestor
44355515|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
44355516|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853201|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
43853202|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853203|NCT03778580|Vitamins|vitamins|mesh-ancestor
43853204|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
43853205|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853206|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43853207|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43853208|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853209|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
43853210|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853211|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853218|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853219|NCT03777813|Antidotes|antidotes|mesh-ancestor
43853220|NCT03777813|Protective Agents|protective agents|mesh-ancestor
43853221|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853222|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853223|NCT03777813|Vitamins|vitamins|mesh-ancestor
43853224|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
43853225|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853226|NCT03777657|Cisplatin|cisplatin|mesh-list
43853227|NCT03777657|Capecitabine|capecitabine|mesh-list
43853228|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
43853229|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853230|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853232|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853233|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
43853234|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
44355517|NCT01108783|Desloratadine|desloratadine|mesh-list
44355518|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44355519|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
44355520|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355521|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355522|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355523|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44355524|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44355525|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
44355526|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
44355527|NCT01108848|Complement C1s|complement c1s|mesh-list
44355528|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44355529|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44355530|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
44355531|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355532|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43853235|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
43853236|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853237|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853238|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
43853239|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133195|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155532|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44155533|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44155534|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155535|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155536|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155537|NCT00227448|Protective Agents|protective agents|mesh-ancestor
44155538|NCT00227461|Levetiracetam|levetiracetam|mesh-list
44155539|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
44155540|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
44155541|NCT00227474|Vaccines|vaccines|mesh-list
44155542|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
44155543|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155544|NCT00227500|Pravastatin|pravastatin|mesh-list
44155545|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44155546|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44155547|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
44155548|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155549|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44155550|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44155551|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155552|NCT00227513|Bortezomib|bortezomib|mesh-list
44155553|NCT00227513|Vorinostat|vorinostat|mesh-list
44155554|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155555|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44155556|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155557|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155558|NCT00227565|Carboplatin|carboplatin|mesh-list
44155559|NCT00227565|Pemetrexed|pemetrexed|mesh-list
44155560|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155561|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155562|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155563|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44155564|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44155565|NCT00227630|Cisplatin|cisplatin|mesh-list
44155566|NCT00227630|Pemetrexed|pemetrexed|mesh-list
44355533|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355534|NCT01108874|Metaraminol|metaraminol|mesh-list
44355535|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
44355536|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
44355537|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355538|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355539|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44355540|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44355541|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44355542|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44355543|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44355544|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355545|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355546|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
44355547|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
44355548|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44355549|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44355550|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355551|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355552|NCT01108900|Urological Agents|urological agents|mesh-ancestor
44355553|NCT01108926|Tenofovir|tenofovir|mesh-list
44355554|NCT01108926|Emtricitabine|emtricitabine|mesh-list
44355555|NCT01108926|Efavirenz|efavirenz|mesh-list
44355556|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44355557|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
44355558|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355559|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43817957|NCT05550207|Meloxicam|meloxicam|mesh-list
44355560|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44355561|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155567|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155568|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155569|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155570|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44155571|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44155572|NCT00227656|Interferons|interferons|mesh-list
44155573|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
44155574|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
44155579|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155580|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155581|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
44155582|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155583|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
44155584|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155586|NCT00227669|Docetaxel|docetaxel|mesh-list
44355562|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355564|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44355565|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44355566|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44355567|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44355568|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44355569|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44355570|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44355571|NCT01108939|Antimalarials|antimalarials|mesh-list
44355572|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44355573|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44355574|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355575|NCT01109030|Pioglitazone|pioglitazone|mesh-list
44355576|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
44355577|NCT01109030|Dexetimide|dexetimide|mesh-list
44355578|NCT01109030|Citalopram|citalopram|mesh-list
44355579|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44355580|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355581|NCT01109030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44355582|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44355583|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44355584|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355585|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355586|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
44355587|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44355588|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
44355589|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355590|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44355591|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44355592|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
44355593|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
44355594|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355595|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44355596|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44355597|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
44355598|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44355599|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44355600|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355601|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44355602|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355603|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
44355604|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
44355605|NCT01109043|Bisoprolol|bisoprolol|mesh-list
44355606|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44355607|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
44355608|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
44355609|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355610|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355611|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44355612|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44355613|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44355614|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44355615|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355616|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355617|NCT01109121|Allopurinol|allopurinol|mesh-list
44355618|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
44355619|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355620|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355621|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
44355622|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355623|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44355624|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
44355625|NCT01109121|Protective Agents|protective agents|mesh-ancestor
44355626|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355627|NCT01109134|Tirofiban|tirofiban|mesh-list
44355628|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44355629|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44355630|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355631|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44355632|NCT01109160|Azithromycin|azithromycin|mesh-list
44355633|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355634|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355636|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355637|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44355638|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355639|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355640|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44355641|NCT01109264|Chlorambucil|chlorambucil|mesh-list
44355642|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44355643|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
44355644|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355645|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010781|NCT03054805|Antacids|antacids|mesh-ancestor
44355646|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44355647|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44355648|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44355649|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44355650|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155587|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155588|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
44155589|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155590|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155591|NCT00227669|Antiviral Agents|antiviral agents|mesh-ancestor
44155592|NCT00227669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155593|NCT00227669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155594|NCT00227669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155595|NCT00227669|Immunologic Factors|immunologic factors|mesh-ancestor
44155596|NCT00227669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853240|NCT03775460|Prednisolone|prednisolone|mesh-list
43853241|NCT03775460|Methotrexate|methotrexate|mesh-list
43853242|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43853243|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
43853244|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43853245|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853246|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853247|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
43853248|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853249|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853250|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853251|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853252|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43853253|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853254|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
43853255|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853256|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43853257|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853258|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
43853259|NCT03775460|Hormones|hormones|mesh-ancestor
43853260|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853261|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853262|NCT03775096|Carvedilol|carvedilol|mesh-list
43853263|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43853264|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43853265|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
43853266|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853267|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355651|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355652|NCT01109485|Analgesics|analgesics|mesh-ancestor
44355653|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
44355654|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355655|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355656|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44355657|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355658|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44355659|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44355660|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44355661|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
44355662|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
44355663|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355664|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355665|NCT01109498|Cyclosporine|cyclosporine|mesh-list
44355666|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
44355667|NCT01109498|Cyclosporins|cyclosporins|mesh-list
44355668|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355669|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355670|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355671|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
44355672|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355673|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
44355674|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355675|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44355676|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355677|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44355678|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44355679|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355680|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43853268|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853269|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43853270|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
43853271|NCT03775096|Protective Agents|protective agents|mesh-ancestor
43853272|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43853273|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43853274|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43853275|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
43853276|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43853277|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43853278|NCT03775070|Simvastatin|simvastatin|mesh-list
43853279|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43853280|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355681|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
44355682|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355683|NCT01109511|Oxycodone|oxycodone|mesh-list
44355684|NCT01109511|Naloxone|naloxone|mesh-list
44355685|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44355686|NCT01109511|Narcotics|narcotics|mesh-ancestor
44355687|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355688|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355689|NCT01109511|Analgesics|analgesics|mesh-ancestor
44355690|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
44355691|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355692|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44355693|NCT01109615|Gemcitabine|gemcitabine|mesh-list
44355695|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355696|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
44355697|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355698|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355699|NCT01109615|Antiviral Agents|antiviral agents|mesh-ancestor
44355700|NCT01109615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355701|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355702|NCT01109615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355703|NCT01109615|Immunologic Factors|immunologic factors|mesh-ancestor
44355704|NCT01109615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355705|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44355706|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44355707|NCT01109654|Cetrorelix|cetrorelix|mesh-list
44355708|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44355709|NCT01109654|Hormones|hormones|mesh-ancestor
44355710|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44355711|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355712|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44355713|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
44355714|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355715|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355716|NCT01109693|Mirtazapine|mirtazapine|mesh-list
44355717|NCT01109693|Sertraline|sertraline|mesh-list
44355718|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
44355720|NCT01109693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44355721|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44355722|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44355723|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355724|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355725|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
44355726|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355727|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44355728|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
44355729|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
44355730|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44355731|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355732|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355733|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44355734|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44355735|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44355736|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44355737|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44355738|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44355739|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44355740|NCT01109758|Fenofibrate|fenofibrate|mesh-list
44355741|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355742|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
43853281|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
43853282|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853283|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43853284|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43853285|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853286|NCT03774732|Paclitaxel|paclitaxel|mesh-list
43853287|NCT03774732|Cisplatin|cisplatin|mesh-list
43853303|NCT03774654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853304|NCT03774654|Immunologic Factors|immunologic factors|mesh-ancestor
43853305|NCT03774654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853306|NCT03774654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853307|NCT03774654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853308|NCT03774654|Alkylating Agents|alkylating agents|mesh-ancestor
43853309|NCT03774654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853310|NCT03774654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853311|NCT03774654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853312|NCT03774394|Clopidogrel|clopidogrel|mesh-list
43853313|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43853314|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43853315|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43853316|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43853317|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
43853318|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853319|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853320|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355743|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355744|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44355745|NCT01109784|Clopidogrel|clopidogrel|mesh-list
44355746|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44355747|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44355748|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44355749|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44355750|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44355751|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
44355752|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355753|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355754|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355755|NCT01109823|Levofloxacin|levofloxacin|mesh-list
44355756|NCT01109823|Ofloxacin|ofloxacin|mesh-list
44355757|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44355758|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355759|NCT01109823|Renal Agents|renal agents|mesh-ancestor
44355760|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355761|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44355762|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44355763|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355764|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010915|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355765|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355766|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44355767|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44355768|NCT01109888|Cetrorelix|cetrorelix|mesh-list
44355769|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44355770|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
44355771|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44355772|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355773|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
44355775|NCT01109927|Insulin|insulin|mesh-list
44355781|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
44355782|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355783|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355784|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355785|NCT01110291|Docetaxel|docetaxel|mesh-list
44355786|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355787|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355788|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355789|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44355790|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355791|NCT01110304|Analgesics|analgesics|mesh-list
44355792|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
44355793|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355794|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355795|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44355796|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44355797|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355798|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355799|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355800|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355801|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44355802|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44355803|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
44355804|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355805|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355806|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44355807|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44355808|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
44355809|NCT01110473|Azacitidine|azacitidine|mesh-list
44355810|NCT01110473|Ilorasertib|ilorasertib|mesh-list
44355811|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355812|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
43847880|NCT04069936|Nivolumab|nivolumab|mesh-list
43853322|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853323|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853324|NCT03773562|Erenumab|erenumab|mesh-list
43853325|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43853326|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853327|NCT03773562|Analgesics|analgesics|mesh-ancestor
43853328|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
44355813|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355814|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355815|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355816|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44355817|NCT01110486|Carboplatin|carboplatin|mesh-list
44355818|NCT01110486|Docetaxel|docetaxel|mesh-list
44355819|NCT01110486|Ilorasertib|ilorasertib|mesh-list
44355820|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355821|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355822|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355823|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
44355824|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355825|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44355826|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355827|NCT01110551|Vaccines|vaccines|mesh-list
44355828|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
44355829|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355830|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44355831|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
44355832|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44355833|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44355834|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355835|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760029|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
43853329|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853330|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853343|NCT03772834|Methylphenidate|methylphenidate|mesh-list
43853344|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43853345|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853346|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43853347|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43853348|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43853349|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853350|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
43853351|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853352|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
43853353|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43853354|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
43853355|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43853356|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
43853357|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853366|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43853367|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43853368|NCT03769025|Narcotics|narcotics|mesh-ancestor
43853369|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853370|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853371|NCT03769025|Analgesics|analgesics|mesh-ancestor
43853372|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
43853373|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355836|NCT01110590|Urological Agents|urological agents|mesh-ancestor
44355837|NCT01110603|Paclitaxel|paclitaxel|mesh-list
44355838|NCT01110603|Carboplatin|carboplatin|mesh-list
44355839|NCT01110603|Doxorubicin|doxorubicin|mesh-list
44355840|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44355841|NCT01110603|Niraparib|niraparib|mesh-list
44355842|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44355843|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355844|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
44355845|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
44355846|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
44355847|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355848|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44355849|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44355850|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44355851|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355852|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44355853|NCT01110616|Lorazepam|lorazepam|mesh-list
44355854|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
44355855|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
44355856|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
43853374|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43853375|NCT03768960|Daratumumab|daratumumab|mesh-list
43853376|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853377|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43853378|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43853379|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853380|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43853381|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43853382|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43853383|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
43853384|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853385|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43853386|NCT03766763|Venetoclax|venetoclax|mesh-list
43853387|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853388|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
43853389|NCT03766750|Linagliptin|linagliptin|mesh-list
43853390|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43853391|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853392|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43853393|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853394|NCT03766750|Incretins|incretins|mesh-ancestor
43853395|NCT03766750|Hormones|hormones|mesh-ancestor
43853396|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853397|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43818302|NCT05546411|Antidotes|antidotes|mesh-ancestor
43853398|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
43853399|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853400|NCT03765541|Cytarabine|cytarabine|mesh-list
43853401|NCT03765541|Dexamethasone|dexamethasone|mesh-list
43853402|NCT03765541|Azacitidine|azacitidine|mesh-list
43853403|NCT03765541|Amsacrine|amsacrine|mesh-list
43853404|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853405|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
43853406|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
43853407|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853408|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853409|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44355857|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355858|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355860|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44355861|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355862|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44355863|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44355864|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44355865|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
44355866|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
44355867|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355868|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355869|NCT01110642|Lovastatin|lovastatin|mesh-list
44355870|NCT01110642|L 647318|l 647318|mesh-list
44355871|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
44355872|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44355873|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355874|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
44355875|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355876|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44355877|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44355878|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355879|NCT01110785|Panitumumab|panitumumab|mesh-list
44355880|NCT01110785|Simvastatin|simvastatin|mesh-list
44355881|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44355882|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44355883|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
44355884|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355885|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44355886|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44355887|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853410|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
43853411|NCT03765541|Hormones|hormones|mesh-ancestor
43853412|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853413|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853414|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853415|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853416|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
43853417|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853418|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
43853419|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355888|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44355889|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355890|NCT01110824|Carvedilol|carvedilol|mesh-list
44355891|NCT01110824|Enalapril|enalapril|mesh-list
44355892|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44355893|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44355894|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
44355895|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44355896|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355897|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355898|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44355899|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
44355900|NCT01110824|Protective Agents|protective agents|mesh-ancestor
44355901|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43649096|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
44355902|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44355903|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44355904|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
44355905|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44355906|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44355907|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44355908|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44355909|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355910|NCT01110941|Leucovorin|leucovorin|mesh-list
44355911|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
44355912|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355913|NCT01110941|Antidotes|antidotes|mesh-ancestor
44355914|NCT01110941|Protective Agents|protective agents|mesh-ancestor
44355915|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355916|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
44355918|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
44355919|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44355920|NCT01111084|Hormones|hormones|mesh-ancestor
44355921|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760106|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
43853420|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853421|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
43853422|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853423|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43853424|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43853431|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853432|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44355922|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355923|NCT01111188|Bortezomib|bortezomib|mesh-list
44355924|NCT01111188|Palbociclib|palbociclib|mesh-list
44355925|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355926|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44355927|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355928|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355929|NCT01111227|Propofol|propofol|mesh-list
44355930|NCT01111227|Isoflurane|isoflurane|mesh-list
44355931|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44355932|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355933|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355934|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44355935|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
44355936|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
44355937|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43853433|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
43853434|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853435|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853436|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
43853437|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853438|NCT03751436|Venetoclax|venetoclax|mesh-list
43853439|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853440|NCT03751423|Fentanyl|fentanyl|mesh-list
43853441|NCT03751423|Ketamine|ketamine|mesh-list
43853442|NCT03751423|Morphine|morphine|mesh-list
43853443|NCT03751423|Analgesics|analgesics|mesh-ancestor
43853444|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
43853445|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853446|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649100|NCT03031535|Octreotide|octreotide|mesh-list
43649101|NCT03031535|Hormones|hormones|mesh-list
43853447|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43853448|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43853449|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
43853450|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
43853451|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853452|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43853453|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43853454|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853455|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853456|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43853457|NCT03751423|Narcotics|narcotics|mesh-ancestor
43853458|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43853459|NCT03750968|Carotenoids|carotenoids|mesh-list
43853460|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
43853461|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853462|NCT03750968|Protective Agents|protective agents|mesh-ancestor
43853463|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853465|NCT03749902|Oxytocin|oxytocin|mesh-list
43853466|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
43853467|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43853468|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853469|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43853470|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
43853471|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43853472|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43853473|NCT03749460|Nivolumab|nivolumab|mesh-list
43853474|NCT03749460|Ipilimumab|ipilimumab|mesh-list
43853475|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853476|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853477|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44355939|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
44355940|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
44355941|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44355942|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355943|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355944|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44355945|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355946|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355948|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355949|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355950|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
44355951|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44355952|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
44355953|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355954|NCT01111422|Expectorants|expectorants|mesh-ancestor
44355955|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44355956|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44355957|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
44355958|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355959|NCT01111422|Protective Agents|protective agents|mesh-ancestor
44355960|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355961|NCT01111422|Antidotes|antidotes|mesh-ancestor
44355963|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44355964|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44355965|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853478|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853479|NCT03749070|Silymarin|silymarin|mesh-list
43853480|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
43853481|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853482|NCT03749070|Protective Agents|protective agents|mesh-ancestor
43853483|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853484|NCT03749018|Prednisone|prednisone|mesh-list
43853485|NCT03749018|Cortisone|cortisone|mesh-list
43853486|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
43853487|NCT03749018|Rituximab|rituximab|mesh-list
43853488|NCT03749018|Doxorubicin|doxorubicin|mesh-list
43853489|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43853490|NCT03749018|Nivolumab|nivolumab|mesh-list
43853491|NCT03749018|Etoposide|etoposide|mesh-list
43853492|NCT03749018|Vincristine|vincristine|mesh-list
43853493|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
43853494|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
43853495|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43853496|NCT03749018|Antibodies|antibodies|mesh-list
43853497|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
43853501|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355967|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
44355968|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44355969|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
44355970|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355971|NCT01111513|Analgesics|analgesics|mesh-list
44355972|NCT01111513|Ropivacaine|ropivacaine|mesh-list
44355973|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
44355974|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
44355975|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44355976|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355977|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
44355978|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355979|NCT01111591|Celecoxib|celecoxib|mesh-list
44355980|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
44355981|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44355982|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44355983|NCT01111591|Analgesics|analgesics|mesh-ancestor
44355984|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
44355985|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44355986|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44355987|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760130|NCT02445547|Hormones|hormones|mesh-list
43853502|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853503|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853504|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
43853505|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853506|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853507|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853508|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853509|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43853510|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853511|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853512|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853513|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
43853515|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853516|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853517|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43853518|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853519|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853520|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853521|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853522|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
43853523|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853524|NCT03748953|Ixazomib|ixazomib|mesh-list
43853525|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853526|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
43853527|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853528|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853529|NCT03748134|Paclitaxel|paclitaxel|mesh-list
43853530|NCT03748134|Cisplatin|cisplatin|mesh-list
43853531|NCT03748134|Fluorouracil|fluorouracil|mesh-list
44355988|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44355989|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44355990|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44355991|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44355992|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
44355993|NCT01111630|Hematinics|hematinics|mesh-ancestor
44355994|NCT01111656|Interferons|interferons|mesh-list
44355995|NCT01111656|Interferon-beta|interferon-beta|mesh-list
44355996|NCT01111656|Atorvastatin|atorvastatin|mesh-list
44355997|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
44355998|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44355999|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
44356000|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356001|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44356002|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44356003|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
44356004|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356005|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44356006|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44356007|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356008|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
44356009|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356010|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44356011|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
44356012|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44356013|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43760150|NCT02445300|Laxatives|laxatives|mesh-ancestor
43853532|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853533|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853534|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853535|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853536|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853537|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853538|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
43853539|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133196|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43853540|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853541|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
43853542|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853543|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
43853545|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43853546|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853547|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853548|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43853549|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
43853550|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
43853551|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43853552|NCT03747432|Analgesics|analgesics|mesh-ancestor
44356014|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356015|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
44356016|NCT01111669|Coagulants|coagulants|mesh-ancestor
44356017|NCT01111682|Mannitol|mannitol|mesh-list
44356018|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44356019|NCT01111682|Diuretics|diuretics|mesh-ancestor
44356020|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
44356021|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356022|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
44356023|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44356024|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356025|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
44356026|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356027|NCT01111734|Expectorants|expectorants|mesh-ancestor
44356028|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356029|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44356030|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
44356031|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356032|NCT01111734|Protective Agents|protective agents|mesh-ancestor
44356033|NCT01111734|Antidotes|antidotes|mesh-ancestor
44356034|NCT01111747|Mitogens|mitogens|mesh-list
44356035|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760174|NCT02445404|Hormones|hormones|mesh-ancestor
43760184|NCT02445066|Vitamin D|vitamin d|mesh-list
43853553|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
43853554|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853555|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43853556|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43853557|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43853558|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
43853559|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853560|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853561|NCT03747120|Paclitaxel|paclitaxel|mesh-list
43853562|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
43853563|NCT03747120|Trastuzumab|trastuzumab|mesh-list
43853564|NCT03747120|Pertuzumab|pertuzumab|mesh-list
43600691|NCT03536520|Diuretics|diuretics|mesh-ancestor
43853565|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853566|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853567|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853568|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853569|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853585|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
43853586|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853587|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
43853588|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853589|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853590|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43853591|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43853592|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133197|NCT00153049|Telmisartan|telmisartan|mesh-list
44133198|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
44133199|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133200|NCT00153049|Diuretics|diuretics|mesh-ancestor
44356036|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011183|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
44356037|NCT01111864|Micronutrients|micronutrients|mesh-list
44356039|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356040|NCT01111890|Timolol|timolol|mesh-list
44356041|NCT01111890|Dorzolamide|dorzolamide|mesh-list
44356042|NCT01111890|Brinzolamide|brinzolamide|mesh-list
44356043|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44356044|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44356045|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356046|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356047|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356048|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356049|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44356050|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356051|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44356052|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356053|NCT01111903|Lenalidomide|lenalidomide|mesh-list
44356054|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
44356055|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356056|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356057|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356058|NCT01111903|Growth Substances|growth substances|mesh-ancestor
44356059|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356060|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356061|NCT01111942|Cisplatin|cisplatin|mesh-list
44356062|NCT01111942|Carboplatin|carboplatin|mesh-list
44356063|NCT01111942|Docetaxel|docetaxel|mesh-list
44356064|NCT01111942|Fluorouracil|fluorouracil|mesh-list
44356065|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760199|NCT02445053|Ivacaftor|ivacaftor|mesh-list
44133201|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
44133202|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133203|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44133204|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133205|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133206|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133207|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133208|NCT00153075|Fenoterol|fenoterol|mesh-list
44133209|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44133210|NCT00153075|Ipratropium|ipratropium|mesh-list
44133211|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44133212|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
44133213|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356067|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
44356068|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
44356069|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356070|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
44356071|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44356072|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356073|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
44356074|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356075|NCT01111968|Vaccines|vaccines|mesh-list
44356076|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
44356077|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356078|NCT01111981|Clobetasol|clobetasol|mesh-list
44356079|NCT01111981|Emollients|emollients|mesh-list
44356080|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356081|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
44356082|NCT01111981|Hormones|hormones|mesh-ancestor
44356083|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356084|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356085|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356086|NCT01111994|Clindamycin|clindamycin|mesh-list
44356087|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
44356088|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
44356089|NCT01111994|Tretinoin|tretinoin|mesh-list
44356090|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44356091|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356092|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44356093|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356094|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356095|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356096|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
44356097|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356098|NCT01112085|Ranibizumab|ranibizumab|mesh-list
44356099|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356100|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356101|NCT01112085|Growth Substances|growth substances|mesh-ancestor
44356106|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44356107|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44356108|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44356109|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44356110|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
44356111|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356112|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356113|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356114|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
44356115|NCT01112215|Azathioprine|azathioprine|mesh-list
44356116|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44356117|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356118|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44356119|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
44356120|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44356121|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356122|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356123|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356124|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
44356125|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44356126|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356127|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
44356128|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356129|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44356130|NCT01112449|Selenium|selenium|mesh-list
44356131|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
44133214|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133215|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44133216|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
43853593|NCT03744793|Pemetrexed|pemetrexed|mesh-list
43853594|NCT03744793|Avelumab|avelumab|mesh-list
43853595|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43853596|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853597|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853598|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853599|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43853600|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43853601|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853602|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
43853603|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853605|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853606|NCT03743025|Dulaglutide|dulaglutide|mesh-list
43853607|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43853616|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
43853617|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
44356132|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356133|NCT01112449|Protective Agents|protective agents|mesh-ancestor
44356134|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356135|NCT01112449|Trace Elements|trace elements|mesh-ancestor
44356136|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
44356137|NCT01112462|Acetaminophen|acetaminophen|mesh-list
44356138|NCT01112462|Phenylephrine|phenylephrine|mesh-list
44356139|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
44356140|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356141|NCT01112462|Analgesics|analgesics|mesh-ancestor
44356142|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
44356143|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356144|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356145|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
44356146|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44356147|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
44356148|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
44356149|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
44356150|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44356151|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
44356152|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356153|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44356154|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44356155|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44356156|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356157|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356158|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356159|NCT01112462|Protective Agents|protective agents|mesh-ancestor
44356160|NCT01112540|Morphine|morphine|mesh-list
44356161|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44356162|NCT01112540|Narcotics|narcotics|mesh-ancestor
43760293|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43853618|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853619|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853620|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43853621|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
43853622|NCT03742297|Hormones|hormones|mesh-ancestor
43853623|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853624|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853625|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853626|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
43853627|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43853628|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43853629|NCT03742297|Growth Substances|growth substances|mesh-ancestor
44356163|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356164|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356166|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
44356167|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356168|NCT01112644|Oxycodone|oxycodone|mesh-list
44356169|NCT01112644|Naloxone|naloxone|mesh-list
44356170|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44356171|NCT01112644|Narcotics|narcotics|mesh-ancestor
44356172|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356173|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356174|NCT01112644|Analgesics|analgesics|mesh-ancestor
44356175|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
44356176|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356177|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44356178|NCT01112722|Histamine|histamine|mesh-list
43853630|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
43853631|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853632|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
43853633|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853634|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853635|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853636|NCT03742245|Olaparib|olaparib|mesh-list
43853637|NCT03742245|Vorinostat|vorinostat|mesh-list
43600733|NCT03384212|Cytarabine|cytarabine|mesh-list
43853638|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43853639|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853640|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853641|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853642|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43853643|NCT03742193|Apatinib|apatinib|mesh-list
43853644|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853645|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43853646|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853647|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853648|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
43853649|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43853650|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43853651|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43853652|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
43853653|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853654|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853655|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853656|NCT03740529|Rituximab|rituximab|mesh-list
43853657|NCT03740529|Venetoclax|venetoclax|mesh-list
43853658|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853659|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853660|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
43853661|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853662|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853663|NCT03739619|Gemcitabine|gemcitabine|mesh-list
43853664|NCT03739619|Nivolumab|nivolumab|mesh-list
43853665|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43853666|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853667|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
44133217|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
43580087|NCT04838301|Pregnanolone|pregnanolone|mesh-list
43853668|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853669|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853670|NCT03739619|Antiviral Agents|antiviral agents|mesh-ancestor
44356179|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
44356180|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
44356181|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356182|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356183|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356184|NCT01112748|Lidocaine|lidocaine|mesh-list
44356185|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
44356186|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
44356187|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853671|NCT03739619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43853672|NCT03739619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853673|NCT03739619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853674|NCT03739619|Immunologic Factors|immunologic factors|mesh-ancestor
43853677|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43853678|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853679|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
43853681|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
43853682|NCT03738917|Ipratropium|ipratropium|mesh-list
43853683|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43853684|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
43853685|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
43853686|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
43853687|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43853688|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43853689|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853690|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853691|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853692|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43853693|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
43853694|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853695|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43853696|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
43853697|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
43853698|NCT03737955|Calicheamicins|calicheamicins|mesh-list
43853699|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853700|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853701|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853702|NCT03737240|Insulin|insulin|mesh-list
43853703|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43853704|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
43853705|NCT03737240|Liraglutide|liraglutide|mesh-list
43853706|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
43853707|NCT03737240|Xultophy|xultophy|mesh-list
43853708|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43853709|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853710|NCT03737240|Incretins|incretins|mesh-ancestor
43853711|NCT03737240|Hormones|hormones|mesh-ancestor
43853712|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853713|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43853714|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43853715|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43853716|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43853717|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853718|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
43853719|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853720|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853721|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43853722|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853723|NCT03736720|Leucovorin|leucovorin|mesh-list
43853724|NCT03736720|Fluorouracil|fluorouracil|mesh-list
43853725|NCT03736720|Irinotecan|irinotecan|mesh-list
43853726|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
43853727|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853728|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853729|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853730|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356188|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356189|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
44356190|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356191|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44356192|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44356193|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44356194|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356195|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356196|NCT01112787|Tazarotene|tazarotene|mesh-list
44356197|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356198|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
44356199|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
44356200|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44356201|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356202|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356203|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356204|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
44356205|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356206|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356207|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356208|NCT01112826|Capecitabine|capecitabine|mesh-list
44356209|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44356210|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
44356211|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356212|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356213|NCT01112852|Terlipressin|terlipressin|mesh-list
44356214|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44356215|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44356216|NCT01112852|Somatostatin|somatostatin|mesh-list
43853731|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
43853732|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853733|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43853734|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853735|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853736|NCT03736720|Antidotes|antidotes|mesh-ancestor
43853737|NCT03736720|Protective Agents|protective agents|mesh-ancestor
43853738|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853739|NCT03736720|Vitamins|vitamins|mesh-ancestor
43853740|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
43853741|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
43853742|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43853743|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
43853744|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
43819118|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
43853746|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853747|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356218|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356219|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356220|NCT01112852|Hormones|hormones|mesh-ancestor
44356221|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356222|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356223|NCT01112878|Clonidine|clonidine|mesh-list
44356224|NCT01112878|Gabapentin|gabapentin|mesh-list
44356225|NCT01112878|Analgesics|analgesics|mesh-ancestor
44356226|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
44356227|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356228|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356229|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
44356230|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44356231|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356232|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356233|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356234|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44356235|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44356236|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356237|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356238|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
44356239|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356240|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
44356241|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
44356242|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44356243|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44356244|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44356245|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356246|NCT01112891|Vitamin D|vitamin d|mesh-list
44356247|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
44356248|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
44356249|NCT01112891|Vitamins|vitamins|mesh-list
44356250|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
44356251|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356252|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44356253|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44356255|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356256|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44356257|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356258|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356259|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44356260|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356261|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
44356262|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
44356263|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44356264|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356265|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44356267|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356268|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
44356269|NCT01113138|Analgesics|analgesics|mesh-ancestor
44356270|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
43853748|NCT03736538|Analgesics|analgesics|mesh-ancestor
43853749|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
43853750|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853751|NCT03735875|Venetoclax|venetoclax|mesh-list
43853752|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853753|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
43853754|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
43853755|NCT03735316|Vitamins|vitamins|mesh-ancestor
43853756|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
43853757|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853758|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853759|NCT03735316|Hematinics|hematinics|mesh-ancestor
43853760|NCT03729011|Propofol|propofol|mesh-list
43853761|NCT03729011|Sevoflurane|sevoflurane|mesh-list
43853762|NCT03729011|Desflurane|desflurane|mesh-list
43853763|NCT03729011|Isoflurane|isoflurane|mesh-list
43853764|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43853765|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853766|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853767|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43853768|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
43853769|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
43655490|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
43853770|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43853771|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43853772|NCT03728933|Rotigotine|rotigotine|mesh-list
43853773|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
43853774|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
43853775|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853776|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853777|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853778|NCT03728673|Dexetimide|dexetimide|mesh-list
43853779|NCT03728673|Citalopram|citalopram|mesh-list
43853780|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43853781|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43853782|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43853783|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853784|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853785|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
43853786|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853787|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43853788|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
43853789|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43853790|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43853791|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43853792|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
44356271|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356272|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356273|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
44356274|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356275|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44356276|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
44356277|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44356278|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356279|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356280|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44356281|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
44356282|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44356283|NCT01113164|Ondansetron|ondansetron|mesh-list
44356284|NCT01113164|Sertraline|sertraline|mesh-list
44356285|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
44356286|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
44356287|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356288|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853793|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
43853794|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853795|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43853796|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43853797|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
43853798|NCT03727776|Hormones|hormones|mesh-list
43853799|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43853800|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43853801|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
43853802|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853803|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853804|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853805|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853806|NCT03727061|Cisplatin|cisplatin|mesh-list
43853807|NCT03727061|Carboplatin|carboplatin|mesh-list
43853808|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
43853809|NCT03727061|Fluorouracil|fluorouracil|mesh-list
43853810|NCT03727061|Nivolumab|nivolumab|mesh-list
43853811|NCT03727061|Cetuximab|cetuximab|mesh-list
43853812|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43853813|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
43853814|NCT03727061|Trioxsalen|trioxsalen|mesh-list
43853815|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853816|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853817|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
43853818|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853819|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853820|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853822|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853823|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43853824|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853825|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43853826|NCT03726268|Fentanyl|fentanyl|mesh-list
43853827|NCT03726268|Sufentanil|sufentanil|mesh-list
43853828|NCT03726268|Morphine|morphine|mesh-list
43853832|NCT03726268|Narcotics|narcotics|mesh-ancestor
43853833|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853834|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853835|NCT03726268|Analgesics|analgesics|mesh-ancestor
44356289|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356290|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
44356291|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356292|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44356293|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
44356294|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356295|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356296|NCT01113164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44356297|NCT01113164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356298|NCT01113164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356299|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43853836|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
43853837|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853838|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43853839|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43853840|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
43853841|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
43853842|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
43853843|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
43853845|NCT03725930|Analgesics|analgesics|mesh-ancestor
43853846|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
43853847|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853848|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853849|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43853850|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
43853851|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
43853852|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43853853|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43853854|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43853855|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
43853856|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853857|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853858|NCT03725501|Ranibizumab|ranibizumab|mesh-list
43853859|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43853860|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43853861|NCT03725501|Growth Substances|growth substances|mesh-ancestor
43853862|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853863|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
43853864|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853865|NCT03725436|Paclitaxel|paclitaxel|mesh-list
43853866|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43853867|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853868|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853869|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853870|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853871|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853872|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853873|NCT03725059|Paclitaxel|paclitaxel|mesh-list
43853874|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
43853875|NCT03725059|Doxorubicin|doxorubicin|mesh-list
43853876|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
43853877|NCT03725059|Epirubicin|epirubicin|mesh-list
43853878|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853879|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853880|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853881|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853882|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853883|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853884|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853885|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
43853886|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853887|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853888|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44356301|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
44356302|NCT01113164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44356303|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44356304|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356305|NCT01113229|Misoprostol|misoprostol|mesh-list
44356306|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44356307|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
44356308|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44356309|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356310|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44356311|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356312|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
44356313|NCT01113281|Vaccines|vaccines|mesh-list
44356314|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
44356315|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356316|NCT01113372|Clopidogrel|clopidogrel|mesh-list
44356317|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44356318|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44356319|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44356320|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44356321|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
44356322|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356323|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356324|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356325|NCT01113424|Nicotine|nicotine|mesh-list
43853889|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
43853890|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853891|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853892|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43853893|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853894|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853895|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853896|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
43853897|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853898|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853899|NCT03722108|Irinotecan|irinotecan|mesh-list
43853900|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43853901|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853909|NCT03721653|Irinotecan|irinotecan|mesh-list
43853910|NCT03721653|Atezolizumab|atezolizumab|mesh-list
43853911|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
43853912|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853913|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853914|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43853915|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43853916|NCT03721653|Growth Substances|growth substances|mesh-ancestor
44356326|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44356327|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
44356328|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356329|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356330|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44356331|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44356332|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
44356333|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356334|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356335|NCT01113437|Omalizumab|omalizumab|mesh-list
44356336|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44356337|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44356338|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356339|NCT01113489|Beclomethasone|beclomethasone|mesh-list
44356340|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356341|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
44356342|NCT01113489|Hormones|hormones|mesh-ancestor
43760421|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43853917|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853918|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
43853919|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
43853920|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853921|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853922|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853923|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
43853924|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43853925|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853926|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853927|NCT03721653|Antidotes|antidotes|mesh-ancestor
43853928|NCT03721653|Protective Agents|protective agents|mesh-ancestor
43853929|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
43853930|NCT03721653|Vitamins|vitamins|mesh-ancestor
43853931|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
43853932|NCT03720717|Baclofen|baclofen|mesh-list
43853933|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43853934|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853935|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43853936|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853937|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43853938|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
43853939|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
43853940|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43853941|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853942|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
43853943|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853944|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133218|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
44133219|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44133220|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44133221|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44133222|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44133223|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
44133224|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133225|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133226|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44133227|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
44133228|NCT00153088|Telmisartan|telmisartan|mesh-list
44133229|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356343|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356344|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356345|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44356346|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356347|NCT01113515|Esmolol|esmolol|mesh-list
44356348|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44356349|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44356350|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44356351|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356352|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356353|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356354|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356355|NCT01113528|Aspirin|aspirin|mesh-list
44356356|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44356357|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356358|NCT01113528|Analgesics|analgesics|mesh-ancestor
44356359|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
44356360|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356361|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356362|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356363|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44356364|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44356365|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44133230|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133231|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133232|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133233|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44133234|NCT00153114|Laxatives|laxatives|mesh-ancestor
44133235|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133236|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44133237|NCT00153127|Laxatives|laxatives|mesh-ancestor
44133238|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133239|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44133240|NCT00153140|Laxatives|laxatives|mesh-ancestor
44133241|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133242|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44133243|NCT00153153|Laxatives|laxatives|mesh-ancestor
44133244|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133246|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
44133247|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853945|NCT03719105|Dexamethasone|dexamethasone|mesh-list
43853947|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
43853948|NCT03719105|Ifosfamide|ifosfamide|mesh-list
43853949|NCT03719105|Doxorubicin|doxorubicin|mesh-list
43853950|NCT03719105|Methotrexate|methotrexate|mesh-list
43853951|NCT03719105|Etoposide|etoposide|mesh-list
43853952|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43853953|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853954|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
43853955|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356366|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356367|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44356368|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44356369|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356370|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
44356372|NCT01113671|Tocopherols|tocopherols|mesh-list
44356373|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
44356374|NCT01113671|Vitamins|vitamins|mesh-ancestor
44356375|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
44356376|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356377|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
44356378|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356379|NCT01113671|Protective Agents|protective agents|mesh-ancestor
44356380|NCT01113762|Cimetidine|cimetidine|mesh-list
44356381|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44356382|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356383|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44356384|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
44356385|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
44356386|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356387|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356388|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356389|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44356390|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44356391|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356392|NCT01114048|Thalidomide|thalidomide|mesh-list
44356393|NCT01114048|Dexamethasone|dexamethasone|mesh-list
44356394|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
44356395|NCT01114048|Bortezomib|bortezomib|mesh-list
44356396|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356397|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
44356410|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
44356411|NCT01114048|Hormones|hormones|mesh-ancestor
44356412|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356413|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44356414|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
44356415|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44356416|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356417|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356418|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356419|NCT01114048|Growth Substances|growth substances|mesh-ancestor
44356420|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356421|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
44356422|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356423|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44356424|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356425|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356426|NCT01114100|Sertraline|sertraline|mesh-list
44356427|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
43760515|NCT00777127|Diclofenac|diclofenac|mesh-list
43853956|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853957|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43853958|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
43853959|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853960|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853961|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43853962|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853963|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
43853964|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
43853965|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43853966|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43853967|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
43853968|NCT03719105|Hormones|hormones|mesh-ancestor
43853969|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853970|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43853971|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43853972|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43853973|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43853974|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853975|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43853976|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
43853977|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43853978|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43853979|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
43853980|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
43853981|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43853982|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43853983|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853984|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853985|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
43853986|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43853987|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43853988|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43853989|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
43853990|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356428|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356429|NCT01114100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44356430|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44356431|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356432|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356433|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356434|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
44356435|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356436|NCT01114191|Ketoconazole|ketoconazole|mesh-list
44356437|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
44356438|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356439|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44356440|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44356441|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853992|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43853993|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853994|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
43853995|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43853996|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853997|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43853998|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853999|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
43854000|NCT03716739|Testosterone|testosterone|mesh-list
43854001|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
43854002|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
43854003|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43854004|NCT03716739|Androgens|androgens|mesh-ancestor
43854005|NCT03716739|Hormones|hormones|mesh-ancestor
43854006|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854007|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854008|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854009|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854010|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
43854011|NCT03716180|Paclitaxel|paclitaxel|mesh-list
43854012|NCT03716180|Trastuzumab|trastuzumab|mesh-list
43854013|NCT03716180|Pertuzumab|pertuzumab|mesh-list
43854014|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43854015|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854016|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854017|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854022|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
43854023|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854024|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854025|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
43854026|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854027|NCT03714620|Ketamine|ketamine|mesh-list
43854028|NCT03714620|Analgesics|analgesics|mesh-ancestor
43854029|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
43854030|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854031|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854032|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43854033|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43854034|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
43854035|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
43854036|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854037|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43854038|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44356443|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44356445|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356446|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356447|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44356448|NCT01114282|Bortezomib|bortezomib|mesh-list
44356449|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356450|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
44356451|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44356452|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44356453|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44356454|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
44356455|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356456|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44356457|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44356458|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356459|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356460|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44356461|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44356462|NCT01114490|Anacetrapib|anacetrapib|mesh-list
44356463|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44356464|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44356465|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
44356466|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356467|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44356468|NCT01114542|Insulin|insulin|mesh-list
44356469|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44356470|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
44356471|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44356472|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356473|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
44356474|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43854039|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854040|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854043|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
43854044|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
44356475|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356476|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44356477|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356478|NCT01114750|Dextrans|dextrans|mesh-list
44356479|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
44356480|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
44356481|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
44356482|NCT01114841|Tazarotene|tazarotene|mesh-list
44356483|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
43760575|NCT00492999|Vitamins|vitamins|mesh-ancestor
43854045|NCT03712878|Tacrolimus|tacrolimus|mesh-list
43854046|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854047|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
43854048|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854049|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854050|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854051|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
43854052|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854053|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854054|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854055|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43854056|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854057|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854058|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43854059|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
43854060|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854061|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854062|NCT03711058|Nivolumab|nivolumab|mesh-list
43854063|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854064|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854065|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854066|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854067|NCT03710603|Dexamethasone|dexamethasone|mesh-list
43600744|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
43854068|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
43854069|NCT03710603|Lenalidomide|lenalidomide|mesh-list
43854070|NCT03710603|Bortezomib|bortezomib|mesh-list
43854071|NCT03710603|Daratumumab|daratumumab|mesh-list
43854072|NCT03710603|BB 1101|bb 1101|mesh-list
43854073|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854074|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
43854075|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
43854076|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854077|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854078|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43854079|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
43854080|NCT03710603|Hormones|hormones|mesh-ancestor
43854081|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854082|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854083|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854084|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
43854085|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854086|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854087|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
43854089|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43854090|NCT03710603|Growth Substances|growth substances|mesh-ancestor
43854091|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
43854093|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854094|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854095|NCT03709043|Ethanol|ethanol|mesh-list
43854096|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43854097|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854098|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854099|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854100|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
43854101|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43854102|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
43854103|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356484|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
44356485|NCT01114854|Topiramate|topiramate|mesh-list
44356486|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
44356487|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44356488|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356489|NCT01114958|Cisplatin|cisplatin|mesh-list
44356490|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356491|NCT01115036|Panobinostat|panobinostat|mesh-list
44356492|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356493|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44356494|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356495|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356496|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
44356497|NCT01115049|Hexetidine|hexetidine|mesh-list
44356498|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44356499|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854104|NCT03707951|Expectorants|expectorants|mesh-ancestor
43854105|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
43854106|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43854107|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
43854108|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854109|NCT03707951|Protective Agents|protective agents|mesh-ancestor
43854110|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854111|NCT03707951|Antidotes|antidotes|mesh-ancestor
43854112|NCT03706690|Durvalumab|durvalumab|mesh-list
43854113|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854114|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854115|NCT03705429|Paclitaxel|paclitaxel|mesh-list
43854116|NCT03705429|Docetaxel|docetaxel|mesh-list
43854117|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43854118|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
43854119|NCT03705429|Trastuzumab|trastuzumab|mesh-list
43854120|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43854121|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854122|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854123|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854124|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854125|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854126|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854127|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
43854128|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854129|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854130|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854131|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
43854132|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854133|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854134|NCT03704766|Defensins|defensins|mesh-list
43854135|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
43854136|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854137|NCT03704714|Prednisone|prednisone|mesh-list
43854138|NCT03704714|Cortisone|cortisone|mesh-list
43854139|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
43854140|NCT03704714|Rituximab|rituximab|mesh-list
43854141|NCT03704714|Doxorubicin|doxorubicin|mesh-list
43854142|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43854143|NCT03704714|Nivolumab|nivolumab|mesh-list
43854144|NCT03704714|Vincristine|vincristine|mesh-list
43854145|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43854146|NCT03704714|Antibodies|antibodies|mesh-list
43854147|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
43854148|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43854149|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854150|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
44356501|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
44356502|NCT01115062|Lidocaine|lidocaine|mesh-list
44356503|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
44356504|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
44356505|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356506|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356507|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
44356508|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356509|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44356510|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44356511|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44356512|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356513|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356514|NCT01115127|Inositol|inositol|mesh-list
44356515|NCT01115127|Melatonin|melatonin|mesh-list
44356516|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
44356517|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356518|NCT01115127|Protective Agents|protective agents|mesh-ancestor
44356519|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356520|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356521|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
44356522|NCT01115127|Vitamins|vitamins|mesh-ancestor
44356523|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
44356524|NCT01115140|Folic Acid|folic acid|mesh-list
44356525|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
44356526|NCT01115140|Metformin|metformin|mesh-list
44356527|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44356528|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356529|NCT01115140|Hematinics|hematinics|mesh-ancestor
44356530|NCT01115140|Vitamins|vitamins|mesh-ancestor
44356546|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
44356547|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
44356548|NCT01115322|Vitamins|vitamins|mesh-ancestor
44356549|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
44356550|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356551|NCT01115426|Losartan|losartan|mesh-list
44356552|NCT01115426|Ramipril|ramipril|mesh-list
44356553|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44356554|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356555|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44356556|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44356557|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356558|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44356559|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
44356560|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356561|NCT01115439|Artesunate|artesunate|mesh-list
44356562|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
44356563|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
44356564|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44356565|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
44356566|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44356567|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44356568|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356569|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356570|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
44356571|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
44356572|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44356573|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
44356574|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44356575|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356576|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356577|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44356578|NCT01115439|Renal Agents|renal agents|mesh-ancestor
44356579|NCT01115478|Vitamin A|vitamin a|mesh-list
44356580|NCT01115478|Vitamins|vitamins|mesh-ancestor
43760664|NCT02444260|Lidocaine|lidocaine|mesh-list
43854151|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854152|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854153|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854154|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
43854155|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356582|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356583|NCT01115504|Thiamine|thiamine|mesh-list
44356584|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
44356585|NCT01115504|Vitamins|vitamins|mesh-ancestor
44011747|NCT03123848|Darunavir|darunavir|mesh-list
44356586|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
44356587|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356588|NCT01115543|Calcitriol|calcitriol|mesh-list
44356589|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
44356590|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43760677|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
43854156|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854157|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854158|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854159|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43854160|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43854161|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854162|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854163|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
43854164|NCT03704714|Hormones|hormones|mesh-ancestor
43854166|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854167|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854168|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43854169|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854170|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854171|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854173|NCT03703167|Lenalidomide|lenalidomide|mesh-list
43854174|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854175|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854176|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
43854177|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854178|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854179|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43854180|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43854181|NCT03703167|Growth Substances|growth substances|mesh-ancestor
43854182|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
43854183|NCT03702179|Durvalumab|durvalumab|mesh-list
43854184|NCT03702179|Tremelimumab|tremelimumab|mesh-list
43854185|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854186|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854187|NCT03701490|Progesterone|progesterone|mesh-list
43854188|NCT03701490|Progestins|progestins|mesh-ancestor
43854189|NCT03701490|Hormones|hormones|mesh-ancestor
43854190|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854191|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854192|NCT03700099|Docetaxel|docetaxel|mesh-list
43854193|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854194|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854195|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854196|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854197|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854198|NCT03699865|Nicotine|nicotine|mesh-list
43854199|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43854200|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
43854201|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854202|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854203|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43854204|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43854205|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
43854206|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854207|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854208|NCT03699319|Leucovorin|leucovorin|mesh-list
43854209|NCT03699319|Folic Acid|folic acid|mesh-list
43854210|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
43854211|NCT03699319|Irinotecan|irinotecan|mesh-list
43854212|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
44356591|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44356592|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356594|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356595|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356596|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44356597|NCT01115543|Vitamins|vitamins|mesh-ancestor
44356598|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
44356599|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44356600|NCT01115712|Pioglitazone|pioglitazone|mesh-list
44356601|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44356602|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356603|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44356604|NCT01115725|Hormones|hormones|mesh-ancestor
44356605|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356606|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356607|NCT01115842|Vitamin D|vitamin d|mesh-list
44356608|NCT01115842|Vitamins|vitamins|mesh-ancestor
44356609|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
44356610|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854213|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854214|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854215|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43854216|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43854217|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854218|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854219|NCT03699319|Antidotes|antidotes|mesh-ancestor
43854220|NCT03699319|Protective Agents|protective agents|mesh-ancestor
43854221|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
43854222|NCT03699319|Vitamins|vitamins|mesh-ancestor
43854223|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
43854224|NCT03699319|Hematinics|hematinics|mesh-ancestor
43854225|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
43854226|NCT03698669|Narcotics|narcotics|mesh-ancestor
43854227|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854228|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854229|NCT03698669|Analgesics|analgesics|mesh-ancestor
43854230|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
43854231|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854232|NCT03696199|Anesthetics|anesthetics|mesh-list
43854233|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854234|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854235|NCT03695237|Leuprolide|leuprolide|mesh-list
43854236|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43854237|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
43854238|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43854239|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854243|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854244|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854246|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
43854247|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854248|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854249|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854250|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854251|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854252|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854254|NCT03692663|Fludarabine|fludarabine|mesh-list
43600752|NCT03384225|Cladribine|cladribine|mesh-list
44356611|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44356613|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44356614|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44356615|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356616|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
44356617|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356618|NCT01115946|Enalapril|enalapril|mesh-list
44356619|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44356620|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
44356621|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356622|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356623|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356624|NCT01115959|Valproic Acid|valproic acid|mesh-list
44356625|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
44356626|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760706|NCT02444013|Hematinics|hematinics|mesh-ancestor
43854255|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854256|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
43854257|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854258|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854259|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854260|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
43854261|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854262|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854263|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854264|NCT03692325|Nivolumab|nivolumab|mesh-list
43854265|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854266|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854267|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854268|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854269|NCT03690986|Nivolumab|nivolumab|mesh-list
43854270|NCT03690986|Ipilimumab|ipilimumab|mesh-list
43854271|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854272|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854273|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854274|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133248|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133249|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133250|NCT00153192|Analgesics|analgesics|mesh-ancestor
44133251|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
44133252|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133253|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44133254|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44133255|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133256|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133257|NCT00153192|Hormones|hormones|mesh-ancestor
44133258|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133259|NCT00153244|Lamotrigine|lamotrigine|mesh-list
44133260|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
44133261|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44133262|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133263|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133264|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44133265|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133266|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44356627|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356628|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
44356629|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356630|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356631|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
44356632|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356633|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356634|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356635|NCT01115972|Valsartan|valsartan|mesh-list
44356636|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356637|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44356638|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44356639|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356640|NCT01115985|Atorvastatin|atorvastatin|mesh-list
44356641|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44356642|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44356643|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
44133267|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133268|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133269|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133270|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44133271|NCT00153270|Valproic Acid|valproic acid|mesh-list
44133272|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
44133273|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133274|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133275|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
44133276|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133277|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133278|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
44133279|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133280|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133281|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133282|NCT00153283|Gabapentin|gabapentin|mesh-list
44133283|NCT00153283|Analgesics|analgesics|mesh-ancestor
43854279|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854280|NCT03685773|Niacin|niacin|mesh-list
43854281|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
43854282|NCT03685773|Niacinamide|niacinamide|mesh-list
43854283|NCT03685773|Diazoxide|diazoxide|mesh-list
43854284|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43854285|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
43854286|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854287|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43854288|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
43854289|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
43854290|NCT03685773|Vitamins|vitamins|mesh-ancestor
43854291|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
43854292|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854293|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43854294|NCT03685331|Olaparib|olaparib|mesh-list
43854295|NCT03685331|Fulvestrant|fulvestrant|mesh-list
43854296|NCT03685331|Palbociclib|palbociclib|mesh-list
43854297|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43854298|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854299|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854300|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854301|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854302|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44356645|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44356646|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44356647|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356648|NCT01116050|Misoprostol|misoprostol|mesh-list
44356649|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44356650|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
44356651|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44356652|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356653|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43854303|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43854304|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
43854305|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854306|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854307|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43854308|NCT03685149|Flecainide|flecainide|mesh-list
43854309|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43854310|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43854311|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43854312|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43854313|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854314|NCT03684538|Zinc|zinc|mesh-list
43854315|NCT03684538|Trace Elements|trace elements|mesh-ancestor
43854316|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
43854317|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854322|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
43854323|NCT03683810|Hematinics|hematinics|mesh-ancestor
43854324|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854325|NCT03682978|Baclofen|baclofen|mesh-list
43854326|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43854327|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854328|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43854329|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854330|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43854331|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
43854332|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
43854333|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854334|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854335|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
43854336|NCT03680092|Methotrexate|methotrexate|mesh-list
43854337|NCT03680092|Abatacept|abatacept|mesh-list
43854338|NCT03680092|Tacrolimus|tacrolimus|mesh-list
43854339|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854340|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
43854341|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854342|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854343|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854344|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
43854345|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854346|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854347|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854348|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43854349|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
43854350|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43854351|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854352|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
43854353|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
43854354|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854355|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43854356|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43854357|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44356654|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356655|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
44356656|NCT01116063|Iloprost|iloprost|mesh-list
44356657|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44356658|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
44356659|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
44356660|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356661|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356662|NCT01116128|Prednisone|prednisone|mesh-list
44356663|NCT01116128|Melphalan|melphalan|mesh-list
44356664|NCT01116128|Dasatinib|dasatinib|mesh-list
44356665|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356666|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
44356667|NCT01116128|Hormones|hormones|mesh-ancestor
44356668|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356669|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854358|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854360|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43854361|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43854362|NCT03678675|Analgesics|analgesics|mesh-ancestor
43854363|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
43854364|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854365|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854366|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854367|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854368|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43854369|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854370|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854371|NCT03677817|Lidocaine|lidocaine|mesh-list
43854372|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
43854373|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
43854374|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854375|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854376|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
43854377|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854378|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43854379|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43854380|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43854381|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43854382|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854383|NCT03676556|Lidocaine|lidocaine|mesh-list
43854384|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
43854385|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
43854386|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854387|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854388|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
43854390|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43854391|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43854392|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43854393|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43854394|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854396|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854397|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854398|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43854399|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43854400|NCT03676192|Growth Substances|growth substances|mesh-ancestor
43854401|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854402|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
43854403|NCT03675737|Cisplatin|cisplatin|mesh-list
44356670|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44356671|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356672|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44356673|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
44356674|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356675|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44356676|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44356677|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
44356678|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44356679|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356680|NCT01116154|Lenalidomide|lenalidomide|mesh-list
44356681|NCT01116154|Vorinostat|vorinostat|mesh-list
44356682|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
44356683|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356684|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356685|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356686|NCT01116154|Growth Substances|growth substances|mesh-ancestor
44356687|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356688|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356689|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43854404|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
43854405|NCT03675737|Fluorouracil|fluorouracil|mesh-list
43854406|NCT03675737|Capecitabine|capecitabine|mesh-list
43854407|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
43854408|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854409|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854410|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
43854411|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854412|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854413|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854414|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
43854415|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854416|NCT03675256|Vaccines|vaccines|mesh-list
43854417|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
43854418|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854419|NCT03674242|Gemcitabine|gemcitabine|mesh-list
43854420|NCT03674242|Carboplatin|carboplatin|mesh-list
43854421|NCT03674242|Asparaginase|asparaginase|mesh-list
43854422|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854423|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854424|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
43854425|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854426|NCT03674242|Antiviral Agents|antiviral agents|mesh-ancestor
43854427|NCT03674242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854428|NCT03674242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854429|NCT03674242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854430|NCT03674242|Immunologic Factors|immunologic factors|mesh-ancestor
43854431|NCT03674242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854432|NCT03673072|Gemcitabine|gemcitabine|mesh-list
43854433|NCT03673072|Cisplatin|cisplatin|mesh-list
43854434|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854435|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854436|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
43854437|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356690|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356691|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356692|NCT01116167|Letrozole|letrozole|mesh-list
44356693|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356694|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44356695|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44356696|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356697|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356698|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44356699|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
44356700|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356701|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356702|NCT01116180|Candesartan|candesartan|mesh-list
44356703|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
44356704|NCT01116180|Giapreza|giapreza|mesh-list
44356705|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44356706|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
44356707|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356708|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44356709|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356710|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44356711|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44356712|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
44356713|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356714|NCT01116193|Dexamethasone|dexamethasone|mesh-list
44356715|NCT01116193|Lenalidomide|lenalidomide|mesh-list
44356716|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356717|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
44356718|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
44356719|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356720|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670831|NCT05423834|Tenofovir|tenofovir|mesh-list
43854438|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
43854439|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854440|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854441|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854442|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
43854443|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854444|NCT03672643|Crizotinib|crizotinib|mesh-list
43854445|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854446|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43854447|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163837|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356721|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356722|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
44356723|NCT01116193|Hormones|hormones|mesh-ancestor
44356724|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356725|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44356726|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356727|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
44356728|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356729|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356730|NCT01116193|Growth Substances|growth substances|mesh-ancestor
44356731|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356732|NCT01116206|Prucalopride|prucalopride|mesh-list
44356733|NCT01116206|Laxatives|laxatives|mesh-ancestor
44356734|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356735|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44356736|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43670860|NCT05423015|Levan|levan|mesh-list
43854448|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854449|NCT03672539|Cytarabine|cytarabine|mesh-list
43854450|NCT03672539|Daunorubicin|daunorubicin|mesh-list
43854451|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
43854452|NCT03672539|Calicheamicins|calicheamicins|mesh-list
43854453|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854454|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
43854455|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854456|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854457|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
43854458|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854459|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854460|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
43854461|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854462|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854469|NCT03671967|Piperacillin|piperacillin|mesh-list
43854470|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43854471|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854472|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854473|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43854474|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854475|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854476|NCT03669718|Cemiplimab|cemiplimab|mesh-list
43854477|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854478|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854479|NCT03668119|Nivolumab|nivolumab|mesh-list
43854480|NCT03668119|Ipilimumab|ipilimumab|mesh-list
43854481|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854482|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854483|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854484|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854485|NCT03667703|Famotidine|famotidine|mesh-list
43854486|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43854487|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43854488|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43854489|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
43854490|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
43854491|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854492|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854493|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163838|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
44356738|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356739|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356740|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356741|NCT01116219|Bevacizumab|bevacizumab|mesh-list
44356742|NCT01116219|Cisplatin|cisplatin|mesh-list
44356743|NCT01116219|Pemetrexed|pemetrexed|mesh-list
44356744|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44356745|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44356746|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356747|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44356748|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44356749|NCT01116219|Growth Substances|growth substances|mesh-ancestor
44356750|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356751|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
44356752|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356753|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356754|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44356755|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44356756|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44356757|NCT01116271|Irinotecan|irinotecan|mesh-list
44356758|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44356759|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44356760|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356761|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854495|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854496|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
43854497|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854498|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854499|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854500|NCT03666351|Losartan|losartan|mesh-list
43854501|NCT03666351|Amlodipine|amlodipine|mesh-list
43854502|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
43854503|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43854504|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43854505|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43854506|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854507|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43600799|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
43854508|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854509|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
43854510|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43854511|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43854512|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43854513|NCT03666351|Diuretics|diuretics|mesh-ancestor
43854514|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
43854515|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43854516|NCT03663543|Estrogens|estrogens|mesh-list
44356763|NCT01116310|Glycine|glycine|mesh-list
44356764|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
44356765|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356766|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356767|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854517|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43854518|NCT03663543|Hormones|hormones|mesh-ancestor
43854519|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854520|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854521|NCT03663205|Cisplatin|cisplatin|mesh-list
43854522|NCT03663205|Carboplatin|carboplatin|mesh-list
43854523|NCT03663205|Pemetrexed|pemetrexed|mesh-list
43854524|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854525|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854526|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854527|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43854528|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43854529|NCT03662074|Gemcitabine|gemcitabine|mesh-list
43854530|NCT03662074|Nivolumab|nivolumab|mesh-list
43854531|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854532|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
43854537|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854538|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854539|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
43854540|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854541|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854542|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854544|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43854545|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
43854546|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854547|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854548|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
43854549|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43854550|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854551|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854552|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43854553|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43854554|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43854555|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43854556|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43854557|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43854558|NCT03661411|Aspirin|aspirin|mesh-list
43854559|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43854560|NCT03661411|Clopidogrel|clopidogrel|mesh-list
43854561|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43854562|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43854563|NCT03661411|Analgesics|analgesics|mesh-ancestor
43854564|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
43854565|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854566|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854567|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854568|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854569|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43854570|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43854571|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854572|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43854573|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43854574|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854575|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
43854576|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43854577|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43854578|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43854579|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
43854580|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854581|NCT03661138|Upadacitinib|upadacitinib|mesh-list
43854582|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44356769|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356770|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44356771|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356772|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356773|NCT01116388|Caseins|caseins|mesh-list
44356774|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
44356775|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
44356776|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356777|NCT01116531|Pregabalin|pregabalin|mesh-list
44356778|NCT01116531|Tramadol|tramadol|mesh-list
44356779|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44356780|NCT01116531|Analgesics|analgesics|mesh-ancestor
44356781|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
44356782|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356783|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356784|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
44356785|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44356786|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356787|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356788|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43854583|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43854584|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854585|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854586|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133295|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133296|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
44133297|NCT00153296|Carbamazepine|carbamazepine|mesh-list
44133298|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
44133299|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
44133300|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133301|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133302|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133303|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133304|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133305|NCT00153296|Analgesics|analgesics|mesh-ancestor
44133306|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
44133307|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133308|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44133315|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44133316|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
44133317|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44133318|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44133319|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133320|NCT00153517|Metronidazole|metronidazole|mesh-list
44133321|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133322|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44133323|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44133324|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44133325|NCT00153530|Methotrexate|methotrexate|mesh-list
44133326|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44133327|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
44356789|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44356790|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356791|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356792|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356793|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44356795|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44356796|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44356797|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356798|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
44356799|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
44356800|NCT01116583|Gabapentin|gabapentin|mesh-list
44356801|NCT01116583|Analgesics|analgesics|mesh-ancestor
44356802|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
44356803|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356804|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356805|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
43670932|NCT05419583|Aspirin|aspirin|mesh-list
44133328|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44133329|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133330|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133331|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
44133332|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133333|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133334|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133335|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133336|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44133337|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133338|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
44133339|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133340|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44133341|NCT00153543|Vaccines|vaccines|mesh-list
44133342|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44133343|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
44133344|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133345|NCT00153556|Vaccines|vaccines|mesh-list
44133346|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
44133347|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133348|NCT00153634|Azithromycin|azithromycin|mesh-list
44133349|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
44133350|NCT00153634|Meropenem|meropenem|mesh-list
44133351|NCT00153634|Tazobactam|tazobactam|mesh-list
44133352|NCT00153634|Piperacillin|piperacillin|mesh-list
44133353|NCT00153634|Tobramycin|tobramycin|mesh-list
44133354|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
44133355|NCT00153634|Amikacin|amikacin|mesh-list
43854587|NCT03660930|Sirolimus|sirolimus|mesh-list
43854588|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854589|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854590|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854591|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854592|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
43854593|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854594|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
43854595|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854596|NCT03660553|Insulin|insulin|mesh-list
43854597|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43854598|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
43854599|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
44356806|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44356807|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356808|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356809|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356810|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44356811|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44356812|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356813|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356814|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
44356815|NCT01116596|Acetaminophen|acetaminophen|mesh-list
44356816|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356817|NCT01116596|Analgesics|analgesics|mesh-ancestor
44356818|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
44356819|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356820|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356821|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
44356822|NCT01116609|Epinephrine|epinephrine|mesh-list
44356823|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44356824|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44356825|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356826|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356827|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356828|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670936|NCT05419583|Edoxaban|edoxaban|mesh-list
43854600|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
43854601|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43854602|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854603|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43854604|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
43854605|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
43854606|NCT03660046|Etonogestrel|etonogestrel|mesh-list
43854607|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43854608|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
43854609|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43854610|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854613|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43854614|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43854615|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43854616|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854617|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854618|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
43854619|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854620|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854621|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43854622|NCT03657433|Hematinics|hematinics|mesh-ancestor
43854623|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43854624|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43854625|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43854626|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
43854627|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854629|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356829|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44356830|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44356831|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
44356832|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356833|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44356834|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356836|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
44356837|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44356838|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44356839|NCT01116622|Bexarotene|bexarotene|mesh-list
44356840|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356841|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44356842|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670959|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
43854630|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854631|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854632|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43854633|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43854634|NCT03654105|Aspirin|aspirin|mesh-list
43854635|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43854636|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43854637|NCT03654105|Analgesics|analgesics|mesh-ancestor
43854638|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
43854639|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854640|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854641|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854642|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854643|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43854644|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43854645|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854646|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43854647|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43854648|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854649|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
43854650|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
43854651|NCT03654040|Everolimus|everolimus|mesh-list
43854652|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854653|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
43854654|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854655|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854656|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854657|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
43854658|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854659|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854660|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854662|NCT03653247|Busulfan|busulfan|mesh-list
43854663|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
43854664|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854665|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854666|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
43854667|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854668|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854669|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854670|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854671|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43854672|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43854673|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
43854674|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854675|NCT03652974|Valproic Acid|valproic acid|mesh-list
44356843|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356845|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44356846|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356847|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44356848|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44356849|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356850|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356851|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
44356852|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44356853|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670974|NCT05392699|Growth Substances|growth substances|mesh-ancestor
43854676|NCT03652974|Clozapine|clozapine|mesh-list
43854677|NCT03652974|Amisulpride|amisulpride|mesh-list
43854678|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
43854679|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854680|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854681|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
43854682|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43854683|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854684|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
43854685|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43854686|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854687|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43854688|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43854689|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
43854690|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43854691|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
43854692|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43854693|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
43854694|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43854695|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
43854696|NCT03652961|Abatacept|abatacept|mesh-list
43854697|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854698|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854699|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854700|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854701|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
43854702|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854703|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854704|NCT03651895|Metformin|metformin|mesh-list
43854705|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43854706|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854707|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
43854708|NCT03649841|Prednisone|prednisone|mesh-list
43854709|NCT03649841|Cortisone|cortisone|mesh-list
43854710|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
43854711|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
43854712|NCT03649841|Hormones|hormones|mesh-list
43854713|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43854714|NCT03649841|Androgens|androgens|mesh-list
43854715|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
43854716|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854717|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
43854718|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854719|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854720|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854721|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854722|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43854723|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854724|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854725|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
43821553|NCT04084717|Crizotinib|crizotinib|mesh-list
44356854|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356855|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356856|NCT01116700|Analgesics|analgesics|mesh-ancestor
44356857|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
44356858|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356859|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44356860|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44356861|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44356862|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356863|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356864|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356865|NCT01116713|Dexamethasone|dexamethasone|mesh-list
44356866|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356867|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
44356868|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
44356869|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356870|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356871|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356872|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
44356873|NCT01116713|Hormones|hormones|mesh-ancestor
44356874|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854726|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43854727|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
43854728|NCT03649841|Protective Agents|protective agents|mesh-ancestor
43854729|NCT03649841|Vitamins|vitamins|mesh-ancestor
43854730|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
43854731|NCT03649841|Estrogens|estrogens|mesh-ancestor
43854732|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
43854733|NCT03649152|Proxigermanium|proxigermanium|mesh-list
43854734|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854735|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
43854736|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
43854737|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854738|NCT03648021|Acetaminophen|acetaminophen|mesh-list
43854739|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43854740|NCT03648021|Analgesics|analgesics|mesh-ancestor
43854741|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
43854742|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854743|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854744|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
43854745|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
43854746|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854747|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854748|NCT03646188|Doxorubicin|doxorubicin|mesh-list
43854749|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43854750|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854751|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854752|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43854753|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43854754|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854755|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854756|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
43854757|NCT03644485|Tacrolimus|tacrolimus|mesh-list
43854758|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854759|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
44356875|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44356876|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356877|NCT01116791|Cisplatin|cisplatin|mesh-list
44356878|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356879|NCT01116817|Ritonavir|ritonavir|mesh-list
44356880|NCT01116817|Lopinavir|lopinavir|mesh-list
44356881|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44356882|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44356883|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
44356884|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356885|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356886|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44356887|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44356888|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
44356889|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356890|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44356891|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44356892|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
44356893|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44356894|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356895|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356896|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44356897|NCT01117038|Amlodipine|amlodipine|mesh-list
44356898|NCT01117038|Enalapril|enalapril|mesh-list
44356899|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44356900|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44356901|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44356902|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356903|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44356904|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356919|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44356920|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
44356921|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356922|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44356923|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
44356924|NCT01117116|Hormones|hormones|mesh-ancestor
44356925|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44356926|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44356927|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44356928|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44356929|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44356930|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44356931|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356932|NCT01117129|Rituximab|rituximab|mesh-list
44356933|NCT01117129|Methotrexate|methotrexate|mesh-list
44356934|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44356935|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44356936|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
44356937|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356938|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44356939|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44356940|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
44356941|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44356942|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44356943|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
44356944|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356945|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44356946|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356947|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44356963|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44356964|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44356965|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44356966|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44356967|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356968|NCT01117298|Urological Agents|urological agents|mesh-ancestor
44356969|NCT01117376|Erythromycin|erythromycin|mesh-list
44356970|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
44356971|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44356972|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
44356973|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
44356974|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44356975|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44356976|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44356977|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44356978|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854760|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854761|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43854781|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854782|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854783|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854784|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
43854785|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854786|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
43854787|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43854788|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
43854789|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43854790|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854791|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43854792|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43854793|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43854794|NCT03640481|Belumosudil|belumosudil|mesh-list
43854795|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43854796|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854797|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854798|NCT03640312|Candesartan|candesartan|mesh-list
43854799|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43854800|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43854801|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43854802|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854804|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
43854805|NCT03638375|Nivolumab|nivolumab|mesh-list
43854806|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854807|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854808|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854809|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854810|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
43854811|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854812|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
43854813|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854814|NCT03637075|Insulin|insulin|mesh-list
43854819|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133357|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44133358|NCT00153634|Ticarcillin|ticarcillin|mesh-list
44356979|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44356980|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44356981|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356982|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
44356983|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356984|NCT01117610|Ropivacaine|ropivacaine|mesh-list
44356985|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
44356986|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
44356987|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44356988|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356989|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
44356990|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356991|NCT01117636|Aspirin|aspirin|mesh-list
44356992|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44356993|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44356994|NCT01117636|Analgesics|analgesics|mesh-ancestor
44356995|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
44356996|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44356997|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44356998|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44356999|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357000|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44357001|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44357002|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357003|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44357004|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44357005|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357006|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
44133359|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44133360|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44133361|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133362|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44133363|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44133364|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133365|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133366|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133367|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44133368|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44133369|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44133370|NCT00153660|Celecoxib|celecoxib|mesh-list
44133371|NCT00153660|Naproxen|naproxen|mesh-list
44133372|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133373|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133374|NCT00153660|Analgesics|analgesics|mesh-ancestor
44357007|NCT01117662|Rituximab|rituximab|mesh-list
44357008|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357009|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357010|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
44357011|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357012|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357013|NCT01118039|Sunitinib|sunitinib|mesh-list
44357014|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357015|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357016|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357017|NCT01118039|Growth Substances|growth substances|mesh-ancestor
44357018|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357019|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357020|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44357021|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357022|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357023|NCT01118065|Everolimus|everolimus|mesh-list
44357024|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357025|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357026|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
44357027|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357028|NCT01118234|Rituximab|rituximab|mesh-list
44357029|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357030|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357031|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
44357032|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357033|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357034|NCT01118260|Anesthetics|anesthetics|mesh-list
44133375|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
44133376|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133377|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133378|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133379|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133380|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44133381|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133382|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133383|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133384|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
44133385|NCT00153673|Celecoxib|celecoxib|mesh-list
44133386|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133387|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133388|NCT00153673|Analgesics|analgesics|mesh-ancestor
44133389|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
44133390|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133391|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133392|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44357035|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357036|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357038|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44357039|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357040|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357041|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357042|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357043|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357044|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
44012150|NCT03179345|Analgesics|analgesics|mesh-ancestor
44357045|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357046|NCT01118403|Ampicillin|ampicillin|mesh-list
44357047|NCT01118403|Sulbactam|sulbactam|mesh-list
44357048|NCT01118403|Sultamicillin|sultamicillin|mesh-list
44357049|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357050|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357051|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44357052|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357053|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357054|NCT01118429|Oxybutynin|oxybutynin|mesh-list
44357055|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
44357056|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
44357057|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357058|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357083|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357084|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44357085|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357086|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44357087|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44357088|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357089|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357090|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
44357092|NCT01118598|Niacinamide|niacinamide|mesh-list
44357093|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
44357094|NCT01118598|Vitamins|vitamins|mesh-ancestor
44357095|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
44357096|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357097|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44357098|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
44357099|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357100|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44357101|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357102|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44357103|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44357104|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357105|NCT01118702|Methylphenidate|methylphenidate|mesh-list
44357106|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44357107|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357108|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44357109|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44357110|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357111|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357112|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
44357113|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357126|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357127|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44357128|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44357129|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44357130|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44357131|NCT01118884|Promethazine|promethazine|mesh-list
44357132|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
44357133|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
44357134|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357135|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44357136|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
44357137|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
44357138|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357139|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357140|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357141|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44357142|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44357143|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44357144|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357145|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
44357146|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
44357147|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
44357148|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357149|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
44357150|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
44357151|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357152|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44357153|NCT01118923|Antacids|antacids|mesh-ancestor
44357154|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357155|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357156|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44357157|NCT01118936|Antacids|antacids|mesh-ancestor
44357160|NCT01119014|Aripiprazole|aripiprazole|mesh-list
44357165|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357166|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357167|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357168|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
44357169|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
44357170|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357171|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357172|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44357173|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44357174|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
44357175|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44357176|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44357177|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44357178|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44357179|NCT01119079|Anesthetics|anesthetics|mesh-list
44357180|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357181|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357182|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
44357183|NCT01119144|Calcium|calcium|mesh-list
44357184|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357185|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357186|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44357187|NCT01119157|Vaccines|vaccines|mesh-list
44357188|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
44357189|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357190|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
44357191|NCT01119196|Icodextrin|icodextrin|mesh-list
44357192|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44357209|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357210|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
44357211|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357212|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44357213|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
44357214|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357215|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44357216|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44357217|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357218|NCT01119482|Vaccines|vaccines|mesh-list
44357219|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
44357220|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357221|NCT01119521|Isoniazid|isoniazid|mesh-list
44357222|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
44357223|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357224|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357225|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44357226|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44357227|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
44357228|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357229|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44357230|NCT01119534|Camphor|camphor|mesh-list
44357231|NCT01119534|Eucalyptol|eucalyptol|mesh-list
44357232|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
44357233|NCT01119534|Menthol|menthol|mesh-list
44357234|NCT01119534|Guaifenesin|guaifenesin|mesh-list
44357235|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44357236|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
44357237|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357238|NCT01119534|Expectorants|expectorants|mesh-ancestor
44357239|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44357240|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44357241|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44357242|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
44357243|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357244|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357245|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357246|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
44357247|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44357248|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
44357249|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
44357250|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357251|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
44357252|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44357253|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44357254|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357255|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
44357256|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
44357257|NCT01119534|Protective Agents|protective agents|mesh-ancestor
44357258|NCT01119599|Temozolomide|temozolomide|mesh-list
44357259|NCT01119599|R04929097|r04929097|mesh-list
44357260|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44357261|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
44357262|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357263|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357264|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357265|NCT01119638|Risperidone|risperidone|mesh-list
44357266|NCT01119638|Citalopram|citalopram|mesh-list
44357267|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44357268|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
44357269|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357270|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357271|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357272|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44357273|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357275|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357294|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
44357295|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357296|NCT01119885|Fentanyl|fentanyl|mesh-list
44357297|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44357298|NCT01119885|Narcotics|narcotics|mesh-ancestor
44357299|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357300|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357301|NCT01119885|Analgesics|analgesics|mesh-ancestor
44357302|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
44357303|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357304|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44357305|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44357306|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
44357307|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
44357308|NCT01120015|Diacetylrhein|diacetylrhein|mesh-list
44357309|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44357310|NCT01120106|Simendan|simendan|mesh-list
44357311|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44357312|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357313|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44357314|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44357315|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357316|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357317|NCT01120106|Protective Agents|protective agents|mesh-ancestor
44357318|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357319|NCT01120119|Calcitriol|calcitriol|mesh-list
44357320|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357321|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357322|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44357323|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357337|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357338|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357339|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357340|NCT01120158|Growth Substances|growth substances|mesh-ancestor
44357341|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357342|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357343|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
44357344|NCT01120171|Doxorubicin|doxorubicin|mesh-list
44357345|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44357346|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357347|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
44357348|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357349|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357350|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44357351|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
44357352|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357353|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357354|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44357355|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44357356|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44357357|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44357358|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357360|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44357361|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
44357362|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44357363|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
44357364|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357365|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357366|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
44357367|NCT01120327|Amlodipine|amlodipine|mesh-list
44357375|NCT01120340|Mesalamine|mesalamine|mesh-list
44357379|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
44357380|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357381|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357382|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44357383|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357384|NCT01120366|Methotrexate|methotrexate|mesh-list
44357385|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44357386|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
44357387|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357388|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357389|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44357390|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
44357391|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357392|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357393|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357394|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357395|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44357396|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357397|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
44357398|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357399|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44357400|NCT01120418|Besifloxacin|besifloxacin|mesh-list
44357401|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357402|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357403|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44357404|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44357405|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357406|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357409|NCT01120444|Insulin|insulin|mesh-list
44357423|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44357424|NCT01120665|Hormones|hormones|mesh-ancestor
44357425|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357426|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357427|NCT01120665|Estrogens|estrogens|mesh-ancestor
44357428|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44357429|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
44357430|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357431|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44357432|NCT01120769|Acetaminophen|acetaminophen|mesh-list
44357433|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44357434|NCT01120769|Analgesics|analgesics|mesh-ancestor
44357435|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
44357436|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357437|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357438|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
44357439|NCT01120795|Interferons|interferons|mesh-list
44357440|NCT01120795|Ribavirin|ribavirin|mesh-list
44357441|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44357442|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
44357443|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357444|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
44357445|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357446|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
44357474|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
44357475|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357476|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44357477|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
44357478|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357479|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357480|NCT01121042|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44357481|NCT01121042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357482|NCT01121042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357483|NCT01121042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357484|NCT01121042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44357485|NCT01121055|Lorazepam|lorazepam|mesh-list
44357486|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
44357487|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
44357488|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
44357489|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357490|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357491|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357492|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44357493|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357494|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44357495|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357496|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357497|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
44357498|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
44357499|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357500|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357501|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43671438|NCT04622865|Quercetin|quercetin|mesh-list
44133393|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133394|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44133395|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133396|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133397|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133398|NCT00153699|Topiramate|topiramate|mesh-list
44133399|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
44133400|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133401|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133402|NCT00153725|Aspirin|aspirin|mesh-list
44133403|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133404|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133405|NCT00153725|Analgesics|analgesics|mesh-ancestor
44133406|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
44133407|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133408|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133409|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43581455|NCT03460405|Vaccines|vaccines|mesh-list
44357502|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44357503|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357504|NCT01121133|Rifampin|rifampin|mesh-list
44357505|NCT01121133|Navitoclax|navitoclax|mesh-list
44357506|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44357507|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
44357508|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357509|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357510|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
44357511|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44357512|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357513|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357514|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44357515|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44357516|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44357517|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44357518|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44357519|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44357520|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357521|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
44357522|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44357523|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357524|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357525|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357526|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
44357527|NCT01121237|Hematinics|hematinics|mesh-ancestor
44357548|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44357549|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357550|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357551|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
44357552|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357553|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357555|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
44357556|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357557|NCT01121705|Interferons|interferons|mesh-list
44357558|NCT01121705|Ribavirin|ribavirin|mesh-list
44357559|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
44357560|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
44357561|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44357562|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357563|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
44357564|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357565|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
44357566|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357567|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
44357568|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357569|NCT01121731|Interferons|interferons|mesh-list
44357570|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
44357571|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357572|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
44357573|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357574|NCT01121744|Sirolimus|sirolimus|mesh-list
44357575|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357576|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357577|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44357578|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357579|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
44357593|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44357594|NCT01121796|Vitamin D|vitamin d|mesh-list
44357595|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
44357596|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
44357597|NCT01121796|Vitamins|vitamins|mesh-list
44357598|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
44357599|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357600|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44357601|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357602|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
44357603|NCT01121809|Etravirine|etravirine|mesh-list
44357604|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44357605|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44357606|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
44357607|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357608|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44357609|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44357610|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357611|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357612|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44357613|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44357614|NCT01121822|Vaccines|vaccines|mesh-list
44357615|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
44357616|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357617|NCT01121835|Insulin|insulin|mesh-list
44357618|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44357619|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
44357620|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
44357621|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357622|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357623|NCT01121848|Leucovorin|leucovorin|mesh-list
44357624|NCT01121848|Fluorouracil|fluorouracil|mesh-list
44357625|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
44357626|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
44357638|NCT01122004|Pregabalin|pregabalin|mesh-list
44357639|NCT01122004|Analgesics|analgesics|mesh-ancestor
44357640|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
44357641|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357642|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357643|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
44357644|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44357645|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357646|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357647|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357648|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44357649|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357650|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357651|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357652|NCT01122056|Interferons|interferons|mesh-list
44357653|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
44357654|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357655|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
44357656|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357657|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44357658|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
44357659|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357660|NCT01122121|Leuprolide|leuprolide|mesh-list
44357661|NCT01122121|Flutamide|flutamide|mesh-list
44357662|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44357663|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
44357664|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357665|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357666|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44357667|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357668|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
44357669|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
43671566|NCT04395079|Durvalumab|durvalumab|mesh-list
44133410|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133411|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44133412|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44133413|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133414|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44133415|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133416|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133417|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
44357670|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357671|NCT01122134|Artesunate|artesunate|mesh-list
44357672|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
44357673|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44357674|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44357675|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357676|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357677|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
44357678|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
44357679|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44357680|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
44357681|NCT01122199|Everolimus|everolimus|mesh-list
44357682|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357683|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357684|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
44357685|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357686|NCT01122251|Valsartan|valsartan|mesh-list
44357687|NCT01122251|Lercanidipine|lercanidipine|mesh-list
44357688|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44357689|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44357690|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44357691|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357692|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44357693|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357694|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44357695|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357696|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
44357697|NCT01122342|Testosterone|testosterone|mesh-list
44012807|NCT04122170|Aspirin|aspirin|mesh-list
44357715|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44357716|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44357717|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
44357718|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357719|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357720|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44357721|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44357722|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
44357723|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357724|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357725|NCT01122472|Lenalidomide|lenalidomide|mesh-list
44357726|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
44357727|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357728|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357729|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357730|NCT01122472|Growth Substances|growth substances|mesh-ancestor
44357731|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357732|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357733|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
44357734|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44357735|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44357736|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
44357737|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357738|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357739|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357740|NCT01122563|Urological Agents|urological agents|mesh-ancestor
44357741|NCT01122602|Aspirin|aspirin|mesh-list
44357742|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44357743|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44357744|NCT01122602|Analgesics|analgesics|mesh-ancestor
44357745|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
44357746|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357747|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357748|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44357749|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357750|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44357752|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357753|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44357754|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44357755|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357756|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
44357758|NCT01122615|Sunitinib|sunitinib|mesh-list
44357759|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357760|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357761|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357762|NCT01122615|Growth Substances|growth substances|mesh-ancestor
44357763|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357764|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357765|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44357766|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357767|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357768|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44357769|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44357770|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44357771|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
44357772|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357773|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
44357774|NCT01122641|Vildagliptin|vildagliptin|mesh-list
44357775|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44357776|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357777|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44357778|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
44357779|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357780|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357781|NCT01122667|Anacetrapib|anacetrapib|mesh-list
44357796|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
44357797|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357798|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44357799|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357801|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
44357802|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44357803|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44357804|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357805|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357806|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44357807|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44357809|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
44357810|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44357811|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44357812|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357813|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357814|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44357815|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44357816|NCT01122966|Bevacizumab|bevacizumab|mesh-list
44357817|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44357818|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357819|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357820|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44357821|NCT01122966|Growth Substances|growth substances|mesh-ancestor
44357822|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357823|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
44357824|NCT01122979|Insulin|insulin|mesh-list
44357825|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44357826|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
44357827|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
44357828|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
44357838|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44357839|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357840|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357841|NCT01123057|Riboflavin|riboflavin|mesh-list
44357842|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
44357843|NCT01123057|Vitamins|vitamins|mesh-ancestor
44357844|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
44357845|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357846|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44357847|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357848|NCT01123265|Methotrexate|methotrexate|mesh-list
44357849|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44357850|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
44357851|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357852|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357853|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44357854|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
44357855|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357856|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357857|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
44357858|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357859|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44357860|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44357861|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
44357862|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44357863|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44357864|NCT01123278|Testosterone|testosterone|mesh-list
44357865|NCT01123278|Androgens|androgens|mesh-ancestor
44357866|NCT01123278|Hormones|hormones|mesh-ancestor
44357867|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357868|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357869|NCT01123317|Oxytocin|oxytocin|mesh-list
44357870|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
44357879|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357880|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357881|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44357882|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44357883|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44357884|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357885|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44357886|NCT01123408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44357887|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44357888|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44357889|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357890|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357891|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
44357892|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44357893|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
44357894|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44357895|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44357896|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
44357897|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
44357898|NCT01123473|Cisplatin|cisplatin|mesh-list
44357899|NCT01123473|Fluorouracil|fluorouracil|mesh-list
44357900|NCT01123473|Capecitabine|capecitabine|mesh-list
44357901|NCT01123473|Epirubicin|epirubicin|mesh-list
44357902|NCT01123473|Lapatinib|lapatinib|mesh-list
44357903|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357904|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
44357905|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357927|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357928|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44357929|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
44357930|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44357931|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
44357932|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
44357933|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357934|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357935|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
44357936|NCT01123538|Progesterone|progesterone|mesh-list
44357937|NCT01123538|Progestins|progestins|mesh-ancestor
44357938|NCT01123538|Hormones|hormones|mesh-ancestor
44357939|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44357940|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357941|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
44357942|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
44357943|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44357944|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44357945|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44357946|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
44357947|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44357948|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44357949|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44357950|NCT01123551|Morphine|morphine|mesh-list
44357951|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44357952|NCT01123551|Narcotics|narcotics|mesh-ancestor
44357953|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44357954|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357955|NCT01123551|Analgesics|analgesics|mesh-ancestor
44357956|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
44357957|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44357958|NCT01123564|Ranibizumab|ranibizumab|mesh-list
44357959|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44357965|NCT01123811|Cetuximab|cetuximab|mesh-list
44357967|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357968|NCT01123824|Clopidogrel|clopidogrel|mesh-list
44357969|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44357970|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44357971|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44357972|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44357973|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
44357974|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44357975|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357976|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357977|NCT01123876|Veliparib|veliparib|mesh-list
44357978|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44357979|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44357980|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357981|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44357982|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44357983|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44357984|NCT01123915|Protective Agents|protective agents|mesh-ancestor
44357985|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44357986|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44357987|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
44357988|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44357989|NCT01123967|Nicotine|nicotine|mesh-list
44357990|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44357991|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
44357992|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358008|NCT01124058|Heparin|heparin|mesh-list
44358012|NCT01124058|Dalteparin|dalteparin|mesh-list
44358013|NCT01124058|Warfarin|warfarin|mesh-list
44358014|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
44358015|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44358016|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44358017|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358018|NCT01124227|Icodextrin|icodextrin|mesh-list
44358019|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
44358020|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44358021|NCT01124240|Temozolomide|temozolomide|mesh-list
44358022|NCT01124240|Procarbazine|procarbazine|mesh-list
44358023|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358024|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
44358025|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358026|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358027|NCT01124253|Endostatins|endostatins|mesh-list
44358028|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358029|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358030|NCT01124253|Growth Substances|growth substances|mesh-ancestor
44358031|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358032|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358033|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358034|NCT01124318|Lactulose|lactulose|mesh-list
44358035|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358036|NCT01124383|Lidocaine|lidocaine|mesh-list
44358037|NCT01124383|Ephedrine|ephedrine|mesh-list
44358038|NCT01124383|Midazolam|midazolam|mesh-list
44358039|NCT01124383|Sufentanil|sufentanil|mesh-list
44358040|NCT01124383|Dsuvia|dsuvia|mesh-list
44358041|NCT01124383|Anesthetics|anesthetics|mesh-list
44358042|NCT01124383|Propofol|propofol|mesh-list
44358043|NCT01124383|Sevoflurane|sevoflurane|mesh-list
44358044|NCT01124383|Rocuronium|rocuronium|mesh-list
44358045|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
44358046|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358047|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358048|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
44358049|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358054|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358055|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44358056|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44358057|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
44358058|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44358059|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44358060|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44358061|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358062|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
44358063|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
44358064|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358065|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358066|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44358067|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44358068|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44358069|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44358070|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44358071|NCT01124383|Narcotics|narcotics|mesh-ancestor
44358072|NCT01124383|Analgesics|analgesics|mesh-ancestor
44358073|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44358074|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
44358075|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
44358076|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44358077|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
44358078|NCT01124435|Celecoxib|celecoxib|mesh-list
44358079|NCT01124435|Carboplatin|carboplatin|mesh-list
44358080|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358083|NCT01124435|Analgesics|analgesics|mesh-ancestor
44358101|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358102|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358103|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
44358104|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358105|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
44358106|NCT01124526|Rituximab|rituximab|mesh-list
44358107|NCT01124526|Fludarabine|fludarabine|mesh-list
44358108|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358109|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
44358110|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358111|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44358112|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358113|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
44358114|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358115|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358116|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44358117|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358118|NCT01124539|Camptothecin|camptothecin|mesh-list
44358119|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
44358120|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44358121|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358122|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44358123|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358124|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358125|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358126|NCT01124630|Leucovorin|leucovorin|mesh-list
44358127|NCT01124630|Fluorouracil|fluorouracil|mesh-list
44358128|NCT01124630|Irinotecan|irinotecan|mesh-list
44358129|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
44133418|NCT00153764|Vitamins|vitamins|mesh-list
44133419|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
44133421|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
44133422|NCT00153868|Hematinics|hematinics|mesh-ancestor
43854820|NCT03630640|Nivolumab|nivolumab|mesh-list
43854821|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854822|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854823|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854824|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854825|NCT03630315|Bevacizumab|bevacizumab|mesh-list
43854826|NCT03630315|Ranibizumab|ranibizumab|mesh-list
43854827|NCT03630315|Aflibercept|aflibercept|mesh-list
43854828|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854829|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854830|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43854831|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358130|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358131|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358132|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358133|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358134|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
44358135|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358136|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44358137|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358138|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358139|NCT01124630|Antidotes|antidotes|mesh-ancestor
44358140|NCT01124630|Protective Agents|protective agents|mesh-ancestor
44358141|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
44358142|NCT01124630|Vitamins|vitamins|mesh-ancestor
44358143|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
44358144|NCT01124656|Pioglitazone|pioglitazone|mesh-list
44358145|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44358146|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44358147|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358148|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44358149|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44358150|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013207|NCT04710368|Evolocumab|evolocumab|mesh-list
44358151|NCT01124760|Ketoconazole|ketoconazole|mesh-list
44358152|NCT01124760|Diltiazem|diltiazem|mesh-list
44358153|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
44358154|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358155|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44358156|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44358157|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358158|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358159|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44358160|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
44358161|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44358162|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854832|NCT03630315|Growth Substances|growth substances|mesh-ancestor
43854833|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854834|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
43854835|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
44358163|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44358165|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358166|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358167|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358168|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358169|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
44358170|NCT01124799|Simeprevir|simeprevir|mesh-list
44358171|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44358172|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358173|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44358174|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358175|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358176|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358177|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358178|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44358179|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44358180|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
44358181|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358182|NCT01124877|Ziprasidone|ziprasidone|mesh-list
44358183|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44358184|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
44358185|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358186|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358187|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358188|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44358189|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44358190|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358191|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358192|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44358193|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
44358194|NCT01125020|Gemcitabine|gemcitabine|mesh-list
44358195|NCT01125020|Cisplatin|cisplatin|mesh-list
44358196|NCT01125020|Doxorubicin|doxorubicin|mesh-list
44358203|NCT01125020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358204|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358205|NCT01125020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358206|NCT01125020|Immunologic Factors|immunologic factors|mesh-ancestor
44358207|NCT01125020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358208|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44358209|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44358210|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358211|NCT01125033|Vitamins|vitamins|mesh-list
44358212|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
44358213|NCT01125033|Vitamin E|vitamin e|mesh-list
44358214|NCT01125033|Tocopherols|tocopherols|mesh-list
44358215|NCT01125033|Tocotrienols|tocotrienols|mesh-list
44358216|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
44358217|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
44358218|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358219|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
44358220|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358221|NCT01125033|Protective Agents|protective agents|mesh-ancestor
44358222|NCT01125059|Methadone|methadone|mesh-list
44358223|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44358224|NCT01125059|Narcotics|narcotics|mesh-ancestor
44358225|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358226|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358227|NCT01125059|Analgesics|analgesics|mesh-ancestor
44358228|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
44358229|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358230|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
44358231|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
44358232|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
44358233|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44358234|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854836|NCT03630211|Thiotepa|thiotepa|mesh-list
43854837|NCT03630211|Rituximab|rituximab|mesh-list
43854838|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
43854839|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
43854840|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43854841|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
43854842|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43854843|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
43854844|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43854845|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854846|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
43854847|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854848|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854849|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854850|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
44358237|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358238|NCT01125215|Capsaicin|capsaicin|mesh-list
44358239|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
44358240|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
44358241|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
44358242|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358243|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358244|NCT01125254|Amlodipine|amlodipine|mesh-list
44358245|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358246|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358247|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358248|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358249|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43854851|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854852|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854853|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854854|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854855|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
43854856|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854857|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854858|NCT03629613|Antioxidants|antioxidants|mesh-list
43854859|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854860|NCT03629613|Protective Agents|protective agents|mesh-ancestor
43649118|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
43854861|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854862|NCT03629288|Azithromycin|azithromycin|mesh-list
43854863|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854864|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854865|NCT03629223|Tepotinib|tepotinib|mesh-list
43854866|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854867|NCT03628339|Tepotinib|tepotinib|mesh-list
43854868|NCT03628339|Midazolam|midazolam|mesh-list
43854869|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43854870|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43854871|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43854872|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854873|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43854874|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43854875|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43854876|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43854877|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
43854878|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
43854879|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
43854880|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
43854881|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43581518|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854882|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854883|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854884|NCT03627741|Triamcinolone|triamcinolone|mesh-list
43854885|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43854886|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43854887|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43854888|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854889|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
43854894|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
43854895|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854896|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854897|NCT03627715|Proxigermanium|proxigermanium|mesh-list
44358253|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
44358254|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
44358255|NCT01125410|Dequalinium|dequalinium|mesh-list
44358256|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44358257|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358258|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44358259|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358260|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854898|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854899|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
43854900|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
43854901|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854902|NCT03626337|Thiamine|thiamine|mesh-list
43854903|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
43854904|NCT03626337|Vitamins|vitamins|mesh-ancestor
43854905|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
43854906|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854907|NCT03625726|Thrombin|thrombin|mesh-list
43854908|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
43854909|NCT03625726|Coagulants|coagulants|mesh-ancestor
43854910|NCT03623854|Nivolumab|nivolumab|mesh-list
43854911|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
43854912|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
43854913|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854914|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854915|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854916|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854917|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
43854918|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854922|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43854923|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43854924|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
43854925|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854926|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854927|NCT03618654|Metformin|metformin|mesh-list
43854928|NCT03618654|Durvalumab|durvalumab|mesh-list
43854929|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
43854930|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43854931|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
43854932|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43854933|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854934|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854935|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854936|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
43854937|NCT03617445|Vancomycin|vancomycin|mesh-list
43854938|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854939|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854940|NCT03616574|Trifluridine|trifluridine|mesh-list
43854941|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
43854942|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854943|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
43854944|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854945|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
43854946|NCT03615105|Melphalan|melphalan|mesh-list
43854947|NCT03615105|Busulfan|busulfan|mesh-list
43854948|NCT03615105|Thiotepa|thiotepa|mesh-list
43854949|NCT03615105|Rituximab|rituximab|mesh-list
43854950|NCT03615105|Fludarabine|fludarabine|mesh-list
43854951|NCT03615105|Clofarabine|clofarabine|mesh-list
43854952|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43854953|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
43854954|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358261|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44358262|NCT01125423|Milnacipran|milnacipran|mesh-list
44358263|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
44358264|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44358265|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44358266|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358267|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358268|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358269|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358270|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44358271|NCT01125423|Analgesics|analgesics|mesh-ancestor
44358272|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
44358273|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358274|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
44358275|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358276|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
44358277|NCT01125449|Vitamins|vitamins|mesh-ancestor
44358278|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
44358279|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358280|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
44358281|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358282|NCT01125449|Protective Agents|protective agents|mesh-ancestor
44358283|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44358284|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
44358285|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43672045|NCT03182231|Exenatide|exenatide|mesh-list
43854955|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
43854956|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854957|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43854958|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43854959|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
43854960|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854961|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854962|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43854963|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854964|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854966|NCT03614741|Tinzaparin|tinzaparin|mesh-list
43854967|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43854968|NCT03614741|Dalteparin|dalteparin|mesh-list
43854969|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
43854970|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43854971|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43854972|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854973|NCT03611556|Leucovorin|leucovorin|mesh-list
43854974|NCT03611556|Gemcitabine|gemcitabine|mesh-list
43854975|NCT03611556|Paclitaxel|paclitaxel|mesh-list
43854976|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
43854977|NCT03611556|Fluorouracil|fluorouracil|mesh-list
43854978|NCT03611556|Durvalumab|durvalumab|mesh-list
44358286|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
44358287|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44358288|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358289|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44358290|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44358291|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358293|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
44358294|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358295|NCT01125553|Insulin|insulin|mesh-list
44358296|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
44358297|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44358298|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358299|NCT01125657|Darexaban|darexaban|mesh-list
44358300|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44358301|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
44358302|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44358303|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358304|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358305|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854979|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
43854980|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43854981|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854982|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854983|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
43854984|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854985|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854986|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43854987|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
43854988|NCT03611556|Antiviral Agents|antiviral agents|mesh-ancestor
43854989|NCT03611556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854990|NCT03611556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854991|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43854992|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
43854993|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854994|NCT03611556|Antidotes|antidotes|mesh-ancestor
43854995|NCT03611556|Protective Agents|protective agents|mesh-ancestor
43854996|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
43854997|NCT03611556|Vitamins|vitamins|mesh-ancestor
43854998|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
43854999|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855000|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
43855001|NCT03610490|Fludarabine|fludarabine|mesh-list
43855002|NCT03610490|Interleukin-2|interleukin-2|mesh-list
43855003|NCT03610490|Mitogens|mitogens|mesh-list
43855004|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855005|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
43855006|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855007|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855008|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855009|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
43855010|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855011|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855012|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43855013|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855014|NCT03610490|Analgesics|analgesics|mesh-ancestor
44358306|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
44358307|NCT01125670|Darexaban|darexaban|mesh-list
44358308|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44358309|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
44358310|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44358311|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358312|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358313|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358314|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
44358315|NCT01125683|Donepezil|donepezil|mesh-list
44358316|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44358317|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358318|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358319|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
44358320|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358321|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358322|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
44358323|NCT01125696|Ritonavir|ritonavir|mesh-list
44358324|NCT01125696|Lopinavir|lopinavir|mesh-list
44358325|NCT01125696|Tenofovir|tenofovir|mesh-list
44358326|NCT01125696|Lamivudine|lamivudine|mesh-list
44358327|NCT01125696|Zidovudine|zidovudine|mesh-list
44358328|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44358329|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44358330|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358331|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358332|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358333|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44358334|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44358343|NCT01125787|Ofatumumab|ofatumumab|mesh-list
44358353|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358354|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
44358355|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358356|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358357|NCT01125891|Antiviral Agents|antiviral agents|mesh-ancestor
44358358|NCT01125891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358359|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358360|NCT01125891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358361|NCT01125891|Immunologic Factors|immunologic factors|mesh-ancestor
44358362|NCT01125891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358363|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44358364|NCT01125904|Crizotinib|crizotinib|mesh-list
44358365|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358366|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44358367|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358368|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358369|NCT01125943|Bevacizumab|bevacizumab|mesh-list
44358370|NCT01125943|Nitroprusside|nitroprusside|mesh-list
44358371|NCT01125943|Acetylcholine|acetylcholine|mesh-list
44358372|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358373|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358374|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358375|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358376|NCT01125943|Growth Substances|growth substances|mesh-ancestor
44358377|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358378|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
43672126|NCT02827435|Bromides|bromides|mesh-list
43855015|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
43855016|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855017|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855018|NCT03609593|Rituximab|rituximab|mesh-list
43855019|NCT03609593|Venetoclax|venetoclax|mesh-list
43855020|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43855021|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855022|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855023|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
43855024|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855025|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855026|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855027|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
43855028|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855029|NCT03609216|Gemcitabine|gemcitabine|mesh-list
43855030|NCT03609216|Cisplatin|cisplatin|mesh-list
43855031|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855032|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855033|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
43855034|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358379|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358380|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358381|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44358382|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358383|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44358384|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
44358385|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358386|NCT01125982|Propofol|propofol|mesh-list
44358387|NCT01125982|Desflurane|desflurane|mesh-list
44358388|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44358389|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358390|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358391|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44358392|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
44358393|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
44358394|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44358395|NCT01126008|Cisplatin|cisplatin|mesh-list
44358396|NCT01126008|Docetaxel|docetaxel|mesh-list
44358397|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358398|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44358399|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44358400|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44358401|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358402|NCT01126073|Niacin|niacin|mesh-list
44358403|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44358404|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
43642518|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
44358405|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358406|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44358407|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358408|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
44358409|NCT01126073|Vitamins|vitamins|mesh-ancestor
44358410|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
44358411|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358412|NCT01126086|Otamixaban|otamixaban|mesh-list
43855035|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
43855036|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855037|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855038|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855039|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
43855040|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855041|NCT03609060|Dexamethasone|dexamethasone|mesh-list
43855049|NCT03609060|Hormones|hormones|mesh-ancestor
43855050|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44358413|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44358414|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
44358415|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44358416|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358417|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358418|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358419|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
44358420|NCT01126112|Panitumumab|panitumumab|mesh-list
44358421|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358422|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358423|NCT01126138|Docetaxel|docetaxel|mesh-list
44358424|NCT01126138|Capecitabine|capecitabine|mesh-list
44358425|NCT01126138|Vinorelbine|vinorelbine|mesh-list
44358426|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358427|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
44358428|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
44358429|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
44358430|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358431|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358432|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
44358433|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44358434|NCT01126177|Interferons|interferons|mesh-list
44358435|NCT01126177|Interferon-beta|interferon-beta|mesh-list
44358436|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
44358437|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358438|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
44358439|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358440|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
44358441|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358442|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44358443|NCT01126216|Paclitaxel|paclitaxel|mesh-list
44358444|NCT01126216|Cisplatin|cisplatin|mesh-list
44358445|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44358446|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358451|NCT01126229|Resveratrol|resveratrol|mesh-list
44358455|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358456|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358457|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358459|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
44358460|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358461|NCT01126294|Protective Agents|protective agents|mesh-ancestor
44358462|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358463|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358464|NCT01126307|Verapamil|verapamil|mesh-list
44358465|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44358466|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358467|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358468|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358469|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358470|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358471|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358472|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44358473|NCT01126450|Cetuximab|cetuximab|mesh-list
44358474|NCT01126450|Lenalidomide|lenalidomide|mesh-list
44358475|NCT01126450|Antibodies|antibodies|mesh-list
44358476|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
44358477|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44358478|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
43855051|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855052|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855053|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43855054|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
43855055|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855056|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43855057|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
43855058|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855059|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855060|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43855061|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43855062|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855063|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855064|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
43855065|NCT03605654|Tacrolimus|tacrolimus|mesh-list
43855066|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43855067|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
43855068|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855069|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43855070|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855071|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855072|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43855073|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855074|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43855075|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
43855076|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44358480|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358481|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358482|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358483|NCT01126450|Growth Substances|growth substances|mesh-ancestor
44358484|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358486|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358487|NCT01126528|Vitamin D|vitamin d|mesh-list
44358488|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
44358489|NCT01126528|Vitamins|vitamins|mesh-ancestor
44358490|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
44358491|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855077|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855078|NCT03604653|Cisplatin|cisplatin|mesh-list
43855079|NCT03604653|Doxorubicin|doxorubicin|mesh-list
43855080|NCT03604653|Mitomycins|mitomycins|mesh-list
43855081|NCT03604653|Mitomycin|mitomycin|mesh-list
43855082|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855083|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43855084|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43855085|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43855086|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855087|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855088|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
43855089|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43855090|NCT03604406|Vaccines|vaccines|mesh-list
43855091|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
43855092|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855093|NCT03603080|Metformin|metformin|mesh-list
43855094|NCT03603080|Topiramate|topiramate|mesh-list
43855095|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
43855096|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43855097|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855098|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
43855099|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43855100|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43855101|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43855102|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
43855103|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43855104|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
43855105|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855106|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855107|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43855108|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
43855109|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43855110|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
43855124|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855125|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
43855126|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600899|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
43855127|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855128|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855129|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
43855130|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855131|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855132|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43855133|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43855134|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43855135|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855136|NCT03600441|Abexinostat|abexinostat|mesh-list
43855137|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43855138|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163839|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358492|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44358493|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358495|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44358496|NCT01126606|Protective Agents|protective agents|mesh-ancestor
44358497|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358498|NCT01126645|Sorafenib|sorafenib|mesh-list
44358499|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358500|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44358501|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358502|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358503|NCT01126684|Atorvastatin|atorvastatin|mesh-list
44358504|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44358505|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44358506|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
44358507|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358508|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44358509|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44358510|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358511|NCT01126697|Ubiquinone|ubiquinone|mesh-list
44358512|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
44358513|NCT01126697|Lisinopril|lisinopril|mesh-list
44358514|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44358515|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
44358516|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358517|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358518|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358519|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44358520|NCT01126697|Protective Agents|protective agents|mesh-ancestor
44358521|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358522|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
44358523|NCT01126697|Vitamins|vitamins|mesh-ancestor
44358524|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
44358525|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672177|NCT02572141|Fluorouracil|fluorouracil|mesh-list
43855139|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855140|NCT03600350|Nivolumab|nivolumab|mesh-list
43855141|NCT03600350|Sargramostim|sargramostim|mesh-list
43855142|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855143|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855144|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44358526|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44358527|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358528|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358529|NCT01126866|Bevacizumab|bevacizumab|mesh-list
44358530|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358531|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358532|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358533|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358534|NCT01126866|Growth Substances|growth substances|mesh-ancestor
44358535|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358536|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358538|NCT01127009|Etoposide|etoposide|mesh-list
44358539|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
43855145|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855146|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
43855147|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855148|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
43855149|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
43855150|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855151|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855152|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43855153|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855154|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855155|NCT03598595|Gemcitabine|gemcitabine|mesh-list
43855156|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
43855157|NCT03598595|Docetaxel|docetaxel|mesh-list
43855158|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855159|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
43855160|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855161|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855162|NCT03598595|Antiviral Agents|antiviral agents|mesh-ancestor
43855163|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855164|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855165|NCT03598595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855166|NCT03598595|Immunologic Factors|immunologic factors|mesh-ancestor
43855167|NCT03598595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855168|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855169|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855170|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133424|NCT00153881|Docetaxel|docetaxel|mesh-list
44133425|NCT00153881|Capecitabine|capecitabine|mesh-list
44133426|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133427|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133428|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133429|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133430|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133431|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133432|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
44133433|NCT00153907|Capecitabine|capecitabine|mesh-list
44133434|NCT00153907|Vinorelbine|vinorelbine|mesh-list
44133435|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133436|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
44133437|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133438|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133439|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133440|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133441|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133442|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133443|NCT00153933|Lenalidomide|lenalidomide|mesh-list
44133444|NCT00153933|Bortezomib|bortezomib|mesh-list
44133445|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
44358541|NCT01127009|Bortezomib|bortezomib|mesh-list
44358542|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
44358543|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44358544|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358545|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44358546|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358547|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358548|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358549|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358550|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
44358551|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
44358552|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358553|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358554|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
44358555|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358556|NCT01127009|Analgesics|analgesics|mesh-ancestor
44358557|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
44358558|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358559|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
44358560|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44358561|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133446|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133447|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44133448|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44133449|NCT00153933|Growth Substances|growth substances|mesh-ancestor
43855175|NCT03595592|Paclitaxel|paclitaxel|mesh-list
43855176|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43855177|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
43855178|NCT03595592|Carboplatin|carboplatin|mesh-list
43855179|NCT03595592|Doxorubicin|doxorubicin|mesh-list
43855180|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43855181|NCT03595592|Trastuzumab|trastuzumab|mesh-list
43855182|NCT03595592|Atezolizumab|atezolizumab|mesh-list
43855183|NCT03595592|Pertuzumab|pertuzumab|mesh-list
43855184|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855185|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855186|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855187|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855188|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855189|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855190|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855191|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
43855192|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855193|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855194|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855195|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
43855196|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43855197|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43855198|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43855199|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43855200|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855201|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855202|NCT03594747|Paclitaxel|paclitaxel|mesh-list
44358562|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44358563|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44358564|NCT01127022|Choline|choline|mesh-list
44358565|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
44358566|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44358567|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
44358568|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358569|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358570|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44358571|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
44358572|NCT01127100|Fentanyl|fentanyl|mesh-list
44358573|NCT01127100|Gabapentin|gabapentin|mesh-list
44358574|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44358575|NCT01127100|Narcotics|narcotics|mesh-ancestor
44358576|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358577|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358578|NCT01127100|Analgesics|analgesics|mesh-ancestor
44358579|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
44358580|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358581|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44358582|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44358583|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
44358584|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
44358585|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
44358586|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44358587|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44358588|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358589|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44358590|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44358591|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358607|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44358609|NCT01127217|Amlodipine|amlodipine|mesh-list
44358610|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358611|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358612|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358613|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358614|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358615|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358616|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358617|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44358618|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44358619|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44358620|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
44358621|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44358622|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358623|NCT01127282|Vitamins|vitamins|mesh-list
44358624|NCT01127282|Vitamin A|vitamin a|mesh-list
44358625|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
44358626|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358627|NCT01127295|Tamoxifen|tamoxifen|mesh-list
44358628|NCT01127295|Letrozole|letrozole|mesh-list
44358629|NCT01127295|Anastrozole|anastrozole|mesh-list
44358659|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
44358660|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358661|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358662|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358663|NCT01127386|Growth Substances|growth substances|mesh-ancestor
44358664|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358665|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358666|NCT01127464|Poly ICLC|poly iclc|mesh-list
44358667|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
44358668|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
44358669|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358670|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44358671|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
44358672|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
44358673|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44358674|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44358675|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44358676|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358677|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855203|NCT03594747|Carboplatin|carboplatin|mesh-list
43855204|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855205|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855206|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855207|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855208|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855209|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855210|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
43855211|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
43855212|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855213|NCT03593408|Fentanyl|fentanyl|mesh-list
43855214|NCT03593408|Midazolam|midazolam|mesh-list
43855215|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
43855216|NCT03593408|Morphine|morphine|mesh-list
43855217|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43855231|NCT03593408|Narcotics|narcotics|mesh-ancestor
43855232|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43855233|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43855234|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
43855235|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
43855236|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43855237|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43855238|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43855239|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
43855240|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
43855241|NCT03592472|Abexinostat|abexinostat|mesh-list
43855242|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43855243|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855244|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855245|NCT03591770|Vaccines|vaccines|mesh-list
43855246|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
43855247|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855248|NCT03587961|Ivacaftor|ivacaftor|mesh-list
43855249|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43855250|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855251|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358678|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358679|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358680|NCT01127490|Analgesics|analgesics|mesh-ancestor
44358681|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
44358682|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358683|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
44358684|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358685|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
44358686|NCT01127529|Protein C|protein c|mesh-list
44358687|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
44358688|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44358689|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44358690|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358691|NCT01127542|Lenalidomide|lenalidomide|mesh-list
44358692|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
44358693|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358694|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358695|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358696|NCT01127542|Growth Substances|growth substances|mesh-ancestor
44358697|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358698|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358699|NCT01127555|Leucovorin|leucovorin|mesh-list
44358700|NCT01127555|Fluorouracil|fluorouracil|mesh-list
44358701|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
44358702|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
44358703|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358704|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358705|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358706|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358707|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
44358708|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358709|NCT01127555|Antidotes|antidotes|mesh-ancestor
44358710|NCT01127555|Protective Agents|protective agents|mesh-ancestor
44358711|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
44358712|NCT01127555|Vitamins|vitamins|mesh-ancestor
44358713|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
44358714|NCT01127568|Propranolol|propranolol|mesh-list
43855252|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43855253|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855254|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358715|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44358716|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44358717|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
44358718|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358719|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358720|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358721|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44358722|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358723|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358724|NCT01127594|Temozolomide|temozolomide|mesh-list
44358725|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358726|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
44358727|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358728|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855255|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855256|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855257|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855258|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855259|NCT03586661|Niraparib|niraparib|mesh-list
43855260|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43855261|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855262|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855263|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855264|NCT03586414|Ubiquinone|ubiquinone|mesh-list
43855265|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
43855266|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855267|NCT03584373|Acetaminophen|acetaminophen|mesh-list
43855268|NCT03584373|Ketorolac|ketorolac|mesh-list
43855269|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43855270|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43855271|NCT03584373|Oxycodone|oxycodone|mesh-list
43855272|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855273|NCT03584373|Analgesics|analgesics|mesh-ancestor
43855274|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
43855275|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855276|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855277|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
43855299|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855300|NCT03582033|Dexamethasone|dexamethasone|mesh-list
43855301|NCT03582033|Pomalidomide|pomalidomide|mesh-list
43855302|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855303|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
43855304|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
43855305|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855306|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855307|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43855309|NCT03582033|Hormones|hormones|mesh-ancestor
43855310|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855311|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855312|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855313|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
43855314|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43855315|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43855316|NCT03582033|Growth Substances|growth substances|mesh-ancestor
43855317|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
43855318|NCT03580408|Nivolumab|nivolumab|mesh-list
43655665|NCT02967432|Mupirocin|mupirocin|mesh-list
43855319|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855320|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855321|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43702395|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44358729|NCT01127620|Cetirizine|cetirizine|mesh-list
44358730|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44358731|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44358732|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44358733|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
44358734|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
44358735|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358736|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358737|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358738|NCT01127672|Betamethasone|betamethasone|mesh-list
43855322|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855323|NCT03580356|Omalizumab|omalizumab|mesh-list
43855324|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43855325|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43855326|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
43855328|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
43855329|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
43855330|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43855334|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855335|NCT03580317|Analgesics|analgesics|mesh-ancestor
43855336|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
43855337|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855338|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43855339|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855340|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855341|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43855342|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43855343|NCT03580187|Morphine|morphine|mesh-list
43855344|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43855345|NCT03580187|Narcotics|narcotics|mesh-ancestor
43855346|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855347|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855348|NCT03580187|Analgesics|analgesics|mesh-ancestor
43855349|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
43855350|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855351|NCT03579615|Insulin|insulin|mesh-list
43855352|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
43855353|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43855354|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855355|NCT03576755|Spironolactone|spironolactone|mesh-list
43855356|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43855357|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43855358|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855359|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855360|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43855361|NCT03576755|Diuretics|diuretics|mesh-ancestor
43855362|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
43855363|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43855364|NCT03575403|Methylphenidate|methylphenidate|mesh-list
43855365|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43855366|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855367|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43855368|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43855369|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855370|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855371|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
43855372|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855373|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43855374|NCT03575403|Analgesics|analgesics|mesh-ancestor
43855375|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
43855376|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855377|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
43855378|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358741|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
44358742|NCT01127672|Hormones|hormones|mesh-ancestor
44358743|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44358744|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358745|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44358746|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
44358747|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
44358748|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
44358749|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358750|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
44358751|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358752|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44358753|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44358754|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44358755|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358756|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358757|NCT01127724|Vitamins|vitamins|mesh-list
44358758|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
44358759|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
44358760|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
44358761|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
43855379|NCT03575052|Pimavanserin|pimavanserin|mesh-list
43582060|NCT04221087|Hormones|hormones|mesh-ancestor
43855380|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43855381|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43855382|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43855383|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43855384|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855385|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855386|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43855387|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43855388|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43855389|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
43855390|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855391|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855392|NCT03573349|Ketamine|ketamine|mesh-list
43855393|NCT03573349|Analgesics|analgesics|mesh-ancestor
43855394|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
43855395|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855396|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855397|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43855398|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43855399|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
43855403|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43855404|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855405|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855406|NCT03573024|Azacitidine|azacitidine|mesh-list
44358762|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358763|NCT01127724|Hematinics|hematinics|mesh-ancestor
44358764|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44358765|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44358766|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358767|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358768|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
44358769|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358770|NCT01127841|Rituximab|rituximab|mesh-list
44358771|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44358772|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855407|NCT03573024|Venetoclax|venetoclax|mesh-list
43855408|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855409|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
43855410|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855411|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855412|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855413|NCT03572530|Azacitidine|azacitidine|mesh-list
43855414|NCT03572530|Decitabine|decitabine|mesh-list
43855415|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855416|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
43855417|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855418|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855419|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855420|NCT03572387|Azacitidine|azacitidine|mesh-list
43855421|NCT03572387|Tretinoin|tretinoin|mesh-list
43855422|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855423|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
43855424|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855425|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855426|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855427|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
43855428|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
43855429|NCT03570814|Azithromycin|azithromycin|mesh-list
43855430|NCT03570814|Ivermectin|ivermectin|mesh-list
43855431|NCT03570814|Albendazole|albendazole|mesh-list
43855432|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855433|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855434|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43855435|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
43855436|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
43855437|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43855438|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43855439|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855440|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855441|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855442|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855443|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855444|NCT03568643|Amoxicillin|amoxicillin|mesh-list
43855445|NCT03568643|Azithromycin|azithromycin|mesh-list
43855446|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855447|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133450|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
44133451|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133452|NCT00153946|Edaravone|edaravone|mesh-list
44133453|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44133454|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
44133455|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133456|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44133457|NCT00153946|Protective Agents|protective agents|mesh-ancestor
44133458|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133459|NCT00153972|Levodopa|levodopa|mesh-list
44133460|NCT00153972|Cabergoline|cabergoline|mesh-list
44133461|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44133462|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44358774|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
44358775|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358776|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44358777|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358778|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
44358779|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358781|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
44358782|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
44358783|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44358784|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358785|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44358786|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358787|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358788|NCT01127906|Oxycodone|oxycodone|mesh-list
44358789|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44358790|NCT01127906|Narcotics|narcotics|mesh-ancestor
44358791|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358792|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358793|NCT01127906|Analgesics|analgesics|mesh-ancestor
44358794|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
44358795|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133463|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
44133464|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133465|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133466|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133467|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
44133468|NCT00153998|Leucovorin|leucovorin|mesh-list
44133469|NCT00153998|Folic Acid|folic acid|mesh-list
44133470|NCT00153998|Fluorouracil|fluorouracil|mesh-list
44133471|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
44133472|NCT00153998|Irinotecan|irinotecan|mesh-list
44133473|NCT00153998|Cetuximab|cetuximab|mesh-list
44133474|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
44133475|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
44133476|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855450|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
43855451|NCT03568383|Isoniazid|isoniazid|mesh-list
43855452|NCT03568383|Vitamins|vitamins|mesh-ancestor
43855453|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
43855454|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855455|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
43855456|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
43855457|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855458|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855459|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43855460|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855461|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
43855462|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855463|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855464|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
44358796|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44358798|NCT01127984|Coagulants|coagulants|mesh-ancestor
44358799|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
44358800|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44358801|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
44358802|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358803|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358804|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
44358805|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358806|NCT01128101|Spironolactone|spironolactone|mesh-list
44358807|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44358808|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
44358809|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44358810|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358811|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44358812|NCT01128101|Diuretics|diuretics|mesh-ancestor
44358813|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
44358814|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44358815|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44358816|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
44358817|NCT01128257|Alendronate|alendronate|mesh-list
43855465|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855466|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855467|NCT03567876|Venetoclax|venetoclax|mesh-list
43855468|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855469|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43855470|NCT03565835|Prednisone|prednisone|mesh-list
43855471|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
43855472|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855473|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
43855474|NCT03565835|Hormones|hormones|mesh-ancestor
43855475|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855476|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855477|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855478|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855479|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43855480|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855481|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855482|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
43855483|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43855484|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
43855485|NCT03564756|Vitamins|vitamins|mesh-ancestor
43855486|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
43855487|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855488|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
43855489|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855490|NCT03564756|Protective Agents|protective agents|mesh-ancestor
43855491|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
43855492|NCT03563729|Nivolumab|nivolumab|mesh-list
43855493|NCT03563729|Ipilimumab|ipilimumab|mesh-list
43855494|NCT03563729|Trametinib|trametinib|mesh-list
43855495|NCT03563729|Dabrafenib|dabrafenib|mesh-list
43855496|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855497|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358818|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
44358819|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44358820|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358821|NCT01128322|Niacin|niacin|mesh-list
44358822|NCT01128322|Amlodipine|amlodipine|mesh-list
44358823|NCT01128322|Telmisartan|telmisartan|mesh-list
44358824|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44358825|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358826|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358827|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358828|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358829|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358830|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
44358831|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44358832|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44358833|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44358834|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
44358835|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44358836|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
44358837|NCT01128322|Vitamins|vitamins|mesh-ancestor
44358838|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
44013933|NCT03198221|Antacids|antacids|mesh-ancestor
44358839|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
44358840|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44358841|NCT01128699|Bevacizumab|bevacizumab|mesh-list
44358842|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358843|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358844|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44358845|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44358846|NCT01128699|Growth Substances|growth substances|mesh-ancestor
43855498|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855499|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855500|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43855501|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855502|NCT03563248|Nivolumab|nivolumab|mesh-list
43855503|NCT03563248|Folfirinox|folfirinox|mesh-list
43855504|NCT03563248|Losartan|losartan|mesh-list
43855505|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855506|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855507|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855508|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855509|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43855510|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43855511|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44358847|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358848|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
44358849|NCT01128712|Pregabalin|pregabalin|mesh-list
44358850|NCT01128712|Analgesics|analgesics|mesh-ancestor
44358851|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
44358852|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358853|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358854|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
44358855|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44358856|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44358857|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358858|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44358859|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44358860|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44358861|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44358862|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44358863|NCT01128985|Canagliflozin|canagliflozin|mesh-list
44358864|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44358865|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358866|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43855512|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43855514|NCT03559348|Gemcitabine|gemcitabine|mesh-list
43855515|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855516|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
43855517|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855518|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855519|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
43855536|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855537|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855538|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43855539|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
43855540|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43855541|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
43855542|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
43855543|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855544|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855546|NCT03557008|Vancomycin|vancomycin|mesh-list
43855547|NCT03557008|Neomycin|neomycin|mesh-list
43855548|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855549|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855550|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43855551|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43855552|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43855553|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855554|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855555|NCT03556332|Dexamethasone|dexamethasone|mesh-list
43855556|NCT03556332|Lenalidomide|lenalidomide|mesh-list
43855557|NCT03556332|Daratumumab|daratumumab|mesh-list
43855558|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855559|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
43855560|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
43855561|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855562|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358867|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358868|NCT01128998|Sorafenib|sorafenib|mesh-list
44358869|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358870|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44358871|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358872|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358873|NCT01129063|Clopidogrel|clopidogrel|mesh-list
44358874|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358875|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358876|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358877|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358878|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
44358879|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358880|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358881|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358882|NCT01129089|Micronutrients|micronutrients|mesh-list
43855563|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43855564|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
43855565|NCT03556332|Hormones|hormones|mesh-ancestor
43855566|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855567|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855568|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855569|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
43855570|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43855571|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43855572|NCT03556332|Growth Substances|growth substances|mesh-ancestor
43855573|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
43855574|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
43855575|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
43855576|NCT03553875|Memantine|memantine|mesh-list
43855577|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43855578|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43855579|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
43855580|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855581|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855584|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43855586|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43855587|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43855588|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855589|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
43855590|NCT03553186|Coagulants|coagulants|mesh-ancestor
43855591|NCT03552471|Rucaparib|rucaparib|mesh-list
43855592|NCT03552471|Maytansine|maytansine|mesh-list
43855593|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43855594|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855595|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855596|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855597|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855598|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855599|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855600|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855601|NCT03551522|Seladelpar|seladelpar|mesh-list
43855602|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855604|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855605|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855606|NCT03550794|Thiamine|thiamine|mesh-list
43855607|NCT03550794|Vitamins|vitamins|mesh-ancestor
43855608|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
44358884|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358885|NCT01129154|Panitumumab|panitumumab|mesh-list
44358886|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44358887|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358888|NCT01129180|Azacitidine|azacitidine|mesh-list
44358889|NCT01129180|Bortezomib|bortezomib|mesh-list
44358890|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44358891|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
44358892|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358893|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358894|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358895|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
44358896|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358897|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358898|NCT01129271|Clopidogrel|clopidogrel|mesh-list
44358899|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358900|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358901|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358902|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358903|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
44358904|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358905|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358906|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358907|NCT01129310|Capecitabine|capecitabine|mesh-list
44358908|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
44358909|NCT01129310|Irinotecan|irinotecan|mesh-list
44358910|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855609|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855610|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
43855611|NCT03548571|Temozolomide|temozolomide|mesh-list
43855612|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855613|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
43855614|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855615|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855616|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43855617|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43855618|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43855619|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855620|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855621|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
43855622|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44358911|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
44358912|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358913|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358914|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44358915|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44358916|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358917|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
44358919|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
44358920|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44358921|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
44358922|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358923|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44358924|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44358925|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
44358926|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358927|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44358928|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44358929|NCT01129375|Omeprazole|omeprazole|mesh-list
44358930|NCT01129375|Clopidogrel|clopidogrel|mesh-list
44358931|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358932|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358933|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358934|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358935|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
44358936|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358937|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358938|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358939|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44358953|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44358954|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358955|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44358956|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358958|NCT01129414|Clopidogrel|clopidogrel|mesh-list
44358959|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358960|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358961|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358962|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358963|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
44358964|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358965|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358966|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358967|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44358968|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358969|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44358970|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358971|NCT01129427|Pantoprazole|pantoprazole|mesh-list
44358972|NCT01129427|Clopidogrel|clopidogrel|mesh-list
44358973|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44358974|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44358975|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44358976|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44358977|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
44358978|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44358979|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44358980|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358981|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44358982|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44358983|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44358984|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44358985|NCT01129479|Galantamine|galantamine|mesh-list
44358991|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358992|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44358993|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
44358994|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44358995|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
44358996|NCT01129518|Vaccines|vaccines|mesh-list
44358997|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
44358998|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44358999|NCT01129570|Silybin|silybin|mesh-list
44359000|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44359001|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359002|NCT01129570|Protective Agents|protective agents|mesh-ancestor
44359003|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359004|NCT01129596|Donepezil|donepezil|mesh-list
44359005|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44359006|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359007|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359008|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
44359009|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359010|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359011|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
43855623|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43855624|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43855625|NCT03547622|Galantamine|galantamine|mesh-list
43855626|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43855627|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855628|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855629|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
43855630|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855631|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855632|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43855633|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
43855634|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855635|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
43855636|NCT03547271|Vaccines|vaccines|mesh-list
43855637|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43855638|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
43855639|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855640|NCT03547115|Venetoclax|venetoclax|mesh-list
43855641|NCT03547115|Voruciclib|voruciclib|mesh-list
43855642|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855643|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43855644|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855645|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855646|NCT03546608|Tepotinib|tepotinib|mesh-list
43855647|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855648|NCT03544567|Paclitaxel|paclitaxel|mesh-list
43855649|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855650|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855651|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855652|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855653|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855654|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855655|NCT03542175|Rucaparib|rucaparib|mesh-list
44359012|NCT01129713|Esomeprazole|esomeprazole|mesh-list
44359013|NCT01129713|Omeprazole|omeprazole|mesh-list
44359014|NCT01129713|Lansoprazole|lansoprazole|mesh-list
44359015|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44359016|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359017|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44359018|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359019|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359020|NCT01129739|Cyclosporine|cyclosporine|mesh-list
44359021|NCT01129739|Cyclosporins|cyclosporins|mesh-list
44359022|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359023|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825165|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
44359024|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359025|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
44359026|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359027|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
44359028|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359029|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
44359030|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359031|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44359032|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44359033|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44359034|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
44359035|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359036|NCT01129856|Dexamethasone|dexamethasone|mesh-list
43855658|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855660|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43855661|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43855662|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855663|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
43855664|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855665|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855666|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43855667|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855668|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
43855669|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43855670|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43855671|NCT03539445|Protective Agents|protective agents|mesh-ancestor
43855672|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855673|NCT03539198|Nivolumab|nivolumab|mesh-list
43855674|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855675|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855676|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855677|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855678|NCT03537495|Linezolid|linezolid|mesh-list
43855679|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43855680|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855681|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43855682|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855683|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359037|NCT01129856|Citric Acid|citric acid|mesh-list
44359038|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
44359039|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44359040|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44359041|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44359042|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359043|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
44359044|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
44359045|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359046|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359047|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359048|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
44359049|NCT01129856|Hormones|hormones|mesh-ancestor
44359050|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359051|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44359052|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359053|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
44359054|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44359055|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
44359056|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
43825177|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
43825178|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43825179|NCT05504265|Analgesics|analgesics|mesh-ancestor
43825180|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
43825186|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359057|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359058|NCT01129934|Promethazine|promethazine|mesh-list
44359059|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
44359060|NCT01129934|Morphine|morphine|mesh-list
44359061|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44359062|NCT01129934|Narcotics|narcotics|mesh-ancestor
44359063|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359064|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359065|NCT01129934|Analgesics|analgesics|mesh-ancestor
44359066|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
44359067|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133479|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133480|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
44133481|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133482|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44133483|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44133484|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133485|NCT00153998|Antidotes|antidotes|mesh-ancestor
44133486|NCT00153998|Protective Agents|protective agents|mesh-ancestor
44133487|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133488|NCT00153998|Vitamins|vitamins|mesh-ancestor
44133489|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
44133490|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44133491|NCT00153998|Hematinics|hematinics|mesh-ancestor
44133492|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
44133493|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44359068|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
44359069|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44359070|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44359071|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
44359072|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
44359073|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359074|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359075|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44359076|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44359077|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44359078|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
44359079|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
44359080|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
44359081|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
44359082|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359084|NCT01130025|Warfarin|warfarin|mesh-list
44359085|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
44359086|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44359087|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44359088|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359089|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
44359090|NCT01130181|Vitamin D|vitamin d|mesh-list
43600986|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
44359091|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359092|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359093|NCT01130181|Vitamins|vitamins|mesh-ancestor
44133494|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133495|NCT00154024|Irbesartan|irbesartan|mesh-list
44133496|NCT00154024|Atorvastatin|atorvastatin|mesh-list
44133497|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44133498|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44133499|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
44133500|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133501|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44133502|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44133503|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133504|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133505|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133506|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133507|NCT00154037|Pioglitazone|pioglitazone|mesh-list
44133508|NCT00154037|Candesartan|candesartan|mesh-list
44133509|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133510|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133511|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133512|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133513|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133514|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133515|NCT00154050|Candesartan|candesartan|mesh-list
44133516|NCT00154050|Quinapril|quinapril|mesh-list
44133517|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133518|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133519|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44359094|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
44359095|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44359096|NCT01130194|Procarbazine|procarbazine|mesh-list
43600998|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43600999|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601000|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43601001|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43601002|NCT03268525|Bupivacaine|bupivacaine|mesh-list
43601003|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601004|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
43601006|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359097|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359098|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
44359099|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44359100|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359101|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359102|NCT01130259|Iniparib|iniparib|mesh-list
44359103|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44359104|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359105|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359106|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359107|NCT01130298|Testosterone|testosterone|mesh-list
44359108|NCT01130298|Androgens|androgens|mesh-ancestor
44359109|NCT01130298|Hormones|hormones|mesh-ancestor
44359110|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359111|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359112|NCT01130311|Vitamin D|vitamin d|mesh-list
44359113|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
44359114|NCT01130311|Vitamins|vitamins|mesh-ancestor
44359115|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
44359116|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359117|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44359118|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359119|NCT01130324|Telavancin|telavancin|mesh-list
44359120|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359121|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133521|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44133523|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133524|NCT00154076|Topiramate|topiramate|mesh-list
44133525|NCT00154076|Zonisamide|zonisamide|mesh-list
44133526|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
44133527|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133528|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133529|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44133530|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133531|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133532|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44133533|NCT00154089|Masoprocol|masoprocol|mesh-list
44133534|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
44133535|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133536|NCT00154089|Protective Agents|protective agents|mesh-ancestor
44133537|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133538|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44133539|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133540|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44359122|NCT01130376|Aldesleukin|aldesleukin|mesh-list
44359123|NCT01130376|Interleukin-2|interleukin-2|mesh-list
44359124|NCT01130376|Hormones|hormones|mesh-list
44359125|NCT01130376|Sargramostim|sargramostim|mesh-list
44359126|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359127|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359128|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359129|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359130|NCT01130376|Analgesics|analgesics|mesh-ancestor
44359131|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
44359132|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359133|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
44359134|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44359135|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44359136|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
44359137|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359138|NCT01130467|Methylphenidate|methylphenidate|mesh-list
44359139|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44359140|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359141|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359142|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44359143|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44359144|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359145|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359146|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
44359147|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359148|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44359149|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359150|NCT01130506|Cytarabine|cytarabine|mesh-list
44359151|NCT01130506|Decitabine|decitabine|mesh-list
44359152|NCT01130506|Vorinostat|vorinostat|mesh-list
44359153|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359154|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
44133541|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133542|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133543|NCT00154089|Analgesics|analgesics|mesh-ancestor
43601008|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601009|NCT03268278|Lidocaine|lidocaine|mesh-list
43601010|NCT03268278|Epinephrine|epinephrine|mesh-list
43601011|NCT03268278|Buprenorphine|buprenorphine|mesh-list
43601013|NCT03268278|Anesthetics|anesthetics|mesh-list
43601014|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601082|NCT03267654|Gefitinib|gefitinib|mesh-list
43601083|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601084|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601085|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601086|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601087|NCT03267407|Fluconazole|fluconazole|mesh-list
43601088|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
43601089|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601090|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43601091|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43601092|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655782|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850124|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655783|NCT02966743|Midazolam|midazolam|mesh-list
43655784|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
43655785|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43655786|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855684|NCT03536039|Prednisone|prednisone|mesh-list
43855685|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
43855686|NCT03536039|Rituximab|rituximab|mesh-list
43855687|NCT03536039|Doxorubicin|doxorubicin|mesh-list
43855688|NCT03536039|Vincristine|vincristine|mesh-list
43855689|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855690|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
43855691|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359155|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359157|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
44359158|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359159|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359160|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
44359161|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359162|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359163|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44359164|NCT01130636|Oseltamivir|oseltamivir|mesh-list
44359165|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
44359166|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359167|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359168|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359169|NCT01130662|Decitabine|decitabine|mesh-list
44359170|NCT01130662|Midostaurin|midostaurin|mesh-list
44359171|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359172|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
44359173|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359174|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359175|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672709|NCT02130687|Aprepitant|aprepitant|mesh-list
43855692|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855693|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855694|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
43855695|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855696|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855697|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43855698|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855699|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43855700|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43855701|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43855702|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855703|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855704|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
43855705|NCT03536039|Hormones|hormones|mesh-ancestor
43855706|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855707|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855708|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855709|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855710|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855711|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855712|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43855713|NCT03534180|Venetoclax|venetoclax|mesh-list
43855714|NCT03534180|Romidepsin|romidepsin|mesh-list
43855715|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855716|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855717|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43855718|NCT03532880|Olaparib|olaparib|mesh-list
43855719|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43855720|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855721|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359177|NCT01130688|Zileuton|zileuton|mesh-list
44359178|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359179|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359180|NCT01130688|Analgesics|analgesics|mesh-ancestor
44359181|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
44359182|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359183|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359184|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359185|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359186|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44359187|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359188|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359189|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44359190|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
44359191|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359192|NCT01130701|Capecitabine|capecitabine|mesh-list
44359193|NCT01130701|Panitumumab|panitumumab|mesh-list
44359194|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359195|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
44359196|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359197|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855722|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855723|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43655797|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850125|NCT05701956|Tenecteplase|tenecteplase|mesh-list
43655798|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43655799|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43655800|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43655801|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655802|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43655803|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
43655804|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
43655805|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
43655806|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
43655807|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
43655808|NCT02966652|Testosterone|testosterone|mesh-list
43655809|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
43655810|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
43655811|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43655812|NCT02966652|Androgens|androgens|mesh-ancestor
43655813|NCT02966652|Hormones|hormones|mesh-ancestor
43655814|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655815|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855724|NCT03532399|Bivalirudin|bivalirudin|mesh-list
43855725|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
43855726|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43855727|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
43855728|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855729|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855730|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
43855731|NCT03532217|Nivolumab|nivolumab|mesh-list
43855732|NCT03532217|Ipilimumab|ipilimumab|mesh-list
43855733|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855735|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855736|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855737|NCT03531762|Tepotinib|tepotinib|mesh-list
43855738|NCT03531762|Omeprazole|omeprazole|mesh-list
43855740|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43855741|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43855742|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855743|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855744|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855745|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
43855746|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43855747|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855748|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855749|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855750|NCT03530371|Analgesics|analgesics|mesh-ancestor
44359198|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44359199|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44359200|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359201|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359202|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359203|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359204|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44359205|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359206|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359207|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359208|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359210|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
44359211|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359212|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
44359213|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359214|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359215|NCT01130909|Ketamine|ketamine|mesh-list
44359216|NCT01130909|Analgesics|analgesics|mesh-ancestor
44359217|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
44359218|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359219|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359220|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44359221|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44359222|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
44359223|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
44359224|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359226|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44359241|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359242|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44359243|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44359244|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44359246|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359247|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359248|NCT01131000|Analgesics|analgesics|mesh-ancestor
44359249|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
44359250|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359251|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359252|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359253|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655824|NCT02966288|Analgesics|analgesics|mesh-ancestor
44359254|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43855751|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
43855752|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855753|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43855754|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43855755|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43855756|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855757|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855758|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855759|NCT03529487|Phenylephrine|phenylephrine|mesh-list
43855760|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
43855761|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43855762|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43855763|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855764|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855765|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855766|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855767|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
43855768|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
43855769|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855770|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
43855771|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43855772|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
43855773|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43855774|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
43855775|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43855776|NCT03529487|Protective Agents|protective agents|mesh-ancestor
43855777|NCT03529448|Temozolomide|temozolomide|mesh-list
43855778|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43855779|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
43855780|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855781|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855783|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43855784|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
43855785|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855786|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855787|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43855788|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855789|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43855790|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43855791|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43855792|NCT03528408|Nivolumab|nivolumab|mesh-list
43855793|NCT03528408|Ipilimumab|ipilimumab|mesh-list
43855794|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855795|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359255|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359256|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359257|NCT01131026|Amoxicillin|amoxicillin|mesh-list
44359258|NCT01131026|Levofloxacin|levofloxacin|mesh-list
44359259|NCT01131026|Ofloxacin|ofloxacin|mesh-list
44359260|NCT01131026|Lansoprazole|lansoprazole|mesh-list
44359261|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
44359262|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359263|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359264|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44359265|NCT01131026|Renal Agents|renal agents|mesh-ancestor
44359266|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44359267|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44359268|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855796|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855797|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855798|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43855799|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
43855800|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855801|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855802|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855803|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43855804|NCT03527147|Rituximab|rituximab|mesh-list
43855805|NCT03527147|Magrolimab|magrolimab|mesh-list
43855806|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
43855818|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43855819|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855826|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43855827|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855828|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855829|NCT03524898|Gemcitabine|gemcitabine|mesh-list
43855830|NCT03524898|Paclitaxel|paclitaxel|mesh-list
43855831|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43855832|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855833|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
43855834|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
43855835|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
43855836|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855837|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855838|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
43855839|NCT03524898|Antiviral Agents|antiviral agents|mesh-ancestor
43855840|NCT03524898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855841|NCT03524898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855842|NCT03524898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855843|NCT03524898|Immunologic Factors|immunologic factors|mesh-ancestor
43855844|NCT03524898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855845|NCT03524820|Cetuximab|cetuximab|mesh-list
43855846|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855847|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855848|NCT03524508|Fluorouracil|fluorouracil|mesh-list
43855849|NCT03524508|Irinotecan|irinotecan|mesh-list
43855850|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
43855851|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855852|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855853|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855854|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855855|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
43855856|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655844|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43855857|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43855858|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43855859|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855860|NCT03523585|Capecitabine|capecitabine|mesh-list
44359269|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359270|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359271|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44359272|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44359274|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359275|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44359276|NCT01131039|Gemcitabine|gemcitabine|mesh-list
44359277|NCT01131039|Bevacizumab|bevacizumab|mesh-list
44359278|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44359279|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359280|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44359281|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44359282|NCT01131039|Growth Substances|growth substances|mesh-ancestor
44359283|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359284|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
44359285|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359287|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359288|NCT01131039|Antiviral Agents|antiviral agents|mesh-ancestor
44359289|NCT01131039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359290|NCT01131039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359291|NCT01131039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359292|NCT01131039|Immunologic Factors|immunologic factors|mesh-ancestor
44359293|NCT01131195|Paclitaxel|paclitaxel|mesh-list
44359294|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
44359295|NCT01131195|Bevacizumab|bevacizumab|mesh-list
44359296|NCT01131195|Capecitabine|capecitabine|mesh-list
44359297|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44359298|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359299|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
44359300|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
44359301|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
44359302|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359303|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359304|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
44359305|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855861|NCT03523585|Trastuzumab|trastuzumab|mesh-list
44359306|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359307|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44359308|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
44359309|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44359310|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44359311|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44359312|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44359313|NCT01131195|Growth Substances|growth substances|mesh-ancestor
44359314|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
44359315|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359316|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
44359317|NCT01131234|Cediranib|cediranib|mesh-list
44359318|NCT01131234|R04929097|r04929097|mesh-list
44359319|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359320|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672842|NCT02081300|Androgens|androgens|mesh-ancestor
43855862|NCT03523585|Lapatinib|lapatinib|mesh-list
43855863|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43855864|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
43855865|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855866|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855867|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855868|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43855869|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855870|NCT03523429|Blinatumomab|blinatumomab|mesh-list
43855871|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855872|NCT03522298|GDC-0084|gdc-0084|mesh-list
43855873|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855874|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855875|NCT03522168|Risperidone|risperidone|mesh-list
43855876|NCT03522168|Aripiprazole|aripiprazole|mesh-list
43855881|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855882|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43855883|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43855884|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855886|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43855887|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
43855888|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
43855889|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
43855890|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43855891|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43855892|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43855893|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43855895|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855896|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855897|NCT03518801|Cannabidiol|cannabidiol|mesh-list
43855898|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
43855899|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
43855900|NCT03516981|Lenvatinib|lenvatinib|mesh-list
43855901|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855902|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855903|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43855904|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855905|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855906|NCT03515837|Cisplatin|cisplatin|mesh-list
43855907|NCT03515837|Carboplatin|carboplatin|mesh-list
43855908|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
43855909|NCT03515837|Pemetrexed|pemetrexed|mesh-list
43855910|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44359321|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359322|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359323|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44359324|NCT01131247|Ofatumumab|ofatumumab|mesh-list
44359325|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44359326|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44359327|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
44359328|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359329|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359330|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
44359331|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359332|NCT01131273|Buprenorphine|buprenorphine|mesh-list
44359333|NCT01131273|Methadone|methadone|mesh-list
44359334|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44359335|NCT01131273|Naloxone|naloxone|mesh-list
44359336|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44359337|NCT01131273|Narcotics|narcotics|mesh-ancestor
44359338|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359339|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359340|NCT01131273|Analgesics|analgesics|mesh-ancestor
44359341|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
44359342|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359343|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44359344|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
44359345|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359346|NCT01131364|Doxorubicin|doxorubicin|mesh-list
44359347|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44359348|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359349|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44359350|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44359351|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359352|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359353|NCT01131377|Acetazolamide|acetazolamide|mesh-list
44359354|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
43672856|NCT02077881|Gemcitabine|gemcitabine|mesh-list
43855911|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855912|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855913|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855914|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359355|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44359356|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359357|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359358|NCT01131377|Diuretics|diuretics|mesh-ancestor
44359359|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
44359360|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359361|NCT01131429|Cisplatin|cisplatin|mesh-list
44359362|NCT01131429|Docetaxel|docetaxel|mesh-list
44359363|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44359364|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359365|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44359366|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44359367|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44359368|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359369|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359370|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359371|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
44359372|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44359373|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
44359374|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359375|NCT01131468|Expectorants|expectorants|mesh-ancestor
44359376|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359377|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44359378|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
44359379|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359380|NCT01131468|Protective Agents|protective agents|mesh-ancestor
44359381|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359382|NCT01131468|Antidotes|antidotes|mesh-ancestor
44359383|NCT01131546|Amlodipine|amlodipine|mesh-list
43855915|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43855916|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43855917|NCT03514589|Cosyntropin|cosyntropin|mesh-list
43855918|NCT03514589|Hormones|hormones|mesh-ancestor
43855919|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43855920|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855921|NCT03513445|Epinephrine|epinephrine|mesh-list
43855922|NCT03513445|Morphine|morphine|mesh-list
43855923|NCT03513445|Ropivacaine|ropivacaine|mesh-list
43855924|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43855925|NCT03513445|Narcotics|narcotics|mesh-ancestor
43855926|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855927|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855928|NCT03513445|Analgesics|analgesics|mesh-ancestor
43855929|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
43855930|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855931|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43855932|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43601214|NCT03266146|Prednisolone|prednisolone|mesh-list
44359385|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44359386|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359387|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359388|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359389|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359390|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44359391|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44359392|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359393|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359394|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44359395|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44359396|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359397|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359398|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
44359399|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855933|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855934|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855935|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855936|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43855937|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43855938|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
43855939|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43855940|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
43855941|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
43855942|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
43855943|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43855944|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
43855945|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
43855946|NCT03511976|Methylphenidate|methylphenidate|mesh-list
43855947|NCT03511976|Amphetamine|amphetamine|mesh-list
43855948|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43855951|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43855952|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855953|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855954|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
43855955|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855956|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
43855957|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
43855958|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855959|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855960|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43855961|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
43855962|NCT03510884|Niacin|niacin|mesh-list
43855963|NCT03510884|Niacinamide|niacinamide|mesh-list
43855964|NCT03510884|Atorvastatin|atorvastatin|mesh-list
43855965|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43855966|NCT03510884|Simvastatin|simvastatin|mesh-list
43855967|NCT03510884|Ezetimibe|ezetimibe|mesh-list
43855968|NCT03510884|Pravastatin|pravastatin|mesh-list
43855969|NCT03510884|Lovastatin|lovastatin|mesh-list
43855970|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
43855971|NCT03510884|Fenofibrate|fenofibrate|mesh-list
43855972|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43601271|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601272|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855973|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855974|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
43855975|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359400|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
44359401|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44359402|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
44359403|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359404|NCT01131572|Expectorants|expectorants|mesh-ancestor
44359405|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359406|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44359407|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
44359408|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359409|NCT01131572|Protective Agents|protective agents|mesh-ancestor
44359410|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359411|NCT01131572|Antidotes|antidotes|mesh-ancestor
44359412|NCT01131689|Sorafenib|sorafenib|mesh-list
44359413|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359414|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359415|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359416|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359417|NCT01131702|Ranitidine|ranitidine|mesh-list
44359418|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44359419|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44359420|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359421|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44359422|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
44359423|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
44359424|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359425|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359426|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359427|NCT01131728|Naproxen|naproxen|mesh-list
44359428|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
44359429|NCT01131728|Ephedrine|ephedrine|mesh-list
44359430|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359431|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359432|NCT01131728|Analgesics|analgesics|mesh-ancestor
44359433|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
44359434|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359435|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359440|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359441|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359442|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359443|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
44359444|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359445|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359446|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359447|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359448|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359449|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
44359450|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359451|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359452|NCT01131741|Epinephrine|epinephrine|mesh-list
44359453|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44359454|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44359455|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359456|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359457|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359458|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855976|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855977|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43855978|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855979|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
43855980|NCT03510884|Vitamins|vitamins|mesh-ancestor
43855981|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
43855982|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855983|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
43855984|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43855985|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43855986|NCT03508921|Trimethoprim|trimethoprim|mesh-list
43855987|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
43855988|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43855989|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43855990|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855991|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
43855992|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43855993|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855994|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855995|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43855996|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43855997|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855998|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
43855999|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856000|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43856001|NCT03508921|Renal Agents|renal agents|mesh-ancestor
43856002|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
43856003|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43856004|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43856005|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43856006|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856007|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44359459|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44359460|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359461|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
44359462|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359463|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359464|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359465|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
44359466|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
44359467|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359468|NCT01131754|Heparin|heparin|mesh-list
44359469|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
44359470|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44359471|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44359472|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359473|NCT01131767|Naproxen|naproxen|mesh-list
44359474|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
44359475|NCT01131767|Ephedrine|ephedrine|mesh-list
44359476|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359477|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359478|NCT01131767|Analgesics|analgesics|mesh-ancestor
44359479|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
44359480|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359481|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359482|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359483|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44359484|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
44014587|NCT03278886|Naltrexone|naltrexone|mesh-list
44359509|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43601310|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601311|NCT03265171|Plasminogen|plasminogen|mesh-list
44359510|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359511|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359512|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359513|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
44359514|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359515|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359516|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359517|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359518|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359519|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
44359520|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359521|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359522|NCT01131806|Fluticasone|fluticasone|mesh-list
44359523|NCT01131806|Xhance|xhance|mesh-list
44359524|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44359525|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44359526|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359527|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359528|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
44359529|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856008|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43856009|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43856010|NCT03507413|Metformin|metformin|mesh-list
43856011|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43856012|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856013|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43856014|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43856015|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856016|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43856017|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43856018|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856019|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
43856020|NCT03503058|Chloroquine|chloroquine|mesh-list
43856021|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43856022|NCT03503058|Amebicides|amebicides|mesh-ancestor
43856024|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43856025|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856026|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
43856027|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856028|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43856029|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856030|NCT03503058|Analgesics|analgesics|mesh-ancestor
43856031|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
43856032|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856033|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856034|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856035|NCT03503058|Filaricides|filaricides|mesh-ancestor
43856036|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
43856037|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
43856038|NCT03502746|Nivolumab|nivolumab|mesh-list
43856039|NCT03502746|Ramucirumab|ramucirumab|mesh-list
43856040|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44359530|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359531|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359532|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359533|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44359534|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44359535|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44359536|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44359537|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44359538|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359539|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359540|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359541|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
43655884|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655885|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44359542|NCT01131806|Hormones|hormones|mesh-ancestor
44359543|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359544|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
44359545|NCT01131845|Treprostinil|treprostinil|mesh-list
43856041|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856042|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856043|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856044|NCT03502018|Bupivacaine|bupivacaine|mesh-list
43856045|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
43856046|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
43856047|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856048|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856049|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
43856050|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133544|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
44133545|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133546|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133547|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133548|NCT00154115|Simendan|simendan|mesh-list
44133549|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44133550|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133551|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44133552|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44133553|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856052|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43856053|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
43856054|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856055|NCT03499249|Expectorants|expectorants|mesh-ancestor
43856056|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
43856057|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43856058|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
43856059|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856060|NCT03499249|Protective Agents|protective agents|mesh-ancestor
43856061|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856062|NCT03499249|Antidotes|antidotes|mesh-ancestor
43856063|NCT03496766|Tipifarnib|tipifarnib|mesh-list
43856064|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856065|NCT03493932|Nivolumab|nivolumab|mesh-list
43856066|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856067|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856068|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856069|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856070|NCT03493165|Everolimus|everolimus|mesh-list
43856071|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856072|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856073|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
44359546|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44359548|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
44359549|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
44359550|NCT01131910|Vaccines|vaccines|mesh-list
44359551|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
44359552|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359553|NCT01131923|Amlodipine|amlodipine|mesh-list
44359554|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44359555|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44359556|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359557|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359558|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359559|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359560|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
44359561|NCT01131936|Amlodipine|amlodipine|mesh-list
44359562|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44359563|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44359564|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359565|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359566|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43655886|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43655887|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655889|NCT02965404|Vaccines|vaccines|mesh-list
44359567|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359568|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
44359569|NCT01131949|Lamotrigine|lamotrigine|mesh-list
44359570|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
44359571|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44359572|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359573|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359574|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359575|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359576|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44359577|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44359578|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856074|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856075|NCT03492658|Methotrexate|methotrexate|mesh-list
43856076|NCT03492658|Abatacept|abatacept|mesh-list
43856077|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43856078|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
44359579|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44359580|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44359581|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
44359582|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44359583|NCT01131975|Lamotrigine|lamotrigine|mesh-list
44359584|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
44359585|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44359586|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359587|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359588|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359589|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359590|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44359591|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44359592|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359593|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43856079|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43856080|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856081|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856082|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
43856083|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856084|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856085|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
43856086|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856087|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43856088|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856091|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43856092|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856094|NCT03492437|Dabigatran|dabigatran|mesh-list
43856095|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
43856096|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43856097|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
43856098|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856099|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856100|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
43856101|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856102|NCT03491345|Avelumab|avelumab|mesh-list
43856103|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856104|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856105|NCT03487016|Gemcitabine|gemcitabine|mesh-list
43856106|NCT03487016|Paclitaxel|paclitaxel|mesh-list
43856107|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
43856108|NCT03487016|Irinotecan|irinotecan|mesh-list
43856109|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43856110|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856111|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
43856112|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856113|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
43655891|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655892|NCT02965677|Paclitaxel|paclitaxel|mesh-list
43655893|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43655894|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856114|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856115|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856116|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
43856117|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
43856118|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856119|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856120|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856121|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
43856122|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856123|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43856124|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43856125|NCT03485677|Eliglustat|eliglustat|mesh-list
44359595|NCT01131988|Tacrolimus|tacrolimus|mesh-list
44359596|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359597|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
44359598|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359599|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44359600|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359601|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359602|NCT01132027|Tacrolimus|tacrolimus|mesh-list
44359603|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359604|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
44359605|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359606|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44359607|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359608|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359609|NCT01132040|Primidone|primidone|mesh-list
44359610|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
44359611|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
44359612|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
43856126|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856127|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856128|NCT03485417|Aripiprazole|aripiprazole|mesh-list
43856129|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43856130|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
43856131|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43856132|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43856133|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43601321|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601322|NCT03265197|Lidocaine|lidocaine|mesh-list
43649127|NCT03031444|Vitamins|vitamins|mesh-ancestor
43649128|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
43649129|NCT03031249|Cytarabine|cytarabine|mesh-list
43649130|NCT03031249|Tretinoin|tretinoin|mesh-list
43649131|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
43649132|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649133|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
43850136|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43850142|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850143|NCT05701865|Ethanol|ethanol|mesh-list
43850144|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43850145|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850146|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856134|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856135|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856136|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
43856137|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
43856138|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856139|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856140|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43856141|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43856142|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
43856143|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43856144|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43856145|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43856146|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43856147|NCT03483883|Gemcitabine|gemcitabine|mesh-list
43856148|NCT03483883|Avelumab|avelumab|mesh-list
43856149|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856150|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
43856151|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856152|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856153|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
43856154|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856155|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856156|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856157|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
43856158|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856159|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856160|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43856161|NCT03483363|Bacitracin|bacitracin|mesh-list
43856166|NCT03483012|Atezolizumab|atezolizumab|mesh-list
44359614|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359615|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359616|NCT01132157|Propofol|propofol|mesh-list
44359617|NCT01132157|Desflurane|desflurane|mesh-list
44359618|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44359619|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359620|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359621|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44359622|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
44359623|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
44359624|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44359625|NCT01132170|Valproic Acid|valproic acid|mesh-list
43856167|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856168|NCT03482297|Midodrine|midodrine|mesh-list
43856169|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
43856170|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
43856171|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856172|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856173|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43856174|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43856175|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43856176|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43856177|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856178|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856179|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856181|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
43856182|NCT03482167|Vitamins|vitamins|mesh-ancestor
43856183|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
43856184|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856185|NCT03482102|Durvalumab|durvalumab|mesh-list
43856186|NCT03482102|Tremelimumab|tremelimumab|mesh-list
43856187|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856188|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856189|NCT03480438|Blinatumomab|blinatumomab|mesh-list
43856190|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856191|NCT03480334|Nivolumab|nivolumab|mesh-list
43850148|NCT05701813|Inositol|inositol|mesh-list
43856192|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856193|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856194|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856195|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856196|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
43856197|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43856198|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856199|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856200|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856201|NCT03480061|Analgesics|analgesics|mesh-ancestor
43856202|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
43856203|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856204|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43856205|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43856206|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43856207|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856208|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856209|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856210|NCT03479476|Metformin|metformin|mesh-list
43856211|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43856212|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856213|NCT03478514|Palbociclib|palbociclib|mesh-list
43856214|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856215|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44359626|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
44359627|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359628|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359629|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
44359630|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359631|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359632|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
44359633|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44359634|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359635|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44359636|NCT01132183|Valproic Acid|valproic acid|mesh-list
44359637|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
44359638|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359639|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856216|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856217|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856218|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43856219|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43856220|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
43856221|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
43856222|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
43856223|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856224|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43856225|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
43856226|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43856227|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43856228|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856229|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
43856230|NCT03475342|Coagulants|coagulants|mesh-ancestor
43856231|NCT03474770|Huperzine A|huperzine a|mesh-list
43856234|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856236|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856237|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856238|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43856239|NCT03474770|Protective Agents|protective agents|mesh-ancestor
43856240|NCT03473730|Daratumumab|daratumumab|mesh-list
43856241|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856242|NCT03472586|Nivolumab|nivolumab|mesh-list
43856243|NCT03472586|Ipilimumab|ipilimumab|mesh-list
43856244|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856245|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856246|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43850153|NCT05701540|Esomeprazole|esomeprazole|mesh-list
43856247|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856248|NCT03472560|Avelumab|avelumab|mesh-list
43856249|NCT03472560|Axitinib|axitinib|mesh-list
43856250|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43583043|NCT03443492|Leucovorin|leucovorin|mesh-list
43856251|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856252|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856253|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856254|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856255|NCT03472274|Cisplatin|cisplatin|mesh-list
43856256|NCT03472274|Durvalumab|durvalumab|mesh-list
43856257|NCT03472274|Tremelimumab|tremelimumab|mesh-list
43856258|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856259|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856260|NCT03471442|Bupivacaine|bupivacaine|mesh-list
43856261|NCT03471442|Ropivacaine|ropivacaine|mesh-list
43856262|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
43856263|NCT03471442|Anesthetics|anesthetics|mesh-list
43856264|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
44359640|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
44359641|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359642|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359643|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
44359644|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44359645|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359646|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44359647|NCT01132196|Valproic Acid|valproic acid|mesh-list
43856265|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856266|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856267|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
43856268|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856269|NCT03471182|Cocaine|cocaine|mesh-list
43856270|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
43856271|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
43856272|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856273|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856274|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
43856275|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856276|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43856277|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43856278|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43856279|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43856280|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856281|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
43856282|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856284|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43856285|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856286|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856287|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856288|NCT03468985|Nivolumab|nivolumab|mesh-list
43856289|NCT03468985|Ipilimumab|ipilimumab|mesh-list
43856290|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856291|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856292|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856293|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856294|NCT03467750|Ketorolac|ketorolac|mesh-list
43856295|NCT03467750|Morphine|morphine|mesh-list
43856296|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43856297|NCT03467750|Narcotics|narcotics|mesh-ancestor
43856298|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856299|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856300|NCT03467750|Analgesics|analgesics|mesh-ancestor
43856301|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
43856302|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856303|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43856308|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850162|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
43850163|NCT05701501|Vitamins|vitamins|mesh-ancestor
43856309|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133554|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133555|NCT00154115|Protective Agents|protective agents|mesh-ancestor
44133556|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133558|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133559|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
44133560|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
44133561|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133562|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44133563|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
44133564|NCT00154141|Coagulants|coagulants|mesh-ancestor
44133565|NCT00154167|Phentolamine|phentolamine|mesh-list
44133566|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44133567|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44133568|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
44133569|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133570|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133571|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133572|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44359650|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359651|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
44359652|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359653|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359654|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
44359655|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44359656|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359657|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44359659|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
44359661|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359662|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359663|NCT01132222|Analgesics|analgesics|mesh-ancestor
44359664|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
43649134|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601323|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601324|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
43601325|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601326|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601327|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
43601328|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601351|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601352|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43601353|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601354|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601355|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850165|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850166|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
43850167|NCT05701488|Durvalumab|durvalumab|mesh-list
43850168|NCT05701488|Tremelimumab|tremelimumab|mesh-list
43850169|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850170|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850171|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44359665|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359666|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359667|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359668|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133573|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44133574|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44133575|NCT00154180|Estradiol|estradiol|mesh-list
44133576|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44133577|NCT00154180|Estrogens|estrogens|mesh-list
44133578|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44133579|NCT00154180|Progesterone|progesterone|mesh-list
44133580|NCT00154180|Hormones|hormones|mesh-ancestor
44133581|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133582|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133583|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44133584|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
44133585|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44133586|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44133587|NCT00154180|Progestins|progestins|mesh-ancestor
44133588|NCT00154193|Cyclosporine|cyclosporine|mesh-list
44133589|NCT00154193|Cyclosporins|cyclosporins|mesh-list
44133590|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133591|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133592|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856310|NCT03466294|Azacitidine|azacitidine|mesh-list
43856311|NCT03466294|Venetoclax|venetoclax|mesh-list
43856312|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856313|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
43856314|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856315|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856316|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856317|NCT03462966|Rifaximin|rifaximin|mesh-list
43856318|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43856319|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856320|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43856321|NCT03462342|Olaparib|olaparib|mesh-list
43856322|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43856323|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359669|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44359670|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359671|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359672|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359673|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
44359674|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359675|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359676|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359677|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359678|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359679|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
44359680|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359681|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014807|NCT03297944|Zolpidem|zolpidem|mesh-list
44359682|NCT01132235|Etanercept|etanercept|mesh-list
44359683|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44359684|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359685|NCT01132235|Analgesics|analgesics|mesh-ancestor
44359686|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
44359687|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359688|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359689|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44359690|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856324|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856325|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856326|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
43856327|NCT03458598|Narcotics|narcotics|mesh-ancestor
43856328|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850172|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
43850173|NCT05701436|Leucovorin|leucovorin|mesh-list
43850174|NCT05701436|Cisplatin|cisplatin|mesh-list
43850175|NCT05701436|Doxorubicin|doxorubicin|mesh-list
43850176|NCT05701436|Fluorouracil|fluorouracil|mesh-list
43856329|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856330|NCT03458598|Analgesics|analgesics|mesh-ancestor
43856331|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
43856332|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856333|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
43856337|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856338|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856339|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856340|NCT03458221|Itraconazole|itraconazole|mesh-list
43856341|NCT03458221|Everolimus|everolimus|mesh-list
43856342|NCT03458221|Letrozole|letrozole|mesh-list
43856343|NCT03458221|Bicalutamide|bicalutamide|mesh-list
43856344|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856345|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856346|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
43856347|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856348|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43856349|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43856350|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856351|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856352|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43856353|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
43856354|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359697|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44359698|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359699|NCT01132352|Levetiracetam|levetiracetam|mesh-list
43856355|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
43856356|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856357|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43856358|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43856359|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43856360|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
43856361|NCT03457818|Denosumab|denosumab|mesh-list
43856362|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43856363|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856364|NCT03456687|Exenatide|exenatide|mesh-list
43856365|NCT03456687|Glucagon|glucagon|mesh-list
43856366|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43856367|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43856368|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856369|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43856370|NCT03456687|Incretins|incretins|mesh-ancestor
43856371|NCT03456687|Hormones|hormones|mesh-ancestor
43856372|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43856373|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43856374|NCT03456102|Pravastatin|pravastatin|mesh-list
43856375|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43856376|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43856377|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
44133593|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
43856378|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856379|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43856380|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43856381|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856383|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856384|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856385|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856386|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856387|NCT03455140|BCT-100|bct-100|mesh-list
43856388|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856389|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
43856390|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856391|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856392|NCT03451591|Cilostazol|cilostazol|mesh-list
43856393|NCT03451591|Isosorbide|isosorbide|mesh-list
43850183|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655895|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
43655896|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
43655897|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856394|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43856395|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43856396|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43856397|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
43856398|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856399|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856400|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43856406|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
43856407|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43856408|NCT03451591|Protective Agents|protective agents|mesh-ancestor
43856409|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43856410|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43856411|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856412|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44359700|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
44359701|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
44359702|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
44359703|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
44359704|NCT01132404|Leuprolide|leuprolide|mesh-list
44359705|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44359706|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
44359707|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44359708|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359709|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44359710|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359711|NCT01132417|Tigecycline|tigecycline|mesh-list
44359712|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359713|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359714|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44359715|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359716|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359717|NCT01132443|Clindamycin|clindamycin|mesh-list
44359718|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
44359719|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
44359720|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44359721|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359722|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359723|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44359724|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359725|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359726|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44359727|NCT01132521|Urinastatin|urinastatin|mesh-list
44359728|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
44359729|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44359730|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
44359731|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359732|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856413|NCT03451591|Diuretics|diuretics|mesh-ancestor
43856414|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
43856415|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43856416|NCT03450707|Thiamine|thiamine|mesh-list
43856417|NCT03450707|Vitamins|vitamins|mesh-ancestor
43856418|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
43856419|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856420|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
43856421|NCT03450343|Azacitidine|azacitidine|mesh-list
43856422|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856423|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
44359734|NCT01132573|Entinostat|entinostat|mesh-list
44359735|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44359736|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359737|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
44359738|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359739|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359740|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359741|NCT01132586|Cytarabine|cytarabine|mesh-list
44359742|NCT01132586|Lenalidomide|lenalidomide|mesh-list
44359743|NCT01132586|Idarubicin|idarubicin|mesh-list
43655898|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359744|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44359745|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
44359746|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359747|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359748|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
44359749|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359750|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359751|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
44359752|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359753|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44359754|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44359755|NCT01132586|Growth Substances|growth substances|mesh-ancestor
44359756|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
44359787|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359788|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359789|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44359790|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
44359791|NCT01132677|Hormones|hormones|mesh-ancestor
44359792|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359793|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44359794|NCT01132677|Protective Agents|protective agents|mesh-ancestor
44359795|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44359796|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359797|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
44359798|NCT01132703|Glyburide|glyburide|mesh-list
44359799|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44359800|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359801|NCT01132716|Valacyclovir|valacyclovir|mesh-list
44359802|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
44359803|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359804|NCT01132729|Valacyclovir|valacyclovir|mesh-list
44359805|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
43856424|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856425|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856426|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856427|NCT03450122|Aldesleukin|aldesleukin|mesh-list
43856428|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
43856429|NCT03450122|Interleukin-2|interleukin-2|mesh-list
43856430|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856431|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
43856432|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856433|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856434|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43856435|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
43856436|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856437|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856438|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43856439|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856441|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
43856442|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856443|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43856444|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43856445|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
43856446|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856447|NCT03449108|Aldesleukin|aldesleukin|mesh-list
43856448|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
43856449|NCT03449108|Nivolumab|nivolumab|mesh-list
43856450|NCT03449108|Fludarabine|fludarabine|mesh-list
43856451|NCT03449108|Ipilimumab|ipilimumab|mesh-list
43856452|NCT03449108|Interleukin-2|interleukin-2|mesh-list
43601361|NCT03264781|CycloProvera|cycloprovera|mesh-list
43856453|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856454|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
43856455|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856456|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856457|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43856458|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
43856459|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856460|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359806|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359807|NCT01132768|Atenolol|atenolol|mesh-list
44359808|NCT01132768|Olmesartan|olmesartan|mesh-list
44359809|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44359810|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44359811|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44359812|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44359813|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359814|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44359815|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
44359816|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
44359817|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359818|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359819|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43673129|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
43856461|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43856462|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856463|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43856464|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856465|NCT03449108|Analgesics|analgesics|mesh-ancestor
43856466|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
43856467|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856468|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43856469|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43856470|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
43856471|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856478|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
43856479|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856480|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856481|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856482|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856483|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43856484|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43856485|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856486|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43856487|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43856488|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856489|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
43856490|NCT03447132|Fulvestrant|fulvestrant|mesh-list
43856491|NCT03447132|Goserelin|goserelin|mesh-list
43856492|NCT03447132|Palbociclib|palbociclib|mesh-list
43856493|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43856494|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856495|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43856496|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43856497|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
43856498|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43856499|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856500|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856501|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856502|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856503|NCT03446001|Methylene Blue|methylene blue|mesh-list
43856504|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856505|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856506|NCT03443128|Vinorelbine|vinorelbine|mesh-list
43856507|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43856508|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856509|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
44359821|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44359822|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359823|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359824|NCT01132781|Theophylline|theophylline|mesh-list
43850193|NCT05701436|Vitamins|vitamins|mesh-ancestor
44359825|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359826|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
44359827|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359828|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359829|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359830|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359831|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44359832|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014915|NCT03309657|Tazobactam|tazobactam|mesh-list
44359833|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359834|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
44359835|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44359836|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44359837|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
44359838|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359839|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
44359840|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44359841|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359842|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359843|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44359844|NCT01132794|Analgesics|analgesics|mesh-ancestor
44359845|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
44359846|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359847|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44359848|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44359849|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44359850|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359851|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359852|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359853|NCT01132911|Bortezomib|bortezomib|mesh-list
44359854|NCT01132911|Vorinostat|vorinostat|mesh-list
43856510|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856511|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
44359855|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359856|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44359857|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359858|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359859|NCT01132989|Lenalidomide|lenalidomide|mesh-list
44359860|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
44359861|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359862|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44359863|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44359864|NCT01132989|Growth Substances|growth substances|mesh-ancestor
44359865|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
44359866|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359867|NCT01133080|Minocycline|minocycline|mesh-list
44359868|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359869|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359870|NCT01133119|Bupivacaine|bupivacaine|mesh-list
44359871|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
44359872|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
44359873|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44359874|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359875|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
44359876|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359877|NCT01133210|Maraviroc|maraviroc|mesh-list
44359878|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44359879|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44359880|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359881|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44359882|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44359883|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
44359884|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44359885|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44359886|NCT01133223|Plasminogen|plasminogen|mesh-list
43655916|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856512|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856513|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43856514|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856515|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856516|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43856517|NCT03440567|Rituximab|rituximab|mesh-list
43856518|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43856519|NCT03440567|Avelumab|avelumab|mesh-list
43856520|NCT03440567|Carboplatin|carboplatin|mesh-list
43856521|NCT03440567|Etoposide|etoposide|mesh-list
43856522|NCT03440567|Ifosfamide|ifosfamide|mesh-list
44359889|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44359890|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359891|NCT01133301|Naltrexone|naltrexone|mesh-list
44359892|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44359893|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44359894|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359895|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
44359896|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359897|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
44359898|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44359899|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44359900|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44359901|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359902|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359903|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359904|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359905|NCT01133366|Warfarin|warfarin|mesh-list
44359906|NCT01133366|Mipomersen|mipomersen|mesh-list
44359907|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
43856523|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
43856524|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
43856525|NCT03440567|Antibodies|antibodies|mesh-list
43856526|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
43856527|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43856528|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
43856529|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
43856530|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856531|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856532|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856533|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43856534|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43856535|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43856536|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856537|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601368|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43601369|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43601370|NCT03264911|Amoxicillin|amoxicillin|mesh-list
43601371|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43601372|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601373|NCT03264586|Lidocaine|lidocaine|mesh-list
43601374|NCT03264586|Prilocaine|prilocaine|mesh-list
43601375|NCT03264586|Mepivacaine|mepivacaine|mesh-list
43601404|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601405|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601406|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43601407|NCT03264430|Ketamine|ketamine|mesh-list
43601408|NCT03264430|Bupivacaine|bupivacaine|mesh-list
43601409|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
43856538|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43856539|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
43856540|NCT03439267|Calcium|calcium|mesh-list
43856541|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43856544|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856545|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
43856546|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43856547|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43856548|NCT03437746|Prednisolone|prednisolone|mesh-list
43856549|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
43856550|NCT03437746|Anesthetics|anesthetics|mesh-list
43856551|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43856552|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
43856553|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856554|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
43856555|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
43856556|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359908|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44359909|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44359910|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
44359911|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359912|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44359913|NCT01133431|Glimepiride|glimepiride|mesh-list
44359914|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44359915|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44359916|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359917|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44359918|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
44359919|NCT01133444|Finasteride|finasteride|mesh-list
44359920|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44359921|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44359922|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359923|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359924|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
44359925|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359926|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359927|NCT01133444|Urological Agents|urological agents|mesh-ancestor
44359928|NCT01133457|Finasteride|finasteride|mesh-list
44359929|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43673235|NCT01983306|Dolcanatide|dolcanatide|mesh-list
43856557|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856558|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43856559|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
43856560|NCT03437746|Hormones|hormones|mesh-ancestor
43856561|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43856562|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43856563|NCT03437746|Protective Agents|protective agents|mesh-ancestor
43856564|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43856565|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856566|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856567|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
43856568|NCT03437330|Empagliflozin|empagliflozin|mesh-list
43856569|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43856570|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856571|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43856572|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856573|NCT03436563|Atezolizumab|atezolizumab|mesh-list
43856574|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856575|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
43856576|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856577|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856578|NCT03435718|Albendazole|albendazole|mesh-list
43856580|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
43856581|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43856582|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856583|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
43856584|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43856585|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44359930|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44359931|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44359932|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359933|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
44359934|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359935|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359936|NCT01133457|Urological Agents|urological agents|mesh-ancestor
44359937|NCT01133470|Fexofenadine|fexofenadine|mesh-list
44359938|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
44359939|NCT01133470|Ephedrine|ephedrine|mesh-list
44359940|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359941|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
44359942|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359943|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359944|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359945|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
44359946|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359947|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359948|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359949|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
44359950|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359951|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856586|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
43856587|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856588|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856589|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856590|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856591|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
43856592|NCT03435250|Gemcitabine|gemcitabine|mesh-list
43856593|NCT03435250|Paclitaxel|paclitaxel|mesh-list
43856594|NCT03435250|Docetaxel|docetaxel|mesh-list
43856595|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43856596|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856597|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
43856598|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856599|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856600|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856601|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856602|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
43856603|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
43856604|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856605|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856606|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856607|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
43856608|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856610|NCT03434678|Bupivacaine|bupivacaine|mesh-list
43856611|NCT03434678|Propofol|propofol|mesh-list
43856612|NCT03434678|Rocuronium|rocuronium|mesh-list
43856613|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
43856614|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
43856615|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856616|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359952|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359953|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44359954|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44359955|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44359956|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
44359958|NCT01133483|Fexofenadine|fexofenadine|mesh-list
44359959|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
44359960|NCT01133483|Ephedrine|ephedrine|mesh-list
44359961|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44359962|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
44359963|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44359964|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359965|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44359966|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655931|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
43655932|NCT02965248|Calcium|calcium|mesh-list
43655933|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
43655934|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44359967|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
44359968|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44359969|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44359970|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
44359971|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44359972|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44359973|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44359974|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43856617|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
43856618|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856625|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43856626|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43856627|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43856628|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43856629|NCT03432650|Dexamethasone|dexamethasone|mesh-list
43856630|NCT03432650|Bupivacaine|bupivacaine|mesh-list
43856631|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856632|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
43856633|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
43856634|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856635|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856636|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43856637|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
43856639|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43856640|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43856641|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856642|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
43856643|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
43856644|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856645|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
43856646|NCT03431987|Ethanol|ethanol|mesh-list
43856647|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43856648|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856649|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856650|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359975|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44359976|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44359977|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
44359978|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
44359979|NCT01133496|Alendronate|alendronate|mesh-list
44359980|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44359981|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359983|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
44359984|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359985|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
44359986|NCT01133548|Testosterone|testosterone|mesh-list
44359987|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
44359988|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
44359989|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44359990|NCT01133548|Androgens|androgens|mesh-ancestor
44359991|NCT01133548|Hormones|hormones|mesh-ancestor
44359992|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44359993|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601413|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
44359994|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44359995|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44359996|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
44359997|NCT01133600|Vancomycin|vancomycin|mesh-list
43856651|NCT03431194|Midodrine|midodrine|mesh-list
43856652|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
43856653|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
43856654|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856655|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856656|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43856657|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43856659|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43856660|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856661|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856662|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856663|NCT03431168|Azithromycin|azithromycin|mesh-list
43856664|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43856665|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43856666|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856667|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43856668|NCT03431168|Renal Agents|renal agents|mesh-ancestor
43856669|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
43856670|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43856671|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43856672|NCT03430947|Vemurafenib|vemurafenib|mesh-list
43856673|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856674|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856675|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856676|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856677|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
43856678|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43856679|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
43856680|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44359998|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44359999|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360000|NCT01133743|Thalidomide|thalidomide|mesh-list
44360001|NCT01133743|Dexamethasone|dexamethasone|mesh-list
43601457|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43601458|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
43601490|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601491|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601492|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601493|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43601494|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43649135|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360002|NCT01133743|Lenalidomide|lenalidomide|mesh-list
44360003|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360004|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
44360005|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
44360006|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360007|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360008|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360009|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
44360010|NCT01133743|Hormones|hormones|mesh-ancestor
44360011|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360012|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360013|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360014|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
44360015|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44360016|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44360017|NCT01133743|Growth Substances|growth substances|mesh-ancestor
44360018|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
44360019|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360020|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
44360021|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360022|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360023|NCT01133795|Midodrine|midodrine|mesh-list
44360024|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
44360025|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
44360026|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360027|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360028|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43856681|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
43856682|NCT03429140|Protective Agents|protective agents|mesh-ancestor
43856683|NCT03426904|Leucovorin|leucovorin|mesh-list
43856684|NCT03426904|Fluorouracil|fluorouracil|mesh-list
43856685|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
43856686|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
43856687|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856688|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856689|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856693|NCT03426904|Antidotes|antidotes|mesh-ancestor
43856694|NCT03426904|Protective Agents|protective agents|mesh-ancestor
43856695|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
43856696|NCT03426904|Vitamins|vitamins|mesh-ancestor
43856697|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
43856698|NCT03426254|Talazoparib|talazoparib|mesh-list
43541784|NCT04535271|Gemcitabine|gemcitabine|mesh-list
44360029|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44360030|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44360031|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44360032|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
44360033|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360034|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360035|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
44360036|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
44360037|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44360038|NCT01133873|Narcotics|narcotics|mesh-ancestor
44360039|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360040|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360041|NCT01133873|Analgesics|analgesics|mesh-ancestor
44360042|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
44360043|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360044|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
44360045|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
44360046|NCT01133886|Decitabine|decitabine|mesh-list
44360047|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44360048|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
44360049|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360050|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360051|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360052|NCT01133912|Gemcitabine|gemcitabine|mesh-list
44360053|NCT01133912|Paclitaxel|paclitaxel|mesh-list
44360054|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44360055|NCT01133912|Lapatinib|lapatinib|mesh-list
44360056|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360057|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360058|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360059|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360060|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360061|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360070|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44360072|NCT01133925|Paclitaxel|paclitaxel|mesh-list
44360073|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360074|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360075|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360076|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360077|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360078|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360079|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360080|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360081|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44360082|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
43856699|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43856700|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856701|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856702|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856703|NCT03425643|Gemcitabine|gemcitabine|mesh-list
43856704|NCT03425643|Cisplatin|cisplatin|mesh-list
43856705|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
43856706|NCT03425643|Pemetrexed|pemetrexed|mesh-list
43856707|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856708|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856709|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
43856710|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856711|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
43856712|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856713|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856714|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856715|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
43856716|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856717|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856718|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43856719|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44133594|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133595|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
44133596|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133597|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133598|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133599|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44133600|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
44133601|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44133602|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133603|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44133604|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
44133605|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44133606|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133607|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133608|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133610|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44133611|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44133612|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133613|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133614|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133615|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133616|NCT00154219|Analgesics|analgesics|mesh-ancestor
44133617|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
44133618|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133619|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133620|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360084|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
44360085|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360086|NCT01134185|Prucalopride|prucalopride|mesh-list
44360087|NCT01134185|Laxatives|laxatives|mesh-ancestor
44360088|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360089|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44360090|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44360091|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
44360092|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360093|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360094|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360095|NCT01134224|Insulin|insulin|mesh-list
44360096|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44360097|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
44360098|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
44360099|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44360100|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
44360101|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44360102|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
43827413|NCT05488899|Iodine|iodine|mesh-list
44133621|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133622|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
44133623|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44133624|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133625|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44133626|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
44133627|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43856720|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43856721|NCT03422536|Cetuximab|cetuximab|mesh-list
43856722|NCT03422536|Antibodies|antibodies|mesh-list
43856723|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
43856724|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43856725|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
43856726|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856727|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856734|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
43856735|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856736|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856737|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856738|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
43856739|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856740|NCT03422523|Antiviral Agents|antiviral agents|mesh-ancestor
43856741|NCT03422523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856742|NCT03422523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856743|NCT03422523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856744|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
43856745|NCT03420963|Etoposide|etoposide|mesh-list
43856746|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
43856747|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
43856748|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856749|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
43856750|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360103|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360104|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360106|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
44360107|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
44360108|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
44360109|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360110|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360111|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
44360112|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360113|NCT01134341|Vitamins|vitamins|mesh-list
44360114|NCT01134341|Folic Acid|folic acid|mesh-list
44360115|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
44360116|NCT01134341|Hydroxocobalamin|hydroxocobalamin|mesh-list
44360117|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
44360118|NCT01134341|Bexarotene|bexarotene|mesh-list
44360119|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
44360120|NCT01134341|Aminopterin|aminopterin|mesh-list
44360121|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
44360122|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360123|NCT01134341|Hematinics|hematinics|mesh-ancestor
44360124|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360125|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44360126|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856751|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856752|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43856753|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
43856754|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856755|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856756|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43856757|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43856758|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43856759|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43856760|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856761|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
43856762|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
43856763|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
43856764|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856765|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856766|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
43856767|NCT03417492|Citric Acid|citric acid|mesh-list
43856768|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
43856769|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
43856770|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43856771|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
43856772|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
43856773|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655969|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655970|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43655971|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
43856774|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
43856775|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43856776|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43856777|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856778|NCT03417492|Urological Agents|urological agents|mesh-ancestor
43856779|NCT03417401|Plasminogen|plasminogen|mesh-list
43856780|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43856781|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44360127|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360128|NCT01134406|Hylan|hylan|mesh-list
44360129|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
44360130|NCT01134406|Protective Agents|protective agents|mesh-ancestor
44360131|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360132|NCT01134432|Prednisolone|prednisolone|mesh-list
43856782|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43856783|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856784|NCT03410043|Osimertinib|osimertinib|mesh-list
43856785|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856786|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856787|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856788|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856789|NCT03409588|Riociguat|riociguat|mesh-list
43856790|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
43856791|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856792|NCT03406897|Vitamin D|vitamin d|mesh-list
43856793|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
43856794|NCT03406897|Vitamins|vitamins|mesh-ancestor
43601621|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
43601623|NCT03262740|Branebrutinib|branebrutinib|mesh-list
43601624|NCT03262740|Estrogens|estrogens|mesh-ancestor
43601625|NCT03262740|Hormones|hormones|mesh-ancestor
43601626|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601627|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601628|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43601629|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
43601630|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601631|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43601632|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43601649|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601650|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43601651|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
43655974|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43655975|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655976|NCT02964715|Empagliflozin|empagliflozin|mesh-list
43655977|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43850202|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856795|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
43856796|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856797|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43856798|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43856815|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43856816|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43856817|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856818|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856819|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856820|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43856821|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43856822|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43856823|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856824|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856825|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43856826|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43856827|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43856828|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43856829|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856830|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856831|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856832|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43856833|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43856834|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
43856835|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43856836|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43856837|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
43856838|NCT03401060|Denosumab|denosumab|mesh-list
43856839|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43856840|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856841|NCT03400826|Simvastatin|simvastatin|mesh-list
43856842|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43856843|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43856844|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
43856845|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856846|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43856847|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43856849|NCT03399318|Acetaminophen|acetaminophen|mesh-list
43856850|NCT03399318|Ibuprofen|ibuprofen|mesh-list
43856851|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856852|NCT03399318|Analgesics|analgesics|mesh-ancestor
43856853|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
43856854|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856855|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856856|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
43856857|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43856860|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43856861|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360133|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44360134|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
44360135|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44360136|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
44360137|NCT01134432|Rituximab|rituximab|mesh-list
44360138|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43856862|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856863|NCT03398252|Doxazosin|doxazosin|mesh-list
44155598|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
43856864|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43856865|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43856866|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43856867|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43856868|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856869|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856870|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856871|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856873|NCT03396588|Morphine|morphine|mesh-list
43856874|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43856875|NCT03396588|Narcotics|narcotics|mesh-ancestor
43856876|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850210|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856877|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856878|NCT03396588|Analgesics|analgesics|mesh-ancestor
43856879|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
43856880|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856881|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43856882|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
43856883|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
43856884|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43856885|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43856886|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43856887|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856888|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856889|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856890|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
43856891|NCT03396575|Fludarabine|fludarabine|mesh-list
43856892|NCT03396575|Vaccines|vaccines|mesh-list
43856893|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
43856894|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856895|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856896|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856897|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43856898|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
43856899|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856900|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856901|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43856902|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43856903|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43856904|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43856905|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856906|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856907|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43856908|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43856909|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43856910|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43856911|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
43856912|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43856913|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856914|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43856915|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43856916|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
43856917|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44360139|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
44360140|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360141|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360142|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
44360143|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360144|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360145|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360146|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
44360147|NCT01134432|Hormones|hormones|mesh-ancestor
44360148|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360149|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360150|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
44360151|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
44360152|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360153|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360154|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44360155|NCT01134432|Protective Agents|protective agents|mesh-ancestor
44360156|NCT01134484|Thalidomide|thalidomide|mesh-list
44360157|NCT01134484|Dexamethasone|dexamethasone|mesh-list
44360158|NCT01134484|Bortezomib|bortezomib|mesh-list
44360159|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360160|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
44360161|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
44360162|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360163|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360164|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360165|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
44360167|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360168|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360169|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360170|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360171|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
44360172|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
44360173|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673377|NCT01930357|Vaccines|vaccines|mesh-list
43856918|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43856919|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
43856920|NCT03395899|Bevacizumab|bevacizumab|mesh-list
43856921|NCT03395899|Atezolizumab|atezolizumab|mesh-list
43856922|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541785|NCT04535271|Dacarbazine|dacarbazine|mesh-list
44360175|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44360176|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44360177|NCT01134484|Growth Substances|growth substances|mesh-ancestor
44360178|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
44360179|NCT01134523|Paclitaxel|paclitaxel|mesh-list
44360180|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44360181|NCT01134523|Epirubicin|epirubicin|mesh-list
44360182|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360183|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360184|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360185|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360186|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360187|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856923|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856927|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856928|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
43856929|NCT03395184|PF-06700841|pf-06700841|mesh-list
43856930|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43856931|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856932|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133628|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133629|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133630|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133631|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
43856933|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43856935|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
43856936|NCT03390296|Azacitidine|azacitidine|mesh-list
43856937|NCT03390296|Venetoclax|venetoclax|mesh-list
43856938|NCT03390296|Calicheamicins|calicheamicins|mesh-list
43856939|NCT03390296|Antibodies|antibodies|mesh-list
43856940|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
43856941|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43856942|NCT03390296|Maleic acid|maleic acid|mesh-list
43856943|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
43856944|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856945|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856946|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43856947|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
43856948|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856949|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856950|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43856951|NCT03389750|Oxymorphone|oxymorphone|mesh-list
43856952|NCT03389750|Morphine|morphine|mesh-list
43856953|NCT03389750|Oxycodone|oxycodone|mesh-list
43856954|NCT03389750|Hydromorphone|hydromorphone|mesh-list
43856955|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43856956|NCT03389750|Narcotics|narcotics|mesh-ancestor
43856957|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856958|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856959|NCT03389750|Analgesics|analgesics|mesh-ancestor
43856960|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
43856961|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856962|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43856963|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43856964|NCT03387579|SMOFlipid|smoflipid|mesh-list
43856965|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43856966|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43856967|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43856968|NCT03387501|Mitogens|mitogens|mesh-list
43856969|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
43856970|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856971|NCT03386578|Tenofovir|tenofovir|mesh-list
44360189|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44360190|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360191|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360192|NCT01134536|Tapentadol|tapentadol|mesh-list
44360193|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44360194|NCT01134536|Narcotics|narcotics|mesh-ancestor
44360195|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360196|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360197|NCT01134536|Analgesics|analgesics|mesh-ancestor
44360198|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
43673410|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856972|NCT03386578|Emtricitabine|emtricitabine|mesh-list
43856973|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43856974|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
43856975|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856976|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43856977|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43856978|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856979|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856980|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43856981|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43856982|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
43856983|NCT03386539|Everolimus|everolimus|mesh-list
43856984|NCT03386539|Tacrolimus|tacrolimus|mesh-list
43856985|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856986|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
43856987|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856988|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43856989|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856990|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856991|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856992|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43856993|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43856994|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
43856995|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43856996|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856997|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
43856998|NCT03384836|Propranolol|propranolol|mesh-list
43856999|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857000|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857001|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43857002|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43857003|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857004|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857005|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857006|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857007|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43857008|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857009|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
43857010|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
43857012|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43857013|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857014|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
43857015|NCT03383575|Azacitidine|azacitidine|mesh-list
43857016|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857017|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
43857018|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857019|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857020|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857021|NCT03382561|Cisplatin|cisplatin|mesh-list
43857022|NCT03382561|Carboplatin|carboplatin|mesh-list
43857023|NCT03382561|Nivolumab|nivolumab|mesh-list
44360199|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360200|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44360201|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44360202|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360203|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360204|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44360205|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360206|NCT01134666|Cetuximab|cetuximab|mesh-list
44360207|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360208|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360209|NCT01134692|Norfloxacin|norfloxacin|mesh-list
44360210|NCT01134692|Propranolol|propranolol|mesh-list
44360211|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44360212|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44360213|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44360214|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360215|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360216|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360217|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44360218|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360219|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44360249|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44360250|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
44360251|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360253|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360254|NCT01134861|Cisplatin|cisplatin|mesh-list
44360255|NCT01134861|Etoposide|etoposide|mesh-list
44360256|NCT01134861|Vinblastine|vinblastine|mesh-list
44360257|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360258|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360259|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44360260|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360261|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360262|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360263|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360264|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857024|NCT03382561|Etoposide|etoposide|mesh-list
43857025|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
43857026|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
43857027|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857028|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857029|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857030|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857031|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857032|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857033|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857034|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857035|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
43857036|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857037|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857038|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857039|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857040|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
43601652|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43857041|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
43857042|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43857043|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43857044|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857045|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857046|NCT03382106|Urological Agents|urological agents|mesh-ancestor
43857047|NCT03380546|Insulin|insulin|mesh-list
43857048|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43857049|NCT03380546|Acarbose|acarbose|mesh-list
43857050|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
43857051|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43857052|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857053|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43857054|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857055|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857056|NCT03379051|Lenalidomide|lenalidomide|mesh-list
43857057|NCT03379051|Venetoclax|venetoclax|mesh-list
43857058|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
43857059|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857060|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43857061|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43857062|NCT03379051|Growth Substances|growth substances|mesh-ancestor
43857063|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
43857064|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857065|NCT03376477|Lenalidomide|lenalidomide|mesh-list
43857066|NCT03376477|Molgramostim|molgramostim|mesh-list
43857067|NCT03376477|Vaccines|vaccines|mesh-list
43857068|NCT03376477|Sargramostim|sargramostim|mesh-list
43541786|NCT04535271|Trabectedin|trabectedin|mesh-list
44360265|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360266|NCT01134926|Misoprostol|misoprostol|mesh-list
44360267|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44360268|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
44360269|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44360270|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360271|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44360272|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360273|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
44360274|NCT01134965|Digoxin|digoxin|mesh-list
44360275|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44360276|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44360277|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360278|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360279|NCT01134965|Protective Agents|protective agents|mesh-ancestor
44360280|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360281|NCT01134991|Minocycline|minocycline|mesh-list
44360282|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360283|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360284|NCT01135056|Sorafenib|sorafenib|mesh-list
44360285|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360286|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43857069|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43857070|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
43857074|NCT03376477|Growth Substances|growth substances|mesh-ancestor
43857075|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
43857076|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857077|NCT03375788|Hormones|hormones|mesh-list
43857078|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43857079|NCT03375788|Tesamorelin|tesamorelin|mesh-list
43857080|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857081|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857082|NCT03375788|Growth Substances|growth substances|mesh-ancestor
43857083|NCT03375242|Crizotinib|crizotinib|mesh-list
43857084|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857085|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43857086|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857087|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857088|NCT03373851|Sufentanil|sufentanil|mesh-list
43857089|NCT03373851|Dsuvia|dsuvia|mesh-list
43857090|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43857091|NCT03373851|Narcotics|narcotics|mesh-ancestor
43857092|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857093|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857094|NCT03373851|Analgesics|analgesics|mesh-ancestor
43857095|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
43857096|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857097|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43857098|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43857099|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
43857100|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
43857101|NCT03371667|Methotrexate|methotrexate|mesh-list
43857102|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43857103|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
44360287|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360288|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360289|NCT01135199|Pomalidomide|pomalidomide|mesh-list
44360290|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
44360291|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360292|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44360293|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44360294|NCT01135199|Growth Substances|growth substances|mesh-ancestor
44360295|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
44360296|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360297|NCT01135212|Candesartan|candesartan|mesh-list
44360298|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
44360299|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360300|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44360301|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44360302|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360303|NCT01135290|Petrolatum|petrolatum|mesh-list
44360304|NCT01135290|Emollients|emollients|mesh-ancestor
44360305|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
44360306|NCT01135433|Metformin|metformin|mesh-list
44360307|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
44360308|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360309|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360310|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44360311|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360312|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
44360313|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43857104|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43857105|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857106|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857107|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
43857108|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857109|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857110|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857111|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857112|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43857113|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857114|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
43857115|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857116|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857117|NCT03369041|Irinotecan|irinotecan|mesh-list
43857118|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43857119|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857120|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857121|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857122|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360314|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360315|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360316|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601663|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
44360317|NCT01135472|Esomeprazole|esomeprazole|mesh-list
44360318|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44360319|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360320|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44360321|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360322|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360323|NCT01135550|Dexamethasone|dexamethasone|mesh-list
44360324|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
44360326|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360327|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
44360328|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
44360329|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360330|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360331|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360332|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
44360333|NCT01135550|Hormones|hormones|mesh-ancestor
44360334|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360335|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360336|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360337|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
44360338|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360339|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360340|NCT01135563|Sirolimus|sirolimus|mesh-list
44360341|NCT01135563|Vinblastine|vinblastine|mesh-list
44360342|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360343|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360344|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44360345|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857123|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
43857124|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857125|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857126|NCT03367533|Ketamine|ketamine|mesh-list
43857127|NCT03367533|Analgesics|analgesics|mesh-ancestor
43857128|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
43857129|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857130|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857131|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43857132|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44360346|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
44360347|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360348|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
44360349|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360350|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360351|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360352|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360353|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360354|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360356|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
44360357|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360358|NCT01135602|Topiramate|topiramate|mesh-list
44360359|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
44360360|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360361|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360362|NCT01135615|Calcium|calcium|mesh-list
44360363|NCT01135615|Sevelamer|sevelamer|mesh-list
43649144|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
43649145|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649146|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43649147|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
44360364|NCT01135615|Calcium acetate|calcium acetate|mesh-list
44360365|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44360366|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360367|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
44360368|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
44360369|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360370|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
44360371|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44360372|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360373|NCT01135641|Cyclosporine|cyclosporine|mesh-list
44360374|NCT01135641|Rituximab|rituximab|mesh-list
44360375|NCT01135641|Cyclosporins|cyclosporins|mesh-list
44360376|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360377|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360378|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
44360379|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360380|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360387|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44360388|NCT01135667|Clopidogrel|clopidogrel|mesh-list
44360389|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44360390|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44360391|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44360392|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44360393|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44360394|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
44360395|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360396|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360397|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360398|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
44360399|NCT01135680|Glycerol|glycerol|mesh-list
44360400|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360401|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360402|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44360403|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360404|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360405|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360406|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360407|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360408|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44360409|NCT01135680|Protective Agents|protective agents|mesh-ancestor
44360410|NCT01135758|Ketamine|ketamine|mesh-list
44360411|NCT01135758|Analgesics|analgesics|mesh-ancestor
44360412|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
44360413|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360414|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360415|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44360416|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44360417|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
43857133|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
43857134|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
43857135|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857136|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43857137|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43857138|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857139|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857141|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857142|NCT03366766|Gemcitabine|gemcitabine|mesh-list
43857155|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360419|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360420|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44360421|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44360422|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360423|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360424|NCT01135771|Insulin|insulin|mesh-list
44360425|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360426|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360427|NCT01135927|Insulin|insulin|mesh-list
44360428|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44360429|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
44360430|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360431|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015535|NCT03395886|Narcotics|narcotics|mesh-ancestor
44360432|NCT01135953|Cycloserine|cycloserine|mesh-list
44360433|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44360434|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360435|NCT01135953|Renal Agents|renal agents|mesh-ancestor
44360436|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44360437|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
44360438|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43673615|NCT01807546|ON 01910|on 01910|mesh-list
43857156|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857157|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857158|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43857159|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857160|NCT03366298|Epinephrine|epinephrine|mesh-list
43857161|NCT03366298|Racepinephrine|racepinephrine|mesh-list
43857162|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
43857163|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43857164|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43857165|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857166|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857167|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857168|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857169|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43857170|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43857171|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
43857172|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857173|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43857174|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
43857175|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
43857176|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
43857177|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43857178|NCT03361735|Leuprolide|leuprolide|mesh-list
43857179|NCT03361735|Goserelin|goserelin|mesh-list
43857180|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43857181|NCT03361735|Hormones|hormones|mesh-list
43857182|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857183|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857184|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43857185|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
44360439|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
44360440|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360441|NCT01136005|Provitamins|provitamins|mesh-list
44360442|NCT01136005|Vitamins|vitamins|mesh-ancestor
43649152|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44360443|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
44360444|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360445|NCT01136031|Paclitaxel|paclitaxel|mesh-list
44360446|NCT01136031|Irinotecan|irinotecan|mesh-list
44360447|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360448|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360449|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360450|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360451|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360452|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360453|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44360454|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360455|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360456|NCT01136213|Fluoxetine|fluoxetine|mesh-list
44360457|NCT01136213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44360458|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44360459|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360460|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857186|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43857187|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857188|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857189|NCT03359538|Sirolimus|sirolimus|mesh-list
43857190|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43857191|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857192|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857193|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857194|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
43857195|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857196|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
43857197|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857198|NCT03358563|Docetaxel|docetaxel|mesh-list
43857199|NCT03358563|Bicalutamide|bicalutamide|mesh-list
43857200|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43857201|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857202|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857203|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857204|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857205|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857206|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
43857207|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
43857212|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44133632|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44133633|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133634|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44133635|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
44133636|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44133637|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133638|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133639|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360462|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
44360463|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360464|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44360465|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
44360466|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44360467|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44360468|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44360469|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360470|NCT01136252|Adalimumab|adalimumab|mesh-list
44133640|NCT00154258|Clozapine|clozapine|mesh-list
44133641|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44133642|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
44133643|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44133644|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656007|NCT02964455|Docetaxel|docetaxel|mesh-list
43656008|NCT02964455|Nedaplatin|nedaplatin|mesh-list
43827085|NCT05491928|Protective Agents|protective agents|mesh-ancestor
44133645|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133646|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44133647|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133648|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133649|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133650|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
44133651|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
44133652|NCT00154271|Valsartan|valsartan|mesh-list
44133653|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133654|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133655|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43857213|NCT03356860|Paclitaxel|paclitaxel|mesh-list
43857214|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
43857215|NCT03356860|Durvalumab|durvalumab|mesh-list
43857216|NCT03356860|Epirubicin|epirubicin|mesh-list
43857217|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857218|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857219|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857220|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857221|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857222|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857223|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857224|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
43857225|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857226|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857227|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857228|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
43857229|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43857230|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857231|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857232|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857233|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857234|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857235|NCT03353831|Bevacizumab|bevacizumab|mesh-list
43857236|NCT03353831|Atezolizumab|atezolizumab|mesh-list
43857237|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857238|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857239|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43857240|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43857241|NCT03353831|Growth Substances|growth substances|mesh-ancestor
43857242|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857243|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
43857244|NCT03351647|Ustekinumab|ustekinumab|mesh-list
43857245|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857246|NCT03350386|Oxaprozin|oxaprozin|mesh-list
43857247|NCT03350386|Dotinurad|dotinurad|mesh-list
43857248|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
43857249|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
43857250|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857251|NCT03350386|Renal Agents|renal agents|mesh-ancestor
44360471|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360472|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360474|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44360475|NCT01136278|Analgesics|analgesics|mesh-ancestor
44360476|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
44360477|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360478|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360479|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360480|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
44360481|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
44360482|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44360483|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44360484|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43857252|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43857253|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43857254|NCT03350386|Analgesics|analgesics|mesh-ancestor
43857255|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
43857256|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857257|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857258|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857259|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43857260|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857261|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857262|NCT03348969|Mitomycins|mitomycins|mesh-list
43857263|NCT03348969|Mitomycin|mitomycin|mesh-list
43857264|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857265|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857266|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
43857267|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857268|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857269|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857270|NCT03347786|Verapamil|verapamil|mesh-list
43857271|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43857272|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43857273|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857274|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857275|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43857276|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857277|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
43857278|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
43857279|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857280|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857281|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43857282|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857283|NCT03342911|Paclitaxel|paclitaxel|mesh-list
43857284|NCT03342911|Carboplatin|carboplatin|mesh-list
43857285|NCT03342911|Nivolumab|nivolumab|mesh-list
43857286|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857287|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857288|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857289|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857290|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857291|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857292|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857293|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857294|NCT03340909|Prednisolone|prednisolone|mesh-list
43857295|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857296|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
43857297|NCT03340909|Hormones|hormones|mesh-ancestor
44360485|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44360486|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360487|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360488|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
44360489|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44360490|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
44360491|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44360492|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44360493|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360494|NCT01136317|Omeprazole|omeprazole|mesh-list
44360495|NCT01136317|Rabeprazole|rabeprazole|mesh-list
44360496|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44360497|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360498|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44360499|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360500|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360501|NCT01136395|Rituximab|rituximab|mesh-list
44360502|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360503|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360504|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
44360505|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360506|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360507|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
44360508|NCT01136421|Bromides|bromides|mesh-list
44360509|NCT01136421|Ipratropium|ipratropium|mesh-list
44360510|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
44360511|NCT01136421|Analgesics|analgesics|mesh-ancestor
44360512|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
43857298|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857299|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656021|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857300|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857301|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857302|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
43857303|NCT03339596|Hematinics|hematinics|mesh-ancestor
43857304|NCT03338244|Azithromycin|azithromycin|mesh-list
43857305|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43857306|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857307|NCT03337009|Naloxone|naloxone|mesh-list
43857308|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43857309|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857310|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
43857311|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857312|NCT03336203|Allopurinol|allopurinol|mesh-list
43857313|NCT03336203|Febuxostat|febuxostat|mesh-list
43857314|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
43857315|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857316|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857317|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
44360513|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360514|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360515|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
44360516|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360517|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44360518|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44360519|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360520|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360521|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44360522|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
44360523|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44360524|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44360525|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
44360526|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44360527|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
44360528|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44360529|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360530|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360531|NCT01136499|Panobinostat|panobinostat|mesh-list
44360532|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360533|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44360534|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360535|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360536|NCT01136525|Valacyclovir|valacyclovir|mesh-list
44360537|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
44360538|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360539|NCT01136538|Valacyclovir|valacyclovir|mesh-list
44360540|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
44360541|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360542|NCT01136551|Huperzine A|huperzine a|mesh-list
44360556|NCT01136590|Coagulants|coagulants|mesh-ancestor
43601679|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601680|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
43601681|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43601682|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601683|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601684|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601685|NCT03262090|Analgesics|analgesics|mesh-ancestor
44360558|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44360559|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
44360560|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360561|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360562|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44360563|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44360564|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360565|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360566|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360567|NCT01136759|Tenofovir|tenofovir|mesh-list
44360568|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
44360569|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360570|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44360571|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44360572|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360573|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360574|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44360575|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44360576|NCT01136850|Azithromycin|azithromycin|mesh-list
44360577|NCT01136850|Chloroquine|chloroquine|mesh-list
44360578|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
44360579|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
44360580|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44360581|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360582|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360583|NCT01136850|Amebicides|amebicides|mesh-ancestor
44360584|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44360585|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44360586|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
44360587|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360588|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44360589|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360590|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857318|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857319|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43857320|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
43857321|NCT03336203|Protective Agents|protective agents|mesh-ancestor
43857322|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857323|NCT03336073|Dexamethasone|dexamethasone|mesh-list
44360591|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44360593|NCT01136863|Felodipine|felodipine|mesh-list
44360594|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44360595|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360596|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44360597|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360598|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360599|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44360600|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360601|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601719|NCT03261635|Analgesics|analgesics|mesh-ancestor
43601720|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
43601721|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601722|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601723|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601724|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
43601725|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
43601726|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601727|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43857324|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
43857325|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857326|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
43857327|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857328|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857329|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857337|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857338|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857339|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
43857340|NCT03336073|Hormones|hormones|mesh-ancestor
43857341|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857342|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857344|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43857345|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43857346|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43857347|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857348|NCT03335540|Nivolumab|nivolumab|mesh-list
43857349|NCT03335540|Ipilimumab|ipilimumab|mesh-list
43857350|NCT03335540|Linrodostat|linrodostat|mesh-list
43857351|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857352|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857353|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857354|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857355|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857356|NCT03334305|Vaccines|vaccines|mesh-list
43857357|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
43857358|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857359|NCT03333668|Guanfacine|guanfacine|mesh-list
43857360|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43857361|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43857362|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857363|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44155599|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857364|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43857365|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857366|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857367|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
43857368|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857369|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857370|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43857371|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43857372|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43857373|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857374|NCT03331341|Doxorubicin|doxorubicin|mesh-list
43857375|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43857376|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
43857377|NCT03331341|Dacarbazine|dacarbazine|mesh-list
43857378|NCT03331341|Vinblastine|vinblastine|mesh-list
43857379|NCT03331341|Imidazole|imidazole|mesh-list
43857380|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857381|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360603|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44360604|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44360605|NCT01136941|Analgesics|analgesics|mesh-ancestor
44360606|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
44360607|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360608|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360609|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360610|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44360611|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44360612|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360613|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360614|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44360615|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
44360616|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360617|NCT01137019|Everolimus|everolimus|mesh-list
44360618|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360619|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360620|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
44360621|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360622|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
44360623|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44360624|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44360625|NCT01137084|Prednisolone|prednisolone|mesh-list
44360626|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
44360627|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44360628|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
44360629|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360630|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
44360631|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
44360632|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360633|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360634|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857382|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857383|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857384|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857385|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857386|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857387|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857388|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
43857389|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360635|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
44360637|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360638|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44360639|NCT01137084|Protective Agents|protective agents|mesh-ancestor
44360640|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360641|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360642|NCT01137253|Trimethaphan|trimethaphan|mesh-list
44360643|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
44360644|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44360645|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360646|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44360647|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
44360648|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360649|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360650|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44360651|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44360652|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360653|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360654|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360655|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44360656|NCT01137383|Interferons|interferons|mesh-list
44360657|NCT01137383|Ribavirin|ribavirin|mesh-list
44360658|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
44360659|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
44360660|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44360661|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360662|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
44360663|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360664|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
44360665|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360666|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
44360667|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360669|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
44360677|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850255|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656041|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
43656042|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44360678|NCT01137591|Expectorants|expectorants|mesh-ancestor
44360679|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
44360680|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44360681|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
44360682|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360683|NCT01137591|Protective Agents|protective agents|mesh-ancestor
44360684|NCT01137656|Acetylcholine|acetylcholine|mesh-list
44360685|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
44360686|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44360687|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
44360688|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360689|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360690|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857390|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857391|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857392|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857394|NCT03330821|Idarubicin|idarubicin|mesh-list
43857395|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43857396|NCT03330821|Pevonedistat|pevonedistat|mesh-list
43857397|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857403|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857404|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
43857405|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857406|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857407|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857408|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857409|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
43857410|NCT03330028|Promethazine|promethazine|mesh-list
43857411|NCT03330028|Dexamethasone|dexamethasone|mesh-list
43857412|NCT03330028|Paclitaxel|paclitaxel|mesh-list
43857413|NCT03330028|Cisplatin|cisplatin|mesh-list
43857414|NCT03330028|Mitomycins|mitomycins|mesh-list
43857415|NCT03330028|Mitomycin|mitomycin|mesh-list
43857416|NCT03330028|Famotidine|famotidine|mesh-list
43857417|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857418|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857419|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857420|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857421|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857422|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857423|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857424|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
43857425|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
43857426|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857427|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857428|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857429|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
43857430|NCT03330028|Hormones|hormones|mesh-ancestor
43857431|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857432|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857433|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857434|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
43857435|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857436|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857437|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43857438|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44155600|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
43857439|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857440|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
43857441|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
44360691|NCT01137695|Pramlintide|pramlintide|mesh-list
44360692|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44360693|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360694|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360695|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
44360696|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44360697|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44360698|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360699|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
44360700|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44360701|NCT01137708|Tofacitinib|tofacitinib|mesh-list
44360702|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44360703|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
44360704|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43673788|NCT01758458|Interferons|interferons|mesh-list
43857442|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
43857443|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43857444|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
43857445|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
43857446|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857447|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43857448|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
43857449|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857450|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43857451|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43857452|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
43857453|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43857455|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43857456|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857457|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857458|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857459|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
43857460|NCT03328104|Etoposide|etoposide|mesh-list
43857461|NCT03328104|Everolimus|everolimus|mesh-list
43857462|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857463|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
43857464|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857465|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857466|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857467|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
43857471|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857472|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857474|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857475|NCT03327805|Choline|choline|mesh-list
43857476|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
43857477|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43857478|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
43857479|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857480|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857481|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43857482|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
43857483|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
43857484|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43857485|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857486|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857487|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43857488|NCT03325972|Analgesics|analgesics|mesh-ancestor
43857489|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
43857490|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857491|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43857492|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44360705|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360706|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44360707|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44360709|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44360710|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360711|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360712|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44360713|NCT01137708|Estrogens|estrogens|mesh-ancestor
44360714|NCT01137708|Hormones|hormones|mesh-ancestor
44360715|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857493|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43857494|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857495|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857496|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857497|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
43649156|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43857498|NCT03323866|Budesonide|budesonide|mesh-list
43857499|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857500|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43857501|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
43857502|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857503|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857504|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43857505|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
43857506|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
43857507|NCT03323866|Hormones|hormones|mesh-ancestor
43857508|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857509|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857510|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43857511|NCT03323437|Risperidone|risperidone|mesh-list
43857512|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43857513|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
43857514|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857515|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857516|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857517|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43857518|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43857519|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857520|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43857521|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43857522|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
43857523|NCT03323346|Disulfiram|disulfiram|mesh-list
43857524|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43857525|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43857526|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857527|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857528|NCT03322995|Fluorouracil|fluorouracil|mesh-list
43857529|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
43857530|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857531|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857532|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857533|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857534|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
43857535|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857536|NCT03321981|Trastuzumab|trastuzumab|mesh-list
43857537|NCT03321981|Letrozole|letrozole|mesh-list
43857541|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857543|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43857544|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43857545|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857546|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360716|NCT01137903|Amoxicillin|amoxicillin|mesh-list
44360717|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
44360718|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
44360719|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
44360720|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44360721|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44360722|NCT01137903|Trimethoprim|trimethoprim|mesh-list
44360723|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
44360724|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360725|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360726|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44360727|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360728|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360729|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360730|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360731|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44360732|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43857547|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43857548|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
43857549|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857550|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857551|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857552|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857553|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857554|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857555|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857556|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43857557|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
43857558|NCT03321630|Lenvatinib|lenvatinib|mesh-list
43857559|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857560|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857561|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43857562|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857563|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857564|NCT03319537|Cisplatin|cisplatin|mesh-list
43857565|NCT03319537|Pemetrexed|pemetrexed|mesh-list
43857566|NCT03319537|Pevonedistat|pevonedistat|mesh-list
43857567|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857568|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857569|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857570|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43857571|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857572|NCT03318900|Aldesleukin|aldesleukin|mesh-list
43857573|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
43857574|NCT03318900|Interleukin-2|interleukin-2|mesh-list
43857575|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43857576|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
43857577|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857578|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
43857579|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857580|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857581|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857582|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
43857583|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857584|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857585|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44360734|NCT01137903|Renal Agents|renal agents|mesh-ancestor
44360735|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
44360736|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44360737|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44360738|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44360739|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44360740|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44360741|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44360742|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
44360743|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360744|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601769|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601770|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601794|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601796|NCT03261102|Adalimumab|adalimumab|mesh-list
43601797|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601798|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601799|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
43601800|NCT03260829|Vitamins|vitamins|mesh-ancestor
43601801|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
43601802|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601803|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
43601804|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360745|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360746|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360747|NCT01137942|Metronidazole|metronidazole|mesh-list
43857586|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43857587|NCT03318900|Analgesics|analgesics|mesh-ancestor
43857588|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
44155601|NCT00227682|Thalidomide|thalidomide|mesh-list
43857589|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857590|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43857591|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43857592|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
43857593|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857594|NCT03318133|Anesthetics|anesthetics|mesh-list
43857595|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857596|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857597|NCT03317535|Anesthetics|anesthetics|mesh-list
43857598|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857599|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133656|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133657|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
44133658|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
44133659|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44133660|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44133661|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133662|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133663|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44133668|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
44133669|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44133670|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133671|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133672|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
44133673|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133674|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133675|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133676|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133677|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44133678|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133679|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
44133680|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133681|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44133682|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44133683|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
44133684|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133685|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44133686|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360751|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360752|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44360753|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44360754|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44360755|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360756|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360757|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44360758|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44360759|NCT01137994|Paclitaxel|paclitaxel|mesh-list
44360760|NCT01137994|Vinorelbine|vinorelbine|mesh-list
44360761|NCT01137994|Docetaxel|docetaxel|mesh-list
44360762|NCT01137994|Trastuzumab|trastuzumab|mesh-list
44360763|NCT01137994|Lapatinib|lapatinib|mesh-list
44360764|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360765|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360766|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360767|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44360768|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133687|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133688|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
44133689|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
44133690|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44133691|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44133692|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656053|NCT02963779|Analgesics|analgesics|mesh-ancestor
44133693|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133694|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44133695|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44133696|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
44133697|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133698|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44133699|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133700|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133701|NCT00154401|Liraglutide|liraglutide|mesh-list
44133702|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133703|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133704|NCT00154401|Incretins|incretins|mesh-ancestor
44133705|NCT00154401|Hormones|hormones|mesh-ancestor
44133706|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133707|NCT00154414|Liraglutide|liraglutide|mesh-list
44133708|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133709|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133710|NCT00154414|Incretins|incretins|mesh-ancestor
44133711|NCT00154414|Hormones|hormones|mesh-ancestor
44133712|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133713|NCT00154440|Amoxicillin|amoxicillin|mesh-list
44133714|NCT00154440|Metronidazole|metronidazole|mesh-list
44133715|NCT00154440|Clarithromycin|clarithromycin|mesh-list
44133716|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44133717|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360770|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360771|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44360772|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360773|NCT01138072|Atorvastatin|atorvastatin|mesh-list
44360774|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44360775|NCT01138072|Simvastatin|simvastatin|mesh-list
44360776|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44360777|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44360778|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
44360779|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360780|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44360781|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44360782|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360783|NCT01138085|Trametinib|trametinib|mesh-list
44360784|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360785|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44360786|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360787|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360788|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
44360789|NCT01138137|Paclitaxel|paclitaxel|mesh-list
44015857|NCT03445390|Analgesics|analgesics|mesh-ancestor
44360790|NCT01138137|Cisplatin|cisplatin|mesh-list
44360791|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44360792|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44360793|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360794|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44360795|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857603|NCT03316118|Bupivacaine|bupivacaine|mesh-list
43857604|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
43857605|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
43857606|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857607|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857608|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
43857609|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857610|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
43857611|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857612|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656055|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656056|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656057|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656058|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656059|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43857613|NCT03311594|Ethanol|ethanol|mesh-list
43857614|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43857615|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857621|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
43857622|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857623|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857624|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360796|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44360797|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360799|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360800|NCT01138137|Expectorants|expectorants|mesh-ancestor
44360801|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
44360802|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44360803|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
44360804|NCT01138137|Protective Agents|protective agents|mesh-ancestor
44360805|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360806|NCT01138137|Antidotes|antidotes|mesh-ancestor
44360807|NCT01138384|Lapatinib|lapatinib|mesh-list
43857626|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
43857627|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
43857628|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
43857629|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857630|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857631|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
43857632|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857633|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
43857634|NCT03308916|Liver Extracts|liver extracts|mesh-list
43857635|NCT03308916|Hematinics|hematinics|mesh-ancestor
43857636|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
43857637|NCT03308448|Hematinics|hematinics|mesh-ancestor
43857638|NCT03302910|Torsemide|torsemide|mesh-list
43857639|NCT03302910|Furosemide|furosemide|mesh-list
43857640|NCT03302910|Bumetanide|bumetanide|mesh-list
43857641|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
43857642|NCT03302910|Diuretics|diuretics|mesh-list
43857643|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43857644|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
43857645|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857646|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857647|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857648|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
43857649|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43601805|NCT03260829|Protective Agents|protective agents|mesh-ancestor
43601806|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
43601807|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601808|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
43601809|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601810|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601811|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
43601812|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601813|NCT03261024|Nickel|nickel|mesh-list
43601814|NCT03261024|Trace Elements|trace elements|mesh-ancestor
43601815|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
43601816|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601817|NCT03260634|Voriconazole|voriconazole|mesh-list
43601818|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
43857650|NCT03302195|Heparin|heparin|mesh-list
43857651|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
43857652|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43857653|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43857654|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857655|NCT03301896|Spartalizumab|spartalizumab|mesh-list
43857656|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857657|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857658|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857659|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
43857660|NCT03301636|Nivolumab|nivolumab|mesh-list
43857661|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857662|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857663|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43601819|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601820|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43601821|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43601822|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601859|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43857664|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857665|NCT03300557|Exemestane|exemestane|mesh-list
43857666|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857667|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43857668|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43857669|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857670|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857671|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43857672|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
43857673|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857674|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857675|NCT03300427|Valsartan|valsartan|mesh-list
43857676|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43857677|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360809|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44360810|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360811|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360812|NCT01138397|Vaccines|vaccines|mesh-list
44360813|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
44360814|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360815|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44360816|NCT01138423|Moxonidine|moxonidine|mesh-list
44360817|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44360818|NCT01138423|Diuretics|diuretics|mesh-ancestor
44360819|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
44360820|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360821|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44360822|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43673902|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857678|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43857679|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43857680|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857681|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43857682|NCT03298945|Laxatives|laxatives|mesh-ancestor
43857683|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857689|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43857690|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857691|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857692|NCT03296813|Torsemide|torsemide|mesh-list
43857693|NCT03296813|Furosemide|furosemide|mesh-list
43857694|NCT03296813|Diuretics|diuretics|mesh-ancestor
43857695|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
43857696|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857697|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43857698|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857699|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857700|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857701|NCT03292926|Dexamethasone|dexamethasone|mesh-list
43857702|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
43857703|NCT03292926|Bupivacaine|bupivacaine|mesh-list
43857704|NCT03292926|BB 1101|bb 1101|mesh-list
43857705|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857706|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
43857707|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
43857708|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857709|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857710|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43857711|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
43857712|NCT03292926|Hormones|hormones|mesh-ancestor
43857713|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857714|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857715|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857716|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
43857717|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857718|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857719|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
43857720|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
43857721|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656073|NCT02963454|Dobutamine|dobutamine|mesh-list
43857722|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
44360823|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360824|NCT01138449|Vitamin A|vitamin a|mesh-list
44360825|NCT01138449|Vitamins|vitamins|mesh-ancestor
44360826|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
44360827|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360828|NCT01138488|Insulin|insulin|mesh-list
44360829|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
44360830|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44360831|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360832|NCT01138553|Mifepristone|mifepristone|mesh-list
44360833|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44360834|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
44360835|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44360836|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360837|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44360838|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44360839|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44360840|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
43673922|NCT01719016|Adenosine|adenosine|mesh-list
43857723|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43857724|NCT03290937|Cetuximab|cetuximab|mesh-list
43857725|NCT03290937|Irinotecan|irinotecan|mesh-list
43857726|NCT03290937|Camptothecin|camptothecin|mesh-list
43857727|NCT03290937|Antibodies|antibodies|mesh-list
43857728|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
43857729|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43857730|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
43857731|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
43857732|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857733|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857734|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43857735|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857736|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857737|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857738|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857739|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
43857740|NCT03290612|Vitamins|vitamins|mesh-ancestor
43857741|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
43857742|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857743|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
43857744|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857745|NCT03290612|Protective Agents|protective agents|mesh-ancestor
43857746|NCT03290391|Naltrexone|naltrexone|mesh-list
43857747|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43857748|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43857749|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857750|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
43857751|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857753|NCT03289949|Psilocybin|psilocybin|mesh-list
43857754|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
43857755|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857761|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857762|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857764|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
43857765|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857766|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43857767|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43857768|NCT03288974|Growth Substances|growth substances|mesh-ancestor
44360841|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44360843|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44360844|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360845|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
43656075|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
43656076|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43656077|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43656078|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656079|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360846|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44360847|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44360848|NCT01138605|Ritonavir|ritonavir|mesh-list
44360849|NCT01138605|Darunavir|darunavir|mesh-list
44360850|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44360851|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44360852|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
44360853|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360854|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360855|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44360856|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44360857|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
44360858|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360859|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44360860|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44360861|NCT01138683|Diuretics|diuretics|mesh-list
44360862|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
44360863|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360864|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
44360865|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
44360866|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857769|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
43857770|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857771|NCT03287947|Nintedanib|nintedanib|mesh-list
43857772|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857773|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43857774|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857775|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857776|NCT03286634|Cytarabine|cytarabine|mesh-list
43857777|NCT03286634|Prednisolone|prednisolone|mesh-list
43857778|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
43857779|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
43857780|NCT03286634|Methotrexate|methotrexate|mesh-list
43857781|NCT03286634|Vincristine|vincristine|mesh-list
43857782|NCT03286634|Daunorubicin|daunorubicin|mesh-list
43857783|NCT03286634|Epirubicin|epirubicin|mesh-list
43857784|NCT03286634|Asparaginase|asparaginase|mesh-list
43857785|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
43857786|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857787|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
43857788|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857789|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857790|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857791|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
44360867|NCT01138774|Protective Agents|protective agents|mesh-ancestor
44360868|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360869|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
44360870|NCT01138774|Vitamins|vitamins|mesh-ancestor
44360871|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
44360872|NCT01138839|Dexamethasone|dexamethasone|mesh-list
44360873|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44360874|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
44360875|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
44360876|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360877|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360878|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360879|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
44360880|NCT01138839|Hormones|hormones|mesh-ancestor
44360881|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44360882|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44360883|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360884|NCT01138852|Ampicillin|ampicillin|mesh-list
44360885|NCT01138852|Cefuroxime|cefuroxime|mesh-list
44360886|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
44360887|NCT01138852|Sulbactam|sulbactam|mesh-list
44360888|NCT01138852|Sultamicillin|sultamicillin|mesh-list
43656080|NCT02963454|Protective Agents|protective agents|mesh-ancestor
43656081|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360889|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44360890|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360891|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44360892|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360893|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360894|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
44360895|NCT01138904|Irinotecan|irinotecan|mesh-list
44360917|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44360918|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360919|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360920|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360921|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360922|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
44360923|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360924|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360926|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44360927|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
44360928|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360929|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360930|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
44360931|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360932|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44360933|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
43674006|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43857792|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857793|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857794|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43857795|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43857796|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
43857797|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43857798|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857799|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
43857800|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857801|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857802|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43857803|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43857804|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
43857805|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857806|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43857807|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
43857808|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
43857809|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
43857810|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857811|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
43857812|NCT03286634|Hormones|hormones|mesh-ancestor
43857813|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857814|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857815|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43857816|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43857817|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857818|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43857819|NCT03286556|Autoantibodies|autoantibodies|mesh-list
43857820|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857821|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
43857822|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857823|NCT03285321|Nivolumab|nivolumab|mesh-list
43857824|NCT03285321|Ipilimumab|ipilimumab|mesh-list
43857825|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857826|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857832|NCT03284385|Adavosertib|adavosertib|mesh-list
43857833|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360934|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360936|NCT01139203|Adefovir|adefovir|mesh-list
44360937|NCT01139203|Entecavir|entecavir|mesh-list
44360938|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44360939|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44360940|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360941|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360942|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
44360943|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44360944|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44360945|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44360946|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44360947|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
44360948|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44360949|NCT01139437|Vaccines|vaccines|mesh-list
44360950|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
44360951|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360952|NCT01139463|Haloperidol|haloperidol|mesh-list
44360953|NCT01139463|Olanzapine|olanzapine|mesh-list
44360954|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
44360955|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
44360956|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
44360957|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360958|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360959|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360960|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43857834|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133718|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133719|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44133720|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44133721|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44133722|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133723|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133724|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44133725|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44155602|NCT00227682|Dexamethasone|dexamethasone|mesh-list
44155603|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
44155604|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155605|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
44155606|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
44155607|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155608|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155609|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155610|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
44155611|NCT00227682|Hormones|hormones|mesh-ancestor
44155612|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155613|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155614|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360961|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43601863|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601885|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601886|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
43601887|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601888|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43601889|NCT03260283|Narcotics|narcotics|mesh-ancestor
43601890|NCT03260283|Analgesics|analgesics|mesh-ancestor
43850274|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656088|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656089|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656090|NCT02963051|Copper|copper|mesh-list
43656091|NCT02963051|Disulfiram|disulfiram|mesh-list
43656092|NCT02963051|Trace Elements|trace elements|mesh-ancestor
43656093|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
44360962|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360963|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44360964|NCT01139463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44360965|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44360966|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44360967|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360968|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44360969|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
44360970|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44360971|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
44360972|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44360974|NCT01139645|Rabeprazole|rabeprazole|mesh-list
44360975|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44360976|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44360977|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44360978|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44360979|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360980|NCT01139671|Remifentanil|remifentanil|mesh-list
44360981|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44360982|NCT01139671|Narcotics|narcotics|mesh-ancestor
44360983|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44360984|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360985|NCT01139671|Analgesics|analgesics|mesh-ancestor
44360986|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
44155615|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155616|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
44155617|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
44155618|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155619|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155620|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44155621|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44155622|NCT00227682|Growth Substances|growth substances|mesh-ancestor
44155623|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
44155624|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
44155625|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155626|NCT00227682|Protective Agents|protective agents|mesh-ancestor
44155627|NCT00227682|Vitamins|vitamins|mesh-ancestor
44155628|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
44155629|NCT00227695|Rituximab|rituximab|mesh-list
44155630|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155631|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155632|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
44155633|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155634|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155636|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155637|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
44155638|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
44155639|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
44155640|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44360987|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44360988|NCT01139723|Bevacizumab|bevacizumab|mesh-list
44360989|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44360990|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44360991|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44360992|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44360993|NCT01139723|Growth Substances|growth substances|mesh-ancestor
44360994|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44360995|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44360996|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
44360997|NCT01139749|Ciclopirox|ciclopirox|mesh-list
44360998|NCT01139749|Salicylates|salicylates|mesh-list
44360999|NCT01139749|Isotretinoin|isotretinoin|mesh-list
44361000|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361001|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155641|NCT00227734|Capecitabine|capecitabine|mesh-list
44155642|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
44155643|NCT00227734|Cetuximab|cetuximab|mesh-list
44155644|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155645|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
44155646|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155647|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656095|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44155648|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155649|NCT00227747|Capecitabine|capecitabine|mesh-list
44155650|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
44155651|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155652|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
44155653|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155654|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155655|NCT00227773|Octreotide|octreotide|mesh-list
44155656|NCT00227773|Hormones|hormones|mesh-list
43857845|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43857846|NCT03284307|Analgesics|analgesics|mesh-ancestor
43857847|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
43857848|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857849|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43857850|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43857851|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43857852|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857853|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857854|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857855|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43857856|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43857857|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43857858|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43857859|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43857860|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43857861|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43857862|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
43857863|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
43857864|NCT03283917|Dexamethasone|dexamethasone|mesh-list
43857865|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
43857866|NCT03283917|Daratumumab|daratumumab|mesh-list
43857867|NCT03283917|Ixazomib|ixazomib|mesh-list
43857868|NCT03283917|Ichthammol|ichthammol|mesh-list
43857869|NCT03283917|BB 1101|bb 1101|mesh-list
43857870|NCT03283917|Glycine|glycine|mesh-list
43857871|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857872|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
43857873|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
43857874|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857875|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857876|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361002|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
44361003|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
44361004|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44361005|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361007|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
44361008|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361009|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361010|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361011|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361012|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44361013|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361014|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361015|NCT01139840|Vitamin D|vitamin d|mesh-list
44361016|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
44361017|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
44361018|NCT01139840|Vitamins|vitamins|mesh-list
44361019|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
44361020|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857877|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
43857878|NCT03283917|Hormones|hormones|mesh-ancestor
43857879|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857880|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857881|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857882|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
43857883|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857884|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857885|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
43857886|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
43857887|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857888|NCT03281954|Atezolizumab|atezolizumab|mesh-list
43857889|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857890|NCT03280251|Methylphenidate|methylphenidate|mesh-list
43857891|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43857892|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857893|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43857894|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43857895|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857896|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857898|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43857899|NCT03280160|Ofatumumab|ofatumumab|mesh-list
43857900|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857901|NCT03280017|Ketamine|ketamine|mesh-list
43857902|NCT03280017|Analgesics|analgesics|mesh-ancestor
43857903|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
43857904|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857905|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857906|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43857907|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43857908|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
43857909|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
43857910|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857911|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43857912|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43857913|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361021|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44361022|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361024|NCT01139905|Lopinavir|lopinavir|mesh-list
44361025|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44361026|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44361027|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
44361028|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361029|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361030|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44361031|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361032|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
44361033|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361034|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43857914|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857915|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43857916|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43857917|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857918|NCT03279250|Prednisone|prednisone|mesh-list
43857919|NCT03279250|Cortisone|cortisone|mesh-list
43857920|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
43857921|NCT03279250|Hormones|hormones|mesh-list
43857922|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43857923|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857924|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
43857925|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857926|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601894|NCT03260166|Niacinamide|niacinamide|mesh-list
43857927|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43857928|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857929|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43857930|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857931|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857932|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
43857933|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43857934|NCT03278717|Olaparib|olaparib|mesh-list
43857935|NCT03278717|Cediranib|cediranib|mesh-list
43857936|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43857937|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857938|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857939|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857940|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43857941|NCT03278509|Metoprolol|metoprolol|mesh-list
43857942|NCT03278509|Bisoprolol|bisoprolol|mesh-list
43857943|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43857944|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857945|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
43857946|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
43857947|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857948|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857949|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43857950|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43857951|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43857952|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
43857953|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656121|NCT02963181|Melatonin|melatonin|mesh-list
43857954|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857955|NCT03277196|Ivacaftor|ivacaftor|mesh-list
43857956|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43857957|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43857958|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361036|NCT01140009|Vaccines|vaccines|mesh-list
44361037|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
44361038|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361039|NCT01140035|Insulin|insulin|mesh-list
44361040|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361041|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361042|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
44361043|NCT01140074|Astringents|astringents|mesh-ancestor
44361044|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361045|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361046|NCT01140100|Thiopental|thiopental|mesh-list
44361047|NCT01140100|Propofol|propofol|mesh-list
44361048|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44361049|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361050|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361051|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44361052|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
44361053|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
44361054|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
44361055|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
44361056|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
44361057|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656122|NCT02963181|Yohimbine|yohimbine|mesh-list
44361058|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361059|NCT01140126|UB-421|ub-421|mesh-list
44361060|NCT01140126|Antibodies|antibodies|mesh-list
44361061|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
44361062|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857959|NCT03275597|Durvalumab|durvalumab|mesh-list
43857960|NCT03275597|Tremelimumab|tremelimumab|mesh-list
43857961|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857962|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857963|NCT03274401|Anticoagulants|anticoagulants|mesh-list
43857965|NCT03274258|Ipilimumab|ipilimumab|mesh-list
43857966|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857967|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857968|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43857975|NCT03267680|Omeprazole|omeprazole|mesh-list
43857976|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857977|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
43857978|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857979|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43857980|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857981|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
43857982|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857983|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857984|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43857985|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43857986|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361063|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361064|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
44361065|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361066|NCT01140308|Ubiquinone|ubiquinone|mesh-list
44361067|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
44361068|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
44361069|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361070|NCT01140308|Vitamins|vitamins|mesh-ancestor
44361071|NCT01140399|Dopamine|dopamine|mesh-list
44361072|NCT01140399|Furosemide|furosemide|mesh-list
44361073|NCT01140399|Diuretics|diuretics|mesh-ancestor
44361074|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
44361075|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361076|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44361077|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44361078|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361079|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44361080|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
44361081|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
44361082|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361083|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
44361084|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361085|NCT01140399|Protective Agents|protective agents|mesh-ancestor
44361086|NCT01140412|Ritonavir|ritonavir|mesh-list
44361087|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
44361088|NCT01140412|Maraviroc|maraviroc|mesh-list
44361089|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43601906|NCT03260010|Fosfomycin|fosfomycin|mesh-list
44361090|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44361091|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
44361092|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361094|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44361110|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361111|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361112|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44361113|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44361114|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361115|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
44361116|NCT01140438|Metformin|metformin|mesh-list
44361117|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44361118|NCT01140438|Repaglinide|repaglinide|mesh-list
44361119|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
44361120|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
44361121|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
44361122|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361123|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361124|NCT01140438|Incretins|incretins|mesh-ancestor
44361125|NCT01140438|Hormones|hormones|mesh-ancestor
44361126|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361127|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44361128|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
44361129|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361130|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361131|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
44361132|NCT01140529|Haloperidol|haloperidol|mesh-list
44361133|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
44361134|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44361135|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361136|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361137|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361138|NCT01140529|Analgesics|analgesics|mesh-ancestor
43857987|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43857988|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857989|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43857990|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43857991|NCT03267680|Analgesics|analgesics|mesh-ancestor
43857992|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
43857993|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43857994|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857995|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
43857996|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
43857997|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43857998|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43857999|NCT03266081|Bupivacaine|bupivacaine|mesh-list
43858000|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858001|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
43858002|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858003|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858004|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
44361139|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
44361140|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361141|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44361142|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44361143|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44361144|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44361145|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361146|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361147|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
44361148|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
44361149|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858005|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858006|NCT03263481|Secretin|secretin|mesh-list
43858007|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858008|NCT03263481|Hormones|hormones|mesh-ancestor
43850277|NCT05698147|Rituximab|rituximab|mesh-list
43656128|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
43858009|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43858010|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858011|NCT03262779|Nivolumab|nivolumab|mesh-list
43858012|NCT03262779|Ipilimumab|ipilimumab|mesh-list
43858013|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858014|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858015|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43858016|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858017|NCT03262103|Poly I-C|poly i-c|mesh-list
43858018|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43858019|NCT03262103|Poly ICLC|poly iclc|mesh-list
43858020|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
43858021|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
43858022|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858023|NCT03262103|Laxatives|laxatives|mesh-ancestor
43858024|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858025|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
43858026|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858027|NCT03261570|Digoxin|digoxin|mesh-list
43858028|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43858029|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43858030|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43858031|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858032|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858033|NCT03261570|Protective Agents|protective agents|mesh-ancestor
43858034|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858035|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43858036|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
43858037|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858040|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43858041|NCT03259503|Melphalan|melphalan|mesh-list
43858042|NCT03259503|Busulfan|busulfan|mesh-list
43858043|NCT03259503|Olaparib|olaparib|mesh-list
43858044|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
43858045|NCT03259503|Vorinostat|vorinostat|mesh-list
43858046|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43858047|NCT03259503|Antibodies|antibodies|mesh-list
43858048|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
43858049|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858050|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
43858051|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858052|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858053|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858054|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858055|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
43858056|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858057|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
43858058|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858059|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858060|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361150|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44361151|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44361152|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44361153|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44361154|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
44361155|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44361156|NCT01140581|Dronedarone|dronedarone|mesh-list
44361157|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44361158|NCT01140620|Ketamine|ketamine|mesh-list
44361159|NCT01140620|Risperidone|risperidone|mesh-list
44361160|NCT01140620|Analgesics|analgesics|mesh-ancestor
43858061|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858062|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
43656135|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656136|NCT02963181|Urological Agents|urological agents|mesh-ancestor
43656137|NCT02963337|Remifentanil|remifentanil|mesh-list
43656138|NCT02963337|Bupivacaine|bupivacaine|mesh-list
43656139|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858063|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43858064|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43858065|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43858066|NCT03259074|Adalimumab|adalimumab|mesh-list
43858067|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43858068|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858069|NCT03257761|Durvalumab|durvalumab|mesh-list
43858070|NCT03257761|Guadecitabine|guadecitabine|mesh-list
43858071|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858072|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858073|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
43858074|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858075|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
43858076|NCT03254589|Methotrexate|methotrexate|mesh-list
43858077|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43858078|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
43858079|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858080|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858081|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858082|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
43858083|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858084|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858085|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858086|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858087|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43858088|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858089|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
43858090|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858091|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43858092|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858093|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43858094|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43858095|NCT03254589|Analgesics|analgesics|mesh-ancestor
43858096|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
43858097|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858098|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43858099|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858100|NCT03252756|Cannabidiol|cannabidiol|mesh-list
43858101|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
43858102|NCT03251300|Mirabegron|mirabegron|mesh-list
43858103|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43858104|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43858105|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43858106|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
43858107|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858108|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858109|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858110|NCT03251300|Urological Agents|urological agents|mesh-ancestor
43858111|NCT03250377|Brivaracetam|brivaracetam|mesh-list
43858112|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
43858113|NCT03249558|Morphine|morphine|mesh-list
43858121|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858122|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43542616|NCT03701321|Bortezomib|bortezomib|mesh-list
44361162|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361163|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361164|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44361165|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44361166|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
44361167|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
44361168|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361169|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44361170|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44361171|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361172|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361173|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44361174|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
43858123|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43858124|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43858125|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858127|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
43858128|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43858129|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
43858130|NCT03249181|Dolutegravir|dolutegravir|mesh-list
43601921|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43601922|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601944|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43601945|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43601946|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
43601947|NCT03259516|Cytarabine|cytarabine|mesh-list
43601948|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
43601949|NCT03259516|Melphalan|melphalan|mesh-list
43601950|NCT03259516|Nivolumab|nivolumab|mesh-list
43601951|NCT03259516|Fludarabine|fludarabine|mesh-list
43601952|NCT03259516|Azacitidine|azacitidine|mesh-list
43601953|NCT03259516|Tretinoin|tretinoin|mesh-list
43601954|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
43656146|NCT02963337|Narcotics|narcotics|mesh-ancestor
43656147|NCT02963337|Analgesics|analgesics|mesh-ancestor
43656148|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43656149|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43656150|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656151|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
43656152|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858131|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43858132|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43858133|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858134|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858135|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43858136|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43858137|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
43858138|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858139|NCT03247582|Edoxaban|edoxaban|mesh-list
43858140|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43858141|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
43858142|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43858143|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
43858144|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858145|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858146|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
43858147|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
43858148|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
43858149|NCT03247088|Busulfan|busulfan|mesh-list
43858150|NCT03247088|Fludarabine|fludarabine|mesh-list
43858151|NCT03247088|Sorafenib|sorafenib|mesh-list
43858152|NCT03247088|Tacrolimus|tacrolimus|mesh-list
43858153|NCT03247088|Lenograstim|lenograstim|mesh-list
43858154|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858155|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
43858156|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858157|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858158|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858159|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
43858160|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858161|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858162|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43858163|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43858164|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858165|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43858166|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858167|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43858168|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
44361176|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44361177|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44361178|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44361179|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
44361180|NCT01140737|Axitinib|axitinib|mesh-list
44361181|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361182|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44361183|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361184|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361185|NCT01140828|Rabeprazole|rabeprazole|mesh-list
44361186|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44361187|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361188|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44361189|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361190|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361191|NCT01140893|Exenatide|exenatide|mesh-list
44361192|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361193|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361194|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44361195|NCT01140893|Incretins|incretins|mesh-ancestor
44361196|NCT01140893|Hormones|hormones|mesh-ancestor
43858169|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43858170|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858171|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858172|NCT03246828|Gliclazide|gliclazide|mesh-list
43858173|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43858174|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858175|NCT03246074|Paclitaxel|paclitaxel|mesh-list
43858176|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43656155|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858177|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858178|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858179|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858180|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858181|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858187|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858188|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858190|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43858191|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858192|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858193|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858194|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
43858195|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858196|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
43858197|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133726|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
44133727|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44133728|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133729|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133730|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44133731|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44133732|NCT00154661|Protective Agents|protective agents|mesh-ancestor
44361203|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44361204|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
44361205|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361206|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
44361207|NCT01140932|Hormones|hormones|mesh-ancestor
44361208|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361209|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361210|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44361211|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361212|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
44361213|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
44361214|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674201|NCT01563731|Atorvastatin|atorvastatin|mesh-list
44133733|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133734|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133735|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44133736|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
44133737|NCT00154687|Paclitaxel|paclitaxel|mesh-list
44133738|NCT00154687|Cisplatin|cisplatin|mesh-list
44133739|NCT00154687|Fluorouracil|fluorouracil|mesh-list
44133740|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133741|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133742|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133743|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858205|NCT03240809|Brodalumab|brodalumab|mesh-list
43858206|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858207|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858208|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
43858209|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858210|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
43858211|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43858212|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858213|NCT03239210|Ondansetron|ondansetron|mesh-list
43858214|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
43858215|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
43858216|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858217|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858218|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858219|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
43858220|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858221|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43858222|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
43858223|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858224|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361215|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361216|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44361218|NCT01140971|Misoprostol|misoprostol|mesh-list
44361219|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44361220|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
44361221|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44361222|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361223|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44361224|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361225|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
44361226|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
44361227|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44361228|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44361229|NCT01140984|Prednisolone|prednisolone|mesh-list
44361230|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
44361231|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44361232|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
44361275|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44361276|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44361277|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44361278|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44361279|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
44016308|NCT03509766|Histamine|histamine|mesh-list
44361280|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361281|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361282|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361283|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44361284|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361285|NCT01141153|Analgesics|analgesics|mesh-ancestor
44361286|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
44361287|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361288|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361289|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361290|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44361291|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44361292|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44361293|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361294|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
44361295|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
44361296|NCT01141192|Vitamin D|vitamin d|mesh-list
44361323|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361325|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44361326|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44361327|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016388|NCT03521505|Propofol|propofol|mesh-list
44361328|NCT01141439|Fluticasone|fluticasone|mesh-list
44361330|NCT01141439|Beclomethasone|beclomethasone|mesh-list
44361331|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601955|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601956|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
43601957|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601958|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601959|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43601960|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
43656173|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43656174|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43656175|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656176|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361332|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44361333|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
44361334|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361335|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858225|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43858226|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43858227|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858228|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43858229|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43858230|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43858231|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858232|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601961|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601962|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601963|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43601964|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43601965|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43601966|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43601967|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
43601968|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
43601969|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601970|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601971|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601972|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43601973|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43702798|NCT02714842|Diclofenac|diclofenac|mesh-list
43858233|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
43858234|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43858235|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
43858236|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858237|NCT03238300|Expectorants|expectorants|mesh-ancestor
43858241|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858243|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858244|NCT03238300|Antidotes|antidotes|mesh-ancestor
43858245|NCT03238027|Durvalumab|durvalumab|mesh-list
43858246|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858247|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858248|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
43858249|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858250|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858251|NCT03237390|Gemcitabine|gemcitabine|mesh-list
43858252|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858253|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
43858254|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858255|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858256|NCT03237390|Antiviral Agents|antiviral agents|mesh-ancestor
43858257|NCT03237390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858258|NCT03237390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858259|NCT03237390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858260|NCT03237390|Immunologic Factors|immunologic factors|mesh-ancestor
43858261|NCT03237390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858262|NCT03236428|Daratumumab|daratumumab|mesh-list
43858263|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858264|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43858265|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
43858266|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43858267|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43858268|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43858269|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
43858270|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858271|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858272|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858273|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43858274|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43858275|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44361336|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44361337|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361338|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361339|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44361340|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
44361341|NCT01141439|Hormones|hormones|mesh-ancestor
44361342|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361343|NCT01141452|Fluticasone|fluticasone|mesh-list
44361344|NCT01141452|Xhance|xhance|mesh-list
44361345|NCT01141452|Beclomethasone|beclomethasone|mesh-list
44361346|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361347|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44361348|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
44361349|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361350|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361351|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44361352|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361353|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361354|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44361355|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
44361356|NCT01141452|Hormones|hormones|mesh-ancestor
44361357|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361358|NCT01141465|Fluticasone|fluticasone|mesh-list
44361359|NCT01141465|Xhance|xhance|mesh-list
44361360|NCT01141465|Budesonide|budesonide|mesh-list
44361361|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
44361362|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44361363|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44361364|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44361365|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361366|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44361367|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
44361368|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361369|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361370|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44361371|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361372|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361373|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44361374|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
44361375|NCT01141465|Hormones|hormones|mesh-ancestor
44361376|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361377|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44361378|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44361379|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44361380|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44361381|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361382|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361383|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
44361384|NCT01141543|Plerixafor|plerixafor|mesh-list
44361385|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44361386|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361387|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
44361388|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361389|NCT01141556|Selenium|selenium|mesh-list
43858276|NCT03233633|Cannabidiol|cannabidiol|mesh-list
43858277|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
43858278|NCT03233139|Gemcitabine|gemcitabine|mesh-list
43858279|NCT03233139|Paclitaxel|paclitaxel|mesh-list
43858280|NCT03233139|Pemetrexed|pemetrexed|mesh-list
43858281|NCT03233139|Ipilimumab|ipilimumab|mesh-list
43858282|NCT03233139|Cemiplimab|cemiplimab|mesh-list
43858283|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43858284|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858285|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858286|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858287|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858288|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858289|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858290|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
43858291|NCT03233139|Antiviral Agents|antiviral agents|mesh-ancestor
43858292|NCT03233139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858293|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858294|NCT03233139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858295|NCT03233139|Immunologic Factors|immunologic factors|mesh-ancestor
43858296|NCT03233139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858297|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43858298|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43858299|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858300|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43858301|NCT03232593|Atezolizumab|atezolizumab|mesh-list
43858302|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858303|NCT03231722|Leucovorin|leucovorin|mesh-list
43858304|NCT03231722|Fluorouracil|fluorouracil|mesh-list
43858305|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
43858306|NCT03231722|Irinotecan|irinotecan|mesh-list
43858307|NCT03231722|Panitumumab|panitumumab|mesh-list
43858308|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
43858309|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
43858311|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858312|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858313|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858314|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
43858315|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858316|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43858317|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43858318|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858319|NCT03231722|Antidotes|antidotes|mesh-ancestor
43858320|NCT03231722|Protective Agents|protective agents|mesh-ancestor
43656187|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
44361391|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361392|NCT01141556|Protective Agents|protective agents|mesh-ancestor
44361393|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361394|NCT01141556|Trace Elements|trace elements|mesh-ancestor
44361395|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
44361397|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44361398|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44361399|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
43674390|NCT02893826|Nimodipine|nimodipine|mesh-list
43858321|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
43858323|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
43858324|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858325|NCT03229798|Sumatriptan|sumatriptan|mesh-list
43858326|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43858327|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43858328|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43858329|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
43858330|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858331|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858332|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858334|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43858335|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43858336|NCT03227926|Panitumumab|panitumumab|mesh-list
43858337|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858338|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858339|NCT03227562|Risperidone|risperidone|mesh-list
43858340|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43858341|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
43858342|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858343|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858344|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858345|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43858346|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43858347|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858348|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43858349|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43858350|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
43858351|NCT03226301|Venetoclax|venetoclax|mesh-list
43858352|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858353|NCT03224767|Vemurafenib|vemurafenib|mesh-list
43858354|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858355|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858356|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858357|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858358|NCT03223779|Trifluridine|trifluridine|mesh-list
43858359|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
43858360|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858361|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
43858362|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858363|NCT03223376|Paclitaxel|paclitaxel|mesh-list
43858364|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43858365|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43858366|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858367|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858368|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858369|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858370|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858371|NCT03222609|Navitoclax|navitoclax|mesh-list
43858372|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858373|NCT03221426|Leucovorin|leucovorin|mesh-list
43858374|NCT03221426|Cisplatin|cisplatin|mesh-list
43858375|NCT03221426|Docetaxel|docetaxel|mesh-list
43858376|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
43858377|NCT03221426|Fluorouracil|fluorouracil|mesh-list
44361400|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361401|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656194|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656195|NCT02962986|Protective Agents|protective agents|mesh-ancestor
43656197|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43656199|NCT02962947|Propranolol|propranolol|mesh-list
44361402|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361403|NCT01141881|Bevacizumab|bevacizumab|mesh-list
44361404|NCT01141881|Plasminogen|plasminogen|mesh-list
44361405|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44361406|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361407|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361408|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44361409|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44361410|NCT01141881|Growth Substances|growth substances|mesh-ancestor
44361411|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361412|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
44361413|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44361414|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44361415|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361416|NCT01141894|Phenylephrine|phenylephrine|mesh-list
44361417|NCT01141894|Dobutamine|dobutamine|mesh-list
44361418|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
44361419|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43674404|NCT02893280|Aspirin|aspirin|mesh-list
43858378|NCT03221426|Capecitabine|capecitabine|mesh-list
43858379|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
43858380|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858381|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858382|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858383|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858384|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858393|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
43858394|NCT03221426|Vitamins|vitamins|mesh-ancestor
43858395|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
43858396|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
43858397|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43858398|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
43858399|NCT03220776|Gabapentin|gabapentin|mesh-list
43858400|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43858401|NCT03220776|Analgesics|analgesics|mesh-ancestor
43858402|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
43858403|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858404|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858405|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
43858406|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43858407|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43858408|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858409|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43858410|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43858411|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43858412|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858413|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858414|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
43858415|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
43858416|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858417|NCT03220776|Expectorants|expectorants|mesh-ancestor
43858418|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
43858419|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44361420|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44361422|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
44361423|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361424|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361425|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
44361426|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44361427|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
44361428|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361429|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43651603|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43651605|NCT03006107|Piroxicam|piroxicam|mesh-list
44361430|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44361431|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44361432|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
44361433|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361434|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858420|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
43858421|NCT03220776|Protective Agents|protective agents|mesh-ancestor
43858422|NCT03220776|Antidotes|antidotes|mesh-ancestor
43858428|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
43858429|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
43858430|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
43858431|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858432|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858433|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858434|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858435|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
43858436|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858437|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858438|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43858439|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858440|NCT03219086|Bupivacaine|bupivacaine|mesh-list
43858441|NCT03219086|Prilocaine|prilocaine|mesh-list
43858442|NCT03219086|Anesthetics|anesthetics|mesh-list
43858443|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858444|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858445|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858446|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
43858447|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858448|NCT03218800|Ertapenem|ertapenem|mesh-list
43858449|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43858450|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858451|NCT03218683|Venetoclax|venetoclax|mesh-list
43858452|NCT03218683|AZD5991|azd5991|mesh-list
43858453|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858454|NCT03217747|Avelumab|avelumab|mesh-list
43858455|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858456|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
43858457|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858458|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858459|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
43858462|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858463|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858464|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
43858465|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858467|NCT03215017|Sorbitol|sorbitol|mesh-list
43858468|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
43858469|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858470|NCT03215017|Cathartics|cathartics|mesh-ancestor
43858471|NCT03212989|Vorinostat|vorinostat|mesh-list
43858472|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858473|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44361435|NCT01141894|Protective Agents|protective agents|mesh-ancestor
44361436|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44361437|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44361438|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
44361439|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
44361441|NCT01141972|Vitamins|vitamins|mesh-ancestor
44361442|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
44361443|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361444|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44361445|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
44361446|NCT01141998|Vitamin D|vitamin d|mesh-list
44361447|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
44361448|NCT01141998|Calcium|calcium|mesh-list
44361449|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361450|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361451|NCT01141998|Vitamins|vitamins|mesh-ancestor
44361452|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
44361453|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44361454|NCT01142011|Belimumab|belimumab|mesh-list
44361455|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361456|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
43850281|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
44361457|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361458|NCT01142245|Esomeprazole|esomeprazole|mesh-list
44361459|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44361460|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361461|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44361462|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361463|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361464|NCT01142258|Trazodone|trazodone|mesh-list
44361465|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44361466|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44361467|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361468|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361469|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44361470|NCT01142258|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44361475|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
44361476|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44361477|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
44361478|NCT01142401|Bortezomib|bortezomib|mesh-list
44361479|NCT01142401|Fulvestrant|fulvestrant|mesh-list
44361480|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361481|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44361482|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44361483|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44361484|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
44361485|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361486|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361487|NCT01142414|Cisplatin|cisplatin|mesh-list
44361488|NCT01142414|Fluorouracil|fluorouracil|mesh-list
44361489|NCT01142414|Panitumumab|panitumumab|mesh-list
44361490|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361491|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
44361492|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361493|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361494|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361495|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
44361496|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361497|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361498|NCT01142453|Interferons|interferons|mesh-list
44361499|NCT01142453|Interferon-beta|interferon-beta|mesh-list
44361500|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
44361501|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361502|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
44361503|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361504|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
44361505|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361519|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361520|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44361521|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
44361522|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361523|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361524|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44361525|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44361526|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361527|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44361528|NCT01142505|Diuretics|diuretics|mesh-ancestor
44361529|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
44361530|NCT01142518|Interferons|interferons|mesh-list
44361531|NCT01142518|Interferon-beta|interferon-beta|mesh-list
44361532|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
43651612|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651617|NCT03006081|Aflibercept|aflibercept|mesh-list
44361533|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361534|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
44361535|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361536|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
44361537|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361538|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361539|NCT01142557|Interferons|interferons|mesh-list
44361540|NCT01142557|Interferon-beta|interferon-beta|mesh-list
44361541|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
44361542|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361543|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
44361544|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361545|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
44361546|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361547|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361548|NCT01142622|Ropivacaine|ropivacaine|mesh-list
44361549|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
44361550|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
44361551|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361552|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361553|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
43858474|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858475|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858476|NCT03211949|Mepivacaine|mepivacaine|mesh-list
43858477|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858478|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
43858479|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361554|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361556|NCT01142635|Rocuronium|rocuronium|mesh-list
44361557|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
44361558|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44361559|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44361560|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44361561|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602005|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602007|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43602008|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43602009|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
43602010|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602011|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43602012|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43602013|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43602014|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
43602015|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43602016|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43656210|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43656211|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656212|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44361562|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361564|NCT01142648|Neostigmine|neostigmine|mesh-list
44361565|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44361566|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361567|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361568|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
44361569|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361570|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361571|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44361572|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
44361573|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361574|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44361575|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44361576|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44361577|NCT01142700|Ribavirin|ribavirin|mesh-list
44361578|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44361579|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
44361580|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361581|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
43858480|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858481|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
43858482|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858483|NCT03204786|Vasopressins|vasopressins|mesh-list
43858484|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
43858485|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
43858486|NCT03204786|Coagulants|coagulants|mesh-ancestor
43858487|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43858488|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43858489|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
43858490|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858491|NCT03204396|Dulaglutide|dulaglutide|mesh-list
43858492|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43858493|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858494|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
43858495|NCT03204188|Fludarabine|fludarabine|mesh-list
43858496|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858497|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133744|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133745|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133746|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
44361582|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361584|NCT01142778|Trastuzumab|trastuzumab|mesh-list
44361585|NCT01142778|Docetaxel|docetaxel|mesh-list
44361586|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361587|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361588|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44361589|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44361590|NCT01142778|Growth Substances|growth substances|mesh-ancestor
44361591|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361592|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
44361593|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44361594|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44361595|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44361596|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361597|NCT01142843|Propolis|propolis|mesh-list
44361598|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361599|NCT01142869|Cetuximab|cetuximab|mesh-list
44361600|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361601|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361602|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
44133747|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133748|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133749|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
44133750|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133751|NCT00154700|Folic Acid|folic acid|mesh-list
44133752|NCT00154700|Paclitaxel|paclitaxel|mesh-list
43858498|NCT03199924|Diclofenac|diclofenac|mesh-list
43858499|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43858500|NCT03199924|Lidocaine|lidocaine|mesh-list
43858501|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
43858502|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858503|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
43858504|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858505|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858506|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
43858507|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858508|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43858509|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43858510|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43858511|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43858512|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858513|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43858514|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43858515|NCT03199924|Analgesics|analgesics|mesh-ancestor
43858516|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858517|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43858518|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858519|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
43858520|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43858521|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43858522|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
43858523|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858524|NCT03199300|Cisplatin|cisplatin|mesh-list
43858525|NCT03199300|Trastuzumab|trastuzumab|mesh-list
44361603|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44361604|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44361605|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361606|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
44361607|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44361608|NCT01143025|Ropivacaine|ropivacaine|mesh-list
44361609|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
44361610|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
44361611|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361612|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361613|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
43674581|NCT02892916|Ketamine|ketamine|mesh-list
43858532|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858533|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858535|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
43858536|NCT03194932|Methotrexate|methotrexate|mesh-list
43858537|NCT03194932|Azacitidine|azacitidine|mesh-list
43858538|NCT03194932|Venetoclax|venetoclax|mesh-list
43858539|NCT03194932|Idarubicin|idarubicin|mesh-list
43858540|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43858541|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
43858542|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858543|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858544|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858545|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
43858546|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858547|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858548|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858549|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858550|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43858551|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858552|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
43858553|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858554|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43858555|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
43858556|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858557|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43858558|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858559|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43858560|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43858561|NCT03194542|Luspatercept|luspatercept|mesh-list
43858562|NCT03194542|Hematinics|hematinics|mesh-ancestor
43858563|NCT03194126|Misoprostol|misoprostol|mesh-list
43858564|NCT03194126|Mifepristone|mifepristone|mesh-list
43858565|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43858566|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
43858567|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858568|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858569|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43858570|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858571|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
43858572|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43858573|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43858574|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43858575|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43858576|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
43858577|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43858578|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43858579|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
43858580|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43858581|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
43858582|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43858583|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43858584|NCT03193866|Interferons|interferons|mesh-list
44361614|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361615|NCT01143129|Dexamethasone|dexamethasone|mesh-list
44361616|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361617|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
44361618|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
44361619|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361620|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361621|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361622|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
44361623|NCT01143129|Hormones|hormones|mesh-ancestor
44361624|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361625|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43602073|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
43602074|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
43602075|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43602076|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
43602077|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361626|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361627|NCT01143545|Celecoxib|celecoxib|mesh-list
44361628|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
44361629|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361630|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
43674589|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
43858585|NCT03193866|Interferon-beta|interferon-beta|mesh-list
43858586|NCT03193866|Rituximab|rituximab|mesh-list
43858587|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
43858588|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
43858589|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43858590|NCT03193866|Natalizumab|natalizumab|mesh-list
43858591|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43858592|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
43858593|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858594|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858595|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
43858596|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858600|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43858601|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858603|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858604|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43858605|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43858606|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43858607|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43858608|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858609|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43858610|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43858611|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858612|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43858613|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43858614|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43858615|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858616|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
43858617|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858618|NCT03187106|Metronidazole|metronidazole|mesh-list
43858619|NCT03187106|Cephalexin|cephalexin|mesh-list
43858620|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858621|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43858622|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43858623|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43858624|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43858625|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43858626|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858627|NCT03186326|Bevacizumab|bevacizumab|mesh-list
44361632|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361633|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44361634|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
44361635|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602085|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602086|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602087|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
43602088|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43602089|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
43602090|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
43602091|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602092|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602093|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43602094|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43602095|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825234|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44361636|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361637|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44361638|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44361639|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361640|NCT01143545|Analgesics|analgesics|mesh-ancestor
43858628|NCT03186326|Cetuximab|cetuximab|mesh-list
43858629|NCT03186326|Avelumab|avelumab|mesh-list
43858630|NCT03186326|Panitumumab|panitumumab|mesh-list
43858631|NCT03186326|Aflibercept|aflibercept|mesh-list
43858632|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858633|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858634|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43858635|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43858636|NCT03186326|Growth Substances|growth substances|mesh-ancestor
43858637|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858638|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
43858639|NCT03186027|Ascorbic Acid|ascorbic acid|mesh-list
43858640|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
43858641|NCT03186027|Ubiquinone|ubiquinone|mesh-list
43858642|NCT03186027|Vitamins|vitamins|mesh-ancestor
43858643|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
43858644|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858645|NCT03186027|Antioxidants|antioxidants|mesh-ancestor
43858646|NCT03186027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858647|NCT03186027|Protective Agents|protective agents|mesh-ancestor
43858648|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43858649|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858650|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858651|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858652|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
43858653|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
43858654|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858655|NCT03180034|Vaccines|vaccines|mesh-list
43858656|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
43858657|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858658|NCT03179995|Octreotide|octreotide|mesh-list
43858659|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858660|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43858661|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858662|NCT03176277|Venetoclax|venetoclax|mesh-list
43858663|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858664|NCT03176173|Immunologic Factors|immunologic factors|mesh-list
43858665|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858666|NCT03175432|Bevacizumab|bevacizumab|mesh-list
43858667|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43858673|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
43858674|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858675|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43858676|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43858677|NCT03175432|Growth Substances|growth substances|mesh-ancestor
43602097|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858678|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858679|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
43858680|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
43858682|NCT03174197|Atezolizumab|atezolizumab|mesh-list
43858683|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858684|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858685|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
43858686|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858687|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361641|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
44361642|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361643|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361644|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44361645|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44361647|NCT01143584|Dopamine|dopamine|mesh-list
44361648|NCT01143584|Cabergoline|cabergoline|mesh-list
44361649|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
44361650|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44361651|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
44361652|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
44361653|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361654|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361655|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
44361656|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361657|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361658|NCT01143584|Protective Agents|protective agents|mesh-ancestor
44361659|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44361660|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43858688|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
43858689|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858690|NCT03174132|Lidocaine|lidocaine|mesh-list
43858691|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
43858692|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858693|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
43858694|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858695|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858696|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
43858697|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858698|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43858699|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43858700|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43858701|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43858702|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858703|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43858704|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
43858705|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
43858706|NCT03174132|Protective Agents|protective agents|mesh-ancestor
43858707|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
43858708|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43858709|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858710|NCT03173612|Cytarabine|cytarabine|mesh-list
43858711|NCT03173612|Etoposide|etoposide|mesh-list
43858712|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
43858713|NCT03173612|Idarubicin|idarubicin|mesh-list
43858714|NCT03173612|Dasatinib|dasatinib|mesh-list
43858715|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
43858716|NCT03173612|Lenograstim|lenograstim|mesh-list
43858717|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43858718|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858719|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43858720|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43858721|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858722|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858723|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361661|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44361662|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
44361663|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361664|NCT01143805|Tofacitinib|tofacitinib|mesh-list
44361665|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44361666|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361667|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361668|NCT01143831|Vitamins|vitamins|mesh-list
44361669|NCT01143831|Vitamin K|vitamin k|mesh-list
44361670|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
44361671|NCT01143831|Menatetrenone|menatetrenone|mesh-list
44361672|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
44361673|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361674|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44361675|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44361676|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361677|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
44361678|NCT01143831|Coagulants|coagulants|mesh-ancestor
44361679|NCT01143857|Varenicline|varenicline|mesh-list
44361680|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44361681|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44361682|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
44361683|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361684|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361685|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361686|NCT01143948|Insulin|insulin|mesh-list
44361687|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44361688|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361689|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361690|NCT01143974|Cisplatin|cisplatin|mesh-list
44361691|NCT01143974|Pemetrexed|pemetrexed|mesh-list
44361692|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361693|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361694|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361695|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44361696|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44361700|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44361701|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
44361702|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361703|NCT01144000|Daptomycin|daptomycin|mesh-list
44361704|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44361705|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361706|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
44361707|NCT01144065|Testosterone|testosterone|mesh-list
44361708|NCT01144065|Androgens|androgens|mesh-ancestor
44361709|NCT01144065|Hormones|hormones|mesh-ancestor
44361710|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44361711|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361712|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361713|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
44361714|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44361715|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361716|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361717|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44361718|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44361719|NCT01144091|Protective Agents|protective agents|mesh-ancestor
44361720|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858724|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
43858725|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
43858726|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858727|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858728|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
43858729|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858730|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858731|NCT03173612|Analgesics|analgesics|mesh-ancestor
43858732|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
43858733|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858734|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43858735|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858736|NCT03173248|Azacitidine|azacitidine|mesh-list
43858737|NCT03173248|Ivosidenib|ivosidenib|mesh-list
43858738|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858739|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
43858740|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858745|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858746|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
43858747|NCT03169881|Hematinics|hematinics|mesh-ancestor
43858748|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43858749|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43858750|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858751|NCT03167905|Fentanyl|fentanyl|mesh-list
43858752|NCT03167905|Meperidine|meperidine|mesh-list
43858753|NCT03167905|Remifentanil|remifentanil|mesh-list
43858754|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
43858755|NCT03167905|Ropivacaine|ropivacaine|mesh-list
43858756|NCT03167905|Entonox|entonox|mesh-list
43858757|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858758|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
43858759|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858760|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361721|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
44361722|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44361723|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
44361724|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
44361725|NCT01144117|Hematinics|hematinics|mesh-ancestor
44361726|NCT01144156|Adalimumab|adalimumab|mesh-list
44361727|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361728|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361729|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
44361730|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
44361731|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44361732|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44361733|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361734|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361735|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361736|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361737|NCT01144195|Panitumumab|panitumumab|mesh-list
44361738|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361739|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361740|NCT01144260|Bafetinib|bafetinib|mesh-list
44361741|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44361742|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361743|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858761|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
43858762|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858763|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43858764|NCT03167905|Narcotics|narcotics|mesh-ancestor
43858765|NCT03167905|Analgesics|analgesics|mesh-ancestor
43858766|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43858767|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43858768|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
43858769|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43858770|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43858771|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43858772|NCT03165942|Ethanol|ethanol|mesh-list
43858773|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43858774|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858775|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858776|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858777|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
43858778|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
43858779|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858780|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
43858781|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858782|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858783|NCT03162627|Olaparib|olaparib|mesh-list
43858784|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43858785|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858786|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858787|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602116|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43858788|NCT03162432|Vitamin D|vitamin d|mesh-list
43858789|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
43858790|NCT03162432|Vitamins|vitamins|mesh-ancestor
43858791|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
43542617|NCT03701321|Venetoclax|venetoclax|mesh-list
44361744|NCT01144312|Fentanyl|fentanyl|mesh-list
44361745|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44361746|NCT01144312|Narcotics|narcotics|mesh-ancestor
44361747|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361748|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361749|NCT01144312|Analgesics|analgesics|mesh-ancestor
44361750|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
44361751|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361752|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44361753|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44361754|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
44361755|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
44361756|NCT01144390|Methadone|methadone|mesh-list
44361757|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44361758|NCT01144390|Narcotics|narcotics|mesh-ancestor
44361759|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361760|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361761|NCT01144390|Analgesics|analgesics|mesh-ancestor
44361762|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
43858792|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858793|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43858794|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43858795|NCT03161522|Fluorouracil|fluorouracil|mesh-list
43858796|NCT03161522|Capecitabine|capecitabine|mesh-list
43858797|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
43858798|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858799|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858800|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858801|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858802|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
43858803|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858804|NCT03156790|Asparaginase|asparaginase|mesh-list
43858805|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858806|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
43858807|NCT03154749|Carboplatin|carboplatin|mesh-list
43858808|NCT03154749|Docetaxel|docetaxel|mesh-list
43858809|NCT03154749|Epirubicin|epirubicin|mesh-list
43858810|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858811|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
43858812|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858813|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858814|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858815|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
43858816|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858817|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858818|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43858819|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858820|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858821|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858822|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858823|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43858824|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43858825|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858826|NCT03153319|Adalimumab|adalimumab|mesh-list
43858827|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602143|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602144|NCT03258398|Avelumab|avelumab|mesh-list
43602145|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602146|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602147|NCT03257930|Ethanol|ethanol|mesh-list
43649170|NCT03031327|Protective Agents|protective agents|mesh-ancestor
43649171|NCT03031353|Misoprostol|misoprostol|mesh-list
43858828|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858829|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
43858830|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858831|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361764|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
44361765|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361766|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
44361767|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361768|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
44361769|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361770|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
44361771|NCT01144533|Protective Agents|protective agents|mesh-ancestor
44361772|NCT01144650|Dapsone|dapsone|mesh-list
44361773|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858832|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
43858833|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858834|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858835|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
43858836|NCT03149029|Trametinib|trametinib|mesh-list
43858837|NCT03149029|Dabrafenib|dabrafenib|mesh-list
43858838|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858839|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858840|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858841|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858842|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858843|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
43858844|NCT03148457|Apixaban|apixaban|mesh-list
43858845|NCT03148457|Edoxaban|edoxaban|mesh-list
43858846|NCT03148457|Dabigatran|dabigatran|mesh-list
43858847|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43858848|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
43858849|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43858850|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
43858851|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602148|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43602149|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602150|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602151|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602152|NCT03257943|Ivermectin|ivermectin|mesh-list
43602153|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43602154|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602155|NCT03257683|Ranolazine|ranolazine|mesh-list
43602156|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43602157|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43858852|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858853|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
43858854|NCT03147287|Fulvestrant|fulvestrant|mesh-list
43858855|NCT03147287|Palbociclib|palbociclib|mesh-list
43858856|NCT03147287|Avelumab|avelumab|mesh-list
43858857|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43858858|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858859|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43858860|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43858861|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
43858862|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43858863|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858864|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858865|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858866|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858867|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858868|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43858869|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858870|NCT03142321|Vedolizumab|vedolizumab|mesh-list
43858871|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858872|NCT03141424|Fluticasone|fluticasone|mesh-list
43858873|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
43858874|NCT03141424|Ciclesonide|ciclesonide|mesh-list
43858875|NCT03141424|Budesonide|budesonide|mesh-list
43858876|NCT03141424|Beclomethasone|beclomethasone|mesh-list
43858877|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43858878|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43858879|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
43858880|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858881|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858882|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43858883|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
43858884|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858885|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43858886|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
44361774|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
44361775|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44361776|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43602158|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602159|NCT03257670|Lidocaine|lidocaine|mesh-list
43602160|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
43602161|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
43602162|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602163|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602164|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
43602165|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602166|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43602167|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43825242|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
43825243|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825244|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44361777|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44361778|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361779|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361780|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
44361781|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44361782|NCT01144676|Dapivirine|dapivirine|mesh-list
44361783|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44361784|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44361785|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
44361786|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361787|NCT01144702|Artesunate|artesunate|mesh-list
43858888|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43858889|NCT03138889|Paclitaxel|paclitaxel|mesh-list
43858890|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43858891|NCT03138889|Cisplatin|cisplatin|mesh-list
43858892|NCT03138889|Carboplatin|carboplatin|mesh-list
43858898|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858899|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858900|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858901|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858902|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858903|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43858904|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43858905|NCT03136146|Dexamethasone|dexamethasone|mesh-list
43858906|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
43858907|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
43858908|NCT03136146|Rituximab|rituximab|mesh-list
43858909|NCT03136146|Etoposide|etoposide|mesh-list
43858910|NCT03136146|Vincristine|vincristine|mesh-list
43858912|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
43858913|NCT03136146|Clofarabine|clofarabine|mesh-list
43858914|NCT03136146|Ofatumumab|ofatumumab|mesh-list
43858915|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
43858916|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43858917|NCT03136146|Antibodies|antibodies|mesh-list
43858918|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
43858919|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858920|NCT03136146|Lenograstim|lenograstim|mesh-list
43858921|NCT03136146|BB 1101|bb 1101|mesh-list
43858922|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858923|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
43858924|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858925|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858926|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43858927|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
43858928|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858929|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858930|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43858931|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43858932|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
43858933|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
43858934|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858935|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43858936|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
43858937|NCT03136146|Hormones|hormones|mesh-ancestor
43858938|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43858939|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43602168|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43858940|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
43858941|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858942|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43858943|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44361789|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
44361790|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44361791|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44361792|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361793|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361794|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
44361795|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
44361796|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44361797|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
44361798|NCT01144728|Metformin|metformin|mesh-list
44361799|NCT01144728|Glimepiride|glimepiride|mesh-list
44361800|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361801|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361802|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44361803|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858944|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43858945|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43858946|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858947|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
43858948|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
43858949|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858950|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
43858951|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
43858952|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43858953|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
43858954|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43858955|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
43858956|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858957|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858958|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43858959|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
43858960|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43858961|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
43858962|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858963|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858964|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43858968|NCT03133546|Bevacizumab|bevacizumab|mesh-list
43858969|NCT03133546|Osimertinib|osimertinib|mesh-list
43858970|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858971|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858972|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43858973|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43858974|NCT03133546|Growth Substances|growth substances|mesh-ancestor
43858975|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858976|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
43858977|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43858978|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858979|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858980|NCT03133325|Lidocaine|lidocaine|mesh-list
43858981|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
43858982|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
43858983|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858984|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858985|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
43858986|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43858987|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43858988|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43858989|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43858990|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44361805|NCT01144754|Rituximab|rituximab|mesh-list
44361806|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361807|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361808|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
44361809|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361810|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44361811|NCT01144832|Ebastine|ebastine|mesh-list
44361812|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44361813|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
43674745|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
43858991|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858992|NCT03132116|Gentamicins|gentamicins|mesh-list
43858993|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43858994|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858995|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43858996|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858997|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858998|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
43858999|NCT03131908|GSK2636771|gsk2636771|mesh-list
43859000|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859001|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859002|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859003|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859004|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859005|NCT03129828|Bortezomib|bortezomib|mesh-list
43859006|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859007|NCT03128879|Venetoclax|venetoclax|mesh-list
43859008|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
43859009|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859010|NCT03128619|Letrozole|letrozole|mesh-list
43859011|NCT03128619|Palbociclib|palbociclib|mesh-list
43859012|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859013|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43859014|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43859015|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859016|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859017|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43859018|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
43859019|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859020|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859021|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859022|NCT03128034|Cyclosporine|cyclosporine|mesh-list
43859023|NCT03128034|Sirolimus|sirolimus|mesh-list
43859024|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
43859025|NCT03128034|Fludarabine|fludarabine|mesh-list
43859026|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
43859027|NCT03128034|Cyclosporins|cyclosporins|mesh-list
43859028|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859029|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859030|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
43859031|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859032|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859033|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
43859034|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859035|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859036|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
43859039|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859040|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43859041|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43602218|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43859042|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43859043|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
43859044|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859045|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
43859047|NCT03126916|Busulfan|busulfan|mesh-list
44361815|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361816|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361817|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361818|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
44361819|NCT01144910|Miotics|miotics|mesh-ancestor
44361820|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
44361821|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361822|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361823|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44361824|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44361825|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
44361826|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44361827|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44361828|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
44361829|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361830|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361831|NCT01144923|Gabapentin|gabapentin|mesh-list
44361832|NCT01144923|Nortriptyline|nortriptyline|mesh-list
44361833|NCT01144923|Analgesics|analgesics|mesh-ancestor
44361834|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
44361835|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674752|NCT02890173|Diuretics|diuretics|mesh-ancestor
43859048|NCT03126916|Thiotepa|thiotepa|mesh-list
43859049|NCT03126916|Carboplatin|carboplatin|mesh-list
43859050|NCT03126916|Doxorubicin|doxorubicin|mesh-list
43859051|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43859052|NCT03126916|Etoposide|etoposide|mesh-list
43859053|NCT03126916|Vincristine|vincristine|mesh-list
43859054|NCT03126916|Topotecan|topotecan|mesh-list
43859055|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
43859056|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
43859057|NCT03126916|Razoxane|razoxane|mesh-list
43859058|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43859059|NCT03126916|Dinutuximab|dinutuximab|mesh-list
43859060|NCT03126916|Isotretinoin|isotretinoin|mesh-list
43859061|NCT03126916|Sargramostim|sargramostim|mesh-list
43859062|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859064|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859065|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859066|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859067|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
43859068|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859069|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859070|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859071|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859072|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43859073|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43859074|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859075|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859076|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859077|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859078|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859079|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44361836|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361838|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44361839|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44361840|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361841|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44361842|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44361843|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44361844|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361845|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361846|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
44361847|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43656217|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361848|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
44361849|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44361850|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44361851|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44361852|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
44361853|NCT01144988|Bevacizumab|bevacizumab|mesh-list
44361854|NCT01144988|Irinotecan|irinotecan|mesh-list
44361855|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361856|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361857|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44361858|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44361859|NCT01144988|Growth Substances|growth substances|mesh-ancestor
44361860|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361861|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44361862|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44361863|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44361864|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361865|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361866|NCT01145079|Sirolimus|sirolimus|mesh-list
44361867|NCT01145079|Everolimus|everolimus|mesh-list
43859080|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
43859081|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43859082|NCT03126916|Protective Agents|protective agents|mesh-ancestor
43859083|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43859084|NCT03126214|Warfarin|warfarin|mesh-list
43859085|NCT03126214|Anticoagulants|anticoagulants|mesh-list
43859086|NCT03122652|Teriflunomide|teriflunomide|mesh-list
43859087|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43859088|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361868|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361869|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361870|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
44361871|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361872|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44361873|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361874|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44361875|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
44361876|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44361877|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44361878|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
44361879|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361880|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
44361881|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44361882|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361883|NCT01145326|Lidocaine|lidocaine|mesh-list
44361884|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
44361885|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
44361886|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361887|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361888|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
44361889|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361890|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44361891|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44361892|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44361893|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44361894|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361895|NCT01145365|Anesthetics|anesthetics|mesh-list
44361896|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44361897|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361898|NCT01145404|Capecitabine|capecitabine|mesh-list
43656218|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656220|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
43656221|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43674812|NCT02890199|Lidocaine|lidocaine|mesh-list
43859089|NCT03122652|Analgesics|analgesics|mesh-ancestor
43859090|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
43859091|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859092|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859093|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43859094|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859095|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859096|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
43859097|NCT03122444|Imipramine|imipramine|mesh-list
44361900|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361901|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
44361902|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361903|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361904|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44361905|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361906|NCT01145430|Doxorubicin|doxorubicin|mesh-list
44361907|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44361908|NCT01145430|Veliparib|veliparib|mesh-list
44361909|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44361910|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361911|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44361912|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44361913|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361914|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361915|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44361916|NCT01145456|Gemcitabine|gemcitabine|mesh-list
44361917|NCT01145456|R04929097|r04929097|mesh-list
44361918|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361919|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
44361920|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361921|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361922|NCT01145456|Antiviral Agents|antiviral agents|mesh-ancestor
44361923|NCT01145456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361924|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361925|NCT01145456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361926|NCT01145456|Immunologic Factors|immunologic factors|mesh-ancestor
44361927|NCT01145456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361928|NCT01145534|Glyburide|glyburide|mesh-list
44361929|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361930|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361931|NCT01145573|Calcium|calcium|mesh-list
43859098|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43859099|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
43859100|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43859101|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43859102|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43859103|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43859104|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859105|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859106|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361932|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361933|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361934|NCT01145612|Losartan|losartan|mesh-list
44361935|NCT01145612|Atenolol|atenolol|mesh-list
44361936|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44361937|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44361938|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44361939|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44361940|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361941|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
44361942|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
44361943|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361944|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361945|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43674871|NCT02889432|Melatonin|melatonin|mesh-list
43859107|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859108|NCT03122301|Bupivacaine|bupivacaine|mesh-list
43859109|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
43859110|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
43859111|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859112|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859113|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
43859142|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43859143|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
43859144|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859145|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859146|NCT03117816|Interferons|interferons|mesh-list
43859147|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
43859148|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
43859149|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859150|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
43859151|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859152|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
43859153|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859154|NCT03115424|Liraglutide|liraglutide|mesh-list
43859155|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43859156|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859157|NCT03115424|Incretins|incretins|mesh-ancestor
43859158|NCT03115424|Hormones|hormones|mesh-ancestor
43859159|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859160|NCT03115151|Fentanyl|fentanyl|mesh-list
43859165|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859167|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
43859168|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859169|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43859170|NCT03115151|Narcotics|narcotics|mesh-ancestor
43859171|NCT03115151|Analgesics|analgesics|mesh-ancestor
43859172|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43859173|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43859174|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
43859175|NCT03112174|Venetoclax|venetoclax|mesh-list
43859176|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859177|NCT03111537|Nicotine|nicotine|mesh-list
43859178|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43859179|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
43859180|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859181|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859182|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43859183|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43859184|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
44361946|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44361947|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44361948|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44361949|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44361950|NCT01145677|Topiramate|topiramate|mesh-list
44361951|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
44361952|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44361953|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361954|NCT01145703|Vitamin D|vitamin d|mesh-list
44361955|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
44361956|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
44361957|NCT01145703|Vitamins|vitamins|mesh-list
44361958|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
43859185|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859186|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859187|NCT03111485|Levodopa|levodopa|mesh-list
44133753|NCT00154700|Cisplatin|cisplatin|mesh-list
43859188|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43859189|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43859190|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43656225|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
43859191|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
43859192|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859193|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859194|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859195|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43859196|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
43859197|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
43859198|NCT03110926|Leucovorin|leucovorin|mesh-list
43859199|NCT03110926|Paclitaxel|paclitaxel|mesh-list
43859200|NCT03110926|Carboplatin|carboplatin|mesh-list
43859201|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
43859202|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859203|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859204|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859205|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859206|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859207|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859208|NCT03110926|Antidotes|antidotes|mesh-ancestor
43859209|NCT03110926|Protective Agents|protective agents|mesh-ancestor
43859210|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859211|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
43859212|NCT03110926|Vitamins|vitamins|mesh-ancestor
43859213|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
43859214|NCT03108131|Atezolizumab|atezolizumab|mesh-list
43859216|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859217|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
43859218|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133754|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133755|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133756|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133757|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133758|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133759|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133760|NCT00154700|Hematinics|hematinics|mesh-ancestor
44133761|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133762|NCT00154700|Vitamins|vitamins|mesh-ancestor
44133763|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
44133764|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133765|NCT00154726|Paclitaxel|paclitaxel|mesh-list
44133766|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133767|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133768|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133769|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133774|NCT00154739|Epirubicin|epirubicin|mesh-list
44133775|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133776|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361960|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44361961|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44361962|NCT01145807|Terbinafine|terbinafine|mesh-list
44361963|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
44361964|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361965|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361966|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361967|NCT01145846|Cytarabine|cytarabine|mesh-list
44361968|NCT01145846|Daunorubicin|daunorubicin|mesh-list
44133777|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
44133778|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133779|NCT00154739|Antiviral Agents|antiviral agents|mesh-ancestor
44133780|NCT00154739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133781|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133782|NCT00154739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133783|NCT00154739|Immunologic Factors|immunologic factors|mesh-ancestor
44133784|NCT00154739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133785|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44133786|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44133787|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44133788|NCT00154778|Leucovorin|leucovorin|mesh-list
44133789|NCT00154778|Antidotes|antidotes|mesh-ancestor
44133790|NCT00154778|Protective Agents|protective agents|mesh-ancestor
44133791|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133792|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133793|NCT00154778|Vitamins|vitamins|mesh-ancestor
44133794|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
44133795|NCT00154791|Gemcitabine|gemcitabine|mesh-list
44133796|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
44133797|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133798|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
44133799|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859220|NCT03105518|Fentanyl|fentanyl|mesh-list
43859221|NCT03105518|Oxycodone|oxycodone|mesh-list
43859222|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43859223|NCT03105518|Narcotics|narcotics|mesh-ancestor
43859224|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859225|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859226|NCT03105518|Analgesics|analgesics|mesh-ancestor
43859227|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
43859228|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859229|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43859230|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43859231|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
43859232|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
43859233|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43859234|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
43859235|NCT03104439|Nivolumab|nivolumab|mesh-list
43859236|NCT03104439|Ipilimumab|ipilimumab|mesh-list
43859237|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859238|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859239|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43859240|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859241|NCT03101501|Mitomycins|mitomycins|mesh-list
43859242|NCT03101501|Mitomycin|mitomycin|mesh-list
43859243|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859244|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859245|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
43859246|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859247|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43859248|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859249|NCT03101254|Vemurafenib|vemurafenib|mesh-list
43859250|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859251|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44361969|NCT01145846|Idarubicin|idarubicin|mesh-list
44361970|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44361971|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
44361972|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361973|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44361974|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
43649175|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649177|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44361975|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44361976|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44361977|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
44361978|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361979|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44361980|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44361981|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44361982|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361983|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
44361984|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44361985|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
43859252|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859253|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859254|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
43859255|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43859256|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
43859257|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859258|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
43859259|NCT03101163|Protective Agents|protective agents|mesh-ancestor
43859260|NCT03100253|Adalimumab|adalimumab|mesh-list
43859261|NCT03100253|Etanercept|etanercept|mesh-list
43859262|NCT03100253|Golimumab|golimumab|mesh-list
43859267|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
43859268|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43859269|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43859270|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43859271|NCT03100253|Analgesics|analgesics|mesh-ancestor
43859272|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
43859273|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859274|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859275|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859276|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
43859277|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43859278|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
43859279|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859280|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859281|NCT03099499|TIC10 compound|tic10 compound|mesh-list
43859282|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859283|NCT03099356|Sirolimus|sirolimus|mesh-list
43859284|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
43859285|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859286|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
43859287|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859288|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859289|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859290|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
43859291|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859292|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859293|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859294|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859295|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859296|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44361986|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44361987|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44361988|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44361989|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44361990|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
44361991|NCT01145950|Etanercept|etanercept|mesh-list
44361992|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44361993|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44361994|NCT01145950|Analgesics|analgesics|mesh-ancestor
44361995|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
44361996|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44361997|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44361998|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44361999|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362000|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656251|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
44362001|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362002|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
44362003|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
44362004|NCT01145976|Fludarabine|fludarabine|mesh-list
44362005|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
44362006|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44362007|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859297|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
43859298|NCT03097783|Lidocaine|lidocaine|mesh-list
43859299|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
43859300|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
43859301|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859302|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859303|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
43859304|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859305|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43859306|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43859307|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43859308|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43859309|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859310|NCT03096418|Paclitaxel|paclitaxel|mesh-list
43859311|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859312|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859313|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859314|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859315|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859316|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859317|NCT03095352|Carboplatin|carboplatin|mesh-list
43859318|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
43859319|NCT03095352|Trastuzumab|trastuzumab|mesh-list
43859320|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859321|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859323|NCT03094637|Azacitidine|azacitidine|mesh-list
43859324|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859325|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859326|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859327|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
43859328|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362024|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362025|NCT01146028|Tizanidine|tizanidine|mesh-list
44362026|NCT01146028|Analgesics|analgesics|mesh-ancestor
44362027|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
44362028|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362029|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859329|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859330|NCT03093064|Natalizumab|natalizumab|mesh-list
43859331|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
43859332|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859333|NCT03092856|Axitinib|axitinib|mesh-list
43859334|NCT03092856|Antibodies|antibodies|mesh-list
43859335|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
43859340|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859360|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
43859361|NCT03089905|Remifentanil|remifentanil|mesh-list
43859362|NCT03089905|Sevoflurane|sevoflurane|mesh-list
43859363|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44362030|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
44362031|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44362032|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44362033|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
43850287|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362034|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
44362035|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44362036|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44362037|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44362038|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
44362039|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362040|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362041|NCT01146041|Rivastigmine|rivastigmine|mesh-list
44362042|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44362043|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362044|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362045|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362046|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362047|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859364|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859365|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859366|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43859367|NCT03089905|Analgesics|analgesics|mesh-ancestor
43859368|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
43859369|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859370|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43859371|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43859372|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43859373|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859374|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859375|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859376|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43859377|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43859378|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
43859379|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
43859380|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43859381|NCT03089905|Narcotics|narcotics|mesh-ancestor
43859382|NCT03088540|Gemcitabine|gemcitabine|mesh-list
43859383|NCT03088540|Paclitaxel|paclitaxel|mesh-list
43859384|NCT03088540|Cisplatin|cisplatin|mesh-list
43859385|NCT03088540|Carboplatin|carboplatin|mesh-list
43859386|NCT03088540|Pemetrexed|pemetrexed|mesh-list
43859387|NCT03088540|Cemiplimab|cemiplimab|mesh-list
43859388|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859389|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859390|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859391|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859392|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859393|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859394|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859395|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
43859396|NCT03088540|Antiviral Agents|antiviral agents|mesh-ancestor
43859397|NCT03088540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859398|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859399|NCT03088540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859400|NCT03088540|Immunologic Factors|immunologic factors|mesh-ancestor
43859401|NCT03088540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649197|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43649198|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
43649199|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602257|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602258|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
43602259|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859402|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44362048|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44362049|NCT01146041|Protective Agents|protective agents|mesh-ancestor
44362050|NCT01146067|Rivastigmine|rivastigmine|mesh-list
44362051|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44362052|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362053|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362054|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362055|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362056|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362057|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44362058|NCT01146067|Protective Agents|protective agents|mesh-ancestor
44362059|NCT01146093|Pravastatin|pravastatin|mesh-list
44362060|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362061|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362062|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
43859403|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43859404|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859406|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859407|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859408|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
43859409|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859410|NCT03087903|Protective Agents|protective agents|mesh-ancestor
43859411|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859413|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43859414|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859415|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
43859416|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859417|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
43859418|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859419|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859420|NCT03082014|Losartan|losartan|mesh-list
43859421|NCT03082014|Atenolol|atenolol|mesh-list
43859422|NCT03082014|Amlodipine|amlodipine|mesh-list
43859423|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43859424|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43859425|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43859426|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859427|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43859428|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859429|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
43859430|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43859431|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43859432|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43859433|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
43859434|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
43859435|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859436|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43859437|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43859438|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43859439|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859440|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859441|NCT03081910|Cyclophosphamide|cyclophosphamide|mesh-list
43859442|NCT03081910|Rituximab|rituximab|mesh-list
43859443|NCT03081910|Fludarabine|fludarabine|mesh-list
43859444|NCT03081910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43859445|NCT03081910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859446|NCT03081910|Immunologic Factors|immunologic factors|mesh-ancestor
43859447|NCT03081910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859448|NCT03081910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362063|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362064|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362065|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44362066|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362067|NCT01146106|Pravastatin|pravastatin|mesh-list
44362068|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362069|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362070|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
44362071|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362072|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362073|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44362074|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362076|NCT01146145|Morphine|morphine|mesh-list
44362077|NCT01146145|Analgesics|analgesics|mesh-ancestor
44362078|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
44362079|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362080|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362081|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44362082|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44362083|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
44362084|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
44362085|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362086|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44362087|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44362088|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43674987|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43859449|NCT03081910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859450|NCT03081910|Alkylating Agents|alkylating agents|mesh-ancestor
43859451|NCT03081910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859452|NCT03081910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859453|NCT03081910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859454|NCT03081910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859455|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
43859456|NCT03079167|Hematinics|hematinics|mesh-ancestor
43859457|NCT03079011|Letrozole|letrozole|mesh-list
43859458|NCT03079011|Fulvestrant|fulvestrant|mesh-list
43859459|NCT03079011|Palbociclib|palbociclib|mesh-list
43859460|NCT03079011|Anastrozole|anastrozole|mesh-list
43859461|NCT03079011|Exemestane|exemestane|mesh-list
43859462|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43859463|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859464|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43859465|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859466|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859467|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43859468|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362089|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362090|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44362091|NCT01146145|Narcotics|narcotics|mesh-ancestor
44362092|NCT01146301|Clopidogrel|clopidogrel|mesh-list
44362093|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44362094|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44362095|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44362096|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44362097|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
44362098|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362099|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362100|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859469|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859470|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859471|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43859472|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43859473|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859475|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43859476|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43602267|NCT03257241|Analgesics|analgesics|mesh-ancestor
43859477|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
43859478|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859479|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859480|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43859481|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43859482|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
43859483|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859490|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859491|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859492|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43859493|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
43859494|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43859495|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43859496|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43859497|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43859498|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43859499|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43859500|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
43859501|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43859503|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
43859504|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
43859505|NCT03071861|Hematinics|hematinics|mesh-ancestor
43859506|NCT03070886|Docetaxel|docetaxel|mesh-list
43859507|NCT03070886|Leuprolide|leuprolide|mesh-list
43859508|NCT03070886|Goserelin|goserelin|mesh-list
43859509|NCT03070886|Bicalutamide|bicalutamide|mesh-list
43859510|NCT03070886|Flutamide|flutamide|mesh-list
43859511|NCT03070886|Nilutamide|nilutamide|mesh-list
43859512|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859513|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859514|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859515|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859516|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859517|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43859518|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
43859519|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43859520|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859521|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43859522|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
43859523|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
43542618|NCT03701321|Daratumumab|daratumumab|mesh-list
44362101|NCT01146431|Anesthetics|anesthetics|mesh-list
44362102|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362103|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602278|NCT03257124|Osimertinib|osimertinib|mesh-list
43602279|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602280|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602281|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649200|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602282|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602283|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
43602296|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656274|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43656275|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43656276|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43656277|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656278|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362104|NCT01146483|Pantoprazole|pantoprazole|mesh-list
44362105|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44362106|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362107|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362108|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
44362109|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362110|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362111|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44362112|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133800|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859524|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859525|NCT03069976|Metronidazole|metronidazole|mesh-list
43859526|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859527|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859528|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43859529|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43859530|NCT03069937|Docetaxel|docetaxel|mesh-list
43859531|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859532|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859533|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859534|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859535|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859536|NCT03069326|Thalidomide|thalidomide|mesh-list
43859537|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859538|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
43859539|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859540|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
43859541|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859542|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859543|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43859544|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43859545|NCT03069326|Growth Substances|growth substances|mesh-ancestor
43586651|NCT03405454|Durvalumab|durvalumab|mesh-list
43859546|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
43859547|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859548|NCT03067051|Verteporfin|verteporfin|mesh-list
43859549|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43859550|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
44133801|NCT00154791|Antiviral Agents|antiviral agents|mesh-ancestor
44133802|NCT00154791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133803|NCT00154791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133804|NCT00154791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133810|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133811|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133812|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133813|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133814|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133816|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133817|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
44133818|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133819|NCT00154843|Protective Agents|protective agents|mesh-ancestor
44133820|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133821|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44133822|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44133823|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133824|NCT00154869|Ribavirin|ribavirin|mesh-list
44133825|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44133826|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
44133827|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362113|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44362114|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362115|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44362116|NCT01146509|Donepezil|donepezil|mesh-list
44362117|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44362118|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362119|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362120|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362121|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362122|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362123|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
44362124|NCT01146535|Interferons|interferons|mesh-list
44362125|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
44362126|NCT01146535|Oseltamivir|oseltamivir|mesh-list
44362127|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362128|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
44362129|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362130|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
43827512|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
44133828|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
44133829|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133830|NCT00154882|Paclitaxel|paclitaxel|mesh-list
44133831|NCT00154882|Cisplatin|cisplatin|mesh-list
44133832|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133833|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133834|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133835|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133836|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133837|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133838|NCT00154895|Minocycline|minocycline|mesh-list
44133839|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44133840|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133841|NCT00155064|Losartan|losartan|mesh-list
44133842|NCT00155064|Captopril|captopril|mesh-list
44133843|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44133844|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44133845|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44133846|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44133847|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133848|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44133849|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
43859551|NCT03064854|Gemcitabine|gemcitabine|mesh-list
43859552|NCT03064854|Paclitaxel|paclitaxel|mesh-list
43859553|NCT03064854|Cisplatin|cisplatin|mesh-list
43859554|NCT03064854|Carboplatin|carboplatin|mesh-list
43859555|NCT03064854|Pemetrexed|pemetrexed|mesh-list
43859556|NCT03064854|Spartalizumab|spartalizumab|mesh-list
43859557|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859558|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859559|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859560|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859561|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859562|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859563|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859564|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
43859565|NCT03064854|Antiviral Agents|antiviral agents|mesh-ancestor
43859566|NCT03064854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859567|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859568|NCT03064854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362131|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362132|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362133|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362134|NCT01146548|Fluoxetine|fluoxetine|mesh-list
44362135|NCT01146548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362136|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362137|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362138|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362139|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362140|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
44362141|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362142|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44362143|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
43656291|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362144|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362145|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44362146|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44362147|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362148|NCT01146626|Vitamin D|vitamin d|mesh-list
44362149|NCT01146626|Ribavirin|ribavirin|mesh-list
44362150|NCT01146626|Vitamins|vitamins|mesh-ancestor
44362151|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
44362152|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859569|NCT03064854|Immunologic Factors|immunologic factors|mesh-ancestor
43859570|NCT03064854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859571|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43859572|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43859573|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43859574|NCT03064568|Misoprostol|misoprostol|mesh-list
43859575|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43859576|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
43859584|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
43859585|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43859586|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
43859587|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859588|NCT03063021|Expectorants|expectorants|mesh-ancestor
43859589|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859590|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43859591|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
43859592|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859593|NCT03063021|Protective Agents|protective agents|mesh-ancestor
43859594|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859595|NCT03063021|Antidotes|antidotes|mesh-ancestor
43859596|NCT03062943|Nintedanib|nintedanib|mesh-list
43859597|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859598|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859599|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859600|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859601|NCT03061539|Nivolumab|nivolumab|mesh-list
43859602|NCT03061539|Ipilimumab|ipilimumab|mesh-list
43859603|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859604|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602297|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602298|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43602299|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43602300|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602301|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
43602302|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43602304|NCT03256864|Tacrolimus|tacrolimus|mesh-list
43602305|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602306|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
43602307|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602308|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43656303|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362153|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44362154|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
44362155|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362156|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
44362157|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362158|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
44362159|NCT01146678|Lixisenatide|lixisenatide|mesh-list
44362160|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44362161|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362162|NCT01146925|Deferiprone|deferiprone|mesh-list
44362163|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44362164|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
44362165|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
44362166|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362167|NCT01146977|Cytarabine|cytarabine|mesh-list
44362168|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362169|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
44362170|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362171|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362172|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
44362173|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362174|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362175|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
44362176|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362177|NCT01147016|Paclitaxel|paclitaxel|mesh-list
44362178|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
44362179|NCT01147016|Doxorubicin|doxorubicin|mesh-list
44362180|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44362181|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44362182|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362183|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44362184|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44362185|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44362187|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362194|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44362195|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44362196|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44362197|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362198|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
44362199|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44362200|NCT01147029|Growth Substances|growth substances|mesh-ancestor
43859605|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43859606|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859607|NCT03060473|Amoxicillin|amoxicillin|mesh-list
43859608|NCT03060473|Azithromycin|azithromycin|mesh-list
43859609|NCT03060473|Erythromycin|erythromycin|mesh-list
43859610|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
43602309|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602310|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859611|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43859612|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
43859613|NCT03060473|Ampicillin|ampicillin|mesh-list
43859614|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859615|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859616|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43859617|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43859618|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859619|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859620|NCT03059940|Nicotine|nicotine|mesh-list
43859621|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
43859622|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43859623|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
43859624|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859625|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859626|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43859627|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43859628|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
43859629|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859630|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859631|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
43859632|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
43859633|NCT03059004|TEMPO|tempo|mesh-list
43859634|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
43859635|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859636|NCT03059004|Protective Agents|protective agents|mesh-ancestor
43859637|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859638|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
43859639|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43859640|NCT03057847|Velpatasvir|velpatasvir|mesh-list
43859641|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
43859642|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859643|NCT03056833|Paclitaxel|paclitaxel|mesh-list
43859644|NCT03056833|Carboplatin|carboplatin|mesh-list
43859655|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
43859656|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859657|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859658|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859659|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
43859660|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859661|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859662|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859663|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859664|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
43859665|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
43859666|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43859667|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
43859668|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859669|NCT03055377|Expectorants|expectorants|mesh-ancestor
43859670|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859671|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43859672|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
43859673|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859674|NCT03055377|Protective Agents|protective agents|mesh-ancestor
43859675|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362201|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362202|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
44362203|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362205|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44362206|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43656331|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656332|NCT02961855|Analgesics|analgesics|mesh-ancestor
44362207|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44362208|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44362209|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
44362210|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362211|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362212|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362213|NCT01147146|Fentanyl|fentanyl|mesh-list
44362214|NCT01147146|Midazolam|midazolam|mesh-list
44362215|NCT01147146|Bupivacaine|bupivacaine|mesh-list
44362216|NCT01147146|Propofol|propofol|mesh-list
44362217|NCT01147146|Atracurium|atracurium|mesh-list
44362218|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
44362219|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
44362220|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362221|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362222|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
44362223|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362224|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44362225|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44362226|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
44362227|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44362228|NCT01147146|Narcotics|narcotics|mesh-ancestor
44362229|NCT01147146|Analgesics|analgesics|mesh-ancestor
44362230|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44362231|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44362232|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362233|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362234|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
44362235|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
44362236|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859676|NCT03055377|Antidotes|antidotes|mesh-ancestor
43859677|NCT03054831|Oxycodone|oxycodone|mesh-list
43859678|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43859679|NCT03054831|Narcotics|narcotics|mesh-ancestor
43859680|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859681|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859682|NCT03054831|Analgesics|analgesics|mesh-ancestor
44362237|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362238|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44362239|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44362240|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44362241|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44362242|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44362243|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362245|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
44362246|NCT01147224|Hormones|hormones|mesh-ancestor
44362247|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362248|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362249|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44362250|NCT01147276|Vildagliptin|vildagliptin|mesh-list
44362251|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44362252|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362253|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44362254|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
44362255|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362256|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362257|NCT01147289|Meloxicam|meloxicam|mesh-list
44362258|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362259|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362260|NCT01147289|Analgesics|analgesics|mesh-ancestor
44362261|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
44362262|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675128|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
43859683|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
43859684|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859685|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
43859686|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859687|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
43859688|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859689|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859690|NCT03049306|Propranolol|propranolol|mesh-list
43859691|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43859692|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43859693|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859694|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859695|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859696|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859697|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43859698|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43859699|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
43859700|NCT03047993|Azacitidine|azacitidine|mesh-list
43859701|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362263|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362265|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362266|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44362267|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44362268|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362269|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362270|NCT01147354|Selenium|selenium|mesh-list
44362271|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
44362272|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362273|NCT01147354|Protective Agents|protective agents|mesh-ancestor
44362274|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362275|NCT01147354|Trace Elements|trace elements|mesh-ancestor
44362276|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
44362277|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
44362278|NCT01147432|Capsaicin|capsaicin|mesh-list
44362279|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
44362280|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
44362281|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
44362282|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362283|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362284|NCT01147510|Montelukast|montelukast|mesh-list
44362285|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44362286|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
44362313|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44362314|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44362315|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44362316|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44362317|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
44362318|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362319|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362320|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362321|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44362322|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362323|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44362324|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362325|NCT01147692|Simvastatin|simvastatin|mesh-list
44362326|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
44362327|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362328|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362329|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
44362330|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362331|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362332|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44362333|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362334|NCT01147692|Incretins|incretins|mesh-ancestor
44362335|NCT01147692|Hormones|hormones|mesh-ancestor
44362336|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362337|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362361|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
44362362|NCT01147731|Incretins|incretins|mesh-ancestor
44362363|NCT01147731|Hormones|hormones|mesh-ancestor
44362364|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362365|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362366|NCT01147757|Remifentanil|remifentanil|mesh-list
44362367|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44362368|NCT01147757|Narcotics|narcotics|mesh-ancestor
44362369|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362370|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362371|NCT01147757|Analgesics|analgesics|mesh-ancestor
44362372|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
44362373|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362374|NCT01147770|Progesterone|progesterone|mesh-list
44362375|NCT01147770|Progestins|progestins|mesh-ancestor
44362376|NCT01147770|Hormones|hormones|mesh-ancestor
44362377|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362378|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362379|NCT01148004|Ritonavir|ritonavir|mesh-list
44362380|NCT01148004|Lopinavir|lopinavir|mesh-list
44362381|NCT01148004|Fenofibrate|fenofibrate|mesh-list
43859702|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
43859703|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859704|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859705|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859707|NCT03047928|Vaccines|vaccines|mesh-list
43859708|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
43859709|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859711|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859712|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43859713|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859714|NCT03047005|Naltrexone|naltrexone|mesh-list
43859715|NCT03047005|Bupropion|bupropion|mesh-list
43859716|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43859717|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43859718|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859719|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
43859720|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859721|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43859722|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
43859723|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43859724|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43859725|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43859726|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43859727|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859728|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
43859729|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859730|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43859731|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43859732|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859733|NCT03046251|Natalizumab|natalizumab|mesh-list
43859734|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
43542619|NCT03701321|Ichthammol|ichthammol|mesh-list
44362382|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44362383|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44362384|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
44362385|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362386|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362387|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44362388|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44362389|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
44362390|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362391|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44362392|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44362393|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362394|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
44362395|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362396|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44362397|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362398|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
44362399|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
44362400|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44362401|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44362402|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362403|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362404|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362405|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362406|NCT01148147|Adenosine|adenosine|mesh-list
44362407|NCT01148147|Analgesics|analgesics|mesh-ancestor
44362408|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
44362409|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362410|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362411|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44362412|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
44362413|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43859735|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859736|NCT03045029|Treprostinil|treprostinil|mesh-list
43859737|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43859739|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43859740|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43859741|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859742|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
43859743|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43859744|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
43859745|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542620|NCT03701321|BB 1101|bb 1101|mesh-list
44362414|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
44362415|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
44362416|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362417|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362418|NCT01148160|Voriconazole|voriconazole|mesh-list
44362419|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
44362420|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362421|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44362422|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44362423|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362424|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362425|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44362426|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362427|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362428|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362429|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44362430|NCT01148173|Ifosfamide|ifosfamide|mesh-list
44362431|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362432|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
44362433|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362434|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602366|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43656518|NCT02960906|Nivolumab|nivolumab|mesh-list
44362435|NCT01148264|Olanzapine|olanzapine|mesh-list
44362436|NCT01148264|Metoclopramide|metoclopramide|mesh-list
44362437|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
44362438|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
44362441|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362460|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362461|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44362462|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
44362463|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
44362464|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44362465|NCT01148277|Narcotics|narcotics|mesh-ancestor
44362466|NCT01148277|Analgesics|analgesics|mesh-ancestor
44362467|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
44362468|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362470|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44362471|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362472|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362473|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
44362474|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
44362475|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362476|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362477|NCT01148303|Etoricoxib|etoricoxib|mesh-list
44362478|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362479|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362480|NCT01148303|Analgesics|analgesics|mesh-ancestor
44362481|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
44362482|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362483|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362484|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362485|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362486|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44362487|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44362488|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362489|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362490|NCT01148316|Fluoxetine|fluoxetine|mesh-list
43859746|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859747|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43859748|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859749|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43859750|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
43859751|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859752|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859753|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43859754|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
43859755|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
43859756|NCT03044314|Protective Agents|protective agents|mesh-ancestor
43859757|NCT03043950|Panitumumab|panitumumab|mesh-list
43859758|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859759|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859760|NCT03041688|Decitabine|decitabine|mesh-list
44362491|NCT01148316|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362492|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362493|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362494|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362495|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362496|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
44362497|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362498|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44362499|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
44362500|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362501|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44362502|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44362503|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362504|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44362505|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
44362506|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362507|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362508|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
44362509|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362510|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362511|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44362512|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362513|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362514|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
44362516|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
44362517|NCT01148446|Rituximab|rituximab|mesh-list
44362518|NCT01148446|Doxorubicin|doxorubicin|mesh-list
44362519|NCT01148446|Vincristine|vincristine|mesh-list
44362520|NCT01148446|Epirubicin|epirubicin|mesh-list
44362532|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44362533|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44362534|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43602382|NCT03255473|BB 1101|bb 1101|mesh-list
43602383|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602384|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
43602385|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
43602386|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602387|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602388|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602389|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
43602390|NCT03255473|Hormones|hormones|mesh-ancestor
43651623|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656609|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
43656611|NCT02959762|Vitamin K|vitamin k|mesh-list
43656643|NCT02959554|Sunitinib|sunitinib|mesh-list
44362535|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362536|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362537|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
44362538|NCT01148446|Hormones|hormones|mesh-ancestor
44362539|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362540|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44017513|NCT04011592|Ketamine|ketamine|mesh-list
44362541|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44362542|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
44362543|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
44362544|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
44362545|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44362547|NCT01148472|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362548|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362549|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362550|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362551|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362552|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
44362553|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362554|NCT01148472|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44362555|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
44362556|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362557|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362558|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44362559|NCT01148472|Analgesics|analgesics|mesh-ancestor
44362560|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
44362561|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
44362562|NCT01148576|Vitamin E|vitamin e|mesh-list
44362563|NCT01148576|Entecavir|entecavir|mesh-list
44362564|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
44362565|NCT01148576|Vitamins|vitamins|mesh-ancestor
44362566|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
44362568|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
44362569|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362570|NCT01148576|Protective Agents|protective agents|mesh-ancestor
44362571|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
44362572|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362573|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44362574|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
44362575|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44362576|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44362577|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
44362578|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44362579|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44362580|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
44362581|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44362582|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44362583|NCT01148615|Docetaxel|docetaxel|mesh-list
44362584|NCT01148615|Aflibercept|aflibercept|mesh-list
44362585|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362586|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44362587|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44362588|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44362589|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362590|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44362591|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44362592|NCT01148615|Growth Substances|growth substances|mesh-ancestor
44362593|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362594|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
44362595|NCT01148628|Everolimus|everolimus|mesh-list
44362617|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44362618|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44362619|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44362620|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
44362621|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362622|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362624|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44362625|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
44362626|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
44362627|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
44362628|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44362629|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362630|NCT01149018|Dronabinol|dronabinol|mesh-list
44362631|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
44362632|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362633|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362634|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362635|NCT01149018|Analgesics|analgesics|mesh-ancestor
44362636|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
44362637|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362638|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44362639|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44362640|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362641|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362642|NCT01149018|Hormones|hormones|mesh-ancestor
44362643|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362644|NCT01149109|Temozolomide|temozolomide|mesh-list
44362645|NCT01149109|Lomustine|lomustine|mesh-list
44362646|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362647|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
43859761|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43859762|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
43859763|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859764|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859765|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859766|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
43859767|NCT03037437|Sorafenib|sorafenib|mesh-list
43859768|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859769|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859770|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859771|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859772|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
44362650|NCT01149122|Gemcitabine|gemcitabine|mesh-list
44362651|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
44362652|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44362653|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362654|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
44362655|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362656|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362657|NCT01149122|Antiviral Agents|antiviral agents|mesh-ancestor
44362658|NCT01149122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362659|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362660|NCT01149122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859773|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43859774|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43859775|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859776|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859777|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
43859778|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
43859779|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859780|NCT03036904|Prednisone|prednisone|mesh-list
43859781|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
43859782|NCT03036904|Rituximab|rituximab|mesh-list
43859788|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859789|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
43859790|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859791|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859792|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859793|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
43859794|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859795|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859796|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859797|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859798|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859799|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43859800|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43859801|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859802|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43859803|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
43859804|NCT03036904|Hormones|hormones|mesh-ancestor
43859805|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859806|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43859807|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859808|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859809|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859810|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859811|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
43859812|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
43859813|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43859814|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859815|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859816|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
43859817|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43859818|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43859819|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859820|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
43859821|NCT03035331|Vaccines|vaccines|mesh-list
43859822|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
43859823|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362674|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362675|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362677|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
44362678|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
44362679|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675436|NCT02884310|Remifentanil|remifentanil|mesh-list
43859824|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859825|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859826|NCT03033758|Budesonide|budesonide|mesh-list
43859827|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
43859828|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43859829|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43859830|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
43859831|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859832|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859833|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43859834|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859835|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
43859836|NCT03033758|Hormones|hormones|mesh-ancestor
43859837|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859838|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43859839|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43859843|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859844|NCT03033576|Nivolumab|nivolumab|mesh-list
43859845|NCT03033576|Ipilimumab|ipilimumab|mesh-list
43859846|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44362680|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362681|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
44362682|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362683|NCT01149304|Enoxaparin|enoxaparin|mesh-list
44362684|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
44362685|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44362686|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
44362687|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44362688|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44362689|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362690|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44362691|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362692|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44362693|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44362694|NCT01149304|Protective Agents|protective agents|mesh-ancestor
44362695|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362696|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
43859847|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859848|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43859849|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859850|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
43859851|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
43859852|NCT03032783|Tacrolimus|tacrolimus|mesh-list
43859853|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859854|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
43859855|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859856|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859857|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859858|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
43859859|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859860|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859861|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859862|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43859863|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859864|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859865|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43859866|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
43859867|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602445|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43859868|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859869|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
43859870|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43859871|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
43859872|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859873|NCT03032601|Expectorants|expectorants|mesh-ancestor
43859874|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859875|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43859876|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
43859877|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859878|NCT03032601|Protective Agents|protective agents|mesh-ancestor
43859879|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859880|NCT03032601|Antidotes|antidotes|mesh-ancestor
43859881|NCT03029429|Theophylline|theophylline|mesh-list
43859882|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43859883|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
43859884|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859885|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859886|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44362708|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362709|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362710|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
44362712|NCT01149356|Goserelin|goserelin|mesh-list
44362713|NCT01149356|R04929097|r04929097|mesh-list
44362714|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362715|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44362716|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44362717|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362718|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362719|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44362720|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
44362721|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859887|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859888|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43859889|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859890|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859891|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
43859892|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43859893|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43859894|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
43859895|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859896|NCT03029169|Amiodarone|amiodarone|mesh-list
43859897|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43859898|NCT03029169|Propafenone|propafenone|mesh-list
43859899|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
43544800|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
44362722|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362723|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44362725|NCT01149395|Lansoprazole|lansoprazole|mesh-list
44362726|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44362727|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362728|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44362729|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362730|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362731|NCT01149408|Decitabine|decitabine|mesh-list
44362732|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362733|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
44362734|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362735|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675496|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43582482|NCT03449524|CXA-10|cxa-10|mesh-list
43859900|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43859905|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43859906|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859907|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43859908|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43859909|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43859910|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43859912|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
43859913|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43859914|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
43859915|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859916|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43859917|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43859918|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
43859919|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
43859920|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43859921|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859922|NCT03024489|Cetuximab|cetuximab|mesh-list
43859923|NCT03024489|Palbociclib|palbociclib|mesh-list
43859924|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859925|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859926|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859927|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859928|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859929|NCT03043053|Oxytocin|oxytocin|mesh-list
43859930|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
43859931|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43859932|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133850|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133851|NCT00155233|Morphine|morphine|mesh-list
44133852|NCT00155233|Nalbuphine|nalbuphine|mesh-list
44133853|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44133854|NCT00155233|Narcotics|narcotics|mesh-ancestor
43602477|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43602478|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
43602479|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44133855|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133856|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133857|NCT00155233|Analgesics|analgesics|mesh-ancestor
44133858|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
44133859|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133860|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
44133861|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44133862|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133863|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362736|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362737|NCT01149499|Valacyclovir|valacyclovir|mesh-list
44362738|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
44362739|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362740|NCT01149564|Ibuprofen|ibuprofen|mesh-list
44362741|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362742|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44362743|NCT01149564|Analgesics|analgesics|mesh-ancestor
44362744|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
44362745|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362746|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362747|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362748|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133864|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44133865|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44133866|NCT00155246|Protective Agents|protective agents|mesh-ancestor
44133867|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133868|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133869|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44133870|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
44133871|NCT00155259|Cisplatin|cisplatin|mesh-list
44133872|NCT00155259|Docetaxel|docetaxel|mesh-list
44133873|NCT00155259|Capecitabine|capecitabine|mesh-list
44133874|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133875|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133876|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133877|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133878|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133879|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133880|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
44133881|NCT00155272|Thalidomide|thalidomide|mesh-list
44133882|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133883|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
44133884|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133885|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
44133886|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43859933|NCT03020303|Spironolactone|spironolactone|mesh-list
43859934|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43859935|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
43859936|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43859937|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859938|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43859939|NCT03020303|Diuretics|diuretics|mesh-ancestor
43602492|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
43859940|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
43859941|NCT03018704|Topiramate|topiramate|mesh-list
43859942|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
43859943|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43859944|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859945|NCT03017326|Gemcitabine|gemcitabine|mesh-list
43859946|NCT03017326|Carboplatin|carboplatin|mesh-list
43859947|NCT03017326|Doxorubicin|doxorubicin|mesh-list
43859948|NCT03017326|Fluorouracil|fluorouracil|mesh-list
43859949|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
43859950|NCT03017326|Irinotecan|irinotecan|mesh-list
43859951|NCT03017326|Etoposide|etoposide|mesh-list
43859952|NCT03017326|Vincristine|vincristine|mesh-list
43859953|NCT03017326|Sorafenib|sorafenib|mesh-list
43859954|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859956|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
43859957|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859958|NCT03017326|Antiviral Agents|antiviral agents|mesh-ancestor
43859959|NCT03017326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859960|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859961|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859962|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
43544801|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
43859963|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859964|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859965|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43859966|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43859967|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43859968|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859969|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859970|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859971|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859972|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859973|NCT03015259|Budesonide|budesonide|mesh-list
43859974|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
43859975|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43859976|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43859977|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43859978|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
43859979|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859980|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859981|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43859982|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
43859983|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
43859984|NCT03015259|Hormones|hormones|mesh-ancestor
43859985|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44362766|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362767|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
44362768|NCT01149629|Droxidopa|droxidopa|mesh-list
44362769|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44362770|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44362771|NCT01149668|Abexinostat|abexinostat|mesh-list
44362772|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44362773|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362774|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362775|NCT01149746|Tamsulosin|tamsulosin|mesh-list
44362776|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43675548|NCT02883192|Ondansetron|ondansetron|mesh-list
43859986|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43859987|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43649210|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
43859988|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43859989|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859990|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859991|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859992|NCT03012880|Dexamethasone|dexamethasone|mesh-list
43859993|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
43859994|NCT03012880|Lenalidomide|lenalidomide|mesh-list
43859995|NCT03012880|Daratumumab|daratumumab|mesh-list
43859996|NCT03012880|Ixazomib|ixazomib|mesh-list
43859997|NCT03012880|Ichthammol|ichthammol|mesh-list
43859998|NCT03012880|BB 1101|bb 1101|mesh-list
43859999|NCT03012880|Glycine|glycine|mesh-list
43860000|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860001|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
43860002|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
43860003|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860004|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860005|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43860006|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
43860007|NCT03012880|Hormones|hormones|mesh-ancestor
43860008|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860009|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860010|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860011|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
43860012|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43860013|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43860014|NCT03012880|Growth Substances|growth substances|mesh-ancestor
43860015|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
43860016|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860017|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43860018|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860019|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
43860020|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
43860021|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860022|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
43860023|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
43860024|NCT03012360|Linezolid|linezolid|mesh-list
43860025|NCT03012360|Imipenem|imipenem|mesh-list
43860026|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43860027|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860028|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43860029|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860030|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860031|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860032|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860033|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43860034|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44362777|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44362778|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44362779|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
44362780|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362781|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362782|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362783|NCT01149746|Urological Agents|urological agents|mesh-ancestor
44362785|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44362786|NCT01149798|Paclitaxel|paclitaxel|mesh-list
44362787|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362788|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44362789|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44362790|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44362791|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
44362792|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362793|NCT01149824|Salvinorin A|salvinorin a|mesh-list
44362794|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
44362795|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362796|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362797|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
44362798|NCT01149902|Docetaxel|docetaxel|mesh-list
44362799|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362800|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
44362801|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675554|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
43860035|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43860036|NCT03010917|Ethanol|ethanol|mesh-list
43860037|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43860038|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860039|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860040|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860041|NCT03008408|Everolimus|everolimus|mesh-list
43860042|NCT03008408|Letrozole|letrozole|mesh-list
43860043|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860044|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860045|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
43860046|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860047|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43860048|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43860049|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860050|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860051|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43860059|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860060|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133891|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
43860061|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43860062|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44362802|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362803|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44362804|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
44362805|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362806|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362807|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44362808|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44362809|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44362810|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44362811|NCT01149941|Ibuprofen|ibuprofen|mesh-list
44362812|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362813|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017810|NCT04390022|Ivermectin|ivermectin|mesh-list
44362814|NCT01149941|Analgesics|analgesics|mesh-ancestor
43602539|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44362815|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
44362816|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362817|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362818|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44362819|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44362820|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44362821|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362822|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362823|NCT01149954|Ibuprofen|ibuprofen|mesh-list
44362824|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44362850|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
44362851|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362852|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44362853|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44362854|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362855|NCT01149980|Dexetimide|dexetimide|mesh-list
44362856|NCT01149980|Citalopram|citalopram|mesh-list
44362857|NCT01149980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44362858|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44362859|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44362860|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362861|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362862|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
44362863|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362864|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44362865|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
44362866|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362867|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44362868|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44362869|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
44362870|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
44362871|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362872|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44362873|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44362874|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
44362875|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
44362876|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
44362877|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44017886|NCT04342130|Morphine|morphine|mesh-list
44362897|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44362898|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44362899|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362900|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362901|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
44362902|NCT01150162|Protective Agents|protective agents|mesh-ancestor
44362903|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362904|NCT01150201|Losartan|losartan|mesh-list
44362905|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44362906|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44362907|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44362908|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44362909|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362910|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44362911|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44362912|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44362913|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362914|NCT01150318|Iodine|iodine|mesh-list
44362915|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44362916|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362917|NCT01150318|Trace Elements|trace elements|mesh-ancestor
44362918|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
44362919|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362920|NCT01150331|Levetiracetam|levetiracetam|mesh-list
44362921|NCT01150331|Clonazepam|clonazepam|mesh-list
44362922|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
43657213|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43657214|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43657215|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43657216|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44362923|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
44362924|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
44362925|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
44362926|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362927|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362928|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362929|NCT01150344|Artemether|artemether|mesh-list
43860063|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43860064|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
43860065|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860066|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860067|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43860069|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43860070|NCT03008278|Ramucirumab|ramucirumab|mesh-list
43860071|NCT03008278|Antibodies|antibodies|mesh-list
44362931|NCT01150344|Proguanil|proguanil|mesh-list
44362932|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44362933|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
44362934|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44362935|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44362936|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362937|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362938|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362939|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
44362940|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44362941|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44362942|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44362943|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44362944|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362945|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44362946|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44362947|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44362948|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
44362949|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44362950|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362951|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44362952|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44362953|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
44362954|NCT01150617|Insulin|insulin|mesh-list
44362955|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44362956|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
44362957|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44362958|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
44362959|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362960|NCT01150630|Gemcitabine|gemcitabine|mesh-list
44362961|NCT01150630|Cisplatin|cisplatin|mesh-list
44362962|NCT01150630|Capecitabine|capecitabine|mesh-list
44362963|NCT01150630|Epirubicin|epirubicin|mesh-list
44362964|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44362965|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44362966|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
43675655|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
43860072|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
44362967|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362968|NCT01150630|Antiviral Agents|antiviral agents|mesh-ancestor
44362969|NCT01150630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362970|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362971|NCT01150630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44362972|NCT01150630|Immunologic Factors|immunologic factors|mesh-ancestor
44362973|NCT01150630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362974|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44362975|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44362976|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44362977|NCT01150747|Azithromycin|azithromycin|mesh-list
43850291|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362978|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
44362979|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44362980|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44362981|NCT01150786|Selenium|selenium|mesh-list
44362982|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
43675696|NCT02882269|Capecitabine|capecitabine|mesh-list
43860073|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43860074|NCT03008278|Lexatumumab|lexatumumab|mesh-list
43860075|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
43860076|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860077|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860078|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860079|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860081|NCT03007732|Prednisone|prednisone|mesh-list
43860082|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
43860083|NCT03007732|Leuprolide|leuprolide|mesh-list
43860084|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
43860085|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
43860086|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43860087|NCT03007732|Androgens|androgens|mesh-list
43860088|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860089|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860090|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860091|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
43860092|NCT03007732|Hormones|hormones|mesh-ancestor
43860093|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860094|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860095|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860096|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43860097|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
43860098|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43860099|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43860100|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860101|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860102|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
43860103|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43860104|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
43860105|NCT03007732|Protective Agents|protective agents|mesh-ancestor
43860106|NCT03007732|Vitamins|vitamins|mesh-ancestor
43860107|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
43860108|NCT03007732|Estrogens|estrogens|mesh-ancestor
43860109|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
43860110|NCT03007420|Lidocaine|lidocaine|mesh-list
43860111|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
43860112|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
43860113|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860114|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860115|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
43860116|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44362983|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362984|NCT01150786|Protective Agents|protective agents|mesh-ancestor
44362985|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362987|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
43602580|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602581|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602582|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
43602583|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602584|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602585|NCT03252496|Ephedrine|ephedrine|mesh-list
43602586|NCT03252496|Fentanyl|fentanyl|mesh-list
43602587|NCT03252496|Bupivacaine|bupivacaine|mesh-list
43602588|NCT03252496|Oxytocin|oxytocin|mesh-list
43602589|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
44362988|NCT01150877|Vitamin D|vitamin d|mesh-list
44362989|NCT01150877|Vitamins|vitamins|mesh-ancestor
44362990|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
44362991|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362992|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44362994|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
43675714|NCT02882217|Histamine|histamine|mesh-list
43860117|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43860118|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43860119|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43860125|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
43860126|NCT03007147|Prednisolone|prednisolone|mesh-list
43860127|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
43860128|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43860129|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43860130|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43860131|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
43860132|NCT03007147|Ifosfamide|ifosfamide|mesh-list
43860133|NCT03007147|Doxorubicin|doxorubicin|mesh-list
43860134|NCT03007147|Methotrexate|methotrexate|mesh-list
43860135|NCT03007147|Etoposide|etoposide|mesh-list
43860136|NCT03007147|Vincristine|vincristine|mesh-list
43860137|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
43860138|NCT03007147|Daunorubicin|daunorubicin|mesh-list
43860139|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
43860140|NCT03007147|Pegaspargase|pegaspargase|mesh-list
43860141|NCT03007147|Thioguanine|thioguanine|mesh-list
43860142|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
43860143|NCT03007147|Razoxane|razoxane|mesh-list
43860144|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
43860145|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860146|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
43860147|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860148|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43860149|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860150|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
43860151|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860152|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860153|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43860154|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860155|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
43860156|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
43860157|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860158|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43860159|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
43860161|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860162|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860163|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43860164|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43860165|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860166|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602624|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
43602625|NCT03252366|Coagulants|coagulants|mesh-ancestor
43602626|NCT03252067|Azithromycin|azithromycin|mesh-list
43602627|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43602628|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602629|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602630|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43602631|NCT03252223|Hormones|hormones|mesh-list
43602632|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43602633|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602634|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602635|NCT03251690|Tenofovir|tenofovir|mesh-list
43850294|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43860167|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43860168|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
43860169|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43860170|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860171|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
43860172|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
43860173|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43860174|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43860175|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860176|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
44362995|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44362996|NCT01150955|Protective Agents|protective agents|mesh-ancestor
44362997|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44362998|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44362999|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44363000|NCT01151072|Insulin|insulin|mesh-list
44363001|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363002|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363003|NCT01151176|Insulin|insulin|mesh-list
44363004|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44363005|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363006|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363007|NCT01151241|Anesthetics|anesthetics|mesh-list
44363008|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
44363009|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363010|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363011|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
44363012|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363013|NCT01151254|Propofol|propofol|mesh-list
44363014|NCT01151254|Sevoflurane|sevoflurane|mesh-list
44363015|NCT01151254|Isoflurane|isoflurane|mesh-list
44363016|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44363017|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363018|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363019|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44363020|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
44363021|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
44363022|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44363023|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43860177|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860178|NCT03007147|Antidotes|antidotes|mesh-ancestor
43860179|NCT03007147|Protective Agents|protective agents|mesh-ancestor
43860180|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
43860181|NCT03007147|Vitamins|vitamins|mesh-ancestor
43860182|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
43860183|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860184|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860185|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860186|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43860187|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43860188|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43860189|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
43860190|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
43860191|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
43860192|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860193|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860194|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363025|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363026|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363027|NCT01151306|Simvastatin|simvastatin|mesh-list
43850295|NCT05697055|Ritonavir|ritonavir|mesh-list
44363028|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44363029|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44363030|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
44363031|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363032|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44363033|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44363034|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363035|NCT01151384|Docetaxel|docetaxel|mesh-list
44363036|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363037|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
44363038|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
44363039|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
43675746|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43860199|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43860200|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860201|NCT03005782|Cemiplimab|cemiplimab|mesh-list
43860202|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860203|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860204|NCT03005366|Flecainide|flecainide|mesh-list
43860205|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43860206|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43860207|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43860208|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43860209|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860210|NCT03004833|Nivolumab|nivolumab|mesh-list
43860211|NCT03004833|Doxorubicin|doxorubicin|mesh-list
43860212|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43860213|NCT03004833|Dacarbazine|dacarbazine|mesh-list
43860214|NCT03004833|Vinblastine|vinblastine|mesh-list
43860215|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860216|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860217|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860218|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860219|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43860220|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43860221|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860222|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860223|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860224|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
43860225|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860226|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860227|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860228|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860229|NCT03004287|Thalidomide|thalidomide|mesh-list
43860230|NCT03004287|Dexamethasone|dexamethasone|mesh-list
43860231|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
43860232|NCT03004287|Melphalan|melphalan|mesh-list
43860233|NCT03004287|Doxorubicin|doxorubicin|mesh-list
43860234|NCT03004287|Etoposide|etoposide|mesh-list
43860235|NCT03004287|Lenalidomide|lenalidomide|mesh-list
43602670|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602671|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
43602696|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602698|NCT03251417|Apatinib|apatinib|mesh-list
43602699|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43602700|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43602701|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602702|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860236|NCT03004287|Bortezomib|bortezomib|mesh-list
43860237|NCT03004287|Daratumumab|daratumumab|mesh-list
43860238|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860239|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
43544802|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
44363040|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363041|NCT01151397|Vitamin D|vitamin d|mesh-list
44363042|NCT01151397|Ribavirin|ribavirin|mesh-list
44363043|NCT01151397|Vitamins|vitamins|mesh-ancestor
44363044|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
44363045|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363046|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44363047|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
44363048|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363049|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
44363050|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363051|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44363052|NCT01151592|Hematinics|hematinics|mesh-ancestor
44363053|NCT01151670|Pioglitazone|pioglitazone|mesh-list
44363054|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363055|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363056|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
44363057|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
44363058|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
44363059|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44363060|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
44363061|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
44363062|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363063|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363064|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363065|NCT01151722|Bevacizumab|bevacizumab|mesh-list
44363066|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44363067|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363068|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44363069|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43860240|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860241|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43860242|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860243|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
43860244|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860245|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860246|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43860247|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860248|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
43860249|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
43860250|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860251|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43860252|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
43602703|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602704|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602705|NCT03251443|Apatinib|apatinib|mesh-list
43602706|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860253|NCT03004287|Hormones|hormones|mesh-ancestor
43860254|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363070|NCT01151722|Growth Substances|growth substances|mesh-ancestor
44363071|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363072|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44363073|NCT01151735|Complement C1s|complement c1s|mesh-list
44363074|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
44363075|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363076|NCT01151787|Amitriptyline|amitriptyline|mesh-list
44363077|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
44363078|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44363079|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44363080|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363081|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44363082|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363083|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44363084|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363085|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44363086|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363087|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363088|NCT01151787|Analgesics|analgesics|mesh-ancestor
44363089|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
44363090|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44363091|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44363092|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363093|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363094|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44363095|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363096|NCT01151800|Benzocaine|benzocaine|mesh-list
44363097|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
44363098|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
44363099|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363100|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649217|NCT03030950|Analgesics|analgesics|mesh-ancestor
43649218|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
44363101|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
43675792|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
43860255|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860256|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43860257|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43860258|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860259|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860260|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860261|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43860262|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44363104|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44363105|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363106|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363107|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363108|NCT01151865|Analgesics|analgesics|mesh-ancestor
44363109|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
44363110|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363111|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44363112|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44363113|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44363114|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
44363115|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363116|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363117|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44363118|NCT01151878|Cathartics|cathartics|mesh-ancestor
44363119|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43860263|NCT03004287|Growth Substances|growth substances|mesh-ancestor
43860264|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
43860269|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43860270|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43860271|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43860272|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
43860273|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860274|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43860275|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43860276|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860277|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
43860278|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860279|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
43860280|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43860281|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
43860282|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860283|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
43860284|NCT03003130|Protective Agents|protective agents|mesh-ancestor
43860285|NCT02996721|Vitamin D|vitamin d|mesh-list
43860286|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
43860287|NCT02996721|Vitamins|vitamins|mesh-ancestor
43860288|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
43860289|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860290|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43860291|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43860292|NCT02992756|Mitogens|mitogens|mesh-list
43860293|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860294|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860295|NCT02985749|Oxytocin|oxytocin|mesh-list
43860296|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
43860297|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602717|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602751|NCT03251222|Analgesics|analgesics|mesh-ancestor
43602752|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
43860298|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860299|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
43860300|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43860301|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
43860302|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860303|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
44363120|NCT01151943|Anesthetics|anesthetics|mesh-list
44363121|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
44363122|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363123|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363124|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
44363125|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363126|NCT01152047|Oxytocin|oxytocin|mesh-list
44363127|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
44363128|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363129|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363130|NCT01152203|Bevacizumab|bevacizumab|mesh-list
44363131|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44363132|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44363133|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363134|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44363135|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44363136|NCT01152203|Growth Substances|growth substances|mesh-ancestor
44363137|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363138|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44363139|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44363140|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
44018121|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
44363141|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363142|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
44363143|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363144|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363145|NCT01152346|Azacitidine|azacitidine|mesh-list
44363147|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
44363165|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44363166|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363167|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363168|NCT01152606|Trastuzumab|trastuzumab|mesh-list
44363169|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44363170|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363171|NCT01152710|Capecitabine|capecitabine|mesh-list
44363172|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44363173|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
44363174|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363175|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363176|NCT01152723|Nicotine|nicotine|mesh-list
44363177|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44363178|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
44363179|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363180|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363181|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44363182|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44363183|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
44363184|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363185|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860304|NCT02984228|Protective Agents|protective agents|mesh-ancestor
43860305|NCT02983071|Fulvestrant|fulvestrant|mesh-list
43860306|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860307|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860308|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43860310|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825306|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43860311|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860312|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860313|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
43860314|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43860315|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860316|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43860317|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860318|NCT02981173|Psilocybin|psilocybin|mesh-list
43860319|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
43860320|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860321|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43860322|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
43860323|NCT02981069|Exenatide|exenatide|mesh-list
43860324|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43860325|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860326|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43860327|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860328|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43860329|NCT02981069|Incretins|incretins|mesh-ancestor
43860330|NCT02981069|Hormones|hormones|mesh-ancestor
43860331|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860332|NCT02980835|Dexamethasone|dexamethasone|mesh-list
43860333|NCT02980835|Epinephrine|epinephrine|mesh-list
43860334|NCT02980835|Ropivacaine|ropivacaine|mesh-list
43860335|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363186|NCT01152736|Nicotine|nicotine|mesh-list
44363187|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44363188|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
44363189|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363190|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363191|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44363192|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44363193|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44363194|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363195|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363196|NCT01152749|Nicotine|nicotine|mesh-list
44363197|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44363198|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
44363199|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363200|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363201|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44363202|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44363203|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
44363204|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363205|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363206|NCT01152801|Everolimus|everolimus|mesh-list
44363207|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363208|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363209|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
44363210|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363211|NCT01152827|Everolimus|everolimus|mesh-list
44363212|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363213|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363214|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
44363215|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363216|NCT01152840|Everolimus|everolimus|mesh-list
44363217|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363218|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825317|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
43825318|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43825319|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825320|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825321|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43825322|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43825323|NCT05502952|Protective Agents|protective agents|mesh-ancestor
43850298|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
44363219|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
44363220|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363221|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43860336|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
43860339|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860340|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363222|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363223|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363224|NCT01152931|Vitamins|vitamins|mesh-list
44363225|NCT01152931|Vitamin E|vitamin e|mesh-list
44363226|NCT01152931|Tocopherols|tocopherols|mesh-list
44363227|NCT01152931|Tocotrienols|tocotrienols|mesh-list
44363228|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
44363229|NCT01152931|Vitamin A|vitamin a|mesh-list
44363231|NCT01152931|Selenium|selenium|mesh-list
44363232|NCT01152931|Artesunate|artesunate|mesh-list
44363233|NCT01152931|Lumefantrine|lumefantrine|mesh-list
44363234|NCT01152931|Artemether|artemether|mesh-list
44363235|NCT01152931|Amodiaquine|amodiaquine|mesh-list
44363236|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
44363237|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
44363238|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363239|NCT01152931|Trace Elements|trace elements|mesh-ancestor
44363240|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
44363241|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363242|NCT01152931|Protective Agents|protective agents|mesh-ancestor
44363243|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
44363244|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44363245|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44363246|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363247|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363248|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
44363249|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
44363250|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44363251|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
44363252|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44363253|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
44363254|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363255|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363256|NCT01153165|Citalopram|citalopram|mesh-list
44363257|NCT01153165|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44363258|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43860342|NCT02980835|Hormones|hormones|mesh-ancestor
43860343|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860344|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860345|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860346|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
43860347|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
43860348|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363259|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363260|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363261|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363262|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
44363263|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363264|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44363265|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
44363266|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363267|NCT01153191|Gentamicins|gentamicins|mesh-list
44363268|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363269|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363270|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44363271|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363272|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363273|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
44363274|NCT01153204|Citric Acid|citric acid|mesh-list
44363275|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
44363276|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
44363277|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44363278|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
44363279|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
44363280|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363281|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363309|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363310|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44363311|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
44363312|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44363313|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363314|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363315|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363316|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
44363317|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363318|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44363319|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44363320|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44363321|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
44363322|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363323|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44363324|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44363325|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363326|NCT01153373|Ethanol|ethanol|mesh-list
44363327|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44363328|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363329|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363330|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363331|NCT01153386|Treprostinil|treprostinil|mesh-list
44363332|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44363333|NCT01153542|Ivacaftor|ivacaftor|mesh-list
44363334|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44363335|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363336|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363337|NCT01153568|Vitamin D|vitamin d|mesh-list
44363338|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
44363339|NCT01153568|Vitamins|vitamins|mesh-ancestor
44363340|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
43602874|NCT03249740|Sunitinib|sunitinib|mesh-list
44363349|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363350|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363351|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
44363352|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363353|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44363354|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363355|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363356|NCT01153802|Dopamine|dopamine|mesh-list
44363357|NCT01153802|Norepinephrine|norepinephrine|mesh-list
44363358|NCT01153802|Serotonin|serotonin|mesh-list
44363359|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
44363360|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44363361|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44363362|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
44363363|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363364|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860349|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
43860350|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43860351|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43860352|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
43860353|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860354|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860355|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43860356|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43860357|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43860358|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
43860359|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
43860360|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
43860361|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43860362|NCT02980510|Leucovorin|leucovorin|mesh-list
43860363|NCT02980510|Folic Acid|folic acid|mesh-list
43860364|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
43860365|NCT02980510|Irinotecan|irinotecan|mesh-list
43860366|NCT02980510|Panitumumab|panitumumab|mesh-list
43860367|NCT02980510|Fluorouracil|fluorouracil|mesh-list
43860368|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
43860369|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860370|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860371|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860372|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860373|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860374|NCT02980510|Antidotes|antidotes|mesh-ancestor
43860375|NCT02980510|Protective Agents|protective agents|mesh-ancestor
43860376|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860377|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
43860378|NCT02980510|Vitamins|vitamins|mesh-ancestor
43860379|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
43860380|NCT02980510|Hematinics|hematinics|mesh-ancestor
43860381|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860382|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
43860384|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860385|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
43860386|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43860387|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
43860388|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43860389|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43860390|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43860391|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860392|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860393|NCT02978404|Nivolumab|nivolumab|mesh-list
44363366|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
44363367|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363368|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44363369|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43657231|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657232|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363370|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
44363371|NCT01153802|Protective Agents|protective agents|mesh-ancestor
44363372|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44363373|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
44363374|NCT01153828|Mupirocin|mupirocin|mesh-list
44363375|NCT01153828|Retapamulin|retapamulin|mesh-list
44363376|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
44363377|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363378|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363379|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44363380|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363381|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363382|NCT01153854|Racecadotril|racecadotril|mesh-list
44363383|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
44363384|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363385|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
44363386|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363387|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363388|NCT01153880|Mupirocin|mupirocin|mesh-list
44363389|NCT01153880|Retapamulin|retapamulin|mesh-list
44363390|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363391|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363392|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44363393|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363394|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363395|NCT01153919|Interferons|interferons|mesh-list
44363412|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363413|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363414|NCT01154361|Cortisone|cortisone|mesh-list
44363415|NCT01154361|Icatibant|icatibant|mesh-list
44363416|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363417|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44363418|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363419|NCT01154361|Analgesics|analgesics|mesh-ancestor
44363420|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
44363421|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363422|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363423|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363424|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44363425|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44363426|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363427|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44363428|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363429|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
44363430|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
43602880|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602881|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
43602882|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602883|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602890|NCT03249506|Glucagon|glucagon|mesh-list
44363431|NCT01154387|Tacrolimus|tacrolimus|mesh-list
44363432|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
44363433|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44363434|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363435|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
44363436|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363437|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44363438|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363440|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44363458|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363459|NCT01154426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363460|NCT01154426|Immunologic Factors|immunologic factors|mesh-ancestor
44363461|NCT01154426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363462|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44363463|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
44363464|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44363465|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363466|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
44363467|NCT01154491|Hematinics|hematinics|mesh-ancestor
44363468|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
44363469|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44363470|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44363471|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
44363472|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363473|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363474|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44363475|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
44363476|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44363477|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363478|NCT01154504|Protective Agents|protective agents|mesh-ancestor
44363479|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
44363480|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44363481|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363482|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
44363483|NCT01154569|Azithromycin|azithromycin|mesh-list
44363484|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363485|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363486|NCT01154647|Citalopram|citalopram|mesh-list
44363487|NCT01154647|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44363488|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44363489|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363490|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363501|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363502|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
44363503|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363504|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44363505|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44363506|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44363507|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43824320|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824321|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43824322|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824324|NCT05513625|Pritelivir|pritelivir|mesh-list
44363508|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363509|NCT01154764|Ketoconazole|ketoconazole|mesh-list
44363510|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
44363511|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363512|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44363513|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44363514|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363515|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363516|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44363517|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
44363518|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363519|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363520|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44363521|NCT01154790|Naproxen|naproxen|mesh-list
44363522|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44363523|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363524|NCT01154790|Analgesics|analgesics|mesh-ancestor
44363525|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
44363526|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363527|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363528|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363529|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363530|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
44363531|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44363532|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363534|NCT01154803|Micronutrients|micronutrients|mesh-list
44363536|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363537|NCT01154829|Aripiprazole|aripiprazole|mesh-list
44363538|NCT01154829|Amisulpride|amisulpride|mesh-list
44363539|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
44363540|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363541|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44363542|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44363543|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363544|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363545|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
44363546|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
44363547|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363548|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363549|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44363550|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44363551|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
43860394|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860395|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860396|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860397|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860398|NCT02977780|Temozolomide|temozolomide|mesh-list
43860399|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860400|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
43860401|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860402|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860403|NCT02975882|Sirolimus|sirolimus|mesh-list
43860404|NCT02975882|Irinotecan|irinotecan|mesh-list
43860405|NCT02975882|Camptothecin|camptothecin|mesh-list
43860406|NCT02975882|Temozolomide|temozolomide|mesh-list
43860407|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860408|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860409|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860410|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860411|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860415|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860416|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43860417|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
43860418|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860419|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
43860420|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657261|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860421|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860422|NCT02975310|Anesthetics|anesthetics|mesh-list
43860423|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860424|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860426|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860427|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43860428|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860429|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860430|NCT02974257|Thiamine|thiamine|mesh-list
43860431|NCT02974257|Vitamins|vitamins|mesh-ancestor
43860432|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
43860433|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860434|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
43860435|NCT02972424|Teriparatide|teriparatide|mesh-list
43860436|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43860437|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860438|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44363552|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44363553|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44363554|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44363555|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44363556|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44363558|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363559|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363560|NCT01154907|Praziquantel|praziquantel|mesh-list
44363561|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
44363562|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44363563|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363564|NCT01154933|Exenatide|exenatide|mesh-list
44363565|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363566|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363567|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44363568|NCT01154933|Incretins|incretins|mesh-ancestor
44363569|NCT01154933|Hormones|hormones|mesh-ancestor
44363570|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363572|NCT01154959|Rifampin|rifampin|mesh-list
44363573|NCT01154959|Isoniazid|isoniazid|mesh-list
44363574|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
44363575|NCT01154959|Ethambutol|ethambutol|mesh-list
44363576|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43824335|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824336|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
43824337|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824338|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602893|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602924|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602925|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43602927|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
43602928|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43651628|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44363577|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363578|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44363579|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44363580|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363581|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363582|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363583|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44363584|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
44363596|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44363597|NCT01155037|Vaccines|vaccines|mesh-list
44363598|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
44363599|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363600|NCT01155089|Anastrozole|anastrozole|mesh-list
44363601|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44363602|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363603|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44363604|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44363605|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363606|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363607|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44363608|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
44363609|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363610|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363611|NCT01155102|Anastrozole|anastrozole|mesh-list
44363612|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44363613|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363614|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44363615|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44363616|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363617|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676169|NCT02878265|Vitamins|vitamins|mesh-list
43860439|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
43860440|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43860441|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
43860442|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860443|NCT02972398|Expectorants|expectorants|mesh-ancestor
43860444|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
43860445|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43860446|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
43860447|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860448|NCT02972398|Protective Agents|protective agents|mesh-ancestor
43860449|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860450|NCT02972398|Antidotes|antidotes|mesh-ancestor
43860451|NCT02972294|Iron|iron|mesh-list
43860452|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
43860453|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43860454|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
43860455|NCT02972294|Trace Elements|trace elements|mesh-ancestor
43860456|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
43860457|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860458|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43860459|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43860460|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860461|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
43860462|NCT02972294|Coagulants|coagulants|mesh-ancestor
43860463|NCT02972294|Hematinics|hematinics|mesh-ancestor
43860464|NCT02970981|Nivolumab|nivolumab|mesh-list
43860465|NCT02970981|Ipilimumab|ipilimumab|mesh-list
43860466|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860467|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363619|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382378|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602963|NCT03249519|Cisplatin|cisplatin|mesh-list
44363620|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363621|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363623|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44363624|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
44363625|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363626|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363627|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44363628|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
44363629|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44363630|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
44363631|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363632|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363633|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44363634|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363635|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
44363636|NCT01155115|Protective Agents|protective agents|mesh-ancestor
44363637|NCT01155206|Glucagon|glucagon|mesh-list
44363638|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44363639|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363640|NCT01155206|Hormones|hormones|mesh-ancestor
44363641|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363642|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363644|NCT01155232|Teriparatide|teriparatide|mesh-list
44363645|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
44363646|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363647|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363648|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43860468|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860469|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860470|NCT02969798|Metformin|metformin|mesh-list
43860471|NCT02969798|Pioglitazone|pioglitazone|mesh-list
43860472|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
43860473|NCT02969798|Saxagliptin|saxagliptin|mesh-list
43860474|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43860475|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860476|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43860477|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860478|NCT02969798|Incretins|incretins|mesh-ancestor
43860479|NCT02969798|Hormones|hormones|mesh-ancestor
44363649|NCT01155245|Teriparatide|teriparatide|mesh-list
44363650|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363651|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363652|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44363653|NCT01155258|Sirolimus|sirolimus|mesh-list
44363654|NCT01155258|Vinorelbine|vinorelbine|mesh-list
44363655|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363656|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363657|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44363658|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363659|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
44363660|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363661|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
44363662|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860480|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860481|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43860482|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602965|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43602966|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43602967|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43602968|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
43860483|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860484|NCT02967289|Irinotecan|irinotecan|mesh-list
43860489|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860491|NCT02967133|Nivolumab|nivolumab|mesh-list
43860492|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860493|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860494|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860495|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860496|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860497|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860498|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860499|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860500|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
43860501|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43860502|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43860503|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43860504|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43860505|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43860506|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860507|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
43860508|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860509|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860510|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43860511|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133892|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133893|NCT00155350|Pioglitazone|pioglitazone|mesh-list
44133894|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44133895|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133896|NCT00155376|Morphine|morphine|mesh-list
44133897|NCT00155376|Glucagon|glucagon|mesh-list
43860512|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
43860513|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860514|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
43860515|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860516|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43860517|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860518|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
43860519|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860520|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860521|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43860522|NCT02965768|Naltrexone|naltrexone|mesh-list
43860523|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43860524|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44363666|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44363667|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363668|NCT01155440|Lidocaine|lidocaine|mesh-list
44363669|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
44363670|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
44363671|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363672|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363673|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
44363674|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363675|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43676242|NCT02877888|Fluorides|fluorides|mesh-list
43860525|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860526|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
43860527|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860529|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43860530|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43860531|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43860532|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43860533|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
43860534|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860535|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860536|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860537|NCT02964182|Nicotine|nicotine|mesh-list
43860538|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43860539|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
43860540|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382379|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
43860541|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860542|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43860543|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43860544|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
43860545|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860546|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860547|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
43860548|NCT02963090|Topotecan|topotecan|mesh-list
43860555|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
43860556|NCT02962401|Idelalisib|idelalisib|mesh-list
43860557|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860558|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860559|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860560|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860564|NCT02959164|Gemcitabine|gemcitabine|mesh-list
43860565|NCT02959164|Decitabine|decitabine|mesh-list
43860566|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860567|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
43860568|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860569|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860570|NCT02959164|Antiviral Agents|antiviral agents|mesh-ancestor
43860571|NCT02959164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860572|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860573|NCT02959164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860574|NCT02959164|Immunologic Factors|immunologic factors|mesh-ancestor
43860575|NCT02959164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860576|NCT02956590|Pitavastatin|pitavastatin|mesh-list
43860577|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44363676|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44363677|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44363678|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363679|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363680|NCT01155453|Trametinib|trametinib|mesh-list
44363681|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363682|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44363683|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363684|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363685|NCT01155505|Lenalidomide|lenalidomide|mesh-list
44363686|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
43824339|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824340|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43824341|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43824342|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602974|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602975|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602976|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43602977|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
43602978|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43602979|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43602980|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
43602981|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602982|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43603016|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603018|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44363687|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363688|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44363689|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44363690|NCT01155505|Growth Substances|growth substances|mesh-ancestor
44363691|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44363692|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860578|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43860579|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43860580|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
43860581|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860582|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860583|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43860584|NCT02955654|Aripiprazole|aripiprazole|mesh-list
43860585|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
43860586|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43860587|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43860588|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43860589|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860590|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860591|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
43860592|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
43860593|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860594|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860595|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43860596|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43860597|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
43860598|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43860599|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43860600|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43860601|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43860603|NCT02954055|Vinorelbine|vinorelbine|mesh-list
43860604|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43860605|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
43860606|NCT02954055|Capecitabine|capecitabine|mesh-list
43860607|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860608|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860609|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860610|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860611|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860612|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860613|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860614|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
43860615|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860616|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363693|NCT01155635|Carvedilol|carvedilol|mesh-list
44363694|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44363695|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44363696|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
44363697|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363698|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363699|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363700|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44363701|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
44363702|NCT01155635|Protective Agents|protective agents|mesh-ancestor
44363703|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44363704|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363705|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363706|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363707|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44363708|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44363709|NCT01155700|Omalizumab|omalizumab|mesh-list
44363710|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44363711|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44363712|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
44363713|NCT01155765|Clopidogrel|clopidogrel|mesh-list
44363714|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44363715|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44363716|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44363717|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44363718|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43657297|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363719|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
44363720|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44363721|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363722|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363723|NCT01155791|Prednisone|prednisone|mesh-list
44363724|NCT01155791|Docetaxel|docetaxel|mesh-list
44363725|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363726|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860621|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
43860622|NCT02953548|Cannabidiol|cannabidiol|mesh-list
43860623|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
43860624|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
43860625|NCT02952222|Propofol|propofol|mesh-list
43860626|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43860627|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363727|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44363728|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44363729|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363730|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363731|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
44363732|NCT01155791|Hormones|hormones|mesh-ancestor
44363733|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363734|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363735|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44363736|NCT01155895|Amlodipine|amlodipine|mesh-list
44363737|NCT01155895|Benazepril|benazepril|mesh-list
44363738|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44363739|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44363740|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363741|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363742|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44363743|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363744|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363745|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44363746|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44363747|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363748|NCT01155908|Amlodipine|amlodipine|mesh-list
43603020|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603034|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603035|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603036|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603037|NCT03248726|Bisacodyl|bisacodyl|mesh-list
43603038|NCT03248726|Cathartics|cathartics|mesh-ancestor
43603039|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603040|NCT03248726|Laxatives|laxatives|mesh-ancestor
43603041|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
43657300|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
43657301|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657302|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
43657303|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
43657304|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363776|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363778|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44363779|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44363780|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363781|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44363782|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44363783|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
44363784|NCT01155947|Anastrozole|anastrozole|mesh-list
44363785|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44363786|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363787|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44363788|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44363789|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363790|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363791|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44363792|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382380|NCT03600909|Busulfan|busulfan|mesh-list
43603042|NCT03248765|Narcotics|narcotics|mesh-ancestor
43603043|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603044|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603045|NCT03248765|Analgesics|analgesics|mesh-ancestor
43603046|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
43603047|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603048|NCT03248817|Phenylephrine|phenylephrine|mesh-list
43603049|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
43603050|NCT03248817|Bupivacaine|bupivacaine|mesh-list
43603051|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
43603052|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
44363793|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363794|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363795|NCT01155960|Anastrozole|anastrozole|mesh-list
44363796|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44363797|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363798|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44363799|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44363800|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363801|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363802|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44363803|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
44363804|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363805|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860628|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860629|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43860630|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
43860631|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
43860632|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43860633|NCT02952222|Analgesics|analgesics|mesh-ancestor
43860634|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
43860635|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860636|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44363806|NCT01155986|Lidocaine|lidocaine|mesh-list
44363807|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
44363808|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
44363809|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363810|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363811|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
44363812|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363813|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44363814|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44363815|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44363816|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44363817|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363818|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
44363819|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363820|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363821|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44363822|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
44363823|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363824|NCT01156233|Anesthetics|anesthetics|mesh-list
44363825|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44363826|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363827|NCT01156246|Metformin|metformin|mesh-list
44363865|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363867|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
44363868|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363869|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
44363870|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363871|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
44363872|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
44363873|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44363874|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43860637|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43860638|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43860639|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
43860640|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860641|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860642|NCT02948543|Mitomycins|mitomycins|mesh-list
43860643|NCT02948543|Mitomycin|mitomycin|mesh-list
43860644|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43860645|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860646|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
43860647|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860648|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43860649|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860650|NCT02947386|Nivolumab|nivolumab|mesh-list
43860651|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
43860652|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860653|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860654|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860655|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860662|NCT02946125|Phenylephrine|phenylephrine|mesh-list
43860663|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
43860664|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43860665|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43860666|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
43860667|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
43860668|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860669|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860670|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
43860671|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44363875|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44363876|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363877|NCT01156636|Urological Agents|urological agents|mesh-ancestor
44018890|NCT03881163|Antidotes|antidotes|mesh-ancestor
44363878|NCT01156649|Acetaminophen|acetaminophen|mesh-list
44363879|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44363880|NCT01156649|Analgesics|analgesics|mesh-ancestor
44363881|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
44363882|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363883|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363884|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
44363885|NCT01156688|Misoprostol|misoprostol|mesh-list
44363886|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44363887|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
44363888|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363889|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363890|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44363891|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363892|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
44363893|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44363894|NCT01156740|Amoxicillin|amoxicillin|mesh-list
44363895|NCT01156740|Penicillins|penicillins|mesh-list
44363896|NCT01156740|beta-Lactams|beta-lactams|mesh-list
44363897|NCT01156740|Penicillin G|penicillin g|mesh-list
44363898|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44363899|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
44363900|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363901|NCT01156779|Exenatide|exenatide|mesh-list
44363902|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44363903|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363904|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44363905|NCT01156779|Incretins|incretins|mesh-ancestor
44363922|NCT01156883|Ifosfamide|ifosfamide|mesh-list
44363923|NCT01156883|Doxorubicin|doxorubicin|mesh-list
43603104|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363924|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44363925|NCT01156883|Methotrexate|methotrexate|mesh-list
44363926|NCT01156883|Vincristine|vincristine|mesh-list
44363927|NCT01156883|Daunorubicin|daunorubicin|mesh-list
44363928|NCT01156883|Asparaginase|asparaginase|mesh-list
44363929|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
44363930|NCT01156883|Thioguanine|thioguanine|mesh-list
44363931|NCT01156883|Vindesine|vindesine|mesh-list
44363932|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44363933|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
44363934|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363935|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363936|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44363937|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
44363938|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363939|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363940|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44363941|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44363942|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
44363943|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
43860672|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
43860673|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
43860674|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43860675|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43860676|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43860677|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
43860678|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860679|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860680|NCT02946125|Protective Agents|protective agents|mesh-ancestor
43860681|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43860682|NCT02943733|Temozolomide|temozolomide|mesh-list
43860683|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860684|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
43860685|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860686|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860721|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860723|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
43860724|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860725|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860726|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860727|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
43860728|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860729|NCT02936102|Spartalizumab|spartalizumab|mesh-list
43860730|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860731|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860732|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860733|NCT02935374|Amoxicillin|amoxicillin|mesh-list
43860734|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
43860735|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
43860736|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44363944|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363945|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363946|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
44363947|NCT01156883|Hormones|hormones|mesh-ancestor
44363948|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44363949|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860737|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860738|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43860739|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860740|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860741|NCT02935361|Atezolizumab|atezolizumab|mesh-list
43860742|NCT02935361|Guadecitabine|guadecitabine|mesh-list
43860743|NCT02935361|Azacitidine|azacitidine|mesh-list
43860744|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43860745|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860746|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
43860747|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860748|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860749|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
43860750|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860751|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860753|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
43860754|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43860787|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860789|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43860790|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860791|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860792|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
43860793|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43860794|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860795|NCT02925234|Bevacizumab|bevacizumab|mesh-list
43860796|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
43860804|NCT02925234|Atezolizumab|atezolizumab|mesh-list
43860805|NCT02925234|Olaparib|olaparib|mesh-list
43860806|NCT02925234|Lenvatinib|lenvatinib|mesh-list
43860807|NCT02925234|Palbociclib|palbociclib|mesh-list
43860808|NCT02925234|Trametinib|trametinib|mesh-list
43860809|NCT02925234|Axitinib|axitinib|mesh-list
43860810|NCT02925234|Afatinib|afatinib|mesh-list
43860811|NCT02925234|Vemurafenib|vemurafenib|mesh-list
43860812|NCT02925234|Dabrafenib|dabrafenib|mesh-list
43860813|NCT02925234|Crizotinib|crizotinib|mesh-list
43860814|NCT02925234|Talazoparib|talazoparib|mesh-list
43860815|NCT02925234|Rucaparib|rucaparib|mesh-list
43860816|NCT02925234|Entrectinib|entrectinib|mesh-list
43860817|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860818|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860819|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43860820|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43860821|NCT02925234|Growth Substances|growth substances|mesh-ancestor
43860822|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860823|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
43860824|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860825|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860826|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43860827|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860828|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43860829|NCT02921256|Leucovorin|leucovorin|mesh-list
43860831|NCT02921256|Fluorouracil|fluorouracil|mesh-list
43860832|NCT02921256|Capecitabine|capecitabine|mesh-list
43860833|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
43860834|NCT02921256|Veliparib|veliparib|mesh-list
43860835|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860836|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860837|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
43860838|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860839|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860840|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860841|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
43860842|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860843|NCT02921256|Antidotes|antidotes|mesh-ancestor
44363950|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44363951|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44363952|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44363953|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018972|NCT03859960|Insulin|insulin|mesh-list
44363954|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44363955|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
44363956|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363957|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44363958|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
44363959|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
44363960|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44363961|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44363962|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
44363963|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44363964|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44363965|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44363966|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44363967|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44363968|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44363969|NCT01156883|Protective Agents|protective agents|mesh-ancestor
44363970|NCT01156909|Rituximab|rituximab|mesh-list
44363971|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44363972|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860844|NCT02921256|Protective Agents|protective agents|mesh-ancestor
43860845|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
43860846|NCT02921256|Vitamins|vitamins|mesh-ancestor
43860847|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
43860848|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43860849|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860850|NCT02919787|Irinotecan|irinotecan|mesh-list
43860851|NCT02919787|Fluorouracil|fluorouracil|mesh-list
43860852|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
43860853|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860854|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860855|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860856|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860857|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860858|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
43860859|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860860|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860861|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
43860862|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860863|NCT02918721|Lidocaine|lidocaine|mesh-list
43860864|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
43860865|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43860866|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
43860867|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860868|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860869|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
43860870|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44363973|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
44363974|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363975|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363977|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43603128|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603129|NCT03248700|Protective Agents|protective agents|mesh-ancestor
43603130|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43603131|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603132|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44363978|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363979|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
44363980|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363981|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44363982|NCT01156948|Misoprostol|misoprostol|mesh-list
44363983|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44363984|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
44363985|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44363986|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44363987|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44363988|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44363989|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
44363990|NCT01156961|Paclitaxel|paclitaxel|mesh-list
44363991|NCT01156961|Bevacizumab|bevacizumab|mesh-list
44363992|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44363993|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44363994|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
44363995|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
44363996|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
44363997|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44363998|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44363999|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44364000|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44364001|NCT01156961|Growth Substances|growth substances|mesh-ancestor
44364002|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364003|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
44364004|NCT01157000|Canagliflozin|canagliflozin|mesh-list
44364007|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364015|NCT01157026|Tocopherols|tocopherols|mesh-list
44364016|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44364017|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364018|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364019|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364020|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364021|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364022|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44364023|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44364024|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44364025|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
44364026|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364027|NCT01157026|Protective Agents|protective agents|mesh-ancestor
44364028|NCT01157026|Vitamins|vitamins|mesh-ancestor
43676491|NCT02875886|Amiloride|amiloride|mesh-list
43860871|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43860872|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43860873|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43860879|NCT02918721|Protective Agents|protective agents|mesh-ancestor
44133898|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44133899|NCT00155376|Narcotics|narcotics|mesh-ancestor
44133900|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133901|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133902|NCT00155376|Analgesics|analgesics|mesh-ancestor
44133903|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
44133904|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133905|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133906|NCT00155376|Hormones|hormones|mesh-ancestor
44133907|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860880|NCT02916771|Dexamethasone|dexamethasone|mesh-list
43860881|NCT02916771|Lenalidomide|lenalidomide|mesh-list
43860882|NCT02916771|Ixazomib|ixazomib|mesh-list
43860883|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860884|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
43860885|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
43860886|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860887|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860888|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43860889|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
43860890|NCT02916771|Hormones|hormones|mesh-ancestor
43860891|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860892|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43860893|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860894|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
43860895|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43860896|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43860897|NCT02916771|Growth Substances|growth substances|mesh-ancestor
43860898|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
43860899|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
43860900|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860901|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860902|NCT02915523|Avelumab|avelumab|mesh-list
43860903|NCT02915523|Entinostat|entinostat|mesh-list
43860904|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860905|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860906|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43860907|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364029|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
44364030|NCT01157052|Capecitabine|capecitabine|mesh-list
44364031|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
44364032|NCT01157052|Calcium|calcium|mesh-list
44364033|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44364034|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364035|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44364036|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
44364037|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364038|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364039|NCT01157247|Fentanyl|fentanyl|mesh-list
44364040|NCT01157247|Anesthetics|anesthetics|mesh-list
44364041|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
44364042|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44364043|NCT01157247|Narcotics|narcotics|mesh-ancestor
44364044|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364045|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364046|NCT01157247|Analgesics|analgesics|mesh-ancestor
44364047|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
44364048|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364049|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44364050|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44364051|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
44364052|NCT01157312|Citric Acid|citric acid|mesh-list
44364053|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
44364054|NCT01157312|Clomiphene|clomiphene|mesh-list
44364055|NCT01157312|Enclomiphene|enclomiphene|mesh-list
44364056|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
44364057|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
44364058|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43860908|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860909|NCT02914366|Ambroxol|ambroxol|mesh-list
43860910|NCT02914366|Expectorants|expectorants|mesh-ancestor
43860911|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
43860912|NCT02913196|Prednisone|prednisone|mesh-list
43860913|NCT02913196|Docetaxel|docetaxel|mesh-list
43860914|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
43860915|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860916|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860917|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860918|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860919|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860920|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860921|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
43860922|NCT02913196|Hormones|hormones|mesh-ancestor
43860923|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860924|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860925|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364059|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
44364060|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
44364061|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364062|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44364063|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364064|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364065|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364066|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44364067|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
44364068|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44364069|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44364070|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44364072|NCT01157455|Everolimus|everolimus|mesh-list
44364073|NCT01157455|Heparin|heparin|mesh-list
44364074|NCT01157455|Bivalirudin|bivalirudin|mesh-list
44364075|NCT01157455|Clopidogrel|clopidogrel|mesh-list
44364076|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44364077|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44364078|NCT01157455|Analgesics|analgesics|mesh-ancestor
44364079|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
44364080|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364081|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364082|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860926|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43860927|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860928|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
43860929|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43860930|NCT02912715|Paclitaxel|paclitaxel|mesh-list
43860931|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860932|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860936|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860937|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
43860938|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43860939|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43860940|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860941|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
43860942|NCT02911831|Coagulants|coagulants|mesh-ancestor
43860943|NCT02910700|Nivolumab|nivolumab|mesh-list
43860944|NCT02910700|Trametinib|trametinib|mesh-list
43860945|NCT02910700|Dabrafenib|dabrafenib|mesh-list
44382381|NCT03600909|Fludarabine|fludarabine|mesh-list
43603212|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603213|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43603214|NCT03247998|Remifentanil|remifentanil|mesh-list
43603215|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43860946|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860947|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860948|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43860949|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860950|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43860951|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860952|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
43860953|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
43860954|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364083|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364084|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44364085|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44364086|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364087|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44364088|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44364089|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364091|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364092|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364093|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
44364094|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44364095|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44364096|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44364097|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
44364098|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364099|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
44364100|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
44364101|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44364102|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364103|NCT01157481|Nifedipine|nifedipine|mesh-list
44364104|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44364105|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364106|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364107|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43860955|NCT02910531|Protective Agents|protective agents|mesh-ancestor
43860956|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860957|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
43860958|NCT02910531|Vitamins|vitamins|mesh-ancestor
43860959|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
43860960|NCT02908477|Cisplatin|cisplatin|mesh-list
43860961|NCT02908477|Docetaxel|docetaxel|mesh-list
43860962|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860963|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603219|NCT03247998|Analgesics|analgesics|mesh-ancestor
43603220|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
43603221|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603222|NCT03248076|Fentanyl|fentanyl|mesh-list
43603223|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43824350|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824351|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824352|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43824353|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43824354|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824355|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657476|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43657477|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860964|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860965|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860966|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860967|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
43860968|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860969|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860970|NCT02906761|Aspirin|aspirin|mesh-list
43860971|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43860972|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43860973|NCT02906761|Analgesics|analgesics|mesh-ancestor
43860974|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
43860975|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860976|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860977|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43860978|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364108|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364109|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
44364110|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
44364111|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44364112|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44364113|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44364114|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44364115|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364116|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364117|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44364118|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364119|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364120|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44364121|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364122|NCT01157546|Lidocaine|lidocaine|mesh-list
44364123|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
44364124|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
44364125|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364126|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364127|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
44364128|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364129|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44364130|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44364160|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44364161|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44364162|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364163|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364164|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364165|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44364166|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44364167|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
44364168|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364169|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364170|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44364171|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44364172|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
43860979|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43860980|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43860981|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860982|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43860983|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43860984|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860985|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
43860986|NCT02905799|Resveratrol|resveratrol|mesh-list
43860987|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
43860988|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860989|NCT02905799|Protective Agents|protective agents|mesh-ancestor
43860990|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860991|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860992|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43860993|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
43860994|NCT02905591|Paclitaxel|paclitaxel|mesh-list
43860995|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43860996|NCT02905591|Carboplatin|carboplatin|mesh-list
43860997|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860998|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860999|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861000|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861001|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861002|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861003|NCT02905591|Vitamins|vitamins|mesh-ancestor
43861004|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
43861005|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861013|NCT02905110|Methotrexate|methotrexate|mesh-list
43861014|NCT02905110|Etoposide|etoposide|mesh-list
43861015|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43861016|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
43861017|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43861018|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861019|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824356|NCT05513209|Anesthetics|anesthetics|mesh-list
43824357|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824358|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824359|NCT05513131|Azacitidine|azacitidine|mesh-list
43824360|NCT05513131|Venetoclax|venetoclax|mesh-list
43824361|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
43603224|NCT03248076|Narcotics|narcotics|mesh-ancestor
43603225|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603226|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603227|NCT03248076|Analgesics|analgesics|mesh-ancestor
43825344|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43825345|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43861020|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
43861021|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861022|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861023|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44364173|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
44364174|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44364175|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
44364176|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44364177|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364178|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44364179|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44364180|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44364181|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
44364182|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861024|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861025|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43861026|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861027|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
43861028|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861029|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861030|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861031|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43861032|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43861033|NCT02902484|Nintedanib|nintedanib|mesh-list
43861034|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861035|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861036|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861037|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861038|NCT02902029|Atezolizumab|atezolizumab|mesh-list
43861039|NCT02902029|Vemurafenib|vemurafenib|mesh-list
43861040|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861041|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861042|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861043|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861044|NCT02899052|Dexamethasone|dexamethasone|mesh-list
43861045|NCT02899052|Venetoclax|venetoclax|mesh-list
43861046|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861047|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
43861048|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
43861049|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861050|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861051|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861052|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
43861053|NCT02899052|Hormones|hormones|mesh-ancestor
43861054|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861055|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861056|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861057|NCT02893423|Ropivacaine|ropivacaine|mesh-list
43861058|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
43861059|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
43861060|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43861061|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861062|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
43861063|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861064|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43861065|NCT02893293|Hematinics|hematinics|mesh-ancestor
43861066|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43861067|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43861068|NCT02886962|Vitamin K|vitamin k|mesh-list
43861069|NCT02886962|Vitamins|vitamins|mesh-ancestor
43861070|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
43861071|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861072|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43861073|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43861074|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861075|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
43861076|NCT02886962|Coagulants|coagulants|mesh-ancestor
43861077|NCT02884245|Estrogens|estrogens|mesh-list
43861078|NCT02884245|Hormones|hormones|mesh-ancestor
43861083|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364183|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364184|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44364185|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44364187|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364188|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364189|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44364190|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44364191|NCT01157858|Everolimus|everolimus|mesh-list
44364192|NCT01157858|Octreotide|octreotide|mesh-list
44364193|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364194|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364195|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
44364196|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364197|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364198|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364199|NCT01157936|Allopurinol|allopurinol|mesh-list
44364200|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
44364201|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364202|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364203|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
44364204|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364205|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44364206|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
44364207|NCT01157936|Protective Agents|protective agents|mesh-ancestor
44364208|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364209|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
44364210|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
44364211|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364212|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364213|NCT01157975|Pioglitazone|pioglitazone|mesh-list
44364214|NCT01157975|Prednisone|prednisone|mesh-list
44364215|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364224|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
44364225|NCT01158014|Coagulants|coagulants|mesh-ancestor
44364226|NCT01158105|Bortezomib|bortezomib|mesh-list
44364227|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364228|NCT01158144|Paclitaxel|paclitaxel|mesh-list
44364229|NCT01158144|Carboplatin|carboplatin|mesh-list
44364230|NCT01158144|Endostar protein|endostar protein|mesh-list
44364231|NCT01158144|Endostatins|endostatins|mesh-list
44364232|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364233|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364234|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364235|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364236|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364237|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364238|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44364239|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44364240|NCT01158144|Growth Substances|growth substances|mesh-ancestor
44364241|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364242|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44364243|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44364244|NCT01158170|Gefitinib|gefitinib|mesh-list
44364245|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364246|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364247|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364248|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364249|NCT01158183|Interferons|interferons|mesh-list
44364250|NCT01158183|Interferon-beta|interferon-beta|mesh-list
44364251|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
44364252|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364253|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
44364254|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364255|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
44364256|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364257|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44364258|NCT01158248|Cisplatin|cisplatin|mesh-list
43861085|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
43861086|NCT02880982|Vitamins|vitamins|mesh-ancestor
43861087|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
43861088|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861089|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861090|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43861091|NCT02880020|Nivolumab|nivolumab|mesh-list
43861092|NCT02880020|Ipilimumab|ipilimumab|mesh-list
44364260|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364261|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44364262|NCT01158274|Capecitabine|capecitabine|mesh-list
44364263|NCT01158274|R04929097|r04929097|mesh-list
44364264|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44364265|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
44364266|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364267|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364268|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364269|NCT01158287|Sorafenib|sorafenib|mesh-list
44364270|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364271|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364272|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364273|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019316|NCT03789175|Niacin|niacin|mesh-list
44364275|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44364276|NCT01158365|Protective Agents|protective agents|mesh-ancestor
44364277|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364278|NCT01158560|Vitamin D|vitamin d|mesh-list
44364279|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
44364280|NCT01158560|Vitamins|vitamins|mesh-ancestor
44364281|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
44364282|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364283|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44364284|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44364285|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
44364286|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
44364287|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
44364288|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364289|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364290|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
44364291|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364302|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
44364303|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44364304|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364305|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44364306|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44364307|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364308|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364309|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364310|NCT01158846|Bivalirudin|bivalirudin|mesh-list
44364311|NCT01158846|Abciximab|abciximab|mesh-list
44364312|NCT01158846|Clopidogrel|clopidogrel|mesh-list
44364313|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44364314|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43827712|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
43861093|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861094|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861095|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43861096|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861097|NCT02879617|Durvalumab|durvalumab|mesh-list
43861098|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861099|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861100|NCT02879318|Gemcitabine|gemcitabine|mesh-list
43861101|NCT02879318|Paclitaxel|paclitaxel|mesh-list
43861102|NCT02879318|Durvalumab|durvalumab|mesh-list
43861103|NCT02879318|Tremelimumab|tremelimumab|mesh-list
43861104|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861105|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861106|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861107|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861108|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861109|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861110|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861111|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
43861112|NCT02879318|Antiviral Agents|antiviral agents|mesh-ancestor
43861113|NCT02879318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861114|NCT02879318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861115|NCT02879318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861116|NCT02879318|Immunologic Factors|immunologic factors|mesh-ancestor
43861117|NCT02879318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861118|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861119|NCT02878798|Topiramate|topiramate|mesh-list
43861120|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
43861121|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43861122|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861123|NCT02876211|Vitamin D|vitamin d|mesh-list
43861124|NCT02876211|Vitamins|vitamins|mesh-ancestor
43861125|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
43861126|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861127|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861128|NCT02875223|Itraconazole|itraconazole|mesh-list
43861129|NCT02875223|Rifampin|rifampin|mesh-list
43861130|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
43861131|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
43861132|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861133|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43861134|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43861135|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861136|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861137|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43861138|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364316|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44364317|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44364318|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
44364319|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364320|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364321|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364322|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
44364323|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44364324|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364325|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364326|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
44364327|NCT01158859|Pregabalin|pregabalin|mesh-list
44364328|NCT01158859|Analgesics|analgesics|mesh-ancestor
44364329|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
44364330|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364331|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364332|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
44364333|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43861139|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861140|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861141|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43861142|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43861143|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
43861144|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861145|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
43861146|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861151|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43861152|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43861153|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861154|NCT02873806|Tobramycin|tobramycin|mesh-list
43861155|NCT02873806|Dexamethasone|dexamethasone|mesh-list
43861156|NCT02873806|Travoprost|travoprost|mesh-list
43861157|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861158|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
43861159|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
43861160|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861161|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861162|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861163|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
43861164|NCT02873806|Hormones|hormones|mesh-ancestor
43861165|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861166|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861167|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861168|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43861169|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861170|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861171|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
43861172|NCT02872259|Trametinib|trametinib|mesh-list
43861173|NCT02872259|Dabrafenib|dabrafenib|mesh-list
43861174|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861175|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861176|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861177|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364334|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364335|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364336|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44364337|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44364338|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44364339|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364340|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364341|NCT01158937|Meropenem|meropenem|mesh-list
44364342|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44364343|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364344|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
44364345|NCT01159080|Tacrolimus|tacrolimus|mesh-list
44364346|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364347|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
44019351|NCT03780010|Paclitaxel|paclitaxel|mesh-list
44364348|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364349|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44364350|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382382|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43603238|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43603260|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603261|NCT03247452|Vitamins|vitamins|mesh-ancestor
43603262|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
43603263|NCT03247283|Linrodostat|linrodostat|mesh-list
43603264|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603265|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850327|NCT05681377|Antidotes|antidotes|mesh-ancestor
43850328|NCT05681377|Protective Agents|protective agents|mesh-ancestor
43850329|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850330|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
43850331|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
43848926|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
43848927|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364351|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364352|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44364353|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364354|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44364355|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
44364389|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364390|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364391|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364392|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
44364393|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364394|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364395|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44364396|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
44364397|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44364398|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44364399|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44364400|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44364401|NCT01159236|Growth Substances|growth substances|mesh-ancestor
44364402|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
43861178|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861179|NCT02869789|Nivolumab|nivolumab|mesh-list
43861180|NCT02869789|Ipilimumab|ipilimumab|mesh-list
43861181|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861182|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861183|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43861184|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861185|NCT02865811|Doxorubicin|doxorubicin|mesh-list
43861186|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43861187|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
43861188|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43861189|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861190|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43861191|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43861192|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861193|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861194|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861195|NCT02864914|Empagliflozin|empagliflozin|mesh-list
43861196|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43861197|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43861198|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861199|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43861200|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861201|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
43861202|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861203|NCT02862132|Vedolizumab|vedolizumab|mesh-list
43861204|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861205|NCT02861300|Capecitabine|capecitabine|mesh-list
43861206|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861207|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
43861208|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861209|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861210|NCT02859402|Fludarabine|fludarabine|mesh-list
43861211|NCT02859402|Busulfan|busulfan|mesh-list
43861212|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364403|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44364404|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44364405|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44364406|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364407|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
44364408|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44364410|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44364411|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44364412|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
43603266|NCT03247140|Amlodipine|amlodipine|mesh-list
44364413|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364414|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364415|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44364416|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44364417|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
44364418|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364419|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44364420|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44364421|NCT01159301|Sorafenib|sorafenib|mesh-list
44019431|NCT03758365|Hormones|hormones|mesh-ancestor
44364422|NCT01159301|Entinostat|entinostat|mesh-list
44364423|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44364424|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364425|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364426|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364427|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861213|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861214|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861215|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
43861216|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861217|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
43861218|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861219|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44133908|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44133909|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
44133910|NCT00155402|Coagulants|coagulants|mesh-ancestor
44133911|NCT00155558|Leucovorin|leucovorin|mesh-list
44133912|NCT00155558|Fluorouracil|fluorouracil|mesh-list
44133913|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
44133914|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133915|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133916|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133917|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133918|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
44133919|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133920|NCT00155558|Antidotes|antidotes|mesh-ancestor
44133921|NCT00155558|Protective Agents|protective agents|mesh-ancestor
44364429|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364430|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364431|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364432|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364433|NCT01159353|Insulin|insulin|mesh-list
44364434|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44364435|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
44364436|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
44364437|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364438|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364439|NCT01159379|Ertapenem|ertapenem|mesh-list
44364440|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44364441|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364442|NCT01159418|Paclitaxel|paclitaxel|mesh-list
44364443|NCT01159418|Carboplatin|carboplatin|mesh-list
44364444|NCT01159418|Panobinostat|panobinostat|mesh-list
44364445|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43848931|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848933|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848934|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848935|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43850333|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848936|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43848937|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364446|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364447|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364448|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364449|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364450|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364451|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44364452|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364453|NCT01159548|Promethazine|promethazine|mesh-list
44364454|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
44364455|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
44364456|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
44364457|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44364458|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
44364459|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
44364460|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364461|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364462|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364463|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44364464|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44364465|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44133922|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133923|NCT00155558|Vitamins|vitamins|mesh-ancestor
44364466|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364468|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
44364469|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
44364470|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364471|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
44364472|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
44364473|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364474|NCT01159587|Factor VIII|factor viii|mesh-list
44364475|NCT01159587|Coagulants|coagulants|mesh-ancestor
44364476|NCT01159639|Clopidogrel|clopidogrel|mesh-list
44364477|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44364478|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44364479|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44364480|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44364481|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
44364482|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364483|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364484|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364485|NCT01159652|Zaleplon|zaleplon|mesh-list
44364486|NCT01159652|Zolpidem|zolpidem|mesh-list
44364487|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44364488|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43676742|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
44133924|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
43603275|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603276|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603277|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43603278|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43603279|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
43603280|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43603281|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43850336|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850337|NCT05654298|Sumatriptan|sumatriptan|mesh-list
43850338|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43850339|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43850340|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43850341|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
44133925|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
44133926|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
44133927|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
44133928|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44133929|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44133930|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133931|NCT00155714|Urological Agents|urological agents|mesh-ancestor
44155661|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155662|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155663|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
44155664|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155665|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155666|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155667|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155668|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44155669|NCT00227812|Bupropion|bupropion|mesh-list
44155670|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44155671|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
43861221|NCT02856893|Osimertinib|osimertinib|mesh-list
43861222|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861223|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861224|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861225|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861226|NCT02856581|Varenicline|varenicline|mesh-list
44364490|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364491|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44364492|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
44364493|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
44364494|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364495|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364496|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
44364497|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
43676764|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
43861227|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43861228|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43861229|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861230|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861231|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861232|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861233|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
43861234|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43861235|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43861236|NCT02849899|Vildagliptin|vildagliptin|mesh-list
43861237|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43861238|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861239|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43861240|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
43861241|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861242|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861243|NCT02849639|Scopolamine|scopolamine|mesh-list
43603282|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603283|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43603284|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43861244|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43861245|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43861246|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
43861247|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
43861248|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861249|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861250|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861251|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
43861252|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43861253|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861254|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861258|NCT02849470|Complement Factor H|complement factor h|mesh-list
43861259|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43861260|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861261|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
43861262|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861263|NCT02848560|Xenon|xenon|mesh-list
43861264|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43861265|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
43861266|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
43861267|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43861268|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861269|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
43861270|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43861271|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43861272|NCT02846623|Atezolizumab|atezolizumab|mesh-list
43861273|NCT02846623|Venetoclax|venetoclax|mesh-list
43861274|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
43861275|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43861276|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861277|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
43861278|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861279|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861280|NCT02846376|Nivolumab|nivolumab|mesh-list
43861281|NCT02846376|Ipilimumab|ipilimumab|mesh-list
43861282|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861283|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861284|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44364498|NCT01159821|Paroxetine|paroxetine|mesh-list
44364499|NCT01159821|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44364500|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44364501|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364502|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364503|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364504|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
44364505|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382383|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
43824364|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824365|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824366|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824367|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824368|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43824369|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43657492|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43657493|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
43657494|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657495|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364506|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44364507|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
43861285|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861286|NCT02844816|Atezolizumab|atezolizumab|mesh-list
43861287|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43861288|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861289|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
43861290|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861291|NCT02842749|Everolimus|everolimus|mesh-list
43861292|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861293|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861294|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
43861295|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861296|NCT02839642|Rivastigmine|rivastigmine|mesh-list
43861297|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43861298|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861299|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861300|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861301|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861302|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861303|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43861304|NCT02839642|Protective Agents|protective agents|mesh-ancestor
43861305|NCT02835131|Pasireotide|pasireotide|mesh-list
43861306|NCT02835131|Hormones|hormones|mesh-ancestor
43861307|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861308|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861309|NCT02834975|Paclitaxel|paclitaxel|mesh-list
43861310|NCT02834975|Carboplatin|carboplatin|mesh-list
43861311|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
43861312|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861313|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861314|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861315|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861316|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861317|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861318|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861319|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
43861320|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
43861321|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43861322|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43861323|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861324|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861325|NCT02832570|Urological Agents|urological agents|mesh-ancestor
43603316|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43603317|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43603318|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
43603320|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43603321|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43603322|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
43603323|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603324|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603325|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657498|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43861326|NCT02827201|Gemcitabine|gemcitabine|mesh-list
43861329|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861331|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861332|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861333|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861334|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861335|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
43861336|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
43861337|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861338|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861339|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861340|NCT02827201|Immunologic Factors|immunologic factors|mesh-ancestor
44364508|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364509|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44364510|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44364511|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364512|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44364513|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364514|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364516|NCT01159847|Hormones|hormones|mesh-ancestor
44364517|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364518|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44364519|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364520|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364521|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364522|NCT01160029|Nateglinide|nateglinide|mesh-list
44364523|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364524|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364525|NCT01160042|Metformin|metformin|mesh-list
44364526|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364527|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364528|NCT01160068|Metformin|metformin|mesh-list
44364529|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44364530|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019596|NCT03565328|Niacin|niacin|mesh-list
44364531|NCT01160172|Vaccines|vaccines|mesh-list
44364532|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
44364533|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364534|NCT01160185|Paclitaxel|paclitaxel|mesh-list
44364535|NCT01160185|Cisplatin|cisplatin|mesh-list
44364536|NCT01160185|Topotecan|topotecan|mesh-list
44364537|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364538|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364539|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364540|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364541|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
43676783|NCT02873091|Analgesics|analgesics|mesh-ancestor
43861341|NCT02827201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861342|NCT02824276|Morphine|morphine|mesh-list
43861343|NCT02824276|Oxycodone|oxycodone|mesh-list
43861344|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43861345|NCT02824276|Narcotics|narcotics|mesh-ancestor
44364542|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364543|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44364544|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44364545|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364546|NCT01160276|Cyclosporine|cyclosporine|mesh-list
44364547|NCT01160276|Colchicine|colchicine|mesh-list
44364548|NCT01160276|Tacrolimus|tacrolimus|mesh-list
44364549|NCT01160276|Cyclosporins|cyclosporins|mesh-list
44364550|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861346|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43861347|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861348|NCT02824276|Analgesics|analgesics|mesh-ancestor
43861349|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
43861350|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861351|NCT02823353|Fenofibrate|fenofibrate|mesh-list
43861352|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43861353|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
43861354|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861355|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43861356|NCT02822573|Donepezil|donepezil|mesh-list
43861357|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43861358|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861359|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861360|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861361|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861362|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861363|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
43861364|NCT02822378|Vitamin D|vitamin d|mesh-list
43861365|NCT02822378|Calcium|calcium|mesh-list
43861366|NCT02822378|Vitamins|vitamins|mesh-ancestor
43861367|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
43861368|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861369|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43861370|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861371|NCT02819596|Durvalumab|durvalumab|mesh-list
43861372|NCT02819596|Tremelimumab|tremelimumab|mesh-list
43861373|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861374|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861375|NCT02818894|Lidocaine|lidocaine|mesh-list
43861376|NCT02818894|Bupivacaine|bupivacaine|mesh-list
43861377|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
43861378|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
43861379|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43861380|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861381|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
43861382|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861383|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43861384|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43861385|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43861386|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43861387|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861389|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
43861390|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861391|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43861392|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43861393|NCT02811510|Analgesics|analgesics|mesh-ancestor
43861394|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
43861395|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861396|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43861397|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43861398|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861399|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861400|NCT02811510|Hormones|hormones|mesh-ancestor
43861404|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861405|NCT02808871|Pirfenidone|pirfenidone|mesh-list
43861406|NCT02808871|Analgesics|analgesics|mesh-ancestor
43861407|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
44364551|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
44364552|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364553|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44364554|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364555|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364556|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
44364557|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364558|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
44364559|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364560|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
44364561|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364562|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364563|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364564|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364565|NCT01160302|Curcumin|curcumin|mesh-list
44364566|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44364567|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44364568|NCT01160302|Analgesics|analgesics|mesh-ancestor
44364569|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
44364570|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364571|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364572|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364573|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364574|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364575|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364576|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364577|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44364578|NCT01160315|Norethindrone|norethindrone|mesh-list
44364579|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
44364580|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
44364581|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44364582|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
44364583|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44364584|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364585|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43676826|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861408|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364586|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364588|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44364589|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44364590|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44364591|NCT01160328|Leuprolide|leuprolide|mesh-list
44364592|NCT01160328|Testosterone|testosterone|mesh-list
44364593|NCT01160328|Androgens|androgens|mesh-ancestor
44364594|NCT01160328|Hormones|hormones|mesh-ancestor
44364595|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364596|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364597|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364598|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364599|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44364600|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
44364601|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44364602|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
44364603|NCT01160341|Testosterone|testosterone|mesh-list
44364604|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
44364605|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
44019654|NCT03426137|Ketorolac|ketorolac|mesh-list
44364606|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44364607|NCT01160341|Androgens|androgens|mesh-ancestor
44364608|NCT01160341|Hormones|hormones|mesh-ancestor
44364609|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364610|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364611|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364612|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364614|NCT01160419|Leucovorin|leucovorin|mesh-list
44364634|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364635|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
44364636|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364637|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44364639|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364640|NCT01160432|Analgesics|analgesics|mesh-ancestor
44364641|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
44364642|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
44364643|NCT01160588|Sertraline|sertraline|mesh-list
43603367|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603368|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43657513|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
43827733|NCT05485883|Lenvatinib|lenvatinib|mesh-list
43861409|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861410|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43861411|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43861412|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861413|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861414|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133932|NCT00155883|Leucovorin|leucovorin|mesh-list
44133933|NCT00155883|Fluorouracil|fluorouracil|mesh-list
44133934|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
44133935|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133936|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133937|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133938|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133939|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
44133940|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133941|NCT00155883|Antidotes|antidotes|mesh-ancestor
44133942|NCT00155883|Protective Agents|protective agents|mesh-ancestor
44133943|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
44133944|NCT00155883|Vitamins|vitamins|mesh-ancestor
44133945|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
44133946|NCT00156078|Pregabalin|pregabalin|mesh-list
44133947|NCT00156078|Analgesics|analgesics|mesh-ancestor
44133948|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
44133949|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133950|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133951|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
44133952|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44133953|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133954|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133955|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44133956|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44133957|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133958|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133959|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44133960|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
44133961|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133962|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44133963|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861415|NCT02798536|Paclitaxel|paclitaxel|mesh-list
43861416|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861417|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861418|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861419|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861420|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861421|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861422|NCT02795156|Afatinib|afatinib|mesh-list
43861423|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861424|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861425|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861426|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861427|NCT02794428|Eflornithine|eflornithine|mesh-list
43861428|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861429|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43861430|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44364645|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364646|NCT01160588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44364647|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44364648|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364649|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364650|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364651|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
44364652|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364653|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
44364654|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44364655|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
43603371|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43603372|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
44364656|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364657|NCT01160627|Expectorants|expectorants|mesh-ancestor
44364658|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
44364659|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44364660|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
44364661|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364662|NCT01160627|Protective Agents|protective agents|mesh-ancestor
43861431|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43861432|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861433|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43861434|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861435|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861436|NCT02792257|Dronabinol|dronabinol|mesh-list
43861437|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
43861438|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861439|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43861440|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43861445|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43861446|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861447|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861448|NCT02792257|Hormones|hormones|mesh-ancestor
43861449|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861450|NCT02792088|Tenofovir|tenofovir|mesh-list
43861451|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
43861452|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861453|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43861454|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861455|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861456|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861457|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43861458|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43861459|NCT02790710|Propranolol|propranolol|mesh-list
43861460|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43861461|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43861462|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
43861463|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861464|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861465|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861466|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43861467|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44364663|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364665|NCT01160666|Belimumab|belimumab|mesh-list
44364666|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364667|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
44364668|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364669|NCT01160705|Docetaxel|docetaxel|mesh-list
44364670|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364671|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364672|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364673|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364674|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364675|NCT01160718|Fulvestrant|fulvestrant|mesh-list
44364676|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364677|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364678|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44364679|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44364680|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364681|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364682|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364683|NCT01160731|Cisplatin|cisplatin|mesh-list
44364684|NCT01160731|Etoposide|etoposide|mesh-list
44364685|NCT01160731|Panobinostat|panobinostat|mesh-list
44364686|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
44364687|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364688|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364689|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44364690|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44364691|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364692|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364707|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364708|NCT01160952|Itraconazole|itraconazole|mesh-list
44364709|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
44364710|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364711|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44364712|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44364713|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861468|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
43861469|NCT02789878|Prednisone|prednisone|mesh-list
43861470|NCT02789878|Goserelin|goserelin|mesh-list
43861471|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861472|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
43861473|NCT02789878|Hormones|hormones|mesh-ancestor
43861474|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861475|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861476|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861477|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861478|NCT02788708|Paclitaxel|paclitaxel|mesh-list
43861479|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43861480|NCT02788708|Lenvatinib|lenvatinib|mesh-list
43861481|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861482|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861483|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861484|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861485|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861486|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861487|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861488|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861490|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861491|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861492|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43861493|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861494|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861495|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861496|NCT02783625|Bortezomib|bortezomib|mesh-list
43861497|NCT02783625|Romidepsin|romidepsin|mesh-list
43861498|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861499|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43861500|NCT02782663|Upadacitinib|upadacitinib|mesh-list
43861501|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43861502|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861503|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861504|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861505|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861523|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861524|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
43861525|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861526|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861527|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861528|NCT02780128|Ceritinib|ceritinib|mesh-list
43861529|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364714|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364715|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44364716|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
44364717|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364718|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364719|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44364720|NCT01160965|Ropivacaine|ropivacaine|mesh-list
44364721|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
44364722|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
44364723|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
44364724|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364725|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364726|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
44364727|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364728|NCT01160978|Simvastatin|simvastatin|mesh-list
43861530|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43861531|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861532|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861533|NCT02780024|Metformin|metformin|mesh-list
43861534|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43861535|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861536|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
43861537|NCT02779751|Anastrozole|anastrozole|mesh-list
43861538|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861539|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861540|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861541|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43861542|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43861543|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861544|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861545|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43861546|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
43861547|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861548|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861549|NCT02777385|Cisplatin|cisplatin|mesh-list
43861550|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
43861551|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861552|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861553|NCT02775695|Doxycycline|doxycycline|mesh-list
43861554|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861555|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861556|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
43861557|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43861558|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43861559|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
43861560|NCT02773732|Etoposide|etoposide|mesh-list
43861561|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861562|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861563|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43861564|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43861565|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861566|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861567|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861568|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861569|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43861570|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43861571|NCT02772081|Poractant alfa|poractant alfa|mesh-list
44364730|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44364731|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
44364732|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364733|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44364734|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43603383|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603411|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603413|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44364735|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364736|NCT01160991|Olanzapine|olanzapine|mesh-list
44364737|NCT01160991|Amisulpride|amisulpride|mesh-list
44364738|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
44364739|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
44364740|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364741|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364742|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364743|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44364744|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43861572|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43861573|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
43861574|NCT02772003|Interleukin-12|interleukin-12|mesh-list
43861575|NCT02772003|Vaccines|vaccines|mesh-list
43861576|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
43861577|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861578|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43861579|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43861580|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43861581|NCT02772003|Growth Substances|growth substances|mesh-ancestor
43861582|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
43861583|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861584|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
43861585|NCT02771197|Fludarabine|fludarabine|mesh-list
43861586|NCT02771197|Melphalan|melphalan|mesh-list
43861590|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861591|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
43861592|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861593|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861594|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
43603422|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603424|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603425|NCT03246113|Temozolomide|temozolomide|mesh-list
43603426|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43603427|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
43603428|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603429|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603430|NCT03245853|Riboflavin|riboflavin|mesh-list
43603447|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
43603448|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603449|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603450|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603451|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
43603452|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
43603453|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603454|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43603455|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43657531|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43657532|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657533|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43861595|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43861596|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
43861597|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861598|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861600|NCT02766465|Methotrexate|methotrexate|mesh-list
43861601|NCT02766465|Fludarabine|fludarabine|mesh-list
43861602|NCT02766465|Melphalan|melphalan|mesh-list
43861603|NCT02766465|Busulfan|busulfan|mesh-list
43861604|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
43861605|NCT02766465|Tacrolimus|tacrolimus|mesh-list
43861606|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43861607|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
43861608|NCT02766465|Lenograstim|lenograstim|mesh-list
43861609|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43861610|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
43861611|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43861612|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861613|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861614|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
43861615|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861616|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861617|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
43861618|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861619|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44364745|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364746|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364747|NCT01160991|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44364748|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44364749|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364750|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364751|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364752|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
44364753|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44364754|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
44364755|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44364756|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
44019757|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364757|NCT01161017|Topiramate|topiramate|mesh-list
44364758|NCT01161017|Amitriptyline|amitriptyline|mesh-list
44364759|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
44364760|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676958|NCT02872064|Verteporfin|verteporfin|mesh-list
43861620|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861621|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
43861622|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861623|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861624|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43861625|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43861626|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861627|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43861628|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
43861629|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43603456|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43603457|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603458|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603459|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
43603462|NCT03245996|Atenolol|atenolol|mesh-list
43861630|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
43861631|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43861632|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43861633|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861634|NCT02763319|Rituximab|rituximab|mesh-list
43861635|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43861636|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861637|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861638|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
43861639|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861640|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861641|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861642|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
43861643|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861644|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
43861645|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861646|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
43861648|NCT02757885|Fludarabine|fludarabine|mesh-list
43861649|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
43861650|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
43861651|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43861652|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
43861653|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861654|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
43861655|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861656|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861657|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861658|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
43861665|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364761|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364762|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44364763|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
44364764|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364765|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44364766|NCT01161017|Analgesics|analgesics|mesh-ancestor
44364767|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
44364768|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364769|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44364770|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44364771|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364772|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364773|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44364774|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364775|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
44364776|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44364777|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44364778|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364779|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364780|NCT01161108|Melatonin|melatonin|mesh-list
44364781|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
44364782|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364783|NCT01161108|Protective Agents|protective agents|mesh-ancestor
44364784|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861666|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861667|NCT02757859|Pancrelipase|pancrelipase|mesh-list
43861668|NCT02757859|Pancreatin|pancreatin|mesh-list
43861669|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861670|NCT02756962|Cytarabine|cytarabine|mesh-list
43861671|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861672|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
43861673|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861674|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861675|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
43861676|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382384|NCT03600909|Lenograstim|lenograstim|mesh-list
43861677|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861678|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
43861679|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861680|NCT02755597|Dexamethasone|dexamethasone|mesh-list
43861681|NCT02755597|Bortezomib|bortezomib|mesh-list
43861682|NCT02755597|Venetoclax|venetoclax|mesh-list
43861683|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861684|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
43861685|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
43861686|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364785|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364787|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44364788|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44364789|NCT01161134|Analgesics|analgesics|mesh-ancestor
44364790|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
44364791|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364792|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364793|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364794|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364795|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44364796|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44364797|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364798|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364799|NCT01161147|Meloxicam|meloxicam|mesh-list
44364800|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44364801|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44364802|NCT01161147|Analgesics|analgesics|mesh-ancestor
44364803|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
44364804|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364805|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364806|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364807|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44364808|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44364809|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44364810|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364811|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364812|NCT01161186|Gemcitabine|gemcitabine|mesh-list
44364813|NCT01161186|Paclitaxel|paclitaxel|mesh-list
44364814|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44364815|NCT01161186|Capecitabine|capecitabine|mesh-list
44364818|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
44019831|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
44364828|NCT01161186|Immunologic Factors|immunologic factors|mesh-ancestor
44364829|NCT01161186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364830|NCT01161277|Haloperidol|haloperidol|mesh-list
44364831|NCT01161277|Aripiprazole|aripiprazole|mesh-list
44364832|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
44364833|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
44364834|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44364835|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44364836|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44364837|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44364838|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364839|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
44364840|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
44364841|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364842|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364843|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44364844|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43861687|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861688|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861689|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
43657553|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
43657554|NCT02952573|Hormones|hormones|mesh-ancestor
43657555|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657556|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657557|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861690|NCT02755597|Hormones|hormones|mesh-ancestor
43861691|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861692|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861693|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861694|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43861695|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43861696|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861697|NCT02753686|Tamoxifen|tamoxifen|mesh-list
43861698|NCT02753686|Everolimus|everolimus|mesh-list
43861699|NCT02753686|Letrozole|letrozole|mesh-list
43861700|NCT02753686|Fulvestrant|fulvestrant|mesh-list
43861701|NCT02753686|Anastrozole|anastrozole|mesh-list
43861702|NCT02753686|Exemestane|exemestane|mesh-list
43861703|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861704|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861705|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
43861706|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861707|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43861708|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43861709|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861710|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861711|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43861712|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
43861713|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861714|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43861715|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43861716|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43861717|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861718|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44364845|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
44364846|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44364847|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44364848|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44364849|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44364850|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
44364851|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
44364852|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364853|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364854|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44364855|NCT01161316|Cetuximab|cetuximab|mesh-list
44364856|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44364857|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364858|NCT01161368|Vinorelbine|vinorelbine|mesh-list
44364859|NCT01161368|Lapatinib|lapatinib|mesh-list
43677069|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43861719|NCT02753283|Vitamin D|vitamin d|mesh-list
43861720|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
43861721|NCT02753283|Denosumab|denosumab|mesh-list
43861722|NCT02753283|Calcium|calcium|mesh-list
43861723|NCT02753283|Vitamins|vitamins|mesh-ancestor
43861724|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
43861725|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861726|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43861747|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861749|NCT02748369|Glucagon|glucagon|mesh-list
43861750|NCT02748369|Hormones|hormones|mesh-list
43861751|NCT02748369|Somatostatin|somatostatin|mesh-list
43861752|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861753|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861754|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43861755|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43861756|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43861757|NCT02744612|Antibodies|antibodies|mesh-list
43861758|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
43861759|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43861760|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
43861761|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
43861762|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861763|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133964|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133965|NCT00156299|Dexamethasone|dexamethasone|mesh-list
43657558|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
44133966|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
44133967|NCT00156299|Choline|choline|mesh-list
44133968|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44133969|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
44133970|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
44133971|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133972|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133973|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44133974|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
44133975|NCT00156299|Hormones|hormones|mesh-ancestor
44133976|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44133977|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44133978|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133979|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
44133980|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44133982|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133983|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44133984|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
44133985|NCT00156299|Analgesics|analgesics|mesh-ancestor
44364860|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44364861|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364862|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364863|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44364864|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44364865|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364866|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364867|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364868|NCT01161459|Prednisone|prednisone|mesh-list
44364869|NCT01161459|Tacrolimus|tacrolimus|mesh-list
44364870|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364871|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
43603469|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603470|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43603471|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43603472|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43603473|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603474|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603475|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657560|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657561|NCT02952599|Edoxaban|edoxaban|mesh-list
43657562|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43657563|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
43827092|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44364872|NCT01161459|Hormones|hormones|mesh-ancestor
44364873|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364874|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364875|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364876|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364877|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44133986|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
44133987|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44133988|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44133989|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861764|NCT02743598|Liraglutide|liraglutide|mesh-list
43861765|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43861766|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861767|NCT02743598|Incretins|incretins|mesh-ancestor
43861768|NCT02743598|Hormones|hormones|mesh-ancestor
43861769|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861770|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
43861771|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
43861772|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43861773|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
43861774|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861775|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
43861776|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861777|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861778|NCT02741323|Maraviroc|maraviroc|mesh-list
43861779|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43861780|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43861781|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861782|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43861783|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43861784|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
43861785|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861786|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43861787|NCT02740595|Nicotine|nicotine|mesh-list
43861788|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43861789|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
43861790|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861791|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861792|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43861793|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43603476|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603477|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43861794|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861795|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861796|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861797|NCT02737787|Nivolumab|nivolumab|mesh-list
43861798|NCT02737787|Vaccines|vaccines|mesh-list
44364879|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44364880|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364881|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364882|NCT01161550|Cytarabine|cytarabine|mesh-list
44364883|NCT01161550|Tretinoin|tretinoin|mesh-list
44364884|NCT01161550|Cladribine|cladribine|mesh-list
44364885|NCT01161550|Midostaurin|midostaurin|mesh-list
44364886|NCT01161550|Lenograstim|lenograstim|mesh-list
44364887|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44364888|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
44364889|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364890|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364891|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
44364892|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44364893|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44364894|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
44364895|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364896|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44364897|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
44364898|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44364899|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44364900|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364901|NCT01161654|Naratriptan|naratriptan|mesh-list
44364902|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44364903|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44364904|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44364905|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
44364906|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364907|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861799|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
43861800|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861801|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861802|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861803|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43861804|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861805|NCT02735122|Acetaminophen|acetaminophen|mesh-list
43861806|NCT02735122|Ibuprofen|ibuprofen|mesh-list
43861807|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43861808|NCT02735122|Analgesics|analgesics|mesh-ancestor
43861809|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
43861810|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861811|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861812|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
44364908|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364910|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44364911|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44364912|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44364913|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
44364914|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364915|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364916|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364917|NCT01161836|Iniparib|iniparib|mesh-list
44364918|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44364919|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44364920|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364921|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364922|NCT01161888|Imiquimod|imiquimod|mesh-list
44364923|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44364924|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
44364925|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364926|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364927|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
44364928|NCT01161927|Nizatidine|nizatidine|mesh-list
44364929|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44364930|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364931|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44364932|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
43861813|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43861814|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43861815|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861816|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43861817|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861818|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861819|NCT02734004|Bevacizumab|bevacizumab|mesh-list
43861820|NCT02734004|Durvalumab|durvalumab|mesh-list
43861821|NCT02734004|Olaparib|olaparib|mesh-list
43861822|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861823|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861824|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43861825|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43861826|NCT02734004|Growth Substances|growth substances|mesh-ancestor
43861827|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861828|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
43861829|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43861832|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
43861833|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43861834|NCT02730715|Basiliximab|basiliximab|mesh-list
43861835|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
43861836|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861837|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861838|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
43861839|NCT02730546|Leucovorin|leucovorin|mesh-list
43861840|NCT02730546|Folic Acid|folic acid|mesh-list
43861841|NCT02730546|Paclitaxel|paclitaxel|mesh-list
44364933|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
44364934|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364935|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364936|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364937|NCT01161940|Nizatidine|nizatidine|mesh-list
44364938|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44364939|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364940|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44364941|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
44364942|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
44364943|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364944|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364945|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861842|NCT02730546|Carboplatin|carboplatin|mesh-list
43861843|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
43861844|NCT02730546|Fluorouracil|fluorouracil|mesh-list
43861845|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
43861846|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43861847|NCT02730546|Calcium|calcium|mesh-list
43861848|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
43861849|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861850|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861851|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861852|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861853|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861854|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861855|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603529|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603530|NCT03245385|Halobetasol|halobetasol|mesh-list
43603531|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43603532|NCT03245333|Hormones|hormones|mesh-list
43603534|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861856|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861857|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861858|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861859|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
43861860|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861861|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861862|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
43861863|NCT02730546|Antidotes|antidotes|mesh-ancestor
43861864|NCT02730546|Protective Agents|protective agents|mesh-ancestor
43861865|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
43861866|NCT02730546|Vitamins|vitamins|mesh-ancestor
43861867|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
43861868|NCT02730546|Hematinics|hematinics|mesh-ancestor
43861869|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
43861870|NCT02727387|Temozolomide|temozolomide|mesh-list
43861871|NCT02727387|Melphalan|melphalan|mesh-list
43861872|NCT02727387|Busulfan|busulfan|mesh-list
43861873|NCT02727387|Ifosfamide|ifosfamide|mesh-list
43861874|NCT02727387|Irinotecan|irinotecan|mesh-list
43861875|NCT02727387|Etoposide|etoposide|mesh-list
43861876|NCT02727387|Vincristine|vincristine|mesh-list
43861877|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861878|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
43861879|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861880|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861881|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861882|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
43861883|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861884|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861885|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43861886|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43861887|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43861888|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861889|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861890|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43861891|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44364948|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44364949|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364950|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364951|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44364952|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364953|NCT01161979|Zonisamide|zonisamide|mesh-list
44364954|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
44364955|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44364956|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44364957|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364958|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44364959|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364960|NCT01162031|Bortezomib|bortezomib|mesh-list
44364961|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364962|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44364963|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
44364964|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44364965|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44364966|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43861892|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861893|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861894|NCT02726711|Trimethaphan|trimethaphan|mesh-list
43861895|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
43861896|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43850382|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657574|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43657575|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657577|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
43861897|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43861898|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43861899|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
43861900|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861901|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861902|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43861903|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43861904|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861905|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861909|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
43861910|NCT02725424|Trastuzumab|trastuzumab|mesh-list
43861911|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861912|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861913|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861914|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861915|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861916|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861917|NCT02725060|Phenylephrine|phenylephrine|mesh-list
43861918|NCT02725060|Isoproterenol|isoproterenol|mesh-list
43861919|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
43861920|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43861921|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
43861922|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
43861923|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861924|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364967|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364968|NCT01162603|Latanoprost|latanoprost|mesh-list
44364969|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44364970|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44364971|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
44364972|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44364973|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44364974|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
44364975|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44364976|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44364977|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364978|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
44364979|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
43861925|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
43861926|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43603539|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603540|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603566|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603567|NCT03244774|Paclitaxel|paclitaxel|mesh-list
43603568|NCT03244774|Fluorouracil|fluorouracil|mesh-list
43603569|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
43603570|NCT03244774|Apatinib|apatinib|mesh-list
43603571|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43603572|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850383|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657582|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43657583|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657584|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43657585|NCT02952157|Lidocaine|lidocaine|mesh-list
43861927|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
43861928|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
43861929|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43861930|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43861931|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43861932|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
43861933|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861934|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861935|NCT02725060|Protective Agents|protective agents|mesh-ancestor
43861936|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43861937|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43861938|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43861939|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
43861940|NCT02724579|Lomustine|lomustine|mesh-list
43861941|NCT02724579|Cisplatin|cisplatin|mesh-list
43861942|NCT02724579|Vincristine|vincristine|mesh-list
43861943|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43861944|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
43861945|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861946|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43861947|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43861948|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
43861949|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861950|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861951|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43861952|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861953|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861954|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861955|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861956|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
43861957|NCT02723162|Varenicline|varenicline|mesh-list
43861958|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43861959|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43861960|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43861961|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
43861962|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43861963|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861964|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861965|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
43861966|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861967|NCT02723162|Expectorants|expectorants|mesh-ancestor
43861968|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
43861969|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43861970|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
43861971|NCT02723162|Protective Agents|protective agents|mesh-ancestor
43861972|NCT02723162|Antidotes|antidotes|mesh-ancestor
43861973|NCT02721537|Niacinamide|niacinamide|mesh-list
43861974|NCT02721537|Niacin|niacin|mesh-list
44364981|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
44364982|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44364983|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
44364984|NCT01162746|Dexamethasone|dexamethasone|mesh-list
44364985|NCT01162746|Ranibizumab|ranibizumab|mesh-list
44364986|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44364987|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
44364988|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
44364989|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44364990|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44364991|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44364992|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
44364993|NCT01162746|Hormones|hormones|mesh-ancestor
44364994|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44364995|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44364996|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44364997|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44364998|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44364999|NCT01162746|Growth Substances|growth substances|mesh-ancestor
44365000|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
43861975|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
43861976|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
43861977|NCT02721537|Vitamins|vitamins|mesh-ancestor
43861978|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
43861979|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861980|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43861981|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
43861982|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861983|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43861984|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
43861985|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43861986|NCT02720094|Cabotegravir|cabotegravir|mesh-list
43861987|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43861988|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43861989|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861990|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861991|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
43861992|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43861993|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43861994|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43861995|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43861996|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43861997|NCT02720068|Leucovorin|leucovorin|mesh-list
43861998|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
43861999|NCT02720068|Fluorouracil|fluorouracil|mesh-list
43862000|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
43862001|NCT02720068|Irinotecan|irinotecan|mesh-list
43862002|NCT02720068|Lenvatinib|lenvatinib|mesh-list
43862003|NCT02720068|Calcium|calcium|mesh-list
43862004|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
43862005|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43862006|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603583|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603585|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43603586|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43862007|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365003|NCT01162824|Analgesics|analgesics|mesh-ancestor
44365004|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
44365005|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365006|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365007|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44365008|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
44365009|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44365010|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
44365011|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
44365012|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365013|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365014|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44365015|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
44365016|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44365017|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
44365018|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365019|NCT01162902|Candesartan|candesartan|mesh-list
44365020|NCT01162902|Bisoprolol|bisoprolol|mesh-list
44365021|NCT01162902|Diltiazem|diltiazem|mesh-list
44365022|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365023|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44365024|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44365025|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365026|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
44365027|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
44365028|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365029|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365030|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43862008|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862009|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
43862010|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862011|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862012|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862013|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
43862014|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43862015|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43862016|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862017|NCT02720068|Antidotes|antidotes|mesh-ancestor
43862018|NCT02720068|Protective Agents|protective agents|mesh-ancestor
43862019|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
43862020|NCT02720068|Vitamins|vitamins|mesh-ancestor
43862021|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
43862022|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43862023|NCT02719613|Dexamethasone|dexamethasone|mesh-list
44365031|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43603627|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603630|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
44365032|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44365033|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44365034|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365035|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44365036|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365037|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44365038|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
44365039|NCT01162941|Prednisolone|prednisolone|mesh-list
44365040|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365041|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
44365042|NCT01162941|Hormones|hormones|mesh-ancestor
44365043|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862024|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
43862025|NCT02719613|Nivolumab|nivolumab|mesh-list
43862026|NCT02719613|Lenalidomide|lenalidomide|mesh-list
43862027|NCT02719613|Bortezomib|bortezomib|mesh-list
43862028|NCT02719613|Pomalidomide|pomalidomide|mesh-list
43862029|NCT02719613|Elotuzumab|elotuzumab|mesh-list
43862030|NCT02719613|BB 1101|bb 1101|mesh-list
43862031|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862032|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
43862033|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
43862034|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862035|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862036|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862037|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
43862038|NCT02719613|Hormones|hormones|mesh-ancestor
43862039|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862040|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862041|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862042|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
43862043|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862044|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862045|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862046|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43862047|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
43862048|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43862049|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43862050|NCT02719613|Growth Substances|growth substances|mesh-ancestor
43862051|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
43862052|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43862053|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43862054|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43862055|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43862056|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862060|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43862061|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862062|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
43862063|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43862064|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
43862065|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862066|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862067|NCT02716974|Docetaxel|docetaxel|mesh-list
43862068|NCT02716974|Leuprolide|leuprolide|mesh-list
43862069|NCT02716974|Bicalutamide|bicalutamide|mesh-list
43862070|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862071|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862072|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862073|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862074|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365044|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365045|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44365046|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850417|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44365047|NCT01162967|Posaconazole|posaconazole|mesh-list
44365048|NCT01162967|Benzonidazole|benzonidazole|mesh-list
44365049|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
44365050|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365051|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44365052|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44365053|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44365054|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44365055|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43603675|NCT03244241|Insulin|insulin|mesh-list
43603676|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603677|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603678|NCT03243903|Insulin|insulin|mesh-list
43603679|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43603680|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603708|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43603709|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43603710|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603711|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657620|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43657621|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850425|NCT05547750|Vitamin K|vitamin k|mesh-list
44365056|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365057|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365058|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44365059|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
44365060|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365061|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365062|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365063|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
44365064|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
43862075|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43862076|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
43862077|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43862078|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862079|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862080|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
43862081|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862082|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862083|NCT02716311|Cetuximab|cetuximab|mesh-list
43862084|NCT02716311|Afatinib|afatinib|mesh-list
43862085|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862086|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862087|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43862088|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862089|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862090|NCT02714439|Proflavine|proflavine|mesh-list
43862091|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43862092|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862093|NCT02713997|Etanercept|etanercept|mesh-list
43862094|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43862095|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
43862096|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862097|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862098|NCT02713997|Analgesics|analgesics|mesh-ancestor
43862099|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
43862100|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862101|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862102|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862103|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862104|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365065|NCT01163201|Fludarabine|fludarabine|mesh-list
44365066|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365067|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
43603712|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43603713|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43603714|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43657622|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43657623|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43657624|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43850426|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
43850427|NCT05547750|Vitamins|vitamins|mesh-ancestor
43657626|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657627|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
43657628|NCT02951728|Hormones|hormones|mesh-ancestor
44365068|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365069|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365070|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44365071|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
44365072|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365073|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020135|NCT02658877|Omalizumab|omalizumab|mesh-list
44365074|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44365075|NCT01163396|Leucovorin|leucovorin|mesh-list
44365076|NCT01163396|Bevacizumab|bevacizumab|mesh-list
44365077|NCT01163396|Fluorouracil|fluorouracil|mesh-list
44365078|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
44365079|NCT01163396|Irinotecan|irinotecan|mesh-list
44365080|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365081|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365082|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365083|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44365084|NCT01163396|Growth Substances|growth substances|mesh-ancestor
44365085|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365086|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
44365087|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
44365088|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365089|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365090|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365091|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
44365092|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44365093|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365094|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862105|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862106|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
43862107|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43862108|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43862109|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
43862110|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862111|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862112|NCT02712801|Ritonavir|ritonavir|mesh-list
43862113|NCT02712801|Lopinavir|lopinavir|mesh-list
43862114|NCT02712801|Lamivudine|lamivudine|mesh-list
43862115|NCT02712801|Zidovudine|zidovudine|mesh-list
43862116|NCT02712801|Nevirapine|nevirapine|mesh-list
43862117|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43862118|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44365095|NCT01163396|Antidotes|antidotes|mesh-ancestor
44365096|NCT01163396|Protective Agents|protective agents|mesh-ancestor
44365097|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
44365098|NCT01163396|Vitamins|vitamins|mesh-ancestor
44365099|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
44365100|NCT01163435|Clarithromycin|clarithromycin|mesh-list
44365101|NCT01163435|Levofloxacin|levofloxacin|mesh-list
44365102|NCT01163435|Ofloxacin|ofloxacin|mesh-list
44365103|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44365104|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365105|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44365106|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365107|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365108|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44365109|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365110|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44365111|NCT01163435|Renal Agents|renal agents|mesh-ancestor
44365112|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44365113|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365114|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365115|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44365116|NCT01163500|Ubiquinone|ubiquinone|mesh-list
44365117|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
44365118|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
44365119|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365120|NCT01163500|Vitamins|vitamins|mesh-ancestor
44365121|NCT01163630|Esomeprazole|esomeprazole|mesh-list
44365122|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44365123|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365124|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44365125|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365126|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365127|NCT01163734|Ranolazine|ranolazine|mesh-list
43862119|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
43862120|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862121|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862122|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43862123|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43862124|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
43862125|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862126|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43862127|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43862128|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44365128|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44365129|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365130|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365131|NCT01163799|Alefacept|alefacept|mesh-list
44365132|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
44365133|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
44365134|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020226|NCT02589145|Vitamins|vitamins|mesh-ancestor
44365135|NCT01163825|Mitogens|mitogens|mesh-list
44365136|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44365137|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365138|NCT01163903|Doxorubicin|doxorubicin|mesh-list
44365139|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44365140|NCT01163903|Pantoprazole|pantoprazole|mesh-list
43603715|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43603716|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43603717|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
43603718|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657635|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657636|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
43657637|NCT02951975|Dexamethasone|dexamethasone|mesh-list
43850428|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
43850429|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657638|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657639|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
43657640|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
43657641|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657642|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657643|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657644|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
43657645|NCT02951975|Hormones|hormones|mesh-ancestor
44365141|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44365142|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365143|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44365144|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365145|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365146|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365147|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44365148|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365149|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44365150|NCT01163929|Paclitaxel|paclitaxel|mesh-list
43862138|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862139|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43862140|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862141|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862142|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862143|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43862144|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
43862145|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862146|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
43862147|NCT02707588|Cetuximab|cetuximab|mesh-list
43862148|NCT02707588|Antibodies|antibodies|mesh-list
43862149|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
43862150|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
43862151|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862152|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862153|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862154|NCT02706678|Tacrolimus|tacrolimus|mesh-list
43862155|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862156|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
43862157|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862158|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43862159|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862160|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862161|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
43862162|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862163|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365151|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44365152|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365153|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
44365154|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
44365155|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44365156|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365157|NCT01163994|Doxycycline|doxycycline|mesh-list
44365158|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
44365159|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44365160|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365161|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
44365162|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44365163|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44365165|NCT01164046|Heparin|heparin|mesh-list
44365166|NCT01164046|Enoxaparin|enoxaparin|mesh-list
44365167|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44365168|NCT01164046|Tinzaparin|tinzaparin|mesh-list
44365169|NCT01164046|Dalteparin|dalteparin|mesh-list
44365170|NCT01164046|Nadroparin|nadroparin|mesh-list
44365171|NCT01164046|Reviparin|reviparin|mesh-list
44365172|NCT01164046|Warfarin|warfarin|mesh-list
44365173|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
44365210|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
44365211|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
44365212|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44365213|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44365214|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44365215|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44365216|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44365217|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44365218|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44365219|NCT01164085|Ketorolac|ketorolac|mesh-list
43850430|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44365220|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44365221|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44365222|NCT01164085|Analgesics|analgesics|mesh-ancestor
44365223|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
44365224|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365225|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365226|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365265|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365266|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365267|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
44365268|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365270|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44365271|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
44365272|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365273|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365274|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44365275|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44365276|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
44365277|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365278|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365279|NCT01164345|Plerixafor|plerixafor|mesh-list
43862164|NCT02705300|Leucovorin|leucovorin|mesh-list
43862165|NCT02705300|Tocotrienols|tocotrienols|mesh-list
43862166|NCT02705300|Vitamin E|vitamin e|mesh-list
43862167|NCT02705300|Tocopherols|tocopherols|mesh-list
43862168|NCT02705300|Fluorouracil|fluorouracil|mesh-list
43862169|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
43862170|NCT02705300|Irinotecan|irinotecan|mesh-list
43862171|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
43862172|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862173|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
43862174|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862175|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862176|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862177|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862178|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
43862179|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43862180|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43603720|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849188|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603721|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603722|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603730|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603731|NCT03243344|Surgiflo|surgiflo|mesh-list
43603732|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
43603771|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603772|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
43603773|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43603774|NCT03243006|Narcotics|narcotics|mesh-ancestor
43603775|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862181|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862182|NCT02705300|Antidotes|antidotes|mesh-ancestor
43862183|NCT02705300|Protective Agents|protective agents|mesh-ancestor
43862184|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
43862185|NCT02705300|Vitamins|vitamins|mesh-ancestor
43862186|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
43862187|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
43862188|NCT02705196|Gemcitabine|gemcitabine|mesh-list
43862189|NCT02705196|Paclitaxel|paclitaxel|mesh-list
43862190|NCT02705196|Atezolizumab|atezolizumab|mesh-list
43862191|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862192|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862193|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862194|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862195|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862196|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862199|NCT02705196|Antiviral Agents|antiviral agents|mesh-ancestor
43862200|NCT02705196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862201|NCT02705196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862202|NCT02705196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862203|NCT02705196|Immunologic Factors|immunologic factors|mesh-ancestor
43862204|NCT02705196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862205|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
43862206|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862207|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862208|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862209|NCT02703948|Lidocaine|lidocaine|mesh-list
43862210|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
43862211|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
43862212|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862213|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365280|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44365281|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44365282|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
44365283|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365284|NCT01164488|Ritonavir|ritonavir|mesh-list
44365285|NCT01164488|Ketoconazole|ketoconazole|mesh-list
44365286|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44365287|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44365288|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365289|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365290|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365291|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44365292|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44365293|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
44365294|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365295|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44365296|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365297|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
44365298|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44365299|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44365300|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
44365301|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365302|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365303|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44365304|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44365305|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44365306|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
43862214|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
43862215|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862216|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43862217|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43862218|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43862219|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43862220|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862221|NCT02703610|Acetaminophen|acetaminophen|mesh-list
43862222|NCT02703610|Ibuprofen|ibuprofen|mesh-list
43862223|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43862224|NCT02703610|Oxycodone|oxycodone|mesh-list
43862225|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862226|NCT02703610|Analgesics|analgesics|mesh-ancestor
43862227|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
43862228|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862229|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862230|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
43862231|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862232|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365307|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365308|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44365309|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44365310|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365311|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
44365312|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44365313|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44365314|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
44365315|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365316|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44365317|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44365318|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365319|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365320|NCT01164709|Nelfinavir|nelfinavir|mesh-list
44365321|NCT01164709|Bortezomib|bortezomib|mesh-list
44365322|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365323|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44365324|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44365325|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365326|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365327|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365328|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43862233|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862234|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43862235|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862236|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862237|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43862239|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862240|NCT02700048|Naloxone|naloxone|mesh-list
43862241|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43862242|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862243|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
43862244|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862245|NCT02697227|Nicotine|nicotine|mesh-list
43862246|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43862247|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
43862248|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862249|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862250|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43862251|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43862252|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
43862253|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862254|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862255|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43862256|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43862257|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
43862258|NCT02689427|Paclitaxel|paclitaxel|mesh-list
43862259|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43862260|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862261|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862262|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44365329|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44365330|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
44365331|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365333|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44365334|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365335|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365336|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365337|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365338|NCT01164774|Ramipril|ramipril|mesh-list
44365339|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44365340|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365341|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365342|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365343|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365344|NCT01164787|Trandolapril|trandolapril|mesh-list
44365345|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44365346|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365347|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365348|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365349|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44365350|NCT01164800|Trandolapril|trandolapril|mesh-list
44365351|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44365352|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365353|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365354|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365356|NCT01164813|Nabumetone|nabumetone|mesh-list
44365373|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
44365374|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365375|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365376|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365377|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365378|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44365379|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44365380|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365381|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365382|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44365383|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
44365384|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365385|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44365386|NCT01164943|Hormones|hormones|mesh-ancestor
43603813|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
43603814|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43603815|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44365387|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365388|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365389|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44365390|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365391|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44365392|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44365393|NCT01165060|Bezafibrate|bezafibrate|mesh-list
44365394|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44365395|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
44365396|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365397|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44365398|NCT01165125|Ketoconazole|ketoconazole|mesh-list
44365399|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
44365400|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365401|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44365402|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365403|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365404|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365410|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44365411|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
44365412|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44365413|NCT01165255|Bupropion|bupropion|mesh-list
44365414|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
44365415|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44365416|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365417|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44365418|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365419|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365420|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365421|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
44365422|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365423|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365424|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44365425|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365426|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862263|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862264|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862265|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862266|NCT02688556|Cyclosporine|cyclosporine|mesh-list
43862267|NCT02688556|Cyclosporins|cyclosporins|mesh-list
43862268|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862269|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862273|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
43862274|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862275|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
43862276|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862277|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43862278|NCT02688140|Cytarabine|cytarabine|mesh-list
43862279|NCT02688140|Methotrexate|methotrexate|mesh-list
43862280|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
43862281|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
43862282|NCT02688140|Idarubicin|idarubicin|mesh-list
43862283|NCT02688140|Tretinoin|tretinoin|mesh-list
43862284|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
43862285|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43862286|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
43862287|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43862288|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862289|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862290|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
43862291|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862292|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862293|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
43862294|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862295|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43862296|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862297|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
43862298|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862299|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43862301|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862302|NCT02688140|Analgesics|analgesics|mesh-ancestor
43862303|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
44365428|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44365429|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365430|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44365431|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365432|NCT01165294|Ketamine|ketamine|mesh-list
44365433|NCT01165294|Analgesics|analgesics|mesh-ancestor
44365434|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
44020490|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
44365435|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365436|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365437|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44365438|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44365439|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
44365440|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
44365441|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365442|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44365443|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44365444|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862304|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862305|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43862306|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43862307|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43862308|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
43862309|NCT02685735|Gabapentin|gabapentin|mesh-list
43862310|NCT02685735|Analgesics|analgesics|mesh-ancestor
43862311|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
43862312|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862313|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862314|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
43862315|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43862316|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43862317|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862318|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43862319|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43862320|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43862321|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603825|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603826|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43603827|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43603828|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43603829|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603830|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
43603831|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
43603832|NCT03242317|Mitomycins|mitomycins|mesh-list
43603833|NCT03242317|Mitomycin|mitomycin|mesh-list
43657662|NCT02951962|Telmisartan|telmisartan|mesh-list
43862322|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862323|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
43862324|NCT02684578|Metformin|metformin|mesh-list
43862325|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43862326|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133990|NCT00156312|Docetaxel|docetaxel|mesh-list
44133991|NCT00156312|Capecitabine|capecitabine|mesh-list
44133992|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133993|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44133994|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44133995|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133996|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133997|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133998|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
44133999|NCT00156325|Citalopram|citalopram|mesh-list
44134000|NCT00156325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44134001|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365445|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365446|NCT01165372|Artesunate|artesunate|mesh-list
44365447|NCT01165372|Piperaquine|piperaquine|mesh-list
44365448|NCT01165372|Artenimol|artenimol|mesh-list
44365449|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
44365450|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44365451|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44365452|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365453|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365454|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
44365455|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
44365456|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44365457|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
44365458|NCT01165385|Cisplatin|cisplatin|mesh-list
44365459|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365460|NCT01165476|Treprostinil|treprostinil|mesh-list
44365508|NCT01165866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44365509|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44365510|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44365511|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
44365512|NCT01165905|Gemcitabine|gemcitabine|mesh-list
44365513|NCT01165905|ON 01910|on 01910|mesh-list
44365514|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365515|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
44365516|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365517|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365518|NCT01165905|Antiviral Agents|antiviral agents|mesh-ancestor
44365519|NCT01165905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365520|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365521|NCT01165905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365522|NCT01165905|Immunologic Factors|immunologic factors|mesh-ancestor
44365523|NCT01165905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365524|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44365525|NCT01165931|Riociguat|riociguat|mesh-list
44365526|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
44365527|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365528|NCT01165944|Pramlintide|pramlintide|mesh-list
44365529|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44365530|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365531|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44365532|NCT01165970|Laxatives|laxatives|mesh-ancestor
44365533|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850458|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850459|NCT05504291|Carboplatin|carboplatin|mesh-list
43850460|NCT05504291|Etoposide|etoposide|mesh-list
44365534|NCT01166035|Lenalidomide|lenalidomide|mesh-list
44365535|NCT01166035|Cetuximab|cetuximab|mesh-list
44365536|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
44365537|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365538|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365539|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44365540|NCT01166035|Growth Substances|growth substances|mesh-ancestor
44134002|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134003|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134004|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134005|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
44134008|NCT00156325|Antidepressive Agents|antidepressive agents|mesh-ancestor
44134009|NCT00156325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134011|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44365543|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365544|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44365545|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44020651|NCT02345772|Docetaxel|docetaxel|mesh-list
44365546|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365547|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365548|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365549|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365550|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365551|NCT01166048|Analgesics|analgesics|mesh-ancestor
44365552|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
44365553|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365554|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
44365555|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365556|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
44365557|NCT01166087|Fluoxetine|fluoxetine|mesh-list
44365558|NCT01166087|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44134012|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134013|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44134014|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134015|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134016|NCT00156403|Amlodipine|amlodipine|mesh-list
44134017|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134018|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134019|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603834|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43603835|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603836|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
43603857|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603858|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603859|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
43603860|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43825356|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43825357|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825358|NCT05502081|Favipiravir|favipiravir|mesh-list
43850461|NCT05504291|Vincristine|vincristine|mesh-list
44134020|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134021|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134022|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134023|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134024|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
44134025|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44134026|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134027|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134028|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
44134029|NCT00156520|Coagulants|coagulants|mesh-ancestor
44134030|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44134031|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134032|NCT00156611|Abciximab|abciximab|mesh-list
44134033|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
44134034|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44134035|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43862327|NCT02684474|HBOC 201|hboc 201|mesh-list
43862328|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
43862329|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
43862330|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43862331|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862332|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862333|NCT02684032|Letrozole|letrozole|mesh-list
43862334|NCT02684032|Fulvestrant|fulvestrant|mesh-list
43862335|NCT02684032|Palbociclib|palbociclib|mesh-list
43862336|NCT02684032|Gedatolisib|gedatolisib|mesh-list
44365559|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365560|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365561|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365562|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603872|NCT03241901|Lumefantrine|lumefantrine|mesh-list
44365564|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365565|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44365566|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
44365567|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365568|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44365569|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365570|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365571|NCT01166100|Fluoxetine|fluoxetine|mesh-list
44365572|NCT01166100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44365573|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44365574|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365575|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365576|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365577|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
44365578|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365579|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44365580|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
44365581|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365582|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44365583|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365584|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365585|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
44365586|NCT01166165|Vitamin D|vitamin d|mesh-list
44365587|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44365588|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365589|NCT01166165|Vitamins|vitamins|mesh-ancestor
44365590|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
44365597|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
44365598|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44365599|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365600|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365601|NCT01166451|Iron|iron|mesh-list
44365602|NCT01166451|Trace Elements|trace elements|mesh-ancestor
44365603|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
44365604|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365605|NCT01166477|Ritonavir|ritonavir|mesh-list
44365606|NCT01166477|Lopinavir|lopinavir|mesh-list
44365607|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44365608|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44365609|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365610|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365611|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365612|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44365613|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44365614|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
43862337|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862338|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43862339|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43862340|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862341|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862342|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43862343|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862344|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862345|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862346|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862347|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43862348|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43862349|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
43862350|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
43862351|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43862352|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43862353|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862354|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862355|NCT02682147|Urological Agents|urological agents|mesh-ancestor
43862356|NCT02680314|Methotrexate|methotrexate|mesh-list
43862357|NCT02680314|Misoprostol|misoprostol|mesh-list
43862358|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43862359|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
43862360|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43862361|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862362|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862363|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
43862364|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862365|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862366|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
43862370|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
43862371|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862372|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43862373|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43862374|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862375|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
43862376|NCT02677038|Olaparib|olaparib|mesh-list
43862377|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43862378|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365615|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365616|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44365617|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365620|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44365621|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365622|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
44365623|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
44365624|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44365625|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365626|NCT01166594|Bevacizumab|bevacizumab|mesh-list
44365627|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365628|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365629|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365630|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44365631|NCT01166594|Growth Substances|growth substances|mesh-ancestor
43677610|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43862379|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862380|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862381|NCT02675829|Trastuzumab|trastuzumab|mesh-list
43862382|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43862383|NCT02675829|Maytansine|maytansine|mesh-list
43862384|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862385|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862386|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862387|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862388|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862389|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862390|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862391|NCT02670707|Cytarabine|cytarabine|mesh-list
43862392|NCT02670707|Prednisone|prednisone|mesh-list
43657736|NCT02951039|Edoxaban|edoxaban|mesh-list
43862393|NCT02670707|Vinblastine|vinblastine|mesh-list
43862394|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862395|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
43862396|NCT02670707|Hormones|hormones|mesh-ancestor
43862397|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862398|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862399|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862400|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862401|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862402|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
43862403|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862404|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
43862405|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862406|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862407|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
43862408|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862409|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862410|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862411|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862412|NCT02669901|Naloxone|naloxone|mesh-list
43862413|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43862414|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862415|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
43862416|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862417|NCT02668666|Tamoxifen|tamoxifen|mesh-list
44365632|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365633|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44365635|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365636|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365637|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
44365638|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365639|NCT01166711|Chromium|chromium|mesh-list
44365640|NCT01166711|Paclitaxel|paclitaxel|mesh-list
44365641|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44365642|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44365643|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365644|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44365645|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44365646|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44365647|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365648|NCT01166711|Trace Elements|trace elements|mesh-ancestor
44365649|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
44365650|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365651|NCT01166789|Lubiprostone|lubiprostone|mesh-list
44365652|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44365653|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365654|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365655|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
44365656|NCT01166815|Astringents|astringents|mesh-ancestor
44365657|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862418|NCT02668666|Palbociclib|palbociclib|mesh-list
43862419|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43862420|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862421|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862422|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862423|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862424|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862425|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43862426|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43862427|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43862428|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603912|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43862429|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862430|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862431|NCT02666742|Aspirin|aspirin|mesh-list
43862432|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
43862433|NCT02666742|Edoxaban|edoxaban|mesh-list
43862434|NCT02666742|Dabigatran|dabigatran|mesh-list
43862435|NCT02666742|Anticoagulants|anticoagulants|mesh-list
43862436|NCT02666742|Coagulants|coagulants|mesh-list
43862437|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862438|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862439|NCT02666742|Analgesics|analgesics|mesh-ancestor
43862445|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44365658|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44365659|NCT01166932|Amoxicillin|amoxicillin|mesh-list
44365660|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
44365661|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
44365662|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
44365663|NCT01166932|Oxacillin|oxacillin|mesh-list
44365664|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44365665|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365666|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365667|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365668|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44365669|NCT01167010|Budesonide|budesonide|mesh-list
44365670|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
44365671|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365672|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44365673|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
44365674|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365675|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365676|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44365677|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
44365678|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
43603924|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43603925|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43603926|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43649226|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43649227|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43649228|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43649229|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649230|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649232|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649233|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43850476|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
43850477|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43850478|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
43850479|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43850480|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365679|NCT01167010|Hormones|hormones|mesh-ancestor
44365680|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365681|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44365682|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44365683|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44365684|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
43862446|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43862447|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862448|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43862449|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43862450|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862451|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
43862452|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43862453|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
43862454|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43862455|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
43862456|NCT02664181|Nivolumab|nivolumab|mesh-list
43862457|NCT02664181|Decitabine|decitabine|mesh-list
43862458|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
43862459|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862460|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862461|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43862462|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862463|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862464|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
43862465|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862466|NCT02663518|Rituximab|rituximab|mesh-list
43862467|NCT02663518|Nivolumab|nivolumab|mesh-list
44365686|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365687|NCT01167049|Capecitabine|capecitabine|mesh-list
43649234|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43649235|NCT03030937|Irinotecan|irinotecan|mesh-list
43649236|NCT03030937|Apatinib|apatinib|mesh-list
43603930|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
44365688|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365689|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
44365690|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365691|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365692|NCT01167062|Tamsulosin|tamsulosin|mesh-list
44020802|NCT02177773|Octreotide|octreotide|mesh-list
44365693|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44365694|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44365696|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44365697|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365698|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365699|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365700|NCT01167062|Urological Agents|urological agents|mesh-ancestor
44365701|NCT01167101|Pantoprazole|pantoprazole|mesh-list
44365702|NCT01167101|Rebamipide|rebamipide|mesh-list
44365703|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44365704|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365705|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44365706|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365707|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365708|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
44365709|NCT01167101|Protective Agents|protective agents|mesh-ancestor
44365710|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365711|NCT01167127|Oxycodone|oxycodone|mesh-list
44365712|NCT01167127|Naloxone|naloxone|mesh-list
44365713|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44365714|NCT01167127|Narcotics|narcotics|mesh-ancestor
44365715|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365716|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862468|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
43862469|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862470|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862471|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
43862472|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862473|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862474|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43862475|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862476|NCT02661932|Letrozole|letrozole|mesh-list
44365717|NCT01167127|Analgesics|analgesics|mesh-ancestor
44365718|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
44365719|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365720|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44365721|NCT01167231|Acarbose|acarbose|mesh-list
44365722|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44365723|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365724|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365725|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44365726|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365727|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
44365728|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
44365729|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
44365730|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44365731|NCT01167465|Protective Agents|protective agents|mesh-ancestor
44365732|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365733|NCT01167478|Caffeine|caffeine|mesh-list
43677713|NCT02866214|Febuxostat|febuxostat|mesh-list
43862477|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862478|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43862479|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43862480|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862481|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862482|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43862483|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862484|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862485|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862486|NCT02661503|Dexamethasone|dexamethasone|mesh-list
43862487|NCT02661503|Prednisone|prednisone|mesh-list
43862488|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
43862489|NCT02661503|Dacarbazine|dacarbazine|mesh-list
43862490|NCT02661503|Doxorubicin|doxorubicin|mesh-list
43862491|NCT02661503|Etoposide|etoposide|mesh-list
43862492|NCT02661503|Vincristine|vincristine|mesh-list
43862493|NCT02661503|Bleomycin|bleomycin|mesh-list
43862494|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43862495|NCT02661503|Procarbazine|procarbazine|mesh-list
43603985|NCT03241550|Isavuconazole|isavuconazole|mesh-list
43862496|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862497|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
43862498|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862499|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862500|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43862501|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
43862502|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862503|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862504|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43862505|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862506|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
43862507|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
43862508|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862509|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862520|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862521|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862522|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862523|NCT02658890|Nivolumab|nivolumab|mesh-list
43862524|NCT02658890|Ipilimumab|ipilimumab|mesh-list
43862525|NCT02658890|Linrodostat|linrodostat|mesh-list
43862526|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862527|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365734|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44365735|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365736|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44365737|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365738|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365739|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44365740|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44365741|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
44365742|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365743|NCT01167530|Everolimus|everolimus|mesh-list
43677731|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
43862528|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43862529|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862530|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862531|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
43862532|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862533|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862534|NCT02655601|Manganese|manganese|mesh-list
43862535|NCT02655601|Temozolomide|temozolomide|mesh-list
43862536|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43862537|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
43862538|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862539|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862540|NCT02655601|Trace Elements|trace elements|mesh-ancestor
43862541|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
43862542|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862543|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
43862544|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43862545|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
43862546|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862547|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862548|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43862549|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
43604009|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604010|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604011|NCT03241303|Acarbose|acarbose|mesh-list
43604012|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43604013|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604014|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862550|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43862551|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
44134036|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
43862552|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862553|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862554|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43862555|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
43862556|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
43862558|NCT02652247|Dimercaprol|dimercaprol|mesh-list
43862559|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
43862560|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
43862561|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862562|NCT02651662|Cemiplimab|cemiplimab|mesh-list
43862563|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862564|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862565|NCT02649790|Dexamethasone|dexamethasone|mesh-list
43862566|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862567|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
43862568|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
43862569|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862570|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862571|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862572|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
43862573|NCT02649790|Hormones|hormones|mesh-ancestor
43862578|NCT02649764|Fludarabine|fludarabine|mesh-list
43862579|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
43862580|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862581|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862582|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
43862583|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365744|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365745|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365746|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
44365747|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365748|NCT01167699|Oxycodone|oxycodone|mesh-list
44365749|NCT01167699|Naloxone|naloxone|mesh-list
44365750|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44365751|NCT01167699|Narcotics|narcotics|mesh-ancestor
44365752|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365753|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365754|NCT01167699|Analgesics|analgesics|mesh-ancestor
44365755|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
44365756|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365757|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44365758|NCT01167725|Leucovorin|leucovorin|mesh-list
44365759|NCT01167725|Bevacizumab|bevacizumab|mesh-list
44365760|NCT01167725|Cetuximab|cetuximab|mesh-list
44365761|NCT01167725|Fluorouracil|fluorouracil|mesh-list
44365762|NCT01167725|Capecitabine|capecitabine|mesh-list
44365763|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
44365764|NCT01167725|Irinotecan|irinotecan|mesh-list
44365765|NCT01167725|Mitomycins|mitomycins|mesh-list
44365766|NCT01167725|Mitomycin|mitomycin|mesh-list
44365767|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
44365768|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44365769|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365770|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365771|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43862584|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862585|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
43862586|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862587|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
43862588|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862589|NCT02647385|Lidocaine|lidocaine|mesh-list
43862590|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
43862591|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
43862592|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862593|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862594|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
43862595|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862596|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43862597|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43862598|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43862599|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382385|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862600|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862601|NCT02635555|Phenylephrine|phenylephrine|mesh-list
43862602|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
43862603|NCT02635555|Ephedrine|ephedrine|mesh-list
43862604|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43862605|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
43862606|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
43862607|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365773|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365774|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
44365775|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
44365776|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365777|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365778|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365779|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
44365780|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44365781|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365782|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365783|NCT01167725|Antidotes|antidotes|mesh-ancestor
44365784|NCT01167725|Protective Agents|protective agents|mesh-ancestor
44365785|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
44365786|NCT01167725|Vitamins|vitamins|mesh-ancestor
44365787|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
44365788|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44365789|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
44365790|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44365791|NCT01167738|Metformin|metformin|mesh-list
44365792|NCT01167738|Gemcitabine|gemcitabine|mesh-list
44365793|NCT01167738|Cisplatin|cisplatin|mesh-list
44365794|NCT01167738|Capecitabine|capecitabine|mesh-list
44365795|NCT01167738|Epirubicin|epirubicin|mesh-list
44365796|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365797|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365798|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
44365799|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365800|NCT01167738|Antiviral Agents|antiviral agents|mesh-ancestor
44365801|NCT01167738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365802|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365803|NCT01167738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44365804|NCT01167738|Immunologic Factors|immunologic factors|mesh-ancestor
43677763|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
43862608|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862609|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
43862610|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43862611|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
43862612|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
43862613|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43862614|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43862615|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43862616|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
44365805|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365807|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44365808|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44365809|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365810|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
44365811|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44365812|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44365813|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365814|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
44365815|NCT01167764|Coagulants|coagulants|mesh-ancestor
44365816|NCT01167803|Desflurane|desflurane|mesh-list
44365817|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44365818|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
44365819|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
44365820|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365821|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850485|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44365822|NCT01167816|Azacitidine|azacitidine|mesh-list
44365823|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44365824|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
44365825|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365826|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365827|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862617|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862618|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862619|NCT02635555|Protective Agents|protective agents|mesh-ancestor
43862620|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43862621|NCT02634008|Ritonavir|ritonavir|mesh-list
43862622|NCT02634008|Ribavirin|ribavirin|mesh-list
43862623|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43862624|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43862625|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
43862626|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862627|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862628|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43862629|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43862630|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
43862631|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862632|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43862633|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43862634|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
43862635|NCT02632708|Cytarabine|cytarabine|mesh-list
43862636|NCT02632708|Etoposide|etoposide|mesh-list
43862637|NCT02632708|Daunorubicin|daunorubicin|mesh-list
43862638|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
43862639|NCT02632708|Idarubicin|idarubicin|mesh-list
43862640|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862641|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862642|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43862643|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43862644|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862654|NCT02632708|Analgesics|analgesics|mesh-ancestor
43862655|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
44365828|NCT01167894|Simvastatin|simvastatin|mesh-list
44365829|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43649241|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649242|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43649243|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
43604020|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604021|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604022|NCT03241043|Tacrolimus|tacrolimus|mesh-list
43604023|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604024|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
43604025|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657892|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657893|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657894|NCT02949492|Analgesics|analgesics|mesh-ancestor
43657895|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
43657896|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365830|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44365831|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
44382386|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
44365832|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365833|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44365834|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44365835|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365836|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
44365837|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
44365838|NCT01167920|Diuretics|diuretics|mesh-list
44365839|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44365840|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44365841|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365842|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
44365843|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
44365844|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365845|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365846|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44365847|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365848|NCT01167933|Simvastatin|simvastatin|mesh-list
44365849|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44365850|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44365851|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
44365852|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365853|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44365854|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44365855|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365856|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
44365857|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44365858|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44365859|NCT01167946|Prednisolone|prednisolone|mesh-list
44365860|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
44365861|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44365862|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
44365863|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365865|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
44365866|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365867|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365868|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365869|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
44365870|NCT01167946|Hormones|hormones|mesh-ancestor
44365871|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365872|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44365873|NCT01167946|Protective Agents|protective agents|mesh-ancestor
44365874|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44365875|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365876|NCT01168011|ON 01910|on 01910|mesh-list
44365877|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365878|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44365879|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365880|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365881|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44365882|NCT01168063|Amoxicillin|amoxicillin|mesh-list
44365883|NCT01168063|Metronidazole|metronidazole|mesh-list
44365884|NCT01168063|Clarithromycin|clarithromycin|mesh-list
44365885|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44365886|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44365887|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
44365888|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44365889|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44365890|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44365891|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862656|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862657|NCT02630316|Treprostinil|treprostinil|mesh-list
43862658|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43862659|NCT02630069|Choline|choline|mesh-list
43862660|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43862661|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
43862662|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43862663|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
43862664|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862665|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862666|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43862667|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
43862668|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
43862669|NCT02630043|Tolcapone|tolcapone|mesh-list
43862670|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862671|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43862672|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43862673|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44365892|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365893|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44365894|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44365896|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
44365897|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
44365899|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365900|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365901|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365902|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44365903|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44365904|NCT01168440|Sunitinib|sunitinib|mesh-list
44365905|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365906|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44365907|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44365908|NCT01168440|Growth Substances|growth substances|mesh-ancestor
44365909|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365910|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
44365911|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44365912|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365913|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365914|NCT01168492|Ketamine|ketamine|mesh-list
44365915|NCT01168492|Analgesics|analgesics|mesh-ancestor
44365916|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
44365917|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365918|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862674|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862675|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862676|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
43862677|NCT02629809|Fludarabine|fludarabine|mesh-list
43862678|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
43862679|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
43862680|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657960|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657961|NCT02949193|Incretins|incretins|mesh-ancestor
43657962|NCT02949193|Hormones|hormones|mesh-ancestor
43657963|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657964|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43862681|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
43862682|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862683|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862684|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43862685|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
43862686|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862687|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862688|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43862689|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862690|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
43862691|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862692|NCT02629419|Amphotericin B|amphotericin b|mesh-list
43862693|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43862694|NCT02629419|Amebicides|amebicides|mesh-ancestor
44365919|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44365920|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44365921|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
44365922|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
44365923|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365924|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44365925|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44365926|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44365927|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365929|NCT01168505|Hematinics|hematinics|mesh-ancestor
44365930|NCT01168531|Dexamethasone|dexamethasone|mesh-list
44365931|NCT01168531|Pregabalin|pregabalin|mesh-list
43862695|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43862696|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43862697|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862698|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43862699|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
43862700|NCT02628626|Clonidine|clonidine|mesh-list
43862701|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43862702|NCT02628626|Analgesics|analgesics|mesh-ancestor
43862703|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
43862704|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862705|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862706|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43862707|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
43862708|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
43862709|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43862710|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43862729|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
43862730|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862731|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43862732|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43862733|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43862734|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43862735|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862736|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43604035|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
43604036|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604037|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604038|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43604039|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604040|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862737|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43862738|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
43862739|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862740|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43862741|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43862742|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
43862743|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43862744|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
43862745|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
43862746|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
43862747|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43862748|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43862749|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
43862750|NCT02625480|Fludarabine|fludarabine|mesh-list
43862751|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862752|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
43862753|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862754|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862755|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43862756|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
43862757|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862758|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862759|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43862760|NCT02624908|Canagliflozin|canagliflozin|mesh-list
43862761|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44365932|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365933|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
44365934|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
44365935|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365936|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365937|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365938|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
44365939|NCT01168531|Hormones|hormones|mesh-ancestor
44365940|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365941|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44365942|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365943|NCT01168531|Analgesics|analgesics|mesh-ancestor
44365944|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
44365945|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
44365946|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44365947|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44365948|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365949|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44365950|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44365951|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44365952|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44365953|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44365954|NCT01168544|Vitamin D|vitamin d|mesh-list
43862762|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862763|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43862764|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862765|NCT02624544|Desonide|desonide|mesh-list
43862766|NCT02624544|Esomeprazole|esomeprazole|mesh-list
43862767|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43862768|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862776|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
43862777|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
43862778|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862779|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862780|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134037|NCT00156650|Testosterone|testosterone|mesh-list
44134039|NCT00156650|Androgens|androgens|mesh-ancestor
43657983|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
43657984|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657985|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44134040|NCT00156650|Hormones|hormones|mesh-ancestor
44134041|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44134042|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134043|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44134044|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134045|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44134046|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44134047|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44134048|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
44134049|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44134050|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44134051|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43544803|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
44365955|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
44365956|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
44365957|NCT01168544|Vitamins|vitamins|mesh-list
44365958|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
44365959|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365960|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44365961|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44365962|NCT01168739|Quercetin|quercetin|mesh-list
44365963|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
43604070|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604071|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604072|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43604073|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
43604075|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43604076|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
43604077|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604078|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604079|NCT03240549|Bevacizumab|bevacizumab|mesh-list
43658005|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43658006|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43658007|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
43658008|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658009|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658010|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43658011|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43658012|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
43658013|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658014|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43658015|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43658016|NCT02947945|Reslizumab|reslizumab|mesh-list
44365964|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365965|NCT01168739|Protective Agents|protective agents|mesh-ancestor
44365966|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365967|NCT01168791|Doxorubicin|doxorubicin|mesh-list
44134052|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44134053|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
44134055|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
44134056|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
44134057|NCT00156858|Busulfan|busulfan|mesh-list
44134058|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
44134059|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134060|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44134061|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
44134062|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134063|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44134064|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134065|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44134066|NCT00156884|Cisplatin|cisplatin|mesh-list
44134067|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134068|NCT00156897|Orlistat|orlistat|mesh-list
44134069|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134070|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134071|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44134072|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44134073|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
44134074|NCT00156949|Hematinics|hematinics|mesh-ancestor
44134075|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
44134076|NCT00156962|Hematinics|hematinics|mesh-ancestor
44134077|NCT00156975|Capecitabine|capecitabine|mesh-list
44134078|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
44134079|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44134080|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
44134081|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134082|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134083|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
44134084|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44134085|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
44134086|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44134087|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134088|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134089|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604080|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604081|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604082|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43604083|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43604084|NCT03240549|Growth Substances|growth substances|mesh-ancestor
43604085|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604122|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43658025|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658026|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43658027|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
43658028|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134090|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
44134091|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44134092|NCT00157040|Factor VIII|factor viii|mesh-list
44134093|NCT00157040|Coagulants|coagulants|mesh-ancestor
44134094|NCT00157053|Factor VIII|factor viii|mesh-list
44134095|NCT00157053|Coagulants|coagulants|mesh-ancestor
44134096|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
44134101|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
44134102|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44134103|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
44134104|NCT00157079|Antibodies|antibodies|mesh-list
44134105|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
44134106|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44134107|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44134108|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
44134109|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44365968|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44365969|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
44365970|NCT01168791|Ifosfamide|ifosfamide|mesh-list
44365971|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44365972|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365973|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44365974|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44365975|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44365976|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365977|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44365978|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
44365979|NCT01168804|Dexamethasone|dexamethasone|mesh-list
44134110|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44134111|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
44134112|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43862781|NCT02620280|Paclitaxel|paclitaxel|mesh-list
43862782|NCT02620280|Carboplatin|carboplatin|mesh-list
43862783|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43862784|NCT02620280|Atezolizumab|atezolizumab|mesh-list
43862785|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862786|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862787|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862788|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862789|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862790|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862792|NCT02620189|Etanercept|etanercept|mesh-list
43862793|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
43862794|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862795|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862796|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862797|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862798|NCT02620189|Analgesics|analgesics|mesh-ancestor
43862799|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
43862800|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862801|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658047|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43658048|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658049|NCT02947932|Analgesics|analgesics|mesh-ancestor
43850504|NCT05418010|Natalizumab|natalizumab|mesh-list
43850505|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
43850506|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850517|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658058|NCT02947880|Bumetanide|bumetanide|mesh-list
43862802|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43862803|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862804|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
43862805|NCT02615691|Factor VIII|factor viii|mesh-list
43862806|NCT02615691|BAX 855|bax 855|mesh-list
43862807|NCT02615691|Coagulants|coagulants|mesh-ancestor
43862808|NCT02614534|Mitomycins|mitomycins|mesh-list
43862809|NCT02614534|Mitomycin|mitomycin|mesh-list
43862810|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43862811|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862812|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
43862813|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862814|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43862815|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862816|NCT02611323|Rituximab|rituximab|mesh-list
43862817|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
43862818|NCT02611323|Venetoclax|venetoclax|mesh-list
43862819|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862820|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862821|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
43862822|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862823|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862824|NCT02611037|Gemcitabine|gemcitabine|mesh-list
43862825|NCT02611037|Cisplatin|cisplatin|mesh-list
43862826|NCT02611037|Methotrexate|methotrexate|mesh-list
43862827|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862828|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862829|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
43862830|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862831|NCT02611037|Antiviral Agents|antiviral agents|mesh-ancestor
44365980|NCT01168804|Bortezomib|bortezomib|mesh-list
44365981|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44365982|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44365983|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
44365984|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
44365985|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44365986|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604159|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44365987|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44365988|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
44365989|NCT01168804|Hormones|hormones|mesh-ancestor
44365990|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44365991|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44365992|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44365993|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44365994|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
44365995|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44365996|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44365997|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44365998|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44365999|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44366000|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366001|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366029|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44366031|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366032|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366033|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44366034|NCT01169025|Narcotics|narcotics|mesh-ancestor
44366035|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44366036|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44366037|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366038|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366039|NCT01169090|Incretins|incretins|mesh-ancestor
44366040|NCT01169090|Hormones|hormones|mesh-ancestor
44366041|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366042|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44366043|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
44366044|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366045|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366046|NCT01169142|Vitamin D|vitamin d|mesh-list
44366047|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
44366048|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
44366049|NCT01169142|Vitamins|vitamins|mesh-list
43862832|NCT02611037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862833|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862834|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862835|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
43862836|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862837|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43862838|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
43862839|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43862840|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
43862841|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43862842|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604198|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862843|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43862844|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
43862845|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862846|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43862847|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862848|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862849|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
43862850|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862851|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862852|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43862854|NCT02608268|Spartalizumab|spartalizumab|mesh-list
43862855|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862856|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
44155672|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43862857|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862858|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862860|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43862861|NCT02608216|Paclitaxel|paclitaxel|mesh-list
43590354|NCT03372109|Calcium|calcium|mesh-list
43862862|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44366050|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
44366051|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366052|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366053|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366054|NCT01169298|Lenalidomide|lenalidomide|mesh-list
44366055|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
43604243|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44366056|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366057|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44366058|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44366059|NCT01169298|Growth Substances|growth substances|mesh-ancestor
44366060|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
44366061|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366062|NCT01169389|Bupivacaine|bupivacaine|mesh-list
44366063|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
44366064|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
44366065|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366066|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366067|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
43862864|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862865|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862866|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862867|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862868|NCT02604537|Ketorolac|ketorolac|mesh-list
43862869|NCT02604537|Betamethasone|betamethasone|mesh-list
43862870|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862871|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862872|NCT02604537|Analgesics|analgesics|mesh-ancestor
43862873|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
43862874|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862875|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862876|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862877|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862878|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43862879|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862880|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862881|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
43862882|NCT02604537|Hormones|hormones|mesh-ancestor
43862883|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604244|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43862884|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43862885|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
43862886|NCT02603328|Atorvastatin|atorvastatin|mesh-list
43862887|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43862888|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43862889|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
43862890|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862891|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43862892|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43862893|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862894|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
43862895|NCT02600949|Imiquimod|imiquimod|mesh-list
43862896|NCT02600949|Vaccines|vaccines|mesh-list
43862897|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43862898|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862899|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43862900|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
43862901|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366068|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366070|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
44366071|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366072|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44366073|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44366074|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366075|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366076|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44366077|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
44366078|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366079|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366080|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44366081|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43862902|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
43862903|NCT02599454|Atezolizumab|atezolizumab|mesh-list
43862904|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862905|NCT02598726|Curcumin|curcumin|mesh-list
43862906|NCT02598726|Piperine|piperine|mesh-list
43862907|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43862908|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43862909|NCT02598726|Analgesics|analgesics|mesh-ancestor
43862910|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
43862911|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862912|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862913|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862918|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43862920|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43862921|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
43862922|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862923|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862924|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43862925|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43862926|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
43862927|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862928|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862929|NCT02594371|Paclitaxel|paclitaxel|mesh-list
43862930|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43862931|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658140|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658141|NCT02947178|Bupivacaine|bupivacaine|mesh-list
43658142|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658143|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
43658144|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658145|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658146|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
43658147|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862932|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862933|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862934|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862935|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862936|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862938|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
43862939|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862940|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862941|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862942|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862943|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862944|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862945|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
43862946|NCT02591251|Povidone|povidone|mesh-list
43862947|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43862948|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
43862949|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
43862950|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44366082|NCT01169415|Dexamethasone|dexamethasone|mesh-list
44366083|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
44366084|NCT01169415|BB 1101|bb 1101|mesh-list
44366085|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366086|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
44366087|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
44366088|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366089|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366090|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366091|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
44366092|NCT01169415|Hormones|hormones|mesh-ancestor
44366093|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366094|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366095|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366096|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44366097|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366098|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366099|NCT01169506|Silicon|silicon|mesh-list
44366100|NCT01169506|Trace Elements|trace elements|mesh-ancestor
44366101|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
44366102|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366103|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
44366104|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604254|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44366105|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366106|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366107|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366108|NCT01169571|Analgesics|analgesics|mesh-ancestor
43862951|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862952|NCT02589600|Vitamin D|vitamin d|mesh-list
43862953|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
43862954|NCT02589600|Calcium|calcium|mesh-list
43862955|NCT02589600|Vitamins|vitamins|mesh-ancestor
43862956|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
43862957|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862958|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43862959|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43862960|NCT02588443|Gemcitabine|gemcitabine|mesh-list
43862961|NCT02588443|Paclitaxel|paclitaxel|mesh-list
43862962|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862963|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862964|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862965|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
43862966|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
43862967|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862968|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862969|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
43862970|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
43862971|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862972|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366109|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
44366110|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366111|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44366112|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44366113|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44366114|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366115|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366116|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366117|NCT01169584|Molgramostim|molgramostim|mesh-list
44366118|NCT01169584|Sargramostim|sargramostim|mesh-list
44366119|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
44366120|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366121|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366122|NCT01169597|Prednisone|prednisone|mesh-list
44366123|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366124|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
44366125|NCT01169597|Hormones|hormones|mesh-ancestor
44366126|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366127|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366129|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366130|NCT01169688|Phenylephrine|phenylephrine|mesh-list
44366131|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
44366132|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
44366133|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44366134|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
44366135|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
44366136|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366137|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366138|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
44366139|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44366140|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
44366141|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366143|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678008|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
43862973|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862974|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
43862975|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862977|NCT02588105|Folic Acid|folic acid|mesh-list
43862978|NCT02588105|Fluorouracil|fluorouracil|mesh-list
43862979|NCT02588105|Irinotecan|irinotecan|mesh-list
43862980|NCT02588105|Olaparib|olaparib|mesh-list
43862981|NCT02588105|AZD0156|azd0156|mesh-list
43862982|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
43862983|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
43862984|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862985|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862986|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862995|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
43862996|NCT02588105|Vitamins|vitamins|mesh-ancestor
43862997|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
43862998|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43862999|NCT02588105|Hematinics|hematinics|mesh-ancestor
43863000|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863010|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
43863011|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43863012|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
43863013|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43863014|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863015|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43863016|NCT02586623|Droxidopa|droxidopa|mesh-list
43863017|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43863018|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43863019|NCT02582359|Cytarabine|cytarabine|mesh-list
43863020|NCT02582359|Daunorubicin|daunorubicin|mesh-list
43863021|NCT02582359|Ixazomib|ixazomib|mesh-list
43863022|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863023|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
43863024|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863025|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863026|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
43863027|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863028|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863029|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
43863030|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863031|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43863032|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863033|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863034|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863035|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
43863036|NCT02581137|Metformin|metformin|mesh-list
43863037|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43863038|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863039|NCT02579044|Everolimus|everolimus|mesh-list
44366168|NCT01169805|Ondansetron|ondansetron|mesh-list
44366169|NCT01169805|Palonosetron|palonosetron|mesh-list
44366170|NCT01169805|Ramosetron|ramosetron|mesh-list
44366171|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
44366172|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
43678019|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
43863040|NCT02579044|Lonafarnib|lonafarnib|mesh-list
43863041|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863042|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863043|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
43863044|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863045|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863046|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863056|NCT02573337|Lidocaine|lidocaine|mesh-list
43863062|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863063|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43863064|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43863065|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43658197|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43658198|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43658199|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863066|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863067|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863068|NCT02564978|Minocycline|minocycline|mesh-list
43863069|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43863070|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863071|NCT02562443|ON 01910|on 01910|mesh-list
43863072|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863073|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863074|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863075|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863076|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
43863077|NCT02562365|Carboplatin|carboplatin|mesh-list
43863078|NCT02562365|Etoposide|etoposide|mesh-list
43863079|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863080|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
43863081|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863082|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863083|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863084|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
43863085|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863087|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863088|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863089|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863090|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863091|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863092|NCT02559778|Eflornithine|eflornithine|mesh-list
43863093|NCT02559778|Sorafenib|sorafenib|mesh-list
43863094|NCT02559778|Dasatinib|dasatinib|mesh-list
44366173|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366174|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366175|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366176|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
44366177|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44366178|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44366179|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
44366180|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366181|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366182|NCT01169805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44366183|NCT01169805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44366184|NCT01169805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366185|NCT01169805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44366186|NCT01169805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604290|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604291|NCT03238612|Clarithromycin|clarithromycin|mesh-list
43604292|NCT03238612|Oseltamivir|oseltamivir|mesh-list
43604293|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
43604294|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604297|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366187|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44366188|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
44366189|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366190|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366191|NCT01169857|Bortezomib|bortezomib|mesh-list
44366192|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43863095|NCT02559778|Vorinostat|vorinostat|mesh-list
43863096|NCT02559778|Ceritinib|ceritinib|mesh-list
43863097|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863098|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863099|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863100|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863101|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43863102|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43863103|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43863104|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43863105|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863106|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43863107|NCT02556424|Dexamethasone|dexamethasone|mesh-list
43863108|NCT02556424|Triamcinolone|triamcinolone|mesh-list
43863109|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863110|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
43863111|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
43863112|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863113|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863114|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863115|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
43863116|NCT02556424|Hormones|hormones|mesh-ancestor
43863117|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863118|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863119|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863120|NCT02553447|Vitamin D|vitamin d|mesh-list
43863121|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
43863122|NCT02553447|Vitamins|vitamins|mesh-ancestor
43863123|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
43863124|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863125|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43863126|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43863127|NCT02552641|Amoxicillin|amoxicillin|mesh-list
43863131|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863132|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44366193|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366194|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
44366195|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366196|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366197|NCT01169870|Paclitaxel|paclitaxel|mesh-list
44366198|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44366199|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366200|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366201|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366202|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366203|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366204|NCT01169909|Ranibizumab|ranibizumab|mesh-list
44366205|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44366206|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44366207|NCT01169909|Growth Substances|growth substances|mesh-ancestor
44366208|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366209|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
44366210|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658228|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43658229|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
43658230|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366211|NCT01169922|Ethanol|ethanol|mesh-list
44366212|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44366213|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366214|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366215|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366216|NCT01169935|Dextrans|dextrans|mesh-list
44366217|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
44366218|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
44366219|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
44366220|NCT01170052|Sirolimus|sirolimus|mesh-list
44366221|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44366222|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44366223|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
44366224|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366225|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863133|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863134|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43863135|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863136|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863137|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43863138|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43863139|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43863140|NCT02551237|Capecitabine|capecitabine|mesh-list
44366226|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366227|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366228|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44366229|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
44366230|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366231|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
44366232|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366233|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
44366234|NCT01170078|Hematinics|hematinics|mesh-ancestor
44366235|NCT01170104|Sorafenib|sorafenib|mesh-list
44366236|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366237|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366238|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366239|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366240|NCT01170130|Lidocaine|lidocaine|mesh-list
44366241|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
44366242|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
44366243|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366244|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366245|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
43863141|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863142|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
43863143|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863144|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863145|NCT02549898|Cilostazol|cilostazol|mesh-list
43863146|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43863147|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43863148|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
43863149|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863150|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863151|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43863152|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
43863153|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43863154|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43863155|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863156|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43863157|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
43863158|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43863159|NCT02549898|Protective Agents|protective agents|mesh-ancestor
43863160|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43658251|NCT02946437|Midazolam|midazolam|mesh-list
43863161|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43863162|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863163|NCT02549898|Hematinics|hematinics|mesh-ancestor
43863164|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43863165|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43863166|NCT02549833|Poly I-C|poly i-c|mesh-list
43863167|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43863168|NCT02549833|Poly ICLC|poly iclc|mesh-list
43863169|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
43863170|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
43863171|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863172|NCT02549833|Laxatives|laxatives|mesh-ancestor
43863173|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863174|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
43863175|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863176|NCT02548364|Vitamin D|vitamin d|mesh-list
43863177|NCT02548364|Calcifediol|calcifediol|mesh-list
44366246|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366247|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44366248|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44366249|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44366250|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44366251|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366252|NCT01170143|Trastuzumab|trastuzumab|mesh-list
44366253|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44366254|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366255|NCT01170169|Omeprazole|omeprazole|mesh-list
44366256|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44366257|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366258|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44366259|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366260|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366261|NCT01170182|Omeprazole|omeprazole|mesh-list
44366262|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44366263|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366264|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44366265|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382387|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604327|NCT03238092|Hormones|hormones|mesh-ancestor
43604328|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604329|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604330|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43604331|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
43604332|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43604333|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43604334|NCT03238092|Androgens|androgens|mesh-ancestor
43658267|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658268|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658269|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43658271|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
43658272|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43658273|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658274|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
44366266|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366267|NCT01170260|Ethanol|ethanol|mesh-list
44366268|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44366269|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366270|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366271|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366272|NCT01170325|Valproic Acid|valproic acid|mesh-list
44366273|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
44366274|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366275|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366276|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
44021447|NCT01701622|Febuxostat|febuxostat|mesh-list
44366277|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366278|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366280|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43863178|NCT02548364|Vitamins|vitamins|mesh-ancestor
43863179|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
43545553|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44366281|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366282|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44366283|NCT01170338|Varenicline|varenicline|mesh-list
44366284|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44366285|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44366286|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
44366287|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366288|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366289|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366290|NCT01170351|Cyclosporine|cyclosporine|mesh-list
44366291|NCT01170351|Cyclosporins|cyclosporins|mesh-list
44366292|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366293|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366294|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366295|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
43649254|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44366296|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366297|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
44366298|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366299|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
44366300|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366301|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44366302|NCT01170429|Procaterol|procaterol|mesh-list
44366303|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44366304|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
44366305|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366306|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366307|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43649255|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649256|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
43649257|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
43649258|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649259|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
43649260|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649261|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649262|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366308|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366328|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366329|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366330|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366331|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
44366332|NCT01170494|Vitamin D|vitamin d|mesh-list
44366333|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
44366334|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366335|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366336|NCT01170494|Vitamins|vitamins|mesh-ancestor
44366337|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
44366338|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366339|NCT01170507|Vitamin D|vitamin d|mesh-list
44366340|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
44366341|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
44366342|NCT01170507|Vitamins|vitamins|mesh-list
44366343|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
44366344|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366345|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366346|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366347|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44366348|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44366349|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44366381|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44366382|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366383|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44366384|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44366385|NCT01170767|Growth Substances|growth substances|mesh-ancestor
44366386|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366387|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
44366388|NCT01170780|Dexamethasone|dexamethasone|mesh-list
44366389|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366390|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
44366391|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
44366392|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366393|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366394|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366395|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
44366396|NCT01170780|Hormones|hormones|mesh-ancestor
44366397|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366398|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366399|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366400|NCT01170806|Orlistat|orlistat|mesh-list
44366401|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366402|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366403|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44366404|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44366405|NCT01170819|Dinoprostone|dinoprostone|mesh-list
44366406|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
43863180|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863181|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43863182|NCT02543944|Clonidine|clonidine|mesh-list
43863183|NCT02543944|Naltrexone|naltrexone|mesh-list
43863184|NCT02543944|Buprenorphine|buprenorphine|mesh-list
43863185|NCT02543944|Gabapentin|gabapentin|mesh-list
43863186|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43863187|NCT02543944|Narcotics|narcotics|mesh-ancestor
43863188|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863189|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863190|NCT02543944|Analgesics|analgesics|mesh-ancestor
43863191|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
43863192|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863193|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43863194|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
43863195|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43863196|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43863197|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43863198|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43863199|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43863200|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546521|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
44366407|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44366408|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366409|NCT01170845|Sivelestat|sivelestat|mesh-list
44366410|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44366411|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44366412|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366413|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366414|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44366415|NCT01170858|Icodextrin|icodextrin|mesh-list
44366416|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
44366417|NCT01170871|Pemetrexed|pemetrexed|mesh-list
44366418|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366419|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366420|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366421|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44366422|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366423|NCT01171092|Bortezomib|bortezomib|mesh-list
44366424|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366426|NCT01171170|Bevacizumab|bevacizumab|mesh-list
44366427|NCT01171170|Carboplatin|carboplatin|mesh-list
44366428|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43863201|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863205|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
43863206|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
43863207|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43863208|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43863209|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43863210|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
43863211|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43863212|NCT02542969|Simvastatin|simvastatin|mesh-list
43863213|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43863214|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43863215|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
43863216|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863217|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43863218|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43863219|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863220|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
43863221|NCT02538510|Vorinostat|vorinostat|mesh-list
43863222|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863223|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863224|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43863225|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863226|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863227|NCT02538484|Letrozole|letrozole|mesh-list
43863228|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649263|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43649264|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649265|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649266|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43649267|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
43649268|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
43649269|NCT03030716|Procyanidin|procyanidin|mesh-list
43649270|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43649271|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649272|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
43863229|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43863230|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43863231|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863232|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863233|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43863234|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
43863235|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863236|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366429|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
44366430|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44366431|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366432|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366433|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366434|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366435|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366436|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44366437|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44366438|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44366439|NCT01171170|Growth Substances|growth substances|mesh-ancestor
43678223|NCT02863120|Bupivacaine|bupivacaine|mesh-list
43863237|NCT02538198|Lenalidomide|lenalidomide|mesh-list
43863238|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
43863239|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863240|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863241|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863242|NCT02538198|Growth Substances|growth substances|mesh-ancestor
43863243|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
43863244|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134113|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44134114|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
44134115|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134116|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134117|NCT00157105|Factor VIII|factor viii|mesh-list
44134118|NCT00157105|Coagulants|coagulants|mesh-ancestor
44134119|NCT00157118|Protein C|protein c|mesh-list
44134120|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
44134121|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44134122|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134123|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134124|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44134125|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
44134126|NCT00157131|Coagulants|coagulants|mesh-ancestor
44134127|NCT00157235|Bromides|bromides|mesh-list
44134128|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
44134129|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44134130|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
44134131|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134132|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134133|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44134134|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134135|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
44134136|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44134137|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
44134138|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134139|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134140|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
44134141|NCT00157261|Tenecteplase|tenecteplase|mesh-list
44134142|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44134144|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134146|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44134147|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134148|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
44134149|NCT00157300|Hematinics|hematinics|mesh-ancestor
44134150|NCT00157326|Tadalafil|tadalafil|mesh-list
44134151|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658286|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658287|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44134152|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44134153|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44134154|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134155|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134156|NCT00157326|Urological Agents|urological agents|mesh-ancestor
44134157|NCT00157378|Haloperidol|haloperidol|mesh-list
44366440|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366441|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44366442|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
44366443|NCT01171209|Interferons|interferons|mesh-list
44366444|NCT01171209|Interferon-beta|interferon-beta|mesh-list
44366445|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
44366446|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
44366447|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366448|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
44366449|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366450|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
44366451|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366452|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44366453|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44366454|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44366455|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366456|NCT01171326|Minocycline|minocycline|mesh-list
44366457|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366458|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366459|NCT01171365|Ciclesonide|ciclesonide|mesh-list
44366460|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
44366461|NCT01171365|Hormones|hormones|mesh-ancestor
44366462|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366463|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366464|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44366465|NCT01171378|Ofatumumab|ofatumumab|mesh-list
44366466|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366467|NCT01171456|Metformin|metformin|mesh-list
44366468|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366469|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366470|NCT01171469|Imiquimod|imiquimod|mesh-list
44366471|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44366472|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
43586161|NCT03413371|Lidocaine|lidocaine|mesh-list
44134158|NCT00157378|Risperidone|risperidone|mesh-list
44134159|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
44134160|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44134161|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
44134162|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134163|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134164|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134165|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44134166|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134167|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366473|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366474|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366475|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
44366476|NCT01171482|Fluorouracil|fluorouracil|mesh-list
44366477|NCT01171482|Sorafenib|sorafenib|mesh-list
44366478|NCT01171482|Mitomycins|mitomycins|mesh-list
44366479|NCT01171482|Mitomycin|mitomycin|mesh-list
44366480|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
44366481|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366482|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366483|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366484|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366485|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
44366486|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366487|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366488|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366489|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44366490|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
44366491|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366492|NCT01171547|Daptomycin|daptomycin|mesh-list
44366493|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366494|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366495|NCT01171651|Sorafenib|sorafenib|mesh-list
44366496|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366497|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366498|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366499|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366500|NCT01171755|Gemcitabine|gemcitabine|mesh-list
44021652|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366501|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366502|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
44366503|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134168|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134169|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44134170|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
44134171|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
44134172|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
44134173|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134174|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134175|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44134176|NCT00157482|Simvastatin|simvastatin|mesh-list
44134177|NCT00157482|Ezetimibe|ezetimibe|mesh-list
44134178|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44134179|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44366504|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366505|NCT01171755|Antiviral Agents|antiviral agents|mesh-ancestor
44366506|NCT01171755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366507|NCT01171755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366508|NCT01171755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366509|NCT01171755|Immunologic Factors|immunologic factors|mesh-ancestor
44366510|NCT01171755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366512|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366513|NCT01171807|Dexamethasone|dexamethasone|mesh-list
44366514|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44366515|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366516|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
44366517|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
44366518|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366519|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366520|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366521|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
44366522|NCT01171807|Hormones|hormones|mesh-ancestor
44366523|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366524|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366525|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366526|NCT01171833|Sevoflurane|sevoflurane|mesh-list
44366527|NCT01171833|Desflurane|desflurane|mesh-list
44366528|NCT01171833|Isoflurane|isoflurane|mesh-list
44366529|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44366530|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44366531|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
44366532|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
44366533|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366534|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649273|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649274|NCT03030716|Protective Agents|protective agents|mesh-ancestor
43649275|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649276|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43649277|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43649278|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649279|NCT03031119|Atorvastatin|atorvastatin|mesh-list
43604335|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43604336|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366535|NCT01171859|Doxycycline|doxycycline|mesh-list
44366536|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44366537|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366538|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366539|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
44366540|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44366541|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134180|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
44366547|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
44366548|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366549|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366550|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
44366551|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366552|NCT01171911|Nicardipine|nicardipine|mesh-list
44366553|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
44366554|NCT01171911|Esmolol|esmolol|mesh-list
44366555|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366556|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366557|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44366558|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44366559|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44366560|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
44366561|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366562|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366563|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44366564|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44366565|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
44366566|NCT01172002|Azathioprine|azathioprine|mesh-list
44366567|NCT01172002|Leflunomide|leflunomide|mesh-list
44366568|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
44366569|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366570|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366571|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366572|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366573|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
44134181|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863249|NCT02535533|Selenium|selenium|mesh-list
43863250|NCT02535533|Axitinib|axitinib|mesh-list
43863251|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863252|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366574|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366575|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366576|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366577|NCT01172028|Docetaxel|docetaxel|mesh-list
44366578|NCT01172028|Pemetrexed|pemetrexed|mesh-list
43604337|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
43604338|NCT03238157|Hormones|hormones|mesh-ancestor
43604339|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604340|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604341|NCT03237936|Cyclosporine|cyclosporine|mesh-list
43604342|NCT03237936|Cyclosporins|cyclosporins|mesh-list
43604343|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604344|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604345|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604346|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
43604347|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604370|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
44366579|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366580|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366581|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366582|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366583|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366584|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366585|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44366586|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366587|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44366588|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43863253|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863254|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863255|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
43863256|NCT02535533|Protective Agents|protective agents|mesh-ancestor
43863257|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863258|NCT02535533|Trace Elements|trace elements|mesh-ancestor
43863259|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
43863260|NCT02531308|Metformin|metformin|mesh-list
43863261|NCT02531308|Prednisone|prednisone|mesh-list
43863262|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
43863263|NCT02531308|Rituximab|rituximab|mesh-list
43863264|NCT02531308|Doxorubicin|doxorubicin|mesh-list
43863265|NCT02531308|Vincristine|vincristine|mesh-list
43863266|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863267|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
43863268|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863269|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863270|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863271|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
43863272|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863273|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863274|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863275|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863276|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43863277|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43863278|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863279|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863280|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863284|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863285|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863286|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863287|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863288|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863289|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863291|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43863292|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
43863293|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863294|NCT02523976|Cytarabine|cytarabine|mesh-list
43863295|NCT02523976|Dexamethasone|dexamethasone|mesh-list
43863296|NCT02523976|Prednisone|prednisone|mesh-list
43863297|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
43863298|NCT02523976|Methotrexate|methotrexate|mesh-list
43863299|NCT02523976|Etoposide|etoposide|mesh-list
43863300|NCT02523976|Vincristine|vincristine|mesh-list
43863301|NCT02523976|Daunorubicin|daunorubicin|mesh-list
43863302|NCT02523976|Dasatinib|dasatinib|mesh-list
43863303|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
43863304|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
44366589|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366591|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
44366592|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366593|NCT01172171|Protective Agents|protective agents|mesh-ancestor
44366594|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366595|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366596|NCT01172223|Paclitaxel|paclitaxel|mesh-list
44366597|NCT01172223|Doxorubicin|doxorubicin|mesh-list
44366598|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44366599|NCT01172223|Lapatinib|lapatinib|mesh-list
44366600|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44366601|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366602|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366603|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366604|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366605|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366606|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44366607|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44366608|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44366609|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366610|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366611|NCT01172236|Lactoferrin|lactoferrin|mesh-list
44366612|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366613|NCT01172392|Interferons|interferons|mesh-list
44366614|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
44366615|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
44366616|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44366617|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366635|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44366637|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44366638|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44366639|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
44366640|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366641|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44366642|NCT01172431|Indapamide|indapamide|mesh-list
44366643|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44366644|NCT01172431|Diuretics|diuretics|mesh-ancestor
44366645|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
44366646|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366647|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44366648|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44366649|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366650|NCT01172444|Mesalamine|mesalamine|mesh-list
44366651|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44366652|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366653|NCT01172444|Analgesics|analgesics|mesh-ancestor
43863305|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863306|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
43863307|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863308|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863309|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863310|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
43863311|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863312|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863313|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863314|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863315|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
43863316|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
43863317|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863318|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863319|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
43863320|NCT02523976|Hormones|hormones|mesh-ancestor
43863321|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863322|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863323|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43863324|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
43863325|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43863326|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863327|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
43863328|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863329|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863330|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43863331|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43863332|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863333|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863334|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863335|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
43863336|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863337|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863338|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366654|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
44366655|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366656|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366657|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366658|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366659|NCT01172470|Gemcitabine|gemcitabine|mesh-list
44366660|NCT01172470|Carboplatin|carboplatin|mesh-list
44366661|NCT01172470|Pemetrexed|pemetrexed|mesh-list
44366662|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604386|NCT03237533|Doxycycline|doxycycline|mesh-list
43604387|NCT03237533|Nystatin|nystatin|mesh-list
43604388|NCT03237533|Dexamethasone|dexamethasone|mesh-list
43604389|NCT03237533|Triamcinolone|triamcinolone|mesh-list
43604390|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43604391|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
43604392|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
43604393|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604394|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604395|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604396|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
43604397|NCT03237533|Hormones|hormones|mesh-ancestor
43658384|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366663|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44366664|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
44366665|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366666|NCT01172470|Antiviral Agents|antiviral agents|mesh-ancestor
44366667|NCT01172470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366668|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366669|NCT01172470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366670|NCT01172470|Immunologic Factors|immunologic factors|mesh-ancestor
44366671|NCT01172470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366672|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44366673|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366674|NCT01172496|Treprostinil|treprostinil|mesh-list
44366675|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44366676|NCT01172509|Baclofen|baclofen|mesh-list
44366677|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44366678|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366679|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44366680|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366681|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44366682|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
44366683|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
44366684|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366685|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863339|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863340|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43863341|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863342|NCT02523976|Analgesics|analgesics|mesh-ancestor
43863343|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
43863344|NCT02523040|Lenalidomide|lenalidomide|mesh-list
43863345|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
43863346|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863347|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863348|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863349|NCT02523040|Growth Substances|growth substances|mesh-ancestor
43863350|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
44366686|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
44366687|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366688|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44366689|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366690|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366691|NCT01172626|Valproic Acid|valproic acid|mesh-list
44366692|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
44366693|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366694|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366695|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
44366696|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366697|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366698|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
44366699|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44366700|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366701|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44366702|NCT01172652|Ziprasidone|ziprasidone|mesh-list
44366703|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44366704|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
44366705|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366706|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366707|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366708|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44366709|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44366710|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366711|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44366712|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43863351|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863352|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
43863353|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863357|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863358|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863359|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863360|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863361|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
43863362|NCT02518945|Liraglutide|liraglutide|mesh-list
43863363|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43863364|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863365|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43863366|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863367|NCT02518945|Incretins|incretins|mesh-ancestor
43863368|NCT02518945|Hormones|hormones|mesh-ancestor
43863369|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863370|NCT02516670|Vitamins|vitamins|mesh-list
43863371|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
43863372|NCT02516670|Docetaxel|docetaxel|mesh-list
43863373|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
44366714|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
44366715|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44366716|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
44366717|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366718|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366719|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44366720|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366721|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44366722|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
44366723|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366724|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366725|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44366726|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
44366727|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
44366728|NCT01172691|Protective Agents|protective agents|mesh-ancestor
44366729|NCT01172717|Panitumumab|panitumumab|mesh-list
44366730|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44366731|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366733|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
43863374|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863375|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863376|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863377|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863378|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863379|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863380|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
43863381|NCT02516670|Protective Agents|protective agents|mesh-ancestor
43863382|NCT02514382|Dexamethasone|dexamethasone|mesh-list
43863383|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
43604493|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604494|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
43604495|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604496|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863384|NCT02514382|Bortezomib|bortezomib|mesh-list
43863385|NCT02514382|Ichthammol|ichthammol|mesh-list
43863386|NCT02514382|BB 1101|bb 1101|mesh-list
43863387|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863388|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
43863389|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
43863390|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863391|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863392|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863393|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
43863394|NCT02514382|Hormones|hormones|mesh-ancestor
43863395|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863396|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863397|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863398|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
43863399|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863400|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863401|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863402|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
43863403|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43863404|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43863406|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
43863407|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863408|NCT02513563|Paclitaxel|paclitaxel|mesh-list
43863409|NCT02513563|Carboplatin|carboplatin|mesh-list
44366734|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366735|NCT01172769|Sirolimus|sirolimus|mesh-list
44366736|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
44366737|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366738|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366739|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44366740|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366741|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
44366742|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44366743|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
44366744|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366745|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366746|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863410|NCT02513563|Adavosertib|adavosertib|mesh-list
43863411|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863412|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863413|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863414|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863415|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863416|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863417|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863418|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
43863419|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43863420|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43863421|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863422|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863423|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
43604539|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658427|NCT02945163|Tenofovir|tenofovir|mesh-list
43863424|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863425|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863426|NCT02507687|Bimatoprost|bimatoprost|mesh-list
43863427|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43863428|NCT02507336|Thalidomide|thalidomide|mesh-list
43863448|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863449|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863450|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863451|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863452|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863453|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863454|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
43863455|NCT02498912|Fludarabine|fludarabine|mesh-list
43863456|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863457|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
43863458|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863459|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863460|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863461|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
43863462|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863463|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863464|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863465|NCT02498600|Nivolumab|nivolumab|mesh-list
43863466|NCT02498600|Ipilimumab|ipilimumab|mesh-list
43863467|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863468|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863469|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43863470|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863471|NCT02496780|Insulin|insulin|mesh-list
43863472|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43863473|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
43863474|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
43863475|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366747|NCT01172782|Hydromorphone|hydromorphone|mesh-list
44366748|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43649308|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649309|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
43649310|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649311|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649312|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
43649313|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649314|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43604549|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850616|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
43850617|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850618|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658434|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658435|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658436|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43658437|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43658438|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43658439|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43658441|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44366749|NCT01172782|Narcotics|narcotics|mesh-ancestor
44366750|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366751|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366752|NCT01172782|Analgesics|analgesics|mesh-ancestor
44366753|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
44366754|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366755|NCT01172912|Dexamethasone|dexamethasone|mesh-list
44366756|NCT01172912|Cisplatin|cisplatin|mesh-list
44366757|NCT01172912|Carboplatin|carboplatin|mesh-list
44366758|NCT01172912|Etoposide|etoposide|mesh-list
44366759|NCT01172912|Ifosfamide|ifosfamide|mesh-list
44366760|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366761|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
44366762|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
43863476|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863478|NCT02495896|Paclitaxel|paclitaxel|mesh-list
43863479|NCT02495896|Docetaxel|docetaxel|mesh-list
43863480|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43863481|NCT02495896|Cisplatin|cisplatin|mesh-list
43863482|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863483|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863484|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863485|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863486|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863493|NCT02495896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863494|NCT02495896|Immunologic Factors|immunologic factors|mesh-ancestor
43863495|NCT02495896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863496|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43863497|NCT02493322|Olmesartan|olmesartan|mesh-list
43863498|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43863499|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
43863500|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43863501|NCT02493322|Diuretics|diuretics|mesh-ancestor
43863502|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
43863503|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863504|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43863505|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863506|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863507|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43863508|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43863509|NCT02491632|Dexamethasone|dexamethasone|mesh-list
43863510|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
43863511|NCT02491632|Ichthammol|ichthammol|mesh-list
43863512|NCT02491632|BB 1101|bb 1101|mesh-list
43863513|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863514|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
43863515|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
43863516|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863517|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863518|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863519|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
43863520|NCT02491632|Hormones|hormones|mesh-ancestor
43863521|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863522|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863523|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863524|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
43863525|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863526|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863527|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863528|NCT02489695|Axitinib|axitinib|mesh-list
43863529|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546523|NCT03661463|Aspirin|aspirin|mesh-list
44366763|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366764|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366766|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
44366767|NCT01172912|Hormones|hormones|mesh-ancestor
44366768|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604636|NCT03236155|Analgesics|analgesics|mesh-ancestor
43604637|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
43604670|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44366769|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366770|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366771|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44366772|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44366773|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863530|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863531|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863532|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863533|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
43863534|NCT02484391|Cytarabine|cytarabine|mesh-list
43863535|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
43863536|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863537|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
43863538|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863539|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863540|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
43863541|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863542|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863543|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
43863544|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863545|NCT02484391|Analgesics|analgesics|mesh-ancestor
43863546|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
43863547|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863548|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863549|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863550|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863551|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
43863552|NCT02484391|Protective Agents|protective agents|mesh-ancestor
43863553|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
43863554|NCT02484391|Vitamins|vitamins|mesh-ancestor
43863555|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
43863562|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
43863563|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863564|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43863565|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863566|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863567|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43863568|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43863569|NCT02479451|Theophylline|theophylline|mesh-list
43863570|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43863571|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
43863572|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382388|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604678|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
43604679|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604680|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604705|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43604707|NCT03235700|Vitamins|vitamins|mesh-ancestor
43604708|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
43604709|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
43604710|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43863573|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863574|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43863575|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
43863576|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43863577|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863578|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863579|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
43863580|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43863581|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43863582|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
43863583|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863584|NCT02478320|Ilorasertib|ilorasertib|mesh-list
44366775|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366776|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44366777|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
44366778|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
44366779|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44366780|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
44366781|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366782|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366783|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44366784|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366785|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
43678496|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
43863585|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863586|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863587|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863588|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863590|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43863591|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382389|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43649325|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649326|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43649327|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43649328|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43649329|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863592|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863593|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863594|NCT02473497|Crizotinib|crizotinib|mesh-list
43863595|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863596|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863597|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863598|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863599|NCT02466334|Calcitonin|calcitonin|mesh-list
43863600|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
43863601|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43863602|NCT02466334|Katacalcin|katacalcin|mesh-list
43863603|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43863604|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863605|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43863606|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
43863607|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
43863608|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43863609|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43863610|NCT02464696|Prednisolone|prednisolone|mesh-list
43863611|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
43863612|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43863613|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
43863614|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863615|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
43863616|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
43863617|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863618|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863619|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863620|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
43863621|NCT02464696|Hormones|hormones|mesh-ancestor
43863622|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863623|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43863630|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43863631|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863632|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43863633|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863634|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
43863635|NCT02461537|Analgesics|analgesics|mesh-ancestor
43863636|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
44366786|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44366787|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
44366788|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366789|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366790|NCT01172964|Flucytosine|flucytosine|mesh-list
44366791|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
44366792|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366793|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
44366794|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366795|NCT01173003|Misoprostol|misoprostol|mesh-list
44366796|NCT01173003|Mifepristone|mifepristone|mesh-list
43678505|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863637|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863638|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863639|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863640|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863641|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863642|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863643|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863644|NCT02460874|Glyburide|glyburide|mesh-list
43863645|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43863646|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863647|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
43863648|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43863649|NCT02460445|Cyproterone|cyproterone|mesh-list
43863650|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43850633|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863651|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43863652|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43863653|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
43863654|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43863655|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863656|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43863657|NCT02460445|Estrogens|estrogens|mesh-ancestor
43863658|NCT02460445|Hormones|hormones|mesh-ancestor
43863659|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863660|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
43863661|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
43863662|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863663|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43863664|NCT02456857|Bevacizumab|bevacizumab|mesh-list
43863665|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43863666|NCT02456857|Doxorubicin|doxorubicin|mesh-list
43863667|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43863668|NCT02456857|Everolimus|everolimus|mesh-list
43863669|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
43863670|NCT02456857|Antibodies|antibodies|mesh-list
43863671|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
43863672|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43863673|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
43863674|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863675|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863676|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863677|NCT02456857|Growth Substances|growth substances|mesh-ancestor
43863678|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863679|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
43863680|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
43863681|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43863682|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863683|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863684|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863685|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649364|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649365|NCT03030105|Scopolamine|scopolamine|mesh-list
43649366|NCT03030105|Donepezil|donepezil|mesh-list
43649367|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43649368|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43604714|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604715|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604717|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604718|NCT03235245|Nivolumab|nivolumab|mesh-list
43604719|NCT03235245|Ipilimumab|ipilimumab|mesh-list
43658508|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43658509|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658510|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658511|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863686|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863687|NCT02456532|Zolpidem|zolpidem|mesh-list
43863688|NCT02456532|Eszopiclone|eszopiclone|mesh-list
44366798|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
44366799|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44366800|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366801|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44366802|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366803|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
44366804|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44366805|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44366806|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44366807|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44366808|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
44366809|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43678518|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863689|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43863690|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43863691|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863692|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863693|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43863700|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863701|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43863702|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
43863703|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863704|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863705|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43863706|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
43863707|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
43863708|NCT02455687|Hormones|hormones|mesh-ancestor
43863709|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863710|NCT02455687|Analgesics|analgesics|mesh-ancestor
43863711|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
43863712|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
43863713|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863714|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43863715|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
43863716|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43863717|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863718|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863719|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43863720|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
43863721|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44134182|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44134183|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44134184|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134185|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
44134186|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44134187|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44134188|NCT00157508|Analgesics|analgesics|mesh-ancestor
44134189|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
44134190|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134191|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134192|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44134193|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134194|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44134195|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134196|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134197|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44366810|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44366811|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
44366812|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366813|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
44366814|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44366815|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44366816|NCT01173068|Ertapenem|ertapenem|mesh-list
44366817|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366818|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366819|NCT01173081|Teriparatide|teriparatide|mesh-list
44366820|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44366821|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366822|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44366823|NCT01173107|Colchicine|colchicine|mesh-list
44366824|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
44366825|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366826|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366827|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366828|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366829|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366830|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366831|NCT01173172|Boron|boron|mesh-list
44366832|NCT01173172|Trace Elements|trace elements|mesh-ancestor
44366833|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
44366834|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678530|NCT02860858|Aflibercept|aflibercept|mesh-list
44134198|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44134199|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
44134200|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134201|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
44134202|NCT00157547|Citalopram|citalopram|mesh-list
44134203|NCT00157547|Fluoxetine|fluoxetine|mesh-list
44134204|NCT00157547|Paroxetine|paroxetine|mesh-list
44134205|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44134206|NCT00157547|Sertraline|sertraline|mesh-list
44134207|NCT00157547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44134208|NCT00157547|Serotonin|serotonin|mesh-list
44134209|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44134210|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134211|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134212|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134213|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
44134214|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604720|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604721|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604722|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43604723|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604724|NCT03235037|Levodopa|levodopa|mesh-list
43604725|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43604726|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43604727|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
43604728|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850640|NCT05353062|Hemostatics|hemostatics|mesh-list
43658512|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43658513|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134215|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44134216|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44134217|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134218|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44134219|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134220|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547333|NCT03653520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44366836|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
44366838|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44366839|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366840|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366841|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44366842|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
44366843|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
44366844|NCT01173315|Vitamins|vitamins|mesh-list
44366845|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
44366846|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366847|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
44366848|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44366849|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44366850|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44134221|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44134222|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44134225|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134226|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44134227|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44134229|NCT00157586|Delapril|delapril|mesh-list
44134230|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43863722|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
43863723|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43863724|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
43863725|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863726|NCT02445651|Expectorants|expectorants|mesh-ancestor
43863727|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
43863728|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43863729|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
43863730|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863731|NCT02445651|Protective Agents|protective agents|mesh-ancestor
43863732|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863733|NCT02445651|Antidotes|antidotes|mesh-ancestor
43863734|NCT02444546|Sargramostim|sargramostim|mesh-list
43863735|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
43863736|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863737|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
43863738|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43863739|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43863740|NCT02444429|Prednisolone|prednisolone|mesh-list
43863741|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
43863742|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43863743|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
43863744|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863745|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
43863746|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
43863747|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863748|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863749|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863750|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
43863752|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863753|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43863754|NCT02444429|Protective Agents|protective agents|mesh-ancestor
43863755|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366852|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
44366853|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366854|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44366855|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44366856|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366857|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366858|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44366859|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366860|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
44366861|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44366862|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366863|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44366864|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44366865|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366866|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863756|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863757|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
43863758|NCT02443324|Ramucirumab|ramucirumab|mesh-list
43863759|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863760|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863761|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
43863762|NCT02442180|Prednisolone|prednisolone|mesh-list
43863763|NCT02442180|Lenograstim|lenograstim|mesh-list
43863764|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43863765|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
43863766|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863767|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863768|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
43863769|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
43863770|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863771|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604730|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863772|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
43863773|NCT02442180|Hormones|hormones|mesh-ancestor
43863774|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863775|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43863776|NCT02442180|Protective Agents|protective agents|mesh-ancestor
43863777|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863778|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863779|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
43863780|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43863781|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
43863782|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863783|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
43863784|NCT02432742|Protective Agents|protective agents|mesh-ancestor
43863785|NCT02429557|Midodrine|midodrine|mesh-list
43863786|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
43863787|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
43863788|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863792|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43863793|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43863794|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
43863795|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863796|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863797|NCT02427620|Cytarabine|cytarabine|mesh-list
43863798|NCT02427620|Dexamethasone|dexamethasone|mesh-list
43863799|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
43863800|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
44366867|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366868|NCT01173549|Canagliflozin|canagliflozin|mesh-list
44366869|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44366870|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366871|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366872|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366873|NCT01173562|Mebendazole|mebendazole|mesh-list
44366874|NCT01173562|Piperazine|piperazine|mesh-list
44366875|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
44366876|NCT01173562|DMP 777|dmp 777|mesh-list
44366877|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
44366878|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
44366879|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44366880|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366881|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44366882|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44366883|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44366884|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366885|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366886|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366887|NCT01173627|Fentanyl|fentanyl|mesh-list
44366888|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44366889|NCT01173627|Narcotics|narcotics|mesh-ancestor
44366890|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863802|NCT02427620|Doxorubicin|doxorubicin|mesh-list
43863803|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43863804|NCT02427620|Methotrexate|methotrexate|mesh-list
43863805|NCT02427620|Vincristine|vincristine|mesh-list
43863806|NCT02427620|Daunorubicin|daunorubicin|mesh-list
43863807|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43863809|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
43863810|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43863811|NCT02427620|BB 1101|bb 1101|mesh-list
43863812|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863813|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
43658561|NCT02944214|Febuxostat|febuxostat|mesh-list
43863814|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863815|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43863816|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863817|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
43863818|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863819|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863820|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863821|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863822|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
43863823|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
43863824|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863825|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863826|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
43863827|NCT02427620|Hormones|hormones|mesh-ancestor
43863828|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863829|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863830|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
43863831|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366891|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366893|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
44366894|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366895|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44366896|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44366897|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
44366898|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
44366899|NCT01173640|Midazolam|midazolam|mesh-list
44366900|NCT01173640|Resveratrol|resveratrol|mesh-list
44366901|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44366902|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44366903|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44366904|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366905|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44366906|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44366907|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43863832|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43863833|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43863834|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863835|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43863836|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
43863837|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43863838|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863839|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
43863840|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863841|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43863842|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43863843|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
43863844|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863845|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863846|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863847|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863848|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863849|NCT02425566|Trimethaphan|trimethaphan|mesh-list
43863850|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
43863851|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
43863852|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
43863853|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43863854|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43863855|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43863856|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
43863857|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863858|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863859|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43863860|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43658582|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43658583|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43658584|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
43863861|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
43863862|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863864|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43863865|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863866|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863867|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863868|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863869|NCT02422381|Gemcitabine|gemcitabine|mesh-list
43863870|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
43863871|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863872|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
43863873|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863874|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366909|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
44366911|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
44366912|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
44366913|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366914|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366915|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
44366916|NCT01173640|Protective Agents|protective agents|mesh-ancestor
44366917|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366918|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44366919|NCT01173809|Amiodarone|amiodarone|mesh-list
44366920|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44366921|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
44366922|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44366923|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43678619|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
43863875|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
43863876|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863877|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863878|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863879|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
43863880|NCT02422381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863881|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863882|NCT02420860|Lenalidomide|lenalidomide|mesh-list
43863883|NCT02420860|Elotuzumab|elotuzumab|mesh-list
43863884|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
43863885|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863886|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863887|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863888|NCT02420860|Growth Substances|growth substances|mesh-ancestor
43863889|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
43863890|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863891|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
43863892|NCT02420314|Paclitaxel|paclitaxel|mesh-list
43604764|NCT03234673|Tacrolimus|tacrolimus|mesh-list
43604765|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604766|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
43604767|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604768|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43604769|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604770|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604771|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863893|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43863894|NCT02420314|Carboplatin|carboplatin|mesh-list
43863895|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43863896|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863897|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863898|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863899|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863900|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863901|NCT02420314|Vitamins|vitamins|mesh-ancestor
43863902|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
43863903|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863904|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
43863905|NCT02420314|Protective Agents|protective agents|mesh-ancestor
43863906|NCT02418195|Ketamine|ketamine|mesh-list
43863907|NCT02418195|Analgesics|analgesics|mesh-ancestor
43863908|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
43863909|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863910|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863911|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43863912|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43863913|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
43863914|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
43863915|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863916|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43863917|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43863918|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44366926|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44366927|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44366928|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366929|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44366930|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44366931|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44366932|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
43604781|NCT03234244|Vitamin D|vitamin d|mesh-list
44366933|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366934|NCT01173926|Insulin|insulin|mesh-list
44366935|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44366936|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
44366937|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
43604829|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366938|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44366939|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366940|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366941|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44366942|NCT01173939|Pravastatin|pravastatin|mesh-list
44366943|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44366944|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44366945|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
44366946|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863919|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863920|NCT02415413|Dexamethasone|dexamethasone|mesh-list
43863921|NCT02415413|Lenalidomide|lenalidomide|mesh-list
43863922|NCT02415413|Melphalan|melphalan|mesh-list
43863923|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863924|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
43863925|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
43863926|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863927|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863928|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863929|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
43863930|NCT02415413|Hormones|hormones|mesh-ancestor
43863931|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43863932|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863933|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863934|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
43863935|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863936|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863942|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43863943|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863944|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
43863945|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863946|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43863947|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863948|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366951|NCT01173978|Hormones|hormones|mesh-list
43604830|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
44366952|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366953|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366954|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366955|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
44366956|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44366957|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366958|NCT01174017|Iodine|iodine|mesh-list
44366959|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
44366960|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43604831|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43604832|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43604833|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43604836|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
44366961|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366962|NCT01174017|Trace Elements|trace elements|mesh-ancestor
44366963|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
44366964|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366965|NCT01174056|Pioglitazone|pioglitazone|mesh-list
44366966|NCT01174056|Zileuton|zileuton|mesh-list
44366967|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
43863956|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
43863958|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863959|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863960|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
43863961|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43863962|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43863963|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43863964|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43863965|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43863966|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863967|NCT02403778|Ipilimumab|ipilimumab|mesh-list
43863968|NCT02403778|Tretinoin|tretinoin|mesh-list
43863969|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863970|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863971|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43863972|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863973|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
43863974|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
43863975|NCT02402439|Pancrelipase|pancrelipase|mesh-list
43863976|NCT02402439|Pancreatin|pancreatin|mesh-list
43863977|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43863978|NCT02401503|Venetoclax|venetoclax|mesh-list
43863979|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43863980|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
43863981|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863982|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863983|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
43863984|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863985|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44366968|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44366969|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604896|NCT03233815|Propofol|propofol|mesh-list
44366970|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44366971|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366972|NCT01174056|Analgesics|analgesics|mesh-ancestor
44366973|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
44366974|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366975|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44366976|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44366977|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44366978|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44366979|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44366980|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44366981|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
44366982|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44366983|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44366984|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
44366985|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44366986|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44366987|NCT01174212|Vancomycin|vancomycin|mesh-list
43678675|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43863986|NCT02400814|Atezolizumab|atezolizumab|mesh-list
43863987|NCT02400814|Antibodies|antibodies|mesh-list
43863988|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43863989|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
43863990|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863991|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863992|NCT02398240|Rituximab|rituximab|mesh-list
43863993|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43863994|NCT02398240|Doxorubicin|doxorubicin|mesh-list
43863995|NCT02398240|Vincristine|vincristine|mesh-list
43863996|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43863997|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863998|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
44382390|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
43604899|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604900|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604901|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604902|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
43604903|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
43604904|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43863999|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864000|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864001|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864002|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864003|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864004|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864005|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864010|NCT02395497|Antibodies|antibodies|mesh-list
43864011|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43864012|NCT02395497|Tacrolimus|tacrolimus|mesh-list
43864013|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
43864014|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864015|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864016|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43864017|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864018|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864019|NCT02394769|Aspirin|aspirin|mesh-list
43864020|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43864021|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44366988|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44366989|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44366990|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
44366991|NCT01174290|Haloperidol|haloperidol|mesh-list
44366992|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
44366993|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
44366994|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
44366995|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44366996|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44366997|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44366998|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44366999|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44367000|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367001|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44367002|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43864022|NCT02394769|Analgesics|analgesics|mesh-ancestor
43864023|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
43864024|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864025|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864026|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864028|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43864029|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43864030|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864031|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43864033|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864034|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
43864035|NCT02394535|Paclitaxel|paclitaxel|mesh-list
43864036|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43864037|NCT02394535|Capecitabine|capecitabine|mesh-list
43864038|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864039|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864040|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864041|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864042|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864043|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864044|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864045|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
43864046|NCT02393690|Iodine|iodine|mesh-list
43864047|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
43864048|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43864049|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864050|NCT02393690|Trace Elements|trace elements|mesh-ancestor
43864051|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
43864052|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864053|NCT02393157|Carboplatin|carboplatin|mesh-list
43825508|NCT05564286|Dexamethasone|dexamethasone|mesh-list
43864054|NCT02393157|Etoposide|etoposide|mesh-list
43864055|NCT02393157|Ifosfamide|ifosfamide|mesh-list
43864056|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
43864057|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864058|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864059|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864060|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864061|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864062|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864063|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864064|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
43864065|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864066|NCT02392572|TIC10 compound|tic10 compound|mesh-list
43864067|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864068|NCT02390869|Rituximab|rituximab|mesh-list
43864069|NCT02390869|Lenalidomide|lenalidomide|mesh-list
43547334|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44367003|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
44367004|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367005|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367006|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44367007|NCT01174303|Insulin|insulin|mesh-list
44367008|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44367009|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
44367010|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
44367011|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44367012|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
44367013|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44367014|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44367015|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367016|NCT01174394|Fluoxetine|fluoxetine|mesh-list
43678705|NCT02858817|Atovaquone|atovaquone|mesh-list
43864070|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864071|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864072|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
43864073|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864074|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604915|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604916|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604917|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43604918|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43604919|NCT03233321|Heparin|heparin|mesh-list
43604920|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43604921|NCT03233321|Tinzaparin|tinzaparin|mesh-list
43849194|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
43604922|NCT03233321|Dalteparin|dalteparin|mesh-list
43604923|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
43604924|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43604925|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43604926|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864075|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864076|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864077|NCT02390869|Growth Substances|growth substances|mesh-ancestor
43864078|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864079|NCT02389946|Sirolimus|sirolimus|mesh-list
43864080|NCT02389946|Everolimus|everolimus|mesh-list
43864084|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864085|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864086|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864087|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864088|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
43864089|NCT02389309|Sirolimus|sirolimus|mesh-list
43864090|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
43864091|NCT02389309|Dasatinib|dasatinib|mesh-list
43864092|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864093|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
43864094|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864095|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864096|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864097|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
43864098|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864099|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864101|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864102|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864103|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864104|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
43864105|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43864106|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864107|NCT02388178|Fluorides|fluorides|mesh-list
43864108|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
43864109|NCT02388178|Protective Agents|protective agents|mesh-ancestor
43864110|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864112|NCT02387203|Clarithromycin|clarithromycin|mesh-list
43864113|NCT02387203|Lansoprazole|lansoprazole|mesh-list
43864114|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864115|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864116|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43864117|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864118|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864119|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44367017|NCT01174394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43649374|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
44367018|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44367019|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367020|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367021|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367022|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
44367023|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367024|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44367025|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
44367026|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44367027|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44367028|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44367029|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367030|NCT01174420|Mitomycins|mitomycins|mesh-list
44367031|NCT01174420|Mitomycin|mitomycin|mesh-list
44367032|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44367033|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367034|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
43678717|NCT02858856|Mitogens|mitogens|mesh-ancestor
43864120|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43864121|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43864122|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43864123|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43864124|NCT02384668|Vitamin D|vitamin d|mesh-list
43605004|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605005|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605006|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43605007|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43605008|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605009|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43605010|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605011|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605012|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
43605013|NCT03232398|Warfarin|warfarin|mesh-list
43605014|NCT03232398|Apixaban|apixaban|mesh-list
43605015|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
43605016|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43605017|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
43605018|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43605019|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605020|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605021|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605022|NCT03232307|Dexamethasone|dexamethasone|mesh-list
43605023|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
43605024|NCT03232307|Rituximab|rituximab|mesh-list
43605025|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43605026|NCT03232307|Lenalidomide|lenalidomide|mesh-list
43605027|NCT03232307|Antibodies|antibodies|mesh-list
43864125|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
43864126|NCT02384668|Vitamins|vitamins|mesh-ancestor
43864127|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
43864128|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864129|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43864130|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43864131|NCT02384083|Dexamethasone|dexamethasone|mesh-list
43864132|NCT02384083|Pomalidomide|pomalidomide|mesh-list
43864133|NCT02384083|Filanesib|filanesib|mesh-list
43864134|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864135|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
43864136|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
43864137|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864138|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864139|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43864140|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
43864141|NCT02384083|Hormones|hormones|mesh-ancestor
43864142|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864143|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864144|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864145|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
43864146|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864147|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864148|NCT02384083|Growth Substances|growth substances|mesh-ancestor
43864149|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864150|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864151|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864152|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864153|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
43864154|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864155|NCT02380573|Methylene Blue|methylene blue|mesh-list
43864159|NCT02379377|Fluorides|fluorides|mesh-list
44367035|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367036|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367037|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367038|NCT01174472|Paclitaxel|paclitaxel|mesh-list
44367039|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44367040|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367041|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44367042|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44367043|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44367044|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367045|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44367046|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44367047|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44367048|NCT01174524|Gestodene|gestodene|mesh-list
44367049|NCT01174524|Femovan|femovan|mesh-list
44367050|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
44367051|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
44022234|NCT01284504|Celecoxib|celecoxib|mesh-list
44367053|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44367054|NCT01174524|Estrogens|estrogens|mesh-ancestor
44367055|NCT01174524|Hormones|hormones|mesh-ancestor
44367056|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367057|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367058|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44367059|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44367060|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43864160|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43864161|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864162|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
43864163|NCT02379377|Protective Agents|protective agents|mesh-ancestor
43864164|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134231|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134232|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134233|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134234|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134235|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134236|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44134237|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
44134238|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155673|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43864165|NCT02369484|Afatinib|afatinib|mesh-list
43864166|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864167|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43864168|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864169|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864170|NCT02363374|Leucovorin|leucovorin|mesh-list
43864171|NCT02363374|Folic Acid|folic acid|mesh-list
43864172|NCT02363374|Fluorouracil|fluorouracil|mesh-list
44367061|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44367062|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44367063|NCT01174524|Progestins|progestins|mesh-ancestor
44367064|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44367065|NCT01174693|Clopidogrel|clopidogrel|mesh-list
44367066|NCT01174693|Triflusal|triflusal|mesh-list
44367067|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44367068|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44367069|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44367070|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44367071|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
44367072|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864173|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
43864174|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
43864175|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
43864176|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864177|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864178|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864179|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864180|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
43864181|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864182|NCT02363374|Antidotes|antidotes|mesh-ancestor
43864183|NCT02363374|Protective Agents|protective agents|mesh-ancestor
43864184|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
43864185|NCT02363374|Vitamins|vitamins|mesh-ancestor
43864186|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
43864187|NCT02363374|Hematinics|hematinics|mesh-ancestor
43864188|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43864189|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43864190|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864191|NCT02363335|Incretins|incretins|mesh-ancestor
43864192|NCT02363335|Hormones|hormones|mesh-ancestor
43864193|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864194|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43864195|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
43864196|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864197|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864198|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
43864199|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864200|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864201|NCT02359968|Paclitaxel|paclitaxel|mesh-list
43864202|NCT02359968|Fluorouracil|fluorouracil|mesh-list
43864203|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
43864204|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864205|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864206|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864207|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864208|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864209|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658659|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
43658660|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43658661|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43658662|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658663|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
43864210|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
43864211|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864212|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864213|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
43864214|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864215|NCT02358967|Vitamin E|vitamin e|mesh-list
43864216|NCT02358967|Tocopherols|tocopherols|mesh-list
43864217|NCT02358967|Tocotrienols|tocotrienols|mesh-list
43864218|NCT02358967|Vitamins|vitamins|mesh-ancestor
43864219|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
43864230|NCT02354131|Growth Substances|growth substances|mesh-ancestor
43864231|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864232|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864233|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43864234|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367073|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367074|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367075|NCT01174810|Exenatide|exenatide|mesh-list
44367076|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44367077|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367078|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44367079|NCT01174810|Incretins|incretins|mesh-ancestor
44367080|NCT01174810|Hormones|hormones|mesh-ancestor
44367081|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367082|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44367083|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
44367084|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367085|NCT01174888|Cytarabine|cytarabine|mesh-list
44367086|NCT01174888|Etoposide|etoposide|mesh-list
44367087|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
44367088|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
44367089|NCT01174888|Bortezomib|bortezomib|mesh-list
44367090|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
44367091|NCT01174888|Midostaurin|midostaurin|mesh-list
44367092|NCT01174888|Staurosporine|staurosporine|mesh-list
44367093|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44367094|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367095|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44367096|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864235|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864236|NCT02352337|Gemcitabine|gemcitabine|mesh-list
43864237|NCT02352337|Folfirinox|folfirinox|mesh-list
43864238|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864239|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
43864240|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864241|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864242|NCT02352337|Antiviral Agents|antiviral agents|mesh-ancestor
43864243|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864244|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864245|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864246|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
43864247|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864248|NCT02349867|Gemcitabine|gemcitabine|mesh-list
43864249|NCT02349867|Sorafenib|sorafenib|mesh-list
43864250|NCT02349867|Vorinostat|vorinostat|mesh-list
43864251|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864252|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
43864253|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864255|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
43864256|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864257|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649381|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43649382|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43649383|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
43864258|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864259|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
43864260|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649384|NCT03030248|Vancomycin|vancomycin|mesh-list
43649385|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649386|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864261|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43864262|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43864263|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
43864264|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367097|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367098|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367099|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367100|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
44367101|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
44367102|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367103|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367104|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
44367105|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367106|NCT01174888|Analgesics|analgesics|mesh-ancestor
44367107|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
44367108|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367109|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
44367110|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367111|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44367112|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44367113|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44367114|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44367115|NCT01174914|Tenofovir|tenofovir|mesh-list
44367116|NCT01174914|Lamivudine|lamivudine|mesh-list
44367117|NCT01174914|Emtricitabine|emtricitabine|mesh-list
44367118|NCT01174914|Efavirenz|efavirenz|mesh-list
44367119|NCT01174914|Lopinavir|lopinavir|mesh-list
44367120|NCT01174914|Nevirapine|nevirapine|mesh-list
44367121|NCT01174914|Stavudine|stavudine|mesh-list
44367122|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
44367123|NCT01174914|Naltrexone|naltrexone|mesh-list
43864265|NCT02346253|Leuprolide|leuprolide|mesh-list
43864266|NCT02346253|Goserelin|goserelin|mesh-list
43864267|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43864268|NCT02346253|Bicalutamide|bicalutamide|mesh-list
43864269|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43864270|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
43864271|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43864272|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864273|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864274|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864275|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
43864276|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
43864277|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864278|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
43864279|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43864280|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
43864281|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43649387|NCT03030157|Pirarubicin|pirarubicin|mesh-list
43864282|NCT02344472|Paclitaxel|paclitaxel|mesh-list
43864283|NCT02344472|Vinorelbine|vinorelbine|mesh-list
43864284|NCT02344472|Docetaxel|docetaxel|mesh-list
43649389|NCT03029455|Ivacaftor|ivacaftor|mesh-list
43864285|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43864286|NCT02344472|Capecitabine|capecitabine|mesh-list
43864290|NCT02344472|Anastrozole|anastrozole|mesh-list
43864291|NCT02344472|Pertuzumab|pertuzumab|mesh-list
43864292|NCT02344472|Exemestane|exemestane|mesh-list
43864293|NCT02344472|Goserelin|goserelin|mesh-list
43864294|NCT02344472|Leuprolide|leuprolide|mesh-list
44367124|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
44367125|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367126|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44367127|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367128|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367129|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367130|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44367131|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44367132|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44367133|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43864295|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864296|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864297|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864298|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864299|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864300|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864301|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864302|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
43864303|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864304|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43864305|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43864306|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864307|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43864308|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
43864309|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864310|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864311|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864312|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43864313|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43864314|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
43864315|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43864316|NCT02344186|Liraglutide|liraglutide|mesh-list
43864317|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43864318|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864319|NCT02344186|Incretins|incretins|mesh-ancestor
43864320|NCT02344186|Hormones|hormones|mesh-ancestor
43864321|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864322|NCT02338232|Telmisartan|telmisartan|mesh-list
43864323|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43864324|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43864325|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43864326|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864327|NCT02337985|Prednisone|prednisone|mesh-list
43864328|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
43864329|NCT02337985|Rituximab|rituximab|mesh-list
43864330|NCT02337985|Doxorubicin|doxorubicin|mesh-list
43864331|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43864332|NCT02337985|Etoposide|etoposide|mesh-list
43864333|NCT02337985|Vincristine|vincristine|mesh-list
43864334|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864335|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
43864336|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864337|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864338|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864339|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
43864340|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864341|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864342|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43864343|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864344|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864345|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864346|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864347|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367134|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367135|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
44367136|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367137|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44367138|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44367139|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44367140|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44367141|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44367142|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44367143|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44367144|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44367145|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
43864348|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864349|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
43864350|NCT02337985|Hormones|hormones|mesh-ancestor
43864351|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864352|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864353|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864354|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864355|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864356|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864357|NCT02334735|Vaccines|vaccines|mesh-list
43864358|NCT02334735|Poly ICLC|poly iclc|mesh-list
43864359|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43864360|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
43864365|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43864366|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864367|NCT02323698|Caffeine|caffeine|mesh-list
43864368|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43864369|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864370|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43605064|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605065|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
43605066|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605067|NCT03231982|Amlodipine|amlodipine|mesh-list
43649404|NCT03028532|Clomiphene|clomiphene|mesh-list
43864371|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864372|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864373|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43864374|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43864375|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
43864376|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864377|NCT02317874|Paclitaxel|paclitaxel|mesh-list
43864378|NCT02317874|Carboplatin|carboplatin|mesh-list
43864379|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43864380|NCT02317874|Talazoparib|talazoparib|mesh-list
43864381|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864382|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864383|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864384|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864385|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864386|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864387|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43864388|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864389|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
43864390|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864391|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864392|NCT02308280|Bortezomib|bortezomib|mesh-list
43864393|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864394|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43864395|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43864396|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864397|NCT02304783|Acetaminophen|acetaminophen|mesh-list
43864398|NCT02304783|Piroxicam|piroxicam|mesh-list
43864399|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43864400|NCT02304783|Analgesics|analgesics|mesh-ancestor
44367146|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44367148|NCT01174927|Heroin|heroin|mesh-list
44367149|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44367150|NCT01174927|Narcotics|narcotics|mesh-ancestor
44367151|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367152|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367153|NCT01174927|Analgesics|analgesics|mesh-ancestor
44367154|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
44367155|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367156|NCT01174953|Finasteride|finasteride|mesh-list
44367157|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43649411|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44367158|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44367159|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367160|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367161|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
44367162|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367163|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367164|NCT01174953|Urological Agents|urological agents|mesh-ancestor
44367165|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
44367166|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44367167|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367168|NCT01175096|Everolimus|everolimus|mesh-list
44367169|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367170|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367171|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
44367172|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864401|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
43864402|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864403|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864404|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
43864405|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43864406|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864407|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864408|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43864409|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864410|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864411|NCT02300922|Antibodies|antibodies|mesh-list
43864412|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
43864413|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864414|NCT02298257|Doxorubicin|doxorubicin|mesh-list
43864415|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43864416|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43864417|NCT02298257|Dacarbazine|dacarbazine|mesh-list
43864418|NCT02298257|Vinblastine|vinblastine|mesh-list
43605146|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605147|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
43605148|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
43605149|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605150|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605151|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605152|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
43605153|NCT03231215|Hormones|hormones|mesh-ancestor
43658772|NCT02942888|Vitamins|vitamins|mesh-ancestor
43864419|NCT02298257|Antibodies|antibodies|mesh-list
43864420|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
44367173|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
44367174|NCT01175109|Panobinostat|panobinostat|mesh-list
44367175|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367176|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44367177|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367178|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367179|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44367181|NCT01175161|Trace Elements|trace elements|mesh-ancestor
44367182|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
44367183|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367184|NCT01175200|Lansoprazole|lansoprazole|mesh-list
44367185|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
44367186|NCT01175200|Clopidogrel|clopidogrel|mesh-list
44367187|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44367188|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44367189|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44367190|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43864421|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43864422|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
43864423|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
43864424|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864425|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864426|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864427|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864428|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864429|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864430|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864431|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864436|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864437|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864438|NCT02297698|Trastuzumab|trastuzumab|mesh-list
43864439|NCT02297698|Sargramostim|sargramostim|mesh-list
43864440|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864441|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864442|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
43864443|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864444|NCT02292979|Doxorubicin|doxorubicin|mesh-list
43864445|NCT02292979|Bleomycin|bleomycin|mesh-list
43864446|NCT02292979|Dacarbazine|dacarbazine|mesh-list
43864447|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43864448|NCT02292979|Vinblastine|vinblastine|mesh-list
43864449|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864450|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864451|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864452|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864453|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864454|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864455|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864456|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
43864457|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864458|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864459|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864460|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864461|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864462|NCT02288195|Capecitabine|capecitabine|mesh-list
43864463|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
44367191|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44367192|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
44367193|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367194|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367195|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367196|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44367197|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367198|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44367199|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367200|NCT01175291|Leucovorin|leucovorin|mesh-list
44367201|NCT01175291|Bevacizumab|bevacizumab|mesh-list
44367202|NCT01175291|Fluorouracil|fluorouracil|mesh-list
44367203|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
44367204|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
44367205|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44367206|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367207|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678791|NCT02858297|Triamcinolone|triamcinolone|mesh-list
43864464|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864465|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
43864466|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864467|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864468|NCT02285959|Bevacizumab|bevacizumab|mesh-list
43864469|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864470|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864471|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864472|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864473|NCT02285959|Growth Substances|growth substances|mesh-ancestor
43864474|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864475|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864477|NCT02285140|Cefazolin|cefazolin|mesh-list
43864478|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864479|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864480|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
43864481|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
43864482|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43864483|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43864484|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864485|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43864486|NCT02282319|Analgesics|analgesics|mesh-ancestor
43864487|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
43864488|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864489|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43864490|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43605159|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605160|NCT03230786|Metformin|metformin|mesh-list
43605161|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43605162|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605163|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
43605164|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
43605165|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43605166|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864491|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43864492|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
43864493|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864494|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864495|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
43864496|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
43864497|NCT02279654|Lenalidomide|lenalidomide|mesh-list
43864498|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
43864499|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864500|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864501|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864502|NCT02279654|Growth Substances|growth substances|mesh-ancestor
43864503|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864506|NCT02278965|Biguanides|biguanides|mesh-list
43864507|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44367208|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44367209|NCT01175291|Growth Substances|growth substances|mesh-ancestor
44367210|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367211|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44367212|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
44367213|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367214|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367215|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367216|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
44367217|NCT01175291|Antidotes|antidotes|mesh-ancestor
44367218|NCT01175291|Protective Agents|protective agents|mesh-ancestor
43605175|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605176|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605177|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605178|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43649414|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43649415|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43649416|NCT03027843|Hormones|hormones|mesh-list
43649417|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605179|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43850729|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
43850730|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850731|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850732|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43850733|NCT05283720|Prednisone|prednisone|mesh-list
43850734|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
44367219|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
44367220|NCT01175291|Vitamins|vitamins|mesh-ancestor
44367221|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
44367222|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44367223|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44367224|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44367225|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44367226|NCT01175460|Nedaplatin|nedaplatin|mesh-list
44367227|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367228|NCT01175486|Pioglitazone|pioglitazone|mesh-list
44367229|NCT01175486|Acarbose|acarbose|mesh-list
44367230|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43678804|NCT02858193|Carbocysteine|carbocysteine|mesh-list
43864508|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864509|NCT02278601|Fentanyl|fentanyl|mesh-list
43864510|NCT02278601|Ropivacaine|ropivacaine|mesh-list
43864511|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
43864512|NCT02278601|Anesthetics|anesthetics|mesh-list
43864513|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43864514|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864515|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
43864516|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864517|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43864518|NCT02278601|Narcotics|narcotics|mesh-ancestor
43864519|NCT02278601|Analgesics|analgesics|mesh-ancestor
43864520|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43864521|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43864522|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
43864523|NCT02274415|Vaccines|vaccines|mesh-list
43864524|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43864525|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
43864526|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134239|NCT00157651|Warfarin|warfarin|mesh-list
44134240|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
44134241|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
44134242|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44134243|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134244|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134245|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
44134246|NCT00157677|Coagulants|coagulants|mesh-ancestor
44134247|NCT00157690|Alendronate|alendronate|mesh-list
44134248|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44134249|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367231|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367232|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44367233|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367234|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367235|NCT01175512|Naltrexone|naltrexone|mesh-list
44367236|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44367237|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43605181|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43605182|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605207|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43605208|NCT03230474|Narcotics|narcotics|mesh-ancestor
43605211|NCT03230474|Analgesics|analgesics|mesh-ancestor
44367238|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367239|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
44367240|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367241|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
44367242|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44367243|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
44367244|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367245|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367246|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367247|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367248|NCT01175538|Lactulose|lactulose|mesh-list
44367249|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367250|NCT01175577|Carotenoids|carotenoids|mesh-list
44367251|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
44367252|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367253|NCT01175577|Protective Agents|protective agents|mesh-ancestor
44367254|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367255|NCT01175733|Panitumumab|panitumumab|mesh-list
44367256|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44367257|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367258|NCT01175746|Nicardipine|nicardipine|mesh-list
44367259|NCT01175746|Remifentanil|remifentanil|mesh-list
44367260|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44367261|NCT01175746|Narcotics|narcotics|mesh-ancestor
44134250|NCT00157716|Pyridoxal|pyridoxal|mesh-list
44134251|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44134252|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
44134253|NCT00157716|Vitamins|vitamins|mesh-ancestor
44134254|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
44134255|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134256|NCT00157729|Pyridoxal|pyridoxal|mesh-list
44134257|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44134258|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44134259|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605214|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43605215|NCT03230227|Bupivacaine|bupivacaine|mesh-list
43605216|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
43605217|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
43864527|NCT02270814|Paclitaxel|paclitaxel|mesh-list
43605220|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
43864528|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43864529|NCT02270814|Cisplatin|cisplatin|mesh-list
43864530|NCT02270814|Carboplatin|carboplatin|mesh-list
43864531|NCT02270814|Cetuximab|cetuximab|mesh-list
44367262|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367263|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367264|NCT01175746|Analgesics|analgesics|mesh-ancestor
44367265|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
44367266|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367267|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44367268|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44367269|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367270|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367271|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44367272|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
44367273|NCT01175772|Celecoxib|celecoxib|mesh-list
44367274|NCT01175772|Methotrexate|methotrexate|mesh-list
43864532|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864533|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864534|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864535|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864536|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864537|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864538|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864539|NCT02268695|Cisplatin|cisplatin|mesh-list
43864540|NCT02268695|Docetaxel|docetaxel|mesh-list
43864541|NCT02268695|Cetuximab|cetuximab|mesh-list
43864542|NCT02268695|Lenograstim|lenograstim|mesh-list
43864543|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864544|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864545|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864546|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864547|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864548|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605272|NCT03230058|Voriconazole|voriconazole|mesh-list
43605273|NCT03230058|Natamycin|natamycin|mesh-list
43605274|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43605275|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43605296|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43605297|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605298|NCT03229889|Tadalafil|tadalafil|mesh-list
43605299|NCT03229889|Tamsulosin|tamsulosin|mesh-list
43605300|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658863|NCT02942602|Atorvastatin|atorvastatin|mesh-list
43658864|NCT02942602|Ezetimibe|ezetimibe|mesh-list
43658865|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
43658866|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43658867|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43658868|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
43864549|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43864550|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
43864551|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864552|NCT02268656|Propofol|propofol|mesh-list
43864553|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43864554|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43864555|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864556|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43864557|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
43864558|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
43864559|NCT02264678|Carboplatin|carboplatin|mesh-list
43864560|NCT02264678|Durvalumab|durvalumab|mesh-list
43864563|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864564|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43864565|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864566|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864567|NCT02259621|Paclitaxel|paclitaxel|mesh-list
43864568|NCT02259621|Carboplatin|carboplatin|mesh-list
43864569|NCT02259621|Nivolumab|nivolumab|mesh-list
43864570|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864571|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864572|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864573|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864574|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864575|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864576|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864577|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43864578|NCT02257138|Decitabine|decitabine|mesh-list
43864579|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864580|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
43548088|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
44367275|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
44367276|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44367277|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
44367278|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44367279|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367280|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367281|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
44367282|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367283|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605301|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43605302|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43605303|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605305|NCT03229889|Urological Agents|urological agents|mesh-ancestor
44367284|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367285|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367286|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44367287|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367288|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
44367289|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367290|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367291|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44367292|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367293|NCT01175772|Analgesics|analgesics|mesh-ancestor
44367294|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
44367295|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367296|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367297|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44367298|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44367299|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367300|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
43864581|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864582|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864583|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864584|NCT02255799|Donepezil|donepezil|mesh-list
43864585|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43864586|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864587|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864588|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
43864589|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864590|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864591|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
43864592|NCT02249104|Adapalene|adapalene|mesh-list
43864593|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43864594|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43864595|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43864596|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43864597|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43864598|NCT02249104|Analgesics|analgesics|mesh-ancestor
43864599|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
43605311|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605312|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
43605313|NCT03229616|Busulfan|busulfan|mesh-list
43605314|NCT03229616|Etoposide|etoposide|mesh-list
43605315|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605316|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
43605317|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605318|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605319|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43605320|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
43864600|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367302|NCT01175954|Lacosamide|lacosamide|mesh-list
44367303|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
44367304|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44367305|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44367306|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367307|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367308|NCT01176175|Progesterone|progesterone|mesh-list
44367309|NCT01176175|Progestins|progestins|mesh-ancestor
44367310|NCT01176175|Hormones|hormones|mesh-ancestor
44367311|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367312|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367313|NCT01176318|Erdosteine|erdosteine|mesh-list
44367314|NCT01176318|Expectorants|expectorants|mesh-ancestor
44367315|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367316|NCT01176344|Vitamin D|vitamin d|mesh-list
43864601|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864602|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864603|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864604|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43864605|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43864606|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43864607|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43864608|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43864609|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
43864610|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864611|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864612|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864614|NCT02248701|Finasteride|finasteride|mesh-list
43864615|NCT02248701|Testosterone|testosterone|mesh-list
43864616|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
43864617|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
43864618|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43864619|NCT02248701|Androgens|androgens|mesh-ancestor
43864620|NCT02248701|Hormones|hormones|mesh-ancestor
43864621|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864622|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864623|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864624|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864625|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
43864626|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43864627|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43864628|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864629|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864630|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
43864631|NCT02248701|Urological Agents|urological agents|mesh-ancestor
43864632|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
43864638|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864640|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864641|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864642|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864643|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
43864644|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864645|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864646|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43864647|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864648|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
43864649|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44367317|NCT01176344|Vitamins|vitamins|mesh-ancestor
44367318|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
44367319|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367320|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44367321|NCT01176409|Valacyclovir|valacyclovir|mesh-list
44367322|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
44367323|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850746|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825543|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
43825544|NCT05563571|Lidocaine|lidocaine|mesh-list
43825545|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43825546|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
44367324|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
44367325|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
44367326|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44367327|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
44367328|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367329|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
44367330|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367331|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367332|NCT01176669|Apatinib|apatinib|mesh-list
44367333|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367334|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44367335|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367336|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864650|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864651|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864652|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43864653|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
43864654|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864655|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864656|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
43864657|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43864658|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43864659|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43864660|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43864661|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864662|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43864663|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864664|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864665|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43864666|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864667|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
43864668|NCT02232152|Fluorouracil|fluorouracil|mesh-list
43864669|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
43864670|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864671|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864672|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864673|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864674|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
43864675|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864676|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
43605335|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605336|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43605337|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605338|NCT03228992|Ibuprofen|ibuprofen|mesh-list
43847633|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43605339|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605340|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605341|NCT03228992|Analgesics|analgesics|mesh-ancestor
43864677|NCT02232152|Protective Agents|protective agents|mesh-ancestor
43864678|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
43864679|NCT02232152|Vitamins|vitamins|mesh-ancestor
43864680|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
43864681|NCT02230969|Interferons|interferons|mesh-list
43864682|NCT02230969|Interferon-beta|interferon-beta|mesh-list
43864683|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
43864684|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864685|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
43864686|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367337|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44367338|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44367339|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367340|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367341|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44367342|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367343|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
44367344|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44367345|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
44367346|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367347|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367348|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367349|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367350|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44367351|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44367352|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44367353|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
44367354|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367355|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367356|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44367357|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44367358|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367359|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367360|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44367361|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367362|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
44367363|NCT01176799|Doxorubicin|doxorubicin|mesh-list
44367364|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44367365|NCT01176799|Sunitinib|sunitinib|mesh-list
44367366|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367367|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
43678928|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
43864687|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
43864688|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864689|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43864690|NCT02229656|Olaparib|olaparib|mesh-list
43864691|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43864692|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864693|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864694|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367368|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367369|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367370|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367371|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
44367372|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367373|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367374|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44367375|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44367376|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44367377|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44367378|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367379|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44367380|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44367381|NCT01176799|Growth Substances|growth substances|mesh-ancestor
44367382|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
44367383|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44367384|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
43864695|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43864696|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
43864697|NCT02227992|Coagulants|coagulants|mesh-ancestor
43864698|NCT02226159|Dexamethasone|dexamethasone|mesh-list
43864699|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
43864700|NCT02226159|Lidocaine|lidocaine|mesh-list
43864701|NCT02226159|BB 1101|bb 1101|mesh-list
43864702|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864703|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
43864704|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
43864705|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864710|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864711|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864712|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864714|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864715|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864716|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
43864717|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
43864718|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43864719|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
43864720|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43864721|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43864722|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43864723|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43864724|NCT02225275|Lenalidomide|lenalidomide|mesh-list
43864725|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
43864726|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
43864727|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605342|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
43605343|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605344|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605345|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605346|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605347|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605348|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605349|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605350|NCT03228901|Oxytocin|oxytocin|mesh-list
43605351|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
43605352|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43605353|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605354|NCT03228797|Ropivacaine|ropivacaine|mesh-list
43605355|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
43605356|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
43850764|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850765|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
43864728|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864729|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864730|NCT02225275|Growth Substances|growth substances|mesh-ancestor
43864731|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864732|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864733|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864734|NCT02223208|Prednisone|prednisone|mesh-list
43864735|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
43864736|NCT02223208|Doxorubicin|doxorubicin|mesh-list
43864737|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43864738|NCT02223208|Etoposide|etoposide|mesh-list
43864739|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
43864740|NCT02223208|Romidepsin|romidepsin|mesh-list
44367385|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44367386|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44367387|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44367388|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
44367389|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864741|NCT02223208|Vincristine|vincristine|mesh-list
43864742|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864743|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
43864744|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864745|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864746|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864747|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
43864748|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864749|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864750|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43864751|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864752|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864753|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864754|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864755|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864756|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
43864757|NCT02223208|Hormones|hormones|mesh-ancestor
43864758|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864759|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605357|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605358|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605359|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
43605360|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605361|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
43605362|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43605363|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
43605364|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
43605365|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605366|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605367|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605368|NCT03228628|Analgesics|analgesics|mesh-ancestor
43605371|NCT03228823|Amiodarone|amiodarone|mesh-list
43864760|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864761|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864762|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864763|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864764|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
43864765|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864766|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864767|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
43864768|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43864769|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43864770|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43864771|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864772|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
43864773|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
43864774|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
43864775|NCT02219373|Gabapentin|gabapentin|mesh-list
43864776|NCT02219373|Analgesics|analgesics|mesh-ancestor
43864779|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864781|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43864782|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43864783|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43864784|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43864785|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43864786|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43864787|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43864788|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864789|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
43864790|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43864791|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43864792|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43864793|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43864794|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43864795|NCT02213575|Minocycline|minocycline|mesh-list
43864796|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864797|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864798|NCT02213107|Dutasteride|dutasteride|mesh-list
43864799|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43864800|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43864801|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605377|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43605378|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43605384|NCT03228732|Fluoxetine|fluoxetine|mesh-list
43864802|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864803|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
43864804|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864805|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864806|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
44367390|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367391|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367393|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
44367394|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44367395|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
44367396|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367397|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367398|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367399|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367400|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
44367401|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44367402|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
44367403|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367404|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367405|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44367406|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44367408|NCT01177176|Nicotine|nicotine|mesh-list
44367409|NCT01177176|Varenicline|varenicline|mesh-list
44367410|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44367411|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
44367412|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367413|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367414|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44367415|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44367416|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
44367417|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367418|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678982|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43864807|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
43864808|NCT02209636|Vitamins|vitamins|mesh-ancestor
43864809|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
43605410|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605411|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
43605412|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605413|NCT03228771|Atorvastatin|atorvastatin|mesh-list
43605414|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43605415|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43605416|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
43605417|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649421|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658923|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
43864810|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864811|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
43864812|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864813|NCT02209636|Protective Agents|protective agents|mesh-ancestor
43864814|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
43864815|NCT02205515|Everolimus|everolimus|mesh-list
43864816|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864817|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864818|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
43864819|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864820|NCT02196961|Nivolumab|nivolumab|mesh-list
43864821|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864822|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367420|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
44367421|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44367422|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44367423|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44367424|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367425|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
44367426|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44367427|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44367428|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367429|NCT01177306|Guanfacine|guanfacine|mesh-list
44367430|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44367431|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44367432|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44367433|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44367434|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44367435|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367436|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367437|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367438|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
44367439|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44367440|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44367441|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43864823|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43864824|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864825|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
43864826|NCT02191930|Doxorubicin|doxorubicin|mesh-list
43864827|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43864828|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43864829|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864830|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
43864831|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864832|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864833|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864834|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
43864835|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864836|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864837|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43864838|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864839|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864840|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864841|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864842|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864843|NCT02185209|Amoxicillin|amoxicillin|mesh-list
43864844|NCT02185209|Metronidazole|metronidazole|mesh-list
43864845|NCT02185209|Penicillin V|penicillin v|mesh-list
43864846|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44367443|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658938|NCT02941562|Antidotes|antidotes|mesh-ancestor
43658939|NCT02941562|Protective Agents|protective agents|mesh-ancestor
43658940|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
43658941|NCT02941562|Vitamins|vitamins|mesh-ancestor
43658942|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
44367444|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
44367445|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367446|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367447|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44367448|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367449|NCT01177371|Cyclosporine|cyclosporine|mesh-list
44367450|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
44367451|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44367452|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44367453|NCT01177371|Prednisolone|prednisolone|mesh-list
44367454|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
44367455|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
44367456|NCT01177371|Busulfan|busulfan|mesh-list
44367457|NCT01177371|Methotrexate|methotrexate|mesh-list
44367458|NCT01177371|Cyclosporins|cyclosporins|mesh-list
44367459|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44367460|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
44367461|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367462|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
44367463|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367464|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864853|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864855|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
43864856|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864857|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864858|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864859|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864860|NCT02180711|Growth Substances|growth substances|mesh-ancestor
43864861|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864862|NCT02177071|Methotrexate|methotrexate|mesh-list
43864863|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
43864864|NCT02177071|Azathioprine|azathioprine|mesh-list
43864865|NCT02177071|Infliximab|infliximab|mesh-list
43864866|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43864867|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
43864868|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43864869|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864870|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43864871|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
43864872|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864873|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864874|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
43864875|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864876|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43864877|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864878|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
43864879|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864880|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43864881|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367465|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367467|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367468|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367469|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44367470|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44367471|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
44367472|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44367473|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367474|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
44367475|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367476|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658956|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
43658957|NCT02941445|Metformin|metformin|mesh-list
43658958|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43658959|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658960|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658961|NCT02941445|Incretins|incretins|mesh-ancestor
43658962|NCT02941445|Hormones|hormones|mesh-ancestor
44367477|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44367478|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367479|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
44367480|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367481|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44367482|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367483|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
44367484|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
44367485|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367486|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367487|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
44367488|NCT01177371|Hormones|hormones|mesh-ancestor
44367489|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367490|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44367491|NCT01177371|Protective Agents|protective agents|mesh-ancestor
44367492|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44367493|NCT01177423|Anesthetics|anesthetics|mesh-list
44367494|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367495|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367496|NCT01177501|Topotecan|topotecan|mesh-list
44367497|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44367498|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44367503|NCT01177514|Analgesics|analgesics|mesh-ancestor
44367504|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
44367505|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367506|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367507|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
44367508|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44367509|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44367510|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367511|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44367512|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44367513|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44367514|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367515|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367516|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
44367517|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
44367518|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43864882|NCT02172872|Decitabine|decitabine|mesh-list
43864883|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649422|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43649423|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43649424|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
43824371|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824372|NCT05512780|Letrozole|letrozole|mesh-list
43864884|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
43864885|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864886|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864887|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134260|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134261|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134262|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
44134263|NCT00157729|Vitamins|vitamins|mesh-ancestor
44134264|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
44134265|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134266|NCT00157859|Chloroquine|chloroquine|mesh-list
44134267|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
44134268|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
44134269|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44134270|NCT00157859|Amebicides|amebicides|mesh-ancestor
44134271|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134272|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134273|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134274|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
44134275|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134276|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43864888|NCT02169089|Spironolactone|spironolactone|mesh-list
43864889|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43824377|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864890|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
43864891|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864892|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864893|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43864894|NCT02169089|Diuretics|diuretics|mesh-ancestor
43864895|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
43864896|NCT02166463|Prednisone|prednisone|mesh-list
43864897|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
43864898|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43864899|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43864900|NCT02166463|Prednisolone|prednisolone|mesh-list
43864905|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43864906|NCT02166463|Etoposide|etoposide|mesh-list
43864907|NCT02166463|Vincristine|vincristine|mesh-list
43864908|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
43864909|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43864910|NCT02166463|Bleomycin|bleomycin|mesh-list
43864911|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
43550326|NCT03624231|Tremelimumab|tremelimumab|mesh-list
44367519|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824378|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43824380|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824381|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605418|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43605419|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43605421|NCT03228576|Everolimus|everolimus|mesh-list
44367520|NCT01177566|Analgesics|analgesics|mesh-ancestor
44367521|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
44367522|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367523|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367524|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367525|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367526|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367527|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367528|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
44367529|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44367530|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864912|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43864914|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
43864915|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43864916|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
43864917|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43864918|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
43864919|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864920|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
43864921|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605427|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605428|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605429|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605430|NCT03228498|Choline|choline|mesh-list
43605431|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
43605432|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43605433|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
43658995|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658996|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658997|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43658998|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43658999|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659000|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659001|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
43659002|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659003|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659004|NCT02941315|Captopril|captopril|mesh-list
43659005|NCT02941315|Spironolactone|spironolactone|mesh-list
43659006|NCT02941315|Furosemide|furosemide|mesh-list
43659007|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43659008|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43850774|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
43850775|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864922|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864923|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864924|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
43864925|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864926|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864927|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43864928|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864929|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43864930|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43864931|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864932|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43864933|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
43864934|NCT02166463|Hormones|hormones|mesh-ancestor
43864935|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864936|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43864937|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864938|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864939|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864940|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864941|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
43864942|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
43864943|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864944|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43864945|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43864946|NCT02166463|Protective Agents|protective agents|mesh-ancestor
43864947|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
43864948|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
43864949|NCT02165007|Sirolimus|sirolimus|mesh-list
43864950|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43864951|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43864952|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43864953|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864954|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
43864955|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864956|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
43864957|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864958|NCT02162667|Trastuzumab|trastuzumab|mesh-list
43864959|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864960|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864961|NCT02160015|Rituximab|rituximab|mesh-list
43864962|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43864963|NCT02160015|Lenalidomide|lenalidomide|mesh-list
44367533|NCT01177579|Trace Elements|trace elements|mesh-ancestor
44367534|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
44367535|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367536|NCT01177683|Doxorubicin|doxorubicin|mesh-list
44367537|NCT01177683|Bortezomib|bortezomib|mesh-list
44367538|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44367539|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44367540|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367541|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44367542|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44367543|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367544|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367545|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367546|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
44367547|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
44367548|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
44367549|NCT01177852|Promethazine|promethazine|mesh-list
44367550|NCT01177852|Brompheniramine|brompheniramine|mesh-list
43864964|NCT02160015|Antibodies|antibodies|mesh-list
43864965|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
43864966|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43659009|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659010|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659011|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864967|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
43864968|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864969|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864970|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43864971|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864972|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864973|NCT02160015|Growth Substances|growth substances|mesh-ancestor
43864974|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864981|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
43864982|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864983|NCT02159755|Palbociclib|palbociclib|mesh-list
43864984|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864985|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43864986|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864987|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864988|NCT02157974|Exenatide|exenatide|mesh-list
43864989|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43864990|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864991|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43864992|NCT02157974|Incretins|incretins|mesh-ancestor
43864993|NCT02157974|Hormones|hormones|mesh-ancestor
43864994|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43864995|NCT02156739|Edetic Acid|edetic acid|mesh-list
43864996|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
43864997|NCT02156739|Antidotes|antidotes|mesh-ancestor
43864998|NCT02156739|Protective Agents|protective agents|mesh-ancestor
43864999|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865000|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
43865001|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
43865002|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865003|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43865004|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
43865005|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43865040|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865041|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865042|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865043|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
43605434|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605435|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605436|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43605437|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
43605438|NCT03228368|Atezolizumab|atezolizumab|mesh-list
43605439|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605440|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
43605441|NCT03228862|Vitamin D|vitamin d|mesh-list
43605458|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
43605459|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605460|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43850776|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659017|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659018|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659019|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43659020|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
43659021|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659022|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43865044|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865045|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865053|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
43865054|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
43865055|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865056|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865057|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865058|NCT02152982|Temozolomide|temozolomide|mesh-list
43865060|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865061|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
43865062|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865063|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367565|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
44367566|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367567|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44367568|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
44367569|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
44367570|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367571|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44367572|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
44367573|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367574|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44367575|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367576|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367577|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
44367578|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43865064|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43865065|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865066|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
43865067|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865068|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
43865069|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865070|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865071|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43865072|NCT02144584|Memantine|memantine|mesh-list
43865073|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43865074|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43865075|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
43865076|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865077|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605461|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43605462|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43605463|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
43605464|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659025|NCT02941224|Sirolimus|sirolimus|mesh-list
43865078|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865079|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43865080|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43865081|NCT02143401|Sorafenib|sorafenib|mesh-list
43865082|NCT02143401|Navitoclax|navitoclax|mesh-list
43865083|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865084|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865085|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865086|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865087|NCT02143388|Cisplatin|cisplatin|mesh-list
43865088|NCT02143388|Capecitabine|capecitabine|mesh-list
43865089|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865090|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865091|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
43865092|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865093|NCT02143219|Leucovorin|leucovorin|mesh-list
43865094|NCT02143219|Folic Acid|folic acid|mesh-list
43865095|NCT02143219|Irinotecan|irinotecan|mesh-list
43865096|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
43865097|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
43865098|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43865099|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865100|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865101|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865102|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865103|NCT02143219|Antidotes|antidotes|mesh-ancestor
43865104|NCT02143219|Protective Agents|protective agents|mesh-ancestor
43865105|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865106|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
43865107|NCT02143219|Vitamins|vitamins|mesh-ancestor
43865108|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
43865109|NCT02143219|Hematinics|hematinics|mesh-ancestor
43865110|NCT02140151|Ranibizumab|ranibizumab|mesh-list
43865111|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44367579|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44367580|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
44367581|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
44367582|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
44367583|NCT01177904|Progesterone|progesterone|mesh-list
44367584|NCT01177904|Progestins|progestins|mesh-ancestor
44367585|NCT01177904|Hormones|hormones|mesh-ancestor
44367586|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367587|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367588|NCT01178021|Chloroquine|chloroquine|mesh-list
44367589|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44367590|NCT01178021|Primaquine|primaquine|mesh-list
43605471|NCT03228355|Cromakalim|cromakalim|mesh-list
43605472|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43605473|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44367591|NCT01178021|Amebicides|amebicides|mesh-ancestor
44367592|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44367593|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44367594|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367595|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
44367596|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367597|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44367598|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367599|NCT01178021|Analgesics|analgesics|mesh-ancestor
44367600|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
44367601|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367602|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367603|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367604|NCT01178021|Filaricides|filaricides|mesh-ancestor
44367605|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
44367606|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
44367607|NCT01178034|Warfarin|warfarin|mesh-list
44367608|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
44367609|NCT01178047|Rasagiline|rasagiline|mesh-list
44367610|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44367611|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367612|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367613|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44367614|NCT01178047|Protective Agents|protective agents|mesh-ancestor
44367615|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865112|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43865113|NCT02140151|Growth Substances|growth substances|mesh-ancestor
43865114|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367616|NCT01178112|Carboplatin|carboplatin|mesh-list
44367617|NCT01178112|Trientine|trientine|mesh-list
44367618|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367619|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
44367620|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
44367621|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824385|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824386|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824387|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43824388|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43824389|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824390|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43824391|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
43824392|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
43824393|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
43824394|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
43824395|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367622|NCT01178151|Everolimus|everolimus|mesh-list
44367623|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367624|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865119|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43865120|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865122|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865123|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865124|NCT02135874|Cytarabine|cytarabine|mesh-list
43865125|NCT02135874|Dexamethasone|dexamethasone|mesh-list
43865126|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
43865128|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43865129|NCT02135874|Vincristine|vincristine|mesh-list
43865130|NCT02135874|Sorafenib|sorafenib|mesh-list
43865131|NCT02135874|Idarubicin|idarubicin|mesh-list
43865132|NCT02135874|Clofarabine|clofarabine|mesh-list
43865133|NCT02135874|Antibodies|antibodies|mesh-list
43865134|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
43865135|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43865136|NCT02135874|BB 1101|bb 1101|mesh-list
43865137|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
43865138|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865139|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865140|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865141|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865142|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
43865143|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
43865144|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865145|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43865146|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
43865147|NCT02135874|Hormones|hormones|mesh-ancestor
43865148|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865149|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865150|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
43865151|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865152|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865153|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865154|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
43865155|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
43865156|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865157|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865158|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865159|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865160|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865161|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865162|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865163|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43865164|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865165|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865166|NCT02135315|Isosorbide|isosorbide|mesh-list
43865167|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43865168|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43865169|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43865170|NCT02135315|Diuretics|diuretics|mesh-ancestor
43865171|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
43865172|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865173|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
43865174|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43865175|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865176|NCT02135133|Ofatumumab|ofatumumab|mesh-list
43865177|NCT02135133|Idelalisib|idelalisib|mesh-list
43865178|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605481|NCT03228108|Amoxicillin|amoxicillin|mesh-list
43605482|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
43605483|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43605484|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
43605485|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
43605486|NCT03228108|Fosfomycin|fosfomycin|mesh-list
43605489|NCT03228108|Trimethoprim|trimethoprim|mesh-list
43865179|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865180|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367625|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
44367626|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367628|NCT01178203|Tramadol|tramadol|mesh-list
44367629|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44367630|NCT01178203|Narcotics|narcotics|mesh-ancestor
44367631|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367632|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367633|NCT01178203|Analgesics|analgesics|mesh-ancestor
44367634|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
44367635|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367636|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43865181|NCT02130453|Regadenoson|regadenoson|mesh-list
43865182|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43865183|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43865184|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
43865188|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865189|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
43865190|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43865191|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
43865192|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865193|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
43865194|NCT02127723|Protective Agents|protective agents|mesh-ancestor
43865195|NCT02127073|Oxytocin|oxytocin|mesh-list
43865196|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
43865197|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865198|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865199|NCT02124421|Paclitaxel|paclitaxel|mesh-list
43865200|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43865201|NCT02124421|Cisplatin|cisplatin|mesh-list
43865203|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865204|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865205|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865206|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865207|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865208|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865209|NCT02122562|Ketamine|ketamine|mesh-list
43865210|NCT02122562|Analgesics|analgesics|mesh-ancestor
43865211|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
43865212|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865213|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865214|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43865215|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43865216|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
43865217|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
43865218|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43865219|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43865220|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43865221|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865222|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865223|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43865224|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865225|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
43865226|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865227|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865228|NCT02117167|Pemetrexed|pemetrexed|mesh-list
43865229|NCT02117167|Durvalumab|durvalumab|mesh-list
43865230|NCT02117167|Olaparib|olaparib|mesh-list
43865231|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865232|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865233|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865234|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43865235|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367637|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367638|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367639|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367640|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
44367641|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44367642|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367643|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367645|NCT01178320|Niacinamide|niacinamide|mesh-list
44367646|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
44367647|NCT01178320|Simvastatin|simvastatin|mesh-list
43865236|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865237|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43865238|NCT02115373|Tepotinib|tepotinib|mesh-list
43865239|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865240|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
43865241|NCT02114229|Cisplatin|cisplatin|mesh-list
43865242|NCT02114229|Carboplatin|carboplatin|mesh-list
43865243|NCT02114229|Methotrexate|methotrexate|mesh-list
43865244|NCT02114229|Etoposide|etoposide|mesh-list
43865245|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
43865246|NCT02114229|Vincristine|vincristine|mesh-list
43865247|NCT02114229|Topotecan|topotecan|mesh-list
43865248|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865249|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
43865250|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865251|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865252|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865253|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
43865254|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865255|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865256|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865257|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43865274|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
43865275|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43865276|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
43865277|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865278|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865279|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43865280|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865281|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865282|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
43865283|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43865284|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43865285|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43865286|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43865287|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865288|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
43865289|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865290|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865291|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43865292|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865293|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
43865294|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865295|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
43865296|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865297|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865298|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865299|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
43865300|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865301|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865302|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865303|NCT02104986|Cisplatin|cisplatin|mesh-list
43865304|NCT02104986|Ifosfamide|ifosfamide|mesh-list
43865305|NCT02104986|Bleomycin|bleomycin|mesh-list
44367658|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
44367659|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367660|NCT01178372|Lactulose|lactulose|mesh-list
44367661|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367662|NCT01178450|Cinacalcet|cinacalcet|mesh-list
44367663|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44367664|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367665|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44367666|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
44412293|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865306|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865307|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865308|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
43865309|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865310|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43865330|NCT02101775|Gemcitabine|gemcitabine|mesh-list
43865331|NCT02101775|Adavosertib|adavosertib|mesh-list
43865332|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865333|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
43865334|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865335|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865336|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
43865337|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865338|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865339|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865340|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
43865341|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865342|NCT02099591|Naloxegol|naloxegol|mesh-list
43865343|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43865344|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865345|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
43865346|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865347|NCT02079181|Fluorides|fluorides|mesh-list
44367667|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367668|NCT01178645|Cytarabine|cytarabine|mesh-list
44367669|NCT01178645|Etoposide|etoposide|mesh-list
44367670|NCT01178645|Melphalan|melphalan|mesh-list
44367671|NCT01178645|Busulfan|busulfan|mesh-list
44367672|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44367673|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367674|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44367675|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44367676|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367677|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367678|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367679|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
43865348|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
43865349|NCT02079181|Protective Agents|protective agents|mesh-ancestor
43592979|NCT03348046|Infliximab|infliximab|mesh-list
43605492|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605493|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43605494|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43605495|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605496|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605497|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605498|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43605499|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43850777|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43865350|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865351|NCT02074839|Ivosidenib|ivosidenib|mesh-list
43865352|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865353|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865354|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134278|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134279|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44134280|NCT00157859|Renal Agents|renal agents|mesh-ancestor
44134281|NCT00157872|Naproxen|naproxen|mesh-list
44134282|NCT00157872|Rofecoxib|rofecoxib|mesh-list
44134283|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44134284|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44134285|NCT00157872|Analgesics|analgesics|mesh-ancestor
44134286|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
44134287|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134288|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134289|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44134290|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134291|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
44134292|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44134293|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134294|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134295|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44134296|NCT00157885|Artesunate|artesunate|mesh-list
44134297|NCT00157885|Amodiaquine|amodiaquine|mesh-list
44134298|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
44134299|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134300|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134301|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134302|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134303|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
44134307|NCT00157898|Metronidazole|metronidazole|mesh-list
44134308|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
44134309|NCT00157898|Ertapenem|ertapenem|mesh-list
44134310|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134311|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44134312|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134313|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134314|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
44134315|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44134316|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
44134317|NCT00158002|Topiramate|topiramate|mesh-list
44134318|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
44134319|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134320|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134321|NCT00158028|Risperidone|risperidone|mesh-list
44134322|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44134323|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
44134324|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367680|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
44367681|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367682|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367683|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
44367684|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367685|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367686|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
44367687|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44367688|NCT01178658|Cytarabine|cytarabine|mesh-list
44367689|NCT01178658|Etoposide|etoposide|mesh-list
44367690|NCT01178658|Melphalan|melphalan|mesh-list
44367691|NCT01178658|Busulfan|busulfan|mesh-list
44367692|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44367693|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367694|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44134325|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134326|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134327|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44134328|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134329|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134330|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134331|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44134332|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
44134333|NCT00158041|Amifostine|amifostine|mesh-list
44134334|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44134335|NCT00158041|Protective Agents|protective agents|mesh-ancestor
44134336|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134337|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
44134338|NCT00158093|Atenolol|atenolol|mesh-list
44134339|NCT00158093|Nebivolol|nebivolol|mesh-list
44134340|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44134341|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134342|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44134343|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44134344|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865356|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865357|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865358|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865359|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43865360|NCT02070705|Hematinics|hematinics|mesh-ancestor
43865361|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43865362|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43865363|NCT02070549|Trametinib|trametinib|mesh-list
43865364|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865365|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865366|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865367|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865368|NCT02069730|Androgens|androgens|mesh-list
43865369|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
43865370|NCT02069730|Hormones|hormones|mesh-ancestor
43865371|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865372|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865373|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
43865374|NCT02068586|Sunitinib|sunitinib|mesh-list
43865375|NCT02068586|Valproic Acid|valproic acid|mesh-list
43865376|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865377|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43865378|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43865379|NCT02068586|Growth Substances|growth substances|mesh-ancestor
43865380|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865381|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
43865382|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44367695|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44367696|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367697|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367698|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44367699|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
44367700|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
44367701|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367702|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367703|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
44367704|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367705|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44367706|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
44367707|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44367708|NCT01178697|Triamcinolone|triamcinolone|mesh-list
44367709|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44367710|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44367711|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44367712|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367713|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
44367714|NCT01178697|Hormones|hormones|mesh-ancestor
44367715|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367716|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367717|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44367718|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
44367719|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367720|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367721|NCT01178710|Simvastatin|simvastatin|mesh-list
44367722|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44367723|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44367724|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
44367725|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367726|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44367727|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44367728|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367733|NCT01178788|Hormones|hormones|mesh-ancestor
44367734|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367735|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367736|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44367737|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
44367738|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
44367739|NCT01178931|Progesterone|progesterone|mesh-list
44367740|NCT01178931|Progestins|progestins|mesh-ancestor
44367741|NCT01178931|Hormones|hormones|mesh-ancestor
44367742|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367743|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367744|NCT01178996|Ribavirin|ribavirin|mesh-list
44367745|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44367746|NCT01178996|Thymalfasin|thymalfasin|mesh-list
44367747|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
44367748|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367749|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
44367750|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605500|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43605524|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605525|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605526|NCT03228043|Apatinib|apatinib|mesh-list
43605527|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605528|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605531|NCT03227679|Bupropion|bupropion|mesh-list
44367751|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44367752|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
44367753|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367754|NCT01179100|Lidocaine|lidocaine|mesh-list
44367755|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
44367756|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
44367757|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43865383|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865384|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865385|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
43865386|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
43865387|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865388|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
43865389|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43865397|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865398|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43865400|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43865401|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43865402|NCT02064673|Analgesics|analgesics|mesh-ancestor
43865403|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
43865404|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865405|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865406|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865407|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865408|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865409|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865410|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865411|NCT02063022|Dactinomycin|dactinomycin|mesh-list
43865412|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
43865413|NCT02063022|Melphalan|melphalan|mesh-list
43865414|NCT02063022|Busulfan|busulfan|mesh-list
43865415|NCT02063022|Ifosfamide|ifosfamide|mesh-list
43865416|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
43865417|NCT02063022|Doxorubicin|doxorubicin|mesh-list
43605536|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605537|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605538|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43605539|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43605540|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
43605541|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605542|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605543|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43605544|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
43824397|NCT05512702|Heparin|heparin|mesh-list
43824398|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43659154|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43659155|NCT02940379|Metoprolol|metoprolol|mesh-list
43659156|NCT02940379|Midazolam|midazolam|mesh-list
43659157|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43659158|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44367758|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367759|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
44367760|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367761|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44367762|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44367763|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44367764|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367765|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367766|NCT01179152|Budesonide|budesonide|mesh-list
43865418|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43865419|NCT02063022|Etoposide|etoposide|mesh-list
43865420|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
43865421|NCT02063022|Vincristine|vincristine|mesh-list
43865422|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865423|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
43865424|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865425|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865426|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865427|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
43865428|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865429|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865430|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865431|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43865432|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865433|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865434|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865435|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865436|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865437|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865438|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865439|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43865440|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865441|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43865442|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43865443|NCT02062463|Budesonide|budesonide|mesh-list
43865444|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
43865445|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43865446|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865447|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43865448|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
43865449|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865450|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865451|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43865452|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
43865453|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
43865454|NCT02062463|Hormones|hormones|mesh-ancestor
43865455|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865456|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43865462|NCT02057133|Tamoxifen|tamoxifen|mesh-list
43824399|NCT05512702|Plasminogen|plasminogen|mesh-list
43649425|NCT03023527|Dexamethasone|dexamethasone|mesh-list
43649426|NCT03023527|Nivolumab|nivolumab|mesh-list
43605545|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605546|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43605547|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43865463|NCT02057133|Trastuzumab|trastuzumab|mesh-list
43865464|NCT02057133|Pertuzumab|pertuzumab|mesh-list
43865465|NCT02057133|Everolimus|everolimus|mesh-list
43865466|NCT02057133|Letrozole|letrozole|mesh-list
43865467|NCT02057133|Fulvestrant|fulvestrant|mesh-list
43865468|NCT02057133|Anastrozole|anastrozole|mesh-list
43865469|NCT02057133|Exemestane|exemestane|mesh-list
43865470|NCT02057133|Loperamide|loperamide|mesh-list
43865471|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865472|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865473|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865474|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
43865475|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865476|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43865477|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43865478|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367767|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
44367768|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367769|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44367770|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
44367771|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367772|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367773|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367774|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367775|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
43865479|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865480|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43865481|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
43865482|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865483|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865484|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43865485|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43865486|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43865487|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43865488|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
43865489|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43865491|NCT02053909|Ticagrelor|ticagrelor|mesh-list
43865492|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43865493|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43865494|NCT02053909|Analgesics|analgesics|mesh-ancestor
43865495|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
43865496|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865497|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865498|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865499|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865500|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43865501|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43865502|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865503|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43865504|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43865505|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865506|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
43865507|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43865508|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43865509|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43865510|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
43865511|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865512|NCT02049593|Irinotecan|irinotecan|mesh-list
43865513|NCT02049593|Temozolomide|temozolomide|mesh-list
43865514|NCT02049593|Talazoparib|talazoparib|mesh-list
43865515|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43865516|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43865517|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43659188|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659189|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659195|NCT02940561|Methotrexate|methotrexate|mesh-list
43865518|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865519|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865520|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865521|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865522|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
43865523|NCT02049047|Everolimus|everolimus|mesh-list
43865524|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865525|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865526|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
43865529|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865530|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865532|NCT02042391|Prednisone|prednisone|mesh-list
43865533|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
43865534|NCT02042391|Rituximab|rituximab|mesh-list
43865535|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
43865536|NCT02042391|Doxorubicin|doxorubicin|mesh-list
44367776|NCT01179152|Hormones|hormones|mesh-ancestor
44367777|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44367778|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44367779|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44367780|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44367781|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
44367782|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367783|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367784|NCT01179230|Dipyridamole|dipyridamole|mesh-list
44367785|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44367786|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367787|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367788|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43865537|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43865538|NCT02042391|Vincristine|vincristine|mesh-list
43865539|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865540|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
43865541|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865542|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605577|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43605578|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43865543|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865544|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
43865545|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865546|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865547|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865548|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865549|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865550|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
43865551|NCT02042391|Hormones|hormones|mesh-ancestor
43865552|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865553|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865554|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865555|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
43865556|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
43865557|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865558|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43865559|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865560|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865561|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865562|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865563|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865564|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865565|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865566|NCT02040376|Metformin|metformin|mesh-list
43865567|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43865568|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865569|NCT02034981|Crizotinib|crizotinib|mesh-list
43865570|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865571|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865572|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865573|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865574|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43865575|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43865576|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
43865577|NCT02030028|Hormones|hormones|mesh-ancestor
43865578|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865579|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865580|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865581|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367789|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
44367790|NCT01179256|Curcumin|curcumin|mesh-list
44367791|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44367792|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367793|NCT01179256|Analgesics|analgesics|mesh-ancestor
44367794|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
44367795|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367796|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367797|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367798|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367799|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367800|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367801|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367802|NCT01179269|Paclitaxel|paclitaxel|mesh-list
44412294|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43865582|NCT02024087|Sorafenib|sorafenib|mesh-list
43865583|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865584|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865585|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865586|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865587|NCT02023463|Leuprolide|leuprolide|mesh-list
43865588|NCT02023463|Goserelin|goserelin|mesh-list
43865589|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43865590|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
43659216|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659217|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659218|NCT02940314|Urological Agents|urological agents|mesh-ancestor
43865591|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865592|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865593|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865594|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865595|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
43865596|NCT02022709|Sertraline|sertraline|mesh-list
43865597|NCT02022709|Fluoxetine|fluoxetine|mesh-list
43865598|NCT02022709|Paroxetine|paroxetine|mesh-list
43865599|NCT02022709|Citalopram|citalopram|mesh-list
43865600|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
43865604|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43865605|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865606|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865608|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865609|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43865610|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43865611|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43865612|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865613|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43865614|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43865615|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43865616|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43865617|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43865618|NCT02022280|Lansoprazole|lansoprazole|mesh-list
43865619|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
43865620|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43865621|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43865622|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43865623|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865624|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605588|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605589|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865625|NCT02020070|Ipilimumab|ipilimumab|mesh-list
43865626|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865627|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865628|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43865629|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865630|NCT02013648|Cytarabine|cytarabine|mesh-list
44367803|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44367804|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367805|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
44367806|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
44367807|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
44367808|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367809|NCT01179308|Anesthetics|anesthetics|mesh-list
44367810|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367811|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367812|NCT01179412|Iodine|iodine|mesh-list
44367813|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
44367814|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
44367815|NCT01179412|Povidone|povidone|mesh-list
44367816|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43679308|NCT02854904|Analgesics|analgesics|mesh-ancestor
43865631|NCT02013648|Daunorubicin|daunorubicin|mesh-list
43865632|NCT02013648|Dasatinib|dasatinib|mesh-list
43865633|NCT02013648|Idarubicin|idarubicin|mesh-list
43865634|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865635|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
43865636|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865637|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865638|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
43865639|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865640|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865641|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
43865642|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865643|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43865644|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865645|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865646|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865647|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865648|NCT01997840|Dexamethasone|dexamethasone|mesh-list
43865649|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
43865650|NCT01997840|Pomalidomide|pomalidomide|mesh-list
43865651|NCT01997840|Ricolinostat|ricolinostat|mesh-list
43865652|NCT01997840|BB 1101|bb 1101|mesh-list
43865653|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865654|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
43865655|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
43865656|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865657|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865658|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43865659|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
43865660|NCT01997840|Hormones|hormones|mesh-ancestor
43865661|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865662|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865663|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865664|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
43865665|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865666|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865667|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
43865668|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43865669|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43865670|NCT01997840|Growth Substances|growth substances|mesh-ancestor
43865675|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43865676|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43865677|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865678|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43865679|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865681|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44367817|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367818|NCT01179412|Trace Elements|trace elements|mesh-ancestor
44367819|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
44367820|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367821|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
44367822|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
44367823|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
44367824|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44367825|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367826|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367827|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367829|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
44367830|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367831|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44367832|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44367833|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44367834|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
43865682|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43865683|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43865684|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43865685|NCT01992952|Fulvestrant|fulvestrant|mesh-list
43865686|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865687|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865688|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43865689|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43865690|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
43865691|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865692|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865693|NCT01991457|Fludarabine|fludarabine|mesh-list
43865694|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865695|NCT01990196|Dasatinib|dasatinib|mesh-list
43865696|NCT01990196|Trametinib|trametinib|mesh-list
43865697|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865698|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865699|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865700|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865701|NCT01989780|Paclitaxel|paclitaxel|mesh-list
43865702|NCT01989780|Bevacizumab|bevacizumab|mesh-list
43865703|NCT01989780|Letrozole|letrozole|mesh-list
43865704|NCT01989780|Fulvestrant|fulvestrant|mesh-list
43865705|NCT01989780|Anastrozole|anastrozole|mesh-list
43865706|NCT01989780|Exemestane|exemestane|mesh-list
43865707|NCT01989780|Goserelin|goserelin|mesh-list
43865708|NCT01989780|Leuprolide|leuprolide|mesh-list
43865709|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865710|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865711|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865712|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865713|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865714|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865715|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865716|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43865717|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43865718|NCT01989780|Growth Substances|growth substances|mesh-ancestor
43865719|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865720|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
43865721|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44367835|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367836|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367837|NCT01179464|Simvastatin|simvastatin|mesh-list
44367838|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44367839|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44367840|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
43865722|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43865723|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865724|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43865725|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
43865726|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865727|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865728|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43865729|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43865730|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
43865731|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865733|NCT01980823|Atorvastatin|atorvastatin|mesh-list
43865734|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43865735|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865736|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43865737|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43865738|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
43865739|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865740|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43865756|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865757|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865758|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865759|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43865760|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43865761|NCT01972919|Gemcitabine|gemcitabine|mesh-list
43865762|NCT01972919|Capecitabine|capecitabine|mesh-list
43865763|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865764|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
43865765|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865766|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865767|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
43865768|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865769|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865770|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865771|NCT01972919|Immunologic Factors|immunologic factors|mesh-ancestor
43865772|NCT01972919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865773|NCT01955499|Lenalidomide|lenalidomide|mesh-list
43865774|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
43865775|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865776|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43865777|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43846648|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43846649|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846651|NCT04185311|Ipilimumab|ipilimumab|mesh-list
43846652|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43846653|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846654|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846655|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43865778|NCT01955499|Growth Substances|growth substances|mesh-ancestor
43865779|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
43865780|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865781|NCT01953588|Fulvestrant|fulvestrant|mesh-list
43865782|NCT01953588|Anastrozole|anastrozole|mesh-list
43865783|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43865784|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865785|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43865786|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43865787|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
43865788|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865789|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865790|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43865791|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43865792|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865793|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865794|NCT01953510|Vaccines|vaccines|mesh-list
43865795|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43865796|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
44367841|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367842|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44367843|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44367844|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367845|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
44367847|NCT01179503|Calcium|calcium|mesh-list
44367848|NCT01179503|Vitamins|vitamins|mesh-ancestor
44367849|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
44367850|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367851|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44367852|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44367853|NCT01179529|Omalizumab|omalizumab|mesh-list
44367854|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44367855|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44367856|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44367857|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44367858|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
44367859|NCT01179594|Entecavir|entecavir|mesh-list
44367860|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
44367861|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367862|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
44367863|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367864|NCT01179620|Certoparin|certoparin|mesh-list
43605770|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367865|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
44367866|NCT01179646|Pantoprazole|pantoprazole|mesh-list
44367867|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44367868|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367869|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44367870|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367871|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367872|NCT01179659|Pantoprazole|pantoprazole|mesh-list
44367873|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44367874|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367875|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44367884|NCT01179776|Iloprost|iloprost|mesh-list
44367885|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44367886|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44367887|NCT01179828|Oxycodone|oxycodone|mesh-list
44367888|NCT01179828|Clobazam|clobazam|mesh-list
44367889|NCT01179828|Imipramine|imipramine|mesh-list
44367890|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44367891|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44367892|NCT01179828|Narcotics|narcotics|mesh-ancestor
44367893|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367894|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367895|NCT01179828|Analgesics|analgesics|mesh-ancestor
44367896|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
44367897|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367898|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44367899|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44367900|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
44367901|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367902|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367903|NCT01179828|Urological Agents|urological agents|mesh-ancestor
44367904|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44367905|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
44367906|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44367907|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44367908|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44367909|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367910|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
44367911|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
44367912|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44367913|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44367914|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44367915|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
44367916|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
44367917|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
44412295|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865797|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134355|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44134356|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134357|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134358|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134359|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44367918|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44367919|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44367920|NCT01179971|Analgesics|analgesics|mesh-ancestor
44367921|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
44367922|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44367923|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367924|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44367925|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44367926|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44367927|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
44367928|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367929|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44367930|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
44367931|NCT01180062|Latanoprost|latanoprost|mesh-list
44367932|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44367933|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44134360|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44134361|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43865862|NCT01943994|Psilocybin|psilocybin|mesh-list
43865863|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43865864|NCT01943994|Nicotine|nicotine|mesh-list
43865865|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43865866|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
43865867|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865868|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865869|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43865870|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43865872|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865873|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865874|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
43865875|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43865876|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43865877|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
43865878|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43865879|NCT01942694|Vitamin D|vitamin d|mesh-list
43865880|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
43865881|NCT01942694|Vitamins|vitamins|mesh-ancestor
43865882|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
43865883|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865884|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43865885|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43865886|NCT01938248|Aspirin|aspirin|mesh-list
43865887|NCT01938248|Apixaban|apixaban|mesh-list
43865888|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43865889|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43865890|NCT01938248|Analgesics|analgesics|mesh-ancestor
43865891|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
43865892|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865893|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865894|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43865895|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43865896|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43865897|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43865898|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865899|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43865900|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43865901|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865902|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
43865903|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44367935|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44367936|NCT01180075|Tenofovir|tenofovir|mesh-list
44367937|NCT01180075|Emtricitabine|emtricitabine|mesh-list
44367938|NCT01180075|Efavirenz|efavirenz|mesh-list
44367939|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44367940|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44367941|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
44367942|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367943|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367944|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44367945|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44367946|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
43588945|NCT03383406|Cytarabine|cytarabine|mesh-list
43865904|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
43865905|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43865906|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
43865907|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
43865908|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43865909|NCT01931033|Oxytocin|oxytocin|mesh-list
43865910|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
43865911|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865912|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865913|NCT01928576|Nivolumab|nivolumab|mesh-list
43865914|NCT01928576|Azacitidine|azacitidine|mesh-list
43865915|NCT01928576|Entinostat|entinostat|mesh-list
43865916|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865917|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865918|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43865919|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865920|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865921|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
43865922|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865923|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43865924|NCT01927744|Docetaxel|docetaxel|mesh-list
43865925|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43865926|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865927|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865930|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865931|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865932|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865933|NCT01924260|Gemcitabine|gemcitabine|mesh-list
43865934|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865935|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
43865936|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865937|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865938|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
43865939|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865940|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865941|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865942|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
43865943|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865944|NCT01924052|Calcitonin|calcitonin|mesh-list
43865945|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43865946|NCT01924052|Katacalcin|katacalcin|mesh-list
43865948|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865949|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43865950|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
43865951|NCT01921335|Trastuzumab|trastuzumab|mesh-list
43865952|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43865953|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865954|NCT01916278|Lidocaine|lidocaine|mesh-list
43865955|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
43865956|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
43865957|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44367947|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44367948|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44367949|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44367950|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44367951|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44367952|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44367953|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44367954|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44367955|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44367956|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44367957|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
43865958|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865959|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
43605789|NCT03224923|Clopidogrel|clopidogrel|mesh-list
43605790|NCT03224923|Ticagrelor|ticagrelor|mesh-list
43649435|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
43649436|NCT03023527|Hormones|hormones|mesh-ancestor
43649437|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43865960|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43865961|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43865962|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43865963|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43865964|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43865965|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865966|NCT01912625|Paclitaxel|paclitaxel|mesh-list
43865967|NCT01912625|Carboplatin|carboplatin|mesh-list
43865968|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43865969|NCT01912625|Trametinib|trametinib|mesh-list
43865970|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865971|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865972|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865973|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865974|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865975|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865976|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43865977|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865978|NCT01908777|Cytarabine|cytarabine|mesh-list
43865979|NCT01908777|Etoposide|etoposide|mesh-list
43865980|NCT01908777|Melphalan|melphalan|mesh-list
43865981|NCT01908777|Carmustine|carmustine|mesh-list
43865982|NCT01908777|Romidepsin|romidepsin|mesh-list
43865983|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865984|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865985|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865986|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865987|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865988|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865989|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865990|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
43865991|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
43865992|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865993|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43865994|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
43865995|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649438|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43649439|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649440|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649441|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43649442|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649443|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
43649444|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43649445|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43649446|NCT03023527|Growth Substances|growth substances|mesh-ancestor
43649447|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
43649448|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
43649449|NCT03023514|Progesterone|progesterone|mesh-list
43865996|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43865997|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
43865998|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865999|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866000|NCT01907191|Bupivacaine|bupivacaine|mesh-list
43866001|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
43866002|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
43866013|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43866014|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866015|NCT01903473|Sirolimus|sirolimus|mesh-list
43866016|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866017|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554590|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44367958|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367959|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
44367960|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44367961|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44367962|NCT01180179|Lansoprazole|lansoprazole|mesh-list
44367963|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
44367964|NCT01180179|Famotidine|famotidine|mesh-list
44367965|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44367966|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44367967|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44367968|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44367969|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367970|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43866018|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866019|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866020|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
43866021|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866022|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
43866023|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866025|NCT01897454|Leucovorin|leucovorin|mesh-list
43866026|NCT01897454|Folic Acid|folic acid|mesh-list
43866027|NCT01897454|Gemcitabine|gemcitabine|mesh-list
43866028|NCT01897454|Fluorouracil|fluorouracil|mesh-list
43866029|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
43866030|NCT01897454|Irinotecan|irinotecan|mesh-list
43866031|NCT01897454|Camptothecin|camptothecin|mesh-list
43866032|NCT01897454|Calcium|calcium|mesh-list
43866033|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
43866034|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866035|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
43866036|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866037|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866038|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
43866039|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866040|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866041|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866042|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
43866043|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866044|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43866045|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43866046|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43866047|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866048|NCT01897454|Antidotes|antidotes|mesh-ancestor
43866049|NCT01897454|Protective Agents|protective agents|mesh-ancestor
43866050|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
43866051|NCT01897454|Vitamins|vitamins|mesh-ancestor
43866052|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
43866053|NCT01897454|Hematinics|hematinics|mesh-ancestor
43866054|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866055|NCT01897441|Paclitaxel|paclitaxel|mesh-list
43866056|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
43866057|NCT01897441|Doxorubicin|doxorubicin|mesh-list
43866058|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43866059|NCT01897441|Trastuzumab|trastuzumab|mesh-list
43866060|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43866061|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866062|NCT01897441|Antibodies|antibodies|mesh-list
43866063|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
43866064|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866065|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866066|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866067|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866068|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866069|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866070|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866079|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44367971|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
44367972|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
44367973|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44367974|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367975|NCT01180205|Amlodipine|amlodipine|mesh-list
44367976|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44367977|NCT01180205|Telmisartan|telmisartan|mesh-list
44367978|NCT01180205|Olmesartan|olmesartan|mesh-list
44367979|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44367980|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44367981|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44367982|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44367983|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44367984|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44367985|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44367986|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
44367987|NCT01180205|Diuretics|diuretics|mesh-ancestor
44367988|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
44367989|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44367990|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44367991|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43679456|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
43866080|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866081|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866082|NCT01893567|Clobetasol|clobetasol|mesh-list
43866083|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866084|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
43866085|NCT01893567|Hormones|hormones|mesh-ancestor
43866086|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866087|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866088|NCT01892527|Cetuximab|cetuximab|mesh-list
43605791|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43866089|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866090|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866091|NCT01892371|Cytarabine|cytarabine|mesh-list
43866092|NCT01892371|Azacitidine|azacitidine|mesh-list
43866093|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866094|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
43866095|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866096|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866097|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
43866098|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866100|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
43866101|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866102|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866103|NCT01886859|Lenalidomide|lenalidomide|mesh-list
43866104|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
43866105|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866106|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866107|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866108|NCT01886859|Growth Substances|growth substances|mesh-ancestor
43866109|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866110|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866111|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
44367993|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44367994|NCT01180322|Cytarabine|cytarabine|mesh-list
44367995|NCT01180322|Etoposide|etoposide|mesh-list
44367996|NCT01180322|Idarubicin|idarubicin|mesh-list
44367997|NCT01180322|Azacitidine|azacitidine|mesh-list
44367998|NCT01180322|Lenograstim|lenograstim|mesh-list
44367999|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866112|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
43866113|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
43866114|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866115|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866116|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43866117|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43866118|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
43866119|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
43866120|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866121|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866122|NCT01884740|Bevacizumab|bevacizumab|mesh-list
43866123|NCT01884740|Cetuximab|cetuximab|mesh-list
43866124|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866125|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866126|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866127|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866128|NCT01884740|Growth Substances|growth substances|mesh-ancestor
43866129|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866130|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866131|NCT01879085|Gemcitabine|gemcitabine|mesh-list
43866132|NCT01879085|Docetaxel|docetaxel|mesh-list
43866133|NCT01879085|Vorinostat|vorinostat|mesh-list
43866134|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866135|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
43866136|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866137|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866138|NCT01879085|Antiviral Agents|antiviral agents|mesh-ancestor
43866139|NCT01879085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866144|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866145|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866146|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866147|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43866149|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43866150|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
43866151|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866152|NCT01878669|Expectorants|expectorants|mesh-ancestor
43866153|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
43866154|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43866155|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
43866156|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866157|NCT01878669|Protective Agents|protective agents|mesh-ancestor
43866158|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866159|NCT01878669|Antidotes|antidotes|mesh-ancestor
43866160|NCT01876628|Clindamycin|clindamycin|mesh-list
43866161|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
43866162|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
43866163|NCT01876628|Floxacillin|floxacillin|mesh-list
43866164|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866165|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866166|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43866167|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866168|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866169|NCT01873131|Timolol|timolol|mesh-list
43866170|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43866171|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43866172|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
43866173|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866174|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866175|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866176|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43866177|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43866178|NCT01871571|Leucovorin|leucovorin|mesh-list
43866179|NCT01871571|Bevacizumab|bevacizumab|mesh-list
43555876|NCT03558243|Hemostatics|hemostatics|mesh-list
44368000|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368001|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44368002|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44368003|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368004|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368005|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368006|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
44368007|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
44368008|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368009|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368010|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
44368011|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866180|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866181|NCT01871571|Fluorouracil|fluorouracil|mesh-list
43649456|NCT03023514|Protective Agents|protective agents|mesh-ancestor
43649457|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
43605839|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605840|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43605841|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43605842|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
43605843|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605845|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605846|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605847|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605848|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605849|NCT03224338|Dolutegravir|dolutegravir|mesh-list
43605850|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43605851|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43866182|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
43866183|NCT01871571|Antibodies|antibodies|mesh-list
43866184|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
43866185|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866186|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
43866187|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866188|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866189|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866190|NCT01871571|Growth Substances|growth substances|mesh-ancestor
43866191|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866192|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866193|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
43866194|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
43866195|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866196|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866197|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866198|NCT01871571|Antidotes|antidotes|mesh-ancestor
43866199|NCT01871571|Protective Agents|protective agents|mesh-ancestor
43866200|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
43866201|NCT01871571|Vitamins|vitamins|mesh-ancestor
43866202|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
43866203|NCT01865110|Prednisone|prednisone|mesh-list
43605854|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43605855|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43605856|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
43605857|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605858|NCT03224377|Antibodies|antibodies|mesh-list
43605859|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
43605860|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
43605861|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605862|NCT03224221|Fluorouracil|fluorouracil|mesh-list
43605863|NCT03224221|Apatinib|apatinib|mesh-list
43605864|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
43605865|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605866|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866204|NCT01865110|Rituximab|rituximab|mesh-list
43866205|NCT01865110|Lenalidomide|lenalidomide|mesh-list
43866206|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
43866207|NCT01865110|Vincristine|vincristine|mesh-list
43866208|NCT01865110|Doxorubicin|doxorubicin|mesh-list
43866209|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866210|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866211|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
43866212|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866219|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866220|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
43866221|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866222|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866223|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866224|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
43866225|NCT01865110|Hormones|hormones|mesh-ancestor
43866226|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866227|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866228|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866229|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866230|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866231|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866232|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866233|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43866234|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866235|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866236|NCT01864772|Cetuximab|cetuximab|mesh-list
43866237|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368012|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368013|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44368014|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
44368015|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43605906|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605907|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605908|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
43605909|NCT03223896|Naloxone|naloxone|mesh-list
43605910|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43605911|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605912|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
43605913|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605914|NCT03223519|Ascorbic Acid|ascorbic acid|mesh-list
43605915|NCT03223519|Ibuprofen|ibuprofen|mesh-list
43605916|NCT03223519|Vitamins|vitamins|mesh-ancestor
43605917|NCT03223519|Micronutrients|micronutrients|mesh-ancestor
43850917|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43850918|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43850919|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659294|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44368016|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44368017|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44368018|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368019|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368020|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368021|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368022|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368023|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44368024|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368025|NCT01180413|Losartan|losartan|mesh-list
44368026|NCT01180413|Amlodipine|amlodipine|mesh-list
44368027|NCT01180413|Ramipril|ramipril|mesh-list
44368028|NCT01180413|Lercanidipine|lercanidipine|mesh-list
44368029|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44368030|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44368031|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368032|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679491|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866238|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866239|NCT01852071|Busulfan|busulfan|mesh-list
43866240|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
43866241|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866242|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866243|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
43866244|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134362|NCT00158132|Amantadine|amantadine|mesh-list
43866245|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866246|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866247|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866248|NCT01851642|Albuterol|albuterol|mesh-list
43866249|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43866251|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866252|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866253|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43866254|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
43866255|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
43866256|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43866257|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43866258|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43866259|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43866260|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
43866261|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866262|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866263|NCT01849146|Temozolomide|temozolomide|mesh-list
43866264|NCT01849146|Adavosertib|adavosertib|mesh-list
43866265|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866266|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
43702460|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44368033|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44368034|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368035|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
44368036|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44368037|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44368038|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44368039|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44368040|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
44368041|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368042|NCT01180426|Tosedostat|tosedostat|mesh-list
44368043|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850922|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
44368044|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368045|NCT01180569|Lenalidomide|lenalidomide|mesh-list
44368046|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
44368047|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368048|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368049|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44368089|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368090|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368091|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368093|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
44368094|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368095|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44368096|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
44368097|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368098|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368099|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44368100|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
44368101|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
44368102|NCT01181063|Hormones|hormones|mesh-ancestor
44368103|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368104|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44368105|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44368106|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44368107|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44368108|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866267|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866268|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866269|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866270|NCT01846663|Rifaximin|rifaximin|mesh-list
43866271|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866272|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866273|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134363|NCT00158132|Propranolol|propranolol|mesh-list
44134364|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44134365|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44134366|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134367|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134368|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134369|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134389|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44134390|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134391|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134392|NCT00158171|Folic Acid|folic acid|mesh-list
44134393|NCT00158171|Nicotine|nicotine|mesh-list
44134394|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44134395|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
44134396|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134397|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134398|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44134399|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44134400|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
44134401|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134402|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134403|NCT00158171|Hematinics|hematinics|mesh-ancestor
44134404|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
44134405|NCT00158171|Vitamins|vitamins|mesh-ancestor
44134406|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
44134407|NCT00158210|Rivastigmine|rivastigmine|mesh-list
44134408|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44368109|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368110|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
44368111|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44368112|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
44368113|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659361|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659362|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659363|NCT02939248|Analgesics|analgesics|mesh-ancestor
43659364|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
44368114|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368115|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
44368116|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368118|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368119|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368120|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
44368121|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368122|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368123|NCT01181193|Vitamin D|vitamin d|mesh-list
43866274|NCT01840046|Interleukin-2|interleukin-2|mesh-list
43866275|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866276|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43866277|NCT01840046|Analgesics|analgesics|mesh-ancestor
43866278|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
43866279|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866280|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866282|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866283|NCT01829568|Lenalidomide|lenalidomide|mesh-list
43866284|NCT01829568|Antibodies|antibodies|mesh-list
43866285|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
43866286|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866287|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
43866288|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866289|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866290|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866291|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866292|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866293|NCT01829568|Growth Substances|growth substances|mesh-ancestor
43866301|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866302|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43866303|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
43866304|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866305|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866306|NCT01823198|Aldesleukin|aldesleukin|mesh-list
43866307|NCT01823198|Fludarabine|fludarabine|mesh-list
43866308|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
43866309|NCT01823198|Busulfan|busulfan|mesh-list
43866310|NCT01823198|Interleukin-2|interleukin-2|mesh-list
43866311|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866312|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866313|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
43866314|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866315|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866316|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
43866317|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866318|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
43866319|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866320|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866321|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43866322|NCT01823198|Analgesics|analgesics|mesh-ancestor
43866323|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
43866324|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866325|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44368124|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
44368125|NCT01181193|Temozolomide|temozolomide|mesh-list
44368126|NCT01181193|Vitamins|vitamins|mesh-ancestor
44368127|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
44368128|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368129|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368130|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44368131|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
44368132|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368133|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659373|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43659374|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
43659375|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44368134|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44368135|NCT01181232|Zolpidem|zolpidem|mesh-list
44368136|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43866326|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43866327|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
43866328|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866329|NCT01822314|Paclitaxel|paclitaxel|mesh-list
43866330|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43866331|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866332|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866333|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866334|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866335|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866336|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866337|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43866338|NCT01816971|Dexamethasone|dexamethasone|mesh-list
43866339|NCT01816971|Lenalidomide|lenalidomide|mesh-list
43866340|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866341|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
43866342|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
43866343|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866344|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866345|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43866346|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
43866347|NCT01816971|Hormones|hormones|mesh-ancestor
43866348|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866349|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866350|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866351|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
43866352|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866353|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866354|NCT01816971|Growth Substances|growth substances|mesh-ancestor
43866355|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866356|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
43866357|NCT01810588|Rituximab|rituximab|mesh-list
43866358|NCT01810588|Fludarabine|fludarabine|mesh-list
43866359|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
43866360|NCT01810588|Melphalan|melphalan|mesh-list
43866361|NCT01810588|Tacrolimus|tacrolimus|mesh-list
43866362|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43866363|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
43866370|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
43649459|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
43649460|NCT03023306|Antiemetics|antiemetics|mesh-list
43649461|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
43605918|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605937|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
43866371|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866372|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866373|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866374|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43866375|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866376|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866377|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43866378|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
43866379|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866380|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866381|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
44368137|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44368138|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368139|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023436|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368140|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44368141|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
44368142|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
44368143|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368144|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368145|NCT01181310|Scopolamine|scopolamine|mesh-list
44368146|NCT01181310|Donepezil|donepezil|mesh-list
44368147|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44368148|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43866382|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866383|NCT01804790|Capecitabine|capecitabine|mesh-list
43866384|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866385|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
43866386|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866387|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866388|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
43866389|NCT01804634|Melphalan|melphalan|mesh-list
43866390|NCT01804634|Fludarabine|fludarabine|mesh-list
43866391|NCT01804634|Tacrolimus|tacrolimus|mesh-list
43866392|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866393|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
43866394|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866395|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866396|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866397|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
43866398|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866399|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866400|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866401|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43866402|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866403|NCT01797523|Metformin|metformin|mesh-list
43866404|NCT01797523|Everolimus|everolimus|mesh-list
43866405|NCT01797523|Letrozole|letrozole|mesh-list
43866406|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43866407|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866408|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866409|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866410|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
43866411|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43866412|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43866413|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866414|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866415|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43866416|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
43866417|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866418|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866419|NCT01787500|Cetuximab|cetuximab|mesh-list
43866420|NCT01787500|Irinotecan|irinotecan|mesh-list
43866421|NCT01787500|Camptothecin|camptothecin|mesh-list
43866422|NCT01787500|Vemurafenib|vemurafenib|mesh-list
43866423|NCT01787500|Antibodies|antibodies|mesh-list
43866424|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
43866425|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866426|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
43866427|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866428|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866429|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43866430|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866431|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368149|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368150|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368151|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368152|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368153|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368154|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
44368155|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44368156|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
44368157|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
44368158|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368159|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368160|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
44368161|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43866432|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866439|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866440|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866441|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
43866442|NCT01783535|Carboplatin|carboplatin|mesh-list
43866443|NCT01783535|Doxorubicin|doxorubicin|mesh-list
43866444|NCT01783535|Etoposide|etoposide|mesh-list
43866445|NCT01783535|Vincristine|vincristine|mesh-list
43866446|NCT01783535|Topotecan|topotecan|mesh-list
43866447|NCT01783535|Lenograstim|lenograstim|mesh-list
43866448|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866449|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
43866450|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866451|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866452|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866453|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
43866454|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866455|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605947|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605948|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605950|NCT03222960|Fluorides|fluorides|mesh-list
43605951|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
43605952|NCT03222960|Protective Agents|protective agents|mesh-ancestor
43605953|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605954|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605955|NCT03222544|Methylene Blue|methylene blue|mesh-list
43866456|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866457|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866458|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43866459|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866460|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866461|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866462|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43866463|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866464|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866465|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866466|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43866467|NCT01782352|Vitamin D|vitamin d|mesh-list
43866468|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
43866469|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
43866470|NCT01782352|Vitamins|vitamins|mesh-list
43866471|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
43866472|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866473|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43866474|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43866475|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866476|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43866477|NCT01771107|Doxorubicin|doxorubicin|mesh-list
43866478|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43866479|NCT01771107|Dacarbazine|dacarbazine|mesh-list
43866480|NCT01771107|Vinblastine|vinblastine|mesh-list
43866481|NCT01771107|Antibodies|antibodies|mesh-list
43866482|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
43866483|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866484|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
43866485|NCT01771107|Imidazole|imidazole|mesh-list
43866486|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
43866487|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866488|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368162|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44368163|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
44368164|NCT01181388|Tirofiban|tirofiban|mesh-list
44368165|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44368166|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44368167|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368168|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368169|NCT01181401|Cisplatin|cisplatin|mesh-list
44368170|NCT01181401|Docetaxel|docetaxel|mesh-list
44368171|NCT01181401|Cetuximab|cetuximab|mesh-list
44368172|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368173|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
44368174|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
44368175|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
44368176|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368177|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368178|NCT01181414|Amiodarone|amiodarone|mesh-list
44368179|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44368180|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44368181|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659424|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659425|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
43659426|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43659436|NCT02938468|Hormones|hormones|mesh-ancestor
44368182|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368215|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
44368216|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
44368217|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44368218|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
44368219|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
44368220|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368221|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368222|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368223|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44368224|NCT01181570|Diuretics|diuretics|mesh-ancestor
44368225|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
44368226|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368227|NCT01181765|Infliximab|infliximab|mesh-list
44368228|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
44368229|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368230|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368231|NCT01181882|Aspirin|aspirin|mesh-list
44368232|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44368233|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44368234|NCT01181882|Analgesics|analgesics|mesh-ancestor
44368271|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44368272|NCT01181999|Rituximab|rituximab|mesh-list
44368273|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368274|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368275|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
44368276|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368277|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368279|NCT01182077|Peficitinib|peficitinib|mesh-list
44368280|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44368281|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44368282|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368283|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605957|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605958|NCT03222765|Metformin|metformin|mesh-list
43605959|NCT03222765|Linagliptin|linagliptin|mesh-list
43605960|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43605961|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605962|NCT03222765|Incretins|incretins|mesh-ancestor
43605963|NCT03222765|Hormones|hormones|mesh-ancestor
43605964|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605965|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43605966|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605967|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368284|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44368285|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368286|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43679645|NCT02851459|Vaccines|vaccines|mesh-list
43866489|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866490|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43866491|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866492|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866493|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866494|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866495|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
43866496|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866497|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
43866498|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866499|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866500|NCT01763580|Prednisolone|prednisolone|mesh-list
43866501|NCT01763580|Tacrolimus|tacrolimus|mesh-list
43866502|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866503|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
43866504|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866512|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866513|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866514|NCT01748175|Triamcinolone|triamcinolone|mesh-list
43866515|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43866516|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43866517|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43866518|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866519|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
43866520|NCT01748175|Hormones|hormones|mesh-ancestor
43866521|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866522|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866523|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866524|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
43866525|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866526|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866527|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
43866528|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43866529|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43866530|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
43866531|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866532|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866533|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866534|NCT01747577|Urological Agents|urological agents|mesh-ancestor
43866535|NCT01743950|Bevacizumab|bevacizumab|mesh-list
43866536|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368288|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
44368289|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
44368290|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
44368291|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
44368292|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368293|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368294|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368295|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368296|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
44368297|NCT01182129|Nicotine|nicotine|mesh-list
44368298|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44368299|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
43866537|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866538|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866539|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866540|NCT01743950|Growth Substances|growth substances|mesh-ancestor
43866541|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866542|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866543|NCT01743872|Dextrans|dextrans|mesh-list
43866544|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
43866545|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
43866546|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
43866547|NCT01740557|Aldesleukin|aldesleukin|mesh-list
43866548|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
43866549|NCT01740557|Fludarabine|fludarabine|mesh-list
43866550|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
43866551|NCT01740557|Interleukin-2|interleukin-2|mesh-list
43866552|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866553|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
43866554|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866555|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866556|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866557|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
43866558|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866559|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866560|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866561|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866562|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
43866563|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43866564|NCT01740557|Analgesics|analgesics|mesh-ancestor
43866565|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
43866566|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866567|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43866568|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43866569|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
43866570|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866571|NCT01740492|Ketamine|ketamine|mesh-list
43866572|NCT01740492|Analgesics|analgesics|mesh-ancestor
43866573|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
43866577|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43605970|NCT03222687|Tacrolimus|tacrolimus|mesh-list
43605971|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605972|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
43605973|NCT03222687|Hormones|hormones|mesh-ancestor
43605974|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605975|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605976|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605996|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850999|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851001|NCT04759586|Prednisone|prednisone|mesh-list
43866578|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
43866580|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43866581|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43866583|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866584|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866585|NCT01738139|Ipilimumab|ipilimumab|mesh-list
43866586|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
43866587|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866588|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866589|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43866590|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866591|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368300|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368301|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368302|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44368303|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44368304|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368305|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368306|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368307|NCT01182142|Capecitabine|capecitabine|mesh-list
44368308|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368309|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
44368310|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368311|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368312|NCT01182168|Gemcitabine|gemcitabine|mesh-list
44368314|NCT01182168|Everolimus|everolimus|mesh-list
44368315|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866592|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866593|NCT01729091|Lenalidomide|lenalidomide|mesh-list
43866594|NCT01729091|Melphalan|melphalan|mesh-list
43866595|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
43866596|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43866597|NCT01729091|Elotuzumab|elotuzumab|mesh-list
43866598|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
43866599|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866600|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866601|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866602|NCT01729091|Growth Substances|growth substances|mesh-ancestor
43866603|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866604|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866605|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866606|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
43866607|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866608|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866609|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866610|NCT01728805|Vorinostat|vorinostat|mesh-list
43866611|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
43866612|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866613|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43605997|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43866614|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866615|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866616|NCT01722708|Metronidazole|metronidazole|mesh-list
43866617|NCT01722708|Clindamycin|clindamycin|mesh-list
43866618|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
43866619|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
43866620|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866621|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866622|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43866623|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43866624|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43866625|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866626|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866627|NCT01718743|Lenalidomide|lenalidomide|mesh-list
43866628|NCT01718743|Ixazomib|ixazomib|mesh-list
43866629|NCT01718743|Glycine|glycine|mesh-list
43866630|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
43866631|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866632|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866633|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866634|NCT01718743|Growth Substances|growth substances|mesh-ancestor
43866635|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368316|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368318|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368319|NCT01182168|Antiviral Agents|antiviral agents|mesh-ancestor
44368320|NCT01182168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368321|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368322|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368323|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
44368324|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368325|NCT01182246|Genistein|genistein|mesh-list
44368326|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43649463|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649464|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43649465|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
43649466|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43649467|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43649468|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649469|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
43649470|NCT03023189|Coagulants|coagulants|mesh-ancestor
43649471|NCT03023111|Miltefosine|miltefosine|mesh-list
43649472|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
43649473|NCT03023111|Molgramostim|molgramostim|mesh-list
43649474|NCT03023111|Sargramostim|sargramostim|mesh-list
43606021|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
44368327|NCT01182246|Protective Agents|protective agents|mesh-ancestor
44368328|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368329|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368330|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368331|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866636|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866637|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866638|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
43866639|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866640|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
43866641|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866642|NCT01712815|Clevudine|clevudine|mesh-list
43866643|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
43866644|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866645|NCT01711632|Vemurafenib|vemurafenib|mesh-list
43866650|NCT01711554|Vitamin A|vitamin a|mesh-list
43866651|NCT01711554|Lenalidomide|lenalidomide|mesh-list
43866652|NCT01711554|Tretinoin|tretinoin|mesh-list
43866653|NCT01711554|Dinutuximab|dinutuximab|mesh-list
43866654|NCT01711554|Isotretinoin|isotretinoin|mesh-list
43866655|NCT01711554|Vitamins|vitamins|mesh-ancestor
43866656|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
43866657|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866659|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866660|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866661|NCT01711554|Growth Substances|growth substances|mesh-ancestor
43866662|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866663|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866664|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
43866665|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606058|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
43606059|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606060|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606061|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43606063|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43606066|NCT03221816|Folic Acid|folic acid|mesh-list
44134409|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134410|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134411|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
44134412|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134413|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134414|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44134415|NCT00158210|Protective Agents|protective agents|mesh-ancestor
44134416|NCT00158236|Buprenorphine|buprenorphine|mesh-list
44134417|NCT00158236|Hydromorphone|hydromorphone|mesh-list
44134418|NCT00158236|Naloxone|naloxone|mesh-list
44134419|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44134420|NCT00158236|Narcotics|narcotics|mesh-ancestor
44134421|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134422|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134423|NCT00158236|Analgesics|analgesics|mesh-ancestor
44134424|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
44134425|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134426|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44134427|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
44134428|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368332|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368333|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
44368334|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44368335|NCT01182246|Estrogens|estrogens|mesh-ancestor
44368336|NCT01182246|Hormones|hormones|mesh-ancestor
44368337|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368338|NCT01182272|Sorafenib|sorafenib|mesh-list
44368339|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368340|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368341|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368342|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368343|NCT01182597|Pantoprazole|pantoprazole|mesh-list
44368344|NCT01182597|Lansoprazole|lansoprazole|mesh-list
44368345|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
44368346|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44368347|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368348|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44368349|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368350|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368351|NCT01182636|Adapalene|adapalene|mesh-list
44368352|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44134429|NCT00158301|Fluoxetine|fluoxetine|mesh-list
44134430|NCT00158301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44134431|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44134432|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134433|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134434|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134435|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
44134436|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134437|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44134438|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
44134439|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134440|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44134441|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134442|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134443|NCT00158405|Ritonavir|ritonavir|mesh-list
44134444|NCT00158405|Indinavir|indinavir|mesh-list
44134445|NCT00158405|Lamivudine|lamivudine|mesh-list
44134446|NCT00158405|Zidovudine|zidovudine|mesh-list
44134447|NCT00158405|Efavirenz|efavirenz|mesh-list
44134448|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44134449|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44134450|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
44134451|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134452|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134453|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43851028|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
44134454|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44134455|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
44134456|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134457|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44134458|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134459|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44134460|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44368353|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44368354|NCT01182636|Analgesics|analgesics|mesh-ancestor
44368355|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
44368356|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368357|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368358|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368359|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368360|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44368361|NCT01182662|Cyclosporine|cyclosporine|mesh-list
44368362|NCT01182662|Cyclosporins|cyclosporins|mesh-list
44368363|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368364|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368365|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368366|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
44368367|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368368|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
44368369|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368370|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44368371|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368372|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44368373|NCT01182792|Ascorbic Acid|ascorbic acid|mesh-list
44368375|NCT01182792|Micronutrients|micronutrients|mesh-ancestor
44368376|NCT01182792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368377|NCT01182792|Antioxidants|antioxidants|mesh-ancestor
44368378|NCT01182792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368379|NCT01182792|Protective Agents|protective agents|mesh-ancestor
44368380|NCT01182883|Sirolimus|sirolimus|mesh-list
44368381|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368382|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368383|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368384|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368385|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
44368386|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368387|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
44368388|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368389|NCT01182974|Acetaminophen|acetaminophen|mesh-list
44368392|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
44368393|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368394|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368396|NCT01183247|Sirolimus|sirolimus|mesh-list
44368397|NCT01183247|Prednisone|prednisone|mesh-list
44368398|NCT01183247|Everolimus|everolimus|mesh-list
44368399|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44134467|NCT00158457|Tenofovir|tenofovir|mesh-list
44134468|NCT00158457|Emtricitabine|emtricitabine|mesh-list
44134469|NCT00158457|Efavirenz|efavirenz|mesh-list
44134470|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
44134471|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134472|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44134473|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43866666|NCT01702831|Lenalidomide|lenalidomide|mesh-list
43866667|NCT01702831|Melphalan|melphalan|mesh-list
43866669|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
43606083|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606084|NCT03221907|Pregabalin|pregabalin|mesh-list
43606085|NCT03221907|Analgesics|analgesics|mesh-ancestor
43606100|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43606101|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606102|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
43606103|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
43866670|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866671|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866672|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866673|NCT01702831|Growth Substances|growth substances|mesh-ancestor
43866674|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866675|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866676|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866677|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
43866678|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866679|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866680|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866681|NCT01701986|Gemcitabine|gemcitabine|mesh-list
43866682|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
43866683|NCT01701986|Rituximab|rituximab|mesh-list
43866684|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43866685|NCT01701986|Busulfan|busulfan|mesh-list
43866686|NCT01701986|Clofarabine|clofarabine|mesh-list
43866687|NCT01701986|Antibodies|antibodies|mesh-list
43866688|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
43866689|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43866690|NCT01701986|Tacrolimus|tacrolimus|mesh-list
43866691|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
43866692|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43866693|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
43866694|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866695|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866696|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866697|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866698|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
43866699|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866700|NCT01701986|Antiviral Agents|antiviral agents|mesh-ancestor
43866701|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866702|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866703|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866704|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43866705|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866706|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43866707|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
43866708|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866709|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
43866710|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866711|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866712|NCT01697566|Metformin|metformin|mesh-list
43866713|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43866714|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866715|NCT01688492|Ipilimumab|ipilimumab|mesh-list
43866716|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866717|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866718|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43866719|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866720|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
43866721|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866722|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368401|NCT01183247|Hormones|hormones|mesh-ancestor
44368402|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368403|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368404|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44368405|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368406|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368407|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
44368408|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368409|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368410|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368411|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
44368412|NCT01183364|Docetaxel|docetaxel|mesh-list
44368413|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368414|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43659540|NCT02937896|Analgesics|analgesics|mesh-ancestor
43659541|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
43659542|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368415|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
44368416|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
44368417|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368418|NCT01183442|Vitamin D|vitamin d|mesh-list
44368419|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
44368420|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
44368421|NCT01183442|Vitamins|vitamins|mesh-list
44368422|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
44368423|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368424|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368425|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43866730|NCT01673217|Vaccines|vaccines|mesh-list
43866731|NCT01673217|Sargramostim|sargramostim|mesh-list
43866732|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
43866733|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
43866734|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866735|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866736|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866737|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43866738|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43866739|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866740|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866741|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866742|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
43866743|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43866744|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43866746|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43866747|NCT01668849|Narcotics|narcotics|mesh-ancestor
43866748|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43866749|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866750|NCT01668849|Analgesics|analgesics|mesh-ancestor
43866751|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
43866752|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368426|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
44368427|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44368428|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368429|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368430|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44368431|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44368433|NCT01183494|Bevacizumab|bevacizumab|mesh-list
44368434|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44368435|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44368436|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649476|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649477|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649478|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
43649479|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649480|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43649481|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43649482|NCT03023059|Levodopa|levodopa|mesh-list
43649483|NCT03023059|Carbidopa|carbidopa|mesh-list
43649484|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43649485|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44368437|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368438|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368439|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368440|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368441|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44368442|NCT01183494|Growth Substances|growth substances|mesh-ancestor
44368443|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368444|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368445|NCT01183572|Iron|iron|mesh-list
44368446|NCT01183572|Folic Acid|folic acid|mesh-list
44368447|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
44368448|NCT01183572|Trace Elements|trace elements|mesh-ancestor
44368449|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
44368450|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368451|NCT01183572|Hematinics|hematinics|mesh-ancestor
44368452|NCT01183572|Vitamins|vitamins|mesh-ancestor
44368453|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44368454|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44368455|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44368456|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
44368457|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368458|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44368460|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368467|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368468|NCT01183663|Leucovorin|leucovorin|mesh-list
44368469|NCT01183663|Sirolimus|sirolimus|mesh-list
44368470|NCT01183663|Bevacizumab|bevacizumab|mesh-list
44368471|NCT01183663|Lenalidomide|lenalidomide|mesh-list
44368472|NCT01183663|Fluorouracil|fluorouracil|mesh-list
44368473|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
44368474|NCT01183663|Sorafenib|sorafenib|mesh-list
44368475|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368476|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368477|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368478|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44368479|NCT01183663|Growth Substances|growth substances|mesh-ancestor
44368480|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368481|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44368482|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
44368483|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368484|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368485|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368486|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
44368487|NCT01183663|Antidotes|antidotes|mesh-ancestor
44368488|NCT01183663|Protective Agents|protective agents|mesh-ancestor
43659576|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
43851044|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43851045|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851046|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43659577|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368489|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
44368490|NCT01183663|Vitamins|vitamins|mesh-ancestor
44368491|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
44368492|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368493|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368494|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368495|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368496|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368515|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44368516|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368517|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44368518|NCT01183806|Rivastigmine|rivastigmine|mesh-list
44368519|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44368520|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368521|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368522|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368523|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368524|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368525|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44368526|NCT01183806|Protective Agents|protective agents|mesh-ancestor
44368527|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
44368528|NCT01183910|Calcium|calcium|mesh-list
44368529|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44368530|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368531|NCT01183910|Antacids|antacids|mesh-ancestor
44368532|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368533|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368534|NCT01183962|Vitamin D|vitamin d|mesh-list
44368535|NCT01183962|Vitamins|vitamins|mesh-ancestor
44368536|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
43866753|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43866754|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43866755|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
43866756|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
43866757|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43866758|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43866759|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866760|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866761|NCT01662050|Cytarabine|cytarabine|mesh-list
43866762|NCT01662050|Rituximab|rituximab|mesh-list
43866763|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43649487|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
43649488|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649489|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649490|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649491|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43649492|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649493|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43649494|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
43649495|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
43649496|NCT03023020|Aspirin|aspirin|mesh-list
43649497|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43606106|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43606107|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43866764|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866765|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866766|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
43866767|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866768|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866769|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866770|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
43866771|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866772|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
43866773|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866774|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866775|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866776|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
43866777|NCT01659658|Thalidomide|thalidomide|mesh-list
43866778|NCT01659658|Dexamethasone|dexamethasone|mesh-list
43866779|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
43866780|NCT01659658|Melphalan|melphalan|mesh-list
43866781|NCT01659658|Lenalidomide|lenalidomide|mesh-list
43866782|NCT01659658|Ixazomib|ixazomib|mesh-list
43866783|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866784|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
43702461|NCT02717052|Ketamine|ketamine|mesh-list
44368545|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
43606108|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43606109|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606110|NCT03221946|Diclofenac|diclofenac|mesh-list
43606111|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43606112|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606113|NCT03221946|Analgesics|analgesics|mesh-ancestor
43606114|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
43606115|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659605|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659606|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
43659607|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43659608|NCT02936934|Morphine|morphine|mesh-list
43659609|NCT02936934|Oxycodone|oxycodone|mesh-list
43659610|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43659611|NCT02936934|Narcotics|narcotics|mesh-ancestor
43659612|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659613|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659614|NCT02936934|Analgesics|analgesics|mesh-ancestor
43659615|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
43659616|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659617|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43659618|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43659619|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659620|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43659621|NCT02937012|Bezafibrate|bezafibrate|mesh-list
44368546|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44368547|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368548|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
44368549|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
44368550|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368551|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368552|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368553|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368554|NCT01184287|Ranpirnase|ranpirnase|mesh-list
44368555|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368556|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44368557|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368558|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866785|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866786|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866787|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866788|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
43866789|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866790|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866791|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866792|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866793|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
43866797|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
43866798|NCT01659658|Hormones|hormones|mesh-ancestor
43866799|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866800|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866801|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866802|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866803|NCT01659658|Growth Substances|growth substances|mesh-ancestor
43866804|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866805|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
43866806|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43866807|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866808|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
43866809|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606116|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606117|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606118|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606122|NCT03221998|Acetaminophen|acetaminophen|mesh-list
43866810|NCT01659307|Aspirin|aspirin|mesh-list
44368560|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368561|NCT01184378|Caseins|caseins|mesh-list
44368562|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
44368563|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
44368564|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368565|NCT01184391|Valproic Acid|valproic acid|mesh-list
44368566|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
44368567|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368568|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368569|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
43594625|NCT03332524|Ibuprofen|ibuprofen|mesh-list
43866812|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43866813|NCT01659307|Analgesics|analgesics|mesh-ancestor
43866814|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
43866815|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866816|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866817|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866818|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866819|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43866820|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43866821|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866822|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43866823|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43866824|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866825|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
43866826|NCT01653678|Vitamin D|vitamin d|mesh-list
43866827|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
43866828|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
43866829|NCT01653678|Vitamins|vitamins|mesh-list
43866830|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
43866831|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866832|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43866833|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43866834|NCT01650701|Rituximab|rituximab|mesh-list
43866835|NCT01650701|Lenalidomide|lenalidomide|mesh-list
43866836|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43866837|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866838|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866839|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
43866840|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866841|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866842|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866843|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866844|NCT01650701|Growth Substances|growth substances|mesh-ancestor
43866845|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866846|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866847|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
43866848|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866849|NCT01639690|Busulfan|busulfan|mesh-list
43866850|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
43866851|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866852|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866853|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
43866854|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659635|NCT02936830|Listerine|listerine|mesh-list
43659636|NCT02936830|Fluorides|fluorides|mesh-list
43659637|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
43659638|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
43866855|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866856|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866857|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866865|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866866|NCT01620788|Losartan|losartan|mesh-list
43866867|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43866868|NCT01620788|Indapamide|indapamide|mesh-list
43866869|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43866870|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44368570|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368571|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368572|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
44368573|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368574|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368575|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368577|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44368578|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44368579|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368580|NCT01184443|Olanzapine|olanzapine|mesh-list
44368581|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
44368582|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
44368583|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368584|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368585|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368586|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44368587|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368588|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368589|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368590|NCT01184443|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44368591|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44368592|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368593|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368594|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368595|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
44368596|NCT01184482|Cetuximab|cetuximab|mesh-list
44368597|NCT01184482|Lapatinib|lapatinib|mesh-list
44368598|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44368599|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368600|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866871|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43866872|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43866873|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866874|NCT01620788|Diuretics|diuretics|mesh-ancestor
43866875|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
43866876|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866877|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43866878|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43866879|NCT01619111|Lapatinib|lapatinib|mesh-list
43866880|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702462|NCT02717052|Esketamine|esketamine|mesh-list
44368601|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368602|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368603|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
44368604|NCT01184495|Hematinics|hematinics|mesh-ancestor
44368605|NCT01184560|Orlistat|orlistat|mesh-list
43606124|NCT03221998|Analgesics|analgesics|mesh-ancestor
43606125|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
43649498|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649499|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43649500|NCT03023020|Analgesics|analgesics|mesh-ancestor
43649501|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
44368606|NCT01184560|Sibutramine|sibutramine|mesh-list
43866881|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866882|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866883|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866884|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43866885|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43866886|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866887|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43866888|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43866889|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43866890|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866892|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866893|NCT01615510|Tapentadol|tapentadol|mesh-list
43866894|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43866895|NCT01615510|Narcotics|narcotics|mesh-ancestor
43866896|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43866897|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866898|NCT01615510|Analgesics|analgesics|mesh-ancestor
43866899|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
43866900|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866901|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43866902|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43866903|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43866904|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866905|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
43866906|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866907|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
43606126|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606127|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606128|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
43606129|NCT03221569|Ketorolac|ketorolac|mesh-list
43606130|NCT03221569|Ketamine|ketamine|mesh-list
43606131|NCT03221569|Analgesics|analgesics|mesh-ancestor
43606132|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
43606133|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606134|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606135|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43606136|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43606137|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
43606138|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
43606139|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606140|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43606141|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43606142|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43866908|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43866909|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
43866910|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43866911|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
43866912|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866913|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866914|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
43866915|NCT01597388|Fulvestrant|fulvestrant|mesh-list
43866916|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866917|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866918|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43866919|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43866920|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
43866921|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866922|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866923|NCT01591577|Temozolomide|temozolomide|mesh-list
43866924|NCT01591577|Lapatinib|lapatinib|mesh-list
43866934|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866935|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866937|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866938|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866939|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866940|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
43866941|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866942|NCT01572662|Methotrexate|methotrexate|mesh-list
43866943|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
43866944|NCT01572662|Fludarabine|fludarabine|mesh-list
43866945|NCT01572662|Busulfan|busulfan|mesh-list
43866946|NCT01572662|Tacrolimus|tacrolimus|mesh-list
43866947|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43866948|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
43866949|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43866950|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866951|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866952|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
43866953|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368607|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606177|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606178|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
43606179|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368608|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368609|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44368610|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44368611|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
44368612|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023918|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
44368613|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
44368615|NCT01184638|Sevoflurane|sevoflurane|mesh-list
44368616|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44368617|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368618|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368619|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44368620|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
44368621|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
44368622|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368623|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44368624|NCT01184664|Nicotine|nicotine|mesh-list
44368625|NCT01184664|Varenicline|varenicline|mesh-list
44368626|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43866954|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866955|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
43866956|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866957|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43866958|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866959|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
43866960|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866961|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43866962|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43866963|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
43866964|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866965|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866966|NCT01555268|Cytarabine|cytarabine|mesh-list
43866967|NCT01555268|Trebananib|trebananib|mesh-list
43866968|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866969|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
43866970|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866971|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866972|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
43866973|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866974|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866975|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
43866976|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866977|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866978|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866979|NCT01555268|Growth Substances|growth substances|mesh-ancestor
43866980|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866981|NCT01547260|Gemcitabine|gemcitabine|mesh-list
43866982|NCT01547260|Lenalidomide|lenalidomide|mesh-list
43866983|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866984|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
43866985|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866986|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866987|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
43866988|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43866989|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368628|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368629|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368630|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44368631|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44368632|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
44368633|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659690|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43659691|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43659692|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
43659693|NCT02935933|Morphine|morphine|mesh-list
43659694|NCT02935933|Bupivacaine|bupivacaine|mesh-list
44368634|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368635|NCT01184716|Vitamin D|vitamin d|mesh-list
44368636|NCT01184716|Vitamins|vitamins|mesh-ancestor
44368637|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
44368638|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368639|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368640|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
44368641|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
43866993|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866994|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866995|NCT01547260|Growth Substances|growth substances|mesh-ancestor
43866996|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866997|NCT01546987|Leuprolide|leuprolide|mesh-list
43866998|NCT01546987|Goserelin|goserelin|mesh-list
43866999|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43867000|NCT01546987|Flutamide|flutamide|mesh-list
43867001|NCT01546987|Bicalutamide|bicalutamide|mesh-list
43867002|NCT01546987|Buserelin|buserelin|mesh-list
43867003|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43867004|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
43867005|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43867006|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867007|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867008|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867009|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-ancestor
43867010|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
43867011|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867012|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
43867013|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43867014|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
43867015|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43867016|NCT01543763|Abexinostat|abexinostat|mesh-list
43867017|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43867018|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867019|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867020|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43867021|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43867022|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43867023|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867024|NCT01542879|Hematinics|hematinics|mesh-ancestor
43867025|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43867026|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43867027|NCT01530009|Amoxicillin|amoxicillin|mesh-list
43867028|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867029|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867030|NCT01525069|Gemcitabine|gemcitabine|mesh-list
43867031|NCT01525069|Dexamethasone|dexamethasone|mesh-list
43867032|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
43867033|NCT01525069|Floxuridine|floxuridine|mesh-list
43867034|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867035|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
43867036|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
43606222|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43606223|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43606224|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606225|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43867037|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867038|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867039|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368642|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
44368643|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368644|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368645|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
44368646|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368647|NCT01184820|Factor VIII|factor viii|mesh-list
44368648|NCT01184820|Coagulants|coagulants|mesh-ancestor
44368649|NCT01184833|Interferons|interferons|mesh-list
44368650|NCT01184833|Interferon-beta|interferon-beta|mesh-list
44368651|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
44368652|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368653|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
44368654|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368655|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
44368656|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368657|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44368658|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
44368659|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
44368660|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44368661|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
44368662|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44368663|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44368664|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368665|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44368666|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368667|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368668|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44368669|NCT01184911|Renal Agents|renal agents|mesh-ancestor
44368670|NCT01185015|Nicorandil|nicorandil|mesh-list
44368675|NCT01185015|Vitamins|vitamins|mesh-ancestor
44023999|NCT00626444|Ascorbic Acid|ascorbic acid|mesh-list
44368691|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368692|NCT01185119|Hormones|hormones|mesh-ancestor
44368693|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368694|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368695|NCT01185119|Incretins|incretins|mesh-ancestor
44368696|NCT01185158|Gefitinib|gefitinib|mesh-list
44368697|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368698|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368699|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606232|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606233|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606234|NCT03220880|Analgesics|analgesics|mesh-ancestor
43659711|NCT02935933|Narcotics|narcotics|mesh-ancestor
43659712|NCT02935725|Ketamine|ketamine|mesh-list
43659713|NCT02935725|Analgesics|analgesics|mesh-ancestor
43659714|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
44368700|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867040|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
43867041|NCT01525069|Hormones|hormones|mesh-ancestor
43867042|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867043|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867044|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867045|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867046|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
43867047|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867048|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
43867049|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867050|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867051|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867052|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
43867053|NCT01523977|Prednisone|prednisone|mesh-list
43867054|NCT01523977|Doxorubicin|doxorubicin|mesh-list
43867055|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
43867056|NCT01523977|Vincristine|vincristine|mesh-list
43867057|NCT01523977|Everolimus|everolimus|mesh-list
43867058|NCT01523977|Asparaginase|asparaginase|mesh-list
43867059|NCT01523977|Pegaspargase|pegaspargase|mesh-list
43867060|NCT01523977|Razoxane|razoxane|mesh-list
43867061|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867062|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867063|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867064|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867066|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867067|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867069|NCT01523977|Hormones|hormones|mesh-ancestor
43867070|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867071|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867072|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867073|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867074|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867075|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867076|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867077|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867078|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
43606235|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
43606236|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606237|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43606238|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43606239|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43606240|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606241|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606242|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606244|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43606245|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
43851142|NCT04579380|Tucatinib|tucatinib|mesh-list
43867079|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43867080|NCT01523977|Protective Agents|protective agents|mesh-ancestor
43867081|NCT01521403|Metronidazole|metronidazole|mesh-list
43867082|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867083|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867084|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43867085|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43867086|NCT01517711|Tramadol|tramadol|mesh-list
43867087|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43867088|NCT01517711|Narcotics|narcotics|mesh-ancestor
43867089|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43867090|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851151|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867091|NCT01517711|Analgesics|analgesics|mesh-ancestor
44368701|NCT01185184|Tofacitinib|tofacitinib|mesh-list
44368702|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44368703|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368704|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368705|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
44368706|NCT01185197|Prednisolone|prednisolone|mesh-list
44368707|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368708|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368709|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44368710|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
44368711|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368712|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368762|NCT01185418|Haloperidol|haloperidol|mesh-list
44368763|NCT01185418|Risperidone|risperidone|mesh-list
44368764|NCT01185418|Aripiprazole|aripiprazole|mesh-list
44368765|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
44368766|NCT01185418|Amisulpride|amisulpride|mesh-list
44368767|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44368768|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
44368769|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368770|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368771|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368772|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44368773|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43679969|NCT05379569|Fludarabine|fludarabine|mesh-list
43867092|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
43867093|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867094|NCT01517243|Sirolimus|sirolimus|mesh-list
43867095|NCT01517243|Sunitinib|sunitinib|mesh-list
43867096|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867097|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867098|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867099|NCT01517243|Growth Substances|growth substances|mesh-ancestor
43867100|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867101|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867102|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867103|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867104|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867105|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867106|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867107|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867108|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
43867109|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867110|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
43867111|NCT01516606|Clarithromycin|clarithromycin|mesh-list
43867112|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867113|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867114|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43867115|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867116|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867117|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43867118|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43867119|NCT01516593|Cytarabine|cytarabine|mesh-list
43867120|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867121|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
43867122|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867123|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867124|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
43867125|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867126|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867127|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
43867128|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867129|NCT01515527|Cytarabine|cytarabine|mesh-list
43867130|NCT01515527|Decitabine|decitabine|mesh-list
43867131|NCT01515527|Cladribine|cladribine|mesh-list
43867132|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867133|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
43867134|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867135|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867136|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
43867137|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134488|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44368774|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368776|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44368777|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
44368778|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
44368779|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
44368780|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44368781|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44368782|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44368783|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44368784|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
44368785|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
44368786|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368787|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134489|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134490|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134491|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
44134492|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134493|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44134494|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44134495|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44134496|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606268|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43606270|NCT03220555|Prilocaine|prilocaine|mesh-list
43606271|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
43606272|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
43606273|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134497|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44134498|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44134499|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44134500|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44134501|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
44134502|NCT00158483|Acyclovir|acyclovir|mesh-list
44134503|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
44134504|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134505|NCT00158496|Interferons|interferons|mesh-list
44134506|NCT00158496|Ribavirin|ribavirin|mesh-list
44134507|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
44134508|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
44134509|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44134510|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134511|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
43867148|NCT01506856|Paclitaxel|paclitaxel|mesh-list
43867149|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43867155|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867156|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867157|NCT01504815|Cisplatin|cisplatin|mesh-list
43867158|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867159|NCT01490502|Vitamin D|vitamin d|mesh-list
43867160|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
43867161|NCT01490502|Vitamins|vitamins|mesh-ancestor
43867162|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
43867163|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867164|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867165|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43867166|NCT01485861|Prednisone|prednisone|mesh-list
43867167|NCT01485861|Prednisolone|prednisolone|mesh-list
43867168|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867169|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
43867170|NCT01485861|Hormones|hormones|mesh-ancestor
43867171|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867172|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606287|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43606288|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867173|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867174|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867175|NCT01476501|Vitamin D|vitamin d|mesh-list
43867176|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
43867177|NCT01476501|Vitamins|vitamins|mesh-ancestor
44368788|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44368789|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44368790|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
44368791|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44368792|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
44368793|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368794|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
44368795|NCT01185444|Protective Agents|protective agents|mesh-ancestor
44368797|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44368798|NCT01185470|Narcotics|narcotics|mesh-ancestor
44368799|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368800|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368801|NCT01185470|Analgesics|analgesics|mesh-ancestor
43828057|NCT05481970|Lidocaine|lidocaine|mesh-list
43867178|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
43867179|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867180|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867181|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43867182|NCT01464034|Dexamethasone|dexamethasone|mesh-list
43867183|NCT01464034|Pomalidomide|pomalidomide|mesh-list
43867184|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867185|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
43867186|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
43867187|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867188|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867189|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867190|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
43867191|NCT01464034|Hormones|hormones|mesh-ancestor
43867192|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867193|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867194|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867195|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
43867196|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867197|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867198|NCT01464034|Growth Substances|growth substances|mesh-ancestor
43606296|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606297|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606298|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606299|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
43606329|NCT03220490|Timolol|timolol|mesh-list
43606330|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43867199|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867200|NCT01460654|Alendronate|alendronate|mesh-list
43867201|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
43867202|NCT01460654|Testosterone|testosterone|mesh-list
43867203|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
43867204|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
43867205|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43867206|NCT01460654|Androgens|androgens|mesh-ancestor
43867207|NCT01460654|Hormones|hormones|mesh-ancestor
43867208|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867209|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867210|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867211|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867212|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
43867213|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867214|NCT01459484|Cisplatin|cisplatin|mesh-list
43867215|NCT01459484|Doxorubicin|doxorubicin|mesh-list
43867216|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43867217|NCT01459484|Methotrexate|methotrexate|mesh-list
43867218|NCT01459484|Ifosfamide|ifosfamide|mesh-list
43867219|NCT01459484|Mifamurtide|mifamurtide|mesh-list
43867220|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
43867221|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867222|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867225|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867226|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867227|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44368802|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
44368803|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368804|NCT01185535|Anesthetics|anesthetics|mesh-list
44368805|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368806|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368807|NCT01185574|Vitamin D|vitamin d|mesh-list
44368808|NCT01185574|Vitamins|vitamins|mesh-ancestor
44368809|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
44368810|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368811|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44368812|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
44368813|NCT01185678|Desogestrel|desogestrel|mesh-list
44368814|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
44368815|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44368816|NCT01185678|Progestins|progestins|mesh-list
44368817|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44368818|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368819|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44368820|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44368821|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44368822|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44368823|NCT01185678|Hormones|hormones|mesh-ancestor
44368824|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44368825|NCT01185743|Olanzapine|olanzapine|mesh-list
44368826|NCT01185743|Ziprasidone|ziprasidone|mesh-list
44368827|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
44368828|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
44368829|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867228|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
43867229|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43867230|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867231|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867232|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
43867233|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
43867234|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43867235|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867236|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
43867237|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867238|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43659787|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867239|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43659792|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
43867240|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
43867241|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43867242|NCT01444040|Travoprost|travoprost|mesh-list
43867243|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43867244|NCT01431755|Lidocaine|lidocaine|mesh-list
43867245|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
43867246|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
43867247|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
43867248|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368830|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368831|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368832|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44368833|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44368834|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44368835|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368836|NCT01185743|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44368837|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44024145|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
44368838|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368839|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368840|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368841|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
44368842|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43867249|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867250|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
43867251|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867252|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43867253|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43867254|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43867255|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43867256|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867257|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43867258|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
43867259|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
43867260|NCT01431755|Protective Agents|protective agents|mesh-ancestor
43867261|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
43867262|NCT01428973|Sirolimus|sirolimus|mesh-list
43867263|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867264|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867265|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43867266|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
43867267|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867268|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867269|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867270|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867271|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
43867272|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867273|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
43867274|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867275|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
43867276|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43867277|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
43867278|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867279|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
43867280|NCT01428024|Protective Agents|protective agents|mesh-ancestor
43867281|NCT01424982|Cytarabine|cytarabine|mesh-list
43867282|NCT01424982|Dexamethasone|dexamethasone|mesh-list
43867283|NCT01424982|Prednisone|prednisone|mesh-list
43867284|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
43867285|NCT01424982|Cortisone|cortisone|mesh-list
43867286|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
43659807|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
43659808|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659809|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43659810|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43867287|NCT01424982|Rituximab|rituximab|mesh-list
43867288|NCT01424982|Doxorubicin|doxorubicin|mesh-list
43867289|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43867290|NCT01424982|Methotrexate|methotrexate|mesh-list
43867291|NCT01424982|Vincristine|vincristine|mesh-list
43867292|NCT01424982|Daunorubicin|daunorubicin|mesh-list
43867293|NCT01424982|Ponatinib|ponatinib|mesh-list
43867294|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43867295|NCT01424982|Antibodies|antibodies|mesh-list
43867296|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
44368843|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44368845|NCT01185769|Tocotrienols|tocotrienols|mesh-list
44368846|NCT01185769|Vitamin E|vitamin e|mesh-list
44368847|NCT01185769|Tocopherols|tocopherols|mesh-list
44368848|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
44368849|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368850|NCT01185769|Protective Agents|protective agents|mesh-ancestor
44368851|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368852|NCT01185769|Vitamins|vitamins|mesh-ancestor
44368853|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
44368854|NCT01185808|Vitamin D|vitamin d|mesh-list
44368855|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
44368856|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
43606336|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606337|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43606338|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43606339|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43606340|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43606341|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43606342|NCT03220152|Tenofovir|tenofovir|mesh-list
43606343|NCT03220152|Emtricitabine|emtricitabine|mesh-list
43606344|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
44368857|NCT01185808|Vitamins|vitamins|mesh-list
44368858|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
44368859|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368860|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867297|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867298|NCT01424982|BB 1101|bb 1101|mesh-list
43867302|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867303|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867304|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
43867305|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867306|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867307|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43867308|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867310|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
43867311|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867312|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867313|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
43867314|NCT01424982|Hormones|hormones|mesh-ancestor
43867315|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867316|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867317|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867318|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867319|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867320|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867321|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43867322|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
43867323|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43867324|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867325|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
43867326|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
43867327|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43867328|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43867329|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
43867330|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867331|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867332|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867333|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867334|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867335|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
43867336|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867337|NCT01422759|Spironolactone|spironolactone|mesh-list
43867338|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43867339|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
43867340|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867341|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368861|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44368862|NCT01185847|Gemcitabine|gemcitabine|mesh-list
44368864|NCT01185847|Pemetrexed|pemetrexed|mesh-list
44368865|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368866|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368867|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
44368868|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368869|NCT01185847|Antiviral Agents|antiviral agents|mesh-ancestor
44368870|NCT01185847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606387|NCT03220113|Hormones|hormones|mesh-ancestor
43606389|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44368871|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368872|NCT01185847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368873|NCT01185847|Immunologic Factors|immunologic factors|mesh-ancestor
44368874|NCT01185847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368875|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43867342|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43867343|NCT01422759|Diuretics|diuretics|mesh-ancestor
43867344|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
43867345|NCT01422746|Metformin|metformin|mesh-list
43867346|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43867347|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867348|NCT01421810|Dexamethasone|dexamethasone|mesh-list
43867349|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867350|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
43867351|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
43867352|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867353|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867354|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867355|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
43867356|NCT01421810|Hormones|hormones|mesh-ancestor
43867357|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867358|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867359|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867360|NCT01421797|Dexamethasone|dexamethasone|mesh-list
43867361|NCT01421797|Cosyntropin|cosyntropin|mesh-list
43867362|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867363|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
43867364|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
43867365|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867366|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867367|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867368|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
43867369|NCT01421797|Hormones|hormones|mesh-ancestor
43867376|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867377|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43867378|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43867379|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867381|NCT01415752|Lenalidomide|lenalidomide|mesh-list
43867382|NCT01415752|Bortezomib|bortezomib|mesh-list
43867383|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43606397|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43849221|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606398|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606399|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606400|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
43606401|NCT03220113|Vitamins|vitamins|mesh-ancestor
43606402|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
43606403|NCT03220009|Nivolumab|nivolumab|mesh-list
43606404|NCT03220009|Ipilimumab|ipilimumab|mesh-list
43606405|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43606406|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867384|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867385|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867386|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
43867387|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867388|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867389|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867390|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867391|NCT01415752|Growth Substances|growth substances|mesh-ancestor
43867392|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867393|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867394|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
44368877|NCT01185860|Ritonavir|ritonavir|mesh-list
44368878|NCT01185860|Ribavirin|ribavirin|mesh-list
44368879|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44368880|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44368881|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44368882|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
44368883|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368884|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368885|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44368886|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44368887|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
44368888|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368889|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44368890|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44368891|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
44368892|NCT01185873|Ritonavir|ritonavir|mesh-list
43867395|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867396|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
43867397|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43867398|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
43867399|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867400|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
43867401|NCT01412190|Protective Agents|protective agents|mesh-ancestor
43867402|NCT01407562|Paclitaxel|paclitaxel|mesh-list
43867403|NCT01407562|Carboplatin|carboplatin|mesh-list
43867404|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867405|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867406|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867407|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867408|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867409|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867410|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867411|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
43867412|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867413|NCT01393522|Milnacipran|milnacipran|mesh-list
43867414|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
43867415|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43867416|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43867417|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43867418|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867419|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867420|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867421|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43867422|NCT01393522|Analgesics|analgesics|mesh-ancestor
43867423|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
43867424|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659871|NCT02935530|Dalteparin|dalteparin|mesh-list
43659872|NCT02935530|Argatroban|argatroban|mesh-list
43851210|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
43659873|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
43659874|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43867425|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
43867426|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43867427|NCT01375829|Sirolimus|sirolimus|mesh-list
43867428|NCT01375829|Epothilone B|epothilone b|mesh-list
43867429|NCT01375829|Epothilones|epothilones|mesh-list
43867430|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867431|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867432|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867433|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867434|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
44368893|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44368894|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44368895|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
44368896|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368897|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368898|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44368899|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44368900|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
44368901|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368902|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43680061|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
43867435|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867436|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
43867440|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867441|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867442|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
43867443|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
43867444|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43867445|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43867446|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
43867447|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867448|NCT01371201|Sunitinib|sunitinib|mesh-list
43867449|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867450|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867451|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867452|NCT01371201|Growth Substances|growth substances|mesh-ancestor
43867453|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867454|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867455|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867456|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851211|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659883|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
43659884|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43659885|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659886|NCT02935231|Nicotine|nicotine|mesh-list
43659887|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43659888|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
43659889|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659890|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659891|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43659892|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43562882|NCT01365195|Ketamine|ketamine|mesh-list
43867457|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867459|NCT01364051|Maleic acid|maleic acid|mesh-list
43867460|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867461|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867462|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867463|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867464|NCT01358669|Denosumab|denosumab|mesh-list
43867465|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867466|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867467|NCT01357772|Tamoxifen|tamoxifen|mesh-list
43867468|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43867469|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
43867470|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867471|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867472|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867473|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867474|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43867475|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43867476|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867477|NCT01344200|Celecoxib|celecoxib|mesh-list
43867478|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43867479|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43867480|NCT01344200|Analgesics|analgesics|mesh-ancestor
43867481|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
43867482|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867483|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867484|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867485|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867486|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43867487|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43867488|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867489|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368903|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44368904|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
44368905|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
44368906|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44368907|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44368908|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368909|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368910|NCT01185925|Urological Agents|urological agents|mesh-ancestor
44368911|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44368912|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44368913|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44368914|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
44368915|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368916|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44368917|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44368918|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368919|NCT01185951|Polidocanol|polidocanol|mesh-list
43867490|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
43867491|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43867492|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659893|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
43659894|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659895|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659896|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
43659897|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43659898|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43659899|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659900|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
43659901|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
43867493|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867494|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43867495|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43867496|NCT01337349|Protective Agents|protective agents|mesh-ancestor
43867497|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867498|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
43867499|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43867500|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
43867501|NCT01331148|Vitamin D|vitamin d|mesh-list
43867502|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
43867503|NCT01331148|Vitamins|vitamins|mesh-ancestor
43867504|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
43867505|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867506|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867507|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43867513|NCT01319981|Prednisolone|prednisolone|mesh-list
43867514|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
43867515|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
43867516|NCT01319981|Rituximab|rituximab|mesh-list
43867517|NCT01319981|Doxorubicin|doxorubicin|mesh-list
43867518|NCT01319981|Methotrexate|methotrexate|mesh-list
43867519|NCT01319981|Vincristine|vincristine|mesh-list
43867520|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
43867521|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43867522|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
43867523|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867524|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
43867525|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867526|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867527|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867528|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
43867529|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867530|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867531|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43867532|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867533|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867534|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
43867535|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
44368921|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44368922|NCT01185977|Fluoxetine|fluoxetine|mesh-list
44368923|NCT01185977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44368924|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44368925|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44368926|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368927|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368928|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
44368929|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368930|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44368931|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
44368932|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44368933|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44368934|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44368935|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368936|NCT01186029|Aprepitant|aprepitant|mesh-list
44368937|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
44368938|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
44368939|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368940|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368941|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44368942|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43851214|NCT04422431|Growth Substances|growth substances|mesh-ancestor
43659920|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43659921|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44368943|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659922|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44368944|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368945|NCT01186094|Sirolimus|sirolimus|mesh-list
44368946|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44368947|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44368948|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44368949|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867536|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867537|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867538|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
43867539|NCT01319981|Hormones|hormones|mesh-ancestor
43867540|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867541|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867542|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867543|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867544|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867545|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867546|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44368950|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
44368951|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368952|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
44368953|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368954|NCT01186120|Umirolimus|umirolimus|mesh-list
44368955|NCT01186120|Everolimus|everolimus|mesh-list
44368956|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44368957|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44368958|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
44368959|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368960|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368961|NCT01186146|Aspirin|aspirin|mesh-list
44368962|NCT01186146|Clopidogrel|clopidogrel|mesh-list
44368963|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44368964|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44368965|NCT01186146|Analgesics|analgesics|mesh-ancestor
44368966|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
44368967|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368968|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368969|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368970|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368971|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43606409|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
43606410|NCT03219008|Mirtazapine|mirtazapine|mesh-list
43606411|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
43606412|NCT03219008|Fluoxetine|fluoxetine|mesh-list
43606426|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606428|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
43606429|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43606430|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606431|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43851215|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368972|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44368973|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368974|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44368975|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44368976|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44368977|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
44368978|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44368979|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44368980|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44368981|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
44368982|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44368983|NCT01186159|Parecoxib|parecoxib|mesh-list
44368984|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44368985|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43867547|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
43867548|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43867549|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44368987|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44368988|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44368989|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44368990|NCT01186159|Analgesics|analgesics|mesh-ancestor
44368991|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
44368992|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44368993|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44368994|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44368995|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44368996|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44368997|NCT01186172|Ethanol|ethanol|mesh-list
44368998|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867550|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
43867551|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
43867552|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43867553|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43867554|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
43867555|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867556|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867557|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867558|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867559|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867560|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43867561|NCT01319981|Protective Agents|protective agents|mesh-ancestor
43867562|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867563|NCT01313702|Atenolol|atenolol|mesh-list
43867564|NCT01313702|Lisinopril|lisinopril|mesh-list
43867565|NCT01313702|Simvastatin|simvastatin|mesh-list
43867566|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43867567|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43867568|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
43867569|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867570|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43867571|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43867572|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867573|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43867574|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
43867575|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43867576|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43867577|NCT01313702|Protective Agents|protective agents|mesh-ancestor
43867578|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867579|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43867583|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43867584|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43867585|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43867586|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
43867587|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867588|NCT01308619|Doxycycline|doxycycline|mesh-list
43867589|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867590|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867591|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
43867592|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43867593|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43867594|NCT01307605|Rituximab|rituximab|mesh-list
43867595|NCT01307605|Lenalidomide|lenalidomide|mesh-list
43867596|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867597|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867598|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
43867599|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867600|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867601|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44368999|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44369000|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369001|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369002|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
44369003|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369005|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44369006|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44369007|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
44369008|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369009|NCT01186289|Atorvastatin|atorvastatin|mesh-list
44369010|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44369011|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44369012|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
44369013|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680172|NCT05336968|Analgesics|analgesics|mesh-ancestor
43867602|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867603|NCT01307605|Growth Substances|growth substances|mesh-ancestor
43867604|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867605|NCT01305499|Azacitidine|azacitidine|mesh-list
43867606|NCT01305499|Entinostat|entinostat|mesh-list
43867607|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867608|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
43867609|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867610|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867611|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867612|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43867613|NCT01303341|Sorafenib|sorafenib|mesh-list
43867614|NCT01303341|Riluzole|riluzole|mesh-list
43867615|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867616|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606432|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
43606433|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
43606434|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43606435|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43867617|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867618|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867619|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
43867620|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43867621|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43867622|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867623|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867624|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43867625|NCT01303341|Protective Agents|protective agents|mesh-ancestor
44134512|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134513|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
44134514|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134515|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
44134516|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134517|NCT00158509|Valacyclovir|valacyclovir|mesh-list
44134518|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
44134519|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134520|NCT00158522|Interferons|interferons|mesh-list
44134521|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
44134522|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
44134523|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44134524|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134525|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
44134526|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134527|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
44134528|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134529|NCT00158548|Artesunate|artesunate|mesh-list
44134530|NCT00158548|Chloroquine|chloroquine|mesh-list
44134531|NCT00158548|Primaquine|primaquine|mesh-list
44134532|NCT00158548|Amodiaquine|amodiaquine|mesh-list
44134533|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
44134534|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44369014|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44369015|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43606442|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43659975|NCT02934906|Antibodies|antibodies|mesh-list
44369016|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369017|NCT01186445|Morphine|morphine|mesh-list
44369018|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44369019|NCT01186445|Narcotics|narcotics|mesh-ancestor
44369020|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369021|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369022|NCT01186445|Analgesics|analgesics|mesh-ancestor
44369023|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
44369024|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369025|NCT01186471|Nicotine|nicotine|mesh-list
44369026|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44369027|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
44369028|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369029|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369030|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44369031|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44369032|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
44369033|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369034|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369035|NCT01186497|Rabeprazole|rabeprazole|mesh-list
44369036|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44369037|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44369038|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44369039|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680184|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44134535|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134536|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134537|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134538|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
44134539|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
44134540|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44134545|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
44134546|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44134547|NCT00158561|Dapsone|dapsone|mesh-list
44134548|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
44134549|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
44134550|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134551|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134552|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134553|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44134554|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134555|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134556|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44134557|NCT00158561|Renal Agents|renal agents|mesh-ancestor
44134558|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
44134559|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44134560|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
44369040|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369041|NCT01186549|Lidocaine|lidocaine|mesh-list
44369042|NCT01186549|Ephedrine|ephedrine|mesh-list
44369043|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
44369044|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
44369045|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
44369046|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369047|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369048|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
44369049|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369050|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44369051|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44369052|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44369053|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44369054|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369055|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44369056|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
44369057|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
44369058|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44369059|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659988|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659989|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44369060|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369061|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44369062|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44369063|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369064|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
44369065|NCT01186588|Canagliflozin|canagliflozin|mesh-list
44369066|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44369067|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369068|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606462|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43606463|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606464|NCT03216356|Renal Agents|renal agents|mesh-ancestor
43606465|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43606466|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
43606467|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606468|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
43606469|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606491|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43606492|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
43606493|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
43606494|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43606495|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43606496|NCT03214302|Tenofovir|tenofovir|mesh-list
43606497|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
43606498|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606499|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43606500|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43606501|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660001|NCT02935010|Renal Agents|renal agents|mesh-ancestor
43660002|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43660003|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43660004|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369069|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369070|NCT01186653|Fluticasone|fluticasone|mesh-list
44369071|NCT01186653|Budesonide|budesonide|mesh-list
44369072|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
44134561|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
44369079|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369080|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44369081|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369082|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44369083|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44369084|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
44369085|NCT01186653|Hormones|hormones|mesh-ancestor
44369086|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369087|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44369088|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44369089|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44369090|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44369091|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369092|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590939|NCT03366584|Zinc|zinc|mesh-list
44134562|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44134563|NCT00158574|Dapsone|dapsone|mesh-list
44134564|NCT00158574|Mefloquine|mefloquine|mesh-list
44134565|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
44134566|NCT00158574|Proguanil|proguanil|mesh-list
43867626|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
43867627|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43867628|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867629|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867630|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43867631|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43867632|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
43867633|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43606502|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606503|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43867634|NCT01276600|Tenofovir|tenofovir|mesh-list
43606504|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43606505|NCT03213769|Ubiquinone|ubiquinone|mesh-list
43606506|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
43606507|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
43606508|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867635|NCT01276600|Emtricitabine|emtricitabine|mesh-list
43867636|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
43867637|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867638|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43867639|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43867640|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867641|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867642|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43867643|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43867644|NCT01273610|Trastuzumab|trastuzumab|mesh-list
43867645|NCT01273610|Lapatinib|lapatinib|mesh-list
43867646|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867647|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867648|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867649|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867650|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867651|NCT01253070|Cytarabine|cytarabine|mesh-list
43867652|NCT01253070|Sorafenib|sorafenib|mesh-list
43867653|NCT01253070|Daunorubicin|daunorubicin|mesh-list
43867654|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867655|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
43867656|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867657|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867658|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
43867659|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867660|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867661|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
43867662|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867663|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867664|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867665|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43702463|NCT02717052|Analgesics|analgesics|mesh-ancestor
44369093|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
44369094|NCT01186731|Docetaxel|docetaxel|mesh-list
44369095|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369096|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
44369097|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
44369098|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
44369099|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369100|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
44369101|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44369102|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44369103|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
43867666|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867667|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867668|NCT01252719|Vancomycin|vancomycin|mesh-list
43867669|NCT01252719|Oritavancin|oritavancin|mesh-list
43606541|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
43867670|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43867671|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867672|NCT01230411|Ibuprofen|ibuprofen|mesh-list
43867673|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43867674|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43867675|NCT01230411|Analgesics|analgesics|mesh-ancestor
43867678|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867679|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867680|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867681|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43867682|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867683|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867684|NCT01229943|Bevacizumab|bevacizumab|mesh-list
43867685|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43867687|NCT01229943|Octreotide|octreotide|mesh-list
43867688|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
43867689|NCT01229943|Antibodies|antibodies|mesh-list
43867690|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
43867691|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867692|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
43867693|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867694|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867695|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867696|NCT01229943|Growth Substances|growth substances|mesh-ancestor
43867697|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867698|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867699|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
43867700|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867701|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867702|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867703|NCT01226563|Calcium|calcium|mesh-list
43867704|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43867705|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867706|NCT01219257|Adalimumab|adalimumab|mesh-list
43867707|NCT01219257|Etanercept|etanercept|mesh-list
43867708|NCT01219257|Golimumab|golimumab|mesh-list
43867709|NCT01219257|Infliximab|infliximab|mesh-list
43867710|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867711|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867712|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
43867713|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867714|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43867715|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43867716|NCT01219257|Analgesics|analgesics|mesh-ancestor
43867717|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
43867718|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867719|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867720|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867721|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
43867722|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43867723|NCT01212822|Leucovorin|leucovorin|mesh-list
43867724|NCT01212822|Bevacizumab|bevacizumab|mesh-list
44369104|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44369105|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44369106|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369107|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
44369108|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369109|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369110|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44369111|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
44369112|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
44369113|NCT01186835|Protective Agents|protective agents|mesh-ancestor
44369114|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43828126|NCT05481684|Progesterone|progesterone|mesh-list
43867725|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43825624|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43825625|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43825626|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43867726|NCT01212822|Fluorouracil|fluorouracil|mesh-list
43867727|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
43867728|NCT01212822|Antibodies|antibodies|mesh-list
43867729|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
43867730|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867731|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
43867732|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867733|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867734|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867735|NCT01212822|Growth Substances|growth substances|mesh-ancestor
43867736|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867737|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867738|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
43867739|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
43867740|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867741|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867742|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867743|NCT01212822|Antidotes|antidotes|mesh-ancestor
43867744|NCT01212822|Protective Agents|protective agents|mesh-ancestor
43867745|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
43867746|NCT01212822|Vitamins|vitamins|mesh-ancestor
43867747|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
43867748|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
43867749|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43867750|NCT01209871|Antibodies|antibodies|mesh-list
43867751|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
43867758|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43867759|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
43867760|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867762|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
43867763|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867764|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867765|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43867766|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
43867767|NCT01209364|Hormones|hormones|mesh-ancestor
43867768|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867769|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43867770|NCT01209364|Protective Agents|protective agents|mesh-ancestor
43867771|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867772|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867773|NCT01189643|Bevacizumab|bevacizumab|mesh-list
43867774|NCT01189643|Irinotecan|irinotecan|mesh-list
43867775|NCT01189643|Temozolomide|temozolomide|mesh-list
43867776|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867777|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867778|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867779|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867780|NCT01189643|Growth Substances|growth substances|mesh-ancestor
44134567|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
43867781|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849229|NCT03948074|Analgesics|analgesics|mesh-ancestor
43849230|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
43849231|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849232|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43849233|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43849234|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867782|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44369115|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369116|NCT01186887|Celecoxib|celecoxib|mesh-list
44369117|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369118|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369119|NCT01186887|Analgesics|analgesics|mesh-ancestor
44369120|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
44369121|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369122|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369123|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369124|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369125|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44369126|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44369127|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369128|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369129|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
44369130|NCT01187108|Acetazolamide|acetazolamide|mesh-list
44369131|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43867783|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43867784|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867785|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867786|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867787|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867788|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
43867789|NCT01125436|Vitamin D|vitamin d|mesh-list
43867790|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
43867791|NCT01125436|Vitamins|vitamins|mesh-ancestor
43867792|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
43867793|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867794|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43867795|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43867796|NCT01121588|Crizotinib|crizotinib|mesh-list
43867797|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867798|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606550|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606551|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606552|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606553|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
43606554|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43606555|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43606556|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43606557|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43606558|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
43606559|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43606560|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43606561|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
43606562|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606563|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
43606564|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43606565|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43606566|NCT03212495|Neostigmine|neostigmine|mesh-list
43867799|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867800|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867801|NCT01113476|Gemcitabine|gemcitabine|mesh-list
43867802|NCT01113476|Paclitaxel|paclitaxel|mesh-list
43867803|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43867804|NCT01113476|Bevacizumab|bevacizumab|mesh-list
43867805|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867806|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867807|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867808|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867809|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
43867810|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867811|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867812|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867813|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867814|NCT01113476|Growth Substances|growth substances|mesh-ancestor
43867815|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867816|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
43867817|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867818|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
43867819|NCT01113476|Antiviral Agents|antiviral agents|mesh-ancestor
43867823|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
43867824|NCT01107236|Naproxen|naproxen|mesh-list
43867825|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369132|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
44369133|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369134|NCT01187108|Expectorants|expectorants|mesh-ancestor
44369135|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369136|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44369137|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
44369138|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369139|NCT01187108|Protective Agents|protective agents|mesh-ancestor
44369140|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369141|NCT01187108|Antidotes|antidotes|mesh-ancestor
44369142|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
44369143|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44369144|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369145|NCT01187108|Diuretics|diuretics|mesh-ancestor
44369146|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
44369147|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
44369148|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44369149|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369150|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44369151|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369152|NCT01187212|Cisplatin|cisplatin|mesh-list
44369153|NCT01187212|Capecitabine|capecitabine|mesh-list
43606567|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606568|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606584|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606585|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606586|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606587|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43851230|NCT04394546|Anticoagulants|anticoagulants|mesh-list
43851231|NCT04393298|Leucovorin|leucovorin|mesh-list
44369154|NCT01187212|Sorafenib|sorafenib|mesh-list
44369155|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369156|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44369157|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
44369158|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369159|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369160|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369161|NCT01187238|Cisplatin|cisplatin|mesh-list
44369162|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369163|NCT01187264|Methotrexate|methotrexate|mesh-list
43867826|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43867827|NCT01107236|Analgesics|analgesics|mesh-ancestor
43867828|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
43867829|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867830|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867831|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867832|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867833|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
43867834|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43867835|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867836|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867837|NCT01067287|Pidilizumab|pidilizumab|mesh-list
44369164|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44369165|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
44369166|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44369167|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369168|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44369169|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
44369170|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369171|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369172|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44369173|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369174|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44369175|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369176|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
44369177|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369178|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44369180|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369181|NCT01187459|Vitamin D|vitamin d|mesh-list
44369182|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
44369183|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
44369184|NCT01187459|Vitamins|vitamins|mesh-list
44369217|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44369218|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44369219|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44369220|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
44369221|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369222|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369224|NCT01187615|Pemetrexed|pemetrexed|mesh-list
44369225|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369226|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649502|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649503|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649504|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649505|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649506|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43649507|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43851232|NCT04393298|Trifluridine|trifluridine|mesh-list
43851233|NCT04393298|Fluorouracil|fluorouracil|mesh-list
44369227|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369228|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43867838|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867839|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867840|NCT01066858|Tenofovir|tenofovir|mesh-list
43867841|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
43867842|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867843|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43867844|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43867845|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867846|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867847|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43867848|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43867849|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
43867850|NCT01064375|Molgramostim|molgramostim|mesh-list
43867851|NCT01064375|Sargramostim|sargramostim|mesh-list
43867852|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867853|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
43867854|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867855|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867856|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867857|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
43867858|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867859|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867860|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43867862|NCT01061411|Dalteparin|dalteparin|mesh-list
43867863|NCT01061411|Tinzaparin|tinzaparin|mesh-list
43867864|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43867865|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867866|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43867867|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43867868|NCT01061411|Growth Substances|growth substances|mesh-ancestor
43867869|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867870|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
43649508|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649509|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43649510|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649511|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
43649512|NCT03022318|Levodopa|levodopa|mesh-list
43649513|NCT03022318|Carbidopa|carbidopa|mesh-list
43649514|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43649515|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43649516|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43649517|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
43649518|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649519|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649520|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606588|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43867871|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867872|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867873|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867874|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
43867875|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43867876|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43867877|NCT01046825|Leucovorin|leucovorin|mesh-list
43867878|NCT01046825|Folic Acid|folic acid|mesh-list
43867879|NCT01046825|Cytarabine|cytarabine|mesh-list
43867880|NCT01046825|Prednisone|prednisone|mesh-list
43867881|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
43867882|NCT01046825|Doxorubicin|doxorubicin|mesh-list
43867883|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43867884|NCT01046825|Rituximab|rituximab|mesh-list
43867885|NCT01046825|Rasburicase|rasburicase|mesh-list
43867886|NCT01046825|Lenograstim|lenograstim|mesh-list
43867887|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
43867888|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43867889|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
43867890|NCT01046825|Hormones|hormones|mesh-ancestor
44369231|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
44369232|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44369233|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44369234|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44369235|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369236|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44369237|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44369238|NCT01187849|Metformin|metformin|mesh-list
44369239|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606589|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606590|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606591|NCT03209908|Tenofovir|tenofovir|mesh-list
43606592|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
43606593|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606594|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43606595|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43606596|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606597|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606598|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44369240|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369241|NCT01187862|Efavirenz|efavirenz|mesh-list
44369242|NCT01187862|Losartan|losartan|mesh-list
44369243|NCT01187862|Metoprolol|metoprolol|mesh-list
44369244|NCT01187862|Midazolam|midazolam|mesh-list
44369245|NCT01187862|Caffeine|caffeine|mesh-list
43867891|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867892|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867893|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867894|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867898|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43867899|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867900|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
43867901|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867902|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43867903|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867904|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867905|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867906|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867907|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867908|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43867909|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
43867910|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
43867911|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867912|NCT01046825|Antidotes|antidotes|mesh-ancestor
43867913|NCT01046825|Protective Agents|protective agents|mesh-ancestor
43867914|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
43867915|NCT01046825|Vitamins|vitamins|mesh-ancestor
43867916|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
43867917|NCT01046825|Hematinics|hematinics|mesh-ancestor
43867918|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
43867919|NCT01039285|Poractant alfa|poractant alfa|mesh-list
43649523|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43649524|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
43649525|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
43849238|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43849241|NCT03945903|Golimumab|golimumab|mesh-list
43867920|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43867921|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
43867922|NCT01026012|Regadenoson|regadenoson|mesh-list
43867923|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43867924|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43867925|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
43867926|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
43867927|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43595818|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
43867928|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867929|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867930|NCT01014936|Tepotinib|tepotinib|mesh-list
43867931|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867932|NCT01012817|Topotecan|topotecan|mesh-list
44369246|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
44369247|NCT01187862|Omeprazole|omeprazole|mesh-list
44369248|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44369249|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44369250|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369251|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369252|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44369253|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369254|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369255|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44369256|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
44369257|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
44369258|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
44369259|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
44369260|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369261|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369262|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44369263|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43867933|NCT01012817|Veliparib|veliparib|mesh-list
43867934|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43867935|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867936|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867937|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606634|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606635|NCT03209661|Menthol|menthol|mesh-list
43606636|NCT03209661|Nicotine|nicotine|mesh-list
43606637|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43606638|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
43606641|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43867938|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867939|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43867940|NCT01004978|Cisplatin|cisplatin|mesh-list
43867941|NCT01004978|Doxorubicin|doxorubicin|mesh-list
43867942|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43867943|NCT01004978|Sorafenib|sorafenib|mesh-list
43867944|NCT01004978|Mitomycins|mitomycins|mesh-list
43867945|NCT01004978|Mitomycin|mitomycin|mesh-list
43867946|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867947|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43867948|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867949|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867950|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867951|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867952|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867953|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
43867954|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43867955|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
43867956|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43867957|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
43867958|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43867959|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867960|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43867961|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43867962|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43867963|NCT00992901|Atropine|atropine|mesh-list
43867964|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43867965|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43867966|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43867969|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867970|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867971|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43867972|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
43867973|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
43867974|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
44369264|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44369266|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44369267|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44369268|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44369269|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369270|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44369271|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44369272|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44369273|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44369274|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
44369275|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44369276|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44369277|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
44369278|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369279|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44369280|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44369281|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43680295|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867975|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43867976|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43867977|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
43867978|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43867979|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867980|NCT00992901|Incretins|incretins|mesh-ancestor
43867981|NCT00992901|Hormones|hormones|mesh-ancestor
43867982|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867983|NCT00981162|Everolimus|everolimus|mesh-list
43867984|NCT00981162|Sorafenib|sorafenib|mesh-list
43660080|NCT02934295|Antibodies|antibodies|mesh-list
43660083|NCT02934022|Maraviroc|maraviroc|mesh-list
43867985|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867986|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867987|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
43867988|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867989|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43867990|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867991|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134568|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134569|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134570|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134571|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44134572|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134573|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134574|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44134575|NCT00158574|Renal Agents|renal agents|mesh-ancestor
44134576|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
44134577|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44134578|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
44134579|NCT00158587|Primaquine|primaquine|mesh-list
44134580|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
44134581|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134582|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134583|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134584|NCT00158652|Carboplatin|carboplatin|mesh-list
44369282|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44369283|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44369284|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44369285|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
44369286|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
44369287|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369288|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44369289|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44369290|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44369291|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
44369292|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44369293|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44369294|NCT01187888|Rasagiline|rasagiline|mesh-list
44369295|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44369296|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369297|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369298|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44369299|NCT01187888|Protective Agents|protective agents|mesh-ancestor
44369300|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369301|NCT01187992|Atorvastatin|atorvastatin|mesh-list
44369302|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44148750|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
44369303|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44369304|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
44369305|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680315|NCT05153174|Sulforaphane|sulforaphane|mesh-list
43867992|NCT00978458|Temozolomide|temozolomide|mesh-list
43867993|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43867994|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
43867995|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43867996|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867997|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
43867998|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
43606652|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606653|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606654|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606655|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43867999|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43868000|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43868001|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868002|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868003|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868004|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868005|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43868006|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868007|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868008|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868009|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868011|NCT00936832|Fluorouracil|fluorouracil|mesh-list
43868012|NCT00936832|Irinotecan|irinotecan|mesh-list
43868013|NCT00936832|Sunitinib|sunitinib|mesh-list
43868014|NCT00936832|Calcium|calcium|mesh-list
43868015|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
44369306|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44369307|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44369308|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369310|NCT01188005|Vitamin E|vitamin e|mesh-list
44369311|NCT01188005|Vitamin A|vitamin a|mesh-list
44369312|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
44369313|NCT01188005|Allopurinol|allopurinol|mesh-list
44369314|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44369315|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
44369316|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369317|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
44369318|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369319|NCT01188005|Protective Agents|protective agents|mesh-ancestor
44369320|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
44369321|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369322|NCT01188005|Expectorants|expectorants|mesh-ancestor
44369323|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369324|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44369325|NCT01188005|Antidotes|antidotes|mesh-ancestor
44369326|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
44369327|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369328|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
44369329|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868016|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43868017|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868018|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
43868019|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868020|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868021|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868022|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868023|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
43868024|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43868032|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868033|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868034|NCT00936832|Growth Substances|growth substances|mesh-ancestor
43868035|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868036|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868037|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43868038|NCT00907283|Deferiprone|deferiprone|mesh-list
43868039|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43868040|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
43868041|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
43868042|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868043|NCT00907101|Adapalene|adapalene|mesh-list
43606663|NCT03209180|Carvedilol|carvedilol|mesh-list
43606664|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43606665|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43606666|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606667|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606668|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649526|NCT03022253|Acetaminophen|acetaminophen|mesh-list
43868044|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43868045|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43868046|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868047|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43868048|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43868049|NCT00907101|Analgesics|analgesics|mesh-ancestor
43868050|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
43868051|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868052|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369330|NCT01188031|Alprazolam|alprazolam|mesh-list
44369331|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44369332|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369333|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369334|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44369335|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369336|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369337|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
44369338|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
44369339|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369340|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369341|NCT01188057|Alprazolam|alprazolam|mesh-list
44369342|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44369343|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369344|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369345|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44369346|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369347|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369348|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
44369349|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
44369350|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369351|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868053|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868054|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868055|NCT00885664|Ritonavir|ritonavir|mesh-list
43868056|NCT00885664|Lopinavir|lopinavir|mesh-list
43868057|NCT00885664|Tenofovir|tenofovir|mesh-list
43868058|NCT00885664|Emtricitabine|emtricitabine|mesh-list
43868059|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43868060|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43868061|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43868062|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
43868063|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868064|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868065|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43868066|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43868067|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
43868068|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868069|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43868070|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43868071|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43868072|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43868074|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43868075|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
43868076|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43868077|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868078|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868079|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43660118|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43660119|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
43660120|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
43660121|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43660122|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43660127|NCT02934217|Cyclosporine|cyclosporine|mesh-list
43868080|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43868081|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868082|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44369352|NCT01188148|Memantine|memantine|mesh-list
44369353|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44369354|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44369355|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
44369356|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369357|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369358|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369359|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44369360|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44369361|NCT01188174|Clofarabine|clofarabine|mesh-list
44369362|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44369363|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
44369364|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369365|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369366|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
44369367|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369368|NCT01188265|Valproic Acid|valproic acid|mesh-list
44369369|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
44369370|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
44369371|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
43680375|NCT05083052|Propolis|propolis|mesh-list
43868083|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868084|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868086|NCT00878254|Cytarabine|cytarabine|mesh-list
43868087|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
43868088|NCT00878254|Ifosfamide|ifosfamide|mesh-list
43868089|NCT00878254|Rituximab|rituximab|mesh-list
43868090|NCT00878254|Doxorubicin|doxorubicin|mesh-list
43868091|NCT00878254|Methotrexate|methotrexate|mesh-list
43868092|NCT00878254|Etoposide|etoposide|mesh-list
43868093|NCT00878254|Vincristine|vincristine|mesh-list
43868094|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868095|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
43868096|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868100|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868101|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649530|NCT03022253|Analgesics|analgesics|mesh-ancestor
43868102|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868103|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868104|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868105|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868106|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868108|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43868109|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
43868110|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43868111|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868112|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
43868113|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868114|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43868115|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43868116|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868117|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
43868118|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868119|NCT00878254|Antidotes|antidotes|mesh-ancestor
43868120|NCT00878254|Protective Agents|protective agents|mesh-ancestor
43868121|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
44369372|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44369373|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44369375|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369376|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369377|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
44369378|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369379|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
44369381|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369382|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369383|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369384|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
44369385|NCT01188278|Dasatinib|dasatinib|mesh-list
44369386|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369387|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369388|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868122|NCT00878254|Vitamins|vitamins|mesh-ancestor
43868123|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
43868124|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
43868125|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868126|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868127|NCT00878163|Gemcitabine|gemcitabine|mesh-list
43868128|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43868129|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868130|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
43868131|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868132|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868133|NCT00878163|Antiviral Agents|antiviral agents|mesh-ancestor
43868134|NCT00878163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868135|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868136|NCT00878163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868137|NCT00878163|Immunologic Factors|immunologic factors|mesh-ancestor
43868138|NCT00878163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43596043|NCT03320460|Clobetasol|clobetasol|mesh-list
43868139|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868140|NCT00877500|Epothilones|epothilones|mesh-list
43868141|NCT00877500|Epothilone B|epothilone b|mesh-list
43868142|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
43868143|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868144|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868145|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868146|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868147|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
43868148|NCT00875004|Hematinics|hematinics|mesh-ancestor
43868149|NCT00869232|Thalidomide|thalidomide|mesh-list
43868150|NCT00869232|Dexamethasone|dexamethasone|mesh-list
43868151|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
43868153|NCT00869232|Cisplatin|cisplatin|mesh-list
43868154|NCT00869232|Doxorubicin|doxorubicin|mesh-list
43868155|NCT00869232|Etoposide|etoposide|mesh-list
43868156|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43868157|NCT00869232|Bortezomib|bortezomib|mesh-list
43868158|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868159|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
43868160|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868161|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868162|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868163|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
43868164|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868165|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868166|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44369389|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369390|NCT01188304|Aspirin|aspirin|mesh-list
44369391|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369392|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369393|NCT01188304|Analgesics|analgesics|mesh-ancestor
44369394|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
44369395|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369396|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369397|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369398|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369399|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44369400|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44369401|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369402|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44369403|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43868167|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868168|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
43868169|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
43868173|NCT00869232|Hormones|hormones|mesh-ancestor
43868174|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868175|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868176|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43606706|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868177|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868178|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868179|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868180|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868181|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
43868182|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43868183|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868184|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868185|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868186|NCT00869232|Growth Substances|growth substances|mesh-ancestor
43868187|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868188|NCT00866840|Riluzole|riluzole|mesh-list
43868189|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
43868190|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43868191|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43868192|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868193|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868194|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868195|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43868196|NCT00866840|Protective Agents|protective agents|mesh-ancestor
43868197|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43868198|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868199|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
43868200|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43868201|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
43868202|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43868203|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43868204|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868205|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868206|NCT00840853|Acetaminophen|acetaminophen|mesh-list
43868207|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
43868208|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43868209|NCT00840853|Analgesics|analgesics|mesh-ancestor
43868210|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
43868211|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830714|NCT05347979|Dabigatran|dabigatran|mesh-list
44369405|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
44369406|NCT01188317|Ibuprofen|ibuprofen|mesh-list
44369407|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369408|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369409|NCT01188317|Analgesics|analgesics|mesh-ancestor
44369410|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
44369411|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606719|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606723|NCT03209206|Docetaxel|docetaxel|mesh-list
44369412|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369413|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369414|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369415|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44369416|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369417|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868212|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868213|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
43868214|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43868215|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43868216|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868217|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
43868218|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
43868219|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
43868220|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
43868221|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868222|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43868223|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
43868224|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
43868225|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868226|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868227|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43868228|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
43868229|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43868230|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868231|NCT00820846|Vaccines|vaccines|mesh-list
43868232|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
43868233|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868234|NCT00819221|Doxorubicin|doxorubicin|mesh-list
43868235|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43868236|NCT00819221|Olaparib|olaparib|mesh-list
43868237|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868238|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606765|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606766|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
43606767|NCT03208556|Fludarabine|fludarabine|mesh-list
43606768|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606769|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
43606770|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606771|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606772|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43606773|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
43606774|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606775|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649532|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649533|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649534|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649535|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606776|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43606777|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
43606778|NCT03208582|Diphosphonates|diphosphonates|mesh-list
43660239|NCT02933645|Insulin|insulin|mesh-list
43868239|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868240|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868241|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868247|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868248|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868249|NCT00813423|Growth Substances|growth substances|mesh-ancestor
43868250|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868251|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868252|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868253|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868254|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868255|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
43868256|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43868257|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43868258|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868259|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868260|NCT00801489|Cytarabine|cytarabine|mesh-list
43868261|NCT00801489|Fludarabine|fludarabine|mesh-list
43868262|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
43868263|NCT00801489|Decitabine|decitabine|mesh-list
43868264|NCT00801489|Idarubicin|idarubicin|mesh-list
44369418|NCT01188408|Docetaxel|docetaxel|mesh-list
44369419|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369420|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44369421|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44369422|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44369423|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369424|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44369425|NCT01188707|Belinostat|belinostat|mesh-list
44369426|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369427|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369428|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369429|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369430|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44369431|NCT01188733|Octreotide|octreotide|mesh-list
43868265|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
43868266|NCT00801489|Calicheamicins|calicheamicins|mesh-list
43868267|NCT00801489|Lenograstim|lenograstim|mesh-list
43606779|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606780|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606808|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
43606809|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606810|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868268|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868269|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868270|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
43868271|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868272|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868273|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
43868274|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868275|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
43868276|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868277|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43868278|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868279|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868280|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868281|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868282|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868284|NCT00789399|Fondaparinux|fondaparinux|mesh-list
43868285|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43868286|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
43868287|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43868288|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
43868289|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868290|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43596203|NCT03319043|Budesonide|budesonide|mesh-list
43868291|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
43868292|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43868293|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43868295|NCT00784823|Melphalan|melphalan|mesh-list
43868296|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868297|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868298|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
43868299|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868300|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868301|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868302|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
43868303|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868304|NCT00777140|Deferoxamine|deferoxamine|mesh-list
43868305|NCT00777140|Siderophores|siderophores|mesh-ancestor
43868306|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43868307|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
43868308|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
43868309|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868310|NCT00773357|Guanfacine|guanfacine|mesh-list
43868311|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43868312|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43868313|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44369432|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44369433|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44369434|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369435|NCT01188759|Voriconazole|voriconazole|mesh-list
44369436|NCT01188759|Anidulafungin|anidulafungin|mesh-list
44369437|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
44369438|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369439|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44369440|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44369441|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369442|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369443|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44369444|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
44369445|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369446|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369447|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44369448|NCT01188824|Cilostazol|cilostazol|mesh-list
44369449|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43660270|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
44369450|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
44369451|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369452|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369453|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43868317|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868319|NCT00754364|Gemcitabine|gemcitabine|mesh-list
43868320|NCT00754364|Carboplatin|carboplatin|mesh-list
43868321|NCT00754364|Pemetrexed|pemetrexed|mesh-list
43868322|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868323|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868324|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
43868325|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868326|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
43868327|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868328|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868329|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868330|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
43868331|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868332|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43868333|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43868334|NCT00750841|Cediranib|cediranib|mesh-list
43868335|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868336|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868337|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868338|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868339|NCT00734877|Thalidomide|thalidomide|mesh-list
43868340|NCT00734877|Dexamethasone|dexamethasone|mesh-list
43868341|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
43868342|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
43868343|NCT00734877|Melphalan|melphalan|mesh-list
43868344|NCT00734877|Cisplatin|cisplatin|mesh-list
43868345|NCT00734877|Etoposide|etoposide|mesh-list
43868346|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
44369454|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369455|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44369456|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44369457|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369458|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43606813|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
43606814|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606815|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43849255|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849256|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606816|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606817|NCT03208218|Growth Substances|growth substances|mesh-ancestor
43606818|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606819|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369459|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
44369460|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44369461|NCT01188824|Protective Agents|protective agents|mesh-ancestor
44369462|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44369463|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44369464|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369465|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44369466|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44369467|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369468|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44369469|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369471|NCT01188889|Everolimus|everolimus|mesh-list
44369472|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369473|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369474|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369475|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369476|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369477|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
44369478|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369479|NCT01188954|Doxycycline|doxycycline|mesh-list
44369480|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44369481|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369482|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
44369483|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44369484|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44369485|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
44369486|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
44369491|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369492|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369493|NCT01189019|Ranibizumab|ranibizumab|mesh-list
44369494|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44369495|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369496|NCT01189019|Growth Substances|growth substances|mesh-ancestor
44369497|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369498|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
44369499|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369500|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
44369501|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
44369502|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369503|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44369504|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44369505|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43680485|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
43868347|NCT00734877|Doxorubicin|doxorubicin|mesh-list
43868348|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43868349|NCT00734877|Bortezomib|bortezomib|mesh-list
43606835|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43606836|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606837|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606838|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606839|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606840|NCT03208270|Antithrombins|antithrombins|mesh-list
43606841|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
43606842|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43868350|NCT00734877|BB 1101|bb 1101|mesh-list
43868351|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868352|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
43868353|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868354|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868355|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868356|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
43868357|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868358|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868359|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868360|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868361|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
43868362|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
43868363|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868364|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868365|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
43868366|NCT00734877|Hormones|hormones|mesh-ancestor
43871179|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868367|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868368|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868369|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
43868370|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868371|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868372|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868373|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868374|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868375|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
43868376|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43868377|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868378|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868379|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868380|NCT00734877|Growth Substances|growth substances|mesh-ancestor
43868381|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868383|NCT00716443|Tetracaine|tetracaine|mesh-list
43868384|NCT00716443|Benzocaine|benzocaine|mesh-list
43868385|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
43868386|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
43868392|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43868393|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44369506|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369507|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369509|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44369510|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44369511|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
44369512|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369513|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369514|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369515|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44369516|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43868394|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868395|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606844|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606845|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868396|NCT00687765|Temozolomide|temozolomide|mesh-list
43868397|NCT00687765|Iniparib|iniparib|mesh-list
43868398|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868399|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
43868400|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868401|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868402|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43868403|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868404|NCT00668655|Metronidazole|metronidazole|mesh-list
43868405|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868406|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43868407|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43868408|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43868409|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43868410|NCT00650143|Lenograstim|lenograstim|mesh-list
43868411|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43868412|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868413|NCT00650143|Incretins|incretins|mesh-ancestor
43868414|NCT00650143|Hormones|hormones|mesh-ancestor
43868415|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868416|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43868417|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
43868418|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868419|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868420|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43868421|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
44134585|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134586|NCT00158678|Cisplatin|cisplatin|mesh-list
44134587|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134588|NCT00158691|Amifostine|amifostine|mesh-list
44134589|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44134590|NCT00158691|Protective Agents|protective agents|mesh-ancestor
44134591|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134592|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44134593|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
44134594|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134595|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44134596|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44134597|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134598|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134599|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44134600|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
44134601|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134602|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43596343|NCT03318354|Olmesartan|olmesartan|mesh-list
44134603|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44134604|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606854|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606855|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606856|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43606857|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43606858|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606859|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606860|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43606861|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825667|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825668|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134605|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369518|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44369519|NCT01189253|Trabectedin|trabectedin|mesh-list
44369520|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44369521|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369522|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44369523|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44369524|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369525|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369526|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44369527|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
44369528|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44369529|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
44369530|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369531|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43680520|NCT04920682|Iodine|iodine|mesh-list
44134606|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44134607|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
44134608|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134609|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43868422|NCT00644280|Ranibizumab|ranibizumab|mesh-list
43868423|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868424|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868425|NCT00644280|Growth Substances|growth substances|mesh-ancestor
43868426|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868427|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868434|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
43868435|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43868436|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
43868437|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868438|NCT00637624|Protective Agents|protective agents|mesh-ancestor
43868439|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868440|NCT00637624|Antidotes|antidotes|mesh-ancestor
43868441|NCT00635700|Ziprasidone|ziprasidone|mesh-list
43868442|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43868443|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
43868444|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868445|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868446|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868447|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43868448|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43868449|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868450|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43868451|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43868452|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
43868453|NCT00608725|Propranolol|propranolol|mesh-list
43868454|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43868455|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43868456|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
43868457|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868458|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868459|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868460|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43868461|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43868462|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
43868463|NCT00595933|Muramidase|muramidase|mesh-list
43868464|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868465|NCT00580489|Fentanyl|fentanyl|mesh-list
43868466|NCT00580489|Morphine|morphine|mesh-list
44369532|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369533|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369534|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369535|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
43825676|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43825677|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369536|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
44369537|NCT01189448|Spiramycin|spiramycin|mesh-list
44369538|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
44369539|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44369540|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44369541|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369542|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44369543|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369544|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369545|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44369546|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
44369547|NCT01189526|Ranibizumab|ranibizumab|mesh-list
44369548|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44369549|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369550|NCT01189526|Growth Substances|growth substances|mesh-ancestor
44369551|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369552|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44369553|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369554|NCT01189656|Vaccines|vaccines|mesh-list
43868467|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43868468|NCT00580489|Narcotics|narcotics|mesh-ancestor
43868469|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868470|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868471|NCT00580489|Analgesics|analgesics|mesh-ancestor
43868472|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
43868473|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868474|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43868475|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43868476|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
43868477|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
43868478|NCT00576654|Irinotecan|irinotecan|mesh-list
43868479|NCT00576654|Camptothecin|camptothecin|mesh-list
43868480|NCT00576654|Veliparib|veliparib|mesh-list
43868481|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43606862|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606863|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43606864|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43868482|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868483|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868484|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868485|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868486|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43868487|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868488|NCT00575718|Nicotine|nicotine|mesh-list
43868489|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43868490|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
43868491|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868492|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868493|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43868494|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43868495|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
43868496|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868497|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369555|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
44369556|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369557|NCT01189695|Ritonavir|ritonavir|mesh-list
44369558|NCT01189695|Lopinavir|lopinavir|mesh-list
44369559|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44369560|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44369561|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
43606874|NCT03208335|Endostatins|endostatins|mesh-list
43606875|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606876|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43606877|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606878|NCT03208335|Growth Substances|growth substances|mesh-ancestor
44369562|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369563|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369564|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44369565|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44369566|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
44369567|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369568|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44369569|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44369570|NCT01189721|Propofol|propofol|mesh-list
44369571|NCT01189721|Sevoflurane|sevoflurane|mesh-list
44369572|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44369573|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369574|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369575|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44369576|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
44369577|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
44369578|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44369579|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44369580|NCT01189773|Ibuprofen|ibuprofen|mesh-list
44369581|NCT01189773|Codeine|codeine|mesh-list
44369582|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369583|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369584|NCT01189773|Analgesics|analgesics|mesh-ancestor
44369585|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
44369586|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369587|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868498|NCT00547196|Cyclosporine|cyclosporine|mesh-list
43868503|NCT00547196|Fludarabine|fludarabine|mesh-list
43868504|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
43868505|NCT00547196|Cyclosporins|cyclosporins|mesh-list
43868506|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868507|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
43868508|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868509|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868510|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868511|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
44369588|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369589|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369590|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44369591|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369592|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369593|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44369594|NCT01189773|Narcotics|narcotics|mesh-ancestor
44369595|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369596|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
44369597|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369598|NCT01189864|Diclofenac|diclofenac|mesh-list
44369599|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
44369600|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44369601|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
44369602|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44369603|NCT01189864|Prednisolone|prednisolone|mesh-list
44369604|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44369605|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
44369606|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369607|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369608|NCT01189864|Analgesics|analgesics|mesh-ancestor
44369609|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
44369610|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369611|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369612|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44369613|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369614|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44369615|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369616|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369617|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
44369618|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
44369619|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680558|NCT04859660|Tamsulosin|tamsulosin|mesh-list
43868512|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868513|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868514|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868515|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868516|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
43868517|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868518|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
43868519|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369621|NCT01189864|Hormones|hormones|mesh-ancestor
44369622|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369623|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44369624|NCT01189864|Protective Agents|protective agents|mesh-ancestor
44369625|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44369626|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369627|NCT01189929|Gemcitabine|gemcitabine|mesh-list
44369628|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44369629|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44369631|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369632|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369633|NCT01189929|Antiviral Agents|antiviral agents|mesh-ancestor
44369634|NCT01189929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369635|NCT01189929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369636|NCT01189929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868520|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868521|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43868522|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868523|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43868524|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
43868525|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43868526|NCT00542451|Paclitaxel|paclitaxel|mesh-list
43868527|NCT00542451|Trastuzumab|trastuzumab|mesh-list
43868528|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868529|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868530|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
43868531|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868532|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868533|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868534|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868535|NCT00530062|Albuterol|albuterol|mesh-list
43868536|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43868537|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
43868538|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868539|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868540|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43868541|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
43868542|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
43868543|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43868544|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43868545|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43868546|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43868547|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43868548|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868549|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868550|NCT00505063|Vaccines|vaccines|mesh-list
43868551|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43868552|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
43868553|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868554|NCT00479128|Gemcitabine|gemcitabine|mesh-list
43868555|NCT00479128|Doxorubicin|doxorubicin|mesh-list
43868556|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43868557|NCT00479128|Bortezomib|bortezomib|mesh-list
43868558|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868559|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
43868560|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369637|NCT01189929|Immunologic Factors|immunologic factors|mesh-ancestor
44369638|NCT01189929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369639|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
44369640|NCT01190137|Vitamin D|vitamin d|mesh-list
44369641|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
44369642|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44369643|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369644|NCT01190137|Vitamins|vitamins|mesh-ancestor
43606921|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43606922|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606923|NCT03207542|Daratumumab|daratumumab|mesh-list
43606924|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606925|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43606926|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
43606927|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43606928|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606929|NCT03207477|Mydriatics|mydriatics|mesh-list
43606930|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
43606931|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606932|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606933|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43606934|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43606935|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606936|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
43606937|NCT03206957|Endostatins|endostatins|mesh-list
44369645|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
44369646|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44369647|NCT01190163|Oxytocin|oxytocin|mesh-list
44369648|NCT01190163|Dinoprostone|dinoprostone|mesh-list
44369649|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
44369650|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44369651|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369652|NCT01190241|Everolimus|everolimus|mesh-list
44369653|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43868561|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868562|NCT00479128|Antiviral Agents|antiviral agents|mesh-ancestor
43868563|NCT00479128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868564|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868565|NCT00479128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868566|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
43868567|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868568|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868569|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868570|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868578|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868579|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
43868581|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868582|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868583|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
43868584|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868585|NCT00472966|Protective Agents|protective agents|mesh-ancestor
43868586|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43868587|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
43868588|NCT00469755|Adapalene|adapalene|mesh-list
43868589|NCT00469755|Tazarotene|tazarotene|mesh-list
43868590|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43868591|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43868592|NCT00469755|Analgesics|analgesics|mesh-ancestor
43868593|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
43868594|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868595|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868596|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868597|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868598|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868599|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
43868600|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
43868601|NCT00469755|Vitamins|vitamins|mesh-ancestor
43868602|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
43868603|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43868604|NCT00469183|Tretinoin|tretinoin|mesh-list
43868605|NCT00469183|Hydroquinone|hydroquinone|mesh-list
43868606|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868607|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
43868608|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868609|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868610|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
43868611|NCT00469183|Hormones|hormones|mesh-ancestor
43868612|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369655|NCT01190241|Sunitinib|sunitinib|mesh-list
44369656|NCT01190241|Lapatinib|lapatinib|mesh-list
44369657|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369658|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369659|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
44369660|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369661|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369662|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369663|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369664|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44369665|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369666|NCT01190241|Growth Substances|growth substances|mesh-ancestor
44369667|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868613|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868614|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
43868615|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868616|NCT00469183|Protective Agents|protective agents|mesh-ancestor
43868617|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43868618|NCT00468715|Bicalutamide|bicalutamide|mesh-list
43868619|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
43868620|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
43868621|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868622|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868623|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868624|NCT00453531|Acetylcholine|acetylcholine|mesh-list
43868625|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
43868626|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43868627|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
43868628|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868629|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868630|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868631|NCT00452023|Interferons|interferons|mesh-list
43868632|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
43868633|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
43868634|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43868635|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868636|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
43868637|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868638|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
43868639|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868640|NCT00437255|Betamethasone|betamethasone|mesh-list
43868641|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
43868645|NCT00437255|Calcipotriene|calcipotriene|mesh-list
43868646|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43868647|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868648|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
43868650|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868651|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868652|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43868653|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
43868654|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868655|NCT00437216|Clobetasol|clobetasol|mesh-list
43868656|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868657|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
43868658|NCT00437216|Hormones|hormones|mesh-ancestor
43868659|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868660|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868661|NCT00436540|Clobetasol|clobetasol|mesh-list
43868662|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868663|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
43868664|NCT00436540|Hormones|hormones|mesh-ancestor
44369669|NCT01190293|Maraviroc|maraviroc|mesh-list
44369670|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44369671|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44369672|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369673|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369674|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
44369675|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369676|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44369677|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44369678|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44369679|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44369680|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44369681|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44369682|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44369683|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44369684|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43680631|NCT04811014|Naloxone|naloxone|mesh-list
43868665|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868666|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868667|NCT00436527|Metronidazole|metronidazole|mesh-list
43868668|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868669|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43868670|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43868671|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43868672|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43868673|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43868674|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43868675|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868676|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868677|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868678|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868679|NCT00425230|Analgesics|analgesics|mesh-ancestor
43868680|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
43868681|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868682|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
43868683|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43868684|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
43868685|NCT00419367|Vorinostat|vorinostat|mesh-list
43868686|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868687|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43868688|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868689|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606951|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606952|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606953|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868690|NCT00412594|Rituximab|rituximab|mesh-list
43868691|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43868692|NCT00412594|Cladribine|cladribine|mesh-list
43868693|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43868694|NCT00412594|Antibodies|antibodies|mesh-list
43868695|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
43868696|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43868697|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
43868698|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868699|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868700|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369685|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44369686|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43868701|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868702|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868703|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
43868704|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868705|NCT00410956|Dexamethasone|dexamethasone|mesh-list
43868706|NCT00410956|Bevacizumab|bevacizumab|mesh-list
43868707|NCT00410956|Floxuridine|floxuridine|mesh-list
43868708|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868709|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868710|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43868711|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43868712|NCT00410956|Growth Substances|growth substances|mesh-ancestor
43868723|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868724|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868725|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
43868726|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868727|NCT00408447|Fludarabine|fludarabine|mesh-list
43868728|NCT00408447|Busulfan|busulfan|mesh-list
43868729|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
43868730|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868731|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606977|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
43606978|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868732|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868733|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
43868734|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868735|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
43868736|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868737|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868738|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868739|NCT00394147|Gemcitabine|gemcitabine|mesh-list
43868740|NCT00394147|Pemetrexed|pemetrexed|mesh-list
43868741|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868742|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
43868743|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868744|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868745|NCT00394147|Antiviral Agents|antiviral agents|mesh-ancestor
43868746|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868747|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868748|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868749|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
43868750|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868751|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43868752|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43868753|NCT00392353|Azacitidine|azacitidine|mesh-list
43868754|NCT00392353|Vorinostat|vorinostat|mesh-list
43868755|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868756|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
43868757|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868758|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868759|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868760|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43868761|NCT00373217|Paclitaxel|paclitaxel|mesh-list
43868762|NCT00373217|Carboplatin|carboplatin|mesh-list
43868763|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868764|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868765|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
43868766|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868767|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868768|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868769|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
43868770|NCT00338377|Fludarabine|fludarabine|mesh-list
43868771|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
43868772|NCT00338377|Interleukin-2|interleukin-2|mesh-list
43868774|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868775|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
43868776|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868777|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868783|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868784|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
43868785|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43868786|NCT00338377|Analgesics|analgesics|mesh-ancestor
43868787|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
44369687|NCT01190345|Bevacizumab|bevacizumab|mesh-list
44369688|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44369689|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369690|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44369691|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369692|NCT01190345|Growth Substances|growth substances|mesh-ancestor
44369693|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369694|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44369695|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
43680642|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
43868788|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868789|NCT00338377|Protective Agents|protective agents|mesh-ancestor
43868790|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
43868791|NCT00332605|Naltrexone|naltrexone|mesh-list
43868792|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43868793|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43868794|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43868795|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868796|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
43868797|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868798|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
43868799|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868800|NCT00332605|Expectorants|expectorants|mesh-ancestor
43868801|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
43868802|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43868804|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868805|NCT00332605|Protective Agents|protective agents|mesh-ancestor
43868806|NCT00332605|Antidotes|antidotes|mesh-ancestor
44134610|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44134611|NCT00158782|Lapatinib|lapatinib|mesh-list
44134612|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134613|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44134614|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134615|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134616|NCT00158821|Tenofovir|tenofovir|mesh-list
44134617|NCT00158821|Lamivudine|lamivudine|mesh-list
44134618|NCT00158821|Efavirenz|efavirenz|mesh-list
44134619|NCT00158821|Stavudine|stavudine|mesh-list
44134620|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
44134621|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134622|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44134623|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44134624|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134625|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134626|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44134627|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44134628|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44134629|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134630|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44134631|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43649565|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
43649566|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649567|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
43649568|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649569|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606987|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
44134632|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44134633|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44134634|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
44134635|NCT00158834|Fluticasone|fluticasone|mesh-list
44134637|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44134638|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44134639|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44134640|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
44134641|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134642|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134643|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44134644|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134645|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44134646|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44134647|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44369696|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44369697|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369699|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369700|NCT01190358|Protective Agents|protective agents|mesh-ancestor
44369701|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369702|NCT01190371|Artesunate|artesunate|mesh-list
44369703|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
44025047|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
44369704|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44134648|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44134649|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44134650|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134651|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134657|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44134658|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
44134659|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134660|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134661|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44134662|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134663|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44134664|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43606992|NCT03206671|Hormones|hormones|mesh-ancestor
43606993|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606994|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43606995|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43606996|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43606997|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43606998|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606999|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43607000|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
44134665|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44134666|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44134667|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44134668|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134669|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134670|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134671|NCT00158873|Fentanyl|fentanyl|mesh-list
44134672|NCT00158873|Midazolam|midazolam|mesh-list
44134673|NCT00158873|Morphine|morphine|mesh-list
44134674|NCT00158873|Remifentanil|remifentanil|mesh-list
44134675|NCT00158873|Lorazepam|lorazepam|mesh-list
44134676|NCT00158873|Propofol|propofol|mesh-list
44134677|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44134678|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134679|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134680|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43868807|NCT00291525|Warfarin|warfarin|mesh-list
43868808|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
43868809|NCT00280761|Fluorouracil|fluorouracil|mesh-list
43868810|NCT00280761|Capecitabine|capecitabine|mesh-list
43868811|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
43868812|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868813|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868814|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868815|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868816|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
43868817|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868818|NCT00273624|Olanzapine|olanzapine|mesh-list
43868819|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
43868820|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
43868821|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868822|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868823|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868824|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43868825|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43868826|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868827|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43868828|NCT00273624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43868829|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43868830|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868831|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868832|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868833|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
43868834|NCT00262470|Indomethacin|indomethacin|mesh-list
44369705|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44369706|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369707|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369708|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
44369709|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
43851323|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43851324|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851325|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851334|NCT04297618|Lifitegrast|lifitegrast|mesh-list
44369710|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44369711|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
44369712|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
44369713|NCT01190384|Antioxidants|antioxidants|mesh-list
44369714|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369715|NCT01190384|Protective Agents|protective agents|mesh-ancestor
44369716|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369717|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44369718|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369719|NCT01190462|Cetuximab|cetuximab|mesh-list
44369720|NCT01190462|Simvastatin|simvastatin|mesh-list
44369721|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44369722|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369723|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44369724|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44369725|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
44369726|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369727|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43607040|NCT03206866|Antibodies|antibodies|mesh-list
43607041|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
43607042|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607043|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
44369728|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44369729|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369730|NCT01190553|Amantadine|amantadine|mesh-list
44369731|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44369732|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44369733|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
44369734|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369750|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369752|NCT01190683|Vitamin D|vitamin d|mesh-list
44369753|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
44369754|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
44369755|NCT01190683|Vitamins|vitamins|mesh-list
44369756|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
44369757|NCT01190683|Calcium|calcium|mesh-list
44369758|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
44369759|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369760|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44369761|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44369762|NCT01190683|Antacids|antacids|mesh-ancestor
44369763|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369764|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44369765|NCT01190722|Diclofenac|diclofenac|mesh-list
44369766|NCT01190722|Etoricoxib|etoricoxib|mesh-list
44369767|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44369768|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369769|NCT01190722|Analgesics|analgesics|mesh-ancestor
44369770|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
44369771|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369772|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369773|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649588|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43649589|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
43649590|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649591|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
43649592|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43607091|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607092|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43607093|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
43607094|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43607131|NCT03205033|Melatonin|melatonin|mesh-list
44369774|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369775|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44369776|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369777|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369778|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44369779|NCT01190735|Caffeine|caffeine|mesh-list
44369780|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44369781|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369782|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44369783|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369785|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44369788|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369789|NCT01190748|Galantamine|galantamine|mesh-list
44369790|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44369791|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369792|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369793|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
44369794|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369795|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369796|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44369797|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
44369798|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369799|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
44369800|NCT01190761|Galantamine|galantamine|mesh-list
44369801|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44369802|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369803|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369804|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
44369805|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369806|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369807|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44369808|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
44369809|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369810|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
44369811|NCT01190982|Paclitaxel|paclitaxel|mesh-list
44369812|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44369813|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369814|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
44369815|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
44369816|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
44369817|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607137|NCT03204734|Capecitabine|capecitabine|mesh-list
43607138|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607167|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44369818|NCT01191021|Propofol|propofol|mesh-list
44369819|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
44369820|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369821|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828218|NCT05480072|Palmidrol|palmidrol|mesh-list
43868835|NCT00262470|Octreotide|octreotide|mesh-list
43868836|NCT00262470|Propranolol|propranolol|mesh-list
43868837|NCT00262470|Clonidine|clonidine|mesh-list
43868838|NCT00262470|Mecamylamine|mecamylamine|mesh-list
43868839|NCT00262470|Acetazolamide|acetazolamide|mesh-list
43868840|NCT00262470|Isosorbide|isosorbide|mesh-list
44369822|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44369823|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44369824|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
44369825|NCT01191034|Imiquimod|imiquimod|mesh-list
44369826|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44369827|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
44369828|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369829|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369830|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
44369831|NCT01191060|Lenalidomide|lenalidomide|mesh-list
44369832|NCT01191060|Bortezomib|bortezomib|mesh-list
44369833|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
44369834|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369835|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44369836|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369837|NCT01191060|Growth Substances|growth substances|mesh-ancestor
44369838|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
44369839|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369840|NCT01191203|Copper|copper|mesh-list
44369841|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44369842|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
44369843|NCT01191203|Trace Elements|trace elements|mesh-ancestor
44369844|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
43868841|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43649593|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43868842|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43868843|NCT00262470|Midodrine|midodrine|mesh-list
43868844|NCT00262470|Memantine|memantine|mesh-list
43868845|NCT00262470|Entacapone|entacapone|mesh-list
43868846|NCT00262470|Melatonin|melatonin|mesh-list
43868847|NCT00262470|Modafinil|modafinil|mesh-list
43868848|NCT00262470|Sertraline|sertraline|mesh-list
43868849|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43868850|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
43868851|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868852|NCT00262470|Protective Agents|protective agents|mesh-ancestor
43868856|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43868857|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
43868858|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868859|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43868860|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43868861|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
43868862|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
43868863|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43868864|NCT00262470|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43868865|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43868866|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868867|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
43868868|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43868869|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43868870|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
43868871|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43868872|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43868873|NCT00262470|Analgesics|analgesics|mesh-ancestor
43868874|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
43868875|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868876|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
44369845|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369846|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44369847|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44369848|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44369849|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
44369850|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44369851|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44369852|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44369853|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43868877|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
43607185|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43607207|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607208|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607209|NCT03204474|Lacosamide|lacosamide|mesh-list
43607210|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
43607211|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43607212|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43607213|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607215|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
43825700|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825701|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825702|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
43825703|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
43825704|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825705|NCT05325762|Analgesics|analgesics|mesh-ancestor
43868878|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43868879|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43868880|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43868881|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868882|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868883|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868884|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43868885|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43868886|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43868887|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43868888|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43868889|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43868890|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43868891|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868892|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868893|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
43868894|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
43868895|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43868896|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43868897|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868898|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
43868899|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43868900|NCT00262470|Diuretics|diuretics|mesh-ancestor
43868901|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
43868902|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
43868903|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43868904|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43868905|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43868906|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43868907|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43868908|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43607216|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43607217|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
43607218|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607219|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
43607220|NCT03204565|Protective Agents|protective agents|mesh-ancestor
43607221|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43607222|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43607223|NCT03204318|Norethindrone|norethindrone|mesh-list
43607224|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
43607225|NCT03204318|Estradiol|estradiol|mesh-list
43868909|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43868910|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43868911|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
43868913|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43868914|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43868915|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43868916|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
43868917|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868918|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868919|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868920|NCT00256399|Urological Agents|urological agents|mesh-ancestor
43868922|NCT00254384|Docetaxel|docetaxel|mesh-list
43868923|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43868928|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868930|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868931|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
43868932|NCT00212147|Anesthetics|anesthetics|mesh-list
43868933|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868934|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868935|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43868936|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
43868937|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44369854|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44369855|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369858|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369859|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44369860|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44369861|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44369862|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369863|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44369864|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
44369865|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369866|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
44369867|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44369868|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
44369869|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607226|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43607227|NCT03204318|Relugolix|relugolix|mesh-list
43607228|NCT03204318|Estrogens|estrogens|mesh-ancestor
43607229|NCT03204318|Hormones|hormones|mesh-ancestor
43607230|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607231|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607232|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43607233|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
43607234|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607235|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43607236|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43607237|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43607238|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43660518|NCT02931071|Plerixafor|plerixafor|mesh-list
43660519|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43660520|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43660521|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
43562909|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
44369870|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369871|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44369872|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
44369873|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44369874|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44369875|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44369876|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
44369877|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369878|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369879|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
44369880|NCT01191450|Amiloride|amiloride|mesh-list
43868938|NCT00212147|Analgesics|analgesics|mesh-ancestor
43868939|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
43868940|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868941|NCT00199108|Dexamethasone|dexamethasone|mesh-list
43868942|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868943|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
43868944|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
43868945|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868946|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868947|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868948|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
43868949|NCT00199108|Hormones|hormones|mesh-ancestor
43868950|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868951|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868952|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868953|NCT00199082|Cytarabine|cytarabine|mesh-list
43868954|NCT00199082|Dexamethasone|dexamethasone|mesh-list
43868955|NCT00199082|Prednisolone|prednisolone|mesh-list
43868956|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
43868957|NCT00199082|Ifosfamide|ifosfamide|mesh-list
43868958|NCT00199082|Rituximab|rituximab|mesh-list
43868959|NCT00199082|Methotrexate|methotrexate|mesh-list
43868960|NCT00199082|Vincristine|vincristine|mesh-list
44369882|NCT01191450|Diuretics|diuretics|mesh-ancestor
44369883|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
44369884|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369885|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44369886|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44369887|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369888|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44369889|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44369890|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44369891|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44369892|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
43680692|NCT04747912|Hormones|hormones|mesh-ancestor
43868961|NCT00199082|Doxorubicin|doxorubicin|mesh-list
43868962|NCT00199082|Vindesine|vindesine|mesh-list
43868963|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43868964|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
43868965|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868966|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43868967|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868968|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
43868969|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868970|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868971|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43868972|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43868973|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868974|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
43868975|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
43868976|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868977|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868978|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
43868979|NCT00199082|Hormones|hormones|mesh-ancestor
43868980|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868981|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43868982|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43868983|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
43868984|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43868985|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43868986|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
43868987|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868988|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868989|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43868990|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43868991|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
43868992|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868993|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43868994|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869000|NCT00198991|Cytarabine|cytarabine|mesh-list
43869001|NCT00198991|Dexamethasone|dexamethasone|mesh-list
43869002|NCT00198991|Prednisolone|prednisolone|mesh-list
43869003|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
43869004|NCT00198991|Methotrexate|methotrexate|mesh-list
43869005|NCT00198991|Fludarabine|fludarabine|mesh-list
43869006|NCT00198991|Etoposide|etoposide|mesh-list
43869007|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
43869008|NCT00198991|Vincristine|vincristine|mesh-list
43869009|NCT00198991|Doxorubicin|doxorubicin|mesh-list
43869010|NCT00198991|Daunorubicin|daunorubicin|mesh-list
43869011|NCT00198991|Asparaginase|asparaginase|mesh-list
43869012|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
43607326|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43869013|NCT00198991|Idarubicin|idarubicin|mesh-list
43869014|NCT00198991|Thioguanine|thioguanine|mesh-list
43869015|NCT00198991|Cladribine|cladribine|mesh-list
44369893|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44369894|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44369895|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369896|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
44369897|NCT01191554|Coagulants|coagulants|mesh-ancestor
44369898|NCT01191593|Ropivacaine|ropivacaine|mesh-list
44369899|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
44369900|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
44369901|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369902|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369903|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
44369904|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369905|NCT01191645|Remifentanil|remifentanil|mesh-list
44369906|NCT01191645|Metoclopramide|metoclopramide|mesh-list
44369907|NCT01191645|Naloxone|naloxone|mesh-list
44369908|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44369909|NCT01191645|Narcotics|narcotics|mesh-ancestor
44369910|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369911|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369912|NCT01191645|Analgesics|analgesics|mesh-ancestor
44369913|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
44369914|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44369915|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44369916|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
44369917|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
44369918|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44369919|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44369920|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44369921|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
44369922|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369923|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869016|NCT00198991|Vindesine|vindesine|mesh-list
43869017|NCT00198991|Teniposide|teniposide|mesh-list
43869018|NCT00198991|Pegaspargase|pegaspargase|mesh-list
43869019|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607410|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607411|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607412|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607413|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607414|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43607415|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43607450|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607451|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43607452|NCT03202862|Fulvestrant|fulvestrant|mesh-list
43660538|NCT02930954|Bevacizumab|bevacizumab|mesh-list
43869020|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
43869021|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869022|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869023|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43869024|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
43869025|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869026|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869027|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43869028|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869029|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
44369924|NCT01191684|Vaccines|vaccines|mesh-list
44369925|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
44369926|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369927|NCT01191710|Progesterone|progesterone|mesh-list
44369928|NCT01191710|Progestins|progestins|mesh-ancestor
44369929|NCT01191710|Hormones|hormones|mesh-ancestor
44369930|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44369931|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369932|NCT01191892|Gemcitabine|gemcitabine|mesh-list
44369933|NCT01191892|Carboplatin|carboplatin|mesh-list
44369934|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369935|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44369936|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
44369937|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369938|NCT01191892|Antiviral Agents|antiviral agents|mesh-ancestor
44369939|NCT01191892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369940|NCT01191892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369941|NCT01191892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369942|NCT01191892|Immunologic Factors|immunologic factors|mesh-ancestor
44369943|NCT01191892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369944|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
44369945|NCT01191918|Donepezil|donepezil|mesh-list
44369946|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43680735|NCT04706130|Artesunate|artesunate|mesh-list
43869030|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
43869031|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869032|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869033|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
43869034|NCT00198991|Hormones|hormones|mesh-ancestor
43869035|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869036|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43869037|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43869038|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
43869039|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869040|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43869041|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
43869042|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869043|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869044|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43869045|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43869046|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43869047|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43869048|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43869049|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
43869050|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869051|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869052|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869053|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43869054|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43869056|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43869057|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869058|NCT00194090|Analgesics|analgesics|mesh-ancestor
44369947|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369948|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369949|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
43660555|NCT02930954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660556|NCT02930954|Immunologic Factors|immunologic factors|mesh-ancestor
44369950|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44369951|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369952|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
44369953|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
44369954|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44369955|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
44369956|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44369957|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44369958|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
44369960|NCT01191957|Fludarabine|fludarabine|mesh-list
44369961|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44369962|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
43869059|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
43869060|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869061|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869062|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869063|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869064|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43869065|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43869066|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869067|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869068|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
43869077|NCT00160173|Estrogens|estrogens|mesh-ancestor
43869078|NCT00160173|Hormones|hormones|mesh-ancestor
43869079|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869080|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869081|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43869082|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
43869083|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869084|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43869085|NCT00136695|Anastrozole|anastrozole|mesh-list
43607490|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43607491|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43607492|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607493|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
43607495|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
43607496|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607497|NCT03202407|Calcium|calcium|mesh-list
43869086|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43869087|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869088|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43869089|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43869090|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869091|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869092|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43869093|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
43869094|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869095|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869096|NCT00099086|Docetaxel|docetaxel|mesh-list
43869097|NCT00099086|Leuprolide|leuprolide|mesh-list
43869098|NCT00099086|Goserelin|goserelin|mesh-list
43869099|NCT00099086|Bicalutamide|bicalutamide|mesh-list
43869100|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869101|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869102|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869104|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869105|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43869106|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
43869107|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869108|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869109|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44369964|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44369965|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44369966|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
44369967|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369968|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369969|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44369970|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
44369971|NCT01191983|Hematinics|hematinics|mesh-ancestor
44369972|NCT01192087|Cetuximab|cetuximab|mesh-list
44369973|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43607532|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
43649606|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
43649607|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
43649608|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43649609|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43649610|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649611|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369974|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869110|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
43869111|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
43869112|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869113|NCT00054314|IDN 5109|idn 5109|mesh-list
43869114|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869115|NCT00048295|Alicaforsen|alicaforsen|mesh-list
43869116|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869117|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43869118|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
43869119|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869120|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
43869121|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43869122|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43869123|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869124|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
43869125|NCT04784039|Coagulants|coagulants|mesh-ancestor
43869126|NCT04784104|Epinephrine|epinephrine|mesh-list
43869127|NCT04784104|Racepinephrine|racepinephrine|mesh-list
43869128|NCT04784104|Bupivacaine|bupivacaine|mesh-list
43869129|NCT04784104|Prilocaine|prilocaine|mesh-list
43869130|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43869131|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
43869132|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869133|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
43869134|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869135|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869136|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
43869152|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
43869153|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
43869154|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869155|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869156|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869157|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869158|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869159|NCT04784000|Analgesics|analgesics|mesh-ancestor
43869160|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
43649613|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649614|NCT03019835|Neostigmine|neostigmine|mesh-list
43607533|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607534|NCT03201861|Paclitaxel|paclitaxel|mesh-list
43607535|NCT03201861|Docetaxel|docetaxel|mesh-list
43869161|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869162|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869163|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869164|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869165|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43869166|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43869167|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
43869168|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43869169|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869170|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869171|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869172|NCT04783753|Itraconazole|itraconazole|mesh-list
43869174|NCT04783753|Carbamazepine|carbamazepine|mesh-list
43869175|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
43869176|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44369976|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
44369977|NCT01192113|Vitamins|vitamins|mesh-ancestor
44369978|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
44369979|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44369980|NCT01192165|Paclitaxel|paclitaxel|mesh-list
44369981|NCT01192165|Docetaxel|docetaxel|mesh-list
44369982|NCT01192165|Cisplatin|cisplatin|mesh-list
44369983|NCT01192165|Carboplatin|carboplatin|mesh-list
43869177|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43869178|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43869179|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869180|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869181|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43869182|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
43869183|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869184|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869185|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43869186|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
43869187|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
43869188|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869189|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869190|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869191|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869192|NCT04783753|Analgesics|analgesics|mesh-ancestor
43869193|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
43869198|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43869199|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43607543|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607544|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
43607545|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43607546|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
43607547|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869200|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43869201|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
43869202|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869203|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43869204|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
43869205|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43869206|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43869207|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43869208|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43869209|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
43869210|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43869211|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43869212|NCT04783636|Leuprolide|leuprolide|mesh-list
43869213|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43869214|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
43869215|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869216|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869217|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43869218|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869219|NCT04783610|Ethanol|ethanol|mesh-list
43869220|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43869221|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869222|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869223|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869224|NCT04782622|Apatinib|apatinib|mesh-list
43869225|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869226|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43869227|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869228|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869229|NCT04782960|Bupivacaine|bupivacaine|mesh-list
43869230|NCT04782960|Anesthetics|anesthetics|mesh-list
43869231|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869232|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869233|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869234|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
43869235|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134681|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
44134682|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
44134683|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44369985|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44369986|NCT01192165|Trametinib|trametinib|mesh-list
44369987|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44369988|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44369989|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
44369990|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
44369991|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
44369992|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44369993|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44369994|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44134684|NCT00158873|Narcotics|narcotics|mesh-ancestor
44134685|NCT00158873|Analgesics|analgesics|mesh-ancestor
44134686|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
44134687|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134688|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44134689|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44134690|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134691|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134692|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
44134693|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
44134694|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134695|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134696|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
44134697|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
44134698|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
44134699|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134700|NCT00158886|Topotecan|topotecan|mesh-list
44134701|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44134702|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44134703|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660655|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43660656|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44134704|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134705|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134706|NCT00158990|Sertraline|sertraline|mesh-list
43869237|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43869238|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869239|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869243|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
43869244|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
43869245|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869246|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869247|NCT04782076|Dabigatran|dabigatran|mesh-list
43869248|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
43869249|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43869250|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
43869251|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869252|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869253|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
43869254|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43869255|NCT04782089|Antibodies|antibodies|mesh-list
43869256|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
43869257|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869258|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869259|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869260|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869261|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
43869262|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43869263|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43869264|NCT04782115|Growth Substances|growth substances|mesh-ancestor
43869265|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869266|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
43869267|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869268|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
43869269|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43869270|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44369995|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44369996|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44369998|NCT01192230|Endostatins|endostatins|mesh-list
44369999|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370000|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44370001|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44370002|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44370003|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370004|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44370005|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370006|NCT01192230|Growth Substances|growth substances|mesh-ancestor
44370007|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370008|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370009|NCT01192243|Cisplatin|cisplatin|mesh-list
44370010|NCT01192243|Carboplatin|carboplatin|mesh-list
44370011|NCT01192243|Pemetrexed|pemetrexed|mesh-list
43607586|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607587|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607588|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607589|NCT03201835|Nabiximols|nabiximols|mesh-list
43607590|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607591|NCT03201835|Analgesics|analgesics|mesh-ancestor
43607592|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
44370012|NCT01192243|Gefitinib|gefitinib|mesh-list
44370013|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370014|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370015|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370016|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44370017|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44370018|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370019|NCT01192308|Tamoxifen|tamoxifen|mesh-list
44370020|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44370021|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
44370022|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370023|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370024|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370025|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869271|NCT04782128|Growth Substances|growth substances|mesh-ancestor
43869272|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869273|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
43869274|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869275|NCT04782310|Pregabalin|pregabalin|mesh-list
43869276|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43869277|NCT04782310|Analgesics|analgesics|mesh-ancestor
43869278|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
43869279|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869280|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869281|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
43869282|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370026|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44370027|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44370028|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44370029|NCT01192490|Lidocaine|lidocaine|mesh-list
44370030|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
44370031|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
44370032|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370033|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370034|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
44370035|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370036|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370037|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44370038|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44370039|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370040|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370041|NCT01192503|Rasagiline|rasagiline|mesh-list
43869283|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869284|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869285|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43869286|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43869287|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869288|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869289|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869290|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43869291|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43660682|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660683|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
43660684|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660685|NCT02929524|Ketamine|ketamine|mesh-list
43660686|NCT02929524|Analgesics|analgesics|mesh-ancestor
43660687|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
43660688|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660689|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869292|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869293|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
43869294|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
43869295|NCT04781998|Liraglutide|liraglutide|mesh-list
43869296|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869297|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869298|NCT04781998|Incretins|incretins|mesh-ancestor
43869299|NCT04781998|Hormones|hormones|mesh-ancestor
43869300|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869301|NCT04781803|Cyclosporine|cyclosporine|mesh-list
43869302|NCT04781803|Cyclosporins|cyclosporins|mesh-list
43869303|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869304|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869305|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43869306|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
43869307|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869308|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
43869309|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869311|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869312|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43869318|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
43869319|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869320|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43869321|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869322|NCT04781777|Insulin|insulin|mesh-list
43869323|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869324|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869325|NCT04781751|Insulin|insulin|mesh-list
43869326|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869327|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370042|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44370043|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607596|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607597|NCT03201393|Acetaminophen|acetaminophen|mesh-list
43607598|NCT03201393|Naltrexone|naltrexone|mesh-list
43607599|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43607600|NCT03201393|Analgesics|analgesics|mesh-ancestor
43607601|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
43607602|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607603|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607604|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
43607605|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43607606|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43607607|NCT03201185|Ramipril|ramipril|mesh-list
43651655|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
43660697|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660698|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370044|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370045|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44370046|NCT01192503|Protective Agents|protective agents|mesh-ancestor
44370047|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370048|NCT01192529|Phentermine|phentermine|mesh-list
44370049|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44370050|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370051|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
44370052|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44370053|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
44370054|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
44370055|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370056|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44370057|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370058|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370059|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44370060|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
44370061|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
44370062|NCT01192724|Aspirin|aspirin|mesh-list
44370063|NCT01192724|Cilostazol|cilostazol|mesh-list
44370064|NCT01192724|Clopidogrel|clopidogrel|mesh-list
44370065|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44370066|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44370067|NCT01192724|Analgesics|analgesics|mesh-ancestor
44370068|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
44370069|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370070|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607608|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43607636|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607637|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607638|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607639|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43607640|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43649615|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43649616|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649617|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649618|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
43649619|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649620|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649621|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43649622|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
43649623|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649624|NCT03019848|Curcumin|curcumin|mesh-list
43649625|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649626|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43607641|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43607642|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
44370071|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370072|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44370073|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44370074|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43680784|NCT04646187|Adalimumab|adalimumab|mesh-list
44370081|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44370082|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44370083|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
44370084|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370085|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44370086|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
44370087|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44370088|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
44370089|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370090|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44370091|NCT01192724|Protective Agents|protective agents|mesh-ancestor
44370092|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44370093|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44370094|NCT01192763|R04929097|r04929097|mesh-list
44370095|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370096|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370097|NCT01192789|Amoxicillin|amoxicillin|mesh-list
44370098|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370099|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370100|NCT01192802|Albendazole|albendazole|mesh-list
44370101|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
44370102|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44370103|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370104|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
44370105|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44370106|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44370107|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
44370108|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869328|NCT04781270|Bevacizumab|bevacizumab|mesh-list
43869329|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43869330|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869331|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43869332|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43869333|NCT04781270|Growth Substances|growth substances|mesh-ancestor
43869334|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869335|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43869336|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43869337|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869338|NCT04781075|Bupivacaine|bupivacaine|mesh-list
43869339|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869340|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
43869341|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869342|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869343|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
43869344|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869345|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43869346|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43869347|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370110|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370111|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370112|NCT01192854|Adefovir|adefovir|mesh-list
44370113|NCT01192854|Clevudine|clevudine|mesh-list
44370114|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
44370115|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370116|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43660713|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660714|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
43660715|NCT02929563|Pantoprazole|pantoprazole|mesh-list
43660716|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43660717|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660718|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44370117|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44370118|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370119|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370120|NCT01192971|Apatinib|apatinib|mesh-list
43869348|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43869349|NCT04780945|Olaparib|olaparib|mesh-list
43869350|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43869351|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869352|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869353|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869354|NCT04780659|Vaccines|vaccines|mesh-list
43869355|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
43869356|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869357|NCT04780750|Docetaxel|docetaxel|mesh-list
43869358|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869359|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869360|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869361|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
43869362|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869363|NCT04780854|Metformin|metformin|mesh-list
43869364|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869365|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869366|NCT04780958|Vitamin A|vitamin a|mesh-list
43869367|NCT04780958|Vitamins|vitamins|mesh-ancestor
43869368|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
43869369|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869370|NCT04780984|Bromides|bromides|mesh-list
43869371|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
43869372|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43869373|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
43869374|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869375|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869376|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43869377|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
43869378|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
43869379|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43869380|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
43869381|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869382|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869383|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
43869384|NCT04780412|Alprostadil|alprostadil|mesh-list
43869388|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869389|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869390|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43869391|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869392|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
43869393|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43869394|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
43869395|NCT04780412|Urological Agents|urological agents|mesh-ancestor
43607647|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607648|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607649|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
43607650|NCT03200964|Anesthetics|anesthetics|mesh-list
43869397|NCT04780347|Capecitabine|capecitabine|mesh-list
43869398|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43869399|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43869400|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869401|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869402|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869403|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
44370121|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370122|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370123|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370124|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370125|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
44370126|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370127|NCT01193166|Olanzapine|olanzapine|mesh-list
44370128|NCT01193166|Risperidone|risperidone|mesh-list
44370129|NCT01193166|Aripiprazole|aripiprazole|mesh-list
44370130|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44370131|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44370132|NCT01193166|Perphenazine|perphenazine|mesh-list
44370133|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44370134|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
43869404|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869405|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43869406|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
43869407|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
43869408|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43869409|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869410|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869411|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869412|NCT04779853|Antibodies|antibodies|mesh-list
43869413|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
43869414|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869415|NCT04779892|Infliximab|infliximab|mesh-list
43869416|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869417|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869418|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869419|NCT04780152|Fluoxetine|fluoxetine|mesh-list
43869420|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
43869421|NCT04780152|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43869422|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43869423|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607657|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607658|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607659|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
43607660|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43607690|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869424|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869425|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869426|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
43869427|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869428|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43869429|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869430|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43869431|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43869432|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134707|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
44134708|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134709|NCT00158990|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44134710|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43607700|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43607701|NCT03200600|BB 1101|bb 1101|mesh-list
43607702|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607703|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
43607704|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
43607705|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607741|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43607742|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607743|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43607744|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
43607745|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43607746|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
43607747|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607766|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
43607767|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607768|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
43607769|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607770|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607771|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
43607772|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43607773|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649627|NCT03019848|Analgesics|analgesics|mesh-ancestor
43649628|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
43660747|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43660748|NCT02929147|Morphine|morphine|mesh-list
43660749|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43660750|NCT02929147|Narcotics|narcotics|mesh-ancestor
43660751|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134711|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134712|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134713|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134714|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
44134715|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134716|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
44134717|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134718|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44134719|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134720|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134721|NCT00159081|Haloperidol|haloperidol|mesh-list
44134722|NCT00159081|Risperidone|risperidone|mesh-list
44134723|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
44134724|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44370136|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370137|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370138|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44370139|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44370140|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370141|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44370142|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44370143|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
44370144|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
44370145|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
44370146|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370147|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370148|NCT01193166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44370149|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44370150|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370151|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
44370152|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
44370153|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43680859|NCT04547439|Melatonin|melatonin|mesh-list
44134725|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
44134726|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134727|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134728|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649629|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649630|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649631|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649632|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649633|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649634|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869436|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869437|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869438|NCT04779255|Analgesics|analgesics|mesh-ancestor
43869439|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
43869440|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869441|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
43869442|NCT04779567|Acetaminophen|acetaminophen|mesh-list
43869443|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869444|NCT04779567|Analgesics|analgesics|mesh-ancestor
43869445|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
43869446|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869447|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869448|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
43869449|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
43869450|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43869451|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43869452|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869453|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
43869454|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869455|NCT04779580|Anesthetics|anesthetics|mesh-list
43869456|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
43869457|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869458|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869459|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
43869460|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869461|NCT04779060|Dexamethasone|dexamethasone|mesh-list
43869462|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869463|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
43869464|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
43869465|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869466|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370154|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43607783|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
43607784|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607785|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607786|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
43607787|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
43607788|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607789|NCT03199989|Capecitabine|capecitabine|mesh-list
43607790|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
43607791|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607792|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
43660781|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660782|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660783|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660784|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660785|NCT02929095|Analgesics|analgesics|mesh-ancestor
44370155|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44370156|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44370158|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
44370159|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370160|NCT01193270|Vitamin E|vitamin e|mesh-list
44370161|NCT01193270|Vitamins|vitamins|mesh-ancestor
44370162|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
44370163|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370164|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
44370165|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370166|NCT01193270|Protective Agents|protective agents|mesh-ancestor
44370167|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44370168|NCT01193296|Vildagliptin|vildagliptin|mesh-list
44370169|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370170|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370171|NCT01193296|Incretins|incretins|mesh-ancestor
44370172|NCT01193296|Hormones|hormones|mesh-ancestor
43680878|NCT04515134|Vitamins|vitamins|mesh-ancestor
43869467|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869468|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
43869469|NCT04779060|Hormones|hormones|mesh-ancestor
43869470|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869471|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43869472|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869473|NCT04778917|Heparin|heparin|mesh-list
43869474|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43869475|NCT04778917|Tinzaparin|tinzaparin|mesh-list
43869476|NCT04778917|Dalteparin|dalteparin|mesh-list
43869477|NCT04778917|Calcium heparin|calcium heparin|mesh-list
43869478|NCT04778917|Calcium|calcium|mesh-list
43869479|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43869480|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869481|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
43869482|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43869483|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43869484|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869485|NCT04778865|Vitamin D|vitamin d|mesh-list
43869486|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
43869487|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
43869488|NCT04778865|Vitamins|vitamins|mesh-list
43869489|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
43869490|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869491|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43869492|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43869493|NCT04778839|Paclitaxel|paclitaxel|mesh-list
43869494|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43869495|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43869496|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869497|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869498|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869499|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
43869502|NCT04778813|Lumefantrine|lumefantrine|mesh-list
43607793|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607794|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607795|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
43869503|NCT04778813|Artemether|artemether|mesh-list
43869504|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43607796|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
43869505|NCT04778813|Artenimol|artenimol|mesh-list
43869506|NCT04778813|Pyronaridine|pyronaridine|mesh-list
43869507|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
43869508|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43869509|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44370173|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370174|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44370175|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
44370176|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370177|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370178|NCT01193387|Insulin|insulin|mesh-list
44370179|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44370180|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
44370181|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370182|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370183|NCT01193400|Cytarabine|cytarabine|mesh-list
44370184|NCT01193400|Clofarabine|clofarabine|mesh-list
44370185|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370186|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
44370187|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370188|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370189|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
43869510|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869511|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869512|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
43869513|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
43869514|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43869515|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
43869516|NCT04779047|Ritonavir|ritonavir|mesh-list
43869517|NCT04779047|Lopinavir|lopinavir|mesh-list
43869518|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
43869519|NCT04779047|Ivermectin|ivermectin|mesh-list
43869520|NCT04779047|Remdesivir|remdesivir|mesh-list
43869521|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43869522|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43869523|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
43869524|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869525|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869526|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43869527|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43869528|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
43869529|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869530|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43869531|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43869532|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
43869533|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43869534|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43869535|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869536|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
43869537|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
43869538|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
43849262|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43849263|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43849264|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
43869539|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43869540|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43869541|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869542|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43869543|NCT04778072|Iron|iron|mesh-list
43869544|NCT04778072|Trace Elements|trace elements|mesh-ancestor
43869545|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
43869546|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869547|NCT04778137|Omalizumab|omalizumab|mesh-list
43869548|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43869549|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43869550|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
43869551|NCT04777968|Fluorides|fluorides|mesh-list
44370190|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370191|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370192|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
44370193|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370195|NCT01193452|Fluorouracil|fluorouracil|mesh-list
44370196|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
44370197|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
44370198|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370199|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370200|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370201|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370202|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
44370203|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370204|NCT01193452|Antidotes|antidotes|mesh-ancestor
44370205|NCT01193452|Protective Agents|protective agents|mesh-ancestor
44370206|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
44370207|NCT01193452|Vitamins|vitamins|mesh-ancestor
44370208|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
44370209|NCT01193465|Anesthetics|anesthetics|mesh-list
44370210|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370211|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370212|NCT01193478|Ledipasvir|ledipasvir|mesh-list
44370213|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
44370214|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370215|NCT01193491|Geldanamycin|geldanamycin|mesh-list
44370216|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44370217|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370218|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
44370219|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370220|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370221|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370222|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44370223|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
44370232|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370233|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
44370234|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
43607821|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370235|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370236|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370237|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370238|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
44370240|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370241|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44370242|NCT01193504|Protective Agents|protective agents|mesh-ancestor
44370243|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370244|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370245|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44370246|NCT01193595|Bevacizumab|bevacizumab|mesh-list
44370247|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44370248|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370249|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44370250|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370251|NCT01193595|Growth Substances|growth substances|mesh-ancestor
44370252|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370253|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370254|NCT01193621|Haloperidol|haloperidol|mesh-list
44370255|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
44370256|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
44370257|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
44370258|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370259|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869552|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
43869553|NCT04777968|Protective Agents|protective agents|mesh-ancestor
43869554|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869555|NCT04777383|Atropine|atropine|mesh-list
43869556|NCT04777383|Phenylephrine|phenylephrine|mesh-list
43869557|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
43869558|NCT04777383|Norepinephrine|norepinephrine|mesh-list
43869559|NCT04777383|Acetylcholine|acetylcholine|mesh-list
43869560|NCT04777383|Neostigmine|neostigmine|mesh-list
43869561|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43869562|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
43869563|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
43869564|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869565|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869566|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
43869567|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43869568|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
43869569|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
43555877|NCT03558243|Coagulants|coagulants|mesh-ancestor
44370260|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370261|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44370262|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44370263|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370264|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44370265|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44370266|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
44370267|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370268|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370269|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44025612|NCT00476827|Docetaxel|docetaxel|mesh-list
43607829|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43607830|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607831|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
43607832|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
44370270|NCT01193816|Loxapine|loxapine|mesh-list
44370271|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44370272|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44370273|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370274|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370275|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44370276|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43869570|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43869571|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43869572|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43869573|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
43869574|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869575|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869576|NCT04777383|Protective Agents|protective agents|mesh-ancestor
43869577|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43869578|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43869586|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869587|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43869588|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
43869589|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43869590|NCT04777838|Amitriptyline|amitriptyline|mesh-list
43869591|NCT04777838|Citalopram|citalopram|mesh-list
43869592|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43869593|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43869594|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869595|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869596|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869597|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
43869598|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869599|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43869600|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
43869601|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869602|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869603|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43869604|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869605|NCT04777838|Analgesics|analgesics|mesh-ancestor
43869606|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
43869607|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43869608|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
43869609|NCT04777552|Diazepam|diazepam|mesh-list
43869610|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43869611|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
43869612|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
43869613|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
43869614|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869615|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370277|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
44370278|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370279|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607839|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607840|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
43607841|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607842|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43607843|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370280|NCT01193855|Dutasteride|dutasteride|mesh-list
44370281|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44370282|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44370283|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370284|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370285|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44412296|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869616|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869617|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43869618|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869619|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43869620|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43869621|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43869622|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869623|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869624|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43869625|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
43869626|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
43869627|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
43869628|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
43869629|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869630|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869631|NCT04777591|Bupivacaine|bupivacaine|mesh-list
43869632|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869633|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
43869634|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869635|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869636|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
43869637|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134733|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44134734|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
44134735|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
44134736|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
44134737|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134738|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134739|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44134740|NCT00159094|Vinorelbine|vinorelbine|mesh-list
43649638|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43649639|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
43607844|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607846|NCT03199690|Dolutegravir|dolutegravir|mesh-list
43607847|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43607848|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
44134741|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44134742|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134748|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44134749|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
44134750|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134751|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134752|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134753|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134755|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
44134756|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
44134757|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
44134758|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
44134759|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134760|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134761|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44134762|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43869639|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43869640|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43869641|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869642|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869643|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43869644|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869645|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
43869646|NCT04777227|Lidocaine|lidocaine|mesh-list
44370286|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370287|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370288|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44370289|NCT01193881|R04929097|r04929097|mesh-list
44370290|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370291|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370292|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370293|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370294|NCT01194037|Interferons|interferons|mesh-list
44370295|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
44370296|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
44370297|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44370298|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370299|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
44370300|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370301|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
44370302|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869647|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
43607924|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43607925|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43607926|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607927|NCT03199261|Exenatide|exenatide|mesh-list
43607928|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43607929|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607930|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43607931|NCT03199261|Incretins|incretins|mesh-ancestor
43869648|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
43869649|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869650|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869651|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
43869652|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869653|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43869654|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43869655|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869656|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869657|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869658|NCT04777110|Esketamine|esketamine|mesh-list
43869659|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
43869660|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869661|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43869662|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43869663|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43869664|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
43869665|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869666|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43869667|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43869668|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869669|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
43869670|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
43869671|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869672|NCT04776512|Bupivacaine|bupivacaine|mesh-list
43869673|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869674|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
43869675|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869676|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869677|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
43869678|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869679|NCT04776655|Leucovorin|leucovorin|mesh-list
43869680|NCT04776655|Bevacizumab|bevacizumab|mesh-list
43869681|NCT04776655|Cetuximab|cetuximab|mesh-list
43869682|NCT04776655|Fluorouracil|fluorouracil|mesh-list
43869683|NCT04776655|Irinotecan|irinotecan|mesh-list
43869684|NCT04776655|Calcium|calcium|mesh-list
43869685|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
43869686|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43869687|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370303|NCT01194115|Metronidazole|metronidazole|mesh-list
44370304|NCT01194115|Cephalexin|cephalexin|mesh-list
44370305|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370306|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370307|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44370308|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44370309|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
44370310|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370311|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44370312|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44370313|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412297|NCT02422303|Ketamine|ketamine|mesh-list
43869688|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43869692|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
43869693|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43869695|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869696|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43869697|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43869698|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
43869699|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43869700|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43869701|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869702|NCT04776655|Antidotes|antidotes|mesh-ancestor
43869703|NCT04776655|Protective Agents|protective agents|mesh-ancestor
43869704|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
43869705|NCT04776655|Vitamins|vitamins|mesh-ancestor
43869706|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
43869707|NCT04776135|Edaravone|edaravone|mesh-list
43660904|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869708|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43869709|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
43869710|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869711|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43869712|NCT04776135|Protective Agents|protective agents|mesh-ancestor
43869713|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869715|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43869716|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43869717|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869718|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869719|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869720|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
43869721|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869722|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43869723|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
43869724|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869725|NCT04775732|Infliximab|infliximab|mesh-list
43869726|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869727|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869728|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869729|NCT04775563|Vaccines|vaccines|mesh-list
43869730|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
43869731|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869732|NCT04775303|Cyclosporine|cyclosporine|mesh-list
43869733|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43869734|NCT04775303|Cyclosporins|cyclosporins|mesh-list
43869735|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869736|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869737|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43869738|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
43869739|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869740|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
43869741|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869742|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869743|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869744|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43869745|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44370314|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370315|NCT01194232|Urological Agents|urological agents|mesh-ancestor
44370316|NCT01194284|Mifamurtide|mifamurtide|mesh-list
44370317|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44370318|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
44370319|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370320|NCT01194336|Huperzine A|huperzine a|mesh-list
44370321|NCT01194336|Donepezil|donepezil|mesh-list
44370322|NCT01194336|Galantamine|galantamine|mesh-list
43607933|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607934|NCT03199482|Dexamethasone|dexamethasone|mesh-list
43607936|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
44370323|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44370324|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370325|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370326|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
44370327|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370328|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869746|NCT04775576|Anesthetics|anesthetics|mesh-list
43869747|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869748|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869749|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43869750|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
43869751|NCT04775212|Sevoflurane|sevoflurane|mesh-list
43869752|NCT04775212|Desflurane|desflurane|mesh-list
43869753|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43869754|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43869755|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
43869756|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
43869757|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869758|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869759|NCT04775238|Copper|copper|mesh-list
43869760|NCT04775238|Trace Elements|trace elements|mesh-ancestor
43869761|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
43869766|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869767|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
43869768|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869769|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
43869770|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
43869771|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869772|NCT04774627|Olaparib|olaparib|mesh-list
43869773|NCT04774627|Niraparib|niraparib|mesh-list
43869774|NCT04774627|Veliparib|veliparib|mesh-list
43869775|NCT04774627|Talazoparib|talazoparib|mesh-list
43869776|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43869777|NCT04774627|Rucaparib|rucaparib|mesh-list
43869778|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869779|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869780|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134763|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134764|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44134765|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134766|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134768|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
44134769|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134770|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134771|NCT00159146|Pindolol|pindolol|mesh-list
43869781|NCT04774029|Lidocaine|lidocaine|mesh-list
43869782|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869783|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
43869784|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869785|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869786|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
43869787|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869788|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370330|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44370331|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
44370332|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370333|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44370334|NCT01194336|Protective Agents|protective agents|mesh-ancestor
44370335|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44370336|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44370337|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
44370338|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370339|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370340|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44370341|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825723|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43825724|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43825725|NCT05284643|Growth Substances|growth substances|mesh-ancestor
43825726|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825727|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370342|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
44370343|NCT01194700|Hormones|hormones|mesh-ancestor
44370344|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370345|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
44370346|NCT01194778|Vitamins|vitamins|mesh-list
44370347|NCT01194778|Vitamin K|vitamin k|mesh-list
44370348|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
44370349|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
44370350|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
44370351|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370352|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44370353|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44370354|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370355|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
44370356|NCT01194778|Coagulants|coagulants|mesh-ancestor
44370357|NCT01194791|Dexamethasone|dexamethasone|mesh-list
44370358|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
44370359|NCT01194791|Lenalidomide|lenalidomide|mesh-list
44370376|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370377|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370378|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44370379|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370380|NCT01194791|Growth Substances|growth substances|mesh-ancestor
44370381|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370382|NCT01194843|Ropivacaine|ropivacaine|mesh-list
44370383|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
44370384|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
44370385|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370386|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370387|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
44370388|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370389|NCT01194882|Insulin|insulin|mesh-list
44370390|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44370391|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370392|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370393|NCT01194934|Lenograstim|lenograstim|mesh-list
44370394|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44370395|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
43607976|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607977|NCT03199157|Fentanyl|fentanyl|mesh-list
43607979|NCT03199157|Narcotics|narcotics|mesh-ancestor
43607980|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607981|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607982|NCT03199157|Analgesics|analgesics|mesh-ancestor
43608014|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43608015|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608016|NCT03198676|Poly I-C|poly i-c|mesh-list
43608017|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
43608018|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608019|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
43608020|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
43608021|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608022|NCT03198585|Empagliflozin|empagliflozin|mesh-list
43608023|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44370396|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370397|NCT01195181|Ribavirin|ribavirin|mesh-list
44370398|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
44370399|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370400|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
44370401|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370402|NCT01195246|Vaccines|vaccines|mesh-list
44370403|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
44370404|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370405|NCT01195259|Metformin|metformin|mesh-list
44370406|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
44370407|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370408|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370409|NCT01195298|Bevacizumab|bevacizumab|mesh-list
43869789|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43869790|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869791|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869792|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869793|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
44370410|NCT01195298|Capecitabine|capecitabine|mesh-list
44370411|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44370412|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370413|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44370414|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370415|NCT01195298|Growth Substances|growth substances|mesh-ancestor
44370416|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370417|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370418|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649640|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649641|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
43649642|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649643|NCT03019536|Flutemetamol|flutemetamol|mesh-list
43649644|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43649645|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649646|NCT03019523|Caffeine|caffeine|mesh-list
43649647|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43649648|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649649|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43649650|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649651|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649652|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43649656|NCT03019562|Fentanyl|fentanyl|mesh-list
43869794|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
43869795|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869796|NCT04773951|Antibodies|antibodies|mesh-list
43869797|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43869798|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
43869799|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869800|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
43869801|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
43869802|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869803|NCT04773717|Protective Agents|protective agents|mesh-ancestor
43869804|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869805|NCT04773717|Vitamins|vitamins|mesh-ancestor
43869806|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
43869807|NCT04774406|Olaparib|olaparib|mesh-list
43869808|NCT04774406|Niraparib|niraparib|mesh-list
43869809|NCT04774406|Veliparib|veliparib|mesh-list
43869810|NCT04774406|Talazoparib|talazoparib|mesh-list
43869811|NCT04774406|Rucaparib|rucaparib|mesh-list
43869812|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43869813|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869814|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869815|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869816|NCT04773301|Ropivacaine|ropivacaine|mesh-list
43869817|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
43869818|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869819|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
43869820|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869821|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869822|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
43869823|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869824|NCT04773236|Lidocaine|lidocaine|mesh-list
43869825|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869826|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
43869827|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869835|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869836|NCT04773093|Lidocaine|lidocaine|mesh-list
43869837|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869838|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
43869839|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869840|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869841|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
43869842|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869843|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43869844|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43869845|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869846|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869847|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869848|NCT04772781|Ibuprofen|ibuprofen|mesh-list
43608054|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
43608055|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608056|NCT03198208|Fentanyl|fentanyl|mesh-list
43608057|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43608058|NCT03198208|Narcotics|narcotics|mesh-ancestor
43608059|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608060|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608061|NCT03198208|Analgesics|analgesics|mesh-ancestor
43608062|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
43608063|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608064|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43608065|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43851383|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
43869849|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43869850|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869851|NCT04772781|Analgesics|analgesics|mesh-ancestor
43869852|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
43869853|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869854|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869855|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869856|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869857|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44370419|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
44370420|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370421|NCT01195324|Canagliflozin|canagliflozin|mesh-list
44370422|NCT01195324|Warfarin|warfarin|mesh-list
44370423|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
44370424|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44370425|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370426|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370427|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370428|NCT01195376|Dactolisib|dactolisib|mesh-list
44370429|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370430|NCT01195428|Simvastatin|simvastatin|mesh-list
44370431|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44370432|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44370433|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
44370434|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370435|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44370436|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44370437|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370438|NCT01195454|Insulin|insulin|mesh-list
44370439|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44370440|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
44370441|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370442|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370443|NCT01195571|Vaccines|vaccines|mesh-list
44370444|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
43869858|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869859|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869860|NCT04772729|Insulin|insulin|mesh-list
43869861|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43869862|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
43869863|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43869864|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869865|NCT04772521|Nicotine|nicotine|mesh-list
43869866|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43869867|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
43869868|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869869|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869870|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43869871|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43869872|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
43608066|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
43608067|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
43608068|NCT03198338|Bupivacaine|bupivacaine|mesh-list
43608069|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608070|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
43608071|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649659|NCT03019562|Narcotics|narcotics|mesh-ancestor
43649660|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608072|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608073|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
43869873|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869874|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869875|NCT04772287|Gemcitabine|gemcitabine|mesh-list
43869876|NCT04772287|Paclitaxel|paclitaxel|mesh-list
43869877|NCT04772287|Vinorelbine|vinorelbine|mesh-list
43869878|NCT04772287|Docetaxel|docetaxel|mesh-list
43869879|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43869880|NCT04772287|Cisplatin|cisplatin|mesh-list
44370445|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370446|NCT01195649|Sorafenib|sorafenib|mesh-list
44370447|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370448|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370449|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370450|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370451|NCT01195714|Ofatumumab|ofatumumab|mesh-list
44370452|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370453|NCT01195727|Apixaban|apixaban|mesh-list
44370454|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44370455|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
44370456|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44370457|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44370458|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370459|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370460|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
44370462|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370463|NCT01195805|Amiloride|amiloride|mesh-list
44370464|NCT01195805|Spironolactone|spironolactone|mesh-list
44370465|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44370466|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
44370467|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370468|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370469|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43608074|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608075|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
43608076|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43608077|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
44370470|NCT01195805|Diuretics|diuretics|mesh-ancestor
44370471|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
43869881|NCT04772287|Carboplatin|carboplatin|mesh-list
43869882|NCT04772287|Pemetrexed|pemetrexed|mesh-list
43869883|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43869884|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869885|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869886|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869887|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
43869888|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869889|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43869890|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
43869891|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
43869892|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869893|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869894|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43869897|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43869898|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43869900|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
43869901|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43869902|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
43869903|NCT04771715|Nivolumab|nivolumab|mesh-list
43869904|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43869905|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869906|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44370472|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44370473|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44370474|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370475|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370476|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44370477|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43608152|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608153|NCT03197571|Leucovorin|leucovorin|mesh-list
43608154|NCT03197571|Paclitaxel|paclitaxel|mesh-list
43608155|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
43608156|NCT03197571|Bevacizumab|bevacizumab|mesh-list
43608157|NCT03197571|Cisplatin|cisplatin|mesh-list
43608158|NCT03197571|Fluorouracil|fluorouracil|mesh-list
44370478|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44370479|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370480|NCT01196013|Clofarabine|clofarabine|mesh-list
44370481|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370482|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
44370483|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370484|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869907|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869908|NCT04771728|Metronidazole|metronidazole|mesh-list
43869909|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869910|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43869911|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43869912|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43608173|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
43608174|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43608175|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608176|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43608202|NCT03197584|Bevacizumab|bevacizumab|mesh-list
43608203|NCT03197584|Fluorouracil|fluorouracil|mesh-list
43608204|NCT03197584|Capecitabine|capecitabine|mesh-list
43608205|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
43608206|NCT03197584|Fulvestrant|fulvestrant|mesh-list
43608207|NCT03197584|Avelumab|avelumab|mesh-list
43608208|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608209|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608210|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43608211|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
43660990|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43660991|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43660992|NCT02927496|Doxycycline|doxycycline|mesh-list
43660993|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660994|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660995|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
43660996|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43660997|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43660998|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43869913|NCT04771884|Vancomycin|vancomycin|mesh-list
43869914|NCT04771884|Meropenem|meropenem|mesh-list
43869915|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
43869916|NCT04771884|Linezolid|linezolid|mesh-list
43869917|NCT04771884|Ceftazidime|ceftazidime|mesh-list
43869918|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
43869919|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43869920|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869921|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43869922|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869923|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869924|NCT04771754|Dolutegravir|dolutegravir|mesh-list
43869925|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43869926|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43869927|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869928|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869929|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43869930|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43869931|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
43869932|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869933|NCT04771559|Antibodies|antibodies|mesh-list
43869934|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
43869935|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869936|NCT04771390|Selitrectinib|selitrectinib|mesh-list
43869937|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869938|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134772|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44134773|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44134774|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44134775|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134776|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134777|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134778|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134779|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44134780|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
44134781|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134782|NCT00159159|Cyclosporine|cyclosporine|mesh-list
44134783|NCT00159159|Cyclosporins|cyclosporins|mesh-list
44134784|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134785|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370485|NCT01196065|Memantine|memantine|mesh-list
44370486|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44370487|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43608212|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608213|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608214|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43608215|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
44370488|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
44370489|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370490|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370491|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370492|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44370493|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44370494|NCT01196169|Vancomycin|vancomycin|mesh-list
44370495|NCT01196169|Daptomycin|daptomycin|mesh-list
44370496|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370497|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370498|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44370499|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44370500|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134786|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44134787|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
44134788|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134789|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
44134790|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134791|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44134792|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134793|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44155674|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44155675|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155676|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155677|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
44155678|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155679|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155680|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44155685|NCT00227942|Hormones|hormones|mesh-ancestor
44155686|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155687|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155688|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44155689|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44155690|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155691|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44155692|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
44155693|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
44155694|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155695|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155696|NCT00227955|Imipramine|imipramine|mesh-list
44155697|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44155698|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155699|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155700|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44155701|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44155702|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155703|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155704|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155705|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155706|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155707|NCT00227981|Fluoxetine|fluoxetine|mesh-list
43661016|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
43661017|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661019|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
43661020|NCT02926976|Valproic Acid|valproic acid|mesh-list
43661021|NCT02926976|Risperidone|risperidone|mesh-list
43661022|NCT02926976|Aripiprazole|aripiprazole|mesh-list
43661023|NCT02926976|Clozapine|clozapine|mesh-list
43661024|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43661025|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
44155708|NCT00227981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44155709|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44370502|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44370503|NCT01196234|Carboplatin|carboplatin|mesh-list
44370504|NCT01196234|Gefitinib|gefitinib|mesh-list
44370505|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44370506|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370507|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
44370508|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681057|NCT04247867|Psyllium|psyllium|mesh-list
44155710|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155711|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155712|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155713|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
44155714|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155715|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44155716|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155717|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155718|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43869939|NCT04771026|Dexamethasone|dexamethasone|mesh-list
43869940|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869941|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
43869942|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
43869943|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869944|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869945|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869946|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
43869948|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869949|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608221|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
43608222|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
43608223|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43608224|NCT03197584|Antidotes|antidotes|mesh-ancestor
43608225|NCT03197584|Protective Agents|protective agents|mesh-ancestor
43608226|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
43608227|NCT03197584|Vitamins|vitamins|mesh-ancestor
43649661|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649662|NCT03019562|Analgesics|analgesics|mesh-ancestor
43649663|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
43649664|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608258|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608260|NCT03197298|Ticagrelor|ticagrelor|mesh-list
43608261|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43869950|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869951|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
43869952|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43869953|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43869954|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43869955|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
43869956|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869957|NCT04770688|Osimertinib|osimertinib|mesh-list
43869958|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869959|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43869960|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869961|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869962|NCT04770961|Ropivacaine|ropivacaine|mesh-list
43869963|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
43869964|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
43869965|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43869966|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869967|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
43869968|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869969|NCT04770389|Ezetimibe|ezetimibe|mesh-list
43869970|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43869976|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869977|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43869978|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43869979|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869980|NCT04769557|Acetaminophen|acetaminophen|mesh-list
43869981|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43869982|NCT04769557|Analgesics|analgesics|mesh-ancestor
43869983|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
43869984|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869985|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869986|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
43869987|NCT05606497|Dexamethasone|dexamethasone|mesh-list
43869988|NCT05606497|Betamethasone|betamethasone|mesh-list
43869989|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43869990|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
43869991|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
43869992|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869993|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370509|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
43608264|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44370510|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370511|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370512|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370514|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
44370515|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370516|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
44370517|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370518|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370519|NCT01196455|Capecitabine|capecitabine|mesh-list
44370520|NCT01196455|Mitomycins|mitomycins|mesh-list
44370521|NCT01196455|Mitomycin|mitomycin|mesh-list
44370522|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370523|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
44370524|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370525|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370526|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44370527|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
44370528|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44370529|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370530|NCT01196481|Carvedilol|carvedilol|mesh-list
44370531|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44370532|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44370533|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44370534|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370535|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370536|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370537|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44370538|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
44370539|NCT01196481|Protective Agents|protective agents|mesh-ancestor
44370540|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370550|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370551|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370552|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370553|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43608311|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43608312|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43608313|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43608314|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608341|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
43608342|NCT03197012|Octreotide|octreotide|mesh-list
43608343|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43608344|NCT03197012|Edotreotide|edotreotide|mesh-list
43608345|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
43661092|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43661093|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
43661094|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44370554|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
44370555|NCT01196507|Protective Agents|protective agents|mesh-ancestor
44370556|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370557|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370558|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370559|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370560|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44370561|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44370562|NCT01196546|Metformin|metformin|mesh-list
44370563|NCT01196546|Vildagliptin|vildagliptin|mesh-list
44370564|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370565|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370566|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44370567|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
44370568|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370569|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370570|NCT01196559|Gemcitabine|gemcitabine|mesh-list
44370571|NCT01196559|Vinorelbine|vinorelbine|mesh-list
44370572|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43869994|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43869995|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
43869996|NCT05606497|Hormones|hormones|mesh-ancestor
43869997|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608346|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
43608347|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608348|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43608349|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608350|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608351|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608352|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
43608353|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43608354|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
43608355|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608356|NCT03197103|Expectorants|expectorants|mesh-ancestor
43608392|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869998|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43869999|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870000|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43870001|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
43870002|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
43870003|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43870004|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
43870005|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870006|NCT05606315|Midazolam|midazolam|mesh-list
43870007|NCT05606315|Propofol|propofol|mesh-list
43870008|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43870009|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870010|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870011|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43870012|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
43870013|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
43870014|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43870015|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43870016|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870017|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870018|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
43870019|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
43870020|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370573|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
44370574|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370575|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370576|NCT01196559|Antiviral Agents|antiviral agents|mesh-ancestor
43608393|NCT03196843|Raltitrexed|raltitrexed|mesh-list
43608394|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43608395|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
43649666|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649667|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
43649668|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
43649669|NCT03019237|Omalizumab|omalizumab|mesh-list
43608396|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849277|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43849278|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43849279|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43849281|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849282|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849283|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849284|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849285|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44370577|NCT01196559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370578|NCT01196559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370579|NCT01196559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370580|NCT01196559|Immunologic Factors|immunologic factors|mesh-ancestor
44370581|NCT01196559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370582|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44370583|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
44370584|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870021|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870022|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
43870023|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870024|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870025|NCT05606107|Tofacitinib|tofacitinib|mesh-list
43870026|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
43870027|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43870028|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870029|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870031|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870032|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870033|NCT05606055|Tenofovir|tenofovir|mesh-list
43870034|NCT05606055|Emtricitabine|emtricitabine|mesh-list
43870035|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
43870036|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870037|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43870038|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43870039|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870040|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870041|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43870045|NCT05605925|Artemether|artemether|mesh-list
43870046|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43870047|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43870048|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870049|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
43870050|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43870051|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43870052|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43870053|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870054|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43870055|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43870056|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43870057|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870058|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870059|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43870060|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870061|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870062|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
43870063|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870064|NCT05605587|Leflunomide|leflunomide|mesh-list
43870065|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870066|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870067|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870068|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
43870069|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134794|NCT00159211|Pioglitazone|pioglitazone|mesh-list
44134795|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134796|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134797|NCT00159224|Ritonavir|ritonavir|mesh-list
44134798|NCT00159224|Lopinavir|lopinavir|mesh-list
44370585|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
44370586|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
44370587|NCT01196715|Hematinics|hematinics|mesh-ancestor
44370588|NCT01196754|Sevoflurane|sevoflurane|mesh-list
44370589|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44370590|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44370591|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
44370592|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
44370593|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370594|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370595|NCT01196767|Ropivacaine|ropivacaine|mesh-list
44134799|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44134800|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44134801|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
44134802|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134803|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134804|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44134805|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44134806|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
43871180|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43871181|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871182|NCT02641314|Analgesics|analgesics|mesh-ancestor
43871183|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
43871184|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871185|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871186|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43871187|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43871188|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871189|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43871190|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43871191|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871192|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871193|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43871194|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871195|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
43871196|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
43871197|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871198|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871199|NCT02600117|Tenofovir|tenofovir|mesh-list
43871200|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
43871201|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871202|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43871203|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43871204|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871205|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871206|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43871207|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43871208|NCT02474173|Paclitaxel|paclitaxel|mesh-list
43871209|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43871210|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871211|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134962|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134963|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134964|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134965|NCT00159705|Pregabalin|pregabalin|mesh-list
44134966|NCT00159705|Analgesics|analgesics|mesh-ancestor
44134967|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
44134968|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134969|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608437|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43608438|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43608439|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134970|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
44134971|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134972|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134973|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134974|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370596|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
44370597|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
44370598|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370599|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370600|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
44370601|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370602|NCT01197001|Losartan|losartan|mesh-list
44370603|NCT01197001|Amlodipine|amlodipine|mesh-list
44370604|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44370605|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370606|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370607|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370608|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370609|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370610|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370611|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370612|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44370613|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44370614|NCT01197014|Losartan|losartan|mesh-list
44370615|NCT01197014|Amlodipine|amlodipine|mesh-list
44134975|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44134976|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134977|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134978|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134979|NCT00159718|Amlodipine|amlodipine|mesh-list
44134980|NCT00159718|Atorvastatin|atorvastatin|mesh-list
44134981|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43608478|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608479|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134982|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44134983|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
44134984|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134985|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44134986|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44134987|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134988|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134989|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134990|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134991|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134992|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669055|NCT02908282|Povidone|povidone|mesh-list
44134993|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134995|NCT00159731|Analgesics|analgesics|mesh-ancestor
44134996|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
44134997|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134998|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134999|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
44135000|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44135001|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135002|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135003|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44135004|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44135005|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44135006|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370616|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44370617|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370618|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370619|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370620|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370621|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370622|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370623|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370624|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43608528|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608553|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43608554|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608555|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608556|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608558|NCT03195673|Urological Agents|urological agents|mesh-ancestor
44370625|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44135007|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135008|NCT00159757|Ziprasidone|ziprasidone|mesh-list
44135009|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44135010|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
44135011|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135012|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135013|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135014|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44135015|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44135016|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44135017|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135018|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44135019|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
44135020|NCT00159770|Olanzapine|olanzapine|mesh-list
44135021|NCT00159770|Risperidone|risperidone|mesh-list
44135022|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44135023|NCT00159770|Ziprasidone|ziprasidone|mesh-list
44135024|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43871216|NCT02428205|Propranolol|propranolol|mesh-list
43871217|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43871218|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43871223|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43871224|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871225|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
43871226|NCT02280239|Acetaminophen|acetaminophen|mesh-list
43871227|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871228|NCT02280239|Analgesics|analgesics|mesh-ancestor
43871229|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
43871230|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871231|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871232|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
43871233|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
43871234|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871235|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43871236|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871237|NCT02022644|Irinotecan|irinotecan|mesh-list
43649678|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43649679|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608563|NCT03195543|Coagulants|coagulants|mesh-ancestor
43608564|NCT03195530|Propofol|propofol|mesh-list
43608567|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608570|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
43871238|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43871239|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43871240|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871241|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871242|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871243|NCT01946477|Dexamethasone|dexamethasone|mesh-list
43871244|NCT01946477|Daratumumab|daratumumab|mesh-list
43871245|NCT01946477|Pomalidomide|pomalidomide|mesh-list
43871246|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871247|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
43871248|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
43871249|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871250|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871251|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669061|NCT02908152|Analgesics|analgesics|mesh-ancestor
43871252|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
43871254|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370626|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
44370628|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370629|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
44370630|NCT01197040|Hormones|hormones|mesh-ancestor
44370631|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370632|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370633|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370634|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370635|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44370636|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44370637|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
44370638|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370639|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370640|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370641|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871255|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871256|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871257|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
43871258|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43871259|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43871260|NCT01946477|Growth Substances|growth substances|mesh-ancestor
43871261|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
43871262|NCT01782989|Doxycycline|doxycycline|mesh-list
43871263|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871264|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871265|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
43871266|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43871267|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43871268|NCT01575925|Thalidomide|thalidomide|mesh-list
43871269|NCT01575925|Dexamethasone|dexamethasone|mesh-list
43871270|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
43871271|NCT01575925|Pomalidomide|pomalidomide|mesh-list
43871272|NCT01575925|BB 1101|bb 1101|mesh-list
43871273|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871274|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
43871275|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
43871276|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871277|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871278|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871279|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
43871280|NCT01575925|Hormones|hormones|mesh-ancestor
43871281|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871282|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871283|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871284|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
43871285|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871286|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871287|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
43871288|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43871289|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43871291|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
43871292|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871293|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
43871294|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871295|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871296|NCT00227253|Hormones|hormones|mesh-list
43871297|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43555878|NCT03558139|Avelumab|avelumab|mesh-list
44370643|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370644|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608694|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370645|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
44370646|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44370647|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370648|NCT01197170|Bevacizumab|bevacizumab|mesh-list
44370649|NCT01197170|Everolimus|everolimus|mesh-list
44370650|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44370651|NCT01197170|Sorafenib|sorafenib|mesh-list
44370652|NCT01197170|Anastrozole|anastrozole|mesh-list
44370653|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44370654|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370655|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44370656|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370657|NCT01197170|Growth Substances|growth substances|mesh-ancestor
44370658|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370659|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370660|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370661|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
44370662|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44370663|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370664|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370665|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370666|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44370667|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44370668|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44370669|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
44370670|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370671|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
44370672|NCT01197235|Hematinics|hematinics|mesh-ancestor
43871298|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871299|NCT04769713|Ropivacaine|ropivacaine|mesh-list
43871300|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
43871301|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
43871302|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871303|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871304|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
43871305|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871306|NCT04769583|Metronidazole|metronidazole|mesh-list
43661242|NCT02924766|Prednisone|prednisone|mesh-list
43871307|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871308|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871309|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43871310|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43871311|NCT04769778|Valsartan|valsartan|mesh-list
44370673|NCT01197261|Oxycodone|oxycodone|mesh-list
44370674|NCT01197261|Naloxone|naloxone|mesh-list
44370675|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44370676|NCT01197261|Narcotics|narcotics|mesh-ancestor
44370677|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370678|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370679|NCT01197261|Analgesics|analgesics|mesh-ancestor
44370680|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
44370681|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370682|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44370683|NCT01197469|Tadalafil|tadalafil|mesh-list
44370684|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370685|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44370686|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44370687|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370688|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370689|NCT01197469|Urological Agents|urological agents|mesh-ancestor
44370690|NCT01197664|Fluorouracil|fluorouracil|mesh-list
44370691|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
43871312|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871313|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43871314|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43871315|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871316|NCT04769258|Vaccines|vaccines|mesh-list
43871317|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
43871318|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871319|NCT04769297|Ketamine|ketamine|mesh-list
43871320|NCT04769297|Analgesics|analgesics|mesh-ancestor
43669070|NCT02908126|Oxytocin|oxytocin|mesh-list
43871321|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
43871322|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871323|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871324|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43871325|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43871326|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
43871327|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
43871328|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871329|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43871330|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43871331|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871332|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871333|NCT04769076|Paclitaxel|paclitaxel|mesh-list
43871334|NCT04769076|Cisplatin|cisplatin|mesh-list
43649690|NCT03019081|Protective Agents|protective agents|mesh-ancestor
43871335|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43871336|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871337|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871338|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871339|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871340|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871341|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871342|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
43871343|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43871344|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871345|NCT04768764|Bupivacaine|bupivacaine|mesh-list
43871346|NCT04768764|Anesthetics|anesthetics|mesh-list
43871347|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
43871348|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370692|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370693|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370694|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370695|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370696|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
44370697|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026127|NCT00074724|Dobutamine|dobutamine|mesh-list
44370698|NCT01197781|Verapamil|verapamil|mesh-list
44370699|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44370700|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370701|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370702|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370703|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370704|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370705|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
44370706|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43871349|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871350|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
43871351|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871352|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
43871353|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43871354|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871355|NCT04768465|Prednisone|prednisone|mesh-list
43871356|NCT04768465|Bromides|bromides|mesh-list
43871357|NCT04768465|Tacrolimus|tacrolimus|mesh-list
43871358|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43871359|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871360|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
43871361|NCT04768465|Hormones|hormones|mesh-ancestor
43871362|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871363|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649700|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43649703|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824400|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43824401|NCT05512702|Tinzaparin|tinzaparin|mesh-list
43824402|NCT05512702|Dalteparin|dalteparin|mesh-list
43824403|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
43824404|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43608705|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43608706|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43661290|NCT02924727|Valsartan|valsartan|mesh-list
43661291|NCT02924727|Ramipril|ramipril|mesh-list
43871367|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
43871368|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43871369|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871370|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871371|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
43871372|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43871373|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
43871374|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871375|NCT04768231|Rifampin|rifampin|mesh-list
43871376|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43871377|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
43871378|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871379|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871380|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
43871381|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43871382|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871383|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871384|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43871385|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43871386|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43871387|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43871388|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43871389|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43871390|NCT04768075|Paclitaxel|paclitaxel|mesh-list
43871391|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43871392|NCT04768075|Cisplatin|cisplatin|mesh-list
44370708|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44370709|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44370710|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44370711|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370712|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370713|NCT01198054|Lenalidomide|lenalidomide|mesh-list
43608707|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608708|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43608744|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608745|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
43608746|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
43608747|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608748|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608749|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608750|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
43608751|NCT03194594|Hormones|hormones|mesh-ancestor
43661300|NCT02924311|Aflibercept|aflibercept|mesh-list
44370714|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
44370715|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370716|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43871393|NCT04768075|Carboplatin|carboplatin|mesh-list
43871394|NCT04768075|Pemetrexed|pemetrexed|mesh-list
43871395|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871396|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871397|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871398|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871399|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871400|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871401|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871402|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43871403|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43871404|NCT04768439|Vitamin D|vitamin d|mesh-list
43871405|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
43871406|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
43871407|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43871408|NCT04768439|Calcitriol|calcitriol|mesh-list
43871409|NCT04768439|Vitamins|vitamins|mesh-list
43871410|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
43871411|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871412|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43871413|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871414|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43871415|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871416|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871417|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43871418|NCT04768023|Vitamin D|vitamin d|mesh-list
43871419|NCT04768023|Vitamins|vitamins|mesh-ancestor
43871420|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
43608780|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608782|NCT03194204|Uric Acid|uric acid|mesh-list
43608783|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
43608784|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43608785|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824405|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824406|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824407|NCT05512546|Aspirin|aspirin|mesh-list
43871421|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871422|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44135025|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
44135026|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135027|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135028|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135029|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44135030|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44135031|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44135032|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135033|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44135034|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
44135035|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
44135040|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44135041|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135042|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
44135043|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
43871423|NCT04767828|Capecitabine|capecitabine|mesh-list
43871424|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43871425|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
43871426|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871427|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871428|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
43871429|NCT04767633|Analgesics|analgesics|mesh-ancestor
43871430|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
43871431|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370717|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44370718|NCT01198054|Growth Substances|growth substances|mesh-ancestor
44370719|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
44370720|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370721|NCT01198106|Cinnarizine|cinnarizine|mesh-list
44370722|NCT01198106|Scopolamine|scopolamine|mesh-list
44370723|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44370724|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44370725|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
44370726|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
44370727|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370728|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370729|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370730|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
44370731|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44370732|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
44370733|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370734|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370735|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44370736|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
44370737|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44370738|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370739|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871432|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871433|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
43871434|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871435|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43871436|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
43871437|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43871438|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871439|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871440|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871441|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
43871442|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43871443|NCT04767295|Paclitaxel|paclitaxel|mesh-list
43871444|NCT04767295|Carboplatin|carboplatin|mesh-list
43871445|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871446|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871447|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871448|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871449|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871450|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871451|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
43871452|NCT04767308|Fludarabine|fludarabine|mesh-list
43871453|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871454|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
43871455|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871456|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871457|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871458|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
43556701|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44370740|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44370741|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
44370742|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
44370743|NCT01198184|Sirolimus|sirolimus|mesh-list
44370744|NCT01198184|R04929097|r04929097|mesh-list
44370745|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370746|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370747|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43608791|NCT03194204|Protective Agents|protective agents|mesh-ancestor
44370748|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370749|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
44370750|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370751|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
44370752|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370753|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370754|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370755|NCT01198210|Dexamethasone|dexamethasone|mesh-list
44370756|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
44370757|NCT01198210|Ketamine|ketamine|mesh-list
44370758|NCT01198210|BB 1101|bb 1101|mesh-list
44370759|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370760|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
44370761|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
43871459|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871460|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871461|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43871462|NCT04767178|Acetaminophen|acetaminophen|mesh-list
43871463|NCT04767178|Ibuprofen|ibuprofen|mesh-list
43871464|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43871465|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871466|NCT04767178|Analgesics|analgesics|mesh-ancestor
43871467|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
43871468|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871469|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871470|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871471|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871472|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43871473|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871474|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871475|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
43871476|NCT04767542|Acetaminophen|acetaminophen|mesh-list
43871477|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871478|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871479|NCT04767542|Analgesics|analgesics|mesh-ancestor
43871480|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
43871481|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871482|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
43871483|NCT04767035|Midazolam|midazolam|mesh-list
43871484|NCT04767035|Ketamine|ketamine|mesh-list
43871485|NCT04767035|Analgesics|analgesics|mesh-ancestor
43871488|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871489|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43871490|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43871491|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
43871492|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
43871493|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871494|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43826787|NCT05494411|Mitomycins|mitomycins|mesh-list
44370762|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608892|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
43608893|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
43608894|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608896|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44370763|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370764|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44370765|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
44370766|NCT01198210|Hormones|hormones|mesh-ancestor
44370767|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370768|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370769|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370770|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
44370771|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370772|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370773|NCT01198210|Analgesics|analgesics|mesh-ancestor
44370774|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
44370775|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43871495|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43871496|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155721|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
43871497|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871498|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43871499|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43871500|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43871501|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43871502|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871503|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
43871504|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
43871505|NCT04766827|Paclitaxel|paclitaxel|mesh-list
43871506|NCT04766827|Docetaxel|docetaxel|mesh-list
43871507|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43871508|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871509|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871510|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871511|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871512|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871513|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871514|NCT04766775|Fluorides|fluorides|mesh-list
43871515|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
43871516|NCT04766775|Protective Agents|protective agents|mesh-ancestor
43871517|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871518|NCT04766736|Antibodies|antibodies|mesh-list
43871519|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
43871520|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871521|NCT04766307|Interleukin-2|interleukin-2|mesh-list
43871522|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871523|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871524|NCT04766307|Analgesics|analgesics|mesh-ancestor
43871525|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
43871526|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871527|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871528|NCT04766359|Paclitaxel|paclitaxel|mesh-list
43871529|NCT04766359|Cisplatin|cisplatin|mesh-list
43871530|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43871531|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871532|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871533|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871534|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871535|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871536|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871537|NCT04766177|Bumetanide|bumetanide|mesh-list
43871538|NCT04766177|Diuretics|diuretics|mesh-ancestor
43871539|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
43871540|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370776|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44370777|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
44370778|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
44370779|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370780|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43661373|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44370781|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44370782|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370783|NCT01198223|Nystatin|nystatin|mesh-list
44370784|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44370785|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370786|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
44370787|NCT01198223|Ionophores|ionophores|mesh-ancestor
44370788|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370789|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370790|NCT01198236|Itraconazole|itraconazole|mesh-list
44370791|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
44370792|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370793|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44370794|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44370795|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370796|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370797|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44370798|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
44370799|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370800|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370801|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44370820|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370821|NCT01198340|Ropivacaine|ropivacaine|mesh-list
44370822|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
44370823|NCT01198340|Anesthetics|anesthetics|mesh-list
43824416|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43824417|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824418|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608897|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608898|NCT03193372|Azelaic acid|azelaic acid|mesh-list
43608899|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608900|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
43608901|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
43608902|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43608903|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
43608921|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43608922|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608923|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608924|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
44370824|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370825|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370826|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
44370827|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370828|NCT01198353|Ziprasidone|ziprasidone|mesh-list
44370829|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44370830|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
44370831|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44370832|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370833|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370834|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44370835|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44370836|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370837|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44370838|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44370839|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
44370840|NCT01198379|Aspirin|aspirin|mesh-list
44370841|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44370842|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44370843|NCT01198379|Analgesics|analgesics|mesh-ancestor
44370844|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
44370845|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370846|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370847|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370848|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44370849|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44370850|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44370851|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370852|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44370853|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44370854|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871541|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43871542|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370855|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
44370856|NCT01198392|Cisplatin|cisplatin|mesh-list
44370857|NCT01198392|Tegafur|tegafur|mesh-list
44370858|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370859|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370860|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
44370861|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370862|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44370863|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44370864|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370865|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
44370866|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44370867|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871543|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871544|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
43871545|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
43608933|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871546|NCT04765904|Fluorides|fluorides|mesh-list
43871547|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
43871548|NCT04765904|Protective Agents|protective agents|mesh-ancestor
43871549|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871550|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
43871551|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43871552|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871553|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871554|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871555|NCT04766047|Analgesics|analgesics|mesh-ancestor
43871556|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
43871557|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871559|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43871560|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43871561|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871562|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826791|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
43871563|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871565|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43871566|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43871567|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43871568|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871569|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871570|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871571|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871572|NCT04766021|Urological Agents|urological agents|mesh-ancestor
43871573|NCT04765267|Vitamin D|vitamin d|mesh-list
43871574|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
43871575|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
43871576|NCT04765267|Vitamins|vitamins|mesh-ancestor
43871577|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
43871578|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871579|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43871580|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871581|NCT04765267|Astringents|astringents|mesh-ancestor
43871582|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
43871583|NCT04765527|Turmeric extract|turmeric extract|mesh-list
43871584|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
43871585|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871586|NCT04765527|Protective Agents|protective agents|mesh-ancestor
43871587|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871588|NCT04765228|Doxorubicin|doxorubicin|mesh-list
43871589|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43871590|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43871591|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370868|NCT01198496|Losartan|losartan|mesh-list
44370869|NCT01198496|Amlodipine|amlodipine|mesh-list
44370870|NCT01198496|Valsartan|valsartan|mesh-list
44370871|NCT01198496|Telmisartan|telmisartan|mesh-list
44370872|NCT01198496|Candesartan|candesartan|mesh-list
44370873|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
44370874|NCT01198496|Olmesartan|olmesartan|mesh-list
44370875|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44370876|NCT01198496|Spironolactone|spironolactone|mesh-list
44370877|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44370878|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43871592|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43871593|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43608942|NCT03193307|BI 409306|bi 409306|mesh-list
43871594|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871595|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871596|NCT04765085|Aripiprazole|aripiprazole|mesh-list
43871597|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
43871598|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871599|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43871600|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43871601|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871602|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871603|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
43871604|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
43871605|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871606|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871607|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43871608|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43871609|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
43871610|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43871611|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43871612|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43871613|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44135044|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135045|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135046|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44135047|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135048|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135049|NCT00159809|Urological Agents|urological agents|mesh-ancestor
44135050|NCT00159835|Atorvastatin|atorvastatin|mesh-list
44135051|NCT00159835|Simvastatin|simvastatin|mesh-list
44135052|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44135053|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44135054|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
44135055|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135056|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44135057|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44135058|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135062|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44135063|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135064|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608950|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43608951|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43608952|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43608953|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43608954|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43608955|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43608956|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43608957|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43608959|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43846679|NCT04182984|Hormones|hormones|mesh-ancestor
44135065|NCT00159887|Urological Agents|urological agents|mesh-ancestor
44135066|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
44135067|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135068|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135069|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44135070|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135071|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135072|NCT00159900|Urological Agents|urological agents|mesh-ancestor
44135073|NCT00159952|Insulin|insulin|mesh-list
44135074|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44135075|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871614|NCT04764955|Vitamin D|vitamin d|mesh-list
43871615|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
43871616|NCT04764955|Vitamins|vitamins|mesh-ancestor
43871617|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
43871618|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370879|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44370880|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370881|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44370882|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370884|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44370885|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44370886|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44412298|NCT02422303|Analgesics|analgesics|mesh-ancestor
43871619|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43871620|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871621|NCT04764825|Morphine|morphine|mesh-list
43871622|NCT04764825|Methadone|methadone|mesh-list
43871623|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43871624|NCT04764825|Narcotics|narcotics|mesh-ancestor
43871625|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871626|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871627|NCT04764825|Analgesics|analgesics|mesh-ancestor
43871628|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
43871629|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871630|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
43871631|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
43871632|NCT04765098|Tamoxifen|tamoxifen|mesh-list
43871633|NCT04765098|Etoposide|etoposide|mesh-list
43871634|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871635|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871636|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43849313|NCT03941730|Estrogens|estrogens|mesh-ancestor
43849314|NCT03941730|Hormones|hormones|mesh-ancestor
43849315|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824419|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43824420|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824421|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824422|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
43846700|NCT04182555|Bilirubin|bilirubin|mesh-list
43871637|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43871638|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871639|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871640|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43871641|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
43871642|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871643|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871644|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871645|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43871646|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43871647|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43871648|NCT04764916|Bupivacaine|bupivacaine|mesh-list
43871649|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
43871650|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
43871651|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871652|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871653|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
43871654|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871655|NCT04764851|Ecopipam|ecopipam|mesh-list
43871656|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43871657|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43871658|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871659|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871660|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871661|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43871662|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
43871663|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871664|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871665|NCT04764396|Heparin|heparin|mesh-list
43871666|NCT04764396|Calcium heparin|calcium heparin|mesh-list
43871667|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
43871668|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43871675|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871676|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871677|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702464|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
44370887|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44370888|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
44370889|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849317|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43609020|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
43849318|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
43849319|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44370890|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44370891|NCT01198496|Diuretics|diuretics|mesh-ancestor
44370892|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
44370893|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43871678|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871679|NCT04764344|Haloperidol|haloperidol|mesh-list
43871680|NCT04764344|Ondansetron|ondansetron|mesh-list
43871681|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
43871682|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
43871683|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
43871684|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871685|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871686|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871687|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
43871688|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
43871689|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43871690|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
43871691|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871692|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871693|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43871694|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43871695|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871696|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871697|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43871698|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43871699|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
43871700|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43871701|NCT04764383|Histamine|histamine|mesh-list
43871702|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
43871703|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
43871704|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871705|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871706|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871707|NCT04764084|Niraparib|niraparib|mesh-list
43871708|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43871709|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871710|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871711|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871712|NCT04764214|Osimertinib|osimertinib|mesh-list
43871713|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871714|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43609061|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43609062|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43609063|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43609064|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871715|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871716|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871717|NCT04764045|Ropivacaine|ropivacaine|mesh-list
43871718|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
43871719|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
43871720|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871721|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871722|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
43871723|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871724|NCT04763876|Ketorolac|ketorolac|mesh-list
43871725|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43871726|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43871727|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871729|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
43871730|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871731|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871732|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871733|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871734|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43871735|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871736|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558871|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44370894|NCT01198535|Cetuximab|cetuximab|mesh-list
44370895|NCT01198535|Antibodies|antibodies|mesh-list
44370896|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
44370897|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44370898|NCT01198535|R04929097|r04929097|mesh-list
44370899|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
43871737|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
43871741|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871742|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871743|NCT04763434|Dexamethasone|dexamethasone|mesh-list
43871744|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
43871745|NCT04763434|Ropivacaine|ropivacaine|mesh-list
43871746|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871747|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
43871748|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
43871749|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871750|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871751|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871752|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
43871753|NCT04763434|Hormones|hormones|mesh-ancestor
43644742|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871754|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871755|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871756|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871757|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43661410|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661411|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661413|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661414|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43871758|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871759|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871760|NCT04763434|Analgesics|analgesics|mesh-ancestor
43871761|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
43871762|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43871763|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43871764|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43871765|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871766|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871767|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871768|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
43871769|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
43871770|NCT04763486|Cefazolin|cefazolin|mesh-list
43871771|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871772|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871773|NCT04763616|Cemiplimab|cemiplimab|mesh-list
43871774|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871775|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871776|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
43871777|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43871778|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43871779|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43871780|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43669087|NCT02907749|Spironolactone|spironolactone|mesh-list
43871781|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871782|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
43871783|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871784|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871785|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43871786|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871787|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
43871788|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871789|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871790|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43871791|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43871792|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370902|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370903|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370904|NCT01198639|Remifentanil|remifentanil|mesh-list
44370905|NCT01198639|Propofol|propofol|mesh-list
44370906|NCT01198639|Anesthetics|anesthetics|mesh-list
44370907|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44370908|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44370909|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370910|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44370911|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
44370912|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43871793|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609101|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43609102|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609103|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609104|NCT03192293|Metformin|metformin|mesh-list
43609105|NCT03192293|Fulvestrant|fulvestrant|mesh-list
43609106|NCT03192293|Simvastatin|simvastatin|mesh-list
43871794|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871795|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43871796|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43871797|NCT04763057|Calcium|calcium|mesh-list
43871802|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
43871803|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871804|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43871805|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871806|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871807|NCT04762992|Enoxaparin|enoxaparin|mesh-list
43871808|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
43871809|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43871810|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43871811|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871812|NCT04762966|Metformin|metformin|mesh-list
43871813|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43871814|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871815|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
43871816|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
43871817|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871818|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
43871819|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871820|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871821|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871822|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
43871823|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871824|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871825|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43871826|NCT04762810|Hormones|hormones|mesh-ancestor
43871827|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871828|NCT04762745|Thalidomide|thalidomide|mesh-list
43871829|NCT04762745|Dexamethasone|dexamethasone|mesh-list
43871830|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
43871831|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43871832|NCT04762745|Pomalidomide|pomalidomide|mesh-list
43871833|NCT04762745|BB 1101|bb 1101|mesh-list
43871834|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871835|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
43871836|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
43871837|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871838|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871839|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871840|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
43871841|NCT04762745|Hormones|hormones|mesh-ancestor
43871842|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871843|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370913|NCT01198639|Narcotics|narcotics|mesh-ancestor
44370914|NCT01198639|Analgesics|analgesics|mesh-ancestor
43609110|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609111|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
43609112|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609113|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609114|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43609115|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609118|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43609119|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43609120|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
43609121|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370915|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
44370916|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44370917|NCT01198665|Prednisolone|prednisolone|mesh-list
44370918|NCT01198665|Doxorubicin|doxorubicin|mesh-list
44370919|NCT01198665|Vincristine|vincristine|mesh-list
44370920|NCT01198665|Everolimus|everolimus|mesh-list
43871844|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871845|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
43871846|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669094|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
43871847|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871848|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871849|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
43871850|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
43871851|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43871852|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43871853|NCT04762745|Growth Substances|growth substances|mesh-ancestor
43871854|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
43871855|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871856|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
43871857|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871858|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871859|NCT04762511|Vaccines|vaccines|mesh-list
43871860|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
43871861|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871862|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
43871863|NCT04762784|Hormones|hormones|mesh-ancestor
43871864|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871865|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871871|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871872|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871874|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871875|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
43609122|NCT03192332|Plasminogen|plasminogen|mesh-list
43609123|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43609124|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43609125|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824424|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824425|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
43824426|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824427|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649704|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43661474|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
43661475|NCT02922803|Vitamins|vitamins|mesh-list
43661476|NCT02922803|Calcium|calcium|mesh-list
43661477|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
43661478|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661479|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661480|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43661481|NCT02922686|Floxacillin|floxacillin|mesh-list
43661482|NCT02922686|Penicillin V|penicillin v|mesh-list
43661483|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871876|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871877|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871878|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
43871879|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871880|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871881|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871882|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
43871883|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43871884|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43871885|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43871886|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43871887|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871888|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44135076|NCT00159978|Alovudine|alovudine|mesh-list
44135077|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
44135078|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135079|NCT00160030|Cisplatin|cisplatin|mesh-list
44135080|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135081|NCT00160043|Vatalanib|vatalanib|mesh-list
44135082|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43649705|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649706|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135083|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135084|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135085|NCT00160069|Sagopilone|sagopilone|mesh-list
44135086|NCT00160069|Epothilones|epothilones|mesh-list
44135087|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135088|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871889|NCT04761952|Azathioprine|azathioprine|mesh-list
43871890|NCT04761952|Infliximab|infliximab|mesh-list
43871891|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
43871892|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871893|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43871894|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
43871895|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871896|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559464|NCT03729362|Miglustat|miglustat|mesh-list
44370921|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44026367|NCT00000160|Xenon|xenon|mesh-list
44370922|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649707|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
43649708|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43649709|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43649711|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
44370923|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44370924|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44370925|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370926|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370927|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44370928|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
44370929|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
44370930|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44370931|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370932|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
44370933|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871897|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871898|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871899|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
43871900|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871901|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
43871902|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871903|NCT04762030|Paclitaxel|paclitaxel|mesh-list
43871904|NCT04762030|Carboplatin|carboplatin|mesh-list
43871905|NCT04762030|Durvalumab|durvalumab|mesh-list
43871906|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871907|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871908|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871909|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871910|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
43609164|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
43609165|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
43609166|NCT03191981|Lenalidomide|lenalidomide|mesh-list
43609167|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609168|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
43871911|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871912|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871913|NCT04762134|Doxycycline|doxycycline|mesh-list
43871914|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43871915|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871916|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
43871917|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43871918|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43871919|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43871920|NCT04761705|Latanoprost|latanoprost|mesh-list
43871921|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43871922|NCT04762147|Acetaminophen|acetaminophen|mesh-list
43871923|NCT04762147|Fentanyl|fentanyl|mesh-list
43871924|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43871925|NCT04762147|Narcotics|narcotics|mesh-ancestor
43871926|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871928|NCT04762147|Analgesics|analgesics|mesh-ancestor
43871929|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
43871930|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871931|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43871932|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43871933|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
43871934|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
43871935|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871936|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
43871937|NCT04761744|Nivolumab|nivolumab|mesh-list
43871938|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871939|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871940|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43871941|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871942|NCT04761731|Tacrolimus|tacrolimus|mesh-list
43871943|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871944|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
43871945|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370935|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
44370937|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609210|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
43609211|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609212|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609213|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609214|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609215|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43609216|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43609217|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609218|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661506|NCT02922673|Analgesics|analgesics|mesh-ancestor
43661507|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
43661508|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661509|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661510|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661511|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661512|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43661513|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43661515|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44370938|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370939|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44370940|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
44370941|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44370942|NCT01198821|Gemcitabine|gemcitabine|mesh-list
44370943|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44370944|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
44370945|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370946|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370947|NCT01198821|Antiviral Agents|antiviral agents|mesh-ancestor
44370948|NCT01198821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370949|NCT01198821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370950|NCT01198821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44370951|NCT01198821|Immunologic Factors|immunologic factors|mesh-ancestor
44370952|NCT01198821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370953|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
44370954|NCT01198860|Tenofovir|tenofovir|mesh-list
44370955|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
44370956|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44370957|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44370958|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44370959|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44370960|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44370961|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44370983|NCT01199029|Prednisone|prednisone|mesh-list
44370984|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44370985|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
44370986|NCT01199029|Hormones|hormones|mesh-ancestor
44370987|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44370988|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44370989|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44370990|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44370991|NCT01199081|Dronedarone|dronedarone|mesh-list
44370992|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43609219|NCT03191383|Vaccines|vaccines|mesh-list
43609220|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
43609221|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609222|NCT03191370|Anesthetics|anesthetics|mesh-list
43609223|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
43609224|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609225|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609226|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
44370993|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
44370994|NCT01199159|Pyridoxal|pyridoxal|mesh-list
44370995|NCT01199159|Pyridoxine|pyridoxine|mesh-list
43681424|NCT03525795|Ipilimumab|ipilimumab|mesh-list
43871946|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43871947|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871948|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871949|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43871950|NCT04761185|Raltitrexed|raltitrexed|mesh-list
43871951|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43871952|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
43871953|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871954|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871955|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43871956|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871957|NCT04761029|Tramadol|tramadol|mesh-list
43871958|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43871959|NCT04761029|Narcotics|narcotics|mesh-ancestor
43871960|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871961|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871962|NCT04761029|Analgesics|analgesics|mesh-ancestor
43871963|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
43871964|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871965|NCT04760821|Trimetazidine|trimetazidine|mesh-list
43871966|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
43871967|NCT04760860|Prazosin|prazosin|mesh-list
43871968|NCT04760860|Terazosin|terazosin|mesh-list
43871969|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43669109|NCT02907593|Budesonide|budesonide|mesh-list
43871970|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43871971|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43871972|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871973|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609227|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609228|NCT03191162|Benzonidazole|benzonidazole|mesh-list
43609229|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609230|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
43609231|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871974|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609232|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43609233|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43609234|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43609235|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609236|NCT03191305|Warfarin|warfarin|mesh-list
43609237|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
43609238|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
43871975|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871976|NCT04760860|Urological Agents|urological agents|mesh-ancestor
43871977|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871978|NCT04760704|Antibodies|antibodies|mesh-list
43871979|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
43871980|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609269|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
43871981|NCT04760574|Testosterone|testosterone|mesh-list
43871982|NCT04760574|Androgens|androgens|mesh-ancestor
43871983|NCT04760574|Hormones|hormones|mesh-ancestor
43871984|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871985|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871986|NCT04760327|Cisplatin|cisplatin|mesh-list
43871987|NCT04760327|Bleomycin|bleomycin|mesh-list
43871988|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871989|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43871990|NCT04760431|Paclitaxel|paclitaxel|mesh-list
43871991|NCT04760431|Docetaxel|docetaxel|mesh-list
44370996|NCT01199159|Misoprostol|misoprostol|mesh-list
44026458|NCT00000195|Naltrexone|naltrexone|mesh-list
44370997|NCT01199159|Vitamins|vitamins|mesh-ancestor
44370998|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
44370999|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371000|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44371001|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
44371002|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371003|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44371004|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871992|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43871993|NCT04760431|Trastuzumab|trastuzumab|mesh-list
43871994|NCT04760431|Pertuzumab|pertuzumab|mesh-list
43871995|NCT04760431|Taxane|taxane|mesh-list
43871996|NCT04760431|Tucatinib|tucatinib|mesh-list
43871997|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871998|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871999|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
43872000|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
43872001|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
43872003|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872004|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43872005|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872006|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
43872007|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43609270|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609271|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609272|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609273|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609274|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43609275|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609276|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851405|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
43851406|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872008|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43872009|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872010|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
43872011|NCT04760301|Coagulants|coagulants|mesh-ancestor
43872012|NCT04759703|Pramipexole|pramipexole|mesh-list
43872013|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
43872014|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872015|NCT04759703|Protective Agents|protective agents|mesh-ancestor
43872016|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872017|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43872018|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43872019|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
43872020|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
43872021|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872022|NCT04759729|Vitamin D|vitamin d|mesh-list
43872023|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
43872024|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
43872025|NCT04759729|Vitamins|vitamins|mesh-list
43872026|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
43872027|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872028|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43872029|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43872030|NCT04759742|Ropivacaine|ropivacaine|mesh-list
43872031|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
43872032|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
43872033|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872034|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872035|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
43872036|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135089|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44135090|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44135091|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135092|NCT00160160|Eprosartan|eprosartan|mesh-list
44135093|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135094|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
43872037|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43872038|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43872039|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872040|NCT04760262|Remifentanil|remifentanil|mesh-list
43872041|NCT04760262|Propofol|propofol|mesh-list
43872042|NCT04760262|Sevoflurane|sevoflurane|mesh-list
43872043|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43872044|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371006|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
44371007|NCT01199224|Veliparib|veliparib|mesh-list
44371008|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44371009|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371010|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609277|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609278|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
43609279|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44371011|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872045|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872046|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43872047|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
43872048|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
43872049|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872050|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43872051|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43872052|NCT04760262|Narcotics|narcotics|mesh-ancestor
43872053|NCT04760262|Analgesics|analgesics|mesh-ancestor
43872054|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
43872055|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872056|NCT04758936|Clonidine|clonidine|mesh-list
43872057|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
43872058|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43872059|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872060|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872061|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872062|NCT04758936|Analgesics|analgesics|mesh-ancestor
43872063|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
43872064|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872065|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43872066|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43872067|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872068|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872069|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872073|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
43872074|NCT04758871|Progesterone|progesterone|mesh-list
43872075|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
43872076|NCT04758871|Progestins|progestins|mesh-ancestor
43872077|NCT04758871|Hormones|hormones|mesh-ancestor
43872078|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872079|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872080|NCT04758858|Glucagon|glucagon|mesh-list
43872081|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872082|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872083|NCT04758858|Hormones|hormones|mesh-ancestor
43872084|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872085|NCT04759079|Antiemetics|antiemetics|mesh-list
43872086|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
43872087|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872088|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872089|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872090|NCT04759196|Topiramate|topiramate|mesh-list
43872091|NCT04759196|Levetiracetam|levetiracetam|mesh-list
43609286|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
43872092|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
43872093|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43872094|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872095|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
43872096|NCT04758689|Methotrexate|methotrexate|mesh-list
43872097|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43872098|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
43872099|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872100|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872101|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43872102|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
43872103|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872104|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872105|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
43872106|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872107|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43872108|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872109|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
44371012|NCT01199276|Sevoflurane|sevoflurane|mesh-list
44371013|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44371014|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44371015|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
44371016|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
44371017|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371018|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371019|NCT01199328|Aspirin|aspirin|mesh-list
43872110|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872111|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43872112|NCT04758728|Epinephrine|epinephrine|mesh-list
43872113|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43872114|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872115|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
43609305|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609306|NCT03190304|Enalapril|enalapril|mesh-list
43609307|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43609308|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43609309|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
43872116|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609310|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609311|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43609312|NCT03189953|Exenatide|exenatide|mesh-list
43609316|NCT03189953|Incretins|incretins|mesh-ancestor
43872117|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872118|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872119|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43872120|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43872121|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
43872122|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872123|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43872124|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
43872125|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
43872126|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
43872127|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43872128|NCT04758260|Antioxidants|antioxidants|mesh-list
43872129|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872130|NCT04758260|Protective Agents|protective agents|mesh-ancestor
43872131|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872132|NCT04758286|Anesthetics|anesthetics|mesh-list
43872133|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872134|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872135|NCT04758273|Vaccines|vaccines|mesh-list
43872136|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
43872137|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872138|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
43609340|NCT03189901|Simendan|simendan|mesh-list
43609341|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43609342|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
43609343|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43609344|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43872139|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43872140|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872144|NCT04757974|Fostemsavir|fostemsavir|mesh-list
43872145|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43872146|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43872147|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
43872148|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872149|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43872150|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43872151|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872152|NCT04757779|Docetaxel|docetaxel|mesh-list
43872153|NCT04757779|Irinotecan|irinotecan|mesh-list
43872154|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872155|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
43872156|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
43872157|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
43872158|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872159|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43872160|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43872161|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872162|NCT04757506|Naltrexone|naltrexone|mesh-list
43872163|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43872164|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43872165|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872166|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
43872167|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872168|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
43872169|NCT04757532|Anastrozole|anastrozole|mesh-list
43872170|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
43872171|NCT04757532|Bupropion|bupropion|mesh-list
43872172|NCT04757532|Testosterone|testosterone|mesh-list
44371020|NCT01199328|Esomeprazole|esomeprazole|mesh-list
44371021|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371022|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371023|NCT01199328|Analgesics|analgesics|mesh-ancestor
44371024|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
44371025|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371026|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371027|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371028|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371029|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44371030|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44371031|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371032|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872173|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
43872174|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
43872175|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43872176|NCT04757532|Danazol|danazol|mesh-list
43872177|NCT04757532|Androgens|androgens|mesh-ancestor
43872178|NCT04757532|Hormones|hormones|mesh-ancestor
43872179|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872180|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872181|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872182|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872183|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
43872184|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43872185|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
43872186|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872187|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44155722|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872188|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43872189|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43872190|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872191|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
43872192|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872193|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43872194|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43872195|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872196|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43872197|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43872198|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43872199|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
43872200|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43872201|NCT04757532|Diuretics|diuretics|mesh-ancestor
43872202|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
43872203|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43872204|NCT04757376|Denosumab|denosumab|mesh-list
43872205|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43872206|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135095|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44135096|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135097|NCT00160186|Pancreatin|pancreatin|mesh-list
44135098|NCT00160186|Pancrelipase|pancrelipase|mesh-list
44135099|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135100|NCT00160238|Betahistine|betahistine|mesh-list
44135107|NCT00160264|Vitamin D|vitamin d|mesh-list
44135108|NCT00160264|Lactulose|lactulose|mesh-list
44135109|NCT00160264|Calcium|calcium|mesh-list
44135110|NCT00160264|Vitamins|vitamins|mesh-ancestor
44135111|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
44371033|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44371034|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371035|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
44371036|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44371037|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44371038|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44371039|NCT01199341|Warfarin|warfarin|mesh-list
44371040|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
44371041|NCT01199367|Letrozole|letrozole|mesh-list
44371042|NCT01199367|Lapatinib|lapatinib|mesh-list
44371043|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371044|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44371045|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44135112|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135113|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44135114|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44135115|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135116|NCT00160277|Moxonidine|moxonidine|mesh-list
44135117|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135118|NCT00160290|Lactulose|lactulose|mesh-list
44135119|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135120|NCT00160316|Estradiol|estradiol|mesh-list
44135121|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
44135122|NCT00160316|Estrogens|estrogens|mesh-ancestor
44135123|NCT00160316|Hormones|hormones|mesh-ancestor
44135124|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135125|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135126|NCT00160316|Progestins|progestins|mesh-ancestor
44135127|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44135128|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44135129|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44135130|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
44135131|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135132|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135133|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44135134|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44135135|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
43609490|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
43609516|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
43609517|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
43609518|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609519|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43609520|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43661665|NCT02921360|Aspirin|aspirin|mesh-list
43661666|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661667|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661668|NCT02921360|Analgesics|analgesics|mesh-ancestor
43661669|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
43661670|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661671|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661672|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661673|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661674|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43661675|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43661676|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661677|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43661678|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44135136|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135138|NCT00160342|Estrogens|estrogens|mesh-list
44135139|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
44135140|NCT00160342|Estrone|estrone|mesh-list
44135141|NCT00160342|Testosterone|testosterone|mesh-list
44135142|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
44135143|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
44135144|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44135145|NCT00160342|Hormones|hormones|mesh-ancestor
44135146|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135147|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135148|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135149|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135150|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
44135151|NCT00160342|Androgens|androgens|mesh-ancestor
43872207|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43872208|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43872209|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43872210|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43872211|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872212|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
43872213|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872214|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872215|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43872216|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872217|NCT04756895|Vancomycin|vancomycin|mesh-list
43872218|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43872219|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371046|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371047|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371048|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43649737|NCT03018626|Vincristine|vincristine|mesh-list
43649738|NCT03018626|Bleomycin|bleomycin|mesh-list
43649739|NCT03018626|Vindesine|vindesine|mesh-list
43649740|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649741|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
43649742|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649743|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649744|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43649745|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
43661679|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661680|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
43661681|NCT02921204|Vitamin D|vitamin d|mesh-list
43661682|NCT02921204|Vitamins|vitamins|mesh-ancestor
43661683|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
43661684|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661685|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43661686|NCT02921191|Lenograstim|lenograstim|mesh-list
43661687|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43661688|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
43661689|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661690|NCT02921178|Omalizumab|omalizumab|mesh-list
44371049|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
44371050|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371051|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371052|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44371053|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
44371054|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
44371055|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
43872220|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
43872221|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43872222|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
43872223|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872224|NCT04756622|Expectorants|expectorants|mesh-ancestor
43872225|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
43872226|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43872227|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
43872234|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872235|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
43872236|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872237|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872238|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872239|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
43872240|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872241|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872242|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43872243|NCT04756661|Misoprostol|misoprostol|mesh-list
43872244|NCT04756661|Oxytocin|oxytocin|mesh-list
43872245|NCT04756661|Carbetocin|carbetocin|mesh-list
43872246|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
43872247|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872248|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872249|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43872250|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
43872251|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43872252|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872253|NCT04756323|Vaccines|vaccines|mesh-list
43872254|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
43669131|NCT02907554|Cyclosporins|cyclosporins|mesh-list
43872255|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872256|NCT04756206|Dutasteride|dutasteride|mesh-list
43872257|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43872258|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43872259|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872260|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872261|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
43872262|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872263|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872264|NCT04756089|Oxytocin|oxytocin|mesh-list
43872265|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
43872266|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872267|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872268|NCT04755868|Talazoparib|talazoparib|mesh-list
43872269|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43872270|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872271|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872272|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872273|NCT04756050|Epinephrine|epinephrine|mesh-list
43872274|NCT04756050|Racepinephrine|racepinephrine|mesh-list
43872275|NCT04756050|Bupivacaine|bupivacaine|mesh-list
43872276|NCT04756050|Prilocaine|prilocaine|mesh-list
43872277|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43872278|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
43872279|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
43872280|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
44371056|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371057|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371058|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
44371059|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371060|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
44371062|NCT01199432|Epirubicin|epirubicin|mesh-list
44371063|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371064|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
44371065|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371066|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371067|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44371068|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
44371069|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371070|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371071|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44371072|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
44371073|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371074|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371075|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44371076|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44371077|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371078|NCT01199445|Vitamin A|vitamin a|mesh-list
44371079|NCT01199445|Vitamins|vitamins|mesh-ancestor
44371080|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
44371106|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44371107|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44371108|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44371109|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371110|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371111|NCT01199523|Urological Agents|urological agents|mesh-ancestor
44371112|NCT01199562|Valganciclovir|valganciclovir|mesh-list
44371113|NCT01199562|Ganciclovir|ganciclovir|mesh-list
44371114|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44371115|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
44371117|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44371118|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371119|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44371120|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649746|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649747|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649748|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43649749|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649750|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43649751|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43649752|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43649753|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649763|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
43649764|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43649765|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43649766|NCT03018535|Prednisolone|prednisolone|mesh-list
43661727|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661728|NCT02920801|Incretins|incretins|mesh-ancestor
43661729|NCT02920801|Hormones|hormones|mesh-ancestor
43661730|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661731|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44371121|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371122|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44371123|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
44371124|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371125|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371126|NCT01199757|Fluticasone|fluticasone|mesh-list
44371127|NCT01199757|Xhance|xhance|mesh-list
44371128|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
44371129|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609521|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
43609522|NCT03187691|Amphotericin B|amphotericin b|mesh-list
43609523|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43609524|NCT03187691|Amebicides|amebicides|mesh-ancestor
43609525|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43609526|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43609527|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609528|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43609529|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
43609530|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
43609531|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43609532|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43661741|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
43661742|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661743|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661744|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43661745|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43661746|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661747|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562911|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44371130|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371131|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
44371132|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371133|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371134|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44371135|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371136|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371137|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44371138|NCT01199783|Vancomycin|vancomycin|mesh-list
44371149|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371150|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371151|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44371152|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371153|NCT01200004|Lenalidomide|lenalidomide|mesh-list
44371154|NCT01200004|Azacitidine|azacitidine|mesh-list
44371155|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
44371156|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371157|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371158|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371159|NCT01200004|Growth Substances|growth substances|mesh-ancestor
43681556|NCT03367572|Dexamethasone|dexamethasone|mesh-list
43872281|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872282|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872283|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
43872284|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872285|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43872286|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872287|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872288|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872289|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872290|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43872291|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43872292|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
43872293|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43872294|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
43872295|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
43872296|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
43872299|NCT04755543|Fluorouracil|fluorouracil|mesh-list
43872300|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872301|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
43872302|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872303|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43872304|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872305|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
43872306|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872307|NCT04755322|Aspirin|aspirin|mesh-list
43872308|NCT04755322|Folic Acid|folic acid|mesh-list
43872309|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
43872310|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43872311|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872312|NCT04755322|Analgesics|analgesics|mesh-ancestor
43872313|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
43872314|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872315|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872316|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872317|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872318|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43872319|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43872320|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872321|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872322|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43872323|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872324|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
43661748|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43661749|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43661750|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43669144|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
43872325|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
43872326|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43872327|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872328|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872329|NCT04755322|Hematinics|hematinics|mesh-ancestor
43872330|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
43872331|NCT04755322|Vitamins|vitamins|mesh-ancestor
44371160|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371161|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371162|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371163|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
44371164|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371165|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371166|NCT01200056|Atorvastatin|atorvastatin|mesh-list
44371167|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44371168|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44371169|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
43681565|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
43872332|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
43872333|NCT04755387|Ticagrelor|ticagrelor|mesh-list
43872334|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872335|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43872336|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43872337|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43872338|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
43872339|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609534|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609535|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849335|NCT03937843|Cisplatin|cisplatin|mesh-list
43849336|NCT03937843|Carboplatin|carboplatin|mesh-list
43609536|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
43609537|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609538|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609539|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43609540|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661763|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661764|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43661765|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661766|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43661767|NCT02920710|Hormones|hormones|mesh-ancestor
43661768|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661769|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661770|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
43661771|NCT02920502|Vitamin D|vitamin d|mesh-list
43661772|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661773|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661774|NCT02920502|Vitamins|vitamins|mesh-ancestor
43872340|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872341|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872342|NCT04755062|Micronutrients|micronutrients|mesh-list
43872343|NCT04755062|Trace Elements|trace elements|mesh-list
43872344|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872345|NCT04754763|Propolis|propolis|mesh-list
43872346|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872347|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43872348|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43872349|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43872350|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872351|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872352|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872353|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43872354|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43872355|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
43872356|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872357|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135152|NCT00160355|Fludarabine|fludarabine|mesh-list
43609576|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609607|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
43609608|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
43609609|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849337|NCT03937843|Etoposide|etoposide|mesh-list
43609610|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609611|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43609612|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43609613|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
43609614|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609615|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43609616|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609617|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43609618|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43609620|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43872358|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43872359|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43872360|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
43872361|NCT04754789|Aspirin|aspirin|mesh-list
43609656|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43609657|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
43872362|NCT04754789|Ticagrelor|ticagrelor|mesh-list
43872363|NCT04754789|Atorvastatin|atorvastatin|mesh-list
43872364|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43872365|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872366|NCT04754789|Analgesics|analgesics|mesh-ancestor
43872367|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
43872368|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872369|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872372|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43872373|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43872374|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872375|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872376|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43872377|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872379|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43872380|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43872381|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
43872382|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43872383|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43872384|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43872385|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43560897|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
44371170|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609658|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43609659|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609660|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43609661|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
43649769|NCT03018535|Rituximab|rituximab|mesh-list
44371171|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44371172|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44371173|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371175|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371176|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371177|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
44371178|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371179|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371180|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44371181|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371182|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
44371183|NCT01200108|Hormones|hormones|mesh-ancestor
44371184|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872386|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43872387|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
43872388|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872389|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
43872390|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43872391|NCT04753918|Trioxsalen|trioxsalen|mesh-list
43872392|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872393|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
43872394|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44135154|NCT00160355|Thiotepa|thiotepa|mesh-list
44135155|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135156|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135157|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135158|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
44135159|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135160|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44135161|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
44135162|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44135163|NCT00160394|Adapalene|adapalene|mesh-list
44135164|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44135165|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44135166|NCT00160394|Analgesics|analgesics|mesh-ancestor
44135167|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
44135168|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135169|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609691|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43609692|NCT03186313|Ribavirin|ribavirin|mesh-list
43609693|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
43609694|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
43609695|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135170|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135171|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135172|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135173|NCT00160407|Orlistat|orlistat|mesh-list
44135174|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135175|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135176|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44135177|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44135178|NCT00160485|Glyburide|glyburide|mesh-list
44135179|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44135180|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135181|NCT00160498|Lercanidipine|lercanidipine|mesh-list
44135182|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135183|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44135184|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135185|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135186|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44135187|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371185|NCT01200121|Bevacizumab|bevacizumab|mesh-list
44371186|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371187|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371188|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371189|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371190|NCT01200121|Growth Substances|growth substances|mesh-ancestor
44371191|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371192|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371193|NCT01200186|Progestins|progestins|mesh-list
44371194|NCT01200186|Hormones|hormones|mesh-ancestor
44371195|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371196|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371197|NCT01200212|Bevacizumab|bevacizumab|mesh-list
44371198|NCT01200212|Taxane|taxane|mesh-list
44371199|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371200|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371201|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371202|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371203|NCT01200212|Growth Substances|growth substances|mesh-ancestor
44371204|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371205|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371206|NCT01200251|Bimatoprost|bimatoprost|mesh-list
44371207|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44371208|NCT01200264|Apremilast|apremilast|mesh-list
44371209|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371210|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44135188|NCT00160511|Levetiracetam|levetiracetam|mesh-list
44135189|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
44135190|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
44135191|NCT00160537|Levocetirizine|levocetirizine|mesh-list
43872395|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
43872396|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43872397|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
43872398|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43872399|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
43872400|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872401|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872402|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
43872403|NCT04753619|Niclosamide|niclosamide|mesh-list
43872404|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
43872411|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43661833|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661834|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661835|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661837|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661838|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43661839|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43872412|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43872413|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872414|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
43872415|NCT04753151|Coagulants|coagulants|mesh-ancestor
43872417|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43872418|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43872419|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43872420|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43560898|NCT03117751|Hormones|hormones|mesh-ancestor
44371212|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
44371213|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371214|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371215|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371216|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371217|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44371218|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44371219|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371220|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371221|NCT01200472|Apremilast|apremilast|mesh-list
43681614|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
43872421|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872422|NCT04753203|Capecitabine|capecitabine|mesh-list
43872423|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43872424|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
43669154|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43872425|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609701|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609702|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
43609703|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43609704|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43609705|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
43609706|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609707|NCT03186443|Pregabalin|pregabalin|mesh-list
43609708|NCT03186443|Gabapentin|gabapentin|mesh-list
43609709|NCT03186443|Analgesics|analgesics|mesh-ancestor
43851446|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
43851447|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872426|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872427|NCT04753177|Paclitaxel|paclitaxel|mesh-list
43872428|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
43872429|NCT04753177|Doxorubicin|doxorubicin|mesh-list
43872430|NCT04753177|Fulvestrant|fulvestrant|mesh-list
43872431|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43872432|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43872433|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872434|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
43872435|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
43872436|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
43872437|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872438|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872439|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
43872440|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872441|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872442|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43872443|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
43872444|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43872445|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43872446|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43872447|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43872448|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872449|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872450|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43872451|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43872452|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
43872453|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872454|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
43872455|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43872456|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
43872457|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872458|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43872459|NCT04753008|Dopamine|dopamine|mesh-list
43872460|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43872461|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
43609710|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
43609711|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609712|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609713|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
43609714|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43609715|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609716|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609717|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43609718|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43609752|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
43851448|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872462|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
43872463|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872464|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872465|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
43872466|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872467|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371222|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371223|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371224|NCT01200472|Analgesics|analgesics|mesh-ancestor
44371225|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
44371226|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371227|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371228|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371229|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371230|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44371231|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44371232|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371233|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371234|NCT01200537|Norinyl|norinyl|mesh-list
44371235|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
44371236|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
44371237|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43872468|NCT04753008|Protective Agents|protective agents|mesh-ancestor
43872469|NCT04753294|Diazepam|diazepam|mesh-list
43872470|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43872471|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
43872474|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872475|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872476|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872477|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43872478|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872479|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43872480|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43872481|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43872482|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43872483|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872484|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43872485|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
43872486|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
43609753|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609754|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609755|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609756|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609757|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43609758|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609759|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609791|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609792|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609793|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
43872487|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
43872488|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
43872489|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872490|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872491|NCT04752852|Dexamethasone|dexamethasone|mesh-list
43872492|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872493|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
43872494|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
43872495|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872496|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669160|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
43872497|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872498|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
43872499|NCT04752852|Hormones|hormones|mesh-ancestor
43872500|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872501|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872502|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872503|NCT04752111|Esmolol|esmolol|mesh-list
43872504|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43872505|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43872506|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43872507|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872508|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872509|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562322|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44371238|NCT01200537|Estradiol|estradiol|mesh-list
44371239|NCT01200537|Estrogens|estrogens|mesh-ancestor
44371240|NCT01200537|Hormones|hormones|mesh-ancestor
44371241|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371242|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371243|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44371244|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371245|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44371246|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44371247|NCT01200641|Gabapentin|gabapentin|mesh-list
44371248|NCT01200641|Melatonin|melatonin|mesh-list
44371249|NCT01200641|Analgesics|analgesics|mesh-ancestor
44371250|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
44371251|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371252|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371253|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
44371254|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44371255|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44371256|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371257|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371258|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44371259|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44371260|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371261|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371262|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
44371263|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
44371287|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44371289|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371290|NCT01200732|Urological Agents|urological agents|mesh-ancestor
43661858|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371291|NCT01200745|Capsaicin|capsaicin|mesh-list
44371292|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
44371293|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371294|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
44371295|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371296|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371297|NCT01200784|Niacinamide|niacinamide|mesh-list
43872510|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872511|NCT04751955|Capecitabine|capecitabine|mesh-list
43872512|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43872513|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
43609802|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649778|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649779|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649780|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609826|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609827|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43609828|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43609829|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43609830|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43609831|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609832|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43609833|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
43609834|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
43609835|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
43609836|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851451|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43851452|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661885|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43661886|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43661887|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661888|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661889|NCT02919501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43661890|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43661891|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43872514|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872515|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872516|NCT04751344|Bupivacaine|bupivacaine|mesh-list
43872517|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
43872518|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
43872519|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872520|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872521|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
43872522|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872523|NCT04751227|Modafinil|modafinil|mesh-list
43872524|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43872525|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872526|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43872527|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43872528|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43872529|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872530|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43872531|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43872532|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43872533|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43872534|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872535|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872536|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872537|NCT04751318|Analgesics|analgesics|mesh-ancestor
43872538|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
43872539|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872540|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
43872541|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872545|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872546|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
43872547|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
43872548|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872549|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609837|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609838|NCT03185104|Fluorides|fluorides|mesh-list
43609839|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
43609840|NCT03185104|Protective Agents|protective agents|mesh-ancestor
43872550|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872551|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
43872552|NCT04751175|Hormones|hormones|mesh-ancestor
43872553|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872554|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872555|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872556|NCT04751175|Analgesics|analgesics|mesh-ancestor
43872557|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
43872558|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43872559|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43872560|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
43872561|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
43872562|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371298|NCT01200784|Niacin|niacin|mesh-list
44371299|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
44371300|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
44371301|NCT01200784|Vitamins|vitamins|mesh-ancestor
44371302|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
44371303|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371304|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44371305|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
44371306|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371307|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44371308|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
44371309|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44371310|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
44371311|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371312|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44371313|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44371314|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371315|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609855|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609856|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43609884|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609885|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609887|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
44371316|NCT01200914|Heparin|heparin|mesh-list
44371317|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
44371318|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44371319|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43681674|NCT03153527|Prednisone|prednisone|mesh-list
43872563|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43872564|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43872565|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872566|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872567|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43872568|NCT04751188|Bezafibrate|bezafibrate|mesh-list
43872569|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43872570|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872571|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43872572|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
43872573|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872574|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43872575|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
43872576|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43872577|NCT04751136|Protective Agents|protective agents|mesh-ancestor
43872578|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872579|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
44135192|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44135193|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44135194|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
44135195|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
44135196|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135197|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135198|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135199|NCT00160550|Levetiracetam|levetiracetam|mesh-list
44135200|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
44135201|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
44135202|NCT00160576|Levetiracetam|levetiracetam|mesh-list
44135203|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
43609897|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609898|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43609899|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
43609900|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
43609901|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43609902|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44135204|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
44135205|NCT00160589|Levocetirizine|levocetirizine|mesh-list
43566887|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44371320|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371321|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
44371323|NCT01201005|Hematinics|hematinics|mesh-ancestor
44371324|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
44371325|NCT01201005|Vitamins|vitamins|mesh-ancestor
44371326|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
44371327|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371328|NCT01201044|Gemcitabine|gemcitabine|mesh-list
44371329|NCT01201044|Nedaplatin|nedaplatin|mesh-list
44371330|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371331|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
44371332|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595891|NCT03321825|Lidocaine|lidocaine|mesh-list
44135206|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44135207|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44135208|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
44135209|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
44135210|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135211|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135212|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135213|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
44135214|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135215|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
44135216|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135217|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135218|NCT00160628|Levetiracetam|levetiracetam|mesh-list
44135219|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
44135220|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
44135221|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44135222|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44135223|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44135224|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
44135225|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135226|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43872586|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609935|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
43609936|NCT03184480|Fluticasone|fluticasone|mesh-list
43609940|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
43872587|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872588|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43649784|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
43649785|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649786|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872589|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
43872590|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43872591|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43872592|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
43872593|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872594|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43872595|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43872596|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872597|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872598|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872599|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872600|NCT04750317|Tofacitinib|tofacitinib|mesh-list
43872601|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43872602|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872603|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872604|NCT04750382|Gemcitabine|gemcitabine|mesh-list
43872605|NCT04750382|Cisplatin|cisplatin|mesh-list
43872606|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872607|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43872608|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
43872609|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872610|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
43872611|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872612|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371334|NCT01201044|Antiviral Agents|antiviral agents|mesh-ancestor
44371335|NCT01201044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371336|NCT01201044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371337|NCT01201044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371338|NCT01201044|Immunologic Factors|immunologic factors|mesh-ancestor
44371339|NCT01201044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649787|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
43649788|NCT03018535|Hormones|hormones|mesh-ancestor
44371340|NCT01201070|Antithrombins|antithrombins|mesh-list
43649791|NCT03018535|Protective Agents|protective agents|mesh-ancestor
44371341|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
44371342|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43872613|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872614|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
43872615|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872616|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43872617|NCT04749940|Laxatives|laxatives|mesh-ancestor
43872618|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872619|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43872620|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
43872621|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43872622|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
43872623|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872624|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872625|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43872626|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872627|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872628|NCT04749914|Dabigatran|dabigatran|mesh-list
43872629|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43872630|NCT04749914|Lasmiditan|lasmiditan|mesh-list
43872631|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43872632|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43872633|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
43872634|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872635|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43872636|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43872637|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872638|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
43872639|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43872640|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
43872641|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
43609995|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609996|NCT03184324|Esomeprazole|esomeprazole|mesh-list
43609997|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43609998|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609999|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43872642|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43872643|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
43610018|NCT03183843|Warfarin|warfarin|mesh-list
43872644|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872645|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872646|NCT04750122|Carboplatin|carboplatin|mesh-list
43872647|NCT04750122|Docetaxel|docetaxel|mesh-list
43872648|NCT04750122|Trastuzumab|trastuzumab|mesh-list
43872649|NCT04750122|Pertuzumab|pertuzumab|mesh-list
43872650|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872651|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
43872652|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
43872660|NCT04750083|Carboplatin|carboplatin|mesh-list
43872661|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
43872662|NCT04750083|Pemetrexed|pemetrexed|mesh-list
43872663|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872664|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872665|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872666|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872667|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43872668|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43872669|NCT04749797|Bupivacaine|bupivacaine|mesh-list
43872670|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
43872671|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
43872672|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872673|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872674|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
43872675|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371344|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371345|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371346|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
44371347|NCT01201122|Mesalamine|mesalamine|mesh-list
44371348|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371349|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44026795|NCT00000236|Narcotics|narcotics|mesh-ancestor
44371350|NCT01201122|Analgesics|analgesics|mesh-ancestor
44371352|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371353|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371354|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371355|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371356|NCT01201161|Ranibizumab|ranibizumab|mesh-list
44371357|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371358|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371359|NCT01201161|Growth Substances|growth substances|mesh-ancestor
44371360|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371361|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371362|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371363|NCT01201213|Anesthetics|anesthetics|mesh-list
44371364|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
44371365|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371366|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371367|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
44371368|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610020|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
43610021|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
43610022|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43610023|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
43610024|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371369|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
44371370|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44371391|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371392|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44371393|NCT01201551|Latanoprost|latanoprost|mesh-list
44371394|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44371395|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44371396|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44371397|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44371398|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44371399|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44371400|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371401|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371402|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371403|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371404|NCT01201577|Azithromycin|azithromycin|mesh-list
44371405|NCT01201577|Sulfalene|sulfalene|mesh-list
44371406|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371407|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371408|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44371409|NCT01201577|Renal Agents|renal agents|mesh-ancestor
44371410|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
43872676|NCT04749602|Nivolumab|nivolumab|mesh-list
43872677|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872678|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872679|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43872680|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872681|NCT04749069|Remifentanil|remifentanil|mesh-list
43872682|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43872683|NCT04749069|Narcotics|narcotics|mesh-ancestor
43872684|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872685|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872686|NCT04749069|Analgesics|analgesics|mesh-ancestor
43872687|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
43872688|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872689|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
43872690|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43872691|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
43872692|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872693|NCT04748887|Protective Agents|protective agents|mesh-ancestor
43872694|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872695|NCT04748562|Progesterone|progesterone|mesh-list
43610028|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43610029|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610030|NCT03183596|Dexamethasone|dexamethasone|mesh-list
43610031|NCT03183596|Bupivacaine|bupivacaine|mesh-list
43610032|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610033|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
43872696|NCT04748562|Progestins|progestins|mesh-ancestor
43872697|NCT04748562|Hormones|hormones|mesh-ancestor
43872698|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872699|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872700|NCT04748757|Annexin A5|annexin a5|mesh-list
43872701|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872702|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872703|NCT04748796|Landiolol|landiolol|mesh-list
43872704|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43872705|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43872706|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872707|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43566888|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44371413|NCT01201642|Prednisolone|prednisolone|mesh-list
44371414|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371415|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
44371416|NCT01201642|Hormones|hormones|mesh-ancestor
44371417|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371418|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371419|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43649795|NCT03018652|Antibodies|antibodies|mesh-list
43649796|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
43649797|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43649798|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
43649800|NCT03018756|Fentanyl|fentanyl|mesh-list
44371420|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371421|NCT01201694|Curcumin|curcumin|mesh-list
44371422|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371423|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371424|NCT01201694|Analgesics|analgesics|mesh-ancestor
44371425|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
44371426|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371427|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371428|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371429|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371430|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872708|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872709|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872710|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43872711|NCT04748276|Norepinephrine|norepinephrine|mesh-list
43872712|NCT04748276|Serotonin|serotonin|mesh-list
43872713|NCT04748276|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43872714|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43872715|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872716|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872717|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872718|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872727|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135227|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43872728|NCT04747678|Ivermectin|ivermectin|mesh-list
43872729|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872730|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872731|NCT04747392|Teriparatide|teriparatide|mesh-list
43872732|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43872733|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872734|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43872735|NCT04747015|Oxytocin|oxytocin|mesh-list
43872736|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
43872737|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43872738|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872739|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
43872740|NCT04746937|Norfloxacin|norfloxacin|mesh-list
43872741|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872742|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872743|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43872744|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43872745|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43872746|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610066|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
43610101|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
43872747|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371431|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371432|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371434|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
44371435|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371436|NCT01201928|Insulin|insulin|mesh-list
44371437|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44371438|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371439|NCT01202032|Bevacizumab|bevacizumab|mesh-list
44371440|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371441|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371442|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371443|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371444|NCT01202032|Growth Substances|growth substances|mesh-ancestor
44371445|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371446|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371447|NCT01202058|Sirolimus|sirolimus|mesh-list
44371448|NCT01202058|Everolimus|everolimus|mesh-list
44371449|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371450|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371451|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
44371452|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371453|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371454|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872748|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872749|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43872750|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43872751|NCT04747080|Dexamethasone|dexamethasone|mesh-list
43872752|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
43872754|NCT04747080|Tacrolimus|tacrolimus|mesh-list
43610135|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
43610136|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610137|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610139|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610140|NCT03182595|Analgesics|analgesics|mesh-ancestor
43610141|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
43872755|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872756|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
43872757|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
43872758|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872759|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872760|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872761|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
43872762|NCT04747080|Hormones|hormones|mesh-ancestor
43872763|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872764|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872765|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872766|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
43872767|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872768|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872769|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872770|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
43872771|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43872772|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
43872773|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43872774|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872775|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371456|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
44371457|NCT01202084|Fluticasone|fluticasone|mesh-list
44371458|NCT01202084|Xhance|xhance|mesh-list
44371459|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
44371460|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610153|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43610154|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610155|NCT03182218|Heparin|heparin|mesh-list
43610156|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43610157|NCT03182218|Tinzaparin|tinzaparin|mesh-list
43610158|NCT03182218|Dalteparin|dalteparin|mesh-list
43610159|NCT03182218|Anticoagulants|anticoagulants|mesh-list
43610160|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43662060|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
43662061|NCT02918747|Hormones|hormones|mesh-ancestor
43662062|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662063|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662064|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43662065|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
43662066|NCT02918747|Antiviral Agents|antiviral agents|mesh-ancestor
43662067|NCT02918747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662068|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662069|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43662070|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662071|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43662072|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43662073|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
43662074|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
43662075|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
44371461|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371462|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
44371463|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371464|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371465|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44371466|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371467|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371468|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44371469|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44371470|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44371471|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872776|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872777|NCT04747171|Analgesics|analgesics|mesh-ancestor
43872778|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
43872779|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872780|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43872781|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43872782|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872783|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872787|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872788|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
43872789|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
43872790|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872791|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872792|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43872793|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
43872794|NCT04746430|Hormones|hormones|mesh-ancestor
43872795|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872796|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872797|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872798|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
43872799|NCT04746365|Ivermectin|ivermectin|mesh-list
43872800|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
43872801|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43872802|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872803|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872804|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872805|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872806|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872807|NCT04746209|Blinatumomab|blinatumomab|mesh-list
43872808|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872809|NCT04746040|Fluticasone|fluticasone|mesh-list
43872810|NCT04746040|Xhance|xhance|mesh-list
43872811|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43872812|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43872813|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872814|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43872815|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
43872816|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872817|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872818|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43872819|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
43872820|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371472|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371473|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371474|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662077|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
43662078|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662079|NCT02918591|Empagliflozin|empagliflozin|mesh-list
44371475|NCT01202097|Fluticasone|fluticasone|mesh-list
44371476|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44371477|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44371478|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371479|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371480|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
44371481|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371482|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371483|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828406|NCT05478044|Vitamins|vitamins|mesh-ancestor
43872821|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43872822|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43872823|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43872824|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43872825|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
43872826|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872827|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872828|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
43872829|NCT04746040|Hormones|hormones|mesh-ancestor
43872830|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872831|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
43872832|NCT04745663|Iodine|iodine|mesh-list
43872833|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
43872834|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
43872835|NCT04745663|Povidone|povidone|mesh-list
43872836|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43872837|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872838|NCT04745663|Trace Elements|trace elements|mesh-ancestor
43872839|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
43872840|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872841|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
43872842|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
43872843|NCT04745260|Fentanyl|fentanyl|mesh-list
43872844|NCT04745260|Midazolam|midazolam|mesh-list
43872845|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43872846|NCT04745260|Narcotics|narcotics|mesh-ancestor
43872847|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872848|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872849|NCT04745260|Analgesics|analgesics|mesh-ancestor
43872850|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
43872851|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872852|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43872853|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43872854|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
43872855|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
43872856|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43872862|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872863|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872864|NCT04745286|Ketamine|ketamine|mesh-list
43610161|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43610162|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610163|NCT03182296|Exenatide|exenatide|mesh-list
43610186|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872865|NCT04745286|Esketamine|esketamine|mesh-list
43872866|NCT04745286|Analgesics|analgesics|mesh-ancestor
43872867|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
43872868|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872869|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872870|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43872871|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43872872|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
43872873|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
43872874|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872875|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44371485|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371486|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44371487|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44371488|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44371489|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44371490|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371491|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371492|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371493|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
43872876|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43872877|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872878|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872879|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
43872880|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872881|NCT04745442|Antithrombins|antithrombins|mesh-list
43872882|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
43872883|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43872884|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
43872885|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872886|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872887|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
43872888|NCT04745130|Cetuximab|cetuximab|mesh-list
43872889|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872890|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135228|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155724|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
44155725|NCT00228020|Prednisone|prednisone|mesh-list
44155726|NCT00228020|Cyclosporins|cyclosporins|mesh-list
44155727|NCT00228020|Basiliximab|basiliximab|mesh-list
44155728|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155729|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
44155730|NCT00228020|Hormones|hormones|mesh-ancestor
43610193|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610194|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
43849344|NCT03935451|Apixaban|apixaban|mesh-list
43610195|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610196|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610197|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
43610198|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155731|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155732|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155733|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155734|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155735|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155736|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155737|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155738|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
44155739|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
44155740|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155741|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
44155742|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649816|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649817|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43649818|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43649819|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649821|NCT03018418|Mitomycin|mitomycin|mesh-list
43649822|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43649823|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649824|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
44155743|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44155744|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44155745|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44155746|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
44155747|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155748|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
44155749|NCT00228033|Calcium|calcium|mesh-list
44155750|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44155751|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155752|NCT00228033|Antacids|antacids|mesh-ancestor
44155753|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155754|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155755|NCT00228046|Valproic Acid|valproic acid|mesh-list
44155756|NCT00228046|Methylphenidate|methylphenidate|mesh-list
44155757|NCT00228046|Amphetamine|amphetamine|mesh-list
44155758|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
44155759|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44155767|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
44155768|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
44371495|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371496|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
44371497|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
44371498|NCT01202149|Emollients|emollients|mesh-list
44371499|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371500|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371501|NCT01202149|Analgesics|analgesics|mesh-ancestor
44371502|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
44371503|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371504|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371505|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371506|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371507|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371508|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371509|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
44371510|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44371511|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371512|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371513|NCT01202240|Ketoconazole|ketoconazole|mesh-list
44371514|NCT01202240|Tofacitinib|tofacitinib|mesh-list
44371515|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
44371516|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371517|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44371518|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44371519|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371520|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371521|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44371522|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
44371523|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371524|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649828|NCT03018171|Clonidine|clonidine|mesh-list
44371525|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44371527|NCT01202331|Azithromycin|azithromycin|mesh-list
44371532|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371533|NCT01202422|Pregabalin|pregabalin|mesh-list
44371534|NCT01202422|Analgesics|analgesics|mesh-ancestor
44371535|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
44371536|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371537|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371538|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
44371539|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44371540|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44371541|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371542|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371543|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44371544|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44371545|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371546|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371547|NCT01202435|Pregabalin|pregabalin|mesh-list
44371548|NCT01202435|Analgesics|analgesics|mesh-ancestor
44371549|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
44371550|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371551|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371552|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
44371553|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44155769|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155770|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155771|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44155772|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
44155773|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155775|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
44155776|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155777|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155778|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155779|NCT00228163|Teriflunomide|teriflunomide|mesh-list
44155780|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44155781|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155782|NCT00228163|Analgesics|analgesics|mesh-ancestor
44155783|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
44155784|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155785|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155786|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872892|NCT04744753|Ionophores|ionophores|mesh-list
43872893|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
43872894|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43872895|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872896|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43610273|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610274|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610276|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43610277|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43610278|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610279|NCT03181815|Cytarabine|cytarabine|mesh-list
43610280|NCT03181815|Cladribine|cladribine|mesh-list
43610281|NCT03181815|Aclarubicin|aclarubicin|mesh-list
43662117|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43662118|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662119|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43662120|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872897|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872898|NCT04744727|Acetaminophen|acetaminophen|mesh-list
43872899|NCT04744727|Meperidine|meperidine|mesh-list
43872900|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872901|NCT04744727|Analgesics|analgesics|mesh-ancestor
43872902|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
43872903|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872904|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371554|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44371555|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371556|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371557|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44371558|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44371559|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371560|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371561|NCT01202474|Insulin|insulin|mesh-list
44371562|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44371563|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
44371564|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
44371565|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44371566|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371567|NCT01202487|Lidocaine|lidocaine|mesh-list
44371568|NCT01202487|Epinephrine|epinephrine|mesh-list
44371569|NCT01202487|Tetracaine|tetracaine|mesh-list
44371570|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
44371571|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
44371572|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371573|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371574|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
44371575|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371576|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44371577|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43872905|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
43872906|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43872907|NCT04744727|Narcotics|narcotics|mesh-ancestor
43872908|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43872909|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43872910|NCT04744675|Triamcinolone|triamcinolone|mesh-list
43872911|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43872912|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43872913|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43872914|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872915|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
43872916|NCT04744675|Hormones|hormones|mesh-ancestor
43872917|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872918|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872919|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872920|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
43872921|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872922|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872923|NCT04744545|Curcumin|curcumin|mesh-list
43872924|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43872925|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872926|NCT04744545|Analgesics|analgesics|mesh-ancestor
43872927|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
43872928|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872929|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872930|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610282|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
43610283|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610284|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
43610287|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
44371578|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44371579|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44371580|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371581|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44371582|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44371583|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371584|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371585|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44371586|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371587|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
44371588|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44371589|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371591|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
44371592|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44371593|NCT01202513|Bimatoprost|bimatoprost|mesh-list
44371594|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44371595|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44371596|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44371597|NCT01202552|Vaccines|vaccines|mesh-list
44371598|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
44371599|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371600|NCT01202734|Methylphenidate|methylphenidate|mesh-list
44371601|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44371602|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371603|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44371604|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43681899|NCT02586038|Ixazomib|ixazomib|mesh-list
43872950|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43872951|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872952|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43872953|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
43872954|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43872955|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872956|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872957|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872958|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872960|NCT04744623|Hormones|hormones|mesh-ancestor
43872961|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43872962|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872963|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43872964|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
43872965|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
43872966|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872967|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44371605|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027121|NCT00000276|Bupropion|bupropion|mesh-list
44371606|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371607|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
44371608|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371609|NCT01202799|Diclofenac|diclofenac|mesh-list
43649838|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649839|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
43649840|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
43649841|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43649842|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
44371610|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371611|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371612|NCT01202799|Analgesics|analgesics|mesh-ancestor
44371613|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
44371614|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371615|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371616|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371617|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371618|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44371619|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371620|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371621|NCT01202825|Simeprevir|simeprevir|mesh-list
44371622|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
44371623|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872968|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43872969|NCT04744623|Protective Agents|protective agents|mesh-ancestor
43872970|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43872971|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
43872972|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
43872973|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43872974|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872975|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43872976|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
43872977|NCT04744571|Aspirin|aspirin|mesh-list
43872978|NCT04744571|Metoprolol|metoprolol|mesh-list
43872979|NCT04744571|Clopidogrel|clopidogrel|mesh-list
43872980|NCT04744571|Ticagrelor|ticagrelor|mesh-list
43872981|NCT04744571|Atorvastatin|atorvastatin|mesh-list
43872982|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43872983|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43872984|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43872985|NCT04744571|Analgesics|analgesics|mesh-ancestor
43872986|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
43872987|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872988|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872992|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43872993|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872994|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43872995|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43872997|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
43872998|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43872999|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43873000|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
43873001|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43873002|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43873003|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43610289|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873004|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43873005|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43873006|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
44371624|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
44371625|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371626|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371627|NCT01202890|Bevacizumab|bevacizumab|mesh-list
44371628|NCT01202890|Lenalidomide|lenalidomide|mesh-list
44371629|NCT01202890|Doxorubicin|doxorubicin|mesh-list
44371630|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44371631|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371632|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371633|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371634|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371635|NCT01202890|Growth Substances|growth substances|mesh-ancestor
44371636|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371637|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371638|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371639|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44371640|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44371641|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371642|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371643|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
44371644|NCT01203020|Fludarabine|fludarabine|mesh-list
44371645|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
44371646|NCT01203020|Busulfan|busulfan|mesh-list
43873007|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873008|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873009|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873010|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
43873011|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
43873012|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43873013|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43873014|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43610299|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610300|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43610301|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43610302|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
43610303|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610304|NCT03180957|Adalimumab|adalimumab|mesh-list
43610305|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610306|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610307|NCT03180970|Lugol's solution|lugol's solution|mesh-list
43610308|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43610309|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
43662146|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662147|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662156|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
43873015|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873016|NCT04743739|Cyclosporine|cyclosporine|mesh-list
43873017|NCT04743739|Rituximab|rituximab|mesh-list
43873018|NCT04743739|Cyclosporins|cyclosporins|mesh-list
43873019|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873020|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873021|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
43873022|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873023|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43873024|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873025|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873026|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873027|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
43873028|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873029|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
43873030|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43873031|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
43873032|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873033|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873034|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873035|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873036|NCT04743544|Voriconazole|voriconazole|mesh-list
44371647|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371648|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371649|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
44371650|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371651|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371652|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
44371653|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371654|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
44371655|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44371656|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44371657|NCT01203111|Insulin|insulin|mesh-list
43610310|NCT03180970|Coagulants|coagulants|mesh-ancestor
43610311|NCT03180879|Ibuprofen|ibuprofen|mesh-list
43610312|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610313|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849347|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44371658|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44371659|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
44371660|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
44371661|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44371662|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371663|NCT01203202|Clomipramine|clomipramine|mesh-list
44371664|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44371665|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
44371666|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371667|NCT01203202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44371668|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44371669|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43873037|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
43873038|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873039|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43873040|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873041|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873042|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873043|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43849354|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43849355|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849356|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849357|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
43849358|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610342|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43610343|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
43649848|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873044|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
43873045|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873046|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873047|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43873048|NCT04743622|Latanoprost|latanoprost|mesh-list
43873049|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43873050|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43873051|NCT04743180|Paclitaxel|paclitaxel|mesh-list
43873052|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43873053|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873054|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
43873055|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
43873056|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
43873057|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873058|NCT04743011|Heparin|heparin|mesh-list
43873062|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43873063|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43873064|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873065|NCT04743297|Dinoprostone|dinoprostone|mesh-list
43873066|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
44371670|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371672|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
44371673|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371674|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
44371675|NCT01203228|Busulfan|busulfan|mesh-list
44371676|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
44371677|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371678|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
44371679|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371680|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371681|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44371683|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371684|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610387|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610388|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610389|NCT03180229|Granisetron|granisetron|mesh-list
43610390|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
43610391|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
43610420|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
44371685|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43873067|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873068|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873069|NCT04743063|Losartan|losartan|mesh-list
43873070|NCT04743063|Valsartan|valsartan|mesh-list
43873071|NCT04743063|Telmisartan|telmisartan|mesh-list
43873072|NCT04743063|Candesartan|candesartan|mesh-list
43873073|NCT04743063|Olmesartan|olmesartan|mesh-list
43873074|NCT04743063|Irbesartan|irbesartan|mesh-list
43873075|NCT04743063|Eprosartan|eprosartan|mesh-list
43873076|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
43873077|NCT04743063|Giapreza|giapreza|mesh-list
43873078|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43873079|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43873080|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
43873081|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873082|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43873083|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873084|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873085|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43873086|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43873087|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873088|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873089|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
43873090|NCT04743193|Sevoflurane|sevoflurane|mesh-list
43873091|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
43873092|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873093|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873094|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43873095|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43873096|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
43873097|NCT04742504|Benralizumab|benralizumab|mesh-list
43873098|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43873099|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
43873100|NCT04742699|Lemborexant|lemborexant|mesh-list
43873101|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43873102|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873103|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873104|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43873105|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43873106|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873107|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873108|NCT04742348|Levodopa|levodopa|mesh-list
43873109|NCT04742348|Carbidopa|carbidopa|mesh-list
43610422|NCT03180242|Trastuzumab|trastuzumab|mesh-list
43610423|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610424|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610425|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43610426|NCT03180281|Glimepiride|glimepiride|mesh-list
43610427|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873110|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44371687|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
44371688|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44371689|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44371690|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44371691|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
44371692|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371693|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44371694|NCT01203267|Paclitaxel|paclitaxel|mesh-list
44371695|NCT01203267|Carboplatin|carboplatin|mesh-list
44371696|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44371697|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371698|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
44371699|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
44371700|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
44371701|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371702|NCT01203306|Bevacizumab|bevacizumab|mesh-list
44371703|NCT01203306|Capecitabine|capecitabine|mesh-list
44371704|NCT01203306|Octreotide|octreotide|mesh-list
44371705|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371706|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371707|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44371708|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44371709|NCT01203306|Growth Substances|growth substances|mesh-ancestor
44371710|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371711|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371712|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371713|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
44371714|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873111|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43873112|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43873113|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
43873114|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873115|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873116|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873117|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43873118|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873119|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43873120|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
43873121|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
44135229|NCT00160849|Lopinavir|lopinavir|mesh-list
44135230|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44135231|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44135232|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
44371715|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44371716|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44371717|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44371718|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
44371719|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371720|NCT01203358|Beractant|beractant|mesh-list
44371721|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44371722|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371723|NCT01203371|Naftopidil|naftopidil|mesh-list
44371724|NCT01203371|Tamsulosin|tamsulosin|mesh-list
44371725|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44371726|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43662240|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43662241|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662242|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
43662243|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
43662244|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
43662245|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662246|NCT02916485|Sirolimus|sirolimus|mesh-list
44371727|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44371728|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44371729|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371730|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371731|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371732|NCT01203371|Urological Agents|urological agents|mesh-ancestor
44371733|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44371734|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44371735|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44371736|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44371737|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44371738|NCT01203384|Flurbiprofen|flurbiprofen|mesh-list
44371739|NCT01203384|Analgesics|analgesics|mesh-ancestor
44371740|NCT01203384|Sensory System Agents|sensory system agents|mesh-ancestor
44135233|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135234|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135235|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44135236|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44135237|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
44135242|NCT00160875|Irinotecan|irinotecan|mesh-list
44135243|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135244|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44135245|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44135246|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135247|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135248|NCT00160888|Nitroprusside|nitroprusside|mesh-list
44135249|NCT00160888|Acetylcholine|acetylcholine|mesh-list
44135250|NCT00160888|Bradykinin|bradykinin|mesh-list
44135251|NCT00160888|Kininogens|kininogens|mesh-list
44135252|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135253|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135254|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44135255|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135256|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44135257|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
44135258|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371741|NCT01203384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371742|NCT01203384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371743|NCT01203384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371744|NCT01203384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371745|NCT01203384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371746|NCT01203384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371747|NCT01203384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44371748|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371749|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371750|NCT01203488|Vitamin A|vitamin a|mesh-list
44371751|NCT01203488|Vitamins|vitamins|mesh-ancestor
44371752|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
44371753|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371754|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
44371755|NCT01203514|Hematinics|hematinics|mesh-ancestor
44371756|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44371757|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44371758|NCT01203592|Albuterol|albuterol|mesh-list
43610431|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662256|NCT02916602|Amlodipine|amlodipine|mesh-list
44371759|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44371760|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
44371761|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371762|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371763|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44371764|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
44371765|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
44371766|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371767|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44371768|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44371786|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
44371787|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371788|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44371789|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371790|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371791|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371792|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371793|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44371794|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
44371795|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371796|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371798|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
44371799|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371800|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371801|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
44371802|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371803|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371804|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
44371805|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44135259|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135260|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44135261|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44135262|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135263|NCT00160927|Nitroprusside|nitroprusside|mesh-list
44135264|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135265|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135266|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44135267|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135268|NCT00160966|Cyclosporine|cyclosporine|mesh-list
44135269|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
44135270|NCT00160966|Everolimus|everolimus|mesh-list
44135271|NCT00160966|Tacrolimus|tacrolimus|mesh-list
44135272|NCT00160966|Cyclosporins|cyclosporins|mesh-list
44135273|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135274|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
43610438|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
43610439|NCT03180255|Dexamethasone|dexamethasone|mesh-list
43610440|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
43610441|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43610442|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135275|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135276|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44135277|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135278|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135279|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
44135280|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135281|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135282|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135283|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135284|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44135285|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44135286|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
44135287|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44135288|NCT00161018|Risperidone|risperidone|mesh-list
44135289|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44135290|NCT00161018|Fluphenazine|fluphenazine|mesh-list
44135291|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
44135292|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44135293|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44371806|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371807|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371808|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44371809|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44371810|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44371811|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
44371812|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371813|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44371814|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44371815|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371816|NCT01204086|Fluoxetine|fluoxetine|mesh-list
44371817|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44371818|NCT01204086|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44371819|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44371820|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682093|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
44135294|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
44135295|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135296|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135297|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135298|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44135299|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43873122|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
43873123|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43873124|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43873125|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873126|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
43873127|NCT04742205|Coagulants|coagulants|mesh-ancestor
43873128|NCT04741880|Lidocaine|lidocaine|mesh-list
43873129|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
43873130|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
43873131|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873132|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873137|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43873138|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43873139|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873141|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43873142|NCT04741464|Dalteparin|dalteparin|mesh-list
43873143|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
43873144|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43873145|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43873146|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873147|NCT04741295|Heparin|heparin|mesh-list
43873148|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43873149|NCT04741295|Tinzaparin|tinzaparin|mesh-list
43873150|NCT04741295|Dalteparin|dalteparin|mesh-list
43873151|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
43873152|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43873153|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43873154|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873155|NCT04741165|Bevacizumab|bevacizumab|mesh-list
43873156|NCT04741165|Lenvatinib|lenvatinib|mesh-list
43873157|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873158|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873159|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873160|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873161|NCT04741165|Growth Substances|growth substances|mesh-ancestor
43566890|NCT00813956|Gemcitabine|gemcitabine|mesh-list
44371821|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371822|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44371823|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
44371824|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371825|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44371826|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
44371827|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44371828|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44371829|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44371830|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371831|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44371832|NCT01204112|Rifampin|rifampin|mesh-list
44371833|NCT01204112|Tofacitinib|tofacitinib|mesh-list
44371834|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44371835|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
44371836|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371837|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873162|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873163|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
43873164|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873165|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873166|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873167|NCT04740840|Amlodipine|amlodipine|mesh-list
43873168|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873169|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43873170|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43873171|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873172|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43873173|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873174|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
43873175|NCT04740554|Prednisone|prednisone|mesh-list
43873176|NCT04740554|Deflazacort|deflazacort|mesh-list
43873177|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873178|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
43873179|NCT04740554|Hormones|hormones|mesh-ancestor
43873180|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873181|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873182|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43873183|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873184|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873185|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
43873186|NCT04740190|Carboplatin|carboplatin|mesh-list
43873187|NCT04740190|Talazoparib|talazoparib|mesh-list
43873188|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873189|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43873190|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873191|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873192|NCT04740021|Carboplatin|carboplatin|mesh-list
43873193|NCT04740021|Etoposide|etoposide|mesh-list
43873194|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873195|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43873196|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43873197|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43873198|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371838|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
44371839|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44371840|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371841|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610449|NCT03180255|Hormones|hormones|mesh-ancestor
44371842|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44371843|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44371844|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44371845|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44371846|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44371847|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44371848|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873199|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873200|NCT04739826|HH-GV-678|hh-gv-678|mesh-list
43873201|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873207|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43873208|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873209|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873210|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873211|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43873212|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
43873213|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873214|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873215|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43610482|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610483|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43873216|NCT04740086|Calcium|calcium|mesh-list
43873217|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43873218|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873219|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43873220|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43873221|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
43610484|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43610485|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610486|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873222|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873223|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
43873224|NCT04739618|Ipilimumab|ipilimumab|mesh-list
43873225|NCT04739618|Sargramostim|sargramostim|mesh-list
43873226|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873227|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873228|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43873229|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873230|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
43873231|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873232|NCT04739566|Trametinib|trametinib|mesh-list
43873233|NCT04739566|Dabrafenib|dabrafenib|mesh-list
43873234|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873235|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873236|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873237|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873238|NCT04739410|Ivermectin|ivermectin|mesh-list
43873239|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43873240|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873241|NCT04739241|Insulin|insulin|mesh-list
43873242|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43873243|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873244|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873245|NCT04739202|Bevacizumab|bevacizumab|mesh-list
43873246|NCT04739202|Atezolizumab|atezolizumab|mesh-list
43873247|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43873248|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873249|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873250|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873251|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873252|NCT04739202|Growth Substances|growth substances|mesh-ancestor
44371850|NCT01204125|Iniparib|iniparib|mesh-list
44371851|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44371852|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371853|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44371854|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
43610554|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371855|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
43610560|NCT03178656|Sorafenib|sorafenib|mesh-list
44371856|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371857|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44371858|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371859|NCT01204138|Apremilast|apremilast|mesh-list
44371860|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44371861|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44371862|NCT01204138|Analgesics|analgesics|mesh-ancestor
44371863|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
44371864|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873253|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873254|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
43873255|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
44135300|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44135301|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135302|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44135303|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
44135304|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
44135305|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44135306|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44135307|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44135308|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135309|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135310|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
44135311|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135312|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135313|NCT00161070|Aspirin|aspirin|mesh-list
44135314|NCT00161070|Dipyridamole|dipyridamole|mesh-list
43873259|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873260|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610600|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43610602|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873261|NCT04738955|Micafungin|micafungin|mesh-list
43873262|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
43873263|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873264|NCT04739111|Antibodies|antibodies|mesh-list
43873265|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
43873266|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43873267|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
43873268|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873269|NCT04738981|Basiliximab|basiliximab|mesh-list
43873270|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873271|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
43873272|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873273|NCT04738838|Oxytocin|oxytocin|mesh-list
43873274|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
43873275|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873276|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873277|NCT04738773|Naltrexone|naltrexone|mesh-list
43873278|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43873279|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43873280|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873281|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
43873282|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873283|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
43873284|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
43873285|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43873286|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371865|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371866|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371867|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371868|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44371869|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44371870|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371871|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371872|NCT01204164|Dexamethasone|dexamethasone|mesh-list
44371873|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44371874|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
44371875|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
44371876|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873287|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873288|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
43873289|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43873290|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873291|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873292|NCT04738058|Lactoferrin|lactoferrin|mesh-list
43873293|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873294|NCT04738188|Epirubicin|epirubicin|mesh-list
43873295|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43873296|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873297|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43873298|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43873299|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873300|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873301|NCT04738045|Ritonavir|ritonavir|mesh-list
43873302|NCT04738045|Lopinavir|lopinavir|mesh-list
43873303|NCT04738045|Remdesivir|remdesivir|mesh-list
43873304|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43873305|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43873306|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873307|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873308|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873309|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43873310|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43873311|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
43873312|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873313|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43873314|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873315|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
43873316|NCT04737889|Rituximab|rituximab|mesh-list
43873317|NCT04737889|Methotrexate|methotrexate|mesh-list
43873318|NCT04737889|Lenalidomide|lenalidomide|mesh-list
43873319|NCT04737889|Temozolomide|temozolomide|mesh-list
43873320|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873321|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873322|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
43873323|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873324|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43873325|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43873326|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
43873327|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873328|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43873333|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43873334|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873335|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43873336|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873337|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873338|NCT04737889|Growth Substances|growth substances|mesh-ancestor
43873339|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44371877|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371878|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44371879|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
44371880|NCT01204164|Hormones|hormones|mesh-ancestor
44371881|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371882|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44371883|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371884|NCT01204177|Sorafenib|sorafenib|mesh-list
44371885|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371886|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44371887|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371888|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371889|NCT01204190|Gestodene|gestodene|mesh-list
44371890|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44371891|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44371892|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44371893|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
44371894|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873340|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43873341|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
43873342|NCT04737928|Latanoprost|latanoprost|mesh-list
43873343|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43873344|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43873345|NCT04737980|Dexamethasone|dexamethasone|mesh-list
43873346|NCT04737980|Bupivacaine|bupivacaine|mesh-list
43873347|NCT04737980|Ropivacaine|ropivacaine|mesh-list
43873348|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873349|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
43873350|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
43873351|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669188|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43873352|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873353|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43873354|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
43873355|NCT04737980|Hormones|hormones|mesh-ancestor
43873356|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873357|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43873358|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873359|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
43873360|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
43873361|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873362|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
43873363|NCT04737967|Memantine|memantine|mesh-list
43873364|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43873365|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43873366|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43873367|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
43873368|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873369|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873370|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873371|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43873372|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43873373|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43873374|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43873375|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702465|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44371895|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371896|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44371897|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44371899|NCT01204190|Hormones|hormones|mesh-ancestor
44371900|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44371901|NCT01204216|Biotin|biotin|mesh-list
44371902|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
44371903|NCT01204216|Vitamins|vitamins|mesh-ancestor
44371904|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
44371905|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371906|NCT01204268|Sevoflurane|sevoflurane|mesh-list
43873376|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43873377|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
43873378|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43873379|NCT04737837|Lacosamide|lacosamide|mesh-list
43873380|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
43873381|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43873382|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43873383|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43873384|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873385|NCT04737655|Beclomethasone|beclomethasone|mesh-list
43873386|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
43873387|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
43873388|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43873389|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
43873390|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873391|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873392|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43873393|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
43873394|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43873395|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43873399|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873400|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43873401|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43873402|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43873403|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
43873404|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873405|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
43873406|NCT04737655|Hormones|hormones|mesh-ancestor
43873407|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851508|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873408|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43873409|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43873410|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43873411|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
43873412|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873413|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43873414|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43873415|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873416|NCT04737473|Anesthetics|anesthetics|mesh-list
43873417|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873418|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873419|NCT04736953|Sirolimus|sirolimus|mesh-list
43873420|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873421|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873422|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43873423|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873424|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
43873425|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873426|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
43873427|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873428|NCT04737057|Fluorides|fluorides|mesh-list
44371907|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44371908|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44371909|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
44371910|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
44371911|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44371912|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371913|NCT01204307|Cisplatin|cisplatin|mesh-list
44371914|NCT01204307|Docetaxel|docetaxel|mesh-list
44371915|NCT01204307|Pemetrexed|pemetrexed|mesh-list
44371916|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371917|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
44371918|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
44371919|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
44371920|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873429|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
43873430|NCT04737057|Protective Agents|protective agents|mesh-ancestor
43873431|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873432|NCT04736836|Rifaximin|rifaximin|mesh-list
43873433|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873434|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873435|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135315|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44135316|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44135317|NCT00161070|Analgesics|analgesics|mesh-ancestor
44135318|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
44135319|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135320|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135321|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135322|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135323|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44135324|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44135325|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135326|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44135327|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44135328|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135329|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
44135330|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135331|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135332|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44135333|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44135334|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135335|NCT00161096|Pantoprazole|pantoprazole|mesh-list
44135336|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44135337|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135338|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44135339|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135340|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135341|NCT00161122|Vaccines|vaccines|mesh-list
44135342|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44135343|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
44135344|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135345|NCT00161200|Pantoprazole|pantoprazole|mesh-list
44135346|NCT00161200|Ranitidine|ranitidine|mesh-list
43873437|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873438|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873439|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873440|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873441|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43873442|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
43873443|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873444|NCT04736927|Midazolam|midazolam|mesh-list
43567311|NCT00758563|Protective Agents|protective agents|mesh-ancestor
44371921|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371922|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44371923|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44371925|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44371926|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44371927|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371928|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44371929|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44371930|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
44371931|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371932|NCT01204333|Heparin|heparin|mesh-list
44371933|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
44371934|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44371935|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44371936|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371937|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
44371938|NCT01204372|Gemcitabine|gemcitabine|mesh-list
44371939|NCT01204372|Trastuzumab|trastuzumab|mesh-list
44371940|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44371941|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371942|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
44371943|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371944|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371945|NCT01204372|Antiviral Agents|antiviral agents|mesh-ancestor
43873445|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43873446|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43873447|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873448|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873450|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43873451|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43873452|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43873453|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
43873454|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
43873455|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
43873456|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
43873457|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873458|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873459|NCT04736524|Antibodies|antibodies|mesh-list
43873460|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
43873461|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873462|NCT04736810|Gemcitabine|gemcitabine|mesh-list
43873463|NCT04736810|Cisplatin|cisplatin|mesh-list
43873464|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662371|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
43873465|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43873466|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
43873467|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873468|NCT04736810|Antiviral Agents|antiviral agents|mesh-ancestor
43873469|NCT04736810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873470|NCT04736810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873471|NCT04736810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371946|NCT01204372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371947|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371948|NCT01204372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371949|NCT01204372|Immunologic Factors|immunologic factors|mesh-ancestor
44371950|NCT01204372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371951|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44371952|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44371953|NCT01204411|Artesunate|artesunate|mesh-list
44371954|NCT01204411|Amodiaquine|amodiaquine|mesh-list
44371955|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
44371956|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44371957|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44371958|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44371959|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44371960|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
44371961|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
44371962|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44371963|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
44371964|NCT01204437|Paclitaxel|paclitaxel|mesh-list
44371965|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
44371966|NCT01204437|Capecitabine|capecitabine|mesh-list
44371967|NCT01204437|Methotrexate|methotrexate|mesh-list
44371968|NCT01204437|Epirubicin|epirubicin|mesh-list
44371969|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44371970|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682194|NCT00433420|Paclitaxel|paclitaxel|mesh-list
43873472|NCT04736810|Immunologic Factors|immunologic factors|mesh-ancestor
43873473|NCT04736810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873474|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
43873475|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43873476|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43873477|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873478|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43873479|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
43873480|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873481|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43873482|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43873483|NCT04736719|Warfarin|warfarin|mesh-list
43873484|NCT04736719|Apixaban|apixaban|mesh-list
43873495|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873496|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43873497|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43873498|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873499|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873500|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873501|NCT04736420|Warfarin|warfarin|mesh-list
43873502|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
43873503|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
43873504|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43873505|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
43873506|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43873507|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
44371972|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
44371973|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
44371974|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44371975|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44371976|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
44371977|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44371978|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44371979|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43662387|NCT02915055|Analgesics|analgesics|mesh-ancestor
44371980|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
44371981|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44371982|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44371983|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
44371984|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44371985|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
44371986|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44371987|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44371988|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44371989|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44371990|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44371991|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44371992|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44371993|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44371994|NCT01204450|Sirolimus|sirolimus|mesh-list
44371995|NCT01204450|Valproic Acid|valproic acid|mesh-list
44371996|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44371997|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372007|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
44372017|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372018|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
44372019|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372020|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372021|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44372023|NCT01204580|Glimepiride|glimepiride|mesh-list
44372024|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372025|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372026|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44372027|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372028|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
44372029|NCT01204593|Insulin|insulin|mesh-list
44372030|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44372031|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
44372032|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
44372033|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372034|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372035|NCT01204723|Aprepitant|aprepitant|mesh-list
44372036|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
44372037|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
44372038|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
44372039|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372040|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372041|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372042|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44372043|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372067|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610625|NCT03178539|Ketorolac|ketorolac|mesh-list
43610626|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610627|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610659|NCT03178123|Interferons|interferons|mesh-list
43610660|NCT03178123|Antibodies|antibodies|mesh-list
43610661|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43610662|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
43610663|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610664|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610665|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
43610666|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851509|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851510|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
44372068|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372069|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
44372070|NCT01204996|Antiviral Agents|antiviral agents|mesh-ancestor
44372071|NCT01204996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372072|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372073|NCT01204996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372074|NCT01204996|Immunologic Factors|immunologic factors|mesh-ancestor
44372075|NCT01204996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372076|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44372077|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44372078|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372079|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44372080|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44372081|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372082|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
44372084|NCT01205022|Bevacizumab|bevacizumab|mesh-list
44372085|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43873508|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873509|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873510|NCT04736589|Sirolimus|sirolimus|mesh-list
43873511|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873512|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873513|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43873514|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873515|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
43873516|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873517|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
43873518|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873519|NCT04736329|Telmisartan|telmisartan|mesh-list
43873520|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873521|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43873522|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43873523|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873525|NCT04736381|Abatacept|abatacept|mesh-list
43873526|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43873527|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873528|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43873529|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
43873530|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873531|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873532|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873533|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873534|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873535|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
43873536|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873537|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43873538|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43873539|NCT04736108|Prednisolone|prednisolone|mesh-list
43873540|NCT04736108|Goserelin|goserelin|mesh-list
43873541|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
43873542|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873543|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
43873544|NCT04736108|Hormones|hormones|mesh-ancestor
43873545|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372087|NCT01205022|Irinotecan|irinotecan|mesh-list
44372088|NCT01205022|Camptothecin|camptothecin|mesh-list
44372089|NCT01205022|Antibodies|antibodies|mesh-list
44372090|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
44372091|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44372092|NCT01205022|Calcium|calcium|mesh-list
44372093|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
44372094|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372095|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44372096|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44372097|NCT01205022|Growth Substances|growth substances|mesh-ancestor
44372098|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372099|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
43873546|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873547|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43873553|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873555|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873556|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873557|NCT04736186|Loperamide|loperamide|mesh-list
43873558|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
43873559|NCT04736186|Bentonite|bentonite|mesh-list
43873560|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43873561|NCT04736186|Antidotes|antidotes|mesh-ancestor
43873562|NCT04736186|Protective Agents|protective agents|mesh-ancestor
43873563|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873564|NCT04735523|Warfarin|warfarin|mesh-list
43873565|NCT04735523|Dabigatran|dabigatran|mesh-list
43873566|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
43873567|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
43873568|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43873569|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873570|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873571|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873572|NCT04735445|Liver Extracts|liver extracts|mesh-list
43873573|NCT04735445|Hematinics|hematinics|mesh-ancestor
43873574|NCT04735510|Cyclosporine|cyclosporine|mesh-list
43873575|NCT04735510|Cyclosporins|cyclosporins|mesh-list
43873576|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873577|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873578|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873579|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
43873580|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873581|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
43873582|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873583|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
43873584|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43873585|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43873586|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
43873587|NCT04735042|Empagliflozin|empagliflozin|mesh-list
43873588|NCT04735042|Linagliptin|linagliptin|mesh-list
43873589|NCT04735042|Saxagliptin|saxagliptin|mesh-list
43873590|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43873591|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873592|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873593|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873594|NCT04735042|Incretins|incretins|mesh-ancestor
43873595|NCT04735042|Hormones|hormones|mesh-ancestor
43873596|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873597|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43873598|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873599|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873600|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
43873601|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873602|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372100|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
44372101|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44372102|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44372103|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
44372104|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372105|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372106|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372107|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44372108|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372109|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372110|NCT01205022|Antidotes|antidotes|mesh-ancestor
44372111|NCT01205022|Protective Agents|protective agents|mesh-ancestor
44372112|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
44372113|NCT01205022|Vitamins|vitamins|mesh-ancestor
43873603|NCT04734782|Antibodies|antibodies|mesh-list
43873604|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
43873605|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873606|NCT04734665|Bevacizumab|bevacizumab|mesh-list
43873607|NCT04734665|Niraparib|niraparib|mesh-list
43873608|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873609|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873610|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873611|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873612|NCT04734665|Growth Substances|growth substances|mesh-ancestor
43873613|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873614|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
43873615|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43873616|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873617|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135363|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44135364|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44135365|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44135366|NCT00161239|Prednisone|prednisone|mesh-list
44135367|NCT00161239|Methotrexate|methotrexate|mesh-list
44135368|NCT00161239|Asparaginase|asparaginase|mesh-list
44135369|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135370|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
44135371|NCT00161239|Hormones|hormones|mesh-ancestor
44135372|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135373|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135374|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135375|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135376|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44135377|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
44135378|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135379|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44135380|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
44135381|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135382|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135383|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135384|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44135385|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135386|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
43610667|NCT03177993|Ivermectin|ivermectin|mesh-list
43610668|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43610669|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610670|NCT03178084|Lamivudine|lamivudine|mesh-list
43610671|NCT03178084|Zidovudine|zidovudine|mesh-list
43610693|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610695|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43610696|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43610697|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610698|NCT03177824|Urological Agents|urological agents|mesh-ancestor
43610699|NCT03177837|Acetazolamide|acetazolamide|mesh-list
43610700|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
43662393|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662394|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662395|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44135387|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135388|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135389|NCT00161278|Paclitaxel|paclitaxel|mesh-list
44135390|NCT00161278|Carboplatin|carboplatin|mesh-list
44135391|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44135392|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135393|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372115|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372116|NCT01205074|Ethanol|ethanol|mesh-list
44372117|NCT01205074|Propranolol|propranolol|mesh-list
44372118|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44372119|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44372120|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
44372121|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372122|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372123|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372124|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44135394|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44135395|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44135396|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135398|NCT00161291|Letrozole|letrozole|mesh-list
44135399|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135400|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135401|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44135402|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44135403|NCT00161291|Growth Substances|growth substances|mesh-ancestor
43873618|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43873619|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873620|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873621|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873622|NCT05314673|Bevacizumab|bevacizumab|mesh-list
43873623|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873624|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873625|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873626|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873627|NCT05314673|Growth Substances|growth substances|mesh-ancestor
43873628|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873629|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
43873630|NCT05314400|Liver Extracts|liver extracts|mesh-list
43873631|NCT05314400|Hematinics|hematinics|mesh-ancestor
43873632|NCT05314270|Copper|copper|mesh-list
43873633|NCT05314270|Trace Elements|trace elements|mesh-ancestor
43873634|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
43873635|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873636|NCT05314257|Granisetron|granisetron|mesh-list
43873637|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
43873638|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
43873639|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873640|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873641|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43873642|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43873643|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
43873644|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873645|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873649|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873651|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
43873652|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
43873653|NCT05314140|Calcium|calcium|mesh-list
43873654|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43873655|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873656|NCT05313958|Cytarabine|cytarabine|mesh-list
43873657|NCT05313958|Sorafenib|sorafenib|mesh-list
43873658|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
43873659|NCT05313958|Idarubicin|idarubicin|mesh-list
43873660|NCT05313958|Cladribine|cladribine|mesh-list
43873661|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43873662|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
43873663|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873664|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372125|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44372126|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
44372127|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44372128|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372129|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372131|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44372132|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372133|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44372134|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372135|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372136|NCT01205139|Simeprevir|simeprevir|mesh-list
43610742|NCT03177850|Diuretics|diuretics|mesh-ancestor
44372137|NCT01205139|Rilpivirine|rilpivirine|mesh-list
44372138|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
43873665|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
43873666|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873667|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873668|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
43873669|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873670|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873671|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873672|NCT05313958|Analgesics|analgesics|mesh-ancestor
43873673|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
43873674|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873675|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43873676|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43873677|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43873678|NCT05313906|Cisplatin|cisplatin|mesh-list
43873679|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873680|NCT05313828|Fluorometholone|fluorometholone|mesh-list
43873681|NCT05313828|Tobramycin|tobramycin|mesh-list
43873682|NCT05313828|Acyclovir|acyclovir|mesh-list
43873683|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
43873684|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873685|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873686|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43873687|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
43873688|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873689|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
43873690|NCT05313828|Protective Agents|protective agents|mesh-ancestor
43873691|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
43873692|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873693|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
43873694|NCT05313828|Hormones|hormones|mesh-ancestor
44135404|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873695|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610755|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610756|NCT03177538|Menotropins|menotropins|mesh-list
43610757|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43610758|NCT03177538|Hormones|hormones|mesh-ancestor
43610760|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873696|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43873697|NCT05313750|Levofloxacin|levofloxacin|mesh-list
43873698|NCT05313750|Ofloxacin|ofloxacin|mesh-list
43873699|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
43873700|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
43873701|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43873702|NCT05313750|Renal Agents|renal agents|mesh-ancestor
43873703|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43873704|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43873705|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43873706|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873707|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873708|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873709|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43873710|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873711|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
43873712|NCT05313477|Vitamin D|vitamin d|mesh-list
44372139|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372140|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
44372141|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372142|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372143|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44372144|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44372145|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44372146|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44372148|NCT01205178|Primaquine|primaquine|mesh-list
44372149|NCT01205178|Tafenoquine|tafenoquine|mesh-list
44372150|NCT01205178|Amebicides|amebicides|mesh-ancestor
44372151|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44372152|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44372153|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372154|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
44372155|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372156|NCT01205204|Clonidine|clonidine|mesh-list
44372157|NCT01205204|Fentanyl|fentanyl|mesh-list
44372158|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372159|NCT01205204|Narcotics|narcotics|mesh-ancestor
44372160|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372161|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372162|NCT01205204|Analgesics|analgesics|mesh-ancestor
44372163|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
44372164|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372165|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44372166|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44372167|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
44372168|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
44372169|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44372170|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
44372171|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
44372172|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44372173|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44372174|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44372175|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
44372176|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682303|NCT02849730|Fentanyl|fentanyl|mesh-list
44372177|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372178|NCT01205217|Paclitaxel|paclitaxel|mesh-list
44372179|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
44372180|NCT01205217|Trastuzumab|trastuzumab|mesh-list
44372181|NCT01205217|Epirubicin|epirubicin|mesh-list
44372182|NCT01205217|Lapatinib|lapatinib|mesh-list
44372183|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44372184|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662444|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
44372185|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
43662445|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
44372186|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44372187|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372188|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372189|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372190|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
44372191|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372192|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372193|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44372194|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
44372195|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44372196|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372197|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44372198|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44372199|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372200|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372201|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44372202|NCT01205243|Abacavir|abacavir|mesh-list
44372203|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44372204|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44372205|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372206|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372207|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
44372208|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873713|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
43873714|NCT05313477|Calcium|calcium|mesh-list
43873715|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43873716|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873717|NCT05313477|Antacids|antacids|mesh-ancestor
43873718|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873725|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
43873726|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43873727|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372209|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44027696|NCT00000344|Naloxone|naloxone|mesh-list
44372210|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44372211|NCT01205256|Methadone|methadone|mesh-list
44372212|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372213|NCT01205256|Narcotics|narcotics|mesh-ancestor
44372214|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372215|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372216|NCT01205256|Analgesics|analgesics|mesh-ancestor
44372217|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
44372218|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873728|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873729|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43873730|NCT05313386|Analgesics|analgesics|mesh-ancestor
43873731|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
43873732|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873733|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43873734|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43873735|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43873736|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873737|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873738|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873739|NCT05313308|Midazolam|midazolam|mesh-list
43873740|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43873741|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43873742|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873743|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873744|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43873745|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43873746|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662466|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
43873747|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43873748|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
43873749|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
43873750|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
43873751|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
43873752|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873753|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873754|NCT05312840|Gemcitabine|gemcitabine|mesh-list
43873755|NCT05312840|Cisplatin|cisplatin|mesh-list
43873756|NCT05312840|Carboplatin|carboplatin|mesh-list
43873757|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873758|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43873759|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
43873760|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873761|NCT05312840|Antiviral Agents|antiviral agents|mesh-ancestor
43873762|NCT05312840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873763|NCT05312840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873764|NCT05312840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43873765|NCT05312840|Immunologic Factors|immunologic factors|mesh-ancestor
43873766|NCT05312840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873767|NCT05296759|Gabapentin|gabapentin|mesh-list
43873768|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43873769|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
43873770|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43873771|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43873772|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43873773|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43873774|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873775|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
43873776|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873777|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873778|NCT05296759|Analgesics|analgesics|mesh-ancestor
43873779|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
43873780|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873781|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
43873782|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44372219|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
44372220|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44372221|NCT01205282|Pioglitazone|pioglitazone|mesh-list
44372222|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372223|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372224|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
44372225|NCT01205321|Bombesin|bombesin|mesh-list
44372226|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372227|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372228|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372229|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610771|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
43610773|NCT03177252|Lidocaine|lidocaine|mesh-list
44372230|NCT01205347|Simvastatin|simvastatin|mesh-list
44372231|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44372232|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44372233|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
44372234|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372235|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44372236|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44372237|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372238|NCT01205360|Fentanyl|fentanyl|mesh-list
44372239|NCT01205360|Bupivacaine|bupivacaine|mesh-list
44372240|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
44372241|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
44372242|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372243|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372244|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
43873783|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43873784|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873785|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43873786|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43873787|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43873788|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
43873794|NCT05292976|Albuterol|albuterol|mesh-list
43873795|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
43873796|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43873797|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
43873798|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873799|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873800|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43873801|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
43873802|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
43873803|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873804|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43873805|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43873806|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43873807|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873808|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702466|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372246|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372247|NCT01205360|Narcotics|narcotics|mesh-ancestor
44372248|NCT01205360|Analgesics|analgesics|mesh-ancestor
44372249|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44372250|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44372251|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
44372252|NCT01205464|Doxycycline|doxycycline|mesh-list
44372253|NCT01205464|Tetracycline|tetracycline|mesh-list
44372254|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372255|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372256|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
44372257|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44372258|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44372259|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44372260|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372261|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372262|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43682421|NCT02848183|Analgesics|analgesics|mesh-ancestor
43873809|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873810|NCT05292976|Miotics|miotics|mesh-ancestor
43873811|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43873812|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43873813|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43873814|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43873815|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
43873816|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43873817|NCT05286554|Hormones|hormones|mesh-list
43873818|NCT05286554|Progesterone|progesterone|mesh-list
43873819|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873820|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873821|NCT05286554|Progestins|progestins|mesh-ancestor
43873822|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
43873823|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43873824|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
43873825|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873826|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43873827|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43873828|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873829|NCT05286190|Bupivacaine|bupivacaine|mesh-list
43873830|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
43873831|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
43873832|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873833|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873834|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
43873835|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873836|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43873837|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873838|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873839|NCT05240898|Adenosine|adenosine|mesh-list
43873840|NCT05240898|Analgesics|analgesics|mesh-ancestor
43873841|NCT05240898|Sensory System Agents|sensory system agents|mesh-ancestor
43873842|NCT05240898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873843|NCT05240898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873844|NCT05240898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873845|NCT05240898|Vasodilator Agents|vasodilator agents|mesh-ancestor
43610811|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43610813|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
43610814|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
43610816|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610817|NCT03177083|Interferons|interferons|mesh-list
43649890|NCT03018015|Ibuprofen|ibuprofen|mesh-list
44372263|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372264|NCT01205516|Morphine|morphine|mesh-list
44372265|NCT01205516|Methadone|methadone|mesh-list
44372266|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372267|NCT01205516|Narcotics|narcotics|mesh-ancestor
44372268|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372269|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372270|NCT01205516|Analgesics|analgesics|mesh-ancestor
44372271|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
44372272|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372273|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
44372274|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
44372275|NCT01205672|Metformin|metformin|mesh-list
44372276|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372277|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372278|NCT01205711|Leucovorin|leucovorin|mesh-list
44372279|NCT01205711|Fluorouracil|fluorouracil|mesh-list
44372280|NCT01205711|Irinotecan|irinotecan|mesh-list
44372281|NCT01205711|Calcium|calcium|mesh-list
44372282|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
43873846|NCT05240898|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43873847|NCT05240898|Purinergic Agonists|purinergic agonists|mesh-ancestor
43873848|NCT05240898|Purinergic Agents|purinergic agents|mesh-ancestor
43873849|NCT05240898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873850|NCT05240898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873851|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
43873852|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135405|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44135406|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44135407|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44135408|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135413|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
44135414|NCT00161304|Testosterone|testosterone|mesh-list
44135415|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
43610826|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44135416|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
44135417|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44135418|NCT00161304|Androgens|androgens|mesh-ancestor
44135419|NCT00161304|Hormones|hormones|mesh-ancestor
44135420|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135421|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135422|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135423|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135424|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
44135425|NCT00161330|Amoxicillin|amoxicillin|mesh-list
44135426|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
44135427|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
44135428|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
44135429|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44135430|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135431|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135432|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135433|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44135434|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44135435|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
44135436|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135437|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44135438|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44135439|NCT00161421|Leuprolide|leuprolide|mesh-list
44135440|NCT00161421|Testosterone|testosterone|mesh-list
44135441|NCT00161421|Dutasteride|dutasteride|mesh-list
44135443|NCT00161421|Hormones|hormones|mesh-ancestor
44372283|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44372284|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372285|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
44372286|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372287|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372288|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372289|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372290|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
43610870|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610871|NCT03176316|Naloxone|naloxone|mesh-list
44372291|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44372292|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372293|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372294|NCT01205711|Antidotes|antidotes|mesh-ancestor
44372295|NCT01205711|Protective Agents|protective agents|mesh-ancestor
44372296|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
44372297|NCT01205711|Vitamins|vitamins|mesh-ancestor
44372298|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
44372299|NCT01205724|Factor VIII|factor viii|mesh-list
44372300|NCT01205724|Coagulants|coagulants|mesh-ancestor
44372301|NCT01205737|Rituximab|rituximab|mesh-list
44372302|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372303|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372304|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
44372305|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372306|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372307|NCT01205750|Insulin|insulin|mesh-list
44372308|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44372309|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372310|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372311|NCT01205880|Calcitriol|calcitriol|mesh-list
44372312|NCT01205880|Clobetasol|clobetasol|mesh-list
44372313|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44135444|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135445|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135446|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135447|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135448|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44135449|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
44135450|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135451|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44135452|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44135453|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135454|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135455|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135456|NCT00161434|Valacyclovir|valacyclovir|mesh-list
44372314|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372315|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44372316|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44372317|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372318|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44372319|NCT01205880|Vitamins|vitamins|mesh-ancestor
44135457|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
44135458|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135459|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44135460|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
44135461|NCT00161447|Testosterone|testosterone|mesh-list
44135462|NCT00161447|Acyline|acyline|mesh-list
44135463|NCT00161447|Androgens|androgens|mesh-ancestor
44135464|NCT00161447|Hormones|hormones|mesh-ancestor
44135465|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135466|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135467|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135468|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135469|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44135470|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44155787|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43873853|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
43873854|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43873855|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
43873856|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873857|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
43873858|NCT05218148|Trastuzumab|trastuzumab|mesh-list
43873859|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873860|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873861|NCT05195996|Propranolol|propranolol|mesh-list
43873867|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873868|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873869|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43873870|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
43873871|NCT05065424|Atropine|atropine|mesh-list
43873872|NCT05065424|Fentanyl|fentanyl|mesh-list
43873873|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43873874|NCT05065424|Narcotics|narcotics|mesh-ancestor
43873875|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873876|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873877|NCT05065424|Analgesics|analgesics|mesh-ancestor
43873878|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
43873879|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873880|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43873881|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43873882|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
43873883|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
43873884|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873885|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873886|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43873887|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
43873888|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43873889|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
43873890|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
43873891|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
43873892|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43873893|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43873894|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
43873895|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873897|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873898|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873899|NCT04943783|Atorvastatin|atorvastatin|mesh-list
43873900|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43873901|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43873902|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
43873903|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873904|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43873905|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43873906|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372320|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
44372321|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44372322|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372323|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
44372324|NCT01205880|Hormones|hormones|mesh-ancestor
44372325|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372326|NCT01205932|Enoxaparin|enoxaparin|mesh-list
44372327|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
44372328|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44372329|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
44372330|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44372331|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44372332|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372333|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372334|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
44372335|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44372336|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44372337|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
44372338|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649893|NCT03018015|Analgesics|analgesics|mesh-ancestor
43649894|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
43649895|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662559|NCT02913469|Analgesics|analgesics|mesh-ancestor
44372339|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44372340|NCT01205958|Analgesics|analgesics|mesh-ancestor
44372341|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
44372342|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372343|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372344|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372345|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372346|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
44372347|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44372348|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
44372349|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44372350|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44372351|NCT01205984|Prednisolone|prednisolone|mesh-list
44372352|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
43873907|NCT04737187|Trifluridine|trifluridine|mesh-list
43873908|NCT04737187|Bevacizumab|bevacizumab|mesh-list
43873909|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873910|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873911|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43873912|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43873913|NCT04737187|Growth Substances|growth substances|mesh-ancestor
43873914|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873915|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
44372353|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44372354|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
44372355|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372356|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
44372357|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
44372358|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372359|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372360|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372361|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
44372362|NCT01205984|Hormones|hormones|mesh-ancestor
44372363|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372364|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44372365|NCT01205984|Protective Agents|protective agents|mesh-ancestor
44372366|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43873916|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
43873917|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873918|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
43873919|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873920|NCT04706013|Pyridoxal|pyridoxal|mesh-list
43873921|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
43873922|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
43873923|NCT04706013|Vitamins|vitamins|mesh-ancestor
43873924|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
43873925|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873926|NCT04685421|Bupivacaine|bupivacaine|mesh-list
43873927|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
43873928|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
43873929|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43873930|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873931|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
43873932|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873960|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43873962|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873963|NCT04502433|Poractant alfa|poractant alfa|mesh-list
43873965|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
43873966|NCT04482959|Carbetocin|carbetocin|mesh-list
43873967|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
43873968|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43873969|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873970|NCT04472767|Nivolumab|nivolumab|mesh-list
43873971|NCT04472767|Ipilimumab|ipilimumab|mesh-list
43873972|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873973|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873974|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43873975|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135471|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44135472|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
44135473|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135474|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44135475|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44135476|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44135477|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135478|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
44135479|NCT00161486|Testosterone|testosterone|mesh-list
44135481|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
44135482|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44135483|NCT00161486|Acyline|acyline|mesh-list
44135484|NCT00161486|Androgens|androgens|mesh-ancestor
44135485|NCT00161486|Hormones|hormones|mesh-ancestor
44135486|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135487|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372368|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372369|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372370|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44372371|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372372|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372373|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
44372374|NCT01205997|Fentanyl|fentanyl|mesh-list
44372375|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372376|NCT01205997|Narcotics|narcotics|mesh-ancestor
44372377|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372378|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372379|NCT01205997|Analgesics|analgesics|mesh-ancestor
44372380|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
44372381|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372382|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44372383|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44372384|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
44372385|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
44372386|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44372387|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
44372388|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44135488|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44135489|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135490|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
44135491|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135492|NCT00161564|Rituximab|rituximab|mesh-list
44135493|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135494|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135495|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
44135496|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135497|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135498|NCT00161577|Ketorolac|ketorolac|mesh-list
44135499|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44135500|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43873976|NCT04403516|Dexamethasone|dexamethasone|mesh-list
43873977|NCT04403516|Prednisolone|prednisolone|mesh-list
43873978|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43873979|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
43873980|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43662595|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43662596|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662597|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662600|NCT02913118|Amoxicillin|amoxicillin|mesh-list
43873981|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
43873982|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43873983|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
43873984|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43873985|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
43873986|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
43873987|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873988|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873989|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43873990|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
43873992|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873993|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44372389|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44372390|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372391|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44372392|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
44372393|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44372394|NCT01206010|Varenicline|varenicline|mesh-list
44372395|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44372396|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44372397|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
44372398|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372399|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372400|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372401|NCT01206036|Sirolimus|sirolimus|mesh-list
44372402|NCT01206036|Docetaxel|docetaxel|mesh-list
44372403|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372404|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372405|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
44372406|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372407|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372408|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372409|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372410|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44372411|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
44372412|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372413|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
44372414|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372415|NCT01206049|Gemcitabine|gemcitabine|mesh-list
43873994|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873995|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43873996|NCT04403516|Protective Agents|protective agents|mesh-ancestor
43873997|NCT04383639|Locust bean gum|locust bean gum|mesh-list
43873998|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
43873999|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874000|NCT04349722|Scopolamine|scopolamine|mesh-list
43874001|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43874002|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43874003|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
43874004|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
43874005|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874006|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874007|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874009|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43874010|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
43874011|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874012|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874013|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43610927|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
43610928|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
43610929|NCT03175926|Hormones|hormones|mesh-ancestor
43610930|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610931|NCT03175679|Interleukin-2|interleukin-2|mesh-list
43610967|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
43874014|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
44372416|NCT01206049|Bevacizumab|bevacizumab|mesh-list
44372417|NCT01206049|Panitumumab|panitumumab|mesh-list
44372418|NCT01206049|Capecitabine|capecitabine|mesh-list
44372419|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
44372420|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372421|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372422|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44372423|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44372424|NCT01206049|Growth Substances|growth substances|mesh-ancestor
44372425|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372426|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
44372427|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372428|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
43874015|NCT04313972|Naltrexone|naltrexone|mesh-list
43874016|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43874017|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43874018|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874019|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
43874020|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874021|NCT04302454|Leuprolide|leuprolide|mesh-list
43874022|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43874023|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
43874024|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43874025|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874026|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43874027|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874028|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43874029|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
43874030|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43874038|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874040|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
43874041|NCT04225819|Vitamins|vitamins|mesh-ancestor
43874042|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
43874043|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874044|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43874045|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43874046|NCT04199624|Ascorbic Acid|ascorbic acid|mesh-list
43874047|NCT04199624|Omeprazole|omeprazole|mesh-list
43874048|NCT04199624|Vitamins|vitamins|mesh-ancestor
43874049|NCT04199624|Micronutrients|micronutrients|mesh-ancestor
43874050|NCT04199624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874051|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43874052|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874053|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43874054|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874055|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874056|NCT04199624|Antioxidants|antioxidants|mesh-ancestor
43874057|NCT04199624|Protective Agents|protective agents|mesh-ancestor
43874058|NCT04154943|Cemiplimab|cemiplimab|mesh-list
43874059|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611008|NCT03175341|Protective Agents|protective agents|mesh-ancestor
43611010|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43611011|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
43611037|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611044|NCT03174938|Flutemetamol|flutemetamol|mesh-list
43874060|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874061|NCT04123470|Atezolizumab|atezolizumab|mesh-list
43874062|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874063|NCT04074343|Irinotecan|irinotecan|mesh-list
43874064|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43874065|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43874066|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874067|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874068|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874069|NCT04069117|Letrozole|letrozole|mesh-list
43874070|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874071|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43874072|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43874073|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372429|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372430|NCT01206049|Antiviral Agents|antiviral agents|mesh-ancestor
44372431|NCT01206049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372432|NCT01206049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372433|NCT01206049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372434|NCT01206049|Immunologic Factors|immunologic factors|mesh-ancestor
44372435|NCT01206075|Plerixafor|plerixafor|mesh-list
44372436|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44027924|NCT00000384|Sertraline|sertraline|mesh-list
44372437|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44372438|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
44372439|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372440|NCT01206153|Metformin|metformin|mesh-list
44372441|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372442|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372443|NCT01206205|Lenalidomide|lenalidomide|mesh-list
44372444|NCT01206205|Bortezomib|bortezomib|mesh-list
44372445|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
44372446|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874074|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874075|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43874076|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
43874077|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43874078|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874079|NCT04061252|Brodalumab|brodalumab|mesh-list
43874080|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874081|NCT04041232|Glycerol|glycerol|mesh-list
43874082|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43874083|NCT04041232|Protective Agents|protective agents|mesh-ancestor
43874084|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874085|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
43874086|NCT04040361|Ramucirumab|ramucirumab|mesh-list
43874087|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611046|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611047|NCT03174860|Diclofenac|diclofenac|mesh-list
43611048|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611049|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611050|NCT03174860|Analgesics|analgesics|mesh-ancestor
43662628|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
43874088|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874089|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43874090|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43874091|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43874092|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43874093|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874094|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874095|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874096|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874097|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874098|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874106|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874107|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43874108|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
43874109|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
43874110|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874111|NCT03996148|Analgesics|analgesics|mesh-ancestor
43874112|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
43874113|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874114|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874115|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874116|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874117|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874118|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43573561|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44372447|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44372448|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44372449|NCT01206205|Growth Substances|growth substances|mesh-ancestor
44372450|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
44372451|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372452|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
44372453|NCT01206270|Castor Oil|castor oil|mesh-list
43874119|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874120|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43874121|NCT03996148|Narcotics|narcotics|mesh-ancestor
43874122|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43874123|NCT03940131|Panitumumab|panitumumab|mesh-list
43874124|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874125|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874126|NCT03926845|Thiamidol|thiamidol|mesh-list
43874127|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874128|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874130|NCT03912818|Cisplatin|cisplatin|mesh-list
43874131|NCT03912818|Carboplatin|carboplatin|mesh-list
43874132|NCT03912818|Doxorubicin|doxorubicin|mesh-list
43874133|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43874134|NCT03912818|Methotrexate|methotrexate|mesh-list
43874135|NCT03912818|Durvalumab|durvalumab|mesh-list
43874136|NCT03912818|Daunorubicin|daunorubicin|mesh-list
43874137|NCT03912818|Vinblastine|vinblastine|mesh-list
43874138|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874139|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43874140|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
43874141|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874142|NCT03912818|Antiviral Agents|antiviral agents|mesh-ancestor
43874143|NCT03912818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874144|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874145|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43874146|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
43874147|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874148|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43874149|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43874150|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43874151|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43874152|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
43874153|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662642|NCT02912910|Labetalol|labetalol|mesh-list
43874154|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874155|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43874156|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874157|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43874158|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874159|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43874160|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
43874161|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874162|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874163|NCT03906539|Atorvastatin|atorvastatin|mesh-list
43874164|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43874165|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43874166|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
43874167|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874168|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43874178|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874179|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874180|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43874181|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44135501|NCT00161577|Analgesics|analgesics|mesh-ancestor
44135502|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
44135503|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135504|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135505|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135506|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135507|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44135508|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573562|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
44372454|NCT01206270|Testosterone|testosterone|mesh-list
44372455|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
44372456|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
44372457|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44372458|NCT01206270|Androgens|androgens|mesh-ancestor
44372460|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372461|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372462|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44372463|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372464|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
44372465|NCT01206270|Cathartics|cathartics|mesh-ancestor
44372466|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372467|NCT01206348|Minocycline|minocycline|mesh-list
44135509|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135510|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
43611054|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611055|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611056|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611057|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611058|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611059|NCT03174821|Insulin|insulin|mesh-list
43611071|NCT03174561|Choline|choline|mesh-list
43611072|NCT03174561|Silymarin|silymarin|mesh-list
43611073|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
43662651|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662652|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43662653|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43662654|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662655|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662656|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135511|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135512|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135513|NCT00161655|Etanercept|etanercept|mesh-list
44135514|NCT00161655|Methotrexate|methotrexate|mesh-list
44135515|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44135516|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
44135517|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135518|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135519|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44135520|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
43874182|NCT03808480|Nivolumab|nivolumab|mesh-list
43874183|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874184|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874185|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43874186|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874187|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
43874188|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43874189|NCT03780790|Bupivacaine|bupivacaine|mesh-list
43874190|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874191|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
43874192|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874193|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874194|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
43874195|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874196|NCT03769298|Tacrolimus|tacrolimus|mesh-list
43874197|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43874198|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
43874199|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874200|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43874201|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874202|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611074|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43611075|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
43611076|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611077|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43611078|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43611079|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
43611080|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
43611081|NCT03174561|Protective Agents|protective agents|mesh-ancestor
43611082|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611083|NCT03174782|Bupivacaine|bupivacaine|mesh-list
43611084|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43611085|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
43611086|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611087|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611088|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
43874203|NCT03761953|Oritavancin|oritavancin|mesh-list
43874204|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43874205|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874206|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43874207|NCT03751800|Dienogest|dienogest|mesh-list
43874208|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
43874209|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
43874210|NCT03751800|Estradiol|estradiol|mesh-list
43874211|NCT03751800|Estrogens|estrogens|mesh-ancestor
43874212|NCT03751800|Hormones|hormones|mesh-ancestor
43849800|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874216|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
43874217|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43874218|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43874219|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44372469|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
44372470|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
44372471|NCT01206348|Tretinoin|tretinoin|mesh-list
44372472|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44372473|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372474|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372475|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44372476|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372477|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372478|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44372479|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372480|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
43874220|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43874221|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43874222|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43874223|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43874224|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874225|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
43874226|NCT03709888|Pregabalin|pregabalin|mesh-list
43874227|NCT03709888|Memantine|memantine|mesh-list
43874228|NCT03709888|Analgesics|analgesics|mesh-ancestor
43874229|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
43874230|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874231|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874232|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
43874233|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43874234|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43874235|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874236|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43874237|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43874238|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43874239|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874240|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43874241|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43874242|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43874243|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
43874244|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874245|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43874246|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43874247|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43874248|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874249|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874250|NCT03616717|Modafinil|modafinil|mesh-list
43669253|NCT02905890|Norethindrone|norethindrone|mesh-list
43874251|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43874252|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874253|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43874254|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43874255|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43874256|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874258|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
43874259|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874260|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
43874261|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43874262|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
43874263|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874264|NCT03575208|Interferons|interferons|mesh-list
43874265|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
43874266|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
43874267|NCT03575208|Antibodies|antibodies|mesh-list
44372482|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
44372483|NCT01206530|Bevacizumab|bevacizumab|mesh-list
44372484|NCT01206530|Fluorouracil|fluorouracil|mesh-list
44372485|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
44372486|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372487|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372488|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44372489|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44372490|NCT01206530|Growth Substances|growth substances|mesh-ancestor
44372491|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372492|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
44372493|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
44372494|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372495|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372496|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372497|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
43874268|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
43874269|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43874270|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43874271|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874272|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
43874273|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874274|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
43874275|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874276|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
43874277|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874278|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874279|NCT03423199|Tamoxifen|tamoxifen|mesh-list
43874280|NCT03423199|Goserelin|goserelin|mesh-list
43874281|NCT03423199|Palbociclib|palbociclib|mesh-list
43874282|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43874295|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874296|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874297|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874298|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874299|NCT03384563|Analgesics|analgesics|mesh-ancestor
43874300|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
43874301|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874302|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874303|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874304|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874305|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874306|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874307|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874308|NCT03295747|Peppermint oil|peppermint oil|mesh-list
43874309|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
43874310|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
43662668|NCT02912702|Pegaspargase|pegaspargase|mesh-list
43662669|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662670|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
43662671|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
43662672|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662673|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662674|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874311|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874312|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874313|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874314|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
43874315|NCT03295552|Carboplatin|carboplatin|mesh-list
43874316|NCT03295552|Decitabine|decitabine|mesh-list
43874317|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874318|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43874319|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
43874320|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874321|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372498|NCT01206530|Antidotes|antidotes|mesh-ancestor
44372499|NCT01206530|Protective Agents|protective agents|mesh-ancestor
44372500|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
44372501|NCT01206530|Vitamins|vitamins|mesh-ancestor
44372502|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
44372503|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
44372504|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44372505|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44372506|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372507|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372508|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372509|NCT01206569|Tacrolimus|tacrolimus|mesh-list
44372510|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372511|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
44372512|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372513|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44372514|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372515|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372516|NCT01206647|Metformin|metformin|mesh-list
44372517|NCT01206647|Saxagliptin|saxagliptin|mesh-list
44372518|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44027993|NCT00000412|Calcitriol|calcitriol|mesh-list
44372519|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372520|NCT01206647|Incretins|incretins|mesh-ancestor
44372521|NCT01206647|Hormones|hormones|mesh-ancestor
44372522|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682610|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874322|NCT03262454|Atezolizumab|atezolizumab|mesh-list
43874323|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874324|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
43874325|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43874326|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43874327|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874328|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
43874329|NCT03216083|Coagulants|coagulants|mesh-ancestor
43874330|NCT03164980|Trabectedin|trabectedin|mesh-list
43874331|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43874332|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
43874333|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874334|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874343|NCT03126799|Bevacizumab|bevacizumab|mesh-list
43874344|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43874345|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874346|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874347|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43874348|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43874349|NCT03126799|Growth Substances|growth substances|mesh-ancestor
43874360|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
43874361|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43874362|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43874363|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44372523|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44372525|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372526|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372527|NCT01206803|Ganirelix|ganirelix|mesh-list
44372528|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
44372529|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43682634|NCT02846857|Insulin|insulin|mesh-list
43874364|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874365|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874366|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
43874367|NCT02858921|Trametinib|trametinib|mesh-list
43874368|NCT02858921|Dabrafenib|dabrafenib|mesh-list
43874369|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874370|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874371|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874372|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874373|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874374|NCT02826161|Paclitaxel|paclitaxel|mesh-list
43874375|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43874376|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874377|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
43874378|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874379|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874380|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135521|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135522|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135523|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135524|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135525|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44135526|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135527|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
44135528|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135529|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135530|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44135531|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44135532|NCT00161655|Analgesics|analgesics|mesh-ancestor
44135533|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
44135534|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135535|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44135536|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135537|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
44135538|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135539|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135540|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
44135541|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44135542|NCT00161681|Estradiol|estradiol|mesh-list
44135543|NCT00161681|Estrogens|estrogens|mesh-ancestor
43874381|NCT02697474|Vaccines|vaccines|mesh-list
43874382|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
43874383|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874384|NCT02315534|Temozolomide|temozolomide|mesh-list
43874385|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43874386|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
43874387|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874388|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874389|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
43874390|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874391|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874398|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874399|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874400|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874401|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874402|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874403|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372530|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372532|NCT01206881|Docetaxel|docetaxel|mesh-list
44372533|NCT01206881|Doxorubicin|doxorubicin|mesh-list
44372534|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44372535|NCT01206881|Trastuzumab|trastuzumab|mesh-list
44372536|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662688|NCT02912676|Methotrexate|methotrexate|mesh-list
44372537|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
44372538|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372539|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372540|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44372541|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
44372542|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372543|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372544|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44372545|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44372546|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874404|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874405|NCT02024607|Leucovorin|leucovorin|mesh-list
43874406|NCT02024607|Bevacizumab|bevacizumab|mesh-list
43874407|NCT02024607|Fluorouracil|fluorouracil|mesh-list
43874408|NCT02024607|Capecitabine|capecitabine|mesh-list
43874409|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
43874410|NCT02024607|Irinotecan|irinotecan|mesh-list
43874411|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874412|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874413|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43874414|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43874415|NCT02024607|Growth Substances|growth substances|mesh-ancestor
43874416|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874417|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
43874418|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
43874419|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874420|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43874421|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611089|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611090|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
43611091|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43611092|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611093|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
43611094|NCT03174483|Fluticasone|fluticasone|mesh-list
43611095|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662697|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662698|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662699|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
43662700|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662701|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43662702|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662703|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
43662704|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662705|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43874422|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
43874423|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43874424|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43874425|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874426|NCT02024607|Antidotes|antidotes|mesh-ancestor
43874427|NCT02024607|Protective Agents|protective agents|mesh-ancestor
43874428|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
43874429|NCT02024607|Vitamins|vitamins|mesh-ancestor
43874430|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
43874431|NCT01929811|Metformin|metformin|mesh-list
43874432|NCT01929811|Docetaxel|docetaxel|mesh-list
43874433|NCT01929811|Epirubicin|epirubicin|mesh-list
43874434|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43874435|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874436|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874437|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
43669264|NCT02906163|Gefitinib|gefitinib|mesh-list
43874438|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874439|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874440|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874441|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43874442|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43874443|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43874444|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874445|NCT01803555|Budesonide|budesonide|mesh-list
43874446|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
44372547|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44372548|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44372549|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44372550|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44372551|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372552|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372553|NCT01206907|Oxymorphone|oxymorphone|mesh-list
44372554|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372555|NCT01206907|Narcotics|narcotics|mesh-ancestor
44372556|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372557|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372558|NCT01206907|Analgesics|analgesics|mesh-ancestor
44372559|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
44372560|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372561|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44028066|NCT00000441|Carbamazepine|carbamazepine|mesh-list
44372562|NCT01206946|Betamethasone|betamethasone|mesh-list
44372563|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372564|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
44372565|NCT01206946|Hormones|hormones|mesh-ancestor
44372566|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372567|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372568|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43682661|NCT02846766|Lenvatinib|lenvatinib|mesh-list
43874447|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43874448|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43874449|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43874450|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
43874451|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874452|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874453|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43874454|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
43874455|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
43662719|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43662720|NCT02912169|Anesthetics|anesthetics|mesh-list
43662721|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662722|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662723|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43874456|NCT01803555|Hormones|hormones|mesh-ancestor
43874457|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43874458|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43874459|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43874460|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874461|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874462|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874470|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874471|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874473|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43874474|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
43874475|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
43874476|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43874477|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874478|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874479|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874480|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583893|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
44372569|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44372570|NCT01206972|Enoxaparin|enoxaparin|mesh-list
44372571|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
44372572|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44372573|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
44372574|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44372575|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
44372576|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372577|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372578|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
44372579|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44372580|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44372581|NCT01206998|Progesterone|progesterone|mesh-list
44372582|NCT01206998|Progestins|progestins|mesh-ancestor
44372583|NCT01206998|Hormones|hormones|mesh-ancestor
44372584|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372585|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372586|NCT01207128|Voriconazole|voriconazole|mesh-list
44372587|NCT01207128|Micafungin|micafungin|mesh-list
44372588|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
44372589|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372590|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44372591|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44372592|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372593|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372594|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44372595|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
44372596|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372597|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372598|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44372599|NCT01207206|Ketamine|ketamine|mesh-list
44372600|NCT01207206|Analgesics|analgesics|mesh-ancestor
44372607|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
43649897|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611096|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43611097|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
43611098|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611099|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611100|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43662731|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43662732|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
43662733|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662734|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
44372610|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44372611|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372612|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372613|NCT01207245|Tobramycin|tobramycin|mesh-list
44372614|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372615|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372616|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
44372617|NCT01207297|Tacrolimus|tacrolimus|mesh-list
44372618|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372619|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
44372620|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372621|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372622|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44372623|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
44372624|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372625|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372626|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44372627|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44372628|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372629|NCT01207310|Nicotine|nicotine|mesh-list
44372630|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44372631|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
44372632|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372633|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372634|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44372635|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44028140|NCT00000447|Naltrexone|naltrexone|mesh-list
44372636|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44372637|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372638|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372654|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44372655|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372656|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
44372657|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372658|NCT05623761|Fluorides|fluorides|mesh-list
44372659|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
44372660|NCT05623761|Protective Agents|protective agents|mesh-ancestor
44372661|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372662|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
44372663|NCT05623319|Olaparib|olaparib|mesh-list
44372664|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372665|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372666|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44372667|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44372668|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372669|NCT05623111|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44372670|NCT05623111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44372710|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372711|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44372712|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
44372713|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372714|NCT05621005|Rifaximin|rifaximin|mesh-list
44372715|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44372716|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372717|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44372718|NCT05618314|Probenecid|probenecid|mesh-list
44372719|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
44372720|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
44372721|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372722|NCT05618314|Renal Agents|renal agents|mesh-ancestor
44372723|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
44372724|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44372725|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372726|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44372727|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372728|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
44372729|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44372730|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
44372731|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372732|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
44372733|NCT05613075|Protective Agents|protective agents|mesh-ancestor
44372734|NCT05602818|Alprazolam|alprazolam|mesh-list
44372761|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44372762|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44372763|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372764|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44372765|NCT05577117|Analgesics|analgesics|mesh-ancestor
44372766|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
44372767|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372768|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44372769|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44372770|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44372771|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
44372772|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372773|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372774|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44372775|NCT05577117|Narcotics|narcotics|mesh-ancestor
44372776|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44372777|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44372778|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
44372779|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
44372780|NCT05575700|Ibuprofen|ibuprofen|mesh-list
44372781|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44372782|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611110|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611111|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611112|NCT03174678|Analgesics|analgesics|mesh-ancestor
44372783|NCT05575700|Analgesics|analgesics|mesh-ancestor
44372784|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
44372785|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372797|NCT05555329|Thalidomide|thalidomide|mesh-list
44372813|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44372814|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44372816|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
44372817|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372818|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372819|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372826|NCT05543785|Ketorolac|ketorolac|mesh-list
44372827|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44372828|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44372829|NCT05543785|Analgesics|analgesics|mesh-ancestor
44372838|NCT05520749|Luspatercept|luspatercept|mesh-list
44372858|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44372859|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
44372860|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44372861|NCT05435053|Nivolumab|nivolumab|mesh-list
44372862|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372863|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372864|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44372865|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372867|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372868|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
44372869|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44372870|NCT05344469|Interferons|interferons|mesh-list
44372871|NCT05344469|Interferon-beta|interferon-beta|mesh-list
44372872|NCT05344469|Ofatumumab|ofatumumab|mesh-list
44372873|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
44372874|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
44372875|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372876|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
44372877|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372878|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44372879|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
44372880|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372881|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44372882|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372883|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
44372884|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44372885|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372907|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
44372908|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44372909|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44372910|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44372911|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
44372912|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44372913|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372914|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44372915|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44372916|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
43611152|NCT03174067|Clonidine|clonidine|mesh-list
43611153|NCT03174067|Buprenorphine|buprenorphine|mesh-list
43611154|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43611155|NCT03174067|Narcotics|narcotics|mesh-ancestor
43611158|NCT03174067|Analgesics|analgesics|mesh-ancestor
44372917|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44372918|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44372919|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
44372920|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
44372921|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44372922|NCT05255276|Itraconazole|itraconazole|mesh-list
44372923|NCT05255276|Rifampin|rifampin|mesh-list
44372924|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
44372925|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372926|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44372958|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
44372959|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372960|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372961|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44372962|NCT05192200|Interferons|interferons|mesh-list
44372963|NCT05192200|Interferon-beta|interferon-beta|mesh-list
44372964|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372965|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
44372966|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44372967|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
44372968|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372969|NCT05101564|Tamoxifen|tamoxifen|mesh-list
44372970|NCT05101564|Fulvestrant|fulvestrant|mesh-list
44372971|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44372972|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
44372973|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44372974|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372975|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44372976|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44372977|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44372978|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44372979|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44372980|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44372981|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44372982|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44372983|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44372984|NCT05036109|Aspirin|aspirin|mesh-list
44372985|NCT05036109|Vitamin D|vitamin d|mesh-list
44372986|NCT05036109|Vitamins|vitamins|mesh-ancestor
44372987|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
44372988|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44372989|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44372990|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44372991|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44372992|NCT05036109|Analgesics|analgesics|mesh-ancestor
44372995|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44372996|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44372997|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44372998|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44372999|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373000|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373001|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44373002|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373003|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
44373004|NCT05034562|Edetic Acid|edetic acid|mesh-list
44373005|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44373006|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
44373007|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
44373008|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373009|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
44373010|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44373011|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44373012|NCT05030818|Aspirin|aspirin|mesh-list
44373013|NCT05030818|Ramipril|ramipril|mesh-list
44373014|NCT05030818|Atorvastatin|atorvastatin|mesh-list
44373051|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373052|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373053|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373054|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
44373055|NCT05027594|Hormones|hormones|mesh-ancestor
44373056|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373057|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373058|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373059|NCT05026905|Leucovorin|leucovorin|mesh-list
44373060|NCT05026905|Gemcitabine|gemcitabine|mesh-list
44373061|NCT05026905|Paclitaxel|paclitaxel|mesh-list
44373062|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44373063|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
44373064|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373065|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373066|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373067|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373068|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373110|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373111|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44373112|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44373113|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44373114|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44373115|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373116|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373117|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
44373118|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44373120|NCT04877093|Analgesics|analgesics|mesh-ancestor
44373121|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
44373122|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373123|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373124|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44373169|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373170|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373171|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44373172|NCT04795531|Insulin|insulin|mesh-list
44373173|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44373174|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
44373175|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44373176|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373177|NCT04785625|Bupivacaine|bupivacaine|mesh-list
44373178|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
44373179|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
44373180|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373181|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373182|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
44373183|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373184|NCT04785326|Ustekinumab|ustekinumab|mesh-list
44373185|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44373186|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44373187|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
44373188|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44373223|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43611183|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43611184|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
43611185|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
43611186|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
43611187|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
43611188|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373224|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44373225|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
44373227|NCT04618913|Apixaban|apixaban|mesh-list
44373228|NCT04618913|Edoxaban|edoxaban|mesh-list
44373229|NCT04618913|Dabigatran|dabigatran|mesh-list
44373230|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44373231|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
44373232|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44373233|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
44373234|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373235|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373236|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
44373237|NCT04612790|Benralizumab|benralizumab|mesh-list
44373238|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44373239|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44373240|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44373241|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44373242|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373243|NCT04536337|Entecavir|entecavir|mesh-list
44373244|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
44373279|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
44373280|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44373281|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
44373283|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373284|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373285|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373286|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373298|NCT04388839|Dactinomycin|dactinomycin|mesh-list
44373299|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
44373300|NCT04388839|Vincristine|vincristine|mesh-list
44373301|NCT04388839|Vinorelbine|vinorelbine|mesh-list
44373302|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373303|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
44373304|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373305|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373306|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44373307|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
44373308|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373309|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373310|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44373311|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373312|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373313|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373314|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373315|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373316|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373317|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44373318|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44373319|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874481|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874482|NCT01791816|Protective Agents|protective agents|mesh-ancestor
43874483|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874484|NCT01786434|Fentanyl|fentanyl|mesh-list
44373320|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44373321|NCT04356352|Lidocaine|lidocaine|mesh-list
44373322|NCT04356352|Esmolol|esmolol|mesh-list
44373323|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
44373324|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
44373325|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373326|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373327|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
44373328|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373329|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44373330|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44373331|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44373332|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44373333|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373334|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44373335|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44373336|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44373337|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373338|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373339|NCT04338204|Tofacitinib|tofacitinib|mesh-list
44373340|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373341|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373342|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373343|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
44373344|NCT04313153|Hematinics|hematinics|mesh-ancestor
44373345|NCT04247542|Vancomycin|vancomycin|mesh-list
44373346|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373347|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373367|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373368|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373369|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
44373370|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44373371|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373372|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44373373|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373374|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44373375|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44373376|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44373377|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44373378|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
44373379|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44373380|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44373381|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
44373382|NCT04246762|Coagulants|coagulants|mesh-ancestor
44373383|NCT04224272|Fulvestrant|fulvestrant|mesh-list
44373384|NCT04224272|Palbociclib|palbociclib|mesh-list
44373385|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373386|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373387|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44373388|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44373389|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
44373390|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373391|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373392|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373393|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611189|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611190|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44373394|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373395|NCT04218409|Oxycodone|oxycodone|mesh-list
44373396|NCT04218409|Oxytocin|oxytocin|mesh-list
44373397|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
44373398|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373399|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373401|NCT04218409|Narcotics|narcotics|mesh-ancestor
44373407|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373408|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44373409|NCT04182360|Carbetocin|carbetocin|mesh-list
44373410|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
44373411|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373412|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373413|NCT04180371|Nivolumab|nivolumab|mesh-list
44373414|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373415|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373416|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373417|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373418|NCT04176172|Nicotine|nicotine|mesh-list
44373419|NCT04176172|Varenicline|varenicline|mesh-list
44373420|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44373421|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
44373422|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373423|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373424|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44373425|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44373426|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
44373427|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373428|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373429|NCT04172402|Gemcitabine|gemcitabine|mesh-list
44373430|NCT04172402|Nivolumab|nivolumab|mesh-list
44373431|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373432|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
44373433|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373434|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373435|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
44373436|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373443|NCT04154787|Rituximab|rituximab|mesh-list
44373452|NCT04140266|Tenofovir|tenofovir|mesh-list
44373453|NCT04140266|Emtricitabine|emtricitabine|mesh-list
44373454|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43611206|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611208|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43611209|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43611210|NCT03173963|Empagliflozin|empagliflozin|mesh-list
43611216|NCT03173417|Fludarabine|fludarabine|mesh-list
44373455|NCT04140266|Dapivirine|dapivirine|mesh-list
44373456|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
44373457|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373458|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44373459|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44373460|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373461|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373462|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44373463|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44373464|NCT04109924|Trifluridine|trifluridine|mesh-list
44373465|NCT04109924|Bevacizumab|bevacizumab|mesh-list
44373466|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44373467|NCT04109924|Irinotecan|irinotecan|mesh-list
44373468|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
43611219|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611220|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611221|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43611222|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
43611223|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611247|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611248|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43611249|NCT03173339|Narcotics|narcotics|mesh-ancestor
43611250|NCT03173339|Analgesics|analgesics|mesh-ancestor
43611251|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
43611252|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611253|NCT03173326|Anesthetics|anesthetics|mesh-list
43662870|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662871|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662872|NCT02910765|Methylene Blue|methylene blue|mesh-list
43662873|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662874|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662875|NCT02910518|Insulin|insulin|mesh-list
43662876|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43662877|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
43662878|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
43662879|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
43662880|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
43662881|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
43662882|NCT02910518|Heparin|heparin|mesh-list
44373469|NCT04109924|Antibodies|antibodies|mesh-list
44373470|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
44373471|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44373472|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373473|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44373474|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44029062|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44373475|NCT04109924|Growth Substances|growth substances|mesh-ancestor
44373476|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373477|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
44373478|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
44373479|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44373480|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44373481|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373482|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373483|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
43874485|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43874486|NCT01786434|Narcotics|narcotics|mesh-ancestor
43874487|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874488|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874489|NCT01786434|Analgesics|analgesics|mesh-ancestor
43874490|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
44373484|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
44373485|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373486|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373488|NCT04102098|Atezolizumab|atezolizumab|mesh-list
44373489|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373490|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373491|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44373492|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44373493|NCT04102098|Growth Substances|growth substances|mesh-ancestor
44373494|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373495|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
44373496|NCT04070768|Venetoclax|venetoclax|mesh-list
44373497|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
44373498|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373499|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373500|NCT03970616|Durvalumab|durvalumab|mesh-list
44373501|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373502|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373503|NCT03920657|Deferasirox|deferasirox|mesh-list
44373504|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44373505|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
44373506|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
44373507|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373508|NCT03836209|Cytarabine|cytarabine|mesh-list
44373509|NCT03836209|Daunorubicin|daunorubicin|mesh-list
44373510|NCT03836209|Midostaurin|midostaurin|mesh-list
44373511|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373512|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
44373534|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373535|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373536|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373537|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373538|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
44373539|NCT03800134|Antiviral Agents|antiviral agents|mesh-ancestor
44373540|NCT03800134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373541|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373542|NCT03800134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373543|NCT03800134|Immunologic Factors|immunologic factors|mesh-ancestor
44373544|NCT03800134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662884|NCT02910518|Glucagon|glucagon|mesh-list
43662885|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662886|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662887|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
43662888|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43662889|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43662891|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373545|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44373546|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44373547|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373548|NCT03772925|Belinostat|belinostat|mesh-list
44373549|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44373550|NCT03772925|Pevonedistat|pevonedistat|mesh-list
44373551|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373552|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373553|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44373554|NCT03742349|Spartalizumab|spartalizumab|mesh-list
44373555|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373556|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373557|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373558|NCT03740165|Paclitaxel|paclitaxel|mesh-list
44373559|NCT03740165|Docetaxel|docetaxel|mesh-list
44373560|NCT03740165|Bevacizumab|bevacizumab|mesh-list
44373561|NCT03740165|Carboplatin|carboplatin|mesh-list
44373562|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
44373563|NCT03740165|Olaparib|olaparib|mesh-list
44373576|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44373577|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373578|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
44373579|NCT03682536|Luspatercept|luspatercept|mesh-list
44373580|NCT03682536|Hematinics|hematinics|mesh-ancestor
44373581|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44373582|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373583|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373584|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44373585|NCT03653546|Gefitinib|gefitinib|mesh-list
44373586|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373587|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373588|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373589|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373590|NCT03578965|Cefazolin|cefazolin|mesh-list
44373591|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373592|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373593|NCT03564873|Azacitidine|azacitidine|mesh-list
44373594|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
44373595|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373596|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
44373597|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373598|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373599|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373600|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373601|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44373602|NCT03497767|Osimertinib|osimertinib|mesh-list
44373603|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373605|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373623|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373624|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373625|NCT03383679|Capecitabine|capecitabine|mesh-list
44373626|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373627|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
44373628|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373629|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373630|NCT03347838|Nivolumab|nivolumab|mesh-list
43611254|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611255|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611256|NCT03173508|Acetazolamide|acetazolamide|mesh-list
43611257|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
44373631|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373632|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373633|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373634|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373635|NCT03342196|Fludarabine|fludarabine|mesh-list
44373636|NCT03342196|Melphalan|melphalan|mesh-list
44373637|NCT03342196|Thiotepa|thiotepa|mesh-list
44373638|NCT03342196|Mitogens|mitogens|mesh-list
44373639|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373640|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373641|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373642|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
44373643|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373644|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44373645|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
44373646|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44373647|NCT03342196|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373648|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44373649|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44373650|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373651|NCT03323151|Ixazomib|ixazomib|mesh-list
44373652|NCT03323151|Glycine|glycine|mesh-list
44373653|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373654|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
44373655|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373656|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373664|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611262|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
43611263|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611264|NCT03173430|Blinatumomab|blinatumomab|mesh-list
43611265|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611266|NCT03172858|Oxytocin|oxytocin|mesh-list
43611267|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
43611268|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43611269|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611270|NCT03172871|Aripiprazole|aripiprazole|mesh-list
43611271|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
43611272|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43611273|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43611274|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43611275|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611276|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611277|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
43611278|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
43611307|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611308|NCT03172988|Analgesics|analgesics|mesh-ancestor
43611309|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
43662898|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662899|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43662900|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44373665|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373666|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373667|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373668|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
44373669|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373670|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373671|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373672|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
44373673|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373674|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
44373675|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373676|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373677|NCT03238534|Omeprazole|omeprazole|mesh-list
44373678|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43611310|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611313|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611314|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
43611315|NCT03173131|Narcotics|narcotics|mesh-ancestor
43611316|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611317|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611318|NCT03173131|Analgesics|analgesics|mesh-ancestor
43611319|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
43611320|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611321|NCT03172676|Amoxicillin|amoxicillin|mesh-list
43611322|NCT03172676|Clarithromycin|clarithromycin|mesh-list
43611323|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43611357|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611358|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611359|NCT03172299|Growth Substances|growth substances|mesh-ancestor
43851528|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
43851529|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373679|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373680|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44373681|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373682|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373683|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
44373684|NCT03229278|Nivolumab|nivolumab|mesh-list
44373685|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44373686|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44373687|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373688|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44373689|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373690|NCT03176953|Topiramate|topiramate|mesh-list
44373691|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
44373710|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
44373711|NCT03128359|Melphalan|melphalan|mesh-list
44373712|NCT03128359|Busulfan|busulfan|mesh-list
44373713|NCT03128359|Fludarabine|fludarabine|mesh-list
44373714|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
44373715|NCT03128359|Tacrolimus|tacrolimus|mesh-list
44373716|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373717|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
44373718|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373719|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373720|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44373721|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
44373722|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373723|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373724|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44373725|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44373726|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
44373727|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44373728|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373729|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44373730|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44373731|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
44373732|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44373734|NCT03023007|Anesthetics|anesthetics|mesh-list
44373735|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44373736|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373737|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
44373760|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44373761|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373762|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44373763|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
44373764|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373765|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
44373766|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44373767|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44373768|NCT02798523|Prednisolone|prednisolone|mesh-list
44373769|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
44373770|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
43611360|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611361|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611362|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611389|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611390|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43611391|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43611392|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44373771|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44373772|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
44373773|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373774|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
44373775|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
44373776|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373777|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373778|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44373779|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
44373780|NCT02798523|Hormones|hormones|mesh-ancestor
44373781|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373782|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44373811|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373812|NCT01730937|Sorafenib|sorafenib|mesh-list
44373813|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373814|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44373815|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373816|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373817|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
44373818|NCT01649947|Paclitaxel|paclitaxel|mesh-list
44373819|NCT01649947|Bevacizumab|bevacizumab|mesh-list
44373820|NCT01649947|Carboplatin|carboplatin|mesh-list
44373821|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373822|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373823|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373824|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373825|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373839|NCT01569633|Erythromycin|erythromycin|mesh-list
44373872|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
44373873|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44373874|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44373875|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44373876|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412300|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874491|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874492|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43874493|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43874494|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
43874495|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
43874496|NCT01784159|Aspirin|aspirin|mesh-list
43874497|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43874498|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874499|NCT01784159|Analgesics|analgesics|mesh-ancestor
43874500|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
43874501|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874502|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874503|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43874504|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874505|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43874506|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43874507|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874508|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43874509|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43874510|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874511|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
43874512|NCT01681264|Guanfacine|guanfacine|mesh-list
43874513|NCT01681264|Morphine|morphine|mesh-list
43874514|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43874515|NCT01681264|Narcotics|narcotics|mesh-ancestor
43874516|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874517|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874518|NCT01681264|Analgesics|analgesics|mesh-ancestor
43874519|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
43874520|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874521|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43874522|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874523|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874524|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874525|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874526|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874527|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874528|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
43874529|NCT01678586|Gabapentin|gabapentin|mesh-list
43874530|NCT01678586|Analgesics|analgesics|mesh-ancestor
43874531|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
43874538|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43874539|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43874540|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43874541|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874542|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874543|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
43874544|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43874545|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874546|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874547|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
43874548|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
43874549|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
43874550|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874551|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43874552|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
43874553|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
43874554|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43874555|NCT01630213|Vitamin D|vitamin d|mesh-list
43874556|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
43874557|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
43874558|NCT01630213|Vitamins|vitamins|mesh-list
43874559|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
43874560|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874561|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44373877|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373878|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44373879|NCT00131235|Renal Agents|renal agents|mesh-ancestor
43611393|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611394|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373880|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44373881|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44373882|NCT00080756|Estradiol|estradiol|mesh-list
44373883|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44373884|NCT00080756|Testosterone|testosterone|mesh-list
44373885|NCT00080756|Deslorelin|deslorelin|mesh-list
44373886|NCT00080756|Estrogens|estrogens|mesh-ancestor
44373887|NCT00080756|Hormones|hormones|mesh-ancestor
44373888|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373889|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373890|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44373891|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
44373892|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44373893|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44373895|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373896|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373897|NCT05625347|Aspirin|aspirin|mesh-list
44373898|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44373899|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44373900|NCT05625347|Analgesics|analgesics|mesh-ancestor
44373901|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
44373902|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373903|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373904|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683196|NCT04793568|Interferons|interferons|mesh-list
43874562|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43874563|NCT01623167|Cyclosporine|cyclosporine|mesh-list
43874564|NCT01623167|Cyclosporins|cyclosporins|mesh-list
43874565|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43874566|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874567|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874568|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43874569|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
43874570|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874571|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
43874572|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874573|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874574|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874575|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43874576|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43874577|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874578|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874579|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373905|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373906|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44373907|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44373908|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373909|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373910|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44373911|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373912|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
44373913|NCT05625334|Aspirin|aspirin|mesh-list
44373914|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44373915|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44373916|NCT05625334|Analgesics|analgesics|mesh-ancestor
44373917|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
43627512|NCT03072485|Metformin|metformin|mesh-list
43874580|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874581|NCT01441349|Simvastatin|simvastatin|mesh-list
43874582|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43874583|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43874584|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
43874585|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874586|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43874587|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43874588|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874590|NCT01156545|Simvastatin|simvastatin|mesh-list
43662935|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
43874591|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43874592|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43874593|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
43874594|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874595|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43874596|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43874597|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874598|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874599|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874605|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43874606|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43874607|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43874608|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874609|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874610|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43874611|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43874612|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43874614|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874615|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874616|NCT00544830|Leuprolide|leuprolide|mesh-list
43874617|NCT00544830|Goserelin|goserelin|mesh-list
43874618|NCT00544830|Bicalutamide|bicalutamide|mesh-list
43874619|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43874620|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
43874621|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43874622|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874623|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43874624|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874625|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
43874626|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
43874627|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43874628|NCT00371059|Memantine|memantine|mesh-list
43874629|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43874630|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43874631|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
43611403|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611404|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
43611405|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
43611406|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611407|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611408|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874632|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44373918|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44373919|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373920|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44373921|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44373922|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44373923|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44373924|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373925|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44373926|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44373927|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373928|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
44373929|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44373930|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
44373931|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44373932|NCT05625243|Protective Agents|protective agents|mesh-ancestor
44373933|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373934|NCT05625087|Fulvestrant|fulvestrant|mesh-list
44373935|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44373936|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373937|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44373938|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44373939|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
44373940|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44373941|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44373942|NCT05624996|Paclitaxel|paclitaxel|mesh-list
44373943|NCT05624996|Etoposide|etoposide|mesh-list
44373944|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
44373945|NCT05624996|Cisplatin|cisplatin|mesh-list
43874633|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874634|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874635|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43874636|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43874637|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
43874638|NCT04734418|Remifentanil|remifentanil|mesh-list
43874639|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874640|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874641|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874642|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874643|NCT04734418|Analgesics|analgesics|mesh-ancestor
43874644|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
43874645|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874646|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874647|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874648|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874649|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
44373946|NCT05624996|Carboplatin|carboplatin|mesh-list
44373947|NCT05624996|Pemetrexed|pemetrexed|mesh-list
44373948|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44373949|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
44373950|NCT05624996|Durvalumab|durvalumab|mesh-list
44373951|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
44373952|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44373953|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
44373954|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44373955|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44373956|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44373957|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
44373958|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44373959|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44373960|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44373961|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44373962|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44373963|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44374003|NCT05624671|Fentanyl|fentanyl|mesh-list
44374004|NCT05624671|Bupivacaine|bupivacaine|mesh-list
44374005|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
44374006|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
44374007|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374008|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374009|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
44374010|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374011|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44374012|NCT05624671|Narcotics|narcotics|mesh-ancestor
44374013|NCT05624671|Analgesics|analgesics|mesh-ancestor
44374014|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44374015|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374016|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
44374017|NCT05624528|Tolcapone|tolcapone|mesh-list
43874650|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874651|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874652|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43874653|NCT04734418|Narcotics|narcotics|mesh-ancestor
43874654|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43874655|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874656|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874657|NCT04734353|Ticagrelor|ticagrelor|mesh-list
43874658|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43874659|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43874660|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43874661|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43874662|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43611443|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611444|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874663|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
43874664|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874665|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874666|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874667|NCT04734119|Anesthetics|anesthetics|mesh-list
43874668|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874671|NCT04733781|Lidocaine|lidocaine|mesh-list
43874672|NCT04733781|Epinephrine|epinephrine|mesh-list
43874673|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874674|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
43874675|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874676|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874677|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
43874678|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874679|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43874680|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43874682|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43874683|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874684|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874685|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874686|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874687|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874688|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43874689|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43874690|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
43874691|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43874692|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
43874693|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
43874694|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
43874695|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43874696|NCT04733625|Vitamin D|vitamin d|mesh-list
43874697|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
43874698|NCT04733625|Vitamins|vitamins|mesh-ancestor
44374018|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44374019|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44374020|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44374021|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374022|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374023|NCT05624424|Sufentanil|sufentanil|mesh-list
44374024|NCT05624424|Remifentanil|remifentanil|mesh-list
44374025|NCT05624424|Propofol|propofol|mesh-list
44374026|NCT05624424|Sevoflurane|sevoflurane|mesh-list
44374027|NCT05624424|Cisatracurium|cisatracurium|mesh-list
44374028|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44374029|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374030|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374031|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374032|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
44374033|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
43683282|NCT04545541|Heparin|heparin|mesh-list
43874699|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
43874700|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874701|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43874702|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43874703|NCT04733326|Ketorolac|ketorolac|mesh-list
43874704|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43874705|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43874706|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874707|NCT04733326|Analgesics|analgesics|mesh-ancestor
43874708|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
43874709|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662997|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662998|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662999|NCT02909751|Tocotrienols|tocotrienols|mesh-list
43663000|NCT02909751|Vitamin E|vitamin e|mesh-list
43663001|NCT02909751|Tocopherols|tocopherols|mesh-list
43663002|NCT02909751|Docetaxel|docetaxel|mesh-list
43874710|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874711|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43874712|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874713|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43874714|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874715|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874716|NCT04733521|Cisplatin|cisplatin|mesh-list
43874717|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874718|NCT04733508|Exenatide|exenatide|mesh-list
43874719|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43874720|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874721|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43874722|NCT04733508|Incretins|incretins|mesh-ancestor
43874723|NCT04733508|Hormones|hormones|mesh-ancestor
43874724|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135544|NCT00161681|Hormones|hormones|mesh-ancestor
44135545|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135546|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135547|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44135548|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
44135549|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135550|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44135551|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44135552|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44135553|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44135554|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44135555|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
44135556|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44135557|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44135558|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44374035|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44374036|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44374037|NCT05624424|Narcotics|narcotics|mesh-ancestor
44374038|NCT05624424|Analgesics|analgesics|mesh-ancestor
44374039|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
44374040|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374041|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44374042|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44374043|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44374044|NCT05624268|Psilocybin|psilocybin|mesh-list
43611453|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611487|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43611488|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611489|NCT03171727|Heparin|heparin|mesh-list
43611490|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43611491|NCT03171727|Tinzaparin|tinzaparin|mesh-list
43611492|NCT03171727|Dalteparin|dalteparin|mesh-list
44374045|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
44374046|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374047|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374048|NCT05624229|Esomeprazole|esomeprazole|mesh-list
44135559|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135560|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135571|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
44135572|NCT00161759|Coagulants|coagulants|mesh-ancestor
44135573|NCT00161811|Vaccines|vaccines|mesh-list
44135574|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
43874725|NCT04733131|Abatacept|abatacept|mesh-list
43874726|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43874727|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874728|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874729|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43874730|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
43874731|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874732|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874733|NCT04733066|Teduglutide|teduglutide|mesh-list
43874734|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874735|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43874736|NCT04733066|Protective Agents|protective agents|mesh-ancestor
43874737|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874738|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
43874739|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874740|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
43874741|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
43874742|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874743|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
43874744|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43874745|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43874746|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43874747|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874748|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
43874749|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874750|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
43874751|NCT04732390|Bupivacaine|bupivacaine|mesh-list
43874752|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874753|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
43874754|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874755|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874756|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
43874757|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874758|NCT04732390|Analgesics|analgesics|mesh-ancestor
43874759|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43874760|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
43874761|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43874762|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43874763|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874764|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44374050|NCT05624229|Rabeprazole|rabeprazole|mesh-list
44374051|NCT05624229|Pantoprazole|pantoprazole|mesh-list
44374052|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44374053|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44374054|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374055|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374056|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374057|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
44374058|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374059|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44374060|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374061|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374062|NCT05623540|Diphosphonates|diphosphonates|mesh-list
44374063|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43663037|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43663038|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663041|NCT02909712|Renal Agents|renal agents|mesh-ancestor
44374064|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374065|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44374066|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
44374067|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44374068|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44374069|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
44374070|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374071|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374072|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
44374073|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44374074|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44374075|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374076|NCT05605639|Bupivacaine|bupivacaine|mesh-list
44374077|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
44374078|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
44374079|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374080|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874765|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
43874766|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43874767|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
43874768|NCT04732377|Bupivacaine|bupivacaine|mesh-list
43874769|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874770|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
43874771|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874772|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874773|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
43583894|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
44374082|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374083|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44374084|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44374085|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
44374086|NCT05586113|Bismuth|bismuth|mesh-list
44374087|NCT05586113|Antacids|antacids|mesh-ancestor
44374088|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374089|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43611497|NCT03171623|Globalagliatin|globalagliatin|mesh-list
43611498|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
43611535|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611536|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611537|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611574|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43874774|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874775|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874776|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874777|NCT04732377|Analgesics|analgesics|mesh-ancestor
43874778|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874788|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874789|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
43874790|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874791|NCT04732598|Paclitaxel|paclitaxel|mesh-list
43874792|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43874793|NCT04732598|Bevacizumab|bevacizumab|mesh-list
43874794|NCT04732598|Atezolizumab|atezolizumab|mesh-list
43874795|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43874796|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874797|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
43874798|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874799|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874800|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874801|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874802|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43874803|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43874804|NCT04732598|Growth Substances|growth substances|mesh-ancestor
43874805|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874806|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
43874808|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
43874809|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43874810|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874811|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43874812|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43874813|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43874814|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874815|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874816|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43874817|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43874818|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874819|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
43874820|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874821|NCT04732104|Lidocaine|lidocaine|mesh-list
43874822|NCT04732104|Xylometazoline|xylometazoline|mesh-list
43874823|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
43874824|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874825|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
43874826|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874827|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874828|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
43874829|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874830|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43874831|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43874832|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43874833|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663079|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663080|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663081|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
43874834|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874835|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43874836|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
43874837|NCT04731727|Riboflavin|riboflavin|mesh-list
43874838|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
44374090|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
44374091|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
44374092|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374093|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374094|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44374095|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
44374096|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374097|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374098|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44374099|NCT05543629|Paclitaxel|paclitaxel|mesh-list
44374100|NCT05543629|Docetaxel|docetaxel|mesh-list
44374101|NCT05543629|Carboplatin|carboplatin|mesh-list
44374102|NCT05543629|Nivolumab|nivolumab|mesh-list
44374104|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374105|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374106|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
44374107|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
44374108|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
44374109|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374110|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374111|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44374112|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
44374113|NCT05495464|Rituximab|rituximab|mesh-list
44374114|NCT05495464|Fludarabine|fludarabine|mesh-list
44374115|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
44374116|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
44374117|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374118|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
44374119|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374137|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
44374138|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374139|NCT05470400|Vaccines|vaccines|mesh-list
44374140|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
44374141|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374143|NCT05419115|Diuretics|diuretics|mesh-ancestor
44374144|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
44374145|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374146|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44374147|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44374148|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374149|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44374150|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44374151|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611604|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611606|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
43611607|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
43611608|NCT03170687|Calpastatin|calpastatin|mesh-list
43611609|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43611613|NCT03170726|Ibuprofen|ibuprofen|mesh-list
44374152|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374153|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374154|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374155|NCT05405244|Bromocriptine|bromocriptine|mesh-list
44374156|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374157|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44374158|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44374159|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
44374160|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374161|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
43874839|NCT04731727|Vitamins|vitamins|mesh-ancestor
43874840|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
43874841|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874851|NCT04731948|Vitamins|vitamins|mesh-list
43874852|NCT04731948|Folic Acid|folic acid|mesh-list
43874853|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
43874854|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
43874855|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
43874856|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
43874857|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874858|NCT04731948|Hematinics|hematinics|mesh-ancestor
43874859|NCT04731909|Cisplatin|cisplatin|mesh-list
43874860|NCT04731909|Carboplatin|carboplatin|mesh-list
43874861|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874863|NCT04731766|Fluorides|fluorides|mesh-list
43874864|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
43874865|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
43874866|NCT04731766|Protective Agents|protective agents|mesh-ancestor
43874867|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874868|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43874869|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874870|NCT04731116|Cannabidiol|cannabidiol|mesh-list
43874871|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
43874872|NCT04731038|Paclitaxel|paclitaxel|mesh-list
43874873|NCT04731038|Cisplatin|cisplatin|mesh-list
43874874|NCT04731038|Carboplatin|carboplatin|mesh-list
43874875|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374163|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374164|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374165|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
44374166|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374167|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374168|NCT05374603|Durvalumab|durvalumab|mesh-list
44374169|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374170|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374171|NCT05316220|Mesalamine|mesalamine|mesh-list
44374172|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44374173|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874876|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874877|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
43874878|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
43874879|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874880|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874881|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43874882|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
43874883|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43874884|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874885|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
43874886|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43874887|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874888|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874889|NCT04730973|Evolocumab|evolocumab|mesh-list
43874890|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43874891|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43874892|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
43874893|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874894|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43874895|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43874896|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874897|NCT04730895|Tretinoin|tretinoin|mesh-list
43874898|NCT04730895|Isotretinoin|isotretinoin|mesh-list
43874899|NCT04730895|Vaccines|vaccines|mesh-list
43874900|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
43874901|NCT04730895|Paraproteins|paraproteins|mesh-list
43874902|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
43874903|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874904|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874905|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
43874906|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135575|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135576|NCT00161837|Vaccines|vaccines|mesh-list
44135577|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
44135578|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135579|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44135580|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
44135589|NCT00161993|Antibodies|antibodies|mesh-list
44135590|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
44135591|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44135592|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44135593|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
44135594|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135595|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
44135596|NCT00162006|Antibodies|antibodies|mesh-list
44135597|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
44135598|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44135599|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44135600|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
44135601|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135602|NCT00162019|Factor VIII|factor viii|mesh-list
44135603|NCT00162019|Coagulants|coagulants|mesh-ancestor
44135604|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44374174|NCT05316220|Analgesics|analgesics|mesh-ancestor
44374175|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
44374176|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374177|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374178|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374179|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374180|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
44374181|NCT05283499|Analgesics|analgesics|mesh-list
44374182|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
44374183|NCT05283499|Narcotics|narcotics|mesh-ancestor
44374184|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374185|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374186|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
43683411|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135605|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44135606|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135607|NCT00162110|Cetuximab|cetuximab|mesh-list
44135608|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135609|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135610|NCT00162149|Ritonavir|ritonavir|mesh-list
44135611|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44135612|NCT00162149|Nevirapine|nevirapine|mesh-list
44135613|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44135614|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44135615|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
44135616|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135617|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135618|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44135619|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44135620|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
44135621|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135622|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44135623|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43874907|NCT04730622|Mitogens|mitogens|mesh-list
43874908|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
43874909|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874910|NCT04730544|Nivolumab|nivolumab|mesh-list
43874911|NCT04730544|Ipilimumab|ipilimumab|mesh-list
43874912|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874913|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874914|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43874915|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874916|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
43874917|NCT04730596|Ketamine|ketamine|mesh-list
43874918|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874919|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874920|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874921|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874922|NCT04730596|Analgesics|analgesics|mesh-ancestor
43874923|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
43874924|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874925|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874926|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874927|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874928|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874929|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874930|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874931|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43874932|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43874933|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
43874934|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
44374187|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029961|NCT00000819|Hormones|hormones|mesh-ancestor
44374189|NCT05695027|Niacin|niacin|mesh-list
44374190|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
44374191|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
44374192|NCT05695027|Vitamins|vitamins|mesh-ancestor
44374193|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
44374194|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374195|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44374196|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
44374197|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374198|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44374199|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
44374200|NCT05694975|Ascorbic Acid|ascorbic acid|mesh-list
44374201|NCT05694975|Vitamins|vitamins|mesh-ancestor
43874940|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
43874941|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874942|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874943|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
43874944|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874945|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43611614|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43611615|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43611616|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611617|NCT03170726|Analgesics|analgesics|mesh-ancestor
43611618|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
43611619|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611620|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611621|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611655|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611657|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
43874946|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43874947|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43874948|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43874949|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874950|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43874951|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874952|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43874953|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874954|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
43874955|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874956|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874957|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874958|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874959|NCT04730375|Analgesics|analgesics|mesh-ancestor
43874960|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
43874961|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874962|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43874963|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874964|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43874965|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874966|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874967|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874968|NCT04730245|Rifaximin|rifaximin|mesh-list
43874969|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43874970|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874971|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43874972|NCT04730297|Acetaminophen|acetaminophen|mesh-list
43874973|NCT04730297|Ibuprofen|ibuprofen|mesh-list
43611724|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611726|NCT03169959|Hormones|hormones|mesh-ancestor
43611727|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611728|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43611729|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
43611730|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611731|NCT03169751|Caffeine|caffeine|mesh-list
43611732|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43611733|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611734|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43663109|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663110|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43663111|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43874974|NCT04730297|Codeine|codeine|mesh-list
43874975|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43874976|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43874977|NCT04730297|Analgesics|analgesics|mesh-ancestor
43874978|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
43874979|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43874980|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874982|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43874983|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43874984|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874985|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874986|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
44374203|NCT05694975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374204|NCT05694975|Antioxidants|antioxidants|mesh-ancestor
44374205|NCT05694975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374206|NCT05694975|Protective Agents|protective agents|mesh-ancestor
44374207|NCT05694923|Empagliflozin|empagliflozin|mesh-list
44374208|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44374209|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374210|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374211|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374212|NCT05694871|Palbociclib|palbociclib|mesh-list
44374213|NCT05694871|Cemiplimab|cemiplimab|mesh-list
44374214|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
44374215|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
44374216|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
44374217|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374218|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374219|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44374220|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374221|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374222|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374223|NCT05694858|Lidocaine|lidocaine|mesh-list
44374224|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874987|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43874988|NCT04730297|Narcotics|narcotics|mesh-ancestor
43874989|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874990|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
43611735|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663128|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663129|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663130|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
43663131|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
43663132|NCT05312346|Hematinics|hematinics|mesh-ancestor
43663133|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
43663134|NCT05312346|Vitamins|vitamins|mesh-ancestor
43663135|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
43663136|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663137|NCT05312242|Folic Acid|folic acid|mesh-list
43874991|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
43874992|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
43874993|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43874994|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
43874995|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43874996|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
43874997|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874998|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874999|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
43875000|NCT04729556|Chitosan|chitosan|mesh-list
43875001|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43875002|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43875003|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
43875004|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875005|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43875010|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
43875011|NCT04729868|Bupivacaine|bupivacaine|mesh-list
43875012|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
43875013|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
43875014|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
43875015|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875016|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611736|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611737|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43611738|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43611739|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
43611768|NCT03169764|Protective Agents|protective agents|mesh-ancestor
43611769|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
43611770|NCT03169764|Vitamins|vitamins|mesh-ancestor
43611771|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
43611772|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43611773|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43611774|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43611775|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
43663138|NCT05312242|Micronutrients|micronutrients|mesh-list
43663139|NCT05312242|Trace Elements|trace elements|mesh-list
43663140|NCT05312242|Hematinics|hematinics|mesh-ancestor
43663141|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
43663142|NCT05312242|Vitamins|vitamins|mesh-ancestor
43663143|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663144|NCT05312190|Progesterone|progesterone|mesh-list
43663145|NCT05312190|Progestins|progestins|mesh-ancestor
43663146|NCT05312190|Hormones|hormones|mesh-ancestor
43663147|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663148|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663149|NCT05311774|Tramadol|tramadol|mesh-list
43875017|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
43875018|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875019|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44374226|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374227|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374228|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
44374229|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374230|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44374231|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44374232|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44374233|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44374234|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875020|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875021|NCT04729868|Analgesics|analgesics|mesh-ancestor
43875022|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43875023|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43875024|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43875025|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
43875026|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875027|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875028|NCT04729465|Propofol|propofol|mesh-list
43875029|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43875030|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875031|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875032|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875033|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
43875034|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
43875035|NCT04729491|Azithromycin|azithromycin|mesh-list
43875036|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
43875037|NCT04729491|Dutasteride|dutasteride|mesh-list
43875038|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875039|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611776|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875040|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43875041|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43875042|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875043|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875044|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875045|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875046|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875047|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875048|NCT04729179|Cannabidiol|cannabidiol|mesh-list
43875049|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
43875050|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
43875051|NCT04729348|Lenvatinib|lenvatinib|mesh-list
43875052|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43875053|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875054|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43875055|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875056|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875057|NCT04729101|Lansoprazole|lansoprazole|mesh-list
43875058|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
43875059|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43875060|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875061|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43875062|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875063|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875064|NCT04728932|Simendan|simendan|mesh-list
43875065|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43875066|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
43875067|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43875068|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43875069|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875070|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875071|NCT04728932|Protective Agents|protective agents|mesh-ancestor
44374236|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
44374237|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374238|NCT05694715|Irinotecan|irinotecan|mesh-list
44374239|NCT05694715|Niraparib|niraparib|mesh-list
44374240|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44374241|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44374242|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374243|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374244|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374245|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44374246|NCT05694689|Vitamin D|vitamin d|mesh-list
44374247|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
44374248|NCT05694689|Vitamins|vitamins|mesh-ancestor
44374249|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
44374250|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374251|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44374252|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43875072|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875073|NCT04728880|Remdesivir|remdesivir|mesh-list
43875074|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
43875075|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875076|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
43875077|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875086|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43875087|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875088|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875089|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43875090|NCT04728581|Mirtazapine|mirtazapine|mesh-list
43875092|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875093|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43875094|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43875095|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875096|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875097|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43663180|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
43663181|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875098|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
43875099|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
43875100|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875101|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875102|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43875103|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43875104|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43875105|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43875106|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43875107|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43875108|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43875109|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
43875110|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43875111|NCT04728659|Desogestrel|desogestrel|mesh-list
43875113|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43875114|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43875115|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43875116|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
43875117|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875118|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875119|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44374253|NCT05694637|Varenicline|varenicline|mesh-list
44374254|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44374255|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44374256|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44374257|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374258|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374259|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374260|NCT05694585|Esmolol|esmolol|mesh-list
44374261|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44374262|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44374263|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43875120|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43875121|NCT04728659|Progestins|progestins|mesh-ancestor
43875122|NCT04728659|Hormones|hormones|mesh-ancestor
43875123|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875124|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875125|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43875126|NCT04728386|Eusol|eusol|mesh-list
43875127|NCT04728386|Curcumin|curcumin|mesh-list
43875128|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875129|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875130|NCT04728386|Analgesics|analgesics|mesh-ancestor
43875131|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
43875132|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875133|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875134|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875135|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875136|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875137|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875138|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875139|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
43875140|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875141|NCT04729088|Isosorbide|isosorbide|mesh-list
43875142|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43875143|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43875144|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43663206|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
43663207|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
43663208|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663209|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43663210|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43663211|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875145|NCT04729088|Diuretics|diuretics|mesh-ancestor
43875146|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
43875150|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875152|NCT04729140|Ivermectin|ivermectin|mesh-list
43875153|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875154|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875155|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
43875156|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875157|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875158|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43875159|NCT04728321|Lenvatinib|lenvatinib|mesh-list
43875160|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875161|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43875162|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875163|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875164|NCT04728308|Bupivacaine|bupivacaine|mesh-list
43875165|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
43875166|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
43875167|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875168|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875169|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
43875170|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875171|NCT04728035|Irinotecan|irinotecan|mesh-list
43875172|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43875173|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43875174|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875175|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875176|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374265|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374266|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374267|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374268|NCT05694533|Midazolam|midazolam|mesh-list
43611828|NCT03169790|Bevacizumab|bevacizumab|mesh-list
43611829|NCT03169790|Rituximab|rituximab|mesh-list
43611830|NCT03169790|Fluorouracil|fluorouracil|mesh-list
43611831|NCT03169790|Capecitabine|capecitabine|mesh-list
43611832|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
43611833|NCT03169790|Avelumab|avelumab|mesh-list
43611834|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43611835|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374269|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44374334|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
44374335|NCT05694130|Hormones|hormones|mesh-ancestor
44374336|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374337|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44374338|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374339|NCT05694013|Atezolizumab|atezolizumab|mesh-list
44374340|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374341|NCT05693844|Paclitaxel|paclitaxel|mesh-list
44374342|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
44374343|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44374344|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374345|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374346|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
44374347|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
44374348|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
44374349|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374350|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374351|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
44374352|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374353|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374354|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44374355|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
44374356|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43875177|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43875178|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43875179|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135624|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44135625|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135626|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44135627|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44135628|NCT00162188|Efavirenz|efavirenz|mesh-list
44135629|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44135630|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135631|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135632|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135633|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
44135634|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135635|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44135636|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44135637|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44135638|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44135639|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44135640|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44135641|NCT00162201|Abatacept|abatacept|mesh-list
44135642|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44135643|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135644|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135645|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135646|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
44374358|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374359|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
44374360|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374361|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374362|NCT05693688|Atosiban|atosiban|mesh-list
44374363|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
44374364|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374365|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135647|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875180|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43875181|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43875182|NCT04727671|Cetrorelix|cetrorelix|mesh-list
43875183|NCT04727671|Menotropins|menotropins|mesh-list
43825959|NCT04151667|Dexamethasone|dexamethasone|mesh-list
43825960|NCT04151667|Lenalidomide|lenalidomide|mesh-list
43875184|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
43875185|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43875186|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
43875187|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875188|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875189|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43875190|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43875191|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875195|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875196|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43875197|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43875200|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
43875201|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43875202|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
43875203|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875204|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875205|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43875206|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43875207|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875208|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43875209|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
43611870|NCT03169777|Leucovorin|leucovorin|mesh-list
43611871|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
43611872|NCT03169777|Bevacizumab|bevacizumab|mesh-list
43611873|NCT03169777|Fluorouracil|fluorouracil|mesh-list
43611874|NCT03169777|Capecitabine|capecitabine|mesh-list
43611875|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
43611877|NCT03169777|Cetuximab|cetuximab|mesh-list
43611878|NCT03169777|Fulvestrant|fulvestrant|mesh-list
43611879|NCT03169777|Avelumab|avelumab|mesh-list
43611880|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611881|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611882|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611883|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
43611884|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611885|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846719|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851551|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
43851552|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851553|NCT03637660|Penicillins|penicillins|mesh-list
43851554|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43851555|NCT03637660|Penicillin G|penicillin g|mesh-list
43846721|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
43846722|NCT04177082|Vitamins|vitamins|mesh-ancestor
43875210|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875211|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875212|NCT04727515|Fentanyl|fentanyl|mesh-list
43875213|NCT04727515|Isoflurane|isoflurane|mesh-list
43875214|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43875215|NCT04727515|Narcotics|narcotics|mesh-ancestor
43875216|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875217|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875218|NCT04727515|Analgesics|analgesics|mesh-ancestor
43875219|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
43875220|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875221|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875222|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875223|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
43875224|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
43875225|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43875226|NCT04727853|Irinotecan|irinotecan|mesh-list
43875227|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43875228|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43875229|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875230|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875231|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875232|NCT04727437|Heparin|heparin|mesh-list
43875233|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43875234|NCT04727437|Tinzaparin|tinzaparin|mesh-list
43875235|NCT04727437|Dalteparin|dalteparin|mesh-list
43875236|NCT04727437|Warfarin|warfarin|mesh-list
43875237|NCT04727437|Anticoagulants|anticoagulants|mesh-list
43875238|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44374366|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
44374367|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44374369|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44374370|NCT05693675|Narcotics|narcotics|mesh-ancestor
44374371|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374372|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374373|NCT05693675|Analgesics|analgesics|mesh-ancestor
44374374|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
44374375|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374376|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
44374377|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
43875239|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43875240|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875241|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43875242|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
43875243|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875244|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43875245|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875246|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43875247|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43875248|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43875249|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875250|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875251|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875252|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875253|NCT04727502|Analgesics|analgesics|mesh-ancestor
43875254|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
44135648|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875255|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875256|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
43875257|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875258|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
43875259|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43875260|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43875261|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875270|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43875271|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875272|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875273|NCT04726982|Diuretics|diuretics|mesh-ancestor
43875274|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
43875275|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875276|NCT04726657|Insulin|insulin|mesh-list
43875277|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43875278|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
43875279|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
43875280|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
43875281|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43875282|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875283|NCT04727073|Spironolactone|spironolactone|mesh-list
43875284|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43875285|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875286|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875287|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875288|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43875289|NCT04727073|Diuretics|diuretics|mesh-ancestor
43875290|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
43875291|NCT04726631|Insulin|insulin|mesh-list
43875292|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43875293|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
43875294|NCT04726631|Protamines|protamines|mesh-list
43875295|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43875296|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875297|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
44374378|NCT05693545|Penicillins|penicillins|mesh-list
44374379|NCT05693545|Penicillin G|penicillin g|mesh-list
44374380|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44374381|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
44374382|NCT05693545|Penicillin V|penicillin v|mesh-list
44374383|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44374384|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374385|NCT05693467|Dexamethasone|dexamethasone|mesh-list
44374386|NCT05693467|Ropivacaine|ropivacaine|mesh-list
44374387|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374388|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
44374389|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
44374390|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374391|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374392|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374393|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
44374394|NCT05693467|Hormones|hormones|mesh-ancestor
44374395|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374396|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44374397|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374398|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
44374399|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
44374400|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374401|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
44374402|NCT05693454|Tramadol|tramadol|mesh-list
44374403|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
44374404|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43875298|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875299|NCT04726631|Coagulants|coagulants|mesh-ancestor
43875300|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
43875301|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43875302|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
43875303|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43875304|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
43875305|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875306|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875307|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
43875308|NCT04726332|Prednisone|prednisone|mesh-list
43875309|NCT04726332|Fulvestrant|fulvestrant|mesh-list
43875310|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875311|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
43875312|NCT04726332|Hormones|hormones|mesh-ancestor
43875313|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875314|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875315|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43875316|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875317|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43875318|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43875319|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875320|NCT04726345|Fexofenadine|fexofenadine|mesh-list
43875321|NCT04726345|Terfenadine|terfenadine|mesh-list
44374405|NCT05693454|Narcotics|narcotics|mesh-ancestor
44374406|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374407|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374408|NCT05693454|Analgesics|analgesics|mesh-ancestor
44374409|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
44374410|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374411|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
44374412|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
44374413|NCT05693428|Propofol|propofol|mesh-list
44374414|NCT05693428|Sevoflurane|sevoflurane|mesh-list
44374415|NCT05693428|Isoflurane|isoflurane|mesh-list
44374416|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44374417|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374418|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651659|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651660|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651661|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651662|NCT03005496|Vitamin D|vitamin d|mesh-list
44374419|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374420|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
44374421|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
44374422|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44374423|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44374424|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
44374425|NCT05693402|Anesthetics|anesthetics|mesh-list
44374426|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374427|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374428|NCT05693402|Narcotics|narcotics|mesh-ancestor
44374429|NCT05693402|Analgesics|analgesics|mesh-ancestor
44374430|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
44374431|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374432|NCT05692271|Propranolol|propranolol|mesh-list
43875322|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43875323|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43875324|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43875325|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
43875326|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
43875332|NCT04726553|Methotrexate|methotrexate|mesh-list
43875333|NCT04726553|Azathioprine|azathioprine|mesh-list
43875334|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43875335|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
43875336|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875337|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875338|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43875339|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
43875340|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875341|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875342|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
43875343|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875344|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43875345|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43875346|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
43875347|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43587249|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
44374433|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44374434|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44374435|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44374436|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374437|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374438|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374439|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44374440|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44374441|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
44374442|NCT05690048|Vancomycin|vancomycin|mesh-list
44374443|NCT05690048|Bevacizumab|bevacizumab|mesh-list
44374444|NCT05690048|Atezolizumab|atezolizumab|mesh-list
44374445|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374446|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374447|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44374448|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44374449|NCT05690048|Growth Substances|growth substances|mesh-ancestor
44374450|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374451|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44374452|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44374453|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374454|NCT05688384|Alfentanil|alfentanil|mesh-list
44374455|NCT05688384|Propofol|propofol|mesh-list
44374456|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663270|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
43663271|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
43663272|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43663273|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
43663274|NCT05124067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44374457|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683537|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43875348|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43875349|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43875350|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43875351|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
43875352|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875353|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875354|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875355|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875356|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43875357|NCT04726046|Cefotetan|cefotetan|mesh-list
43875358|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875359|NCT04725747|Midazolam|midazolam|mesh-list
43875360|NCT04725747|Ketamine|ketamine|mesh-list
43875361|NCT04725747|Analgesics|analgesics|mesh-ancestor
43875362|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
43875363|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875364|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875365|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43875366|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875367|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
43875368|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
43875369|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875370|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43875371|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44374458|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374459|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374460|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
44374462|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44374463|NCT05688384|Narcotics|narcotics|mesh-ancestor
44374464|NCT05688384|Analgesics|analgesics|mesh-ancestor
44374465|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
44374466|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374467|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
44374468|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44374469|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44374470|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374471|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
44374472|NCT05688111|Coagulants|coagulants|mesh-ancestor
43875372|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875373|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875374|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875375|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43875376|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43875377|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43875378|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875379|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
43875380|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
43875381|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43875382|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43875383|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875384|NCT04725942|Posaconazole|posaconazole|mesh-list
43875385|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
43875386|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611906|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611907|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
43611908|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
43611909|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43875387|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43875388|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875389|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875390|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43875391|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43875392|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875393|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875394|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43875402|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43875403|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
43875404|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875405|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43875406|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875407|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875408|NCT04725617|Varenicline|varenicline|mesh-list
43875409|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43875410|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43875411|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
43875412|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875413|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875414|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875416|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43875417|NCT04725448|Bevacizumab|bevacizumab|mesh-list
43875418|NCT04725448|Carboplatin|carboplatin|mesh-list
43875419|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43875420|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875421|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
43875422|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
43875423|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
43611923|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43611924|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43611925|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
43611926|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611927|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611928|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43611929|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
43611930|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
43611931|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43611932|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
43611933|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43611934|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
43611935|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611936|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851562|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875424|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374474|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44374475|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374476|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374477|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374478|NCT05685225|Acetaminophen|acetaminophen|mesh-list
44374479|NCT05685225|Naltrexone|naltrexone|mesh-list
44374480|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44374481|NCT05685225|Analgesics|analgesics|mesh-ancestor
44374482|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
44374483|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683577|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
43875425|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43875426|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43875427|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43875428|NCT04725448|Growth Substances|growth substances|mesh-ancestor
43875429|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875430|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
43875431|NCT04725253|Niacinamide|niacinamide|mesh-list
43875432|NCT04725253|Niacin|niacin|mesh-list
43875433|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
43875434|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
43875435|NCT04725253|Vitamins|vitamins|mesh-ancestor
43875436|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
43875437|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875438|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43875439|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
43875440|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875441|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43875442|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
43875443|NCT04725383|Amitriptyline|amitriptyline|mesh-list
43875444|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43875445|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
43875446|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875447|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875448|NCT04725383|Analgesics|analgesics|mesh-ancestor
43875449|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
43875450|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875451|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875452|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43875453|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43875454|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875455|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875456|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
43875457|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875458|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43875459|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43875460|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875461|NCT04725357|Meloxicam|meloxicam|mesh-list
43875462|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875466|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875467|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875468|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875469|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875470|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43875471|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43875472|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875473|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875474|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
43875475|NCT04725422|Pamidronate|pamidronate|mesh-list
43875476|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
43851564|NCT03594435|Ibudilast|ibudilast|mesh-list
43875477|NCT04725422|Adalimumab|adalimumab|mesh-list
43875478|NCT04725422|Etanercept|etanercept|mesh-list
44374484|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374485|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
44374486|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44374487|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44374488|NCT05683223|Sertraline|sertraline|mesh-list
43875479|NCT04725422|Golimumab|golimumab|mesh-list
43875480|NCT04725422|Methotrexate|methotrexate|mesh-list
43875481|NCT04725422|Infliximab|infliximab|mesh-list
43875482|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
43875483|NCT04725422|Leflunomide|leflunomide|mesh-list
43875484|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43875485|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
43875486|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875487|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875488|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43875489|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
43875490|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875491|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875492|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
43875493|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875494|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43875495|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43875496|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
43875497|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875498|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43875499|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875500|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875501|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875502|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875503|NCT04725422|Analgesics|analgesics|mesh-ancestor
43875504|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
43875505|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875506|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43875507|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43875508|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875509|NCT04725214|Temozolomide|temozolomide|mesh-list
43875510|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43875511|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
43875512|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875513|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135649|NCT00162214|Ketoconazole|ketoconazole|mesh-list
44135650|NCT00162214|Dasatinib|dasatinib|mesh-list
44135651|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611937|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
43611938|NCT03169426|Carvedilol|carvedilol|mesh-list
43611963|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43611964|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
43611965|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
43611966|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611967|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611969|NCT03169335|Bevacizumab|bevacizumab|mesh-list
43611970|NCT03169335|Carboplatin|carboplatin|mesh-list
43611971|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43611972|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611973|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
43611974|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
43611975|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663303|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44135652|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44135653|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135654|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135655|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
44135656|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135657|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44135658|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44135659|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44135660|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135661|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135662|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135663|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44135664|NCT00162227|Efavirenz|efavirenz|mesh-list
44135665|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44135666|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135667|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135668|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135676|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44135677|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
44135678|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44135679|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135680|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44135681|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135682|NCT00162318|Cetuximab|cetuximab|mesh-list
44135683|NCT00162318|Gefitinib|gefitinib|mesh-list
44135684|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374489|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
44374490|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374491|NCT05683223|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44374492|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44374493|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44374494|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374495|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374496|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
44374497|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374498|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
44374499|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374500|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374501|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
44374502|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44374503|NCT05664750|Antibodies|antibodies|mesh-list
44374504|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
44135685|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875514|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43875515|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43875516|NCT04724486|Cetrorelix|cetrorelix|mesh-list
43875517|NCT04724486|Menotropins|menotropins|mesh-list
43875518|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
43875519|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43875520|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
43875521|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875522|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875523|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43875524|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43875525|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875526|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43875527|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
43875528|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875529|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875530|NCT04724473|Tretinoin|tretinoin|mesh-list
43875531|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875532|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
43875533|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
43875534|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
43875535|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43875536|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875537|NCT04724187|Misoprostol|misoprostol|mesh-list
43875538|NCT04724187|Oxytocin|oxytocin|mesh-list
43875539|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
43875540|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875541|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875542|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43875543|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
43875544|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43875545|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875546|NCT04724226|Apatinib|apatinib|mesh-list
43875547|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875548|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43875549|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875550|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875551|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43875552|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43875553|NCT04724343|Cetrorelix|cetrorelix|mesh-list
43875554|NCT04724343|Menotropins|menotropins|mesh-list
43875555|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
44374505|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374506|NCT05664061|Fluticasone|fluticasone|mesh-list
44374508|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44374509|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44374510|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374511|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44374512|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
44374513|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374514|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374515|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44374516|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44374517|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
44374518|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44374519|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44374520|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44374521|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44374522|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
44374565|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374566|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44374567|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44374568|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44374569|NCT05626322|Lenalidomide|lenalidomide|mesh-list
44374570|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
44374571|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663330|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
43663331|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663336|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
44374572|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44374573|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44374574|NCT05626322|Growth Substances|growth substances|mesh-ancestor
43683662|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
43875556|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43875557|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
43875558|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43875559|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875560|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43875561|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43875562|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875570|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875571|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875572|NCT04724148|Analgesics|analgesics|mesh-ancestor
43875573|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
43875574|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875575|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875576|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875577|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
43875578|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
43875579|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43875580|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875581|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875582|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875583|NCT04723836|Riboflavin|riboflavin|mesh-list
43875584|NCT04723836|Vitamins|vitamins|mesh-ancestor
43875585|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
43875586|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875587|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
43875588|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43875589|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
43875590|NCT04723940|Doxycycline|doxycycline|mesh-list
43875591|NCT04723940|Clindamycin|clindamycin|mesh-list
43875592|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
43875593|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
43875594|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43875595|NCT04723940|Cefadroxil|cefadroxil|mesh-list
43875596|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875597|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612020|NCT03168828|Trospium chloride|trospium chloride|mesh-list
43612021|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
43612022|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
43612023|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612024|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612025|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43612026|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43612027|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
43612028|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612050|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43612051|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663351|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663352|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663353|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
43875598|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
43875599|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875600|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875601|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43875602|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875603|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875604|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43875605|NCT04723940|Renal Agents|renal agents|mesh-ancestor
43875606|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
43875607|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43875608|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43875609|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875610|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
43875611|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
43875612|NCT04723875|Paclitaxel|paclitaxel|mesh-list
43875613|NCT04723875|Docetaxel|docetaxel|mesh-list
43875614|NCT04723875|Cisplatin|cisplatin|mesh-list
43875615|NCT04723875|Carboplatin|carboplatin|mesh-list
43875616|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43875617|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374575|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
44374576|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374577|NCT05625399|Nivolumab|nivolumab|mesh-list
44374578|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374579|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374580|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44374581|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374582|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44374583|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43875618|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
43875619|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
43875620|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
43875621|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875622|NCT04723563|Heparin|heparin|mesh-list
43875623|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
43875624|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43875625|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43875626|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875627|NCT04723147|Levodopa|levodopa|mesh-list
43875628|NCT04723147|Carbidopa|carbidopa|mesh-list
43875629|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43875630|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43612053|NCT03168191|Nicotine|nicotine|mesh-list
43663373|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
43663374|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
43663375|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663376|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663377|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
43663378|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663379|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43663380|NCT04932083|Narcotics|narcotics|mesh-ancestor
43663381|NCT04932083|Analgesics|analgesics|mesh-ancestor
43663382|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43663383|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663384|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
43663385|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43875631|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43875632|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
43875633|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826851|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
43875637|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875638|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43875639|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
43875640|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
43875641|NCT04723342|Blinatumomab|blinatumomab|mesh-list
43875642|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875643|NCT04723459|Ivermectin|ivermectin|mesh-list
43875644|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875645|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875646|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43875647|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43875648|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43875649|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875650|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875651|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875652|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875653|NCT04723238|Analgesics|analgesics|mesh-ancestor
43875654|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
43875655|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875656|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
43875657|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875658|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
43875659|NCT04723069|Metronidazole|metronidazole|mesh-list
43875660|NCT04723069|Doxycycline|doxycycline|mesh-list
43875661|NCT04723069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875662|NCT04723069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875663|NCT04723069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875664|NCT04723069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875665|NCT04723069|Antimalarials|antimalarials|mesh-ancestor
43875666|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43875667|NCT04723030|Paclitaxel|paclitaxel|mesh-list
43875668|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43875669|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875670|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
43875671|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
43875672|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
43875673|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875674|NCT04722471|Progesterone|progesterone|mesh-list
43875675|NCT04722471|Progestins|progestins|mesh-ancestor
43875676|NCT04722471|Hormones|hormones|mesh-ancestor
43875677|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374584|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
44374585|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374586|NCT05615025|Propofol|propofol|mesh-list
44374587|NCT05615025|Sevoflurane|sevoflurane|mesh-list
44374588|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44374589|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374590|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374591|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374592|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
44374593|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
44374594|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44374595|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44374596|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
44374597|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374598|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374599|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
43875678|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135686|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44135687|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135688|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851566|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
43851567|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135689|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44135690|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44135691|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135692|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44135693|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44135694|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135695|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44135696|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44135697|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155788|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155789|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
44158235|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158236|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
44158237|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158238|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158239|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44158240|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
44158241|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158242|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
44158243|NCT00236444|Risperidone|risperidone|mesh-list
44158250|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158251|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158252|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158253|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158254|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
44158255|NCT00236457|Risperidone|risperidone|mesh-list
44158256|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158257|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
44158258|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158259|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158260|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158261|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158262|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158263|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158264|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158265|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158266|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
44158267|NCT00236470|Risperidone|risperidone|mesh-list
44374600|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374601|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374602|NCT05605964|Leuprolide|leuprolide|mesh-list
44374603|NCT05605964|Relugolix|relugolix|mesh-list
44374604|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44374605|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
44374606|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44374607|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374608|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43612054|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43612055|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
44374609|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374610|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
44374611|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
44374612|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44030442|NCT00000912|Efavirenz|efavirenz|mesh-list
44374613|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
44374614|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374615|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374616|NCT05573724|Itraconazole|itraconazole|mesh-list
44374617|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
44374618|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374619|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44374620|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44374621|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374622|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374623|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44374624|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44374625|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374626|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374627|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44158268|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158269|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
44158270|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158271|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158272|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158273|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158274|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158275|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158276|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158277|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158278|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
44158279|NCT00236483|Acetaminophen|acetaminophen|mesh-list
44158280|NCT00236483|Tramadol|tramadol|mesh-list
44158281|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44374628|NCT05560399|Dexamethasone|dexamethasone|mesh-list
44374630|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374631|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
44374632|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
44374633|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374634|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374635|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374636|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
44374637|NCT05560399|Hormones|hormones|mesh-ancestor
44374638|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374639|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44374640|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374641|NCT05539391|Rocuronium|rocuronium|mesh-list
44374642|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44374643|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44374644|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44374645|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374646|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374647|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
43851570|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825980|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43825981|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825982|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44374648|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44158282|NCT00236483|Analgesics|analgesics|mesh-ancestor
43875679|NCT04721899|Vitamin D|vitamin d|mesh-list
43875680|NCT04721899|Vitamins|vitamins|mesh-ancestor
43875681|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
43875682|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875683|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43875684|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
43875685|NCT04721964|Trace Elements|trace elements|mesh-ancestor
43875686|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
43875687|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875688|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
43875689|NCT04721795|Atorvastatin|atorvastatin|mesh-list
43875690|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43875691|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43875692|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
43875693|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875694|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43875695|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43875696|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875697|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875698|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875699|NCT04721704|Amoxicillin|amoxicillin|mesh-list
43875700|NCT04721704|Metronidazole|metronidazole|mesh-list
43875701|NCT04721704|Clarithromycin|clarithromycin|mesh-list
43875702|NCT04721704|Omeprazole|omeprazole|mesh-list
43875703|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875704|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875705|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43875706|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43875707|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43875708|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875709|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43875710|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612062|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612063|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
43612064|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
43612065|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43612066|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43612067|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612068|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
43612069|NCT03168412|Vaccines|vaccines|mesh-list
43612070|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
43612071|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612072|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
43612073|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612075|NCT03168074|Lenvatinib|lenvatinib|mesh-list
43875718|NCT04721054|Lidocaine|lidocaine|mesh-list
43875719|NCT04721054|Bupivacaine|bupivacaine|mesh-list
43875720|NCT04721054|Anesthetics|anesthetics|mesh-list
44374649|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374650|NCT05532319|Lenvatinib|lenvatinib|mesh-list
44374651|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374652|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44374653|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374654|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374655|NCT05531890|Betamethasone|betamethasone|mesh-list
44374656|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
44374657|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44374658|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
44374659|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44374660|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44374661|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44374662|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
44374663|NCT05531890|Hormones|hormones|mesh-ancestor
44374664|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374665|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374666|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44374667|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
44374668|NCT05517486|Bupivacaine|bupivacaine|mesh-list
44374669|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
44374670|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
44374671|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374672|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374673|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
44374674|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374675|NCT05514509|Cabotegravir|cabotegravir|mesh-list
44374676|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44374677|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43875722|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612079|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612109|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43612110|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612111|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43612112|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43612113|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
43612114|NCT03167918|Coagulants|coagulants|mesh-ancestor
43826007|NCT03760458|Abacavir|abacavir|mesh-list
43826008|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
43826009|NCT03760458|Dolutegravir|dolutegravir|mesh-list
43826010|NCT03760458|Triumeq|triumeq|mesh-list
43826011|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43826012|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826013|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826014|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826015|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
43826016|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826017|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43826018|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43875723|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875724|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
43875725|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875726|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43875727|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43875728|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43875729|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875730|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875731|NCT04721119|Anesthetics|anesthetics|mesh-list
43875732|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875733|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875734|NCT04721301|Maraviroc|maraviroc|mesh-list
43875735|NCT04721301|Nivolumab|nivolumab|mesh-list
43875736|NCT04721301|Ipilimumab|ipilimumab|mesh-list
43875737|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43875738|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875739|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43669435|NCT02904304|Ibuprofen|ibuprofen|mesh-list
43875740|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875741|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43875742|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43875743|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43875744|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43875745|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
43875746|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875747|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43875748|NCT04720807|Letrozole|letrozole|mesh-list
43875749|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875750|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43875751|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43875752|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875753|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875754|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43875755|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875756|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875757|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612115|NCT03167957|Amphotericin B|amphotericin b|mesh-list
43612116|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43612117|NCT03167957|Amebicides|amebicides|mesh-ancestor
43612118|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43612119|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43612120|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612121|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649900|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875758|NCT04720768|Palbociclib|palbociclib|mesh-list
43875759|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875760|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43875761|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702467|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43875769|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43875771|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43875772|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875773|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43875785|NCT04720287|Bupivacaine|bupivacaine|mesh-list
43875786|NCT04720287|Neostigmine|neostigmine|mesh-list
43875787|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
43875788|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
43875789|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875790|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875791|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
43875792|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875793|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43875794|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875795|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875796|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
43875797|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875798|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43875799|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
43875800|NCT04720248|Dipyrone|dipyrone|mesh-list
43649901|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649902|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
43649903|NCT03017963|Antidotes|antidotes|mesh-ancestor
43649904|NCT03017963|Protective Agents|protective agents|mesh-ancestor
43649905|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649906|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
43849370|NCT03933631|Prednisolone|prednisolone|mesh-list
43612127|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
43612128|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43612129|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
43612150|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43612151|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612152|NCT03167216|Cetirizine|cetirizine|mesh-list
43612153|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
43612154|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43612155|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43875801|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875802|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875803|NCT04720248|Analgesics|analgesics|mesh-ancestor
43875804|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
43875805|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875806|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875807|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875808|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875809|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
43875810|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
43875811|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875812|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875813|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875814|NCT04720183|Analgesics|analgesics|mesh-ancestor
43875815|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
43875816|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875817|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875818|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875819|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875820|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875821|NCT04720131|Capecitabine|capecitabine|mesh-list
43875822|NCT04720131|Apatinib|apatinib|mesh-list
43875823|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43875824|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
43875825|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875826|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875827|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43875828|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875829|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
43875843|NCT04719507|Meperidine|meperidine|mesh-list
43875844|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43875845|NCT04719507|Narcotics|narcotics|mesh-ancestor
43875846|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875847|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875848|NCT04719507|Analgesics|analgesics|mesh-ancestor
43875849|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
43875850|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875851|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875852|NCT04719715|Antibodies|antibodies|mesh-list
43875853|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
43875854|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135698|NCT00162383|Dapsone|dapsone|mesh-list
44135699|NCT00162383|Debrisoquin|debrisoquin|mesh-list
44135700|NCT00162383|Mephenytoin|mephenytoin|mesh-list
44135701|NCT00162383|Caffeine|caffeine|mesh-list
44135702|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44135703|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135704|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44135705|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135706|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669469|NCT02904031|Leucovorin|leucovorin|mesh-list
44135707|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44135708|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44135709|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
44135710|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135711|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135712|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
44135713|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44135714|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44135715|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44135716|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
44135717|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44135718|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135719|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
44135720|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
44135721|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135722|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
43663457|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44135723|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
43663458|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
44135724|NCT00162396|Albuterol|albuterol|mesh-list
44135725|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44135726|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
44135727|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135728|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135737|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135738|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135740|NCT00162409|Hematinics|hematinics|mesh-ancestor
44135741|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
44135742|NCT00162409|Vitamins|vitamins|mesh-ancestor
44135743|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
44135744|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135745|NCT00162422|Albuterol|albuterol|mesh-list
44135746|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44135747|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
44155790|NCT00228254|Vitamin A|vitamin a|mesh-list
43875855|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43875856|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875857|NCT04719585|Analgesics|analgesics|mesh-ancestor
43875858|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
43875859|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875867|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
43875868|NCT04719481|Pravastatin|pravastatin|mesh-list
43875869|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43875870|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43875871|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
43669482|NCT02904031|Protective Agents|protective agents|mesh-ancestor
43875872|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875873|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43875874|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43875875|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875877|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
43875878|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875879|NCT04719104|Protective Agents|protective agents|mesh-ancestor
43875880|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875881|NCT04718701|Paclitaxel|paclitaxel|mesh-list
43875882|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43875883|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875884|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
43875885|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
43875886|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
43875887|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875888|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
43875889|NCT04718402|Analgesics|analgesics|mesh-ancestor
43875890|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
43875891|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875892|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612164|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612165|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43612166|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
43875893|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875894|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43875895|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43875896|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875897|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875898|NCT04718311|Tacrolimus|tacrolimus|mesh-list
43875899|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43875900|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
43588104|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
43875903|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875904|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875905|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
43875906|NCT04718376|Analgesics|analgesics|mesh-ancestor
43875907|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
43875908|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875909|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875910|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875911|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43875912|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43875913|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875914|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875915|NCT04718584|Antibodies|antibodies|mesh-list
43875916|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43875917|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
43875918|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875919|NCT04718649|Celecoxib|celecoxib|mesh-list
43875920|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43875921|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875922|NCT04718649|Analgesics|analgesics|mesh-ancestor
43669502|NCT02903901|Melatonin|melatonin|mesh-list
43875925|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875926|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43875927|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43875928|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43875929|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43875930|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875931|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875932|NCT04718714|Midazolam|midazolam|mesh-list
43875933|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
43875934|NCT04718714|Propofol|propofol|mesh-list
43875935|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43875936|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875937|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875938|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875939|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
43875940|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
43875941|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875942|NCT04718714|Analgesics|analgesics|mesh-ancestor
43875943|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
43875944|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875945|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43875946|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43875947|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43875948|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
43875949|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875950|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374750|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374752|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44374753|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44374754|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44374755|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374756|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44374757|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
43663474|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
44374758|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374759|NCT05401058|Droperidol|droperidol|mesh-list
44374760|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44374761|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
44374762|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
44374763|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374764|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374765|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374766|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44374767|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44374768|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44374806|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44374807|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374808|NCT05300048|Paclitaxel|paclitaxel|mesh-list
44374809|NCT05300048|Serabelisib|serabelisib|mesh-list
44374810|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44374811|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374812|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
44374813|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
44374814|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
44374815|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374816|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683850|NCT00705211|Ezetimibe|ezetimibe|mesh-list
43875951|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875952|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43875953|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43875954|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875955|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
43875956|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
43875957|NCT04718038|Cetuximab|cetuximab|mesh-list
43875958|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43875959|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875960|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
43875961|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
43875962|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43875963|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43875964|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612183|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612184|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
43612185|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
43612186|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
43612214|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
43612215|NCT03167112|Irinotecan|irinotecan|mesh-list
43612216|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
43612217|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612218|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43612219|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663495|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663496|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
43875965|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875966|NCT04718233|Urological Agents|urological agents|mesh-ancestor
43875967|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43875968|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43875969|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875970|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43875971|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
43875972|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875973|NCT04718259|Midazolam|midazolam|mesh-list
43875974|NCT04718259|Bupivacaine|bupivacaine|mesh-list
43875975|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
43875976|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
43875977|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875978|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875979|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
43875980|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875981|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43875982|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43875983|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43875984|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43875985|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875986|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43875987|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
43875988|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
43875990|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875991|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875992|NCT04717908|Linezolid|linezolid|mesh-list
43875993|NCT04717908|Cycloserine|cycloserine|mesh-list
43875994|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
43875995|NCT04717908|Bedaquiline|bedaquiline|mesh-list
43702468|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44374836|NCT05294341|Norethindrone|norethindrone|mesh-list
44374837|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
44374838|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43649907|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649909|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649910|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649911|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
43649912|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
43649913|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43649914|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
43649915|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649916|NCT03017703|Eplerenone|eplerenone|mesh-list
43612220|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612221|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
43612222|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612223|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43663513|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43663514|NCT04573556|Lemborexant|lemborexant|mesh-list
44374839|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44374840|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44374841|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
43876011|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876012|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43876013|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876014|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43876015|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43876016|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876017|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
43876018|NCT04717531|Docetaxel|docetaxel|mesh-list
43876019|NCT04717531|Trastuzumab|trastuzumab|mesh-list
43876020|NCT04717531|Epirubicin|epirubicin|mesh-list
43876021|NCT04717531|Pertuzumab|pertuzumab|mesh-list
43876022|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876023|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
43876024|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876025|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876026|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876027|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
43876028|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876029|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876030|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43876031|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
43876032|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
43876033|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
43876034|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43876035|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43876036|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43876037|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43876038|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876039|NCT04717609|Ropivacaine|ropivacaine|mesh-list
43876040|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
43876041|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
43876042|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876043|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876044|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
43612224|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43612225|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612226|NCT03167112|Antidotes|antidotes|mesh-ancestor
43612227|NCT03167112|Protective Agents|protective agents|mesh-ancestor
43612228|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
43612229|NCT03167112|Vitamins|vitamins|mesh-ancestor
43612230|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
43612231|NCT03167034|Acetazolamide|acetazolamide|mesh-list
43612232|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
43612233|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43612234|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612269|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43612270|NCT03166644|Narcotics|narcotics|mesh-ancestor
43612271|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851574|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43876045|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876046|NCT04717102|Desflurane|desflurane|mesh-list
43876047|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43876048|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
43876049|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
43876050|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876051|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876052|NCT04717089|Anesthetics|anesthetics|mesh-list
43876053|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876057|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876058|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43876059|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876060|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876061|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876062|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43876063|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876064|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44374843|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374844|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44374845|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44374847|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374848|NCT05275400|Insulin|insulin|mesh-list
44374849|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44374850|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374851|NCT05261490|Doxorubicin|doxorubicin|mesh-list
44374852|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44374853|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44374854|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374855|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44374856|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43876065|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876066|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43876067|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43876068|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43876069|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135748|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135749|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135750|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44135751|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
44135752|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
43876070|NCT04716569|Ivermectin|ivermectin|mesh-list
43876071|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43876072|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876073|NCT04716868|Levan|levan|mesh-list
43876074|NCT04716868|Psyllium|psyllium|mesh-list
43876075|NCT04716868|Cathartics|cathartics|mesh-ancestor
43876076|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876077|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876078|NCT04716751|Paclitaxel|paclitaxel|mesh-list
43876079|NCT04716751|Carboplatin|carboplatin|mesh-list
43876080|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43876081|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876082|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43876083|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43876084|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43876085|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876086|NCT04716686|Niraparib|niraparib|mesh-list
43876087|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43876088|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876089|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876090|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876091|NCT04716296|Ketamine|ketamine|mesh-list
43876092|NCT04716296|Analgesics|analgesics|mesh-ancestor
43612272|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612273|NCT03166644|Analgesics|analgesics|mesh-ancestor
43612274|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
43612275|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876093|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
43876094|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876095|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876096|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43876097|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876098|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
43876099|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
43876100|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876101|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43876102|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43876103|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374857|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374858|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374859|NCT05254184|Nivolumab|nivolumab|mesh-list
44374860|NCT05254184|Ipilimumab|ipilimumab|mesh-list
44374861|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374862|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374863|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44374864|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876104|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876105|NCT04716179|Hormones|hormones|mesh-list
43876106|NCT04716179|Testosterone|testosterone|mesh-list
43876107|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876108|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876109|NCT04716179|Androgens|androgens|mesh-ancestor
43876110|NCT04715737|Vasopressins|vasopressins|mesh-list
43876111|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
43876112|NCT04715737|Oxytocin|oxytocin|mesh-list
43876113|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
43876114|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43876115|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876116|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
43876117|NCT04715737|Coagulants|coagulants|mesh-ancestor
43876118|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43876119|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43876132|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876133|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43876134|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
43612309|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612310|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612311|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876135|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876136|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
43876137|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876138|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876139|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876140|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
43876141|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876142|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876143|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43876145|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43876146|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876147|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876148|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876149|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876150|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876151|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
43876152|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
43876153|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876154|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876155|NCT04715152|Dexamethasone|dexamethasone|mesh-list
43876156|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
43876157|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
43876159|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876160|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
43876161|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
43876162|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876163|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876164|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876165|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
43876166|NCT04715152|Hormones|hormones|mesh-ancestor
43876167|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876168|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876169|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876170|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
43876171|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702469|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
43876173|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
43612321|NCT03166605|Simethicone|simethicone|mesh-list
43876175|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876176|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
43876177|NCT04715360|Favipiravir|favipiravir|mesh-list
43876178|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
43876179|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876180|NCT04715295|Azithromycin|azithromycin|mesh-list
43876181|NCT04715295|Doxycycline|doxycycline|mesh-list
43876182|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
43876186|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
43876187|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43876188|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43876189|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876190|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876191|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876192|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43876193|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
43876194|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43876195|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
43876196|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
43876197|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43876198|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43876199|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876200|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
43876201|NCT04715165|Bupivacaine|bupivacaine|mesh-list
43876202|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
43876203|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
43876204|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876205|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876206|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
43876207|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876208|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43876209|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43876210|NCT04715165|Analgesics|analgesics|mesh-ancestor
43876211|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43876212|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43876213|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43876214|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612384|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876215|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876216|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876217|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
43876218|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
43876219|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43876220|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43876221|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876222|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876223|NCT04715113|Urological Agents|urological agents|mesh-ancestor
43876225|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876226|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
43876227|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876228|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876229|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876230|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
43876231|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876232|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876233|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44135753|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135754|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44374894|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
44374895|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374896|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44374897|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44374898|NCT05222555|Growth Substances|growth substances|mesh-ancestor
44374899|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
44374900|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374901|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
44374902|NCT05216328|Antacids|antacids|mesh-ancestor
44374903|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135755|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44135756|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44135757|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
44135758|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135759|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135760|NCT00162435|Warfarin|warfarin|mesh-list
44135761|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
44135762|NCT00162461|Phenytoin|phenytoin|mesh-list
44135763|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
44135764|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44135765|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44135766|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135767|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135768|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44135769|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44135770|NCT00162474|Phenytoin|phenytoin|mesh-list
44135771|NCT00162474|Warfarin|warfarin|mesh-list
44135772|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
44135778|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44135779|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44135781|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43612388|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612390|NCT03165825|Betamethasone|betamethasone|mesh-list
43612391|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612392|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
43612393|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
44135782|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
44135783|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135784|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135785|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44135786|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
44135787|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
44135788|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135789|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44135790|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44135791|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44135792|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
44135793|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135794|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135795|NCT00162526|Tocopherols|tocopherols|mesh-list
44135796|NCT00162526|Vitamin E|vitamin e|mesh-list
44135797|NCT00162526|Tocotrienols|tocotrienols|mesh-list
44135798|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
44135799|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
44135800|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135801|NCT00162526|Protective Agents|protective agents|mesh-ancestor
43702470|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
44135810|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44135811|NCT00162552|Protective Agents|protective agents|mesh-ancestor
44135812|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876234|NCT04714554|Erythromycin|erythromycin|mesh-list
43876235|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
43876236|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43876237|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
43876238|NCT04714554|Relugolix|relugolix|mesh-list
43876239|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43876240|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876241|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876242|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43876243|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876244|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876245|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
43876246|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876247|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876248|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876249|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
43876250|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876251|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
43876252|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876253|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876254|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876255|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
43876256|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876257|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876258|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43876259|NCT04714242|Ranibizumab|ranibizumab|mesh-list
43876260|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43876265|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876266|NCT04714229|Vaccines|vaccines|mesh-list
43876267|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
43876268|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876269|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
43876270|NCT04714515|Ivermectin|ivermectin|mesh-list
43876271|NCT04714515|Montelukast|montelukast|mesh-list
43876272|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
43876273|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43876274|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43876275|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876276|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876277|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876278|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876279|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43876280|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
43663613|NCT04299880|Leucovorin|leucovorin|mesh-list
44374931|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374932|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44374933|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
43876281|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43876282|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876283|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876284|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876285|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43876286|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43876287|NCT04714073|Itraconazole|itraconazole|mesh-list
43876288|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
43876289|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876290|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43876291|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876292|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876293|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876294|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43876295|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876296|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876297|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876298|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43876299|NCT04714099|Cyclosporine|cyclosporine|mesh-list
43876300|NCT04714099|Cyclosporins|cyclosporins|mesh-list
43876301|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876302|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876303|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876304|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
43876305|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876306|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
43876307|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876308|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
43876309|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876310|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43876311|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
43876312|NCT04713956|Busulfan|busulfan|mesh-list
43876313|NCT04713956|Fludarabine|fludarabine|mesh-list
43876314|NCT04713956|Decitabine|decitabine|mesh-list
43876315|NCT04713956|Lenograstim|lenograstim|mesh-list
43876316|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44374934|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374935|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374936|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44374937|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374938|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44374939|NCT05207722|Analgesics|analgesics|mesh-ancestor
44374940|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
44374941|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44374942|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44374943|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44374944|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
44374945|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374946|NCT05186974|Cisplatin|cisplatin|mesh-list
44374947|NCT05186974|Carboplatin|carboplatin|mesh-list
44374948|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
44374949|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374950|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374951|NCT05178407|Micronutrients|micronutrients|mesh-list
44374952|NCT05178407|Trace Elements|trace elements|mesh-list
44374953|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374954|NCT05168683|Rasburicase|rasburicase|mesh-list
44374955|NCT05168683|Uric Acid|uric acid|mesh-list
44374956|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
43663632|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
43663633|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851577|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663634|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
43663635|NCT04299880|Antiviral Agents|antiviral agents|mesh-ancestor
43663636|NCT04299880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44374957|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374958|NCT05168683|Protective Agents|protective agents|mesh-ancestor
44374959|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374960|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
44374961|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44374962|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
44374963|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374964|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374965|NCT05155709|Azacitidine|azacitidine|mesh-list
44374966|NCT05155709|Venetoclax|venetoclax|mesh-list
44374967|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44374968|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
43876317|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
43876318|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876319|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876320|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876321|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
43876322|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374969|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374970|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374971|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44374972|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44374973|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
44374974|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44374975|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44374976|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
44374977|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44374978|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374979|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44374980|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44374981|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876323|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876324|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43876325|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43876326|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
43876327|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876328|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43612399|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612400|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43612401|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612402|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43612403|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
43612404|NCT03165344|Prednisone|prednisone|mesh-list
43612405|NCT03165344|Triamcinolone|triamcinolone|mesh-list
43612406|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43612407|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43612408|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
43612409|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43663642|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43876329|NCT04714177|Edaravone|edaravone|mesh-list
43876330|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43876331|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
43876334|NCT04714177|Protective Agents|protective agents|mesh-ancestor
43876335|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876336|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43876337|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43876338|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43876339|NCT04713904|Estradiol|estradiol|mesh-list
43876340|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43876341|NCT04713904|Estrogens|estrogens|mesh-ancestor
43876342|NCT04713904|Hormones|hormones|mesh-ancestor
43876343|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876344|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876345|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43876346|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
43876347|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43876348|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43876349|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43876350|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43876351|NCT04713891|Atezolizumab|atezolizumab|mesh-list
43876352|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43876353|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876354|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
43876355|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669540|NCT02903537|Vitamin D|vitamin d|mesh-list
43876356|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43876357|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876359|NCT04713787|Oxfendazole|oxfendazole|mesh-list
43876360|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
43876361|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43876362|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876363|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
43876364|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43876365|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43876366|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
43876367|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
43876368|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
43876369|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876370|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876371|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
43876372|NCT04713644|Propofol|propofol|mesh-list
44374982|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
44374983|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
44374984|NCT05129670|Antacids|antacids|mesh-ancestor
44374985|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44374986|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44374987|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
44374988|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44374989|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876373|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663655|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663656|NCT04244630|Antioxidants|antioxidants|mesh-list
43663657|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663658|NCT04244630|Protective Agents|protective agents|mesh-ancestor
43663659|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663660|NCT04243616|Paclitaxel|paclitaxel|mesh-list
43663661|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
43663662|NCT04243616|Carboplatin|carboplatin|mesh-list
43663663|NCT04243616|Doxorubicin|doxorubicin|mesh-list
43663664|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43663665|NCT04243616|Cemiplimab|cemiplimab|mesh-list
43851580|NCT03589339|Nivolumab|nivolumab|mesh-list
43876374|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876375|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876376|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876377|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
43876378|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
43876379|NCT04713488|Vaccines|vaccines|mesh-list
43876380|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
43876381|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876382|NCT04713735|Lactoferrin|lactoferrin|mesh-list
43876383|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876384|NCT04713761|Carboplatin|carboplatin|mesh-list
43876385|NCT04713761|Pemetrexed|pemetrexed|mesh-list
43876386|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876387|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876388|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876389|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43876390|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43876391|NCT04713254|Metoprolol|metoprolol|mesh-list
43876392|NCT04713254|Midazolam|midazolam|mesh-list
43876393|NCT04713254|Bupropion|bupropion|mesh-list
43876394|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43876395|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43876396|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876397|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876398|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876399|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876400|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876401|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876402|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
43876403|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
43876404|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
43876405|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
43876406|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876408|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43876409|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
43876410|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43876411|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43876412|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876413|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
43876414|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43876415|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876416|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876417|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43876418|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43876419|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
43876420|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
43876421|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876422|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43876423|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43876424|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43876425|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
43876426|NCT04713176|Remdesivir|remdesivir|mesh-list
43876427|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
43876428|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876429|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
43876430|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876431|NCT04713410|Prednisolone|prednisolone|mesh-list
43876432|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876433|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
43876434|NCT04713410|Hormones|hormones|mesh-ancestor
44374997|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44374998|NCT05045703|Vitamin A|vitamin a|mesh-list
44374999|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
44375000|NCT05045703|Vitamins|vitamins|mesh-ancestor
44375001|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
44375002|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375003|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
44375004|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375005|NCT05045703|Protective Agents|protective agents|mesh-ancestor
44382391|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876435|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876436|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876437|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876438|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876439|NCT04713189|Fentanyl|fentanyl|mesh-list
43876440|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43876441|NCT04713189|Narcotics|narcotics|mesh-ancestor
43876442|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876443|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876444|NCT04713189|Analgesics|analgesics|mesh-ancestor
43876445|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
43876446|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876447|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43876448|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876449|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
43876450|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
43876451|NCT04713163|Vaccines|vaccines|mesh-list
43876452|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
43876453|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876454|NCT04713332|Vitamin E|vitamin e|mesh-list
43876455|NCT04713332|Tocopherols|tocopherols|mesh-list
43876456|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
43876457|NCT04713332|Vitamins|vitamins|mesh-ancestor
43876458|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
43876459|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876460|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
44135813|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
43876461|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876462|NCT04713332|Protective Agents|protective agents|mesh-ancestor
43876464|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
43876465|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876466|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43876467|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43612410|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43612411|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43612412|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
43612413|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43612414|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612415|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
43612416|NCT03165344|Hormones|hormones|mesh-ancestor
43612417|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612418|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612419|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43612420|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826031|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826032|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826033|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826034|NCT03629925|Gemcitabine|gemcitabine|mesh-list
43826036|NCT03629925|Carboplatin|carboplatin|mesh-list
43826037|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826038|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826039|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
43876468|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876469|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876470|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43876471|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876472|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876473|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876474|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43876475|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43876476|NCT04712799|Xylometazoline|xylometazoline|mesh-list
43876477|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
43876478|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44375007|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375008|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44375009|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375010|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44375011|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030908|NCT00000982|Zidovudine|zidovudine|mesh-list
43876483|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876485|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
43876486|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43876487|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
43876488|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876489|NCT04712435|Protective Agents|protective agents|mesh-ancestor
43876490|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876491|NCT04712435|Antidotes|antidotes|mesh-ancestor
43876492|NCT04712357|Ascorbic Acid|ascorbic acid|mesh-list
43876493|NCT04712357|Tenofovir|tenofovir|mesh-list
43876494|NCT04712357|Emtricitabine|emtricitabine|mesh-list
43876495|NCT04712357|Vitamins|vitamins|mesh-ancestor
43876496|NCT04712357|Micronutrients|micronutrients|mesh-ancestor
43876497|NCT04712357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876498|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
43876499|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876500|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43876501|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43876502|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876503|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876504|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43876505|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43876506|NCT04712357|Antioxidants|antioxidants|mesh-ancestor
43876507|NCT04712357|Protective Agents|protective agents|mesh-ancestor
43876508|NCT04712396|Itraconazole|itraconazole|mesh-list
43876509|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
43876510|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876511|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43876512|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876513|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876514|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876515|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43876516|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876517|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876518|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876519|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43876520|NCT04712266|Insulin|insulin|mesh-list
43876521|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43876522|NCT04712266|Glucagon|glucagon|mesh-list
43876523|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43876524|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876525|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876526|NCT04712266|Hormones|hormones|mesh-ancestor
43876527|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876528|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
43876529|NCT04712279|Ivermectin|ivermectin|mesh-list
43826042|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876530|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
43876531|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43876532|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43876533|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876534|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876535|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876536|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375043|NCT05005273|Nivolumab|nivolumab|mesh-list
44375044|NCT05005273|Ipilimumab|ipilimumab|mesh-list
44375045|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375046|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375047|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44375048|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375049|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
44375050|NCT05003895|Fludarabine|fludarabine|mesh-list
44375051|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375052|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
44375053|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375054|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375055|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375056|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
44375057|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375058|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375059|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375060|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
44375061|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44375062|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375063|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375064|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
44135814|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44135815|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
44135816|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43612421|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612422|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
43612423|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612424|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612425|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43612426|NCT03165344|Antacids|antacids|mesh-ancestor
43612427|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612428|NCT03165383|Morphine|morphine|mesh-list
43612429|NCT03165383|Bupivacaine|bupivacaine|mesh-list
43612430|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
43826054|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826055|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135817|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44135818|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
44135819|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375065|NCT04971226|Dasatinib|dasatinib|mesh-list
44375066|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375067|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375068|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375069|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375070|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44375071|NCT04964544|Calcium|calcium|mesh-list
43669584|NCT02902861|Methotrexate|methotrexate|mesh-list
44135820|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135821|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135822|NCT00162591|Remifentanil|remifentanil|mesh-list
44135823|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44135824|NCT00162591|Narcotics|narcotics|mesh-ancestor
44135825|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44135832|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44135833|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135834|NCT00162643|Ritonavir|ritonavir|mesh-list
44135835|NCT00162643|Lopinavir|lopinavir|mesh-list
44135836|NCT00162643|Lamivudine|lamivudine|mesh-list
44135837|NCT00162643|Zidovudine|zidovudine|mesh-list
44135838|NCT00162643|Efavirenz|efavirenz|mesh-list
44135839|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44135840|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44135841|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
44135842|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135843|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135844|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44135845|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44135846|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
44135847|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669616|NCT02902744|Hormones|hormones|mesh-ancestor
44135848|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44135849|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44135850|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44135851|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135852|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
44135853|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44135854|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44135855|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44135856|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44135857|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44135858|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
44135859|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135860|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
44135861|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135862|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44135863|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44135864|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
44135865|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135866|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135867|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44135868|NCT00162669|Bevacizumab|bevacizumab|mesh-list
44135869|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135870|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135871|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44135872|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44135873|NCT00162669|Growth Substances|growth substances|mesh-ancestor
44135874|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135875|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44135876|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44135877|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
44135878|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826083|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43826084|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44135879|NCT00162695|Etoposide|etoposide|mesh-list
44135880|NCT00162695|Vincristine|vincristine|mesh-list
44135881|NCT00162695|Epirubicin|epirubicin|mesh-list
44135882|NCT00162695|Ifosfamide|ifosfamide|mesh-list
44135883|NCT00162695|Carboplatin|carboplatin|mesh-list
44135884|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44135885|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375072|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44375073|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375074|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44375075|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44375076|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
44375077|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375078|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44375079|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44375080|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375081|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
44135886|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43876537|NCT04711889|Urinastatin|urinastatin|mesh-list
43876538|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43876539|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43876540|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
43876541|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876542|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876543|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
43876544|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876545|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876555|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43876556|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
43876557|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43876558|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876559|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876560|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43876562|NCT04712058|Emtricitabine|emtricitabine|mesh-list
43876563|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43876564|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
43876565|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876566|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43669631|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
43876567|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43876568|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876569|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876570|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43876571|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43876572|NCT04711668|Lidocaine|lidocaine|mesh-list
43876573|NCT04711668|Ketamine|ketamine|mesh-list
43876574|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
43876575|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
43876576|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876577|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876578|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
43876579|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876580|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43876581|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43876582|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43876583|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876584|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876585|NCT04711668|Analgesics|analgesics|mesh-ancestor
43876586|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43876587|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876588|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
43876589|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43876590|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43876591|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876592|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
43876593|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43876594|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
43876595|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375082|NCT04949256|Leucovorin|leucovorin|mesh-list
44375083|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
44375084|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
44375085|NCT04949256|Lenvatinib|lenvatinib|mesh-list
44375086|NCT04949256|Calcium|calcium|mesh-list
44375087|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
44375088|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375089|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375090|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44375091|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375092|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44375093|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375094|NCT04949256|Antidotes|antidotes|mesh-ancestor
44375095|NCT04949256|Protective Agents|protective agents|mesh-ancestor
44375096|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
44375097|NCT04949256|Vitamins|vitamins|mesh-ancestor
44375098|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
44375099|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375100|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375101|NCT04933552|Siponimod|siponimod|mesh-list
44375102|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44375103|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375104|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375105|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
44375106|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375107|NCT04931342|Maytansine|maytansine|mesh-list
44375108|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44375109|NCT04931342|Bevacizumab|bevacizumab|mesh-list
44375110|NCT04931342|Trastuzumab|trastuzumab|mesh-list
43876596|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
43876597|NCT04711642|Protective Agents|protective agents|mesh-ancestor
43876598|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43876599|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43876600|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43876601|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43612431|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
43612458|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612459|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43612460|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612461|NCT03165500|Analgesics|analgesics|mesh-ancestor
43612462|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
43612463|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612464|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
43612465|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
43612466|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
43663700|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
43663701|NCT04087096|Denosumab|denosumab|mesh-list
43663702|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43876602|NCT04711291|Tacrolimus|tacrolimus|mesh-list
43876603|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876604|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
43876605|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876614|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876615|NCT04711213|Dexamethasone|dexamethasone|mesh-list
43876616|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
43876617|NCT04711213|BB 1101|bb 1101|mesh-list
43876618|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876619|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
43876620|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
43876621|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876622|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375111|NCT04931342|Atezolizumab|atezolizumab|mesh-list
44375112|NCT04931342|Letrozole|letrozole|mesh-list
44375113|NCT04931342|Olaparib|olaparib|mesh-list
44375114|NCT04931342|Palbociclib|palbociclib|mesh-list
44375115|NCT04931342|Hormones|hormones|mesh-list
44375116|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44375117|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375118|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375119|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375120|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
43684064|NCT00156117|Olanzapine|olanzapine|mesh-list
43876623|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876624|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
43876625|NCT04711213|Hormones|hormones|mesh-ancestor
43876626|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876627|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876628|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876629|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
43876630|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876631|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876632|NCT04711161|Paclitaxel|paclitaxel|mesh-list
43876633|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43876634|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876635|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
43876636|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
43876637|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
43876638|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876639|NCT04711096|Bupivacaine|bupivacaine|mesh-list
43876640|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
43876641|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
43876642|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876643|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876644|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
43876645|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876646|NCT04710927|Fluorides|fluorides|mesh-list
43876647|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
43876648|NCT04710927|Protective Agents|protective agents|mesh-ancestor
43876649|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876650|NCT04710914|Midazolam|midazolam|mesh-list
43876651|NCT04710914|Isoflurane|isoflurane|mesh-list
43876652|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43876653|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43876654|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876655|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612467|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612468|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43649924|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43649925|NCT03017768|Tryptophan|tryptophan|mesh-list
43876656|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876657|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876658|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876659|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876660|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
43876661|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
43876662|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
43876663|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
43876664|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876665|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876666|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43876667|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43876668|NCT04711044|Menthol|menthol|mesh-list
43876669|NCT04711044|Histamine|histamine|mesh-list
43876670|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
43876671|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
43876672|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
43876673|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
43876676|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876678|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
43876679|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876680|NCT04710329|Protective Agents|protective agents|mesh-ancestor
43876681|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876682|NCT04710329|Vitamins|vitamins|mesh-ancestor
44375122|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375123|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375124|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375125|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375127|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375128|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375129|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375130|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44375131|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44375132|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375133|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44375134|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
44375135|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44375136|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375137|NCT04905316|Durvalumab|durvalumab|mesh-list
43649937|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649938|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
43649939|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649940|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649941|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43649942|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649943|NCT03017495|Midazolam|midazolam|mesh-list
43649944|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649945|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43649946|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649947|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649948|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44375138|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684072|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876683|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
43876684|NCT04710498|Atezolizumab|atezolizumab|mesh-list
44155792|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
43876686|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43876687|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
43876688|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
43876689|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43876690|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43876691|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876692|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
43876693|NCT04710017|Coagulants|coagulants|mesh-ancestor
43876694|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43876695|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43876696|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43876697|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
43876698|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669647|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876699|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876700|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43876701|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43876702|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43876703|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876704|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876705|NCT04710160|Calcium|calcium|mesh-list
43876706|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43876707|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876708|NCT04709770|Simethicone|simethicone|mesh-list
43876709|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876710|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
43876711|NCT04709770|Emollients|emollients|mesh-ancestor
43876712|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
43876713|NCT04709731|Ponatinib|ponatinib|mesh-list
43876714|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375147|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375148|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375149|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375151|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375152|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
44375153|NCT04897321|Fludarabine|fludarabine|mesh-list
44375154|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375155|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
44375156|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375157|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375158|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375159|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
44375160|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375161|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375162|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375163|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
44375164|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44375165|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43876715|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43876716|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876717|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375179|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44375180|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
44375181|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375182|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44375183|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44375184|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375185|NCT04868877|Osimertinib|osimertinib|mesh-list
44375186|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375187|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375188|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375189|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375190|NCT04867343|Fentanyl|fentanyl|mesh-list
44375191|NCT04867343|Remifentanil|remifentanil|mesh-list
44375192|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44375193|NCT04867343|Narcotics|narcotics|mesh-ancestor
44375194|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44375195|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375196|NCT04867343|Analgesics|analgesics|mesh-ancestor
44375197|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
44375198|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375199|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44375200|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44375201|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
43876718|NCT04709744|Vitamin D|vitamin d|mesh-list
43876719|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
43876720|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
43876721|NCT04709744|Vitamins|vitamins|mesh-list
43876722|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
43876723|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876724|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43876725|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43876726|NCT04709380|Sorafenib|sorafenib|mesh-list
43876727|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876728|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43876729|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876730|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876731|NCT04709185|Dexamethasone|dexamethasone|mesh-list
43876732|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876733|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
43876734|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
43876735|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375206|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
44375208|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375209|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375210|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375211|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375212|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375213|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375217|NCT04813926|Riociguat|riociguat|mesh-list
44375218|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
44375219|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375220|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
43649949|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43649950|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649951|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649952|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
43649953|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
43649954|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
43649955|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
43649956|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649957|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649959|NCT03017222|Ramosetron|ramosetron|mesh-list
43663821|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
44375221|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375222|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375223|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375224|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375225|NCT04779151|Niraparib|niraparib|mesh-list
44375226|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44375227|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375228|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375229|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375230|NCT04765202|Carisoprodol|carisoprodol|mesh-list
44375231|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44375232|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375233|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44375234|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375235|NCT04739813|Prednisone|prednisone|mesh-list
43876736|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876737|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876738|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
43876739|NCT04709185|Hormones|hormones|mesh-ancestor
43876740|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876741|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876742|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876743|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
44135898|NCT00162721|Ifosfamide|ifosfamide|mesh-list
44375236|NCT04739813|Lenalidomide|lenalidomide|mesh-list
44375237|NCT04739813|Venetoclax|venetoclax|mesh-list
44375238|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
44375239|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375240|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
44375241|NCT04739813|Hormones|hormones|mesh-ancestor
44375242|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375243|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375244|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44375245|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135899|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876747|NCT04709315|Choline|choline|mesh-list
43876748|NCT04709315|Rocuronium|rocuronium|mesh-list
43876749|NCT04709315|Succinylcholine|succinylcholine|mesh-list
43876750|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43876751|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43876752|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43876753|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876754|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876755|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
43876756|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43876757|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
43876758|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876759|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876760|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43876761|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
43876762|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43649960|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
43876763|NCT04709094|Bupropion|bupropion|mesh-list
43876764|NCT04709094|Warfarin|warfarin|mesh-list
43876765|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43876766|NCT04709094|Norethindrone|norethindrone|mesh-list
43876767|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
43876768|NCT04709094|Norinyl|norinyl|mesh-list
43876769|NCT04709094|Estradiol|estradiol|mesh-list
43876770|NCT04709094|Estrogens|estrogens|mesh-ancestor
43876771|NCT04709094|Hormones|hormones|mesh-ancestor
43876772|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876773|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876774|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43876775|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
43876776|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43876777|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43876778|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
43876779|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43876780|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
43876781|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876782|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43876783|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43876784|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876785|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876786|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
43876787|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876788|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43876789|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876790|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876791|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43876792|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43876803|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876804|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876805|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876806|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876807|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876808|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43876809|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
43876811|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
43876812|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
44375246|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
44375247|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375248|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375249|NCT04739813|Growth Substances|growth substances|mesh-ancestor
44375250|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375251|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375255|NCT04735549|Hormones|hormones|mesh-list
44375256|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375257|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375258|NCT04703101|Leucovorin|leucovorin|mesh-list
44375259|NCT04703101|Fluorouracil|fluorouracil|mesh-list
44375260|NCT04703101|Capecitabine|capecitabine|mesh-list
44375261|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
44375262|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
44375263|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375264|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375265|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375266|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851582|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663869|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663870|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663871|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43663872|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663873|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
43663875|NCT05467319|Hematinics|hematinics|mesh-ancestor
44375267|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
44375268|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375269|NCT04703101|Antidotes|antidotes|mesh-ancestor
44375270|NCT04703101|Protective Agents|protective agents|mesh-ancestor
44375299|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375300|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44375301|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
44375302|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375303|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375304|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
44375305|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375306|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44375307|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
44375308|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
43876813|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876814|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876815|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
43876816|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876817|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43876818|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43876819|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876820|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43876821|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
43876822|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876823|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43876824|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43876825|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43876826|NCT04709081|Protective Agents|protective agents|mesh-ancestor
43876827|NCT04709029|Dexamethasone|dexamethasone|mesh-list
43876828|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
43876830|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876831|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
43876832|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
43876833|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876834|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876835|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876836|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
43876837|NCT04709029|Hormones|hormones|mesh-ancestor
43876838|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876839|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876840|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876841|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
43876842|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876843|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876844|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43876845|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43876846|NCT04708821|Dexamethasone|dexamethasone|mesh-list
43876847|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43876848|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876849|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
43876850|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
43876851|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876852|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876853|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43876854|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
43876855|NCT04708821|Hormones|hormones|mesh-ancestor
43876856|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876857|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43876870|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876871|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876872|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
43876873|NCT04708964|Analgesics|analgesics|mesh-ancestor
44375309|NCT04647721|Protective Agents|protective agents|mesh-ancestor
44375310|NCT04628572|Ceftazidime|ceftazidime|mesh-list
44375311|NCT04628572|Avibactam|avibactam|mesh-list
44375312|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44375313|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44375314|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375315|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44375316|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375317|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375318|NCT04599634|Venetoclax|venetoclax|mesh-list
44375319|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
43876874|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
43876875|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876876|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876877|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43876878|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43876879|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876880|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876881|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43876882|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876883|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876884|NCT04708249|Inositol|inositol|mesh-list
43876885|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
43876886|NCT04708249|Vitamins|vitamins|mesh-ancestor
43876887|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
43876888|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876889|NCT04708353|Ascorbic Acid|ascorbic acid|mesh-list
43876890|NCT04708353|Pregabalin|pregabalin|mesh-list
43876891|NCT04708353|Vitamins|vitamins|mesh-ancestor
43876892|NCT04708353|Micronutrients|micronutrients|mesh-ancestor
43876893|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876894|NCT04708353|Analgesics|analgesics|mesh-ancestor
43876895|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
43876896|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43876897|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
43876898|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43876899|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876900|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876901|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43876902|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43876903|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43876904|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876905|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876906|NCT04708353|Antioxidants|antioxidants|mesh-ancestor
43876907|NCT04708353|Protective Agents|protective agents|mesh-ancestor
43876908|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
43876909|NCT04707950|Oxytocin|oxytocin|mesh-list
43876910|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
43876911|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43876912|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876913|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43876914|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43876915|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876916|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
43876917|NCT04707950|Coagulants|coagulants|mesh-ancestor
43876918|NCT04708106|Menthol|menthol|mesh-list
43876919|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
43876920|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
43876921|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
43876931|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43612525|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876932|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43876933|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876935|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43876936|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876937|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44375321|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375322|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375343|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44375344|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
44375345|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375346|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876938|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876939|NCT04707508|Metformin|metformin|mesh-list
43876940|NCT04707508|Valsartan|valsartan|mesh-list
43876941|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43876942|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876943|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43876944|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43876945|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43876946|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876947|NCT04707209|Sirolimus|sirolimus|mesh-list
43876948|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43876949|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876950|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43876951|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876952|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
43876953|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876954|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
43876955|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876956|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43876957|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876958|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
43876959|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43876960|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876961|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43876962|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876963|NCT04707118|Paclitaxel|paclitaxel|mesh-list
43876964|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43876965|NCT04707118|Cisplatin|cisplatin|mesh-list
43876966|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43876967|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876968|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
43876969|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
43876970|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
43876971|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876972|NCT04707027|Aflibercept|aflibercept|mesh-list
43876973|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43876974|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43876975|NCT04707027|Growth Substances|growth substances|mesh-ancestor
43876976|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375347|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44375348|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44375349|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
44375350|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375351|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375353|NCT04545411|Volagidemab|volagidemab|mesh-list
44375354|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44375355|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663981|NCT05465902|Vaccines|vaccines|mesh-list
43663982|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
43663983|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663984|NCT05465733|Pemetrexed|pemetrexed|mesh-list
43663985|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663986|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663987|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375356|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44375357|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375358|NCT04539405|Sevoflurane|sevoflurane|mesh-list
44375359|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44375360|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44375361|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
44375362|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
44375363|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684232|NCT00093899|Simvastatin|simvastatin|mesh-list
43876977|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
43876978|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876979|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
43876980|NCT04706936|Fludarabine|fludarabine|mesh-list
43876981|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43876982|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
43876983|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876984|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876985|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43876986|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
43876994|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43876995|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876997|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135900|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44135901|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44135902|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44135903|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135904|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135905|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44135906|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
44135907|NCT00162734|Interferons|interferons|mesh-list
44135908|NCT00162734|Ribavirin|ribavirin|mesh-list
44135909|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
44135910|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135911|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
44135912|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135913|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
44135914|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135915|NCT00162760|Thalidomide|thalidomide|mesh-list
44135916|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135917|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
44135918|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135919|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
44135920|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44135921|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135922|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44135923|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44135924|NCT00162760|Growth Substances|growth substances|mesh-ancestor
44375364|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375366|NCT04524871|Atezolizumab|atezolizumab|mesh-list
44375367|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375368|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375369|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375370|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375371|NCT04524871|Growth Substances|growth substances|mesh-ancestor
44375372|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375373|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375374|NCT04478838|Olanzapine|olanzapine|mesh-list
44375375|NCT04478838|Risperidone|risperidone|mesh-list
44375376|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44375377|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
44375378|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375379|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375380|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375381|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44375382|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44375383|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44375384|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44375385|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44375386|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
44375387|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
44375388|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
44375389|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135925|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
44135926|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135927|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
44135928|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
44135929|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135930|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44135931|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
44135932|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
44135933|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135934|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135935|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135936|NCT00162799|Triflusal|triflusal|mesh-list
44135937|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44135938|NCT00162812|Epirubicin|epirubicin|mesh-list
44135939|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44135940|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44135941|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44135942|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44135943|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135944|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135945|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
44135946|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44135947|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375390|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375391|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44375392|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44375393|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44375394|NCT04461639|Factor VIII|factor viii|mesh-list
44375395|NCT04461639|Coagulants|coagulants|mesh-ancestor
44375396|NCT04384367|Naproxen|naproxen|mesh-list
44375397|NCT04384367|Rizatriptan|rizatriptan|mesh-list
44375398|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44375399|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44375400|NCT04384367|Analgesics|analgesics|mesh-ancestor
44375401|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
44031291|NCT00001057|Zidovudine|zidovudine|mesh-list
44375402|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375403|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135948|NCT00162864|Montelukast|montelukast|mesh-list
43876999|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43877000|NCT04706910|Diuretics|diuretics|mesh-ancestor
43877001|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
43877002|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877012|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877013|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43877014|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43877015|NCT04706897|Lidocaine|lidocaine|mesh-list
43877016|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
43877017|NCT04706897|Ketamine|ketamine|mesh-list
43877018|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877019|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
43877020|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877021|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877022|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
43877023|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877024|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877025|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43877026|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877027|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877028|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877029|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877030|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877031|NCT04706897|Analgesics|analgesics|mesh-ancestor
43877032|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877033|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877034|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877035|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877036|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877037|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43877038|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877039|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
43877040|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43877041|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43877042|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
43877043|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43877044|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
43877045|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877046|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
43877047|NCT04706455|Protective Agents|protective agents|mesh-ancestor
43877052|NCT04706247|Anesthetics|anesthetics|mesh-list
43877053|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877054|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877055|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
43877056|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
44375404|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375405|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375406|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
44375407|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44375408|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375409|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375410|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44375411|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
44375412|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375413|NCT04320602|Eculizumab|eculizumab|mesh-list
44375414|NCT04320602|Ravulizumab|ravulizumab|mesh-list
44375415|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44375416|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375417|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
44375418|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375419|NCT04310020|Atezolizumab|atezolizumab|mesh-list
44375420|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44375421|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375422|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
44375423|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375424|NCT04300647|Atezolizumab|atezolizumab|mesh-list
44375425|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375426|NCT04296890|Maytansine|maytansine|mesh-list
44375427|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375428|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877057|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43877058|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43877059|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877060|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877061|NCT04706546|Urological Agents|urological agents|mesh-ancestor
43877062|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
43877063|NCT04706377|Vitamins|vitamins|mesh-ancestor
43877064|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
43877065|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877066|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
43877067|NCT04706091|Suvorexant|suvorexant|mesh-list
43877083|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
43877084|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
43877085|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877086|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43877087|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43877088|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877089|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877090|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877091|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
43877092|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43877093|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877094|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43877095|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
43877096|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43664150|NCT05272202|Propofol|propofol|mesh-list
43877097|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44375429|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375430|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375431|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375432|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375433|NCT04276376|Atezolizumab|atezolizumab|mesh-list
44375434|NCT04276376|Rucaparib|rucaparib|mesh-list
44375435|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375436|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44375437|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375438|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375439|NCT04267939|Niraparib|niraparib|mesh-list
44375440|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44375441|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375442|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375443|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375444|NCT04259255|Edaravone|edaravone|mesh-list
44375445|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44375446|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
44375447|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375448|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44375449|NCT04259255|Protective Agents|protective agents|mesh-ancestor
44375450|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375451|NCT04254692|Bupivacaine|bupivacaine|mesh-list
43877098|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43877099|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43877100|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
43877101|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877102|NCT04705987|Colchicine|colchicine|mesh-list
43877103|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
43877104|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43877105|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
43877106|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
43877107|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877108|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877109|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877110|NCT04705909|Pitavastatin|pitavastatin|mesh-list
43669712|NCT02902432|Endostatins|endostatins|mesh-list
43877111|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43877112|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43877113|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43877114|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
43877115|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877116|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877117|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43877118|NCT04705584|Cyclosporine|cyclosporine|mesh-list
43877119|NCT04705584|Prednisolone|prednisolone|mesh-list
43877120|NCT04705584|Cyclosporins|cyclosporins|mesh-list
43877121|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877122|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877123|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43877124|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
44375452|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
44375453|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
43612573|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44375454|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44375455|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375456|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
44375457|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375458|NCT04249401|Warfarin|warfarin|mesh-list
44375459|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
44375460|NCT04249401|Dabigatran|dabigatran|mesh-list
44375461|NCT04249401|Apixaban|apixaban|mesh-list
44375462|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
44375463|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44375464|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
44375465|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44375466|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44375467|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375468|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375469|NCT04240002|Cytarabine|cytarabine|mesh-list
44375470|NCT04240002|Fludarabine|fludarabine|mesh-list
44375471|NCT04240002|Lenograstim|lenograstim|mesh-list
44375472|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375473|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375474|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
44375475|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375476|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375477|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
44375478|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375480|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375482|NCT04216316|Gemcitabine|gemcitabine|mesh-list
44375501|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375502|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44375503|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44375504|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
44375505|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44375506|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375507|NCT04150029|Azacitidine|azacitidine|mesh-list
44375508|NCT04150029|Venetoclax|venetoclax|mesh-list
44375509|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375510|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
44375511|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375512|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375513|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375514|NCT04148105|Cilostazol|cilostazol|mesh-list
44375515|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44375516|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
44375517|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375518|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826154|NCT02489903|Gemcitabine|gemcitabine|mesh-list
44375519|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44375520|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
44375521|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44375522|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44375523|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375524|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44375525|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
44375526|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44375527|NCT04148105|Protective Agents|protective agents|mesh-ancestor
44375528|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44375529|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44375531|NCT04140721|Moxonidine|moxonidine|mesh-list
44375545|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375546|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44375547|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375548|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
44375549|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375550|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375551|NCT04140162|Growth Substances|growth substances|mesh-ancestor
44375552|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375554|NCT04068597|Azacitidine|azacitidine|mesh-list
44375555|NCT04068597|Venetoclax|venetoclax|mesh-list
44375556|NCT04068597|Pomalidomide|pomalidomide|mesh-list
44375557|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375558|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
44375559|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
44375560|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375561|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375562|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375563|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
44375564|NCT04068597|Hormones|hormones|mesh-ancestor
44375565|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375566|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44375567|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375568|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375569|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
44375595|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375596|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375597|NCT04047472|Growth Substances|growth substances|mesh-ancestor
44375598|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375599|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375600|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375601|NCT04034251|Paclitaxel|paclitaxel|mesh-list
44375602|NCT04034251|Capecitabine|capecitabine|mesh-list
44375603|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375604|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375605|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375606|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375607|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375608|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630509|NCT03051698|Vancomycin|vancomycin|mesh-list
43877127|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877128|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
43877129|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43877130|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43877131|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43877132|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
43877133|NCT04705584|Hormones|hormones|mesh-ancestor
43877134|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877135|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43877136|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877137|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43877138|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43877139|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877140|NCT04705337|Simendan|simendan|mesh-list
43877141|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43877142|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877143|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43877144|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43877145|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877146|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877147|NCT04705337|Protective Agents|protective agents|mesh-ancestor
43877148|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877149|NCT04705402|Mannitol|mannitol|mesh-list
43877150|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43877151|NCT04705402|Diuretics|diuretics|mesh-ancestor
43877152|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
43877153|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877154|NCT04705519|Paclitaxel|paclitaxel|mesh-list
43877155|NCT04705519|Bevacizumab|bevacizumab|mesh-list
43877156|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43877157|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877158|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
43877159|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
43877160|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877161|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877162|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43877163|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43877164|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43877165|NCT04705519|Growth Substances|growth substances|mesh-ancestor
43877166|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877167|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
43877169|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
43877170|NCT04705428|Protective Agents|protective agents|mesh-ancestor
44375609|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375610|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
44375611|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44375612|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375613|NCT04005352|Aflibercept|aflibercept|mesh-list
44375614|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375615|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375616|NCT04005352|Growth Substances|growth substances|mesh-ancestor
44375617|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375618|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375619|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612613|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612614|NCT03164291|Rifabutin|rifabutin|mesh-list
43612615|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44375620|NCT03999684|Tretinoin|tretinoin|mesh-list
44375621|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375622|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
44375623|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
44375624|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
44375625|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375626|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375627|NCT03975231|Trametinib|trametinib|mesh-list
44375628|NCT03975231|Dabrafenib|dabrafenib|mesh-list
44375629|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375630|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375631|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375632|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375633|NCT03973268|Complement Factor H|complement factor h|mesh-list
44375634|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43877171|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877172|NCT04705415|Niclosamide|niclosamide|mesh-list
43877173|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
43877174|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43877175|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
43877176|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43877177|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877178|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
43877179|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
43877180|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877181|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43877182|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877183|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877184|NCT04704947|Alendronate|alendronate|mesh-list
43877185|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43877186|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
43877187|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43877188|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877189|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43877190|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877191|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877192|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877193|NCT04704622|Midazolam|midazolam|mesh-list
44375635|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375637|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375638|NCT03972527|Analgesics|analgesics|mesh-list
44375639|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
44375640|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375641|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375642|NCT03969212|Baloxavir|baloxavir|mesh-list
44375643|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
44375644|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375645|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375646|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375647|NCT03937713|Eszopiclone|eszopiclone|mesh-list
44375648|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44375649|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44375650|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375651|NCT03928600|Misoprostol|misoprostol|mesh-list
44375652|NCT03928600|Dinoprostone|dinoprostone|mesh-list
44375653|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43828619|NCT05475873|Ondansetron|ondansetron|mesh-list
43877194|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
43877195|NCT04704622|Ketamine|ketamine|mesh-list
43877196|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877197|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877207|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877208|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877209|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43664268|NCT05132153|Milrinone|milrinone|mesh-list
43877210|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877211|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
43877212|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
43877213|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43877214|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43877215|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43877216|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43877217|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43877218|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43877219|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
43877220|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
43877221|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
43877222|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877223|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43877224|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43877225|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877226|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877227|NCT04704440|Urological Agents|urological agents|mesh-ancestor
43877228|NCT04704713|Afamelanotide|afamelanotide|mesh-list
43877229|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
43877230|NCT04704297|Acetaminophen|acetaminophen|mesh-list
43877231|NCT04704297|Ibuprofen|ibuprofen|mesh-list
43877232|NCT04704297|Ketorolac|ketorolac|mesh-list
43877233|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43877234|NCT04704297|Amitriptyline|amitriptyline|mesh-list
43877235|NCT04704297|Bupivacaine|bupivacaine|mesh-list
43877236|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
43877237|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877238|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
43877239|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877240|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877241|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
44375655|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44375656|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375657|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44375658|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375659|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
44375660|NCT03927690|Ranibizumab|ranibizumab|mesh-list
44375661|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375662|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375663|NCT03927690|Growth Substances|growth substances|mesh-ancestor
44375664|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375665|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44375666|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375667|NCT03924856|Gemcitabine|gemcitabine|mesh-list
44375668|NCT03924856|Cisplatin|cisplatin|mesh-list
44375669|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
44375670|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375671|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375672|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
44375673|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375674|NCT03924856|Antiviral Agents|antiviral agents|mesh-ancestor
44375675|NCT03924856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375676|NCT03924856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375677|NCT03924856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375678|NCT03924856|Immunologic Factors|immunologic factors|mesh-ancestor
44375679|NCT03924856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375680|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375681|NCT03923374|Buprenorphine|buprenorphine|mesh-list
44375682|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44375683|NCT03923374|Narcotics|narcotics|mesh-ancestor
44375684|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44375685|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375686|NCT03923374|Analgesics|analgesics|mesh-ancestor
44375697|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375698|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664278|NCT05131997|Atorvastatin|atorvastatin|mesh-list
43664279|NCT05131997|Ezetimibe|ezetimibe|mesh-list
44375699|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43877242|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664281|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43877243|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877244|NCT04704297|Analgesics|analgesics|mesh-ancestor
43877245|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
43877246|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43877247|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43877248|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43877249|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43877250|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877251|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877252|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43877253|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
43877254|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43877255|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43877256|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43877257|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43877258|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43877259|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43877260|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877261|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877262|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877263|NCT04704245|Petrolatum|petrolatum|mesh-list
43877264|NCT04704245|Mitogens|mitogens|mesh-list
44135957|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135958|NCT00162877|Esomeprazole|esomeprazole|mesh-list
44135959|NCT00162877|Rabeprazole|rabeprazole|mesh-list
44135960|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44135961|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135962|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44135963|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135964|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135965|NCT00162916|Citalopram|citalopram|mesh-list
44135966|NCT00162916|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44135967|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44135968|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135969|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612623|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612624|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
43612625|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612626|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
43612627|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
43612628|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612651|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612652|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43612653|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43664285|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43664286|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664287|NCT05104229|Aspirin|aspirin|mesh-list
43664288|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44135970|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135971|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
44135972|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135973|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44135974|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
43877269|NCT04704141|Hormones|hormones|mesh-list
43877270|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877271|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877272|NCT04703868|Rabeprazole|rabeprazole|mesh-list
43877273|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43877274|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877275|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43877276|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877277|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877278|NCT04703803|Lidocaine|lidocaine|mesh-list
43877279|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877280|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
43877281|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877282|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877283|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
43877284|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877285|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877286|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44375708|NCT03878979|Nivolumab|nivolumab|mesh-list
44375709|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375710|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375711|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44375712|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375713|NCT03869190|Gemcitabine|gemcitabine|mesh-list
44375714|NCT03869190|Cisplatin|cisplatin|mesh-list
44375715|NCT03869190|Atezolizumab|atezolizumab|mesh-list
44375716|NCT03869190|Niraparib|niraparib|mesh-list
44375717|NCT03869190|Magrolimab|magrolimab|mesh-list
44375718|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375719|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375720|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
44375721|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375722|NCT03869190|Antiviral Agents|antiviral agents|mesh-ancestor
44375723|NCT03869190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375724|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375725|NCT03869190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375726|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
44375727|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375728|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44375729|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375730|NCT03850782|Bimatoprost|bimatoprost|mesh-list
43684432|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
43877287|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877288|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877289|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877290|NCT04703465|Tenofovir|tenofovir|mesh-list
43877291|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
43877292|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877293|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43877294|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43877295|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877296|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877306|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877307|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
43877308|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877309|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877310|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
43877311|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877312|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877313|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43877314|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877315|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877316|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877317|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877318|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44375731|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44375732|NCT03801525|Venetoclax|venetoclax|mesh-list
44375733|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375734|NCT03794999|Benralizumab|benralizumab|mesh-list
44375735|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44375736|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
44375737|NCT03778996|Sirolimus|sirolimus|mesh-list
44375738|NCT03778996|Phenytoin|phenytoin|mesh-list
44375739|NCT03778996|Methoxsalen|methoxsalen|mesh-list
44375740|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
44375741|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44375742|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375743|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44375744|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375745|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
44375746|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375747|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
43612654|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
43612655|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612656|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44375748|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375749|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
44375750|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44375751|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44375752|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44375753|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375754|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44375755|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44375756|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44375780|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375781|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44375782|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44375783|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
44375784|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031759|NCT00001228|Interferons|interferons|mesh-list
44375785|NCT03742102|Paclitaxel|paclitaxel|mesh-list
44375786|NCT03742102|Trastuzumab|trastuzumab|mesh-list
44375787|NCT03742102|Durvalumab|durvalumab|mesh-list
44375788|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375789|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375790|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375791|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375792|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375793|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375794|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375795|NCT03714308|Aflibercept|aflibercept|mesh-list
44375796|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44375797|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44375798|NCT03714308|Growth Substances|growth substances|mesh-ancestor
44375799|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375834|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
44375835|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
44375836|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375837|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375838|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
44375839|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375840|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
44375841|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375842|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44375843|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44375844|NCT03599453|Analgesics|analgesics|mesh-ancestor
44375845|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
44375846|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375847|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44375848|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375849|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44375850|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44375851|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382392|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612663|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43612664|NCT03163914|Protective Agents|protective agents|mesh-ancestor
43612665|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
44375852|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375853|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
44375854|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44375855|NCT03591510|Cytarabine|cytarabine|mesh-list
44375856|NCT03591510|Fludarabine|fludarabine|mesh-list
44375857|NCT03591510|Etoposide|etoposide|mesh-list
44375858|NCT03591510|Daunorubicin|daunorubicin|mesh-list
44375859|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
44375860|NCT03591510|Idarubicin|idarubicin|mesh-list
44375861|NCT03591510|Midostaurin|midostaurin|mesh-list
44375862|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877319|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43877320|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877321|NCT04703127|Urological Agents|urological agents|mesh-ancestor
43877322|NCT04702971|Flunarizine|flunarizine|mesh-list
43877323|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
43877324|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43877325|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877326|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877327|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43877328|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877329|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43877330|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
43877331|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
43877332|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877333|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877334|NCT04703088|Ondansetron|ondansetron|mesh-list
43877335|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
43612671|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
43612672|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612673|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877336|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
43877337|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375863|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375864|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
44375865|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375866|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375867|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
44375868|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375869|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375870|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44375871|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44375872|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375873|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
44375874|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375875|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44375876|NCT03591510|Analgesics|analgesics|mesh-ancestor
44375877|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
44375878|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375879|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375880|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
44375881|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
44375883|NCT03565913|Calcium acetate|calcium acetate|mesh-list
44375884|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44375885|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375886|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44375887|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
44375888|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
44375889|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375890|NCT03565913|Cathartics|cathartics|mesh-ancestor
44375891|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375892|NCT03556202|Mirikizumab|mirikizumab|mesh-list
44375893|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44375894|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44375895|NCT03556202|Analgesics|analgesics|mesh-ancestor
44375896|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
44375897|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44375902|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44375903|NCT03515304|Evolocumab|evolocumab|mesh-list
44375904|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44375905|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44375906|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
44375907|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375908|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44375909|NCT03493854|Paclitaxel|paclitaxel|mesh-list
43649981|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649982|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375910|NCT03493854|Docetaxel|docetaxel|mesh-list
44375911|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
44375912|NCT03493854|Doxorubicin|doxorubicin|mesh-list
44375913|NCT03493854|Trastuzumab|trastuzumab|mesh-list
44375914|NCT03493854|Pertuzumab|pertuzumab|mesh-list
44375915|NCT03493854|Hormones|hormones|mesh-list
43684598|NCT02841332|Misonidazole|misonidazole|mesh-list
43877338|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877339|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877340|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
43877341|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
43877342|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43877343|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
43877344|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877345|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877346|NCT04703088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43877347|NCT04703088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43877348|NCT04703088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877349|NCT04703088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43877350|NCT04703088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43877352|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43877353|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877354|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877355|NCT04702685|Ropivacaine|ropivacaine|mesh-list
43877356|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877357|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
43877358|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877359|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877360|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
43877361|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877362|NCT04702490|Empagliflozin|empagliflozin|mesh-list
43877363|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43877367|NCT04702048|Aflibercept|aflibercept|mesh-list
43877368|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43877369|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43877370|NCT04702048|Growth Substances|growth substances|mesh-ancestor
43877371|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877372|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
43877373|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877375|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877376|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877377|NCT04702334|Lidocaine|lidocaine|mesh-list
43877378|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
43877379|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877380|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
43877381|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877382|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877383|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
43877384|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877385|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877386|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43664389|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
43877387|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877388|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877389|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375916|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375917|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375918|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375919|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375920|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375921|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375922|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375923|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
44375924|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375925|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375926|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375927|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
44375928|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375929|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44375930|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44375931|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44375932|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375933|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375934|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44375936|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375937|NCT03456076|Gemcitabine|gemcitabine|mesh-list
44375938|NCT03456076|Cisplatin|cisplatin|mesh-list
44375939|NCT03456076|Carboplatin|carboplatin|mesh-list
44375940|NCT03456076|Pemetrexed|pemetrexed|mesh-list
44375941|NCT03456076|Vinorelbine|vinorelbine|mesh-list
44375942|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375943|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44375944|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
44375945|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375946|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
44375947|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375948|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375949|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375950|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
43877390|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43877391|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
43877392|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
43877393|NCT04702334|Protective Agents|protective agents|mesh-ancestor
43877394|NCT04702360|Ivacaftor|ivacaftor|mesh-list
43877395|NCT04702360|Elexacaftor|elexacaftor|mesh-list
44375952|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44375953|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44375954|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44375955|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
44375956|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
44375957|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
44375958|NCT03412877|Aldesleukin|aldesleukin|mesh-list
44375959|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
44375960|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
44375961|NCT03412877|Fludarabine|fludarabine|mesh-list
44375962|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44375963|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
44375964|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375965|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44375966|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44375967|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
44412301|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877396|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43877397|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877398|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877399|NCT04702204|Denosumab|denosumab|mesh-list
43877400|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43877401|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877402|NCT04702009|Antibodies|antibodies|mesh-list
43877403|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43877404|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
43877405|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877406|NCT04701606|Artesunate|artesunate|mesh-list
43877407|NCT04701606|Pyronaridine|pyronaridine|mesh-list
43877408|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
43877409|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43877410|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43877411|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877412|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877413|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
43877414|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
43877415|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43877416|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
43877417|NCT04701710|Ivermectin|ivermectin|mesh-list
43877418|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43877419|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877420|NCT04701528|Tacrolimus|tacrolimus|mesh-list
43877421|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43877422|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
43877423|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877424|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43877425|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877426|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877427|NCT04701463|Calcium|calcium|mesh-list
43877428|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43877429|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877430|NCT04701242|Ezetimibe|ezetimibe|mesh-list
43877431|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43877432|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43877433|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
43877434|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375968|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375969|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375970|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44375971|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375972|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44375973|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44375974|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
44375975|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44375977|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375978|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375979|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44375980|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375981|NCT03280030|Midostaurin|midostaurin|mesh-list
44375982|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375983|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375984|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375985|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375986|NCT03215069|Empagliflozin|empagliflozin|mesh-list
44375987|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44375988|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375989|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44375990|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44375991|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
44375992|NCT03211416|Sorafenib|sorafenib|mesh-list
44375993|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44375994|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44375995|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44375996|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44375997|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44375998|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
44375999|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43877435|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43877444|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877445|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877446|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43877447|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43877448|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877449|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44376000|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376001|NCT03176784|Nicotine|nicotine|mesh-list
44376002|NCT03176784|Varenicline|varenicline|mesh-list
44376003|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44376004|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
44376005|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376006|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376007|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44376008|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44376009|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
44376010|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44031968|NCT00001428|Fluorouracil|fluorouracil|mesh-list
44376011|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376012|NCT03165292|Topotecan|topotecan|mesh-list
44376013|NCT03165292|Thiotepa|thiotepa|mesh-list
44376014|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44376015|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376016|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376017|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376018|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376019|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376020|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
44376021|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376022|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376023|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
44376024|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376025|NCT03120780|Fentanyl|fentanyl|mesh-list
44376026|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44376027|NCT03120780|Narcotics|narcotics|mesh-ancestor
44376028|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44135975|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135976|NCT00162955|Valsartan|valsartan|mesh-list
44135977|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44135978|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44135979|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44135980|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135981|NCT00162968|Citalopram|citalopram|mesh-list
44135982|NCT00162968|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664469|NCT04808323|Capecitabine|capecitabine|mesh-list
44135983|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44135984|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135985|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135986|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135987|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
44135988|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376029|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376030|NCT03120780|Analgesics|analgesics|mesh-ancestor
44376031|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
44376032|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376033|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44376034|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44376035|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
44376036|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
44376037|NCT03118986|Olanzapine|olanzapine|mesh-list
44376038|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
44376039|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
44376040|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376041|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376042|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376043|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44376044|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44376045|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376046|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376047|NCT03118986|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44376048|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44376049|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44376050|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376051|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376052|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
44376053|NCT03109288|Pioglitazone|pioglitazone|mesh-list
44376054|NCT03109288|Clemastine|clemastine|mesh-list
44376055|NCT03109288|Pirfenidone|pirfenidone|mesh-list
44376056|NCT03109288|Dantrolene|dantrolene|mesh-list
44376057|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44376058|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376059|NCT03109288|Analgesics|analgesics|mesh-ancestor
44135989|NCT00162968|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44135990|NCT00162968|Antidepressive Agents|antidepressive agents|mesh-ancestor
44135991|NCT00162968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44135992|NCT00163046|Gabapentin|gabapentin|mesh-list
44135993|NCT00163046|Analgesics|analgesics|mesh-ancestor
44135994|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
44135995|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135996|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135997|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
44135998|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44135999|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44136000|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136001|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44136002|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44376060|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
44376061|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376062|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44376063|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376064|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376065|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376066|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376067|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
44376068|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44376069|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44376070|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
44376071|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
44376072|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382393|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376073|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376074|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44376075|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44376076|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44376077|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
44376078|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376079|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376080|NCT03068624|Aldesleukin|aldesleukin|mesh-list
44376081|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
44376082|NCT03068624|Ipilimumab|ipilimumab|mesh-list
44376083|NCT03068624|Interleukin-2|interleukin-2|mesh-list
44376084|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376085|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
44376086|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376087|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376088|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376089|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
44376090|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376091|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376092|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376093|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376099|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44376100|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44376101|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
44376102|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376103|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
44376104|NCT02955290|Nivolumab|nivolumab|mesh-list
44376105|NCT02955290|Vaccines|vaccines|mesh-list
44376106|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44376107|NCT02955290|Mitogens|mitogens|mesh-list
44376108|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
44376109|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376110|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376111|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376112|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44376113|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376114|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
44376115|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44376116|NCT02922764|Carboplatin|carboplatin|mesh-list
44376117|NCT02922764|Docetaxel|docetaxel|mesh-list
44376118|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
44376119|NCT02922764|Pemetrexed|pemetrexed|mesh-list
44376120|NCT02922764|Ipilimumab|ipilimumab|mesh-list
44376121|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612765|NCT03163407|Ephedrine|ephedrine|mesh-list
44376122|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
44376123|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
43684772|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
44136003|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44136004|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136005|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136006|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
44136007|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
44136008|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44136009|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136010|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
44136011|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44136012|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136013|NCT00163111|Amphotericin B|amphotericin b|mesh-list
44136014|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44136015|NCT00163111|Fluconazole|fluconazole|mesh-list
43877451|NCT04700826|Apixaban|apixaban|mesh-list
43877452|NCT04700826|Edoxaban|edoxaban|mesh-list
43877453|NCT04700826|Dabigatran|dabigatran|mesh-list
43877454|NCT04700826|Anticoagulants|anticoagulants|mesh-list
43877455|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43877456|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
43877457|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43877458|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
43877459|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877460|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877461|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
43877468|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877469|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43877470|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877471|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
44376124|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
44376125|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376126|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376127|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376128|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44376129|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44376130|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44376131|NCT02913313|Nivolumab|nivolumab|mesh-list
44376132|NCT02913313|Ipilimumab|ipilimumab|mesh-list
44376133|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376134|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376135|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43612811|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43612812|NCT03162653|Allopurinol|allopurinol|mesh-list
43649986|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
44376136|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376137|NCT02657434|Cisplatin|cisplatin|mesh-list
44376138|NCT02657434|Carboplatin|carboplatin|mesh-list
44376139|NCT02657434|Pemetrexed|pemetrexed|mesh-list
44376140|NCT02657434|Atezolizumab|atezolizumab|mesh-list
44376141|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376142|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376143|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376144|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44376145|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44376146|NCT02652052|Dasatinib|dasatinib|mesh-list
44376147|NCT02652052|Quercetin|quercetin|mesh-list
44376148|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376149|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44376150|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376151|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376152|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
44376153|NCT02652052|Protective Agents|protective agents|mesh-ancestor
44376154|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376155|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
44376156|NCT02612311|Chlorambucil|chlorambucil|mesh-list
44376157|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376160|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
44376164|NCT02593123|Lenograstim|lenograstim|mesh-list
44376165|NCT02593123|Sargramostim|sargramostim|mesh-list
44376166|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44376167|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
44376168|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376169|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376170|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376171|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44376172|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
44376173|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376174|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376175|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376176|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376177|NCT02583893|Cytarabine|cytarabine|mesh-list
44376178|NCT02583893|Sirolimus|sirolimus|mesh-list
44376179|NCT02583893|Etoposide|etoposide|mesh-list
44376180|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
43612848|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612849|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612850|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
43612851|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43612856|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
44376181|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
44376182|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44376183|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376184|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44376185|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376186|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376187|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376188|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43877472|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
43877473|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877474|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43877475|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43877476|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877477|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877478|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
43877479|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43877480|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43877481|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43877482|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
43877484|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877485|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877486|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
43877487|NCT04700709|Sirolimus|sirolimus|mesh-list
43877488|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43877489|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877490|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43877491|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
43877492|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43877493|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877494|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877495|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376189|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
44376190|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
44376191|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376192|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376193|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
44376194|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376195|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376196|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376197|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
44376198|NCT02583893|Analgesics|analgesics|mesh-ancestor
44376199|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
44376200|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376201|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
44376202|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376203|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
44376204|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376205|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376206|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44376207|NCT02527434|Durvalumab|durvalumab|mesh-list
44376208|NCT02527434|Tremelimumab|tremelimumab|mesh-list
44376209|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44376210|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376211|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376212|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
44376213|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376214|NCT02493426|Oxytocin|oxytocin|mesh-list
44376215|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
44376237|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44376238|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44376239|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
44032195|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
44376241|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376242|NCT02327455|Protective Agents|protective agents|mesh-ancestor
44376243|NCT02133196|Aldesleukin|aldesleukin|mesh-list
44376244|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
44376245|NCT02133196|Fludarabine|fludarabine|mesh-list
44376246|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376247|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
44376248|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376249|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376250|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376251|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
44376252|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376253|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376254|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43877496|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
43877497|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43877498|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
43877499|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877500|NCT04700475|Citric Acid|citric acid|mesh-list
43877501|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
43877502|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
43877503|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43877504|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
43877505|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
43612913|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43612914|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43612915|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877506|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877507|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43877508|NCT04700436|Ezetimibe|ezetimibe|mesh-list
43877509|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43877510|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43877511|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
43877512|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877513|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43877514|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43877515|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877516|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
43877517|NCT04700228|Bupivacaine|bupivacaine|mesh-list
43877518|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877519|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
43877520|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877521|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877522|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
43877523|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877524|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877525|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877526|NCT04700228|Analgesics|analgesics|mesh-ancestor
43877527|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877528|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877529|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877530|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877531|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877532|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877536|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43588105|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
44376255|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44376256|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44376257|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
44376258|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612958|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43612971|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612972|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613009|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43613010|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613045|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376259|NCT02115295|Cytarabine|cytarabine|mesh-list
44376260|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44376261|NCT02115295|Venetoclax|venetoclax|mesh-list
44376262|NCT02115295|Idarubicin|idarubicin|mesh-list
44376263|NCT02115295|Cladribine|cladribine|mesh-list
44376264|NCT02115295|Midostaurin|midostaurin|mesh-list
44376265|NCT02115295|Staurosporine|staurosporine|mesh-list
44376266|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376267|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
43877537|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43877538|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877539|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877540|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877541|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
43877542|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669879|NCT02901236|Growth Substances|growth substances|mesh-ancestor
43877544|NCT04699903|Antibodies|antibodies|mesh-list
43877545|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
43877546|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
43877547|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877548|NCT04699734|Lidocaine|lidocaine|mesh-list
43877549|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877550|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
43877551|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877552|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877553|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
43877554|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877555|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877556|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43877557|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43877558|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877559|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877560|NCT04699721|Paclitaxel|paclitaxel|mesh-list
43877561|NCT04699721|Carboplatin|carboplatin|mesh-list
43877562|NCT04699721|Nivolumab|nivolumab|mesh-list
43877563|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43877564|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877565|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
43877566|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
43877567|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877568|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877569|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649996|NCT03017391|Granisetron|granisetron|mesh-list
43649997|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649998|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
43649999|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
43650000|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650001|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650002|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650003|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
43650004|NCT03017391|Hormones|hormones|mesh-ancestor
43650005|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650006|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43650007|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650008|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43664599|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877570|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43877571|NCT04699214|Endostar protein|endostar protein|mesh-list
43877572|NCT04699214|Endostatins|endostatins|mesh-list
43877573|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43877574|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43877575|NCT04699214|Growth Substances|growth substances|mesh-ancestor
43877576|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877577|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
43877578|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877579|NCT04698941|Paclitaxel|paclitaxel|mesh-list
43877580|NCT04698941|Simvastatin|simvastatin|mesh-list
43877581|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43877582|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877583|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
43877584|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
43877585|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877586|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877587|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43877588|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44376268|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376269|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376270|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
44376271|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376272|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376273|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
44376274|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376275|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376276|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44376277|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376278|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376279|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44376280|NCT02107976|Ascorbic Acid|ascorbic acid|mesh-list
44376281|NCT02107976|Vitamins|vitamins|mesh-ancestor
44376282|NCT02107976|Micronutrients|micronutrients|mesh-ancestor
44376283|NCT02107976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376284|NCT02107976|Antioxidants|antioxidants|mesh-ancestor
44376285|NCT02107976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376286|NCT02107976|Protective Agents|protective agents|mesh-ancestor
44376287|NCT02105766|Sirolimus|sirolimus|mesh-list
44376288|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
44376289|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
44376290|NCT02105766|Pentostatin|pentostatin|mesh-list
43877589|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
43877590|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43877591|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43877592|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877593|NCT04699110|Adenosine|adenosine|mesh-list
43650009|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43877594|NCT04699110|Epinephrine|epinephrine|mesh-list
43877595|NCT04699110|Racepinephrine|racepinephrine|mesh-list
43877596|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
43877597|NCT04699110|Analgesics|analgesics|mesh-ancestor
43877598|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
43877599|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877600|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877601|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877602|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877603|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43877604|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
43877605|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
43877614|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43877615|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
43877616|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
43877617|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
43877618|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43877619|NCT04699097|Azithromycin|azithromycin|mesh-list
43877620|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43877621|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877622|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43877623|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43877624|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43877625|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
43877626|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877627|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44376291|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376292|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
44376293|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376294|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376295|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376296|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
44376297|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877628|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43877629|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877630|NCT04698746|Anesthetics|anesthetics|mesh-list
43877631|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
43877632|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877633|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613081|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613082|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
43613083|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
43613087|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
43877634|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
43877635|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877637|NCT04698772|Morphine|morphine|mesh-list
43877638|NCT04698772|Analgesics|analgesics|mesh-ancestor
43877639|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
43877640|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877641|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877642|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43877643|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877644|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
43877645|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
43877646|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877647|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43877648|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43877649|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877650|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877651|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43877652|NCT04698772|Narcotics|narcotics|mesh-ancestor
43877653|NCT04698512|Sirolimus|sirolimus|mesh-list
43877654|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43877655|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877656|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43877657|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877658|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
43877659|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43877660|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
43877661|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136016|NCT00163111|Amebicides|amebicides|mesh-ancestor
44136017|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44136018|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136019|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136020|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136021|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
44136022|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44136023|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44136024|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136025|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136026|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44136027|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
43650020|NCT03017430|Loperamide|loperamide|mesh-list
43650021|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
43650022|NCT03017430|Analgesics|analgesics|mesh-ancestor
43650023|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
43650024|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136028|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877666|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43877667|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877668|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877670|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877671|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877672|NCT04697992|Vitamins|vitamins|mesh-list
43877673|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
43877674|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
43877675|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
43877676|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877677|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43877678|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44376298|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376299|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376300|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376301|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376302|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376303|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
44376304|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376305|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44376306|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376307|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
44376308|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44376309|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
44376310|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44376311|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376312|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44376313|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44376314|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44376315|NCT01932125|Bevacizumab|bevacizumab|mesh-list
44376316|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376317|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376318|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44376319|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44376321|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376322|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44376323|NCT01532310|Belimumab|belimumab|mesh-list
44376324|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376325|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
44376326|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376327|NCT01446016|Paclitaxel|paclitaxel|mesh-list
43613096|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44376328|NCT01446016|Docetaxel|docetaxel|mesh-list
44376329|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44376343|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
44376344|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376345|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376346|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376347|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44376348|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376349|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376350|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376351|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
44376352|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44376353|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44376354|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
44376355|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376356|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44376357|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44376359|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
44376399|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44376400|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
44376401|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376402|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376403|NCT00353158|Doxycycline|doxycycline|mesh-list
44376404|NCT00353158|Voriconazole|voriconazole|mesh-list
44376405|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376406|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376407|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
44376408|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44376409|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376410|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
44376411|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44376412|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44376413|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376414|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376415|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44376416|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
44376417|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376418|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613138|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
43613139|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376419|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44376421|NCT05263206|Fexofenadine|fexofenadine|mesh-list
44376422|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
44376423|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
44376424|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43684983|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
43877679|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877680|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
43877681|NCT04697992|Coagulants|coagulants|mesh-ancestor
43877682|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
43877683|NCT04697992|Protective Agents|protective agents|mesh-ancestor
43877684|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
43877685|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877686|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43877687|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43877688|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877689|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877690|NCT04697862|Urological Agents|urological agents|mesh-ancestor
43877691|NCT04697641|Amoxicillin|amoxicillin|mesh-list
43877692|NCT04697641|Clarithromycin|clarithromycin|mesh-list
43877693|NCT04697641|Pantoprazole|pantoprazole|mesh-list
43877694|NCT04697641|Z 338|z 338|mesh-list
43877695|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43877696|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877697|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43877698|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877699|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877700|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44376425|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44376426|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44376427|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
44376428|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
43685010|NCT02838719|Hormones|hormones|mesh-ancestor
43877701|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43877702|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43877703|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877704|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43877705|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43877706|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
43877707|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877708|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877710|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877711|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877712|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
43877713|NCT04697537|Ropivacaine|ropivacaine|mesh-list
43877714|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
43877715|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877716|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877717|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877718|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877719|NCT04697537|Analgesics|analgesics|mesh-ancestor
43877720|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
43877721|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877722|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877723|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877724|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877725|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877726|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877727|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877728|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
43877729|NCT04697745|Dexamethasone|dexamethasone|mesh-list
43877730|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
43877731|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43877732|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
43877740|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43877741|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877742|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877743|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877744|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877745|NCT04697745|Analgesics|analgesics|mesh-ancestor
43877746|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
43877747|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877748|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877749|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877750|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877751|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877752|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877753|NCT04697511|Midazolam|midazolam|mesh-list
43877754|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43877755|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877756|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877757|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877758|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43877759|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43877760|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43877761|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877762|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
43877763|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
43877764|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
43877765|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
43877766|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877767|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877768|NCT04697355|Beta Carotene|beta carotene|mesh-list
43877769|NCT04697355|Naringenin|naringenin|mesh-list
43877770|NCT04697355|Carotenoids|carotenoids|mesh-list
43877771|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
43877772|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877773|NCT04697355|Protective Agents|protective agents|mesh-ancestor
44376429|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376430|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376431|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376432|NCT05236647|Morphine|morphine|mesh-list
44376433|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44376434|NCT05236647|Narcotics|narcotics|mesh-ancestor
44376435|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376436|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376437|NCT05236647|Analgesics|analgesics|mesh-ancestor
44376438|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
44376439|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376440|NCT05208268|Rabeprazole|rabeprazole|mesh-list
44376441|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44376442|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376443|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44376444|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376445|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376446|NCT05133804|Methylphenidate|methylphenidate|mesh-list
44376447|NCT05133804|Reboxetine|reboxetine|mesh-list
44376448|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44376449|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376450|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43826274|NCT05499234|Acetaminophen|acetaminophen|mesh-list
44376451|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44376452|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44376453|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376454|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
43685014|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
43877774|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877775|NCT04697355|Provitamins|provitamins|mesh-ancestor
43877776|NCT04697355|Vitamins|vitamins|mesh-ancestor
43877777|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
43877778|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43877779|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877780|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43877781|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
43877782|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877783|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43877784|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877785|NCT04696939|Carboplatin|carboplatin|mesh-list
43877786|NCT04696939|Etoposide|etoposide|mesh-list
43877787|NCT04696939|Atezolizumab|atezolizumab|mesh-list
43877788|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877789|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43877790|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43877791|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43877792|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877793|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376455|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376456|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
44376457|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376458|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44376459|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44376460|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
44376461|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
44376462|NCT05115630|Melphalan|melphalan|mesh-list
44376463|NCT05115630|Fludarabine|fludarabine|mesh-list
44376464|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
44376465|NCT05115630|Tacrolimus|tacrolimus|mesh-list
44376466|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376467|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
44376468|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376469|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376470|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44376471|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
44376472|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376473|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376474|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44376475|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376476|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
44376477|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44376478|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376479|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376480|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44376505|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376506|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376507|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44376508|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376510|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376511|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44376512|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376513|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376514|NCT05085665|Ivermectin|ivermectin|mesh-list
44376515|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376516|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376517|NCT05081583|Midazolam|midazolam|mesh-list
44376518|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44376519|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44376520|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376521|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376522|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44376523|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44376524|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376525|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44376526|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
44376527|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
44376528|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
44376529|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
44376530|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376531|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376532|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
44376533|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44376534|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44376554|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376555|NCT05041647|Analgesics|analgesics|mesh-ancestor
44376556|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
44376557|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376558|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44376559|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44376560|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376561|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376562|NCT05041647|Hormones|hormones|mesh-ancestor
44376563|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376565|NCT05024734|Docetaxel|docetaxel|mesh-list
44376566|NCT05024734|Epirubicin|epirubicin|mesh-list
44376567|NCT05024734|Mitomycins|mitomycins|mesh-list
44376568|NCT05024734|Mitomycin|mitomycin|mesh-list
44376569|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376570|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
44376571|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376572|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376573|NCT05024734|Antiviral Agents|antiviral agents|mesh-ancestor
44376574|NCT05024734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376575|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376576|NCT05024734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376577|NCT05024734|Immunologic Factors|immunologic factors|mesh-ancestor
44376578|NCT05024734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376579|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44376580|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44376581|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44376582|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376583|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44376584|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44376585|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
43685122|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
44376586|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44376587|NCT05012189|Oseltamivir|oseltamivir|mesh-list
44376588|NCT05012189|Baloxavir|baloxavir|mesh-list
44376589|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
44376590|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376591|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376592|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376593|NCT05004662|Nicotine|nicotine|mesh-list
44376594|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44376595|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
44376596|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376597|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376598|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44376599|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44376600|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
44376601|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376602|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376603|NCT05004077|Amiodarone|amiodarone|mesh-list
44376604|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44376605|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
44376606|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44376607|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44376608|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376609|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44376610|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44376611|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44376612|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376613|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44376614|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44376628|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44376629|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376630|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376631|NCT04956575|Vaccines|vaccines|mesh-list
44376632|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
44376633|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376634|NCT04953910|Decitabine|decitabine|mesh-list
44376635|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376636|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
44376637|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376638|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376639|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376640|NCT04953897|Decitabine|decitabine|mesh-list
44376641|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44376642|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
44376643|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376644|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376645|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376646|NCT04948203|Sirolimus|sirolimus|mesh-list
44376647|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376648|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376649|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44376650|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376651|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
44376652|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44376653|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
44376654|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376655|NCT04927312|Metronidazole|metronidazole|mesh-list
44376656|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376674|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44376675|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44376676|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
44376677|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376678|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376679|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376680|NCT04907032|Urological Agents|urological agents|mesh-ancestor
44376681|NCT04899232|Antithrombins|antithrombins|mesh-list
44376682|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
44376683|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44376684|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
44376685|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376686|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376687|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
44376688|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
44376689|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44376690|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44376691|NCT04873583|Prednisolone|prednisolone|mesh-list
44376692|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
44376693|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44376694|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
44376695|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376696|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
44376697|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
44376698|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376723|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376724|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376725|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44376726|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
44376727|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44376728|NCT04848662|Budesonide|budesonide|mesh-list
44376729|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376730|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44376731|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
44376732|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376733|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376734|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44376735|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44376736|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
44376737|NCT04848662|Hormones|hormones|mesh-ancestor
44376738|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376739|NCT04842045|Midazolam|midazolam|mesh-list
44376740|NCT04842045|Psilocybin|psilocybin|mesh-list
44376741|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44376742|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44376777|NCT04798339|Hematinics|hematinics|mesh-ancestor
44376778|NCT04792073|Avelumab|avelumab|mesh-list
44376779|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376780|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376781|NCT04790812|Acetaminophen|acetaminophen|mesh-list
44376782|NCT04790812|Celecoxib|celecoxib|mesh-list
44376783|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44376784|NCT04790812|Analgesics|analgesics|mesh-ancestor
44376785|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
44376786|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376787|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650042|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
44376788|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
44376789|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44376790|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376791|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376792|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44376793|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44376794|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376795|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376796|NCT04766086|Vaccines|vaccines|mesh-list
44376797|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
44376798|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376799|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44376800|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44376801|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44376802|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376809|NCT04748341|Benzocaine|benzocaine|mesh-list
44376832|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376833|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
44376834|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
44376835|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376836|NCT04684394|Aflibercept|aflibercept|mesh-list
44376837|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44376838|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44376839|NCT04684394|Growth Substances|growth substances|mesh-ancestor
44376840|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376841|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
44376842|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376843|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
44376844|NCT04676412|Lenvatinib|lenvatinib|mesh-list
44376845|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376846|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376847|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44376848|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376849|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376850|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
43650050|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44376851|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43877811|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877812|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
43877813|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43877814|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
43877815|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877816|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
43877817|NCT04696666|Protective Agents|protective agents|mesh-ancestor
43877818|NCT04696783|Esomeprazole|esomeprazole|mesh-list
43877819|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43877820|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877821|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43877822|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877823|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877825|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43877826|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
43877827|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
43877828|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376852|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44376853|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376854|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376855|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44376856|NCT04668950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44376857|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44376858|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44376859|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376860|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44376861|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
44376862|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44376863|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
44376864|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44376865|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44376866|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376867|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44376868|NCT04668274|Resveratrol|resveratrol|mesh-list
44376869|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
44376870|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376871|NCT04668274|Protective Agents|protective agents|mesh-ancestor
44376872|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376873|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376874|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44032838|NCT00001995|Rifabutin|rifabutin|mesh-list
44376876|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
44376877|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44376878|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376879|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
44376883|NCT04647916|Irinotecan|irinotecan|mesh-list
44376895|NCT04646109|Ivermectin|ivermectin|mesh-list
44376896|NCT04646109|Favipiravir|favipiravir|mesh-list
44376897|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376898|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376899|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
44376900|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44376901|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376902|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376903|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376904|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376905|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
44376906|NCT04640168|Remdesivir|remdesivir|mesh-list
44376907|NCT04640168|Dexamethasone|dexamethasone|mesh-list
44376908|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44376909|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
44376910|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
44376911|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44376912|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877829|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877830|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
43877831|NCT04696536|Listerine|listerine|mesh-list
43877832|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43877833|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877834|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
43877835|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43877836|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877837|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43877838|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877840|NCT04695925|Pemetrexed|pemetrexed|mesh-list
43877841|NCT04695925|Osimertinib|osimertinib|mesh-list
43877842|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877843|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877844|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877845|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43877846|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43877847|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43877848|NCT04696120|Apixaban|apixaban|mesh-list
43877849|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43877850|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
43877851|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43877852|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
43877853|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877854|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877855|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
43877856|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
43877857|NCT04695613|Analgesics|analgesics|mesh-ancestor
43877858|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
43877859|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877860|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877861|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
43877862|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877863|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877864|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
43877865|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43877866|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877867|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877868|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43877869|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
44376916|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44376917|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44376918|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376919|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
44376920|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376921|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
44376922|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376923|NCT04633564|Bevacizumab|bevacizumab|mesh-list
44376924|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44376925|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44376926|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44376927|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44376928|NCT04633564|Growth Substances|growth substances|mesh-ancestor
44376929|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376930|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
43877877|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
43877878|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877879|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877880|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43877881|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136029|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136030|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44136031|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43877882|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43877883|NCT04695483|Hormones|hormones|mesh-ancestor
43877884|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877885|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877886|NCT04695509|Propofol|propofol|mesh-list
43877887|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877888|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877889|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877890|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877891|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
43877892|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
43877893|NCT04695197|Artesunate|artesunate|mesh-list
43877894|NCT04695197|Lumefantrine|lumefantrine|mesh-list
43877895|NCT04695197|Artemether|artemether|mesh-list
43877896|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43877897|NCT04695197|Pyronaridine|pyronaridine|mesh-list
43877898|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
43877899|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43877900|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43877901|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877902|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877903|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
43877904|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
43877905|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43877906|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
43877907|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
43877908|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877909|NCT04694612|Favipiravir|favipiravir|mesh-list
43877910|NCT04694612|Remdesivir|remdesivir|mesh-list
44376931|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44376932|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
44376933|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376934|NCT04608500|Minocycline|minocycline|mesh-list
44376935|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44376936|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376937|NCT04607980|Ustekinumab|ustekinumab|mesh-list
44376938|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
44376939|NCT04605588|Ribavirin|ribavirin|mesh-list
44376940|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
44376941|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
44376942|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
44376943|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376944|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
44376945|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376946|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
44376947|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44376948|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44376949|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44376950|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44376951|NCT04582266|Remdesivir|remdesivir|mesh-list
44376952|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
44376953|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376955|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44376986|NCT04558125|Dalteparin|dalteparin|mesh-list
44376987|NCT04558125|Tenecteplase|tenecteplase|mesh-list
44376988|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
44376989|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
44376990|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44376991|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44376992|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376993|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
44376994|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
44376995|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44376996|NCT04555096|Protective Agents|protective agents|mesh-ancestor
44376997|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44376998|NCT04547907|Paclitaxel|paclitaxel|mesh-list
44376999|NCT04547907|Docetaxel|docetaxel|mesh-list
44377000|NCT04547907|Carboplatin|carboplatin|mesh-list
44377001|NCT04547907|Trastuzumab|trastuzumab|mesh-list
44377002|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44377003|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377004|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44377005|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44377006|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44377007|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377008|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377009|NCT04544995|Niraparib|niraparib|mesh-list
44377010|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43650053|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
43650057|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
44377011|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377012|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377013|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377014|NCT04542694|Favipiravir|favipiravir|mesh-list
44377015|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
44377016|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377017|NCT04539262|Remdesivir|remdesivir|mesh-list
44377018|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
43877911|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
43877912|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877913|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
43877914|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877915|NCT04694677|Misoprostol|misoprostol|mesh-list
43877916|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
43877917|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43877918|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43877919|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877920|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
44377019|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377020|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
44377021|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377022|NCT04537806|Pregnanolone|pregnanolone|mesh-list
44377023|NCT04537806|Brexanolone|brexanolone|mesh-list
44377024|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
44377025|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377026|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377027|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
44377028|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377029|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377031|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
44377032|NCT04537234|Vaccines|vaccines|mesh-list
44377033|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
44377034|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377035|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44377036|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
44377037|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
44377038|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44377039|NCT04537078|Cetrorelix|cetrorelix|mesh-list
44377040|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44377041|NCT04537078|Progesterone|progesterone|mesh-list
44377042|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
44377043|NCT04537078|Estradiol|estradiol|mesh-list
44377044|NCT04537078|Progestins|progestins|mesh-ancestor
44377045|NCT04537078|Hormones|hormones|mesh-ancestor
44377046|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377047|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377048|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44377049|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44377067|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
44377068|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377069|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377070|NCT04534491|Urological Agents|urological agents|mesh-ancestor
44377071|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
44377072|NCT04532164|Clotrimazole|clotrimazole|mesh-list
44377073|NCT04532164|Miconazole|miconazole|mesh-list
44377074|NCT04532164|Butenafine|butenafine|mesh-list
44377075|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377076|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44377077|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43665172|NCT02226276|Trace Elements|trace elements|mesh-ancestor
43665173|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
44377078|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43665180|NCT02116335|Bosentan|bosentan|mesh-list
44377079|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377080|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377081|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44377082|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
44377083|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377084|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377085|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44377086|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44377087|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44377120|NCT04507776|Etanercept|etanercept|mesh-list
44377121|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377122|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377123|NCT04507776|Analgesics|analgesics|mesh-ancestor
44377124|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
44377125|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377126|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377127|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377128|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377129|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377130|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377131|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
44377132|NCT04507763|Etanercept|etanercept|mesh-list
43613444|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
43613445|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613446|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43613447|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613448|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613449|NCT05561660|Aspirin|aspirin|mesh-list
43613450|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650066|NCT03017404|Docetaxel|docetaxel|mesh-list
44377133|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377134|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377135|NCT04507763|Analgesics|analgesics|mesh-ancestor
44377136|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
44377137|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377138|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377139|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377140|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377141|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377142|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377143|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
44377144|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
44377145|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44377146|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
44377147|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44377148|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
44377149|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377150|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377151|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
44377152|NCT04501952|Remdesivir|remdesivir|mesh-list
44377153|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
44377154|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377160|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
44377161|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377162|NCT04495374|Pregabalin|pregabalin|mesh-list
44377163|NCT04495374|Analgesics|analgesics|mesh-ancestor
44377164|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
44377165|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377166|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377167|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
44377168|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44377169|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377170|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377171|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44377172|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44377173|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44377174|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377175|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377176|NCT04495283|Acetaminophen|acetaminophen|mesh-list
44377177|NCT04495283|Pregabalin|pregabalin|mesh-list
44377178|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377179|NCT04495283|Analgesics|analgesics|mesh-ancestor
44377180|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
44377181|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377182|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377183|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
44377184|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
44377185|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44377186|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377187|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377188|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44377189|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44377190|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44377191|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685663|NCT02834052|Laxatives|laxatives|mesh-ancestor
43877921|NCT04694677|Coagulants|coagulants|mesh-ancestor
43877922|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43877923|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
43877924|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43877925|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877926|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43877927|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877928|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
43877929|NCT04694183|Paclitaxel|paclitaxel|mesh-list
44377192|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377194|NCT04493931|Digoxin|digoxin|mesh-list
44377195|NCT04493931|Midazolam|midazolam|mesh-list
44377196|NCT04493931|Cimetidine|cimetidine|mesh-list
44377197|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44377198|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44377199|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377200|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377201|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44377202|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44377203|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377204|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44377205|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
44377206|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
44377207|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
44377208|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
44377209|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377210|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377251|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377252|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
44377253|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377254|NCT04482309|Trastuzumab|trastuzumab|mesh-list
44377255|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377256|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377257|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
44377258|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377259|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377261|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
44377262|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
44377263|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377264|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377265|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377266|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44377267|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377268|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377269|NCT04465396|Teduglutide|teduglutide|mesh-list
44377270|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377271|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44377272|NCT04465396|Protective Agents|protective agents|mesh-ancestor
44377273|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377274|NCT04465357|Erenumab|erenumab|mesh-list
44377275|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44377276|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377277|NCT04465357|Analgesics|analgesics|mesh-ancestor
44377278|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
44377279|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377280|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377281|NCT04461795|Erenumab|erenumab|mesh-list
44377282|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44377283|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
44377284|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877930|NCT04694183|Antibodies|antibodies|mesh-list
43877931|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
44377285|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44377286|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377287|NCT04461795|Analgesics|analgesics|mesh-ancestor
44377288|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
44377289|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377290|NCT04461015|Insulin|insulin|mesh-list
44377291|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44377292|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44377293|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377294|NCT04459715|Cisplatin|cisplatin|mesh-list
44377295|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377296|NCT04459598|Efavirenz|efavirenz|mesh-list
44377297|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44377298|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44377299|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377300|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377301|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
44377302|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377303|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44377304|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44377305|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44377306|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44377307|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44377308|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44377309|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43613553|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613554|NCT05366764|Albuterol|albuterol|mesh-list
43613555|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43613556|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
43613557|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613559|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43613560|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
43613599|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
43613600|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613636|NCT05225116|Lenvatinib|lenvatinib|mesh-list
44377310|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44377311|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377312|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377313|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
44377314|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377315|NCT04451330|Doxycycline|doxycycline|mesh-list
44377316|NCT04451330|Trifarotene|trifarotene|mesh-list
44377317|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377318|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377321|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377322|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
44377323|NCT04448561|Morphine|morphine|mesh-list
44377324|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44377325|NCT04448561|Narcotics|narcotics|mesh-ancestor
44377326|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377327|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377328|NCT04448561|Analgesics|analgesics|mesh-ancestor
44377329|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
44377330|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377331|NCT04439279|Trametinib|trametinib|mesh-list
44377332|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44377333|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377334|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44377335|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377336|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377337|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44377338|NCT04439279|Protective Agents|protective agents|mesh-ancestor
44377339|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377376|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377377|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44377378|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
44377379|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377380|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377381|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44377382|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44377383|NCT04428502|Etanercept|etanercept|mesh-list
44377384|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650078|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
43650079|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
43650080|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
43650081|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43650082|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43650083|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43650084|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650086|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
43650087|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650088|NCT03016988|Cytarabine|cytarabine|mesh-list
43650089|NCT03016988|Fludarabine|fludarabine|mesh-list
43650090|NCT03016988|Bortezomib|bortezomib|mesh-list
43851599|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851600|NCT03420742|Midazolam|midazolam|mesh-list
43650091|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650092|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44377385|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377386|NCT04428502|Analgesics|analgesics|mesh-ancestor
44377387|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
44377388|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377389|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377390|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377391|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377392|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377433|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377434|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377435|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
44377436|NCT04425863|Hormones|hormones|mesh-ancestor
44377437|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377438|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44377439|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377440|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
44377441|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685861|NCT02832778|Efavirenz|efavirenz|mesh-list
43877932|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43877933|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877936|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877937|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877938|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
43877939|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877940|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
43877941|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877942|NCT04694092|Landiolol|landiolol|mesh-list
43824441|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824442|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43824443|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
43824444|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824445|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824447|NCT05512364|Letrozole|letrozole|mesh-list
43824448|NCT05512364|Anastrozole|anastrozole|mesh-list
43824449|NCT05512364|Exemestane|exemestane|mesh-list
43824450|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824451|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43824452|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43824453|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824454|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665329|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665330|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
43877943|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43877944|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43877945|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877946|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877947|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877948|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877949|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43877950|NCT04694105|Dexamethasone|dexamethasone|mesh-list
43877951|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
43877952|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43877953|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
43877954|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
43877955|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877956|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877957|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877958|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
43877960|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877961|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43877962|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877963|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877964|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877965|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877966|NCT04694105|Analgesics|analgesics|mesh-ancestor
43877967|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
43877968|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877969|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877970|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877971|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877972|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877973|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877974|NCT04693910|Hormones|hormones|mesh-list
43877975|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877976|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613642|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613643|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613644|NCT05177796|Paclitaxel|paclitaxel|mesh-list
43613646|NCT05177796|Carboplatin|carboplatin|mesh-list
43877977|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
43613687|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
43877978|NCT04693897|Mirabegron|mirabegron|mesh-list
43877979|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43877980|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43877981|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
43877982|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877983|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877984|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377442|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377443|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377444|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377445|NCT04425863|Analgesics|analgesics|mesh-ancestor
44377446|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
44377447|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377448|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44377449|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44377450|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44377451|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44377452|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
44377453|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
44377454|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377455|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377456|NCT04425252|Brequinar|brequinar|mesh-list
44377457|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377458|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377459|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377460|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377461|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
44377462|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377463|NCT04422561|Ivermectin|ivermectin|mesh-list
44377464|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377465|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377466|NCT04416568|Nivolumab|nivolumab|mesh-list
44377467|NCT04416568|Ipilimumab|ipilimumab|mesh-list
44377468|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377469|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877985|NCT04693897|Urological Agents|urological agents|mesh-ancestor
43877986|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43877987|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43877988|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877989|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877990|NCT04693962|Mitogens|mitogens|mesh-list
43877991|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877992|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877993|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
43877994|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43877995|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43877996|NCT04693312|Prednisolone|prednisolone|mesh-list
43877997|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
43877998|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43877999|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
43878000|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613688|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878001|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
43613689|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613690|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613692|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878002|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
43878003|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43588226|NCT03389321|Macitentan|macitentan|mesh-list
44377470|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44377471|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377472|NCT04412707|Dexamethasone|dexamethasone|mesh-list
44377473|NCT04412707|Melphalan|melphalan|mesh-list
44377474|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377475|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
44377476|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
44377477|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377478|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377479|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377480|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
44377481|NCT04412707|Hormones|hormones|mesh-ancestor
44377482|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377483|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44377484|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377485|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44377486|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
44377487|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377488|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44377489|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377490|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
44377491|NCT04411680|Sargramostim|sargramostim|mesh-list
44377492|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
44377493|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377494|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
44033501|NCT00002078|Interferons|interferons|mesh-list
44377495|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44377496|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44377497|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
43878004|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878005|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136034|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
44136035|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136036|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613705|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613747|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613748|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613749|NCT05030298|Temozolomide|temozolomide|mesh-list
43826331|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
43826332|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136037|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44136038|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44136039|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44136040|NCT00163150|Atorvastatin|atorvastatin|mesh-list
44136041|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44136042|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136043|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
44136044|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136045|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43588362|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
44377498|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377499|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
44377500|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
44377501|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377502|NCT04407507|Ivermectin|ivermectin|mesh-list
44377503|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377504|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377505|NCT04407247|Infliximab|infliximab|mesh-list
44377506|NCT04407247|Vedolizumab|vedolizumab|mesh-list
44377507|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
44377508|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
44377509|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
44377510|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377511|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
44377512|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377513|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377514|NCT04406194|Favipiravir|favipiravir|mesh-list
44377515|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
44377516|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377517|NCT04405167|Dexamethasone|dexamethasone|mesh-list
44377518|NCT04405167|Lenalidomide|lenalidomide|mesh-list
44377519|NCT04405167|Ixazomib|ixazomib|mesh-list
44377520|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377521|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
44377522|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
44377523|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377524|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377525|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377526|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
44377527|NCT04405167|Hormones|hormones|mesh-ancestor
44377528|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377529|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44377530|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377531|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
44377532|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377542|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
44377543|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377544|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377545|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377546|NCT04401579|Remdesivir|remdesivir|mesh-list
44377547|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
43613754|NCT05015439|Cannabidiol|cannabidiol|mesh-list
44377548|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377549|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
44377550|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377551|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44377552|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44377553|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
44377554|NCT04401293|Heparin|heparin|mesh-list
44377555|NCT04401293|Enoxaparin|enoxaparin|mesh-list
44377556|NCT04401293|Calcium heparin|calcium heparin|mesh-list
44377557|NCT04401293|Dalteparin|dalteparin|mesh-list
44377558|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
44377559|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
44136046|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44136047|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136048|NCT00163202|Atorvastatin|atorvastatin|mesh-list
44136049|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43878013|NCT04693026|Remdesivir|remdesivir|mesh-list
43878014|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
43878015|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878017|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878018|NCT04692623|Insulin|insulin|mesh-list
43878019|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43878020|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
43878021|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
43878022|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878023|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878024|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878025|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878026|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878027|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878028|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878029|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878030|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878031|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
43878032|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43613794|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613795|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
43613796|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613797|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613798|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613799|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613800|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
43613801|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43613829|NCT04880434|Fludarabine|fludarabine|mesh-list
43665498|NCT05469204|Acetaminophen|acetaminophen|mesh-list
43878033|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
43878034|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878035|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
43878036|NCT04692558|Protective Agents|protective agents|mesh-ancestor
43878037|NCT04692844|Propranolol|propranolol|mesh-list
43878038|NCT04692844|Primidone|primidone|mesh-list
43878039|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43878040|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43878041|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878042|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878043|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878044|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878045|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43878046|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878047|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
43878048|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
43878049|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
43878050|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
43878051|NCT04692896|Lidocaine|lidocaine|mesh-list
43878052|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
44377560|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44377561|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44377562|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377563|NCT04400682|Favipiravir|favipiravir|mesh-list
44377564|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
44377565|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377566|NCT04399356|Niclosamide|niclosamide|mesh-list
44377567|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
44377568|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44377569|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
44377570|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377571|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377572|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
44377573|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
44377574|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44377575|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377576|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
44377577|NCT04399122|Acetaminophen|acetaminophen|mesh-list
44377578|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44377579|NCT04399122|Oxycodone|oxycodone|mesh-list
44377580|NCT04399122|Codeine|codeine|mesh-list
44377581|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377582|NCT04399122|Analgesics|analgesics|mesh-ancestor
43613837|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377583|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
44377584|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377585|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377586|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
44377587|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44377588|NCT04399122|Narcotics|narcotics|mesh-ancestor
44377589|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377590|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
44377591|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
44377592|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377593|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377594|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377595|NCT04398732|Etanercept|etanercept|mesh-list
44377596|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377597|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377598|NCT04398732|Analgesics|analgesics|mesh-ancestor
44377599|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
44377600|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377601|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377602|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377603|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377604|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377605|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377606|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
44377607|NCT04398134|Entecavir|entecavir|mesh-list
44377608|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
44377609|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377610|NCT04397445|Ranitidine|ranitidine|mesh-list
44377611|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44377612|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44377613|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44377614|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44377615|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
44377616|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
43613886|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665518|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
43665519|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665520|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
43665521|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43665522|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43665523|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377617|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377618|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377620|NCT04396639|Factor VIII|factor viii|mesh-list
44377653|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377655|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44377656|NCT04387136|Narcotics|narcotics|mesh-ancestor
44377657|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377658|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377659|NCT04387136|Analgesics|analgesics|mesh-ancestor
44377660|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
44377661|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377662|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44377663|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44377664|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
44377665|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
44377666|NCT04384107|Vaccines|vaccines|mesh-list
44377667|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44377668|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
44377669|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377670|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
44377671|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377672|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44377673|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377674|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377675|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377676|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
44377677|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377678|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377679|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377680|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377681|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377682|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613887|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43613888|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
43613889|NCT04764942|Dexamethasone|dexamethasone|mesh-list
43613890|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
43613891|NCT04764942|Pomalidomide|pomalidomide|mesh-list
43613892|NCT04764942|Ichthammol|ichthammol|mesh-list
43613893|NCT04764942|BB 1101|bb 1101|mesh-list
43613894|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613919|NCT04715230|Lorazepam|lorazepam|mesh-list
44377683|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
44377684|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377696|NCT04377308|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44377697|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44377698|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377699|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377700|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377701|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
44377702|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377703|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44377704|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
44377705|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377706|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44377707|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44377708|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377709|NCT04369950|Lidocaine|lidocaine|mesh-list
44377710|NCT04369950|Epinephrine|epinephrine|mesh-list
44377711|NCT04369950|Morphine|morphine|mesh-list
44377712|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
44377713|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
44377714|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
44377715|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377716|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377717|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
44377718|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377719|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44377720|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44377721|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43686085|NCT02831101|Narcotics|narcotics|mesh-ancestor
43878053|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
43878054|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878059|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43878060|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43878061|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43878062|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878063|NCT04692740|Chlorambucil|chlorambucil|mesh-list
43878064|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43878065|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
43878066|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878067|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878069|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43878070|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878071|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613941|NCT04678661|Insulin|insulin|mesh-list
43826955|NCT05492968|Phenylephrine|phenylephrine|mesh-list
43878073|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43878074|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
43878075|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
44377723|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377724|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44377725|NCT04369950|Narcotics|narcotics|mesh-ancestor
44377726|NCT04369950|Analgesics|analgesics|mesh-ancestor
44377727|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44377728|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44377729|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
44377730|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377731|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44377732|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44377733|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
44377734|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44377735|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44377736|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
43613984|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613985|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43613986|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43613987|NCT04553692|Growth Substances|growth substances|mesh-ancestor
43613988|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613989|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
43613990|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43613991|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
43665612|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665614|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665615|NCT05468164|Omeprazole|omeprazole|mesh-list
43665616|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43665617|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665618|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43665619|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665620|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665621|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
43665622|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
43665623|NCT05468099|Povidone|povidone|mesh-list
43665624|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43665625|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665626|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
43851607|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377737|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
44377738|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44377739|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377740|NCT04369742|Calcium|calcium|mesh-list
44377741|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44377742|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878076|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878077|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878078|NCT04692376|Cyclosporine|cyclosporine|mesh-list
43878079|NCT04692376|Cyclosporins|cyclosporins|mesh-list
43878080|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
43878081|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878082|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878083|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878084|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
43878085|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878086|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
43878087|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878088|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
43878089|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878090|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43878091|NCT04692376|Hormones|hormones|mesh-ancestor
43878092|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878093|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
43878094|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878095|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878096|NCT04692051|Gemcitabine|gemcitabine|mesh-list
43878097|NCT04692051|Paclitaxel|paclitaxel|mesh-list
43878098|NCT04692051|Cisplatin|cisplatin|mesh-list
43878099|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878100|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878101|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
43878102|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
43878103|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
43878104|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878105|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878106|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
43613993|NCT04553692|Antiviral Agents|antiviral agents|mesh-ancestor
43878107|NCT04692051|Antiviral Agents|antiviral agents|mesh-ancestor
43878108|NCT04692051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377743|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377744|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
44377745|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377746|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377747|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377748|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377749|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377750|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44377751|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44377752|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44377753|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377754|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
44377755|NCT04358549|Favipiravir|favipiravir|mesh-list
44377756|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
44377757|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377758|NCT04358068|Azithromycin|azithromycin|mesh-list
44377759|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377760|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377761|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377762|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
44377763|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377764|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377765|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377766|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377767|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377768|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
44377769|NCT04357782|Vitamins|vitamins|mesh-ancestor
44377770|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
44377771|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377772|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
44377773|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377774|NCT04357782|Protective Agents|protective agents|mesh-ancestor
43878109|NCT04692051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878110|NCT04692051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878111|NCT04692051|Immunologic Factors|immunologic factors|mesh-ancestor
43878112|NCT04692051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878113|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43878114|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878115|NCT04691687|Furosemide|furosemide|mesh-list
43878116|NCT04691687|Diuretics|diuretics|mesh-ancestor
43878117|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
43878118|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878119|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44377776|NCT04353817|Elexacaftor|elexacaftor|mesh-list
44377777|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44377778|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377779|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377780|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44377781|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44377782|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
44377783|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377784|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377785|NCT04349917|Methylphenidate|methylphenidate|mesh-list
44377786|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44377787|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377788|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44377789|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44377790|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377791|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377792|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
44377793|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377794|NCT04347954|Iodine|iodine|mesh-list
44377795|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
44377796|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
44377797|NCT04347954|Povidone|povidone|mesh-list
44377798|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44377799|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377800|NCT04347954|Trace Elements|trace elements|mesh-ancestor
44377801|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
44377802|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377803|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
44377804|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
44377819|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44377820|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377821|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377822|NCT04343976|Interferons|interferons|mesh-list
44377823|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377824|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
44377825|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377826|NCT04342897|Zansecimab|zansecimab|mesh-list
44377827|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
44377828|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377829|NCT04340557|Losartan|losartan|mesh-list
44377830|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44377831|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44377832|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44377833|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44377834|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377835|NCT04336228|Dexetimide|dexetimide|mesh-list
44377836|NCT04336228|Citalopram|citalopram|mesh-list
44377837|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377838|NCT04336228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44377839|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44377840|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44377841|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377842|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44377843|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
44377844|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44377845|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
44377846|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44377847|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43614030|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
43614034|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
44377861|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377862|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377864|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
44377865|NCT04332874|Melphalan|melphalan|mesh-list
44377866|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44377867|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377868|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44377869|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
44377870|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377871|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44377872|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44377873|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
44377874|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377875|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377876|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377877|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44377878|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44377879|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377880|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44377881|NCT04332107|Azithromycin|azithromycin|mesh-list
44377882|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44377883|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377884|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377885|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
44377886|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377887|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377888|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377889|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377890|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377891|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377892|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
44377893|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
44377894|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377895|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43878120|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43878121|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878122|NCT04691934|Anesthetics|anesthetics|mesh-list
43878129|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
43878130|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
44377896|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377897|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377898|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377899|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44033948|NCT00002124|Lamivudine|lamivudine|mesh-list
44377901|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
44377902|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377903|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44377904|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44377905|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44382394|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44377906|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377907|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44377908|NCT04322526|Naltrexone|naltrexone|mesh-list
44377909|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44377910|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44377911|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377912|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
44377913|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377914|NCT04320745|Testosterone|testosterone|mesh-list
44377915|NCT04320745|Androgens|androgens|mesh-ancestor
44377916|NCT04320745|Hormones|hormones|mesh-ancestor
44377917|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44377918|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377919|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44377920|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44377921|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44377922|NCT04318535|Griseofulvin|griseofulvin|mesh-list
44377923|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
44377924|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377925|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44377926|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
44377927|NCT04314037|Praziquantel|praziquantel|mesh-list
44377928|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
44377938|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
44377939|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44377940|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44377941|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377942|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377943|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377944|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377945|NCT04307940|Acetaminophen|acetaminophen|mesh-list
44377946|NCT04307940|Naproxen|naproxen|mesh-list
44377947|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44377948|NCT04307940|Hydrocodone|hydrocodone|mesh-list
44377949|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44377950|NCT04307940|Analgesics|analgesics|mesh-ancestor
44377951|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
44377952|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377953|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377954|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
44377955|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44377956|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44377957|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44377958|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
44377959|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44377960|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44377961|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377962|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44377963|NCT04307940|Narcotics|narcotics|mesh-ancestor
44377964|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44377965|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
44377966|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
44377967|NCT04297241|Isosorbide|isosorbide|mesh-list
44377968|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44377969|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44377970|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44377971|NCT04297241|Diuretics|diuretics|mesh-ancestor
44377972|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
43878131|NCT04691076|Fentanyl|fentanyl|mesh-list
43878132|NCT04691076|Propofol|propofol|mesh-list
43878133|NCT04691076|Esketamine|esketamine|mesh-list
43878134|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878135|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878136|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377973|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377974|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
44377975|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44377976|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377977|NCT04292899|Remdesivir|remdesivir|mesh-list
44377978|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
44377979|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377980|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
44377981|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377982|NCT04292730|Remdesivir|remdesivir|mesh-list
44377983|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
44377984|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44377985|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
44377986|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44377987|NCT04292535|Insulin|insulin|mesh-list
44377988|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44377989|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
44377990|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
44377991|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44377992|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44377993|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377994|NCT04292171|Gabapentin|gabapentin|mesh-list
44377995|NCT04292171|Analgesics|analgesics|mesh-ancestor
44377996|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
44377997|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44377998|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44377999|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
44378000|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44378001|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44378002|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378003|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378004|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44378005|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44378006|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378007|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878137|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878138|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
43878139|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
44378008|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
44378010|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378011|NCT04280705|Remdesivir|remdesivir|mesh-list
44378012|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
44378013|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378014|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
44378015|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378016|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
44378017|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44378018|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378019|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44378020|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
44378021|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
44378022|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378023|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665731|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
44378024|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
44378025|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378026|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44378027|NCT04273776|Zolpidem|zolpidem|mesh-list
44378028|NCT04273776|Suvorexant|suvorexant|mesh-list
44378029|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44378030|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44378031|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378032|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378033|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44378034|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
44378035|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
44378036|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43828810|NCT05469893|Dexamethasone|dexamethasone|mesh-list
43878140|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43878141|NCT04691076|Narcotics|narcotics|mesh-ancestor
43878142|NCT04691076|Analgesics|analgesics|mesh-ancestor
43878143|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
43878144|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878145|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43878146|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
43878147|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878148|NCT04691063|Carboplatin|carboplatin|mesh-list
43878149|NCT04691063|Etoposide|etoposide|mesh-list
43878150|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
43878151|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878152|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878153|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878154|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878155|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878156|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378037|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378038|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44378040|NCT04272775|Lenalidomide|lenalidomide|mesh-list
44378041|NCT04272775|Ixazomib|ixazomib|mesh-list
44378042|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378043|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
44378044|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
44378045|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378046|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378047|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378048|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
44378049|NCT04272775|Hormones|hormones|mesh-ancestor
44378050|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378051|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44378052|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378053|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
44378054|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44378055|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43828819|NCT05469893|Hormones|hormones|mesh-ancestor
43878157|NCT04690608|Triamcinolone|triamcinolone|mesh-list
43878158|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43878159|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43878160|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43878161|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878162|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
43878164|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878165|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878166|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878167|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
43878168|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878169|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878170|NCT04690647|Dexamethasone|dexamethasone|mesh-list
43878171|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43878172|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878173|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
43878174|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
43878175|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878176|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878177|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43878178|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
43878179|NCT04690647|Hormones|hormones|mesh-ancestor
43878180|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878181|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43878182|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614119|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
43614120|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
43614121|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
43614122|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43878183|NCT04690647|Analgesics|analgesics|mesh-ancestor
43878184|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
43878185|NCT04690751|Cenobamate|cenobamate|mesh-list
43878186|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
43878187|NCT04690556|Ranibizumab|ranibizumab|mesh-list
43878188|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43878189|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43878190|NCT04690556|Growth Substances|growth substances|mesh-ancestor
43878191|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378056|NCT04272775|Growth Substances|growth substances|mesh-ancestor
44378057|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44378058|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
44378059|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378060|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378061|NCT04259346|Ixekizumab|ixekizumab|mesh-list
44378062|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378063|NCT04256317|Azacitidine|azacitidine|mesh-list
44378064|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44378065|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
44378066|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378067|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378068|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378069|NCT04252586|Cannabidiol|cannabidiol|mesh-list
44378070|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
44378071|NCT04249336|Listerine|listerine|mesh-list
44378072|NCT04249336|Calcium|calcium|mesh-list
44378073|NCT04249336|Fluorides|fluorides|mesh-list
44378074|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
44378075|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44378076|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378077|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
44378078|NCT04249336|Protective Agents|protective agents|mesh-ancestor
44378079|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44378080|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378081|NCT04245709|Clenbuterol|clenbuterol|mesh-list
44378082|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44378083|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44378084|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378085|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378086|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378087|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878192|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
43614127|NCT04381936|Empagliflozin|empagliflozin|mesh-list
43614128|NCT04381936|Ritonavir|ritonavir|mesh-list
43614129|NCT04381936|Lopinavir|lopinavir|mesh-list
43614130|NCT04381936|Azithromycin|azithromycin|mesh-list
43614131|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
43614132|NCT04381936|Colchicine|colchicine|mesh-list
43614133|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43614134|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43614135|NCT04381936|Antibodies|antibodies|mesh-list
43614136|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
43614137|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
43614138|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665766|NCT05339256|Analgesics|analgesics|mesh-ancestor
43665770|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
44136054|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44136055|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136056|NCT00163241|Celecoxib|celecoxib|mesh-list
44136057|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44136058|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44136059|NCT00163241|Analgesics|analgesics|mesh-ancestor
44136060|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
44136061|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136062|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136063|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378093|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
44136064|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136065|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44136066|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44136067|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136068|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136070|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
44136071|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44136072|NCT00163267|Clopidogrel|clopidogrel|mesh-list
44136073|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44136074|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44136075|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44136076|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44136077|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
44136078|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136079|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136080|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136081|NCT00163306|Pantoprazole|pantoprazole|mesh-list
44136082|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44136083|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136084|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44136085|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136086|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136087|NCT00163319|Ciclesonide|ciclesonide|mesh-list
44136088|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
44136090|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136091|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878194|NCT04690270|Sumatriptan|sumatriptan|mesh-list
43878195|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43878196|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43878197|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43878198|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
43878199|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878200|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878201|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878202|NCT04689958|Vitamin D|vitamin d|mesh-list
43878203|NCT04689958|Vitamins|vitamins|mesh-ancestor
43878204|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
43878205|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878206|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43878207|NCT04689971|Vitamins|vitamins|mesh-list
43878208|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
43878209|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
43878210|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878211|NCT04690309|Insulin|insulin|mesh-list
43878212|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43878213|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878214|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878215|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
43878216|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878217|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43878218|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
44378105|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44378106|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44378107|NCT04238663|Growth Substances|growth substances|mesh-ancestor
44378108|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378109|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44378110|NCT04238650|Bevacizumab|bevacizumab|mesh-list
44378111|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378112|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378113|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44378114|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44378115|NCT04238650|Growth Substances|growth substances|mesh-ancestor
44378116|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378117|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
43878219|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
43878233|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
43878234|NCT04689100|Irinotecan|irinotecan|mesh-list
43878235|NCT04689100|Calcium|calcium|mesh-list
43878236|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
43878237|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43878238|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878239|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
43878240|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878241|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878242|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878243|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878244|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
43878245|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43878246|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878247|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614139|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43878248|NCT04689100|Antidotes|antidotes|mesh-ancestor
43614140|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614141|NCT04381936|Analgesics|analgesics|mesh-ancestor
43614145|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878249|NCT04689100|Protective Agents|protective agents|mesh-ancestor
43878250|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
43878251|NCT04689100|Vitamins|vitamins|mesh-ancestor
43878252|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
43878253|NCT04689165|Vaccines|vaccines|mesh-list
43878254|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
43878255|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878256|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
43878257|NCT04688983|Blinatumomab|blinatumomab|mesh-list
43878258|NCT04688983|Ponatinib|ponatinib|mesh-list
43878259|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878260|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878261|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878262|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878263|NCT04688723|Dabigatran|dabigatran|mesh-list
43878264|NCT04688723|Clopidogrel|clopidogrel|mesh-list
43878265|NCT04688723|Ticagrelor|ticagrelor|mesh-list
43878266|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43878267|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43878268|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43878269|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44378118|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
44378119|NCT04237792|Propofol|propofol|mesh-list
44378120|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44378121|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378122|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378123|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44378124|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
44378125|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
44378126|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378127|NCT04237792|Analgesics|analgesics|mesh-ancestor
44378128|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
44378129|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378130|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44378131|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44378132|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44378133|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378134|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378135|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378136|NCT04236141|Rituximab|rituximab|mesh-list
44378137|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44378138|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378139|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378140|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
44378141|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378142|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378143|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44378144|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
44378145|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378146|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
44378147|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44378148|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44378149|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614192|NCT04301661|Lamivudine|lamivudine|mesh-list
43614193|NCT04301661|Emtricitabine|emtricitabine|mesh-list
43665834|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665835|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665836|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43665837|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43665838|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43665839|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378150|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
44378151|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378157|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378158|NCT04223791|Islatravir|islatravir|mesh-list
44378159|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
44378160|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378161|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378162|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378163|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44378164|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44378165|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44378166|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44378167|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44378168|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
44378169|NCT04222699|Mupirocin|mupirocin|mesh-list
44378170|NCT04222699|Calcium|calcium|mesh-list
44412303|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878270|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
43878271|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878272|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878273|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878274|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
43878275|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43878276|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
43878277|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878278|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
43878279|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43878280|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
43878281|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43878282|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878283|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878284|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878290|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
43878291|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43878292|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878293|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43878294|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43878295|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43878296|NCT04688346|Epinephrine|epinephrine|mesh-list
43878297|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43878298|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43878299|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878300|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878301|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878302|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878303|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43878304|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43878305|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
43878306|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878307|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43878308|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
43878309|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
43878310|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
43878311|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43878312|NCT04688021|Cytarabine|cytarabine|mesh-list
43878313|NCT04688021|Cyclosporine|cyclosporine|mesh-list
43878314|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
43878315|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
43878316|NCT04688021|Busulfan|busulfan|mesh-list
43878317|NCT04688021|Cyclosporins|cyclosporins|mesh-list
43878318|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43878319|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
43878320|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878321|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
43588363|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
44378171|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44378172|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378173|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44378174|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378175|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
44378176|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378177|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44378178|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378179|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378180|NCT04219774|Aspirin|aspirin|mesh-list
44378181|NCT04219774|Clopidogrel|clopidogrel|mesh-list
44378182|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44378183|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378184|NCT04219774|Analgesics|analgesics|mesh-ancestor
44378185|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
43878322|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878323|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878324|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43878325|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
43878326|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878327|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878328|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43878329|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878330|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
43878331|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
43878332|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878333|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878334|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
43878335|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
43878336|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43878337|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43878338|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43878339|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
43614194|NCT04301661|Abacavir|abacavir|mesh-list
43614195|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
43614196|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614234|NCT04205838|Vidarabine|vidarabine|mesh-list
43878340|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878341|NCT04688151|Rituximab|rituximab|mesh-list
43878342|NCT04688151|Durvalumab|durvalumab|mesh-list
43878343|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
43878344|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878345|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878346|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
43878347|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878348|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136092|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136093|NCT00163332|Ciclesonide|ciclesonide|mesh-list
44136094|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
44136095|NCT00163332|Hormones|hormones|mesh-ancestor
44136096|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136102|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136104|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136105|NCT00163358|Ciclesonide|ciclesonide|mesh-list
44136106|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
44136107|NCT00163358|Hormones|hormones|mesh-ancestor
44136108|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136109|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136110|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136111|NCT00163371|Ciclesonide|ciclesonide|mesh-list
44136112|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
44136113|NCT00163371|Hormones|hormones|mesh-ancestor
44136114|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378186|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378187|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378188|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378189|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378190|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44378191|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44378192|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378193|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44378194|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44378195|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378196|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
44378197|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44378198|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44378199|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44378200|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
44378201|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378202|NCT04219358|Imiquimod|imiquimod|mesh-list
44378244|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
44378245|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
44378246|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44378247|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
44378248|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44378249|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44378250|NCT04195828|Paclitaxel|paclitaxel|mesh-list
44378251|NCT04195828|Apatinib|apatinib|mesh-list
44378252|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44378253|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378254|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44378255|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44378256|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44378257|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378258|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44378259|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378260|NCT04194151|Propofol|propofol|mesh-list
44378261|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44378262|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378263|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378264|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44378265|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
44378266|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
44378267|NCT04189952|Rituximab|rituximab|mesh-list
44378268|NCT04189952|Carboplatin|carboplatin|mesh-list
44378269|NCT04189952|Etoposide|etoposide|mesh-list
44378270|NCT04189952|Ifosfamide|ifosfamide|mesh-list
44378297|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
44378298|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
44378299|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44378300|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44378301|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
44378302|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44378303|NCT04179461|Vitamins|vitamins|mesh-ancestor
44378304|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
44378305|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378306|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44378307|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378308|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44378309|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
44378310|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378311|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44378312|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
44378313|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378314|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44378315|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44378316|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
44378317|NCT04179461|Hormones|hormones|mesh-ancestor
44378331|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
44378351|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44378352|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378353|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378354|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378355|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
44378356|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44378357|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
44378358|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378359|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44378360|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378361|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44378362|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378363|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44378364|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378365|NCT04171414|Adalimumab|adalimumab|mesh-list
44378366|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378367|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378368|NCT04169373|Upadacitinib|upadacitinib|mesh-list
44378369|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44378370|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44378371|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378372|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378373|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378374|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44378375|NCT04169061|Hormones|hormones|mesh-ancestor
44378376|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378377|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378378|NCT04168190|Vaccines|vaccines|mesh-list
43826492|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43826493|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43826494|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43826495|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43826496|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43826497|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43826498|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
43826499|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
43826500|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851616|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44378379|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44378380|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
44378381|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378382|NCT04167670|Amoxicillin|amoxicillin|mesh-list
44378383|NCT04167670|Clarithromycin|clarithromycin|mesh-list
44378384|NCT04167670|Lansoprazole|lansoprazole|mesh-list
44378385|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
44378386|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378387|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43593453|NCT03344042|Narcotics|narcotics|mesh-ancestor
44378388|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44378389|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378390|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378391|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44378392|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44378393|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44378394|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378395|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44378396|NCT04167085|Doxycycline|doxycycline|mesh-list
44378397|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378398|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378399|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
44378400|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44378401|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44378402|NCT04165824|Edaravone|edaravone|mesh-list
44378403|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44378404|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
44378405|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378406|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44378407|NCT04165824|Protective Agents|protective agents|mesh-ancestor
44378408|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378409|NCT04165031|Docetaxel|docetaxel|mesh-list
44378410|NCT04165031|Cetuximab|cetuximab|mesh-list
44412304|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
44136115|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136116|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136117|NCT00163384|Ciclesonide|ciclesonide|mesh-list
44136118|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
44136119|NCT00163384|Hormones|hormones|mesh-ancestor
44136120|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136121|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136122|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136123|NCT00163397|Ciclesonide|ciclesonide|mesh-list
44136124|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
44136125|NCT00163397|Hormones|hormones|mesh-ancestor
44136126|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136127|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136128|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136129|NCT00163410|Ciclesonide|ciclesonide|mesh-list
44136130|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
44136131|NCT00163410|Hormones|hormones|mesh-ancestor
44136132|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136133|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136134|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136135|NCT00163423|Ciclesonide|ciclesonide|mesh-list
44136136|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
44136137|NCT00163423|Hormones|hormones|mesh-ancestor
44136138|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136139|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136140|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136141|NCT00163436|Ciclesonide|ciclesonide|mesh-list
44378411|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44378412|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378413|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44378414|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44378415|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44378416|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846760|NCT04176055|Haloperidol|haloperidol|mesh-list
44378417|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378418|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44378419|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378420|NCT04164758|Pimavanserin|pimavanserin|mesh-list
44378421|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44378422|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
44378423|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378424|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44378425|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44378426|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378427|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378428|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44378429|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44378430|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44378431|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44378432|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
44378433|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378435|NCT04162795|Loratadine|loratadine|mesh-list
44378461|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44378462|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
44378463|NCT04157738|Insulin|insulin|mesh-list
44378464|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44378465|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
44378466|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
44378467|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44378468|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378469|NCT04156646|Esomeprazole|esomeprazole|mesh-list
44378470|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44378471|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378472|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44378473|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378474|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378475|NCT04154293|Isotretinoin|isotretinoin|mesh-list
44378476|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378477|NCT04153188|Phenylephrine|phenylephrine|mesh-list
44378478|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
44378479|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44378480|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44378481|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378482|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136142|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
44136143|NCT00163436|Hormones|hormones|mesh-ancestor
44136144|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136145|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136146|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136147|NCT00163449|Ciclesonide|ciclesonide|mesh-list
44136148|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
44136149|NCT00163449|Hormones|hormones|mesh-ancestor
44136150|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136151|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614249|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
43614271|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43614272|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614273|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43614274|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
43614277|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44136152|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136153|NCT00163462|Ciclesonide|ciclesonide|mesh-list
44136154|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
44136155|NCT00163462|Hormones|hormones|mesh-ancestor
44136156|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136157|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136158|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136159|NCT00163488|Ciclesonide|ciclesonide|mesh-list
44136160|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
44136161|NCT00163488|Hormones|hormones|mesh-ancestor
44136162|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136163|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136164|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136165|NCT00163501|Ciclesonide|ciclesonide|mesh-list
44136166|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
43878354|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
43878355|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43878356|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43878357|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
43878358|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878359|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878360|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594314|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44378483|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378484|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378485|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
44378486|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
44378487|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378488|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
44378489|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44034555|NCT00002190|Lamivudine|lamivudine|mesh-list
44378490|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
44378492|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
44378493|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44378494|NCT04153188|Protective Agents|protective agents|mesh-ancestor
44378495|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44378496|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378497|NCT04148911|Paclitaxel|paclitaxel|mesh-list
44378498|NCT04148911|Atezolizumab|atezolizumab|mesh-list
44378499|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44378500|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378501|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44378502|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44378503|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44378505|NCT04147715|Dolutegravir|dolutegravir|mesh-list
44378538|NCT04139018|Timolol|timolol|mesh-list
44378539|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44378540|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44378541|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
44378542|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378543|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378544|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378545|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44378546|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43665890|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
43851617|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851618|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665891|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43665892|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665893|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43665894|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665895|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
44378547|NCT04135937|Bupropion|bupropion|mesh-list
44378548|NCT04135937|Nicotine|nicotine|mesh-list
44378549|NCT04135937|Varenicline|varenicline|mesh-list
44378550|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44378551|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
44378552|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378553|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378554|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44378555|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44378556|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
44378557|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378558|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378559|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44378560|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
44378561|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378562|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44378563|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43878361|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43878362|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43878363|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
43878364|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
43878365|NCT04687332|Tryptophan|tryptophan|mesh-list
43878366|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43878367|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
43878368|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878369|NCT04687449|Curcumin|curcumin|mesh-list
43878370|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43878371|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43878372|NCT04687449|Analgesics|analgesics|mesh-ancestor
43878373|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
43878374|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878375|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878376|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878377|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878378|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878379|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878380|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878381|NCT04687111|Valsartan|valsartan|mesh-list
44378564|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378565|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
44378567|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44378568|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378569|NCT04135495|Ivacaftor|ivacaftor|mesh-list
44378570|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44378571|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378572|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378573|NCT04132336|Naproxen|naproxen|mesh-list
44378574|NCT04132336|Caffeine|caffeine|mesh-list
44378575|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44378576|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378577|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44378578|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378579|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378580|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44378581|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44378582|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
44378583|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378584|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44378585|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378586|NCT04132336|Analgesics|analgesics|mesh-ancestor
44378587|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
44378588|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378589|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378590|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378591|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
44378592|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44378593|NCT04131556|Maribavir|maribavir|mesh-list
44378594|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
44378595|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378606|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378607|NCT04124926|Lansoprazole|lansoprazole|mesh-list
44378608|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
44378609|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44378610|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378611|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44378612|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378613|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378614|NCT04123665|Fluorides|fluorides|mesh-list
44378615|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
44378616|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
44378617|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
44378618|NCT04123665|Protective Agents|protective agents|mesh-ancestor
44378619|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378620|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
44378621|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44378622|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
44378623|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378624|NCT04123405|Expectorants|expectorants|mesh-ancestor
44378625|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
44378626|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44378627|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
44378628|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378629|NCT04123405|Protective Agents|protective agents|mesh-ancestor
43686688|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
43878382|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43878383|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878384|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43878385|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43878386|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878387|NCT04686890|Acetaminophen|acetaminophen|mesh-list
43878388|NCT04686890|Tramadol|tramadol|mesh-list
43878389|NCT04686890|Analgesics|analgesics|mesh-list
43878390|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43878391|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
43878392|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878393|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878394|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
43878395|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43878396|NCT04686890|Narcotics|narcotics|mesh-ancestor
43878397|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878398|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
43878399|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878400|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
43878401|NCT04687163|Fluorouracil|fluorouracil|mesh-list
43614279|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
43878402|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878403|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
43878404|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878405|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878406|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878407|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
43878408|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878409|NCT04687098|Idarubicin|idarubicin|mesh-list
44378630|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378632|NCT04123067|Pioglitazone|pioglitazone|mesh-list
44378633|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44378634|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378635|NCT04118166|Nivolumab|nivolumab|mesh-list
44378636|NCT04118166|Ipilimumab|ipilimumab|mesh-list
44378637|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378638|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378639|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44034701|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44378640|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378642|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
44378643|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378644|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
44378645|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44378646|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
43878410|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43878411|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878412|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878413|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878414|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878415|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878416|NCT04686448|Fentanyl|fentanyl|mesh-list
43878417|NCT04686448|Ketamine|ketamine|mesh-list
43878418|NCT04686448|Propofol|propofol|mesh-list
43878419|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878424|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
43878425|NCT04686448|Analgesics|analgesics|mesh-ancestor
43878426|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
43878427|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878428|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43878429|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43878430|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43878431|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878432|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878433|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43878434|NCT04686448|Narcotics|narcotics|mesh-ancestor
43878435|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43878436|NCT04686825|DA-8010|da-8010|mesh-list
43878437|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43878438|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43878439|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
43878440|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878441|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878442|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878444|NCT04686643|Amlodipine|amlodipine|mesh-list
43878445|NCT04686643|Valsartan|valsartan|mesh-list
43878446|NCT04686643|Indapamide|indapamide|mesh-list
43878447|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878448|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43878449|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43878450|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878451|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43878452|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878453|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
43594315|NCT03335241|Fludarabine|fludarabine|mesh-list
44378647|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378648|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
44378649|NCT04115358|Protective Agents|protective agents|mesh-ancestor
44378651|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44378652|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
44378653|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034776|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378654|NCT04110145|Linaclotide|linaclotide|mesh-list
44378655|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44378656|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
44378657|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378658|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378659|NCT04109456|Atezolizumab|atezolizumab|mesh-list
44378660|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378661|NCT04109391|Trastuzumab|trastuzumab|mesh-list
44378662|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378663|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378665|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
44378666|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378667|NCT04105998|Oxytocin|oxytocin|mesh-list
44378668|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
44378669|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44378699|NCT04095858|Tacrolimus|tacrolimus|mesh-list
44378700|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44378701|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
44378702|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44378703|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378704|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44378705|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
44378706|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378707|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378708|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378709|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378710|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44378711|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44378712|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
44378713|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378714|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44378715|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44378716|NCT04094883|Vaccines|vaccines|mesh-list
44378717|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
44378718|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378719|NCT04094870|Sertraline|sertraline|mesh-list
44378720|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
44378721|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378722|NCT04094870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44378723|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44378724|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378725|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378726|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378727|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
44378728|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378729|NCT04093570|Decitabine|decitabine|mesh-list
43878454|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43878455|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43878456|NCT04686643|Diuretics|diuretics|mesh-ancestor
43878457|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
43878458|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43878459|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43878460|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
43878461|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43878462|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
43878463|NCT04686643|Vitamins|vitamins|mesh-ancestor
43878464|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
43878465|NCT04686058|Midazolam|midazolam|mesh-list
43878466|NCT04686058|Meperidine|meperidine|mesh-list
43878467|NCT04686058|Propofol|propofol|mesh-list
44378731|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
44378732|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382395|NCT03600805|Prednisone|prednisone|mesh-list
44378733|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378734|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378735|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
44378736|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378737|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686785|NCT02825121|Iodine|iodine|mesh-list
43878468|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878469|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878470|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878471|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878472|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
43878473|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
43878474|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43878475|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43878476|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43878477|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878478|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
43878479|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
43878480|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878481|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878482|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43878483|NCT04686058|Narcotics|narcotics|mesh-ancestor
43878484|NCT04686058|Analgesics|analgesics|mesh-ancestor
43878485|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
43878486|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878487|NCT04685512|Tenofovir|tenofovir|mesh-list
43878488|NCT04685512|Emtricitabine|emtricitabine|mesh-list
43878489|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
43878490|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136167|NCT00163501|Hormones|hormones|mesh-ancestor
43878499|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43878500|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43878501|NCT04685642|Analgesics|analgesics|mesh-ancestor
43878502|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
43878503|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878504|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878505|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878506|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878507|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43878508|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43878509|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878510|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43878511|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43878512|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878513|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
43878514|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43878515|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43878516|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
43614292|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
43878517|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43878518|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44136168|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136169|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136170|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136171|NCT00163514|Ciclesonide|ciclesonide|mesh-list
44136172|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
44136173|NCT00163514|Hormones|hormones|mesh-ancestor
44136174|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136175|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136176|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136177|NCT00163540|Formaldehyde|formaldehyde|mesh-list
44136178|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
44136179|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136180|NCT00163553|Meperidine|meperidine|mesh-list
44378738|NCT04084769|Vaccines|vaccines|mesh-list
44378739|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
44378740|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378741|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44378742|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44378743|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
44378744|NCT04075604|Nivolumab|nivolumab|mesh-list
44378745|NCT04075604|Palbociclib|palbociclib|mesh-list
44378746|NCT04075604|Anastrozole|anastrozole|mesh-list
44378747|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378748|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378749|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44378750|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136181|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44136182|NCT00163553|Narcotics|narcotics|mesh-ancestor
44136183|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136184|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136185|NCT00163553|Analgesics|analgesics|mesh-ancestor
44136186|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
44136187|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136188|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44136189|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44136190|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
44136191|NCT00163592|Coagulants|coagulants|mesh-ancestor
44136192|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44136193|NCT00163605|Thrombin|thrombin|mesh-list
44136194|NCT00163605|Calcium|calcium|mesh-list
44136195|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44136196|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136197|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
44136198|NCT00163605|Coagulants|coagulants|mesh-ancestor
44136199|NCT00163618|Formaldehyde|formaldehyde|mesh-list
44136200|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
44136201|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136202|NCT00163748|Gemcitabine|gemcitabine|mesh-list
44136203|NCT00163748|Vinorelbine|vinorelbine|mesh-list
43614299|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43614300|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614301|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614302|NCT04182633|Vancomycin|vancomycin|mesh-list
43614338|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
43614339|NCT04132427|Citric Acid|citric acid|mesh-list
43614340|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
43614341|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
43614374|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136204|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44136205|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
44136206|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650100|NCT03017066|Anesthetics|anesthetics|mesh-list
43650101|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136208|NCT00163748|Antiviral Agents|antiviral agents|mesh-ancestor
44136209|NCT00163748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136210|NCT00163748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136211|NCT00163748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136212|NCT00163748|Immunologic Factors|immunologic factors|mesh-ancestor
44136213|NCT00163748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136214|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136215|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136216|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
43650102|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650103|NCT03016832|Irbesartan|irbesartan|mesh-list
43614375|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614376|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43614377|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
43614378|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43614379|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614380|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614381|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43614383|NCT04039230|Talazoparib|talazoparib|mesh-list
43614384|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614410|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43614411|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614412|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614413|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43614414|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
43614415|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136217|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136218|NCT00163761|Gemcitabine|gemcitabine|mesh-list
44136219|NCT00163761|Vinorelbine|vinorelbine|mesh-list
44136220|NCT00163761|Ifosfamide|ifosfamide|mesh-list
44136221|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44136222|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
44155793|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878519|NCT04685148|Estradiol|estradiol|mesh-list
43878520|NCT04685148|Estrogens|estrogens|mesh-ancestor
43878521|NCT04685148|Hormones|hormones|mesh-ancestor
43614416|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614417|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614418|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43614419|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614420|NCT03955198|Durvalumab|durvalumab|mesh-list
43614421|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614422|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614423|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
43614424|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878522|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878523|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878524|NCT04685031|Clobetasol|clobetasol|mesh-list
43878525|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
43878526|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
43878527|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378751|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44378752|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378753|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44378754|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44378755|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44378756|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44378757|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
44378758|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378759|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378760|NCT04075513|Insulin|insulin|mesh-list
44378761|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44378762|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
44378763|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
44378764|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44378765|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378766|NCT04074161|Liraglutide|liraglutide|mesh-list
44378767|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44378768|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878528|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
43878529|NCT04685031|Hormones|hormones|mesh-ancestor
43878530|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878531|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878532|NCT04685005|Caffeine|caffeine|mesh-list
43878533|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43878534|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878535|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43878536|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878537|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878538|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43878539|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43878540|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
43878541|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878542|NCT04684667|Propranolol|propranolol|mesh-list
43878543|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43878544|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43878545|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878546|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878547|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878548|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878549|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43878550|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878551|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
43878552|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43878553|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44382396|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878554|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878555|NCT04684199|Melatonin|melatonin|mesh-list
43878556|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
43878557|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878558|NCT04684199|Protective Agents|protective agents|mesh-ancestor
43878559|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878560|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878561|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
43878562|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878563|NCT04684498|Oseltamivir|oseltamivir|mesh-list
43878564|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
44378769|NCT04074161|Incretins|incretins|mesh-ancestor
44378770|NCT04074161|Hormones|hormones|mesh-ancestor
44378771|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378772|NCT04072835|Etripamil|etripamil|mesh-list
44378773|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44378774|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378775|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378776|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44378777|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378778|NCT04068753|Niraparib|niraparib|mesh-list
44378779|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44378780|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378781|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378782|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378783|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
44378784|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44378785|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378786|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378787|NCT04067518|Pegaspargase|pegaspargase|mesh-list
44378788|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378789|NCT04067492|Diclofenac|diclofenac|mesh-list
44378790|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44378791|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44378792|NCT04067492|Analgesics|analgesics|mesh-ancestor
44378793|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
44378794|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378795|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378796|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378797|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44378798|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44378799|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034866|NCT00002217|Lamivudine|lamivudine|mesh-list
43686827|NCT02824601|Calcium|calcium|mesh-list
43878565|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878566|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878567|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878568|NCT04684017|Carboplatin|carboplatin|mesh-list
43878569|NCT04684017|Etoposide|etoposide|mesh-list
43878570|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878571|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44378800|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378802|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
44378803|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378804|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378805|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
44378806|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44378807|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44378808|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44378809|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44378810|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378811|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378812|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378813|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44378814|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44378815|NCT04060654|Buprenorphine|buprenorphine|mesh-list
43851619|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378816|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44378817|NCT04060654|Narcotics|narcotics|mesh-ancestor
44378818|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878572|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878573|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878574|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878579|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878580|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
43878581|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
43878582|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
43878583|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878584|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
43878585|NCT04683445|Trastuzumab|trastuzumab|mesh-list
43878586|NCT04683445|Pertuzumab|pertuzumab|mesh-list
43878587|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878588|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878589|NCT04683406|Oseltamivir|oseltamivir|mesh-list
43878590|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
43878591|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878592|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878593|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878594|NCT04683341|Tenofovir|tenofovir|mesh-list
43878595|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
43878596|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878597|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43878598|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43878599|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878600|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878601|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43614525|NCT03620578|Nivolumab|nivolumab|mesh-list
43878602|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43878603|NCT04683198|Carboplatin|carboplatin|mesh-list
43878604|NCT04683198|Etoposide|etoposide|mesh-list
43878605|NCT04683198|Apatinib|apatinib|mesh-list
43878606|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878607|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878608|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878609|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878610|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878611|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378819|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378820|NCT04060654|Analgesics|analgesics|mesh-ancestor
44378821|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
44378822|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378823|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44378824|NCT04058353|Ivacaftor|ivacaftor|mesh-list
44378825|NCT04058353|Elexacaftor|elexacaftor|mesh-list
44378826|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44378827|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378828|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378829|NCT04054193|Dexamethasone|dexamethasone|mesh-list
44378830|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
44378831|NCT04054193|Aprepitant|aprepitant|mesh-list
44378832|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
44378833|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378834|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
44378835|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
44378836|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378837|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378838|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378839|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
44378840|NCT04054193|Hormones|hormones|mesh-ancestor
44378841|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378842|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44378843|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378844|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44378845|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378846|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378847|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44378848|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
44378849|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
44378861|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44378862|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378863|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378864|NCT04052204|Avelumab|avelumab|mesh-list
44378865|NCT04052204|Talazoparib|talazoparib|mesh-list
44378866|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378867|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378868|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44378869|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378870|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378871|NCT04052139|Naltrexone|naltrexone|mesh-list
44378872|NCT04052139|Gabapentin|gabapentin|mesh-list
44378873|NCT04052139|Analgesics|analgesics|mesh-ancestor
44034937|NCT00002225|Efavirenz|efavirenz|mesh-list
44378875|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378876|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378877|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
44378878|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44378879|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44378880|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378881|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44378882|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44378883|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44378884|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382397|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
44378885|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378886|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
44378887|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44378888|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44378889|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
44378890|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44378891|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
44378892|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878612|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878613|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43878614|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878615|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43878616|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43878617|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43878618|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878619|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878620|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878621|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378894|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378895|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
44378896|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
44378897|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378898|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378899|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378900|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
44378901|NCT04050865|Hormones|hormones|mesh-ancestor
44378902|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378903|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44378904|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378905|NCT04050722|Listerine|listerine|mesh-list
44378906|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
44378907|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
44378908|NCT04050722|Protective Agents|protective agents|mesh-ancestor
43828905|NCT05464173|Fulvestrant|fulvestrant|mesh-list
43878622|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
43878623|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43878624|NCT04683146|Propranolol|propranolol|mesh-list
43878625|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43878626|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878627|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
43878628|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43878629|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43878630|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43878631|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878632|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650112|NCT03016806|Mesna|mesna|mesh-list
43666080|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878633|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878634|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878635|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43669938|NCT02900157|Durvalumab|durvalumab|mesh-list
43878636|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878637|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
43878638|NCT04683237|Liraglutide|liraglutide|mesh-list
43878639|NCT04683237|Megestrol|megestrol|mesh-list
43878640|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
43878641|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878642|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878643|NCT04683237|Incretins|incretins|mesh-ancestor
43878644|NCT04683237|Hormones|hormones|mesh-ancestor
43878654|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878655|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
43878656|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44136223|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136224|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136225|NCT00163761|Antiviral Agents|antiviral agents|mesh-ancestor
44136226|NCT00163761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136227|NCT00163761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136228|NCT00163761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136229|NCT00163761|Immunologic Factors|immunologic factors|mesh-ancestor
44136230|NCT00163761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878658|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
43878659|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878660|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43878661|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43878662|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43878663|NCT04682691|Erythromycin|erythromycin|mesh-list
43878664|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
43878665|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44378909|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378910|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44378911|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378912|NCT04050371|Tenofovir|tenofovir|mesh-list
44378913|NCT04050371|Emtricitabine|emtricitabine|mesh-list
44378914|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
44378915|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378916|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44378917|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44378918|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378919|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378920|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44378921|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44378922|NCT04049552|Sirolimus|sirolimus|mesh-list
44378923|NCT04049552|Petrolatum|petrolatum|mesh-list
44378924|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44378925|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44378926|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44378927|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878666|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
43878667|NCT04682691|Metoclopramide|metoclopramide|mesh-list
43878668|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
43878669|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
43878670|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878671|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878672|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43878673|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43851622|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666088|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878674|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43878675|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
43666092|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
43878676|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878677|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878678|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878679|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878680|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43878681|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878682|NCT04682795|Insulin|insulin|mesh-list
43878683|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878684|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878685|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43878686|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43878687|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878688|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
43878689|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
43878690|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43878691|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43878693|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
43878694|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43878695|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
43878696|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
43878697|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878698|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
43878699|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
43878700|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878713|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43878714|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878715|NCT04682249|Apatinib|apatinib|mesh-list
43878716|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378928|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
44378929|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44378930|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
44378931|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378932|NCT04049552|Emollients|emollients|mesh-ancestor
44378933|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
44378934|NCT04048681|Cocaine|cocaine|mesh-list
44378935|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
44378936|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
43614610|NCT03498521|Ivosidenib|ivosidenib|mesh-list
43614611|NCT03498521|Entrectinib|entrectinib|mesh-list
43614612|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614613|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614614|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614615|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43614616|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43614617|NCT03498521|Growth Substances|growth substances|mesh-ancestor
43614618|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614619|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
43614620|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614621|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
44378937|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378938|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378939|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
44378940|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378941|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43686949|NCT02823912|Capsaicin|capsaicin|mesh-list
43878717|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878718|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878719|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878720|NCT04682184|Propranolol|propranolol|mesh-list
43878721|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
43878722|NCT04682184|Ephedrine|ephedrine|mesh-list
43878723|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43878724|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43878725|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878726|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878727|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878728|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878729|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43878730|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43614663|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614664|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
43878731|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
43878732|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43878733|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
43878734|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878735|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43878736|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
43878737|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
43878738|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43878739|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43614665|NCT03324113|Hormones|hormones|mesh-ancestor
43614666|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614667|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614668|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614669|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43614670|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43614671|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43614672|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43614673|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43614674|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
43614675|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
43650117|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43878740|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
43878742|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878743|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878744|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43878745|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43878746|NCT04682210|Growth Substances|growth substances|mesh-ancestor
43878747|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878748|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
43878749|NCT04682132|Antibodies|antibodies|mesh-list
43878750|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
43878751|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878752|NCT04681820|HH-GV-678|hh-gv-678|mesh-list
43878753|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878754|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878755|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878756|NCT04681911|Gemcitabine|gemcitabine|mesh-list
43878757|NCT04681911|Paclitaxel|paclitaxel|mesh-list
43878758|NCT04681911|Vinorelbine|vinorelbine|mesh-list
43878759|NCT04681911|Carboplatin|carboplatin|mesh-list
43878760|NCT04681911|Capecitabine|capecitabine|mesh-list
43878761|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878762|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878763|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44378942|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44378943|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44378944|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44378945|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378947|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44378948|NCT04047446|Dexamethasone|dexamethasone|mesh-list
44378949|NCT04047446|Bupivacaine|bupivacaine|mesh-list
44378950|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44378951|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
44378952|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
44378953|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44378954|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378955|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44378956|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
44378957|NCT04047446|Hormones|hormones|mesh-ancestor
44378958|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44378959|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44378960|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378961|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
44378962|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
44378963|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378964|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
44378965|NCT04046939|Pramipexole|pramipexole|mesh-list
44378966|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
44378967|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650132|NCT03016793|Puerarin|puerarin|mesh-list
44378968|NCT04046939|Protective Agents|protective agents|mesh-ancestor
44378969|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378970|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44378971|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44378972|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
44378973|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
44378974|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878764|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
43878781|NCT04680884|Clotrimazole|clotrimazole|mesh-list
43878782|NCT04680884|Miconazole|miconazole|mesh-list
43878783|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878784|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43878785|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43878786|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43878787|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702471|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44378977|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
44378978|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44378979|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
44378980|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378981|NCT04036110|Protective Agents|protective agents|mesh-ancestor
44378982|NCT04035473|Paclitaxel|paclitaxel|mesh-list
44378983|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44378984|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378985|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44378986|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44378987|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44378988|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378989|NCT04034238|Tofacitinib|tofacitinib|mesh-list
44378990|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43878788|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878789|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43878790|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
43878791|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878792|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878793|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43878794|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43878795|NCT04680962|Rituximab|rituximab|mesh-list
43878796|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878797|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878798|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
43878799|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878800|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43878801|NCT04681027|Oxymorphone|oxymorphone|mesh-list
43878802|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43878803|NCT04681027|Narcotics|narcotics|mesh-ancestor
43878804|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878805|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878806|NCT04681027|Analgesics|analgesics|mesh-ancestor
43878807|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
43650136|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43878808|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878809|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43878810|NCT04681053|Ivermectin|ivermectin|mesh-list
43878811|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43878812|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878813|NCT04680923|Bupivacaine|bupivacaine|mesh-list
43878814|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43878815|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
43878816|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878817|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878818|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
43878819|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878820|NCT04680819|Propolis|propolis|mesh-list
43878821|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878822|NCT04680650|Anesthetics|anesthetics|mesh-list
43878831|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43878832|NCT04680221|Bupivacaine|bupivacaine|mesh-list
43878833|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
43878834|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
43878835|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878836|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878837|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
44378991|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44378992|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44378993|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
44378994|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44378995|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44378996|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
44378997|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44378998|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
44378999|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379000|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379001|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
44379002|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650149|NCT03016650|Ibuprofen|ibuprofen|mesh-list
44379003|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
44379004|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44379005|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
44379006|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379007|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379008|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
44379009|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379010|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
44379011|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44379012|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379013|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379014|NCT04024891|Phentolamine|phentolamine|mesh-list
44379015|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44379016|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44379017|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44379018|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44379019|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379020|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379021|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379022|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379023|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43878838|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878839|NCT04680091|Efavirenz|efavirenz|mesh-list
43878840|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878841|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878842|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43878843|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43878844|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
44379024|NCT04024228|Vaccines|vaccines|mesh-list
44379025|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
44379026|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
44379027|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379028|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
44379029|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
44379030|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44379031|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379032|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
44379033|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
44379034|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44379035|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44379036|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44379037|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379038|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
44379039|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379040|NCT04018612|Acetaminophen|acetaminophen|mesh-list
44379041|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379042|NCT04018612|Analgesics|analgesics|mesh-ancestor
44379043|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
44379044|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379045|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379046|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
44379047|NCT04016779|Viloxazine|viloxazine|mesh-list
44379048|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44379049|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44379050|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379051|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44379052|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44379053|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379054|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379055|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
43878845|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878846|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43878847|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43878848|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43878849|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43878850|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43666147|NCT04388852|Ipilimumab|ipilimumab|mesh-list
43878851|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43878852|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
43878853|NCT04680143|Hematinics|hematinics|mesh-ancestor
44136231|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136232|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44379056|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379057|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379058|NCT04014075|Trastuzumab|trastuzumab|mesh-list
44379059|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379060|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379061|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
44379062|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44379063|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
44379064|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379065|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379066|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44379067|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379068|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
44379069|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44379070|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379071|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379072|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379073|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44379074|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44379075|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44379076|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
44379077|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379079|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379080|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44379081|NCT04009577|Lemborexant|lemborexant|mesh-list
44379082|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44379083|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379084|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379085|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44379086|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44379087|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379088|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614719|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
43614720|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614721|NCT03278106|Trifluridine|trifluridine|mesh-list
43614722|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
43614723|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614724|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
43614725|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666167|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666171|NCT04355143|Colchicine|colchicine|mesh-list
44379089|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44136233|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136234|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136235|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44379090|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
44379091|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379092|NCT04004442|Avelumab|avelumab|mesh-list
44379093|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379094|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379095|NCT04004208|Aflibercept|aflibercept|mesh-list
44379096|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44379097|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44379098|NCT04004208|Growth Substances|growth substances|mesh-ancestor
44379099|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379100|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
44379101|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379102|NCT04003610|Gemcitabine|gemcitabine|mesh-list
44379103|NCT04003610|Carboplatin|carboplatin|mesh-list
44379104|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
44379105|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136236|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
44155795|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44155796|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155797|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155798|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44155799|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
44155800|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
44155801|NCT00228319|Vitamins|vitamins|mesh-list
44155802|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
44155803|NCT00228319|Vitamin E|vitamin e|mesh-list
44155804|NCT00228319|Vitamin A|vitamin a|mesh-list
44155805|NCT00228319|Carboplatin|carboplatin|mesh-list
44155806|NCT00228319|Carotenoids|carotenoids|mesh-list
44155807|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155808|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155809|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
44155810|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155811|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
44155812|NCT00228319|Protective Agents|protective agents|mesh-ancestor
44155813|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
44155814|NCT00228358|Interleukin-2|interleukin-2|mesh-list
44155815|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
44155816|NCT00228358|Immunotoxins|immunotoxins|mesh-list
44155817|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155818|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
43878854|NCT04680208|Anesthetics|anesthetics|mesh-list
43878855|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878856|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878857|NCT04679948|Midazolam|midazolam|mesh-list
43878858|NCT04679948|Caffeine|caffeine|mesh-list
43878859|NCT04679948|Omeprazole|omeprazole|mesh-list
43878860|NCT04679948|Warfarin|warfarin|mesh-list
43878861|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43878873|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878874|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878875|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
43878876|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43878877|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43878878|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43878879|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878880|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43878881|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43878882|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43878883|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43878884|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
43878885|NCT04680286|Methadone|methadone|mesh-list
43878886|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44379106|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44379107|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
44382398|NCT03600805|Hormones|hormones|mesh-ancestor
44379108|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379109|NCT04003610|Antiviral Agents|antiviral agents|mesh-ancestor
44379110|NCT04003610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379111|NCT04003610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379112|NCT04003610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44379113|NCT04003610|Immunologic Factors|immunologic factors|mesh-ancestor
44379114|NCT04003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379115|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379116|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44379117|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
44379118|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379119|NCT04000009|Pimavanserin|pimavanserin|mesh-list
44379120|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43614732|NCT03258853|Pancrelipase|pancrelipase|mesh-list
44379121|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44379122|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44379123|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379124|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379125|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379126|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379127|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44379128|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44379129|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
44379130|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379131|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379132|NCT03999554|Vaccines|vaccines|mesh-list
44379133|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
44379134|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379135|NCT03996694|Oxycodone|oxycodone|mesh-list
44379136|NCT03996694|Buprenorphine|buprenorphine|mesh-list
43687066|NCT02822729|Timolol|timolol|mesh-list
43878887|NCT04680286|Narcotics|narcotics|mesh-ancestor
43878888|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878889|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878890|NCT04680286|Analgesics|analgesics|mesh-ancestor
43878891|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
43878892|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878893|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
43878894|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
43878895|NCT04679740|Sirolimus|sirolimus|mesh-list
43878896|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878897|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379137|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44379138|NCT03996694|Narcotics|narcotics|mesh-ancestor
43614733|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614760|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
43614761|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
43614762|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614763|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
44379139|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379140|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379141|NCT03996694|Analgesics|analgesics|mesh-ancestor
44379142|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
44379143|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379144|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44379145|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44379146|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44379147|NCT03993392|Buprenorphine|buprenorphine|mesh-list
44379148|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44379149|NCT03993392|Narcotics|narcotics|mesh-ancestor
44379150|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379151|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379152|NCT03993392|Analgesics|analgesics|mesh-ancestor
44379153|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
44379154|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379155|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44379156|NCT03993379|Ipilimumab|ipilimumab|mesh-list
44379157|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379158|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379159|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44379160|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379161|NCT03993288|Iron|iron|mesh-list
44379162|NCT03993288|Trace Elements|trace elements|mesh-ancestor
43614770|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43614771|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614772|NCT03043599|Nivolumab|nivolumab|mesh-list
43614773|NCT03043599|Ipilimumab|ipilimumab|mesh-list
44379163|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
44379164|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379185|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44379186|NCT03988842|Plasminogen|plasminogen|mesh-list
44379187|NCT03988842|Apixaban|apixaban|mesh-list
44379188|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
44379189|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44379190|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44379191|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379192|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44379193|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
44379194|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44379195|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
44379196|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379197|NCT03988803|Memantine|memantine|mesh-list
44379198|NCT03988803|BI 425809|bi 425809|mesh-list
44379199|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44379200|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43878898|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43878899|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878900|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
43878901|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878902|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
43878903|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614825|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614826|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614827|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43650151|NCT03016650|Analgesics|analgesics|mesh-ancestor
43650152|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
43650153|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650154|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650155|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
43650156|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43614828|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614829|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614865|NCT02794571|Cisplatin|cisplatin|mesh-list
43614866|NCT02794571|Carboplatin|carboplatin|mesh-list
43614867|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
43614868|NCT02794571|Capecitabine|capecitabine|mesh-list
43614869|NCT02794571|Pemetrexed|pemetrexed|mesh-list
43614870|NCT02794571|Atezolizumab|atezolizumab|mesh-list
43878904|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
43614893|NCT02769689|Prednisolone|prednisolone|mesh-list
43614894|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
43878905|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43878906|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878907|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
43878908|NCT04680195|Thalidomide|thalidomide|mesh-list
43878909|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878910|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
43878911|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878912|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
43878913|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43878914|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878915|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43878916|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43878917|NCT04680195|Growth Substances|growth substances|mesh-ancestor
43878918|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
43878919|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878920|NCT04679597|Capecitabine|capecitabine|mesh-list
43878921|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
43878922|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878923|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
43878924|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878925|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878926|NCT04679506|Cytarabine|cytarabine|mesh-list
43878927|NCT04679506|Etoposide|etoposide|mesh-list
43878934|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878935|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878938|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878939|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878940|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
43878941|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878942|NCT04679142|Baclofen|baclofen|mesh-list
43878943|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43878944|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878945|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43878946|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878947|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43878948|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
43878949|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
44379201|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
44379202|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379203|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379204|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614910|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614911|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
43614912|NCT02639026|Durvalumab|durvalumab|mesh-list
43614913|NCT02639026|Tremelimumab|tremelimumab|mesh-list
43614914|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614915|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614916|NCT02521311|Clemastine|clemastine|mesh-list
43614917|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
43614918|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
43614919|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43614920|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
43614921|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
43614922|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379205|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44379206|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44379207|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
44379209|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44379210|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
44379211|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379212|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379213|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379214|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
44379215|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
44379216|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379217|NCT03987191|Insulin|insulin|mesh-list
44379218|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
44379219|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44379220|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379221|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379222|NCT03987074|Firsocostat|firsocostat|mesh-list
44379223|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379224|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379225|NCT03982069|Vaccines|vaccines|mesh-list
44379226|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
44379227|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878950|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43878951|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878952|NCT04679064|Gemcitabine|gemcitabine|mesh-list
43878953|NCT04679064|Paclitaxel|paclitaxel|mesh-list
43878954|NCT04679064|Bevacizumab|bevacizumab|mesh-list
43878955|NCT04679064|Doxorubicin|doxorubicin|mesh-list
43878956|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43878957|NCT04679064|Topotecan|topotecan|mesh-list
43878958|NCT04679064|Niraparib|niraparib|mesh-list
43878959|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878960|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878961|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
43878962|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
43878963|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
43878964|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878965|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43878966|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43878967|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43878968|NCT04679064|Growth Substances|growth substances|mesh-ancestor
44379231|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614965|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43614966|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
43614999|NCT02037126|Psilocybin|psilocybin|mesh-list
43615000|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43615001|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43615002|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615003|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615004|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43615005|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
43615006|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
43615007|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615008|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
43849383|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43849384|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43849385|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
43615024|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615025|NCT01938001|Rituximab|rituximab|mesh-list
44379232|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44379233|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44379234|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379235|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44379236|NCT03981861|Diuretics|diuretics|mesh-ancestor
44379237|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
44379238|NCT03981822|Cantharidin|cantharidin|mesh-list
44035384|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
44379239|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379240|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379241|NCT03980522|Rilonacept|rilonacept|mesh-list
44379242|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379243|NCT03979820|Phenelzine|phenelzine|mesh-list
44379244|NCT03979820|Tyramine|tyramine|mesh-list
44379245|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
44379246|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379247|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44379248|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687134|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
43878969|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878970|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
43878971|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878972|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
43878973|NCT04679064|Antiviral Agents|antiviral agents|mesh-ancestor
43878974|NCT04679064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878975|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878976|NCT04679064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878977|NCT04679064|Immunologic Factors|immunologic factors|mesh-ancestor
43878978|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43878979|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878980|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878981|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43878982|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43878983|NCT04679103|Eculizumab|eculizumab|mesh-list
43878984|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43878985|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878986|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
43878987|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878988|NCT04678830|Leronlimab|leronlimab|mesh-list
43878989|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43878990|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43878991|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878992|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43878993|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43878994|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
43878995|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878996|NCT04678791|Cisplatin|cisplatin|mesh-list
43878997|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
44379261|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
44379262|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379263|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379264|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379265|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44379266|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379267|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379268|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379269|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44379270|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
44379271|NCT03978091|Ceftazidime|ceftazidime|mesh-list
44379272|NCT03978091|Avibactam|avibactam|mesh-list
44379273|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44379274|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879026|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
43879027|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43879028|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879029|NCT04678076|Ketoprofen|ketoprofen|mesh-list
43879030|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
43879031|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43879032|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879033|NCT04678076|Analgesics|analgesics|mesh-ancestor
43879034|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
43879035|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379275|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379276|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44379277|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379278|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379279|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
44379280|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379281|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379282|NCT03977454|Ropivacaine|ropivacaine|mesh-list
44379283|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
44379284|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
44379285|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379286|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379287|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
44379288|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379289|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44379290|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44379291|NCT03976466|Calcium|calcium|mesh-list
44379292|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44379293|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379294|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379295|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
44379296|NCT03972137|Nicotine|nicotine|mesh-list
44379297|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44379298|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
44379299|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379300|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379301|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44379302|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44379303|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379304|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379305|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379306|NCT03970824|Adalimumab|adalimumab|mesh-list
44379307|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379308|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379309|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44379310|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
43879036|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879037|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379312|NCT03968159|Pimavanserin|pimavanserin|mesh-list
43615026|NCT01938001|Lenalidomide|lenalidomide|mesh-list
44379313|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44379314|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44379315|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44379316|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379317|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379318|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379319|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379320|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44379321|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44379323|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379324|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379325|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
44379326|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44379327|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
44379328|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379329|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
44379330|NCT03967444|Protective Agents|protective agents|mesh-ancestor
44379331|NCT03966807|Nicotine|nicotine|mesh-list
44379332|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44379333|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
44379334|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379335|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379336|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44379337|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44379338|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379339|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379340|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379341|NCT03966365|Timolol|timolol|mesh-list
44379342|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44379343|NCT03966365|Dorzolamide|dorzolamide|mesh-list
44379344|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44379345|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44379346|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379347|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879038|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879039|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44379348|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379349|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379350|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44379351|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379352|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44379353|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44379354|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44379355|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44379356|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379357|NCT03965351|Probenecid|probenecid|mesh-list
44379358|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
44379359|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
44379360|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379361|NCT03965351|Renal Agents|renal agents|mesh-ancestor
44379362|NCT03965052|Travoprost|travoprost|mesh-list
44379363|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44379364|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44379365|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379366|NCT03963401|PF-06700841|pf-06700841|mesh-list
44379367|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44379368|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379369|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379370|NCT03962738|Lasmiditan|lasmiditan|mesh-list
44379371|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44379372|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
44379373|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379374|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379375|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379376|NCT03961308|Vedolizumab|vedolizumab|mesh-list
44379377|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44379378|NCT03959423|Insulin|insulin|mesh-list
44379379|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379390|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035532|NCT00002290|Zidovudine|zidovudine|mesh-list
44379391|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44379392|NCT03955471|Niraparib|niraparib|mesh-list
44379393|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44379394|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379395|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379396|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379397|NCT03954834|Tirzepatide|tirzepatide|mesh-list
44379398|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379399|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379400|NCT03954834|Incretins|incretins|mesh-ancestor
44379401|NCT03954834|Hormones|hormones|mesh-ancestor
44379402|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379403|NCT03954444|Phenylephrine|phenylephrine|mesh-list
44379404|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
44379405|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44379406|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44379407|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379408|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379409|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379410|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379411|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
44379412|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
44379413|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379414|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
44379415|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44379416|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379417|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44379418|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
43687228|NCT02821390|Nepafenac|nepafenac|mesh-list
43879040|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879041|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879042|NCT04677985|Analgesics|analgesics|mesh-list
43879043|NCT04677985|Menthol|menthol|mesh-list
43879044|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
43879045|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879046|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879047|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
43879048|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
43879049|NCT04677868|Methotrexate|methotrexate|mesh-list
43879050|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43879051|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
43879052|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43594990|NCT03328936|Melphalan|melphalan|mesh-list
44379419|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44379420|NCT03954444|Protective Agents|protective agents|mesh-ancestor
44379421|NCT03953820|Diazepam|diazepam|mesh-list
44379422|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44379423|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
44379424|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
44379425|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
44379426|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379427|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379428|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44379429|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44379430|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379431|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44379432|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44379433|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44379434|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379435|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379436|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44379437|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
44379438|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
44379439|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
44379440|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
44379441|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379442|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379443|NCT03952650|Chloroquine|chloroquine|mesh-list
44379444|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44379445|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
44379446|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44379447|NCT03952650|Ibuprofen|ibuprofen|mesh-list
44379448|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44379449|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379450|NCT03952650|Analgesics|analgesics|mesh-ancestor
44379451|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
44379455|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379461|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44379462|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035612|NCT00002300|Megestrol|megestrol|mesh-list
44379463|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
44379464|NCT03952650|Filaricides|filaricides|mesh-ancestor
44379465|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
44379466|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
44379467|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44379469|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44379470|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
44379471|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
44379472|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379473|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379474|NCT03951805|Insulin|insulin|mesh-list
44379475|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44379476|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
44379477|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379478|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379479|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44379480|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
44379481|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379482|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44379483|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
44379484|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379485|NCT03948581|Vedolizumab|vedolizumab|mesh-list
44379486|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44379487|NCT03946124|Fesoterodine|fesoterodine|mesh-list
44379488|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44379489|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44379490|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379491|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379492|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379493|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379494|NCT03946124|Urological Agents|urological agents|mesh-ancestor
44379495|NCT03945981|Lamivudine|lamivudine|mesh-list
44379496|NCT03945981|Dolutegravir|dolutegravir|mesh-list
44379497|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44379498|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43879053|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379499|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379500|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379501|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
44379502|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379503|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44379504|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44379505|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44379506|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44379508|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
44379509|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
44379510|NCT03943095|Protective Agents|protective agents|mesh-ancestor
44379511|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379512|NCT03942042|Ixekizumab|ixekizumab|mesh-list
44379513|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379514|NCT03938857|Fentanyl|fentanyl|mesh-list
44379515|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
44379516|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44379517|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379518|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379519|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379520|NCT03938857|Analgesics|analgesics|mesh-ancestor
44379521|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
44379522|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879054|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43879055|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
43615086|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879056|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879057|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879058|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
43879061|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879062|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
43879063|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879064|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44136238|NCT00163969|Analgesics|analgesics|mesh-ancestor
44136239|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
44136240|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136241|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136242|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44136243|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44136244|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
44136245|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
44136246|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136247|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44136248|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44136249|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136250|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136251|NCT00163982|Norfloxacin|norfloxacin|mesh-list
44136252|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136253|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615098|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44136254|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43879066|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44379523|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44379524|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44379525|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44379526|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379527|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379528|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379529|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44379530|NCT03938857|Narcotics|narcotics|mesh-ancestor
44379531|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44379532|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44379533|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
44379534|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
44379535|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
44379536|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43879067|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43879068|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
43879069|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879070|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43879071|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43879072|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879073|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
43879074|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879075|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879076|NCT04676997|Paclitaxel|paclitaxel|mesh-list
43879077|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
43879078|NCT04676997|Epirubicin|epirubicin|mesh-list
43879079|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879080|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879081|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
43879082|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879083|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879084|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879085|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879086|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
43879087|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879088|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879089|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43879090|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
43879091|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43879092|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43879093|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43879094|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43879095|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879096|NCT04676763|Histamine|histamine|mesh-list
43879097|NCT04676763|Substance P|substance p|mesh-list
43879098|NCT04676763|Neurokinin A|neurokinin a|mesh-list
43615189|NCT03160261|Exenatide|exenatide|mesh-list
43879099|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
43879100|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
43879101|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879102|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879103|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879104|NCT04676789|Pegaspargase|pegaspargase|mesh-list
43879105|NCT04676789|Antibodies|antibodies|mesh-list
43879106|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43879107|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
43879108|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879109|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879110|NCT04676659|Tenecteplase|tenecteplase|mesh-list
43879111|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43879112|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43879113|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379537|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
44379538|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379539|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379540|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44379541|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379542|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
44379543|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44379544|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379545|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379546|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379547|NCT03934541|Vaccines|vaccines|mesh-list
44379548|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
44379549|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379550|NCT03933449|Paclitaxel|paclitaxel|mesh-list
44379551|NCT03933449|Docetaxel|docetaxel|mesh-list
44379552|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
44379553|NCT03933449|Irinotecan|irinotecan|mesh-list
44379554|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44379555|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379556|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44379557|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44379558|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44379559|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379560|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379561|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44379562|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44379563|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379564|NCT03927950|Citalopram|citalopram|mesh-list
44379565|NCT03927950|Bupropion|bupropion|mesh-list
44379566|NCT03927950|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44379567|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44379568|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379569|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379570|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379571|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
43879114|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
43879119|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43879120|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
43615314|NCT03153436|Inositol|inositol|mesh-list
43879121|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43879122|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379573|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44379574|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
44379575|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379576|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44379577|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
44379578|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44379579|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44379580|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379581|NCT03927911|Bupivacaine|bupivacaine|mesh-list
44379582|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
44379583|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
44379584|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379585|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379586|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
44379587|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379589|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44379590|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379591|NCT03927144|Analgesics|analgesics|mesh-ancestor
44379592|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
44379593|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379594|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879123|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43879124|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43879125|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43879126|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43879127|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
43879128|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43879129|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43879130|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
43615320|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
43650172|NCT03016442|Dinoprostone|dinoprostone|mesh-list
43650173|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
43615357|NCT03149653|SMOFlipid|smoflipid|mesh-list
43879131|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879132|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
43879133|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43879134|NCT04676139|Fluoxetine|fluoxetine|mesh-list
43879135|NCT04676139|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43879136|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43879137|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879138|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879139|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879140|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
43879141|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879142|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43879143|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
43879144|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379596|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
44379597|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379598|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
44379599|NCT03923933|Bumetanide|bumetanide|mesh-list
44379600|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379601|NCT03923933|Diuretics|diuretics|mesh-ancestor
44379602|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
44379603|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379604|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44379605|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379606|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035741|NCT00002315|Acyclovir|acyclovir|mesh-list
44379607|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44379608|NCT03923530|Eplerenone|eplerenone|mesh-list
44379609|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44379610|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
43879145|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43879146|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43879147|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879148|NCT04676061|Norethindrone|norethindrone|mesh-list
43879149|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
43615375|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
43879150|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43879151|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43879152|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43879153|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
43879154|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43879155|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879156|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43879157|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43879158|NCT04676035|Vitamin K|vitamin k|mesh-list
43879159|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
43879160|NCT04676035|Midazolam|midazolam|mesh-list
43879161|NCT04676035|Omeprazole|omeprazole|mesh-list
43879162|NCT04676035|Warfarin|warfarin|mesh-list
43879163|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43879164|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879165|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879166|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879167|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43879168|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43879169|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879170|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43879171|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
43879172|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
43879173|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
43879174|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
43879175|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879176|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879177|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
43879178|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43879179|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43879180|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43879181|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879182|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43879188|NCT04675944|Treprostinil|treprostinil|mesh-list
43879189|NCT04675944|Zamicastat|zamicastat|mesh-list
43879190|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379611|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379612|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379613|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44379614|NCT03923530|Diuretics|diuretics|mesh-ancestor
44379615|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
44379616|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379618|NCT03922945|Phentermine|phentermine|mesh-list
44379619|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
44379620|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379621|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379622|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44379623|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
44379624|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44379625|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
44379626|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
44379627|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379628|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379629|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379630|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379631|NCT03922477|Atezolizumab|atezolizumab|mesh-list
44379632|NCT03922477|Magrolimab|magrolimab|mesh-list
43615426|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44379633|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379634|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379635|NCT03921723|Dolutegravir|dolutegravir|mesh-list
44379636|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44379637|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44379638|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379639|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379656|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44379657|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44379658|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44379659|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
44379660|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44379661|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44379662|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
44379663|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44379664|NCT03920293|Ravulizumab|ravulizumab|mesh-list
44379665|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44379666|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44379667|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
44379668|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379669|NCT03920215|Varenicline|varenicline|mesh-list
44379670|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44379671|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44379672|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379673|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379674|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379675|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379676|NCT03917472|Aflibercept|aflibercept|mesh-list
44379677|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44379678|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44379679|NCT03917472|Growth Substances|growth substances|mesh-ancestor
44379680|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379681|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44379682|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379683|NCT03914417|Imiquimod|imiquimod|mesh-list
44379684|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44379685|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
44379686|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379687|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379688|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
44379689|NCT03912337|Erenumab|erenumab|mesh-list
44379695|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379696|NCT03912259|Emollients|emollients|mesh-list
44379697|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379698|NCT03911843|Vitamin D|vitamin d|mesh-list
44379699|NCT03911843|Vitamins|vitamins|mesh-ancestor
44379700|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
44379701|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379702|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44379703|NCT03909295|Valsartan|valsartan|mesh-list
43650177|NCT03016260|Etanercept|etanercept|mesh-list
43650178|NCT03016260|Golimumab|golimumab|mesh-list
43650179|NCT03016260|Infliximab|infliximab|mesh-list
44379704|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44379705|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44379706|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44379707|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44379708|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379709|NCT03905642|Amikacin|amikacin|mesh-list
44379710|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44379711|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379712|NCT03905135|Avelumab|avelumab|mesh-list
44379713|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379714|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379715|NCT03905096|Donepezil|donepezil|mesh-list
44379716|NCT03905096|BI 425809|bi 425809|mesh-list
44379717|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44379718|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379719|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379720|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379721|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379722|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379723|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
44379739|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379740|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44379741|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44379742|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
44379743|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44379744|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44379745|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
44379747|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
44379748|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379749|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379750|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379751|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
44379752|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
44379753|NCT03896477|Vaccines|vaccines|mesh-list
44379754|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44379755|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
44379756|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379757|NCT03895840|Triamcinolone|triamcinolone|mesh-list
44379758|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44379759|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44379760|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43879191|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879192|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879193|NCT04675697|Etoposide|etoposide|mesh-list
43879194|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879195|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879196|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43879197|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43879198|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615475|NCT03148561|Misoprostol|misoprostol|mesh-list
43615476|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43879199|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879200|NCT04676126|Dorzolamide|dorzolamide|mesh-list
43879201|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43669993|NCT02899364|Antidotes|antidotes|mesh-ancestor
43879202|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43879203|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879204|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879205|NCT04675619|Pirfenidone|pirfenidone|mesh-list
43879206|NCT04675619|Analgesics|analgesics|mesh-ancestor
43879207|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
43879208|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879209|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879210|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43879211|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879212|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879213|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879214|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879215|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43879216|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43879217|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379761|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379762|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
44379763|NCT03895840|Hormones|hormones|mesh-ancestor
44379764|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379765|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379766|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44379767|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
44379768|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379769|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379770|NCT03894969|Vaccines|vaccines|mesh-list
44379771|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
44379772|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379773|NCT03894813|Metronidazole|metronidazole|mesh-list
44379774|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379775|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44379776|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44379777|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44379778|NCT03894540|Paclitaxel|paclitaxel|mesh-list
44379779|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
44379780|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44379781|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379782|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
43615507|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615508|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615509|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43615510|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379783|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
44379784|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879218|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879219|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
43879220|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879221|NCT04675528|Paclitaxel|paclitaxel|mesh-list
43879222|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879223|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879224|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
43879225|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879226|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879227|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879228|NCT04675177|Polidocanol|polidocanol|mesh-list
43879229|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43879230|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43879231|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
43879232|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43879233|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
43879234|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879235|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
43879236|NCT04675385|Protective Agents|protective agents|mesh-ancestor
43879237|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
43879238|NCT04675086|Remdesivir|remdesivir|mesh-list
43879239|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
43879240|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43879241|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879242|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
43879243|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879244|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879245|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43879246|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44379785|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379786|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379787|NCT03892889|Aripiprazole|aripiprazole|mesh-list
44379788|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
44379789|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44379790|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44379791|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44379792|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379793|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379794|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
44379795|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
44379796|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379797|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379798|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44379799|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44379800|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
44379801|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44379802|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44379803|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44379804|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44379805|NCT03892707|Folic Acid|folic acid|mesh-list
44379806|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
44379807|NCT03892707|Celecoxib|celecoxib|mesh-list
44379808|NCT03892707|Etoricoxib|etoricoxib|mesh-list
44379809|NCT03892707|Meloxicam|meloxicam|mesh-list
43879247|NCT04675372|Midazolam|midazolam|mesh-list
43879248|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
43650194|NCT03016234|Propofol|propofol|mesh-list
43879249|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879250|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879251|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879252|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879253|NCT04675372|Analgesics|analgesics|mesh-ancestor
43879265|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879266|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43879267|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
43879268|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
43879269|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
43879270|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
43879271|NCT04674956|Gemcitabine|gemcitabine|mesh-list
43879272|NCT04674956|Paclitaxel|paclitaxel|mesh-list
43879273|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879274|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879275|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
43879276|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879277|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879278|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879279|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43879280|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
43879281|NCT04674956|Antiviral Agents|antiviral agents|mesh-ancestor
43879282|NCT04674956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879283|NCT04674956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379810|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44379812|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44379813|NCT03892707|Benphothiamine|benphothiamine|mesh-list
44379814|NCT03892707|Vitamins|vitamins|mesh-ancestor
44379815|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
44379816|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379817|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379818|NCT03892707|Analgesics|analgesics|mesh-ancestor
44379819|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
44379820|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379821|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379822|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44379823|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44379824|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379825|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379826|NCT03892707|Hematinics|hematinics|mesh-ancestor
44379827|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44379828|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
44379829|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
44379830|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
44379831|NCT03891264|Cannabidiol|cannabidiol|mesh-list
44379832|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
44379833|NCT03890367|Vaccines|vaccines|mesh-list
44379834|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
43615522|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687528|NCT02819180|Vaccines|vaccines|mesh-list
43879284|NCT04674956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879285|NCT04674956|Immunologic Factors|immunologic factors|mesh-ancestor
43879286|NCT04674956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879287|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43879289|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
43879290|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879291|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43879292|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43879293|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879294|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879295|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43879296|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43879297|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
43879298|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879299|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879300|NCT04674176|Rifaximin|rifaximin|mesh-list
43879301|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879302|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879303|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43879304|NCT04674527|Temozolomide|temozolomide|mesh-list
43879305|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43879306|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
43879307|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879308|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879309|NCT04673955|Cetuximab|cetuximab|mesh-list
44379835|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379836|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44379837|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44379838|NCT03887442|Paclitaxel|paclitaxel|mesh-list
44379839|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44379840|NCT03887442|Cetuximab|cetuximab|mesh-list
44379841|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44379842|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379843|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44379844|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44379845|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44379846|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379847|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44379848|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44379849|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44379850|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44379851|NCT03885596|Acetaminophen|acetaminophen|mesh-list
44379852|NCT03885596|Celecoxib|celecoxib|mesh-list
44379853|NCT03885596|Ketorolac|ketorolac|mesh-list
43879310|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879311|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879312|NCT04673799|Denosumab|denosumab|mesh-list
43615565|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650204|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43650205|NCT03016208|Misoprostol|misoprostol|mesh-list
43650206|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43650207|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
43666427|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
43666428|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666429|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666430|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666431|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666432|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
43666433|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
43666434|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879313|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43879314|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879315|NCT04673812|Fentanyl|fentanyl|mesh-list
43879316|NCT04673812|Bupivacaine|bupivacaine|mesh-list
43879317|NCT04673812|Naloxone|naloxone|mesh-list
43879320|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879321|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879322|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
43879323|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879324|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43879325|NCT04673812|Narcotics|narcotics|mesh-ancestor
43879326|NCT04673812|Analgesics|analgesics|mesh-ancestor
43879327|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43879328|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43879329|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
43879330|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43879332|NCT04674137|Glutarimide|glutarimide|mesh-list
43879333|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
43879334|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
43879335|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879336|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650208|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43650209|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650210|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43650211|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650212|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
43650213|NCT03016000|Thalidomide|thalidomide|mesh-list
43650214|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650215|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
43615576|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615577|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43615578|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615579|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
43615580|NCT03148288|Vitamin D|vitamin d|mesh-list
43615581|NCT03148288|Vitamins|vitamins|mesh-ancestor
43615582|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
43615583|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615584|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43615585|NCT03148002|Lactulose|lactulose|mesh-list
43615586|NCT03148002|Sennosides|sennosides|mesh-list
43615587|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615588|NCT03148002|Laxatives|laxatives|mesh-ancestor
43615589|NCT03147963|Docetaxel|docetaxel|mesh-list
43615590|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849389|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849390|NCT03933631|Renal Agents|renal agents|mesh-ancestor
43849391|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849392|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43615610|NCT03147599|Mebeverine|mebeverine|mesh-list
43615611|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
43615612|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
43879337|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879338|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43879339|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879340|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
43879341|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
43879342|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
43669996|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
43879343|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879344|NCT04673461|Xylometazoline|xylometazoline|mesh-list
43879345|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
43879346|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43879347|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879348|NCT04673500|Lidocaine|lidocaine|mesh-list
43879349|NCT04673500|Propofol|propofol|mesh-list
43879350|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
44379854|NCT03885596|Lidocaine|lidocaine|mesh-list
44379855|NCT03885596|Fentanyl|fentanyl|mesh-list
44379856|NCT03885596|Bupivacaine|bupivacaine|mesh-list
44379857|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
44379858|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
44379859|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379860|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379861|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
44379862|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379863|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44379864|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44379865|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44379866|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44379867|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379868|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44379869|NCT03885596|Narcotics|narcotics|mesh-ancestor
43615630|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615633|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379870|NCT03885596|Analgesics|analgesics|mesh-ancestor
44379871|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44379872|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44379873|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
44379874|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379875|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
44379876|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44379877|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379878|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44379879|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44379880|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44379882|NCT03883386|Loratadine|loratadine|mesh-list
44379901|NCT03882047|Fluticasone|fluticasone|mesh-list
44379902|NCT03882047|Xhance|xhance|mesh-list
44379903|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
44379904|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379905|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44379906|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
44036041|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
44379907|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379908|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379909|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44379910|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379911|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379912|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44379913|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
44379914|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44379915|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44379916|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44379917|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
44379918|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379919|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379920|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379921|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
44379922|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
44379923|NCT03879772|Beclomethasone|beclomethasone|mesh-list
43687579|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
43879351|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
43879352|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879353|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879354|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
43879355|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879356|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43879357|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43879358|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43879359|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879360|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879361|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879362|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43879363|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
43879364|NCT04673396|Norcantharidin|norcantharidin|mesh-list
43879365|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615708|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
43615709|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615710|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615711|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615712|NCT03146650|Nivolumab|nivolumab|mesh-list
43615713|NCT03146650|Ipilimumab|ipilimumab|mesh-list
43615714|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615715|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615716|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43879366|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879367|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879368|NCT04672928|Paclitaxel|paclitaxel|mesh-list
43879369|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879370|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879371|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
43879372|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879373|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879374|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879375|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
44379924|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379925|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379926|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44379927|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44379928|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
44379929|NCT03879772|Hormones|hormones|mesh-ancestor
44379930|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379931|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379932|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44379933|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379934|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
44379935|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44379936|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
44379937|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
44379938|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379939|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
44379940|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44379941|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379942|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379943|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379944|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
44379945|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44379946|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379947|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44379948|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379949|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43615717|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615718|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
43615719|NCT03146533|Fludarabine|fludarabine|mesh-list
43615720|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615721|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
43615722|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615723|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615724|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43615748|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
43615749|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615750|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379950|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
44379951|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379952|NCT03875313|Talazoparib|talazoparib|mesh-list
44379953|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44379954|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879376|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43879377|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43879378|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43879379|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879380|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879381|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
43879382|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879383|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379955|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379956|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379957|NCT03873987|Oritavancin|oritavancin|mesh-list
44379958|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44379959|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44379960|NCT03872843|Ibuprofen|ibuprofen|mesh-list
44379961|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44379962|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44379963|NCT03872843|Analgesics|analgesics|mesh-ancestor
44379964|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
44379965|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44379966|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379967|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44379968|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615756|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43615758|NCT03146377|Capecitabine|capecitabine|mesh-list
44379969|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44379970|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379971|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379972|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
44379973|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44379974|NCT03868059|Testosterone|testosterone|mesh-list
44379975|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
44379976|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
44379977|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44379978|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44379979|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
44379980|NCT03868059|Hormones|hormones|mesh-ancestor
44379981|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44379982|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633126|NCT05612867|Vitamins|vitamins|mesh-ancestor
43879384|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43879385|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879386|NCT04673214|Acetaminophen|acetaminophen|mesh-list
43879387|NCT04673214|Azithromycin|azithromycin|mesh-list
43879388|NCT04673214|Ivermectin|ivermectin|mesh-list
43879389|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879390|NCT04673214|Analgesics|analgesics|mesh-ancestor
43879399|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43879400|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879401|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879402|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
43879403|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879404|NCT04672499|Cortisone|cortisone|mesh-list
43879405|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879406|NCT04672707|Bromhexine|bromhexine|mesh-list
43879407|NCT04672707|Expectorants|expectorants|mesh-ancestor
43879408|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
44379983|NCT03868059|Androgens|androgens|mesh-ancestor
44379984|NCT03865732|Pregnanolone|pregnanolone|mesh-list
44379986|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
44379987|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44379988|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379989|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44379990|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
44379991|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
44379992|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
44379993|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44379994|NCT03865407|Allopurinol|allopurinol|mesh-list
44379995|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
44379996|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44379997|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44379998|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
44379999|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380000|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44380001|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
44380002|NCT03865407|Protective Agents|protective agents|mesh-ancestor
44380003|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380004|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
44380005|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44380006|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44380007|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44380008|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44380009|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380010|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380011|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44036193|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
44380012|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380013|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44380014|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380015|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
43828965|NCT05458453|Esketamine|esketamine|mesh-list
43879409|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
43879410|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43879411|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
43879412|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879413|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
43879414|NCT04671914|Protective Agents|protective agents|mesh-ancestor
44136255|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380016|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380017|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380018|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44380020|NCT03861052|Tirzepatide|tirzepatide|mesh-list
44380021|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380022|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380023|NCT03861052|Incretins|incretins|mesh-ancestor
44380024|NCT03861052|Hormones|hormones|mesh-ancestor
44380025|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380026|NCT03860844|Cytarabine|cytarabine|mesh-list
44380027|NCT03860844|Dexamethasone|dexamethasone|mesh-list
44380028|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
44380029|NCT03860844|Doxorubicin|doxorubicin|mesh-list
44380030|NCT03860844|Methotrexate|methotrexate|mesh-list
44380031|NCT03860844|Fludarabine|fludarabine|mesh-list
44380032|NCT03860844|Etoposide|etoposide|mesh-list
44380033|NCT03860844|Vincristine|vincristine|mesh-list
44380034|NCT03860844|Daunorubicin|daunorubicin|mesh-list
44380035|NCT03860844|Asparaginase|asparaginase|mesh-list
44380036|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
44380037|NCT03860844|Idarubicin|idarubicin|mesh-list
44380038|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
43615815|NCT03146325|Bismuth|bismuth|mesh-list
43615816|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615817|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615818|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43615819|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43615820|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43615821|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615847|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615848|NCT03145714|Analgesics|analgesics|mesh-ancestor
43615849|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
44380039|NCT03860844|Pegaspargase|pegaspargase|mesh-list
44380040|NCT03860844|Montelukast|montelukast|mesh-list
43615850|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615853|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380041|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136256|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136257|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136258|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136259|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44136260|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44136261|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
44136262|NCT00164008|Pamidronate|pamidronate|mesh-list
44136263|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44136264|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136265|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
44136266|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44136267|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
44136268|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
44136269|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136270|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136271|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44136272|NCT00164047|Analgesics|analgesics|mesh-ancestor
44136273|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
44136274|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136275|NCT00164086|Atorvastatin|atorvastatin|mesh-list
44136276|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44136277|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136278|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
44136279|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879415|NCT04671836|Lorazepam|lorazepam|mesh-list
43879416|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
43615862|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43615863|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615864|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43615865|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43615866|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
43615867|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615868|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43615869|NCT03146104|Propofol|propofol|mesh-list
43615870|NCT03146104|Isoflurane|isoflurane|mesh-list
43879417|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
43879418|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
43879419|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879420|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380042|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
44380043|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380044|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380045|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44380046|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
44380047|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380048|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380049|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44380050|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380051|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
44380052|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
44380053|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380054|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380055|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
44380056|NCT03860844|Hormones|hormones|mesh-ancestor
44380057|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380058|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44380059|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44380060|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44380061|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380062|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380063|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44380064|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
44380065|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44380066|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44380067|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
44380068|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380069|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43615912|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615913|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43615914|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
43650264|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
43650265|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43650266|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
43650267|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
43650268|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
43650269|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44380070|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44380071|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44380072|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
43879421|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43879422|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879423|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879424|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43879425|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43879426|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879427|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
43879428|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
43879429|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879430|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879431|NCT04671589|Meropenem|meropenem|mesh-list
44380073|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380074|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380075|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
44380076|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
44380077|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44380078|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380079|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44380080|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
44380081|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44380082|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44380083|NCT03860844|Analgesics|analgesics|mesh-ancestor
44380084|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
44380085|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
44380086|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
44380087|NCT03855228|Loratadine|loratadine|mesh-list
44380088|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380089|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380090|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44380091|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
44380092|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43879432|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879433|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879439|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879440|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879441|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43879442|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43879443|NCT04671446|Autoantibodies|autoantibodies|mesh-list
43879444|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
43879445|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879446|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43879447|NCT04671160|Dalteparin|dalteparin|mesh-list
43879448|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
43879449|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43879450|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43879451|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615917|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
43615918|NCT05254899|Pegaspargase|pegaspargase|mesh-list
43615919|NCT05254899|Antibodies|antibodies|mesh-list
43615920|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43615921|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
43615922|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879452|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
43879453|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
43879454|NCT04671420|Rituximab|rituximab|mesh-list
43879455|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879456|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879457|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
43879458|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879459|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879460|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
43879461|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43879462|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
43879463|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879464|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
43879465|NCT04671108|Protective Agents|protective agents|mesh-ancestor
43879466|NCT04670978|Bevacizumab|bevacizumab|mesh-list
43879467|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879468|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879469|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43879470|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43879471|NCT04670978|Growth Substances|growth substances|mesh-ancestor
43879472|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380093|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44380094|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
44380095|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
44380096|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380097|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380098|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380099|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
44380100|NCT03855189|Beclomethasone|beclomethasone|mesh-list
44380101|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380102|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380103|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44380104|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
44380105|NCT03855189|Hormones|hormones|mesh-ancestor
44380106|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380107|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380108|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44380109|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380110|NCT03854227|Docetaxel|docetaxel|mesh-list
44380111|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380112|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380113|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44380114|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44380115|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380116|NCT03853551|Osimertinib|osimertinib|mesh-list
44380117|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615952|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43615953|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43615954|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615955|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
43615956|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
43615957|NCT05254574|Diclofenac|diclofenac|mesh-list
43615958|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44380118|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44380119|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380120|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380121|NCT03850444|Paclitaxel|paclitaxel|mesh-list
44380122|NCT03850444|Carboplatin|carboplatin|mesh-list
44380123|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
44380124|NCT03850444|Pemetrexed|pemetrexed|mesh-list
44380125|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44380126|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380127|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380128|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
44380131|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380132|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380133|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44380134|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44380136|NCT03850093|Gabapentin|gabapentin|mesh-list
44380137|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380138|NCT03850093|Analgesics|analgesics|mesh-ancestor
44380139|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
44380140|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380141|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
44380142|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44380143|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44380144|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380145|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44380146|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44380147|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44380148|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380149|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380150|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
44380151|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44380152|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
44380153|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
44380154|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44380155|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44380156|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44380157|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380158|NCT03848832|Cannabidiol|cannabidiol|mesh-list
43687743|NCT02818140|Ropivacaine|ropivacaine|mesh-list
43879473|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
43879474|NCT04671056|Pioglitazone|pioglitazone|mesh-list
43879475|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879476|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879477|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
43879478|NCT04670601|Analgesics|analgesics|mesh-ancestor
43879479|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
43879480|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879481|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879482|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43879483|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879484|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879485|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879486|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43879487|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879488|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380159|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
44380160|NCT03848416|Ixekizumab|ixekizumab|mesh-list
44380161|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380162|NCT03847610|Penicillins|penicillins|mesh-list
44380163|NCT03847610|Penicillin V|penicillin v|mesh-list
44380164|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380165|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380166|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44380168|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
44380169|NCT03846219|Calcium|calcium|mesh-list
44380170|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44380171|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380172|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44380173|NCT03845296|Rucaparib|rucaparib|mesh-list
44380174|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44380175|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380176|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380177|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380178|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44380179|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44380180|NCT03843047|Nicotine|nicotine|mesh-list
44380181|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44380182|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
44380183|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380184|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380185|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44380186|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44380187|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380188|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380189|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380190|NCT03841331|Serlopitant|serlopitant|mesh-list
44380191|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44380192|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380202|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380203|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380204|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380205|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44380206|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44380207|NCT03839940|Dexamethasone|dexamethasone|mesh-list
44380208|NCT03839940|Everolimus|everolimus|mesh-list
43616001|NCT05178823|Fluorides|fluorides|mesh-list
43616002|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
43616003|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
43616004|NCT05178823|Protective Agents|protective agents|mesh-ancestor
43616005|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616006|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43616007|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616008|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
44380209|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380210|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
44380211|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
44380212|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380213|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380214|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380215|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
44380216|NCT03839940|Hormones|hormones|mesh-ancestor
44380217|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380218|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44380219|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380220|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380221|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
44380222|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
44380223|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44380224|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43687787|NCT02817503|Amlodipine|amlodipine|mesh-list
43616013|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
43616014|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616015|NCT05166304|Protective Agents|protective agents|mesh-ancestor
43616016|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616017|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616049|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616050|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43650270|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
43650271|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650272|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43650273|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43650274|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650275|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616051|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
43616052|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826585|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
43826586|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666504|NCT03795701|Liraglutide|liraglutide|mesh-list
43666505|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43666506|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666507|NCT03795701|Incretins|incretins|mesh-ancestor
43666508|NCT03795701|Hormones|hormones|mesh-ancestor
43666509|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666510|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
43666515|NCT03757585|Inositol|inositol|mesh-list
43879489|NCT04670913|Apatinib|apatinib|mesh-list
43879490|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879491|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43879493|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879494|NCT04671069|Clopidogrel|clopidogrel|mesh-list
43879495|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43879496|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43879497|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43879498|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43879499|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
43879500|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879501|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879502|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879503|NCT04670809|Clevidipine|clevidipine|mesh-list
43879511|NCT04670497|Bupivacaine|bupivacaine|mesh-list
43879512|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
43879513|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
43879514|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
43879515|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879516|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879517|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
43616057|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
43879518|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879519|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43879520|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43879521|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
43879522|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380225|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44380226|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44380227|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380228|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380229|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380230|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380231|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44380232|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380233|NCT03839355|Warfarin|warfarin|mesh-list
44380234|NCT03839355|Apixaban|apixaban|mesh-list
44380235|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
43616165|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380236|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44380237|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
44380238|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44380239|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
44380240|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380241|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380242|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44380243|NCT03836729|Tenofovir|tenofovir|mesh-list
44380244|NCT03836729|Emtricitabine|emtricitabine|mesh-list
44380245|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
44380246|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380247|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44380248|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44380249|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380250|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380251|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44380252|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44380253|NCT03836664|Timolol|timolol|mesh-list
43879523|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879524|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43879525|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43879526|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
43879527|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43879528|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879529|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
43879530|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
43879531|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43879532|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43879533|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879534|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879535|NCT04670224|Anesthetics|anesthetics|mesh-list
43879536|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879537|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380254|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44380255|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44380256|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44380257|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44380258|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380259|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380260|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380261|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380262|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44380263|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44380264|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44380265|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
44380266|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380267|NCT03834623|Nivolumab|nivolumab|mesh-list
43616368|NCT03117933|Olaparib|olaparib|mesh-list
43616371|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616372|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380268|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380269|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380270|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44380271|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036500|NCT00002392|Growth Substances|growth substances|mesh-ancestor
44380272|NCT03830892|Nicotine|nicotine|mesh-list
44380273|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44380274|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
44380275|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380276|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380277|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44380278|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44380279|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380280|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380281|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380282|NCT03830281|Insulin|insulin|mesh-list
44380283|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44380284|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
44380285|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380286|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380287|NCT03828539|Topiramate|topiramate|mesh-list
44380288|NCT03828539|Erenumab|erenumab|mesh-list
44380289|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44380290|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
44380291|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380292|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380293|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44380294|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380295|NCT03828539|Analgesics|analgesics|mesh-ancestor
44380296|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
44380297|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380298|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
44380299|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
44380300|NCT03827473|Prednisone|prednisone|mesh-list
44380301|NCT03827473|Cortisone|cortisone|mesh-list
44380302|NCT03827473|Docetaxel|docetaxel|mesh-list
44380303|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
44380304|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
44380305|NCT03827473|Hormones|hormones|mesh-list
44380306|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44380307|NCT03827473|Androgens|androgens|mesh-list
44380308|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
44380309|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380310|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380311|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44380312|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44380313|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380314|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380315|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
44380316|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380317|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380318|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44380319|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44380320|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380321|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
44380322|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44380323|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
44380324|NCT03827473|Protective Agents|protective agents|mesh-ancestor
44380325|NCT03827473|Vitamins|vitamins|mesh-ancestor
43879539|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43616413|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43616414|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666542|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666543|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666545|NCT03724019|Ketamine|ketamine|mesh-list
43666546|NCT03724019|Analgesics|analgesics|mesh-ancestor
43666547|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
43879540|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879541|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879542|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44380326|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
44380327|NCT03827473|Estrogens|estrogens|mesh-ancestor
44380328|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
44380329|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
44380330|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380331|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
44380332|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380333|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380334|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44380335|NCT03824912|Ketoconazole|ketoconazole|mesh-list
43650284|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
43650285|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650286|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43650287|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43650288|NCT03015922|Growth Substances|growth substances|mesh-ancestor
43650289|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
43650290|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650292|NCT03015727|Docetaxel|docetaxel|mesh-list
43650293|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650294|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
43650295|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
43650296|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
43650297|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650298|NCT03015831|Colchicine|colchicine|mesh-list
43650299|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
43650300|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650301|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
43650302|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
43650303|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616415|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616416|NCT03049540|Urological Agents|urological agents|mesh-ancestor
43616418|NCT02938013|Velpatasvir|velpatasvir|mesh-list
43666550|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43666551|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43666552|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
43666553|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
43666554|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666555|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43666556|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43666557|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380336|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
44380337|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380338|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44380339|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44380340|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380341|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380342|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44380343|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
44380344|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380345|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380346|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44380347|NCT03824704|Nivolumab|nivolumab|mesh-list
44380348|NCT03824704|Rucaparib|rucaparib|mesh-list
44380349|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380350|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380351|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44380352|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380353|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44380370|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380371|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
44380372|NCT03822884|Hematinics|hematinics|mesh-ancestor
44380373|NCT03822416|Nicotine|nicotine|mesh-list
44380374|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44380375|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
44380376|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380377|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380378|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44380379|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44380380|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380381|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380382|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380383|NCT03822182|Dexamethasone|dexamethasone|mesh-list
44380384|NCT03822182|Bupivacaine|bupivacaine|mesh-list
44380385|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380386|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
44380387|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
44380388|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380389|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380390|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380391|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
44380392|NCT03822182|Hormones|hormones|mesh-ancestor
44380393|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380394|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43616419|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43616454|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616474|NCT02669173|Capecitabine|capecitabine|mesh-list
43616475|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616476|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616477|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43616478|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43616479|NCT02669173|Growth Substances|growth substances|mesh-ancestor
43616480|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616481|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
43616482|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851715|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44380395|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380396|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
44380397|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
44380398|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380399|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
44380400|NCT03818399|Buprenorphine|buprenorphine|mesh-list
44380413|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380414|NCT03818321|Renal Agents|renal agents|mesh-ancestor
44380415|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380416|NCT03817853|Prednisone|prednisone|mesh-list
44380417|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
44380418|NCT03817853|Prednisolone|prednisolone|mesh-list
44380419|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
44380420|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44380421|NCT03817853|Doxorubicin|doxorubicin|mesh-list
44380422|NCT03817853|Vincristine|vincristine|mesh-list
44380423|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
44380424|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380425|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
44380426|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616483|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
43616484|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616485|NCT02642315|Gabapentin|gabapentin|mesh-list
43616486|NCT02642315|Analgesics|analgesics|mesh-ancestor
43616487|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
43616488|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616489|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616490|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
43616491|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43650304|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650305|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851718|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
43851719|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851720|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851721|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851722|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851723|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851724|NCT02845323|Nivolumab|nivolumab|mesh-list
43851725|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851726|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851727|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851728|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851729|NCT02752035|Azacitidine|azacitidine|mesh-list
43666562|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43666565|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380427|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380428|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44380429|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
44380430|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380431|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380432|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44380433|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44380434|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44380435|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380436|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380437|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380438|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
44380439|NCT03817853|Hormones|hormones|mesh-ancestor
44380440|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380441|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44380442|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44380443|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
44380444|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
44380457|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44380458|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44380459|NCT03815175|Analgesics|analgesics|mesh-ancestor
44380460|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
44380461|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380462|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380463|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380464|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380465|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44380466|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44380467|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380468|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44380469|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44380470|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380471|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
44380472|NCT03814590|Vaccines|vaccines|mesh-list
44380473|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
43650307|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43650308|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
43650309|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43650310|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616492|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43616493|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616494|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616495|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43616496|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43616497|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849395|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43666568|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666570|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380474|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380475|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44380476|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44380477|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380478|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
44380479|NCT03812380|Cathartics|cathartics|mesh-ancestor
44380480|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380488|NCT03809611|Choline|choline|mesh-list
44380489|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
44380490|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44380491|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
44380492|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380493|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380494|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44380495|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
44380496|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43879543|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
43879544|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
44380497|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44380498|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
44380499|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44380500|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380501|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380502|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44380503|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44380504|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380505|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380506|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380507|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44380508|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
44380509|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44380510|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380511|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44380512|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44380513|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44380514|NCT03807843|Vaccines|vaccines|mesh-list
44380515|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
44380516|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380517|NCT03806231|Dinoprostone|dinoprostone|mesh-list
44380518|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
44380519|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44380520|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380521|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
44380522|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
44380523|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
44380524|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380525|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879545|NCT04669990|Remdesivir|remdesivir|mesh-list
43879546|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
43879547|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879548|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
43879549|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879550|NCT04669392|Ethanol|ethanol|mesh-list
43879551|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43879552|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879553|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879554|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879555|NCT04669158|Idebenone|idebenone|mesh-list
43879556|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
43879557|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879558|NCT04669158|Protective Agents|protective agents|mesh-ancestor
43879559|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380526|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
44380527|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380528|NCT03803475|Edetic Acid|edetic acid|mesh-list
44380529|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44380530|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
44380531|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
43616498|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380532|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380533|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
44380534|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44380535|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44380536|NCT03802994|Vaccines|vaccines|mesh-list
44380537|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44380538|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
44380539|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380540|NCT03802916|Deferiprone|deferiprone|mesh-list
44380541|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44380542|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
44380543|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
44380544|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380552|NCT03801928|Infliximab|infliximab|mesh-list
44380553|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380554|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380555|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380556|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
44380557|NCT03801148|Lansoprazole|lansoprazole|mesh-list
44380558|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44036738|NCT00002417|Amprenavir|amprenavir|mesh-list
44380577|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380578|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
44380579|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380580|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44380581|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44380582|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44380583|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44380584|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380585|NCT03796676|Abrocitinib|abrocitinib|mesh-list
44380586|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44380587|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380588|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380589|NCT03793556|Omeprazole|omeprazole|mesh-list
44380590|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44380591|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380592|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44380593|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380594|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380595|NCT03792672|Ketamine|ketamine|mesh-list
44380596|NCT03792672|Analgesics|analgesics|mesh-ancestor
44380597|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
44380598|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380625|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380626|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380627|NCT03783923|Deflazacort|deflazacort|mesh-list
44380628|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380629|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380630|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
44380631|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380632|NCT03783702|Acetaminophen|acetaminophen|mesh-list
44380634|NCT03783702|Oxycodone|oxycodone|mesh-list
44380635|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44380636|NCT03783702|Analgesics|analgesics|mesh-ancestor
44380637|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
44380638|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616499|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
43616500|NCT02631447|Nivolumab|nivolumab|mesh-list
43616501|NCT02631447|Ipilimumab|ipilimumab|mesh-list
43616502|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616503|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616504|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44380639|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380640|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
44380641|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44380642|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380643|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380644|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44380645|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380646|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380647|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44380648|NCT03783702|Narcotics|narcotics|mesh-ancestor
43616533|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43616534|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380649|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380650|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
44380651|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
44380652|NCT03783039|Coagulants|coagulants|mesh-ancestor
44380653|NCT03781375|Etanercept|etanercept|mesh-list
44380654|NCT03781375|Methotrexate|methotrexate|mesh-list
44380655|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44380656|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
44380657|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44380658|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380659|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44380660|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
43616535|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616536|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
43616537|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43616538|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616539|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616541|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616542|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
43616543|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616544|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616545|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616546|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616547|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
43616548|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43616549|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
43616550|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879560|NCT04669145|Ropivacaine|ropivacaine|mesh-list
43879561|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
43879562|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
43879563|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879564|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616551|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879565|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
44380661|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380662|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380663|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380664|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380665|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44380666|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380667|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
44380668|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44380669|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44380670|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44380671|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44380672|NCT03781375|Analgesics|analgesics|mesh-ancestor
44380673|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
44380674|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380675|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380676|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380677|NCT03780959|Etanercept|etanercept|mesh-list
44380678|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44380679|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44380680|NCT03780959|Analgesics|analgesics|mesh-ancestor
44380681|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
44380682|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380683|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380684|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380689|NCT03780244|Mannitol|mannitol|mesh-list
44380709|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380710|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616552|NCT02383251|Paclitaxel|paclitaxel|mesh-list
43616553|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616585|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
43616586|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616587|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616588|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666580|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43666581|NCT03534284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43666582|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44380711|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44380712|NCT03773796|Nabilone|nabilone|mesh-list
44380713|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
44380714|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
44380715|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380716|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380717|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380718|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44380719|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44380720|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380721|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44380722|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
44380723|NCT03773484|Narcotics|narcotics|mesh-ancestor
44380724|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380725|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380726|NCT03773484|Analgesics|analgesics|mesh-ancestor
44380727|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
44380728|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380729|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44380730|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
44380731|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
44380732|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380733|NCT03772041|Tolvaptan|tolvaptan|mesh-list
44380734|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44380735|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380736|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
44380737|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380738|NCT03770728|Metformin|metformin|mesh-list
44380739|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
44380740|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879566|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136280|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44136281|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44136282|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136283|NCT00164112|Azithromycin|azithromycin|mesh-list
44136294|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380741|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380742|NCT03769896|Nabilone|nabilone|mesh-list
44380743|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
44380744|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
44380745|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380746|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380747|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44380748|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44380749|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44380750|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380751|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616589|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616590|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616591|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616592|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
43616593|NCT01861496|Cisplatin|cisplatin|mesh-list
43616630|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616631|NCT00069238|Prednisone|prednisone|mesh-list
43616632|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
43616634|NCT00069238|Etoposide|etoposide|mesh-list
44380752|NCT03769311|Cetuximab|cetuximab|mesh-list
44380753|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44380754|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380755|NCT03769090|Budesonide|budesonide|mesh-list
44380756|NCT03769090|Albuterol|albuterol|mesh-list
44380757|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380758|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44380759|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
44380760|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380761|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380762|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44380763|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380764|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
44380765|NCT03769090|Hormones|hormones|mesh-ancestor
44380766|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380767|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
44380768|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44380769|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44380770|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44380771|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380772|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380773|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688236|NCT02813486|Vaccines|vaccines|mesh-list
44136296|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44136297|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44136298|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44136299|NCT00164125|Laxatives|laxatives|mesh-ancestor
44136300|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136301|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44136302|NCT00164164|Laxatives|laxatives|mesh-ancestor
44136303|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136304|NCT00164216|Artesunate|artesunate|mesh-list
44380774|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380775|NCT03768726|Ziprasidone|ziprasidone|mesh-list
44380776|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44380777|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
44380778|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380779|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380780|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380781|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43616654|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43616655|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616656|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616657|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616658|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616659|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43616660|NCT03145467|Acetaminophen|acetaminophen|mesh-list
43616661|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
43650312|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44380782|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44380783|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44380784|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44380785|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44380786|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
44380787|NCT03768089|Ivacaftor|ivacaftor|mesh-list
44380788|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44380789|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44380790|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380791|NCT03765138|Pramipexole|pramipexole|mesh-list
44380792|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
44380793|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380794|NCT03765138|Protective Agents|protective agents|mesh-ancestor
44380795|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380796|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44380797|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44380798|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
44380799|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
44380800|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380801|NCT03764631|Empagliflozin|empagliflozin|mesh-list
44380802|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44380803|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412307|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44136305|NCT00164216|Mefloquine|mefloquine|mesh-list
44136306|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
44136307|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44136308|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136309|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136310|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136311|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
44136312|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
44136313|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44136315|NCT00164242|Galantamine|galantamine|mesh-list
44136316|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44380804|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380805|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380806|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380807|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
44380808|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380809|NCT03760666|Ribavirin|ribavirin|mesh-list
44380810|NCT03760666|Brequinar|brequinar|mesh-list
44380811|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
44380812|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380813|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
44380814|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44380815|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380816|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380817|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380818|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
44380819|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380820|NCT03760250|Imiquimod|imiquimod|mesh-list
44380821|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44380822|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
44380823|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380824|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380825|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
44380826|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44380827|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44380828|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44380829|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44380830|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380831|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380832|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380833|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851747|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43851748|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
43851749|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
43851750|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44380834|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380835|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44136317|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136318|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136319|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
44136320|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136321|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136322|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44136323|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
44136324|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380836|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
44380837|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380838|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
44380839|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380840|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380842|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44380843|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380844|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380845|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380846|NCT03759587|Niraparib|niraparib|mesh-list
44380847|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44380848|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380849|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380850|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380851|NCT03759366|Eculizumab|eculizumab|mesh-list
44380852|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44380853|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44380854|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
44380855|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380856|NCT03759041|Vancomycin|vancomycin|mesh-list
44380857|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44380858|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650315|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43650316|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43616662|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616663|NCT03145467|Analgesics|analgesics|mesh-ancestor
43616664|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
43616665|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616666|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616667|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
43616668|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43851754|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
43851755|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666630|NCT03421353|Durvalumab|durvalumab|mesh-list
43666631|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44380859|NCT03757715|Dexamethasone|dexamethasone|mesh-list
44380868|NCT03757715|Hormones|hormones|mesh-ancestor
44380886|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44380887|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44380888|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44380889|NCT03756883|Fluticasone|fluticasone|mesh-list
44380890|NCT03756883|Xhance|xhance|mesh-list
44380891|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44380892|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44380893|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44380894|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44380895|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
44380896|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380897|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380898|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44380899|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380900|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
44380901|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44380902|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44380903|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44380904|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380905|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380906|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380907|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380908|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
44380909|NCT03756883|Hormones|hormones|mesh-ancestor
44380910|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44380911|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
44380912|NCT03756129|Ketamine|ketamine|mesh-list
44380913|NCT03756129|Analgesics|analgesics|mesh-ancestor
44380914|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
44380915|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380916|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380928|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
44380929|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380930|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44380931|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44380932|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380933|NCT03751657|Insulin|insulin|mesh-list
44380934|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44380935|NCT03751657|Metformin|metformin|mesh-list
44380936|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
44380937|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44380938|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44380939|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380940|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
44380941|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44380942|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380943|NCT03751631|Phenylephrine|phenylephrine|mesh-list
44380944|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
44380945|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44380946|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44380947|NCT03751631|Tropicamide|tropicamide|mesh-list
44380948|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44380949|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
44380950|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
44380951|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380952|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380953|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
43666646|NCT03379207|Dimercaprol|dimercaprol|mesh-list
44380954|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44380955|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
44136325|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
44136326|NCT00164255|Artesunate|artesunate|mesh-list
44136327|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
44136328|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
44136329|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
44136330|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44136331|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136332|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136333|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136334|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
44136335|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
44136336|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44136337|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
44136338|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44136339|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136340|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136341|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44136342|NCT00164255|Renal Agents|renal agents|mesh-ancestor
44136343|NCT00164281|Isoniazid|isoniazid|mesh-list
44136344|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
44380956|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380957|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44380958|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44380959|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380960|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380961|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380962|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380963|NCT03751631|Protective Agents|protective agents|mesh-ancestor
44380964|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44380965|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44380966|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380968|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
44380969|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44380970|NCT03751098|Tropicamide|tropicamide|mesh-list
44380971|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44380972|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44380973|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
43616670|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
44380974|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
44136345|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136346|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136347|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44136348|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136349|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
44136350|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879577|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879578|NCT04668976|Antiviral Agents|antiviral agents|mesh-ancestor
43879579|NCT04668976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879580|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879581|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879582|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
43879583|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879584|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43879585|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43879586|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879587|NCT04669366|Sunitinib|sunitinib|mesh-list
43879588|NCT04669366|Axitinib|axitinib|mesh-list
43879589|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879590|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43879591|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43879592|NCT04669366|Growth Substances|growth substances|mesh-ancestor
43879593|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879594|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670029|NCT02899026|Prednisone|prednisone|mesh-list
43879595|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43879597|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879598|NCT04668456|Lidocaine|lidocaine|mesh-list
43879599|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
43879600|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
43879601|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
43879602|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879603|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879604|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
43879605|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879606|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43879607|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44380975|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44380976|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380977|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
43616726|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616727|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44380978|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44380979|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
44380980|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
44380981|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44380982|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44380983|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44380984|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44380985|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380986|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380987|NCT03751098|Protective Agents|protective agents|mesh-ancestor
44380988|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44380989|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44380990|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
44380991|NCT03749109|Quinagolide|quinagolide|mesh-list
44380992|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
44380993|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
44380994|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44380995|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44380996|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44380997|NCT03748823|Ravulizumab|ravulizumab|mesh-list
44380998|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44380999|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381000|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
44381001|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381002|NCT03743038|Minocycline|minocycline|mesh-list
44381003|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381004|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381020|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381021|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44381022|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381023|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44381024|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381025|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381026|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44381027|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381028|NCT03739528|Renal Agents|renal agents|mesh-ancestor
44381029|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381030|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44381031|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381032|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44381033|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44381034|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44381035|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44381036|NCT03739203|Cariprazine|cariprazine|mesh-list
44381037|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
44381038|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381039|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44381040|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381041|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381042|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381043|NCT03738865|Glucagon|glucagon|mesh-list
43616772|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616773|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381044|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44381045|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381046|NCT03738865|Hormones|hormones|mesh-ancestor
43879608|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43879609|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879610|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879611|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879612|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879613|NCT04668456|Analgesics|analgesics|mesh-ancestor
43879614|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43879615|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43879616|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43879617|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
43879618|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879619|NCT04668417|Vaccines|vaccines|mesh-list
43879620|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
43879621|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879622|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
43879623|NCT04668690|Analgesics|analgesics|mesh-ancestor
43879624|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
43879625|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879626|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879627|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381047|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381048|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381049|NCT03738865|Incretins|incretins|mesh-ancestor
44381050|NCT03738215|Cariprazine|cariprazine|mesh-list
44381051|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44381052|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381053|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381054|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381055|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381056|NCT03737110|Rilonacept|rilonacept|mesh-list
44381057|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381058|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44381059|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
44381060|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381061|NCT03736785|Insulin|insulin|mesh-list
44381062|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381063|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381064|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
44381065|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
44381066|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381067|NCT03733899|Anesthetics|anesthetics|mesh-list
44381068|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879628|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43879633|NCT04668469|Vitamins|vitamins|mesh-list
43879634|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
43879635|NCT04668469|Zinc|zinc|mesh-list
43879636|NCT04668469|Azithromycin|azithromycin|mesh-list
43879637|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
43879638|NCT04668469|Ivermectin|ivermectin|mesh-list
43879639|NCT04668469|Lactoferrin|lactoferrin|mesh-list
43879640|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
43879641|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
43879642|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879643|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879644|NCT04668469|Analgesics|analgesics|mesh-ancestor
43879645|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
43879646|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879647|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
43879648|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879649|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879650|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
43879651|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43879652|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43879653|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879654|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879655|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879656|NCT04668469|Trace Elements|trace elements|mesh-ancestor
43879657|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
43879658|NCT04668469|Protective Agents|protective agents|mesh-ancestor
43879659|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43879660|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43879661|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
43879662|NCT04668469|Coagulants|coagulants|mesh-ancestor
43879663|NCT04668352|Dactolisib|dactolisib|mesh-list
43879664|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879665|NCT04667910|Ranibizumab|ranibizumab|mesh-list
43879666|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44381069|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381070|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
44381071|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381072|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44381073|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44381074|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381075|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381076|NCT03733470|Urological Agents|urological agents|mesh-ancestor
44381077|NCT03732248|Sirolimus|sirolimus|mesh-list
44381078|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381079|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381080|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44381081|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650317|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
43650318|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381082|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
44381083|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381084|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
44381085|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381086|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44381087|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
44381088|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381089|NCT03730961|Furosemide|furosemide|mesh-list
44381090|NCT03730961|Diuretics|diuretics|mesh-ancestor
44381091|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
44381092|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381093|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44381094|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381095|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381096|NCT03730012|Atezolizumab|atezolizumab|mesh-list
44381097|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381098|NCT03726996|Desipramine|desipramine|mesh-list
44381099|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44381100|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44381101|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381107|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44381108|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381109|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381110|NCT03726879|Paclitaxel|paclitaxel|mesh-list
44381111|NCT03726879|Maytansine|maytansine|mesh-list
44381112|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44381113|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
44381114|NCT03726879|Doxorubicin|doxorubicin|mesh-list
44381115|NCT03726879|Trastuzumab|trastuzumab|mesh-list
44381116|NCT03726879|Atezolizumab|atezolizumab|mesh-list
44381117|NCT03726879|Pertuzumab|pertuzumab|mesh-list
44381118|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44381119|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381120|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
44381121|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
44381122|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
44381123|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381124|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381125|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
44381126|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381127|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381128|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44381129|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
44381130|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44381131|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44381132|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44381133|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381134|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381135|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381136|NCT03725085|Guaifenesin|guaifenesin|mesh-list
44381137|NCT03725085|Expectorants|expectorants|mesh-ancestor
44381138|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
44381139|NCT03724981|Dulaglutide|dulaglutide|mesh-list
44381140|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879667|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43879668|NCT04667910|Growth Substances|growth substances|mesh-ancestor
43879669|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879671|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879672|NCT04667897|Ranibizumab|ranibizumab|mesh-list
43616866|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
43616893|NCT03143465|Katacalcin|katacalcin|mesh-list
43879673|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43879674|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43879675|NCT04667897|Growth Substances|growth substances|mesh-ancestor
43879676|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381141|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381142|NCT03724968|Nivolumab|nivolumab|mesh-list
44381143|NCT03724968|Ipilimumab|ipilimumab|mesh-list
44381144|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381145|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381146|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44381147|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381148|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
44381149|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381150|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381151|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
44381152|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44381153|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
44381154|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381155|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
43879677|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
43879678|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879679|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
43879680|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43879681|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
43879682|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879683|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
43879684|NCT04667819|Protective Agents|protective agents|mesh-ancestor
43879685|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43879686|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43879687|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43879688|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43879689|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879690|NCT04667351|Fluorouracil|fluorouracil|mesh-list
43879691|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
43879692|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879693|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43879694|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879695|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879696|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
43879697|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879698|NCT04667299|Amoxicillin|amoxicillin|mesh-list
43879699|NCT04667299|Metronidazole|metronidazole|mesh-list
43879700|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
43879701|NCT04667299|Rabeprazole|rabeprazole|mesh-list
43879702|NCT04667299|Bismuth|bismuth|mesh-list
43616897|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616898|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616899|NCT03143465|Urological Agents|urological agents|mesh-ancestor
43616900|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43616901|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616902|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43616903|NCT03143491|Paclitaxel|paclitaxel|mesh-list
43616904|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616905|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879703|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879714|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
43879715|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879716|NCT04667299|Expectorants|expectorants|mesh-ancestor
43879717|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879718|NCT04667143|Metformin|metformin|mesh-list
43879719|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879720|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879721|NCT04666805|Tamoxifen|tamoxifen|mesh-list
43879722|NCT04666805|Toremifene|toremifene|mesh-list
43879723|NCT04666805|Letrozole|letrozole|mesh-list
43879724|NCT04666805|Anastrozole|anastrozole|mesh-list
43879725|NCT04666805|Exemestane|exemestane|mesh-list
43879726|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879727|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43879728|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43879729|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879730|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879731|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43879732|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
44381156|NCT03723590|Protective Agents|protective agents|mesh-ancestor
44381157|NCT03722524|Amlodipine|amlodipine|mesh-list
44381158|NCT03722524|Perindopril|perindopril|mesh-list
44381159|NCT03722524|Indapamide|indapamide|mesh-list
44381160|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
44381161|NCT03722524|Diuretics|diuretics|mesh-list
44381162|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44381163|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44381164|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44381165|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381166|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381167|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44381168|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381169|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381170|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
44381171|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44381172|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381173|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44381174|NCT03722238|Ibuprofen|ibuprofen|mesh-list
44381175|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381176|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381177|NCT03722238|Analgesics|analgesics|mesh-ancestor
44381178|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
44381179|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688591|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
43879733|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879734|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879735|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43879736|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43879737|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43879738|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43879740|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43879741|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43879742|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879743|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879744|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879745|NCT04666623|Esketamine|esketamine|mesh-list
43879746|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
43879747|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44136354|NCT00164359|Dapsone|dapsone|mesh-list
44136355|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
44136356|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
44136357|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44136358|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136359|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136360|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136361|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
44136362|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
44136363|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44381180|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381181|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381182|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381183|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381184|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381185|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381186|NCT03720847|Estradiol|estradiol|mesh-list
44381187|NCT03720847|Progesterone|progesterone|mesh-list
44381188|NCT03720847|Estrogens|estrogens|mesh-ancestor
44381189|NCT03720847|Hormones|hormones|mesh-ancestor
44381190|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381191|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381192|NCT03720847|Progestins|progestins|mesh-ancestor
44381193|NCT03720470|Abrocitinib|abrocitinib|mesh-list
44381194|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44381195|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381196|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381197|NCT03719586|Remdesivir|remdesivir|mesh-list
44381198|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
44381199|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
44381200|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381201|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
44381202|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381203|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
44136364|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
44136365|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44136366|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136367|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136368|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136369|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136370|NCT00164411|Vaccines|vaccines|mesh-list
44136371|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44136372|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
44136373|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136374|NCT00164424|Acyclovir|acyclovir|mesh-list
44136375|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
44136376|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136377|NCT00164450|Isoniazid|isoniazid|mesh-list
44136378|NCT00164450|Rifapentine|rifapentine|mesh-list
43879756|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
43879757|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879758|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879759|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43616907|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879760|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
43879770|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879772|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879773|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
43879774|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43879775|NCT04665986|Docetaxel|docetaxel|mesh-list
43879776|NCT04665986|Vinorelbine|vinorelbine|mesh-list
44381205|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
44381206|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44381207|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
44381208|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381209|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381210|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
44381211|NCT03718143|Adavosertib|adavosertib|mesh-list
44381212|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381213|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381214|NCT03717064|Pitavastatin|pitavastatin|mesh-list
44381215|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44381216|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44381217|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43879777|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879778|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
43879779|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
43879780|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
43879781|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879782|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43879783|NCT04665830|Evolocumab|evolocumab|mesh-list
43879784|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43879785|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43879786|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
43879787|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879788|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43879789|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43879790|NCT04665362|Apatinib|apatinib|mesh-list
43879791|NCT04665362|Antibodies|antibodies|mesh-list
43879792|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
43879793|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879794|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879795|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43879796|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879797|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879798|NCT04665232|Progesterone|progesterone|mesh-list
43879799|NCT04665232|Progestins|progestins|mesh-ancestor
43879800|NCT04665232|Hormones|hormones|mesh-ancestor
43879801|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879802|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879803|NCT04665141|Omalizumab|omalizumab|mesh-list
43879804|NCT04665141|Benralizumab|benralizumab|mesh-list
43879805|NCT04665141|Reslizumab|reslizumab|mesh-list
43879806|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43879807|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43879808|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879809|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
43879810|NCT04665063|Fludarabine|fludarabine|mesh-list
43879811|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879812|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
43879813|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879814|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879815|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43879816|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
43879817|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879818|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879819|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43879820|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
43879821|NCT04665076|Fludarabine|fludarabine|mesh-list
43879822|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381218|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
44381219|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666743|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666744|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851779|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381220|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381221|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44381222|NCT03717012|Nintedanib|nintedanib|mesh-list
44381223|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381224|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44381225|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381226|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037431|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
44381227|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
44381228|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381229|NCT03716024|Linezolid|linezolid|mesh-list
44381230|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381231|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381232|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44381233|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381234|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381235|NCT03714815|Macitentan|macitentan|mesh-list
44381236|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44381237|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44381238|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381239|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44381240|NCT03714672|Diclofenac|diclofenac|mesh-list
44381241|NCT03714672|Tramadol|tramadol|mesh-list
44381242|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381243|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43879823|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
43879824|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879825|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879826|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43879827|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
43879837|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879838|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879839|NCT04665310|Tacrolimus|tacrolimus|mesh-list
43879840|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879841|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
43879842|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879843|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43879844|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879845|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616954|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43616956|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
43616957|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43616958|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616959|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43616960|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43879846|NCT04664894|Ribavirin|ribavirin|mesh-list
43879847|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
43879848|NCT04664894|Velpatasvir|velpatasvir|mesh-list
43879849|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
43879850|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381244|NCT03714672|Analgesics|analgesics|mesh-ancestor
44381245|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
44381246|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381247|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381248|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381249|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381250|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381251|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381252|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381253|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44381254|NCT03714672|Narcotics|narcotics|mesh-ancestor
44381255|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381256|NCT03714022|Abatacept|abatacept|mesh-list
44381257|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44381258|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381259|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381260|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381261|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
44381262|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381263|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381264|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
44381265|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381266|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381267|NCT03713320|Vorinostat|vorinostat|mesh-list
44381268|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381269|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44381270|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381271|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381272|NCT03712917|Topiramate|topiramate|mesh-list
44381273|NCT03712917|Flunarizine|flunarizine|mesh-list
44381274|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
44381275|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879851|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
43879852|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879853|NCT04664803|Cefdinir|cefdinir|mesh-list
43879854|NCT04664803|Cefetamet|cefetamet|mesh-list
43879855|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879856|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879857|NCT04664725|Repaglinide|repaglinide|mesh-list
43879858|NCT04664725|Bupropion|bupropion|mesh-list
43879859|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43879860|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
43879861|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879862|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44381276|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381277|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44381278|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381279|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381280|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44381281|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44381282|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
44381283|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
44381284|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381285|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381286|NCT03712787|Tilavonemab|tilavonemab|mesh-list
44381287|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
44381288|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44381289|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43666758|NCT03147612|Rituximab|rituximab|mesh-list
43666759|NCT03147612|Methotrexate|methotrexate|mesh-list
43666760|NCT03147612|Vincristine|vincristine|mesh-list
43666761|NCT03147612|Blinatumomab|blinatumomab|mesh-list
43666762|NCT03147612|Ponatinib|ponatinib|mesh-list
44381290|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44381291|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381292|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381293|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44381294|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381295|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381296|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
44381297|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381298|NCT03712345|Vilobelimab|vilobelimab|mesh-list
44381299|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44381300|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381301|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
44381302|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381304|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
43688710|NCT02809963|Eplerenone|eplerenone|mesh-list
43879863|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43879864|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879865|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879866|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
43879867|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879868|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879869|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43879870|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43879871|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879872|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879873|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
43616964|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
43616965|NCT03143023|Protective Agents|protective agents|mesh-ancestor
43616966|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616967|NCT03142789|Cerivastatin|cerivastatin|mesh-list
43616992|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43616993|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879874|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
43879875|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
43879876|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879877|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381305|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381306|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381307|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381308|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44381309|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
44381310|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381311|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381312|NCT03710889|Abaloparatide|abaloparatide|mesh-list
44381313|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44381314|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381322|NCT03710161|Vitamin D|vitamin d|mesh-list
44381323|NCT03710161|Vitamins|vitamins|mesh-ancestor
44381324|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
44381325|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381326|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44381327|NCT03709576|Azacitidine|azacitidine|mesh-list
44381328|NCT03709576|Pevonedistat|pevonedistat|mesh-list
44381329|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44381330|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
44381331|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381332|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381333|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381334|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
44381335|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
44381336|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44381337|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44381338|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
44381339|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381340|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381341|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381342|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381343|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44381347|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381348|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44381349|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381350|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381351|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
44381352|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381353|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
44381354|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44381355|NCT03701074|Acetaminophen|acetaminophen|mesh-list
44381356|NCT03701074|Ibuprofen|ibuprofen|mesh-list
44381357|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381358|NCT03701074|Analgesics|analgesics|mesh-ancestor
44381359|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
44381360|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381361|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381362|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
44381363|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381364|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381369|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
44381403|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44381404|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44381405|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
44381406|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
44381407|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381408|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381409|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44381410|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44381411|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44381412|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381413|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381414|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381415|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381416|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
44381417|NCT03695367|Acetaminophen|acetaminophen|mesh-list
44381418|NCT03695367|Ibuprofen|ibuprofen|mesh-list
44381419|NCT03695367|Ketorolac|ketorolac|mesh-list
44381420|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381421|NCT03695367|Analgesics|analgesics|mesh-ancestor
44381422|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
44381423|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381424|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381425|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
44381426|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43879878|NCT04664595|Propofol|propofol|mesh-list
43879879|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43879880|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879881|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879882|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43879883|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
43879884|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
43879885|NCT04664530|Esketamine|esketamine|mesh-list
43879886|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
43879887|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879888|NCT04664517|Anesthetics|anesthetics|mesh-list
43879889|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879890|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879891|NCT04664010|Vitamins|vitamins|mesh-list
43879892|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
43879893|NCT04664010|Interferons|interferons|mesh-list
43879904|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
43879905|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
43879906|NCT04664010|Protective Agents|protective agents|mesh-ancestor
43879907|NCT04664127|Valacyclovir|valacyclovir|mesh-list
43879908|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
43879909|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879910|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43879911|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43879912|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43879913|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879914|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879915|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44037660|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
44381427|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381428|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381429|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381430|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381431|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381432|NCT03695094|Lamotrigine|lamotrigine|mesh-list
44381433|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
44381434|NCT03695094|Levetiracetam|levetiracetam|mesh-list
44381435|NCT03695094|Brivaracetam|brivaracetam|mesh-list
44381436|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
44381437|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
44381438|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44381439|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381440|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617086|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43617087|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43617088|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617089|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617090|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
44381441|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44381442|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381443|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44381444|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381445|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381446|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381447|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44381448|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44381449|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44381450|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44381451|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
44381452|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43688828|NCT02809105|Linaclotide|linaclotide|mesh-list
43879916|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879917|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43879918|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
43879919|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43879920|NCT04663763|Capecitabine|capecitabine|mesh-list
43879921|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
43879922|NCT04663763|Antibodies|antibodies|mesh-list
43879923|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
43879924|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879925|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43879926|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
43879927|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879928|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155821|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44155822|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
44155823|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155824|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381453|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44381454|NCT03694821|Prednisolone|prednisolone|mesh-list
44381455|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
44381456|NCT03694821|Ketorolac|ketorolac|mesh-list
44381457|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44381458|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44381459|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
44381461|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381462|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
44381463|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
44381464|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381465|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381466|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381467|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
44381468|NCT03694821|Hormones|hormones|mesh-ancestor
44381469|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381470|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44381471|NCT03694821|Protective Agents|protective agents|mesh-ancestor
44381472|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44381473|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381474|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381475|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381476|NCT03694821|Analgesics|analgesics|mesh-ancestor
44381477|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
44381478|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155825|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44155826|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44155827|NCT00228358|Analgesics|analgesics|mesh-ancestor
44155828|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
44155829|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155830|NCT00228397|Sirolimus|sirolimus|mesh-list
44155831|NCT00228397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155832|NCT00228397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155833|NCT00228397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44155834|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155835|NCT00228397|Antifungal Agents|antifungal agents|mesh-ancestor
44155836|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155837|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
44155838|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155839|NCT00228410|Vancomycin|vancomycin|mesh-list
44155840|NCT00228410|Tigecycline|tigecycline|mesh-list
44155841|NCT00228410|Aztreonam|aztreonam|mesh-list
44155842|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155843|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155844|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44155845|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155846|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617095|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
43617096|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617097|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43617098|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
43617099|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
43617100|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650332|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666816|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43666818|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43666819|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43666820|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155847|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44155848|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155849|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381479|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381480|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381481|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381482|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
44381483|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
44381484|NCT03693989|Difluprednate|difluprednate|mesh-list
44381485|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
44381486|NCT03693989|Hormones|hormones|mesh-ancestor
44381487|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381488|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381489|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381490|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
44381491|NCT03693950|Hematinics|hematinics|mesh-ancestor
44381492|NCT03693612|Paclitaxel|paclitaxel|mesh-list
44381493|NCT03693612|Docetaxel|docetaxel|mesh-list
44381494|NCT03693612|Cetuximab|cetuximab|mesh-list
44381495|NCT03693612|Tremelimumab|tremelimumab|mesh-list
44381496|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44381497|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381498|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44381499|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44381500|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44381501|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155850|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44155851|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155852|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155853|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155855|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44155856|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44155858|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155859|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155860|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44155861|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
44155862|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
44155863|NCT00228475|Hormones|hormones|mesh-ancestor
44155864|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155865|NCT00228488|Gefitinib|gefitinib|mesh-list
44155866|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879929|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
43879930|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43879931|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879932|NCT04663386|Budesonide|budesonide|mesh-list
43879933|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
43617101|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617102|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43617127|NCT03141970|Prednisone|prednisone|mesh-list
43879934|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879935|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43879936|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
43879937|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879938|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879939|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43879940|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
43879941|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
43879942|NCT04663386|Hormones|hormones|mesh-ancestor
43702472|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44381502|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381503|NCT03693404|Ketorolac|ketorolac|mesh-list
44381504|NCT03693404|Morphine|morphine|mesh-list
44381505|NCT03693404|Bupivacaine|bupivacaine|mesh-list
44381506|NCT03693404|Anesthetics|anesthetics|mesh-list
44381507|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
44381508|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
44381509|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381510|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381511|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
44381512|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381513|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381514|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381515|NCT03693404|Analgesics|analgesics|mesh-ancestor
44381516|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381517|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381518|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381519|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381520|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381521|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44381522|NCT03693404|Narcotics|narcotics|mesh-ancestor
44381523|NCT03693170|Cetuximab|cetuximab|mesh-list
44381524|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381525|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381526|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44381527|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
44381528|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381529|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
44381530|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43879943|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879944|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43879945|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43879946|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43879947|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
43879948|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879949|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879950|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
43879951|NCT04663269|Dexamethasone|dexamethasone|mesh-list
43879952|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879953|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
43879954|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
43879955|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879956|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879957|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43879958|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
44381531|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
44381532|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381533|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381534|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44381535|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
44381536|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
44381537|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44381538|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
43666832|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666833|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666834|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
43666835|NCT02816021|Azacitidine|azacitidine|mesh-list
43666836|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381539|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381540|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381541|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
44381542|NCT03691948|Narcotics|narcotics|mesh-ancestor
44381543|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381544|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381545|NCT03691948|Analgesics|analgesics|mesh-ancestor
44381546|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
44381547|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381548|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44381549|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44381550|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381551|NCT03691779|Ivacaftor|ivacaftor|mesh-list
44381552|NCT03691779|Elexacaftor|elexacaftor|mesh-list
44381553|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44381554|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381555|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381556|NCT03689855|Atezolizumab|atezolizumab|mesh-list
44381557|NCT03689855|Ramucirumab|ramucirumab|mesh-list
44381558|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381559|NCT03689374|Insulin|insulin|mesh-list
44381560|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44381561|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
44381562|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
44381563|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879959|NCT04663269|Hormones|hormones|mesh-ancestor
43879960|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879961|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617136|NCT03141658|Ketamine|ketamine|mesh-list
43617137|NCT03141658|Analgesics|analgesics|mesh-ancestor
43617138|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
43617139|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617140|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617141|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43617142|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43617143|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
43617194|NCT03141476|Cefuroxime|cefuroxime|mesh-list
43879962|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879963|NCT04662788|Antibodies|antibodies|mesh-list
43879964|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43879965|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
43879966|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879967|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43879968|NCT04662736|Tedizolid|tedizolid|mesh-list
44381564|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381565|NCT03687827|Insulin|insulin|mesh-list
44381566|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44381567|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
44381568|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381569|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381570|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44381571|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44381572|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44381573|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381574|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381575|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44381576|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381577|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381578|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44381579|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381580|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44381581|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44381582|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381583|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
44381584|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381617|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381618|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
44381619|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44381620|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381621|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381622|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381623|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44381624|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44381625|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381626|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381627|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
44381628|NCT03682302|Bupivacaine|bupivacaine|mesh-list
44381629|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
44381630|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
44381631|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617195|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
44381632|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381633|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
44381634|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381635|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
44381636|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381637|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381638|NCT03681691|Estradiol|estradiol|mesh-list
44381639|NCT03681691|Estrogens|estrogens|mesh-ancestor
44381640|NCT03681691|Hormones|hormones|mesh-ancestor
44381641|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381642|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381643|NCT03681470|Dapsone|dapsone|mesh-list
44381644|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381645|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
44381646|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43879969|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879970|NCT04662840|Anesthetics|anesthetics|mesh-list
43879971|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
43879972|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43879973|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879974|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
43879975|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879976|NCT04662866|Metformin|metformin|mesh-list
43879977|NCT04662866|Pioglitazone|pioglitazone|mesh-list
43879978|NCT04662866|Empagliflozin|empagliflozin|mesh-list
43879979|NCT04662866|Linagliptin|linagliptin|mesh-list
43879980|NCT04662866|Biguanides|biguanides|mesh-list
43879981|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
43879982|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43879983|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381647|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44381648|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44381649|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381650|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381651|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
44381652|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617240|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
43617241|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381653|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
44381654|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44381655|NCT03681093|Growth Substances|growth substances|mesh-ancestor
44381656|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381657|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
44381658|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44381659|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
44381660|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381661|NCT03680911|Expectorants|expectorants|mesh-ancestor
44381662|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
44381663|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44381664|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
44381665|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381666|NCT03680911|Protective Agents|protective agents|mesh-ancestor
44381667|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381668|NCT03680911|Antidotes|antidotes|mesh-ancestor
44381669|NCT03680521|Nivolumab|nivolumab|mesh-list
44381670|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381671|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381672|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44381673|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381674|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
44381675|NCT03678870|Narcotics|narcotics|mesh-ancestor
43879984|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43879985|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879987|NCT04662866|Hormones|hormones|mesh-ancestor
44165310|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879997|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43879999|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43880000|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
43880001|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
43880002|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880003|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880004|NCT04662385|Listerine|listerine|mesh-list
43880005|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
43880006|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
43617273|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617274|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617275|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43617276|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617277|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617278|NCT03140787|Lidocaine|lidocaine|mesh-list
43666915|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666916|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666917|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
43880007|NCT04662385|Protective Agents|protective agents|mesh-ancestor
43880008|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880009|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43880010|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381676|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381677|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381678|NCT03678870|Analgesics|analgesics|mesh-ancestor
44381679|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
44381680|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037987|NCT00002517|Cytarabine|cytarabine|mesh-list
44381681|NCT03677934|Ranibizumab|ranibizumab|mesh-list
43880012|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880013|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880014|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880015|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880016|NCT04662177|Analgesics|analgesics|mesh-ancestor
43880017|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
43880018|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880019|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880020|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880021|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880022|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880023|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880024|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880025|NCT04662125|Acetaminophen|acetaminophen|mesh-list
43880026|NCT04662125|Prednisolone|prednisolone|mesh-list
43880027|NCT04662125|Pregabalin|pregabalin|mesh-list
43880028|NCT04662125|Caffeine|caffeine|mesh-list
43880029|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880030|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
43880031|NCT04662125|Hormones|hormones|mesh-ancestor
43880032|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880033|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880034|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880035|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880036|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880037|NCT04662125|Analgesics|analgesics|mesh-ancestor
43880038|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
43880039|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
43880040|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43880041|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43880042|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880043|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880044|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880045|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880046|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880047|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880048|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880049|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
43880050|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43880051|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43880052|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880061|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880063|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880064|NCT04662242|Trace Elements|trace elements|mesh-ancestor
43880065|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
43880066|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
43880067|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880068|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
43880069|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
43880070|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880071|NCT04661709|Aspirin|aspirin|mesh-list
43880072|NCT04661709|Metoprolol|metoprolol|mesh-list
43880073|NCT04661709|Isosorbide|isosorbide|mesh-list
43880074|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43880075|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43880076|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
43880077|NCT04661709|Trimetazidine|trimetazidine|mesh-list
43880078|NCT04661709|Clopidogrel|clopidogrel|mesh-list
43880079|NCT04661709|Atorvastatin|atorvastatin|mesh-list
43880080|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880081|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43880082|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381682|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44381683|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44381684|NCT03677934|Growth Substances|growth substances|mesh-ancestor
44381685|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381686|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44381687|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381688|NCT03677401|Serlopitant|serlopitant|mesh-list
44381689|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44381690|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381691|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381692|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381693|NCT03674177|Vaccines|vaccines|mesh-list
44381694|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
44381695|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381696|NCT03673956|Vancomycin|vancomycin|mesh-list
44381697|NCT03673956|Levofloxacin|levofloxacin|mesh-list
44381698|NCT03673956|Ofloxacin|ofloxacin|mesh-list
44381699|NCT03673956|Tobramycin|tobramycin|mesh-list
44381700|NCT03673956|Mupirocin|mupirocin|mesh-list
44381701|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44381702|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381703|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44381704|NCT03673956|Renal Agents|renal agents|mesh-ancestor
44381705|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44381706|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381707|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412308|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43880083|NCT04661709|Analgesics|analgesics|mesh-ancestor
43880084|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
43880085|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880086|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880087|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880088|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43880089|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43880090|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880091|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43880092|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43880093|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880094|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
43880095|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43880096|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43880097|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
43617288|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617290|NCT03140384|Misoprostol|misoprostol|mesh-list
43880098|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43880099|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43880100|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43880101|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43880102|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43880103|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
44381708|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381709|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381710|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44381711|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44381712|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44381714|NCT03673670|Olodaterol|olodaterol|mesh-list
44381715|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44381716|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
44381717|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381718|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880104|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880105|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43880106|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43880107|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
43880108|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
43880109|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43880110|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43880111|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43880112|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880113|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43880114|NCT04661709|Diuretics|diuretics|mesh-ancestor
43880115|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
43880116|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
43880117|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43880118|NCT04661696|Paclitaxel|paclitaxel|mesh-list
43880119|NCT04661696|Carboplatin|carboplatin|mesh-list
43880120|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43880121|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880135|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880136|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880137|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880138|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880139|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880140|NCT04661345|Coagulase|coagulase|mesh-list
43880141|NCT04661345|Coagulants|coagulants|mesh-ancestor
44155867|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44155868|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155869|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155870|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44155871|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44155872|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44155873|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
44155874|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155875|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44155876|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44155877|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155878|NCT00228527|Esomeprazole|esomeprazole|mesh-list
44155879|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44155880|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880143|NCT04660773|Analgesics|analgesics|mesh-ancestor
43880144|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
43880145|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880146|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880147|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
43880148|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43880149|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43880150|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880151|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880152|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880153|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880154|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381719|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44381720|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
44381721|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
44381722|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44381723|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
44381724|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381725|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381726|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44381727|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44381728|NCT03672006|Heparin|heparin|mesh-list
44381729|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44381730|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
44381731|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44381732|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44381733|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381734|NCT03670810|Lasmiditan|lasmiditan|mesh-list
44381735|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44381736|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
44381737|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381738|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381739|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880155|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880156|NCT04660916|Isotretinoin|isotretinoin|mesh-list
43880157|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880158|NCT04660786|Vitamin D|vitamin d|mesh-list
43880159|NCT04660786|Triamcinolone|triamcinolone|mesh-list
43880160|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43880161|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43880162|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43880163|NCT04660786|Vitamins|vitamins|mesh-ancestor
43880164|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
43617321|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617322|NCT03140358|Atropine|atropine|mesh-list
43617323|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43617324|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43617325|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43617327|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617328|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617329|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43617331|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
43880165|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880166|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43880167|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880168|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
43880169|NCT04660786|Hormones|hormones|mesh-ancestor
43880170|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880174|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880176|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
43880177|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43880178|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880179|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43880180|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880181|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880182|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
43880183|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880184|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880185|NCT04660565|Prednisone|prednisone|mesh-list
43880186|NCT04660565|Belimumab|belimumab|mesh-list
43880187|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880188|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
43880189|NCT04660565|Hormones|hormones|mesh-ancestor
43880190|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43596066|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
44381741|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
44381742|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381743|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381744|NCT03669861|Abatacept|abatacept|mesh-list
44381745|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44381746|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381747|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381748|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381749|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
44381750|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381751|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381752|NCT03669081|Ketorolac|ketorolac|mesh-list
44381753|NCT03669081|Pregabalin|pregabalin|mesh-list
44381754|NCT03669081|Analgesics|analgesics|mesh-ancestor
44381755|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
44038044|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
44381756|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381757|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381758|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
44381759|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44381760|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381761|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381762|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44381763|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44381764|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43689052|NCT02807116|Rifampin|rifampin|mesh-list
43880191|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880192|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880193|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880194|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880195|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
43880196|NCT04660110|Piperaquine|piperaquine|mesh-list
43880197|NCT04660110|Artenimol|artenimol|mesh-list
43880198|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
43880199|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43880200|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43880201|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880202|NCT04659915|Metformin|metformin|mesh-list
43880203|NCT04659915|Prednisone|prednisone|mesh-list
43880204|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880205|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880206|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880207|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
43880208|NCT04659915|Hormones|hormones|mesh-ancestor
43880209|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880210|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880211|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381767|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44381769|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381770|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381771|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381772|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381774|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381775|NCT03667053|Hormones|hormones|mesh-ancestor
44381776|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381777|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381778|NCT03665441|Leucovorin|leucovorin|mesh-list
44381779|NCT03665441|Gemcitabine|gemcitabine|mesh-list
44381780|NCT03665441|Paclitaxel|paclitaxel|mesh-list
44381781|NCT03665441|Irinotecan|irinotecan|mesh-list
44381782|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44381783|NCT03665441|Asparaginase|asparaginase|mesh-list
44381784|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44381785|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381786|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44381787|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44381788|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44381789|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381790|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43880216|NCT04659785|Apatinib|apatinib|mesh-list
43880217|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880218|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43880219|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880220|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880221|NCT04659525|Ezetimibe|ezetimibe|mesh-list
43880222|NCT04659525|Evolocumab|evolocumab|mesh-list
43880223|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43880224|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43880225|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
43880226|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880227|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43880228|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
43880229|NCT04659551|Nivolumab|nivolumab|mesh-list
43880230|NCT04659551|Epirubicin|epirubicin|mesh-list
43617335|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
43617336|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617337|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617338|NCT03140293|Lidocaine|lidocaine|mesh-list
43617339|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
43880231|NCT04659551|Exemestane|exemestane|mesh-list
43880232|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43880233|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880234|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
43880235|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880236|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880237|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43880238|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
44381791|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
44381792|NCT03665441|Antiviral Agents|antiviral agents|mesh-ancestor
44381793|NCT03665441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381794|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381795|NCT03665441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44381796|NCT03665441|Immunologic Factors|immunologic factors|mesh-ancestor
44381797|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381798|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44381799|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44381801|NCT03665441|Protective Agents|protective agents|mesh-ancestor
44381802|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
44381803|NCT03665441|Vitamins|vitamins|mesh-ancestor
44381804|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
43880239|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880240|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880241|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43880242|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165311|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
43880245|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43880246|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43880247|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880248|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43880249|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43880250|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43880251|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
43880252|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880253|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
43880254|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43880255|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
43880256|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43880257|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43880258|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880259|NCT04659499|Paclitaxel|paclitaxel|mesh-list
43880260|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43880261|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880262|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
43880263|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
43880264|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
43880265|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880266|NCT04659642|Fentanyl|fentanyl|mesh-list
43880267|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
43880268|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880269|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880270|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880271|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880272|NCT04659642|Analgesics|analgesics|mesh-ancestor
43880273|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
43880274|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880275|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880276|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880277|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880278|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880279|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880280|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880281|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43880282|NCT04659642|Narcotics|narcotics|mesh-ancestor
43880283|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43851835|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
43880284|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880285|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
43880286|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
43880287|NCT04659109|Glenzocimab|glenzocimab|mesh-list
44381806|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
44381807|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381808|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381809|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381810|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
44381811|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
44381812|NCT03664024|Cisplatin|cisplatin|mesh-list
44381813|NCT03664024|Carboplatin|carboplatin|mesh-list
44381814|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
44381815|NCT03664024|Pemetrexed|pemetrexed|mesh-list
44381816|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44381817|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44381818|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381819|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381820|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44381821|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44381822|NCT03663582|Teduglutide|teduglutide|mesh-list
44381823|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44381824|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44381825|NCT03663582|Protective Agents|protective agents|mesh-ancestor
44381826|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381827|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44381828|NCT03662789|Hematinics|hematinics|mesh-ancestor
44381829|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
44381830|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44381831|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381832|NCT03661983|Aripiprazole|aripiprazole|mesh-list
44381833|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
44381834|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381835|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44381836|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880288|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
43880289|NCT04659070|Telmisartan|telmisartan|mesh-list
43880290|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43880291|NCT04659070|Ezetimibe|ezetimibe|mesh-list
43880292|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43880293|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43880294|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
43880295|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617370|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
43617371|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617372|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617373|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43617374|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617375|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43851836|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43851837|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43851838|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851839|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
43851840|NCT02187120|Coagulants|coagulants|mesh-ancestor
43851841|NCT02077959|Lenalidomide|lenalidomide|mesh-list
43666998|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666999|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667000|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43880296|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43880297|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44381837|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381838|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381839|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
44381840|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
44381841|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381842|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381843|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44381844|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44381845|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
44381846|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44381847|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44381848|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44381849|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44381850|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44381851|NCT03658876|Hematinics|hematinics|mesh-ancestor
43880298|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880299|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43880300|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43880301|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43880302|NCT04659057|Lidocaine|lidocaine|mesh-list
43880304|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
43880305|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
43880306|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880307|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880308|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
43880309|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880310|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43880311|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43880312|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43880313|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165312|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
43880316|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880317|NCT04659057|Analgesics|analgesics|mesh-ancestor
43880318|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880319|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880320|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880321|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880322|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880323|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
43880324|NCT04658732|Gabapentin|gabapentin|mesh-list
43617376|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617377|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43880325|NCT04658732|Alprazolam|alprazolam|mesh-list
43880326|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880327|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880328|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880329|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880330|NCT04658732|Analgesics|analgesics|mesh-ancestor
43880331|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
43880332|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880333|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880334|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880335|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880336|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880337|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880338|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880339|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
43880340|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880341|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880342|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381852|NCT03657095|Beraprost|beraprost|mesh-list
44381853|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44381854|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
44381855|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44381856|NCT03656692|Hormones|hormones|mesh-ancestor
44381857|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381858|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381859|NCT03655717|Ethanol|ethanol|mesh-list
44381860|NCT03655717|Dronabinol|dronabinol|mesh-list
44381861|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44381862|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44381863|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381864|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381865|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
44381866|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381867|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381868|NCT03655717|Analgesics|analgesics|mesh-ancestor
44381869|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
44381870|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381871|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44381872|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44381873|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381874|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381875|NCT03655717|Hormones|hormones|mesh-ancestor
44381876|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44381877|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
44381878|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44381879|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44381880|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44381881|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381882|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381883|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
44381890|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381892|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
44381893|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381894|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381895|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44381896|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44381897|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
44381898|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44381899|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44381900|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381901|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
44381902|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44381903|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44381904|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851846|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44381905|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
44381906|NCT03653429|Coagulants|coagulants|mesh-ancestor
44381907|NCT03653416|Bupivacaine|bupivacaine|mesh-list
44381908|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
44381909|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
44381910|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381911|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381912|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
44381913|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381914|NCT03652818|Acetaminophen|acetaminophen|mesh-list
44381915|NCT03652818|Pregabalin|pregabalin|mesh-list
44381916|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44381917|NCT03652818|Analgesics|analgesics|mesh-ancestor
44381918|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
44381919|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381920|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381921|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
44381922|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
44381923|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44381924|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381925|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381928|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381929|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381930|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381931|NCT03652610|Vaccines|vaccines|mesh-list
44381932|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
44381933|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381934|NCT03650387|Lidocaine|lidocaine|mesh-list
44381935|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
44381936|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
44381937|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381938|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381939|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
44381940|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381941|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44381942|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44381943|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44381944|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44381945|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381946|NCT03649477|Carbetocin|carbetocin|mesh-list
44381947|NCT03649477|Oxytocin|oxytocin|mesh-list
44381948|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
44381949|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44381950|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381951|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
44381952|NCT03647709|Narcotics|narcotics|mesh-ancestor
44381953|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381954|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381955|NCT03647709|Analgesics|analgesics|mesh-ancestor
44381956|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
44381958|NCT03645057|Tacrolimus|tacrolimus|mesh-list
43617388|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
43617389|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
43617390|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43617391|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43617418|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
43617419|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617420|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617421|NCT03139487|Dalteparin|dalteparin|mesh-list
43617422|NCT03139487|Tinzaparin|tinzaparin|mesh-list
43617423|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43617424|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
43851847|NCT02077959|Growth Substances|growth substances|mesh-ancestor
44381973|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44381974|NCT03643575|Expectorants|expectorants|mesh-ancestor
44381975|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44381976|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44381977|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44381978|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44381979|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381980|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44381981|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381982|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
44381983|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44381984|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
44381985|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
44381986|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44381987|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
44381988|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44381989|NCT03643159|Aripiprazole|aripiprazole|mesh-list
44381990|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
44381991|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
44381992|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44381993|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44381994|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44381995|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44381996|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
44381997|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
44381998|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44381999|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382000|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43880343|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43880344|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43880345|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
43880346|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
43880347|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
43880348|NCT04658420|Ketamine|ketamine|mesh-list
43880349|NCT04658420|Analgesics|analgesics|mesh-ancestor
43880350|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
43880351|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880352|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880353|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43880354|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880355|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
43880356|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
43880357|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880358|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43880359|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43880360|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382002|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
44382003|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44382004|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44382005|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44382006|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44382007|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
44382008|NCT03642873|Hydrocodone|hydrocodone|mesh-list
44382009|NCT03642873|Guaifenesin|guaifenesin|mesh-list
44382010|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44382011|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44382012|NCT03642873|Narcotics|narcotics|mesh-ancestor
44382013|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382014|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382015|NCT03642873|Analgesics|analgesics|mesh-ancestor
44382016|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
44382017|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382018|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
44382019|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
43880361|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667021|NCT01666080|Levetiracetam|levetiracetam|mesh-list
43667025|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
44155881|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44155882|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155883|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155884|NCT00228540|Modafinil|modafinil|mesh-list
43880362|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43880363|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
43880364|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880365|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
43880366|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43880367|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
43880368|NCT04658355|Povidone|povidone|mesh-list
43880369|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43880370|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880371|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
43880372|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880373|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
43880374|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
43880375|NCT04658134|Glycine|glycine|mesh-list
43880376|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
43880377|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880378|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880379|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880380|NCT04657939|Pioglitazone|pioglitazone|mesh-list
43880381|NCT04657939|Liraglutide|liraglutide|mesh-list
43880382|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880386|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880387|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
43880388|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43880389|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880390|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
43880391|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43880392|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43880393|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880394|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880395|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
44382020|NCT03642873|Expectorants|expectorants|mesh-ancestor
44382021|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44382022|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44382023|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43617425|NCT03139487|Apixaban|apixaban|mesh-list
43617426|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43617427|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
43617428|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43617429|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
43617430|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617431|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617432|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
43617433|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667033|NCT01628029|Methylphenidate|methylphenidate|mesh-list
43667036|NCT01628029|Protective Agents|protective agents|mesh-ancestor
44382024|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382025|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382026|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
44382027|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44382028|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
44382029|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
44382030|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
44382031|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44382032|NCT03642717|Empagliflozin|empagliflozin|mesh-list
43689259|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
43880396|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880397|NCT04657497|Camostat|camostat|mesh-list
43880398|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
43880399|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880400|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880401|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43880402|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43880403|NCT04657484|Prednisolone|prednisolone|mesh-list
43880404|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43880405|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
43880406|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43880407|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
43880408|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43880409|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
43880410|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880411|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
43880412|NCT04657484|Hormones|hormones|mesh-ancestor
43880413|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880414|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880415|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617434|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43617435|NCT03139253|Amoxicillin|amoxicillin|mesh-list
43617436|NCT03139253|Clarithromycin|clarithromycin|mesh-list
43880416|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880417|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
43880418|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
43880419|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880420|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880421|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43880422|NCT04657484|Protective Agents|protective agents|mesh-ancestor
43880423|NCT04657107|Ketamine|ketamine|mesh-list
43880424|NCT04657107|Esketamine|esketamine|mesh-list
43880425|NCT04657107|Analgesics|analgesics|mesh-ancestor
43880426|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
43880427|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880428|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880430|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880431|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
43880432|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
43880433|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880434|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43880435|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43880436|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880437|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880438|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
43880439|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880440|NCT04657172|Pilocarpine|pilocarpine|mesh-list
43880441|NCT04657172|Miotics|miotics|mesh-ancestor
43880442|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
43880443|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880444|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382033|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44382034|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382035|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44382036|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382037|NCT03642262|Guaifenesin|guaifenesin|mesh-list
44382038|NCT03642262|Expectorants|expectorants|mesh-ancestor
44382039|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44382040|NCT03641651|Frovatriptan|frovatriptan|mesh-list
44382041|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44382042|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
44382043|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689276|NCT02805426|Misoprostol|misoprostol|mesh-list
43880445|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43880446|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43880447|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
43880448|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880449|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880450|NCT04656665|Aspirin|aspirin|mesh-list
43880451|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43880452|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880453|NCT04656665|Analgesics|analgesics|mesh-ancestor
43880454|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
43880455|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880458|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880459|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43880460|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43880461|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880462|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43617474|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617475|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
43617476|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617477|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
43880463|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43880464|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880465|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
43880466|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43880467|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880468|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880469|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
43880470|NCT04656262|Doxorubicin|doxorubicin|mesh-list
43880471|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880472|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
43880473|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880474|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880475|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43880476|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
43880477|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880478|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880479|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43880480|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43880481|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43880482|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43880483|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880484|NCT04656249|Lenvatinib|lenvatinib|mesh-list
43880485|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880486|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43880487|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880488|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155885|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44155886|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155887|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44155888|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44155889|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44155890|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382044|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382045|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382046|NCT03641508|Dexamethasone|dexamethasone|mesh-list
44382047|NCT03641508|Triamcinolone|triamcinolone|mesh-list
44382048|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382049|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
44382050|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
44382051|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382052|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382053|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382054|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
44382055|NCT03641508|Hormones|hormones|mesh-ancestor
44382056|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382057|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44382058|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382059|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
44382060|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44382061|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382062|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
44382063|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
43617484|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617485|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382064|NCT03639779|Antidotes|antidotes|mesh-ancestor
44382065|NCT03639779|Protective Agents|protective agents|mesh-ancestor
44382066|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382067|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
44382068|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382069|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
44382070|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44382071|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382072|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
44382073|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
44382074|NCT03639675|Aflibercept|aflibercept|mesh-list
44382075|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44382076|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44382077|NCT03639675|Growth Substances|growth substances|mesh-ancestor
44382078|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382079|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
44155892|NCT00228592|Antibodies|antibodies|mesh-list
44155893|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
44155894|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44155895|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44382080|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382081|NCT03638635|Bupivacaine|bupivacaine|mesh-list
44382082|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382083|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
44382084|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382085|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382086|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
44382087|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382088|NCT03636906|Vaccines|vaccines|mesh-list
44382089|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
44382090|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382091|NCT03635957|Folic Acid|folic acid|mesh-list
44382092|NCT03635957|Methotrexate|methotrexate|mesh-list
44382093|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44382094|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
44382095|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44382096|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382097|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44382098|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
44382099|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689318|NCT02804815|Aspirin|aspirin|mesh-list
44155896|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
44155897|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155898|NCT00228605|Fentanyl|fentanyl|mesh-list
44155899|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44155900|NCT00228605|Narcotics|narcotics|mesh-ancestor
44155901|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155902|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155903|NCT00228605|Analgesics|analgesics|mesh-ancestor
44155904|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
44155905|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155906|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43617527|NCT03139331|Irinotecan|irinotecan|mesh-list
44155907|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880489|NCT04655807|Adalimumab|adalimumab|mesh-list
43880490|NCT04655807|Ustekinumab|ustekinumab|mesh-list
43880491|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880492|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880493|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880494|NCT04655664|Vitamin D|vitamin d|mesh-list
43880495|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
43880496|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
43880497|NCT04655664|Vitamins|vitamins|mesh-list
43880498|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
43880499|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880500|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43880501|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880502|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
43880503|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43880504|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43880505|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43880508|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880509|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880511|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
43880512|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
43880513|NCT04655508|Hormones|hormones|mesh-ancestor
44382100|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382101|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
44382102|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382103|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44382104|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44382105|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
44382106|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382107|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44382108|NCT03635957|Hematinics|hematinics|mesh-ancestor
44382109|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
44382110|NCT03635957|Vitamins|vitamins|mesh-ancestor
44382111|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
44382112|NCT03634800|Nivolumab|nivolumab|mesh-list
44382113|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382114|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382115|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44382116|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382117|NCT03633331|Letrozole|letrozole|mesh-list
44382118|NCT03633331|Fulvestrant|fulvestrant|mesh-list
44382119|NCT03633331|Palbociclib|palbociclib|mesh-list
44382120|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382121|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44382122|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44382123|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382124|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382125|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44382126|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382127|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382128|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382129|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880514|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880515|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
43880516|NCT04655729|Infliximab|infliximab|mesh-list
43880517|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880518|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880519|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880520|NCT04655183|Niraparib|niraparib|mesh-list
43880521|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43880522|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880523|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880524|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880525|NCT04655040|Caffeine|caffeine|mesh-list
43880526|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43598255|NCT03301207|Midazolam|midazolam|mesh-list
44382130|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44382131|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382133|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382134|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382135|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
44382136|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382137|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382138|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
44382139|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44382140|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44382141|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382142|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
44382143|NCT03631355|Coagulants|coagulants|mesh-ancestor
44382144|NCT03630120|Sorafenib|sorafenib|mesh-list
44382145|NCT03630120|Lenvatinib|lenvatinib|mesh-list
44382146|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382147|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382148|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382149|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382150|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
44382151|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44382152|NCT03629249|Growth Substances|growth substances|mesh-ancestor
44382153|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382154|NCT03629184|Oseltamivir|oseltamivir|mesh-list
44382155|NCT03629184|Baloxavir|baloxavir|mesh-list
44382156|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
44382157|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382158|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880527|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880528|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43880529|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880530|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880531|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43880532|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43880533|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
43880534|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880535|NCT04654962|Anesthetics|anesthetics|mesh-list
43880536|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880537|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880538|NCT04654416|Colchicine|colchicine|mesh-list
43880539|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
43880540|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880541|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
43880542|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
43880543|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
44382159|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382160|NCT03629054|Metformin|metformin|mesh-list
44382161|NCT03629054|Empagliflozin|empagliflozin|mesh-list
44382162|NCT03629054|Linagliptin|linagliptin|mesh-list
44382163|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44038473|NCT00002544|Docetaxel|docetaxel|mesh-list
44382164|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382165|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44382166|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382167|NCT03629054|Incretins|incretins|mesh-ancestor
44382168|NCT03629054|Hormones|hormones|mesh-ancestor
44382169|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382170|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44382171|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
44382172|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382173|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44382174|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
44382175|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382176|NCT03628716|Atezolizumab|atezolizumab|mesh-list
44382177|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382178|NCT03628417|Bleomycin|bleomycin|mesh-list
44382179|NCT03628417|Calcium|calcium|mesh-list
44382180|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44382181|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382182|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44382183|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382184|NCT03627767|Abrocitinib|abrocitinib|mesh-list
44382185|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382186|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382187|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382188|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44382199|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382200|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44382202|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
44382203|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44382204|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44382205|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
44382206|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
44382207|NCT03624946|Antibodies|antibodies|mesh-list
44382208|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
44382209|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44382210|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44382211|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
44382212|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
44382213|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382214|NCT03622593|Aflibercept|aflibercept|mesh-list
44382215|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44382216|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44382217|NCT03622593|Growth Substances|growth substances|mesh-ancestor
44382218|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382219|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
44382220|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382221|NCT03622580|Aflibercept|aflibercept|mesh-list
44382222|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44382223|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44382224|NCT03622580|Growth Substances|growth substances|mesh-ancestor
43847147|NCT04136756|Rituximab|rituximab|mesh-list
43880544|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880545|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880546|NCT04654676|Vildagliptin|vildagliptin|mesh-list
43880547|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617536|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43617537|NCT03138759|Probenecid|probenecid|mesh-list
43617538|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
43617539|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
43617540|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617541|NCT03138759|Renal Agents|renal agents|mesh-ancestor
43617542|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
43617543|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43617544|NCT03138681|Protective Agents|protective agents|mesh-ancestor
43617545|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617546|NCT03138668|Ropivacaine|ropivacaine|mesh-list
43880548|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880549|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43880550|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
43880551|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880552|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880553|NCT04654819|Anesthetics|anesthetics|mesh-list
43880554|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880555|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880556|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43880557|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
43880558|NCT04654741|Ganirelix|ganirelix|mesh-list
43880559|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43880560|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43880561|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43880562|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
43880563|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43880564|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382225|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382226|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
44382227|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382228|NCT03621696|Cisplatin|cisplatin|mesh-list
44382229|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382230|NCT03620708|Nicotine|nicotine|mesh-list
44382231|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44382232|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
44382233|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382234|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382235|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44382236|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44382237|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
44038546|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
44382238|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382239|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382240|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
44382241|NCT03619837|Velpatasvir|velpatasvir|mesh-list
44382242|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44382243|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
44382244|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382245|NCT03618823|Acetaminophen|acetaminophen|mesh-list
44382246|NCT03618823|Ibuprofen|ibuprofen|mesh-list
44382247|NCT03618823|Oxycodone|oxycodone|mesh-list
44382248|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382249|NCT03618823|Analgesics|analgesics|mesh-ancestor
44382250|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
43848963|NCT03976323|Cisplatin|cisplatin|mesh-list
43880565|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43880566|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43880567|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43880568|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880569|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880570|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
43880571|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880572|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
43880573|NCT04654195|Doxorubicin|doxorubicin|mesh-list
43880574|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880575|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
43880577|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880578|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43880579|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
43880580|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880581|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880582|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43880583|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43880584|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43880585|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43880586|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382251|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382252|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382253|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
44382254|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382255|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382256|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382257|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44382258|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382259|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382260|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44382261|NCT03618823|Narcotics|narcotics|mesh-ancestor
44382262|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617614|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
43617615|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617616|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617617|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
43617618|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617619|NCT03137498|Ketorolac|ketorolac|mesh-list
44382263|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
44382264|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44382265|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382266|NCT03617861|Secretin|secretin|mesh-list
44382267|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382268|NCT03617861|Hormones|hormones|mesh-ancestor
44382269|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382270|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382271|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
44382272|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44382273|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382274|NCT03615924|Ticagrelor|ticagrelor|mesh-list
44382275|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44382276|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43880587|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
43880588|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43880589|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43880590|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880591|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
43880592|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
43880593|NCT04654026|Aspirin|aspirin|mesh-list
43880594|NCT04654026|Clopidogrel|clopidogrel|mesh-list
43880595|NCT04654026|Ticagrelor|ticagrelor|mesh-list
43880596|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43880597|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880598|NCT04654026|Analgesics|analgesics|mesh-ancestor
43880599|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
43880600|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880601|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880602|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880603|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880604|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43880605|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43880606|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880607|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44382277|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44382278|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44382279|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
44382280|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382281|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382282|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382283|NCT03615482|Vaccines|vaccines|mesh-list
44382284|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
44382285|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382286|NCT03615404|Molgramostim|molgramostim|mesh-list
44382287|NCT03615404|Sargramostim|sargramostim|mesh-list
44382288|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
44382289|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382290|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382291|NCT03615144|Fludarabine|fludarabine|mesh-list
44382292|NCT03615144|Melphalan|melphalan|mesh-list
44382293|NCT03615144|Thiotepa|thiotepa|mesh-list
44382294|NCT03615144|Clofarabine|clofarabine|mesh-list
44382295|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
44382296|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44382297|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382298|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44382299|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
44382300|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382301|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44382302|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
44382303|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382304|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44382307|NCT03615040|Astegolimab|astegolimab|mesh-list
44382324|NCT03608774|Doxycycline|doxycycline|mesh-list
44382325|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44382326|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382327|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
43667180|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
44382328|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44382329|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44382330|NCT03607422|Upadacitinib|upadacitinib|mesh-list
44382331|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44382332|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382333|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382334|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382335|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382336|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
44382337|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
44382338|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382339|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
44382340|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44382341|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44382342|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382343|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
44382344|NCT03606109|Coagulants|coagulants|mesh-ancestor
44382345|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
44382346|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43689495|NCT02802995|Thrombin|thrombin|mesh-list
43880608|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43880609|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880610|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
43880611|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43880612|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43880613|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43880614|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
43880615|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880616|NCT04653506|Acetaminophen|acetaminophen|mesh-list
43880617|NCT04653506|Ibuprofen|ibuprofen|mesh-list
43880618|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43880619|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880620|NCT04653506|Analgesics|analgesics|mesh-ancestor
43880621|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
43880622|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880623|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880624|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880625|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880626|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43880627|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880628|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880629|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
43880630|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
43880631|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43880632|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43880633|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880634|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
43880635|NCT04653623|Coagulants|coagulants|mesh-ancestor
43880636|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
44382347|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382349|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
44382350|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382352|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
44382353|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382354|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44382355|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382356|NCT03604341|Analgesics|analgesics|mesh-ancestor
44382357|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
44382358|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382359|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44382360|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44382361|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382362|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382363|NCT03604341|Hormones|hormones|mesh-ancestor
44382364|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382365|NCT03603496|Nicotine|nicotine|mesh-list
44382366|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44382367|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
44382368|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382369|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382370|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44382371|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44382372|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
44382373|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382374|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382375|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44382376|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
44382377|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
43880637|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617639|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617640|NCT03137316|Hormones|hormones|mesh-list
43617641|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
43617675|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617676|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43617677|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
43617678|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617711|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43617712|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43617713|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
43667192|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43851889|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063467|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44063468|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063469|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
44063470|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063471|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063472|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063473|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063474|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
44063476|NCT00006050|Protective Agents|protective agents|mesh-ancestor
44063477|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
44063478|NCT00006050|Vitamins|vitamins|mesh-ancestor
44063479|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
44063480|NCT00006051|Cisplatin|cisplatin|mesh-list
44063481|NCT00006051|Fluorouracil|fluorouracil|mesh-list
43560822|NCT03184870|Leucovorin|leucovorin|mesh-list
44063490|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063491|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063492|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063493|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063494|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
44063495|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063496|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063497|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063498|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063499|NCT00006054|Cyclosporine|cyclosporine|mesh-list
44063501|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
44063502|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
44063503|NCT00006054|Busulfan|busulfan|mesh-list
44063504|NCT00006054|Methotrexate|methotrexate|mesh-list
44063505|NCT00006054|Etoposide|etoposide|mesh-list
44063506|NCT00006054|Cyclosporins|cyclosporins|mesh-list
44063507|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44063508|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063509|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
44063510|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063511|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256166|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
44256167|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256168|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44256169|NCT00618579|Warfarin|warfarin|mesh-list
44256170|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
44256171|NCT00618631|Carfentanil|carfentanil|mesh-list
44256172|NCT00618631|Nicotine|nicotine|mesh-list
44256173|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44256174|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
44256175|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256176|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256177|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44256178|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44256179|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
44256180|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256181|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256182|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44256183|NCT00618631|Narcotics|narcotics|mesh-ancestor
43824903|NCT05506787|Esketamine|esketamine|mesh-list
44063512|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44063513|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
44063514|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063515|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063516|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44063517|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063518|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
44063519|NCT00006054|Hormones|hormones|mesh-ancestor
43617717|NCT03137004|Docetaxel|docetaxel|mesh-list
44063520|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063521|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063522|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44063523|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
44063524|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44063525|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063526|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
44063527|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44063528|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063529|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44063530|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063531|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063532|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063533|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063534|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
44063535|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063536|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44063537|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
44063538|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
44063539|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063540|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063541|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44063542|NCT00006054|Protective Agents|protective agents|mesh-ancestor
44063543|NCT00006055|Cyclosporine|cyclosporine|mesh-list
44063544|NCT00006055|Prednisone|prednisone|mesh-list
44063545|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
44063546|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
44063547|NCT00006055|Cyclosporins|cyclosporins|mesh-list
44063548|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44063557|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44063558|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256184|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256185|NCT00618631|Analgesics|analgesics|mesh-ancestor
44256186|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
44063560|NCT00006055|Hormones|hormones|mesh-ancestor
44063561|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063562|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44063563|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063564|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
44063565|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063566|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
44063567|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44063568|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
44063569|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
44063570|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063571|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063572|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44063573|NCT00006055|Protective Agents|protective agents|mesh-ancestor
44063574|NCT00006056|Cyclosporine|cyclosporine|mesh-list
44063575|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
44063576|NCT00006056|Busulfan|busulfan|mesh-list
44063577|NCT00006056|Methotrexate|methotrexate|mesh-list
44063578|NCT00006056|Etoposide|etoposide|mesh-list
44063579|NCT00006056|Cyclosporins|cyclosporins|mesh-list
44063580|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44063581|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063582|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
44063583|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063584|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063585|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44063586|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
44063587|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063588|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063589|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44063590|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44063591|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
44063592|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44063593|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063594|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
44063595|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44063596|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063597|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44063598|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063599|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063600|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063601|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063602|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
44063603|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063604|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44063605|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
44063606|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063607|NCT00006063|Pancrelipase|pancrelipase|mesh-list
44063608|NCT00006063|Pancreatin|pancreatin|mesh-list
44063609|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063610|NCT00006066|Aldesleukin|aldesleukin|mesh-list
44063611|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063612|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44063613|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44063614|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
44063615|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063616|NCT00006070|Etanercept|etanercept|mesh-list
43560957|NCT02903368|Prednisone|prednisone|mesh-list
44063625|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063626|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063627|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
44063629|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063630|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063631|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
44063632|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063633|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063634|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
44063635|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44063636|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44063637|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063638|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
44063639|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256187|NCT00618644|Ranibizumab|ranibizumab|mesh-list
44256188|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256189|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256190|NCT00618644|Growth Substances|growth substances|mesh-ancestor
44256191|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256192|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256193|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256194|NCT00618657|Paclitaxel|paclitaxel|mesh-list
44256195|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44256196|NCT00618657|Bevacizumab|bevacizumab|mesh-list
44256197|NCT00618657|Carboplatin|carboplatin|mesh-list
44063640|NCT00006077|Levodopa|levodopa|mesh-list
44063641|NCT00006077|Domperidone|domperidone|mesh-list
43617766|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
44063642|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44063643|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44063644|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
44063645|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617767|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44063646|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063647|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063648|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
44063649|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
44063650|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063651|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063652|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44063653|NCT00006078|Lycopene|lycopene|mesh-list
44063654|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063655|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
44063656|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063657|NCT00006078|Protective Agents|protective agents|mesh-ancestor
44063658|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063659|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44063660|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44063661|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063662|NCT00006079|Eflornithine|eflornithine|mesh-list
44063663|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063664|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44063665|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44063667|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063668|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44063669|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063670|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063671|NCT00006080|Fenretinide|fenretinide|mesh-list
44063672|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063673|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44063674|NCT00006080|Protective Agents|protective agents|mesh-ancestor
44063675|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063676|NCT00006081|Paclitaxel|paclitaxel|mesh-list
44063677|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
44063678|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063679|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063680|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063681|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063682|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063683|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063684|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43561029|NCT02646982|Candesartan|candesartan|mesh-list
44063690|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063691|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063692|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063693|NCT00006083|Dalteparin|dalteparin|mesh-list
44063694|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
44063695|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44063696|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44063697|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063698|NCT00006084|Lintuzumab|lintuzumab|mesh-list
44063699|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256198|NCT00618657|Trastuzumab|trastuzumab|mesh-list
44256199|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44256200|NCT00618657|Antibodies|antibodies|mesh-list
44256201|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
44256202|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44256203|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256204|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653555|NCT02983344|Narcotics|narcotics|mesh-ancestor
44063700|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063701|NCT00006086|Carboplatin|carboplatin|mesh-list
44063702|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063703|NCT00006088|Vinorelbine|vinorelbine|mesh-list
44063704|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063705|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667197|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667198|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667202|NCT05431595|Valproic Acid|valproic acid|mesh-list
43667203|NCT05431595|Haloperidol|haloperidol|mesh-list
44063706|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063707|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063708|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063709|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063710|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44063711|NCT00006089|Trastuzumab|trastuzumab|mesh-list
44063712|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44063713|NCT00006089|Antibodies|antibodies|mesh-list
44063714|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
44063715|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44063716|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
44063717|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063718|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063719|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
44063720|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063721|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
44063722|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063723|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
44063724|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063725|NCT00006094|Fluorouracil|fluorouracil|mesh-list
44063726|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
44063727|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
44063728|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063729|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063730|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063731|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063732|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
44063733|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063734|NCT00006095|Irinotecan|irinotecan|mesh-list
44063735|NCT00006095|Vincristine|vincristine|mesh-list
44063736|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44063737|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063738|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063739|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063740|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063741|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063742|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063743|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063744|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063745|NCT00006096|Cisplatin|cisplatin|mesh-list
44063746|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063747|NCT00006098|Bortezomib|bortezomib|mesh-list
44063748|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063749|NCT00006100|Aldesleukin|aldesleukin|mesh-list
44063750|NCT00006100|Fludarabine|fludarabine|mesh-list
44063751|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
44063752|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063753|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063754|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
44063755|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063756|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617847|NCT03135795|Parecoxib|parecoxib|mesh-list
43617848|NCT03135795|Sufentanil|sufentanil|mesh-list
44063757|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
43650333|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650334|NCT03015350|Sevoflurane|sevoflurane|mesh-list
43617849|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
43617850|NCT03135795|Remifentanil|remifentanil|mesh-list
44063758|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063759|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44063760|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44063761|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
44256205|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256206|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256207|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256208|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256209|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256210|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256211|NCT00618657|Growth Substances|growth substances|mesh-ancestor
44256212|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256213|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256214|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
44256215|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44256217|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
44063762|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063763|NCT00006103|Leucovorin|leucovorin|mesh-list
44063764|NCT00006103|Fluorouracil|fluorouracil|mesh-list
44063765|NCT00006103|Irinotecan|irinotecan|mesh-list
44063766|NCT00006103|Calcium|calcium|mesh-list
44063767|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
44063768|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44063769|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063770|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
44063771|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063772|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063773|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063774|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063775|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
44063776|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44063777|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063778|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063779|NCT00006103|Antidotes|antidotes|mesh-ancestor
44063780|NCT00006103|Protective Agents|protective agents|mesh-ancestor
44063781|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
44063782|NCT00006103|Vitamins|vitamins|mesh-ancestor
44063783|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
44063784|NCT00006104|Docetaxel|docetaxel|mesh-list
44063785|NCT00006104|Trastuzumab|trastuzumab|mesh-list
44063786|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063787|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063788|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063789|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063790|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063791|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063792|NCT00006105|Gemcitabine|gemcitabine|mesh-list
44063793|NCT00006105|Cisplatin|cisplatin|mesh-list
44063794|NCT00006105|Amifostine|amifostine|mesh-list
44063795|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063796|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063797|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
44063798|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063799|NCT00006105|Antiviral Agents|antiviral agents|mesh-ancestor
44063800|NCT00006105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063801|NCT00006105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063802|NCT00006105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063803|NCT00006105|Immunologic Factors|immunologic factors|mesh-ancestor
44063804|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063805|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44063806|NCT00006105|Protective Agents|protective agents|mesh-ancestor
44063807|NCT00006106|Cisplatin|cisplatin|mesh-list
44063808|NCT00006106|Fluorouracil|fluorouracil|mesh-list
43667214|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43851894|NCT01745757|Paclitaxel|paclitaxel|mesh-list
44063809|NCT00006106|Dl1520|dl1520|mesh-list
44063810|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063811|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
44063812|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256218|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44256219|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
44256220|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256221|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256222|NCT00618852|Furosemide|furosemide|mesh-list
44256223|NCT00618852|Diuretics|diuretics|mesh-ancestor
44256224|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
44063813|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063814|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063815|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
44063816|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063817|NCT00006107|Docetaxel|docetaxel|mesh-list
44063818|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063819|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063820|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063821|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063822|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063823|NCT00006108|Paclitaxel|paclitaxel|mesh-list
44063824|NCT00006108|Capecitabine|capecitabine|mesh-list
44063825|NCT00006108|Trastuzumab|trastuzumab|mesh-list
44063826|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063827|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063828|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063829|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063830|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063831|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063832|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063833|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
44063834|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063835|NCT00006111|Cisplatin|cisplatin|mesh-list
44063836|NCT00006111|Fluorouracil|fluorouracil|mesh-list
44063837|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063838|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
44063839|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063840|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063841|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063842|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
44063843|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063844|NCT00006112|Leucovorin|leucovorin|mesh-list
44063845|NCT00006112|Fluorouracil|fluorouracil|mesh-list
44063846|NCT00006112|Mitomycins|mitomycins|mesh-list
44063847|NCT00006112|Mitomycin|mitomycin|mesh-list
44063848|NCT00006112|Calcium|calcium|mesh-list
44063849|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
44063850|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44063851|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063852|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
44063853|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063854|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063855|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063856|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063857|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
44063858|NCT00006112|Antidotes|antidotes|mesh-ancestor
44063859|NCT00006112|Protective Agents|protective agents|mesh-ancestor
44063860|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
44063861|NCT00006112|Vitamins|vitamins|mesh-ancestor
44063862|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
44063863|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44063864|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
44063865|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063866|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063867|NCT00006113|Interferons|interferons|mesh-list
44063868|NCT00006113|Aldesleukin|aldesleukin|mesh-list
44063869|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
44063870|NCT00006113|Interleukin-4|interleukin-4|mesh-list
44063871|NCT00006113|Sargramostim|sargramostim|mesh-list
44063872|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063873|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
44063874|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063875|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
44063876|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063877|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256225|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256226|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44256227|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256228|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063878|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44063879|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44063880|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063881|NCT00006114|Vinorelbine|vinorelbine|mesh-list
44063882|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
44063883|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063884|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063885|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063886|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063887|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063888|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063889|NCT00006114|Analgesics|analgesics|mesh-ancestor
44063890|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
44063891|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063892|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063893|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063894|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063895|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063896|NCT00006115|Leucovorin|leucovorin|mesh-list
44063897|NCT00006115|Fluorouracil|fluorouracil|mesh-list
44063898|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
44063899|NCT00006115|Irinotecan|irinotecan|mesh-list
44063900|NCT00006115|Calcium|calcium|mesh-list
44063901|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
44063902|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44063903|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063904|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
44063905|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063906|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063907|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063908|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063909|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
44063910|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44063911|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063912|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063913|NCT00006115|Antidotes|antidotes|mesh-ancestor
44063926|NCT00006116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063927|NCT00006116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063928|NCT00006116|Immunologic Factors|immunologic factors|mesh-ancestor
44063929|NCT00006116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063930|NCT00006117|Gemcitabine|gemcitabine|mesh-list
44063931|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
44063932|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063933|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
44063934|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063935|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063937|NCT00006117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063938|NCT00006117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063939|NCT00006117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617892|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617893|NCT03136120|Bromides|bromides|mesh-list
43617894|NCT03136120|Ipratropium|ipratropium|mesh-list
43617895|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
43617896|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43617897|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
43617898|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617899|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617900|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43617901|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44063940|NCT00006117|Immunologic Factors|immunologic factors|mesh-ancestor
44063941|NCT00006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063942|NCT00006118|Gemcitabine|gemcitabine|mesh-list
44063943|NCT00006118|Paclitaxel|paclitaxel|mesh-list
44063944|NCT00006118|Cisplatin|cisplatin|mesh-list
44063945|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063946|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063947|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063948|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063949|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063950|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063951|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063952|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
44063953|NCT00006118|Antiviral Agents|antiviral agents|mesh-ancestor
44063954|NCT00006118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063955|NCT00006118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063956|NCT00006118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256229|NCT00618969|Busulfan|busulfan|mesh-list
44256230|NCT00618969|Melphalan|melphalan|mesh-list
44256231|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
44256232|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256233|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256234|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
44256235|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256236|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44256237|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063957|NCT00006118|Immunologic Factors|immunologic factors|mesh-ancestor
44063958|NCT00006118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063959|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
44063960|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063961|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
44063962|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063963|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063964|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063965|NCT00006120|Paclitaxel|paclitaxel|mesh-list
44063966|NCT00006120|Docetaxel|docetaxel|mesh-list
44063967|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063968|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063969|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063970|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063971|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063972|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063973|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
44063974|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063975|NCT00006122|Cytarabine|cytarabine|mesh-list
44063976|NCT00006122|Etoposide|etoposide|mesh-list
44063978|NCT00006122|Idarubicin|idarubicin|mesh-list
44063979|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
44063980|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063981|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063985|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063986|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063987|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
44063988|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
44063989|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063990|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063991|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
44063992|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063993|NCT00006122|Analgesics|analgesics|mesh-ancestor
44063994|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
43667216|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
43667217|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44063995|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063996|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44063997|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063998|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
44063999|NCT00006123|Thiotepa|thiotepa|mesh-list
44064000|NCT00006123|Carmustine|carmustine|mesh-list
44064001|NCT00006123|Cisplatin|cisplatin|mesh-list
44064002|NCT00006123|Carboplatin|carboplatin|mesh-list
44064003|NCT00006123|Trastuzumab|trastuzumab|mesh-list
44064004|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064005|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
44064006|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064007|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064008|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064009|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
44064010|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064011|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064012|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44064013|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44064014|NCT00006124|Celecoxib|celecoxib|mesh-list
44064015|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44064016|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44064017|NCT00006124|Analgesics|analgesics|mesh-ancestor
44064018|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
44256238|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44256239|NCT00619021|Gemcitabine|gemcitabine|mesh-list
44256240|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256241|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
44256242|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256243|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064019|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064020|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064021|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44064022|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064023|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44064024|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44064025|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064026|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064027|NCT00006125|Doxorubicin|doxorubicin|mesh-list
44064028|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44064029|NCT00006125|Topotecan|topotecan|mesh-list
44064030|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064031|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064032|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064033|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064034|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064035|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064036|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44064037|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
44064038|NCT00006126|Busulfan|busulfan|mesh-list
44064039|NCT00006126|Fludarabine|fludarabine|mesh-list
44064040|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
44064041|NCT00006126|Etoposide|etoposide|mesh-list
44064042|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064043|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
44064044|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064045|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064046|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064047|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
44064048|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064049|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064050|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44064051|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064052|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
44064053|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064054|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064055|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064056|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064057|NCT00006127|Amifostine|amifostine|mesh-list
44064058|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44064059|NCT00006127|Protective Agents|protective agents|mesh-ancestor
44064060|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064061|NCT00006129|Testosterone|testosterone|mesh-list
44064062|NCT00006129|Androgens|androgens|mesh-ancestor
44064063|NCT00006129|Hormones|hormones|mesh-ancestor
44064064|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064065|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064066|NCT00006131|Valacyclovir|valacyclovir|mesh-list
44064067|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
44064068|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064069|NCT00006132|Acyclovir|acyclovir|mesh-list
44064070|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
44064071|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064072|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44064073|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44064074|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44064075|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44064076|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
44064077|NCT00006133|Norethindrone|norethindrone|mesh-list
44064078|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
44064079|NCT00006133|Estradiol|estradiol|mesh-list
44064080|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44064081|NCT00006133|Estrogens|estrogens|mesh-ancestor
44064082|NCT00006133|Hormones|hormones|mesh-ancestor
44256244|NCT00619021|Antiviral Agents|antiviral agents|mesh-ancestor
44256245|NCT00619021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256246|NCT00619021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256247|NCT00619021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256248|NCT00619021|Immunologic Factors|immunologic factors|mesh-ancestor
44256249|NCT00619021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256250|NCT00619034|Diclofenac|diclofenac|mesh-list
44256251|NCT00619034|Dorzolamide|dorzolamide|mesh-list
44256252|NCT00619034|Latanoprost|latanoprost|mesh-list
44064083|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064084|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064085|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44064086|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
44064087|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786825|NCT05116462|Paclitaxel|paclitaxel|mesh-list
44064088|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44064089|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44064090|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44064091|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44064092|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44064093|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064094|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064095|NCT00006135|Acyclovir|acyclovir|mesh-list
44064096|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
44064097|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064098|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
44064099|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
44064100|NCT00006136|Hematinics|hematinics|mesh-ancestor
44064101|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064102|NCT00006137|Enalapril|enalapril|mesh-list
44064103|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44064104|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064105|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064106|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064107|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44064108|NCT00006144|Ritonavir|ritonavir|mesh-list
44064109|NCT00006144|Lopinavir|lopinavir|mesh-list
44064110|NCT00006144|Emtricitabine|emtricitabine|mesh-list
44064111|NCT00006144|Stavudine|stavudine|mesh-list
44064112|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064113|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44064114|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064115|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064116|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064117|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064118|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064119|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
44064120|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064121|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44064122|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064123|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064124|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064125|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
44064126|NCT00006145|Valganciclovir|valganciclovir|mesh-list
44064127|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
44064128|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064129|NCT00006152|Ritonavir|ritonavir|mesh-list
44064130|NCT00006152|Amprenavir|amprenavir|mesh-list
44064131|NCT00006152|Abacavir|abacavir|mesh-list
44064134|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064135|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064136|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064137|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064138|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064139|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
44064140|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064141|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44064142|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43839960|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
44256253|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44256254|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44256255|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256256|NCT00619034|Analgesics|analgesics|mesh-ancestor
44256257|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
44256258|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256259|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256260|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256261|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256262|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44256263|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256264|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256265|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44256266|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44064143|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064144|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064145|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44064146|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
44064147|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064148|NCT00006154|Ritonavir|ritonavir|mesh-list
44064149|NCT00006154|Indinavir|indinavir|mesh-list
44064150|NCT00006154|Aldesleukin|aldesleukin|mesh-list
44064151|NCT00006154|Abacavir|abacavir|mesh-list
44064152|NCT00006154|Didanosine|didanosine|mesh-list
44064153|NCT00006154|Stavudine|stavudine|mesh-list
44064154|NCT00006154|Efavirenz|efavirenz|mesh-list
44064155|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064156|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44064157|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064158|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064159|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064160|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064161|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064162|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
44064163|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064164|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44064165|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064166|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064167|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064168|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064169|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44064170|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44064171|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44064172|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44064173|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44064174|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
44064175|NCT00006155|Carboplatin|carboplatin|mesh-list
44064176|NCT00006155|Semaxinib|semaxinib|mesh-list
44064177|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064178|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064179|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064180|NCT00006155|Growth Substances|growth substances|mesh-ancestor
44064181|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064182|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064183|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44064184|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617980|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617981|NCT03134547|Sevoflurane|sevoflurane|mesh-list
43617982|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43617984|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
43617985|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
43617986|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618011|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43618013|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43618014|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618015|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
43618016|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
43618017|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618018|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
43618019|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618020|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43618021|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
43618022|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650335|NCT03015350|Desflurane|desflurane|mesh-list
43667259|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667260|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44064185|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064186|NCT00006157|Desipramine|desipramine|mesh-list
44064187|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44256267|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44256268|NCT00619203|Acetaminophen|acetaminophen|mesh-list
44256269|NCT00619203|Glycerol|glycerol|mesh-list
44256270|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44064188|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
44064189|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44064190|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064191|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064192|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44064193|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44064194|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064195|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44064196|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064197|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064198|NCT00006158|Testosterone|testosterone|mesh-list
44064199|NCT00006158|Androgens|androgens|mesh-ancestor
44064200|NCT00006158|Hormones|hormones|mesh-ancestor
44064201|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064202|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150554|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44150556|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150557|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150558|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150559|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150560|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150561|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150562|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150563|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150564|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
44150565|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44150566|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150567|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150568|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150569|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150570|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150571|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44150572|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44150573|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
44150574|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150575|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650337|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44150576|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150577|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150578|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
44150579|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
44150580|NCT00210730|Hematinics|hematinics|mesh-ancestor
44150581|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
44150582|NCT00210743|Hematinics|hematinics|mesh-ancestor
44150583|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
44150584|NCT00210756|Hematinics|hematinics|mesh-ancestor
44150585|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44150586|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150587|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150588|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150589|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150590|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44064203|NCT00006167|Oxandrolone|oxandrolone|mesh-list
44064204|NCT00006167|Androgens|androgens|mesh-ancestor
44064205|NCT00006167|Hormones|hormones|mesh-ancestor
44064206|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064207|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064208|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
44064209|NCT00006168|Methotrexate|methotrexate|mesh-list
44064210|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44064211|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
44064212|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44064213|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064214|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064215|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
44064216|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064217|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064218|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256271|NCT00619203|Analgesics|analgesics|mesh-ancestor
44256272|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
44256273|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256274|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256275|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
44256276|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44256277|NCT00619203|Protective Agents|protective agents|mesh-ancestor
44256278|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
44256279|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44256280|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256281|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44256282|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
43910337|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
44256283|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256284|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256285|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256286|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256287|NCT00619268|Interferons|interferons|mesh-list
44256288|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
44256289|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
44256291|NCT00619268|Bevacizumab|bevacizumab|mesh-list
44256292|NCT00619268|Sunitinib|sunitinib|mesh-list
44256293|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256294|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256295|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256296|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256297|NCT00619268|Growth Substances|growth substances|mesh-ancestor
44256298|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256299|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256300|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
44256301|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618033|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
44256302|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
44256303|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256304|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256305|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064219|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064220|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44064221|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064222|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
44256306|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256307|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064223|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064224|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064225|NCT00006174|Letrozole|letrozole|mesh-list
44064226|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064227|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44064228|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44064229|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064230|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064231|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44064232|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
44064233|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064234|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064235|NCT00006180|Alendronate|alendronate|mesh-list
44064236|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44064237|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064238|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
44064239|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44064240|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064253|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44064254|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064255|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44064256|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44064257|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44064258|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44064259|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064260|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44064261|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064262|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
44064263|NCT00006195|Olanzapine|olanzapine|mesh-list
44064264|NCT00006195|Risperidone|risperidone|mesh-list
44064265|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44064266|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
44064267|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064268|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064269|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064270|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44064271|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618065|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44064272|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44064273|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44064274|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44064275|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
44064276|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
44064277|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
44064278|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064279|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064280|NCT00006195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44064281|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44064282|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064284|NCT00006196|Vitamins|vitamins|mesh-ancestor
44064285|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
44064286|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064287|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44064288|NCT00006198|Thalidomide|thalidomide|mesh-list
44064289|NCT00006198|Doxorubicin|doxorubicin|mesh-list
44064290|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064291|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064292|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064293|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064294|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064295|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064296|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064297|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
44064298|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064299|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
44064300|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064301|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064302|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064303|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064304|NCT00006198|Growth Substances|growth substances|mesh-ancestor
44256308|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
44256309|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256310|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44256311|NCT00619333|Hormones|hormones|mesh-ancestor
44256312|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256313|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064305|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064306|NCT00006199|Topotecan|topotecan|mesh-list
44064311|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064312|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064313|NCT00006200|Thalidomide|thalidomide|mesh-list
44064314|NCT00006200|Dacarbazine|dacarbazine|mesh-list
44064315|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064316|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
44064317|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064318|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
44064319|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064320|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064321|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064322|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064323|NCT00006200|Growth Substances|growth substances|mesh-ancestor
44064324|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064325|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064326|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064327|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
44064328|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064329|NCT00006203|Naltrexone|naltrexone|mesh-list
44064330|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44064331|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44064332|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064333|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
44064334|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064335|NCT00006204|Naltrexone|naltrexone|mesh-list
44064336|NCT00006204|Fluoxetine|fluoxetine|mesh-list
44064337|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44064338|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44064339|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064340|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
44064341|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064342|NCT00006204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44064343|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44064344|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064345|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064346|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064347|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
44064348|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44064349|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44064350|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44064351|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44064352|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064353|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064354|NCT00006205|Topiramate|topiramate|mesh-list
44064355|NCT00006205|Ondansetron|ondansetron|mesh-list
44064356|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
44064357|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
44064358|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064359|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064360|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064361|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
44064362|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064363|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44064364|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
44064365|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064366|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064367|NCT00006205|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44064368|NCT00006205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44064369|NCT00006205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44064370|NCT00006205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256314|NCT00619346|Pafuramidine|pafuramidine|mesh-list
44256315|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44256316|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44256317|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44256318|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256319|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
44256320|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
44256321|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256322|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064371|NCT00006205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44064372|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
44064373|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44064374|NCT00006206|Naltrexone|naltrexone|mesh-list
44064375|NCT00006206|Acamprosate|acamprosate|mesh-list
44064376|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44064377|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44064378|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064380|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064382|NCT00006208|Efavirenz|efavirenz|mesh-list
44064383|NCT00006208|Didanosine|didanosine|mesh-list
44064384|NCT00006208|Stavudine|stavudine|mesh-list
44064385|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
44064386|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064387|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064388|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064389|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064390|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064391|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064392|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064393|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44064394|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064395|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44064396|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44064397|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44064398|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44064399|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
44064400|NCT00006211|Nelfinavir|nelfinavir|mesh-list
44064401|NCT00006211|Capravirine|capravirine|mesh-list
44064402|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064403|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44064404|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064405|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064406|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064407|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064408|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064409|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
44064410|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064411|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064412|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064413|NCT00006212|Cisplatin|cisplatin|mesh-list
44064414|NCT00006212|Vinblastine|vinblastine|mesh-list
44064415|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064416|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064417|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064418|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064419|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064420|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064421|NCT00006214|Flutamide|flutamide|mesh-list
44064422|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
44064423|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
44064424|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064425|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064426|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064427|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064429|NCT00006215|Vinorelbine|vinorelbine|mesh-list
44064430|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064431|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256324|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256325|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
44256326|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256327|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44256328|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256329|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256330|NCT00619424|Pemetrexed|pemetrexed|mesh-list
44256331|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44256332|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256333|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256334|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256335|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44256336|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44256337|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44461523|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461524|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44461525|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461526|NCT01545817|Everolimus|everolimus|mesh-list
44461527|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064432|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064433|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064434|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064435|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064436|NCT00006216|Ganciclovir|ganciclovir|mesh-list
44064437|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44064438|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
44064439|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064440|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064441|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064442|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064443|NCT00006219|Clarithromycin|clarithromycin|mesh-list
44064444|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44064445|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064446|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064447|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44064448|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064449|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064450|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43561808|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
44064459|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064460|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
44064461|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44064462|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
44064463|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064464|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44064465|NCT00006223|Protective Agents|protective agents|mesh-ancestor
44064466|NCT00006224|Gemcitabine|gemcitabine|mesh-list
44064467|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064468|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
44064469|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064470|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064471|NCT00006224|Antiviral Agents|antiviral agents|mesh-ancestor
44461528|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461529|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
44461530|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461531|NCT01545388|Metformin|metformin|mesh-list
44461532|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44461533|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44064472|NCT00006224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064473|NCT00006224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064474|NCT00006224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064475|NCT00006224|Immunologic Factors|immunologic factors|mesh-ancestor
44064476|NCT00006224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064477|NCT00006226|Thalidomide|thalidomide|mesh-list
44064478|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064479|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
44064480|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064481|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
44064482|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064483|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064484|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064485|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064486|NCT00006226|Growth Substances|growth substances|mesh-ancestor
44064487|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064488|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064489|NCT00006228|Aldesleukin|aldesleukin|mesh-list
44064490|NCT00006228|Trastuzumab|trastuzumab|mesh-list
44064491|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44064492|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064493|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064494|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064495|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
44064496|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064497|NCT00006229|Paclitaxel|paclitaxel|mesh-list
44064498|NCT00006229|Carboplatin|carboplatin|mesh-list
44064499|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064500|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064501|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064502|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
43787121|NCT03169985|Ezetimibe|ezetimibe|mesh-list
44064503|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064504|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064505|NCT00006230|Rubitecan|rubitecan|mesh-list
44064506|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064507|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44064508|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064509|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064510|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064511|NCT00006232|Dexamethasone|dexamethasone|mesh-list
44064512|NCT00006232|Doxorubicin|doxorubicin|mesh-list
44064513|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44064514|NCT00006232|Vincristine|vincristine|mesh-list
44064515|NCT00006232|Idarubicin|idarubicin|mesh-list
44064516|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44064517|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
44064518|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
44064519|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064521|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064523|NCT00006232|Hormones|hormones|mesh-ancestor
44064524|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064525|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064526|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064527|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064528|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064529|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064530|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064531|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064532|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064533|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064534|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064535|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064536|NCT00006233|Cyclosporine|cyclosporine|mesh-list
44461534|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461535|NCT01545388|Incretins|incretins|mesh-ancestor
44461536|NCT01545388|Hormones|hormones|mesh-ancestor
44461537|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461538|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44461539|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461540|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461541|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461542|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44256338|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
44256339|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44064537|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
44064538|NCT00006233|Fludarabine|fludarabine|mesh-list
44064539|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
44064540|NCT00006233|Cyclosporins|cyclosporins|mesh-list
44064541|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064542|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064543|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
44064544|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064545|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064546|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
44064547|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064548|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618256|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
43618257|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618261|NCT03132272|Autoantibodies|autoantibodies|mesh-list
44064549|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
44064550|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064551|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064552|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064553|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44064554|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064555|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44064556|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
44064557|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064558|NCT00006235|Carboplatin|carboplatin|mesh-list
44064559|NCT00006235|Doxorubicin|doxorubicin|mesh-list
44064560|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44064561|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064562|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064563|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064564|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064565|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064566|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064567|NCT00006239|Tretinoin|tretinoin|mesh-list
44064568|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44064569|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064570|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
44064571|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064572|NCT00006240|Dexamethasone|dexamethasone|mesh-list
44064573|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44064574|NCT00006240|Sargramostim|sargramostim|mesh-list
44064575|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44064576|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
43787200|NCT05038475|Antibodies|antibodies|mesh-list
44064577|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
44064578|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064579|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064580|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064581|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
44064582|NCT00006240|Hormones|hormones|mesh-ancestor
44064583|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064584|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064585|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064586|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
44064587|NCT00006241|Lenograstim|lenograstim|mesh-list
44256341|NCT00619541|Fluorouracil|fluorouracil|mesh-list
44064588|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44064589|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
44064590|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064591|NCT00006243|Sargramostim|sargramostim|mesh-list
44064592|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
43561950|NCT01593228|Gemcitabine|gemcitabine|mesh-list
44064594|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064595|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44064597|NCT00006245|Alvocidib|alvocidib|mesh-list
44064598|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064599|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064600|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064601|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064602|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064603|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064604|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064605|NCT00006245|Growth Substances|growth substances|mesh-ancestor
44064606|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064607|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44064608|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064609|NCT00006246|Busulfan|busulfan|mesh-list
44064610|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
44064611|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064612|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064613|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
44064614|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064615|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064616|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064617|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44064618|NCT00006247|Semaxinib|semaxinib|mesh-list
44064619|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064620|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064621|NCT00006247|Growth Substances|growth substances|mesh-ancestor
44064622|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064623|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064624|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064625|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44064626|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064627|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064628|NCT00006248|Paclitaxel|paclitaxel|mesh-list
44064629|NCT00006248|Cisplatin|cisplatin|mesh-list
44064630|NCT00006248|Fluorouracil|fluorouracil|mesh-list
44064631|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064632|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064633|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064634|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064635|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064636|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064637|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
44064638|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064639|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064640|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
44064641|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064642|NCT00006249|Interferons|interferons|mesh-list
44064643|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
44064644|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064645|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
44064646|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064647|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
44064648|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064649|NCT00006250|Dexamethasone|dexamethasone|mesh-list
44064650|NCT00006250|Fludarabine|fludarabine|mesh-list
44064651|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
44064652|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
44064653|NCT00006250|Chlorambucil|chlorambucil|mesh-list
44064654|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44064655|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
44064656|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
44064657|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064658|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064659|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064660|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
44064661|NCT00006250|Hormones|hormones|mesh-ancestor
44256343|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
44256344|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256345|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256346|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784164|NCT05101954|Mitogens|mitogens|mesh-list
44064662|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064663|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064664|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064665|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064666|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
44064667|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064669|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
44064670|NCT00006250|Analgesics|analgesics|mesh-ancestor
44064671|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
44064672|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064673|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064674|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064675|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064676|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
44064677|NCT00006251|Cyclosporine|cyclosporine|mesh-list
44064678|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
44064679|NCT00006251|Fludarabine|fludarabine|mesh-list
44064680|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
44064681|NCT00006251|Cyclosporins|cyclosporins|mesh-list
43667306|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064682|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064683|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064684|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
44064685|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064686|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064687|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
44064688|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064689|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064690|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
44064691|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064692|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064693|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064694|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44064695|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064696|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44064697|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
44064698|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064699|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
44064700|NCT00006252|Fludarabine|fludarabine|mesh-list
44064701|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
43667307|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826628|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44064702|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064703|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
44064704|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064705|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064706|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064707|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
44064708|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064709|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064710|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44064711|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064712|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
44064713|NCT00006257|Paclitaxel|paclitaxel|mesh-list
44064714|NCT00006257|Semaxinib|semaxinib|mesh-list
43618357|NCT03131700|Bevacizumab|bevacizumab|mesh-list
44064715|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064716|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064717|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064718|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064719|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064720|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064721|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064722|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44064723|NCT00006257|Growth Substances|growth substances|mesh-ancestor
44064724|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064725|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
44064726|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256347|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256348|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
44256349|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256350|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256351|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256352|NCT00619671|Rituximab|rituximab|mesh-list
44256353|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256354|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256355|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
44256356|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256357|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256358|NCT00619697|Insulin|insulin|mesh-list
44256359|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44256360|NCT00619697|Metformin|metformin|mesh-list
44256361|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
44256362|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
44256363|NCT00619697|Glimepiride|glimepiride|mesh-list
44256364|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
44256365|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44256366|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44256367|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256368|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44256369|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256370|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
44256371|NCT00619710|Meropenem|meropenem|mesh-list
44256372|NCT00619710|Imipenem|imipenem|mesh-list
44256397|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44256398|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256399|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256400|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256401|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256402|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256403|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
44256404|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256405|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44256406|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256407|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
44064727|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064728|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
44064730|NCT00006258|Methotrexate|methotrexate|mesh-list
44064732|NCT00006258|Vincristine|vincristine|mesh-list
44064733|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064734|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
44064735|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064736|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064737|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064738|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
44064739|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064740|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064741|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43562100|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826634|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43826635|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43826636|NCT05495958|Vitamin D|vitamin d|mesh-list
43826637|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44064743|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
44064744|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44064745|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064746|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
44064747|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064748|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064749|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44064750|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064751|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064752|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064753|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064754|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064755|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064756|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064757|NCT00006260|Cisplatin|cisplatin|mesh-list
44064758|NCT00006260|Etoposide|etoposide|mesh-list
44064759|NCT00006260|Ifosfamide|ifosfamide|mesh-list
44064760|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064761|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44064762|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064763|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064764|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064765|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064766|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064767|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
44064768|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
44064769|NCT00006261|Docetaxel|docetaxel|mesh-list
44064770|NCT00006261|Doxorubicin|doxorubicin|mesh-list
44064771|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44064772|NCT00006261|Fludarabine|fludarabine|mesh-list
44064773|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
44064774|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064775|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
44064776|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064777|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064778|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064779|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
44064780|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256408|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44256409|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44256411|NCT00619996|Sorafenib|sorafenib|mesh-list
44064781|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064782|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44064783|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064784|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064785|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064786|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44064787|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064788|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064789|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064790|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064791|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
44064792|NCT00006263|Carboplatin|carboplatin|mesh-list
44064793|NCT00006263|Temozolomide|temozolomide|mesh-list
44064794|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064795|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44064796|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
44064797|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064798|NCT00006264|Zidovudine|zidovudine|mesh-list
44064799|NCT00006264|Aldesleukin|aldesleukin|mesh-list
44064800|NCT00006264|Ganciclovir|ganciclovir|mesh-list
44064801|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44064802|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
44064803|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064804|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064805|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064806|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064807|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
44064808|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064809|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064810|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064811|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064812|NCT00006265|Cytarabine|cytarabine|mesh-list
44064813|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
44064814|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44064815|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
44064816|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064826|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44064827|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064828|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064829|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064830|NCT00006269|Irinotecan|irinotecan|mesh-list
44064831|NCT00006269|Octreotide|octreotide|mesh-list
44064832|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44064833|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064834|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064835|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064836|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064837|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064838|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064839|NCT00006270|Cosyntropin|cosyntropin|mesh-list
44064840|NCT00006270|Metyrapone|metyrapone|mesh-list
44064841|NCT00006270|Hormones|hormones|mesh-ancestor
44064842|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064843|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064844|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
44064845|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064846|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064847|NCT00006275|Calcitriol|calcitriol|mesh-list
44064848|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44064849|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064850|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44064851|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064852|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064853|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44064855|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
44064856|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44064857|NCT00006276|Paclitaxel|paclitaxel|mesh-list
44064858|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256412|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256413|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256414|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
43618479|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618480|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618481|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
43618482|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43618483|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
43618484|NCT03131336|Coagulants|coagulants|mesh-ancestor
43618485|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
43618486|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618487|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618488|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618489|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618490|NCT03131375|Analgesics|analgesics|mesh-ancestor
43618491|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
43618492|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618493|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44256415|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256416|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256417|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256418|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256420|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256421|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256422|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256423|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256424|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256425|NCT00620165|Levetiracetam|levetiracetam|mesh-list
44256426|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
43653733|NCT02982395|Mitomycin|mitomycin|mesh-list
44064859|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064860|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44064861|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44064862|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44064863|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064864|NCT00006279|Nevirapine|nevirapine|mesh-list
44064865|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064866|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064867|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064868|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064869|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
44064870|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064871|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064872|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064873|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44064874|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44150591|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44150592|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44150593|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
44150594|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618494|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43618495|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43618496|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
43618497|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618498|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618499|NCT03130933|Amoxicillin|amoxicillin|mesh-list
43618500|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618501|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618502|NCT03131050|Scopolamine|scopolamine|mesh-list
43618536|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618537|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618538|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
43618539|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851916|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851917|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851918|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851919|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150595|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064875|NCT00006280|Tobramycin|tobramycin|mesh-list
44064876|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064881|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064882|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064883|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064884|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
44064885|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064886|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44064887|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
44064888|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44064889|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44064890|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064891|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064892|NCT00006291|Aldesleukin|aldesleukin|mesh-list
44064893|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064894|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064895|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064896|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
44064897|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064899|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44064900|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44064901|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064902|NCT00006294|Amlodipine|amlodipine|mesh-list
44256427|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
44256428|NCT00620178|Losartan|losartan|mesh-list
44256429|NCT00620178|Candesartan|candesartan|mesh-list
44256430|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
44256431|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44256432|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44256433|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44256434|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44256435|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256436|NCT00620204|Atorvastatin|atorvastatin|mesh-list
44256437|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44256438|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44256439|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
44256440|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256441|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44256442|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44256443|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256444|NCT00620269|Cisplatin|cisplatin|mesh-list
44256445|NCT00620269|Irinotecan|irinotecan|mesh-list
44256446|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44256447|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256448|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44256449|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44256450|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256451|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256452|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256453|NCT00620295|Gemcitabine|gemcitabine|mesh-list
44256454|NCT00620295|Bortezomib|bortezomib|mesh-list
44256455|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256456|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
44256457|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256458|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256459|NCT00620295|Antiviral Agents|antiviral agents|mesh-ancestor
43824462|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618540|NCT03130842|Midazolam|midazolam|mesh-list
43618541|NCT03130842|Alprazolam|alprazolam|mesh-list
43618542|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618543|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618544|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618545|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618546|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44256460|NCT00620295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256461|NCT00620295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064903|NCT00006294|Lisinopril|lisinopril|mesh-list
44064904|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
44064905|NCT00006294|Doxazosin|doxazosin|mesh-list
44064906|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44256462|NCT00620295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256463|NCT00620295|Immunologic Factors|immunologic factors|mesh-ancestor
44256464|NCT00620295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256465|NCT00620347|Sunitinib|sunitinib|mesh-list
43784409|NCT02683018|Dronabinol|dronabinol|mesh-list
44064907|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44064908|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44064909|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064910|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44064911|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064912|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
44064913|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44064914|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
44064915|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064916|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44064917|NCT00006294|Protective Agents|protective agents|mesh-ancestor
44064919|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
44064920|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44064921|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44064922|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44064923|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44064924|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
44064925|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44064926|NCT00006299|Celecoxib|celecoxib|mesh-list
44064927|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44064928|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44064929|NCT00006299|Analgesics|analgesics|mesh-ancestor
44064930|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
44064931|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44064932|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064933|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44064934|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44064935|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44064936|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44064937|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064938|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064939|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
44064940|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064941|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
44064942|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064943|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44064944|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
44064945|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44064946|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
44064947|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44064948|NCT00006324|Estradiol|estradiol|mesh-list
44064949|NCT00006324|Estrogens|estrogens|mesh-ancestor
44064950|NCT00006324|Hormones|hormones|mesh-ancestor
44064951|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44064952|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064953|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44064954|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
44064955|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44064956|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44064957|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43618547|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618583|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618584|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618585|NCT03130452|Amoxicillin|amoxicillin|mesh-list
44064958|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44064959|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44064960|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44064961|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44064962|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064963|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44064964|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44064965|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
44064966|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064967|NCT00006326|Ritonavir|ritonavir|mesh-list
44064968|NCT00006326|Indinavir|indinavir|mesh-list
44064969|NCT00006326|Delavirdine|delavirdine|mesh-list
44064970|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064971|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44064972|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256466|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256467|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256468|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256469|NCT00620347|Growth Substances|growth substances|mesh-ancestor
44256470|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256471|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256472|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256473|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256474|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256475|NCT00620438|Efavirenz|efavirenz|mesh-list
44256476|NCT00620438|Nevirapine|nevirapine|mesh-list
44256477|NCT00620438|Rifampin|rifampin|mesh-list
44256478|NCT00620438|Lumefantrine|lumefantrine|mesh-list
44256479|NCT00620438|Artemether|artemether|mesh-list
44256480|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44256481|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44256482|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064973|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064974|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064975|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064976|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064977|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
44064978|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064979|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44064980|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064981|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064982|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064983|NCT00006330|Digoxin|digoxin|mesh-list
44064984|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44064985|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44064986|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064987|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064988|NCT00006330|Protective Agents|protective agents|mesh-ancestor
44064989|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064990|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44064991|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
44064992|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
44064993|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064994|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064995|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44064996|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43618620|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43618621|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
43618622|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618623|NCT03130348|Dexamethasone|dexamethasone|mesh-list
44064997|NCT00006332|Growth Substances|growth substances|mesh-ancestor
44064998|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064999|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44065000|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065001|NCT00006337|Levodopa|levodopa|mesh-list
44065002|NCT00006337|Istradefylline|istradefylline|mesh-list
44065003|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44065004|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44065005|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
44065006|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065007|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065008|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065009|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44065010|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44065011|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44065012|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
44256484|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256485|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
44256486|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910586|NCT00360685|Tacrolimus|tacrolimus|mesh-list
44256487|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44256488|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256489|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44256490|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44065013|NCT00006339|Ritonavir|ritonavir|mesh-list
44065014|NCT00006339|Indinavir|indinavir|mesh-list
44065015|NCT00006339|Didanosine|didanosine|mesh-list
44065016|NCT00006339|Stavudine|stavudine|mesh-list
44065017|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
44065018|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065019|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065020|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065021|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065022|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065024|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065025|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
44065026|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065027|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44065028|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44065029|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065030|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
44065031|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065033|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065034|NCT00006340|Ganciclovir|ganciclovir|mesh-list
44065035|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44065036|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
44065037|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
44065038|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065039|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065040|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065041|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065042|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618635|NCT03130348|Hormones|hormones|mesh-ancestor
43618662|NCT03130218|Peppermint oil|peppermint oil|mesh-list
44065043|NCT00006343|Interferons|interferons|mesh-list
44065044|NCT00006343|Cytarabine|cytarabine|mesh-list
44065045|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
44065046|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
44065047|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065048|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
44065049|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065050|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065051|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
44065052|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065053|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065054|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
44065055|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065056|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065057|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065058|NCT00006345|Dexamethasone|dexamethasone|mesh-list
44065059|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
44065060|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44065061|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
44065062|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
44065063|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065064|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065065|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44065066|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
44065067|NCT00006345|Hormones|hormones|mesh-ancestor
44065068|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065069|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44065070|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256491|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44256492|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44256493|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44256494|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
44256495|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256496|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
44256497|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44065071|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44065072|NCT00006347|Antibodies|antibodies|mesh-list
44065073|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
44065074|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44065075|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
44065076|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065077|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065078|NCT00006348|Ondansetron|ondansetron|mesh-list
44065079|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
44065080|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
44065081|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065082|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065083|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44065084|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
44065085|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44065086|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44065087|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
44065088|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065089|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065090|NCT00006348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44065091|NCT00006348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44065092|NCT00006348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44065093|NCT00006348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44065094|NCT00006348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44065095|NCT00006349|Vitamin E|vitamin e|mesh-list
44065096|NCT00006349|Donepezil|donepezil|mesh-list
44065097|NCT00006349|Vitamins|vitamins|mesh-ancestor
44065098|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
44065099|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065100|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44065102|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065103|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
44065104|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065105|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
44065106|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
44065107|NCT00006349|Protective Agents|protective agents|mesh-ancestor
44065108|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
44065109|NCT00006350|Tacrolimus|tacrolimus|mesh-list
44065110|NCT00006350|Daclizumab|daclizumab|mesh-list
44065111|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065112|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
44065113|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065114|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44065115|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065116|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065117|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44065118|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065119|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44065120|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
44065121|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44065122|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065123|NCT00006351|Gemcitabine|gemcitabine|mesh-list
44065124|NCT00006351|Lonafarnib|lonafarnib|mesh-list
44065125|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065126|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
44065127|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065128|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065129|NCT00006351|Antiviral Agents|antiviral agents|mesh-ancestor
44065130|NCT00006351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065131|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065132|NCT00006351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065133|NCT00006351|Immunologic Factors|immunologic factors|mesh-ancestor
44256498|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44256499|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44256500|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256501|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256502|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
44256503|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44256504|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44256505|NCT00620490|Ropivacaine|ropivacaine|mesh-list
44256506|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
44256507|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
44256508|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653803|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
44065134|NCT00006351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065135|NCT00006352|Antibodies|antibodies|mesh-list
44065136|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44065137|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
44065138|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
44065139|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065141|NCT00006353|Temozolomide|temozolomide|mesh-list
44065142|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065143|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
43851928|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065144|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065145|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065146|NCT00006355|NSC 366140|nsc 366140|mesh-list
44065147|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065148|NCT00006356|Cisplatin|cisplatin|mesh-list
44065149|NCT00006356|Carboplatin|carboplatin|mesh-list
44065150|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065151|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
44065152|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065153|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065154|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065155|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065156|NCT00006358|Thalidomide|thalidomide|mesh-list
44065157|NCT00006358|Temozolomide|temozolomide|mesh-list
44065158|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065159|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
44065160|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065161|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065162|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065163|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
44065164|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065165|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
44065166|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44065167|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065168|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44065169|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44065170|NCT00006358|Growth Substances|growth substances|mesh-ancestor
44065171|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
44065172|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
44065173|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
44065174|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065175|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065187|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065189|NCT00006363|Aldesleukin|aldesleukin|mesh-list
44065190|NCT00006363|Etoposide|etoposide|mesh-list
44065191|NCT00006363|Daunorubicin|daunorubicin|mesh-list
44065192|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
44065193|NCT00006363|Busulfan|busulfan|mesh-list
44065194|NCT00006363|Interleukin-2|interleukin-2|mesh-list
44065195|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065196|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065197|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065198|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065199|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256510|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
44256511|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256513|NCT00620581|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44256514|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44256515|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256516|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256517|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065200|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065201|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065202|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
44065203|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
44065204|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065205|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065206|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
44065207|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065208|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
44065209|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065210|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43618719|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065211|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44065212|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44065213|NCT00006363|Analgesics|analgesics|mesh-ancestor
44065214|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
44065215|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065216|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065217|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065218|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
44065219|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065220|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065221|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44065222|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065223|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065224|NCT00006366|Fluorouracil|fluorouracil|mesh-list
44065225|NCT00006366|Irinotecan|irinotecan|mesh-list
44065226|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
44065227|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065228|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065229|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065230|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065231|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
44065232|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065233|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065234|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065235|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065236|NCT00006367|Cytarabine|cytarabine|mesh-list
44065237|NCT00006367|Busulfan|busulfan|mesh-list
44065238|NCT00006367|Idarubicin|idarubicin|mesh-list
44065239|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065240|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
44065245|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065246|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
44065247|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065248|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
44065249|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065250|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44065251|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44065252|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065253|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065254|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065255|NCT00006368|Edotreotide|edotreotide|mesh-list
44065256|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44065257|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256518|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
44256519|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256520|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44256521|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
44256522|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256523|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44256524|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256525|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256526|NCT00620594|Dactolisib|dactolisib|mesh-list
44256527|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256528|NCT00620620|Zaleplon|zaleplon|mesh-list
44256529|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
44256530|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44256531|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256532|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256533|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
44065258|NCT00006370|Edotreotide|edotreotide|mesh-list
44065259|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44065260|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065261|NCT00006371|Ketoconazole|ketoconazole|mesh-list
44065262|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
44065263|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44065264|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44065265|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44065266|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
44065267|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44065268|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
44065269|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065270|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44065271|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44065272|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065273|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065274|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44065275|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
44065276|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065277|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065278|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44065279|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44065280|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065281|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44065282|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44065283|NCT00006372|Gemcitabine|gemcitabine|mesh-list
44065284|NCT00006372|Doxorubicin|doxorubicin|mesh-list
44065285|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44065286|NCT00006372|Vinorelbine|vinorelbine|mesh-list
44065287|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065288|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
44065289|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065290|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065291|NCT00006372|Antiviral Agents|antiviral agents|mesh-ancestor
44065292|NCT00006372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065293|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065294|NCT00006372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065295|NCT00006372|Immunologic Factors|immunologic factors|mesh-ancestor
44065296|NCT00006372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065297|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44065298|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44256534|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
44256535|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256536|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256537|NCT00620646|Aspirin|aspirin|mesh-list
44256538|NCT00620646|Cilostazol|cilostazol|mesh-list
44256539|NCT00620646|Clopidogrel|clopidogrel|mesh-list
44256540|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44065299|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065300|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065301|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065302|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065303|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065304|NCT00006373|Etoposide|etoposide|mesh-list
44065305|NCT00006373|Topotecan|topotecan|mesh-list
44065306|NCT00006373|Ifosfamide|ifosfamide|mesh-list
44065307|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065308|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065309|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065312|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065313|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065314|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065315|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
44065316|NCT00006374|Paclitaxel|paclitaxel|mesh-list
44065317|NCT00006374|Etoposide|etoposide|mesh-list
44065318|NCT00006374|Cisplatin|cisplatin|mesh-list
44065319|NCT00006374|Topotecan|topotecan|mesh-list
44065320|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065321|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065322|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065323|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065324|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065325|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065326|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065327|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065328|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065329|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065330|NCT00006376|Tipifarnib|tipifarnib|mesh-list
44065331|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065332|NCT00006377|Paclitaxel|paclitaxel|mesh-list
44065333|NCT00006377|Carboplatin|carboplatin|mesh-list
44065334|NCT00006377|Doxorubicin|doxorubicin|mesh-list
44065335|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44065336|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065337|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065338|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065339|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065340|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065341|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065342|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44065343|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065344|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065345|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065346|NCT00006378|Paclitaxel|paclitaxel|mesh-list
44065347|NCT00006378|Carboplatin|carboplatin|mesh-list
44065348|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065349|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065350|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065351|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065352|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065353|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065354|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
44065355|NCT00006379|Fludarabine|fludarabine|mesh-list
44065356|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
44065357|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44065358|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065359|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
44065360|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065361|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44065362|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065363|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
44256541|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256542|NCT00620646|Analgesics|analgesics|mesh-ancestor
44256543|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
44256544|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256545|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256546|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256547|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256548|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44256549|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44256550|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653836|NCT02981459|Mirabegron|mirabegron|mesh-list
44065364|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065365|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065366|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44065367|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065368|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
44065369|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44065370|NCT00006380|Antibodies|antibodies|mesh-list
44065371|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
44065372|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44065373|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
44065374|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065375|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150596|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150597|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150598|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
44150599|NCT00210782|Topiramate|topiramate|mesh-list
44150600|NCT00210782|Phenytoin|phenytoin|mesh-list
44150601|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
44150602|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43618730|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618731|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
43618732|NCT03129490|Apixaban|apixaban|mesh-list
43618733|NCT03129490|Edoxaban|edoxaban|mesh-list
44150603|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150604|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44150606|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150607|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150608|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44150609|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44150611|NCT00210795|Hematinics|hematinics|mesh-ancestor
44150612|NCT00210808|Topiramate|topiramate|mesh-list
44150613|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
44150614|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150615|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150616|NCT00210821|Topiramate|topiramate|mesh-list
44150617|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
44150618|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150619|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150620|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
44150621|NCT00210834|Hematinics|hematinics|mesh-ancestor
44150622|NCT00210847|Acetaminophen|acetaminophen|mesh-list
44150623|NCT00210847|Tramadol|tramadol|mesh-list
44150624|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44150625|NCT00210847|Analgesics|analgesics|mesh-ancestor
44065377|NCT00006381|Trastuzumab|trastuzumab|mesh-list
44065378|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44065379|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065380|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44065381|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44065382|NCT00006381|Analgesics|analgesics|mesh-ancestor
44065383|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
44065384|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065385|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618760|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43618762|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
43618763|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618764|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618765|NCT03129256|Apatinib|apatinib|mesh-list
43618766|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618767|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618768|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618769|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618770|NCT03129074|Capecitabine|capecitabine|mesh-list
43667344|NCT05209412|Analgesics|analgesics|mesh-ancestor
44065386|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44065387|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44065388|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44065389|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44065390|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256551|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44256553|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256554|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
44256555|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44256556|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44256557|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44256558|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
44256559|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910636|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256560|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44256561|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
44256562|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653845|NCT02981121|Metformin|metformin|mesh-list
44065391|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065392|NCT00006383|Vincristine|vincristine|mesh-list
44065393|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065394|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065395|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065396|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065397|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065398|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065399|NCT00006384|Interferons|interferons|mesh-list
44065400|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
44065401|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065402|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
44065403|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065404|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
44065405|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065406|NCT00006385|Interferons|interferons|mesh-list
44065407|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
44065408|NCT00006385|Sargramostim|sargramostim|mesh-list
44065409|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
44065410|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065411|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
44065412|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065413|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
44065414|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065415|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44065416|NCT00006386|Carmustine|carmustine|mesh-list
43618773|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065417|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065418|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
44065419|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065420|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065421|NCT00006388|Tamoxifen|tamoxifen|mesh-list
44065422|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44065423|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
44065424|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065425|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065426|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44065427|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065428|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44065429|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44065450|NCT00006394|Hormones|hormones|mesh-list
44065451|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065452|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150626|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
44150627|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150628|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150629|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
44256563|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
44256564|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
44256565|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44256566|NCT00620646|Protective Agents|protective agents|mesh-ancestor
44256567|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44256568|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44256569|NCT00620724|Nifedipine|nifedipine|mesh-list
44256570|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44256571|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256572|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256573|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44256574|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256575|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44256576|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
44256577|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44256578|NCT00620789|Dexetimide|dexetimide|mesh-list
44256579|NCT00620789|Citalopram|citalopram|mesh-list
44256580|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
44256581|NCT00620789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44150630|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44150631|NCT00210847|Narcotics|narcotics|mesh-ancestor
44150632|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150633|NCT00210860|Topiramate|topiramate|mesh-list
44150634|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
44150635|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150636|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150637|NCT00210873|Topiramate|topiramate|mesh-list
44150638|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
44150639|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150640|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150641|NCT00210886|Levofloxacin|levofloxacin|mesh-list
44150642|NCT00210886|Ofloxacin|ofloxacin|mesh-list
44150643|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44150644|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150645|NCT00210886|Renal Agents|renal agents|mesh-ancestor
44150646|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44150647|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44150648|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44150649|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150650|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150651|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150652|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44150653|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44150654|NCT00210899|Vancomycin|vancomycin|mesh-list
44150657|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44150658|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44150659|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150660|NCT00210912|Topiramate|topiramate|mesh-list
44150661|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
44150662|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150663|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150664|NCT00210925|Topiramate|topiramate|mesh-list
44150665|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
44150666|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150667|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150668|NCT00210938|Doripenem|doripenem|mesh-list
44150669|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256582|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44256583|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256584|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256585|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256586|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
44256587|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785219|NCT04658147|Nivolumab|nivolumab|mesh-list
44150670|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150671|NCT00210990|Doripenem|doripenem|mesh-list
44150672|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44150673|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150674|NCT00211003|Doripenem|doripenem|mesh-list
44150675|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44150676|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150677|NCT00211016|Doripenem|doripenem|mesh-list
44150678|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44150679|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157952|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157953|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157954|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157955|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157956|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
44157957|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157958|NCT00235898|Antidotes|antidotes|mesh-ancestor
44157959|NCT00235898|Protective Agents|protective agents|mesh-ancestor
44157960|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
44157961|NCT00235898|Vitamins|vitamins|mesh-ancestor
44157962|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
44157963|NCT00235911|Budesonide|budesonide|mesh-list
44157964|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
44157965|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157966|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44157967|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
43618781|NCT03128736|Esomeprazole|esomeprazole|mesh-list
43618782|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
44157968|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157969|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157970|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44157971|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
44065453|NCT00006396|Zidovudine|zidovudine|mesh-list
44065454|NCT00006396|Nevirapine|nevirapine|mesh-list
44065455|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
44065456|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065457|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065458|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065459|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065460|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
44065461|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065462|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065463|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065464|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44065465|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44065466|NCT00006397|Ritonavir|ritonavir|mesh-list
44065467|NCT00006397|Indinavir|indinavir|mesh-list
44065468|NCT00006397|Didanosine|didanosine|mesh-list
44065469|NCT00006397|Stavudine|stavudine|mesh-list
44065470|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065471|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065472|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065473|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065474|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065475|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065476|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065477|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
44065478|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065479|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44065480|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44065481|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
44065482|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065483|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065484|NCT00006398|Timolol|timolol|mesh-list
44256588|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44256589|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256590|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44256591|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43653883|NCT02980809|Apatinib|apatinib|mesh-list
44065486|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44065487|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
44065488|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065489|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065490|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065491|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44065492|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44065493|NCT00006399|Donepezil|donepezil|mesh-list
44065494|NCT00006399|Progesterone|progesterone|mesh-list
44065495|NCT00006399|Estrogens|estrogens|mesh-list
44065496|NCT00006399|Progestins|progestins|mesh-ancestor
44065497|NCT00006399|Hormones|hormones|mesh-ancestor
44065498|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065499|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065500|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44065501|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065502|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065503|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
44065504|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065505|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
44065506|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
44065507|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44065508|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
44065509|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065510|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065511|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44065512|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
43667396|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065513|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44065514|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
44065515|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065516|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065517|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44065518|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
44065519|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
44065520|NCT00006401|Protective Agents|protective agents|mesh-ancestor
44065521|NCT00006412|Fenofibrate|fenofibrate|mesh-list
44065522|NCT00006412|Pravastatin|pravastatin|mesh-list
44065523|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44065524|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
44065525|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065526|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44065527|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44150680|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
44065528|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44065529|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065530|NCT00006427|Amitriptyline|amitriptyline|mesh-list
44065531|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44065532|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
44065533|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44065534|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44065535|NCT00006427|Analgesics|analgesics|mesh-ancestor
44065536|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
44065537|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065538|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065539|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44065540|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44065541|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44065542|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065543|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
44065544|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065545|NCT00006428|Amitriptyline|amitriptyline|mesh-list
44065546|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44065547|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
44065548|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256592|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
44256593|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
44256594|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256595|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44256596|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44256597|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44256598|NCT00620802|Clopidogrel|clopidogrel|mesh-list
44256599|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44256600|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44256601|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44256602|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44256603|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
44065549|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44065550|NCT00006428|Analgesics|analgesics|mesh-ancestor
44065551|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
44065552|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065553|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618795|NCT03128528|Empagliflozin|empagliflozin|mesh-list
44065554|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44065555|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44065556|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44065557|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065558|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44065559|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44065560|NCT00006441|Lamivudine|lamivudine|mesh-list
44065561|NCT00006441|Zidovudine|zidovudine|mesh-list
44065562|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44065563|NCT00006441|Aldesleukin|aldesleukin|mesh-list
44065564|NCT00006441|Nelfinavir|nelfinavir|mesh-list
44065565|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065566|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065567|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065568|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065569|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
44065570|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065571|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065572|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065573|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
44065574|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065575|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065576|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065577|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065578|NCT00006443|Lamivudine|lamivudine|mesh-list
44065579|NCT00006443|Stavudine|stavudine|mesh-list
44065580|NCT00006443|Nelfinavir|nelfinavir|mesh-list
44065581|NCT00006443|Indinavir|indinavir|mesh-list
44065582|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065583|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065584|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065585|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065586|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
44065587|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065588|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065589|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065590|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065591|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065592|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065593|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
44065594|NCT00006448|Methadone|methadone|mesh-list
44065595|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44065596|NCT00006448|Narcotics|narcotics|mesh-ancestor
44065597|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44065598|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065599|NCT00006448|Analgesics|analgesics|mesh-ancestor
44256604|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256605|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653899|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44065600|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
44065601|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065602|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
44065603|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
44065604|NCT00006449|Naltrexone|naltrexone|mesh-list
44065605|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44065606|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44065607|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065608|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
44065609|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065610|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44065611|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065612|NCT00006451|Cyclosporine|cyclosporine|mesh-list
44065613|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
44065614|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
44065615|NCT00006451|Methotrexate|methotrexate|mesh-list
44065616|NCT00006451|Cyclosporins|cyclosporins|mesh-list
44065617|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44065618|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065619|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
44065620|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065621|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44065622|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065623|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
44065624|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065625|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065626|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44065627|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44065628|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
44065629|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44065630|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065631|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
44065632|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
44065633|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065634|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44065635|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065636|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
44065637|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065638|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44065639|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44065640|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
44065641|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
44065642|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065643|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44065644|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
44065645|NCT00006451|Hormones|hormones|mesh-ancestor
44065646|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44065647|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44065648|NCT00006451|Protective Agents|protective agents|mesh-ancestor
44065649|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
44065650|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065651|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44065652|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
44065653|NCT00006453|Gemcitabine|gemcitabine|mesh-list
44065654|NCT00006453|Carboplatin|carboplatin|mesh-list
44065655|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065656|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065657|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
44065658|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065659|NCT00006453|Antiviral Agents|antiviral agents|mesh-ancestor
44065660|NCT00006453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065661|NCT00006453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065662|NCT00006453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065663|NCT00006453|Immunologic Factors|immunologic factors|mesh-ancestor
44065664|NCT00006453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065665|NCT00006454|Paclitaxel|paclitaxel|mesh-list
44065666|NCT00006454|Carboplatin|carboplatin|mesh-list
44065667|NCT00006454|Topotecan|topotecan|mesh-list
44065668|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065669|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256606|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256607|NCT00620867|Ibuprofen|ibuprofen|mesh-list
44256608|NCT00620867|Celecoxib|celecoxib|mesh-list
44256609|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44256610|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256611|NCT00620867|Analgesics|analgesics|mesh-ancestor
44256612|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
44065670|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065671|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065672|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065673|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065674|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065675|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065676|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065677|NCT00006457|Oltipraz|oltipraz|mesh-list
44065678|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
44065679|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065680|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
44065681|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44065682|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
44065683|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44065684|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44065685|NCT00006457|Protective Agents|protective agents|mesh-ancestor
44065686|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065687|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065688|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065689|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065690|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065691|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065692|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44065693|NCT00006458|Antibodies|antibodies|mesh-list
44065694|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
44065695|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44065696|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
44065697|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065698|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065699|NCT00006459|Gemcitabine|gemcitabine|mesh-list
44065700|NCT00006459|Paclitaxel|paclitaxel|mesh-list
44065701|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065702|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065703|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065704|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065705|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065706|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065707|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065708|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
44065709|NCT00006459|Antiviral Agents|antiviral agents|mesh-ancestor
44065710|NCT00006459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065712|NCT00006459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065713|NCT00006459|Immunologic Factors|immunologic factors|mesh-ancestor
44065714|NCT00006459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065716|NCT00006461|Cisplatin|cisplatin|mesh-list
44065717|NCT00006461|Etoposide|etoposide|mesh-list
44065718|NCT00006461|Vincristine|vincristine|mesh-list
44065719|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
44065720|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065721|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
44065722|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065723|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44065724|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065725|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
44065726|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065727|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065728|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44065729|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065730|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065731|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065732|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065733|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256613|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256614|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256615|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44065734|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065735|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065736|NCT00006462|Gemcitabine|gemcitabine|mesh-list
44065737|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065738|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
44065739|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065740|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065741|NCT00006462|Antiviral Agents|antiviral agents|mesh-ancestor
44065742|NCT00006462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065743|NCT00006462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065744|NCT00006462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065745|NCT00006462|Immunologic Factors|immunologic factors|mesh-ancestor
44065746|NCT00006462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065747|NCT00006463|Trabectedin|trabectedin|mesh-list
44065748|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065749|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
44065750|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065751|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065752|NCT00006464|Cisplatin|cisplatin|mesh-list
44065753|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44065754|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150681|NCT00211120|Hematinics|hematinics|mesh-ancestor
44065755|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065756|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065757|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065758|NCT00006465|Capecitabine|capecitabine|mesh-list
44065759|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
44065761|NCT00006465|Camptothecin|camptothecin|mesh-list
44065762|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065763|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
44065764|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065765|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065766|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065767|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065768|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065769|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065770|NCT00006467|Gemcitabine|gemcitabine|mesh-list
44065771|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065772|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
44065773|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065774|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065775|NCT00006467|Antiviral Agents|antiviral agents|mesh-ancestor
44065776|NCT00006467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065777|NCT00006467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065778|NCT00006467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065779|NCT00006467|Immunologic Factors|immunologic factors|mesh-ancestor
44065780|NCT00006467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065781|NCT00006468|Leucovorin|leucovorin|mesh-list
44065782|NCT00006468|Fluorouracil|fluorouracil|mesh-list
44065783|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
44065784|NCT00006468|Calcium|calcium|mesh-list
44065785|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
43563230|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065786|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44065787|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065789|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065790|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065791|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065792|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065793|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
44065794|NCT00006468|Antidotes|antidotes|mesh-ancestor
44065795|NCT00006468|Protective Agents|protective agents|mesh-ancestor
44065796|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
44065798|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
44065799|NCT00006469|Paclitaxel|paclitaxel|mesh-list
44065800|NCT00006469|Carboplatin|carboplatin|mesh-list
44065801|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065802|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065803|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065804|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256616|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256617|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44256618|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256619|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256620|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44256621|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
44256622|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44256623|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44256625|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256626|NCT00620919|Hormones|hormones|mesh-ancestor
43653911|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065805|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065806|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065807|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44065808|NCT00006470|Vaccines|vaccines|mesh-list
44065809|NCT00006470|Antibodies|antibodies|mesh-list
44065810|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
44065811|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44065812|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44065813|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
44065814|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065815|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065816|NCT00006471|Fenretinide|fenretinide|mesh-list
44065817|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065818|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44065819|NCT00006471|Protective Agents|protective agents|mesh-ancestor
44065820|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065821|NCT00006472|Paclitaxel|paclitaxel|mesh-list
44065822|NCT00006472|Carboplatin|carboplatin|mesh-list
44065823|NCT00006472|Fluorouracil|fluorouracil|mesh-list
44065824|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065825|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065826|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065827|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065828|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065829|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065830|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
44065831|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065832|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065833|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
44065834|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065835|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
44065836|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065837|NCT00006474|Temozolomide|temozolomide|mesh-list
44065838|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44065839|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065840|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
44065841|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065842|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065843|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065844|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
44065845|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065846|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065847|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065848|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065849|NCT00006476|Suramin|suramin|mesh-list
44065850|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
44065851|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
44065852|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44065853|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065854|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065855|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44065856|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44256627|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653921|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44065857|NCT00006479|Leucovorin|leucovorin|mesh-list
44065858|NCT00006479|Fluorouracil|fluorouracil|mesh-list
44065859|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
44065860|NCT00006479|Calcium|calcium|mesh-list
44065861|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
44065862|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44065863|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065875|NCT00006480|Aldesleukin|aldesleukin|mesh-list
44065876|NCT00006480|Ganciclovir|ganciclovir|mesh-list
44065877|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44065878|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065879|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065880|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065881|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
44065882|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065883|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065884|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065885|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065886|NCT00006482|Gemcitabine|gemcitabine|mesh-list
44065887|NCT00006482|Cisplatin|cisplatin|mesh-list
44065888|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065889|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065890|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
44065891|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065892|NCT00006482|Antiviral Agents|antiviral agents|mesh-ancestor
44065893|NCT00006482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065894|NCT00006482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065895|NCT00006482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065896|NCT00006482|Immunologic Factors|immunologic factors|mesh-ancestor
44065897|NCT00006482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065898|NCT00006483|Sargramostim|sargramostim|mesh-list
44065899|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
44065900|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065901|NCT00006484|Paclitaxel|paclitaxel|mesh-list
44065902|NCT00006484|Carboplatin|carboplatin|mesh-list
44065903|NCT00006484|Tirapazamine|tirapazamine|mesh-list
44065904|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065905|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065906|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
44065907|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
44065908|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
44065909|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065911|NCT00006485|Alvocidib|alvocidib|mesh-list
44065912|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065913|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065914|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065915|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065916|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065917|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
44065918|NCT00006485|Growth Substances|growth substances|mesh-ancestor
44065919|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065920|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065921|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44065922|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065923|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44065924|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44065925|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065926|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44065927|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065928|NCT00006487|Cisplatin|cisplatin|mesh-list
44065929|NCT00006487|Etoposide|etoposide|mesh-list
44065930|NCT00006487|Tirapazamine|tirapazamine|mesh-list
44065931|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065939|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065941|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44065942|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150682|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
44150683|NCT00211133|Hematinics|hematinics|mesh-ancestor
44150684|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
44150685|NCT00211146|Hematinics|hematinics|mesh-ancestor
44150686|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
44150687|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256628|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256629|NCT00620971|Gemcitabine|gemcitabine|mesh-list
44256630|NCT00620971|Bevacizumab|bevacizumab|mesh-list
44256631|NCT00620971|Cisplatin|cisplatin|mesh-list
44256632|NCT00620971|Docetaxel|docetaxel|mesh-list
44256633|NCT00620971|Vinorelbine|vinorelbine|mesh-list
44461543|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
43653923|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150688|NCT00211224|Riluzole|riluzole|mesh-list
44150689|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
44150690|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44150691|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44150692|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150693|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150694|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150695|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44150696|NCT00211224|Protective Agents|protective agents|mesh-ancestor
44150697|NCT00211250|Valproic Acid|valproic acid|mesh-list
44150698|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
44150699|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150700|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150701|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
44150702|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150703|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150704|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
44150705|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150706|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150707|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150708|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
44150709|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150710|NCT00211302|Aripiprazole|aripiprazole|mesh-list
44150711|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
44150712|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150713|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150714|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150715|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150716|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618963|NCT03126864|Fludarabine|fludarabine|mesh-list
43619013|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
44150717|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
44150718|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
44150719|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150720|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150721|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44150722|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44150723|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
44065943|NCT00006519|Capravirine|capravirine|mesh-list
44065944|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065945|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065946|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065947|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065948|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
44065949|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065950|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065951|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065952|NCT00006578|Ritonavir|ritonavir|mesh-list
44065953|NCT00006578|Amprenavir|amprenavir|mesh-list
44065954|NCT00006578|Lamivudine|lamivudine|mesh-list
44065955|NCT00006578|Abacavir|abacavir|mesh-list
44065956|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065957|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065958|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065959|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065960|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065961|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065962|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065963|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
44065964|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065965|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44065966|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44065967|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44256634|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44256635|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256636|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256637|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44065968|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065969|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44065970|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
44065971|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44065972|NCT00006591|Ritonavir|ritonavir|mesh-list
44065973|NCT00006591|Amprenavir|amprenavir|mesh-list
44065974|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44065975|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44065976|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44065977|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065978|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065979|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065980|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44065981|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
44065982|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619015|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
44065983|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44065984|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44065985|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44065986|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
44065987|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44065988|NCT00006617|Lamivudine|lamivudine|mesh-list
44065989|NCT00006617|Zidovudine|zidovudine|mesh-list
44065990|NCT00006617|Abacavir|abacavir|mesh-list
44065991|NCT00006617|Amprenavir|amprenavir|mesh-list
44065992|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44065993|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44065994|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065995|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065996|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
44065997|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065998|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065999|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44066000|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
44066001|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44066002|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
44066003|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066004|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44066005|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44066006|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
44066007|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
44066008|NCT00006630|Antibodies|antibodies|mesh-list
44066009|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
44066010|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44066011|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44066012|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
44066013|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066014|NCT00006656|Ethanol|ethanol|mesh-list
44066015|NCT00006656|Carmustine|carmustine|mesh-list
44066016|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44066017|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066018|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619023|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43619028|NCT03126695|Ticagrelor|ticagrelor|mesh-list
44066019|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066020|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066021|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
44066022|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066023|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066025|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
44066026|NCT00006669|Rituximab|rituximab|mesh-list
44066027|NCT00006669|Doxorubicin|doxorubicin|mesh-list
44066028|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066029|NCT00006669|Etoposide|etoposide|mesh-list
44066030|NCT00006669|Vincristine|vincristine|mesh-list
44066031|NCT00006669|Sargramostim|sargramostim|mesh-list
44066032|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066033|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
44066034|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066035|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066045|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256638|NCT00620971|Growth Substances|growth substances|mesh-ancestor
44256639|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066046|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066047|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
44066048|NCT00006669|Hormones|hormones|mesh-ancestor
44066049|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066050|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066051|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066052|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066053|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066054|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066055|NCT00006682|Docetaxel|docetaxel|mesh-list
44066056|NCT00006682|Vinorelbine|vinorelbine|mesh-list
44066057|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066058|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066059|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066060|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066061|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066062|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066063|NCT00006695|Iodine|iodine|mesh-list
44066064|NCT00006695|Cytarabine|cytarabine|mesh-list
44066065|NCT00006695|Etoposide|etoposide|mesh-list
44066066|NCT00006695|Melphalan|melphalan|mesh-list
44066067|NCT00006695|Carmustine|carmustine|mesh-list
44066068|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
44066069|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066070|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066071|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066072|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066073|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066074|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066075|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066076|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
44066077|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
44066078|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066079|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066080|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
44066081|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066082|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066083|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
44066084|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066085|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44066086|NCT00006695|Trace Elements|trace elements|mesh-ancestor
44066087|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
44066088|NCT00006708|Rituximab|rituximab|mesh-list
44066089|NCT00006708|Carboplatin|carboplatin|mesh-list
44066090|NCT00006708|Etoposide|etoposide|mesh-list
44066091|NCT00006708|Ifosfamide|ifosfamide|mesh-list
44066092|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066093|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066094|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
44066095|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066096|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066097|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066098|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066099|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066100|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563581|NCT01225380|Ribavirin|ribavirin|mesh-list
44066112|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
44066113|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066114|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066115|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066116|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
44066117|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066118|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066119|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066120|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066121|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066122|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066123|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066124|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066125|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44066126|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256640|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256641|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256642|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
44256643|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256644|NCT00620971|Antiviral Agents|antiviral agents|mesh-ancestor
44066127|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066128|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066130|NCT00006747|Methotrexate|methotrexate|mesh-list
44066131|NCT00006747|Etoposide|etoposide|mesh-list
44066132|NCT00006747|Melphalan|melphalan|mesh-list
44066133|NCT00006747|Carmustine|carmustine|mesh-list
44066134|NCT00006747|Tacrolimus|tacrolimus|mesh-list
44066135|NCT00006747|Sargramostim|sargramostim|mesh-list
44066136|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44066137|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
44066138|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44066139|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066140|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066141|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
44066142|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066143|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066144|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066145|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066146|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44066147|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066148|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
44066149|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066150|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44066151|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066152|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066153|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066154|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
44066155|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066156|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066157|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066158|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
44066159|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066160|NCT00006760|Vinorelbine|vinorelbine|mesh-list
44066161|NCT00006760|Ifosfamide|ifosfamide|mesh-list
44066162|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066163|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066164|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066165|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066166|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066181|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44066183|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066184|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44066185|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066186|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
44066187|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066188|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066189|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066190|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
44066191|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44066192|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066193|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066194|NCT00006786|Antidotes|antidotes|mesh-ancestor
44066195|NCT00006786|Protective Agents|protective agents|mesh-ancestor
44066196|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
44066197|NCT00006786|Vitamins|vitamins|mesh-ancestor
44066198|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
44066199|NCT00006799|Megestrol|megestrol|mesh-list
44066200|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
44066201|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44066202|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44066203|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44066204|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
44066205|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44066206|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066207|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44066208|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44256645|NCT00620971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256646|NCT00620971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256647|NCT00620971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256648|NCT00620971|Immunologic Factors|immunologic factors|mesh-ancestor
44066209|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066210|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066211|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
44066212|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44066213|NCT00006812|Capecitabine|capecitabine|mesh-list
44066214|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066215|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
43880638|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824473|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066216|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066217|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066218|NCT00006825|Doxorubicin|doxorubicin|mesh-list
44066219|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066220|NCT00006825|Trastuzumab|trastuzumab|mesh-list
44066221|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066222|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066223|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066224|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066225|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066226|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066227|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066228|NCT00006864|Aldesleukin|aldesleukin|mesh-list
44066229|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066237|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066239|NCT00006890|Thalidomide|thalidomide|mesh-list
44066240|NCT00006890|Prednisone|prednisone|mesh-list
44066241|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066242|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
44066243|NCT00006890|Hormones|hormones|mesh-ancestor
44066244|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066245|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066246|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066247|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066248|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066249|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
44066250|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
44066251|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066252|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066253|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44066254|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44066255|NCT00006890|Growth Substances|growth substances|mesh-ancestor
44066256|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
44066257|NCT00006929|Suramin|suramin|mesh-list
44066258|NCT00006929|Paclitaxel|paclitaxel|mesh-list
44066259|NCT00006929|Carboplatin|carboplatin|mesh-list
44066260|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066261|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066262|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066263|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066264|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066265|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066266|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
44066267|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
44066268|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44066269|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066270|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44066271|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44066272|NCT00006942|Cisplatin|cisplatin|mesh-list
44066273|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
44066274|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066275|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44066276|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
44066277|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066278|NCT00006968|Cyclosporine|cyclosporine|mesh-list
44066279|NCT00006968|Pentostatin|pentostatin|mesh-list
44066280|NCT00006968|Cyclosporins|cyclosporins|mesh-list
44066281|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
44066282|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066283|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066284|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667523|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667524|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667525|NCT05071352|Nefopam|nefopam|mesh-list
43667526|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667527|NCT05071352|Analgesics|analgesics|mesh-ancestor
43667528|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
43667529|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256649|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256650|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256651|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256652|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256653|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
44256654|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
44256655|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
44256656|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256657|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256658|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
44256659|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256660|NCT00621036|Methotrexate|methotrexate|mesh-list
44256661|NCT00621036|Thiotepa|thiotepa|mesh-list
44256662|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
44256663|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44256664|NCT00621036|Antibodies|antibodies|mesh-list
44256665|NCT00621036|Sargramostim|sargramostim|mesh-list
44256666|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44256667|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653951|NCT02980562|Bisacodyl|bisacodyl|mesh-list
44066285|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066286|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
44066287|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066288|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066289|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066290|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066291|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066292|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44066293|NCT00006981|Immunotoxins|immunotoxins|mesh-list
44066294|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
44066295|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066296|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
44066297|NCT00007033|Analgesics|analgesics|mesh-ancestor
44066298|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
43563770|NCT01189396|Albuterol|albuterol|mesh-list
44066308|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066309|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
44066310|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44066311|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
44066312|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066313|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066314|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44066315|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
44066316|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066317|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066318|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066319|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066320|NCT00007189|Celecoxib|celecoxib|mesh-list
44066321|NCT00007189|Naproxen|naproxen|mesh-list
44066322|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44066323|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44066324|NCT00007189|Analgesics|analgesics|mesh-ancestor
44066325|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
44066326|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066327|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066328|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066329|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066330|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44256668|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
44256669|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44256670|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256671|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256672|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
43653962|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
43851948|NCT01126190|Docetaxel|docetaxel|mesh-list
44066331|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44066332|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066333|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066334|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
44066335|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44066336|NCT00007202|Didanosine|didanosine|mesh-list
44066337|NCT00007202|Stavudine|stavudine|mesh-list
44066338|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44066339|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44066340|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
44066341|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066342|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066343|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44066344|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44066345|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
44066346|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066347|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
44066348|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44066349|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44066350|NCT00007306|Hormones|hormones|mesh-list
44066351|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
44066352|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066353|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066354|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066355|NCT00007358|Dexamethasone|dexamethasone|mesh-list
44066356|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066357|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
44066358|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
44066359|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066360|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066361|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44066362|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
44066372|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066373|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
44066374|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066375|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
44066376|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44066377|NCT00007423|Protective Agents|protective agents|mesh-ancestor
44066378|NCT00007436|Tenofovir|tenofovir|mesh-list
44066379|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
44066380|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066381|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44066382|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44066383|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066384|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066385|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44066386|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44066387|NCT00007527|Buprenorphine|buprenorphine|mesh-list
44066388|NCT00007527|Naloxone|naloxone|mesh-list
44066389|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44066390|NCT00007527|Narcotics|narcotics|mesh-ancestor
44066391|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066392|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066393|NCT00007527|Analgesics|analgesics|mesh-ancestor
44066394|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
44066395|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066396|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44066397|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
44066398|NCT00007592|Furosemide|furosemide|mesh-list
43619069|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44066399|NCT00007592|Diuretics|diuretics|mesh-ancestor
44066400|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
43788756|NCT04562558|Leucovorin|leucovorin|mesh-list
44066401|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066402|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44256673|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256674|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256675|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256676|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653969|NCT02980250|Domperidone|domperidone|mesh-list
44066403|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066404|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066405|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44066406|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44066407|NCT00007605|Amiodarone|amiodarone|mesh-list
44066408|NCT00007605|Sotalol|sotalol|mesh-list
44066409|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44066410|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
44066411|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44066412|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066413|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066414|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44066415|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44066416|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44066417|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066418|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44066419|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44066420|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44066421|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44066422|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44066423|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
44066424|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44066425|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066437|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
44066438|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066439|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066440|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
44066441|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44066442|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44066443|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066444|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44066445|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44066446|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44066447|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44066448|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066449|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
44066450|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44066451|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066452|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066453|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44066454|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43826640|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826641|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43826642|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43826643|NCT05495945|Propofol|propofol|mesh-list
43826644|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43826645|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066455|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44066456|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44066457|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44066458|NCT00007683|Aspirin|aspirin|mesh-list
44066459|NCT00007683|Warfarin|warfarin|mesh-list
44066460|NCT00007683|Clopidogrel|clopidogrel|mesh-list
44066461|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44066462|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44066463|NCT00007683|Analgesics|analgesics|mesh-ancestor
44066464|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
44066465|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066466|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066467|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066468|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066469|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44066470|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44066471|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066472|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44066473|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44066474|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256677|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44256678|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256679|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
44066475|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
44066476|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44066477|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44066478|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44066479|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
44066480|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44066481|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
44066482|NCT00007735|Doxycycline|doxycycline|mesh-list
44066483|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066484|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066485|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
44066486|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44066487|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44066488|NCT00007774|Haloperidol|haloperidol|mesh-list
44066489|NCT00007774|Olanzapine|olanzapine|mesh-list
44066490|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
44066491|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
44066492|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
43880639|NCT04653792|Pregabalin|pregabalin|mesh-list
43619086|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619120|NCT03126071|Irinotecan|irinotecan|mesh-list
44066502|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066503|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066504|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44066505|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
44066506|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44066507|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
44066508|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44066509|NCT00007787|Cyclosporine|cyclosporine|mesh-list
44066510|NCT00007787|Tacrolimus|tacrolimus|mesh-list
44066511|NCT00007787|Cyclosporins|cyclosporins|mesh-list
44066512|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
44066513|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066514|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
44066515|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066516|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066517|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066518|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066519|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
44066520|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066521|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066522|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066523|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
44066524|NCT00007813|Carboplatin|carboplatin|mesh-list
44066525|NCT00007813|Etoposide|etoposide|mesh-list
44066526|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066527|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
44066528|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066529|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066530|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066531|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
44066532|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066533|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066534|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066535|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066536|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066537|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066538|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066539|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44066540|NCT00007826|Vaccines|vaccines|mesh-list
44066541|NCT00007826|Antibodies|antibodies|mesh-list
44066542|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44066543|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
44066544|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
44066545|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
44066546|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066547|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44066548|NCT00007826|Antacids|antacids|mesh-ancestor
44066549|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066550|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44066551|NCT00007852|Cytarabine|cytarabine|mesh-list
44066552|NCT00007852|Rituximab|rituximab|mesh-list
44066553|NCT00007852|Etoposide|etoposide|mesh-list
44066554|NCT00007852|Melphalan|melphalan|mesh-list
44066555|NCT00007852|Carmustine|carmustine|mesh-list
44256680|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256681|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44256682|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44256683|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
43619121|NCT03126071|Raltitrexed|raltitrexed|mesh-list
44066556|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066557|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066558|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
44066559|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066565|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066567|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
44066568|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
44066569|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066570|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066571|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066572|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
44066573|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066574|NCT00007865|Rituximab|rituximab|mesh-list
44066575|NCT00007865|Carboplatin|carboplatin|mesh-list
44066576|NCT00007865|Etoposide|etoposide|mesh-list
44066577|NCT00007865|Ifosfamide|ifosfamide|mesh-list
44066578|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066579|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066580|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
44066581|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066582|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066583|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066584|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066585|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066586|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066587|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066588|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066589|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
44066590|NCT00007878|Leucovorin|leucovorin|mesh-list
44066591|NCT00007878|Fluorouracil|fluorouracil|mesh-list
44066592|NCT00007878|Bortezomib|bortezomib|mesh-list
44066593|NCT00007878|Calcium|calcium|mesh-list
44066594|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
44066595|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066596|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066597|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
44066598|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066599|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066600|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066601|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066602|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
44066603|NCT00007878|Antidotes|antidotes|mesh-ancestor
44066604|NCT00007878|Protective Agents|protective agents|mesh-ancestor
44066605|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
44066606|NCT00007878|Vitamins|vitamins|mesh-ancestor
44066607|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
44066608|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43824478|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
44066609|NCT00007891|Antibodies|antibodies|mesh-list
44066610|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
44066611|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44066612|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
44066613|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066614|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066615|NCT00007904|Tamoxifen|tamoxifen|mesh-list
44066616|NCT00007904|Paclitaxel|paclitaxel|mesh-list
44066617|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
44066618|NCT00007904|Doxorubicin|doxorubicin|mesh-list
44066619|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066620|NCT00007904|Lenograstim|lenograstim|mesh-list
44066621|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066622|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066623|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066624|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066625|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066626|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066627|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066628|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
44066629|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564103|NCT01128530|Linezolid|linezolid|mesh-list
44256684|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44256685|NCT00621101|Sirolimus|sirolimus|mesh-list
44256686|NCT00621101|Ezetimibe|ezetimibe|mesh-list
44256687|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256688|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256689|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44256690|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256691|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
44256692|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256693|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
44256694|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256695|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44256696|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44256697|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
44256698|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256699|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44256700|NCT00621166|Ritonavir|ritonavir|mesh-list
44256701|NCT00621166|Lopinavir|lopinavir|mesh-list
44256702|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44256703|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44256704|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256705|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256706|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256707|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256708|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256709|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
44256710|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256711|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44256712|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256713|NCT00621218|Tretinoin|tretinoin|mesh-list
44256714|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619147|NCT03125694|Pioglitazone|pioglitazone|mesh-list
43619148|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43619149|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619150|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619151|NCT03125694|Incretins|incretins|mesh-ancestor
44256715|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
44256716|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
44256717|NCT00621283|Secretin|secretin|mesh-list
44256718|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256719|NCT00621283|Hormones|hormones|mesh-ancestor
44256722|NCT00621361|Cisplatin|cisplatin|mesh-list
44256724|NCT00621361|Cediranib|cediranib|mesh-list
44256725|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066639|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44066640|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44066641|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066642|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066643|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44066644|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44066645|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44150724|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44150725|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44150726|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150727|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150729|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150730|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150731|NCT00211315|Growth Substances|growth substances|mesh-ancestor
44150732|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150733|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150734|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150736|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150737|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150738|NCT00211328|Growth Substances|growth substances|mesh-ancestor
44150739|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150740|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150741|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150742|NCT00211341|Vitamin A|vitamin a|mesh-list
44150743|NCT00211341|Vitamins|vitamins|mesh-ancestor
44150744|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
44150745|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150746|NCT00211354|Anecortave|anecortave|mesh-list
44150747|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150748|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150749|NCT00211354|Growth Substances|growth substances|mesh-ancestor
44150750|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150751|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150752|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150753|NCT00211367|Anecortave|anecortave|mesh-list
44150754|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150755|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150756|NCT00211367|Growth Substances|growth substances|mesh-ancestor
44150757|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150758|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150759|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150760|NCT00211380|Aripiprazole|aripiprazole|mesh-list
44150761|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
44150762|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150763|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44150764|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43619161|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43619162|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619164|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44150765|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150766|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150767|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
44150768|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
44150769|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150770|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150771|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44150772|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44150773|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
43564179|NCT01116141|Vitamins|vitamins|mesh-ancestor
44150776|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44150777|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44150778|NCT00211393|Ketoconazole|ketoconazole|mesh-list
44150779|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
44150780|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150781|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44066646|NCT00007917|Gemcitabine|gemcitabine|mesh-list
44066647|NCT00007917|Alvocidib|alvocidib|mesh-list
44066648|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066649|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
44066650|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066651|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066652|NCT00007917|Antiviral Agents|antiviral agents|mesh-ancestor
44066653|NCT00007917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066654|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256726|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256727|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44256728|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066655|NCT00007917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066656|NCT00007917|Immunologic Factors|immunologic factors|mesh-ancestor
44066657|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066658|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44066659|NCT00007917|Growth Substances|growth substances|mesh-ancestor
44066660|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44066661|NCT00007943|Gemcitabine|gemcitabine|mesh-list
44066662|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066663|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
44066664|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066665|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066666|NCT00007943|Antiviral Agents|antiviral agents|mesh-ancestor
44066667|NCT00007943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066668|NCT00007943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066669|NCT00007943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066670|NCT00007943|Immunologic Factors|immunologic factors|mesh-ancestor
44066671|NCT00007943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066672|NCT00007956|Antibodies|antibodies|mesh-list
44066673|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44066674|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
43619201|NCT03124524|Estrogens|estrogens|mesh-ancestor
44066675|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066676|NCT00007969|Verteporfin|verteporfin|mesh-list
44066677|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
44066678|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44066679|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066680|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44066681|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
44066682|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066683|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
44066685|NCT00007982|Carmustine|carmustine|mesh-list
44066686|NCT00007982|Cisplatin|cisplatin|mesh-list
44066687|NCT00007982|Etoposide|etoposide|mesh-list
44066688|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066689|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
44066690|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066691|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066692|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066693|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
44066694|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066695|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066696|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066697|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066698|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066699|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066700|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066701|NCT00007995|Interferons|interferons|mesh-list
44066702|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
44066703|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
44066704|NCT00007995|Melphalan|melphalan|mesh-list
44066705|NCT00007995|Busulfan|busulfan|mesh-list
44066706|NCT00007995|Sargramostim|sargramostim|mesh-list
44066707|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066708|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
44066709|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066710|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066711|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066712|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
44066713|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066725|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066726|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
44066727|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066728|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066729|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066730|NCT00008021|Cyclosporine|cyclosporine|mesh-list
44066732|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44066733|NCT00008021|Antibodies|antibodies|mesh-list
44066734|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
44066735|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44066736|NCT00008021|Cyclosporins|cyclosporins|mesh-list
44066737|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44256729|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256730|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066738|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066739|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066740|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066741|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066742|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066743|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
44066744|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066745|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066746|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066747|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
44066748|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066749|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066750|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066751|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066752|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
44066753|NCT00008034|Capecitabine|capecitabine|mesh-list
44066754|NCT00008034|Epirubicin|epirubicin|mesh-list
44066755|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066756|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
43880640|NCT04653792|Analgesics|analgesics|mesh-ancestor
44066757|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066758|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066759|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066760|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
44066761|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066762|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066763|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066764|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066765|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
44066766|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066767|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066768|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066769|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066770|NCT00008047|Paclitaxel|paclitaxel|mesh-list
44066771|NCT00008047|Fluorouracil|fluorouracil|mesh-list
44066772|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
44066773|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066774|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066775|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066776|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
44066777|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066778|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066779|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
44066780|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066791|NCT00008060|Calcium|calcium|mesh-list
44066792|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
44066793|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066794|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066795|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
44066796|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066797|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066798|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066799|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066800|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
44066801|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44066802|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066803|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066805|NCT00008060|Protective Agents|protective agents|mesh-ancestor
44066806|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
44066807|NCT00008060|Vitamins|vitamins|mesh-ancestor
44066808|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
44066809|NCT00008073|Doxorubicin|doxorubicin|mesh-list
44066810|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066811|NCT00008073|Octreotide|octreotide|mesh-list
44066812|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066813|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066814|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066815|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43619234|NCT03124082|Clonidine|clonidine|mesh-list
43619235|NCT03124082|Ketamine|ketamine|mesh-list
43619236|NCT03124082|Remifentanil|remifentanil|mesh-list
43619237|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619238|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
43619239|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650343|NCT03015246|Buprenorphine|buprenorphine|mesh-list
43650344|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43650345|NCT03015246|Naloxone|naloxone|mesh-list
43650346|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43650347|NCT03015246|Narcotics|narcotics|mesh-ancestor
43650348|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650349|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066816|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066817|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066818|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256731|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256733|NCT00621387|Roxithromycin|roxithromycin|mesh-list
44256734|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44256735|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066819|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066820|NCT00008086|Calcitriol|calcitriol|mesh-list
44066821|NCT00008086|Carboplatin|carboplatin|mesh-list
44066822|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066823|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44066824|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066825|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44066826|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066827|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066828|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44066829|NCT00008086|Vitamins|vitamins|mesh-ancestor
44066830|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
44066831|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44066832|NCT00008112|Cisplatin|cisplatin|mesh-list
44066833|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066834|NCT00008125|Gemcitabine|gemcitabine|mesh-list
44066835|NCT00008125|Carboplatin|carboplatin|mesh-list
44066836|NCT00008125|Docetaxel|docetaxel|mesh-list
44066837|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066838|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066839|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
44066840|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066841|NCT00008125|Antiviral Agents|antiviral agents|mesh-ancestor
44066842|NCT00008125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066843|NCT00008125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066844|NCT00008125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066845|NCT00008125|Immunologic Factors|immunologic factors|mesh-ancestor
44066846|NCT00008125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066847|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44066848|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564371|NCT01072981|Gemcitabine|gemcitabine|mesh-list
44066866|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066867|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44066868|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619243|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43619244|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43619245|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43619246|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619247|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619248|NCT03124082|Analgesics|analgesics|mesh-ancestor
43619249|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43619265|NCT03123770|Docetaxel|docetaxel|mesh-list
44066869|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
44066870|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066871|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44066872|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
44066873|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066874|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066875|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066876|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44066877|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
44066878|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066879|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066880|NCT00008177|Iodine|iodine|mesh-list
44066881|NCT00008177|Cyclosporine|cyclosporine|mesh-list
44066882|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
44066883|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44066884|NCT00008177|Fludarabine|fludarabine|mesh-list
44066885|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
44066886|NCT00008177|Antibodies|antibodies|mesh-list
44066887|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
44066888|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44066889|NCT00008177|Cyclosporins|cyclosporins|mesh-list
44066890|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
44066891|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066892|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066893|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066894|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
44066895|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066896|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066897|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066898|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
44066899|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066900|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066901|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783685|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44256736|NCT00621387|Renal Agents|renal agents|mesh-ancestor
44256737|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256738|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44256739|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44256740|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256741|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066902|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066903|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066904|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44066905|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
44066906|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066907|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44066908|NCT00008177|Trace Elements|trace elements|mesh-ancestor
44066919|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066921|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066922|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619269|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066923|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066924|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066925|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066926|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066927|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066928|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44066929|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44066930|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
44066931|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066932|NCT00008203|Interferons|interferons|mesh-list
44066933|NCT00008203|Aldesleukin|aldesleukin|mesh-list
44066934|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
44066935|NCT00008203|Cyclosporine|cyclosporine|mesh-list
44066936|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
44066937|NCT00008203|Thiotepa|thiotepa|mesh-list
44066938|NCT00008203|Carboplatin|carboplatin|mesh-list
44066939|NCT00008203|Cyclosporins|cyclosporins|mesh-list
44066940|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066941|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
44066942|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066943|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066944|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066945|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
44066946|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066947|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066948|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066949|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
44066950|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066951|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066952|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
44066953|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066954|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44066955|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44066956|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43619296|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619297|NCT03123718|Methotrexate|methotrexate|mesh-list
44066957|NCT00008229|Melphalan|melphalan|mesh-list
44066958|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
43619298|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44066959|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066960|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066961|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
44066962|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066963|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066964|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066965|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066966|NCT00008242|Thalidomide|thalidomide|mesh-list
44066967|NCT00008242|Dexamethasone|dexamethasone|mesh-list
44066968|NCT00008242|Doxorubicin|doxorubicin|mesh-list
44066969|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066970|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44066971|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
44066972|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
44066973|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066974|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066975|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44066976|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
44256742|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256743|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44256744|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256746|NCT00621400|Lenalidomide|lenalidomide|mesh-list
44256747|NCT00621400|Melphalan|melphalan|mesh-list
44256748|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44256749|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
44066977|NCT00008242|Hormones|hormones|mesh-ancestor
44066985|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066987|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
44066988|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
44066989|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44066990|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066991|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44066992|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44066993|NCT00008242|Growth Substances|growth substances|mesh-ancestor
44066994|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44066996|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
44066997|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066998|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066999|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
44067000|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067001|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067002|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44067003|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067004|NCT00008281|Leucovorin|leucovorin|mesh-list
44067005|NCT00008281|Fluorouracil|fluorouracil|mesh-list
44067006|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
44067007|NCT00008281|Calcium|calcium|mesh-list
44067008|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
44067009|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44067010|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067011|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
44067012|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067013|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44067014|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067015|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067016|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
44067017|NCT00008281|Antidotes|antidotes|mesh-ancestor
44067018|NCT00008281|Protective Agents|protective agents|mesh-ancestor
44067019|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
44067020|NCT00008281|Vitamins|vitamins|mesh-ancestor
44067021|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
44067022|NCT00008294|Leucovorin|leucovorin|mesh-list
44067023|NCT00008294|Dexamethasone|dexamethasone|mesh-list
44067024|NCT00008294|Fluorouracil|fluorouracil|mesh-list
44067025|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
44067026|NCT00008294|Floxuridine|floxuridine|mesh-list
44067027|NCT00008294|Calcium|calcium|mesh-list
44067028|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
44067029|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067030|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
44067031|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
43789216|NCT04875871|Copper|copper|mesh-list
44067032|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067033|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067034|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43619331|NCT03123445|Endostatins|endostatins|mesh-list
43619332|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619333|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619373|NCT03123107|Vitamins|vitamins|mesh-ancestor
44067035|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
44067036|NCT00008294|Hormones|hormones|mesh-ancestor
44067037|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067038|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067039|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067040|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44067041|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
44067042|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067043|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564539|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256751|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256752|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256753|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256754|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
44067053|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
44067054|NCT00008307|Fludarabine|fludarabine|mesh-list
44067055|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
44067056|NCT00008307|Melphalan|melphalan|mesh-list
44067057|NCT00008307|Cyclosporins|cyclosporins|mesh-list
44067058|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44067059|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067060|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44067061|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
44067062|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067064|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
44067065|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067066|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067067|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
44067068|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067069|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44067070|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067071|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44067072|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44067073|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44067074|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
44067075|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44067076|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067077|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
44067078|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
44067079|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067080|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067081|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
44067082|NCT00008307|Hormones|hormones|mesh-ancestor
44067083|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067084|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44067085|NCT00008307|Protective Agents|protective agents|mesh-ancestor
44067086|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44067087|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
44067088|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44067089|NCT00008333|Vinorelbine|vinorelbine|mesh-list
44067090|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44067091|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067092|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067093|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44067094|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44067095|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067096|NCT00008359|Amphotericin B|amphotericin b|mesh-list
44067097|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44067098|NCT00008359|Caspofungin|caspofungin|mesh-list
44067099|NCT00008359|Amebicides|amebicides|mesh-ancestor
44067100|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44067101|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44067102|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067103|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44067104|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
44067105|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067106|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067107|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
44067108|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067109|NCT00008398|Sargramostim|sargramostim|mesh-list
44067110|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
44067111|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067112|NCT00008411|Docetaxel|docetaxel|mesh-list
44067113|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067114|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067124|NCT00008450|Cyclosporine|cyclosporine|mesh-list
44067125|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
44067126|NCT00008450|Cyclosporins|cyclosporins|mesh-list
44067127|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067128|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067129|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256755|NCT00621400|Hormones|hormones|mesh-ancestor
44256756|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256757|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44256758|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787078|NCT03797469|Niacin|niacin|mesh-list
44067130|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
44067131|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067132|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
44067133|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067134|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
44067135|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067136|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44067138|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067139|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44067140|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
44067141|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44067142|NCT00008463|Interferons|interferons|mesh-list
44067143|NCT00008463|Ribavirin|ribavirin|mesh-list
44067144|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
44067145|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
44067146|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44067147|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067148|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
44067149|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067150|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
43667576|NCT04971356|Analgesics|analgesics|mesh-ancestor
44067151|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067152|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
44067153|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067154|NCT00008476|Capsaicin|capsaicin|mesh-list
44067155|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
44067156|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
44067157|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
44067158|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067159|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067160|NCT00008489|Didanosine|didanosine|mesh-list
44067161|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
44067162|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067163|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44067164|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067165|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067166|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
44067167|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067168|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44067169|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44067170|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44067171|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067172|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
44067173|NCT00008515|Hormones|hormones|mesh-ancestor
44067174|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067175|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067176|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
44067177|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44067178|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44067179|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067180|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44067181|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44067194|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44067195|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44067196|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44067197|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44067198|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
44067199|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
44067200|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067201|NCT00008736|Metoclopramide|metoclopramide|mesh-list
44067202|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
44067203|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
44067204|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067205|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067206|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067207|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44067208|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44256759|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
44256760|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256761|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256762|NCT00621400|Growth Substances|growth substances|mesh-ancestor
44256763|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
44256764|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44256765|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
44256766|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256767|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44256768|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256769|NCT00621452|Aldesleukin|aldesleukin|mesh-list
44256770|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
44256771|NCT00621452|Interleukin-2|interleukin-2|mesh-list
44256772|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256773|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
44256774|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256775|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256776|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44067209|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
44067210|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067211|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067212|NCT05636111|Paclitaxel|paclitaxel|mesh-list
44067213|NCT05636111|Bevacizumab|bevacizumab|mesh-list
44067214|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44067215|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067216|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067217|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
44067218|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
44067219|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067220|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44067221|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44067222|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44067223|NCT05636111|Growth Substances|growth substances|mesh-ancestor
44067224|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067225|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
44067226|NCT05636267|Carboplatin|carboplatin|mesh-list
44067227|NCT05636267|Pemetrexed|pemetrexed|mesh-list
44067228|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067229|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067230|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067231|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44067232|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067233|NCT05636501|Prednisolone|prednisolone|mesh-list
44067234|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067235|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
44067236|NCT05636501|Hormones|hormones|mesh-ancestor
44067237|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067238|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067239|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067240|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067241|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
44067242|NCT05636566|Propofol|propofol|mesh-list
44067243|NCT05636566|Sevoflurane|sevoflurane|mesh-list
44067244|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44067245|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067246|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256777|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
44256778|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256779|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256780|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44256781|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44256782|NCT00621452|Analgesics|analgesics|mesh-ancestor
44067247|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44067259|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067260|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44067261|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44150782|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43619409|NCT03122678|Thiamine|thiamine|mesh-list
44150783|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150784|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150785|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44150786|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
44150787|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44150788|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150789|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44150790|NCT00211406|Anecortave|anecortave|mesh-list
44150791|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150792|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150793|NCT00211406|Growth Substances|growth substances|mesh-ancestor
44150794|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150795|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150796|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150797|NCT00211419|Triamcinolone|triamcinolone|mesh-list
44150798|NCT00211419|Anecortave|anecortave|mesh-list
44150799|NCT00211419|Verteporfin|verteporfin|mesh-list
44150800|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44150801|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
44150802|NCT00211419|Hormones|hormones|mesh-ancestor
44150803|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44150804|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150805|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44150806|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
44150807|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150808|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150809|NCT00211419|Growth Substances|growth substances|mesh-ancestor
44150810|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150811|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150812|NCT00211432|Anecortave|anecortave|mesh-list
44150813|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150814|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150815|NCT00211432|Growth Substances|growth substances|mesh-ancestor
44150816|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150817|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150818|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150819|NCT00211445|Verteporfin|verteporfin|mesh-list
44150820|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44150821|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
44150822|NCT00211458|Anecortave|anecortave|mesh-list
44150823|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150824|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150825|NCT00211458|Growth Substances|growth substances|mesh-ancestor
44150826|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150827|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150828|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150829|NCT00211471|Anecortave|anecortave|mesh-list
44150830|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150831|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150844|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150845|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
44150846|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150848|NCT00211562|Olanzapine|olanzapine|mesh-list
44150849|NCT00211562|Vitamins|vitamins|mesh-ancestor
44150850|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
44150851|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150852|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
44150853|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
44256783|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
44256784|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256785|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256786|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256787|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
44256788|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256789|NCT00621478|Diazepam|diazepam|mesh-list
44256790|NCT00621478|Lorazepam|lorazepam|mesh-list
44256791|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
44256792|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
44256793|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
44150854|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150855|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44150856|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44067262|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44067263|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44067264|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067265|NCT05637073|Dienogest|dienogest|mesh-list
44067266|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44067267|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
44067268|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44067269|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067270|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44067271|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44067272|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44067273|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44067274|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
44067275|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067276|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067277|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067278|NCT05637164|Norepinephrine|norepinephrine|mesh-list
44067279|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44067280|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44067281|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
44067282|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067283|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067284|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067285|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
44067286|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
44067287|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067288|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44067289|NCT05637216|Losartan|losartan|mesh-list
44067290|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44067291|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44067292|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44067293|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44067294|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067295|NCT05637268|Paclitaxel|paclitaxel|mesh-list
44067296|NCT05637268|Cisplatin|cisplatin|mesh-list
44067297|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44067298|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067310|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067311|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067312|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
44067313|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
44067314|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44067315|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44067316|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067317|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067318|NCT05637398|Colchicine|colchicine|mesh-list
44067319|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
44067320|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067321|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067322|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
44067323|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256794|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256795|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256796|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256797|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44067324|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067325|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067327|NCT05637671|Oxybutynin|oxybutynin|mesh-list
44067328|NCT05637671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44067329|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44067330|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44067331|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067332|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067333|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
44067334|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067335|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44067336|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
44067337|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067338|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44067339|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44067340|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067341|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
44067342|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
43619437|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
43619438|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43619439|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43619440|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619441|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619442|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43619444|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
43619445|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43619446|NCT03122158|Citalopram|citalopram|mesh-list
43619447|NCT03122158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43619448|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43619449|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619450|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619451|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619452|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
43619453|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619454|NCT03122158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43619455|NCT03122158|Antidepressive Agents|antidepressive agents|mesh-ancestor
43619456|NCT03122158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619457|NCT03121963|Acetaminophen|acetaminophen|mesh-list
43619458|NCT03121963|Celecoxib|celecoxib|mesh-list
43667621|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43667622|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43667624|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
43667625|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067343|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067344|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44067345|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44067346|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
44067347|NCT05637671|Urological Agents|urological agents|mesh-ancestor
44067348|NCT05637970|Hemostatics|hemostatics|mesh-list
44067349|NCT05637970|Coagulants|coagulants|mesh-ancestor
44067350|NCT05638087|Dexamethasone|dexamethasone|mesh-list
44067351|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067352|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
44067353|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
44067354|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067355|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067356|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067357|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
44067358|NCT05638087|Hormones|hormones|mesh-ancestor
44067359|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067360|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067361|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067374|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
44067375|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44067376|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
44067377|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067378|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067379|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44067380|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067381|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067382|NCT05638451|Bevacizumab|bevacizumab|mesh-list
44067383|NCT05638451|Temozolomide|temozolomide|mesh-list
44067384|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44067385|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067386|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44067387|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44067388|NCT05638451|Growth Substances|growth substances|mesh-ancestor
44067389|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067390|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
44067391|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44067392|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
44067393|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067394|NCT05638594|Carboplatin|carboplatin|mesh-list
44067395|NCT05638594|Docetaxel|docetaxel|mesh-list
44067396|NCT05638594|Trastuzumab|trastuzumab|mesh-list
44067397|NCT05638594|Letrozole|letrozole|mesh-list
44067398|NCT05638594|Pertuzumab|pertuzumab|mesh-list
44067399|NCT05638594|Hormones|hormones|mesh-list
44067400|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067401|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067402|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256798|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256800|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256801|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256802|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
44256803|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
44256804|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619460|NCT03121963|Oxycodone|oxycodone|mesh-list
44256805|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256806|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44256807|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44256808|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44256809|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44067403|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
44067404|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650359|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
43619492|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
43619493|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619494|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619495|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43619496|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43619497|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
43619498|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619499|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43667635|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667636|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067405|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44067406|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067407|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067408|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44067409|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43789533|NCT05127707|Narcotics|narcotics|mesh-ancestor
44067410|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067411|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44067412|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
44067413|NCT05638633|Vitamins|vitamins|mesh-list
44067414|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
44067415|NCT05638633|Prednisolone|prednisolone|mesh-list
44067416|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44067417|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
44067418|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44067419|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
44067420|NCT05638633|Corticosterone|corticosterone|mesh-list
44067421|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44067422|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
44067423|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
44067424|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067425|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067426|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
44067427|NCT05638633|Hormones|hormones|mesh-ancestor
43564968|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44067436|NCT05638633|Protective Agents|protective agents|mesh-ancestor
44150857|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150858|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150859|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150860|NCT00211562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44150861|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44150862|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150863|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150864|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150865|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
44150867|NCT00211562|Protective Agents|protective agents|mesh-ancestor
44150868|NCT00211588|Galantamine|galantamine|mesh-list
44150869|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44150870|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150871|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150872|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
44150873|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150874|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150875|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44150876|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
44150877|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150878|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
44150879|NCT00211614|Lansoprazole|lansoprazole|mesh-list
44150880|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
44256810|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
44256811|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
44256812|NCT00621491|Warfarin|warfarin|mesh-list
44256813|NCT00621491|Anticoagulants|anticoagulants|mesh-list
44256814|NCT00621556|Secretin|secretin|mesh-list
43654034|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44150881|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44150882|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44150883|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44150884|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150885|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150886|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
44150887|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44150888|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
44150889|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150890|NCT00211653|Expectorants|expectorants|mesh-ancestor
44150891|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
44150892|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44150893|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
44150894|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150895|NCT00211653|Protective Agents|protective agents|mesh-ancestor
44150896|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150897|NCT00211653|Antidotes|antidotes|mesh-ancestor
44150898|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
44150899|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44150900|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44150901|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44150902|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150903|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150904|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
44150905|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067438|NCT05638763|Dasatinib|dasatinib|mesh-list
44067439|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067440|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43619539|NCT03121807|Leucovorin|leucovorin|mesh-list
44067441|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067442|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067443|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
44067444|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067453|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
44067454|NCT05638867|Clopidogrel|clopidogrel|mesh-list
44067455|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44067456|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067457|NCT05638867|Analgesics|analgesics|mesh-ancestor
44067458|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
44067459|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067460|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067461|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067462|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067463|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44067464|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44067465|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067466|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44067467|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44067468|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067469|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
44067470|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44067471|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44067472|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44067473|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
44067474|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067475|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44067476|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
44067477|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44067478|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
44067479|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
44067480|NCT05638880|Empagliflozin|empagliflozin|mesh-list
44067481|NCT05638880|Valsartan|valsartan|mesh-list
44067482|NCT05638880|Levocetirizine|levocetirizine|mesh-list
44067483|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44067484|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44067485|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44256815|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256816|NCT00621556|Hormones|hormones|mesh-ancestor
44256817|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44256818|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461544|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461545|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
44461546|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
44067486|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067487|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44067488|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44067489|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067490|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44067491|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44067492|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
44067493|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
44067494|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067495|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
44067496|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067497|NCT05638984|Decitabine|decitabine|mesh-list
44067498|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44067499|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
44067500|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067501|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067502|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067503|NCT05639127|Prednisolone|prednisolone|mesh-list
44067504|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067505|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
44067506|NCT05639127|Hormones|hormones|mesh-ancestor
44067507|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067508|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067519|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44067520|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43667657|NCT04824911|Clopidogrel|clopidogrel|mesh-list
44067521|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067522|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067523|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44067524|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44067525|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44067526|NCT05639322|Ketamine|ketamine|mesh-list
44067527|NCT05639322|Analgesics|analgesics|mesh-ancestor
44067528|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
44067529|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067530|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067531|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44067532|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44067533|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
44067534|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
44067535|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067536|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44067537|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44067538|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067539|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067540|NCT05639647|Aztreonam|aztreonam|mesh-list
44067541|NCT05639647|Avibactam|avibactam|mesh-list
44067542|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44067543|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067544|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44067545|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067546|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067547|NCT05639686|Remifentanil|remifentanil|mesh-list
44067548|NCT05639686|Anesthetics|anesthetics|mesh-list
44067549|NCT05639686|Propofol|propofol|mesh-list
44067550|NCT05639686|Isoflurane|isoflurane|mesh-list
44067551|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
44067552|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067553|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067554|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44461547|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461549|NCT01544920|Ribavirin|ribavirin|mesh-list
44461550|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
44067555|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44067556|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
44067557|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067558|NCT05639686|Narcotics|narcotics|mesh-ancestor
44067559|NCT05639686|Analgesics|analgesics|mesh-ancestor
44067560|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
44067561|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067562|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44067563|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44067564|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067565|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
44067566|NCT05639686|Coagulants|coagulants|mesh-ancestor
44067567|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067568|NCT00000114|Vitamins|vitamins|mesh-list
44067569|NCT00000114|Vitamin E|vitamin e|mesh-list
44067570|NCT00000114|Vitamin A|vitamin a|mesh-list
44067571|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
44067572|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067573|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
43565168|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
44067583|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067584|NCT00000116|Vitamin A|vitamin a|mesh-list
44067585|NCT00000116|Vitamins|vitamins|mesh-ancestor
44067586|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
44067587|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067588|NCT00000120|Erythromycin|erythromycin|mesh-list
44067589|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
44067590|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44067591|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
44067592|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
44067593|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44067594|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067595|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067596|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44067597|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067598|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067599|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44067600|NCT00000122|Fluorouracil|fluorouracil|mesh-list
44067601|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
44067602|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067603|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44067604|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067605|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067606|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
44067607|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067608|NCT00000134|Ganciclovir|ganciclovir|mesh-list
44067609|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44067610|NCT00000134|Foscarnet|foscarnet|mesh-list
44067611|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
44067612|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067613|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067614|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067615|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067616|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44067617|NCT00000136|Ganciclovir|ganciclovir|mesh-list
44067618|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44067620|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
44067621|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067622|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067623|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067624|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067625|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44067626|NCT00000139|Acyclovir|acyclovir|mesh-list
44067627|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
44067628|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067629|NCT00000142|Cidofovir|cidofovir|mesh-list
44067630|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
44067631|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067632|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067633|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461552|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44461553|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461554|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
44067634|NCT00000143|Ganciclovir|ganciclovir|mesh-list
44067635|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44067636|NCT00000143|Cidofovir|cidofovir|mesh-list
44067637|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
44067638|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067639|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067640|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067659|NCT00000146|Hormones|hormones|mesh-ancestor
44067660|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067661|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067662|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067663|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067664|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
44067665|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
44067666|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067667|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067668|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44067669|NCT00000146|Protective Agents|protective agents|mesh-ancestor
44067670|NCT00000147|Prednisone|prednisone|mesh-list
44067671|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
43650360|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650361|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650362|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
43650363|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
43650364|NCT03014843|Bromides|bromides|mesh-list
43650365|NCT03014843|Naloxone|naloxone|mesh-list
43650366|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
43619570|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619571|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43619572|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43667690|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
43667691|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667693|NCT04805541|Mydriatics|mydriatics|mesh-list
43667694|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
43667695|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667696|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667697|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44067672|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44067673|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44067674|NCT00000147|Prednisolone|prednisolone|mesh-list
44067675|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
44067676|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44067677|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
44067678|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067679|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
44067680|NCT00000147|Hormones|hormones|mesh-ancestor
44067681|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067682|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067683|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067684|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067685|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
44067686|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
44067687|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067688|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067690|NCT00000147|Protective Agents|protective agents|mesh-ancestor
44067691|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44067692|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44067693|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44067694|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067695|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067696|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067697|NCT00000151|Aspirin|aspirin|mesh-list
44067698|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44067699|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067711|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067712|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
44067713|NCT00000152|Aspirin|aspirin|mesh-list
44067714|NCT00000152|Beta Carotene|beta carotene|mesh-list
44067715|NCT00000152|Carotenoids|carotenoids|mesh-list
44067716|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44067717|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067718|NCT00000152|Analgesics|analgesics|mesh-ancestor
44067719|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
44067720|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067721|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067722|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067723|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067724|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44067725|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44067726|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067727|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44067728|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44067729|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067730|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
44067731|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
44067732|NCT00000152|Protective Agents|protective agents|mesh-ancestor
44461555|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461556|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
44461557|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461558|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
44461559|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067733|NCT00000152|Provitamins|provitamins|mesh-ancestor
44067734|NCT00000152|Vitamins|vitamins|mesh-ancestor
44067735|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
44067736|NCT00000157|Aspirin|aspirin|mesh-list
43667702|NCT04800302|Morphine|morphine|mesh-list
44067737|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44067738|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067739|NCT00000157|Analgesics|analgesics|mesh-ancestor
44067740|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
44067741|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067742|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067743|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067744|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067745|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44067746|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44067747|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067748|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44067749|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44067750|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067751|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
44150906|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150907|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44150908|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150909|NCT00211705|Pravastatin|pravastatin|mesh-list
44150910|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44150911|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44150912|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
44150913|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150914|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44150915|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44150916|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150930|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150931|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150932|NCT00211796|Valproic Acid|valproic acid|mesh-list
44150933|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
44150934|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150935|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150936|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
44150937|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150938|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150939|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
44150940|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44150941|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150942|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150943|NCT00211848|Interferons|interferons|mesh-list
44150944|NCT00211848|Ribavirin|ribavirin|mesh-list
44150945|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150946|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
44150947|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150948|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
44150949|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150950|NCT00211939|Atorvastatin|atorvastatin|mesh-list
44150951|NCT00211939|Calcium|calcium|mesh-list
44150952|NCT00211939|Sevelamer|sevelamer|mesh-list
44150953|NCT00211939|Calcium acetate|calcium acetate|mesh-list
44150954|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44150955|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150956|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44150957|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44150958|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
44150959|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150960|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44150961|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44150962|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619573|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43619574|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43619575|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619576|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619577|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619592|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
44461561|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461562|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461563|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
44461564|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461565|NCT01544348|Omalizumab|omalizumab|mesh-list
44150963|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
44150964|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
44150965|NCT00211952|Celecoxib|celecoxib|mesh-list
44150966|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44150967|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067752|NCT00000170|Atropine|atropine|mesh-list
44067753|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44067754|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44067755|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44067756|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
43619594|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067757|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067758|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067759|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44067760|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
44067761|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
44067762|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
43565420|NCT00906334|ON 01910|on 01910|mesh-list
44067774|NCT00000172|Galantamine|galantamine|mesh-list
44067775|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44067776|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067777|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067778|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
44067779|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067780|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067781|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44067782|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
44067783|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067784|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
44067785|NCT00000173|Vitamin E|vitamin e|mesh-list
44067786|NCT00000173|Donepezil|donepezil|mesh-list
44067787|NCT00000173|Vitamins|vitamins|mesh-ancestor
44067788|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
44067789|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067790|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44067791|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067792|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067793|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
44067794|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067795|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
44067796|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
44067797|NCT00000173|Protective Agents|protective agents|mesh-ancestor
44067798|NCT00000175|Testosterone|testosterone|mesh-list
44067799|NCT00000175|Estrogens|estrogens|mesh-list
44067800|NCT00000175|Androgens|androgens|mesh-ancestor
44067801|NCT00000175|Hormones|hormones|mesh-ancestor
44067802|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067803|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067804|NCT00000176|Progesterone|progesterone|mesh-list
44067805|NCT00000176|Estrogens|estrogens|mesh-list
44067806|NCT00000176|Progestins|progestins|mesh-ancestor
44067807|NCT00000176|Hormones|hormones|mesh-ancestor
44067808|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067809|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067810|NCT00000177|Estrogens|estrogens|mesh-list
44067811|NCT00000177|Hormones|hormones|mesh-ancestor
44067812|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067813|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067814|NCT00000179|Haloperidol|haloperidol|mesh-list
44067815|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
44067816|NCT00000179|Trazodone|trazodone|mesh-list
44067817|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
44067818|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
44067819|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067820|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067821|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067822|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44067823|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44067824|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461566|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44461567|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44461568|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
44067825|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067826|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44067827|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
44067839|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44067840|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
44067841|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067842|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067843|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067844|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44067845|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44067846|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067847|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067848|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44067849|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44067850|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
44067851|NCT00000191|Carbamazepine|carbamazepine|mesh-list
44067852|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
44067853|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
44067854|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44067855|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067856|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619616|NCT03121547|Tramadol|tramadol|mesh-list
43619617|NCT03121547|Tapentadol|tapentadol|mesh-list
43619618|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619620|NCT03121547|Narcotics|narcotics|mesh-ancestor
44067857|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067858|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067859|NCT00000191|Analgesics|analgesics|mesh-ancestor
44067860|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
44067861|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067862|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44067863|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44067864|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067865|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44067866|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44067867|NCT00000205|Buprenorphine|buprenorphine|mesh-list
44067868|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067869|NCT00000205|Narcotics|narcotics|mesh-ancestor
44067870|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067871|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067872|NCT00000205|Analgesics|analgesics|mesh-ancestor
44067873|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
44067874|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067875|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44067876|NCT00000214|Buprenorphine|buprenorphine|mesh-list
44067877|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067878|NCT00000214|Narcotics|narcotics|mesh-ancestor
44067879|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067880|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067881|NCT00000214|Analgesics|analgesics|mesh-ancestor
44067882|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
43619666|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619667|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43619668|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619669|NCT03120936|Tenofovir|tenofovir|mesh-list
43619670|NCT03120936|Emtricitabine|emtricitabine|mesh-list
43619671|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
43619672|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619673|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43619675|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067883|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067884|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44067885|NCT00000216|Buprenorphine|buprenorphine|mesh-list
44067886|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067887|NCT00000216|Narcotics|narcotics|mesh-ancestor
44067888|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067889|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067902|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43790064|NCT03828045|Analgesics|analgesics|mesh-ancestor
44067903|NCT00000221|Buprenorphine|buprenorphine|mesh-list
44067904|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067905|NCT00000221|Narcotics|narcotics|mesh-ancestor
44067906|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067907|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067908|NCT00000221|Analgesics|analgesics|mesh-ancestor
44067909|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
44067910|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067911|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44067913|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
44067914|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
44067915|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067916|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461570|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44461571|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44461572|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44461573|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
44461574|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461575|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43787827|NCT05122377|Goserelin|goserelin|mesh-list
44067917|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067918|NCT00000251|Isoflurane|isoflurane|mesh-list
44067919|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067920|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
44067921|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
44067922|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067923|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067924|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
44067925|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067926|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
44067927|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
44067928|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067929|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067930|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067931|NCT00000252|Analgesics|analgesics|mesh-ancestor
44067932|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
44067933|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067934|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
44067935|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067936|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
44067937|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
44067938|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067939|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067940|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067941|NCT00000255|Analgesics|analgesics|mesh-ancestor
44067942|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
43619720|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44067943|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067944|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
44067945|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067946|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
44067947|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
44067948|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067949|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067950|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067951|NCT00000256|Analgesics|analgesics|mesh-ancestor
44067952|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
44067953|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067964|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
44067965|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067966|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
44067967|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
44067968|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067969|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067970|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067971|NCT00000258|Analgesics|analgesics|mesh-ancestor
44067972|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
44067973|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067974|NCT00000324|Tryptophan|tryptophan|mesh-list
44067975|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44067976|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
44067977|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067978|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
43790139|NCT03023462|Droperidol|droperidol|mesh-list
44067979|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44067980|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
44067981|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067982|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619733|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
44067983|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067984|NCT00000368|Paroxetine|paroxetine|mesh-list
44067985|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44067986|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461576|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44461577|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461578|NCT01544179|Cisplatin|cisplatin|mesh-list
44461579|NCT01544179|Pemetrexed|pemetrexed|mesh-list
44067987|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44067988|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067989|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067990|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
44067991|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067992|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44067993|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
44067994|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44067995|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44067996|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44067997|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067998|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
43619775|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619776|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619777|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619778|NCT03120533|Treprostinil|treprostinil|mesh-list
43619779|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619780|NCT03120403|Morphine|morphine|mesh-list
43619781|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619782|NCT03120403|Narcotics|narcotics|mesh-ancestor
43619783|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619784|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619785|NCT03120403|Analgesics|analgesics|mesh-ancestor
43619786|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
43619787|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619788|NCT03120494|Tenofovir|tenofovir|mesh-list
43619789|NCT03120494|Emtricitabine|emtricitabine|mesh-list
43619790|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
44067999|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068000|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068001|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068002|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068003|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
44068004|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44068005|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068006|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068007|NCT00000375|Nortriptyline|nortriptyline|mesh-list
44068008|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068009|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068010|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068011|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068012|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068013|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068014|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068015|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068026|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068028|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068029|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068030|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068031|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068032|NCT00000381|Fluoxetine|fluoxetine|mesh-list
44068033|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44068034|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068035|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068036|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068037|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068038|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
44068039|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068040|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44068041|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068042|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068043|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068044|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068045|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068046|NCT00000395|Folic Acid|folic acid|mesh-list
44068047|NCT00000395|Leucovorin|leucovorin|mesh-list
44068048|NCT00000395|Methotrexate|methotrexate|mesh-list
44068049|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
44068050|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44068051|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
44068052|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068053|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068054|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44068055|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
43619793|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44068056|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068057|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068058|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
44068059|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068060|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44068061|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461580|NCT01544179|Gefitinib|gefitinib|mesh-list
44461581|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461582|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068062|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
44068063|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068064|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44068065|NCT00000395|Hematinics|hematinics|mesh-ancestor
44068066|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
44068067|NCT00000395|Vitamins|vitamins|mesh-ancestor
44068068|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
44068069|NCT00000395|Antidotes|antidotes|mesh-ancestor
44068070|NCT00000395|Protective Agents|protective agents|mesh-ancestor
44068071|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44068072|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44068073|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44068075|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068076|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068077|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44068078|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44068079|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068095|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
44068097|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068098|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068099|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068100|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068101|NCT00000425|Acetaminophen|acetaminophen|mesh-list
44068102|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44068103|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44068104|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068105|NCT00000425|Analgesics|analgesics|mesh-ancestor
44068106|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
44068107|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068108|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068109|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
44068110|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068111|NCT00000426|Calcium|calcium|mesh-list
44068112|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068113|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068114|NCT00000427|Alendronate|alendronate|mesh-list
44068115|NCT00000427|Hormones|hormones|mesh-list
44068116|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
44068117|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068118|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068119|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44068120|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068121|NCT00000428|Amitriptyline|amitriptyline|mesh-list
44068122|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068123|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
43619821|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790278|NCT05129085|Hormones|hormones|mesh-ancestor
44068124|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068125|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068126|NCT00000428|Analgesics|analgesics|mesh-ancestor
44068127|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
44068128|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068129|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068130|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068131|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068132|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068133|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068134|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068135|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650372|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
44068136|NCT00000456|Naltrexone|naltrexone|mesh-list
44068146|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44068147|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068148|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068149|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068151|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068152|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068153|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068154|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44461583|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461584|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44461585|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44068155|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068157|NCT00000461|Pravastatin|pravastatin|mesh-list
44068158|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
44068159|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
44068160|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068161|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
44068162|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068163|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068164|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068165|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
44068166|NCT00000461|Vitamins|vitamins|mesh-ancestor
44068167|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
44068168|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068169|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068170|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44068171|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068172|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44068173|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068174|NCT00000463|Warfarin|warfarin|mesh-list
44068175|NCT00000463|Lovastatin|lovastatin|mesh-list
44068176|NCT00000463|L 647318|l 647318|mesh-list
44068177|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
44068178|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
44068179|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
44068180|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068181|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068182|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
44068183|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068184|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068185|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44068186|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068187|NCT00000464|Quinidine|quinidine|mesh-list
44068188|NCT00000464|Amiodarone|amiodarone|mesh-list
44068189|NCT00000464|Sotalol|sotalol|mesh-list
44068190|NCT00000464|Propafenone|propafenone|mesh-list
44068191|NCT00000464|Mexiletine|mexiletine|mesh-list
44068192|NCT00000464|Procainamide|procainamide|mesh-list
44068193|NCT00000464|Imipramine|imipramine|mesh-list
44068194|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068195|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068196|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44068197|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068198|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068199|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068200|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44068201|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068204|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068205|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44068206|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068207|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068208|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068209|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068210|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068211|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
44068212|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
44068213|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068214|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44068215|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
44068216|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44068217|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44068218|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068219|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44068220|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44068221|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
44068222|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44068223|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068224|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068225|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068226|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44461586|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44068227|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068228|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44068229|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
44068231|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44068232|NCT00000466|Estrogens|estrogens|mesh-list
44068233|NCT00000466|Progestins|progestins|mesh-ancestor
44068234|NCT00000466|Hormones|hormones|mesh-ancestor
44068235|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068236|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068237|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44068238|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44068239|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44068240|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
44068241|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068242|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44068243|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44068244|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44068245|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068246|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068247|NCT00000468|Plasminogen|plasminogen|mesh-list
44068248|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44068249|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068250|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068251|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068252|NCT00000472|Heparin|heparin|mesh-list
44068253|NCT00000472|Plasminogen|plasminogen|mesh-list
44068254|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44068255|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
44068256|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068257|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068258|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068259|NCT00000478|Atenolol|atenolol|mesh-list
44068260|NCT00000478|Diltiazem|diltiazem|mesh-list
44068261|NCT00000478|Nifedipine|nifedipine|mesh-list
44068262|NCT00000478|Isosorbide|isosorbide|mesh-list
44068263|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44068264|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44068265|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44068266|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068267|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068268|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068269|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068270|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068271|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
44068272|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068273|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43565923|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
44068284|NCT00000478|Diuretics|diuretics|mesh-ancestor
44068285|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068286|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44068287|NCT00000479|Aspirin|aspirin|mesh-list
44068288|NCT00000479|Vitamin E|vitamin e|mesh-list
44068289|NCT00000479|Vitamins|vitamins|mesh-ancestor
44068290|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
44068291|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068292|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44068293|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068294|NCT00000479|Analgesics|analgesics|mesh-ancestor
44068295|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
44068296|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068297|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068298|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068299|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068300|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068301|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068302|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44068303|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068304|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068305|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
44068306|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
44068307|NCT00000479|Protective Agents|protective agents|mesh-ancestor
44068308|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44068309|NCT00000482|Niacin|niacin|mesh-list
44256819|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44256820|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068310|NCT00000482|Clofibrate|clofibrate|mesh-list
44068311|NCT00000482|Estrogens|estrogens|mesh-list
44068312|NCT00000482|Hormones|hormones|mesh-ancestor
44068313|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068314|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068315|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068316|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
44068317|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068318|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068319|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068320|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
44068321|NCT00000482|Vitamins|vitamins|mesh-ancestor
44068322|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
44068323|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068324|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
44068325|NCT00000485|Diuretics|diuretics|mesh-list
44068326|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068327|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068328|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
44068329|NCT00000487|Diuretics|diuretics|mesh-list
44068330|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068331|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068332|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
44068333|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068334|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068335|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
44068336|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068337|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068338|NCT00000491|Aspirin|aspirin|mesh-list
44068339|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43565994|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068348|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068349|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068350|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44068351|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068352|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068353|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
44068354|NCT00000492|Propranolol|propranolol|mesh-list
44068355|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068356|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068357|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068358|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068359|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068360|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068361|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068362|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068363|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068364|NCT00000493|Propranolol|propranolol|mesh-list
44068365|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068366|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068367|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068368|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068369|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068370|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068371|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068372|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068373|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068374|NCT00000494|Indomethacin|indomethacin|mesh-list
44068375|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44068376|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068377|NCT00000494|Analgesics|analgesics|mesh-ancestor
44068378|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
44068379|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068380|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068381|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068382|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068383|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
44068384|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
44068385|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068386|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068387|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256821|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256822|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44256823|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256824|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068388|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068389|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
44068391|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
44068392|NCT00000499|Hydralazine|hydralazine|mesh-list
44068393|NCT00000499|Reserpine|reserpine|mesh-list
44068394|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068395|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068396|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
44068397|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
44068398|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068399|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068400|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44068401|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068402|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068403|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068404|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068405|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068433|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
44068434|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
44068435|NCT00000500|Protective Agents|protective agents|mesh-ancestor
44068436|NCT00000503|Streptokinase|streptokinase|mesh-list
44068437|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
44068438|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068439|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068440|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068441|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068443|NCT00000504|Moricizine|moricizine|mesh-list
44068444|NCT00000504|Encainide|encainide|mesh-list
44068445|NCT00000504|Imipramine|imipramine|mesh-list
44068446|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068447|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44068448|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068449|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068450|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068451|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068452|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068453|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44150972|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44150973|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44150974|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44150975|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44150976|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150977|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150978|NCT00211978|Calcium|calcium|mesh-list
44150979|NCT00211978|Calcium acetate|calcium acetate|mesh-list
44150980|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44150981|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150982|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
44150983|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
44150984|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150985|NCT00212004|Pioglitazone|pioglitazone|mesh-list
44150986|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150987|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150988|NCT00212017|Voglibose|voglibose|mesh-list
44150989|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150990|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150991|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44150992|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150993|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150994|NCT00212030|Nicorandil|nicorandil|mesh-list
44150995|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44150996|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44150997|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
44150998|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
44150999|NCT00212030|Vitamins|vitamins|mesh-ancestor
44151000|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
43783686|NCT02806687|Gemcitabine|gemcitabine|mesh-list
44256825|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256826|NCT00621673|Factor VIII|factor viii|mesh-list
44256827|NCT00621673|Coagulants|coagulants|mesh-ancestor
44256828|NCT00621699|Ezetimibe|ezetimibe|mesh-list
44256829|NCT00621699|Tacrolimus|tacrolimus|mesh-list
44256830|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256831|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
43654091|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151001|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151002|NCT00212043|Gemcitabine|gemcitabine|mesh-list
44151003|NCT00212043|Carboplatin|carboplatin|mesh-list
44151004|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151005|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151006|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
44151007|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151008|NCT00212043|Antiviral Agents|antiviral agents|mesh-ancestor
44151009|NCT00212043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068459|NCT00000514|Atenolol|atenolol|mesh-list
44068460|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
44068461|NCT00000514|Reserpine|reserpine|mesh-list
44068462|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068463|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068464|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
44068465|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
44068466|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068467|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068468|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44068469|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068470|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068471|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068472|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068473|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068474|NCT00000514|Diuretics|diuretics|mesh-ancestor
44068475|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068476|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44068480|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068481|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068482|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068483|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068484|NCT00000516|Enalapril|enalapril|mesh-list
44068485|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44068486|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
44068487|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068488|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068489|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068490|NCT00000517|Warfarin|warfarin|mesh-list
44068491|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
44068492|NCT00000518|Quinidine|quinidine|mesh-list
44068493|NCT00000518|Sotalol|sotalol|mesh-list
44068494|NCT00000518|Mexiletine|mexiletine|mesh-list
44068495|NCT00000518|Procainamide|procainamide|mesh-list
44068496|NCT00000518|Imipramine|imipramine|mesh-list
44068497|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068498|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068499|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068500|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068501|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068502|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068503|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068504|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
44068505|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
44068506|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068507|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44068508|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
44068509|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44068510|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44068511|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068512|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068513|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44068514|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44256832|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256833|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44256834|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256835|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256836|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068515|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
44068516|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44068517|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068518|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068519|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068520|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068521|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44068522|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068523|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068524|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068525|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068526|NCT00000520|Aspirin|aspirin|mesh-list
44068527|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
44068528|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44068529|NCT00000520|Antibodies|antibodies|mesh-list
44068530|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
44068531|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44068532|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43619971|NCT05463809|Oxycodone|oxycodone|mesh-list
44068533|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068534|NCT00000520|Analgesics|analgesics|mesh-ancestor
44068535|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
44068536|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068537|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068538|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068539|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068540|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068541|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068542|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068543|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44068544|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068545|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068546|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
44068547|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
44068548|NCT00000522|Acebutolol|acebutolol|mesh-list
44068549|NCT00000522|Amlodipine|amlodipine|mesh-list
44068556|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068558|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068559|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068560|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44068561|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
44068562|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068563|NCT00000522|Diuretics|diuretics|mesh-ancestor
44068564|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068565|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44068566|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44068567|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44068568|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068569|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068570|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068571|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068572|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
44068573|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
44068574|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068575|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44068576|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068577|NCT00000524|Cyclosporine|cyclosporine|mesh-list
44068578|NCT00000524|Prednisone|prednisone|mesh-list
44068579|NCT00000524|Cyclosporins|cyclosporins|mesh-list
44068580|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068581|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
44068582|NCT00000524|Hormones|hormones|mesh-ancestor
44068583|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068584|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256837|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44256838|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
44256839|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44256840|NCT00621725|Cediranib|cediranib|mesh-list
44256841|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256842|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44068585|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068586|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068587|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068588|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068589|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44068590|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
44068591|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
44068592|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068593|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44068594|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068595|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44068596|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44068597|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
44068598|NCT00000525|Triamterene|triamterene|mesh-list
44068599|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068600|NCT00000525|Diuretics|diuretics|mesh-ancestor
44068601|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068602|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068603|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44068604|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068605|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068606|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44068607|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068608|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44068609|NCT00000526|Flecainide|flecainide|mesh-list
44068610|NCT00000526|Moricizine|moricizine|mesh-list
44068611|NCT00000526|Encainide|encainide|mesh-list
44068612|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068613|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44068614|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068615|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068616|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068617|NCT00000527|Aspirin|aspirin|mesh-list
44068623|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068624|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068625|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068626|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068627|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068628|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068629|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068630|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44068631|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068632|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068633|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
44068634|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44068635|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068636|NCT00000529|Tamoxifen|tamoxifen|mesh-list
44068637|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44068638|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
44068639|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068640|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068641|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068642|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068643|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44068644|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44068645|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44068646|NCT00000530|Nifedipine|nifedipine|mesh-list
44068647|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44068648|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068649|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068650|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44256843|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256844|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256845|NCT00621790|Fenoldopam|fenoldopam|mesh-list
44256846|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068651|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068652|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068653|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
44068654|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068655|NCT00000531|Amiodarone|amiodarone|mesh-list
44068656|NCT00000531|Sotalol|sotalol|mesh-list
44068657|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068658|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068659|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44068660|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068661|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068662|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068663|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44068664|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068665|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068666|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44068667|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068668|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44068669|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068670|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068671|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068672|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068673|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068674|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
44068675|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
44068676|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619976|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068677|NCT00000534|Calcium|calcium|mesh-list
44068678|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068679|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068680|NCT00000539|Vitamins|vitamins|mesh-list
44068681|NCT00000539|Vitamin E|vitamin e|mesh-list
44068682|NCT00000539|Beta Carotene|beta carotene|mesh-list
44068683|NCT00000539|Warfarin|warfarin|mesh-list
44068684|NCT00000539|Pravastatin|pravastatin|mesh-list
44068685|NCT00000539|Carotenoids|carotenoids|mesh-list
44068686|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
44068693|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
44068694|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068695|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068696|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44068697|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068698|NCT00000539|Provitamins|provitamins|mesh-ancestor
44068699|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
44068700|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068701|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068703|NCT00000553|Simvastatin|simvastatin|mesh-list
44068704|NCT00000553|Antioxidants|antioxidants|mesh-list
44068705|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068706|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068707|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
44068708|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068709|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068710|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44068711|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068712|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068713|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
44068714|NCT00000553|Vitamins|vitamins|mesh-ancestor
44068715|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
44068716|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068717|NCT00000553|Protective Agents|protective agents|mesh-ancestor
44068718|NCT00000554|Dobutamine|dobutamine|mesh-list
44068719|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44068720|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
44068721|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
44068722|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068723|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068724|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44068725|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44256847|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
44256848|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
44256849|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
44068726|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44068727|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068728|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068729|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068730|NCT00000554|Protective Agents|protective agents|mesh-ancestor
44068731|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
44068732|NCT00000555|Vitamin E|vitamin e|mesh-list
44068733|NCT00000555|Hormones|hormones|mesh-list
44068734|NCT00000555|Progesterone|progesterone|mesh-list
44068735|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44068736|NCT00000555|Estrogens|estrogens|mesh-list
44068737|NCT00000555|Vitamins|vitamins|mesh-ancestor
44068738|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
44068739|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619980|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44068740|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068741|NCT00000555|Progestins|progestins|mesh-ancestor
44068742|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
44068743|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068744|NCT00000555|Protective Agents|protective agents|mesh-ancestor
44068745|NCT00000556|Quinidine|quinidine|mesh-list
44068746|NCT00000556|Digoxin|digoxin|mesh-list
44068747|NCT00000556|Amiodarone|amiodarone|mesh-list
44068748|NCT00000556|Verapamil|verapamil|mesh-list
44068749|NCT00000556|Sotalol|sotalol|mesh-list
44068750|NCT00000556|Flecainide|flecainide|mesh-list
44068751|NCT00000556|Propafenone|propafenone|mesh-list
44068752|NCT00000556|Procainamide|procainamide|mesh-list
44068753|NCT00000556|Moricizine|moricizine|mesh-list
44068754|NCT00000556|Disopyramide|disopyramide|mesh-list
44068755|NCT00000556|Diltiazem|diltiazem|mesh-list
44068756|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44068757|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
44068758|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068759|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44068760|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068788|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44068789|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44068790|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44068791|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44068792|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068793|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
44068794|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44068795|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
44068796|NCT00000559|Hormones|hormones|mesh-list
44068797|NCT00000559|Estradiol|estradiol|mesh-list
44068798|NCT00000559|Estrogens|estrogens|mesh-list
44068799|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068800|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068801|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44068802|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
44068803|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068814|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068815|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068816|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068817|NCT00000563|Dexamethasone|dexamethasone|mesh-list
44068818|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068819|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
44068820|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
44068821|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068822|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068823|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44068824|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
44068825|NCT00000563|Hormones|hormones|mesh-ancestor
44068826|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068827|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068828|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068829|NCT00000568|Ipratropium|ipratropium|mesh-list
44068830|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44068831|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
44068832|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068833|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068834|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44068835|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
44256850|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256851|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256852|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256853|NCT00621816|Nitroprusside|nitroprusside|mesh-list
44256854|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44256855|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
44256856|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44256857|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256858|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
44256859|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44256860|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256861|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44256862|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256863|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44256864|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44068836|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44068837|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
44068838|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068839|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068840|NCT00000569|Triamcinolone|triamcinolone|mesh-list
44068841|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068842|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
44068844|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068845|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068846|NCT00000575|Nedocromil|nedocromil|mesh-list
44068847|NCT00000575|Budesonide|budesonide|mesh-list
44068848|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068849|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44068850|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
44068851|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068852|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068853|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44068854|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44068855|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
44068856|NCT00000575|Hormones|hormones|mesh-ancestor
44068857|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068858|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
44068859|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
44068860|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44068861|NCT00000576|Beclomethasone|beclomethasone|mesh-list
44068862|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068863|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
44068864|NCT00000576|Hormones|hormones|mesh-ancestor
44068865|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068866|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068877|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068878|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
44068879|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
44068880|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068881|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068882|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44068883|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
44068884|NCT00000579|Hormones|hormones|mesh-ancestor
44068885|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068886|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44068887|NCT00000579|Protective Agents|protective agents|mesh-ancestor
44256865|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256866|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
44256867|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
44256868|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
43654133|NCT02978443|Ipilimumab|ipilimumab|mesh-list
44068888|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068889|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068890|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
44068891|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068892|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44068893|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068894|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068895|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068896|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44068897|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
44068898|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44068899|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
44068900|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068901|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
44068902|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068903|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068904|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44068905|NCT00000588|Pyridoxal|pyridoxal|mesh-list
44068906|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
44068907|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
43790862|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
44068908|NCT00000588|Vitamins|vitamins|mesh-ancestor
44068909|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
44068910|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068911|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
44068912|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
44068913|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068914|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44068915|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
44068916|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44068917|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068918|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
44068919|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068920|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44068921|NCT00000595|Deferoxamine|deferoxamine|mesh-list
44068922|NCT00000595|Siderophores|siderophores|mesh-ancestor
44068923|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44068924|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
44068925|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
44068926|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068927|NCT00000596|Dapsone|dapsone|mesh-list
44068928|NCT00000596|Prednisone|prednisone|mesh-list
44068929|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
44068930|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43566616|NCT00833495|Prednisone|prednisone|mesh-list
44068936|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068938|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44068939|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068940|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
44068941|NCT00000596|Hormones|hormones|mesh-ancestor
44068942|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068943|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068944|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068945|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
44068946|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44068947|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44068948|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44068949|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068950|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
44068951|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44068952|NCT00000599|Niacin|niacin|mesh-list
44068953|NCT00000599|Colestipol|colestipol|mesh-list
44068954|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068955|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
44068956|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068957|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44256869|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256870|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256871|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
44256872|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256873|NCT00621998|Olanzapine|olanzapine|mesh-list
44256874|NCT00621998|Risperidone|risperidone|mesh-list
44256875|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44256876|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
44256877|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256878|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256879|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068958|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068959|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
44068960|NCT00000599|Vitamins|vitamins|mesh-ancestor
44068961|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
44068962|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068963|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
44068964|NCT00000601|Hormones|hormones|mesh-list
44068965|NCT00000601|Progesterone|progesterone|mesh-list
44068966|NCT00000601|Estrogens|estrogens|mesh-list
44068967|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068968|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068969|NCT00000601|Progestins|progestins|mesh-ancestor
44068970|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
44068971|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068972|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
44068973|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068974|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068975|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44068976|NCT00000609|Amiodarone|amiodarone|mesh-list
44068977|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44068978|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068979|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44068980|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068981|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068982|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068983|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44068984|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068985|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068986|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44068987|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068988|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44068989|NCT00000611|Vitamin D|vitamin d|mesh-list
44068990|NCT00000611|Calcium|calcium|mesh-list
44068991|NCT00000611|Hormones|hormones|mesh-list
44068992|NCT00000611|Estrogens|estrogens|mesh-list
44068993|NCT00000611|Progestins|progestins|mesh-list
44068994|NCT00000611|Vitamins|vitamins|mesh-ancestor
44068995|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
44068996|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068997|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068998|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44068999|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069013|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
44069014|NCT00000620|Acarbose|acarbose|mesh-list
44069015|NCT00000620|Repaglinide|repaglinide|mesh-list
44069016|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44069017|NCT00000620|Metoprolol|metoprolol|mesh-list
44069018|NCT00000620|Felodipine|felodipine|mesh-list
44069019|NCT00000620|Amlodipine|amlodipine|mesh-list
44069020|NCT00000620|Valsartan|valsartan|mesh-list
44069021|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44069022|NCT00000620|Carvedilol|carvedilol|mesh-list
44069023|NCT00000620|Candesartan|candesartan|mesh-list
44069024|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
44069025|NCT00000620|Lisinopril|lisinopril|mesh-list
44256881|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256882|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256883|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256884|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44256885|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
44256886|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
44256887|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
44256888|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256889|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44256890|NCT00621998|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44256891|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44069026|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
44069027|NCT00000620|Diltiazem|diltiazem|mesh-list
44069028|NCT00000620|Benazepril|benazepril|mesh-list
44069029|NCT00000620|Hydralazine|hydralazine|mesh-list
44069030|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
44069031|NCT00000620|Reserpine|reserpine|mesh-list
44069032|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
44069033|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
44069034|NCT00000620|Triamterene|triamterene|mesh-list
44069035|NCT00000620|Furosemide|furosemide|mesh-list
44069036|NCT00000620|Simvastatin|simvastatin|mesh-list
44069037|NCT00000620|Fenofibrate|fenofibrate|mesh-list
44069038|NCT00000620|Terazosin|terazosin|mesh-list
44069039|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069040|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44069041|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44069042|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069043|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44069044|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
44069045|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44069046|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44069047|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
44069048|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44069049|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44069050|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069051|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44069052|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44069053|NCT00000620|Diuretics|diuretics|mesh-ancestor
44069054|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
44069055|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44069056|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44069057|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069058|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
44069059|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44069060|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
44069061|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
44069062|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069063|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44069064|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44069065|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44069066|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
43566756|NCT00829530|Ramipril|ramipril|mesh-list
44069077|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44069078|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44069079|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44069080|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44069081|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44069082|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44069083|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44069084|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44069085|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43910943|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44256892|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44256893|NCT00622011|Risperidone|risperidone|mesh-list
44256894|NCT00622011|Zotepine|zotepine|mesh-list
44256895|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44256896|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
44256897|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44256898|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256899|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256900|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44256901|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256902|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256903|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44069086|NCT00000625|Zidovudine|zidovudine|mesh-list
44069087|NCT00000625|Didanosine|didanosine|mesh-list
44069088|NCT00000625|Zalcitabine|zalcitabine|mesh-list
44069089|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
44069090|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069091|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069092|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069093|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069094|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
44069095|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069096|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069097|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069098|NCT00000635|Trifluridine|trifluridine|mesh-list
44069099|NCT00000635|Polymyxins|polymyxins|mesh-list
44069100|NCT00000635|Bacitracin|bacitracin|mesh-list
44069101|NCT00000635|Polymyxin B|polymyxin b|mesh-list
44069102|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
44069103|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069104|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
44069105|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069106|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069107|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44069108|NCT00000637|Zidovudine|zidovudine|mesh-list
44069109|NCT00000637|Didanosine|didanosine|mesh-list
44069110|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
44069111|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069112|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069113|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069114|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069115|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
44069116|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069117|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069118|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069119|NCT00000639|Itraconazole|itraconazole|mesh-list
44069120|NCT00000639|Fluconazole|fluconazole|mesh-list
44069121|NCT00000639|Amphotericin B|amphotericin b|mesh-list
43620000|NCT05463601|Letrozole|letrozole|mesh-list
44069122|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44069123|NCT00000639|Flucytosine|flucytosine|mesh-list
44069124|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
44069125|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069126|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44069127|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069128|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069129|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069130|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44069131|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
43566808|NCT00821249|Dexamethasone|dexamethasone|mesh-list
44069146|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44069148|NCT00000640|Trimethoprim|trimethoprim|mesh-list
44069149|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
44069150|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44256904|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44256905|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
44256906|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
44256907|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44256908|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44256909|NCT00622115|Enoxaparin|enoxaparin|mesh-list
44256910|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
44256911|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44069151|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069152|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44069153|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069154|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069155|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
44069156|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069157|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069158|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44069159|NCT00000640|Renal Agents|renal agents|mesh-ancestor
44069160|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069161|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44069162|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44069163|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069164|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
44069165|NCT00000641|Azithromycin|azithromycin|mesh-list
44069166|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
44069167|NCT00000641|Rifampin|rifampin|mesh-list
44069168|NCT00000641|Amikacin|amikacin|mesh-list
44069169|NCT00000641|Ethambutol|ethambutol|mesh-list
44069170|NCT00000641|Clofazimine|clofazimine|mesh-list
44069171|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069172|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069173|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44069174|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44069175|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069176|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069177|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069178|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44069179|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069180|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44069181|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44069182|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
44069183|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069184|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44069185|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44069186|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44069187|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44069188|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44069189|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43566877|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
44069203|NCT00000643|Vitamins|vitamins|mesh-ancestor
44069204|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
44069205|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
44069206|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069207|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069208|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069209|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069210|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069211|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069213|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069214|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069215|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44069216|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069217|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069218|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44069219|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069220|NCT00000645|Hypericin|hypericin|mesh-list
44069221|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44069222|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44069223|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256912|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44256913|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256914|NCT00622141|Saquinavir|saquinavir|mesh-list
44069224|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
44069225|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069226|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069227|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069228|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069229|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
44069230|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069231|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
44069232|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44069233|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069234|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069235|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44069236|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43620013|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44069237|NCT00000646|Protective Agents|protective agents|mesh-ancestor
44069238|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069239|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
44069240|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44069241|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
44069242|NCT00000651|Zidovudine|zidovudine|mesh-list
44069243|NCT00000651|Zalcitabine|zalcitabine|mesh-list
44069244|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
44069245|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069246|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069247|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069248|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069249|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
44069250|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069251|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069252|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069253|NCT00000652|Zidovudine|zidovudine|mesh-list
44069254|NCT00000652|Didanosine|didanosine|mesh-list
44069271|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069272|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069273|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069274|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
44069275|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
44069276|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069277|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069278|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069279|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069280|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069281|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069282|NCT00000671|Zidovudine|zidovudine|mesh-list
44069283|NCT00000671|Didanosine|didanosine|mesh-list
44069284|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
44069285|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069286|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069287|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069288|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069289|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
44069290|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069291|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069292|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069293|NCT00000672|Didanosine|didanosine|mesh-list
44069294|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
44069295|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069296|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069297|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069298|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069299|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
44069300|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069301|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069302|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069303|NCT00000674|Leucovorin|leucovorin|mesh-list
44069304|NCT00000674|Clindamycin|clindamycin|mesh-list
44069305|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
44069306|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
44069307|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
44069308|NCT00000674|Calcium|calcium|mesh-list
44069309|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
44256915|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44256916|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44256917|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256918|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650417|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44256919|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256920|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256921|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44256922|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
44256923|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256924|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44256925|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256926|NCT00622206|Ritonavir|ritonavir|mesh-list
44256927|NCT00622206|Saquinavir|saquinavir|mesh-list
44256928|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44256929|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44256930|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
44256931|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256932|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256933|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256934|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069310|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44069311|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069312|NCT00000674|Antidotes|antidotes|mesh-ancestor
44069313|NCT00000674|Protective Agents|protective agents|mesh-ancestor
44069314|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
44069315|NCT00000674|Vitamins|vitamins|mesh-ancestor
44069324|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069325|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069326|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44069327|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
44069328|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069329|NCT00000676|Fluconazole|fluconazole|mesh-list
44069330|NCT00000676|Clotrimazole|clotrimazole|mesh-list
44069331|NCT00000676|Miconazole|miconazole|mesh-list
44069332|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
44069333|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069334|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44069335|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069336|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069337|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069338|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44069339|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
44069340|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069341|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069342|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44069343|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44069344|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44069345|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44069346|NCT00000677|Sch 39304|sch 39304|mesh-list
44069347|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
44069348|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069349|NCT00000678|Zidovudine|zidovudine|mesh-list
44069350|NCT00000678|Zalcitabine|zalcitabine|mesh-list
44069351|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
44256935|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
44256936|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256937|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44069352|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069353|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069354|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069355|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069356|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
44069357|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069358|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069359|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069360|NCT00000679|Zidovudine|zidovudine|mesh-list
44069361|NCT00000679|Zalcitabine|zalcitabine|mesh-list
44069362|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
44069363|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069364|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069365|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069366|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069367|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
44069368|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069369|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069370|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069372|NCT00000681|Doxorubicin|doxorubicin|mesh-list
44069373|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44069374|NCT00000681|Bleomycin|bleomycin|mesh-list
44069375|NCT00000681|Vincristine|vincristine|mesh-list
44069376|NCT00000681|Sargramostim|sargramostim|mesh-list
44069377|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44069378|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069379|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44069380|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44069381|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069382|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069383|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44069392|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069393|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069394|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
44069395|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069396|NCT00000682|Zidovudine|zidovudine|mesh-list
44069397|NCT00000682|Zalcitabine|zalcitabine|mesh-list
44069398|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
44069399|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069400|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069401|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069402|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069403|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
44069404|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069405|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069406|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069407|NCT00000684|Dextrans|dextrans|mesh-list
44069408|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
44069409|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
44069410|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
44069411|NCT00000686|Stavudine|stavudine|mesh-list
44069412|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
44069413|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069414|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069415|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069416|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069417|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
44069418|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069419|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069420|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44151010|NCT00212043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151011|NCT00212043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151012|NCT00212043|Immunologic Factors|immunologic factors|mesh-ancestor
44151013|NCT00212043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151014|NCT00212069|Gemcitabine|gemcitabine|mesh-list
44151015|NCT00212069|Carboplatin|carboplatin|mesh-list
44151016|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151017|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151018|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
44151019|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256938|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44256939|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44256940|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
44256941|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44256942|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43789130|NCT05123976|Olanzapine|olanzapine|mesh-list
44151020|NCT00212069|Antiviral Agents|antiviral agents|mesh-ancestor
44151021|NCT00212069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151022|NCT00212069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151023|NCT00212069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151024|NCT00212069|Immunologic Factors|immunologic factors|mesh-ancestor
44151025|NCT00212069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151026|NCT00212082|Docetaxel|docetaxel|mesh-list
44151027|NCT00212082|Doxorubicin|doxorubicin|mesh-list
44151028|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151029|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151030|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151031|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151032|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151033|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44069421|NCT00000687|Interferons|interferons|mesh-list
44069422|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
44069423|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
44069424|NCT00000687|Zidovudine|zidovudine|mesh-list
44069425|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069426|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
44069427|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069428|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
43567126|NCT00772785|Analgesics|analgesics|mesh-ancestor
44069441|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069442|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069443|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069444|NCT00000689|Leucovorin|leucovorin|mesh-list
44069445|NCT00000689|Cytarabine|cytarabine|mesh-list
44069446|NCT00000689|Dexamethasone|dexamethasone|mesh-list
44069447|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
44069448|NCT00000689|Doxorubicin|doxorubicin|mesh-list
44069449|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44069450|NCT00000689|Methotrexate|methotrexate|mesh-list
44069451|NCT00000689|Vincristine|vincristine|mesh-list
44069452|NCT00000689|Bleomycin|bleomycin|mesh-list
44069453|NCT00000689|Sargramostim|sargramostim|mesh-list
44069454|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
44069455|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069456|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
44069457|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069458|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44069459|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44069460|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
44069461|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069462|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069463|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44069464|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44069465|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
44069466|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
44069467|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069468|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44069469|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
44069470|NCT00000689|Hormones|hormones|mesh-ancestor
44069471|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069472|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44069473|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44069474|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44069475|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44069476|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069477|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44069478|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
44069479|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44069480|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44069481|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
44069482|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
44069483|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44256943|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44256944|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44256945|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256946|NCT00622258|Everolimus|everolimus|mesh-list
44069484|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069485|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
44069486|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069487|NCT00000689|Antidotes|antidotes|mesh-ancestor
44069488|NCT00000689|Protective Agents|protective agents|mesh-ancestor
44069489|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
44069490|NCT00000689|Vitamins|vitamins|mesh-ancestor
44069491|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
44069492|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44069513|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069514|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069515|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069516|NCT00000705|Zidovudine|zidovudine|mesh-list
44069517|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
44069518|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069519|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069520|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069521|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069522|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
44069523|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069524|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069525|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069526|NCT00000707|Pentamidine|pentamidine|mesh-list
44069527|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
44069528|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069529|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069530|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069531|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44069532|NCT00000708|Fluconazole|fluconazole|mesh-list
44069533|NCT00000708|Amphotericin B|amphotericin b|mesh-list
44069534|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44069535|NCT00000708|Flucytosine|flucytosine|mesh-list
44069536|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
44069537|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069538|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44069539|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069540|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069541|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069542|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44069543|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
44069544|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069545|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069546|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44069547|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44069548|NCT00000708|Amebicides|amebicides|mesh-ancestor
44069549|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069550|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069559|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
44069560|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069561|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069562|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069563|NCT00000711|Zidovudine|zidovudine|mesh-list
44069564|NCT00000711|Sargramostim|sargramostim|mesh-list
44069565|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
44069566|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069567|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069568|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069569|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069570|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
44069571|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791323|NCT04313608|Gemcitabine|gemcitabine|mesh-list
44069572|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069573|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069574|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
44069575|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069576|NCT00000712|Zidovudine|zidovudine|mesh-list
44069577|NCT00000712|Acyclovir|acyclovir|mesh-list
44069578|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
44106647|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256947|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256948|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256949|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
44256950|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069579|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069580|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069581|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069582|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069584|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069585|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069586|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069587|NCT00000715|Trimethoprim|trimethoprim|mesh-list
44069588|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44069589|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
44069590|NCT00000715|Pentamidine|pentamidine|mesh-list
44069591|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44069592|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069593|NCT00000715|Renal Agents|renal agents|mesh-ancestor
44069594|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
44069595|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069596|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069597|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069598|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069599|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069600|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44069601|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44069602|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069603|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
44069604|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44069605|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069606|NCT00000716|Zidovudine|zidovudine|mesh-list
44069607|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
44069608|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069609|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069610|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069611|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069612|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
43620123|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620124|NCT05434663|Granisetron|granisetron|mesh-list
44069613|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069614|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069615|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069616|NCT00000717|Clindamycin|clindamycin|mesh-list
44069617|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
44069626|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069627|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43620125|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
43620126|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
43650418|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43650419|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650420|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650421|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43650422|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43650423|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069629|NCT00000718|Zalcitabine|zalcitabine|mesh-list
44069630|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
44069631|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069632|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069633|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069634|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069635|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
44069636|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069637|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069638|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069639|NCT00000719|Zidovudine|zidovudine|mesh-list
44069640|NCT00000719|Zalcitabine|zalcitabine|mesh-list
44069641|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
44069642|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069643|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069644|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069645|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069646|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
44069647|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069648|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069649|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069651|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
44069652|NCT00000720|Antibodies|antibodies|mesh-list
44069653|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
44069654|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069655|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44256951|NCT00622349|Gemcitabine|gemcitabine|mesh-list
44256952|NCT00622349|Cisplatin|cisplatin|mesh-list
44256953|NCT00622349|Docetaxel|docetaxel|mesh-list
44256954|NCT00622349|Ifosfamide|ifosfamide|mesh-list
44256955|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
44256956|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789359|NCT03930602|BMS-986165|bms-986165|mesh-list
44069656|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069657|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069658|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
44069659|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069660|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069661|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069662|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
44069663|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069664|NCT00000722|Pentamidine|pentamidine|mesh-list
44069665|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
44069666|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069667|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069668|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069669|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44069670|NCT00000726|Foscarnet|foscarnet|mesh-list
44069671|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44069672|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
44069673|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069674|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069675|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069676|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069677|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069678|NCT00000739|Dapsone|dapsone|mesh-list
44069679|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069680|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
44069681|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069682|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069683|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069684|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069685|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069686|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
44069699|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069700|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44069701|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
44069703|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069704|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44069705|NCT00000741|Protective Agents|protective agents|mesh-ancestor
44069706|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44069707|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069708|NCT00000742|Zidovudine|zidovudine|mesh-list
44069709|NCT00000742|Didanosine|didanosine|mesh-list
44069710|NCT00000742|Atevirdine|atevirdine|mesh-list
44069711|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
44069712|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069713|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069714|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069715|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069716|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
44069717|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069718|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069719|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069720|NCT00000744|Fluconazole|fluconazole|mesh-list
44069721|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
44069722|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069723|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44069724|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069725|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151034|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44069726|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069727|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44069728|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44069729|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069730|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256957|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44256958|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
44256959|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44256960|NCT00622349|Antiviral Agents|antiviral agents|mesh-ancestor
44069731|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44069732|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44069734|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
44069735|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069736|NCT00000747|Nevirapine|nevirapine|mesh-list
44069737|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069738|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069739|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069740|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069741|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
44069742|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069743|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069744|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069745|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44069746|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44069747|NCT00000748|Trimethoprim|trimethoprim|mesh-list
43567439|NCT00750295|Hematinics|hematinics|mesh-ancestor
44069757|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069758|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069759|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44069760|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44069761|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069762|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069763|NCT00000751|Zidovudine|zidovudine|mesh-list
44069764|NCT00000751|Immune Sera|immune sera|mesh-list
44069765|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
44069766|NCT00000751|Antibodies|antibodies|mesh-list
44069767|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
44069768|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069769|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069770|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069771|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069772|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
44069773|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069774|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069775|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069776|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
44069777|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620139|NCT05429489|Analgesics|analgesics|mesh-ancestor
44069778|NCT00000752|Cefuroxime|cefuroxime|mesh-list
44069779|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
44069780|NCT00000752|Beclomethasone|beclomethasone|mesh-list
44069781|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
44069782|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
44069783|NCT00000752|Ephedrine|ephedrine|mesh-list
44069784|NCT00000752|Guaifenesin|guaifenesin|mesh-list
44069785|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44069786|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44069787|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
44069788|NCT00000752|Hormones|hormones|mesh-ancestor
44069789|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069790|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069791|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44069792|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
44069793|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44069794|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
44069795|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069796|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
44069797|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44069798|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43791556|NCT05134558|Xenon|xenon|mesh-list
44069799|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
44069800|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
44069801|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44069802|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069803|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069804|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256962|NCT00622349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256963|NCT00622349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44256964|NCT00622349|Immunologic Factors|immunologic factors|mesh-ancestor
44256965|NCT00622349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256966|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44256967|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44256968|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44256969|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44256971|NCT00622375|Mesalamine|mesalamine|mesh-list
44069805|NCT00000752|Expectorants|expectorants|mesh-ancestor
44069806|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44069807|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44069808|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
44069809|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44069810|NCT00000753|Zidovudine|zidovudine|mesh-list
44069811|NCT00000753|Didanosine|didanosine|mesh-list
44069812|NCT00000753|Zalcitabine|zalcitabine|mesh-list
44069813|NCT00000753|Atevirdine|atevirdine|mesh-list
44069814|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
44069828|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069829|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
44069830|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069831|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
44069832|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069833|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
44069834|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069835|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069836|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069837|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069838|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069839|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069841|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
44069842|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069843|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069844|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069845|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069846|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
44069847|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069848|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069849|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069850|NCT00000758|Fluorouracil|fluorouracil|mesh-list
44069851|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
44069852|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069853|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44069854|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069855|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069856|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
44069857|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069858|NCT00000760|Zidovudine|zidovudine|mesh-list
44069859|NCT00000760|Didanosine|didanosine|mesh-list
44069860|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
44069861|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069862|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069863|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069864|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069865|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
44069866|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069867|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069868|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069869|NCT00000761|Interferons|interferons|mesh-list
44069870|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
44069871|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069872|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
44069873|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44256972|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44256973|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654180|NCT02977637|Hematinics|hematinics|mesh-ancestor
44069874|NCT00000768|Ganciclovir|ganciclovir|mesh-list
44069875|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44069876|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
44069877|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069892|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44069893|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069894|NCT00000788|Analgesics|analgesics|mesh-ancestor
44069895|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
44069896|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069897|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
44069898|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44069899|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
44069900|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069901|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44069902|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069903|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069904|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069905|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44069906|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
44069907|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069908|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44069909|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44069910|NCT00000789|Zidovudine|zidovudine|mesh-list
44069911|NCT00000789|Stavudine|stavudine|mesh-list
44069912|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
44069913|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069914|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069915|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069916|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069917|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
44069918|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069919|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069920|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069921|NCT00000790|Thalidomide|thalidomide|mesh-list
44069922|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069923|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
44069924|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069925|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
44069926|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069927|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069928|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44069929|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44069930|NCT00000790|Growth Substances|growth substances|mesh-ancestor
44069931|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44069932|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069933|NCT00000792|Hypericin|hypericin|mesh-list
44069934|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
44069935|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44069936|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069937|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
44069954|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069955|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44069956|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44069957|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44069958|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069960|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44069961|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44069962|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44069963|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44069964|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44069965|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44069966|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
44069967|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
43791685|NCT04717154|Nivolumab|nivolumab|mesh-list
44069968|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44069969|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44256975|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
44256976|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44256977|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256978|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44069970|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
44069971|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44069972|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
44069973|NCT00000794|Leucovorin|leucovorin|mesh-list
44069974|NCT00000794|Clarithromycin|clarithromycin|mesh-list
44069975|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
44069976|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
44069977|NCT00000794|Atovaquone|atovaquone|mesh-list
44069978|NCT00000794|Calcium|calcium|mesh-list
44069979|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
44069980|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44069981|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069982|NCT00000794|Antidotes|antidotes|mesh-ancestor
44069983|NCT00000794|Protective Agents|protective agents|mesh-ancestor
44069984|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
44069985|NCT00000794|Vitamins|vitamins|mesh-ancestor
44069986|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
44069987|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069988|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069989|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44069990|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069991|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069992|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44069993|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44069994|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
44069995|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069996|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069997|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070011|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
44070012|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070013|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44070014|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070015|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
44070016|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070017|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
44070018|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44070019|NCT00000813|Protective Agents|protective agents|mesh-ancestor
44070020|NCT00000816|Trimethoprim|trimethoprim|mesh-list
44070021|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44070022|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
44070023|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44070024|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070025|NCT00000816|Renal Agents|renal agents|mesh-ancestor
44070026|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
44070027|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070028|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070029|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070030|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070031|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070032|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44070033|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44070034|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070035|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070036|NCT00000817|Amitriptyline|amitriptyline|mesh-list
44070037|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44070038|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
44070039|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44070040|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44070041|NCT00000817|Analgesics|analgesics|mesh-ancestor
44070042|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
44070043|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44070044|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070045|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44070046|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44070047|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44070048|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070049|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
44256979|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44256980|NCT00622414|Aflibercept|aflibercept|mesh-list
44256981|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
44256982|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44256983|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44256984|NCT00622414|Growth Substances|growth substances|mesh-ancestor
44256985|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256986|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654189|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44070050|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44070051|NCT00000820|Aldesleukin|aldesleukin|mesh-list
44070052|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070053|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070054|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070055|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
44070056|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070057|NCT00000821|Aldesleukin|aldesleukin|mesh-list
44070058|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070059|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070060|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070061|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
44070071|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070072|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070073|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
44070074|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070075|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070076|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070077|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
44070078|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070079|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070080|NCT00000826|Clarithromycin|clarithromycin|mesh-list
44070081|NCT00000826|Dapsone|dapsone|mesh-list
44070082|NCT00000826|Rifabutin|rifabutin|mesh-list
44070083|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44070084|NCT00000826|Fluconazole|fluconazole|mesh-list
44070085|NCT00000826|Trimethoprim|trimethoprim|mesh-list
44070086|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
44070087|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070088|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070089|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44070090|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070091|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070092|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070093|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070094|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
44070095|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44070096|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44070097|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
44070098|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44070099|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070100|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070101|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44157972|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
44070102|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44070103|NCT00000826|Renal Agents|renal agents|mesh-ancestor
44070104|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
44070105|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070106|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070107|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070108|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44070109|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44070110|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
44070111|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44070112|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070113|NCT00000827|Immune Sera|immune sera|mesh-list
44070114|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
44256988|NCT00622479|Sorafenib|sorafenib|mesh-list
44256989|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44256990|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44256991|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44256992|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654199|NCT02977533|Acyclovir|acyclovir|mesh-list
44070115|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070116|NCT00000831|Lamivudine|lamivudine|mesh-list
44070117|NCT00000831|Zidovudine|zidovudine|mesh-list
44070118|NCT00000831|Didanosine|didanosine|mesh-list
44070119|NCT00000831|Stavudine|stavudine|mesh-list
44070120|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070121|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070122|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070123|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070124|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
44070125|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070126|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070127|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070139|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070140|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070141|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070142|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
44070143|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070144|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070145|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070147|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
44070148|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070149|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070150|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070151|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070152|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
44070153|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070154|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070155|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070156|NCT00000857|Interleukin-12|interleukin-12|mesh-list
44070157|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44070158|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
44070159|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070160|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44070161|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44070162|NCT00000857|Growth Substances|growth substances|mesh-ancestor
44070163|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
44070164|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070165|NCT00000859|Ritonavir|ritonavir|mesh-list
44070166|NCT00000859|Nelfinavir|nelfinavir|mesh-list
44070167|NCT00000859|Indinavir|indinavir|mesh-list
44070168|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070169|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070170|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070171|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070172|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070173|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070174|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070175|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
44070176|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070177|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070178|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070179|NCT00000867|Memantine|memantine|mesh-list
44070180|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44070181|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44070182|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
44070183|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44070184|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070185|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070186|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44070187|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44070188|NCT00000869|Nevirapine|nevirapine|mesh-list
44256993|NCT00622570|Pentobarbital|pentobarbital|mesh-list
44256994|NCT00622570|Thiopental|thiopental|mesh-list
44256995|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
44256996|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44256997|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44070189|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070190|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070191|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567879|NCT00692484|Povidone|povidone|mesh-list
43567887|NCT00692445|Dexetimide|dexetimide|mesh-list
44070206|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070207|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070208|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070209|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
44070210|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070211|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070212|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070213|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
44070214|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070215|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070216|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070217|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070219|NCT00000877|Rifabutin|rifabutin|mesh-list
44070220|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070221|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070222|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070223|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070224|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070225|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070226|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070227|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
43620201|NCT05278065|Nicotine|nicotine|mesh-list
44070228|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070229|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070230|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44070231|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070232|NCT00000882|Lamivudine|lamivudine|mesh-list
44070233|NCT00000882|Zidovudine|zidovudine|mesh-list
44070234|NCT00000882|Stavudine|stavudine|mesh-list
44070235|NCT00000882|Delavirdine|delavirdine|mesh-list
44070236|NCT00000882|Indinavir|indinavir|mesh-list
44070237|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070238|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070239|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070240|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070241|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
44070242|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070243|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070244|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070245|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
44070246|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070247|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070248|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070249|NCT00000883|Azithromycin|azithromycin|mesh-list
44070250|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070251|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070252|NCT00000888|Ritonavir|ritonavir|mesh-list
44070253|NCT00000888|Lamivudine|lamivudine|mesh-list
44070254|NCT00000888|Zidovudine|zidovudine|mesh-list
44070255|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070256|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070266|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070267|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070269|NCT00000891|Ritonavir|ritonavir|mesh-list
44070270|NCT00000891|Saquinavir|saquinavir|mesh-list
44070271|NCT00000891|Lamivudine|lamivudine|mesh-list
44070272|NCT00000891|Zidovudine|zidovudine|mesh-list
44070273|NCT00000891|Didanosine|didanosine|mesh-list
44070274|NCT00000891|Stavudine|stavudine|mesh-list
44070275|NCT00000891|Delavirdine|delavirdine|mesh-list
44070276|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070277|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070278|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070279|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070280|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070281|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44256998|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44256999|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44257000|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
44257001|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
44257002|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
44257003|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
44257004|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44070282|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070283|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
44070284|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070285|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070286|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070287|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070288|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070289|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
44070290|NCT00000892|Ritonavir|ritonavir|mesh-list
44070291|NCT00000892|Nelfinavir|nelfinavir|mesh-list
44070292|NCT00000892|Saquinavir|saquinavir|mesh-list
44070293|NCT00000892|Delavirdine|delavirdine|mesh-list
44070294|NCT00000892|Adefovir|adefovir|mesh-list
44070295|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44070296|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070297|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070298|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070299|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070300|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070301|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070302|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070303|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
44070304|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070305|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070306|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070307|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070308|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070309|NCT00000893|Efavirenz|efavirenz|mesh-list
44070310|NCT00000893|Nelfinavir|nelfinavir|mesh-list
44070311|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070312|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070313|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070314|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070315|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
44070316|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070317|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070318|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070319|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44070320|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44070321|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070325|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070326|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070327|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070328|NCT00000895|Azithromycin|azithromycin|mesh-list
44070329|NCT00000895|Nevirapine|nevirapine|mesh-list
44070330|NCT00000895|Nelfinavir|nelfinavir|mesh-list
44070331|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070332|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070333|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070334|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070335|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070336|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070337|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
44070338|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070339|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070340|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070341|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070342|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070343|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070344|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070345|NCT00000898|Ritonavir|ritonavir|mesh-list
44070346|NCT00000898|Nelfinavir|nelfinavir|mesh-list
44257005|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257006|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44257007|NCT00622622|Gemcitabine|gemcitabine|mesh-list
44257008|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257009|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
44257010|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257011|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257012|NCT00622622|Antiviral Agents|antiviral agents|mesh-ancestor
44257013|NCT00622622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257014|NCT00622622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257015|NCT00622622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257016|NCT00622622|Immunologic Factors|immunologic factors|mesh-ancestor
44257017|NCT00622622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257018|NCT00622648|Enoxaparin|enoxaparin|mesh-list
44257019|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
44257020|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44257021|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44257022|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257023|NCT00622674|Cetuximab|cetuximab|mesh-list
44257024|NCT00622674|Bortezomib|bortezomib|mesh-list
44257025|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44257026|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257027|NCT00622687|Iloprost|iloprost|mesh-list
44257028|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44070347|NCT00000898|Saquinavir|saquinavir|mesh-list
44070348|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070349|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070350|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070351|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070352|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070353|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070354|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070355|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
44070356|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070357|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070358|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070359|NCT00000899|Lamivudine|lamivudine|mesh-list
44070360|NCT00000899|Stavudine|stavudine|mesh-list
44070361|NCT00000899|Nelfinavir|nelfinavir|mesh-list
44070362|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
44070363|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44070364|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
44070365|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070366|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44070367|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44070368|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
44070369|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070370|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070371|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44070372|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106648|NCT00076726|Infliximab|infliximab|mesh-list
44257029|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
44257030|NCT00622752|Nicotine|nicotine|mesh-list
44257031|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44257032|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
44257033|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257034|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257035|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44070373|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070374|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070375|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
44070376|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070377|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070378|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070379|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070380|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070381|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070382|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
44070383|NCT00000903|Lamivudine|lamivudine|mesh-list
44070384|NCT00000903|Zidovudine|zidovudine|mesh-list
44070385|NCT00000903|Efavirenz|efavirenz|mesh-list
44070386|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44070387|NCT00000903|Nelfinavir|nelfinavir|mesh-list
44070388|NCT00000903|Indinavir|indinavir|mesh-list
44070389|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070390|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070391|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070392|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070393|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
44070394|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070395|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070404|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070405|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070406|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070407|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
44070408|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44070409|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
44070410|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070411|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44070412|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070413|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
44070414|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070415|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
44070416|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44070417|NCT00000904|Protective Agents|protective agents|mesh-ancestor
44070418|NCT00000906|Ritonavir|ritonavir|mesh-list
44070419|NCT00000906|Saquinavir|saquinavir|mesh-list
44070420|NCT00000906|Methadone|methadone|mesh-list
44070421|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070422|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070423|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070424|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070425|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070426|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070427|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070428|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
44070429|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070430|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070431|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070432|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44070433|NCT00000906|Narcotics|narcotics|mesh-ancestor
44070434|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44070435|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070436|NCT00000906|Analgesics|analgesics|mesh-ancestor
44070437|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
44070438|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44070439|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
44070440|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
44070441|NCT00000919|Ritonavir|ritonavir|mesh-list
44070442|NCT00000919|Nelfinavir|nelfinavir|mesh-list
44070443|NCT00000919|Indinavir|indinavir|mesh-list
44070444|NCT00000919|Amprenavir|amprenavir|mesh-list
44070445|NCT00000919|Lamivudine|lamivudine|mesh-list
44257036|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44257037|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257038|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790169|NCT02963064|Antibodies|antibodies|mesh-list
44070446|NCT00000919|Zidovudine|zidovudine|mesh-list
44070447|NCT00000919|Abacavir|abacavir|mesh-list
44070448|NCT00000919|Didanosine|didanosine|mesh-list
44070449|NCT00000919|Stavudine|stavudine|mesh-list
44070450|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44070451|NCT00000919|Efavirenz|efavirenz|mesh-list
44070452|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
44070453|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070454|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070455|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070456|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070457|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070458|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070459|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070460|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
44070461|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070462|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070463|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070473|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
44070474|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44070475|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070476|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070478|NCT00000922|Efavirenz|efavirenz|mesh-list
44070479|NCT00000922|Nevirapine|nevirapine|mesh-list
44070480|NCT00000922|Abacavir|abacavir|mesh-list
44070481|NCT00000922|Didanosine|didanosine|mesh-list
44070482|NCT00000922|Stavudine|stavudine|mesh-list
44070483|NCT00000922|Nelfinavir|nelfinavir|mesh-list
44070484|NCT00000922|Indinavir|indinavir|mesh-list
44070485|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070486|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070487|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151035|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44070488|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070489|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
44070490|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070491|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070492|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070493|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070494|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070495|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44070496|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44070497|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070498|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070499|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070500|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070501|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070502|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
44070504|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44070505|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44070506|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070507|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44070508|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
44070509|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44070510|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44070511|NCT00000940|Ritonavir|ritonavir|mesh-list
44070512|NCT00000940|Amprenavir|amprenavir|mesh-list
44070513|NCT00000940|Lamivudine|lamivudine|mesh-list
44070514|NCT00000940|Abacavir|abacavir|mesh-list
44070515|NCT00000940|Stavudine|stavudine|mesh-list
43620348|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
44070516|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070517|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070518|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070519|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070520|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070521|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070522|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070523|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
44070524|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070525|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44257039|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257041|NCT00622817|Xylometazoline|xylometazoline|mesh-list
44257042|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44257043|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44257044|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
44070526|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070527|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070528|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070529|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
44070540|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070541|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070542|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44070543|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44070544|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
44070545|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070546|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44070547|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44070548|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070549|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070550|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070552|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070553|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070554|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
44070555|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070556|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070557|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070558|NCT00000943|Vaccines|vaccines|mesh-list
44070559|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
44070560|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070561|NCT00000951|Fluconazole|fluconazole|mesh-list
44070562|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
43792059|NCT01019616|Paclitaxel|paclitaxel|mesh-list
44070563|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070564|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44070565|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070566|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070567|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070568|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44070569|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
44070570|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44070571|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070572|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070573|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44070574|NCT00000952|Ritonavir|ritonavir|mesh-list
44070575|NCT00000952|Lamivudine|lamivudine|mesh-list
44070576|NCT00000952|Zidovudine|zidovudine|mesh-list
44070577|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070578|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070579|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620361|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070580|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070581|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070582|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070583|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070584|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
44070585|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070586|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070587|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070588|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070589|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070590|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
44151036|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151037|NCT00212095|Ketoconazole|ketoconazole|mesh-list
44151038|NCT00212095|Docetaxel|docetaxel|mesh-list
44151039|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151040|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151041|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257045|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257046|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257047|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257048|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43790354|NCT04955938|Ivosidenib|ivosidenib|mesh-list
44151045|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151046|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44151047|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44151048|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151049|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44151050|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
44151051|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151052|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151053|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44151054|NCT00212108|Celecoxib|celecoxib|mesh-list
44151055|NCT00212108|Gefitinib|gefitinib|mesh-list
44151056|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44151057|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44151058|NCT00212108|Analgesics|analgesics|mesh-ancestor
44151059|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
44151060|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151061|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151062|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44151063|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151064|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44151065|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44151066|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151067|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151068|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151069|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44151070|NCT00212173|Sibutramine|sibutramine|mesh-list
44151071|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151072|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151073|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
44151074|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44151075|NCT00212186|Selenium|selenium|mesh-list
44151076|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
44151077|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151078|NCT00212186|Protective Agents|protective agents|mesh-ancestor
44151079|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792129|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
44070591|NCT00000959|Pyridoxine|pyridoxine|mesh-list
44070592|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
44070593|NCT00000959|Isoniazid|isoniazid|mesh-list
44070594|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070595|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070596|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070597|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44070598|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44070599|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
44070600|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070601|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44070602|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070603|NCT00000959|Vitamins|vitamins|mesh-ancestor
44070604|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
44070605|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070606|NCT00000962|Nevirapine|nevirapine|mesh-list
44070607|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070608|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070609|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070610|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070611|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
44070612|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070613|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070614|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070615|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070616|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070617|NCT00000965|Zidovudine|zidovudine|mesh-list
44070618|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
44257049|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44257050|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
44257051|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257052|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44257053|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257055|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
44257056|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44257057|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
44070619|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070620|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070621|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070622|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070636|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070638|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
44070639|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070640|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070641|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
44070642|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070643|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070644|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070645|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070646|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070647|NCT00000969|Didanosine|didanosine|mesh-list
44070648|NCT00000969|Zalcitabine|zalcitabine|mesh-list
44070649|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
44070650|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070651|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070652|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070653|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070654|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
44070655|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070656|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070657|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070658|NCT00000970|Ganciclovir|ganciclovir|mesh-list
44070659|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44070660|NCT00000970|Foscarnet|foscarnet|mesh-list
44070661|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44070662|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
44070663|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070664|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070665|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070666|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070667|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070668|NCT00000971|Zidovudine|zidovudine|mesh-list
44070669|NCT00000971|Didanosine|didanosine|mesh-list
44070670|NCT00000971|Clarithromycin|clarithromycin|mesh-list
44070671|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
44070672|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070673|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070674|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070675|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070676|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
44070677|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070678|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070679|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070680|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070681|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43650451|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
44070682|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070683|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070684|NCT00000973|Leucovorin|leucovorin|mesh-list
44070685|NCT00000973|Zidovudine|zidovudine|mesh-list
44070686|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
44070687|NCT00000973|Calcium|calcium|mesh-list
44070688|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
43568414|NCT00642148|Hormones|hormones|mesh-ancestor
44070698|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070699|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44257058|NCT00622830|Darapladib|darapladib|mesh-list
44257059|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44257060|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257061|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070700|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070701|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
44070702|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070703|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070704|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070705|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
44070706|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070707|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070708|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070709|NCT00000975|Itraconazole|itraconazole|mesh-list
44070710|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
44070711|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070712|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44070713|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070714|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070715|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070716|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44070717|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
44070718|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44070719|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070720|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070721|NCT00000978|Zidovudine|zidovudine|mesh-list
44070722|NCT00000978|Zalcitabine|zalcitabine|mesh-list
44070723|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
44070724|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070725|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070726|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070727|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070728|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
44070729|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070730|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070731|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070732|NCT00000985|Acyclovir|acyclovir|mesh-list
44070733|NCT00000985|Foscarnet|foscarnet|mesh-list
44070734|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44070735|NCT00000985|Vidarabine|vidarabine|mesh-list
44070736|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
44070737|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070738|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070739|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070740|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070741|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070742|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
44070743|NCT00000986|Zidovudine|zidovudine|mesh-list
44070744|NCT00000986|Aldesleukin|aldesleukin|mesh-list
44070745|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
44070746|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070747|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070748|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070749|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070750|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
44070751|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070752|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070753|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070754|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070764|NCT00000998|Vitamins|vitamins|mesh-ancestor
44070765|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
44070766|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
44070767|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070768|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44070769|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
44070770|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070771|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070772|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070773|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070774|NCT00000999|Zidovudine|zidovudine|mesh-list
44070775|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
44106649|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257063|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44257064|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
44257065|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070776|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070777|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070778|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070779|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070780|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
44070781|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070782|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070783|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070784|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44070785|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
44070786|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070787|NCT00001001|Zidovudine|zidovudine|mesh-list
44070788|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
44070789|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070790|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070791|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070792|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070793|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
44070794|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070795|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070796|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070797|NCT00001002|Zidovudine|zidovudine|mesh-list
44070798|NCT00001002|Foscarnet|foscarnet|mesh-list
44070799|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44070800|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
44070801|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070802|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070803|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070804|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070805|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
44070806|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070807|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070808|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070809|NCT00001003|Zidovudine|zidovudine|mesh-list
44070810|NCT00001003|Pentamidine|pentamidine|mesh-list
44070811|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
44070812|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070813|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070814|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070815|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070816|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
44070817|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070818|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070819|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070820|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
44070821|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070822|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070823|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44070834|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070836|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
44070837|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070838|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070839|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070840|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070841|NCT00001007|Zidovudine|zidovudine|mesh-list
44070842|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
44070843|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070844|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070845|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070846|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070847|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
44070848|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070849|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070850|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070851|NCT00001008|Zidovudine|zidovudine|mesh-list
44070852|NCT00001008|Methadone|methadone|mesh-list
44070853|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
44070854|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257067|NCT00622934|Hematinics|hematinics|mesh-ancestor
44257068|NCT00623064|Gemcitabine|gemcitabine|mesh-list
44257069|NCT00623064|Cisplatin|cisplatin|mesh-list
44257070|NCT00623064|Lapatinib|lapatinib|mesh-list
44070855|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070856|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070857|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070858|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
44070859|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070860|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070861|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070862|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44070863|NCT00001008|Narcotics|narcotics|mesh-ancestor
44070864|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44070865|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070866|NCT00001008|Analgesics|analgesics|mesh-ancestor
44070867|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
44070868|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44070869|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
44070870|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
44070871|NCT00001010|Zidovudine|zidovudine|mesh-list
44070872|NCT00001010|Acyclovir|acyclovir|mesh-list
44070873|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
44070874|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070875|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070876|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070877|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070878|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
44070879|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070880|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070881|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070882|NCT00001011|Zidovudine|zidovudine|mesh-list
43620448|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070883|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
44070884|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070885|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070886|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070887|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070888|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
44070889|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070898|NCT00001013|Calcium|calcium|mesh-list
44070899|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
44151080|NCT00212186|Trace Elements|trace elements|mesh-ancestor
44070900|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070901|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070902|NCT00001013|Antidotes|antidotes|mesh-ancestor
44070903|NCT00001013|Protective Agents|protective agents|mesh-ancestor
44070904|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070905|NCT00001013|Vitamins|vitamins|mesh-ancestor
44070906|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
44070907|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44070908|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070909|NCT00001013|Renal Agents|renal agents|mesh-ancestor
44070910|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
44070911|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070912|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070913|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070914|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070915|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070916|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44070917|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44070918|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070919|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
44070920|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44070921|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070922|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44070923|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
44070924|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070925|NCT00001014|Leucovorin|leucovorin|mesh-list
44070926|NCT00001014|Trimethoprim|trimethoprim|mesh-list
44070927|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44070928|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
44070929|NCT00001014|Trimetrexate|trimetrexate|mesh-list
44070930|NCT00001014|Calcium|calcium|mesh-list
44257071|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257072|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257073|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
44257074|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257075|NCT00623064|Antiviral Agents|antiviral agents|mesh-ancestor
44070931|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
44070932|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070933|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070934|NCT00001014|Antidotes|antidotes|mesh-ancestor
44070935|NCT00001014|Protective Agents|protective agents|mesh-ancestor
44070936|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070937|NCT00001014|Vitamins|vitamins|mesh-ancestor
44070938|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
44070939|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44070940|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070941|NCT00001014|Renal Agents|renal agents|mesh-ancestor
44070942|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
44070943|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44070944|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44070945|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44070946|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070947|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070948|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44070949|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44070950|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070951|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070952|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
44070953|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44070954|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
44070955|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070956|NCT00001029|Zidovudine|zidovudine|mesh-list
44070958|NCT00001029|Zalcitabine|zalcitabine|mesh-list
44070959|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
43568658|NCT00609323|Lidocaine|lidocaine|mesh-list
44070967|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070968|NCT00001030|Clarithromycin|clarithromycin|mesh-list
44070969|NCT00001030|Rifabutin|rifabutin|mesh-list
44070970|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070971|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070972|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44070973|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070974|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070975|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44151081|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
44070976|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070977|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44070978|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070980|NCT00001032|Zalcitabine|zalcitabine|mesh-list
44070981|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
44070982|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070983|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070984|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070985|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070986|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
44070987|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070988|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070989|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070990|NCT00001033|Pyridoxine|pyridoxine|mesh-list
44070991|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
44070992|NCT00001033|Levofloxacin|levofloxacin|mesh-list
44070993|NCT00001033|Rifampin|rifampin|mesh-list
44070994|NCT00001033|Isoniazid|isoniazid|mesh-list
44070995|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
44070996|NCT00001033|Ethambutol|ethambutol|mesh-list
44070997|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44070998|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070999|NCT00001033|Renal Agents|renal agents|mesh-ancestor
44071000|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071001|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44071002|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44071003|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071004|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257076|NCT00623064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257077|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257078|NCT00623064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257079|NCT00623064|Immunologic Factors|immunologic factors|mesh-ancestor
44257080|NCT00623064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257081|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44257082|NCT00623077|Etoposide|etoposide|mesh-list
44257083|NCT00623077|Melphalan|melphalan|mesh-list
44257084|NCT00623077|Busulfan|busulfan|mesh-list
44257085|NCT00623077|Ifosfamide|ifosfamide|mesh-list
44257086|NCT00623077|Thiotepa|thiotepa|mesh-list
44257087|NCT00623077|Sargramostim|sargramostim|mesh-list
44257088|NCT00623077|Mesna|mesna|mesh-list
44257089|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44257090|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071005|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071006|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44071007|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071008|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44071009|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
44071010|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
44071011|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071012|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44071013|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071014|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44071015|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44071016|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44071017|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071018|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44071019|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44071020|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
44071021|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44071022|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
44071023|NCT00001033|Vitamins|vitamins|mesh-ancestor
44071024|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
44071025|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071026|NCT00001036|Zidovudine|zidovudine|mesh-list
44071037|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071038|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071039|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071040|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
44071041|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071042|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071043|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071044|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071045|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
44071046|NCT00001038|Valacyclovir|valacyclovir|mesh-list
44071047|NCT00001038|Acyclovir|acyclovir|mesh-list
44071048|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
44071049|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071050|NCT00001040|Zidovudine|zidovudine|mesh-list
44071051|NCT00001040|Zalcitabine|zalcitabine|mesh-list
44071052|NCT00001040|Saquinavir|saquinavir|mesh-list
44071053|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
44071054|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071055|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071056|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071057|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071058|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
44071059|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071060|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071061|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071062|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071063|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44257091|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44257092|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44257093|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257094|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257095|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
44257096|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257097|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257098|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
44257099|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44257100|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257101|NCT00623077|Protective Agents|protective agents|mesh-ancestor
44257102|NCT00623116|Testosterone|testosterone|mesh-list
44257103|NCT00623116|Estrogens|estrogens|mesh-list
44257104|NCT00623116|Androgens|androgens|mesh-ancestor
44257105|NCT00623116|Hormones|hormones|mesh-ancestor
44257106|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257107|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257108|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
44257109|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
44257110|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44257111|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
44257112|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44257113|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44257114|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257115|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44257116|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257117|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257118|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44257119|NCT00623155|Renal Agents|renal agents|mesh-ancestor
44257120|NCT00623168|Ribavirin|ribavirin|mesh-list
44257121|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
44257125|NCT00623207|Atropine|atropine|mesh-list
44257135|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
44257136|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44257137|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44257138|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257139|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257140|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257142|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44257143|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
44257144|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
44257145|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257146|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257147|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44257148|NCT00623220|Analgesics|analgesics|mesh-ancestor
44257149|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
44257150|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257151|NCT00623285|Pregabalin|pregabalin|mesh-list
44071064|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071065|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071066|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071068|NCT00001045|Nevirapine|nevirapine|mesh-list
44071069|NCT00001045|Didanosine|didanosine|mesh-list
44071070|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
44071071|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071072|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071073|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071074|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071075|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
44071076|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071077|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071078|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071079|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071080|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071081|NCT00001047|Clarithromycin|clarithromycin|mesh-list
44071082|NCT00001047|Ethambutol|ethambutol|mesh-list
44071083|NCT00001047|Rifabutin|rifabutin|mesh-list
44071084|NCT00001047|Clofazimine|clofazimine|mesh-list
44071085|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071086|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071087|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44071088|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071089|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071090|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071091|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071092|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
44071093|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44071097|NCT00001048|Zidovudine|zidovudine|mesh-list
44071098|NCT00001048|Didanosine|didanosine|mesh-list
44071099|NCT00001048|Zalcitabine|zalcitabine|mesh-list
44071100|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071101|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
44071102|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071103|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071104|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
44071105|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071106|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071107|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
44071108|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783805|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
44257152|NCT00623285|Analgesics|analgesics|mesh-ancestor
44257153|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
44257154|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257155|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257156|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
44257157|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44257158|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257159|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257160|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44257161|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44257162|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257163|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257164|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257165|NCT00623376|Dronabinol|dronabinol|mesh-list
44257166|NCT00623376|Nabilone|nabilone|mesh-list
44257167|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
44071109|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071110|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071112|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071113|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071114|NCT00001066|Lamivudine|lamivudine|mesh-list
44071115|NCT00001066|Zidovudine|zidovudine|mesh-list
44071116|NCT00001066|Didanosine|didanosine|mesh-list
44071117|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071118|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071119|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071120|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071121|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
44071122|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071123|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071124|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071125|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
44071126|NCT00001071|Lenograstim|lenograstim|mesh-list
44071127|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071128|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
44071129|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071130|NCT00001073|Isotretinoin|isotretinoin|mesh-list
44071131|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44071132|NCT00001074|Didanosine|didanosine|mesh-list
44071133|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
44071134|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071135|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
44071136|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071137|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071138|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071139|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
44071140|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071141|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
44071142|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071143|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071144|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071145|NCT00001075|Ritonavir|ritonavir|mesh-list
44071146|NCT00001075|Lamivudine|lamivudine|mesh-list
44071147|NCT00001075|Zidovudine|zidovudine|mesh-list
44071148|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071149|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071150|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071151|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071152|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071153|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43591519|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
44257168|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
44257169|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257170|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257171|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257172|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44257173|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257174|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257175|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257176|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
44071154|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071155|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
44071156|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071157|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071158|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071159|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071160|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071161|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
44071162|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
44071163|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071164|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
44071165|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071166|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44071167|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071168|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
43568856|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44071178|NCT00001083|Stavudine|stavudine|mesh-list
44071179|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071180|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071181|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071182|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071183|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071184|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071185|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071186|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
44071187|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071188|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071189|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071190|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071191|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071192|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
44071193|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071194|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071196|NCT00001084|Zidovudine|zidovudine|mesh-list
44071197|NCT00001084|Stavudine|stavudine|mesh-list
44071198|NCT00001084|Indinavir|indinavir|mesh-list
44071199|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071200|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071201|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071202|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071203|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
44071204|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071205|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44151082|NCT00212199|Orlistat|orlistat|mesh-list
44071206|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071207|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
44071208|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071209|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071210|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071211|NCT00001085|Lamivudine|lamivudine|mesh-list
44071212|NCT00001085|Zidovudine|zidovudine|mesh-list
44071213|NCT00001085|Amprenavir|amprenavir|mesh-list
44071214|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071215|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071216|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071217|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071218|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
44257177|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44257178|NCT00623376|Analgesics|analgesics|mesh-ancestor
44257179|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
44257180|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44257181|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44257182|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257183|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257184|NCT00623376|Hormones|hormones|mesh-ancestor
44257185|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257186|NCT00623402|Interferons|interferons|mesh-list
44071219|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071220|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071221|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071222|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
44071223|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44071224|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
44071225|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071226|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071227|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071228|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071229|NCT00001086|Efavirenz|efavirenz|mesh-list
44071230|NCT00001086|Abacavir|abacavir|mesh-list
44071231|NCT00001086|Indinavir|indinavir|mesh-list
44071232|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071233|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071234|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071235|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071236|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
44071237|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568933|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
44071244|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071245|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071246|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071247|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071248|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071250|NCT00001087|Nelfinavir|nelfinavir|mesh-list
44071251|NCT00001087|Saquinavir|saquinavir|mesh-list
44071252|NCT00001087|Lamivudine|lamivudine|mesh-list
44071253|NCT00001087|Zidovudine|zidovudine|mesh-list
44071254|NCT00001087|Didanosine|didanosine|mesh-list
44071255|NCT00001087|Stavudine|stavudine|mesh-list
44071256|NCT00001087|Zalcitabine|zalcitabine|mesh-list
44071257|NCT00001087|Efavirenz|efavirenz|mesh-list
44071258|NCT00001087|Adefovir|adefovir|mesh-list
44071259|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44071260|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071261|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43620532|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
44071262|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071263|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071264|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071265|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071266|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071267|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
44071268|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071269|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071270|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071271|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071272|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071273|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
44071274|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44071275|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44071276|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43650472|NCT03013881|Trastuzumab|trastuzumab|mesh-list
44071277|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071278|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071279|NCT00001105|Antibodies|antibodies|mesh-list
44071280|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44257188|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257189|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
44257190|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257191|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44257192|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257193|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257194|NCT00623415|Flupirtine|flupirtine|mesh-list
44257195|NCT00623415|Analgesics|analgesics|mesh-ancestor
44257196|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
44257197|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257198|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257199|NCT00623558|Cisplatin|cisplatin|mesh-list
44257200|NCT00623558|Docetaxel|docetaxel|mesh-list
44257201|NCT00623558|Cetuximab|cetuximab|mesh-list
44257202|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257203|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44257204|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257205|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257206|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257207|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44461588|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44461589|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
44461590|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461591|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461592|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44461593|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44461594|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461595|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461596|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071281|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
44071282|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071283|NCT00001111|Zidovudine|zidovudine|mesh-list
44071284|NCT00001111|Nevirapine|nevirapine|mesh-list
44071285|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
44071286|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071287|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071288|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071289|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071290|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
44071291|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071292|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071293|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071294|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43911257|NCT04971187|Cisplatin|cisplatin|mesh-list
44257208|NCT00623688|Imidacloprid|imidacloprid|mesh-list
44257209|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257210|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257211|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257212|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257213|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
44257214|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44257215|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44257216|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44257217|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257218|NCT00623857|Vitamins|vitamins|mesh-list
44257219|NCT00623857|Zinc|zinc|mesh-list
44257220|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
44257221|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257222|NCT00623857|Trace Elements|trace elements|mesh-ancestor
44257223|NCT00623987|Warfarin|warfarin|mesh-list
44257224|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
44257225|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44257226|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44257227|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44257228|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257229|NCT00624026|Memantine|memantine|mesh-list
44071295|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071296|NCT00001113|Interferons|interferons|mesh-list
44071297|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
44071298|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
44071299|NCT00001113|Zidovudine|zidovudine|mesh-list
44071300|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071301|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
44071302|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071303|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
44071304|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071305|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
43568991|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44071321|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
44071322|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071323|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071324|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071325|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071326|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071327|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071328|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
44071329|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44071330|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44071331|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071332|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071333|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43620718|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44071334|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
44071335|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071336|NCT00001119|Ritonavir|ritonavir|mesh-list
44071337|NCT00001119|Indinavir|indinavir|mesh-list
44071338|NCT00001119|Amprenavir|amprenavir|mesh-list
44071339|NCT00001119|Lamivudine|lamivudine|mesh-list
44071340|NCT00001119|Zidovudine|zidovudine|mesh-list
44071341|NCT00001119|Abacavir|abacavir|mesh-list
44257230|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44257231|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44257232|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
44257233|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257234|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257235|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257236|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44257237|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44257238|NCT00624039|Pilocarpine|pilocarpine|mesh-list
44257239|NCT00624039|Miotics|miotics|mesh-ancestor
44257240|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
44257241|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257242|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257243|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44257244|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44257245|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257246|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257247|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257248|NCT00624078|Antivenins|antivenins|mesh-list
44257249|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
44257250|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257251|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44257252|NCT00624130|Dacuronium|dacuronium|mesh-list
44257253|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44257254|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257255|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44257256|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43791955|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
44071342|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44071343|NCT00001119|Efavirenz|efavirenz|mesh-list
44071344|NCT00001119|Vaccines|vaccines|mesh-list
44071345|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
44071346|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071347|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071348|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071349|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071350|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071351|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071352|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071353|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071354|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
44071355|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071356|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43620850|NCT02074436|Coagulants|coagulants|mesh-ancestor
44071357|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071358|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44257257|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44257258|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257259|NCT00624143|Voriconazole|voriconazole|mesh-list
44257260|NCT00624143|Amphotericin B|amphotericin b|mesh-list
44257261|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44257262|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
44257263|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257264|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44257265|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44257266|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257267|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257268|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44257269|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
44257270|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257271|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257272|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44257273|NCT00624143|Amebicides|amebicides|mesh-ancestor
44257274|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44257275|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43792156|NCT05136976|Rituximab|rituximab|mesh-list
44071359|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071360|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
44071361|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44071362|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44071363|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44071364|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071365|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071371|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44071372|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44071373|NCT00001151|Calcitriol|calcitriol|mesh-list
44071374|NCT00001151|Vitamins|vitamins|mesh-ancestor
44071375|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
44071376|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071377|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44071378|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44071379|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44071380|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071381|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071382|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44071383|NCT00001165|Doxorubicin|doxorubicin|mesh-list
44071384|NCT00001165|Streptozocin|streptozocin|mesh-list
44071385|NCT00001165|Fluorouracil|fluorouracil|mesh-list
44071386|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44071387|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071388|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44071389|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44071390|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071391|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071392|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
44071393|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071394|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071395|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
44071396|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257276|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44257278|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071397|NCT00001180|Hormones|hormones|mesh-list
44071398|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44071399|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44071400|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071401|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071402|NCT00001181|Testolactone|testolactone|mesh-list
44071403|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071404|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071406|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071407|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071408|NCT00001191|Omeprazole|omeprazole|mesh-list
44071409|NCT00001191|Pantoprazole|pantoprazole|mesh-list
44071410|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44071411|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44071412|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44071413|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071414|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071415|NCT00001202|Testolactone|testolactone|mesh-list
44071416|NCT00001202|Spironolactone|spironolactone|mesh-list
44071417|NCT00001202|Deslorelin|deslorelin|mesh-list
44071418|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44071419|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
44071420|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071421|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071422|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44071423|NCT00001202|Diuretics|diuretics|mesh-ancestor
44071424|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
44071425|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071426|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071427|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071428|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071429|NCT00001212|Cyclosporine|cyclosporine|mesh-list
44071430|NCT00001212|Prednisone|prednisone|mesh-list
44071431|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
44071432|NCT00001212|Cyclosporins|cyclosporins|mesh-list
43792688|NCT05128617|Paclitaxel|paclitaxel|mesh-list
44071433|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071434|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
44071446|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071447|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071448|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
44071449|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824491|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071450|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
44071451|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44071452|NCT00001213|Cysteamine|cysteamine|mesh-list
44071453|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44071454|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151083|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151084|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151085|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44151086|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44151087|NCT00212212|Selenium|selenium|mesh-list
44151088|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
44151089|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151090|NCT00212212|Protective Agents|protective agents|mesh-ancestor
44151091|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151092|NCT00212212|Trace Elements|trace elements|mesh-ancestor
44151093|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
44151094|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44151095|NCT00212277|Norethindrone|norethindrone|mesh-list
44151096|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
44151097|NCT00212277|Estradiol|estradiol|mesh-list
44151098|NCT00212277|Estrogens|estrogens|mesh-ancestor
44151099|NCT00212277|Hormones|hormones|mesh-ancestor
44151100|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151101|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151102|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44151103|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
44151104|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151105|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44257279|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
44257280|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257281|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257282|NCT00624182|Antiviral Agents|antiviral agents|mesh-ancestor
44257283|NCT00624182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257284|NCT00624182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257285|NCT00624182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257286|NCT00624182|Immunologic Factors|immunologic factors|mesh-ancestor
44257287|NCT00624182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257288|NCT00624208|Droperidol|droperidol|mesh-list
44257289|NCT00624208|Ondansetron|ondansetron|mesh-list
44257290|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
44257291|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
44257292|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257293|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257294|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257295|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
44151106|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44151107|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44151108|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44151109|NCT00212290|Pioglitazone|pioglitazone|mesh-list
44151110|NCT00212290|Nateglinide|nateglinide|mesh-list
44151111|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151112|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151113|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44151114|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151115|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44151116|NCT00212342|Norethindrone|norethindrone|mesh-list
44151117|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
44151118|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43621005|NCT03119623|Valsartan|valsartan|mesh-list
44151119|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44151120|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44151121|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
44151122|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151123|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151124|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44151125|NCT00212342|Estrogens|estrogens|mesh-ancestor
44071456|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071457|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071458|NCT00001251|Mafosfamide|mafosfamide|mesh-list
44071459|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071460|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
44071461|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071462|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071463|NCT00001259|Leuprolide|leuprolide|mesh-list
44071464|NCT00001259|Estradiol|estradiol|mesh-list
44071465|NCT00001259|Progesterone|progesterone|mesh-list
44071466|NCT00001259|Estrogens|estrogens|mesh-ancestor
44071467|NCT00001259|Hormones|hormones|mesh-ancestor
44071468|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071469|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071470|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44071471|NCT00001259|Progestins|progestins|mesh-ancestor
44071472|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44071473|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
44071474|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071475|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071476|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
44071477|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44071478|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44257296|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257297|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44257299|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257300|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257301|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44257302|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257303|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257304|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257305|NCT00624208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44071479|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
44071480|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071481|NCT00001262|Copper|copper|mesh-list
44071482|NCT00001262|Trace Elements|trace elements|mesh-ancestor
44071483|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
44071484|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071485|NCT00001266|Suramin|suramin|mesh-list
44071486|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
44071487|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
44071488|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44071489|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071490|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071491|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44071492|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44071493|NCT00001267|Zidovudine|zidovudine|mesh-list
44071494|NCT00001267|Didanosine|didanosine|mesh-list
44071495|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
44071496|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071497|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071498|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071499|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071500|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
44071501|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071502|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071503|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071504|NCT00001280|Itraconazole|itraconazole|mesh-list
44071505|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
44071506|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071507|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44071508|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071509|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43569255|NCT00537043|Carvedilol|carvedilol|mesh-list
43621033|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
44071513|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071515|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071516|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
44071517|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44071518|NCT00001287|Antibodies|antibodies|mesh-list
44071519|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
44071520|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44071521|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
44071522|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071523|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
44071524|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44071525|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
44071526|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071527|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071528|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44071529|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
44071530|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44071531|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
44071532|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071533|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071534|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44071535|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
44071536|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
44071537|NCT00001303|Protective Agents|protective agents|mesh-ancestor
44257307|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44257308|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44257309|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
44257310|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
44257311|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
44257312|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44257313|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44257314|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257315|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257316|NCT00624273|Urological Agents|urological agents|mesh-ancestor
44257317|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
44257318|NCT00624312|Hematinics|hematinics|mesh-ancestor
44257319|NCT00624325|Interferons|interferons|mesh-list
44257320|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
44257321|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
44257322|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257323|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
44257324|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257325|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
44257326|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257327|NCT00624364|Metformin|metformin|mesh-list
44257328|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
44257329|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
44257330|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44071538|NCT00001304|Vitamin D|vitamin d|mesh-list
44071539|NCT00001304|Calcitriol|calcitriol|mesh-list
44071540|NCT00001304|Calcium|calcium|mesh-list
44071541|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
44071542|NCT00001304|Hormones|hormones|mesh-list
44071543|NCT00001304|Vitamins|vitamins|mesh-ancestor
44071544|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
44071545|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071546|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44071547|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44071548|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071549|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44071550|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071551|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071552|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44071553|NCT00001322|Leuprolide|leuprolide|mesh-list
44071554|NCT00001322|Estradiol|estradiol|mesh-list
44071555|NCT00001322|Progesterone|progesterone|mesh-list
44071556|NCT00001322|Estrogens|estrogens|mesh-ancestor
44071557|NCT00001322|Hormones|hormones|mesh-ancestor
44071558|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071559|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071560|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44071561|NCT00001322|Progestins|progestins|mesh-ancestor
44071562|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43621038|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44071563|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
44071564|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071565|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071566|NCT00001328|Ganciclovir|ganciclovir|mesh-list
44257332|NCT00624429|Budesonide|budesonide|mesh-list
44257333|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841109|NCT04652414|Prednisone|prednisone|mesh-list
44071567|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44071568|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
44071569|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071570|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071571|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071572|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071573|NCT00001332|Cisplatin|cisplatin|mesh-list
44071574|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071575|NCT00001333|Topotecan|topotecan|mesh-list
44071576|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44071577|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44071578|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071579|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071592|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071593|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
44071594|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
44071595|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
44071596|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44071597|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44071598|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44071599|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071600|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071601|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071602|NCT00001359|Penicillins|penicillins|mesh-list
44071603|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071604|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071605|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
44071606|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
44071607|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
44071608|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44071609|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44071610|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071611|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071612|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071613|NCT00001378|Fenretinide|fenretinide|mesh-list
44071614|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071615|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44071616|NCT00001378|Protective Agents|protective agents|mesh-ancestor
44071617|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071618|NCT00001387|Paclitaxel|paclitaxel|mesh-list
44071619|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44071620|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071621|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44071622|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44071623|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44071624|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071625|NCT00001421|Methimazole|methimazole|mesh-list
44071626|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
44071627|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
44071628|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071629|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071630|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
44071631|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071632|NCT00001436|Tamoxifen|tamoxifen|mesh-list
44071633|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44071634|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
43880641|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
43824498|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44071635|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071636|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071637|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44071638|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071639|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43569377|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
44071647|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
44071648|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071649|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071650|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44257334|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44257335|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
44257336|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257337|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257338|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44257339|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257340|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
44257341|NCT00624429|Hormones|hormones|mesh-ancestor
44257342|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257343|NCT00624455|Gabapentin|gabapentin|mesh-list
44257344|NCT00624455|Analgesics|analgesics|mesh-ancestor
44071651|NCT00001474|Interleukin-2|interleukin-2|mesh-list
44071652|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071653|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44071654|NCT00001474|Analgesics|analgesics|mesh-ancestor
44071655|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
44071656|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071657|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071658|NCT00001475|Thalidomide|thalidomide|mesh-list
44071659|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071660|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
44071661|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071662|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
44071663|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071664|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071665|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44071666|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44071667|NCT00001475|Growth Substances|growth substances|mesh-ancestor
44071668|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
44071669|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071670|NCT00001482|Lamotrigine|lamotrigine|mesh-list
44071672|NCT00001482|Analgesics|analgesics|mesh-ancestor
44071673|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
44071674|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071675|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071676|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
44071677|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44071678|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44071679|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44071680|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44071681|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44071682|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44071683|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071684|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071685|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
44071686|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44071687|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071688|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44071689|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44071690|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44071691|NCT00001483|Sertraline|sertraline|mesh-list
44071692|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44071693|NCT00001483|Bupropion|bupropion|mesh-list
44071694|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
44071695|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44071696|NCT00001483|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44071697|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44071698|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071699|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071700|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071701|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
44071702|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257345|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
44257346|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257347|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257348|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
44257349|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44257350|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257351|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257352|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257353|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44257354|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43911367|NCT04259060|Vitamins|vitamins|mesh-ancestor
44257355|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257356|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257357|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
44257358|NCT00624481|Teriparatide|teriparatide|mesh-list
43654358|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
44071703|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44071704|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44071705|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44071706|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
43621051|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
44071711|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071712|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
44071713|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151137|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151138|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151139|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151140|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151141|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
44151142|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151143|NCT00212589|Antidotes|antidotes|mesh-ancestor
44151144|NCT00212589|Protective Agents|protective agents|mesh-ancestor
44151145|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
44151146|NCT00212589|Vitamins|vitamins|mesh-ancestor
44151147|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
44151148|NCT00212589|Hematinics|hematinics|mesh-ancestor
44157973|NCT00235911|Hormones|hormones|mesh-ancestor
44157974|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157975|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44157976|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44157977|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44157978|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
44157979|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157980|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157981|NCT00235937|Anastrozole|anastrozole|mesh-list
44157982|NCT00235937|Goserelin|goserelin|mesh-list
44157983|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44157984|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157985|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44157986|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44157987|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157988|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157989|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44157990|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
44157991|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157992|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157993|NCT00235950|Clopidogrel|clopidogrel|mesh-list
44157994|NCT00235950|Atorvastatin|atorvastatin|mesh-list
44257359|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44257360|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257361|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44257363|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
44257364|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44257365|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257366|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44257367|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257368|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257369|NCT00624663|Rivastigmine|rivastigmine|mesh-list
44257370|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44257371|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257372|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257373|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257374|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257375|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257376|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44257377|NCT00624663|Protective Agents|protective agents|mesh-ancestor
44257378|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
44257379|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
44257380|NCT00624676|Salicylates|salicylates|mesh-list
44257381|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44257382|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157995|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44157996|NCT00235950|Simvastatin|simvastatin|mesh-list
44157997|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44157998|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44157999|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
44158433|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071715|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44071716|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44071717|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071718|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536612|NCT04671355|Hormones|hormones|mesh-ancestor
44071719|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071720|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44071721|NCT00001507|Antibodies|antibodies|mesh-list
44071722|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
44071723|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44071724|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
44071725|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071726|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071727|NCT00001509|Tretinoin|tretinoin|mesh-list
44071728|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071729|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
44071730|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44071731|NCT00001524|Thalidomide|thalidomide|mesh-list
44071732|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071733|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
44071734|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071735|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
44071736|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44257384|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
44257385|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
44257386|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44257387|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44257388|NCT00624676|Analgesics|analgesics|mesh-ancestor
44257389|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
44257390|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257391|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257392|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257393|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071737|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43569507|NCT00508989|Niacin|niacin|mesh-list
44071746|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071747|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071748|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
44071749|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071750|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
44071751|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071752|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
44071753|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071754|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44071755|NCT00001542|Fluconazole|fluconazole|mesh-list
44071756|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
44071757|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071758|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44071759|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071760|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071761|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071762|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44071763|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
44071764|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071765|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071766|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44071767|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44071768|NCT00001563|Rituximab|rituximab|mesh-list
44071769|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44071770|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071771|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
44071772|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071773|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071774|NCT00001566|Indinavir|indinavir|mesh-list
44071775|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071776|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071777|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071778|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071779|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071780|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071781|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071782|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
44071783|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071784|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
44071785|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071786|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
44071787|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071788|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
44071789|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44071790|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
44071791|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071792|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
44071793|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071794|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44257395|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257396|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257397|NCT00624702|Maleic acid|maleic acid|mesh-list
44257398|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257399|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257400|NCT00624741|Pergolide|pergolide|mesh-list
44257401|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
44257402|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
44257403|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257404|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257405|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257406|NCT00624754|Budesonide|budesonide|mesh-list
44257407|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
44257408|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257409|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44257410|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
44257411|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257412|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257413|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44257414|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257415|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
44257416|NCT00624754|Hormones|hormones|mesh-ancestor
44257417|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257418|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44257419|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44257420|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44257421|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
44257422|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824974|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
44071795|NCT00001575|Edetic Acid|edetic acid|mesh-list
44071796|NCT00001575|Calcium|calcium|mesh-list
44071797|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
44071798|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44071799|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071800|NCT00001575|Antidotes|antidotes|mesh-ancestor
44071801|NCT00001575|Protective Agents|protective agents|mesh-ancestor
44071802|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
44071803|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
44071814|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
44071815|NCT00001576|Vitamins|vitamins|mesh-ancestor
44071816|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
44071817|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257423|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257424|NCT00624767|Insulin|insulin|mesh-list
44257425|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44257426|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
44257427|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44257428|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257429|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
44257430|NCT00624871|Ibuprofen|ibuprofen|mesh-list
44257431|NCT00624871|Vitamins|vitamins|mesh-ancestor
44257432|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
44257433|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911434|NCT03983226|Taxane|taxane|mesh-list
44071818|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
44071819|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071820|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071821|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44071822|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071823|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
44071824|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071825|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
44071826|NCT00001586|Rituximab|rituximab|mesh-list
44071827|NCT00001586|Fludarabine|fludarabine|mesh-list
44071828|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
44071829|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44071830|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071831|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
44071832|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071833|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071834|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071835|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
44071836|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071837|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44071838|NCT00001596|Pirfenidone|pirfenidone|mesh-list
44071839|NCT00001596|Analgesics|analgesics|mesh-ancestor
44071840|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
44071841|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071842|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071843|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44071844|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44071845|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44071846|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071847|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071848|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44071849|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071850|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
44071851|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071852|NCT00001624|Insulin|insulin|mesh-list
44071853|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44071854|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071855|NCT00001644|Lamivudine|lamivudine|mesh-list
44071856|NCT00001644|Zidovudine|zidovudine|mesh-list
44071857|NCT00001644|Nevirapine|nevirapine|mesh-list
44071858|NCT00001644|Indinavir|indinavir|mesh-list
44071859|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071860|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071861|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071862|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793050|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
44071863|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
44071864|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071865|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071866|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071867|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
44071868|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071869|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071897|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44257434|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44257435|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846555|NCT04192136|Niacinamide|niacinamide|mesh-list
44071898|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071899|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
44071900|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
44071901|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071902|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
44071903|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071904|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071905|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
44071906|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44071907|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44071908|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071909|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44071910|NCT00001669|Mecasermin|mecasermin|mesh-list
44071911|NCT00001669|Growth Substances|growth substances|mesh-ancestor
44071912|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071913|NCT00001688|Ritonavir|ritonavir|mesh-list
44071914|NCT00001688|Nevirapine|nevirapine|mesh-list
44071915|NCT00001688|Stavudine|stavudine|mesh-list
44071916|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071917|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071918|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071926|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071927|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071928|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071929|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071930|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071931|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
44071933|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44071934|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44071935|NCT00001693|Analgesics|analgesics|mesh-ancestor
44071936|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
44071937|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071938|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071939|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44071940|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071941|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44071942|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44071943|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071944|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071946|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44071947|NCT00001696|Protective Agents|protective agents|mesh-ancestor
44071948|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071949|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071950|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44071951|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071952|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071953|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
44071954|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44071955|NCT00001696|Estrogens|estrogens|mesh-ancestor
44071957|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071958|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
44071959|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44071960|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
44071961|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071962|NCT00001720|Alendronate|alendronate|mesh-list
44071963|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44071964|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071965|NCT00001723|Orlistat|orlistat|mesh-list
44071966|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071967|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071968|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44071969|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44071970|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
44071971|NCT00001724|Analgesics|analgesics|mesh-ancestor
44071972|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
44257437|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
44257438|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257439|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257440|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257441|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44257442|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071973|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071974|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071975|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44071976|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44071977|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44071978|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071979|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44071980|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071981|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071982|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
44071983|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
43569756|NCT00479258|Insulin|insulin|mesh-list
44071989|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071991|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44071992|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071993|NCT00001729|Ribavirin|ribavirin|mesh-list
44071994|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
44071995|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071996|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
44071997|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071998|NCT00001731|Cyclosporine|cyclosporine|mesh-list
44071999|NCT00001731|Cyclosporins|cyclosporins|mesh-list
44072000|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072001|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072002|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072003|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
44072004|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072005|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
44072006|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072007|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
44072008|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072009|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44151149|NCT00212602|Aprepitant|aprepitant|mesh-list
44151150|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
44151151|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
44151152|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
44151153|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072010|NCT00001741|Losartan|losartan|mesh-list
44072011|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44072012|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44072013|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44072014|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44072015|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072016|NCT00001749|Cyclosporine|cyclosporine|mesh-list
44072017|NCT00001749|Cyclosporins|cyclosporins|mesh-list
44072018|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44072019|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072020|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072021|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072022|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
44072023|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072024|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
44072025|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072026|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44072027|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072028|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44072029|NCT00001752|Estrogens|estrogens|mesh-list
44072030|NCT00001752|Hormones|hormones|mesh-ancestor
44072031|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072032|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072033|NCT00001758|Efavirenz|efavirenz|mesh-list
44072034|NCT00001758|Abacavir|abacavir|mesh-list
44072035|NCT00001758|Amprenavir|amprenavir|mesh-list
43785566|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
44257443|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257444|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
44257445|NCT00624871|Protective Agents|protective agents|mesh-ancestor
44257446|NCT00624936|Azacitidine|azacitidine|mesh-list
44257447|NCT00624936|Bortezomib|bortezomib|mesh-list
44257448|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257449|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
44257450|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257451|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257452|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257453|NCT00625014|Haloperidol|haloperidol|mesh-list
44257454|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
44257455|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
44257456|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
44257457|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257458|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257459|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257460|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44257461|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257462|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257463|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257464|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44257465|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
44257466|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257467|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257468|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44257469|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
44257470|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
44257471|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44257472|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44257473|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072036|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44072037|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44072038|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072039|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072040|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
44072041|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072042|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44072043|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44072044|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44072045|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43569827|NCT00468039|Metformin|metformin|mesh-list
44072060|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44257474|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257475|NCT00625079|Urological Agents|urological agents|mesh-ancestor
44257476|NCT00625092|Leucovorin|leucovorin|mesh-list
44257477|NCT00625092|Fluorouracil|fluorouracil|mesh-list
44257478|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
44257479|NCT00625092|Calcium|calcium|mesh-list
44257480|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
44257481|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44257482|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257483|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
44257484|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257485|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257486|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257487|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257488|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
43846576|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
44072061|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44072062|NCT00001763|Growth Substances|growth substances|mesh-ancestor
44072063|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
44072064|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072065|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
44072066|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44072067|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072068|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44072069|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
44072070|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072071|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072072|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072073|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072074|NCT00001766|Ritonavir|ritonavir|mesh-list
44072075|NCT00001766|Nelfinavir|nelfinavir|mesh-list
44072076|NCT00001766|Amprenavir|amprenavir|mesh-list
44072077|NCT00001766|Abacavir|abacavir|mesh-list
44072078|NCT00001766|Efavirenz|efavirenz|mesh-list
44072079|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44072080|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44072081|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
44072082|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072083|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072084|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072085|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072086|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
44072087|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072088|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44072089|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44072090|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44072091|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44072092|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44072093|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44072094|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44072095|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44072096|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44072097|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44072098|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
44072099|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072100|NCT00001777|Sertraline|sertraline|mesh-list
44072101|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
44072102|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257489|NCT00625092|Antidotes|antidotes|mesh-ancestor
44257490|NCT00625092|Protective Agents|protective agents|mesh-ancestor
44257491|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
44257492|NCT00625092|Vitamins|vitamins|mesh-ancestor
44257493|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
44257494|NCT00625170|Haloperidol|haloperidol|mesh-list
44257495|NCT00625170|Olanzapine|olanzapine|mesh-list
44072103|NCT00001777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44072104|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44072105|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072113|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44072114|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072115|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072116|NCT00001805|Rituximab|rituximab|mesh-list
44072117|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072118|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072119|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
44072120|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072121|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072122|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
44072123|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072124|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
44072125|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072126|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072127|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44072128|NCT00000102|Nifedipine|nifedipine|mesh-list
44072129|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44072130|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072131|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072132|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44072133|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072134|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
44072135|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
44072136|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44072137|NCT05641636|Hormones|hormones|mesh-list
44072138|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072139|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072140|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
44072141|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44072142|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44072143|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
44072144|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072145|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072146|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072148|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44072149|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072150|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072151|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072152|NCT05641467|Methamphetamine|methamphetamine|mesh-list
44072153|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43793271|NCT04084860|Ketamine|ketamine|mesh-list
44072154|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072155|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
44072156|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
44072157|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072158|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
44072159|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072160|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072161|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072162|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44072163|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44072164|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072165|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44072166|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
44072167|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072168|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257496|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
44257497|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
44257498|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
44257499|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257500|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257501|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257502|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44257503|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257504|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257505|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257506|NCT00625170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44257507|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44257508|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257509|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257510|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257511|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
44257512|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44257513|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
44257514|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44072174|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072175|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072176|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072177|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072178|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072179|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072180|NCT05641363|Ketorolac|ketorolac|mesh-list
44072181|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44072182|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44072183|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072184|NCT05641363|Analgesics|analgesics|mesh-ancestor
44072185|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
44072186|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072187|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072188|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072189|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072190|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44072191|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072192|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072193|NCT05641337|Insulin|insulin|mesh-list
44072194|NCT05641337|Metformin|metformin|mesh-list
44072195|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
44072196|NCT05641337|Linagliptin|linagliptin|mesh-list
44072197|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44072198|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44072199|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072200|NCT05641337|Incretins|incretins|mesh-ancestor
44072201|NCT05641337|Hormones|hormones|mesh-ancestor
44072202|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072203|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43621256|NCT03117439|Clotrimazole|clotrimazole|mesh-list
43621257|NCT03117439|Miconazole|miconazole|mesh-list
44072204|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
44072205|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072206|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072207|NCT05641324|Dexamethasone|dexamethasone|mesh-list
44072208|NCT05641324|Lenalidomide|lenalidomide|mesh-list
44257517|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257518|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44257519|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
44257520|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257521|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257522|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44257523|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
44257524|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257525|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44257526|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44257527|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
44257528|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44257529|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44257530|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44257531|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
44257532|NCT00625209|Protein C|protein c|mesh-list
44257533|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257534|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
44257535|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44072209|NCT05641324|Daratumumab|daratumumab|mesh-list
44072210|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072211|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
44072212|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
44072213|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072214|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072215|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072216|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
44072217|NCT05641324|Hormones|hormones|mesh-ancestor
44072218|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072219|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44072220|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072221|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
44072222|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44072223|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44072224|NCT05641324|Growth Substances|growth substances|mesh-ancestor
44072225|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
44072226|NCT05641259|Azacitidine|azacitidine|mesh-list
44072227|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072228|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
44072229|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072230|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072231|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072232|NCT05641194|Caffeine|caffeine|mesh-list
44072233|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44072234|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072235|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44072236|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072237|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072241|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072242|NCT05641142|Anticoagulants|anticoagulants|mesh-list
44072243|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
44072244|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072245|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072246|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072247|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072248|NCT05641064|Analgesics|analgesics|mesh-ancestor
44257536|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44257537|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257538|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257540|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44257541|NCT00625274|Esomeprazole|esomeprazole|mesh-list
44257542|NCT00625274|Pantoprazole|pantoprazole|mesh-list
44257543|NCT00625274|Lansoprazole|lansoprazole|mesh-list
44257544|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
44257545|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44257546|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257547|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44257548|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257549|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257550|NCT00625339|Lamivudine|lamivudine|mesh-list
44257551|NCT00625339|Entecavir|entecavir|mesh-list
44257552|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44257553|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44257554|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072249|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
44072250|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072251|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072252|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072253|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072254|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072255|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072256|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072257|NCT05641051|Metoclopramide|metoclopramide|mesh-list
44072258|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
44072259|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
44072260|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072261|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072262|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072263|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44072264|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44072265|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
44072266|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072267|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072268|NCT05640817|Cisplatin|cisplatin|mesh-list
44072269|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
44072270|NCT05640817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072271|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44072272|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072273|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072274|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44072275|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44072276|NCT05640817|Protective Agents|protective agents|mesh-ancestor
44072277|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072278|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
44072279|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44072280|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
44072281|NCT05640791|Gemcitabine|gemcitabine|mesh-list
44072282|NCT05640791|Paclitaxel|paclitaxel|mesh-list
44072283|NCT05640791|Cisplatin|cisplatin|mesh-list
44072284|NCT05640791|Durvalumab|durvalumab|mesh-list
44072285|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072286|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257555|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257556|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
44257557|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257558|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44257559|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44257560|NCT00625352|Gemcitabine|gemcitabine|mesh-list
44257561|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257562|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
44257563|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072287|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
44072288|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072289|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072290|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072291|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072293|NCT05640791|Antiviral Agents|antiviral agents|mesh-ancestor
44072294|NCT05640791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072295|NCT05640791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072296|NCT05640791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072297|NCT05640791|Immunologic Factors|immunologic factors|mesh-ancestor
44072298|NCT05640791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072299|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072300|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
44072301|NCT05640778|Taxane|taxane|mesh-list
44072302|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44072303|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072304|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
44072305|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072306|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072307|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072308|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
44072309|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072310|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072313|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072314|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44072315|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44072316|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072317|NCT05640726|Leucovorin|leucovorin|mesh-list
44072318|NCT05640726|Bevacizumab|bevacizumab|mesh-list
44072319|NCT05640726|Fluorouracil|fluorouracil|mesh-list
44072320|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
44072321|NCT05640726|Calcium|calcium|mesh-list
44072322|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
44072323|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072324|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072325|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44072326|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44072327|NCT05640726|Growth Substances|growth substances|mesh-ancestor
44072328|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072329|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
44072330|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44072331|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
44072332|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072333|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072334|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072335|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
44072336|NCT05640726|Antidotes|antidotes|mesh-ancestor
44072337|NCT05640726|Protective Agents|protective agents|mesh-ancestor
44072338|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
44072339|NCT05640726|Vitamins|vitamins|mesh-ancestor
44072340|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
44072341|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
44072342|NCT05640713|Fludarabine|fludarabine|mesh-list
44072343|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072344|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
44072345|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072346|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257564|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257565|NCT00625352|Antiviral Agents|antiviral agents|mesh-ancestor
44257566|NCT00625352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257567|NCT00625352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072347|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072348|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
44072349|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072350|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072351|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072352|NCT05640674|Acetaminophen|acetaminophen|mesh-list
44072353|NCT05640674|Ibuprofen|ibuprofen|mesh-list
44072354|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44072355|NCT05640674|Hydrocodone|hydrocodone|mesh-list
44072356|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072357|NCT05640674|Analgesics|analgesics|mesh-ancestor
44072358|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
44072359|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072360|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072361|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
44072362|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44072363|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072364|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072365|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44072366|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072367|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072368|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44072369|NCT05640674|Narcotics|narcotics|mesh-ancestor
44072370|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072371|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
44072372|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
44072373|NCT05640609|Bevacizumab|bevacizumab|mesh-list
43621364|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
44072374|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072375|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072376|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44072377|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44072378|NCT05640609|Growth Substances|growth substances|mesh-ancestor
44072379|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072380|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44072381|NCT05640479|Pregabalin|pregabalin|mesh-list
44072382|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
44072383|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072384|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072386|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072388|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
44072389|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072390|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072391|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072392|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072393|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072394|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072395|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072396|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
44072397|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44072398|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072399|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44072400|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44072401|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44072402|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151154|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151155|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151156|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44151157|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151158|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151159|NCT00212615|Capecitabine|capecitabine|mesh-list
44151160|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
44151161|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151162|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
44151163|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151164|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257568|NCT00625352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257569|NCT00625352|Immunologic Factors|immunologic factors|mesh-ancestor
44257570|NCT00625352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257571|NCT00625430|Fludarabine|fludarabine|mesh-list
44257572|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
44257573|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257574|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257575|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
44257576|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257577|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257578|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
44257579|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151165|NCT00212654|Landiolol|landiolol|mesh-list
44151166|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44151167|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44151168|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151169|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151170|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151171|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151172|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44151173|NCT00212680|Landiolol|landiolol|mesh-list
44151174|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44151175|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44151176|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151177|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151178|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151179|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151180|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44151181|NCT00212810|Topiramate|topiramate|mesh-list
44151182|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
44151183|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151184|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151185|NCT00212823|Almotriptan|almotriptan|mesh-list
44151186|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44151187|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
44151188|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151189|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151190|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151191|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
44151192|NCT00212875|Hematinics|hematinics|mesh-ancestor
44151193|NCT00213070|Miglitol|miglitol|mesh-list
44151194|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151195|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151196|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151197|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151198|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44151199|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44151200|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44151201|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
44151202|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44072403|NCT05640453|Pregabalin|pregabalin|mesh-list
44072404|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
44072405|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072406|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072407|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072421|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44072422|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44072423|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44072424|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44072425|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
44072426|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072427|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257580|NCT00625456|Molgramostim|molgramostim|mesh-list
44257581|NCT00625456|Sargramostim|sargramostim|mesh-list
44257582|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
44257583|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072428|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072429|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072430|NCT05640427|Analgesics|analgesics|mesh-ancestor
44072431|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
44072432|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072433|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072434|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072435|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072436|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072437|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072438|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072439|NCT05640362|Benzydamine|benzydamine|mesh-list
44072440|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072441|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
44072442|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072443|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44072444|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072445|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072446|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
44072447|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072448|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
44072449|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44072450|NCT05639946|Brivaracetam|brivaracetam|mesh-list
44072451|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
44072452|NCT05639907|Ethanol|ethanol|mesh-list
44072453|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44072454|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072455|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072456|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072457|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
44072458|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072459|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072460|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072461|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072462|NCT05639777|Analgesics|analgesics|mesh-ancestor
44072463|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
44072464|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072465|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072466|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072480|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072481|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072482|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072483|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072485|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
44072486|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072487|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44072488|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44072489|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44072490|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44072491|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
44072492|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
44072493|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44072494|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44072495|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44072496|NCT05637606|Protective Agents|protective agents|mesh-ancestor
44072497|NCT05637567|Aspirin|aspirin|mesh-list
44072498|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44072499|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072500|NCT05637567|Analgesics|analgesics|mesh-ancestor
44072501|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
44072502|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072503|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072504|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072505|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072506|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44072507|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44257585|NCT00625469|Bosentan|bosentan|mesh-list
43911566|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257586|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44257587|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43621388|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621389|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257588|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257589|NCT00625495|Esomeprazole|esomeprazole|mesh-list
44257590|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44257591|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257592|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44257593|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257594|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257595|NCT00625547|Levodopa|levodopa|mesh-list
44257596|NCT00625547|Cabergoline|cabergoline|mesh-list
44072508|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072509|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44072510|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44072511|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072512|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
44072513|NCT05637086|Phenytoin|phenytoin|mesh-list
44072514|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
44072515|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44072516|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072517|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072518|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44072519|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44072520|NCT05637086|Protective Agents|protective agents|mesh-ancestor
44072521|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072522|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
44072523|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44072525|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
44072526|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44072527|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44072528|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570370|NCT00415142|Citalopram|citalopram|mesh-list
44072534|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43621395|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621396|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072535|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
44072536|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072537|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072538|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072539|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072540|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
44072541|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072542|NCT05636436|Vaccines|vaccines|mesh-list
44072543|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
44072544|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072545|NCT05636189|Anesthetics|anesthetics|mesh-list
44072546|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072547|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072548|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44072549|NCT05635604|Growth Substances|growth substances|mesh-ancestor
44072550|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072551|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
44072552|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072553|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072554|NCT05634564|Gemcitabine|gemcitabine|mesh-list
44072556|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072557|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072558|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
44257597|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44257598|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44257599|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
44257600|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257601|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257602|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654439|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
44072559|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072560|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072561|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072562|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072563|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
44072564|NCT05634564|Antiviral Agents|antiviral agents|mesh-ancestor
44072565|NCT05634564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072566|NCT05634564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072567|NCT05634564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072568|NCT05634564|Immunologic Factors|immunologic factors|mesh-ancestor
44072569|NCT05634564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072570|NCT05633472|Vitamin D|vitamin d|mesh-list
44072571|NCT05633472|Vitamins|vitamins|mesh-ancestor
44072572|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
44072573|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072574|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44072575|NCT05632809|Durvalumab|durvalumab|mesh-list
44072576|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072577|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072578|NCT05631925|Propofol|propofol|mesh-list
44072579|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44072580|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072581|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072582|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44072583|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
44072584|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
44072585|NCT05629468|Azithromycin|azithromycin|mesh-list
44072586|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44072587|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072588|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072589|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
44072590|NCT05627245|Belinostat|belinostat|mesh-list
44072591|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072592|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44072593|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072594|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072595|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
44072596|NCT05626621|Azelastine|azelastine|mesh-list
44072597|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072598|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537749|NCT05351229|Morphine|morphine|mesh-list
44072599|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44072600|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44072610|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44072611|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
44072612|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
44072613|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072614|NCT05626478|Moxifloxacin|moxifloxacin|mesh-list
44072615|NCT05626478|Dexamethasone|dexamethasone|mesh-list
44072616|NCT05626478|Prednisolone|prednisolone|mesh-list
44072617|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44072618|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
44072619|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44072620|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
44072621|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44072622|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44072623|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43793640|NCT04740008|Nicotine|nicotine|mesh-list
44072624|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
44072625|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072626|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
44072627|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
44072628|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072629|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257603|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
44257604|NCT00625560|Lamivudine|lamivudine|mesh-list
44257605|NCT00625560|Entecavir|entecavir|mesh-list
44257606|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44257607|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44257608|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257609|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257610|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
44257611|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257612|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44257613|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44257614|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44072630|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072631|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
44072632|NCT05626478|Hormones|hormones|mesh-ancestor
44072633|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072634|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44072635|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072636|NCT05626478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072637|NCT05626478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072638|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44072639|NCT05626478|Protective Agents|protective agents|mesh-ancestor
44072640|NCT05626478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072641|NCT05626478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072642|NCT05626478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44072643|NCT05626478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44072644|NCT05624918|Gemcitabine|gemcitabine|mesh-list
44072645|NCT05624918|Paclitaxel|paclitaxel|mesh-list
44072646|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072647|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072648|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44072649|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072650|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072651|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072652|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072653|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
44072654|NCT05624918|Antiviral Agents|antiviral agents|mesh-ancestor
44072655|NCT05624918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072656|NCT05624918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072657|NCT05624918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072658|NCT05624918|Immunologic Factors|immunologic factors|mesh-ancestor
44072659|NCT05624918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072660|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
44072661|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44072662|NCT05624554|Rituximab|rituximab|mesh-list
44072663|NCT05624554|Fludarabine|fludarabine|mesh-list
44072664|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072665|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
44072673|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44151204|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
44151205|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
44151206|NCT00213096|Estradiol|estradiol|mesh-list
44151207|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44151208|NCT00213096|Estrogens|estrogens|mesh-ancestor
44151209|NCT00213096|Hormones|hormones|mesh-ancestor
44151210|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151211|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151212|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44151213|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151214|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44151215|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44151216|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44151217|NCT00213109|Miglitol|miglitol|mesh-list
44257615|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461597|NCT01544114|Naproxen|naproxen|mesh-list
44461598|NCT01544114|Esomeprazole|esomeprazole|mesh-list
44461599|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44461600|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461601|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44461602|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461603|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461604|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461605|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461606|NCT01544114|Analgesics|analgesics|mesh-ancestor
44461607|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
44461608|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461609|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461610|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461611|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461612|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
44461613|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44461614|NCT01543958|Sevelamer|sevelamer|mesh-list
44461615|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
44461616|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
43793715|NCT04198506|Tacrolimus|tacrolimus|mesh-list
44151218|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151219|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151220|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151221|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151222|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44151223|NCT00213122|Miglitol|miglitol|mesh-list
44151224|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151225|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151226|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151227|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151228|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44151229|NCT00213200|Morphine|morphine|mesh-list
44072674|NCT05619172|Cetuximab|cetuximab|mesh-list
44072675|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072676|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072677|NCT05614037|Felodipine|felodipine|mesh-list
44072678|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44072679|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43621454|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621455|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
43621456|NCT03116087|Testosterone|testosterone|mesh-list
43621457|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
43621458|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
43621459|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43621492|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537943|NCT05190770|Hormones|hormones|mesh-ancestor
44072680|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44072681|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072682|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072683|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44072684|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072685|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
44072686|NCT05605665|Sirolimus|sirolimus|mesh-list
44072687|NCT05605665|Aldesleukin|aldesleukin|mesh-list
44072688|NCT05605665|Interleukin-2|interleukin-2|mesh-list
44072689|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072690|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072691|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44072692|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072693|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
44461617|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461619|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461620|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44461621|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654473|NCT02975570|Linezolid|linezolid|mesh-list
44072694|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072695|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
44072696|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072697|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072698|NCT05605665|Analgesics|analgesics|mesh-ancestor
44072699|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
44072700|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072701|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072702|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072703|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
44072712|NCT05604222|Urological Agents|urological agents|mesh-ancestor
44072713|NCT05597553|Pemetrexed|pemetrexed|mesh-list
44072714|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072715|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072716|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072717|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44072718|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44072719|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
44072720|NCT05597150|Cathartics|cathartics|mesh-ancestor
44072721|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072722|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
44072723|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072724|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072725|NCT05564377|Leucovorin|leucovorin|mesh-list
44072726|NCT05564377|Paclitaxel|paclitaxel|mesh-list
44072727|NCT05564377|Fluorouracil|fluorouracil|mesh-list
44072728|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
44072729|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44072730|NCT05564377|Olaparib|olaparib|mesh-list
44072731|NCT05564377|Fulvestrant|fulvestrant|mesh-list
44072732|NCT05564377|Palbociclib|palbociclib|mesh-list
44072733|NCT05564377|Panitumumab|panitumumab|mesh-list
44072734|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44072735|NCT05564377|Antibodies|antibodies|mesh-list
44072736|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
44072737|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44072738|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072739|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072740|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44072741|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072742|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072743|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072744|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
44072745|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072746|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
44072747|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44072748|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072749|NCT05564377|Antidotes|antidotes|mesh-ancestor
44072750|NCT05564377|Protective Agents|protective agents|mesh-ancestor
44072751|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
44072753|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
44072754|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44072755|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072756|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44072757|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44072758|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44072759|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44072760|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072761|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44072762|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
44072763|NCT05559983|Vaccines|vaccines|mesh-list
44072764|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
44072765|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072766|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44072767|NCT05559983|Antacids|antacids|mesh-ancestor
44461622|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461624|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461625|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461626|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44461627|NCT01543685|Celecoxib|celecoxib|mesh-list
44461628|NCT01543685|Indomethacin|indomethacin|mesh-list
44461629|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461630|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461631|NCT01543685|Analgesics|analgesics|mesh-ancestor
44461632|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
44461633|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461634|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461635|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461636|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461637|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44461638|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44072768|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072769|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072770|NCT05553834|Cemiplimab|cemiplimab|mesh-list
44072771|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072772|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072791|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072792|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44072793|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072795|NCT05519683|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44072796|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44072797|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072798|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072799|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072800|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
44072801|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072802|NCT05519683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44072803|NCT05519683|Antidepressive Agents|antidepressive agents|mesh-ancestor
44072804|NCT05519683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44072805|NCT05517291|Paclitaxel|paclitaxel|mesh-list
44072806|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072807|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072808|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44072809|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072810|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072811|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072812|NCT05495321|Aldesleukin|aldesleukin|mesh-list
44072813|NCT05495321|Interleukin-2|interleukin-2|mesh-list
44072814|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072815|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072816|NCT05495321|Analgesics|analgesics|mesh-ancestor
44072817|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
44072818|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621557|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44072819|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072820|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072821|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072822|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
44461639|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257616|NCT00625677|Vaccines|vaccines|mesh-list
44257617|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
44257618|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257619|NCT00625781|Insulin|insulin|mesh-list
44257620|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44257621|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
43654497|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
44072823|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151230|NCT00213200|Tetracaine|tetracaine|mesh-list
43793850|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44151231|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44072824|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44072825|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
43570715|NCT00388960|Etoposide|etoposide|mesh-list
44072839|NCT05481112|Buprenorphine|buprenorphine|mesh-list
44072840|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44072841|NCT05481112|Narcotics|narcotics|mesh-ancestor
44072842|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072843|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072844|NCT05481112|Analgesics|analgesics|mesh-ancestor
44072845|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
44072846|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072847|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44072848|NCT05478499|BMS-986165|bms-986165|mesh-list
44072849|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44072850|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44072851|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072852|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072853|NCT05468619|Valacyclovir|valacyclovir|mesh-list
44072854|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
44072855|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072856|NCT05448820|Doxorubicin|doxorubicin|mesh-list
44072857|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44072858|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072859|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44072860|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44072861|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072862|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072863|NCT05447286|Oxycodone|oxycodone|mesh-list
44072864|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44072865|NCT05447286|Narcotics|narcotics|mesh-ancestor
44072866|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072867|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072868|NCT05447286|Analgesics|analgesics|mesh-ancestor
44072869|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
44072870|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072871|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44072872|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072873|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072874|NCT05441215|Ritonavir|ritonavir|mesh-list
44072875|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44072876|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44072877|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44072878|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072879|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072880|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072881|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072882|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
44072883|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072884|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44072885|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44072886|NCT05437887|Fucoidan|fucoidan|mesh-list
44072887|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44072897|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
44072898|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072899|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072900|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072901|NCT05418868|Cabotegravir|cabotegravir|mesh-list
44072902|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44072903|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44257623|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257624|NCT00625794|Nicotine|nicotine|mesh-list
44257625|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44072904|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072905|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072906|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072907|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072908|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
44072909|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072910|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44072911|NCT05393505|Amoxicillin|amoxicillin|mesh-list
44072912|NCT05393505|Levofloxacin|levofloxacin|mesh-list
44072913|NCT05393505|Ofloxacin|ofloxacin|mesh-list
44072914|NCT05393505|Meropenem|meropenem|mesh-list
44072915|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
44072916|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
44072917|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44072918|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072919|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44072920|NCT05393505|Renal Agents|renal agents|mesh-ancestor
44072921|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44072922|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44072923|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072924|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072925|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072926|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44072927|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44072928|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44072929|NCT05371093|Prednisone|prednisone|mesh-list
44072930|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
44072931|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44072932|NCT05371093|Rituximab|rituximab|mesh-list
44072933|NCT05371093|Doxorubicin|doxorubicin|mesh-list
44072934|NCT05371093|Fludarabine|fludarabine|mesh-list
44072935|NCT05371093|Vincristine|vincristine|mesh-list
44072936|NCT05371093|Lenalidomide|lenalidomide|mesh-list
44072937|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072938|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
44072939|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072940|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072941|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072942|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
44072943|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072944|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072945|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072946|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072947|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44072948|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44072949|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44072950|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072951|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44072952|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
44072953|NCT05371093|Hormones|hormones|mesh-ancestor
43570828|NCT00375791|Hormones|hormones|mesh-ancestor
44072963|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44072964|NCT05361720|Nivolumab|nivolumab|mesh-list
44072965|NCT05361720|Ipilimumab|ipilimumab|mesh-list
44072966|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072967|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072968|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44072969|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072970|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
44072971|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
44072972|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
44072973|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072974|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072975|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
44072976|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072977|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44072978|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072979|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072980|NCT05349838|Dolutegravir|dolutegravir|mesh-list
44257626|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
44257627|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257628|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257629|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44257630|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44257631|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257632|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257633|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072981|NCT05349838|Rilpivirine|rilpivirine|mesh-list
44072982|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
44072983|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44072984|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44072985|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072986|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072987|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072988|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072989|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
44072990|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44072991|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43849418|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621579|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
43621580|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43621581|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621582|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621583|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621584|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621585|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621587|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072992|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44072993|NCT05349188|Melatonin|melatonin|mesh-list
44072994|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
44072995|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072996|NCT05349188|Protective Agents|protective agents|mesh-ancestor
44072997|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072998|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44072999|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
44073000|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44073001|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073002|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44073003|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073004|NCT05325164|Morphine|morphine|mesh-list
44073005|NCT05325164|Methadone|methadone|mesh-list
44073006|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44073007|NCT05325164|Narcotics|narcotics|mesh-ancestor
44073008|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073009|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073010|NCT05325164|Analgesics|analgesics|mesh-ancestor
44073011|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
44073012|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073013|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
44073014|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
44073015|NCT05321160|Ketamine|ketamine|mesh-list
44073025|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
44073026|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073027|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44073028|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44073029|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073030|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073031|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44073032|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44073033|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
44073034|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151232|NCT00213200|Narcotics|narcotics|mesh-ancestor
44151233|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151234|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151235|NCT00213200|Analgesics|analgesics|mesh-ancestor
44151236|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
44151237|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151238|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
44151239|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
44151240|NCT00213226|Dexamethasone|dexamethasone|mesh-list
44151241|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44151242|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
44257634|NCT00625859|Bupropion|bupropion|mesh-list
43621628|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44257635|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44257636|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
44257637|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257638|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44257639|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44257640|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257641|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257642|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
44257643|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257644|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257645|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43654512|NCT02975076|Aspirin|aspirin|mesh-list
44151243|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
44151244|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151245|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073035|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
44073036|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073038|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073039|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073040|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073041|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073042|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073043|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073044|NCT05312008|Oxytocin|oxytocin|mesh-list
44073045|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
44073046|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44073047|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073048|NCT05305456|Vitamins|vitamins|mesh-list
44073049|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
44073050|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
44073051|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073052|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
44073053|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073054|NCT05305456|Protective Agents|protective agents|mesh-ancestor
44073055|NCT05263908|Ritonavir|ritonavir|mesh-list
44073056|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44073057|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44073058|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
43621677|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621678|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621679|NCT03113396|Baclofen|baclofen|mesh-list
43621680|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43621681|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621682|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43621683|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621684|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43621685|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
43621686|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
44073059|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073060|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073061|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44073062|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44073063|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
44073064|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073065|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44073066|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44073067|NCT05233696|Paclitaxel|paclitaxel|mesh-list
44073068|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44073069|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
44073079|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073080|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
44073081|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073082|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
44073084|NCT05219435|Ipilimumab|ipilimumab|mesh-list
44073085|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073086|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073087|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44073088|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073089|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
44257646|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44257647|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257648|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
44257649|NCT00625898|Bevacizumab|bevacizumab|mesh-list
44257650|NCT00625898|Carboplatin|carboplatin|mesh-list
44257651|NCT00625898|Docetaxel|docetaxel|mesh-list
44257652|NCT00625898|Fluorouracil|fluorouracil|mesh-list
44257653|NCT00625898|Trastuzumab|trastuzumab|mesh-list
44257654|NCT00625898|Epirubicin|epirubicin|mesh-list
44257655|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257656|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
44257657|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257658|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257659|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257660|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
44257661|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257662|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654527|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073090|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
44073091|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073092|NCT05183984|Bevacizumab|bevacizumab|mesh-list
44073093|NCT05183984|Niraparib|niraparib|mesh-list
44073094|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073095|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073096|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44073097|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44073098|NCT05183984|Growth Substances|growth substances|mesh-ancestor
44073099|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073100|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44073101|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44073102|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073103|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073104|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
44073105|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073106|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073107|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
44073108|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43794107|NCT03869944|Lamivudine|lamivudine|mesh-list
44073109|NCT05140941|Velpatasvir|velpatasvir|mesh-list
44073110|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
44073111|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073112|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44073113|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44073114|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073115|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
44073116|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44073117|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073118|NCT05138822|Renal Agents|renal agents|mesh-ancestor
44073119|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44073120|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
44073121|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
44073122|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44073123|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44073124|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073125|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073126|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073127|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151246|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151247|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
44257663|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44257664|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44257665|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44257666|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44151248|NCT00213226|Hormones|hormones|mesh-ancestor
44151249|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151250|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43571013|NCT00356681|Imetelstat|imetelstat|mesh-list
44151261|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
44151262|NCT00213252|Hormones|hormones|mesh-ancestor
44151263|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151264|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151265|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44151266|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151267|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
44151268|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
44151269|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151270|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151271|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44151272|NCT00213252|Protective Agents|protective agents|mesh-ancestor
44151273|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151274|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151275|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44151276|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
44151277|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44151278|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44151279|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151280|NCT00213265|Vaccines|vaccines|mesh-list
44151281|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44151282|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
44151283|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151284|NCT00213278|Vinblastine|vinblastine|mesh-list
44151285|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44151286|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151287|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151288|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151289|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151290|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151291|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
44151292|NCT00213291|Hematinics|hematinics|mesh-ancestor
44151293|NCT00213486|Irinotecan|irinotecan|mesh-list
44151294|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44151295|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44151296|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151297|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151298|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151299|NCT00213512|Rituximab|rituximab|mesh-list
44151300|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44151301|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073128|NCT05116930|Atropine|atropine|mesh-list
44073129|NCT05116930|Neostigmine|neostigmine|mesh-list
44073130|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44073131|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44073132|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44073133|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
44073134|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073135|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073136|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44073137|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
44073138|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
44073139|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
44073140|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44073141|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44073142|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
44073145|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44073146|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073147|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44073148|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
44073149|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073150|NCT05109442|Atezolizumab|atezolizumab|mesh-list
44257667|NCT00625898|Growth Substances|growth substances|mesh-ancestor
44257668|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
44257669|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44257670|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257671|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257672|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
44257673|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073151|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073152|NCT05091372|Lenalidomide|lenalidomide|mesh-list
44073153|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
44073154|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073155|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44073156|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44073157|NCT05091372|Growth Substances|growth substances|mesh-ancestor
44073158|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44073159|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073160|NCT05083754|Temozolomide|temozolomide|mesh-list
44073161|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44073162|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
44073163|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073164|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073165|NCT05080322|Fluticasone|fluticasone|mesh-list
44073167|NCT05080322|Azelastine|azelastine|mesh-list
44073168|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073169|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44073170|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
44073171|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073172|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073173|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44073174|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
44073175|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073176|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44073177|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44073178|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073179|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073180|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44073181|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44073182|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
44073183|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
44073184|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073185|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
44073186|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073187|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073188|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44073189|NCT05070585|Protective Agents|protective agents|mesh-ancestor
44073190|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073191|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073192|NCT05068661|Fentanyl|fentanyl|mesh-list
44073193|NCT05068661|Bupivacaine|bupivacaine|mesh-list
44073194|NCT05068661|Ropivacaine|ropivacaine|mesh-list
44073195|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44073196|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073197|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
44073198|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073199|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073200|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
44073201|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073202|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44073203|NCT05068661|Narcotics|narcotics|mesh-ancestor
44073204|NCT05068661|Analgesics|analgesics|mesh-ancestor
44073205|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44073206|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44073207|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
44073208|NCT05061134|Durvalumab|durvalumab|mesh-list
44073209|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073210|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073211|NCT05049616|Nifedipine|nifedipine|mesh-list
44073212|NCT05049616|Diuretics|diuretics|mesh-list
44073213|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43787388|NCT02578394|Protective Agents|protective agents|mesh-ancestor
44257674|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44257675|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44257676|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44257677|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257678|NCT00625911|Ketamine|ketamine|mesh-list
44257679|NCT00625911|Morphine|morphine|mesh-list
44257680|NCT00625911|Analgesics|analgesics|mesh-ancestor
44257681|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
44257682|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654551|NCT02975323|Protective Agents|protective agents|mesh-ancestor
44073214|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44073215|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43571147|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44073218|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073219|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
44073220|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
44073221|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44073222|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
44073223|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
44073224|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073225|NCT05047770|Vaccines|vaccines|mesh-list
44073226|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
44073227|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073228|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44073229|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44073230|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44073231|NCT05041127|Cetuximab|cetuximab|mesh-list
44073232|NCT05041127|Antibodies|antibodies|mesh-list
44073233|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
44073234|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44073235|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
44073236|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073237|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073238|NCT05029973|Bevacizumab|bevacizumab|mesh-list
44073239|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073240|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073241|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44073242|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44073243|NCT05029973|Growth Substances|growth substances|mesh-ancestor
44073244|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073245|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44073246|NCT05027633|Cisplatin|cisplatin|mesh-list
44073247|NCT05027633|Carboplatin|carboplatin|mesh-list
44073248|NCT05027633|Docetaxel|docetaxel|mesh-list
44073249|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
44073250|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073251|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073252|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073253|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073254|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073255|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073256|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44073257|NCT05020483|Coagulants|coagulants|mesh-ancestor
44073258|NCT05019430|Cocaine|cocaine|mesh-list
44073259|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
44073260|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073261|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
44073262|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073263|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073264|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
44073265|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073266|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44073267|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44073268|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44073269|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44073270|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073271|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
44257683|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257684|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44257685|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44073272|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073273|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44073274|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44073275|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
44073276|NCT05010707|Spironolactone|spironolactone|mesh-list
44073277|NCT05010707|Hormones|hormones|mesh-list
44073278|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073279|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073280|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44073281|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
44073282|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44073283|NCT05010707|Diuretics|diuretics|mesh-ancestor
44073284|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
44073286|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073287|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073288|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44073298|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
44073299|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073300|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073301|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073302|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44073303|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44073304|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073305|NCT04963712|Thymalfasin|thymalfasin|mesh-list
44073306|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44073307|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
44073308|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073314|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44073315|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073316|NCT04935814|Vasopressins|vasopressins|mesh-list
44073317|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
44073318|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
44073319|NCT04935814|Coagulants|coagulants|mesh-ancestor
44073320|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44073321|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44073322|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
44073323|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073324|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
44073325|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073326|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
44073327|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073328|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073329|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
44073330|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151302|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
44151303|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151304|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151305|NCT00213538|Methotrexate|methotrexate|mesh-list
44151306|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44151307|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44151308|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
44151309|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151310|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151311|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151312|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
44151313|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151314|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151315|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44151316|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151317|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44151318|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151319|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
44151320|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151321|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44151322|NCT00213551|Antioxidants|antioxidants|mesh-list
44151323|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151324|NCT00213551|Protective Agents|protective agents|mesh-ancestor
44257686|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
44257687|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
44257688|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151325|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073344|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44073345|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44073346|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073347|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44073349|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44073350|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073351|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44073352|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44073353|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
44073354|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44073355|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
44073356|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
44073357|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
44073358|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44073372|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
44073373|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44073374|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
44073375|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073376|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
44073377|NCT04893174|Protective Agents|protective agents|mesh-ancestor
44073378|NCT04888858|Fentanyl|fentanyl|mesh-list
44073379|NCT04888858|Bupivacaine|bupivacaine|mesh-list
44073380|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073381|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
44073382|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073383|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073384|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
44073385|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073386|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44073387|NCT04888858|Narcotics|narcotics|mesh-ancestor
44073388|NCT04888858|Analgesics|analgesics|mesh-ancestor
44073389|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44073390|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44073391|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
44073392|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44073393|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44073394|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44073409|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44073410|NCT04862221|Prednisolone|prednisolone|mesh-list
44073411|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
44073412|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44073413|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
44073414|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44073415|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073416|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
44073417|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
44073418|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073419|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073420|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073421|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
44073422|NCT04862221|Hormones|hormones|mesh-ancestor
44073423|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073424|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44073425|NCT04862221|Protective Agents|protective agents|mesh-ancestor
44257689|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44257690|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44257691|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257692|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257693|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44073426|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44073427|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073428|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
44073429|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073430|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44073431|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44073432|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073433|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073434|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
44073435|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
44073436|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44073437|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
44073438|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
44073439|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073440|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073441|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43621871|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43621872|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43650504|NCT03013556|Tenofovir|tenofovir|mesh-list
44073442|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
44073443|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073445|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
44073446|NCT04843904|Venetoclax|venetoclax|mesh-list
44073447|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073448|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073449|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
44073450|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073451|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44073452|NCT04840589|Nivolumab|nivolumab|mesh-list
44073453|NCT04840589|Ipilimumab|ipilimumab|mesh-list
44073454|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073455|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073456|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43571425|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073470|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
44073471|NCT04827953|Antiviral Agents|antiviral agents|mesh-ancestor
44073472|NCT04827953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073473|NCT04827953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073474|NCT04827953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073475|NCT04827953|Immunologic Factors|immunologic factors|mesh-ancestor
44073476|NCT04827953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073477|NCT04821830|Levodopa|levodopa|mesh-list
44073478|NCT04821830|Carbidopa|carbidopa|mesh-list
44073479|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44073480|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44073481|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44073482|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
44073483|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073484|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073485|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073486|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44073487|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073488|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44073489|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
44073490|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
44073492|NCT04817254|Ipilimumab|ipilimumab|mesh-list
44073493|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073494|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073495|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44073496|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073497|NCT04802746|Alprazolam|alprazolam|mesh-list
44073498|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44073499|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073500|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073501|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44073502|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44073503|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257695|NCT00625937|Cisplatin|cisplatin|mesh-list
44257696|NCT00625937|Docetaxel|docetaxel|mesh-list
44257697|NCT00625937|Tegafur|tegafur|mesh-list
44257698|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257699|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44257700|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257701|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073504|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
44073505|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
44073506|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073507|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073508|NCT04798638|Osimertinib|osimertinib|mesh-list
44073509|NCT04798638|Complement Factor H|complement factor h|mesh-list
44073510|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073511|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073512|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073513|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073514|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44073515|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073516|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
44073517|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073526|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44073527|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
44073528|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44073529|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
44073530|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073531|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073532|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
44073533|NCT04767776|Antidotes|antidotes|mesh-ancestor
44073534|NCT04767776|Protective Agents|protective agents|mesh-ancestor
44073535|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073537|NCT04762953|Paclitaxel|paclitaxel|mesh-list
44073538|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44073539|NCT04762953|Fluorouracil|fluorouracil|mesh-list
44073540|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073541|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073542|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073543|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073544|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073545|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073546|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
44073547|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073548|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073549|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
44073550|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073551|NCT04762953|Antidotes|antidotes|mesh-ancestor
44073552|NCT04762953|Protective Agents|protective agents|mesh-ancestor
44073553|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
44073554|NCT04762953|Vitamins|vitamins|mesh-ancestor
44073555|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
44073556|NCT04760613|Cannabidiol|cannabidiol|mesh-list
44073557|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
44073558|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
44073559|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073560|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073561|NCT04742101|Azacitidine|azacitidine|mesh-list
44073562|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073563|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
44073564|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073565|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073566|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073567|NCT04736199|Androgens|androgens|mesh-list
44073568|NCT04736199|Hormones|hormones|mesh-ancestor
44073569|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073570|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073571|NCT04732286|Bevacizumab|bevacizumab|mesh-list
44073572|NCT04732286|Atezolizumab|atezolizumab|mesh-list
44073573|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073574|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073575|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44257702|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257703|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257704|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
44073576|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44073577|NCT04732286|Growth Substances|growth substances|mesh-ancestor
44073578|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073579|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
44073580|NCT04729595|Tempol|tempol|mesh-list
44073581|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
44073582|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073583|NCT04729595|Protective Agents|protective agents|mesh-ancestor
44073584|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073585|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44073586|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073587|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44073588|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44073596|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
44073597|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
44073598|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073599|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073600|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073601|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44073602|NCT04676477|Osimertinib|osimertinib|mesh-list
44073603|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
44073604|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44073605|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073606|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073607|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073608|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073609|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
44073610|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073611|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073612|NCT04657081|Decitabine|decitabine|mesh-list
44073613|NCT04657081|Venetoclax|venetoclax|mesh-list
44073614|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073615|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
44073616|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073617|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073618|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073619|NCT04650880|Vitamin D|vitamin d|mesh-list
44073620|NCT04650880|Vitamins|vitamins|mesh-ancestor
44073621|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
44073622|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073623|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44151326|NCT00213564|Methotrexate|methotrexate|mesh-list
44151327|NCT00213564|Infliximab|infliximab|mesh-list
44151328|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44151329|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
43622010|NCT03111342|Lidocaine|lidocaine|mesh-list
44151330|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151331|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151332|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151333|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
44151334|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151335|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151336|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073624|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
44073625|NCT04633902|Olaparib|olaparib|mesh-list
44073626|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073627|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073628|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44073629|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073630|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073631|NCT04632992|Paclitaxel|paclitaxel|mesh-list
44073632|NCT04632992|Maytansine|maytansine|mesh-list
44073633|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44073634|NCT04632992|Trastuzumab|trastuzumab|mesh-list
44073635|NCT04632992|Atezolizumab|atezolizumab|mesh-list
44073636|NCT04632992|Pertuzumab|pertuzumab|mesh-list
44073637|NCT04632992|Tucatinib|tucatinib|mesh-list
44073638|NCT04632992|Pralsetinib|pralsetinib|mesh-list
44073639|NCT04632992|Entrectinib|entrectinib|mesh-list
44073640|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44257705|NCT00626015|Temozolomide|temozolomide|mesh-list
44257706|NCT00626015|Daclizumab|daclizumab|mesh-list
44257707|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257708|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
43798913|NCT05015621|Leucovorin|leucovorin|mesh-list
44073641|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073642|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073643|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073644|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073645|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073646|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571610|NCT00252005|Apixaban|apixaban|mesh-list
44073655|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44073656|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073657|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44073658|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
44073659|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073660|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43622088|NCT03110952|Vitamins|vitamins|mesh-ancestor
44073661|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44073662|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073663|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073664|NCT04619706|Hormones|hormones|mesh-ancestor
44073665|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073666|NCT04608409|Paclitaxel|paclitaxel|mesh-list
44073667|NCT04608409|Lapatinib|lapatinib|mesh-list
44073668|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073669|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073670|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073671|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073672|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073673|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073674|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073675|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073676|NCT04606771|Osimertinib|osimertinib|mesh-list
44073677|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073678|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073679|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073680|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073681|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
44073682|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44073683|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
44073684|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073685|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073686|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44073687|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
44073688|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44073689|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
44073690|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073691|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073692|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44073693|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
44073694|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
44073695|NCT04601077|Protective Agents|protective agents|mesh-ancestor
44073702|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44073703|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
44073704|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073705|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44073706|NCT04591808|Perindopril|perindopril|mesh-list
44073707|NCT04591808|Atorvastatin|atorvastatin|mesh-list
44073708|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44073709|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44073710|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
44073711|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073712|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44073713|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44073714|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073715|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44073716|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
44073717|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44073727|NCT04544683|Dexamethasone|dexamethasone|mesh-list
44257710|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257711|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257712|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
44257713|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257714|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44257715|NCT00626080|Insulin|insulin|mesh-list
44073728|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
44073729|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44073730|NCT04544683|BB 1101|bb 1101|mesh-list
44073731|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073732|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
44073733|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
44073734|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073735|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073736|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073737|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
44073738|NCT04544683|Hormones|hormones|mesh-ancestor
44073739|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073740|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44073741|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073742|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
44073743|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073744|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073745|NCT04511702|Methotrexate|methotrexate|mesh-list
44073746|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44073747|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
44073748|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44073749|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073750|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073751|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
44073752|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073753|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073754|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073755|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073756|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44073757|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073758|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
44073759|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44073760|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44073761|NCT04495504|Ropivacaine|ropivacaine|mesh-list
44073762|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073763|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
44073764|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073765|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073766|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
44073767|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073768|NCT04492566|Pancrelipase|pancrelipase|mesh-list
44073769|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073770|NCT04487067|Bevacizumab|bevacizumab|mesh-list
44073771|NCT04487067|Atezolizumab|atezolizumab|mesh-list
44073772|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073773|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794628|NCT02455141|Taxane|taxane|mesh-list
44073774|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44073775|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44073776|NCT04487067|Growth Substances|growth substances|mesh-ancestor
44073777|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073778|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44073783|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44073784|NCT04476030|Citalopram|citalopram|mesh-list
44073785|NCT04476030|Sertraline|sertraline|mesh-list
44073792|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
44073793|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622120|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073794|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44073795|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
44257716|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44257717|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
44257718|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
44257719|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
44257720|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
44257721|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44257722|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257723|NCT00626158|Gemcitabine|gemcitabine|mesh-list
44073796|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44073797|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073798|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44073799|NCT04476030|Analgesics|analgesics|mesh-ancestor
44073800|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
44073801|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
44073802|NCT04472429|Paclitaxel|paclitaxel|mesh-list
44073803|NCT04472429|Carboplatin|carboplatin|mesh-list
44073804|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073805|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073806|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073807|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073808|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073809|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073810|NCT04467086|Propranolol|propranolol|mesh-list
44073811|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44073812|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44073813|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
44073814|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073815|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073816|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073817|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44073818|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44073819|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
44073821|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073822|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073823|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073824|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073825|NCT04439149|GSK2636771|gsk2636771|mesh-list
44073826|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073827|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073828|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073829|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073830|NCT04432428|Sufentanil|sufentanil|mesh-list
44073831|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44073832|NCT04432428|Narcotics|narcotics|mesh-ancestor
44073833|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073834|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073835|NCT04432428|Analgesics|analgesics|mesh-ancestor
44073836|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
44073837|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073838|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44073839|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44073840|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
44073841|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
44073842|NCT04423367|Dexamethasone|dexamethasone|mesh-list
44073843|NCT04423367|Bortezomib|bortezomib|mesh-list
44073844|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073845|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
44073846|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
44073847|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073848|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073849|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073850|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
44073851|NCT04423367|Hormones|hormones|mesh-ancestor
44073852|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073853|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44151340|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
44151341|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151342|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44257724|NCT00626158|Capecitabine|capecitabine|mesh-list
44257725|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257726|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
44257727|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257728|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257729|NCT00626158|Antiviral Agents|antiviral agents|mesh-ancestor
44257730|NCT00626158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257731|NCT00626158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151343|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151344|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
44151345|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44151346|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151347|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151348|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44151349|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151350|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151351|NCT00213590|Cyclosporine|cyclosporine|mesh-list
44151352|NCT00213590|Cyclosporins|cyclosporins|mesh-list
44151353|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151354|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151355|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151356|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
44151357|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151358|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
44151359|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151360|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
44151361|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151362|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44151364|NCT00213694|Docetaxel|docetaxel|mesh-list
44151365|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151366|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151367|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151368|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151369|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151370|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44151371|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44151372|NCT00213694|Analgesics|analgesics|mesh-ancestor
44151373|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
44151374|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151375|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151376|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44151377|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151378|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44151379|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44151380|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151381|NCT00213759|Lenograstim|lenograstim|mesh-list
44151382|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44151383|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
44151384|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158000|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158001|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44158002|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44158003|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158004|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44158005|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44158006|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44158007|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44158008|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
44158009|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158010|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158011|NCT00235963|Simvastatin|simvastatin|mesh-list
44158012|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44158013|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44158014|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
44257732|NCT00626158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257733|NCT00626158|Immunologic Factors|immunologic factors|mesh-ancestor
44257734|NCT00626158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257736|NCT00626223|Hematinics|hematinics|mesh-ancestor
43799520|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
44158015|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073867|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073869|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
44073870|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073871|NCT04294836|Curcumin|curcumin|mesh-list
44073872|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44073873|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44073874|NCT04294836|Analgesics|analgesics|mesh-ancestor
44073875|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
44073876|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073877|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073878|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073879|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44073880|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073881|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073882|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073883|NCT04290546|Ipilimumab|ipilimumab|mesh-list
44073884|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44073885|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073886|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073887|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073888|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
44073889|NCT04262466|Atezolizumab|atezolizumab|mesh-list
44073890|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073891|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073892|NCT04258852|Nicotine|nicotine|mesh-list
44073893|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44073894|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
44073895|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073896|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073897|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44073898|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44073899|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
44073900|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073901|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073903|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44073904|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073905|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073906|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073907|NCT04231851|Cytarabine|cytarabine|mesh-list
44073908|NCT04231851|Daunorubicin|daunorubicin|mesh-list
44073909|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073910|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
44073911|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073912|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073913|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
44073914|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073915|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44073916|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
44073917|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073918|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44073919|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44073920|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44073921|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073922|NCT04226690|Dronabinol|dronabinol|mesh-list
44073923|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
44073939|NCT04205812|Carboplatin|carboplatin|mesh-list
43622203|NCT03110055|Grazoprevir|grazoprevir|mesh-list
44073941|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073942|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073943|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073944|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073945|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257737|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
44257738|NCT00626223|Vitamins|vitamins|mesh-ancestor
44257739|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
44257740|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257741|NCT00626262|Esomeprazole|esomeprazole|mesh-list
44257742|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44073946|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073947|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073948|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44073949|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44073950|NCT04169347|Leucovorin|leucovorin|mesh-list
44073951|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
44073952|NCT04169347|Irinotecan|irinotecan|mesh-list
44073953|NCT04169347|Panitumumab|panitumumab|mesh-list
44073954|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073955|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44073956|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44073957|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073958|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073959|NCT04169347|Antidotes|antidotes|mesh-ancestor
44073960|NCT04169347|Protective Agents|protective agents|mesh-ancestor
44073961|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073962|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
44073963|NCT04169347|Vitamins|vitamins|mesh-ancestor
44073964|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
44073965|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073966|NCT04143711|Paclitaxel|paclitaxel|mesh-list
44073967|NCT04143711|Nivolumab|nivolumab|mesh-list
44073968|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073969|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073970|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073971|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073972|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073973|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073974|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073975|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44073977|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
44073978|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073979|NCT04104139|Trifluridine|trifluridine|mesh-list
44073980|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
44073981|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074011|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
44074012|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44074013|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44074014|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074015|NCT04060862|Fulvestrant|fulvestrant|mesh-list
44074016|NCT04060862|Palbociclib|palbociclib|mesh-list
44074017|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074018|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074019|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44074020|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44074021|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
44074022|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074023|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074024|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074025|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074026|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074027|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
44074028|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
44074029|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44074030|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074031|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44074032|NCT04038346|Acetaminophen|acetaminophen|mesh-list
44074033|NCT04038346|Naproxen|naproxen|mesh-list
44074034|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074035|NCT04038346|Analgesics|analgesics|mesh-ancestor
44074036|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
44074046|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074047|NCT04020172|Dobutamine|dobutamine|mesh-list
44074048|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44257743|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257744|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44257745|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257746|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257747|NCT00626288|Mesalamine|mesalamine|mesh-list
44257748|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44257749|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44257750|NCT00626288|Analgesics|analgesics|mesh-ancestor
44257751|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
44074049|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
44074050|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
44074051|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074052|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074053|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44074054|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44074055|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44074056|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
44074057|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074058|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074059|NCT04020172|Protective Agents|protective agents|mesh-ancestor
44074060|NCT04009681|Antibodies|antibodies|mesh-list
44074061|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
44074062|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074063|NCT04004416|Lorazepam|lorazepam|mesh-list
44074064|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
44074065|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
44074066|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
44074067|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074068|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074069|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074070|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44074071|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074072|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44074073|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44074074|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44074075|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
44074076|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
44074077|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074078|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074079|NCT03991884|Prednisone|prednisone|mesh-list
44074080|NCT03991884|Cortisone|cortisone|mesh-list
44074081|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
44074082|NCT03991884|Doxorubicin|doxorubicin|mesh-list
44074083|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44074084|NCT03991884|Etoposide|etoposide|mesh-list
44074085|NCT03991884|Vincristine|vincristine|mesh-list
44074086|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
44074087|NCT03991884|Daunorubicin|daunorubicin|mesh-list
44074088|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
44074089|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44074090|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074091|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
44074092|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074093|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074094|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074095|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
44074096|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074097|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074098|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074099|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074100|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44074101|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44074102|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074103|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074110|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074111|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074112|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
44074113|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257752|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257753|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074114|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074116|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074117|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074118|NCT03991741|Analgesics|analgesics|mesh-ancestor
44074119|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
44074120|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074121|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074123|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074124|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074125|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44074126|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074127|NCT03969004|Cemiplimab|cemiplimab|mesh-list
44074128|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074129|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074130|NCT03968822|Lidocaine|lidocaine|mesh-list
44074131|NCT03968822|Bupivacaine|bupivacaine|mesh-list
44074132|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44074133|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
44074134|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
44074135|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074136|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074137|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
44074138|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074139|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44074140|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44074141|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44074142|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074143|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151385|NCT00214032|Pycnogenols|pycnogenols|mesh-list
44151386|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44151387|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
44151388|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151389|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
44151390|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151391|NCT00214032|Protective Agents|protective agents|mesh-ancestor
44151392|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44151393|NCT00214058|Carboplatin|carboplatin|mesh-list
44151394|NCT00214058|Docetaxel|docetaxel|mesh-list
44151395|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151396|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151397|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151398|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074144|NCT03944941|Cetuximab|cetuximab|mesh-list
44074145|NCT03944941|Avelumab|avelumab|mesh-list
44074146|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074147|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074148|NCT03937609|Infliximab|infliximab|mesh-list
44074149|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
44074150|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074151|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074152|NCT03893825|Risperidone|risperidone|mesh-list
44074153|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44074154|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
44074155|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074156|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074157|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074185|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
44074186|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074187|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074188|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
44074189|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44074190|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074191|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074192|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
44074193|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44074194|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074195|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074196|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44074197|NCT03879408|Narcotics|narcotics|mesh-ancestor
44257754|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257755|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257756|NCT00626483|Basiliximab|basiliximab|mesh-list
44257757|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257758|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
44257759|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257760|NCT00626509|Sunitinib|sunitinib|mesh-list
44257761|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074198|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074199|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
44074200|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44074201|NCT03877549|Dexamethasone|dexamethasone|mesh-list
44074202|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074203|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
44074204|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
44074212|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074213|NCT03869892|Trifluridine|trifluridine|mesh-list
44074214|NCT03869892|Bevacizumab|bevacizumab|mesh-list
44074215|NCT03869892|Capecitabine|capecitabine|mesh-list
44074216|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074217|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074218|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44074219|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44074220|NCT03869892|Growth Substances|growth substances|mesh-ancestor
44074221|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074222|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
44074223|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074224|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
44074225|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074226|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
44074227|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074228|NCT03862950|Metformin|metformin|mesh-list
44074229|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44074230|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074231|NCT03861767|Metformin|metformin|mesh-list
44074232|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44074233|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074234|NCT03844412|Lidocaine|lidocaine|mesh-list
44074235|NCT03844412|Nortriptyline|nortriptyline|mesh-list
44074236|NCT03844412|Estradiol|estradiol|mesh-list
44074237|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
44074238|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
44074239|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074240|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074241|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
44074242|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074243|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44074244|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44074245|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44074246|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074247|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074248|NCT03844412|Estrogens|estrogens|mesh-ancestor
44074249|NCT03844412|Hormones|hormones|mesh-ancestor
44074250|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074251|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44074252|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
44074253|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44074254|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44074255|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44074256|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44074257|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074258|NCT03837977|Leucovorin|leucovorin|mesh-list
44074259|NCT03837977|Folic Acid|folic acid|mesh-list
44074260|NCT03837977|Docetaxel|docetaxel|mesh-list
44074261|NCT03837977|Fluorouracil|fluorouracil|mesh-list
44074262|NCT03837977|Irinotecan|irinotecan|mesh-list
44074263|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
44074264|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074265|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074266|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257762|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44257763|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44257764|NCT00626509|Growth Substances|growth substances|mesh-ancestor
43654618|NCT02974712|Analgesics|analgesics|mesh-ancestor
44074267|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074268|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074269|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
44074270|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074271|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074272|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
44074281|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
44074282|NCT03837977|Hematinics|hematinics|mesh-ancestor
44074283|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
44074284|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074285|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074286|NCT03809988|Letrozole|letrozole|mesh-list
44074287|NCT03809988|Fulvestrant|fulvestrant|mesh-list
44074288|NCT03809988|Palbociclib|palbociclib|mesh-list
44074289|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074290|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44074291|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44074292|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074293|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074294|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44074295|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
44074296|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074297|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074298|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074299|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44074300|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074301|NCT03801031|Lidocaine|lidocaine|mesh-list
44074302|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
44074303|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
44074304|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074305|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074306|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
44074307|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074308|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44074309|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44074310|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44074311|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074312|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074313|NCT03797560|Pregabalin|pregabalin|mesh-list
44074314|NCT03797560|Analgesics|analgesics|mesh-ancestor
44074315|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
44074316|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074317|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074318|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
44074319|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44074320|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074321|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074322|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44074323|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44074324|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44074325|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074326|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44074327|NCT03746106|Thiamine|thiamine|mesh-list
44074328|NCT03746106|Metformin|metformin|mesh-list
44074330|NCT03746106|Vitamins|vitamins|mesh-ancestor
44074331|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
44074332|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074333|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44074334|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
44074335|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44074336|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074337|NCT03746106|Renal Agents|renal agents|mesh-ancestor
44074338|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
44074339|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44074340|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44074341|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44257765|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257766|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
44257767|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44257768|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257769|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074359|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
44074360|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074361|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074362|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074363|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074364|NCT03729271|Rifaximin|rifaximin|mesh-list
44074365|NCT03729271|Lactulose|lactulose|mesh-list
44074366|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44074367|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074368|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074369|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
44074370|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074371|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074372|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
44074373|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44074374|NCT03696784|Fludarabine|fludarabine|mesh-list
44074375|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074376|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
44074377|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074378|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074379|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074380|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
44074381|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074382|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074383|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074384|NCT03683667|Azithromycin|azithromycin|mesh-list
44074385|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44074386|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074388|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074389|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074390|NCT03646123|Doxorubicin|doxorubicin|mesh-list
44074391|NCT03646123|Nivolumab|nivolumab|mesh-list
44074392|NCT03646123|Dacarbazine|dacarbazine|mesh-list
44074393|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44074394|NCT03646123|Vinblastine|vinblastine|mesh-list
44074395|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074396|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074397|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44074398|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44074399|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074400|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074401|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074402|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44074403|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074405|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074407|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074408|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074409|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
44074410|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074411|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074412|NCT03623321|Pimavanserin|pimavanserin|mesh-list
44074413|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44074414|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44074415|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44074416|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44074417|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074418|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074419|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44074420|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44074421|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44074422|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
44074423|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257770|NCT00626535|Esomeprazole|esomeprazole|mesh-list
44257771|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44257772|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44257773|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44257774|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654625|NCT02974556|Capecitabine|capecitabine|mesh-list
44074424|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074425|NCT03620019|Denosumab|denosumab|mesh-list
44074426|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
44074427|NCT03620019|Nivolumab|nivolumab|mesh-list
44074428|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074429|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074430|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44074431|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074432|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44074433|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074434|NCT03619551|Busulfan|busulfan|mesh-list
44074435|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
44074436|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074437|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074438|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
44074439|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074440|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074441|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074442|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074443|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44074444|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44074445|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44074446|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074447|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074448|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44074449|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074450|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074451|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
44074452|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074453|NCT03595917|Prednisone|prednisone|mesh-list
44074454|NCT03595917|Dasatinib|dasatinib|mesh-list
44074455|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074456|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
44074457|NCT03595917|Hormones|hormones|mesh-ancestor
44074458|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074459|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074460|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074461|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074462|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074463|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074464|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074465|NCT03593018|Gemcitabine|gemcitabine|mesh-list
44074466|NCT03593018|Azacitidine|azacitidine|mesh-list
44074467|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44074468|NCT03593018|Romidepsin|romidepsin|mesh-list
44074469|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074470|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
44074471|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074472|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074473|NCT03593018|Antiviral Agents|antiviral agents|mesh-ancestor
44074474|NCT03593018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074475|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074484|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
44074485|NCT03588767|Vitamins|vitamins|mesh-list
44074486|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
44074487|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
44074488|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074489|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44074490|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44074491|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
44074492|NCT03588767|Hormones|hormones|mesh-ancestor
44074493|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074494|NCT03580928|Venetoclax|venetoclax|mesh-list
44257775|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257777|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44257778|NCT00626600|Narcotics|narcotics|mesh-ancestor
44257779|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654631|NCT02974660|Protamines|protamines|mesh-list
44074495|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
44074496|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
44074497|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074498|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074499|NCT03576547|Dexamethasone|dexamethasone|mesh-list
44074500|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
44074501|NCT03576547|Rituximab|rituximab|mesh-list
44074502|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44074503|NCT03576547|Venetoclax|venetoclax|mesh-list
44074504|NCT03576547|Ponatinib|ponatinib|mesh-list
44074505|NCT03576547|Antibodies|antibodies|mesh-list
44074506|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
44074507|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44074508|NCT03576547|BB 1101|bb 1101|mesh-list
44074509|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
44074510|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074511|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074512|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074513|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074514|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
44074515|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
44074516|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074517|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074518|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
44074519|NCT03576547|Hormones|hormones|mesh-ancestor
44074520|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074521|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074522|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44074523|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074524|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074525|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074527|NCT03574402|Cisplatin|cisplatin|mesh-list
44074528|NCT03574402|Carboplatin|carboplatin|mesh-list
44074529|NCT03574402|Pemetrexed|pemetrexed|mesh-list
44074530|NCT03574402|Afatinib|afatinib|mesh-list
44074531|NCT03574402|Crizotinib|crizotinib|mesh-list
44074532|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
44074533|NCT03574402|Ensartinib|ensartinib|mesh-list
44074534|NCT03574402|Maleic acid|maleic acid|mesh-list
44074535|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074536|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074537|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
44074538|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074539|NCT03574402|Antiviral Agents|antiviral agents|mesh-ancestor
44074540|NCT03574402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074541|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074542|NCT03574402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074543|NCT03574402|Immunologic Factors|immunologic factors|mesh-ancestor
44074544|NCT03574402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074545|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44074546|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44074547|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074556|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074558|NCT03539302|Flecainide|flecainide|mesh-list
44074559|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44074560|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44074561|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44074562|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074563|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074564|NCT03534453|Olaparib|olaparib|mesh-list
44074565|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44074566|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074567|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074568|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074569|NCT03502668|Decitabine|decitabine|mesh-list
44074570|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074571|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
44257780|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257781|NCT00626600|Analgesics|analgesics|mesh-ancestor
44257782|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
44257783|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257784|NCT00626613|Risperidone|risperidone|mesh-list
44257785|NCT00626613|Galantamine|galantamine|mesh-list
44257786|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44257787|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
44257788|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257789|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257790|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257791|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44257792|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257793|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257794|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44257795|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44257796|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
43654635|NCT02974439|Amlodipine|amlodipine|mesh-list
44074572|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074573|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074574|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151399|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151400|NCT00214084|Allopurinol|allopurinol|mesh-list
44151401|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
44151402|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151403|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151404|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
44151405|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151406|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44151407|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
44151408|NCT00214084|Protective Agents|protective agents|mesh-ancestor
44151409|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151410|NCT00214110|Tamoxifen|tamoxifen|mesh-list
44151411|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44151412|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
44151413|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151414|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151415|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44151416|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074580|NCT03496610|Bupivacaine|bupivacaine|mesh-list
44074581|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
44074582|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
44074583|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074584|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074585|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
44074586|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074587|NCT03467373|Prednisone|prednisone|mesh-list
44074588|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
44074589|NCT03467373|Rituximab|rituximab|mesh-list
44074590|NCT03467373|Doxorubicin|doxorubicin|mesh-list
44074591|NCT03467373|Vincristine|vincristine|mesh-list
44074592|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
44074593|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074594|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
43572651|NCT00004106|Temozolomide|temozolomide|mesh-list
44074606|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074607|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074608|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
44074609|NCT03467373|Hormones|hormones|mesh-ancestor
44257797|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44257798|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257799|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
44257800|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44257802|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257803|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
44074610|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074611|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074612|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074614|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074615|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074616|NCT03454035|Palbociclib|palbociclib|mesh-list
44074617|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074618|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074619|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074620|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074621|NCT03440385|Ozanimod|ozanimod|mesh-list
44074622|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44074623|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074624|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074625|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
44074626|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074627|NCT03434262|Gemcitabine|gemcitabine|mesh-list
44074628|NCT03434262|Trametinib|trametinib|mesh-list
44074629|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074630|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
44074631|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074632|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074633|NCT03434262|Antiviral Agents|antiviral agents|mesh-ancestor
44074634|NCT03434262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074635|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074636|NCT03434262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074637|NCT03434262|Immunologic Factors|immunologic factors|mesh-ancestor
44074638|NCT03434262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074639|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074640|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
44074641|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074642|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074643|NCT03357952|Daratumumab|daratumumab|mesh-list
44074644|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074645|NCT03333343|Gefitinib|gefitinib|mesh-list
44074646|NCT03333343|Trametinib|trametinib|mesh-list
44074647|NCT03333343|Nazartinib|nazartinib|mesh-list
44074648|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074649|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074650|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074651|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074652|NCT03330639|Capsaicin|capsaicin|mesh-list
44074653|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
44074654|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
44074655|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
44074656|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43572721|NCT00002371|Lamivudine|lamivudine|mesh-list
44074668|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074670|NCT03272295|Sorbitol|sorbitol|mesh-list
44074671|NCT03272295|Glycerol|glycerol|mesh-list
44074672|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
44074673|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
44074674|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44074675|NCT03272295|Protective Agents|protective agents|mesh-ancestor
44074676|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074677|NCT03272295|Cathartics|cathartics|mesh-ancestor
44074678|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074679|NCT03211741|Bevacizumab|bevacizumab|mesh-list
44074680|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074681|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074682|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44074683|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44257804|NCT00626665|Tadalafil|tadalafil|mesh-list
44257805|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
44257806|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44257807|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44074684|NCT03211741|Growth Substances|growth substances|mesh-ancestor
44074685|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074686|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
44074687|NCT03206203|Carboplatin|carboplatin|mesh-list
44074688|NCT03206203|Atezolizumab|atezolizumab|mesh-list
44074689|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074690|NCT03191786|Gemcitabine|gemcitabine|mesh-list
44074691|NCT03191786|Atezolizumab|atezolizumab|mesh-list
44074692|NCT03191786|Vinorelbine|vinorelbine|mesh-list
44074693|NCT03191786|Antibodies|antibodies|mesh-list
44074694|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44074695|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
44074696|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074697|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074698|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
44074699|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074700|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074701|NCT03191786|Antiviral Agents|antiviral agents|mesh-ancestor
44074702|NCT03191786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074703|NCT03191786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074704|NCT03191786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074705|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074706|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074707|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074708|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074709|NCT03128021|Milnacipran|milnacipran|mesh-list
44074710|NCT03128021|Citalopram|citalopram|mesh-list
44074711|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
44074712|NCT03128021|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44074713|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44074714|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074715|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074716|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074717|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
44074718|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074719|NCT03128021|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44074720|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
44074721|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43572790|NCT03532620|Atorvastatin|atorvastatin|mesh-list
43795376|NCT03885921|Ezetimibe|ezetimibe|mesh-list
44074731|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
44074733|NCT03096782|Rituximab|rituximab|mesh-list
44074734|NCT03096782|Fludarabine|fludarabine|mesh-list
44074735|NCT03096782|Clofarabine|clofarabine|mesh-list
44074736|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44074737|NCT03096782|Tacrolimus|tacrolimus|mesh-list
44074738|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
44074739|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44074740|NCT03096782|Antibodies|antibodies|mesh-list
44074741|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
44074742|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44074743|NCT03096782|Lenograstim|lenograstim|mesh-list
44074744|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074745|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
44074746|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074747|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074748|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074749|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
44074750|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074751|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074752|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074753|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074754|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
44074755|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44074756|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074757|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44074758|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074759|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44074760|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
44074761|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44257808|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257809|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257810|NCT00626665|Urological Agents|urological agents|mesh-ancestor
44257812|NCT00626678|Azathioprine|azathioprine|mesh-list
44257813|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44257814|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
44257815|NCT00626678|Hormones|hormones|mesh-ancestor
44257816|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257817|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257818|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44257819|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257820|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
44257821|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654647|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
44074762|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074763|NCT03094884|Paclitaxel|paclitaxel|mesh-list
44074764|NCT03094884|Carboplatin|carboplatin|mesh-list
44074765|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074766|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074767|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074768|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074769|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074770|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074772|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
44074773|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074774|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
44074775|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074776|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074777|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074778|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
44074779|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074780|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074781|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074782|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074783|NCT03090737|Nivolumab|nivolumab|mesh-list
44074784|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074785|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074786|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44074787|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074788|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44074789|NCT03087071|Panitumumab|panitumumab|mesh-list
44074790|NCT03087071|Trametinib|trametinib|mesh-list
44074806|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074807|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074809|NCT03079440|Temozolomide|temozolomide|mesh-list
44074810|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074811|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
44074812|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074813|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074814|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074815|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
44074816|NCT03079427|Gemcitabine|gemcitabine|mesh-list
44074817|NCT03079427|Cisplatin|cisplatin|mesh-list
44074818|NCT03079427|Capecitabine|capecitabine|mesh-list
44074819|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074820|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44074821|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
44257822|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257823|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257825|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257826|NCT00626717|Riboflavin|riboflavin|mesh-list
44257827|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
44074822|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074823|NCT03079427|Antiviral Agents|antiviral agents|mesh-ancestor
44074824|NCT03079427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074825|NCT03079427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074826|NCT03079427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074827|NCT03079427|Immunologic Factors|immunologic factors|mesh-ancestor
44074828|NCT03079427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074829|NCT03034200|TIC10 compound|tic10 compound|mesh-list
44074830|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074831|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
44074832|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
44074833|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44074834|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44074835|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44074836|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074837|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074838|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074839|NCT03007407|Durvalumab|durvalumab|mesh-list
44074840|NCT03007407|Tremelimumab|tremelimumab|mesh-list
44074841|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074842|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074843|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44074844|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44074845|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
44074846|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074847|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44074848|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074849|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43572916|NCT03531281|Sirolimus|sirolimus|mesh-list
44074873|NCT02909322|Bupivacaine|bupivacaine|mesh-list
44074874|NCT02909322|Ropivacaine|ropivacaine|mesh-list
44074875|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
44074876|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
44074877|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074878|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074879|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
43795514|NCT03415854|Gemcitabine|gemcitabine|mesh-list
44074880|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074881|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44074882|NCT02909322|Narcotics|narcotics|mesh-ancestor
44074883|NCT02909322|Analgesics|analgesics|mesh-ancestor
44074884|NCT02901041|Zonisamide|zonisamide|mesh-list
44074885|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
44074886|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44074887|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074888|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074889|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44074890|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074891|NCT02811133|Inositol|inositol|mesh-list
44074892|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
44074893|NCT02811133|Vitamins|vitamins|mesh-ancestor
44074894|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
44074895|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074896|NCT02762981|Paclitaxel|paclitaxel|mesh-list
44074897|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44074898|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074899|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074900|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074901|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074902|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074903|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257828|NCT00626717|Vitamins|vitamins|mesh-ancestor
44257829|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
44257830|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257831|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44257832|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257833|NCT00626769|Genistein|genistein|mesh-list
44257834|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43825001|NCT05505591|Cangrelor|cangrelor|mesh-list
44074916|NCT02752815|Prednisone|prednisone|mesh-list
44074918|NCT02752815|Rituximab|rituximab|mesh-list
44074919|NCT02752815|Vincristine|vincristine|mesh-list
44074920|NCT02752815|Epirubicin|epirubicin|mesh-list
44074921|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074922|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
44074923|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074924|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074925|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074926|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
44074927|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074928|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074929|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074930|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074931|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074932|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
44074933|NCT02752815|Hormones|hormones|mesh-ancestor
44074934|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074935|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074936|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074937|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074938|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44074939|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44074940|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074941|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44074942|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44074943|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074944|NCT02743455|Vaccines|vaccines|mesh-list
44074945|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
44074946|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074947|NCT02739035|Dexamethasone|dexamethasone|mesh-list
44074948|NCT02739035|Celecoxib|celecoxib|mesh-list
44074949|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074950|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
44074951|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
44074952|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074953|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074954|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074955|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
43795590|NCT03138720|Gemcitabine|gemcitabine|mesh-list
44074956|NCT02739035|Hormones|hormones|mesh-ancestor
43880642|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074957|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074958|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074959|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074960|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44074961|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074962|NCT02739035|Analgesics|analgesics|mesh-ancestor
44074963|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
44074964|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074965|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44074966|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44074967|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074968|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151417|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44151418|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44151419|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44151420|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
44257835|NCT00626769|Protective Agents|protective agents|mesh-ancestor
44257836|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257837|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257838|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44257839|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151421|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44151422|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151423|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
44151424|NCT00214240|Antibodies|antibodies|mesh-list
44151425|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
44151426|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44151427|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44151428|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
44151429|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151430|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44151431|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44151437|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151438|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
44151439|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151440|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151441|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44151442|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44151443|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
44151444|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44151445|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151446|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151447|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151450|NCT00214318|Terbutaline|terbutaline|mesh-list
44151451|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44151452|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44151453|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
44151454|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
44151455|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151456|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151457|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44151458|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44151459|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44151460|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151461|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151462|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151463|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
44151464|NCT00214318|Protective Agents|protective agents|mesh-ancestor
44151465|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44151466|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151467|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44151468|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
44151469|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44151470|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44151471|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151472|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151473|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151474|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
44151475|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
44151476|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44074969|NCT02723994|Leucovorin|leucovorin|mesh-list
44074970|NCT02723994|Cytarabine|cytarabine|mesh-list
44074971|NCT02723994|Dexamethasone|dexamethasone|mesh-list
44074972|NCT02723994|Prednisone|prednisone|mesh-list
44074973|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
44074974|NCT02723994|Doxorubicin|doxorubicin|mesh-list
44074975|NCT02723994|Methotrexate|methotrexate|mesh-list
44074976|NCT02723994|Vincristine|vincristine|mesh-list
44074977|NCT02723994|Asparaginase|asparaginase|mesh-list
44074978|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
44074979|NCT02723994|Pegaspargase|pegaspargase|mesh-list
44074980|NCT02723994|Thioguanine|thioguanine|mesh-list
44074981|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
44074982|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074983|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
44074984|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074985|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074986|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257840|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257841|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
44257842|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44257843|NCT00626769|Estrogens|estrogens|mesh-ancestor
44257844|NCT00626769|Hormones|hormones|mesh-ancestor
44257845|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257846|NCT00626834|Vigabatrin|vigabatrin|mesh-list
44257847|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
44257848|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257849|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074987|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
44074988|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074989|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074990|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074991|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074992|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
44074993|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
44074994|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074995|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074996|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
44075007|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075008|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
44075009|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075010|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44075011|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075012|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
44075013|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075014|NCT02723994|Antidotes|antidotes|mesh-ancestor
44075015|NCT02723994|Protective Agents|protective agents|mesh-ancestor
44075016|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075017|NCT02723994|Vitamins|vitamins|mesh-ancestor
44075018|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
44075019|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075020|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075021|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075022|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075023|NCT02710734|Cisplatin|cisplatin|mesh-list
44075024|NCT02710734|Doxorubicin|doxorubicin|mesh-list
44075025|NCT02710734|Methotrexate|methotrexate|mesh-list
44075026|NCT02710734|Mitomycins|mitomycins|mesh-list
44075027|NCT02710734|Mitomycin|mitomycin|mesh-list
44075028|NCT02710734|Vinblastine|vinblastine|mesh-list
44075029|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075030|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075031|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075032|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075033|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075034|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075035|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44075036|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
44075037|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44075038|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075039|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075040|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
44075041|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075042|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44075043|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075044|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
44075045|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075046|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075047|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
44075048|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075049|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075050|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075051|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075053|NCT02706873|Upadacitinib|upadacitinib|mesh-list
44257851|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257852|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257853|NCT00626977|Clonidine|clonidine|mesh-list
44257854|NCT00626977|Ropivacaine|ropivacaine|mesh-list
44257855|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
44257856|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
44257857|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257858|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257859|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
44257860|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257861|NCT00626977|Analgesics|analgesics|mesh-ancestor
44257862|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44257863|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
44257864|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
43825018|NCT05505461|Antibodies|antibodies|mesh-list
44075054|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44075055|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
44075056|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44075057|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075058|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075059|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
44075060|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075061|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075086|NCT02681302|Nivolumab|nivolumab|mesh-list
44075087|NCT02681302|Ipilimumab|ipilimumab|mesh-list
44075088|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075089|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075090|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44075091|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075092|NCT02647892|Lidocaine|lidocaine|mesh-list
44075093|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
44075094|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
44075095|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075096|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075097|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
44075098|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075099|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44075100|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44075101|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44075102|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075103|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075104|NCT02646683|Vedolizumab|vedolizumab|mesh-list
44075105|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44075106|NCT02627443|Gemcitabine|gemcitabine|mesh-list
44075107|NCT02627443|Carboplatin|carboplatin|mesh-list
44075108|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075109|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075110|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
44075111|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075112|NCT02627443|Antiviral Agents|antiviral agents|mesh-ancestor
44075123|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075124|NCT02621151|Antiviral Agents|antiviral agents|mesh-ancestor
44075125|NCT02621151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075126|NCT02621151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075127|NCT02621151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075128|NCT02621151|Immunologic Factors|immunologic factors|mesh-ancestor
44075129|NCT02621151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075130|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075131|NCT02593175|Paclitaxel|paclitaxel|mesh-list
44257865|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44257866|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44257867|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44257868|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
44257869|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257870|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257871|NCT00626990|Temozolomide|temozolomide|mesh-list
44075132|NCT02593175|Carboplatin|carboplatin|mesh-list
44075133|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44075134|NCT02593175|Panitumumab|panitumumab|mesh-list
44075135|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44075136|NCT02593175|Antibodies|antibodies|mesh-list
44075137|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
44075138|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44075139|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075140|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075141|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075142|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075143|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075144|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075145|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
44075146|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075147|NCT02505893|Sirolimus|sirolimus|mesh-list
44075148|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44075149|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075150|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075151|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075152|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
44075153|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075154|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
44075155|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075156|NCT02491099|Afatinib|afatinib|mesh-list
44075157|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075158|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075159|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075160|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075162|NCT02454933|Osimertinib|osimertinib|mesh-list
44075163|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075164|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075165|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075166|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075167|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075168|NCT02423876|Hydromorphone|hydromorphone|mesh-list
44075169|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075170|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075171|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
44075172|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075173|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44075174|NCT02423876|Narcotics|narcotics|mesh-ancestor
44075175|NCT02423876|Analgesics|analgesics|mesh-ancestor
44075176|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
44075177|NCT02419495|Leucovorin|leucovorin|mesh-list
44075178|NCT02419495|Folic Acid|folic acid|mesh-list
44075179|NCT02419495|Paclitaxel|paclitaxel|mesh-list
44075201|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075202|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075203|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075204|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075205|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075206|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
44075207|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075208|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075209|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075210|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
44075211|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44075212|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075213|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075214|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44257872|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257873|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
44257874|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257875|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257876|NCT00627003|Cabergoline|cabergoline|mesh-list
44257877|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43622377|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257878|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44257879|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
44257880|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
44257881|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44257882|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257883|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257884|NCT00627081|Remifentanil|remifentanil|mesh-list
44257885|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44257886|NCT00627081|Narcotics|narcotics|mesh-ancestor
44257887|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257888|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257889|NCT00627081|Analgesics|analgesics|mesh-ancestor
44257890|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
44257891|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257892|NCT00627133|Levetiracetam|levetiracetam|mesh-list
44257893|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
44075215|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075216|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075217|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44075218|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075219|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
44075220|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075221|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44075222|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44075223|NCT02419495|Antidotes|antidotes|mesh-ancestor
44075224|NCT02419495|Protective Agents|protective agents|mesh-ancestor
44075225|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075227|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
44075228|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44075229|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075230|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44075231|NCT02419495|Hematinics|hematinics|mesh-ancestor
44075232|NCT02399215|Nintedanib|nintedanib|mesh-list
44075233|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075234|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075235|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075236|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075237|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
44075238|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075239|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075243|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44075244|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44075245|NCT02157077|Growth Substances|growth substances|mesh-ancestor
44075246|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075247|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
44075248|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257894|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
44257895|NCT00627354|Prednisone|prednisone|mesh-list
44257896|NCT00627354|Etoposide|etoposide|mesh-list
44257897|NCT00627354|Vinorelbine|vinorelbine|mesh-list
44257898|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
44257899|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44075249|NCT02075840|Crizotinib|crizotinib|mesh-list
44075250|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075251|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075252|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075253|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075254|NCT02013492|Propranolol|propranolol|mesh-list
44075255|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44075256|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44075257|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
44075258|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075259|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075260|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075261|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44075262|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44075263|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
44075264|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44075265|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44075266|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075267|NCT01925131|Prednisone|prednisone|mesh-list
44075268|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
44075269|NCT01925131|Vincristine|vincristine|mesh-list
44075270|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44075271|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075272|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
44075273|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075274|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075275|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075276|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
44075277|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075278|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075279|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44075280|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44075281|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
44075282|NCT01925131|Hormones|hormones|mesh-ancestor
44075283|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44075284|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44075285|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075286|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075287|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075288|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075289|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075290|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075291|NCT01903421|Fentanyl|fentanyl|mesh-list
44075292|NCT01903421|Bupivacaine|bupivacaine|mesh-list
44075293|NCT01903421|Anesthetics|anesthetics|mesh-list
44075294|NCT01903421|Propofol|propofol|mesh-list
44075295|NCT01903421|Sevoflurane|sevoflurane|mesh-list
44075296|NCT01903421|Isoflurane|isoflurane|mesh-list
44075297|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
44075298|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075299|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075300|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
44075301|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075302|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44075303|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44075304|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
44075305|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44075306|NCT01903421|Narcotics|narcotics|mesh-ancestor
44075307|NCT01903421|Analgesics|analgesics|mesh-ancestor
44075308|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44075309|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44075310|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44075312|NCT01902173|Dabrafenib|dabrafenib|mesh-list
44075313|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44075314|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075326|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44257900|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
44257901|NCT00627354|Hormones|hormones|mesh-ancestor
44257902|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44257903|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257904|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825035|NCT05505292|Lifitegrast|lifitegrast|mesh-list
44075327|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075328|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
44075329|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075330|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
44075331|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075332|NCT01878617|Gemcitabine|gemcitabine|mesh-list
44075333|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
44075334|NCT01878617|Cisplatin|cisplatin|mesh-list
44075335|NCT01878617|Vincristine|vincristine|mesh-list
44075336|NCT01878617|Pemetrexed|pemetrexed|mesh-list
44075337|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075338|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
44075339|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075340|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075341|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075342|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
44075343|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075344|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075345|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44075346|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075347|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
44075348|NCT01878617|Antiviral Agents|antiviral agents|mesh-ancestor
44075349|NCT01878617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075350|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075351|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075352|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075353|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075354|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075355|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44075356|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075367|NCT01720407|Imiquimod|imiquimod|mesh-list
44075368|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44075369|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
44075370|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075371|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075372|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
44075373|NCT01682083|Trametinib|trametinib|mesh-list
44075374|NCT01682083|Dabrafenib|dabrafenib|mesh-list
44075375|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075376|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075377|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075378|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075401|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
44075402|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075403|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075404|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075405|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44075406|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075407|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075408|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
44075409|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075410|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
44075411|NCT00063830|Alicaforsen|alicaforsen|mesh-list
44257906|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44257907|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44257908|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44257909|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257910|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257911|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
44257912|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
44257913|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257914|NCT00627354|Analgesics|analgesics|mesh-ancestor
44257915|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
44257916|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44257917|NCT00627432|Gemcitabine|gemcitabine|mesh-list
44257918|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
44257919|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257920|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
43825042|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
44075412|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44075413|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075414|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
44075415|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075416|NCT00063414|Alicaforsen|alicaforsen|mesh-list
44075417|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44075418|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075419|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
44075420|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075422|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
44075423|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075424|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
44075425|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075426|NCT00048113|Alicaforsen|alicaforsen|mesh-list
44075427|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44075428|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075429|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
44075430|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075432|NCT00017407|Carboplatin|carboplatin|mesh-list
44075433|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075434|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075451|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44075452|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44075453|NCT00001832|Analgesics|analgesics|mesh-ancestor
44075454|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
44075455|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075456|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44075457|NCT00008866|Didanosine|didanosine|mesh-list
44075458|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
44075459|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075460|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
44075461|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075462|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075463|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075464|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
44075465|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44075466|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
44075467|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075468|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44075469|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44075470|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44075471|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
44257921|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075472|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
44075473|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075474|NCT00009048|Levodopa|levodopa|mesh-list
44075475|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44075476|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44075477|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
44075478|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075479|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075480|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075481|NCT00009061|Ritonavir|ritonavir|mesh-list
44075482|NCT00009061|Nelfinavir|nelfinavir|mesh-list
44075483|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
44075484|NCT00009061|Lamivudine|lamivudine|mesh-list
44075485|NCT00009061|Abacavir|abacavir|mesh-list
44075486|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44075487|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44075488|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
44075489|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075490|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075491|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44075492|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44075493|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
43573602|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
44075503|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075505|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
44075506|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075507|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44075508|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
44075509|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075510|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44075511|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44075512|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075513|NCT00009191|Sertraline|sertraline|mesh-list
44075514|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
44075515|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075516|NCT00009191|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44075517|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44075518|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075519|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075520|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075521|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
44075522|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075523|NCT00009204|Perphenazine|perphenazine|mesh-list
44075524|NCT00009204|Citalopram|citalopram|mesh-list
44075525|NCT00009204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44075526|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44075527|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075528|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075529|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075530|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
44075531|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650538|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44075532|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44075533|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44075534|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075535|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44075536|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44075537|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075538|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44075539|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
44151477|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151478|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151479|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151480|NCT00214331|Azithromycin|azithromycin|mesh-list
44151481|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
44151482|NCT00214331|Gentamicins|gentamicins|mesh-list
44151483|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44151484|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151485|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44151486|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44151487|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151488|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151489|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257922|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257923|NCT00627432|Antiviral Agents|antiviral agents|mesh-ancestor
44257924|NCT00627432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257925|NCT00627432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257926|NCT00627432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257927|NCT00627432|Immunologic Factors|immunologic factors|mesh-ancestor
44257928|NCT00627432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151490|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44151491|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44151492|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44151493|NCT00214370|Fentanyl|fentanyl|mesh-list
44151503|NCT00214370|Analgesics|analgesics|mesh-ancestor
44151504|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
44151505|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151506|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44151507|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44151508|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
44151509|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151510|NCT00214552|Rabeprazole|rabeprazole|mesh-list
44151511|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44151512|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151513|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44151514|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075541|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
44075542|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
44075543|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
44075544|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075545|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075546|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44075547|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44075548|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44075549|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075550|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075551|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44075552|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
44075553|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075554|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075555|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44075556|NCT00009230|Celecoxib|celecoxib|mesh-list
44075557|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44075558|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44075559|NCT00009230|Analgesics|analgesics|mesh-ancestor
44075560|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
44075561|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075562|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075563|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44075564|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075565|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44075566|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44075567|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075568|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075569|NCT00009555|Testosterone|testosterone|mesh-list
44075570|NCT00009555|Androgens|androgens|mesh-ancestor
44075571|NCT00009555|Hormones|hormones|mesh-ancestor
44075572|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44075573|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075574|NCT00009581|Acetylcholine|acetylcholine|mesh-list
44075575|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
44075576|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44075577|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
44075578|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075579|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075580|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075581|NCT00009620|Phenobarbital|phenobarbital|mesh-list
44075582|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
44075583|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44075584|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075585|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257930|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44257931|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
44257932|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44257933|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257934|NCT00627536|Mitogens|mitogens|mesh-list
44257935|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
44257936|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257937|NCT00627575|Lamotrigine|lamotrigine|mesh-list
44257938|NCT00627575|Phenytoin|phenytoin|mesh-list
44257939|NCT00627575|Atorvastatin|atorvastatin|mesh-list
44257940|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44257941|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44257942|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
44075586|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44075598|NCT00009646|Analgesics|analgesics|mesh-ancestor
44075599|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
44075600|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075601|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075602|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44075603|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075604|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
44075605|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
44075606|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44075607|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44075608|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075609|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075610|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
44075611|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44075612|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
44075613|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44075614|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075615|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44075616|NCT00009672|Morphine|morphine|mesh-list
44075617|NCT00009672|Nortriptyline|nortriptyline|mesh-list
44075618|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44075619|NCT00009672|Narcotics|narcotics|mesh-ancestor
44075620|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075621|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075622|NCT00009672|Analgesics|analgesics|mesh-ancestor
44075623|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
44075624|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075625|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44075626|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
44075627|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075628|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44075629|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44075630|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075631|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075632|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
44075633|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075634|NCT00009698|Aldesleukin|aldesleukin|mesh-list
44075635|NCT00009698|Interleukin-2|interleukin-2|mesh-list
44075636|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075637|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44075638|NCT00009698|Analgesics|analgesics|mesh-ancestor
44075639|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
44075640|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075641|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075642|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44075643|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44075644|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
44075645|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44257943|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257945|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44257946|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44257947|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
44257948|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44257949|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44257950|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44257951|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44257952|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44257953|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44257954|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44257955|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075646|NCT00009750|Cyclosporine|cyclosporine|mesh-list
44075647|NCT00009750|Paclitaxel|paclitaxel|mesh-list
44075648|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44075649|NCT00009750|Antibodies|antibodies|mesh-list
44075654|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075655|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075656|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075657|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075658|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075659|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
44075660|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075661|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075662|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075663|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
44075664|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075665|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075666|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075667|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44075668|NCT00009763|Cyclosporine|cyclosporine|mesh-list
44075669|NCT00009763|Paclitaxel|paclitaxel|mesh-list
44075670|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44075671|NCT00009763|Antibodies|antibodies|mesh-list
44075672|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
44075673|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44075674|NCT00009763|Cyclosporins|cyclosporins|mesh-list
43650543|NCT03013400|Analgesics|analgesics|mesh-ancestor
43541293|NCT05577637|Tacrolimus|tacrolimus|mesh-list
44075675|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075676|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075677|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075678|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075679|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075680|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075681|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
44075682|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075683|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075684|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075685|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
44075686|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075687|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075688|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075689|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44075690|NCT00009776|Cyclosporine|cyclosporine|mesh-list
44075691|NCT00009776|Paclitaxel|paclitaxel|mesh-list
44075692|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44075693|NCT00009776|Antibodies|antibodies|mesh-list
44075694|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
44075695|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44075696|NCT00009776|Cyclosporins|cyclosporins|mesh-list
44075697|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075698|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257956|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44257957|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43654681|NCT02974361|Ibuprofen|ibuprofen|mesh-list
44075699|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075700|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075701|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075702|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075703|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
44075704|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075705|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075706|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075707|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
44075708|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075709|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075710|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075711|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44075712|NCT00009802|Calcitriol|calcitriol|mesh-list
44075713|NCT00009802|Paclitaxel|paclitaxel|mesh-list
44075714|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075715|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075716|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075717|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075718|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075719|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075720|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075721|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075722|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44075746|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075747|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
44075748|NCT00009828|Leucovorin|leucovorin|mesh-list
44075749|NCT00009828|Paclitaxel|paclitaxel|mesh-list
44075750|NCT00009828|Tegafur|tegafur|mesh-list
44075751|NCT00009828|Calcium|calcium|mesh-list
44075752|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
44075753|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43622430|NCT03108326|Infliximab|infliximab|mesh-list
44075754|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075755|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075756|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075757|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075758|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075759|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075760|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075761|NCT00009828|Antidotes|antidotes|mesh-ancestor
44075762|NCT00009828|Protective Agents|protective agents|mesh-ancestor
44075763|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075764|NCT00009828|Vitamins|vitamins|mesh-ancestor
44075765|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
44075766|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075767|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
44075768|NCT00009841|Mitogens|mitogens|mesh-list
44075769|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075770|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075771|NCT00009854|Ethanol|ethanol|mesh-list
44075772|NCT00009854|Carmustine|carmustine|mesh-list
44075773|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44075774|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075775|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075776|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075777|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075779|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075781|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
44075782|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075783|NCT00009880|Paclitaxel|paclitaxel|mesh-list
44075784|NCT00009880|Cisplatin|cisplatin|mesh-list
44075785|NCT00009880|Fluorouracil|fluorouracil|mesh-list
44075786|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075787|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075788|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075789|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075790|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075791|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075792|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
44075793|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257958|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44257959|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44257960|NCT00627653|Fenofibrate|fenofibrate|mesh-list
44257961|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44257962|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
44075794|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075795|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
44075796|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075797|NCT00009893|Leucovorin|leucovorin|mesh-list
44075798|NCT00009893|Gemcitabine|gemcitabine|mesh-list
44075799|NCT00009893|Fluorouracil|fluorouracil|mesh-list
44075800|NCT00009893|Calcium|calcium|mesh-list
44075801|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
44075802|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075803|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
44075804|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075805|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075806|NCT00009893|Antiviral Agents|antiviral agents|mesh-ancestor
44075807|NCT00009893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075808|NCT00009893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075809|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075810|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
44075811|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075812|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075813|NCT00009893|Antidotes|antidotes|mesh-ancestor
44075814|NCT00009893|Protective Agents|protective agents|mesh-ancestor
44075815|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075816|NCT00009893|Vitamins|vitamins|mesh-ancestor
44075817|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
44075818|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
44075819|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075820|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075821|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075822|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075823|NCT00009919|Semaxinib|semaxinib|mesh-list
44075824|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44075825|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44075826|NCT00009919|Growth Substances|growth substances|mesh-ancestor
44075827|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075828|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
44075829|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075830|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075831|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075832|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075833|NCT00009932|Paclitaxel|paclitaxel|mesh-list
44075834|NCT00009932|Cisplatin|cisplatin|mesh-list
44075835|NCT00009932|Fenretinide|fenretinide|mesh-list
44075836|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075837|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075838|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075839|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075840|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075841|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075842|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44075843|NCT00009932|Protective Agents|protective agents|mesh-ancestor
44075844|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075845|NCT00009958|Metronidazole|metronidazole|mesh-list
44075847|NCT00009958|Sargramostim|sargramostim|mesh-list
44075848|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
44075849|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075850|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075851|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44075852|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44075853|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44075856|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44075857|NCT00009971|Protective Agents|protective agents|mesh-ancestor
44075858|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075859|NCT00009984|Thalidomide|thalidomide|mesh-list
44075860|NCT00009984|Fludarabine|fludarabine|mesh-list
44075861|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
44075862|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257963|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257964|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44257965|NCT00627666|Leucovorin|leucovorin|mesh-list
44257966|NCT00627666|Methotrexate|methotrexate|mesh-list
44257967|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
44257968|NCT00627666|Fludarabine|fludarabine|mesh-list
44075863|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075864|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
44075865|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075866|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075867|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
44075868|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075869|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
44075870|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44075871|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075872|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44075873|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44075874|NCT00009984|Growth Substances|growth substances|mesh-ancestor
44075875|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44075876|NCT00009997|Tamoxifen|tamoxifen|mesh-list
44075877|NCT00009997|Paclitaxel|paclitaxel|mesh-list
44075878|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
44075879|NCT00009997|Doxorubicin|doxorubicin|mesh-list
44075880|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44075881|NCT00009997|Trastuzumab|trastuzumab|mesh-list
44075882|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075883|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075884|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075885|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075886|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075887|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075888|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075889|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
44075890|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075891|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075892|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075893|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
44075894|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44075895|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075896|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075897|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075898|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075899|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075900|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44075901|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
44075902|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44075903|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44075904|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44075905|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44075906|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44075907|NCT00010010|Exemestane|exemestane|mesh-list
44075908|NCT00010010|Goserelin|goserelin|mesh-list
44075909|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075910|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44075911|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44075912|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075913|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075914|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44075915|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44075916|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44075917|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075918|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44075919|NCT00010023|Cisplatin|cisplatin|mesh-list
44075920|NCT00010023|Capecitabine|capecitabine|mesh-list
44075921|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075922|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075923|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
44075924|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257969|NCT00627666|Busulfan|busulfan|mesh-list
44257970|NCT00627666|Calcium|calcium|mesh-list
44257971|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44257972|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
44257973|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075925|NCT00010036|Carboplatin|carboplatin|mesh-list
44075926|NCT00010036|Irinotecan|irinotecan|mesh-list
44075928|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44075929|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075930|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075931|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075932|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
44075933|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075934|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075935|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075936|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075937|NCT00010062|Fluorouracil|fluorouracil|mesh-list
44075938|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
44075939|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075940|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075941|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075942|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075943|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
44075944|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075945|NCT00010075|Leucovorin|leucovorin|mesh-list
44075946|NCT00010075|Fluorouracil|fluorouracil|mesh-list
44075947|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
44075948|NCT00010075|Calcium|calcium|mesh-list
44075949|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
44075950|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075951|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075952|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
44075953|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075954|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075955|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075956|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075957|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
44075958|NCT00010075|Antidotes|antidotes|mesh-ancestor
44075959|NCT00010075|Protective Agents|protective agents|mesh-ancestor
44075960|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075961|NCT00010075|Vitamins|vitamins|mesh-ancestor
44075962|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
44075963|NCT00010075|Analgesics|analgesics|mesh-ancestor
44075964|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
44075965|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075966|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075967|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075968|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075969|NCT00010088|Leucovorin|leucovorin|mesh-list
44075970|NCT00010088|Gemcitabine|gemcitabine|mesh-list
44075971|NCT00010088|Fluorouracil|fluorouracil|mesh-list
44075972|NCT00010088|Calcium|calcium|mesh-list
44075973|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
44075974|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075975|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
44075976|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075977|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075978|NCT00010088|Antiviral Agents|antiviral agents|mesh-ancestor
44075979|NCT00010088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075980|NCT00010088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075981|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075982|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
44075983|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075984|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075985|NCT00010088|Antidotes|antidotes|mesh-ancestor
44075986|NCT00010088|Protective Agents|protective agents|mesh-ancestor
44075987|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075988|NCT00010088|Vitamins|vitamins|mesh-ancestor
44075989|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
44075990|NCT00010140|Tamoxifen|tamoxifen|mesh-list
44075991|NCT00010140|Docetaxel|docetaxel|mesh-list
44075992|NCT00010140|Epirubicin|epirubicin|mesh-list
44075993|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257975|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44257976|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
44257977|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44257978|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44257979|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
44257980|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44257981|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44257982|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
44257983|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075994|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075995|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075996|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075997|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075998|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075999|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44076000|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076001|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076002|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44076003|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076013|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44076014|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44076015|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076016|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076017|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076018|NCT00010166|Gemcitabine|gemcitabine|mesh-list
44076019|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076020|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
44076021|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076022|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076023|NCT00010166|Antiviral Agents|antiviral agents|mesh-ancestor
44076024|NCT00010166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076025|NCT00010166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076026|NCT00010166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076027|NCT00010166|Immunologic Factors|immunologic factors|mesh-ancestor
44076028|NCT00010166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076029|NCT00010179|Lurtotecan|lurtotecan|mesh-list
44076030|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076031|NCT00010192|Aldesleukin|aldesleukin|mesh-list
44076032|NCT00010192|Rituximab|rituximab|mesh-list
44076033|NCT00010192|Interleukin-2|interleukin-2|mesh-list
44076034|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44076035|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076036|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
44076037|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076038|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076039|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44076040|NCT00010192|Analgesics|analgesics|mesh-ancestor
44076041|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
44076042|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076043|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076044|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076045|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
44076046|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076047|NCT00010231|Calcitriol|calcitriol|mesh-list
44076048|NCT00010231|Dexamethasone|dexamethasone|mesh-list
44076049|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076050|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
44076051|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
44076052|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076053|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076054|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43796492|NCT05066516|Hormones|hormones|mesh-ancestor
44076055|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
44257984|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44257985|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257986|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
44257987|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44257988|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44257989|NCT00627666|Antidotes|antidotes|mesh-ancestor
44257990|NCT00627666|Protective Agents|protective agents|mesh-ancestor
44257991|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
44257992|NCT00627666|Vitamins|vitamins|mesh-ancestor
44257993|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
44076056|NCT00010231|Hormones|hormones|mesh-ancestor
44076057|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076058|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076059|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076060|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44076061|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44076062|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076063|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076064|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44076065|NCT00010231|Vitamins|vitamins|mesh-ancestor
44076066|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
44076068|NCT00010270|Immunotoxins|immunotoxins|mesh-list
44076069|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
44076070|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076071|NCT00010283|Beclomethasone|beclomethasone|mesh-list
44076072|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076073|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
44076074|NCT00010283|Hormones|hormones|mesh-ancestor
44076075|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076076|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076077|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44076078|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44076079|NCT00010322|Toremifene|toremifene|mesh-list
44076080|NCT00010322|Atamestane|atamestane|mesh-list
44076081|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076082|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076083|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44076084|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44076085|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076086|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076087|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076088|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44076089|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076090|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076091|NCT00010361|Cyclosporine|cyclosporine|mesh-list
44076092|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
44076093|NCT00010361|Fludarabine|fludarabine|mesh-list
44076094|NCT00010361|Cyclosporins|cyclosporins|mesh-list
44076095|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076096|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076097|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076098|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
44076099|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076100|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076101|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
44076102|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076103|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076104|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076105|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44076106|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076107|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44076108|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
44076109|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44076110|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
44076111|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44257994|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
44257995|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44257996|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44257998|NCT00627692|Laxatives|laxatives|mesh-ancestor
44257999|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258000|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44258001|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44258002|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
44258003|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076112|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
44076113|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076114|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076115|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076116|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
44076117|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076118|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076119|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076120|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
44076121|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076122|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
44076123|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076124|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076125|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076126|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
44076127|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076128|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076129|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076130|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
44076131|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076132|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
44076133|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076134|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076135|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076136|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
44076137|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076138|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076141|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44076142|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076143|NCT00010452|Picibanil|picibanil|mesh-list
44076144|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076145|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
44076146|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44076147|NCT00010686|Estrogens|estrogens|mesh-ancestor
44076149|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076150|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076151|NCT00010699|Vitamin E|vitamin e|mesh-list
44076152|NCT00010699|Vitamins|vitamins|mesh-ancestor
44076153|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
44076154|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076155|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
44076156|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076157|NCT00010699|Protective Agents|protective agents|mesh-ancestor
44076158|NCT00010725|Vitamins|vitamins|mesh-list
44076159|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
44076160|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076161|NCT00010842|Vitamin E|vitamin e|mesh-list
44076162|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
44076163|NCT00010842|Selenium|selenium|mesh-list
44076164|NCT00010842|Vitamins|vitamins|mesh-ancestor
44076165|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
44076166|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076167|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
44076168|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076169|NCT00010842|Protective Agents|protective agents|mesh-ancestor
44076170|NCT00010842|Trace Elements|trace elements|mesh-ancestor
44076171|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
44258004|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258005|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258006|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
44258007|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44258008|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44258009|NCT00627731|Prednisolone|prednisolone|mesh-list
44258010|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
44258011|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44258012|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
44258013|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258014|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
44258015|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
44076172|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44076173|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076174|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076175|NCT00010881|Antioxidants|antioxidants|mesh-list
44076176|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076177|NCT00010881|Protective Agents|protective agents|mesh-ancestor
44076178|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151515|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151517|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151518|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151519|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44151520|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44151521|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151522|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151523|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44151524|NCT00214604|Pravastatin|pravastatin|mesh-list
44151525|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44151526|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44151527|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
44151528|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151529|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44151530|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44151531|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151532|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44151533|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44151534|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44151535|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
44151536|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151537|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44151538|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44151539|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151540|NCT00214630|Atorvastatin|atorvastatin|mesh-list
44151541|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44151542|NCT00214630|Calcium|calcium|mesh-list
44151543|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44151544|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151545|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44151546|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44151547|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
44151548|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151549|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44151550|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44151551|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151552|NCT00214643|Clindamycin|clindamycin|mesh-list
44151553|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
44151554|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
44151555|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
44076179|NCT00011076|Pirfenidone|pirfenidone|mesh-list
44076180|NCT00011076|Analgesics|analgesics|mesh-ancestor
44076181|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
44258016|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258017|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258018|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258019|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
44076182|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076183|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076184|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44076185|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44076186|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076187|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076188|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076189|NCT00011089|Tenofovir|tenofovir|mesh-list
44076190|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
44076191|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076192|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44076193|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076194|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076195|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076196|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076197|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076198|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44076199|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
44076200|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076201|NCT00011297|Gabapentin|gabapentin|mesh-list
44076202|NCT00011297|Lorazepam|lorazepam|mesh-list
44076203|NCT00011297|Analgesics|analgesics|mesh-ancestor
44076204|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
44076205|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076206|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076207|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
44076208|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44076209|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44076210|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076211|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076212|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44076213|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44076214|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076215|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076216|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
44076217|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
44076218|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
44076219|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44076220|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44076221|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
44076222|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
44076223|NCT00011362|Dexamethasone|dexamethasone|mesh-list
44076224|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
44076225|NCT00011362|BB 1101|bb 1101|mesh-list
44076226|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076227|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
44076228|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
44076229|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076230|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076231|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44076232|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
44076233|NCT00011362|Hormones|hormones|mesh-ancestor
44076234|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076235|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076236|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076237|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
44076238|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076239|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076240|NCT00011375|Rolipram|rolipram|mesh-list
44076241|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076242|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076243|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44076244|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44076245|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076246|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076247|NCT00011479|Abacavir|abacavir|mesh-list
44076248|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44258020|NCT00627731|Hormones|hormones|mesh-ancestor
44258021|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258022|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44258023|NCT00627731|Protective Agents|protective agents|mesh-ancestor
44258024|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258025|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461640|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461641|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
44461642|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
44461643|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44461644|NCT01543204|Etanercept|etanercept|mesh-list
44461645|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461646|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461647|NCT01543204|Analgesics|analgesics|mesh-ancestor
44461648|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
43654696|NCT02974348|Lumefantrine|lumefantrine|mesh-list
44076249|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076250|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076251|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076253|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076254|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076255|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076257|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
44076258|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076259|NCT00011635|Protective Agents|protective agents|mesh-ancestor
44076260|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076261|NCT00011765|Fluoxetine|fluoxetine|mesh-list
44076262|NCT00011765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44076263|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44076264|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076265|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076266|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076267|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
44076268|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076269|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44076270|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076271|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076272|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44076273|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076274|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076275|NCT00011778|Bortezomib|bortezomib|mesh-list
44076276|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076277|NCT00011804|Topiramate|topiramate|mesh-list
44076278|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
44076279|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44076280|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076281|NCT00011895|Lamivudine|lamivudine|mesh-list
44076282|NCT00011895|Zidovudine|zidovudine|mesh-list
44076283|NCT00011895|Efavirenz|efavirenz|mesh-list
44076284|NCT00011895|Abacavir|abacavir|mesh-list
44076285|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44076286|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076287|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076288|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076289|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
44076290|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076291|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076292|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44461649|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461650|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461651|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076293|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
44076294|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44076295|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076296|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44076297|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44076298|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44076299|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44076300|NCT00011908|Epratuzumab|epratuzumab|mesh-list
44076301|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44076302|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076304|NCT00011921|Etoposide|etoposide|mesh-list
44076305|NCT00011921|Carboplatin|carboplatin|mesh-list
44076306|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
44076307|NCT00011921|Epirubicin|epirubicin|mesh-list
44076308|NCT00011921|Ifosfamide|ifosfamide|mesh-list
44076309|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076310|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076311|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076312|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076313|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076314|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076315|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44076316|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076317|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076318|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076319|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076320|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
44076321|NCT00011934|Interferons|interferons|mesh-list
44076322|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
44076323|NCT00011934|Sargramostim|sargramostim|mesh-list
43574480|NCT03516500|Hematinics|hematinics|mesh-ancestor
44076344|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076345|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076346|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076347|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076348|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076349|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076350|NCT00012025|Fulvestrant|fulvestrant|mesh-list
44076351|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076352|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076353|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44076354|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44076355|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076356|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076357|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076358|NCT00012038|Irofulven|irofulven|mesh-list
44076359|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076360|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
44076361|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076362|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076363|NCT00012051|Cytarabine|cytarabine|mesh-list
44076364|NCT00012051|Dexamethasone|dexamethasone|mesh-list
44076365|NCT00012051|Rituximab|rituximab|mesh-list
44076366|NCT00012051|Cisplatin|cisplatin|mesh-list
44076367|NCT00012051|Methotrexate|methotrexate|mesh-list
44076368|NCT00012051|Etoposide|etoposide|mesh-list
44076369|NCT00012051|Melphalan|melphalan|mesh-list
44076370|NCT00012051|Ifosfamide|ifosfamide|mesh-list
44076371|NCT00012051|Carmustine|carmustine|mesh-list
44076372|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44076373|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076374|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
44076375|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076376|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076377|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076378|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
44076379|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
44076380|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076381|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461653|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461654|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461655|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
44461656|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
44461657|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461658|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
44461659|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461660|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461661|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461662|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
44461663|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076382|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
44076383|NCT00012051|Hormones|hormones|mesh-ancestor
44076384|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076385|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076386|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44076387|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
44076388|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44076389|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076390|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
44076391|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076392|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076393|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076394|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44076395|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076396|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076397|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076398|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44076399|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076400|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
44076401|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076402|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076403|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
44076404|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076405|NCT00012090|Goserelin|goserelin|mesh-list
43796765|NCT05059418|Clonazepam|clonazepam|mesh-list
44076407|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076408|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076409|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
44076410|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076411|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076412|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076413|NCT00012103|Dimercaprol|dimercaprol|mesh-list
44076414|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
44076415|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
44076416|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076417|NCT00012116|Temozolomide|temozolomide|mesh-list
44076418|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076419|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
44076420|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076421|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076422|NCT00012129|Annamycin|annamycin|mesh-list
44076423|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076424|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076425|NCT00012142|Sirolimus|sirolimus|mesh-list
44076426|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44076427|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076428|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076429|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076430|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
44461664|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461665|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44461666|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
44461667|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
44461668|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461669|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
44461670|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44076431|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076432|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
44076433|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076434|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44076435|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44076436|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076437|NCT00012181|Alvocidib|alvocidib|mesh-list
44076438|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076439|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
44076440|NCT00012181|Growth Substances|growth substances|mesh-ancestor
44076441|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076442|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076443|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076444|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076445|NCT00012194|Cisplatin|cisplatin|mesh-list
44076446|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44076447|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076448|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076449|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076450|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076451|NCT00012207|Aldesleukin|aldesleukin|mesh-list
44076452|NCT00012207|Prednisone|prednisone|mesh-list
44076453|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
44076454|NCT00012207|Vincristine|vincristine|mesh-list
44076455|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076458|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076459|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076460|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
44076461|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076462|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076463|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076464|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076465|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
44076466|NCT00012207|Hormones|hormones|mesh-ancestor
44076467|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076468|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076469|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076470|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076471|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076472|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076473|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076474|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076475|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
44076476|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076477|NCT00012220|Gemcitabine|gemcitabine|mesh-list
44076478|NCT00012220|Cisplatin|cisplatin|mesh-list
44076479|NCT00012220|Docetaxel|docetaxel|mesh-list
44076480|NCT00012220|Irinotecan|irinotecan|mesh-list
44076481|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076482|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076484|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076485|NCT00012220|Antiviral Agents|antiviral agents|mesh-ancestor
44076486|NCT00012220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076487|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076488|NCT00012220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076489|NCT00012220|Immunologic Factors|immunologic factors|mesh-ancestor
44076490|NCT00012220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076491|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076492|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076493|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076494|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44076495|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076496|NCT00012246|Sargramostim|sargramostim|mesh-list
44461671|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461672|NCT01541930|Metronidazole|metronidazole|mesh-list
44461673|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461674|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461675|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44461676|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44461677|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44461678|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44461679|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44461680|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076497|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
44076498|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
44076499|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076500|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44076501|NCT00012259|Troxacitabine|troxacitabine|mesh-list
44076502|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076503|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076504|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076505|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
44076506|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076507|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
44076508|NCT00012311|Ifosfamide|ifosfamide|mesh-list
44076509|NCT00012311|Thiotepa|thiotepa|mesh-list
44076510|NCT00012311|Carboplatin|carboplatin|mesh-list
44076511|NCT00012311|Docetaxel|docetaxel|mesh-list
44076512|NCT00012311|Doxorubicin|doxorubicin|mesh-list
44076513|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44076514|NCT00012311|Fluorouracil|fluorouracil|mesh-list
44076515|NCT00012311|Methotrexate|methotrexate|mesh-list
44076516|NCT00012311|Etoposide|etoposide|mesh-list
44076517|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076518|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
44076519|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076520|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076521|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076522|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
44076523|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076524|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076525|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076526|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076527|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076528|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076529|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076530|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44076531|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076532|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076538|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076539|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44076540|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076541|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076543|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44076544|NCT00012324|Nolatrexed|nolatrexed|mesh-list
44076545|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076546|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076547|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44076548|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076549|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076550|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076551|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076552|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
44076553|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44076554|NCT00012337|Gefitinib|gefitinib|mesh-list
44076555|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076556|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076557|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076558|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076560|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076561|NCT00012363|Gemcitabine|gemcitabine|mesh-list
44461681|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461682|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461683|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44461684|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44258026|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44258027|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44258028|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258029|NCT00627744|Incretins|incretins|mesh-ancestor
44076562|NCT00012363|Irinotecan|irinotecan|mesh-list
44076563|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076564|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
44076565|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076566|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076567|NCT00012363|Antiviral Agents|antiviral agents|mesh-ancestor
44076568|NCT00012363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076569|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076570|NCT00012363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076571|NCT00012363|Immunologic Factors|immunologic factors|mesh-ancestor
44076572|NCT00012363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076573|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44076574|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076575|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
44076576|NCT00012376|Sargramostim|sargramostim|mesh-list
44076577|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
44076578|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076579|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076580|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44076581|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
44076582|NCT00012389|Irinotecan|irinotecan|mesh-list
44076583|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076584|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44076585|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44076586|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076587|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076588|NCT00012467|Interferons|interferons|mesh-list
44076589|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
44076590|NCT00012467|Itraconazole|itraconazole|mesh-list
44076591|NCT00012467|Fluconazole|fluconazole|mesh-list
44076592|NCT00012467|Amphotericin B|amphotericin b|mesh-list
44076593|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44076594|NCT00012467|Flucytosine|flucytosine|mesh-list
44076595|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076596|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
44076597|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076598|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
44076599|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44076600|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076601|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076602|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076603|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44076625|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076626|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
44076628|NCT00012519|Indinavir|indinavir|mesh-list
44076629|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44076630|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44076631|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44076632|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076633|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076634|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076635|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076636|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
44076637|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076638|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44076639|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076640|NCT00012558|Inositol|inositol|mesh-list
44076641|NCT00012558|Lamotrigine|lamotrigine|mesh-list
44076642|NCT00012558|Valproic Acid|valproic acid|mesh-list
44258030|NCT00627744|Hormones|hormones|mesh-ancestor
44258031|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258032|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44258033|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
44258034|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258035|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076643|NCT00012558|Risperidone|risperidone|mesh-list
44076644|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
44076645|NCT00012558|Bupropion|bupropion|mesh-list
44076646|NCT00012558|Paroxetine|paroxetine|mesh-list
44076647|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44076648|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
44076649|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076650|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076651|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076652|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44076653|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44076654|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076657|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
44076658|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44076659|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076660|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44076661|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44076662|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076663|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44076664|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076665|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076666|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
44076667|NCT00012558|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44076669|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44076670|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44076671|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44076672|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
44076673|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44076674|NCT00012558|Vitamins|vitamins|mesh-ancestor
44076675|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
44076676|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44076677|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44076678|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
44076679|NCT00012584|Methylphenidate|methylphenidate|mesh-list
44076680|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44076681|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076682|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44076683|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43542415|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
44076684|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076685|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076686|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
44076687|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076688|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44076689|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44076690|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076691|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076692|NCT00012584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44076693|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
44076694|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44076695|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076696|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44076697|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076698|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076699|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44151556|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44151557|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151558|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44151559|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151560|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258036|NCT00627796|Lanreotide|lanreotide|mesh-list
44258037|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258038|NCT00627809|Streptokinase|streptokinase|mesh-list
44151561|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
44151562|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
44076700|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
44076701|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44076702|NCT00012688|Doxycycline|doxycycline|mesh-list
44076703|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44076704|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076705|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
44076706|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076707|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44076708|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
44076709|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44076710|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44076711|NCT00012857|Acetaminophen|acetaminophen|mesh-list
44076712|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44076713|NCT00012857|Analgesics|analgesics|mesh-ancestor
44076714|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
44076715|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076716|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076717|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
44076718|NCT00012909|Hormones|hormones|mesh-list
44076719|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076720|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076723|NCT00013520|Efavirenz|efavirenz|mesh-list
44076724|NCT00013520|Nevirapine|nevirapine|mesh-list
44076725|NCT00013520|Abacavir|abacavir|mesh-list
44076726|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
44076727|NCT00013520|Didanosine|didanosine|mesh-list
44076728|NCT00013520|Stavudine|stavudine|mesh-list
44076729|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44076730|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44076731|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44076732|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076733|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076734|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076735|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
44076736|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076737|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076738|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076739|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
44076740|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44076741|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44076742|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44076743|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44076744|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44076745|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44076746|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44076747|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44076748|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
44076749|NCT00013585|Selegiline|selegiline|mesh-list
44076750|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076751|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076752|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44076753|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44076754|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44076755|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076756|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076757|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44076758|NCT00013585|Protective Agents|protective agents|mesh-ancestor
44076759|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076760|NCT00013598|Pioglitazone|pioglitazone|mesh-list
44076761|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44076762|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076763|NCT00013624|Levodopa|levodopa|mesh-list
44076764|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44076765|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44076766|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
44076767|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076768|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076769|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076770|NCT00013663|Aldesleukin|aldesleukin|mesh-list
44076771|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258039|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44258040|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44258041|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258042|NCT00627835|Cisplatin|cisplatin|mesh-list
44258043|NCT00627835|Sorafenib|sorafenib|mesh-list
44076772|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076773|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076774|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
43797050|NCT05052359|Coagulants|coagulants|mesh-ancestor
44076775|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076776|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
44076777|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
44076778|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44076779|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
44076780|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44076781|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44076782|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076783|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44076784|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076785|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076786|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44076787|NCT00013689|Renal Agents|renal agents|mesh-ancestor
44076788|NCT00013702|Adefovir|adefovir|mesh-list
44076789|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
44076790|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076791|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44076792|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076793|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076794|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076795|NCT00013871|Vaccines|vaccines|mesh-list
44076796|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44076797|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
44076798|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076799|NCT00013962|Vitamin D|vitamin d|mesh-list
44076800|NCT00013962|Vitamins|vitamins|mesh-ancestor
44076801|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
44076802|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076803|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44151563|NCT00214682|Vitamins|vitamins|mesh-ancestor
44151564|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
44151565|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151566|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
44151567|NCT00214682|Hematinics|hematinics|mesh-ancestor
44151568|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
44151569|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44151570|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
44151571|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44151572|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44151573|NCT00214825|Eplerenone|eplerenone|mesh-list
44151574|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44151575|NCT00214825|Diuretics|diuretics|mesh-ancestor
44151576|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
44151577|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151578|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44151579|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151580|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151581|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44151582|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
44151583|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151584|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44151585|NCT00214864|Docetaxel|docetaxel|mesh-list
44151586|NCT00214864|Capecitabine|capecitabine|mesh-list
44151587|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151588|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151589|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151590|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151591|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151592|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151593|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
44151594|NCT00214877|Methylene Blue|methylene blue|mesh-list
44151595|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258044|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258045|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44258046|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258047|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258048|NCT00627848|Rivastigmine|rivastigmine|mesh-list
44258049|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44258050|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258051|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151596|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151597|NCT00214942|Fentanyl|fentanyl|mesh-list
44151598|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44151599|NCT00214942|Narcotics|narcotics|mesh-ancestor
44151600|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151601|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151602|NCT00214942|Analgesics|analgesics|mesh-ancestor
44151603|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
44151604|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151605|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44151606|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44151607|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
44151608|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
44151609|NCT00214955|Fentanyl|fentanyl|mesh-list
44151610|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44151611|NCT00214955|Narcotics|narcotics|mesh-ancestor
44076804|NCT00014001|Olanzapine|olanzapine|mesh-list
44076805|NCT00014001|Risperidone|risperidone|mesh-list
44076806|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44076807|NCT00014001|Ziprasidone|ziprasidone|mesh-list
44076808|NCT00014001|Clozapine|clozapine|mesh-list
44076809|NCT00014001|Perphenazine|perphenazine|mesh-list
44076810|NCT00014001|Fluphenazine|fluphenazine|mesh-list
44076811|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
44076812|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44076813|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44076814|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
44076815|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076816|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076817|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076818|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44076819|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44076820|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44076821|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076822|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44076823|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
44076830|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076831|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
44076832|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
44076833|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
44076834|NCT00014014|Lamivudine|lamivudine|mesh-list
44076835|NCT00014014|Zidovudine|zidovudine|mesh-list
44076836|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44076837|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44076838|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44076839|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076840|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076841|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
44076842|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076843|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076844|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076845|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
44076846|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
44076847|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44076848|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
44076849|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076850|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076851|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44076852|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
44076853|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44076854|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
44258052|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
44258053|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258054|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258055|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44258056|NCT00627848|Protective Agents|protective agents|mesh-ancestor
44258057|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44258058|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
44258059|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258060|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258061|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654750|NCT02973958|Ketorolac|ketorolac|mesh-list
44076855|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076856|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076857|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44076858|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
44076859|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
44076860|NCT00014040|Protective Agents|protective agents|mesh-ancestor
44076861|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44076862|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
44076863|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44076864|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076865|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076866|NCT00014092|Interferons|interferons|mesh-list
44076867|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
44076868|NCT00014092|Aldesleukin|aldesleukin|mesh-list
44076869|NCT00014092|Temozolomide|temozolomide|mesh-list
44076870|NCT00014092|Sargramostim|sargramostim|mesh-list
44076871|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076872|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
44076873|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076874|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076875|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
44076876|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076877|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
44076878|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076879|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44076880|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44076881|NCT00014105|Carboplatin|carboplatin|mesh-list
44076882|NCT00014105|Temozolomide|temozolomide|mesh-list
44076883|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076884|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076885|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
44076886|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076887|NCT00014118|Paclitaxel|paclitaxel|mesh-list
44076888|NCT00014118|Carboplatin|carboplatin|mesh-list
44076889|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076890|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076891|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076892|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076893|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076894|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076896|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076897|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076898|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076899|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076900|NCT00014170|Gefitinib|gefitinib|mesh-list
44076901|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076902|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076903|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076904|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076905|NCT00014183|Gefitinib|gefitinib|mesh-list
44076906|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258062|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44258063|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258064|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44076907|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44076908|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076909|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076911|NCT00014196|Docetaxel|docetaxel|mesh-list
44076912|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076913|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076914|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076915|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076916|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076917|NCT00014209|Gemcitabine|gemcitabine|mesh-list
44076918|NCT00014209|Dexamethasone|dexamethasone|mesh-list
44076919|NCT00014209|Cisplatin|cisplatin|mesh-list
44076920|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076921|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
44076922|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
44076923|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076924|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076925|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44076926|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
44076927|NCT00014209|Hormones|hormones|mesh-ancestor
44076928|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076929|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076930|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076931|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076932|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
44076933|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076934|NCT00014209|Antiviral Agents|antiviral agents|mesh-ancestor
44076935|NCT00014209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076936|NCT00014209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076937|NCT00014209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076938|NCT00014209|Immunologic Factors|immunologic factors|mesh-ancestor
44076939|NCT00014235|Cyclosporine|cyclosporine|mesh-list
44076940|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
44076941|NCT00014235|Fludarabine|fludarabine|mesh-list
44076942|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
44076943|NCT00014235|Cyclosporins|cyclosporins|mesh-list
44076944|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076945|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076946|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
44076947|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076948|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076949|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
44076950|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076951|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076952|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
44076953|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076954|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44076955|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44076956|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43797155|NCT05049473|Doxorubicin|doxorubicin|mesh-list
44076957|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44076958|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44076959|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
44076960|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44076961|NCT00014248|Adenosine|adenosine|mesh-list
44076962|NCT00014248|Analgesics|analgesics|mesh-ancestor
44076963|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
44076964|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076965|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076966|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44076967|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
43575163|NCT03509701|Antibodies|antibodies|mesh-list
44076968|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44076970|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
44076971|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44076972|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076973|NCT00014261|Interferons|interferons|mesh-list
44076974|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
44258065|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258066|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44258067|NCT00627900|Sirolimus|sirolimus|mesh-list
44258068|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258069|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258070|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44258071|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258072|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
44258073|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258074|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
44258075|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258076|NCT00627913|Anesthetics|anesthetics|mesh-list
44076975|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
44076976|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44076977|NCT00014261|Temozolomide|temozolomide|mesh-list
44076978|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076979|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
44076980|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076981|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44076982|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
44076983|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076984|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
44076985|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076986|NCT00014274|Gemcitabine|gemcitabine|mesh-list
44076987|NCT00014274|Carboplatin|carboplatin|mesh-list
44076988|NCT00014274|Methotrexate|methotrexate|mesh-list
44076990|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076991|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076992|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
44076993|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076994|NCT00014274|Antiviral Agents|antiviral agents|mesh-ancestor
44076995|NCT00014274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076996|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076997|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44076998|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
44076999|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077000|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44077001|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
44077002|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44077003|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077004|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44077005|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077006|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077007|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077008|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077009|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077010|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077011|NCT00014287|Gemcitabine|gemcitabine|mesh-list
44077012|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077013|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
44077014|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077015|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077016|NCT00014287|Antiviral Agents|antiviral agents|mesh-ancestor
44077017|NCT00014287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077018|NCT00014287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077019|NCT00014287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077020|NCT00014287|Immunologic Factors|immunologic factors|mesh-ancestor
44077021|NCT00014287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077022|NCT00014313|Cisplatin|cisplatin|mesh-list
44077023|NCT00014313|Etoposide|etoposide|mesh-list
44077024|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077025|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077026|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43788166|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44258077|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258078|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258079|NCT00627952|Amlodipine|amlodipine|mesh-list
44258080|NCT00627952|Manidipine|manidipine|mesh-list
44258081|NCT00627952|Delapril|delapril|mesh-list
44258082|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44258083|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44258084|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258085|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258086|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258087|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258088|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
44258089|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44258090|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
44258091|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258092|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
44258093|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258094|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
44258095|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44258096|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44258097|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258098|NCT00627965|Urological Agents|urological agents|mesh-ancestor
44258099|NCT00627991|Valsartan|valsartan|mesh-list
43654771|NCT02973763|Aflutinib|aflutinib|mesh-list
44077027|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077028|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077029|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077030|NCT00014339|Prednisone|prednisone|mesh-list
44077031|NCT00014339|Melphalan|melphalan|mesh-list
44077032|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077033|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
44077034|NCT00014339|Hormones|hormones|mesh-ancestor
44077035|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077036|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077037|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077038|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077039|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077040|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
44077041|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077042|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077048|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44077049|NCT00014352|Estramustine|estramustine|mesh-list
44077050|NCT00014352|Warfarin|warfarin|mesh-list
44077051|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077052|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077053|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077054|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077055|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077056|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43788449|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
44258100|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44258101|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44258102|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44258103|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258104|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
44258105|NCT00628043|Hematinics|hematinics|mesh-ancestor
44258106|NCT00628056|Perhexiline|perhexiline|mesh-list
44258107|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44258108|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258109|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654782|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
44077057|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077058|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077059|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077060|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
44077061|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
44077062|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077063|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44077064|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44077065|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44077066|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
44077067|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077068|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077069|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44077070|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077071|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
44077072|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077073|NCT00014391|Ribavirin|ribavirin|mesh-list
44077074|NCT00014391|Palivizumab|palivizumab|mesh-list
44077075|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
44077076|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077077|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
44077078|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077079|NCT00014404|Celecoxib|celecoxib|mesh-list
44077080|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44077081|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44077082|NCT00014404|Analgesics|analgesics|mesh-ancestor
44077083|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
44077084|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077085|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077086|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077087|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077088|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44077089|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44077090|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077091|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077092|NCT00014430|Trastuzumab|trastuzumab|mesh-list
44077093|NCT00014430|Vinorelbine|vinorelbine|mesh-list
44077094|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44077095|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622578|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
44077096|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077097|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077098|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077099|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077100|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077101|NCT00014456|Gemcitabine|gemcitabine|mesh-list
44077102|NCT00014456|Docetaxel|docetaxel|mesh-list
44077103|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077104|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
44077105|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797311|NCT05047211|Hematinics|hematinics|mesh-ancestor
44258110|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258111|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258112|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
44258113|NCT00628121|Cetrorelix|cetrorelix|mesh-list
44258114|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44258115|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
44258116|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258117|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258118|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
44258119|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258120|NCT00628160|Terlipressin|terlipressin|mesh-list
44258121|NCT00628160|Dopamine|dopamine|mesh-list
44258122|NCT00628160|Norepinephrine|norepinephrine|mesh-list
44258123|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
44258124|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44258125|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44258126|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077106|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077107|NCT00014456|Antiviral Agents|antiviral agents|mesh-ancestor
44077108|NCT00014456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077109|NCT00014456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077110|NCT00014456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077111|NCT00014456|Immunologic Factors|immunologic factors|mesh-ancestor
44077112|NCT00014456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077123|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077124|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077125|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
44077126|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077127|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077128|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077129|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077130|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44077131|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077132|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
44077133|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077134|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077135|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44077136|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077137|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
44077138|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077139|NCT00014508|Cyclosporine|cyclosporine|mesh-list
44077140|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
44077141|NCT00014508|Melphalan|melphalan|mesh-list
44077142|NCT00014508|Fludarabine|fludarabine|mesh-list
44077143|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
44077144|NCT00014508|Cyclosporins|cyclosporins|mesh-list
44077145|NCT00014508|Sargramostim|sargramostim|mesh-list
44077146|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077147|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
44077148|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077149|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077150|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077151|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
44077152|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077153|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077154|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077155|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077156|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
44077157|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258127|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258128|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258129|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
44258130|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
43622584|NCT03107507|Phenobarbital|phenobarbital|mesh-list
44258131|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258132|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44258133|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44258134|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44258135|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
44258136|NCT00628160|Protective Agents|protective agents|mesh-ancestor
44258137|NCT00628225|Bupropion|bupropion|mesh-list
44258138|NCT00628225|Nicotine|nicotine|mesh-list
44258139|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44258140|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
44258141|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258142|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258143|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44077158|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
44077159|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077160|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077161|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44077162|NCT00014534|Gemcitabine|gemcitabine|mesh-list
44077163|NCT00014534|Cisplatin|cisplatin|mesh-list
44077164|NCT00014534|Doxorubicin|doxorubicin|mesh-list
44077165|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44077166|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077167|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077168|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
44077169|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077170|NCT00014534|Antiviral Agents|antiviral agents|mesh-ancestor
44077171|NCT00014534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077172|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077173|NCT00014534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077174|NCT00014534|Immunologic Factors|immunologic factors|mesh-ancestor
44077175|NCT00014534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077176|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077177|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077178|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077179|NCT00014547|BBR 3464|bbr 3464|mesh-list
44077180|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077183|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
44077184|NCT00014573|Cisplatin|cisplatin|mesh-list
44077185|NCT00014573|Carmustine|carmustine|mesh-list
44077186|NCT00014573|Sargramostim|sargramostim|mesh-list
44077187|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077188|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077189|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077190|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077191|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077192|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077193|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077194|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
44077195|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077196|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077197|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077198|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
44077199|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077200|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44077201|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44077202|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
44258144|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44258145|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
44258146|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258147|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258148|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44258149|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
44258150|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622585|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
44077203|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077205|NCT00014586|Bicalutamide|bicalutamide|mesh-list
44077206|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077207|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077208|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
44077209|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
44077210|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077211|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077212|NCT00014599|Paclitaxel|paclitaxel|mesh-list
44077213|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077214|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077215|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077216|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077217|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077218|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077219|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44077220|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077221|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44077222|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077223|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077224|NCT00014638|Letrozole|letrozole|mesh-list
44077225|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077226|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44077227|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44077228|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077229|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077230|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44077231|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
44077232|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077233|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077234|NCT00014651|Vapreotide|vapreotide|mesh-list
44077235|NCT00014651|Analgesics|analgesics|mesh-ancestor
44077236|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
44077237|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077238|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077239|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077240|NCT00014677|Interleukin-4|interleukin-4|mesh-list
44077241|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44077242|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
44077243|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077244|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077245|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077246|NCT00014690|Topotecan|topotecan|mesh-list
44077247|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44077248|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077249|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077250|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077251|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077252|NCT00014729|Isotretinoin|isotretinoin|mesh-list
44077253|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077254|NCT00014755|Prednisone|prednisone|mesh-list
44077269|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077271|NCT00014937|Ritonavir|ritonavir|mesh-list
44077272|NCT00014937|Lopinavir|lopinavir|mesh-list
44077273|NCT00014937|Lamivudine|lamivudine|mesh-list
44077274|NCT00014937|Zidovudine|zidovudine|mesh-list
44077275|NCT00014937|Didanosine|didanosine|mesh-list
44077276|NCT00014937|Stavudine|stavudine|mesh-list
44077277|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44258151|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44258152|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258153|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258155|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44077278|NCT00014937|Efavirenz|efavirenz|mesh-list
44077279|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44077280|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44077281|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
44077282|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077283|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077284|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44077285|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44077286|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
44077287|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077288|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44077289|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44077290|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44077291|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077292|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
44077293|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44077294|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44077295|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44077296|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44077297|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44077298|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
44077299|NCT00014989|Analgesics|analgesics|mesh-ancestor
44077300|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
44077301|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077302|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077303|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
44077304|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077305|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44077306|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
44077307|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44077308|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077309|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077310|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44077311|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
44077312|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44077313|NCT00015028|Buprenorphine|buprenorphine|mesh-list
44077314|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44077315|NCT00015028|Naloxone|naloxone|mesh-list
44077316|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44077317|NCT00015028|Narcotics|narcotics|mesh-ancestor
44077318|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077319|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077320|NCT00015028|Analgesics|analgesics|mesh-ancestor
44077321|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
44077322|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077323|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077324|NCT00015041|Buprenorphine|buprenorphine|mesh-list
44077325|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44077326|NCT00015041|Narcotics|narcotics|mesh-ancestor
44077327|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077328|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077329|NCT00015041|Analgesics|analgesics|mesh-ancestor
44077330|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
44077331|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077332|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077333|NCT00015054|Methylphenidate|methylphenidate|mesh-list
44077334|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44077335|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077336|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44077337|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077338|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106650|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258156|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44258157|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258158|NCT00628238|Rituximab|rituximab|mesh-list
44258159|NCT00628238|Lenalidomide|lenalidomide|mesh-list
44258160|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44258161|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258162|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
44258163|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258164|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258165|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44258166|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44258167|NCT00628238|Growth Substances|growth substances|mesh-ancestor
44258168|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077339|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077340|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
44077341|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077342|NCT00015067|Methylphenidate|methylphenidate|mesh-list
44077343|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44077344|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077345|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44077346|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077347|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077348|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077349|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
44077350|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077352|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44077353|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077354|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077355|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
44077356|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077357|NCT00015106|Lamotrigine|lamotrigine|mesh-list
44077358|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
44077359|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44077360|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077361|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077362|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44077363|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077364|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44077365|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44077366|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077367|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44077368|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44077369|NCT00015132|Sertraline|sertraline|mesh-list
44077370|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
44077371|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44077372|NCT00015132|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44077373|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077374|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077375|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077376|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077377|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
44077378|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077379|NCT00015171|Buprenorphine|buprenorphine|mesh-list
44077380|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44077381|NCT00015171|Naloxone|naloxone|mesh-list
44077382|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44077383|NCT00015171|Narcotics|narcotics|mesh-ancestor
44077384|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077385|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077386|NCT00015171|Analgesics|analgesics|mesh-ancestor
44258169|NCT00628290|Cannabidiol|cannabidiol|mesh-list
44258170|NCT00628290|Amisulpride|amisulpride|mesh-list
44258171|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
44258172|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44258173|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258174|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258175|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077387|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
44077388|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077390|NCT00015210|Nefazodone|nefazodone|mesh-list
44077391|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44077392|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077393|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077394|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077395|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077396|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077397|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44077398|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44077399|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44077400|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44077401|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44077402|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
44077403|NCT00015223|Methylphenidate|methylphenidate|mesh-list
44077404|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44077405|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077406|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44077407|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077408|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077409|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077411|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077412|NCT00015236|Amantadine|amantadine|mesh-list
44077413|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44077414|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44077415|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
44077416|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077417|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
44077418|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077419|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077420|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077421|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44077422|NCT00015236|Analgesics|analgesics|mesh-ancestor
44077423|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
44077424|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077425|NCT00015249|Amantadine|amantadine|mesh-list
44077426|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44077427|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44077428|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
44077429|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077430|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
44077431|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077432|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077433|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077434|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44077435|NCT00015249|Analgesics|analgesics|mesh-ancestor
44077436|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
44077437|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077438|NCT00015275|Cocaine|cocaine|mesh-list
44077439|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
44077440|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
44077441|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077442|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077443|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
44077444|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077445|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44077446|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44077447|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258177|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44258178|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
44258179|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807738|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
44077448|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077449|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077450|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
44077451|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077452|NCT00015288|Buprenorphine|buprenorphine|mesh-list
44077453|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44077454|NCT00015288|Naloxone|naloxone|mesh-list
44077455|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44077456|NCT00015288|Narcotics|narcotics|mesh-ancestor
44077457|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077458|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077459|NCT00015288|Analgesics|analgesics|mesh-ancestor
44077460|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
44077461|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077477|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077478|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077479|NCT00015340|Analgesics|analgesics|mesh-ancestor
44077480|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
44077481|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077482|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077483|NCT00015548|Olanzapine|olanzapine|mesh-list
44077484|NCT00015548|Risperidone|risperidone|mesh-list
44077485|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44077486|NCT00015548|Citalopram|citalopram|mesh-list
44077487|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44077488|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
44077489|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077490|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077491|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077492|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44077493|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44077494|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44077495|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44077496|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44077497|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
44077498|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
44077499|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
44077500|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077501|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44077502|NCT00015548|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44077503|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077504|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077505|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
44077506|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44077507|NCT00015626|Metformin|metformin|mesh-list
44077508|NCT00015626|Pioglitazone|pioglitazone|mesh-list
44077509|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
44077510|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44077511|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077512|NCT00015652|Ribavirin|ribavirin|mesh-list
44077513|NCT00015652|Aldesleukin|aldesleukin|mesh-list
44077514|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44077515|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
44077516|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077517|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
44077518|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077519|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077520|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44077521|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44077522|NCT00015665|Voriconazole|voriconazole|mesh-list
44077523|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
44077524|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077525|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44077526|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44077527|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077528|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258180|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258181|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44258182|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
44258183|NCT00628316|Caffeine|caffeine|mesh-list
44258184|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44258185|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258186|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44077529|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44077530|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
44077531|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077532|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077533|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44077534|NCT00015691|Metformin|metformin|mesh-list
44077535|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
44077536|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44077537|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077538|NCT00015704|Aldesleukin|aldesleukin|mesh-list
44077539|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077540|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44077541|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44077542|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
44077543|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151612|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151613|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151614|NCT00214955|Analgesics|analgesics|mesh-ancestor
44151615|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
44151616|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151617|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44151618|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44151619|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
44151620|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
44077544|NCT00015769|Levetiracetam|levetiracetam|mesh-list
44077545|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
44077546|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
44077547|NCT00015808|Idebenone|idebenone|mesh-list
44077548|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
44077549|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077550|NCT00015808|Protective Agents|protective agents|mesh-ancestor
44077551|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077552|NCT00015821|Thalidomide|thalidomide|mesh-list
44077553|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077554|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
44077555|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077556|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
44077557|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44077558|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077559|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077560|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077561|NCT00015821|Growth Substances|growth substances|mesh-ancestor
44077562|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077563|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077564|NCT00015834|Cytarabine|cytarabine|mesh-list
44077565|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
44077566|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077567|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
44077568|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077569|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077570|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
44077571|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077572|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077573|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
44077574|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077575|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44077576|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077577|NCT00015860|Prednisone|prednisone|mesh-list
44077578|NCT00015860|Vincristine|vincristine|mesh-list
44077579|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
44077580|NCT00015860|Daunorubicin|daunorubicin|mesh-list
44258187|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258188|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258189|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44258190|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44258191|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
44258192|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258193|NCT00628342|Esomeprazole|esomeprazole|mesh-list
44258194|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258195|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44077581|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077582|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
44077583|NCT00015860|Hormones|hormones|mesh-ancestor
44077584|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077585|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077586|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077587|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077588|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077590|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077591|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077592|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077593|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44077594|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077595|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077596|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077597|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077598|NCT00015873|Cytarabine|cytarabine|mesh-list
44077599|NCT00015873|Prednisolone|prednisolone|mesh-list
44077600|NCT00015873|Methotrexate|methotrexate|mesh-list
44077601|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
44077602|NCT00015873|Vincristine|vincristine|mesh-list
44077603|NCT00015873|Asparaginase|asparaginase|mesh-list
44077604|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44077605|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
44077606|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44077607|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077608|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077609|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
44077610|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077611|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077612|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077613|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077614|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44077615|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077616|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
44077617|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077618|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077619|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
44077620|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077621|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077622|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077623|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077624|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077625|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077626|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
44077627|NCT00015873|Hormones|hormones|mesh-ancestor
44077628|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077629|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077630|NCT00015886|Docetaxel|docetaxel|mesh-list
44077631|NCT00015886|Fluorouracil|fluorouracil|mesh-list
44077632|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077633|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077634|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077635|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077636|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077637|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
44258196|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44258197|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258198|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258199|NCT00628459|Micronutrients|micronutrients|mesh-list
44258200|NCT00628459|Trace Elements|trace elements|mesh-list
44258201|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258202|NCT00628550|Vasopressins|vasopressins|mesh-list
44258203|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
44258204|NCT00628550|Epinephrine|epinephrine|mesh-list
44258205|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44077638|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077639|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077640|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
44077641|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077642|NCT00015899|Lonafarnib|lonafarnib|mesh-list
44077643|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077644|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077645|NCT00015912|Interferons|interferons|mesh-list
44077646|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
44077647|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
44077648|NCT00015912|Thalidomide|thalidomide|mesh-list
44077649|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077650|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
44077651|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077652|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
44077653|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077654|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077655|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
44077656|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44077657|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077658|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077659|NCT00015912|Growth Substances|growth substances|mesh-ancestor
44077660|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077661|NCT00015925|Entinostat|entinostat|mesh-list
44077662|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077663|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44077664|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077676|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
44077677|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44077678|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077679|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077680|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077681|NCT00015951|Growth Substances|growth substances|mesh-ancestor
44077682|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077683|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077684|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077685|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
44077686|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077687|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
44077688|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077689|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077690|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
44077691|NCT00015951|Analgesics|analgesics|mesh-ancestor
44077692|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
44077693|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077694|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077695|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797743|NCT05038449|Colchicine|colchicine|mesh-list
44077696|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077697|NCT00015964|Gefitinib|gefitinib|mesh-list
44077698|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077699|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44077700|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077701|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077702|NCT00015977|Interleukin-12|interleukin-12|mesh-list
44077703|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44077704|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
44258206|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44258207|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
44258208|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258209|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077705|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077706|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077707|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077708|NCT00015977|Growth Substances|growth substances|mesh-ancestor
44077709|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077710|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077711|NCT00015990|Thalidomide|thalidomide|mesh-list
44077712|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077713|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
44077714|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077715|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
44077716|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44077717|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077718|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077719|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077720|NCT00015990|Growth Substances|growth substances|mesh-ancestor
44077721|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077722|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077723|NCT00016016|Cytarabine|cytarabine|mesh-list
44077724|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
44077725|NCT00016016|Alvocidib|alvocidib|mesh-list
44077726|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077727|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
44077728|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077729|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077730|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
44077731|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077732|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077733|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
44077734|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077735|NCT00016016|Analgesics|analgesics|mesh-ancestor
44077736|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
44077737|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077738|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077739|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077740|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077741|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077742|NCT00016016|Growth Substances|growth substances|mesh-ancestor
44077743|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44077744|NCT00016042|Interferons|interferons|mesh-list
44077745|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
44077746|NCT00016042|Fluorouracil|fluorouracil|mesh-list
44077747|NCT00016042|Sargramostim|sargramostim|mesh-list
44077748|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
44077749|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077750|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077751|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077752|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077753|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
44077754|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077755|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
44077756|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077757|NCT00016055|Temozolomide|temozolomide|mesh-list
44077758|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077759|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
44077760|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077761|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077762|NCT00016068|Valganciclovir|valganciclovir|mesh-list
44077763|NCT00016068|Ganciclovir|ganciclovir|mesh-list
44077764|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44077765|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
44077766|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077767|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077768|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077769|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077770|NCT00016081|Ribavirin|ribavirin|mesh-list
43797819|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
44077771|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
44258210|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258211|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44258212|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44258213|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
44258214|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258215|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44258216|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44258217|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
44258218|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
44258219|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44258220|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
44077772|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077773|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
44077774|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077775|NCT00016094|Bevacizumab|bevacizumab|mesh-list
44077776|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44077778|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
44077779|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44077780|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077781|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077782|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077783|NCT00016094|Growth Substances|growth substances|mesh-ancestor
44077784|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077785|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077786|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
44077787|NCT00016107|Bevacizumab|bevacizumab|mesh-list
44077788|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44077789|NCT00016107|Docetaxel|docetaxel|mesh-list
44077790|NCT00016107|Estramustine|estramustine|mesh-list
44077791|NCT00016107|Antibodies|antibodies|mesh-list
44077792|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
44077793|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44077794|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077795|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077796|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077797|NCT00016107|Growth Substances|growth substances|mesh-ancestor
44077798|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077799|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077800|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
44077801|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077802|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077803|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077804|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077805|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077806|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
44077807|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077809|NCT00016133|Fluorouracil|fluorouracil|mesh-list
44077810|NCT00016133|Vaccines|vaccines|mesh-list
44077811|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
44077812|NCT00016133|Calcium|calcium|mesh-list
44077813|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
44077814|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
44077815|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077816|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44077817|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
44077818|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077819|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077820|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077821|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077822|NCT00016133|Antidotes|antidotes|mesh-ancestor
44077823|NCT00016133|Protective Agents|protective agents|mesh-ancestor
44077824|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
44077825|NCT00016133|Vitamins|vitamins|mesh-ancestor
44077826|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
44077827|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44077828|NCT00016159|Idarubicin|idarubicin|mesh-list
44258222|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44258223|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
44258224|NCT00628576|Heparin|heparin|mesh-list
44258225|NCT00628576|Calcium heparin|calcium heparin|mesh-list
44258226|NCT00628576|Tinzaparin|tinzaparin|mesh-list
44258227|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44258228|NCT00628576|Dalteparin|dalteparin|mesh-list
44258229|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
44258230|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44258231|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44258232|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077829|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
44077830|NCT00016159|Tretinoin|tretinoin|mesh-list
44077831|NCT00016159|Lintuzumab|lintuzumab|mesh-list
44077832|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077833|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077834|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077835|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077836|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077837|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077838|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
44077839|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077840|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44077841|NCT00016172|Doxorubicin|doxorubicin|mesh-list
44077842|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44077843|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077844|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077845|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077846|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077847|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077848|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077849|NCT00016185|Docetaxel|docetaxel|mesh-list
44077850|NCT00016185|Alvocidib|alvocidib|mesh-list
44077851|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077852|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077853|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077854|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077855|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077856|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077857|NCT00016185|Growth Substances|growth substances|mesh-ancestor
44077858|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077859|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44077860|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077861|NCT00016198|Leucovorin|leucovorin|mesh-list
44077862|NCT00016198|Fluorouracil|fluorouracil|mesh-list
44077863|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
44077864|NCT00016198|Calcium|calcium|mesh-list
44077865|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
44077866|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44077867|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077868|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
44077869|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077870|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077871|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077872|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077873|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
44077874|NCT00016198|Antidotes|antidotes|mesh-ancestor
44077875|NCT00016198|Protective Agents|protective agents|mesh-ancestor
44077876|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
44077877|NCT00016198|Vitamins|vitamins|mesh-ancestor
44077878|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
44077879|NCT00016224|Thalidomide|thalidomide|mesh-list
44077880|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077881|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
44077882|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077885|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258233|NCT00628667|Esomeprazole|esomeprazole|mesh-list
44258234|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258235|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258236|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44258237|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077886|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077887|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077888|NCT00016224|Growth Substances|growth substances|mesh-ancestor
44077889|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077890|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077891|NCT00016263|Dacarbazine|dacarbazine|mesh-list
44077892|NCT00016263|Oblimersen|oblimersen|mesh-list
44077893|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077894|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
44077895|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077896|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077897|NCT00016276|Tamoxifen|tamoxifen|mesh-list
44077898|NCT00016276|Paclitaxel|paclitaxel|mesh-list
44077899|NCT00016276|Razoxane|razoxane|mesh-list
44077900|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
44077901|NCT00016276|Doxorubicin|doxorubicin|mesh-list
44077902|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44077903|NCT00016276|Trastuzumab|trastuzumab|mesh-list
44077904|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
44077905|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077906|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077907|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077908|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077909|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077910|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077911|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077912|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
44077913|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077914|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077915|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077916|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
44077917|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077918|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077919|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077920|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077921|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077922|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44077923|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44077924|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44077925|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077926|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077927|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44077928|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44077929|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44077930|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44077931|NCT00016276|Protective Agents|protective agents|mesh-ancestor
44077932|NCT00016289|Interleukin-12|interleukin-12|mesh-list
44077933|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44077934|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
44077935|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077936|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44077937|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44077938|NCT00016289|Growth Substances|growth substances|mesh-ancestor
44077939|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44077940|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077941|NCT00016302|Leucovorin|leucovorin|mesh-list
44077942|NCT00016302|Cytarabine|cytarabine|mesh-list
44077943|NCT00016302|Dexamethasone|dexamethasone|mesh-list
44077944|NCT00016302|Prednisone|prednisone|mesh-list
44077945|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
44077946|NCT00016302|Doxorubicin|doxorubicin|mesh-list
44077947|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44077948|NCT00016302|Methotrexate|methotrexate|mesh-list
44077949|NCT00016302|Vincristine|vincristine|mesh-list
44077950|NCT00016302|Daunorubicin|daunorubicin|mesh-list
44077951|NCT00016302|Asparaginase|asparaginase|mesh-list
44077952|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
44077953|NCT00016302|Pegaspargase|pegaspargase|mesh-list
44077954|NCT00016302|Thioguanine|thioguanine|mesh-list
44258238|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258239|NCT00628680|Heparin|heparin|mesh-list
44258240|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
44258241|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44258242|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44258243|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077955|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
44077956|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077957|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
44077958|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077959|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077968|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44077969|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44077970|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
44077971|NCT00016302|Hormones|hormones|mesh-ancestor
44077972|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44077973|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077974|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44077975|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44077976|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44077977|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44077978|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44077979|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
44077980|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44077981|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44077982|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
44077983|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44077984|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44077985|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44077986|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
44077987|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44077988|NCT00016302|Antidotes|antidotes|mesh-ancestor
44077989|NCT00016302|Protective Agents|protective agents|mesh-ancestor
44077990|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
44077991|NCT00016302|Vitamins|vitamins|mesh-ancestor
44077992|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
44077993|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077994|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077995|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077996|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077997|NCT00016315|Gemcitabine|gemcitabine|mesh-list
44077998|NCT00016315|Paclitaxel|paclitaxel|mesh-list
44077999|NCT00016315|Carboplatin|carboplatin|mesh-list
44078000|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078001|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078002|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078003|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078004|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151621|NCT00214981|Modafinil|modafinil|mesh-list
44078005|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078006|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078007|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
44078008|NCT00016315|Antiviral Agents|antiviral agents|mesh-ancestor
44078009|NCT00016315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078010|NCT00016315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078011|NCT00016315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078012|NCT00016315|Immunologic Factors|immunologic factors|mesh-ancestor
44078013|NCT00016315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078014|NCT00016328|Sirolimus|sirolimus|mesh-list
44078015|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44078016|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078017|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078018|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078019|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
44078020|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078021|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
44078022|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078023|NCT00016341|Tamoxifen|tamoxifen|mesh-list
44078024|NCT00016341|Paclitaxel|paclitaxel|mesh-list
44078025|NCT00016341|Cisplatin|cisplatin|mesh-list
44258244|NCT00628706|Dronabinol|dronabinol|mesh-list
44078026|NCT00016341|Doxorubicin|doxorubicin|mesh-list
43576252|NCT03500367|Sirolimus|sirolimus|mesh-list
44078029|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
44078030|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078031|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078032|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078033|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078034|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078035|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078036|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078037|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078038|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078039|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078040|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078041|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44078042|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
44078043|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078044|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078045|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44078046|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44078047|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44078048|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44078049|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44078050|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44078051|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
44078052|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44078053|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44078054|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44078055|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
44078056|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44078057|NCT00016367|Gemcitabine|gemcitabine|mesh-list
44078059|NCT00016367|Trastuzumab|trastuzumab|mesh-list
44078060|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078061|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078062|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
44078063|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078064|NCT00016367|Antiviral Agents|antiviral agents|mesh-ancestor
44078065|NCT00016367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078066|NCT00016367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078067|NCT00016367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078068|NCT00016367|Immunologic Factors|immunologic factors|mesh-ancestor
44078069|NCT00016367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078070|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44078071|NCT00016380|Dexamethasone|dexamethasone|mesh-list
44078072|NCT00016380|Ondansetron|ondansetron|mesh-list
44078073|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078074|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
44078075|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
44078076|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078077|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078078|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798054|NCT05032001|Biguanides|biguanides|mesh-list
44078079|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
44078080|NCT00016380|Hormones|hormones|mesh-ancestor
44078081|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078082|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078083|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078084|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
44078085|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
44078086|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44078087|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
44078088|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078089|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078090|NCT00016380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44078091|NCT00016380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44078092|NCT00016380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44078093|NCT00016380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44078094|NCT00016380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44078095|NCT00016406|Paclitaxel|paclitaxel|mesh-list
44078096|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
44078097|NCT00016406|Doxorubicin|doxorubicin|mesh-list
43576311|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
44078118|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106651|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258245|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
44258246|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258247|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258248|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44078119|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078120|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078121|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
44078122|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078123|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
44078124|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078125|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
44078126|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078127|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44078129|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078130|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44078131|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44078132|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078133|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078134|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44078135|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
44078136|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078137|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078138|NCT00016445|Hormones|hormones|mesh-list
44078139|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078140|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078141|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
44078142|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44078143|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078144|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
44078145|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078146|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078147|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078148|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
44078149|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078150|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078151|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43798127|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078153|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44078154|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
44078155|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078156|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078157|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44078158|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
44078159|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44078160|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
44078161|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078162|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078163|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44078164|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
44078165|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
44078166|NCT00016523|Protective Agents|protective agents|mesh-ancestor
44078167|NCT00016549|Bevacizumab|bevacizumab|mesh-list
44078168|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44078169|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078170|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44078171|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44078172|NCT00016549|Growth Substances|growth substances|mesh-ancestor
44078173|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078174|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
44078175|NCT00016588|Tenofovir|tenofovir|mesh-list
44078176|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
44078177|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078178|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078179|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078180|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078181|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078182|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44078183|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078184|NCT00016601|Ritonavir|ritonavir|mesh-list
44258249|NCT00628706|Analgesics|analgesics|mesh-ancestor
44258250|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
44258251|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258252|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43808830|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
44078185|NCT00016601|Nelfinavir|nelfinavir|mesh-list
44078186|NCT00016601|Indinavir|indinavir|mesh-list
44078187|NCT00016601|Nevirapine|nevirapine|mesh-list
44078188|NCT00016601|Efavirenz|efavirenz|mesh-list
44078189|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44078190|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
44078191|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44078192|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44078193|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
44078194|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078195|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078196|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44078197|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078198|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
44078199|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078200|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44078201|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44078202|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078203|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078204|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44078205|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44078206|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44078207|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44078208|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44078209|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44078210|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44078211|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44078212|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
44078213|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44078214|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078215|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44078216|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44078217|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44078218|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078219|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078220|NCT00016666|Propranolol|propranolol|mesh-list
44078221|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44078222|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44078223|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
44078225|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078226|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078227|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44078228|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44078229|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
44078230|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44078231|NCT00016744|Genistein|genistein|mesh-list
44078232|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078233|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44078234|NCT00016744|Protective Agents|protective agents|mesh-ancestor
44078235|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078236|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44078237|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078238|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078239|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
44078240|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44078241|NCT00016744|Estrogens|estrogens|mesh-ancestor
44078242|NCT00016744|Hormones|hormones|mesh-ancestor
44078243|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078244|NCT00016835|Metronidazole|metronidazole|mesh-list
44078245|NCT00016835|Doxycycline|doxycycline|mesh-list
44078246|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078247|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44078248|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44078249|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44258253|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44258254|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258255|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258257|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258258|NCT00628719|Amphotericin B|amphotericin b|mesh-list
44258259|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44078250|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
44078251|NCT00016861|Irinotecan|irinotecan|mesh-list
44078252|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44078253|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078254|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078255|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078256|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078257|NCT00016874|Paclitaxel|paclitaxel|mesh-list
44078258|NCT00016874|Cisplatin|cisplatin|mesh-list
44078259|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078260|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078261|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078262|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078263|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078264|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078265|NCT00016887|Interferons|interferons|mesh-list
44078266|NCT00016887|Cytarabine|cytarabine|mesh-list
44078267|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
44078268|NCT00016887|Dexamethasone|dexamethasone|mesh-list
44078269|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
44078270|NCT00016887|Melphalan|melphalan|mesh-list
44078271|NCT00016887|Carmustine|carmustine|mesh-list
44078272|NCT00016887|Etoposide|etoposide|mesh-list
44078273|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078274|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
44078275|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078276|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078277|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078278|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
44078279|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078280|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078281|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078282|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078283|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
44078284|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
44078285|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078286|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078287|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
44078288|NCT00016887|Hormones|hormones|mesh-ancestor
44078289|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078290|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078291|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078292|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078293|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078294|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078295|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
44078296|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078297|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078298|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
44078299|NCT00016900|Paclitaxel|paclitaxel|mesh-list
44078300|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078301|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078302|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078303|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078304|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078305|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078307|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078308|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
44078309|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078310|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078312|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078313|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
44258260|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44258261|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
44258262|NCT00628719|Amebicides|amebicides|mesh-ancestor
44258263|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44258264|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44258265|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258266|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44078314|NCT00016939|Growth Substances|growth substances|mesh-ancestor
44078315|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078316|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44078317|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078318|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078319|NCT00016952|Leucovorin|leucovorin|mesh-list
44078320|NCT00016952|Fluorouracil|fluorouracil|mesh-list
44078321|NCT00016952|Irinotecan|irinotecan|mesh-list
44078322|NCT00016952|Calcium|calcium|mesh-list
44078323|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
44078324|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44078325|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078326|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
44078327|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078328|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078329|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078330|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078331|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
44078332|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44078333|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078334|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078335|NCT00016952|Antidotes|antidotes|mesh-ancestor
44078336|NCT00016952|Protective Agents|protective agents|mesh-ancestor
44078337|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
44078338|NCT00016952|Vitamins|vitamins|mesh-ancestor
44078339|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
44078340|NCT00016978|Leucovorin|leucovorin|mesh-list
44078341|NCT00016978|Fluorouracil|fluorouracil|mesh-list
44078342|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
44078343|NCT00016978|Calcium|calcium|mesh-list
44078344|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
44078345|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44078346|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078347|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
44078348|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078349|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078350|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078351|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078352|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
44078353|NCT00016978|Antidotes|antidotes|mesh-ancestor
44078354|NCT00016978|Protective Agents|protective agents|mesh-ancestor
44078355|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
44078356|NCT00016978|Vitamins|vitamins|mesh-ancestor
44078357|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
44078358|NCT00016991|Gefitinib|gefitinib|mesh-list
44078359|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078360|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44078361|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078362|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078363|NCT00017004|Cisplatin|cisplatin|mesh-list
44078364|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
44078365|NCT00017004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078366|NCT00017004|Hematinics|hematinics|mesh-ancestor
44078367|NCT00017017|Paclitaxel|paclitaxel|mesh-list
44078368|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44078369|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078370|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078371|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078372|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078373|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078374|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078375|NCT00017030|Trabectedin|trabectedin|mesh-list
44078376|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44258267|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
44258268|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44258269|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258270|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
44258272|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258273|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
44258274|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258275|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258276|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44258277|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
44258278|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258279|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258280|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44258281|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44258282|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258283|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258284|NCT00628810|Leucovorin|leucovorin|mesh-list
44258285|NCT00628810|Bevacizumab|bevacizumab|mesh-list
44258286|NCT00628810|Fluorouracil|fluorouracil|mesh-list
44258287|NCT00628810|Irinotecan|irinotecan|mesh-list
44258288|NCT00628810|Calcium|calcium|mesh-list
44258289|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
44258291|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258321|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44258322|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
44258323|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258324|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44258325|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44258326|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
44258327|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
44258328|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258329|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44258330|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44258331|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
43576588|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
44078402|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078403|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078404|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
44078405|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078406|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078407|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078408|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078409|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078410|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078412|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078413|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078414|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078415|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078416|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078417|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
44078418|NCT00017108|Chlorambucil|chlorambucil|mesh-list
44078419|NCT00017108|Fludarabine|fludarabine|mesh-list
44078420|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
44078421|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078422|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
44078423|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078424|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078425|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078426|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
44078427|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078428|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078429|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078430|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078432|NCT00017121|Sargramostim|sargramostim|mesh-list
44078433|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
44078434|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078435|NCT00017134|Fenretinide|fenretinide|mesh-list
44078436|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078437|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44078438|NCT00017134|Protective Agents|protective agents|mesh-ancestor
44078439|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078440|NCT00017147|Carmustine|carmustine|mesh-list
44078441|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44078442|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078443|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
44078444|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078445|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078446|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078447|NCT00017160|Doxorubicin|doxorubicin|mesh-list
44078448|NCT00017160|Ifosfamide|ifosfamide|mesh-list
44078449|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
44078450|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078451|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078452|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078453|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078454|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078455|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258333|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258334|NCT00628953|Esomeprazole|esomeprazole|mesh-list
44258335|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258336|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258337|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43654875|NCT02973204|Octreotide|octreotide|mesh-list
44078456|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078457|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078458|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
44078459|NCT00017173|Cisplatin|cisplatin|mesh-list
44078460|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078461|NCT00017186|Gemcitabine|gemcitabine|mesh-list
44078462|NCT00017186|Epirubicin|epirubicin|mesh-list
44078463|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078464|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
44078465|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078466|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078467|NCT00017186|Antiviral Agents|antiviral agents|mesh-ancestor
44078468|NCT00017186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078469|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078470|NCT00017186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078471|NCT00017186|Immunologic Factors|immunologic factors|mesh-ancestor
44078472|NCT00017186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078473|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078474|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078475|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078476|NCT00017199|Bortezomib|bortezomib|mesh-list
44078477|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078478|NCT00017212|Exatecan|exatecan|mesh-list
44078479|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44078480|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078481|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078482|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078483|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078484|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
44078486|NCT00017225|Ifosfamide|ifosfamide|mesh-list
44078487|NCT00017225|Dacarbazine|dacarbazine|mesh-list
44078488|NCT00017225|Carboplatin|carboplatin|mesh-list
44078489|NCT00017225|Doxorubicin|doxorubicin|mesh-list
44078490|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44078491|NCT00017225|Etoposide|etoposide|mesh-list
44078492|NCT00017225|Vincristine|vincristine|mesh-list
44078493|NCT00017225|Tretinoin|tretinoin|mesh-list
44078494|NCT00017225|Vindesine|vindesine|mesh-list
44078495|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078496|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
44078497|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078498|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078499|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078500|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
44078501|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078502|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078503|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078504|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078505|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43576725|NCT03496519|Durvalumab|durvalumab|mesh-list
44078507|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078508|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078509|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078510|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078511|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078512|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
44078513|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
44151622|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44151623|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151624|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44151625|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44151626|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44151627|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258338|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258339|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258340|NCT00629031|Paromomycin|paromomycin|mesh-list
44258341|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258342|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258343|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44258344|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44258345|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
44258346|NCT00629135|Metronidazole|metronidazole|mesh-list
44258347|NCT00629135|Tazobactam|tazobactam|mesh-list
44258348|NCT00629135|Piperacillin|piperacillin|mesh-list
43654882|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151628|NCT00214994|Tiagabine|tiagabine|mesh-list
44151629|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
44151630|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44151631|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44151632|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151633|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151634|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
44151635|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151636|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151637|NCT00215007|Levofloxacin|levofloxacin|mesh-list
43798403|NCT05024877|Androgens|androgens|mesh-ancestor
44151638|NCT00215007|Ofloxacin|ofloxacin|mesh-list
44151639|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44078514|NCT00017238|KRN 5500|krn 5500|mesh-list
44078515|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078516|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44078517|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078518|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078519|NCT00017251|Carboplatin|carboplatin|mesh-list
44078520|NCT00017251|Etoposide|etoposide|mesh-list
44078521|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
44078522|NCT00017251|Oblimersen|oblimersen|mesh-list
44078523|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078524|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078525|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078526|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078527|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078528|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078529|NCT00017264|Atrasentan|atrasentan|mesh-list
44078530|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078531|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44078532|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44078533|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078534|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
44078535|NCT00017277|Hematinics|hematinics|mesh-ancestor
44078536|NCT00017290|Prednisone|prednisone|mesh-list
44078537|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
44078538|NCT00017290|Vincristine|vincristine|mesh-list
44078539|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
44078540|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44078541|NCT00017290|Antibodies|antibodies|mesh-list
44078542|NCT00017290|Sargramostim|sargramostim|mesh-list
44078543|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44078544|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44078545|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078546|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
44078547|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078548|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078549|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078550|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
44078551|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078552|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078553|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078554|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258349|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44258350|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258351|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258352|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44258353|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258354|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258355|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258356|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258357|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44078555|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
44078556|NCT00017290|Hormones|hormones|mesh-ancestor
44078557|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078558|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078559|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078560|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078575|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078576|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
44078577|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44078578|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078579|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44078580|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44078581|NCT00017316|Growth Substances|growth substances|mesh-ancestor
44078582|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
44078583|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078585|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078586|NCT00017342|Cytarabine|cytarabine|mesh-list
44078587|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
44078588|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078589|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
43798478|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
44078590|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078591|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078592|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
44078593|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078594|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078595|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
44078596|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078597|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44078598|NCT00017355|Lenograstim|lenograstim|mesh-list
44078599|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44078600|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
44078601|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078602|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
44078603|NCT00017368|Melphalan|melphalan|mesh-list
44078604|NCT00017368|Ifosfamide|ifosfamide|mesh-list
44078605|NCT00017368|Thiotepa|thiotepa|mesh-list
44078606|NCT00017368|Carboplatin|carboplatin|mesh-list
44078607|NCT00017368|Doxorubicin|doxorubicin|mesh-list
44078608|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44078609|NCT00017368|Etoposide|etoposide|mesh-list
44078610|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
44078611|NCT00017368|Vincristine|vincristine|mesh-list
44078612|NCT00017368|Isotretinoin|isotretinoin|mesh-list
44078613|NCT00017368|Sargramostim|sargramostim|mesh-list
44078614|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078615|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
44078616|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078617|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078618|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078619|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
44078620|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078621|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078622|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078623|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078625|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078626|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106652|NCT00076791|Tenofovir|tenofovir|mesh-list
44258358|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44258359|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44258360|NCT00629148|Capecitabine|capecitabine|mesh-list
44258361|NCT00629148|Vinorelbine|vinorelbine|mesh-list
44078627|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078628|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078629|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078630|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078631|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44078632|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
44078633|NCT00017381|Rituximab|rituximab|mesh-list
44078634|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44078635|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078636|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
44078637|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078638|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078639|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078640|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
44078641|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078642|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078643|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078644|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44078645|NCT00017394|Bevacizumab|bevacizumab|mesh-list
44078646|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44078647|NCT00017394|Vinorelbine|vinorelbine|mesh-list
44078648|NCT00017394|Antibodies|antibodies|mesh-list
44078649|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
44078650|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44078651|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078652|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44078653|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44078654|NCT00017394|Growth Substances|growth substances|mesh-ancestor
44078655|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078656|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
44078657|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
44078658|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078659|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078660|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078661|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078662|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078663|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
44078664|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078665|NCT00017459|Cisplatin|cisplatin|mesh-list
44078666|NCT00017459|Vinorelbine|vinorelbine|mesh-list
44078667|NCT00017459|Tirapazamine|tirapazamine|mesh-list
44078668|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078669|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078670|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078671|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078672|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078673|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078674|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44078675|NCT00017472|Antibodies|antibodies|mesh-list
44078676|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
44078677|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44078678|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
44078679|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078680|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078681|NCT00017498|Gemcitabine|gemcitabine|mesh-list
44078682|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44078683|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
44078684|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078685|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078686|NCT00017498|Antiviral Agents|antiviral agents|mesh-ancestor
44078687|NCT00017498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078688|NCT00017498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078689|NCT00017498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078690|NCT00017498|Immunologic Factors|immunologic factors|mesh-ancestor
44078691|NCT00017498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078692|NCT00017511|Cevimeline|cevimeline|mesh-list
44078693|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44078694|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
44078695|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258362|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258363|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
44258364|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078696|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078697|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44078698|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44078700|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078701|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078702|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44078703|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
44078704|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078705|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078706|NCT00017576|Calcitriol|calcitriol|mesh-list
44078707|NCT00017576|Carboplatin|carboplatin|mesh-list
44078708|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078709|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44078710|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078711|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44078712|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44078713|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078714|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44078715|NCT00017576|Vitamins|vitamins|mesh-ancestor
44078716|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
44078717|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44078718|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
44078719|NCT00017589|Oblimersen|oblimersen|mesh-list
44078720|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44078721|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078722|NCT00017602|Dexamethasone|dexamethasone|mesh-list
44078723|NCT00017602|Oblimersen|oblimersen|mesh-list
44078724|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078725|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
44078726|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
44078727|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078728|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078729|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078730|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
44078731|NCT00017602|Hormones|hormones|mesh-ancestor
44078732|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078733|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078734|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078735|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
44078736|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44078737|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44078738|NCT00017628|Prednisolone|prednisolone|mesh-list
44078739|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
44078740|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
44078741|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44078742|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
44078743|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078744|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
44078745|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078746|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078747|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078748|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
44078749|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078750|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078751|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078752|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078753|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
44078754|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
44078755|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078756|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078757|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
44078758|NCT00017628|Hormones|hormones|mesh-ancestor
44078759|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078760|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44078761|NCT00017628|Protective Agents|protective agents|mesh-ancestor
44078762|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078763|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
44078764|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44258365|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258366|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44258367|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
44258368|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
44258369|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44258370|NCT00629187|Temozolomide|temozolomide|mesh-list
44078765|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078766|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
44078767|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078768|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078769|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078770|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
44078771|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078772|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078774|NCT00017654|Cyclosporine|cyclosporine|mesh-list
44078775|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
44078776|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
44078777|NCT00017654|Cyclosporins|cyclosporins|mesh-list
44078778|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44078779|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078780|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
44078781|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544661|NCT03679442|Antidotes|antidotes|mesh-list
44078782|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078783|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078784|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
44078785|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078786|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078787|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078788|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078789|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
44078790|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078791|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
44078792|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44078793|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078794|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
44078795|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
44078796|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078797|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078798|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
44078799|NCT00017654|Hormones|hormones|mesh-ancestor
44078800|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078801|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44078802|NCT00017654|Protective Agents|protective agents|mesh-ancestor
44078803|NCT00017680|Melphalan|melphalan|mesh-list
44078804|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078805|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
44078806|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078807|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078808|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078809|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078810|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
44078811|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078812|NCT00017693|Interleukin-4|interleukin-4|mesh-list
44078813|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44078814|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
44078815|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078816|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078817|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44078818|NCT00017719|Lamivudine|lamivudine|mesh-list
44078819|NCT00017719|Zidovudine|zidovudine|mesh-list
44078820|NCT00017719|Nevirapine|nevirapine|mesh-list
44078821|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44078822|NCT00017719|Nelfinavir|nelfinavir|mesh-list
44078823|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078824|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078825|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078826|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078827|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
44078828|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078829|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44258371|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44258372|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
44258373|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258374|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622756|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258375|NCT00629200|Interferons|interferons|mesh-list
44258376|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
44258377|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
43654916|NCT02972866|Budesonide|budesonide|mesh-list
44078830|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078831|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
44078832|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44078833|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44078834|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44078835|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44078836|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44078837|NCT00017758|Efavirenz|efavirenz|mesh-list
44078838|NCT00017758|Nelfinavir|nelfinavir|mesh-list
44078839|NCT00017758|Atorvastatin|atorvastatin|mesh-list
44078840|NCT00017758|Simvastatin|simvastatin|mesh-list
44078841|NCT00017758|Pravastatin|pravastatin|mesh-list
44078842|NCT00017758|Calcium|calcium|mesh-list
44078843|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44078844|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078845|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44078846|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44078847|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
44078848|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078849|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44078850|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44078851|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078852|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078853|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078854|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
44078855|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078856|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44078857|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44078858|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44078859|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44078860|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44078861|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44078862|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44078863|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44078864|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
44078865|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44078866|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078868|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
44078869|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078871|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44078872|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44078873|NCT00017940|Mitogens|mitogens|mesh-list
44078874|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078875|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078876|NCT00017992|Ritonavir|ritonavir|mesh-list
44078877|NCT00017992|Lopinavir|lopinavir|mesh-list
44078878|NCT00017992|Emtricitabine|emtricitabine|mesh-list
44078879|NCT00017992|Stavudine|stavudine|mesh-list
44078880|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44078881|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44078882|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
44078883|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078884|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078885|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44078886|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078887|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
44078888|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078889|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44078890|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44258378|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44258379|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258380|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
44258381|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078891|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078892|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078893|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
44078894|NCT00018018|Zidovudine|zidovudine|mesh-list
44078895|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
44078896|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078897|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078898|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078899|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078900|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
44078901|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078902|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44078903|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44078904|NCT00018083|Efavirenz|efavirenz|mesh-list
44078905|NCT00018083|Isoniazid|isoniazid|mesh-list
44078906|NCT00018083|Rifabutin|rifabutin|mesh-list
44078907|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44078908|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44078909|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078910|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078911|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
44078912|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44078913|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44078914|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44078915|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44078916|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44078917|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44078918|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44078919|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
44078920|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44078921|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44078922|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44078925|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44078926|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44078927|NCT00018135|Calcium|calcium|mesh-list
44078928|NCT00018135|Sevelamer|sevelamer|mesh-list
44078929|NCT00018135|Calcium acetate|calcium acetate|mesh-list
44078930|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44078931|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078932|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
44078933|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
44078934|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078935|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44078936|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
44078937|NCT00018135|Antacids|antacids|mesh-ancestor
44078938|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078939|NCT00018148|Nortriptyline|nortriptyline|mesh-list
44078940|NCT00018148|Nicotine|nicotine|mesh-list
44078941|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44078942|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
44078943|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078944|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078945|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44078946|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44078947|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44078948|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078949|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078950|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44078951|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
44078952|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44078953|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44078954|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44078955|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44078956|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
44078957|NCT00018161|Mecamylamine|mecamylamine|mesh-list
44078958|NCT00018161|Nicotine|nicotine|mesh-list
44078959|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44258382|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
44258383|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258384|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44258385|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43654925|NCT02972866|Hormones|hormones|mesh-ancestor
44078960|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
44078961|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078962|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078963|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44078964|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44078965|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
44078966|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078967|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078968|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43798784|NCT05017272|Narcotics|narcotics|mesh-ancestor
44078969|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44078970|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44078971|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44078972|NCT00018174|Fluoxetine|fluoxetine|mesh-list
44078973|NCT00018174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44078974|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44078975|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44078976|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078977|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078978|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
44078979|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078980|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44078981|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
44078982|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44078983|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44078984|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44078985|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078986|NCT00018187|Mecamylamine|mecamylamine|mesh-list
44078987|NCT00018187|Bupropion|bupropion|mesh-list
44078988|NCT00018187|Nicotine|nicotine|mesh-list
44078989|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44078990|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
44078991|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078992|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078993|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44078994|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44078995|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
44078998|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44078999|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
44079000|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079001|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44079002|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44079003|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079004|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
44079005|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44079006|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44079007|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079008|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44079009|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44079010|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44079011|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44079012|NCT00018200|Benztropine|benztropine|mesh-list
44079014|NCT00018200|Desipramine|desipramine|mesh-list
44079015|NCT00018200|Clomipramine|clomipramine|mesh-list
44079016|NCT00018200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44079017|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44079018|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079019|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079020|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079021|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
44079022|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079023|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44079024|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
44079025|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258386|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
44258387|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44258388|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
44258390|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44258391|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258392|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258393|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44258394|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079026|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44079027|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44079028|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079029|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44079030|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44079031|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079032|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44079033|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44079034|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
44079035|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
44079036|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079037|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44079038|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44079039|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
44079040|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44079041|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
44079042|NCT00018213|Naltrexone|naltrexone|mesh-list
44079043|NCT00018213|Nicotine|nicotine|mesh-list
44079044|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44079045|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
44079046|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079047|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079048|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44079049|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44079050|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
44079051|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079052|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079053|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44079054|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44079055|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
44079056|NCT00018278|Donepezil|donepezil|mesh-list
44079057|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44079058|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079059|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079060|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
44079061|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079062|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079063|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
44079064|NCT00018291|Gabapentin|gabapentin|mesh-list
44079065|NCT00018291|Risperidone|risperidone|mesh-list
44079066|NCT00018291|Analgesics|analgesics|mesh-ancestor
44079067|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
44079068|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079082|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44079083|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44079084|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
44079085|NCT00018343|Estrogens|estrogens|mesh-list
44079086|NCT00018343|Hormones|hormones|mesh-ancestor
44079087|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079088|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079089|NCT00018356|Testosterone|testosterone|mesh-list
44079090|NCT00018356|Androgens|androgens|mesh-ancestor
44079091|NCT00018356|Hormones|hormones|mesh-ancestor
44079092|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079093|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079094|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
44079095|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44079096|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258395|NCT00629226|Cisplatin|cisplatin|mesh-list
44258396|NCT00629226|Cetuximab|cetuximab|mesh-list
44258397|NCT00629226|Bortezomib|bortezomib|mesh-list
44258398|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258399|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44258400|NCT00629252|Risperidone|risperidone|mesh-list
44258401|NCT00629252|Sertindole|sertindole|mesh-list
44258402|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44258403|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
44258404|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258405|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258406|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258407|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44258408|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079097|NCT00018447|Fluorides|fluorides|mesh-list
44079098|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
44079099|NCT00018447|Protective Agents|protective agents|mesh-ancestor
44079100|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079101|NCT00018460|Vitamins|vitamins|mesh-list
44079102|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
44079103|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
44079104|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079105|NCT00018551|Folic Acid|folic acid|mesh-list
44079106|NCT00018551|Hematinics|hematinics|mesh-ancestor
44079107|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
44079108|NCT00018551|Vitamins|vitamins|mesh-ancestor
44079109|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
44079110|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079111|NCT04394130|Ropivacaine|ropivacaine|mesh-list
44079112|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079113|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
44079114|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079115|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079116|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
44079117|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079118|NCT04380207|QPX7728|qpx7728|mesh-list
44079119|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44079120|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079121|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079122|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079123|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079124|NCT04378426|Midazolam|midazolam|mesh-list
44079125|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
44079126|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44079127|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44079128|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079129|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079130|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44079131|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079135|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
44079136|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
44079137|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
44079138|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079139|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079140|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44079141|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079142|NCT04378426|Analgesics|analgesics|mesh-ancestor
44079143|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
44079144|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079145|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44079146|NCT04369560|Hematinics|hematinics|mesh-ancestor
44079147|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44079148|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44151640|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151641|NCT00215007|Renal Agents|renal agents|mesh-ancestor
44258409|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258411|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44258412|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
44258413|NCT00629278|Tamoxifen|tamoxifen|mesh-list
44258414|NCT00629278|Docetaxel|docetaxel|mesh-list
44258415|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
44258416|NCT00629278|Doxorubicin|doxorubicin|mesh-list
44258417|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44151642|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44151643|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44151644|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44151645|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151646|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151647|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151648|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44151649|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44151650|NCT00215046|Methotrexate|methotrexate|mesh-list
44151651|NCT00215046|Vinblastine|vinblastine|mesh-list
44151652|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44151653|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
44151654|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44151655|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151656|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151657|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
44151658|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151659|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151660|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
44151661|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151662|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44151663|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151664|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
44151665|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151666|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44151667|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44151668|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151669|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151670|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151671|NCT00215124|Lenograstim|lenograstim|mesh-list
44151672|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44151673|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
44151674|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151676|NCT00215163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44151677|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44151678|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151679|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151680|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151681|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
44151682|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151683|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44151684|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151685|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079149|NCT04305405|Benralizumab|benralizumab|mesh-list
44079150|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44079151|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079152|NCT04258410|Quercetin|quercetin|mesh-list
44079153|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
44079154|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079155|NCT04258410|Protective Agents|protective agents|mesh-ancestor
44079156|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079157|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44079158|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44079159|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
44079160|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079161|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258418|NCT00629278|Fluorouracil|fluorouracil|mesh-list
44258419|NCT00629278|Trastuzumab|trastuzumab|mesh-list
44258420|NCT00629278|Epirubicin|epirubicin|mesh-list
44258421|NCT00629278|Hormones|hormones|mesh-list
44258422|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44258423|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258424|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44079162|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
44079163|NCT04196491|Fludarabine|fludarabine|mesh-list
44079164|NCT04196491|Lenalidomide|lenalidomide|mesh-list
44079165|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079166|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
44079167|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079168|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079169|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44079170|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
44079171|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079172|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079173|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44079174|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44079175|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44079176|NCT04196491|Growth Substances|growth substances|mesh-ancestor
44079177|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
44079178|NCT04163874|Pramlintide|pramlintide|mesh-list
44079179|NCT04163874|Pancrelipase|pancrelipase|mesh-list
44079180|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079181|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44079182|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079183|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44079184|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
44079185|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079186|NCT03370406|Fluorouracil|fluorouracil|mesh-list
44079187|NCT03370406|Imiquimod|imiquimod|mesh-list
44079188|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
44079189|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079190|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44079191|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079192|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079193|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
44079194|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079195|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44079196|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
44079197|NCT03366103|Navitoclax|navitoclax|mesh-list
44079198|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079199|NCT03346135|Melphalan|melphalan|mesh-list
44079200|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
44079201|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44079202|NCT03346135|Daratumumab|daratumumab|mesh-list
44079203|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44079204|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
44079205|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079206|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079207|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44079208|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079209|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
44079210|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079211|NCT03326063|Ifetroban|ifetroban|mesh-list
44079212|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44079213|NCT03306264|Decitabine|decitabine|mesh-list
44079214|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44079215|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
44079216|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079217|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079218|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079219|NCT03273712|Octreotide|octreotide|mesh-list
44079220|NCT03273712|Edotreotide|edotreotide|mesh-list
44079221|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079222|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079223|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079224|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44079225|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258425|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44258426|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44258427|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258428|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258429|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
44258430|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079227|NCT00512070|Melatonin|melatonin|mesh-list
44079228|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
44079229|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079230|NCT00512070|Protective Agents|protective agents|mesh-ancestor
44079231|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079232|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079233|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
44079234|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
44079235|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079236|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079237|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44079238|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079239|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079240|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44079241|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44079242|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079243|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079244|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
44079245|NCT00393783|Trastuzumab|trastuzumab|mesh-list
44079246|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079247|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079248|NCT00142454|Imiquimod|imiquimod|mesh-list
44079249|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44079250|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
44079251|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079252|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079253|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
44079254|NCT05576675|Sufentanil|sufentanil|mesh-list
44079256|NCT05576675|Hydromorphone|hydromorphone|mesh-list
44079257|NCT05576675|Nalbuphine|nalbuphine|mesh-list
44079258|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44079259|NCT05576675|Narcotics|narcotics|mesh-ancestor
44079260|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079261|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079262|NCT05576675|Analgesics|analgesics|mesh-ancestor
44079263|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
44079264|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079265|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44079266|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44079267|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
44079268|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
44079269|NCT05576480|Capecitabine|capecitabine|mesh-list
44079270|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
44079271|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44079272|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
44079273|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079274|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079275|NCT05576324|Ivacaftor|ivacaftor|mesh-list
44079276|NCT05576324|Elexacaftor|elexacaftor|mesh-list
44079277|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44079278|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079279|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079280|NCT05576298|Insulin|insulin|mesh-list
44079281|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44079282|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
44079283|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44079284|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079285|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44079286|NCT05576194|Taurolidine|taurolidine|mesh-list
44079287|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44079288|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079289|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079290|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
44079291|NCT05576181|Fludarabine|fludarabine|mesh-list
44079292|NCT05576181|Etoposide|etoposide|mesh-list
44258431|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258432|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44258433|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
44258434|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44258435|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44258436|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44079293|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079294|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
44079295|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079296|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079297|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44079298|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
44079299|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079300|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079301|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44079302|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44079303|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44079304|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44079305|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079306|NCT05574712|Leuprolide|leuprolide|mesh-list
44079307|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
44079308|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44079309|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
44079310|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44079311|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079312|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079313|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079314|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44079316|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079317|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
44079318|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079319|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44079320|NCT05574257|Propofol|propofol|mesh-list
44079321|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44079322|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079323|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079324|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44079325|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
44079326|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
44079327|NCT05574218|Glycine|glycine|mesh-list
44079328|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
44079329|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079330|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079331|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079332|NCT05574179|Midazolam|midazolam|mesh-list
44079333|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
44079334|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44079335|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079336|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079337|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079338|NCT05574179|Analgesics|analgesics|mesh-ancestor
44079339|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
44079340|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079341|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44079342|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44079343|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44079344|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079345|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079346|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079347|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44079348|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44079349|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079350|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079351|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44079352|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
44079353|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
44079354|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
44258437|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258438|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258439|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
44258440|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258441|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43811223|NCT04847921|Dalbavancin|dalbavancin|mesh-list
44079355|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
44151686|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44151687|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44151688|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151689|NCT00215176|Modafinil|modafinil|mesh-list
44151690|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44151691|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151692|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44151693|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44151694|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44151695|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151696|NCT00215202|Gefitinib|gefitinib|mesh-list
44151697|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151698|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44151699|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151700|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151701|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44151702|NCT00215228|Citalopram|citalopram|mesh-list
44151703|NCT00215228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44151704|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44079356|NCT05573958|Aspirin|aspirin|mesh-list
44079357|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
44079358|NCT05573958|Clopidogrel|clopidogrel|mesh-list
44079359|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44079360|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079361|NCT05573958|Analgesics|analgesics|mesh-ancestor
44079362|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
44079363|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079364|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079365|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079366|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079368|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44079369|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079370|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44079371|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44079373|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
44079374|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44079375|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44079376|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44079377|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
44079378|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079379|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44079381|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44079382|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
44079383|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
44079384|NCT05573386|Lenograstim|lenograstim|mesh-list
44079385|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44079386|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
44079387|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079388|NCT05573204|Vitamin E|vitamin e|mesh-list
44079389|NCT05573204|Vitamins|vitamins|mesh-ancestor
44079390|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
44079391|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079392|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
44079393|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079394|NCT05573204|Protective Agents|protective agents|mesh-ancestor
44079395|NCT05573191|Lidocaine|lidocaine|mesh-list
44079396|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079397|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
44079398|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079399|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079400|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
44106653|NCT00076791|Emtricitabine|emtricitabine|mesh-list
44258442|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258443|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44258444|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
44258445|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258446|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44079401|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079402|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44079403|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44079404|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44079405|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079406|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079407|NCT05572996|Treprostinil|treprostinil|mesh-list
44079408|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44079409|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
44079410|NCT05572723|Remifentanil|remifentanil|mesh-list
44079411|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44079412|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079413|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079414|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079415|NCT05572723|Analgesics|analgesics|mesh-ancestor
44079416|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
44079417|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079418|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44079419|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44079420|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44079421|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079422|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079423|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079424|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44079425|NCT05572723|Narcotics|narcotics|mesh-ancestor
44079426|NCT05572645|Trastuzumab|trastuzumab|mesh-list
44079427|NCT05572645|Pertuzumab|pertuzumab|mesh-list
44079428|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079429|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079430|NCT05571670|Sirolimus|sirolimus|mesh-list
44079431|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079432|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079433|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079434|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44079435|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079436|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
44079437|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079438|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
44079440|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079441|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079479|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44079480|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44079481|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
44079482|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079483|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44079484|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44079485|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079486|NCT05547100|Olanzapine|olanzapine|mesh-list
44079487|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
44079488|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
44079489|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079490|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079491|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079492|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44079493|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079494|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079495|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079496|NCT05547100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44079497|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44079498|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079499|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258447|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44258448|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44258449|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44258450|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
44258451|NCT00629304|Antithrombins|antithrombins|mesh-list
44079500|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079501|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
44079502|NCT05543850|Pancrelipase|pancrelipase|mesh-list
44079503|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151705|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079504|NCT05528952|Bevacizumab|bevacizumab|mesh-list
44079505|NCT05528952|Atezolizumab|atezolizumab|mesh-list
44079506|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079507|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079508|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44079509|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44079510|NCT05528952|Growth Substances|growth substances|mesh-ancestor
44079511|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079512|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
44079514|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44079515|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
44079516|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079517|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079518|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44079519|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079520|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
44079521|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44079522|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44079523|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44079524|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44079525|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079526|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079527|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079529|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079530|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079531|NCT05518734|Itraconazole|itraconazole|mesh-list
44079532|NCT05518734|Midazolam|midazolam|mesh-list
44079533|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44079534|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44079535|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079536|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079537|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44079538|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079539|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079540|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44079541|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
44079542|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
44079543|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
44079544|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
44079545|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079546|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079547|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
44079548|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079549|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44079550|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44079552|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44079553|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
44079554|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079555|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44079556|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44079557|NCT05512754|Ibuprofen|ibuprofen|mesh-list
44079558|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44079559|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079560|NCT05512754|Analgesics|analgesics|mesh-ancestor
44079561|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
44079562|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079563|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079564|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258452|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44258453|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
44258454|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258455|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258456|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
44258457|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44258458|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44258459|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44258460|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
44258461|NCT00629343|Temozolomide|temozolomide|mesh-list
44258462|NCT00629343|Azacitidine|azacitidine|mesh-list
44258463|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44258464|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
44258465|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258466|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654986|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
44079565|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079566|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44079567|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079568|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079569|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
44079570|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44079571|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
44079572|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079573|NCT05485558|Expectorants|expectorants|mesh-ancestor
44079574|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079575|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44079576|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
44079577|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079579|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079580|NCT05485558|Antidotes|antidotes|mesh-ancestor
44079581|NCT05465317|Empagliflozin|empagliflozin|mesh-list
44079582|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44079583|NCT05465317|Glucagon|glucagon|mesh-list
44079584|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44079585|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079586|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44079587|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079588|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079589|NCT05465317|Hormones|hormones|mesh-ancestor
44079590|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079591|NCT05465317|Incretins|incretins|mesh-ancestor
44079592|NCT05445440|Leucovorin|leucovorin|mesh-list
44079593|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
44079594|NCT05445440|Methotrexate|methotrexate|mesh-list
44079595|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44079596|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
44079597|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44079598|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079599|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44079600|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
44079601|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079602|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079603|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
44079604|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079605|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44079606|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079607|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
44079608|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258467|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258468|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
44258469|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258470|NCT00629382|Polymyxins|polymyxins|mesh-list
44258471|NCT00629382|Polymyxin B|polymyxin b|mesh-list
44258472|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079609|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44079610|NCT05445440|Antidotes|antidotes|mesh-ancestor
44079611|NCT05445440|Protective Agents|protective agents|mesh-ancestor
44079612|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
44079613|NCT05445440|Vitamins|vitamins|mesh-ancestor
44079614|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
44079615|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079616|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44079617|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079618|NCT05445440|Analgesics|analgesics|mesh-ancestor
44079619|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
44079620|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079621|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079622|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079623|NCT05433675|Macitentan|macitentan|mesh-list
44079624|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44079625|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44079626|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079627|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44079628|NCT05419921|Lidocaine|lidocaine|mesh-list
44079629|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079630|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
44079631|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079632|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079633|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
44079634|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079635|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44079636|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44079637|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44079638|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079639|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079640|NCT05410197|Gemcitabine|gemcitabine|mesh-list
44079641|NCT05410197|Cisplatin|cisplatin|mesh-list
44079642|NCT05410197|Lenvatinib|lenvatinib|mesh-list
44079643|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079644|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44079645|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
44079646|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079647|NCT05410197|Antiviral Agents|antiviral agents|mesh-ancestor
44079648|NCT05410197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079649|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079650|NCT05410197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079651|NCT05410197|Immunologic Factors|immunologic factors|mesh-ancestor
44079652|NCT05410197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079653|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44079654|NCT05372354|Dexamethasone|dexamethasone|mesh-list
44079655|NCT05372354|Trametinib|trametinib|mesh-list
44079656|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079657|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
44079658|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
44079659|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079660|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079661|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079662|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
44079663|NCT05372354|Hormones|hormones|mesh-ancestor
44079664|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079665|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079666|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079667|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44079668|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079669|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079670|NCT05367271|Dexamethasone|dexamethasone|mesh-list
44079671|NCT05367271|Cortisone|cortisone|mesh-list
44079672|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44258473|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258475|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
44258476|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44258477|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43912488|NCT00382590|Cytarabine|cytarabine|mesh-list
44258478|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461685|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
44461686|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844386|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
44079673|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
44079674|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44079675|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079676|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
44079677|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
44079678|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079679|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079680|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079681|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
44079682|NCT05367271|Hormones|hormones|mesh-ancestor
44079683|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079684|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079685|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079686|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44079687|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079688|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079689|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
44079690|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079691|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44079692|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
44079693|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44079694|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44079695|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079696|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
44079697|NCT05359172|Coagulants|coagulants|mesh-ancestor
44079698|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
44079700|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079701|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
44079702|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079703|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
44079704|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079705|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079706|NCT05309304|Cefazolin|cefazolin|mesh-list
44079707|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079708|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079709|NCT05298592|Nivolumab|nivolumab|mesh-list
44079710|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079711|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079712|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44079713|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079714|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44079715|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079716|NCT05268185|Vaccines|vaccines|mesh-list
44079717|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
44079718|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079719|NCT05239286|Anesthetics|anesthetics|mesh-list
44079720|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079721|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079722|NCT05233956|Chrysarobin|chrysarobin|mesh-list
44079723|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44079724|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079725|NCT05233956|Analgesics|analgesics|mesh-ancestor
44079726|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
44079727|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079728|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461687|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461688|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44461690|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
44461691|NCT01541215|Metformin|metformin|mesh-list
44461692|NCT01541215|Liraglutide|liraglutide|mesh-list
44461693|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44461694|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461695|NCT01541215|Incretins|incretins|mesh-ancestor
44461696|NCT01541215|Hormones|hormones|mesh-ancestor
44461697|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079729|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079730|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44151706|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151707|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151708|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
44151709|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151710|NCT00215228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44151711|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151712|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151713|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151714|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44151715|NCT00215228|Analgesics|analgesics|mesh-ancestor
44151716|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
44151717|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
44151718|NCT00215241|Risperidone|risperidone|mesh-list
44151719|NCT00215241|Sertraline|sertraline|mesh-list
44151720|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44151721|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
44151722|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151723|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151724|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151725|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44151726|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44151727|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151728|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151729|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44151730|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
44151731|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151732|NCT00215241|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44151733|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44151734|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151735|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44151736|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
44151737|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151738|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44151739|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44151740|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151741|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151742|NCT00215267|Praziquantel|praziquantel|mesh-list
44151743|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
44151744|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44151745|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151746|NCT00215280|Ivermectin|ivermectin|mesh-list
44151747|NCT00215280|Albendazole|albendazole|mesh-list
44151774|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44151775|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44151776|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079732|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
44079733|NCT05223582|Androgens|androgens|mesh-list
44079734|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079735|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
44079736|NCT05223582|Hormones|hormones|mesh-ancestor
44079737|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461698|NCT01540838|Acetaminophen|acetaminophen|mesh-list
44461699|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461700|NCT01540838|Analgesics|analgesics|mesh-ancestor
44461701|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
44461702|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461703|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461704|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
44461705|NCT01540565|Veliparib|veliparib|mesh-list
44461706|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44461707|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079738|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079739|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079740|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079741|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44079742|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079743|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079744|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
44079745|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44079746|NCT05221840|Durvalumab|durvalumab|mesh-list
44079747|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079748|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079749|NCT05171179|Lidocaine|lidocaine|mesh-list
44079755|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
44079756|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079757|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44079758|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44079759|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44079760|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44079761|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079763|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079764|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44079765|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44079766|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44079767|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079768|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
44079769|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44079770|NCT05114941|Antibodies|antibodies|mesh-list
44079771|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
44079772|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44079773|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
44079774|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079775|NCT05105685|Hormones|hormones|mesh-list
44079776|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079777|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079778|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
44079779|NCT05080049|Hematinics|hematinics|mesh-ancestor
44079780|NCT05076175|Ozanimod|ozanimod|mesh-list
44079781|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44079782|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079783|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079784|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
44079785|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079786|NCT05072444|QPX7728|qpx7728|mesh-list
44079787|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44079788|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079789|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079790|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079791|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079792|NCT05055830|Acetaminophen|acetaminophen|mesh-list
44079793|NCT05055830|Methadone|methadone|mesh-list
44079794|NCT05055830|Caffeine|caffeine|mesh-list
44079795|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44079796|NCT05055830|Analgesics|analgesics|mesh-ancestor
44079797|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
43788934|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
44461708|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461710|NCT01540487|Metformin|metformin|mesh-list
44461711|NCT01540487|Linagliptin|linagliptin|mesh-list
44461712|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44461713|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079798|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079799|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079800|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
44079801|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44079802|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44079803|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079804|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799550|NCT05005715|Analgesics|analgesics|mesh-ancestor
44079805|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44079806|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44079807|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
44079808|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079809|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44079810|NCT05055830|Narcotics|narcotics|mesh-ancestor
44079811|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079812|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
44079813|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079815|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
44079816|NCT05051891|Vincristine|vincristine|mesh-list
44079817|NCT05051891|Rituximab|rituximab|mesh-list
44079818|NCT05051891|Doxorubicin|doxorubicin|mesh-list
44079819|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079821|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079822|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079823|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44079824|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
44079825|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079826|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079827|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44079828|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079829|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
44079830|NCT05051891|Hormones|hormones|mesh-ancestor
44079831|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079832|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44079833|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44079834|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44079835|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44079836|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
44079837|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079838|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44079839|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44079840|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44079841|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079842|NCT05038410|Wobenzym|wobenzym|mesh-list
44079843|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44079844|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
44079845|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079846|NCT05030493|Bevacizumab|bevacizumab|mesh-list
44079847|NCT05030493|Panitumumab|panitumumab|mesh-list
44079848|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079849|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079850|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44079851|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44079852|NCT05030493|Growth Substances|growth substances|mesh-ancestor
44079853|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079854|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
44079855|NCT05023382|Teduglutide|teduglutide|mesh-list
44079856|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079857|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44079858|NCT05023382|Protective Agents|protective agents|mesh-ancestor
44079859|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079860|NCT04997304|Albuterol|albuterol|mesh-list
44079861|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44461715|NCT01540487|Hormones|hormones|mesh-ancestor
44461716|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079862|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
44079863|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079864|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079865|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44079866|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079867|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44079868|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44079869|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44079870|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079871|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079872|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079873|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
44079874|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44079875|NCT04996251|Bupivacaine|bupivacaine|mesh-list
44079876|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079877|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
44079878|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079879|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079880|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
44079881|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079882|NCT04983901|Vancomycin|vancomycin|mesh-list
44079883|NCT04983901|Meropenem|meropenem|mesh-list
44079884|NCT04983901|Tazobactam|tazobactam|mesh-list
44079885|NCT04983901|Linezolid|linezolid|mesh-list
44079886|NCT04983901|Piperacillin|piperacillin|mesh-list
44079887|NCT04983901|Daptomycin|daptomycin|mesh-list
44079888|NCT04983901|Imipenem|imipenem|mesh-list
44079889|NCT04983901|Cefepime|cefepime|mesh-list
44079890|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44079891|NCT04983901|Relebactam|relebactam|mesh-list
44079892|NCT04983901|Cilastatin|cilastatin|mesh-list
44079893|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44079894|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079895|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44079896|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079897|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079898|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44079899|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
44079900|NCT04978675|Fluorides|fluorides|mesh-list
44079901|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
44079902|NCT04978675|Protective Agents|protective agents|mesh-ancestor
44079903|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079904|NCT04971343|Antibodies|antibodies|mesh-list
44079905|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
44079906|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
44079907|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079908|NCT04964414|Budesonide|budesonide|mesh-list
44079909|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
44079910|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44079911|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44079912|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
44079913|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079914|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079915|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44079916|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
44079917|NCT04964414|Hormones|hormones|mesh-ancestor
44079918|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44079919|NCT04955678|Sorbitol|sorbitol|mesh-list
44079920|NCT04955678|Calcium|calcium|mesh-list
44079921|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44079922|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079923|NCT04955678|Cathartics|cathartics|mesh-ancestor
44079924|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44079925|NCT04954365|Amisulpride|amisulpride|mesh-list
44079926|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44079927|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079928|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079929|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079930|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079931|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44461717|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44461718|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
44461719|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461720|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079932|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
44079933|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079934|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079935|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44079936|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
44079937|NCT04951804|Bupivacaine|bupivacaine|mesh-list
44079938|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079939|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
44079940|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079941|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079942|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
44079943|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079944|NCT04917900|Paclitaxel|paclitaxel|mesh-list
44079945|NCT04917900|Trastuzumab|trastuzumab|mesh-list
44079946|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44079947|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44079948|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079949|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
44079950|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
44079951|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
44079952|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079953|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079954|NCT04905121|Psilocybin|psilocybin|mesh-list
43799695|NCT05003596|Hormones|hormones|mesh-ancestor
44079955|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
44079956|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079957|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079958|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
44079959|NCT04887805|Lenvatinib|lenvatinib|mesh-list
44079960|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44079961|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079962|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44079963|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079964|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079965|NCT04877288|Cyclosporine|cyclosporine|mesh-list
44079966|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
44079967|NCT04877288|Abatacept|abatacept|mesh-list
44079968|NCT04877288|Tacrolimus|tacrolimus|mesh-list
44079969|NCT04877288|Cyclosporins|cyclosporins|mesh-list
44079970|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44079971|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
44079973|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44079974|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079975|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079976|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
44079978|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44079979|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079980|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44079981|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44079982|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44079983|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
44079984|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622865|NCT03105193|Lidocaine|lidocaine|mesh-list
44079985|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44079986|NCT04876079|Insulin|insulin|mesh-list
44079987|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44079988|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079989|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
44079990|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44079991|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
44079992|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079993|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
44079994|NCT04866706|Protective Agents|protective agents|mesh-ancestor
44151777|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
44151778|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151779|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
44151780|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151781|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461722|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44461723|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
44461724|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
44461725|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461726|NCT01539642|Sufentanil|sufentanil|mesh-list
44461727|NCT01539642|Dsuvia|dsuvia|mesh-list
44461728|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44461729|NCT01539642|Narcotics|narcotics|mesh-ancestor
44461730|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461731|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461732|NCT01539642|Analgesics|analgesics|mesh-ancestor
44461733|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
43655042|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
44151782|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151783|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151784|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151785|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151786|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151787|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151788|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151789|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151790|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
44151791|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151792|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
44151793|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151794|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151795|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151796|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151797|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151798|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151799|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151800|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151801|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151802|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151803|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
44151804|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151805|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
44151806|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151807|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151808|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151809|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151810|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151811|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151812|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151813|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079995|NCT04815902|Losartan|losartan|mesh-list
44079996|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44079997|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44079998|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44079999|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44080000|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080001|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44080002|NCT04808414|Polymyxins|polymyxins|mesh-list
44080003|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080004|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
44080005|NCT04796779|Trace Elements|trace elements|mesh-ancestor
44080006|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
44080007|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080008|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
44080010|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461734|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461735|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44080011|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080012|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080014|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080015|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080016|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080017|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080018|NCT04752475|Furosemide|furosemide|mesh-list
44080019|NCT04752475|Diuretics|diuretics|mesh-ancestor
44080020|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
44080021|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080022|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44080023|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080024|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080025|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44080026|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44080027|NCT04736823|Paclitaxel|paclitaxel|mesh-list
44080028|NCT04736823|Docetaxel|docetaxel|mesh-list
44080029|NCT04736823|Carboplatin|carboplatin|mesh-list
44080030|NCT04736823|Pemetrexed|pemetrexed|mesh-list
44080031|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44080032|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080033|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
44080034|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
44080035|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
44080036|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080037|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080038|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44080039|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44080040|NCT04734730|Prednisone|prednisone|mesh-list
44080041|NCT04734730|Cortisone|cortisone|mesh-list
44080042|NCT04734730|Leuprolide|leuprolide|mesh-list
44080043|NCT04734730|Goserelin|goserelin|mesh-list
44080044|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
44080045|NCT04734730|Bicalutamide|bicalutamide|mesh-list
44080046|NCT04734730|Talazoparib|talazoparib|mesh-list
44080047|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080048|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
44080049|NCT04734730|Hormones|hormones|mesh-ancestor
44080050|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080051|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080052|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44080053|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080054|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44080055|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
44080056|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44080057|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44080058|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080059|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080060|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
44080061|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44080062|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
44080063|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44080064|NCT04726280|Ropivacaine|ropivacaine|mesh-list
44080065|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44080066|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44080067|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
44080068|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080069|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080070|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
44080071|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080072|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
44080073|NCT04674813|Fludarabine|fludarabine|mesh-list
44080074|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080075|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
44080076|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080077|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080078|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44080079|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
44080080|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080081|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578489|NCT03480191|Daptomycin|daptomycin|mesh-list
44461736|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44461737|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
44461738|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
44461739|NCT01539538|Sufentanil|sufentanil|mesh-list
44461740|NCT01539538|Morphine|morphine|mesh-list
44461741|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44461742|NCT01539538|Narcotics|narcotics|mesh-ancestor
44461743|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461744|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080094|NCT04623775|Nivolumab|nivolumab|mesh-list
44080095|NCT04623775|Pemetrexed|pemetrexed|mesh-list
44080096|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44080097|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080098|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
44080099|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
44080100|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
44080101|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080102|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080103|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080104|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080105|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44080106|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44080107|NCT04619680|Nintedanib|nintedanib|mesh-list
44080108|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080109|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44080110|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080111|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080112|NCT04610684|Carboplatin|carboplatin|mesh-list
44080113|NCT04610684|Etoposide|etoposide|mesh-list
44080114|NCT04610684|Atezolizumab|atezolizumab|mesh-list
44080115|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080116|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44080117|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44080118|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44080119|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080120|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080121|NCT04604782|Regadenoson|regadenoson|mesh-list
44080122|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44080123|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44080124|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
44080125|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
44080126|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080127|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080128|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080129|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44080130|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44080131|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44080132|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080133|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080134|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080135|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080136|NCT04560673|Analgesics|analgesics|mesh-ancestor
44080137|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
44080138|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080139|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
44080140|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44080141|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
44080142|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
44080143|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44080144|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080145|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080146|NCT04526119|Z 338|z 338|mesh-list
44080147|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44080148|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080149|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461745|NCT01539538|Analgesics|analgesics|mesh-ancestor
44461746|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
44461747|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461748|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44461749|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44461750|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
43655067|NCT02971878|Vitamins|vitamins|mesh-ancestor
44080150|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
44080151|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080152|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080153|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080154|NCT04495894|Ketorolac|ketorolac|mesh-list
44080157|NCT04495894|Analgesics|analgesics|mesh-ancestor
44080158|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
44080159|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080160|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080161|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080162|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080163|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44080164|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080165|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080166|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
44080167|NCT04488081|Cyclosporine|cyclosporine|mesh-list
44080168|NCT04488081|Remdesivir|remdesivir|mesh-list
44080169|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
44080170|NCT04488081|Dexamethasone|dexamethasone|mesh-list
44080171|NCT04488081|Celecoxib|celecoxib|mesh-list
44080172|NCT04488081|Apremilast|apremilast|mesh-list
44080173|NCT04488081|Icatibant|icatibant|mesh-list
44080174|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
44080175|NCT04488081|Famotidine|famotidine|mesh-list
44080176|NCT04488081|Cyclosporins|cyclosporins|mesh-list
44080177|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080178|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
44080179|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
44080180|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080181|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080182|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080183|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
44080184|NCT04488081|Hormones|hormones|mesh-ancestor
44080185|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080186|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44080187|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080188|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080189|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080190|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080191|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
44080192|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
44080193|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080194|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
44080195|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080196|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44080197|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44080198|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44080199|NCT04488081|Analgesics|analgesics|mesh-ancestor
44080200|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
44080201|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44080202|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44080203|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44080204|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44080205|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44080206|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44080207|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44080208|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
44080209|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
44080210|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080211|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
44080212|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
44080213|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
44080214|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44080215|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44461752|NCT01539512|Rituximab|rituximab|mesh-list
44461753|NCT01539512|Idelalisib|idelalisib|mesh-list
44461754|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44461755|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461756|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
44461757|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461758|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461759|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461760|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080216|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
44080217|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44080218|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44080219|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44080220|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44080221|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44080222|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44080223|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44080224|NCT04487236|Capecitabine|capecitabine|mesh-list
44080225|NCT04487236|Trastuzumab|trastuzumab|mesh-list
44080226|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44080227|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
44080228|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43578650|NCT03478475|Vitamin D|vitamin d|mesh-list
44080230|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080231|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
44080233|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080234|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080235|NCT04477304|Analgesics|analgesics|mesh-ancestor
44080236|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
44080237|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080239|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44080240|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080241|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
44080242|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080243|NCT04473482|Ethanol|ethanol|mesh-list
44080244|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44080245|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080246|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080247|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080248|NCT04415944|Carboplatin|carboplatin|mesh-list
44080249|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080250|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
44080251|NCT04401150|Vitamins|vitamins|mesh-ancestor
44080252|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
44080253|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080254|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
44080255|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080256|NCT04401150|Protective Agents|protective agents|mesh-ancestor
44080257|NCT04388475|Temozolomide|temozolomide|mesh-list
44080258|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44080259|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
44080260|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080261|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080262|NCT04258488|Vitamin K|vitamin k|mesh-list
44080263|NCT04258488|Warfarin|warfarin|mesh-list
44080264|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
44080265|NCT04258488|Vitamins|vitamins|mesh-ancestor
44080266|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
44080267|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080268|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
44080269|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44080270|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
44080271|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44080272|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
44080273|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258479|NCT00629473|Dexamethasone|dexamethasone|mesh-list
44258480|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44258481|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258482|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
44080274|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080275|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44080276|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44080277|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
44080278|NCT04258488|Coagulants|coagulants|mesh-ancestor
44080279|NCT04235673|Melatonin|melatonin|mesh-list
44080280|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
44080281|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080282|NCT04235673|Protective Agents|protective agents|mesh-ancestor
44080283|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080284|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080285|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44080286|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080287|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080288|NCT04206488|Digoxin|digoxin|mesh-list
44080289|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44080290|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44080291|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080292|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080293|NCT04206488|Protective Agents|protective agents|mesh-ancestor
44080294|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151814|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151815|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080295|NCT04137887|Vaccines|vaccines|mesh-list
44080296|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
44080297|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080298|NCT04137536|Antibodies|antibodies|mesh-list
44080299|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44080300|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
44080301|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080302|NCT04091880|Vaccines|vaccines|mesh-list
44080316|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44080317|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44080318|NCT03981900|Tofacitinib|tofacitinib|mesh-list
44080319|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44080320|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080321|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080322|NCT03964532|Avelumab|avelumab|mesh-list
44080323|NCT03964532|Talazoparib|talazoparib|mesh-list
44080324|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080325|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080326|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44080327|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080328|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080329|NCT03960151|Dexamethasone|dexamethasone|mesh-list
44080330|NCT03960151|Olanzapine|olanzapine|mesh-list
44080331|NCT03960151|Palonosetron|palonosetron|mesh-list
44080332|NCT03960151|Rolapitant|rolapitant|mesh-list
44080333|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080334|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
44080335|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
44080336|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080337|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080338|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080339|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
44080340|NCT03960151|Hormones|hormones|mesh-ancestor
44080341|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080342|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44080343|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080344|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44080345|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44080346|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080347|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44080348|NCT03960151|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44080349|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44080350|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080351|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258483|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
44258484|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258485|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258486|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650640|NCT03013075|Narcotics|narcotics|mesh-ancestor
44258487|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
44258489|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258490|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258491|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080352|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080353|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
44080354|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44080355|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44080356|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44080357|NCT03960125|Imipramine|imipramine|mesh-list
44080358|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44080359|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
44080360|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44080361|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44080362|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44080363|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080365|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44080366|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080367|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080368|NCT03959969|Ibuprofen|ibuprofen|mesh-list
44080369|NCT03959969|Oxycodone|oxycodone|mesh-list
44080370|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44080371|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44080372|NCT03959969|Analgesics|analgesics|mesh-ancestor
44080373|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
44080374|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080375|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080376|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080377|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080378|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44080379|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080380|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080381|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44080382|NCT03959969|Narcotics|narcotics|mesh-ancestor
44080383|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080384|NCT03959865|Glucagon|glucagon|mesh-list
44080385|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44080386|NCT03959865|Incretins|incretins|mesh-ancestor
44080387|NCT03959865|Hormones|hormones|mesh-ancestor
44080388|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080389|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080390|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080391|NCT03959852|Fentanyl|fentanyl|mesh-list
44080392|NCT03959852|Ketamine|ketamine|mesh-list
44080393|NCT03959852|Analgesics|analgesics|mesh-ancestor
44080394|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
44080395|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080396|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080397|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44080398|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44080399|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
44080400|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
44080401|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080402|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44080403|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44080404|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080405|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080406|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44080407|NCT03959852|Narcotics|narcotics|mesh-ancestor
44258492|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
44258493|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258494|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258495|NCT00629512|Esomeprazole|esomeprazole|mesh-list
44258496|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258497|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258498|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44080408|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44080409|NCT03959761|Nivolumab|nivolumab|mesh-list
44080410|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080411|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080412|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080413|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080414|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
44080415|NCT03959566|Bedaquiline|bedaquiline|mesh-list
44080416|NCT03959566|Midazolam|midazolam|mesh-list
44080417|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44080418|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44080419|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080420|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080421|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44080422|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44080423|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44080424|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44080425|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
44080426|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
44080427|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
44080428|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
44080429|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080430|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080431|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44080432|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080433|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44080434|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44080435|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080436|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080437|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
44080438|NCT03959540|Levodopa|levodopa|mesh-list
44080439|NCT03959540|Opicapone|opicapone|mesh-list
44080440|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44080441|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44080442|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
44080443|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800086|NCT04997564|Tenofovir|tenofovir|mesh-list
44080444|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080445|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080446|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44080447|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080448|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
44080449|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080450|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080451|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44080452|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
44080453|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080454|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080455|NCT03959501|Incretins|incretins|mesh-ancestor
44080456|NCT03959501|Hormones|hormones|mesh-ancestor
44080457|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080458|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44080459|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
44080460|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080461|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080462|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44080463|NCT03959488|Palivizumab|palivizumab|mesh-list
44080464|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
44080465|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080466|NCT03959436|Carbetocin|carbetocin|mesh-list
44080467|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
44080468|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258500|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258501|NCT00629564|Esomeprazole|esomeprazole|mesh-list
44258502|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258503|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258504|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44080469|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080470|NCT03959397|Paclitaxel|paclitaxel|mesh-list
44080471|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44080472|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44080473|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080474|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
44080475|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
44080476|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
44080477|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080478|NCT03959384|Poractant alfa|poractant alfa|mesh-list
44080479|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44080480|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
44080481|NCT03959358|Lenalidomide|lenalidomide|mesh-list
44080482|NCT03959358|Pomalidomide|pomalidomide|mesh-list
44080483|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
44080484|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668878|NCT02240407|Sirolimus|sirolimus|mesh-list
44080485|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44080486|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44080487|NCT03959358|Growth Substances|growth substances|mesh-ancestor
44080488|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
44080489|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151816|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
44151817|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151818|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
44151819|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151820|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151821|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151822|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151823|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151824|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151825|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151826|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151827|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151828|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151829|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
44151830|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151831|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
44151832|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151833|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151834|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151835|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151836|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151837|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151838|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151839|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151840|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151841|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151842|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
44151843|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151844|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
44080491|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
44080492|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080493|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080494|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080495|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44080496|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080497|NCT03959293|Durvalumab|durvalumab|mesh-list
44080498|NCT03959293|Tremelimumab|tremelimumab|mesh-list
44080499|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080500|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080501|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44080502|NCT03959176|Phenylephrine|phenylephrine|mesh-list
44258505|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258506|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258507|NCT00629616|Fulvestrant|fulvestrant|mesh-list
44258508|NCT00629616|Anastrozole|anastrozole|mesh-list
44258509|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258510|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258511|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44258512|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44258513|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
44258514|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258515|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258516|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43655106|NCT02971540|Dipyrone|dipyrone|mesh-list
44080503|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
44080504|NCT03959176|Tropicamide|tropicamide|mesh-list
44080505|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44080506|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
44080507|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
44080508|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080509|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080510|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
44080511|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44080512|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
44080513|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
44080514|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44080515|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44080516|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44080517|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
44080518|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080519|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080520|NCT03959176|Protective Agents|protective agents|mesh-ancestor
44080521|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44080522|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44080523|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44080524|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44080525|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
44080526|NCT03959150|Capecitabine|capecitabine|mesh-list
44080527|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44080528|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
44080529|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080530|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080531|NCT03959124|Memantine|memantine|mesh-list
44080532|NCT03959124|Rivastigmine|rivastigmine|mesh-list
44080533|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44080534|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44080535|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
44080536|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080537|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080538|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080539|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44080540|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44080541|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44080542|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080543|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
44080544|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44080545|NCT03959124|Protective Agents|protective agents|mesh-ancestor
44080546|NCT03958981|Castor Oil|castor oil|mesh-list
44080547|NCT03958981|Cathartics|cathartics|mesh-ancestor
44080548|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080549|NCT03958942|Bupivacaine|bupivacaine|mesh-list
44080550|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
44080551|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
44258517|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44258518|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258519|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258520|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
44258521|NCT00629642|Oxybutynin|oxybutynin|mesh-list
44258522|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44258523|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44258524|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
44258525|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258526|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258527|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258528|NCT00629642|Urological Agents|urological agents|mesh-ancestor
44258529|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
44258530|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
44258531|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258532|NCT00629681|Pregabalin|pregabalin|mesh-list
44258533|NCT00629681|Analgesics|analgesics|mesh-ancestor
44258534|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
44258535|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258536|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258537|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
44258538|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44258539|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655116|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44080552|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080553|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080554|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
44080555|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080556|NCT03958877|Interferons|interferons|mesh-list
44080557|NCT03958877|Interferon-beta|interferon-beta|mesh-list
44080558|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080573|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080574|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080575|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
44080576|NCT03958565|Denosumab|denosumab|mesh-list
44080577|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44080578|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44080579|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080580|NCT03958513|Bupivacaine|bupivacaine|mesh-list
44080581|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
44080582|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
44080583|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080584|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080585|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
44080586|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080587|NCT03958500|Methylene Blue|methylene blue|mesh-list
44080588|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080589|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080591|NCT03958396|Remifentanil|remifentanil|mesh-list
44080592|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44258540|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258541|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258542|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44258543|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258544|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258545|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258546|NCT00629720|Alfuzosin|alfuzosin|mesh-list
44080593|NCT03958396|Narcotics|narcotics|mesh-ancestor
44080594|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080595|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080596|NCT03958396|Analgesics|analgesics|mesh-ancestor
44080597|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
44080598|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080599|NCT03958383|Nivolumab|nivolumab|mesh-list
44080600|NCT03958383|Ipilimumab|ipilimumab|mesh-list
44080601|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080602|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080603|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080604|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080605|NCT03958344|Prednisolone|prednisolone|mesh-list
44080606|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44080607|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
44080608|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44080609|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
44080610|NCT03958344|Triamcinolone|triamcinolone|mesh-list
44080611|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44080612|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
44080613|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080614|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
44080615|NCT03958344|Hormones|hormones|mesh-ancestor
44080616|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44080617|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080618|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44080619|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080620|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
44080621|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
44080622|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080624|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44080625|NCT03958344|Protective Agents|protective agents|mesh-ancestor
44080626|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
44080627|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44080628|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44080629|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080630|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44080631|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44080632|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080633|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080634|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080635|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44080636|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
44080637|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44080638|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080639|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44080640|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44080641|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44080642|NCT03958097|Antibodies|antibodies|mesh-list
44080643|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
44080644|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080645|NCT03951207|Amlodipine|amlodipine|mesh-list
44080646|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44080647|NCT03951207|Atorvastatin|atorvastatin|mesh-list
44080648|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44080649|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44080650|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
44080651|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080652|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43789042|NCT02117076|Gabapentin|gabapentin|mesh-list
44258547|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44258548|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44258549|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44258550|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
44258551|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461761|NCT01539317|Lidocaine|lidocaine|mesh-list
44080653|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44080654|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080655|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44080656|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44080657|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080658|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44080659|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080660|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
44080662|NCT03933865|Hydromorphone|hydromorphone|mesh-list
44080663|NCT03933865|Analgesics|analgesics|mesh-ancestor
44080664|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
44080665|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080666|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080667|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44080668|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44080669|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
44080670|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
44080671|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080672|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44080673|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44080674|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080675|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080676|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44080677|NCT03933865|Narcotics|narcotics|mesh-ancestor
44080678|NCT03927222|Temozolomide|temozolomide|mesh-list
44080679|NCT03927222|Molgramostim|molgramostim|mesh-list
44080680|NCT03927222|Sargramostim|sargramostim|mesh-list
44080681|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
44080682|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080683|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44080684|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
44080685|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080686|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080687|NCT03873857|Venetoclax|venetoclax|mesh-list
44080688|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080689|NCT03866408|Pioglitazone|pioglitazone|mesh-list
44080690|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080691|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080692|NCT03857087|Edetic Acid|edetic acid|mesh-list
44080693|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44080694|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
44080695|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
44080696|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080699|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44080700|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
44080702|NCT03852407|Fludarabine|fludarabine|mesh-list
44080703|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
44080704|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080705|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
44080706|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080707|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080708|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44080709|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
44080710|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080711|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080712|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44080713|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
44080714|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080715|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080716|NCT03823274|Aspirin|aspirin|mesh-list
44080717|NCT03823274|Clopidogrel|clopidogrel|mesh-list
44080718|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44080719|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44258552|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258553|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258554|NCT00629720|Urological Agents|urological agents|mesh-ancestor
44258555|NCT00629811|Mitogens|mitogens|mesh-list
44258556|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
43655148|NCT02971306|Protective Agents|protective agents|mesh-ancestor
44080720|NCT03823274|Analgesics|analgesics|mesh-ancestor
44080721|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
44080722|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080723|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080724|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080725|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080726|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44080727|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44080728|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080729|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44080730|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44080731|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080733|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44080734|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44080735|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44080736|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
44080737|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151845|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151846|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151847|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151848|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151849|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151850|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151851|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151852|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151853|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151854|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151855|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
44151856|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151857|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
44151858|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151859|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151860|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151861|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151862|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151863|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151864|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151865|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151866|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151867|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151868|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
44151869|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44151870|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
44151871|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151872|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151873|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44151874|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
44151875|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44151876|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44151877|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44151878|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
44151879|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151880|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151881|NCT00215462|Vinorelbine|vinorelbine|mesh-list
44151882|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44151883|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151884|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151885|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151886|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
43789043|NCT02117076|Analgesics|analgesics|mesh-ancestor
44258557|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258559|NCT00629824|Ribavirin|ribavirin|mesh-list
44258560|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
44258561|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44151887|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151888|NCT00215501|Cisplatin|cisplatin|mesh-list
44151889|NCT00215501|Fluorouracil|fluorouracil|mesh-list
44151890|NCT00215501|Capecitabine|capecitabine|mesh-list
44151891|NCT00215501|Irinotecan|irinotecan|mesh-list
44151892|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151893|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
44151894|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151895|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151896|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080738|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
44080739|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44080740|NCT03819322|Velpatasvir|velpatasvir|mesh-list
44080741|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
44080742|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080743|NCT03815890|Nivolumab|nivolumab|mesh-list
44080744|NCT03815890|Ipilimumab|ipilimumab|mesh-list
44080745|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080746|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080747|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080748|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080749|NCT03779789|Vortioxetine|vortioxetine|mesh-list
44080750|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
44080752|NCT03779789|Fluoxetine|fluoxetine|mesh-list
44080753|NCT03779789|Paroxetine|paroxetine|mesh-list
44080754|NCT03779789|Sertraline|sertraline|mesh-list
44080755|NCT03779789|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44080756|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44080757|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44080758|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080759|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080760|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
44080761|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080762|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44080763|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
44080764|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44080765|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44080766|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44080767|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080768|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44080769|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44080770|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080771|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44080772|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44080773|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44080774|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44080775|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44080776|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44080777|NCT03766581|Aspirin|aspirin|mesh-list
44080778|NCT03766581|Clopidogrel|clopidogrel|mesh-list
44080779|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44080780|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44080781|NCT03766581|Analgesics|analgesics|mesh-ancestor
44080782|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
44080783|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080784|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080785|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080786|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080787|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44080788|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44080789|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080790|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44080791|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44080801|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44258562|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258563|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
44258564|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258565|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
44258566|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258567|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
44258568|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258569|NCT00629837|Factor VIII|factor viii|mesh-list
44258570|NCT00629837|Coagulants|coagulants|mesh-ancestor
44258571|NCT00629863|Cisplatin|cisplatin|mesh-list
44258572|NCT00629863|Fluorouracil|fluorouracil|mesh-list
44258573|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258574|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
44258575|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258576|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258577|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258578|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
44258579|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258580|NCT00629889|Pregabalin|pregabalin|mesh-list
44258581|NCT00629889|Levetiracetam|levetiracetam|mesh-list
44258582|NCT00629889|Analgesics|analgesics|mesh-ancestor
44258583|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
44258584|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258585|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258586|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
44258587|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44258588|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258589|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258590|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258591|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44258592|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258593|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258594|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258595|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
44258596|NCT00629928|Esomeprazole|esomeprazole|mesh-list
44258597|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44258600|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258601|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258602|NCT00629967|Interferons|interferons|mesh-list
44258603|NCT00629967|Ribavirin|ribavirin|mesh-list
44258604|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
44258605|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
44258606|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44258607|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080802|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44080804|NCT03732664|Nivolumab|nivolumab|mesh-list
44080805|NCT03732664|Durvalumab|durvalumab|mesh-list
44080806|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080807|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080808|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080809|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080810|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
44080811|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800371|NCT04991207|Bosentan|bosentan|mesh-list
44080812|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080813|NCT03700476|Gemcitabine|gemcitabine|mesh-list
44080814|NCT03700476|Cisplatin|cisplatin|mesh-list
44080815|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080816|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44080817|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
44080818|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080819|NCT03700476|Antiviral Agents|antiviral agents|mesh-ancestor
44080820|NCT03700476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080821|NCT03700476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080822|NCT03700476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080823|NCT03700476|Immunologic Factors|immunologic factors|mesh-ancestor
44080824|NCT03700476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080825|NCT03698006|Ropivacaine|ropivacaine|mesh-list
44080826|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44080827|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
44080828|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
44080829|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080830|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080831|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
44080832|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080833|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
44080834|NCT03655002|Nivolumab|nivolumab|mesh-list
44080835|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080836|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
44080837|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080838|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080839|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44080840|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
44080841|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080842|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080843|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44080844|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080845|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080846|NCT03647124|Lenalidomide|lenalidomide|mesh-list
44080847|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
44080848|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080849|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44080850|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44080851|NCT03647124|Growth Substances|growth substances|mesh-ancestor
44080852|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
44080853|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080854|NCT03638141|Durvalumab|durvalumab|mesh-list
44080855|NCT03638141|Ipilimumab|ipilimumab|mesh-list
44080856|NCT03638141|Tremelimumab|tremelimumab|mesh-list
44080857|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44080860|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
44080861|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080862|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44080863|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258608|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
44258609|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258610|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
43844818|NCT04331691|Amiloride|amiloride|mesh-list
44080871|NCT03564340|Cemiplimab|cemiplimab|mesh-list
44080872|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080873|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080874|NCT03559985|Acetaminophen|acetaminophen|mesh-list
44080875|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44080876|NCT03559985|Analgesics|analgesics|mesh-ancestor
44080877|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
44080878|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080879|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080880|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
44080881|NCT03526107|Theobromine|theobromine|mesh-list
44080882|NCT03526107|Caffeine|caffeine|mesh-list
44080883|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44080884|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080885|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44080886|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800471|NCT04990167|Bromides|bromides|mesh-list
44080887|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080888|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44080889|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44080890|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
44080891|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080892|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44080893|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
44080894|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080895|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44080896|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
44080897|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
44080898|NCT03514108|Metformin|metformin|mesh-list
44080899|NCT03514108|Hydralazine|hydralazine|mesh-list
44080900|NCT03514108|Isosorbide|isosorbide|mesh-list
44080901|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44080902|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44080903|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080904|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080905|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44080906|NCT03514108|Diuretics|diuretics|mesh-ancestor
44080907|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
44080908|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
44080909|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44080910|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080911|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44080912|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
44080913|NCT03508726|Vitamins|vitamins|mesh-ancestor
44080914|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
44080915|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080916|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
44080917|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080918|NCT03508726|Protective Agents|protective agents|mesh-ancestor
44080919|NCT03506373|Ixazomib|ixazomib|mesh-list
44080920|NCT03506373|Glycine|glycine|mesh-list
44080921|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080922|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080923|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
44080924|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080925|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
44080926|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080927|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080928|NCT03432091|Melatonin|melatonin|mesh-list
44080929|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
44080930|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080932|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080933|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080934|NCT03187080|Bupivacaine|bupivacaine|mesh-list
44258611|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814487|NCT04796675|Fludarabine|fludarabine|mesh-list
44080935|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
44080936|NCT03187080|Anesthetics|anesthetics|mesh-list
44080937|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44080938|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080939|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
44080940|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080941|NCT03183115|Lugol's solution|lugol's solution|mesh-list
44080942|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
44080943|NCT03183115|Coagulants|coagulants|mesh-ancestor
44080944|NCT03152175|Propranolol|propranolol|mesh-list
44080945|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44080946|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44080947|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44080948|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080949|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080950|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080951|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44080952|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44080953|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44080954|NCT03152149|Fluticasone|fluticasone|mesh-list
44080956|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
44080957|NCT03152149|Olodaterol|olodaterol|mesh-list
44080958|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080959|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44080960|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
44080961|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080962|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080963|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44080964|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44080965|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44080966|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44080967|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
44080968|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44080969|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
44080970|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080971|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080972|NCT03152123|Phentermine|phentermine|mesh-list
44080973|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44080974|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080975|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
44080976|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44080977|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
44080978|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
44080979|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44080980|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
44080981|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080982|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080983|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44080984|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44080985|NCT03152097|Protective Agents|protective agents|mesh-ancestor
44080986|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080987|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080988|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
44080989|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44080990|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080991|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44080992|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080993|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
44080994|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44080995|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
44080996|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080997|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44080998|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44080999|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44081000|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44081001|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081002|NCT03151876|Gemcitabine|gemcitabine|mesh-list
44081004|NCT03151876|Cladribine|cladribine|mesh-list
43840688|NCT04678050|Analgesics|analgesics|mesh-ancestor
44258613|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258614|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
44258615|NCT00630019|Levofloxacin|levofloxacin|mesh-list
44258616|NCT00630019|Ofloxacin|ofloxacin|mesh-list
44258617|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44258618|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44081005|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081006|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
44081010|NCT03151876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081011|NCT03151876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081012|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081013|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
44081014|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081015|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
44081016|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081017|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081018|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
44081019|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
44081020|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081021|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081022|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081023|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44081024|NCT03151863|Analgesics|analgesics|mesh-ancestor
44081025|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
44081026|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081027|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44081028|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44081029|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44081030|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44081031|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081032|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081033|NCT03151863|Narcotics|narcotics|mesh-ancestor
44151897|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
44151898|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151899|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44151900|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44081034|NCT03151772|Metformin|metformin|mesh-list
44081035|NCT03151772|Disulfiram|disulfiram|mesh-list
44081036|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44081037|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081038|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44081039|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44081040|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081041|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081042|NCT03151746|Gabapentin|gabapentin|mesh-list
44081043|NCT03151746|Analgesics|analgesics|mesh-ancestor
44081044|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
44081045|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081046|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081047|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
44081048|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081049|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081050|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081051|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44081052|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44081053|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44081054|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081055|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081056|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
44081057|NCT03151720|Loratadine|loratadine|mesh-list
44081058|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
44081059|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
44081060|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44081061|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44081062|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44081063|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
44081064|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
44081065|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081066|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258619|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44258620|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258621|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258622|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44258623|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258624|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258625|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258626|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258627|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44258628|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
44258629|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258630|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258631|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44258632|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44258633|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44081067|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081068|NCT03151707|Niacinamide|niacinamide|mesh-list
44081070|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
44081071|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
44081072|NCT03151707|Vitamins|vitamins|mesh-ancestor
44081073|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
44081074|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081076|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
44081077|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081078|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44081079|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
44081080|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
44081081|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081082|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081083|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081084|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44081085|NCT03151668|Analgesics|analgesics|mesh-ancestor
44081086|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
44081087|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081088|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44081089|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44081090|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44081091|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
44081092|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081093|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081094|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44081095|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
44081096|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081097|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081098|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081099|NCT03151603|Fosfomycin|fosfomycin|mesh-list
44081100|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081101|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081102|NCT03151525|Azathioprine|azathioprine|mesh-list
44081103|NCT03151525|Infliximab|infliximab|mesh-list
44081104|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
44081105|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081106|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081107|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
44151901|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842223|NCT04545736|Metformin|metformin|mesh-list
44081108|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258634|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44258635|NCT00630019|Renal Agents|renal agents|mesh-ancestor
44258636|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44258637|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44258638|NCT00630045|Capecitabine|capecitabine|mesh-list
44081109|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081110|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081111|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081112|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
44081113|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081115|NCT03151499|BI 409306|bi 409306|mesh-list
44081116|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44081117|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
44081118|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081119|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081120|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
44081121|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44081122|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081123|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081124|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44081125|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44081126|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44081127|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44081128|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44081129|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44081130|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44081131|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
44081132|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
44081133|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44081134|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44081135|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
44081136|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081137|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081138|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081139|NCT03151460|Dopamine|dopamine|mesh-list
44081140|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
44081141|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44081142|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
44081143|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
44081144|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081145|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081165|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
44081166|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081167|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081168|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
44081169|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081170|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081171|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081172|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44081173|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44081174|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
44081175|NCT03151369|Morphine|morphine|mesh-list
44081176|NCT03151369|Analgesics|analgesics|mesh-list
44081177|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44081178|NCT03151369|Narcotics|narcotics|mesh-ancestor
44081179|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081180|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081181|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
44081182|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081184|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44081185|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081186|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44081187|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081188|NCT03151239|Niacinamide|niacinamide|mesh-list
44081189|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
44081190|NCT03151239|Vitamins|vitamins|mesh-ancestor
44081191|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
44081192|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258639|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
44258640|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258641|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
44258642|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258643|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258644|NCT00630084|Interferons|interferons|mesh-list
44258645|NCT00630084|Ribavirin|ribavirin|mesh-list
44081193|NCT03151213|Pregabalin|pregabalin|mesh-list
44081194|NCT03151213|Analgesics|analgesics|mesh-ancestor
44081195|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
44081196|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081197|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081198|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
44081199|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44081200|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081201|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081202|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081204|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081205|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081206|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44081207|NCT03151174|Vitamin D|vitamin d|mesh-list
44081208|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
44081209|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
44081210|NCT03151174|Vitamins|vitamins|mesh-list
44081211|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
44081212|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081213|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44081214|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081215|NCT03151161|Carboplatin|carboplatin|mesh-list
44081216|NCT03151161|Pemetrexed|pemetrexed|mesh-list
44081217|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081218|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081219|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081220|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44081221|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44081222|NCT03151096|Riboflavin|riboflavin|mesh-list
44081223|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
44081224|NCT03151096|Vitamins|vitamins|mesh-ancestor
44081225|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
44081226|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081227|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44081228|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
44081229|NCT03151044|Rituximab|rituximab|mesh-list
44081230|NCT03151044|Epirubicin|epirubicin|mesh-list
44081231|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081232|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081233|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
44081234|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081235|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081236|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44081237|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44081238|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44081239|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081240|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081241|NCT03151005|Metformin|metformin|mesh-list
44081242|NCT03151005|Liraglutide|liraglutide|mesh-list
44081243|NCT03151005|Exenatide|exenatide|mesh-list
44081244|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
44081245|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
44081246|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44081247|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081248|NCT03151005|Incretins|incretins|mesh-ancestor
44081249|NCT03151005|Hormones|hormones|mesh-ancestor
44081250|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081251|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44081252|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44081253|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44081254|NCT03150914|Sirolimus|sirolimus|mesh-list
44081255|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081256|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258647|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
44258648|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44258649|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258650|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
44258651|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258652|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
44258653|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258654|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
44258655|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258656|NCT00630097|Modafinil|modafinil|mesh-list
44258657|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44258658|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258659|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44258660|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44258661|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43655209|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
44081257|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44081258|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081259|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
44081260|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081261|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
44081262|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081263|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
44081264|NCT03150875|Docetaxel|docetaxel|mesh-list
44081265|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081266|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081267|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44081268|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081269|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081270|NCT03150836|Durvalumab|durvalumab|mesh-list
44081271|NCT03150836|Tremelimumab|tremelimumab|mesh-list
44081272|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081273|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081275|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081276|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
44081277|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081278|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081279|NCT03150797|Melatonin|melatonin|mesh-list
44081282|NCT03150797|Protective Agents|protective agents|mesh-ancestor
44081283|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081284|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081285|NCT03150771|Aripiprazole|aripiprazole|mesh-list
44081286|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
44081287|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44081288|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44081289|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081290|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081291|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081292|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
44081293|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
44081294|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081295|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081296|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44081297|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44081298|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
44081299|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44258662|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258663|NCT00630110|Docetaxel|docetaxel|mesh-list
43815359|NCT04661514|Psilocybin|psilocybin|mesh-list
44081300|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44081301|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44081302|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44081303|NCT03150732|Nalbuphine|nalbuphine|mesh-list
44081304|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44081305|NCT03150732|Narcotics|narcotics|mesh-ancestor
44081306|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081307|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081308|NCT03150732|Analgesics|analgesics|mesh-ancestor
44081309|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
44081310|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081311|NCT03150706|Avelumab|avelumab|mesh-list
44081312|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081313|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081314|NCT03150693|Cytarabine|cytarabine|mesh-list
44081315|NCT03150693|Dexamethasone|dexamethasone|mesh-list
44081316|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
44081317|NCT03150693|Rituximab|rituximab|mesh-list
44081318|NCT03150693|Doxorubicin|doxorubicin|mesh-list
44081319|NCT03150693|Methotrexate|methotrexate|mesh-list
44081320|NCT03150693|Vincristine|vincristine|mesh-list
44081321|NCT03150693|Daunorubicin|daunorubicin|mesh-list
44081322|NCT03150693|Asparaginase|asparaginase|mesh-list
44081323|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
44081324|NCT03150693|Thioguanine|thioguanine|mesh-list
44081325|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44081326|NCT03150693|Pegaspargase|pegaspargase|mesh-list
44081327|NCT03150693|Allopurinol|allopurinol|mesh-list
44081328|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081329|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
44081330|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081331|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081332|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081333|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
44081334|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081335|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081336|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081337|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081338|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44081339|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
44081340|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
44081341|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081342|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081343|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
44081344|NCT03150693|Hormones|hormones|mesh-ancestor
44081345|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081346|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44081347|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44081348|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44081349|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44081350|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081351|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44081352|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
44081353|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44081357|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44081358|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44081359|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
44081360|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081361|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44081362|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081363|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
44081364|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081365|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
44081366|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44081367|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
44081368|NCT03150693|Protective Agents|protective agents|mesh-ancestor
44081369|NCT03150680|Clopidogrel|clopidogrel|mesh-list
44081370|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44081371|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44081372|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44081373|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44081374|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
44258664|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258665|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
44258666|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
44258667|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
44258668|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081375|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081376|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081377|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081378|NCT03150667|Clopidogrel|clopidogrel|mesh-list
44081379|NCT03150667|Ticagrelor|ticagrelor|mesh-list
44081380|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44081381|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44081382|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44081383|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44081384|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
44081385|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081386|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081387|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081388|NCT03150524|Verapamil|verapamil|mesh-list
44081389|NCT03150524|Nimodipine|nimodipine|mesh-list
44081390|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44081391|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44081392|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081393|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081394|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081395|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081396|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
44081397|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44081398|NCT03150459|Rifaximin|rifaximin|mesh-list
44081399|NCT03150459|Simvastatin|simvastatin|mesh-list
44081400|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44081401|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44081402|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
44081403|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081404|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44081405|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44081406|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800753|NCT04985201|Irinotecan|irinotecan|mesh-list
44081407|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081408|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081409|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081410|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
44081411|NCT03150420|Antidotes|antidotes|mesh-ancestor
44081412|NCT03150420|Protective Agents|protective agents|mesh-ancestor
44081413|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081414|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
44081415|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081416|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
44081417|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081418|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081419|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
44081420|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
44081421|NCT03150368|Docetaxel|docetaxel|mesh-list
44081422|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081423|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081424|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44081425|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081426|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081428|NCT03150316|Lenalidomide|lenalidomide|mesh-list
44081429|NCT03150316|CKD-581|ckd-581|mesh-list
44081430|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44081431|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
44081432|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
44081433|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081434|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081435|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081436|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
44081437|NCT03150316|Hormones|hormones|mesh-ancestor
44081438|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258671|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258672|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258673|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44258674|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44258675|NCT00630175|Zolpidem|zolpidem|mesh-list
44258676|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44258677|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44258678|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655232|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081439|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44081440|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081441|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081442|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081443|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
44081444|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44081445|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44081446|NCT03150316|Growth Substances|growth substances|mesh-ancestor
44081447|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
44081448|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44081449|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44081450|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44081451|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151902|NCT00215514|Cisplatin|cisplatin|mesh-list
44151903|NCT00215514|Fluorouracil|fluorouracil|mesh-list
44151904|NCT00215514|Epirubicin|epirubicin|mesh-list
44151905|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151906|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
44151907|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151908|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44151909|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44151910|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
44151911|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151912|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44151913|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44151914|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44151915|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151916|NCT00215579|Risperidone|risperidone|mesh-list
44151917|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44151918|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
44151919|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44151920|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151921|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151922|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44151923|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44151924|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151925|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44151926|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44151927|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
44151928|NCT00215592|Zonisamide|zonisamide|mesh-list
44151929|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
44151930|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44151931|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158434|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44081452|NCT03136497|Rituximab|rituximab|mesh-list
44081453|NCT03136497|Venetoclax|venetoclax|mesh-list
44081454|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081455|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081456|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
44081457|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081458|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081459|NCT03110978|Nivolumab|nivolumab|mesh-list
44258680|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44258681|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
44258682|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
44081460|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081461|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081462|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44081463|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081464|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
44081465|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44081466|NCT03086044|Velpatasvir|velpatasvir|mesh-list
44081467|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
44081468|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081470|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
44081471|NCT03073941|Cimetidine|cimetidine|mesh-list
44081472|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44081473|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081474|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44081475|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
44081476|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
44081477|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081478|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081479|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081480|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44081481|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44081482|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081483|NCT02984384|Aspirin|aspirin|mesh-list
44081484|NCT02984384|Heparin|heparin|mesh-list
44081485|NCT02984384|Enoxaparin|enoxaparin|mesh-list
44081486|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44081487|NCT02984384|Tinzaparin|tinzaparin|mesh-list
44081488|NCT02984384|Dalteparin|dalteparin|mesh-list
44081489|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44081490|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44081491|NCT02984384|Analgesics|analgesics|mesh-ancestor
44081492|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
44081493|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081494|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081495|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44081496|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081497|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44081498|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44081499|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081500|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44081501|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44081502|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081503|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
44081504|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
44081505|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
44081506|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081507|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081508|NCT02866006|Topotecan|topotecan|mesh-list
44081509|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44081510|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44081511|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081512|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081513|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081514|NCT02825979|Sotalol|sotalol|mesh-list
44081515|NCT02825979|Flecainide|flecainide|mesh-list
44081516|NCT02825979|Dronedarone|dronedarone|mesh-list
44081517|NCT02825979|Propafenone|propafenone|mesh-list
44081518|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44081519|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44081520|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44081521|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
44081522|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081523|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081524|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081525|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
44081526|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
44081527|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081528|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44258683|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258684|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258686|NCT00630214|Vitamin D|vitamin d|mesh-list
44258687|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
44081529|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44081530|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081531|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
44081532|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44081533|NCT02810743|Olaparib|olaparib|mesh-list
44081534|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44081535|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081536|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081537|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081538|NCT02806050|Letrozole|letrozole|mesh-list
44081539|NCT02806050|Palbociclib|palbociclib|mesh-list
44081540|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081541|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44081542|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44081543|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43580052|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
44081550|NCT02781792|Temozolomide|temozolomide|mesh-list
44081551|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081552|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
44081553|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081554|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081555|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
44081556|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081557|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081558|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081559|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44081560|NCT02780427|Analgesics|analgesics|mesh-ancestor
44081561|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
44081562|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081563|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44081564|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44081565|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44081566|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
44081567|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081568|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081569|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43623009|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623010|NCT05376202|Cetuximab|cetuximab|mesh-list
43623012|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081570|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44081571|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44081572|NCT02633098|Artesunate|artesunate|mesh-list
44081573|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
44081574|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44081575|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44081576|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081577|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081578|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
44081579|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
44081580|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44081581|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
44081582|NCT02554383|Amoxicillin|amoxicillin|mesh-list
44081583|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
44081584|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
44081585|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44081586|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44081587|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081588|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44081589|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081590|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081591|NCT02548559|Cannabidiol|cannabidiol|mesh-list
44081592|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
44081593|NCT02285179|Tamoxifen|tamoxifen|mesh-list
44081594|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44081595|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
44081596|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081597|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081598|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258688|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
44258689|NCT00630214|Vitamins|vitamins|mesh-list
44258690|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
44258691|NCT00630214|Calcium|calcium|mesh-list
44258692|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
44258693|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258694|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44258695|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44258696|NCT00630214|Antacids|antacids|mesh-ancestor
43825087|NCT05504642|Ipilimumab|ipilimumab|mesh-list
44081599|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081600|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44081601|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44081602|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44081604|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
44081605|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
44081606|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44081607|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44081608|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580134|NCT04586062|Plasminogen|plasminogen|mesh-list
44081609|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081610|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081611|NCT02250937|Fludarabine|fludarabine|mesh-list
44081612|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
44081613|NCT02250937|Busulfan|busulfan|mesh-list
44081614|NCT02250937|Venetoclax|venetoclax|mesh-list
44081615|NCT02250937|Cladribine|cladribine|mesh-list
44081616|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44081617|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081618|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081619|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
44081620|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081621|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081622|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
44081623|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081624|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
44081625|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081626|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081627|NCT02231775|Trametinib|trametinib|mesh-list
44081628|NCT02231775|Dabrafenib|dabrafenib|mesh-list
44081629|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081630|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44081631|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880643|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081632|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081633|NCT02149823|Oxytocin|oxytocin|mesh-list
44081634|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
44081635|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44081636|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081637|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
44081638|NCT02122081|Methotrexate|methotrexate|mesh-list
44081639|NCT02122081|Tacrolimus|tacrolimus|mesh-list
44081640|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
44081641|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44081642|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
44081643|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081644|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
44081645|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081646|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081647|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081648|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
44081649|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081650|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081651|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081652|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44081653|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
44081654|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44081655|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258697|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258698|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258699|NCT00630357|Levetiracetam|levetiracetam|mesh-list
44258700|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
44081656|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
44081657|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
44081658|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081659|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44081660|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44081661|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44081662|NCT02111941|Vaccines|vaccines|mesh-list
44081663|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
44081664|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081665|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
44081666|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44081667|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44081668|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44081669|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081670|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081671|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
44081672|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081673|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081674|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44081675|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081676|NCT02020720|Fluorides|fluorides|mesh-list
44081677|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
44081678|NCT02020720|Protective Agents|protective agents|mesh-ancestor
44081679|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081680|NCT01996267|Paclitaxel|paclitaxel|mesh-list
44081681|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
44081682|NCT01996267|Carboplatin|carboplatin|mesh-list
44081683|NCT01996267|Fluorouracil|fluorouracil|mesh-list
44081684|NCT01996267|Trastuzumab|trastuzumab|mesh-list
44081685|NCT01996267|Pertuzumab|pertuzumab|mesh-list
44081686|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44081688|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081689|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
44081690|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081691|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081692|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081693|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
44081694|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081695|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081696|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081697|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
44081698|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081699|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
44081700|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081701|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081702|NCT01940094|Prednisone|prednisone|mesh-list
44081703|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
43547873|NCT03648008|Morphine|morphine|mesh-list
44081704|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44081705|NCT01940094|Hormones|hormones|mesh-ancestor
44081706|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081707|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081708|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44081709|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081710|NCT01919619|Lenalidomide|lenalidomide|mesh-list
44081711|NCT01919619|Ipilimumab|ipilimumab|mesh-list
44081712|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
44081713|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081714|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44081715|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44081716|NCT01919619|Growth Substances|growth substances|mesh-ancestor
44081717|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
44081718|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081719|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081720|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44081721|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081722|NCT01898117|Paclitaxel|paclitaxel|mesh-list
44081723|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44081724|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
44258702|NCT00630370|ATI 7505|ati 7505|mesh-list
44461762|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
44258703|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44258704|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44258705|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
44258706|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081725|NCT01898117|Carboplatin|carboplatin|mesh-list
44081726|NCT01898117|Atezolizumab|atezolizumab|mesh-list
44081727|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44081728|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44081729|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081730|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
44081731|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
44081732|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
44081733|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081734|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081735|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
44081736|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081737|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44081738|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081739|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
44081740|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081741|NCT01807494|Cimetidine|cimetidine|mesh-list
44081742|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44081743|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081744|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44081745|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
44081746|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
44081747|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081748|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081749|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081750|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44081751|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44081752|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081754|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
44081755|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
44081756|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081757|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081758|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
44081759|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081761|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44081762|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44081763|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081764|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081766|NCT01807429|Ketamine|ketamine|mesh-list
44081767|NCT01807429|Morphine|morphine|mesh-list
44081768|NCT01807429|Analgesics|analgesics|mesh-ancestor
44081769|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
44081770|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081771|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081772|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44081773|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44081774|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
44081775|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
44081776|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081777|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44081778|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44081779|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081780|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081781|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44081782|NCT01807429|Narcotics|narcotics|mesh-ancestor
44081783|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44081784|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081785|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081786|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081787|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258707|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258708|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258709|NCT00630383|Histamine|histamine|mesh-list
44258710|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
44258711|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
44258712|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825104|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
44081788|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
44081789|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
44081790|NCT01807377|Midazolam|midazolam|mesh-list
44081791|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44081792|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081793|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081794|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081795|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081796|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081797|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44081798|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44081799|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
44081800|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
44081801|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
44081802|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
44081803|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081804|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081805|NCT01807325|Pancrelipase|pancrelipase|mesh-list
44081806|NCT01807325|Pancreatin|pancreatin|mesh-list
44081807|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081808|NCT01807286|Dexamethasone|dexamethasone|mesh-list
44081809|NCT01807286|Melphalan|melphalan|mesh-list
44081810|NCT01807286|Pomalidomide|pomalidomide|mesh-list
44081811|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44081812|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
44081813|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
44081814|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081815|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081816|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081817|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
44081818|NCT01807286|Hormones|hormones|mesh-ancestor
44081819|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081820|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44081821|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081822|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44081823|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
44081824|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081825|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44081826|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081827|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
44081828|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44081829|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44081830|NCT01807286|Growth Substances|growth substances|mesh-ancestor
44081831|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
44081832|NCT01807078|Ezetimibe|ezetimibe|mesh-list
44081833|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44081834|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44081836|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081837|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44081840|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44081841|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44081842|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44081843|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
44081844|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081845|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081846|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081847|NCT01806948|Ramosetron|ramosetron|mesh-list
44081848|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
44081849|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
44081850|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081851|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081852|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258713|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258714|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258715|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44258716|NCT00630435|Estrogens|estrogens|mesh-ancestor
44258717|NCT00630435|Hormones|hormones|mesh-ancestor
44258718|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258719|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258720|NCT00630474|Xylometazoline|xylometazoline|mesh-list
44258721|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
44258722|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44258723|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
44258724|NCT00630500|Memantine|memantine|mesh-list
44258725|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44258726|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44258727|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
44258728|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258729|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258730|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258731|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44258732|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44081853|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44081854|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
44081855|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081856|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151932|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151933|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44151934|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151935|NCT00215631|Tadalafil|tadalafil|mesh-list
44151936|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
44151937|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44151938|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44151939|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151940|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151941|NCT00215631|Urological Agents|urological agents|mesh-ancestor
44151942|NCT00215709|Docetaxel|docetaxel|mesh-list
44151943|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151944|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151945|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151946|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151947|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151948|NCT00215722|Cetuximab|cetuximab|mesh-list
44151949|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44151950|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158017|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44158018|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158019|NCT00236002|Alendronate|alendronate|mesh-list
44158020|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44158021|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158022|NCT00236015|Tiagabine|tiagabine|mesh-list
44158023|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
44158024|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44258733|NCT00630513|Ampicillin|ampicillin|mesh-list
44258734|NCT00630513|Ertapenem|ertapenem|mesh-list
44258735|NCT00630513|Sulbactam|sulbactam|mesh-list
44258736|NCT00630513|Sultamicillin|sultamicillin|mesh-list
44258737|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258738|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825134|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158025|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158026|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158027|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158028|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
44158029|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158030|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158031|NCT00236028|Infliximab|infliximab|mesh-list
44158032|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
44158033|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158034|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158035|NCT00236054|Tiagabine|tiagabine|mesh-list
44158036|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
44158037|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44158038|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158039|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158040|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158041|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
43801177|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
44081857|NCT01806857|Quinidine|quinidine|mesh-list
44081858|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
44081859|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
44081860|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
44081861|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44081862|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44081875|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44081876|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44081877|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
44081878|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44081879|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44081880|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081881|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44081882|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44081883|NCT01806805|Zonisamide|zonisamide|mesh-list
44081884|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
44081885|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44081886|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081887|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081888|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081889|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081890|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
44081891|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
44081892|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
44081893|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081894|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081895|NCT01806792|Vitamins|vitamins|mesh-ancestor
44081896|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
44081897|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44081898|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44081899|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081900|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081901|NCT01806753|Midazolam|midazolam|mesh-list
44081902|NCT01806753|Propofol|propofol|mesh-list
44081903|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44081904|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081905|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081906|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44081907|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
44081908|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
44081909|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44081910|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081911|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44081912|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258740|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258741|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258742|NCT00630630|Levetiracetam|levetiracetam|mesh-list
44258743|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
44258744|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
44258745|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
44258746|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
43825135|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
44081913|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
44081914|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
44081915|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081916|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081917|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44081918|NCT01806675|Glycine|glycine|mesh-list
44081919|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44081920|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081921|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
44081922|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081923|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580495|NCT02616055|XL647|xl647|mesh-list
44081926|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081927|NCT01806571|Cytarabine|cytarabine|mesh-list
44081928|NCT01806571|Daunorubicin|daunorubicin|mesh-list
44081929|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081930|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
44081931|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081932|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081933|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
44081934|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081935|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44081936|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
44081937|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081938|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44081939|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44081940|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44081941|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081942|NCT01806454|Calcium|calcium|mesh-list
44081943|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081944|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081945|NCT01806415|Imidazole|imidazole|mesh-list
44081946|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081947|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081948|NCT01806376|Maleic acid|maleic acid|mesh-list
44081949|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081950|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081951|NCT01806363|Telmisartan|telmisartan|mesh-list
44081952|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
44081953|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44081954|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44081955|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44081956|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081957|NCT01806363|Diuretics|diuretics|mesh-ancestor
44081958|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
44081959|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081960|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44081961|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081962|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
44081963|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44081964|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081965|NCT01806324|Losartan|losartan|mesh-list
44081966|NCT01806324|Atorvastatin|atorvastatin|mesh-list
44081967|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44081968|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44081969|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
44081970|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258747|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258748|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44258749|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
44258750|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44258751|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258752|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44258753|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258754|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258755|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258756|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
44258757|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258758|NCT00630695|Lanreotide|lanreotide|mesh-list
44081971|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44081972|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44081973|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081974|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44081975|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44081976|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44081977|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44081978|NCT01806311|Amlodipine|amlodipine|mesh-list
44081979|NCT01806311|Candesartan|candesartan|mesh-list
44081980|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44081981|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44081982|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44081983|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081984|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44081985|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081986|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44081987|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44081988|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44081989|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
44081990|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
44081991|NCT01806272|Vitamins|vitamins|mesh-ancestor
44081992|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
44081993|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081994|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
44081997|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44081998|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44081999|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082000|NCT01806259|Analgesics|analgesics|mesh-ancestor
44082001|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
44082002|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151951|NCT00215748|Dexamethasone|dexamethasone|mesh-list
43801252|NCT05392933|Lidocaine|lidocaine|mesh-list
44082003|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082004|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082005|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082006|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082007|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082008|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082009|NCT01806116|Decitabine|decitabine|mesh-list
44082010|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44082011|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
44082012|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082013|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082014|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082015|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
44082016|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44082017|NCT01806090|Clopidogrel|clopidogrel|mesh-list
44082018|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44258759|NCT00630695|Somatostatin|somatostatin|mesh-list
44258760|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258761|NCT00630695|Hormones|hormones|mesh-ancestor
44258762|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258763|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258764|NCT00630708|Losartan|losartan|mesh-list
44082019|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44082020|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44082021|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44082022|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
44082023|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082024|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082025|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082027|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
44082028|NCT01805999|Cathartics|cathartics|mesh-ancestor
44082029|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082030|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
44082031|NCT01805908|Pertuzumab|pertuzumab|mesh-list
44082032|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082033|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082034|NCT01805895|Minocycline|minocycline|mesh-list
44082035|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082036|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082037|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
44082038|NCT01805882|Ledipasvir|ledipasvir|mesh-list
44082039|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
44082040|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082041|NCT01805856|Cefazolin|cefazolin|mesh-list
44082042|NCT01805856|Piperacillin|piperacillin|mesh-list
44082043|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082044|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082045|NCT01805817|Copper|copper|mesh-list
44082046|NCT01805817|Drospirenone|drospirenone|mesh-list
44082047|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
44082048|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44082049|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44082050|NCT01805817|Estradiol|estradiol|mesh-list
44082051|NCT01805817|Estrogens|estrogens|mesh-ancestor
44082052|NCT01805817|Hormones|hormones|mesh-ancestor
44082053|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082054|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082055|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44082056|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
44082057|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082058|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44082059|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44082060|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44082061|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44082062|NCT01805817|Trace Elements|trace elements|mesh-ancestor
44082063|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
44082064|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44082065|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
44082066|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44082067|NCT01805817|Diuretics|diuretics|mesh-ancestor
44082068|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
44082069|NCT01805804|Valsartan|valsartan|mesh-list
44082070|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082071|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44082072|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44082073|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082074|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
44082075|NCT01805726|Alfentanil|alfentanil|mesh-list
44082076|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44082077|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082078|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082079|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082080|NCT01805726|Analgesics|analgesics|mesh-ancestor
44082081|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
44082082|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082083|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44258766|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44258767|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44258768|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44082084|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44082085|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44082086|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44082087|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082088|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082089|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44082090|NCT01805726|Narcotics|narcotics|mesh-ancestor
44082091|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44082092|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
44082093|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
44082094|NCT01805700|Caffeine|caffeine|mesh-list
44082095|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44082096|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082097|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44082098|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082099|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082100|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44082101|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44082102|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
44082103|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082104|NCT01805687|Zileuton|zileuton|mesh-list
44082105|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082106|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082107|NCT01805687|Analgesics|analgesics|mesh-ancestor
44082108|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
44082109|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082110|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082111|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082112|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082113|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44082114|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082115|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082116|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44082117|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
44082118|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082119|NCT01805596|Clopidogrel|clopidogrel|mesh-list
44082120|NCT01805596|Ticagrelor|ticagrelor|mesh-list
44082121|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082122|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44082123|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44082124|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44082125|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
44082126|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082127|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082128|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082129|NCT01805570|Ticagrelor|ticagrelor|mesh-list
44082130|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44082131|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082132|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44082133|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44082134|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44082135|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
44082136|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082137|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082138|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082139|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
44082140|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44082141|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
44082149|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
44082150|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44082151|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
44082152|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082153|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082154|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
44082156|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44258769|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44258770|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258771|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44258772|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
44258773|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258774|NCT00630851|Donepezil|donepezil|mesh-list
44258775|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43912871|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
44258776|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258777|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817190|NCT00476190|Etoposide|etoposide|mesh-list
44082157|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082158|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44082159|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44082160|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151952|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44151954|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
44151955|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151956|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151957|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44151958|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
44151959|NCT00215748|Hormones|hormones|mesh-ancestor
44151960|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151961|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44151962|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151963|NCT00215774|Flecainide|flecainide|mesh-list
44151964|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44151965|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44151966|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44151967|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151968|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151969|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44151970|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
44151971|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151972|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
44151973|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
44151974|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151975|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
44151976|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151977|NCT00215839|Ribavirin|ribavirin|mesh-list
44151978|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
44151979|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151980|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
44151981|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151982|NCT00215865|Ribavirin|ribavirin|mesh-list
44151983|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44151984|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
44151985|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151986|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
44151987|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151988|NCT00215891|Interferons|interferons|mesh-list
44151989|NCT00215891|Ribavirin|ribavirin|mesh-list
44151990|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151991|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
44151992|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151993|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
44151994|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151995|NCT00215956|Topotecan|topotecan|mesh-list
44151996|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44151997|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44151998|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151999|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258778|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
44258779|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258780|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258782|NCT00630890|Capecitabine|capecitabine|mesh-list
44258783|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258784|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
44258785|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258786|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258787|NCT00630903|Methoxsalen|methoxsalen|mesh-list
44258788|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44258789|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
44258790|NCT00630929|Ibuprofen|ibuprofen|mesh-list
44258791|NCT00630929|Celecoxib|celecoxib|mesh-list
44258792|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44258793|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44258794|NCT00630929|Analgesics|analgesics|mesh-ancestor
44258795|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
44258796|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258797|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258798|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258799|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258800|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44258801|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152000|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152001|NCT00215982|Capecitabine|capecitabine|mesh-list
44152002|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
44152004|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152005|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
44152006|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152007|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152008|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44152009|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152010|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152011|NCT00215995|Cisplatin|cisplatin|mesh-list
44152012|NCT00215995|Irinotecan|irinotecan|mesh-list
44152013|NCT00215995|Gefitinib|gefitinib|mesh-list
44152014|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152015|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44152016|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152017|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158042|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082161|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
44082163|NCT01723839|Fludarabine|fludarabine|mesh-list
44082164|NCT01723839|Lenalidomide|lenalidomide|mesh-list
44082165|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082166|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
44082167|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082168|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082169|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44082170|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
44082171|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258802|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258803|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44258804|NCT00630942|Minocycline|minocycline|mesh-list
44258805|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258806|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258807|NCT00630968|Levetiracetam|levetiracetam|mesh-list
43655295|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
44082172|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082173|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082174|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082175|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44082176|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44082177|NCT01723839|Growth Substances|growth substances|mesh-ancestor
44082178|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44082179|NCT01698840|Vitamin D|vitamin d|mesh-list
44082180|NCT01698840|Vitamins|vitamins|mesh-ancestor
44082181|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
44082182|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082183|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082184|NCT01646034|Gemcitabine|gemcitabine|mesh-list
44082185|NCT01646034|Paclitaxel|paclitaxel|mesh-list
44082186|NCT01646034|Docetaxel|docetaxel|mesh-list
44082187|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
44082188|NCT01646034|Carboplatin|carboplatin|mesh-list
44082189|NCT01646034|Doxorubicin|doxorubicin|mesh-list
44082190|NCT01646034|Thiotepa|thiotepa|mesh-list
44082191|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44082192|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082193|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
44082194|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
44082195|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082196|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082197|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082198|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
44082199|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082200|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082201|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44082202|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
44082203|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082204|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44082205|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
44082206|NCT01646034|Antiviral Agents|antiviral agents|mesh-ancestor
44082207|NCT01646034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082208|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082209|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44082210|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44082211|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44082212|NCT01628640|Interferons|interferons|mesh-list
44082213|NCT01628640|Interferon-beta|interferon-beta|mesh-list
44082214|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082215|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
44082216|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082217|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
44082218|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082219|NCT01466543|Udenafil|udenafil|mesh-list
44082220|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44082221|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44082223|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082224|NCT01466530|Misoprostol|misoprostol|mesh-list
44082225|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44082226|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
44082227|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082228|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082229|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44082230|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082231|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
44082232|NCT01466517|Ibuprofen|ibuprofen|mesh-list
44082233|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082234|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082235|NCT01466517|Analgesics|analgesics|mesh-ancestor
44258809|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
44258810|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44258811|NCT00630981|Citalopram|citalopram|mesh-list
44258812|NCT00630981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44258813|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44258814|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258815|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258816|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258817|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
44258818|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082236|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
44082237|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082238|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082239|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082240|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082241|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082242|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082243|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082245|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44082246|NCT01466478|Calcipotriene|calcipotriene|mesh-list
44082247|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44082248|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082249|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082250|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44082251|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082252|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082253|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44082254|NCT01466478|Vitamins|vitamins|mesh-ancestor
44082255|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
44082256|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082257|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082258|NCT01466465|Vitamin D|vitamin d|mesh-list
44082259|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
44082260|NCT01466465|Vitamins|vitamins|mesh-ancestor
44082261|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
44082262|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082263|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082264|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082265|NCT01466452|Aspirin|aspirin|mesh-list
44082266|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082267|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082268|NCT01466452|Analgesics|analgesics|mesh-ancestor
44082269|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
44082270|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082271|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082272|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082273|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082274|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082275|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082276|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082277|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082278|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082279|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082280|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
44082281|NCT01466374|Antibodies|antibodies|mesh-list
44082282|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
44082283|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44082284|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
44082285|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082286|NCT01466361|Nicotine|nicotine|mesh-list
44082287|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44082288|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
44258819|NCT00630981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44258820|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
44258821|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258822|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44258823|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258824|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258825|NCT00631033|Metformin|metformin|mesh-list
44258826|NCT00631033|Diazoxide|diazoxide|mesh-list
44258827|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44258828|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258829|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44258830|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
44258831|NCT00631085|Tocopherols|tocopherols|mesh-list
44258832|NCT00631085|Vitamin E|vitamin e|mesh-list
44258833|NCT00631085|Tocotrienols|tocotrienols|mesh-list
44258834|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
44258835|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
44258836|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
44258837|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258838|NCT00631085|Protective Agents|protective agents|mesh-ancestor
44258839|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258840|NCT00631085|Vitamins|vitamins|mesh-ancestor
44258841|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
44258842|NCT00631124|Drospirenone|drospirenone|mesh-list
44258843|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44082289|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082290|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082291|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44082292|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44082293|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082294|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082295|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082296|NCT01466257|Cisplatin|cisplatin|mesh-list
44082297|NCT01466257|Cetuximab|cetuximab|mesh-list
44082298|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082299|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082300|NCT01466244|Cisplatin|cisplatin|mesh-list
44082301|NCT01466244|Cetuximab|cetuximab|mesh-list
44082302|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082303|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082304|NCT01466231|Everolimus|everolimus|mesh-list
44082305|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082306|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082307|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
44082308|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082309|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
44082310|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
44082311|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
44082312|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082313|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082314|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082316|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
44082317|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258844|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44258845|NCT00631124|Estradiol|estradiol|mesh-list
44258846|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44258847|NCT00631124|Estrogens|estrogens|mesh-ancestor
44258848|NCT00631124|Hormones|hormones|mesh-ancestor
44258849|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082318|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082319|NCT01466114|Norethindrone|norethindrone|mesh-list
44082320|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
44082321|NCT01466114|Progestins|progestins|mesh-list
44082322|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44082323|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44082324|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44082325|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
44082326|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082327|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082328|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44082329|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44082330|NCT01466114|Hormones|hormones|mesh-ancestor
44082331|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082332|NCT01466101|Pregabalin|pregabalin|mesh-list
44082333|NCT01466101|Analgesics|analgesics|mesh-ancestor
44082334|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
44082335|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082336|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082337|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
44082338|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44082339|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082340|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082341|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082342|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44082343|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44082344|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082345|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44082346|NCT01466088|Donepezil|donepezil|mesh-list
44082347|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44082348|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082349|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082350|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082351|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082352|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082353|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
44082354|NCT01465984|Acetaminophen|acetaminophen|mesh-list
44082355|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082356|NCT01465984|Analgesics|analgesics|mesh-ancestor
44082357|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
44082358|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082359|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082360|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
44082361|NCT01465919|Mirtazapine|mirtazapine|mesh-list
44082362|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44082363|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44082364|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44082365|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
44082366|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
44082367|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082368|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082369|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082370|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44082371|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44082372|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082373|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44082375|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44082376|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44082377|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44082378|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44082379|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
44082380|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44258850|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258851|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44258852|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
44258853|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258854|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44258855|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44258856|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44258857|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44258859|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
44258860|NCT00631150|Levetiracetam|levetiracetam|mesh-list
44258861|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
44258862|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
44258863|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
44258864|NCT00631202|Hematinics|hematinics|mesh-ancestor
44258865|NCT00631228|Everolimus|everolimus|mesh-list
44258866|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258867|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082381|NCT01465906|Bromides|bromides|mesh-list
44082382|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
44082383|NCT01465906|Tulobuterol|tulobuterol|mesh-list
44082384|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44082385|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
44082386|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082387|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082388|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44082389|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
44082390|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
44082391|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44082392|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082393|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082394|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082396|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44082397|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44082398|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
44082399|NCT01465893|Vitamin D|vitamin d|mesh-list
44082400|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
44082401|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
44082402|NCT01465893|Vitamins|vitamins|mesh-list
44082403|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
44082404|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082405|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082406|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082407|NCT01465867|Selenium|selenium|mesh-list
44082408|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
44082409|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082410|NCT01465867|Protective Agents|protective agents|mesh-ancestor
44082411|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548638|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43548639|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548640|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548641|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
43548642|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43548643|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082412|NCT01465867|Trace Elements|trace elements|mesh-ancestor
44082413|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
44082414|NCT01465828|Clopidogrel|clopidogrel|mesh-list
44082415|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44082416|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082417|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44082418|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44082419|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44082420|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
44082421|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082422|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082423|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258868|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
44258869|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461763|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
44461764|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461765|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082424|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44082425|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082426|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44082427|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082428|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082429|NCT01465685|Methylphenidate|methylphenidate|mesh-list
44082430|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44082431|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44082432|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082433|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44082434|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44082435|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082436|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082437|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
44082438|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082439|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
44082440|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44082441|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
44082442|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44082443|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
44082444|NCT01465568|Denosumab|denosumab|mesh-list
44082445|NCT01465568|Diphosphonates|diphosphonates|mesh-list
44082446|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082458|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
44082459|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082460|NCT01465438|Adalimumab|adalimumab|mesh-list
44082461|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082462|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082463|NCT01465412|Adenosine|adenosine|mesh-list
44082464|NCT01465412|Analgesics|analgesics|mesh-ancestor
44082465|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
44082466|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082467|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082468|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44082469|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
44082470|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44082471|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
44082472|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
44082473|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082474|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082475|NCT01465399|Mitogens|mitogens|mesh-list
44082476|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082477|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082478|NCT01465373|Progesterone|progesterone|mesh-list
44082479|NCT01465373|Progestins|progestins|mesh-ancestor
44082480|NCT01465373|Hormones|hormones|mesh-ancestor
44082481|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082482|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082483|NCT01465256|Aspirin|aspirin|mesh-list
44082484|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082485|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082486|NCT01465256|Analgesics|analgesics|mesh-ancestor
44082487|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
44082488|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082489|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082490|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082491|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082492|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082493|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082494|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082495|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082496|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082497|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082498|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
44461766|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
44152018|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152019|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44152020|NCT00216008|Cisplatin|cisplatin|mesh-list
44152021|NCT00216008|Docetaxel|docetaxel|mesh-list
44152022|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152023|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152024|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44152025|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152026|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152027|NCT00216021|Capecitabine|capecitabine|mesh-list
44152028|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
44152029|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152030|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
43581168|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
44152031|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152032|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152033|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
44152035|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152036|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
44152037|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152038|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152039|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44152040|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
44152041|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152042|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152043|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
44152044|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152045|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
44152046|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44152047|NCT00216034|Protective Agents|protective agents|mesh-ancestor
44152048|NCT00216047|Trastuzumab|trastuzumab|mesh-list
44152049|NCT00216047|Vatalanib|vatalanib|mesh-list
44152050|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152051|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152052|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44152053|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152054|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152055|NCT00216073|Capecitabine|capecitabine|mesh-list
44152056|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
44152057|NCT00216073|Trastuzumab|trastuzumab|mesh-list
44082500|NCT01465152|Repaglinide|repaglinide|mesh-list
44082501|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44082502|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082504|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
44082505|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
44082506|NCT01465113|Vitamins|vitamins|mesh-list
44082507|NCT01465113|Metformin|metformin|mesh-list
44082508|NCT01465113|Omeprazole|omeprazole|mesh-list
44082509|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
44082510|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082511|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44082512|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082513|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082514|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44082515|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082516|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44082517|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082518|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082519|NCT01465074|Nicotine|nicotine|mesh-list
44082520|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44082521|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
44082522|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082523|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082524|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44082525|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44082526|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082527|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082528|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082529|NCT01465009|Aspirin|aspirin|mesh-list
44082530|NCT01465009|Acetaminophen|acetaminophen|mesh-list
44082531|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082532|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082533|NCT01465009|Analgesics|analgesics|mesh-ancestor
44082534|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
43790490|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
44461767|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461768|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44461769|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44461770|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44461771|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461772|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461773|NCT01539291|Idelalisib|idelalisib|mesh-list
44461774|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461775|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655356|NCT02969629|Apomorphine|apomorphine|mesh-list
44082535|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082536|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082537|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082538|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082539|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082540|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082541|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082542|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082543|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082544|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082545|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
44082546|NCT01464983|Aspirin|aspirin|mesh-list
44082547|NCT01464983|Ibuprofen|ibuprofen|mesh-list
44082548|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43581233|NCT03462446|Vitamin K|vitamin k|mesh-list
44082550|NCT01464983|Analgesics|analgesics|mesh-ancestor
44082551|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
44082552|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082553|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082554|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082555|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082556|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082557|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082558|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082559|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082560|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082561|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082562|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
44082563|NCT01464944|Aspirin|aspirin|mesh-list
44082564|NCT01464944|Acetaminophen|acetaminophen|mesh-list
44082565|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082566|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082567|NCT01464944|Analgesics|analgesics|mesh-ancestor
44082568|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
44082569|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082570|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082571|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082572|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082573|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082574|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082575|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082576|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082577|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082578|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082579|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
44082580|NCT01464840|Azithromycin|azithromycin|mesh-list
44082581|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082582|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082583|NCT01464801|Resveratrol|resveratrol|mesh-list
44082584|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
44082585|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082586|NCT01464801|Protective Agents|protective agents|mesh-ancestor
44082587|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082588|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461776|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461777|NCT01539226|Dapivirine|dapivirine|mesh-list
44461778|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44461779|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44461780|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
44461781|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461782|NCT01539083|Thalidomide|thalidomide|mesh-list
44461783|NCT01539083|Dexamethasone|dexamethasone|mesh-list
44082589|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082590|NCT01464762|Bedaquiline|bedaquiline|mesh-list
44082591|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
44082592|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082593|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082594|NCT01464723|Ranibizumab|ranibizumab|mesh-list
44082595|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44082596|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44082597|NCT01464723|Growth Substances|growth substances|mesh-ancestor
44082598|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082599|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
44082600|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082601|NCT01464697|Progesterone|progesterone|mesh-list
44082602|NCT01464697|Progestins|progestins|mesh-ancestor
44082603|NCT01464697|Hormones|hormones|mesh-ancestor
44082604|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082605|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082606|NCT01464671|Heparin|heparin|mesh-list
44082607|NCT01464671|Bivalirudin|bivalirudin|mesh-list
44082608|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
44082609|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082610|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082611|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082612|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
44082613|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44082614|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
44082615|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082616|NCT01464606|Dactinomycin|dactinomycin|mesh-list
44082617|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
44082618|NCT01464606|Ifosfamide|ifosfamide|mesh-list
44082619|NCT01464606|Doxorubicin|doxorubicin|mesh-list
44082620|NCT01464606|Vincristine|vincristine|mesh-list
44082621|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082622|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
44082623|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082624|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082625|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44082626|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
44082627|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082628|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082629|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082630|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44082631|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44082632|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44082633|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082634|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44082635|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
44082636|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
44082637|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082638|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082639|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082640|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44082641|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44082642|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
44082643|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44082644|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
44082645|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082646|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
44082647|NCT01464528|Protective Agents|protective agents|mesh-ancestor
44082649|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44082650|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
44461784|NCT01539083|Prednisolone|prednisolone|mesh-list
44461785|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
44461786|NCT01539083|Bortezomib|bortezomib|mesh-list
44461787|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461788|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
44461789|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461790|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461791|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461792|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
44461793|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461794|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461795|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082651|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
44082652|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082653|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082655|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44082656|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
44082657|NCT01057069|Carboplatin|carboplatin|mesh-list
44082658|NCT01057069|Doxorubicin|doxorubicin|mesh-list
44082659|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44082660|NCT01057069|Thiotepa|thiotepa|mesh-list
44082661|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44082662|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082663|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44082664|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44082665|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082666|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082667|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082668|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
44082669|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082670|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082671|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44082672|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
44082673|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082674|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44082675|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44082676|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44082677|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082678|NCT00847938|Neostigmine|neostigmine|mesh-list
44082679|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44082680|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082681|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082682|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082683|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082684|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082685|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44082686|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
44082687|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082688|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
44082689|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082690|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082691|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082692|NCT00847860|Aspirin|aspirin|mesh-list
44082693|NCT00847860|Cilostazol|cilostazol|mesh-list
44082694|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082695|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082696|NCT00847860|Analgesics|analgesics|mesh-ancestor
44082697|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
44082698|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082699|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082700|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082713|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
44461796|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461797|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
44461798|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
44461799|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461800|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461801|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
44461802|NCT01539083|Hormones|hormones|mesh-ancestor
44461803|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461804|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461805|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
44461806|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461807|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461808|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44461809|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44461810|NCT01539083|Growth Substances|growth substances|mesh-ancestor
44461811|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
44461812|NCT01538719|Rilonacept|rilonacept|mesh-list
44082714|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44082715|NCT00847860|Protective Agents|protective agents|mesh-ancestor
44082716|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44082717|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44082718|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44082719|NCT00847834|Irbesartan|irbesartan|mesh-list
44082720|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082721|NCT00847834|Diuretics|diuretics|mesh-ancestor
44082722|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
44082723|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082724|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44082725|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082726|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082727|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44082728|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44082729|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44082730|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
44082731|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44082732|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
44082733|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082734|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082735|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44082736|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44082737|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082738|NCT00847678|Amphotericin B|amphotericin b|mesh-list
44082739|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44082740|NCT00847678|Flucytosine|flucytosine|mesh-list
44082741|NCT00847678|Efungumab|efungumab|mesh-list
44082742|NCT00847678|Amebicides|amebicides|mesh-ancestor
44082743|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44082744|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44082745|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082746|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082747|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
44082748|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
44082749|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082750|NCT00847639|Lenalidomide|lenalidomide|mesh-list
44082751|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
44082752|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082753|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43790491|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
44461813|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461815|NCT01538472|Rituximab|rituximab|mesh-list
44461816|NCT01538472|Melphalan|melphalan|mesh-list
44461817|NCT01538472|Carmustine|carmustine|mesh-list
44461818|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44461819|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43655391|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
44082754|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44082755|NCT00847639|Growth Substances|growth substances|mesh-ancestor
44082756|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
44082757|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082758|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
44082759|NCT00847587|Etonogestrel|etonogestrel|mesh-list
44082760|NCT00847587|Desogestrel|desogestrel|mesh-list
44082761|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082762|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082763|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44082764|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44082765|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44082766|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44082767|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44082768|NCT00847587|Progestins|progestins|mesh-ancestor
44082769|NCT00847587|Hormones|hormones|mesh-ancestor
44082770|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082771|NCT00847483|Bimatoprost|bimatoprost|mesh-list
44082772|NCT00847483|Travoprost|travoprost|mesh-list
44082773|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44082774|NCT00847483|Latanoprost|latanoprost|mesh-list
44082775|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44082776|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082777|NCT00847418|Esketamine|esketamine|mesh-list
44082778|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
44082779|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44082780|NCT00847366|Tamoxifen|tamoxifen|mesh-list
44082781|NCT00847366|Trastuzumab|trastuzumab|mesh-list
44082782|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082783|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082784|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44082785|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
44082786|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082787|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082788|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44082789|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44082790|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44082791|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44082792|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
44082793|NCT00847314|Testosterone|testosterone|mesh-list
44082794|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
44082795|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
44082796|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44082797|NCT00847314|Androgens|androgens|mesh-ancestor
44082798|NCT00847314|Hormones|hormones|mesh-ancestor
44082799|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082800|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082801|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44082803|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
44082804|NCT00847262|Amlodipine|amlodipine|mesh-list
44082805|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44082806|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44082807|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082808|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082809|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44082810|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082811|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44082812|NCT00847223|Tipifarnib|tipifarnib|mesh-list
44082813|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082814|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
44082815|NCT00847210|Lansoprazole|lansoprazole|mesh-list
44461820|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461821|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
44461822|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258870|NCT00631501|Doxycycline|doxycycline|mesh-list
44082816|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44082817|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082818|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44082819|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082820|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152058|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152059|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
44152060|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152061|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152062|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152063|NCT00216112|Docetaxel|docetaxel|mesh-list
44152064|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
44152065|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152066|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152067|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
44152068|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152069|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152070|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44152071|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152072|NCT00216138|Docetaxel|docetaxel|mesh-list
44152073|NCT00216138|Capecitabine|capecitabine|mesh-list
44152074|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152075|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152077|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152078|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152079|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152080|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
44152081|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
44152082|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44152083|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152084|NCT00216164|Gemcitabine|gemcitabine|mesh-list
44152085|NCT00216164|Rituximab|rituximab|mesh-list
44152086|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152087|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152088|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
44152089|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152090|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152091|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152092|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
44152093|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152094|NCT00216164|Antiviral Agents|antiviral agents|mesh-ancestor
44152095|NCT00216164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152096|NCT00216164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152097|NCT00216164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152098|NCT00216177|Adalimumab|adalimumab|mesh-list
44152099|NCT00216177|Infliximab|infliximab|mesh-list
44152100|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152101|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152102|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152103|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152104|NCT00216190|Midazolam|midazolam|mesh-list
44152105|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
44152106|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44152107|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152108|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152109|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44152110|NCT00216190|Analgesics|analgesics|mesh-ancestor
44152111|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
44152112|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082821|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
44082822|NCT00847171|Trastuzumab|trastuzumab|mesh-list
44082823|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082824|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
44082825|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082826|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082827|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44082828|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
43790492|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
44258871|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44258872|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258873|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
44258874|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44082829|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082830|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082831|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44082832|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082833|NCT00847119|Bevacizumab|bevacizumab|mesh-list
44082834|NCT00847119|Capecitabine|capecitabine|mesh-list
44082835|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44082836|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082837|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44082838|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44082839|NCT00847119|Growth Substances|growth substances|mesh-ancestor
44082840|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082841|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
44082842|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44082843|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
44082844|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082845|NCT00847106|Daclizumab|daclizumab|mesh-list
44082846|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082847|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
44082848|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082849|NCT00847093|Lidocaine|lidocaine|mesh-list
44082850|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
44082851|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
44082852|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082853|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082854|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
44082855|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082856|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44082857|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44082860|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082861|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44082862|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44082863|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082864|NCT00847080|Incretins|incretins|mesh-ancestor
44082865|NCT00847080|Hormones|hormones|mesh-ancestor
44082866|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082867|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44082868|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
44082869|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082870|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082871|NCT00847054|Antibodies|antibodies|mesh-list
44082872|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44082873|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
44082874|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082875|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44082876|NCT00847002|Laxatives|laxatives|mesh-ancestor
44082877|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082878|NCT00846989|Latanoprost|latanoprost|mesh-list
44082879|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44082880|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44082881|NCT00846976|Bicalutamide|bicalutamide|mesh-list
44082882|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
44082883|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
44082884|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082885|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082886|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082887|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44082888|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44082889|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082890|NCT00846950|Lorazepam|lorazepam|mesh-list
44082891|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44082892|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
44082893|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
44082894|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
43802066|NCT03337698|Docetaxel|docetaxel|mesh-list
44082895|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44082896|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258875|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44258876|NCT00631514|Acetaminophen|acetaminophen|mesh-list
44258877|NCT00631514|Ibuprofen|ibuprofen|mesh-list
44258878|NCT00631514|Piroxicam|piroxicam|mesh-list
44258879|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44258880|NCT00631514|Analgesics|analgesics|mesh-ancestor
44258881|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
44258882|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258883|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258884|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
44258885|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44082898|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44082899|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082900|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44082901|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44082902|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44082903|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
44082904|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
44082905|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082906|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082907|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44082908|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
44082909|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
44082910|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
44082911|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44082912|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44082913|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44082914|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44082915|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44082916|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082917|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082918|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082919|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44082920|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
44082921|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082922|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082923|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44082924|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44082925|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44082926|NCT00846885|Sumatriptan|sumatriptan|mesh-list
44082927|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44082928|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43581675|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
44082933|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082934|NCT00846872|Mannitol|mannitol|mesh-list
44082935|NCT00846872|Hormones|hormones|mesh-list
44082936|NCT00846872|Secretagogues|secretagogues|mesh-list
44082937|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082938|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082939|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44082940|NCT00846872|Diuretics|diuretics|mesh-ancestor
44082941|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
44082942|NCT00846859|Varenicline|varenicline|mesh-list
44082943|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44082944|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44082945|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
44082946|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082947|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082948|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082949|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
44082950|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
44082951|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082952|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
44082953|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43790701|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44258886|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258887|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258888|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44258889|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258890|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258891|NCT00631527|Sunitinib|sunitinib|mesh-list
44258892|NCT00631527|Leuprolide|leuprolide|mesh-list
44258893|NCT00631527|Goserelin|goserelin|mesh-list
44258894|NCT00631527|Bicalutamide|bicalutamide|mesh-list
44258895|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44258896|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44258897|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44258898|NCT00631527|Growth Substances|growth substances|mesh-ancestor
44258899|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258900|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
44258901|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44258902|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258903|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258904|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44258905|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
44258906|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44258907|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44258908|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
43655413|NCT02969252|Rifamycins|rifamycins|mesh-list
44082954|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082955|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082956|NCT00846716|Pioglitazone|pioglitazone|mesh-list
44082957|NCT00846716|Biguanides|biguanides|mesh-list
44082958|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44082959|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082960|NCT00846703|Dexamethasone|dexamethasone|mesh-list
44082961|NCT00846703|Methotrexate|methotrexate|mesh-list
44082962|NCT00846703|Vincristine|vincristine|mesh-list
44082963|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
44082964|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44082965|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
44082966|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
44082967|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802149|NCT03103971|Fludarabine|fludarabine|mesh-list
44082968|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082969|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44082970|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
44082972|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44082973|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44082974|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44082975|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44082976|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
44082977|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44082978|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44082979|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
44082980|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258909|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
44258910|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44258911|NCT00631579|Rasburicase|rasburicase|mesh-list
44258912|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
44258913|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258914|NCT00631592|Dolutegravir|dolutegravir|mesh-list
44258915|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44258916|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44258917|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258918|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258919|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44258920|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43818262|NCT05546853|Irinotecan|irinotecan|mesh-list
44082981|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
44082982|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082983|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44082984|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44082985|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
44082986|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082987|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44082988|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44082989|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44082990|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44082991|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082992|NCT00846690|Lidocaine|lidocaine|mesh-list
44082993|NCT00846690|Phenylephrine|phenylephrine|mesh-list
44082994|NCT00846690|Benzocaine|benzocaine|mesh-list
44082995|NCT00846690|Tetracaine|tetracaine|mesh-list
44082996|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
44082997|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
44082998|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44082999|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083003|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44083004|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44083005|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083006|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083007|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44083008|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
44083009|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
44083010|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
44083011|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44083012|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
44083013|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
44083014|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44083015|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44083016|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44083017|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
44083018|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083019|NCT00846690|Protective Agents|protective agents|mesh-ancestor
44083020|NCT00846677|Vitamin D|vitamin d|mesh-list
44083021|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
44083022|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
44083023|NCT00846677|Vitamins|vitamins|mesh-list
44083024|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
44083025|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083026|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44083027|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083028|NCT00846651|Phenylephrine|phenylephrine|mesh-list
44083029|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
44083030|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44083031|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
44083032|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
44083033|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083034|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258922|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44258923|NCT00631618|Sunitinib|sunitinib|mesh-list
44258924|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083035|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
44083036|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44083037|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
44083038|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44083039|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44083040|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44083041|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44083042|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44083043|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880644|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
44083044|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083045|NCT00846651|Protective Agents|protective agents|mesh-ancestor
44083046|NCT00846625|Triamcinolone|triamcinolone|mesh-list
44083047|NCT00846625|Ranibizumab|ranibizumab|mesh-list
44083048|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083049|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083050|NCT00846625|Growth Substances|growth substances|mesh-ancestor
44083051|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083052|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083053|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083054|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083055|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
44083056|NCT00846625|Hormones|hormones|mesh-ancestor
44083057|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083058|NCT00846612|Bevacizumab|bevacizumab|mesh-list
44083059|NCT00846612|Doxorubicin|doxorubicin|mesh-list
44083060|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083061|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083062|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083063|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083064|NCT00846612|Growth Substances|growth substances|mesh-ancestor
44083065|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083066|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083067|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083068|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083069|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083070|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083071|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083074|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
44083075|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083076|NCT00846443|Cisplatin|cisplatin|mesh-list
44083077|NCT00846443|Pemetrexed|pemetrexed|mesh-list
44083078|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083079|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083080|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083081|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44083082|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44083083|NCT00846339|Bupropion|bupropion|mesh-list
44083084|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44083085|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083086|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083087|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44083088|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44083089|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083090|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083091|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
44083092|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083093|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083094|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44083095|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44083096|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083097|NCT00846326|Fluticasone|fluticasone|mesh-list
44083098|NCT00846326|Xhance|xhance|mesh-list
44083099|NCT00846326|Phenylephrine|phenylephrine|mesh-list
44083100|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
44083101|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083102|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44083103|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
44258925|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44258926|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44258927|NCT00631618|Growth Substances|growth substances|mesh-ancestor
44258928|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258929|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
44258930|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44258931|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258932|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258933|NCT00631631|Mifamurtide|mifamurtide|mesh-list
44258934|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44258935|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
44258936|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258937|NCT00631722|Haloperidol|haloperidol|mesh-list
44258938|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
44258939|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
44258940|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
44258941|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083104|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083105|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083106|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44083107|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
44083108|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
44083109|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44083110|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44083111|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44083112|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44083113|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083114|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083115|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
44083116|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
44083117|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44083118|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44083119|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
44083120|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44083121|NCT00846326|Protective Agents|protective agents|mesh-ancestor
44083122|NCT00846274|Antithrombins|antithrombins|mesh-list
44083123|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
44083124|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44083125|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
44083126|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083127|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083128|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
44083129|NCT00846248|Chromium|chromium|mesh-list
44083130|NCT00846248|Trace Elements|trace elements|mesh-ancestor
44083131|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
44083132|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083133|NCT00846235|Glycerol|glycerol|mesh-list
44083134|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44083135|NCT00846235|Protective Agents|protective agents|mesh-ancestor
44083136|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083137|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
44083138|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
44083139|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44083140|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083141|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083142|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083143|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083144|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44258942|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258943|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44258944|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44258945|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258946|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258947|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258948|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44083145|NCT00846144|Copper|copper|mesh-list
44083147|NCT00846144|Trace Elements|trace elements|mesh-ancestor
44083148|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
44083149|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083150|NCT00846144|Antidotes|antidotes|mesh-ancestor
44083151|NCT00846144|Protective Agents|protective agents|mesh-ancestor
44083153|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
44083154|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083155|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44083156|NCT00846131|Sorafenib|sorafenib|mesh-list
44083157|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083158|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44083159|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083160|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083161|NCT00846118|Pitavastatin|pitavastatin|mesh-list
44083162|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44083163|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44083164|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44083165|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
44083166|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083167|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083168|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44083169|NCT00846079|Regadenoson|regadenoson|mesh-list
44083170|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44083171|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44083172|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
44083173|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
44083174|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083175|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083176|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083177|NCT00845988|Aripiprazole|aripiprazole|mesh-list
44083178|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083179|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083180|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44083181|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083182|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083183|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083184|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
44083185|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
44083186|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083187|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083188|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44083189|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44083190|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
44083191|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44083192|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44083193|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44083194|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44083195|NCT00845962|Bupivacaine|bupivacaine|mesh-list
44083196|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
44083197|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
44083198|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
44083199|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083200|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083201|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
44083202|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083203|NCT00845936|Metformin|metformin|mesh-list
44083204|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44083205|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083206|NCT00845910|Bevacizumab|bevacizumab|mesh-list
44083207|NCT00845910|Docetaxel|docetaxel|mesh-list
44258949|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
44258950|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258951|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258952|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44258953|NCT00631813|Prucalopride|prucalopride|mesh-list
44258954|NCT00631813|Laxatives|laxatives|mesh-ancestor
44258955|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44083208|NCT00845910|Capecitabine|capecitabine|mesh-list
44083209|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083210|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083211|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083212|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083213|NCT00845910|Growth Substances|growth substances|mesh-ancestor
44083214|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083215|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083216|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083217|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083218|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083219|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083221|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
44083223|NCT00680628|Tenecteplase|tenecteplase|mesh-list
44083224|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
44083225|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
44083226|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44083227|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44083228|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083229|NCT00277108|Citalopram|citalopram|mesh-list
44083230|NCT00277108|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44083231|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44083232|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083233|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083234|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083235|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
44083236|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083237|NCT00277108|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44083238|NCT00277108|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083239|NCT00277108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083240|NCT00277082|Camptothecin|camptothecin|mesh-list
44083241|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083242|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083243|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44083244|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083245|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083246|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083247|NCT00277069|Carboplatin|carboplatin|mesh-list
44083248|NCT00277069|Capecitabine|capecitabine|mesh-list
44083249|NCT00277069|Vinorelbine|vinorelbine|mesh-list
44083250|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083251|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083252|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
44083253|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083254|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083255|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083256|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083257|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083258|NCT00277043|Paclitaxel|paclitaxel|mesh-list
44083259|NCT00277043|Docetaxel|docetaxel|mesh-list
44083260|NCT00277043|Taxane|taxane|mesh-list
44083261|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083262|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083263|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083264|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083265|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083266|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083267|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44083268|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
44083269|NCT00277017|Interferons|interferons|mesh-list
44083270|NCT00277017|Thalidomide|thalidomide|mesh-list
44258956|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44258957|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44083271|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083272|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
44083273|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083274|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083275|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
44083276|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083277|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
44083278|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44083279|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083280|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083281|NCT00277017|Growth Substances|growth substances|mesh-ancestor
44083282|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083283|NCT00276978|Aripiprazole|aripiprazole|mesh-list
44083284|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083285|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083286|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44083287|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083288|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083289|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083290|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
44083291|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
44083292|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083293|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083294|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44083295|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44083296|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
44083297|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44083298|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44083299|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44083300|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44083301|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
44083302|NCT00276965|Sertraline|sertraline|mesh-list
44083303|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083304|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083305|NCT00276965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44083306|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44083307|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083308|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083309|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083310|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
44083311|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083312|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083313|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
44083314|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083315|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152113|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44152114|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44152115|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44152116|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152117|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152118|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152119|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44152120|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44152121|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152122|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152123|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44152124|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
44152125|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
44152126|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
44152127|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
44152128|NCT00216216|Pemetrexed|pemetrexed|mesh-list
44152129|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152130|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152131|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152132|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44152133|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44152134|NCT00216268|Ribavirin|ribavirin|mesh-list
44152135|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
44152136|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258958|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
44258959|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44258960|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258961|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258962|NCT00631943|Pregabalin|pregabalin|mesh-list
44258963|NCT00631943|Analgesics|analgesics|mesh-ancestor
44152137|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
44152138|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152140|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44152141|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44083316|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
44083317|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083318|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44083319|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083320|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083321|NCT00276900|Sertraline|sertraline|mesh-list
44083322|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083323|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083324|NCT00276900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44083325|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44083326|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083327|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083328|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083329|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
44083330|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083331|NCT00276874|Aripiprazole|aripiprazole|mesh-list
44083332|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083333|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083334|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44083335|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083336|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083337|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083338|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
44083340|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083341|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083342|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44083343|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43831701|NCT05301608|Psilocybin|psilocybin|mesh-list
44083344|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
44083345|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44083346|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44083347|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44083348|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44083349|NCT00276861|Gemcitabine|gemcitabine|mesh-list
44083350|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
44083351|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083352|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
44083353|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083354|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083355|NCT00276861|Antiviral Agents|antiviral agents|mesh-ancestor
44083356|NCT00276861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083357|NCT00276861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083358|NCT00276861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083359|NCT00276861|Immunologic Factors|immunologic factors|mesh-ancestor
44083360|NCT00276861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083361|NCT00276848|Vidarabine|vidarabine|mesh-list
44083362|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
44083363|NCT00276848|Fludarabine|fludarabine|mesh-list
44083364|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
44083365|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083366|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
44083367|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083368|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083369|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083370|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
44083371|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083372|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083373|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44083374|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44258964|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
44258965|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845610|NCT04265534|Pemetrexed|pemetrexed|mesh-list
44083375|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
44083376|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
44083377|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083378|NCT00276835|Aldesleukin|aldesleukin|mesh-list
44083379|NCT00276835|Interleukin-2|interleukin-2|mesh-list
44083380|NCT00276835|Genistein|genistein|mesh-list
44083381|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083382|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44083383|NCT00276835|Analgesics|analgesics|mesh-ancestor
44083384|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
44083385|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083386|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083387|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44083388|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44083389|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
44083390|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083391|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44083392|NCT00276835|Protective Agents|protective agents|mesh-ancestor
44083393|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44083394|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083395|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083396|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
44083397|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44083398|NCT00276835|Estrogens|estrogens|mesh-ancestor
44083400|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083401|NCT00276809|Cytarabine|cytarabine|mesh-list
44083402|NCT00276809|Dexamethasone|dexamethasone|mesh-list
44083403|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
44083404|NCT00276809|Melphalan|melphalan|mesh-list
44083405|NCT00276809|Carmustine|carmustine|mesh-list
44083406|NCT00276809|Fludarabine|fludarabine|mesh-list
44083407|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
44083408|NCT00276809|Etoposide|etoposide|mesh-list
44083409|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
44083410|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083411|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
44083412|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083413|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083414|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083415|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
43711099|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
44083416|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083418|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44083419|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083420|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
44083421|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
44083422|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083423|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44083424|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
44083425|NCT00276809|Hormones|hormones|mesh-ancestor
44083426|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083427|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44083428|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083429|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
44083430|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083431|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083432|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083433|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083434|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
44083435|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083436|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083437|NCT00276796|Paclitaxel|paclitaxel|mesh-list
44083438|NCT00276796|Cisplatin|cisplatin|mesh-list
44083439|NCT00276796|Topotecan|topotecan|mesh-list
44083440|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083441|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083442|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083443|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083444|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083445|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083446|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44083447|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44258966|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258967|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
44083448|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083449|NCT00276783|Pemetrexed|pemetrexed|mesh-list
44083450|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083451|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083452|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083453|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44083454|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44083455|NCT00276770|Fluorides|fluorides|mesh-list
44083456|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
44083457|NCT00276770|Protective Agents|protective agents|mesh-ancestor
44083458|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083459|NCT00276757|Leucovorin|leucovorin|mesh-list
44083460|NCT00276757|Prednisolone|prednisolone|mesh-list
44083461|NCT00276757|Methotrexate|methotrexate|mesh-list
44083462|NCT00276757|Vinblastine|vinblastine|mesh-list
44083463|NCT00276757|Calcium|calcium|mesh-list
44083464|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
44083465|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083466|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083467|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44083468|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
44083469|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44083470|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083471|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
44083472|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083473|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083474|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
44083475|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083476|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44083477|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083478|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
44083479|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083480|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44083481|NCT00276757|Antidotes|antidotes|mesh-ancestor
44083482|NCT00276757|Protective Agents|protective agents|mesh-ancestor
44083483|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
44083485|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
44083486|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083487|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
44083488|NCT00276757|Hormones|hormones|mesh-ancestor
44083489|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083490|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43582263|NCT02525692|TIC10 compound|tic10 compound|mesh-list
44083492|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083493|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083494|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083495|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
44083496|NCT00276731|Cisplatin|cisplatin|mesh-list
44083497|NCT00276731|Carboplatin|carboplatin|mesh-list
44083498|NCT00276731|Etoposide|etoposide|mesh-list
44083499|NCT00276731|Vincristine|vincristine|mesh-list
44083500|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083501|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
44083502|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083503|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083504|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083505|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
44083506|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083507|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083508|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44083509|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083510|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083511|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083512|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083513|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083514|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083515|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083516|NCT00276718|Carboplatin|carboplatin|mesh-list
44083517|NCT00276718|Etoposide|etoposide|mesh-list
44083518|NCT00276718|Bleomycin|bleomycin|mesh-list
44083519|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083520|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083521|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43790865|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
44258968|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44258969|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44258970|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258971|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083522|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083523|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083524|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083525|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083526|NCT00276705|Thalidomide|thalidomide|mesh-list
44083527|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
44083528|NCT00276705|Cisplatin|cisplatin|mesh-list
44083529|NCT00276705|Doxorubicin|doxorubicin|mesh-list
44083530|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44083531|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083532|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
44083533|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083534|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083535|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083536|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
44083537|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083539|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44083540|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083541|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083542|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083543|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083545|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44083546|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083547|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083548|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083549|NCT00276705|Growth Substances|growth substances|mesh-ancestor
44083550|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083551|NCT00276692|Irinotecan|irinotecan|mesh-list
44083552|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44083553|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083554|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083555|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083556|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083557|NCT00276679|Temozolomide|temozolomide|mesh-list
44083558|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083559|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
44083560|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083561|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083562|NCT00276666|Cisplatin|cisplatin|mesh-list
44083563|NCT00276666|Vincristine|vincristine|mesh-list
44083564|NCT00276666|Lomustine|lomustine|mesh-list
44083565|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083566|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43582353|NCT02099175|Leucovorin|leucovorin|mesh-list
44083573|NCT00276640|Carboplatin|carboplatin|mesh-list
44083575|NCT00276640|Vincristine|vincristine|mesh-list
44083576|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083577|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083578|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083579|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083580|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083581|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083582|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083583|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083584|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083585|NCT00276601|Cytarabine|cytarabine|mesh-list
44083586|NCT00276601|Methotrexate|methotrexate|mesh-list
44083587|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
44083588|NCT00276601|Daunorubicin|daunorubicin|mesh-list
44083589|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
44083590|NCT00276601|Tretinoin|tretinoin|mesh-list
44083591|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44083592|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
44083593|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44083594|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083595|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083596|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
44258972|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44258973|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44258974|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44258975|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44258977|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
44258978|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258979|NCT00632073|Maleic acid|maleic acid|mesh-list
44258980|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083597|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083598|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083599|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
44083600|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083601|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44083602|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083603|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
44083604|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083605|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44083606|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
44083607|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083608|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083609|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44083610|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083611|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
44083612|NCT00276588|Gemcitabine|gemcitabine|mesh-list
44083613|NCT00276588|Paclitaxel|paclitaxel|mesh-list
44083614|NCT00276588|Carboplatin|carboplatin|mesh-list
44083615|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083616|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083617|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083618|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083619|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083620|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083621|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083623|NCT00276588|Antiviral Agents|antiviral agents|mesh-ancestor
44083624|NCT00276588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083625|NCT00276588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083626|NCT00276588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083627|NCT00276588|Immunologic Factors|immunologic factors|mesh-ancestor
44083628|NCT00276588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083630|NCT00276575|Everolimus|everolimus|mesh-list
44083631|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44083632|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083633|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083634|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083635|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083636|NCT00276575|Growth Substances|growth substances|mesh-ancestor
44083637|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083638|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083639|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083640|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
44083641|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44083642|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083643|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083644|NCT00276549|Gemcitabine|gemcitabine|mesh-list
44083645|NCT00276549|Docetaxel|docetaxel|mesh-list
44083646|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083647|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
44083648|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083649|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083650|NCT00276549|Antiviral Agents|antiviral agents|mesh-ancestor
44083651|NCT00276549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083652|NCT00276549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083653|NCT00276549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083654|NCT00276549|Immunologic Factors|immunologic factors|mesh-ancestor
44083655|NCT00276549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083656|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
44258981|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258982|NCT00632086|Aspirin|aspirin|mesh-list
44258983|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44258984|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44258985|NCT00632086|Analgesics|analgesics|mesh-ancestor
44083657|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083658|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083659|NCT00276536|Interferons|interferons|mesh-list
44083660|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
44083661|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44083662|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083663|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
44083664|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083665|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
44083666|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083667|NCT00276523|Interferons|interferons|mesh-list
44083668|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
44083669|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
44083670|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44083671|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083672|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
44083673|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083674|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
44083675|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083676|NCT00276497|Pioglitazone|pioglitazone|mesh-list
44083677|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44083678|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083679|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
44083680|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44083681|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
44083682|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083683|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44083684|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44083685|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083686|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083687|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
44083688|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083689|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083690|NCT00276393|Insulin|insulin|mesh-list
44083691|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44083692|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083693|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
44083694|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44083695|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44083696|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44083697|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43549875|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
44083698|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083699|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44083700|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083701|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083702|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44083703|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083704|NCT00276289|Spironolactone|spironolactone|mesh-list
44083705|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44083706|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
44083707|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083708|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083709|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44083710|NCT00276289|Diuretics|diuretics|mesh-ancestor
44083711|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
44083712|NCT00276276|Topotecan|topotecan|mesh-list
44083713|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44083714|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083715|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083716|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083717|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083718|NCT00276250|Abatacept|abatacept|mesh-list
44083719|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44083720|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258986|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
44258987|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44258988|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44258989|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44258990|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44258991|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44258992|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44258993|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44258994|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44258995|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44258996|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44258997|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
44258998|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
44258999|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44259000|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259001|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259002|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083721|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083722|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083723|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
44083724|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083725|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083726|NCT00276198|Vitamin D|vitamin d|mesh-list
44083727|NCT00276198|Vitamin A|vitamin a|mesh-list
44083728|NCT00276198|Vitamins|vitamins|mesh-ancestor
44083729|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
44083730|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083731|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44083732|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
44083733|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44083734|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083735|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083736|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
44083737|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083738|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083739|NCT00276172|Natalizumab|natalizumab|mesh-list
44083740|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
44083741|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083742|NCT00276146|Dipyridamole|dipyridamole|mesh-list
44083743|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44083744|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083745|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083746|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44083747|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
44083748|NCT00276133|Atorvastatin|atorvastatin|mesh-list
44083749|NCT00276133|Probucol|probucol|mesh-list
44083750|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44083751|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44083752|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
44083753|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083754|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44083755|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44083756|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083757|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
44083758|NCT00276133|Protective Agents|protective agents|mesh-ancestor
44259003|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259004|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44259005|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
44259006|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259007|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259008|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259009|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259011|NCT00632268|Cisplatin|cisplatin|mesh-list
44259012|NCT00632268|Everolimus|everolimus|mesh-list
44259013|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259014|NCT00632268|Antidotes|antidotes|mesh-ancestor
44259015|NCT00632268|Protective Agents|protective agents|mesh-ancestor
44259016|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259017|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
44259018|NCT00632268|Vitamins|vitamins|mesh-ancestor
44259019|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
44083759|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083760|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44083761|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
44083762|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083763|NCT00276081|Gabapentin|gabapentin|mesh-list
44083764|NCT00276081|Estrogens|estrogens|mesh-list
44083765|NCT00276081|Analgesics|analgesics|mesh-ancestor
44083766|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
44083767|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083768|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802737|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
44083769|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
44083770|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44083771|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083772|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083773|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083774|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44083775|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44083776|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083777|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083778|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
44083779|NCT00276081|Hormones|hormones|mesh-ancestor
44083780|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083781|NCT00276068|Lidocaine|lidocaine|mesh-list
44083782|NCT00276068|Desipramine|desipramine|mesh-list
44083783|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
44083784|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
44083785|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44083786|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083787|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
44083788|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083789|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44083790|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44083791|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44083792|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083793|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083794|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44083795|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
44083796|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44083797|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083798|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44259020|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259021|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
44083799|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44083800|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
44083801|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083802|NCT00276055|Gemcitabine|gemcitabine|mesh-list
44083803|NCT00276055|Bevacizumab|bevacizumab|mesh-list
44083805|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083806|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083807|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44083808|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44083809|NCT00276055|Growth Substances|growth substances|mesh-ancestor
44083810|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083811|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
44083812|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083813|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
44083814|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083815|NCT00276055|Antiviral Agents|antiviral agents|mesh-ancestor
44083816|NCT00276055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083817|NCT00276055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083818|NCT00276055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083819|NCT00276055|Immunologic Factors|immunologic factors|mesh-ancestor
44083820|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083821|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083822|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083823|NCT00276029|Etanercept|etanercept|mesh-list
44083824|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44083825|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44083826|NCT00276029|Analgesics|analgesics|mesh-ancestor
44083827|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
44083828|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083829|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083830|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083831|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083832|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44083833|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083834|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
44083835|NCT00276003|Gemcitabine|gemcitabine|mesh-list
44083836|NCT00276003|Irinotecan|irinotecan|mesh-list
44083837|NCT00276003|Allopurinol|allopurinol|mesh-list
44083838|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083839|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
44083840|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083842|NCT00276003|Antiviral Agents|antiviral agents|mesh-ancestor
44083843|NCT00276003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083844|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083845|NCT00276003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083846|NCT00276003|Immunologic Factors|immunologic factors|mesh-ancestor
44083847|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083848|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44083849|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44083850|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
44083851|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083852|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44083853|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
44083854|NCT00276003|Protective Agents|protective agents|mesh-ancestor
44083855|NCT00275951|Cetuximab|cetuximab|mesh-list
44083856|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083857|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083858|NCT00275938|Interferons|interferons|mesh-list
44083859|NCT00275938|Ribavirin|ribavirin|mesh-list
44083860|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
44083861|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
44083862|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083863|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
44083864|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083866|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083868|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083869|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
44083870|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
44083871|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44083872|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44083873|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083874|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259023|NCT00632333|Fluorouracil|fluorouracil|mesh-list
44259024|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259025|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
44259026|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845735|NCT04253457|Triamcinolone|triamcinolone|mesh-list
43550067|NCT03626064|Nicotine|nicotine|mesh-list
44083875|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44083876|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44083877|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
44083878|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
44083879|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44083880|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44083881|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083882|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083883|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44083884|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44083885|NCT00275834|Zonisamide|zonisamide|mesh-list
44083886|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
44083887|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44083888|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44083889|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083890|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44083891|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083892|NCT00275756|Timolol|timolol|mesh-list
44083893|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44083894|NCT00275756|Dorzolamide|dorzolamide|mesh-list
44083895|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44083896|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44083897|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
44083898|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44083899|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083900|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083901|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44083902|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44083903|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44083904|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44083905|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44083906|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44083907|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083908|NCT00275730|Indomethacin|indomethacin|mesh-list
44083909|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44083910|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44083911|NCT00275730|Analgesics|analgesics|mesh-ancestor
44083912|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
44083913|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083914|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083915|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083916|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083917|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
44083918|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
44083919|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44083920|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44083921|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083922|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083923|NCT00275665|Valganciclovir|valganciclovir|mesh-list
44083924|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
44083925|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083926|NCT00275652|Lamivudine|lamivudine|mesh-list
44083927|NCT00275652|Telbivudine|telbivudine|mesh-list
44083928|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44083929|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44083930|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083931|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083932|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
44083933|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083934|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44083935|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44083939|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44083940|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44259027|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259028|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083941|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083942|NCT00275613|Rituximab|rituximab|mesh-list
44083943|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44083944|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083945|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
44083946|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550143|NCT03625518|Oxytocin|oxytocin|mesh-list
44083947|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44083948|NCT00275600|Vitamin E|vitamin e|mesh-list
44083949|NCT00275600|Vitamins|vitamins|mesh-ancestor
44083950|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
44083951|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083952|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
44083953|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083954|NCT00275600|Protective Agents|protective agents|mesh-ancestor
44083955|NCT00275548|Ribavirin|ribavirin|mesh-list
44083956|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44083957|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
44083958|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083959|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
44083960|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083961|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
44083962|NCT00275535|Sirolimus|sirolimus|mesh-list
44083963|NCT00275535|Prednisone|prednisone|mesh-list
44083964|NCT00275535|Tacrolimus|tacrolimus|mesh-list
44083965|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
44083966|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44083967|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44083968|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
44083969|NCT00275535|Hormones|hormones|mesh-ancestor
44083970|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44083971|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083972|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44083973|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083974|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083975|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
44083976|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44083977|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44083978|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083979|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083980|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44083981|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
44083982|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44083983|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083984|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
44083985|NCT00275522|Sirolimus|sirolimus|mesh-list
44083986|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44083987|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44083988|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44083990|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
44083991|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44083992|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
44083993|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083994|NCT00275457|Pramipexole|pramipexole|mesh-list
44083995|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
44083996|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083997|NCT00275457|Protective Agents|protective agents|mesh-ancestor
44083998|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44083999|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44084000|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44084001|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
44084002|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
44084003|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084004|NCT00275444|Tipranavir|tipranavir|mesh-list
44084005|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44084006|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44084007|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
44084008|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084009|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
43582792|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084010|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084011|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084012|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44084013|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
44259029|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
44259030|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259031|NCT00632385|Eletriptan|eletriptan|mesh-list
44259032|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44084014|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084015|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084016|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44084017|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44084018|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44084019|NCT00275418|Beta Carotene|beta carotene|mesh-list
44084020|NCT00275418|Carotenoids|carotenoids|mesh-list
44084021|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
44084022|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084023|NCT00275418|Protective Agents|protective agents|mesh-ancestor
44084024|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084025|NCT00275418|Provitamins|provitamins|mesh-ancestor
44084026|NCT00275418|Vitamins|vitamins|mesh-ancestor
44084027|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
44084028|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
44084029|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
44084030|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084031|NCT00275405|Protective Agents|protective agents|mesh-ancestor
44084032|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084033|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44084034|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084035|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44084036|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152142|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152143|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152144|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152145|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152146|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152147|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152148|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152149|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
44152150|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44152151|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152152|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152153|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152154|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
44152155|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
44152156|NCT00216294|Secretin|secretin|mesh-list
44152157|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152158|NCT00216294|Hormones|hormones|mesh-ancestor
44152159|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152160|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152161|NCT00216346|Amphotericin B|amphotericin b|mesh-list
44152162|NCT00216346|Paromomycin|paromomycin|mesh-list
44152163|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44152164|NCT00216346|Amebicides|amebicides|mesh-ancestor
44152165|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44152166|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44152167|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152168|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152169|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
44152170|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44152171|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
44152172|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
44152173|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152174|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44152175|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44084037|NCT00275314|Valganciclovir|valganciclovir|mesh-list
44084038|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
44084039|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084040|NCT00275275|Pramipexole|pramipexole|mesh-list
44084041|NCT00275275|Ropinirole|ropinirole|mesh-list
44084042|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
44084043|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084044|NCT00275275|Protective Agents|protective agents|mesh-ancestor
44084045|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084046|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44084047|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44084048|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
44259034|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259035|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259036|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259037|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
44259038|NCT00632476|Vitamins|vitamins|mesh-ancestor
44259039|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
44259040|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259041|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
44259042|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084049|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
44084050|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084051|NCT00275249|Levorphanol|levorphanol|mesh-list
44084052|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44084054|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44084055|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084056|NCT00275249|Analgesics|analgesics|mesh-ancestor
44084057|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
44084058|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084059|NCT00275236|Rotigotine|rotigotine|mesh-list
44084060|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
44084061|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
44084062|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084063|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084064|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084065|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
44084066|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084067|NCT00275197|Sertraline|sertraline|mesh-list
44084068|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
44084069|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44084070|NCT00275197|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44084071|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44084072|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084073|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084074|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084075|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
44084076|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084077|NCT00275184|Metoclopramide|metoclopramide|mesh-list
44084078|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
44084079|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
44084080|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084081|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084082|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084083|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44084084|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44084085|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
44084086|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084087|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084088|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44084089|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084090|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44084091|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084092|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084093|NCT00275119|Gemcitabine|gemcitabine|mesh-list
44084094|NCT00275119|Fluorouracil|fluorouracil|mesh-list
44084095|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
44084096|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084097|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
44084098|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084099|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084100|NCT00275119|Antiviral Agents|antiviral agents|mesh-ancestor
44084101|NCT00275119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084102|NCT00275119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259043|NCT00632476|Protective Agents|protective agents|mesh-ancestor
44259044|NCT00632554|Prednisolone|prednisolone|mesh-list
44259045|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44259046|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
44259047|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44084103|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084104|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
44084105|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084106|NCT00275106|Leucovorin|leucovorin|mesh-list
44084107|NCT00275106|Cytarabine|cytarabine|mesh-list
44084108|NCT00275106|Dexamethasone|dexamethasone|mesh-list
44084109|NCT00275106|Prednisolone|prednisolone|mesh-list
44084110|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
44084111|NCT00275106|Doxorubicin|doxorubicin|mesh-list
44084112|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44084113|NCT00275106|Methotrexate|methotrexate|mesh-list
44084114|NCT00275106|Vincristine|vincristine|mesh-list
44084115|NCT00275106|Daunorubicin|daunorubicin|mesh-list
44084116|NCT00275106|Asparaginase|asparaginase|mesh-list
44084117|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
44084118|NCT00275106|Thioguanine|thioguanine|mesh-list
44084119|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
44084120|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084121|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
44084122|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084123|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084124|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084125|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
44084126|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084127|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084128|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44084131|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
44084132|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084133|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084134|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
44084135|NCT00275106|Hormones|hormones|mesh-ancestor
44084136|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084137|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084138|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084139|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084140|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084141|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084142|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44084143|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
44084144|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084145|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084146|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
44084147|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084148|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44084149|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44084150|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
44084151|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084152|NCT00275106|Antidotes|antidotes|mesh-ancestor
44084153|NCT00275106|Protective Agents|protective agents|mesh-ancestor
44084154|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
44084155|NCT00275106|Vitamins|vitamins|mesh-ancestor
44084156|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
44084157|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084158|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084159|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084160|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084161|NCT00275093|Sirolimus|sirolimus|mesh-list
44084162|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084163|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084164|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084165|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084166|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
44084167|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084168|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
44084169|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084170|NCT00275080|Decitabine|decitabine|mesh-list
44084171|NCT00275080|Azacitidine|azacitidine|mesh-list
44084172|NCT00275080|Vorinostat|vorinostat|mesh-list
44084173|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259048|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
44259049|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44259050|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
44259051|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259053|NCT00632554|Hormones|hormones|mesh-ancestor
43655493|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44084174|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
44084175|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084176|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084177|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084178|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44084179|NCT00275067|Temozolomide|temozolomide|mesh-list
44084180|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
44084181|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084182|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
44084183|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084184|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084185|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
44084187|NCT00275054|Fludarabine|fludarabine|mesh-list
44084188|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084189|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
44084190|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084191|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084192|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084193|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
44084194|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084195|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084196|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44084197|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084198|NCT00275041|Irinotecan|irinotecan|mesh-list
44084199|NCT00275041|Cetuximab|cetuximab|mesh-list
44084200|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44084201|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084202|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084203|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084209|NCT00275015|Melphalan|melphalan|mesh-list
44084210|NCT00275015|Carmustine|carmustine|mesh-list
44084211|NCT00275015|Fludarabine|fludarabine|mesh-list
44084212|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
44084213|NCT00275015|Etoposide|etoposide|mesh-list
44084214|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084215|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
44084216|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084217|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084218|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084219|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
44084220|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084221|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084222|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44084223|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084224|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
44084225|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
44084226|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084227|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084228|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
44084229|NCT00275015|Hormones|hormones|mesh-ancestor
44084230|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084231|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084232|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084233|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
44084234|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084235|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084236|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084237|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084238|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
44084239|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084240|NCT00274989|Rituximab|rituximab|mesh-list
44084241|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44259054|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259055|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084242|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084244|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
44084245|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084246|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084247|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084248|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
44084249|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084250|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
44084251|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084252|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084253|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44084254|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
43623092|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
44084255|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084256|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
44084257|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084258|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084259|NCT00274963|Analgesics|analgesics|mesh-ancestor
44084260|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
44084261|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084262|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084263|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084264|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43803132|NCT04971304|Lenograstim|lenograstim|mesh-list
44084265|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084266|NCT00274950|Cisplatin|cisplatin|mesh-list
44084267|NCT00274950|Carboplatin|carboplatin|mesh-list
44084268|NCT00274950|Etoposide|etoposide|mesh-list
44084269|NCT00274950|Ifosfamide|ifosfamide|mesh-list
44084270|NCT00274950|Bleomycin|bleomycin|mesh-list
44084271|NCT00274950|Vinblastine|vinblastine|mesh-list
44084272|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084273|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084274|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084276|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084277|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084278|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084279|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
44084280|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084281|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084282|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084283|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084285|NCT00130455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44084286|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44084287|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084288|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084289|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084290|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
44084291|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084292|NCT00130455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44084293|NCT00130455|Antidepressive Agents|antidepressive agents|mesh-ancestor
44084294|NCT00130455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44084295|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
44084296|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44084297|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084298|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084299|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44084300|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084301|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44084302|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
44084303|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44084304|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084305|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
44084306|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44084307|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44084308|NCT00130364|Analgesics|analgesics|mesh-ancestor
44084309|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
44084310|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259056|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44259057|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259059|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
44259060|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259061|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655504|NCT02968498|Methamphetamine|methamphetamine|mesh-list
44084311|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084312|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084313|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084314|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084315|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084316|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
44084317|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44084318|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084319|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084320|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
44084321|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44084322|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
44084323|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084324|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084325|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44084326|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
44084327|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44084328|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44084329|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44084330|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
44084331|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084332|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084334|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44084335|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084336|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084337|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
44084338|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803150|NCT04971239|Methotrexate|methotrexate|mesh-list
44084339|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084340|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44084341|NCT00130338|Protective Agents|protective agents|mesh-ancestor
44084342|NCT00130325|Isoniazid|isoniazid|mesh-list
44084343|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
44084344|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084345|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084347|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44084348|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
44084349|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084350|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44084351|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
44084352|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
44084353|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44084354|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
44084355|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084356|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44084357|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44084358|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44084359|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44084360|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084361|NCT00130234|Omalizumab|omalizumab|mesh-list
44084362|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44084363|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44084364|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44084365|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
44084366|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44084367|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44084368|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084369|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
44084370|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084371|NCT00130195|Cytarabine|cytarabine|mesh-list
44084372|NCT00130195|Dexamethasone|dexamethasone|mesh-list
44259063|NCT00632554|Protective Agents|protective agents|mesh-ancestor
44259064|NCT00632580|Ropivacaine|ropivacaine|mesh-list
44259065|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
44259066|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
44084373|NCT00130195|Prednisolone|prednisolone|mesh-list
44084374|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
44084375|NCT00130195|Methotrexate|methotrexate|mesh-list
44084376|NCT00130195|Vincristine|vincristine|mesh-list
44084377|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
44084378|NCT00130195|Daunorubicin|daunorubicin|mesh-list
44084379|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084380|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
44084381|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084382|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084383|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084384|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
44084385|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084386|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084387|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44084388|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084389|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
44084390|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
44084391|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084392|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084393|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
44084394|NCT00130195|Hormones|hormones|mesh-ancestor
44084395|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084396|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084397|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44084398|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
44084399|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084400|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084401|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
44084402|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084403|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084404|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44084405|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44084406|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
44084407|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084408|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084409|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084410|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084411|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084412|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44084413|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084414|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084415|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084416|NCT00130156|Doxazosin|doxazosin|mesh-list
44084417|NCT00130156|Bunazosin|bunazosin|mesh-list
44084418|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084419|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44084420|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44084424|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084425|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084426|NCT00130143|Amifostine|amifostine|mesh-list
44084427|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44084428|NCT00130143|Protective Agents|protective agents|mesh-ancestor
44084429|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084430|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
44084431|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
44084432|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44084433|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084434|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084435|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44084436|NCT00130091|Clonidine|clonidine|mesh-list
44084437|NCT00130091|Analgesics|analgesics|mesh-ancestor
44084438|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
44084439|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084440|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084441|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44259067|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259068|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259069|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
44259070|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084442|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
44084443|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
44084444|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44084445|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44084446|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44084447|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
44084448|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084449|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084450|NCT00130065|Folic Acid|folic acid|mesh-list
44084451|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
44084452|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
44084453|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44084454|NCT00130065|Hematinics|hematinics|mesh-ancestor
44084455|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
44084456|NCT00130065|Vitamins|vitamins|mesh-ancestor
44084457|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
44084458|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084459|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
44084460|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44084461|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44084462|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084463|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44084464|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084465|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084466|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44084467|NCT00130065|Renal Agents|renal agents|mesh-ancestor
44084468|NCT00130026|Caffeine|caffeine|mesh-list
44084469|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44084470|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084471|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44084472|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084473|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084474|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44084475|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44084476|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
44084477|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084478|NCT00130013|Amoxicillin|amoxicillin|mesh-list
44084479|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084480|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084481|NCT00130000|Eculizumab|eculizumab|mesh-list
44084482|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44084483|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084484|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
44084485|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084486|NCT00129948|Troxacitabine|troxacitabine|mesh-list
44084487|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084488|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44084489|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44084490|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
44084491|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084493|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
44084494|NCT00129922|Fluorouracil|fluorouracil|mesh-list
44084496|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084497|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084498|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084499|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084500|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084501|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084502|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084503|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
44084504|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084505|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084506|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084507|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
44084508|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44084509|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
44084510|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259071|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
44259072|NCT00632606|Metoclopramide|metoclopramide|mesh-list
44259073|NCT00632606|Analgesics|analgesics|mesh-ancestor
44259074|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
44259075|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084511|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084512|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084513|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084514|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084515|NCT00129896|Docetaxel|docetaxel|mesh-list
44084516|NCT00129896|Doxorubicin|doxorubicin|mesh-list
44084517|NCT00129896|Trastuzumab|trastuzumab|mesh-list
44084518|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084519|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084520|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084521|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084522|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084523|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084524|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084525|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084526|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084527|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084528|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
44084529|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084530|NCT00129857|HU 211|hu 211|mesh-list
44084531|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44084532|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
44084533|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
44084534|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084535|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084536|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084537|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44084538|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44084539|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084540|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084541|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44084542|NCT00129857|Protective Agents|protective agents|mesh-ancestor
44084543|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
44084544|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084545|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44084546|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084547|NCT00129818|Famciclovir|famciclovir|mesh-list
44084548|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
44084549|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084550|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44084551|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084552|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084553|NCT00129805|Aspirin|aspirin|mesh-list
44084554|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
44084555|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44084556|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44084557|NCT00129805|Analgesics|analgesics|mesh-ancestor
44084558|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
44084559|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084560|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084561|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084562|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084563|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44084564|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44084565|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084566|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44084567|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44084568|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084571|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
44084572|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084573|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
44084574|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084575|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084576|NCT00129727|Paclitaxel|paclitaxel|mesh-list
44084577|NCT00129727|Bevacizumab|bevacizumab|mesh-list
44084578|NCT00129727|Carboplatin|carboplatin|mesh-list
44259076|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259078|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259079|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44259080|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
44259081|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44084579|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084580|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084581|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084582|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084583|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084584|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084585|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084586|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44084587|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44084588|NCT00129727|Growth Substances|growth substances|mesh-ancestor
44084589|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084590|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
44084591|NCT00129688|Amikacin|amikacin|mesh-list
44084592|NCT00129688|Cloxacillin|cloxacillin|mesh-list
44084593|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084594|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084595|NCT00129597|Ketamine|ketamine|mesh-list
44084596|NCT00129597|Analgesics|analgesics|mesh-ancestor
44084597|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
44084598|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084599|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084600|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44084601|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44084602|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
44084603|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
44084604|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44084605|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44084606|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44084607|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084608|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084609|NCT00129519|Imiquimod|imiquimod|mesh-list
44084610|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44084611|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
44084612|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084613|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084614|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
44084615|NCT00129506|Methotrexate|methotrexate|mesh-list
44084616|NCT00129506|Misoprostol|misoprostol|mesh-list
44084617|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44084618|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
44084619|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084620|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084621|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084622|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
44084623|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084624|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084625|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
44084626|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084627|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44084628|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084629|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
44084630|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084631|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44084632|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44084633|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44084634|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
44084635|NCT00129363|Carvedilol|carvedilol|mesh-list
44084636|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44084637|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44084638|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
43803328|NCT04968002|Apatinib|apatinib|mesh-list
44084639|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084640|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259082|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259083|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259084|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44259085|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
44259086|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44259087|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
44259088|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
44259089|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259090|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44259091|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44259092|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
44259093|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259094|NCT00632645|Olanzapine|olanzapine|mesh-list
44259095|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
44259096|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
44259097|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
44259098|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
44259099|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655525|NCT02968342|Progestins|progestins|mesh-ancestor
44084641|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084645|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44084646|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084647|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44084648|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
44084649|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44084650|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44084651|NCT00129337|Bavituximab|bavituximab|mesh-list
44084652|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084653|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084654|NCT00129298|Tiagabine|tiagabine|mesh-list
44084655|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
44084656|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44084657|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44084658|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084659|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084660|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
44084661|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084662|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084663|NCT00129285|Modafinil|modafinil|mesh-list
44084664|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44084665|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084666|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44084667|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44084668|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44084669|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084670|NCT00129246|Naltrexone|naltrexone|mesh-list
44084671|NCT00129246|Bupropion|bupropion|mesh-list
44084672|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44084673|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44084674|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084675|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
44084676|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084677|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44084678|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
44084679|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259100|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259101|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259102|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44084680|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44084681|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44084682|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084683|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084684|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
44084685|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084686|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44084687|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44084688|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084689|NCT00129233|Amlodipine|amlodipine|mesh-list
44084690|NCT00129233|Valsartan|valsartan|mesh-list
44084691|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084692|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44084693|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084694|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084695|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44084696|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084697|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
44084698|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44084699|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44152176|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550828|NCT03620253|Modafinil|modafinil|mesh-list
44152177|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44152178|NCT00216372|Lanreotide|lanreotide|mesh-list
44152179|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152180|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
44152181|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152182|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152183|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44152184|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44152185|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44152186|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084720|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
44084721|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084722|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084723|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
44084724|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084725|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084726|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
44084727|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084728|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084729|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084730|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084731|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084732|NCT00129155|Treosulfan|treosulfan|mesh-list
44084733|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084734|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
44084735|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084736|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084737|NCT00129142|Toremifene|toremifene|mesh-list
44084738|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084739|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084740|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44084741|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44084742|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
44084743|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084744|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084745|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44084746|NCT00129090|Rituximab|rituximab|mesh-list
44084747|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084748|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084749|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
44084751|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084752|NCT00129038|Aspirin|aspirin|mesh-list
44084753|NCT00129038|Dipyridamole|dipyridamole|mesh-list
44084754|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44084755|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44259103|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259104|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259105|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44084756|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44084757|NCT00129038|Analgesics|analgesics|mesh-ancestor
44084758|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
44084759|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084760|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084761|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084762|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084763|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44084764|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44084765|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084766|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44084767|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44084768|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084769|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
44084770|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44084771|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
44084772|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
44084773|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084774|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084775|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44084776|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
44084777|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084778|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084779|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084780|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084781|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
44084782|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44084783|NCT00128934|Estradiol|estradiol|mesh-list
44084784|NCT00128934|Estrogens|estrogens|mesh-ancestor
44084785|NCT00128934|Hormones|hormones|mesh-ancestor
44084786|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084787|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084788|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44084789|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
44084790|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084791|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44084792|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44084793|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44084794|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44084795|NCT00128921|Bortezomib|bortezomib|mesh-list
44084796|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084797|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44084798|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
44084799|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084800|NCT00128895|Azathioprine|azathioprine|mesh-list
44084801|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
44084802|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084803|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084804|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084805|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084806|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
44084807|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084808|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084809|NCT00128856|Gemcitabine|gemcitabine|mesh-list
44084810|NCT00128856|Paclitaxel|paclitaxel|mesh-list
44084811|NCT00128856|Doxorubicin|doxorubicin|mesh-list
44084812|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44084813|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084814|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084815|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084816|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084817|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084818|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084819|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
44084820|NCT00128856|Antiviral Agents|antiviral agents|mesh-ancestor
44084821|NCT00128856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084822|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084823|NCT00128856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44084824|NCT00128856|Immunologic Factors|immunologic factors|mesh-ancestor
44259106|NCT00632645|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44259107|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44259108|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084825|NCT00128856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084826|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084827|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084828|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084829|NCT00128843|Anastrozole|anastrozole|mesh-list
44084830|NCT00128843|Exemestane|exemestane|mesh-list
44084831|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084832|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084833|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44084834|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44084835|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084836|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084837|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44084838|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
44084839|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084840|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084841|NCT00128804|Beta Carotene|beta carotene|mesh-list
44084842|NCT00128804|Carotenoids|carotenoids|mesh-list
44084843|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
44084844|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084845|NCT00128804|Protective Agents|protective agents|mesh-ancestor
44084846|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084847|NCT00128804|Provitamins|provitamins|mesh-ancestor
44084848|NCT00128804|Vitamins|vitamins|mesh-ancestor
44084849|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
44084850|NCT00128791|Nitroprusside|nitroprusside|mesh-list
44084851|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084852|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
44084853|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44084854|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084855|NCT00128778|Doxorubicin|doxorubicin|mesh-list
44084856|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44084857|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44084858|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084859|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44084860|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084861|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084862|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084863|NCT00128752|Beta Carotene|beta carotene|mesh-list
44084864|NCT00128752|Carotenoids|carotenoids|mesh-list
44084865|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
44084866|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084867|NCT00128752|Protective Agents|protective agents|mesh-ancestor
44084868|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084869|NCT00128752|Provitamins|provitamins|mesh-ancestor
44084870|NCT00128752|Vitamins|vitamins|mesh-ancestor
44084871|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
44084872|NCT00128739|Budesonide|budesonide|mesh-list
44084873|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084874|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44084875|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
44084876|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084877|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084878|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44084879|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
44084880|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
44084881|NCT00128739|Hormones|hormones|mesh-ancestor
44084882|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084883|NCT00128700|Temozolomide|temozolomide|mesh-list
44084884|NCT00128700|Vatalanib|vatalanib|mesh-list
44084885|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44084886|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
44084887|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084888|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084889|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44084890|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084891|NCT00128635|Antibodies|antibodies|mesh-list
44084892|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44259109|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259110|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259111|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
44259112|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44259113|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
44084893|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
44084894|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084895|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
44084896|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084897|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
44084898|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084910|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44084912|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084913|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084914|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44084915|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084916|NCT00128518|Perindopril|perindopril|mesh-list
44084917|NCT00128518|Indapamide|indapamide|mesh-list
44084918|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44084919|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
44084920|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550957|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
44084921|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084922|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084923|NCT00128518|Diuretics|diuretics|mesh-ancestor
44084924|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
43803510|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
44084925|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084926|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44084927|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44084928|NCT00128505|Mifepristone|mifepristone|mesh-list
44084929|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44084930|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
44084931|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084932|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084933|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44084934|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44084935|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44084936|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
44084937|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44084938|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44084939|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
44084940|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084941|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
44084942|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44084943|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44084944|NCT00128479|Mifepristone|mifepristone|mesh-list
44084945|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44084946|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
44084947|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44084948|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084949|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44084950|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44084951|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44084952|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
44084953|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44084954|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44084955|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
44084956|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44084957|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
44084958|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44084959|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44084985|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084986|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084987|NCT00128427|Colchicine|colchicine|mesh-list
44084988|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
44084989|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084990|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44259115|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
44259116|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
44259117|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44259118|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259119|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259120|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44259121|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44084991|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084992|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084993|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084994|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084995|NCT00128414|Colchicine|colchicine|mesh-list
44084996|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
44084997|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084998|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084999|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085000|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085001|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650717|NCT03011905|Etoricoxib|etoricoxib|mesh-list
44085002|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085003|NCT00128401|Cycloserine|cycloserine|mesh-list
44085004|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44085005|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085006|NCT00128401|Renal Agents|renal agents|mesh-ancestor
44085007|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44085008|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
43583885|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
44085011|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085012|NCT00128323|Nystatin|nystatin|mesh-list
44085013|NCT00128323|Gentian Violet|gentian violet|mesh-list
44085014|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44085015|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44085016|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085017|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
44085018|NCT00128323|Ionophores|ionophores|mesh-ancestor
44085019|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085020|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085021|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44085022|NCT00128310|Gemcitabine|gemcitabine|mesh-list
44085023|NCT00128310|Vinorelbine|vinorelbine|mesh-list
44085024|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085025|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
44085026|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085027|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085028|NCT00128310|Antiviral Agents|antiviral agents|mesh-ancestor
44085029|NCT00128310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085030|NCT00128310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085031|NCT00128310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085032|NCT00128310|Immunologic Factors|immunologic factors|mesh-ancestor
44085033|NCT00128310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085034|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085035|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085036|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085037|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085038|NCT00128297|Pamidronate|pamidronate|mesh-list
44085039|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44085040|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085041|NCT00070070|Sargramostim|sargramostim|mesh-list
44085042|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
44085043|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
44085044|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085045|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085046|NCT00006099|Antibodies|antibodies|mesh-list
44085047|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44085048|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
44085049|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259122|NCT00632697|Protective Agents|protective agents|mesh-ancestor
44259123|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259124|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
43821140|NCT04742673|Guanfacine|guanfacine|mesh-list
44085050|NCT00018603|Guanfacine|guanfacine|mesh-list
44085051|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44085052|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44085053|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44085054|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44085055|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
44085056|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085057|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085058|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085059|NCT00018642|Haloperidol|haloperidol|mesh-list
44085060|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44085061|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
44085062|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
44085063|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085064|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44085065|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44085066|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44085067|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085068|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
44085069|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
44085070|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085071|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44085072|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44085073|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
44085074|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085075|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085076|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44085077|NCT00018668|Olanzapine|olanzapine|mesh-list
44085078|NCT00018668|Risperidone|risperidone|mesh-list
44085079|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44085080|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44085081|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
44085082|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43583929|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
44085083|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085084|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085085|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44085086|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44085087|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44085088|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085089|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44085090|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
44085091|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
44085092|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
43623167|NCT05261464|Metoprolol|metoprolol|mesh-list
44085093|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085094|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44085095|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44085096|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44085097|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085098|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
44085099|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44085100|NCT00018694|Cathartics|cathartics|mesh-ancestor
44085101|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44085102|NCT00018733|Paroxetine|paroxetine|mesh-list
44085103|NCT00018733|Desipramine|desipramine|mesh-list
44085104|NCT00018733|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44085105|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44085106|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085107|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085108|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085109|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
44085110|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085111|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44085112|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
44085113|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085114|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44085115|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44259126|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
44259127|NCT00632723|Gefitinib|gefitinib|mesh-list
44259128|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259129|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259130|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259131|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259132|NCT00632762|Amantadine|amantadine|mesh-list
44259133|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44259134|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44259135|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
44259136|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085116|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085117|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44085118|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44085119|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
44085120|NCT00018759|Paroxetine|paroxetine|mesh-list
44085121|NCT00018759|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44085122|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44085123|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085124|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085125|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085126|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
44085127|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085128|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44085129|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
44085130|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085131|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44085132|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44085133|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085134|NCT00018824|Naltrexone|naltrexone|mesh-list
44085135|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44085136|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44085137|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085138|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
44085139|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085140|NCT00018850|Haloperidol|haloperidol|mesh-list
44085141|NCT00018850|Ondansetron|ondansetron|mesh-list
44085142|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
44085143|NCT00018850|Nicotine|nicotine|mesh-list
44085144|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44085145|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
44085146|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085147|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085148|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44085149|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44085150|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
44085151|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085152|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085153|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
44085154|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44085155|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
44085156|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
44085157|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44085158|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
44085159|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44085160|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44085161|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44085162|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085163|NCT00018850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44085164|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44085165|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
44085166|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44085167|NCT00018863|Methylphenidate|methylphenidate|mesh-list
44259137|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
44259138|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259139|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259140|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259141|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44259142|NCT00632762|Analgesics|analgesics|mesh-ancestor
44259143|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
44085168|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44085169|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085170|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44085171|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44085172|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085173|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085174|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
44085175|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085176|NCT00018902|Fluoxetine|fluoxetine|mesh-list
44085177|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44085178|NCT00018902|Citalopram|citalopram|mesh-list
44085179|NCT00018902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44085180|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44085181|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085182|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085183|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085184|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
44085185|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085186|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44085187|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
44085188|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44085189|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44085190|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44085191|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085192|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44085193|NCT00018941|Aldesleukin|aldesleukin|mesh-list
44085194|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085195|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085196|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085197|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
44085198|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085199|NCT00018954|Cytarabine|cytarabine|mesh-list
44085200|NCT00018954|Prednisone|prednisone|mesh-list
44085201|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
44085202|NCT00018954|Ifosfamide|ifosfamide|mesh-list
44085203|NCT00018954|Doxorubicin|doxorubicin|mesh-list
44085204|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085205|NCT00018954|Methotrexate|methotrexate|mesh-list
44085206|NCT00018954|Etoposide|etoposide|mesh-list
44085207|NCT00018954|Vincristine|vincristine|mesh-list
44085208|NCT00018954|Daunorubicin|daunorubicin|mesh-list
44085209|NCT00018954|Asparaginase|asparaginase|mesh-list
44085210|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
44085211|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085212|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
44085213|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085214|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44085215|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085216|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
44085217|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085218|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085219|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085220|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085221|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085222|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085223|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085224|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44085226|NCT00018954|Hormones|hormones|mesh-ancestor
44085227|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44085228|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44259144|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259145|NCT00632840|Atorvastatin|atorvastatin|mesh-list
44259146|NCT00632840|Fenofibrate|fenofibrate|mesh-list
44259147|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44259148|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44259149|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
44259150|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259151|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44259152|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44259153|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085229|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44085230|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
44085231|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44085232|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085242|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085243|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
44085244|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43623247|NCT04966676|Ipilimumab|ipilimumab|mesh-list
44085245|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
44085246|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085247|NCT00019019|Paclitaxel|paclitaxel|mesh-list
44085248|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44085249|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085250|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085251|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085252|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085253|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085254|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085255|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44085256|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085257|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085258|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085259|NCT00019032|Antibodies|antibodies|mesh-list
44085260|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44085261|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
44085262|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085263|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
44085264|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
44085265|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085266|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
44085267|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085268|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085269|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44085270|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44085271|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44085272|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44085273|NCT00019058|Protective Agents|protective agents|mesh-ancestor
44085274|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085275|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
44085276|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44085277|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
44085278|NCT00019071|Cladribine|cladribine|mesh-list
44085279|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085280|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085281|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
44085282|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085283|NCT00019084|Aldesleukin|aldesleukin|mesh-list
44085284|NCT00019084|Vaccines|vaccines|mesh-list
44085285|NCT00019084|Sargramostim|sargramostim|mesh-list
44085286|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
44085287|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085288|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085289|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085290|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085291|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
44085292|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259154|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
44259155|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
44259156|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44259157|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44085293|NCT00019097|Melphalan|melphalan|mesh-list
44085294|NCT00019097|Sargramostim|sargramostim|mesh-list
44085295|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44085296|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085297|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
44085298|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085299|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085301|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085302|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
44085303|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085304|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085305|NCT00019123|Thalidomide|thalidomide|mesh-list
44085306|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085307|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
44085308|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085309|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
44085310|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44085311|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085312|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44085313|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44085314|NCT00019123|Growth Substances|growth substances|mesh-ancestor
44085315|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085316|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085317|NCT00019136|Aldesleukin|aldesleukin|mesh-list
44085318|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085319|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085320|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085321|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
44085322|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152189|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152190|NCT00216398|Lanreotide|lanreotide|mesh-list
44152191|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152192|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
44152193|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44152194|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44152195|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44152196|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152197|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152198|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152199|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152200|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152201|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44152202|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152203|NCT00216424|Capecitabine|capecitabine|mesh-list
44152204|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152205|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
44152206|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152207|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152208|NCT00216437|Capecitabine|capecitabine|mesh-list
43623438|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623439|NCT04520048|Acetylcholine|acetylcholine|mesh-list
43623440|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
43623441|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43623442|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
43650732|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
43650733|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650734|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
43650735|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650736|NCT03011905|Analgesics|analgesics|mesh-ancestor
43650737|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
43650738|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152209|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152210|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
44152211|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152212|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152213|NCT00216450|Rabeprazole|rabeprazole|mesh-list
44152214|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44152215|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152216|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44152217|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152218|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152219|NCT00216463|Mipomersen|mipomersen|mesh-list
44152220|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44152221|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44152222|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
44152223|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152224|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44152225|NCT00216489|Rabeprazole|rabeprazole|mesh-list
44152226|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44259158|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259159|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259160|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259161|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259162|NCT00633035|Esomeprazole|esomeprazole|mesh-list
44152227|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152228|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44152229|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152230|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152231|NCT00216502|Galantamine|galantamine|mesh-list
44152232|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44152233|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152234|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152235|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152236|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152237|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152238|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44152239|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
44152240|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085324|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085325|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085326|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085327|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
44085328|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085329|NCT00019188|Interleukin-12|interleukin-12|mesh-list
44085330|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085331|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
44085332|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085333|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44085334|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44085335|NCT00019188|Growth Substances|growth substances|mesh-ancestor
44085336|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085337|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085338|NCT00019214|Aldesleukin|aldesleukin|mesh-list
44085339|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085340|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085341|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085342|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
44085343|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085344|NCT00019227|Calcium|calcium|mesh-list
44085345|NCT00019227|Daclizumab|daclizumab|mesh-list
44085346|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
44085347|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085348|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085349|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085350|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
44085351|NCT00019227|Antidotes|antidotes|mesh-ancestor
44085352|NCT00019227|Protective Agents|protective agents|mesh-ancestor
44085353|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
44085354|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
44085355|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085356|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44085357|NCT00019240|Cidofovir|cidofovir|mesh-list
44085358|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
44085359|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085360|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085361|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085362|NCT00019318|Romidepsin|romidepsin|mesh-list
44085363|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085364|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085365|NCT00019331|Aldesleukin|aldesleukin|mesh-list
44085366|NCT00019331|Sargramostim|sargramostim|mesh-list
44085367|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
44085368|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085369|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085370|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085371|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085372|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
44085373|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085374|NCT00019344|Alvocidib|alvocidib|mesh-list
44085375|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085376|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44259163|NCT00633035|Famotidine|famotidine|mesh-list
44259164|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44259165|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43821808|NCT03455504|Venetoclax|venetoclax|mesh-list
44085377|NCT00019344|Growth Substances|growth substances|mesh-ancestor
44085378|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085379|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44085380|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085381|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085382|NCT00019357|Aldesleukin|aldesleukin|mesh-list
44085383|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085384|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085385|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085386|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
44085387|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085388|NCT00019383|Aldesleukin|aldesleukin|mesh-list
44085389|NCT00019383|Sargramostim|sargramostim|mesh-list
44085390|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
44085391|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
44085392|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085393|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085394|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085395|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085396|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
43803842|NCT04956094|Uric Acid|uric acid|mesh-list
44085397|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085398|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085399|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44085400|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
44085404|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44085405|NCT00019396|Protective Agents|protective agents|mesh-ancestor
44085406|NCT00019409|Cytarabine|cytarabine|mesh-list
44085407|NCT00019409|Prednisone|prednisone|mesh-list
44085408|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
44085409|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44085410|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44085411|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44085412|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
44085413|NCT00019409|Methotrexate|methotrexate|mesh-list
44085414|NCT00019409|Vincristine|vincristine|mesh-list
44085415|NCT00019409|Daunorubicin|daunorubicin|mesh-list
44085416|NCT00019409|Asparaginase|asparaginase|mesh-list
44085417|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
44085418|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085419|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
44085420|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085421|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44085422|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085423|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
44085424|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085425|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085426|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085427|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44085428|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
44085429|NCT00019409|Hormones|hormones|mesh-ancestor
44085430|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44085431|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44085432|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44085433|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
44085434|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44085435|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085436|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
44085437|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44085438|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085439|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44085440|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44085441|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
44085442|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085443|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085444|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085445|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085446|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085447|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085448|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085450|NCT00019422|Carboplatin|carboplatin|mesh-list
44085451|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085452|NCT00019435|Immunotoxins|immunotoxins|mesh-list
44085453|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
44085454|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085455|NCT00019448|Interleukin-2|interleukin-2|mesh-list
44085456|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085457|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44085458|NCT00019448|Analgesics|analgesics|mesh-ancestor
44085459|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
43623462|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
44085460|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085461|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085462|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
44085463|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085464|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44085465|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44085466|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085467|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085468|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085469|NCT00019474|Interferons|interferons|mesh-list
44085470|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
44085471|NCT00019474|Fluorouracil|fluorouracil|mesh-list
44085472|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
44085473|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
44085491|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085492|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085493|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
44085494|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085495|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44085496|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44085497|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
44085498|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44085499|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085500|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44085501|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44085502|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44085503|NCT00019513|Leucovorin|leucovorin|mesh-list
44085504|NCT00019513|Gemcitabine|gemcitabine|mesh-list
44085505|NCT00019513|Fluorouracil|fluorouracil|mesh-list
44085506|NCT00019513|Calcium|calcium|mesh-list
44085507|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
44085508|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085509|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
44085510|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085511|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085512|NCT00019513|Antiviral Agents|antiviral agents|mesh-ancestor
44085513|NCT00019513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085514|NCT00019513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085515|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085516|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
44085517|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650742|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44085518|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085519|NCT00019513|Antidotes|antidotes|mesh-ancestor
44085520|NCT00019513|Protective Agents|protective agents|mesh-ancestor
44085521|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
44085522|NCT00019513|Vitamins|vitamins|mesh-ancestor
44085523|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
44085524|NCT00019539|Thalidomide|thalidomide|mesh-list
44085525|NCT00019539|Bevacizumab|bevacizumab|mesh-list
44085526|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44085527|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085528|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44085529|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44085530|NCT00019539|Growth Substances|growth substances|mesh-ancestor
43584442|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
44085541|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085543|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44085544|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44085545|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085546|NCT00019591|Aldesleukin|aldesleukin|mesh-list
44085547|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085548|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085549|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44259167|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259168|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259169|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44259170|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
44259171|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
44259172|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259173|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259174|NCT00633269|Olaparib|olaparib|mesh-list
44259175|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44085550|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
44085551|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085552|NCT00019630|Doxorubicin|doxorubicin|mesh-list
44085553|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085554|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085555|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085556|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085557|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085558|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085559|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085560|NCT00019669|Aldesleukin|aldesleukin|mesh-list
44085561|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085562|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085563|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085564|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
44085565|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085566|NCT00019695|Alendronate|alendronate|mesh-list
44085567|NCT00019695|Ketoconazole|ketoconazole|mesh-list
44085568|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
44085569|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085570|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44085571|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44085572|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085573|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085574|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44085575|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
44085576|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44085577|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085578|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44085579|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44085580|NCT00019721|Aldesleukin|aldesleukin|mesh-list
44085581|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
44085582|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085583|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085584|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085585|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
44085586|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085587|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085588|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
44085589|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085590|NCT00019734|Aldesleukin|aldesleukin|mesh-list
44085591|NCT00019734|Vaccines|vaccines|mesh-list
44085592|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
44085593|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085594|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085595|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085596|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085598|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085599|NCT00019760|Leucovorin|leucovorin|mesh-list
44085600|NCT00019760|Melphalan|melphalan|mesh-list
44085601|NCT00019760|Floxuridine|floxuridine|mesh-list
44085602|NCT00019760|Calcium|calcium|mesh-list
44085603|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
44085604|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085605|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259176|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259177|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259178|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259179|NCT00633282|Pioglitazone|pioglitazone|mesh-list
44085606|NCT00019760|Antidotes|antidotes|mesh-ancestor
44085607|NCT00019760|Protective Agents|protective agents|mesh-ancestor
44085608|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
44085609|NCT00019760|Vitamins|vitamins|mesh-ancestor
44085610|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
44085611|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085612|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
44085613|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085614|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085615|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085616|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085617|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
44085618|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085619|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
44085620|NCT00019773|Capecitabine|capecitabine|mesh-list
44085621|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
44085622|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085623|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
44085624|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085625|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085626|NCT00019786|Melphalan|melphalan|mesh-list
44085627|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085628|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
44085629|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085630|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085631|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085632|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085633|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
44085634|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085636|NCT00019812|Trastuzumab|trastuzumab|mesh-list
44085637|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085638|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085639|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085640|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085641|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085642|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085643|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44085644|NCT00019825|Decitabine|decitabine|mesh-list
44085645|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085646|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
44085647|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085648|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085649|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085650|NCT00019838|Fludarabine|fludarabine|mesh-list
44085651|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
44085652|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44085653|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085654|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085655|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
44085656|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085657|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085658|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
44085659|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085660|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44085661|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085662|NCT00019864|Leucovorin|leucovorin|mesh-list
44085663|NCT00019864|Doxorubicin|doxorubicin|mesh-list
44085664|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085665|NCT00019864|Methotrexate|methotrexate|mesh-list
44085666|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
44085667|NCT00019864|Razoxane|razoxane|mesh-list
44085668|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
44085669|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085670|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085671|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085672|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085673|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791054|NCT00094016|Beclomethasone|beclomethasone|mesh-list
44259180|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44259181|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44259182|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259183|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44259185|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44259186|NCT00633347|Hormones|hormones|mesh-ancestor
44259187|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259188|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085674|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085676|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44085677|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
44085678|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44085679|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085680|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
44085681|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
44085682|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44085683|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085684|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
44085685|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44085686|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44085687|NCT00019864|Antidotes|antidotes|mesh-ancestor
44085688|NCT00019864|Protective Agents|protective agents|mesh-ancestor
44085689|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
44085690|NCT00019864|Vitamins|vitamins|mesh-ancestor
44085691|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
44085692|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44085693|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085694|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085695|NCT00019890|Sargramostim|sargramostim|mesh-list
44085696|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
44085697|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085698|NCT00019916|Aldesleukin|aldesleukin|mesh-list
44085699|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085700|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085701|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085702|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
44085703|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085704|NCT00019968|Melphalan|melphalan|mesh-list
44085705|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085706|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
44085707|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085708|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085709|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085710|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085711|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
44085712|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085713|NCT00019994|Aldesleukin|aldesleukin|mesh-list
44085714|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
44085715|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085716|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085717|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085718|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
44085719|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085720|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085721|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
44085722|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085723|NCT00020007|Paclitaxel|paclitaxel|mesh-list
44085724|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824533|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
43824535|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
43824536|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
44085725|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085726|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085727|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085728|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085729|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085730|NCT00020046|Thalidomide|thalidomide|mesh-list
44085731|NCT00020046|Docetaxel|docetaxel|mesh-list
44085732|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259189|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44259190|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
44259191|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44085733|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085734|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085735|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085736|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085737|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085738|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
44085739|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085740|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
44085741|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44085742|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085743|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44085744|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44085745|NCT00020046|Growth Substances|growth substances|mesh-ancestor
44085746|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085747|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
44085748|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085749|NCT00020124|Doxorubicin|doxorubicin|mesh-list
44085762|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085763|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085764|NCT00020176|Cyclosporine|cyclosporine|mesh-list
44085765|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
44085766|NCT00020176|Fludarabine|fludarabine|mesh-list
44085767|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
44085768|NCT00020176|Cyclosporins|cyclosporins|mesh-list
44085769|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085770|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
44085771|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085772|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44085773|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085774|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
44085775|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085776|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085777|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085778|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085779|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
44085780|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085781|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
44085782|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085783|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44085784|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44085785|NCT00020189|Aspirin|aspirin|mesh-list
44085786|NCT00020189|Alvocidib|alvocidib|mesh-list
44085787|NCT00020189|Clopidogrel|clopidogrel|mesh-list
44085788|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44085789|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44085790|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44085791|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44085792|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
44085793|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44085794|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085795|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085796|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44085797|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44085798|NCT00020189|Analgesics|analgesics|mesh-ancestor
44085799|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
44085800|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085801|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44085802|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44085803|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44085804|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44085805|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44085806|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085807|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
44085808|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085809|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085810|NCT00020189|Growth Substances|growth substances|mesh-ancestor
44085811|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44085834|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
44085835|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085836|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259192|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259193|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
44259194|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44259195|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
44259196|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44259197|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44085837|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085838|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
44085840|NCT00020332|Alvocidib|alvocidib|mesh-list
44085841|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085842|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085843|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085844|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085845|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085846|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085847|NCT00020332|Growth Substances|growth substances|mesh-ancestor
44085848|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085849|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44085850|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085852|NCT00020345|Fluorouracil|fluorouracil|mesh-list
44085853|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085854|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
44085855|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085856|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085857|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
44085858|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085859|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085860|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085861|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
44085862|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085863|NCT00020358|Aldesleukin|aldesleukin|mesh-list
44085864|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
44085865|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085866|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085867|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085868|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
44085870|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085871|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
44085872|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085873|NCT00020371|Lenograstim|lenograstim|mesh-list
44085874|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085875|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
44085876|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085877|NCT00020397|Aldesleukin|aldesleukin|mesh-list
44085878|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085879|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085880|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085881|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
44085882|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085883|NCT00020410|Antibodies|antibodies|mesh-list
44085884|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44085885|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
44085886|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085887|NCT00020449|Paclitaxel|paclitaxel|mesh-list
44085888|NCT00020449|Doxorubicin|doxorubicin|mesh-list
44085889|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085890|NCT00020449|Interleukin-12|interleukin-12|mesh-list
44085891|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085892|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085893|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085894|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085895|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44085896|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085897|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085898|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085899|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085900|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085901|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43650820|NCT03011463|Ranitidine|ranitidine|mesh-list
44085902|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
44085903|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085904|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44259198|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259199|NCT00633373|Cyclosporine|cyclosporine|mesh-list
44259200|NCT00633373|Cyclosporins|cyclosporins|mesh-list
44259201|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259202|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259203|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259204|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
43655568|NCT02967939|Tenofovir|tenofovir|mesh-list
44085905|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44085906|NCT00020449|Growth Substances|growth substances|mesh-ancestor
44085907|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085908|NCT00020462|Aldesleukin|aldesleukin|mesh-list
44085909|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085910|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085911|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085912|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
44085913|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085914|NCT00020475|Interleukin-2|interleukin-2|mesh-list
44085915|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44085916|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085917|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44085918|NCT00020475|Analgesics|analgesics|mesh-ancestor
44085919|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
44085920|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44085921|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085922|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085923|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
44085925|NCT00020488|Fluorouracil|fluorouracil|mesh-list
44085926|NCT00020488|Irinotecan|irinotecan|mesh-list
44085927|NCT00020488|Calcium|calcium|mesh-list
44085928|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
44085929|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085930|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085931|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
44085932|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085933|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085934|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085935|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085936|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
44085937|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44085938|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085939|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085940|NCT00020488|Antidotes|antidotes|mesh-ancestor
44085941|NCT00020488|Protective Agents|protective agents|mesh-ancestor
44085942|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
44085943|NCT00020488|Vitamins|vitamins|mesh-ancestor
44085944|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
44085945|NCT00020501|Leucovorin|leucovorin|mesh-list
44085946|NCT00020501|Fluorouracil|fluorouracil|mesh-list
44085947|NCT00020501|Floxuridine|floxuridine|mesh-list
44085949|NCT00020501|Melphalan|melphalan|mesh-list
44085950|NCT00020501|Calcium|calcium|mesh-list
44085951|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
44085952|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44085953|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085954|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
44085955|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085956|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085957|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085958|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085959|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
44085960|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44085961|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085962|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085963|NCT00020501|Antidotes|antidotes|mesh-ancestor
44085964|NCT00020501|Protective Agents|protective agents|mesh-ancestor
44085965|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44085966|NCT00020501|Vitamins|vitamins|mesh-ancestor
44085967|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
44085968|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085969|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
44259205|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259206|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
44259207|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259208|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
44259209|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259210|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44085970|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085971|NCT00020527|Caspofungin|caspofungin|mesh-list
44085972|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
44085973|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085974|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085975|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085976|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
44085977|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44085978|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
44085979|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085980|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44085981|NCT00020540|Protective Agents|protective agents|mesh-ancestor
44085982|NCT00020566|Dactinomycin|dactinomycin|mesh-list
44085983|NCT00020566|Doxorubicin|doxorubicin|mesh-list
44085984|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085985|NCT00020566|Etoposide|etoposide|mesh-list
44085986|NCT00020566|Vincristine|vincristine|mesh-list
44085987|NCT00020566|Melphalan|melphalan|mesh-list
44085988|NCT00020566|Busulfan|busulfan|mesh-list
44085989|NCT00020566|Ifosfamide|ifosfamide|mesh-list
44085990|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085991|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085992|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085993|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085994|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085995|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085996|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085997|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085998|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085999|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086000|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086001|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
44086002|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44086003|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086004|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
44086005|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086006|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086007|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086008|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44086009|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086010|NCT00020579|Entinostat|entinostat|mesh-list
44086011|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086012|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44086013|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880645|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44086014|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086015|NCT00020605|Naloxone|naloxone|mesh-list
44086016|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44086017|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086018|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
44086019|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086020|NCT00020618|Morphine|morphine|mesh-list
44086021|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44086022|NCT00020618|Narcotics|narcotics|mesh-ancestor
44086023|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584916|NCT03425162|Morphine|morphine|mesh-list
44086034|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086035|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086036|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086037|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086038|NCT00020644|Gemcitabine|gemcitabine|mesh-list
44086039|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086040|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
44086041|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086042|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461823|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461824|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44461825|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
44461826|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086043|NCT00020644|Antiviral Agents|antiviral agents|mesh-ancestor
44086044|NCT00020644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086045|NCT00020644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086046|NCT00020644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086047|NCT00020644|Immunologic Factors|immunologic factors|mesh-ancestor
44086048|NCT00020644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086049|NCT00020657|Ondansetron|ondansetron|mesh-list
44086050|NCT00020657|Granisetron|granisetron|mesh-list
44086051|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
44086052|NCT00020657|Dolasetron|dolasetron|mesh-list
44086053|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
44086054|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
44086055|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086056|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086057|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44086058|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
44086059|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
44086060|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44086061|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
44086062|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44086063|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086064|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44086065|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44086066|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44086067|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44086068|NCT00020657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44086069|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44086070|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
44086071|NCT00020670|Vaccines|vaccines|mesh-list
44086072|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
44086073|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086074|NCT00020696|Cisplatin|cisplatin|mesh-list
44086075|NCT00020696|Tirapazamine|tirapazamine|mesh-list
44086076|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086078|NCT00020709|Docetaxel|docetaxel|mesh-list
44086079|NCT00020709|Etoposide|etoposide|mesh-list
44086080|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
44086081|NCT00020709|Gefitinib|gefitinib|mesh-list
44086082|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086083|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086084|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086085|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086086|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086087|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086088|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086089|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086090|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086091|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44086093|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086094|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086095|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44086096|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44086097|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
44086098|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086099|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086100|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44086102|NCT00020748|Epirubicin|epirubicin|mesh-list
44086103|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086104|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086105|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086106|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086107|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086108|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086109|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086110|NCT00020761|Paclitaxel|paclitaxel|mesh-list
44086111|NCT00020761|Irinotecan|irinotecan|mesh-list
44086112|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086113|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461827|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
43650862|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461828|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461829|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44461830|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461831|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
44086114|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086115|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086116|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086117|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086118|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086119|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086120|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086121|NCT00020774|Gemcitabine|gemcitabine|mesh-list
44086122|NCT00020774|Lonafarnib|lonafarnib|mesh-list
44086123|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086124|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
44086125|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086126|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086127|NCT00020774|Antiviral Agents|antiviral agents|mesh-ancestor
44086128|NCT00020774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086129|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086130|NCT00020774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086131|NCT00020774|Immunologic Factors|immunologic factors|mesh-ancestor
44086132|NCT00020774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086133|NCT00020787|Cisplatin|cisplatin|mesh-list
44086134|NCT00020787|Fluorouracil|fluorouracil|mesh-list
44086135|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086136|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
44086137|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086138|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086139|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086140|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
44086141|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086142|NCT00020800|Rituximab|rituximab|mesh-list
44086143|NCT00020800|Fludarabine|fludarabine|mesh-list
44086144|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
44086145|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086146|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086147|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
44086148|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086149|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086150|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086151|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
44086152|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086153|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086154|NCT00020839|Temozolomide|temozolomide|mesh-list
44086155|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086156|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
44086157|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086158|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086159|NCT00020865|Levofloxacin|levofloxacin|mesh-list
44086160|NCT00020865|Ofloxacin|ofloxacin|mesh-list
44086161|NCT00020865|Cefepime|cefepime|mesh-list
44086162|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44086163|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086164|NCT00020865|Renal Agents|renal agents|mesh-ancestor
44086165|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086167|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086168|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152241|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
44086169|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086170|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086171|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44086172|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44086174|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086175|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086176|NCT00020878|Analgesics|analgesics|mesh-ancestor
44086177|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
44086178|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461832|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44461834|NCT01537887|Evacetrapib|evacetrapib|mesh-list
44461835|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461836|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086179|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086180|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086181|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086182|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44086183|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44086184|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086185|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086186|NCT00020917|Leucovorin|leucovorin|mesh-list
44086187|NCT00020917|Fluorouracil|fluorouracil|mesh-list
44086188|NCT00020917|Irinotecan|irinotecan|mesh-list
44086189|NCT00020917|Cetuximab|cetuximab|mesh-list
44086190|NCT00020917|Calcium|calcium|mesh-list
44086191|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
44086192|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086193|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086194|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
44086195|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086196|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086197|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086198|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086199|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
44086200|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086201|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086202|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086203|NCT00020917|Antidotes|antidotes|mesh-ancestor
44086204|NCT00020917|Protective Agents|protective agents|mesh-ancestor
44086205|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
44086206|NCT00020917|Vitamins|vitamins|mesh-ancestor
44086207|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
44086208|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086209|NCT00020930|Cetuximab|cetuximab|mesh-list
44086210|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086211|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086212|NCT00020943|Leucovorin|leucovorin|mesh-list
44086213|NCT00020943|Cytarabine|cytarabine|mesh-list
44086214|NCT00020943|Prednisone|prednisone|mesh-list
44086215|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
44086216|NCT00020943|Carmustine|carmustine|mesh-list
44086217|NCT00020943|Rituximab|rituximab|mesh-list
44086218|NCT00020943|Doxorubicin|doxorubicin|mesh-list
44086219|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44086220|NCT00020943|Methotrexate|methotrexate|mesh-list
44086221|NCT00020943|Etoposide|etoposide|mesh-list
44086222|NCT00020943|Vincristine|vincristine|mesh-list
44086223|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
44086224|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086225|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
44086226|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086227|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086228|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086229|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
44086230|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086231|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086232|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44086233|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086234|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43804565|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43804566|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804567|NCT04944212|Vitamin D|vitamin d|mesh-list
43804568|NCT04944212|Vitamins|vitamins|mesh-ancestor
43804569|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
43804570|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804571|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43804572|NCT04943692|Metformin|metformin|mesh-list
44086248|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
44086249|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44086250|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086251|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086252|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
44461837|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086253|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086254|NCT00020943|Antidotes|antidotes|mesh-ancestor
44086255|NCT00020943|Protective Agents|protective agents|mesh-ancestor
44086256|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
44086258|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
44086259|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086260|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086261|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152242|NCT00216515|Galantamine|galantamine|mesh-list
44152243|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44152244|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152245|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152246|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152247|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152248|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152249|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44152250|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
44152251|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152252|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
44152253|NCT00216528|Risperidone|risperidone|mesh-list
44152254|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152255|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
44152256|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152257|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152258|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152259|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44152260|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152261|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152262|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152263|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44152264|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
44152265|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
44152266|NCT00216541|Hematinics|hematinics|mesh-ancestor
44152267|NCT00216554|Risperidone|risperidone|mesh-list
44152268|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152269|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
44152270|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152271|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152272|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152284|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152285|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
44152286|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152287|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152288|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152289|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44152290|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152291|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44086262|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
44086263|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086265|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086266|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44086267|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086268|NCT00021047|Carboplatin|carboplatin|mesh-list
44086269|NCT00021047|Capecitabine|capecitabine|mesh-list
44086270|NCT00021047|Epirubicin|epirubicin|mesh-list
44086271|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086272|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086273|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
44086274|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086275|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086276|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086277|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086278|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086279|NCT00021060|Paclitaxel|paclitaxel|mesh-list
44086280|NCT00021060|Bevacizumab|bevacizumab|mesh-list
44086281|NCT00021060|Carboplatin|carboplatin|mesh-list
43650922|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
43650923|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43650924|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650925|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
43650926|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
43650927|NCT03010579|Hematinics|hematinics|mesh-list
43650928|NCT03010761|Citalopram|citalopram|mesh-list
43650929|NCT03010761|Moclobemide|moclobemide|mesh-list
43650930|NCT03010761|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43650931|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43650932|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43650933|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650934|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650935|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
44086282|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44086283|NCT00021060|Antibodies|antibodies|mesh-list
44086284|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
44086285|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44086286|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086287|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086288|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086289|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086290|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
44461838|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44461839|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461840|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461841|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461842|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44086291|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086292|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44086293|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44086294|NCT00021060|Growth Substances|growth substances|mesh-ancestor
44086295|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086296|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
44086297|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
44086298|NCT00021073|Leucovorin|leucovorin|mesh-list
44086299|NCT00021073|Fluorouracil|fluorouracil|mesh-list
44086300|NCT00021073|Irinotecan|irinotecan|mesh-list
44086301|NCT00021073|Alvocidib|alvocidib|mesh-list
44086302|NCT00021073|Calcium|calcium|mesh-list
44086303|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
44086304|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086305|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086306|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
44086307|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086308|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086309|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086310|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086312|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086313|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086314|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086315|NCT00021073|Antidotes|antidotes|mesh-ancestor
44086316|NCT00021073|Protective Agents|protective agents|mesh-ancestor
44086317|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
44086318|NCT00021073|Vitamins|vitamins|mesh-ancestor
43623816|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623817|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623818|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623819|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623820|NCT03905811|Urological Agents|urological agents|mesh-ancestor
43623821|NCT03878368|Sulforaphane|sulforaphane|mesh-list
43623822|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43623823|NCT03878368|Protective Agents|protective agents|mesh-ancestor
43623824|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623825|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623826|NCT03818061|Bevacizumab|bevacizumab|mesh-list
43623827|NCT03818061|Atezolizumab|atezolizumab|mesh-list
43623828|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086319|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
44086320|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
44086321|NCT00021073|Growth Substances|growth substances|mesh-ancestor
44086322|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44086323|NCT00021099|Epothilones|epothilones|mesh-list
44086324|NCT00021099|Epothilone B|epothilone b|mesh-list
44086325|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086326|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086327|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086328|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086329|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086330|NCT00021112|Cisplatin|cisplatin|mesh-list
44086331|NCT00021112|Etoposide|etoposide|mesh-list
44086332|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086333|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086334|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086335|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086336|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086337|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086338|NCT00021138|Nicotine|nicotine|mesh-list
44086339|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44086340|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
44086341|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086342|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086343|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44086344|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44086345|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44086346|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44086347|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086348|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
44086349|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086350|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086351|NCT00021164|Aldesleukin|aldesleukin|mesh-list
44086352|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
44086353|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086354|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086355|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086356|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
44086357|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461843|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44461844|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
44461845|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44461846|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
44086358|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44086359|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
44086360|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086361|NCT00021216|Bortezomib|bortezomib|mesh-list
44086362|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086363|NCT00021242|Docetaxel|docetaxel|mesh-list
44086364|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086365|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086366|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086367|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086368|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086369|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
44086370|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086371|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
44086372|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086373|NCT00021281|Leucovorin|leucovorin|mesh-list
44086374|NCT00021281|Fluorouracil|fluorouracil|mesh-list
44086375|NCT00021281|Irinotecan|irinotecan|mesh-list
44086376|NCT00021281|Calcium|calcium|mesh-list
44086377|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
44086378|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086379|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623902|NCT02724410|Ertapenem|ertapenem|mesh-list
44086380|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
44086381|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086382|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086383|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086384|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086385|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
44086386|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086388|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086389|NCT00021281|Antidotes|antidotes|mesh-ancestor
44086390|NCT00021281|Protective Agents|protective agents|mesh-ancestor
44086391|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
44086392|NCT00021281|Vitamins|vitamins|mesh-ancestor
44086393|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
44086394|NCT00021294|Eflornithine|eflornithine|mesh-list
44086395|NCT00021294|Triamcinolone|triamcinolone|mesh-list
44086396|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086397|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
44086398|NCT00021294|Hormones|hormones|mesh-ancestor
44086399|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086400|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804735|NCT04941976|Benzydamine|benzydamine|mesh-list
43804736|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804737|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
43804738|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43804739|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43804740|NCT04942002|Prednisolone|prednisolone|mesh-list
43804741|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
43804742|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43804743|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
43804744|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804745|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
43804746|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
43804747|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804748|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804749|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804750|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
44086401|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086402|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086403|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086404|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44086405|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44086406|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44086407|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086408|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44086409|NCT00021307|Carboplatin|carboplatin|mesh-list
44086410|NCT00021307|Temozolomide|temozolomide|mesh-list
44086411|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086412|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44461847|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44461848|NCT01537783|Mupirocin|mupirocin|mesh-list
44461849|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44461850|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086413|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
44086414|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623910|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43623911|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623912|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623913|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623914|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
43623946|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
43623947|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086416|NCT00021320|Cisplatin|cisplatin|mesh-list
44086417|NCT00021320|Fluorouracil|fluorouracil|mesh-list
44086418|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086419|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086420|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086421|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086422|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086423|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086424|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
44086425|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086426|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086427|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
44086428|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086429|NCT00021333|Paclitaxel|paclitaxel|mesh-list
44086430|NCT00021333|Cisplatin|cisplatin|mesh-list
44086431|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086432|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086433|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086434|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086435|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086436|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086437|NCT00021346|Gemcitabine|gemcitabine|mesh-list
44086438|NCT00021346|Carboplatin|carboplatin|mesh-list
44086439|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086440|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086441|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
44086442|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086443|NCT00021346|Antiviral Agents|antiviral agents|mesh-ancestor
44086444|NCT00021346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086445|NCT00021346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086446|NCT00021346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086447|NCT00021346|Immunologic Factors|immunologic factors|mesh-ancestor
44086470|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086471|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086472|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
44086473|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086474|NCT00021385|Squalamine|squalamine|mesh-list
44086475|NCT00021385|Carboplatin|carboplatin|mesh-list
44086476|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086477|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086478|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086479|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44086480|NCT00021385|Protective Agents|protective agents|mesh-ancestor
44086481|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086482|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44086483|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44086484|NCT00021385|Growth Substances|growth substances|mesh-ancestor
44086485|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
44086487|NCT00021398|Fluorouracil|fluorouracil|mesh-list
44086488|NCT00021398|Calcium|calcium|mesh-list
44086489|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
44086490|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086491|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086492|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
44086493|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086494|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086495|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086496|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086497|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
44086498|NCT00021398|Antidotes|antidotes|mesh-ancestor
44086499|NCT00021398|Protective Agents|protective agents|mesh-ancestor
44086500|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
44086501|NCT00021398|Vitamins|vitamins|mesh-ancestor
44086502|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
44086503|NCT00021450|Goserelin|goserelin|mesh-list
44086504|NCT00021450|Bicalutamide|bicalutamide|mesh-list
43840885|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461851|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
44461852|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461853|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44461854|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44461855|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461856|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086505|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086506|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086507|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
44086508|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
44086509|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086510|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086511|NCT00021463|Lamivudine|lamivudine|mesh-list
44086512|NCT00021463|Zidovudine|zidovudine|mesh-list
44086513|NCT00021463|Efavirenz|efavirenz|mesh-list
44086514|NCT00021463|Nevirapine|nevirapine|mesh-list
44086515|NCT00021463|Abacavir|abacavir|mesh-list
44086516|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
44086517|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44086518|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086519|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086520|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086521|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
44086522|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086523|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086524|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086525|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
44086526|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44086527|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44086528|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43624035|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43624036|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624037|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43624038|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43624039|NCT01903330|Growth Substances|growth substances|mesh-ancestor
44086529|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44086530|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44086531|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44086532|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
44086533|NCT00021489|Abacavir|abacavir|mesh-list
44086534|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086535|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086536|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44086537|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
44086538|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086539|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086540|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086541|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086542|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44086543|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086544|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
44086545|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086546|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086547|NCT00021502|Chrysarobin|chrysarobin|mesh-list
44086548|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086549|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086550|NCT00021502|Analgesics|analgesics|mesh-ancestor
43804829|NCT04940689|Narcotics|narcotics|mesh-ancestor
44086551|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
44086552|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086553|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086554|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086555|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086556|NCT00021528|Mirtazapine|mirtazapine|mesh-list
44086557|NCT00021528|Buspirone|buspirone|mesh-list
44086558|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
44086559|NCT00021528|Sertraline|sertraline|mesh-list
44086560|NCT00021528|Citalopram|citalopram|mesh-list
44086561|NCT00021528|Nortriptyline|nortriptyline|mesh-list
44086562|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
44086563|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44086564|NCT00021528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44086565|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461858|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
43624040|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44259211|NCT00633386|Celecoxib|celecoxib|mesh-list
44259212|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44259213|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086566|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44086567|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086568|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44086569|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
44086570|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086571|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086572|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44086573|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44086574|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44086575|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44086576|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
44086585|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44086586|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44086587|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44086588|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44086589|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44086590|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
44086591|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44086592|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44086593|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086594|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086595|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086596|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
44086597|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086598|NCT00021567|Interferons|interferons|mesh-list
44086599|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
44086600|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086601|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
44086602|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086603|NCT00021645|Vitamin E|vitamin e|mesh-list
44086604|NCT00021645|Vitamins|vitamins|mesh-ancestor
44086605|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
44086606|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086607|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
44086608|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086609|NCT00021645|Protective Agents|protective agents|mesh-ancestor
44086610|NCT00021671|Metronidazole|metronidazole|mesh-list
44086611|NCT00021671|Nevirapine|nevirapine|mesh-list
44086613|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
44086614|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44086615|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
44086616|NCT00021671|Ampicillin|ampicillin|mesh-list
44086617|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086618|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086619|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44086620|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44086621|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44086622|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086623|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624131|NCT05403489|Dimercaprol|dimercaprol|mesh-list
43624132|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
43624133|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
43650939|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43650940|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44086624|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086625|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
44086626|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086627|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086628|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44086629|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44086630|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44086631|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44086632|NCT00021814|Doxazosin|doxazosin|mesh-list
44086633|NCT00021814|Finasteride|finasteride|mesh-list
44086634|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44086635|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44086636|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086637|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086638|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
44086639|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086640|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259214|NCT00633386|Analgesics|analgesics|mesh-ancestor
44259215|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
44259216|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655611|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44086641|NCT00021814|Urological Agents|urological agents|mesh-ancestor
44086642|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44086643|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44086646|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
44086647|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44086648|NCT00021827|Hormones|hormones|mesh-list
44086649|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
44086650|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44086651|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086652|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086653|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086654|NCT00021983|Immunotoxins|immunotoxins|mesh-list
44086655|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
44086656|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086657|NCT00021996|Valdecoxib|valdecoxib|mesh-list
44086658|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44086659|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44086660|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086661|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086662|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086663|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086664|NCT00021996|Analgesics|analgesics|mesh-ancestor
44086665|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
44086666|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086667|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086668|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086669|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086670|NCT00022009|Gemcitabine|gemcitabine|mesh-list
44086671|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086672|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
44086673|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086674|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086675|NCT00022009|Antiviral Agents|antiviral agents|mesh-ancestor
44086676|NCT00022009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086677|NCT00022009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086678|NCT00022009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086679|NCT00022009|Immunologic Factors|immunologic factors|mesh-ancestor
44086680|NCT00022009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086681|NCT00022022|Docetaxel|docetaxel|mesh-list
44086682|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086683|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086684|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086685|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086686|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086687|NCT00022048|Bevacizumab|bevacizumab|mesh-list
44086688|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086689|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086690|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44086691|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44086692|NCT00022048|Growth Substances|growth substances|mesh-ancestor
44086693|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086694|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
44086695|NCT00022074|Gabapentin|gabapentin|mesh-list
44086696|NCT00022074|Analgesics|analgesics|mesh-ancestor
44086697|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
44086698|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086699|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086700|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
44086701|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44086702|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44086703|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44086704|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44086705|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44086706|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44086707|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700515|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44259218|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259219|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259220|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44259221|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44259222|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086708|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086709|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
44086711|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
44086712|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
44086713|NCT00022087|Calcium|calcium|mesh-list
44086714|NCT00022087|Vitamins|vitamins|mesh-ancestor
44086715|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
44086716|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086718|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44086719|NCT00022126|Cytarabine|cytarabine|mesh-list
44086720|NCT00022126|Cyclosporine|cyclosporine|mesh-list
44086721|NCT00022126|Dexamethasone|dexamethasone|mesh-list
44086722|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
44086723|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
44086724|NCT00022126|Doxorubicin|doxorubicin|mesh-list
44086725|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44086726|NCT00022126|Methotrexate|methotrexate|mesh-list
44086727|NCT00022126|Vincristine|vincristine|mesh-list
44086728|NCT00022126|Daunorubicin|daunorubicin|mesh-list
44086729|NCT00022126|Asparaginase|asparaginase|mesh-list
44086730|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
44086731|NCT00022126|Pegaspargase|pegaspargase|mesh-list
44086732|NCT00022126|Thioguanine|thioguanine|mesh-list
44086733|NCT00022126|Cyclosporins|cyclosporins|mesh-list
44086734|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086735|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
44086736|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086737|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086738|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086739|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
44086740|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086741|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086742|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44086743|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086744|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
44086745|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
44086746|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086747|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44086748|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
44086749|NCT00022126|Hormones|hormones|mesh-ancestor
44086750|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086751|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086752|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086753|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086754|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086755|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086756|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44086757|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
44086758|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44086759|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086760|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
44086761|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
44086762|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44086763|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44086764|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
44086765|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086766|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086767|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086768|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086769|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086770|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
44086771|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44086772|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44086773|NCT00022126|Protective Agents|protective agents|mesh-ancestor
44086774|NCT00022139|Paclitaxel|paclitaxel|mesh-list
44259223|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259225|NCT00633412|Ranitidine|ranitidine|mesh-list
44259226|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44259227|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44259228|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259229|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44259230|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650950|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44259231|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259232|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44259233|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
44086775|NCT00022139|Carboplatin|carboplatin|mesh-list
44086776|NCT00022139|Fluorouracil|fluorouracil|mesh-list
44086777|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086778|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086779|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086780|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086781|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086782|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086783|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
44086784|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086785|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086786|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
44086787|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086788|NCT00022152|Vinorelbine|vinorelbine|mesh-list
44086789|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086790|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086791|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086792|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086794|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086796|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
44086797|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086798|NCT00022165|Protective Agents|protective agents|mesh-ancestor
44086799|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086800|NCT00022165|Trace Elements|trace elements|mesh-ancestor
44086801|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
44086802|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
44086803|NCT00022178|Cisplatin|cisplatin|mesh-list
44086804|NCT00022178|Doxorubicin|doxorubicin|mesh-list
44086805|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44086806|NCT00022178|Fluorouracil|fluorouracil|mesh-list
44086807|NCT00022178|Vincristine|vincristine|mesh-list
44086808|NCT00022178|Epirubicin|epirubicin|mesh-list
44086809|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086810|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
44086811|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086812|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086813|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086814|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
44086815|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086816|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086817|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44086818|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086819|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086820|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086821|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086822|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
44086823|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086824|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086825|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086826|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086827|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086828|NCT00022191|Gemcitabine|gemcitabine|mesh-list
44086829|NCT00022191|Paclitaxel|paclitaxel|mesh-list
44086830|NCT00022191|Cisplatin|cisplatin|mesh-list
44259234|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
44259235|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259236|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259237|NCT00633425|Glimepiride|glimepiride|mesh-list
44259238|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44086831|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086832|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086833|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086834|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086835|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086836|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086837|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086838|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
44086839|NCT00022191|Antiviral Agents|antiviral agents|mesh-ancestor
44086840|NCT00022191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086841|NCT00022191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086842|NCT00022191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086843|NCT00022191|Immunologic Factors|immunologic factors|mesh-ancestor
44086844|NCT00022191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086845|NCT00022204|Vitamin E|vitamin e|mesh-list
44086846|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
44086847|NCT00022204|Vitamins|vitamins|mesh-ancestor
44086848|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
44086849|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086850|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
44086851|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086852|NCT00022204|Protective Agents|protective agents|mesh-ancestor
44086853|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44086854|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086855|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44086856|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44086857|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
44086858|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44086859|NCT00022217|Paclitaxel|paclitaxel|mesh-list
44086860|NCT00022217|Cisplatin|cisplatin|mesh-list
44086861|NCT00022217|Carboplatin|carboplatin|mesh-list
44086862|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086863|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086864|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086865|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086866|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086867|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086868|NCT00022230|Aldesleukin|aldesleukin|mesh-list
44086879|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086880|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086881|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
44086882|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086883|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086884|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44086885|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
44086886|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44086887|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086888|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086889|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086890|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086891|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086892|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086893|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
44086894|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086895|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
44086896|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086897|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44086898|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
44086899|NCT00022308|Cisplatin|cisplatin|mesh-list
44086900|NCT00022308|Irinotecan|irinotecan|mesh-list
44086901|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086902|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44086903|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086904|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086905|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086906|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
43700516|NCT02730845|Analgesics|analgesics|mesh-ancestor
44259239|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44259240|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259241|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259242|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
44259243|NCT00633438|Celecoxib|celecoxib|mesh-list
44259244|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086907|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086908|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086909|NCT00022360|Taurolidine|taurolidine|mesh-list
44086910|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086911|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44086912|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086913|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
44086914|NCT00022386|Hematinics|hematinics|mesh-ancestor
44086915|NCT00022399|Celecoxib|celecoxib|mesh-list
44086916|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086917|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44086918|NCT00022399|Analgesics|analgesics|mesh-ancestor
44086919|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
44086920|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086921|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086922|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086923|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44086924|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44086925|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44086926|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086927|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086928|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44086929|NCT00022412|Vitamins|vitamins|mesh-ancestor
44086930|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
44086931|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086932|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44086933|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
44086934|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086935|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086936|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086938|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
44086939|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086940|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44086941|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44086942|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
44086943|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086944|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44086945|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
44086946|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086947|NCT00022451|Tipifarnib|tipifarnib|mesh-list
44086948|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086949|NCT00022464|Sirolimus|sirolimus|mesh-list
44086950|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086951|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086952|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44086953|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086954|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
44086955|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086956|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
44086957|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152292|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152293|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44152294|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
44152295|NCT00216606|Topiramate|topiramate|mesh-list
44152296|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
44152297|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44152298|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152299|NCT00216619|Topiramate|topiramate|mesh-list
44152300|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
44152301|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44152302|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152303|NCT00216632|Risperidone|risperidone|mesh-list
44152304|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152305|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
44152306|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259245|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44259247|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
44259248|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259249|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259250|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259251|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259252|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44152307|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152308|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152309|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44152310|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152311|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152312|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152313|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44152314|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
44152315|NCT00216645|Doxorubicin|doxorubicin|mesh-list
44152316|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44152317|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152318|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152319|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44152320|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152321|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152322|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152323|NCT00216658|Fentanyl|fentanyl|mesh-list
44152324|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152325|NCT00216658|Narcotics|narcotics|mesh-ancestor
44152326|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152327|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152328|NCT00216658|Analgesics|analgesics|mesh-ancestor
44152329|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
44152330|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152331|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44152332|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44152333|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
44152334|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
44152335|NCT00216684|Fentanyl|fentanyl|mesh-list
44152336|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152337|NCT00216684|Narcotics|narcotics|mesh-ancestor
44152338|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805145|NCT04935450|Dimercaprol|dimercaprol|mesh-list
44152339|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152340|NCT00216684|Analgesics|analgesics|mesh-ancestor
44152341|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
44152342|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086958|NCT00022529|Trastuzumab|trastuzumab|mesh-list
44086959|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43586005|NCT03415594|Glucagon|glucagon|mesh-list
44086960|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086961|NCT00022542|Epothilones|epothilones|mesh-list
44086962|NCT00022542|Epothilone B|epothilone b|mesh-list
44086963|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086964|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086965|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086966|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086967|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086968|NCT00022555|Vincristine|vincristine|mesh-list
44086969|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
44086970|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086971|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086972|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086973|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086974|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086975|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086976|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44086977|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
44086978|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086979|NCT00022581|Thalidomide|thalidomide|mesh-list
44259253|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44259254|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259255|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259256|NCT00633490|Apatinib|apatinib|mesh-list
44259257|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259258|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259259|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259260|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259261|NCT00633542|Interferons|interferons|mesh-list
44086980|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44086981|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
44086982|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086983|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
44086984|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44086985|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44086986|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44086987|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44086988|NCT00022581|Growth Substances|growth substances|mesh-ancestor
44086989|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44086990|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086991|NCT00022594|Lurtotecan|lurtotecan|mesh-list
44086992|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086993|NCT00022607|Thalidomide|thalidomide|mesh-list
44086994|NCT00022607|Bevacizumab|bevacizumab|mesh-list
44086995|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44086996|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086997|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44086998|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44086999|NCT00022607|Growth Substances|growth substances|mesh-ancestor
44087000|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087001|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087002|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087003|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
44087004|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087005|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087006|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087007|NCT00022620|Paclitaxel|paclitaxel|mesh-list
44087008|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087009|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087010|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087011|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087012|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087013|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087014|NCT00022646|Gemcitabine|gemcitabine|mesh-list
43624504|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087016|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087017|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
44087018|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087019|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087020|NCT00022646|Antiviral Agents|antiviral agents|mesh-ancestor
44087021|NCT00022646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087022|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087023|NCT00022646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087024|NCT00022646|Immunologic Factors|immunologic factors|mesh-ancestor
44087025|NCT00022646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087026|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087027|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087028|NCT00022685|Epratuzumab|epratuzumab|mesh-list
44087029|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44087030|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087031|NCT00022711|Temozolomide|temozolomide|mesh-list
44087032|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087033|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
44087034|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087035|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087036|NCT00022724|Sirolimus|sirolimus|mesh-list
44259262|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
44259263|NCT00633542|Thalidomide|thalidomide|mesh-list
44259264|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259265|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
44087037|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087038|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087039|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087040|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087041|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
44087042|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087043|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
44087044|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087045|NCT00022737|Leucovorin|leucovorin|mesh-list
44087046|NCT00022737|Cytarabine|cytarabine|mesh-list
44087047|NCT00022737|Cyclosporine|cyclosporine|mesh-list
44087048|NCT00022737|Dexamethasone|dexamethasone|mesh-list
44087049|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
44087050|NCT00022737|Ifosfamide|ifosfamide|mesh-list
44087051|NCT00022737|Methotrexate|methotrexate|mesh-list
44087052|NCT00022737|Etoposide|etoposide|mesh-list
44087053|NCT00022737|Vincristine|vincristine|mesh-list
44087054|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
44087055|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
44087056|NCT00022737|Daunorubicin|daunorubicin|mesh-list
44087057|NCT00022737|Asparaginase|asparaginase|mesh-list
44087058|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
44087059|NCT00022737|Pegaspargase|pegaspargase|mesh-list
44087060|NCT00022737|Cyclosporins|cyclosporins|mesh-list
44087061|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
44087062|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087063|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
44087064|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087065|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087066|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087067|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
44087068|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087069|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087070|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087071|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087072|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
44087073|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
43624538|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
44087074|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087075|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44087076|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
44087077|NCT00022737|Hormones|hormones|mesh-ancestor
44087078|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087079|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087080|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44087081|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
44087082|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44087083|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087084|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
44087085|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087086|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087087|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087088|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087089|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087090|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087091|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087092|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
44087093|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087094|NCT00022737|Antidotes|antidotes|mesh-ancestor
44087095|NCT00022737|Protective Agents|protective agents|mesh-ancestor
44087096|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
44087097|NCT00022737|Vitamins|vitamins|mesh-ancestor
44087098|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
44087099|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087100|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087101|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087102|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
44087103|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44087104|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087105|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087106|NCT00022841|Pamidronate|pamidronate|mesh-list
44087107|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44087108|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259266|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259267|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
44259268|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087109|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
44087110|NCT00022880|Antibodies|antibodies|mesh-list
44087111|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
44087112|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087113|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087114|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
44087115|NCT00022893|Antibodies|antibodies|mesh-list
44087123|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087124|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
44087126|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
44087127|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087128|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087129|NCT00022945|Prednisone|prednisone|mesh-list
44087130|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
44087131|NCT00022945|Doxorubicin|doxorubicin|mesh-list
44087132|NCT00022945|Vincristine|vincristine|mesh-list
44087133|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
44087134|NCT00022945|Antibodies|antibodies|mesh-list
44087135|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087136|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
44087137|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087138|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087139|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087140|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
44087141|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087142|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087143|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087144|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087145|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087146|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087147|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087148|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087149|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
44087150|NCT00022945|Hormones|hormones|mesh-ancestor
44087151|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087152|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087153|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087154|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087155|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087156|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087157|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
44087158|NCT00022958|Antibodies|antibodies|mesh-list
44087159|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
44087160|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087161|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087162|NCT00022971|Rituximab|rituximab|mesh-list
44087163|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44087164|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087165|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
44087166|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087167|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087168|NCT00023153|Adefovir|adefovir|mesh-list
44087169|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44087170|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
44087171|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087172|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44087173|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087174|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087175|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087176|NCT00023166|Paclitaxel|paclitaxel|mesh-list
44087177|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087178|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087179|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087180|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087181|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087182|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087183|NCT00023218|Ritonavir|ritonavir|mesh-list
44087184|NCT00023218|Lopinavir|lopinavir|mesh-list
44087185|NCT00023218|Efavirenz|efavirenz|mesh-list
44087190|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087191|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44259269|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259270|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
44259271|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44259272|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44259273|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44259274|NCT00633542|Growth Substances|growth substances|mesh-ancestor
44259275|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087192|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44087193|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
44087194|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624606|NCT03738878|Kininogens|kininogens|mesh-list
44087195|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44087196|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44087197|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44087198|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087199|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44087200|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44087201|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44087202|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44087203|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44087204|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
44087205|NCT00023231|Sirolimus|sirolimus|mesh-list
44087206|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44087207|NCT00023231|Ganciclovir|ganciclovir|mesh-list
44087208|NCT00023231|Prednisone|prednisone|mesh-list
44087209|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
44087210|NCT00023231|Atorvastatin|atorvastatin|mesh-list
44087211|NCT00023231|Daclizumab|daclizumab|mesh-list
44087212|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087213|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
44087214|NCT00023231|Hormones|hormones|mesh-ancestor
44087215|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087216|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087217|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087218|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087219|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087220|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087221|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087222|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087223|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087224|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087225|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087226|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
44087227|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087228|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
44087229|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
44087230|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
44087231|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087232|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44087233|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44087234|NCT00023231|Protective Agents|protective agents|mesh-ancestor
44087235|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44087236|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44087237|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
44087238|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44087239|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44087240|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
44087241|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44087242|NCT00023231|Renal Agents|renal agents|mesh-ancestor
44087243|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
43624641|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
44087244|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44087245|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44087246|NCT00023244|Cyclosporine|cyclosporine|mesh-list
44087247|NCT00023244|Sirolimus|sirolimus|mesh-list
44087248|NCT00023244|Trimethoprim|trimethoprim|mesh-list
43805338|NCT04931433|Lidocaine|lidocaine|mesh-list
44087249|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
44087250|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44087251|NCT00023244|Prednisone|prednisone|mesh-list
44087252|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
44259276|NCT00633568|Cisplatin|cisplatin|mesh-list
44259277|NCT00633568|Docetaxel|docetaxel|mesh-list
44259278|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259279|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
44259280|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
43643523|NCT05011487|Pemetrexed|pemetrexed|mesh-list
44087253|NCT00023244|Tacrolimus|tacrolimus|mesh-list
44087254|NCT00023244|Cyclosporins|cyclosporins|mesh-list
44087255|NCT00023244|Basiliximab|basiliximab|mesh-list
44087256|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087258|NCT00023244|Hormones|hormones|mesh-ancestor
44087259|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087260|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087261|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087262|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087263|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087264|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
44087265|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44087266|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087267|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087268|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
44087269|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087270|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087271|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087272|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087273|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087274|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
44087275|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
44087276|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087277|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44087278|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44087279|NCT00023244|Protective Agents|protective agents|mesh-ancestor
44087280|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44087281|NCT00023244|Renal Agents|renal agents|mesh-ancestor
44087282|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
44087283|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44087284|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44087285|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087286|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44087287|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44087288|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44087289|NCT00023283|Buprenorphine|buprenorphine|mesh-list
44087290|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44087291|NCT00023283|Narcotics|narcotics|mesh-ancestor
44087292|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44087293|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087294|NCT00023283|Analgesics|analgesics|mesh-ancestor
44087295|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
44087296|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087297|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44087298|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
43624662|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
43624685|NCT03337087|Antidotes|antidotes|mesh-ancestor
44087299|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44087300|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
44087301|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087302|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087303|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44087304|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44087305|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44087306|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
44087307|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087308|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44087309|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44087310|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
44087311|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
44087312|NCT00023296|Protective Agents|protective agents|mesh-ancestor
44087313|NCT00023335|Isoniazid|isoniazid|mesh-list
44087314|NCT00023335|Rifapentine|rifapentine|mesh-list
44087315|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087316|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087317|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087318|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44087319|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44259281|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259282|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259283|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
44259284|NCT00633581|Vitamins|vitamins|mesh-ancestor
44259285|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
43913454|NCT00402194|Losartan|losartan|mesh-list
44461859|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
44259286|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087320|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
44087321|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087322|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44087323|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087324|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087325|NCT00023348|Isoniazid|isoniazid|mesh-list
44087326|NCT00023348|Rifabutin|rifabutin|mesh-list
44087327|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087328|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087329|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087330|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44087341|NCT00023374|Rifampin|rifampin|mesh-list
44087342|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
44087343|NCT00023374|Ethambutol|ethambutol|mesh-list
44087344|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087345|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087346|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087347|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087348|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087349|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087350|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087351|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087352|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44087353|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44087354|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44087355|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44087356|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44087357|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44087358|NCT00023387|Isoniazid|isoniazid|mesh-list
44087359|NCT00023387|Rifapentine|rifapentine|mesh-list
44087360|NCT00023387|Rifampin|rifampin|mesh-list
44087361|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087362|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087363|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087364|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44087365|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44087366|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
44087367|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087368|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44087369|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087370|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087371|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087372|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087373|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44087374|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44087375|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44087376|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44087377|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44087378|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44087379|NCT00023400|Nelfinavir|nelfinavir|mesh-list
44087380|NCT00023400|Rifabutin|rifabutin|mesh-list
44087381|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44087382|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44087383|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
44087384|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087385|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087386|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44087387|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44087388|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
44259287|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
44259288|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259289|NCT00633581|Protective Agents|protective agents|mesh-ancestor
44259290|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43655681|NCT02967172|Analgesics|analgesics|mesh-ancestor
44087389|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087390|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087391|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087392|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087394|NCT00023413|Rifabutin|rifabutin|mesh-list
44087395|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44087396|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087397|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087398|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087399|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
44087400|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087401|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44087402|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44087403|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44087404|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44087405|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44087406|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44087407|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087408|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087409|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087410|NCT00023426|Rifapentine|rifapentine|mesh-list
44087411|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087412|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087413|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087414|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087415|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087416|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44087417|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
44087418|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087419|NCT00023530|Thalidomide|thalidomide|mesh-list
44087420|NCT00023530|Fluconazole|fluconazole|mesh-list
44087421|NCT00023530|Voriconazole|voriconazole|mesh-list
44087422|NCT00023530|Dexamethasone|dexamethasone|mesh-list
44087423|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087424|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
44087425|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
44087426|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087427|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087428|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44087429|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
44087430|NCT00023530|Hormones|hormones|mesh-ancestor
44087431|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087432|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087433|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087434|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087435|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
44087436|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
44087437|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087438|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087439|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44087440|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44087441|NCT00023530|Growth Substances|growth substances|mesh-ancestor
44087442|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087443|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
44087444|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44087445|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44087446|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087447|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087448|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44087449|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
44087450|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44087451|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43791276|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44259291|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44259292|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
44259293|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
44259294|NCT00633672|Esomeprazole|esomeprazole|mesh-list
44259295|NCT00633672|Ranitidine|ranitidine|mesh-list
43643902|NCT04879992|Antacids|antacids|mesh-ancestor
44087452|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44087453|NCT00023621|Celecoxib|celecoxib|mesh-list
44087454|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44087455|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44087456|NCT00023621|Analgesics|analgesics|mesh-ancestor
44087457|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
44087458|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087459|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087460|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087461|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087462|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44087463|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44087464|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43586506|NCT03410524|Simethicone|simethicone|mesh-list
44087465|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087467|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
44087468|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087469|NCT00023660|Celecoxib|celecoxib|mesh-list
44087470|NCT00023660|Cisplatin|cisplatin|mesh-list
44087471|NCT00023660|Fluorouracil|fluorouracil|mesh-list
44087472|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087473|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
44087474|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087475|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087476|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087477|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
44087478|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087479|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44087480|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44087481|NCT00023660|Analgesics|analgesics|mesh-ancestor
44087482|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
44087483|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44087484|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087485|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087486|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44087487|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44087488|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087489|NCT00023699|Gefitinib|gefitinib|mesh-list
44087490|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087491|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087492|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087493|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087494|NCT00023725|Semaxinib|semaxinib|mesh-list
44087495|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44087496|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44087497|NCT00023725|Growth Substances|growth substances|mesh-ancestor
44087498|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087499|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087500|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087501|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087502|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087503|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087504|NCT00023738|Doxorubicin|doxorubicin|mesh-list
44087505|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087506|NCT00023738|Ifosfamide|ifosfamide|mesh-list
44087507|NCT00023738|Dacarbazine|dacarbazine|mesh-list
44087508|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087509|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087510|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087511|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087512|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087513|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087514|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087515|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
44259296|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44259297|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44259298|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823860|NCT05518383|Etoposide|etoposide|mesh-list
44087516|NCT00023751|Leucovorin|leucovorin|mesh-list
44087517|NCT00023751|Fluorouracil|fluorouracil|mesh-list
44087518|NCT00023751|Calcium|calcium|mesh-list
44087519|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
44087520|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44087521|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624761|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
44087522|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
44087523|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087524|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087525|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087526|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087527|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
44087528|NCT00023751|Antidotes|antidotes|mesh-ancestor
44087529|NCT00023751|Protective Agents|protective agents|mesh-ancestor
44087530|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
44087531|NCT00023751|Vitamins|vitamins|mesh-ancestor
44087532|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
44087533|NCT00023777|Cytarabine|cytarabine|mesh-list
44087534|NCT00023777|Daunorubicin|daunorubicin|mesh-list
44087535|NCT00023777|Sargramostim|sargramostim|mesh-list
44087536|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087537|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
44087538|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087539|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087543|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
44087544|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087545|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087546|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087547|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087548|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087549|NCT00023790|Silicon|silicon|mesh-list
44087550|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
44087551|NCT00023790|Trace Elements|trace elements|mesh-ancestor
44087552|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
44087553|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087554|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
44087555|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44087556|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44087557|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087558|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
44087559|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43805560|NCT04927858|Empagliflozin|empagliflozin|mesh-list
44087560|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087561|NCT00023816|Carbendazim|carbendazim|mesh-list
44087562|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
44087563|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
44087564|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44087565|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087566|NCT00023829|Bicalutamide|bicalutamide|mesh-list
44087567|NCT00023829|Flutamide|flutamide|mesh-list
44087568|NCT00023829|Hormones|hormones|mesh-list
44087569|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087570|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087571|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
44087572|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
44087573|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087574|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087575|NCT00023842|Mitomycins|mitomycins|mesh-list
44087576|NCT00023842|Mitomycin|mitomycin|mesh-list
44087577|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
44087578|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087579|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087580|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
44087581|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087582|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087583|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087584|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44087585|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
44087586|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087587|NCT00023855|Doxorubicin|doxorubicin|mesh-list
44087588|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087589|NCT00023855|Bortezomib|bortezomib|mesh-list
44259299|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43624843|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
44259300|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259301|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259302|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44259303|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
44087590|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087591|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087592|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087593|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087594|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087595|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087597|NCT00023868|Doxorubicin|doxorubicin|mesh-list
44087598|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087599|NCT00023868|Fluorouracil|fluorouracil|mesh-list
44087600|NCT00023868|Irinotecan|irinotecan|mesh-list
44087601|NCT00023868|Mitomycins|mitomycins|mesh-list
44087602|NCT00023868|Mitomycin|mitomycin|mesh-list
44087603|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
44087604|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087605|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087606|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087607|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087608|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087609|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087610|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087611|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
44087612|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087613|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087614|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
44087615|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44087616|NCT00023868|Antidotes|antidotes|mesh-ancestor
44087626|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087627|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087628|NCT00023894|Growth Substances|growth substances|mesh-ancestor
44087629|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087630|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087631|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087632|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087634|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087635|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087636|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087637|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087638|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087639|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087640|NCT00023920|Cytarabine|cytarabine|mesh-list
44087641|NCT00023920|Bevacizumab|bevacizumab|mesh-list
44087642|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44087644|NCT00023920|Antibodies|antibodies|mesh-list
44087645|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
44087646|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44087647|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087648|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44087649|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44087650|NCT00023920|Growth Substances|growth substances|mesh-ancestor
44087651|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087652|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087653|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
44087654|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087655|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
44087656|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087657|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
44087658|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087659|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087660|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087661|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087662|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087663|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087664|NCT00023933|Antibodies|antibodies|mesh-list
44087665|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44259304|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
44259305|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259306|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259307|NCT00633685|Fluoxetine|fluoxetine|mesh-list
44259308|NCT00633685|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44259309|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44259310|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259311|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259312|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259313|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
44259314|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259315|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44259316|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44259317|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259318|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44087666|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
44087667|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087668|NCT00023946|Epothilones|epothilones|mesh-list
44087669|NCT00023946|Epothilone B|epothilone b|mesh-list
44087670|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087671|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087672|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087673|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087674|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087675|NCT00023959|Bevacizumab|bevacizumab|mesh-list
44087676|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44087677|NCT00023959|Fluorouracil|fluorouracil|mesh-list
44087678|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
44087679|NCT00023959|Antibodies|antibodies|mesh-list
44087680|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
44087681|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44087682|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087683|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44087684|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44087685|NCT00023959|Growth Substances|growth substances|mesh-ancestor
43586731|NCT03401619|Katacalcin|katacalcin|mesh-list
44087690|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087691|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087692|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087693|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
44087694|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087695|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087696|NCT00023972|Gemcitabine|gemcitabine|mesh-list
44087698|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087699|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
44087700|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087701|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087702|NCT00023972|Antiviral Agents|antiviral agents|mesh-ancestor
44087703|NCT00023972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087704|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087705|NCT00023972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087706|NCT00023972|Immunologic Factors|immunologic factors|mesh-ancestor
44087707|NCT00023972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087708|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44087709|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087711|NCT00023998|Doxorubicin|doxorubicin|mesh-list
44087712|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087713|NCT00023998|Methotrexate|methotrexate|mesh-list
44087714|NCT00023998|Trastuzumab|trastuzumab|mesh-list
44259319|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44259321|NCT00633698|Niacin|niacin|mesh-list
44259322|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
44259323|NCT00633698|Niacinamide|niacinamide|mesh-list
44259324|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44259325|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
44259326|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259327|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44259328|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
44259329|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
44259330|NCT00633698|Vitamins|vitamins|mesh-ancestor
44259331|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
44259332|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259333|NCT00633763|Fallypride|fallypride|mesh-list
44259334|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44259335|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44259336|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
43655715|NCT02967029|Remifentanil|remifentanil|mesh-list
44087715|NCT00023998|Etoposide|etoposide|mesh-list
44087716|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
44087717|NCT00023998|Ifosfamide|ifosfamide|mesh-list
44087718|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
44087719|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087720|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087721|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087722|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087723|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087724|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087725|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087726|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44087727|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
44087728|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44087729|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087730|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
44087731|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087732|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087733|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087734|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
44087735|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087736|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087737|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44087738|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087739|NCT00023998|Antidotes|antidotes|mesh-ancestor
44087740|NCT00023998|Protective Agents|protective agents|mesh-ancestor
44087741|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
44087742|NCT00023998|Vitamins|vitamins|mesh-ancestor
44087743|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
44087744|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087745|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
44087746|NCT00024011|Bortezomib|bortezomib|mesh-list
44087747|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087748|NCT00024050|Cyclosporine|cyclosporine|mesh-list
44087749|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
44087750|NCT00024050|Busulfan|busulfan|mesh-list
44087751|NCT00024050|Methotrexate|methotrexate|mesh-list
44087752|NCT00024050|Cyclosporins|cyclosporins|mesh-list
44087753|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087754|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
44087755|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259337|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259338|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259339|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259340|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
44259341|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44259342|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
44259343|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259344|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259345|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44259346|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
44087756|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087757|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087758|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
43586798|NCT03399526|Clobetasol|clobetasol|mesh-list
44087760|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087761|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087762|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44087763|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
44087764|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44087765|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087766|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
44087767|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087768|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087769|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087770|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087771|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
44087772|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087773|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44087774|NCT00024063|Orantinib|orantinib|mesh-list
44087775|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087776|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087777|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087778|NCT00024089|Gefitinib|gefitinib|mesh-list
44087779|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087780|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087781|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087782|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087783|NCT00024115|Antibodies|antibodies|mesh-list
44087784|NCT00024115|Immunotoxins|immunotoxins|mesh-list
44087785|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
44087786|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152343|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44152344|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44152345|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
44152346|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
44152347|NCT00216697|Bortezomib|bortezomib|mesh-list
44152348|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152349|NCT00216723|Aripiprazole|aripiprazole|mesh-list
44152350|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
44152351|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44087787|NCT00024128|Cyclosporine|cyclosporine|mesh-list
44087788|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
44087789|NCT00024128|Cyclosporins|cyclosporins|mesh-list
44087790|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44087791|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087792|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
44087793|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087794|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087795|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087796|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
44087797|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087798|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087799|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087800|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259347|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44259348|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44259349|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44259350|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
44259351|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259352|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259353|NCT00633802|Risperidone|risperidone|mesh-list
44259354|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44259355|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
44259356|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259357|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259358|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259359|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44259360|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259361|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259362|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259363|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44259364|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
44259365|NCT00633958|Alovudine|alovudine|mesh-list
44259366|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
44259367|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259368|NCT00634062|Lamotrigine|lamotrigine|mesh-list
44259369|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
44259370|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44087801|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
44087802|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087803|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
44087804|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44087805|NCT00024141|Fluorouracil|fluorouracil|mesh-list
44087806|NCT00024141|Irinotecan|irinotecan|mesh-list
44087807|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
44087808|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087809|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087810|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087811|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087812|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
44087813|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087814|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44087815|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087816|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087817|NCT00024154|Trastuzumab|trastuzumab|mesh-list
44087818|NCT00024154|Gefitinib|gefitinib|mesh-list
44087819|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44087820|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087821|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087822|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087823|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087825|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087826|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087827|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
44087828|NCT00024193|Melphalan|melphalan|mesh-list
44087829|NCT00024193|Busulfan|busulfan|mesh-list
44259371|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259372|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259373|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44259374|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259375|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44087830|NCT00024193|Cisplatin|cisplatin|mesh-list
44087831|NCT00024193|Doxorubicin|doxorubicin|mesh-list
44087832|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087833|NCT00024193|Etoposide|etoposide|mesh-list
44087834|NCT00024193|Vincristine|vincristine|mesh-list
44087835|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087836|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
44087837|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087838|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087839|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087840|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
44087841|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087842|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087843|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087844|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087845|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087846|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087847|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087848|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087849|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087850|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087851|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087852|NCT00024206|Orantinib|orantinib|mesh-list
44087853|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44087854|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625317|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625318|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44087855|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087856|NCT00024232|Antibodies|antibodies|mesh-list
44087857|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44087858|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
44087859|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087860|NCT00024245|Probenecid|probenecid|mesh-list
44087861|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
44087862|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
44087863|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087864|NCT00024245|Renal Agents|renal agents|mesh-ancestor
44087865|NCT00024271|Gemcitabine|gemcitabine|mesh-list
44087866|NCT00024271|Interferons|interferons|mesh-list
44087867|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
44087868|NCT00024271|Cisplatin|cisplatin|mesh-list
44087869|NCT00024271|Doxorubicin|doxorubicin|mesh-list
44087870|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44087871|NCT00024271|Mitomycins|mitomycins|mesh-list
44087872|NCT00024271|Mitomycin|mitomycin|mesh-list
44087873|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087874|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087875|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
44087876|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087877|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
44087878|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087879|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087880|NCT00024271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087881|NCT00024271|Immunologic Factors|immunologic factors|mesh-ancestor
44087882|NCT00024271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087883|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087884|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087885|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087886|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
44087887|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087888|NCT00024284|Carboplatin|carboplatin|mesh-list
44087889|NCT00024284|Irinotecan|irinotecan|mesh-list
43625319|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087890|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625362|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
44087891|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44087892|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44087893|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087894|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087895|NCT00024297|Warfarin|warfarin|mesh-list
44259376|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259377|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259378|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259379|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44259380|NCT00634140|Ezetimibe|ezetimibe|mesh-list
44259381|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44259382|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44259383|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
44259384|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259385|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44259386|NCT00634192|Tobramycin|tobramycin|mesh-list
44259387|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44259388|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259389|NCT00634205|Doxorubicin|doxorubicin|mesh-list
44259390|NCT00634205|Valproic Acid|valproic acid|mesh-list
44259391|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44259392|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259393|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44087896|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
44087897|NCT00024310|Folic Acid|folic acid|mesh-list
44087898|NCT00024310|Paclitaxel|paclitaxel|mesh-list
44087899|NCT00024310|Lometrexol|lometrexol|mesh-list
44087900|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087901|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087902|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087903|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087904|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087905|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087906|NCT00024310|Hematinics|hematinics|mesh-ancestor
44087907|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
44087908|NCT00024310|Vitamins|vitamins|mesh-ancestor
44087909|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
44087910|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087911|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087912|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
44087913|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44087914|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087915|NCT00024323|Cisplatin|cisplatin|mesh-list
43824563|NCT05510544|Plerixafor|plerixafor|mesh-list
44087916|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087917|NCT00024336|Tamoxifen|tamoxifen|mesh-list
44087918|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44087919|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44087920|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44087921|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087922|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44087923|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087924|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44087925|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44087926|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44087927|NCT00024349|Fluorouracil|fluorouracil|mesh-list
44087928|NCT00024349|Mitomycins|mitomycins|mesh-list
44087929|NCT00024349|Mitomycin|mitomycin|mesh-list
44087930|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
44087931|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087932|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087933|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087934|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087935|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
44087936|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259394|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44259396|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259397|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
44259398|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
44259399|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626042|NCT03096405|Methicillin|methicillin|mesh-list
44259400|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259401|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
44259402|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259403|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44087937|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44087938|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
44087939|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087940|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087941|NCT00024362|BBR 3464|bbr 3464|mesh-list
44087942|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087943|NCT00024375|Paclitaxel|paclitaxel|mesh-list
44087944|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087945|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087946|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087947|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087948|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087949|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087950|NCT00024388|Paclitaxel|paclitaxel|mesh-list
44087951|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087952|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087953|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087954|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087955|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087956|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087957|NCT00024401|Paclitaxel|paclitaxel|mesh-list
44087958|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087959|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087960|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087961|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087962|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
43651027|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44087963|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087964|NCT00024414|Paclitaxel|paclitaxel|mesh-list
44087965|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44087966|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087967|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
44087968|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
44087969|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
44087970|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087971|NCT00024427|Gemcitabine|gemcitabine|mesh-list
44087972|NCT00024427|Fluorouracil|fluorouracil|mesh-list
44087973|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087974|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
44087975|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087976|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087977|NCT00024427|Antiviral Agents|antiviral agents|mesh-ancestor
44087980|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087981|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
44087982|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087983|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
44087985|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
44087986|NCT00024440|Oblimersen|oblimersen|mesh-list
44087987|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44087988|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
44087989|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087990|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44087991|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44087992|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
44087993|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259405|NCT00634231|Valacyclovir|valacyclovir|mesh-list
44259406|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
44259407|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259408|NCT00634309|Candesartan|candesartan|mesh-list
44259409|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44259410|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43651061|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714929|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
44259411|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44259412|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259413|NCT00634348|Aripiprazole|aripiprazole|mesh-list
44259414|NCT00634348|Ziprasidone|ziprasidone|mesh-list
44259415|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44259416|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259417|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44259418|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259419|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259420|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259421|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
44259422|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
44259423|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259424|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259425|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44259426|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44259427|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
44259428|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44259429|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44259430|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44259431|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44259432|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44259433|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44259434|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44259435|NCT00634400|Candesartan|candesartan|mesh-list
44259436|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43846597|NCT04191434|Hormones|hormones|mesh-ancestor
44087994|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087995|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44087996|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44087997|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
44087998|NCT00024453|Teicoplanin|teicoplanin|mesh-list
44259437|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44259438|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44259439|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259440|NCT00634413|Budesonide|budesonide|mesh-list
44259441|NCT00634413|Theophylline|theophylline|mesh-list
44259442|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259443|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44259444|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
44259445|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259446|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259447|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44087999|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44088000|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088001|NCT00024466|Vaccines|vaccines|mesh-list
44088002|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
43651080|NCT03009461|Sorafenib|sorafenib|mesh-list
43651081|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651082|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651083|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088003|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088004|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
44088005|NCT00024492|Analgesics|analgesics|mesh-ancestor
44088006|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
44088007|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44088008|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088009|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088010|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088011|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088012|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088013|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088014|NCT00024518|Interferons|interferons|mesh-list
44088015|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
44088016|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088017|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
44088018|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088019|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
44088020|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088021|NCT00024531|Atorvastatin|atorvastatin|mesh-list
44088022|NCT00024531|Calcium|calcium|mesh-list
44088023|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44088024|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088025|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44088026|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44088027|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
44088028|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088029|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44088030|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44088031|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088032|NCT00024544|Antibodies|antibodies|mesh-list
44088033|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44088034|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
44088035|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088036|NCT00024687|Immunotoxins|immunotoxins|mesh-list
44088037|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
44088038|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088039|NCT00024986|Tenofovir|tenofovir|mesh-list
44088040|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
44088041|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088042|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44088043|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088044|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088045|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088046|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44088047|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44088048|NCT00025012|Isotretinoin|isotretinoin|mesh-list
44088049|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44088050|NCT00025038|Cytarabine|cytarabine|mesh-list
43626526|NCT03091595|Drospirenone|drospirenone|mesh-list
44088051|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
44259449|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
44259450|NCT00634413|Hormones|hormones|mesh-ancestor
44259451|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259452|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44259453|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259454|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259455|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
44259456|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44259457|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44259458|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
44259459|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259460|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43655770|NCT02966522|Growth Substances|growth substances|mesh-ancestor
44088060|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
44088061|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088062|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088063|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088064|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
44088065|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088066|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088067|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088068|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088069|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
44088070|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
44088071|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088072|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
44088073|NCT00025051|Celecoxib|celecoxib|mesh-list
43626527|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43626528|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43651101|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43651102|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43651103|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43651104|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651105|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651106|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
43651107|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
43626578|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626579|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
43626580|NCT03091257|Trametinib|trametinib|mesh-list
43626581|NCT03091257|Dabrafenib|dabrafenib|mesh-list
43626582|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626583|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43626584|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626585|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088074|NCT00025051|Mitogens|mitogens|mesh-list
44088075|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44088076|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44088077|NCT00025051|Analgesics|analgesics|mesh-ancestor
44088078|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
44088079|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44088080|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088081|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44088082|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088083|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44088084|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44088085|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088086|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088087|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088088|NCT00025064|Prednisolone|prednisolone|mesh-list
44088089|NCT00025064|Doxorubicin|doxorubicin|mesh-list
44088090|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088091|NCT00025064|Etoposide|etoposide|mesh-list
44088092|NCT00025064|Vincristine|vincristine|mesh-list
44088093|NCT00025064|Melphalan|melphalan|mesh-list
44088094|NCT00025064|Ifosfamide|ifosfamide|mesh-list
44088095|NCT00025064|Dacarbazine|dacarbazine|mesh-list
43805898|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
44088096|NCT00025064|Bleomycin|bleomycin|mesh-list
44088098|NCT00025064|Procarbazine|procarbazine|mesh-list
44088099|NCT00025064|Chlorambucil|chlorambucil|mesh-list
44088100|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088101|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088102|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088103|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088104|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088105|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088106|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44259461|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44259462|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44259463|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44088107|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088108|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088109|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626595|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43626596|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626597|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626598|NCT03090698|Triamcinolone|triamcinolone|mesh-list
43626599|NCT03090698|Hylan|hylan|mesh-list
43626600|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626601|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
44088110|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088111|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
44088112|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088113|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088114|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
44088115|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088116|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44088117|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
44088118|NCT00025064|Hormones|hormones|mesh-ancestor
44088119|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44088120|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088121|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
44088122|NCT00025077|Thiotepa|thiotepa|mesh-list
44088145|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
44088146|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088147|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088148|NCT00025103|Dactinomycin|dactinomycin|mesh-list
44088149|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
44088150|NCT00025103|Melphalan|melphalan|mesh-list
44088151|NCT00025103|Carboplatin|carboplatin|mesh-list
44088152|NCT00025103|Doxorubicin|doxorubicin|mesh-list
44088153|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088154|NCT00025103|Etoposide|etoposide|mesh-list
44088155|NCT00025103|Vincristine|vincristine|mesh-list
44088156|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088157|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
44088158|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088159|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088160|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088161|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
44088162|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088163|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088164|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088165|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088166|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088167|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088168|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088169|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43805974|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44088170|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088171|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088172|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088173|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44088174|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088175|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44088176|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088177|NCT00025116|Gefitinib|gefitinib|mesh-list
44088178|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088179|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088180|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088181|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088182|NCT00025142|Leucovorin|leucovorin|mesh-list
44088183|NCT00025142|Fluorouracil|fluorouracil|mesh-list
44088184|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
44088185|NCT00025142|Gefitinib|gefitinib|mesh-list
44088186|NCT00025142|Calcium|calcium|mesh-list
44088187|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
44088188|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651116|NCT03009513|Glimepiride|glimepiride|mesh-list
44088189|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088190|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
44088191|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088192|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088193|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088194|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088195|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
44088196|NCT00025142|Antidotes|antidotes|mesh-ancestor
44088197|NCT00025142|Protective Agents|protective agents|mesh-ancestor
44259464|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259465|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44259466|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259467|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259468|NCT00634491|Acetazolamide|acetazolamide|mesh-list
44259469|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
44259470|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44259471|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259472|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259473|NCT00634491|Diuretics|diuretics|mesh-ancestor
44259474|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
44259475|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259476|NCT00634556|Levodopa|levodopa|mesh-list
44259477|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44259478|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44259479|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44259480|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
44259481|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259482|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259483|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259484|NCT00634595|Paclitaxel|paclitaxel|mesh-list
44259485|NCT00634595|Cisplatin|cisplatin|mesh-list
44259486|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44259487|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259488|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
44259489|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
44259490|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
43655788|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44088198|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
44088199|NCT00025142|Vitamins|vitamins|mesh-ancestor
44088200|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
44088201|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088202|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088203|NCT00025168|Gemcitabine|gemcitabine|mesh-list
44088204|NCT00025168|Irinotecan|irinotecan|mesh-list
44088205|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088206|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
44088207|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088208|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088209|NCT00025168|Antiviral Agents|antiviral agents|mesh-ancestor
44088210|NCT00025168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088211|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088212|NCT00025168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088213|NCT00025168|Immunologic Factors|immunologic factors|mesh-ancestor
44088214|NCT00025168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088215|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088216|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088217|NCT00025181|Ipilimumab|ipilimumab|mesh-list
44259491|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259493|NCT00634634|Letrozole|letrozole|mesh-list
44259494|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259495|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259496|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259497|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259498|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44259499|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44259500|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44259501|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259502|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259503|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259504|NCT00634686|Vitamin D|vitamin d|mesh-list
44259505|NCT00634686|Calcium|calcium|mesh-list
44259506|NCT00634686|Vitamins|vitamins|mesh-ancestor
44259507|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
44259508|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259509|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44259510|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44259511|NCT00634712|Candesartan|candesartan|mesh-list
44259512|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44259513|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44259514|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44259515|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259516|NCT00634725|Gemcitabine|gemcitabine|mesh-list
44259517|NCT00634725|Capecitabine|capecitabine|mesh-list
44259518|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44259519|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259520|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
44259521|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259522|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259523|NCT00634725|Antiviral Agents|antiviral agents|mesh-ancestor
44259530|NCT00634790|Alprazolam|alprazolam|mesh-list
44259531|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44259532|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259533|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259534|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44259535|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259536|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259537|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
44259538|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
44088218|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
44088219|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44088220|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088221|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44088222|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088223|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44088224|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
44088225|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088226|NCT00025194|Estramustine|estramustine|mesh-list
44088227|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088228|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
44088229|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088230|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088231|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088232|NCT00025207|Gefitinib|gefitinib|mesh-list
44088233|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088234|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088235|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088236|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088237|NCT00025220|Thalidomide|thalidomide|mesh-list
44088238|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088239|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
44088240|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088241|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
44088242|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44088243|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088244|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088245|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43806052|NCT04917627|Vancomycin|vancomycin|mesh-list
44088246|NCT00025220|Growth Substances|growth substances|mesh-ancestor
44088247|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088248|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088249|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
44088250|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088253|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088255|NCT00025272|Etoposide|etoposide|mesh-list
44088256|NCT00025272|Topotecan|topotecan|mesh-list
44088257|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088258|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088259|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088260|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088261|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088262|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088263|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088264|NCT00025285|Thalidomide|thalidomide|mesh-list
44088265|NCT00025285|Carboplatin|carboplatin|mesh-list
44088266|NCT00025285|Irinotecan|irinotecan|mesh-list
44088267|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088268|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088269|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088270|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088271|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088272|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651158|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44088273|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
44088274|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088275|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
44088276|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44259539|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259540|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259542|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44259543|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259544|NCT00634894|Letrozole|letrozole|mesh-list
44259545|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259546|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44259547|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44259548|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088277|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088278|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088279|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088280|NCT00025285|Growth Substances|growth substances|mesh-ancestor
44088281|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088282|NCT00025298|Paclitaxel|paclitaxel|mesh-list
44088283|NCT00025298|Cisplatin|cisplatin|mesh-list
44088284|NCT00025298|Carboplatin|carboplatin|mesh-list
44088285|NCT00025298|Amifostine|amifostine|mesh-list
44088286|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088288|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088289|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088290|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088291|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088292|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44088293|NCT00025298|Protective Agents|protective agents|mesh-ancestor
44088294|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088295|NCT00025311|Topotecan|topotecan|mesh-list
44088296|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088297|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088298|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088299|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088300|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088301|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
44088302|NCT00025324|Thiotepa|thiotepa|mesh-list
44088303|NCT00025324|Carboplatin|carboplatin|mesh-list
44088304|NCT00025324|Etoposide|etoposide|mesh-list
44088305|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088306|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
44088307|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088308|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088309|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088310|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
44088311|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088312|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088313|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088314|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088315|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088316|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088317|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088318|NCT00025337|Leucovorin|leucovorin|mesh-list
44088319|NCT00025337|Bevacizumab|bevacizumab|mesh-list
44088320|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44088321|NCT00025337|Fluorouracil|fluorouracil|mesh-list
44088322|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
44088323|NCT00025337|Antibodies|antibodies|mesh-list
44088324|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
44088325|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44088329|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088330|NCT00025337|Growth Substances|growth substances|mesh-ancestor
44088331|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088332|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088333|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
44088334|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
44088335|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088336|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259549|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259550|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44259551|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259552|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259553|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259554|NCT00634959|Maraviroc|maraviroc|mesh-list
44259555|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44259556|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44088337|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088338|NCT00025337|Antidotes|antidotes|mesh-ancestor
44088339|NCT00025337|Protective Agents|protective agents|mesh-ancestor
44088340|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
44088341|NCT00025337|Vitamins|vitamins|mesh-ancestor
44088342|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
44088343|NCT00025350|Gefitinib|gefitinib|mesh-list
44088344|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088345|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088346|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088347|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088348|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
44088349|NCT00025363|Ifosfamide|ifosfamide|mesh-list
44088350|NCT00025363|Doxorubicin|doxorubicin|mesh-list
44088351|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088352|NCT00025363|Irinotecan|irinotecan|mesh-list
44088353|NCT00025363|Etoposide|etoposide|mesh-list
44088354|NCT00025363|Vincristine|vincristine|mesh-list
44088355|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
44088356|NCT00025363|Tirapazamine|tirapazamine|mesh-list
44088357|NCT00025363|Sargramostim|sargramostim|mesh-list
44088358|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088359|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
44088360|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088361|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088362|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088363|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
44088364|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088365|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088366|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088367|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088368|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088369|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088370|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088371|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088372|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088373|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088374|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088375|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088376|NCT00025376|Bortezomib|bortezomib|mesh-list
44088377|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088378|NCT00025389|Paclitaxel|paclitaxel|mesh-list
44088379|NCT00025389|Bevacizumab|bevacizumab|mesh-list
44088380|NCT00025389|Carboplatin|carboplatin|mesh-list
44088381|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088382|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088383|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088384|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088385|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088386|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088387|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44088388|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088389|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088390|NCT00025389|Growth Substances|growth substances|mesh-ancestor
44088391|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088392|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088393|NCT00025402|Interferons|interferons|mesh-list
44088394|NCT00025402|Cytarabine|cytarabine|mesh-list
44088395|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
44088396|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
44259557|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259558|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44259559|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44259560|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
44259561|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259562|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44259563|NCT00634985|Eletriptan|eletriptan|mesh-list
44259564|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44259565|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
44259566|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259567|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259568|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651211|NCT03009058|Vitamins|vitamins|mesh-ancestor
44259569|NCT00634998|Ascorbic Acid|ascorbic acid|mesh-list
44259570|NCT00634998|Vitamins|vitamins|mesh-ancestor
44259571|NCT00634998|Micronutrients|micronutrients|mesh-ancestor
44259572|NCT00634998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259573|NCT00634998|Antioxidants|antioxidants|mesh-ancestor
44088397|NCT00025402|Busulfan|busulfan|mesh-list
44088398|NCT00025402|Etoposide|etoposide|mesh-list
44088399|NCT00025402|Idarubicin|idarubicin|mesh-list
44088400|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
44088401|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088402|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
44088403|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088423|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088424|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088425|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088426|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
44088427|NCT00025428|Carboplatin|carboplatin|mesh-list
44088428|NCT00025428|Doxorubicin|doxorubicin|mesh-list
44088429|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088430|NCT00025428|Etoposide|etoposide|mesh-list
44088431|NCT00025428|Vincristine|vincristine|mesh-list
44088432|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088433|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
44088434|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088435|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088436|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088437|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
44088438|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088439|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088440|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088441|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088442|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088443|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088444|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088445|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088446|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088447|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088448|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088450|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
44088451|NCT00025441|Ifosfamide|ifosfamide|mesh-list
44088452|NCT00025441|Carboplatin|carboplatin|mesh-list
44088453|NCT00025441|Doxorubicin|doxorubicin|mesh-list
44088454|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088455|NCT00025441|Etoposide|etoposide|mesh-list
44088456|NCT00025441|Vincristine|vincristine|mesh-list
44088457|NCT00025441|Epirubicin|epirubicin|mesh-list
44088458|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088459|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
44088460|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088461|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259574|NCT00634998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259575|NCT00634998|Protective Agents|protective agents|mesh-ancestor
44259577|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
44259578|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
43655848|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
44088462|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088463|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
44088464|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088465|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088466|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088467|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088468|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088469|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088470|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088471|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088472|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088473|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088474|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088475|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44088476|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088477|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44152352|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44088478|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088480|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088481|NCT00025467|Thalidomide|thalidomide|mesh-list
44088482|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088483|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
44088484|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088485|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
44088486|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44088487|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088488|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088489|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088490|NCT00025467|Growth Substances|growth substances|mesh-ancestor
44088491|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088492|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088493|NCT00025480|Paclitaxel|paclitaxel|mesh-list
44088494|NCT00025480|Carboplatin|carboplatin|mesh-list
44088495|NCT00025480|Tipifarnib|tipifarnib|mesh-list
44088496|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088497|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088498|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088499|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088500|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088501|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088502|NCT00025493|Docetaxel|docetaxel|mesh-list
44088503|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088504|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088505|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088506|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088507|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088508|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
44088509|NCT00025519|Thalidomide|thalidomide|mesh-list
44088510|NCT00025519|Fludarabine|fludarabine|mesh-list
44088511|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
44088512|NCT00025519|Tacrolimus|tacrolimus|mesh-list
44088513|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651234|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43651236|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
44088514|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088515|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
44088516|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088517|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088518|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
44088519|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088520|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44088521|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088522|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088523|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44088524|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
44088525|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44259579|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259580|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259581|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
43913761|NCT00410423|Analgesics|analgesics|mesh-ancestor
44259582|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44088526|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088527|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
44088528|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088529|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088530|NCT00025519|Growth Substances|growth substances|mesh-ancestor
44088531|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088532|NCT00025532|Antibodies|antibodies|mesh-list
44088533|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44088534|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
44088535|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088536|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
44088538|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088539|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
44088540|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088541|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088542|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088543|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
44088544|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088545|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088546|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088547|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44088548|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
44088549|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44088550|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088551|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
44088552|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
44088553|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088554|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44088555|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088556|NCT00025558|Carboplatin|carboplatin|mesh-list
44088557|NCT00025558|Temozolomide|temozolomide|mesh-list
44088558|NCT00025558|Thiotepa|thiotepa|mesh-list
44088559|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088560|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
44088561|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088562|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088563|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
44088564|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088565|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088566|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088567|NCT00025584|Bortezomib|bortezomib|mesh-list
44088568|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088569|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
44088570|NCT00025597|Carboplatin|carboplatin|mesh-list
44088571|NCT00025597|Doxorubicin|doxorubicin|mesh-list
44088572|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088573|NCT00025597|Etoposide|etoposide|mesh-list
44088574|NCT00025597|Vincristine|vincristine|mesh-list
44088575|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088576|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
44088577|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088578|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088579|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088580|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
44088581|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088582|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088583|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088584|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088585|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088586|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088587|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088588|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088589|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088590|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088591|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259583|NCT00635076|Alprazolam|alprazolam|mesh-list
44259584|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44259585|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259586|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259587|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44259588|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259589|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259590|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
44259591|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
44259592|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259593|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259594|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44259595|NCT00635258|Ganirelix|ganirelix|mesh-list
44259596|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655855|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44088592|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
44088593|NCT00025610|Carboplatin|carboplatin|mesh-list
44088594|NCT00025610|Doxorubicin|doxorubicin|mesh-list
44088595|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088596|NCT00025610|Etoposide|etoposide|mesh-list
44088597|NCT00025610|Vincristine|vincristine|mesh-list
44088598|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088599|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
44088600|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088601|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088602|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088603|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
44088604|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088605|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088606|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088607|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088608|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088609|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088610|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088611|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088615|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
44088616|NCT00025623|Carboplatin|carboplatin|mesh-list
44088617|NCT00025623|Doxorubicin|doxorubicin|mesh-list
44088618|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088619|NCT00025623|Etoposide|etoposide|mesh-list
44088620|NCT00025623|Vincristine|vincristine|mesh-list
44088621|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088622|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
44088623|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088624|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088625|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088626|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
44088627|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088628|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088629|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088630|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088631|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088632|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088633|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088634|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088635|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088636|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088637|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088638|NCT00025636|Cytarabine|cytarabine|mesh-list
44088639|NCT00025636|Dexamethasone|dexamethasone|mesh-list
44088640|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
44259597|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259598|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
44259599|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44259600|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
44259601|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44259602|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44259603|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088641|NCT00025636|Melphalan|melphalan|mesh-list
44088642|NCT00025636|Carmustine|carmustine|mesh-list
44088643|NCT00025636|Cisplatin|cisplatin|mesh-list
44088644|NCT00025636|Methotrexate|methotrexate|mesh-list
44088645|NCT00025636|Etoposide|etoposide|mesh-list
44088646|NCT00025636|Vincristine|vincristine|mesh-list
44088647|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088648|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
44088649|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088650|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088651|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088652|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
44088653|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088654|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088655|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088656|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44088657|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
44088658|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
44088659|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552554|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
44088660|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44088661|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
44088662|NCT00025636|Hormones|hormones|mesh-ancestor
44088663|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44088664|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088665|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44088666|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
44088667|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44088668|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088669|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
44088670|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44088671|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088672|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44088673|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088674|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088675|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088676|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088677|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
44088678|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088679|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088680|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088681|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088682|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
44088683|NCT00025649|Melphalan|melphalan|mesh-list
44088684|NCT00025649|Busulfan|busulfan|mesh-list
44088685|NCT00025649|Carboplatin|carboplatin|mesh-list
44088686|NCT00025649|Doxorubicin|doxorubicin|mesh-list
44088687|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44088689|NCT00025649|Vincristine|vincristine|mesh-list
44088690|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088691|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
44088692|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088693|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088694|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088695|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
44088696|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088697|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088698|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088699|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088700|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43627336|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43627337|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
43627338|NCT03074578|Hormones|hormones|mesh-ancestor
43627339|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627340|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627341|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627342|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627343|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
43627345|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44088701|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088702|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259604|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259605|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259606|NCT00635284|Sirolimus|sirolimus|mesh-list
44259607|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44259608|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259609|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44259610|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088703|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088704|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088705|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088706|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088707|NCT00025675|Gefitinib|gefitinib|mesh-list
44088708|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088709|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088710|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088711|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088712|NCT00025688|Paclitaxel|paclitaxel|mesh-list
44088713|NCT00025688|Carboplatin|carboplatin|mesh-list
44088714|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088715|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088716|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088717|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088718|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088719|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088720|NCT00025727|Ritonavir|ritonavir|mesh-list
44088721|NCT00025727|Lopinavir|lopinavir|mesh-list
44088722|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
44088723|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44088724|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44088725|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
44088726|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088727|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088728|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44088729|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44088730|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
44088731|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088732|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44088733|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44088734|NCT00025740|Clonazepam|clonazepam|mesh-list
44088735|NCT00025740|Paroxetine|paroxetine|mesh-list
44088736|NCT00025740|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44088737|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44088738|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44088739|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088740|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44088741|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
44088742|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088743|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44088744|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
44088745|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44088746|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44088747|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44088748|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088749|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
44088750|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
44088751|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
44088752|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
44088753|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44088754|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152353|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152354|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152355|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152356|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
44152357|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
44152358|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152359|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152374|NCT00216775|Ribavirin|ribavirin|mesh-list
44152375|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
44152376|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
44259611|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
44259612|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259613|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
44259614|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259615|NCT00635310|Liver Extracts|liver extracts|mesh-list
44259616|NCT00635310|Hematinics|hematinics|mesh-ancestor
44259617|NCT00635323|Capecitabine|capecitabine|mesh-list
44259618|NCT00635323|Irinotecan|irinotecan|mesh-list
44259619|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259620|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
44259621|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259622|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259623|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44259624|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44259625|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461860|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461861|NCT01537549|Protective Agents|protective agents|mesh-ancestor
44461862|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461863|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
44461864|NCT01537549|Vitamins|vitamins|mesh-ancestor
44152377|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152378|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
44152379|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152380|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
44152381|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088755|NCT00025779|Guanfacine|guanfacine|mesh-list
44088756|NCT00025779|Methylphenidate|methylphenidate|mesh-list
44088757|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44088758|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088759|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44088760|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44088761|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44088762|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088763|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
44088764|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760803|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760804|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760805|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43760806|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760807|NCT02443064|Vancomycin|vancomycin|mesh-list
43760808|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43760809|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43760810|NCT02443142|Acetaminophen|acetaminophen|mesh-list
43552671|NCT03602508|Urological Agents|urological agents|mesh-ancestor
43552673|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44088765|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44088766|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44088767|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44088768|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44088769|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44088770|NCT00025792|Pramipexole|pramipexole|mesh-list
44088771|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
44088772|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088773|NCT00025792|Protective Agents|protective agents|mesh-ancestor
44088774|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088775|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44088776|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44088777|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
44088778|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
44088779|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44088780|NCT00026039|Estrogens|estrogens|mesh-list
44088781|NCT00026039|Hormones|hormones|mesh-ancestor
44088782|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44088783|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088784|NCT00026052|Riluzole|riluzole|mesh-list
44461865|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
44461866|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
44461867|NCT01537133|Fluticasone|fluticasone|mesh-list
44461868|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461869|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44461870|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
44461871|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461872|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461873|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44461874|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
44461875|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461876|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44088785|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
44088786|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44088787|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44088788|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44088789|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088790|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088791|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44088792|NCT00026052|Protective Agents|protective agents|mesh-ancestor
44088793|NCT00026078|Docetaxel|docetaxel|mesh-list
44088794|NCT00026078|Ifosfamide|ifosfamide|mesh-list
44088796|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088797|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088798|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088799|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088800|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088801|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
44088803|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088804|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44088805|NCT00026091|Protective Agents|protective agents|mesh-ancestor
44088806|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088807|NCT00026104|Gemcitabine|gemcitabine|mesh-list
44088808|NCT00026104|Paclitaxel|paclitaxel|mesh-list
44088809|NCT00026104|Tipifarnib|tipifarnib|mesh-list
44088810|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088811|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088812|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088813|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
43760909|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43760910|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43760946|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
43552734|NCT03602131|Gemcitabine|gemcitabine|mesh-list
44088814|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088815|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088816|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088817|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
44088818|NCT00026104|Antiviral Agents|antiviral agents|mesh-ancestor
44088819|NCT00026104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088820|NCT00026104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088821|NCT00026104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088822|NCT00026104|Immunologic Factors|immunologic factors|mesh-ancestor
44088823|NCT00026104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088824|NCT00026130|Gemcitabine|gemcitabine|mesh-list
44088825|NCT00026130|Fluorouracil|fluorouracil|mesh-list
44088826|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088827|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
44088828|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088829|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088831|NCT00026130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088832|NCT00026130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088833|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088834|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
44088835|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088836|NCT00026143|Interferons|interferons|mesh-list
44088837|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
44088838|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
44088839|NCT00026143|Interleukin-12|interleukin-12|mesh-list
44461878|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44461879|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461880|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44461881|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44088840|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088841|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
44088842|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088843|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
44088844|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088845|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44088846|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088847|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088848|NCT00026143|Growth Substances|growth substances|mesh-ancestor
44088849|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088850|NCT00026156|Docetaxel|docetaxel|mesh-list
44088851|NCT00026156|Vinorelbine|vinorelbine|mesh-list
44088852|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088853|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088854|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088855|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088856|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088857|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088858|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
44088859|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088860|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088861|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088862|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088863|NCT00026182|Rituximab|rituximab|mesh-list
44088864|NCT00026182|Interleukin-12|interleukin-12|mesh-list
44088865|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44088866|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088867|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
44088868|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088869|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088870|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44088872|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088874|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088875|NCT00026195|Irinotecan|irinotecan|mesh-list
44088876|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088877|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088878|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761191|NCT02440750|Dienogest|dienogest|mesh-list
43761192|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
43761193|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44088879|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088880|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088881|NCT00026234|Dexamethasone|dexamethasone|mesh-list
44088882|NCT00026234|Capecitabine|capecitabine|mesh-list
44088883|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
44088884|NCT00026234|Floxuridine|floxuridine|mesh-list
44088885|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44088886|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
44088887|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
44088888|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44088889|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088890|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44088891|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
44088892|NCT00026234|Hormones|hormones|mesh-ancestor
44088893|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44088894|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088895|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088896|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088897|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
44088898|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088899|NCT00026260|Semaxinib|semaxinib|mesh-list
44088900|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088901|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44088902|NCT00026260|Growth Substances|growth substances|mesh-ancestor
44088903|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088904|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
44088905|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088906|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44461882|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461883|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461884|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
44461885|NCT01537081|Guaifenesin|guaifenesin|mesh-list
44461886|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44461887|NCT01537081|Expectorants|expectorants|mesh-ancestor
44461888|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44088907|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088908|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088909|NCT00026273|Leucovorin|leucovorin|mesh-list
44088910|NCT00026273|Fluorouracil|fluorouracil|mesh-list
44088911|NCT00026273|Irinotecan|irinotecan|mesh-list
44088912|NCT00026273|Calcium|calcium|mesh-list
44088913|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
44088914|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44088915|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088916|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
44088917|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088918|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088919|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088920|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088921|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
44088922|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44088923|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088924|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088925|NCT00026273|Antidotes|antidotes|mesh-ancestor
44088926|NCT00026273|Protective Agents|protective agents|mesh-ancestor
44088927|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
44088928|NCT00026273|Vitamins|vitamins|mesh-ancestor
44088929|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
44088930|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44088931|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
44088932|NCT00026286|Estrogens|estrogens|mesh-list
44088933|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44088934|NCT00026286|Hormones|hormones|mesh-ancestor
44088935|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44088936|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761231|NCT02440828|Tobramycin|tobramycin|mesh-list
44088937|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44088938|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44088939|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44088940|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
44088941|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44088942|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44088943|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44088944|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44088969|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088970|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
44088971|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088972|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088973|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44088974|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088975|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088976|NCT00026364|Leucovorin|leucovorin|mesh-list
44088977|NCT00026364|Fluorouracil|fluorouracil|mesh-list
44088978|NCT00026364|Irinotecan|irinotecan|mesh-list
44088979|NCT00026364|Gefitinib|gefitinib|mesh-list
44088980|NCT00026364|Calcium|calcium|mesh-list
44088981|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
44152382|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
44088982|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44088983|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088984|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
44088985|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088986|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088987|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088988|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088989|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
44088990|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44461889|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44461890|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44259627|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44259628|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44259629|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
44259630|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259631|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259632|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259633|NCT00635414|Esomeprazole|esomeprazole|mesh-list
44259634|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44259635|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259636|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44259637|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259638|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259639|NCT00635531|Alprazolam|alprazolam|mesh-list
44259640|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43655890|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
44088991|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088992|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088993|NCT00026364|Antidotes|antidotes|mesh-ancestor
43588082|NCT03390608|Trastuzumab|trastuzumab|mesh-list
44088994|NCT00026364|Protective Agents|protective agents|mesh-ancestor
44088995|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
44088996|NCT00026364|Vitamins|vitamins|mesh-ancestor
44088997|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
44088998|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088999|NCT00026377|Leuprolide|leuprolide|mesh-list
43837403|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
43837404|NCT04912427|Hormones|hormones|mesh-ancestor
43837405|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089000|NCT00026377|Goserelin|goserelin|mesh-list
44089001|NCT00026377|Flutamide|flutamide|mesh-list
44089002|NCT00026377|Bicalutamide|bicalutamide|mesh-list
44089003|NCT00026377|Semaxinib|semaxinib|mesh-list
44089004|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44089005|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
44089006|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089007|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089008|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44089009|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089010|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
44089011|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44089012|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089013|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089014|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089015|NCT00026377|Growth Substances|growth substances|mesh-ancestor
44089016|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089017|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44089018|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089019|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089020|NCT00026403|Gemcitabine|gemcitabine|mesh-list
44089021|NCT00026403|Cisplatin|cisplatin|mesh-list
44089022|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089023|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089024|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
44089025|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089026|NCT00026403|Antiviral Agents|antiviral agents|mesh-ancestor
44089027|NCT00026403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089028|NCT00026403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089029|NCT00026403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259641|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259642|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259643|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44259644|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44089030|NCT00026403|Immunologic Factors|immunologic factors|mesh-ancestor
44089031|NCT00026403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089032|NCT00026416|Interferons|interferons|mesh-list
44089033|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
44089034|NCT00026416|Thalidomide|thalidomide|mesh-list
44089035|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089036|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
44089037|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089038|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
44089039|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089040|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089041|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
44089042|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089043|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43651264|NCT03008551|Metformin|metformin|mesh-list
44089044|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089045|NCT00026416|Growth Substances|growth substances|mesh-ancestor
44089046|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089047|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
44089048|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089049|NCT00026442|Capecitabine|capecitabine|mesh-list
44089050|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089051|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
44089052|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089053|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089054|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
44089055|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089056|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44089057|NCT00026468|Protective Agents|protective agents|mesh-ancestor
43806641|NCT04908345|Fentanyl|fentanyl|mesh-list
44089058|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089059|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44089060|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089061|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089062|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089063|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44089064|NCT00026468|Analgesics|analgesics|mesh-ancestor
44089065|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
44089066|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089067|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089068|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089070|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
44089071|NCT00026520|Thalidomide|thalidomide|mesh-list
44089072|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089073|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
44089074|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089075|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
44089076|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089077|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089078|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
44089079|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089080|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089081|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089082|NCT00026520|Growth Substances|growth substances|mesh-ancestor
44089083|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089084|NCT00026533|Thalidomide|thalidomide|mesh-list
44089085|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089086|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
44089087|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089088|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
44089089|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089090|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089091|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089092|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089093|NCT00026533|Growth Substances|growth substances|mesh-ancestor
44089094|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089095|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089097|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44089098|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259646|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
44259647|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
44259648|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259649|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259650|NCT00635557|Carboplatin|carboplatin|mesh-list
44259651|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259652|NCT00635713|Fulvestrant|fulvestrant|mesh-list
44259653|NCT00635713|Anastrozole|anastrozole|mesh-list
44259654|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44259655|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259656|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44259657|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44259658|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259659|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089099|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089100|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089101|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44089102|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089103|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44089104|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44089105|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44089106|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44089107|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44089108|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
44089109|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089110|NCT00026637|Sertraline|sertraline|mesh-list
44089111|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
44089112|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089113|NCT00026637|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44089114|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44089115|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44089116|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089117|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089118|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
44089119|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089120|NCT00026819|Rofecoxib|rofecoxib|mesh-list
44089121|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44089122|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44089123|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089124|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089125|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089126|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44089127|NCT00026819|Analgesics|analgesics|mesh-ancestor
44089128|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
44089129|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089130|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089131|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089132|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089133|NCT00026962|Estradiol|estradiol|mesh-list
44089134|NCT00026962|Progesterone|progesterone|mesh-list
44089135|NCT00026962|Estrogens|estrogens|mesh-ancestor
44089136|NCT00026962|Hormones|hormones|mesh-ancestor
44089137|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089138|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089139|NCT00026962|Progestins|progestins|mesh-ancestor
44259660|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259661|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44259662|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44259663|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259664|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259665|NCT00635726|Gemcitabine|gemcitabine|mesh-list
44259666|NCT00635726|Cisplatin|cisplatin|mesh-list
44259667|NCT00635726|Doxorubicin|doxorubicin|mesh-list
44259668|NCT00635726|Methotrexate|methotrexate|mesh-list
44089140|NCT00027014|Fentanyl|fentanyl|mesh-list
44089141|NCT00027014|Oxycodone|oxycodone|mesh-list
44089142|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43806796|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
44089143|NCT00027014|Narcotics|narcotics|mesh-ancestor
44089144|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44089145|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089146|NCT00027014|Analgesics|analgesics|mesh-ancestor
44089147|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
44089148|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089149|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44089150|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44089151|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
44089152|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
44089153|NCT00027040|Selegiline|selegiline|mesh-list
44089154|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
44089155|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089156|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44089157|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44089158|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44089159|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089160|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089161|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44089162|NCT00027040|Protective Agents|protective agents|mesh-ancestor
44089163|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089164|NCT00027053|Trazodone|trazodone|mesh-list
44089165|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44089166|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44089167|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44089168|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089169|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089170|NCT00027053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44089171|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44089172|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44089173|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089174|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089175|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
44089176|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44089177|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
44089178|NCT00027066|Aspirin|aspirin|mesh-list
44089179|NCT00027066|Warfarin|warfarin|mesh-list
44089180|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089181|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44089182|NCT00027066|Analgesics|analgesics|mesh-ancestor
44089183|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
44089184|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089185|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089186|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089187|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089188|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44089189|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44089190|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089191|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44089192|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44089193|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089194|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
44089195|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
44089196|NCT00027079|Naltrexone|naltrexone|mesh-list
44089197|NCT00027079|Ondansetron|ondansetron|mesh-list
44259669|NCT00635726|Vinblastine|vinblastine|mesh-list
44259670|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259671|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259672|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
44259673|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259674|NCT00635726|Antiviral Agents|antiviral agents|mesh-ancestor
44259675|NCT00635726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259676|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089198|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44089199|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44089200|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089201|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
44089202|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089203|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
44089204|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
44089205|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44089206|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
44089207|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089208|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44089209|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
44089210|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089211|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089212|NCT00027079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44089213|NCT00027079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44089214|NCT00027079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44089215|NCT00027079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089216|NCT00027079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44089217|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
44089218|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089238|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089240|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089241|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
44089242|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089243|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44089244|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089245|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44089246|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089247|NCT00027391|Albuterol|albuterol|mesh-list
44089248|NCT00027391|Oxandrolone|oxandrolone|mesh-list
44089249|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44089250|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
44089251|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089252|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089253|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44089254|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
44089255|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
44089256|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089257|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44089258|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44089259|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44089260|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44089261|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089262|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089263|NCT00027391|Androgens|androgens|mesh-ancestor
44089264|NCT00027391|Hormones|hormones|mesh-ancestor
44089265|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089266|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
44089267|NCT00027404|Fluoxetine|fluoxetine|mesh-list
44089268|NCT00027404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44089269|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44089270|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44089271|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089272|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089273|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
44089274|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259677|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259678|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
44259679|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259680|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44259681|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44259682|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44259683|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44259684|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
44089275|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44089282|NCT00027443|Cyclosporins|cyclosporins|mesh-list
44089283|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
44089284|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089285|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089286|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089287|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
44089288|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089289|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
44089290|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089291|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089292|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089293|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089295|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089296|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44089297|NCT00027495|Analgesics|analgesics|mesh-ancestor
44089298|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
44089299|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089300|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089301|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089302|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089303|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089304|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089305|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089306|NCT00027508|Trabectedin|trabectedin|mesh-list
44089307|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089308|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
44089309|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089310|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089311|NCT00027521|Bleomycin|bleomycin|mesh-list
44089312|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089313|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089314|NCT00027534|Metronidazole|metronidazole|mesh-list
44089315|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089316|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089317|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44089318|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44089319|NCT00027547|Cytarabine|cytarabine|mesh-list
44089320|NCT00027547|Cyclosporine|cyclosporine|mesh-list
44089321|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
44089322|NCT00027547|Methotrexate|methotrexate|mesh-list
44089323|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
44089324|NCT00027547|Fludarabine|fludarabine|mesh-list
44089325|NCT00027547|Cyclosporins|cyclosporins|mesh-list
44089326|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44089327|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
44089328|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089329|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089330|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089331|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
44089332|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089333|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089334|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089335|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089336|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44089337|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089338|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
44089339|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259686|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44259687|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43761480|NCT02438865|Epirubicin|epirubicin|mesh-list
44259688|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43850164|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
44089340|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089341|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
44089342|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806883|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089355|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
44089356|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089357|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089358|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089359|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
44089360|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089361|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089362|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089363|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44089364|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
44089365|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089366|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089368|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089369|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089370|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44089371|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089372|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089373|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
44089374|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089375|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44089376|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089377|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089378|NCT00027599|Bevacizumab|bevacizumab|mesh-list
44089379|NCT00027599|Sargramostim|sargramostim|mesh-list
44089380|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089381|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089382|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089383|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089384|NCT00027599|Growth Substances|growth substances|mesh-ancestor
44089385|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089386|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089387|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
44089388|NCT00027612|Irinotecan|irinotecan|mesh-list
44089389|NCT00027612|Carmustine|carmustine|mesh-list
44089390|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44089391|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089392|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089393|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089394|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089395|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089396|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
44089397|NCT00027625|Temozolomide|temozolomide|mesh-list
44089398|NCT00027625|Gefitinib|gefitinib|mesh-list
44089399|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089400|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
44089401|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089402|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089403|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44089404|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089410|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089411|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089412|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089413|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089415|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089416|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089417|NCT00027664|Interferons|interferons|mesh-list
44089418|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
44089419|NCT00027664|Thalidomide|thalidomide|mesh-list
44089420|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089421|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
44089422|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259689|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44259690|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44259691|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
44259692|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
44259693|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259695|NCT00635791|Vorinostat|vorinostat|mesh-list
44259696|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259697|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259698|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259699|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259700|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44259701|NCT00635856|Gefitinib|gefitinib|mesh-list
44259702|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259703|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259704|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259705|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259706|NCT00635921|Ziprasidone|ziprasidone|mesh-list
44259707|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44259708|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
44259709|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259710|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089423|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
44089424|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089425|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089426|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
44089427|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089428|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089429|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089430|NCT00027664|Growth Substances|growth substances|mesh-ancestor
44089431|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089432|NCT00027677|Halofuginone|halofuginone|mesh-list
44089433|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089434|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
44089435|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44089436|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44089437|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089438|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44089439|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089440|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089441|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089442|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089443|NCT00027677|Growth Substances|growth substances|mesh-ancestor
44089444|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089445|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089446|NCT00027690|Gefitinib|gefitinib|mesh-list
44089447|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089448|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44089449|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089450|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089451|NCT00027703|Gemcitabine|gemcitabine|mesh-list
44089452|NCT00027703|Bevacizumab|bevacizumab|mesh-list
44259711|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259712|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44259713|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259714|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259715|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259716|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44259718|NCT00635960|Hormones|hormones|mesh-list
44259719|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259720|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259721|NCT00635973|Gefitinib|gefitinib|mesh-list
44259722|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259723|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44259724|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259725|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259726|NCT00635986|Fentanyl|fentanyl|mesh-list
44259727|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44259728|NCT00635986|Narcotics|narcotics|mesh-ancestor
44259729|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259730|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259731|NCT00635986|Analgesics|analgesics|mesh-ancestor
44259732|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
44259733|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259734|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44259735|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44259736|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
44259737|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
44259738|NCT00636038|Beta Carotene|beta carotene|mesh-list
44259739|NCT00636038|Carotenoids|carotenoids|mesh-list
44259740|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
44259741|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259742|NCT00636038|Protective Agents|protective agents|mesh-ancestor
44259743|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259744|NCT00636038|Provitamins|provitamins|mesh-ancestor
44259745|NCT00636038|Vitamins|vitamins|mesh-ancestor
44089453|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44089454|NCT00027703|Cisplatin|cisplatin|mesh-list
44089455|NCT00027703|Antibodies|antibodies|mesh-list
44089456|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
44089457|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44089458|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089459|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44259746|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
44259747|NCT00636064|Parecoxib|parecoxib|mesh-list
44259748|NCT00636064|Valdecoxib|valdecoxib|mesh-list
44259749|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44259750|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44259751|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259752|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089460|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089461|NCT00027703|Growth Substances|growth substances|mesh-ancestor
44089462|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089463|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089464|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
44089465|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089467|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089468|NCT00027703|Antiviral Agents|antiviral agents|mesh-ancestor
44089469|NCT00027703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089470|NCT00027703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089471|NCT00027703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089472|NCT00027716|Bortezomib|bortezomib|mesh-list
44089473|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089474|NCT00027742|Interferons|interferons|mesh-list
44089475|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
44089476|NCT00027742|Temozolomide|temozolomide|mesh-list
44089477|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089484|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089486|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089487|NCT00027807|Aldesleukin|aldesleukin|mesh-list
44089488|NCT00027807|Molgramostim|molgramostim|mesh-list
44089489|NCT00027807|Sargramostim|sargramostim|mesh-list
44089490|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
44089491|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089492|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089493|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089494|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089495|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
44089496|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089497|NCT00027820|Cyclosporine|cyclosporine|mesh-list
44089498|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
44089499|NCT00027820|Fludarabine|fludarabine|mesh-list
44089500|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
44089501|NCT00027820|Cyclosporins|cyclosporins|mesh-list
44089502|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089503|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089504|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
44089505|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089506|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089507|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
44089508|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089509|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089510|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
44089511|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089512|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089513|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089514|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089515|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089516|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44089517|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
44089518|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089519|NCT00027833|Leucovorin|leucovorin|mesh-list
44089520|NCT00027833|Fluorouracil|fluorouracil|mesh-list
44089521|NCT00027833|Irinotecan|irinotecan|mesh-list
44089522|NCT00027833|Calcium|calcium|mesh-list
44089523|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
44089524|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44089525|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089526|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
44089527|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089528|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089529|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089530|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089531|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
44259754|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44259755|NCT00636064|Analgesics|analgesics|mesh-ancestor
44259756|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
44259757|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259758|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089532|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44089533|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089534|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089535|NCT00027833|Antidotes|antidotes|mesh-ancestor
44089536|NCT00027833|Protective Agents|protective agents|mesh-ancestor
44089537|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
44089538|NCT00027833|Vitamins|vitamins|mesh-ancestor
44089539|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
44089540|NCT00027859|Ketoconazole|ketoconazole|mesh-list
44089541|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
44089542|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44089543|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44089544|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44089545|NCT00027859|Docetaxel|docetaxel|mesh-list
44089546|NCT00027859|Estramustine|estramustine|mesh-list
44089547|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089548|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089555|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44089556|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089557|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089558|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44089559|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
44089560|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089561|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089562|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44089563|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089564|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
44089565|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44089566|NCT00027872|Tipifarnib|tipifarnib|mesh-list
44089567|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089568|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
44089569|NCT00027885|Bevacizumab|bevacizumab|mesh-list
44089570|NCT00027885|Docetaxel|docetaxel|mesh-list
44089571|NCT00027885|Doxorubicin|doxorubicin|mesh-list
44089572|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44089573|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089574|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
44089575|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089576|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089577|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089578|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
44089579|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089580|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089581|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089582|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089583|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089584|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089585|NCT00027885|Growth Substances|growth substances|mesh-ancestor
44089586|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089587|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089588|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089589|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089590|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089591|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089592|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089593|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089594|NCT00027898|Carboplatin|carboplatin|mesh-list
44089595|NCT00027898|Etoposide|etoposide|mesh-list
44089596|NCT00027898|Bortezomib|bortezomib|mesh-list
44089597|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
43761622|NCT02437656|Metformin|metformin|mesh-list
44089598|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089599|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089600|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089601|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44259759|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259760|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259761|NCT00636116|Antivenins|antivenins|mesh-list
44259762|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
44259763|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259764|NCT00636142|Infliximab|infliximab|mesh-list
44259765|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
44259766|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259767|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259768|NCT00636246|Sertraline|sertraline|mesh-list
44259769|NCT00636246|Reboxetine|reboxetine|mesh-list
44089602|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089603|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089604|NCT00027911|Sargramostim|sargramostim|mesh-list
44089605|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
44089606|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089607|NCT00027924|Cyclosporine|cyclosporine|mesh-list
44089608|NCT00027924|Methotrexate|methotrexate|mesh-list
44089609|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
44089610|NCT00027924|Fludarabine|fludarabine|mesh-list
44089611|NCT00027924|Busulfan|busulfan|mesh-list
44089612|NCT00027924|Cyclosporins|cyclosporins|mesh-list
44089613|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44089614|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
44089615|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089616|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089617|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089619|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089621|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089622|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089623|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44089624|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089625|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
44089626|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089627|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089628|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
44089629|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089630|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089631|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
44089632|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089633|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089634|NCT00027937|Aldesleukin|aldesleukin|mesh-list
44089635|NCT00027937|Paclitaxel|paclitaxel|mesh-list
44089636|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
44089637|NCT00027937|Melphalan|melphalan|mesh-list
44089638|NCT00027937|Busulfan|busulfan|mesh-list
44089639|NCT00027937|Thiotepa|thiotepa|mesh-list
44089640|NCT00027937|Sargramostim|sargramostim|mesh-list
44089641|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089642|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089643|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089644|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089645|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089646|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089647|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089648|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
44089649|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089650|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089651|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089652|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
44089653|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089654|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089655|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089656|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
44089657|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089658|NCT00027963|Gabapentin|gabapentin|mesh-list
44089659|NCT00027963|Analgesics|analgesics|mesh-ancestor
44089660|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
43792235|NCT05305183|Alendronate|alendronate|mesh-list
44259770|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
44259771|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259772|NCT00636246|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44259773|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44259774|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259775|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259776|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259777|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
44259778|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089661|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089662|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089663|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
44089664|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44089665|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44089666|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44089667|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089668|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44089669|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44089670|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089671|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089672|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
44089674|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44089675|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44089676|NCT00027976|Analgesics|analgesics|mesh-ancestor
44089677|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
44089678|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089679|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089680|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089681|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089682|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44089683|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44089684|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089685|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089686|NCT00027989|Gemcitabine|gemcitabine|mesh-list
44089687|NCT00027989|Doxorubicin|doxorubicin|mesh-list
44089688|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44089689|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089690|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
44089691|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089698|NCT00027989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089699|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089700|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089701|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089702|NCT00028028|Sirolimus|sirolimus|mesh-list
44089703|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089704|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089705|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089706|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089707|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
44089708|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089709|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
44089710|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089711|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44089712|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089713|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089714|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089715|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44089716|NCT00028132|Tenofovir|tenofovir|mesh-list
44089717|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
44089718|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089719|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44259779|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44259780|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
44259781|NCT00636259|Bicalutamide|bicalutamide|mesh-list
44259782|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
44259783|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
44259784|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655915|NCT02965196|Dexamethasone|dexamethasone|mesh-list
44089720|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089721|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089722|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089723|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089724|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089726|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089727|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
44089728|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089729|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089730|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089731|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089732|NCT00028275|Interferons|interferons|mesh-list
44089733|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
44089734|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089735|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
44089736|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089737|NCT00028288|Daclizumab|daclizumab|mesh-list
44089738|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089739|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
44089740|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089741|NCT00028314|Ritonavir|ritonavir|mesh-list
44089742|NCT00028314|Lopinavir|lopinavir|mesh-list
44089743|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44089744|NCT00028314|Nevirapine|nevirapine|mesh-list
44089745|NCT00028314|Abacavir|abacavir|mesh-list
44089746|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44089747|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44089748|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
44089749|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089750|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089751|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089752|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089753|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
44089754|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089755|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44089756|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089757|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44089758|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089759|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44089760|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44089761|NCT00028327|Lamivudine|lamivudine|mesh-list
44089767|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089769|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089770|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
44089771|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089772|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089773|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089774|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
44089775|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44089776|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089777|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44089778|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44089779|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44089780|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44089781|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44089782|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44089783|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
44089784|NCT00028353|Toremifene|toremifene|mesh-list
44089785|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44259785|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259786|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259787|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44259788|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
44259789|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259790|NCT00636298|Bevacizumab|bevacizumab|mesh-list
44089786|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089787|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44089788|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44089789|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
44089790|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089791|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089792|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44089793|NCT00028366|Ritonavir|ritonavir|mesh-list
44089794|NCT00028366|Lopinavir|lopinavir|mesh-list
44089795|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
44089796|NCT00028366|Tenofovir|tenofovir|mesh-list
44089797|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44089798|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44089799|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
44089800|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089801|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089802|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089803|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44089804|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
44089805|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089806|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44089807|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089808|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44089809|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089810|NCT00028405|Talaporfin|talaporfin|mesh-list
44089811|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089812|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44089813|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089814|NCT00028418|Clofarabine|clofarabine|mesh-list
44089815|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44089816|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
44089817|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089818|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089819|NCT00028431|Ipilimumab|ipilimumab|mesh-list
44089820|NCT00028431|Antibodies|antibodies|mesh-list
44089821|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
44089822|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089823|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089824|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089825|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44089826|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089827|NCT00028483|Docetaxel|docetaxel|mesh-list
44089828|NCT00028483|Doxorubicin|doxorubicin|mesh-list
44089829|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
43588910|NCT03384121|Rifampin|rifampin|mesh-list
44089834|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089836|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089837|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089838|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089839|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
44089840|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837493|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089841|NCT00028496|Metronidazole|metronidazole|mesh-list
44089842|NCT00028496|Molgramostim|molgramostim|mesh-list
44089844|NCT00028496|Sargramostim|sargramostim|mesh-list
44089845|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
44089846|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089847|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089848|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089849|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089850|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44089851|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44089852|NCT00028535|Paclitaxel|paclitaxel|mesh-list
44089853|NCT00028535|Trastuzumab|trastuzumab|mesh-list
44089854|NCT00028535|Interleukin-12|interleukin-12|mesh-list
44259791|NCT00636298|Cetuximab|cetuximab|mesh-list
44259792|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44259793|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259794|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44259795|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44259796|NCT00636298|Growth Substances|growth substances|mesh-ancestor
44259797|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089855|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089856|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089857|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089858|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089859|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089860|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089861|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089862|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44089863|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
44089864|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089865|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089866|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089867|NCT00028535|Growth Substances|growth substances|mesh-ancestor
44089868|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089869|NCT00028561|Carboplatin|carboplatin|mesh-list
44089870|NCT00028561|Epothilone B|epothilone b|mesh-list
44089871|NCT00028561|Epothilones|epothilones|mesh-list
44089872|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089873|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089874|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089875|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089876|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089877|NCT00028574|Gabapentin|gabapentin|mesh-list
44089878|NCT00028574|Analgesics|analgesics|mesh-ancestor
44089879|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
44089880|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44089881|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089882|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
44089883|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44089884|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44089885|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44089886|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089887|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44089888|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44089889|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44089890|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089891|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
44089892|NCT00028587|Paclitaxel|paclitaxel|mesh-list
44089893|NCT00028587|Carboplatin|carboplatin|mesh-list
44089894|NCT00028587|Bortezomib|bortezomib|mesh-list
44089895|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089896|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089897|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089898|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089899|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089900|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089901|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
44089902|NCT00028600|Melphalan|melphalan|mesh-list
44089903|NCT00028600|Methotrexate|methotrexate|mesh-list
44089909|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089910|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089911|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089912|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
44089913|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089914|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089915|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089916|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44089917|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
44089918|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44089919|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259798|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
44259799|NCT00636311|Gemcitabine|gemcitabine|mesh-list
44259801|NCT00636311|Vinorelbine|vinorelbine|mesh-list
44259802|NCT00636311|Ifosfamide|ifosfamide|mesh-list
44259803|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259804|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
44259805|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259806|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259807|NCT00636311|Antiviral Agents|antiviral agents|mesh-ancestor
44259808|NCT00636311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259809|NCT00636311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089920|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
44089921|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
44089922|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089923|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44089924|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44089925|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089927|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44089928|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
44089929|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089930|NCT00028652|Interleukin-12|interleukin-12|mesh-list
44089931|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44089932|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
44089933|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089934|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44089935|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44089936|NCT00028652|Growth Substances|growth substances|mesh-ancestor
44089937|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
44089938|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089939|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
44089940|NCT00028665|Carmustine|carmustine|mesh-list
44089941|NCT00028665|Rituximab|rituximab|mesh-list
44089942|NCT00028665|Cisplatin|cisplatin|mesh-list
44089943|NCT00028665|Etoposide|etoposide|mesh-list
44089944|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807343|NCT04899817|Granisetron|granisetron|mesh-list
44089945|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
44089946|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089947|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089948|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089949|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
44089950|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089951|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089952|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089953|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089954|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089955|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089956|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089957|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089958|NCT00028678|Dalteparin|dalteparin|mesh-list
44089959|NCT00028678|Tinzaparin|tinzaparin|mesh-list
44089960|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44089961|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
44089962|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44089963|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44089964|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089965|NCT00028691|Chlorambucil|chlorambucil|mesh-list
44089966|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089967|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
44089968|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089969|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089970|NCT00028717|Prednisone|prednisone|mesh-list
44089971|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
44089972|NCT00028717|Rituximab|rituximab|mesh-list
44089973|NCT00028717|Doxorubicin|doxorubicin|mesh-list
44259810|NCT00636311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259811|NCT00636311|Immunologic Factors|immunologic factors|mesh-ancestor
44259812|NCT00636311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259813|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44259814|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44259815|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44259816|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44259817|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44259818|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
44259819|NCT00636415|Morphine|morphine|mesh-list
44259820|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44259821|NCT00636415|Narcotics|narcotics|mesh-ancestor
44089974|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44089981|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
44089982|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089983|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089984|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44089985|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089986|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089987|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44089988|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44089989|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089990|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089991|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
44089993|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44089994|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44089995|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44089996|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089997|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089998|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089999|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
44090000|NCT00028730|Thiotepa|thiotepa|mesh-list
44090001|NCT00028730|Fludarabine|fludarabine|mesh-list
44090002|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
44090003|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44090004|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090005|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
44090006|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090007|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090008|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090009|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
44090010|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090011|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090012|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090013|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090014|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
44090015|NCT00028743|Paclitaxel|paclitaxel|mesh-list
44090016|NCT00028743|Cisplatin|cisplatin|mesh-list
44090017|NCT00028743|Carboplatin|carboplatin|mesh-list
44090018|NCT00028743|Topotecan|topotecan|mesh-list
44090019|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090020|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090021|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090022|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090023|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090024|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090025|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090026|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090027|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090028|NCT00028756|Gemcitabine|gemcitabine|mesh-list
44090029|NCT00028756|Cisplatin|cisplatin|mesh-list
44090030|NCT00028756|Doxorubicin|doxorubicin|mesh-list
44090031|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090032|NCT00028756|Methotrexate|methotrexate|mesh-list
44090033|NCT00028756|Vinblastine|vinblastine|mesh-list
44259822|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259823|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259824|NCT00636415|Analgesics|analgesics|mesh-ancestor
44259825|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
44259826|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259827|NCT00636428|Midazolam|midazolam|mesh-list
44259828|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44259829|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44259830|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259831|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259832|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44259833|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44259834|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259835|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44259836|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
44259837|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
44259838|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
44259839|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
44259840|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259841|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259842|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44259843|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259844|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
44259845|NCT00636493|Hormones|hormones|mesh-ancestor
44259846|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090034|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090035|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090036|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
44090037|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090038|NCT00028756|Antiviral Agents|antiviral agents|mesh-ancestor
44090039|NCT00028756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090040|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090041|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090042|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
44090043|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090044|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43589120|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
44090054|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090055|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090056|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090057|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090058|NCT00028782|Etanidazole|etanidazole|mesh-list
44090059|NCT00028782|Imidazole|imidazole|mesh-list
44090060|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090061|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090062|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090064|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090065|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
44090066|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259847|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259849|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
44090067|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090068|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44090069|NCT00028821|Estradiol|estradiol|mesh-list
44090070|NCT00028821|Estrogens|estrogens|mesh-ancestor
44090071|NCT00028821|Hormones|hormones|mesh-ancestor
44090072|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090073|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090074|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090075|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090076|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090077|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090078|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090079|NCT00028834|Gemcitabine|gemcitabine|mesh-list
44090080|NCT00028834|Bevacizumab|bevacizumab|mesh-list
44090081|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44090082|NCT00028834|Antibodies|antibodies|mesh-list
44090083|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
44090084|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44090085|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090086|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44090087|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44090088|NCT00028834|Growth Substances|growth substances|mesh-ancestor
44090089|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090090|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
44090091|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
44090092|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090093|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
44090094|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090095|NCT00028834|Antiviral Agents|antiviral agents|mesh-ancestor
44090096|NCT00028834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090097|NCT00028834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090098|NCT00028834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090099|NCT00028847|Cytarabine|cytarabine|mesh-list
44090100|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
44090101|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090102|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
43715681|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
44090103|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090104|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090105|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
44090106|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090107|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090108|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
44090109|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43589187|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090119|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090120|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090121|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090122|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090123|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
44090124|NCT00028860|Antiviral Agents|antiviral agents|mesh-ancestor
44090125|NCT00028860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090126|NCT00028860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090127|NCT00028860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090128|NCT00028860|Immunologic Factors|immunologic factors|mesh-ancestor
44090129|NCT00028860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090130|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090131|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
44090132|NCT00028873|Paclitaxel|paclitaxel|mesh-list
44090133|NCT00028873|Docetaxel|docetaxel|mesh-list
44090134|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090135|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090136|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090137|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090138|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090139|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090140|NCT00028886|Interferons|interferons|mesh-list
44090141|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
44090142|NCT00028886|Thalidomide|thalidomide|mesh-list
44090143|NCT00028886|Dexamethasone|dexamethasone|mesh-list
44090144|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
44090145|NCT00028886|Melphalan|melphalan|mesh-list
44259850|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
44259851|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090146|NCT00028886|Doxorubicin|doxorubicin|mesh-list
44090147|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090148|NCT00028886|Vincristine|vincristine|mesh-list
44090149|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090150|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
44090151|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090152|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651400|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44090153|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090154|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
44090155|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090156|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090157|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090158|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44090159|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
44090160|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
44090161|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090162|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090163|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
44090164|NCT00028886|Hormones|hormones|mesh-ancestor
44090165|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090166|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44090167|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090168|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090169|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090170|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090171|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
44090172|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090173|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090174|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090175|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090176|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090177|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
44090178|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090188|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
44090189|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090190|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090191|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
44090192|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090193|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090194|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
44090195|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090196|NCT00028899|Analgesics|analgesics|mesh-ancestor
44090197|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
44090198|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090199|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090200|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090201|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090202|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44090203|NCT00028912|Carboplatin|carboplatin|mesh-list
44090204|NCT00028912|Bortezomib|bortezomib|mesh-list
44090205|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651420|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090206|NCT00028925|Carboplatin|carboplatin|mesh-list
44090207|NCT00028925|Topotecan|topotecan|mesh-list
44090208|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090209|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090210|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090211|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090212|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090213|NCT00028938|Paclitaxel|paclitaxel|mesh-list
44090214|NCT00028938|Carboplatin|carboplatin|mesh-list
44090215|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
44090216|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090217|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090218|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090219|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090220|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090221|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090222|NCT00028938|Hematinics|hematinics|mesh-ancestor
44090223|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44090224|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
44090225|NCT00028951|Coagulants|coagulants|mesh-ancestor
44259852|NCT00636545|Oblimersen|oblimersen|mesh-list
44259853|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259854|NCT00636584|Nitroprusside|nitroprusside|mesh-list
44259855|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44090226|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
44090227|NCT00028964|Doxorubicin|doxorubicin|mesh-list
44090228|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090229|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090230|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
44090231|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090232|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090233|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090234|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
44090235|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090236|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090237|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090238|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090239|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090240|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090241|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090243|NCT00028990|Bevacizumab|bevacizumab|mesh-list
44090244|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090245|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090246|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090247|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090248|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090256|NCT00029003|Gefitinib|gefitinib|mesh-list
44090257|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090258|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090259|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090260|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090261|NCT00029042|Infliximab|infliximab|mesh-list
44090262|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090263|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090264|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152384|NCT00216788|Esomeprazole|esomeprazole|mesh-list
44152385|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44152386|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152387|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44152388|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807568|NCT04896164|Curcumin|curcumin|mesh-list
44158043|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090265|NCT00029159|Estrogens|estrogens|mesh-list
44090266|NCT00029159|Androgens|androgens|mesh-list
44090267|NCT00029159|Hormones|hormones|mesh-ancestor
44090268|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090269|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090270|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
44090271|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44090272|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090273|NCT00029250|Allicin|allicin|mesh-list
44090274|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090275|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44090276|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
44090277|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090278|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44090279|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
44090280|NCT00029250|Protective Agents|protective agents|mesh-ancestor
44090281|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090282|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44090283|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44090284|NCT00029315|Plasminogen|plasminogen|mesh-list
44090285|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44090286|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44090287|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44090288|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090289|NCT00029328|Etanercept|etanercept|mesh-list
44090290|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44090291|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44090292|NCT00029328|Analgesics|analgesics|mesh-ancestor
44090293|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
44090294|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090295|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259856|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
44259857|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44259858|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259859|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
44259860|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44259861|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259862|NCT00636766|Metformin|metformin|mesh-list
44259863|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
44259864|NCT00636766|Rimonabant|rimonabant|mesh-list
44259865|NCT00636766|Atorvastatin|atorvastatin|mesh-list
44259866|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44259867|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259868|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44259869|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44259870|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
44259871|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259872|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44259873|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44259874|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259875|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44259876|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44259877|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44259878|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259879|NCT00636766|Hormones|hormones|mesh-ancestor
44259880|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259881|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44259882|NCT00636831|Cefazolin|cefazolin|mesh-list
44259883|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259884|NCT00636870|Fexofenadine|fexofenadine|mesh-list
44259885|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44259886|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44090296|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44090297|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090298|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090299|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090300|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
44090301|NCT00029380|Cyclosporine|cyclosporine|mesh-list
44090302|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
44090303|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
44090304|NCT00029380|Busulfan|busulfan|mesh-list
44090305|NCT00029380|Cyclosporins|cyclosporins|mesh-list
44090306|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090307|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
43762197|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
44090308|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090309|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259887|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44259888|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
44259889|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
44259890|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259891|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259892|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259893|NCT00636883|Gemcitabine|gemcitabine|mesh-list
44259894|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
44259895|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44259896|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
44259897|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259898|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259899|NCT00636883|Antiviral Agents|antiviral agents|mesh-ancestor
44259900|NCT00636883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259901|NCT00636883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259902|NCT00636883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259903|NCT00636883|Immunologic Factors|immunologic factors|mesh-ancestor
44259904|NCT00636883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259905|NCT00636896|Olanzapine|olanzapine|mesh-list
44259906|NCT00636896|Modafinil|modafinil|mesh-list
44259907|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
44259908|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
44259909|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44259910|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259911|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44259912|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44259913|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44090319|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44090320|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090321|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44090322|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
44090323|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090324|NCT00029458|Clozapine|clozapine|mesh-list
44090325|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44090326|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
44090327|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090328|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090329|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090330|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44090331|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44090332|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44090333|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44090334|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
44090335|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
44090336|NCT00029497|Amitriptyline|amitriptyline|mesh-list
44090337|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44090338|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
43807580|NCT04895657|Tazobactam|tazobactam|mesh-list
44090339|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158044|NCT00236067|Tiagabine|tiagabine|mesh-list
44259914|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259915|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44259916|NCT00636896|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44259917|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44259918|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44259919|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259920|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44259921|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
44259922|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44259923|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44259924|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44259925|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44259926|NCT00636909|Cyclosporine|cyclosporine|mesh-list
44259927|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
44259928|NCT00636909|Methotrexate|methotrexate|mesh-list
44259929|NCT00636909|Fludarabine|fludarabine|mesh-list
44090340|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44090341|NCT00029497|Analgesics|analgesics|mesh-ancestor
44090342|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
44090343|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090344|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090345|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44090346|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44090347|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44090348|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090349|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
44090350|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090352|NCT00029523|Methotrexate|methotrexate|mesh-list
44090353|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44090354|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
44090355|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44090356|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090357|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090358|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
44090359|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090360|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090361|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090362|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090363|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44090364|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090365|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
44090366|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090367|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44090368|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
44090369|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090370|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44090371|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44090372|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44090383|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44090384|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44090385|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44090386|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44090387|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090388|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090389|NCT00029627|Urological Agents|urological agents|mesh-ancestor
44259930|NCT00636909|Cyclosporins|cyclosporins|mesh-list
44259931|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259932|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
44259933|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259934|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44259935|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44259936|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
44259937|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090390|NCT00029679|Borage oil|borage oil|mesh-list
44090391|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090392|NCT00029757|Estrogens|estrogens|mesh-list
44090393|NCT00029757|Hormones|hormones|mesh-ancestor
44090394|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090395|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090396|NCT00029770|Acetaminophen|acetaminophen|mesh-list
44090397|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44090398|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44090399|NCT00029770|Codeine|codeine|mesh-list
44090400|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44090401|NCT00029770|Analgesics|analgesics|mesh-ancestor
44090402|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
44090403|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090404|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090405|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
44090406|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44090407|NCT00029770|Narcotics|narcotics|mesh-ancestor
44090408|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44090409|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
44090410|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
44090411|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090412|NCT00029822|Alfuzosin|alfuzosin|mesh-list
44090413|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44090414|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44090415|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44090416|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
44090417|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090418|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090419|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090420|NCT00029822|Urological Agents|urological agents|mesh-ancestor
44090421|NCT00029835|Rimonabant|rimonabant|mesh-list
44090422|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44090423|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44090424|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44090425|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090426|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090427|NCT00029835|Hormones|hormones|mesh-ancestor
44090428|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090429|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090430|NCT00029848|Rimonabant|rimonabant|mesh-list
44090431|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44090432|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44090433|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44090434|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090435|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090444|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090446|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651482|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44090447|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090448|NCT00029874|Minocycline|minocycline|mesh-list
44090449|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090450|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090451|NCT00030004|Midazolam|midazolam|mesh-list
44090452|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44090453|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43793105|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
44259938|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090454|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44090455|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090456|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44090457|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44090458|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44090459|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44090460|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
44090462|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
44090463|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
44090464|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090465|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090466|NCT00030030|Silymarin|silymarin|mesh-list
44090467|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
44090468|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090469|NCT00030030|Protective Agents|protective agents|mesh-ancestor
44090470|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090471|NCT00030056|Molgramostim|molgramostim|mesh-list
44090472|NCT00030056|Sargramostim|sargramostim|mesh-list
44090473|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
44090474|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090475|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090476|NCT00030069|Calcitriol|calcitriol|mesh-list
44090477|NCT00030069|Dexamethasone|dexamethasone|mesh-list
44090478|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44090479|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
44090480|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
44090481|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090482|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090483|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090484|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
44090485|NCT00030069|Hormones|hormones|mesh-ancestor
44090486|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158045|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
44090487|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44090488|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090489|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44090490|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44090491|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44090492|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090493|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44090494|NCT00030069|Vitamins|vitamins|mesh-ancestor
44090495|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
44090496|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44090497|NCT00030082|Melphalan|melphalan|mesh-list
44090498|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090499|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
43589588|NCT03378401|Octenidine|octenidine|mesh-list
44090508|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090509|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762214|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
43762215|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090510|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090511|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090512|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
44090513|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
44090514|NCT00030173|Epothilones|epothilones|mesh-list
44090515|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
44090516|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090517|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090518|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090519|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090520|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090521|NCT00030238|Calcium|calcium|mesh-list
44090522|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44090523|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090524|NCT00030342|Interferons|interferons|mesh-list
44090525|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
44090526|NCT00030342|Fluorouracil|fluorouracil|mesh-list
44090527|NCT00030342|Sargramostim|sargramostim|mesh-list
44090528|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
44090529|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090530|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090531|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090532|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090533|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
44090534|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090535|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
44090536|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090537|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
44090538|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090539|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090540|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44090541|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090542|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090544|NCT00030368|Bortezomib|bortezomib|mesh-list
44090545|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090546|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090547|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090548|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090549|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090550|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090551|NCT00030381|Esorubicin|esorubicin|mesh-list
44090552|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090553|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090554|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
44090555|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090556|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090557|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090558|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090559|NCT00030407|Celecoxib|celecoxib|mesh-list
44090560|NCT00030407|Docetaxel|docetaxel|mesh-list
44090561|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090562|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090563|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090564|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090565|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43589655|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
44090573|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090574|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44090575|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44090577|NCT00030420|Celecoxib|celecoxib|mesh-list
44090578|NCT00030420|Docetaxel|docetaxel|mesh-list
44090579|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090580|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090581|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090582|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090583|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762285|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762286|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43762287|NCT02432976|Hormones|hormones|mesh-ancestor
43762288|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090584|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44090585|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44090586|NCT00030420|Analgesics|analgesics|mesh-ancestor
44090587|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
44090588|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090589|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090590|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44090591|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090592|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44090593|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44090594|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090595|NCT00030433|Gemcitabine|gemcitabine|mesh-list
44090596|NCT00030433|Irinotecan|irinotecan|mesh-list
44090597|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090598|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
44090599|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090600|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090601|NCT00030433|Antiviral Agents|antiviral agents|mesh-ancestor
44090602|NCT00030433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090603|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090604|NCT00030433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090605|NCT00030433|Immunologic Factors|immunologic factors|mesh-ancestor
44090606|NCT00030433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090607|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090608|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090609|NCT00030446|Carboplatin|carboplatin|mesh-list
44090610|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44090611|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090612|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090613|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090614|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090615|NCT00030459|Cisplatin|cisplatin|mesh-list
44259939|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44259940|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44259941|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
44259942|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44259943|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090616|NCT00030459|Vinorelbine|vinorelbine|mesh-list
44090617|NCT00030459|Mitomycins|mitomycins|mesh-list
44090618|NCT00030459|Mitomycin|mitomycin|mesh-list
44090619|NCT00030459|Vinblastine|vinblastine|mesh-list
44090620|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090621|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090622|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090623|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090624|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090625|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090626|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090627|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
44090628|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44090629|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090630|NCT00030472|Doxorubicin|doxorubicin|mesh-list
44090631|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090632|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090633|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43589718|NCT03377335|Metformin|metformin|mesh-list
43762289|NCT02432833|Tacrolimus|tacrolimus|mesh-list
43762290|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762291|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
43762292|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762293|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43762294|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762295|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762296|NCT02432872|Cytarabine|cytarabine|mesh-list
43762297|NCT02432872|Daunorubicin|daunorubicin|mesh-list
43762298|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090638|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44090639|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090640|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090641|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090642|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090643|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44090644|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090645|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090646|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090647|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090650|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090651|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090652|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090653|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090654|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
44090655|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090656|NCT00030524|Gefitinib|gefitinib|mesh-list
44090657|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090658|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090659|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090660|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090661|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44090662|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090663|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090664|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090665|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090666|NCT00030550|Thalidomide|thalidomide|mesh-list
44090667|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090668|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
44090669|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090670|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
44090671|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090672|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090673|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44090674|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44090675|NCT00030550|Growth Substances|growth substances|mesh-ancestor
44090676|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
44090677|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090678|NCT00030563|Irinotecan|irinotecan|mesh-list
44090679|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090680|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090681|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090682|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090683|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090684|NCT00030576|Cisplatin|cisplatin|mesh-list
44259944|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
44259945|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
44259946|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44259947|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44259948|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44259949|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
44259950|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259951|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44259952|NCT00636922|Everolimus|everolimus|mesh-list
44259953|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259954|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44259955|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
44259956|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259957|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44090685|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44090686|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090687|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090688|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090689|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090690|NCT00030589|Bexarotene|bexarotene|mesh-list
44090691|NCT00030589|Methoxsalen|methoxsalen|mesh-list
44090692|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090693|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44090694|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090695|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
44090696|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44090697|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
44090698|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090699|NCT00030615|Decitabine|decitabine|mesh-list
44090700|NCT00030615|Azacitidine|azacitidine|mesh-list
44090701|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090705|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090706|NCT00030641|Docetaxel|docetaxel|mesh-list
44090707|NCT00030641|Oblimersen|oblimersen|mesh-list
44090708|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090709|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807859|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44090710|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090711|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090712|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090713|NCT00030654|Ketoconazole|ketoconazole|mesh-list
44090714|NCT00030654|Vinblastine|vinblastine|mesh-list
44090715|NCT00030654|Docetaxel|docetaxel|mesh-list
44090716|NCT00030654|Doxorubicin|doxorubicin|mesh-list
44090717|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090718|NCT00030654|Bicalutamide|bicalutamide|mesh-list
44090719|NCT00030654|Flutamide|flutamide|mesh-list
44090720|NCT00030654|Estramustine|estramustine|mesh-list
44090721|NCT00030654|Hormones|hormones|mesh-list
44090722|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090723|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090724|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090725|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090726|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090727|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090728|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090729|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090730|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090731|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090732|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090733|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090734|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
44090735|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090736|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44259958|NCT00636935|Clindamycin|clindamycin|mesh-list
44259959|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
44259960|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
44259961|NCT00636935|Dapsone|dapsone|mesh-list
43762423|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762424|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762493|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762494|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762495|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43762496|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43762497|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
43762533|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259962|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43825198|NCT05504083|Benzbromarone|benzbromarone|mesh-list
44090737|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44090738|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44090739|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44090740|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44090741|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
44090742|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44090743|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090744|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
44090745|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
44090746|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090747|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090748|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090749|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152389|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152390|NCT00216827|Betamethasone|betamethasone|mesh-list
44152391|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
44152392|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44152393|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
44152394|NCT00216827|Calcipotriene|calcipotriene|mesh-list
44152395|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44152396|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152397|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
44152398|NCT00216827|Hormones|hormones|mesh-ancestor
44152399|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152400|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152401|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44152402|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152403|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152404|NCT00216840|Betamethasone|betamethasone|mesh-list
44152405|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
44152406|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44152407|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
44152408|NCT00216840|Calcipotriene|calcipotriene|mesh-list
44152409|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44152410|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152411|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
44152415|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44152416|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152417|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152418|NCT00216866|Dalteparin|dalteparin|mesh-list
44152419|NCT00216866|Tinzaparin|tinzaparin|mesh-list
44152420|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44152421|NCT00216866|Warfarin|warfarin|mesh-list
43807933|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152422|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
44090750|NCT00030693|Metronidazole|metronidazole|mesh-list
44090752|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
44090753|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090754|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716285|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43716286|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43716287|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716288|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716322|NCT02654665|Incretins|incretins|mesh-ancestor
43716323|NCT02654665|Hormones|hormones|mesh-ancestor
43716324|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716325|NCT02654730|Piperaquine|piperaquine|mesh-list
44090755|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44090756|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44090757|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44090758|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
44090759|NCT00030719|Melphalan|melphalan|mesh-list
44090760|NCT00030719|Busulfan|busulfan|mesh-list
44090761|NCT00030719|Carboplatin|carboplatin|mesh-list
44090762|NCT00030719|Etoposide|etoposide|mesh-list
44090763|NCT00030719|Vincristine|vincristine|mesh-list
44090764|NCT00030719|Dinutuximab|dinutuximab|mesh-list
44090765|NCT00030719|Isotretinoin|isotretinoin|mesh-list
44090767|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44090768|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090769|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
44090770|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090771|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090772|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44259963|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44259964|NCT00636935|Primaquine|primaquine|mesh-list
44259965|NCT00636935|Trimethoprim|trimethoprim|mesh-list
44259966|NCT00636935|Atovaquone|atovaquone|mesh-list
44259967|NCT00636935|Pentamidine|pentamidine|mesh-list
44259968|NCT00636935|Prednisone|prednisone|mesh-list
44090773|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
44090774|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090775|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090776|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090777|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090778|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090779|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090780|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090781|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090782|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090783|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090784|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090785|NCT00030732|Gemcitabine|gemcitabine|mesh-list
44090786|NCT00030732|Capecitabine|capecitabine|mesh-list
44090787|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090788|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
44090789|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090790|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090791|NCT00030732|Antiviral Agents|antiviral agents|mesh-ancestor
44090792|NCT00030732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090793|NCT00030732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090794|NCT00030732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090795|NCT00030732|Immunologic Factors|immunologic factors|mesh-ancestor
44090796|NCT00030732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090797|NCT00030745|Gemcitabine|gemcitabine|mesh-list
44090798|NCT00030745|Cisplatin|cisplatin|mesh-list
44090799|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090800|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090801|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
44090802|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090803|NCT00030745|Antiviral Agents|antiviral agents|mesh-ancestor
43762708|NCT02429973|Antiviral Agents|antiviral agents|mesh-ancestor
43762709|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762710|NCT02429973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762711|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762712|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
43762713|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762714|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762715|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762716|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
43762717|NCT02429960|Remifentanil|remifentanil|mesh-list
43553891|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553892|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44090804|NCT00030745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090805|NCT00030745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090806|NCT00030745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090807|NCT00030745|Immunologic Factors|immunologic factors|mesh-ancestor
44090808|NCT00030745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090809|NCT00030758|Lenograstim|lenograstim|mesh-list
44090810|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44090811|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
44090812|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090813|NCT00030784|Doxorubicin|doxorubicin|mesh-list
44090814|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44090824|NCT00030797|Irinotecan|irinotecan|mesh-list
44090825|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090826|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090827|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090828|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090829|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090830|NCT00030810|Cisplatin|cisplatin|mesh-list
44090831|NCT00030810|Docetaxel|docetaxel|mesh-list
44090832|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090833|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090834|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090835|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090836|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090837|NCT00030849|Interferons|interferons|mesh-list
44090838|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
44090839|NCT00030849|Bexarotene|bexarotene|mesh-list
44090840|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090841|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
44090842|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090843|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
44090844|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090845|NCT00030862|Cisplatin|cisplatin|mesh-list
44090846|NCT00030862|Irinotecan|irinotecan|mesh-list
44090847|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090848|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44090849|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44259969|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44259970|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
44259971|NCT00636935|Hormones|hormones|mesh-ancestor
43825205|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44090850|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090851|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090852|NCT00030875|Bortezomib|bortezomib|mesh-list
44090853|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090854|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44090855|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762741|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762742|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43837538|NCT04903509|Acetaminophen|acetaminophen|mesh-list
43762743|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762744|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
43762745|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
43762746|NCT02429726|Cisplatin|cisplatin|mesh-list
43762747|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762748|NCT02429700|Paclitaxel|paclitaxel|mesh-list
43762749|NCT02429700|Etoposide|etoposide|mesh-list
43762750|NCT02429700|Cisplatin|cisplatin|mesh-list
43762751|NCT02429700|Carboplatin|carboplatin|mesh-list
43651496|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
43651497|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
43651498|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44090856|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090857|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090858|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090859|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44090860|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44090861|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
44090862|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44090863|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44090864|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44090865|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090866|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090867|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090868|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44090869|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
44090870|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44090871|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44090872|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44090873|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44090874|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
44090875|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44090876|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44090877|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43589997|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
44090883|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090885|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44090886|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090887|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090888|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
44090889|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090890|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090891|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
44090892|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
44090893|NCT00031018|Donepezil|donepezil|mesh-list
44090894|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44090895|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090896|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090897|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
44090898|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090899|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090900|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
44090901|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
44090902|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090903|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090904|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
44090905|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44090906|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44090907|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090908|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44090909|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44090910|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
44090911|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090912|NCT00031057|Riboflavin|riboflavin|mesh-list
44090913|NCT00031057|Thiamine|thiamine|mesh-list
44090914|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
44090915|NCT00031057|Vitamins|vitamins|mesh-ancestor
44090916|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
44090917|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090918|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44090919|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090920|NCT00031070|Cyclosporine|cyclosporine|mesh-list
44090921|NCT00031070|Lamivudine|lamivudine|mesh-list
44259972|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44259973|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259974|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44259975|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259976|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44259977|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
44259978|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44259979|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655983|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
44090922|NCT00031070|Zidovudine|zidovudine|mesh-list
44090923|NCT00031070|Efavirenz|efavirenz|mesh-list
44090924|NCT00031070|Abacavir|abacavir|mesh-list
44090925|NCT00031070|Vaccines|vaccines|mesh-list
44090926|NCT00031070|Cyclosporins|cyclosporins|mesh-list
44090927|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44090928|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
44090929|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090930|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090931|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090932|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090933|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
44090934|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090935|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090936|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090937|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44090938|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44090939|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44090940|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
44090941|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44090942|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44090943|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
44090944|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44090945|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44090946|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44090947|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44090948|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44090954|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090955|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
44090956|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090957|NCT00031096|Azelaic acid|azelaic acid|mesh-list
44090958|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090959|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090960|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44090961|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44090962|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
44090963|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090964|NCT00031109|Antacids|antacids|mesh-ancestor
44090965|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090966|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090967|NCT00031135|Choline|choline|mesh-list
44090968|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
44090969|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44090970|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
44090971|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090972|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44090973|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44090974|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
44090975|NCT00031148|Mitogens|mitogens|mesh-list
44090976|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090977|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090978|NCT00031161|Nitisinone|nitisinone|mesh-list
44090979|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090980|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090981|NCT00031187|Docetaxel|docetaxel|mesh-list
44090982|NCT00031187|Doxorubicin|doxorubicin|mesh-list
44090983|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
44259980|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44259981|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
44259982|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44259983|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44259984|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44259985|NCT00636935|Renal Agents|renal agents|mesh-ancestor
44259986|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44259987|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44259988|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44259989|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43716572|NCT02652793|Lamivudine|lamivudine|mesh-list
44259990|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
44090984|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090985|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090986|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
44090987|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
44090988|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090989|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090990|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090991|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090992|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090993|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
44090994|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090995|NCT00031278|Trastuzumab|trastuzumab|mesh-list
44090996|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44090997|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090998|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
44090999|NCT00031291|Antibodies|antibodies|mesh-list
44091000|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
44091001|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44091002|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44091003|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
44091004|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091005|NCT00031317|Clozapine|clozapine|mesh-list
44091006|NCT00031317|Paroxetine|paroxetine|mesh-list
44091007|NCT00031317|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44091008|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44091009|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091010|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091011|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091012|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
44091013|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091014|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44091015|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
44091016|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091017|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44091018|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44091019|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091029|NCT00031395|Clonidine|clonidine|mesh-list
44091030|NCT00031395|Methylphenidate|methylphenidate|mesh-list
44091031|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44091032|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091033|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44091034|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44091035|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091036|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091037|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
44091038|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091039|NCT00031395|Analgesics|analgesics|mesh-ancestor
44091040|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
44091041|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091042|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44091043|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
44259991|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
44259992|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44259994|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44259995|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44259996|NCT00637026|Gefitinib|gefitinib|mesh-list
44259997|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44259998|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091044|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
44091045|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44091046|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44091047|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44091048|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
44091049|NCT00031434|Valganciclovir|valganciclovir|mesh-list
44091050|NCT00031434|Ganciclovir|ganciclovir|mesh-list
44091051|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44091052|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
44091053|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091054|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44091055|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091056|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091057|NCT00031473|Ribavirin|ribavirin|mesh-list
44091058|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
44091059|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091060|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
44091061|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091062|NCT00031499|Azithromycin|azithromycin|mesh-list
44091063|NCT00031499|Doxycycline|doxycycline|mesh-list
44091064|NCT00031499|Penicillins|penicillins|mesh-list
44091065|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44091066|NCT00031499|Penicillin G|penicillin g|mesh-list
44091067|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
44091068|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091069|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091070|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
44091071|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44091072|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44091073|NCT00031564|Aldesleukin|aldesleukin|mesh-list
44091074|NCT00031564|Interleukin-2|interleukin-2|mesh-list
44091075|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091076|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091077|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44091078|NCT00031564|Analgesics|analgesics|mesh-ancestor
44091079|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
44091080|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091081|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44091082|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44091083|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
44091084|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091085|NCT00031577|Paclitaxel|paclitaxel|mesh-list
44091086|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091087|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091088|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091093|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
44091094|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
44091095|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091096|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091097|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091098|NCT00031629|Gemcitabine|gemcitabine|mesh-list
44091099|NCT00031629|Docetaxel|docetaxel|mesh-list
44091100|NCT00031629|Lenograstim|lenograstim|mesh-list
44091101|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091102|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
44091103|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091104|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091105|NCT00031629|Antiviral Agents|antiviral agents|mesh-ancestor
44091106|NCT00031629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091107|NCT00031629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091108|NCT00031629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091109|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
44260000|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260001|NCT00637065|Bosentan|bosentan|mesh-list
44260002|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44091110|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091111|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091112|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091113|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091114|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091115|NCT00031642|Rituximab|rituximab|mesh-list
44091116|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44091117|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091118|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
44091119|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091120|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091121|NCT00031655|Cyclosporine|cyclosporine|mesh-list
44091122|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
44091123|NCT00031655|Fludarabine|fludarabine|mesh-list
44091124|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
44091125|NCT00031655|Cyclosporins|cyclosporins|mesh-list
44091126|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091127|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091128|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
44091129|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091130|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091131|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
44091132|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091133|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091134|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
44091135|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091136|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
44091137|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091138|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44091139|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091140|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44091141|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
44091142|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091143|NCT00031681|Irinotecan|irinotecan|mesh-list
44091144|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44091145|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44091146|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091147|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091148|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091149|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091150|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091151|NCT00031707|Megestrol|megestrol|mesh-list
44091152|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
44091153|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44091154|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44091155|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44091156|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
44091157|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44091158|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091159|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43590274|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44091167|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091168|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091169|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091170|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091171|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091172|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44091173|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44091174|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44091175|NCT00031733|Interleukin-12|interleukin-12|mesh-list
44091176|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44091177|NCT00031733|Sargramostim|sargramostim|mesh-list
44091178|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
44091179|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
44091180|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
44091181|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091182|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260003|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44260004|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260005|NCT00637078|Amlodipine|amlodipine|mesh-list
44260006|NCT00637078|Spironolactone|spironolactone|mesh-list
43824635|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260007|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44260008|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44260009|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260010|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260011|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44091183|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091184|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44091185|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44091186|NCT00031733|Growth Substances|growth substances|mesh-ancestor
44091187|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
44091188|NCT00031733|Antacids|antacids|mesh-ancestor
44091189|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091190|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44091191|NCT00031746|Caseins|caseins|mesh-list
44091192|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
44091193|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
44091194|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091195|NCT00031759|Imiquimod|imiquimod|mesh-list
44091196|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091197|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
44091198|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091199|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091200|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
44091201|NCT00031785|Megestrol|megestrol|mesh-list
44091202|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
44091203|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44091204|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44091205|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44091206|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
44091207|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44091208|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091209|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44091210|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44091211|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091212|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091213|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
44091214|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44091215|NCT00031798|Methylphenidate|methylphenidate|mesh-list
44091216|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44091217|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091218|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44091219|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44091220|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091221|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091222|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
44091223|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091224|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44091225|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44091227|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091228|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091229|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44091231|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44091232|NCT00031824|Cyclosporine|cyclosporine|mesh-list
44091233|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
44091234|NCT00031824|Prednisone|prednisone|mesh-list
44091235|NCT00031824|Tacrolimus|tacrolimus|mesh-list
44091236|NCT00031824|Cyclosporins|cyclosporins|mesh-list
44091237|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091238|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
44260012|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260013|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
44260014|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44260015|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
43656018|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44091239|NCT00031824|Hormones|hormones|mesh-ancestor
44091240|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091241|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091242|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091243|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091244|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091245|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
44091246|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44091247|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091248|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091249|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
44091250|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091251|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
44091252|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091253|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
44091254|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44091255|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44091256|NCT00031837|Gemcitabine|gemcitabine|mesh-list
44091257|NCT00031837|Dalteparin|dalteparin|mesh-list
44091258|NCT00031837|Tinzaparin|tinzaparin|mesh-list
44091259|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44091260|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091261|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
44091262|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091263|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091264|NCT00031837|Antiviral Agents|antiviral agents|mesh-ancestor
44091265|NCT00031837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091266|NCT00031837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091267|NCT00031837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091268|NCT00031837|Immunologic Factors|immunologic factors|mesh-ancestor
44091269|NCT00031837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091270|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
44091271|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44091272|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44091273|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44091274|NCT00031850|Goserelin|goserelin|mesh-list
44091275|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091276|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091277|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44091278|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091279|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152423|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43808287|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
44091280|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091281|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44091282|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44091283|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44091284|NCT00031863|Rofecoxib|rofecoxib|mesh-list
44091285|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44091286|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44091287|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091288|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091289|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44091291|NCT00031863|Analgesics|analgesics|mesh-ancestor
44091292|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
44091293|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091294|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091295|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091296|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091297|NCT00031876|Paclitaxel|paclitaxel|mesh-list
44091341|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091342|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091343|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091344|NCT00031928|Mafosfamide|mafosfamide|mesh-list
44260016|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44260017|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44260018|NCT00637078|Diuretics|diuretics|mesh-ancestor
44260019|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
44260020|NCT00637091|Irinotecan|irinotecan|mesh-list
44260021|NCT00637091|Cetuximab|cetuximab|mesh-list
44260022|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44260023|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44260024|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260025|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260026|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260027|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260028|NCT00637104|Chromium|chromium|mesh-list
44260029|NCT00637104|Trace Elements|trace elements|mesh-ancestor
44260030|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
44260031|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260032|NCT00637117|Interferons|interferons|mesh-list
44260033|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
44260034|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260035|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
44260036|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260037|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
44260038|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260039|NCT00637143|Cyclosporine|cyclosporine|mesh-list
44260040|NCT00637143|Tacrolimus|tacrolimus|mesh-list
44260041|NCT00637143|Cyclosporins|cyclosporins|mesh-list
44260042|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260043|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
44091345|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091346|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
44091347|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091348|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091349|NCT00031941|Lenalidomide|lenalidomide|mesh-list
44091350|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
44091351|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091352|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44091353|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44091354|NCT00031941|Growth Substances|growth substances|mesh-ancestor
44091355|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
44091356|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091357|NCT00031954|Gemcitabine|gemcitabine|mesh-list
44091358|NCT00031954|Paclitaxel|paclitaxel|mesh-list
44091359|NCT00031954|Carboplatin|carboplatin|mesh-list
44091360|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091361|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091362|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091363|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091364|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091365|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260044|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260045|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44260046|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260047|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091366|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091367|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
44091368|NCT00031954|Antiviral Agents|antiviral agents|mesh-ancestor
44091369|NCT00031954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091370|NCT00031954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091371|NCT00031954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091372|NCT00031954|Immunologic Factors|immunologic factors|mesh-ancestor
44091373|NCT00031954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091374|NCT00031967|Melatonin|melatonin|mesh-list
44091375|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
44091376|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091377|NCT00031967|Protective Agents|protective agents|mesh-ancestor
44091378|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091379|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091380|NCT00031980|Cyclosporine|cyclosporine|mesh-list
44091381|NCT00031980|Cyclosporins|cyclosporins|mesh-list
44091382|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091383|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091384|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091385|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
44091386|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091387|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
44091388|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091389|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
44091390|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091391|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44091392|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44091393|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091394|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091395|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091396|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091397|NCT00032019|Prednisone|prednisone|mesh-list
44091398|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
44091399|NCT00032019|Rituximab|rituximab|mesh-list
44091404|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091406|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091407|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091408|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44091409|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
44091410|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091411|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091412|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44091413|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44091414|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091415|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44091416|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091417|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091418|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091419|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
44091420|NCT00032019|Hormones|hormones|mesh-ancestor
44091421|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091422|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091423|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091424|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091425|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091426|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091427|NCT00032032|Paclitaxel|paclitaxel|mesh-list
44091428|NCT00032032|Carboplatin|carboplatin|mesh-list
44091429|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091430|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091431|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091432|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091433|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091434|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091435|NCT00032045|Ipilimumab|ipilimumab|mesh-list
44091436|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
44260048|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
44260049|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260050|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
44260051|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260052|NCT00637182|Anastrozole|anastrozole|mesh-list
44260053|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44260054|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260055|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44260056|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44091437|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44091438|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091439|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44091440|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091441|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091442|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
44091443|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091445|NCT00032084|Nicotine|nicotine|mesh-list
44091446|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44091447|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
44091448|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091449|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091450|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44091451|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44091452|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
44091453|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091454|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091455|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44091456|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
44091457|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091458|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44091459|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44091460|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091461|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
44091462|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44091463|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44091464|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091465|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
44091466|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091467|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44091468|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
44091469|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43590583|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
44091478|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091480|NCT00032136|Exemestane|exemestane|mesh-list
44091481|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091482|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44091483|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091484|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091485|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091486|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091487|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091488|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44091489|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44091490|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44091491|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44091492|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44091493|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091494|NCT00032149|Prednisolone|prednisolone|mesh-list
44091495|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
44091496|NCT00032149|Etoposide|etoposide|mesh-list
44091497|NCT00032149|Vincristine|vincristine|mesh-list
44091498|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
44091499|NCT00032149|Bleomycin|bleomycin|mesh-list
44091500|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091501|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
44260057|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260058|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260059|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44260060|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
44260061|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091502|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091503|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091504|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44091506|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091507|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091508|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44091509|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091510|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44091511|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091512|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091513|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091514|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091515|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091516|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091517|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
44091518|NCT00032149|Hormones|hormones|mesh-ancestor
44091519|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091520|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091521|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091522|NCT00032149|Analgesics|analgesics|mesh-ancestor
44091523|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
44091524|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091525|NCT00032162|Carboplatin|carboplatin|mesh-list
44091526|NCT00032162|Doxorubicin|doxorubicin|mesh-list
44091527|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44091528|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091529|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091530|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44091531|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091532|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091533|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091534|NCT00032175|Gemcitabine|gemcitabine|mesh-list
44091535|NCT00032175|Capecitabine|capecitabine|mesh-list
44091541|NCT00032175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091542|NCT00032175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091543|NCT00032175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091544|NCT00032175|Immunologic Factors|immunologic factors|mesh-ancestor
44091545|NCT00032175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091546|NCT00032188|Aldesleukin|aldesleukin|mesh-list
44091547|NCT00032188|Interleukin-2|interleukin-2|mesh-list
44091548|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
44091549|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091550|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44091551|NCT00032188|Analgesics|analgesics|mesh-ancestor
44091552|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
44091553|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091554|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091555|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44091556|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44091557|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
44091558|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762935|NCT02428751|Prednisone|prednisone|mesh-list
44091559|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44091560|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
44152424|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44152425|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152426|NCT00216879|Betamethasone|betamethasone|mesh-list
44152427|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
44152428|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44152429|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
44152430|NCT00216879|Calcipotriene|calcipotriene|mesh-list
44152431|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44152432|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152433|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
44152434|NCT00216879|Hormones|hormones|mesh-ancestor
44260062|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260063|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
44260064|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
43656040|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
44152435|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152436|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152437|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44152438|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152439|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152440|NCT00216892|Betamethasone|betamethasone|mesh-list
44152441|NCT00216892|Calcipotriene|calcipotriene|mesh-list
44091561|NCT00032279|Visilizumab|visilizumab|mesh-list
44091562|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
44091563|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091564|NCT00032292|Visilizumab|visilizumab|mesh-list
44091565|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
44091566|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091567|NCT00032305|Visilizumab|visilizumab|mesh-list
44091568|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
44091569|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091570|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44091571|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091572|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
44091573|NCT00032396|Hormones|hormones|mesh-ancestor
44091574|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091575|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091576|NCT00032734|Satavaptan|satavaptan|mesh-list
44091577|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44091578|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091579|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
44091580|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091581|NCT00032747|Vasopressins|vasopressins|mesh-list
44091582|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
44091583|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
44091584|NCT00032747|Coagulants|coagulants|mesh-ancestor
44091585|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44091586|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44091587|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
44091588|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091604|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091605|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091606|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44091607|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
44091608|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091609|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091610|NCT00032825|Ketoconazole|ketoconazole|mesh-list
44091611|NCT00032825|Docetaxel|docetaxel|mesh-list
44091612|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091613|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091614|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091615|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091616|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091617|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
44091618|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091619|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44091620|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44091621|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091622|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44091623|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091624|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091625|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554203|NCT03574064|Glucagon|glucagon|mesh-list
44091626|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44091627|NCT00032838|Yohimbine|yohimbine|mesh-list
44091628|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
44091629|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
44091630|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091631|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091632|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44091633|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44091634|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44260065|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44260066|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44091636|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091637|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091638|NCT00032838|Urological Agents|urological agents|mesh-ancestor
44091639|NCT00032890|Celecoxib|celecoxib|mesh-list
44091640|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44091641|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44091642|NCT00032890|Analgesics|analgesics|mesh-ancestor
44091643|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
44091644|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091645|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091646|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091647|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091662|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091664|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44091665|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44091666|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091667|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
44091668|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091669|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44091670|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44091671|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44091672|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
44091673|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091674|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091675|NCT00032955|Buprenorphine|buprenorphine|mesh-list
44091676|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44091677|NCT00032955|Naloxone|naloxone|mesh-list
44091678|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44091679|NCT00032955|Narcotics|narcotics|mesh-ancestor
44091680|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091681|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091682|NCT00032955|Analgesics|analgesics|mesh-ancestor
44091683|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
44091684|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091685|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44091686|NCT00032968|Buprenorphine|buprenorphine|mesh-list
44091687|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44091688|NCT00032968|Naloxone|naloxone|mesh-list
44091689|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44091690|NCT00032968|Narcotics|narcotics|mesh-ancestor
44091691|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091692|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091693|NCT00032968|Analgesics|analgesics|mesh-ancestor
44091694|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
44091695|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091696|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44091697|NCT00033033|Reserpine|reserpine|mesh-list
44091698|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44091699|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44091700|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44091701|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091702|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091703|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091704|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44091705|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43590846|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091716|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091718|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43762939|NCT02428751|Vincristine|vincristine|mesh-list
44091719|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44091720|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44091721|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091722|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091723|NCT00033072|Selegiline|selegiline|mesh-list
44091724|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
44091725|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091726|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44091727|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44091728|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44260067|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260068|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260069|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44260070|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44260072|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44260073|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44260074|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
44260075|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260076|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260077|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260078|NCT00637325|Trastuzumab|trastuzumab|mesh-list
44260079|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260080|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461891|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44461892|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461893|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461894|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461895|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
44461896|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44461897|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
44461898|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
44461899|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461900|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
44461901|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44461902|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44461903|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44461904|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44461905|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44461906|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461907|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461908|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461915|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656048|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
44091729|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091730|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091731|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44091732|NCT00033072|Protective Agents|protective agents|mesh-ancestor
44091733|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091734|NCT00033085|Ondansetron|ondansetron|mesh-list
44091735|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
44091736|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
44091737|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091738|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091739|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44091740|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
44091741|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
44091742|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44091743|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
44091744|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091745|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091746|NCT00033085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44091747|NCT00033085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44091748|NCT00033085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091749|NCT00033085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091750|NCT00033085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44091751|NCT00033098|Metyrapone|metyrapone|mesh-list
44091752|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
44091753|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091754|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091755|NCT00033111|Cabergoline|cabergoline|mesh-list
44091756|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44091757|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44091758|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
44091759|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
44091760|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091761|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091762|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091763|NCT00033163|Tenofovir|tenofovir|mesh-list
44091764|NCT00033163|Adefovir|adefovir|mesh-list
44091765|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44091766|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
44091767|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091768|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44091769|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44091778|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091779|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
44091780|NCT00033176|Vitamins|vitamins|mesh-ancestor
44091781|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
44091782|NCT00033189|Ubiquinone|ubiquinone|mesh-list
44091783|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
44091784|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
44091785|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091787|NCT00033215|S 3304|s 3304|mesh-list
44091788|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44091789|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44091790|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091791|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091792|NCT00033241|Gemcitabine|gemcitabine|mesh-list
44091793|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44091794|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091795|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
44091796|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091797|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091798|NCT00033241|Antiviral Agents|antiviral agents|mesh-ancestor
44091799|NCT00033241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091800|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091801|NCT00033241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091802|NCT00033241|Immunologic Factors|immunologic factors|mesh-ancestor
44091803|NCT00033241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091804|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091805|NCT00033254|Thalidomide|thalidomide|mesh-list
44091806|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091807|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
44091808|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091809|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
44461916|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461917|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
44461918|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091810|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091811|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091812|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44091813|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44091814|NCT00033254|Growth Substances|growth substances|mesh-ancestor
44091815|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
44091816|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091817|NCT00033267|Sirolimus|sirolimus|mesh-list
44091818|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091819|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091820|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091821|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091822|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
44091823|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091824|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
44091825|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091826|NCT00033280|Temozolomide|temozolomide|mesh-list
44091827|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44091828|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
44091829|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091830|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091831|NCT00033306|Irinotecan|irinotecan|mesh-list
44091832|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44091833|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091834|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091835|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091836|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091837|NCT00033319|Aspirin|aspirin|mesh-list
44091838|NCT00033319|Folic Acid|folic acid|mesh-list
44091843|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091844|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44091845|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44091846|NCT00033319|Analgesics|analgesics|mesh-ancestor
44091847|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
44091848|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091849|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091850|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091851|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44091852|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44091853|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091854|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44091855|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44091856|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091857|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
44091858|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
44091859|NCT00033332|Pamidronate|pamidronate|mesh-list
44091860|NCT00033332|Thalidomide|thalidomide|mesh-list
44091861|NCT00033332|Dexamethasone|dexamethasone|mesh-list
44091862|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091863|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
44091864|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
44091865|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091866|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091867|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44091869|NCT00033332|Hormones|hormones|mesh-ancestor
44091870|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091871|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091872|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091873|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091874|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
44091875|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
44091876|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44091877|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091878|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44091879|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44091880|NCT00033332|Growth Substances|growth substances|mesh-ancestor
44091881|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44091882|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44091883|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
44091884|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44461919|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44461920|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44461921|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44091885|NCT00033345|Protective Agents|protective agents|mesh-ancestor
44091886|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091887|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091888|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44091889|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44091890|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
44091891|NCT00033358|Norgestrel|norgestrel|mesh-list
44091892|NCT00033358|Estradiol|estradiol|mesh-list
44091893|NCT00033358|Estrogens|estrogens|mesh-ancestor
44091894|NCT00033358|Hormones|hormones|mesh-ancestor
44091895|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091896|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091897|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44091898|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
44091899|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44091900|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44091901|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44091902|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44091903|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44091904|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44091905|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091906|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091907|NCT00033410|Paclitaxel|paclitaxel|mesh-list
44091908|NCT00033410|Carboplatin|carboplatin|mesh-list
44091909|NCT00033410|Tirapazamine|tirapazamine|mesh-list
44091910|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091911|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591042|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
44091920|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091922|NCT00033436|Niacinamide|niacinamide|mesh-list
44091923|NCT00033436|Niacin|niacin|mesh-list
44091924|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
44091925|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
44091926|NCT00033436|Vitamins|vitamins|mesh-ancestor
44091927|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
44091928|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091929|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44091930|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
44091931|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091932|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44091933|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
44091934|NCT00033449|Cisplatin|cisplatin|mesh-list
44091935|NCT00033449|Gefitinib|gefitinib|mesh-list
44091936|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091937|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091938|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091939|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091940|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44091941|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091942|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091943|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091944|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091946|NCT00033553|Paclitaxel|paclitaxel|mesh-list
44091947|NCT00033553|Carboplatin|carboplatin|mesh-list
44091948|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091949|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091950|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091951|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091952|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091953|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091954|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091955|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
44091956|NCT00033553|Antiviral Agents|antiviral agents|mesh-ancestor
44091957|NCT00033553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091958|NCT00033553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091959|NCT00033553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44091960|NCT00033553|Immunologic Factors|immunologic factors|mesh-ancestor
44091961|NCT00033553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091962|NCT00033566|S 3304|s 3304|mesh-list
44091963|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44461922|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44461923|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461924|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44461925|NCT01536704|Nicotine|nicotine|mesh-list
44461926|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44091964|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
44091965|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091966|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091967|NCT00033592|Bupropion|bupropion|mesh-list
44091968|NCT00033592|Nicotine|nicotine|mesh-list
44091969|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44091970|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
44091971|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44091972|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091973|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44091974|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44091975|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
44091976|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091977|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091978|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44092004|NCT00033644|Dacarbazine|dacarbazine|mesh-list
44092005|NCT00033644|Sargramostim|sargramostim|mesh-list
44092006|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092007|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44092008|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44092009|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092010|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808819|NCT05189730|Paclitaxel|paclitaxel|mesh-list
44092011|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092012|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
44092013|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092014|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
44092015|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092016|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44092017|NCT00033683|Tamoxifen|tamoxifen|mesh-list
44092018|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
44092019|NCT00033683|Docetaxel|docetaxel|mesh-list
44092020|NCT00033683|Fluorouracil|fluorouracil|mesh-list
44092021|NCT00033683|Methotrexate|methotrexate|mesh-list
44092022|NCT00033683|Epirubicin|epirubicin|mesh-list
44092023|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092024|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
44092025|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092026|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092027|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43763021|NCT02429050|Morphine|morphine|mesh-list
44092028|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
43591181|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
44092033|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092034|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092035|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
44092036|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092037|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44092038|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
44092039|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44092040|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
44092041|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092042|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092043|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092044|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44092045|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44092046|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092047|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44092048|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092049|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092050|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44092051|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44092052|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44092053|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44092054|NCT00033696|Paclitaxel|paclitaxel|mesh-list
44461927|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
44461928|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461929|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461930|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44461931|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44461932|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
44461933|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461934|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461935|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44461936|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44461937|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
44092055|NCT00033696|Etoposide|etoposide|mesh-list
44092056|NCT00033696|Carboplatin|carboplatin|mesh-list
44092057|NCT00033696|Topotecan|topotecan|mesh-list
44092058|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092059|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092060|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092061|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092062|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092063|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092064|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44092065|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092066|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092067|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44092068|NCT00033709|Thalidomide|thalidomide|mesh-list
44092069|NCT00033709|Temozolomide|temozolomide|mesh-list
44092070|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44092071|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
44092072|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092073|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092074|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092075|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
44092076|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092077|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
44092078|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092079|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092080|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44092081|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44092082|NCT00033709|Growth Substances|growth substances|mesh-ancestor
44092083|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
44092084|NCT00033722|Folic Acid|folic acid|mesh-list
44092085|NCT00033722|Lometrexol|lometrexol|mesh-list
44092086|NCT00033722|Hematinics|hematinics|mesh-ancestor
44092087|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
44092088|NCT00033722|Vitamins|vitamins|mesh-ancestor
44092089|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
44092090|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092091|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092092|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
44092093|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092094|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092095|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092096|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092097|NCT00033735|Fluorouracil|fluorouracil|mesh-list
44092098|NCT00033735|Irofulven|irofulven|mesh-list
44092099|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
44092111|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44092112|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
44092113|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092114|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092115|NCT00033813|Oxatomide|oxatomide|mesh-list
44092116|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44092117|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
44092118|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
44092119|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700517|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
44461938|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461939|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461940|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44461941|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
44092120|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092121|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092122|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44092123|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44092124|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152442|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152444|NCT00216892|Hormones|hormones|mesh-ancestor
44152445|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152446|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152447|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44152448|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152449|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152450|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44152451|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44152452|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152453|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152454|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152455|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152456|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152457|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152458|NCT00216931|Iloprost|iloprost|mesh-list
44152459|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44152460|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44152461|NCT00217009|Furocoumarins|furocoumarins|mesh-list
44152462|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152463|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44152464|NCT00217048|Yohimbine|yohimbine|mesh-list
44152465|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
44152466|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
44152467|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152468|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152469|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44152470|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44152471|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44152472|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152473|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152474|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152475|NCT00217048|Urological Agents|urological agents|mesh-ancestor
44152476|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
44152477|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43591308|NCT03363477|Enoxaparin|enoxaparin|mesh-list
44092131|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092132|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44092133|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44092134|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44092135|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44092136|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092137|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092138|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092139|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44092140|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092141|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092142|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092144|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44092145|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
44092146|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44092147|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092148|NCT00034060|Etanercept|etanercept|mesh-list
44092149|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44092150|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44092151|NCT00034060|Analgesics|analgesics|mesh-ancestor
44092152|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
44092153|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461942|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44461943|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44461944|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44461945|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
44461946|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656064|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092154|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092155|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44092156|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092157|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092158|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092159|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
44092161|NCT00034086|Lopinavir|lopinavir|mesh-list
44092162|NCT00034086|Tenofovir|tenofovir|mesh-list
44092163|NCT00034086|Lamivudine|lamivudine|mesh-list
44092164|NCT00034086|Zidovudine|zidovudine|mesh-list
44092165|NCT00034086|Didanosine|didanosine|mesh-list
44092166|NCT00034086|Stavudine|stavudine|mesh-list
44092167|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44092168|NCT00034086|Vaccines|vaccines|mesh-list
44092169|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44092170|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
44092171|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092172|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44092173|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44092174|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
44092175|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092176|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092177|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44092178|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44092179|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
44092180|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092181|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44092182|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092183|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44092184|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092185|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
44092186|NCT00034125|Tamoxifen|tamoxifen|mesh-list
44092187|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44092188|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092189|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43591377|NCT03362905|Lidocaine|lidocaine|mesh-list
44092195|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44092196|NCT00034138|Oregovomab|oregovomab|mesh-list
43809017|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092197|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44092198|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092199|NCT00034151|Paclitaxel|paclitaxel|mesh-list
44092200|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092201|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092202|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092203|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092204|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092205|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092206|NCT00034164|Paclitaxel|paclitaxel|mesh-list
43763029|NCT02428972|Propofol|propofol|mesh-list
44092207|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092208|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092209|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092210|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092211|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092212|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092213|NCT00034177|Paclitaxel|paclitaxel|mesh-list
44092214|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44092215|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092216|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092217|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092218|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092219|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092220|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461947|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461949|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44461950|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43656072|NCT02963454|Simendan|simendan|mesh-list
44092221|NCT00034190|Paclitaxel|paclitaxel|mesh-list
44092222|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092223|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092224|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092225|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092226|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092227|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092228|NCT00034229|Felbamate|felbamate|mesh-list
44092229|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
44092230|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44092231|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44092232|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092233|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092234|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092235|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
44092236|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44092237|NCT00034242|Antibodies|antibodies|mesh-list
44092238|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
44092239|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44092240|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
44092241|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092242|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
44092243|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44092244|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092245|NCT00034346|Paclitaxel|paclitaxel|mesh-list
44092246|NCT00034346|Carboplatin|carboplatin|mesh-list
44092247|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092248|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092249|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092250|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092251|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092252|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092253|NCT00034359|Lamivudine|lamivudine|mesh-list
44092254|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44092255|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092256|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092259|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092260|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44092261|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44092262|NCT00034372|Oregovomab|oregovomab|mesh-list
44092263|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44092264|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092265|NCT00034385|Valganciclovir|valganciclovir|mesh-list
44092266|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
44092267|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092268|NCT00034463|Folic Acid|folic acid|mesh-list
44092269|NCT00034463|Vitamins|vitamins|mesh-ancestor
44092270|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
44092271|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092272|NCT00034463|Hematinics|hematinics|mesh-ancestor
44092273|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
44092274|NCT00034489|Gemcitabine|gemcitabine|mesh-list
44092275|NCT00034489|Pemetrexed|pemetrexed|mesh-list
44092276|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092277|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
44092278|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092279|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092280|NCT00034489|Antiviral Agents|antiviral agents|mesh-ancestor
44092281|NCT00034489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092282|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092283|NCT00034489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092284|NCT00034489|Immunologic Factors|immunologic factors|mesh-ancestor
44092285|NCT00034489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092286|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092287|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092289|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44461951|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
44461952|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
44461953|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461954|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461955|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461956|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
44461957|NCT01536561|Antibodies|antibodies|mesh-list
44461958|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44092290|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092291|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092292|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092293|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092294|NCT00034528|Prednisone|prednisone|mesh-list
44092295|NCT00034528|Fludarabine|fludarabine|mesh-list
44092296|NCT00034528|Busulfan|busulfan|mesh-list
44092297|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44092298|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
44092299|NCT00034528|Hormones|hormones|mesh-ancestor
44092300|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092301|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092302|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44092303|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092304|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092305|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092306|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
44092307|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
44092308|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44092309|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44092310|NCT00034541|Paclitaxel|paclitaxel|mesh-list
44092311|NCT00034541|Carboplatin|carboplatin|mesh-list
44092312|NCT00034541|Cetuximab|cetuximab|mesh-list
44092313|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092314|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092315|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092316|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092317|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092318|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092319|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44092320|NCT00034580|Olanzapine|olanzapine|mesh-list
44092321|NCT00034580|Risperidone|risperidone|mesh-list
44092322|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092323|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
44092324|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092325|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092326|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092327|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092328|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092329|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092330|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092331|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092335|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092336|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092337|NCT00034580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092338|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092339|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092341|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092342|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
44092343|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092344|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092345|NCT00034593|Antiviral Agents|antiviral agents|mesh-ancestor
44092346|NCT00034593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092347|NCT00034593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092348|NCT00034593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809111|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
44092349|NCT00034593|Immunologic Factors|immunologic factors|mesh-ancestor
44092350|NCT00034593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092351|NCT00034606|Gemcitabine|gemcitabine|mesh-list
44461959|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
44260081|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
44260082|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260083|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092353|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092354|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
44092355|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092356|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092357|NCT00034606|Antiviral Agents|antiviral agents|mesh-ancestor
44092358|NCT00034606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092359|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092360|NCT00034606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092361|NCT00034606|Immunologic Factors|immunologic factors|mesh-ancestor
44092362|NCT00034606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092363|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092364|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092365|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
44092366|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092367|NCT00034632|Posaconazole|posaconazole|mesh-list
44092368|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
44092369|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092370|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44092371|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44092372|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44092373|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44092374|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092375|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092376|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092377|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44092378|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092379|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092380|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092381|NCT00034645|Posaconazole|posaconazole|mesh-list
44092382|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
44092383|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092384|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44092385|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44092386|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44092387|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44092388|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092389|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092390|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092391|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44092392|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092393|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092394|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092395|NCT00034658|Posaconazole|posaconazole|mesh-list
44092396|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
44092397|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092398|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44092399|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44092400|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44092401|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44092407|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092408|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092409|NCT00034671|Posaconazole|posaconazole|mesh-list
44092410|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
44092411|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092412|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44092413|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44092414|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44092415|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44092416|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092417|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092418|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092419|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44092420|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
44260085|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
44260086|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44260087|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44260088|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44260089|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
44260090|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44260091|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092421|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092422|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092424|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44092425|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
44092426|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092427|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092428|NCT00034710|Capsaicin|capsaicin|mesh-list
44092429|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
44092430|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44092431|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
44092432|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092433|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092434|NCT00034736|Levofloxacin|levofloxacin|mesh-list
44092435|NCT00034736|Ofloxacin|ofloxacin|mesh-list
44092436|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44092437|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092438|NCT00034736|Renal Agents|renal agents|mesh-ancestor
44092439|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092440|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44092441|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092442|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092443|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092444|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092445|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44092446|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092447|NCT00034749|Risperidone|risperidone|mesh-list
44092448|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092449|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
44092450|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092451|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092452|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092453|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092454|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092455|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092456|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092457|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092458|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
44092459|NCT00034762|Risperidone|risperidone|mesh-list
44092460|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092461|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
44092462|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092463|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092464|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092465|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092466|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092467|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092468|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092475|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092476|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092477|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092478|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092479|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092480|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092481|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092482|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
44092483|NCT00034788|Becaplermin|becaplermin|mesh-list
44092484|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
43793106|NCT04460352|Vitamins|vitamins|mesh-ancestor
44260092|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44260093|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44260094|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44260095|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260096|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
44092485|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44092486|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44092487|NCT00034788|Growth Substances|growth substances|mesh-ancestor
44092488|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092489|NCT00034801|Olanzapine|olanzapine|mesh-list
44092490|NCT00034801|Ziprasidone|ziprasidone|mesh-list
44092491|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
44092492|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
44092493|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092494|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092495|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092497|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092498|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092499|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092500|NCT00034801|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092501|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092502|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092503|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092504|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092505|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
44092506|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092507|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092508|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
44092510|NCT00034840|Telmisartan|telmisartan|mesh-list
44092511|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44092512|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44092513|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44092514|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092515|NCT00034853|Naproxen|naproxen|mesh-list
44092516|NCT00034853|Meloxicam|meloxicam|mesh-list
44092517|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44092518|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44092519|NCT00034853|Analgesics|analgesics|mesh-ancestor
44092520|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
44092521|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092522|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092523|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44092524|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092525|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
44092526|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44092527|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092528|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092529|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44092530|NCT00034866|Tipranavir|tipranavir|mesh-list
44092531|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44092532|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
44092533|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44092534|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44092535|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
44092536|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092537|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092538|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092539|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44092542|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44092543|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092544|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092545|NCT00034892|Olanzapine|olanzapine|mesh-list
44092546|NCT00034892|Risperidone|risperidone|mesh-list
44092547|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092548|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
44092549|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092550|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092551|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260097|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44260098|NCT00637442|Galantamine|galantamine|mesh-list
44260099|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44260100|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260101|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260102|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
44260103|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092552|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092553|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092554|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092555|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092556|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092557|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
44092558|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
44092559|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
44092560|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092561|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092562|NCT00034892|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092563|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092564|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092565|NCT00034905|Risperidone|risperidone|mesh-list
44092566|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44092567|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092568|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
44092569|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092570|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092571|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092572|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092573|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092574|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092575|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092576|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092577|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
44092578|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
44092579|NCT00034944|Aprepitant|aprepitant|mesh-list
44092580|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
44092581|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
44092582|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092583|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092584|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092585|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092586|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092587|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092588|NCT00034983|Aprepitant|aprepitant|mesh-list
44092589|NCT00034983|Paroxetine|paroxetine|mesh-list
44092590|NCT00034983|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092591|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092592|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092593|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092594|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092595|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
44092596|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092597|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44092598|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
44092599|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092600|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44092601|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092602|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092603|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
44092604|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
44092605|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092606|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092607|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092608|NCT00035009|Aprepitant|aprepitant|mesh-list
44092609|NCT00035009|Paroxetine|paroxetine|mesh-list
44092610|NCT00035009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44260104|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260105|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44260106|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
44260107|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260108|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
44260109|NCT00637455|Fexofenadine|fexofenadine|mesh-list
44260110|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260111|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260112|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260113|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
44260114|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
44260115|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43591796|NCT03359057|Estradiol|estradiol|mesh-list
44092614|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092615|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
44092616|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092617|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44092618|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
44092619|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092620|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44092621|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092622|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092623|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
44092624|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
44092625|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092626|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092627|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092628|NCT00035035|Gemcitabine|gemcitabine|mesh-list
44092629|NCT00035035|Pemetrexed|pemetrexed|mesh-list
44092630|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092631|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
44092632|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092633|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092634|NCT00035035|Antiviral Agents|antiviral agents|mesh-ancestor
44092635|NCT00035035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092636|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092637|NCT00035035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092638|NCT00035035|Immunologic Factors|immunologic factors|mesh-ancestor
44092639|NCT00035035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092640|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092641|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092642|NCT00035048|Aprepitant|aprepitant|mesh-list
44092643|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
44092644|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
44092645|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092646|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092647|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092648|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092649|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092650|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092652|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092653|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092654|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092655|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092656|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092657|NCT00035074|Methotrexate|methotrexate|mesh-list
44092658|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44092659|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
44092660|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44092661|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092662|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092663|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
44260116|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260117|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260119|NCT00637468|Heparin|heparin|mesh-list
44260120|NCT00637468|Acetazolamide|acetazolamide|mesh-list
44260121|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44260122|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
44092664|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092665|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092666|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44092667|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092668|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092669|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092670|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
44092671|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092672|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092673|NCT00035087|Epothilones|epothilones|mesh-list
44092674|NCT00035087|Epothilone B|epothilone b|mesh-list
44092675|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092676|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092677|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092678|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092679|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092680|NCT00035100|Epothilones|epothilones|mesh-list
44092702|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44092703|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092704|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44092705|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092706|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092707|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092708|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
44092709|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092710|NCT00035152|Paclitaxel|paclitaxel|mesh-list
44092711|NCT00035152|Carboplatin|carboplatin|mesh-list
44092712|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44092713|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092714|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092715|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092716|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092717|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092718|NCT00035165|Epothilones|epothilones|mesh-list
44092719|NCT00035165|Epothilone B|epothilone b|mesh-list
44092720|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092721|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092722|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092723|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092724|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092725|NCT00035178|Argatroban|argatroban|mesh-list
44092726|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
44092727|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44092728|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
44092729|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092730|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092731|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
44092732|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44092733|NCT00035191|Galantamine|galantamine|mesh-list
44092734|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44092744|NCT00035204|Galantamine|galantamine|mesh-list
44092745|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44092746|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092747|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092748|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44092749|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092750|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092751|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44092752|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
44092753|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092754|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
44260123|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260124|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44260125|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260126|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260127|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44092755|NCT00035230|Topiramate|topiramate|mesh-list
44092756|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
44092757|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44092758|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152480|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
44152481|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152482|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152483|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152484|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152485|NCT00217178|Folic Acid|folic acid|mesh-list
44152486|NCT00217178|Vitamins|vitamins|mesh-ancestor
44152487|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
44152488|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152489|NCT00217178|Hematinics|hematinics|mesh-ancestor
44152490|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
44152491|NCT00217191|Ibuprofen|ibuprofen|mesh-list
43717489|NCT02647632|Ribavirin|ribavirin|mesh-list
44152492|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44152493|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44152494|NCT00217191|Analgesics|analgesics|mesh-ancestor
44152495|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
44152496|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152497|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152498|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152499|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152500|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44152501|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152502|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152503|NCT00217204|Pancrelipase|pancrelipase|mesh-list
44152504|NCT00217204|Pancreatin|pancreatin|mesh-list
44152505|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44152506|NCT00217243|Lidocaine|lidocaine|mesh-list
44152507|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
44152508|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
44152509|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152510|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152511|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
44152512|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152513|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44092759|NCT00035243|Epothilones|epothilones|mesh-list
44092760|NCT00035243|Epothilone B|epothilone b|mesh-list
44092761|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092762|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092763|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092764|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092765|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092766|NCT00035256|Teriparatide|teriparatide|mesh-list
44092767|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44092774|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44092775|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44092777|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092778|NCT00035282|Aprepitant|aprepitant|mesh-list
44092779|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
44092780|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
44092781|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092782|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092783|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092784|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092785|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092786|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092787|NCT00035295|Aprepitant|aprepitant|mesh-list
44092788|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
44092789|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
44092790|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092791|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092792|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260128|NCT00637468|Analgesics|analgesics|mesh-ancestor
44260129|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
44260130|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260131|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260132|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260133|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092793|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44092794|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092795|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092796|NCT00035308|Abetimus|abetimus|mesh-list
44092797|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092798|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
44092799|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092800|NCT00035321|Olanzapine|olanzapine|mesh-list
44092801|NCT00035321|Fluoxetine|fluoxetine|mesh-list
44092802|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
44092803|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
44092804|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092805|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092806|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092807|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092808|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092809|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092810|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092811|NCT00035321|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092812|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092813|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092814|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092815|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092816|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
44092817|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44092818|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
44092819|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44092820|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092821|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092822|NCT00035347|Azithromycin|azithromycin|mesh-list
44092823|NCT00035347|Levofloxacin|levofloxacin|mesh-list
44092824|NCT00035347|Ofloxacin|ofloxacin|mesh-list
44092825|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
44092826|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092827|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092828|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44092829|NCT00035347|Renal Agents|renal agents|mesh-ancestor
44092830|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44092831|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44092832|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43592059|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
44092841|NCT00035425|Linezolid|linezolid|mesh-list
44092842|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092843|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092844|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44092845|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092846|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092847|NCT00035451|Sotalol|sotalol|mesh-list
44092848|NCT00035451|Azimilide|azimilide|mesh-list
44092849|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44092850|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44092851|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
44092852|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092853|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092854|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092855|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44092856|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
44092857|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
44092858|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092859|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44092860|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092861|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44092862|NCT00035464|Azimilide|azimilide|mesh-list
44260134|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260135|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260136|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260137|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
44260138|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
44260139|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44260140|NCT00637468|Diuretics|diuretics|mesh-ancestor
44260141|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
44260142|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44260143|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
44260144|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260145|NCT00637481|Atorvastatin|atorvastatin|mesh-list
44260146|NCT00637481|Calcium|calcium|mesh-list
44260147|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44260148|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260149|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44260150|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44092863|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44092864|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44092865|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092866|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092867|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44092868|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092869|NCT00035477|Azimilide|azimilide|mesh-list
43554877|NCT03567408|Bivalirudin|bivalirudin|mesh-list
44092870|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44092871|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44092872|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092873|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092874|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44092875|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092876|NCT00035490|Azimilide|azimilide|mesh-list
44092877|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44092878|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44092879|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092880|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092881|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44092882|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092883|NCT00035516|Epothilones|epothilones|mesh-list
44092884|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092885|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092886|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092887|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092888|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092889|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44092890|NCT00035581|Poly I-C|poly i-c|mesh-list
44092891|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
44092892|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092893|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
44092894|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
44092895|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092896|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
44092897|NCT00035607|Hematinics|hematinics|mesh-ancestor
44092898|NCT00035620|Lenograstim|lenograstim|mesh-list
43592126|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
44092908|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092909|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44092910|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700518|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260151|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
44260152|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260153|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44461960|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
43914428|NCT00427037|Vitamin D|vitamin d|mesh-list
44260154|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44260155|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260156|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
44260157|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44092911|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092912|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44092913|NCT00035893|Poly I-C|poly i-c|mesh-list
44092914|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
44092915|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092916|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
44092917|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
44092918|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092919|NCT00035958|Prednisone|prednisone|mesh-list
44092920|NCT00035958|Etanercept|etanercept|mesh-list
44092921|NCT00035958|Methotrexate|methotrexate|mesh-list
44092922|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44092923|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
44092924|NCT00035958|Hormones|hormones|mesh-ancestor
44092925|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092926|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092927|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44092928|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092929|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44092930|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
43763058|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763059|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
43763060|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43763061|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44092931|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44092932|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092933|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
44092934|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092935|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
44092936|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092937|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44092938|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092939|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
44092940|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092941|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44092942|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44092943|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44092944|NCT00035958|Analgesics|analgesics|mesh-ancestor
44092945|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
44092946|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092947|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092948|NCT00035971|Alendronate|alendronate|mesh-list
44092949|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44092950|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44092951|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092952|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44092953|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092954|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092955|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44092956|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44092957|NCT00035984|Exenatide|exenatide|mesh-list
44092958|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44092959|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092960|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44092961|NCT00035984|Incretins|incretins|mesh-ancestor
44092962|NCT00035984|Hormones|hormones|mesh-ancestor
44092963|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092964|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
44092968|NCT00036023|Hematinics|hematinics|mesh-ancestor
44092969|NCT00036062|Sivelestat|sivelestat|mesh-list
44260158|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44260159|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44260160|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260161|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260162|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
44260163|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092970|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44092971|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
44092972|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092973|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092974|NCT00036088|Olanzapine|olanzapine|mesh-list
44092975|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
44092976|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
44092977|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092978|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092979|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092980|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092981|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092982|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092983|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092984|NCT00036088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44092985|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092986|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092987|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092988|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092989|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
44092990|NCT00036101|Aripiprazole|aripiprazole|mesh-list
44092991|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
44092992|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44092993|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44092994|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44092995|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44092996|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092997|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
44092998|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
44092999|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093000|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093001|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44093002|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44093003|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
44093004|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44093005|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093006|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44093007|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44093008|NCT00036114|Aripiprazole|aripiprazole|mesh-list
44093009|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093010|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093011|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44093012|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093013|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093014|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093015|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
44093016|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
44093017|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093018|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093019|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44093020|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44093021|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
44093022|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44093023|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093024|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44093025|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44093026|NCT00036127|Aripiprazole|aripiprazole|mesh-list
44093027|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093028|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093029|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44260164|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260165|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44260166|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260167|NCT00637559|Esomeprazole|esomeprazole|mesh-list
44260168|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44260169|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260170|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44093030|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093031|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093032|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093033|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
44093034|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
44093035|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093043|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44093044|NCT00036153|Methotrexate|methotrexate|mesh-list
44093045|NCT00036153|Tacrolimus|tacrolimus|mesh-list
44093046|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44093047|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
43846505|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093048|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44093049|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093050|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093051|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
44093052|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093053|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093054|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093055|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093056|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44093057|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093058|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
44093059|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093060|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093061|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44093063|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
44093064|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093065|NCT00036179|Micafungin|micafungin|mesh-list
44093066|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
44093067|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093068|NCT00036218|Ropinirole|ropinirole|mesh-list
44093069|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44093070|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44093071|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
44093072|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
44093073|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093074|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093075|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093076|NCT00036231|Secretin|secretin|mesh-list
44093077|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093078|NCT00036231|Hormones|hormones|mesh-ancestor
44093079|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093080|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093081|NCT00036244|Secretin|secretin|mesh-list
44093082|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093083|NCT00036244|Hormones|hormones|mesh-ancestor
44093084|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093085|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093086|NCT00036283|Celecoxib|celecoxib|mesh-list
44093087|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093088|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093089|NCT00036283|Analgesics|analgesics|mesh-ancestor
44093090|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
44093091|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093092|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093093|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093094|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093095|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44093096|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093097|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793107|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
44260171|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260172|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260173|NCT00637585|Fexofenadine|fexofenadine|mesh-list
44260174|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260175|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260176|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260177|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
44093098|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093099|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44093100|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43592338|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
43763067|NCT02428543|Cytarabine|cytarabine|mesh-list
44093104|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093105|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093106|NCT00036309|Analgesics|analgesics|mesh-ancestor
44093107|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
44093108|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093109|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093110|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093111|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
44093112|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44093113|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44093114|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44093115|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44093116|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093117|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093118|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093119|NCT00036335|Analgesics|analgesics|mesh-ancestor
44093120|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
44093121|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093122|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093123|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093124|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
44093125|NCT00036348|Aripiprazole|aripiprazole|mesh-list
43809816|NCT04870060|Analgesics|analgesics|mesh-ancestor
44093127|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093128|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44093129|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093130|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093131|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093132|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
44093133|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
44093134|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093135|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093136|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44093137|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44093138|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
44093139|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44093140|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093141|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44093142|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44093143|NCT00036361|Aripiprazole|aripiprazole|mesh-list
44093144|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093145|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093146|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44093147|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093148|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093149|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093150|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
44093151|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
44093152|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093153|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093154|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44093155|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44093156|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
44093157|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44260179|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260180|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260181|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260182|NCT00637611|Fexofenadine|fexofenadine|mesh-list
44260183|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260184|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260185|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260186|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
44260187|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
44260188|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260189|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260190|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260191|NCT00637637|Ritonavir|ritonavir|mesh-list
44260192|NCT00637637|Indinavir|indinavir|mesh-list
44260193|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44260194|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44260195|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44260196|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260197|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260198|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260199|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260200|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
44260201|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260202|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44260203|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44260204|NCT00637663|Lamivudine|lamivudine|mesh-list
44260205|NCT00637663|Entecavir|entecavir|mesh-list
44260206|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44260207|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44260208|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260210|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
44260220|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260221|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260222|NCT00637715|Urological Agents|urological agents|mesh-ancestor
44260223|NCT00637767|Melphalan|melphalan|mesh-list
44260224|NCT00637767|Antibodies|antibodies|mesh-list
44260225|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44260226|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
44260227|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260228|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44093158|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093159|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44093160|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44093161|NCT00036374|Infliximab|infliximab|mesh-list
44093162|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093163|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093164|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093165|NCT00036387|Infliximab|infliximab|mesh-list
44093166|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093167|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093168|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093169|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
44093170|NCT00036400|Hematinics|hematinics|mesh-ancestor
44093178|NCT00036452|Emtricitabine|emtricitabine|mesh-list
44093179|NCT00036452|Stavudine|stavudine|mesh-list
44093180|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44093181|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44093182|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
44093183|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093184|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093185|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44093186|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44093187|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
44093188|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093189|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44093190|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44093191|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44093192|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093193|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
44093194|NCT00036491|Rituximab|rituximab|mesh-list
44093195|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093196|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093197|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
44093198|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093199|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093201|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093202|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093203|NCT00036543|Atrasentan|atrasentan|mesh-list
44093204|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093205|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44093206|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44093207|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093208|NCT00036556|Atrasentan|atrasentan|mesh-list
43763104|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43763105|NCT02428374|Simvastatin|simvastatin|mesh-list
43763106|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43555035|NCT03566134|DA-8010|da-8010|mesh-list
44093209|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093210|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44093211|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44093212|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093213|NCT00036582|Clozapine|clozapine|mesh-list
44093214|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093215|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
44093216|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093217|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093218|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093219|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44093220|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093221|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260229|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
44260230|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260231|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260232|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44260233|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260234|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
44260235|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44093222|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093223|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
44093224|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
44093225|NCT00036634|Tenofovir|tenofovir|mesh-list
44093226|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
44093227|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093228|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44093229|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093230|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093231|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093232|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44093233|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44093234|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44093235|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093236|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093237|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093238|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093239|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
44093240|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093249|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093250|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093251|NCT00036777|Carboplatin|carboplatin|mesh-list
44093252|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44093253|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093254|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093255|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093256|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093257|NCT00036790|Doxorubicin|doxorubicin|mesh-list
44093258|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44093259|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
44093260|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093261|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093262|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44093263|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44093264|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093265|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093266|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44093267|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093268|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
44093269|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152514|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43567910|NCT00691964|Etanercept|etanercept|mesh-list
44152515|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44152516|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152517|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809906|NCT04868513|Fluorides|fluorides|mesh-list
44093270|NCT00036855|Rituximab|rituximab|mesh-list
44093271|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44093272|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093273|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093274|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
44093275|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093276|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093277|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
44093278|NCT00036868|Fluorouracil|fluorouracil|mesh-list
44093279|NCT00036868|Methotrexate|methotrexate|mesh-list
44093280|NCT00036868|Trastuzumab|trastuzumab|mesh-list
44093281|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093282|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
44093283|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260236|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44260237|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
44260238|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260239|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260240|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260241|NCT00637819|Leflunomide|leflunomide|mesh-list
44093284|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093285|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44093286|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
44093287|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093288|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093289|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44093290|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
44093291|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093292|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44093293|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
44093294|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44093295|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093296|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093297|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44093298|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093299|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093300|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
44093301|NCT00036881|Astringents|astringents|mesh-ancestor
43592543|NCT03352362|Propacetamol|propacetamol|mesh-list
44093307|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093308|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093309|NCT00036894|Growth Substances|growth substances|mesh-ancestor
44093310|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093311|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093312|NCT00036946|Aflibercept|aflibercept|mesh-list
44093313|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093314|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093315|NCT00036946|Growth Substances|growth substances|mesh-ancestor
44093316|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093317|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093318|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093319|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
44093320|NCT00036985|Doxorubicin|doxorubicin|mesh-list
44093321|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44093322|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093323|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
44093324|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093325|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093326|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44093327|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
44093328|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093329|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093330|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44093331|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093332|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44093333|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44093334|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093335|NCT00037011|Antibodies|antibodies|mesh-list
44093336|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44093337|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
44093338|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093339|NCT00037037|Sargramostim|sargramostim|mesh-list
44093340|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
44093341|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093342|NCT00037050|Vancomycin|vancomycin|mesh-list
44093343|NCT00037050|Linezolid|linezolid|mesh-list
44093344|NCT00037050|Oxacillin|oxacillin|mesh-list
44093345|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
44093346|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093347|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093348|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44093349|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260242|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260243|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260244|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260245|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
44093350|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093351|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
44093352|NCT00037063|Vitamin E|vitamin e|mesh-list
44093353|NCT00037063|Riboflavin|riboflavin|mesh-list
44093354|NCT00037063|Thiamine|thiamine|mesh-list
44093355|NCT00037063|Vitamins|vitamins|mesh-ancestor
44093356|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
44093357|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093358|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
44093359|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093360|NCT00037063|Protective Agents|protective agents|mesh-ancestor
44093361|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
44093362|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44093363|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093364|NCT00037089|Tegafur|tegafur|mesh-list
44093365|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093366|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
44093367|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093368|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093369|NCT00037102|Interferons|interferons|mesh-list
44093370|NCT00037102|Interferon-beta|interferon-beta|mesh-list
44093371|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
44093372|NCT00037102|Methotrexate|methotrexate|mesh-list
44093373|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44093374|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
44093383|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44093384|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093385|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
44093386|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093387|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093388|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
44093389|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093390|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44093391|NCT00037115|Interferons|interferons|mesh-list
44093392|NCT00037115|Interferon-beta|interferon-beta|mesh-list
44093393|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
44093394|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
44093395|NCT00037115|Methotrexate|methotrexate|mesh-list
44093396|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44093397|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
44093398|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44093399|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093400|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093401|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
44093402|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093403|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093404|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093405|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093406|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44093407|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093408|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
44093409|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093410|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093411|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
44093412|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093413|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093414|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
44093415|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
44093416|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093417|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093418|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
44093419|NCT00037115|Hormones|hormones|mesh-ancestor
44093420|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093421|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44093422|NCT00037115|Protective Agents|protective agents|mesh-ancestor
44093423|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44093424|NCT00037141|Ethanol|ethanol|mesh-list
44093425|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44093426|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260246|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260248|NCT00637845|Lansoprazole|lansoprazole|mesh-list
44260249|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
44260250|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44260251|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260252|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44260253|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260254|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260255|NCT00637858|Lycopene|lycopene|mesh-list
44260256|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260257|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
44260258|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260259|NCT00637858|Protective Agents|protective agents|mesh-ancestor
44260260|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260261|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44260262|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44260263|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260264|NCT00637871|Tamoxifen|tamoxifen|mesh-list
44260265|NCT00637871|Bicalutamide|bicalutamide|mesh-list
44260266|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44260267|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
44260268|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44260269|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260270|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44260271|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260272|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44260273|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44260274|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44260275|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
44093427|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093428|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093429|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
44093430|NCT00037154|Urological Agents|urological agents|mesh-ancestor
44093431|NCT00037180|Leucovorin|leucovorin|mesh-list
44093432|NCT00037180|Celecoxib|celecoxib|mesh-list
44093433|NCT00037180|Fluorouracil|fluorouracil|mesh-list
44093434|NCT00037180|Irinotecan|irinotecan|mesh-list
44093435|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
44093436|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093437|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093438|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093439|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093440|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
44260277|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260278|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260279|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260280|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
44260281|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
44260282|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260283|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260284|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260285|NCT00637897|Paclitaxel|paclitaxel|mesh-list
44260286|NCT00637897|Docetaxel|docetaxel|mesh-list
44260287|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44260288|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44260289|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260290|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44260291|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
44260292|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
44260293|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260294|NCT00637910|Docetaxel|docetaxel|mesh-list
44260295|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44260296|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260297|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
44260298|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656185|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
43592673|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44093448|NCT00037180|Vitamins|vitamins|mesh-ancestor
44093449|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
44093450|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093451|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093452|NCT00037180|Analgesics|analgesics|mesh-ancestor
44093453|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
44093454|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093455|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093456|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093457|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44093458|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093459|NCT00037206|Anidulafungin|anidulafungin|mesh-list
44093460|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
44093461|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093462|NCT00037219|Anidulafungin|anidulafungin|mesh-list
44093463|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
44093464|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093465|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
44093466|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093467|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093468|NCT00037518|Cinacalcet|cinacalcet|mesh-list
44093469|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44093470|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093471|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44093472|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
44093473|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093474|NCT00037531|Sirolimus|sirolimus|mesh-list
44260300|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260301|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44260302|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093475|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093476|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093477|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093478|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093479|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
44093480|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093481|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
44093482|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093483|NCT00037544|Factor VIII|factor viii|mesh-list
44093484|NCT00037544|Coagulants|coagulants|mesh-ancestor
44093485|NCT00037570|Pantoprazole|pantoprazole|mesh-list
44093486|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44093487|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093488|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44093489|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093490|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093491|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
44093492|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093493|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093494|NCT00037596|Cytarabine|cytarabine|mesh-list
44093495|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
44093496|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093498|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093499|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093500|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
44152518|NCT00217282|Gemcitabine|gemcitabine|mesh-list
44093501|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093502|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093503|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
44093504|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093505|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093506|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
44093507|NCT00037609|Capecitabine|capecitabine|mesh-list
44093508|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093509|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
43592742|NCT03349957|Idarubicin|idarubicin|mesh-list
44093521|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093522|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093523|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093524|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
44093525|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44093526|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093527|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093528|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093529|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
44093530|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093531|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44093532|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44093534|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44093535|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093536|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44093537|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
44093538|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093539|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44093540|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093541|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44093542|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44093543|NCT00037674|Topiramate|topiramate|mesh-list
44093544|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
44093545|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093546|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093547|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44093548|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093549|NCT00037752|Sibutramine|sibutramine|mesh-list
44093550|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093551|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093552|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
44260303|NCT00637949|Rofecoxib|rofecoxib|mesh-list
44260304|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
44260305|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260306|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260307|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260308|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260309|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260310|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260311|NCT00637949|Analgesics|analgesics|mesh-ancestor
43656196|NCT02963324|Ivermectin|ivermectin|mesh-list
44093553|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44093554|NCT00037804|Irinotecan|irinotecan|mesh-list
44093555|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44093556|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44093557|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651535|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093558|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093559|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093560|NCT00037817|Celecoxib|celecoxib|mesh-list
44093561|NCT00037817|Decitabine|decitabine|mesh-list
44093562|NCT00037817|Romidepsin|romidepsin|mesh-list
44093563|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093564|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093565|NCT00037817|Analgesics|analgesics|mesh-ancestor
44093566|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
44093567|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093568|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093569|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093571|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43592811|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
44093578|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093579|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44093580|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093581|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093582|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093583|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44093584|NCT00037882|Interferons|interferons|mesh-list
44093585|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
44093586|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
44093587|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44093588|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093589|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
44093590|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093591|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
44093592|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093593|NCT00037999|Testosterone|testosterone|mesh-list
44093594|NCT00037999|Androgens|androgens|mesh-ancestor
44093595|NCT00037999|Hormones|hormones|mesh-ancestor
44093596|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093597|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093598|NCT00038012|Carboplatin|carboplatin|mesh-list
44093599|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093600|NCT00038025|Pentostatin|pentostatin|mesh-list
44093601|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093602|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44093603|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093604|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810195|NCT04863742|Prednisolone|prednisolone|mesh-list
44093605|NCT00038051|Lintuzumab|lintuzumab|mesh-list
44093606|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093607|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093608|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
44093609|NCT00038064|Hematinics|hematinics|mesh-ancestor
44093610|NCT00038077|Metoprolol|metoprolol|mesh-list
44093611|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44093612|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44093613|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
44093614|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
44093615|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260312|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
44260313|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260314|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260315|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093616|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093617|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44093618|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44093619|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44093620|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
44093621|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093622|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093623|NCT00038090|Thalidomide|thalidomide|mesh-list
44093624|NCT00038090|Dexamethasone|dexamethasone|mesh-list
44093625|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093626|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
44093627|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
44093628|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093629|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093630|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093631|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
44093632|NCT00038090|Hormones|hormones|mesh-ancestor
44093633|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093634|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093635|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093636|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093637|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
44093638|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
44093639|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093648|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
44093649|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152519|NCT00217282|Bevacizumab|bevacizumab|mesh-list
44093650|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093651|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
44093652|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093653|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093654|NCT00038116|Protective Agents|protective agents|mesh-ancestor
44093656|NCT00038168|Estramustine|estramustine|mesh-list
44093657|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44093658|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093659|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093660|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
44093661|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
44093662|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093663|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44093664|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
44093665|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093666|NCT00038181|Thalidomide|thalidomide|mesh-list
44093667|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093668|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
44093669|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093670|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
44093671|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093672|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093673|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093674|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093675|NCT00038181|Growth Substances|growth substances|mesh-ancestor
44093676|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093677|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093678|NCT00038194|Docetaxel|docetaxel|mesh-list
44093679|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
44093680|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093681|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093682|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
44093683|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
44093684|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093685|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093686|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093687|NCT00038207|Vincristine|vincristine|mesh-list
44093688|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44093689|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260316|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260317|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
44260318|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44093690|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093691|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
44093692|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
44093693|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093695|NCT00038220|Lopinavir|lopinavir|mesh-list
44093696|NCT00038220|Tenofovir|tenofovir|mesh-list
44093697|NCT00038220|Lamivudine|lamivudine|mesh-list
44093698|NCT00038220|Efavirenz|efavirenz|mesh-list
44093699|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44093700|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44093701|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
44093702|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093703|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093704|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44093705|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44093706|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
44093707|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093708|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44093728|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093729|NCT00038246|Thalidomide|thalidomide|mesh-list
44093731|NCT00038246|Estramustine|estramustine|mesh-list
44093732|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44093733|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093734|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093735|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44093736|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44093737|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093738|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093739|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
44093740|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093741|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
44093742|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093743|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093744|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093745|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093746|NCT00038246|Growth Substances|growth substances|mesh-ancestor
44093747|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093748|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44093749|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
44093764|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093765|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093766|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
44093767|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093768|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
44093769|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093770|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093771|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093772|NCT05433896|Dasatinib|dasatinib|mesh-list
44093773|NCT05433896|Omeprazole|omeprazole|mesh-list
44093774|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44093775|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093776|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44093777|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093778|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093779|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093780|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093781|NCT05433597|Cisplatin|cisplatin|mesh-list
44093782|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093783|NCT05433480|Fulvestrant|fulvestrant|mesh-list
44093784|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093785|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093786|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44093787|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44093788|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44093789|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093790|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093791|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44093792|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
44260319|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
44260320|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260321|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44260322|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260323|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
44260324|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260325|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
44093793|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44093794|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
44093795|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44093796|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093797|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
44093798|NCT05433116|Lenvatinib|lenvatinib|mesh-list
44093799|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093800|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093801|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093802|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093803|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093804|NCT05432934|Dexamethasone|dexamethasone|mesh-list
44093805|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093806|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
44093807|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
44093808|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093809|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093810|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093817|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44093819|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093820|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093821|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
44093822|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093823|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44093824|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44093825|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093839|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
44093840|NCT05428683|Triamcinolone|triamcinolone|mesh-list
44093841|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093842|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093843|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44093844|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44093845|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093846|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093847|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093848|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093849|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093850|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
44093851|NCT05428683|Hormones|hormones|mesh-ancestor
44093852|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093853|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44093854|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44093855|NCT05417646|Empagliflozin|empagliflozin|mesh-list
44093856|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44093857|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093858|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093859|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260326|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44260327|NCT00637962|Protective Agents|protective agents|mesh-ancestor
44260328|NCT00637975|Pregabalin|pregabalin|mesh-list
44260329|NCT00637975|Oxycodone|oxycodone|mesh-list
44260330|NCT00637975|Analgesics|analgesics|mesh-ancestor
44260331|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
44260332|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260333|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260334|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
44260335|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44260336|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260337|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260338|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44260339|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44260340|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44260341|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260342|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093860|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
44093861|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
44093862|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093863|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763265|NCT02427165|Albuterol|albuterol|mesh-list
44093864|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093865|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
44093866|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093867|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093868|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093870|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44093871|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093872|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093873|NCT05382546|Analgesics|analgesics|mesh-ancestor
44093874|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
44093875|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093876|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093877|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093878|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093881|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152527|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
44152528|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152529|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
44152530|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152531|NCT00217282|Antiviral Agents|antiviral agents|mesh-ancestor
44152532|NCT00217282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152533|NCT00217282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152534|NCT00217282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152535|NCT00217282|Immunologic Factors|immunologic factors|mesh-ancestor
44158046|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44158047|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158048|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158049|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158050|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
44158051|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158052|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158053|NCT00236093|Fentanyl|fentanyl|mesh-list
44158054|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158055|NCT00236093|Narcotics|narcotics|mesh-ancestor
44158056|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260343|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44260344|NCT00637975|Narcotics|narcotics|mesh-ancestor
44260345|NCT00637988|Aspirin|aspirin|mesh-list
44260346|NCT00637988|Rofecoxib|rofecoxib|mesh-list
44260347|NCT00637988|Esomeprazole|esomeprazole|mesh-list
44260348|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260349|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260350|NCT00637988|Analgesics|analgesics|mesh-ancestor
44260351|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
44260352|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260353|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260354|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260355|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260356|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260357|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44260358|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260359|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260360|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260361|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260362|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
44158057|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158058|NCT00236093|Analgesics|analgesics|mesh-ancestor
43810403|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
44158059|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
44158060|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158061|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44158062|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158063|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
44158064|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
44158065|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
44158066|NCT00236106|Tacrolimus|tacrolimus|mesh-list
43651568|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
44158067|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44158068|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
44158069|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158070|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44158071|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158072|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158073|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158074|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
44158075|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44158076|NCT00236145|Fentanyl|fentanyl|mesh-list
44158077|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158078|NCT00236145|Narcotics|narcotics|mesh-ancestor
44158079|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158080|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158081|NCT00236145|Analgesics|analgesics|mesh-ancestor
44158082|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
44158083|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158084|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44158085|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158086|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
44158087|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
44158088|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
44158089|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158090|NCT00236223|Dexamethasone|dexamethasone|mesh-list
44158091|NCT00236223|Ketamine|ketamine|mesh-list
44158092|NCT00236223|Gabapentin|gabapentin|mesh-list
44158093|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260363|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44260364|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260365|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44260366|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260367|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
44260368|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44260369|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44260370|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44260371|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260372|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260373|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
44260374|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158094|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
44158095|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
44093882|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
44093883|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44093884|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093885|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093886|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093887|NCT05217498|Istradefylline|istradefylline|mesh-list
44093888|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44093889|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44093890|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44093891|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
44093892|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093906|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093907|NCT05184920|Nicotine|nicotine|mesh-list
44093908|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44093909|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
44093910|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093911|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093912|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44093913|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44093914|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
44093915|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093916|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093917|NCT05116059|Amphotericin B|amphotericin b|mesh-list
44093918|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44093919|NCT05116059|Amebicides|amebicides|mesh-ancestor
44093920|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44093921|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44093922|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093923|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093924|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
44093925|NCT05083975|Anesthetics|anesthetics|mesh-list
44093926|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
44093927|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093928|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093929|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
44093930|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093931|NCT05076877|Metformin|metformin|mesh-list
44093932|NCT05076877|Midazolam|midazolam|mesh-list
44093933|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44093934|NCT05076877|Lazertinib|lazertinib|mesh-list
44093935|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093936|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093937|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44093938|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44093939|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44093940|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44093941|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44093942|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44093943|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44260375|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260376|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44260377|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260378|NCT00638079|Megestrol|megestrol|mesh-list
44260379|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
44260380|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44093944|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
44093945|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
44093946|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
44093947|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
44093948|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44093949|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093950|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44093951|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44093952|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
44093953|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44093954|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44093960|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44093961|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093962|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44093964|NCT04941521|Hormones|hormones|mesh-ancestor
44093965|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093966|NCT04888377|Aspirin|aspirin|mesh-list
44093967|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093968|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093969|NCT04888377|Analgesics|analgesics|mesh-ancestor
44093970|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
44093971|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093972|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093973|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093974|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093975|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44093976|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44093977|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093978|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44093979|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093980|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093981|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
44093982|NCT04760782|Abaloparatide|abaloparatide|mesh-list
44093983|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44093984|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093985|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44093986|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44093987|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
44093988|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
44093989|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093990|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44093991|NCT04680442|Trastuzumab|trastuzumab|mesh-list
44093992|NCT04680442|Pertuzumab|pertuzumab|mesh-list
44093993|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44093994|NCT04680442|Maytansine|maytansine|mesh-list
44093995|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44093996|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093997|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44093998|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093999|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094000|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094001|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094002|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
44094003|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
44094004|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094005|NCT04604548|Protective Agents|protective agents|mesh-ancestor
44094006|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094007|NCT04436744|Palbociclib|palbociclib|mesh-list
44094008|NCT04436744|Anastrozole|anastrozole|mesh-list
44094009|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094010|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44260381|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44260382|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44260383|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
44260384|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44260385|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260386|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44260387|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44260388|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44260389|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260390|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
44260391|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44260392|NCT00638118|Fexofenadine|fexofenadine|mesh-list
44260393|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260394|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260395|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260396|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
44260397|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
44094011|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094012|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094013|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44094014|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44094015|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44094016|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44094017|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
44094018|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094019|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094020|NCT04430790|Doxapram|doxapram|mesh-list
44094021|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44094022|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094029|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094030|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094031|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
44094032|NCT04319757|Fludarabine|fludarabine|mesh-list
44094033|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094034|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
44094035|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094036|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094037|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094038|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
44094039|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094040|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094041|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094042|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
44094043|NCT04245722|Rituximab|rituximab|mesh-list
44094044|NCT04245722|Fludarabine|fludarabine|mesh-list
44094045|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
44094046|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094047|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
44094048|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094049|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094050|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094051|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
44094052|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094053|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094054|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44260399|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094055|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094056|NCT04231643|Dronabinol|dronabinol|mesh-list
44094057|NCT04231643|Cannabidiol|cannabidiol|mesh-list
44094058|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
44094059|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094060|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44094061|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094062|NCT04231643|Analgesics|analgesics|mesh-ancestor
44094063|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
44094064|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094065|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44094066|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44094067|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094068|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094069|NCT04231643|Hormones|hormones|mesh-ancestor
44094070|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094071|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
44094072|NCT04201665|Oxytocin|oxytocin|mesh-list
44094073|NCT04201665|Carbetocin|carbetocin|mesh-list
44094074|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
44094075|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44094076|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152536|NCT00217295|Topiramate|topiramate|mesh-list
44152537|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
44152538|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44152539|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152540|NCT00217373|Interferons|interferons|mesh-list
44152541|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
44152542|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
44152543|NCT00217373|Metronidazole|metronidazole|mesh-list
44152544|NCT00217373|Vaccines|vaccines|mesh-list
44152545|NCT00217373|Sargramostim|sargramostim|mesh-list
44152546|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
44152547|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152548|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152549|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
44152550|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152560|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152561|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152562|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152563|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152564|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44094078|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
44094079|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44094080|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44094081|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094082|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
44094083|NCT04149210|Hormones|hormones|mesh-ancestor
44094084|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094085|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094086|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44094087|NCT04088188|Gemcitabine|gemcitabine|mesh-list
44094088|NCT04088188|Cisplatin|cisplatin|mesh-list
44094089|NCT04088188|Ivosidenib|ivosidenib|mesh-list
44094090|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094091|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094092|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
44094093|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094094|NCT04088188|Antiviral Agents|antiviral agents|mesh-ancestor
44094095|NCT04088188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094096|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094097|NCT04088188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094098|NCT04088188|Immunologic Factors|immunologic factors|mesh-ancestor
44094099|NCT04088188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094100|NCT04078295|Nivolumab|nivolumab|mesh-list
44094101|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094102|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094103|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44094104|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094105|NCT04061421|Decitabine|decitabine|mesh-list
44094106|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094107|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
44260400|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260401|NCT00638131|Bosentan|bosentan|mesh-list
44260402|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44260403|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44260404|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260405|NCT00638209|Insulin|insulin|mesh-list
44094108|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094109|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094110|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094111|NCT03957057|Iron|iron|mesh-list
44094112|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44094113|NCT03957057|Trace Elements|trace elements|mesh-ancestor
44094114|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
44094115|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094116|NCT03957057|Hematinics|hematinics|mesh-ancestor
44094117|NCT03828201|Levofloxacin|levofloxacin|mesh-list
44094118|NCT03828201|Ofloxacin|ofloxacin|mesh-list
44094119|NCT03828201|Linezolid|linezolid|mesh-list
44094120|NCT03828201|Bedaquiline|bedaquiline|mesh-list
44094121|NCT03828201|Clofazimine|clofazimine|mesh-list
44094122|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44094123|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094124|NCT03828201|Renal Agents|renal agents|mesh-ancestor
44094125|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094126|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094127|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094128|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094129|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094130|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094131|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44094141|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094142|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094143|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094144|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44094145|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
44094146|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
44094147|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094148|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094149|NCT03533946|Rucaparib|rucaparib|mesh-list
44094150|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44094151|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094152|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094153|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094154|NCT03439865|Ivacaftor|ivacaftor|mesh-list
44094155|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44094156|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44094157|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094158|NCT03430596|Pramipexole|pramipexole|mesh-list
44094159|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
44094160|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
44094161|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094162|NCT03430596|Protective Agents|protective agents|mesh-ancestor
44094163|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094164|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44094165|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44094166|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
44094167|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
44094168|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094169|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44094170|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44094171|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
44094172|NCT03358875|Docetaxel|docetaxel|mesh-list
44094173|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094174|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094175|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094176|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094177|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094178|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
44094179|NCT03338621|Rifampin|rifampin|mesh-list
44094180|NCT03338621|Isoniazid|isoniazid|mesh-list
44260406|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44260407|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44260408|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260409|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44260410|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260411|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44094181|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
44094182|NCT03338621|Ethambutol|ethambutol|mesh-list
44094183|NCT03338621|Bedaquiline|bedaquiline|mesh-list
44094184|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094185|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094186|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094187|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094188|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094189|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094190|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094191|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44094192|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
44094193|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
44094194|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44094195|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44094196|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44094197|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43593516|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094218|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094219|NCT03208179|Azithromycin|azithromycin|mesh-list
44094220|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
44094221|NCT03208179|Piperaquine|piperaquine|mesh-list
44094222|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
44094223|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44094224|NCT03208179|Artenimol|artenimol|mesh-list
44094225|NCT03208179|Artemisinins|artemisinins|mesh-list
44094226|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094227|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094228|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
44094229|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44094230|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44094232|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094233|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094234|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44094235|NCT03208179|Renal Agents|renal agents|mesh-ancestor
44094236|NCT03062826|Aspirin|aspirin|mesh-list
44094237|NCT03062826|Clopidogrel|clopidogrel|mesh-list
44094238|NCT03062826|Ticagrelor|ticagrelor|mesh-list
44094239|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44094240|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094241|NCT03062826|Analgesics|analgesics|mesh-ancestor
44094242|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
44094243|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094244|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094245|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094246|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094247|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44094248|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44094249|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094250|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44094251|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44094252|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094253|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
44094265|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094267|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44094268|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094269|NCT03057106|Durvalumab|durvalumab|mesh-list
44094270|NCT03057106|Tremelimumab|tremelimumab|mesh-list
44094271|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094272|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094273|NCT02734771|Prednisone|prednisone|mesh-list
44094274|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
44094275|NCT02734771|Rituximab|rituximab|mesh-list
44094276|NCT02734771|Doxorubicin|doxorubicin|mesh-list
44260412|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260414|NCT00638300|Calcium|calcium|mesh-list
44094277|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44094278|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094279|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
44094280|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094281|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094282|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094283|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
44094284|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094285|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094286|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094287|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094288|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094289|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094290|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094291|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094292|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094293|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
44094294|NCT02734771|Hormones|hormones|mesh-ancestor
44094295|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094296|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44094298|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44094299|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44094300|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094301|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094302|NCT02544815|Protective Agents|protective agents|mesh-ancestor
44094303|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094304|NCT02347111|Sotalol|sotalol|mesh-list
44094305|NCT02347111|Flecainide|flecainide|mesh-list
44094306|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44094307|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44094308|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
44094309|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094310|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094311|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094312|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44094313|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
44094314|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
44094315|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094316|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44094317|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44094327|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44094328|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
44094329|NCT01331018|Lenograstim|lenograstim|mesh-list
44094330|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094331|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
44094332|NCT01331018|Hormones|hormones|mesh-ancestor
44094333|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094334|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094335|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44094336|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094337|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44094338|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
44094339|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
44094340|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
44094341|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094342|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44094343|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44094344|NCT01331018|Protective Agents|protective agents|mesh-ancestor
44094345|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094346|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094347|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
44094348|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094349|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
44094350|NCT00712881|Docetaxel|docetaxel|mesh-list
44094351|NCT00712881|Doxorubicin|doxorubicin|mesh-list
44094352|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44094353|NCT00712881|Trastuzumab|trastuzumab|mesh-list
44260416|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260417|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44260419|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260420|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44260421|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44260422|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44260423|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
44260424|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260425|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260426|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260427|NCT00638391|Anastrozole|anastrozole|mesh-list
44260428|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44260429|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260430|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44260431|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44260432|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260433|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260434|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44260435|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
44094354|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094355|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
44094356|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094357|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094358|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094359|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
44094360|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094361|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094362|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094363|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094364|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094365|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094366|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094367|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094368|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094369|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094370|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094371|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
44094372|NCT00470223|Cisplatin|cisplatin|mesh-list
44094373|NCT00470223|Doxorubicin|doxorubicin|mesh-list
44094374|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44094375|NCT00470223|Methotrexate|methotrexate|mesh-list
44094376|NCT00470223|Etoposide|etoposide|mesh-list
44094377|NCT00470223|Ifosfamide|ifosfamide|mesh-list
44094378|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094379|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094380|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43793108|NCT04440735|Atezolizumab|atezolizumab|mesh-list
44260436|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44260437|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260438|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44094381|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094382|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152565|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094383|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094384|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44094395|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44094396|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094397|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094399|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44094400|NCT00103389|Docetaxel|docetaxel|mesh-list
44094401|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094402|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094403|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094404|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094405|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094406|NCT00097851|Docetaxel|docetaxel|mesh-list
44094407|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094408|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094409|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094410|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094411|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094412|NCT00038376|Interferons|interferons|mesh-list
44094413|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
44094414|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
44094415|NCT00038376|Isotretinoin|isotretinoin|mesh-list
44094416|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094417|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
44094418|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094419|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
44094420|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094421|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
44094422|NCT00038389|Rofecoxib|rofecoxib|mesh-list
44094423|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44094424|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44094425|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094426|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094427|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44094428|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094429|NCT00038389|Analgesics|analgesics|mesh-ancestor
44094430|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
44094431|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094432|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094433|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094434|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094435|NCT00038402|Paclitaxel|paclitaxel|mesh-list
44094436|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
44094437|NCT00038402|Fluorouracil|fluorouracil|mesh-list
44094438|NCT00038402|Trastuzumab|trastuzumab|mesh-list
44094439|NCT00038402|Epirubicin|epirubicin|mesh-list
44094440|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094441|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094442|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094443|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094444|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094445|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094446|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094447|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
44094448|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593777|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
44094457|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094458|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094459|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152566|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
44152568|NCT00217412|Isotretinoin|isotretinoin|mesh-list
44152569|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152570|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44260439|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44260440|NCT00638482|Diuretics|diuretics|mesh-ancestor
44260441|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
44260442|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260443|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44260444|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260445|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152571|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152572|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152573|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44152574|NCT00217451|Clindamycin|clindamycin|mesh-list
44152575|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
44152576|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
44152577|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
44152578|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152579|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152580|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44152581|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152582|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152583|NCT00217477|Gemcitabine|gemcitabine|mesh-list
44152584|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152585|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
44152586|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152587|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152588|NCT00217477|Antiviral Agents|antiviral agents|mesh-ancestor
44152589|NCT00217477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152590|NCT00217477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152591|NCT00217477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152592|NCT00217477|Immunologic Factors|immunologic factors|mesh-ancestor
44152593|NCT00217477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152594|NCT00217503|Zidovudine|zidovudine|mesh-list
44152595|NCT00217503|Valganciclovir|valganciclovir|mesh-list
44152596|NCT00217503|Ganciclovir|ganciclovir|mesh-list
44152597|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
44152598|NCT00217503|Bevacizumab|bevacizumab|mesh-list
44152599|NCT00217503|Doxorubicin|doxorubicin|mesh-list
44152600|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44152601|NCT00217503|Etoposide|etoposide|mesh-list
44152602|NCT00217503|Bortezomib|bortezomib|mesh-list
44152603|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152604|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
44152605|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152606|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152607|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44152608|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
44152609|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152610|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152611|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44152612|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152613|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44152614|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44152615|NCT00217503|Growth Substances|growth substances|mesh-ancestor
44152616|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
44152617|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152618|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44152619|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152620|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152621|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44152623|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44152628|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44152630|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
44152631|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152632|NCT00217516|Protective Agents|protective agents|mesh-ancestor
44152633|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152634|NCT00217516|Trace Elements|trace elements|mesh-ancestor
44152635|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
44152636|NCT00217529|Carboplatin|carboplatin|mesh-list
44152637|NCT00217529|Docetaxel|docetaxel|mesh-list
44260446|NCT00638534|Telithromycin|telithromycin|mesh-list
44260447|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44260448|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260449|NCT00638560|Vitamins|vitamins|mesh-list
44260450|NCT00638560|Ascorbic Acid|ascorbic acid|mesh-list
44152638|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44152639|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152640|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094460|NCT00038454|Chrysarobin|chrysarobin|mesh-list
44094461|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651600|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44094462|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094463|NCT00038454|Analgesics|analgesics|mesh-ancestor
44094464|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
44094465|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094466|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094467|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094468|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094469|NCT00038480|Ritonavir|ritonavir|mesh-list
44094470|NCT00038480|Lopinavir|lopinavir|mesh-list
44094471|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44094472|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44094473|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
44094474|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094475|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094476|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094477|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094478|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
44094479|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094480|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44094481|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44094482|NCT00038493|Temozolomide|temozolomide|mesh-list
44094483|NCT00038493|Lonafarnib|lonafarnib|mesh-list
44094484|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094485|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
44094486|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094487|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094488|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094489|NCT00038506|Tenofovir|tenofovir|mesh-list
44094490|NCT00038506|Lamivudine|lamivudine|mesh-list
44094491|NCT00038506|Zidovudine|zidovudine|mesh-list
44094492|NCT00038506|Abacavir|abacavir|mesh-list
44094493|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44094494|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
44094495|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094496|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44094497|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44094498|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094499|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094500|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094501|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094502|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
44094503|NCT00038519|Ritonavir|ritonavir|mesh-list
44094504|NCT00038519|Saquinavir|saquinavir|mesh-list
44094505|NCT00038519|Amprenavir|amprenavir|mesh-list
44094506|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44094507|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44094508|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44094509|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094510|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094511|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094512|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094513|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
44094514|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094515|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44094523|NCT00038532|Efavirenz|efavirenz|mesh-list
44094524|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44094525|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44094526|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44094527|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094528|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094529|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094530|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094531|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
44260451|NCT00638560|Vitamin E|vitamin e|mesh-list
44260452|NCT00638560|Antioxidants|antioxidants|mesh-list
44260453|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
44260454|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260455|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260456|NCT00638560|Protective Agents|protective agents|mesh-ancestor
44260457|NCT00638612|Valacyclovir|valacyclovir|mesh-list
44260458|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
44260459|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260460|NCT00638638|Abciximab|abciximab|mesh-list
44260461|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
44260462|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260463|NCT00638677|Sorbitol|sorbitol|mesh-list
44260464|NCT00638677|Cathartics|cathartics|mesh-ancestor
44260465|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260466|NCT00638729|Clonidine|clonidine|mesh-list
44260467|NCT00638729|Midazolam|midazolam|mesh-list
44260468|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44260469|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44260470|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260471|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260472|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44260473|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44260474|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44260475|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44260476|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
44260477|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
44260478|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
44094532|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094533|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44094534|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43810865|NCT04851977|Vaccines|vaccines|mesh-list
44094535|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44094536|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44094537|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44094538|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44094539|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44094540|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44094541|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44094542|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44094543|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
44094544|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094545|NCT00038545|Paclitaxel|paclitaxel|mesh-list
44094546|NCT00038545|Topotecan|topotecan|mesh-list
44094547|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094548|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094549|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094550|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094551|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094552|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260479|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
44260480|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825249|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094553|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44094554|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094555|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094556|NCT00038558|Doxorubicin|doxorubicin|mesh-list
44094557|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44094558|NCT00038558|Bleomycin|bleomycin|mesh-list
44094559|NCT00038558|Dacarbazine|dacarbazine|mesh-list
44094560|NCT00038558|Vinblastine|vinblastine|mesh-list
44094561|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094562|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094563|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094564|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094565|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094566|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094567|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094568|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
44094569|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094570|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094571|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094572|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094573|NCT00038571|Bortezomib|bortezomib|mesh-list
44094574|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094575|NCT00038584|Lonafarnib|lonafarnib|mesh-list
44094576|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094577|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094578|NCT00038597|Lonafarnib|lonafarnib|mesh-list
44094579|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094580|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094581|NCT00038623|Rituximab|rituximab|mesh-list
43593970|NCT03338205|Ketamine|ketamine|mesh-list
44094593|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094594|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094595|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094596|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
44094597|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094598|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44094599|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44094600|NCT00038662|Atrasentan|atrasentan|mesh-list
44094601|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094602|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44094603|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44094604|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094605|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
44094606|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094607|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094608|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44094609|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44094610|NCT00038701|Growth Substances|growth substances|mesh-ancestor
44094611|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094612|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
44094613|NCT00038766|Semapimod|semapimod|mesh-list
44094614|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44094615|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094616|NCT00038766|Analgesics|analgesics|mesh-ancestor
44094617|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
44094618|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094619|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094620|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094621|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094622|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094623|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
44094624|NCT00038792|Mitogens|mitogens|mesh-list
44094625|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094626|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094627|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
44094628|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094629|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094630|NCT00038831|Fludarabine|fludarabine|mesh-list
44260481|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260482|NCT00638729|Analgesics|analgesics|mesh-ancestor
44260483|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
44094631|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
44094632|NCT00038831|Melphalan|melphalan|mesh-list
44094633|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
44094634|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44094635|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
44094636|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094637|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094638|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
44094639|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094640|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094641|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
44094642|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094643|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094644|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
44094645|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094662|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094663|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
44094664|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
44094665|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094666|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094667|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44094668|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44094669|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44094670|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44094671|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094672|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094673|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094674|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44094675|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
44094676|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44094677|NCT00038922|Oprelvekin|oprelvekin|mesh-list
44094678|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094679|NCT00038935|Factor VIII|factor viii|mesh-list
44094680|NCT00038935|Coagulants|coagulants|mesh-ancestor
44094682|NCT00038961|Fondaparinux|fondaparinux|mesh-list
44094683|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44094684|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
44094685|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44094686|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
44094687|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094688|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094689|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
44094690|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44094691|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44094692|NCT00038974|Ribavirin|ribavirin|mesh-list
44094693|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44094694|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
44094695|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094696|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
44094697|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094698|NCT00039013|Exenatide|exenatide|mesh-list
44094699|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44094700|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094701|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44094702|NCT00039013|Incretins|incretins|mesh-ancestor
44094703|NCT00039013|Hormones|hormones|mesh-ancestor
44094704|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094717|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094718|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094719|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094720|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094721|NCT00039052|Interleukin-4|interleukin-4|mesh-list
44094722|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44094723|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
44094724|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094725|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094726|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094727|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44260484|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260485|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44260486|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
44260487|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
44260488|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44260489|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44260490|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44260491|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44260492|NCT00638742|Latanoprost|latanoprost|mesh-list
44094729|NCT00039091|Antibodies|antibodies|mesh-list
44094730|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
44094731|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44094732|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
44094733|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094734|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824106|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43824107|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43824108|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
43824109|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824110|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094735|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44094736|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094737|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
44094738|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44094739|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094740|NCT00039117|Cytarabine|cytarabine|mesh-list
44094741|NCT00039117|Daunorubicin|daunorubicin|mesh-list
44094742|NCT00039117|Oblimersen|oblimersen|mesh-list
44094743|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094744|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
44094745|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094746|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094747|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
44094748|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094749|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094750|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
44094751|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094752|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094753|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094754|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094755|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094756|NCT00039156|IDN 5109|idn 5109|mesh-list
44094757|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094758|NCT00039169|IDN 5109|idn 5109|mesh-list
44094759|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094760|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44094761|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094762|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094763|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094764|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094766|NCT00039208|Fluorouracil|fluorouracil|mesh-list
44094767|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
44094768|NCT00039208|Irinotecan|irinotecan|mesh-list
44094769|NCT00039208|Calcium|calcium|mesh-list
44094770|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
43594173|NCT03336593|Vaccines|vaccines|mesh-list
44094784|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
44094785|NCT00039208|Vitamins|vitamins|mesh-ancestor
44094786|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
44094787|NCT00039234|Aldesleukin|aldesleukin|mesh-list
44094788|NCT00039234|Histamine|histamine|mesh-list
44094789|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
44094790|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094791|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44094792|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44094793|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
44094794|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094795|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
44094796|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
44094797|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094798|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094799|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094800|NCT00039273|Panitumumab|panitumumab|mesh-list
44094801|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260493|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44260494|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44260495|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
44094802|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094803|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44094804|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44094805|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094806|NCT00039338|Cisplatin|cisplatin|mesh-list
44094807|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094808|NCT00039351|Prednisone|prednisone|mesh-list
44094809|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
44094810|NCT00039351|Vincristine|vincristine|mesh-list
44094811|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094812|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
44094813|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094814|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719379|NCT02636842|Aripiprazole|aripiprazole|mesh-list
44094815|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094816|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
44094817|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094818|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094819|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094820|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094821|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
44094822|NCT00039351|Hormones|hormones|mesh-ancestor
44094823|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094824|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44094825|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094826|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094827|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094828|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094829|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
44094830|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094831|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094832|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094892|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094893|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44094894|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44094895|NCT00039468|Growth Substances|growth substances|mesh-ancestor
44094896|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
44094897|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
44094898|NCT00039481|Doxorubicin|doxorubicin|mesh-list
44094899|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44094900|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
44094901|NCT00039481|Razoxane|razoxane|mesh-list
44094902|NCT00039481|Oblimersen|oblimersen|mesh-list
44094903|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094904|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
44094905|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094906|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094907|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094908|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
44094909|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094910|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094911|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094912|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152641|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094913|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094914|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094915|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094916|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44094973|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094974|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094976|NCT00039611|Fluorouracil|fluorouracil|mesh-list
44094977|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
44094978|NCT00039611|Calcium|calcium|mesh-list
44094979|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
44094980|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44094981|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094982|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
44094983|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094984|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793391|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260496|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260497|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44260498|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260500|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260501|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832612|NCT05255653|Olaparib|olaparib|mesh-list
43832613|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43832614|NCT05255653|Megestrol|megestrol|mesh-list
43832615|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
43832616|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
44260502|NCT00638807|Analgesics|analgesics|mesh-ancestor
44260503|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
44260504|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260505|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260506|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260507|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260508|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260509|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260510|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260511|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260512|NCT00638833|Memantine|memantine|mesh-list
44260513|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44260514|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44260515|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
44260516|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260517|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260518|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260519|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44260520|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44260521|NCT00638859|Telithromycin|telithromycin|mesh-list
44260522|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44260523|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260524|NCT00638976|Eptifibatide|eptifibatide|mesh-list
44260525|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260526|NCT00639015|Phenylephrine|phenylephrine|mesh-list
44260527|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
44260538|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44094985|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094986|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094987|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
44094989|NCT00039611|Protective Agents|protective agents|mesh-ancestor
44094990|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
44094991|NCT00039611|Vitamins|vitamins|mesh-ancestor
44094992|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
44094993|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
44094994|NCT00039663|Pravastatin|pravastatin|mesh-list
44094995|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
44094996|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44094997|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095002|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44095003|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44095004|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095005|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44095006|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44095008|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
44095009|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44095010|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
44095011|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095012|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095013|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
44095014|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44095015|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44095016|NCT00039832|Reteplase|reteplase|mesh-list
44095017|NCT00039832|Abciximab|abciximab|mesh-list
44095018|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
44095019|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44095020|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44095021|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44095022|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095023|NCT00039858|Argatroban|argatroban|mesh-list
44095024|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
44095025|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44095026|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
44095027|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095028|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095029|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
44095030|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44095031|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
44095032|NCT00039884|Hematinics|hematinics|mesh-ancestor
44095033|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44095034|NCT00039962|Thymalfasin|thymalfasin|mesh-list
44095035|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
44095036|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095037|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44095038|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
44095039|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095040|NCT00039975|Ritonavir|ritonavir|mesh-list
44095041|NCT00039975|Indinavir|indinavir|mesh-list
44095042|NCT00039975|Amlodipine|amlodipine|mesh-list
44095043|NCT00039975|Diltiazem|diltiazem|mesh-list
44095044|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44095045|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44095046|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
44095047|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095048|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095049|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095050|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44095051|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
44095052|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095053|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44095054|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44095055|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44095056|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44095057|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095058|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44095059|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095060|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
44095061|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
44095062|NCT00039988|Albuterol|albuterol|mesh-list
44095063|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
44260539|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44260540|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44260541|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
44095064|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44095065|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
44095066|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095067|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095068|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44095069|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
44095119|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44095120|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
44095121|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095122|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44095123|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
44095124|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095125|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095126|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44095127|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44095128|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44095129|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095130|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44095131|NCT00040066|Cocaine|cocaine|mesh-list
44095132|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
44095133|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
44095134|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44095135|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095136|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
44095137|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095138|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44095139|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43647265|NCT02126917|Narcotics|narcotics|mesh-ancestor
43647266|NCT02126917|Analgesics|analgesics|mesh-ancestor
44152642|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095140|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44095141|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095142|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095144|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095148|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095149|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095150|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152643|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152644|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44152645|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152646|NCT00217542|Interferons|interferons|mesh-list
44152647|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
43651601|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
44152648|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
44152649|NCT00217542|Azacitidine|azacitidine|mesh-list
44152651|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152652|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
44152653|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152654|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152655|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
44152656|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152657|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152658|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
44152659|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152660|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44152661|NCT00217542|Protective Agents|protective agents|mesh-ancestor
44152662|NCT00217555|Gemcitabine|gemcitabine|mesh-list
44152663|NCT00217555|Topotecan|topotecan|mesh-list
44152664|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152665|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
44152666|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152667|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152668|NCT00217555|Antiviral Agents|antiviral agents|mesh-ancestor
44152669|NCT00217555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152670|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647267|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
43647268|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647269|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
43647270|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
43719588|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43555986|NCT03556839|Bevacizumab|bevacizumab|mesh-list
43555987|NCT03556839|Cisplatin|cisplatin|mesh-list
44152671|NCT00217555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152672|NCT00217555|Immunologic Factors|immunologic factors|mesh-ancestor
44152673|NCT00217555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152674|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44152675|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152676|NCT00217568|Carboplatin|carboplatin|mesh-list
44152677|NCT00217568|Docetaxel|docetaxel|mesh-list
44260542|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260543|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260544|NCT00639015|Protective Agents|protective agents|mesh-ancestor
44260545|NCT00639119|Ropinirole|ropinirole|mesh-list
44260546|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44260547|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44260548|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
44260549|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
44260550|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152678|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152679|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152680|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
44152681|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152682|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152683|NCT00217607|Paclitaxel|paclitaxel|mesh-list
44152684|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44152685|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152686|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152687|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
44152688|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152689|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152690|NCT00217646|Sorafenib|sorafenib|mesh-list
44152691|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152692|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44152693|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152694|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152695|NCT00217659|Anastrozole|anastrozole|mesh-list
44152696|NCT00217659|Goserelin|goserelin|mesh-list
44152697|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44152698|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152699|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44152700|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44152701|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152702|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152703|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44152704|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
44152705|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095151|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
44095152|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44095153|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647277|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647278|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647280|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43647281|NCT02117141|Narcotics|narcotics|mesh-ancestor
43647282|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44095164|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095165|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
44095166|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095167|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095168|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44095169|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44095170|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095171|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095172|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095173|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095174|NCT00040209|Levodopa|levodopa|mesh-list
44095175|NCT00040209|Apomorphine|apomorphine|mesh-list
44095176|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44095177|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44095178|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
44095179|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095180|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095181|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647283|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647284|NCT02117141|Analgesics|analgesics|mesh-ancestor
43647285|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
43647286|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719597|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095182|NCT00040209|Emetics|emetics|mesh-ancestor
44095183|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
44095184|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095185|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44095186|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
44095187|NCT00040248|Daclizumab|daclizumab|mesh-list
44095188|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095189|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
44260551|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260552|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461961|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461962|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095190|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095191|NCT00040261|Memantine|memantine|mesh-list
44095192|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44095193|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44095194|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
44095195|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095196|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095197|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095198|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44095199|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44095200|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
44095201|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44095202|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647292|NCT02112734|Vitamins|vitamins|mesh-list
43647293|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
43647294|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647295|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43556044|NCT03556371|Expectorants|expectorants|mesh-ancestor
44095203|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095204|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095205|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
44095206|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095207|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095208|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44095209|NCT00040300|Racivir|racivir|mesh-list
44095210|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
44095211|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095212|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
44095213|NCT00040378|Vitamins|vitamins|mesh-list
44095214|NCT00040378|Vitamin E|vitamin e|mesh-list
44095215|NCT00040378|Tocopherols|tocopherols|mesh-list
44095216|NCT00040378|Tocotrienols|tocotrienols|mesh-list
44095217|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
44095218|NCT00040378|Selenium|selenium|mesh-list
44095219|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
44095228|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
44095229|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095230|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095231|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095232|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095233|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
44095234|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095235|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095237|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095239|NCT00040391|Protective Agents|protective agents|mesh-ancestor
44095240|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
44095241|NCT00040391|Vitamins|vitamins|mesh-ancestor
44095242|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
44095243|NCT00040417|Fludarabine|fludarabine|mesh-list
44095244|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
44095245|NCT00040417|Lenograstim|lenograstim|mesh-list
44095246|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095247|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
44095248|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095249|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44095250|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095251|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
44095252|NCT00040469|Busulfan|busulfan|mesh-list
44095253|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
44095254|NCT00040469|Phenytoin|phenytoin|mesh-list
44095255|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095256|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
44095257|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095258|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095259|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095260|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
44095261|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095262|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095263|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43647296|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43647297|NCT02079740|Trametinib|trametinib|mesh-list
43647298|NCT02079740|Navitoclax|navitoclax|mesh-list
43647299|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647300|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647301|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647302|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647303|NCT02015611|Vitamin D|vitamin d|mesh-list
43647304|NCT02015611|Vitamins|vitamins|mesh-ancestor
43647305|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
43647306|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647307|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43647308|NCT02009449|Leucovorin|leucovorin|mesh-list
43647309|NCT02009449|Gemcitabine|gemcitabine|mesh-list
43647310|NCT02009449|Paclitaxel|paclitaxel|mesh-list
43647311|NCT02009449|Docetaxel|docetaxel|mesh-list
43647312|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43647313|NCT02009449|Carboplatin|carboplatin|mesh-list
43647314|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
43647315|NCT02009449|Fluorouracil|fluorouracil|mesh-list
43647316|NCT02009449|Capecitabine|capecitabine|mesh-list
43647317|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
43647318|NCT02009449|Nivolumab|nivolumab|mesh-list
43647319|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
43719625|NCT02634970|Ranibizumab|ranibizumab|mesh-list
44095264|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095265|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
44461964|NCT01536535|Mesalamine|mesalamine|mesh-list
44461965|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44461966|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
44461967|NCT01536535|Hormones|hormones|mesh-ancestor
44461968|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44461969|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461970|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44461971|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656243|NCT02962258|Amlodipine|amlodipine|mesh-list
44095266|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44095267|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44095268|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095269|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44095270|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44095271|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
44095272|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095273|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
44095274|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095275|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095276|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095277|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
43647320|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647321|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647322|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647323|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
43719634|NCT02634541|Adalimumab|adalimumab|mesh-list
44095278|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095279|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095280|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095281|NCT00040495|Pantoprazole|pantoprazole|mesh-list
44095282|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44095283|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44095284|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44095285|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095286|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095287|NCT00040508|Sirolimus|sirolimus|mesh-list
43594753|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
43647325|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647326|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43647327|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
43647328|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
43647329|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647330|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647331|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647332|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
43647333|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647334|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647335|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43647336|NCT02009449|Antidotes|antidotes|mesh-ancestor
43647337|NCT02009449|Protective Agents|protective agents|mesh-ancestor
43647338|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
43647340|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
43647341|NCT01969227|Ketamine|ketamine|mesh-list
43647342|NCT01969227|Analgesics|analgesics|mesh-ancestor
43647343|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
43647344|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647345|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647346|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43647347|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43647348|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
43647349|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
43647350|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44095291|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095292|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
44095293|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095294|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
44095295|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095296|NCT00040521|Oprelvekin|oprelvekin|mesh-list
44095297|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095298|NCT00040586|Interleukin-2|interleukin-2|mesh-list
44095299|NCT00040586|Antibodies|antibodies|mesh-list
43811446|NCT04843943|Growth Substances|growth substances|mesh-ancestor
44095300|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44095301|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
44095302|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095303|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095304|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44095305|NCT00040586|Analgesics|analgesics|mesh-ancestor
44095306|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
44095307|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095308|NCT00040599|Labetuzumab|labetuzumab|mesh-list
44095309|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095310|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095311|NCT00040625|Cisplatin|cisplatin|mesh-list
44095312|NCT00040625|Pemetrexed|pemetrexed|mesh-list
44095313|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095314|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095315|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095316|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44095317|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095318|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
44095319|NCT00040651|Fludarabine|fludarabine|mesh-list
44095320|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
44095321|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095322|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
44095323|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095324|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44461972|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44461973|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44461974|NCT01536535|Analgesics|analgesics|mesh-ancestor
44461975|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
44461976|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461977|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095325|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095326|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
44095327|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095328|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647351|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43647352|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43647353|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647354|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095329|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095330|NCT00040690|Leucovorin|leucovorin|mesh-list
44095331|NCT00040690|Cytarabine|cytarabine|mesh-list
44095332|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
44095333|NCT00040690|Ifosfamide|ifosfamide|mesh-list
44095334|NCT00040690|Doxorubicin|doxorubicin|mesh-list
44095335|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44095336|NCT00040690|Methotrexate|methotrexate|mesh-list
44095337|NCT00040690|Etoposide|etoposide|mesh-list
44095338|NCT00040690|Vincristine|vincristine|mesh-list
44095339|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
44095340|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095341|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
44095342|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095343|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095344|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095345|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
44095346|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095347|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095348|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095349|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095350|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095351|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095352|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095353|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44095354|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
44095355|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44095356|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095357|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
44095358|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095359|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44095360|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095365|NCT00040690|Protective Agents|protective agents|mesh-ancestor
44095366|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
44095367|NCT00040690|Vitamins|vitamins|mesh-ancestor
44095368|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
44095369|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095370|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095371|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095372|NCT00040768|Bortezomib|bortezomib|mesh-list
44095373|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647358|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647359|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647360|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
43647361|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
43647362|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43647363|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43647364|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095374|NCT00040781|Gefitinib|gefitinib|mesh-list
44095375|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095376|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095377|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095378|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095379|NCT00040794|Paclitaxel|paclitaxel|mesh-list
44095380|NCT00040794|Carboplatin|carboplatin|mesh-list
44095381|NCT00040794|Gefitinib|gefitinib|mesh-list
44095382|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095383|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095384|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095385|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095386|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095387|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095388|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095389|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095390|NCT00040807|Docetaxel|docetaxel|mesh-list
44095391|NCT00040807|Irinotecan|irinotecan|mesh-list
44095392|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095393|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095394|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44461978|NCT01536392|Ondansetron|ondansetron|mesh-list
44461979|NCT01536392|Granisetron|granisetron|mesh-list
44461980|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
44461981|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
43647365|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647366|NCT01954524|Urological Agents|urological agents|mesh-ancestor
43647367|NCT01867333|Metronidazole|metronidazole|mesh-list
43647368|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647369|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43647370|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43647371|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44461982|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44461983|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44461984|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44461985|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
44461986|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
44461987|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44461988|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
44461989|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44461990|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44461991|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44095395|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095396|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095397|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095398|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095399|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095400|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
44095401|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095402|NCT00040859|Capecitabine|capecitabine|mesh-list
44095403|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
43647372|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43647373|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43647374|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647376|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43647377|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647378|NCT01782443|Growth Substances|growth substances|mesh-ancestor
43647379|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647380|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647381|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647383|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43647384|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43647385|NCT01667120|Analgesics|analgesics|mesh-ancestor
43647386|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
43647387|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647388|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095404|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095405|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
44095406|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095407|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095408|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
44095409|NCT00040872|Thiotepa|thiotepa|mesh-list
44095410|NCT00040872|Carboplatin|carboplatin|mesh-list
44095411|NCT00040872|Doxorubicin|doxorubicin|mesh-list
44095412|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44095413|NCT00040872|Etoposide|etoposide|mesh-list
44095414|NCT00040872|Vincristine|vincristine|mesh-list
44095415|NCT00040872|Topotecan|topotecan|mesh-list
44095416|NCT00040872|Isotretinoin|isotretinoin|mesh-list
44095417|NCT00040872|Antibodies|antibodies|mesh-list
44095418|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44095419|NCT00040872|Sargramostim|sargramostim|mesh-list
44095420|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095421|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
44095422|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095423|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095424|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095425|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
44095426|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647389|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43647390|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647391|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43647392|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647393|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647395|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647396|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647397|NCT01592110|Risperidone|risperidone|mesh-list
43647398|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43647399|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
43647400|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647401|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647402|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647403|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43647404|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43647405|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647406|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43647407|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43647408|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
43647412|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647414|NCT01511042|Norepinephrine|norepinephrine|mesh-list
43647415|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
43647416|NCT01511042|Giapreza|giapreza|mesh-list
43647417|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
44095427|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095428|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095429|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095430|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095431|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095432|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095433|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095434|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095435|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095468|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095469|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095470|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095471|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095472|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
44095473|NCT00041054|Carboplatin|carboplatin|mesh-list
44095474|NCT00041054|Etoposide|etoposide|mesh-list
44095475|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095476|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44461993|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44461994|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44461995|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44461996|NCT01536379|Belimumab|belimumab|mesh-list
44461997|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095477|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43647422|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647423|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556200|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
44095485|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44095487|NCT00041054|Analgesics|analgesics|mesh-ancestor
44095488|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
44095489|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095490|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44095491|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095492|NCT00041093|Docetaxel|docetaxel|mesh-list
44095493|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095494|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095495|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095496|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095497|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095498|NCT00041106|Gemcitabine|gemcitabine|mesh-list
44095499|NCT00041106|Cisplatin|cisplatin|mesh-list
44095500|NCT00041106|Gefitinib|gefitinib|mesh-list
44095501|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095502|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095503|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
44095504|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095505|NCT00041106|Antiviral Agents|antiviral agents|mesh-ancestor
44095506|NCT00041106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095507|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095508|NCT00041106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095509|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
44095510|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095511|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095512|NCT00041171|Docetaxel|docetaxel|mesh-list
44095513|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095514|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095515|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095516|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095517|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095518|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
43647424|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
43647425|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
43556207|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
44095519|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095520|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095521|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095522|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095523|NCT00041210|Prednisone|prednisone|mesh-list
44095524|NCT00041210|Doxorubicin|doxorubicin|mesh-list
44095525|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44095526|NCT00041210|Bleomycin|bleomycin|mesh-list
44095527|NCT00041210|Etoposide|etoposide|mesh-list
44095528|NCT00041210|Vincristine|vincristine|mesh-list
44095529|NCT00041210|Dacarbazine|dacarbazine|mesh-list
44095530|NCT00041210|Vinblastine|vinblastine|mesh-list
44095531|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
44095532|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43647426|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647427|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44095533|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095534|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095535|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095536|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647428|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43647429|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
43647430|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647431|NCT01478542|Rituximab|rituximab|mesh-list
43647432|NCT01478542|Vincristine|vincristine|mesh-list
43647433|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647434|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556235|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
43556236|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43556237|NCT03554408|Antibodies|antibodies|mesh-list
43556238|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
43556239|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44095537|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095538|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44095540|NCT00041210|Hormones|hormones|mesh-ancestor
44095541|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095542|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095543|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44095544|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095545|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095550|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
44095551|NCT00041223|Procyanidin|procyanidin|mesh-list
44095552|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
44095553|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095554|NCT00041223|Protective Agents|protective agents|mesh-ancestor
44461998|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
44461999|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462001|NCT01536262|Olodaterol|olodaterol|mesh-list
44462002|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462003|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
43914888|NCT00438802|Alefacept|alefacept|mesh-list
44462004|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656265|NCT02962518|Triamcinolone|triamcinolone|mesh-list
44095555|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095556|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44095557|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44095558|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095559|NCT00041236|Exatecan|exatecan|mesh-list
43556240|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
43556241|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556242|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556243|NCT03554395|Antibodies|antibodies|mesh-list
43719682|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43719683|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43719685|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
43719686|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43719687|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44095560|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095561|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095562|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095563|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095564|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095565|NCT00041262|Cisplatin|cisplatin|mesh-list
44095566|NCT00041262|Fluorouracil|fluorouracil|mesh-list
44095567|NCT00041262|Epirubicin|epirubicin|mesh-list
44095568|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095569|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
44095570|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095571|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095572|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095573|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
44095574|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095575|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095576|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095577|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095578|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095579|NCT00041275|Megestrol|megestrol|mesh-list
44095580|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
44095581|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44095582|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44095583|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44095584|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
44095585|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44095586|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095587|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43647435|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
43647436|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647437|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647438|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647439|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647440|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
43647441|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
43647443|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44095588|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44095589|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44095590|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095591|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
44095592|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44095593|NCT00041288|Cyclosporine|cyclosporine|mesh-list
44095594|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
44095595|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
44095596|NCT00041288|Methotrexate|methotrexate|mesh-list
44095597|NCT00041288|Fludarabine|fludarabine|mesh-list
44095598|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
44095599|NCT00041288|Tacrolimus|tacrolimus|mesh-list
44095600|NCT00041288|Cyclosporins|cyclosporins|mesh-list
44095601|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095602|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
44095603|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095604|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095605|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095606|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
44095607|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647481|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556270|NCT03554109|Avelumab|avelumab|mesh-list
44095608|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095609|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095610|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44095611|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
44095612|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44095613|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462005|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462006|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462007|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
44095614|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
44095615|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095616|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095617|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44095625|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44095627|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
43647482|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647483|NCT01210625|Psyllium|psyllium|mesh-list
43647484|NCT01210625|Cathartics|cathartics|mesh-ancestor
44095628|NCT00041314|Carboplatin|carboplatin|mesh-list
44095629|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095630|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095631|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
44095632|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095633|NCT00041314|Antiviral Agents|antiviral agents|mesh-ancestor
44095634|NCT00041314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095635|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095636|NCT00041314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647485|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647486|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
43647487|NCT01204905|Maraviroc|maraviroc|mesh-list
44095637|NCT00041314|Immunologic Factors|immunologic factors|mesh-ancestor
44095638|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095639|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44095640|NCT00041314|Protective Agents|protective agents|mesh-ancestor
44095641|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44095642|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44095643|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44095644|NCT00041314|Analgesics|analgesics|mesh-ancestor
44095645|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
44095646|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095647|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44095648|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095649|NCT00041327|Interferons|interferons|mesh-list
44095650|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
44095651|NCT00041327|Lamivudine|lamivudine|mesh-list
44095652|NCT00041327|Zidovudine|zidovudine|mesh-list
44095653|NCT00041327|Prednisone|prednisone|mesh-list
44095654|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
44095655|NCT00041327|Doxorubicin|doxorubicin|mesh-list
44095656|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44095658|NCT00041327|Vincristine|vincristine|mesh-list
44095659|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095660|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
44095661|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095662|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095663|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095664|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
44095665|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095666|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095667|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095668|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095669|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095670|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095671|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095672|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44095673|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
44095674|NCT00041327|Hormones|hormones|mesh-ancestor
43647489|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43647490|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
43647491|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647492|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43647493|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43556311|NCT03553537|Doxorubicin|doxorubicin|mesh-list
43556312|NCT03553537|Vincristine|vincristine|mesh-list
44095675|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095676|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44095677|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095678|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
44095679|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095680|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095681|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095682|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095683|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44095684|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647494|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647495|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647496|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43647497|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43556351|NCT03553329|Trametinib|trametinib|mesh-list
44095685|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095686|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44095702|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095703|NCT00041535|Miglustat|miglustat|mesh-list
44095704|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095705|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095706|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095707|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260555|NCT00639262|Temozolomide|temozolomide|mesh-list
44260556|NCT00639262|Sorafenib|sorafenib|mesh-list
44260557|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44260558|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
44260559|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260560|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095708|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
44095709|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095710|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44095711|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44095712|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095713|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
44095714|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44095715|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
44095716|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095717|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095718|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44095719|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
44095720|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44095721|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
44095722|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647498|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43647500|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
43647501|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719704|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719705|NCT02634515|Insulin|insulin|mesh-list
44095723|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095724|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44095725|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
44095726|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
44095727|NCT00041548|Protective Agents|protective agents|mesh-ancestor
44095728|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
44095729|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44095730|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
44095731|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095732|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095733|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44095734|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
44095735|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44095736|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
44095737|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095738|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095739|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44095740|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
44095741|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
44095742|NCT00041561|Protective Agents|protective agents|mesh-ancestor
44095743|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
44095744|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44095745|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
44095753|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095754|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44095755|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
44095756|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
44095757|NCT00041574|Protective Agents|protective agents|mesh-ancestor
44095758|NCT00041639|Labetuzumab|labetuzumab|mesh-list
44095759|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095760|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095761|NCT00041652|Labetuzumab|labetuzumab|mesh-list
44095762|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095763|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095764|NCT00041665|Mitogens|mitogens|mesh-list
44095765|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095766|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095767|NCT00041678|Aripiprazole|aripiprazole|mesh-list
44095768|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
44095769|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095770|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44095771|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44095772|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260561|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44260562|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260563|NCT00639327|Irinotecan|irinotecan|mesh-list
44260564|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44260565|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44260566|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260567|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260568|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260569|NCT00639366|Trastuzumab|trastuzumab|mesh-list
44260570|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260571|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095773|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647502|NCT01158417|Protective Agents|protective agents|mesh-ancestor
43647503|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647504|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647505|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43647506|NCT01154920|Paclitaxel|paclitaxel|mesh-list
43647507|NCT01154920|Docetaxel|docetaxel|mesh-list
43647508|NCT01154920|Cisplatin|cisplatin|mesh-list
43647509|NCT01154920|Carboplatin|carboplatin|mesh-list
43647510|NCT01154920|Fluorouracil|fluorouracil|mesh-list
43647511|NCT01154920|Cetuximab|cetuximab|mesh-list
43647512|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647513|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647514|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647515|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
43647516|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556411|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43556412|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
43556413|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095774|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
44095775|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
44095776|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095777|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095778|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44095779|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44095780|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
44095781|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44095782|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44095783|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44095784|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44095785|NCT00041691|Labetuzumab|labetuzumab|mesh-list
44095786|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095787|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095788|NCT00041704|Anidulafungin|anidulafungin|mesh-list
43647517|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647519|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095789|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
44095790|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095791|NCT00041782|Dalteparin|dalteparin|mesh-list
44095792|NCT00041782|Tinzaparin|tinzaparin|mesh-list
44095793|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44095794|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
44095795|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44095796|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44095797|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152706|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152707|NCT00217698|Gemcitabine|gemcitabine|mesh-list
44152708|NCT00217698|Cisplatin|cisplatin|mesh-list
44152709|NCT00217698|Gefitinib|gefitinib|mesh-list
44152710|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152711|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152713|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152714|NCT00217698|Antiviral Agents|antiviral agents|mesh-ancestor
44152715|NCT00217698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152716|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152717|NCT00217698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44152718|NCT00217698|Immunologic Factors|immunologic factors|mesh-ancestor
44152719|NCT00217698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152720|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43595281|NCT03326258|Nivolumab|nivolumab|mesh-list
44152729|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43647520|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647521|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
43647522|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647523|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647524|NCT01028846|Diazoxide|diazoxide|mesh-list
43647525|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43647526|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43647527|NCT00945269|Aldesleukin|aldesleukin|mesh-list
43647528|NCT00945269|Interleukin-2|interleukin-2|mesh-list
43647529|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
43647530|NCT00945269|Immunotoxins|immunotoxins|mesh-list
43647531|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647532|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43647533|NCT00945269|Analgesics|analgesics|mesh-ancestor
43556450|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
43647534|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
43647535|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647536|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647537|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43647538|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44152730|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152731|NCT00217789|Dimercaprol|dimercaprol|mesh-list
44152732|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
44152733|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
44152734|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152735|NCT00217815|Efungumab|efungumab|mesh-list
44152736|NCT00217815|Docetaxel|docetaxel|mesh-list
44152737|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152738|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44152739|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44152740|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44152741|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152742|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
44260572|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
44260573|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44260574|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260576|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260577|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260578|NCT00639483|Analgesics|analgesics|mesh-ancestor
44260579|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
44260580|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260581|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656293|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
43811858|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647539|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
43647540|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647541|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
43647542|NCT00868179|Dabigatran|dabigatran|mesh-list
43647543|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
43647544|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43556471|NCT03552601|Methamphetamine|methamphetamine|mesh-list
43647545|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
43647546|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647547|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647548|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
43647550|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
43647551|NCT00856947|Vitamins|vitamins|mesh-ancestor
43647552|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
43647553|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647554|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43647555|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43647556|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
43647557|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43647558|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647559|NCT00830895|Everolimus|everolimus|mesh-list
43647560|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647561|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647562|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
44095799|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44095800|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
44095801|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44095802|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095803|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44095804|NCT00041977|Doxycycline|doxycycline|mesh-list
44095805|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44095806|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095807|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
44095808|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43647563|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647564|NCT00704106|Entecavir|entecavir|mesh-list
43647565|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
43647566|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647567|NCT00620425|Sumatriptan|sumatriptan|mesh-list
43647568|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43647569|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43647570|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43647571|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
43647572|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647573|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647574|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647575|NCT00614029|Sumatriptan|sumatriptan|mesh-list
43647576|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43647577|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43647578|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43647579|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
43647580|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556494|NCT03552354|Argatroban|argatroban|mesh-list
44095809|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44095810|NCT00041990|Decitabine|decitabine|mesh-list
44095811|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095812|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
44095813|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095814|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095815|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095816|NCT00042003|Decitabine|decitabine|mesh-list
44095817|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095818|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
44095819|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095820|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095821|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095822|NCT00042016|Decitabine|decitabine|mesh-list
44095823|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43647581|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647582|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647584|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43556513|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44095824|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
44095825|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095826|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095827|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095828|NCT00042029|Aprepitant|aprepitant|mesh-list
44095829|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
44095830|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
44095831|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647585|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43647586|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43647587|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
43647588|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647589|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647590|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647591|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
43556530|NCT03552016|Vitamins|vitamins|mesh-ancestor
44095832|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095833|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44095834|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44095835|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538178|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
44095836|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095837|NCT00042068|Meloxicam|meloxicam|mesh-list
44095838|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44095839|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44095840|NCT00042068|Analgesics|analgesics|mesh-ancestor
44095841|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
43647592|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43647593|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
43647594|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647595|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647596|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43647597|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
43719740|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719741|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43719742|NCT02634203|Riociguat|riociguat|mesh-list
43719743|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
43719744|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719745|NCT02634021|Midazolam|midazolam|mesh-list
43595341|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
44095876|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095878|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43595405|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
44095885|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
44095886|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095887|NCT00042354|Clofarabine|clofarabine|mesh-list
44260582|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260583|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260584|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260585|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260586|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260587|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260588|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
43556537|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43647598|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43647600|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647601|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647602|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43647603|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
43647604|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
44260589|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44260590|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
44260591|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260592|NCT00639496|Expectorants|expectorants|mesh-ancestor
44260593|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
44260594|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44260595|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
44260596|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260597|NCT00639496|Protective Agents|protective agents|mesh-ancestor
44095888|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095889|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
44095890|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095891|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095892|NCT00042367|Mafosfamide|mafosfamide|mesh-list
44095893|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
43556551|NCT03551808|Analgesics|analgesics|mesh-ancestor
43647605|NCT00515281|Protective Agents|protective agents|mesh-ancestor
43647607|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
43647608|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43647609|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43647610|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824121|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824122|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
43824125|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095894|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44095895|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
44095896|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095897|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095898|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095899|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095900|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095901|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
44095902|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095903|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44095904|NCT00042393|Adefovir|adefovir|mesh-list
44095905|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44095906|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
44095907|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824127|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824128|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824129|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824130|NCT05515120|Aspirin|aspirin|mesh-list
43824131|NCT05515120|Vitamin K|vitamin k|mesh-list
43824132|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
43824133|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
43824134|NCT05515120|Vitamins|vitamins|mesh-ancestor
43556576|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095908|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44095909|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095910|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095911|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095912|NCT00042406|Zanolimumab|zanolimumab|mesh-list
44095913|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095914|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095915|NCT00042458|Pramlintide|pramlintide|mesh-list
44095916|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44095917|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095918|NCT00042471|Pramlintide|pramlintide|mesh-list
44095919|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44095920|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44095921|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095922|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
43824135|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
43824136|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824137|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44095923|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44095924|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44095925|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095926|NCT00042536|Naltrexone|naltrexone|mesh-list
44095927|NCT00042536|Yohimbine|yohimbine|mesh-list
44095928|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44095929|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44095930|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260598|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260599|NCT00639496|Antidotes|antidotes|mesh-ancestor
44260600|NCT00639522|Paclitaxel|paclitaxel|mesh-list
44260601|NCT00639522|Capecitabine|capecitabine|mesh-list
44260602|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44260603|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260604|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
43824138|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824139|NCT05515120|Analgesics|analgesics|mesh-ancestor
43824140|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
44260605|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
44260606|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
44260607|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260608|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44260609|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
44260610|NCT00639574|Nefopam|nefopam|mesh-list
44260611|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260612|NCT00639574|Analgesics|analgesics|mesh-ancestor
44260613|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
44260614|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260615|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260616|NCT00639587|Cetirizine|cetirizine|mesh-list
44260617|NCT00639587|Ketotifen|ketotifen|mesh-list
44260618|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43824141|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824142|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824143|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824144|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43824145|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824146|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824147|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43824148|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824149|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824150|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
44260619|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44260620|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44260621|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
44260622|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
44260623|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260624|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260625|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260626|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
44260627|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
44260628|NCT00639691|Omalizumab|omalizumab|mesh-list
44260629|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44260630|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44260631|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44260632|NCT00639743|Tenecteplase|tenecteplase|mesh-list
44260633|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260634|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44260635|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260638|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260639|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260640|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
44260641|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260642|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44260643|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
44260644|NCT00639756|Protective Agents|protective agents|mesh-ancestor
43556611|NCT03551171|Niraparib|niraparib|mesh-list
44260645|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260646|NCT00639873|Doxycycline|doxycycline|mesh-list
44260647|NCT00639873|Artesunate|artesunate|mesh-list
44260648|NCT00639873|Quinine|quinine|mesh-list
44260649|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44260650|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260651|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
44260652|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44095931|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
44095932|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095933|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
44095934|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
44095935|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44095936|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44095937|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44095938|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
44095939|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095940|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095941|NCT00042536|Urological Agents|urological agents|mesh-ancestor
44095942|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44095943|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44095944|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811898|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095945|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43595445|NCT03324867|Insulin|insulin|mesh-list
44095950|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095951|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095952|NCT00042562|Analgesics|analgesics|mesh-ancestor
43556628|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43556629|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556634|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
44095953|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
44095954|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095955|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
44095956|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095957|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
44095958|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44095959|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44095960|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44095961|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095962|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095963|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095964|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095965|NCT00042575|Analgesics|analgesics|mesh-ancestor
44095966|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
44095967|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095968|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
44095969|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095970|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
44095971|NCT00042588|Antibodies|antibodies|mesh-list
44095972|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44095973|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
43556650|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44095974|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095975|NCT00042601|Pramlintide|pramlintide|mesh-list
44095976|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44095977|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260653|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44260654|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260655|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
44260656|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
44260657|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44260658|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
44260659|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44260660|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260661|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44260662|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260663|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260664|NCT00639873|Analgesics|analgesics|mesh-ancestor
44095978|NCT00042653|Cinacalcet|cinacalcet|mesh-list
44095979|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44095980|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095981|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44095982|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
44095983|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095984|NCT00042679|Gemcitabine|gemcitabine|mesh-list
44095985|NCT00042679|Carboplatin|carboplatin|mesh-list
44095986|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095987|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44095988|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
44095989|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095990|NCT00042679|Antiviral Agents|antiviral agents|mesh-ancestor
44095991|NCT00042679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095992|NCT00042679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095993|NCT00042679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44095994|NCT00042679|Immunologic Factors|immunologic factors|mesh-ancestor
44095995|NCT00042679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095996|NCT00042718|Amoxicillin|amoxicillin|mesh-list
44095997|NCT00042718|Azithromycin|azithromycin|mesh-list
44095998|NCT00042718|Levofloxacin|levofloxacin|mesh-list
44095999|NCT00042718|Ofloxacin|ofloxacin|mesh-list
44096000|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
44096001|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
44096002|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44096003|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096004|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096005|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44096006|NCT00042718|Renal Agents|renal agents|mesh-ancestor
44096007|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096008|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096009|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096010|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096011|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096012|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43595518|NCT03324490|Bupivacaine|bupivacaine|mesh-list
44096017|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
44096018|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096019|NCT00042731|Protective Agents|protective agents|mesh-ancestor
44096020|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096021|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44096022|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44096023|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096024|NCT00042796|Decitabine|decitabine|mesh-list
44096025|NCT00042796|Azacitidine|azacitidine|mesh-list
44096026|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096027|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
44096028|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096029|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096030|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096031|NCT00042809|Paclitaxel|paclitaxel|mesh-list
44096032|NCT00042809|Trastuzumab|trastuzumab|mesh-list
44260665|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
44260666|NCT00639925|Gemcitabine|gemcitabine|mesh-list
44260667|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44260668|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
43647611|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
43647612|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43647613|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647614|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43647615|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43647616|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43824151|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43647617|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647618|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
43647619|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647621|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43647622|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44260669|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260670|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260671|NCT00639925|Antiviral Agents|antiviral agents|mesh-ancestor
44260672|NCT00639925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260673|NCT00639925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260674|NCT00639925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260675|NCT00639925|Immunologic Factors|immunologic factors|mesh-ancestor
44260676|NCT00639925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260677|NCT00639938|Nevirapine|nevirapine|mesh-list
44260678|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
44260679|NCT00639938|Antibodies|antibodies|mesh-list
44260680|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
44260681|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44260682|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44260683|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
43647623|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647624|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
43647625|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647626|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
43647627|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43556737|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
44260684|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260685|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44260686|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44260687|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260688|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260689|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
44260690|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096033|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44096034|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44096035|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096036|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
44096037|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
44096038|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
44096039|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096040|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096041|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096042|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096043|NCT00042822|Romidepsin|romidepsin|mesh-list
44096044|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096045|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096046|NCT00042835|Paclitaxel|paclitaxel|mesh-list
44096047|NCT00042835|Etoposide|etoposide|mesh-list
44096048|NCT00042835|Docetaxel|docetaxel|mesh-list
44096049|NCT00042835|Cisplatin|cisplatin|mesh-list
44096050|NCT00042835|Carboplatin|carboplatin|mesh-list
44096051|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
44096052|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44096053|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647629|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43647630|NCT05620901|Prednisolone|prednisolone|mesh-list
43647631|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43647632|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
43647633|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43647634|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
43647635|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
43647636|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719791|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43719792|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719793|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719794|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43719795|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096054|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096055|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44260691|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260692|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260693|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44260694|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44260695|NCT00640003|Baclofen|baclofen|mesh-list
44260696|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44260697|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260698|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44260699|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260700|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44260701|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
44260702|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
44260703|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647637|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647638|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647639|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
43647640|NCT05620901|Hormones|hormones|mesh-ancestor
43647641|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647642|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44096056|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44096057|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44096058|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096059|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096060|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096061|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096062|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096063|NCT00042848|Modafinil|modafinil|mesh-list
44096064|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44096065|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096066|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44096067|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44096068|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44096069|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096070|NCT00042861|Leucovorin|leucovorin|mesh-list
44096071|NCT00042861|Fluorouracil|fluorouracil|mesh-list
44096072|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44096073|NCT00042861|Calcium|calcium|mesh-list
44096074|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
44096075|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096076|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096077|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
44096078|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096079|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096080|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096081|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096082|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
44096083|NCT00042861|Antidotes|antidotes|mesh-ancestor
44096084|NCT00042861|Protective Agents|protective agents|mesh-ancestor
44096095|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
44096096|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43719804|NCT02633878|Progestins|progestins|mesh-ancestor
44096097|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096099|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096100|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096101|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096102|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096103|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
44096104|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44096105|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096106|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096107|NCT00042874|Antidotes|antidotes|mesh-ancestor
44096108|NCT00042874|Protective Agents|protective agents|mesh-ancestor
44096109|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
44096110|NCT00042874|Vitamins|vitamins|mesh-ancestor
44096111|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
44096112|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
44096113|NCT00042874|Growth Substances|growth substances|mesh-ancestor
44096114|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647644|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43647645|NCT05620901|Protective Agents|protective agents|mesh-ancestor
43647646|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
43647647|NCT05620862|Analgesics|analgesics|mesh-ancestor
43647648|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
43647649|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647650|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647651|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647652|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43647653|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43647654|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647655|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647656|NCT05620771|Bevacizumab|bevacizumab|mesh-list
43647657|NCT05620771|Atezolizumab|atezolizumab|mesh-list
43647658|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647659|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647660|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43647661|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647662|NCT05620771|Growth Substances|growth substances|mesh-ancestor
43647663|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647664|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647665|NCT05620654|Paclitaxel|paclitaxel|mesh-list
43647666|NCT05620654|Cisplatin|cisplatin|mesh-list
43647667|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647668|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096115|NCT00042887|Mitomycins|mitomycins|mesh-list
44096116|NCT00042887|Mitomycin|mitomycin|mesh-list
44260704|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260706|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260707|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260709|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
44260710|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260711|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260712|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644734|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43647693|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
43647694|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44260713|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260714|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260715|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260716|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260717|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260718|NCT00640081|Leucovorin|leucovorin|mesh-list
44260719|NCT00640081|Fluorouracil|fluorouracil|mesh-list
44260720|NCT00640081|Capecitabine|capecitabine|mesh-list
44260721|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
44260722|NCT00640081|Cetuximab|cetuximab|mesh-list
44260723|NCT00640081|Calcium|calcium|mesh-list
44260724|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
44260725|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44260726|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260727|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
44260728|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260729|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44260730|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260731|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260732|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
44260733|NCT00640081|Antidotes|antidotes|mesh-ancestor
44260734|NCT00640081|Protective Agents|protective agents|mesh-ancestor
44260735|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
44260736|NCT00640081|Vitamins|vitamins|mesh-ancestor
44260737|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
44260738|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260739|NCT00640094|Melatonin|melatonin|mesh-list
44260746|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
44260747|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44260748|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44260749|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44260750|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44260751|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260752|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260753|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43647695|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
43647696|NCT05620641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43647698|NCT05620589|Tetracycline|tetracycline|mesh-list
43647699|NCT05620589|Esomeprazole|esomeprazole|mesh-list
43647700|NCT05620589|Bismuth|bismuth|mesh-list
43647701|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43647702|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647703|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43647704|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647705|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43647706|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260754|NCT00640159|Protective Agents|protective agents|mesh-ancestor
44260755|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260756|NCT00640198|Memantine|memantine|mesh-list
44260757|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44260758|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44260759|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
44260760|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260761|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260762|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260763|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44260764|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44260765|NCT00640237|Calcifediol|calcifediol|mesh-list
44260766|NCT00640237|Vitamins|vitamins|mesh-ancestor
44260767|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
44260768|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260769|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44260770|NCT00640263|Ritonavir|ritonavir|mesh-list
44260771|NCT00640263|Lopinavir|lopinavir|mesh-list
44260772|NCT00640263|Lamivudine|lamivudine|mesh-list
44260773|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44260774|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44260775|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
44260776|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260777|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260778|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260785|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44260786|NCT00640276|Pitavastatin|pitavastatin|mesh-list
43880646|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647707|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647709|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43647710|NCT05620498|Lenvatinib|lenvatinib|mesh-list
43647711|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647712|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647713|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647714|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647715|NCT05620277|Tocopherols|tocopherols|mesh-list
43647716|NCT05620277|Vitamin E|vitamin e|mesh-list
43647717|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
43647718|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
43647719|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647720|NCT05620277|Protective Agents|protective agents|mesh-ancestor
43647721|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647722|NCT05620277|Vitamins|vitamins|mesh-ancestor
43647723|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
43647724|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
43647725|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647726|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647727|NCT05619848|Midazolam|midazolam|mesh-list
43647728|NCT05619848|Remifentanil|remifentanil|mesh-list
43647729|NCT05619848|Bromides|bromides|mesh-list
43647730|NCT05619848|Propofol|propofol|mesh-list
44260787|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44260788|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44260789|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44260790|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
44260791|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260792|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260793|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44260794|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44260795|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44260796|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44260797|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260799|NCT00640432|Diclofenac|diclofenac|mesh-list
44260800|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260801|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43647734|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647735|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647736|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44260802|NCT00640432|Analgesics|analgesics|mesh-ancestor
44260803|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
44260804|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260805|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260806|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260807|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260808|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260809|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260810|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260811|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260812|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
43656464|NCT02961634|Ciclopirox|ciclopirox|mesh-list
44096117|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096118|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096119|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
44096120|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719821|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
44096121|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096122|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096123|NCT00042913|Epratuzumab|epratuzumab|mesh-list
44096124|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096125|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096126|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44096127|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44096128|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096129|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
44260813|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
44260814|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44260815|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43647737|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
43647738|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
43647739|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43647740|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43647741|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43647742|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43647743|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
43832634|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44260816|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260817|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260818|NCT00640458|Urological Agents|urological agents|mesh-ancestor
44260819|NCT00640471|Cetuximab|cetuximab|mesh-list
44260820|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260821|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260822|NCT00640549|Atorvastatin|atorvastatin|mesh-list
44260823|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44260824|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44260825|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
44260826|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260827|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44260828|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44260829|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260830|NCT00640575|Triamcinolone|triamcinolone|mesh-list
44260831|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44096130|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096131|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096132|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096133|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096134|NCT00042965|Gemcitabine|gemcitabine|mesh-list
44096135|NCT00042965|Capecitabine|capecitabine|mesh-list
44096136|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096137|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
44096138|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096139|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096140|NCT00042965|Antiviral Agents|antiviral agents|mesh-ancestor
43647745|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647746|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647747|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43647748|NCT05619848|Narcotics|narcotics|mesh-ancestor
43647749|NCT05619848|Analgesics|analgesics|mesh-ancestor
43647750|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
43647751|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647753|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43647754|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43647755|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43647756|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
43647757|NCT05619627|Anesthetics|anesthetics|mesh-list
44096141|NCT00042965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096142|NCT00042965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096143|NCT00042965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096144|NCT00042965|Immunologic Factors|immunologic factors|mesh-ancestor
44096145|NCT00042965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096146|NCT00042978|Carboplatin|carboplatin|mesh-list
44096147|NCT00042978|Etoposide|etoposide|mesh-list
44096148|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
44096149|NCT00042978|Oblimersen|oblimersen|mesh-list
44096150|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096151|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44096152|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096153|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096154|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096164|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44096165|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647779|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647780|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647781|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43647782|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556868|NCT03549221|Analgesics|analgesics|mesh-ancestor
44096166|NCT00043004|Growth Substances|growth substances|mesh-ancestor
44096167|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096168|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
44096169|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096170|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
44096171|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096172|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096173|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096174|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
44260832|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43647783|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
43647784|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43647785|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647786|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647787|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832642|NCT05255302|Pemetrexed|pemetrexed|mesh-list
44260833|NCT00640575|Lidocaine|lidocaine|mesh-list
44260834|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44260835|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
44260836|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
44260837|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44260838|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260839|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
44260840|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260841|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43647788|NCT05615194|Analgesics|analgesics|mesh-ancestor
43647789|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
43647790|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647791|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44260842|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44260843|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44260844|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44260845|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260846|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260847|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
44260848|NCT00640575|Hormones|hormones|mesh-ancestor
44260849|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44260850|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44260851|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
44096176|NCT00043004|Protective Agents|protective agents|mesh-ancestor
44096177|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
43647792|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43647793|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43647794|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
43647795|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647796|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647797|NCT05605470|Vaccines|vaccines|mesh-list
43647798|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
43647799|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824152|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
43824153|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43824154|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
43824155|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
43824156|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43734433|NCT02540070|Narcotics|narcotics|mesh-ancestor
44096178|NCT00043004|Vitamins|vitamins|mesh-ancestor
44096179|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
44096180|NCT00043043|Celecoxib|celecoxib|mesh-list
44096181|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44096182|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44096183|NCT00043043|Analgesics|analgesics|mesh-ancestor
44096184|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
44096185|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44096186|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824158|NCT05515120|Coagulants|coagulants|mesh-ancestor
43824159|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
43824160|NCT05515029|Abatacept|abatacept|mesh-list
43824161|NCT05515029|Vedolizumab|vedolizumab|mesh-list
43824162|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43824163|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556882|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43556883|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096187|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096188|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44096189|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44096190|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44096191|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096192|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096193|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
44096194|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
44096195|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
44096196|NCT00043069|Estrogens|estrogens|mesh-list
44096197|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
44096198|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
44096199|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096200|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096201|NCT00043069|Vitamins|vitamins|mesh-ancestor
44096202|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
44096203|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44096204|NCT00043069|Hormones|hormones|mesh-ancestor
44096205|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096206|NCT00043069|Antacids|antacids|mesh-ancestor
44096207|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096208|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260853|NCT00640588|Adefovir|adefovir|mesh-list
44260854|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44260855|NCT00640588|Telbivudine|telbivudine|mesh-list
44260856|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
44260857|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824164|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
43824165|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824166|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824167|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44260858|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44260859|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44260860|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260861|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260862|NCT00640627|Celecoxib|celecoxib|mesh-list
44260863|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260864|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260865|NCT00640627|Analgesics|analgesics|mesh-ancestor
44260866|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
44260867|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260868|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260869|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096209|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44096210|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096211|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
44096213|NCT00043082|Doxorubicin|doxorubicin|mesh-list
44096214|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44096215|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556925|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
43556926|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556927|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43556928|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43556929|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
43556930|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44096216|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096217|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096218|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096219|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096220|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096221|NCT00043095|Gemcitabine|gemcitabine|mesh-list
44096222|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096223|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
44096229|NCT00043095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096230|NCT00043095|Immunologic Factors|immunologic factors|mesh-ancestor
44096231|NCT00043095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096232|NCT00043121|Leucovorin|leucovorin|mesh-list
44096233|NCT00043121|Fluorouracil|fluorouracil|mesh-list
44096234|NCT00043121|Capecitabine|capecitabine|mesh-list
44096235|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
44096236|NCT00043121|Calcium|calcium|mesh-list
44096237|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
44096238|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43824169|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556931|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556932|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556933|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43556934|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
44096239|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096240|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
44096241|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096242|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096243|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096244|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096245|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
44096246|NCT00043121|Antidotes|antidotes|mesh-ancestor
43812131|NCT04834752|Esomeprazole|esomeprazole|mesh-list
44096247|NCT00043121|Protective Agents|protective agents|mesh-ancestor
44096248|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
44096249|NCT00043121|Vitamins|vitamins|mesh-ancestor
44096250|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
44096251|NCT00043134|Decitabine|decitabine|mesh-list
44096252|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096253|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
43824170|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824171|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824172|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43824173|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824174|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824175|NCT05514925|Bevacizumab|bevacizumab|mesh-list
43824177|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556948|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096254|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260871|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260872|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260873|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260874|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260875|NCT00640640|Bevacizumab|bevacizumab|mesh-list
44260876|NCT00640640|Ranibizumab|ranibizumab|mesh-list
44260877|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44260878|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824178|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824179|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824180|NCT05514925|Growth Substances|growth substances|mesh-ancestor
43824181|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824182|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
44260879|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44260880|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44260881|NCT00640640|Growth Substances|growth substances|mesh-ancestor
44260882|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260883|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
44260884|NCT00640679|Clopidogrel|clopidogrel|mesh-list
44260885|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44260886|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44260887|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44260888|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44260889|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
44260890|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44260891|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260920|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260921|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44260922|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
43824183|NCT05514899|Dronabinol|dronabinol|mesh-list
43824184|NCT05514899|Cannabidiol|cannabidiol|mesh-list
43824185|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
43824186|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
43824187|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824188|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824189|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824190|NCT05514899|Analgesics|analgesics|mesh-ancestor
43824191|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
43824192|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824193|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43824195|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846392|NCT04201197|Dronabinol|dronabinol|mesh-list
43647800|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
43647801|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43647802|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647803|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647804|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647805|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43647806|NCT05555251|Trastuzumab|trastuzumab|mesh-list
44260923|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260924|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44260925|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44260926|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260927|NCT00640796|Analgesics|analgesics|mesh-ancestor
44260928|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
44260929|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260930|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260931|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260932|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
44260933|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260934|NCT00640809|Ibuprofen|ibuprofen|mesh-list
44260935|NCT00640809|Celecoxib|celecoxib|mesh-list
44260936|NCT00640809|Omeprazole|omeprazole|mesh-list
44260937|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260938|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260939|NCT00640809|Analgesics|analgesics|mesh-ancestor
44260940|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
43656588|NCT02959957|Cefoxitin|cefoxitin|mesh-list
43647807|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647808|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647809|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43647810|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
44096255|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096256|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096257|NCT00043147|Prednisone|prednisone|mesh-list
44096258|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
44096259|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44096260|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44096261|NCT00043147|Prednisolone|prednisolone|mesh-list
44096262|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
44096263|NCT00043147|Beclomethasone|beclomethasone|mesh-list
43647811|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647812|NCT05508594|Sufentanil|sufentanil|mesh-list
43647813|NCT05508594|Ketamine|ketamine|mesh-list
43647814|NCT05508594|Analgesics|analgesics|mesh-ancestor
43647815|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
43647816|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647817|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647818|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43647819|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43647820|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
43647821|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
44096264|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44096265|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
44096266|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096267|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
44096268|NCT00043147|Hormones|hormones|mesh-ancestor
44096269|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096270|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096271|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44096272|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096273|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
44096274|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
44096275|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44096276|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44096277|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44096278|NCT00043147|Protective Agents|protective agents|mesh-ancestor
44096279|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44096280|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647822|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647823|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43647824|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43647825|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43557015|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096281|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
44096282|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096283|NCT00043264|Azithromycin|azithromycin|mesh-list
44096284|NCT00043264|Rifampin|rifampin|mesh-list
44096285|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096286|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096287|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44096288|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
44260941|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260942|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260943|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260944|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260945|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260946|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260947|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260948|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44260949|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43647826|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647827|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43647828|NCT05508594|Narcotics|narcotics|mesh-ancestor
43647829|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43647830|NCT05435677|Insulin|insulin|mesh-list
43647831|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43647832|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647833|NCT05417100|Methadone|methadone|mesh-list
43557021|NCT03547505|Protective Agents|protective agents|mesh-ancestor
44260950|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44260951|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44260953|NCT00640861|Sargramostim|sargramostim|mesh-list
44260954|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
44260955|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
44260956|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260957|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44260958|NCT00640887|Ritonavir|ritonavir|mesh-list
44260959|NCT00640887|Lopinavir|lopinavir|mesh-list
44260960|NCT00640887|Nevirapine|nevirapine|mesh-list
44260961|NCT00640887|Efavirenz|efavirenz|mesh-list
44260962|NCT00640887|Rifabutin|rifabutin|mesh-list
44260963|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44260964|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44260965|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
43647837|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647838|NCT05417100|Analgesics|analgesics|mesh-ancestor
44260966|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44260967|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260968|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44260969|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44260970|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
44260971|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44260985|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44260986|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44260988|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
44260989|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44260990|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44260991|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44260992|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44260993|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44260994|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096289|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
44096290|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096291|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096292|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096293|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44096302|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096303|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647839|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
43647840|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44096304|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096305|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
44096306|NCT00043303|Interferons|interferons|mesh-list
44096307|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
44096308|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096309|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
44096310|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096311|NCT00043316|Interferons|interferons|mesh-list
44096312|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
43647850|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43647851|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
43647852|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43647853|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647854|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43557070|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44096313|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096314|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
44096315|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096316|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
44096317|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
44096318|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096319|NCT00043342|Interferons|interferons|mesh-list
44096320|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
44096321|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096322|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
44096323|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096324|NCT00043355|Interferons|interferons|mesh-list
44096325|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
44096326|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096327|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
44096328|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096329|NCT00043381|Decitabine|decitabine|mesh-list
44096330|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096331|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
43644739|NCT04443569|Lidocaine|lidocaine|mesh-list
43647855|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43647856|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43647857|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647858|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
43647859|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43719835|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44096332|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096333|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096334|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096335|NCT00043394|Trastuzumab|trastuzumab|mesh-list
44096336|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096337|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152743|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152744|NCT00217828|Citalopram|citalopram|mesh-list
44152745|NCT00217828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44152746|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152747|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152748|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152749|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152750|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
44152751|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152752|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44152753|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
44152754|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152755|NCT00217932|Valproic Acid|valproic acid|mesh-list
44152756|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
44260995|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44260997|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44260998|NCT00640991|Insulin|insulin|mesh-list
44260999|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
44261000|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
44261001|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44261002|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261003|NCT00641004|Esomeprazole|esomeprazole|mesh-list
44261004|NCT00641004|Rebamipide|rebamipide|mesh-list
44261005|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44261006|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261007|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44261008|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261009|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261010|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
44261011|NCT00641004|Protective Agents|protective agents|mesh-ancestor
44261012|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462008|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
43647860|NCT05278884|Anesthetics|anesthetics|mesh-list
43647861|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647862|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557078|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462009|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44462010|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462011|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462012|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462013|NCT01536067|Bortezomib|bortezomib|mesh-list
44462014|NCT01536067|Ofatumumab|ofatumumab|mesh-list
44462015|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462016|NCT01536015|Rotigotine|rotigotine|mesh-list
44462017|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
44462018|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
44462019|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462037|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
44462038|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647863|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44462039|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44462040|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44462041|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44462042|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
44462043|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462044|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462045|NCT01535261|Ranibizumab|ranibizumab|mesh-list
44462046|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44462047|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647864|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647865|NCT05227833|Pantoprazole|pantoprazole|mesh-list
43647866|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43647867|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647868|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43647869|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719853|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462048|NCT01535261|Growth Substances|growth substances|mesh-ancestor
44462049|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462050|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462051|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462052|NCT01535235|Lisinopril|lisinopril|mesh-list
44462053|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44462054|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
44462055|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656690|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152757|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152758|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152759|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
44152760|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152761|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152762|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
44152763|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152764|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152766|NCT00218049|Vanoxerine|vanoxerine|mesh-list
44152767|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43719857|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719858|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43647870|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647872|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
43647873|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43647874|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647875|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43647877|NCT05171686|Torsemide|torsemide|mesh-list
43647878|NCT05171686|Furosemide|furosemide|mesh-list
43647879|NCT05171686|Bumetanide|bumetanide|mesh-list
43647880|NCT05171686|Diuretics|diuretics|mesh-list
43647881|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43647882|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
43647883|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647884|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43647885|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647892|NCT05153590|Hormones|hormones|mesh-ancestor
44152768|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152773|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152775|NCT00218075|Carbidopa|carbidopa|mesh-list
44152776|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44152777|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44152778|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
44152779|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647904|NCT05100862|Rituximab|rituximab|mesh-list
43647905|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
43647906|NCT05100862|Lenalidomide|lenalidomide|mesh-list
43647907|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
43647908|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647909|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152780|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152781|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152782|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44152783|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152784|NCT00218101|Buprenorphine|buprenorphine|mesh-list
44152785|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152786|NCT00218101|Narcotics|narcotics|mesh-ancestor
44152787|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152788|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152789|NCT00218101|Analgesics|analgesics|mesh-ancestor
44152790|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
44152791|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152792|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44152793|NCT00218114|Valproic Acid|valproic acid|mesh-list
44152794|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
44152795|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462056|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462057|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44462058|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44462059|NCT01535235|Protective Agents|protective agents|mesh-ancestor
43557154|NCT03546283|Protective Agents|protective agents|mesh-ancestor
43557156|NCT03546088|Anesthetics|anesthetics|mesh-list
44462060|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462061|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
44462062|NCT01535053|Leucovorin|leucovorin|mesh-list
44462063|NCT01535053|Folic Acid|folic acid|mesh-list
44462064|NCT01535053|Dactinomycin|dactinomycin|mesh-list
44462065|NCT01535053|Methotrexate|methotrexate|mesh-list
44462066|NCT01535053|Calcium|calcium|mesh-list
44462067|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
44462068|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44462069|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462070|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44462071|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44462072|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
44462073|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915344|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
44261013|NCT00641030|Melphalan|melphalan|mesh-list
44261014|NCT00641030|Clofarabine|clofarabine|mesh-list
44261015|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44261016|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
44261017|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261018|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261019|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44261020|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261021|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
44261022|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261023|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44261024|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
44261025|NCT00641082|Adefovir|adefovir|mesh-list
44261027|NCT00641082|Clevudine|clevudine|mesh-list
44261038|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
44261039|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261040|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719877|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261041|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44261042|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
44261043|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261044|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261045|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44261046|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44261047|NCT00641160|Vinorelbine|vinorelbine|mesh-list
44261048|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44261049|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261050|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
44261051|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
44261052|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
44261053|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261093|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44261094|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44261095|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44261096|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261097|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261098|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261099|NCT00641407|Insulin|insulin|mesh-list
44261100|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44261101|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
44261102|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44261103|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261104|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
44261105|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44261106|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261107|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261108|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44261109|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44261110|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
44261111|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44261112|NCT00641446|Budesonide|budesonide|mesh-list
44261113|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261114|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261115|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
44261146|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261147|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44261148|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261149|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261150|NCT00641654|Interferons|interferons|mesh-list
44261151|NCT00641654|Ribavirin|ribavirin|mesh-list
44261152|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
44261153|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
44261154|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44261155|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261156|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
44261157|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261158|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
44261159|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261160|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
44261161|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261162|NCT00641680|Fluticasone|fluticasone|mesh-list
44261163|NCT00641680|Xhance|xhance|mesh-list
44261164|NCT00641680|Budesonide|budesonide|mesh-list
44261165|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261166|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261167|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
44261168|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261169|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261170|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261198|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261199|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44261200|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261201|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261202|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44261203|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44261204|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
44261205|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261206|NCT00641914|Budesonide|budesonide|mesh-list
44261207|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261208|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261209|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
44261210|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261211|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261212|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261213|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647914|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647915|NCT05100862|Growth Substances|growth substances|mesh-ancestor
43647916|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647917|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647918|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719890|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43719891|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261214|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
44261215|NCT00641914|Hormones|hormones|mesh-ancestor
44261216|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261217|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
44261218|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44261219|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
44261220|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261221|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261222|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261223|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
44261224|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261225|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261226|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261227|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44261228|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44261236|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261237|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261238|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261239|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261242|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261243|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
44261244|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44261245|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44261246|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261247|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261248|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261249|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261250|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261251|NCT00642096|Metoprolol|metoprolol|mesh-list
44261252|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44261253|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44261254|NCT00642096|Diuretics|diuretics|mesh-ancestor
44261255|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
44261256|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261257|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44261258|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261259|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261260|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44261261|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
44152796|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152797|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
44152798|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152799|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152800|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
44152801|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43557268|NCT03544125|Durvalumab|durvalumab|mesh-list
44152802|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152803|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096338|NCT00043537|Fluoxetine|fluoxetine|mesh-list
44096339|NCT00043537|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44096340|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44096341|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096342|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096343|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096344|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
44096345|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096346|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44096347|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096348|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096349|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43793489|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
44261263|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261264|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44261265|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44261266|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44261267|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261268|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261269|NCT00642122|Budesonide|budesonide|mesh-list
44261270|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261271|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261272|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
44261273|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261274|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261275|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261276|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261277|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
44261278|NCT00642122|Hormones|hormones|mesh-ancestor
44261279|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261280|NCT00642135|Phenylephrine|phenylephrine|mesh-list
44261281|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
44261282|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44261283|NCT00642135|Tropicamide|tropicamide|mesh-list
44261284|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44096350|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096351|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096352|NCT00043576|Calcitriol|calcitriol|mesh-list
44096353|NCT00043576|Docetaxel|docetaxel|mesh-list
44096354|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096355|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44096356|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44096357|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44096358|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096359|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096360|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096361|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44096362|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096363|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44096364|NCT00043576|Vitamins|vitamins|mesh-ancestor
44096365|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
43647919|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647921|NCT05099848|Fluorouracil|fluorouracil|mesh-list
43647922|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
43647923|NCT05099848|Apatinib|apatinib|mesh-list
43647924|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
43647925|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557352|NCT03543202|Anesthetics|anesthetics|mesh-list
43557353|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096366|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44096367|NCT00043589|Donepezil|donepezil|mesh-list
44096368|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44096369|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096370|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43595927|NCT03321734|Caffeine|caffeine|mesh-list
44096378|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44096379|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096380|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44096381|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44096382|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44096383|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
44096384|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44261285|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
43647926|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43647927|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647928|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647929|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
43719903|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43557406|NCT03542552|Analgesics|analgesics|mesh-ancestor
44261286|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
44261287|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261288|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261289|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
44261290|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44261291|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
44261292|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261293|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44261294|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44261295|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44096385|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44096386|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
44096387|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096388|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
44096389|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44096390|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44096391|NCT00043667|Daclizumab|daclizumab|mesh-list
44096392|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096393|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
44096394|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096395|NCT00043680|Celecoxib|celecoxib|mesh-list
44096396|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44096397|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44096398|NCT00043680|Analgesics|analgesics|mesh-ancestor
44096399|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
44096400|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44096401|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096402|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096403|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44096404|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44096405|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44096406|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096407|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096408|NCT00043706|Antibodies|antibodies|mesh-list
44096409|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44096410|NCT00043706|Mitogens|mitogens|mesh-list
43647930|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647931|NCT05099848|Antidotes|antidotes|mesh-ancestor
43647932|NCT05099848|Protective Agents|protective agents|mesh-ancestor
43557421|NCT03542422|Apatinib|apatinib|mesh-list
44096411|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
44096412|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096413|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44096414|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096415|NCT00043719|Vitamin D|vitamin d|mesh-list
44096416|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
44096417|NCT00043719|Calcium|calcium|mesh-list
44096418|NCT00043719|Vitamins|vitamins|mesh-ancestor
44096419|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
44096420|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096421|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096422|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44096423|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
44096424|NCT00043758|Tolvaptan|tolvaptan|mesh-list
44096425|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44096426|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096427|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
44096428|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096429|NCT00043771|Tolvaptan|tolvaptan|mesh-list
44096430|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44096431|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096432|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
44096433|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096434|NCT00043784|Enoxaparin|enoxaparin|mesh-list
44096435|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
44096436|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44261296|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
44261297|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261298|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261299|NCT00642135|Protective Agents|protective agents|mesh-ancestor
44261300|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44261301|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44261302|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44261303|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
44261304|NCT00642161|Budesonide|budesonide|mesh-list
44261305|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261306|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44261307|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
44261308|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261309|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915649|NCT00457366|Lorazepam|lorazepam|mesh-list
44261310|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44261311|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44261312|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
44261313|NCT00642161|Hormones|hormones|mesh-ancestor
44261314|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261315|NCT00642187|Budesonide|budesonide|mesh-list
44261349|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
43647933|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
43647934|NCT05099848|Vitamins|vitamins|mesh-ancestor
43647935|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
43719904|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44261350|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261351|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261352|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261353|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261354|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44261355|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261356|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261357|NCT00642395|Bortezomib|bortezomib|mesh-list
44261358|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261359|NCT00642408|Micronutrients|micronutrients|mesh-list
44261360|NCT00642408|Trace Elements|trace elements|mesh-list
44261361|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261362|NCT00642421|Octreotide|octreotide|mesh-list
44261363|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261364|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44261365|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261366|NCT00642434|Metoprolol|metoprolol|mesh-list
44261367|NCT00642434|Carvedilol|carvedilol|mesh-list
44261368|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44261369|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44261370|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
44261371|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
44261372|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261399|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261400|NCT00642499|Hormones|hormones|mesh-ancestor
44261401|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261402|NCT00642512|Dronabinol|dronabinol|mesh-list
44261403|NCT00642512|Ondansetron|ondansetron|mesh-list
44261404|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
44261405|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
44261406|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261407|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261408|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261409|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
44261410|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
44261411|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44261412|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
44261413|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261414|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261415|NCT00642512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44261416|NCT00642512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261417|NCT00642512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261418|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261419|NCT00642512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44261420|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
44261421|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261422|NCT00642512|Analgesics|analgesics|mesh-ancestor
44261423|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
43657047|NCT02957266|Gemcitabine|gemcitabine|mesh-list
44096437|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44096443|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096444|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096445|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
44096446|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647936|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43647937|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647938|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
43557500|NCT03541993|Protective Agents|protective agents|mesh-ancestor
44096447|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096448|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
44096449|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096450|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
44096451|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44096452|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44096453|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44096454|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44096455|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096456|NCT00043823|Bevacizumab|bevacizumab|mesh-list
44096457|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44096458|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096459|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096460|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44096461|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44096462|NCT00043823|Growth Substances|growth substances|mesh-ancestor
44096463|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261424|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44261425|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44261427|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261428|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
44261429|NCT00642551|Vitamin K|vitamin k|mesh-list
44261430|NCT00642551|Vitamin MK 7|vitamin mk 7|mesh-list
44261431|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44261432|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44261433|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261434|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
44261435|NCT00642551|Coagulants|coagulants|mesh-ancestor
44261436|NCT00642551|Vitamins|vitamins|mesh-ancestor
44261437|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
44261438|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261439|NCT00642655|Rituximab|rituximab|mesh-list
44261440|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44261441|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261442|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
44261443|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261444|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261445|NCT00642681|Insulin|insulin|mesh-list
44261446|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44261447|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261448|NCT00642733|Gemcitabine|gemcitabine|mesh-list
44261449|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44261450|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43557552|NCT03541681|Anesthetics|anesthetics|mesh-list
44261451|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
44261452|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261453|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261454|NCT00642733|Antiviral Agents|antiviral agents|mesh-ancestor
44261455|NCT00642733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261456|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261457|NCT00642733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261458|NCT00642733|Immunologic Factors|immunologic factors|mesh-ancestor
44261459|NCT00642733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261460|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44261461|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44096464|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
44261463|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261464|NCT00642798|Incretins|incretins|mesh-ancestor
44261465|NCT00642798|Hormones|hormones|mesh-ancestor
44261466|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261467|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44261468|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
44261469|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261470|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261471|NCT00642824|Bevacizumab|bevacizumab|mesh-list
44261472|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44261473|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261474|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44261475|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44261476|NCT00642824|Growth Substances|growth substances|mesh-ancestor
44261477|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261478|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
44261479|NCT00642837|Acetaminophen|acetaminophen|mesh-list
44261480|NCT00642837|Tramadol|tramadol|mesh-list
44261481|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261482|NCT00642837|Analgesics|analgesics|mesh-ancestor
44096465|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096466|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096467|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096468|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44096469|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096470|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096471|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096472|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43647939|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43647940|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43647941|NCT05097976|Prednisolone|prednisolone|mesh-list
44096473|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096474|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096475|NCT00043862|Topotecan|topotecan|mesh-list
44096476|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44096477|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096478|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096479|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096480|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096481|NCT00043875|Lamotrigine|lamotrigine|mesh-list
44096482|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
44096483|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43812341|NCT04831528|Cetuximab|cetuximab|mesh-list
44096484|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096485|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096486|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096487|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096488|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096489|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096490|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096491|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096492|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44096493|NCT00043888|Ritonavir|ritonavir|mesh-list
44096494|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
44261483|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
44261484|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261485|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261486|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
44261487|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44261488|NCT00642837|Narcotics|narcotics|mesh-ancestor
44261489|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261490|NCT00642863|Vitamin D|vitamin d|mesh-list
44261491|NCT00642863|Vitamins|vitamins|mesh-list
44261492|NCT00642863|Vitamin A|vitamin a|mesh-list
44261493|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
44261494|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
44261495|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261496|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
44261497|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261498|NCT00642863|Protective Agents|protective agents|mesh-ancestor
44261499|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44261500|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261501|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44462074|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096495|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44096496|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44096497|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44096498|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096499|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096500|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096501|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44096502|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44096503|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
44096504|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096505|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44096506|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096507|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44096508|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096510|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
44096511|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44096512|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096513|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096514|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096515|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096516|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096517|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096518|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096519|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096520|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44096521|NCT00043914|Lamotrigine|lamotrigine|mesh-list
44096522|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
44096523|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44096524|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096525|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096526|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096527|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096528|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096529|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44462075|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
44462076|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462077|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462078|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44462079|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462080|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44462081|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462082|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
44462083|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462084|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462086|NCT01535053|Protective Agents|protective agents|mesh-ancestor
44462087|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
44462088|NCT01535053|Vitamins|vitamins|mesh-ancestor
44462089|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
44462090|NCT01535053|Hematinics|hematinics|mesh-ancestor
43647943|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43647944|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
43647945|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43647946|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
43647947|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
43647948|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43557640|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462091|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44462092|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462093|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44462094|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44462095|NCT01535040|Memantine|memantine|mesh-list
44462096|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44462097|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44462098|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
44462099|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261521|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
44261522|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261523|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44261524|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261525|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261526|NCT00643136|Pregabalin|pregabalin|mesh-list
44261527|NCT00643136|Analgesics|analgesics|mesh-ancestor
44261528|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
44261529|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261530|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261531|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
44261532|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44261533|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261534|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261535|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44261536|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44261537|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261538|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096530|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096531|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096532|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44096534|NCT00043927|Etoposide|etoposide|mesh-list
44096535|NCT00043927|Topotecan|topotecan|mesh-list
44096536|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096537|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44096538|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096539|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096540|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096541|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096542|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44096543|NCT00043940|Bivalirudin|bivalirudin|mesh-list
44096544|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
44096545|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43557681|NCT03539718|Taurolidine|taurolidine|mesh-list
44096546|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096547|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096548|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096549|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
44096550|NCT00043953|Ritonavir|ritonavir|mesh-list
44096551|NCT00043953|Lopinavir|lopinavir|mesh-list
44096552|NCT00043953|Saquinavir|saquinavir|mesh-list
44096553|NCT00043953|Lamivudine|lamivudine|mesh-list
44096554|NCT00043953|Zidovudine|zidovudine|mesh-list
44096555|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44096556|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44096557|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44096558|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096559|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096560|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096561|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44096562|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44096563|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
44096564|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096565|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44096566|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261539|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261540|NCT00643149|Amoxicillin|amoxicillin|mesh-list
44261541|NCT00643149|Azithromycin|azithromycin|mesh-list
44261542|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261543|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261544|NCT00643227|Azithromycin|azithromycin|mesh-list
44261545|NCT00643227|Clarithromycin|clarithromycin|mesh-list
44261546|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261547|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261548|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44261549|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096567|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44096568|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096569|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
44096570|NCT00043966|Ritonavir|ritonavir|mesh-list
44096571|NCT00043966|Lopinavir|lopinavir|mesh-list
44096572|NCT00043966|Tenofovir|tenofovir|mesh-list
44096573|NCT00043966|Emtricitabine|emtricitabine|mesh-list
44096574|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44096575|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44096576|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096577|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539011|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43596133|NCT03319563|Epinephrine|epinephrine|mesh-list
44096585|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44096586|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096587|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44096588|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44096589|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44096590|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096591|NCT00044135|Clevudine|clevudine|mesh-list
44096592|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
44096593|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096594|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
44096595|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096596|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096597|NCT00044187|Sibutramine|sibutramine|mesh-list
44096598|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096599|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096600|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
44096601|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44096602|NCT00044265|Ramipril|ramipril|mesh-list
44096603|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44096604|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
44096605|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096606|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096607|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44096608|NCT00044278|Lamotrigine|lamotrigine|mesh-list
44096609|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
44096610|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44096611|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096612|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096613|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44096614|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096615|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096616|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096617|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096618|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096619|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44096620|NCT00044291|Toremifene|toremifene|mesh-list
44096621|NCT00044291|Letrozole|letrozole|mesh-list
44096622|NCT00044291|Hormones|hormones|mesh-list
44096623|NCT00044291|Atamestane|atamestane|mesh-list
44096624|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
44096625|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
44096626|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
43700519|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44261550|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261551|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44261552|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261553|NCT00643240|Antibodies|antibodies|mesh-list
44261554|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43647949|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647950|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647951|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
43647952|NCT05097976|Hormones|hormones|mesh-ancestor
43647953|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261555|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
44261556|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096627|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096628|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096629|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812457|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
44096630|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44096631|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44096632|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096633|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096634|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
44096635|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44096636|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44096637|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44096638|NCT00044343|Lapatinib|lapatinib|mesh-list
44096639|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096640|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096641|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43596210|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44096647|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44096648|NCT00044382|Growth Substances|growth substances|mesh-ancestor
44096649|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
44096650|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096651|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
44096652|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096653|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096654|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
44096655|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824215|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
43824216|NCT05514652|Anesthetics|anesthetics|mesh-list
43824217|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824218|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824219|NCT05514652|Narcotics|narcotics|mesh-ancestor
43824220|NCT05514652|Analgesics|analgesics|mesh-ancestor
43824221|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
43824226|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824227|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43824229|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
43557771|NCT03539003|Narcotics|narcotics|mesh-ancestor
44096656|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096657|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
44096658|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096659|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096660|NCT00044434|Bupropion|bupropion|mesh-list
44096661|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44096662|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096663|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096664|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44096665|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44096666|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096667|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096668|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
44096669|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096670|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096671|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44096672|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096673|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096674|NCT00044447|Glimepiride|glimepiride|mesh-list
44096675|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44096676|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44096677|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096678|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096679|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
44096680|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
44096681|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44096682|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096683|NCT00044473|Levofloxacin|levofloxacin|mesh-list
44096684|NCT00044473|Ofloxacin|ofloxacin|mesh-list
44096685|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44096686|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096687|NCT00044473|Renal Agents|renal agents|mesh-ancestor
44261558|NCT00643292|Azithromycin|azithromycin|mesh-list
44261559|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
44261560|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
44261561|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44261562|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261563|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261564|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44261565|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261566|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261567|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
44261568|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44261569|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
44261570|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
44261571|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096688|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096689|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096690|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096691|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096692|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096693|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096694|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44096695|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096696|NCT00044486|Posaconazole|posaconazole|mesh-list
44096697|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
44096698|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096699|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44096700|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44096701|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44096702|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44096703|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43812498|NCT04828525|Dexamethasone|dexamethasone|mesh-list
44096704|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096705|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096706|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44096707|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
43596277|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096716|NCT00044551|Taxane|taxane|mesh-list
44096717|NCT00044551|IDN 5109|idn 5109|mesh-list
44096718|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096719|NCT00044564|IDN 5109|idn 5109|mesh-list
44096720|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096721|NCT00044577|Tenofovir|tenofovir|mesh-list
44096722|NCT00044577|Lamivudine|lamivudine|mesh-list
44096723|NCT00044577|Abacavir|abacavir|mesh-list
44096724|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
44096725|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
44096726|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096727|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44096728|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44096729|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096730|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096731|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44096732|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44096733|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
44096734|NCT00044616|Fluoxetine|fluoxetine|mesh-list
44096735|NCT00044616|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44096736|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44096737|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096738|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096739|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261573|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261575|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
44261576|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261577|NCT00643409|Azithromycin|azithromycin|mesh-list
44261578|NCT00643409|Levofloxacin|levofloxacin|mesh-list
44261579|NCT00643409|Ofloxacin|ofloxacin|mesh-list
44261580|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261581|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261582|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44261583|NCT00643409|Renal Agents|renal agents|mesh-ancestor
44261584|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44261585|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44261586|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096740|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
44096741|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096742|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44096743|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096744|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096745|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44096746|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096747|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096748|NCT00044629|Zolpidem|zolpidem|mesh-list
44096749|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44096750|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43824230|NCT05514275|Capecitabine|capecitabine|mesh-list
43824231|NCT05514275|Endostatins|endostatins|mesh-list
43824232|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824233|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
43824234|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557841|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096751|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096752|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096753|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44096754|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
44096755|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
44096756|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096757|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096758|NCT00044642|Lorazepam|lorazepam|mesh-list
44096759|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
44096760|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
44096761|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
44096762|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44096763|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096764|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44096765|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44096766|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096767|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44096768|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096769|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096770|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
44096771|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
44096772|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096773|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096774|NCT00044668|Exenatide|exenatide|mesh-list
44096775|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44096776|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096777|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44096778|NCT00044668|Incretins|incretins|mesh-ancestor
44096782|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44096783|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
44096784|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096785|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539245|NCT03433313|Trastuzumab|trastuzumab|mesh-list
44261587|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261588|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096786|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096787|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44096788|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096789|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44096790|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096791|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44096794|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44096795|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096796|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44096797|NCT00044694|Incretins|incretins|mesh-ancestor
44096798|NCT00044694|Hormones|hormones|mesh-ancestor
44096799|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096800|NCT00044707|Pramlintide|pramlintide|mesh-list
44096801|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44096802|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096803|NCT00044720|Sirolimus|sirolimus|mesh-list
44096804|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096805|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096806|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096807|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096808|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
44096809|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096810|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
44096811|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096812|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
44096813|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096814|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096815|NCT00044746|Tazobactam|tazobactam|mesh-list
44096816|NCT00044746|Piperacillin|piperacillin|mesh-list
44096817|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44096818|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096819|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096820|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44096821|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096822|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096823|NCT00044759|Tazobactam|tazobactam|mesh-list
44096824|NCT00044759|Piperacillin|piperacillin|mesh-list
44096825|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44096826|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096827|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096828|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44096829|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096830|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096831|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44096832|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44096833|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44096834|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44096835|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096836|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096837|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096838|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44096839|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096840|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096841|NCT00044785|Leucovorin|leucovorin|mesh-list
44096842|NCT00044785|Fluorouracil|fluorouracil|mesh-list
44096843|NCT00044785|Irinotecan|irinotecan|mesh-list
44096844|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
44096845|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096846|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096847|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096857|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096858|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096859|NCT00044798|Citalopram|citalopram|mesh-list
44096860|NCT00044798|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44096861|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43647964|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
43647965|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647966|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647967|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
43647968|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647969|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647970|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
43647971|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647972|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647974|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
43557947|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
44096862|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261589|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44261590|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261592|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
44261593|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
44261594|NCT00643539|Azithromycin|azithromycin|mesh-list
44261595|NCT00643539|Amoxicillin|amoxicillin|mesh-list
44261596|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261597|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261598|NCT00643643|Maraviroc|maraviroc|mesh-list
44261599|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44261600|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44261601|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261602|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44261603|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44261604|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
44096863|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096864|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096865|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
44096866|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096867|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44096868|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
44096869|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44096870|NCT00044811|Fexofenadine|fexofenadine|mesh-list
44096871|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44096872|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44096873|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44096874|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
44096875|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
44096876|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096877|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096878|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096879|NCT00044824|Fexofenadine|fexofenadine|mesh-list
44096880|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44096881|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44096882|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44096883|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
44096884|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
44096885|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096886|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096887|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096888|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44096889|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
44096890|NCT00044837|Estradiol|estradiol|mesh-list
44096891|NCT00044837|Estrogens|estrogens|mesh-ancestor
44096892|NCT00044837|Hormones|hormones|mesh-ancestor
44096893|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557981|NCT03536806|Canrenone|canrenone|mesh-list
43557982|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43557987|NCT03536806|Diuretics|diuretics|mesh-ancestor
44096894|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096895|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44096896|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
44096897|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44096898|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44096899|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44096900|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44096901|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44096902|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44096903|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44096904|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261606|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44261607|NCT00643734|Azithromycin|azithromycin|mesh-list
44261608|NCT00643734|Levofloxacin|levofloxacin|mesh-list
44261609|NCT00643734|Ofloxacin|ofloxacin|mesh-list
44261610|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261611|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261612|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44261613|NCT00643734|Renal Agents|renal agents|mesh-ancestor
44261614|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44261615|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44261616|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261617|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261618|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261619|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44261620|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261621|NCT00643799|Celecoxib|celecoxib|mesh-list
44261622|NCT00643799|Naproxen|naproxen|mesh-list
44096905|NCT00044863|Cetuximab|cetuximab|mesh-list
44096906|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096907|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096908|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
44096909|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44096910|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
43596483|NCT03317275|Fluorides|fluorides|mesh-list
44096939|NCT00044954|Fludarabine|fludarabine|mesh-list
44096940|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
44096941|NCT00044954|Cyclosporins|cyclosporins|mesh-list
44096942|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096943|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558013|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
43558014|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44096944|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
44096945|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096946|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096947|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
44096948|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096949|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096950|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
44096951|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096952|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44096953|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44096954|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44096955|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096956|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44152819|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152820|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152821|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152822|NCT00218153|Naltrexone|naltrexone|mesh-list
44152823|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44152824|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44152825|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152826|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
44152827|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152828|NCT00218166|Triazolam|triazolam|mesh-list
44152829|NCT00218166|Tiagabine|tiagabine|mesh-list
44152830|NCT00218166|Baclofen|baclofen|mesh-list
44152831|NCT00218166|GABA Agonists|gaba agonists|mesh-list
44152832|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44261623|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44261624|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261626|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
44261627|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261628|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261629|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261630|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261631|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44261632|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44261633|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261634|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261635|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
44261636|NCT00643825|Temozolomide|temozolomide|mesh-list
44261637|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44261638|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
44261639|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647975|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558040|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558041|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558042|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558043|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558044|NCT03536494|Urological Agents|urological agents|mesh-ancestor
43558045|NCT03536481|Ensartinib|ensartinib|mesh-list
43558046|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558047|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558048|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558050|NCT03536390|Methylphenidate|methylphenidate|mesh-list
44152833|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152834|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44152835|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152836|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44152837|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
44152838|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152839|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152840|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44152841|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44152842|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152843|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152844|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152845|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
43812748|NCT04824391|Vaccines|vaccines|mesh-list
44152846|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
44096959|NCT00044993|Docetaxel|docetaxel|mesh-list
44096960|NCT00044993|Doxorubicin|doxorubicin|mesh-list
44096961|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44096962|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096963|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44096964|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44096965|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44096966|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096967|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44096968|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44096969|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096970|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096971|NCT00045006|Vorinostat|vorinostat|mesh-list
44096972|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096973|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44096974|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096984|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44096985|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096986|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
44096987|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096988|NCT00045149|Aldesleukin|aldesleukin|mesh-list
44096989|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096990|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44096991|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44261640|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261641|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
44261642|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261643|NCT00644020|Fluorouracil|fluorouracil|mesh-list
44261644|NCT00644020|Mitomycins|mitomycins|mesh-list
44261645|NCT00644020|Mitomycin|mitomycin|mesh-list
44261646|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
44261647|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261648|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44261649|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261650|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261651|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
43916030|NCT00464685|Hormones|hormones|mesh-ancestor
44261652|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558079|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558080|NCT03535961|Etoposide|etoposide|mesh-list
44261653|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44261654|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
44261655|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44261656|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261657|NCT00644033|Frovatriptan|frovatriptan|mesh-list
44261658|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44261659|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
44096992|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
44096993|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096994|NCT00045175|Topotecan|topotecan|mesh-list
44096995|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44096996|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44096997|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44096998|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096999|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097000|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097001|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097002|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
44097003|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097004|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097005|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097006|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097007|NCT00045227|Docetaxel|docetaxel|mesh-list
44097008|NCT00045227|Vaccines|vaccines|mesh-list
44097009|NCT00045227|Sargramostim|sargramostim|mesh-list
44097010|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
44097011|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097012|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097013|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097014|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097015|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44097016|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097017|NCT00045266|Aflibercept|aflibercept|mesh-list
44097018|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097019|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097020|NCT00045266|Growth Substances|growth substances|mesh-ancestor
44097021|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097022|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097023|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097024|NCT00045279|Interferons|interferons|mesh-list
44097025|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
44097026|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
44261660|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261661|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261662|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261663|NCT00644085|Aspirin|aspirin|mesh-list
44261664|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44261665|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261666|NCT00644085|Analgesics|analgesics|mesh-ancestor
44261667|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
44261668|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261669|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097027|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44097028|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097029|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
44097030|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647992|NCT04984330|Dexamethasone|dexamethasone|mesh-list
43647993|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43647994|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
43647995|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
43647996|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647997|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097031|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
44097032|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097033|NCT00045292|Valacyclovir|valacyclovir|mesh-list
44097034|NCT00045292|Acyclovir|acyclovir|mesh-list
44097035|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
44097036|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097037|NCT00045318|Exatecan|exatecan|mesh-list
44097038|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44097039|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43596654|NCT03316339|Narcotics|narcotics|mesh-ancestor
44097048|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097049|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
44097050|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097051|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097052|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44097053|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
44097054|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097056|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097057|NCT00045422|Interferons|interferons|mesh-list
44097058|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
44097059|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
44097060|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097061|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
44097062|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097063|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
44097064|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097065|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097066|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097067|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812814|NCT04822649|Adenosine|adenosine|mesh-list
44097068|NCT00045448|Docetaxel|docetaxel|mesh-list
44097069|NCT00045448|Alvocidib|alvocidib|mesh-list
44097070|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097071|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097072|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097073|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44097074|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097075|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097076|NCT00045448|Growth Substances|growth substances|mesh-ancestor
44097077|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097078|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097079|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097080|NCT00045461|Carboplatin|carboplatin|mesh-list
44097081|NCT00045461|Ifosfamide|ifosfamide|mesh-list
44097082|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097083|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097084|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
44097085|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097086|NCT00045500|Prednisone|prednisone|mesh-list
44097087|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44097088|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097089|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
44097090|NCT00045500|Hormones|hormones|mesh-ancestor
44261670|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261671|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261672|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44261673|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44261674|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261675|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44261676|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44261677|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261678|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
44261679|NCT00644111|Hydromorphone|hydromorphone|mesh-list
44097091|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44097092|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097093|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44097094|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097095|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097096|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097097|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097098|NCT00045513|Fludarabine|fludarabine|mesh-list
44097099|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
44097100|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44097101|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097102|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097103|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
44097104|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097105|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097106|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
44097111|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097112|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097113|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097114|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097115|NCT00045539|Leucovorin|leucovorin|mesh-list
44097116|NCT00045539|Methotrexate|methotrexate|mesh-list
44097117|NCT00045539|Thiotepa|thiotepa|mesh-list
44097118|NCT00045539|Calcium|calcium|mesh-list
44097119|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
44097120|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44097121|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097122|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44097123|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
44097124|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44097125|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097126|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
44097127|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097128|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097129|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44097130|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097131|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44097132|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097133|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
44097134|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097135|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44097136|NCT00045539|Antidotes|antidotes|mesh-ancestor
44097137|NCT00045539|Protective Agents|protective agents|mesh-ancestor
44097138|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
44097139|NCT00045539|Vitamins|vitamins|mesh-ancestor
44097140|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
44097141|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43647998|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647999|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
43648000|NCT04984330|Hormones|hormones|mesh-ancestor
43648001|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558233|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43558234|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097142|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
44097143|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44097144|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
44097145|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097146|NCT00045591|Celecoxib|celecoxib|mesh-list
44097147|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44097148|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097149|NCT00045591|Analgesics|analgesics|mesh-ancestor
44261680|NCT00644111|Bupivacaine|bupivacaine|mesh-list
44261681|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
44261682|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
44261683|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261684|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261685|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
44261686|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261687|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44261688|NCT00644111|Narcotics|narcotics|mesh-ancestor
44261689|NCT00644111|Analgesics|analgesics|mesh-ancestor
44261690|NCT00644124|Aflibercept|aflibercept|mesh-list
44261691|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44261692|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44261693|NCT00644124|Growth Substances|growth substances|mesh-ancestor
44261694|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261695|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
44261696|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261697|NCT00644137|Pregabalin|pregabalin|mesh-list
44261698|NCT00644137|Analgesics|analgesics|mesh-ancestor
44261699|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
44261700|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261701|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261702|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
44261703|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44261704|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261705|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261706|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44261707|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44261708|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261709|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261710|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261711|NCT00644176|Azithromycin|azithromycin|mesh-list
44261712|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261713|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261714|NCT00644215|Mitomycins|mitomycins|mesh-list
44261715|NCT00644215|Mitomycin|mitomycin|mesh-list
44261718|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
44261720|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44261721|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261722|NCT00644293|Azithromycin|azithromycin|mesh-list
44261723|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261724|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261725|NCT00644306|Thalidomide|thalidomide|mesh-list
44261726|NCT00644306|Prednisone|prednisone|mesh-list
44261727|NCT00644306|Melphalan|melphalan|mesh-list
44261728|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261729|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
44261730|NCT00644306|Hormones|hormones|mesh-ancestor
44097150|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
44097151|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097152|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097153|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097154|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097155|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44097156|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44097157|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097158|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097159|NCT00045604|Cisplatin|cisplatin|mesh-list
44097160|NCT00045604|Irinotecan|irinotecan|mesh-list
44097161|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
44097162|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097163|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44097164|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097165|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097166|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097167|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097168|NCT00045617|Cisplatin|cisplatin|mesh-list
44097169|NCT00045617|Etoposide|etoposide|mesh-list
44097170|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44097171|NCT00045617|Vaccines|vaccines|mesh-list
44097172|NCT00045617|Antibodies|antibodies|mesh-list
44097173|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
44097174|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44097175|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44097176|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
44097177|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097178|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097187|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097188|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644745|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648002|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648003|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648005|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648006|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648007|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
43558306|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097190|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44097191|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44097192|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44097193|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097194|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097195|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097196|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44097197|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097198|NCT00045695|Bortezomib|bortezomib|mesh-list
44097199|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097200|NCT00045721|Carmustine|carmustine|mesh-list
44097201|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44097202|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097203|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
44097204|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097205|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097206|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097207|NCT00045747|Fluorouracil|fluorouracil|mesh-list
44097208|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44097209|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
44097210|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097211|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097212|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097213|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097214|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
44261731|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44261732|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261733|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44261734|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261735|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44261736|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
44097215|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097216|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097217|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097218|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44097219|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097220|NCT00045773|Sertraline|sertraline|mesh-list
44097221|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097222|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097223|NCT00045773|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44097224|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097225|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097226|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097227|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097228|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
44097229|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097230|NCT00045799|Omeprazole|omeprazole|mesh-list
44097231|NCT00045799|Cimetidine|cimetidine|mesh-list
44097232|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44097233|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44097234|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44097235|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44097236|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097237|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097238|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44097239|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
44097240|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
44097241|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097242|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097243|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44097247|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44097248|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
44097249|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097250|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44097251|NCT00045864|Aldesleukin|aldesleukin|mesh-list
44097253|NCT00045864|Interleukin-2|interleukin-2|mesh-list
44097254|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097255|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097256|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
44097257|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097258|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097259|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097260|NCT00045864|Analgesics|analgesics|mesh-ancestor
44097261|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
44097262|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097263|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44097264|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44097265|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
44097266|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097267|NCT00045877|Aldesleukin|aldesleukin|mesh-list
44097268|NCT00045877|Rituximab|rituximab|mesh-list
44097269|NCT00045877|Interleukin-2|interleukin-2|mesh-list
44097270|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097271|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097272|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
44097273|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097274|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097275|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097276|NCT00045877|Analgesics|analgesics|mesh-ancestor
44097277|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
44097278|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097279|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44261737|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261738|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44261739|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44261740|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
44261741|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
43832711|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832712|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832713|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43832722|NCT05253794|Colchicine|colchicine|mesh-list
44261742|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261743|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097280|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44097281|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
44097282|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097283|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44097284|NCT00045916|Nortriptyline|nortriptyline|mesh-list
44097285|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097286|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097287|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097288|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097289|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44097290|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097291|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097292|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097293|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44097294|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44097295|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44097296|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
44097297|NCT00045955|Fexofenadine|fexofenadine|mesh-list
44097298|NCT00045955|Montelukast|montelukast|mesh-list
44097299|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44097300|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
44097301|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44097302|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
44097303|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44097304|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097305|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44097306|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44097307|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097308|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44097309|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44097310|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44097311|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
44097312|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
44097313|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43596925|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
44097325|NCT00046033|Lopinavir|lopinavir|mesh-list
44097326|NCT00046033|Saquinavir|saquinavir|mesh-list
44097327|NCT00046033|Amprenavir|amprenavir|mesh-list
44097328|NCT00046033|Tenofovir|tenofovir|mesh-list
44097329|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44097330|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44097331|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
44097332|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097333|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097334|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44097335|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44097336|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
44097337|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097338|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44097339|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44097340|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44097341|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648009|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648010|NCT04933942|Lomustine|lomustine|mesh-list
43648011|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097342|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44097343|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
44097344|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097346|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44097347|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097348|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261744|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44261745|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44261746|NCT00644306|Growth Substances|growth substances|mesh-ancestor
44261747|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
44261749|NCT00644319|Morphine|morphine|mesh-list
44261750|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44261751|NCT00644319|Narcotics|narcotics|mesh-ancestor
44261752|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44097349|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097350|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097351|NCT00046137|Teriparatide|teriparatide|mesh-list
44097352|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44097353|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44097354|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097355|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44097356|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44097357|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
44097358|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44097359|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44097360|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44097361|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
44097362|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44097363|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097364|NCT00046163|Midodrine|midodrine|mesh-list
44097365|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
44097366|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
44097367|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097368|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097369|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44097370|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44097371|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44097372|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44097373|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
44097374|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097380|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44097381|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097382|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097383|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
44097384|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097385|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44097386|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44097387|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
44097388|NCT00046241|Bupropion|bupropion|mesh-list
44097389|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44097390|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097391|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648015|NCT04831320|Paclitaxel|paclitaxel|mesh-list
44097392|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44097393|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097394|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097395|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097396|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
44097397|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097398|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097399|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44097400|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44097401|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097402|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
44097403|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44097404|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097405|NCT00046267|Niacin|niacin|mesh-list
44097406|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44097407|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
44097408|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097409|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44261753|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261754|NCT00644319|Analgesics|analgesics|mesh-ancestor
44261755|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
44261756|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261757|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44261758|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44261759|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44261760|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261761|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43657234|NCT02954939|Prednisone|prednisone|mesh-list
44097410|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
44097411|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
44097412|NCT00046267|Vitamins|vitamins|mesh-ancestor
44097413|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
43648022|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558427|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558428|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558429|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43720208|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720209|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720210|NCT02631252|Analgesics|analgesics|mesh-ancestor
43720211|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
43720212|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720213|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720214|NCT02631460|Carboplatin|carboplatin|mesh-list
43720215|NCT02631460|Pemetrexed|pemetrexed|mesh-list
43720216|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720217|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720218|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720221|NCT02631408|Vancomycin|vancomycin|mesh-list
44097414|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097415|NCT00046293|Abciximab|abciximab|mesh-list
44097416|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
44097417|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44097418|NCT00046306|Antioxidants|antioxidants|mesh-list
44097419|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097420|NCT00046306|Protective Agents|protective agents|mesh-ancestor
44097421|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097422|NCT00046319|Ambrisentan|ambrisentan|mesh-list
44097423|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44097424|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44097425|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44097426|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44097427|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
44097428|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097429|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097430|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44097431|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44097432|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
44097433|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097434|NCT00046358|Ibuprofen|ibuprofen|mesh-list
44097435|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43648023|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648024|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43648025|NCT04801797|Cytarabine|cytarabine|mesh-list
43648026|NCT04801797|Azacitidine|azacitidine|mesh-list
43648027|NCT04801797|Daunorubicin|daunorubicin|mesh-list
43648028|NCT04801797|Venetoclax|venetoclax|mesh-list
43648029|NCT04801797|Idarubicin|idarubicin|mesh-list
43648030|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43648031|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
43648032|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720239|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43720240|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
43720241|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43720242|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43720243|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
43720244|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720245|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
43720246|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720247|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43720248|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720249|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
43720250|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720251|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43720252|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44097436|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097437|NCT00046358|Analgesics|analgesics|mesh-ancestor
44097438|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
44097439|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097440|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097441|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097442|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097443|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44097444|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097462|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44097463|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44097464|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44097465|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097466|NCT00046462|Metformin|metformin|mesh-list
44097467|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
44097468|NCT00046462|Glyburide|glyburide|mesh-list
44097469|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44097470|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44097471|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097472|NCT00046501|Insulin|insulin|mesh-list
44097473|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
44097474|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44097475|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
44097476|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
44097477|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44097478|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097479|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44097480|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097481|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44097482|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097483|NCT00046553|Mifepristone|mifepristone|mesh-list
44261762|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261763|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261764|NCT00644371|Rituximab|rituximab|mesh-list
44261765|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44261766|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261767|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
43720261|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720262|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43720263|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
43720264|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
43720265|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720266|NCT02631135|Analgesics|analgesics|mesh-ancestor
43720267|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
43720268|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720269|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43720270|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43558430|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43558431|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43558432|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558433|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558436|NCT03533361|Lenvatinib|lenvatinib|mesh-list
44261768|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261769|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261770|NCT00644384|Acitretin|acitretin|mesh-list
44261771|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
44261772|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
44261773|NCT00644449|Azithromycin|azithromycin|mesh-list
44261774|NCT00644449|Levofloxacin|levofloxacin|mesh-list
44097484|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44097485|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
44097486|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44097487|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097488|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44097489|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44097490|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44097491|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
44097492|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44097493|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44097494|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44097495|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44097496|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
44097497|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44097498|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44097499|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
44097500|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097510|NCT00046748|Omalizumab|omalizumab|mesh-list
44097511|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44097512|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44097513|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152847|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44152848|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152849|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152850|NCT00218205|Celecoxib|celecoxib|mesh-list
44152851|NCT00218205|Epirubicin|epirubicin|mesh-list
44152852|NCT00218205|Estramustine|estramustine|mesh-list
44152853|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44152854|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558441|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
43558442|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
43558443|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43558444|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558445|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
43558446|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
43558447|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43558448|NCT03533231|Metronidazole|metronidazole|mesh-list
43558449|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
43558450|NCT03533231|Propolis|propolis|mesh-list
43558451|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558452|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43558453|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43558454|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43558455|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43558456|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558457|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558458|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152855|NCT00218205|Analgesics|analgesics|mesh-ancestor
44152856|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
44152857|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152858|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152859|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44152860|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152861|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44152862|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44152863|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152864|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152865|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152866|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152867|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44152868|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152869|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44152870|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
44152871|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44152872|NCT00218218|Nicotine|nicotine|mesh-list
44152873|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44261775|NCT00644449|Ofloxacin|ofloxacin|mesh-list
43648033|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648035|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648036|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648037|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
43648038|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648039|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648040|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648041|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648042|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648043|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
43648044|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648045|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648046|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648047|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648048|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648049|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720297|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720298|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720299|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43720300|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720301|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
43720302|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43720303|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
44261776|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261777|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261778|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44261779|NCT00644449|Renal Agents|renal agents|mesh-ancestor
44261780|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44261781|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44152874|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
44152875|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152876|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152877|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44152878|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44152879|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152880|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152881|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152882|NCT00218231|Bupropion|bupropion|mesh-list
44152883|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44152884|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
44152885|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152886|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44152887|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152888|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097515|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097516|NCT00046800|Lurtotecan|lurtotecan|mesh-list
44097517|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097518|NCT00046813|Nicotine|nicotine|mesh-list
44097519|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44097520|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
44097521|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097522|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097523|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44097524|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44097525|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
44097536|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097537|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
44097538|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097539|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
44097540|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097541|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097542|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648050|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648051|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43720317|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720318|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43720319|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43720322|NCT02631109|Etoposide|etoposide|mesh-list
44097543|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097544|NCT00046826|Growth Substances|growth substances|mesh-ancestor
44097545|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097546|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097547|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
44097548|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44097549|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
44097550|NCT00046852|Melphalan|melphalan|mesh-list
44097551|NCT00046852|Carmustine|carmustine|mesh-list
44097552|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44097553|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097554|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
44097555|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097556|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097557|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097558|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
44097559|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097560|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097561|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44097562|NCT00046878|Carmustine|carmustine|mesh-list
44097563|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44097564|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097565|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
44097566|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097567|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097568|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097569|NCT00046904|Etanercept|etanercept|mesh-list
44097570|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44261782|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261783|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261784|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261785|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44261786|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261787|NCT00644475|Candesartan|candesartan|mesh-list
43648052|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43558470|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43558471|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43558472|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558473|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558474|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558475|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
43558487|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
43558488|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43558489|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44261788|NCT00644475|Imidapril|imidapril|mesh-list
44261789|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44261790|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44261791|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43657263|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
44097571|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097572|NCT00046904|Analgesics|analgesics|mesh-ancestor
44097573|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
44097574|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097575|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097576|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097577|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097578|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44097579|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097580|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
44097581|NCT00046917|Cisplatin|cisplatin|mesh-list
44097582|NCT00046917|Irinotecan|irinotecan|mesh-list
44097583|NCT00046917|Alvocidib|alvocidib|mesh-list
44097584|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097585|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44097586|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648054|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43648055|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
43648056|NCT04765111|Antibodies|antibodies|mesh-list
43648057|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
43648058|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43558504|NCT03532906|Bupivacaine|bupivacaine|mesh-list
43558505|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
43558506|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
43558507|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558508|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558509|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
43720357|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720358|NCT02630511|Miotics|miotics|mesh-ancestor
43720359|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
43720360|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720361|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43720362|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43720363|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
43558511|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
44097587|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097588|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097589|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097590|NCT00046917|Growth Substances|growth substances|mesh-ancestor
44097599|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097600|NCT00046995|Leucovorin|leucovorin|mesh-list
44097601|NCT00046995|Carboplatin|carboplatin|mesh-list
44097602|NCT00046995|Fluorouracil|fluorouracil|mesh-list
44097603|NCT00046995|Calcium|calcium|mesh-list
44097604|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
44097605|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097606|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44097607|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097608|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
44097609|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097610|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097611|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097612|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
44097613|NCT00046995|Antidotes|antidotes|mesh-ancestor
44097614|NCT00046995|Protective Agents|protective agents|mesh-ancestor
44097615|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
44097616|NCT00046995|Vitamins|vitamins|mesh-ancestor
44097617|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
44097618|NCT00047021|Cytarabine|cytarabine|mesh-list
44097619|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
44097620|NCT00047021|Sargramostim|sargramostim|mesh-list
44097621|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097622|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
44097623|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097624|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097625|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
44097626|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097627|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097628|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
43644748|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43558514|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558515|NCT03532854|Valsartan|valsartan|mesh-list
43558516|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43558517|NCT03532854|Ezetimibe|ezetimibe|mesh-list
43558518|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43558519|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43558520|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
43558521|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558522|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43720368|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720370|NCT02630485|Letrozole|letrozole|mesh-list
43720371|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720372|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43720373|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43720374|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097629|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097630|NCT00047021|Analgesics|analgesics|mesh-ancestor
44097631|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
44097632|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261792|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261793|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44261794|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
44261795|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261796|NCT00644540|Vaccines|vaccines|mesh-list
44261797|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
44261798|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261799|NCT00644553|Amoxicillin|amoxicillin|mesh-list
44261800|NCT00644553|Clarithromycin|clarithromycin|mesh-list
44261801|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
44261802|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43916167|NCT00469508|Modafinil|modafinil|mesh-list
44261803|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261804|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261805|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44261806|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261807|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261808|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44261809|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261810|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44462109|NCT01534637|Fluorouracil|fluorouracil|mesh-list
44462110|NCT01534637|Capecitabine|capecitabine|mesh-list
44462111|NCT01534637|Aprepitant|aprepitant|mesh-list
44462112|NCT01534637|Antiemetics|antiemetics|mesh-list
44462113|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462114|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
44462115|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462116|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462117|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
44462118|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462119|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558531|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558532|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558533|NCT03532841|Analgesics|analgesics|mesh-ancestor
43558534|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
43558535|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720384|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720385|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720386|NCT02630394|Azithromycin|azithromycin|mesh-list
43720387|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43720388|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720390|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
43720392|NCT02630264|Paclitaxel|paclitaxel|mesh-list
44462120|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462121|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
44462122|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462123|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
44462124|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462125|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462127|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462129|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
44462130|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
44462131|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44462132|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097633|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44097634|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097635|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097636|NCT00047047|Gemcitabine|gemcitabine|mesh-list
44097637|NCT00047047|Cisplatin|cisplatin|mesh-list
44097638|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097639|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097640|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
44097641|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097642|NCT00047047|Antiviral Agents|antiviral agents|mesh-ancestor
44097643|NCT00047047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097644|NCT00047047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097645|NCT00047047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097646|NCT00047047|Immunologic Factors|immunologic factors|mesh-ancestor
44097647|NCT00047047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097648|NCT00047073|Sirolimus|sirolimus|mesh-list
44097649|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097650|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097651|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44097652|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097653|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
44097654|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097655|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
44097656|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097657|NCT00047099|Tamoxifen|tamoxifen|mesh-list
44097658|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
44097659|NCT00047099|Docetaxel|docetaxel|mesh-list
43648059|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
43648060|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648061|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648062|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648063|NCT04762160|Rituximab|rituximab|mesh-list
43648064|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648065|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648066|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
43648067|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648069|NCT04728633|Carmustine|carmustine|mesh-list
44097660|NCT00047099|Fluorouracil|fluorouracil|mesh-list
44097661|NCT00047099|Epirubicin|epirubicin|mesh-list
44097669|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097670|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097671|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44097672|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097673|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097675|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
44097676|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097677|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44097678|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44097679|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097680|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097681|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44097682|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
44097683|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44097684|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44097685|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44097686|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44097687|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44097688|NCT00047112|Cisplatin|cisplatin|mesh-list
44097689|NCT00047112|Fluorouracil|fluorouracil|mesh-list
44097690|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097691|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
44097692|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097693|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097694|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097695|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
44097696|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097697|NCT00047138|Dactinomycin|dactinomycin|mesh-list
44097698|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
44097699|NCT00047138|Carboplatin|carboplatin|mesh-list
44097700|NCT00047138|Doxorubicin|doxorubicin|mesh-list
44097701|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44097702|NCT00047138|Etoposide|etoposide|mesh-list
44097703|NCT00047138|Vincristine|vincristine|mesh-list
44097704|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097705|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
44462133|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
44462134|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462135|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44462136|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44462137|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43657280|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44097706|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097707|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097708|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097709|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
44097710|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648074|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648075|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43648076|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
44097711|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097712|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44097713|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44097714|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44097715|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097716|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097717|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44097718|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097719|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097720|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
44097721|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097722|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097723|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44097724|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44097725|NCT00047164|Ipilimumab|ipilimumab|mesh-list
44097726|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097727|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097728|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43597386|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097741|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097743|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097744|NCT00047229|Doxorubicin|doxorubicin|mesh-list
44097745|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44097746|NCT00047229|Oblimersen|oblimersen|mesh-list
44097747|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44097748|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097749|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44097750|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097751|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097752|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097753|NCT00047242|Irinotecan|irinotecan|mesh-list
43720445|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43720446|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43720447|NCT02630277|Growth Substances|growth substances|mesh-ancestor
43720448|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720449|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
43720450|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720451|NCT02630108|Epirubicin|epirubicin|mesh-list
43720452|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
43720453|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720454|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720455|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720456|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720457|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720458|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097754|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44097755|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44097756|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097757|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097758|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097759|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097760|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097761|NCT00047255|Carboplatin|carboplatin|mesh-list
44097762|NCT00047255|Docetaxel|docetaxel|mesh-list
44097763|NCT00047255|Trastuzumab|trastuzumab|mesh-list
44097764|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097765|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097766|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097767|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
44097768|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097769|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097770|NCT00047268|Cytarabine|cytarabine|mesh-list
44097771|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
44097772|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097773|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
44097774|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097775|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097776|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
44097777|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097778|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462138|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462139|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462140|NCT01534351|Tamsulosin|tamsulosin|mesh-list
44462141|NCT01534351|Finasteride|finasteride|mesh-list
44097779|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
44097780|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097781|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44097782|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097783|NCT00047281|Thalidomide|thalidomide|mesh-list
44097784|NCT00047281|Celecoxib|celecoxib|mesh-list
44097785|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
44097786|NCT00047281|Etoposide|etoposide|mesh-list
44097787|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097788|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
44097789|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097790|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097791|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097792|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
44097793|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097797|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44097798|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097799|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097800|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44097801|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832763|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097802|NCT00047281|Analgesics|analgesics|mesh-ancestor
44097803|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
44097804|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097805|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097806|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44097807|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44097808|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
44097809|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097810|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097811|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097812|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097813|NCT00047281|Growth Substances|growth substances|mesh-ancestor
44097814|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097815|NCT00047294|Thalidomide|thalidomide|mesh-list
44097816|NCT00047294|Celecoxib|celecoxib|mesh-list
44097817|NCT00047294|Temozolomide|temozolomide|mesh-list
44097818|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097819|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
44097820|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097821|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097822|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44097823|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097824|NCT00047294|Analgesics|analgesics|mesh-ancestor
44097825|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
44097826|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097827|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097828|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44097829|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097830|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44097831|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44097832|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097833|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097834|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
44097835|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
44097836|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097837|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097838|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097839|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097840|NCT00047294|Growth Substances|growth substances|mesh-ancestor
44097841|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097842|NCT00047307|Gemcitabine|gemcitabine|mesh-list
44097843|NCT00047307|Alvocidib|alvocidib|mesh-list
44097844|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097845|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
44097846|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097847|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097848|NCT00047307|Antiviral Agents|antiviral agents|mesh-ancestor
44462142|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44462143|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44462144|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44462145|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
44462146|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657290|NCT02954484|Acetaminophen|acetaminophen|mesh-list
44097849|NCT00047307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097850|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648083|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43648085|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
43558626|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558629|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558630|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
43558631|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558632|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558633|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558634|NCT05262413|Lenvatinib|lenvatinib|mesh-list
44097851|NCT00047307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097852|NCT00047307|Immunologic Factors|immunologic factors|mesh-ancestor
44097853|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097854|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097855|NCT00047307|Growth Substances|growth substances|mesh-ancestor
44097856|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097857|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44097858|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097859|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097860|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097861|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097862|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44097863|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097864|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097878|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44097879|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44097880|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097881|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44097882|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097883|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097884|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097885|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
44097886|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097887|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
44097888|NCT00047502|Lonafarnib|lonafarnib|mesh-list
43813385|NCT04814056|Afatinib|afatinib|mesh-list
44097889|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097891|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097892|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097893|NCT00047554|Travoprost|travoprost|mesh-list
44097894|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44097895|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44097896|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44097897|NCT00047567|Zonisamide|zonisamide|mesh-list
44097898|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
44097899|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44097900|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097901|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097902|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44097903|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097904|NCT00047580|Tizanidine|tizanidine|mesh-list
44097905|NCT00047580|Analgesics|analgesics|mesh-ancestor
44097906|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
44097907|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097908|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097909|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
43648086|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558675|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558676|NCT05261971|Etodolac|etodolac|mesh-list
43558677|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558678|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558679|NCT05261971|Analgesics|analgesics|mesh-ancestor
43558680|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
43558681|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558682|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558683|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558684|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097910|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44097911|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44097912|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
44097913|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
44097914|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44097915|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44097916|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44097917|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
44097918|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097919|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097920|NCT00047632|Interferons|interferons|mesh-list
44097921|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
44097922|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097923|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
44462147|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462148|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462149|NCT01534351|Urological Agents|urological agents|mesh-ancestor
44462150|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44462151|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44097930|NCT00047658|Interferons|interferons|mesh-list
44097931|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
44097932|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097933|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
44097934|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097935|NCT00047671|Citalopram|citalopram|mesh-list
44097936|NCT00047671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44097937|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097938|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097939|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097940|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097941|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
44097942|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097943|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44097944|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097945|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097946|NCT00047710|Bevacizumab|bevacizumab|mesh-list
44097947|NCT00047710|Capecitabine|capecitabine|mesh-list
44097948|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097949|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097950|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097951|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097952|NCT00047710|Growth Substances|growth substances|mesh-ancestor
44097953|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097954|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097955|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44097956|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
44097957|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097958|NCT00047723|Minocycline|minocycline|mesh-list
44097959|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44097960|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097961|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43720520|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
43720521|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720522|NCT02629536|Expectorants|expectorants|mesh-ancestor
43720523|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
43720524|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43720525|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
43720526|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720527|NCT02629536|Protective Agents|protective agents|mesh-ancestor
43558700|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43558701|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097962|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097963|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097964|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097965|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097967|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44097968|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097969|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097970|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44097971|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097972|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44097973|NCT00047749|Protective Agents|protective agents|mesh-ancestor
44097974|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44097975|NCT00047749|Analgesics|analgesics|mesh-ancestor
44097976|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
44097977|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44097978|NCT00047762|Bevacizumab|bevacizumab|mesh-list
44097979|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44097980|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44097981|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097982|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097983|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097984|NCT00047762|Growth Substances|growth substances|mesh-ancestor
43644749|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43720547|NCT02629224|Gabapentin|gabapentin|mesh-list
43720548|NCT02629224|Analgesics|analgesics|mesh-ancestor
43720549|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
43720550|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720551|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720552|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
43720553|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43720554|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43720555|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720556|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43720557|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43720558|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43720559|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720560|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558725|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
44097985|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097986|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097987|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097988|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097989|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097990|NCT00047801|Docetaxel|docetaxel|mesh-list
44097991|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43597654|NCT03306745|Folic Acid|folic acid|mesh-list
44462152|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462153|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
44462154|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462155|NCT01534260|Bortezomib|bortezomib|mesh-list
44462156|NCT01534260|Sorafenib|sorafenib|mesh-list
44462157|NCT01534260|Vorinostat|vorinostat|mesh-list
44462158|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462159|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462160|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462161|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462162|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44261811|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
44261812|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
44261813|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44261814|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44261815|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261816|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261817|NCT00644605|Urological Agents|urological agents|mesh-ancestor
44261818|NCT00644618|Gemcitabine|gemcitabine|mesh-list
44261819|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44261820|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
43657299|NCT02954484|Analgesics|analgesics|mesh-ancestor
44097995|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097996|NCT00047827|Amphotericin B|amphotericin b|mesh-list
44097997|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44097998|NCT00047827|Micafungin|micafungin|mesh-list
44097999|NCT00047827|Amebicides|amebicides|mesh-ancestor
44098000|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44098001|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44098002|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098003|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098004|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
44098005|NCT00047840|Docetaxel|docetaxel|mesh-list
44098006|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098007|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098008|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098009|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098010|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648088|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43558726|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558727|NCT05186129|Clopidogrel|clopidogrel|mesh-list
43558728|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43558729|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43558730|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43558731|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43558732|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
43558733|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558742|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558743|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
44098011|NCT00048087|Docetaxel|docetaxel|mesh-list
44098012|NCT00048087|Gefitinib|gefitinib|mesh-list
44098013|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098014|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098015|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098016|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098017|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098018|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098019|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098020|NCT00048126|Capecitabine|capecitabine|mesh-list
44098021|NCT00048126|Irinotecan|irinotecan|mesh-list
44098022|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098023|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
44098024|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098025|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098026|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44261821|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261822|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261823|NCT00644618|Antiviral Agents|antiviral agents|mesh-ancestor
44261824|NCT00644618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261825|NCT00644618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261826|NCT00644618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098027|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098028|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098029|NCT00048139|Capecitabine|capecitabine|mesh-list
44098030|NCT00048139|Irinotecan|irinotecan|mesh-list
44098031|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098032|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
43720583|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43720584|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
43720585|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
43720586|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43720587|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43720588|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43720590|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
44098033|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098034|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098035|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44098036|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098037|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540554|NCT05137600|Clarithromycin|clarithromycin|mesh-list
44098039|NCT00048152|Cyclosporine|cyclosporine|mesh-list
44098041|NCT00048152|Daclizumab|daclizumab|mesh-list
44098042|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44098043|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098044|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44098045|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
44098046|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098047|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098048|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098049|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098050|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
44098051|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44098052|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098053|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
44098054|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098055|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098056|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44098057|NCT00048204|Paroxetine|paroxetine|mesh-list
44098058|NCT00048204|Vestipitant|vestipitant|mesh-list
44098059|NCT00048204|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098060|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098061|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098062|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098063|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098064|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
44098065|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43597717|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098069|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44098070|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44098071|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098072|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44098074|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098075|NCT00048334|Romidepsin|romidepsin|mesh-list
44098076|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44098077|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098078|NCT00048360|Bupropion|bupropion|mesh-list
44098079|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44098080|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098081|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098082|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44098083|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43720612|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720613|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720614|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720615|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43720616|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
43720617|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558760|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558761|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43558762|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558763|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098084|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098085|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098086|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
44098087|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098088|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098089|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44098090|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44098091|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261827|NCT00644618|Immunologic Factors|immunologic factors|mesh-ancestor
44261828|NCT00644618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261829|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
44261830|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
44098092|NCT00048373|Etanercept|etanercept|mesh-list
44098093|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44098094|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44098095|NCT00048373|Analgesics|analgesics|mesh-ancestor
44098096|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
44098097|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098098|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098099|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098100|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098101|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098102|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098103|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
44098104|NCT00048399|Fludarabine|fludarabine|mesh-list
44098105|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
44098106|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098107|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098108|NCT00048412|Fludarabine|fludarabine|mesh-list
44098109|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
44098110|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098111|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098112|NCT00048425|Simendan|simendan|mesh-list
44098113|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44098114|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
44098115|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44098116|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44098117|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098118|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098119|NCT00048425|Protective Agents|protective agents|mesh-ancestor
44098120|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098121|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43648089|NCT04661007|Growth Substances|growth substances|mesh-ancestor
43648090|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648091|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648092|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
43648093|NCT04653818|Velpatasvir|velpatasvir|mesh-list
43648094|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43648095|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
43720641|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43720642|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43720643|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43720644|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
43720645|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720646|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098122|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098123|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098124|NCT00048503|Tipifarnib|tipifarnib|mesh-list
44098125|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152889|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152890|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
44152891|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152892|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152893|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44152894|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44152895|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152896|NCT00218244|Lobeline|lobeline|mesh-list
44152897|NCT00218244|Nicotine|nicotine|mesh-list
44152898|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44152908|NCT00218283|Nicotine|nicotine|mesh-list
44152909|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44152910|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
44152911|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152912|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152913|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44152914|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44152915|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152916|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152917|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152918|NCT00218309|Hydromorphone|hydromorphone|mesh-list
44152919|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152920|NCT00218309|Narcotics|narcotics|mesh-ancestor
44152921|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152922|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152923|NCT00218309|Analgesics|analgesics|mesh-ancestor
44152924|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
44152925|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152926|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44152927|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44152928|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152929|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152930|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261831|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44261832|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44261833|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261834|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261835|NCT00644631|Urological Agents|urological agents|mesh-ancestor
44261836|NCT00644670|Atorvastatin|atorvastatin|mesh-list
44261837|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44152931|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152932|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152933|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152934|NCT00218348|Amphetamine|amphetamine|mesh-list
44152935|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
44152936|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44152937|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152938|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
44152939|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
44152940|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152941|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
44152942|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152943|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152944|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
44152945|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44152946|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44152947|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152948|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44152949|NCT00218361|Hydromorphone|hydromorphone|mesh-list
44098127|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098128|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098130|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
44098131|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
44098132|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098133|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098134|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098135|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44098136|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098137|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098138|NCT00048607|Aprepitant|aprepitant|mesh-list
44098139|NCT00048607|Paroxetine|paroxetine|mesh-list
44098140|NCT00048607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098149|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098150|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44098151|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44098152|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098153|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
44098154|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
43720675|NCT02628522|Epinephrine|epinephrine|mesh-list
43720676|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
43720677|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
43720678|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720679|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720680|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
43720681|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720682|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43720683|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43720684|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43720685|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43720686|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720687|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43720688|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720689|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558820|NCT05055713|Hormones|hormones|mesh-ancestor
44098155|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098156|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098157|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44098158|NCT00048646|Progesterone|progesterone|mesh-list
44098159|NCT00048646|Progestins|progestins|mesh-ancestor
44098160|NCT00048646|Hormones|hormones|mesh-ancestor
44098161|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098162|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098163|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
44098164|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44098165|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098166|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
44098167|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098168|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098169|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098170|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098171|NCT00048750|Micafungin|micafungin|mesh-list
44098172|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
44098173|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098174|NCT00048763|Cilostazol|cilostazol|mesh-list
44261838|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44261839|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
44261840|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261841|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44261842|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44098175|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44098176|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
44098177|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098178|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098179|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44098180|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
44098181|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44098182|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44098183|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098184|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44098186|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44098187|NCT00048763|Protective Agents|protective agents|mesh-ancestor
44098188|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43558831|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43720691|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43720692|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43720693|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
43720694|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43720695|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
43720696|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
43720697|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
43720698|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43832784|NCT05251038|Antiviral Agents|antiviral agents|mesh-ancestor
44098189|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44098190|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098191|NCT00048776|Cilostazol|cilostazol|mesh-list
44098192|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44098193|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
44098194|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098195|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098196|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813710|NCT04808648|Itraconazole|itraconazole|mesh-list
44098197|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
44098198|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44098199|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44098200|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098201|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44098202|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
44098207|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098209|NCT00048802|Olanzapine|olanzapine|mesh-list
44098210|NCT00048802|Risperidone|risperidone|mesh-list
44098211|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44098212|NCT00048802|Ziprasidone|ziprasidone|mesh-list
44098213|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44098214|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
44098215|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098216|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098217|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098218|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44098219|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44098220|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098221|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098222|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44098223|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
44098224|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
44098225|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
44098226|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098227|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098228|NCT00048802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098229|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098230|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098231|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098232|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098233|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
44098234|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
44098235|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
44098236|NCT00048828|Olanzapine|olanzapine|mesh-list
44098237|NCT00048828|Clozapine|clozapine|mesh-list
44098238|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
44098239|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
44098240|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648096|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648098|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
43558842|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43558843|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
43558844|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558845|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558847|NCT04961619|Dabrafenib|dabrafenib|mesh-list
43558848|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558849|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558852|NCT04947007|Bupivacaine|bupivacaine|mesh-list
44098241|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098242|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098243|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44098244|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261843|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261845|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
44261846|NCT00644696|Irinotecan|irinotecan|mesh-list
44261847|NCT00644696|Bortezomib|bortezomib|mesh-list
44098245|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098246|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098247|NCT00048828|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098248|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098249|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098250|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098251|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098252|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
44098253|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44098254|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
44098255|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
44098256|NCT00048841|Alendronate|alendronate|mesh-list
44098257|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44098258|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098259|NCT00048854|Sertraline|sertraline|mesh-list
44098260|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098261|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098262|NCT00048854|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098263|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098264|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098265|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098266|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098268|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098269|NCT00048880|Antibodies|antibodies|mesh-list
44098270|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43813734|NCT04808895|Aspirin|aspirin|mesh-list
44098271|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
44098272|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098273|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44098274|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
44098279|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098280|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098282|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098283|NCT00049062|Gefitinib|gefitinib|mesh-list
44098284|NCT00049062|Anastrozole|anastrozole|mesh-list
44098285|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098286|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098287|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098288|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098289|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098290|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44098291|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43720705|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43720706|NCT02628002|Regadenoson|regadenoson|mesh-list
43720707|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44098292|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44098293|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
44098294|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098295|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098296|NCT00049075|Fludarabine|fludarabine|mesh-list
44098297|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
44098298|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098299|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098300|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
44098301|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098302|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098303|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
44098304|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098305|NCT00049088|Bevacizumab|bevacizumab|mesh-list
44098306|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44098307|NCT00049088|Docetaxel|docetaxel|mesh-list
44098308|NCT00049088|Antibodies|antibodies|mesh-list
44098309|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
44098310|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44098311|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098312|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098313|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098314|NCT00049088|Growth Substances|growth substances|mesh-ancestor
44098315|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261848|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44261849|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44261850|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261851|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720743|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
43720744|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720745|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720746|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720747|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
43558887|NCT04772248|Adalimumab|adalimumab|mesh-list
43558888|NCT04772248|Etanercept|etanercept|mesh-list
43720749|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720750|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720751|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43720752|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43720753|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
43720754|NCT02627807|Gemcitabine|gemcitabine|mesh-list
43720755|NCT02627807|Cisplatin|cisplatin|mesh-list
43720756|NCT02627807|Docetaxel|docetaxel|mesh-list
43720757|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720758|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43720759|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
43720760|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720761|NCT02627807|Antiviral Agents|antiviral agents|mesh-ancestor
43720762|NCT02627807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720763|NCT02627807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261852|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261853|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261854|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261855|NCT00644709|Atorvastatin|atorvastatin|mesh-list
44261856|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44261857|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44261858|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
44261859|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261860|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44261861|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44261862|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261863|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
44261864|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
44261865|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
44261866|NCT00644735|Esomeprazole|esomeprazole|mesh-list
44261867|NCT00644735|Lansoprazole|lansoprazole|mesh-list
44261868|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
44261869|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44261870|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44261871|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44261872|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261873|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261874|NCT00644748|Gabapentin|gabapentin|mesh-list
44261875|NCT00644748|Analgesics|analgesics|mesh-ancestor
44261876|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
44261877|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44261878|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261879|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
44261880|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43657320|NCT02954068|Oxytocin|oxytocin|mesh-list
44098316|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098317|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
44098318|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098319|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098320|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098321|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098322|NCT00049101|Leucovorin|leucovorin|mesh-list
44098323|NCT00049101|Fluorouracil|fluorouracil|mesh-list
44261881|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261882|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261883|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261884|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44261885|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43648099|NCT04641104|Vitamins|vitamins|mesh-ancestor
43648100|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
43648101|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648102|NCT04609111|Aspirin|aspirin|mesh-list
43648103|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43648104|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558889|NCT04772248|Golimumab|golimumab|mesh-list
43558890|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43558891|NCT04772248|Infliximab|infliximab|mesh-list
43558892|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
43558893|NCT04772248|Tofacitinib|tofacitinib|mesh-list
43558894|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558895|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44261886|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261887|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261888|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
44261889|NCT00644761|Adefovir|adefovir|mesh-list
44261890|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44261891|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
44261892|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261893|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44261894|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44261895|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261896|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261897|NCT00644774|Azithromycin|azithromycin|mesh-list
44261898|NCT00644774|Cefdinir|cefdinir|mesh-list
44261899|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261900|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261901|NCT00644800|Ziprasidone|ziprasidone|mesh-list
44261902|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44261903|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
44261904|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261905|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261906|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261907|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44261908|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44261909|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44261910|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261911|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44261912|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
44261913|NCT00644891|Amoxicillin|amoxicillin|mesh-list
44261914|NCT00644891|Cefdinir|cefdinir|mesh-list
44261915|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261916|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261917|NCT00644904|Vitamin D|vitamin d|mesh-list
44261918|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
44261919|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
44261920|NCT00644904|Vitamins|vitamins|mesh-list
44261921|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
44261922|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261923|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44261924|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44261925|NCT00644943|Amoxicillin|amoxicillin|mesh-list
44261926|NCT00644943|Cefdinir|cefdinir|mesh-list
44261927|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261928|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261929|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
44261930|NCT00644956|Tadalafil|tadalafil|mesh-list
44261931|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
43558919|NCT04581473|Irinotecan|irinotecan|mesh-list
43558920|NCT04581473|Apatinib|apatinib|mesh-list
43558921|NCT04581473|Antibodies|antibodies|mesh-list
43720777|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
43720778|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43720779|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
43720780|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720781|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720783|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
43720784|NCT02627573|Busulfan|busulfan|mesh-list
43720785|NCT02627573|Fludarabine|fludarabine|mesh-list
43720786|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
43720787|NCT02627573|Tacrolimus|tacrolimus|mesh-list
43720788|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
43720789|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720790|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
44261932|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44261933|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44261934|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261935|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261936|NCT00644956|Urological Agents|urological agents|mesh-ancestor
44261937|NCT00644982|Sertraline|sertraline|mesh-list
44261938|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44261939|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
44261940|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44261941|NCT00644982|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44261942|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44261943|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44261944|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261945|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44261946|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
44261947|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261948|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44261949|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44261950|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
44261951|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
44261952|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44261953|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44261954|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261956|NCT00645034|Urological Agents|urological agents|mesh-ancestor
44261958|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44261959|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
44261960|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44261961|NCT00645073|Levofloxacin|levofloxacin|mesh-list
44261962|NCT00645073|Ofloxacin|ofloxacin|mesh-list
44261963|NCT00645073|Cefdinir|cefdinir|mesh-list
44261964|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44261965|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261966|NCT00645073|Renal Agents|renal agents|mesh-ancestor
44261967|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261968|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44261969|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44261970|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720810|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720811|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
43720812|NCT02627560|Coagulants|coagulants|mesh-ancestor
43720813|NCT02627521|Ticagrelor|ticagrelor|mesh-list
43720814|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720815|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43720816|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43720825|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
44261971|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261972|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44261973|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44261974|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261975|NCT00645086|Clarithromycin|clarithromycin|mesh-list
44261976|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261977|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261978|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44261979|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44261980|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261981|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44261982|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44261983|NCT00645112|Azithromycin|azithromycin|mesh-list
44261984|NCT00645112|Cefdinir|cefdinir|mesh-list
44261985|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261986|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261987|NCT00645125|Amoxicillin|amoxicillin|mesh-list
44261988|NCT00645125|Cefdinir|cefdinir|mesh-list
44261989|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44261990|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44261991|NCT00645138|Anesthetics|anesthetics|mesh-list
44261998|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44261999|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44262000|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44262001|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262002|NCT00645190|Galantamine|galantamine|mesh-list
44262003|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44262004|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262005|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262006|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
44262007|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262008|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262009|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44262010|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
44262011|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262012|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
44262013|NCT00645203|Cefdinir|cefdinir|mesh-list
44262014|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262015|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262016|NCT00645229|Ziprasidone|ziprasidone|mesh-list
44262017|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262018|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
44262019|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262020|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648105|NCT04609111|Analgesics|analgesics|mesh-ancestor
43648106|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
43648107|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648108|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648109|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648110|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648111|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43648112|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44262021|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262022|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262023|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262024|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262025|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262026|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44262027|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
44262039|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44262040|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44262041|NCT00645255|Sibutramine|sibutramine|mesh-list
44262042|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
44262043|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262044|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
44262045|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44262046|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
44262047|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
44262048|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44262049|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44262050|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262051|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262052|NCT00645268|Urological Agents|urological agents|mesh-ancestor
44262053|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44262054|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44262055|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44262056|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
44262057|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262058|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262059|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262060|NCT00645281|Urological Agents|urological agents|mesh-ancestor
44262061|NCT00645294|Adefovir|adefovir|mesh-list
44262062|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43720890|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720891|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720892|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720893|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720894|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720895|NCT02626936|Insulin|insulin|mesh-list
43720896|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43720897|NCT02626936|Glucagon|glucagon|mesh-list
44262063|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
44262064|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262065|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44262066|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44262067|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262068|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262069|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44262070|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262071|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262072|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262073|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098324|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
44098325|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44098326|NCT00049101|Calcium|calcium|mesh-list
44262074|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262075|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44262076|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262077|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
44262078|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262079|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262080|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44262081|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44262082|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
44262083|NCT00645320|Ziprasidone|ziprasidone|mesh-list
44262084|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262085|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
44262086|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262087|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262088|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262089|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262090|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262091|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262092|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262093|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44262094|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
43720907|NCT02626754|Growth Substances|growth substances|mesh-ancestor
43720908|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720909|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
43720910|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43720911|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720912|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720913|NCT02626845|Rituximab|rituximab|mesh-list
43720914|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720915|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262095|NCT00645372|Risperidone|risperidone|mesh-list
44262096|NCT00645372|Ziprasidone|ziprasidone|mesh-list
44262097|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262098|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
44262099|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262100|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262101|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262102|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262103|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262104|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262105|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262106|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44262107|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
44262112|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262114|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44262115|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262116|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262117|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262118|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44262119|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262120|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262121|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262122|NCT00645424|Atorvastatin|atorvastatin|mesh-list
44262123|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44262124|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44262125|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
44262126|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262127|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44262128|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44262129|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262130|NCT00645437|Levofloxacin|levofloxacin|mesh-list
44262131|NCT00645437|Ofloxacin|ofloxacin|mesh-list
44262132|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44262133|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262134|NCT00645437|Renal Agents|renal agents|mesh-ancestor
44262135|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262136|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262137|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44262138|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262139|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262143|NCT00645502|Risperidone|risperidone|mesh-list
44262155|NCT00645515|Risperidone|risperidone|mesh-list
44262156|NCT00645515|Ziprasidone|ziprasidone|mesh-list
44262157|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44262158|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
44262159|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262160|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262161|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262162|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262163|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262164|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657465|NCT02953106|Fluticasone|fluticasone|mesh-list
44098327|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
44098328|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43648113|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648114|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44098329|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098330|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
44098331|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098332|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43540923|NCT02616146|Estradiol|estradiol|mesh-list
44098334|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098335|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
44098336|NCT00049101|Antidotes|antidotes|mesh-ancestor
44098337|NCT00049101|Protective Agents|protective agents|mesh-ancestor
44098338|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
44098339|NCT00049101|Vitamins|vitamins|mesh-ancestor
44098340|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
44098341|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098342|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098343|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
44098344|NCT00049114|Doxorubicin|doxorubicin|mesh-list
44098345|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44098346|NCT00049114|Tipifarnib|tipifarnib|mesh-list
44098347|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098399|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098400|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098401|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098402|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098403|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098404|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098405|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098406|NCT00049296|Thalidomide|thalidomide|mesh-list
44098407|NCT00049296|Docetaxel|docetaxel|mesh-list
44098408|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098409|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098410|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098411|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098412|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098413|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098414|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
44098415|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098416|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
44098417|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098418|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098419|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098420|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098421|NCT00049296|Growth Substances|growth substances|mesh-ancestor
44098422|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098424|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098425|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
43720928|NCT02626247|Vitamin A|vitamin a|mesh-list
43720929|NCT02626247|Vitamins|vitamins|mesh-ancestor
44098426|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098436|NCT00049348|Antiviral Agents|antiviral agents|mesh-ancestor
43720930|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
43720931|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098437|NCT00049348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098438|NCT00049348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098439|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098440|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
44098441|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098442|NCT00049348|Hematinics|hematinics|mesh-ancestor
44262167|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
44262168|NCT00645554|Galantamine|galantamine|mesh-list
44262169|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44262170|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262171|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262172|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
44262173|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262174|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098443|NCT00049361|Thalidomide|thalidomide|mesh-list
44098444|NCT00049361|Temozolomide|temozolomide|mesh-list
43648115|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43648116|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648118|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
43648119|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
43648120|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648121|NCT04603898|Protective Agents|protective agents|mesh-ancestor
43648122|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648123|NCT04603898|Vitamins|vitamins|mesh-ancestor
43648124|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
43648125|NCT04601883|Colchicine|colchicine|mesh-list
43648126|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
43720976|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720977|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720978|NCT02626065|Nivolumab|nivolumab|mesh-list
43720979|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720980|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720981|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44098445|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098446|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
44098447|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098448|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098449|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098450|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
44098451|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098452|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
44098453|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098454|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098455|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098456|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098457|NCT00049361|Growth Substances|growth substances|mesh-ancestor
44098458|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098459|NCT00049374|Thalidomide|thalidomide|mesh-list
44098460|NCT00049374|Dexamethasone|dexamethasone|mesh-list
44098461|NCT00049374|Oblimersen|oblimersen|mesh-list
44098462|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098463|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
44098464|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
44098465|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098466|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098467|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098468|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
44098469|NCT00049374|Hormones|hormones|mesh-ancestor
44098470|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098471|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098472|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098473|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098474|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
44098475|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
44098476|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098477|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098478|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098479|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098480|NCT00049374|Growth Substances|growth substances|mesh-ancestor
44098481|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098482|NCT00049387|Temozolomide|temozolomide|mesh-list
44098483|NCT00049387|Tipifarnib|tipifarnib|mesh-list
43558966|NCT04528563|Narcotics|narcotics|mesh-ancestor
43558967|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43558968|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558969|NCT04528563|Analgesics|analgesics|mesh-ancestor
43558970|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
43558971|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558972|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558973|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43720982|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720983|NCT02626104|Lactoferrin|lactoferrin|mesh-list
43720984|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720989|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
44098484|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098485|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
44098486|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098487|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098488|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
44098489|NCT00049413|Rituximab|rituximab|mesh-list
44098490|NCT00049413|Pentostatin|pentostatin|mesh-list
44098491|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098492|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
44098493|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098494|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098495|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098496|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
44098521|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44262175|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44262176|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
44262177|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262178|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
44098522|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098523|NCT00049556|Gefitinib|gefitinib|mesh-list
44098524|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098525|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098526|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098527|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098528|NCT00049569|Leucovorin|leucovorin|mesh-list
44098529|NCT00049569|Cytarabine|cytarabine|mesh-list
44098530|NCT00049569|Prednisone|prednisone|mesh-list
44098531|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
44098532|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44098533|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44098534|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44098535|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
44098536|NCT00049569|Doxorubicin|doxorubicin|mesh-list
44098537|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44098538|NCT00049569|Methotrexate|methotrexate|mesh-list
44098539|NCT00049569|Etoposide|etoposide|mesh-list
44098540|NCT00049569|Vincristine|vincristine|mesh-list
44098541|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
44098542|NCT00049569|Asparaginase|asparaginase|mesh-list
44098543|NCT00049569|Pegaspargase|pegaspargase|mesh-list
44098544|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
44098545|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098546|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
44098547|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098548|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098549|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098569|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44098570|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44098571|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44098572|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
44098573|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098574|NCT00049569|Antidotes|antidotes|mesh-ancestor
44098575|NCT00049569|Protective Agents|protective agents|mesh-ancestor
44098576|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
44098578|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
44098579|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098580|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098581|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098582|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098583|NCT00049582|Decitabine|decitabine|mesh-list
44098584|NCT00049582|Azacitidine|azacitidine|mesh-list
44098585|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43721014|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721015|NCT02625805|Methylphenidate|methylphenidate|mesh-list
43721016|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43721017|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098586|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
44098587|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098588|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098589|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098590|NCT00049608|Gemcitabine|gemcitabine|mesh-list
44098591|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098592|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
44098593|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098594|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098595|NCT00049608|Antiviral Agents|antiviral agents|mesh-ancestor
44098596|NCT00049608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098597|NCT00049608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098598|NCT00049608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098599|NCT00049608|Immunologic Factors|immunologic factors|mesh-ancestor
44098600|NCT00049608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098601|NCT00049634|Cyclosporine|cyclosporine|mesh-list
44098602|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
44098603|NCT00049634|Busulfan|busulfan|mesh-list
44098604|NCT00049634|Methotrexate|methotrexate|mesh-list
44098605|NCT00049634|Cyclosporins|cyclosporins|mesh-list
44098606|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098636|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098637|NCT00049725|Daclizumab|daclizumab|mesh-list
44098638|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098640|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098641|NCT00049751|Adalimumab|adalimumab|mesh-list
44098642|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098643|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262180|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44262181|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262182|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262183|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262184|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262185|NCT00645580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43657481|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
44098644|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44098645|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098646|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44098647|NCT00049777|Heparin|heparin|mesh-list
44098648|NCT00049777|Calcium heparin|calcium heparin|mesh-list
44098649|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44098650|NCT00049777|Tinzaparin|tinzaparin|mesh-list
44098651|NCT00049777|Dalteparin|dalteparin|mesh-list
44098652|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
43648127|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648128|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
43648129|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
43721072|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721073|NCT02625454|Analgesics|analgesics|mesh-ancestor
43721074|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
43721075|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721076|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721077|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
43721078|NCT02625103|Clozapine|clozapine|mesh-list
43721079|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44098681|NCT00049946|Risperidone|risperidone|mesh-list
44098682|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44098683|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
44098684|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098685|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098686|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098687|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44098688|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44098689|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098690|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098691|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44098692|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
44098693|NCT00049972|Paroxetine|paroxetine|mesh-list
44098694|NCT00049972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098695|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098696|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098697|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721102|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721103|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
43721104|NCT02625337|Trametinib|trametinib|mesh-list
43721105|NCT02625337|Dabrafenib|dabrafenib|mesh-list
43721106|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721107|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721108|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43721109|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721110|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721111|NCT02624999|Cisplatin|cisplatin|mesh-list
43721112|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721113|NCT02624856|Dexamethasone|dexamethasone|mesh-list
43558989|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
43558990|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43558991|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43721114|NCT02624856|Bupivacaine|bupivacaine|mesh-list
44098698|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098699|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
44098718|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098719|NCT00050180|Indinavir|indinavir|mesh-list
44098720|NCT00050180|Saquinavir|saquinavir|mesh-list
44098721|NCT00050180|Midazolam|midazolam|mesh-list
44098722|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44098723|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44098724|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098725|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098726|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44098727|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44098728|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098729|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44098730|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
44098731|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
44098732|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
44098733|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
44098734|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098735|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098736|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44098737|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44098738|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
44098739|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098740|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44098741|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44098742|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
44098743|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098744|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44098745|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44098746|NCT00050206|Olanzapine|olanzapine|mesh-list
44098747|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
44098748|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
44098749|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262186|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44262187|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262188|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098750|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098751|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098752|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44098753|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44098754|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098755|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098756|NCT00050206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098757|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098758|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152971|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
44152972|NCT00218413|Vaccines|vaccines|mesh-list
44152973|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
44152974|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098789|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
44098791|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098792|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098793|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
43648130|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648131|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648132|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648133|NCT04601350|Midazolam|midazolam|mesh-list
43648134|NCT04601350|Anesthetics|anesthetics|mesh-list
43721118|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098794|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098795|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44098796|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44098797|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098798|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098799|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44098800|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44098801|NCT00050362|Analgesics|analgesics|mesh-ancestor
44098802|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098803|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098804|NCT00050375|Oregovomab|oregovomab|mesh-list
44098805|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098806|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098807|NCT00050401|Vancomycin|vancomycin|mesh-list
44098808|NCT00050401|Tobramycin|tobramycin|mesh-list
44098809|NCT00050401|Meropenem|meropenem|mesh-list
44098810|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098811|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098812|NCT00050414|Dexamethasone|dexamethasone|mesh-list
44098813|NCT00050414|Trabectedin|trabectedin|mesh-list
44098814|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098815|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
44098816|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
44098817|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721172|NCT02624726|Fluorouracil|fluorouracil|mesh-list
43721173|NCT02624726|Irinotecan|irinotecan|mesh-list
43721174|NCT02624726|Aflibercept|aflibercept|mesh-list
43721175|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
43721176|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
43721177|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721178|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43721179|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721180|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43721181|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
43721182|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721183|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43721184|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721185|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721186|NCT02624726|Antidotes|antidotes|mesh-ancestor
43721187|NCT02624726|Protective Agents|protective agents|mesh-ancestor
43721188|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
43721189|NCT02624726|Vitamins|vitamins|mesh-ancestor
43559004|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43559006|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44098818|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098819|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098820|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
44098821|NCT00050414|Hormones|hormones|mesh-ancestor
44098830|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
44098831|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098832|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098833|NCT00050440|Dexamethasone|dexamethasone|mesh-list
44098834|NCT00050440|Trabectedin|trabectedin|mesh-list
44098836|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
44098837|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
44098838|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098839|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098840|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098841|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
44098843|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098844|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098845|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152980|NCT00218504|Analgesics|analgesics|mesh-ancestor
43814104|NCT04802967|Ketoprofen|ketoprofen|mesh-list
44098846|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098847|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
44098848|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098849|NCT00050479|Celecoxib|celecoxib|mesh-list
44098850|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43793787|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
44262189|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262190|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
44262191|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44262192|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
43825347|NCT05502458|Propofol|propofol|mesh-list
44098851|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44098852|NCT00050479|Analgesics|analgesics|mesh-ancestor
44098853|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
44098854|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098855|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098856|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098857|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098858|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44098859|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44098860|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098861|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098862|NCT00050505|Vaccines|vaccines|mesh-list
44098863|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
44098864|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098865|NCT00050531|Interferons|interferons|mesh-list
44098866|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
44098867|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
44098868|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44098869|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44098870|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
44098871|NCT00050531|Molgramostim|molgramostim|mesh-list
44098872|NCT00050531|Sargramostim|sargramostim|mesh-list
44098873|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098874|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
44098875|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098876|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
44098877|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098878|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098879|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098880|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098881|NCT00050596|Docetaxel|docetaxel|mesh-list
44098882|NCT00050596|Ipilimumab|ipilimumab|mesh-list
44098883|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098884|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098885|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098904|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098905|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098906|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098907|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
44098909|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
44098910|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098911|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
44098912|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098913|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44098914|NCT00050661|Daclizumab|daclizumab|mesh-list
44098915|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098916|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
44098917|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098918|NCT00050674|Lenograstim|lenograstim|mesh-list
44098919|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44098920|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
44098921|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098923|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098924|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098925|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44098926|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098927|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
44098928|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098929|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
43648135|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648136|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648137|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43648138|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43648139|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43648140|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43648141|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648142|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43648143|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
43648144|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
43832872|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
43832873|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832874|NCT05248139|Prednisolone|prednisolone|mesh-list
43721209|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43721210|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
43721211|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098930|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098931|NCT00050726|Interleukin-2|interleukin-2|mesh-list
44098932|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098933|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44098934|NCT00050726|Analgesics|analgesics|mesh-ancestor
44098935|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
44098936|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098937|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262193|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44262194|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44262195|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262196|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44262197|NCT00645606|Rituximab|rituximab|mesh-list
44262198|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44262199|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262200|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
44098938|NCT00050804|Sertraline|sertraline|mesh-list
44098939|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098940|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098941|NCT00050804|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44098942|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098943|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098944|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098963|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44098964|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098965|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44098966|NCT00050830|Protective Agents|protective agents|mesh-ancestor
43559025|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43559026|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43559027|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43559029|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
43559030|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559031|NCT04448834|Vincristine|vincristine|mesh-list
43559032|NCT04448834|Blinatumomab|blinatumomab|mesh-list
43559033|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43559034|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559035|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559036|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559037|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
43721237|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721238|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721239|NCT02624453|Fluconazole|fluconazole|mesh-list
43721240|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43721241|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
43721242|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098967|NCT00050843|Thalidomide|thalidomide|mesh-list
44098968|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098969|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
44098970|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098971|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
44098972|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44098973|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098974|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098975|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098976|NCT00050843|Growth Substances|growth substances|mesh-ancestor
44098977|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098978|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098979|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
44098980|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44098981|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43541594|NCT05234307|Nivolumab|nivolumab|mesh-list
44098982|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098983|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44098984|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44098985|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
44098986|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098988|NCT00050895|Lopinavir|lopinavir|mesh-list
44098989|NCT00050895|Tenofovir|tenofovir|mesh-list
44098990|NCT00050895|Lamivudine|lamivudine|mesh-list
44098991|NCT00050895|Zidovudine|zidovudine|mesh-list
44098992|NCT00050895|Stavudine|stavudine|mesh-list
44098993|NCT00050895|Efavirenz|efavirenz|mesh-list
44098994|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43648145|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
43648146|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648147|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648148|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
43648149|NCT04579523|Fludarabine|fludarabine|mesh-list
43559038|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559039|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43559040|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43559041|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43559042|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559043|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098995|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44098996|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44098997|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098998|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098999|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099000|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099001|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
44099009|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44099010|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44099011|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099012|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44099013|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44099014|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44099015|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
44099016|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099017|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
44099018|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
44099019|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44099020|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44099021|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43721265|NCT02624388|Hormones|hormones|mesh-ancestor
43721266|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721267|NCT02624531|Cisplatin|cisplatin|mesh-list
43721268|NCT02624531|Taxane|taxane|mesh-list
43721269|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721270|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
43721271|NCT02624401|Ketamine|ketamine|mesh-list
43721272|NCT02624401|Propofol|propofol|mesh-list
43721273|NCT02624401|Sevoflurane|sevoflurane|mesh-list
43721274|NCT02624401|Esketamine|esketamine|mesh-list
43721275|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43721276|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721277|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721278|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43721279|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
43721280|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
43721281|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721282|NCT02624401|Analgesics|analgesics|mesh-ancestor
43721283|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
44262201|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262202|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262203|NCT00645632|Cisplatin|cisplatin|mesh-list
44262204|NCT00645632|Doxorubicin|doxorubicin|mesh-list
44262205|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44262206|NCT00645632|Methotrexate|methotrexate|mesh-list
44099022|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099023|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44099024|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099025|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
44099026|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
44099027|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44099028|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44099029|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099030|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099031|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44099032|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099033|NCT00050973|Bexarotene|bexarotene|mesh-list
44099034|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099035|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
44099036|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
44099037|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
44099038|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44099039|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099040|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
44099041|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099042|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099043|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44099044|NCT00051051|Protective Agents|protective agents|mesh-ancestor
44099045|NCT00051077|Ribavirin|ribavirin|mesh-list
44099046|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44099047|NCT00051077|Adefovir|adefovir|mesh-list
44099048|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44099049|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
44099050|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099051|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
44099052|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099053|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099054|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099055|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099056|NCT00051090|Lamivudine|lamivudine|mesh-list
44099057|NCT00051090|Efavirenz|efavirenz|mesh-list
44099058|NCT00051090|Abacavir|abacavir|mesh-list
43648150|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
43648151|NCT04579523|Daratumumab|daratumumab|mesh-list
43648152|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43559049|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
43559050|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559051|NCT04379518|Interferons|interferons|mesh-list
43559052|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
43559053|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
43721288|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721289|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721290|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721291|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43721292|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43721293|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43721294|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44099059|NCT00051090|Didanosine|didanosine|mesh-list
44099060|NCT00051090|Telbivudine|telbivudine|mesh-list
44099061|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099062|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099063|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099064|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099065|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
44099066|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099083|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099084|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099086|NCT00051142|Latanoprost|latanoprost|mesh-list
44099087|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44099088|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44099089|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44099090|NCT00051155|Timolol|timolol|mesh-list
44099091|NCT00051155|Travoprost|travoprost|mesh-list
44099092|NCT00051155|Latanoprost|latanoprost|mesh-list
44099093|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44099094|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44099095|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
44099096|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099097|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099098|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099099|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44099100|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44099101|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44099102|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44099103|NCT00051181|Travoprost|travoprost|mesh-list
44262208|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262209|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44262210|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262211|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44262212|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262213|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099104|NCT00051181|Latanoprost|latanoprost|mesh-list
44099105|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44099106|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44099107|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44099108|NCT00051259|Bupropion|bupropion|mesh-list
44099109|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44099110|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
44099111|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44099112|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44099113|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44099114|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099115|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099116|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
44099117|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099118|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099119|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44099120|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099121|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099122|NCT00051272|Bupropion|bupropion|mesh-list
44099123|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44099144|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099146|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
44099147|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
44099148|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099149|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099150|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721315|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721346|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44099151|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44099152|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44099153|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44099154|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44099155|NCT00051298|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44099156|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44099157|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099158|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099159|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099160|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
44099161|NCT00051389|Fosinopril|fosinopril|mesh-list
44099162|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44099163|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
44099164|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099165|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099166|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44099167|NCT00051441|Benzydamine|benzydamine|mesh-list
44099168|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099169|NCT00051493|Carboplatin|carboplatin|mesh-list
44099170|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099171|NCT00051506|Cisplatin|cisplatin|mesh-list
44099172|NCT00051506|Carboplatin|carboplatin|mesh-list
44099173|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099174|NCT00051532|Seocalcitol|seocalcitol|mesh-list
44099175|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099176|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099177|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
44099187|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099188|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099189|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099190|NCT00051584|Gemcitabine|gemcitabine|mesh-list
44099191|NCT00051584|Doxorubicin|doxorubicin|mesh-list
43721347|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43721348|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721349|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721350|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
43721351|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721352|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721353|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43721354|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
43721355|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721356|NCT02623621|Bevacizumab|bevacizumab|mesh-list
43721357|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721358|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721359|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43721360|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43721361|NCT02623621|Growth Substances|growth substances|mesh-ancestor
44099192|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
44262214|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44262216|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44262217|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099193|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099194|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
44099195|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099196|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099197|NCT00051584|Antiviral Agents|antiviral agents|mesh-ancestor
44099198|NCT00051584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099199|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099200|NCT00051584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099201|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
44099202|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099203|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44099204|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43541832|NCT04238780|Fentanyl|fentanyl|mesh-list
44099205|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099206|NCT00051597|Antibodies|antibodies|mesh-list
44099207|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44099208|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
44099209|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099210|NCT00051623|Infliximab|infliximab|mesh-list
44099211|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
44099212|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44099213|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099214|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
44099215|NCT00051688|Tezacitabine|tezacitabine|mesh-list
44099216|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099217|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099218|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099219|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
44099220|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099221|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648153|NCT04579523|Antibodies|antibodies|mesh-list
43648154|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
43559109|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
43559110|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
43559111|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559112|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43559113|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43559114|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559115|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559116|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43721365|NCT02623738|Latanoprost|latanoprost|mesh-list
44099222|NCT00051753|Amoxicillin|amoxicillin|mesh-list
44099223|NCT00051753|Levofloxacin|levofloxacin|mesh-list
44099224|NCT00051753|Ofloxacin|ofloxacin|mesh-list
44099225|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
44099226|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
44099227|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44099228|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099229|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099230|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44099231|NCT00051753|Renal Agents|renal agents|mesh-ancestor
44099232|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099233|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099234|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099235|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099236|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099237|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44099238|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721389|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721390|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721391|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
43721392|NCT02623673|Hormones|hormones|mesh-ancestor
43721393|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721394|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43721395|NCT02623569|Atenolol|atenolol|mesh-list
43721396|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43721397|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43721398|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
43721399|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
43721400|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721401|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721402|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44099239|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44099240|NCT00051831|Ritonavir|ritonavir|mesh-list
44099241|NCT00051831|Saquinavir|saquinavir|mesh-list
44099242|NCT00051831|Tenofovir|tenofovir|mesh-list
44099243|NCT00051831|Emtricitabine|emtricitabine|mesh-list
44099244|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
44099245|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44099263|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099264|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099265|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
44099266|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099267|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099268|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44152981|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
44152982|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152983|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44152984|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44152985|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152986|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152987|NCT00218504|Hormones|hormones|mesh-ancestor
44262219|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
44262220|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
44262221|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44262222|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262223|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
44262224|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262225|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43848930|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152988|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152990|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
44152991|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152993|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44152994|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44152995|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152996|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152997|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44152998|NCT00218517|Protective Agents|protective agents|mesh-ancestor
44152999|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153000|NCT00218530|Lofexidine|lofexidine|mesh-list
44153001|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153002|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44153003|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153004|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
44153005|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153006|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44153007|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44099269|NCT00051896|Vanoxerine|vanoxerine|mesh-list
44099270|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44099271|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44099272|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648155|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43648156|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648157|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
43648158|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721406|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721407|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721408|NCT02623595|Molgramostim|molgramostim|mesh-list
43721409|NCT02623595|Sargramostim|sargramostim|mesh-list
43721439|NCT02623062|Antacids|antacids|mesh-ancestor
44099289|NCT00052026|Carvedilol|carvedilol|mesh-list
44099290|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44099291|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44099292|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
44099293|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099294|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099295|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099296|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44099297|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
44099298|NCT00052026|Protective Agents|protective agents|mesh-ancestor
44099299|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44099300|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099301|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44099302|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
44099303|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44099304|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44099305|NCT00052039|Interferons|interferons|mesh-list
44099306|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
44099307|NCT00052039|Azathioprine|azathioprine|mesh-list
44099308|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099309|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
44099310|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099311|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
44099312|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099313|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099314|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099315|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
44099316|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099317|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099318|NCT00052052|Interferons|interferons|mesh-list
44099319|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
44262226|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44262227|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
44262228|NCT00645658|Testosterone|testosterone|mesh-list
44262229|NCT00645658|Androgens|androgens|mesh-ancestor
44262230|NCT00645658|Hormones|hormones|mesh-ancestor
44262231|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262232|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262233|NCT00645723|Colistin|colistin|mesh-list
44262234|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262235|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262236|NCT00645801|Lubiprostone|lubiprostone|mesh-list
44262237|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44262238|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262239|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262240|NCT00645814|Adalimumab|adalimumab|mesh-list
44262241|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262242|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262243|NCT00645866|Docetaxel|docetaxel|mesh-list
44262244|NCT00645866|Capecitabine|capecitabine|mesh-list
44262245|NCT00645866|Epirubicin|epirubicin|mesh-list
44262246|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262247|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559125|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
43559126|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559127|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559128|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
43559129|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559130|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559131|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
43559132|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559133|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44262248|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44262249|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44262250|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848932|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
44099320|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099321|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
44099322|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099323|NCT00052117|Capravirine|capravirine|mesh-list
44099324|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099325|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099326|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099327|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099328|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
44099329|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099330|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099331|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099332|NCT00052169|Docetaxel|docetaxel|mesh-list
44099350|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
44099351|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099352|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099353|NCT00052286|Modafinil|modafinil|mesh-list
44099354|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44099355|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099356|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44099357|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44099358|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099359|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099360|NCT00052299|Cytarabine|cytarabine|mesh-list
44262251|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262252|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
44262253|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44262254|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43559148|NCT04163185|Rizatriptan|rizatriptan|mesh-list
43559149|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43559150|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559151|NCT04163185|Analgesics|analgesics|mesh-ancestor
43559152|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
43559153|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559155|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262255|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099361|NCT00052299|Etoposide|etoposide|mesh-list
44099362|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
44099363|NCT00052299|Idarubicin|idarubicin|mesh-list
44099364|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
44099365|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099366|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099367|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099368|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099369|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099370|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099371|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099372|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
44099373|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
44099374|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099375|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099376|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
44099377|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099378|NCT00052299|Analgesics|analgesics|mesh-ancestor
44099379|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
44099380|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099381|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44099382|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099383|NCT00052312|Paclitaxel|paclitaxel|mesh-list
44099384|NCT00052312|Cisplatin|cisplatin|mesh-list
44099385|NCT00052312|Doxorubicin|doxorubicin|mesh-list
44099386|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44099387|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099388|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099389|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099390|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099391|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099427|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099428|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
44099429|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099430|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648159|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648160|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43721485|NCT02623114|Methylphenidate|methylphenidate|mesh-list
43721486|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43721487|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43721488|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721489|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43721490|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43721491|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099431|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099432|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099433|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099447|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099448|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099449|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099450|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099451|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
44099452|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099453|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44099454|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
44099455|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099456|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099457|NCT00052377|Growth Substances|growth substances|mesh-ancestor
44099458|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099459|NCT00052390|Bevacizumab|bevacizumab|mesh-list
44099460|NCT00052390|Doxorubicin|doxorubicin|mesh-list
44099461|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44099462|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099463|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099464|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099465|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099466|NCT00052390|Growth Substances|growth substances|mesh-ancestor
44099467|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099468|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099469|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43832882|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43832883|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
43832884|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832885|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
43832886|NCT05248139|Hormones|hormones|mesh-ancestor
43832887|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832888|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832889|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832890|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832891|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
43832893|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099470|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099471|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099472|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099473|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262257|NCT00645879|Citric Acid|citric acid|mesh-list
43916679|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
44262258|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
44262259|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
44262260|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44099474|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44099476|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
44099477|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44099478|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
44099479|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
44099480|NCT00052403|Mitogens|mitogens|mesh-list
44099481|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099482|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099483|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099484|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099485|NCT00052416|Thalidomide|thalidomide|mesh-list
44099486|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099487|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
44099488|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099489|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
44099490|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099491|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099492|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099493|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099494|NCT00052416|Growth Substances|growth substances|mesh-ancestor
44099495|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099496|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099497|NCT00052455|Vincristine|vincristine|mesh-list
44099498|NCT00052455|Temozolomide|temozolomide|mesh-list
44099499|NCT00052455|Lomustine|lomustine|mesh-list
44099526|NCT00052468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099528|NCT00052494|Irinotecan|irinotecan|mesh-list
44099529|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
44099530|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099531|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44099532|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099533|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099534|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099535|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099536|NCT00052507|Bortezomib|bortezomib|mesh-list
44099537|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099538|NCT00052559|Bevacizumab|bevacizumab|mesh-list
44099539|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44099540|NCT00052559|Fluorouracil|fluorouracil|mesh-list
44099541|NCT00052559|Antibodies|antibodies|mesh-list
44099542|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
44099543|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44099544|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099545|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099546|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099547|NCT00052559|Growth Substances|growth substances|mesh-ancestor
43559181|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559182|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559183|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43559184|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559185|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43559186|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559187|NCT04104685|Minocycline|minocycline|mesh-list
43559188|NCT04104685|Adapalene|adapalene|mesh-list
43559189|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559197|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099548|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099610|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44099612|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44099613|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099614|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44099615|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44099616|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44099617|NCT00052754|Gefitinib|gefitinib|mesh-list
44099618|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099619|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099620|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099621|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099622|NCT00052780|Temozolomide|temozolomide|mesh-list
44099623|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44099624|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099625|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
44099626|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099627|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262262|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
44262263|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262264|NCT00645892|Adalimumab|adalimumab|mesh-list
44262265|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262266|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262267|NCT00645905|Adalimumab|adalimumab|mesh-list
44262268|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262269|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262270|NCT00645918|Clopidogrel|clopidogrel|mesh-list
44262271|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44099664|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099665|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099686|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099687|NCT00052936|Prednisone|prednisone|mesh-list
44099688|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
44099689|NCT00052936|Rituximab|rituximab|mesh-list
44099690|NCT00052936|Doxorubicin|doxorubicin|mesh-list
44099691|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44099692|NCT00052936|Vincristine|vincristine|mesh-list
43648162|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648163|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648171|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
43648172|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648173|NCT04544943|Gentamicins|gentamicins|mesh-list
43648174|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648175|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648176|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43824246|NCT05514197|Vitamins|vitamins|mesh-ancestor
43648181|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099693|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099694|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
44099695|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099696|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099697|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099698|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
44099699|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099700|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099701|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099702|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099703|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44099704|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099705|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099706|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099707|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099708|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
44099709|NCT00052936|Hormones|hormones|mesh-ancestor
44099710|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44099711|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44099712|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099713|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099714|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099715|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099716|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
44099717|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099718|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099719|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099720|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099732|NCT00053001|Growth Substances|growth substances|mesh-ancestor
44099733|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099734|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099736|NCT00053027|Cladribine|cladribine|mesh-list
44099737|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099738|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099739|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
44099740|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099741|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099742|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099743|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
44099744|NCT00053092|Rituximab|rituximab|mesh-list
44099745|NCT00053092|Fludarabine|fludarabine|mesh-list
44099746|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
44099747|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099748|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
44099749|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262272|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44262273|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43648182|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
44262274|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44262275|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
44262276|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657491|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44099750|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099751|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099752|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
44099753|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099754|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099755|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099756|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099757|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099758|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
44099759|NCT00053105|Cytarabine|cytarabine|mesh-list
44099760|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
44099761|NCT00053105|Pixantrone|pixantrone|mesh-list
44099762|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099763|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099764|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
44099765|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099766|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
44099767|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099768|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099769|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
44099770|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099771|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099772|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
44099773|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
44099774|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099775|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44099776|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
44099777|NCT00053105|Hormones|hormones|mesh-ancestor
44099778|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44099779|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44099780|NCT00053105|Protective Agents|protective agents|mesh-ancestor
44099781|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099782|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099783|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099784|NCT00053118|Carboplatin|carboplatin|mesh-list
44099785|NCT00053118|Etoposide|etoposide|mesh-list
44099786|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099804|NCT00053131|Analgesics|analgesics|mesh-ancestor
44099805|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
44099806|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099807|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099808|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099809|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099810|NCT00053144|Cytarabine|cytarabine|mesh-list
44099811|NCT00053144|Irinotecan|irinotecan|mesh-list
44099812|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44099813|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099814|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648183|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721563|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721564|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43721565|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43721566|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44099815|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099816|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099817|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099818|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
44099819|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
44099820|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099821|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099822|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
44099823|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099824|NCT00053157|Sargramostim|sargramostim|mesh-list
44099825|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
44099826|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099827|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
44099828|NCT00053196|Methotrexate|methotrexate|mesh-list
44099829|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
44099830|NCT00053196|Fludarabine|fludarabine|mesh-list
44262277|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262278|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262279|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44262280|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262281|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262282|NCT00646009|Fluticasone|fluticasone|mesh-list
44262283|NCT00646009|Budesonide|budesonide|mesh-list
44262284|NCT00646009|Albuterol|albuterol|mesh-list
44262285|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
44262286|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44262287|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44262288|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262289|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44262290|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
44262291|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262292|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262293|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262294|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44262295|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44262296|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44262297|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
44262298|NCT00646009|Hormones|hormones|mesh-ancestor
44262299|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262300|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43721617|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43721618|NCT02622022|Morphine|morphine|mesh-list
43721619|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721620|NCT02622022|Narcotics|narcotics|mesh-ancestor
43721621|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721622|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721623|NCT02622022|Analgesics|analgesics|mesh-ancestor
43721634|NCT02621970|Cisplatin|cisplatin|mesh-list
44262301|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44262302|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44262303|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262306|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
44262323|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262324|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099831|NCT00053196|Busulfan|busulfan|mesh-list
44099832|NCT00053196|Allopurinol|allopurinol|mesh-list
44099833|NCT00053196|Tacrolimus|tacrolimus|mesh-list
44099834|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44099835|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44099836|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
44099837|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44099838|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099839|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099840|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
44099841|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099842|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099843|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
44099844|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099867|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099869|NCT00053209|Antiviral Agents|antiviral agents|mesh-ancestor
44099870|NCT00053209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099871|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099872|NCT00053209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099873|NCT00053209|Immunologic Factors|immunologic factors|mesh-ancestor
44099874|NCT00053209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099875|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44153009|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
44099876|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099877|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
44099878|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099879|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
44099880|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
44099881|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099882|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099883|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099884|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099885|NCT00053287|Thalidomide|thalidomide|mesh-list
43648184|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721653|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43721654|NCT02621827|Calcifediol|calcifediol|mesh-list
43721655|NCT02621827|Vitamins|vitamins|mesh-ancestor
43721656|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
43721657|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721658|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43721659|NCT02621554|Resveratrol|resveratrol|mesh-list
43721660|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
43721662|NCT02621554|Protective Agents|protective agents|mesh-ancestor
44099886|NCT00053287|Carboplatin|carboplatin|mesh-list
44099887|NCT00053287|Fludarabine|fludarabine|mesh-list
44099888|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
44099890|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099891|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099892|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
44099893|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099894|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099895|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
44099896|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099897|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44099913|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099914|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099915|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099916|NCT00053300|Growth Substances|growth substances|mesh-ancestor
43721693|NCT02621489|Incretins|incretins|mesh-ancestor
43721694|NCT02621489|Hormones|hormones|mesh-ancestor
43721695|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44099917|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099918|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099919|NCT00053326|Fenretinide|fenretinide|mesh-list
44099920|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099921|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44099922|NCT00053326|Protective Agents|protective agents|mesh-ancestor
44099923|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099925|NCT00053339|Trastuzumab|trastuzumab|mesh-list
44099926|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099927|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099928|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44099929|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
44099930|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44099931|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099932|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44099933|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44099934|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44099935|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44099937|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262326|NCT00646087|Analgesics|analgesics|mesh-ancestor
44262327|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
44262328|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648186|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
43648187|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648188|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43648189|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648190|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648191|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721709|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43721710|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43721711|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43721712|NCT02621359|Renal Agents|renal agents|mesh-ancestor
43721713|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43721714|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43721715|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721716|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43721717|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43721718|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43721719|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43721720|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43721721|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721722|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721723|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
43721724|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262329|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262330|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44262331|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44262332|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
44262333|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
44262334|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262335|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44262336|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44262337|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262338|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099938|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099939|NCT00053430|Thalidomide|thalidomide|mesh-list
44099940|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099941|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
44099942|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099943|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
44099944|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099945|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099946|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099947|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099948|NCT00053430|Growth Substances|growth substances|mesh-ancestor
44099949|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
43814923|NCT04787510|Heparin|heparin|mesh-list
44099950|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099951|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44099952|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44099953|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
44099954|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099955|NCT00053599|Simvastatin|simvastatin|mesh-list
44099956|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44099957|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44099976|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099977|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099978|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099979|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44099980|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099981|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44099982|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44099983|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099984|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44153010|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559217|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43559218|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43559219|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43559220|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43559221|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559222|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
43559223|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
43559224|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648192|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44153011|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153012|NCT00218569|Naltrexone|naltrexone|mesh-list
44153013|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44153014|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44153015|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153016|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
44153017|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153018|NCT00218608|Disulfiram|disulfiram|mesh-list
44153019|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44153020|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43648193|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43648194|NCT04329728|Dexamethasone|dexamethasone|mesh-list
44153021|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153022|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153023|NCT00218621|Buprenorphine|buprenorphine|mesh-list
44153024|NCT00218621|Methadone|methadone|mesh-list
44153025|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44153026|NCT00218621|Narcotics|narcotics|mesh-ancestor
44262339|NCT00646126|Artesunate|artesunate|mesh-list
44262340|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
44262341|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
44262342|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
44262343|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44262344|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44262345|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262346|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262347|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
44153027|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153028|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153030|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
44153031|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153032|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44153033|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
44153034|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44153035|NCT00218660|Naltrexone|naltrexone|mesh-list
44153036|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44153037|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44153038|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153039|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
44153040|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153041|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
44153044|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648195|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43648196|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648197|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
43648198|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
43648199|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559235|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43559236|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559237|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559238|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559239|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559240|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559241|NCT03949673|Celecoxib|celecoxib|mesh-list
43559242|NCT03949673|Diclofenac|diclofenac|mesh-list
43559243|NCT03949673|Naproxen|naproxen|mesh-list
43559244|NCT03949673|Fasinumab|fasinumab|mesh-list
43559247|NCT03949673|Analgesics|analgesics|mesh-ancestor
44153046|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153047|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
44153048|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44153049|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153050|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099985|NCT00053716|Alprostadil|alprostadil|mesh-list
44099986|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44099987|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44099988|NCT00053716|Urological Agents|urological agents|mesh-ancestor
44099989|NCT00053768|Prednisone|prednisone|mesh-list
44099990|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
44099991|NCT00053768|Doxorubicin|doxorubicin|mesh-list
44099992|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44099993|NCT00053768|Etoposide|etoposide|mesh-list
44099994|NCT00053768|Vincristine|vincristine|mesh-list
44099995|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099996|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
44099997|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099998|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099999|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100000|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
44100001|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100002|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100003|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100004|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100005|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44100006|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100007|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100008|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100009|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
44100010|NCT00053768|Hormones|hormones|mesh-ancestor
44100011|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100012|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100013|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100014|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100015|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100016|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100017|NCT00053807|Interferons|interferons|mesh-list
44100018|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
44100019|NCT00053807|Aldesleukin|aldesleukin|mesh-list
44100020|NCT00053807|Fluorouracil|fluorouracil|mesh-list
44100021|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
44100022|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100023|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100024|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721732|NCT02621255|Bupivacaine|bupivacaine|mesh-list
44262348|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
44262349|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44262350|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
44262351|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44262352|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100025|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100026|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
44100027|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100028|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
44100029|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100030|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44100031|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44100033|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
44100034|NCT00053820|Aldesleukin|aldesleukin|mesh-list
44100035|NCT00053820|Fluorouracil|fluorouracil|mesh-list
44100036|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
44100037|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100038|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100039|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648200|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648201|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648202|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
43648203|NCT04329728|Hormones|hormones|mesh-ancestor
43648204|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648205|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43721769|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721770|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43721771|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43721772|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43721773|NCT02620800|Growth Substances|growth substances|mesh-ancestor
43721774|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721775|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43721776|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43721777|NCT02620800|Antidotes|antidotes|mesh-ancestor
43721778|NCT02620800|Protective Agents|protective agents|mesh-ancestor
43721779|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
43721781|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
43721782|NCT02620813|Tretinoin|tretinoin|mesh-list
43721783|NCT02620813|Isotretinoin|isotretinoin|mesh-list
43721784|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559273|NCT03928184|Lorecivivint|lorecivivint|mesh-list
43559274|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559275|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44100040|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100041|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
44100042|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100043|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
44100044|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100045|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44100046|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44100047|NCT00053833|Irinotecan|irinotecan|mesh-list
44100048|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100049|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100050|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100073|NCT00053911|Anastrozole|anastrozole|mesh-list
44100074|NCT00053911|Goserelin|goserelin|mesh-list
44100075|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100076|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
44100077|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100078|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100079|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100080|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
44100081|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100082|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100083|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100084|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100085|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100086|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100087|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
44100088|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100089|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100090|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44100091|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100092|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100093|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44100094|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
43880647|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644756|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559277|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44100095|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100096|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100097|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44100098|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44100099|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44100100|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44100101|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44100102|NCT00053937|Pirfenidone|pirfenidone|mesh-list
44100103|NCT00053937|Analgesics|analgesics|mesh-ancestor
44100104|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
44100108|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44100109|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100110|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100111|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100112|NCT00053950|NSC 366140|nsc 366140|mesh-list
44100113|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100114|NCT00053963|Romidepsin|romidepsin|mesh-list
44100115|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100116|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262353|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100118|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44100119|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44100120|NCT00053976|Prednisolone|prednisolone|mesh-list
43648206|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648207|NCT04320940|Phenobarbital|phenobarbital|mesh-list
43648208|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
43648209|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43648210|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721793|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
43721794|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721795|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721796|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721797|NCT02620618|Infliximab|infliximab|mesh-list
43721798|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
43721799|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721800|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721801|NCT02620566|Bupivacaine|bupivacaine|mesh-list
43721802|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721803|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
43559302|NCT03896009|Rizatriptan|rizatriptan|mesh-list
43559303|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43721804|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721805|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721806|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
44100121|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
44100122|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44100123|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
44100124|NCT00053976|Daclizumab|daclizumab|mesh-list
44100125|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100126|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
44100127|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
44100128|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100129|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100130|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44100131|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
44100132|NCT00053976|Hormones|hormones|mesh-ancestor
44100133|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100134|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44100135|NCT00053976|Protective Agents|protective agents|mesh-ancestor
44100136|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100137|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100138|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100139|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
44100140|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44100141|NCT00054002|Trioxsalen|trioxsalen|mesh-list
44100142|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100143|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100144|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44100145|NCT00054041|Vaccines|vaccines|mesh-list
44100146|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
44100147|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100148|NCT00054054|Cisplatin|cisplatin|mesh-list
44100149|NCT00054054|Docetaxel|docetaxel|mesh-list
44100150|NCT00054054|Fluorouracil|fluorouracil|mesh-list
44100151|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100152|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100153|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100154|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100155|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100156|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
44100157|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100158|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100159|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
44100160|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100161|NCT00054067|Cisplatin|cisplatin|mesh-list
44100162|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100163|NCT00054106|Flutamide|flutamide|mesh-list
44100164|NCT00054106|Buserelin|buserelin|mesh-list
44100165|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
44100166|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
44100167|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100168|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100169|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100170|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100171|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44100172|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
44100173|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44100174|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44100175|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44100176|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100177|NCT00054184|Paclitaxel|paclitaxel|mesh-list
44100178|NCT00054184|Docetaxel|docetaxel|mesh-list
44100179|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44100180|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100181|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100182|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100183|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100184|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100185|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100186|NCT00054197|Gemcitabine|gemcitabine|mesh-list
44100187|NCT00054197|Paclitaxel|paclitaxel|mesh-list
44100188|NCT00054197|Vinorelbine|vinorelbine|mesh-list
44100189|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44100190|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100191|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262354|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44262355|NCT00646126|Renal Agents|renal agents|mesh-ancestor
44262356|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
44262357|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262358|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262359|NCT00646152|Poly ICLC|poly iclc|mesh-list
44262360|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
44262361|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
44262362|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262363|NCT00646178|Adalimumab|adalimumab|mesh-list
44262364|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262365|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262366|NCT00646191|Adalimumab|adalimumab|mesh-list
44100192|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100193|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100194|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100195|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100196|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100197|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
44100198|NCT00054197|Antiviral Agents|antiviral agents|mesh-ancestor
44100199|NCT00054197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100200|NCT00054197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100201|NCT00054197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100202|NCT00054197|Immunologic Factors|immunologic factors|mesh-ancestor
44100203|NCT00054197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100204|NCT00054210|Paclitaxel|paclitaxel|mesh-list
44100205|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44100206|NCT00054210|Carboplatin|carboplatin|mesh-list
44100207|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44100208|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100209|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100210|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100211|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100212|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100213|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100214|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
44100215|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
44100216|NCT00054236|Fludarabine|fludarabine|mesh-list
44100217|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
44100218|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44100219|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100220|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
44100221|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100222|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100223|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100224|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
44100225|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100226|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100227|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100228|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100229|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
44100230|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100231|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
44100232|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
44100233|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100234|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44100235|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
44100236|NCT00054236|Hormones|hormones|mesh-ancestor
44100237|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100238|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44100239|NCT00054236|Protective Agents|protective agents|mesh-ancestor
44100240|NCT00054288|Gemcitabine|gemcitabine|mesh-list
44100241|NCT00054288|Irinotecan|irinotecan|mesh-list
43721884|NCT02620345|Hormones|hormones|mesh-ancestor
44100242|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262367|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262368|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262370|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262371|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44262372|NCT00646230|Protective Agents|protective agents|mesh-ancestor
44262373|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100243|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
44100244|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100245|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100246|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
44100247|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100248|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100249|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100250|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
44100251|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100252|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100253|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100254|NCT00054340|Cyclosporine|cyclosporine|mesh-list
44100255|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
44100256|NCT00054340|Busulfan|busulfan|mesh-list
44100257|NCT00054340|Methotrexate|methotrexate|mesh-list
44100258|NCT00054340|Cyclosporins|cyclosporins|mesh-list
44100259|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44100260|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100261|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
44100262|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100263|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100264|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100265|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
44100266|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100267|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100268|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100269|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44100270|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
44100271|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44100272|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100273|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
44100274|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100275|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100276|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44100277|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44100278|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
44100279|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100280|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44100282|NCT00054392|Paclitaxel|paclitaxel|mesh-list
44100283|NCT00054392|Carboplatin|carboplatin|mesh-list
43559306|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
43559307|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559308|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559309|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559310|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43559311|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43721923|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43721924|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
43721926|NCT02620007|Rifaximin|rifaximin|mesh-list
43721927|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721928|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721929|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43721937|NCT02619773|Mupirocin|mupirocin|mesh-list
44100284|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100285|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100286|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100287|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100288|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100289|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100290|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100291|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
44100292|NCT00054392|Antiviral Agents|antiviral agents|mesh-ancestor
44100293|NCT00054392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100294|NCT00054392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100295|NCT00054392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100296|NCT00054392|Immunologic Factors|immunologic factors|mesh-ancestor
44100297|NCT00054392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100298|NCT00054405|Aldesleukin|aldesleukin|mesh-list
44100299|NCT00054405|Interleukin-2|interleukin-2|mesh-list
44100300|NCT00054405|Interleukin-12|interleukin-12|mesh-list
44100301|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100302|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44100303|NCT00054405|Analgesics|analgesics|mesh-ancestor
44100304|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
44100305|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100306|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262375|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
44262376|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44262377|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262378|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44262379|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
44262380|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262381|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262382|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262383|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
44262384|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
44100307|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44100308|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44100309|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
44100310|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100311|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44100312|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
44100313|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100314|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100315|NCT00054405|Growth Substances|growth substances|mesh-ancestor
44100316|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100317|NCT00054418|Vitamin D|vitamin d|mesh-list
44100318|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
44100319|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
44100320|NCT00054418|Calcium|calcium|mesh-list
44100321|NCT00054418|Vitamins|vitamins|mesh-ancestor
44100322|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
44100323|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100324|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100325|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44100326|NCT00054418|Antacids|antacids|mesh-ancestor
44100327|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100328|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44100329|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44100330|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44100331|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
44100332|NCT00054431|Decitabine|decitabine|mesh-list
44100333|NCT00054431|Azacitidine|azacitidine|mesh-list
44100334|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100335|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100336|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100337|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100338|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100339|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
44100340|NCT00054444|Cisplatin|cisplatin|mesh-list
44100341|NCT00054444|Topotecan|topotecan|mesh-list
44100342|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100343|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100344|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100345|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100346|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100348|NCT00054457|Capecitabine|capecitabine|mesh-list
44100349|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100350|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100351|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100352|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100353|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100354|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100355|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
44100356|NCT00054470|Trastuzumab|trastuzumab|mesh-list
44100357|NCT00054470|Tipifarnib|tipifarnib|mesh-list
44100358|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100359|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100360|NCT00054483|Bortezomib|bortezomib|mesh-list
44100361|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100362|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44262386|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262387|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44262388|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44262389|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44262390|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262391|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262392|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462164|NCT01534208|Clomiphene|clomiphene|mesh-list
44462165|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
44462166|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44462167|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
44462168|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462169|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100363|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100364|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100365|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100366|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100367|NCT00054522|Calcitriol|calcitriol|mesh-list
44100368|NCT00054522|Dexamethasone|dexamethasone|mesh-list
44100369|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100370|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
43722001|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43722002|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43722003|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43722004|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722005|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559331|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43559332|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44100371|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
44100372|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100373|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100374|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44100375|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
44100376|NCT00054522|Hormones|hormones|mesh-ancestor
44100377|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100378|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100379|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100380|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100381|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44100382|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44100383|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100384|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44100385|NCT00054522|Vitamins|vitamins|mesh-ancestor
44100386|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
44100387|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44100388|NCT00054535|Aldesleukin|aldesleukin|mesh-list
44100389|NCT00054535|Vaccines|vaccines|mesh-list
44100390|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
44100391|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100392|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100393|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44100394|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44100395|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
44100396|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100397|NCT00054548|Paclitaxel|paclitaxel|mesh-list
44100398|NCT00054548|Oblimersen|oblimersen|mesh-list
44100399|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100400|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100401|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100402|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100403|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100404|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100405|NCT00054561|Vitamin E|vitamin e|mesh-list
44462170|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44462171|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
44462172|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44462173|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44462174|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44462175|NCT01534195|Prednisolone|prednisolone|mesh-list
44462176|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44462177|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
44462178|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44262393|NCT00646386|Adalimumab|adalimumab|mesh-list
44262394|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262395|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262396|NCT00646425|Basiliximab|basiliximab|mesh-list
44262397|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262398|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
44262399|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262400|NCT00646503|Telbivudine|telbivudine|mesh-list
44100406|NCT00054561|Interferons|interferons|mesh-list
44100407|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
44100408|NCT00054561|Isotretinoin|isotretinoin|mesh-list
44100409|NCT00054561|Vitamins|vitamins|mesh-ancestor
44100410|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
44100411|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559337|NCT03856047|Liraglutide|liraglutide|mesh-list
44100414|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100415|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
44100416|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
44100417|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100418|NCT00054561|Protective Agents|protective agents|mesh-ancestor
44100419|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100420|NCT00054574|Panitumumab|panitumumab|mesh-list
44100421|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100422|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100423|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
44100424|NCT00054587|Docetaxel|docetaxel|mesh-list
44100425|NCT00054587|Fluorouracil|fluorouracil|mesh-list
44100426|NCT00054587|Trastuzumab|trastuzumab|mesh-list
44100427|NCT00054587|Epirubicin|epirubicin|mesh-list
44100428|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100429|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
44100430|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100431|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100432|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100433|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
44100434|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100435|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100436|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100437|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100438|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100439|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100440|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
44100441|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100442|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100443|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100444|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44100445|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100446|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100447|NCT00054600|Methoxsalen|methoxsalen|mesh-list
44100448|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44100449|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100450|NCT00054613|Methoxsalen|methoxsalen|mesh-list
44100451|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44262401|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
44262402|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262403|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44262404|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262405|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262406|NCT00646516|Budesonide|budesonide|mesh-list
44262407|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
44262408|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44262409|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262410|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44262411|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
44262412|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598256|NCT03301207|Bupropion|bupropion|mesh-list
43832969|NCT05244213|Carboplatin|carboplatin|mesh-list
43832970|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832971|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832972|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832973|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832974|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832975|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832976|NCT05243563|Clobetasol|clobetasol|mesh-list
44262413|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262414|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262415|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
44262416|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
44262417|NCT00646516|Hormones|hormones|mesh-ancestor
44262418|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262419|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44262420|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44262421|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44262422|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262423|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262424|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262425|NCT00646529|Budesonide|budesonide|mesh-list
44262426|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
44100452|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100453|NCT00054626|Gemcitabine|gemcitabine|mesh-list
44100454|NCT00054626|Cisplatin|cisplatin|mesh-list
44100455|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100456|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100457|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
44100458|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100459|NCT00054626|Antiviral Agents|antiviral agents|mesh-ancestor
44100460|NCT00054626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100461|NCT00054626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100462|NCT00054626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100463|NCT00054626|Immunologic Factors|immunologic factors|mesh-ancestor
44100464|NCT00054626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100465|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
44100466|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100467|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44100468|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100469|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
44100470|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100471|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100472|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262427|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44262428|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262429|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44262430|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
44262431|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262432|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262433|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262434|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
44262435|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
44262436|NCT00646529|Hormones|hormones|mesh-ancestor
44262437|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262438|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44262439|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44262440|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44100473|NCT00054834|Epratuzumab|epratuzumab|mesh-list
44100474|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100475|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100476|NCT00054873|Fluorouracil|fluorouracil|mesh-list
44100477|NCT00054873|Tezacitabine|tezacitabine|mesh-list
44100478|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
44100479|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100480|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100481|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100482|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100483|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
44100484|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100485|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100486|NCT00054886|Sunitinib|sunitinib|mesh-list
44100487|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100488|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100489|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100490|NCT00054886|Growth Substances|growth substances|mesh-ancestor
44100491|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100492|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100493|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100494|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100495|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100496|NCT00054938|Aspirin|aspirin|mesh-list
44100497|NCT00054938|Ramipril|ramipril|mesh-list
44100498|NCT00054938|Pravastatin|pravastatin|mesh-list
44100499|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100500|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44100501|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44100502|NCT00054938|Analgesics|analgesics|mesh-ancestor
44100503|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
44100504|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100505|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100506|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100507|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44100508|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44100509|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100510|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44100511|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44100512|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100513|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
44100514|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44100515|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
44100516|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44100517|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44262441|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262442|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262443|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262444|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44262445|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44100518|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44100519|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
44100520|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44100521|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44100522|NCT00054977|Fluorouracil|fluorouracil|mesh-list
44100523|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
44100524|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100525|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100526|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100527|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100528|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
44100529|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100530|NCT00055042|Vitamin E|vitamin e|mesh-list
44100531|NCT00055042|Vitamins|vitamins|mesh-ancestor
44100532|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
44100533|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100534|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
44100535|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100536|NCT00055042|Protective Agents|protective agents|mesh-ancestor
44100537|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
44100538|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44100539|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100540|NCT00055120|Ritonavir|ritonavir|mesh-list
44100541|NCT00055120|Lopinavir|lopinavir|mesh-list
44100542|NCT00055120|Tenofovir|tenofovir|mesh-list
44100543|NCT00055120|Emtricitabine|emtricitabine|mesh-list
44100544|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44100545|NCT00055120|Stavudine|stavudine|mesh-list
44100546|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44100547|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44100548|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44100549|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100550|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100551|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44100552|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44100553|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
44100554|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100555|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44100556|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44100557|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44100558|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44100559|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
44100560|NCT00055133|Paclitaxel|paclitaxel|mesh-list
44100561|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100598|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100601|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44100602|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
44100603|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100604|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
44100605|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100606|NCT00055367|Natalizumab|natalizumab|mesh-list
44100607|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
44100608|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100609|NCT00055393|Bupropion|bupropion|mesh-list
44100610|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44100611|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
44100612|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44100613|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44100614|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44100615|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44100616|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100617|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
44100618|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262446|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262447|NCT00646594|Fluticasone|fluticasone|mesh-list
44262448|NCT00646594|Budesonide|budesonide|mesh-list
44262449|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
44262450|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44262451|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44262452|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44262453|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262454|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44100619|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100620|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44100621|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44100622|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100623|NCT00055419|Cetuximab|cetuximab|mesh-list
44100624|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100625|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100626|NCT00055432|Gemcitabine|gemcitabine|mesh-list
44100627|NCT00055432|Pemetrexed|pemetrexed|mesh-list
44100628|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100629|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
44100630|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100631|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100632|NCT00055432|Antiviral Agents|antiviral agents|mesh-ancestor
44100633|NCT00055432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100634|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100635|NCT00055432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100636|NCT00055432|Immunologic Factors|immunologic factors|mesh-ancestor
43722099|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
44100637|NCT00055432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100638|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44100639|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44153051|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44153052|NCT00218855|Growth Substances|growth substances|mesh-ancestor
44153053|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
44153054|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158096|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158097|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158098|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158100|NCT00236223|Hormones|hormones|mesh-ancestor
44158101|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158102|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44158103|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158104|NCT00236223|Analgesics|analgesics|mesh-ancestor
44158105|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
44158106|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44158107|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158108|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
44158109|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
44158110|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158111|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44158112|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44158113|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158114|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158115|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
44158116|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44158117|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158118|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158119|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
44158120|NCT00236249|Lidocaine|lidocaine|mesh-list
44158121|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
44158122|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
44100641|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
44100642|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44100643|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44100644|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793991|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
44262455|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
44262456|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262457|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262458|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262459|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
44100645|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100646|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100647|NCT00055523|Adalimumab|adalimumab|mesh-list
44100648|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100649|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100650|NCT00055536|Natalizumab|natalizumab|mesh-list
44100651|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
44100652|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100653|NCT00055549|Lorazepam|lorazepam|mesh-list
44100654|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
44100655|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
44100656|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
44100657|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44100658|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44100659|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44100660|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100661|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100662|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
44100663|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
44100664|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
44100665|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100666|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722207|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44100667|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44100668|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44100669|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44100670|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44100671|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44100672|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
44100673|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
44100674|NCT00055562|Lenalidomide|lenalidomide|mesh-list
44100675|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
44100676|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100677|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100678|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100679|NCT00055562|Growth Substances|growth substances|mesh-ancestor
44100680|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100681|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100683|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100684|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100685|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100686|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100687|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100688|NCT00055640|Prednisone|prednisone|mesh-list
44100689|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
44100690|NCT00055640|Rituximab|rituximab|mesh-list
44100691|NCT00055640|Doxorubicin|doxorubicin|mesh-list
44100692|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44100693|NCT00055640|Vincristine|vincristine|mesh-list
44100694|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100695|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
44100696|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100697|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100698|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100699|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
44100700|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100701|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100702|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100703|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44100704|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100705|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44100706|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100707|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100708|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100709|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
44100710|NCT00055640|Hormones|hormones|mesh-ancestor
43794180|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
44262460|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
44262461|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44262462|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
44262463|NCT00646594|Hormones|hormones|mesh-ancestor
44262464|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262465|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44262466|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44100711|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100712|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100713|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100714|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100715|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100716|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100717|NCT00055653|Cyclosporine|cyclosporine|mesh-list
44100718|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
44100719|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
44100720|NCT00055653|Melphalan|melphalan|mesh-list
44100721|NCT00055653|Busulfan|busulfan|mesh-list
44100722|NCT00055653|Fludarabine|fludarabine|mesh-list
44100723|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
44100724|NCT00055653|Cyclosporins|cyclosporins|mesh-list
44100725|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44100726|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100727|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
44100728|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100729|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100730|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100731|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
44100732|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100733|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100734|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100735|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100736|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
44100737|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100738|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
44100741|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44100742|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100744|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
44100745|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100746|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44100747|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
44100748|NCT00055653|Hormones|hormones|mesh-ancestor
44100749|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100750|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44100751|NCT00055653|Protective Agents|protective agents|mesh-ancestor
44100752|NCT00055666|Beclomethasone|beclomethasone|mesh-list
44100753|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100754|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
44100755|NCT00055666|Hormones|hormones|mesh-ancestor
44100756|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100757|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100758|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44100759|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44100760|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
44100761|NCT00055679|Fluorouracil|fluorouracil|mesh-list
44100762|NCT00055679|Epirubicin|epirubicin|mesh-list
44100763|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100764|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
44100765|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100766|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100767|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100768|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
44100769|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100770|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100771|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44100773|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100774|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44100775|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262468|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262469|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44100776|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100777|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100778|NCT00055718|Silymarin|silymarin|mesh-list
44100779|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
44100780|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100781|NCT00055718|Protective Agents|protective agents|mesh-ancestor
44100782|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100783|NCT00055757|Gemcitabine|gemcitabine|mesh-list
44100784|NCT00055757|Cisplatin|cisplatin|mesh-list
44100785|NCT00055757|Tipifarnib|tipifarnib|mesh-list
44100786|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100787|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100788|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
44100789|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100790|NCT00055757|Antiviral Agents|antiviral agents|mesh-ancestor
44100791|NCT00055757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100792|NCT00055757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100793|NCT00055757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100794|NCT00055757|Immunologic Factors|immunologic factors|mesh-ancestor
43648211|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648212|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43722298|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722299|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43722300|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44100795|NCT00055757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100797|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44100798|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100799|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100800|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100801|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100802|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100803|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100804|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100805|NCT00055809|Interferons|interferons|mesh-list
44100806|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
44100807|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
44100808|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44100809|NCT00055809|Bevacizumab|bevacizumab|mesh-list
44100810|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44100811|NCT00055809|Antibodies|antibodies|mesh-list
44100812|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
44100813|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44100814|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100815|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100816|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100817|NCT00055809|Growth Substances|growth substances|mesh-ancestor
44100818|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100819|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100820|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
44100821|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
44100822|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100824|NCT00055822|Fluorouracil|fluorouracil|mesh-list
44100825|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
44100826|NCT00055822|Oblimersen|oblimersen|mesh-list
44100827|NCT00055822|Calcium|calcium|mesh-list
44100828|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
44100829|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100830|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100831|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
44100832|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100833|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100834|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100835|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100836|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
44100837|NCT00055822|Antidotes|antidotes|mesh-ancestor
44100838|NCT00055822|Protective Agents|protective agents|mesh-ancestor
44100839|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
44100840|NCT00055822|Vitamins|vitamins|mesh-ancestor
44100841|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
44100842|NCT00055835|Gemcitabine|gemcitabine|mesh-list
44100843|NCT00055835|Paclitaxel|paclitaxel|mesh-list
44100844|NCT00055835|Cisplatin|cisplatin|mesh-list
44100845|NCT00055835|Carboplatin|carboplatin|mesh-list
44100846|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100847|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100849|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100850|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100851|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262470|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262471|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
44262472|NCT00646607|Leucovorin|leucovorin|mesh-list
44262473|NCT00646607|Fluorouracil|fluorouracil|mesh-list
44262474|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
44262475|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
44262476|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
44100852|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100853|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
44100854|NCT00055835|Antiviral Agents|antiviral agents|mesh-ancestor
44100855|NCT00055835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100856|NCT00055835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100857|NCT00055835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100858|NCT00055835|Immunologic Factors|immunologic factors|mesh-ancestor
44100859|NCT00055835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100860|NCT00055861|Bevacizumab|bevacizumab|mesh-list
44100861|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44100862|NCT00055861|Docetaxel|docetaxel|mesh-list
44100863|NCT00055861|Antibodies|antibodies|mesh-list
44100864|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
44100865|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44100866|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100867|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100868|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100869|NCT00055861|Growth Substances|growth substances|mesh-ancestor
44100870|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100871|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100872|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
44100873|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100874|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100875|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100876|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100878|NCT00055874|Cytarabine|cytarabine|mesh-list
44100879|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
44100880|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
44100881|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
44100882|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100883|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
44100884|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100885|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100886|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
44100887|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100888|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100889|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
44100890|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100891|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100892|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100893|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
44100894|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44100895|NCT00055887|Gemcitabine|gemcitabine|mesh-list
44100896|NCT00055887|Paclitaxel|paclitaxel|mesh-list
44100897|NCT00055887|Vinorelbine|vinorelbine|mesh-list
44100898|NCT00055887|Cisplatin|cisplatin|mesh-list
44100899|NCT00055887|Carboplatin|carboplatin|mesh-list
44100900|NCT00055887|Efaproxiral|efaproxiral|mesh-list
44100901|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100902|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100903|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100904|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100905|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
43648213|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44100906|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100907|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100908|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
44100909|NCT00055887|Antiviral Agents|antiviral agents|mesh-ancestor
44100910|NCT00055887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100911|NCT00055887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100912|NCT00055887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100913|NCT00055887|Immunologic Factors|immunologic factors|mesh-ancestor
44100914|NCT00055887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100915|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
44100916|NCT00055913|Bevacizumab|bevacizumab|mesh-list
44100917|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44262477|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262478|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262479|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262480|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262482|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262483|NCT00646607|Antidotes|antidotes|mesh-ancestor
44262484|NCT00646607|Protective Agents|protective agents|mesh-ancestor
44262485|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
44262486|NCT00646607|Vitamins|vitamins|mesh-ancestor
43657576|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
44100918|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44100919|NCT00055913|Antibodies|antibodies|mesh-list
44100920|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
44100921|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44100922|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100923|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44100924|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44100925|NCT00055913|Growth Substances|growth substances|mesh-ancestor
44100926|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100927|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
44100928|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
44100929|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100930|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100931|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100933|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100934|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100935|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100936|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100937|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100938|NCT00055952|Exatecan|exatecan|mesh-list
44100939|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44100940|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44100941|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100942|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100943|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100944|NCT00055965|Gemcitabine|gemcitabine|mesh-list
44100945|NCT00055965|Cisplatin|cisplatin|mesh-list
44100946|NCT00055965|Carboplatin|carboplatin|mesh-list
44100947|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100948|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100949|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
44100950|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100951|NCT00055965|Antiviral Agents|antiviral agents|mesh-ancestor
44100952|NCT00055965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100953|NCT00055965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100954|NCT00055965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100955|NCT00055965|Immunologic Factors|immunologic factors|mesh-ancestor
44100956|NCT00055965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100957|NCT00055978|Celecoxib|celecoxib|mesh-list
44100958|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44100959|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44100960|NCT00055978|Analgesics|analgesics|mesh-ancestor
44100961|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
44100962|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100963|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100964|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100965|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100966|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44100967|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44100968|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722453|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100969|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100970|NCT00055991|Bexarotene|bexarotene|mesh-list
44100971|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262487|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
44262488|NCT00646620|Fluticasone|fluticasone|mesh-list
44262489|NCT00646620|Budesonide|budesonide|mesh-list
44262490|NCT00646620|Albuterol|albuterol|mesh-list
44262491|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
44262492|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44262493|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44262494|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44262495|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262496|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44262497|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
44262498|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262499|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262500|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44262501|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
44262502|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
44262503|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44262504|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
44262505|NCT00646620|Hormones|hormones|mesh-ancestor
44262506|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262507|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44262508|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44262509|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44262510|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262511|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262512|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262513|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
44262514|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44262515|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
44262516|NCT00646659|Cisplatin|cisplatin|mesh-list
44262517|NCT00646659|Carboplatin|carboplatin|mesh-list
44262533|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
44262534|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262535|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262536|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
44262537|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44100972|NCT00056004|Zileuton|zileuton|mesh-list
44100973|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44100974|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44100975|NCT00056004|Analgesics|analgesics|mesh-ancestor
44100976|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
44100977|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100978|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648225|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648226|NCT04182373|Antithrombins|antithrombins|mesh-list
43648227|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
43648228|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43648229|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
43648230|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722527|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
43722528|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43722529|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43722530|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43722531|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722532|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722534|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722542|NCT02616003|Hormones|hormones|mesh-ancestor
44100979|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44100980|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44100981|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44100982|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100983|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100984|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44100985|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44100986|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44100987|NCT00056030|Leucovorin|leucovorin|mesh-list
44100988|NCT00056030|Fluorouracil|fluorouracil|mesh-list
44100989|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
44100990|NCT00056030|Cetuximab|cetuximab|mesh-list
44100991|NCT00056030|Calcium|calcium|mesh-list
44100992|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
44100993|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44100994|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100995|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
44100996|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100997|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100998|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100999|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101000|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
44101001|NCT00056030|Antidotes|antidotes|mesh-ancestor
44101002|NCT00056030|Protective Agents|protective agents|mesh-ancestor
44101003|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
44101004|NCT00056030|Vitamins|vitamins|mesh-ancestor
44101005|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
44101006|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101007|NCT00056056|Bexarotene|bexarotene|mesh-list
44101008|NCT00056056|Methoxsalen|methoxsalen|mesh-list
44101009|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101010|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44101011|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
44101012|NCT00056082|Celecoxib|celecoxib|mesh-list
44101013|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44101014|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101015|NCT00056082|Analgesics|analgesics|mesh-ancestor
44101016|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
44101017|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101018|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101019|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101020|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101021|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44101022|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44101023|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101024|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101025|NCT00056095|Cyclosporine|cyclosporine|mesh-list
44101026|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
44101027|NCT00056095|Fludarabine|fludarabine|mesh-list
44101028|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
44101029|NCT00056095|Cyclosporins|cyclosporins|mesh-list
44101030|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101031|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
44101032|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101033|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101034|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101035|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
43700520|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44262538|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262539|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
44262540|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262541|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101036|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101037|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101038|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44101039|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101040|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
44101041|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101042|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
44101043|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101044|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44101045|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44101046|NCT00056225|Vitamins|vitamins|mesh-list
44101047|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
44101048|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
44101049|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
44101050|NCT00056225|Pyridoxal|pyridoxal|mesh-list
44101051|NCT00056225|Pyridoxine|pyridoxine|mesh-list
44101052|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
44101053|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
44101054|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101055|NCT00056225|Hematinics|hematinics|mesh-ancestor
44101056|NCT00056264|Infliximab|infliximab|mesh-list
44101057|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44101058|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44101059|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101060|NCT00056277|Lamotrigine|lamotrigine|mesh-list
44101061|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
44101062|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44101063|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101064|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101065|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44101066|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101067|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44101068|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44101069|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101070|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101071|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44101072|NCT00056329|Vitamin E|vitamin e|mesh-list
44101073|NCT00056329|Tocopherols|tocopherols|mesh-list
44101074|NCT00056329|Vitamins|vitamins|mesh-ancestor
44101075|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
44101076|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101077|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
44101078|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101079|NCT00056329|Protective Agents|protective agents|mesh-ancestor
44101080|NCT00056368|Fluconazole|fluconazole|mesh-list
44101081|NCT00056368|Anidulafungin|anidulafungin|mesh-list
44101082|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
44101083|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101084|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44101085|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44101086|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101087|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101088|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44101089|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
44101090|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44101091|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101092|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44101093|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44101094|NCT00056381|Anidulafungin|anidulafungin|mesh-list
44101095|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
44101096|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101097|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
44101098|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
44101099|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44101100|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44101101|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44101102|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101103|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262542|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262543|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
44262544|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44262545|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262546|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44262547|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
44262548|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262549|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262550|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262551|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262552|NCT00646750|Rituximab|rituximab|mesh-list
44262553|NCT00646750|Melphalan|melphalan|mesh-list
44262554|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44262555|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262556|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
44262557|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262558|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657594|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44101104|NCT00056433|Urological Agents|urological agents|mesh-ancestor
44101105|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101106|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
44101107|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101108|NCT00056446|Vatalanib|vatalanib|mesh-list
44101109|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101110|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101111|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101112|NCT00056459|Vatalanib|vatalanib|mesh-list
44101113|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101114|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101115|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101116|NCT00056576|Zonisamide|zonisamide|mesh-list
44101117|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
44101118|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44101119|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101120|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101121|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44101122|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101123|NCT00056641|Ritonavir|ritonavir|mesh-list
44101124|NCT00056641|Lopinavir|lopinavir|mesh-list
44101125|NCT00056641|Saquinavir|saquinavir|mesh-list
44101126|NCT00056641|Amprenavir|amprenavir|mesh-list
44101127|NCT00056641|Tipranavir|tipranavir|mesh-list
44101128|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44101129|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44101130|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
44101131|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101132|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101133|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44101134|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44101135|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
44101136|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101137|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44101138|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44101139|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44101140|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44101141|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44101142|NCT00056654|Leuprolide|leuprolide|mesh-list
44262559|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44262560|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
44262561|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262562|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44262563|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262564|NCT00646802|Progesterone|progesterone|mesh-list
44262565|NCT00646802|Progestins|progestins|mesh-ancestor
44262566|NCT00646802|Hormones|hormones|mesh-ancestor
44262567|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262568|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262569|NCT00646815|Hormones|hormones|mesh-list
44262570|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262571|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262572|NCT00646841|Doxazosin|doxazosin|mesh-list
44262573|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262574|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44262575|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44262576|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44262577|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262578|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262579|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262580|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262581|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
44262582|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
44262583|NCT00646854|Doxorubicin|doxorubicin|mesh-list
44262584|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44262585|NCT00646854|Vincristine|vincristine|mesh-list
44262586|NCT00646854|Lenograstim|lenograstim|mesh-list
44262587|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262588|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
44101143|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44101144|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
44101145|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44101146|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101147|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44101148|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101149|NCT00056693|Sunitinib|sunitinib|mesh-list
44101150|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101151|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101152|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101153|NCT00056693|Growth Substances|growth substances|mesh-ancestor
44101154|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101155|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101156|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44262589|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262590|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262591|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101157|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101158|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101159|NCT00056797|Interleukin-2|interleukin-2|mesh-list
44101160|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101161|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101162|NCT00056797|Analgesics|analgesics|mesh-ancestor
44101163|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
44101164|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101165|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101166|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
44101167|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44101168|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101169|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101170|NCT00056823|Ranibizumab|ranibizumab|mesh-list
44101171|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101172|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101173|NCT00056823|Growth Substances|growth substances|mesh-ancestor
44101174|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101175|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101176|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101177|NCT00056836|Ranibizumab|ranibizumab|mesh-list
44101178|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101179|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101180|NCT00056836|Growth Substances|growth substances|mesh-ancestor
44101181|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101182|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101183|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101184|NCT00056875|Mitogens|mitogens|mesh-list
44101185|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101186|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101187|NCT00056966|Fludarabine|fludarabine|mesh-list
44101188|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
44101189|NCT00056966|Tacrolimus|tacrolimus|mesh-list
44101190|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101191|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101192|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101193|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
44101194|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101195|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44101196|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101197|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101198|NCT00056979|Fludarabine|fludarabine|mesh-list
44101199|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
44101214|NCT00057031|Calcitriol|calcitriol|mesh-list
44101215|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44101216|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101217|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44101218|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101219|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101220|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44101221|NCT00057031|Vitamins|vitamins|mesh-ancestor
44101222|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
44101223|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153055|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
44153056|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153057|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153058|NCT00219232|Rivastigmine|rivastigmine|mesh-list
44153059|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44153060|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153061|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153062|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
44153063|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153064|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153065|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44153066|NCT00219232|Protective Agents|protective agents|mesh-ancestor
44153067|NCT00219245|Rivastigmine|rivastigmine|mesh-list
44262592|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
44262593|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153068|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44153069|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153070|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153071|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
44153072|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153073|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153074|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44153075|NCT00219245|Protective Agents|protective agents|mesh-ancestor
44153076|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
44153077|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153078|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153079|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
44101224|NCT00057122|Rifampin|rifampin|mesh-list
44101225|NCT00057122|Rifapentine|rifapentine|mesh-list
43648231|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722730|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43722731|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43722732|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43722739|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44101226|NCT00057122|Isoniazid|isoniazid|mesh-list
44101227|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44101228|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
44101229|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44101230|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101231|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
44101232|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101233|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101234|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101235|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44101236|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44101237|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44101238|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44101239|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44101240|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44101241|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44101242|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44101244|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44101245|NCT00057265|Lamivudine|lamivudine|mesh-list
44101246|NCT00057265|Telbivudine|telbivudine|mesh-list
44101247|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44101248|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101249|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101250|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101251|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
44101252|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101253|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44101254|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44101255|NCT00057278|Gabapentin|gabapentin|mesh-list
44101256|NCT00057278|Analgesics|analgesics|mesh-ancestor
44101257|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
44101258|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101259|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101260|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
44101261|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44101262|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44101263|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101264|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101265|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44101266|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44101267|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101268|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101269|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
44101270|NCT00057304|Insulin|insulin|mesh-list
44101271|NCT00057304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44101272|NCT00057304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101273|NCT00057343|Rituximab|rituximab|mesh-list
44101274|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101275|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101276|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
44101277|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101278|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101279|NCT00057356|Conivaptan|conivaptan|mesh-list
43700521|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44262594|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262595|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44262596|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44262597|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44262598|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44262599|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262600|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44262601|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262602|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44262603|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
44262604|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101280|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44101281|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101282|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
44101283|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101284|NCT00057369|Dalbavancin|dalbavancin|mesh-list
44101285|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44101286|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101287|NCT00057382|Doxorubicin|doxorubicin|mesh-list
44101288|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44101289|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101290|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44101291|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101292|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101293|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101294|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
44101295|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101296|NCT00057408|Olanzapine|olanzapine|mesh-list
43816051|NCT01014598|Cisplatin|cisplatin|mesh-list
44101297|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
44101298|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
44101299|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
44101300|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101301|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101302|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44101303|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44101304|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101305|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101306|NCT00057408|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44101307|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44101308|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101309|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101310|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101311|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
44101312|NCT00057421|Prednisolone|prednisolone|mesh-list
44101313|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101314|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
44101315|NCT00057421|Hormones|hormones|mesh-ancestor
44101316|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44101317|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101318|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44101319|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101320|NCT00057447|Interferons|interferons|mesh-list
44101321|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
44101322|NCT00057447|Rituximab|rituximab|mesh-list
44101323|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101324|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101325|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
44101326|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101327|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101328|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
44101329|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722821|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43722822|NCT02614118|Analgesics|analgesics|mesh-ancestor
43722823|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
43722824|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559503|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
43559504|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559505|NCT03712371|Chitosan|chitosan|mesh-list
44262606|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44262607|NCT00646880|Propiverine|propiverine|mesh-list
43657625|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101330|NCT00057512|Masoprocol|masoprocol|mesh-list
44101331|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
44101332|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101333|NCT00057512|Protective Agents|protective agents|mesh-ancestor
44101334|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101335|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44101336|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101337|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44101338|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44101339|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101340|NCT00057512|Analgesics|analgesics|mesh-ancestor
44101341|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
44101342|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101343|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101344|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101345|NCT00057564|Thalidomide|thalidomide|mesh-list
44101346|NCT00057564|Dexamethasone|dexamethasone|mesh-list
44101347|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
44101348|NCT00057564|BB 1101|bb 1101|mesh-list
44101349|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101350|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
44101351|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
44101352|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101353|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101354|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44101355|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
44101356|NCT00057564|Hormones|hormones|mesh-ancestor
44101357|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44101358|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44101359|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101360|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
44101361|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101362|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101363|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101364|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
44101365|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
44101366|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44101367|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101368|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101369|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101370|NCT00057564|Growth Substances|growth substances|mesh-ancestor
44101371|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101372|NCT00057616|Lenalidomide|lenalidomide|mesh-list
44101373|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
44101374|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101375|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101376|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101377|NCT00057616|Growth Substances|growth substances|mesh-ancestor
44101378|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101379|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101380|NCT00057642|Sertraline|sertraline|mesh-list
44101381|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44101382|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
44101383|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101384|NCT00057642|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44101385|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44101386|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101387|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101388|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101389|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
44101390|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101391|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44101392|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44101393|NCT00057707|Modafinil|modafinil|mesh-list
44101394|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44101395|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101396|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44262608|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44262609|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44262610|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
44262611|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262612|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262613|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262614|NCT00646880|Urological Agents|urological agents|mesh-ancestor
44262615|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
44262616|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
44262617|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262618|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
44262619|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262620|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262621|NCT00646932|Vitamins|vitamins|mesh-ancestor
44262622|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
44262623|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44262624|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
44262625|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44262626|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
44262627|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
44101397|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44101398|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44101399|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101400|NCT00057720|Doxorubicin|doxorubicin|mesh-list
44101401|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44101402|NCT00057720|Topotecan|topotecan|mesh-list
44101403|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44101404|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101405|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44101406|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101407|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101408|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101409|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44101410|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
44101411|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101412|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
44101413|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44101414|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44101415|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101416|NCT00057759|Urological Agents|urological agents|mesh-ancestor
44101417|NCT00057798|Gemcitabine|gemcitabine|mesh-list
44101418|NCT00057798|Vinorelbine|vinorelbine|mesh-list
44101419|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101420|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
44101421|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101422|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101424|NCT00057798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101425|NCT00057798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101426|NCT00057798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101427|NCT00057798|Immunologic Factors|immunologic factors|mesh-ancestor
44101428|NCT00057798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101429|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101430|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101431|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44262628|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262629|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262630|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44262632|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
44262633|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262634|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44262635|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
44262636|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262637|NCT00647023|Metformin|metformin|mesh-list
44101432|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101433|NCT00057850|Cisplatin|cisplatin|mesh-list
44101434|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101435|NCT00057889|Ipilimumab|ipilimumab|mesh-list
44101436|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101437|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101438|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44101439|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101440|NCT00057928|Gemcitabine|gemcitabine|mesh-list
44101441|NCT00057928|Paclitaxel|paclitaxel|mesh-list
44101442|NCT00057928|Cisplatin|cisplatin|mesh-list
44101443|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101444|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816168|NCT05474053|Ticagrelor|ticagrelor|mesh-list
44101445|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101446|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101447|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101448|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101449|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101450|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
44101451|NCT00057928|Antiviral Agents|antiviral agents|mesh-ancestor
44101452|NCT00057928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101453|NCT00057928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101454|NCT00057928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101455|NCT00057928|Immunologic Factors|immunologic factors|mesh-ancestor
44101456|NCT00057928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101457|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
44101458|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101459|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101460|NCT00058006|Celecoxib|celecoxib|mesh-list
44101461|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44101462|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101463|NCT00058006|Analgesics|analgesics|mesh-ancestor
44101464|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
44101465|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101466|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101467|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101468|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101469|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44101470|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44101471|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101472|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101473|NCT00058045|Aldesleukin|aldesleukin|mesh-list
44101474|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101475|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44101476|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44101477|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
44101478|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101479|NCT00058071|Amifostine|amifostine|mesh-list
44101480|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44101481|NCT00058071|Protective Agents|protective agents|mesh-ancestor
44101482|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101483|NCT00058084|Prednisone|prednisone|mesh-list
44101484|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
44101485|NCT00058084|Epothilone B|epothilone b|mesh-list
44101486|NCT00058084|Epothilones|epothilones|mesh-list
44101487|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262638|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44262639|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262640|NCT00647049|Cytarabine|cytarabine|mesh-list
44101488|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
44101489|NCT00058084|Hormones|hormones|mesh-ancestor
44101490|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44101491|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101492|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44101493|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101494|NCT00058084|Analgesics|analgesics|mesh-ancestor
44101495|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
44101496|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101497|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44101498|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101499|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101500|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101501|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101502|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101503|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101504|NCT00058097|Tipifarnib|tipifarnib|mesh-list
44101505|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101506|NCT00058149|Gemcitabine|gemcitabine|mesh-list
44101507|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
44101508|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101509|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
44101510|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101511|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101512|NCT00058149|Antiviral Agents|antiviral agents|mesh-ancestor
44101513|NCT00058149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101514|NCT00058149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101515|NCT00058149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101516|NCT00058149|Immunologic Factors|immunologic factors|mesh-ancestor
44101517|NCT00058149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101518|NCT00058201|Leucovorin|leucovorin|mesh-list
44101519|NCT00058201|Gemcitabine|gemcitabine|mesh-list
44101520|NCT00058201|Fluorouracil|fluorouracil|mesh-list
44101521|NCT00058201|Calcium|calcium|mesh-list
44101522|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
44101523|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101524|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
44101525|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101526|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101527|NCT00058201|Antiviral Agents|antiviral agents|mesh-ancestor
44101528|NCT00058201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101529|NCT00058201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101530|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101531|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
44101568|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44101569|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44101570|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
44101571|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101572|NCT00058292|Cytarabine|cytarabine|mesh-list
44101573|NCT00058292|Rituximab|rituximab|mesh-list
44101575|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
44101578|NCT00058292|Lenograstim|lenograstim|mesh-list
44101579|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101580|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101581|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
44101582|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101583|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101584|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101585|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44101586|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101587|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101588|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101589|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101590|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
44101591|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
44101592|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101593|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101594|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44101595|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101596|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
44101597|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44262642|NCT00647049|Methotrexate|methotrexate|mesh-list
44262643|NCT00647049|Thiotepa|thiotepa|mesh-list
44262644|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44262645|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101598|NCT00058305|Vincristine|vincristine|mesh-list
44101599|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
44101600|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101601|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101602|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101603|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101604|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101605|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101606|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44101607|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
44101608|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101609|NCT00058318|Gemcitabine|gemcitabine|mesh-list
44101610|NCT00058318|Capecitabine|capecitabine|mesh-list
44101611|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101612|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
44101613|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101614|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101615|NCT00058318|Antiviral Agents|antiviral agents|mesh-ancestor
44101616|NCT00058318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101617|NCT00058318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101618|NCT00058318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101619|NCT00058318|Immunologic Factors|immunologic factors|mesh-ancestor
44101620|NCT00058318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101621|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
44101622|NCT00058331|Hematinics|hematinics|mesh-ancestor
44101623|NCT00058357|Lidocaine|lidocaine|mesh-list
44101624|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
44101625|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
44101626|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101627|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101628|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
44101629|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101630|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44101631|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44101632|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44101633|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101634|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101635|NCT00058435|Abagovomab|abagovomab|mesh-list
44101636|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101637|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101638|NCT00058448|Docetaxel|docetaxel|mesh-list
44101639|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101640|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101641|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101642|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101643|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101644|NCT00058461|Cytarabine|cytarabine|mesh-list
44101645|NCT00058461|Rituximab|rituximab|mesh-list
44101646|NCT00058461|Carboplatin|carboplatin|mesh-list
44101647|NCT00058461|Methotrexate|methotrexate|mesh-list
44101648|NCT00058461|Etoposide|etoposide|mesh-list
44101649|NCT00058461|Ifosfamide|ifosfamide|mesh-list
44101650|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101654|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101655|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44101656|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
44101657|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44101658|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101659|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
44101660|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101661|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
44101662|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101663|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44101664|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101665|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101666|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101667|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262646|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
44262647|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262648|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262649|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44262650|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
44262651|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44262652|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262653|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
43723143|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44262654|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262655|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
44262656|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262657|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44262658|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262659|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44262660|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
44101668|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101669|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
44101670|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101671|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101672|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
44101673|NCT00058474|Fluorouracil|fluorouracil|mesh-list
44101674|NCT00058474|Capecitabine|capecitabine|mesh-list
44101675|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
44101676|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
44101677|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101678|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101679|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101680|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101681|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
44101682|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101683|NCT00058487|Thalidomide|thalidomide|mesh-list
44101684|NCT00058487|Epirubicin|epirubicin|mesh-list
44101685|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44101686|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101687|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44101688|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101689|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101690|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101691|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101692|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
44101693|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101694|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
44101695|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44101696|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101697|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101698|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101699|NCT00058487|Growth Substances|growth substances|mesh-ancestor
44101700|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101701|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
44101702|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101703|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
44101704|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101705|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101706|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101708|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101709|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101710|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44101711|NCT00058682|Anidulafungin|anidulafungin|mesh-list
44101712|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
44262661|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262662|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44262663|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
43657654|NCT02951806|Analgesics|analgesics|mesh-ancestor
44101713|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101714|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
44101715|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101716|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101717|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101718|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101719|NCT00058890|Gabapentin|gabapentin|mesh-list
44101720|NCT00058890|Analgesics|analgesics|mesh-ancestor
44101721|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
44101722|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101727|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101728|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723193|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101729|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44101730|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44101731|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101732|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101734|NCT00058903|Sertraline|sertraline|mesh-list
44101735|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
44101736|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101737|NCT00058903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44101738|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44101739|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101740|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101741|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101742|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
44101743|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101744|NCT00058929|Treprostinil|treprostinil|mesh-list
44101745|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44101746|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
44101747|NCT00058955|Triazolam|triazolam|mesh-list
44101748|NCT00058955|Pentobarbital|pentobarbital|mesh-list
44101749|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44101750|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44101751|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
44101752|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
44101753|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44101754|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101755|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44101756|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44101757|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101758|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
44101759|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
44101760|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101761|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101762|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44101763|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44101764|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44101765|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44101766|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44101767|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101768|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101769|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101770|NCT00058968|Analgesics|analgesics|mesh-ancestor
44101771|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
44101772|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101773|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
44101774|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44101775|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
44153080|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153081|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153082|NCT00219310|Famciclovir|famciclovir|mesh-list
44153083|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
44153085|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44153086|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153087|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262664|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44262665|NCT00647101|Latanoprost|latanoprost|mesh-list
44262666|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44262667|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44262668|NCT00647127|Fentanyl|fentanyl|mesh-list
44262669|NCT00647127|Buprenorphine|buprenorphine|mesh-list
44262670|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44262671|NCT00647127|Narcotics|narcotics|mesh-ancestor
44262672|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153088|NCT00219323|Omalizumab|omalizumab|mesh-list
44153089|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44153090|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44153091|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44153092|NCT00219375|Sivelestat|sivelestat|mesh-list
44153093|NCT00219375|Glycine|glycine|mesh-list
44153094|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44153095|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
44153096|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627571|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
44153107|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153109|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153110|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44153111|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
44153112|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153113|NCT00219440|Metformin|metformin|mesh-list
44153114|NCT00219440|Pioglitazone|pioglitazone|mesh-list
44153115|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44153116|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153117|NCT00219466|Zinc|zinc|mesh-list
44153118|NCT00219466|Tocopherols|tocopherols|mesh-list
44153119|NCT00219466|Vitamin E|vitamin e|mesh-list
44153120|NCT00219466|Tocotrienols|tocotrienols|mesh-list
44153121|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
44153122|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
44153123|NCT00219466|Trace Elements|trace elements|mesh-ancestor
44153124|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
44153125|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153126|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
44153127|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153128|NCT00219466|Protective Agents|protective agents|mesh-ancestor
43816495|NCT04776148|Lenvatinib|lenvatinib|mesh-list
44101777|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44101778|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44101779|NCT00058994|Growth Substances|growth substances|mesh-ancestor
44101780|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101781|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101782|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101783|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
44101784|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101785|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101786|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44101787|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44101788|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101789|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101790|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101791|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
44101792|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101793|NCT00059306|Aspirin|aspirin|mesh-list
44101794|NCT00059306|Clopidogrel|clopidogrel|mesh-list
44101795|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44101796|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101797|NCT00059306|Analgesics|analgesics|mesh-ancestor
44101798|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
44101799|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101800|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101801|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44101802|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101803|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44101804|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43700522|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262674|NCT00647127|Analgesics|analgesics|mesh-ancestor
44262675|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
44262676|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262677|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44262678|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44262679|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
44262680|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
44262681|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44262682|NCT00647140|Levodopa|levodopa|mesh-list
44262683|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
44262684|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262685|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262686|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262687|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44262688|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44262689|NCT00647166|Azathioprine|azathioprine|mesh-list
44262690|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
44262691|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262692|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262693|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262694|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101805|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101806|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44101807|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44101821|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
44101822|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101823|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
44101824|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101825|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
44101826|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101827|NCT00059462|Interleukin-2|interleukin-2|mesh-list
44101828|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101829|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44101830|NCT00059462|Analgesics|analgesics|mesh-ancestor
44101831|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
44101832|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101833|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101834|NCT00059592|Valacyclovir|valacyclovir|mesh-list
44101835|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
44101836|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101837|NCT00059618|Carboplatin|carboplatin|mesh-list
44101838|NCT00059618|Bortezomib|bortezomib|mesh-list
44101839|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101840|NCT00059631|Bortezomib|bortezomib|mesh-list
44101841|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
44101842|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101843|NCT00059631|Analgesics|analgesics|mesh-ancestor
44101844|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
44101845|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44101846|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101847|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44262695|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
44262696|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262697|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262699|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44262700|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
44262701|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262702|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262703|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44262704|NCT00647192|Diuretics|diuretics|mesh-ancestor
44262705|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
44262706|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262707|NCT00647218|Paclitaxel|paclitaxel|mesh-list
44262708|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43657661|NCT02951962|Amlodipine|amlodipine|mesh-list
44101848|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101849|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101850|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101851|NCT00059722|Gefitinib|gefitinib|mesh-list
44101852|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101853|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101854|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101855|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723320|NCT02610933|Coagulants|coagulants|mesh-ancestor
44101856|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44101857|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101858|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44101859|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101860|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101861|NCT00059761|Cisplatin|cisplatin|mesh-list
44101862|NCT00059761|Irinotecan|irinotecan|mesh-list
44101863|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101864|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44101865|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101866|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101867|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101868|NCT00059800|Boron|boron|mesh-list
44101869|NCT00059800|Trace Elements|trace elements|mesh-ancestor
44101870|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
44101871|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101882|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
44101883|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
44101884|NCT00059826|Cisplatin|cisplatin|mesh-list
44101885|NCT00059826|Fluorouracil|fluorouracil|mesh-list
44101886|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101887|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
44101888|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101889|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101890|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101891|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
44101892|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101893|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
44101894|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101895|NCT00059852|Gemcitabine|gemcitabine|mesh-list
44101896|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44101897|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101898|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
44101899|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101900|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101901|NCT00059852|Antiviral Agents|antiviral agents|mesh-ancestor
44101902|NCT00059852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101903|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262709|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262710|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
44262711|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
44262712|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
44262713|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262714|NCT00647244|Tenofovir|tenofovir|mesh-list
44262715|NCT00647244|Abacavir|abacavir|mesh-list
44262716|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
44262717|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262718|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44262719|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44262720|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262721|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101904|NCT00059852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101905|NCT00059852|Immunologic Factors|immunologic factors|mesh-ancestor
44101906|NCT00059852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101907|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101908|NCT00059865|Gemcitabine|gemcitabine|mesh-list
44101909|NCT00059865|Pemetrexed|pemetrexed|mesh-list
44101910|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101911|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
44101912|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101913|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101914|NCT00059865|Antiviral Agents|antiviral agents|mesh-ancestor
43723363|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101915|NCT00059865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101916|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101917|NCT00059865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101918|NCT00059865|Immunologic Factors|immunologic factors|mesh-ancestor
44101919|NCT00059865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101920|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44101921|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44101922|NCT00059878|Interferons|interferons|mesh-list
44101923|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
44101924|NCT00059878|Voriconazole|voriconazole|mesh-list
44101925|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101926|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
44101927|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101928|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
44101929|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44101930|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44101931|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101932|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101933|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44101934|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
44101935|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44101936|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101937|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44101938|NCT00059904|Aldesleukin|aldesleukin|mesh-list
44101944|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101945|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44101946|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44101947|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
44101948|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101949|NCT00059917|Camptothecin|camptothecin|mesh-list
44101950|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44101951|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101952|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44101953|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44101954|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101955|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101956|NCT00059943|Docetaxel|docetaxel|mesh-list
44262722|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44262723|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44262724|NCT00647257|Losartan|losartan|mesh-list
44262725|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44262726|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262727|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44262728|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44262729|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262730|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
44262731|NCT00647491|Adalimumab|adalimumab|mesh-list
44262732|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262733|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262734|NCT00647530|Fluorouracil|fluorouracil|mesh-list
44262735|NCT00647530|Capecitabine|capecitabine|mesh-list
44262736|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
44262737|NCT00647530|Panitumumab|panitumumab|mesh-list
44262738|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
44262739|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262740|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44262741|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44262742|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44262743|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
44262744|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262745|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101957|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101958|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101959|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101960|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101961|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101962|NCT00060112|Gemcitabine|gemcitabine|mesh-list
44101963|NCT00060112|Oblimersen|oblimersen|mesh-list
44101964|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101965|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
44101966|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101967|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101968|NCT00060112|Antiviral Agents|antiviral agents|mesh-ancestor
44101969|NCT00060112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101970|NCT00060112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101971|NCT00060112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101972|NCT00060112|Immunologic Factors|immunologic factors|mesh-ancestor
44101973|NCT00060112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101974|NCT00060125|Tipifarnib|tipifarnib|mesh-list
44101975|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101976|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
44101977|NCT00060138|Antibodies|antibodies|mesh-list
44101978|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44101979|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
44101980|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101981|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44101982|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
44101983|NCT00060242|Combretastatin|combretastatin|mesh-list
44101984|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44262746|NCT00647543|Atorvastatin|atorvastatin|mesh-list
44262747|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44262748|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44262749|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
44262750|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262751|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44262752|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44262753|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262754|NCT00647608|Propranolol|propranolol|mesh-list
44262755|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44262756|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44262757|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
43825359|NCT05502081|Remdesivir|remdesivir|mesh-list
44101985|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101986|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101987|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101988|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101989|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101990|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
44101991|NCT00060255|Melphalan|melphalan|mesh-list
44101992|NCT00060255|Busulfan|busulfan|mesh-list
44101993|NCT00060255|Thiotepa|thiotepa|mesh-list
44101994|NCT00060255|Carmustine|carmustine|mesh-list
44101995|NCT00060255|Carboplatin|carboplatin|mesh-list
44101996|NCT00060255|Etoposide|etoposide|mesh-list
44101997|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101998|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
44101999|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102000|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102001|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102002|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
44102003|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102004|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102005|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44102006|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102007|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102008|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102009|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102011|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102018|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102019|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102020|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102021|NCT00060359|Paclitaxel|paclitaxel|mesh-list
44102022|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44102023|NCT00060359|Carboplatin|carboplatin|mesh-list
44102024|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44102025|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102026|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102027|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44102028|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44102029|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44102030|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102031|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44102032|NCT00060372|Ipilimumab|ipilimumab|mesh-list
44102033|NCT00060372|Antibodies|antibodies|mesh-list
44102034|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
44102035|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44102036|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
44102037|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102038|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102039|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44102040|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102042|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
44262758|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262759|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262760|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262761|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44262762|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262763|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
44262764|NCT00647621|Phenytoin|phenytoin|mesh-list
44262765|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
44262766|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44262767|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44262768|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262769|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262770|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44262771|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44262772|NCT00647634|Alprazolam|alprazolam|mesh-list
44262773|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44262774|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262775|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262776|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44262777|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262778|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102043|NCT00060385|Doxorubicin|doxorubicin|mesh-list
44102044|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44102045|NCT00060385|Etoposide|etoposide|mesh-list
44102046|NCT00060385|Vincristine|vincristine|mesh-list
44102047|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102048|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
44102049|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102050|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102051|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102052|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
44102053|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102054|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102055|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44102056|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102057|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102058|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102059|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102060|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102061|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
44102062|NCT00060385|Hormones|hormones|mesh-ancestor
44102063|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44102064|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44102065|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102066|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44102067|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44102068|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44102069|NCT00060398|Dexamethasone|dexamethasone|mesh-list
44102070|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
44102071|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102072|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
44102073|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
44262779|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
44262780|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
44262781|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262782|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262783|NCT00647647|Terbinafine|terbinafine|mesh-list
44262784|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
44262785|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262786|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262787|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262788|NCT00647660|Nadolol|nadolol|mesh-list
44262789|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
44262790|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44262791|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44262792|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
44262793|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262794|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262795|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262796|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44262797|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44262798|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
44262799|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
44262800|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262801|NCT00647660|Diuretics|diuretics|mesh-ancestor
44262802|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
44262803|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44262804|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262805|NCT00647673|Verapamil|verapamil|mesh-list
44262806|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44262807|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44262808|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262809|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262811|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262820|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262821|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44262822|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44262823|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
44262824|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
44262825|NCT00647712|Valproic Acid|valproic acid|mesh-list
44262826|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
44262827|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262828|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262829|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
44262830|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262831|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262832|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
44262833|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262834|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262835|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262836|NCT00647738|Baclofen|baclofen|mesh-list
44262837|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44262838|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262839|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44262840|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262841|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44262842|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
44262843|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
44262844|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262845|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102074|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102075|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102076|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44102077|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
44102078|NCT00060398|Hormones|hormones|mesh-ancestor
44102079|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44102080|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43627895|NCT03070704|Liraglutide|liraglutide|mesh-list
44102087|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
44102088|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44102089|NCT00060411|Antibodies|antibodies|mesh-list
44102090|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
44102091|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44102092|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
44102093|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102094|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102095|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44102096|NCT00060411|Growth Substances|growth substances|mesh-ancestor
44102097|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102098|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
44102099|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
44102100|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
44102101|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262846|NCT00647751|Lamotrigine|lamotrigine|mesh-list
44262847|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
44262848|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44262849|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262850|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262851|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44262852|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262853|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262854|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262855|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262856|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262857|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44262859|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
44262860|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
44262861|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262862|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262863|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44262864|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262865|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262866|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262867|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262868|NCT00647777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44262873|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
44262894|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262895|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262896|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262897|NCT00647842|Fentanyl|fentanyl|mesh-list
44262898|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44262899|NCT00647842|Narcotics|narcotics|mesh-ancestor
44262900|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262901|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262902|NCT00647842|Analgesics|analgesics|mesh-ancestor
44262903|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
44262904|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262905|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44262906|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44262907|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
44262908|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
44262909|NCT00647868|Testosterone|testosterone|mesh-list
44262910|NCT00647868|Androgens|androgens|mesh-ancestor
44262911|NCT00647868|Hormones|hormones|mesh-ancestor
44262912|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44262913|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102102|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102103|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102104|NCT00060411|Antidotes|antidotes|mesh-ancestor
44102105|NCT00060411|Protective Agents|protective agents|mesh-ancestor
44102106|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
44102107|NCT00060411|Vitamins|vitamins|mesh-ancestor
44102108|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
44102109|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102110|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102111|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
44102112|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44102113|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
44102114|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102115|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102116|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44102117|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
44102118|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44102119|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
44102120|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102121|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102122|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44102123|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102124|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
44102125|NCT00060450|Protective Agents|protective agents|mesh-ancestor
44102126|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
44102127|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
44102128|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44102129|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102130|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44102131|NCT00060476|Rofecoxib|rofecoxib|mesh-list
44102132|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44102133|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44102134|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102135|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102136|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44262914|NCT00647881|Paroxetine|paroxetine|mesh-list
44262915|NCT00647881|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44262916|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44262917|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262918|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262919|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262920|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
44262921|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262922|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44262923|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
44262924|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262925|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44262926|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44262927|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262928|NCT00647894|Alprazolam|alprazolam|mesh-list
44262929|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44262930|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262931|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262932|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44262933|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262934|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262935|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
44262936|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
44262937|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262938|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262939|NCT00647907|Voriconazole|voriconazole|mesh-list
44262940|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
44262941|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262942|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44262943|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44262944|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262945|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262946|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44262947|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
44262952|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44262953|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44262954|NCT00647946|Tenofovir|tenofovir|mesh-list
44262955|NCT00647946|Abacavir|abacavir|mesh-list
44262956|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
44262957|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262958|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44262959|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44262960|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44262961|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262962|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44262963|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44462179|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
44462180|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44462181|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44462182|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44462183|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
44462184|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462185|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
44462186|NCT01534195|Hormones|hormones|mesh-ancestor
44462187|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462188|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462189|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462190|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462191|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
44462192|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
44462193|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102137|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102138|NCT00060476|Analgesics|analgesics|mesh-ancestor
44102139|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
44102140|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102141|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102142|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102143|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102144|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44102145|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
44102146|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102147|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44102148|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44102149|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44102150|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102151|NCT00060502|Gemcitabine|gemcitabine|mesh-list
44102156|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102157|NCT00060502|Antiviral Agents|antiviral agents|mesh-ancestor
44102158|NCT00060502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102159|NCT00060502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102160|NCT00060502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462195|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44462196|NCT01534195|Protective Agents|protective agents|mesh-ancestor
44462197|NCT01534182|Interferons|interferons|mesh-list
44462198|NCT01534182|Interferon-beta|interferon-beta|mesh-list
44462199|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
44462200|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44462201|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
44462202|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462203|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
43917370|NCT00499408|Vitamin D|vitamin d|mesh-list
44262964|NCT00647959|Doxycycline|doxycycline|mesh-list
44262965|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262966|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44262967|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
44262968|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44262969|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44262970|NCT00647972|Olanzapine|olanzapine|mesh-list
44262971|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
44262972|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
44262973|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44262974|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102161|NCT00060502|Immunologic Factors|immunologic factors|mesh-ancestor
44102162|NCT00060502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102163|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
44102164|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44102165|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102166|NCT00060554|Heparin|heparin|mesh-list
44102168|NCT00060554|Fondaparinux|fondaparinux|mesh-list
44102169|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
44102170|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44102171|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44102172|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102173|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44102174|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
44102175|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44102176|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
44102177|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102178|NCT00060567|Irinotecan|irinotecan|mesh-list
44102179|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44102180|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102181|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102182|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102183|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102184|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102185|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44102187|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102188|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102189|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102190|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102191|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
44102192|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102193|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
44102194|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102195|NCT00060645|Sirolimus|sirolimus|mesh-list
44102196|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44262975|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44262976|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44262977|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44262978|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44262979|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44262980|NCT00647972|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44262981|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44262982|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44262983|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262984|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262985|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
44262986|NCT00647985|Fexofenadine|fexofenadine|mesh-list
44262987|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44262988|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44262989|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44262990|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
44262991|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
44262992|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44262993|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44262994|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44262995|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44262996|NCT00648011|Quinapril|quinapril|mesh-list
44262997|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263023|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44263024|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263025|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263026|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44263027|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44263028|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263029|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263030|NCT00648076|Valproic Acid|valproic acid|mesh-list
44263031|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
44263032|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263033|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263034|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
44263035|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263036|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263037|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
44263038|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263039|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263040|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263041|NCT00648128|Clarithromycin|clarithromycin|mesh-list
44263042|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263043|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263044|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44263045|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263046|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263047|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44263048|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263049|NCT00648141|Celecoxib|celecoxib|mesh-list
44263050|NCT00648141|Diclofenac|diclofenac|mesh-list
44263051|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263052|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263053|NCT00648141|Analgesics|analgesics|mesh-ancestor
44263054|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
44263055|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263062|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263063|NCT00648154|Letrozole|letrozole|mesh-list
44263064|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263065|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44263066|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44263067|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263068|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263069|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44263070|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
44263071|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263072|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263073|NCT00648180|Doxycycline|doxycycline|mesh-list
44263074|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263075|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263076|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
44263077|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44263078|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44263079|NCT00648193|Paroxetine|paroxetine|mesh-list
44263080|NCT00648193|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263081|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263082|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263083|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263084|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263085|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
44263086|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263087|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44263088|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263089|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263090|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44263093|NCT00648219|Olmesartan|olmesartan|mesh-list
44263104|NCT00648258|Analgesics|analgesics|mesh-ancestor
44263105|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
44263106|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263107|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263108|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263109|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263110|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
44263111|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263112|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263113|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263114|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263115|NCT00648271|Metoprolol|metoprolol|mesh-list
44263116|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263117|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263118|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
44263119|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
44263120|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263121|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263122|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44263123|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263124|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263125|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263126|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263127|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263128|NCT00648297|Nadolol|nadolol|mesh-list
44263129|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
44102197|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102198|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102199|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102200|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
44102201|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102202|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
44102203|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102204|NCT00060671|Rituximab|rituximab|mesh-list
44102205|NCT00060671|Pixantrone|pixantrone|mesh-list
44102206|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102207|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102208|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
44102209|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102210|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102211|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102212|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102213|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102214|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263130|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263131|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263132|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263133|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263134|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263135|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263136|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263137|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263138|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
44263139|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
44263140|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263141|NCT00648297|Diuretics|diuretics|mesh-ancestor
44263142|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263143|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263144|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263145|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44263146|NCT00648310|Estrogens|estrogens|mesh-list
44263147|NCT00648310|Hormones|hormones|mesh-ancestor
44263148|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263149|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263150|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263151|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263152|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263153|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263154|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263155|NCT00648310|Urological Agents|urological agents|mesh-ancestor
44263156|NCT00648323|Doxazosin|doxazosin|mesh-list
44263157|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263158|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44263159|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44263160|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263161|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263162|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263164|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263167|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263168|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44263169|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263170|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44263172|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263173|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44263174|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263175|NCT00648349|Rabeprazole|rabeprazole|mesh-list
44263176|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44263177|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263178|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44263179|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263180|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263181|NCT00648362|Glimepiride|glimepiride|mesh-list
43917597|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
44263182|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263183|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263184|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263185|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44263186|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
44263187|NCT00648388|Cilostazol|cilostazol|mesh-list
44263188|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44263189|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
44263190|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263191|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263192|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44263193|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
44263194|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44263195|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44263196|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263197|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44263198|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263199|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44263204|NCT00648401|Verapamil|verapamil|mesh-list
44263205|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263206|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44263207|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263208|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263209|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44263210|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263211|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263212|NCT00648414|Fentanyl|fentanyl|mesh-list
44263213|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44263214|NCT00648414|Narcotics|narcotics|mesh-ancestor
44263215|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263216|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263217|NCT00648414|Analgesics|analgesics|mesh-ancestor
44263218|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
44263219|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263220|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44263221|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44263222|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
44263223|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
44263224|NCT00648427|Paroxetine|paroxetine|mesh-list
44263225|NCT00648427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263226|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263227|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263228|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263229|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263230|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
44263231|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263232|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44263233|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263234|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263235|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44263236|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263237|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263242|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263243|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44263244|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44263245|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44263246|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44263247|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263248|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263249|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263250|NCT00648453|Clopidogrel|clopidogrel|mesh-list
44263251|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44263252|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44263253|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44263254|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44263255|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
44263256|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263257|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263258|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263259|NCT00648466|Sumatriptan|sumatriptan|mesh-list
44263260|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44263261|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44263262|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44263263|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
44263264|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263265|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263266|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263267|NCT00648492|Metformin|metformin|mesh-list
44263268|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263269|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263270|NCT00648505|Metformin|metformin|mesh-list
44263271|NCT00648505|Glipizide|glipizide|mesh-list
44263272|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263273|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263274|NCT00648518|Metformin|metformin|mesh-list
44263275|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44102215|NCT00060684|Dexamethasone|dexamethasone|mesh-list
44102216|NCT00060684|Rituximab|rituximab|mesh-list
44102217|NCT00060684|Fludarabine|fludarabine|mesh-list
44102218|NCT00060684|Pixantrone|pixantrone|mesh-list
44102219|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44263276|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263277|NCT00648531|Balsalazide|balsalazide|mesh-list
44263278|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263279|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263280|NCT00648531|Analgesics|analgesics|mesh-ancestor
44263281|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
44263282|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263283|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263284|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263285|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263286|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263287|NCT00648544|Pravastatin|pravastatin|mesh-list
44263288|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44263289|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44263290|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
44263291|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263292|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44263293|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44263294|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263295|NCT00648570|Dexetimide|dexetimide|mesh-list
44263296|NCT00648570|Citalopram|citalopram|mesh-list
44263297|NCT00648570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263298|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263299|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263300|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102220|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102221|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
43628032|NCT03069820|Cisplatin|cisplatin|mesh-list
44102228|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44102229|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
44102230|NCT00060684|Hormones|hormones|mesh-ancestor
44153130|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
44102231|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44102232|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43724284|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
44102233|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102235|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102236|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153131|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
44153132|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44153133|NCT00219479|Phenytoin|phenytoin|mesh-list
44153134|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
44153135|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44153136|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44153137|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153138|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153139|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44153140|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44263301|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263302|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
44263303|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263304|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44263305|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263306|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263307|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44263308|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44263309|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
44263310|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
44263311|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263312|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263313|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263314|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263315|NCT00648583|Ondansetron|ondansetron|mesh-list
44263316|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
44263317|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
44263318|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263319|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153141|NCT00219570|Clindamycin|clindamycin|mesh-list
44153142|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
44153143|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
44153144|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
44153145|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44153146|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153147|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44153148|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153149|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153150|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44153151|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153152|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153153|NCT00219596|Timolol|timolol|mesh-list
44153154|NCT00219596|Latanoprost|latanoprost|mesh-list
44153155|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44153156|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44153157|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44153158|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153159|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153160|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153161|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44153162|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153163|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44153164|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44153165|NCT00219700|Ibuprofen|ibuprofen|mesh-list
44153166|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44153167|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153168|NCT00219700|Analgesics|analgesics|mesh-ancestor
44153169|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
44153170|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153171|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153172|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44153173|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153174|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44153175|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153176|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153177|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
44263320|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263321|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
44263322|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263323|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44263324|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
44263325|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263326|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263327|NCT00648583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263328|NCT00648583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263329|NCT00648583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263330|NCT00648583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263331|NCT00648583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44263332|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
44263333|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263334|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44263335|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44263336|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263337|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263338|NCT00648596|Urological Agents|urological agents|mesh-ancestor
44263339|NCT00648622|Carvedilol|carvedilol|mesh-list
44263340|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263341|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263342|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263369|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
44263370|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
44263371|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263372|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263373|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263374|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263375|NCT00648713|Terbinafine|terbinafine|mesh-list
44263376|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
44263377|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263378|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263379|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263380|NCT00648726|Azithromycin|azithromycin|mesh-list
44263381|NCT00648726|Erythromycin|erythromycin|mesh-list
44263382|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
44263383|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44263384|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
44263385|NCT00648726|Cefuroxime|cefuroxime|mesh-list
44263386|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
44263387|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263388|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263389|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263390|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44263391|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263392|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263393|NCT00648765|Anagrelide|anagrelide|mesh-list
44263394|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44263395|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44153178|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44153179|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
44153180|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
44153181|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153182|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153183|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153197|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102238|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44102239|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44102240|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
44102241|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102242|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102243|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102244|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44102245|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102246|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102247|NCT00060905|Valproic Acid|valproic acid|mesh-list
44102248|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
44102249|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102250|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102251|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
44102252|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263396|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263397|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44263399|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263400|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263401|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917821|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
44263402|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263403|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263404|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44263406|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263407|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263408|NCT00648791|Finasteride|finasteride|mesh-list
44263409|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44263410|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44263411|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263412|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102253|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102254|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
44102255|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44102256|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44102257|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102258|NCT00060918|Metoprolol|metoprolol|mesh-list
44102259|NCT00060918|Carvedilol|carvedilol|mesh-list
44102260|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44102261|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102262|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
44102263|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
44102264|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102265|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102266|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44102267|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44102268|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44102270|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102271|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102272|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
44102273|NCT00060918|Protective Agents|protective agents|mesh-ancestor
44102274|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44102275|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102276|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44102277|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102278|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44102279|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44102280|NCT00060931|Metoprolol|metoprolol|mesh-list
44102281|NCT00060931|Carvedilol|carvedilol|mesh-list
44102282|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44102283|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102284|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
44102285|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
44102286|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102287|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102311|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44102312|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102314|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102315|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
44102316|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
44263414|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263415|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263416|NCT00648791|Urological Agents|urological agents|mesh-ancestor
44263417|NCT00648804|Ondansetron|ondansetron|mesh-list
44263418|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
44263419|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
44263420|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263421|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263422|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263423|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
44263424|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263425|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44102317|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102318|NCT00061022|Protective Agents|protective agents|mesh-ancestor
44102319|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102320|NCT00061074|Nicotine|nicotine|mesh-list
44102321|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44102322|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
44102323|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102324|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102325|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44102326|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44102327|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
44102328|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102329|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102330|NCT00061087|Methylphenidate|methylphenidate|mesh-list
44102331|NCT00061087|Bupropion|bupropion|mesh-list
44102332|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44102333|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102334|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44102335|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44102344|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44102345|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102346|NCT00061113|Fluoxetine|fluoxetine|mesh-list
44102347|NCT00061113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44102348|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44102349|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102350|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102351|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102352|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
44102353|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102354|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44102355|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
44102356|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102357|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44102358|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44102359|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102360|NCT00061152|Capsaicin|capsaicin|mesh-list
44102361|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
44102362|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44102363|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
44102364|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102365|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102366|NCT00061178|Bevacizumab|bevacizumab|mesh-list
44102367|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102368|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102369|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102370|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44263426|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
44263427|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263428|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263429|NCT00648804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263430|NCT00648804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263431|NCT00648804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263432|NCT00648804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263433|NCT00648804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44263435|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
44263436|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263437|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44263438|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44263439|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263440|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263441|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44263442|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44263443|NCT00648830|Clarithromycin|clarithromycin|mesh-list
44263444|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263445|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263446|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44263447|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263448|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263449|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44263450|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263451|NCT00648843|Oxybutynin|oxybutynin|mesh-list
44263452|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
44263453|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
44263454|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263455|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263456|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263457|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263458|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263459|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657973|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
44102371|NCT00061178|Growth Substances|growth substances|mesh-ancestor
44102372|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102373|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
44102374|NCT00061243|Vaccines|vaccines|mesh-list
44263460|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263461|NCT00648843|Urological Agents|urological agents|mesh-ancestor
44263463|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263464|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263465|NCT00648856|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263466|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263467|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263468|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263469|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263470|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
44263471|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263472|NCT00648869|Metformin|metformin|mesh-list
44263473|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43917900|NCT00513292|Paclitaxel|paclitaxel|mesh-list
44263474|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263476|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
44263477|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
44102375|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
44102376|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102377|NCT00061256|Vitamin D|vitamin d|mesh-list
44102378|NCT00061256|Alendronate|alendronate|mesh-list
44102379|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
44102380|NCT00061256|Calcium|calcium|mesh-list
44102381|NCT00061256|Vitamins|vitamins|mesh-ancestor
44102382|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
44102383|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102384|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44102385|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44102386|NCT00061256|Antacids|antacids|mesh-ancestor
44102387|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102388|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44102389|NCT00061308|Gemcitabine|gemcitabine|mesh-list
44102390|NCT00061308|Topotecan|topotecan|mesh-list
44102391|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102392|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
44102393|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102394|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102395|NCT00061308|Antiviral Agents|antiviral agents|mesh-ancestor
44102396|NCT00061308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102397|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102398|NCT00061308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102399|NCT00061308|Immunologic Factors|immunologic factors|mesh-ancestor
43628260|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
44102404|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44102405|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44102406|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102407|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102409|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102410|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44102411|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44102412|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44102413|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44102415|NCT00061360|Sirolimus|sirolimus|mesh-list
44102416|NCT00061360|Cyclosporins|cyclosporins|mesh-list
44102417|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102418|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263478|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263479|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263480|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263481|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263482|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263483|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263484|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263485|NCT00648921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44263486|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263487|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263488|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263489|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263490|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
44263491|NCT00648934|Topiramate|topiramate|mesh-list
44263492|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
44263493|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263494|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102419|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102420|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
44102421|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102422|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
44102423|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102424|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
44102425|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102426|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44102427|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102428|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102429|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102430|NCT00061425|Epratuzumab|epratuzumab|mesh-list
44102431|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102432|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102433|NCT00061438|Meropenem|meropenem|mesh-list
44102434|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102435|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102436|NCT00061451|Gemcitabine|gemcitabine|mesh-list
44102437|NCT00061451|Pemetrexed|pemetrexed|mesh-list
44102438|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102439|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
44102440|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102441|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102442|NCT00061451|Antiviral Agents|antiviral agents|mesh-ancestor
44102443|NCT00061451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102444|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102445|NCT00061451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102446|NCT00061451|Immunologic Factors|immunologic factors|mesh-ancestor
44102447|NCT00061451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102448|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44102449|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44102450|NCT00061464|Gemcitabine|gemcitabine|mesh-list
44102451|NCT00061464|Pemetrexed|pemetrexed|mesh-list
44102452|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102453|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
44102454|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102455|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817126|NCT01463072|Paclitaxel|paclitaxel|mesh-list
44102456|NCT00061464|Antiviral Agents|antiviral agents|mesh-ancestor
44102457|NCT00061464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102458|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263496|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44263497|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44263498|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44263499|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44263500|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
44263501|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263502|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263503|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263504|NCT00648960|Clarithromycin|clarithromycin|mesh-list
44263505|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263506|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263507|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44263508|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263509|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263510|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44263511|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263512|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
44263513|NCT00648973|Promethazine|promethazine|mesh-list
44263514|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
44263515|NCT00648973|Ephedrine|ephedrine|mesh-list
44263516|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44263517|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44263518|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263519|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263520|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
44263521|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
44263522|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
44263523|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263524|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
44263525|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
44263526|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263527|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44102459|NCT00061464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102460|NCT00061464|Immunologic Factors|immunologic factors|mesh-ancestor
44102461|NCT00061464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102462|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44102463|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44102464|NCT00061477|Gemcitabine|gemcitabine|mesh-list
44102465|NCT00061477|Pemetrexed|pemetrexed|mesh-list
44263528|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
44263529|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
44263530|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263531|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263532|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44263533|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
44263534|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263535|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44263536|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44263537|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
44263538|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
44263539|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44263540|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44263541|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
44263542|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263543|NCT00648986|Tazarotene|tazarotene|mesh-list
44263544|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263545|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
44263546|NCT00648999|Ritonavir|ritonavir|mesh-list
44263547|NCT00648999|Lopinavir|lopinavir|mesh-list
44102466|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102467|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
44102468|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102469|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102470|NCT00061477|Antiviral Agents|antiviral agents|mesh-ancestor
44102479|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102480|NCT00061516|Brinzolamide|brinzolamide|mesh-list
44102481|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44102482|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102483|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102484|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44102485|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44102486|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44102487|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43545349|NCT03673280|Morphine|morphine|mesh-list
43724745|NCT02602509|Celecoxib|celecoxib|mesh-list
44102488|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44102489|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44102490|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44102491|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44102492|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102493|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102494|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102495|NCT00061542|Timolol|timolol|mesh-list
44102496|NCT00061542|Betaxolol|betaxolol|mesh-list
44102497|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44102498|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44102499|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44102500|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102501|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102502|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102503|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44102504|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44102505|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
44102506|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
44102507|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102508|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44263549|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44263551|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263552|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263553|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44263554|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44263555|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
44263556|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263557|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44263558|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263559|NCT00649012|Pioglitazone|pioglitazone|mesh-list
44263560|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263561|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263562|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263563|NCT00649038|Benazepril|benazepril|mesh-list
44263564|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263565|NCT00649038|Diuretics|diuretics|mesh-ancestor
44102509|NCT00061594|Ranibizumab|ranibizumab|mesh-list
44102510|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102511|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44102512|NCT00061594|Growth Substances|growth substances|mesh-ancestor
44102513|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102514|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
44102515|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102516|NCT00061620|Tezacitabine|tezacitabine|mesh-list
44102517|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102518|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102519|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102520|NCT00061646|Carboplatin|carboplatin|mesh-list
44102521|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102522|NCT00061711|Hormones|hormones|mesh-list
44102523|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
44102524|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44102525|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102526|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44102527|NCT00061711|Estrogens|estrogens|mesh-ancestor
44102528|NCT00061750|Deferasirox|deferasirox|mesh-list
44102529|NCT00061750|Deferoxamine|deferoxamine|mesh-list
44102530|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44102531|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
44102532|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
44153198|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102533|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102534|NCT00061750|Siderophores|siderophores|mesh-ancestor
44102535|NCT00061763|Deferasirox|deferasirox|mesh-list
44102541|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
44102542|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
44102543|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
44102544|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102545|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102546|NCT00061789|Acetylcholine|acetylcholine|mesh-list
44102547|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102548|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44102549|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44102550|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102551|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263566|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263567|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263568|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263569|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263570|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263571|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263572|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263573|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263574|NCT00649051|Metolazone|metolazone|mesh-list
44263575|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263576|NCT00649051|Diuretics|diuretics|mesh-ancestor
44263577|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263578|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263579|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263580|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263581|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102552|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102553|NCT00061802|Risperidone|risperidone|mesh-list
44102554|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44102555|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44102556|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
44102557|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102558|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102559|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102560|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44102561|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44102562|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44102563|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102564|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44102565|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
44102566|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
44102568|NCT00061815|Fluorouracil|fluorouracil|mesh-list
44102569|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
44102570|NCT00061815|Cetuximab|cetuximab|mesh-list
44102571|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
44102572|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102573|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102574|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102575|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102576|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
44102577|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102578|NCT00061815|Antidotes|antidotes|mesh-ancestor
44102579|NCT00061815|Protective Agents|protective agents|mesh-ancestor
44102580|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
44102581|NCT00061815|Vitamins|vitamins|mesh-ancestor
44102582|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
44102583|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102584|NCT00061854|Soblidotin|soblidotin|mesh-list
44102585|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102586|NCT00061867|Doxorubicin|doxorubicin|mesh-list
44102587|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44102588|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102589|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102590|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102591|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102592|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102593|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263583|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44263584|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
44263585|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263586|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263587|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263588|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263589|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263590|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263591|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263592|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43724949|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724952|NCT02601157|Aspirin|aspirin|mesh-list
44263593|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
44263594|NCT00649077|Meloxicam|meloxicam|mesh-list
44263595|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263596|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263597|NCT00649077|Analgesics|analgesics|mesh-ancestor
44263598|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
44263599|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263600|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263601|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263602|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263603|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263604|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263605|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263606|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263607|NCT00649090|Exemestane|exemestane|mesh-list
44263608|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263609|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44263610|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44263611|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263625|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263626|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
44263627|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
44263628|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263629|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263630|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44263631|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263632|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263633|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263634|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263635|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263636|NCT00649129|Oxybutynin|oxybutynin|mesh-list
44263637|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
44263638|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
44263639|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263640|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263641|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263642|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263643|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263644|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263645|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263646|NCT00649129|Urological Agents|urological agents|mesh-ancestor
44263647|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
44263648|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263649|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263650|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44263651|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44263652|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263653|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263654|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263655|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44102594|NCT00061906|Celecoxib|celecoxib|mesh-list
44263666|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263667|NCT00649181|Metolazone|metolazone|mesh-list
44263668|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263669|NCT00649181|Diuretics|diuretics|mesh-ancestor
44263670|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263671|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263672|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263673|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263674|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263675|NCT00649194|Rabeprazole|rabeprazole|mesh-list
44263676|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44263677|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263678|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44263679|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263680|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263681|NCT00649207|Veliparib|veliparib|mesh-list
44263682|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44263683|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263684|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263685|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263686|NCT00649233|Metoprolol|metoprolol|mesh-list
44263687|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263688|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263689|NCT00649233|Diuretics|diuretics|mesh-ancestor
44263690|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263691|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263692|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263711|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263712|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263713|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263714|NCT00649259|Urological Agents|urological agents|mesh-ancestor
44263715|NCT00649272|Oxybutynin|oxybutynin|mesh-list
44263716|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
44263717|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
44263718|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263719|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263720|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44263721|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44263722|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
44263723|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263724|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263725|NCT00649272|Urological Agents|urological agents|mesh-ancestor
44263726|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
44263727|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44263728|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263729|NCT00649285|Renal Agents|renal agents|mesh-ancestor
44263730|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263731|NCT00649311|Losartan|losartan|mesh-list
44263732|NCT00649311|Eplerenone|eplerenone|mesh-list
44263733|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263734|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263735|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44263736|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44263737|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263738|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44263739|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44263740|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44263741|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263742|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44263743|NCT00649311|Diuretics|diuretics|mesh-ancestor
44263744|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
44102595|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44102596|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102597|NCT00061906|Analgesics|analgesics|mesh-ancestor
44102598|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
44263745|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263746|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263747|NCT00649324|Diuretics|diuretics|mesh-ancestor
44263748|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263749|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263750|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263751|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263752|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263753|NCT00649350|Metformin|metformin|mesh-list
44263754|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263755|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263756|NCT00649363|Ondansetron|ondansetron|mesh-list
44263757|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
44263758|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
44263759|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263760|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263761|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263762|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
44263763|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263764|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44263765|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
44263766|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263767|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263768|NCT00649363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263769|NCT00649363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263770|NCT00649363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263771|NCT00649363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263772|NCT00649363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44102599|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102600|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102601|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102602|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102603|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44102604|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44102605|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102606|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102607|NCT00061919|Thalidomide|thalidomide|mesh-list
44102618|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
44102619|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102620|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
44102621|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102622|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102623|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102624|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44102625|NCT00061919|Growth Substances|growth substances|mesh-ancestor
44102626|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
44263774|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44263775|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44263776|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44263777|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
44263778|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
44263779|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263780|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263781|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263782|NCT00649402|Amlodipine|amlodipine|mesh-list
44263783|NCT00649402|Benazepril|benazepril|mesh-list
44263784|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263785|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44263786|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263787|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263788|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44263789|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263790|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658139|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44102627|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
44102628|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102629|NCT00061984|Doxorubicin|doxorubicin|mesh-list
44102630|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44102631|NCT00061984|Ifosfamide|ifosfamide|mesh-list
44102632|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102633|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102634|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102635|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102636|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102637|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102638|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102639|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
44102640|NCT00061997|Inositol|inositol|mesh-list
44102641|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
44102642|NCT00061997|Vitamins|vitamins|mesh-ancestor
44102643|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
44102644|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102645|NCT00062023|Aspirin|aspirin|mesh-list
44102646|NCT00062023|Sulindac|sulindac|mesh-list
44102647|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44102648|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44102649|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102650|NCT00062023|Analgesics|analgesics|mesh-ancestor
44102651|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
44102652|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102653|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102654|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102655|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102656|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44102657|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44102658|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102659|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44102660|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44102661|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102662|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
43725187|NCT02599675|Vitamin D|vitamin d|mesh-list
44102663|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44263791|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263793|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263794|NCT00649415|Valdecoxib|valdecoxib|mesh-list
44263795|NCT00649415|Piroxicam|piroxicam|mesh-list
44263796|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263797|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263798|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263799|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263800|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263801|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263802|NCT00649415|Analgesics|analgesics|mesh-ancestor
44263803|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
44263804|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263805|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263806|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102664|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44102665|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102666|NCT00062036|Aldesleukin|aldesleukin|mesh-list
44102667|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
44102668|NCT00062036|Fludarabine|fludarabine|mesh-list
44102669|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
44102670|NCT00062036|Interleukin-2|interleukin-2|mesh-list
44102671|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
44102672|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102673|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
44102685|NCT00062036|Analgesics|analgesics|mesh-ancestor
44102686|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
44102687|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102688|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44102689|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44102690|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
44102691|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102692|NCT00062062|Paclitaxel|paclitaxel|mesh-list
44102693|NCT00062062|Carboplatin|carboplatin|mesh-list
44102694|NCT00062062|Gefitinib|gefitinib|mesh-list
44102695|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102696|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102697|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
44102698|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
44102699|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
44102700|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102701|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102702|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102703|NCT00062075|Romidepsin|romidepsin|mesh-list
44102704|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102705|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102706|NCT00062101|Celecoxib|celecoxib|mesh-list
44102707|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44102708|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102709|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102710|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102711|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102712|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44102713|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102714|NCT00062101|Analgesics|analgesics|mesh-ancestor
44102715|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
44102716|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102717|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263807|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263808|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263809|NCT00649441|Quinapril|quinapril|mesh-list
44263810|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263811|NCT00649441|Diuretics|diuretics|mesh-ancestor
44263812|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263813|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263814|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263815|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263816|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263817|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263818|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263819|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462205|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
44462206|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462207|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44462208|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462209|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462210|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44462211|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462212|NCT01534078|Doxorubicin|doxorubicin|mesh-list
44462213|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44462214|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44462215|NCT01534078|Dacarbazine|dacarbazine|mesh-list
44462216|NCT01534078|Vinblastine|vinblastine|mesh-list
44462217|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44462218|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462219|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44462220|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44462221|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462222|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462223|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44263820|NCT00649454|Metformin|metformin|mesh-list
44263821|NCT00649454|Glipizide|glipizide|mesh-list
44263822|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658165|NCT02947269|Prucalopride|prucalopride|mesh-list
44102718|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263823|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263824|NCT00649467|Topiramate|topiramate|mesh-list
44263825|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
44263826|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263827|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263828|NCT00649480|Balsalazide|balsalazide|mesh-list
44263829|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263830|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263831|NCT00649480|Analgesics|analgesics|mesh-ancestor
44263832|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
44263833|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263834|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263835|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263836|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263837|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263838|NCT00649493|Rabeprazole|rabeprazole|mesh-list
44263839|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44263840|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263841|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44263842|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263843|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263844|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
44263845|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44263846|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263847|NCT00649506|Renal Agents|renal agents|mesh-ancestor
44263848|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263849|NCT00649519|Amlodipine|amlodipine|mesh-list
44263850|NCT00649519|Benazepril|benazepril|mesh-list
44263851|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263852|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44263853|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263854|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263855|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44263856|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263857|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
44263863|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
44263864|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263865|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263866|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44263867|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
44263868|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
44263869|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44263870|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
44263871|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263872|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263873|NCT00649532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44263874|NCT00649532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44263875|NCT00649532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44263876|NCT00649532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263877|NCT00649532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44263878|NCT00649545|Adalimumab|adalimumab|mesh-list
44263879|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263880|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263881|NCT00649558|Pioglitazone|pioglitazone|mesh-list
44263882|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44263883|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263884|NCT00649571|Doxycycline|doxycycline|mesh-list
44263885|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263886|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263887|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
44263888|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44263889|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44263890|NCT00649584|Gemcitabine|gemcitabine|mesh-list
44263891|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44263892|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44263893|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
44263894|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102719|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102720|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44102721|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44102723|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102724|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102725|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
44102726|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102727|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102728|NCT00062127|Thalidomide|thalidomide|mesh-list
44102729|NCT00062127|Irinotecan|irinotecan|mesh-list
44102730|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102731|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44263895|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263896|NCT00649584|Antiviral Agents|antiviral agents|mesh-ancestor
44263897|NCT00649584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44263898|NCT00649584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263899|NCT00649584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44263900|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
44263901|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263902|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44263903|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263904|NCT00649597|Benazepril|benazepril|mesh-list
44263905|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263906|NCT00649597|Diuretics|diuretics|mesh-ancestor
44263907|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263908|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263909|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263910|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263911|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658205|NCT02946970|Analgesics|analgesics|mesh-ancestor
44102732|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102733|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102734|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102735|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102736|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
44102737|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102742|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44102743|NCT00062127|Growth Substances|growth substances|mesh-ancestor
44102744|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
44102745|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
44102746|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102747|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
44102748|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102749|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102750|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102751|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
44102752|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102753|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102754|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44102755|NCT00062179|Celecoxib|celecoxib|mesh-list
44102756|NCT00062179|Paclitaxel|paclitaxel|mesh-list
44102757|NCT00062179|Carboplatin|carboplatin|mesh-list
44102758|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102759|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102760|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
44102761|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
44102762|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
44102763|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102764|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44102765|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102766|NCT00062179|Analgesics|analgesics|mesh-ancestor
44102767|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
44102768|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102769|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102770|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102771|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102772|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263912|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263913|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263914|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263915|NCT00649610|Diclofenac|diclofenac|mesh-list
44263916|NCT00649610|Valdecoxib|valdecoxib|mesh-list
44263917|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263918|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263919|NCT00649610|Analgesics|analgesics|mesh-ancestor
44263920|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
44263921|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263922|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263923|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263924|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263925|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263926|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658216|NCT02946671|Nivolumab|nivolumab|mesh-list
44102773|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44102774|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102775|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
44102776|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102777|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102778|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102779|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102780|NCT00062231|Amoxicillin|amoxicillin|mesh-list
44102781|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
44102782|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
44102783|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
44102784|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
44102785|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44102786|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44102787|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102788|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102789|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102790|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102792|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102793|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102794|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44102795|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
44102796|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44102797|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102798|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44102799|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44102800|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44102801|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44102802|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44102803|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44102804|NCT00062244|Oblimersen|oblimersen|mesh-list
44102805|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102806|NCT00062257|Irofulven|irofulven|mesh-list
44102807|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102808|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
44102818|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102819|NCT00062270|Antiviral Agents|antiviral agents|mesh-ancestor
44102820|NCT00062270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102821|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102822|NCT00062270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102823|NCT00062270|Immunologic Factors|immunologic factors|mesh-ancestor
44102824|NCT00062270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263927|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263929|NCT00649623|Olmesartan|olmesartan|mesh-list
44263930|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44263931|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263932|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44263933|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44263934|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263935|NCT00649636|Fluoxetine|fluoxetine|mesh-list
44263936|NCT00649636|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43725631|NCT02596763|Baclofen|baclofen|mesh-list
44263937|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44263938|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263939|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263940|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263941|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
44263942|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263943|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44263944|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
44263945|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44263946|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44263947|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263948|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263949|NCT00649649|Quinapril|quinapril|mesh-list
44263950|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44263951|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
44263952|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263953|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263954|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263955|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
44263956|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44263957|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102825|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44102826|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44102827|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44102828|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102829|NCT00062283|Alanosine|alanosine|mesh-list
44102830|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102831|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102832|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
44263959|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44263960|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263961|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263962|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44263963|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44263964|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44263965|NCT00649675|Meloxicam|meloxicam|mesh-list
44263966|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44263967|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44263968|NCT00649675|Analgesics|analgesics|mesh-ancestor
44263969|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
44102833|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
44102834|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102835|NCT00062296|Rituximab|rituximab|mesh-list
44102836|NCT00062296|Epirubicin|epirubicin|mesh-list
44102837|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44102838|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102839|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
44102840|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102841|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102842|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102843|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102844|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102845|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102846|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102847|NCT00062322|Cisplatin|cisplatin|mesh-list
44102848|NCT00062322|Irinotecan|irinotecan|mesh-list
44102849|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102850|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102851|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102852|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102853|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153199|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
44153200|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153201|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153202|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
44153203|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153204|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44153205|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153206|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
44153207|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153208|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44153209|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153210|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153211|NCT00219765|Cytarabine|cytarabine|mesh-list
44153212|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
44153213|NCT00219765|Daunorubicin|daunorubicin|mesh-list
44153214|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153215|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
44153216|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153217|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153218|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
44153219|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43628713|NCT03064282|Papaverine|papaverine|mesh-list
44153223|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44153224|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153225|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44153226|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44263970|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263971|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263972|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44263973|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44263974|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44263975|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44263976|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44263977|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263979|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44263980|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44263981|NCT00649688|Diuretics|diuretics|mesh-ancestor
44263982|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
44263983|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44263984|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44263985|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44263986|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44263987|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44263988|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
44153227|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153228|NCT00219778|Mifepristone|mifepristone|mesh-list
44153229|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44153230|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
44153231|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44153232|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153233|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44153234|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44153235|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44153236|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
44153237|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44153238|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44153239|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
44153240|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44153241|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
44153242|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44153243|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44153244|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
44153245|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44153246|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44153247|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153248|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153249|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
44153250|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153251|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153252|NCT00219856|Propofol|propofol|mesh-list
44102854|NCT00062426|Leucovorin|leucovorin|mesh-list
44102855|NCT00062426|Bevacizumab|bevacizumab|mesh-list
44102856|NCT00062426|Fluorouracil|fluorouracil|mesh-list
44102857|NCT00062426|Capecitabine|capecitabine|mesh-list
44102858|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
44102859|NCT00062426|Calcium|calcium|mesh-list
44102860|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
44102861|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44263989|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
44263990|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44263991|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44263992|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44263993|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44263994|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44263995|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44263996|NCT00649714|Zonisamide|zonisamide|mesh-list
44263997|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
44263998|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44263999|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264000|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264001|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264002|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264003|NCT00649727|Oxybutynin|oxybutynin|mesh-list
44264004|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
44264005|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
44264006|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658270|NCT02946814|Listerine|listerine|mesh-list
44102862|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102863|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102864|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44102865|NCT00062426|Growth Substances|growth substances|mesh-ancestor
44102866|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102867|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
44102868|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44102869|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
44102870|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102871|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102872|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102873|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
44102874|NCT00062426|Antidotes|antidotes|mesh-ancestor
44102875|NCT00062426|Protective Agents|protective agents|mesh-ancestor
44102876|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
44102877|NCT00062426|Vitamins|vitamins|mesh-ancestor
44102878|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
44102879|NCT00062478|Camptothecin|camptothecin|mesh-list
44102880|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102881|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102882|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102883|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102885|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102886|NCT00062556|Niacin|niacin|mesh-list
44102887|NCT00062556|Lovastatin|lovastatin|mesh-list
44102888|NCT00062556|L 647318|l 647318|mesh-list
44102889|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
44102890|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44102891|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
44102892|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102893|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44102898|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102899|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44102900|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44102902|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
44102903|NCT00062595|Vitamin K|vitamin k|mesh-list
44264008|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44264009|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44264010|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
44264011|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264012|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264013|NCT00649727|Urological Agents|urological agents|mesh-ancestor
44264014|NCT00649740|Topiramate|topiramate|mesh-list
44264015|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
44264016|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264017|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264018|NCT00649779|Albuterol|albuterol|mesh-list
44264019|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264020|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
44264021|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264022|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264023|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264024|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264025|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
44102904|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44102905|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44102906|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102907|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
44102908|NCT00062595|Coagulants|coagulants|mesh-ancestor
44102909|NCT00062595|Vitamins|vitamins|mesh-ancestor
44102910|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
44102911|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102912|NCT00062660|Tipranavir|tipranavir|mesh-list
44102913|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44102914|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44102915|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
44102916|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102917|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44102918|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44102919|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44102920|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102921|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102922|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102923|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102924|NCT00062673|Analgesics|analgesics|mesh-ancestor
44102925|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
44102926|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44102927|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
44102928|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102929|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
44102930|NCT00062686|Lapatinib|lapatinib|mesh-list
44102931|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102932|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44102933|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102934|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102935|NCT00062699|Calcitriol|calcitriol|mesh-list
44102936|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44102937|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264027|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264029|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264030|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264031|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264032|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264033|NCT00649805|Verapamil|verapamil|mesh-list
44264034|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264035|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264036|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264037|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264038|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264039|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918456|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
44264040|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44264041|NCT00649818|Lorazepam|lorazepam|mesh-list
44264042|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
44264043|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
44264044|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
44264045|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264046|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264047|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44264048|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44102938|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44102939|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102940|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102941|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44102942|NCT00062699|Vitamins|vitamins|mesh-ancestor
44102943|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
44102944|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44102945|NCT00062712|Sirolimus|sirolimus|mesh-list
44102946|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44102947|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102948|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102949|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44102950|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102951|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
44102952|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102953|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
44102954|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102955|NCT00062790|Dutasteride|dutasteride|mesh-list
44102956|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44102957|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44102958|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102959|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102961|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264049|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264050|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44264051|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264052|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264053|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
44264054|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
44264055|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264056|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264057|NCT00649831|Amoxicillin|amoxicillin|mesh-list
44264058|NCT00649831|Azithromycin|azithromycin|mesh-list
44264059|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264060|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264061|NCT00649844|Ziprasidone|ziprasidone|mesh-list
44264062|NCT00649844|Clozapine|clozapine|mesh-list
44264063|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44264064|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
44102962|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102963|NCT00062803|Heparin|heparin|mesh-list
44102964|NCT00062803|Warfarin|warfarin|mesh-list
44102965|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
44102971|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102972|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102973|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102974|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102975|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102976|NCT00062881|Mafosfamide|mafosfamide|mesh-list
44102977|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44102978|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
44102979|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102980|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102981|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
44102982|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102983|NCT00062946|Fallypride|fallypride|mesh-list
44102984|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44102985|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44102986|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
44102987|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102988|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102989|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102990|NCT00062972|Donepezil|donepezil|mesh-list
44102991|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44102992|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102993|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102994|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44102995|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102996|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102997|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
44102998|NCT00063011|Calcium|calcium|mesh-list
44102999|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103000|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103001|NCT00063024|Calcium|calcium|mesh-list
44103002|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103003|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103004|NCT00063076|Bexarotene|bexarotene|mesh-list
43817574|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
44103005|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103006|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
44103007|NCT00063089|Antibodies|antibodies|mesh-list
44103008|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
44103009|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44103010|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44103011|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
44264065|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264066|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264067|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264068|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264069|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264070|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264071|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264072|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44264074|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
44264075|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
44264076|NCT00649857|Cetirizine|cetirizine|mesh-list
44264077|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44264078|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44264079|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44264080|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
44264081|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
44264082|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264083|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264084|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264085|NCT00649870|Valacyclovir|valacyclovir|mesh-list
44264086|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
44264087|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264088|NCT00649883|Vaccines|vaccines|mesh-list
44264089|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
44264090|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264091|NCT00649896|Estradiol|estradiol|mesh-list
44264092|NCT00649896|Estrogens|estrogens|mesh-ancestor
44264093|NCT00649896|Hormones|hormones|mesh-ancestor
44264094|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103012|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103013|NCT00063128|Insulin|insulin|mesh-list
44103014|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44103015|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44103016|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103017|NCT00063141|Irinotecan|irinotecan|mesh-list
44103018|NCT00063141|Cetuximab|cetuximab|mesh-list
44103019|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103020|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103021|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103022|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103023|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103024|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103025|NCT00063193|Minocycline|minocycline|mesh-list
44103026|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264096|NCT00649922|Adalimumab|adalimumab|mesh-list
44264097|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264098|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264099|NCT00649935|Azithromycin|azithromycin|mesh-list
44264100|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264101|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264102|NCT00649948|Metformin|metformin|mesh-list
44264103|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264104|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264105|NCT00649974|Valacyclovir|valacyclovir|mesh-list
44264106|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
44264107|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264108|NCT00649987|Albuterol|albuterol|mesh-list
44264109|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264110|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
44264111|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264112|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264113|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264114|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264115|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
43726088|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726089|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726090|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726091|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726092|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
43726093|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43726094|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43726096|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264116|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44264117|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44103027|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103028|NCT00063310|Leuprolide|leuprolide|mesh-list
44103029|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44103030|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
44103031|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103032|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103033|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103034|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103035|NCT00063323|Bupropion|bupropion|mesh-list
44103040|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44103041|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44103042|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103043|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
44103044|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103045|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103046|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44103047|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44103048|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103049|NCT00063388|Cetuximab|cetuximab|mesh-list
44103050|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103051|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103052|NCT00063401|Paclitaxel|paclitaxel|mesh-list
44103053|NCT00063401|Carboplatin|carboplatin|mesh-list
44103054|NCT00063401|Cetuximab|cetuximab|mesh-list
44103055|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44103056|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103057|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
44103058|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103059|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
44264118|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264119|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264120|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264121|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264122|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264124|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44264125|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264126|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44264127|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44264128|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44264129|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264130|NCT00650013|Midodrine|midodrine|mesh-list
44264131|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
44264132|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
44264133|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264134|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264135|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44264136|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44103060|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103061|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103062|NCT00063453|Vitamins|vitamins|mesh-list
44103063|NCT00063453|Vitamin E|vitamin e|mesh-list
44103064|NCT00063453|Tocopherols|tocopherols|mesh-list
44103065|NCT00063453|Tocotrienols|tocotrienols|mesh-list
44103066|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
44103067|NCT00063453|Selenium|selenium|mesh-list
44103068|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
44103069|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103070|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
44103071|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103072|NCT00063453|Protective Agents|protective agents|mesh-ancestor
44103073|NCT00063453|Trace Elements|trace elements|mesh-ancestor
44103074|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
44103075|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44103076|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103077|NCT00063583|Pirfenidone|pirfenidone|mesh-list
44103078|NCT00063583|Analgesics|analgesics|mesh-ancestor
44103079|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
44103080|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817620|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
44103081|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103082|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103083|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44103084|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103085|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103086|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103087|NCT00063596|Vitamin A|vitamin a|mesh-list
44103088|NCT00063596|Vitamins|vitamins|mesh-ancestor
44103089|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
44103090|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103091|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
44103092|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44103093|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103094|NCT00063687|Oxypurinol|oxypurinol|mesh-list
44103095|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264137|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44264138|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264139|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264140|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264141|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264142|NCT00650026|Adalimumab|adalimumab|mesh-list
44264143|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264144|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264145|NCT00650039|Valdecoxib|valdecoxib|mesh-list
44264146|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44264147|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44264148|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264149|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264150|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44264151|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44264152|NCT00650039|Analgesics|analgesics|mesh-ancestor
44264153|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
44264154|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264155|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264156|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264157|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264158|NCT00650052|Zonisamide|zonisamide|mesh-list
44264159|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
44264160|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264161|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264162|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103096|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103097|NCT00063713|Bortezomib|bortezomib|mesh-list
44103098|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103099|NCT00063726|Bortezomib|bortezomib|mesh-list
44103100|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103101|NCT00063791|Bortezomib|bortezomib|mesh-list
44103102|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103103|NCT00063804|Ritonavir|ritonavir|mesh-list
44103104|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44103105|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44103106|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44103107|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103119|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
44103120|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103121|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103122|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103123|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103124|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103125|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103126|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
44103127|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44103128|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264163|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264164|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264165|NCT00650065|Cetirizine|cetirizine|mesh-list
44264166|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44264167|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44264168|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44264169|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
44264170|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
44264171|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264172|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264173|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264174|NCT00650117|Fentanyl|fentanyl|mesh-list
44103129|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103130|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103131|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103132|NCT00063947|Gemcitabine|gemcitabine|mesh-list
44103133|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44103134|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103135|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
44103136|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103137|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103138|NCT00063947|Antiviral Agents|antiviral agents|mesh-ancestor
44103139|NCT00063947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103140|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103141|NCT00063947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103142|NCT00063947|Immunologic Factors|immunologic factors|mesh-ancestor
44103143|NCT00063947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103144|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103145|NCT00063960|Irinotecan|irinotecan|mesh-list
44103146|NCT00063960|Floxuridine|floxuridine|mesh-list
44103147|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103148|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103149|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103150|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103151|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103152|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103153|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
44103154|NCT00064012|Docetaxel|docetaxel|mesh-list
44103155|NCT00064012|Bortezomib|bortezomib|mesh-list
43817696|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
44103157|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44103158|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103159|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103160|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103161|NCT00064051|Gemcitabine|gemcitabine|mesh-list
44103162|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103163|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
44103164|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103165|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103166|NCT00064051|Antiviral Agents|antiviral agents|mesh-ancestor
44103167|NCT00064051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103168|NCT00064051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103169|NCT00064051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103170|NCT00064051|Immunologic Factors|immunologic factors|mesh-ancestor
44103171|NCT00064051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103172|NCT00064064|Gemcitabine|gemcitabine|mesh-list
44103175|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103176|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103177|NCT00064064|Antiviral Agents|antiviral agents|mesh-ancestor
44103178|NCT00064064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103179|NCT00064064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103180|NCT00064064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44264175|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44264176|NCT00650117|Narcotics|narcotics|mesh-ancestor
44264177|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264178|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264179|NCT00650117|Analgesics|analgesics|mesh-ancestor
44103181|NCT00064064|Immunologic Factors|immunologic factors|mesh-ancestor
44103182|NCT00064064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103183|NCT00064090|Cytarabine|cytarabine|mesh-list
44103184|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103185|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
44103186|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103187|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103188|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
44103189|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103190|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103191|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
44103192|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103193|NCT00064116|Rituximab|rituximab|mesh-list
44103194|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103195|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103196|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
44103197|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103198|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103199|NCT00064129|Ipilimumab|ipilimumab|mesh-list
44103200|NCT00064129|Sargramostim|sargramostim|mesh-list
44103201|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103202|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103203|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44103204|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103205|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
44103206|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153253|NCT00219856|Desflurane|desflurane|mesh-list
44153254|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44153255|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153256|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153257|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44153258|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
44153259|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
44153260|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44153261|NCT00219869|Galantamine|galantamine|mesh-list
44153262|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44153263|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153264|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153265|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
44153266|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153267|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153268|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44153269|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
44153270|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153271|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
44153272|NCT00219882|Turmeric extract|turmeric extract|mesh-list
44153273|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
44153274|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153275|NCT00219882|Protective Agents|protective agents|mesh-ancestor
44103207|NCT00064142|Halofuginone|halofuginone|mesh-list
44103208|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103209|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
44103210|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103211|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103212|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103213|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44103214|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103215|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103216|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44103217|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44103218|NCT00064142|Growth Substances|growth substances|mesh-ancestor
44103219|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103220|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
44103221|NCT00064181|Leucovorin|leucovorin|mesh-list
44103222|NCT00064181|Celecoxib|celecoxib|mesh-list
44103227|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
44264180|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
44264181|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264182|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44264183|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44264184|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
44264185|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
44264186|NCT00650156|Adalimumab|adalimumab|mesh-list
44264187|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264188|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264189|NCT00650169|Clopidogrel|clopidogrel|mesh-list
44264190|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44264191|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44264192|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44264193|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44264194|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
44264195|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264196|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264197|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264198|NCT00650182|Fentanyl|fentanyl|mesh-list
44264199|NCT00650182|Naltrexone|naltrexone|mesh-list
44264200|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44264201|NCT00650182|Narcotics|narcotics|mesh-ancestor
44264202|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264203|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264204|NCT00650182|Analgesics|analgesics|mesh-ancestor
44264205|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
44264206|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264207|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44264208|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44264209|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
44264210|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
44264211|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44264223|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264224|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264225|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264226|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264227|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264228|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264229|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264230|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264231|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264232|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44264233|NCT00650221|Pravastatin|pravastatin|mesh-list
44264234|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44264235|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44264236|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
43658341|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
44103228|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103229|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103230|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
44103231|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103232|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103233|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103234|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103236|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103237|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103238|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103239|NCT00064181|Antidotes|antidotes|mesh-ancestor
44103240|NCT00064181|Protective Agents|protective agents|mesh-ancestor
44103241|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
44103242|NCT00064181|Vitamins|vitamins|mesh-ancestor
44103243|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
44103244|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103245|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44103246|NCT00064181|Analgesics|analgesics|mesh-ancestor
44103247|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
44103248|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103249|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103250|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103251|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44103252|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44103253|NCT00064194|Vitamin E|vitamin e|mesh-list
44103254|NCT00064194|Selenium|selenium|mesh-list
44103255|NCT00064194|Vitamins|vitamins|mesh-ancestor
44103256|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
44103257|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103258|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
44103259|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103260|NCT00064194|Protective Agents|protective agents|mesh-ancestor
44103261|NCT00064194|Trace Elements|trace elements|mesh-ancestor
44103262|NCT00064207|Gemcitabine|gemcitabine|mesh-list
44103263|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103264|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
44103265|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103266|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103267|NCT00064207|Antiviral Agents|antiviral agents|mesh-ancestor
44103268|NCT00064207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103269|NCT00064207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103270|NCT00064207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103271|NCT00064207|Immunologic Factors|immunologic factors|mesh-ancestor
44103272|NCT00064207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103273|NCT00064220|Soblidotin|soblidotin|mesh-list
44264237|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726627|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
44264238|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44264239|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44264240|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264241|NCT00650234|Metformin|metformin|mesh-list
44264242|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264243|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264244|NCT00650247|Sumatriptan|sumatriptan|mesh-list
44264245|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44264246|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44264247|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44264248|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
44264249|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264250|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264251|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264252|NCT00650273|Azithromycin|azithromycin|mesh-list
44264253|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264254|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264255|NCT00650286|Modafinil|modafinil|mesh-list
44264256|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44264257|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264258|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44264259|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44264260|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44264284|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
44264285|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264286|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44264287|NCT00650338|Latanoprost|latanoprost|mesh-list
44264288|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264289|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
44264290|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264291|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264292|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44264293|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44264294|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264295|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264296|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264297|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44264298|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44264299|NCT00650364|Midodrine|midodrine|mesh-list
44264300|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
44264301|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
44264302|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264303|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264304|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44264305|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44264306|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44264307|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44103274|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103275|NCT00064233|Dasatinib|dasatinib|mesh-list
44103276|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103277|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103278|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103279|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559607|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559608|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
43559609|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
43559610|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
43559611|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833495|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43833496|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43833497|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
43833498|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103280|NCT00064246|Rituximab|rituximab|mesh-list
44103281|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44103282|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103283|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103284|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
44103285|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103286|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103287|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
44103288|NCT00064285|Alvocidib|alvocidib|mesh-list
44103289|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103290|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103291|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103292|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103293|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
44103294|NCT00064285|Growth Substances|growth substances|mesh-ancestor
44103295|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103296|NCT00064389|Albuterol|albuterol|mesh-list
44103297|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43629197|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
44103302|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264309|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264310|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264311|NCT00650377|Finasteride|finasteride|mesh-list
44264312|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44264313|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44264314|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264315|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264316|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
44264317|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264318|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264319|NCT00650377|Urological Agents|urological agents|mesh-ancestor
44264320|NCT00650390|Adalimumab|adalimumab|mesh-list
44264321|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264322|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264323|NCT00650403|Paroxetine|paroxetine|mesh-list
44264324|NCT00650403|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44264325|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44103303|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
44103304|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103305|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44103306|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44103307|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44103308|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44103309|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103310|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103312|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
44103313|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44103314|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44103315|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
44103316|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103317|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103318|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44103319|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
44103320|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44103321|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44103322|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44103323|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44103324|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103325|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103326|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
44103327|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44103328|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44103329|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
44103330|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103331|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103332|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44103333|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
44103334|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44103335|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44103336|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44103337|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
44103338|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264327|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264328|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264329|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
44264330|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264331|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44264332|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
44264333|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264334|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44264335|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44264336|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264337|NCT00650416|Carvedilol|carvedilol|mesh-list
44264338|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44103339|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103340|NCT00064428|PENTA|penta|mesh-list
44103341|NCT00064428|Fondaparinux|fondaparinux|mesh-list
44103342|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44103343|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
44103344|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44103345|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
44103346|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103347|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103348|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
44103349|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44103350|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44103351|NCT00064467|Bupropion|bupropion|mesh-list
44103352|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44103353|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
44103354|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103355|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44103356|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44103357|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153276|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103358|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103359|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
44103360|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103361|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103362|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44103363|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44103364|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103365|NCT00064610|Bortezomib|bortezomib|mesh-list
44103366|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103374|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103375|NCT00064649|Finasteride|finasteride|mesh-list
44103376|NCT00064649|Alfuzosin|alfuzosin|mesh-list
44103377|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44103378|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44103379|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103380|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103381|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103382|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103383|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103384|NCT00064649|Urological Agents|urological agents|mesh-ancestor
44103385|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44103386|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44103387|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44103388|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44103389|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103390|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
44264339|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44264340|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264341|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264342|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264343|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264344|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264345|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
44264346|NCT00650416|Protective Agents|protective agents|mesh-ancestor
44264347|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264348|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726777|NCT02588196|Dexamethasone|dexamethasone|mesh-list
44264349|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264350|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
44264351|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44264352|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44103391|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44103392|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103393|NCT00064766|Doxycycline|doxycycline|mesh-list
44103394|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44103395|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103396|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
44103397|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103398|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103399|NCT00064857|Pycnogenols|pycnogenols|mesh-list
44103400|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44103401|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
44103402|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103403|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
44103404|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103405|NCT00064857|Protective Agents|protective agents|mesh-ancestor
44103406|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44103407|NCT00064974|Lenalidomide|lenalidomide|mesh-list
44103408|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
44103409|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103410|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44103411|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44103412|NCT00064974|Growth Substances|growth substances|mesh-ancestor
44103413|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
44103414|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103415|NCT00065117|Leucovorin|leucovorin|mesh-list
44103416|NCT00065117|Fluorouracil|fluorouracil|mesh-list
44103417|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
44103418|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
44103419|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103420|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103421|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103422|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103423|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
44103424|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103425|NCT00065117|Antidotes|antidotes|mesh-ancestor
44103426|NCT00065117|Protective Agents|protective agents|mesh-ancestor
44103427|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
44103428|NCT00065117|Vitamins|vitamins|mesh-ancestor
44103429|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
44103430|NCT00065130|Insulin|insulin|mesh-list
44103431|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44103432|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
44103433|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
44103434|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
44103435|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
44103436|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264353|NCT00650429|Ziprasidone|ziprasidone|mesh-list
44264354|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44264355|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
44264356|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264357|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264358|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264359|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264360|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264361|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264362|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264363|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44264364|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
44264365|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43658419|NCT02945241|Vancomycin|vancomycin|mesh-list
44103437|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103443|NCT00065169|Celecoxib|celecoxib|mesh-list
44103444|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103445|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726940|NCT02586961|Hormones|hormones|mesh-ancestor
44103446|NCT00065169|Analgesics|analgesics|mesh-ancestor
44103447|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
44103448|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103449|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103450|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103451|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103452|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44103453|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44103454|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103455|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103456|NCT00065273|Olanzapine|olanzapine|mesh-list
44103457|NCT00065273|Risperidone|risperidone|mesh-list
44103458|NCT00065273|Clozapine|clozapine|mesh-list
44103459|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44103460|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
44103461|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103462|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103463|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103464|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44103465|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44103466|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44103467|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103468|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44103469|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
44103470|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
44103471|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
44103472|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103473|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103474|NCT00065273|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44103475|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44103476|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44103477|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
44103478|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
44103479|NCT00065325|Fulvestrant|fulvestrant|mesh-list
44103480|NCT00065325|Exemestane|exemestane|mesh-list
44103481|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103482|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103483|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44103484|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44103485|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103486|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103487|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103488|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44264366|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44264367|NCT00650442|Estradiol|estradiol|mesh-list
44264368|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44264369|NCT00650442|Estrogens|estrogens|mesh-ancestor
44264370|NCT00650442|Hormones|hormones|mesh-ancestor
44264371|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264372|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264373|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44264374|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
44264375|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103489|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44103490|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103491|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103492|NCT00065351|Lenalidomide|lenalidomide|mesh-list
44103493|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
44103494|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103495|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44103496|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44103497|NCT00065351|Growth Substances|growth substances|mesh-ancestor
44103498|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
44103499|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103500|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
44103501|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
44103502|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103503|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103504|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103505|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44103506|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103507|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103508|NCT00065455|Vitamin A|vitamin a|mesh-list
44103514|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103515|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103516|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44103517|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44103519|NCT00065546|Estrogens|estrogens|mesh-list
44103520|NCT00065546|Hormones|hormones|mesh-ancestor
44103521|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103522|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103523|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
44103524|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44103525|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
44103526|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103527|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103528|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44103529|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
44103530|NCT00065559|Celecoxib|celecoxib|mesh-list
44103531|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103532|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44103533|NCT00065559|Analgesics|analgesics|mesh-ancestor
43833529|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833530|NCT05205382|Nicotine|nicotine|mesh-list
43833531|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43833532|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
43833533|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833534|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833535|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43833536|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44103534|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
44103535|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103536|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103537|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103538|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103539|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44103540|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44103541|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103542|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103544|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
44103545|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103546|NCT00065624|Protective Agents|protective agents|mesh-ancestor
44103547|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103548|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
44103549|NCT00065624|Vitamins|vitamins|mesh-ancestor
44264376|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44264377|NCT00650455|Naproxen|naproxen|mesh-list
44264378|NCT00650455|Valdecoxib|valdecoxib|mesh-list
44264379|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44264380|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44264381|NCT00650455|Analgesics|analgesics|mesh-ancestor
44264382|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
44264383|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264384|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264385|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264386|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264387|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
44264388|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44264389|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264390|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264391|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44264392|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
44264393|NCT00650468|Prednisone|prednisone|mesh-list
44264394|NCT00650468|Tacrolimus|tacrolimus|mesh-list
44103550|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
44103551|NCT00065637|Teriparatide|teriparatide|mesh-list
44103552|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103553|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103554|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44103555|NCT00065741|Silymarin|silymarin|mesh-list
44103556|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
44103557|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103558|NCT00065741|Protective Agents|protective agents|mesh-ancestor
44103559|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103560|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44103561|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44103562|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103563|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103564|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103565|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44103566|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44103567|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153277|NCT00219895|Ibuprofen|ibuprofen|mesh-list
44153278|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44153279|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153280|NCT00219895|Analgesics|analgesics|mesh-ancestor
44153281|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
44153282|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153283|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153284|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44153285|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153286|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44153287|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726995|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
44153288|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103569|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103570|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103571|NCT00065884|Valproic Acid|valproic acid|mesh-list
44103572|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
44103573|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103574|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264396|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
44264397|NCT00650468|Hormones|hormones|mesh-ancestor
44264398|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264399|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264400|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44264401|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264402|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44264403|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
44264404|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44264405|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264406|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264407|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44264408|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44264409|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
44264410|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264411|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264412|NCT00650481|Oxybutynin|oxybutynin|mesh-list
44264413|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
44264414|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
44264415|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264416|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264417|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44264418|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44103575|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
44103576|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103577|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103578|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
44103579|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44103580|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44103581|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103582|NCT00065923|Topiramate|topiramate|mesh-list
44103583|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
44103584|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44103585|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103586|NCT00065936|Naltrexone|naltrexone|mesh-list
44103587|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44103588|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44103589|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103590|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
44103591|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103592|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
44103593|NCT00065949|Analgesics|analgesics|mesh-ancestor
44103594|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
44103595|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103596|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103598|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727024|NCT02586454|Ropivacaine|ropivacaine|mesh-list
44103599|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44103600|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
44103601|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264419|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
44264420|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264421|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264422|NCT00650481|Urological Agents|urological agents|mesh-ancestor
44264423|NCT00650494|Valacyclovir|valacyclovir|mesh-list
44264424|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
44264425|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264426|NCT00650520|Bromocriptine|bromocriptine|mesh-list
44264427|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44264428|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44264429|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
44264430|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658460|NCT02945020|Simeprevir|simeprevir|mesh-list
44103602|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44103603|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103604|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103605|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
44103606|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103607|NCT00065962|Secretin|secretin|mesh-list
44103608|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103609|NCT00065962|Hormones|hormones|mesh-ancestor
44103610|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103611|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103612|NCT00066001|Metronidazole|metronidazole|mesh-list
44103613|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103614|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44103615|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103616|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103617|NCT00066027|Doxycycline|doxycycline|mesh-list
44103618|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44103619|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103620|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
44103621|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103622|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103623|NCT00066092|Lenograstim|lenograstim|mesh-list
44103624|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44103625|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
44103626|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103627|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44103628|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44103629|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44103630|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
44103631|NCT00066157|Estradiol|estradiol|mesh-list
44103632|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44103633|NCT00066157|Estrogens|estrogens|mesh-list
44103634|NCT00066157|Progesterone|progesterone|mesh-list
44103635|NCT00066157|Hormones|hormones|mesh-ancestor
44103636|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103637|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43629555|NCT03058900|Methotrexate|methotrexate|mesh-list
44103640|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103641|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44103643|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44103645|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44103646|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44103647|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103648|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103649|NCT00066196|Dacarbazine|dacarbazine|mesh-list
43559668|NCT03553498|Narcotics|narcotics|mesh-ancestor
44103650|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44103651|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
44103652|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103653|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264431|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264432|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
44264433|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
44264434|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264435|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264436|NCT00650533|Glimepiride|glimepiride|mesh-list
44264437|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264438|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44264439|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264440|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44264441|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
44264442|NCT00650598|Diclofenac|diclofenac|mesh-list
44264443|NCT00650598|Valdecoxib|valdecoxib|mesh-list
44264444|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43658471|NCT02944981|Gabapentin|gabapentin|mesh-list
44103654|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
44103655|NCT00066248|Megestrol|megestrol|mesh-list
44103656|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
44103657|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44103658|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44103659|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44103660|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
44103661|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44103662|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103663|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44103664|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44103665|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103666|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103667|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
44103668|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44103669|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
44103671|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103672|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44103673|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
44103674|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
44103675|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103676|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103677|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44103678|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
44103679|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44103680|NCT00066274|Leucovorin|leucovorin|mesh-list
44103681|NCT00066274|Fluorouracil|fluorouracil|mesh-list
44103682|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
44103683|NCT00066274|Irinotecan|irinotecan|mesh-list
44103684|NCT00066274|Calcium|calcium|mesh-list
44103685|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
44103686|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103687|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103688|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
44103689|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103690|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103691|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103692|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103693|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
44103694|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103695|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103696|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103697|NCT00066274|Antidotes|antidotes|mesh-ancestor
43727081|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727082|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
43727083|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43727084|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43727085|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43727088|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44103698|NCT00066274|Protective Agents|protective agents|mesh-ancestor
44103699|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
44103700|NCT00066274|Vitamins|vitamins|mesh-ancestor
44103701|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
44264445|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44264446|NCT00650598|Analgesics|analgesics|mesh-ancestor
44264447|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
44264448|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264449|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264450|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264451|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264452|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44264453|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264454|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264455|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44264456|NCT00650611|Ziprasidone|ziprasidone|mesh-list
44264457|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44264458|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
44264459|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264460|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264461|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264462|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264463|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264464|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264465|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103702|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
44103703|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103704|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103705|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103706|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103707|NCT00066339|Gefitinib|gefitinib|mesh-list
44103708|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103709|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103710|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103711|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103712|NCT00066352|Bortezomib|bortezomib|mesh-list
44103718|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818147|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
44103719|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103720|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103721|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44103722|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44103723|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44103724|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103725|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103726|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103728|NCT00066391|Irinotecan|irinotecan|mesh-list
44103729|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103730|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103731|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103732|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103733|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103734|NCT00066417|Cyclosporine|cyclosporine|mesh-list
44103735|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
44103736|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
44103737|NCT00066417|Thiotepa|thiotepa|mesh-list
44264466|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44264467|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
44264468|NCT00650624|Valdecoxib|valdecoxib|mesh-list
44264469|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44264470|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44264471|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264472|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727127|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727128|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
43727129|NCT02586610|Capecitabine|capecitabine|mesh-list
43727133|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
44264473|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44264474|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44264475|NCT00650624|Analgesics|analgesics|mesh-ancestor
44264476|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
44264477|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264478|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264479|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264480|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264481|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
44264482|NCT00650637|Lamivudine|lamivudine|mesh-list
44264483|NCT00650637|Zidovudine|zidovudine|mesh-list
44264484|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44264485|NCT00650637|Nelfinavir|nelfinavir|mesh-list
44264486|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
44264487|NCT00650637|Loperamide|loperamide|mesh-list
44264488|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
44103738|NCT00066417|Fludarabine|fludarabine|mesh-list
44103739|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
44103740|NCT00066417|Cyclosporins|cyclosporins|mesh-list
44103741|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103742|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
44103743|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103744|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103745|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44103747|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103748|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103749|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44103750|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103751|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
44103752|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103753|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
44103754|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103755|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
44103756|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44103757|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103758|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
44103759|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
44103760|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103761|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103762|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
44103763|NCT00066417|Hormones|hormones|mesh-ancestor
44103764|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103765|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44103766|NCT00066417|Protective Agents|protective agents|mesh-ancestor
44103767|NCT00066443|Docetaxel|docetaxel|mesh-list
44103768|NCT00066443|Epirubicin|epirubicin|mesh-list
44103769|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103770|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
44264490|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264491|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264492|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44264493|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44264494|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44264495|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264496|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264497|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
44264498|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264499|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44264500|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44264501|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
44264502|NCT00650637|Antacids|antacids|mesh-ancestor
44264503|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44264504|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44264505|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44264506|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
44264507|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44264508|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44264509|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
44264510|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264511|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44264512|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264513|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44103771|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103772|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103773|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103774|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44103775|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44103776|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103777|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103778|NCT00066456|Docetaxel|docetaxel|mesh-list
44103779|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103780|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44103781|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103782|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103783|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103784|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
44103785|NCT00066482|Cisplatin|cisplatin|mesh-list
43818196|NCT05547659|Celecoxib|celecoxib|mesh-list
44103794|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44103795|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
44103796|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103797|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103798|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44103799|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44103800|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44103801|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44264514|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44264515|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264516|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264517|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44264518|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44264519|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
44264520|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264521|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264522|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44264523|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44264524|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
44264525|NCT00650871|Casopitant|casopitant|mesh-list
44264526|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
44264527|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
44264528|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264529|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264530|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44264531|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44264532|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727243|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
43727244|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727245|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727246|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43727247|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43727248|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
43727249|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264533|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264534|NCT00650897|Citalopram|citalopram|mesh-list
44264535|NCT00650897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44264536|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44264537|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264538|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264539|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264540|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
44264541|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264542|NCT00650897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44264543|NCT00650897|Antidepressive Agents|antidepressive agents|mesh-ancestor
44264544|NCT00650897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103802|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103803|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44103804|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44103805|NCT00066482|Protective Agents|protective agents|mesh-ancestor
44103806|NCT00066508|Bortezomib|bortezomib|mesh-list
44103807|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103808|NCT00066547|Antibodies|antibodies|mesh-list
44103809|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44103810|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
44103811|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264546|NCT00650910|Digoxin|digoxin|mesh-list
44264547|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264548|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44264549|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264550|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264551|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264552|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44264553|NCT00650910|Protective Agents|protective agents|mesh-ancestor
44264554|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264555|NCT00650923|Temozolomide|temozolomide|mesh-list
44264556|NCT00650923|Aflibercept|aflibercept|mesh-list
44264557|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
44264558|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44264559|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
44264560|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103812|NCT00066586|Exemestane|exemestane|mesh-list
44103813|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103814|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44103815|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44103816|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103817|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103818|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44103819|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103820|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103822|NCT00066599|Voriconazole|voriconazole|mesh-list
44103823|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
44103824|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103825|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44103826|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44103827|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103828|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103829|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44103830|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103831|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103832|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103833|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44103834|NCT00066612|Irinotecan|irinotecan|mesh-list
44103835|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44103836|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103837|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103838|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103839|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103840|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
44103841|NCT00066625|Bortezomib|bortezomib|mesh-list
44103842|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103843|NCT00066638|Romidepsin|romidepsin|mesh-list
44103844|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44103845|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103846|NCT00066651|Immunotoxins|immunotoxins|mesh-list
44103847|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
44103848|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103849|NCT00066716|Celecoxib|celecoxib|mesh-list
44103850|NCT00066716|Paclitaxel|paclitaxel|mesh-list
44103851|NCT00066716|Carboplatin|carboplatin|mesh-list
44103852|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44264561|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264562|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44264563|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44264564|NCT00650923|Growth Substances|growth substances|mesh-ancestor
44264565|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264566|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462224|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44462225|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
44462226|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44462227|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44462228|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44462229|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462230|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
44462232|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462233|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
44462234|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462235|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462236|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44103853|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43629771|NCT03057314|Calcium|calcium|mesh-list
44103862|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103863|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103864|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44103865|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103866|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44103867|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44103868|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103869|NCT00066768|Gemcitabine|gemcitabine|mesh-list
44103870|NCT00066768|Suramin|suramin|mesh-list
44103871|NCT00066768|Docetaxel|docetaxel|mesh-list
44103872|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103873|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
44103874|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103875|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103876|NCT00066768|Antiviral Agents|antiviral agents|mesh-ancestor
44103877|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103878|NCT00066768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103879|NCT00066768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103880|NCT00066768|Immunologic Factors|immunologic factors|mesh-ancestor
44103881|NCT00066768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103882|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
44103883|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103884|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103885|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
44103886|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
44103887|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44103888|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44103889|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44103890|NCT00066794|Cytarabine|cytarabine|mesh-list
44103891|NCT00066794|Cyclosporine|cyclosporine|mesh-list
44103892|NCT00066794|Daunorubicin|daunorubicin|mesh-list
44103893|NCT00066794|Cyclosporins|cyclosporins|mesh-list
44103894|NCT00066794|Sargramostim|sargramostim|mesh-list
44103895|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103896|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
44103897|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103898|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103899|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
44462237|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462238|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
44462239|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44462240|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462241|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462242|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462244|NCT01533922|Olodaterol|olodaterol|mesh-list
44462245|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462246|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
44462247|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462248|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462249|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462250|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462251|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
44462252|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44462253|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462254|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462255|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462256|NCT01533688|Bisacodyl|bisacodyl|mesh-list
44462257|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44462258|NCT01533688|Cathartics|cathartics|mesh-ancestor
44462259|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462260|NCT01533688|Laxatives|laxatives|mesh-ancestor
44462261|NCT01533493|Memantine|memantine|mesh-list
44462262|NCT01533493|Methylphenidate|methylphenidate|mesh-list
44462263|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44462264|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462265|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44462266|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44462267|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462268|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462269|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
44462270|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462271|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44462274|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44462275|NCT01533428|Capsaicin|capsaicin|mesh-list
44462276|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
44462277|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
44462278|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
44462279|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462280|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462281|NCT01533181|Topotecan|topotecan|mesh-list
44462282|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44462283|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44462284|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462285|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462286|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462287|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
44462288|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
44462289|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462290|NCT01532687|Gemcitabine|gemcitabine|mesh-list
44462291|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462292|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
44264568|NCT00651066|Lopinavir|lopinavir|mesh-list
44264569|NCT00651066|Rifabutin|rifabutin|mesh-list
44264570|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44264571|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44264572|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
44264573|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264574|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264575|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44264576|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44264577|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
44264578|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264579|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44264580|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44264581|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264582|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44264583|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
44264590|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264591|NCT00651131|Daptomycin|daptomycin|mesh-list
44264592|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264593|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264594|NCT00651209|Tenofovir|tenofovir|mesh-list
44264595|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
44264596|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264597|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44264598|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44264599|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264600|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264601|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44264602|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44264603|NCT00651235|Losartan|losartan|mesh-list
44264604|NCT00651235|Propranolol|propranolol|mesh-list
44264605|NCT00651235|Atenolol|atenolol|mesh-list
44264606|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264607|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264608|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44264609|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44264610|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264611|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44264612|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44264613|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264614|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264615|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264616|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
44264617|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
44264618|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
44264619|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264620|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44264621|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44264622|NCT00651287|Quinapril|quinapril|mesh-list
44264623|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44103900|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103901|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103902|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
44103903|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103904|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44103905|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
43559783|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43727372|NCT02584231|Coagulants|coagulants|mesh-ancestor
43727373|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43727374|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
43727375|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727376|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43727377|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
43727378|NCT02584153|Coagulants|coagulants|mesh-ancestor
44103906|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
44264624|NCT00651287|Diuretics|diuretics|mesh-ancestor
44264625|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
44264626|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264627|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44264628|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264629|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264630|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44264631|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
44264632|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264633|NCT00651300|Parecoxib|parecoxib|mesh-list
44264634|NCT00651300|Valdecoxib|valdecoxib|mesh-list
44264635|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44264636|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44264637|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264638|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264639|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44264640|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44264641|NCT00651300|Analgesics|analgesics|mesh-ancestor
43658541|NCT02944292|Propofol|propofol|mesh-list
44103907|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103908|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44103909|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44103910|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44103911|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44103912|NCT00066846|Leucovorin|leucovorin|mesh-list
44103913|NCT00066846|Bevacizumab|bevacizumab|mesh-list
44103914|NCT00066846|Fluorouracil|fluorouracil|mesh-list
44103915|NCT00066846|Calcium|calcium|mesh-list
44103916|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
44103917|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44103918|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103919|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44103920|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44103921|NCT00066846|Growth Substances|growth substances|mesh-ancestor
44103922|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103927|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103929|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
44103930|NCT00066846|Antidotes|antidotes|mesh-ancestor
44103931|NCT00066846|Protective Agents|protective agents|mesh-ancestor
44103932|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
44103933|NCT00066846|Vitamins|vitamins|mesh-ancestor
44103934|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
44103935|NCT00066859|Sertraline|sertraline|mesh-list
44103936|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
44103937|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103938|NCT00066859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44103939|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43727422|NCT02583594|Acyclovir|acyclovir|mesh-list
43727423|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
43727424|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
43727425|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
43727426|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727427|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
43727428|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
43727429|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727430|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727431|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44103940|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44103941|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103942|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103943|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
44103944|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103945|NCT00066872|Imiquimod|imiquimod|mesh-list
44103946|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44103947|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
44103948|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264642|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
44264643|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264644|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264645|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264646|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264647|NCT00651326|Docetaxel|docetaxel|mesh-list
44264648|NCT00651326|Leuprolide|leuprolide|mesh-list
44264649|NCT00651326|Goserelin|goserelin|mesh-list
44264650|NCT00651326|Bicalutamide|bicalutamide|mesh-list
44264651|NCT00651326|Flutamide|flutamide|mesh-list
44264652|NCT00651326|Buserelin|buserelin|mesh-list
44264653|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264654|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44264655|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44264656|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44264657|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264658|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44264659|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
44264660|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44264661|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264662|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44264663|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
44264664|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103949|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103950|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
44103951|NCT00066885|Calcitriol|calcitriol|mesh-list
44103952|NCT00066885|Docetaxel|docetaxel|mesh-list
44103953|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103954|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44103955|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103956|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103957|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103958|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103959|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103960|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44103961|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44103962|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44103963|NCT00066885|Vitamins|vitamins|mesh-ancestor
44103964|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
44103965|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44103966|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
44103967|NCT00066989|Antibodies|antibodies|mesh-list
44103968|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
44103969|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44103970|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44103971|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
44103972|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103973|NCT00067015|Goserelin|goserelin|mesh-list
44103974|NCT00067015|Bicalutamide|bicalutamide|mesh-list
44103975|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44103976|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103977|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
43727469|NCT02583451|Zopiclone|zopiclone|mesh-list
44103978|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
44103979|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44103980|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264665|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264667|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44264668|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
44264669|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264670|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264671|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44264672|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44264673|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
44264674|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264675|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264676|NCT00651443|Galiximab|galiximab|mesh-list
44264677|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264678|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264679|NCT00651456|Bevacizumab|bevacizumab|mesh-list
44264680|NCT00651456|Cisplatin|cisplatin|mesh-list
44264681|NCT00651456|Pemetrexed|pemetrexed|mesh-list
44264682|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44264683|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264684|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44264685|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44264686|NCT00651456|Growth Substances|growth substances|mesh-ancestor
44264687|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264688|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
44264689|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264690|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264713|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44264714|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264715|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264716|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264718|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44264719|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264720|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264721|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264722|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44264723|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44264725|NCT00651599|Estradiol|estradiol|mesh-list
44264726|NCT00651599|Estrogens|estrogens|mesh-ancestor
44264727|NCT00651599|Hormones|hormones|mesh-ancestor
44264728|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264729|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264730|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44264731|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
44264732|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44264733|NCT00651599|Diuretics|diuretics|mesh-ancestor
44264734|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
44264735|NCT00651612|Timolol|timolol|mesh-list
44264736|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44264737|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264738|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44264739|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44264740|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44264741|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264742|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44103981|NCT00067041|Treprostinil|treprostinil|mesh-list
44103982|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44103983|NCT00067080|Deferasirox|deferasirox|mesh-list
44103984|NCT00067080|Deferoxamine|deferoxamine|mesh-list
44103985|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44103986|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
44103987|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
44103988|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103989|NCT00067080|Siderophores|siderophores|mesh-ancestor
44103990|NCT00067093|Vitamin K|vitamin k|mesh-list
44103991|NCT00067093|Heparin|heparin|mesh-list
44103992|NCT00067093|Calcium heparin|calcium heparin|mesh-list
44103993|NCT00067093|Idraparinux|idraparinux|mesh-list
44103994|NCT00067093|Vitamins|vitamins|mesh-ancestor
44104000|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104001|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44104002|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
44104003|NCT00067093|Coagulants|coagulants|mesh-ancestor
44104004|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44264743|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264744|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264745|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264746|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264747|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44264748|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44264749|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264750|NCT00651651|Budesonide|budesonide|mesh-list
44264751|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
44264752|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264753|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264754|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
44264755|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104005|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
44104006|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44104007|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
44104008|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104009|NCT00067119|Dipyridamole|dipyridamole|mesh-list
44104010|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
44104011|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104012|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44104013|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104014|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44104015|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
44104017|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44104018|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
44104019|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104020|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104021|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43818367|NCT05545800|Empagliflozin|empagliflozin|mesh-list
44104022|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44104023|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
44104025|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104026|NCT00067262|Valproic Acid|valproic acid|mesh-list
44104027|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
44104028|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104029|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104030|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
44104031|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104032|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104033|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
44104034|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44104035|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44104036|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104037|NCT00067301|Citalopram|citalopram|mesh-list
44104038|NCT00067301|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44104039|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104040|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104041|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104042|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104043|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
44104044|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104045|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43833624|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
43833625|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104046|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
44104047|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104048|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
44104049|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44104051|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
44104052|NCT00067353|Fluorides|fluorides|mesh-list
44104053|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
44104054|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
44264756|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264757|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264758|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264760|NCT00651651|Hormones|hormones|mesh-ancestor
44264761|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264762|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264763|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264764|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264765|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264766|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264767|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264768|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
44264769|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44264770|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43658591|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
44104055|NCT00067353|Protective Agents|protective agents|mesh-ancestor
44104056|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104057|NCT00067405|Micronutrients|micronutrients|mesh-list
44104058|NCT00067405|Trace Elements|trace elements|mesh-list
44104059|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104060|NCT00067431|Valproic Acid|valproic acid|mesh-list
44104061|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
44104062|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104063|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104064|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
44104065|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43629979|NCT03056053|Zolpidem|zolpidem|mesh-list
44104069|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44104070|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104071|NCT00067444|Paroxetine|paroxetine|mesh-list
44104072|NCT00067444|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44104073|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104074|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104075|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104076|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104077|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
44104078|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104079|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44104080|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
44104081|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104082|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44104083|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44104084|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104085|NCT00067457|Alosetron|alosetron|mesh-list
44104086|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104087|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44104088|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
44104089|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104090|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104091|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727563|NCT02583243|Buprenorphine|buprenorphine|mesh-list
43727564|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43727565|NCT02583243|Narcotics|narcotics|mesh-ancestor
43727566|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727567|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104092|NCT00067496|Modafinil|modafinil|mesh-list
44104093|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44104094|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104095|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44104096|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44104097|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44264771|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44264772|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264773|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264774|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
44264775|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264776|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264777|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44264778|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264780|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44264781|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44264782|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
44264783|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264784|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264785|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
44264786|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
44264787|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44264788|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43658602|NCT02944201|Carvedilol|carvedilol|mesh-list
44104098|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104099|NCT00067509|Progesterone|progesterone|mesh-list
44104100|NCT00067509|Estrogens|estrogens|mesh-list
44104101|NCT00067509|Progestins|progestins|mesh-ancestor
44104102|NCT00067509|Hormones|hormones|mesh-ancestor
44104103|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104104|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104105|NCT00067535|Cocaine|cocaine|mesh-list
44104106|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
44104107|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
44104108|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44104109|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104110|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
44104111|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104112|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44104113|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44104114|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104115|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104116|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104117|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
44104118|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104119|NCT00067548|EKB 569|ekb 569|mesh-list
44104120|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104121|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44104122|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104123|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104124|NCT00067561|Alosetron|alosetron|mesh-list
44104125|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104126|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44104127|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
44104128|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104129|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104130|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153292|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153293|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264789|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44264790|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727597|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264791|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264793|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264794|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264795|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44264796|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264797|NCT00651768|Budesonide|budesonide|mesh-list
44264798|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
44264799|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44264800|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264801|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264802|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
44153294|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630050|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
44153302|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153303|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153304|NCT00219921|Analgesics|analgesics|mesh-ancestor
44153305|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
44153306|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153307|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44153308|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
44153309|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153310|NCT00219973|Bemiparin|bemiparin|mesh-list
44153311|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
44153312|NCT00220051|Capecitabine|capecitabine|mesh-list
44153313|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
44153314|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153315|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
44153316|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153317|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153318|NCT00220064|Leucovorin|leucovorin|mesh-list
44153319|NCT00220064|Fluorouracil|fluorouracil|mesh-list
44153320|NCT00220064|Irinotecan|irinotecan|mesh-list
44153321|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
44153322|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153323|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153324|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153325|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153326|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
44153327|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727679|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727680|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43559854|NCT03148860|Methotrexate|methotrexate|mesh-list
43559855|NCT03148860|Ustekinumab|ustekinumab|mesh-list
43559856|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43559857|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
43727681|NCT02582372|Narcotics|narcotics|mesh-ancestor
43727682|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43727685|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
44153328|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44153329|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153330|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153331|NCT00220064|Antidotes|antidotes|mesh-ancestor
44153332|NCT00220064|Protective Agents|protective agents|mesh-ancestor
44104132|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104133|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104134|NCT00067626|Chromium|chromium|mesh-list
44104135|NCT00067626|Trace Elements|trace elements|mesh-ancestor
44104136|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
44104137|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104138|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44104139|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104140|NCT00067743|Lenalidomide|lenalidomide|mesh-list
44104141|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
44104142|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104143|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44104144|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44104145|NCT00067743|Growth Substances|growth substances|mesh-ancestor
44104146|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
44104147|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264803|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264804|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264805|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264806|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264807|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
44264809|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264810|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264811|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264812|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264813|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264814|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264815|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264816|NCT00651781|Bortezomib|bortezomib|mesh-list
44264817|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264818|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44264819|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44264820|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44264821|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264822|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44264823|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
44264824|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44264825|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44264826|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44104148|NCT00067756|Butyric Acid|butyric acid|mesh-list
44104149|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
44104150|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
44104151|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104152|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104153|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104154|NCT00067860|Hormones|hormones|mesh-list
44104155|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104156|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104157|NCT00067899|Vitamins|vitamins|mesh-list
44104158|NCT00067899|Ascorbic Acid|ascorbic acid|mesh-list
44104159|NCT00067899|Vitamin E|vitamin e|mesh-list
44104160|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
44104161|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104162|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
43630123|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104176|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
44104177|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104178|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
44104179|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44104180|NCT00067925|Calcium|calcium|mesh-list
43559893|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
44104181|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104182|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104183|NCT00067938|Lamotrigine|lamotrigine|mesh-list
44264827|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44264828|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44264829|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44264830|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44264831|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44264832|NCT00651859|Bimatoprost|bimatoprost|mesh-list
44264833|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44264834|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264835|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264836|NCT00651885|Treprostinil|treprostinil|mesh-list
44264837|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264838|NCT00651911|Rasburicase|rasburicase|mesh-list
44264839|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
44264840|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44264841|NCT00651976|Letrozole|letrozole|mesh-list
44264842|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264843|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44264844|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44264845|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264846|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264847|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44264848|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
44264849|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264850|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264851|NCT00652002|Budesonide|budesonide|mesh-list
44264852|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
44264853|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44264854|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264855|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
44104184|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
44104185|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44104186|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104187|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104188|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104189|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104190|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44104191|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44104192|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44104193|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104194|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44104195|NCT00067951|Metformin|metformin|mesh-list
44104196|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
43727725|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727726|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727727|NCT02582177|Ketoconazole|ketoconazole|mesh-list
43727729|NCT02582177|Miconazole|miconazole|mesh-list
43727730|NCT02582177|Dexamethasone|dexamethasone|mesh-list
43727731|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
43727732|NCT02582177|Betamethasone|betamethasone|mesh-list
43727733|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
43727734|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43727735|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
43727736|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44104197|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44104198|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104199|NCT00068029|Octreotide|octreotide|mesh-list
44104200|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44264856|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264857|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264858|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264859|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264860|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
44264861|NCT00652002|Hormones|hormones|mesh-ancestor
44264862|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264863|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264864|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264865|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264866|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264867|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264868|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264869|NCT00652041|Thalidomide|thalidomide|mesh-list
44264870|NCT00652041|Bortezomib|bortezomib|mesh-list
44264871|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264872|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44264873|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
44264874|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264875|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
44264876|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264877|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264878|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44264879|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43658653|NCT02944045|Hormones|hormones|mesh-ancestor
44104201|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44104202|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104203|NCT00068042|Octreotide|octreotide|mesh-list
44104204|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104205|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44104206|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104207|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
44104208|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44104209|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44104210|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
44104211|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104212|NCT00068068|Talaporfin|talaporfin|mesh-list
44104213|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104214|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44104215|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
44104216|NCT00068081|Capsaicin|capsaicin|mesh-list
44104217|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
44104218|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
43648233|NCT04031833|Amphotericin B|amphotericin b|mesh-list
43648234|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43648235|NCT04031833|Amebicides|amebicides|mesh-ancestor
43648236|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43727772|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104219|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
44104220|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104221|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104232|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44104233|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104234|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104235|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264880|NCT00652041|Growth Substances|growth substances|mesh-ancestor
44264881|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
44264882|NCT00652106|Timolol|timolol|mesh-list
44264883|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44264884|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44264885|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264886|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44264887|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44264888|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264889|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264890|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264891|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264892|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44264893|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264894|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44104236|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
44104237|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104238|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
44104239|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104240|NCT00068315|Rituximab|rituximab|mesh-list
44104241|NCT00068315|Fludarabine|fludarabine|mesh-list
44104242|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
44104243|NCT00068315|Bortezomib|bortezomib|mesh-list
44104244|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104245|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104246|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
44104247|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104248|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104249|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104250|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
44104251|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104252|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104253|NCT00068432|Gemcitabine|gemcitabine|mesh-list
44104254|NCT00068432|Celecoxib|celecoxib|mesh-list
44104255|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104256|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
43559958|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43559959|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559960|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43727791|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
43727792|NCT02581696|Irsogladine|irsogladine|mesh-list
43727793|NCT02581696|Lafutidine|lafutidine|mesh-list
43727794|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727795|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43727796|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104257|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104258|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104259|NCT00068432|Antiviral Agents|antiviral agents|mesh-ancestor
44104260|NCT00068432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104261|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104262|NCT00068432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104263|NCT00068432|Immunologic Factors|immunologic factors|mesh-ancestor
44104264|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104265|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44104266|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104267|NCT00068432|Analgesics|analgesics|mesh-ancestor
44104268|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
44104269|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104270|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104271|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104272|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44104273|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44104274|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
44104275|NCT00068458|Calcium|calcium|mesh-list
44104276|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104277|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104278|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44104279|NCT00068471|Anidulafungin|anidulafungin|mesh-list
44104280|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
44264895|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44264896|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264898|NCT00652119|Bevacizumab|bevacizumab|mesh-list
44264899|NCT00652119|Carboplatin|carboplatin|mesh-list
44264900|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44264901|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264902|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
44264903|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
44264904|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
44264905|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264906|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44264907|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44264908|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44264909|NCT00652119|Growth Substances|growth substances|mesh-ancestor
44264910|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264911|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
44264912|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
44264913|NCT00652132|Cisplatin|cisplatin|mesh-list
44264914|NCT00652132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264915|NCT00652132|Antidotes|antidotes|mesh-ancestor
44264916|NCT00652132|Protective Agents|protective agents|mesh-ancestor
44264917|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264918|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
44264919|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264920|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
43727827|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727828|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
43727829|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727830|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43727831|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
43727832|NCT02581553|Protective Agents|protective agents|mesh-ancestor
43727833|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727834|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
43727835|NCT02581553|Renal Agents|renal agents|mesh-ancestor
43727836|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
44264921|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44264922|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44264923|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
44264924|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
44264925|NCT00652171|Lamotrigine|lamotrigine|mesh-list
44264926|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
43825519|NCT05564286|Hormones|hormones|mesh-ancestor
44104281|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104282|NCT00068484|Bortezomib|bortezomib|mesh-list
44104283|NCT00068484|Topotecan|topotecan|mesh-list
44104284|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104285|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44104286|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104287|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104288|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104291|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44104292|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104293|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264927|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44264928|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44264929|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264930|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44264931|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264932|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44264933|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44264934|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919421|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44264935|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44264936|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44264937|NCT00652184|Valacyclovir|valacyclovir|mesh-list
44264938|NCT00652184|Sorivudine|sorivudine|mesh-list
44264939|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
44264940|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104295|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
44104296|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
44104297|NCT00068523|Fludarabine|fludarabine|mesh-list
44104298|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
44104299|NCT00068523|Cyclosporins|cyclosporins|mesh-list
44104300|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44104301|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104302|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
44104303|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104304|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104305|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104306|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
44104307|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104308|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104309|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104310|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104311|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
44104312|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104313|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
44104314|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104315|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
44104316|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44104317|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104318|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
44104319|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
44104320|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104321|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104322|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
44104323|NCT00068523|Hormones|hormones|mesh-ancestor
44104324|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104325|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44104326|NCT00068523|Protective Agents|protective agents|mesh-ancestor
44104327|NCT00068549|Gemcitabine|gemcitabine|mesh-list
44104328|NCT00068549|Cisplatin|cisplatin|mesh-list
44104329|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104330|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104331|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
43818596|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
44104332|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104333|NCT00068549|Antiviral Agents|antiviral agents|mesh-ancestor
44104334|NCT00068549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104335|NCT00068549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104336|NCT00068549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104337|NCT00068549|Immunologic Factors|immunologic factors|mesh-ancestor
44104338|NCT00068549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264942|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264943|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44264944|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
44264945|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44264946|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44264947|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44264948|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264949|NCT00652262|Urological Agents|urological agents|mesh-ancestor
44264950|NCT00652288|Insulin|insulin|mesh-list
44264951|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44264952|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
44264953|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
44264954|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
44264955|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44264956|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
44264957|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
44264958|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44104339|NCT00068653|Celecoxib|celecoxib|mesh-list
44104340|NCT00068653|Gefitinib|gefitinib|mesh-list
44104341|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44104342|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104343|NCT00068653|Analgesics|analgesics|mesh-ancestor
44104344|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
44104345|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104346|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104347|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104348|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104349|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44104350|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44104351|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104352|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104353|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104354|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44104355|NCT00068666|Temozolomide|temozolomide|mesh-list
44104356|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104357|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
43833633|NCT05200481|Carboplatin|carboplatin|mesh-list
43833634|NCT05200481|Pemetrexed|pemetrexed|mesh-list
43833635|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833636|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833637|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833638|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43833639|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43833640|NCT05200364|Bevacizumab|bevacizumab|mesh-list
43833645|NCT05200364|Growth Substances|growth substances|mesh-ancestor
44104358|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104359|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104360|NCT00068731|Lycopene|lycopene|mesh-list
43630316|NCT03053544|Metformin|metformin|mesh-list
44104365|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104367|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44104368|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104369|NCT00068744|Cisplatin|cisplatin|mesh-list
44104370|NCT00068744|Fluorouracil|fluorouracil|mesh-list
44104371|NCT00068744|Mitomycins|mitomycins|mesh-list
44104372|NCT00068744|Mitomycin|mitomycin|mesh-list
44104373|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104374|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
44104375|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104376|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104377|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104378|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
44104379|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104380|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104381|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
44264959|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264960|NCT00652379|Octreotide|octreotide|mesh-list
44264961|NCT00652379|Lanreotide|lanreotide|mesh-list
44264962|NCT00652379|Somatostatin|somatostatin|mesh-list
44264963|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44264964|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44264965|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44264966|NCT00652379|Hormones|hormones|mesh-ancestor
44264967|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264968|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264969|NCT00652392|Budesonide|budesonide|mesh-list
44264970|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
44264971|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104382|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44104383|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104384|NCT00068757|Paclitaxel|paclitaxel|mesh-list
44104385|NCT00068757|Trastuzumab|trastuzumab|mesh-list
44104386|NCT00068757|Lonafarnib|lonafarnib|mesh-list
44104387|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104388|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104389|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104390|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104391|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104392|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104393|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104394|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104395|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
44104396|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104397|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44104398|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104399|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104400|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44104401|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
44104402|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104403|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
44104404|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
44104405|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44104406|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104407|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44104408|NCT00068861|Metformin|metformin|mesh-list
44104409|NCT00068861|Clomiphene|clomiphene|mesh-list
43727915|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727916|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104410|NCT00068861|Enclomiphene|enclomiphene|mesh-list
44104411|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
44104412|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44104413|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104414|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44104415|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
44104416|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104417|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44104418|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
44104419|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44104420|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44104421|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44104422|NCT00068952|Temozolomide|temozolomide|mesh-list
44104423|NCT00068952|Carmustine|carmustine|mesh-list
44104424|NCT00068952|Lomustine|lomustine|mesh-list
44104425|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104426|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
44104427|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104428|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104429|NCT00069251|Bupropion|bupropion|mesh-list
44104430|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43630390|NCT03052660|Midazolam|midazolam|mesh-list
44264972|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44264973|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
44264974|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44264975|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264976|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44264977|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
44264978|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
44264980|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44264981|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44264982|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44264983|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264984|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264985|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264986|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264987|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44264988|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44264989|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44264990|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44264991|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44104450|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44104451|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44104452|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
44104453|NCT00069459|Bupropion|bupropion|mesh-list
44104454|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44104455|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
44104456|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104457|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44104458|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104459|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104460|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104461|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
44104462|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104463|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727976|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44104464|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44104465|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44104466|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104467|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44104469|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
44104470|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44104471|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104472|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44104473|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104474|NCT00069498|Analgesics|analgesics|mesh-ancestor
44104475|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
44104476|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104477|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104478|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104479|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153333|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
44153334|NCT00220064|Vitamins|vitamins|mesh-ancestor
44153335|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
44264992|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44264993|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44264994|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
44264995|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44264996|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44264997|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44264998|NCT00652496|Bimatoprost|bimatoprost|mesh-list
44264999|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44265000|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44265001|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265002|NCT00652600|Propranolol|propranolol|mesh-list
44265003|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44265004|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44265005|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265006|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265007|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265008|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919497|NCT00549042|Hydromorphone|hydromorphone|mesh-list
44265009|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44265010|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265011|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265013|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
44265014|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
44265015|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
44265016|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265017|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265018|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265019|NCT00652652|Furosemide|furosemide|mesh-list
44265020|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44265021|NCT00652652|Diuretics|diuretics|mesh-ancestor
44265022|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265023|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265024|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44265025|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265027|NCT00652665|Leflunomide|leflunomide|mesh-list
44265030|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265031|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
43728019|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728020|NCT02579590|Progestins|progestins|mesh-ancestor
43728021|NCT02579590|Hormones|hormones|mesh-ancestor
43728022|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728023|NCT02579564|Gemcitabine|gemcitabine|mesh-list
43728024|NCT02579564|Paclitaxel|paclitaxel|mesh-list
43728025|NCT02579564|Vinorelbine|vinorelbine|mesh-list
43728026|NCT02579564|Cisplatin|cisplatin|mesh-list
43728027|NCT02579564|Pemetrexed|pemetrexed|mesh-list
43728028|NCT02579564|Endostar protein|endostar protein|mesh-list
44265032|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265033|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
44265034|NCT00652691|Carboplatin|carboplatin|mesh-list
44265035|NCT00652691|Topotecan|topotecan|mesh-list
44265036|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265037|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
44265038|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265039|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265040|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44265041|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
44265042|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265043|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265044|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44265045|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44265046|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44265047|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265048|NCT00652704|Doxycycline|doxycycline|mesh-list
44265049|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44265050|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265051|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
44265052|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44265053|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44265054|NCT00652730|Buspirone|buspirone|mesh-list
44265055|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44265056|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265057|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265058|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265059|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265060|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44265061|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
44265062|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265073|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44265074|NCT00652808|Naproxen|naproxen|mesh-list
44265075|NCT00652808|Valdecoxib|valdecoxib|mesh-list
44265076|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265077|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265078|NCT00652808|Analgesics|analgesics|mesh-ancestor
44265079|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
44265080|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265081|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265082|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265083|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265084|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
44265086|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265087|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265088|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44265089|NCT00652821|Tramadol|tramadol|mesh-list
44265090|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44265091|NCT00652821|Narcotics|narcotics|mesh-ancestor
44265092|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265093|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265094|NCT00652821|Analgesics|analgesics|mesh-ancestor
44265095|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
44265096|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265097|NCT00652860|Cisplatin|cisplatin|mesh-list
44265098|NCT00652860|Doxorubicin|doxorubicin|mesh-list
44265099|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44265100|NCT00652860|Ifosfamide|ifosfamide|mesh-list
44265101|NCT00652860|Molgramostim|molgramostim|mesh-list
44265102|NCT00652860|Mitomycins|mitomycins|mesh-list
44265103|NCT00652860|Mitomycin|mitomycin|mesh-list
44265104|NCT00652860|Sargramostim|sargramostim|mesh-list
43560026|NCT05331690|Analgesics|analgesics|mesh-ancestor
44265105|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265106|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44265107|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44265108|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44265109|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265110|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153336|NCT00220103|Cisplatin|cisplatin|mesh-list
44153337|NCT00220103|Capecitabine|capecitabine|mesh-list
44153345|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153346|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153347|NCT00220116|Capecitabine|capecitabine|mesh-list
44265111|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44265112|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
44265113|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
44265114|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265115|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44265116|NCT00652873|Cabergoline|cabergoline|mesh-list
44265117|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44265118|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44265119|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
44265120|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
44265121|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265122|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265123|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265124|NCT00652886|Oxandrolone|oxandrolone|mesh-list
44265125|NCT00652886|Androgens|androgens|mesh-ancestor
44265126|NCT00652886|Hormones|hormones|mesh-ancestor
44265127|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265128|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265129|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
44265130|NCT00652912|Clonazepam|clonazepam|mesh-list
44265131|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
44265132|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
44265133|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
43658714|NCT02943655|Progestins|progestins|mesh-ancestor
44153348|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
44153349|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153350|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
44153351|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153352|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153353|NCT00220129|Cisplatin|cisplatin|mesh-list
44153354|NCT00220129|Capecitabine|capecitabine|mesh-list
44153355|NCT00220129|Epirubicin|epirubicin|mesh-list
44153356|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153357|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153358|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
44153359|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104480|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
44104481|NCT00069550|Donepezil|donepezil|mesh-list
44104482|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44104483|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104484|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104485|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
44104486|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104487|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104488|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
44104489|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
44104490|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44104491|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44104492|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44104493|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44104494|NCT00069706|Latanoprost|latanoprost|mesh-list
44104495|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44104496|NCT00069836|Metformin|metformin|mesh-list
44265134|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560057|NCT05309928|Renal Agents|renal agents|mesh-ancestor
43560058|NCT05292339|Triamcinolone|triamcinolone|mesh-list
43560059|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43560070|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
44265135|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265136|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462293|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462294|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462295|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
44462296|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462297|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462298|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462299|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
44462300|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462301|NCT01532648|Budesonide|budesonide|mesh-list
44462302|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462303|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462304|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
44462305|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462306|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658730|NCT02943317|Avelumab|avelumab|mesh-list
44104497|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
44104498|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44104499|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104500|NCT00069875|Gemcitabine|gemcitabine|mesh-list
44104501|NCT00069875|Cisplatin|cisplatin|mesh-list
44104502|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104503|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104504|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
44104505|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104506|NCT00069875|Antiviral Agents|antiviral agents|mesh-ancestor
44104507|NCT00069875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104508|NCT00069875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104509|NCT00069875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104510|NCT00069875|Immunologic Factors|immunologic factors|mesh-ancestor
44104511|NCT00069875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104513|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104514|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104515|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104516|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104517|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104518|NCT00069901|Paclitaxel|paclitaxel|mesh-list
44104519|NCT00069901|Carboplatin|carboplatin|mesh-list
44104520|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44104521|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104522|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104523|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104524|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104525|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728056|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728057|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
43728058|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728059|NCT02579733|Azathioprine|azathioprine|mesh-list
43728060|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
43728061|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728062|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728063|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728064|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728065|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
43728066|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728067|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104526|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104527|NCT00069927|Methylphenidate|methylphenidate|mesh-list
44104537|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
44104538|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104539|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
44104540|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
44104541|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104542|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
44104543|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44104544|NCT00069940|Sargramostim|sargramostim|mesh-list
44104545|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
44462307|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462308|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462309|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
44462310|NCT01532648|Hormones|hormones|mesh-ancestor
44462311|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462312|NCT01532414|Enclomiphene|enclomiphene|mesh-list
44462313|NCT01532414|Clomiphene|clomiphene|mesh-list
44462314|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
44462315|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44462316|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265137|NCT00652925|Celecoxib|celecoxib|mesh-list
44265138|NCT00652925|Naproxen|naproxen|mesh-list
44265139|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265140|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265141|NCT00652925|Analgesics|analgesics|mesh-ancestor
44265142|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
44265143|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265144|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265145|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265146|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265147|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44265148|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44265149|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265150|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265151|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
44265152|NCT00653003|Leflunomide|leflunomide|mesh-list
44265153|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265154|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265155|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658738|NCT02943356|Tadalafil|tadalafil|mesh-list
44104546|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104547|NCT00069966|Cytarabine|cytarabine|mesh-list
44104548|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
44104549|NCT00069966|Rituximab|rituximab|mesh-list
44104550|NCT00069966|Pixantrone|pixantrone|mesh-list
44104551|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104552|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648237|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43648238|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833659|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43833660|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833661|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833662|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833663|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104553|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
44104554|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104555|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818744|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
44104556|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104557|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
44104558|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104559|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
44104560|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104561|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265156|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
44265157|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265158|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44265159|NCT00653016|Norelgestromin|norelgestromin|mesh-list
44265160|NCT00653016|Estradiol|estradiol|mesh-list
44265161|NCT00653016|Estrogens|estrogens|mesh-ancestor
44265162|NCT00653016|Hormones|hormones|mesh-ancestor
44265163|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265164|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265165|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44265166|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
44265167|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44265168|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43658745|NCT02943252|Apatinib|apatinib|mesh-list
44104562|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104563|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
44104564|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
44104565|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104566|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44104567|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
44104568|NCT00069966|Hormones|hormones|mesh-ancestor
44104569|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104570|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44104571|NCT00069966|Protective Agents|protective agents|mesh-ancestor
44104572|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104573|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104574|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104575|NCT00069992|Fludarabine|fludarabine|mesh-list
44104576|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
44104577|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104578|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104580|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44104581|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104582|NCT00070057|Analgesics|analgesics|mesh-ancestor
44104583|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
44104584|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104585|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104586|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104587|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43728106|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43728107|NCT02579161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43728108|NCT02579161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43728109|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43728110|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728111|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728112|NCT02579161|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43728113|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44104588|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44104589|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44104590|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104591|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104592|NCT00070083|Prednisone|prednisone|mesh-list
43630556|NCT03051373|Paclitaxel|paclitaxel|mesh-list
44104602|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104603|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104604|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
44104605|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104606|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104607|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104608|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104609|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104610|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104611|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104612|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104613|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104614|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
44104615|NCT00070083|Hormones|hormones|mesh-ancestor
44104616|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104617|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265169|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44265170|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44265171|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44265172|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265173|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265174|NCT00653055|Cabergoline|cabergoline|mesh-list
44265175|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44265176|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44265177|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
44265178|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
44265179|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265180|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265181|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265182|NCT00653120|Propranolol|propranolol|mesh-list
44265183|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44265184|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44265185|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265186|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265187|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265188|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658756|NCT02943135|Lidocaine|lidocaine|mesh-list
44104618|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104619|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104620|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104621|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104622|NCT00070122|Leucovorin|leucovorin|mesh-list
44104623|NCT00070122|Bevacizumab|bevacizumab|mesh-list
44104624|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44104625|NCT00070122|Fluorouracil|fluorouracil|mesh-list
44104626|NCT00070122|Capecitabine|capecitabine|mesh-list
44104627|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
44104628|NCT00070122|Antibodies|antibodies|mesh-list
44104629|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
44104630|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44104631|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
44104632|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104633|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44104634|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44104635|NCT00070122|Growth Substances|growth substances|mesh-ancestor
44104636|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104637|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
44104638|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
44104639|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
44104640|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104641|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104642|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104643|NCT00070122|Antidotes|antidotes|mesh-ancestor
44104644|NCT00070122|Protective Agents|protective agents|mesh-ancestor
44104645|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
44104646|NCT00070122|Vitamins|vitamins|mesh-ancestor
44104647|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
44104648|NCT00070148|Megestrol|megestrol|mesh-list
44104649|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
44104650|NCT00070148|Oxandrolone|oxandrolone|mesh-list
44104651|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44265189|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44265190|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265191|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265192|NCT00653172|Streptogramin A|streptogramin a|mesh-list
44265193|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44265194|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265195|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
44265196|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44265197|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265198|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
44265199|NCT00653250|Celecoxib|celecoxib|mesh-list
44265200|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265201|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265202|NCT00653250|Analgesics|analgesics|mesh-ancestor
44265203|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
44265204|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728174|NCT02578251|Acetaminophen|acetaminophen|mesh-list
43728175|NCT02578251|Meperidine|meperidine|mesh-list
43728176|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43728177|NCT02578251|Analgesics|analgesics|mesh-ancestor
43728178|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
43728179|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728186|NCT02578277|BMS-955176|bms-955176|mesh-list
44265205|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265206|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265207|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265208|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44265209|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44265210|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265211|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265212|NCT00653302|Metformin|metformin|mesh-list
44265213|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
44265214|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265215|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265216|NCT00653315|Tramadol|tramadol|mesh-list
44265217|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44265218|NCT00653315|Narcotics|narcotics|mesh-ancestor
44104652|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44104653|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44104654|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
44104655|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44104656|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104657|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44104658|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44104659|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44104660|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104661|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
44104676|NCT00070174|Cyclosporine|cyclosporine|mesh-list
44104677|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
44104678|NCT00070174|Busulfan|busulfan|mesh-list
44104679|NCT00070174|Methotrexate|methotrexate|mesh-list
44104680|NCT00070174|Etoposide|etoposide|mesh-list
44104681|NCT00070174|Daunorubicin|daunorubicin|mesh-list
44104682|NCT00070174|Asparaginase|asparaginase|mesh-list
44104683|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
44265219|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265220|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265221|NCT00653315|Analgesics|analgesics|mesh-ancestor
44265222|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
44265223|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265224|NCT00653341|Insulin|insulin|mesh-list
44265225|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44265226|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
44265227|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
44265228|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
44265229|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
44265230|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265231|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265232|NCT00653354|Valdecoxib|valdecoxib|mesh-list
44265233|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44265234|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44265235|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265236|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265237|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265238|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265239|NCT00653354|Analgesics|analgesics|mesh-ancestor
44265240|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
43658799|NCT02942693|Apatinib|apatinib|mesh-list
44104684|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
44104685|NCT00070174|Cyclosporins|cyclosporins|mesh-list
43728207|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
44104686|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104687|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
44104688|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104689|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104690|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104691|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
44104692|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104693|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104694|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104695|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44104696|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
44104697|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44104698|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104699|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
44104700|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
44104701|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104702|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44104703|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44104704|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104705|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104706|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104707|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
43818832|NCT05539521|Propofol|propofol|mesh-list
44104708|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104709|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
44104710|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44104711|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104712|NCT00070174|Analgesics|analgesics|mesh-ancestor
44265241|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265242|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265243|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265244|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265245|NCT00653380|Doxycycline|doxycycline|mesh-list
44265246|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44265247|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265248|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
44265249|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44265250|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44265251|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
44265252|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
44265253|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265254|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44265255|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265256|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265257|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44265258|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44104713|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
44104714|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104715|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104716|NCT00070187|Interferons|interferons|mesh-list
44104717|NCT00070187|Cytarabine|cytarabine|mesh-list
44104718|NCT00070187|Aldesleukin|aldesleukin|mesh-list
43560184|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104719|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
43560185|NCT05139017|Antiviral Agents|antiviral agents|mesh-ancestor
43560186|NCT05139017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560187|NCT05139017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560188|NCT05139017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560189|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43560190|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
43560191|NCT05127044|Bilirubin|bilirubin|mesh-list
43560192|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
44104720|NCT00070187|Cyclosporine|cyclosporine|mesh-list
44104721|NCT00070187|Etoposide|etoposide|mesh-list
44104722|NCT00070187|Melphalan|melphalan|mesh-list
44104723|NCT00070187|Interleukin-2|interleukin-2|mesh-list
44104724|NCT00070187|Carmustine|carmustine|mesh-list
44104725|NCT00070187|Cyclosporins|cyclosporins|mesh-list
44104735|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104736|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
44104737|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104738|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
44104739|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104740|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44104741|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
44104742|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
44104743|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104744|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44104745|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104746|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
44104747|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104748|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104749|NCT00070187|Analgesics|analgesics|mesh-ancestor
44104750|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
44104751|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104752|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44104753|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44104754|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
44104755|NCT00070200|Melphalan|melphalan|mesh-list
44104756|NCT00070200|Cisplatin|cisplatin|mesh-list
44104757|NCT00070200|Doxorubicin|doxorubicin|mesh-list
44104758|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44104759|NCT00070200|Etoposide|etoposide|mesh-list
44104760|NCT00070200|Vincristine|vincristine|mesh-list
44104761|NCT00070200|Topotecan|topotecan|mesh-list
44104762|NCT00070200|Isotretinoin|isotretinoin|mesh-list
44104763|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265259|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265260|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265261|NCT00653406|Risperidone|risperidone|mesh-list
44265262|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44265263|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
44265264|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265265|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265266|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265267|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44265268|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265269|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265270|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265271|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44265272|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
44265273|NCT00653419|Buspirone|buspirone|mesh-list
44265274|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44104764|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
44104765|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104766|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104767|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104768|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
44104769|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104770|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104771|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104772|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43728249|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728250|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728251|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728252|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
43728253|NCT02578121|Hormones|hormones|mesh-ancestor
43728256|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104773|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104774|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104775|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104776|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104777|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104778|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104779|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104780|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44104781|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
44104782|NCT00070213|Leucovorin|leucovorin|mesh-list
44104783|NCT00070213|Fluorouracil|fluorouracil|mesh-list
44104784|NCT00070213|Capecitabine|capecitabine|mesh-list
44104785|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
44104786|NCT00070213|Calcium|calcium|mesh-list
44104787|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
44104788|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104789|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104790|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
44104791|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104792|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43630744|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
44104803|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44104804|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104805|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104806|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104807|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44104808|NCT00070239|Growth Substances|growth substances|mesh-ancestor
44104809|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44104810|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104811|NCT00070252|Docetaxel|docetaxel|mesh-list
44104812|NCT00070252|Capecitabine|capecitabine|mesh-list
44104813|NCT00070252|Tipifarnib|tipifarnib|mesh-list
44104814|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104815|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
44265275|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265276|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265277|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265278|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265279|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44265280|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
44265281|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265282|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265283|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265284|NCT00653445|Ezetimibe|ezetimibe|mesh-list
44265285|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265286|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265287|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
44265288|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265289|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265290|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265291|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265292|NCT00653458|Ondansetron|ondansetron|mesh-list
44265293|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
44265294|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
43658833|NCT02942420|Bucillamine|bucillamine|mesh-list
44104816|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104817|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104818|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104819|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104820|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
44104821|NCT00070265|Capecitabine|capecitabine|mesh-list
44104822|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
44104823|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104824|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
43728308|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
44104825|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104826|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104827|NCT00070278|Gemcitabine|gemcitabine|mesh-list
44104828|NCT00070278|Paclitaxel|paclitaxel|mesh-list
44104829|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
44104830|NCT00070278|Epirubicin|epirubicin|mesh-list
44104831|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104832|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104833|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104834|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104835|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104836|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104837|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104838|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
44104839|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104840|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104841|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104842|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
44104843|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104844|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104845|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
44104846|NCT00070278|Antiviral Agents|antiviral agents|mesh-ancestor
44104847|NCT00070278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104848|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841453|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
44265295|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265296|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265297|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265298|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
44265299|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44265300|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44265301|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
44265302|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265303|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265304|NCT00653458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44265305|NCT00653458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265306|NCT00653458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658845|NCT02942706|Cetuximab|cetuximab|mesh-list
44104849|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104850|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104851|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104852|NCT00070304|Gemcitabine|gemcitabine|mesh-list
44104853|NCT00070304|Vinorelbine|vinorelbine|mesh-list
44104854|NCT00070304|Lenograstim|lenograstim|mesh-list
44104855|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104856|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
44104857|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104858|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104859|NCT00070304|Antiviral Agents|antiviral agents|mesh-ancestor
44104860|NCT00070304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104861|NCT00070304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104873|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
44104874|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104875|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104877|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
44104878|NCT00070382|Hematinics|hematinics|mesh-ancestor
44104879|NCT00070434|Leucovorin|leucovorin|mesh-list
44104880|NCT00070434|Pyridoxine|pyridoxine|mesh-list
44104881|NCT00070434|Fluorouracil|fluorouracil|mesh-list
44104882|NCT00070434|Capecitabine|capecitabine|mesh-list
44104883|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
44104884|NCT00070434|Irinotecan|irinotecan|mesh-list
44104885|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
44104886|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104887|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
44104888|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104889|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104890|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728381|NCT02577432|Narcotics|narcotics|mesh-ancestor
44104891|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104892|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
44104893|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44104894|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104895|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104896|NCT00070434|Antidotes|antidotes|mesh-ancestor
44104897|NCT00070434|Protective Agents|protective agents|mesh-ancestor
44104898|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
44104899|NCT00070434|Vitamins|vitamins|mesh-ancestor
44104900|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
44104901|NCT00070447|Prednisone|prednisone|mesh-list
44104902|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
44104903|NCT00070447|Rituximab|rituximab|mesh-list
44104904|NCT00070447|Doxorubicin|doxorubicin|mesh-list
44104905|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44104906|NCT00070447|Vincristine|vincristine|mesh-list
44104907|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104908|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
44104909|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104910|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104911|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104912|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
44265308|NCT00653458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44265309|NCT00653510|Insulin|insulin|mesh-list
44265310|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44265311|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265312|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265313|NCT00653549|Torsemide|torsemide|mesh-list
44265314|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265315|NCT00653549|Diuretics|diuretics|mesh-ancestor
44265316|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265317|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265318|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44265319|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265320|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104913|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104914|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104915|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44104916|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44104917|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44104918|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104919|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104920|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104921|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104922|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
44104923|NCT00070447|Hormones|hormones|mesh-ancestor
44104924|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104925|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44104926|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104927|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104932|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104933|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104934|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44104935|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44104936|NCT00070486|Gemcitabine|gemcitabine|mesh-list
44104937|NCT00070486|Celecoxib|celecoxib|mesh-list
44104938|NCT00070486|Zileuton|zileuton|mesh-list
44104939|NCT00070486|Carboplatin|carboplatin|mesh-list
44104940|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104941|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104942|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
44104943|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648243|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
43833711|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833712|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833713|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43833714|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43833716|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
44104944|NCT00070486|Antiviral Agents|antiviral agents|mesh-ancestor
44104945|NCT00070486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104946|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104947|NCT00070486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104948|NCT00070486|Immunologic Factors|immunologic factors|mesh-ancestor
44104949|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104950|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44104951|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44104952|NCT00070486|Analgesics|analgesics|mesh-ancestor
44104953|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
44104954|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104955|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104956|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44104957|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44104958|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44104959|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44104960|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44104961|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265321|NCT00653562|Zolpidem|zolpidem|mesh-list
44265322|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44265323|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44265324|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265325|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265326|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44265327|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
44265328|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
44265329|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265330|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265331|NCT00653588|Atorvastatin|atorvastatin|mesh-list
44265332|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265333|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265334|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265335|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
44265336|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265337|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265338|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265339|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265340|NCT00653614|Drospirenone|drospirenone|mesh-list
44265341|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44265342|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265343|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265344|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265345|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44265346|NCT00653614|Diuretics|diuretics|mesh-ancestor
44265347|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265348|NCT00653744|Atorvastatin|atorvastatin|mesh-list
44265349|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265350|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265351|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44104962|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104964|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104965|NCT00070538|Cytarabine|cytarabine|mesh-list
44104966|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104967|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
44104968|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104969|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104970|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
44104971|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104972|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104973|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
44265352|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
44265353|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265354|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265355|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265356|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265357|NCT00653757|Leuprolide|leuprolide|mesh-list
44265358|NCT00653757|Goserelin|goserelin|mesh-list
44265359|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44265360|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
44265361|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44265362|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265363|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265365|NCT00653822|Alefacept|alefacept|mesh-list
44265366|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
44265367|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
44265368|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265369|NCT00653848|Docetaxel|docetaxel|mesh-list
44104974|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104975|NCT00070551|Cytarabine|cytarabine|mesh-list
44104976|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44104977|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
44104978|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104979|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104980|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
44104981|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104982|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104983|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
44104984|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104985|NCT00070629|Paclitaxel|paclitaxel|mesh-list
44104986|NCT00070629|Docetaxel|docetaxel|mesh-list
44104987|NCT00070629|Cisplatin|cisplatin|mesh-list
44104988|NCT00070629|Carboplatin|carboplatin|mesh-list
44104989|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104990|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104991|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104992|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104993|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104994|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104995|NCT00070642|Dacarbazine|dacarbazine|mesh-list
44104996|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104997|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
44104998|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104999|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105000|NCT00070655|Vitamin K|vitamin k|mesh-list
44105039|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105041|NCT00071084|Zanolimumab|zanolimumab|mesh-list
43631011|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
44105047|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
44105048|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105049|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105050|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44105051|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44105052|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
44105053|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105054|NCT00071136|Gemcitabine|gemcitabine|mesh-list
44105056|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105057|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
44105058|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265370|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265371|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
44265372|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
44265373|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
44265374|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265375|NCT00653874|Bilirubin|bilirubin|mesh-list
44265376|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
44265377|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265378|NCT00653874|Protective Agents|protective agents|mesh-ancestor
44265379|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265380|NCT00653926|Epinephrine|epinephrine|mesh-list
44265381|NCT00653926|Ropivacaine|ropivacaine|mesh-list
44105059|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105060|NCT00071136|Antiviral Agents|antiviral agents|mesh-ancestor
44105061|NCT00071136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105062|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105063|NCT00071136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105064|NCT00071136|Immunologic Factors|immunologic factors|mesh-ancestor
44105065|NCT00071136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105066|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44105067|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44105068|NCT00071188|Paclitaxel|paclitaxel|mesh-list
44105069|NCT00071188|Carboplatin|carboplatin|mesh-list
44105070|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105071|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105072|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105073|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105074|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105075|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105076|NCT00071201|Adefovir|adefovir|mesh-list
44105077|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44105078|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
44105079|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105080|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44105081|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44105082|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105083|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105084|NCT00071227|Triamcinolone|triamcinolone|mesh-list
44105085|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44105086|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44105087|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44105088|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105089|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
44105090|NCT00071227|Hormones|hormones|mesh-ancestor
44105091|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105092|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105093|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105094|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
44105095|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105096|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105098|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105099|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105100|NCT00071253|Valproic Acid|valproic acid|mesh-list
44105101|NCT00071253|Olanzapine|olanzapine|mesh-list
44105102|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
44105103|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
44105104|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105105|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105106|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105107|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44105108|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44105109|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105110|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265382|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
44265383|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
44265384|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265385|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265386|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
44265387|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265388|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44265389|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44265390|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265391|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265392|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265393|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44265394|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44105111|NCT00071253|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105115|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105116|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
44105117|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
44105118|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728571|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44105119|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
44105120|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
44105123|NCT00071266|L 647318|l 647318|mesh-list
44105124|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
44105125|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44105126|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
44105127|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105128|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44105129|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
44105130|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
44105131|NCT00071266|Vitamins|vitamins|mesh-ancestor
44105132|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
44105133|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105134|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44105135|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44105136|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105137|NCT00071279|Idraparinux|idraparinux|mesh-list
44105138|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44105139|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
44105140|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44105141|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
44105142|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105143|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105144|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
44153360|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44153361|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44153362|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153363|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153364|NCT00220155|Gemcitabine|gemcitabine|mesh-list
44153365|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153366|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
44153367|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153368|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153369|NCT00220155|Antiviral Agents|antiviral agents|mesh-ancestor
44153370|NCT00220155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153371|NCT00220155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153372|NCT00220155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153373|NCT00220155|Immunologic Factors|immunologic factors|mesh-ancestor
44153374|NCT00220155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153375|NCT00220168|Capecitabine|capecitabine|mesh-list
44153376|NCT00220168|Irinotecan|irinotecan|mesh-list
44153377|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153378|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
43700523|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265395|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
44265396|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44265397|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
44265398|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
44265399|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
44265400|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44265401|NCT00653952|Paclitaxel|paclitaxel|mesh-list
44265402|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44265403|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265404|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728645|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
44265405|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
44265406|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
44265407|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265408|NCT00653965|Atorvastatin|atorvastatin|mesh-list
44265409|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265410|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265411|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265412|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
44265413|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265414|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43825542|NCT05563571|Prednisolone|prednisolone|mesh-list
44153379|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153380|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153381|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44153382|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153383|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153384|NCT00220194|Leuprolide|leuprolide|mesh-list
44153385|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44153386|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
44105145|NCT00071331|Tolvaptan|tolvaptan|mesh-list
44105146|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44105147|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105148|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
44105149|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105150|NCT00071448|Insulin|insulin|mesh-list
44105151|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44105152|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
44105153|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
44105154|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44105155|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105156|NCT00071539|Immunotoxins|immunotoxins|mesh-list
44105157|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
43631118|NCT03045783|Cefotiam|cefotiam|mesh-list
44105164|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105165|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
44105166|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105167|NCT00071643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105168|NCT00071643|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105169|NCT00071643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105170|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44105171|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44105172|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44105173|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105174|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265415|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265416|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265417|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
44265418|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265419|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265420|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265421|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265422|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265423|NCT00654017|Urological Agents|urological agents|mesh-ancestor
44265424|NCT00654043|Torsemide|torsemide|mesh-list
44265425|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265426|NCT00654043|Diuretics|diuretics|mesh-ancestor
44265427|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
44265428|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728700|NCT02575768|Adenosine|adenosine|mesh-list
44265429|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44265430|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265431|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265432|NCT00654056|Insulin|insulin|mesh-list
44265433|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44265434|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265435|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265436|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
44265437|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265438|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265439|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265440|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265441|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265442|NCT00654082|Urological Agents|urological agents|mesh-ancestor
44265443|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
44265444|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
44265445|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44265446|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105175|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105176|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105177|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105178|NCT00071695|Analgesics|analgesics|mesh-ancestor
44105179|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
44105180|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105181|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105182|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105183|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
44265447|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44265448|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44265450|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265451|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265452|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44265453|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44265454|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
44265455|NCT00654108|Protective Agents|protective agents|mesh-ancestor
44265456|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265457|NCT00654108|Vitamins|vitamins|mesh-ancestor
44265458|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
44265459|NCT00654121|Insulin|insulin|mesh-list
44265460|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44265461|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44105184|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105185|NCT00071747|Lamotrigine|lamotrigine|mesh-list
44105186|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
44105187|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44105188|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105189|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105190|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44105191|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105192|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44105193|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44105194|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105195|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105196|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44105197|NCT00071838|Daclizumab|daclizumab|mesh-list
44105198|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105199|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
44105200|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105201|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
44105202|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105203|NCT00071942|Metronidazole|metronidazole|mesh-list
44105204|NCT00071942|Vaccines|vaccines|mesh-list
44105205|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
44105206|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105207|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105208|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44105209|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44105210|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44105211|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
44105212|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44105213|NCT00071955|Antibodies|antibodies|mesh-list
44105214|NCT00071955|Sargramostim|sargramostim|mesh-list
44105215|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44105216|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
44105217|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845714|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
44105219|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44105220|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105221|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44105222|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105223|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
44105224|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105232|NCT00072007|Prednisone|prednisone|mesh-list
44105233|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
44105234|NCT00072007|Rituximab|rituximab|mesh-list
44105235|NCT00072007|Doxorubicin|doxorubicin|mesh-list
44105236|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44105237|NCT00072007|Vincristine|vincristine|mesh-list
44265462|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265463|NCT00654160|Leucovorin|leucovorin|mesh-list
44265464|NCT00654160|Fluorouracil|fluorouracil|mesh-list
44265465|NCT00654160|Irinotecan|irinotecan|mesh-list
44265466|NCT00654160|Calcium|calcium|mesh-list
44265467|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
44265468|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44265469|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265470|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
44265471|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265472|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44265473|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265474|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265475|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
44265476|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44265477|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44265478|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265479|NCT00654160|Antidotes|antidotes|mesh-ancestor
44265480|NCT00654160|Protective Agents|protective agents|mesh-ancestor
44265481|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
44265482|NCT00654160|Vitamins|vitamins|mesh-ancestor
44105238|NCT00072007|Cladribine|cladribine|mesh-list
44105239|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105240|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
44105241|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105242|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105243|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105244|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
44105245|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105246|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105247|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44105248|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105249|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44105250|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105251|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105252|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105253|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105254|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
44105255|NCT00072007|Hormones|hormones|mesh-ancestor
44105256|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105257|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105258|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105259|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105260|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105261|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105262|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
44105263|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44105264|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105265|NCT00072033|Cisplatin|cisplatin|mesh-list
44105266|NCT00072033|Docetaxel|docetaxel|mesh-list
44105267|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105268|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105269|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105270|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105271|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265485|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265486|NCT00654173|Simvastatin|simvastatin|mesh-list
44265487|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265488|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265489|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
44265490|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265491|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265492|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265493|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265494|NCT00654225|Atorvastatin|atorvastatin|mesh-list
44265495|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265496|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265497|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265498|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
44265499|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265500|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265501|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265502|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265503|NCT00654277|Ondansetron|ondansetron|mesh-list
44265504|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
44265505|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
44265506|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265507|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265508|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265509|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
44105272|NCT00072046|Interferons|interferons|mesh-list
44105273|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
44105274|NCT00072046|Bevacizumab|bevacizumab|mesh-list
44105275|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105276|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105277|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648244|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648245|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648246|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
43648247|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43560285|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560286|NCT04981678|Buprenorphine|buprenorphine|mesh-list
43560287|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43560288|NCT04981678|Narcotics|narcotics|mesh-ancestor
43560289|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833739|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105278|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44105279|NCT00072046|Growth Substances|growth substances|mesh-ancestor
44105280|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105281|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105282|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
44105283|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105284|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
44105285|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
44105286|NCT00072059|Hematinics|hematinics|mesh-ancestor
44105287|NCT00072072|Celecoxib|celecoxib|mesh-list
44105288|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44105289|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105290|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105291|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105292|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265510|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
44265511|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44265513|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265514|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265515|NCT00654277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44265516|NCT00654277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265517|NCT00654277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265518|NCT00654277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265519|NCT00654277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44265520|NCT00654290|Propranolol|propranolol|mesh-list
44265521|NCT00654290|Amiodarone|amiodarone|mesh-list
44265522|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44265523|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44265524|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265525|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265526|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265527|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265528|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44265529|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265530|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265531|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44265532|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265533|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44265534|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44265535|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43648248|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648249|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648251|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43648252|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43833754|NCT05189977|Propranolol|propranolol|mesh-list
44265536|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265537|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43631260|NCT03045133|Analgesics|analgesics|mesh-ancestor
44105315|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
43548311|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
44105316|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105318|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44105319|NCT00072098|Growth Substances|growth substances|mesh-ancestor
44105320|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105321|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105322|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44105323|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105324|NCT00072124|Cisplatin|cisplatin|mesh-list
44105325|NCT00072124|Dacarbazine|dacarbazine|mesh-list
44105326|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105327|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105328|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
44105329|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105330|NCT00072137|Metronidazole|metronidazole|mesh-list
44105331|NCT00072137|Molgramostim|molgramostim|mesh-list
44105332|NCT00072137|Vaccines|vaccines|mesh-list
44105333|NCT00072137|Sargramostim|sargramostim|mesh-list
44265538|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44265539|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44265541|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265542|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265543|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
44265544|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265545|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265546|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265547|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265548|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265549|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265550|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265551|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
44265552|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265553|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265554|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265555|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265556|NCT00654407|Atorvastatin|atorvastatin|mesh-list
44265557|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265558|NCT00654407|Simvastatin|simvastatin|mesh-list
44265559|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265560|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265561|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
44265562|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265563|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265564|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265583|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265585|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265586|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
44265587|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265588|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265589|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265590|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265591|NCT00654524|Vitamin D|vitamin d|mesh-list
44265592|NCT00654524|Goserelin|goserelin|mesh-list
44265593|NCT00654524|Hormones|hormones|mesh-list
44265594|NCT00654524|Vitamins|vitamins|mesh-ancestor
44265595|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
44265596|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265597|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44265598|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265599|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265600|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105334|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
44105335|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105336|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105337|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105338|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44105339|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44105340|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44105341|NCT00072150|Bortezomib|bortezomib|mesh-list
44105342|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105343|NCT00072163|Thalidomide|thalidomide|mesh-list
44105344|NCT00072163|Temozolomide|temozolomide|mesh-list
44105345|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105346|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
43631328|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
44105382|NCT00072228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105383|NCT00072267|Topotecan|topotecan|mesh-list
44105384|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44105385|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44105386|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105387|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105388|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105397|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105398|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105399|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105400|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105401|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
44105402|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105403|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105404|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105405|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
44105406|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44105407|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44105408|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105409|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105410|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105411|NCT00072332|Cisplatin|cisplatin|mesh-list
44105412|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105413|NCT00072345|Thalidomide|thalidomide|mesh-list
44105414|NCT00072345|Temozolomide|temozolomide|mesh-list
44105415|NCT00072345|Lomustine|lomustine|mesh-list
44105416|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44265602|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265603|NCT00654537|Simvastatin|simvastatin|mesh-list
44265604|NCT00654537|Pravastatin|pravastatin|mesh-list
44265605|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265606|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265607|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
44265608|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265609|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265610|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265611|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265612|NCT00654576|Olanzapine|olanzapine|mesh-list
44265613|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
44265614|NCT00654576|Risperidone|risperidone|mesh-list
44265615|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44265616|NCT00654576|Clozapine|clozapine|mesh-list
44265617|NCT00654576|Sulpiride|sulpiride|mesh-list
44265618|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44265619|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
44265620|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265621|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265622|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265623|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44265624|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265625|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105417|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
44105418|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105419|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105420|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105421|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
44105422|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105423|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
44105424|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44105425|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105426|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44105427|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44105428|NCT00072345|Growth Substances|growth substances|mesh-ancestor
44105429|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105430|NCT00072436|Gemcitabine|gemcitabine|mesh-list
44105431|NCT00072436|Alvocidib|alvocidib|mesh-list
44105432|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105433|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
44105434|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105435|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105436|NCT00072436|Antiviral Agents|antiviral agents|mesh-ancestor
44105437|NCT00072436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105438|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105439|NCT00072436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105440|NCT00072436|Immunologic Factors|immunologic factors|mesh-ancestor
44105441|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105442|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105443|NCT00072436|Growth Substances|growth substances|mesh-ancestor
44265626|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265627|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44265628|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
44265630|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
44265631|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265632|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265633|NCT00654576|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44265634|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44265635|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265636|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
44265637|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
44265638|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
44265639|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44265640|NCT00654589|Deferasirox|deferasirox|mesh-list
44265641|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44265642|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
44265643|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
44265644|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265645|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44265646|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265647|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265648|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
44265649|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265650|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265651|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44265652|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265653|NCT00654667|Resveratrol|resveratrol|mesh-list
44265654|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
44265655|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265656|NCT00654667|Protective Agents|protective agents|mesh-ancestor
44265657|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265658|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265659|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44265660|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44265664|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265665|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265666|NCT00654680|Urological Agents|urological agents|mesh-ancestor
44265668|NCT00654758|Carboplatin|carboplatin|mesh-list
44265669|NCT00654758|Volociximab|volociximab|mesh-list
44265670|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44265671|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44265672|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265673|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
44265674|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
44265675|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
44265676|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265677|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44265678|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44265679|NCT00654758|Growth Substances|growth substances|mesh-ancestor
44265680|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265681|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
44265682|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
44462317|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462318|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105444|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105445|NCT00072462|Tamoxifen|tamoxifen|mesh-list
44105446|NCT00072462|Anastrozole|anastrozole|mesh-list
44105447|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105449|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
44105450|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105451|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105452|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105453|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105454|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44105455|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44105456|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44105459|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105460|NCT00072527|Cisplatin|cisplatin|mesh-list
44105461|NCT00072527|Carboplatin|carboplatin|mesh-list
44105462|NCT00072527|Irinotecan|irinotecan|mesh-list
44105463|NCT00072527|Etoposide|etoposide|mesh-list
44105464|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105465|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44105466|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105467|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105468|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105469|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105470|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105471|NCT00072540|Celecoxib|celecoxib|mesh-list
44105472|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44105473|NCT00072540|Mitogens|mitogens|mesh-list
44105474|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43728948|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
43728949|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43728950|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728951|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728952|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
43728953|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728954|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728955|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728956|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43728968|NCT02574663|Antidotes|antidotes|mesh-ancestor
44105475|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44105476|NCT00072540|Analgesics|analgesics|mesh-ancestor
44105477|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
44462320|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
44462321|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44462322|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44462323|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44462324|NCT01531998|Dexamethasone|dexamethasone|mesh-list
44462325|NCT01531998|Lenalidomide|lenalidomide|mesh-list
44462326|NCT01531998|Bortezomib|bortezomib|mesh-list
44462327|NCT01531998|Siltuximab|siltuximab|mesh-list
44105478|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105479|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105480|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105481|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105482|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44105483|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44105484|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105485|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105486|NCT00072553|Leucovorin|leucovorin|mesh-list
44105487|NCT00072553|Celecoxib|celecoxib|mesh-list
44105488|NCT00072553|Fluorouracil|fluorouracil|mesh-list
44105489|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
44105490|NCT00072553|Calcium|calcium|mesh-list
44105491|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
44105492|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44105493|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105494|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
44105495|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105496|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105497|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105498|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105499|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
44105500|NCT00072553|Antidotes|antidotes|mesh-ancestor
44105501|NCT00072553|Protective Agents|protective agents|mesh-ancestor
44105502|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
44105503|NCT00072553|Vitamins|vitamins|mesh-ancestor
44105504|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
44105505|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44105506|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44105507|NCT00072553|Analgesics|analgesics|mesh-ancestor
44105508|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
44105509|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105510|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105511|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105512|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44105513|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44105514|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105515|NCT00072579|Sargramostim|sargramostim|mesh-list
44105516|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
44105517|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105518|NCT00072592|Rituximab|rituximab|mesh-list
44105519|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105520|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105521|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
44105522|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105523|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105524|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
44105525|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105526|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44105527|NCT00072618|Protective Agents|protective agents|mesh-ancestor
44105528|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105529|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44105530|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105531|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105533|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44105534|NCT00072618|Analgesics|analgesics|mesh-ancestor
44105535|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
44105536|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105537|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462328|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462329|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
44462330|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
44462331|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462332|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462333|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462334|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
44462336|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462337|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462338|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462339|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
44462340|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44462341|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44462342|NCT01531998|Growth Substances|growth substances|mesh-ancestor
44462343|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105538|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105539|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44105540|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105541|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105542|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105543|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105544|NCT00072670|Trabectedin|trabectedin|mesh-list
44105545|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105546|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
44105547|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105548|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105549|NCT00072683|Tolvaptan|tolvaptan|mesh-list
44105550|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44105551|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105552|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
44105553|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105554|NCT00072722|Pomalidomide|pomalidomide|mesh-list
44105555|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
44105556|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105557|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44105558|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44105559|NCT00072722|Growth Substances|growth substances|mesh-ancestor
44105560|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105561|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105562|NCT00072748|EKB 569|ekb 569|mesh-list
44105563|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105564|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105565|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105566|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105567|NCT00072787|Cisplatin|cisplatin|mesh-list
44105568|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105569|NCT00072826|Acetylcholine|acetylcholine|mesh-list
44105570|NCT00072826|Oxypurinol|oxypurinol|mesh-list
44105571|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
44105572|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44105573|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
44105574|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105575|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105576|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105577|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105578|NCT00072839|Teduglutide|teduglutide|mesh-list
44105579|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462344|NCT01531673|Ivacaftor|ivacaftor|mesh-list
44462345|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44462346|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44462347|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462348|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
44462349|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462350|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
44462351|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462352|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462353|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462354|NCT01531205|Leuprolide|leuprolide|mesh-list
44462355|NCT01531205|Goserelin|goserelin|mesh-list
44462356|NCT01531205|Bicalutamide|bicalutamide|mesh-list
44462357|NCT01531205|Androgens|androgens|mesh-list
44462358|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44462359|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
43658976|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
44105580|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44105581|NCT00072839|Protective Agents|protective agents|mesh-ancestor
44105582|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105583|NCT00072852|Irinotecan|irinotecan|mesh-list
44105584|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44105585|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105586|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105587|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105588|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105589|NCT00072865|Carboplatin|carboplatin|mesh-list
44105590|NCT00072865|Pemetrexed|pemetrexed|mesh-list
44105591|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105592|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105593|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105594|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44105595|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44105596|NCT00072904|Repaglinide|repaglinide|mesh-list
44105597|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44105598|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105599|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
44105601|NCT00072930|Docetaxel|docetaxel|mesh-list
44105602|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105603|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105604|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105605|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
43631537|NCT03043248|Digoxin|digoxin|mesh-list
44105610|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105612|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105613|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44105614|NCT00072943|Interferons|interferons|mesh-list
44105615|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
44105616|NCT00072943|Antibodies|antibodies|mesh-list
44105617|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43729046|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43729047|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729051|NCT02573909|Oxycodone|oxycodone|mesh-list
44105618|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
44105619|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105620|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105621|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
44105622|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105623|NCT00072969|Daclizumab|daclizumab|mesh-list
44105624|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105625|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
44105626|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105627|NCT00072982|Borage oil|borage oil|mesh-list
44462360|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44462361|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462362|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462363|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462364|NCT01531205|Hormones|hormones|mesh-ancestor
44462365|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462366|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
44462367|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265683|NCT00654888|Mitomycins|mitomycins|mesh-list
44265684|NCT00654888|Mitomycin|mitomycin|mesh-list
44265685|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44265686|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265687|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
44105628|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105629|NCT00073047|Daclizumab|daclizumab|mesh-list
44105630|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105631|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
44105632|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153387|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44153388|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153389|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44153390|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153391|NCT00220220|Amlodipine|amlodipine|mesh-list
44153392|NCT00220220|Olmesartan|olmesartan|mesh-list
44153393|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44153394|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153395|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44153396|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153397|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153398|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44153399|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153400|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
44153401|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44153402|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44153403|NCT00220233|Amlodipine|amlodipine|mesh-list
44153404|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44153405|NCT00220233|Olmesartan|olmesartan|mesh-list
44153406|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44153407|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153408|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44153409|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153410|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153411|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44153412|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153413|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
44153414|NCT00220233|Diuretics|diuretics|mesh-ancestor
44153415|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
44153416|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44153417|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44153418|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44153419|NCT00220259|Fluticasone|fluticasone|mesh-list
44153420|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44153421|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44153422|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
44153423|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153424|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105633|NCT00073164|Valproic Acid|valproic acid|mesh-list
44105634|NCT00073164|Olanzapine|olanzapine|mesh-list
44105635|NCT00073164|Risperidone|risperidone|mesh-list
44105636|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44105637|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
44105641|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44265688|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265689|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44265691|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44265692|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265693|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265694|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265695|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265696|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265697|NCT00654914|Urological Agents|urological agents|mesh-ancestor
44265698|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
44265699|NCT00655018|Tocopherols|tocopherols|mesh-list
44265700|NCT00655018|Vitamin E|vitamin e|mesh-list
44265701|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
44265702|NCT00655018|Vitamins|vitamins|mesh-ancestor
44265703|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
44265704|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265705|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
44265706|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265707|NCT00655018|Protective Agents|protective agents|mesh-ancestor
44105642|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44105643|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105644|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105645|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44105646|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
44105647|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
44105648|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
44105649|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105650|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105651|NCT00073164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105652|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105653|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105654|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
44105655|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105657|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
44105658|NCT00073203|Paroxetine|paroxetine|mesh-list
44105659|NCT00073203|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105660|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105661|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105662|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105663|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105664|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
44105665|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105666|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105667|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105668|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105669|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44105670|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44105671|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105672|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44105673|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44105674|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43819476|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794566|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
44265708|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
44265709|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265710|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265711|NCT00655109|Fluticasone|fluticasone|mesh-list
44265712|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44265713|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
44265714|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265715|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44265716|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
44265717|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265718|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265719|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44265720|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
44265721|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
44265722|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44265723|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44265724|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44105675|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105676|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105677|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105678|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44105679|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44105680|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
44105681|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105682|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105683|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44105684|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44105685|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
44105686|NCT00073372|Abciximab|abciximab|mesh-list
44105687|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
44105688|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44105689|NCT00073385|Docetaxel|docetaxel|mesh-list
44105690|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105691|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105692|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105693|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105694|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105695|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44105696|NCT00073411|Citalopram|citalopram|mesh-list
44105697|NCT00073411|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105698|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105699|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105700|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105701|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819477|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819478|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43819479|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819481|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
43631682|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
44105707|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105708|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44105709|NCT00073411|Analgesics|analgesics|mesh-ancestor
44105710|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
44105711|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
44105712|NCT00073437|Infliximab|infliximab|mesh-list
44105713|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44105714|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105715|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729158|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43729168|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265725|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265726|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265727|NCT00655109|Analgesics|analgesics|mesh-ancestor
44265728|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
44265729|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265730|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44265731|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44265732|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
44265733|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
44105716|NCT00073580|Hirudins|hirudins|mesh-list
44105717|NCT00073580|Anticoagulants|anticoagulants|mesh-list
44105718|NCT00073580|Bivalirudin|bivalirudin|mesh-list
44105719|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
44105720|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44105721|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
44105722|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105723|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105724|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44105725|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44105727|NCT00073593|Bivalirudin|bivalirudin|mesh-list
44105728|NCT00073593|Protamines|protamines|mesh-list
44105729|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
44105730|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44105731|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44105732|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105733|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
44105734|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44105735|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
44105736|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105737|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
44105738|NCT00073593|Coagulants|coagulants|mesh-ancestor
44105739|NCT00073658|Risperidone|risperidone|mesh-list
44105740|NCT00073658|Citalopram|citalopram|mesh-list
44105741|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44105742|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
44105743|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105744|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105745|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105746|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44105747|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44105748|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44105749|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105750|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44105751|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
44105752|NCT00073658|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105753|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105754|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105755|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105756|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105757|NCT00073697|Dexetimide|dexetimide|mesh-list
44105758|NCT00073697|Citalopram|citalopram|mesh-list
44105759|NCT00073697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105760|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105761|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43648253|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43648254|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43729184|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729185|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729186|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
43729187|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
43729188|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729189|NCT02573558|Analgesics|analgesics|mesh-ancestor
43729190|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
44105762|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105763|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105764|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
44105765|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105766|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105767|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105768|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105769|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44105770|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44105771|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
44105772|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
44105773|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794567|NCT02786498|Vitamins|vitamins|mesh-ancestor
44265734|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265735|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265736|NCT00655122|Dalteparin|dalteparin|mesh-list
44265737|NCT00655122|Tinzaparin|tinzaparin|mesh-list
44265738|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44265739|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
44265740|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44265741|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44265742|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265743|NCT00655135|Vedolizumab|vedolizumab|mesh-list
44265744|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265745|NCT00655148|Vaccines|vaccines|mesh-list
44265746|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
44265747|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265748|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
44265749|NCT00655174|Sertraline|sertraline|mesh-list
44265750|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105774|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44105781|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105782|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105783|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44105784|NCT00073710|Vitamins|vitamins|mesh-ancestor
44105785|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
44105786|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44105787|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44105788|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105789|NCT00073736|Cytarabine|cytarabine|mesh-list
44105790|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105791|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
44105792|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105793|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105794|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
44105795|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105796|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105797|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
44105798|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105799|NCT00073814|Albuterol|albuterol|mesh-list
44105800|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44105801|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
44105802|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105803|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105804|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44105805|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
44105806|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
44105807|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44105808|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44105809|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44105810|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44105811|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
44105812|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105813|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105814|NCT00073827|Albuterol|albuterol|mesh-list
44105815|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44105816|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
44105817|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105818|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105819|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44105820|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
44105821|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
44265751|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44265752|NCT00655174|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44265753|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44265754|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265755|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265756|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265757|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
44265758|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265759|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44265760|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44265761|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265762|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44265763|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44105822|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44105823|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44105824|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44105825|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44105826|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
44105827|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105828|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105829|NCT00073840|Albuterol|albuterol|mesh-list
44105830|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44105831|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
44105832|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105833|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105834|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44105835|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44105836|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
44105837|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44105838|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44105839|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44105840|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44105841|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
44105842|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105848|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105849|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
44105850|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105851|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105852|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105853|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
44105854|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105855|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105856|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44105857|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105858|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
44105859|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105860|NCT00073905|Gemcitabine|gemcitabine|mesh-list
44105861|NCT00073905|Capecitabine|capecitabine|mesh-list
44105862|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105863|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
44105864|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105865|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105866|NCT00073905|Antiviral Agents|antiviral agents|mesh-ancestor
44105867|NCT00073905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105868|NCT00073905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105869|NCT00073905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105870|NCT00073905|Immunologic Factors|immunologic factors|mesh-ancestor
43794568|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
44265764|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44265765|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265766|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44265767|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
44265768|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44265769|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265770|NCT00655252|Everolimus|everolimus|mesh-list
44265771|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729315|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44265772|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265773|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
44265774|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265775|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44265776|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265777|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265778|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
44265779|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265780|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44265781|NCT00655330|Valsartan|valsartan|mesh-list
44265782|NCT00655330|Probucol|probucol|mesh-list
44265783|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265784|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44265785|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44265786|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265787|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44265788|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44265789|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
44265790|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44105871|NCT00073905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105872|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
44105873|NCT00073931|Sargramostim|sargramostim|mesh-list
44105874|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
44105875|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105876|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105877|NCT00073970|Celecoxib|celecoxib|mesh-list
44105878|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44105879|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44105880|NCT00073970|Analgesics|analgesics|mesh-ancestor
44105881|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
44105882|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105883|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105884|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105885|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105886|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44105887|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44105888|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105889|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265792|NCT00655330|Protective Agents|protective agents|mesh-ancestor
44265793|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265794|NCT00655408|Iron|iron|mesh-list
44265795|NCT00655408|Trace Elements|trace elements|mesh-ancestor
44265796|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
44265797|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265798|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
44265799|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
44265800|NCT00655421|Coagulants|coagulants|mesh-ancestor
44265801|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
44265802|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265803|NCT00655512|Clobetasol|clobetasol|mesh-list
44265804|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
44265805|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265806|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
44265807|NCT00655512|Hormones|hormones|mesh-ancestor
43659072|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105890|NCT00074009|Bortezomib|bortezomib|mesh-list
44105891|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105892|NCT00074022|Docetaxel|docetaxel|mesh-list
44105893|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105894|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105895|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105896|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105897|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105898|NCT00074074|Infliximab|infliximab|mesh-list
44105899|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44105900|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105901|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105902|NCT00074087|Doxorubicin|doxorubicin|mesh-list
44105903|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44105904|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44105905|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105906|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105907|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105908|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105909|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105910|NCT00074100|Amonafide|amonafide|mesh-list
44105911|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105912|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
44105913|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105915|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105916|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
44105918|NCT00074139|Doxorubicin|doxorubicin|mesh-list
44105919|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44105920|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105921|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
44105922|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105923|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105924|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105925|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
44105926|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105927|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105928|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44105929|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105930|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105931|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105932|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44105933|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105934|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44265808|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265809|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265810|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44265811|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44265812|NCT00655512|Analgesics|analgesics|mesh-ancestor
44265813|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
44265814|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265815|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265816|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
43659082|NCT02940912|Emetics|emetics|mesh-ancestor
44105935|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105936|NCT00074178|Cytarabine|cytarabine|mesh-list
44105937|NCT00074178|Dexamethasone|dexamethasone|mesh-list
44105938|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
44105939|NCT00074178|Methotrexate|methotrexate|mesh-list
43833848|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
43833849|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833850|NCT05180474|Antibodies|antibodies|mesh-list
43833851|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43833852|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
43833853|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833854|NCT05179772|Olanzapine|olanzapine|mesh-list
43833855|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
43729420|NCT02571712|Timolol|timolol|mesh-list
43729421|NCT02571712|Bimatoprost|bimatoprost|mesh-list
44105940|NCT00074178|Etoposide|etoposide|mesh-list
44105941|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
44105942|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105943|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
44105944|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105945|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105946|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105947|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
44105948|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105949|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105950|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44105951|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105952|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
44105953|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
44105954|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105955|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105956|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
44105957|NCT00074178|Hormones|hormones|mesh-ancestor
44105958|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105959|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105960|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44105961|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
44105962|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44105963|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105964|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
44105965|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44105966|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105967|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44105968|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44105969|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105970|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44105971|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44105972|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
44105973|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105974|NCT00074191|Cytarabine|cytarabine|mesh-list
44105975|NCT00074191|Dexamethasone|dexamethasone|mesh-list
44105976|NCT00074191|Methotrexate|methotrexate|mesh-list
44105977|NCT00074191|Lomustine|lomustine|mesh-list
44105978|NCT00074191|Procarbazine|procarbazine|mesh-list
44105979|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105980|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
44105981|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
44105982|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105983|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105984|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44105985|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
44105986|NCT00074191|Hormones|hormones|mesh-ancestor
44105987|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105988|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105992|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44265817|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265818|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
44265819|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44265820|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265821|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265822|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
44265823|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44265824|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265825|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265826|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265827|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265828|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265829|NCT00655590|Urological Agents|urological agents|mesh-ancestor
44265830|NCT00655603|Pancrelipase|pancrelipase|mesh-list
44265831|NCT00655603|Hormones|hormones|mesh-list
44265832|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462368|NCT01531153|Galantamine|galantamine|mesh-list
44265833|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265834|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265836|NCT00655616|Montelukast|montelukast|mesh-list
44265837|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44265838|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
44265839|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265840|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265841|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44265842|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
44265843|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44265844|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44265845|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44265846|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44265847|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44265854|NCT00655655|Everolimus|everolimus|mesh-list
44265858|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
44265859|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265860|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44265861|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265862|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265863|NCT00655681|Pamidronate|pamidronate|mesh-list
44265864|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44265865|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265866|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
44265867|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
44265868|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
44265869|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265870|NCT00655785|Gemcitabine|gemcitabine|mesh-list
43659131|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
44105993|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105994|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
44105995|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105996|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44105997|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105998|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44105999|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106000|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
44106001|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106002|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106003|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
44106004|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106005|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106006|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
44106007|NCT00074204|Gemcitabine|gemcitabine|mesh-list
44106008|NCT00074204|Carboplatin|carboplatin|mesh-list
44106009|NCT00074204|Docetaxel|docetaxel|mesh-list
44106010|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106011|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106012|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
44106013|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106014|NCT00074204|Antiviral Agents|antiviral agents|mesh-ancestor
44106015|NCT00074204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106016|NCT00074204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106017|NCT00074204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106018|NCT00074204|Immunologic Factors|immunologic factors|mesh-ancestor
44106019|NCT00074204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106020|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106021|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106022|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106023|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
44106024|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44106025|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
44106027|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106028|NCT00074321|Capecitabine|capecitabine|mesh-list
44106029|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
44106030|NCT00074321|Irinotecan|irinotecan|mesh-list
44106031|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106032|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
44106033|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106034|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106035|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44106036|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106037|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106038|NCT00074334|Immunotoxins|immunotoxins|mesh-list
44106039|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
44106040|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106041|NCT00074399|Nevirapine|nevirapine|mesh-list
44265871|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44265872|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
44265873|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265874|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265875|NCT00655785|Antiviral Agents|antiviral agents|mesh-ancestor
44265876|NCT00655785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265877|NCT00655785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265878|NCT00655785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265879|NCT00655785|Immunologic Factors|immunologic factors|mesh-ancestor
44265880|NCT00655785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265881|NCT00655798|Antioxidants|antioxidants|mesh-list
44106042|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106043|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106044|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106045|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106046|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
44106047|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106048|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44106049|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44106050|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44106051|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44106053|NCT00074438|Methotrexate|methotrexate|mesh-list
44106054|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106055|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106056|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
44106057|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106058|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106059|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44106060|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
44106061|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44106068|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106069|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106070|NCT00074607|Gemcitabine|gemcitabine|mesh-list
44106071|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106072|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
44106073|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106074|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106075|NCT00074607|Antiviral Agents|antiviral agents|mesh-ancestor
44106076|NCT00074607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106077|NCT00074607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106078|NCT00074607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106080|NCT00074607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106081|NCT00074620|Hirudins|hirudins|mesh-list
44106082|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
44106083|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44106084|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
44106085|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106086|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106087|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
44106088|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44106089|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44106090|NCT00074737|Cytarabine|cytarabine|mesh-list
44106091|NCT00074737|Idarubicin|idarubicin|mesh-list
43729636|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43729637|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
43729638|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729639|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729640|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729641|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729642|NCT02570581|Analgesics|analgesics|mesh-ancestor
43729643|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
43729644|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729645|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
44106092|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106093|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
44106094|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106095|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106096|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
44106097|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106098|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106099|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
44106100|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265882|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265883|NCT00655798|Protective Agents|protective agents|mesh-ancestor
44265884|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265885|NCT00655837|Gemcitabine|gemcitabine|mesh-list
44265886|NCT00655837|Rituximab|rituximab|mesh-list
44265887|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
44265888|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44265889|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265890|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
44265891|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265892|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265893|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44265894|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
44265895|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265896|NCT00655837|Antiviral Agents|antiviral agents|mesh-ancestor
44265897|NCT00655837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265898|NCT00655837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106101|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106102|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106103|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106104|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106105|NCT00074750|Molgramostim|molgramostim|mesh-list
44106106|NCT00074750|Sargramostim|sargramostim|mesh-list
44106107|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
44106108|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106109|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106110|NCT00074776|Lamotrigine|lamotrigine|mesh-list
44106111|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106112|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106113|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44106114|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44106115|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106116|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
44106117|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44106118|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106119|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44106120|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44106121|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44106122|NCT00074828|Enoxaparin|enoxaparin|mesh-list
44106123|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
44106124|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44106125|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44106126|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106127|NCT00074841|Azithromycin|azithromycin|mesh-list
44106128|NCT00074841|Chloroquine|chloroquine|mesh-list
44106129|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44106130|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
44106131|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
44106135|NCT00074841|Amebicides|amebicides|mesh-ancestor
44106136|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44106137|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44106138|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
44106139|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106140|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44106141|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44106142|NCT00074841|Analgesics|analgesics|mesh-ancestor
44106143|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
44106144|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265901|NCT00655915|Lidocaine|lidocaine|mesh-list
44265902|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44265903|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
44265904|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265905|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265906|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
44265907|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265908|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44265909|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44265910|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44265911|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265912|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265913|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265914|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
44265915|NCT00655915|Hormones|hormones|mesh-ancestor
44265916|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106145|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106146|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44106147|NCT00074841|Filaricides|filaricides|mesh-ancestor
44106148|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
44106149|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
44106150|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44106151|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106152|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106153|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44106154|NCT00074841|Renal Agents|renal agents|mesh-ancestor
44153425|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44153426|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
44153427|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153428|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44153429|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44153430|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
44153431|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153432|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
44153433|NCT00220298|Testosterone|testosterone|mesh-list
44153434|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
44153435|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
44153436|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44153437|NCT00220298|Androgens|androgens|mesh-ancestor
44153438|NCT00220298|Hormones|hormones|mesh-ancestor
44153439|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44153440|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153441|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44153442|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153443|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
44153444|NCT00220311|Fludarabine|fludarabine|mesh-list
44153445|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
44153446|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153447|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153449|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153450|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153451|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
44265917|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44265918|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
44265919|NCT00655967|Acamprosate|acamprosate|mesh-list
44265920|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44265921|NCT00656006|Ribavirin|ribavirin|mesh-list
44265922|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
44265923|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265924|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
44265925|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265926|NCT00656032|Cinacalcet|cinacalcet|mesh-list
44265927|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44265928|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265929|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44265930|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44265931|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265932|NCT00656110|Ethanol|ethanol|mesh-list
44265933|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
44153452|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153453|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44153454|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44153455|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44153456|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44153457|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
44153458|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44153459|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153460|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44153461|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44153462|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44153463|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44153464|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44153465|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44153466|NCT00220337|Lacosamide|lacosamide|mesh-list
44153467|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
44153468|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44153469|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44153470|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43632184|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153478|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158123|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158124|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158125|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
44158126|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158127|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44158128|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44158129|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44158130|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158131|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158133|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
44158134|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158135|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44158136|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158137|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158138|NCT00236288|Bupropion|bupropion|mesh-list
44106155|NCT00075010|Decitabine|decitabine|mesh-list
44106156|NCT00075010|Valproic Acid|valproic acid|mesh-list
44265934|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44265935|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44265936|NCT00656110|Prednisolone|prednisolone|mesh-list
44265937|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
44265938|NCT00656110|Lidocaine|lidocaine|mesh-list
44265939|NCT00656110|Bupivacaine|bupivacaine|mesh-list
44265940|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44265941|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
44265942|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
44265943|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
44265944|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44265945|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265946|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
44265947|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44265948|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44265949|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44265950|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44265951|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44265952|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106157|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106158|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
44106159|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106160|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106161|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106162|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
44106163|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
44106164|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106165|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106166|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
44106167|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44106168|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44106169|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106170|NCT00075075|Infliximab|infliximab|mesh-list
44106171|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
44106172|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44106173|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106174|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44106175|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44106176|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106177|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106178|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
44106179|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106180|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106181|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44106182|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
44106183|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106184|NCT00075192|Leuprolide|leuprolide|mesh-list
44106185|NCT00075192|Bicalutamide|bicalutamide|mesh-list
44106186|NCT00075192|Tremelimumab|tremelimumab|mesh-list
44106187|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44106188|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
43648255|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43648256|NCT03944681|Droperidol|droperidol|mesh-list
43648257|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43648258|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
43560517|NCT04446962|Lenalidomide|lenalidomide|mesh-list
43560518|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
43560519|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560520|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44106189|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44106190|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106191|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106192|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106193|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
44265953|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265954|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
44265955|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
44265956|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44265957|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
44265958|NCT00656110|Hormones|hormones|mesh-ancestor
44265959|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265960|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44265961|NCT00656110|Protective Agents|protective agents|mesh-ancestor
44265962|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44265963|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265964|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44265965|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44265966|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
44265967|NCT00656123|Molgramostim|molgramostim|mesh-list
44265968|NCT00656123|Sargramostim|sargramostim|mesh-list
44265969|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
44265970|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265971|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44265972|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44265973|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44265974|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
44265975|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265976|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265977|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44265978|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44265979|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
44265980|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44265981|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44265982|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44265983|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265984|NCT00656188|Urological Agents|urological agents|mesh-ancestor
44265985|NCT00656214|Lycopene|lycopene|mesh-list
44265986|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44265987|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
44106194|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
44106195|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106202|NCT00075205|Hormones|hormones|mesh-ancestor
44106203|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44265988|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44265990|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44265991|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44265992|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44265993|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265994|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44265995|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43560568|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43560569|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43560570|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560571|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560572|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44265996|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
44265997|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44265998|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44265999|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44266000|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
44106204|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106205|NCT00075231|Ritonavir|ritonavir|mesh-list
44106206|NCT00075231|Lopinavir|lopinavir|mesh-list
44106207|NCT00075231|Lamivudine|lamivudine|mesh-list
44106208|NCT00075231|Zidovudine|zidovudine|mesh-list
44106209|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44106210|NCT00075231|Efavirenz|efavirenz|mesh-list
44106211|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44106212|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44106213|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
44106214|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106215|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106216|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44106217|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44106218|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
44106219|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106220|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44106221|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44106222|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106223|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106224|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
44106225|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44106226|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44106227|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44106228|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44153479|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
44106229|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44106231|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106232|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106233|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106234|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106235|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106236|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
44106237|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106238|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
44106239|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106240|NCT00075439|Gefitinib|gefitinib|mesh-list
44106241|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106242|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44106243|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106244|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106245|NCT00075452|Gemcitabine|gemcitabine|mesh-list
44106246|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
44106247|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106248|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
44106249|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106250|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266001|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266002|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266003|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266004|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266005|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
43763351|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
44266006|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
44266007|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44266008|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44266009|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266010|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44266012|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44266013|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44266014|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266015|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266016|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44266017|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266018|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266019|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44266020|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
44266021|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266022|NCT00656422|Insulin|insulin|mesh-list
44266023|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44266024|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
44266025|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266026|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266027|NCT00656435|Bevacizumab|bevacizumab|mesh-list
44266028|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266029|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266030|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266031|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266032|NCT00656435|Growth Substances|growth substances|mesh-ancestor
44106251|NCT00075452|Antiviral Agents|antiviral agents|mesh-ancestor
44106252|NCT00075452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106253|NCT00075452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106254|NCT00075452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106255|NCT00075452|Immunologic Factors|immunologic factors|mesh-ancestor
44106256|NCT00075452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106258|NCT00075465|Epirubicin|epirubicin|mesh-list
44106259|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106260|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
44266033|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266034|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266035|NCT00656526|Lidocaine|lidocaine|mesh-list
44266036|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
44266037|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
44266038|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266039|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266040|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
44266041|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266042|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44266043|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44266044|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44266045|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266046|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266047|NCT00656552|Citalopram|citalopram|mesh-list
44266048|NCT00656552|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44266049|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266050|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266051|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106261|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106262|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106263|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106264|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106267|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106268|NCT00075491|Fenretinide|fenretinide|mesh-list
44106269|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106270|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44106271|NCT00075491|Protective Agents|protective agents|mesh-ancestor
44106272|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106273|NCT00075517|Gemcitabine|gemcitabine|mesh-list
44106274|NCT00075517|Docetaxel|docetaxel|mesh-list
44106275|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106276|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
44106277|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729804|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106278|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106279|NCT00075517|Antiviral Agents|antiviral agents|mesh-ancestor
44106280|NCT00075517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106281|NCT00075517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106282|NCT00075517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106283|NCT00075517|Immunologic Factors|immunologic factors|mesh-ancestor
44106284|NCT00075517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106285|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106286|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106287|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106288|NCT00075543|Docetaxel|docetaxel|mesh-list
44106289|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
44106290|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106291|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106292|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106293|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106294|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106295|NCT00075556|Capecitabine|capecitabine|mesh-list
44106296|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266052|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266054|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266055|NCT00656552|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44266056|NCT00656552|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266057|NCT00656552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266059|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44266060|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
44266061|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44266062|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266063|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266064|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
44266065|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266066|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266067|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
44266068|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266069|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44266070|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266071|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
44266072|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266073|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44266074|NCT00656643|Sirolimus|sirolimus|mesh-list
44266075|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266076|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266077|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266078|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266079|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
44106297|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
44106298|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106299|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106300|NCT00075595|Leucovorin|leucovorin|mesh-list
44106301|NCT00075595|Fluorouracil|fluorouracil|mesh-list
44106302|NCT00075595|Irinotecan|irinotecan|mesh-list
44106303|NCT00075595|Calcium|calcium|mesh-list
44106304|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
44106305|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44106306|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106307|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
44106308|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106309|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106310|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106311|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106312|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
44106313|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44106314|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106315|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729893|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729894|NCT02568709|Oxytocin|oxytocin|mesh-list
43729895|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
44106316|NCT00075595|Antidotes|antidotes|mesh-ancestor
44266080|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266081|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
44266082|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266083|NCT00656695|Cyclosporine|cyclosporine|mesh-list
44266084|NCT00656695|Cyclosporins|cyclosporins|mesh-list
44266085|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
44266086|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266087|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
44266088|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266089|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266090|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266091|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
44266092|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266093|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266094|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44266095|NCT00656747|Amoxicillin|amoxicillin|mesh-list
44266096|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
44266097|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
44266098|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
44266099|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44266100|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44266101|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266102|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266103|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44266104|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266105|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266106|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266107|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266108|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44266109|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
44266110|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44266111|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266122|NCT00656773|Analgesics|analgesics|mesh-ancestor
44266123|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
44266124|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266125|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44266126|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44266128|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
44462369|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44462370|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462371|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106317|NCT00075595|Protective Agents|protective agents|mesh-ancestor
44106318|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
44106319|NCT00075595|Vitamins|vitamins|mesh-ancestor
44106320|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
44106321|NCT00075621|Melphalan|melphalan|mesh-list
44106322|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
44106323|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106324|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106325|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
44106326|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106327|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106328|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44106329|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106330|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
44106331|NCT00075634|Doxorubicin|doxorubicin|mesh-list
44106332|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44106333|NCT00075634|Decitabine|decitabine|mesh-list
44106334|NCT00075634|Azacitidine|azacitidine|mesh-list
44106335|NCT00075634|Lenograstim|lenograstim|mesh-list
44106336|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106337|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
44106338|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729973|NCT02567955|Vaccines|vaccines|mesh-list
44106339|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106340|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106345|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106346|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106347|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106348|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106349|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44106350|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106352|NCT00075647|Sirolimus|sirolimus|mesh-list
44106353|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44106354|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106355|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106356|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106357|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
44106358|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106359|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
44106360|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106361|NCT00075673|Celecoxib|celecoxib|mesh-list
44106362|NCT00075673|Vinorelbine|vinorelbine|mesh-list
44106363|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44106364|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44106365|NCT00075673|Analgesics|analgesics|mesh-ancestor
44106366|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
44106367|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44106368|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106369|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44106370|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106371|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44106372|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44106373|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106374|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106375|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106376|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106377|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106378|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
44462373|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462374|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462375|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44462376|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
44462377|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462378|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
44462379|NCT01530464|Ambrisentan|ambrisentan|mesh-list
44462380|NCT01530464|Aminophylline|aminophylline|mesh-list
44462381|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44462382|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462383|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
44106379|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106380|NCT00075686|Gemcitabine|gemcitabine|mesh-list
43820100|NCT05678647|Iron|iron|mesh-list
44106381|NCT00075686|Cetuximab|cetuximab|mesh-list
44106382|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106383|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
43730006|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43730007|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43730008|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43730009|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43730010|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730011|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730012|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730013|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43730015|NCT02567981|Micronutrients|micronutrients|mesh-list
44106384|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106385|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106386|NCT00075686|Antiviral Agents|antiviral agents|mesh-ancestor
44106387|NCT00075686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106388|NCT00075686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106389|NCT00075686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106390|NCT00075686|Immunologic Factors|immunologic factors|mesh-ancestor
44106391|NCT00075686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106392|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106393|NCT00075699|Cisplatin|cisplatin|mesh-list
44106394|NCT00075699|Vincristine|vincristine|mesh-list
44106395|NCT00075699|Vinorelbine|vinorelbine|mesh-list
44106396|NCT00075699|Mitomycins|mitomycins|mesh-list
44106397|NCT00075699|Mitomycin|mitomycin|mesh-list
44106398|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106399|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106400|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106401|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106402|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106403|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106404|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106405|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
44106406|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106407|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106408|NCT00075712|Paclitaxel|paclitaxel|mesh-list
44106409|NCT00075712|Carboplatin|carboplatin|mesh-list
44106410|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106417|NCT00075738|Cisplatin|cisplatin|mesh-list
44106418|NCT00075738|Fluorouracil|fluorouracil|mesh-list
44106419|NCT00075738|Irinotecan|irinotecan|mesh-list
44106420|NCT00075738|Calcium|calcium|mesh-list
44106421|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
44106422|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106423|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44106424|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106425|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
44106426|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106427|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106428|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106429|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
44106430|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44106431|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106432|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106433|NCT00075738|Antidotes|antidotes|mesh-ancestor
44106434|NCT00075738|Protective Agents|protective agents|mesh-ancestor
44106435|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
44106436|NCT00075738|Vitamins|vitamins|mesh-ancestor
44106437|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
44462385|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462386|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462387|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462388|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44462389|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44462390|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462391|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462392|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44462393|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44462394|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
44462395|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462396|NCT01530464|Protective Agents|protective agents|mesh-ancestor
44462397|NCT01530334|Gefitinib|gefitinib|mesh-list
43560749|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560750|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560751|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43560752|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43560754|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560755|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462398|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462399|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462400|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462401|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462402|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
44462403|NCT01529749|Losartan|losartan|mesh-list
44462404|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44462405|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44106438|NCT00075751|Gemcitabine|gemcitabine|mesh-list
44106439|NCT00075751|Carboplatin|carboplatin|mesh-list
44106440|NCT00075751|Bortezomib|bortezomib|mesh-list
44106441|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106442|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106443|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
44106444|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106445|NCT00075751|Antiviral Agents|antiviral agents|mesh-ancestor
44106446|NCT00075751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106447|NCT00075751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106448|NCT00075751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106449|NCT00075751|Immunologic Factors|immunologic factors|mesh-ancestor
44106450|NCT00075751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106451|NCT00075777|Valproic Acid|valproic acid|mesh-list
44106452|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
44106453|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106454|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106455|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
44106456|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106457|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106458|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
44106459|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44106460|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44106461|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106463|NCT00075855|Androgens|androgens|mesh-ancestor
44106464|NCT00075855|Hormones|hormones|mesh-ancestor
44106465|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106466|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106467|NCT00075868|Octreotide|octreotide|mesh-list
44106468|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462406|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44462407|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44462408|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462409|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44462410|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44462411|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
44462412|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462413|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44462414|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44462415|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462416|NCT01529645|Vaccines|vaccines|mesh-list
44462417|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
43730048|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43730049|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43730050|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43730051|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43730052|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730053|NCT02567838|Lidocaine|lidocaine|mesh-list
43730054|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730055|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
44462418|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462419|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
44462420|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44462421|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44462422|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44462423|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462424|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825560|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
44106469|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106470|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106471|NCT00075894|Alanosine|alanosine|mesh-list
44106472|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106473|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106474|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
44106475|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
44106476|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106477|NCT00075907|Ritonavir|ritonavir|mesh-list
44106478|NCT00075907|Lopinavir|lopinavir|mesh-list
44106479|NCT00075907|Efavirenz|efavirenz|mesh-list
44106480|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44106481|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44106482|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
44106483|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106494|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44106495|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44106496|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44106497|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44106498|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
44106499|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106500|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106501|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106502|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106503|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106504|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
44106505|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
44106506|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
44106507|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106508|NCT00075959|Protective Agents|protective agents|mesh-ancestor
44106509|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106510|NCT00075972|Nicotine|nicotine|mesh-list
44106511|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44106512|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
44106513|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462425|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462426|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462427|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44462428|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44462429|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44462430|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44462432|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43846624|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
44106514|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106515|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44106516|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44106517|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44106518|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106519|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560801|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43560802|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44106520|NCT00075998|Interferons|interferons|mesh-list
44106521|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
44106522|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106523|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
44106524|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106525|NCT00076115|Risperidone|risperidone|mesh-list
44106526|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44106527|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
44106528|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106529|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106530|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106531|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44106532|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44106533|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44106534|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106535|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44106536|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
44106537|NCT00076206|Sirolimus|sirolimus|mesh-list
44106538|NCT00076206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44106539|NCT00076206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106540|NCT00076206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106541|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106542|NCT00076206|Antifungal Agents|antifungal agents|mesh-ancestor
44106543|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106544|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
44106547|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
44106548|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106549|NCT00076284|Aplaviroc|aplaviroc|mesh-list
44106550|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44106551|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44106552|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106553|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44106554|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44106555|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
44106556|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106558|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
44106559|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44106560|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44106561|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106562|NCT00076349|Rituximab|rituximab|mesh-list
44106563|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44106564|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106565|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106566|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
44106567|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106568|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106569|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106570|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
44106571|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106572|NCT00076362|Octreotide|octreotide|mesh-list
44462433|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44462435|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
44462436|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462437|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648259|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
43648260|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648261|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730117|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43730118|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
43730119|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730120|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44462438|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139286|NCT00174720|Hormones|hormones|mesh-ancestor
44462439|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266129|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
44266130|NCT00656786|Vitamin K|vitamin k|mesh-list
44266131|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44266132|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44266133|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266134|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
44266135|NCT00656786|Coagulants|coagulants|mesh-ancestor
44266136|NCT00656786|Vitamins|vitamins|mesh-ancestor
44266137|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
44266138|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266139|NCT00656812|Rituximab|rituximab|mesh-list
43846633|NCT04187703|Azacitidine|azacitidine|mesh-list
44106573|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44106574|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106575|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106576|NCT00076388|Docetaxel|docetaxel|mesh-list
44106577|NCT00076388|Gefitinib|gefitinib|mesh-list
44106578|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106579|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106580|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106581|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106582|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106583|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44106584|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106585|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
44106586|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106587|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44106588|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
44106589|NCT00076414|Acetylcholine|acetylcholine|mesh-list
44106590|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44106591|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44106592|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
44106593|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106594|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106595|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106596|NCT00076440|Leuprolide|leuprolide|mesh-list
44106597|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44106598|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
44106599|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44106600|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106601|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106602|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106603|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
44106604|NCT00076492|Vitamins|vitamins|mesh-ancestor
44106605|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
43560846|NCT03184870|Antidotes|antidotes|mesh-ancestor
43560847|NCT03184870|Protective Agents|protective agents|mesh-ancestor
43560848|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
43560850|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
43560851|NCT03138512|Nivolumab|nivolumab|mesh-list
43560852|NCT03138512|Ipilimumab|ipilimumab|mesh-list
43560853|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560854|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560855|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43560856|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560857|NCT03136263|Oxytocin|oxytocin|mesh-list
43560858|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
43560859|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44106606|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106607|NCT00076518|Fenofibrate|fenofibrate|mesh-list
44106608|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44106609|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
44106610|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106611|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44266140|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266141|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266142|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
44266143|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266144|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266145|NCT00656864|Pioglitazone|pioglitazone|mesh-list
44266146|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266147|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266148|NCT00656929|Vitamin D|vitamin d|mesh-list
44266149|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
44266150|NCT00656929|Vitamins|vitamins|mesh-ancestor
44266151|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
43846650|NCT04185311|Nivolumab|nivolumab|mesh-list
44426859|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426860|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426861|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44426862|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44426863|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
44426864|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44426865|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
44426866|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426867|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
44426868|NCT02207608|Protective Agents|protective agents|mesh-ancestor
44426886|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426887|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44426888|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44426889|NCT02207413|Vaccines|vaccines|mesh-list
44426890|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
44426891|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426892|NCT02207400|Listerine|listerine|mesh-list
44426893|NCT02207400|Fluorides|fluorides|mesh-list
44426894|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
44426895|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
44426896|NCT02207400|Protective Agents|protective agents|mesh-ancestor
44426897|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730153|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730154|NCT02567032|Oxytocin|oxytocin|mesh-list
43730155|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
43730156|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43730157|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730158|NCT02567149|Cidofovir|cidofovir|mesh-list
43730159|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
43730160|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730161|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730162|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730163|NCT02567279|Denosumab|denosumab|mesh-list
43730164|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43560861|NCT03117751|Cytarabine|cytarabine|mesh-list
44426898|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44426899|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426900|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44426901|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426902|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426903|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426904|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426905|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426906|NCT02207244|Adalimumab|adalimumab|mesh-list
44426907|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44426908|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426909|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426910|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
44426911|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426912|NCT02207231|Adalimumab|adalimumab|mesh-list
44426913|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44426914|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426915|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426916|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
44426917|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426918|NCT02207088|Ritonavir|ritonavir|mesh-list
44426919|NCT02207088|Ribavirin|ribavirin|mesh-list
44426920|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44426921|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44426922|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426923|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426924|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426925|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44426926|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44426927|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
44266152|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266153|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44266154|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44266155|NCT00657007|Belimumab|belimumab|mesh-list
44266156|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266157|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
44266158|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266159|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44266160|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266161|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44266162|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44266163|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266164|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266165|NCT00657033|Urological Agents|urological agents|mesh-ancestor
44426928|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426949|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
44426950|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
44426951|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44426952|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
44426953|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426954|NCT02206152|Expectorants|expectorants|mesh-ancestor
44426955|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
44426956|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44426957|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
44426958|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426959|NCT02206152|Protective Agents|protective agents|mesh-ancestor
44426960|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426961|NCT02206152|Antidotes|antidotes|mesh-ancestor
43560866|NCT03117751|Doxorubicin|doxorubicin|mesh-list
43560867|NCT03117751|Methotrexate|methotrexate|mesh-list
43560868|NCT03117751|Etoposide|etoposide|mesh-list
43560869|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
43560870|NCT03117751|Vincristine|vincristine|mesh-list
43560871|NCT03117751|Bortezomib|bortezomib|mesh-list
43560872|NCT03117751|Daunorubicin|daunorubicin|mesh-list
43560873|NCT03117751|Asparaginase|asparaginase|mesh-list
43560874|NCT03117751|Dasatinib|dasatinib|mesh-list
43560875|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
44426962|NCT02206048|Proflavine|proflavine|mesh-list
44426963|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44426964|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426965|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
44426966|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44426967|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44426968|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426969|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44426970|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426971|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
44426972|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426973|NCT02205333|Rituximab|rituximab|mesh-list
44426974|NCT02205333|Durvalumab|durvalumab|mesh-list
44426975|NCT02205333|Tremelimumab|tremelimumab|mesh-list
44426976|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426977|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426978|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
44426979|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426980|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427016|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427017|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427035|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44427036|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427037|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427038|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44427039|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
44427040|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427041|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266166|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
44266168|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
44266169|NCT00657059|Irbesartan|irbesartan|mesh-list
44266170|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266171|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
44266172|NCT00657059|Hormones|hormones|mesh-ancestor
44266173|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266174|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266175|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44266176|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266177|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266178|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44266179|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
43648262|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648263|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43560919|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560920|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43560921|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
43560922|NCT03112603|Sirolimus|sirolimus|mesh-list
43560923|NCT03112603|Rituximab|rituximab|mesh-list
43560924|NCT03112603|Methotrexate|methotrexate|mesh-list
43560925|NCT03112603|Everolimus|everolimus|mesh-list
43560926|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
43560927|NCT03112603|Pentostatin|pentostatin|mesh-list
43560928|NCT03112603|Infliximab|infliximab|mesh-list
43560929|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560930|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730186|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
44266180|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266181|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266182|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427042|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44427043|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
44427044|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44427045|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44427046|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
44427047|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44427048|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44427049|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44427050|NCT02203149|Grazoprevir|grazoprevir|mesh-list
44427051|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
44427052|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427053|NCT02203032|Ustekinumab|ustekinumab|mesh-list
44427054|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44427055|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427056|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
44427057|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427059|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
44427060|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427061|NCT02202850|Etanercept|etanercept|mesh-list
44427062|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44427063|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427064|NCT02202850|Analgesics|analgesics|mesh-ancestor
44427065|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
44427066|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427067|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427068|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427069|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427070|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44427071|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427072|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
44427073|NCT02202837|Etanercept|etanercept|mesh-list
44427074|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44427075|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427076|NCT02202837|Analgesics|analgesics|mesh-ancestor
44427077|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
44427078|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427105|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427106|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
44427107|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427108|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427109|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427110|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43648264|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266185|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
44266186|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266187|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266188|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44266189|NCT00657059|Protective Agents|protective agents|mesh-ancestor
44266190|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44266191|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44266192|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44266193|NCT00657137|Capecitabine|capecitabine|mesh-list
44266194|NCT00657137|Lapatinib|lapatinib|mesh-list
44427111|NCT02202551|Analgesics|analgesics|mesh-ancestor
44427112|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
44427113|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427114|NCT02202499|Varenicline|varenicline|mesh-list
44427115|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44427116|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44427117|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427118|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427119|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427120|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427122|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44427123|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427124|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427125|NCT02202161|Incretins|incretins|mesh-ancestor
44427126|NCT02202161|Hormones|hormones|mesh-ancestor
44427127|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427157|NCT02201771|Analgesics|analgesics|mesh-ancestor
44427158|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
44427159|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427160|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427161|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427162|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427163|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44427164|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44427165|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427166|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44427167|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44427168|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427169|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
44427170|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44427171|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44427172|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44427173|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
44427209|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
44427210|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427211|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427212|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
44427213|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44427214|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44427232|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44427233|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427234|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44427235|NCT02198235|Narcotics|narcotics|mesh-ancestor
44427236|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427237|NCT02198235|Analgesics|analgesics|mesh-ancestor
44427238|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
44427239|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44427240|NCT02197897|Tamoxifen|tamoxifen|mesh-list
44427241|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44266195|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266196|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
44266197|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266198|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266199|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44266200|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266201|NCT00657163|Fluoxetine|fluoxetine|mesh-list
44266202|NCT00657163|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44266203|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266204|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659237|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427242|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
44427243|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427244|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427245|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44427246|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427247|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44427248|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44427249|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44427250|NCT02197520|Insulin|insulin|mesh-list
44427251|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44427252|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
44427253|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
44427254|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427255|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427256|NCT02197416|Dabigatran|dabigatran|mesh-list
44427257|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
44427258|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44427259|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
44427260|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427261|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427262|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
44427263|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
44427264|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44427265|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427266|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
44427267|NCT02197247|Rifampin|rifampin|mesh-list
44427268|NCT02197247|Osimertinib|osimertinib|mesh-list
44427269|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44427270|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
44427271|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44427272|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427273|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
44427274|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427298|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427299|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44427300|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44427301|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44427302|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427303|NCT02196701|Adalimumab|adalimumab|mesh-list
44427304|NCT02196701|Methotrexate|methotrexate|mesh-list
44427305|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44427306|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
44427307|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44427308|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427309|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44427310|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
44427311|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427312|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427313|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427314|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427315|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44427316|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648284|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427317|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
44427318|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427319|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427320|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427321|NCT02196558|Quetmolimab|quetmolimab|mesh-list
44427322|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427348|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427349|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
44085323|NCT00019175|Aldesleukin|aldesleukin|mesh-list
44427350|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44427352|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44427353|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427354|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427355|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427356|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427357|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427358|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44427359|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427360|NCT02195583|Zinc|zinc|mesh-list
44427361|NCT02195583|Listerine|listerine|mesh-list
44427362|NCT02195583|Fluorides|fluorides|mesh-list
44427363|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
44427364|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
44427365|NCT02195583|Protective Agents|protective agents|mesh-ancestor
44427366|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427367|NCT02195583|Trace Elements|trace elements|mesh-ancestor
44427368|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
44427369|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44427370|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427371|NCT02195518|Tenofovir|tenofovir|mesh-list
44427400|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
44427401|NCT02194465|Spironolactone|spironolactone|mesh-list
44427402|NCT02194465|Tadalafil|tadalafil|mesh-list
44427403|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44427404|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
44427405|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
44427406|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44427407|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44427408|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427409|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427410|NCT02194465|Urological Agents|urological agents|mesh-ancestor
44427411|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44427412|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427413|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427414|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44427415|NCT02194465|Diuretics|diuretics|mesh-ancestor
44427416|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
44427449|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44427450|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427451|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44427452|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44427453|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427454|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427455|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427456|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44427457|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
44427458|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
44427459|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427460|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44427461|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44427472|NCT02193165|Fluorides|fluorides|mesh-list
44427473|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
44427474|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
44427475|NCT02193165|Protective Agents|protective agents|mesh-ancestor
44427476|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427477|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44427478|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427479|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44427480|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44427481|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
44427482|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427483|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44427484|NCT02192970|Bevacizumab|bevacizumab|mesh-list
44266206|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266207|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
44266208|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266209|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44266210|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266211|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266212|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44266213|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44266214|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427485|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44427486|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427487|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44427488|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44427489|NCT02192970|Growth Substances|growth substances|mesh-ancestor
44427490|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427491|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
44427492|NCT02192190|Celecoxib|celecoxib|mesh-list
44427493|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44427494|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427495|NCT02192190|Analgesics|analgesics|mesh-ancestor
44427496|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
44427497|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427498|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427499|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427500|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427501|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44427502|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44427503|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427504|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427505|NCT02191579|Topiramate|topiramate|mesh-list
44427506|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
44427507|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44427508|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44427509|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44427510|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427511|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427512|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427513|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427514|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427515|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44427516|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427517|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
44427518|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427519|NCT02191397|Dexetimide|dexetimide|mesh-list
44427520|NCT02191397|Citalopram|citalopram|mesh-list
44427521|NCT02191397|Bupropion|bupropion|mesh-list
44427522|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44427523|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44427524|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427552|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427553|NCT02189837|Atorvastatin|atorvastatin|mesh-list
44427554|NCT02189837|Evolocumab|evolocumab|mesh-list
44427555|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44427556|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44427557|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44427558|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
44427559|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427560|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44427561|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44427562|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648291|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648292|NCT03874884|Olaparib|olaparib|mesh-list
43763494|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
44266215|NCT00657202|Ranibizumab|ranibizumab|mesh-list
44266216|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266217|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266218|NCT00657202|Growth Substances|growth substances|mesh-ancestor
44266219|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266220|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266221|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266223|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
44266224|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44266225|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44266226|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266227|NCT00657254|Sorafenib|sorafenib|mesh-list
44266228|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266229|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44266230|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266231|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266232|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
44266233|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266234|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
44266235|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
44266236|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44266237|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266238|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266239|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
44266240|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44266241|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44266242|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266264|NCT00657410|Hormones|hormones|mesh-ancestor
44427563|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
44427564|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427566|NCT02188784|Trace Elements|trace elements|mesh-ancestor
44427567|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
44427568|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427569|NCT02188719|Acetaminophen|acetaminophen|mesh-list
44427570|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
44427571|NCT02188719|Promethazine|promethazine|mesh-list
44427572|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
44427591|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
44427592|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44427593|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427594|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427595|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427596|NCT02188719|Analgesics|analgesics|mesh-ancestor
44427597|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
44427598|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427599|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
44427600|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44427601|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44427602|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
44427603|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44427604|NCT02188719|Hematinics|hematinics|mesh-ancestor
44427605|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44427606|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44427607|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648293|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43648294|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648295|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648296|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560951|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43560952|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560953|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44427608|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
44427609|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
44427610|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
44427611|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
44427612|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44427613|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44427614|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
44427615|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
44427616|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427617|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44427618|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
44427619|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427620|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
44427621|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44427622|NCT02188719|Protective Agents|protective agents|mesh-ancestor
44427623|NCT02188459|Bupropion|bupropion|mesh-list
44427624|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44427625|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
44427626|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427627|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44427628|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44427629|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427630|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427631|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
44427632|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427662|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427664|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
44427665|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44427666|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44427667|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427668|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427669|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427670|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44427671|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
44427672|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
44427673|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427674|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427675|NCT02187744|Carboplatin|carboplatin|mesh-list
44427676|NCT02187744|Docetaxel|docetaxel|mesh-list
44427677|NCT02187744|Trastuzumab|trastuzumab|mesh-list
44427678|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427679|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
44427680|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
44427681|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
44427682|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427683|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44427684|NCT02187471|Pregabalin|pregabalin|mesh-list
44427685|NCT02187471|Analgesics|analgesics|mesh-ancestor
44266265|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266266|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44266268|NCT00657423|Cisplatin|cisplatin|mesh-list
44266269|NCT00657423|Docetaxel|docetaxel|mesh-list
44266270|NCT00657423|Endostar protein|endostar protein|mesh-list
44266271|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730550|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730552|NCT02563795|Analgesics|analgesics|mesh-ancestor
43730553|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43730554|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43730555|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
43730556|NCT02563847|Erythritol|erythritol|mesh-list
43730557|NCT02563847|Tryptophan|tryptophan|mesh-list
43730558|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43730564|NCT02563769|Cocaine|cocaine|mesh-list
44266272|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
44266273|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
44266274|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
44266275|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266276|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266277|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266278|NCT00657423|Growth Substances|growth substances|mesh-ancestor
43920790|NCT05533580|Sufentanil|sufentanil|mesh-list
44266279|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266280|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266282|NCT00657449|Rofecoxib|rofecoxib|mesh-list
44266283|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44266284|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44427686|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
44427687|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427688|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427706|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44427707|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427708|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427709|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44427710|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44427711|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44427712|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427713|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427716|NCT02187055|Tofacitinib|tofacitinib|mesh-list
44427717|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44427718|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
44427719|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44427720|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427721|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44427722|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
44427723|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427724|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427725|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427726|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427727|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44427728|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427729|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
44427730|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427731|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427732|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427733|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427734|NCT02186873|Golimumab|golimumab|mesh-list
44427735|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44427736|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427737|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427738|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
44266287|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44266288|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44266289|NCT00657449|Analgesics|analgesics|mesh-ancestor
44266290|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
43560978|NCT02763579|Antibodies|antibodies|mesh-list
43560979|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43560980|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
43560981|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560982|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560983|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560984|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43560985|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266291|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266292|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266293|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266294|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266295|NCT00657475|Heparin|heparin|mesh-list
44266296|NCT00657475|Calcium heparin|calcium heparin|mesh-list
44266297|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
44266298|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44427739|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427740|NCT02186821|Ceritinib|ceritinib|mesh-list
44427741|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427742|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427743|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427744|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427771|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427772|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427773|NCT02185014|Adalimumab|adalimumab|mesh-list
44427774|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427775|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427776|NCT02184611|Bromides|bromides|mesh-list
44427777|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
44427778|NCT02184572|Vaccines|vaccines|mesh-list
44427779|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
44427780|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427781|NCT02183675|Amlodipine|amlodipine|mesh-list
44427782|NCT02183675|Telmisartan|telmisartan|mesh-list
44427783|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44427784|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
44427785|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44427786|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44427787|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427788|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427789|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44427790|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427791|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
44427824|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427825|NCT02181842|Pioglitazone|pioglitazone|mesh-list
44427826|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427827|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427829|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44427830|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44427831|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44427859|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427860|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427861|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427862|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
44427863|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427864|NCT02181556|Aflibercept|aflibercept|mesh-list
44427865|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44427866|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44427867|NCT02181556|Growth Substances|growth substances|mesh-ancestor
44427868|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266300|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266301|NCT00657488|Thalidomide|thalidomide|mesh-list
44266302|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266303|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
43560991|NCT02737826|Narcotics|narcotics|mesh-ancestor
43560992|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560993|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560994|NCT02737826|Analgesics|analgesics|mesh-ancestor
43560995|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
43560996|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560997|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43560998|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
43560999|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44266304|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266305|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
44266306|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266307|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266308|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266309|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266310|NCT00657488|Growth Substances|growth substances|mesh-ancestor
44266311|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266312|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266313|NCT00657514|Ranolazine|ranolazine|mesh-list
44266314|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44427869|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
44427870|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427871|NCT02181504|Ranibizumab|ranibizumab|mesh-list
44427872|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44427873|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44427874|NCT02181504|Growth Substances|growth substances|mesh-ancestor
44427875|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427876|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44427877|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427892|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427893|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44427894|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
44427895|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427896|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44427897|NCT02180659|Buprenorphine|buprenorphine|mesh-list
44427898|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44427899|NCT02180659|Narcotics|narcotics|mesh-ancestor
44427900|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427901|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427902|NCT02180659|Analgesics|analgesics|mesh-ancestor
44427903|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
44427904|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427905|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44427906|NCT02180438|Tenofovir|tenofovir|mesh-list
44427907|NCT02180438|Emtricitabine|emtricitabine|mesh-list
44427908|NCT02180438|Cobicistat|cobicistat|mesh-list
44427909|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44427910|NCT02180438|Elvitegravir|elvitegravir|mesh-list
44427911|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
44427912|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427913|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44427914|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427915|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427916|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427917|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44427918|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44427919|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44427920|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44427921|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44427922|NCT02180165|Voriconazole|voriconazole|mesh-list
44427923|NCT02180165|Posaconazole|posaconazole|mesh-list
44266315|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266316|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266317|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44266318|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43561043|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
43561044|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561045|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561046|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
43561047|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730641|NCT02563340|Bortezomib|bortezomib|mesh-list
43730642|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266319|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44266320|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
44266321|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266322|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44266323|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44266324|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266325|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44266326|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44266327|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266328|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
44266329|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44266330|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44266331|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44266332|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266333|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44266334|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44266335|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266336|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266337|NCT00657644|Urological Agents|urological agents|mesh-ancestor
44266338|NCT00657748|Triacetin|triacetin|mesh-list
44266339|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
44266340|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266341|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266342|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266358|NCT00657774|Prednisone|prednisone|mesh-list
44266359|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266360|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
44266361|NCT00657774|Hormones|hormones|mesh-ancestor
44266362|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266363|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266364|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44266365|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266366|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44266367|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266368|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44266369|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44266370|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266371|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266372|NCT00657839|Urological Agents|urological agents|mesh-ancestor
44266373|NCT00657852|Pamidronate|pamidronate|mesh-list
44266374|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44427924|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
44427925|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427926|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44427927|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44427928|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427929|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427930|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44427931|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
44427932|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427934|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43730666|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427935|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44427936|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44427937|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44427938|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
44427950|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427951|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
44427952|NCT02178995|Methylphenidate|methylphenidate|mesh-list
44427953|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44427954|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427955|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44427956|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44427957|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427958|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427959|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
44427960|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427961|NCT02178956|Paclitaxel|paclitaxel|mesh-list
44427962|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44427963|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427964|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
44427965|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
44427966|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
44427967|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427968|NCT02178709|Leucovorin|leucovorin|mesh-list
44427969|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
44427970|NCT02178709|Irinotecan|irinotecan|mesh-list
44427971|NCT02178709|Folfirinox|folfirinox|mesh-list
44427972|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427973|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44427974|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44427975|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266377|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44266378|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
44266379|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266380|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266381|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44266382|NCT00657878|Gemcitabine|gemcitabine|mesh-list
44266383|NCT00657878|Paclitaxel|paclitaxel|mesh-list
44266384|NCT00657878|Carboplatin|carboplatin|mesh-list
44266385|NCT00657878|Doxorubicin|doxorubicin|mesh-list
44266386|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44266387|NCT00657878|Topotecan|topotecan|mesh-list
44266388|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266389|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266390|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
44266391|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
44266392|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
44266393|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266394|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266395|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
44266396|NCT00657878|Antiviral Agents|antiviral agents|mesh-ancestor
44266397|NCT00657878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266398|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648297|NCT03871465|Triamcinolone|triamcinolone|mesh-list
43648298|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43648299|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43648300|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43730683|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43730684|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730686|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427976|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427977|NCT02178709|Antidotes|antidotes|mesh-ancestor
44427978|NCT02178709|Protective Agents|protective agents|mesh-ancestor
44427979|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427980|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
44427981|NCT02178709|Vitamins|vitamins|mesh-ancestor
44427982|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
44427983|NCT02178566|Treprostinil|treprostinil|mesh-list
44427984|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44427985|NCT02178553|Bupivacaine|bupivacaine|mesh-list
44427986|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
44427987|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
44427988|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427989|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427990|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
44427991|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427992|NCT02178358|Sorafenib|sorafenib|mesh-list
44427993|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427994|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427995|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427996|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427997|NCT02178059|Terbutaline|terbutaline|mesh-list
44427998|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44427999|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
44428000|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428001|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428002|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44266399|NCT00657878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266400|NCT00657878|Immunologic Factors|immunologic factors|mesh-ancestor
44266401|NCT00657878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266402|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266403|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44266404|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266405|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44266406|NCT00657891|Omalizumab|omalizumab|mesh-list
44266407|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266408|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43730732|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730733|NCT02562742|Ribavirin|ribavirin|mesh-list
43730734|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
43730735|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730736|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
43730737|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730738|NCT02562690|Thrombin|thrombin|mesh-list
43730739|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
43730740|NCT02562690|Coagulants|coagulants|mesh-ancestor
44266409|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
44266410|NCT00657904|Bicalutamide|bicalutamide|mesh-list
44266411|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
44266412|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44266413|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266414|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266415|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266416|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
44266417|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266418|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266419|NCT00657943|Insulin|insulin|mesh-list
44266420|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44266421|NCT00657943|Metformin|metformin|mesh-list
44266422|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
44266423|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
44266424|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44266425|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
44266426|NCT00657943|Protamines|protamines|mesh-list
44266427|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266428|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266445|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266446|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266447|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44266448|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266449|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44266450|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44266451|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266452|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266453|NCT00658177|Urological Agents|urological agents|mesh-ancestor
44266454|NCT00658255|Budesonide|budesonide|mesh-list
44266455|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
44266456|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266457|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44266458|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
44266459|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266460|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266461|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44266462|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
44266463|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
44266464|NCT00658255|Hormones|hormones|mesh-ancestor
44266465|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266466|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44266467|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44266468|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44266469|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
44266470|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266471|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266472|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
44266473|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43561085|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561086|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561087|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43561088|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561089|NCT02187991|Paclitaxel|paclitaxel|mesh-list
43561090|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561095|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561097|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
43561098|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43561099|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43561100|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266474|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266475|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44266476|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44266477|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44266478|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
44266480|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44266481|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44266482|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266483|NCT00658580|Cisplatin|cisplatin|mesh-list
44266484|NCT00658580|Etoposide|etoposide|mesh-list
44266485|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
44266486|NCT00658580|Epirubicin|epirubicin|mesh-list
44266487|NCT00658580|Ifosfamide|ifosfamide|mesh-list
44266488|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266489|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266490|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44266491|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266492|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659366|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44428019|NCT02177838|Antibodies|antibodies|mesh-list
44428020|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
44428021|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44428022|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
44428023|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428024|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428025|NCT02177786|Selonsertib|selonsertib|mesh-list
44428026|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44428027|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428028|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428029|NCT02177266|Colchicine|colchicine|mesh-list
44428030|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
44428031|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428032|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
44428033|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
44428034|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
44428035|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428036|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428037|NCT02177175|Carvedilol|carvedilol|mesh-list
44428038|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44428039|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44428040|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428041|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428042|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428043|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428044|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428045|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
44428046|NCT02177175|Protective Agents|protective agents|mesh-ancestor
44428047|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44428048|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428049|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44428050|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
44428051|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43763495|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43730761|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730763|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43730764|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730765|NCT02562508|Vaccines|vaccines|mesh-list
43730766|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
43730767|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730768|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
43730769|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43730770|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730771|NCT02562144|Lidocaine|lidocaine|mesh-list
43730772|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
44428052|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44428053|NCT02177032|Vaccines|vaccines|mesh-list
44428054|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
44428055|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44428056|NCT02177032|Antibodies|antibodies|mesh-list
44428057|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
44428058|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428059|NCT02176655|Aspirin|aspirin|mesh-list
44428060|NCT02176655|Sumatriptan|sumatriptan|mesh-list
44428061|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428062|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428071|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428072|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44428073|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44428074|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428075|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
44428076|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44266493|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266494|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266495|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44266496|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
44266497|NCT00658593|Gemcitabine|gemcitabine|mesh-list
44266498|NCT00658593|Capecitabine|capecitabine|mesh-list
44266499|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266500|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
44266501|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266502|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920973|NCT05169658|Antibodies|antibodies|mesh-list
44266504|NCT00658593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428077|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44428078|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44428079|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
44428080|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428081|NCT02176642|Oxybutynin|oxybutynin|mesh-list
44428082|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
44428083|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
44428084|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428085|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428086|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44428087|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44428088|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428089|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428090|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428091|NCT02176642|Urological Agents|urological agents|mesh-ancestor
44428092|NCT02176421|Lidocaine|lidocaine|mesh-list
44428093|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
44428094|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
44428095|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428096|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428097|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
44428098|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428099|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44428100|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44428101|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44428102|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428103|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428104|NCT02176356|Bimatoprost|bimatoprost|mesh-list
44428105|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44428106|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
44428107|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43730815|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
43730816|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730817|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730818|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428108|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44428109|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
44428110|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44428111|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44428112|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428113|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428114|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428115|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428116|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428117|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44428118|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428119|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428120|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44428121|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
44428122|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
44428123|NCT02176356|Protective Agents|protective agents|mesh-ancestor
44428124|NCT02176291|Buprenorphine|buprenorphine|mesh-list
44428125|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44266506|NCT00658593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266507|NCT00658593|Immunologic Factors|immunologic factors|mesh-ancestor
44266508|NCT00658593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266509|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44266510|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266511|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266512|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44266513|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266514|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266515|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462440|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44462441|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428127|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428143|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44428144|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428145|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44428146|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
44428147|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44428148|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44428149|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428150|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428151|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44428152|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44428153|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428154|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44428155|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44428156|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428157|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44428158|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44428160|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
44428161|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
44428162|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428163|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
44428164|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428165|NCT02175771|Fluticasone|fluticasone|mesh-list
44428166|NCT02175771|Xhance|xhance|mesh-list
44428167|NCT02175771|Albuterol|albuterol|mesh-list
44428168|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44428169|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44428170|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
44428171|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428172|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44428173|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
44428174|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428175|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428176|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44428177|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428178|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
44428179|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44428180|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44428181|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44428182|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428183|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428184|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428185|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
44428197|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44428198|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
44428199|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106612|NCT00076531|Leuprolide|leuprolide|mesh-list
44462442|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462443|NCT01529268|Cysteamine|cysteamine|mesh-list
44462444|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44462445|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462446|NCT01529112|Lenvatinib|lenvatinib|mesh-list
44462447|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462448|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462449|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462450|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462451|NCT01528969|Sorbitol|sorbitol|mesh-list
44462452|NCT01528969|Cathartics|cathartics|mesh-ancestor
44462453|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462454|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44462455|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44462456|NCT01528735|Ribavirin|ribavirin|mesh-list
44462457|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
44462458|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462459|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
44462460|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462461|NCT01528709|Atorvastatin|atorvastatin|mesh-list
44462462|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44462463|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44462464|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
43659392|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44428200|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428201|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428202|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
44428204|NCT02175225|Deferoxamine|deferoxamine|mesh-list
44428205|NCT02175225|Siderophores|siderophores|mesh-ancestor
44428206|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44428207|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
44428208|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
44428209|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428210|NCT02174848|Deferiprone|deferiprone|mesh-list
44428211|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44428212|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
44428213|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
44428214|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428215|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
44428216|NCT02174731|Hematinics|hematinics|mesh-ancestor
44428217|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44428218|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44428219|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44428220|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648301|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648303|NCT03871465|Hormones|hormones|mesh-ancestor
43730925|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
43730926|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730927|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730928|NCT02561117|Metronidazole|metronidazole|mesh-list
43730929|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730930|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43730935|NCT02561169|Antacids|antacids|mesh-ancestor
44428221|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428222|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428223|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44428224|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44428225|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44428226|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428227|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462465|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462466|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44462467|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44462468|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462469|NCT01528345|Fulvestrant|fulvestrant|mesh-list
44462470|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462471|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462472|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44462473|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44462474|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
44462475|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462476|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462477|NCT01528254|Metformin|metformin|mesh-list
44462478|NCT01528254|Vildagliptin|vildagliptin|mesh-list
44462479|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462480|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462481|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44462482|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
44462483|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462484|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462485|NCT01527682|Dorzolamide|dorzolamide|mesh-list
44462486|NCT01527682|Latanoprost|latanoprost|mesh-list
44462487|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44428228|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428229|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44428230|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44428231|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
44428232|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44428233|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44428234|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
44428235|NCT02174276|Tenofovir|tenofovir|mesh-list
44428236|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
44428237|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428238|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44428239|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44428240|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428241|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428242|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44428243|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44428244|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
44428245|NCT02173769|Olodaterol|olodaterol|mesh-list
44428246|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44428247|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
44428248|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428249|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428261|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428262|NCT02173054|Analgesics|analgesics|mesh-ancestor
44428263|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
44428264|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428265|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462488|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44462489|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44462490|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44462491|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462492|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833976|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
43833977|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462493|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
44462495|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462496|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
44462497|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462498|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462499|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44462500|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
44266517|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266518|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
44428266|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428267|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428268|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44428269|NCT02172040|Celecoxib|celecoxib|mesh-list
44428270|NCT02172040|Amlodipine|amlodipine|mesh-list
44428271|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428272|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44428273|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428274|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428275|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44428276|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428277|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
44428278|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428279|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428280|NCT02172040|Analgesics|analgesics|mesh-ancestor
44428281|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
44428282|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428283|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428284|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428285|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44428286|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44428287|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428288|NCT02171429|Adalimumab|adalimumab|mesh-list
44428289|NCT02171429|Etrolizumab|etrolizumab|mesh-list
44086264|NCT00021034|Taurolidine|taurolidine|mesh-list
44428290|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428292|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428293|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
44428294|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428295|NCT02171130|Glucagon|glucagon|mesh-list
44428296|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44428297|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428298|NCT02171130|Hormones|hormones|mesh-ancestor
44428299|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428300|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428301|NCT02171130|Incretins|incretins|mesh-ancestor
44428302|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44428303|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44428304|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561169|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43561170|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561171|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43561172|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43561173|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561174|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
43561175|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
43561176|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44428305|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44428306|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44428307|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428308|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266519|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266520|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266521|NCT00658892|Antibodies|antibodies|mesh-list
44266522|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
44266523|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266524|NCT00658918|Ciclesonide|ciclesonide|mesh-list
44266525|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
44266526|NCT00658918|Hormones|hormones|mesh-ancestor
44266527|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266528|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266529|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266530|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44266531|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44266532|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266533|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266534|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266535|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266536|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266537|NCT00658931|Analgesics|analgesics|mesh-ancestor
44266538|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
44266539|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266540|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266541|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266542|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
44266543|NCT00658957|Gentamicins|gentamicins|mesh-list
44266544|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266545|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266546|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44266547|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266548|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428309|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
44428310|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428311|NCT02170207|Lansoprazole|lansoprazole|mesh-list
44428342|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44428343|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428344|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428345|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428346|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428347|NCT02169791|Ixazomib|ixazomib|mesh-list
44428348|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428349|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
44266550|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266551|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266552|NCT00659022|Bevacizumab|bevacizumab|mesh-list
44266553|NCT00659022|Capecitabine|capecitabine|mesh-list
44266554|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
44266555|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266556|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266557|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266558|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266559|NCT00659022|Growth Substances|growth substances|mesh-ancestor
44266560|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266561|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266562|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266563|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
44428350|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428351|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428352|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44428421|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
44428422|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428423|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428455|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43731027|NCT02560376|Incretins|incretins|mesh-ancestor
44428456|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44428457|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44428458|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44428459|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44428460|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44428461|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44428462|NCT02168816|Renal Agents|renal agents|mesh-ancestor
44428463|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
44428464|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44428465|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44428466|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44428467|NCT02168803|Evacetrapib|evacetrapib|mesh-list
44428468|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44428469|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44428470|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
44428498|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44428499|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44428500|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44428501|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428502|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44428503|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
44428504|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
44428505|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
44428506|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
44428507|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
44428508|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44428509|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
44428510|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428511|NCT02168387|Expectorants|expectorants|mesh-ancestor
44428512|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428513|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44428514|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
44428515|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731089|NCT02559674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731090|NCT02559648|Denosumab|denosumab|mesh-list
43731091|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43731092|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731093|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
43731094|NCT02559440|Phenylephrine|phenylephrine|mesh-list
43731095|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
43731096|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561178|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561179|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43561180|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561181|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43731097|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
43731098|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44428516|NCT02168387|Protective Agents|protective agents|mesh-ancestor
44428523|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428524|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428525|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
44428526|NCT02168270|Protective Agents|protective agents|mesh-ancestor
44266564|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266565|NCT00659048|Ciclesonide|ciclesonide|mesh-list
44266566|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
44266567|NCT00659048|Hormones|hormones|mesh-ancestor
44266568|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266569|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266570|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266571|NCT00659074|Ondansetron|ondansetron|mesh-list
44266572|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
44266573|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
44266574|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266575|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266576|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266577|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
44428527|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428528|NCT02168270|Vitamins|vitamins|mesh-ancestor
44428529|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
44428530|NCT02168101|Ixazomib|ixazomib|mesh-list
44428531|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428532|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
44428533|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428534|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428535|NCT02167893|Leuprolide|leuprolide|mesh-list
44428536|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44428537|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
44428538|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44428539|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428540|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428541|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428542|NCT02167451|Maraviroc|maraviroc|mesh-list
44428543|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44428544|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44428545|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428546|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44428547|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44428548|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
44428549|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428550|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44428551|NCT02167256|Saracatinib|saracatinib|mesh-list
44428552|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428553|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428554|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428555|NCT02167139|Adalimumab|adalimumab|mesh-list
44428556|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428557|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428558|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
44428559|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44428560|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44428561|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731114|NCT02559440|Protective Agents|protective agents|mesh-ancestor
43731115|NCT02559388|Montelukast|montelukast|mesh-list
43731116|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731117|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
43731118|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43731119|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
43731120|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731121|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731122|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43731125|NCT02559297|Sevoflurane|sevoflurane|mesh-list
44428562|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428563|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428564|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428565|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44428566|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44428567|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44428568|NCT02166697|Candesartan|candesartan|mesh-list
44428569|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
44428570|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428571|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44428572|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44266578|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44266579|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44266580|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
44266581|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266582|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266583|NCT00659074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44266584|NCT00659074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266585|NCT00659074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266586|NCT00659074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266587|NCT00659074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44266588|NCT00659100|Gabapentin|gabapentin|mesh-list
44266589|NCT00659100|Analgesics|analgesics|mesh-ancestor
44266590|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
44266591|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266592|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266593|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
44266594|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44266595|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266596|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266597|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266598|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44266599|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44266600|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266601|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266602|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
44266603|NCT00659113|Cisplatin|cisplatin|mesh-list
44266604|NCT00659113|Tegafur|tegafur|mesh-list
44266605|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266606|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266607|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
44266608|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266609|NCT00659178|Doxorubicin|doxorubicin|mesh-list
44266610|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44266611|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266612|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266613|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44428573|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266614|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266616|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266617|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
44266618|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
43731155|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731156|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43731157|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43731158|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43731159|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266619|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44266620|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266621|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266622|NCT00659321|Nicotine|nicotine|mesh-list
44266623|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44266624|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
44266625|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266626|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266627|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44266628|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44266629|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
44266630|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266631|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266632|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
44266633|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44266634|NCT00659386|Antibodies|antibodies|mesh-list
44266635|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
44428574|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44428575|NCT02166476|Levofloxacin|levofloxacin|mesh-list
44428576|NCT02166476|Ofloxacin|ofloxacin|mesh-list
44428577|NCT02166476|Meropenem|meropenem|mesh-list
44428578|NCT02166476|Tazobactam|tazobactam|mesh-list
44428579|NCT02166476|Piperacillin|piperacillin|mesh-list
44428580|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44428581|NCT02166476|Vaborbactam|vaborbactam|mesh-list
44428582|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44428583|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428584|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44428585|NCT02166476|Renal Agents|renal agents|mesh-ancestor
44428612|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44428613|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428614|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428615|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
44428616|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428617|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44428618|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44428619|NCT02164981|Nitroprusside|nitroprusside|mesh-list
44428620|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428621|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
44428622|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44428623|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428624|NCT02164929|Acetaminophen|acetaminophen|mesh-list
44428625|NCT02164929|Dexamethasone|dexamethasone|mesh-list
44428626|NCT02164929|Lidocaine|lidocaine|mesh-list
44428627|NCT02164929|Epinephrine|epinephrine|mesh-list
44428628|NCT02164929|Midazolam|midazolam|mesh-list
44428629|NCT02164929|Hydromorphone|hydromorphone|mesh-list
44428630|NCT02164929|Ropivacaine|ropivacaine|mesh-list
44428631|NCT02164929|Propofol|propofol|mesh-list
44266637|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
44266638|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266639|NCT00659399|PENTA|penta|mesh-list
44266640|NCT00659399|Fondaparinux|fondaparinux|mesh-list
44266641|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44266642|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
44266643|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44266644|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
44266645|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266646|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266647|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
44266648|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44266649|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44266650|NCT00659412|Methotrexate|methotrexate|mesh-list
43648304|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648305|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648306|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561236|NCT02989597|Ketamine|ketamine|mesh-list
44266651|NCT00659412|Alefacept|alefacept|mesh-list
44428632|NCT02164929|Sevoflurane|sevoflurane|mesh-list
44428633|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428634|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
44428635|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
44428636|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428666|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44428667|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44428668|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44428669|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44428670|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428671|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44428672|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44428673|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44428674|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428675|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
44428676|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
44428677|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44428678|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44428679|NCT02164929|Narcotics|narcotics|mesh-ancestor
44428680|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44428681|NCT02164916|Cetuximab|cetuximab|mesh-list
44428682|NCT02164916|Irinotecan|irinotecan|mesh-list
44428719|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
44428720|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44428721|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44428770|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428771|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44428772|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428773|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428774|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44428775|NCT02163447|Renal Agents|renal agents|mesh-ancestor
44428776|NCT02162862|Bupropion|bupropion|mesh-list
44428777|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44428778|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
44428779|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428780|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44428781|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44428782|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428783|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428784|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
44428785|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428786|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428787|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44428788|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44266652|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44266653|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
43561278|NCT02975271|Serlopitant|serlopitant|mesh-list
43561279|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43561280|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561281|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561282|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561283|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43561284|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
43561285|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
43561286|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561287|NCT02971891|Furosemide|furosemide|mesh-list
44266654|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44266655|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266656|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266657|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
44266658|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266659|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266660|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
44266661|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266662|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44266663|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266664|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
44266665|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266666|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44266667|NCT00659451|Losartan|losartan|mesh-list
44266668|NCT00659451|Amlodipine|amlodipine|mesh-list
44428789|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428790|NCT02162771|Prednisone|prednisone|mesh-list
44428791|NCT02162771|Prednisolone|prednisolone|mesh-list
44428792|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
44428793|NCT02162771|Rituximab|rituximab|mesh-list
44428794|NCT02162771|Vincristine|vincristine|mesh-list
44428795|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44428796|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
44428797|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428798|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428799|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44428800|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
44428801|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428802|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428803|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44428804|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44428805|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428806|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
44428807|NCT02162771|Hormones|hormones|mesh-ancestor
44428808|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428809|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428810|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44428811|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
44428812|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
44428813|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
44428814|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
44428815|NCT02162758|Lansoprazole|lansoprazole|mesh-list
44428816|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44428817|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428818|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44428819|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428820|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428821|NCT02162719|Paclitaxel|paclitaxel|mesh-list
43561311|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
43561312|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561313|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561324|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561325|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561326|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
43561327|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561328|NCT02866227|TOL-463|tol-463|mesh-list
43731203|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44428822|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44428823|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428824|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
44428825|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
44428826|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
44428827|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428853|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44428854|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44428856|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428857|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
44428858|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428859|NCT02161562|Omalizumab|omalizumab|mesh-list
44428860|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44428861|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44428862|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44428863|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428864|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
44428865|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428866|NCT02161458|Dexetimide|dexetimide|mesh-list
44428867|NCT02161458|Citalopram|citalopram|mesh-list
44428868|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44428869|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44428870|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428871|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428872|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428873|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
44428874|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428875|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44428888|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428889|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428890|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44428891|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
44428892|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428893|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428895|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44428896|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44428897|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428898|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428899|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44428900|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44428901|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428902|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44428903|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
44428904|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
44428905|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
44428906|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
44428907|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428908|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428909|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44428910|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428911|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428912|NCT02161146|Analgesics|analgesics|mesh-ancestor
44428913|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
44428914|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428915|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561341|NCT02822508|Laxatives|laxatives|mesh-list
44428916|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428917|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428918|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44428919|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44428920|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44428921|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
44428922|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
44428923|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428924|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428925|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44428926|NCT02160145|Tolvaptan|tolvaptan|mesh-list
44428927|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44428928|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428929|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
44428930|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428931|NCT02160041|Infigratinib|infigratinib|mesh-list
44428932|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428933|NCT02159950|Vaccines|vaccines|mesh-list
44428934|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
44428935|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428936|NCT02159807|Fentanyl|fentanyl|mesh-list
44428937|NCT02159807|Bupivacaine|bupivacaine|mesh-list
44428938|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
44106613|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44266669|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44266670|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44266671|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266672|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266673|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44266674|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266675|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
44266676|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44266677|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44266678|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44266679|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
44266680|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266681|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428969|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428970|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428971|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428972|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428973|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
44428974|NCT02159365|Dexamethasone|dexamethasone|mesh-list
44428975|NCT02159365|Lenalidomide|lenalidomide|mesh-list
44428976|NCT02159365|Elotuzumab|elotuzumab|mesh-list
44428977|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428978|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
44428979|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
44428980|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428981|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428982|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428983|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
44428984|NCT02159365|Hormones|hormones|mesh-ancestor
44428985|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428997|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44428998|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
44428999|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561369|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43834014|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834015|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43834016|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43834017|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
43834018|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834020|NCT05169957|Ipilimumab|ipilimumab|mesh-list
44429000|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429001|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44429002|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44429003|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
44429004|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429005|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44429006|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44429007|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44429008|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
44429009|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429010|NCT02159040|Azacitidine|azacitidine|mesh-list
44429011|NCT02159040|Deferasirox|deferasirox|mesh-list
44429012|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429013|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
44429014|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429015|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429016|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429017|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44429018|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
44429019|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
44429021|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731212|NCT02558972|Droxidopa|droxidopa|mesh-list
44429022|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
44429023|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106614|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
44266683|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
44266684|NCT00659503|Hormones|hormones|mesh-ancestor
44266685|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266686|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266687|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266688|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44266689|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44266690|NCT00659568|Metformin|metformin|mesh-list
44266691|NCT00659568|Sirolimus|sirolimus|mesh-list
44266692|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266693|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266694|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44266695|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266696|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44266697|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731213|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43731214|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43731215|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43731216|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
43731217|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731218|NCT02558933|Protective Agents|protective agents|mesh-ancestor
43731219|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561414|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561415|NCT02771626|Nivolumab|nivolumab|mesh-list
43561416|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561417|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266698|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
44429024|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429025|NCT02158936|Azacitidine|azacitidine|mesh-list
44429026|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429027|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
44429028|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429029|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429030|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429031|NCT02158806|Aspirin|aspirin|mesh-list
44429032|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44429033|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429034|NCT02158806|Analgesics|analgesics|mesh-ancestor
44429035|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
44429036|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429037|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429038|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429039|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429040|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44429041|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44429042|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429043|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44429044|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44429045|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429046|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
44429047|NCT02158533|Naltrexone|naltrexone|mesh-list
44429048|NCT02158533|Buprenorphine|buprenorphine|mesh-list
44429049|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44429050|NCT02158533|Narcotics|narcotics|mesh-ancestor
44429051|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429073|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429075|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
44429076|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429077|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44429078|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44429079|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44429080|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429081|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429082|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44429083|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429084|NCT02157948|Denosumab|denosumab|mesh-list
44429085|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44429086|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429087|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
44266699|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266701|NCT00659594|Ciclesonide|ciclesonide|mesh-list
44266702|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
44266703|NCT00659594|Hormones|hormones|mesh-ancestor
44266704|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266705|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266706|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266707|NCT00659659|Benralizumab|benralizumab|mesh-list
44266708|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43561425|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
43561426|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561427|NCT02744833|Enoxaparin|enoxaparin|mesh-list
43561428|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
43561429|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
43561430|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43561431|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43561432|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561433|NCT02741791|Bupropion|bupropion|mesh-list
43561435|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266709|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
44266710|NCT00659685|Ondansetron|ondansetron|mesh-list
44266711|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
44266712|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
44266713|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266714|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266715|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266716|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
44266717|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
44266718|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44266719|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
44266720|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266721|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266722|NCT00659685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44266723|NCT00659685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266724|NCT00659685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266725|NCT00659685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266726|NCT00659685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44266727|NCT00659698|Pancrelipase|pancrelipase|mesh-list
44266728|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44266729|NCT00659750|Ciclesonide|ciclesonide|mesh-list
44266730|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
44266731|NCT00659750|Hormones|hormones|mesh-ancestor
44266732|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266733|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266734|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429088|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44429089|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44429090|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
44266735|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44266737|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44266738|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44266739|NCT00659841|Ciclesonide|ciclesonide|mesh-list
43921200|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266740|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
44266741|NCT00659841|Hormones|hormones|mesh-ancestor
44266742|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266743|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266744|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44266745|NCT00659919|Trazodone|trazodone|mesh-list
44266746|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44266747|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44266748|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44266749|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266750|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266751|NCT00659919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44266752|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266753|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266754|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266755|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266756|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
44266757|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44266758|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266759|NCT00659958|Zonisamide|zonisamide|mesh-list
44266760|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
44266761|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44266762|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429091|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429092|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429093|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429094|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429095|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44429096|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429097|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44429098|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429099|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429100|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429101|NCT02157376|Esomeprazole|esomeprazole|mesh-list
44429102|NCT02157376|Cimetidine|cimetidine|mesh-list
44429103|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44429108|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44429109|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
44266763|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266764|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44266765|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266766|NCT00659997|Albendazole|albendazole|mesh-list
44266767|NCT00659997|Levamisole|levamisole|mesh-list
44266768|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
44266769|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44266770|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266771|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
44266772|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44266773|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44266774|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
44266775|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
44266776|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
44266777|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266778|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266779|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44266780|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
44266781|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266782|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
44266783|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266784|NCT00660036|Etoposide|etoposide|mesh-list
44266785|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
44266786|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
43659549|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
44429111|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429112|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429113|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44429114|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44429115|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
44429116|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44429117|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429118|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429119|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731274|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731275|NCT02558452|Tacrolimus|tacrolimus|mesh-list
43731276|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731277|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
43731278|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731279|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43731280|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731281|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429120|NCT02157116|Cisplatin|cisplatin|mesh-list
44429121|NCT02157116|Docetaxel|docetaxel|mesh-list
44429122|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429123|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429124|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
44429125|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429126|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429127|NCT02156804|Nivolumab|nivolumab|mesh-list
44429128|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44429129|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429130|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44429131|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429132|NCT02156492|Atorvastatin|atorvastatin|mesh-list
44429133|NCT02156492|Simvastatin|simvastatin|mesh-list
44429134|NCT02156492|Evacetrapib|evacetrapib|mesh-list
44429135|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44266787|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266788|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266789|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44266790|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44266791|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266792|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266793|NCT00660036|Analgesics|analgesics|mesh-ancestor
44266794|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
44266795|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266796|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266797|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266798|NCT00660062|Dexetimide|dexetimide|mesh-list
44266799|NCT00660062|Citalopram|citalopram|mesh-list
44266800|NCT00660062|Nortriptyline|nortriptyline|mesh-list
44266801|NCT00660062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44266802|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266803|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266804|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266805|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266806|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
44266807|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266808|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44266809|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266810|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266811|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44266812|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44429136|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44429137|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
44429138|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429139|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44429140|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44429141|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429142|NCT02155985|Aspirin|aspirin|mesh-list
44429143|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44429144|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429145|NCT02155985|Analgesics|analgesics|mesh-ancestor
44429146|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
44429147|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429148|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648307|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
43648308|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561500|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43561501|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43561502|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
43561503|NCT02661282|Temozolomide|temozolomide|mesh-list
43561504|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43561505|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
43561507|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429149|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429150|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429151|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44429152|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44429153|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429154|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44266813|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
44266814|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
44266815|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266816|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44266817|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44266818|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
44266819|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44266820|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44266821|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44266822|NCT00660140|Gemcitabine|gemcitabine|mesh-list
44266823|NCT00660140|Carboplatin|carboplatin|mesh-list
44266824|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266825|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266826|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
43659569|NCT02937519|Cisplatin|cisplatin|mesh-list
44429155|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44429156|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429157|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
44429158|NCT02155881|Ciclesonide|ciclesonide|mesh-list
44429159|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
44429160|NCT02155881|Hormones|hormones|mesh-ancestor
44429161|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429162|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429163|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429164|NCT02155829|Riluzole|riluzole|mesh-list
44429165|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
44429166|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44429167|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44429168|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429169|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429170|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429171|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44429184|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44429185|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429187|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
44429188|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
44429189|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44429190|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429191|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
44429192|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429193|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
44429194|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429195|NCT02155309|Scopolamine|scopolamine|mesh-list
44429196|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44429197|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44429198|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
44429199|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
44429200|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429201|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429202|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429203|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
44429204|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44429205|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429206|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429207|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429208|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44429209|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
44429210|NCT02154529|Trastuzumab|trastuzumab|mesh-list
44429212|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44429213|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429214|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44266829|NCT00660140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266830|NCT00660140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266831|NCT00660140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266832|NCT00660140|Immunologic Factors|immunologic factors|mesh-ancestor
44266833|NCT00660140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266834|NCT00660231|Gemcitabine|gemcitabine|mesh-list
44266835|NCT00660231|Bexarotene|bexarotene|mesh-list
44266836|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266837|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
44266838|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266839|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266840|NCT00660231|Antiviral Agents|antiviral agents|mesh-ancestor
44266841|NCT00660231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266842|NCT00660231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266843|NCT00660231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266844|NCT00660231|Immunologic Factors|immunologic factors|mesh-ancestor
44266845|NCT00660231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266846|NCT00660244|Anastrozole|anastrozole|mesh-list
44266847|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44266848|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266849|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44266850|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44429215|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429216|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429217|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
44429218|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429219|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
44429220|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429221|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429222|NCT02154347|Mitiglinide|mitiglinide|mesh-list
44429223|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429224|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429225|NCT02154139|Leuprolide|leuprolide|mesh-list
44429226|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44429227|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
44429228|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429229|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429230|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44429231|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429233|NCT02154061|Vancomycin|vancomycin|mesh-list
44429234|NCT02154061|Neomycin|neomycin|mesh-list
44429235|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429236|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429237|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44429289|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429291|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
44429292|NCT02152371|Dulaglutide|dulaglutide|mesh-list
44429293|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266851|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266852|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266853|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44266854|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
44266855|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266856|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266857|NCT00660257|Vaccines|vaccines|mesh-list
44266858|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
44266859|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429294|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429295|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
44429296|NCT02152345|Abatacept|abatacept|mesh-list
44429297|NCT02152345|Tacrolimus|tacrolimus|mesh-list
44429298|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44429299|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
44429300|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429301|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
44429302|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429303|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44429304|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429305|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429306|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429307|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429308|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
44429309|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
44429310|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429311|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429312|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
44429313|NCT02152345|Hormones|hormones|mesh-ancestor
44429314|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429315|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44429316|NCT02152345|Protective Agents|protective agents|mesh-ancestor
44429317|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44429318|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429319|NCT02152163|Ibuprofen|ibuprofen|mesh-list
44429320|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44429321|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429322|NCT02152163|Analgesics|analgesics|mesh-ancestor
44429323|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
44429324|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429325|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429326|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429327|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429328|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44429329|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429330|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429331|NCT02152137|Paclitaxel|paclitaxel|mesh-list
44429332|NCT02152137|Efatutazone|efatutazone|mesh-list
44429333|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44429334|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429356|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429357|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429358|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429359|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429360|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44429361|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429362|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
44429363|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429364|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44429365|NCT02151786|Lansoprazole|lansoprazole|mesh-list
44429366|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
44429367|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44429368|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429369|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44429370|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266861|NCT00660270|Interferons|interferons|mesh-list
44266862|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
44266863|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44266864|NCT00660270|Cisplatin|cisplatin|mesh-list
44266865|NCT00660270|Fluorouracil|fluorouracil|mesh-list
44266866|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266867|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266868|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
44266869|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266870|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
44266871|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266872|NCT00660270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266873|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266874|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
44266875|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266876|NCT00660283|Temozolomide|temozolomide|mesh-list
44266877|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44266878|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
44266879|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266880|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266881|NCT00660335|Secretin|secretin|mesh-list
44266882|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429371|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429372|NCT02151773|Vaccines|vaccines|mesh-list
44429373|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
44429374|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429375|NCT02151682|Morphine|morphine|mesh-list
44429376|NCT02151682|Tapentadol|tapentadol|mesh-list
44429377|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44429378|NCT02151682|Narcotics|narcotics|mesh-ancestor
44429379|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429380|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429381|NCT02151682|Analgesics|analgesics|mesh-ancestor
44429382|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
44429383|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429384|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44429385|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44429386|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429387|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429413|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
44429414|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
44429415|NCT02151058|Protective Agents|protective agents|mesh-ancestor
44429416|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429417|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44429418|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429419|NCT02150954|Oxytocin|oxytocin|mesh-list
44429420|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
44429421|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429422|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429423|NCT02150213|Dexamethasone|dexamethasone|mesh-list
44429424|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429425|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
44429426|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
44266884|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266885|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266886|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
44266887|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
44266888|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
44266889|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44266890|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266891|NCT00660426|Gemcitabine|gemcitabine|mesh-list
44266892|NCT00660426|Capecitabine|capecitabine|mesh-list
44266893|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
44266894|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429427|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429428|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429429|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648336|NCT03729245|Sunitinib|sunitinib|mesh-list
43648337|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44429430|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
44429431|NCT02150213|Hormones|hormones|mesh-ancestor
44429432|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429433|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44429434|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429435|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
44429436|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
44429437|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44429438|NCT02149875|Protective Agents|protective agents|mesh-ancestor
44429439|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429465|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429466|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44429467|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429468|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429469|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429470|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
44429471|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
44429472|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429473|NCT02149108|Nintedanib|nintedanib|mesh-list
44429474|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429475|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44429476|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429477|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429478|NCT02148718|Adalimumab|adalimumab|mesh-list
44429479|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429480|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429481|NCT02148445|Nicotine|nicotine|mesh-list
44429482|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44429483|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
44429484|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429485|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429486|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44429487|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44429488|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429537|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
44429538|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429539|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429540|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44429541|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44429542|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429543|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429544|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429546|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44429547|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429548|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429549|NCT02146430|Pregabalin|pregabalin|mesh-list
44429550|NCT02146430|Analgesics|analgesics|mesh-ancestor
44266896|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266897|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266898|NCT00660426|Antiviral Agents|antiviral agents|mesh-ancestor
44266899|NCT00660426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266900|NCT00660426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266901|NCT00660426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266902|NCT00660426|Immunologic Factors|immunologic factors|mesh-ancestor
44266903|NCT00660426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266904|NCT00660582|Leucovorin|leucovorin|mesh-list
44266905|NCT00660582|Folic Acid|folic acid|mesh-list
44266906|NCT00660582|Fluorouracil|fluorouracil|mesh-list
44266907|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
44266908|NCT00660582|Cetuximab|cetuximab|mesh-list
44266909|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
44266910|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
44266911|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266912|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429551|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
43561616|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429552|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429553|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429554|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
44429555|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44429556|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429557|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429558|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44429559|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44429560|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44429561|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429562|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44429563|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44429564|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
44429565|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
44429591|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429592|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429593|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
44429594|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429595|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429596|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44429597|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429598|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44429599|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44429600|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
44429601|NCT02145026|Hematinics|hematinics|mesh-ancestor
44429602|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44429603|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44429604|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44429605|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429606|NCT02144012|Docetaxel|docetaxel|mesh-list
44429607|NCT02144012|Trastuzumab|trastuzumab|mesh-list
44429608|NCT02144012|Maytansine|maytansine|mesh-list
44429609|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44429610|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429611|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429612|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44429613|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429614|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429615|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266913|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266914|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266915|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
44266916|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266917|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266918|NCT00660582|Antidotes|antidotes|mesh-ancestor
44266919|NCT00660582|Protective Agents|protective agents|mesh-ancestor
44266920|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
44266922|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
44266923|NCT00660582|Hematinics|hematinics|mesh-ancestor
44266924|NCT00660621|Bevacizumab|bevacizumab|mesh-list
44266925|NCT00660621|Temozolomide|temozolomide|mesh-list
44266926|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44266927|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266928|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44266929|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44266930|NCT00660621|Growth Substances|growth substances|mesh-ancestor
44266931|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266932|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
44266933|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44266934|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
44266935|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429616|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44429648|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
44429650|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429651|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429652|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
44429653|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429654|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
44429655|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
44087643|NCT00023920|Idarubicin|idarubicin|mesh-list
44429656|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44429657|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44429658|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44429659|NCT02141997|Adalimumab|adalimumab|mesh-list
44429660|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429661|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429688|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429689|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429690|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
44429691|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429692|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429693|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44429695|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
44429696|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
44429697|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429698|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429699|NCT02141633|Fluticasone|fluticasone|mesh-list
44429700|NCT02141633|Xhance|xhance|mesh-list
44429701|NCT02141633|Albuterol|albuterol|mesh-list
44429702|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429703|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43648352|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
43648353|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648354|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
43648355|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648356|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648357|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731505|NCT02557373|Vitamin A|vitamin a|mesh-list
43731506|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
43731507|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
43731509|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
44266936|NCT00660647|Adalimumab|adalimumab|mesh-list
44266937|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44266938|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44266939|NCT00660725|Gemcitabine|gemcitabine|mesh-list
44266940|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
44266941|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44266942|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
44266943|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266944|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266945|NCT00660725|Antiviral Agents|antiviral agents|mesh-ancestor
44266946|NCT00660725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44266947|NCT00660725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266948|NCT00660725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44266949|NCT00660725|Immunologic Factors|immunologic factors|mesh-ancestor
44266950|NCT00660725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266951|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44266952|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44266953|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44266954|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44266955|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266956|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44266957|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429704|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
44429705|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429706|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429707|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429708|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429709|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429710|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429711|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
44429744|NCT02141490|Hematinics|hematinics|mesh-ancestor
44429745|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44429746|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44429747|NCT02141295|Leucovorin|leucovorin|mesh-list
44429748|NCT02141295|Folic Acid|folic acid|mesh-list
44429749|NCT02141295|Bevacizumab|bevacizumab|mesh-list
44429750|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
44429751|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
44429752|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834051|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43834052|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834053|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
43834054|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43834055|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834056|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834057|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43834058|NCT05168280|Analgesics|analgesics|mesh-ancestor
43834059|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
43834062|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44429753|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429754|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44429780|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429781|NCT02140970|Analgesics|analgesics|mesh-ancestor
44429782|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
44429783|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429784|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429785|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429786|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429787|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44429788|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429789|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266959|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
44266960|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44266961|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
44266962|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44266963|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
44462501|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921404|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44266964|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44266965|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44266966|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44266967|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
43659673|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
44429790|NCT02140645|Linagliptin|linagliptin|mesh-list
44429791|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429792|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429793|NCT02140645|Incretins|incretins|mesh-ancestor
44429794|NCT02140645|Hormones|hormones|mesh-ancestor
44429795|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429796|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44429797|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
44429798|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429799|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429800|NCT02140411|Ranibizumab|ranibizumab|mesh-list
44429801|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44429802|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44429803|NCT02140411|Growth Substances|growth substances|mesh-ancestor
44429804|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429842|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429873|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44429875|NCT02139046|Analgesics|analgesics|mesh-ancestor
44429876|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
44429877|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429878|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429879|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429880|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429881|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
44429882|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44429883|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429884|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648358|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
43648359|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731519|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
43731520|NCT02557269|Hormones|hormones|mesh-ancestor
43731521|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43731522|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731523|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44429885|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429922|NCT02137837|Fulvestrant|fulvestrant|mesh-list
44429923|NCT02137837|Anastrozole|anastrozole|mesh-list
44429924|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429957|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
44429958|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429959|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44429960|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44429961|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44429962|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44429963|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
44429991|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429992|NCT02136576|Listerine|listerine|mesh-list
44429993|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
44429994|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
44429995|NCT02136576|Protective Agents|protective agents|mesh-ancestor
44429996|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429997|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44429998|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429999|NCT02135445|Relugolix|relugolix|mesh-list
44430000|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
44266968|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266969|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44266970|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44266971|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44266973|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44266974|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266975|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44266976|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44266977|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659683|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
44430001|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
44430002|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430003|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430004|NCT02135107|Rabeprazole|rabeprazole|mesh-list
44430005|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44430006|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430007|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44430008|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430009|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430010|NCT02134977|Leuprolide|leuprolide|mesh-list
44430011|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44430012|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
44430040|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430041|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
44430042|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
44430043|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430044|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44088097|NCT00025064|Vinblastine|vinblastine|mesh-list
44430045|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44430046|NCT02133924|Protective Agents|protective agents|mesh-ancestor
44430047|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
44430048|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
44430049|NCT02133742|Axitinib|axitinib|mesh-list
44430050|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430051|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430052|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430053|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430054|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430055|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
44430056|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
43648360|NCT03609047|Paclitaxel|paclitaxel|mesh-list
43648361|NCT03609047|Docetaxel|docetaxel|mesh-list
43648362|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
43731583|NCT02556970|Analgesics|analgesics|mesh-ancestor
43731584|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
44430057|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430058|NCT02133664|Protective Agents|protective agents|mesh-ancestor
44430059|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430072|NCT02133001|Esketamine|esketamine|mesh-list
44430073|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
44430074|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44430075|NCT02132949|Paclitaxel|paclitaxel|mesh-list
44430076|NCT02132949|Docetaxel|docetaxel|mesh-list
44430077|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
44430078|NCT02132949|Doxorubicin|doxorubicin|mesh-list
44430079|NCT02132949|Fluorouracil|fluorouracil|mesh-list
44430080|NCT02132949|Trastuzumab|trastuzumab|mesh-list
44430081|NCT02132949|Epirubicin|epirubicin|mesh-list
44430082|NCT02132949|Pertuzumab|pertuzumab|mesh-list
44430083|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44430084|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430085|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430086|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430087|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430088|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430089|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430090|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
44430091|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430092|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430093|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44266978|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44266979|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266980|NCT00660842|Paclitaxel|paclitaxel|mesh-list
44266981|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44266982|NCT00660842|Carboplatin|carboplatin|mesh-list
44266983|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44266984|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44266985|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
44266986|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
44266987|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
44266988|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44266989|NCT00660855|Parecoxib|parecoxib|mesh-list
44266990|NCT00660855|Valdecoxib|valdecoxib|mesh-list
44266991|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44266992|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44266993|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430094|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
44430095|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44430096|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44430097|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44430098|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44430099|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430100|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
44430101|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44430102|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430103|NCT02132767|Digoxin|digoxin|mesh-list
44430104|NCT02132767|Amiodarone|amiodarone|mesh-list
44430105|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
44430106|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43561699|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43561700|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
43561701|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43561702|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43561703|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43561704|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
43561705|NCT02578771|Methylene Blue|methylene blue|mesh-list
43561706|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561707|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561708|NCT02570490|Linezolid|linezolid|mesh-list
43561726|NCT02564744|Rituximab|rituximab|mesh-list
44430107|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430108|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44430109|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44430110|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430111|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430112|NCT02132767|Protective Agents|protective agents|mesh-ancestor
44430113|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
44430114|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44430115|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430116|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44430117|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44430118|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44430119|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44430120|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44430121|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44430122|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
44430123|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430159|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430160|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430161|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44430162|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44430193|NCT02131272|Insulin|insulin|mesh-list
44430194|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44430195|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
44430196|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
44430198|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
44430199|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430200|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44266995|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44266996|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44266997|NCT00660855|Analgesics|analgesics|mesh-ancestor
44266998|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
44266999|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267000|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267001|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267002|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267003|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
44267004|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267005|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267006|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430201|NCT02131259|Afatinib|afatinib|mesh-list
44430202|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430203|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430204|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731599|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
43731600|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731601|NCT02556879|Hematinics|hematinics|mesh-ancestor
43731602|NCT02556866|Prednisone|prednisone|mesh-list
43731603|NCT02556866|Rituximab|rituximab|mesh-list
43731604|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731605|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731606|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
43731607|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731608|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43731609|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731610|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
43731611|NCT02556866|Hormones|hormones|mesh-ancestor
43731612|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430205|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430206|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
44430233|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430234|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430235|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44430236|NCT02130882|Benralizumab|benralizumab|mesh-list
44430237|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44430238|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430239|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
44430240|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430241|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430242|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430243|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430244|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
44430245|NCT02130466|Trametinib|trametinib|mesh-list
44430246|NCT02130466|Dabrafenib|dabrafenib|mesh-list
44430247|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430248|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430249|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430250|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430251|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430252|NCT02130284|Insulin|insulin|mesh-list
44430253|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44430254|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430280|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
44430281|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
44430282|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430283|NCT02128490|Naproxen|naproxen|mesh-list
44430284|NCT02128490|Colchicine|colchicine|mesh-list
44430285|NCT02128490|Febuxostat|febuxostat|mesh-list
44430286|NCT02128490|Lansoprazole|lansoprazole|mesh-list
44430287|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
44430288|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44430289|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44430290|NCT02128490|Analgesics|analgesics|mesh-ancestor
44430291|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
44430292|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430293|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430294|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430295|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430296|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
44430297|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267007|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267008|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44267009|NCT00660868|Protective Agents|protective agents|mesh-ancestor
44267010|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267011|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267012|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44267013|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
44267014|NCT00660894|Leucovorin|leucovorin|mesh-list
44267015|NCT00660894|Tegafur|tegafur|mesh-list
43561745|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561746|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561747|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43561748|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561749|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561750|NCT02539537|Leucovorin|leucovorin|mesh-list
43561751|NCT02539537|Folic Acid|folic acid|mesh-list
43561752|NCT02539537|Gemcitabine|gemcitabine|mesh-list
43561753|NCT02539537|Fluorouracil|fluorouracil|mesh-list
44267016|NCT00660894|Calcium|calcium|mesh-list
44267017|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
44267018|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44267019|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267020|NCT00660894|Antidotes|antidotes|mesh-ancestor
44267021|NCT00660894|Protective Agents|protective agents|mesh-ancestor
44267022|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
44267023|NCT00660894|Vitamins|vitamins|mesh-ancestor
44267024|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
44267025|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44267026|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
44267027|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267028|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267029|NCT00660920|Ponatinib|ponatinib|mesh-list
44267030|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267031|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267032|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267033|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267034|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44267035|NCT00660933|Hematinics|hematinics|mesh-ancestor
44267036|NCT00660972|Tenofovir|tenofovir|mesh-list
44267037|NCT00660972|Emtricitabine|emtricitabine|mesh-list
44267038|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
44267039|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44267040|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
44267041|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659710|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44430298|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430299|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430300|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430301|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430302|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44267042|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44267043|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44267044|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267045|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267046|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44267047|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44267048|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44267049|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44267050|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267051|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267052|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267053|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267054|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267055|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267056|NCT00660998|Urological Agents|urological agents|mesh-ancestor
44267057|NCT00661063|Clonidine|clonidine|mesh-list
44267058|NCT00661063|Ketamine|ketamine|mesh-list
44267059|NCT00661063|Analgesics|analgesics|mesh-ancestor
44267060|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
44267061|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267062|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267063|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44267064|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44267065|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
44267066|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
44267067|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267068|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44267069|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44267070|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267071|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267072|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44267073|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
44267074|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
44430331|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
44430332|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430333|NCT02126969|Carboplatin|carboplatin|mesh-list
44430334|NCT02126969|Docetaxel|docetaxel|mesh-list
44430335|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430336|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430337|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
44267075|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44267076|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44267077|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44267078|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
44267079|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44267080|NCT00661076|Adefovir|adefovir|mesh-list
44267081|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44267082|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
44267083|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267084|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44267085|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44267086|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267087|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267088|NCT00661102|Capecitabine|capecitabine|mesh-list
44267089|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44267090|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
44267091|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267092|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267093|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267094|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267095|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267096|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267097|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267098|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267099|NCT00661115|Urological Agents|urological agents|mesh-ancestor
44267100|NCT00661154|Bevacizumab|bevacizumab|mesh-list
44267101|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44267102|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267103|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44267104|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44267105|NCT00661154|Growth Substances|growth substances|mesh-ancestor
44267106|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267107|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
44267108|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43659726|NCT02935764|Leucovorin|leucovorin|mesh-list
44430338|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430339|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430340|NCT02126839|Albuterol|albuterol|mesh-list
44267110|NCT00661180|Sorafenib|sorafenib|mesh-list
44267111|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267112|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267113|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267114|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267115|NCT00661206|Clopidogrel|clopidogrel|mesh-list
44267116|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267117|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44267118|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44267119|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44267120|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
44267121|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267122|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267123|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267124|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267125|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267126|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267127|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267128|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267129|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267130|NCT00661219|Urological Agents|urological agents|mesh-ancestor
44267131|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267132|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267133|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267134|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44430341|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44430342|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
44430343|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430344|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430345|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44430346|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430347|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
44430348|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44430349|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44430350|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44430351|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44430352|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
44430365|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430366|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44430367|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430368|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
44430369|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44430370|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
44430371|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267136|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267137|NCT00661297|Urological Agents|urological agents|mesh-ancestor
44267139|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
44267140|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44267141|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
44267142|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267143|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267144|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44267145|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44267146|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
44267147|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267148|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
44267149|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44267150|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267151|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44267152|NCT00661336|Protective Agents|protective agents|mesh-ancestor
44267154|NCT00661349|Lopinavir|lopinavir|mesh-list
44267155|NCT00661349|Nevirapine|nevirapine|mesh-list
44267156|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44267157|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44267158|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
44267159|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267160|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267161|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44267162|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44267163|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
44267164|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267165|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44267166|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44267167|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44267168|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44267169|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44430372|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430373|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
44267173|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267174|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267175|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267176|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
44267177|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
44267178|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267179|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267180|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267181|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267182|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43561857|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44267183|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267184|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267185|NCT00661596|Urological Agents|urological agents|mesh-ancestor
44267186|NCT00661635|Valdecoxib|valdecoxib|mesh-list
44267187|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44267188|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44430374|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44430375|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430376|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430377|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
44430378|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430382|NCT02125279|Calcitriol|calcitriol|mesh-list
44430383|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44430384|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430385|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44430386|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430387|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430388|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44430389|NCT02125279|Vitamins|vitamins|mesh-ancestor
44430390|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
44430391|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44430392|NCT02124811|Minocycline|minocycline|mesh-list
44430393|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430394|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430395|NCT02124798|Belimumab|belimumab|mesh-list
44430396|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430397|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
44430398|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430399|NCT02124772|Trametinib|trametinib|mesh-list
44430400|NCT02124772|Dabrafenib|dabrafenib|mesh-list
44430401|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430402|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430403|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430404|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430405|NCT02124759|Sevelamer|sevelamer|mesh-list
44430406|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
44430407|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
44430408|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561858|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43561859|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
43561860|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561861|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
43561862|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561863|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561864|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561865|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561866|NCT02471222|Analgesics|analgesics|mesh-ancestor
43561867|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
44106615|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44267189|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267190|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267191|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267192|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267193|NCT00661635|Analgesics|analgesics|mesh-ancestor
44267194|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
44267195|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267196|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267197|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267198|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267199|NCT00661648|Pancrelipase|pancrelipase|mesh-list
44267200|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44267201|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43659746|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
44430409|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44430410|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430411|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430412|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430443|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44430444|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430445|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430446|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44430447|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44430448|NCT02123576|Protective Agents|protective agents|mesh-ancestor
44430449|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430450|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
44430451|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44430452|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
44430453|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
44430454|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44430455|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
44430456|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430457|NCT02123511|Expectorants|expectorants|mesh-ancestor
44430458|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430490|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430491|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430492|NCT02122770|Itraconazole|itraconazole|mesh-list
44430493|NCT02122770|Fluconazole|fluconazole|mesh-list
44430494|NCT02122770|Paclitaxel|paclitaxel|mesh-list
44430495|NCT02122770|Docetaxel|docetaxel|mesh-list
44430496|NCT02122770|Carboplatin|carboplatin|mesh-list
44430497|NCT02122770|Pevonedistat|pevonedistat|mesh-list
44430498|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44430499|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430500|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430501|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430502|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430503|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430504|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
44430533|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430534|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
43648364|NCT03609047|Epirubicin|epirubicin|mesh-list
43648365|NCT03609047|Palbociclib|palbociclib|mesh-list
43648366|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561906|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561907|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
43561908|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561909|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
43561910|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430535|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430536|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
44430537|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430538|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430539|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430540|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44430541|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44430542|NCT02121847|Laxatives|laxatives|mesh-ancestor
44430543|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44267202|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267203|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267204|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267205|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267206|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267207|NCT00661700|Urological Agents|urological agents|mesh-ancestor
44267208|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44267209|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44267210|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
44267211|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267212|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267213|NCT00661765|Varenicline|varenicline|mesh-list
44267214|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44267215|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44267216|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
44267217|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267218|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267219|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267220|NCT00661856|Genistein|genistein|mesh-list
44267221|NCT00661856|Daidzein|daidzein|mesh-list
44267222|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44267223|NCT00661856|Protective Agents|protective agents|mesh-ancestor
44267224|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267225|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267226|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430544|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44430545|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
44430546|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430609|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430611|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44430612|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
44430613|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430614|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430615|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
44430616|NCT02120833|Decanoic acid|decanoic acid|mesh-list
44430617|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
44430618|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430619|NCT02120794|Insulin|insulin|mesh-list
44430620|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430621|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430622|NCT02120664|Corticosterone|corticosterone|mesh-list
44430623|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430624|NCT02120469|Everolimus|everolimus|mesh-list
44430625|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430626|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430627|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
44430628|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430629|NCT02120417|Capecitabine|capecitabine|mesh-list
44430630|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44267227|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267228|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267229|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
44267230|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44267231|NCT00661856|Estrogens|estrogens|mesh-ancestor
44267232|NCT00661856|Hormones|hormones|mesh-ancestor
44267233|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267234|NCT00661973|Budesonide|budesonide|mesh-list
43731756|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731757|NCT02555800|Growth Substances|growth substances|mesh-ancestor
43731759|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
44267235|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267236|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44267237|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
44267238|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267239|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267240|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44267241|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267242|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
44267243|NCT00661973|Hormones|hormones|mesh-ancestor
44267244|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267245|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
44267246|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44267247|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267248|NCT00662220|Ribavirin|ribavirin|mesh-list
44267249|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44430648|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430649|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44430650|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44430651|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430652|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44430653|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44430654|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
44430655|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430656|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430658|NCT02119819|Exenatide|exenatide|mesh-list
44430659|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430660|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430661|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44430662|NCT02119819|Incretins|incretins|mesh-ancestor
44430663|NCT02119819|Hormones|hormones|mesh-ancestor
44430664|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430665|NCT02119663|Capecitabine|capecitabine|mesh-list
44430666|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44430667|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
44430668|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430669|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430670|NCT02119650|Cisplatin|cisplatin|mesh-list
44430671|NCT02119650|Pemetrexed|pemetrexed|mesh-list
44430672|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430673|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430674|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430675|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44430676|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44430677|NCT02119416|Caffeine|caffeine|mesh-list
44267251|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
44267252|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267253|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
44267254|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267255|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
44267256|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267257|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
44267259|NCT00662233|Doxorubicin|doxorubicin|mesh-list
44267260|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44267261|NCT00662233|Etoposide|etoposide|mesh-list
44267262|NCT00662233|Vincristine|vincristine|mesh-list
44267263|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44267264|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
44430678|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44430679|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430680|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44430681|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430682|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430683|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44430684|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44430685|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
44430686|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430687|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44430688|NCT02119156|Belimumab|belimumab|mesh-list
44430712|NCT02118961|Vaccines|vaccines|mesh-list
44430713|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
44430714|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430715|NCT02118896|Tacrolimus|tacrolimus|mesh-list
44430716|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430717|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
44430718|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430719|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44430720|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430721|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430722|NCT02118714|Atrasentan|atrasentan|mesh-list
44430723|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430724|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44430725|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44430726|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430727|NCT02118597|Interferons|interferons|mesh-list
44430728|NCT02118597|Ribavirin|ribavirin|mesh-list
44430729|NCT02118597|Simeprevir|simeprevir|mesh-list
44430730|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430731|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
44430732|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430733|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
44088830|NCT00026130|Antiviral Agents|antiviral agents|mesh-ancestor
44430734|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430735|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
44430736|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430737|NCT02118337|Nivolumab|nivolumab|mesh-list
44430738|NCT02118337|Durvalumab|durvalumab|mesh-list
44430739|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430770|NCT02117479|Capecitabine|capecitabine|mesh-list
44430771|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44430772|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
44430773|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430774|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430775|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44430776|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44430777|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
44430778|NCT02117349|Coagulants|coagulants|mesh-ancestor
44430779|NCT02117050|Interferons|interferons|mesh-list
44267266|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267267|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44267268|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
44267269|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267270|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267271|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44267272|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44267273|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44267274|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44267275|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267276|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44267277|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
44267278|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
44267279|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
44267281|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
44267282|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659801|NCT02935972|Lidocaine|lidocaine|mesh-list
44430780|NCT02117050|Interferon-beta|interferon-beta|mesh-list
44430781|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
44430782|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430783|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
44430816|NCT02116972|FX006|fx006|mesh-list
44430817|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430818|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
44430819|NCT02116972|Hormones|hormones|mesh-ancestor
44430820|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430821|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430822|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430823|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
44430824|NCT02116803|Fulvestrant|fulvestrant|mesh-list
44430825|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430826|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430890|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430891|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430892|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44430893|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430895|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430896|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430897|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
44430898|NCT02116530|Hormones|hormones|mesh-ancestor
44430899|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430900|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430901|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44430902|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44430903|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44430904|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430905|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
44430906|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430907|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44430908|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
44430909|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430943|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44267284|NCT00662337|Promethazine|promethazine|mesh-list
44267285|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44267286|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44267287|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267288|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267289|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
44267290|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
44267291|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
44267292|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267293|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
44267294|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
44267295|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44267296|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44267297|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
44267298|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
44267299|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267300|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267301|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44267302|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
44267303|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267304|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267305|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267306|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267307|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267308|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267309|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267310|NCT00662441|Urological Agents|urological agents|mesh-ancestor
44267311|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44267312|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44267313|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
44267314|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44267315|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44267316|NCT00662454|Estradiol|estradiol|mesh-list
44267317|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44267323|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
44267324|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44267325|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44267326|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44267327|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44267328|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44267329|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44267330|NCT00662467|Aspirin|aspirin|mesh-list
44267331|NCT00662467|Warfarin|warfarin|mesh-list
44267332|NCT00662467|Clopidogrel|clopidogrel|mesh-list
43921732|NCT00565916|Estradiol|estradiol|mesh-list
44267333|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267334|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267335|NCT00662467|Analgesics|analgesics|mesh-ancestor
44267336|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
44267337|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267338|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267339|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430944|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430945|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
44430946|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
44430983|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44430984|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430985|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431052|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431053|NCT02113007|Rituximab|rituximab|mesh-list
44431054|NCT02113007|Temozolomide|temozolomide|mesh-list
44431055|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44431056|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431057|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
44431058|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431059|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431060|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44431061|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
44431062|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431063|NCT02112448|Acetaminophen|acetaminophen|mesh-list
44431064|NCT02112448|Ketorolac|ketorolac|mesh-list
44431065|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44431066|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44431067|NCT02112448|Analgesics|analgesics|mesh-ancestor
44431068|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
44431124|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44431125|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431126|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431127|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431128|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
44431130|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
44431131|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44431132|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431133|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431134|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
44431135|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431136|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431137|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44431138|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43731906|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43731907|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731908|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731909|NCT02554851|Mitogens|mitogens|mesh-list
43731910|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
43731911|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731912|NCT02554734|Levodopa|levodopa|mesh-list
43731913|NCT02554734|Carbidopa|carbidopa|mesh-list
43731914|NCT02554734|Entacapone|entacapone|mesh-list
43731915|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43561991|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
43561992|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
43561993|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431139|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
44267342|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44267343|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267344|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267345|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267346|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267347|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
44431140|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44431141|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44431142|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
44431143|NCT02111096|Metformin|metformin|mesh-list
44431144|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44431145|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431188|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431189|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44431190|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44431192|NCT02109484|Vaccines|vaccines|mesh-list
44431193|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
44431194|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431195|NCT02109445|Gemcitabine|gemcitabine|mesh-list
44431196|NCT02109445|Paclitaxel|paclitaxel|mesh-list
44431197|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44431198|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44431199|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431200|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
44431201|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
44431202|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431203|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431204|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431205|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
44431206|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
44431207|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431208|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431209|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431210|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
44431211|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431212|NCT02109133|Rocuronium|rocuronium|mesh-list
44431213|NCT02109133|Atracurium|atracurium|mesh-list
44431214|NCT02109133|Neostigmine|neostigmine|mesh-list
44431215|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44431216|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44431217|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44431218|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431219|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431220|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44431221|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431222|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431223|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
44431224|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431225|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44431226|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
44431227|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44431228|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44431229|NCT02109029|Insulin|insulin|mesh-list
44431230|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44431231|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431232|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431233|NCT02108964|Nazartinib|nazartinib|mesh-list
44431234|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431235|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44431236|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
44431237|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431238|NCT02107703|Fulvestrant|fulvestrant|mesh-list
44431239|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44431240|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731947|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267348|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44267349|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44267350|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44267351|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
44267352|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267353|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
44267354|NCT00662519|Lenograstim|lenograstim|mesh-list
44267355|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44267356|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
44267357|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267358|NCT00662571|Acamprosate|acamprosate|mesh-list
44267359|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44267360|NCT00662610|Naproxen|naproxen|mesh-list
44267361|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44267362|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267363|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267364|NCT00662610|Analgesics|analgesics|mesh-ancestor
44267365|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
44267366|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267367|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267368|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267369|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267370|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
44267371|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267372|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267373|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267374|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44267375|NCT00662636|Dasatinib|dasatinib|mesh-list
44267376|NCT00662636|Lapatinib|lapatinib|mesh-list
44267377|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267378|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267379|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267380|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267381|NCT00662714|Insulin|insulin|mesh-list
44267382|NCT00662714|Repaglinide|repaglinide|mesh-list
44267390|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267391|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267392|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44267393|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267394|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44267395|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44267396|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44267397|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44267398|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267399|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267400|NCT00662805|Fluticasone|fluticasone|mesh-list
43561994|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561995|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561996|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561997|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
43561998|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561999|NCT01590719|Antidotes|antidotes|mesh-ancestor
43562000|NCT01590719|Protective Agents|protective agents|mesh-ancestor
43562001|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
43562002|NCT01590719|Vitamins|vitamins|mesh-ancestor
43562003|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
43562004|NCT01590719|Hematinics|hematinics|mesh-ancestor
43562005|NCT01578655|Prednisone|prednisone|mesh-list
43562006|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562007|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
43562008|NCT01578655|Hormones|hormones|mesh-ancestor
44267401|NCT00662805|Xhance|xhance|mesh-list
44267402|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44267403|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431241|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44431242|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44431243|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
44431244|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431245|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431246|NCT02107274|Azithromycin|azithromycin|mesh-list
44431247|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44431248|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431249|NCT02107131|Ranibizumab|ranibizumab|mesh-list
44431319|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431320|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
44431321|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44431339|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44431340|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
44431341|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
44431342|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431343|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44431344|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44431345|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431346|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431347|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44431348|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44431349|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44431350|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
44431351|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
44431352|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431353|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44431354|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
44431355|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
44431356|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44431357|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
44431358|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431359|NCT02106156|Interferons|interferons|mesh-list
44431360|NCT02106156|Ribavirin|ribavirin|mesh-list
44431361|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
44431362|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
44431363|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44431364|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431365|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
44431366|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431367|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
44431368|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267404|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44267405|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
44267406|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267407|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267408|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44267409|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267410|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267411|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44267412|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44267413|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44267414|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44431369|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
44431370|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431371|NCT02105974|Fluticasone|fluticasone|mesh-list
44431373|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431374|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44431375|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
44431376|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431377|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431378|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43648367|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732046|NCT02553044|Vitamin D|vitamin d|mesh-list
44431379|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44431404|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
44431405|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44431406|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431407|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431408|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
44431409|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431410|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431411|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44431412|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431413|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
44431414|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431415|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44431416|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44431417|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44431418|NCT02105467|Grazoprevir|grazoprevir|mesh-list
44431419|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44431420|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
44431421|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431422|NCT02105454|Ribavirin|ribavirin|mesh-list
44431423|NCT02105454|Grazoprevir|grazoprevir|mesh-list
44431424|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
44431425|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431426|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
44431427|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431428|NCT02105285|Carteolol|carteolol|mesh-list
44431429|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44431430|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44431431|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44431432|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44431433|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431434|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431494|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431495|NCT02104505|Tocopherols|tocopherols|mesh-list
44431496|NCT02104505|Vitamin E|vitamin e|mesh-list
44431497|NCT02104505|Tocotrienols|tocotrienols|mesh-list
44431498|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
44431499|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
44431500|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
44431501|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431502|NCT02104505|Protective Agents|protective agents|mesh-ancestor
44431503|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431504|NCT02104505|Vitamins|vitamins|mesh-ancestor
44431505|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
44431506|NCT02103478|Decitabine|decitabine|mesh-list
44267415|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44267416|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267417|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267418|NCT00662844|Vitamin D|vitamin d|mesh-list
44267419|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
44267420|NCT00662844|Vitamins|vitamins|mesh-ancestor
44267421|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
44267422|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267423|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44267424|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44462502|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462503|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44462504|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
44462505|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
44462506|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462507|NCT01527383|Vaccines|vaccines|mesh-list
44462508|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
44462509|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462510|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44462511|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
43648368|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
43648369|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648370|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732127|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462512|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
44462513|NCT01527357|Coagulants|coagulants|mesh-ancestor
44462514|NCT01527149|Cytarabine|cytarabine|mesh-list
44462515|NCT01527149|Dexamethasone|dexamethasone|mesh-list
44462516|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
44462517|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
44462518|NCT01527149|Doxorubicin|doxorubicin|mesh-list
44462519|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44462520|NCT01527149|Methotrexate|methotrexate|mesh-list
44462521|NCT01527149|Vincristine|vincristine|mesh-list
44462522|NCT01527149|Ofatumumab|ofatumumab|mesh-list
44462523|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44462524|NCT01527149|BB 1101|bb 1101|mesh-list
44462525|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44462526|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
44462527|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462528|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431507|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431508|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
44431509|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431510|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431511|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431512|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44431513|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
44462529|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44462530|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
44462531|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462532|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462533|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44462534|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44462535|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
44462536|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
44462537|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462538|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462539|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
44462540|NCT01527149|Hormones|hormones|mesh-ancestor
44462541|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44462542|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44462543|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44462544|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44462545|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44462546|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462547|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44462548|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
44462549|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44462550|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44462551|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
44462552|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431514|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431515|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44431516|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431517|NCT02101983|Cytarabine|cytarabine|mesh-list
44431518|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431519|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
44431545|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44431547|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431548|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431549|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
44431550|NCT02101021|Gemcitabine|gemcitabine|mesh-list
44431551|NCT02101021|Paclitaxel|paclitaxel|mesh-list
44431552|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44431553|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44431554|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431555|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44431556|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44431557|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431558|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431559|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431560|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
44431561|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
44431562|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431563|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462553|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44462554|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462555|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
44462556|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462557|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44462558|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44462559|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
44462560|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462561|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
44462562|NCT01527110|Zanamivir|zanamivir|mesh-list
44267425|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
44267426|NCT00662883|Ketamine|ketamine|mesh-list
44267427|NCT00662883|Analgesics|analgesics|mesh-ancestor
44267428|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
44267429|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267430|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267431|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44267432|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44267433|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
44267434|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
44267435|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267436|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44267437|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44267438|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267439|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267440|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431564|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431565|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
44431566|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431567|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44431568|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
44431592|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431593|NCT02100657|Dexamethasone|dexamethasone|mesh-list
44431594|NCT02100657|Bortezomib|bortezomib|mesh-list
44431595|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431596|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
44431597|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
44431598|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431599|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431600|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431601|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
44431602|NCT02100657|Hormones|hormones|mesh-ancestor
44431603|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431604|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44431605|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431606|NCT02100644|Lamotrigine|lamotrigine|mesh-list
44431607|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
44431608|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44431609|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44267442|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44267443|NCT00662896|Ibuprofen|ibuprofen|mesh-list
44267444|NCT00662896|Naproxen|naproxen|mesh-list
44267445|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44267446|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267447|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267448|NCT00662896|Analgesics|analgesics|mesh-ancestor
44267449|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
44267450|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267451|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732228|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44267452|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267453|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267454|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267455|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431610|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431611|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44431612|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431613|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44431614|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44431615|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431616|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44431617|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44431618|NCT02100514|Bococizumab|bococizumab|mesh-list
44431619|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44431689|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431715|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431716|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431717|NCT02098395|Incretins|incretins|mesh-ancestor
44431718|NCT02098395|Hormones|hormones|mesh-ancestor
44431719|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431720|NCT02098109|Plerixafor|plerixafor|mesh-list
44431721|NCT02098109|Lenograstim|lenograstim|mesh-list
44431722|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44431723|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
44431724|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431725|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44431726|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44431727|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
44431728|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431729|NCT02097823|Olanzapine|olanzapine|mesh-list
44431730|NCT02097823|Aprepitant|aprepitant|mesh-list
44431731|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
44431732|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
44431733|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431734|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431735|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431736|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44431737|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44431738|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431739|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44431740|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44431741|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44431808|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431809|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
44431810|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431811|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431812|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
44431813|NCT02096952|Methylphenidate|methylphenidate|mesh-list
44267456|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267458|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44267459|NCT00662948|Rituximab|rituximab|mesh-list
44267460|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44267461|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267462|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
44267463|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267464|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267465|NCT00662987|Amoxicillin|amoxicillin|mesh-list
44267466|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44267467|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267468|NCT00663130|Tadalafil|tadalafil|mesh-list
44267469|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267470|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267471|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267472|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267473|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267474|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267475|NCT00663130|Urological Agents|urological agents|mesh-ancestor
44267476|NCT00663182|Entecavir|entecavir|mesh-list
44267477|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
44267478|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267479|NCT00663195|Furosemide|furosemide|mesh-list
44267480|NCT00663195|Spironolactone|spironolactone|mesh-list
44267481|NCT00663195|Diuretics|diuretics|mesh-ancestor
44267482|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
44267483|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267484|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44267485|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44267486|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659932|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
44431814|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44431815|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431816|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44431817|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44431818|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431819|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431878|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
44431879|NCT02096588|Doxorubicin|doxorubicin|mesh-list
44431880|NCT02096588|Simvastatin|simvastatin|mesh-list
43794845|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
44267487|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44267488|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
44267489|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267490|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44267491|NCT00663221|Vitamin D|vitamin d|mesh-list
44267492|NCT00663221|Calcium|calcium|mesh-list
44267493|NCT00663221|Vitamins|vitamins|mesh-ancestor
44267494|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
44267495|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267496|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44267497|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44267498|NCT00663247|Mesalamine|mesalamine|mesh-list
44267499|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267500|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267501|NCT00663247|Analgesics|analgesics|mesh-ancestor
44267502|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
44267503|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659938|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
44431881|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431882|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
44431883|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431884|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431885|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44431886|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
44431887|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431888|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732371|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732372|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43732373|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
43732374|NCT02550314|Coagulants|coagulants|mesh-ancestor
43732375|NCT02550119|Dexamethasone|dexamethasone|mesh-list
43732376|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
43732377|NCT02550119|Aprepitant|aprepitant|mesh-list
43732378|NCT02550119|Dolasetron|dolasetron|mesh-list
43732379|NCT02550119|Ichthammol|ichthammol|mesh-list
43732380|NCT02550119|BB 1101|bb 1101|mesh-list
43732381|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732382|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
43732387|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
44431889|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44431890|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44431891|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44431892|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44431893|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431894|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44431895|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44431896|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
44431897|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44431898|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44431899|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44431900|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
44431930|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44431932|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44431933|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44431934|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431935|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
44431936|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431937|NCT02095197|Triamcinolone|triamcinolone|mesh-list
44431938|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431939|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
44431940|NCT02095197|Hormones|hormones|mesh-ancestor
44431941|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431942|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431943|NCT02095158|Phenylephrine|phenylephrine|mesh-list
44431944|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
44431945|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44431970|NCT02095106|Calpastatin|calpastatin|mesh-list
44431971|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44431972|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
44267505|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267506|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267507|NCT00663286|Clindamycin|clindamycin|mesh-list
44267508|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
44267509|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
44267510|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44267511|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44267512|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267513|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43644763|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732427|NCT02550262|Analgesics|analgesics|mesh-ancestor
43732428|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43732429|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43732456|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732458|NCT02550028|Phenobarbital|phenobarbital|mesh-list
43732459|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
43732460|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
43732461|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43732462|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732463|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732464|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43732465|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43732466|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267514|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267515|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267516|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267517|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43659948|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
44431973|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431974|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431975|NCT02094937|Fluticasone|fluticasone|mesh-list
44431977|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431978|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44431979|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
44431980|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431981|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431982|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44431983|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44431984|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431985|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44431986|NCT02094898|Ketamine|ketamine|mesh-list
44431987|NCT02094898|Analgesics|analgesics|mesh-ancestor
44431988|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
44431989|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431990|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431991|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44431992|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44431993|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
44431994|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
44431995|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432024|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
44432025|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432026|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44432027|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44432028|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44432029|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432030|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432031|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432032|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44432033|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44432034|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
44432035|NCT02093351|Tamoxifen|tamoxifen|mesh-list
44432036|NCT02093351|Letrozole|letrozole|mesh-list
44432037|NCT02093351|Olaparib|olaparib|mesh-list
44432038|NCT02093351|Anastrozole|anastrozole|mesh-list
44432039|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432040|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44432041|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44432042|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432099|NCT02092467|Tofacitinib|tofacitinib|mesh-list
44432100|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432101|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267518|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267519|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267520|NCT00663338|Rotigotine|rotigotine|mesh-list
44267521|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
44267522|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
44267523|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267524|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267525|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267526|NCT00663377|Losartan|losartan|mesh-list
44267527|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44267528|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44267529|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44267530|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44267531|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267532|NCT00663442|Methylphenidate|methylphenidate|mesh-list
44267533|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44267534|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267535|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44267536|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44267537|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562054|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44267538|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267539|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
44267540|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432102|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432103|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432104|NCT02092467|Analgesics|analgesics|mesh-ancestor
44432132|NCT02091986|Budesonide|budesonide|mesh-list
44432133|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44432134|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432135|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44432136|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
44432137|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432138|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432139|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44432140|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
44432141|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
44432142|NCT02091986|Hormones|hormones|mesh-ancestor
44432143|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432144|NCT02091921|Ticagrelor|ticagrelor|mesh-list
44432145|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44432146|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44432147|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44432148|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44432149|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
44432184|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
44432185|NCT02091362|Metformin|metformin|mesh-list
44432186|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44267543|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267544|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267545|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44267546|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
44267547|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267548|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
44267549|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267550|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267551|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267552|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44267553|NCT00663481|Leucovorin|leucovorin|mesh-list
44267554|NCT00663481|Antidotes|antidotes|mesh-ancestor
44267555|NCT00663481|Protective Agents|protective agents|mesh-ancestor
44267556|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267557|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
44267558|NCT00663481|Vitamins|vitamins|mesh-ancestor
44267559|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
44267560|NCT00663559|Sunitinib|sunitinib|mesh-list
44267561|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267562|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44267563|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44267564|NCT00663559|Growth Substances|growth substances|mesh-ancestor
44432187|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432188|NCT02091206|Cannabidiol|cannabidiol|mesh-list
44432189|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
44432190|NCT02090413|Aspirin|aspirin|mesh-list
44432224|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432225|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432226|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432227|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44432228|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
44432229|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44432254|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432256|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44432257|NCT02088177|Naltrexone|naltrexone|mesh-list
44432258|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44432259|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44432260|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432261|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
44432262|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432263|NCT02088034|Metformin|metformin|mesh-list
44432264|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432265|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432266|NCT02087943|Thalidomide|thalidomide|mesh-list
44432267|NCT02087943|Apremilast|apremilast|mesh-list
44432268|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432269|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432270|NCT02087943|Analgesics|analgesics|mesh-ancestor
44432271|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
44432272|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267565|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267566|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
44267567|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267568|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267569|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267570|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267571|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267572|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267573|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44432273|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432274|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432275|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432276|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44432313|NCT02086591|Doxycycline|doxycycline|mesh-list
44432328|NCT02085252|Leuprolide|leuprolide|mesh-list
44432329|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
44432330|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432331|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432332|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432333|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432334|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44432335|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
44432336|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44432337|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432338|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
44432339|NCT02085161|Olodaterol|olodaterol|mesh-list
44432340|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44432341|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
44432342|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432343|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432344|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44432345|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44432346|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
44432347|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44432348|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43648371|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732530|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
43732531|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732532|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732533|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732534|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732535|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732536|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732537|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732538|NCT02549651|Durvalumab|durvalumab|mesh-list
43732539|NCT02549651|Tremelimumab|tremelimumab|mesh-list
44432349|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432350|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432351|NCT02084238|Interleukin-2|interleukin-2|mesh-list
44432352|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432353|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432354|NCT02084238|Analgesics|analgesics|mesh-ancestor
44432355|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
44432356|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432357|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432358|NCT02084134|Dexamethasone|dexamethasone|mesh-list
44432359|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
44432360|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
44432361|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44432362|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44432363|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44432364|NCT02084134|BB 1101|bb 1101|mesh-list
44432365|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432366|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
44432367|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
44432368|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432369|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432370|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432371|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
44432372|NCT02084134|Hormones|hormones|mesh-ancestor
44432373|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432374|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432375|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432407|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432408|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44267576|NCT00663598|Urological Agents|urological agents|mesh-ancestor
44267577|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
44267578|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44267579|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267580|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44267581|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267582|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267583|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267584|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267585|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267586|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267587|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267588|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267589|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267590|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432409|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44432410|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
44432411|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
44432412|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432413|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44432414|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44432415|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432416|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432417|NCT02083783|Amphetamine|amphetamine|mesh-list
44432418|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44432475|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432476|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
44432477|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432478|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432479|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432480|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
44432481|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432482|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432483|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44432484|NCT02082210|Ramucirumab|ramucirumab|mesh-list
44432485|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432486|NCT02081690|Macitentan|macitentan|mesh-list
44432487|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44432488|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43732575|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44432489|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432490|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44432491|NCT02081599|Insulin|insulin|mesh-list
44432492|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432493|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648372|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432494|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
44432495|NCT02081183|Prednisone|prednisone|mesh-list
44432496|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
44432530|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44432532|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432533|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432534|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
44267592|NCT00663741|Sorafenib|sorafenib|mesh-list
44267593|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267594|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44267595|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267596|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267597|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
44267598|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44267599|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267600|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44267601|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44267602|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267603|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267604|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267605|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44267606|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44267607|NCT00663832|Panobinostat|panobinostat|mesh-list
44267608|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267609|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44267610|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267611|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267612|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267641|NCT00663949|Captopril|captopril|mesh-list
44267642|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
44267643|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267644|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267645|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267646|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267647|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44267648|NCT00663949|Protective Agents|protective agents|mesh-ancestor
44267649|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267650|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267651|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44267652|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
44267653|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44267654|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
44267655|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44267656|NCT00664001|Antioxidants|antioxidants|mesh-list
44267657|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267658|NCT00664001|Protective Agents|protective agents|mesh-ancestor
44267659|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267660|NCT00664014|Tolvaptan|tolvaptan|mesh-list
44267661|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44267662|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267663|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
44267664|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648373|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
43648374|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648375|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648376|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44267665|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44267666|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44267667|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
44267668|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267669|NCT00664144|Rasburicase|rasburicase|mesh-list
44267670|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
44267671|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267672|NCT00664170|Docetaxel|docetaxel|mesh-list
44267673|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267674|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44267675|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44267676|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44432535|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432569|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43795077|NCT05243706|Loratadine|loratadine|mesh-list
44267678|NCT00664196|Hormones|hormones|mesh-list
44267679|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267680|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267681|NCT00664222|Furosemide|furosemide|mesh-list
44267682|NCT00664222|Spironolactone|spironolactone|mesh-list
44267683|NCT00664222|Diuretics|diuretics|mesh-ancestor
44267684|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
44267685|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825613|NCT05562869|Abatacept|abatacept|mesh-list
44432570|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44432571|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44432572|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432573|NCT02079649|Dexamethasone|dexamethasone|mesh-list
44432574|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44432575|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44432576|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432577|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
44432578|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
44432608|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432609|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432611|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432612|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432613|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44432614|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44432615|NCT02079519|Growth Substances|growth substances|mesh-ancestor
44432616|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432617|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
44432618|NCT02079077|Aspirin|aspirin|mesh-list
44432619|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
44432620|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
44432621|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44432622|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44432650|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44432651|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44432652|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
44432653|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
44432654|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432655|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44432656|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44432657|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432658|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432659|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
44432660|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44432661|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432662|NCT02078219|Allopurinol|allopurinol|mesh-list
44432663|NCT02078219|Verinurad|verinurad|mesh-list
44432664|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
43648382|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648383|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43648385|NCT03559114|Tinzaparin|tinzaparin|mesh-list
43648386|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43732648|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43732649|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44432665|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432666|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432699|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432701|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44432702|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
44432703|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
44432704|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44432705|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
44432706|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432707|NCT02075073|Trastuzumab|trastuzumab|mesh-list
44432708|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432742|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44432743|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44432744|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432745|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44267686|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44267687|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44267688|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267689|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44267690|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
44267691|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44267692|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44267693|NCT00664248|Clindamycin|clindamycin|mesh-list
44432746|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
44432747|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44432748|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432749|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432750|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
44432751|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44432752|NCT02073656|Ledipasvir|ledipasvir|mesh-list
44432753|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
44432754|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432780|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432781|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
44432782|NCT02072434|Enoxaparin|enoxaparin|mesh-list
44432783|NCT02072434|Warfarin|warfarin|mesh-list
44432784|NCT02072434|Edoxaban|edoxaban|mesh-list
44432785|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
44432786|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44432787|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44432788|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432789|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44432790|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
44432791|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44432792|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432793|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432794|NCT02072226|Aspirin|aspirin|mesh-list
44432795|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44432796|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432797|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432798|NCT02072226|Analgesics|analgesics|mesh-ancestor
44432799|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
44432800|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432801|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432802|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432803|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432804|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44432839|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432840|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432841|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44432842|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44432843|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44432844|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
43648387|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
43648388|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43648389|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43648390|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432853|NCT02070757|Ceftolozane|ceftolozane|mesh-list
44432854|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44432855|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432856|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432857|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44432858|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432859|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432860|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44432861|NCT02070757|Renal Agents|renal agents|mesh-ancestor
44432862|NCT02070744|Ivacaftor|ivacaftor|mesh-list
44432863|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44432864|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432865|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432866|NCT02069392|Nicotine|nicotine|mesh-list
44432867|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44432868|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
44267694|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
44267695|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
44267696|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44267697|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44267698|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267699|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44267700|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267701|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267702|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44267703|NCT00664287|Niacin|niacin|mesh-list
44267704|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44267705|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
44267706|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267707|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44267708|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267709|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
44267710|NCT00664287|Vitamins|vitamins|mesh-ancestor
44267711|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
44267712|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267713|NCT00664313|Linezolid|linezolid|mesh-list
44267714|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432869|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432870|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432871|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44432872|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44432873|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
44432874|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432875|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432876|NCT02069379|Metformin|metformin|mesh-list
44432877|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432878|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432879|NCT02069366|Dronabinol|dronabinol|mesh-list
44432880|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
44432881|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432882|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44432883|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43562108|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
43562109|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
43562110|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562111|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432884|NCT02069366|Analgesics|analgesics|mesh-ancestor
43562112|NCT01520545|Baclofen|baclofen|mesh-list
43562113|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43562114|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562115|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43562116|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43562117|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44432885|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
44432886|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432887|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44432888|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44432889|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432890|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432891|NCT02069366|Hormones|hormones|mesh-ancestor
44432892|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432893|NCT02069093|Dexamethasone|dexamethasone|mesh-list
44432894|NCT02069093|Everolimus|everolimus|mesh-list
44432895|NCT02069093|Exemestane|exemestane|mesh-list
44432896|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432897|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
44432898|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
44432899|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432900|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432901|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432902|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
44432903|NCT02069093|Hormones|hormones|mesh-ancestor
44267715|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267716|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44267717|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267718|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267719|NCT00664417|Vaccines|vaccines|mesh-list
43922133|NCT05065671|Tolcapone|tolcapone|mesh-list
44267720|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
44267721|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267722|NCT00664469|Atorvastatin|atorvastatin|mesh-list
44267723|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44267724|NCT00664469|Simvastatin|simvastatin|mesh-list
44267725|NCT00664469|Ezetimibe|ezetimibe|mesh-list
44267726|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44267727|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44267728|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
44267729|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267730|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44267731|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44267732|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267733|NCT00664586|Masoprocol|masoprocol|mesh-list
44267734|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
44267735|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267736|NCT00664586|Protective Agents|protective agents|mesh-ancestor
44267737|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432904|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432905|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432906|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432907|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432908|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
44432909|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44432910|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44432923|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432924|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432925|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44432926|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432927|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
44432928|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44432929|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44432931|NCT02068443|Alogliptin|alogliptin|mesh-list
44432932|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432933|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432934|NCT02068443|Incretins|incretins|mesh-ancestor
44432935|NCT02068443|Hormones|hormones|mesh-ancestor
44432936|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432937|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44432938|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432939|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732805|NCT02548195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432940|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432941|NCT02068222|Ritonavir|ritonavir|mesh-list
44267739|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267740|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267741|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267742|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267743|NCT00664586|Analgesics|analgesics|mesh-ancestor
44267744|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
44267745|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267746|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267747|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267748|NCT00664599|Rituximab|rituximab|mesh-list
44267749|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44267750|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432942|NCT02068222|Ribavirin|ribavirin|mesh-list
44432943|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44432944|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44432945|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432946|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432947|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432948|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44432949|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44432950|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
44432951|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432952|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44432953|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44432954|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
44432955|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44432956|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44432957|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
44432958|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432959|NCT02067676|Antacids|antacids|mesh-ancestor
44432960|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432961|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432962|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
44432963|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44432964|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
44432965|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44432966|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432967|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44432968|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44432969|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44432970|NCT02066402|Linezolid|linezolid|mesh-list
44432971|NCT02066402|Tedizolid|tedizolid|mesh-list
44432972|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
44433070|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433071|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433073|NCT02065245|Streptomycin|streptomycin|mesh-list
44433074|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433075|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433076|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44433077|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433078|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433079|NCT02064920|Donepezil|donepezil|mesh-list
44433080|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44433081|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433082|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433083|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433084|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433085|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433086|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
44433087|NCT02064894|Ibuprofen|ibuprofen|mesh-list
44433088|NCT02064894|Morphine|morphine|mesh-list
44267752|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267753|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462563|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
44462564|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44462565|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462566|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462567|NCT01526733|Insulin|insulin|mesh-list
44462568|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44462569|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
44462570|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
44462571|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462572|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462573|NCT01526551|Vaccines|vaccines|mesh-list
44462574|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
44433089|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44433090|NCT02064894|Narcotics|narcotics|mesh-ancestor
44433091|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433092|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433093|NCT02064894|Analgesics|analgesics|mesh-ancestor
44433094|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
44433095|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433096|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44433097|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44433098|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433099|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433124|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433125|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433126|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44433127|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433128|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44433129|NCT02063698|Auranofin|auranofin|mesh-list
44433130|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433131|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
44433132|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44433133|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44433134|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
44433135|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
44433136|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433137|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433138|NCT02062944|Sirolimus|sirolimus|mesh-list
44433139|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44433140|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433141|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433142|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44433143|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433144|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
44433145|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
44433146|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433147|NCT02062879|Ketamine|ketamine|mesh-list
44433148|NCT02062879|Hydromorphone|hydromorphone|mesh-list
44433149|NCT02062879|Analgesics|analgesics|mesh-ancestor
44433150|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
44433151|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433170|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44433171|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
44433172|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
44433173|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433174|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44462576|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44462577|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
44462578|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
44462579|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44462580|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44462581|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44462582|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44462583|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462584|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462585|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433175|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44433176|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433177|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433178|NCT02062645|Amlodipine|amlodipine|mesh-list
44433179|NCT02062645|Valsartan|valsartan|mesh-list
44433180|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
44433181|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44433182|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44433183|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433184|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433185|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44433186|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433187|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433188|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44433189|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44433190|NCT02062632|Doxepin|doxepin|mesh-list
44433191|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44433192|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44433193|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433194|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433195|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44433196|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44433197|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44433198|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
44433199|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
44433200|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433201|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433202|NCT02061280|Fluticasone|fluticasone|mesh-list
44433204|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44433205|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44433236|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433237|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433238|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44433239|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44433240|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433241|NCT02060487|Urological Agents|urological agents|mesh-ancestor
44433242|NCT02060383|Metformin|metformin|mesh-list
44433243|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44433244|NCT02060383|Liraglutide|liraglutide|mesh-list
44433245|NCT02060383|Pasireotide|pasireotide|mesh-list
44433246|NCT02060383|Somatostatin|somatostatin|mesh-list
44433247|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433248|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433249|NCT02060383|Incretins|incretins|mesh-ancestor
44433250|NCT02060383|Hormones|hormones|mesh-ancestor
44433251|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433286|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44091505|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
44433326|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44433327|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
44462590|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
44462591|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462592|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44462594|NCT01525901|Mecasermin|mecasermin|mesh-list
44462595|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462596|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462597|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462598|NCT01525901|Growth Substances|growth substances|mesh-ancestor
44462599|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
44462600|NCT01525875|Antacids|antacids|mesh-ancestor
44462601|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462602|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44462603|NCT01525641|Pramipexole|pramipexole|mesh-list
43922210|NCT04501380|Rifamycins|rifamycins|mesh-list
44462604|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
44267755|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
44267756|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267757|NCT00664677|Protective Agents|protective agents|mesh-ancestor
44267758|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433328|NCT02059174|MK-1293|mk-1293|mesh-list
44433329|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433330|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433331|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44433403|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433405|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44433406|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433407|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433408|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433444|NCT02058147|Metformin|metformin|mesh-list
44433445|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
44433446|NCT02058147|Lixisenatide|lixisenatide|mesh-list
44433447|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433448|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433449|NCT02058108|Telbivudine|telbivudine|mesh-list
44433450|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
44433486|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44433487|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
44433501|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433502|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
44433503|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
44433504|NCT02057250|Methotrexate|methotrexate|mesh-list
44433505|NCT02057250|Leflunomide|leflunomide|mesh-list
44433506|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44433507|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
44267760|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267761|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267762|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267763|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267764|NCT00664677|Analgesics|analgesics|mesh-ancestor
44267765|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
44267766|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267767|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267768|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267769|NCT00664690|Celecoxib|celecoxib|mesh-list
44267770|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267771|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267772|NCT00664690|Analgesics|analgesics|mesh-ancestor
44267773|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
44267774|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267775|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267776|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267777|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733138|NCT02545972|Tacrolimus|tacrolimus|mesh-list
44267778|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44267779|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267780|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267781|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267782|NCT00664703|Methylphenidate|methylphenidate|mesh-list
44267783|NCT00664703|Lobeline|lobeline|mesh-list
44433508|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433509|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433510|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433511|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
44433512|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433513|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433514|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433515|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433516|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44433517|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433518|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
44433519|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433520|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44433521|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
44433522|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44433523|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44433524|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433525|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44433526|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44433527|NCT02057250|Analgesics|analgesics|mesh-ancestor
44433528|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
44433529|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267784|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44267785|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267786|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44267787|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44267788|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44267789|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267790|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
44267791|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267792|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44267793|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
44267794|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267795|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44267796|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44267797|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
44267798|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267799|NCT00664781|Rucaparib|rucaparib|mesh-list
44267800|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44267801|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267802|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267803|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433530|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433531|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733172|NCT02545634|Renal Agents|renal agents|mesh-ancestor
43733173|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
43733174|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43733175|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43733176|NCT02545738|Liraglutide|liraglutide|mesh-list
43733177|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43733178|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733179|NCT02545738|Incretins|incretins|mesh-ancestor
43733180|NCT02545738|Hormones|hormones|mesh-ancestor
43733182|NCT02545465|Riociguat|riociguat|mesh-list
44433532|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44433533|NCT02057198|Metronidazole|metronidazole|mesh-list
44433534|NCT02057198|Vancomycin|vancomycin|mesh-list
44433535|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
44433536|NCT02057198|Amebicides|amebicides|mesh-list
44091786|NCT00033189|Vitamins|vitamins|mesh-ancestor
44433537|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433538|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44433539|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44433540|NCT02056626|Carvedilol|carvedilol|mesh-list
44433541|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44433542|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44433543|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433544|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433545|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433546|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433562|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433563|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433565|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44433566|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44433567|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
44433568|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433569|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44433570|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44433571|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433572|NCT02056301|Morphine|morphine|mesh-list
44433573|NCT02056301|Hydromorphone|hydromorphone|mesh-list
44433574|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44433575|NCT02056301|Narcotics|narcotics|mesh-ancestor
44433576|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267804|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267805|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267806|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267807|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267808|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267809|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267810|NCT00664833|Urological Agents|urological agents|mesh-ancestor
44267811|NCT00664846|Aspirin|aspirin|mesh-list
44267812|NCT00664846|Clopidogrel|clopidogrel|mesh-list
44267813|NCT00664846|Atorvastatin|atorvastatin|mesh-list
44267814|NCT00664846|Simvastatin|simvastatin|mesh-list
44267815|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267816|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267817|NCT00664846|Analgesics|analgesics|mesh-ancestor
44267818|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
44267819|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267820|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267821|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648392|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
43648393|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648394|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562125|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43733224|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43733225|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43733227|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43733228|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43733229|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43733230|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
43733231|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733232|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433577|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433578|NCT02056301|Analgesics|analgesics|mesh-ancestor
44433579|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
44433580|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433581|NCT02056288|Fentanyl|fentanyl|mesh-list
44433582|NCT02056288|Ropivacaine|ropivacaine|mesh-list
44433583|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
44433584|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
44433585|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433586|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433587|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
44433588|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433589|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44433590|NCT02056288|Narcotics|narcotics|mesh-ancestor
44433591|NCT02056288|Analgesics|analgesics|mesh-ancestor
44433592|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44433593|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44433594|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
44433595|NCT02055976|Ezetimibe|ezetimibe|mesh-list
44433596|NCT02055976|Bococizumab|bococizumab|mesh-list
44433597|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44433598|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44433599|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
44433600|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433601|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44433602|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
44433603|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44433604|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44433605|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
44433606|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
44433638|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
44433639|NCT02055352|Fluticasone|fluticasone|mesh-list
44433640|NCT02055352|Budesonide|budesonide|mesh-list
44433641|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44433642|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433643|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44433644|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
44433645|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433646|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433647|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44433648|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267822|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267823|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44267824|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44267825|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267826|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43562146|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562147|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43562148|NCT01516476|Liraglutide|liraglutide|mesh-list
43562149|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43562150|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562151|NCT01516476|Incretins|incretins|mesh-ancestor
43562152|NCT01516476|Hormones|hormones|mesh-ancestor
43562153|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43562164|NCT01516203|Rifampin|rifampin|mesh-list
44267827|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44267828|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267829|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
44267830|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44267831|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44267832|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
44267833|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44267834|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44267835|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44267836|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44267837|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44267838|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
44267839|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267840|NCT00664963|Sirolimus|sirolimus|mesh-list
44267841|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660066|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433649|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433650|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433651|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
44433666|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44433667|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44433668|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44433669|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433670|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433671|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
44433673|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433674|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433675|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44433676|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44433677|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
44433678|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44433679|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44433680|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44433681|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44433682|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
44433683|NCT02054520|Nivolumab|nivolumab|mesh-list
44433684|NCT02054520|Ipilimumab|ipilimumab|mesh-list
44433685|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44433686|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433687|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44433688|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433689|NCT02054481|Ustekinumab|ustekinumab|mesh-list
44433690|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44433691|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433692|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
44433693|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433694|NCT02054325|Polidocanol|polidocanol|mesh-list
44433695|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44267842|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267843|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44267844|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267845|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
44267846|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44267847|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
44267848|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267849|NCT00665041|Quinagolide|quinagolide|mesh-list
44267850|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
44267851|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
44267852|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267853|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267854|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267855|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267856|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267857|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267858|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267859|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267860|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267861|NCT00665054|Urological Agents|urological agents|mesh-ancestor
44267862|NCT00665093|Insulin|insulin|mesh-list
44267863|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43644764|NCT04430452|Durvalumab|durvalumab|mesh-list
44433696|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44433697|NCT02053753|Denosumab|denosumab|mesh-list
44433698|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44433699|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433700|NCT02053610|Rituximab|rituximab|mesh-list
44433701|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
44433702|NCT02053610|Chlorambucil|chlorambucil|mesh-list
44433703|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44433704|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433705|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
44433706|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433707|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433708|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44433709|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
44433710|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433780|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
44433781|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44433782|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44433783|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44433784|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433785|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433786|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433787|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433788|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433789|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44433790|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433811|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44433812|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44433813|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267864|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
44267865|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
44267866|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
44267867|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44267868|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44267869|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267870|NCT00665119|Remifentanil|remifentanil|mesh-list
44267871|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44267872|NCT00665119|Narcotics|narcotics|mesh-ancestor
44267873|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267874|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267875|NCT00665119|Analgesics|analgesics|mesh-ancestor
44267876|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
44267877|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267878|NCT00665314|Plerixafor|plerixafor|mesh-list
44267879|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44267880|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44433814|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433815|NCT02049944|Cefazolin|cefazolin|mesh-list
44433816|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433817|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433818|NCT02049814|Metformin|metformin|mesh-list
44433819|NCT02049814|Acarbose|acarbose|mesh-list
44433820|NCT02049814|Voglibose|voglibose|mesh-list
44433821|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433822|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433823|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44433824|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433825|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433826|NCT02049138|Upadacitinib|upadacitinib|mesh-list
44433827|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44433828|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44433829|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733300|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43733301|NCT02544828|Hematinics|hematinics|mesh-ancestor
44433830|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433831|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433832|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44433833|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433834|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433835|NCT02048904|Incretins|incretins|mesh-ancestor
44433836|NCT02048904|Hormones|hormones|mesh-ancestor
44433837|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433838|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44433840|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433841|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433842|NCT02048241|Guanfacine|guanfacine|mesh-list
44433843|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44433844|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44433845|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44433912|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433913|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44433914|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
44433915|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433917|NCT02047045|Serotonin|serotonin|mesh-list
44433918|NCT02047045|Laxatives|laxatives|mesh-ancestor
44433919|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44433920|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44433921|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44433922|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
44267883|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
44267884|NCT00665327|Levofloxacin|levofloxacin|mesh-list
44267885|NCT00665327|Ofloxacin|ofloxacin|mesh-list
44267886|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44267887|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44267888|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267889|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44267890|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44267891|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267892|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267893|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44267894|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44267895|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
44267896|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433923|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433924|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433925|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433956|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433957|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44433958|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44433959|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44433960|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44433961|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733362|NCT02544529|Laxatives|laxatives|mesh-ancestor
43733363|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43562170|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43562171|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562172|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
43562173|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562174|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562175|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562176|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43562184|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
44433962|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433963|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44433964|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44433965|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44433966|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44433967|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434002|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44434003|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434005|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
44434006|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434007|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434008|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
44434043|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44434044|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434045|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434046|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434047|NCT02045836|Vaccines|vaccines|mesh-list
44434084|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
44434117|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44434118|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44434119|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
44434121|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44434122|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434123|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434124|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434125|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44434126|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434127|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434128|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
44434140|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267897|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267898|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44267899|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44267900|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44267901|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44267902|NCT00665327|Renal Agents|renal agents|mesh-ancestor
44267903|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44267904|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44267905|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267906|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267907|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267908|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267909|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267910|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267911|NCT00665340|Urological Agents|urological agents|mesh-ancestor
44267912|NCT00665418|Sevoflurane|sevoflurane|mesh-list
44267913|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44267914|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44267915|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
44267916|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
44267917|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44267918|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267919|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44267920|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
44267921|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44267922|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44267923|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267924|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733387|NCT02544425|Hormones|hormones|mesh-ancestor
44267925|NCT00665496|Urological Agents|urological agents|mesh-ancestor
44267926|NCT00665522|Fentanyl|fentanyl|mesh-list
44267927|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44267928|NCT00665522|Narcotics|narcotics|mesh-ancestor
44267931|NCT00665522|Analgesics|analgesics|mesh-ancestor
44267936|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
44267937|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
44267938|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44267939|NCT00665600|Albuterol|albuterol|mesh-list
44267940|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44267941|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
44267942|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267943|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267944|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44267945|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
44267946|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
44267947|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44267948|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44267949|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44267950|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44267951|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
44267952|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267953|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267954|NCT00665639|Caspofungin|caspofungin|mesh-list
44267955|NCT00665639|Micafungin|micafungin|mesh-list
44267956|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
44267957|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434141|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
44434142|NCT02043132|Coagulants|coagulants|mesh-ancestor
44434143|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
44434145|NCT02042443|Folic Acid|folic acid|mesh-list
44434146|NCT02042443|Fluorouracil|fluorouracil|mesh-list
44434148|NCT02042443|Trametinib|trametinib|mesh-list
44434149|NCT02042443|Calcium|calcium|mesh-list
44434150|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
44434151|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434152|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434153|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44434154|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
44434155|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434156|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44434157|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434158|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434159|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
44434160|NCT02042443|Antidotes|antidotes|mesh-ancestor
44434161|NCT02042443|Protective Agents|protective agents|mesh-ancestor
44434162|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
44434163|NCT02042443|Vitamins|vitamins|mesh-ancestor
44434164|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
44434165|NCT02042443|Hematinics|hematinics|mesh-ancestor
44434166|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44434167|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434168|NCT02042183|Lubiprostone|lubiprostone|mesh-list
44434169|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44434170|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434171|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434172|NCT02041533|Gemcitabine|gemcitabine|mesh-list
44434173|NCT02041533|Paclitaxel|paclitaxel|mesh-list
44434174|NCT02041533|Cisplatin|cisplatin|mesh-list
44434175|NCT02041533|Carboplatin|carboplatin|mesh-list
44434176|NCT02041533|Nivolumab|nivolumab|mesh-list
44434177|NCT02041533|Pemetrexed|pemetrexed|mesh-list
44267958|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267959|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267960|NCT00665678|Paroxetine|paroxetine|mesh-list
44267961|NCT00665678|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44267962|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44267963|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44267964|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267965|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44267966|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
44267967|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267968|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44267969|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
44267970|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43562222|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
43660129|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434178|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434179|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434180|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434181|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434182|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434183|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434184|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44434185|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
44434186|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
44434187|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434188|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434189|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434190|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
44434191|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434192|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44434193|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44434194|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44434195|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44434248|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44434249|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434250|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434251|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434252|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434253|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434254|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434280|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44434281|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434282|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434283|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
44434284|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434285|NCT02039778|Temozolomide|temozolomide|mesh-list
44434286|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44434287|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
44434288|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434289|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434290|NCT02039505|Vedolizumab|vedolizumab|mesh-list
44434291|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434292|NCT02039427|Dexamethasone|dexamethasone|mesh-list
44434293|NCT02039427|Ketorolac|ketorolac|mesh-list
44434294|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434295|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
44434296|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
44434297|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267971|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44267972|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44267973|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267974|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
43922394|NCT03642366|Tadalafil|tadalafil|mesh-list
43733461|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
43733462|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
43733463|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
43733464|NCT02544269|Bupivacaine|bupivacaine|mesh-list
43733465|NCT02544269|Ropivacaine|ropivacaine|mesh-list
43733466|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
43733467|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
43733468|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43733469|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733470|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
43733471|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267975|NCT00665717|Pravastatin|pravastatin|mesh-list
44267976|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44267977|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44267978|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
44267979|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44267980|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44267981|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44267982|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44267983|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44267984|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44267985|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44267986|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
44267987|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44267988|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44267989|NCT00665743|Naproxen|naproxen|mesh-list
44267990|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44267991|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44267992|NCT00665743|Analgesics|analgesics|mesh-ancestor
44267993|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
44267994|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44267995|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44267996|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44267997|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44267998|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
44267999|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44268000|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268001|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268002|NCT00665756|Mitomycins|mitomycins|mesh-list
44268003|NCT00665756|Mitomycin|mitomycin|mesh-list
44268004|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44268005|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268008|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268010|NCT00665808|Insulin|insulin|mesh-list
44268011|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44268012|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
44268013|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
44268014|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
44268015|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
44268016|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44268017|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268018|NCT00665834|Atorvastatin|atorvastatin|mesh-list
44268019|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44268020|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44268021|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44268022|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
44268023|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268024|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44268025|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44268026|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268027|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44268028|NCT00665873|Amoxicillin|amoxicillin|mesh-list
44268029|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
44268030|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
44268031|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44268032|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268033|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
44268034|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268035|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268036|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44268037|NCT00665951|Ritonavir|ritonavir|mesh-list
44268038|NCT00665951|Lopinavir|lopinavir|mesh-list
44268039|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44268040|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44268041|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268042|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268043|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268044|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44434298|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795078|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
44268045|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44268047|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268048|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44268049|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268050|NCT00665977|Triamcinolone|triamcinolone|mesh-list
44268051|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44268052|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44268053|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44268054|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268055|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
44268057|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268058|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268059|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268060|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
44268061|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268062|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268063|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
44268064|NCT00665990|Bevacizumab|bevacizumab|mesh-list
44268065|NCT00665990|Sorafenib|sorafenib|mesh-list
44268066|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434299|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434300|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
44434301|NCT02039427|Hormones|hormones|mesh-ancestor
44434302|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434367|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434368|NCT02038010|Trastuzumab|trastuzumab|mesh-list
44434369|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44434370|NCT02038010|Maytansine|maytansine|mesh-list
44434371|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
44434372|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
44434373|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44434374|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434375|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434376|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434377|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434378|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434379|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434380|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
44434381|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434382|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648395|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43648396|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
43733552|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
43733553|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43733554|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
43733555|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733556|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
43733557|NCT05157412|Hormones|hormones|mesh-ancestor
43733558|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733559|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733560|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733561|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733562|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
43733563|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
43733564|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733565|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43733566|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43733567|NCT05157412|Protective Agents|protective agents|mesh-ancestor
44434383|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44434417|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44434418|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44434419|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434420|NCT02036775|Ambroxol|ambroxol|mesh-list
44434421|NCT02036775|Expectorants|expectorants|mesh-ancestor
44434422|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434423|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44434424|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
44434425|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434455|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44268067|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
44268068|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268069|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268070|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44268071|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
44268072|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268073|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268074|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44268075|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44268076|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44268077|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44268078|NCT00665990|Growth Substances|growth substances|mesh-ancestor
44268079|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44268080|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44268081|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268082|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
44268083|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44268084|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44268085|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44268086|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268087|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268088|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268089|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268090|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268091|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268092|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268093|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44268094|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
44268095|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268096|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268111|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44268112|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44268113|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268114|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268115|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268116|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44268117|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44268118|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
44268119|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268120|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44268121|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268122|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44268123|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268124|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
44268125|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44434457|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44434458|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
44434459|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44434460|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44434461|NCT02036502|Growth Substances|growth substances|mesh-ancestor
44434462|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
44434463|NCT02035696|Vaccines|vaccines|mesh-list
44434464|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
44434465|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434466|NCT02035553|Pimavanserin|pimavanserin|mesh-list
44434467|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44434468|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44434469|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44434470|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44434499|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434501|NCT02034565|Apixaban|apixaban|mesh-list
44434502|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44434503|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
44434504|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44434505|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434506|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434507|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434508|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
44434509|NCT02034552|Prednisone|prednisone|mesh-list
44434510|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
44434511|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44434512|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434513|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
44434514|NCT02034552|Hormones|hormones|mesh-ancestor
43962655|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434622|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44434623|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434624|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434625|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434626|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434627|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434628|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434629|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
44434630|NCT02031640|Hormones|hormones|mesh-ancestor
44434661|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434662|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
44268127|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44268128|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44268129|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44268130|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44268131|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44268132|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44268133|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44268134|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44268136|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44268137|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
44268138|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268139|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268140|NCT00666107|Vaccines|vaccines|mesh-list
44268141|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
44434663|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44434664|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
44434665|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733625|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43733626|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43733627|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733628|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
43733629|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43733630|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43733631|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
43562282|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
43562283|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
43733633|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434666|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434667|NCT02030405|Ixazomib|ixazomib|mesh-list
44434668|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
44434669|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434670|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434671|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434672|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434673|NCT02030041|Vitamin D|vitamin d|mesh-list
44434674|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
44434675|NCT02030041|Simvastatin|simvastatin|mesh-list
44434676|NCT02030041|Vitamins|vitamins|mesh-ancestor
44434677|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
44434711|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434712|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434713|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434714|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962656|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
44434747|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44434748|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
44434749|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44434750|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434751|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434752|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
44434753|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
44434754|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434755|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44434756|NCT02029638|Protective Agents|protective agents|mesh-ancestor
44434757|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44434758|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44434759|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434790|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434791|NCT02029235|Acetaminophen|acetaminophen|mesh-list
44434792|NCT02029235|Ibuprofen|ibuprofen|mesh-list
44434793|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44434794|NCT02029235|Hydrocodone|hydrocodone|mesh-list
44434795|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434796|NCT02029235|Analgesics|analgesics|mesh-ancestor
44434797|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
44434798|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268142|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268144|NCT00666159|Tacrolimus|tacrolimus|mesh-list
44268145|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268146|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
44268147|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268148|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44268149|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268150|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268151|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44268152|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44268153|NCT00666159|Analgesics|analgesics|mesh-ancestor
44268154|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
44268155|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268156|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268157|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268158|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
44268159|NCT00666185|Fluconazole|fluconazole|mesh-list
43733663|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43733664|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733665|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43733666|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
44434799|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093062|NCT00036166|Micafungin|micafungin|mesh-list
44434800|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
44434801|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44434802|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434803|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434804|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44434836|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434837|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434839|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434840|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434841|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434842|NCT02027376|Docetaxel|docetaxel|mesh-list
44434843|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434844|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434845|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434846|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434847|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434848|NCT02027311|Midazolam|midazolam|mesh-list
44434849|NCT02027311|Meperidine|meperidine|mesh-list
44434872|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434873|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434874|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434875|NCT02026141|Analgesics|analgesics|mesh-ancestor
44434876|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
44434877|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093126|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44434878|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44434879|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44434880|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434881|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434882|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434883|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434884|NCT02026011|Naltrexone|naltrexone|mesh-list
44434885|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44434886|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44434887|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434888|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
44268160|NCT00666185|Micafungin|micafungin|mesh-list
44268161|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
44268162|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268163|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44268164|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268165|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268166|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268167|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44268168|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562287|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43562288|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43562289|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
43562290|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562291|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43562292|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43562293|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562294|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44268169|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268170|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268171|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44268172|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44268173|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
44268174|NCT00666302|Tacrolimus|tacrolimus|mesh-list
44268175|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268176|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
44268177|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268178|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44268179|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268180|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268181|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44268182|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44268183|NCT00666302|Analgesics|analgesics|mesh-ancestor
44268184|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
44268185|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268186|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268187|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268188|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
44268189|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
44268190|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268191|NCT00666354|Methotrexate|methotrexate|mesh-list
44268192|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44268193|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
44268196|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44268197|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
44268198|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268199|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268200|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
44268201|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268202|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44268203|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268204|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
44268205|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268206|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44462605|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462606|NCT01525641|Protective Agents|protective agents|mesh-ancestor
44462607|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462608|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44462609|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44462610|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
44462611|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
44462612|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462613|NCT01525628|Tolbutamide|tolbutamide|mesh-list
44462614|NCT01525628|Interferons|interferons|mesh-list
44462615|NCT01525628|Tenofovir|tenofovir|mesh-list
44462616|NCT01525628|Ribavirin|ribavirin|mesh-list
44462617|NCT01525628|Midazolam|midazolam|mesh-list
44462618|NCT01525628|Caffeine|caffeine|mesh-list
44462619|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434889|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434890|NCT02025907|Canagliflozin|canagliflozin|mesh-list
44434891|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44434892|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434893|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434894|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434895|NCT02025751|Metoclopramide|metoclopramide|mesh-list
44434896|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
44434897|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
44434898|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434899|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434900|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434901|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43733755|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434937|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44434938|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434939|NCT02024867|Renal Agents|renal agents|mesh-ancestor
44434969|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44434970|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44434971|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
44434972|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434973|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44434974|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44434975|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
44434976|NCT02023099|Ritonavir|ritonavir|mesh-list
43795079|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44462622|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44462623|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44462624|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44462625|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462626|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44462627|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44462628|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44462629|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44462630|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
44462631|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
44462632|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
44462633|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
44462634|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462635|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462636|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44462637|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44434977|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44434978|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44434979|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434980|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434981|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434982|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44434983|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44434984|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
44434985|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435019|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435021|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44435022|NCT02021656|Ledipasvir|ledipasvir|mesh-list
44435023|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
44435056|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435057|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
44435059|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435060|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44435061|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435062|NCT02020616|Metformin|metformin|mesh-list
44435063|NCT02020616|Exenatide|exenatide|mesh-list
44435064|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435065|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435098|NCT02019472|Adalimumab|adalimumab|mesh-list
44435099|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44435100|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435101|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435102|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
44435103|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435104|NCT02019420|Linezolid|linezolid|mesh-list
43733776|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733777|NCT04140214|Expectorants|expectorants|mesh-ancestor
43733778|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
43733779|NCT04115774|Diphosphonates|diphosphonates|mesh-list
43733780|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43733781|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733787|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
44435105|NCT02019420|Tedizolid|tedizolid|mesh-list
44435106|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
44435107|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435108|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435131|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435132|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435133|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435134|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44462638|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462639|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44462640|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44462641|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
44462642|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44462643|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44462644|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44462645|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44462646|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
44462647|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44462648|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
44462649|NCT01525615|Olodaterol|olodaterol|mesh-list
44462650|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44462651|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
44462652|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44462653|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660292|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435135|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44435136|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435137|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435138|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435139|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
44435141|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435142|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44435143|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
44435144|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
44435145|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435146|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435147|NCT02018458|Paclitaxel|paclitaxel|mesh-list
44435148|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44435149|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
44435150|NCT02018458|Carboplatin|carboplatin|mesh-list
44435151|NCT02018458|Doxorubicin|doxorubicin|mesh-list
44435152|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44435153|NCT02018458|Vaccines|vaccines|mesh-list
44435154|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
44435155|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435156|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435157|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435158|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435159|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435160|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435161|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435162|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435190|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435191|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435192|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648397|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648399|NCT03516968|Vitamin D|vitamin d|mesh-list
43562339|NCT01484119|Cetirizine|cetirizine|mesh-list
44435193|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
44435194|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435195|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44435196|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
44435197|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44435198|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44435199|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44435200|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435201|NCT02017171|Allopurinol|allopurinol|mesh-list
44435202|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
44435203|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462654|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44462655|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
44462656|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
44462657|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44462658|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
44462659|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44462660|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462662|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44462663|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462664|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
44462665|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
44462666|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
44462667|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44462668|NCT01525550|Sunitinib|sunitinib|mesh-list
44462669|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44462670|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43825656|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
44435204|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435205|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
44435206|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435207|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44435208|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
44435226|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435228|NCT02016898|Mitomycin|mitomycin|mesh-list
44435229|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435230|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435231|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
44435232|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435233|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44435234|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435235|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44435236|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
44435237|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435238|NCT02016625|Cyclosporine|cyclosporine|mesh-list
44435239|NCT02016625|Tacrolimus|tacrolimus|mesh-list
44435240|NCT02016625|Cyclosporins|cyclosporins|mesh-list
44435241|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435242|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
44435243|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435244|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44435245|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435246|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435247|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
44435248|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435249|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44435250|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435251|NCT02016482|Adalimumab|adalimumab|mesh-list
44435252|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435253|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435254|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44435255|NCT02016183|Candesartan|candesartan|mesh-list
44435256|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
44435257|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44435258|NCT02016183|Diuretics|diuretics|mesh-ancestor
44435259|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
44435260|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268208|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44268209|NCT00666393|Narcotics|narcotics|mesh-ancestor
44268210|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268211|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268212|NCT00666393|Analgesics|analgesics|mesh-ancestor
44268213|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
44268214|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268215|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44268216|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44268217|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
44268218|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
44268219|NCT00666484|Prednisolone|prednisolone|mesh-list
44268220|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
44268221|NCT00666484|Doxorubicin|doxorubicin|mesh-list
44435261|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44435262|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435263|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435264|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44435265|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44435266|NCT02016170|Ticagrelor|ticagrelor|mesh-list
44435291|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435292|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
44435293|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435294|NCT02015793|Adalimumab|adalimumab|mesh-list
44435295|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435296|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435297|NCT02015676|Paclitaxel|paclitaxel|mesh-list
44435298|NCT02015676|Trastuzumab|trastuzumab|mesh-list
44435299|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435300|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435301|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435302|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435303|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435304|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435305|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435306|NCT02015663|Tobramycin|tobramycin|mesh-list
44435307|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435308|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435309|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
44435310|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435311|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435312|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44435313|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
44435314|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44435315|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44435316|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44435317|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435345|NCT02015195|Protective Agents|protective agents|mesh-ancestor
43834275|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834276|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43834277|NCT05156632|Vaccines|vaccines|mesh-list
43834278|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
43834279|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834280|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43834281|NCT05156632|Antacids|antacids|mesh-ancestor
43834282|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834283|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435346|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435347|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
44435348|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44435349|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
44435350|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435351|NCT02014740|Metformin|metformin|mesh-list
44435352|NCT02014740|Liraglutide|liraglutide|mesh-list
44435353|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435354|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435355|NCT02014740|Incretins|incretins|mesh-ancestor
44435356|NCT02014740|Hormones|hormones|mesh-ancestor
43795080|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44268223|NCT00666484|Etoposide|etoposide|mesh-list
44268224|NCT00666484|Vincristine|vincristine|mesh-list
44268225|NCT00666484|Procarbazine|procarbazine|mesh-list
44268226|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268227|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
44268228|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268229|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268230|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44268231|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
44268232|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268233|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268234|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44268235|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44268236|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268237|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268238|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268239|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268240|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435357|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435358|NCT02014584|Dutasteride|dutasteride|mesh-list
44435359|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44435360|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44435361|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435362|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435363|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
44435399|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435401|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435424|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435425|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
44435426|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
44435427|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
44435428|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
44435429|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435430|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435431|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435432|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
44435433|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
44435434|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44435435|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44435436|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
44435437|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435438|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
44435439|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
44435440|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435441|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435442|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435443|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
44435444|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
43562399|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562400|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43562401|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
43562402|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43562403|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
44435445|NCT02013375|Sirolimus|sirolimus|mesh-list
44435446|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
44435447|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
44435448|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435449|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
44435450|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268242|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268243|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268244|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
44268245|NCT00666484|Hormones|hormones|mesh-ancestor
44268246|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268247|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44268248|NCT00666575|Gabapentin|gabapentin|mesh-list
44268249|NCT00666575|Analgesics|analgesics|mesh-ancestor
44268250|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
44268251|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268252|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268253|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
44268254|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44435451|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435452|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435453|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
43962657|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44435465|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435466|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435468|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44435469|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435470|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
44435471|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435472|NCT02012959|Tolvaptan|tolvaptan|mesh-list
44435473|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44435474|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435475|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
44435476|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435477|NCT02012491|Misoprostol|misoprostol|mesh-list
44435478|NCT02012491|Mifepristone|mifepristone|mesh-list
44435479|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44435480|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
44435481|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44435482|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435483|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44435484|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435485|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
44435486|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44435487|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44435488|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44435489|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44435490|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
44435491|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44435492|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44435493|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
44435494|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435495|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
44435496|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44435497|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44435498|NCT02012296|Mifepristone|mifepristone|mesh-list
44435499|NCT02012296|Androgens|androgens|mesh-list
44435500|NCT02012296|Hormones|hormones|mesh-ancestor
44435501|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435502|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435503|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44435504|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
44435505|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44435506|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44268255|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268256|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268257|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268258|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268259|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44268260|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268261|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268262|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
44268263|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
44268264|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268265|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268266|NCT00666627|Alendronate|alendronate|mesh-list
44268267|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
44268268|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
44268269|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44268270|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268271|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44268272|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44268273|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268274|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44268275|NCT00666653|Pramipexole|pramipexole|mesh-list
44268276|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
44268278|NCT00666653|Protective Agents|protective agents|mesh-ancestor
44268305|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
44268306|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268307|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268309|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44268310|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268311|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268312|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268313|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268314|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44268315|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268316|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660309|NCT02932761|Goserelin|goserelin|mesh-list
44435507|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44435508|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44435509|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
44435510|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44435511|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44435535|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
44435536|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435537|NCT02011113|Dexamethasone|dexamethasone|mesh-list
44435538|NCT02011113|Pomalidomide|pomalidomide|mesh-list
44435539|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435540|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
44435541|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
44435542|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435543|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435544|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435545|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
44435546|NCT02011113|Hormones|hormones|mesh-ancestor
44435547|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435548|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44435549|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435550|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
44435551|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44435552|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44435553|NCT02011113|Growth Substances|growth substances|mesh-ancestor
44435554|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
44435555|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
44435556|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44435557|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44435558|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44435559|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435560|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435561|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
44435562|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435588|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
44435589|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435590|NCT02009878|Tolvaptan|tolvaptan|mesh-list
44435591|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44435592|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435593|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
44435594|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435595|NCT02009722|Morphine|morphine|mesh-list
44435596|NCT02009722|Hydromorphone|hydromorphone|mesh-list
44435597|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44435598|NCT02009722|Narcotics|narcotics|mesh-ancestor
44435599|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435600|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435601|NCT02009722|Analgesics|analgesics|mesh-ancestor
44435602|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
44268317|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
44268318|NCT00666783|Palonosetron|palonosetron|mesh-list
44268319|NCT00666783|Granisetron|granisetron|mesh-list
44268320|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
44268321|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
44268322|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268323|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268324|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44268325|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44268326|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44268327|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
44268328|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268329|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268330|NCT00666796|Ethanol|ethanol|mesh-list
44268331|NCT00666796|Gabapentin|gabapentin|mesh-list
44268332|NCT00666796|Analgesics|analgesics|mesh-ancestor
43660322|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
44435603|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435604|NCT02009397|Ipilimumab|ipilimumab|mesh-list
44435605|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435606|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435607|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44093869|NCT05382546|Ketorolac|ketorolac|mesh-list
44435608|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435610|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435632|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44435633|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44435634|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435635|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435636|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
44435637|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435638|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44435639|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
44435640|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435641|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44435642|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
44435643|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435644|NCT02008877|Sirolimus|sirolimus|mesh-list
44435645|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435646|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435647|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435648|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435649|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
44435650|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435651|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
44435652|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435653|NCT02008773|Valacyclovir|valacyclovir|mesh-list
44435654|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
44435655|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435656|NCT02008565|Loperamide|loperamide|mesh-list
44435657|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
44435658|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435659|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44435660|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
44435661|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435662|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44435697|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435698|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435699|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44268333|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
44268334|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268335|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268336|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
44268337|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44268338|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268339|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268340|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268341|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268342|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44268343|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268344|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268345|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
44268346|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44268347|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268348|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268349|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268350|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268351|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268352|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268353|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268354|NCT00666809|Urological Agents|urological agents|mesh-ancestor
44268355|NCT00666887|Minocycline|minocycline|mesh-list
44268356|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268357|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268359|NCT00666939|Analgesics|analgesics|mesh-ancestor
44268360|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
44268361|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268362|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268363|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
44268364|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44268365|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268375|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268376|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268377|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268378|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268379|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268380|NCT00667043|Fentanyl|fentanyl|mesh-list
44268381|NCT00667043|Midazolam|midazolam|mesh-list
44268382|NCT00667043|Remifentanil|remifentanil|mesh-list
44268383|NCT00667043|Propofol|propofol|mesh-list
44268384|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44268385|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268386|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268387|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44268388|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
44268389|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
44268390|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44268391|NCT00667043|Narcotics|narcotics|mesh-ancestor
44268392|NCT00667043|Analgesics|analgesics|mesh-ancestor
44268393|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
44268394|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268395|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44268396|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44268403|NCT00667056|Tacrolimus|tacrolimus|mesh-list
44268429|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268430|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268431|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
44268432|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44268433|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44268434|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268435|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44268436|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268437|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44268438|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733945|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
44268439|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268440|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
44268441|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44268442|NCT00667147|Paclitaxel|paclitaxel|mesh-list
44268443|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268444|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268445|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268446|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268447|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268448|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268449|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
44268450|NCT00667160|Tacrolimus|tacrolimus|mesh-list
44435700|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
44435717|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435718|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435719|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44435721|NCT02007434|Analgesics|analgesics|mesh-ancestor
44435722|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435723|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435724|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44435725|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435726|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44435727|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44435728|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44435729|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435730|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44435731|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44435732|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
44435733|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44435734|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44435735|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
44435736|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
44435737|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44435738|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
44435739|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
44435740|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44435741|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44435742|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44435743|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
44435744|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
43795292|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268451|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268452|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
44268453|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268454|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44268455|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268456|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268457|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44268458|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44268459|NCT00667160|Analgesics|analgesics|mesh-ancestor
44268460|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
44435745|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44435746|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435747|NCT02007278|Metformin|metformin|mesh-list
44435748|NCT02007278|Glimepiride|glimepiride|mesh-list
44435749|NCT02007278|Vildagliptin|vildagliptin|mesh-list
44435750|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435751|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435752|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44435753|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435754|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
44435755|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44435756|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
44435757|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435758|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435759|NCT02007096|Bupivacaine|bupivacaine|mesh-list
44435760|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
44435795|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435796|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44435797|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
44435798|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44435799|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435800|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
44435801|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435802|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44435818|NCT02006667|Gemcitabine|gemcitabine|mesh-list
44435819|NCT02006667|Cisplatin|cisplatin|mesh-list
44435820|NCT02006667|Trastuzumab|trastuzumab|mesh-list
44435821|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435822|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435823|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
44435824|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435825|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
44435826|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435827|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435828|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435829|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
44435830|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435831|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435832|NCT02006628|Cannabidiol|cannabidiol|mesh-list
44435833|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
44435834|NCT02006576|Ibuprofen|ibuprofen|mesh-list
44435835|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44435836|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44435837|NCT02006576|Analgesics|analgesics|mesh-ancestor
44435838|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
44435839|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435840|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435841|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435842|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435843|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44435844|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435845|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435846|NCT02006121|Apomorphine|apomorphine|mesh-list
44435847|NCT02006121|Emetics|emetics|mesh-ancestor
44435848|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268462|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268463|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268464|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
44268465|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44268466|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268467|NCT00667264|Ropivacaine|ropivacaine|mesh-list
44268468|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
44268469|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
44268470|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44268471|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268472|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
44268473|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268474|NCT00667303|Antibodies|antibodies|mesh-list
44268475|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
44268476|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268477|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44268478|NCT00667407|Albuterol|albuterol|mesh-list
44268479|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44268480|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
44268481|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268482|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268483|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44268484|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44435849|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
44435850|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435851|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435852|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
44435853|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
44435854|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648400|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43648401|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648402|NCT03516968|Vitamins|vitamins|mesh-ancestor
43648403|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
43648404|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44435855|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435856|NCT02005887|Letrozole|letrozole|mesh-list
44435857|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44435858|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435859|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44435860|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44435861|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962659|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44435881|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435882|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435883|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
44435884|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435885|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
44435886|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435887|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
44435888|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435889|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44435890|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435891|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435892|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44435893|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
44268485|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
44268486|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268487|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44268488|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44268489|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44268490|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44268491|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268492|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268493|NCT00667433|Tenofovir|tenofovir|mesh-list
44268494|NCT00667433|Emtricitabine|emtricitabine|mesh-list
44268495|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
44268496|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44268497|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
44268498|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268499|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44268500|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268501|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268502|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268503|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44268504|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44268505|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44268506|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44268507|NCT00667472|Ranibizumab|ranibizumab|mesh-list
44268508|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648406|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
43648407|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648408|NCT03490864|Protective Agents|protective agents|mesh-ancestor
43648411|NCT03490825|Melatonin|melatonin|mesh-list
44268509|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44268510|NCT00667472|Growth Substances|growth substances|mesh-ancestor
44268511|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268512|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
44268530|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44268531|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268532|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44268533|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268535|NCT00667641|Bortezomib|bortezomib|mesh-list
44268536|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44268537|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268538|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44268539|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44268540|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44268541|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268542|NCT00667758|Cetrorelix|cetrorelix|mesh-list
44268543|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44268544|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
44268545|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268546|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268547|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
44268548|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268549|NCT00667771|Naltrexone|naltrexone|mesh-list
44268550|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44268551|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44268552|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268553|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
44268554|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268555|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44435894|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435895|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435896|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
44435897|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
44435898|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435899|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435900|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
44435901|NCT02005562|Hormones|hormones|mesh-ancestor
44435902|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435903|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44435904|NCT02005562|Protective Agents|protective agents|mesh-ancestor
44435905|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44435906|NCT02005484|Trastuzumab|trastuzumab|mesh-list
44435907|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435908|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435909|NCT02005471|Rituximab|rituximab|mesh-list
44435910|NCT02005471|Venetoclax|venetoclax|mesh-list
44435911|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44435912|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435913|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435914|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
44435946|NCT02004093|Paclitaxel|paclitaxel|mesh-list
44435947|NCT02004093|Carboplatin|carboplatin|mesh-list
44268556|NCT00667797|Albuterol|albuterol|mesh-list
44268557|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44268558|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
44268559|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44268560|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268561|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44268562|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
44268563|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
44268564|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268565|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44268566|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44268567|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44268568|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44268569|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44268570|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268571|NCT00667901|Riluzole|riluzole|mesh-list
44268572|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
44268573|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44268574|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44435948|NCT02004093|Pertuzumab|pertuzumab|mesh-list
44435949|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435950|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435951|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435952|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435953|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435954|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435955|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435956|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
44435957|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
44435958|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435991|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435992|NCT02003391|Timolol|timolol|mesh-list
44435993|NCT02003391|Travoprost|travoprost|mesh-list
44435994|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44435995|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44435996|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44435997|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44435998|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
44435999|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436000|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436021|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
44436022|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436023|NCT02003014|Pioglitazone|pioglitazone|mesh-list
44436024|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436025|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436026|NCT02002975|Pioglitazone|pioglitazone|mesh-list
44436027|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436028|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436029|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
44436030|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44436031|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44436032|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44436033|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44436034|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44436035|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268576|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268577|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268578|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44268579|NCT00667901|Protective Agents|protective agents|mesh-ancestor
44268580|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
44268581|NCT00667927|Busulfan|busulfan|mesh-list
44268582|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44268583|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
44268584|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268585|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44268586|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44268587|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
44268588|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268589|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268590|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44268591|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268592|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268593|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268594|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268595|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436036|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
44436037|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436038|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436039|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44436040|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436041|NCT02002221|Metformin|metformin|mesh-list
44436042|NCT02002221|Vildagliptin|vildagliptin|mesh-list
44436043|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436044|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436045|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44436046|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436047|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436048|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436049|NCT02001987|Methotrexate|methotrexate|mesh-list
44436050|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44436051|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
44436052|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44436075|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44436076|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
44436077|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436078|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436079|NCT02000882|Capecitabine|capecitabine|mesh-list
44436080|NCT02000882|Trastuzumab|trastuzumab|mesh-list
44436081|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436082|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
44436083|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436084|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436085|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436086|NCT02000622|Olaparib|olaparib|mesh-list
44436087|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44268596|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268598|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268599|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268600|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268601|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268602|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268603|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268604|NCT00667979|Urological Agents|urological agents|mesh-ancestor
44268605|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268606|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268607|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268608|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268609|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268610|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268611|NCT00668005|Urological Agents|urological agents|mesh-ancestor
44268612|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268613|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
44436088|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436089|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436090|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436091|NCT02000531|Gemcitabine|gemcitabine|mesh-list
44436092|NCT02000531|Cisplatin|cisplatin|mesh-list
44436093|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44436094|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436095|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436096|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
44436097|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436098|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
44436099|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436100|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436101|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436102|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
44436135|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436136|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436137|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436138|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436139|NCT01999335|Dexamethasone|dexamethasone|mesh-list
43734194|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
43562693|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562694|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436140|NCT01999335|Pomalidomide|pomalidomide|mesh-list
44436141|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436142|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
44436143|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
44436144|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436145|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436177|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44436178|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436179|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
44436180|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44436181|NCT01999179|Heparin|heparin|mesh-list
44436182|NCT01999179|Enoxaparin|enoxaparin|mesh-list
44436183|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44436184|NCT01999179|Tinzaparin|tinzaparin|mesh-list
44436185|NCT01999179|Dalteparin|dalteparin|mesh-list
44436186|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
44436187|NCT01999179|Dabigatran|dabigatran|mesh-list
44436188|NCT01999179|Apixaban|apixaban|mesh-list
44436189|NCT01999179|Anticoagulants|anticoagulants|mesh-list
44268614|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268615|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268616|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268617|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268618|NCT00668018|Urological Agents|urological agents|mesh-ancestor
44268619|NCT00668031|Aprotinin|aprotinin|mesh-list
44268620|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
44268621|NCT00668031|Coagulants|coagulants|mesh-ancestor
44268622|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44268623|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44268624|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
44268625|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268626|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268627|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
44268628|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268629|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268630|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268631|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268632|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268633|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268634|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268635|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44268636|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268637|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268638|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268639|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268640|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268641|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268642|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268643|NCT00668057|Urological Agents|urological agents|mesh-ancestor
44268644|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43922978|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
44268653|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268654|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268655|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268656|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268657|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268658|NCT00668109|Urological Agents|urological agents|mesh-ancestor
44268660|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268661|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268662|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268663|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268664|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734219|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
43734220|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
43734221|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734223|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44268665|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268666|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268667|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44268668|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268669|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44268670|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
44268671|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44268672|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44268673|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660419|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
44436190|NCT01999179|Edoxaban|edoxaban|mesh-list
44436258|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436260|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
44436261|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436262|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436263|NCT01998880|Rituximab|rituximab|mesh-list
44436264|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
44436265|NCT01998880|Chlorambucil|chlorambucil|mesh-list
44436266|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436267|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436268|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
44436269|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436270|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436271|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44436272|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
44436306|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436307|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436308|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436309|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436310|NCT01995825|Lamotrigine|lamotrigine|mesh-list
44436336|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436338|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436339|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436340|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44436341|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436342|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
44436343|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436344|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268674|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268675|NCT00668135|Urological Agents|urological agents|mesh-ancestor
44268676|NCT00668239|Triamcinolone|triamcinolone|mesh-list
44268677|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44268678|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
44268679|NCT00668239|Hormones|hormones|mesh-ancestor
44268680|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268681|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268682|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
44268683|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44268684|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44268685|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268686|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44268687|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44268688|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268689|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268690|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268691|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44268692|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
44268693|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44268694|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268695|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44268696|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44268697|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44436345|NCT01995136|Travoprost|travoprost|mesh-list
43734256|NCT02540824|Apatinib|apatinib|mesh-list
44436346|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44436347|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44436348|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44436349|NCT01995071|Ribavirin|ribavirin|mesh-list
44436350|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
44436351|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436352|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
44436353|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436354|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44436355|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436356|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436357|NCT01994837|Venetoclax|venetoclax|mesh-list
44436392|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436393|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
44436394|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44436396|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436428|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436429|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44436430|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436431|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436432|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44436433|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
44268700|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
44268701|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44268702|NCT00668330|Calcium|calcium|mesh-list
44268703|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44268704|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268705|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44268706|NCT00668330|Vitamins|vitamins|mesh-ancestor
44268707|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
44268708|NCT00668343|Simvastatin|simvastatin|mesh-list
44268709|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44268710|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44268711|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
44268712|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268713|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44268714|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44268715|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268716|NCT00668356|Didanosine|didanosine|mesh-list
44268717|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
44268718|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268719|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44436434|NCT01993888|Coagulants|coagulants|mesh-ancestor
44436435|NCT01993836|Anesthetics|anesthetics|mesh-list
44436436|NCT01993836|Propofol|propofol|mesh-list
44436437|NCT01993836|Isoflurane|isoflurane|mesh-list
44436438|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436439|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436440|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44436465|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
44436466|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436468|NCT01993329|Cisplatin|cisplatin|mesh-list
44436469|NCT01993329|Ifosfamide|ifosfamide|mesh-list
44436470|NCT01993329|Mesna|mesna|mesh-list
44436471|NCT01993329|Protective Agents|protective agents|mesh-ancestor
44436472|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436473|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
44436474|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436475|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44436476|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436477|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44436478|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436479|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44436480|NCT01993186|Glycerol|glycerol|mesh-list
44436481|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44436482|NCT01993186|Protective Agents|protective agents|mesh-ancestor
43648415|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436483|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436484|NCT01993017|Bupropion|bupropion|mesh-list
44436485|NCT01993017|Sertraline|sertraline|mesh-list
44436486|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
44436487|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44436488|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44436489|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44268720|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268721|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268722|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
44268723|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268724|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44268725|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44268726|NCT00668499|Cisplatin|cisplatin|mesh-list
44268727|NCT00668499|Pemetrexed|pemetrexed|mesh-list
44268728|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268729|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268730|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268731|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44268732|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44268733|NCT00668538|Miconazole|miconazole|mesh-list
44268734|NCT00668538|Clotrimazole|clotrimazole|mesh-list
44268735|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
44268736|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44268737|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44268738|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44268739|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44268740|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44268741|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44268742|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
44268743|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44268744|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44268745|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43660445|NCT02931877|Propofol|propofol|mesh-list
44436524|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44436525|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436552|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44436553|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436554|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44436555|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44436556|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44436557|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
44436558|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44436559|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44436560|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
44436561|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436562|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
44436563|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44436564|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44436565|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44436566|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436567|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44268747|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44462672|NCT01525550|Growth Substances|growth substances|mesh-ancestor
44462673|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44462674|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
44462675|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44462676|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44462677|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648416|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648417|NCT03461445|Tacrolimus|tacrolimus|mesh-list
43734306|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43734307|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43734308|NCT02540720|Dexamethasone|dexamethasone|mesh-list
43734309|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
44436569|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
44436570|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44436604|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436605|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436606|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436607|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
44436608|NCT01989572|Sargramostim|sargramostim|mesh-list
44436642|NCT01989156|Menthol|menthol|mesh-list
44436643|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
44436644|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436645|NCT01988779|Levofloxacin|levofloxacin|mesh-list
44436646|NCT01988779|Ofloxacin|ofloxacin|mesh-list
44436647|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44436648|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436649|NCT01988779|Renal Agents|renal agents|mesh-ancestor
44436650|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44436651|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44436687|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436688|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436689|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436725|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436726|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436727|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44436728|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44436747|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436748|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436749|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436750|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44436751|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436752|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
44436753|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436754|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44436755|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
44436756|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44436757|NCT01987453|Ledipasvir|ledipasvir|mesh-list
44436758|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
44436759|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436760|NCT01987427|Phentermine|phentermine|mesh-list
44436761|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44436762|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436763|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
44436764|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44436765|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
44436766|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
44436767|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734379|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43734380|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
43734382|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43734383|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
44436768|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
43912049|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912050|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
43912051|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912052|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912053|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912054|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
43912055|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912056|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912057|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912058|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43912059|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912060|NCT00538031|Analgesics|analgesics|mesh-ancestor
43912061|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
43912062|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912063|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912064|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43912065|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43912066|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912068|NCT00370838|Levetiracetam|levetiracetam|mesh-list
43912069|NCT00370838|Analgesics|analgesics|mesh-ancestor
43912070|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
43912071|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912072|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912073|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43912074|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
43912075|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
43912076|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43912077|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43912091|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
43912092|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912093|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
43912094|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43912095|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43912096|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43912097|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43912098|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912099|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
43912100|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912101|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912102|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43912103|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912104|NCT00373334|Nizatidine|nizatidine|mesh-list
43912105|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43912106|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43912107|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43912108|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
43912109|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
43912110|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912111|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912112|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912113|NCT00373360|Treprostinil|treprostinil|mesh-list
43912114|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43912115|NCT00373386|Hormones|hormones|mesh-list
43912116|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912117|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912118|NCT00373399|Dronabinol|dronabinol|mesh-list
43912119|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
43912120|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912121|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43651667|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
43651668|NCT03005496|Nifedipine|nifedipine|mesh-list
43651669|NCT03005496|BB 1101|bb 1101|mesh-list
43763504|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
43562922|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562923|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
43562925|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43912122|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912123|NCT00373399|Analgesics|analgesics|mesh-ancestor
43912124|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
44165369|NCT00259870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43637070|NCT04697628|Vinorelbine|vinorelbine|mesh-list
43912125|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912126|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43912127|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43912128|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912129|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912130|NCT00373399|Hormones|hormones|mesh-ancestor
43912131|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912132|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
43912133|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43912134|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
43912135|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912136|NCT00374088|Expectorants|expectorants|mesh-ancestor
43912137|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
43912138|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43912139|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
43912140|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912141|NCT00374088|Protective Agents|protective agents|mesh-ancestor
43912142|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912143|NCT00374088|Antidotes|antidotes|mesh-ancestor
43912144|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
43912145|NCT00374231|Prednisone|prednisone|mesh-list
43912146|NCT00374231|Tacrolimus|tacrolimus|mesh-list
43912147|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912148|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
43912149|NCT00374231|Hormones|hormones|mesh-ancestor
43912150|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912151|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912152|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43912153|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912168|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912169|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912170|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43912171|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
43912172|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912173|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912174|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43912175|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
43912176|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912177|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912178|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43912179|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
43912180|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912229|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912230|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
43912231|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
43912232|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
43912233|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912234|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912235|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43912236|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912237|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912238|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
43912239|NCT00376805|Fludarabine|fludarabine|mesh-list
43912240|NCT00376805|Interleukin-2|interleukin-2|mesh-list
43912241|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912242|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
43912243|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912244|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912245|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912246|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
43912247|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912248|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912249|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912250|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912251|NCT00376805|Analgesics|analgesics|mesh-ancestor
43912252|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
43912253|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912254|NCT00376948|Gemcitabine|gemcitabine|mesh-list
43912255|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43912256|NCT00376948|Genistein|genistein|mesh-list
43912276|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43912277|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43912278|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43912279|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
43912280|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
43912281|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912282|NCT00377741|Valganciclovir|valganciclovir|mesh-list
43912283|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
43912284|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912285|NCT00377832|Acetaminophen|acetaminophen|mesh-list
43912286|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912287|NCT00377832|Analgesics|analgesics|mesh-ancestor
43912288|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
43912289|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912290|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912291|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
43912292|NCT00378326|Tacrolimus|tacrolimus|mesh-list
43912293|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912294|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
43912295|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912297|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912298|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912299|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
43912300|NCT00378352|Hematinics|hematinics|mesh-ancestor
43912301|NCT00379145|Trabectedin|trabectedin|mesh-list
43912302|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912303|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
43912304|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912305|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912306|NCT00379197|Naltrexone|naltrexone|mesh-list
43912307|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43912308|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43912309|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912310|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
43912311|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912312|NCT00379574|Prednisolone|prednisolone|mesh-list
43912313|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
43912316|NCT00379574|Bortezomib|bortezomib|mesh-list
43912317|NCT00379574|Lenograstim|lenograstim|mesh-list
43912318|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912319|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
43912320|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912321|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912322|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912323|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
43912324|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912325|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912326|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912327|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912328|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43912329|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912330|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912331|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912332|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
43912333|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
43912334|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
43912335|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912336|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
43912337|NCT00379574|Hormones|hormones|mesh-ancestor
43912338|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912339|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43912340|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43912341|NCT00379821|Azithromycin|azithromycin|mesh-list
43912342|NCT00379821|Artesunate|artesunate|mesh-list
43912343|NCT00379821|Chloroquine|chloroquine|mesh-list
43912344|NCT00379821|Atovaquone|atovaquone|mesh-list
43912345|NCT00379821|Proguanil|proguanil|mesh-list
43912346|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43912347|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912348|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912349|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
43912350|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43912351|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43912352|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912353|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
43840908|NCT04666129|Hormones|hormones|mesh-ancestor
43912355|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43912356|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
43912357|NCT00379821|Amebicides|amebicides|mesh-ancestor
43912358|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912359|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912360|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912361|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
43912362|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43912363|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912364|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912365|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912366|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912367|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
43912368|NCT00381004|Rituximab|rituximab|mesh-list
43912369|NCT00381004|Fludarabine|fludarabine|mesh-list
43912370|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
43912371|NCT00381004|Sargramostim|sargramostim|mesh-list
43912372|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912373|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
43912374|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912375|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912376|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912377|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
43912378|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912379|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912380|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912381|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912384|NCT00381550|Fludarabine|fludarabine|mesh-list
43912398|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912399|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912400|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
43912401|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912402|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912403|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912404|NCT00381810|Analgesics|analgesics|mesh-ancestor
43912405|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
43912406|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912407|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
43912408|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912409|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
43912410|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
43912411|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43912412|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
43912413|NCT00381810|Hormones|hormones|mesh-ancestor
43912414|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912415|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43912416|NCT00381810|Protective Agents|protective agents|mesh-ancestor
43912417|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43912418|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43912419|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912420|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
43912421|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
43912422|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43912423|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
43912424|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
43912425|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912426|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912427|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43912428|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
43912430|NCT00381862|Leucovorin|leucovorin|mesh-list
43912443|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912444|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43912445|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
43912447|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43912448|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43912449|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912450|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
43912451|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912452|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912453|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912454|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
43912455|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43912456|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912457|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912458|NCT00381862|Antidotes|antidotes|mesh-ancestor
43912459|NCT00381862|Protective Agents|protective agents|mesh-ancestor
43912460|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
43912461|NCT00381862|Vitamins|vitamins|mesh-ancestor
43912462|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
43912463|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43912464|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912475|NCT00382148|Omalizumab|omalizumab|mesh-list
44138985|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44138986|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138987|NCT00174200|Risperidone|risperidone|mesh-list
44138988|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44138989|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
44138990|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837603|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
43837604|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
43837605|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563046|NCT01338883|Efavirenz|efavirenz|mesh-list
44138991|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138992|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138993|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44138994|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44138995|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138996|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660620|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
44138997|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43912489|NCT00382590|Azacitidine|azacitidine|mesh-list
43912490|NCT00382590|Valproic Acid|valproic acid|mesh-list
43912491|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912492|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
43912493|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912494|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912495|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
43912496|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912497|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912498|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
43912499|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912500|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912501|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
43912502|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
43912503|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912504|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
43912505|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912506|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912507|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912517|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912519|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43912520|NCT00383448|Cyclosporine|cyclosporine|mesh-list
43912521|NCT00383448|Melphalan|melphalan|mesh-list
43912522|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
43912523|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
43912524|NCT00383448|Clofarabine|clofarabine|mesh-list
43912525|NCT00383448|Cyclosporins|cyclosporins|mesh-list
43912526|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912527|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912528|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912529|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
43912530|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912531|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
43912532|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912533|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43912534|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912535|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43912536|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912537|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
43912538|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912539|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912540|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912541|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
43912542|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43912543|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912544|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
43912545|NCT00383565|Romidepsin|romidepsin|mesh-list
43912546|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912561|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
43912562|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
43912563|NCT00383747|Nicotine|nicotine|mesh-list
43912564|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43912565|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
43912566|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912567|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912568|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43912569|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43912570|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
43912571|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912572|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912573|NCT00383942|Misoprostol|misoprostol|mesh-list
43912574|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43912575|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
43912576|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43912577|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912578|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43912579|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43912580|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
43912581|NCT00384449|Ranibizumab|ranibizumab|mesh-list
43912582|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43912583|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43912584|NCT00384449|Growth Substances|growth substances|mesh-ancestor
43912585|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912586|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
43912588|NCT00384670|Vaccines|vaccines|mesh-list
43912609|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912610|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43912611|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43912612|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912613|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
43912614|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43912615|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43912616|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
43912617|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43912618|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43912619|NCT00385008|Naproxen|naproxen|mesh-list
43912620|NCT00385008|Sumatriptan|sumatriptan|mesh-list
43912621|NCT00385008|Eletriptan|eletriptan|mesh-list
43912622|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43912623|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43912624|NCT00385008|Analgesics|analgesics|mesh-ancestor
43912625|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
43912626|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912627|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912628|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912629|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912630|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
43912631|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43912632|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912633|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912634|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43912635|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43912636|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43912637|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
43912638|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912651|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
43912652|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912653|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912654|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43912655|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43912656|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
43912657|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912658|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912659|NCT00385268|Acamprosate|acamprosate|mesh-list
43912660|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43912661|NCT00385580|Dasatinib|dasatinib|mesh-list
43912715|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912716|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912717|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
43763925|NCT02423824|Incretins|incretins|mesh-ancestor
43763926|NCT02423824|Hormones|hormones|mesh-ancestor
43912718|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912719|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
43912720|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43912721|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43912722|NCT00387023|Rituximab|rituximab|mesh-list
43912723|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912724|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912725|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
43912726|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912727|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912728|NCT00387036|Fluticasone|fluticasone|mesh-list
43912729|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912730|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43912731|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
43912732|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912733|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912734|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43912735|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
43912736|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43912737|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43912738|NCT00387335|Sunitinib|sunitinib|mesh-list
43912739|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912740|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43912741|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43912742|NCT00387335|Growth Substances|growth substances|mesh-ancestor
43912743|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912744|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
43912745|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912746|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912747|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912748|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43791552|NCT05135013|Diuretics|diuretics|mesh-ancestor
44165370|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44165371|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165372|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912749|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
43912750|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912751|NCT00387660|Carboplatin|carboplatin|mesh-list
43912752|NCT00387660|Irinotecan|irinotecan|mesh-list
43912753|NCT00387660|Camptothecin|camptothecin|mesh-list
43912754|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912755|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43912756|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912757|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912758|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912759|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912760|NCT00387751|Bevacizumab|bevacizumab|mesh-list
43912761|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43912762|NCT00387751|Sorafenib|sorafenib|mesh-list
43912763|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
43912764|NCT00387751|Antibodies|antibodies|mesh-list
43912765|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
43912766|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43912767|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
43912768|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912769|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43912770|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43912771|NCT00387751|Growth Substances|growth substances|mesh-ancestor
43912772|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912773|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
43912774|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
43912775|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912776|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912777|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912778|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43912779|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43912794|NCT00387959|Fludarabine|fludarabine|mesh-list
43912795|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
43912796|NCT00387959|Cyclosporins|cyclosporins|mesh-list
43912797|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912798|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
43912799|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912800|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912801|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912802|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
43912803|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912804|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912805|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912806|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912807|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43912854|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912855|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43912856|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43912857|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43912858|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
43912859|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912860|NCT00389493|Risperidone|risperidone|mesh-list
43912861|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43912862|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
43912863|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912864|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912865|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912866|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43912867|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912868|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912869|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912870|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43912872|NCT00389532|Vaccines|vaccines|mesh-list
43912873|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
43912874|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912875|NCT00389805|Pemetrexed|pemetrexed|mesh-list
43912876|NCT00389805|Bortezomib|bortezomib|mesh-list
43912877|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912878|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912879|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912880|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43912881|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43912882|NCT00389818|Prednisone|prednisone|mesh-list
43912883|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
43912884|NCT00389818|Rituximab|rituximab|mesh-list
43912885|NCT00389818|Doxorubicin|doxorubicin|mesh-list
43912898|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43912899|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43912900|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43912901|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912902|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912903|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43912904|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
43912905|NCT00389818|Hormones|hormones|mesh-ancestor
43912906|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651680|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
43912907|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43912908|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912909|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
43912910|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
43912911|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
43912912|NCT00389857|Vaccines|vaccines|mesh-list
43912913|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
43912914|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912915|NCT00389974|Sunitinib|sunitinib|mesh-list
43912916|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912917|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43912918|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43912919|NCT00389974|Growth Substances|growth substances|mesh-ancestor
43912920|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912921|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
43912922|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912923|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912924|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912943|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912945|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912946|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912947|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
43912948|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912949|NCT00390429|Docetaxel|docetaxel|mesh-list
43912950|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43912951|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912952|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
43912953|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
43912954|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
43912955|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912956|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43912957|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912959|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43912960|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
43912961|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912962|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912963|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43912964|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43912965|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
43912966|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43912967|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912968|NCT00390611|Paclitaxel|paclitaxel|mesh-list
43912969|NCT00390611|Carboplatin|carboplatin|mesh-list
43912970|NCT00390611|Sorafenib|sorafenib|mesh-list
43912971|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43912972|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912973|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
43912974|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
43912975|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
43912976|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912977|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165373|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165374|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
44165375|NCT00259883|Paroxetine|paroxetine|mesh-list
44165376|NCT00259883|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44165377|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44165378|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702525|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43912978|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912980|NCT00391079|Analgesics|analgesics|mesh-ancestor
43912981|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
43912982|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912983|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912984|NCT00391443|Bosentan|bosentan|mesh-list
43912985|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43912986|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43764123|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764124|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43764125|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
43912987|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912988|NCT00391716|Gabapentin|gabapentin|mesh-list
43912989|NCT00391716|Analgesics|analgesics|mesh-ancestor
43912990|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
43912991|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43912992|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912993|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
43912994|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43912995|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43912996|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43912997|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43912998|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43912999|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43913000|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913001|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913002|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
43913003|NCT00391989|Dasatinib|dasatinib|mesh-list
43913004|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913005|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913006|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913007|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913008|NCT00392041|Eszopiclone|eszopiclone|mesh-list
43913012|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43913021|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913022|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913023|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913024|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913025|NCT00392392|Growth Substances|growth substances|mesh-ancestor
43913026|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913027|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913028|NCT00392444|Sunitinib|sunitinib|mesh-list
43913029|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913030|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913031|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913032|NCT00392444|Growth Substances|growth substances|mesh-ancestor
43913033|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913034|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913035|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913036|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913037|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913039|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913040|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913041|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913042|NCT00392496|Growth Substances|growth substances|mesh-ancestor
43913043|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913044|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913045|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913046|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913047|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913048|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43913049|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
43913050|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43913051|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43913052|NCT00392678|Analgesics|analgesics|mesh-ancestor
43913053|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
43913059|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913060|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913061|NCT00392704|Paclitaxel|paclitaxel|mesh-list
43913062|NCT00392704|Bevacizumab|bevacizumab|mesh-list
43913063|NCT00392704|Fluorouracil|fluorouracil|mesh-list
43913064|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43913065|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913066|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913067|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913068|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913069|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913070|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913071|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43563195|NCT01312454|Travoprost|travoprost|mesh-list
43913072|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913073|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913074|NCT00392704|Growth Substances|growth substances|mesh-ancestor
43913075|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913076|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913077|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
43913078|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913079|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913080|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
43913081|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913082|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913083|NCT00392782|Fludarabine|fludarabine|mesh-list
43913084|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
43913085|NCT00392782|Thiotepa|thiotepa|mesh-list
43913086|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43913087|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913088|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913089|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
43913091|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913102|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43913103|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
43913104|NCT00392834|Ifosfamide|ifosfamide|mesh-list
43913105|NCT00392834|Rituximab|rituximab|mesh-list
43913106|NCT00392834|Doxorubicin|doxorubicin|mesh-list
43913107|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43913108|NCT00392834|Methotrexate|methotrexate|mesh-list
43913109|NCT00392834|Etoposide|etoposide|mesh-list
43913110|NCT00392834|Vincristine|vincristine|mesh-list
43913111|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
43913112|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913113|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
43913114|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913115|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913116|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43913117|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
43913118|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913119|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913120|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43913121|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913122|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913123|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913124|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913125|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913126|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43913127|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
43913128|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43913152|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913153|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
43913154|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913155|NCT00393380|Teriparatide|teriparatide|mesh-list
43651695|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43651696|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
43651697|NCT03005496|Protective Agents|protective agents|mesh-ancestor
43651698|NCT03005496|Provitamins|provitamins|mesh-ancestor
43651699|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43651700|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
43651701|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
43651702|NCT03005808|Ropivacaine|ropivacaine|mesh-list
43913157|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
43913158|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913159|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913160|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43913161|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43913162|NCT00393796|Sunitinib|sunitinib|mesh-list
43661142|NCT02925351|Clofarabine|clofarabine|mesh-list
43913163|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913164|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913165|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913166|NCT00393796|Growth Substances|growth substances|mesh-ancestor
43913167|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913168|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913169|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913170|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913171|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913172|NCT00393874|Prazosin|prazosin|mesh-list
43913173|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43913174|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43913175|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43913176|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43913177|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
43913178|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913179|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913180|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913181|NCT00393978|Topiramate|topiramate|mesh-list
43913182|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43913183|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
43913184|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913189|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
43913190|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43913191|NCT00394277|Ribavirin|ribavirin|mesh-list
43913192|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43913193|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
43913194|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
43913195|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913196|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
43913197|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913198|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
43913199|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913200|NCT00394329|Beclomethasone|beclomethasone|mesh-list
43913201|NCT00394329|Albuterol|albuterol|mesh-list
43913202|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43913203|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
43913204|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913205|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913206|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43913207|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
43913208|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
43913209|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43913210|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43913211|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43913212|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43913213|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
43913214|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913215|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913216|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913217|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
43913218|NCT00394329|Hormones|hormones|mesh-ancestor
43913219|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913220|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
43913221|NCT00395044|Gabapentin|gabapentin|mesh-list
43913229|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913230|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913231|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43913232|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43913233|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913234|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913235|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
43913236|NCT00395057|Ranibizumab|ranibizumab|mesh-list
43913237|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44157380|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913238|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913239|NCT00395057|Growth Substances|growth substances|mesh-ancestor
43913240|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913241|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913242|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913243|NCT00395161|Selenium|selenium|mesh-list
43913244|NCT00395161|Metoclopramide|metoclopramide|mesh-list
43913245|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
43913246|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913247|NCT00395161|Protective Agents|protective agents|mesh-ancestor
43913248|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913249|NCT00395161|Trace Elements|trace elements|mesh-ancestor
43913250|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
43913251|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
43913252|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
43913253|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913254|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43913255|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43913256|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43913257|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
43913258|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913273|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913274|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913275|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913276|NCT00396201|Plerixafor|plerixafor|mesh-list
43913277|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43913278|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43913279|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
43913280|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913281|NCT00396266|Plerixafor|plerixafor|mesh-list
43913282|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43913283|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43913284|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
43913285|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913286|NCT00397020|Valproic Acid|valproic acid|mesh-list
43913287|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43913288|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
43913289|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913290|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43913291|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43913292|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913293|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913294|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
43913295|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913296|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913297|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
43913298|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913299|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
44139000|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44139001|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44139002|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44139003|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139004|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913302|NCT00397813|Fludarabine|fludarabine|mesh-list
43913303|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
43913304|NCT00397813|Cyclosporins|cyclosporins|mesh-list
43913305|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913306|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913307|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
43913308|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913309|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913310|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
43913311|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913312|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913313|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
43913314|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913315|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
43913316|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913317|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43913318|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913319|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43913320|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
43913321|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43913323|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43913324|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913325|NCT00397878|Saracatinib|saracatinib|mesh-list
43913326|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913327|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913328|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651717|NCT03005405|Methamphetamine|methamphetamine|mesh-list
43913329|NCT00397904|Cisplatin|cisplatin|mesh-list
43913330|NCT00397904|Irinotecan|irinotecan|mesh-list
43913331|NCT00397904|Cetuximab|cetuximab|mesh-list
43913332|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913333|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43913334|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913335|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913336|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913337|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913338|NCT00398398|Capecitabine|capecitabine|mesh-list
43913339|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
43637071|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
43913340|NCT00398398|Cetuximab|cetuximab|mesh-list
43913341|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913342|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
43913343|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913344|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913345|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913346|NCT00398476|Fluticasone|fluticasone|mesh-list
43913347|NCT00398476|Xhance|xhance|mesh-list
43913348|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913349|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43913350|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
43913351|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913352|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913353|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43913354|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
43913355|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
43913356|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43913357|NCT00398918|Zonisamide|zonisamide|mesh-list
43913358|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
43913359|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43913360|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43913361|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913362|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43913363|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913364|NCT00398983|Decitabine|decitabine|mesh-list
43913365|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913366|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
43913367|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913386|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
43913387|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913388|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43913389|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
43913390|NCT00400686|Hematinics|hematinics|mesh-ancestor
43913391|NCT00400803|Gemcitabine|gemcitabine|mesh-list
43913392|NCT00400803|Bevacizumab|bevacizumab|mesh-list
43913393|NCT00400803|Carboplatin|carboplatin|mesh-list
43913394|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913396|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913397|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913398|NCT00400803|Growth Substances|growth substances|mesh-ancestor
43913399|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913400|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913401|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913402|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
43913403|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913404|NCT00400803|Antiviral Agents|antiviral agents|mesh-ancestor
43913405|NCT00400803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913406|NCT00400803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913407|NCT00400803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913408|NCT00400803|Immunologic Factors|immunologic factors|mesh-ancestor
43913409|NCT00401401|Cisplatin|cisplatin|mesh-list
43913410|NCT00401401|Zalutumumab|zalutumumab|mesh-list
43913411|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913412|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913413|NCT00401414|Warfarin|warfarin|mesh-list
43913414|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
43913415|NCT00401778|Everolimus|everolimus|mesh-list
43913416|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913417|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913418|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
43913420|NCT00401817|Bevacizumab|bevacizumab|mesh-list
43913432|NCT00401882|Epinephrine|epinephrine|mesh-list
43913433|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43913434|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43913435|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
43913436|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913437|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913438|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913439|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43913440|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43913441|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
43913442|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913443|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43913444|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
43913445|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
43913446|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
43913447|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43913448|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43913449|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43913450|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
43913451|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43825741|NCT05215106|Durvalumab|durvalumab|mesh-list
43913452|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43913453|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43913455|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43913456|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43913457|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43913458|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43913459|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913460|NCT00402714|Pentostatin|pentostatin|mesh-list
43913475|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43913476|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43913477|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913478|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
43913479|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913480|NCT00403403|Bevacizumab|bevacizumab|mesh-list
43913481|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913482|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913483|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913484|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913485|NCT00403403|Growth Substances|growth substances|mesh-ancestor
43913486|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913487|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913488|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
43913489|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43913490|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43913491|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43913492|NCT00405288|Pramoxine|pramoxine|mesh-list
43913493|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913494|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
43913495|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
43913496|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43913497|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913498|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
43913499|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913500|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
43913501|NCT00405353|Testosterone|testosterone|mesh-list
43913502|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
43913503|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
43913504|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43913505|NCT00405353|Androgens|androgens|mesh-ancestor
43913506|NCT00405353|Hormones|hormones|mesh-ancestor
43913519|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
43913520|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43913521|NCT00405522|Narcotics|narcotics|mesh-ancestor
43913522|NCT00405522|Analgesics|analgesics|mesh-ancestor
43913523|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
43913524|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913525|NCT00405704|Trimethoprim|trimethoprim|mesh-list
43913526|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43661404|NCT02923687|Ketorolac|ketorolac|mesh-list
43913527|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
43913528|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43913529|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913530|NCT00405704|Renal Agents|renal agents|mesh-ancestor
43913531|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
43913532|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43913533|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43913534|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43913535|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913536|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913537|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43913538|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43913539|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43913540|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43913541|NCT00405938|Bevacizumab|bevacizumab|mesh-list
43913542|NCT00405938|Fulvestrant|fulvestrant|mesh-list
43913543|NCT00405938|Anastrozole|anastrozole|mesh-list
43913544|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913560|NCT00406276|Docetaxel|docetaxel|mesh-list
43913564|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913565|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913566|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913567|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913568|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
43913569|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913570|NCT00407355|Ranibizumab|ranibizumab|mesh-list
43913571|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913572|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913573|NCT00407355|Growth Substances|growth substances|mesh-ancestor
43913574|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913575|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913576|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913577|NCT00407381|Ranibizumab|ranibizumab|mesh-list
43913578|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913579|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913580|NCT00407381|Growth Substances|growth substances|mesh-ancestor
43913581|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913582|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913583|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913584|NCT00407485|Aflibercept|aflibercept|mesh-list
43913585|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913586|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913587|NCT00407485|Growth Substances|growth substances|mesh-ancestor
43913588|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913589|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913590|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913591|NCT00407654|Aflibercept|aflibercept|mesh-list
43913592|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
43913593|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913594|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913595|NCT00407654|Growth Substances|growth substances|mesh-ancestor
43913596|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913597|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913598|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913599|NCT00407888|Paclitaxel|paclitaxel|mesh-list
43913603|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43913604|NCT00407888|Trastuzumab|trastuzumab|mesh-list
43913605|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913606|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913607|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913608|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913609|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913610|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913611|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913612|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
43913613|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913614|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913615|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43913616|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
43913617|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43913618|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913619|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913620|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913621|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913622|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913623|NCT00407966|Cytarabine|cytarabine|mesh-list
43913624|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
43913625|NCT00407966|Alvocidib|alvocidib|mesh-list
43913626|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913627|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
43913628|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913629|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913630|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
43913631|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913632|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913633|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
43913647|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913648|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913649|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913650|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913651|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913652|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913653|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913654|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913655|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913656|NCT00408070|Growth Substances|growth substances|mesh-ancestor
43913657|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913658|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913660|NCT00408200|Flecainide|flecainide|mesh-list
43913661|NCT00408200|Propafenone|propafenone|mesh-list
43913662|NCT00408200|Dofetilide|dofetilide|mesh-list
43913663|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43913664|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43913665|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
43913666|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913667|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913668|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913669|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43913670|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
43913671|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
43913672|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913674|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43913695|NCT00408564|Antiviral Agents|antiviral agents|mesh-ancestor
43913696|NCT00408564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913697|NCT00408564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913698|NCT00408564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913699|NCT00408564|Immunologic Factors|immunologic factors|mesh-ancestor
43913700|NCT00408564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913701|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913702|NCT00409292|Everolimus|everolimus|mesh-list
43913703|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913704|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913705|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
43913706|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913707|NCT00409565|Bevacizumab|bevacizumab|mesh-list
43913708|NCT00409565|Cetuximab|cetuximab|mesh-list
43913709|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913710|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913711|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43913712|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43913713|NCT00409565|Growth Substances|growth substances|mesh-ancestor
43913714|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913715|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
43913716|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43913717|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43764317|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764355|NCT02420652|Metformin|metformin|mesh-list
43764356|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43764357|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764392|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
43764423|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
43764424|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
43764514|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
43913718|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43913719|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
43913720|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913721|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913722|NCT00409825|Progestins|progestins|mesh-ancestor
43913723|NCT00409825|Hormones|hormones|mesh-ancestor
43913724|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43913725|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913726|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913727|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791960|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
44165379|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165380|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165381|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
44165382|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913728|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913729|NCT00410150|Albuterol|albuterol|mesh-list
43913730|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43913731|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
43913732|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913733|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913734|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43913735|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
43913736|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
43913737|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43913738|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43913739|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43913740|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43913741|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
43913742|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913743|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913744|NCT00410423|Cytarabine|cytarabine|mesh-list
43913745|NCT00410423|Etoposide|etoposide|mesh-list
43913746|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
43913747|NCT00410423|Bortezomib|bortezomib|mesh-list
43913748|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913749|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913750|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913751|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913752|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913753|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913754|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43913755|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
43913775|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
43913776|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913777|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913778|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43913779|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
43913780|NCT00410488|Hormones|hormones|mesh-ancestor
43913781|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913782|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43913783|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913784|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
43913785|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913786|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913787|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913788|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913789|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913790|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43913791|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
43913792|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
43913793|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
43913794|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43913795|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
43913796|NCT00410488|Protective Agents|protective agents|mesh-ancestor
43913797|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43913802|NCT00410826|Cisplatin|cisplatin|mesh-list
43913824|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43764622|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764624|NCT02418533|Hormones|hormones|mesh-list
43913825|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43913826|NCT00411086|Rituximab|rituximab|mesh-list
43913827|NCT00411086|Molgramostim|molgramostim|mesh-list
43913828|NCT00411086|Sargramostim|sargramostim|mesh-list
43913829|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913830|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913831|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
43913832|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913833|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913834|NCT00411398|Memantine|memantine|mesh-list
43913835|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43913836|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43913837|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
43913838|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913839|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913840|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913841|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43913842|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43913843|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43913844|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43913845|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913847|NCT00411411|Hormones|hormones|mesh-ancestor
43913848|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43913849|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43913850|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
43913851|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913852|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913853|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43913860|NCT00411619|Everolimus|everolimus|mesh-list
43913867|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
43913868|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43913869|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913870|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43913871|NCT00412074|Vitamin D|vitamin d|mesh-list
43913872|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
43913873|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
43913874|NCT00412074|Vitamins|vitamins|mesh-list
43913875|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
43913876|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913877|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43913878|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43913879|NCT00412087|Vitamin D|vitamin d|mesh-list
43913880|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
43913881|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
43913882|NCT00412087|Vitamins|vitamins|mesh-list
43913883|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
43913884|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913885|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43913886|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43913887|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
43913888|NCT00412243|Clofarabine|clofarabine|mesh-list
43913889|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913890|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
43913891|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913892|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913893|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43913894|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
43913895|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913896|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913897|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43913900|NCT00412425|Palonosetron|palonosetron|mesh-list
43913910|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913911|NCT00412451|Plasminogen|plasminogen|mesh-list
43913912|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913913|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913914|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913916|NCT00412464|Fondaparinux|fondaparinux|mesh-list
43913917|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43913918|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
43913919|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43913920|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
43913921|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913922|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913923|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
43913924|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913925|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913926|NCT00412529|Entecavir|entecavir|mesh-list
43913927|NCT00412529|Telbivudine|telbivudine|mesh-list
43913928|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
43913929|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43913930|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43913931|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913932|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913933|NCT00412841|Atorvastatin|atorvastatin|mesh-list
43913934|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43913935|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43913936|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
43913937|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913938|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44165383|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44165384|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
44165385|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165386|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44165387|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44165388|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165389|NCT00259896|Exenatide|exenatide|mesh-list
44165390|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44165391|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165420|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165422|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
44165423|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165424|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
44165425|NCT00260052|Hematinics|hematinics|mesh-ancestor
44165426|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
44165427|NCT00260143|Testosterone|testosterone|mesh-list
43913939|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43913940|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913941|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43913942|NCT00412867|Plasminogen|plasminogen|mesh-list
43913943|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913944|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913945|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913946|NCT00413166|Idarubicin|idarubicin|mesh-list
43913947|NCT00413166|Tretinoin|tretinoin|mesh-list
43913948|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
43913949|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
43913950|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43913951|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913952|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43913953|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43913954|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913955|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913956|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
43913957|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
43913958|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43913959|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
43913960|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43913961|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913962|NCT00413400|Etanercept|etanercept|mesh-list
43913963|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43913964|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43913965|NCT00413400|Analgesics|analgesics|mesh-ancestor
43913966|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
43913967|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43913968|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913969|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43913970|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43913971|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43913972|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43913978|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43913979|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913980|NCT00413634|Anagrelide|anagrelide|mesh-list
43913981|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43913982|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43913983|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913984|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43913985|NCT00414167|Bupropion|bupropion|mesh-list
43913986|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43913987|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
43913988|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43913989|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43913990|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43913991|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43913992|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43913993|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
43913994|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43913995|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43913996|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43913997|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43913998|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43913999|NCT00414206|Mecamylamine|mecamylamine|mesh-list
43914000|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43914001|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43914002|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
43914003|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914004|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914005|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43914010|NCT00414271|Docetaxel|docetaxel|mesh-list
43914022|NCT00414518|Emtricitabine|emtricitabine|mesh-list
43914023|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43914024|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43914025|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
43914026|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914027|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914028|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43914029|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43914030|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
43914031|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914032|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43914033|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43914034|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43914035|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43914036|NCT00415506|Rituximab|rituximab|mesh-list
43914037|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914038|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914039|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
43914040|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914041|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914042|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43914043|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
43914044|NCT00415857|Vaccines|vaccines|mesh-list
43914045|NCT00415857|Sargramostim|sargramostim|mesh-list
43914074|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43914075|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914076|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
43914077|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43914078|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
43914079|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914080|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914081|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914082|NCT00417417|Rilonacept|rilonacept|mesh-list
43914083|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43914084|NCT00418028|Capecitabine|capecitabine|mesh-list
43914085|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914086|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
43914087|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914088|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914089|NCT00418093|Gemcitabine|gemcitabine|mesh-list
43914090|NCT00418093|Bevacizumab|bevacizumab|mesh-list
43914091|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
43914092|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914093|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914094|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914095|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914096|NCT00418093|Growth Substances|growth substances|mesh-ancestor
43914097|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914124|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914126|NCT00418951|Amphotericin B|amphotericin b|mesh-list
43914127|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43914128|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
43661899|NCT02919579|Esketamine|esketamine|mesh-list
43914129|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914130|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43914131|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43914132|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914133|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914134|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43914135|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
43914136|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914137|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914138|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43914139|NCT00418951|Amebicides|amebicides|mesh-ancestor
43914140|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43914141|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43914142|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43914143|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
43914144|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43914145|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43914146|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
43914147|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914148|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914149|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914150|NCT00419666|Calcitriol|calcitriol|mesh-list
43914151|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914165|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914166|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43914167|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43914168|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43914169|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914170|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43914171|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43914172|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43914173|NCT00420459|Aripiprazole|aripiprazole|mesh-list
43914174|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
43914175|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914176|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43914177|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914178|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914179|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914180|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
43914181|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
43914182|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914183|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914184|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43914185|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43914186|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
43914187|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43914188|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43914189|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43914190|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43914191|NCT00420771|Gabapentin|gabapentin|mesh-list
43914192|NCT00420771|Analgesics|analgesics|mesh-ancestor
43914193|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
43914194|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914195|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914196|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
43914197|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43914198|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914199|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165428|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
43914200|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914201|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43914202|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43914203|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914204|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914205|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
43914206|NCT00420992|Naltrexone|naltrexone|mesh-list
43914207|NCT00420992|Morphine|morphine|mesh-list
43914208|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43914209|NCT00420992|Narcotics|narcotics|mesh-ancestor
43914210|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914211|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914212|NCT00420992|Analgesics|analgesics|mesh-ancestor
43914213|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
43914214|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914215|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43914216|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43914217|NCT00421603|Topiramate|topiramate|mesh-list
43914218|NCT00421603|Adderall|adderall|mesh-list
43914219|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
43914220|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43914221|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914222|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43914223|NCT00422032|Clofarabine|clofarabine|mesh-list
43914224|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914225|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
43914226|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914227|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165429|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
44165430|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44165432|NCT00260143|Hormones|hormones|mesh-ancestor
44165433|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165434|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165435|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165436|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165437|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
44165438|NCT00260247|Carbamazepine|carbamazepine|mesh-list
44165439|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
44165440|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
44165441|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
44165475|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165476|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165477|NCT00260351|Vaccines|vaccines|mesh-list
44165478|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
44165479|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165480|NCT00260364|Gemcitabine|gemcitabine|mesh-list
44165481|NCT00260364|Bevacizumab|bevacizumab|mesh-list
44165486|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914228|NCT00422201|Mifepristone|mifepristone|mesh-list
43914229|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43914230|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
43914231|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43914232|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914233|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43914234|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43914235|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43914236|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
43914237|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43914238|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43914239|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
43914240|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914241|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
43914242|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43914243|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43914244|NCT00423358|Vitamin D|vitamin d|mesh-list
43914245|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
43914246|NCT00423358|Vitamins|vitamins|mesh-ancestor
43914247|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
43914248|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914249|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914250|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914252|NCT00423683|Fondaparinux|fondaparinux|mesh-list
43914253|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43914254|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
43914255|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43914256|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
43914257|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914258|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914259|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
43914260|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43914261|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43914262|NCT00423878|Olanzapine|olanzapine|mesh-list
43914263|NCT00423878|Risperidone|risperidone|mesh-list
43914269|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914270|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914271|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43914272|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914273|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914274|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662022|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
43914275|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43914276|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
43914277|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
43914278|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
43914279|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914280|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914281|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43914282|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43914283|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914284|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
43914285|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
43914286|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43914287|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43914288|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43914289|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43914291|NCT00424502|Methotrexate|methotrexate|mesh-list
44165487|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44165488|NCT00260364|Growth Substances|growth substances|mesh-ancestor
44165489|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165490|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
44165491|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43764660|NCT02418065|Hormones|hormones|mesh-ancestor
44165492|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
44165493|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165494|NCT00260364|Antiviral Agents|antiviral agents|mesh-ancestor
44165495|NCT00260364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165496|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165497|NCT00260364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165498|NCT00260364|Immunologic Factors|immunologic factors|mesh-ancestor
44165499|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165501|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165502|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165503|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
44165504|NCT00260390|Hormones|hormones|mesh-ancestor
44165505|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165506|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165507|NCT00260416|Abciximab|abciximab|mesh-list
44165508|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
44165509|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44165510|NCT00260520|Dalteparin|dalteparin|mesh-list
44165511|NCT00260520|Tinzaparin|tinzaparin|mesh-list
44165512|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43914292|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914293|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914294|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
43914295|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914296|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914297|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43914298|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
43914299|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43914300|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914301|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
43914302|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914303|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914304|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914305|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43914306|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914307|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43914308|NCT00424554|Temozolomide|temozolomide|mesh-list
43914309|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914310|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
43914311|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914312|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914313|NCT00424619|Vitamin D|vitamin d|mesh-list
43914314|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
43914315|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
43914316|NCT00424619|Vitamins|vitamins|mesh-list
43914317|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
43914318|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914319|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914320|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44165513|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
44165514|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44165515|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165516|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165517|NCT00260611|Docetaxel|docetaxel|mesh-list
44165518|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
44165519|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165520|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165521|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165522|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165523|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165524|NCT00260624|Citalopram|citalopram|mesh-list
44165525|NCT00260624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44165526|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43914322|NCT00424840|Carboplatin|carboplatin|mesh-list
43914323|NCT00424840|Bortezomib|bortezomib|mesh-list
43914324|NCT00424840|Docetaxel|docetaxel|mesh-list
43914325|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914326|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914327|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914328|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914329|NCT00424840|Growth Substances|growth substances|mesh-ancestor
43914330|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914331|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914332|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914333|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914334|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914335|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914336|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43914337|NCT00425386|Sunitinib|sunitinib|mesh-list
43914338|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914339|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914340|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914341|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914342|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914343|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914344|NCT00425386|Growth Substances|growth substances|mesh-ancestor
43914345|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165527|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165528|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165529|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165530|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
44165531|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165532|NCT00260624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44165533|NCT00260624|Antidepressive Agents|antidepressive agents|mesh-ancestor
44165534|NCT00260624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165535|NCT00260702|Omalizumab|omalizumab|mesh-list
44165536|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44165537|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44165538|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44165539|NCT00260793|Ropinirole|ropinirole|mesh-list
44165540|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44165541|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44165542|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
44165543|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
44165544|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165545|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165546|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165547|NCT00260819|Bosentan|bosentan|mesh-list
44165548|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44165549|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44165550|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914346|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914347|NCT00425477|Bexarotene|bexarotene|mesh-list
43914348|NCT00425477|Sargramostim|sargramostim|mesh-list
43914349|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
43914350|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914351|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914352|NCT00425672|Interleukin-2|interleukin-2|mesh-list
43914353|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
43914354|NCT00425672|Immunotoxins|immunotoxins|mesh-list
43914355|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914356|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43914357|NCT00425672|Analgesics|analgesics|mesh-ancestor
43914358|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
43914359|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914360|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914361|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
43914362|NCT00425802|Cyclosporine|cyclosporine|mesh-list
43914363|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
43914364|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
43914365|NCT00425802|Rituximab|rituximab|mesh-list
43914366|NCT00425802|Fludarabine|fludarabine|mesh-list
43914367|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
43914368|NCT00425802|Cyclosporins|cyclosporins|mesh-list
43914369|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43914370|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914371|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
43914372|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914373|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914374|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914375|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
43914376|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914391|NCT00426153|Octreotide|octreotide|mesh-list
43914392|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914393|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43914394|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914395|NCT00426283|Fluticasone|fluticasone|mesh-list
43914397|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43914398|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43914399|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
43914400|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914401|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914402|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43914403|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
43914404|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914405|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43914406|NCT00426517|Sirolimus|sirolimus|mesh-list
43914407|NCT00426517|Busulfan|busulfan|mesh-list
43914408|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
43914409|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43914410|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914411|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43914412|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914413|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
43914414|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914415|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
43914416|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914417|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
43914418|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914419|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914420|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914421|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914422|NCT00426855|Bortezomib|bortezomib|mesh-list
43914423|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43914424|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914425|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43914426|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
43792329|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
44165551|NCT00260988|Dalteparin|dalteparin|mesh-list
44165552|NCT00260988|Tinzaparin|tinzaparin|mesh-list
44165553|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44165554|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
44165555|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43914427|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914430|NCT00427037|Vitamins|vitamins|mesh-ancestor
43914431|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
43914432|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914433|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914434|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914435|NCT00427297|Ritonavir|ritonavir|mesh-list
43914436|NCT00427297|Lopinavir|lopinavir|mesh-list
43914437|NCT00427297|Tenofovir|tenofovir|mesh-list
43914438|NCT00427297|Lamivudine|lamivudine|mesh-list
43914439|NCT00427297|Zidovudine|zidovudine|mesh-list
43914440|NCT00427297|Nevirapine|nevirapine|mesh-list
43914441|NCT00427297|Abacavir|abacavir|mesh-list
43914442|NCT00427297|Didanosine|didanosine|mesh-list
43914443|NCT00427297|Stavudine|stavudine|mesh-list
43914444|NCT00427297|Efavirenz|efavirenz|mesh-list
43914445|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
43914446|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43914447|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43914448|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
43914449|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914450|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914451|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43914452|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43914453|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
43914454|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914455|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44165556|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165557|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165559|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165560|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44165561|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44165562|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165563|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165564|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44165565|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
43764738|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44165566|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165567|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165568|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44165569|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44165570|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165571|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
44165572|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165573|NCT00261079|Fexofenadine|fexofenadine|mesh-list
44165574|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44165575|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44165576|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44165577|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
43914456|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43914457|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43914458|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43914459|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
43914460|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43914461|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43914462|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43914463|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43914521|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43914522|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43914523|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
43914524|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914525|NCT00427791|Rituximab|rituximab|mesh-list
43914526|NCT00427791|Etoposide|etoposide|mesh-list
43914527|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914528|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914529|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
43914530|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914531|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914532|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43914533|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43914534|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43914535|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914536|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914537|NCT00427804|Calcitriol|calcitriol|mesh-list
43914538|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914539|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914540|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43914541|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914542|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914543|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43914544|NCT00427804|Vitamins|vitamins|mesh-ancestor
43914545|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
43914546|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914547|NCT00427973|Cediranib|cediranib|mesh-list
43914568|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914569|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914570|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914571|NCT00428922|Growth Substances|growth substances|mesh-ancestor
43914572|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914573|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914574|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914575|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914576|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914577|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914578|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
43914579|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
43914597|NCT00429403|Goserelin|goserelin|mesh-list
43914631|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914632|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43914633|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43914634|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43914635|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
43914636|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
43914637|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
43914638|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43914639|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
43914640|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
43914641|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43914642|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
43914643|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
43914644|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
43914645|NCT00429949|Dasatinib|dasatinib|mesh-list
43914646|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914647|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914648|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914649|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914650|NCT00430183|Docetaxel|docetaxel|mesh-list
43914651|NCT00430183|Leuprolide|leuprolide|mesh-list
43914652|NCT00430183|Goserelin|goserelin|mesh-list
43914653|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914654|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914655|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914656|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139014|NCT00174239|Levodopa|levodopa|mesh-list
43914657|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914658|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43914659|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
43914660|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43914661|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914676|NCT00431132|Estrogens|estrogens|mesh-ancestor
43914677|NCT00431132|Hormones|hormones|mesh-ancestor
43914678|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914679|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914680|NCT00431184|Pentazocine|pentazocine|mesh-list
43914681|NCT00431184|Lorazepam|lorazepam|mesh-list
43914682|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
43914683|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
43914684|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
43914685|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914686|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914687|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43914688|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43914689|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914690|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43914691|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914692|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914693|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
43914694|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
43914695|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914696|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914697|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43914698|NCT00431184|Narcotics|narcotics|mesh-ancestor
43914727|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
43914728|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43914729|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914730|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44139015|NCT00174239|Carbidopa|carbidopa|mesh-list
43914731|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43914732|NCT00432458|Growth Substances|growth substances|mesh-ancestor
43914733|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914734|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914735|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43914736|NCT00433550|Capecitabine|capecitabine|mesh-list
43914737|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
43914738|NCT00433550|Irinotecan|irinotecan|mesh-list
43914739|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914740|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
43914741|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914742|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914743|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43914744|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43914745|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914747|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
43914748|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914749|NCT00434356|Paclitaxel|paclitaxel|mesh-list
43914750|NCT00434356|Bevacizumab|bevacizumab|mesh-list
43914751|NCT00434356|Sunitinib|sunitinib|mesh-list
43914752|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43914753|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914754|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914755|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914756|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914757|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914758|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914759|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43914760|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44165578|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
44165579|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165580|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165581|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165582|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
44165583|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165584|NCT00261105|Telithromycin|telithromycin|mesh-list
43914762|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914763|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
43914764|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43914765|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914766|NCT00434993|Albuterol|albuterol|mesh-list
43914767|NCT00434993|Dimercaprol|dimercaprol|mesh-list
43914768|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43914769|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
43914770|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914771|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914772|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43914773|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
43914774|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
43914775|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43914776|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43914777|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43914778|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43914779|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
43914780|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914781|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914782|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
43914783|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
43914784|NCT00435539|Plasminogen|plasminogen|mesh-list
43914785|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
43914786|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43914787|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43914788|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914789|NCT00435591|Conivaptan|conivaptan|mesh-list
43914790|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43914791|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914792|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
43914793|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914794|NCT00435812|Vaccines|vaccines|mesh-list
43914801|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
43914802|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914803|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914804|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43914805|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43914806|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
43914807|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914808|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43914809|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43914810|NCT00436046|Interferons|interferons|mesh-list
43914867|NCT00438451|Carbamazepine|carbamazepine|mesh-list
43914868|NCT00438451|Levetiracetam|levetiracetam|mesh-list
43914869|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
43914870|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
43914871|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43914872|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914873|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914874|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43914875|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914876|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43914877|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43914878|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43914879|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914880|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43914881|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
43914882|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43914883|NCT00438451|Analgesics|analgesics|mesh-ancestor
43914884|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
43914885|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914886|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43914887|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43914889|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914890|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
43914891|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139016|NCT00174239|Cabergoline|cabergoline|mesh-list
44139039|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44139040|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139041|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139042|NCT00174317|Celecoxib|celecoxib|mesh-list
44139043|NCT00174317|Diclofenac|diclofenac|mesh-list
44139044|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139045|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139046|NCT00174317|Analgesics|analgesics|mesh-ancestor
44139047|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
44139048|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139049|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139050|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139051|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139052|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44139053|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139054|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139055|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139056|NCT00174330|Amlodipine|amlodipine|mesh-list
44139057|NCT00174330|Atorvastatin|atorvastatin|mesh-list
44139058|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44139059|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44139060|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
44139061|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139062|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44139063|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44139064|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914896|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914897|NCT00438880|Rituximab|rituximab|mesh-list
43914898|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43914899|NCT00438880|Antibodies|antibodies|mesh-list
43914900|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
43914901|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43914902|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
43914903|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914904|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914905|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43914906|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43914907|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43914908|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43914909|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43914910|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914911|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43914912|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914914|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
43914915|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43914916|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
43914917|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914918|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
43914919|NCT00439296|Cytarabine|cytarabine|mesh-list
43914920|NCT00439296|Dexamethasone|dexamethasone|mesh-list
43914921|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
43914922|NCT00439296|Doxorubicin|doxorubicin|mesh-list
43914923|NCT00439296|Methotrexate|methotrexate|mesh-list
43914924|NCT00439296|Asparaginase|asparaginase|mesh-list
43914944|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914945|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43914946|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43914947|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43914948|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43914949|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914950|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43914951|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
43914952|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43914953|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914954|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
43914955|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
43914956|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43914957|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43914958|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
43914959|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43914960|NCT00439335|Vaccines|vaccines|mesh-list
43914961|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
43914962|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914963|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43914964|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43914965|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43914966|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662585|NCT02913690|Vitamin E|vitamin e|mesh-list
43914967|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43914968|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43914969|NCT00439374|Progestins|progestins|mesh-ancestor
43914970|NCT00439374|Hormones|hormones|mesh-ancestor
43914971|NCT00439413|Selegiline|selegiline|mesh-list
43914973|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43914987|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
43914988|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
43914989|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
43914990|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914991|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43914992|NCT00439673|Azacitidine|azacitidine|mesh-list
43914993|NCT00439673|Valproic Acid|valproic acid|mesh-list
43914994|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43914995|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
43914996|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43914997|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43914998|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43914999|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
43915000|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
43915001|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915002|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915003|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
43915004|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43915005|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915006|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915007|NCT00439946|Treprostinil|treprostinil|mesh-list
43915008|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43915009|NCT00440180|Anastrozole|anastrozole|mesh-list
43915010|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915011|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915012|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43915013|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43915014|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915015|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915016|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43915017|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
43915019|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915028|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915029|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915031|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43915032|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
43915033|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915034|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915035|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43915036|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43915037|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915038|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915039|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915040|NCT00441285|Albendazole|albendazole|mesh-list
43915041|NCT00441285|Praziquantel|praziquantel|mesh-list
43915042|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
43915043|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43915044|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915045|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
43915046|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43915047|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43915048|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915049|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
43915050|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
43915051|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915052|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915053|NCT00441883|Latanoprost|latanoprost|mesh-list
43915054|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43915055|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43915056|NCT00442013|Lansoprazole|lansoprazole|mesh-list
43915057|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
43915058|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43915059|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43915060|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43915061|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915062|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915063|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44165585|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165586|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165587|NCT00261118|Rituximab|rituximab|mesh-list
43915066|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43915067|NCT00442507|Bevacizumab|bevacizumab|mesh-list
43915068|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43915069|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915070|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915071|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915072|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915073|NCT00442507|Growth Substances|growth substances|mesh-ancestor
43915074|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915075|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915076|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915077|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915078|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915079|NCT00442611|Abatacept|abatacept|mesh-list
43915080|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43764787|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
43915081|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915082|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915083|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915084|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
43915085|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915086|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915087|NCT00442689|Flutamide|flutamide|mesh-list
43915088|NCT00442689|Drospirenone|drospirenone|mesh-list
43915089|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43915090|NCT00442689|Estradiol|estradiol|mesh-list
43915091|NCT00442689|Estrogens|estrogens|mesh-ancestor
43915092|NCT00442689|Hormones|hormones|mesh-ancestor
43915093|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915094|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915095|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43915096|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
44165588|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165589|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165590|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
44165591|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165592|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165593|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
43915097|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915098|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43915099|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43915100|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43915101|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43915102|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
43915103|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43915105|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
43915106|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
43915107|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915108|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915109|NCT00442767|Insulin|insulin|mesh-list
43915110|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43915111|NCT00442767|Pramlintide|pramlintide|mesh-list
43915112|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
43915113|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43915114|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915115|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
43915116|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43915117|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
43915118|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915119|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43915120|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43915121|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915122|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915144|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915145|NCT00445211|Heparin|heparin|mesh-list
43915146|NCT00445211|Calcium heparin|calcium heparin|mesh-list
43915147|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
43915148|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43915149|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43915150|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915151|NCT00445263|Tirofiban|tirofiban|mesh-list
43915152|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43915153|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43915154|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915155|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43915156|NCT00445302|Plerixafor|plerixafor|mesh-list
43915157|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43915158|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43915159|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
43915160|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915161|NCT00445484|Lenalidomide|lenalidomide|mesh-list
43915162|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43915163|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
43915164|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915165|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915166|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915167|NCT00445484|Growth Substances|growth substances|mesh-ancestor
43915168|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915169|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915170|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43915171|NCT00445588|Sorafenib|sorafenib|mesh-list
43915172|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915191|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915192|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915193|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
43915194|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915195|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915196|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43915197|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915198|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43915199|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
43915200|NCT00445887|Norgestrel|norgestrel|mesh-list
43915201|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43915202|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
43915203|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915204|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915205|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43915206|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43915207|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43915208|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43915209|NCT00446147|Pyridoxine|pyridoxine|mesh-list
43915210|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
43915211|NCT00446147|Vitamins|vitamins|mesh-ancestor
43915212|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
43915213|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915214|NCT00446264|Sirolimus|sirolimus|mesh-list
43915215|NCT00446264|Tacrolimus|tacrolimus|mesh-list
43915216|NCT00446264|Daclizumab|daclizumab|mesh-list
43915217|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915218|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
43915219|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915220|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43915221|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915222|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915223|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165594|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44165595|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44165596|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44165597|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165598|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165599|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
44165600|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165601|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915224|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915225|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43915226|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915227|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
43915228|NCT00446290|Docetaxel|docetaxel|mesh-list
43915229|NCT00446290|Capecitabine|capecitabine|mesh-list
43915230|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
43915231|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915232|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915233|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
43915234|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
43915235|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915236|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915237|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
43915238|NCT00447330|Bevacizumab|bevacizumab|mesh-list
43915239|NCT00447330|Capecitabine|capecitabine|mesh-list
43915240|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
43915241|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915242|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915243|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915244|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915245|NCT00447330|Growth Substances|growth substances|mesh-ancestor
43915246|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915247|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915248|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915249|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
43915250|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915251|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43915252|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43915253|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43915254|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915255|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915267|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
43915268|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915269|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915270|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915271|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
43915272|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915273|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915274|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915275|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915276|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43915277|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915278|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
43915279|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915280|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915281|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43915282|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
43915283|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43915284|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43915286|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
43915287|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915288|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915289|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915290|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915291|NCT00448357|Methotrexate|methotrexate|mesh-list
43915292|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
43915293|NCT00448357|Fludarabine|fludarabine|mesh-list
43915294|NCT00448357|Busulfan|busulfan|mesh-list
43915295|NCT00448357|Tacrolimus|tacrolimus|mesh-list
43915296|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43915297|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
43915299|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
43915309|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915310|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
43915311|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915312|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915313|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43915314|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
43915315|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43915316|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43915317|NCT00449007|Bupropion|bupropion|mesh-list
43915318|NCT00449007|Fluoxetine|fluoxetine|mesh-list
43764966|NCT02416167|Renal Agents|renal agents|mesh-ancestor
43915319|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43915320|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915321|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915322|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43915323|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915324|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915325|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915326|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
43915327|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915328|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915329|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43915330|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43915331|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915332|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43915333|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
43915334|NCT00449046|Fluticasone|fluticasone|mesh-list
43915335|NCT00449046|Xhance|xhance|mesh-list
43915336|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43915337|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915338|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43915339|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
43915340|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792820|NCT04951986|Levofloxacin|levofloxacin|mesh-list
44165602|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44165603|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165604|NCT00261170|Bupropion|bupropion|mesh-list
44165605|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44165606|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
44165607|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165608|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44165609|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915341|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915342|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44157381|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43915343|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
43915345|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43915346|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43915347|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43915348|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43915409|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
43915410|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915411|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915412|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43915413|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
43915414|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43915415|NCT00451048|Sunitinib|sunitinib|mesh-list
43915416|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915417|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915418|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915419|NCT00451048|Growth Substances|growth substances|mesh-ancestor
43915420|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915421|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915422|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915423|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915424|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915425|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
43915426|NCT00451698|Hematinics|hematinics|mesh-ancestor
43915427|NCT00452335|Lubiprostone|lubiprostone|mesh-list
43915428|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43915429|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915430|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915432|NCT00452374|Rituximab|rituximab|mesh-list
43915433|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
43915434|NCT00452374|Fludarabine|fludarabine|mesh-list
43915435|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
43915436|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915437|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915442|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
43915456|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915457|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915458|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915459|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915461|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
43915462|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915463|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43915464|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43915465|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
43915466|NCT00452426|Narcotics|narcotics|mesh-ancestor
43915467|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915468|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915469|NCT00452426|Analgesics|analgesics|mesh-ancestor
43915470|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
43915471|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915472|NCT00452543|Acamprosate|acamprosate|mesh-list
43915473|NCT00452543|Dexetimide|dexetimide|mesh-list
43915474|NCT00452543|Citalopram|citalopram|mesh-list
43915475|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43915476|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915477|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915478|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915479|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915480|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
43915505|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915506|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43915507|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915508|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915509|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43915511|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915512|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915513|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43915514|NCT00453388|Cyclosporine|cyclosporine|mesh-list
43915515|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
43915516|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
43915517|NCT00453388|Fludarabine|fludarabine|mesh-list
43915518|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
43915519|NCT00453388|Cyclosporins|cyclosporins|mesh-list
43915520|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915521|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
43915522|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915523|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915524|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43915525|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
43915526|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915527|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915528|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43915529|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915530|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
43915531|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915532|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
43915533|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915534|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
43915540|NCT00453895|Sunitinib|sunitinib|mesh-list
43915550|NCT00454324|Paclitaxel|paclitaxel|mesh-list
43915551|NCT00454324|Carboplatin|carboplatin|mesh-list
43915552|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43915553|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43915554|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915555|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
43915556|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
43915557|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
43915558|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915616|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43915617|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915618|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43915619|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
43915621|NCT00456508|Analgesics|analgesics|mesh-ancestor
43915622|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
43915623|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915624|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915625|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43915626|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43915627|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915628|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915629|NCT00456625|Vaccines|vaccines|mesh-list
43915630|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
43915631|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915632|NCT00456807|Vaccines|vaccines|mesh-list
43915633|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
43915634|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915635|NCT00456885|Exenatide|exenatide|mesh-list
43915636|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43915637|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915638|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43915670|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43915671|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43915672|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
43915673|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
43915674|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43915675|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
43915676|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43915677|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43915678|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915679|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43915680|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915681|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915682|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43915683|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43915684|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43915685|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915686|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915687|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915688|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915689|NCT00457730|Analgesics|analgesics|mesh-ancestor
43915690|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
43915691|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915692|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
43915693|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915719|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
43915720|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915721|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915722|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43915723|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
43915725|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915726|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915727|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915728|NCT00458848|Prednisone|prednisone|mesh-list
43915729|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
43915730|NCT00458848|Methotrexate|methotrexate|mesh-list
43915731|NCT00458848|Etoposide|etoposide|mesh-list
43915732|NCT00458848|Vincristine|vincristine|mesh-list
43915733|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
43915734|NCT00458848|Daunorubicin|daunorubicin|mesh-list
43915735|NCT00458848|Asparaginase|asparaginase|mesh-list
43915736|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
43915737|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
43915738|NCT00458848|Idarubicin|idarubicin|mesh-list
43915739|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915740|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
43915741|NCT00458848|Hormones|hormones|mesh-ancestor
43915742|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915743|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915744|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43915745|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915746|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43915747|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
43915748|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43915749|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915764|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
43915765|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
43915766|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
43915767|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915768|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43915769|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43915770|NCT00458848|Protective Agents|protective agents|mesh-ancestor
43915771|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43915772|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43915773|NCT00458848|Analgesics|analgesics|mesh-ancestor
43915774|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
43915775|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43915776|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915777|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915778|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915779|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44139080|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139081|NCT00174356|Paclitaxel|paclitaxel|mesh-list
44139082|NCT00174356|Carboplatin|carboplatin|mesh-list
44139083|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44139084|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139085|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139086|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139087|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139088|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139089|NCT00174395|Eletriptan|eletriptan|mesh-list
44139090|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44139091|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
44139092|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139093|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139094|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915793|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
43915794|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
43915795|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915797|NCT00459810|Hormones|hormones|mesh-ancestor
43915798|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43915799|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915800|NCT00460551|Zalutumumab|zalutumumab|mesh-list
43915801|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915802|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915803|NCT00460993|Eszopiclone|eszopiclone|mesh-list
43915804|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43915805|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43915806|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915807|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
43915808|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43915809|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43915810|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43915811|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43915812|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915813|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
43915814|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915815|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915816|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43915817|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915818|NCT00461331|Insulin|insulin|mesh-list
43915819|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43915820|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
43915821|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
43915822|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43915823|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
43915824|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43915825|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915826|NCT00461591|Apaziquone|apaziquone|mesh-list
43915827|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915828|NCT00461773|Bevacizumab|bevacizumab|mesh-list
43915831|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915832|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915833|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915834|NCT00461773|Growth Substances|growth substances|mesh-ancestor
43915835|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915836|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915837|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43915838|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43915839|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915841|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43915897|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
43915899|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915900|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915901|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
43915902|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915903|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915904|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
43915905|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915906|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
43915907|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43915908|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915909|NCT00462423|Bevacizumab|bevacizumab|mesh-list
43915910|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43915911|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915912|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915913|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43915914|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43915915|NCT00462423|Growth Substances|growth substances|mesh-ancestor
43915916|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915917|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
43915918|NCT00462605|Entinostat|entinostat|mesh-list
43915919|NCT00462605|Sargramostim|sargramostim|mesh-list
43915920|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43915921|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
43915922|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915923|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43915924|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915925|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915926|NCT00462644|Fentanyl|fentanyl|mesh-list
43915927|NCT00462644|Midazolam|midazolam|mesh-list
43915928|NCT00462644|Etomidate|etomidate|mesh-list
43915929|NCT00462644|Succinylcholine|succinylcholine|mesh-list
43915930|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43915938|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43915939|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
43915940|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
43915941|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43915942|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43915943|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43915944|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43915945|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
43915946|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
43915947|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43915948|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915949|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43915950|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43915951|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43915952|NCT00462722|Ibuprofen|ibuprofen|mesh-list
43915953|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43915954|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43915955|NCT00462722|Analgesics|analgesics|mesh-ancestor
43915956|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
43915957|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43915958|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915959|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43915960|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43915961|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43915962|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915963|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915964|NCT00462735|Fluorouracil|fluorouracil|mesh-list
43915965|NCT00462735|Cetuximab|cetuximab|mesh-list
43915966|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
43915967|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
43915968|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43915969|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43915970|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165610|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165611|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165612|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
44165613|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165614|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165615|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43915971|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43915972|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
43915973|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43915974|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43915975|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
43915976|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43915977|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43915979|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43915980|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
43915985|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
43916035|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43916036|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43916037|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916038|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916039|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916040|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916041|NCT00464698|Analgesics|analgesics|mesh-ancestor
43916042|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
43916043|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916044|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
43916045|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916046|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
43916047|NCT00464711|Citalopram|citalopram|mesh-list
43916048|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43916049|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43916050|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916051|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916052|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916053|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
43916054|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916055|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43916056|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43916057|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916058|NCT00465088|Niacin|niacin|mesh-list
43916059|NCT00465088|Niacinamide|niacinamide|mesh-list
43916060|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
43916061|NCT00465088|Atorvastatin|atorvastatin|mesh-list
43916062|NCT00465088|Simvastatin|simvastatin|mesh-list
43916063|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43916064|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43916065|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
43916066|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916069|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916074|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916075|NCT00465530|Gentamicins|gentamicins|mesh-list
43916076|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43916077|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916078|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43916079|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916080|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916081|NCT00465595|Psilocybin|psilocybin|mesh-list
43916082|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43916083|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
43916084|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916085|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916086|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43916087|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
43916088|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916089|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916090|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43916091|NCT00466310|Risperidone|risperidone|mesh-list
43916092|NCT00466310|Aripiprazole|aripiprazole|mesh-list
43916094|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
43916095|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916096|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916097|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916098|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43916099|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43916100|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916101|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916102|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43916103|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
43916104|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
43916105|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
43916106|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43916107|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43916108|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43916109|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43916114|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916115|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916116|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916117|NCT00466817|Valganciclovir|valganciclovir|mesh-list
43916118|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
43916119|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916120|NCT00466960|Paclitaxel|paclitaxel|mesh-list
43916121|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43916122|NCT00466960|Sargramostim|sargramostim|mesh-list
43916123|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916124|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916125|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916126|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916127|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916128|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916129|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
43916130|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916131|NCT00467077|Interferons|interferons|mesh-list
43916132|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
43916133|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
43916134|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43916135|NCT00467077|Gefitinib|gefitinib|mesh-list
43916136|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916137|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
43916138|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916139|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
43916140|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916141|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916142|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916143|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916144|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43916145|NCT00467350|Laxatives|laxatives|mesh-ancestor
43765083|NCT02415699|Antidotes|antidotes|mesh-ancestor
43916146|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916147|NCT00467389|Donepezil|donepezil|mesh-list
43916155|NCT00468208|Abatacept|abatacept|mesh-list
43916156|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43916157|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916158|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916159|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765084|NCT02415699|Protective Agents|protective agents|mesh-ancestor
43765085|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
43765086|NCT02415699|Vitamins|vitamins|mesh-ancestor
43765087|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
43765088|NCT02415192|Amlodipine|amlodipine|mesh-list
43765089|NCT02415192|Valsartan|valsartan|mesh-list
43765090|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43765091|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43765092|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916160|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
43765093|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916161|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916162|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916163|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43916164|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43916165|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916166|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
43916168|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43916169|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916170|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43916171|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43916172|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43916173|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916175|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
43916176|NCT00470301|Doxorubicin|doxorubicin|mesh-list
43916177|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43916178|NCT00470301|Tipifarnib|tipifarnib|mesh-list
43916179|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916180|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916181|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916182|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916183|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916184|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916185|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916186|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
43916199|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
43916200|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916201|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916202|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
43916203|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916204|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
43916205|NCT00470392|Hormones|hormones|mesh-ancestor
43916206|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916207|NCT00470548|Paclitaxel|paclitaxel|mesh-list
43916208|NCT00470548|Pemetrexed|pemetrexed|mesh-list
43916209|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43916210|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916211|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916212|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916213|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916214|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916258|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916259|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916260|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43916261|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43916263|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43916264|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
43916265|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916266|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916267|NCT00472056|Cytarabine|cytarabine|mesh-list
43916268|NCT00472056|Rituximab|rituximab|mesh-list
43916269|NCT00472056|Etoposide|etoposide|mesh-list
43916270|NCT00472056|Melphalan|melphalan|mesh-list
43916271|NCT00472056|Carmustine|carmustine|mesh-list
43916272|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43916273|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916274|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
43916275|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916276|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916277|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916278|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916279|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916280|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916281|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916282|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43916283|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
43916284|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
43916285|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916286|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916287|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916288|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
43916289|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916290|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
43916292|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
43916301|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43916302|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916303|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
43916304|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916305|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916306|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43916307|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
43916308|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663522|NCT04567160|Propofol|propofol|mesh-list
43916309|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916310|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
43916311|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916312|NCT00473642|Ranibizumab|ranibizumab|mesh-list
43916313|NCT00473642|Verteporfin|verteporfin|mesh-list
43916314|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916315|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43916316|NCT00473642|Growth Substances|growth substances|mesh-ancestor
43916317|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916318|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916319|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916320|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43916321|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
43916322|NCT00473837|Chloroquine|chloroquine|mesh-list
43916323|NCT00473837|Amebicides|amebicides|mesh-ancestor
43916324|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43916325|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43916350|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43916351|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43916352|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43916353|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
43916354|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43916355|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43916356|NCT00474851|Norethindrone|norethindrone|mesh-list
43916357|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
43916359|NCT00474851|Hormones|hormones|mesh-ancestor
43916360|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916361|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916362|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43916363|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43916364|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43916365|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
43916366|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43916367|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43916368|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43916369|NCT00475085|Dexamethasone|dexamethasone|mesh-list
43916370|NCT00475085|Aprepitant|aprepitant|mesh-list
43916371|NCT00475085|Palonosetron|palonosetron|mesh-list
43916372|NCT00475085|Granisetron|granisetron|mesh-list
43916373|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
43916375|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
43916399|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916400|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916401|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916402|NCT00475215|Rocuronium|rocuronium|mesh-list
43916403|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43916404|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43916405|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43916406|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916407|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916408|NCT00475319|Rebamipide|rebamipide|mesh-list
43916409|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43765111|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765112|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43564353|NCT01077297|Tezosentan|tezosentan|mesh-list
43916410|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916411|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
43916412|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916413|NCT00475319|Protective Agents|protective agents|mesh-ancestor
43916414|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916415|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916416|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
43916417|NCT00475501|Finasteride|finasteride|mesh-list
43916418|NCT00475501|Testosterone|testosterone|mesh-list
43916419|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
43916420|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
43916421|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43916422|NCT00475501|Androgens|androgens|mesh-ancestor
43916423|NCT00475501|Hormones|hormones|mesh-ancestor
43916424|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916425|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916426|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916427|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916428|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
43916429|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43916435|NCT00475878|Citalopram|citalopram|mesh-list
43916440|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916442|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916443|NCT00475878|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43916444|NCT00475878|Antidepressive Agents|antidepressive agents|mesh-ancestor
43916445|NCT00475878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916446|NCT00475904|Gabapentin|gabapentin|mesh-list
43916447|NCT00475904|Analgesics|analgesics|mesh-ancestor
43916448|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
43916449|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916450|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916451|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
43916452|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43916453|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43916454|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916455|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916456|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43916457|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43916458|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826035|NCT03629925|Cisplatin|cisplatin|mesh-list
43916459|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916460|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
43916461|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
43916462|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43916463|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
43916464|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43916465|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916466|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43916467|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43916468|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43916470|NCT00476242|Memantine|memantine|mesh-list
43916482|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916483|NCT00476645|Fulvestrant|fulvestrant|mesh-list
43916484|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916485|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916486|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43916487|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43916488|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
43916489|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735899|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
43916490|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916491|NCT00476788|Insulin|insulin|mesh-list
43916492|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43916493|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43916494|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916495|NCT00477087|Molgramostim|molgramostim|mesh-list
43916496|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
43916497|NCT00477087|Sargramostim|sargramostim|mesh-list
43916498|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
43916499|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916500|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916501|NCT00477087|Analgesics|analgesics|mesh-ancestor
43916502|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
43916503|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916504|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916505|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916506|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916507|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916508|NCT00477191|Etanercept|etanercept|mesh-list
43916509|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916510|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916521|NCT00477204|Ezetimibe|ezetimibe|mesh-list
43916526|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916527|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43916528|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43916529|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139096|NCT00174434|Sunitinib|sunitinib|mesh-list
44139097|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44139098|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916531|NCT00477451|Doxapram|doxapram|mesh-list
43916532|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43916533|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916534|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916535|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43916536|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43916537|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916538|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
43916539|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
43916540|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916541|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916542|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43916543|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
43916544|NCT00477659|Donepezil|donepezil|mesh-list
43916545|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43916546|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735945|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43916547|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916548|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
43916549|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916550|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916551|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
43916552|NCT00478036|Prednisolone|prednisolone|mesh-list
43916553|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
43916554|NCT00478036|Ketorolac|ketorolac|mesh-list
43916555|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43916556|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43916557|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916558|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
43916559|NCT00478036|Hormones|hormones|mesh-ancestor
44165616|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44165617|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916560|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916561|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916562|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916563|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916564|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916565|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916566|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916567|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916568|NCT00478036|Analgesics|analgesics|mesh-ancestor
43916569|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
43916570|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916571|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43916572|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916573|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916574|NCT00478036|Laxatives|laxatives|mesh-ancestor
43916576|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43916577|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916578|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
43916579|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916580|NCT00478218|Dexamethasone|dexamethasone|mesh-list
43916581|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
43916582|NCT00478218|Lenalidomide|lenalidomide|mesh-list
43916583|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916584|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
43916585|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916586|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916587|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916588|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
43916589|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916590|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916591|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916592|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916598|NCT00478218|Hormones|hormones|mesh-ancestor
43916599|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916600|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916601|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916602|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43663712|NCT03910998|Rocuronium|rocuronium|mesh-list
43916603|NCT00478218|Growth Substances|growth substances|mesh-ancestor
43916604|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916605|NCT00478335|Calcitonin|calcitonin|mesh-list
43916606|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
43916607|NCT00478335|Indomethacin|indomethacin|mesh-list
43916608|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43916609|NCT00478335|Amiloride|amiloride|mesh-list
43916610|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
43916611|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43916612|NCT00478335|Katacalcin|katacalcin|mesh-list
44165618|NCT00261183|Melatonin|melatonin|mesh-list
44165619|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
44165620|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165621|NCT00261183|Protective Agents|protective agents|mesh-ancestor
44165622|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165623|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165624|NCT00261222|Amodiaquine|amodiaquine|mesh-list
44165625|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
44165632|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165633|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165634|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44165635|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44165636|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165637|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44165638|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
44165639|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
44165640|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
44165641|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
44165642|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165643|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165644|NCT00261287|Ciclesonide|ciclesonide|mesh-list
44165645|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
44165646|NCT00261287|Hormones|hormones|mesh-ancestor
44165647|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165648|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165649|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44165650|NCT00261300|Pantoprazole|pantoprazole|mesh-list
44165651|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44165652|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165653|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44165654|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165655|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165656|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
44165657|NCT00261313|Hematinics|hematinics|mesh-ancestor
44165658|NCT00261326|Simvastatin|simvastatin|mesh-list
44165659|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44165660|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44165661|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
44165662|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165663|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44165664|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44165665|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165666|NCT00261339|Pantoprazole|pantoprazole|mesh-list
44165667|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44165668|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165669|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43916613|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
43916614|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43916615|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43916616|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916617|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916618|NCT00478335|Urological Agents|urological agents|mesh-ancestor
43916619|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43916620|NCT00478335|Diuretics|diuretics|mesh-ancestor
43916621|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
43916622|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916623|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43916624|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916625|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916626|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916627|NCT00478335|Analgesics|analgesics|mesh-ancestor
43916628|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
43916629|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916630|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916631|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916632|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
43916633|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
43916634|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43916635|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43916636|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43916637|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43916638|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43916639|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43916640|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916641|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43916642|NCT00478361|Gemcitabine|gemcitabine|mesh-list
43916643|NCT00478361|Paclitaxel|paclitaxel|mesh-list
43916644|NCT00478361|Doxorubicin|doxorubicin|mesh-list
43916645|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43916646|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916647|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165670|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637794|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43916648|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916649|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916650|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916651|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916652|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43916653|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
43916654|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
43916655|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916656|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916657|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916658|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
43916659|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916660|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916661|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44165671|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165672|NCT00261352|Metformin|metformin|mesh-list
44165673|NCT00261352|Fenofibrate|fenofibrate|mesh-list
44165674|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44165675|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165676|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44165677|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
44165678|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165679|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44165680|NCT00261365|Ipilimumab|ipilimumab|mesh-list
44165681|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165682|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165683|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44165684|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165685|NCT00261378|Doxorubicin|doxorubicin|mesh-list
44165686|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44165687|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44165688|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165689|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44165690|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44165691|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736092|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736093|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43564424|NCT01038739|Mesalamine|mesalamine|mesh-list
44165692|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165693|NCT00261391|Marimastat|marimastat|mesh-list
44165694|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734403|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165716|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165717|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165718|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165719|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44165720|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44165721|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165722|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165723|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44165724|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
44165725|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
44165726|NCT00261521|Hematinics|hematinics|mesh-ancestor
44165727|NCT00261547|Rituximab|rituximab|mesh-list
44165728|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165729|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165730|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
44165731|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165732|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165733|NCT00261560|Acetaminophen|acetaminophen|mesh-list
44165734|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165735|NCT00261560|Analgesics|analgesics|mesh-ancestor
44165736|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
43916662|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916663|NCT00478569|Hormones|hormones|mesh-list
43916664|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
43916665|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916666|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916667|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916668|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
43916669|NCT00479037|Hormones|hormones|mesh-list
43916670|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
43916671|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916672|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916673|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916674|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43916675|NCT00479089|Dexamethasone|dexamethasone|mesh-list
43916676|NCT00479089|Docetaxel|docetaxel|mesh-list
43916677|NCT00479089|Gefitinib|gefitinib|mesh-list
43916678|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916680|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
43916681|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916682|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916683|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916684|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
43916685|NCT00479089|Hormones|hormones|mesh-ancestor
43916686|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916687|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916688|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916689|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916690|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916691|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916692|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916693|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916694|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916695|NCT00479115|Plerixafor|plerixafor|mesh-list
43916696|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43916702|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43916703|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43916704|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916705|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916706|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
43916707|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916708|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916709|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43916710|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916711|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
43916712|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43916713|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916714|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916715|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916717|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
43916718|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916719|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43916720|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43916721|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43916722|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43916723|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916724|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916725|NCT00480987|Cytarabine|cytarabine|mesh-list
44165737|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165738|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165739|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
44165740|NCT00261573|Galantamine|galantamine|mesh-list
44165741|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44165742|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165743|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165744|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
44165745|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165746|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165747|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44165748|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
44165749|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165750|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
44165751|NCT00261586|Aspirin|aspirin|mesh-list
44165752|NCT00261586|Acetaminophen|acetaminophen|mesh-list
44165753|NCT00261586|Ibuprofen|ibuprofen|mesh-list
44165754|NCT00261586|Celecoxib|celecoxib|mesh-list
44165755|NCT00261586|Naproxen|naproxen|mesh-list
44165756|NCT00261586|Rofecoxib|rofecoxib|mesh-list
44165757|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44165758|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165759|NCT00261586|Analgesics|analgesics|mesh-ancestor
44165760|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
44165761|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916726|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
43916727|NCT00480987|Fludarabine|fludarabine|mesh-list
43916728|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
43916729|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916730|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43916731|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
43916732|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916733|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916734|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
43916735|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916736|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
43916737|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916738|NCT00481351|Simvastatin|simvastatin|mesh-list
43916739|NCT00481351|Ezetimibe|ezetimibe|mesh-list
43916740|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43916741|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44165762|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165763|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165764|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165765|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44165766|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165767|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165768|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44165769|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44165770|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165771|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
44165772|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44165773|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
44165774|NCT00261599|Midazolam|midazolam|mesh-list
44165775|NCT00261599|Fospropofol|fospropofol|mesh-list
44165776|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44165777|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44165778|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165779|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165780|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44165781|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44165782|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165783|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44165784|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
44165785|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
44165786|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
44165787|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
44165788|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165789|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165790|NCT00261612|Dexamethasone|dexamethasone|mesh-list
44165791|NCT00261612|Rituximab|rituximab|mesh-list
44165792|NCT00261612|Bortezomib|bortezomib|mesh-list
44165793|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165794|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165795|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
44165796|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165797|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165798|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165799|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
44165800|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
44165801|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165802|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165803|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
44165804|NCT00261612|Hormones|hormones|mesh-ancestor
44165805|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165806|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916742|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
43916743|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916744|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43916745|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43916746|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916747|NCT00481845|Anastrozole|anastrozole|mesh-list
43916748|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43916749|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916750|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43916751|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43916752|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916753|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916754|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43916755|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
43916756|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916757|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916758|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43916759|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165807|NCT00261625|Alendronate|alendronate|mesh-list
44165808|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44165809|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165810|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
44165811|NCT00261677|Hematinics|hematinics|mesh-ancestor
44165812|NCT00261703|Cisplatin|cisplatin|mesh-list
44165813|NCT00261703|Docetaxel|docetaxel|mesh-list
44165814|NCT00261703|Fluorouracil|fluorouracil|mesh-list
44165815|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165816|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165817|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165818|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165819|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165820|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
44165821|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165822|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165823|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
44165824|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165825|NCT00261729|Prazosin|prazosin|mesh-list
44165826|NCT00261729|Paroxetine|paroxetine|mesh-list
44165827|NCT00261729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44165830|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165832|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
44165833|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165834|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44165835|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
44165836|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165837|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44165838|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44165839|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165840|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44165841|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44165842|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44165843|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44165844|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44165845|NCT00261742|Penicillins|penicillins|mesh-list
43916760|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916761|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916762|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916764|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916765|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
43916766|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916767|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916768|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
43916770|NCT00482911|Sunitinib|sunitinib|mesh-list
43916771|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916772|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
43916773|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916774|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916775|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916776|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
43916777|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916778|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916779|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916780|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916781|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43916782|NCT00482911|Growth Substances|growth substances|mesh-ancestor
43916783|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916784|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916785|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916786|NCT00483223|Cisplatin|cisplatin|mesh-list
43916787|NCT00483223|Carboplatin|carboplatin|mesh-list
44165846|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165847|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165848|NCT00261755|Analgesics|analgesics|mesh-list
44165849|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
44165850|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165851|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165852|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
44165853|NCT00261820|Sirolimus|sirolimus|mesh-list
44165854|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
44165855|NCT00261820|Prednisolone|prednisolone|mesh-list
44165856|NCT00261820|Tacrolimus|tacrolimus|mesh-list
44165857|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165858|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
44165859|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165861|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165862|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165863|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44165864|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165865|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44165866|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
43916788|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916789|NCT00483262|Bortezomib|bortezomib|mesh-list
43916790|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916791|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
43916792|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
43916793|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43916794|NCT00483496|Protective Agents|protective agents|mesh-ancestor
43916795|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916796|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43916797|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43916798|NCT00483509|Doxorubicin|doxorubicin|mesh-list
43916799|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916800|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916801|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916802|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916803|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916804|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916805|NCT00483561|Etoposide|etoposide|mesh-list
43916806|NCT00483561|Gefitinib|gefitinib|mesh-list
43916807|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916808|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916809|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43916810|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43916811|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916812|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916813|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916814|NCT00484393|Tetracaine|tetracaine|mesh-list
43916815|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
43916816|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
43916817|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916818|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841292|NCT04634838|Copper|copper|mesh-list
44165867|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165868|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165869|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
44165870|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165871|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
44165872|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
44165873|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165874|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165875|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
44165876|NCT00261820|Hormones|hormones|mesh-ancestor
44165877|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43637795|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
43916820|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916821|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
43916822|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916823|NCT00485433|Epinephrine|epinephrine|mesh-list
43916824|NCT00485433|Bupivacaine|bupivacaine|mesh-list
43916825|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
43663939|NCT05466604|Hormones|hormones|mesh-ancestor
43916826|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
43916827|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916828|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916829|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
43916830|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916831|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43916832|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43916833|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43916834|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916835|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916836|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43916837|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44165878|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44165879|NCT00261820|Protective Agents|protective agents|mesh-ancestor
44165880|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165881|NCT00261872|Methylphenidate|methylphenidate|mesh-list
44165882|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44165883|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165884|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44165885|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44165886|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165887|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165888|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
44165889|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165890|NCT00261911|Sibutramine|sibutramine|mesh-list
44165891|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
44165892|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165893|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
44165894|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44165895|NCT00261937|Furosemide|furosemide|mesh-list
44165896|NCT00261937|Diuretics|diuretics|mesh-ancestor
44165897|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
44165898|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165912|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
44165913|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44165914|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165915|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165916|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
44165917|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44165918|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
44165919|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165920|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
44165921|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44165922|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165923|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44165924|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
43916838|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
43916839|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43916840|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
43916841|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
43916842|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
43916843|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43916845|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
43916846|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916847|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916848|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916849|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916850|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916851|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43916852|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916853|NCT00485836|Ranibizumab|ranibizumab|mesh-list
43916854|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916855|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43916856|NCT00485836|Growth Substances|growth substances|mesh-ancestor
43916857|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916858|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916859|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916860|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
43916861|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43916862|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43916863|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165925|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165926|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165927|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165928|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165929|NCT00262210|Prednisolone|prednisolone|mesh-list
44165930|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
44165931|NCT00262210|Etoposide|etoposide|mesh-list
44165932|NCT00262210|Epirubicin|epirubicin|mesh-list
44165933|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165934|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
44165935|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165936|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165937|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44165938|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
44165939|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165940|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165941|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44165942|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44165943|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44165944|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44165945|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165946|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165947|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
43702526|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916864|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43916865|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916866|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43916867|NCT00486018|Ranibizumab|ranibizumab|mesh-list
43916868|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43916869|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43916870|NCT00486018|Growth Substances|growth substances|mesh-ancestor
43916871|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916872|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
43916873|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916874|NCT00486031|Balsalazide|balsalazide|mesh-list
43916875|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43916876|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43916877|NCT00486031|Analgesics|analgesics|mesh-ancestor
43916878|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
43916879|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43916880|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916881|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43916882|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916883|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43916884|NCT00486642|Bicalutamide|bicalutamide|mesh-list
43916885|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
43916886|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
43916887|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43916888|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916889|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916890|NCT00486824|Indomethacin|indomethacin|mesh-list
43916908|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43916909|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916910|NCT00486863|Praziquantel|praziquantel|mesh-list
43916911|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
43916912|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43916913|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916914|NCT00487669|Paclitaxel|paclitaxel|mesh-list
43765245|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765278|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765279|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43765280|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43765281|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
43765282|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43765283|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
43765284|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
43765285|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916915|NCT00487669|Pemetrexed|pemetrexed|mesh-list
43916916|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
43916917|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43916918|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916919|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
43916920|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
43916921|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
43916922|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916923|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916924|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43916925|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43916926|NCT00487721|Silymarin|silymarin|mesh-list
43916927|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
43916928|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916929|NCT00487721|Protective Agents|protective agents|mesh-ancestor
43916930|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916931|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
43916932|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
43916933|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
43916934|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43916935|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43916936|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916937|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43916938|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43916939|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
43916940|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916941|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916942|NCT00488488|Tigecycline|tigecycline|mesh-list
43916943|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43916947|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916949|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
43916950|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
43916951|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
43916953|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
43916954|NCT00489281|Fludarabine|fludarabine|mesh-list
43916955|NCT00489281|Levetiracetam|levetiracetam|mesh-list
43916956|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
43916957|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43916958|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43916959|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
43916960|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916961|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43916962|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43916963|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
43916964|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916965|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43916966|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43916967|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43916968|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43916969|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
43916970|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43916971|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43916972|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43916973|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
43916974|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
43916975|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
44165949|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165950|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165951|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44165952|NCT00262262|Levetiracetam|levetiracetam|mesh-list
44165953|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
44165954|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
44165955|NCT00262275|Aspirin|aspirin|mesh-list
44165956|NCT00262275|Clopidogrel|clopidogrel|mesh-list
44165957|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44165958|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165959|NCT00262275|Analgesics|analgesics|mesh-ancestor
44165960|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
44165961|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165962|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165963|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165964|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165965|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44165966|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43916976|NCT00489866|Aripiprazole|aripiprazole|mesh-list
43916977|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
43916978|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43916979|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43916980|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43916981|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43916982|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43916983|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
43916985|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43916986|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43916987|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43916988|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43916989|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
43916990|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43916991|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43916992|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43916993|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43916994|NCT00490009|Acetaminophen|acetaminophen|mesh-list
43916995|NCT00490009|Iodine|iodine|mesh-list
43916996|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
43916997|NCT00490009|Promethazine|promethazine|mesh-list
43916998|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
43916999|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
43917000|NCT00490009|Lugol's solution|lugol's solution|mesh-list
43917001|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43917002|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917003|NCT00490009|Analgesics|analgesics|mesh-ancestor
43917004|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
43917005|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917006|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917007|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
43917008|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43917009|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917010|NCT00490009|Trace Elements|trace elements|mesh-ancestor
43917011|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
43917012|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43917018|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
43917019|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917020|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43917021|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
43917022|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
43917023|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917024|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917025|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43917026|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
43917027|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917028|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917029|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
43917030|NCT00490009|Coagulants|coagulants|mesh-ancestor
43917031|NCT00490100|Mecasermin|mecasermin|mesh-list
43917032|NCT00490100|Growth Substances|growth substances|mesh-ancestor
43917033|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917034|NCT00490269|Dronabinol|dronabinol|mesh-list
43917035|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
43917036|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917037|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43917038|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917039|NCT00490269|Analgesics|analgesics|mesh-ancestor
43917040|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
43917041|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917042|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43736562|NCT05360433|Analgesics|analgesics|mesh-ancestor
43917043|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43917044|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917045|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917046|NCT00490269|Hormones|hormones|mesh-ancestor
43917047|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917048|NCT00490477|Polymyxins|polymyxins|mesh-list
43917049|NCT00490477|Polymyxin B|polymyxin b|mesh-list
43917050|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43917051|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165967|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165968|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44165969|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44165970|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165972|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44165973|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44165974|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43917052|NCT00490802|Oxytocin|oxytocin|mesh-list
43917053|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
43917054|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43917055|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917056|NCT00491244|Interferons|interferons|mesh-list
43917057|NCT00491244|Ribavirin|ribavirin|mesh-list
43917058|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
43917059|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
43917060|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43917062|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
43917063|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917064|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
43917065|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917066|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
43917067|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917068|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
43917069|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917070|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917071|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43917072|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
43917073|NCT00491751|Atorvastatin|atorvastatin|mesh-list
43917074|NCT00491751|Vitamins|vitamins|mesh-ancestor
43917075|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
43917076|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917077|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43917078|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43917079|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
43917080|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917081|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43917082|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43917083|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917084|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
43917085|NCT00491751|Protective Agents|protective agents|mesh-ancestor
43917086|NCT00492089|Bevacizumab|bevacizumab|mesh-list
43917087|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43917088|NCT00492089|Antibodies|antibodies|mesh-list
43917089|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
43917095|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917096|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917097|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
43917099|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917100|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917101|NCT00492336|Rasagiline|rasagiline|mesh-list
43917102|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43917103|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917104|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917105|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43917106|NCT00492336|Protective Agents|protective agents|mesh-ancestor
43917107|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917108|NCT00492401|Decitabine|decitabine|mesh-list
43917109|NCT00492401|Azacitidine|azacitidine|mesh-list
43917110|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917111|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
43917112|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917113|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917114|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917115|NCT00492544|Vaccines|vaccines|mesh-list
43917116|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
43917117|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917118|NCT00492622|Omeprazole|omeprazole|mesh-list
43917119|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43917120|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917121|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43917122|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793724|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165975|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
44165976|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165977|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44165978|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44165979|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165980|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
44165981|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165982|NCT00262327|Endostatins|endostatins|mesh-list
44165983|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165984|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44165985|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44165986|NCT00262327|Growth Substances|growth substances|mesh-ancestor
44165987|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165988|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
44165989|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
44165990|NCT00262379|Hematinics|hematinics|mesh-ancestor
44165991|NCT00262392|Pamidronate|pamidronate|mesh-list
44165992|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43702527|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
43917123|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917124|NCT00492973|Cefuroxime|cefuroxime|mesh-list
43917125|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
43917126|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43917127|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43917128|NCT00492973|Prednisolone|prednisolone|mesh-list
43917129|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
43917130|NCT00492973|Clonidine|clonidine|mesh-list
43917131|NCT00492973|Epinephrine|epinephrine|mesh-list
43917132|NCT00492973|Morphine|morphine|mesh-list
43917133|NCT00492973|Bupivacaine|bupivacaine|mesh-list
43917134|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43917135|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
43917136|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
43917137|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
43917138|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917139|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917140|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
43917141|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917142|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43917143|NCT00492973|Narcotics|narcotics|mesh-ancestor
43917144|NCT00492973|Analgesics|analgesics|mesh-ancestor
43917145|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917146|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
43917147|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
43793736|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165993|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165994|NCT00262405|Prednisone|prednisone|mesh-list
44165995|NCT00262405|Zileuton|zileuton|mesh-list
44165996|NCT00262405|Azathioprine|azathioprine|mesh-list
44165997|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165998|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
44165999|NCT00262405|Hormones|hormones|mesh-ancestor
44166000|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166001|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166002|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166003|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166004|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
44166005|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166006|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166007|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606269|NCT03220555|Lidocaine|lidocaine|mesh-list
44166008|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
44166009|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166010|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166011|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166012|NCT00262405|Analgesics|analgesics|mesh-ancestor
44166013|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
44166014|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166015|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44166016|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166017|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43917148|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917149|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
43917151|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917152|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43917153|NCT00492973|Protective Agents|protective agents|mesh-ancestor
43917154|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43917155|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917156|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43917157|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43917158|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
43917159|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793741|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166018|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
44166019|NCT00262418|Ivermectin|ivermectin|mesh-list
44166020|NCT00262418|Permethrin|permethrin|mesh-list
44166021|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44166022|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166023|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166024|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166025|NCT00262483|Ribavirin|ribavirin|mesh-list
44166026|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44166027|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
44166028|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166029|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
44166030|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166031|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44166032|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44166033|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44166034|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
44166035|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166036|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44166044|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166045|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166046|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166047|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166048|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166049|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166050|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166051|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44166052|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44166053|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166054|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
44166055|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44166056|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166057|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166058|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44166059|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44166060|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
44166061|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166062|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166063|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44166064|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
44166065|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
44166066|NCT00262587|Hormones|hormones|mesh-ancestor
44166067|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166068|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
44166069|NCT00262769|Gemcitabine|gemcitabine|mesh-list
44166070|NCT00262769|Cisplatin|cisplatin|mesh-list
44166071|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166072|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166073|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
43702528|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43917160|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917161|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43917162|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43917163|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43917164|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
43917165|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
43917166|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
43917167|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43917168|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43917169|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
43917170|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43917171|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43917172|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917173|NCT00493064|Niacin|niacin|mesh-list
43917174|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
43917175|NCT00493064|Niacinamide|niacinamide|mesh-list
43917176|NCT00493064|Prednisolone|prednisolone|mesh-list
43917177|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43917178|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
43917179|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43917180|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
43917181|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43917182|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
43917183|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917184|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
43917185|NCT00493064|Hormones|hormones|mesh-ancestor
43917186|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917187|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917188|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43917189|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917190|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
43917191|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
43917192|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166074|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166075|NCT00262769|Antiviral Agents|antiviral agents|mesh-ancestor
44166076|NCT00262769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166077|NCT00262769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166078|NCT00262769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166079|NCT00262769|Immunologic Factors|immunologic factors|mesh-ancestor
44166080|NCT00262769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166081|NCT00262782|Fludarabine|fludarabine|mesh-list
44166082|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917193|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917194|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43917195|NCT00493064|Protective Agents|protective agents|mesh-ancestor
43917196|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43917197|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
43917198|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917199|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43917200|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
43917201|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
43917202|NCT00493064|Vitamins|vitamins|mesh-ancestor
43917203|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
43917204|NCT00493181|Oprelvekin|oprelvekin|mesh-list
43664211|NCT05201300|Propofol|propofol|mesh-list
43917205|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917206|NCT00493805|Interferons|interferons|mesh-list
43917207|NCT00493805|Ribavirin|ribavirin|mesh-list
43917208|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
43917209|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
43917210|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43917211|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917212|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
43917213|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166083|NCT00262795|Fludarabine|fludarabine|mesh-list
44166084|NCT00262795|Chlorambucil|chlorambucil|mesh-list
44166085|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166086|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166087|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44166088|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
44166089|NCT00262808|Leucovorin|leucovorin|mesh-list
44166090|NCT00262808|Fluorouracil|fluorouracil|mesh-list
44166091|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
44166092|NCT00262808|Calcium|calcium|mesh-list
44166093|NCT00262808|Sargramostim|sargramostim|mesh-list
44166094|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
44166095|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44166096|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166097|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
44166098|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166099|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166100|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166101|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166102|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
44166103|NCT00262808|Antidotes|antidotes|mesh-ancestor
44166104|NCT00262808|Protective Agents|protective agents|mesh-ancestor
44166110|NCT00262886|Fludarabine|fludarabine|mesh-list
44166111|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
44166112|NCT00262886|Tacrolimus|tacrolimus|mesh-list
44166113|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44166114|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166115|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
44166116|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166117|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166118|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44166119|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
44166120|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166121|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166122|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640369|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
43917215|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917216|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
43917217|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917218|NCT00494494|Nepafenac|nepafenac|mesh-list
43917219|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43917220|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917221|NCT00494494|Analgesics|analgesics|mesh-ancestor
43917222|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
43917223|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917224|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917225|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917226|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917227|NCT00495079|Vincristine|vincristine|mesh-list
43917228|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917229|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917230|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917231|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917232|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917233|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917234|NCT00496340|Rituximab|rituximab|mesh-list
43917235|NCT00496340|Busulfan|busulfan|mesh-list
43917236|NCT00496340|Pentostatin|pentostatin|mesh-list
43917237|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917238|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166123|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166124|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
44166125|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44166126|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166127|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166128|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44166129|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
44166130|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44166131|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166132|NCT00262977|Aspirin|aspirin|mesh-list
44166133|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166134|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166135|NCT00262977|Analgesics|analgesics|mesh-ancestor
44166136|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
44166137|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166138|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166139|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166140|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166141|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166142|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166143|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166144|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44166145|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44166146|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917239|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
43917240|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917241|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917242|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
43917243|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917244|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917245|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917246|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917247|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43917248|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917249|NCT00496379|Epothilones|epothilones|mesh-list
43917251|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917252|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917253|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917254|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917255|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917256|NCT00496808|Trastuzumab|trastuzumab|mesh-list
43917257|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917258|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917259|NCT00497055|Aripiprazole|aripiprazole|mesh-list
43917260|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
43917261|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43917262|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43917263|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43917264|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917265|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917266|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
43917267|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
43917268|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917269|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917270|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43917271|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43917278|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
43917279|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43917280|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43917281|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
43917282|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
43917283|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139100|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917284|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917285|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917286|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43917287|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43917288|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917289|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43917290|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43917291|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43917292|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
43917293|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43917294|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43917295|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
43917296|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43917297|NCT00497770|Pemetrexed|pemetrexed|mesh-list
43917298|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917299|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917300|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917301|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43917302|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43917303|NCT00498550|Clozapine|clozapine|mesh-list
43917304|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43917305|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
43917306|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917319|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43917320|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917321|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
43917322|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917323|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917324|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43917325|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
43917326|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43917327|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43917328|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43917329|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917330|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917331|NCT00498927|Temozolomide|temozolomide|mesh-list
43917332|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917333|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
43917334|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917335|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917336|NCT00499109|Gemcitabine|gemcitabine|mesh-list
43917337|NCT00499109|Carboplatin|carboplatin|mesh-list
43917338|NCT00499109|Docetaxel|docetaxel|mesh-list
43917339|NCT00499109|Vinorelbine|vinorelbine|mesh-list
43917340|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
43917341|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917342|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
43917343|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917344|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
43917345|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917346|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917347|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917348|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
43917349|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917350|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917351|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917352|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166147|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
44166148|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44166149|NCT00263003|Irbesartan|irbesartan|mesh-list
44166150|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166151|NCT00263003|Diuretics|diuretics|mesh-ancestor
44166152|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166153|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917353|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917354|NCT00499343|Rituximab|rituximab|mesh-list
43917355|NCT00499343|Etoposide|etoposide|mesh-list
43917356|NCT00499343|Ifosfamide|ifosfamide|mesh-list
43917357|NCT00499343|Sargramostim|sargramostim|mesh-list
44139101|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917358|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917359|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917360|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
43917361|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917362|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917363|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917364|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917365|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917366|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917367|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917368|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917369|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
44139102|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139103|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44139104|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44139105|NCT00174434|Growth Substances|growth substances|mesh-ancestor
44139106|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139107|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
44139108|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44139109|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139110|NCT00174473|Voriconazole|voriconazole|mesh-list
44139111|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
44139112|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139113|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44139126|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139127|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139128|NCT00174486|Urological Agents|urological agents|mesh-ancestor
44139129|NCT00174499|Nicotine|nicotine|mesh-list
44139130|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44139131|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
44139132|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139133|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139134|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44139135|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44139136|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44139137|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139138|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139139|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
44139140|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44139141|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139142|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44139143|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44139144|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139145|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139146|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139147|NCT00174538|Codeine|codeine|mesh-list
44139148|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44139149|NCT00174538|Narcotics|narcotics|mesh-ancestor
44139150|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139151|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139152|NCT00174538|Analgesics|analgesics|mesh-ancestor
44139153|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
44139154|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139155|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
44139156|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139157|NCT00174551|Prazosin|prazosin|mesh-list
44139158|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166154|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44166155|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166156|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43640370|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
44139159|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44139160|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43826162|NCT02489903|Taxane|taxane|mesh-list
43917371|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
43917372|NCT00499408|Vitamins|vitamins|mesh-ancestor
43917373|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
43917374|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917375|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43917376|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43917377|NCT00499473|Sunitinib|sunitinib|mesh-list
43917378|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917379|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917380|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917381|NCT00499473|Growth Substances|growth substances|mesh-ancestor
43917382|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917383|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917384|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917385|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917386|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917387|NCT00499655|Celecoxib|celecoxib|mesh-list
43917388|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43917389|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917390|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917391|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917392|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917393|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43917394|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917395|NCT00499655|Analgesics|analgesics|mesh-ancestor
43917396|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
43917397|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917398|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917399|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917410|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
43917411|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917412|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
43917413|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917414|NCT00500656|Icatibant|icatibant|mesh-list
43917415|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
43917416|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43917417|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43917418|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917419|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
43917420|NCT00500656|Coagulants|coagulants|mesh-ancestor
43917421|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43917422|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917423|NCT00500656|Analgesics|analgesics|mesh-ancestor
43917424|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
43917425|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917426|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917427|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917428|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917429|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43917430|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43917431|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43917432|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917433|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
43917434|NCT00501631|Naltrexone|naltrexone|mesh-list
43917435|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43917436|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43917437|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917456|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917457|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
43917458|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917459|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
43917460|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917461|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43917462|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
43917463|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43917464|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43917465|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917466|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917467|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43917468|NCT00501943|Protective Agents|protective agents|mesh-ancestor
43917469|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
43917470|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917471|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
43917472|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917473|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917474|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917475|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
43917476|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917477|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917478|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917479|NCT00502216|Naltrexone|naltrexone|mesh-list
43917480|NCT00502216|Varenicline|varenicline|mesh-list
43917481|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43917482|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43917491|NCT00502853|Rituximab|rituximab|mesh-list
43917501|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917502|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
43917503|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917504|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917505|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917506|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43917507|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917508|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43917510|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
43917511|NCT00502905|Busulfan|busulfan|mesh-list
43917512|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917513|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917514|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
43917515|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917516|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917517|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
43917518|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917519|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
43917520|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917521|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917522|NCT00503113|Alendronate|alendronate|mesh-list
43917523|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
43917524|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43917525|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917526|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43917527|NCT00503750|Vinorelbine|vinorelbine|mesh-list
43917528|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917529|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917530|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917531|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917532|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917533|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917535|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43917536|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
44166157|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44166158|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44166159|NCT00263016|Docetaxel|docetaxel|mesh-list
43917538|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917539|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
43917540|NCT00504504|Rituximab|rituximab|mesh-list
43917541|NCT00504504|Doxorubicin|doxorubicin|mesh-list
43917542|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43917543|NCT00504504|Dacarbazine|dacarbazine|mesh-list
43917544|NCT00504504|Bleomycin|bleomycin|mesh-list
43917545|NCT00504504|Vinblastine|vinblastine|mesh-list
43917546|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917547|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917548|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
43917549|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917550|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917551|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43917552|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917553|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917554|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917555|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917556|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917557|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
43917558|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917559|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917560|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917561|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917562|NCT00504660|Celecoxib|celecoxib|mesh-list
43917563|NCT00504660|Capecitabine|capecitabine|mesh-list
43917564|NCT00504660|Thioguanine|thioguanine|mesh-list
43917565|NCT00504660|Temozolomide|temozolomide|mesh-list
43917566|NCT00504660|Lomustine|lomustine|mesh-list
44166160|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166161|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166162|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166163|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166164|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166165|NCT00263029|Capecitabine|capecitabine|mesh-list
44166166|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
44166167|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166168|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
44166169|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166170|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166171|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
44166172|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166173|NCT00263068|Rotigotine|rotigotine|mesh-list
44166188|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166189|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166190|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917567|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917568|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
43917569|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917570|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917571|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917572|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
43917573|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43917574|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917575|NCT00504660|Analgesics|analgesics|mesh-ancestor
43917576|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
43917577|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917578|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917579|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917580|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917581|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43917582|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43917583|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917584|NCT00504751|Dexamethasone|dexamethasone|mesh-list
43917586|NCT00504751|Cisplatin|cisplatin|mesh-list
43917587|NCT00504751|Etoposide|etoposide|mesh-list
43917588|NCT00504751|Bortezomib|bortezomib|mesh-list
43917589|NCT00504751|Ifosfamide|ifosfamide|mesh-list
43917590|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917591|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917592|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
43917593|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917594|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917595|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917598|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917599|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917600|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
43917601|NCT00504751|Hormones|hormones|mesh-ancestor
44166191|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166192|NCT00263133|Sertraline|sertraline|mesh-list
44166193|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
44166194|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166195|NCT00263133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44166196|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44166197|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166198|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166199|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166200|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
43917602|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917603|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43917604|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917605|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917606|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917607|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917608|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917609|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917610|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
43917611|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
43917612|NCT00505635|Interferons|interferons|mesh-list
43917613|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
43917614|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
43917615|NCT00505635|Thalidomide|thalidomide|mesh-list
43917616|NCT00505635|Cisplatin|cisplatin|mesh-list
43917617|NCT00505635|Temozolomide|temozolomide|mesh-list
43917618|NCT00505635|Interleukin-2|interleukin-2|mesh-list
43917619|NCT00505635|Vinblastine|vinblastine|mesh-list
43917620|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917621|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
43917622|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917623|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917624|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
43917625|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917626|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
43917627|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917628|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43917629|NCT00505635|Analgesics|analgesics|mesh-ancestor
43917633|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
43917648|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917649|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
43917650|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917651|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917652|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917653|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
43917654|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917655|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917656|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917657|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
43917658|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917659|NCT00506155|Bevacizumab|bevacizumab|mesh-list
43917660|NCT00506155|Cisplatin|cisplatin|mesh-list
43917661|NCT00506155|Doxorubicin|doxorubicin|mesh-list
43917662|NCT00506155|Methotrexate|methotrexate|mesh-list
43917663|NCT00506155|Vinblastine|vinblastine|mesh-list
43917664|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43917665|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917666|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917667|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917668|NCT00506155|Growth Substances|growth substances|mesh-ancestor
43917669|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917670|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917671|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43664600|NCT04462627|Antibodies|antibodies|mesh-list
43917672|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917673|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917674|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917675|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917676|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43917677|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
43917689|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917690|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917692|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917693|NCT00506675|Atropine|atropine|mesh-list
43917694|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43917695|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43917696|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43917697|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
43917698|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917699|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917700|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43917701|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
43917702|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
43917703|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
43917704|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43917705|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43917706|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
43917707|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917708|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917709|NCT00506857|Fludarabine|fludarabine|mesh-list
43917710|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
43917711|NCT00506857|Busulfan|busulfan|mesh-list
43917712|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917713|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917714|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
43917715|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917716|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917717|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
43917718|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917719|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
43917720|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917721|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917722|NCT00507767|Dasatinib|dasatinib|mesh-list
43917730|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43917731|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917732|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43917733|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917735|NCT00508469|Timolol|timolol|mesh-list
43917736|NCT00508469|Travoprost|travoprost|mesh-list
43917737|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43917738|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43917739|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43917740|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43917741|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
43917742|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43917743|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917744|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664656|NCT04269408|Nicardipine|nicardipine|mesh-list
43917745|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43917746|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43917748|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917749|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166201|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166202|NCT00263185|Vitamin D|vitamin d|mesh-list
44166203|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
44166204|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
44166205|NCT00263185|Vitamins|vitamins|mesh-list
44166206|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
44166207|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
44166208|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166209|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44166210|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44166211|NCT00263185|Antacids|antacids|mesh-ancestor
44166212|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166213|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166214|NCT00263198|Letrozole|letrozole|mesh-list
44166215|NCT00263198|Vatalanib|vatalanib|mesh-list
44166216|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166217|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44166218|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44166219|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166220|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166222|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
44166223|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166224|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166225|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166226|NCT00263263|Sirolimus|sirolimus|mesh-list
44166227|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44166229|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166230|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166231|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
44166232|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166233|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
44166234|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765356|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917750|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917751|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917752|NCT00509041|Dasatinib|dasatinib|mesh-list
43917753|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917754|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917755|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917756|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917757|NCT00509197|Fluticasone|fluticasone|mesh-list
43917758|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917759|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43917760|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
43917761|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917762|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917763|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43917764|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
43917765|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917766|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43917767|NCT00509249|Aflibercept|aflibercept|mesh-list
43917768|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
43917769|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917770|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917771|NCT00509249|Growth Substances|growth substances|mesh-ancestor
43917772|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917773|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917774|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765360|NCT02414399|Azithromycin|azithromycin|mesh-list
43917775|NCT00509288|Aldesleukin|aldesleukin|mesh-list
43917776|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
43917777|NCT00509288|Fludarabine|fludarabine|mesh-list
43917778|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917796|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
43917797|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917798|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917799|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917800|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
43917801|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917802|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917803|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917804|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917805|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
43917806|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43917807|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43917808|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
43917809|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917810|NCT00509665|Gemcitabine|gemcitabine|mesh-list
43917811|NCT00509665|Doxorubicin|doxorubicin|mesh-list
43917812|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43917855|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
43917856|NCT00511706|Dexamethasone|dexamethasone|mesh-list
43917857|NCT00511706|Ranibizumab|ranibizumab|mesh-list
43917858|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917859|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
43917860|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
43917861|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43917862|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917863|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917864|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
43917865|NCT00511706|Hormones|hormones|mesh-ancestor
43917866|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917867|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43917868|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917869|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917870|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917871|NCT00511706|Growth Substances|growth substances|mesh-ancestor
43917872|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
43917873|NCT00511992|Paclitaxel|paclitaxel|mesh-list
43917874|NCT00511992|Bevacizumab|bevacizumab|mesh-list
43917875|NCT00511992|Cisplatin|cisplatin|mesh-list
43917876|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917877|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917909|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43917910|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917911|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
43917912|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
43917913|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
43917914|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917915|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917916|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
43917917|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917918|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917919|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43917920|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
43917921|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43917922|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43917923|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43917924|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43917925|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917926|NCT00513370|Adalimumab|adalimumab|mesh-list
43917927|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43917928|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917929|NCT00513435|Saracatinib|saracatinib|mesh-list
43917930|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917931|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917932|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917933|NCT00513526|Vaccines|vaccines|mesh-list
43917934|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
43917935|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917936|NCT00513747|Rituximab|rituximab|mesh-list
43917937|NCT00513747|Fludarabine|fludarabine|mesh-list
43917938|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
43917939|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166235|NCT00263276|Metformin|metformin|mesh-list
44166236|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
44166237|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166238|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166239|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44166240|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166241|NCT00263302|Dexamethasone|dexamethasone|mesh-list
44166242|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166243|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
44166244|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
44166245|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166246|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917940|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917941|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
43917942|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917943|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43917944|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43917945|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
43917946|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917947|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43917948|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
43917949|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43917950|NCT00513799|Mupirocin|mupirocin|mesh-list
43917951|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43917952|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43917953|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
43917954|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
43917955|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43917956|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43917957|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43917958|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917959|NCT00514137|Sunitinib|sunitinib|mesh-list
43917960|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917961|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43917962|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43917963|NCT00514137|Growth Substances|growth substances|mesh-ancestor
43917964|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917965|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
43841395|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
44166247|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166248|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
44166249|NCT00263302|Hormones|hormones|mesh-ancestor
44166250|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166251|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166252|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166253|NCT00263315|Amphotericin B|amphotericin b|mesh-list
44166254|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44166255|NCT00263315|Amebicides|amebicides|mesh-ancestor
44166256|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44166257|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44166258|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166259|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44166260|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
44166261|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
44166262|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166263|NCT00263393|Atenolol|atenolol|mesh-list
44166264|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44166265|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44166266|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166267|NCT00263393|Diuretics|diuretics|mesh-ancestor
43917966|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43917968|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43917969|NCT00514215|Molgramostim|molgramostim|mesh-list
43917970|NCT00514215|Sargramostim|sargramostim|mesh-list
43917971|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
43917972|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917973|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43917975|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
43917976|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917977|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43917978|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
43917979|NCT00514852|Glycerol|glycerol|mesh-list
43917980|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43917981|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44166268|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166269|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166270|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44166271|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166272|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166273|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44166274|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
44166275|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
44166276|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166277|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44166278|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44166279|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44166280|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
44166281|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166282|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
44166283|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166284|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44166285|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
44166286|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166287|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166288|NCT00263458|Buprenorphine|buprenorphine|mesh-list
44166289|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44166290|NCT00263458|Narcotics|narcotics|mesh-ancestor
44166291|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166292|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166293|NCT00263458|Analgesics|analgesics|mesh-ancestor
44166294|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
44166295|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166296|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44166297|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
44166298|NCT00263484|Thalidomide|thalidomide|mesh-list
44166299|NCT00263484|Dexamethasone|dexamethasone|mesh-list
44166300|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
44166301|NCT00263484|BB 1101|bb 1101|mesh-list
44166302|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166303|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
44166304|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
44166305|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166306|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166307|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166308|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
44166344|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44166345|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44166346|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44166347|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
43917982|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43917983|NCT00514852|Protective Agents|protective agents|mesh-ancestor
43917984|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917985|NCT00514852|Laxatives|laxatives|mesh-ancestor
43917986|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43917988|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43917989|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
43917990|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43917991|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43917992|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43917993|NCT00515021|Diuretics|diuretics|mesh-ancestor
43917994|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
43917995|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43917996|NCT00515177|Eszopiclone|eszopiclone|mesh-list
43917997|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43917998|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43917999|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918000|NCT00515411|Leucovorin|leucovorin|mesh-list
43918001|NCT00515411|Cisplatin|cisplatin|mesh-list
43918002|NCT00515411|Docetaxel|docetaxel|mesh-list
43918003|NCT00515411|Fluorouracil|fluorouracil|mesh-list
43918004|NCT00515411|Trastuzumab|trastuzumab|mesh-list
43918005|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918006|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
43918007|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
43918008|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
43918009|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918010|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
43918011|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918012|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918013|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
43841417|NCT04621500|Vitamin D|vitamin d|mesh-list
44166348|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166349|NCT00263744|Antacids|antacids|mesh-ancestor
44166350|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166351|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166352|NCT00263796|Oxytocin|oxytocin|mesh-list
44166353|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
44166354|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44166355|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166356|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44166357|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918014|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918015|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918016|NCT00515411|Antidotes|antidotes|mesh-ancestor
43918017|NCT00515411|Protective Agents|protective agents|mesh-ancestor
43918018|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
43918019|NCT00515411|Vitamins|vitamins|mesh-ancestor
43918020|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
43918021|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43918022|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
43918023|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43918024|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43918025|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43918026|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918027|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918028|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918029|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918030|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918031|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43918032|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918033|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43918034|NCT00515697|Ramucirumab|ramucirumab|mesh-list
43918035|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918036|NCT00515723|Olanzapine|olanzapine|mesh-list
43918037|NCT00515723|Risperidone|risperidone|mesh-list
43918038|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44166358|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166359|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166360|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166361|NCT00263965|Metformin|metformin|mesh-list
44166362|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166363|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166364|NCT00263978|Defibrotide|defibrotide|mesh-list
44166365|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166366|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166367|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166368|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44166369|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
44166370|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
44166371|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166372|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166373|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166374|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166376|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44166377|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166378|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
44166379|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
44166380|NCT00264108|Hematinics|hematinics|mesh-ancestor
44166381|NCT00264134|Carboplatin|carboplatin|mesh-list
44166382|NCT00264134|Docetaxel|docetaxel|mesh-list
44166383|NCT00264134|Irinotecan|irinotecan|mesh-list
44166384|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918039|NCT00515723|Ziprasidone|ziprasidone|mesh-list
43918040|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43918041|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
43918042|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918043|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918044|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918045|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43737721|NCT04502095|Ofloxacin|ofloxacin|mesh-list
43918046|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43918047|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664866|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
43918048|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918049|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43918050|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
43918051|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
43918052|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
43918053|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166385|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166386|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166387|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166388|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166389|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44166390|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44166391|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166392|NCT00264173|Valproic Acid|valproic acid|mesh-list
44166393|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
44166394|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166395|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166396|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
44166397|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166398|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166399|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
44166400|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166401|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166402|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166403|NCT00264186|Norepinephrine|norepinephrine|mesh-list
44166404|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
44166405|NCT00264186|Acetylcholine|acetylcholine|mesh-list
44166406|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44166407|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44166408|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
44166409|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166410|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166411|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166412|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
44166413|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
44166414|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166415|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44166416|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
44166417|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44166418|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
44166419|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44166421|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166422|NCT00264212|Diuretics|diuretics|mesh-ancestor
44166423|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166424|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166435|NCT00264225|Analgesics|analgesics|mesh-ancestor
44166436|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
44166437|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166438|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
44166439|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
44166440|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
43918054|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43918055|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43918056|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918057|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918058|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918059|NCT00515879|Cycloserine|cycloserine|mesh-list
43918060|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43918061|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918062|NCT00515879|Renal Agents|renal agents|mesh-ancestor
43918063|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43918064|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
43918065|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918066|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
43918067|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918068|NCT00516165|Everolimus|everolimus|mesh-list
43918069|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918070|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918071|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
43918072|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918073|NCT00516217|Galiximab|galiximab|mesh-list
43918074|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918075|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918076|NCT00516503|Ketamine|ketamine|mesh-list
43918077|NCT00516503|Amitriptyline|amitriptyline|mesh-list
43918078|NCT00516503|Baclofen|baclofen|mesh-list
43918079|NCT00516503|Analgesics|analgesics|mesh-ancestor
43918080|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
43918081|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918082|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918083|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43918084|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43918085|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
43918086|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
44166441|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166442|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166443|NCT00264277|Vitamin K|vitamin k|mesh-list
44166444|NCT00264277|Anticoagulants|anticoagulants|mesh-list
44166445|NCT00264277|Vitamins|vitamins|mesh-ancestor
44166446|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
44166447|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166448|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44166449|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166450|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166452|NCT00264277|Coagulants|coagulants|mesh-ancestor
43918087|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918088|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43918089|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43918090|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918091|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918092|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43918093|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43918094|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43918095|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
43918096|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
43918097|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43918098|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918099|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918100|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918101|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43918102|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918103|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918104|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43918105|NCT00516919|Orlistat|orlistat|mesh-list
43918106|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918107|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166453|NCT00264355|Cyclosporine|cyclosporine|mesh-list
44166454|NCT00264355|Cyclosporins|cyclosporins|mesh-list
44166455|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166456|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166457|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166458|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
44166459|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166460|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
44166461|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166462|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
44166463|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166464|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44166465|NCT00264368|Ganciclovir|ganciclovir|mesh-list
44166466|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44166467|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
44166468|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166469|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44166470|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166471|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166472|NCT00264407|Hormones|hormones|mesh-list
44166473|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166474|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166475|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
44166476|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44166477|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166479|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166480|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166481|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
44166482|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918111|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918112|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918113|NCT00517010|Growth Substances|growth substances|mesh-ancestor
43918114|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918115|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918116|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918117|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
43918118|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918119|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664964|NCT03436992|Resveratrol|resveratrol|mesh-list
43918120|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
43918121|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
43918122|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44166483|NCT00264472|Eniluracil|eniluracil|mesh-list
44166484|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166485|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166486|NCT00264485|Fentanyl|fentanyl|mesh-list
44166487|NCT00264485|Morphine|morphine|mesh-list
44166488|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44166489|NCT00264485|Narcotics|narcotics|mesh-ancestor
44166490|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166491|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166492|NCT00264485|Analgesics|analgesics|mesh-ancestor
44166493|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
44166494|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166495|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44166496|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44166497|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
44166498|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
44166499|NCT00264615|Lamotrigine|lamotrigine|mesh-list
44166500|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
44166501|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44166502|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166503|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166504|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44166505|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166506|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44166507|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166508|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166509|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166510|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44166511|NCT00264628|Casopitant|casopitant|mesh-list
44166512|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
44166513|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
44166514|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166515|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166516|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166517|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44166518|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166519|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166520|NCT00264654|Paroxetine|paroxetine|mesh-list
44166521|NCT00264654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44166522|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44166523|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918123|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918124|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43918125|NCT00517595|Gemcitabine|gemcitabine|mesh-list
43918126|NCT00517595|Bevacizumab|bevacizumab|mesh-list
43918127|NCT00517595|Pemetrexed|pemetrexed|mesh-list
43918128|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918129|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918130|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918131|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918132|NCT00517595|Growth Substances|growth substances|mesh-ancestor
43918133|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918134|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918135|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918136|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
43918137|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918138|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
43918139|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918140|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918141|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918142|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
43918143|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43918144|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43918145|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
43918146|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43918147|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43918148|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918149|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918150|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43918151|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43918152|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918153|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918154|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139170|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
44139171|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139172|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139173|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139174|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44139175|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139176|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139177|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139178|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44139179|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
44139180|NCT00174590|Risperidone|risperidone|mesh-list
44139181|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44139182|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
44139183|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139184|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139185|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139186|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44139187|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139188|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139189|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139190|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44166524|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166525|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166526|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
44166527|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166528|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44166529|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
44166530|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166531|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44166532|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44166533|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166534|NCT00264680|Lamotrigine|lamotrigine|mesh-list
44166535|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
44166536|NCT00264680|Valproic Acid|valproic acid|mesh-list
44166537|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44166538|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166539|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166540|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44166541|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166542|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44166543|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166544|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166545|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166546|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44166547|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166548|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
43834848|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
44166549|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166550|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
44166551|NCT00264719|Metoclopramide|metoclopramide|mesh-list
43606891|NCT03207334|Cytarabine|cytarabine|mesh-list
44166553|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
44166554|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139191|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
44139192|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44139193|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
44139194|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139195|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44139196|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139197|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139198|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139199|NCT00174616|Capecitabine|capecitabine|mesh-list
44139200|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
44139201|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139202|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
44157382|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918155|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43918156|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43918157|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794234|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44166555|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166556|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166557|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44166558|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44166559|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
44166560|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166561|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166562|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
44166564|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166566|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44166567|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166568|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166569|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166570|NCT00264927|Satavaptan|satavaptan|mesh-list
44166571|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44166572|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166573|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
44166574|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166575|NCT00264953|Prednisone|prednisone|mesh-list
44166576|NCT00264953|Etoposide|etoposide|mesh-list
44166577|NCT00264953|Vincristine|vincristine|mesh-list
44166578|NCT00264953|Doxorubicin|doxorubicin|mesh-list
44166579|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44166580|NCT00264953|Bleomycin|bleomycin|mesh-list
44166581|NCT00264953|Vinblastine|vinblastine|mesh-list
44166582|NCT00264953|Procarbazine|procarbazine|mesh-list
44166583|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166584|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
44166585|NCT00264953|Hormones|hormones|mesh-ancestor
44166586|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166587|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166588|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166589|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166590|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44166591|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44166592|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44166593|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166594|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166595|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166596|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166597|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
43918158|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918159|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918160|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918161|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918162|NCT00518713|Clobazam|clobazam|mesh-list
43918163|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
43918164|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43918165|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43918166|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918167|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918168|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918169|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43918170|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
43918171|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
43918172|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918173|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918174|NCT00519584|Bupivacaine|bupivacaine|mesh-list
43918175|NCT00519584|Ropivacaine|ropivacaine|mesh-list
43918176|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
43918177|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
44166598|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166599|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44166600|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166601|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166602|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166603|NCT00265018|Doxorubicin|doxorubicin|mesh-list
44166604|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44166605|NCT00265018|Bleomycin|bleomycin|mesh-list
44166606|NCT00265018|Vinblastine|vinblastine|mesh-list
44166607|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166609|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44166610|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44166611|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166612|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166613|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44166614|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166615|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166616|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166617|NCT00265031|Prednisone|prednisone|mesh-list
44166618|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
44166619|NCT00265031|Etoposide|etoposide|mesh-list
44166620|NCT00265031|Vincristine|vincristine|mesh-list
44166621|NCT00265031|Doxorubicin|doxorubicin|mesh-list
44166622|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44166623|NCT00265031|Bleomycin|bleomycin|mesh-list
44166624|NCT00265031|Procarbazine|procarbazine|mesh-list
44166625|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166626|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
44166627|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166628|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166629|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44166630|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
44166631|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166632|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166633|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44166634|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166635|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
43918178|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918179|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918180|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
43918181|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918182|NCT00520234|Caspofungin|caspofungin|mesh-list
43918183|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
43918184|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918185|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738229|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
43918186|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918187|NCT00520286|Modafinil|modafinil|mesh-list
43918188|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43918189|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918190|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43918191|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43918192|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43918193|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918194|NCT00520468|Cyclosporine|cyclosporine|mesh-list
43918195|NCT00520468|Prednisone|prednisone|mesh-list
43918196|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
43918197|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
43918198|NCT00520468|Cyclosporins|cyclosporins|mesh-list
43918199|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918200|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
44166636|NCT00265031|Hormones|hormones|mesh-ancestor
44166637|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166640|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44166641|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44166642|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166643|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166644|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166645|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166646|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166647|NCT00265070|Gefitinib|gefitinib|mesh-list
44166648|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166649|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166650|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166651|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166652|NCT00265135|Siltuximab|siltuximab|mesh-list
44166653|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166654|NCT00265252|Alendronate|alendronate|mesh-list
44166655|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44166656|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166657|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44166658|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44166659|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44166660|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166661|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166662|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
44166663|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166664|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918201|NCT00520468|Hormones|hormones|mesh-ancestor
43918202|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918203|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918204|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43918205|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918206|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918207|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918208|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918209|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
43918210|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
43918211|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918212|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
43918213|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918214|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43918215|NCT00520468|Hematinics|hematinics|mesh-ancestor
43918216|NCT00521456|Ketorolac|ketorolac|mesh-list
43918217|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43918218|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44166665|NCT00265278|Modafinil|modafinil|mesh-list
44166666|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44166667|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166668|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44166669|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44166670|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44166671|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166672|NCT00265291|Fluoxetine|fluoxetine|mesh-list
44166673|NCT00265291|Desipramine|desipramine|mesh-list
44166674|NCT00265291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44166675|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44166676|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166677|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166678|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166679|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
44166680|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166681|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44166682|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
44166683|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166684|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44166685|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44166686|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166687|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44166688|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44166689|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
44166690|NCT00265304|Ketoprofen|ketoprofen|mesh-list
44166691|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166692|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166693|NCT00265304|Analgesics|analgesics|mesh-ancestor
44166694|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
44166695|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166696|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166697|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166698|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166699|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44166700|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918219|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918221|NCT00521456|Analgesics|analgesics|mesh-ancestor
43918222|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
43918223|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918224|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918225|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918226|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918227|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43918228|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918229|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918230|NCT00521989|Prednisolone|prednisolone|mesh-list
43918232|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
43918233|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43918234|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
43918235|NCT00521989|Dipyridamole|dipyridamole|mesh-list
43918236|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43918237|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
43918238|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918239|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
43918240|NCT00521989|Hormones|hormones|mesh-ancestor
43918241|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918242|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918244|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918271|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43918272|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918273|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918274|NCT00524017|Cetuximab|cetuximab|mesh-list
43918275|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918276|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918277|NCT00524225|Oprelvekin|oprelvekin|mesh-list
43918278|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918279|NCT00524264|Ketorolac|ketorolac|mesh-list
43918280|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918281|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918282|NCT00524264|Analgesics|analgesics|mesh-ancestor
43918283|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
43918284|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918285|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918286|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918287|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918288|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43918289|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918290|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918291|NCT00524342|Oprelvekin|oprelvekin|mesh-list
43918292|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918293|NCT00524472|Insulin|insulin|mesh-list
43918294|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44166701|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166702|NCT00265408|Aspirin|aspirin|mesh-list
44166703|NCT00265408|Warfarin|warfarin|mesh-list
44166704|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166705|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166706|NCT00265408|Analgesics|analgesics|mesh-ancestor
44166707|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
44166709|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166710|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166711|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166712|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166713|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166714|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166715|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44166716|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44166717|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166719|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
44166720|NCT00265460|Lobeline|lobeline|mesh-list
44166721|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44166722|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
44166723|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166724|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166725|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44166726|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44166727|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918295|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43918296|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918298|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
43918299|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918300|NCT00525057|Dalteparin|dalteparin|mesh-list
43918301|NCT00525057|Tinzaparin|tinzaparin|mesh-list
43918302|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43918303|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
43918304|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43918305|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44157383|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918306|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918308|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
43918309|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918310|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918311|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
43918312|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918313|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918314|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
43918315|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43918316|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918317|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918318|NCT00525421|Curcumin|curcumin|mesh-list
43918319|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918320|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918321|NCT00525421|Analgesics|analgesics|mesh-ancestor
44166728|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166729|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166730|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44166731|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
44166732|NCT00265486|Hematinics|hematinics|mesh-ancestor
44166733|NCT00265551|Olanzapine|olanzapine|mesh-list
44166734|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
44166735|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
44166736|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166737|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166738|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44166739|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44166740|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166741|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166742|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166743|NCT00265551|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44166744|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44166745|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166746|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166747|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166748|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
43841474|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918322|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
43918323|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918324|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918325|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918326|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918327|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918328|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918329|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918330|NCT00525525|Bevacizumab|bevacizumab|mesh-list
43918331|NCT00525525|Temozolomide|temozolomide|mesh-list
43918332|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43918333|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918334|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918335|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918336|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918337|NCT00525525|Growth Substances|growth substances|mesh-ancestor
43918338|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918339|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918340|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43918341|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
43918342|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918343|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43918344|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918345|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
43918346|NCT00525603|Rituximab|rituximab|mesh-list
44166749|NCT00265642|Irbesartan|irbesartan|mesh-list
44166750|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166751|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44166752|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44166753|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166754|NCT00265694|Gemcitabine|gemcitabine|mesh-list
44166755|NCT00265694|Carboplatin|carboplatin|mesh-list
44166756|NCT00265694|Vinorelbine|vinorelbine|mesh-list
44166757|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166758|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166759|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
44166760|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166761|NCT00265694|Antiviral Agents|antiviral agents|mesh-ancestor
44166762|NCT00265694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166763|NCT00265694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166764|NCT00265694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166765|NCT00265694|Immunologic Factors|immunologic factors|mesh-ancestor
44166766|NCT00265694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166767|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44166768|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166769|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
43918348|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
43918349|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
43918350|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918351|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
43918352|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918353|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918354|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43918355|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
43918356|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918357|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918358|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43918359|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918360|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918361|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
43918362|NCT00525733|Ritonavir|ritonavir|mesh-list
43918363|NCT00525733|Darunavir|darunavir|mesh-list
43918364|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
43918365|NCT00525733|Maraviroc|maraviroc|mesh-list
43918366|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43918367|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43918368|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
43918369|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166770|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166771|NCT00265733|Paclitaxel|paclitaxel|mesh-list
44166772|NCT00265733|Capecitabine|capecitabine|mesh-list
44166773|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44166774|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44166775|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166776|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
44166777|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
44166778|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
44166779|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166780|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166789|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166790|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166791|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166792|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166793|NCT00265811|Cetuximab|cetuximab|mesh-list
44166794|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166795|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166796|NCT00265824|Bevacizumab|bevacizumab|mesh-list
44166797|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44166798|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166799|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166800|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44166801|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44166802|NCT00265824|Growth Substances|growth substances|mesh-ancestor
44166803|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166804|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
44166805|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166806|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918370|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918371|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43918372|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43918373|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
43918374|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918375|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43918376|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918377|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43918378|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43918379|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44157384|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43918380|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43918381|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43918383|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
43918384|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43918385|NCT00525798|Katacalcin|katacalcin|mesh-list
43918386|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43918387|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918388|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43918389|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
43918390|NCT00525837|Varenicline|varenicline|mesh-list
43918391|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43918392|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43918393|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918394|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918395|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918396|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918397|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
43918398|NCT00525876|Rituximab|rituximab|mesh-list
43918399|NCT00525876|Fludarabine|fludarabine|mesh-list
43918400|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
43918401|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
43918402|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918403|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
43794336|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
43918407|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
43918408|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918409|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918410|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43918411|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918412|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918413|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
43918414|NCT00526058|Clotrimazole|clotrimazole|mesh-list
43918415|NCT00526058|Miconazole|miconazole|mesh-list
43918416|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43918417|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918418|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
43918419|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43918420|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918421|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918422|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918423|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43918424|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
43918425|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918426|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918427|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43918428|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43918429|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
43918430|NCT00526292|Fludarabine|fludarabine|mesh-list
43918431|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918432|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
43918433|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918434|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918435|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43918440|NCT00526474|Vorapaxar|vorapaxar|mesh-list
43918450|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918451|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
43918452|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
43918453|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157385|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43918454|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918455|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918458|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918459|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918460|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43918461|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918462|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43918463|NCT00527475|Ranibizumab|ranibizumab|mesh-list
43918464|NCT00527475|Verteporfin|verteporfin|mesh-list
43918465|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918466|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918467|NCT00527475|Growth Substances|growth substances|mesh-ancestor
43918468|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918469|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918470|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918471|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43918472|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
43918473|NCT00527592|Travoprost|travoprost|mesh-list
43918474|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43918475|NCT00527592|Latanoprost|latanoprost|mesh-list
43918476|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43918477|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43918478|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43918479|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43918480|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
43918481|NCT00527644|Hormones|hormones|mesh-ancestor
43918482|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918483|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918484|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918485|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918487|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43918488|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43918489|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43918490|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43918491|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
43918492|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
43918493|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918494|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918495|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918496|NCT00527943|Vorapaxar|vorapaxar|mesh-list
43918497|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43918498|NCT00528190|Itraconazole|itraconazole|mesh-list
43918499|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
43918500|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918501|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43918502|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918503|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918504|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918505|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43918506|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
43918507|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918508|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918509|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43918510|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43918511|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918512|NCT00528398|Cytarabine|cytarabine|mesh-list
43918513|NCT00528398|Idarubicin|idarubicin|mesh-list
43918532|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43918533|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43918534|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918535|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918536|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
43918537|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
43918538|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
43918539|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43918540|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43918541|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43918542|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918543|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918544|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918545|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918546|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918547|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43918548|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918549|NCT00528580|Simvastatin|simvastatin|mesh-list
43918550|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43918551|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43918552|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
43918553|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918554|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918555|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43918556|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918557|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
43918558|NCT00528788|Vitamins|vitamins|mesh-ancestor
43918559|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
43918560|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918561|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43918562|NCT00529126|Epinephrine|epinephrine|mesh-list
43918563|NCT00529126|Bupivacaine|bupivacaine|mesh-list
43794409|NCT03189641|Cilostazol|cilostazol|mesh-list
44166807|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166808|NCT00265863|Mitomycins|mitomycins|mesh-list
44166809|NCT00265863|Mitomycin|mitomycin|mesh-list
44166810|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166811|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166812|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
44166813|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166814|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43918564|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43918565|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
43918566|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918567|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918568|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
43918569|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918570|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43918571|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43918572|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
43918573|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918574|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918575|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43918576|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43918577|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
43918578|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43918579|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
43918580|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
43918581|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
43918582|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43918583|NCT00529191|Atorvastatin|atorvastatin|mesh-list
43918584|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43918585|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43918586|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
43918587|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918588|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918589|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43918590|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918591|NCT00529204|Exenatide|exenatide|mesh-list
43918592|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43918593|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918594|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43918595|NCT00529204|Incretins|incretins|mesh-ancestor
43918596|NCT00529204|Hormones|hormones|mesh-ancestor
43918597|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918598|NCT00529555|Minocycline|minocycline|mesh-list
43918601|NCT00530634|Gemcitabine|gemcitabine|mesh-list
43918603|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918604|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918605|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
43918606|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918607|NCT00530634|Antiviral Agents|antiviral agents|mesh-ancestor
43918608|NCT00530634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918609|NCT00530634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918610|NCT00530634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918611|NCT00530634|Immunologic Factors|immunologic factors|mesh-ancestor
43918612|NCT00530634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918613|NCT00530764|Nabiximols|nabiximols|mesh-list
43918614|NCT00530764|Dronabinol|dronabinol|mesh-list
43918615|NCT00530764|Cannabidiol|cannabidiol|mesh-list
43918616|NCT00530764|Analgesics|analgesics|mesh-ancestor
43918617|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
43918618|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918619|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918620|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
43918621|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
43918622|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918623|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918624|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43918625|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43918626|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918627|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918628|NCT00530764|Hormones|hormones|mesh-ancestor
43918629|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918630|NCT00530803|Lidocaine|lidocaine|mesh-list
43918631|NCT00530803|Tetracaine|tetracaine|mesh-list
43918632|NCT00530803|Prilocaine|prilocaine|mesh-list
43918633|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43918634|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
43918635|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
43918638|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
43918644|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918645|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43918646|NCT00531453|Thalidomide|thalidomide|mesh-list
43918647|NCT00531453|Dexamethasone|dexamethasone|mesh-list
43918648|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
43918649|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
43918651|NCT00531453|BB 1101|bb 1101|mesh-list
43918652|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918653|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
43918654|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918655|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918656|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43918657|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
43918658|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918659|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918660|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43918661|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918662|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
43918663|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
43918664|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918665|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43918666|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
43918667|NCT00531453|Hormones|hormones|mesh-ancestor
43918668|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918669|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43918670|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
43918671|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918672|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
44166815|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166816|NCT00265876|Gemcitabine|gemcitabine|mesh-list
44166817|NCT00265876|Saracatinib|saracatinib|mesh-list
44166818|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166819|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
44166820|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166821|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166822|NCT00265876|Antiviral Agents|antiviral agents|mesh-ancestor
44166823|NCT00265876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166824|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166825|NCT00265876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166826|NCT00265876|Immunologic Factors|immunologic factors|mesh-ancestor
44166827|NCT00265876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166828|NCT00265915|Rituximab|rituximab|mesh-list
44166829|NCT00265915|Sargramostim|sargramostim|mesh-list
44166830|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166831|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166832|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
43918675|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918676|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918677|NCT00531453|Growth Substances|growth substances|mesh-ancestor
43918678|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918679|NCT00531518|Lamotrigine|lamotrigine|mesh-list
43918680|NCT00531518|Aripiprazole|aripiprazole|mesh-list
43918681|NCT00531518|Bupropion|bupropion|mesh-list
43918682|NCT00531518|Fluoxetine|fluoxetine|mesh-list
43918683|NCT00531518|Sertraline|sertraline|mesh-list
43918684|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43918685|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918686|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918687|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43794442|NCT03113942|Growth Substances|growth substances|mesh-ancestor
44166833|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166834|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166835|NCT00265928|Rituximab|rituximab|mesh-list
44166836|NCT00265928|Bortezomib|bortezomib|mesh-list
44166837|NCT00265928|Antibodies|antibodies|mesh-list
44166838|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
44166839|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44166840|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44166841|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
44166842|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166843|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166844|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166845|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166846|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166847|NCT00265967|Irbesartan|irbesartan|mesh-list
43765528|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44166848|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166850|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44166851|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166853|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
44166854|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44166855|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44166856|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166857|NCT00266058|Ritonavir|ritonavir|mesh-list
44166858|NCT00266058|Lopinavir|lopinavir|mesh-list
44166859|NCT00266058|Efavirenz|efavirenz|mesh-list
44166860|NCT00266058|Lumefantrine|lumefantrine|mesh-list
44166861|NCT00266058|Artemether|artemether|mesh-list
44166862|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44166863|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44166864|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44166865|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44166866|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166867|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166868|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44166869|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44166870|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
44166871|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166872|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44166873|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44166874|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44166875|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44166876|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44166877|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43918688|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918689|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918690|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918692|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918693|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918694|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43918695|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918696|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918697|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43918698|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43918699|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918700|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
43918701|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43918702|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43918703|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
43918704|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43918705|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43918706|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43918707|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43918708|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43918709|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
43918710|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43918711|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43918712|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43918713|NCT00531843|PENTA|penta|mesh-list
43918714|NCT00531843|Fondaparinux|fondaparinux|mesh-list
43918715|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43918716|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
43918717|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43918718|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
43918719|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918720|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918721|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
43918722|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43918724|NCT00531882|Pioglitazone|pioglitazone|mesh-list
43918725|NCT00531882|Ibuprofen|ibuprofen|mesh-list
43918726|NCT00531882|Simvastatin|simvastatin|mesh-list
43918727|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918728|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918729|NCT00531882|Analgesics|analgesics|mesh-ancestor
43918730|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
43918731|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918732|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918733|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918734|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918735|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43918736|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918737|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918738|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43918739|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43918740|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
43918741|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918742|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43918743|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43918744|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43918745|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43918746|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918747|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918748|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918749|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918750|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918752|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
43918753|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918754|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918755|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918756|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
43918757|NCT00533117|Fluoxetine|fluoxetine|mesh-list
44166878|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44166879|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44166880|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44166881|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
44166882|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43918758|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43918759|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918760|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918761|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918763|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
43918764|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918765|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43918766|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918767|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918768|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43918769|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918770|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918771|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
43918772|NCT00533442|Sirolimus|sirolimus|mesh-list
43918773|NCT00533442|Tacrolimus|tacrolimus|mesh-list
43918774|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918775|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
43918776|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918777|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43918778|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918779|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918780|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43918781|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918782|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43918783|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
43918784|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918785|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918786|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
43918787|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44166883|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44166884|NCT00266097|Gemcitabine|gemcitabine|mesh-list
44166885|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
44166886|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44166887|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166888|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
44166889|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166890|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166891|NCT00266097|Antiviral Agents|antiviral agents|mesh-ancestor
44166892|NCT00266097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166893|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166894|NCT00266097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918788|NCT00533546|Protein C|protein c|mesh-list
43918789|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
43918790|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43918791|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43918792|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918793|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918794|NCT00533910|Rifaximin|rifaximin|mesh-list
43918795|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918796|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918797|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43918798|NCT00534001|Bupropion|bupropion|mesh-list
43918799|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43918800|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
43918801|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43918802|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43918803|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43918804|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918805|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918806|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
43918807|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918808|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918809|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43918810|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43918811|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918812|NCT00534417|Capecitabine|capecitabine|mesh-list
43918813|NCT00534417|Fulvestrant|fulvestrant|mesh-list
43918814|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918815|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
43918816|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918817|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918818|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43918819|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43918820|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43918821|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
43918822|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43918825|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918826|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918827|NCT00534794|Analgesics|analgesics|mesh-ancestor
43918828|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
43918829|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918830|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918831|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43918832|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918833|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43918834|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43918835|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43918836|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
43918837|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
43918838|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918839|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918840|NCT00534833|Vaccines|vaccines|mesh-list
43918841|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
43918842|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918843|NCT00535002|Yohimbine|yohimbine|mesh-list
43918844|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
43918845|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
43918846|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918847|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918848|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43918849|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43918850|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43918851|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
43918852|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794524|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44166895|NCT00266097|Immunologic Factors|immunologic factors|mesh-ancestor
44166896|NCT00266097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166897|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44166898|NCT00266123|Sirolimus|sirolimus|mesh-list
44166899|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44166900|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166901|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166902|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166903|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
44166904|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166905|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
44166906|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166907|NCT00266136|Cytarabine|cytarabine|mesh-list
43918854|NCT00535002|Urological Agents|urological agents|mesh-ancestor
43918855|NCT00535392|Levetiracetam|levetiracetam|mesh-list
43918856|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
43918857|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
43918858|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43918859|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43918860|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918861|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918862|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918863|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918864|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918865|NCT00535613|Propofol|propofol|mesh-list
43918866|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43918867|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43918868|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918869|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43918870|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
43918871|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
43918872|NCT00535652|Ertapenem|ertapenem|mesh-list
43918873|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43918874|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43918875|NCT00535743|Bromides|bromides|mesh-list
43918876|NCT00535743|Rocuronium|rocuronium|mesh-list
44166908|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
44166909|NCT00266136|Daunorubicin|daunorubicin|mesh-list
44166910|NCT00266136|Thioguanine|thioguanine|mesh-list
44166911|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166912|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
44166913|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166914|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44166915|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44166916|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
44166917|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166918|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166919|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44166940|NCT00266162|Bosentan|bosentan|mesh-list
44166941|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44166942|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44166943|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166944|NCT00266214|Lidocaine|lidocaine|mesh-list
44166945|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
44166946|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
44166947|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166948|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166949|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
44166950|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166951|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44166952|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44166953|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44166954|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918879|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43918880|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43918881|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918882|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918883|NCT00535782|Methotrexate|methotrexate|mesh-list
43918884|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43918885|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
43918886|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43918887|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918888|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43918889|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
43918890|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918891|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918892|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
43918893|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918894|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44166955|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166957|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166958|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607266|NCT03204032|Thalidomide|thalidomide|mesh-list
44166959|NCT00266318|Interferons|interferons|mesh-list
44166960|NCT00266318|Ribavirin|ribavirin|mesh-list
44166961|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
44166962|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166963|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
44166964|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166965|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
44166966|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166967|NCT00266344|Gaboxadol|gaboxadol|mesh-list
44166968|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166969|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166970|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166973|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
44166974|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
44166975|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
44166977|NCT00266357|Gaboxadol|gaboxadol|mesh-list
44166978|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166979|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166980|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166981|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166982|NCT00266357|Analgesics|analgesics|mesh-ancestor
44166983|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
44166984|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
44166985|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
44166986|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
44166987|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
44166988|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44166989|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166990|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
44166991|NCT00266487|Vitamins|vitamins|mesh-list
44166992|NCT00266487|Folic Acid|folic acid|mesh-list
44166993|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
43918895|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918897|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918898|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43918899|NCT00535873|Lenalidomide|lenalidomide|mesh-list
43918900|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
43918901|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918902|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918903|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918904|NCT00535873|Growth Substances|growth substances|mesh-ancestor
43918905|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918906|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918907|NCT00535925|Aspirin|aspirin|mesh-list
43918908|NCT00535925|Atenolol|atenolol|mesh-list
43918909|NCT00535925|Amlodipine|amlodipine|mesh-list
43918910|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43918911|NCT00535925|Clonidine|clonidine|mesh-list
43918912|NCT00535925|Ramipril|ramipril|mesh-list
43918913|NCT00535925|Irbesartan|irbesartan|mesh-list
43918914|NCT00535925|Doxazosin|doxazosin|mesh-list
43918915|NCT00535925|Furosemide|furosemide|mesh-list
43918916|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
43918917|NCT00535925|Simvastatin|simvastatin|mesh-list
43918918|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918919|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43918920|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43918921|NCT00535925|Analgesics|analgesics|mesh-ancestor
43918922|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
43918923|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918924|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166994|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
44166995|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
44166996|NCT00266487|Pyridoxal|pyridoxal|mesh-list
44166997|NCT00266487|Pyridoxine|pyridoxine|mesh-list
44166998|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
44166999|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
44167000|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167001|NCT00266487|Hematinics|hematinics|mesh-ancestor
44167002|NCT00266539|Fentanyl|fentanyl|mesh-list
44167003|NCT00266539|Morphine|morphine|mesh-list
44167004|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44167005|NCT00266539|Narcotics|narcotics|mesh-ancestor
44167006|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167007|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167008|NCT00266539|Analgesics|analgesics|mesh-ancestor
44167009|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
44167010|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167011|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44167012|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44167013|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
44167014|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
44167015|NCT00266552|Risperidone|risperidone|mesh-list
44167016|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44167017|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
43918925|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918926|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43918927|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43918928|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918929|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43918930|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43918931|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43918932|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
43918933|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43918934|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43918935|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918936|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43918937|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
43918938|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43918939|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43918940|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
43918941|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43918942|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43918943|NCT00535925|Diuretics|diuretics|mesh-ancestor
43918944|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
43918945|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43794580|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167018|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167019|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167020|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167021|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44167022|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44167023|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167024|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167025|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44167026|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
44167027|NCT00266578|Fluticasone|fluticasone|mesh-list
44167028|NCT00266578|Xhance|xhance|mesh-list
44167029|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167030|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167031|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
44167032|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607348|NCT03203356|Hormones|hormones|mesh-list
44167033|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167034|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167035|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167036|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167037|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44167038|NCT00266591|Topiramate|topiramate|mesh-list
44167039|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
44167040|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167041|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167042|NCT00266604|Topiramate|topiramate|mesh-list
44167043|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
44167044|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167045|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167046|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
43918946|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43918947|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
43918948|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
43918949|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43918950|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43918951|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43918952|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
43918953|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918954|NCT00535925|Hematinics|hematinics|mesh-ancestor
43918955|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43918956|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
43918957|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43918958|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43918959|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43918960|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44167047|NCT00266617|Hematinics|hematinics|mesh-ancestor
44167048|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44167049|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44167050|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167051|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167052|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167053|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167054|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167055|NCT00266643|Analgesics|analgesics|mesh-ancestor
44167056|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
44167057|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167058|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
44167059|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167060|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
44167061|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
44167062|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
44167063|NCT00266721|Pancrelipase|pancrelipase|mesh-list
44167064|NCT00266721|Pancreatin|pancreatin|mesh-list
44167065|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167066|NCT00266747|Amibegron|amibegron|mesh-list
44167067|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167068|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167069|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167070|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167071|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167072|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167073|NCT00266786|Ketorolac|ketorolac|mesh-list
44167074|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44167075|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44167076|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44167077|NCT00266786|Analgesics|analgesics|mesh-ancestor
44167078|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
44167079|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167080|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167081|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167082|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167083|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44167084|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167085|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765539|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765540|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43765541|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
43765564|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43765565|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
43765566|NCT02412345|Urological Agents|urological agents|mesh-ancestor
43765567|NCT02412267|Carboplatin|carboplatin|mesh-list
43765568|NCT02412267|Etoposide|etoposide|mesh-list
43765569|NCT02412267|Ifosfamide|ifosfamide|mesh-list
43765570|NCT02412267|Ofatumumab|ofatumumab|mesh-list
44167086|NCT00266838|Dexamethasone|dexamethasone|mesh-list
44167087|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167088|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
43918961|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43918962|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43918963|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43918964|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44139203|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139204|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139206|NCT00174629|Docetaxel|docetaxel|mesh-list
44139207|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139208|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
44139209|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139210|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918965|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
43918966|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43918967|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43918968|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43918969|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43918970|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43918971|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
43918972|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43918973|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918974|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43918975|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43918976|NCT00536341|Rituximab|rituximab|mesh-list
43918977|NCT00536341|Fludarabine|fludarabine|mesh-list
43918978|NCT00536341|Lenalidomide|lenalidomide|mesh-list
43918979|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43918980|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43918981|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
43918982|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918983|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43918984|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43918985|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43918986|NCT00536341|Growth Substances|growth substances|mesh-ancestor
43918987|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
43918992|NCT00536601|Carmustine|carmustine|mesh-list
43918993|NCT00536601|Carboplatin|carboplatin|mesh-list
43918994|NCT00536601|Etoposide|etoposide|mesh-list
43918995|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
43918996|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43918997|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
43918998|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43918999|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919000|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919001|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
43919002|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919003|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919004|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43919005|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919006|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919007|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919008|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919009|NCT00536913|Budesonide|budesonide|mesh-list
43919010|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
43919011|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43919012|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43919013|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43919014|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
43919015|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919016|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919017|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43919018|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919019|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
43919020|NCT00536913|Hormones|hormones|mesh-ancestor
43919021|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919022|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43919023|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43919024|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43919025|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
43919026|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919030|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919031|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
43919032|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919033|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919034|NCT00537407|Ribavirin|ribavirin|mesh-list
43919035|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43919036|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
43919037|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919038|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
43665666|NCT05578872|Ipilimumab|ipilimumab|mesh-list
43919039|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919040|NCT00537511|Cisplatin|cisplatin|mesh-list
43919041|NCT00537511|Etoposide|etoposide|mesh-list
43919042|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
43919043|NCT00537511|Pomalidomide|pomalidomide|mesh-list
43919044|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919045|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919046|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919047|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919048|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919049|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919050|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
43919051|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603719|NCT03243643|Apatinib|apatinib|mesh-list
44167089|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
44167090|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167091|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167092|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167093|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
44167094|NCT00266838|Hormones|hormones|mesh-ancestor
44167095|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167096|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44167097|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167098|NCT00267163|Donepezil|donepezil|mesh-list
44167099|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44167100|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167101|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167102|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
44167103|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167104|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167105|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
44167106|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
44167107|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44167108|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44167109|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167110|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167111|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43607418|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167112|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44167113|NCT00267176|Analgesics|analgesics|mesh-ancestor
44167114|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
43641465|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43919052|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919053|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919054|NCT00537511|Growth Substances|growth substances|mesh-ancestor
43919055|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919056|NCT00537680|Ubiquinone|ubiquinone|mesh-list
43919057|NCT00537680|Idebenone|idebenone|mesh-list
43919058|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
43919059|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919060|NCT00537680|Protective Agents|protective agents|mesh-ancestor
43919061|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919062|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
43919063|NCT00538304|Bimatoprost|bimatoprost|mesh-list
43919064|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43919065|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43919066|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43919067|NCT00538434|Reslizumab|reslizumab|mesh-list
43919068|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43919069|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919070|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
43919071|NCT00538616|Propofol|propofol|mesh-list
43919072|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43919073|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919074|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919075|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43919076|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
43919077|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
43919078|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43919079|NCT00538616|Analgesics|analgesics|mesh-ancestor
43919080|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
43919081|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919082|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43919083|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43919084|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43919085|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
43919093|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919094|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43919095|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43919096|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919097|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43919098|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43919099|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
43919100|NCT00538824|Thalidomide|thalidomide|mesh-list
43919101|NCT00538824|Dexamethasone|dexamethasone|mesh-list
43919102|NCT00538824|Lenalidomide|lenalidomide|mesh-list
43919103|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43919104|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
43919105|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
43919106|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919107|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919108|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919109|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
43919110|NCT00538824|Hormones|hormones|mesh-ancestor
43919111|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919112|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43919113|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919114|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
43919115|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44139211|NCT00174629|Antiviral Agents|antiviral agents|mesh-ancestor
43919116|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919117|NCT00538824|Growth Substances|growth substances|mesh-ancestor
43919118|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919119|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919120|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
43919121|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43919122|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919123|NCT00538850|Fentanyl|fentanyl|mesh-list
43919124|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43919125|NCT00538850|Narcotics|narcotics|mesh-ancestor
43794625|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
44167115|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167116|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167117|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167118|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167119|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
44167120|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44167121|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43919126|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919127|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919129|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
43919130|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919131|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43919132|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43919133|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
43919134|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
43919135|NCT00538863|Fentanyl|fentanyl|mesh-list
43919136|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43919137|NCT00538863|Narcotics|narcotics|mesh-ancestor
43919138|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919139|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919140|NCT00538863|Analgesics|analgesics|mesh-ancestor
43919141|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
43919142|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919143|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43919144|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43919145|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
43919146|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
43919147|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
43919148|NCT00538915|Antibodies|antibodies|mesh-list
43919149|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
43919151|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43919180|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
43919181|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43919182|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43919183|NCT00540007|Lenalidomide|lenalidomide|mesh-list
43919184|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
43919185|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919186|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919187|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919188|NCT00540007|Growth Substances|growth substances|mesh-ancestor
43919189|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919190|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919191|NCT00540579|Gemcitabine|gemcitabine|mesh-list
43919192|NCT00540579|Pomalidomide|pomalidomide|mesh-list
43919193|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43665746|NCT05414058|Methylphenidate|methylphenidate|mesh-list
43919194|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
43919195|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919196|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919197|NCT00540579|Antiviral Agents|antiviral agents|mesh-ancestor
43919198|NCT00540579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919199|NCT00540579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919200|NCT00540579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919201|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
43919202|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919203|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919204|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919205|NCT00540579|Growth Substances|growth substances|mesh-ancestor
43919206|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919226|NCT00540982|Vinorelbine|vinorelbine|mesh-list
43919227|NCT00540982|Lidocaine|lidocaine|mesh-list
43919228|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
43919229|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
43919230|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919231|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919232|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
43919233|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919234|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43919235|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43919236|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43919237|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919238|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919239|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919240|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919241|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
43919242|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
43919243|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
43919244|NCT00541242|Bimatoprost|bimatoprost|mesh-list
43919245|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43919246|NCT00541242|Latanoprost|latanoprost|mesh-list
43919247|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43919248|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43919249|NCT00541671|Promethazine|promethazine|mesh-list
43919259|NCT00542308|Zalutumumab|zalutumumab|mesh-list
43919277|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
43919278|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919279|NCT00542750|Protective Agents|protective agents|mesh-ancestor
43919280|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919281|NCT00542750|Antidotes|antidotes|mesh-ancestor
43919282|NCT00542971|Cytarabine|cytarabine|mesh-list
43919283|NCT00542971|Sorafenib|sorafenib|mesh-list
43919284|NCT00542971|Idarubicin|idarubicin|mesh-list
43919285|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919286|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
43919287|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919288|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919289|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
43919290|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919291|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919292|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
43919293|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919294|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919295|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919296|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43919297|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919298|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919299|NCT00543101|Darunavir|darunavir|mesh-list
43919300|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43919301|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43919302|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
43919303|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919304|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919305|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43919306|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43919307|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
43919308|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919309|NCT00543127|Fulvestrant|fulvestrant|mesh-list
43919310|NCT00543127|Anastrozole|anastrozole|mesh-list
43794758|NCT01764711|Cosyntropin|cosyntropin|mesh-list
43919317|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919318|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43919319|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43919320|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919321|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919322|NCT00543400|Heparin|heparin|mesh-list
43919323|NCT00543400|Calcium heparin|calcium heparin|mesh-list
43919324|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
43919325|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43919326|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43919327|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919328|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
43919329|NCT00544076|Alprostadil|alprostadil|mesh-list
43919330|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919331|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
43919332|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43919333|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43919334|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919335|NCT00544076|Urological Agents|urological agents|mesh-ancestor
43919336|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43919337|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43919338|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
43919339|NCT00544713|Glycerol|glycerol|mesh-list
43919340|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43919341|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43919342|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43919343|NCT00544713|Protective Agents|protective agents|mesh-ancestor
44167122|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167123|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167124|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44167125|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44167126|NCT00267215|Analgesics|analgesics|mesh-ancestor
44167127|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
44167128|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167129|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167130|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167131|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167132|NCT00267254|Atorvastatin|atorvastatin|mesh-list
44167133|NCT00267254|Simvastatin|simvastatin|mesh-list
44167134|NCT00267254|Torcetrapib|torcetrapib|mesh-list
44167135|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44167136|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44167137|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
44167138|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167139|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44167140|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44167141|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665872|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
43919344|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919345|NCT00544713|Laxatives|laxatives|mesh-ancestor
43919346|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919347|NCT00544778|Doxorubicin|doxorubicin|mesh-list
43919348|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43919349|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
43919352|NCT00544778|Razoxane|razoxane|mesh-list
43919353|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43919354|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919355|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919356|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919357|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919358|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919359|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43919360|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919361|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919362|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
43919363|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43919364|NCT00544778|Protective Agents|protective agents|mesh-ancestor
44167142|NCT00267267|Atorvastatin|atorvastatin|mesh-list
44167143|NCT00267267|Simvastatin|simvastatin|mesh-list
44167144|NCT00267267|Ezetimibe|ezetimibe|mesh-list
44167145|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44167146|NCT00267267|Torcetrapib|torcetrapib|mesh-list
44167147|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44167148|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44167149|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
44167150|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167151|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44167152|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44167153|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167154|NCT00267306|Visilizumab|visilizumab|mesh-list
44167155|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
44167156|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167157|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
44167158|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
44167159|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44167160|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
44167161|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167162|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167163|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167164|NCT00267332|Modafinil|modafinil|mesh-list
44167165|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167166|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167167|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44167168|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44167169|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44167170|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167172|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44167173|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
44167174|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167175|NCT00267384|Expectorants|expectorants|mesh-ancestor
44167176|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919365|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
43919366|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43919367|NCT00544908|Dasatinib|dasatinib|mesh-list
43919368|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919369|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919370|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919371|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919372|NCT00545181|Metronidazole|metronidazole|mesh-list
43919373|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919374|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43919375|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43919376|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43919377|NCT00545662|Choline|choline|mesh-list
43919378|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43919379|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
43919380|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43919381|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
43919382|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919383|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919384|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43919385|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
43919386|NCT00545974|Memantine|memantine|mesh-list
43919387|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43919388|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43919389|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
43919390|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919391|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919392|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919393|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43919394|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43919395|NCT00546104|Dasatinib|dasatinib|mesh-list
43919396|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919397|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919398|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919399|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919406|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
43919407|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
43919408|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
43919409|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919410|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919411|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
43919412|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919413|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919414|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919415|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
43919416|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43919417|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919418|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919420|NCT00546156|Growth Substances|growth substances|mesh-ancestor
43919422|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43919423|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919424|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919425|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919426|NCT00546728|Metformin|metformin|mesh-list
43919427|NCT00546728|Exenatide|exenatide|mesh-list
43919428|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43919429|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919430|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43919431|NCT00546728|Incretins|incretins|mesh-ancestor
43919432|NCT00546728|Hormones|hormones|mesh-ancestor
43919456|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919457|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
43919458|NCT00548197|Bevacizumab|bevacizumab|mesh-list
43919459|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919460|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919461|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919462|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919463|NCT00548197|Growth Substances|growth substances|mesh-ancestor
43919464|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919465|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919466|NCT00548418|Bevacizumab|bevacizumab|mesh-list
43919467|NCT00548418|Cisplatin|cisplatin|mesh-list
43919468|NCT00548418|Topotecan|topotecan|mesh-list
43919469|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919470|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919471|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919472|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919473|NCT00548418|Growth Substances|growth substances|mesh-ancestor
43919474|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919475|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919476|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43919477|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919478|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919479|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167177|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44167178|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
44167179|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167180|NCT00267384|Protective Agents|protective agents|mesh-ancestor
44167181|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167182|NCT00267384|Antidotes|antidotes|mesh-ancestor
44167183|NCT00267514|Sevelamer|sevelamer|mesh-list
44167184|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
44167185|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
44167186|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607494|NCT03202719|Vaccines|vaccines|mesh-list
44167187|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
44167188|NCT00267540|Vitamin D|vitamin d|mesh-list
44167189|NCT00267540|Vitamins|vitamins|mesh-ancestor
44167190|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
44167191|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167192|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44167193|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44167194|NCT00267553|Toremifene|toremifene|mesh-list
44167195|NCT00267553|Letrozole|letrozole|mesh-list
44167196|NCT00267553|Atamestane|atamestane|mesh-list
44167197|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167198|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44167199|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44167200|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167201|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167202|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44167203|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
43919480|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
43919481|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
43919482|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919483|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919484|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919485|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919486|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
43919487|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919488|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43919489|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919490|NCT00548470|Varenicline|varenicline|mesh-list
43919491|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43919492|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43919493|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
43919494|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919495|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919496|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919499|NCT00549042|Narcotics|narcotics|mesh-ancestor
43919500|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919501|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919502|NCT00549042|Analgesics|analgesics|mesh-ancestor
43919503|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
43919504|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919505|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
44167204|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167205|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167206|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44167207|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44167208|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44167209|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44167210|NCT00267657|Reserpine|reserpine|mesh-list
44167211|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44167212|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44167213|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44167214|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167215|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167216|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167217|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44167218|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167219|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167220|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167221|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167222|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167223|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
44167224|NCT00267683|Glyburide|glyburide|mesh-list
44167225|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167226|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167227|NCT00267709|Visilizumab|visilizumab|mesh-list
43919506|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43919507|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43919508|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919509|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
43919510|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
43919511|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
43919512|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43919513|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43919514|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43919515|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919516|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919517|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
43919518|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919519|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919520|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43919521|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919522|NCT00549822|Letrozole|letrozole|mesh-list
43919523|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919524|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43919525|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43919526|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919527|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919528|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43919529|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
43919530|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919531|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167228|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
44167229|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167230|NCT00267722|Visilizumab|visilizumab|mesh-list
44167231|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
44167232|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167233|NCT00267813|Bupropion|bupropion|mesh-list
44167234|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44167235|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44167236|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167237|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44167238|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167239|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167240|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167241|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
44167242|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167243|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167244|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44167245|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44167246|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919534|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43919535|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919536|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919537|NCT00550290|Cefazolin|cefazolin|mesh-list
43919538|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43919539|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919540|NCT00550394|Topiramate|topiramate|mesh-list
43919541|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43919542|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
43919543|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43919544|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43919545|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43919546|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919547|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919548|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
43919549|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43919550|NCT00550589|Cidofovir|cidofovir|mesh-list
43919551|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
43919552|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919553|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919554|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919555|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43919556|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43765684|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919557|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919558|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
43919559|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43919560|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919561|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44167247|NCT00267826|Rituximab|rituximab|mesh-list
44167248|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44167249|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167250|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
44167251|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167252|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167253|NCT00267917|Fenoterol|fenoterol|mesh-list
44167254|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
44167255|NCT00267917|Ipratropium|ipratropium|mesh-list
44167256|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167257|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
44167258|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167259|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607566|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919564|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43919565|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
43919566|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43919567|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
43919568|NCT00551707|Dipyridamole|dipyridamole|mesh-list
43919569|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43919570|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
43919571|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43919572|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
43919574|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919575|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919576|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43919577|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919578|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
43919579|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
43919580|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919581|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919582|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43919583|NCT00551707|Protective Agents|protective agents|mesh-ancestor
43919584|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43919585|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919586|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919587|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43919588|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
43919589|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
43919590|NCT00552409|Vitamin D|vitamin d|mesh-list
44167260|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167261|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167262|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
44167263|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
44167264|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44167265|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44167266|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167267|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167268|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167269|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167270|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167271|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44167272|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
44167273|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44167274|NCT00267943|Telmisartan|telmisartan|mesh-list
44167275|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44167276|NCT00267943|Diuretics|diuretics|mesh-ancestor
44167277|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
43919591|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43919592|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919593|NCT00552409|Vitamins|vitamins|mesh-ancestor
43919594|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
43919595|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43919596|NCT00552422|Domperidone|domperidone|mesh-list
43919597|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
43919598|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
43919599|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919600|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919601|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43919602|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43919603|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
43919604|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919605|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919606|NCT00552695|Lidocaine|lidocaine|mesh-list
43919607|NCT00552695|Tetracaine|tetracaine|mesh-list
43919608|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
43919609|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
43919610|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919648|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919649|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
43919650|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919651|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
43919652|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919653|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43919654|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43919655|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43919656|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
43919657|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44139212|NCT00174629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139213|NCT00174629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139214|NCT00174629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139215|NCT00174629|Immunologic Factors|immunologic factors|mesh-ancestor
44139216|NCT00174629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139217|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139218|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139219|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139220|NCT00174642|Insulin|insulin|mesh-list
44139221|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44139222|NCT00174642|Metformin|metformin|mesh-list
44139223|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
44139224|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
44139225|NCT00174642|Secretagogues|secretagogues|mesh-list
44139226|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44139227|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139228|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
44139229|NCT00174655|Docetaxel|docetaxel|mesh-list
44139230|NCT00174655|Doxorubicin|doxorubicin|mesh-list
44139231|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44139232|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139233|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
44139234|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139235|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139236|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44139237|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
44139239|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139243|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139244|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44139245|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44139246|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44139247|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139248|NCT00174668|Insulin|insulin|mesh-list
44139249|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44139250|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
44139251|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
44139252|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44139253|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139254|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
44139255|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44139256|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139257|NCT00174694|Telithromycin|telithromycin|mesh-list
44139258|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44139259|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139260|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
44139261|NCT00174707|Docetaxel|docetaxel|mesh-list
44139262|NCT00174707|Methotrexate|methotrexate|mesh-list
44139263|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139264|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
44139265|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919658|NCT00553410|Letrozole|letrozole|mesh-list
43919674|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
43919675|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919676|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
43919677|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919678|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
43919679|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919680|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43919681|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43919682|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43919683|NCT00553839|Ketamine|ketamine|mesh-list
43919684|NCT00553839|Analgesics|analgesics|mesh-ancestor
43919685|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
43919686|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919687|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919688|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43919689|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43919690|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
43919691|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
43919692|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919693|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43919694|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43919695|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919696|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919697|NCT00553969|Carvedilol|carvedilol|mesh-list
43919698|NCT00553969|Lisinopril|lisinopril|mesh-list
43919699|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43919700|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43919721|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43919722|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919723|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919724|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919725|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919726|NCT00554853|Pioglitazone|pioglitazone|mesh-list
43919727|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
43919728|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43919729|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919730|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
43666191|NCT04255160|Estradiol|estradiol|mesh-list
43919732|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43919733|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43919734|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
43919735|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919736|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919737|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43919738|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
43919739|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
43919740|NCT00554970|Hormones|hormones|mesh-ancestor
43919741|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919742|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
43919743|NCT00555048|Busulfan|busulfan|mesh-list
43919744|NCT00555048|Methotrexate|methotrexate|mesh-list
43919745|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
43919746|NCT00555048|Tacrolimus|tacrolimus|mesh-list
43919747|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919748|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
43919749|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919750|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919751|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919752|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
43919753|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919754|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919755|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44167278|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167279|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44167280|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43919756|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43919757|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
43919758|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43919759|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919760|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
43919761|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
43919762|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919763|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43919764|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43919765|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43919766|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43919767|NCT00555152|Lapatinib|lapatinib|mesh-list
43919768|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919769|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919770|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919771|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919772|NCT00555464|Prednisone|prednisone|mesh-list
43919773|NCT00555464|Prednisolone|prednisolone|mesh-list
43739570|NCT02534571|Coagulants|coagulants|mesh-ancestor
43919774|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43919775|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
43919776|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43919777|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
43919778|NCT00555464|Vincristine|vincristine|mesh-list
43919779|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43919780|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
43919781|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43919782|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
43919783|NCT00555464|Hormones|hormones|mesh-ancestor
43919784|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919785|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919786|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43919787|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919789|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
43919797|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43919799|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
43919800|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919801|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919802|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919803|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919804|NCT00555750|Eszopiclone|eszopiclone|mesh-list
43919805|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43919806|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919807|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919808|NCT00555880|Midodrine|midodrine|mesh-list
43919809|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
43919810|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
43919811|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919812|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919813|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43794934|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167281|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167282|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44167283|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44167284|NCT00268138|Fluorides|fluorides|mesh-list
44167285|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
44167286|NCT00268138|Protective Agents|protective agents|mesh-ancestor
44167287|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167288|NCT00268151|Capecitabine|capecitabine|mesh-list
44167289|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
44167290|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167291|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
44167292|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167293|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167294|NCT00268177|Fluticasone|fluticasone|mesh-list
44167295|NCT00268177|Xhance|xhance|mesh-list
44167296|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44167297|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167298|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167299|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
44167300|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167301|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167302|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167303|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167304|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167305|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44167306|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44167307|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167308|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167309|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167310|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167311|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167312|NCT00268216|Fluticasone|fluticasone|mesh-list
44167313|NCT00268216|Xhance|xhance|mesh-list
44167314|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44167315|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167316|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167317|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
43919814|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43919815|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43919816|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43919817|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43919818|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919819|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919821|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
43919822|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919823|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919824|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919825|NCT00555997|Ziprasidone|ziprasidone|mesh-list
43919826|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43919827|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
43919828|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167318|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167319|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167320|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167321|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167322|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167323|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44167324|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44167325|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167326|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167327|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167328|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167329|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167330|NCT00268229|Cytarabine|cytarabine|mesh-list
44167331|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
44167332|NCT00268229|Daunorubicin|daunorubicin|mesh-list
44167333|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167334|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
44167335|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167336|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167337|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
44167338|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167339|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167340|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
44167341|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167342|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44167343|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167344|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44167345|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44167346|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44167348|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44167349|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167350|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44167351|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167352|NCT00268333|Leucovorin|leucovorin|mesh-list
44167353|NCT00268333|Fluorouracil|fluorouracil|mesh-list
44167354|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
44167355|NCT00268333|Calcium|calcium|mesh-list
44167356|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
44167357|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44167358|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167359|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
43607722|NCT03200561|Prednisolone|prednisolone|mesh-list
44167360|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167361|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919829|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919831|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43919832|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43919833|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919834|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43919835|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43919836|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
43919837|NCT00556049|Gemcitabine|gemcitabine|mesh-list
43919838|NCT00556049|Sunitinib|sunitinib|mesh-list
43919839|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919840|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
43919841|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919842|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919843|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
43919844|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43919845|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919846|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919847|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
43919848|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919849|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43919850|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43919851|NCT00556049|Growth Substances|growth substances|mesh-ancestor
43919852|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
43919853|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43919854|NCT00556140|Aripiprazole|aripiprazole|mesh-list
43919855|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
43919856|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43919857|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43919858|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43919859|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919860|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919861|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
43919862|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
43919863|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919864|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167362|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919865|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43919866|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43919867|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
43919868|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43919869|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43919870|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43919871|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43919872|NCT00556452|Busulfan|busulfan|mesh-list
43919873|NCT00556452|Clofarabine|clofarabine|mesh-list
43919874|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
43919875|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919876|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919877|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
43919878|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919879|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919880|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919881|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43919882|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43919883|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
43919884|NCT00556478|Lidocaine|lidocaine|mesh-list
43919885|NCT00556478|Prilocaine|prilocaine|mesh-list
43919886|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43919887|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
43919888|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
43919889|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43919913|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43919914|NCT05622656|Analgesics|analgesics|mesh-ancestor
43919915|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
43919916|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43919917|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43919918|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43919919|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43919920|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
43919921|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919922|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919942|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43919943|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
43919944|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919945|NCT05622123|Exenatide|exenatide|mesh-list
43919946|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43919947|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919948|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43919949|NCT05622123|Incretins|incretins|mesh-ancestor
43919950|NCT05622123|Hormones|hormones|mesh-ancestor
43919951|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43919952|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
43919953|NCT05622058|Docetaxel|docetaxel|mesh-list
43919954|NCT05622058|Doxorubicin|doxorubicin|mesh-list
43919955|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919956|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
43919957|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919961|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919962|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43919963|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43919964|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43919965|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43919966|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43919967|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43919968|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43919969|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43919970|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43919971|NCT05621915|Nadroparin|nadroparin|mesh-list
43919972|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
43919973|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43919974|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43919975|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919976|NCT05621811|ATI 7505|ati 7505|mesh-list
43919977|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43919978|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43919979|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
43919980|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43919981|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919982|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919983|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
43919984|NCT05621759|Abatacept|abatacept|mesh-list
43919985|NCT05621759|Tacrolimus|tacrolimus|mesh-list
43919986|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43919987|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
43919988|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43919989|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43919990|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43919991|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
43919992|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43919993|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920001|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
43920002|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43920003|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
43920004|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920005|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920006|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43920007|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
43920008|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920009|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920010|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43920011|NCT05621655|Vaccines|vaccines|mesh-list
43920012|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
43920013|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920014|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
43920015|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43920016|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920017|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43920018|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920019|NCT05621499|Lenvatinib|lenvatinib|mesh-list
43920020|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920021|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43920022|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920023|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920025|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920026|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139279|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
44139280|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
43920027|NCT05618002|Clonidine|clonidine|mesh-list
43920028|NCT05618002|Lemborexant|lemborexant|mesh-list
43920029|NCT05618002|Zopiclone|zopiclone|mesh-list
43920030|NCT05618002|Analgesics|analgesics|mesh-ancestor
43920031|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
43920032|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920033|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920034|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43920035|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
43920038|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43920040|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
43920041|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920042|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920043|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43920044|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43920045|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43920046|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920047|NCT05617742|FAPI-46|fapi-46|mesh-list
43920048|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43920049|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920050|NCT05616260|Acetazolamide|acetazolamide|mesh-list
43920051|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
43920052|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43920053|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920054|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920055|NCT05616260|Diuretics|diuretics|mesh-ancestor
43920056|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
43920057|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920058|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43920059|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920060|NCT05590676|Metformin|metformin|mesh-list
43920061|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167363|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167364|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
44167365|NCT00268333|Antidotes|antidotes|mesh-ancestor
44167366|NCT00268333|Protective Agents|protective agents|mesh-ancestor
44167367|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
44167368|NCT00268333|Vitamins|vitamins|mesh-ancestor
44167369|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
44167370|NCT00268359|Bevacizumab|bevacizumab|mesh-list
44167371|NCT00268359|Irinotecan|irinotecan|mesh-list
44167372|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44167373|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167374|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44167375|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44167376|NCT00268359|Growth Substances|growth substances|mesh-ancestor
44167377|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167378|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
44167379|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44167380|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44167381|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167382|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167383|NCT00268372|Cisplatin|cisplatin|mesh-list
44167384|NCT00268372|Docetaxel|docetaxel|mesh-list
44167385|NCT00268372|Fluorouracil|fluorouracil|mesh-list
44167386|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167387|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167388|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920062|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920063|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
43920064|NCT05576896|Cetuximab|cetuximab|mesh-list
43920065|NCT05576896|Panitumumab|panitumumab|mesh-list
43920066|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920067|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920068|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
43920069|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43920070|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43920071|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920072|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920073|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920074|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920075|NCT05575804|Capecitabine|capecitabine|mesh-list
43920076|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43920077|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
43920078|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920079|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920080|NCT05461092|Morphine|morphine|mesh-list
43920081|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
43920082|NCT05461092|Bupivacaine|bupivacaine|mesh-list
43920083|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
43920084|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
43920085|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920086|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920087|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
43920088|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920089|NCT05461092|Narcotics|narcotics|mesh-ancestor
43920090|NCT05461092|Analgesics|analgesics|mesh-ancestor
43920091|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
43920092|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43795067|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167389|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167390|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167391|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
44167392|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167393|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167394|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
44167395|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167396|NCT00268398|Leucovorin|leucovorin|mesh-list
44167397|NCT00268398|Folic Acid|folic acid|mesh-list
44167398|NCT00268398|Fluorouracil|fluorouracil|mesh-list
44167399|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
44167400|NCT00268398|Irinotecan|irinotecan|mesh-list
44167401|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
43920093|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920094|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43920095|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920096|NCT05344833|Lenalidomide|lenalidomide|mesh-list
43920097|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
43920098|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920099|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920100|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920101|NCT05344833|Growth Substances|growth substances|mesh-ancestor
43666481|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
43920102|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920103|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920104|NCT05317936|Venetoclax|venetoclax|mesh-list
43920105|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920106|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
43920107|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43920108|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43920109|NCT05293249|Prednisolone|prednisolone|mesh-list
43920110|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
43920111|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43920112|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
43920113|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43920145|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
43920146|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43920147|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920148|NCT05072236|Lidocaine|lidocaine|mesh-list
43920149|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
43920150|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
43920151|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920152|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920153|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
43920154|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920155|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43920156|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43920157|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43920158|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920159|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920160|NCT05067998|Vitamins|vitamins|mesh-list
43920161|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
43920162|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920163|NCT04994717|Blinatumomab|blinatumomab|mesh-list
43920164|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920165|NCT04847440|Tenofovir|tenofovir|mesh-list
43920166|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
43920167|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920168|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44167402|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
44167403|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167404|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167405|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167406|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167407|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
44167408|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167409|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44167410|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44167411|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167412|NCT00268398|Antidotes|antidotes|mesh-ancestor
44167413|NCT00268398|Protective Agents|protective agents|mesh-ancestor
44167414|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
44167415|NCT00268398|Vitamins|vitamins|mesh-ancestor
44167416|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
44167417|NCT00268398|Hematinics|hematinics|mesh-ancestor
44167418|NCT00268411|Gemcitabine|gemcitabine|mesh-list
44167419|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
44167420|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167421|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
44167431|NCT00268489|Pemetrexed|pemetrexed|mesh-list
44167432|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44167433|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167434|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44167435|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44167436|NCT00268489|Growth Substances|growth substances|mesh-ancestor
44167437|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920169|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43920170|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920171|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920172|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43920173|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44139281|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139282|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44139283|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43920174|NCT04792502|Lenalidomide|lenalidomide|mesh-list
43920175|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
43920176|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920177|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920178|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920179|NCT04792502|Growth Substances|growth substances|mesh-ancestor
43920180|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920181|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167438|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
44167439|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167440|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167441|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44167442|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44167443|NCT00268515|Cyclosporine|cyclosporine|mesh-list
44167444|NCT00268515|Prednisone|prednisone|mesh-list
44167445|NCT00268515|Azathioprine|azathioprine|mesh-list
44167446|NCT00268515|Tacrolimus|tacrolimus|mesh-list
44167447|NCT00268515|Cyclosporins|cyclosporins|mesh-list
44167448|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167449|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
44167450|NCT00268515|Hormones|hormones|mesh-ancestor
44167451|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167452|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167453|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44167454|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167455|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167456|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
44167457|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44167458|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167459|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167460|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
44167461|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167462|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167463|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167464|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
44167465|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167466|NCT00268528|Methotrexate|methotrexate|mesh-list
44167467|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
44167468|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44167469|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
44167470|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44167471|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167472|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167473|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
44167474|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167475|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167476|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
43920182|NCT04747236|Gemcitabine|gemcitabine|mesh-list
43920183|NCT04747236|Azacitidine|azacitidine|mesh-list
43920185|NCT04747236|Belinostat|belinostat|mesh-list
43920186|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43920187|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
43765722|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
43920188|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920189|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920190|NCT04747236|Antiviral Agents|antiviral agents|mesh-ancestor
43920191|NCT04747236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920192|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920193|NCT04747236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43920194|NCT04747236|Immunologic Factors|immunologic factors|mesh-ancestor
43920195|NCT04747236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920196|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43920197|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43920198|NCT04655976|Docetaxel|docetaxel|mesh-list
43920199|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920200|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920201|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920202|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
43920203|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920204|NCT04616248|Poly I-C|poly i-c|mesh-list
43920205|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44167477|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167478|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44167479|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167480|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
44167481|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167482|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44167483|NCT00268554|Dipyridamole|dipyridamole|mesh-list
44167484|NCT00268554|Caffeine|caffeine|mesh-list
44167485|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167486|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167487|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44167488|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167489|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167490|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44167491|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44167492|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
44167493|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167494|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44167495|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44167496|NCT00268567|Prednisone|prednisone|mesh-list
44167497|NCT00268567|Leflunomide|leflunomide|mesh-list
44167498|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167499|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
44167500|NCT00268567|Hormones|hormones|mesh-ancestor
44167501|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167502|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167503|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920206|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43920207|NCT04616248|Antibodies|antibodies|mesh-list
43920208|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
43920209|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43920210|NCT04616248|Poly ICLC|poly iclc|mesh-list
43920211|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
43920212|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
43920213|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920214|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920215|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
43920216|NCT04616248|Laxatives|laxatives|mesh-ancestor
43920217|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920218|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
43765728|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43920219|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920220|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43920221|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43920222|NCT04616248|Protective Agents|protective agents|mesh-ancestor
43920223|NCT04521140|Dexamethasone|dexamethasone|mesh-list
43920224|NCT04521140|Prednisolone|prednisolone|mesh-list
43920225|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43920226|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
43920227|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43920228|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
43920229|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43920230|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
43920231|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43920232|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
43920233|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
43920234|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920235|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920236|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167504|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167505|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167506|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167507|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167508|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
44167509|NCT00268593|Prednisone|prednisone|mesh-list
44167510|NCT00268593|Docetaxel|docetaxel|mesh-list
44167511|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167512|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167513|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167514|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167515|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167516|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167518|NCT00268593|Hormones|hormones|mesh-ancestor
44167519|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167520|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920238|NCT04521140|Hormones|hormones|mesh-ancestor
43920239|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920240|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920241|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920242|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43920243|NCT04521140|Protective Agents|protective agents|mesh-ancestor
43920244|NCT04457297|Trifluridine|trifluridine|mesh-list
43920245|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
43920246|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920247|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
43920248|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920249|NCT04410445|Nivolumab|nivolumab|mesh-list
44139284|NCT00174720|Ciclesonide|ciclesonide|mesh-list
43920250|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920251|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920252|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43920253|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920254|NCT04372927|Cisplatin|cisplatin|mesh-list
43920255|NCT04372927|Etoposide|etoposide|mesh-list
43920256|NCT04372927|Pemetrexed|pemetrexed|mesh-list
43920257|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
43920258|NCT04372927|Durvalumab|durvalumab|mesh-list
43920259|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
43920260|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
43920261|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43920262|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
43920263|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920264|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43920282|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920283|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920284|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
43920285|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920286|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43920287|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920288|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920290|NCT04245865|Tocotrienols|tocotrienols|mesh-list
43920291|NCT04245865|Vitamin E|vitamin e|mesh-list
43920292|NCT04245865|Tocopherols|tocopherols|mesh-list
43920293|NCT04245865|Bevacizumab|bevacizumab|mesh-list
43920294|NCT04245865|Fluorouracil|fluorouracil|mesh-list
43920295|NCT04245865|Capecitabine|capecitabine|mesh-list
43920296|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
43920297|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
43920298|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920299|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920300|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920301|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920302|NCT04245865|Growth Substances|growth substances|mesh-ancestor
43920303|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920304|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920305|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
43920308|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43920334|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43920335|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43920336|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43920337|NCT04092673|Trastuzumab|trastuzumab|mesh-list
43920338|NCT04092673|Fulvestrant|fulvestrant|mesh-list
43920339|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920340|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920341|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920342|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43920343|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43920344|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
43920345|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920346|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920347|NCT04054115|Alprostadil|alprostadil|mesh-list
43920348|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43920349|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
43920350|NCT04054115|Urological Agents|urological agents|mesh-ancestor
43920356|NCT03946358|Atezolizumab|atezolizumab|mesh-list
43920357|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920358|NCT03940807|Estradiol|estradiol|mesh-list
43920359|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43920360|NCT03940807|Estrogens|estrogens|mesh-ancestor
43920361|NCT03940807|Hormones|hormones|mesh-ancestor
43920362|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920363|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920364|NCT03807765|Nivolumab|nivolumab|mesh-list
43920365|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920366|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920379|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920380|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43920381|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920383|NCT03620123|Nivolumab|nivolumab|mesh-list
43920384|NCT03620123|Ipilimumab|ipilimumab|mesh-list
43920385|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920386|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920387|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920388|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
43920389|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920390|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920391|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43920392|NCT03572790|Prucalopride|prucalopride|mesh-list
43920393|NCT03572790|Laxatives|laxatives|mesh-ancestor
43920394|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920395|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43920396|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43920397|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
43920398|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920399|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920400|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139285|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
43920401|NCT03495388|Oxycodone|oxycodone|mesh-list
43920402|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43920403|NCT03495388|Narcotics|narcotics|mesh-ancestor
43920404|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920405|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920406|NCT03495388|Analgesics|analgesics|mesh-ancestor
43920407|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
43920408|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920409|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
43920410|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920411|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167521|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44167522|NCT00268619|Ramipril|ramipril|mesh-list
44167523|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44167524|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
44167525|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702529|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920412|NCT03410615|Cisplatin|cisplatin|mesh-list
43920413|NCT03410615|Durvalumab|durvalumab|mesh-list
43920414|NCT03410615|Tremelimumab|tremelimumab|mesh-list
43920415|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920416|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920417|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43920418|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920419|NCT03340675|Ifetroban|ifetroban|mesh-list
43920420|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43920421|NCT03321643|Gemcitabine|gemcitabine|mesh-list
43920422|NCT03321643|Rituximab|rituximab|mesh-list
43920423|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43920424|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
43920425|NCT03321643|Atezolizumab|atezolizumab|mesh-list
43920426|NCT03321643|Antibodies|antibodies|mesh-list
43920427|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
44167526|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167527|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44167528|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
44167529|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44167530|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167531|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167532|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44167533|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167534|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44167535|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
44167536|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167537|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167538|NCT00268671|Docetaxel|docetaxel|mesh-list
44167539|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167540|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167541|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167542|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167543|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167544|NCT00268684|Temozolomide|temozolomide|mesh-list
44167545|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44167546|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44167547|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
44167548|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167549|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167550|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44167551|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167552|NCT00268697|Ezetimibe|ezetimibe|mesh-list
44167553|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44167554|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44167555|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
44167556|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167557|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44167558|NCT00268710|Docetaxel|docetaxel|mesh-list
44167559|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167560|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167570|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167571|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
44167572|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44167573|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44167574|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167575|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167576|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167577|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167578|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167579|NCT00268749|Glycine|glycine|mesh-list
43920429|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
43920430|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920431|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920432|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920433|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43920434|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
43920435|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920436|NCT03321643|Antiviral Agents|antiviral agents|mesh-ancestor
43920437|NCT03321643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920438|NCT03321643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920439|NCT03321643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43920440|NCT03117972|Leucovorin|leucovorin|mesh-list
43920441|NCT03117972|Bevacizumab|bevacizumab|mesh-list
43920442|NCT03117972|Fluorouracil|fluorouracil|mesh-list
43920443|NCT03117972|Capecitabine|capecitabine|mesh-list
43920444|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
43920445|NCT03117972|Irinotecan|irinotecan|mesh-list
43920446|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
43920447|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920448|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920449|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920450|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920451|NCT03117972|Growth Substances|growth substances|mesh-ancestor
43920452|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920453|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920454|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
43920455|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920456|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43795302|NCT04302766|Remdesivir|remdesivir|mesh-list
44167580|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
44167581|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167582|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167583|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167584|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
44167585|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44167587|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
44167588|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44167589|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
44167590|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167591|NCT00268814|Methadone|methadone|mesh-list
44167592|NCT00268814|Heroin|heroin|mesh-list
44167593|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44167594|NCT00268814|Narcotics|narcotics|mesh-ancestor
44167595|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167596|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167597|NCT00268814|Analgesics|analgesics|mesh-ancestor
43920457|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43920458|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
43920459|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43920460|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43920461|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920462|NCT03117972|Antidotes|antidotes|mesh-ancestor
43920463|NCT03117972|Protective Agents|protective agents|mesh-ancestor
43920464|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
43920465|NCT03117972|Vitamins|vitamins|mesh-ancestor
43920466|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
43920467|NCT03095612|Docetaxel|docetaxel|mesh-list
43920468|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920469|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920470|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920471|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
43920472|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920473|NCT02949284|Prednisone|prednisone|mesh-list
43920474|NCT02949284|Cortisone|cortisone|mesh-list
43920475|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
43795315|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44167598|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
44167599|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167600|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
44167601|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167602|NCT00268840|Gemcitabine|gemcitabine|mesh-list
44167603|NCT00268840|Docetaxel|docetaxel|mesh-list
44167604|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44167605|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
44167606|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167607|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167608|NCT00268840|Antiviral Agents|antiviral agents|mesh-ancestor
44167609|NCT00268840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43565469|NCT00901979|Incretins|incretins|mesh-ancestor
44167610|NCT00268840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167611|NCT00268840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167612|NCT00268840|Immunologic Factors|immunologic factors|mesh-ancestor
44167613|NCT00268840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167614|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167615|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167616|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167617|NCT00268879|Renzapride|renzapride|mesh-list
44167618|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44167619|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
44167620|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167621|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167622|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167623|NCT00268918|Docetaxel|docetaxel|mesh-list
44167624|NCT00268918|Vatalanib|vatalanib|mesh-list
44167625|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167626|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167627|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167628|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167635|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167637|NCT00268970|Satraplatin|satraplatin|mesh-list
44167638|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44167639|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167640|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167641|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167642|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702530|NCT02716415|Menthol|menthol|mesh-list
43702531|NCT02716415|Petrolatum|petrolatum|mesh-list
43920477|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43920478|NCT02949284|Androgens|androgens|mesh-list
43920479|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43920480|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43920481|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
43920482|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920483|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920484|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43920485|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920486|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43920487|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920488|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920489|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
43920490|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43920491|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
43920492|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
43920493|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920494|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920495|NCT02685969|Flutemetamol|flutemetamol|mesh-list
43920496|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43920497|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920498|NCT02675452|Itraconazole|itraconazole|mesh-list
43920499|NCT02675452|Azacitidine|azacitidine|mesh-list
43920500|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43920501|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
43920502|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920503|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920504|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920505|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
43920506|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920507|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43920508|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44167643|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167644|NCT00269035|Risperidone|risperidone|mesh-list
44167645|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44167646|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
44167647|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167648|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920509|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43920510|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
43920511|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920512|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920513|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43920514|NCT01855451|Cisplatin|cisplatin|mesh-list
43920515|NCT01855451|Cetuximab|cetuximab|mesh-list
43920516|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920517|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920518|NCT01330446|Modafinil|modafinil|mesh-list
43920519|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43920520|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920521|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43920522|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43920523|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43920524|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920525|NCT01013779|Carboplatin|carboplatin|mesh-list
43920526|NCT01013779|Etoposide|etoposide|mesh-list
43920527|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920528|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43920529|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43920530|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43920531|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920557|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920558|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920559|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43920560|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920561|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43920562|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920563|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920564|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
43920565|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43920566|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
43920567|NCT00115700|Hormones|hormones|mesh-ancestor
43920568|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920569|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44167649|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167650|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44167651|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44167652|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167653|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167654|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44167655|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
44167656|NCT00269061|Pioglitazone|pioglitazone|mesh-list
44167657|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44167658|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167659|NCT00269126|Fluticasone|fluticasone|mesh-list
44167660|NCT00269126|Xhance|xhance|mesh-list
44167661|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44167662|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44167663|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167664|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167665|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
44167666|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167667|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167668|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167669|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
44167670|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167671|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44167672|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44167673|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44167674|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44167675|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44167676|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167677|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167678|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
44167679|NCT00269126|Hormones|hormones|mesh-ancestor
44167680|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167681|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
44167682|NCT00269204|Niacin|niacin|mesh-list
44167683|NCT00269204|Niacinamide|niacinamide|mesh-list
44167684|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
44167685|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44167686|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
44167687|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740246|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
44167688|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44167689|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
44167690|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
44167691|NCT00269204|Vitamins|vitamins|mesh-ancestor
44167692|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
44167693|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167694|NCT00269217|Niacin|niacin|mesh-list
44167695|NCT00269217|Niacinamide|niacinamide|mesh-list
44167696|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
44167697|NCT00269217|Simvastatin|simvastatin|mesh-list
43920570|NCT00557284|Montelukast|montelukast|mesh-list
43920571|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43920572|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
43920573|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43920574|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
43962674|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167698|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44167723|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167724|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
44167725|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167726|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44167727|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
44167728|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167729|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44167730|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44167731|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167733|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44167734|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167735|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44167736|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167737|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167738|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44167739|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44167741|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44167742|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167743|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167744|NCT00269542|Iron|iron|mesh-list
44167745|NCT00269542|Folic Acid|folic acid|mesh-list
44167746|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
44167747|NCT00269542|Trace Elements|trace elements|mesh-ancestor
44167748|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
44167770|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167772|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167773|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
44167774|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44167775|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44167776|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44167777|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44167778|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
44167779|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44167780|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44167781|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
44167782|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167783|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
44167784|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44167785|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44167786|NCT00269594|Lamotrigine|lamotrigine|mesh-list
44167787|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
44167788|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44167789|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167790|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167791|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44167792|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167793|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44167794|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44167795|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167796|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44167797|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44167798|NCT00269607|Naltrexone|naltrexone|mesh-list
44167810|NCT00269620|Ortho Evra|ortho evra|mesh-list
44167811|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
44167812|NCT00269620|Estradiol|estradiol|mesh-list
44167813|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44167814|NCT00269620|Estrogens|estrogens|mesh-ancestor
44167815|NCT00269620|Hormones|hormones|mesh-ancestor
44167816|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920575|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920576|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920577|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43920578|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43920579|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920581|NCT00557349|Famotidine|famotidine|mesh-list
43920582|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43920583|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920584|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43920585|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920586|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920587|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43920588|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
43920589|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
43920590|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920591|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920592|NCT00557362|Voriconazole|voriconazole|mesh-list
43920593|NCT00557362|Natamycin|natamycin|mesh-list
44167817|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167818|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44167819|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44167820|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44167821|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44167822|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44167823|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44167824|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
44167825|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167826|NCT00269685|Vasopressins|vasopressins|mesh-list
44167827|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
44167828|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
44167829|NCT00269685|Coagulants|coagulants|mesh-ancestor
44167830|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44167831|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44167832|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
44167833|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167834|NCT00269724|Oxybutynin|oxybutynin|mesh-list
44167835|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
44167836|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
44167837|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167838|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167839|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44167840|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44167841|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
44167842|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167843|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167844|NCT00269724|Urological Agents|urological agents|mesh-ancestor
44167845|NCT00269737|Fentanyl|fentanyl|mesh-list
44167846|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44167847|NCT00269737|Narcotics|narcotics|mesh-ancestor
44167848|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167849|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167850|NCT00269737|Analgesics|analgesics|mesh-ancestor
44167851|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
44167852|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920594|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
43920595|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920596|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43920597|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43920598|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920599|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920600|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43920601|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
43920602|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43920603|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920604|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43920605|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43920606|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43920607|NCT00558012|Vitamin D|vitamin d|mesh-list
43920608|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
43920609|NCT00558012|Calcium|calcium|mesh-list
43920610|NCT00558012|Vitamins|vitamins|mesh-ancestor
43920611|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
43920612|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920613|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43920614|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43920615|NCT00558571|Empagliflozin|empagliflozin|mesh-list
43920616|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44167853|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44167854|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44167855|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
44167856|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
44167857|NCT00269750|Oxybutynin|oxybutynin|mesh-list
44167858|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
44167859|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
44167860|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167861|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167862|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44167863|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44167864|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
44167865|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167874|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
44167875|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167876|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44167877|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44167878|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
44167879|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
44167880|NCT00269776|Methylphenidate|methylphenidate|mesh-list
44167881|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167882|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167883|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44167884|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167885|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167886|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920620|NCT00559468|Bromides|bromides|mesh-list
43920621|NCT00559468|Propofol|propofol|mesh-list
43920622|NCT00559468|Sevoflurane|sevoflurane|mesh-list
43920623|NCT00559468|Rocuronium|rocuronium|mesh-list
43666896|NCT02529852|Prednisone|prednisone|mesh-list
43920624|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43920625|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920626|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167887|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
44167888|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849269|NCT03945513|Hormones|hormones|mesh-ancestor
44167889|NCT00269789|Methylphenidate|methylphenidate|mesh-list
44167890|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167891|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167892|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44167893|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167894|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167895|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167896|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
44167897|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167898|NCT00269802|Methylphenidate|methylphenidate|mesh-list
44167899|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167900|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167901|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44167902|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167903|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167904|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167905|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
44167906|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167907|NCT00269815|Methylphenidate|methylphenidate|mesh-list
44167908|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44167909|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167910|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44167911|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167912|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167913|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167914|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
44167915|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44167916|NCT00269828|Paclitaxel|paclitaxel|mesh-list
44167917|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44167918|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44167919|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44167920|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167921|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44167922|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167923|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167924|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167936|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44167937|NCT00269854|Infliximab|infliximab|mesh-list
44167938|NCT00269854|Antibodies|antibodies|mesh-list
44167939|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
44167940|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44167941|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
44167942|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167943|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167944|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
43920627|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43920628|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
43920629|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
43920630|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43920631|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43920632|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
43920633|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43920634|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43920635|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43920636|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920637|NCT00560612|Paroxetine|paroxetine|mesh-list
43920638|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43920639|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43920640|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920641|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920642|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920643|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
43920644|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920645|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43920646|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
43920647|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43920648|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43920649|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43920650|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920651|NCT00561002|Vaccines|vaccines|mesh-list
43920652|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
43920653|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920654|NCT00561418|Vorinostat|vorinostat|mesh-list
43920655|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920656|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43920657|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920658|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920659|NCT00561834|Ranibizumab|ranibizumab|mesh-list
43920660|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44167945|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167946|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167947|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44167948|NCT00269867|Infliximab|infliximab|mesh-list
44167949|NCT00269867|Antibodies|antibodies|mesh-list
43920661|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920662|NCT00561834|Growth Substances|growth substances|mesh-ancestor
43920663|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920664|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920665|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920666|NCT00562328|Rituximab|rituximab|mesh-list
43920667|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
43920668|NCT00562328|Sargramostim|sargramostim|mesh-list
43920669|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920670|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920671|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
43920672|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920673|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43920674|NCT00563290|Dasatinib|dasatinib|mesh-list
43920675|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920676|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43920677|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920678|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920679|NCT05560620|Caffeine|caffeine|mesh-list
43920680|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43920681|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920682|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43920683|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920684|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920685|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43920686|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43920708|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920709|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43920710|NCT05560373|Protective Agents|protective agents|mesh-ancestor
44139287|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139288|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139289|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44139290|NCT00174733|Ciclesonide|ciclesonide|mesh-list
44139291|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
44139292|NCT00174733|Hormones|hormones|mesh-ancestor
44139293|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139294|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139295|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44139296|NCT00174759|Clopidogrel|clopidogrel|mesh-list
44139297|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44139298|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44139299|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44139300|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44139301|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
44139302|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139303|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139336|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139337|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139338|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139339|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
44139340|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
44139341|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139342|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920711|NCT05560165|Listerine|listerine|mesh-list
43920712|NCT05560165|Anesthetics|anesthetics|mesh-list
43920713|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
43920714|NCT05560165|Fluorides|fluorides|mesh-list
43920715|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
43920716|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
43920717|NCT05560165|Protective Agents|protective agents|mesh-ancestor
43920718|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920719|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920720|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
43920721|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920722|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43920723|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920724|NCT05560035|Lidocaine|lidocaine|mesh-list
43920725|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
43920726|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
43920727|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920728|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920729|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
43920730|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167950|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
44167951|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44167952|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
44167953|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167954|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167955|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167956|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167957|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44167958|NCT00269880|Heparin|heparin|mesh-list
44167959|NCT00269880|Abciximab|abciximab|mesh-list
44167960|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
44167961|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44167962|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44167963|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167964|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44167965|NCT00269893|Abciximab|abciximab|mesh-list
44167966|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
44167967|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44167968|NCT00269906|Abciximab|abciximab|mesh-list
44167969|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
44167970|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44167971|NCT00269932|Levofloxacin|levofloxacin|mesh-list
44167972|NCT00269932|Ofloxacin|ofloxacin|mesh-list
43920731|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43920732|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43920733|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43920734|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920735|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920737|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43920738|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
43920739|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920740|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
43920741|NCT05559996|Protective Agents|protective agents|mesh-ancestor
43920742|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43920743|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
43920744|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920745|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43920746|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43920747|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
43920748|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920749|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920750|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43920751|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
43920752|NCT05559619|Vitamin D|vitamin d|mesh-list
43920753|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
43920754|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
44167973|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44167974|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167975|NCT00269932|Renal Agents|renal agents|mesh-ancestor
44167976|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44167977|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44167978|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44167979|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167980|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167981|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167982|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44167983|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44167984|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
44167985|NCT00269945|Hematinics|hematinics|mesh-ancestor
44167986|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
44167987|NCT00269958|Hematinics|hematinics|mesh-ancestor
44167988|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
44167989|NCT00269971|Hematinics|hematinics|mesh-ancestor
44167990|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
44167991|NCT00269984|Hematinics|hematinics|mesh-ancestor
43849275|NCT03944434|Leuprolide|leuprolide|mesh-list
44167992|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
44167993|NCT00269997|Hematinics|hematinics|mesh-ancestor
44167994|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
44168055|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168056|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168057|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44168058|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43920755|NCT05559619|Calcium|calcium|mesh-list
43920756|NCT05559619|Vitamins|vitamins|mesh-ancestor
43920757|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
43920758|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920759|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43920760|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43920761|NCT05559619|Antacids|antacids|mesh-ancestor
43920762|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920763|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43920764|NCT05559450|Blinatumomab|blinatumomab|mesh-list
43920765|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920766|NCT05559398|Glenzocimab|glenzocimab|mesh-list
43920767|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
43920768|NCT05559268|Denosumab|denosumab|mesh-list
43920769|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43920770|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920771|NCT05559112|Vitamin D|vitamin d|mesh-list
43920772|NCT05559112|Vitamins|vitamins|mesh-ancestor
43920773|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
43920774|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920775|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43920776|NCT05558878|Ambroxol|ambroxol|mesh-list
43920777|NCT05558878|Expectorants|expectorants|mesh-ancestor
43920778|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
43920779|NCT05555901|Bevacizumab|bevacizumab|mesh-list
43920780|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43920781|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920782|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43920783|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43920784|NCT05555901|Growth Substances|growth substances|mesh-ancestor
43920785|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920786|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
43920787|NCT05543642|Vaccines|vaccines|mesh-list
43920788|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
43920789|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920791|NCT05533580|Dsuvia|dsuvia|mesh-list
43920792|NCT05533580|Propofol|propofol|mesh-list
43920797|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920798|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43920799|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
43920801|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43920802|NCT05533580|Narcotics|narcotics|mesh-ancestor
43920803|NCT05533580|Analgesics|analgesics|mesh-ancestor
43920804|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
43920805|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920806|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43920807|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43920808|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43920809|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43920810|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43920811|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43920812|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
43920813|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962675|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168059|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168060|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168061|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44168062|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168063|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168064|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44168065|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168066|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168067|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44168068|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168069|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168071|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44168072|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
44168073|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168074|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168075|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168076|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
44168077|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
44168078|NCT00270478|Hematinics|hematinics|mesh-ancestor
44168079|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168080|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
44168081|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168098|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
44168099|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44168100|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
44168101|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44168102|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44168103|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168104|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44168105|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168106|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168107|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44168108|NCT00270530|Renal Agents|renal agents|mesh-ancestor
44168109|NCT00270543|Leucovorin|leucovorin|mesh-list
44168110|NCT00270543|Fluorouracil|fluorouracil|mesh-list
44168111|NCT00270543|Docetaxel|docetaxel|mesh-list
44168112|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
44168113|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920814|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920815|NCT05533567|Sufentanil|sufentanil|mesh-list
43920816|NCT05533567|Dsuvia|dsuvia|mesh-list
43920817|NCT05533567|Propofol|propofol|mesh-list
43920818|NCT05533567|Cisatracurium|cisatracurium|mesh-list
43920819|NCT05533567|Atracurium|atracurium|mesh-list
43920820|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43920821|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920822|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920823|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43920824|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
43920825|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
43920826|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43920827|NCT05533567|Narcotics|narcotics|mesh-ancestor
43920828|NCT05533567|Analgesics|analgesics|mesh-ancestor
43920829|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
44168114|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168115|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168116|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168117|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
44168118|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168119|NCT00270543|Antidotes|antidotes|mesh-ancestor
44168120|NCT00270543|Protective Agents|protective agents|mesh-ancestor
44168121|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
44168122|NCT00270543|Vitamins|vitamins|mesh-ancestor
44168123|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
44168124|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168125|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168126|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168127|NCT00270556|Tenofovir|tenofovir|mesh-list
44168128|NCT00270556|Abacavir|abacavir|mesh-list
44168129|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
44168130|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168131|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44168132|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44168133|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168134|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168135|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44168136|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44168137|NCT00270569|Cisplatin|cisplatin|mesh-list
44168138|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168139|NCT00270582|Gemcitabine|gemcitabine|mesh-list
44168140|NCT00270582|Cisplatin|cisplatin|mesh-list
44168141|NCT00270582|Docetaxel|docetaxel|mesh-list
44168142|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168166|NCT00270751|Minocycline|minocycline|mesh-list
44168167|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44168168|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168169|NCT00270777|Promethazine|promethazine|mesh-list
44168170|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
44168171|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
44168172|NCT00270777|Epinephrine|epinephrine|mesh-list
44168173|NCT00270777|Racepinephrine|racepinephrine|mesh-list
44168174|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
44168175|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168176|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44168177|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44168178|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168179|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168180|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168181|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168182|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44168183|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168184|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
44168185|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920831|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43920832|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43920833|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43920834|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43920835|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43920836|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43920837|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
43920838|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920839|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920840|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
43920841|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43920842|NCT05503979|Velpatasvir|velpatasvir|mesh-list
43920843|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
43920844|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920845|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43920846|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43920847|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44168186|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168187|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168188|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
44168189|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
44168190|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44168191|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
44168192|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44168193|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44168194|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
44168195|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
44168196|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44168197|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44168228|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44168229|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168230|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
44168231|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168232|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168233|NCT00270907|Antiviral Agents|antiviral agents|mesh-ancestor
44168234|NCT00270907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168235|NCT00270907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168236|NCT00270907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168237|NCT00270907|Immunologic Factors|immunologic factors|mesh-ancestor
44168238|NCT00270907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168239|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44168240|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
44168241|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168242|NCT00271063|Annamycin|annamycin|mesh-list
44168243|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44168244|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168245|NCT00271206|Progesterone|progesterone|mesh-list
44168266|NCT00271271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168267|NCT00271271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168268|NCT00271271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168269|NCT00271271|Immunologic Factors|immunologic factors|mesh-ancestor
44168270|NCT00271271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168271|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44168272|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168273|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920848|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920849|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920850|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
43920851|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920852|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920853|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43920854|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920856|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43920857|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
43920858|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43920859|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920860|NCT05418777|Renal Agents|renal agents|mesh-ancestor
43920861|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
43920862|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43920863|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43920864|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43920865|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920871|NCT05415397|Celecoxib|celecoxib|mesh-list
44139360|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44139361|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44139362|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139363|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44139364|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139365|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139366|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
44139367|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44139368|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44139369|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44139370|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139371|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44139372|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44139373|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139374|NCT00174928|Lansoprazole|lansoprazole|mesh-list
44139375|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
44168274|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168275|NCT00271284|Insulin|insulin|mesh-list
44168276|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43849294|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44168277|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
44168278|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
44168279|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
43608663|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44168280|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44168281|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168282|NCT00271323|Cisplatin|cisplatin|mesh-list
44168283|NCT00271323|Docetaxel|docetaxel|mesh-list
44168284|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168285|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168286|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168287|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168288|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608741|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
44168289|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
44168290|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44168291|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168292|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168293|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44168294|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44168295|NCT00271336|Protective Agents|protective agents|mesh-ancestor
44168296|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168297|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168298|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44168299|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
44168322|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
44168323|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168324|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44168325|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44168326|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
44168327|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
44168328|NCT00271427|Selenium|selenium|mesh-list
44168329|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
44168330|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168331|NCT00271427|Protective Agents|protective agents|mesh-ancestor
44168332|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168333|NCT00271427|Trace Elements|trace elements|mesh-ancestor
44139376|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44139377|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139378|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44139379|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139380|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139382|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44139383|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139384|NCT00175032|Aspirin|aspirin|mesh-list
44139385|NCT00175032|Celecoxib|celecoxib|mesh-list
44139386|NCT00175032|Naproxen|naproxen|mesh-list
44139387|NCT00175032|Lansoprazole|lansoprazole|mesh-list
44139388|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
44139389|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139390|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44168334|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
44168335|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
44168336|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44168337|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168338|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
44168339|NCT00271453|Fentanyl|fentanyl|mesh-list
44168340|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44168341|NCT00271453|Narcotics|narcotics|mesh-ancestor
44168342|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168343|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168344|NCT00271453|Analgesics|analgesics|mesh-ancestor
44168345|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
44168346|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168347|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44168348|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44168349|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
44168350|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
44168351|NCT00271466|Fentanyl|fentanyl|mesh-list
44168352|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44168353|NCT00271466|Narcotics|narcotics|mesh-ancestor
44168388|NCT00271635|Protective Agents|protective agents|mesh-ancestor
44168389|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
44168391|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
44168392|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
44168393|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
44168394|NCT00271713|Vitamins|vitamins|mesh-list
44168395|NCT00271713|Calcium|calcium|mesh-list
44168396|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
44168397|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168398|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44168399|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44168400|NCT00271791|Prednisone|prednisone|mesh-list
44168401|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168402|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
44168403|NCT00271791|Hormones|hormones|mesh-ancestor
44168404|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168405|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168406|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44168407|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168408|NCT00271804|Bortezomib|bortezomib|mesh-list
44168409|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168410|NCT00271973|Oxycodone|oxycodone|mesh-list
44168411|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44168412|NCT00271973|Narcotics|narcotics|mesh-ancestor
44168413|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168414|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168415|NCT00271973|Analgesics|analgesics|mesh-ancestor
44168416|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
43702532|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
44139391|NCT00175032|Analgesics|analgesics|mesh-ancestor
44139392|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
44139393|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139394|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139395|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139396|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139397|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43920886|NCT05395910|Paclitaxel|paclitaxel|mesh-list
43920887|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43920888|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920889|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920890|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920891|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168417|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168418|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
44168419|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44168420|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168421|NCT00272025|Citalopram|citalopram|mesh-list
44168422|NCT00272025|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44168423|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44168424|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168425|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168426|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168427|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
44168428|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168429|NCT00272025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44168430|NCT00272025|Antidepressive Agents|antidepressive agents|mesh-ancestor
44168431|NCT00272025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44168432|NCT00272051|Xaliproden|xaliproden|mesh-list
44168433|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44168434|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44168435|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
44168436|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168437|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168438|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168439|NCT00272064|Insulin|insulin|mesh-list
43608818|NCT03193944|Vitamin D|vitamin d|mesh-list
44168440|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44168441|NCT00272064|Metformin|metformin|mesh-list
44168442|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
44168447|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44168448|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168449|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
44168450|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44168451|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168452|NCT00272116|Vitamins|vitamins|mesh-list
44168453|NCT00272116|Vitamin A|vitamin a|mesh-list
44168454|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
44168455|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
44168456|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168457|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
44168458|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168459|NCT00272116|Protective Agents|protective agents|mesh-ancestor
44168460|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44168461|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168462|NCT00272207|Nabilone|nabilone|mesh-list
44168463|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
44168464|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
44168465|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168466|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168467|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168468|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44168469|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43920893|NCT05389046|Dexetimide|dexetimide|mesh-list
43920894|NCT05389046|Aripiprazole|aripiprazole|mesh-list
43920895|NCT05389046|Citalopram|citalopram|mesh-list
43920896|NCT05389046|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43920897|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43920898|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920899|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920900|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43920901|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
43920902|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920903|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43920904|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
43920905|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43920906|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43920907|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43920908|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
43920909|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
43920910|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920911|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43920912|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43920913|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
43920914|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43920915|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43920916|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920917|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
43920918|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
43920919|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43920920|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44168470|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168471|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44168472|NCT00272285|Granisetron|granisetron|mesh-list
44168473|NCT00272285|Ramosetron|ramosetron|mesh-list
44168474|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
44168475|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
44168476|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168477|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168478|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168479|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44168480|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
44168481|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168482|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168483|NCT00272324|Aspirin|aspirin|mesh-list
43920923|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43920924|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43920927|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
43920928|NCT05227716|Analgesics|analgesics|mesh-ancestor
43920929|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
43920930|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43920931|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920932|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
43920933|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43920934|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43920935|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
43920936|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43920937|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43920938|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920939|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43920940|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
43920941|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44168484|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44168485|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44168486|NCT00272324|Analgesics|analgesics|mesh-ancestor
44168487|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
44168488|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168489|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168490|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168491|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168492|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44168493|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44168494|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168495|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44168496|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44168497|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168498|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
44168499|NCT00272415|Temozolomide|temozolomide|mesh-list
44168500|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44168501|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
44168502|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168503|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168504|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
44168505|NCT00272428|Vitamin E|vitamin e|mesh-list
44168506|NCT00272428|Beta Carotene|beta carotene|mesh-list
44168507|NCT00272428|Selenium|selenium|mesh-list
44168508|NCT00272428|Carotenoids|carotenoids|mesh-list
44168509|NCT00272428|Vitamins|vitamins|mesh-ancestor
44168510|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
44168511|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608895|NCT03194009|Metformin|metformin|mesh-list
44168512|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
44168513|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168514|NCT00272428|Protective Agents|protective agents|mesh-ancestor
43920942|NCT05214222|Paclitaxel|paclitaxel|mesh-list
43920943|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43920944|NCT05214222|Cisplatin|cisplatin|mesh-list
43920945|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43920946|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920947|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
43920948|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
43920949|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
43920950|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920951|NCT05209074|Ivosidenib|ivosidenib|mesh-list
43920952|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920953|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43920954|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920956|NCT05193994|Abacavir|abacavir|mesh-list
43920957|NCT05193994|Dolutegravir|dolutegravir|mesh-list
43920958|NCT05193994|Triumeq|triumeq|mesh-list
43920959|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43920960|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43795649|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
44168515|NCT00272428|Trace Elements|trace elements|mesh-ancestor
44168530|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44168531|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44168532|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168533|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
44168534|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168535|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
44168536|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168537|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168538|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168539|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44168540|NCT00272454|Protective Agents|protective agents|mesh-ancestor
44168541|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44168542|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44168543|NCT00272467|Omeprazole|omeprazole|mesh-list
44168544|NCT00272467|Rebamipide|rebamipide|mesh-list
44168545|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44168546|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168547|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44168548|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168549|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168550|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
44168551|NCT00272467|Protective Agents|protective agents|mesh-ancestor
44168552|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168553|NCT00272480|Lamivudine|lamivudine|mesh-list
44168554|NCT00272480|Zidovudine|zidovudine|mesh-list
44168555|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44168556|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44168557|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168558|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168559|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
44168560|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168561|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44168562|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44168563|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
44168564|NCT00272493|Vaccines|vaccines|mesh-list
44168565|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
44168566|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168567|NCT00272558|Carboplatin|carboplatin|mesh-list
44168568|NCT00272558|Vinorelbine|vinorelbine|mesh-list
43920967|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43920968|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43920969|NCT05174650|Atezolizumab|atezolizumab|mesh-list
43920970|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920971|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43920972|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
43920974|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
43920975|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43920976|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
43920977|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43920978|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
43920979|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43920980|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43920981|NCT05150587|Rifaximin|rifaximin|mesh-list
43920982|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43920983|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920984|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168569|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168570|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44168571|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168572|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168573|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168574|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168575|NCT00272584|Risperidone|risperidone|mesh-list
44168576|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44168577|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
44168586|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
44168587|NCT00272597|Risperidone|risperidone|mesh-list
44168588|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44168589|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
44168590|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168591|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168592|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168593|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44168594|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43920993|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43920994|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43920995|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43920996|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
43920997|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
43920998|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43920999|NCT05041946|Methylphenidate|methylphenidate|mesh-list
43921000|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43921001|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921002|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43921003|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43921004|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921005|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921006|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
43841620|NCT04602221|BI 425809|bi 425809|mesh-list
44168595|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168596|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44168597|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44168598|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
44168599|NCT00272610|Vitamin A|vitamin a|mesh-list
44168600|NCT00272610|Vitamins|vitamins|mesh-ancestor
44168601|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
44168602|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168603|NCT00272636|Amiodarone|amiodarone|mesh-list
44168604|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44168605|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168606|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44168607|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168608|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168609|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44168610|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44168611|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44168612|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168613|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44168614|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44168615|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44168616|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
44168617|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44168618|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44168619|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168620|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
44168621|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44168622|NCT00272688|Levodopa|levodopa|mesh-list
44168623|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44168624|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44168625|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
44168626|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168627|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168628|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168629|NCT00272701|Esomeprazole|esomeprazole|mesh-list
44168630|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44168631|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168632|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44168633|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168634|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921007|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921009|NCT05028075|Trace Elements|trace elements|mesh-ancestor
43921010|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
43921011|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921012|NCT05014438|Branebrutinib|branebrutinib|mesh-list
43921013|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43921014|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921015|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921016|NCT05004896|Midazolam|midazolam|mesh-list
43921017|NCT05004896|Ketamine|ketamine|mesh-list
43921018|NCT05004896|Analgesics|analgesics|mesh-ancestor
43921019|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
43921020|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921021|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921022|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43921023|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43921024|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
43921025|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
43921026|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921027|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44168635|NCT00272714|Afimoxifene|afimoxifene|mesh-list
44168636|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168637|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44168638|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
44168639|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168640|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168641|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44168642|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44168643|NCT00272740|Fulvestrant|fulvestrant|mesh-list
44168644|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44168645|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168646|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44168647|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44168648|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
44168649|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168650|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168652|NCT00272753|Albuterol|albuterol|mesh-list
44168653|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
44168654|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168655|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168656|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
43566006|NCT00840879|Analgesics|analgesics|mesh-ancestor
44168657|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168658|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168659|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168660|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168661|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
44168662|NCT00272753|Hormones|hormones|mesh-ancestor
44168663|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168664|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44168665|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44168666|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43609021|NCT03192618|Calcium|calcium|mesh-list
43921028|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43921029|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921030|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921031|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43921032|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43921033|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43921034|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43921035|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43921038|NCT04961359|Vaccines|vaccines|mesh-list
43921039|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
43921040|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921041|NCT04934800|Cladribine|cladribine|mesh-list
43921042|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921043|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921044|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
43921045|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921046|NCT04926285|Venetoclax|venetoclax|mesh-list
43921047|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
43921048|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921049|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43921050|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43921051|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921052|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139398|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43841642|NCT04600336|Oxybutynin|oxybutynin|mesh-list
44139422|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139423|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139424|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
44139425|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139426|NCT00175227|Furosemide|furosemide|mesh-list
44139427|NCT00175227|Mannitol|mannitol|mesh-list
44139428|NCT00175227|Diuretics|diuretics|mesh-ancestor
44139429|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
44139430|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139431|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44139432|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139433|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139434|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44139435|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
44139436|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44139437|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139438|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
43921076|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43921077|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921078|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921079|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43921080|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
43921081|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
43921082|NCT04895709|Nivolumab|nivolumab|mesh-list
43921083|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921084|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921085|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921086|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921087|NCT04827056|Ethanol|ethanol|mesh-list
43921088|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
43921089|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43921090|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921091|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921092|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43921093|NCT04827056|Analgesics|analgesics|mesh-ancestor
43921094|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
43651815|NCT03005015|Lenvatinib|lenvatinib|mesh-list
43921095|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921096|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43921097|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43921098|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43921099|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
43921100|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921101|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921102|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43921103|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168667|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168668|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168669|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168670|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
44168671|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44168672|NCT00272805|Carvedilol|carvedilol|mesh-list
44168673|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44168674|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44168675|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168676|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168677|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168678|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168679|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168680|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
43921104|NCT04777071|Edetic Acid|edetic acid|mesh-list
43921105|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43921106|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
43921107|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
43921108|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921109|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
43921110|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43921111|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43921112|NCT04742751|Metformin|metformin|mesh-list
43921113|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921114|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921115|NCT04741204|Metformin|metformin|mesh-list
43921116|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921117|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921118|NCT04738643|Varenicline|varenicline|mesh-list
43921119|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43921120|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43921121|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921122|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921123|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795752|NCT00794846|Cetirizine|cetirizine|mesh-list
44168681|NCT00272805|Protective Agents|protective agents|mesh-ancestor
44168682|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44168683|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168684|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44168685|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168686|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44168687|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44168688|NCT00272831|Cilostazol|cilostazol|mesh-list
44168689|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168690|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
44168691|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168692|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168693|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168694|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168695|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44168696|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44168697|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168698|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44168699|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168700|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44168701|NCT00272831|Protective Agents|protective agents|mesh-ancestor
44168702|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44168703|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44168704|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168705|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44168706|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168707|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168708|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765971|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44168709|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
44168710|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168711|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168712|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44168713|NCT00272896|Protective Agents|protective agents|mesh-ancestor
43921126|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921127|NCT04699240|Clotrimazole|clotrimazole|mesh-list
43921128|NCT04699240|Miconazole|miconazole|mesh-list
43921129|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43921130|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921131|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
43921132|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43921133|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43921134|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921135|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168741|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44168742|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168743|NCT00273026|Fluticasone|fluticasone|mesh-list
44168744|NCT00273026|Xhance|xhance|mesh-list
44168745|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44168746|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168747|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168748|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
44168749|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168750|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168751|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168752|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168753|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44168754|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44168755|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44168756|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44168757|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44168778|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168779|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168781|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
44168782|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
44168783|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168784|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
44168785|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168786|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
44168787|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168788|NCT00273299|Valsartan|valsartan|mesh-list
44168789|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44168790|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168791|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44168792|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44168793|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168794|NCT00273299|Diuretics|diuretics|mesh-ancestor
44168795|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168796|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168797|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44168798|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168799|NCT00273312|Epothilone B|epothilone b|mesh-list
44168800|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168801|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168802|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168803|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168804|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168806|NCT00273338|Docetaxel|docetaxel|mesh-list
44168807|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168808|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168809|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168846|NCT00273429|Maleic acid|maleic acid|mesh-list
44168847|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44168858|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44168860|NCT00273442|Dorzolamide|dorzolamide|mesh-list
44168861|NCT00273442|Maleic acid|maleic acid|mesh-list
43921136|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43921137|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
43921138|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921139|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921140|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43921141|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43921142|NCT04479813|Moxonidine|moxonidine|mesh-list
43921143|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43921144|NCT04478500|Minocycline|minocycline|mesh-list
43921145|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43921146|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921147|NCT04474899|Amlodipine|amlodipine|mesh-list
43921148|NCT04474899|Moxonidine|moxonidine|mesh-list
43921149|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43921150|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43921151|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921152|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921153|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43921154|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921155|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
43921156|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
43921157|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921158|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921159|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43921160|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43921161|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43921162|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921163|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921164|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921165|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921166|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
43921167|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43921168|NCT04239599|Leuprolide|leuprolide|mesh-list
43921169|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44168862|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44168863|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43921170|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
43921171|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43921172|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921173|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43921174|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921175|NCT04176835|Oxytocin|oxytocin|mesh-list
43921176|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
43921177|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43921178|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921179|NCT04166331|Dobutamine|dobutamine|mesh-list
43921180|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43921181|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
43921182|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
43921183|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921184|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921185|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43921186|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43921187|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43921188|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
43921189|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921190|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921191|NCT04166331|Protective Agents|protective agents|mesh-ancestor
43921192|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43921193|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43921194|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921195|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921196|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43921197|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921216|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921217|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43921218|NCT03990623|Liver Extracts|liver extracts|mesh-list
43921219|NCT03990623|Hematinics|hematinics|mesh-ancestor
43921220|NCT03988387|Tenofovir|tenofovir|mesh-list
43921221|NCT03988387|Emtricitabine|emtricitabine|mesh-list
43921222|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
43921223|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921224|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43921225|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43921226|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921227|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921228|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43921229|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43921230|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
43921231|NCT03925025|Nimodipine|nimodipine|mesh-list
43921232|NCT03925025|Analgesics|analgesics|mesh-ancestor
43921233|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
43921234|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921235|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921236|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
43921237|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921238|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43921239|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
43921240|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43921241|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921242|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921243|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43921244|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
43921245|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43921246|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43795840|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
44168864|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168865|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168866|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168867|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168868|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44168869|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168870|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168871|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44168872|NCT00273455|Timolol|timolol|mesh-list
44168873|NCT00273455|Bimatoprost|bimatoprost|mesh-list
44168874|NCT00273455|Dorzolamide|dorzolamide|mesh-list
43921248|NCT03912909|Empagliflozin|empagliflozin|mesh-list
43921249|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43921250|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921251|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921252|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139459|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139460|NCT00175370|Vancomycin|vancomycin|mesh-list
44139461|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44139462|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139463|NCT00175383|Hormones|hormones|mesh-list
44139464|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44139465|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139466|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139467|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
44139468|NCT00175396|Leuprolide|leuprolide|mesh-list
44168875|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44168876|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44168877|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168878|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168879|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168880|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168881|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44168882|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168883|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168884|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44168885|NCT00273468|Granisetron|granisetron|mesh-list
44168886|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
44168887|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
44168888|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168889|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168890|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168891|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44168892|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
44168893|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168894|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168895|NCT00273481|Timolol|timolol|mesh-list
44168896|NCT00273481|Dorzolamide|dorzolamide|mesh-list
44168897|NCT00273481|Latanoprost|latanoprost|mesh-list
44168898|NCT00273481|Maleic acid|maleic acid|mesh-list
44168899|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44168900|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44168901|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168902|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168903|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168904|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168905|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44168906|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168907|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168908|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44168909|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44168910|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44168911|NCT00273507|Paclitaxel|paclitaxel|mesh-list
44168931|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168932|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168933|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168934|NCT00273559|Prednisone|prednisone|mesh-list
44168935|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139469|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
44139471|NCT00175396|Bicalutamide|bicalutamide|mesh-list
44139472|NCT00175396|Nilutamide|nilutamide|mesh-list
44139473|NCT00175396|Buserelin|buserelin|mesh-list
44139474|NCT00175396|Androgens|androgens|mesh-list
44139475|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44139476|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44139477|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
44139478|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44139479|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139480|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44139481|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139482|NCT00175396|Hormones|hormones|mesh-ancestor
43921253|NCT03842839|Albuterol|albuterol|mesh-list
43921254|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
43921255|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43921256|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
43962676|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44168936|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
44168937|NCT00273559|Hormones|hormones|mesh-ancestor
44168938|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168939|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168940|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44168941|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168942|NCT00273611|Vitamin D|vitamin d|mesh-list
44168943|NCT00273611|Vitamins|vitamins|mesh-ancestor
44168944|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
44168945|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168946|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44168947|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44168948|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44168949|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168950|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
43609329|NCT03189836|Rituximab|rituximab|mesh-list
44168951|NCT00273689|Albuterol|albuterol|mesh-list
44168952|NCT00273689|Montelukast|montelukast|mesh-list
44168953|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168954|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168955|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44168956|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
44168957|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168958|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168959|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44168960|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44168961|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168962|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168963|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
44168964|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168965|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
44168992|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168994|NCT00273767|Hematinics|hematinics|mesh-ancestor
44168995|NCT00273871|Cyclosporine|cyclosporine|mesh-list
44168996|NCT00273871|Tacrolimus|tacrolimus|mesh-list
44168997|NCT00273871|Cyclosporins|cyclosporins|mesh-list
44168998|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168999|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
44169000|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169001|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44169002|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169003|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921257|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921258|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921259|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43921260|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
43921261|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
43921262|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43921263|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921264|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921265|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921266|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
43921267|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43921268|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43921269|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43921270|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43921271|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
43921318|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921319|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43921320|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921321|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921322|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
43921323|NCT03519412|Temozolomide|temozolomide|mesh-list
43921324|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921325|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921326|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43921327|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
44157386|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667572|NCT04971356|Aspirin|aspirin|mesh-list
43921328|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921329|NCT03440879|Goserelin|goserelin|mesh-list
43921330|NCT03440879|Androgens|androgens|mesh-list
43921331|NCT03440879|Hormones|hormones|mesh-ancestor
43921332|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921333|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795910|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44169004|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
44169005|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169006|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
44169007|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169008|NCT00273884|Cytarabine|cytarabine|mesh-list
44169009|NCT00273884|Amonafide|amonafide|mesh-list
44169010|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169011|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
44169012|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169027|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169028|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169029|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169030|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
44169031|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44169032|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44169033|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44169034|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44169035|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
44169036|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169037|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169038|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169039|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169040|NCT00273975|Lamivudine|lamivudine|mesh-list
44169041|NCT00273975|Zidovudine|zidovudine|mesh-list
44169042|NCT00273975|Nevirapine|nevirapine|mesh-list
44169043|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44169044|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44169045|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169046|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169047|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
43921334|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43921335|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921336|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
43921337|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921338|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921339|NCT03416244|Nivolumab|nivolumab|mesh-list
43921340|NCT03416244|Ipilimumab|ipilimumab|mesh-list
43921341|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921342|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921343|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921344|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921345|NCT03393884|Paclitaxel|paclitaxel|mesh-list
43921346|NCT03393884|Carboplatin|carboplatin|mesh-list
43921347|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43921348|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921349|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921350|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921351|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921352|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921353|NCT03390933|Fluoxetine|fluoxetine|mesh-list
43921354|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43921355|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43921356|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921357|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921358|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921359|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
44169048|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169049|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44169050|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44169051|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
44169052|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44169053|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44169054|NCT00273988|Nevirapine|nevirapine|mesh-list
44169055|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44169056|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44169057|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169058|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169059|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
44169060|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169061|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44169062|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44169063|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44169064|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44169065|NCT00274001|Nevirapine|nevirapine|mesh-list
44169066|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44169067|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43921360|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921361|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43921362|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
43921363|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43921364|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43921365|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43921366|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921367|NCT03389477|Cisplatin|cisplatin|mesh-list
43921368|NCT03389477|Cetuximab|cetuximab|mesh-list
43921369|NCT03389477|Palbociclib|palbociclib|mesh-list
43921370|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921371|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921372|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43921373|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921374|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921375|NCT03385304|Iodine|iodine|mesh-list
43921376|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
43921377|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43921378|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
43921379|NCT03385304|Povidone|povidone|mesh-list
43921380|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43921381|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921382|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
43921383|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921384|NCT03385304|Trace Elements|trace elements|mesh-ancestor
43921385|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
43921386|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921387|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
43921388|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
43921389|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
43921390|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921391|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921392|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43921393|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
43921394|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921395|NCT03243890|Vitamin D|vitamin d|mesh-list
43921396|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
43921397|NCT03243890|Vitamin K|vitamin k|mesh-list
43921398|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
43921399|NCT03243890|Vitamins|vitamins|mesh-ancestor
43921400|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
43921401|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921402|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43921403|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43921405|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921406|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
43921407|NCT03243890|Coagulants|coagulants|mesh-ancestor
43921408|NCT03236792|Dexamethasone|dexamethasone|mesh-list
43921409|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
43921410|NCT03236792|Ixazomib|ixazomib|mesh-list
43921411|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921412|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
43921413|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169068|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169069|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169070|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
44169071|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169072|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44169073|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44169082|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169083|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
44169084|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169085|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169086|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169087|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169088|NCT00274027|Bromides|bromides|mesh-list
44169089|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
44169090|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169091|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
44169092|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169093|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169094|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169095|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169096|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
44169097|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169098|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169099|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169100|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169101|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
44169102|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
44169103|NCT00274040|Ipratropium|ipratropium|mesh-list
44169104|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169105|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
44169106|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169107|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169108|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169109|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169110|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
44169111|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169112|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169113|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169114|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169115|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
44169116|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169117|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
44169118|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169119|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169120|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169121|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169122|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
44169123|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43921414|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921415|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43921416|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
43921417|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921418|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921419|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43921420|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921421|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
43921422|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
43921423|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921424|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921425|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
43921426|NCT03236792|Hormones|hormones|mesh-ancestor
43921427|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921428|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43921429|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
43921430|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921431|NCT03232138|Sulforaphane|sulforaphane|mesh-list
43921432|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43921433|NCT03232138|Protective Agents|protective agents|mesh-ancestor
43921434|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921435|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921436|NCT03214562|Cytarabine|cytarabine|mesh-list
43921437|NCT03214562|Fludarabine|fludarabine|mesh-list
43921438|NCT03214562|Venetoclax|venetoclax|mesh-list
43921439|NCT03214562|Idarubicin|idarubicin|mesh-list
43921440|NCT03214562|Lenograstim|lenograstim|mesh-list
43921441|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921442|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921443|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
43921444|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921445|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921446|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
43921447|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921455|NCT03174405|Avelumab|avelumab|mesh-list
43921456|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921457|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921458|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
43921459|NCT03172416|Nivolumab|nivolumab|mesh-list
43921460|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921461|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921462|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921463|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921464|NCT03143270|Nivolumab|nivolumab|mesh-list
43921465|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921466|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921467|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921468|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921469|NCT03121677|Poly I-C|poly i-c|mesh-list
43921470|NCT03121677|Rituximab|rituximab|mesh-list
43921471|NCT03121677|Nivolumab|nivolumab|mesh-list
43921472|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43921473|NCT03121677|Poly ICLC|poly iclc|mesh-list
43921474|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43921475|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921476|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
43921477|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921478|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921479|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43921480|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921481|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
43921482|NCT03121677|Laxatives|laxatives|mesh-ancestor
43921483|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921484|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
43921485|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169124|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169125|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169126|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169127|NCT00274066|Fenoterol|fenoterol|mesh-list
44169128|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
44169129|NCT00274066|Ipratropium|ipratropium|mesh-list
44169130|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169131|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
44169132|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169133|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169134|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169135|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169136|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
43921496|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
43921497|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921498|NCT02799602|Docetaxel|docetaxel|mesh-list
43921499|NCT02799602|Androgens|androgens|mesh-list
43921500|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921501|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921502|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921503|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921504|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921505|NCT02799602|Hormones|hormones|mesh-ancestor
43921506|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921507|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921508|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43921509|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921567|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
43921568|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921569|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921570|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43921571|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
43921572|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921573|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921574|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43921575|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921576|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
43921577|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921578|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921579|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43921604|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921605|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43921606|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43921607|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921608|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921609|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
43921610|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921611|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
43921612|NCT00634166|Amphotericin B|amphotericin b|mesh-list
43921613|NCT00634166|Clotrimazole|clotrimazole|mesh-list
43921615|NCT00634166|Bacitracin|bacitracin|mesh-list
43921616|NCT00634166|Mafenide|mafenide|mesh-list
43921617|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43921618|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
43921619|NCT00634166|Amebicides|amebicides|mesh-ancestor
43921620|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43921621|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43921622|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43921623|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43921624|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43921625|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921626|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921627|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43921628|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
43921629|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921630|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921631|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43921632|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43921633|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43921635|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921636|NCT00564447|Azithromycin|azithromycin|mesh-list
43921637|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
43921638|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43921639|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921640|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43921641|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43921642|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921643|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921644|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921645|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
43921646|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43921647|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43921648|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43921649|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921650|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921651|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921652|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921653|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921654|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43921655|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921656|NCT00564954|Methylphenidate|methylphenidate|mesh-list
43921657|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43921658|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43921659|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921660|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43921661|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43921662|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921663|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921664|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
43921665|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921666|NCT00565084|Ibuprofen|ibuprofen|mesh-list
43921667|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44169168|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
44169169|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169170|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169171|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169172|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169173|NCT00274105|Telmisartan|telmisartan|mesh-list
44169174|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169175|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169176|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169177|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169178|NCT00274118|Telmisartan|telmisartan|mesh-list
44169179|NCT00274118|Enalapril|enalapril|mesh-list
44169180|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169181|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169182|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43921668|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43921669|NCT00565084|Analgesics|analgesics|mesh-ancestor
43921670|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
43921671|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921672|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921673|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921674|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921675|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43921676|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921677|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921678|NCT00565266|Beclomethasone|beclomethasone|mesh-list
43921679|NCT00565266|Bromides|bromides|mesh-list
43921680|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
43921681|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43921682|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43921683|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
43921684|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921685|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921686|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43921687|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
43921688|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
43921689|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43921690|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921691|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921692|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921693|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43921694|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43921695|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43921696|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
43921700|NCT00565266|Hormones|hormones|mesh-ancestor
44139484|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
44139485|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139486|NCT00175396|Protective Agents|protective agents|mesh-ancestor
44139487|NCT00175396|Vitamins|vitamins|mesh-ancestor
44139488|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
44139489|NCT00175396|Estrogens|estrogens|mesh-ancestor
44139490|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
44139491|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
44139492|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
44139493|NCT00175435|Vaccines|vaccines|mesh-list
44139494|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
44139495|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139496|NCT00175513|Valacyclovir|valacyclovir|mesh-list
44139497|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
44139498|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139499|NCT00175565|Fluticasone|fluticasone|mesh-list
44139500|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139501|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44139502|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
43765976|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139503|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139504|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139505|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44139506|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139507|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
44139508|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44139509|NCT00175591|Bupivacaine|bupivacaine|mesh-list
44139510|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
44139511|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
44139512|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139513|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139514|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
44139515|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157387|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157388|NCT00234390|Budesonide|budesonide|mesh-list
44157389|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157390|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44157391|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
44157392|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169183|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157393|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157394|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44157395|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44157396|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
44157397|NCT00234390|Hormones|hormones|mesh-ancestor
44157398|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157399|NCT00234403|Fulvestrant|fulvestrant|mesh-list
44157400|NCT00234403|Gefitinib|gefitinib|mesh-list
44157401|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44157402|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157403|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44157404|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44157405|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
44157406|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157407|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157408|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157409|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157410|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157411|NCT00234416|Gemcitabine|gemcitabine|mesh-list
44157413|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157414|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
44157415|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157416|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157417|NCT00234416|Antiviral Agents|antiviral agents|mesh-ancestor
44157418|NCT00234416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157419|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157420|NCT00234416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157421|NCT00234416|Immunologic Factors|immunologic factors|mesh-ancestor
43921711|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43921712|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
43921713|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44169184|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44169185|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
44169186|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169187|NCT00274131|Pramipexole|pramipexole|mesh-list
44169188|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
44169189|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169190|NCT00274131|Protective Agents|protective agents|mesh-ancestor
44169191|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169192|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44169193|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43921714|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
43921715|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921716|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
43921717|NCT00565643|Protective Agents|protective agents|mesh-ancestor
43921718|NCT00565643|Laxatives|laxatives|mesh-ancestor
43921719|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921720|NCT00565669|Cyclosporine|cyclosporine|mesh-list
43921721|NCT00565669|Cyclosporins|cyclosporins|mesh-list
43921722|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921723|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921724|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921725|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
43921726|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921727|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
43921728|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921729|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921730|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921731|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43921733|NCT00565916|Estrogens|estrogens|mesh-list
43921734|NCT00565916|Progesterone|progesterone|mesh-list
43921735|NCT00565916|Hormones|hormones|mesh-ancestor
43921736|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921737|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921738|NCT00565916|Progestins|progestins|mesh-ancestor
43921739|NCT00566150|Levetiracetam|levetiracetam|mesh-list
43921740|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
43921741|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
43921742|NCT00566540|Paclitaxel|paclitaxel|mesh-list
43921743|NCT00566540|Cisplatin|cisplatin|mesh-list
43921744|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43921745|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921746|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921747|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921748|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921749|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921750|NCT00566813|Exenatide|exenatide|mesh-list
43921751|NCT00566813|Etanercept|etanercept|mesh-list
43921754|NCT00566813|Analgesics|analgesics|mesh-ancestor
43921755|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
43921756|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921757|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921758|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921759|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921760|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921761|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921762|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
43921763|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921764|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43921765|NCT00566813|Incretins|incretins|mesh-ancestor
43921766|NCT00566813|Hormones|hormones|mesh-ancestor
43921767|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921768|NCT00566969|Carvedilol|carvedilol|mesh-list
43921769|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43921770|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43921771|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
43921772|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921773|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921774|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921775|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43921776|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
43921777|NCT00566969|Protective Agents|protective agents|mesh-ancestor
43921778|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43921779|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43921780|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43921781|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
43921803|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43921804|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43921805|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
43921806|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43921807|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921808|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921809|NCT00568022|Capecitabine|capecitabine|mesh-list
43921810|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921811|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
43921812|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921813|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921814|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
43921815|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43921816|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
43921817|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921818|NCT00568087|Expectorants|expectorants|mesh-ancestor
43921819|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
43921820|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43921821|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
43921822|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921823|NCT00568087|Protective Agents|protective agents|mesh-ancestor
43921824|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921825|NCT00568087|Antidotes|antidotes|mesh-ancestor
43921826|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43921827|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
43921828|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43921829|NCT00568633|Cyclosporine|cyclosporine|mesh-list
43921830|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
43921831|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
43921832|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43921833|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43921834|NCT00568633|Prednisolone|prednisolone|mesh-list
43921835|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
43921836|NCT00568633|Cyclosporins|cyclosporins|mesh-list
43921837|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
43921838|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43921839|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44169194|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
43921840|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
43921841|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921842|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921843|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921844|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
43921845|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921846|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
43921847|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921848|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921849|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921850|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43921851|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43921852|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921853|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43921854|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
43921855|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43921856|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921857|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
43921858|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
43921859|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921860|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921861|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
43921862|NCT00568633|Hormones|hormones|mesh-ancestor
43921863|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921864|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43921865|NCT00568633|Protective Agents|protective agents|mesh-ancestor
43921866|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43921867|NCT05363449|Naftifine|naftifine|mesh-list
43921868|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
44169195|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
44169219|NCT00274274|Insulin|insulin|mesh-list
44169220|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44169221|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
44169222|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
44169223|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44169224|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169225|NCT00274326|Satavaptan|satavaptan|mesh-list
44169226|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44169227|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169228|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169229|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169230|NCT00274339|Lansoprazole|lansoprazole|mesh-list
44169231|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44169232|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169233|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44169234|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702533|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
43921869|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921870|NCT05363202|Fluticasone|fluticasone|mesh-list
43921871|NCT05363202|Xhance|xhance|mesh-list
43921872|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921873|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43921874|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
43921875|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43921876|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921877|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43921878|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
43921879|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921880|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43921881|NCT05362942|Cytarabine|cytarabine|mesh-list
43921882|NCT05362942|Azacitidine|azacitidine|mesh-list
43921883|NCT05362942|Decitabine|decitabine|mesh-list
43921884|NCT05362942|Venetoclax|venetoclax|mesh-list
43921885|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43921886|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
43921887|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921888|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921889|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
43921890|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921891|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43921892|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
43921893|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921894|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921895|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
43921896|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921897|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
43921898|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
43921899|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
43921900|NCT05362851|Celecoxib|celecoxib|mesh-list
43921901|NCT05362851|Tramadol|tramadol|mesh-list
43921914|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43921915|NCT05362851|Narcotics|narcotics|mesh-ancestor
43921916|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43921917|NCT05362799|Metformin|metformin|mesh-list
43921918|NCT05362799|Letrozole|letrozole|mesh-list
43921919|NCT05362799|Lactitol|lactitol|mesh-list
43921920|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43921921|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921922|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921923|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43921924|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43921925|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921926|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921927|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43921928|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
43921929|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43921930|NCT05362799|Cathartics|cathartics|mesh-ancestor
43921931|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43921932|NCT05362513|Ivermectin|ivermectin|mesh-list
43921933|NCT05362513|Permethrin|permethrin|mesh-list
43921934|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43921935|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43921936|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921937|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921938|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
43921939|NCT05362500|Glycolic acid|glycolic acid|mesh-list
43921940|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
43668156|NCT03918252|Nivolumab|nivolumab|mesh-list
43921941|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43921942|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43921943|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921944|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
43921945|NCT05362500|Coagulants|coagulants|mesh-ancestor
43921962|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921963|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43921964|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
43921965|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921966|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43921967|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
43921968|NCT05362019|Norethindrone|norethindrone|mesh-list
43921969|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
43921970|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
43921971|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43921972|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43921973|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43921974|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
43921975|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43921976|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43921977|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43921978|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44169235|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169236|NCT00274352|Adalimumab|adalimumab|mesh-list
44169237|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169238|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169239|NCT00274391|Amiloride|amiloride|mesh-list
44169240|NCT00274391|Diuretics|diuretics|mesh-ancestor
44169241|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169242|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766087|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169243|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44169244|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44169245|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44169246|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169254|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44169255|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169256|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169257|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
44169258|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169259|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169260|NCT00274430|Dexamethasone|dexamethasone|mesh-list
44169261|NCT00274430|Tadalafil|tadalafil|mesh-list
44169262|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43921984|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
43921985|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43921986|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
43921987|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
43921988|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43921989|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921990|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921991|NCT05361655|Palbociclib|palbociclib|mesh-list
43921992|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43921993|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43921994|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43921995|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43921996|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43921997|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43921998|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43921999|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
43922000|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922001|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922002|NCT05361291|Dexamethasone|dexamethasone|mesh-list
43922003|NCT05361291|Lidocaine|lidocaine|mesh-list
43922004|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922005|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
43922006|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
43922007|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922008|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922009|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43922011|NCT05361291|Hormones|hormones|mesh-ancestor
43922012|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922013|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668194|NCT03789916|Aspirin|aspirin|mesh-list
43922026|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922027|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
43922028|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
43922029|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
43922031|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
43922032|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922033|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
43922034|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
43922035|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922036|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922037|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
43922038|NCT05353374|Petrolatum|petrolatum|mesh-list
43922039|NCT05353374|Emollients|emollients|mesh-ancestor
43922040|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
43922041|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922042|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922043|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43922044|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922045|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922046|NCT05324449|Cannabidiol|cannabidiol|mesh-list
43922047|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
43922048|NCT05305313|Propofol|propofol|mesh-list
43922049|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43922050|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922051|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922052|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43922053|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
43922054|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
44139517|NCT00175617|Spironolactone|spironolactone|mesh-list
44139518|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44139519|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
44139520|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169263|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
44169264|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
44169265|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169266|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169267|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169268|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
44169269|NCT00274430|Hormones|hormones|mesh-ancestor
44169270|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169271|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169272|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139522|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44139523|NCT00175617|Diuretics|diuretics|mesh-ancestor
44139524|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
44139525|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44139526|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139527|NCT00175630|Bupivacaine|bupivacaine|mesh-list
44139528|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
44139529|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
44139530|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139531|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139532|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
44139533|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139535|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44139536|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
44139537|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139538|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139539|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
44139540|NCT00175682|Prazosin|prazosin|mesh-list
44139541|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43841711|NCT04594772|Gemcitabine|gemcitabine|mesh-list
44169273|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
44169274|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44169275|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44169276|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169277|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169278|NCT00274430|Urological Agents|urological agents|mesh-ancestor
43849342|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169279|NCT00274443|Carboplatin|carboplatin|mesh-list
44169280|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44169281|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169282|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
44169283|NCT00274495|Ribavirin|ribavirin|mesh-list
44169284|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44169285|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
44169286|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169287|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
44169288|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169289|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44169290|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169291|NCT00274508|Bromides|bromides|mesh-list
44169292|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
44169293|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169294|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
44169295|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169296|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169297|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169298|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169299|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
44169300|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169318|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44169319|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44139542|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44139543|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44139544|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44139545|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
44139546|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139547|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139548|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139549|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
44139551|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
44139552|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43922055|NCT05290740|Norepinephrine|norepinephrine|mesh-list
43922056|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43922057|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43922058|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922059|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922060|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922061|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922062|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
43922063|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
43922064|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922065|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43922066|NCT05236894|Nicotine|nicotine|mesh-list
43922067|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43922068|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
43922069|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922070|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922071|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43922072|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43922073|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
43922074|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922075|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922076|NCT05214339|Bevacizumab|bevacizumab|mesh-list
43922077|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922078|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922079|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43922081|NCT05214339|Growth Substances|growth substances|mesh-ancestor
43922082|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922083|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
43922084|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
43922085|NCT05198232|TEMPO|tempo|mesh-list
43922086|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
43922087|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922088|NCT05198232|Protective Agents|protective agents|mesh-ancestor
43922089|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922090|NCT05198232|Antacids|antacids|mesh-ancestor
43922091|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43922092|NCT05183854|Vaccines|vaccines|mesh-list
43848501|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
44169320|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
44169321|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169322|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169323|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169324|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169325|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
44169326|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169327|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169328|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169329|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169330|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44169331|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44169332|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44169333|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
44169334|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
44169335|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169336|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
44169337|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169338|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169339|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169340|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169341|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
44169342|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169343|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169344|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169345|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169346|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
44169347|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44169348|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169349|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
44169350|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169351|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169352|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43609748|NCT03185871|Celecoxib|celecoxib|mesh-list
43741972|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
44169353|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169354|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
44169355|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169362|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
44169364|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
44169365|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169366|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
44169367|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169368|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169369|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169370|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169371|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
44169372|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169373|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43922093|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43922094|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
43922095|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922096|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43922097|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922098|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
43922099|NCT05163223|Capecitabine|capecitabine|mesh-list
43922100|NCT05163223|Sargramostim|sargramostim|mesh-list
43922101|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922102|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922103|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922104|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
43922105|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922106|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
43922107|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922108|NCT05099185|Trace Elements|trace elements|mesh-list
43922109|NCT05099185|Micronutrients|micronutrients|mesh-list
43922110|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922111|NCT05092412|Cisplatin|cisplatin|mesh-list
43922112|NCT05092412|Carboplatin|carboplatin|mesh-list
43922113|NCT05092412|Etoposide|etoposide|mesh-list
43922114|NCT05092412|Durvalumab|durvalumab|mesh-list
43922115|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922116|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43922117|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922118|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922119|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922120|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922121|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922122|NCT05076292|Glucagon|glucagon|mesh-list
43922123|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43922124|NCT05076292|Hormones|hormones|mesh-ancestor
43922125|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922126|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922127|NCT05068609|Nivolumab|nivolumab|mesh-list
44169374|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169375|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169376|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
44169377|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
43668343|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
43922128|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922129|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922130|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43922131|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922132|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43922134|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43922135|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43922136|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922137|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922138|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922139|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922140|NCT05065671|Analgesics|analgesics|mesh-ancestor
43922141|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
43922142|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766089|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
43766090|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
43922143|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
43922144|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922145|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
43922146|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43922147|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43922148|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43922149|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922150|NCT05017194|Emodepside|emodepside|mesh-list
43922151|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43922152|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922153|NCT04866602|Atovaquone|atovaquone|mesh-list
43922154|NCT04866602|Proguanil|proguanil|mesh-list
43922155|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43922156|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169378|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44169379|NCT00274599|Telmisartan|telmisartan|mesh-list
44169380|NCT00274599|Ramipril|ramipril|mesh-list
44169381|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169382|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169383|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169384|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169385|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44169386|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
44169387|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169388|NCT00274612|Telmisartan|telmisartan|mesh-list
44169389|NCT00274612|Ramipril|ramipril|mesh-list
44169390|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169391|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43922157|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
43922158|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43922159|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43922160|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922161|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922162|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
43922163|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
43922164|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922165|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922166|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922167|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922168|NCT04789330|Phenylephrine|phenylephrine|mesh-list
43922169|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
43922170|NCT04789330|Norepinephrine|norepinephrine|mesh-list
43922171|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43922172|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
43922173|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
43922174|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922175|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922176|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
43922177|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43922178|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
43922179|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
43922180|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43922181|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43922182|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43922183|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922184|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922185|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922186|NCT04789330|Protective Agents|protective agents|mesh-ancestor
43922187|NCT04704505|Androgens|androgens|mesh-list
43922188|NCT04704505|Hormones|hormones|mesh-ancestor
43922189|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922190|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922191|NCT04606576|Insulin|insulin|mesh-list
43922192|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43922193|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43922194|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922196|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43922197|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922198|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922199|NCT04509622|Cytarabine|cytarabine|mesh-list
43922200|NCT04509622|Venetoclax|venetoclax|mesh-list
43922201|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922202|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
43922203|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922204|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922205|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
43922206|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922207|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922208|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
43922209|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922211|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
43922212|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922213|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922214|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922215|NCT04465734|Sorafenib|sorafenib|mesh-list
43922216|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922217|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922218|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922219|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922220|NCT04415905|Propofol|propofol|mesh-list
43922221|NCT04415905|Sevoflurane|sevoflurane|mesh-list
43922222|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43922223|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922224|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922225|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43922226|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
43922227|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
43922228|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43922238|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922239|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139553|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44139554|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139555|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139556|NCT00175734|Chrysarobin|chrysarobin|mesh-list
44139557|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139558|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139559|NCT00175734|Analgesics|analgesics|mesh-ancestor
44139560|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
44139561|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139562|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139563|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139564|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139565|NCT00175747|Budesonide|budesonide|mesh-list
44139566|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139567|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44139568|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
44139569|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139570|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139571|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44139572|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139573|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
44139574|NCT00175747|Hormones|hormones|mesh-ancestor
44139575|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139576|NCT00175812|Tretinoin|tretinoin|mesh-list
44139577|NCT00175812|Theophylline|theophylline|mesh-list
44139578|NCT00175812|Valproic Acid|valproic acid|mesh-list
44139579|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139580|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
44139581|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
44139582|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
44139583|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139584|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139585|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
44139586|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43766099|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766100|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43766101|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43766103|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43766104|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766105|NCT02409004|Rifampin|rifampin|mesh-list
44139589|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139590|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922240|NCT04315233|Belinostat|belinostat|mesh-list
43922241|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922242|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43922243|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922244|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922245|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
43922246|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
43922247|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922248|NCT04286178|Vitamins|vitamins|mesh-ancestor
43922249|NCT04268199|Bortezomib|bortezomib|mesh-list
43922250|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922251|NCT04259398|Propofol|propofol|mesh-list
43922252|NCT04259398|Sevoflurane|sevoflurane|mesh-list
43922253|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43922254|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922255|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922256|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43922257|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
43922258|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
43922259|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43922260|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43922261|NCT04257188|Anesthetics|anesthetics|mesh-list
43922262|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922263|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922264|NCT04224428|Fexofenadine|fexofenadine|mesh-list
43922265|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43922286|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922287|NCT04165135|Factor VIII|factor viii|mesh-list
43922288|NCT04165135|Coagulants|coagulants|mesh-ancestor
43922289|NCT03952403|Bevacizumab|bevacizumab|mesh-list
43922290|NCT03952403|Carboplatin|carboplatin|mesh-list
43922291|NCT03952403|Pemetrexed|pemetrexed|mesh-list
43922292|NCT03952403|Antibodies|antibodies|mesh-list
43922293|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922294|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922295|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43922296|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43922297|NCT03952403|Growth Substances|growth substances|mesh-ancestor
43922298|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922299|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
43922300|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
43922301|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922302|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922303|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43922304|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43922305|NCT03944902|Niraparib|niraparib|mesh-list
43922306|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43922307|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922308|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922309|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922310|NCT03916094|Trastuzumab|trastuzumab|mesh-list
43922311|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922312|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922313|NCT03895762|Fentanyl|fentanyl|mesh-list
43922314|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43922315|NCT03895762|Narcotics|narcotics|mesh-ancestor
44139591|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922316|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922317|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922318|NCT03895762|Analgesics|analgesics|mesh-ancestor
43922319|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
43922320|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922321|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43922322|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43922323|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
43922324|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
43922325|NCT03874338|Colchicine|colchicine|mesh-list
43922326|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
43922327|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922328|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
43922329|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
43922330|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
43922331|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922332|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922333|NCT03869034|Leucovorin|leucovorin|mesh-list
43922334|NCT03869034|Fluorouracil|fluorouracil|mesh-list
43922335|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
43922336|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
43922337|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922338|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922339|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922340|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922341|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
43922342|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922343|NCT03869034|Antidotes|antidotes|mesh-ancestor
43922344|NCT03869034|Protective Agents|protective agents|mesh-ancestor
43922345|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
43922346|NCT03869034|Vitamins|vitamins|mesh-ancestor
43922347|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
43922348|NCT03856632|Liraglutide|liraglutide|mesh-list
43922349|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43922350|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43922351|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922352|NCT03856632|Incretins|incretins|mesh-ancestor
43922353|NCT03856632|Hormones|hormones|mesh-ancestor
43922355|NCT03840421|Gemcitabine|gemcitabine|mesh-list
43922368|NCT03805477|Nintedanib|nintedanib|mesh-list
43922369|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922370|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922371|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922372|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922373|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43922374|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
43922375|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922376|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922377|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43922378|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
43922379|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922380|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922381|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43922382|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
43922383|NCT03725384|Iron|iron|mesh-list
43922384|NCT03725384|Vitamins|vitamins|mesh-ancestor
43922386|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922387|NCT03725384|Trace Elements|trace elements|mesh-ancestor
43922388|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
43922389|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922390|NCT03725384|Protective Agents|protective agents|mesh-ancestor
43922391|NCT03674827|Vaccines|vaccines|mesh-list
43922392|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
43922393|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922395|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139603|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
44139604|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139605|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139606|NCT00175838|Analgesics|analgesics|mesh-ancestor
44139607|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
44139608|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139609|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139610|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139611|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139612|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44139613|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44139614|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139615|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44139616|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139617|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139618|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
44139619|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139620|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
44169392|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169393|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169394|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44169395|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
44169396|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169397|NCT00274638|Losartan|losartan|mesh-list
44169398|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44169399|NCT00274638|Telmisartan|telmisartan|mesh-list
44169400|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44169401|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169402|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169403|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169404|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169405|NCT00274638|Diuretics|diuretics|mesh-ancestor
44169406|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169407|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169408|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44169409|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44169410|NCT00274677|Lamotrigine|lamotrigine|mesh-list
44169411|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
44169412|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44169413|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44169414|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169415|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44169416|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169417|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44169418|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44169419|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169420|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169430|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169431|NCT00274794|Rituximab|rituximab|mesh-list
44169432|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44169433|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169434|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
44169435|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169436|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139621|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44139622|NCT00175890|Levetiracetam|levetiracetam|mesh-list
44139623|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
44139624|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
44139625|NCT00175903|Carbamazepine|carbamazepine|mesh-list
44139626|NCT00175903|Levetiracetam|levetiracetam|mesh-list
44139627|NCT00175903|Valproic Acid|valproic acid|mesh-list
44139628|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
44139629|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
44139630|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139631|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139632|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
44139633|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139634|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139635|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
44139636|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139637|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139638|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139639|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139640|NCT00175903|Analgesics|analgesics|mesh-ancestor
44139641|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
44139642|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139643|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44139644|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139645|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43668612|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668613|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
43668614|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668615|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668616|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668617|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
43922408|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43922409|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
43922410|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922411|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43922412|NCT03548454|Desipramine|desipramine|mesh-list
43796486|NCT05066516|Linagliptin|linagliptin|mesh-list
44169437|NCT00274807|Cytarabine|cytarabine|mesh-list
44169438|NCT00274807|Etoposide|etoposide|mesh-list
44169439|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
43922413|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43922415|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922416|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922417|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922418|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922419|NCT03548454|Analgesics|analgesics|mesh-ancestor
43922420|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
43922421|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922422|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
43922423|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922424|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
43922425|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43922426|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922427|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43922428|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922429|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
43922430|NCT03517137|Dacarbazine|dacarbazine|mesh-list
43922431|NCT03517137|Etoposide|etoposide|mesh-list
43922432|NCT03517137|Doxorubicin|doxorubicin|mesh-list
43922433|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43922434|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43922435|NCT03517137|Vinblastine|vinblastine|mesh-list
43922436|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922437|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
43922438|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922439|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922440|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922441|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
43922442|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922443|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796510|NCT05066360|Hormones|hormones|mesh-list
44169440|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169441|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169442|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169443|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169444|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169445|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169446|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169447|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
44169448|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
43922444|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922445|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43922446|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922447|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922448|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922449|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43922450|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922451|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
43922452|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43922453|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
43922454|NCT03481972|Doxycycline|doxycycline|mesh-list
43922455|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
43922456|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922457|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922458|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
43922459|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43922460|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43922461|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
43922462|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43922463|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43922464|NCT03474458|Doxycycline|doxycycline|mesh-list
43922465|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922466|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922467|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
43922468|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43922469|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43922470|NCT03439280|Dexamethasone|dexamethasone|mesh-list
43922471|NCT03439280|Pomalidomide|pomalidomide|mesh-list
43922472|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922473|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
43922474|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
43922475|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922477|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43922478|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
43922479|NCT03439280|Hormones|hormones|mesh-ancestor
43922480|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169449|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169450|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169451|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
44169452|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169453|NCT00274807|Analgesics|analgesics|mesh-ancestor
43922481|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43922482|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922483|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
43922484|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43922485|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43922486|NCT03439280|Growth Substances|growth substances|mesh-ancestor
43922487|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
43922488|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
43922489|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43922490|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
43922491|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43922492|NCT03357159|Antibodies|antibodies|mesh-list
43922493|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922494|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
43922495|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922496|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922497|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922498|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
43922499|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922500|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922501|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922502|NCT03316859|Naloxegol|naloxegol|mesh-list
43922503|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43922504|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922505|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
43922506|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922507|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
43922508|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43922509|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922510|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
43922511|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
43922512|NCT03303950|Busulfan|busulfan|mesh-list
43922513|NCT03303950|Fludarabine|fludarabine|mesh-list
43922514|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922523|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
43922524|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922525|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922526|NCT03258320|Docetaxel|docetaxel|mesh-list
43922527|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
43922528|NCT03258320|Satraplatin|satraplatin|mesh-list
43922529|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922530|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
43922531|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
43922532|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
43922533|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922534|NCT03258320|Analgesics|analgesics|mesh-ancestor
43922535|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
43922536|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922537|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922538|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922539|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922540|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922541|NCT03169101|Nicotine|nicotine|mesh-list
43922542|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43922543|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
43922544|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922545|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922546|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43922547|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43922548|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
43922549|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922550|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922552|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922553|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922554|NCT03072771|Cytarabine|cytarabine|mesh-list
43922555|NCT03072771|Etoposide|etoposide|mesh-list
43922566|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
43922567|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
43922568|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922569|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922570|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
43922571|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922572|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922573|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
43922574|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922575|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
43922576|NCT03071666|Vitamins|vitamins|mesh-ancestor
43922577|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
43922578|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922579|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
43922580|NCT03031210|Amoxicillin|amoxicillin|mesh-list
43922581|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922582|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922583|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43922584|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43922585|NCT03018366|Estradiol|estradiol|mesh-list
43922586|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43922587|NCT03018366|Progesterone|progesterone|mesh-list
43922588|NCT03018366|Estrogens|estrogens|mesh-ancestor
43922589|NCT03018366|Hormones|hormones|mesh-ancestor
43922590|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922591|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922592|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43922593|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
43922594|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43922595|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43922596|NCT03018366|Progestins|progestins|mesh-ancestor
43922611|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
43922612|NCT02958514|Hormones|hormones|mesh-ancestor
43922613|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43922614|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43922615|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922616|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43922617|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922618|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
43922619|NCT02897700|Doxorubicin|doxorubicin|mesh-list
43922620|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43922621|NCT02897700|Fluorouracil|fluorouracil|mesh-list
43922622|NCT02897700|Methotrexate|methotrexate|mesh-list
43922624|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922625|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
43922626|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922627|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922628|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922629|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
43922630|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169454|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
44169455|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169456|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
44169457|NCT00274820|Thalidomide|thalidomide|mesh-list
44169458|NCT00274820|Dexamethasone|dexamethasone|mesh-list
44169459|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
44169460|NCT00274820|Vitamins|vitamins|mesh-ancestor
44169461|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
44169462|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169463|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169464|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
44169465|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
44169466|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169467|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169468|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
44169469|NCT00274820|Hormones|hormones|mesh-ancestor
44169470|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169471|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169472|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169473|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
44169474|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169475|NCT00274820|Protective Agents|protective agents|mesh-ancestor
44169476|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169477|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
44169478|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
44169479|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44169480|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169481|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44169482|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44169483|NCT00274820|Growth Substances|growth substances|mesh-ancestor
44169484|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
44169485|NCT00274833|Temozolomide|temozolomide|mesh-list
44169486|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44169487|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169516|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169517|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
44169518|NCT00274872|Antidotes|antidotes|mesh-ancestor
44169519|NCT00274872|Protective Agents|protective agents|mesh-ancestor
43922631|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922632|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922633|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43922634|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922635|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922636|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922637|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
43922638|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922639|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43922640|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
43922641|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43922642|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
43922643|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43922644|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43922645|NCT02889666|Gemcitabine|gemcitabine|mesh-list
43922646|NCT02889666|Cisplatin|cisplatin|mesh-list
43922647|NCT02889666|Carboplatin|carboplatin|mesh-list
43922648|NCT02889666|Docetaxel|docetaxel|mesh-list
43922649|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
43922650|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922651|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922652|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
43922653|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922654|NCT02889666|Antiviral Agents|antiviral agents|mesh-ancestor
43922655|NCT02889666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922656|NCT02889666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922657|NCT02889666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922658|NCT02889666|Immunologic Factors|immunologic factors|mesh-ancestor
43922659|NCT02889666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922660|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
43922661|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
43922662|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
43922663|NCT02738229|Valacyclovir|valacyclovir|mesh-list
43922664|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
43922666|NCT02476409|Tolvaptan|tolvaptan|mesh-list
43922672|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922673|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
43922674|NCT02454322|Analgesics|analgesics|mesh-ancestor
43922675|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
43922676|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922677|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922678|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
43922679|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922680|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43922681|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
43922682|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43922683|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922684|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922685|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43922686|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
43922687|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43922688|NCT02446236|Rituximab|rituximab|mesh-list
43922689|NCT02446236|Lenalidomide|lenalidomide|mesh-list
43922690|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43922691|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922693|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922694|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922695|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43922696|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43922697|NCT02446236|Growth Substances|growth substances|mesh-ancestor
43922698|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
43922699|NCT02431845|Fluoxetine|fluoxetine|mesh-list
43922700|NCT02431845|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43922701|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43922702|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922703|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922704|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922713|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
43922714|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43922715|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43922716|NCT02429570|Analgesics|analgesics|mesh-ancestor
43922717|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
43922718|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922719|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922720|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43922721|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43922722|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43922723|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922724|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139646|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44139647|NCT00175929|Brivaracetam|brivaracetam|mesh-list
44139648|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
44139649|NCT00175955|Levetiracetam|levetiracetam|mesh-list
44139650|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
44139651|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
44139652|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
44139653|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
44139654|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139655|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44139656|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44139657|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139658|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139659|NCT00175981|Urological Agents|urological agents|mesh-ancestor
44139660|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44139661|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139662|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139663|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139677|NCT00176020|Niacinamide|niacinamide|mesh-list
44139678|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
44139679|NCT00176020|Vitamins|vitamins|mesh-ancestor
44139680|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
44139681|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139682|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44139683|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
44139684|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139685|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44139686|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
44139687|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
44139688|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139689|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44139690|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44139691|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
44139692|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139693|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
44139694|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44139695|NCT00176059|Antibodies|antibodies|mesh-list
44139696|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
44139697|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44139698|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
44139699|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139700|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44139701|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139702|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139703|NCT00176241|Gemcitabine|gemcitabine|mesh-list
44139704|NCT00176241|Paclitaxel|paclitaxel|mesh-list
43922725|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43922726|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43922727|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
43922728|NCT02184416|Everolimus|everolimus|mesh-list
43922729|NCT02184416|Sorafenib|sorafenib|mesh-list
43922730|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922731|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922732|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
43922733|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922734|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922736|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922737|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
43922738|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43922739|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43922740|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922741|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
43922742|NCT01980355|Coagulants|coagulants|mesh-ancestor
43922743|NCT01941641|Capecitabine|capecitabine|mesh-list
43742471|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
43922744|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922745|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
43922746|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922747|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922748|NCT01711242|Capecitabine|capecitabine|mesh-list
43922749|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
43922750|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922751|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
43922752|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922753|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922754|NCT00569010|Cytarabine|cytarabine|mesh-list
43922755|NCT00569010|Azacitidine|azacitidine|mesh-list
43922756|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922757|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
43922758|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922759|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922760|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
43796707|NCT05061641|Progesterone|progesterone|mesh-list
44169520|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
44169521|NCT00274872|Vitamins|vitamins|mesh-ancestor
44169522|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
44169523|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
44169524|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169525|NCT00274898|Celecoxib|celecoxib|mesh-list
44169526|NCT00274898|Docetaxel|docetaxel|mesh-list
44169527|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169528|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169529|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169530|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169531|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169532|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44169533|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44169534|NCT00274898|Analgesics|analgesics|mesh-ancestor
44169535|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
44169536|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169548|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169549|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169550|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169551|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169552|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169553|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
43922761|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922762|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43922763|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
43922764|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922765|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922766|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43922767|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
43922768|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922770|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43922771|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
43922772|NCT00569660|Azacitidine|azacitidine|mesh-list
43922773|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922774|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
43922775|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922776|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922777|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922778|NCT00569673|Docetaxel|docetaxel|mesh-list
43922779|NCT00569673|Trabectedin|trabectedin|mesh-list
43922780|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922781|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
43922782|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
43922783|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
43922784|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922785|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922786|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
43922787|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
43922788|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43922789|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43922790|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922791|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922792|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922793|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922794|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43922795|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
43922796|NCT00570089|Ranolazine|ranolazine|mesh-list
43922798|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922799|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922800|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
43922801|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43922802|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
43922803|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922804|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922805|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43922806|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
43922807|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43922808|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
43922809|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922810|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922811|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43922812|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
43922813|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
43922814|NCT00570349|Protective Agents|protective agents|mesh-ancestor
43922816|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922817|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922818|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922819|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922820|NCT00570960|Dextrans|dextrans|mesh-list
43922821|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
43922822|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
43922823|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
43922824|NCT00571259|Gentamicins|gentamicins|mesh-list
43922825|NCT00571259|Heparin|heparin|mesh-list
43922826|NCT00571259|Citric Acid|citric acid|mesh-list
43922827|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
43922828|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
43922829|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43922830|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
43922831|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
43922832|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922833|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43922834|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43922837|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43922838|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922839|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43922840|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
43922841|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43922842|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
43922843|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922844|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922845|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43922846|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
43922847|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43922848|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43922849|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43922850|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922851|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922852|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922853|NCT00571493|Cytarabine|cytarabine|mesh-list
43922854|NCT00571493|Etoposide|etoposide|mesh-list
43922855|NCT00571493|Bortezomib|bortezomib|mesh-list
43922857|NCT00571493|Carmustine|carmustine|mesh-list
43922858|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43922859|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922860|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43922861|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43922862|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922863|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922864|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43922865|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
43922885|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43922886|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43922887|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43922888|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43922889|NCT00571961|Narcotics|narcotics|mesh-ancestor
43922890|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43922891|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922892|NCT00571961|Analgesics|analgesics|mesh-ancestor
43922893|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
43922894|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922895|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44139705|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44139706|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139707|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139708|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139709|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139710|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139711|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139712|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
44139713|NCT00176241|Antiviral Agents|antiviral agents|mesh-ancestor
44139714|NCT00176241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139715|NCT00176241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139716|NCT00176241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139717|NCT00176241|Immunologic Factors|immunologic factors|mesh-ancestor
44139718|NCT00176241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139719|NCT00176267|Paclitaxel|paclitaxel|mesh-list
44139720|NCT00176267|Carboplatin|carboplatin|mesh-list
44139721|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44139722|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139723|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139724|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139725|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139726|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169554|NCT00277199|Abatacept|abatacept|mesh-list
44169555|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44169556|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169557|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169558|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169559|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
44169560|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139727|NCT00176280|Dexamethasone|dexamethasone|mesh-list
44139728|NCT00176280|Sargramostim|sargramostim|mesh-list
44139729|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139730|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
44139731|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
44139732|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139733|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139734|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139735|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
44139736|NCT00176280|Hormones|hormones|mesh-ancestor
44139737|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139738|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44139739|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139740|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
44139741|NCT00176293|Dexamethasone|dexamethasone|mesh-list
44139742|NCT00176293|Doxorubicin|doxorubicin|mesh-list
44139743|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139744|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
44139745|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
44139746|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139747|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139748|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44139749|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
44139750|NCT00176293|Hormones|hormones|mesh-ancestor
44139751|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44139752|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44139753|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139754|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44139755|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44139756|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44139757|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139758|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139759|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44139760|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43922902|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922903|NCT00572234|Bupropion|bupropion|mesh-list
43922904|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43922905|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
43922906|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43922907|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43922908|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43922909|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43922910|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922911|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
43922912|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922913|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922914|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43922915|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43922916|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922917|NCT00572468|Simvastatin|simvastatin|mesh-list
43922918|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43922919|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43922920|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
43922921|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922922|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43922923|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43922924|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922925|NCT00572897|Fludarabine|fludarabine|mesh-list
43922926|NCT00572897|Melphalan|melphalan|mesh-list
43922927|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922928|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922929|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43796825|NCT05058209|Triamcinolone|triamcinolone|mesh-list
44169561|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169562|NCT00277225|Abatacept|abatacept|mesh-list
44169563|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44169564|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169565|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169566|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169567|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
44169568|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169569|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169570|NCT00277251|Alendronate|alendronate|mesh-list
44169571|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44169572|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169573|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
43922930|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
43922931|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922932|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43922933|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
43922934|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43922935|NCT00572936|Timolol|timolol|mesh-list
43922936|NCT00572936|Dorzolamide|dorzolamide|mesh-list
43922937|NCT00572936|Latanoprost|latanoprost|mesh-list
43922938|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43922939|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43922940|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
43922941|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922942|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922943|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922944|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43922945|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43922946|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43922947|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43922948|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43922949|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922950|NCT00573261|Pregabalin|pregabalin|mesh-list
43922951|NCT00573261|Analgesics|analgesics|mesh-ancestor
43922952|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
43922953|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43922954|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922955|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
43922964|NCT00573287|Risperidone|risperidone|mesh-list
43922977|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
43922979|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
43922980|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43922981|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43922982|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43922983|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43922984|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922985|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43922986|NCT00573508|Urological Agents|urological agents|mesh-ancestor
43922987|NCT00573989|Pemetrexed|pemetrexed|mesh-list
43922988|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43922989|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43922990|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43922991|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43922992|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43922993|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43922994|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43922995|NCT00574067|Buprenorphine|buprenorphine|mesh-list
43922996|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43922997|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43922998|NCT00574067|Narcotics|narcotics|mesh-ancestor
43922999|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923000|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923001|NCT00574067|Analgesics|analgesics|mesh-ancestor
43923002|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
43923003|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923004|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43923005|NCT00574171|Capecitabine|capecitabine|mesh-list
43923006|NCT00574171|Lapatinib|lapatinib|mesh-list
43923007|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923008|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
43923009|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923010|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169574|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169575|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
44169576|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169577|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169578|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169579|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169580|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
43923011|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43923012|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923013|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
43923014|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43923015|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923016|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43923017|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
43923018|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43923019|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923020|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923021|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923022|NCT00574236|Doxorubicin|doxorubicin|mesh-list
43923023|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43923024|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923025|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43923026|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43923027|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923028|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923029|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43923030|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923031|NCT00574548|Vaccines|vaccines|mesh-list
43923032|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43923033|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
43923034|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923035|NCT00574587|Paclitaxel|paclitaxel|mesh-list
43923036|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
43923037|NCT00574587|Doxorubicin|doxorubicin|mesh-list
43923038|NCT00574587|Trastuzumab|trastuzumab|mesh-list
43923039|NCT00574587|Vorinostat|vorinostat|mesh-list
43923040|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43923041|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923053|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43923054|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43923055|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43923056|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923057|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923058|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43923059|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43923060|NCT00574834|Ramipril|ramipril|mesh-list
43923061|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43923062|NCT00574834|Diuretics|diuretics|mesh-ancestor
43923063|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
43923064|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923065|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43923066|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923067|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923068|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43923069|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
43923070|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923071|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
43923072|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43923073|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43923074|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43923075|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923076|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923077|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923078|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923082|NCT00575029|Megestrol|megestrol|mesh-list
43923097|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
43923098|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43923099|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43923100|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43923101|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43923102|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923103|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43923104|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43923105|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923106|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923107|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923108|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43923109|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
43923110|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923111|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923112|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43923113|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43923114|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43923115|NCT00575887|Temozolomide|temozolomide|mesh-list
43923116|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923117|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
43923118|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923119|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923120|NCT00575965|Simvastatin|simvastatin|mesh-list
43923121|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43923122|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43923123|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
43923141|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923142|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43923143|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923144|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43923145|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43923146|NCT00576680|Temozolomide|temozolomide|mesh-list
43923147|NCT00576680|Everolimus|everolimus|mesh-list
43923148|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923149|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
43923150|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923151|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923152|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923153|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
43923154|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923155|NCT00577135|Furosemide|furosemide|mesh-list
43923203|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43923204|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
43923205|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923206|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923208|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923209|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
43923210|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923211|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43923212|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923213|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43923214|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923215|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
43923216|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
43923217|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923218|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923219|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
43923220|NCT00578305|Hormones|hormones|mesh-ancestor
43923221|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43923222|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43923223|NCT00578305|Protective Agents|protective agents|mesh-ancestor
43923224|NCT00578305|Hematinics|hematinics|mesh-ancestor
43923225|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
43923226|NCT00578305|Vitamins|vitamins|mesh-ancestor
43923227|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
43923228|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43923229|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923230|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923231|NCT00578331|Analgesics|analgesics|mesh-ancestor
43923232|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
43923233|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923246|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923247|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
43923248|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923249|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923250|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923251|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
43923252|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923253|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923254|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923255|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923256|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
43923257|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
43923258|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923260|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
43923261|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
43923262|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923263|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
43923264|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923265|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923266|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43669356|NCT02905045|Ketoprofen|ketoprofen|mesh-list
43923267|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
43923268|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923269|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841848|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44169581|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169582|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169583|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169584|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169585|NCT00277342|Insulin|insulin|mesh-list
44169586|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44169587|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169588|NCT00277472|Valsartan|valsartan|mesh-list
44169589|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44169590|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169591|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169592|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169593|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169594|NCT00277472|Diuretics|diuretics|mesh-ancestor
44169595|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169596|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169597|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44169598|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44169599|NCT00277498|Timolol|timolol|mesh-list
44169604|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169605|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923270|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923271|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923272|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
43923273|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
43923274|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923275|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923276|NCT00578552|Gabapentin|gabapentin|mesh-list
43923277|NCT00578552|Analgesics|analgesics|mesh-ancestor
43923278|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
43923279|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923280|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923281|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
43923282|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43923283|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43923284|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923285|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923286|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43923287|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43923288|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923289|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923290|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
43923291|NCT00578617|Amiodarone|amiodarone|mesh-list
43923292|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923293|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43923294|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
43923295|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43923296|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923297|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43923298|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43923299|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923300|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923301|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43923302|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43923303|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43923304|NCT00578669|Fluoxetine|fluoxetine|mesh-list
43841863|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923306|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43923307|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923308|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923309|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923310|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
43923311|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923312|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43923313|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
43923314|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923315|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43923316|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923317|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139761|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44139762|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
44139763|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139764|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44139765|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44139766|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139767|NCT00176449|Bupropion|bupropion|mesh-list
44139768|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44139769|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
44139770|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139771|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44139772|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44139773|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44139774|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923331|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923332|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923333|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43923334|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
43923335|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923336|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923337|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
43923338|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
43923339|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923340|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43923341|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43923342|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43923343|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923344|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43923345|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923346|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923347|NCT00578929|Analgesics|analgesics|mesh-ancestor
43923348|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
43923349|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923350|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923351|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923352|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923353|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43923354|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43923355|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43923356|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
43923357|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
43923358|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923359|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923360|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
43923361|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43923362|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
43923363|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923364|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923368|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43923370|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923371|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923372|NCT00579111|Fludarabine|fludarabine|mesh-list
43923373|NCT00579111|Busulfan|busulfan|mesh-list
43923374|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
43923375|NCT00579111|Tacrolimus|tacrolimus|mesh-list
43923376|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923377|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923378|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923379|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
43923380|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923381|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43923382|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923383|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
43923384|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923385|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923386|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923387|NCT00579137|Fludarabine|fludarabine|mesh-list
43923388|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
43923391|NCT00579280|Valproic Acid|valproic acid|mesh-list
43923424|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
43923425|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923426|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43923427|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
43923428|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43923429|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43923430|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923431|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923432|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923433|NCT00579878|Analgesics|analgesics|mesh-ancestor
43923434|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
43923435|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923436|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923437|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923438|NCT00580073|Leucovorin|leucovorin|mesh-list
43923439|NCT00580073|Fluorouracil|fluorouracil|mesh-list
43923440|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
44169606|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169607|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44169608|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169609|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44169610|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44169612|NCT00277511|Ofloxacin|ofloxacin|mesh-list
44169613|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44169614|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169615|NCT00277511|Renal Agents|renal agents|mesh-ancestor
44169616|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44169617|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169618|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169619|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169620|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169621|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169622|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44169623|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44169624|NCT00277537|Mannitol|mannitol|mesh-list
44169625|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44169626|NCT00277537|Diuretics|diuretics|mesh-ancestor
44169627|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169628|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169629|NCT00277550|Tegaserod|tegaserod|mesh-list
44169630|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44169631|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
44169632|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169633|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169634|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169635|NCT00277589|Iodine|iodine|mesh-list
44169636|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44169637|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169638|NCT00277589|Trace Elements|trace elements|mesh-ancestor
44169639|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
44169640|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169641|NCT00277602|Riluzole|riluzole|mesh-list
44169642|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
44169643|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44169644|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44169645|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169646|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923443|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923444|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923445|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923446|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923447|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
43923448|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923449|NCT00580073|Antidotes|antidotes|mesh-ancestor
43923450|NCT00580073|Protective Agents|protective agents|mesh-ancestor
43923451|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
43923452|NCT00580073|Vitamins|vitamins|mesh-ancestor
43923453|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
43923454|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923455|NCT00580151|Clonidine|clonidine|mesh-list
43923456|NCT00580151|Analgesics|analgesics|mesh-ancestor
43923457|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
43923458|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923459|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923460|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43923461|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
43923462|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
43923463|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43923464|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43923465|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43923466|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
43923467|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923469|NCT00580229|Prednisone|prednisone|mesh-list
43923488|NCT00580333|Bevacizumab|bevacizumab|mesh-list
43923489|NCT00580333|Cisplatin|cisplatin|mesh-list
43923490|NCT00580333|Doxorubicin|doxorubicin|mesh-list
43923491|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43923492|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923493|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923494|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923495|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923496|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923497|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923498|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
43923499|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923500|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923501|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923502|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
43923503|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923504|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923505|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43923506|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43923507|NCT00580333|Growth Substances|growth substances|mesh-ancestor
43923508|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
43923509|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43923510|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43923511|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43923512|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923513|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
43923514|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923515|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
43923516|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923517|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923531|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43923532|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43923533|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923534|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923535|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923536|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923537|NCT00580853|Bupropion|bupropion|mesh-list
43923538|NCT00580853|Varenicline|varenicline|mesh-list
43923539|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43923540|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
43923541|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923542|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43923543|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43923544|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923545|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923546|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
43923547|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923548|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923549|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43923550|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923551|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923552|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43923553|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43923554|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923555|NCT00580957|Trimethaphan|trimethaphan|mesh-list
43923556|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43923557|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43923558|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
43923559|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
43923560|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923561|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923562|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43923563|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43923564|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923570|NCT00581048|Vitamins|vitamins|mesh-ancestor
43923571|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
43923572|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923573|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
43923574|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923575|NCT00581048|Protective Agents|protective agents|mesh-ancestor
43923576|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
43923577|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43923578|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43923579|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923580|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923581|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923582|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923583|NCT00581061|Urological Agents|urological agents|mesh-ancestor
43923584|NCT00581867|Insulin|insulin|mesh-list
43923585|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43923586|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
43923587|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43923588|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923589|NCT00581971|Celecoxib|celecoxib|mesh-list
43923590|NCT00581971|Paclitaxel|paclitaxel|mesh-list
43923591|NCT00581971|Carboplatin|carboplatin|mesh-list
43923592|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43923593|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923594|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923595|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923596|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923597|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923598|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923599|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923600|NCT00581971|Analgesics|analgesics|mesh-ancestor
43923601|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
43923609|NCT00582075|Temozolomide|temozolomide|mesh-list
43923610|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923611|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
43923612|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923613|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923614|NCT00582205|Paclitaxel|paclitaxel|mesh-list
43923615|NCT00582205|Cisplatin|cisplatin|mesh-list
43923616|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43669604|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
43923617|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923618|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923619|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923620|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923621|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923622|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
43923623|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923624|NCT00582660|Celecoxib|celecoxib|mesh-list
43923625|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43923626|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923627|NCT00582660|Analgesics|analgesics|mesh-ancestor
43923628|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
43923629|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923630|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923631|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923632|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923633|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43923634|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43923635|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923636|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923637|NCT00582894|Fludarabine|fludarabine|mesh-list
43923638|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
43923639|NCT00582894|Busulfan|busulfan|mesh-list
43923640|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923649|NCT00583011|Anesthetics|anesthetics|mesh-list
43923650|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923651|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923652|NCT00583622|Gemcitabine|gemcitabine|mesh-list
43923653|NCT00583622|Bevacizumab|bevacizumab|mesh-list
43923654|NCT00583622|Carboplatin|carboplatin|mesh-list
43923655|NCT00583622|Docetaxel|docetaxel|mesh-list
43923656|NCT00583622|Melphalan|melphalan|mesh-list
43923657|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923658|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923659|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43923660|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43923661|NCT00583622|Growth Substances|growth substances|mesh-ancestor
43923662|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923663|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
43923664|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43923665|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
43923666|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923667|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
43923668|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923669|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923670|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923671|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
43923672|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923673|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923674|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923675|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43923676|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
43923677|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43923678|NCT00583700|Vitamin E|vitamin e|mesh-list
43923679|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
43923680|NCT00583700|Vitamins|vitamins|mesh-ancestor
43923681|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
43923682|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923683|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
43923684|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923685|NCT00583700|Protective Agents|protective agents|mesh-ancestor
43923690|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
43669672|NCT02902354|Nifedipine|nifedipine|mesh-list
43923691|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43923692|NCT00584701|Risperidone|risperidone|mesh-list
43923693|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43923694|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
43923695|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923696|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923697|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923698|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43923699|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43797202|NCT05048914|Acetaminophen|acetaminophen|mesh-list
43923700|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923701|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923702|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43923703|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
43923704|NCT00584857|Paclitaxel|paclitaxel|mesh-list
43923705|NCT00584857|Carboplatin|carboplatin|mesh-list
43923706|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43923707|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923708|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923709|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923710|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923711|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923712|NCT00584948|Memantine|memantine|mesh-list
43923713|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43923714|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43923715|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
43923716|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923734|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
43923735|NCT00585013|Protective Agents|protective agents|mesh-ancestor
43923736|NCT00585104|Simendan|simendan|mesh-list
43923737|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43923738|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
43923739|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43923740|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43923741|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923742|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923743|NCT00585104|Protective Agents|protective agents|mesh-ancestor
43923744|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923745|NCT00585182|Enoxaparin|enoxaparin|mesh-list
43923746|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
43923747|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43923748|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43923749|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923750|NCT00585377|Bevacizumab|bevacizumab|mesh-list
43923751|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43923752|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923753|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923754|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43923755|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43923756|NCT00585377|Growth Substances|growth substances|mesh-ancestor
43923757|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923758|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
43923759|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43923760|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923761|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923762|NCT00585637|Vitamin D|vitamin d|mesh-list
43923763|NCT00585637|Vitamins|vitamins|mesh-ancestor
43923764|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
43923765|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923776|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923777|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43923778|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
43923779|NCT00585780|Prazosin|prazosin|mesh-list
43923780|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43923781|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43923782|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43923783|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43923784|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
43923785|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923786|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923787|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923788|NCT00585910|Methylphenidate|methylphenidate|mesh-list
43923789|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43923790|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43923791|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923792|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43923793|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43923794|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923795|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923796|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
43923797|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923798|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43923799|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
43923800|NCT00586196|Donepezil|donepezil|mesh-list
43923801|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43923802|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923803|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923804|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923805|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923806|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923807|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
43923808|NCT00586261|Pioglitazone|pioglitazone|mesh-list
43923809|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
43923810|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44169647|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923813|NCT00586482|Nicotine|nicotine|mesh-list
43923814|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43923815|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
43923816|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923817|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923818|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43923819|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43923820|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
43923821|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923822|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923823|NCT00586573|Memantine|memantine|mesh-list
43923824|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43923825|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43923826|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
43923827|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923828|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923829|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923830|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43923831|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43923832|NCT00586729|Mafenide|mafenide|mesh-list
43923833|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43923834|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43923835|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43923836|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43923837|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923838|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923839|NCT00587132|Secretin|secretin|mesh-list
43923840|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923841|NCT00587132|Hormones|hormones|mesh-ancestor
43923842|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169648|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44169649|NCT00277602|Protective Agents|protective agents|mesh-ancestor
44169650|NCT00277641|Lamotrigine|lamotrigine|mesh-list
44169651|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
44169652|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44169653|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44169654|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923843|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923844|NCT00587483|Lidocaine|lidocaine|mesh-list
43923845|NCT00587483|Amiodarone|amiodarone|mesh-list
43923846|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
43923847|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
43923848|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923849|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923850|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
43923851|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923852|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43923853|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43923854|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43923855|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43923856|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923857|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
43923858|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43923859|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43923860|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43923861|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923862|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43923895|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43923896|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43923897|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923898|NCT05247385|Ticagrelor|ticagrelor|mesh-list
43923899|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43923900|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43923901|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43923902|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43923903|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43923904|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
43923905|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923906|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923907|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923908|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
43923909|NCT05247177|Ketamine|ketamine|mesh-list
43923910|NCT05247177|Anesthetics|anesthetics|mesh-list
43669847|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
43923911|NCT05247177|Sevoflurane|sevoflurane|mesh-list
43923912|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923913|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923914|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43923915|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923916|NCT05247177|Analgesics|analgesics|mesh-ancestor
43923917|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
43923918|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923919|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43923920|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43923921|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43923922|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
43923923|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923924|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923925|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43923926|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43923927|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
43702534|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
43923929|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43923930|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43923931|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43923933|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
43923934|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43923935|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139782|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44139783|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139784|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
44139785|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139786|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139787|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
44139788|NCT00176527|Interferons|interferons|mesh-list
44139789|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
44139790|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
44139791|NCT00176527|Docetaxel|docetaxel|mesh-list
44139792|NCT00176527|Estramustine|estramustine|mesh-list
44139793|NCT00176527|Isotretinoin|isotretinoin|mesh-list
44139794|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139795|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
44139796|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
44139797|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
44139798|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139799|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
44139800|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139801|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
44139802|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139803|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
44139804|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44139805|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
44139806|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44139807|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
44139808|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
44139809|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
43841926|NCT04572256|Montelukast|montelukast|mesh-list
44169655|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44169656|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169657|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44169658|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139812|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139813|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139814|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139815|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
44139816|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
44139817|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
44139818|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44139819|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44139820|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139821|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139822|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139823|NCT00176618|Curcumin|curcumin|mesh-list
44139824|NCT00176618|Sulindac|sulindac|mesh-list
44169659|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169660|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169661|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44169662|NCT00277654|Risperidone|risperidone|mesh-list
44169663|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44169664|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
44169665|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169666|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169667|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169676|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169677|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44169678|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44169679|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169680|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169681|NCT00277693|Spironolactone|spironolactone|mesh-list
44169682|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44169683|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
43651829|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
44169684|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169685|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169686|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44169687|NCT00277693|Diuretics|diuretics|mesh-ancestor
44169688|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
44169689|NCT00277706|Vitamin D|vitamin d|mesh-list
44169690|NCT00277706|Calcium|calcium|mesh-list
44169691|NCT00277706|Vitamins|vitamins|mesh-ancestor
44169692|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
44169693|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169694|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44169695|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44169696|NCT00277758|Interferons|interferons|mesh-list
44169697|NCT00277758|Ribavirin|ribavirin|mesh-list
44169698|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
44169699|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44169700|NCT00277758|Interleukin-2|interleukin-2|mesh-list
44169701|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169702|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
44169703|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169704|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
44169705|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169706|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
44169707|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139825|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139827|NCT00176618|Analgesics|analgesics|mesh-ancestor
44139828|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
44139829|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923936|NCT05246644|Acetaminophen|acetaminophen|mesh-list
43923937|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43923938|NCT05246644|Analgesics|analgesics|mesh-ancestor
43923939|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
43923940|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923941|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923942|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
43923943|NCT05246631|Dexamethasone|dexamethasone|mesh-list
43923944|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
43923945|NCT05246631|Haloperidol|haloperidol|mesh-list
43923946|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
43923947|NCT05246631|BB 1101|bb 1101|mesh-list
43923948|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43923949|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
43923950|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
43923951|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43923952|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43923953|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43923954|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
43923955|NCT05246631|Hormones|hormones|mesh-ancestor
43923956|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169708|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44169709|NCT00277758|Analgesics|analgesics|mesh-ancestor
44169710|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
44169711|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169712|NCT00277862|Ribavirin|ribavirin|mesh-list
44169713|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
44169714|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
44169715|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44169716|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44169717|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
44169718|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169719|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
44169720|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169721|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
44169722|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169723|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169724|NCT00278070|Vinorelbine|vinorelbine|mesh-list
44169725|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169726|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169727|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169728|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169729|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169730|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923958|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923959|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
43923960|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923961|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923962|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43923963|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43923964|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923965|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43923966|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43923967|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
43923968|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43923969|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43923970|NCT05246072|Ivermectin|ivermectin|mesh-list
43923971|NCT05246072|Colchicine|colchicine|mesh-list
43923972|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
43923973|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43923974|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
43923975|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
43923976|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
43923977|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923978|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923979|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43923980|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169731|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
44169732|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169733|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
44169734|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169735|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169736|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169739|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
44169740|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169741|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169742|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44169743|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
44169744|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
44169745|NCT00278083|Protective Agents|protective agents|mesh-ancestor
44169746|NCT00278122|Paclitaxel|paclitaxel|mesh-list
44169747|NCT00278122|Sargramostim|sargramostim|mesh-list
44169748|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169749|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169750|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169751|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169752|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169753|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169754|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
44169755|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169756|NCT00278174|Interferons|interferons|mesh-list
44169757|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
44169758|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44169759|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169760|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
43923981|NCT05245994|Cisplatin|cisplatin|mesh-list
43923982|NCT05245994|Carboplatin|carboplatin|mesh-list
43923983|NCT05245994|Etoposide|etoposide|mesh-list
43923984|NCT05245994|Durvalumab|durvalumab|mesh-list
43923985|NCT05245994|Olaparib|olaparib|mesh-list
43923986|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43923987|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43923988|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43923990|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43923991|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43923992|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43923993|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43923994|NCT05245721|Nalbuphine|nalbuphine|mesh-list
43923995|NCT05245721|Bupivacaine|bupivacaine|mesh-list
43923996|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43923997|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
43923998|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43923999|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924000|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
43766379|NCT02407912|Cisplatin|cisplatin|mesh-list
43924001|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924002|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43924003|NCT05245721|Narcotics|narcotics|mesh-ancestor
43924004|NCT05245721|Analgesics|analgesics|mesh-ancestor
43924005|NCT05245604|Cyclosporine|cyclosporine|mesh-list
43924006|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43924007|NCT05245604|Cyclosporins|cyclosporins|mesh-list
43924008|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924009|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924010|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924011|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
43924012|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924013|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
43924014|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924015|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
43924016|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169761|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169762|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
44169763|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169764|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44169765|NCT00278187|Volociximab|volociximab|mesh-list
44169766|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169767|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924018|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43924019|NCT05245448|Tetrandrine|tetrandrine|mesh-list
43924020|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
43924021|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43924022|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43924023|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924024|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43924025|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924026|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
43924027|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43924028|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924029|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924030|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43924031|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924032|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924033|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
43924034|NCT05220917|Insulin|insulin|mesh-list
43924035|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43924036|NCT05220917|Metformin|metformin|mesh-list
43924037|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
43924038|NCT05220917|Pioglitazone|pioglitazone|mesh-list
43924039|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43924040|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
43924041|NCT05220917|Liraglutide|liraglutide|mesh-list
43924042|NCT05220917|Empagliflozin|empagliflozin|mesh-list
43924043|NCT05220917|Exenatide|exenatide|mesh-list
43924044|NCT05220917|Glimepiride|glimepiride|mesh-list
43924045|NCT05220917|Linagliptin|linagliptin|mesh-list
43924046|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
44169768|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169769|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169770|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44169771|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44169772|NCT00278187|Growth Substances|growth substances|mesh-ancestor
44169773|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169774|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
44169775|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
44169776|NCT00278213|Fludarabine|fludarabine|mesh-list
44169777|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
44169778|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
44169779|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
44169780|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169781|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
44169782|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169783|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169784|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169785|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
43924048|NCT05220917|Saxagliptin|saxagliptin|mesh-list
43924049|NCT05220917|Alogliptin|alogliptin|mesh-list
43924050|NCT05220917|Dulaglutide|dulaglutide|mesh-list
43924051|NCT05220917|Glyburide|glyburide|mesh-list
43924052|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
43924053|NCT05220917|Lixisenatide|lixisenatide|mesh-list
43924054|NCT05220917|Glipizide|glipizide|mesh-list
43924055|NCT05220917|Xultophy|xultophy|mesh-list
43924056|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43924057|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43924058|NCT05220917|Simvastatin|simvastatin|mesh-list
43924059|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
43924060|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43924061|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924062|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924063|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924064|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
43924065|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924066|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924067|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43924068|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924069|NCT05220917|Incretins|incretins|mesh-ancestor
44169786|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169787|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169788|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44169789|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169790|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
44169791|NCT00278213|Analgesics|analgesics|mesh-ancestor
44169792|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
44169793|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169794|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169795|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169796|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169797|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44169798|NCT00278252|Etoposide|etoposide|mesh-list
44169799|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169800|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169801|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169802|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169803|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169804|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169805|NCT00278265|Methotrexate|methotrexate|mesh-list
44169806|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
44169807|NCT00278265|Fludarabine|fludarabine|mesh-list
44169808|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44169817|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169818|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44169819|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169820|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
44169821|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169822|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44169823|NCT00278278|Prednisone|prednisone|mesh-list
44169824|NCT00278278|Cisplatin|cisplatin|mesh-list
44169825|NCT00278278|Methotrexate|methotrexate|mesh-list
44169826|NCT00278278|Etoposide|etoposide|mesh-list
43924070|NCT05220917|Hormones|hormones|mesh-ancestor
43924071|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924072|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
43924073|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43924074|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43924075|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924076|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
43924077|NCT05219877|Levofloxacin|levofloxacin|mesh-list
43924078|NCT05219877|Ofloxacin|ofloxacin|mesh-list
43924079|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43924080|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924081|NCT05219877|Renal Agents|renal agents|mesh-ancestor
43924082|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43924083|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43924084|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43924085|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669925|NCT02900469|Denosumab|denosumab|mesh-list
43924086|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924087|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924088|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43924089|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43924124|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43924125|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924126|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43924127|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43924128|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924129|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924130|NCT05097846|Amoxicillin|amoxicillin|mesh-list
43924131|NCT05097846|Doxycycline|doxycycline|mesh-list
43924132|NCT05097846|Furazolidone|furazolidone|mesh-list
43924133|NCT05097846|Esomeprazole|esomeprazole|mesh-list
43924134|NCT05097846|Bismuth|bismuth|mesh-list
43924135|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43924136|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924137|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43924138|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43924139|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43924140|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924141|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924142|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
43924143|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43924144|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43924145|NCT05097846|Antacids|antacids|mesh-ancestor
43924146|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43924147|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43924148|NCT05097846|Renal Agents|renal agents|mesh-ancestor
43924149|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43924150|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43924151|NCT05069051|Belimumab|belimumab|mesh-list
43924152|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924153|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
43924154|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924155|NCT04929392|Paclitaxel|paclitaxel|mesh-list
43924156|NCT04929392|Carboplatin|carboplatin|mesh-list
43924157|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
43924158|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43924167|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924168|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924169|NCT04856228|Lidocaine|lidocaine|mesh-list
43924170|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
43924171|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
43924172|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924173|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924174|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
43924175|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924176|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43924177|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43924178|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43924179|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924180|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139830|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139831|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139832|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139833|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139834|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139835|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139836|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139837|NCT00176670|Midazolam|midazolam|mesh-list
44139838|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44139839|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44139840|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139841|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169827|NCT00278278|Vincristine|vincristine|mesh-list
44169828|NCT00278278|Ifosfamide|ifosfamide|mesh-list
44169829|NCT00278278|Lomustine|lomustine|mesh-list
44169830|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169831|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169832|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
44169833|NCT00278278|Hormones|hormones|mesh-ancestor
44169834|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169835|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169836|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169837|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44169838|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
44169839|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44169840|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169841|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
44169842|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169843|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
44169844|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169845|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44139842|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44139843|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139844|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139845|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44139846|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
44139847|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
44139848|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
44139849|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
44139850|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139851|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139852|NCT00176735|Capecitabine|capecitabine|mesh-list
44139853|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139854|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
44139855|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139856|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139857|NCT00176761|Interleukin-2|interleukin-2|mesh-list
44139858|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139859|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139860|NCT00176761|Analgesics|analgesics|mesh-ancestor
44139861|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
44139862|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139863|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139864|NCT00176774|Leucovorin|leucovorin|mesh-list
44139865|NCT00176774|Fluorouracil|fluorouracil|mesh-list
44139867|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44139868|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
44139869|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139892|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139893|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670040|NCT02898961|Amikacin|amikacin|mesh-list
43924181|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
43924182|NCT04784052|Rituximab|rituximab|mesh-list
43924183|NCT04784052|Fludarabine|fludarabine|mesh-list
43924184|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
43924185|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43924186|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924187|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
43924188|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924189|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924190|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43924191|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
43924192|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924193|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924194|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43924195|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43924196|NCT04771871|Paclitaxel|paclitaxel|mesh-list
43924197|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
43924198|NCT04771871|Carboplatin|carboplatin|mesh-list
43924199|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43924200|NCT04771871|Epirubicin|epirubicin|mesh-list
43924201|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43924202|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924203|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
43924204|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
43924205|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
43924206|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924207|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924208|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
43924221|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924222|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43924223|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43924224|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924225|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924227|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924229|NCT04575857|Atorvastatin|atorvastatin|mesh-list
43924230|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924231|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43924232|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
43924233|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924234|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43924235|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43924236|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924237|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43924238|NCT04561206|Nivolumab|nivolumab|mesh-list
43924239|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43924240|NCT04561206|Antibodies|antibodies|mesh-list
43924241|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
43924242|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43924243|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
44169846|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169847|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
44169848|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169849|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44169850|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169851|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169852|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169853|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169854|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169855|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169856|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169857|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
43610272|NCT03181243|Anesthetics|anesthetics|mesh-list
44169859|NCT00278330|Alvocidib|alvocidib|mesh-list
44169860|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169861|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44169862|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169863|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169864|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44169865|NCT00278330|Growth Substances|growth substances|mesh-ancestor
44169866|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169867|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44169868|NCT00278343|Cediranib|cediranib|mesh-list
44169869|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169870|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169871|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169872|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44169873|NCT00278369|Aldesleukin|aldesleukin|mesh-list
43924244|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
43924245|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924246|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924247|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43924248|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924249|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
43924250|NCT04545008|Famotidine|famotidine|mesh-list
43924251|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43924252|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
43924253|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924254|NCT04545008|Expectorants|expectorants|mesh-ancestor
43924255|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
43924256|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43924257|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
43924258|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924259|NCT04545008|Protective Agents|protective agents|mesh-ancestor
43924260|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924261|NCT04545008|Antidotes|antidotes|mesh-ancestor
43924262|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43924263|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43924264|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43924265|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
43924266|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
43924267|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924268|NCT04527770|Dexamethasone|dexamethasone|mesh-list
43924269|NCT04527770|Midazolam|midazolam|mesh-list
43924270|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924271|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
43924272|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
43924273|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924274|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924275|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169874|NCT00278369|Interleukin-2|interleukin-2|mesh-list
44169875|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
44169882|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44169883|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44169884|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
44169885|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169886|NCT00278382|Sorafenib|sorafenib|mesh-list
44169887|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169888|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44169889|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169890|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169891|NCT00278408|Prednisone|prednisone|mesh-list
44169892|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
43924277|NCT04527770|Hormones|hormones|mesh-ancestor
43924278|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924279|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43924280|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924281|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43924282|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43924283|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924284|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43924285|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43924286|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43924287|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43924288|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
43924289|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
43924290|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
43924291|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
43924292|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924293|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924294|NCT04514211|Propofol|propofol|mesh-list
43924295|NCT04514211|Sevoflurane|sevoflurane|mesh-list
43924296|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43924297|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924298|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924299|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43924300|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
43924301|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
43924302|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43924303|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43924304|NCT04507204|Methylphenidate|methylphenidate|mesh-list
43924305|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43924306|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924307|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43924308|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43797673|NCT05039580|Antibodies|antibodies|mesh-list
44169893|NCT00278408|Rituximab|rituximab|mesh-list
44169894|NCT00278408|Doxorubicin|doxorubicin|mesh-list
44169895|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44169896|NCT00278408|Vincristine|vincristine|mesh-list
44169897|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924309|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924310|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924311|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
43924312|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924313|NCT04505566|Ketorolac|ketorolac|mesh-list
43924314|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43924315|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
43924316|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43924317|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924318|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924319|NCT04505566|Analgesics|analgesics|mesh-ancestor
43924320|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
43924321|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924322|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924323|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924324|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924325|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924326|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924327|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924328|NCT04497298|Vaccines|vaccines|mesh-list
43924329|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
43924330|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924331|NCT04483102|Liver Extracts|liver extracts|mesh-list
43924332|NCT04483102|Hematinics|hematinics|mesh-ancestor
43924334|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
43924335|NCT04459117|Acetaminophen|acetaminophen|mesh-list
43924336|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924337|NCT04459117|Analgesics|analgesics|mesh-ancestor
43924338|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
43924339|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924340|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924341|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
43924342|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43924354|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43924355|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
43924356|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924357|NCT04405908|Antacids|antacids|mesh-ancestor
43924358|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924359|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43924360|NCT04363437|Colchicine|colchicine|mesh-list
43924361|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
43924362|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924363|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
43924364|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
43924365|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
43924366|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924367|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924368|NCT04333459|Vaccines|vaccines|mesh-list
43924369|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
43924370|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924371|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43924372|NCT04304274|Morphine|morphine|mesh-list
43924373|NCT04304274|Ropivacaine|ropivacaine|mesh-list
43924374|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43924375|NCT04304274|Narcotics|narcotics|mesh-ancestor
43924378|NCT04304274|Analgesics|analgesics|mesh-ancestor
43924407|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43924408|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
43924409|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43924410|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43924411|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43924412|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
43924414|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43924415|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924416|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924417|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43924418|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
43924419|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
43924420|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924421|NCT04142502|Analgesics|analgesics|mesh-ancestor
43924422|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
43924423|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924424|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43924425|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43924426|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43924427|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
43924428|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924429|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924430|NCT04066725|Aspirin|aspirin|mesh-list
43924431|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924432|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924433|NCT04066725|Analgesics|analgesics|mesh-ancestor
43924434|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
43924435|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924436|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924437|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924438|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924439|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43924440|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43962678|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169898|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
44169899|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169900|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924441|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835658|NCT05031975|Irinotecan|irinotecan|mesh-list
43924442|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43924443|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924445|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
43924446|NCT04062032|Aspirin|aspirin|mesh-list
43924447|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924448|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924449|NCT04062032|Analgesics|analgesics|mesh-ancestor
43924450|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
43924451|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924452|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924453|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924454|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924455|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43924456|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43924457|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924458|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43924459|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924460|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924461|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
43924462|NCT04033991|Sunitinib|sunitinib|mesh-list
43924463|NCT04033991|Axitinib|axitinib|mesh-list
43924464|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924465|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43924466|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43924467|NCT04033991|Growth Substances|growth substances|mesh-ancestor
43924468|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924469|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
43924484|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43924485|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924486|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43924487|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
43924488|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
43924489|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
43924490|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43924491|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924492|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
43924493|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924494|NCT03973229|Estradiol|estradiol|mesh-list
43924495|NCT03973229|Estrogens|estrogens|mesh-ancestor
43924496|NCT03973229|Hormones|hormones|mesh-ancestor
43924497|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924498|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924499|NCT03934840|Prednisone|prednisone|mesh-list
43924500|NCT03934840|Carboplatin|carboplatin|mesh-list
43924501|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924502|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924503|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
43924504|NCT03934840|Hormones|hormones|mesh-ancestor
43924505|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924506|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924507|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43924508|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
43924509|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43924510|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924511|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924512|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924513|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43924514|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
43924515|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924524|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924525|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924526|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924527|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924529|NCT03729401|Clopidogrel|clopidogrel|mesh-list
43924530|NCT03729401|Ticagrelor|ticagrelor|mesh-list
43924531|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924532|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924533|NCT03729401|Analgesics|analgesics|mesh-ancestor
43924534|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
43924535|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924536|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924537|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924538|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924539|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43924540|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43924541|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924542|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43924543|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924544|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924545|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
43924546|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43924547|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43924548|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43924549|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
43924550|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924551|NCT03722966|Nicotine|nicotine|mesh-list
43924552|NCT03722966|Varenicline|varenicline|mesh-list
43924553|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43924554|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
43924555|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924556|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924557|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43924558|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43924559|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169901|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169902|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
43924560|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924561|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139894|NCT00176813|Gemcitabine|gemcitabine|mesh-list
44139895|NCT00176813|Celecoxib|celecoxib|mesh-list
44139896|NCT00176813|Cisplatin|cisplatin|mesh-list
44139897|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139898|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44139899|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
44139900|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139901|NCT00176813|Antiviral Agents|antiviral agents|mesh-ancestor
44139902|NCT00176813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139903|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139904|NCT00176813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139905|NCT00176813|Immunologic Factors|immunologic factors|mesh-ancestor
44139906|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139907|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44139908|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44139909|NCT00176813|Analgesics|analgesics|mesh-ancestor
44139910|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
44139911|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44139912|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44139913|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139914|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44139915|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44139916|NCT00176943|Imiquimod|imiquimod|mesh-list
44139917|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44139918|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
44139919|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139920|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139921|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
44139922|NCT00176969|Capsaicin|capsaicin|mesh-list
44139923|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
44139924|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
44139934|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139935|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44139937|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44139938|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44139939|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44139940|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44139941|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44139942|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44139943|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139944|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139945|NCT00177008|Aripiprazole|aripiprazole|mesh-list
44139946|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
44139947|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44139948|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44139949|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44139950|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44139951|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139952|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
44139953|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
44139954|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44139955|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44139956|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44139957|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44139958|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
44139959|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44139960|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44139961|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44139962|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44139963|NCT00177021|Imiquimod|imiquimod|mesh-list
44139964|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44139965|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
44139966|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924562|NCT03708354|Tocotrienols|tocotrienols|mesh-list
43924563|NCT03708354|Vitamin E|vitamin e|mesh-list
43924568|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924570|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
43924571|NCT03571191|Denosumab|denosumab|mesh-list
43924572|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43924573|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924574|NCT03527472|Memantine|memantine|mesh-list
43924575|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43924576|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43924577|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
43924578|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924579|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924580|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924581|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43924582|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43924583|NCT03480971|Tempol|tempol|mesh-list
43924584|NCT03480971|TEMPO|tempo|mesh-list
43924585|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
43924586|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924587|NCT03480971|Protective Agents|protective agents|mesh-ancestor
43924588|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924589|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43924590|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924591|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43924592|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43924593|NCT03433833|Digoxin|digoxin|mesh-list
43924594|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44169903|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169904|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169905|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44169906|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44169907|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44169908|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169909|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169910|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169911|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169912|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
44169913|NCT00278408|Hormones|hormones|mesh-ancestor
44169914|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169915|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169916|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169917|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169918|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169919|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169920|NCT00278421|Prednisone|prednisone|mesh-list
44169921|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
44169922|NCT00278421|Rituximab|rituximab|mesh-list
44169923|NCT00278421|Doxorubicin|doxorubicin|mesh-list
43924595|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43924596|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924597|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924598|NCT03433833|Protective Agents|protective agents|mesh-ancestor
43924599|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924601|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43924602|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924603|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
43924604|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
43924605|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
43924606|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924607|NCT03297684|Aflibercept|aflibercept|mesh-list
43924608|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43924609|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43924610|NCT03297684|Growth Substances|growth substances|mesh-ancestor
43924611|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924612|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
43924613|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924614|NCT03262662|Varenicline|varenicline|mesh-list
43924615|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43924616|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43924617|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
43924618|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924619|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924620|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924621|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43924622|NCT03179163|Enalapril|enalapril|mesh-list
43924623|NCT03179163|Captopril|captopril|mesh-list
43924624|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43924625|NCT03179163|Diuretics|diuretics|mesh-ancestor
43924626|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
43924638|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924639|NCT02959775|Vaccines|vaccines|mesh-list
43924640|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
43924641|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924642|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
43924643|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924644|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924645|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924646|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924647|NCT02829268|Dantrolene|dantrolene|mesh-list
43924648|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43924649|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924650|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43924651|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924652|NCT02776605|Prednisone|prednisone|mesh-list
43924653|NCT02776605|Methotrexate|methotrexate|mesh-list
43924654|NCT02776605|Vincristine|vincristine|mesh-list
43924655|NCT02776605|Daunorubicin|daunorubicin|mesh-list
43924656|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
43924657|NCT02776605|Ponatinib|ponatinib|mesh-list
43924658|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924659|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
43924660|NCT02776605|Hormones|hormones|mesh-ancestor
43924661|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924662|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924663|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43924664|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924665|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43924666|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
43924667|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44169924|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44169925|NCT00278421|Vincristine|vincristine|mesh-list
44169926|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169927|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
44169928|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169929|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169930|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44169931|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
44169932|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169933|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169934|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44169935|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43924668|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924669|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
43924670|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924671|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
43924672|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924673|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43924674|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924675|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
43924676|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924677|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43743693|NCT04297150|Apixaban|apixaban|mesh-list
43924678|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43924679|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
43924680|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
43924681|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
43924682|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43924683|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43924684|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43924685|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924687|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924688|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43924689|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924690|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924691|NCT02506933|Vaccines|vaccines|mesh-list
43924692|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
43924693|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924694|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
43924695|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
43924696|NCT02446964|Fludarabine|fludarabine|mesh-list
43924697|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
43924698|NCT02446964|Tacrolimus|tacrolimus|mesh-list
43924699|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924700|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
43924701|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924702|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924703|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43924704|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
44169936|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43702535|NCT02716415|Emollients|emollients|mesh-ancestor
43924705|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924706|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924707|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43924708|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924710|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43924711|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924712|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43924713|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43924714|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
43924715|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43924716|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924718|NCT02394795|Leucovorin|leucovorin|mesh-list
43924719|NCT02394795|Bevacizumab|bevacizumab|mesh-list
43924720|NCT02394795|Panitumumab|panitumumab|mesh-list
43924721|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
43924722|NCT02394795|Fluorouracil|fluorouracil|mesh-list
43924723|NCT02394795|Calcium|calcium|mesh-list
43924724|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
43924725|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43924726|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924727|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43924728|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43924729|NCT02394795|Growth Substances|growth substances|mesh-ancestor
43924730|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924731|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
43924732|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43797947|NCT05035147|Paclitaxel|paclitaxel|mesh-list
44169937|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44169938|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44169939|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169940|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169942|NCT00278421|Hormones|hormones|mesh-ancestor
44169943|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44169944|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169947|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169948|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
44169949|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
44169950|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44169951|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169952|NCT00278460|Gemcitabine|gemcitabine|mesh-list
44169953|NCT00278460|Docetaxel|docetaxel|mesh-list
44169954|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169955|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
44169956|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169957|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169958|NCT00278460|Antiviral Agents|antiviral agents|mesh-ancestor
43924733|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43924734|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
43924735|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924736|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924737|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924738|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
43924739|NCT02394795|Antidotes|antidotes|mesh-ancestor
43924740|NCT02394795|Protective Agents|protective agents|mesh-ancestor
43924741|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
43924743|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
43924744|NCT02202772|Gemcitabine|gemcitabine|mesh-list
43924745|NCT02202772|Cisplatin|cisplatin|mesh-list
43924746|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924747|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924748|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
43924749|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924750|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
43924751|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924752|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924753|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924754|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
43924755|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924756|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43924757|NCT02174822|Paroxetine|paroxetine|mesh-list
43924758|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43924759|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43924760|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43924761|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924762|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43924763|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924764|NCT02174822|Analgesics|analgesics|mesh-ancestor
43924765|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
43924766|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924770|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43924772|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43924773|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43924774|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43924775|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924776|NCT01961063|Busulfan|busulfan|mesh-list
43924777|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
43924778|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924779|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924780|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
43924781|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924782|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43924783|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924784|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43924785|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43924786|NCT01909245|Gastrins|gastrins|mesh-list
43924787|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
43924788|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924789|NCT01909245|Hormones|hormones|mesh-ancestor
43924790|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924791|NCT01885689|Sirolimus|sirolimus|mesh-list
43924792|NCT01885689|Melphalan|melphalan|mesh-list
43924793|NCT01885689|Clofarabine|clofarabine|mesh-list
43924794|NCT01885689|Tacrolimus|tacrolimus|mesh-list
43924795|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43924796|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
43924797|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924798|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43924799|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924800|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924801|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43924802|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43924803|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43924808|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43924809|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43924810|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
43924811|NCT01872260|Letrozole|letrozole|mesh-list
43924812|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43924813|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43924814|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43924815|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924816|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924817|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43924818|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924819|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924820|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924821|NCT01740648|Fluorouracil|fluorouracil|mesh-list
43924867|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924868|NCT01429168|Analgesics|analgesics|mesh-ancestor
43924869|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
43924870|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924871|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924872|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924873|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924874|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43924875|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924876|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924877|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924878|NCT01327638|Etoricoxib|etoricoxib|mesh-list
43924879|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43924880|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924881|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924882|NCT01327638|Analgesics|analgesics|mesh-ancestor
43924883|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
43924884|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924885|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924886|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43924887|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924888|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43924889|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924890|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924891|NCT01077843|Etoricoxib|etoricoxib|mesh-list
43924892|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43924893|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43924894|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43924895|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43924896|NCT01077843|Analgesics|analgesics|mesh-ancestor
43924897|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
43924898|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43924899|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924900|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43924910|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924911|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43924912|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43924913|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924914|NCT00756418|Theophylline|theophylline|mesh-list
43924915|NCT00756418|Montelukast|montelukast|mesh-list
43924916|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43924917|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
43924918|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43924919|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924920|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924921|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924922|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43924923|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43924924|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924925|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43924940|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924941|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924942|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43924943|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43924944|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924946|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43924947|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
43924948|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43924949|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
43924950|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43924951|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43924952|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43924953|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43924954|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43924994|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43924995|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43924996|NCT00652301|Simvastatin|simvastatin|mesh-list
43924997|NCT00652301|Ezetimibe|ezetimibe|mesh-list
43924998|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43924999|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43670700|NCT05426798|Decitabine|decitabine|mesh-list
43925001|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925002|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925003|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925004|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925005|NCT00651963|Ezetimibe|ezetimibe|mesh-list
43925006|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925007|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925008|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
43925009|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925010|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925011|NCT00651560|Simvastatin|simvastatin|mesh-list
43925012|NCT00651560|Ezetimibe|ezetimibe|mesh-list
43925013|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925014|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925015|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
43925016|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925017|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925018|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925019|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925020|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
43925021|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925022|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925023|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43925024|NCT00551876|Simvastatin|simvastatin|mesh-list
43925025|NCT00551876|Ezetimibe|ezetimibe|mesh-list
43925026|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925027|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925028|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
43925029|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925030|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925031|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925033|NCT00551447|Simvastatin|simvastatin|mesh-list
43925034|NCT00551447|Ezetimibe|ezetimibe|mesh-list
43925035|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925036|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925037|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
43925038|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925039|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925040|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925041|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925042|NCT00542087|Diclofenac|diclofenac|mesh-list
43925043|NCT00542087|Etoricoxib|etoricoxib|mesh-list
43925044|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925045|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925047|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
43925048|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925049|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925050|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925051|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925052|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925053|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925054|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925055|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925056|NCT00541697|Atorvastatin|atorvastatin|mesh-list
43925057|NCT00541697|Simvastatin|simvastatin|mesh-list
43925058|NCT00541697|Ezetimibe|ezetimibe|mesh-list
43925059|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925077|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43925078|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925079|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43925080|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
43925081|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43925082|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43925083|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43925085|NCT00395603|Simvastatin|simvastatin|mesh-list
43925086|NCT00395603|Ezetimibe|ezetimibe|mesh-list
43925087|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925088|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925089|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
43925090|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925091|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925092|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925093|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925094|NCT00395473|Ezetimibe|ezetimibe|mesh-list
43925095|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925096|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925097|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
43925098|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925099|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925100|NCT00393354|Etoricoxib|etoricoxib|mesh-list
43925101|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925102|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925103|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925104|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925105|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925106|NCT00393354|Analgesics|analgesics|mesh-ancestor
43925107|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
43925108|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925109|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169959|NCT00278460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169960|NCT00278460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169961|NCT00278460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169962|NCT00278460|Immunologic Factors|immunologic factors|mesh-ancestor
44169963|NCT00278460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169964|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
44169965|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
44169966|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
43925110|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925111|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925112|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925113|NCT00393211|Etoricoxib|etoricoxib|mesh-list
43925114|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925115|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925116|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925117|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925118|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925119|NCT00393211|Analgesics|analgesics|mesh-ancestor
43925120|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
43925121|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925122|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925123|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925124|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925125|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925126|NCT00328523|Ezetimibe|ezetimibe|mesh-list
43925127|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925128|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925129|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
43925130|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925131|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925132|NCT00269191|Ibuprofen|ibuprofen|mesh-list
43925133|NCT00269191|Etoricoxib|etoricoxib|mesh-list
43925134|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925135|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925136|NCT00269191|Analgesics|analgesics|mesh-ancestor
43925137|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
43925138|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925139|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925140|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925141|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169967|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
44169968|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169969|NCT00278772|Valproic Acid|valproic acid|mesh-list
44169970|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
44169971|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169972|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169973|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
44169974|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169975|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169976|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
43925142|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925143|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925144|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925145|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925146|NCT00251576|Heparin|heparin|mesh-list
43925147|NCT00251576|Calcium heparin|calcium heparin|mesh-list
43925148|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43925149|NCT00251576|Tinzaparin|tinzaparin|mesh-list
43925150|NCT00251576|Dalteparin|dalteparin|mesh-list
43925151|NCT00251576|Tirofiban|tirofiban|mesh-list
43925152|NCT00251576|Simvastatin|simvastatin|mesh-list
43925153|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
43925154|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43925155|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43925156|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925157|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925158|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925159|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
43925160|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925161|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43925162|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925163|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43925164|NCT00250445|Diclofenac|diclofenac|mesh-list
43925165|NCT00250445|Etoricoxib|etoricoxib|mesh-list
43925166|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43925167|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925168|NCT00250445|Analgesics|analgesics|mesh-ancestor
43925169|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
43925170|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925171|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925187|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925188|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43925189|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925190|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925191|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43925192|NCT00166530|Atorvastatin|atorvastatin|mesh-list
43925193|NCT00166530|Simvastatin|simvastatin|mesh-list
43925194|NCT00166530|Ezetimibe|ezetimibe|mesh-list
43925195|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43925196|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43925197|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
43925198|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925199|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43925229|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43925230|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43925231|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925232|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925233|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
43925234|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43925235|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43925236|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
43925237|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
43925238|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
43925239|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
43925240|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43925241|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43925242|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
43925243|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
43925244|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43925245|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
43925246|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925247|NCT00588406|Prednisone|prednisone|mesh-list
43925248|NCT00588406|Budesonide|budesonide|mesh-list
43925249|NCT00588406|Bromides|bromides|mesh-list
43925251|NCT00588406|Ipratropium|ipratropium|mesh-list
43925252|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925285|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925286|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
43925287|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925288|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925289|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925290|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925291|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43925292|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925293|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
43925294|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925295|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43925296|NCT00588536|Antidotes|antidotes|mesh-ancestor
43925297|NCT00588536|Protective Agents|protective agents|mesh-ancestor
43925298|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
43925299|NCT00588536|Vitamins|vitamins|mesh-ancestor
43925300|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
43925301|NCT00588900|Irinotecan|irinotecan|mesh-list
43925302|NCT00588900|Cediranib|cediranib|mesh-list
43925303|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43925304|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925305|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925307|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925340|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
43925341|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925342|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43925343|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43925344|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43925345|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43925346|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925347|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925348|NCT00589563|Sirolimus|sirolimus|mesh-list
43925349|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
43925350|NCT00589563|Melphalan|melphalan|mesh-list
43925351|NCT00589563|Methotrexate|methotrexate|mesh-list
43925352|NCT00589563|Fludarabine|fludarabine|mesh-list
43925353|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
43925354|NCT00589563|Etoposide|etoposide|mesh-list
43925355|NCT00589563|Tacrolimus|tacrolimus|mesh-list
43925356|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44139988|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
43925357|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925358|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
43925359|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925360|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925361|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925362|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
43925363|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925364|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925365|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43925366|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43925367|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
43925386|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43925387|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
43925388|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925389|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
43925390|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43925391|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925392|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925393|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43925394|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43925395|NCT00590161|Protective Agents|protective agents|mesh-ancestor
43925396|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925397|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
43925398|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43925399|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
43925400|NCT00590226|Insulin|insulin|mesh-list
43925401|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43925402|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
43925403|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
43925404|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
43925405|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
43925406|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43925407|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925408|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43925409|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43744160|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925410|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925411|NCT00590460|Fludarabine|fludarabine|mesh-list
43925412|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
43925413|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925414|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925415|NCT00590772|Montelukast|montelukast|mesh-list
43925416|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43925417|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925418|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43925419|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
43925428|NCT00590863|Bupropion|bupropion|mesh-list
43925430|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43925431|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43925432|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925433|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925434|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925435|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
43925436|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925437|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43925438|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925439|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925440|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43925441|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43925442|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
43925443|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
43925444|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925445|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43925446|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43925447|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
43925448|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43925449|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
43925452|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925476|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
43925477|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43925478|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
43925479|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925480|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
43925481|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925482|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925483|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925484|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925485|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
43925486|NCT00591123|Antidotes|antidotes|mesh-ancestor
43925487|NCT00591123|Protective Agents|protective agents|mesh-ancestor
43925488|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
43925489|NCT00591123|Vitamins|vitamins|mesh-ancestor
43925490|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
43925491|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43925492|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925493|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
43925494|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43925495|NCT00591305|Protective Agents|protective agents|mesh-ancestor
43925496|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925497|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925498|NCT00591825|Cycloserine|cycloserine|mesh-list
43925499|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43925500|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925524|NCT00592475|Conivaptan|conivaptan|mesh-list
43925526|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925527|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
43925528|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925529|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
43925530|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
43925532|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
43925533|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925534|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
43925535|NCT00592943|Modafinil|modafinil|mesh-list
43925536|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43925537|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925538|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43925539|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43925540|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43925541|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925542|NCT00593450|Bevacizumab|bevacizumab|mesh-list
43925543|NCT00593450|Ranibizumab|ranibizumab|mesh-list
43925544|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925545|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925546|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925547|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925548|NCT00593450|Growth Substances|growth substances|mesh-ancestor
43925549|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925550|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925551|NCT00593645|Cytarabine|cytarabine|mesh-list
43925552|NCT00593645|Clofarabine|clofarabine|mesh-list
43925553|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
43925554|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43925555|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925556|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
43925557|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925558|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925559|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
43925560|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925561|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169977|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43702536|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
43925562|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
43925563|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925565|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925566|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
43925567|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925568|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925569|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
43925570|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925571|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925572|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925573|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
43925574|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925575|NCT00594230|Panobinostat|panobinostat|mesh-list
43925576|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925577|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43925578|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925579|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925580|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
43925581|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43925582|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43925583|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
43925584|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
43925585|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43925586|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925587|NCT00594308|Cyclosporine|cyclosporine|mesh-list
43925588|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
43925589|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
43925590|NCT00594308|Fludarabine|fludarabine|mesh-list
43925591|NCT00594308|Cyclosporins|cyclosporins|mesh-list
43925592|NCT00594308|Basiliximab|basiliximab|mesh-list
43925593|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925594|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
43925595|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925596|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925597|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925598|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
43962682|NCT01516684|Lidocaine|lidocaine|mesh-list
43925599|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925600|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925601|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43925602|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925603|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
43925604|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925605|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925606|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43925607|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43925608|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43925609|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
43925610|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925611|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43925612|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43925613|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43925614|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
43925615|NCT00594945|Clonazepam|clonazepam|mesh-list
43925616|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
43925617|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
43925618|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
43925619|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925620|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925621|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925622|NCT00595101|Latanoprost|latanoprost|mesh-list
43925623|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43925624|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43925625|NCT00595153|Budesonide|budesonide|mesh-list
43925626|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925627|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43925628|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
43925629|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925630|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925631|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43925632|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925633|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
43925635|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43925639|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43925640|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925641|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925643|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
43925644|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925645|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43925646|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43925647|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
43925648|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925649|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925650|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43671183|NCT05096117|ASP8062|asp8062|mesh-list
43925651|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
43925652|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43925653|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43925654|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43925655|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
43925656|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925657|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925658|NCT00595530|Ketamine|ketamine|mesh-list
43925659|NCT00595530|Analgesics|analgesics|mesh-ancestor
43925660|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
43925661|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925686|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43925687|NCT00596167|Vancomycin|vancomycin|mesh-list
43925688|NCT00596167|Levofloxacin|levofloxacin|mesh-list
43925689|NCT00596167|Gentamicins|gentamicins|mesh-list
43925690|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925691|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43925692|NCT00596167|Renal Agents|renal agents|mesh-ancestor
43925693|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925694|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925695|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925696|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925704|NCT00596440|Nicotine|nicotine|mesh-list
43925750|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925751|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43925752|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925753|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925754|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925755|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925756|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
43925757|NCT00597428|Lubiprostone|lubiprostone|mesh-list
43925758|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43925759|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925760|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925761|NCT00597493|Temozolomide|temozolomide|mesh-list
43925762|NCT00597493|Sorafenib|sorafenib|mesh-list
43925763|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925764|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
43925765|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925766|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925767|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43925768|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925769|NCT00597727|Glycerol|glycerol|mesh-list
43925770|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43925771|NCT00597727|Protective Agents|protective agents|mesh-ancestor
43925772|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925773|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43925774|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43925775|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43925776|NCT00597818|Analgesics|analgesics|mesh-ancestor
43925777|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
43925778|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925779|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925780|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925781|NCT00597896|Pramipexole|pramipexole|mesh-list
43925791|NCT00598507|Sagopilone|sagopilone|mesh-list
43925792|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925793|NCT00598663|Insulin|insulin|mesh-list
43925794|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43925795|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43925796|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925797|NCT00598806|Apaziquone|apaziquone|mesh-list
43925798|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925799|NCT00599053|Azithromycin|azithromycin|mesh-list
43925800|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925801|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925802|NCT00600340|Paclitaxel|paclitaxel|mesh-list
43925803|NCT00600340|Bevacizumab|bevacizumab|mesh-list
43925804|NCT00600340|Capecitabine|capecitabine|mesh-list
43925805|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43925806|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925807|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
43925808|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
43925809|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
43925810|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925811|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925812|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43925813|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925814|NCT00600340|Growth Substances|growth substances|mesh-ancestor
43925815|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925816|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925817|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925818|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
43925819|NCT00600925|Gentamicins|gentamicins|mesh-list
43925820|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43925821|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925822|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43925823|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44139994|NCT00177138|Tacrolimus|tacrolimus|mesh-list
44139995|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44139996|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
44139997|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44139998|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44139999|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140000|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140001|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44140002|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140003|NCT00177242|Gefitinib|gefitinib|mesh-list
44140004|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140005|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44140006|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140007|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140008|NCT00177281|Belotecan|belotecan|mesh-list
44140009|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44140010|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140012|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140013|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140014|NCT00177333|Doxycycline|doxycycline|mesh-list
44140015|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44140016|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140017|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
44140018|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44140019|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44140020|NCT00177372|Misoprostol|misoprostol|mesh-list
44140021|NCT00177372|Mifepristone|mifepristone|mesh-list
44140022|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44140023|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
43925829|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925830|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
43925831|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925832|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925833|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
43925834|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43925835|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925836|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925837|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
43925838|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925839|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925840|NCT00601718|Rituximab|rituximab|mesh-list
43925841|NCT00601718|Carboplatin|carboplatin|mesh-list
43925842|NCT00601718|Etoposide|etoposide|mesh-list
43925843|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
43925844|NCT00601718|Ifosfamide|ifosfamide|mesh-list
43925845|NCT00601718|Vorinostat|vorinostat|mesh-list
43925846|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43925847|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925848|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
43925849|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925850|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925851|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43925852|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925853|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925860|NCT00601796|Tretinoin|tretinoin|mesh-list
43925877|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43925879|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925880|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
43925881|NCT00601965|Citalopram|citalopram|mesh-list
43925882|NCT00601965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43925883|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43925884|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925885|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925886|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925887|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
43925888|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925889|NCT00601965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43925890|NCT00601965|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925891|NCT00601965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925892|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43925893|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43925894|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925895|NCT00602225|Cytarabine|cytarabine|mesh-list
43925896|NCT00602225|Clofarabine|clofarabine|mesh-list
43925897|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43925898|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
43671419|NCT04656184|Antibodies|antibodies|mesh-list
44140036|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
43925900|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925923|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925924|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43925925|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43925926|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925927|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925928|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925929|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
43925930|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925931|NCT00602446|Deferasirox|deferasirox|mesh-list
43925932|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43925933|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
43925934|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
43925935|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925936|NCT00602771|Etoposide|etoposide|mesh-list
43925937|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
43925938|NCT00602771|Tipifarnib|tipifarnib|mesh-list
43925939|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43925940|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925941|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43925942|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43925943|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925944|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925946|NCT00602836|Rituximab|rituximab|mesh-list
43925947|NCT00602836|Lenalidomide|lenalidomide|mesh-list
43925948|NCT00602836|Pentostatin|pentostatin|mesh-list
43925949|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43925950|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
43925951|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925952|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43925953|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43925954|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
43925955|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925956|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43925963|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43925964|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925965|NCT00603018|Fluoxetine|fluoxetine|mesh-list
43925966|NCT00603018|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43925967|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43925968|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43925969|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43925970|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43925971|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
43925972|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43925973|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43925974|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
43925975|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43925976|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43925977|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43925978|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43925979|NCT00603044|Fluticasone|fluticasone|mesh-list
43925980|NCT00603044|Xhance|xhance|mesh-list
43925981|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43925982|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43925983|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
43925984|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43925986|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43926013|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926014|NCT00603720|Protective Agents|protective agents|mesh-ancestor
43926015|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926016|NCT00603993|Adalimumab|adalimumab|mesh-list
43926017|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926018|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926020|NCT00604019|Norepinephrine|norepinephrine|mesh-list
43926021|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43926022|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43926023|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926024|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926025|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926026|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926027|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
43926028|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
43926029|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926030|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43926031|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43926071|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926072|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43926073|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43926074|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43926075|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926076|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926077|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43926078|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43926079|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43926080|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43926081|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
43926082|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
43926083|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43926084|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43926085|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
43926086|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926087|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43926088|NCT00605072|Protective Agents|protective agents|mesh-ancestor
43926089|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43926090|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43926091|NCT00605202|Diuretics|diuretics|mesh-ancestor
43926092|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
43926093|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926094|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43926095|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926096|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926097|NCT00605384|Tenofovir|tenofovir|mesh-list
43926098|NCT00605384|Lamivudine|lamivudine|mesh-list
43926099|NCT00605384|Entecavir|entecavir|mesh-list
43926100|NCT00605384|Adefovir|adefovir|mesh-list
43926101|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
43926102|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926112|NCT00605423|Hormones|hormones|mesh-ancestor
43926113|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43926114|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926115|NCT00605696|Insulin|insulin|mesh-list
43926116|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43926117|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926118|NCT00605904|Acamprosate|acamprosate|mesh-list
43926119|NCT00605904|Yohimbine|yohimbine|mesh-list
43926120|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43926121|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
43926122|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
43926123|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926124|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926125|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43926126|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43926127|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43926128|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926129|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926130|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926131|NCT00605904|Urological Agents|urological agents|mesh-ancestor
43926132|NCT00606138|Ranibizumab|ranibizumab|mesh-list
43926133|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926134|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926135|NCT00606138|Growth Substances|growth substances|mesh-ancestor
43926136|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926137|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926138|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926140|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926141|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926142|NCT00606489|Analgesics|analgesics|mesh-ancestor
43926143|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
43926144|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926145|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926146|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926152|NCT00607113|Everolimus|everolimus|mesh-list
43926153|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926154|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926155|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926156|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926157|NCT00607113|Growth Substances|growth substances|mesh-ancestor
43926158|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926159|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926160|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926161|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
43926162|NCT00607594|Saracatinib|saracatinib|mesh-list
43926163|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926164|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926165|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926166|NCT00607672|Candesartan|candesartan|mesh-list
43926167|NCT00607672|Ramipril|ramipril|mesh-list
43926168|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43926169|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43926170|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43926171|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926172|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43926173|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
43926174|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926176|NCT00608062|Ganirelix|ganirelix|mesh-list
43926177|NCT00608062|Estrogens|estrogens|mesh-ancestor
43926178|NCT00608062|Hormones|hormones|mesh-ancestor
43926179|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43926180|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926181|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
43926182|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
43926183|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926184|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926185|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926186|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43926187|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926188|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926189|NCT00609128|Analgesics|analgesics|mesh-ancestor
43926190|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
43926191|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926192|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926193|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926194|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926195|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43926196|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43926197|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43926198|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
43926199|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
43926200|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926201|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926202|NCT00609739|Cytarabine|cytarabine|mesh-list
43926203|NCT00609739|Cyclosporine|cyclosporine|mesh-list
43926204|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
43926205|NCT00609739|Methotrexate|methotrexate|mesh-list
43926206|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
43926207|NCT00609739|Tretinoin|tretinoin|mesh-list
43926208|NCT00609739|Isotretinoin|isotretinoin|mesh-list
43926209|NCT00609739|Cyclosporins|cyclosporins|mesh-list
43926210|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43926211|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
43926212|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43926213|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926214|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926215|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
43926216|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926217|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926218|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
43926219|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926234|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
43926235|NCT00609739|Hormones|hormones|mesh-ancestor
43926236|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43926237|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43926238|NCT00609739|Protective Agents|protective agents|mesh-ancestor
43926239|NCT00609739|Analgesics|analgesics|mesh-ancestor
43926240|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
43926241|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43926242|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926243|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
43926244|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43926245|NCT00609804|Sorafenib|sorafenib|mesh-list
43926246|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926247|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926248|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926249|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926250|NCT00610311|Aldesleukin|aldesleukin|mesh-list
43926251|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
43926252|NCT00610311|Fludarabine|fludarabine|mesh-list
43926253|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
43926254|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926255|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
43926256|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926257|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926258|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926259|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
43926260|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926261|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926262|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926263|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926264|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
43926265|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43926266|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43926276|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926277|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926278|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926279|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43926280|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
43926281|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926282|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926283|NCT00610688|Vitamin D|vitamin d|mesh-list
43926284|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
43926285|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
43926286|NCT00610688|Vitamins|vitamins|mesh-list
43926287|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
43926288|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926289|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43926290|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43926291|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
43926292|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
43926293|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
43926294|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926295|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926296|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926297|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926298|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926299|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926300|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926301|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43926302|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
43926303|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926304|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926305|NCT00610740|Gemcitabine|gemcitabine|mesh-list
43926306|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926307|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
43926308|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926309|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926310|NCT00610740|Antiviral Agents|antiviral agents|mesh-ancestor
43926311|NCT00610740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926312|NCT00610740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926314|NCT00610740|Immunologic Factors|immunologic factors|mesh-ancestor
43926315|NCT00610740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926316|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
43926318|NCT00610883|Asparaginase|asparaginase|mesh-list
43926319|NCT00610883|Daunorubicin|daunorubicin|mesh-list
43926320|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926322|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926323|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926324|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926325|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
43926326|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926327|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926328|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926329|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43926330|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
43926331|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43926332|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926333|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
43926334|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
43926335|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926336|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43926337|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926338|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43926339|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43926340|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926341|NCT00610987|Cefazolin|cefazolin|mesh-list
43926342|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43926343|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926344|NCT00611325|Bevacizumab|bevacizumab|mesh-list
43926345|NCT00611325|Bortezomib|bortezomib|mesh-list
43926346|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926347|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926348|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43671753|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43962684|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
44169978|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169979|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169980|NCT00278824|Fentanyl|fentanyl|mesh-list
43926349|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926350|NCT00611325|Growth Substances|growth substances|mesh-ancestor
43926351|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926352|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926353|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
43926354|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
43926356|NCT00611351|Tacrolimus|tacrolimus|mesh-list
43926357|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43926358|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926359|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
43926360|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926361|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926362|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926363|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
43926364|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926365|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926366|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926367|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43926368|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926369|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43926370|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43926371|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
43926372|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43926373|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926374|NCT00611403|Cyclosporine|cyclosporine|mesh-list
43926375|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
43926376|NCT00611403|Cyclosporins|cyclosporins|mesh-list
43926377|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926378|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926379|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926380|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
44169981|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44169982|NCT00278824|Narcotics|narcotics|mesh-ancestor
44169983|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169984|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169985|NCT00278824|Analgesics|analgesics|mesh-ancestor
44169986|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
44169987|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169988|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44169989|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44169990|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
44169991|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
44169992|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43926381|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926382|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
43926383|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926384|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
43926385|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926386|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43926387|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43926388|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43926451|NCT00612235|Levetiracetam|levetiracetam|mesh-list
43926452|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
43926453|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
43926454|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43926455|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926456|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926457|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43926458|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926459|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926460|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926461|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926462|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926463|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43926464|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
43926465|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926466|NCT00612235|Analgesics|analgesics|mesh-ancestor
43926467|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
43926468|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926469|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43926470|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43926471|NCT00612339|Bevacizumab|bevacizumab|mesh-list
43926472|NCT00612339|Temozolomide|temozolomide|mesh-list
43926473|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926474|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926475|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43837942|NCT04877639|Analgesics|analgesics|mesh-ancestor
43926476|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926484|NCT00612430|Etoposide|etoposide|mesh-list
43926494|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43926495|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926496|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926497|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926498|NCT00612560|Anastrozole|anastrozole|mesh-list
43926499|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43926500|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926501|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43926502|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43926503|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926504|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926505|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43926506|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
43926507|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43926508|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926509|NCT00612573|Doxycycline|doxycycline|mesh-list
43926510|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43926511|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926512|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
43926513|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43926514|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43926515|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
43926516|NCT00612716|Busulfan|busulfan|mesh-list
43926517|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926526|NCT00613028|Bevacizumab|bevacizumab|mesh-list
43926542|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
43926543|NCT00613379|Leronlimab|leronlimab|mesh-list
43926544|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
43926545|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43926546|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43926547|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926548|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43926549|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43926550|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
43926551|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926552|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
43926553|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926554|NCT00614198|Caseins|caseins|mesh-list
43926555|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
43926556|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
43926557|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926558|NCT00614406|Celecoxib|celecoxib|mesh-list
43926559|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926560|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926561|NCT00614406|Analgesics|analgesics|mesh-ancestor
43926562|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
43926563|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926564|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926565|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926566|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926567|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43926568|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43926569|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926570|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671915|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43671916|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43671922|NCT03381183|Durvalumab|durvalumab|mesh-list
43926572|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
43926573|NCT00614445|Doxylamine|doxylamine|mesh-list
43926574|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
43926575|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
43926576|NCT00614445|Vitamins|vitamins|mesh-ancestor
43926578|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926579|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
43926580|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
43926581|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926582|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926583|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43926584|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
43926585|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
43926586|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926587|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926588|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
43926589|NCT00614458|Valproic Acid|valproic acid|mesh-list
43926590|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43926591|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43926592|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
43926593|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926594|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43926595|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43926596|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926597|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926598|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
43926599|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
43926600|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926601|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926602|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
43926603|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43799330|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44169993|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44169994|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44169995|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44169996|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44169997|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
44169998|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169999|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44170000|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170001|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170002|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170003|NCT00278967|Bisacodyl|bisacodyl|mesh-list
44170004|NCT00278967|Cathartics|cathartics|mesh-ancestor
44170005|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170006|NCT00278967|Laxatives|laxatives|mesh-ancestor
44170007|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
44170008|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44170009|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
44170010|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170011|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170012|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44170013|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170014|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
44170015|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43926604|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926605|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926606|NCT00614484|Paclitaxel|paclitaxel|mesh-list
43926607|NCT00614484|Carboplatin|carboplatin|mesh-list
43926608|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43926609|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926610|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
43926611|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
43926612|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
43926613|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140037|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140038|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
44140039|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44140040|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44157422|NCT00234416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157423|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157425|NCT00234429|Raltitrexed|raltitrexed|mesh-list
44157426|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157427|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157428|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157429|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157430|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157431|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
44157432|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44157433|NCT00234442|Gefitinib|gefitinib|mesh-list
44157434|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157435|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157436|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157437|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926615|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43926616|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
43926617|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
43926618|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926619|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926620|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926621|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926622|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926623|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926624|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926625|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43926626|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43926627|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926628|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926629|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926630|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
43926631|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43926632|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43926633|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43926634|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926635|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43926636|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43926637|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43926638|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43926639|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
43926640|NCT00615472|Remifentanil|remifentanil|mesh-list
43926642|NCT00615472|Isoflurane|isoflurane|mesh-list
43926643|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43926644|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926645|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926646|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43926647|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
43926655|NCT00615589|Fludarabine|fludarabine|mesh-list
43926658|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926659|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926660|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
43926661|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926662|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
43926663|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926664|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926665|NCT00615784|Bexarotene|bexarotene|mesh-list
43926666|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926667|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
43926668|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
43926669|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926670|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926671|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926672|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926673|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
43926674|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926675|NCT00616109|Sunitinib|sunitinib|mesh-list
43926676|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926677|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926678|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926679|NCT00616109|Growth Substances|growth substances|mesh-ancestor
43926680|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926681|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926682|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926683|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926684|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926685|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
43926686|NCT00616122|Methotrexate|methotrexate|mesh-list
43926687|NCT00616122|Sunitinib|sunitinib|mesh-list
43926688|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170016|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
44170017|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170018|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170031|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170032|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170033|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170034|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170035|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43926689|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
43926690|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926691|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926692|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926693|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
43744726|NCT03170518|Canagliflozin|canagliflozin|mesh-list
43926694|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926695|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926696|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43926697|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43926698|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
43926699|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43926700|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926701|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
43926702|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
43926703|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926704|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43926705|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43926706|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926707|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926708|NCT00616122|Growth Substances|growth substances|mesh-ancestor
43926709|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926710|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926711|NCT00616772|Choline|choline|mesh-list
43926712|NCT00616772|Atorvastatin|atorvastatin|mesh-list
43926713|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
43926714|NCT00616772|Fenofibrate|fenofibrate|mesh-list
43926715|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43926716|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43926717|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
43926718|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926719|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43926720|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43926721|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926722|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
43926723|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926724|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
43926727|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926728|NCT00617097|Ketorolac|ketorolac|mesh-list
43926729|NCT00617097|Lidocaine|lidocaine|mesh-list
43926730|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
43926731|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
43926732|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926733|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926734|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
43926735|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926736|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43926737|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43926738|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43926739|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926740|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926741|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926742|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926743|NCT00617097|Analgesics|analgesics|mesh-ancestor
43926744|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926745|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926746|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43926747|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926748|NCT00617188|Fulvestrant|fulvestrant|mesh-list
43926749|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43926750|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926751|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43926752|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43926753|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
43926754|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170037|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170038|NCT00279123|Pantoprazole|pantoprazole|mesh-list
44170039|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44170040|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170041|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44170042|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170043|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170044|NCT00279162|Betamethasone|betamethasone|mesh-list
44170045|NCT00279162|Calcipotriene|calcipotriene|mesh-list
44170046|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170047|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
44170048|NCT00279162|Hormones|hormones|mesh-ancestor
44170049|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170050|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170051|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43926755|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926756|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43926757|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
43926758|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926759|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926760|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926761|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926762|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926764|NCT00617539|Temozolomide|temozolomide|mesh-list
43926765|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43926766|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43926767|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926768|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926769|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926770|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43926771|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
43926772|NCT00617942|Paclitaxel|paclitaxel|mesh-list
43926773|NCT00617942|Carboplatin|carboplatin|mesh-list
43926814|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
43926815|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43926816|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926817|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
43926818|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
43926819|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
43926820|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926821|NCT00618917|Trace Elements|trace elements|mesh-ancestor
43926822|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
43926823|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926824|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43926825|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
43926826|NCT00618917|Protective Agents|protective agents|mesh-ancestor
43926827|NCT00619060|Niacin|niacin|mesh-list
43926828|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
43926829|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43926830|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
43926831|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926832|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43926833|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
43926834|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
43926835|NCT00619060|Vitamins|vitamins|mesh-ancestor
43926836|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
43926837|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926838|NCT00619073|Aspirin|aspirin|mesh-list
43926839|NCT00619073|Clopidogrel|clopidogrel|mesh-list
43926840|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926841|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926842|NCT00619073|Analgesics|analgesics|mesh-ancestor
43926843|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
43926844|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926845|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926846|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170052|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170053|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44170054|NCT00279240|Metformin|metformin|mesh-list
44170055|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170056|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170057|NCT00279253|Clonidine|clonidine|mesh-list
44170058|NCT00279253|Analgesics|analgesics|mesh-ancestor
44170059|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
44170060|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926847|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926848|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43926849|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43926850|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926851|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43926852|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43926853|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837943|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
43926854|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
43926855|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43926856|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43926857|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43926858|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
43926859|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926860|NCT00619190|Aripiprazole|aripiprazole|mesh-list
43926861|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
43926862|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43926863|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43926864|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43926865|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43926866|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926867|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
43926868|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
43926869|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926870|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926871|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43926872|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43926873|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
43926874|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43926875|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43926876|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43926877|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43926878|NCT00619684|Lenalidomide|lenalidomide|mesh-list
43926879|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
43926880|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926887|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43926888|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
43926889|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43926890|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
43926891|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926892|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926893|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43926894|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
43926895|NCT00619970|Rifaximin|rifaximin|mesh-list
43926896|NCT00619970|Lactulose|lactulose|mesh-list
43926897|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43926898|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43926899|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43926900|NCT00620061|Lubiprostone|lubiprostone|mesh-list
43926901|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43926902|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43926903|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926904|NCT00620191|Metformin|metformin|mesh-list
43926905|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43926906|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926907|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
43926908|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43926909|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43926910|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
43926911|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43926912|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926913|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926934|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43926935|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
43926936|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43926937|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926938|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43926939|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926940|NCT00621530|Ketorolac|ketorolac|mesh-list
43926941|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43926942|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43926943|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43926944|NCT00621530|Analgesics|analgesics|mesh-ancestor
43926945|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
43926946|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926947|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926948|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43926949|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43926950|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43926951|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926952|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926953|NCT00621686|Bevacizumab|bevacizumab|mesh-list
43926954|NCT00621686|Sorafenib|sorafenib|mesh-list
43926955|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43926956|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926957|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43926958|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43926959|NCT00621686|Growth Substances|growth substances|mesh-ancestor
43926960|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926961|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
43926962|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43926963|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926977|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43926978|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43926979|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
43926980|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
43926981|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43926982|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43926983|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43926984|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
43926985|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
43926986|NCT00622895|Fludarabine|fludarabine|mesh-list
43926987|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
43926988|NCT00622895|Tacrolimus|tacrolimus|mesh-list
43926989|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43926990|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43926991|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
43926992|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43926993|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43926994|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
43926995|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43926996|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43926997|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43926998|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44170061|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170062|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44170063|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
44170064|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
44170065|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44170066|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44170067|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44170068|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
44170069|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170070|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170072|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
44170073|NCT00279266|Vitamins|vitamins|mesh-ancestor
44170074|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
44170075|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170076|NCT00279344|Fentanyl|fentanyl|mesh-list
44170077|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44170078|NCT00279344|Narcotics|narcotics|mesh-ancestor
44170079|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170080|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170081|NCT00279344|Analgesics|analgesics|mesh-ancestor
44170082|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
44170083|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170084|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44170085|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44170093|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170094|NCT00279435|Visilizumab|visilizumab|mesh-list
44170095|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
44170096|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170097|NCT00279448|Tamoxifen|tamoxifen|mesh-list
44170098|NCT00279448|Exemestane|exemestane|mesh-list
43926999|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43927000|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
43927001|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927002|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927004|NCT00623012|Tacrolimus|tacrolimus|mesh-list
43927005|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927006|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
43927007|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927008|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43927009|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927010|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927011|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927012|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927013|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43927014|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927015|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
43927016|NCT00623181|Vaccines|vaccines|mesh-list
43927017|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
43927018|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927019|NCT00623714|Fluticasone|fluticasone|mesh-list
43927020|NCT00623714|Xhance|xhance|mesh-list
43927021|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927022|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43927023|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
43927024|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927025|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927026|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43927028|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927046|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
43927047|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927048|NCT00624416|Prednisolone|prednisolone|mesh-list
43927049|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43927050|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
43927051|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43927052|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
43927053|NCT00624416|Cortisone|cortisone|mesh-list
43927054|NCT00624416|Isoproterenol|isoproterenol|mesh-list
43927055|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43927056|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
43927057|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927058|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
43927059|NCT00624416|Hormones|hormones|mesh-ancestor
43927060|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927061|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927062|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927063|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927064|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
43927065|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
43927066|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927067|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927068|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43927069|NCT00624416|Protective Agents|protective agents|mesh-ancestor
43927070|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44170099|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44170100|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
44170101|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170102|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170103|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44170104|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170105|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44170106|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44170107|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44170108|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44170109|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44170110|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170111|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170112|NCT00279461|Vitamin D|vitamin d|mesh-list
44170113|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
44170114|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
44170115|NCT00279461|Vitamins|vitamins|mesh-list
44170116|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
43745019|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745020|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43745021|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44170117|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170118|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44170119|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44170120|NCT00279487|Gabapentin|gabapentin|mesh-list
44170121|NCT00279487|Analgesics|analgesics|mesh-ancestor
44170122|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
44170123|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927071|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43927072|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927073|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927074|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927075|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43927076|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43927077|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927078|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43927079|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
43927081|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43927082|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927083|NCT00624559|Analgesics|analgesics|mesh-ancestor
43927084|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
43927085|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927086|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927087|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927088|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927089|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43927090|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43927091|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927092|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927093|NCT00624910|Bupivacaine|bupivacaine|mesh-list
43927094|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
43927095|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
43927096|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927097|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927098|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
43927099|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927100|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43927101|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
43927102|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43927103|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927104|NCT00624923|Analgesics|analgesics|mesh-ancestor
43927110|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43927111|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927112|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927114|NCT00625404|Emtricitabine|emtricitabine|mesh-list
43927115|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43927116|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
43927117|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927118|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43927119|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43927120|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927121|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927122|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43927123|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927124|NCT00625729|Aldesleukin|aldesleukin|mesh-list
43927125|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
43927126|NCT00625729|Rituximab|rituximab|mesh-list
43927127|NCT00625729|Fludarabine|fludarabine|mesh-list
43927128|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
43927129|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927130|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
43927131|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927132|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927133|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927134|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
43927135|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927136|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927137|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927138|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44140041|NCT00177398|Insulin|insulin|mesh-list
43927139|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927140|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
43927141|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43799757|NCT05002361|Hormones|hormones|mesh-ancestor
44170124|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170125|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
44170126|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44170127|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170128|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170129|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170130|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43927142|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927143|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
43927144|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927145|NCT00626210|Modafinil|modafinil|mesh-list
43927146|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43927147|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927148|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43927149|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43927150|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43927151|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927152|NCT00626340|Fluoxetine|fluoxetine|mesh-list
43927153|NCT00626340|Estrogens|estrogens|mesh-list
43927154|NCT00626340|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43927155|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927156|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927157|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927158|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927159|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
43927160|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927161|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43766506|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766507|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766508|NCT02406872|Propofol|propofol|mesh-list
43766509|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43927162|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927163|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927164|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43927165|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43927166|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927167|NCT00626340|Hormones|hormones|mesh-ancestor
43927168|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927169|NCT00626431|Leuprolide|leuprolide|mesh-list
43927170|NCT00626431|Hormones|hormones|mesh-list
43927171|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43927172|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927173|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927174|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43927178|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927180|NCT00626574|Hematinics|hematinics|mesh-ancestor
43927181|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
43927182|NCT00626626|Clofarabine|clofarabine|mesh-list
43927183|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
43927184|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43927185|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927186|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927187|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
43927188|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927189|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927190|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
43927191|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927192|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927193|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927194|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
43927195|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927196|NCT00626743|Amlodipine|amlodipine|mesh-list
43927197|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43927198|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43927199|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927200|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927201|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43927202|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927203|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
43927204|NCT00626782|Ranibizumab|ranibizumab|mesh-list
43927205|NCT00626782|Mitomycins|mitomycins|mesh-list
43927206|NCT00626782|Mitomycin|mitomycin|mesh-list
43927207|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43927208|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43927209|NCT00626782|Growth Substances|growth substances|mesh-ancestor
43927222|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927223|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
43927224|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927225|NCT00627367|Hydromorphone|hydromorphone|mesh-list
43927226|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43927227|NCT00627367|Narcotics|narcotics|mesh-ancestor
43927228|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927229|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927230|NCT00627367|Analgesics|analgesics|mesh-ancestor
43927231|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
43927232|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927233|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43927234|NCT00627406|Buserelin|buserelin|mesh-list
43927235|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927236|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927237|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43927238|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
43927239|NCT00627679|Budesonide|budesonide|mesh-list
43927240|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927241|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43927242|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
43927243|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927244|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927245|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43927246|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927247|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
43927248|NCT00627679|Hormones|hormones|mesh-ancestor
43927249|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927250|NCT00627861|Metoprolol|metoprolol|mesh-list
43927251|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43927252|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43927253|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
43927265|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927266|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43927267|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43927268|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927269|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927270|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927271|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927272|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927273|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927275|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43927276|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43927277|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927278|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43927279|NCT00628589|Loxapine|loxapine|mesh-list
43927280|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43927281|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927282|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927283|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927284|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927285|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43927286|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
43927287|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927288|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927290|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
43927291|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927292|NCT00629122|Clotrimazole|clotrimazole|mesh-list
43927293|NCT00629122|Miconazole|miconazole|mesh-list
44170131|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44170132|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170133|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170134|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
44170135|NCT00279539|Mitogens|mitogens|mesh-list
44170136|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
44170137|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170138|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170139|NCT00279539|Growth Substances|growth substances|mesh-ancestor
44170140|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170141|NCT00279565|Interferons|interferons|mesh-list
44170143|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
44170144|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
44170145|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44170146|NCT00279565|Buprenorphine|buprenorphine|mesh-list
44170147|NCT00279565|Methadone|methadone|mesh-list
44170148|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170149|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
43927295|NCT00629122|Tacrolimus|tacrolimus|mesh-list
43927296|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927297|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
43927298|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927299|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43927300|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927301|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927302|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43927303|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927304|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
43927305|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43927306|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43927307|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43927308|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
43927309|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927310|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43927311|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43927312|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927313|NCT00629122|Ionophores|ionophores|mesh-ancestor
43927314|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927315|NCT00629499|Paclitaxel|paclitaxel|mesh-list
43927316|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
43927317|NCT00629499|Trastuzumab|trastuzumab|mesh-list
43927318|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43927319|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927320|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
43927321|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
43927322|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
43927324|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927336|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927337|NCT00630253|Cyclosporine|cyclosporine|mesh-list
43927338|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
43927339|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
43927340|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
43927341|NCT00630253|Fludarabine|fludarabine|mesh-list
43927342|NCT00630253|Cyclosporins|cyclosporins|mesh-list
43927343|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43927344|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927345|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
43927346|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927347|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927348|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927349|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
43927351|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140053|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140054|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140055|NCT00177424|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140056|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140057|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140058|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140059|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140060|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
44140061|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140062|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44140063|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44140064|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140065|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140066|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140067|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140068|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140069|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140070|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140071|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140073|NCT00177567|Valproic Acid|valproic acid|mesh-list
44140074|NCT00177567|Olanzapine|olanzapine|mesh-list
44140075|NCT00177567|Risperidone|risperidone|mesh-list
44140076|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
44140077|NCT00177567|Mirtazapine|mirtazapine|mesh-list
44140078|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
44140079|NCT00177567|Bupropion|bupropion|mesh-list
44140080|NCT00177567|Paroxetine|paroxetine|mesh-list
44140081|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44140082|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44140083|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
44140084|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927394|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927395|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43927396|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927397|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
43927398|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927399|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43927400|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43927401|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43927402|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43927403|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
43927404|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43927405|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43927406|NCT00630955|Memantine|memantine|mesh-list
43927407|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43927408|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43927409|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
43927410|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927411|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927412|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927413|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43927414|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43927415|NCT00631319|Hydromorphone|hydromorphone|mesh-list
43766521|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927416|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43927417|NCT00631319|Narcotics|narcotics|mesh-ancestor
43927418|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927419|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927420|NCT00631319|Analgesics|analgesics|mesh-ancestor
43927421|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
43927422|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927423|NCT00631358|Dexamethasone|dexamethasone|mesh-list
43927424|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927425|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
43927426|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
43927427|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927428|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927429|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927431|NCT00631358|Hormones|hormones|mesh-ancestor
43927432|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927433|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927434|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927435|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
43927436|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43927437|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927438|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
43927439|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927440|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43927441|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43927442|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927443|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927444|NCT00631566|Mupirocin|mupirocin|mesh-list
43927445|NCT00631566|Triclosan|triclosan|mesh-list
43927446|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
43927447|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927448|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927449|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43927450|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927451|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927452|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43927453|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43927483|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43927484|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43927485|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927486|NCT00632632|Cycloserine|cycloserine|mesh-list
43927487|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43927488|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927489|NCT00632632|Renal Agents|renal agents|mesh-ancestor
43927490|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43927491|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
43927492|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927493|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
43927494|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927495|NCT00632814|Factor VIII|factor viii|mesh-list
43927496|NCT00632814|Coagulants|coagulants|mesh-ancestor
43927497|NCT00632970|Ritonavir|ritonavir|mesh-list
43927498|NCT00632970|Lopinavir|lopinavir|mesh-list
43927499|NCT00632970|Tenofovir|tenofovir|mesh-list
43927500|NCT00632970|Emtricitabine|emtricitabine|mesh-list
43927501|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
43927502|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43927503|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43927504|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43927505|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
43927506|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927507|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927508|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43927509|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927510|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
43927511|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927512|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43927513|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43927514|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44170150|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651831|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44170151|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
44170152|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170153|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
44170154|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170155|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44170156|NCT00279565|Narcotics|narcotics|mesh-ancestor
44170157|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170162|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
44170163|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927515|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43927516|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43927517|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43927518|NCT00633256|Isoniazid|isoniazid|mesh-list
43927519|NCT00633256|Cycloserine|cycloserine|mesh-list
43927520|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
43927521|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927522|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927523|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43927524|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43927525|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
43927526|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927527|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43927528|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43927529|NCT00633256|Renal Agents|renal agents|mesh-ancestor
43927530|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43927531|NCT00633399|Ziprasidone|ziprasidone|mesh-list
43927532|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43927533|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
43927534|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927535|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927536|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927537|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43927543|NCT00633919|Prednisone|prednisone|mesh-list
43927566|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
43927567|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927568|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43927569|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
43927570|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43927571|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43927572|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
43927573|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
43927574|NCT00634270|Sirolimus|sirolimus|mesh-list
43927575|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927576|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927577|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43927578|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927579|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
43927580|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927581|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
43927582|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927583|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43927584|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43927585|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927586|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927587|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927588|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927589|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927590|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43927591|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927592|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927594|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43927595|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43927596|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43927597|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927598|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
44170164|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
44170165|NCT00279578|Factor VIII|factor viii|mesh-list
44170166|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44170167|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44170168|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170169|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
43927599|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43927600|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
43927601|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927602|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927603|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43927604|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43927605|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43927606|NCT00635609|Doxycycline|doxycycline|mesh-list
43927607|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43927608|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927609|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
43927610|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43927611|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43927612|NCT00635817|Leuprolide|leuprolide|mesh-list
43927613|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43927614|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
43927615|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927616|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927617|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927618|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927619|NCT00636649|Citalopram|citalopram|mesh-list
43927620|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43927621|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927622|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927623|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927624|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927625|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
43927626|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927627|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43927628|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
43927629|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927630|NCT00636805|Dexamethasone|dexamethasone|mesh-list
43927631|NCT00636805|Palonosetron|palonosetron|mesh-list
43927632|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927633|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
43927634|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
44170170|NCT00279578|Coagulants|coagulants|mesh-ancestor
44170171|NCT00279617|Levetiracetam|levetiracetam|mesh-list
44170172|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
43927635|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927636|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927637|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927639|NCT00636805|Hormones|hormones|mesh-ancestor
43927640|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927641|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43927642|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927643|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43927644|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43927645|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
43927646|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927647|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927648|NCT00637247|Gemcitabine|gemcitabine|mesh-list
43927649|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927650|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
43927651|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927652|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927653|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
43927654|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927655|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927656|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927657|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
43927658|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927659|NCT00637494|Mifepristone|mifepristone|mesh-list
43927660|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43927661|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
43927662|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43927663|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927664|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43927665|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43927666|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43927667|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
43927668|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44170173|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
43927669|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43927670|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
43745440|NCT02425644|Analgesics|analgesics|mesh-ancestor
43927671|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43927672|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
43927673|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43927674|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43927675|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
43927676|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927677|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43927678|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927679|NCT00637780|Analgesics|analgesics|mesh-ancestor
43927680|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
43927681|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927682|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927683|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927684|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927685|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927686|NCT00637923|Ribavirin|ribavirin|mesh-list
43927687|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43927726|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927727|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43927728|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43927729|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927730|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
43927731|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927732|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
43927733|NCT00639717|Etanercept|etanercept|mesh-list
43927734|NCT00639717|Methoxsalen|methoxsalen|mesh-list
43927735|NCT00639717|Tacrolimus|tacrolimus|mesh-list
43927736|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927737|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
43927738|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927739|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43927740|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927741|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927742|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43927743|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927744|NCT00639717|Analgesics|analgesics|mesh-ancestor
43927745|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
43927746|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927747|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927748|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43927749|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43927750|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43927751|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927752|NCT00640822|Calcitriol|calcitriol|mesh-list
43927753|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
43927754|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43927755|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43927756|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43927757|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
43927758|NCT00640822|Calcipotriene|calcipotriene|mesh-list
43927759|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43927760|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927762|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927763|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43927764|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927765|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927766|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43927768|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
43927769|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43927770|NCT00640978|Everolimus|everolimus|mesh-list
43927771|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43927772|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927773|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43927774|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
43927775|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927776|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43927777|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927778|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927779|NCT00641563|Midazolam|midazolam|mesh-list
43927780|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
43927781|NCT00641563|Remifentanil|remifentanil|mesh-list
43927782|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43927783|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927784|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927785|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927786|NCT00641563|Analgesics|analgesics|mesh-ancestor
43927787|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
43927788|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927789|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43927790|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43927791|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43927792|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927793|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927794|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927795|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43927796|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43927797|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170174|NCT00279734|Abatacept|abatacept|mesh-list
44170175|NCT00279734|Vaccines|vaccines|mesh-list
43927798|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927799|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43927800|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
43927801|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
43927802|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
43927803|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
43927804|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43927805|NCT00641563|Narcotics|narcotics|mesh-ancestor
43927806|NCT00641641|Tenofovir|tenofovir|mesh-list
43927807|NCT00641641|Emtricitabine|emtricitabine|mesh-list
43927808|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
43927809|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
43927810|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927811|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43927812|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43927813|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927814|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927815|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43927816|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43927817|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43927818|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43927819|NCT00641745|Risperidone|risperidone|mesh-list
43927820|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43927821|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43927822|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
43927823|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927824|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927840|NCT00641797|Meclizine|meclizine|mesh-list
43927848|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
43927849|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
43927850|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43927851|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
43927852|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927853|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927854|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43927855|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927856|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927857|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927858|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43927859|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43927860|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43927861|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
43927862|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
43927863|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
43927864|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43927865|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
43927866|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
43927867|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43927868|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
43927869|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
43927870|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
43927871|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
43927872|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
43927873|NCT00641862|Vitamins|vitamins|mesh-ancestor
43766526|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43927874|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
43927875|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927876|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
43927877|NCT00641862|Hematinics|hematinics|mesh-ancestor
43927878|NCT00642694|Dexetimide|dexetimide|mesh-list
43927880|NCT00642694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43927881|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43927882|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43927883|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927884|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927889|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927890|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43927891|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43927892|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
43927893|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
43927894|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927895|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43927896|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43927897|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
43927898|NCT00643097|Temozolomide|temozolomide|mesh-list
43927899|NCT00643097|Sargramostim|sargramostim|mesh-list
43927900|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43927901|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
43927902|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927903|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927904|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
43927905|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927906|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
43927907|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43927908|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
43927909|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927910|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927911|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43927912|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
43927913|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43927914|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43927915|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43927916|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927917|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927933|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43927934|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
43927935|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927936|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927937|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927938|NCT00645333|Docetaxel|docetaxel|mesh-list
43927939|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927940|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
43927941|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
43927942|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
43927943|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927944|NCT00645450|Propranolol|propranolol|mesh-list
43927945|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43927946|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43927947|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927948|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927949|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927950|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927951|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43927952|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43927953|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
43927954|NCT00645710|Gemcitabine|gemcitabine|mesh-list
43927955|NCT00645710|Floxuridine|floxuridine|mesh-list
43927956|NCT00645710|Antibodies|antibodies|mesh-list
43927957|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43927958|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
43927959|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927960|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43927961|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
43927962|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927963|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43927964|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
43927965|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43927966|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43927967|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170176|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
44170177|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170178|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44170179|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927968|NCT00646581|Insulin|insulin|mesh-list
43927969|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43927970|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43927971|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927972|NCT00646646|Midazolam|midazolam|mesh-list
43927973|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
43927974|NCT00646646|Propofol|propofol|mesh-list
43927975|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43927976|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43927977|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43927978|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43927979|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
43927980|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
43927981|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43927982|NCT00646646|Analgesics|analgesics|mesh-ancestor
43927983|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
43927984|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43927985|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43927986|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43927987|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43927988|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
43927989|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43927990|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43927991|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43927992|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43927993|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43927994|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43927995|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
43927996|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
43927997|NCT00646763|Lenograstim|lenograstim|mesh-list
43928015|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928016|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928017|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43928018|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43928019|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
43928020|NCT00648648|Gemcitabine|gemcitabine|mesh-list
43928021|NCT00648648|Cisplatin|cisplatin|mesh-list
43928022|NCT00648648|Carboplatin|carboplatin|mesh-list
43928023|NCT00648648|Adavosertib|adavosertib|mesh-list
43928024|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928025|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43928026|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
43928027|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928028|NCT00648648|Antiviral Agents|antiviral agents|mesh-ancestor
43928029|NCT00648648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928030|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928031|NCT00648648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928032|NCT00648648|Immunologic Factors|immunologic factors|mesh-ancestor
43928071|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928073|NCT00651040|Hormones|hormones|mesh-ancestor
43928074|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928075|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928076|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928077|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928078|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43928079|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
43928080|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43928081|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43928082|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
43928083|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928084|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928085|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928086|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43928087|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928088|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
43928089|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928090|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43928091|NCT00651482|Bevacizumab|bevacizumab|mesh-list
43928092|NCT00651482|Everolimus|everolimus|mesh-list
43928093|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928094|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928095|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43928096|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43928097|NCT00651482|Growth Substances|growth substances|mesh-ancestor
43928098|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928099|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
43928100|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140101|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140102|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44140103|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44140104|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140105|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140106|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
44140107|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44140108|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
44140109|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44140110|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44140111|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44140112|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44140113|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
44140114|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
44140115|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43928139|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928141|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
43928142|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928143|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43928145|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
43928146|NCT00654069|Vitamins|vitamins|mesh-ancestor
43928147|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
43928148|NCT00654147|Ritonavir|ritonavir|mesh-list
43928149|NCT00654147|Lopinavir|lopinavir|mesh-list
43928150|NCT00654147|Tenofovir|tenofovir|mesh-list
43928151|NCT00654147|Emtricitabine|emtricitabine|mesh-list
43928152|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
43928153|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43928154|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43928155|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928156|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928157|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928158|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43928159|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43928160|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
43928161|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928162|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43928163|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43928164|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43928165|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43928166|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43928167|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43928168|NCT00654329|Fentanyl|fentanyl|mesh-list
43928169|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
43928170|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43928171|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928174|NCT00654329|Analgesics|analgesics|mesh-ancestor
43928182|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928183|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43928185|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43928186|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43928187|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
43928188|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
43928190|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
43928191|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43928192|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928193|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928194|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43928195|NCT00654511|Analgesics|analgesics|mesh-ancestor
43928196|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
43928197|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928200|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43928242|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928243|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928244|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
43928245|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
43928246|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43928247|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43928248|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928310|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928311|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928313|NCT00656448|Hematinics|hematinics|mesh-ancestor
43928314|NCT00656487|Rimonabant|rimonabant|mesh-list
43928315|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43928316|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43928317|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43928318|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928319|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928320|NCT00656487|Hormones|hormones|mesh-ancestor
43928321|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928322|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928323|NCT00656630|Naltrexone|naltrexone|mesh-list
43928324|NCT00656630|Acamprosate|acamprosate|mesh-list
43928325|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43928326|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43928327|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928328|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
44140124|NCT00177580|Pravastatin|pravastatin|mesh-list
43928329|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928330|NCT00656656|Dexamethasone|dexamethasone|mesh-list
43928331|NCT00656656|Rituximab|rituximab|mesh-list
43928332|NCT00656656|Azathioprine|azathioprine|mesh-list
43928333|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928334|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928335|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
43928336|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928337|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928338|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928339|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
43928340|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
43928341|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928342|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928343|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
43928344|NCT00656656|Hormones|hormones|mesh-ancestor
43928347|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
43928348|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928349|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43928350|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928351|NCT00656968|Esomeprazole|esomeprazole|mesh-list
43928352|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43928353|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928354|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43928355|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928356|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928357|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43928358|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43928359|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928360|NCT00657280|Incretins|incretins|mesh-ancestor
43928361|NCT00657280|Hormones|hormones|mesh-ancestor
43928362|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928363|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43928364|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928365|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928366|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928367|NCT00657917|Gentamicins|gentamicins|mesh-list
43928369|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43928370|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928371|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43928372|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928373|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928374|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43928375|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43928376|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43928377|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928378|NCT00658411|Deferoxamine|deferoxamine|mesh-list
43928379|NCT00658411|Siderophores|siderophores|mesh-ancestor
43928380|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43928381|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
43928382|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
44170180|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170181|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170182|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170183|NCT00279747|Naproxen|naproxen|mesh-list
43928383|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928385|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43928386|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43928387|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
43928388|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928389|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43928390|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43928391|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43928392|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43928393|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43928394|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43928395|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928396|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928397|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928398|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928399|NCT00658697|Bevacizumab|bevacizumab|mesh-list
44170184|NCT00279747|Meloxicam|meloxicam|mesh-list
44170185|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44170186|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44170187|NCT00279747|Analgesics|analgesics|mesh-ancestor
44170188|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
44170189|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170190|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170191|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170192|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170193|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
44170194|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44170195|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170196|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170197|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44170198|NCT00279760|Abatacept|abatacept|mesh-list
44170199|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44170200|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170201|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170202|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170203|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
44170204|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170205|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170206|NCT00279825|Levodopa|levodopa|mesh-list
44170207|NCT00279825|Carbidopa|carbidopa|mesh-list
44170208|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44170209|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44170210|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44170211|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
44170212|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170213|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170214|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170215|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44170217|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44170218|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
44170219|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
44170220|NCT00279903|Cortisone|cortisone|mesh-list
44170221|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
44170222|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43928400|NCT00658697|Docetaxel|docetaxel|mesh-list
43928401|NCT00658697|Bicalutamide|bicalutamide|mesh-list
43928402|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928403|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928404|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43928405|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43928406|NCT00658697|Growth Substances|growth substances|mesh-ancestor
43928407|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928408|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
43928409|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
43928410|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
43928411|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
43928412|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928413|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
43928414|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
43928415|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928417|NCT00658736|Bupivacaine|bupivacaine|mesh-list
43928418|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
43928419|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
43928420|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928421|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928422|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
43928423|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928424|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928425|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
43928426|NCT00658736|Hormones|hormones|mesh-ancestor
43928427|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928428|NCT00659165|Insulin|insulin|mesh-list
43928429|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43928430|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
43928431|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
43928432|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43928433|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928434|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
43800560|NCT04989348|Hormones|hormones|mesh-list
44170223|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44170224|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44170225|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170226|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928436|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928437|NCT00659360|Saracatinib|saracatinib|mesh-list
43928438|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928439|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928440|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928441|NCT00659633|Lidocaine|lidocaine|mesh-list
43928442|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
43928443|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
43928444|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928445|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928447|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928448|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43928449|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43928450|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43928451|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928452|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928453|NCT00659737|Scopolamine|scopolamine|mesh-list
43928454|NCT00659737|Aprepitant|aprepitant|mesh-list
43928455|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
43928456|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43928457|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
43928458|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
43928459|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800587|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
44170227|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
44170228|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170242|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44170243|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
44170244|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170246|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170247|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170248|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
44170249|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
44170250|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170251|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170252|NCT00280098|Docetaxel|docetaxel|mesh-list
44170253|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170254|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170255|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170256|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170257|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170258|NCT00280176|Fluorouracil|fluorouracil|mesh-list
44170259|NCT00280176|Bortezomib|bortezomib|mesh-list
44170260|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
44170261|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170262|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170263|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928460|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928461|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928462|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43928463|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928464|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928465|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43928466|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
43928467|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43928468|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
43928469|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43928470|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
43928471|NCT00659945|Ondansetron|ondansetron|mesh-list
43928472|NCT00659945|Aprepitant|aprepitant|mesh-list
43928473|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
43928474|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
43928475|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928476|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928477|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928478|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
43928479|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928480|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43928481|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
43928482|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928483|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170264|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170265|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
44170266|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170267|NCT00280215|Losartan|losartan|mesh-list
44170268|NCT00280215|Lisinopril|lisinopril|mesh-list
44170269|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44170270|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44170271|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44170272|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44170273|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44170274|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44170275|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170276|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44170277|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44170278|NCT00280215|Protective Agents|protective agents|mesh-ancestor
44170279|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170280|NCT00280267|Testosterone|testosterone|mesh-list
44170281|NCT00280267|Androgens|androgens|mesh-ancestor
44170282|NCT00280267|Hormones|hormones|mesh-ancestor
44170283|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170284|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170285|NCT00280280|Baclofen|baclofen|mesh-list
44170286|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44170287|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170288|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44170289|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928484|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43928485|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43928486|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928487|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928488|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43928489|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43928490|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43928491|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43928492|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928493|NCT00660075|Incretins|incretins|mesh-ancestor
43928495|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928496|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43928497|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928498|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928499|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928500|NCT00660504|Cisplatin|cisplatin|mesh-list
43928501|NCT00660504|Etoposide|etoposide|mesh-list
43928502|NCT00660504|Amrubicin|amrubicin|mesh-list
43928503|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928504|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43928505|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43928506|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43928507|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928508|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928509|NCT00660517|Fluticasone|fluticasone|mesh-list
43928510|NCT00660517|Xhance|xhance|mesh-list
43928511|NCT00660517|Azelastine|azelastine|mesh-list
43928512|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928513|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43928514|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
43928515|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928516|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928517|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43928518|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
43928519|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928520|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43928523|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928524|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43928525|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43928526|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
43928527|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
43928528|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928529|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43928530|NCT00660543|Hematinics|hematinics|mesh-ancestor
43928531|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43928532|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43928533|NCT00660985|Adapalene|adapalene|mesh-list
43928534|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43928535|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43928536|NCT00660985|Analgesics|analgesics|mesh-ancestor
43928537|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
43928538|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928539|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928540|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928541|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928542|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928543|NCT00661141|Ethanol|ethanol|mesh-list
43928544|NCT00661141|Fomepizole|fomepizole|mesh-list
43928545|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43928546|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928547|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170290|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44170314|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44170315|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
44170316|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170317|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170318|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44170319|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170320|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44170321|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44170322|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44170323|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
44170324|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170325|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170326|NCT00280423|Casopitant|casopitant|mesh-list
44170327|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
44170328|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
44170329|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170330|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170331|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170332|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44170333|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170334|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170335|NCT00280436|Casopitant|casopitant|mesh-list
44170336|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
43928548|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928549|NCT00661141|Antidotes|antidotes|mesh-ancestor
43928550|NCT00661141|Protective Agents|protective agents|mesh-ancestor
43928551|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928552|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928553|NCT00661453|Valproic Acid|valproic acid|mesh-list
43928554|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
43928555|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928556|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928557|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
43928558|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928559|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928560|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
43928561|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43928562|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928563|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928564|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43928565|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43928566|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43928567|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43928568|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43928569|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928570|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928571|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928572|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170337|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
44170338|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170339|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170340|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170341|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44170344|NCT00280462|Nifedipine|nifedipine|mesh-list
44170345|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44170346|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170347|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170348|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44170349|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170350|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
44170351|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
44170352|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44170353|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44170354|NCT00280501|Sulpiride|sulpiride|mesh-list
44170355|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
44170356|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170357|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44170358|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170359|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170360|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928573|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
43928574|NCT00661544|Melphalan|melphalan|mesh-list
43928575|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
43928576|NCT00661544|Vitamins|vitamins|mesh-ancestor
43928577|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
43928578|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928579|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43928580|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
43928581|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928582|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928583|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43928584|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928585|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
43928586|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
43928587|NCT00661544|Protective Agents|protective agents|mesh-ancestor
43928588|NCT00661583|Ranibizumab|ranibizumab|mesh-list
43928589|NCT00661583|Mitomycins|mitomycins|mesh-list
43928590|NCT00661583|Mitomycin|mitomycin|mesh-list
43928591|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43928592|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43928593|NCT00661583|Growth Substances|growth substances|mesh-ancestor
43928594|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928595|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
43928596|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928597|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43928598|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
43928599|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928601|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928623|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43928624|NCT00661895|Clonidine|clonidine|mesh-list
43928625|NCT00661895|Lisinopril|lisinopril|mesh-list
43928626|NCT00661895|Doxazosin|doxazosin|mesh-list
43928627|NCT00661895|Hydralazine|hydralazine|mesh-list
43928628|NCT00661895|Nifedipine|nifedipine|mesh-list
43928629|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43928630|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43928631|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928632|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928633|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43928634|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928635|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
43928636|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43928637|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43928638|NCT00661895|Diuretics|diuretics|mesh-ancestor
43928639|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
43928640|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43928641|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43928642|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
43928643|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
43928644|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928645|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43928646|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43928647|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43928671|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928672|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43928673|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43928674|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43928675|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43928676|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43928677|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43928678|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43928679|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43928680|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43928681|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43928683|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43928684|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43928685|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928686|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928687|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43928688|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
43928689|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
43928690|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928691|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928692|NCT00662298|Prednisolone|prednisolone|mesh-list
43928693|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928694|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
43928695|NCT00662298|Hormones|hormones|mesh-ancestor
43928696|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928697|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928698|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928699|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928700|NCT00662545|Tenofovir|tenofovir|mesh-list
43928701|NCT00662545|Lamivudine|lamivudine|mesh-list
43928702|NCT00662545|Emtricitabine|emtricitabine|mesh-list
43928703|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43928705|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43928706|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
43928707|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800687|NCT04986254|Meropenem|meropenem|mesh-list
43928708|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43928709|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43928710|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928711|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928712|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43928713|NCT00662675|Pancrelipase|pancrelipase|mesh-list
43928714|NCT00662675|Pancreatin|pancreatin|mesh-list
43928715|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928716|NCT00662818|Acetaminophen|acetaminophen|mesh-list
43928717|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43928718|NCT00662818|Analgesics|analgesics|mesh-ancestor
43928719|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
43928720|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928771|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928772|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43928773|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928774|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827445|NCT05488457|Oxytocin|oxytocin|mesh-list
43928775|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43928776|NCT00664430|Vitamins|vitamins|mesh-ancestor
43928777|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
43928778|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43928779|NCT00664755|Nicotine|nicotine|mesh-list
43928780|NCT00664755|Varenicline|varenicline|mesh-list
43928781|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43928782|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
43928783|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928784|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928785|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43928786|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43928787|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
43928788|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928789|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928790|NCT00665457|Celecoxib|celecoxib|mesh-list
43928791|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
43928792|NCT00665457|Docetaxel|docetaxel|mesh-list
43928793|NCT00665457|Doxorubicin|doxorubicin|mesh-list
43928794|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43928795|NCT00665457|Capecitabine|capecitabine|mesh-list
43928796|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928797|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
43928798|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928799|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800741|NCT04985526|Octenidine|octenidine|mesh-list
43928815|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43928816|NCT00665457|Analgesics|analgesics|mesh-ancestor
43928817|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
43928818|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928819|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928820|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43928821|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43928822|NCT00665470|Aldesleukin|aldesleukin|mesh-list
43928823|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928824|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43928825|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43928826|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
43928827|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928828|NCT00666029|Atorvastatin|atorvastatin|mesh-list
43928829|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43928830|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43928831|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
43928832|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928833|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43928834|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43928835|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928836|NCT00666406|Factor VIII|factor viii|mesh-list
43928837|NCT00666406|Coagulants|coagulants|mesh-ancestor
43928838|NCT00666666|Acetic Acid|acetic acid|mesh-list
43928839|NCT00666666|Bicalutamide|bicalutamide|mesh-list
43928840|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
43928841|NCT00666666|Gossypol|gossypol|mesh-list
43928842|NCT00666666|Hormones|hormones|mesh-list
43928843|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928844|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928845|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
43928846|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
43928847|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928848|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43928849|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43928850|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43928851|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44170361|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44170362|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
43928852|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
43928853|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43928854|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43673695|NCT01780428|Acetaminophen|acetaminophen|mesh-list
43928855|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43928856|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43928857|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43928858|NCT00666848|Enalapril|enalapril|mesh-list
43928859|NCT00666848|Enalaprilat|enalaprilat|mesh-list
43928860|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43928861|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928862|NCT00666848|Incretins|incretins|mesh-ancestor
43928863|NCT00666848|Hormones|hormones|mesh-ancestor
43928864|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928865|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43928866|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
43928867|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928868|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928869|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43928870|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43928871|NCT00666978|Bupropion|bupropion|mesh-list
43928872|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43928873|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
43928874|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928875|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43928876|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43928877|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928878|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928879|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
43928885|NCT00667004|Ecabet|ecabet|mesh-list
43928893|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928894|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43928895|NCT00667004|Protective Agents|protective agents|mesh-ancestor
43928896|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928897|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928898|NCT00667589|Fluocinonide|fluocinonide|mesh-list
43928899|NCT00667589|Tazarotene|tazarotene|mesh-list
43928900|NCT00667589|Emollients|emollients|mesh-list
43928901|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
43928902|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
43928903|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928904|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
43928905|NCT00667589|Hormones|hormones|mesh-ancestor
43928906|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928907|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928908|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43928909|NCT00667615|Prednisone|prednisone|mesh-list
43928910|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
43928911|NCT00667615|Rituximab|rituximab|mesh-list
43928912|NCT00667615|Etoposide|etoposide|mesh-list
43928913|NCT00667615|Vorinostat|vorinostat|mesh-list
43928914|NCT00667615|Lenograstim|lenograstim|mesh-list
43928915|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928916|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
43928917|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928918|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928919|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43928920|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
43928921|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928922|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928923|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43928924|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928925|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928926|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
43928927|NCT00667615|Hormones|hormones|mesh-ancestor
43710257|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928928|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928929|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928931|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43928933|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928934|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43928935|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44140125|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44140126|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44140127|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
44140128|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140129|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44140130|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44140131|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140132|NCT00177619|Alendronate|alendronate|mesh-list
44140133|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44140134|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140135|NCT00177684|Amphotericin B|amphotericin b|mesh-list
44140136|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44140137|NCT00177684|Amebicides|amebicides|mesh-ancestor
44140138|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44140139|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44170363|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170364|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170365|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44170366|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
44170367|NCT00280514|Cefpirome|cefpirome|mesh-list
44170368|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170369|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170370|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44170371|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44170372|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170373|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170374|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170375|NCT00280540|Valsartan|valsartan|mesh-list
44170376|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44170377|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44170378|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44170379|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44170380|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170381|NCT00280540|Diuretics|diuretics|mesh-ancestor
44170382|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
44170383|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170384|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44170385|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170386|NCT00280553|Bupivacaine|bupivacaine|mesh-list
44170387|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
44170388|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
44170389|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170390|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170391|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
44170392|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170393|NCT00280605|Alfuzosin|alfuzosin|mesh-list
44170394|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44140140|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140141|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44140142|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
44140143|NCT00177710|Amphotericin B|amphotericin b|mesh-list
44140144|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44140145|NCT00177710|Amebicides|amebicides|mesh-ancestor
44140146|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44140147|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44140148|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140149|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44140150|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
44140151|NCT00177749|Posaconazole|posaconazole|mesh-list
44140152|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
44140153|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140154|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44140155|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44140156|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44140157|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44140158|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140159|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653230|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140160|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140161|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44140162|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
44140163|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140165|NCT00177853|Celecoxib|celecoxib|mesh-list
44140188|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140189|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140190|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
44140191|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140192|NCT00178035|Paroxetine|paroxetine|mesh-list
44140193|NCT00178035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43928936|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
43928937|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
43928938|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43928939|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928940|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928941|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
43928942|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43928943|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43928944|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928946|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43928947|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
43928948|NCT00668434|Hormones|hormones|mesh-ancestor
43928949|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43928950|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928951|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43928952|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928953|NCT00668525|Dexetimide|dexetimide|mesh-list
43928954|NCT00668525|Citalopram|citalopram|mesh-list
43928955|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43928956|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43928957|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43928958|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928959|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43928960|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
43928961|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928962|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43928963|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
43800846|NCT04982809|Prednisolone|prednisolone|mesh-list
44170395|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44170396|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44170397|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
43928965|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43928966|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43928967|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
43928968|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
43928969|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43928970|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43928971|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43928972|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
43928973|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
43928975|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
43928976|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43928977|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
43928978|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928979|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43928980|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43928981|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
43928982|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928983|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928984|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43928985|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43928986|NCT00668811|Sunitinib|sunitinib|mesh-list
43928987|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43928988|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43928989|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43928990|NCT00668811|Growth Substances|growth substances|mesh-ancestor
43928991|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43928992|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
43928993|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43928994|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43928995|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43928996|NCT00668902|Pantoprazole|pantoprazole|mesh-list
43928997|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43928998|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43928999|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43929000|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929003|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929004|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929005|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929006|NCT00669279|Atenolol|atenolol|mesh-list
43929007|NCT00669279|Carvedilol|carvedilol|mesh-list
43929008|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43929009|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43929010|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
43929011|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929012|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929013|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929014|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43929016|NCT00669279|Protective Agents|protective agents|mesh-ancestor
43929017|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43929018|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929019|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929020|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
43929021|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43929022|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43929023|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43929024|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
43929025|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
43929026|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929028|NCT00669383|Betamethasone|betamethasone|mesh-list
43929049|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929050|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
43929051|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929052|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929053|NCT00670241|Betamethasone|betamethasone|mesh-list
43929054|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
43929055|NCT00670241|Calcipotriene|calcipotriene|mesh-list
43929056|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929057|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
43929059|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929060|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929061|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43929062|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
43929063|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929064|NCT00670267|Nadolol|nadolol|mesh-list
43929065|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43929066|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43929067|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
43929068|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929069|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929070|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929071|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43929072|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43929073|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
43929074|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
43929075|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929076|NCT00670774|Eculizumab|eculizumab|mesh-list
43929077|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43929078|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929079|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
43929080|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929081|NCT00670956|Betamethasone|betamethasone|mesh-list
43673997|NCT01699464|Timolol|timolol|mesh-list
43929082|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929088|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
43929089|NCT00670982|Bevacizumab|bevacizumab|mesh-list
43929090|NCT00670982|Trastuzumab|trastuzumab|mesh-list
43929091|NCT00670982|Vinorelbine|vinorelbine|mesh-list
43929092|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929093|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929094|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929095|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929096|NCT00670982|Growth Substances|growth substances|mesh-ancestor
43929097|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929098|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929099|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43929100|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
43929101|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
43929102|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
43929103|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929104|NCT00671502|Carisoprodol|carisoprodol|mesh-list
43929105|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43929106|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929107|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43929108|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929109|NCT00671515|Pioglitazone|pioglitazone|mesh-list
43929110|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43929111|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929112|NCT00671970|Bevacizumab|bevacizumab|mesh-list
43929113|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43929114|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929115|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929116|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929117|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929118|NCT00671970|Growth Substances|growth substances|mesh-ancestor
43929119|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929120|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929121|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929122|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929123|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929124|NCT00672100|Ropivacaine|ropivacaine|mesh-list
43929125|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
43929126|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
43929127|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929128|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929129|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
43929130|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929131|NCT00672204|Sirolimus|sirolimus|mesh-list
43929132|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
43929133|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43929134|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43929135|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929136|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43929137|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929138|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
43929139|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929140|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
43929141|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929142|NCT00672243|Sirolimus|sirolimus|mesh-list
43929143|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43929144|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929145|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929146|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929147|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929148|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43929149|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929150|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43929151|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
43929152|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929153|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
43929154|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929155|NCT00672438|Alfentanil|alfentanil|mesh-list
44170398|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170399|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170400|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170401|NCT00280605|Urological Agents|urological agents|mesh-ancestor
44170402|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
44170403|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170404|NCT00280644|Leflunomide|leflunomide|mesh-list
44170405|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170406|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170407|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170408|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
43929156|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43929157|NCT00672438|Narcotics|narcotics|mesh-ancestor
43766622|NCT02406014|Diclofenac|diclofenac|mesh-list
43929158|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929159|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929160|NCT00672438|Analgesics|analgesics|mesh-ancestor
43929161|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
43929162|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929163|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43929164|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
43929165|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
43929167|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929168|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929169|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929170|NCT00672594|Growth Substances|growth substances|mesh-ancestor
43929171|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929172|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929173|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929174|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929175|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929176|NCT00672737|Remifentanil|remifentanil|mesh-list
43929177|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43929178|NCT00672737|Narcotics|narcotics|mesh-ancestor
43929179|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929180|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929181|NCT00672737|Analgesics|analgesics|mesh-ancestor
43929182|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
43929183|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929184|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43929185|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43929186|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43929197|NCT00673075|Carvedilol|carvedilol|mesh-list
43929199|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43929200|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43929201|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
43929202|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929203|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929204|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929205|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43929206|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
43929207|NCT00673075|Protective Agents|protective agents|mesh-ancestor
43929208|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43929209|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929210|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929211|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
43929212|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43929213|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43929214|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43929215|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43929216|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43929217|NCT00673127|Ketoconazole|ketoconazole|mesh-list
43929218|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
43929219|NCT00673127|Dutasteride|dutasteride|mesh-list
43929220|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929221|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
43929222|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929223|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43929224|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43929225|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929226|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929227|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43929228|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
43929229|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929230|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929231|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43929232|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43929235|NCT00673153|Calicheamicins|calicheamicins|mesh-list
43929236|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929237|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43929238|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929239|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929240|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929241|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43929242|NCT00673439|PENTA|penta|mesh-list
43929243|NCT00673439|Warfarin|warfarin|mesh-list
43929244|NCT00673439|Fondaparinux|fondaparinux|mesh-list
43929245|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
43929246|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43929247|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
43929248|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43929249|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
43929250|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929251|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929252|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43929253|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43929254|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
43929255|NCT00673712|Narcotics|narcotics|mesh-ancestor
43929256|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170409|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170410|NCT00280696|Levetiracetam|levetiracetam|mesh-list
44170411|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
44170412|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
44170420|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44170421|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44170423|NCT00280787|Carboplatin|carboplatin|mesh-list
44170424|NCT00280787|Irinotecan|irinotecan|mesh-list
44170425|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44170426|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170427|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170428|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170429|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170430|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170431|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44170432|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44170433|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170434|NCT00280839|Topiramate|topiramate|mesh-list
44170435|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
44170436|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170437|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170438|NCT00280865|Pioglitazone|pioglitazone|mesh-list
44170439|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170440|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170441|NCT00280878|Gemcitabine|gemcitabine|mesh-list
44170442|NCT00280878|Rituximab|rituximab|mesh-list
44170443|NCT00280878|Vinorelbine|vinorelbine|mesh-list
44170444|NCT00280878|Ifosfamide|ifosfamide|mesh-list
44170445|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44170446|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170447|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
44170448|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170449|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929257|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929258|NCT00673712|Analgesics|analgesics|mesh-ancestor
43929259|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
43929260|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929261|NCT00673738|Docetaxel|docetaxel|mesh-list
43929262|NCT00673738|Cetuximab|cetuximab|mesh-list
43929263|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929264|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
43929265|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
43929266|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
43929267|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929268|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929269|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43929270|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
43929271|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43929272|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43929273|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
43929274|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43929275|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43929276|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
43929277|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43929279|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
43929280|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43929281|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929282|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43929283|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929284|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929285|NCT00674206|Gemcitabine|gemcitabine|mesh-list
43929286|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
43929303|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929304|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43929305|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43929306|NCT00674583|Vaccines|vaccines|mesh-list
43929307|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
43929308|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929310|NCT00674609|Analgesics|analgesics|mesh-ancestor
43929311|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
43929312|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929313|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929314|NCT00674739|Imiquimod|imiquimod|mesh-list
43929315|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43929316|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
43929317|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929318|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929319|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
43929320|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43929321|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
43929322|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929323|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43929324|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43929325|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929326|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929327|NCT00675259|Paclitaxel|paclitaxel|mesh-list
43929328|NCT00675259|Bevacizumab|bevacizumab|mesh-list
43929329|NCT00675259|Carboplatin|carboplatin|mesh-list
43929330|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43929331|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929350|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
43929352|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929353|NCT00675792|Bromides|bromides|mesh-list
43929354|NCT00675792|Rocuronium|rocuronium|mesh-list
43929355|NCT00675792|Neostigmine|neostigmine|mesh-list
43929356|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
43929357|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43929358|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43929359|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43929360|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929361|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929362|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43929363|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929364|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929365|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
43929366|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929367|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43929368|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
43929369|NCT00675909|Midazolam|midazolam|mesh-list
43929370|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43929371|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43929372|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929373|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929374|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43929375|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43929376|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929377|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43929378|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
43929379|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
43929380|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
43929381|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
43929382|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929383|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929384|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
43929385|NCT00675922|Mafenide|mafenide|mesh-list
43929386|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43766721|NCT02405715|Oxytocin|oxytocin|mesh-list
44170450|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170451|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
43702551|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
43929387|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929388|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43929389|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43929390|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929391|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929393|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43929394|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43929395|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43929396|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43929397|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929398|NCT00676364|Lidocaine|lidocaine|mesh-list
43929399|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
43929400|NCT00676364|Anesthetics|anesthetics|mesh-list
43929401|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929402|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929403|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
43929404|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929405|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43929406|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43929407|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43929408|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962689|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170452|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170453|NCT00280878|Antiviral Agents|antiviral agents|mesh-ancestor
44170454|NCT00280878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170455|NCT00280878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170456|NCT00280878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170457|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44170459|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170460|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170461|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44170462|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
44170463|NCT00280930|Letrozole|letrozole|mesh-list
44170464|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170465|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44170466|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44170467|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170468|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170469|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44170470|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
44170471|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170472|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170473|NCT00280956|Natalizumab|natalizumab|mesh-list
44170474|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
44170475|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170476|NCT00280969|Efavirenz|efavirenz|mesh-list
43929409|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929410|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
43929411|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929412|NCT00676676|Testosterone|testosterone|mesh-list
43929413|NCT00676676|Androgens|androgens|mesh-ancestor
43929414|NCT00676676|Hormones|hormones|mesh-ancestor
43929415|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929416|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929417|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
43929418|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929419|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
43929420|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929421|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929422|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43929423|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
43929424|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929425|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929426|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43929427|NCT00676897|Simvastatin|simvastatin|mesh-list
43929428|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43929429|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43929430|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
43929431|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929432|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43929433|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43929434|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929435|NCT00677924|Zalutumumab|zalutumumab|mesh-list
43929436|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929437|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929438|NCT00678015|Masoprocol|masoprocol|mesh-list
43929439|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
43929448|NCT00678015|Analgesics|analgesics|mesh-ancestor
43929450|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929451|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929452|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929453|NCT00678418|Naltrexone|naltrexone|mesh-list
43929454|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43929456|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929457|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
43929458|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929459|NCT00678470|Alefacept|alefacept|mesh-list
43929460|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929461|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
43929462|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929463|NCT00678535|Cisplatin|cisplatin|mesh-list
43929464|NCT00678535|Capecitabine|capecitabine|mesh-list
43929465|NCT00678535|Cetuximab|cetuximab|mesh-list
43929466|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929467|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43929468|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
43929469|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929470|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929471|NCT00678834|Tocopherols|tocopherols|mesh-list
43929472|NCT00678834|Vitamin E|vitamin e|mesh-list
43929473|NCT00678834|Tocotrienols|tocotrienols|mesh-list
43929474|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
43929475|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
43929476|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170477|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44170478|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44170479|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44170480|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734404|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170484|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44170485|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44170486|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44170487|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44170488|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44170489|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44170490|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44170491|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44170492|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
44170493|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44170494|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44170495|NCT00280995|Mipomersen|mipomersen|mesh-list
44170496|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44170497|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44170498|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
44170499|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170500|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44170501|NCT00281008|Mipomersen|mipomersen|mesh-list
44170502|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43929477|NCT00678834|Protective Agents|protective agents|mesh-ancestor
43929478|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929479|NCT00678834|Vitamins|vitamins|mesh-ancestor
43929480|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
43929481|NCT00679380|Budesonide|budesonide|mesh-list
43766727|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
43929482|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929483|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43929484|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
43929485|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929486|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929487|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43929488|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
43929489|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
43929490|NCT00679380|Hormones|hormones|mesh-ancestor
43929491|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929492|NCT00680225|Ranibizumab|ranibizumab|mesh-list
43929493|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929494|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929495|NCT00680225|Growth Substances|growth substances|mesh-ancestor
43929496|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929497|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929498|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929499|NCT00680459|Ethanol|ethanol|mesh-list
43929500|NCT00680459|Heparin|heparin|mesh-list
43929501|NCT00680459|Anticoagulants|anticoagulants|mesh-list
43929502|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43929503|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43929504|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929505|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43929506|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929507|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140204|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140205|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140207|NCT00178048|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140208|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140209|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140210|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140211|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140212|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
43674371|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929509|NCT00680706|Thiamine|thiamine|mesh-list
43929510|NCT00680706|Vitamins|vitamins|mesh-ancestor
43929511|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
43929512|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929513|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
43929514|NCT00680797|Testosterone|testosterone|mesh-list
43929515|NCT00680797|Estrogens|estrogens|mesh-list
43929516|NCT00680797|Androgens|androgens|mesh-ancestor
43929517|NCT00680797|Hormones|hormones|mesh-ancestor
43929518|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929519|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929520|NCT00680823|Ropivacaine|ropivacaine|mesh-list
43929521|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
43929522|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
43929523|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929524|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929525|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
43929526|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929527|NCT00680953|Denosumab|denosumab|mesh-list
43929528|NCT00680953|Alendronate|alendronate|mesh-list
43929529|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43929530|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170503|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44170504|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
44170505|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170506|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44170507|NCT00281125|Cisplatin|cisplatin|mesh-list
44170508|NCT00281125|Pemetrexed|pemetrexed|mesh-list
44170509|NCT00281125|Vatalanib|vatalanib|mesh-list
44170510|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170511|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170512|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170513|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43702552|NCT02716129|Morphine|morphine|mesh-list
43929532|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43929533|NCT00681265|Protective Agents|protective agents|mesh-ancestor
43929534|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929535|NCT00681538|Nabiximols|nabiximols|mesh-list
43929536|NCT00681538|Analgesics|analgesics|mesh-ancestor
43929537|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
43929538|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929539|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929540|NCT00681889|Ranibizumab|ranibizumab|mesh-list
43929541|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929542|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929543|NCT00681889|Growth Substances|growth substances|mesh-ancestor
43929544|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929545|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929546|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929547|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
43929548|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43929549|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43929550|NCT00682357|Prednisolone|prednisolone|mesh-list
43929551|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
43929552|NCT00682357|Lidocaine|lidocaine|mesh-list
43929553|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43929554|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
43929555|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
43929556|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
43929557|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929558|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929559|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
43929560|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929561|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43929562|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43929563|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43929567|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
43929572|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929574|NCT00682357|Protective Agents|protective agents|mesh-ancestor
43929575|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43929576|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929577|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
43929578|NCT00682734|Promethazine|promethazine|mesh-list
43929579|NCT00682734|Metoclopramide|metoclopramide|mesh-list
43929580|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43929581|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43929582|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929583|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929584|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
43929585|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
43929587|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929588|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
43929589|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
43929590|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929591|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43929592|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
43929593|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
43929594|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929595|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929596|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43929597|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
43929598|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929599|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43929600|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44170514|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44170515|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44170516|NCT00281190|Dimercaprol|dimercaprol|mesh-list
44170517|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
44170518|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
44170519|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170520|NCT00281255|Allopurinol|allopurinol|mesh-list
44170521|NCT00281255|Dobutamine|dobutamine|mesh-list
44170522|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
44170523|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170524|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170525|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
44170526|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170527|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44170528|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
44170529|NCT00281255|Protective Agents|protective agents|mesh-ancestor
44170530|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170531|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43929601|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
43929602|NCT00683046|Fludarabine|fludarabine|mesh-list
43929603|NCT00683046|Melphalan|melphalan|mesh-list
43929604|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
43929605|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929606|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929607|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43929608|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
43929609|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929610|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43929611|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
43929612|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43929613|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43929614|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
43929615|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
43929616|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43929617|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929618|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929619|NCT00683332|Tigecycline|tigecycline|mesh-list
43929620|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43929621|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929622|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43929623|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929624|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929625|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43929626|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
43929647|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43929648|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929649|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43929650|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
43929651|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43929652|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929653|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929654|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929655|NCT00684242|Lenalidomide|lenalidomide|mesh-list
43929656|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
43929657|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929658|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929659|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929660|NCT00684242|Growth Substances|growth substances|mesh-ancestor
43929661|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
43929662|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929663|NCT00684554|Buprenorphine|buprenorphine|mesh-list
43929664|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43929665|NCT00684554|Narcotics|narcotics|mesh-ancestor
43929666|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929667|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929668|NCT00684554|Analgesics|analgesics|mesh-ancestor
43929669|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
43929670|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929671|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43929672|NCT00684723|Lovastatin|lovastatin|mesh-list
43929673|NCT00684723|L 647318|l 647318|mesh-list
43929674|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
43929675|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43929676|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43929677|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
43929678|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929679|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43929680|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44170532|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
44170533|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
44170534|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170535|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44170536|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44170537|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43929681|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929682|NCT00684775|Naltrexone|naltrexone|mesh-list
43929683|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43929684|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43929685|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929686|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
43929687|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929688|NCT00684983|Capecitabine|capecitabine|mesh-list
43929689|NCT00684983|Lapatinib|lapatinib|mesh-list
43929690|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43929691|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43929692|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
43929693|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929694|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929695|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929696|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929697|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
43929698|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929699|NCT00685139|Zonisamide|zonisamide|mesh-list
43929700|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
43929701|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43929702|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929703|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929704|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929705|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929706|NCT00685295|Fentanyl|fentanyl|mesh-list
43929707|NCT00685295|Oxycodone|oxycodone|mesh-list
43929708|NCT00685295|Lansoprazole|lansoprazole|mesh-list
43929709|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
43929710|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43929711|NCT00685295|Narcotics|narcotics|mesh-ancestor
43929712|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929713|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929714|NCT00685295|Analgesics|analgesics|mesh-ancestor
43929722|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929723|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43929724|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929725|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929726|NCT00686231|Lidocaine|lidocaine|mesh-list
43929727|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
43929728|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
43929729|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
43929730|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929731|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929732|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
43929733|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929734|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43674575|NCT02893111|Bortezomib|bortezomib|mesh-list
43929735|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43929736|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43929737|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929738|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929739|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
43929740|NCT00687076|Aspirin|aspirin|mesh-list
43929741|NCT00687076|Niacin|niacin|mesh-list
43929742|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
43929743|NCT00687076|Clopidogrel|clopidogrel|mesh-list
43929744|NCT00687076|Ezetimibe|ezetimibe|mesh-list
43929745|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43801334|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170538|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
44170539|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170541|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170542|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170543|NCT00281307|Tocopherols|tocopherols|mesh-list
44170544|NCT00281307|Vitamin E|vitamin e|mesh-list
44170545|NCT00281307|Tocotrienols|tocotrienols|mesh-list
44170546|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
44170547|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
44170548|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170549|NCT00281307|Protective Agents|protective agents|mesh-ancestor
44170550|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170551|NCT00281307|Vitamins|vitamins|mesh-ancestor
44170552|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
44170553|NCT00281476|Simvastatin|simvastatin|mesh-list
44170554|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44170563|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170564|NCT00281502|Rifaximin|rifaximin|mesh-list
44170565|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170566|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170567|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170568|NCT00281515|Lonafarnib|lonafarnib|mesh-list
44170569|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170570|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170571|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
43929746|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43929748|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
43929749|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929750|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929751|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929752|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929753|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43929754|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43929755|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929756|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43929757|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43929758|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929759|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
43929760|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43929761|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43929762|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43929763|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
43929764|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929765|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43929766|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43929767|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
43929768|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43929769|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
43929770|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
43929771|NCT00687076|Vitamins|vitamins|mesh-ancestor
43929772|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
43929773|NCT00687102|Tamoxifen|tamoxifen|mesh-list
43929774|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43929775|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43929776|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
43929777|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929787|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929788|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929789|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929790|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929791|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
43929792|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43929793|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929794|NCT00687544|Ribavirin|ribavirin|mesh-list
43929795|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43929796|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
43929797|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929798|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
43929799|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929800|NCT00687674|Dexamethasone|dexamethasone|mesh-list
43929801|NCT00687674|Lenalidomide|lenalidomide|mesh-list
43929802|NCT00687674|Sorafenib|sorafenib|mesh-list
43929803|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929804|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
43929805|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
43929806|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929807|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929808|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929809|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
43929810|NCT00687674|Hormones|hormones|mesh-ancestor
43929811|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929812|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43929813|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929814|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
43929815|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43929816|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43929817|NCT00687674|Growth Substances|growth substances|mesh-ancestor
43929818|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801379|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
44170572|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44170573|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
44170574|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170575|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170576|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44170577|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170578|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
44170579|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43929819|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43929820|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929821|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929822|NCT00687713|Bupropion|bupropion|mesh-list
43929823|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43929824|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
43929825|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929826|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43929827|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43929828|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929829|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929830|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
43929831|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929832|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929833|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43929834|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43929835|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929836|NCT00687908|Adapalene|adapalene|mesh-list
43929837|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43929838|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929839|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43929840|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43929841|NCT00687908|Analgesics|analgesics|mesh-ancestor
43929842|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
43929843|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929844|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929845|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929846|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929847|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43929849|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43929850|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
43929851|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43929852|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
43929853|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
43929854|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44170580|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702553|NCT02716129|Nalbuphine|nalbuphine|mesh-list
43929855|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
43929856|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929857|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
43929858|NCT00689078|Hormones|hormones|mesh-ancestor
43929859|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43929860|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929861|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43929862|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43929863|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
43929864|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
43929865|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929866|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929867|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43929868|NCT00689078|Protective Agents|protective agents|mesh-ancestor
43929869|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43929870|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43929871|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43929872|NCT00689572|Ondansetron|ondansetron|mesh-list
43929873|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
43929874|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
43929875|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929876|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929877|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929878|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
43929879|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929880|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43929881|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
43929882|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929883|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929884|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43929885|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43929886|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929887|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929888|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43929889|NCT00690235|Pramlintide|pramlintide|mesh-list
43929890|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43929891|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929893|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43929894|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653232|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929895|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929896|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43929897|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
43929899|NCT00690833|Desonide|desonide|mesh-list
43929900|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929901|NCT00690924|Calcitriol|calcitriol|mesh-list
43929902|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929903|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929904|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43929905|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929906|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929907|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43929908|NCT00690924|Vitamins|vitamins|mesh-ancestor
43929909|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
43929910|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43929911|NCT00691002|Calcitriol|calcitriol|mesh-list
43929912|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
43929913|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43929914|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43929915|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43929916|NCT00691002|Calcipotriene|calcipotriene|mesh-list
43929917|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929918|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929919|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43929920|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929921|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43929922|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43929938|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43929939|NCT00691600|Renal Agents|renal agents|mesh-ancestor
43929940|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
43929941|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43929942|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43929943|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43929944|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43929945|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929946|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43929947|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43929948|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43929949|NCT00691665|Fluticasone|fluticasone|mesh-list
43929950|NCT00691665|Xhance|xhance|mesh-list
43929951|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43929952|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43929953|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43929954|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
43929955|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43929956|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929957|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43929958|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
43929959|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
43929960|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43929961|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43929962|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43929963|NCT00691665|Analgesics|analgesics|mesh-ancestor
43929964|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
43929965|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43929966|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43929967|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43929968|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
43929969|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
43929970|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929971|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929972|NCT00692185|Olanzapine|olanzapine|mesh-list
43929973|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
43929976|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43929977|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43929978|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43929979|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43929980|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43929981|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43929982|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43929983|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43929984|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835793|NCT05022329|Vaccines|vaccines|mesh-list
43929985|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43929986|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43929987|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
43929988|NCT00692341|Axitinib|axitinib|mesh-list
43929989|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930037|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930038|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930039|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43930040|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43930042|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930043|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930044|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930045|NCT00693992|Growth Substances|growth substances|mesh-ancestor
43930046|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930047|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930048|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43930049|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930050|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930051|NCT00694603|Cetuximab|cetuximab|mesh-list
43930052|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930053|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930054|NCT00695097|Rituximab|rituximab|mesh-list
43930055|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930056|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930057|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
43930058|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930059|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930060|NCT00695188|Methotrexate|methotrexate|mesh-list
43930061|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43930062|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
43930063|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43930064|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930065|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930066|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
43930067|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930068|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930069|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930070|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930071|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43930072|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930074|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930075|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44140213|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140214|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140215|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140216|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140217|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44140218|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140219|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140220|NCT00178100|Paroxetine|paroxetine|mesh-list
44140221|NCT00178100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140222|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140223|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140224|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140225|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140226|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
44140227|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140228|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140229|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140230|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140231|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44140232|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140233|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140234|NCT00178113|Lycopene|lycopene|mesh-list
44140235|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140236|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
44140237|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140238|NCT00178113|Protective Agents|protective agents|mesh-ancestor
43766736|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44140239|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930085|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930086|NCT00695292|Growth Substances|growth substances|mesh-ancestor
43930087|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930088|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930089|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43930090|NCT00695409|Cytarabine|cytarabine|mesh-list
43930091|NCT00695409|Rituximab|rituximab|mesh-list
43930092|NCT00695409|Etoposide|etoposide|mesh-list
43930093|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
43930094|NCT00695409|Melphalan|melphalan|mesh-list
43930095|NCT00695409|Carmustine|carmustine|mesh-list
43930096|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43930097|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930098|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930099|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
43930100|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930101|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930102|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43930103|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43930104|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43930105|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930106|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930107|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930108|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
43930109|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
43930110|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930111|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930112|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43930113|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
43930114|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43930115|NCT00695435|Tobramycin|tobramycin|mesh-list
43930116|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43930117|NCT00695435|Dexamethasone|dexamethasone|mesh-list
43930118|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43930119|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930120|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
43930124|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43930125|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
43930126|NCT00695435|Hormones|hormones|mesh-ancestor
43930127|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930128|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43930129|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930130|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43930131|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930132|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930133|NCT00695500|Varenicline|varenicline|mesh-list
43930134|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43930135|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930136|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930137|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930138|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930139|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930140|NCT00695578|Bacitracin|bacitracin|mesh-list
43930141|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43930142|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930143|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930144|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43930145|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43930146|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930147|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930148|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930149|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930150|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930151|NCT00696293|Analgesics|analgesics|mesh-ancestor
43930152|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
43930153|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930154|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930155|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930156|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
44170581|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170582|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170583|NCT00281593|Telmisartan|telmisartan|mesh-list
44170584|NCT00281593|Ramipril|ramipril|mesh-list
44170585|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930157|NCT00696449|Adapalene|adapalene|mesh-list
43930158|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43930159|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43930160|NCT00696449|Analgesics|analgesics|mesh-ancestor
43930161|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
43930162|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930163|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930164|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930165|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930166|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930167|NCT00696488|Fluorouracil|fluorouracil|mesh-list
43930168|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
43930169|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930170|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930171|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930172|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930173|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
43930174|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930175|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
43930176|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43930177|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43930178|NCT00696761|Alfuzosin|alfuzosin|mesh-list
43930179|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43930180|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43930181|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43930182|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930183|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930184|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930185|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930186|NCT00696761|Urological Agents|urological agents|mesh-ancestor
43930187|NCT00697203|Pravastatin|pravastatin|mesh-list
43930188|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
43930189|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43930190|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43930191|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
43930192|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930194|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43930195|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930196|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43930197|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43930198|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43930199|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930200|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43930201|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43930202|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43930203|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930204|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930205|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930206|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930207|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
43930208|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43930209|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43930210|NCT00698035|Testosterone|testosterone|mesh-list
43930211|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
43930212|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
43930213|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43930214|NCT00698035|Estradiol|estradiol|mesh-list
43930215|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43930216|NCT00698035|Androgens|androgens|mesh-ancestor
43930217|NCT00698035|Hormones|hormones|mesh-ancestor
43930218|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930219|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930220|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43930221|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930222|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
43930223|NCT00698035|Estrogens|estrogens|mesh-ancestor
43930224|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43930225|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
43930226|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43930227|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43930228|NCT00699010|Oxycodone|oxycodone|mesh-list
43930229|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43930232|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930234|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
43930235|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930236|NCT00699491|Sirolimus|sirolimus|mesh-list
43930237|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43930238|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930239|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930240|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43930241|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930242|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
43930243|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930244|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
43930245|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930246|NCT00699556|Nicotine|nicotine|mesh-list
43930247|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43930248|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
43930249|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930250|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930251|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43930252|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930253|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930254|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930255|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930256|NCT00699803|Prednisone|prednisone|mesh-list
43930257|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
43930258|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43930259|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
43930260|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43930262|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43930263|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
43930277|NCT00700336|Cisplatin|cisplatin|mesh-list
43930278|NCT00700336|Pemetrexed|pemetrexed|mesh-list
43930279|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930280|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930281|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930282|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43930283|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43930284|NCT00700440|Cetuximab|cetuximab|mesh-list
43930285|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930286|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930287|NCT00701376|Liver Extracts|liver extracts|mesh-list
43930288|NCT00701376|Hematinics|hematinics|mesh-ancestor
43930289|NCT00701389|Sumatriptan|sumatriptan|mesh-list
43930290|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43930291|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43930292|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43930293|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
43930294|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930295|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930296|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930297|NCT00701636|Daptomycin|daptomycin|mesh-list
43930298|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930299|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930300|NCT00701675|Sertraline|sertraline|mesh-list
43930301|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930302|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930303|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43930310|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
43930326|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43930327|NCT00701935|Incretins|incretins|mesh-ancestor
43930328|NCT00701935|Hormones|hormones|mesh-ancestor
43930329|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930330|NCT00702299|Paclitaxel|paclitaxel|mesh-list
43930331|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43930332|NCT00702299|Cisplatin|cisplatin|mesh-list
43930333|NCT00702299|Pemetrexed|pemetrexed|mesh-list
43930334|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43930335|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930336|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
43930337|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
43930338|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
43930339|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930340|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930341|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43930342|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43930343|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43930344|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43653233|NCT02985606|Caffeine|caffeine|mesh-list
43930345|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930346|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930347|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930348|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930349|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930350|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930351|NCT00702468|Nabiximols|nabiximols|mesh-list
43930352|NCT00702468|Analgesics|analgesics|mesh-ancestor
43930353|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
43930354|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930355|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930356|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43930357|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
43930368|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43930369|NCT00702780|Citalopram|citalopram|mesh-list
43930370|NCT00702780|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43930371|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930372|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930373|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930374|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930375|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
43930376|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930377|NCT00702780|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43930378|NCT00702780|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930379|NCT00702780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930381|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930382|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930383|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930384|NCT00702884|Growth Substances|growth substances|mesh-ancestor
43930385|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930386|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930387|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43930388|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930389|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930390|NCT00703261|Atorvastatin|atorvastatin|mesh-list
43930391|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43930392|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43930393|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
43930394|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930395|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43930396|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43930397|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930398|NCT00703508|Metformin|metformin|mesh-list
43930399|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43930400|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930404|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43930405|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930406|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930407|NCT00703976|Bevacizumab|bevacizumab|mesh-list
43930408|NCT00703976|Cetuximab|cetuximab|mesh-list
43930409|NCT00703976|Pemetrexed|pemetrexed|mesh-list
43930410|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930411|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930412|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930413|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930414|NCT00703976|Growth Substances|growth substances|mesh-ancestor
43930415|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930416|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930417|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930418|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930419|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43930420|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43930421|NCT00704028|Dextrans|dextrans|mesh-list
43930422|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
43930423|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
43930424|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
43930425|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
43930426|NCT00704028|Hematinics|hematinics|mesh-ancestor
43930427|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
43930428|NCT00704262|Calcipotriene|calcipotriene|mesh-list
43766739|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930429|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930430|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930431|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
43930432|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
43930450|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930451|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
43930452|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930453|NCT00704847|Calcitonin|calcitonin|mesh-list
43930454|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
43930455|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43930456|NCT00704847|Katacalcin|katacalcin|mesh-list
43930518|NCT00705133|Treprostinil|treprostinil|mesh-list
43930519|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930520|NCT00705874|Leucovorin|leucovorin|mesh-list
43930521|NCT00705874|Gemcitabine|gemcitabine|mesh-list
43930522|NCT00705874|Bevacizumab|bevacizumab|mesh-list
43930523|NCT00705874|Sunitinib|sunitinib|mesh-list
43930524|NCT00705874|Cisplatin|cisplatin|mesh-list
43930525|NCT00705874|Docetaxel|docetaxel|mesh-list
43930526|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43930527|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930528|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930529|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930530|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930531|NCT00705874|Growth Substances|growth substances|mesh-ancestor
43930532|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930533|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930534|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930535|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
43930536|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930537|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
43930538|NCT00705874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930539|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930540|NCT00705874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930541|NCT00705874|Immunologic Factors|immunologic factors|mesh-ancestor
43930542|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
43930543|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
43930544|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
43930545|NCT00705874|Antidotes|antidotes|mesh-ancestor
43930546|NCT00705874|Protective Agents|protective agents|mesh-ancestor
43930547|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
44170586|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44170587|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44170588|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170589|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44170590|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
44170591|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170592|NCT00281606|Ritonavir|ritonavir|mesh-list
44170593|NCT00281606|Lopinavir|lopinavir|mesh-list
44170594|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44170595|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44170596|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
44170597|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170598|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170599|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44170600|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44170601|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
44170602|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702554|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43930549|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
43930550|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43930551|NCT00706121|Vitamins|vitamins|mesh-list
43930552|NCT00706121|Vitamin E|vitamin e|mesh-list
43930553|NCT00706121|Tocopherols|tocopherols|mesh-list
43930554|NCT00706121|Tocotrienols|tocotrienols|mesh-list
43930555|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
43930556|NCT00706121|Selenium|selenium|mesh-list
43930557|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
43930558|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930559|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
43930560|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930561|NCT00706121|Protective Agents|protective agents|mesh-ancestor
43930562|NCT00706121|Trace Elements|trace elements|mesh-ancestor
43930563|NCT00706264|Silicon|silicon|mesh-list
43930564|NCT00706264|Trace Elements|trace elements|mesh-ancestor
43930565|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
43930566|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930567|NCT00706446|Fluticasone|fluticasone|mesh-list
43930568|NCT00706446|Xhance|xhance|mesh-list
43930569|NCT00706446|Budesonide|budesonide|mesh-list
43930570|NCT00706446|Bromides|bromides|mesh-list
43930571|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
43930572|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
43930573|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43930574|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930575|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43930576|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
43930577|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930578|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930579|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43930580|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
43930581|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930582|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43930583|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
43930584|NCT00706446|Hormones|hormones|mesh-ancestor
44170603|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44170604|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44170605|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
44170606|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44170607|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170608|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43702555|NCT02716129|Narcotics|narcotics|mesh-ancestor
43930585|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930586|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43930587|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43930588|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43930589|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930590|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930591|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930592|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
43930593|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43930594|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930596|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43930597|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
43930598|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930599|NCT00706589|Aripiprazole|aripiprazole|mesh-list
43930600|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930601|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930602|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43930603|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43930604|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930605|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930606|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
43930607|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
43930608|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930609|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930610|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43930611|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43930612|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
43930613|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43930614|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43930615|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43930625|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43930626|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
43930627|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43930628|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
43930629|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43930630|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43930631|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43930632|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
43930633|NCT00706810|Verapamil|verapamil|mesh-list
43930634|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930635|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
43930636|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930637|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930638|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43930639|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43930640|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43930641|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930642|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43930643|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746860|NCT02521298|Prednisolone|prednisolone|mesh-list
43930644|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
43930646|NCT00706836|Analgesics|analgesics|mesh-ancestor
43930647|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
43930648|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801989|NCT03660475|Naltrexone|naltrexone|mesh-list
44170609|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
44170610|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170611|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170612|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170613|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170614|NCT00281645|Analgesics|analgesics|mesh-list
44170615|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
44170616|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170617|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170618|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
44170619|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44170642|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170643|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170644|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170645|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170646|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170647|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170649|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44170650|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170651|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44170652|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170653|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170654|NCT00281892|Vidarabine|vidarabine|mesh-list
44170655|NCT00281892|Fludarabine|fludarabine|mesh-list
44170656|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
43930649|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930650|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
43930651|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43930652|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930653|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930654|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43930655|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43930656|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43930657|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930658|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930659|NCT00706979|Nicotine|nicotine|mesh-list
43930660|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43930661|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
43930662|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930663|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930664|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43930665|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930666|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930667|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930668|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930669|NCT00707655|Zalutumumab|zalutumumab|mesh-list
43930670|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930671|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930672|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
43930673|NCT00707759|Prednisone|prednisone|mesh-list
43930674|NCT00707759|Prednisolone|prednisolone|mesh-list
43930675|NCT00707759|Tacrolimus|tacrolimus|mesh-list
43930676|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43930677|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
43930678|NCT00707759|Hormones|hormones|mesh-ancestor
43930679|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930680|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930681|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43930682|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930683|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930687|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930688|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43930689|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43930690|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
43930691|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930692|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930694|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43930695|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43930696|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43930697|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930698|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930699|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
43930700|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930701|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43930702|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
43930703|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43930704|NCT00707967|Vaccines|vaccines|mesh-list
43930705|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
43930706|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930707|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43930708|NCT00708071|Thrombin|thrombin|mesh-list
43930709|NCT00708071|Aprotinin|aprotinin|mesh-list
43930710|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
43930711|NCT00708071|Coagulants|coagulants|mesh-ancestor
43930712|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43930713|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43930714|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
43930715|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930716|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930717|NCT00708110|Dolutegravir|dolutegravir|mesh-list
43930718|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43930719|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43930720|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930721|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930722|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43930725|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930726|NCT00708721|Clofarabine|clofarabine|mesh-list
43930727|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930728|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
43930729|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930730|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930731|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43930732|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43930733|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930734|NCT00709696|Varenicline|varenicline|mesh-list
43930735|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43930736|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930737|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930738|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930739|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930740|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930741|NCT00709826|Gemcitabine|gemcitabine|mesh-list
43930742|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43930743|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43930744|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
43930745|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930746|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930747|NCT00709826|Antiviral Agents|antiviral agents|mesh-ancestor
43930748|NCT00709826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930749|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930750|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930751|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
43930752|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930753|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44140244|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140245|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
44140246|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
44140247|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
44140248|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140249|NCT00178373|Modafinil|modafinil|mesh-list
44170657|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170658|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140250|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44140251|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140252|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44140253|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44140254|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44140255|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140257|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
44140258|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44140259|NCT00178620|Reteplase|reteplase|mesh-list
44140260|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44140261|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44140262|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140263|NCT00178698|Gemcitabine|gemcitabine|mesh-list
44140264|NCT00178698|Interferons|interferons|mesh-list
44140265|NCT00178698|Cisplatin|cisplatin|mesh-list
44140266|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140267|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140268|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
44140269|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140270|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
44140271|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140272|NCT00178698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140273|NCT00178698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140274|NCT00178698|Immunologic Factors|immunologic factors|mesh-ancestor
44140275|NCT00178698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140276|NCT00178763|Gemcitabine|gemcitabine|mesh-list
44140277|NCT00178763|Interferons|interferons|mesh-list
44140278|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
44140279|NCT00178763|Cisplatin|cisplatin|mesh-list
44140280|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140281|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140282|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
44140283|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140284|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
44140290|NCT00178802|Interferons|interferons|mesh-list
44140291|NCT00178802|Doxorubicin|doxorubicin|mesh-list
44140292|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44140293|NCT00178802|Fluorouracil|fluorouracil|mesh-list
44140294|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44140295|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140296|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140297|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140298|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140299|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140300|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
44140301|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140302|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140303|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
44140304|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140305|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
44140306|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140307|NCT00178828|Bupropion|bupropion|mesh-list
44140308|NCT00178828|Sertraline|sertraline|mesh-list
44140309|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140310|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
44140311|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140312|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44140313|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140314|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140315|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140316|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
43930754|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
43930755|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43930756|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
43930757|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930758|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
43930759|NCT00711347|Protective Agents|protective agents|mesh-ancestor
43930760|NCT00711464|Modafinil|modafinil|mesh-list
43930761|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43930764|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43930765|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43930766|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930767|NCT00711490|Sirolimus|sirolimus|mesh-list
43930768|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930769|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930770|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43930771|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930772|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
43930773|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930774|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
43930775|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930776|NCT00711828|Dexamethasone|dexamethasone|mesh-list
43930777|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
43930778|NCT00711828|Rituximab|rituximab|mesh-list
43930779|NCT00711828|Bortezomib|bortezomib|mesh-list
43930780|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930781|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
43930782|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930783|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930784|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43930785|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
43930786|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930787|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930788|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43930789|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930791|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
43930792|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
43930793|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930794|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43930795|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
43930796|NCT00711828|Hormones|hormones|mesh-ancestor
43930797|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930798|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802138|NCT03190954|Raclopride|raclopride|mesh-list
43930803|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
43930804|NCT00712244|Protective Agents|protective agents|mesh-ancestor
43930805|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43930806|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
43930807|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930808|NCT00713284|Sirolimus|sirolimus|mesh-list
43930809|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930810|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930811|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43930812|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930813|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
43930814|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930815|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
43930816|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930817|NCT00713479|Varenicline|varenicline|mesh-list
43930818|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43930819|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43930820|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930821|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930822|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930823|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930824|NCT00713583|Levodopa|levodopa|mesh-list
43930825|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43930826|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43930827|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
43930828|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930829|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930830|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930832|NCT00713817|Analgesics|analgesics|mesh-ancestor
43930833|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
43930834|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930835|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930836|NCT00714233|Metformin|metformin|mesh-list
43930837|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
43930838|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
43930844|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43930845|NCT00715884|Sirolimus|sirolimus|mesh-list
43930846|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43930847|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930848|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43930849|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930850|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
43930851|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930852|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
43930853|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930854|NCT00716079|Metoprolol|metoprolol|mesh-list
43930855|NCT00716079|Clonidine|clonidine|mesh-list
43930856|NCT00716079|Labetalol|labetalol|mesh-list
43930857|NCT00716079|Hydralazine|hydralazine|mesh-list
43930858|NCT00716079|Nicardipine|nicardipine|mesh-list
43930859|NCT00716079|Phentolamine|phentolamine|mesh-list
43930860|NCT00716079|Urapidil|urapidil|mesh-list
43930861|NCT00716079|Enalaprilat|enalaprilat|mesh-list
43930862|NCT00716079|Esmolol|esmolol|mesh-list
43930863|NCT00716079|Glycerol|glycerol|mesh-list
43930864|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43930865|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930866|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
43930867|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
43930868|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930869|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930870|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43930871|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43930872|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43930873|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
43930874|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930875|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930890|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43930891|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
43930892|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43930893|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
43930894|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930895|NCT00716586|Dorzolamide|dorzolamide|mesh-list
43930896|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930897|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43930898|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930899|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930900|NCT00716742|Bimatoprost|bimatoprost|mesh-list
43930902|NCT00716742|Latanoprost|latanoprost|mesh-list
43930903|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43930904|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43930905|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43930906|NCT00716820|Sunitinib|sunitinib|mesh-list
43930907|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930908|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930909|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930910|NCT00716820|Growth Substances|growth substances|mesh-ancestor
43930911|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930912|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930913|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43930914|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930915|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930916|NCT00716963|Fluticasone|fluticasone|mesh-list
43930917|NCT00716963|Xhance|xhance|mesh-list
43930918|NCT00716963|Budesonide|budesonide|mesh-list
44170659|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
44170660|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170661|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170662|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
44170663|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170664|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
44170665|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170666|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
44170667|NCT00281905|Cisplatin|cisplatin|mesh-list
44170668|NCT00281905|Carboplatin|carboplatin|mesh-list
44170669|NCT00281905|Methotrexate|methotrexate|mesh-list
44170670|NCT00281905|Vincristine|vincristine|mesh-list
44170671|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170672|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
44170683|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170684|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
43930920|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43930921|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
43930922|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930923|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930924|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43930925|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
43930926|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930927|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43930928|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
43930929|NCT00716963|Hormones|hormones|mesh-ancestor
43930930|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43930931|NCT00717054|Scopolamine|scopolamine|mesh-list
43930932|NCT00717054|Aprepitant|aprepitant|mesh-list
43930933|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43930934|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
43930935|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
43930936|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930937|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930938|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43930939|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43930940|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43930941|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170685|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
44170686|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170687|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44170688|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44170689|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44170690|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170691|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170692|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170693|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
44170694|NCT00281931|Rituximab|rituximab|mesh-list
44170695|NCT00281931|Fludarabine|fludarabine|mesh-list
44170696|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
44170697|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170698|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
44170699|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170700|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170701|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44170702|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
44170703|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170704|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170705|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44170706|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44170707|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170708|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
44170709|NCT00281944|Leucovorin|leucovorin|mesh-list
44170710|NCT00281944|Fluorouracil|fluorouracil|mesh-list
44170711|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
44170712|NCT00281944|Calcium|calcium|mesh-list
43930942|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43930944|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43930945|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
43930946|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43930947|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
43930948|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
43930949|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43930950|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930951|NCT00717405|Bevacizumab|bevacizumab|mesh-list
43930952|NCT00717405|Trastuzumab|trastuzumab|mesh-list
43930953|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43930954|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43930955|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43930956|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43930957|NCT00717405|Growth Substances|growth substances|mesh-ancestor
43930958|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930959|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
43930960|NCT00717418|Cyclosporine|cyclosporine|mesh-list
43930961|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
43930962|NCT00717418|Cyclosporins|cyclosporins|mesh-list
43930963|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43930964|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43930965|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43930966|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
43930967|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930968|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
43930969|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43930970|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
43930971|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43930972|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43930973|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43930974|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44170713|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
44170714|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44170715|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170716|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
44170717|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170718|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170719|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170720|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170721|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
44170722|NCT00281944|Antidotes|antidotes|mesh-ancestor
44170723|NCT00281944|Protective Agents|protective agents|mesh-ancestor
43930975|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
43930976|NCT00717574|Propofol|propofol|mesh-list
43930977|NCT00717574|Sevoflurane|sevoflurane|mesh-list
43930978|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43930979|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43930980|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43930981|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43930982|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
43930983|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
43930984|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43930985|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43930986|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43930987|NCT00717574|Analgesics|analgesics|mesh-ancestor
43930988|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
43930989|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43930990|NCT00717626|Factor VIII|factor viii|mesh-list
43930991|NCT00717626|Coagulants|coagulants|mesh-ancestor
43931035|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43931036|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43931037|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43931038|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931039|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931040|NCT00720330|Analgesics|analgesics|mesh-ancestor
43931041|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43931042|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43931043|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
43931044|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43931045|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43931046|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931047|NCT00720369|Ubiquinone|ubiquinone|mesh-list
43931048|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
43931049|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
43931050|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931051|NCT00720369|Vitamins|vitamins|mesh-ancestor
43931052|NCT00720473|Lamotrigine|lamotrigine|mesh-list
43931053|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
43931054|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43931055|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931056|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931057|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43931058|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931059|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43931060|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170724|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
44170725|NCT00281944|Vitamins|vitamins|mesh-ancestor
44170726|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
44170727|NCT00281970|Cisplatin|cisplatin|mesh-list
44170728|NCT00281970|Docetaxel|docetaxel|mesh-list
44170729|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170730|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170731|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
44170732|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
44170733|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170734|NCT00281983|Cyclosporine|cyclosporine|mesh-list
44170735|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
44170736|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
44170737|NCT00281983|Busulfan|busulfan|mesh-list
44170740|NCT00281983|Fludarabine|fludarabine|mesh-list
44170741|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
44170742|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
44170743|NCT00281983|Cyclosporins|cyclosporins|mesh-list
44170744|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44170745|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170746|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
44170747|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170748|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931061|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931062|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931063|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43931064|NCT00720629|Methotrexate|methotrexate|mesh-list
43931066|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
43931067|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43931068|NCT00720629|Visilizumab|visilizumab|mesh-list
43931069|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43931070|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
43931071|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931072|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931073|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43931074|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
43931075|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931076|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931077|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931078|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931079|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43931080|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931081|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
43931082|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931083|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931084|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43931085|NCT00721136|Heparin|heparin|mesh-list
43931086|NCT00721136|Warfarin|warfarin|mesh-list
43931087|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
43931088|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43931089|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43931090|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931091|NCT00721162|Ramucirumab|ramucirumab|mesh-list
43931092|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931094|NCT00721188|Hematinics|hematinics|mesh-ancestor
43931095|NCT00721513|Cisplatin|cisplatin|mesh-list
43931096|NCT00721513|Docetaxel|docetaxel|mesh-list
43931097|NCT00721513|Fluorouracil|fluorouracil|mesh-list
43931098|NCT00721513|Cetuximab|cetuximab|mesh-list
43931099|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170749|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44170750|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
43931101|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
43931102|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
43931103|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931104|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
43931105|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43931106|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931107|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
43931108|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931109|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931110|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43931111|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43931112|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43931113|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43931114|NCT00722072|Sorafenib|sorafenib|mesh-list
43931115|NCT00722072|Fulvestrant|fulvestrant|mesh-list
43931116|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931117|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43931118|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931119|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931120|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43931121|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43931122|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43931123|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
43931124|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931125|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931126|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
43931127|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43931128|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43931129|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931130|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
43931131|NCT00722436|Coagulants|coagulants|mesh-ancestor
43931132|NCT00722553|Vitamins|vitamins|mesh-list
44170751|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170752|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170753|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44170754|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931133|NCT00722553|Folic Acid|folic acid|mesh-list
43931134|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
43931135|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
43931136|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
43931137|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
43931138|NCT00722553|Aminopterin|aminopterin|mesh-list
43931139|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
43931140|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931141|NCT00722553|Hematinics|hematinics|mesh-ancestor
43931142|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43931143|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931144|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931145|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931146|NCT00722566|Bortezomib|bortezomib|mesh-list
43931147|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931148|NCT00722722|Bortezomib|bortezomib|mesh-list
43931149|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931150|NCT00722865|Bevacizumab|bevacizumab|mesh-list
43931151|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931152|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931153|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931154|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931155|NCT00722865|Growth Substances|growth substances|mesh-ancestor
43931156|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931157|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931158|NCT00723099|Cyclosporine|cyclosporine|mesh-list
43931159|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
43931160|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
43931161|NCT00723099|Fludarabine|fludarabine|mesh-list
43931162|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
43931163|NCT00723099|Cyclosporins|cyclosporins|mesh-list
43931164|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931165|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
43931166|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931167|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170755|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44170756|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
44170757|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44170758|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170759|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
44170760|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
44170761|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170762|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44170763|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931168|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43931169|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
43931170|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931172|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43931173|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43931174|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
43931175|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931176|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
43931177|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931178|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931179|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43931180|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43931181|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43931182|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
43931183|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43931184|NCT00723177|Ibudilast|ibudilast|mesh-list
43931185|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43931186|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
43931187|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931188|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931189|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43931190|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
43931191|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43931192|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931193|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931196|NCT00723580|Risperidone|risperidone|mesh-list
43931216|NCT00723749|Naloxone|naloxone|mesh-list
43931217|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43931218|NCT00723749|Narcotics|narcotics|mesh-ancestor
43931219|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931220|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931221|NCT00723749|Analgesics|analgesics|mesh-ancestor
43931222|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
43931223|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931224|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43931225|NCT00723827|Temozolomide|temozolomide|mesh-list
43931226|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43931227|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
43931228|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931229|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931230|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43931231|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
43931232|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140317|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140318|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140319|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44140320|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44140321|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140324|NCT00178854|Risperidone|risperidone|mesh-list
44140351|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140352|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140353|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44140355|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140356|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157451|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157452|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
44157453|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44157454|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44157455|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44157456|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157457|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157458|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
44157459|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157460|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157461|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44157462|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931233|NCT00724009|Clofarabine|clofarabine|mesh-list
43931234|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43931235|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
43931236|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931237|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931238|NCT00724464|Interferons|interferons|mesh-list
43931239|NCT00724464|Ribavirin|ribavirin|mesh-list
43931240|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
43931241|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
43931242|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43931243|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931244|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
43931245|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931246|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
43931247|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931248|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
44170764|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
44170765|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170766|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44170767|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43931249|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931250|NCT00724568|Dexamethasone|dexamethasone|mesh-list
43931251|NCT00724568|Lenalidomide|lenalidomide|mesh-list
43931252|NCT00724568|Bortezomib|bortezomib|mesh-list
43931253|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43931254|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
43931255|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
43931256|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931257|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931258|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931259|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
43931260|NCT00724568|Hormones|hormones|mesh-ancestor
43931261|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931262|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43931263|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931264|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
43931265|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931266|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931267|NCT00724568|Growth Substances|growth substances|mesh-ancestor
43931268|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931269|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
43931270|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43931271|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
43931272|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931273|NCT00724594|Expectorants|expectorants|mesh-ancestor
43931274|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
43931275|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43931276|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
43931277|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931278|NCT00724594|Protective Agents|protective agents|mesh-ancestor
43931279|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931280|NCT00724594|Antidotes|antidotes|mesh-ancestor
43931281|NCT00724984|Abexinostat|abexinostat|mesh-list
43931294|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43931295|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43931296|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
43931297|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931298|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
43931299|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43931300|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43931302|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43931303|NCT00725504|Lidocaine|lidocaine|mesh-list
43931304|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
43931305|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
43931306|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931307|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931308|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
43931309|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931310|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43931311|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43931312|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43931313|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931314|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931315|NCT00725751|Interferons|interferons|mesh-list
43931316|NCT00725751|Ribavirin|ribavirin|mesh-list
43931317|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
43931318|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
43931319|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43931320|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931321|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
43931322|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931323|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
43931324|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931325|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
43931326|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931327|NCT00726375|Etanercept|etanercept|mesh-list
43931328|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43931329|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43931330|NCT00726375|Analgesics|analgesics|mesh-ancestor
43931331|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
43931332|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931333|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931334|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43931335|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931336|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931337|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931338|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
43931339|NCT00726414|Quinine|quinine|mesh-list
43931340|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
43931341|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43931342|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43931343|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931344|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43931345|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931346|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43931347|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931348|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43931349|NCT00726414|Analgesics|analgesics|mesh-ancestor
43931350|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
43931351|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
43931352|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
43931353|NCT00726713|Vitamins|vitamins|mesh-ancestor
43931354|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
43931355|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931356|NCT00726739|Aldesleukin|aldesleukin|mesh-list
43931357|NCT00726739|Interleukin-2|interleukin-2|mesh-list
43931358|NCT00726739|Vaccines|vaccines|mesh-list
43931359|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
43931360|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931361|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931362|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43931363|NCT00726739|Analgesics|analgesics|mesh-ancestor
43931364|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
43931365|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931366|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43931367|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43931368|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
43931369|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931370|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43931371|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43931372|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43931373|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931374|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931375|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931376|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931377|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931378|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43931379|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
43931380|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931381|NCT00727298|Infliximab|infliximab|mesh-list
43931382|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931383|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931384|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931385|NCT00727597|Efavirenz|efavirenz|mesh-list
43931386|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
43931387|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43931388|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931389|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931390|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931391|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
43931392|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931393|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43931394|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43931395|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43931404|NCT00727636|Vaccines|vaccines|mesh-list
43931405|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
43931406|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931407|NCT00727740|Indomethacin|indomethacin|mesh-list
43931408|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43931409|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43931410|NCT00727740|Analgesics|analgesics|mesh-ancestor
43931411|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
43931412|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931413|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931414|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43931415|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931416|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
43931417|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
43931418|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931419|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43931420|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931421|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931422|NCT00727857|Metformin|metformin|mesh-list
43931423|NCT00727857|Pioglitazone|pioglitazone|mesh-list
43931424|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43931425|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931426|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
43931427|NCT00728507|Rifampin|rifampin|mesh-list
43931428|NCT00728507|Isoniazid|isoniazid|mesh-list
43931429|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
43931430|NCT00728507|Ethambutol|ethambutol|mesh-list
43931431|NCT00728507|Rifapentine|rifapentine|mesh-list
43931432|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43931433|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931434|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43931449|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43931450|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43931451|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
43931452|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43931454|NCT00728910|Atorvastatin|atorvastatin|mesh-list
43931455|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43931456|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43676105|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
43931457|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
43931458|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931459|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43931460|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43931461|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931462|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
43931463|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
43931465|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
43931466|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931467|NCT00729482|Everolimus|everolimus|mesh-list
43931468|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931469|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931470|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
43931471|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931472|NCT00729807|Pentamidine|pentamidine|mesh-list
43931473|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
43931474|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931475|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43931476|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43931477|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43931478|NCT00729846|Bevacizumab|bevacizumab|mesh-list
43931479|NCT00729846|Verteporfin|verteporfin|mesh-list
43931480|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931481|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931482|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931483|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931484|NCT00729846|Growth Substances|growth substances|mesh-ancestor
43931485|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931486|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931487|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43931488|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931489|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
43931490|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43931491|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43931492|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
43931493|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931494|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43931495|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43570239|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570240|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570241|NCT00431873|Mocetinostat|mocetinostat|mesh-list
43570242|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43570243|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931496|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931497|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931498|NCT00730353|Paclitaxel|paclitaxel|mesh-list
43931499|NCT00730353|Sunitinib|sunitinib|mesh-list
43931500|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43931501|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931502|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
43931503|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
43931504|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
43931505|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931506|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931507|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931508|NCT00730353|Growth Substances|growth substances|mesh-ancestor
43931509|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931510|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931511|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43931512|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931513|NCT00730483|Doxorubicin|doxorubicin|mesh-list
43931514|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43931515|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43931516|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931517|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43931533|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931534|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931536|NCT00731198|Scopolamine|scopolamine|mesh-list
43931537|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43931538|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43931539|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
43931540|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
43931541|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931542|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931543|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931544|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
43931545|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43931546|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
43931547|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931548|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931549|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43931550|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
43931551|NCT00731198|Analgesics|analgesics|mesh-ancestor
43931552|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
43931553|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
43931555|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
43931556|NCT00731588|Vitamins|vitamins|mesh-ancestor
43931557|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
43931558|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931559|NCT00731874|Tacrolimus|tacrolimus|mesh-list
43931560|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931561|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
43931562|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931563|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43931564|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931565|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931566|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
43931567|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43931568|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
44170768|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44170769|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
44170770|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170771|NCT00281996|Gemcitabine|gemcitabine|mesh-list
43931569|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931570|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
43931571|NCT00732225|Protective Agents|protective agents|mesh-ancestor
43931572|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
43931574|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931575|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
43931576|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
43931577|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931578|NCT00732901|Citalopram|citalopram|mesh-list
43931579|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43931580|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931581|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931582|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931583|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931584|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
43931585|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931586|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44170772|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
44170773|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170774|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
44170775|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170776|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170777|NCT00281996|Antiviral Agents|antiviral agents|mesh-ancestor
44170778|NCT00281996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170779|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170780|NCT00281996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170781|NCT00281996|Immunologic Factors|immunologic factors|mesh-ancestor
44170782|NCT00281996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170783|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44170784|NCT00282061|Melatonin|melatonin|mesh-list
44170785|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
44170786|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170787|NCT00282061|Protective Agents|protective agents|mesh-ancestor
44170788|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170789|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170790|NCT00282100|Gefitinib|gefitinib|mesh-list
44170791|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170792|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44170793|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170794|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170795|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
44170796|NCT00282126|Diuretics|diuretics|mesh-ancestor
44170797|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
44170798|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170799|NCT00282126|Expectorants|expectorants|mesh-ancestor
44170800|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170801|NCT00282139|Aripiprazole|aripiprazole|mesh-list
44170802|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
44170803|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170804|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44170805|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170806|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170807|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170808|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
44170809|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
43931587|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
43931588|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931589|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
43931590|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43931591|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43931592|NCT00733096|Prednisolone|prednisolone|mesh-list
43931593|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
43931594|NCT00733096|Etanercept|etanercept|mesh-list
43931595|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43931596|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
43931597|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43931598|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
43931599|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
43931600|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931601|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931602|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931603|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
43931604|NCT00733096|Hormones|hormones|mesh-ancestor
43931605|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931606|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43676247|NCT02877615|S44819|s44819|mesh-list
43931607|NCT00733096|Protective Agents|protective agents|mesh-ancestor
43931608|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43931609|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931610|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43931611|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43931612|NCT00733096|Analgesics|analgesics|mesh-ancestor
43931613|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
43931614|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931615|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931616|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
43931630|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
43931631|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931632|NCT00733993|Caffeine|caffeine|mesh-list
43931633|NCT00733993|Amphetamine|amphetamine|mesh-list
43931634|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43931635|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931636|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43931697|NCT00735436|Growth Substances|growth substances|mesh-ancestor
43931698|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931699|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931700|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43931701|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43931702|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931703|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931704|NCT00735449|Timolol|timolol|mesh-list
43931705|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43931706|NCT00735449|Latanoprost|latanoprost|mesh-list
43931707|NCT00735449|Maleic acid|maleic acid|mesh-list
43931708|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43931709|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43931710|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
43931711|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931712|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931713|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931714|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43931715|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43931716|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931717|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43931718|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43931719|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43931720|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43931721|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43931722|NCT00735462|Imiquimod|imiquimod|mesh-list
43931723|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43931724|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
43931725|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931726|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931727|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
43931739|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43931740|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931742|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931743|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43931744|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931745|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931746|NCT00735917|Saracatinib|saracatinib|mesh-list
43931747|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43931748|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43931749|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931750|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931751|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676365|NCT02876796|Firsocostat|firsocostat|mesh-list
43931752|NCT00735969|Ribavirin|ribavirin|mesh-list
43931753|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
43931754|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931755|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
43931756|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931757|NCT00736073|Aprepitant|aprepitant|mesh-list
43931758|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
43931759|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
43931760|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931761|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931762|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931763|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43931764|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931765|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931766|NCT00736229|Exenatide|exenatide|mesh-list
43931785|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43931787|NCT00737178|Trace Elements|trace elements|mesh-ancestor
43931788|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
43931789|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931790|NCT00737204|Modafinil|modafinil|mesh-list
43931791|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43931792|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931793|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43931794|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43931795|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43931796|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931797|NCT00737243|Paclitaxel|paclitaxel|mesh-list
43931798|NCT00737243|Bevacizumab|bevacizumab|mesh-list
43931799|NCT00737243|Carboplatin|carboplatin|mesh-list
43931800|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43931801|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43931802|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931803|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
43931804|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
43931805|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
43931806|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931807|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43931808|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43931809|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43931810|NCT00737243|Growth Substances|growth substances|mesh-ancestor
43931811|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931812|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
43931813|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43931814|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931815|NCT00737737|Morphine|morphine|mesh-list
43931816|NCT00737737|Oxycodone|oxycodone|mesh-list
43931817|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43931818|NCT00737737|Narcotics|narcotics|mesh-ancestor
43931819|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170810|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170811|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170820|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44170821|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43931820|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931821|NCT00737737|Analgesics|analgesics|mesh-ancestor
43931822|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
43931823|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140357|NCT00179023|Trimethaphan|trimethaphan|mesh-list
44140358|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
44140360|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
44140361|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43931824|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
43931825|NCT00737893|Hematinics|hematinics|mesh-ancestor
43931826|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
43931827|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43931828|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43766821|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
43931829|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931830|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43931831|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43931832|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43931833|NCT00738049|Darusentan|darusentan|mesh-list
43931834|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43931835|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931836|NCT00738361|Paclitaxel|paclitaxel|mesh-list
43931837|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43931838|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43931839|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931840|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
43931841|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
43931842|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
43931843|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931844|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
43931845|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43931846|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931859|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931860|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43931861|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43931862|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931863|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
43931864|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43931865|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931866|NCT00740831|Leuprolide|leuprolide|mesh-list
43931867|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
43931868|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43931869|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
43931870|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931871|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931872|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43931873|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931874|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43931875|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
43931876|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43931877|NCT00741026|Olanzapine|olanzapine|mesh-list
43931878|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
43931879|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
43931880|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43931881|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931882|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931883|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43931884|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43931885|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931886|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931887|NCT00741026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43931888|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931889|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931890|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931891|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170822|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44170823|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
44170824|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931892|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
43931893|NCT00741104|Infliximab|infliximab|mesh-list
43931894|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931895|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931896|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931897|NCT00741156|Enalaprilat|enalaprilat|mesh-list
43931898|NCT00741156|Enalapril|enalapril|mesh-list
43931899|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43931900|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
43931901|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931902|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931903|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43931904|NCT00741455|Cyclosporine|cyclosporine|mesh-list
43931905|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
43931906|NCT00741455|Methotrexate|methotrexate|mesh-list
43931907|NCT00741455|Fludarabine|fludarabine|mesh-list
43931908|NCT00741455|Cyclosporins|cyclosporins|mesh-list
43931909|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43931910|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
43931911|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931912|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43931913|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43931914|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
43931915|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931916|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43931917|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43931918|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43931919|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
43931920|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43931921|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43931922|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
43931923|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
43931924|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931925|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43931926|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43931927|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
43931933|NCT00741468|Caffeine|caffeine|mesh-list
43931934|NCT00741468|Omeprazole|omeprazole|mesh-list
43931935|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43931936|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43931937|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43931938|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931939|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43931940|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43931941|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931942|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43931943|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
43931944|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
43931945|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
43931946|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
43931947|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931948|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931949|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43931950|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931951|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43931952|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43931953|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43931954|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43931955|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43931956|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43931957|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
43931958|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
43931959|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
43931960|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43931961|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43931962|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43931963|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44170825|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170826|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170827|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44170829|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44170830|NCT00282178|Diuretics|diuretics|mesh-ancestor
44170831|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
44170832|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170833|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44170834|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931964|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43931965|NCT00741858|Estradiol|estradiol|mesh-list
43931966|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43931967|NCT00741858|Estrogens|estrogens|mesh-ancestor
43931968|NCT00741858|Hormones|hormones|mesh-ancestor
43931969|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43931970|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931971|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43931972|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
43931973|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44140362|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
43931974|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43931975|NCT00742313|Hemostatics|hemostatics|mesh-list
43931976|NCT00742313|Coagulants|coagulants|mesh-ancestor
43931977|NCT00742469|Rifaximin|rifaximin|mesh-list
43931978|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43931979|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43931980|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43931981|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
43931982|NCT00742573|Bupropion|bupropion|mesh-list
43931983|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43931984|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43931985|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43931986|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43931987|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43931988|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43931989|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43931990|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
43931991|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43931992|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43931993|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43932006|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932007|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932009|NCT00743574|Vitamin D|vitamin d|mesh-list
43932010|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
43932011|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
43932012|NCT00743574|Vitamins|vitamins|mesh-list
43932013|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43932014|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
43932074|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932075|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932076|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
43932077|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932078|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43932079|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
43932080|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43932081|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
43932082|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932083|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43932084|NCT00744848|Epinephrine|epinephrine|mesh-list
43932085|NCT00744848|Bupivacaine|bupivacaine|mesh-list
43932086|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
43932087|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
43932088|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932089|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932090|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
43932091|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932092|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43932093|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43932094|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932095|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932096|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932097|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43932098|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43932099|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
43932100|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43932101|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
43932102|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
43932103|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
43932117|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932118|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932119|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43932120|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
43932121|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932122|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43932123|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43932124|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932125|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932126|NCT00746512|Prednisone|prednisone|mesh-list
43932127|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932128|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
43932129|NCT00746512|Hormones|hormones|mesh-ancestor
43932130|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932131|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932132|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43932133|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932134|NCT00746863|Bupivacaine|bupivacaine|mesh-list
43932135|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
43932136|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
43932137|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932138|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932139|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
43932140|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932141|NCT00746889|Triamcinolone|triamcinolone|mesh-list
43932142|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43932143|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43932144|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43932145|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932146|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
43932147|NCT00746889|Hormones|hormones|mesh-ancestor
43932148|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932149|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932154|NCT00746954|Acetazolamide|acetazolamide|mesh-list
43932157|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43932158|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932159|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932160|NCT00746954|Diuretics|diuretics|mesh-ancestor
43932161|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
43932162|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932164|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43932165|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932166|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932167|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43932168|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
43932169|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932170|NCT00747214|Prednisolone|prednisolone|mesh-list
43932171|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
43932172|NCT00747214|Dipyridamole|dipyridamole|mesh-list
43932173|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932174|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
43932175|NCT00747214|Hormones|hormones|mesh-ancestor
43932176|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932177|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932178|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43932179|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932180|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43932181|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932182|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932183|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43932184|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
43932185|NCT00748072|Vasopressins|vasopressins|mesh-list
43932186|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
43570443|NCT00406809|Navitoclax|navitoclax|mesh-list
43570444|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932187|NCT00748072|Coagulants|coagulants|mesh-ancestor
43932188|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43932199|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932200|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43932201|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43932202|NCT00748657|Growth Substances|growth substances|mesh-ancestor
43932203|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932204|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
43932205|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
43932206|NCT00748826|Infliximab|infliximab|mesh-list
43932207|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932208|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932209|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932210|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43932211|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
43932212|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932213|NCT00749125|Citalopram|citalopram|mesh-list
43932214|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43932215|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43932216|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932217|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932218|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932219|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
43932220|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932221|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43932222|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
43932223|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43932224|NCT00749515|Deferasirox|deferasirox|mesh-list
43932225|NCT00749515|Deferoxamine|deferoxamine|mesh-list
43932226|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43932227|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
43932228|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
43932229|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932243|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932244|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
43932245|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932246|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932247|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43932248|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
43932249|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932250|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932251|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43932252|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932253|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
43932254|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
43932255|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932256|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932257|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
43932258|NCT00750815|Hormones|hormones|mesh-ancestor
43932259|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932260|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43932261|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43932262|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43932263|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43932264|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932265|NCT00751179|Bromides|bromides|mesh-list
43932266|NCT00751179|Rocuronium|rocuronium|mesh-list
43932267|NCT00751179|Succinylcholine|succinylcholine|mesh-list
43932268|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
43932269|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43932270|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43932271|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43932284|NCT00751777|Vaccines|vaccines|mesh-list
43932286|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932287|NCT00752102|Calcitriol|calcitriol|mesh-list
43837974|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
43932288|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932289|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932290|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43932291|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932292|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932293|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43932294|NCT00752102|Vitamins|vitamins|mesh-ancestor
43932295|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
43932296|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43932297|NCT00752973|Malathion|malathion|mesh-list
43932298|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43932299|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932300|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932301|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
43932302|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932303|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932304|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43932305|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43932306|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43932307|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932308|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
43932309|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932310|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
43932311|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932313|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43932314|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
43932315|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932316|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932317|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43932327|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43932328|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932329|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
43932330|NCT00753935|Aspirin|aspirin|mesh-list
43932331|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932332|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932333|NCT00753935|Analgesics|analgesics|mesh-ancestor
43932334|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
43932335|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932336|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932337|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932338|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932339|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43932340|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43932341|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932342|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43932343|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43932344|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932345|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
43932346|NCT00754247|Vitamin E|vitamin e|mesh-list
43932347|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
43932348|NCT00754247|Vitamins|vitamins|mesh-ancestor
43932349|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
43932350|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932351|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932352|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
43932353|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932354|NCT00754247|Protective Agents|protective agents|mesh-ancestor
44140363|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140364|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140365|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43747500|NCT05583214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170835|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170836|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44170837|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44170838|NCT00282217|Sirolimus|sirolimus|mesh-list
44170839|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44170840|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170841|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44170842|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170843|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
44170844|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44170845|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
44140366|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140367|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
44140368|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44140369|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44140370|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
44140371|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44140372|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140373|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140374|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44140375|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44140376|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44140377|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44140378|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44140379|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140380|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
44140381|NCT00179062|Olanzapine|olanzapine|mesh-list
44140382|NCT00179062|Risperidone|risperidone|mesh-list
44140383|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44140384|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
44140385|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140386|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140387|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140388|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44140389|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140390|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140391|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140392|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44140393|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
44140394|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
44140395|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
44140396|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140397|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44140398|NCT00179062|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140401|NCT00179114|Baclofen|baclofen|mesh-list
44140407|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140408|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140409|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140410|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140411|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44140412|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140413|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44140414|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44140415|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
44140416|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
44140417|NCT00179231|Olanzapine|olanzapine|mesh-list
44140418|NCT00179231|Clozapine|clozapine|mesh-list
44140419|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
44140420|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
44140421|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140422|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140423|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44140424|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44140425|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140426|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140427|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140428|NCT00179231|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44140429|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140430|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44140431|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140432|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676798|NCT02873065|Antacids|antacids|mesh-ancestor
43932355|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43932356|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932357|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43932358|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932359|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932360|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
43932361|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43932362|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
43932367|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43932368|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43932369|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43932370|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932371|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932372|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932374|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932375|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43932376|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43932377|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932378|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932379|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43932380|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
43932381|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43932382|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932383|NCT00754923|Sorafenib|sorafenib|mesh-list
43932384|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932385|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43932386|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932387|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932388|NCT00755040|Cyclosporine|cyclosporine|mesh-list
43932389|NCT00755040|Cyclosporins|cyclosporins|mesh-list
43932390|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932391|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932392|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932393|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
43932394|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932395|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
43932396|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932397|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932398|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932399|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43932400|NCT00755274|Vaccines|vaccines|mesh-list
43932401|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
43932402|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932404|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
43932405|NCT00755755|Trace Elements|trace elements|mesh-ancestor
43932406|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
43932407|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932408|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43932409|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
43747606|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
43932410|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43932411|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43932412|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43932413|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
43932414|NCT00755911|Coagulants|coagulants|mesh-ancestor
43932415|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43932416|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
43932417|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932418|NCT00756106|Temozolomide|temozolomide|mesh-list
43932419|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43932420|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
43932421|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932422|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932423|NCT00756236|Metoprolol|metoprolol|mesh-list
43932424|NCT00756236|Esmolol|esmolol|mesh-list
43932425|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43932426|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932427|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
43932428|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
43932429|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932430|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747607|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932431|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43932432|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43932433|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43932434|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932435|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932436|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932437|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44170846|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170847|NCT00282360|Trimetazidine|trimetazidine|mesh-list
44170848|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
44170849|NCT00282386|Rofecoxib|rofecoxib|mesh-list
44170850|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932438|NCT00756548|Laxatives|laxatives|mesh-ancestor
43932439|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932440|NCT00756600|Anesthetics|anesthetics|mesh-list
43932441|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43932442|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932443|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43932444|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
43932445|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43932446|NCT00756964|Rasburicase|rasburicase|mesh-list
43932447|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
43932448|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932449|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43932450|NCT00756977|Laxatives|laxatives|mesh-ancestor
43932451|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932452|NCT00757822|Dronabinol|dronabinol|mesh-list
43932453|NCT00757822|Ondansetron|ondansetron|mesh-list
43932454|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
43932499|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932500|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932501|NCT00758836|Acetaminophen|acetaminophen|mesh-list
43932502|NCT00758836|Ibuprofen|ibuprofen|mesh-list
43932503|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932504|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932505|NCT00758836|Analgesics|analgesics|mesh-ancestor
43932506|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
43932507|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932508|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747608|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43747609|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747611|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
43932509|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932510|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932511|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43932512|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932513|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932514|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
43932515|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
43932516|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43932518|NCT00759187|Fluorides|fluorides|mesh-list
43932519|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
43932520|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
43932521|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932522|NCT00759187|Protective Agents|protective agents|mesh-ancestor
43932523|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932524|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932525|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932526|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
43932527|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932528|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932529|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932530|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
43932531|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932532|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932533|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
43932543|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932544|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932545|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
43932546|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932547|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43932548|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932549|NCT00759473|Cycloserine|cycloserine|mesh-list
43932550|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43932551|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932552|NCT00759473|Renal Agents|renal agents|mesh-ancestor
43932553|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43932554|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
43932555|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43932556|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
43932557|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932558|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
43932559|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932560|NCT00759603|Rituximab|rituximab|mesh-list
43932561|NCT00759603|Lenalidomide|lenalidomide|mesh-list
43932562|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43932563|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932564|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
43932565|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932566|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932567|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43932568|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43932569|NCT00759603|Growth Substances|growth substances|mesh-ancestor
43932570|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
43932571|NCT00759642|Lapatinib|lapatinib|mesh-list
43932572|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932573|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43932574|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932575|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932582|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43932583|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
43932584|NCT00759798|Rituximab|rituximab|mesh-list
43932585|NCT00759798|Fludarabine|fludarabine|mesh-list
43932586|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932587|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
43932588|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932589|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932590|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43932591|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
43570480|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
43932592|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932593|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932594|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43932595|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43932596|NCT00759811|Methotrexate|methotrexate|mesh-list
43932597|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43932598|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
44170851|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170852|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170853|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44170854|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44170855|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170856|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44170857|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44170858|NCT00282386|Analgesics|analgesics|mesh-ancestor
44170859|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
44170860|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170861|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170862|NCT00282399|Decitabine|decitabine|mesh-list
44170863|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44170864|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
44170865|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170866|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170867|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170868|NCT00282451|Insulin|insulin|mesh-list
44170869|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44170870|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
44170871|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
44170872|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44170873|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
44170874|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170875|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170880|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
44170881|NCT00282503|Methoxsalen|methoxsalen|mesh-list
44170882|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44170883|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
44170884|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170885|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
44170886|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
44170887|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170888|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170889|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170890|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
44170891|NCT00282503|Hormones|hormones|mesh-ancestor
44170892|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170893|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44170894|NCT00282503|Protective Agents|protective agents|mesh-ancestor
43932599|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43932600|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932601|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43932602|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
43932603|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932604|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932605|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932606|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932607|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43932608|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932609|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
43932610|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932611|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43932612|NCT00760006|Ampicillin|ampicillin|mesh-list
43932613|NCT00760006|Sulbactam|sulbactam|mesh-list
43932614|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43932615|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43932616|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932617|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43932618|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932619|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932620|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43932621|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932622|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932623|NCT00760019|Analgesics|analgesics|mesh-ancestor
43932624|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
43932625|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932626|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932627|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932628|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932629|NCT00760435|Infliximab|infliximab|mesh-list
43932630|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932641|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932643|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
43932644|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932645|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
43932646|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
43932647|NCT00761137|Tropicamide|tropicamide|mesh-list
43932648|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
43932649|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
43932650|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932651|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932652|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43932653|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43932654|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
43677074|NCT02870634|Copper|copper|mesh-list
43932655|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932656|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932657|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43932658|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
43932659|NCT00761202|Glycerol|glycerol|mesh-list
43932660|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43932661|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
43932662|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932663|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
43932664|NCT00761202|Protective Agents|protective agents|mesh-ancestor
43932665|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43932666|NCT00761202|Laxatives|laxatives|mesh-ancestor
43932667|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932668|NCT00761345|Gemcitabine|gemcitabine|mesh-list
43932669|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43932670|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43932671|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
43932672|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932673|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932674|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
43932682|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43932683|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43932684|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43932685|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932686|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932687|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
43932688|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932689|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932690|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43932691|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932693|NCT00761930|Triclosan|triclosan|mesh-list
43932694|NCT00761930|Fluorides|fluorides|mesh-list
43932695|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
43932696|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932697|NCT00761930|Protective Agents|protective agents|mesh-ancestor
43932698|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932699|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932700|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932701|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932702|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932703|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
43932704|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932705|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932706|NCT00762177|Triclosan|triclosan|mesh-list
43932707|NCT00762177|Fluorides|fluorides|mesh-list
43932708|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
43932709|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932710|NCT00762177|Protective Agents|protective agents|mesh-ancestor
43932711|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932712|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932713|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932714|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932715|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932716|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
43803286|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
44170895|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44170896|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170897|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43932717|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932718|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932719|NCT00762320|Ritonavir|ritonavir|mesh-list
43932720|NCT00762320|Lopinavir|lopinavir|mesh-list
43932721|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43932722|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43932723|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
43932724|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932725|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932726|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43932727|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43932728|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
43932729|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932730|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43932731|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43932732|NCT00762450|Triclosan|triclosan|mesh-list
43932733|NCT00762450|Fluorides|fluorides|mesh-list
43932734|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932735|NCT00762450|Protective Agents|protective agents|mesh-ancestor
43932736|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932737|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932738|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932739|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932740|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932741|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
43932742|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932743|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932744|NCT00762515|Triclosan|triclosan|mesh-list
43932745|NCT00762515|Fluorides|fluorides|mesh-list
43932746|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932747|NCT00762515|Protective Agents|protective agents|mesh-ancestor
43932748|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932749|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44170898|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
44170899|NCT00282594|Insulin|insulin|mesh-list
44170900|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170901|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170902|NCT00282607|Udenafil|udenafil|mesh-list
44170903|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44170904|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44170905|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170906|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170907|NCT00282698|Insulin|insulin|mesh-list
43932751|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932752|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932753|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
43932754|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932755|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932756|NCT00762528|Triclosan|triclosan|mesh-list
43932757|NCT00762528|Fluorides|fluorides|mesh-list
43932758|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
43932759|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932760|NCT00762528|Protective Agents|protective agents|mesh-ancestor
43932761|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932762|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932763|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932764|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932765|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932766|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
43932767|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932769|NCT00762619|Triclosan|triclosan|mesh-list
43932770|NCT00762619|Fluorides|fluorides|mesh-list
43932771|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932772|NCT00762619|Protective Agents|protective agents|mesh-ancestor
43932773|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932774|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932775|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932776|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932777|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932778|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
43932779|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932780|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932781|NCT00762645|Travoprost|travoprost|mesh-list
43932782|NCT00762645|Pilocarpine|pilocarpine|mesh-list
43932783|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932784|NCT00762645|Miotics|miotics|mesh-ancestor
43932785|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
43932786|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932787|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170908|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43932789|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43932790|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
43932791|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932792|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932793|NCT00762710|Prazosin|prazosin|mesh-list
43932794|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932795|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43932796|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43932797|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43932798|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932799|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932800|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932801|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932802|NCT00762853|Triclosan|triclosan|mesh-list
43932803|NCT00762853|Fluorides|fluorides|mesh-list
43932804|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932805|NCT00762853|Protective Agents|protective agents|mesh-ancestor
43932806|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932807|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43932808|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932809|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43932810|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43932811|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
43932812|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932813|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43932814|NCT00763048|Triclosan|triclosan|mesh-list
43932815|NCT00763048|Fluorides|fluorides|mesh-list
43932816|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
43932817|NCT00763048|Protective Agents|protective agents|mesh-ancestor
43932823|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
43932831|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43932832|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932833|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932834|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932835|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932836|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43932837|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932838|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
43932839|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43932840|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
43932841|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932842|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
43932843|NCT00763360|Protective Agents|protective agents|mesh-ancestor
43932844|NCT00763412|Repaglinide|repaglinide|mesh-list
43932845|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43932846|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932847|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
43932848|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43932849|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932850|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43932851|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
43932852|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43932853|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932854|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932855|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932856|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
43932857|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
43932858|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43932859|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43932860|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932861|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932862|NCT00763867|Urological Agents|urological agents|mesh-ancestor
43932863|NCT00764309|Dasatinib|dasatinib|mesh-list
43932864|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932865|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43932869|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43932870|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43932871|NCT00764738|Growth Substances|growth substances|mesh-ancestor
43932872|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932873|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
43932874|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932875|NCT00765128|Ketorolac|ketorolac|mesh-list
43932876|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932877|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932878|NCT00765128|Analgesics|analgesics|mesh-ancestor
43932879|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
43932880|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932881|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932882|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932883|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932884|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43932885|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932886|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932887|NCT00765206|Omeprazole|omeprazole|mesh-list
43932888|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
43932889|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43932890|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43932891|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43932892|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932893|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932894|NCT00765232|Ketorolac|ketorolac|mesh-list
43932895|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43932896|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43932897|NCT00765232|Analgesics|analgesics|mesh-ancestor
43932898|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
43932899|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932900|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170909|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170910|NCT00282724|Liarozole|liarozole|mesh-list
44170911|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
44170912|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
44170913|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170914|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170915|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
43932901|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43932902|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43932903|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43932904|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932905|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932906|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
43932907|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43932908|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43932909|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43932910|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43932911|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932912|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
43932913|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932914|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932915|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43932916|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932917|NCT00765648|Labetalol|labetalol|mesh-list
43932918|NCT00765648|Nicardipine|nicardipine|mesh-list
43932919|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43932920|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43932921|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
43932922|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43932923|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932924|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932925|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43932926|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
43932927|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
43932928|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43932929|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43932930|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43932931|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43932935|NCT00765661|Tacrolimus|tacrolimus|mesh-list
43932941|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932942|NCT00765856|Oxymorphone|oxymorphone|mesh-list
43932943|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44140471|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140472|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44140473|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44140474|NCT00179465|Tiagabine|tiagabine|mesh-list
44140475|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
44140476|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140477|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140478|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140479|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140480|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
44140481|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44140482|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44140483|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803413|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
44170916|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170917|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170918|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44170919|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170920|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44170921|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44170922|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44170923|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
44170924|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170925|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170926|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170927|NCT00282932|Urological Agents|urological agents|mesh-ancestor
44170928|NCT00282945|Metformin|metformin|mesh-list
44170929|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
44170930|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170931|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170932|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
44170933|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44170934|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44170935|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44170936|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170937|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170938|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
44170939|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170940|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170941|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44170942|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170943|NCT00282997|Pregabalin|pregabalin|mesh-list
44170945|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
44170946|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170958|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44170959|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44170960|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44170961|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170962|NCT00283088|Plasminogen|plasminogen|mesh-list
44170963|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44170964|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44170965|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44140484|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932974|NCT00766116|Azacitidine|azacitidine|mesh-list
43932976|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43932977|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
43932978|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43932979|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932980|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43932981|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43932982|NCT00766649|Sirolimus|sirolimus|mesh-list
43932983|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43932984|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43932985|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43932986|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43932987|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
43932988|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43932989|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
43932990|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932991|NCT00766753|Vaccines|vaccines|mesh-list
43932992|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
43932993|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932994|NCT00767364|Vaccines|vaccines|mesh-list
43932995|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
43932996|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43932997|NCT00767507|Cangrelor|cangrelor|mesh-list
43932998|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43932999|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43933000|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43933001|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43933002|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
43933003|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933004|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933005|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933006|NCT00767572|Atorvastatin|atorvastatin|mesh-list
43933007|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43933012|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43933013|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933014|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
43933015|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43933017|NCT00767767|Propofol|propofol|mesh-list
43933018|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43933019|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933020|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933021|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43933022|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
43933023|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
43933024|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
43933025|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
43933026|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
43933027|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170966|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170967|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
44170968|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44170969|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170970|NCT00283114|Lintuzumab|lintuzumab|mesh-list
44170971|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44170972|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170973|NCT00283179|Risperidone|risperidone|mesh-list
44170974|NCT00283179|Aripiprazole|aripiprazole|mesh-list
44170975|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44170976|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
44170977|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170978|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170979|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170980|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44170981|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170982|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170983|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170984|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44170985|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
44170986|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
44170987|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
44170988|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44170989|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44170990|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44170991|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44170992|NCT00283192|Sertraline|sertraline|mesh-list
44170993|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
44170994|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170995|NCT00283192|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44170996|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44170997|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170998|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170999|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171000|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
43747884|NCT04892706|Analgesics|analgesics|mesh-ancestor
44171001|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171002|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
44171003|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44171004|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171005|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171006|NCT00283309|Riluzole|riluzole|mesh-list
44171007|NCT00283309|Memantine|memantine|mesh-list
43933028|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933029|NCT00768118|Curcumin|curcumin|mesh-list
43933030|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43933031|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933097|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933098|NCT00769600|Itraconazole|itraconazole|mesh-list
43933099|NCT00769600|Pemetrexed|pemetrexed|mesh-list
43933100|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933101|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933102|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933103|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43933104|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43933105|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
43933106|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933107|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43933108|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43933109|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43933110|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
43933111|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933112|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933113|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43933114|NCT00769886|Ketotifen|ketotifen|mesh-list
43933115|NCT00769886|Naphazoline|naphazoline|mesh-list
43933116|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
43933117|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933118|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43933119|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
43933120|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
43933121|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140485|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
43933122|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933141|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43933142|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43933143|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43933144|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
43933145|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
43933146|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43933147|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
43933148|NCT00770757|Pomalidomide|pomalidomide|mesh-list
43933149|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
43933150|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933151|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933152|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933153|NCT00770757|Growth Substances|growth substances|mesh-ancestor
43933154|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933155|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933156|NCT00770861|Nebivolol|nebivolol|mesh-list
43933157|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43933158|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
43933159|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43933160|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43933161|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43933162|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
43933163|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933164|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551125|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
43933165|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933166|NCT00770874|Cisplatin|cisplatin|mesh-list
43933167|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933168|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
43933169|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
43933170|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43933188|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43933189|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
43933190|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933191|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933192|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
43933193|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933194|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933195|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43677499|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
43933197|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
43933198|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933200|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933201|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
43933202|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
43933203|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43933204|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
43933205|NCT00771875|Hormones|hormones|mesh-ancestor
43933206|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933207|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43933208|NCT00771875|Protective Agents|protective agents|mesh-ancestor
43933209|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933210|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43933211|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43933212|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933213|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
43933214|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
43933215|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
43933216|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933220|NCT00772304|Azelastine|azelastine|mesh-list
43933233|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
43933234|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933235|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933236|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43933237|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
43933238|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43933239|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43933240|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43933241|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933242|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
43933243|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43933244|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43933245|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
43933246|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933247|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43933248|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43933249|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933250|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933251|NCT00772772|Vitamin D|vitamin d|mesh-list
43933252|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
43933253|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
43933254|NCT00772772|Vitamins|vitamins|mesh-list
43933255|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
43933256|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933257|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43933258|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43933259|NCT00772915|Dexamethasone|dexamethasone|mesh-list
43933260|NCT00772915|Lenalidomide|lenalidomide|mesh-list
43933261|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933262|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
43933263|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
43747961|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747962|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747963|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
43747965|NCT04663997|Docetaxel|docetaxel|mesh-list
43933278|NCT00773422|Varenicline|varenicline|mesh-list
43933279|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43933280|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43933281|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933282|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
43933283|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933284|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43933285|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43933286|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
43933287|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933288|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933289|NCT00773474|Lonafarnib|lonafarnib|mesh-list
43933290|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933291|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933292|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
43933293|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43933294|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
43933295|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933296|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933297|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43933298|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
43933299|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43933300|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43933301|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43933302|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
43933303|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933305|NCT00773955|Acetic Acid|acetic acid|mesh-list
43933322|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
43933323|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
43933324|NCT00774202|Prednisone|prednisone|mesh-list
43933325|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
43933326|NCT00774202|Rituximab|rituximab|mesh-list
43933327|NCT00774202|Vincristine|vincristine|mesh-list
43933328|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933329|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
43933330|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933331|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933332|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933333|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
43933334|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933335|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933336|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933337|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933338|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933339|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
43933340|NCT00774202|Hormones|hormones|mesh-ancestor
43933341|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933342|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43933374|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933375|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933376|NCT00775411|Growth Substances|growth substances|mesh-ancestor
43933377|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933378|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
43933379|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
43933380|NCT00775645|Vitamins|vitamins|mesh-ancestor
43933381|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
43933382|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933383|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
43933384|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43933385|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43933386|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933388|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
43933389|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570740|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
43933390|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933391|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933392|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933393|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43933394|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43933395|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43933396|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
43933397|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
43933398|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933399|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933400|NCT00775671|Metoprolol|metoprolol|mesh-list
43933401|NCT00775671|Nebivolol|nebivolol|mesh-list
43933402|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43933403|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43933404|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
43933405|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
43933406|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933407|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933409|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43933415|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43933417|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43933418|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
43933419|NCT00775931|Busulfan|busulfan|mesh-list
43933420|NCT00775931|Fludarabine|fludarabine|mesh-list
43933421|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
43933422|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
43933423|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933424|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
43933425|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933426|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933427|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933428|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
43933429|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933430|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933431|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933432|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933433|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
43933434|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933435|NCT00775944|Nicotine|nicotine|mesh-list
43933436|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43933437|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
43933438|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933439|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933440|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43933441|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43933463|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
43933464|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933466|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933467|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43933468|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933469|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933470|NCT00777855|Rifampin|rifampin|mesh-list
43933471|NCT00777855|Warfarin|warfarin|mesh-list
43933472|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
43933473|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43933508|NCT00779285|Doxorubicin|doxorubicin|mesh-list
43933525|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43933526|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933527|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933528|NCT00779558|Heparin|heparin|mesh-list
43933529|NCT00779558|Calcium heparin|calcium heparin|mesh-list
43933530|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
43933531|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43933532|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43933533|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933534|NCT00779701|Insulin|insulin|mesh-list
43933535|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43933536|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933537|NCT00780026|Insulin|insulin|mesh-list
43933538|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43933539|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933540|NCT00780208|Methylphenidate|methylphenidate|mesh-list
43933541|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43933542|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933543|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43933544|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43933545|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43933546|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933547|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
43933548|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933549|NCT00780234|Pioglitazone|pioglitazone|mesh-list
43933550|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43933551|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933552|NCT00780442|Cycloserine|cycloserine|mesh-list
43933553|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44171012|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171013|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171014|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44171015|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44171016|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
44171017|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44171018|NCT00283309|Protective Agents|protective agents|mesh-ancestor
44171019|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
44171020|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44171021|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
44171022|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171023|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43933554|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933555|NCT00780442|Renal Agents|renal agents|mesh-ancestor
43933556|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43933557|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
43933558|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43933559|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
43933560|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933561|NCT00780494|Bevacizumab|bevacizumab|mesh-list
43933562|NCT00780494|Carboplatin|carboplatin|mesh-list
43933563|NCT00780494|Capecitabine|capecitabine|mesh-list
43933564|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933565|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677815|NCT02866032|Ciclopirox|ciclopirox|mesh-list
43933566|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933567|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933568|NCT00780494|Growth Substances|growth substances|mesh-ancestor
43933569|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933570|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933571|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933572|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
43933573|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933574|NCT00780676|Dasatinib|dasatinib|mesh-list
43933575|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933576|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43933577|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933578|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933579|NCT00780715|Metformin|metformin|mesh-list
43933580|NCT00780715|Pioglitazone|pioglitazone|mesh-list
43933581|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43933598|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43933599|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
43933600|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933601|NCT00780962|Protective Agents|protective agents|mesh-ancestor
43933602|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933603|NCT00780962|Antidotes|antidotes|mesh-ancestor
43933604|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
43933605|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
43933606|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43933607|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43933608|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933609|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933610|NCT00781508|Urological Agents|urological agents|mesh-ancestor
43933612|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43933613|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43933614|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933615|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
43933616|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933617|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
43933618|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
43933619|NCT00782379|Busulfan|busulfan|mesh-list
43933620|NCT00782379|Fludarabine|fludarabine|mesh-list
43933621|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
44171024|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44171025|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44171026|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171027|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
44171028|NCT00283465|Hematinics|hematinics|mesh-ancestor
44171029|NCT00283478|Gemcitabine|gemcitabine|mesh-list
44171030|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44171031|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
44171032|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171033|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171034|NCT00283478|Antiviral Agents|antiviral agents|mesh-ancestor
44171035|NCT00283478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171036|NCT00283478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171037|NCT00283478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171038|NCT00283478|Immunologic Factors|immunologic factors|mesh-ancestor
44171039|NCT00283478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611455|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
44171040|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
44171041|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44171042|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171043|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171044|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171045|NCT00283543|Temozolomide|temozolomide|mesh-list
44171046|NCT00283543|Carmustine|carmustine|mesh-list
44171047|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171048|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
44171049|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171050|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171051|NCT00283556|Irinotecan|irinotecan|mesh-list
43933622|NCT00782379|Tacrolimus|tacrolimus|mesh-list
43933623|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933624|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
43933625|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933626|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933627|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140493|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140494|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140495|NCT00179686|Lenalidomide|lenalidomide|mesh-list
44140496|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
44140497|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140498|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140499|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140500|NCT00179686|Growth Substances|growth substances|mesh-ancestor
44140501|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140502|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140503|NCT00179699|Pemetrexed|pemetrexed|mesh-list
44140504|NCT00179699|Lenalidomide|lenalidomide|mesh-list
44140505|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140506|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140507|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140508|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44140509|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44140510|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
44140511|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140512|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140513|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140514|NCT00179699|Growth Substances|growth substances|mesh-ancestor
44140515|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140516|NCT00179712|Topotecan|topotecan|mesh-list
44140517|NCT00179712|Lenalidomide|lenalidomide|mesh-list
43677867|NCT02865668|Metformin|metformin|mesh-list
43933685|NCT00784225|Vitamins|vitamins|mesh-list
43933686|NCT00784225|Vitamin E|vitamin e|mesh-list
43933687|NCT00784225|Tocopherols|tocopherols|mesh-list
43933688|NCT00784225|Tocotrienols|tocotrienols|mesh-list
43933689|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
43933707|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
43933708|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933709|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933710|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43933711|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43933712|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
43933713|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933714|NCT00784849|Methylene Blue|methylene blue|mesh-list
43933715|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933716|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933717|NCT00785772|Gabapentin|gabapentin|mesh-list
43933718|NCT00785772|Analgesics|analgesics|mesh-ancestor
43933719|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
43933720|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933721|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933722|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
43933723|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43933724|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43933725|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933726|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43933727|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43933728|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43933729|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933730|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933732|NCT00786019|Vitamins|vitamins|mesh-list
43933733|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
43933734|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
43933735|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933736|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
43933737|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933738|NCT00786019|Protective Agents|protective agents|mesh-ancestor
43933739|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43933740|NCT00786487|Glycerol|glycerol|mesh-list
43933741|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43933742|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43933745|NCT00786487|Protective Agents|protective agents|mesh-ancestor
43933746|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933747|NCT00786643|Leucovorin|leucovorin|mesh-list
43933748|NCT00786643|Interferons|interferons|mesh-list
43933749|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
43933750|NCT00786643|Bevacizumab|bevacizumab|mesh-list
43933751|NCT00786643|Fluorouracil|fluorouracil|mesh-list
43933752|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
43933753|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933754|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933755|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43933756|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43933757|NCT00786643|Growth Substances|growth substances|mesh-ancestor
43933758|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933759|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
43933760|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
43933761|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933762|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933763|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933764|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
43933765|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
43933766|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933767|NCT00786643|Antidotes|antidotes|mesh-ancestor
43933768|NCT00786643|Protective Agents|protective agents|mesh-ancestor
43933769|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
43933770|NCT00786643|Vitamins|vitamins|mesh-ancestor
43933771|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
43933772|NCT00786825|Somatostatin|somatostatin|mesh-list
43933773|NCT00786825|Hormones|hormones|mesh-ancestor
43933774|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933775|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933776|NCT00786916|Lidocaine|lidocaine|mesh-list
43933777|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
44171052|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44171053|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44171054|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171055|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171056|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171057|NCT00283621|Doxorubicin|doxorubicin|mesh-list
44171058|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44171059|NCT00283621|Ifosfamide|ifosfamide|mesh-list
44171060|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
44171061|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44171062|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171063|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44171064|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43933778|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
43933779|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933780|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933781|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
43933782|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933783|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43933784|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43933785|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43933786|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43933787|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933788|NCT00786994|Petrolatum|petrolatum|mesh-list
43933789|NCT00786994|Emollients|emollients|mesh-ancestor
43933790|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933791|NCT00787332|Desirudin|desirudin|mesh-list
43933792|NCT00787332|Argatroban|argatroban|mesh-list
43933793|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
43933794|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43933795|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
43933796|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933797|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933798|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
43933799|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43933800|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43933801|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43933802|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
43933803|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43933804|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43933805|NCT00787722|Prednisolone|prednisolone|mesh-list
43933806|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
43933807|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
43933808|NCT00787722|Rituximab|rituximab|mesh-list
43933809|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
43933810|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43933811|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43933812|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
43933819|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933820|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933821|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933822|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43933823|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43933824|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
43933825|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
43933826|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43933827|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43933828|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
43933829|NCT00787722|Hormones|hormones|mesh-ancestor
43933830|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933831|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43933832|NCT00787722|Protective Agents|protective agents|mesh-ancestor
43933833|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43933834|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
43933835|NCT00787761|Busulfan|busulfan|mesh-list
43933836|NCT00787761|Methotrexate|methotrexate|mesh-list
43933837|NCT00787761|Fludarabine|fludarabine|mesh-list
43933838|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
43933839|NCT00787761|Tacrolimus|tacrolimus|mesh-list
43933840|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
43933841|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43933842|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933843|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
43933844|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933845|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933846|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43933847|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
43933848|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842926|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44171065|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171066|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171067|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171068|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
44171069|NCT00283621|Hematinics|hematinics|mesh-ancestor
44171070|NCT00283634|Bortezomib|bortezomib|mesh-list
44171071|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44171072|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171073|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44171074|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171075|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171076|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
44171077|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933849|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933850|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933851|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43933852|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
43933853|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43933854|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43933855|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
43933856|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933857|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933858|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43933859|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43933860|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43933861|NCT00787852|Paclitaxel|paclitaxel|mesh-list
43933862|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43933863|NCT00787852|Dasatinib|dasatinib|mesh-list
43933864|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43933865|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933866|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
43933867|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
43933868|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
43933869|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933870|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43933871|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933872|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43933873|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
43933874|NCT00788008|Propofol|propofol|mesh-list
43933875|NCT00788008|Isoflurane|isoflurane|mesh-list
43933876|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
43933877|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933878|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933879|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43933880|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43933881|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
43933882|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43933884|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
43933885|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43933890|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
43933891|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933892|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933893|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
43933894|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933895|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933896|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
43933897|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933898|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43933899|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43933900|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43933901|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933902|NCT00789074|Varenicline|varenicline|mesh-list
43933903|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43933904|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43933905|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
43933906|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933907|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933908|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933909|NCT00789113|Lamotrigine|lamotrigine|mesh-list
43933910|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
43933911|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43933912|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43933913|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933914|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43678055|NCT02864095|Coagulants|coagulants|mesh-ancestor
43933915|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933916|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43933917|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43933918|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43933919|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43933920|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43933921|NCT00789256|Bortezomib|bortezomib|mesh-list
43933922|NCT00789256|Melphalan|melphalan|mesh-list
43933923|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933927|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43933928|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43933929|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
43933930|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933931|NCT00789672|Levodopa|levodopa|mesh-list
43933932|NCT00789672|Carbidopa|carbidopa|mesh-list
43933933|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43933934|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43933935|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
43933936|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43933937|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43933938|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933939|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43933940|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43933941|NCT00789685|Interferons|interferons|mesh-list
43933942|NCT00789685|Interferon-beta|interferon-beta|mesh-list
43933943|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43933944|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
43933945|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933946|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
43933947|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933948|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43933949|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43933950|NCT00789750|Pioglitazone|pioglitazone|mesh-list
43933952|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43933978|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43933979|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
43933980|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43933981|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43933982|NCT00789802|Naproxen|naproxen|mesh-list
43933983|NCT00789802|Estradiol|estradiol|mesh-list
43933984|NCT00789802|Estrogens|estrogens|mesh-ancestor
43933985|NCT00789802|Hormones|hormones|mesh-ancestor
43933986|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43933987|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43933988|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43933989|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43933990|NCT00789802|Analgesics|analgesics|mesh-ancestor
43933991|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
43934040|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934041|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43934042|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43934043|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43934044|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
43934045|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934046|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934047|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43934048|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43934049|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
43934050|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43934051|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934052|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
43934053|NCT00790270|Ibuprofen|ibuprofen|mesh-list
43934054|NCT00790270|Amitriptyline|amitriptyline|mesh-list
43934055|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
43934056|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934057|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934058|NCT00790270|Analgesics|analgesics|mesh-ancestor
43934059|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
43934060|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934061|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934062|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934063|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934064|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43934065|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934066|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934067|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43804011|NCT04951505|Cefepime|cefepime|mesh-list
43934078|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934079|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43934080|NCT00790335|Plasminogen|plasminogen|mesh-list
43934081|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43934082|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43934083|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934084|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43934085|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934086|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
43934087|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934088|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934089|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
43934090|NCT00791037|Sargramostim|sargramostim|mesh-list
43934091|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934092|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
43934093|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934094|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934095|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934096|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
43934097|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934098|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934099|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934100|NCT00791219|Itraconazole|itraconazole|mesh-list
43934101|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43934102|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
43934103|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934104|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43934105|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43934106|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934107|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934108|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43934117|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934118|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934119|NCT00791323|Analgesics|analgesics|mesh-ancestor
43934120|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
43934121|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934122|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934123|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934124|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934125|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43934126|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934127|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934128|NCT00791973|Fluticasone|fluticasone|mesh-list
43934129|NCT00791973|Xhance|xhance|mesh-list
43934130|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934131|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43934132|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
43934133|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934134|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678271|NCT02862691|Oxycodone|oxycodone|mesh-list
43934136|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
43934137|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934138|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43934139|NCT00792077|Lenalidomide|lenalidomide|mesh-list
43934140|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
43934141|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934142|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43934143|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43934144|NCT00792077|Growth Substances|growth substances|mesh-ancestor
43934145|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
43934146|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934147|NCT00792142|Thalidomide|thalidomide|mesh-list
43934148|NCT00792142|Dexamethasone|dexamethasone|mesh-list
43934149|NCT00792142|Bortezomib|bortezomib|mesh-list
43934150|NCT00792142|Melphalan|melphalan|mesh-list
43934151|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934152|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
43934153|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
43934154|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934156|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934157|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
43934158|NCT00792142|Hormones|hormones|mesh-ancestor
43934159|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934160|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934161|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934162|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934163|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
43934164|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934165|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934166|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934167|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
43934168|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
43934169|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934170|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934171|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43934172|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43934173|NCT00792142|Growth Substances|growth substances|mesh-ancestor
43934174|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
43934175|NCT00792922|Azithromycin|azithromycin|mesh-list
43934176|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934177|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934178|NCT00793572|Cyclosporine|cyclosporine|mesh-list
43934179|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
43934180|NCT00793572|Fludarabine|fludarabine|mesh-list
43934181|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
43934182|NCT00793572|Bortezomib|bortezomib|mesh-list
43934183|NCT00793572|Melphalan|melphalan|mesh-list
43934184|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
43934185|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43934186|NCT00793572|Cyclosporins|cyclosporins|mesh-list
43934187|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934188|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43934189|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
43804111|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
44171083|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
44171084|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44171085|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171086|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
44171087|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44171088|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44171089|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
43934190|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934191|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934193|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934194|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934195|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
43934196|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934197|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934198|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934199|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43934200|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43934201|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43934202|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
43934203|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934204|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934205|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
43934206|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934207|NCT00793650|Bortezomib|bortezomib|mesh-list
43934208|NCT00793650|Melphalan|melphalan|mesh-list
43934209|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934210|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934211|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
43934212|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934213|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934214|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934215|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
43934216|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934217|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43934218|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934219|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934220|NCT00794144|Analgesics|analgesics|mesh-ancestor
43934221|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
43934222|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934223|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171090|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171091|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171092|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171093|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934224|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934225|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934226|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43934227|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43934228|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43934229|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
43934230|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
43934231|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934232|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934233|NCT00794313|Topiramate|topiramate|mesh-list
43934234|NCT00794313|Amantadine|amantadine|mesh-list
43934235|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
43934236|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934237|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934238|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43934239|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43934240|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
43934241|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934242|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
43934243|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934244|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934245|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934246|NCT00794313|Analgesics|analgesics|mesh-ancestor
43934247|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
43934248|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934249|NCT00794547|Calcitriol|calcitriol|mesh-list
43934250|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43934251|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934252|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43804153|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44171094|NCT00283751|Insulin|insulin|mesh-list
44171095|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44171096|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
44171097|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
44171098|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837992|NCT04877275|Hormones|hormones|mesh-ancestor
44171099|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171100|NCT00283764|Latanoprost|latanoprost|mesh-list
44171101|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44171102|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44171103|NCT00283777|Chromium|chromium|mesh-list
44171104|NCT00283777|Picolinic acid|picolinic acid|mesh-list
44171105|NCT00283777|Trace Elements|trace elements|mesh-ancestor
44171106|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
44171107|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171108|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44171109|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
43934253|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934254|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934255|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43934256|NCT00794547|Vitamins|vitamins|mesh-ancestor
43934257|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
43934258|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43934259|NCT00795002|Cytarabine|cytarabine|mesh-list
43934260|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
43934261|NCT00795002|Alvocidib|alvocidib|mesh-list
43934262|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43934263|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
43934264|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934265|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934266|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
43934267|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934268|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934269|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
43934270|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934271|NCT00795002|Analgesics|analgesics|mesh-ancestor
43934272|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
43934273|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934274|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43934275|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43934276|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934277|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
43934278|NCT00795002|Growth Substances|growth substances|mesh-ancestor
43934279|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43934280|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
43934281|NCT00795145|Linezolid|linezolid|mesh-list
43934282|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934283|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934284|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43934285|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43934286|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934294|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43934295|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934296|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934297|NCT00795275|Incretins|incretins|mesh-ancestor
43934298|NCT00795275|Hormones|hormones|mesh-ancestor
43934299|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934300|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43934301|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
43934302|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934303|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934304|NCT00795288|Simvastatin|simvastatin|mesh-list
43934305|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43934306|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43934307|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
43934308|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934309|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43934310|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43934311|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934312|NCT00795340|Paclitaxel|paclitaxel|mesh-list
43934313|NCT00795340|Carboplatin|carboplatin|mesh-list
43934314|NCT00795340|Cediranib|cediranib|mesh-list
43934315|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43934316|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934317|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
43934318|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
43934319|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
43934320|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934321|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934322|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804212|NCT04947826|Antibodies|antibodies|mesh-list
43934338|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934339|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43934340|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
43934341|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934342|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934343|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934344|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934345|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934346|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934347|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43934348|NCT00796302|Risperidone|risperidone|mesh-list
43934349|NCT00796302|Methylphenidate|methylphenidate|mesh-list
43934350|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43934351|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
43934352|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934353|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934354|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934355|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934356|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934357|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934358|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934359|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934360|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
43934361|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43934362|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43934363|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934364|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934366|NCT00796705|Etanercept|etanercept|mesh-list
43934367|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934368|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171110|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
44171111|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171112|NCT00283790|Zolpidem|zolpidem|mesh-list
44171113|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44171114|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44171115|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171116|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171117|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44171118|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
44171119|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
44171120|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171121|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171122|NCT00283829|Docetaxel|docetaxel|mesh-list
43934369|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934370|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934371|NCT00796705|Analgesics|analgesics|mesh-ancestor
43934372|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
43934373|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934374|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934375|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934376|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934377|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
43934378|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43934379|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43934380|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
43934381|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43934382|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43934383|NCT00797277|Lorazepam|lorazepam|mesh-list
43934384|NCT00797277|Haloperidol|haloperidol|mesh-list
43934385|NCT00797277|Olanzapine|olanzapine|mesh-list
43934386|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
43934387|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
43934388|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
43934389|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934390|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934391|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934392|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934393|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934394|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934395|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934396|NCT00797277|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43934397|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934398|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934399|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934400|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934401|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
44171123|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171124|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44171125|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171126|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171127|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171128|NCT00283946|Zolpidem|zolpidem|mesh-list
44171129|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44171130|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43934402|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934403|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
43934404|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43934405|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
43934406|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43934407|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43934408|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
43934409|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
43934410|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
43934411|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43934412|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
43934413|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934414|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
43934415|NCT00797459|Protective Agents|protective agents|mesh-ancestor
43934416|NCT00797797|Milnacipran|milnacipran|mesh-list
43934417|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
43934418|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43934419|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934420|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934459|NCT00799227|Hormones|hormones|mesh-ancestor
43934460|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934461|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934462|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934463|NCT00799435|Exenatide|exenatide|mesh-list
43934464|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934465|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934466|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43934467|NCT00799435|Incretins|incretins|mesh-ancestor
43934468|NCT00799435|Hormones|hormones|mesh-ancestor
43934469|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934470|NCT00799578|Cysteamine|cysteamine|mesh-list
43934471|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43934472|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934473|NCT00799604|Clevidipine|clevidipine|mesh-list
43934474|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43934475|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804251|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44171131|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171132|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171133|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44171134|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
44171135|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
44171136|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171137|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171138|NCT00283985|Dexamethasone|dexamethasone|mesh-list
44171139|NCT00283985|Methotrexate|methotrexate|mesh-list
44171140|NCT00283985|Asparaginase|asparaginase|mesh-list
44171141|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44171142|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
44171143|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
44171144|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171145|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171146|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171147|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
44171148|NCT00283985|Hormones|hormones|mesh-ancestor
44171149|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171164|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44171165|NCT00284024|Domperidone|domperidone|mesh-list
44171166|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
44171167|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
44171168|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171169|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171170|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171171|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44171172|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
44171173|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171174|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171176|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44171177|NCT00284193|Factor VIII|factor viii|mesh-list
44171178|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
44171179|NCT00284193|Coagulants|coagulants|mesh-ancestor
44171180|NCT00284206|Risperidone|risperidone|mesh-list
44171181|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44171182|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
44171183|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702556|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934476|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934477|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43934478|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934480|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
43934481|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43934482|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934483|NCT00799643|Analgesics|analgesics|mesh-ancestor
43934484|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
43934485|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934486|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934487|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934488|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934489|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43934490|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934491|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934492|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43934493|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44171184|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171185|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171186|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44171187|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44171188|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171189|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171190|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44171191|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
44171192|NCT00284232|Insulin|insulin|mesh-list
44171193|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171194|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171195|NCT00284258|Irinotecan|irinotecan|mesh-list
44171196|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44171197|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44171198|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171199|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171200|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171201|NCT00284271|Prednisone|prednisone|mesh-list
44171202|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
44171203|NCT00284271|Vincristine|vincristine|mesh-list
44171204|NCT00284271|Bleomycin|bleomycin|mesh-list
44171205|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
44171206|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171207|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
44171208|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171209|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171210|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171218|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171219|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171220|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44171221|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44171222|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171223|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171224|NCT00284271|Hematinics|hematinics|mesh-ancestor
44171225|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44171227|NCT00284323|Analgesics|analgesics|mesh-ancestor
43934494|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934495|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934497|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43934498|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43934499|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934500|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934501|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140518|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44140519|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140520|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140521|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140522|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140523|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
43934502|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
43934503|NCT00800839|Busulfan|busulfan|mesh-list
43934504|NCT00800839|Fludarabine|fludarabine|mesh-list
43934505|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
43934506|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934507|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
43934508|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934509|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934510|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43934511|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
43934512|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934513|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934514|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43934515|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43934516|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
43934534|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
43934535|NCT00801398|Oxymorphone|oxymorphone|mesh-list
43934536|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43934537|NCT00801398|Narcotics|narcotics|mesh-ancestor
43934538|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934539|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934540|NCT00801398|Analgesics|analgesics|mesh-ancestor
43571056|NCT00352560|Irbesartan|irbesartan|mesh-list
43934541|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
43934542|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934543|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43934544|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43934545|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
43934546|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43934547|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
43934548|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934549|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934550|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43934551|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
43934552|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43934553|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43934554|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43934555|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
43934556|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934557|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934558|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
43934559|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43934560|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
43934561|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43934562|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43934563|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934564|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934565|NCT00801723|Budesonide|budesonide|mesh-list
43934566|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934567|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44171228|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
44171229|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934569|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934570|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934571|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43934572|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
43934573|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
43934574|NCT00801723|Hormones|hormones|mesh-ancestor
43934575|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934576|NCT00801801|Docetaxel|docetaxel|mesh-list
43934577|NCT00801801|Sorafenib|sorafenib|mesh-list
43934578|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934579|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
43934580|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
43934581|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
43934582|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934583|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43934584|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934585|NCT00801827|Fallypride|fallypride|mesh-list
43934586|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43934587|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43934588|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
43934589|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934590|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934591|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934592|NCT00802100|Metformin|metformin|mesh-list
43934593|NCT00802100|Benztropine|benztropine|mesh-list
43934594|NCT00802100|Olanzapine|olanzapine|mesh-list
43934595|NCT00802100|Aripiprazole|aripiprazole|mesh-list
43934596|NCT00802100|Perphenazine|perphenazine|mesh-list
43934597|NCT00802100|Simvastatin|simvastatin|mesh-list
43934598|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43934602|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
43934613|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934614|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934615|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43934617|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934684|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934685|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934686|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
43934687|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571103|NCT00337532|Paclitaxel|paclitaxel|mesh-list
43934688|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43934689|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934690|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
43934691|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43934692|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43934693|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43934694|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43934695|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934696|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43934698|NCT00803062|Paclitaxel|paclitaxel|mesh-list
43934699|NCT00803062|Bevacizumab|bevacizumab|mesh-list
43934700|NCT00803062|Cisplatin|cisplatin|mesh-list
43934701|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43934702|NCT00803062|Topotecan|topotecan|mesh-list
43934703|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43934704|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
43934705|NCT00803062|Antibodies|antibodies|mesh-list
43934706|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
43934707|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43934708|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
43934709|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43934710|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804425|NCT04945824|Hormones|hormones|mesh-ancestor
44171230|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171231|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44171232|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
44171233|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44171234|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
44171235|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
44171236|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171237|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171238|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
44171239|NCT00284336|Doxorubicin|doxorubicin|mesh-list
44171240|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44171241|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171242|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
44171243|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171244|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171245|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171246|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
44171247|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171248|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171249|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44171250|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43934712|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43934713|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43934714|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934715|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43934716|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43934717|NCT00803062|Growth Substances|growth substances|mesh-ancestor
43934718|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934719|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
43934720|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
43934721|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43934722|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43934723|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934724|NCT00803400|Alprazolam|alprazolam|mesh-list
43934725|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43934726|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934727|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934728|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43934729|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934730|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934731|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
43934732|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
43934733|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571137|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
43571138|NCT00332657|Anecortave|anecortave|mesh-list
43934734|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934735|NCT00803543|Valacyclovir|valacyclovir|mesh-list
43934736|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
43934737|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934738|NCT00803647|Leucovorin|leucovorin|mesh-list
43934739|NCT00803647|Fluorouracil|fluorouracil|mesh-list
43934740|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
43934741|NCT00803647|Cetuximab|cetuximab|mesh-list
43934742|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
43934743|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934749|NCT00803647|Antidotes|antidotes|mesh-ancestor
43934754|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43934755|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
43934756|NCT00803686|Calcitonin|calcitonin|mesh-list
43934757|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43934758|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934759|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43934760|NCT00804609|Lidocaine|lidocaine|mesh-list
43934761|NCT00804609|Morphine|morphine|mesh-list
43934762|NCT00804609|Anesthetics|anesthetics|mesh-list
43934763|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
43934764|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934765|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934766|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
43934767|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934768|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43934769|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43934770|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43934771|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934772|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934774|NCT00804609|Narcotics|narcotics|mesh-ancestor
43934775|NCT00804609|Analgesics|analgesics|mesh-ancestor
43934776|NCT00804648|Timolol|timolol|mesh-list
43934777|NCT00804648|Maleic acid|maleic acid|mesh-list
43934778|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43934779|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43934780|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
43934781|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934782|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934783|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934784|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43934785|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842981|NCT04496401|Tacrolimus|tacrolimus|mesh-list
44171251|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44171252|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44171253|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171254|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
44171255|NCT00284427|Vitamins|vitamins|mesh-ancestor
44171256|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
44171257|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171258|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
43934786|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934787|NCT00804973|Sumatriptan|sumatriptan|mesh-list
43934788|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43934789|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43934790|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43934791|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
43934792|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934793|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934794|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934795|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43934796|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43934797|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43934798|NCT00805493|Riluzole|riluzole|mesh-list
43934799|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
43934800|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43934801|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43934802|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934805|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43934845|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
43934846|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
43934847|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934848|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934849|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43934850|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43934851|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934852|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
43934853|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
43934854|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43934855|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43934856|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43934857|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43934858|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43934859|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43934860|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43934861|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934862|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43934863|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43934864|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43934865|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
43934866|NCT00806598|Cyclosporine|cyclosporine|mesh-list
43934867|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
43934868|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43934869|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43934870|NCT00806598|Prednisolone|prednisolone|mesh-list
43934890|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934891|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43934892|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
43934893|NCT00806598|Hormones|hormones|mesh-ancestor
43934894|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43934895|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43934896|NCT00806598|Protective Agents|protective agents|mesh-ancestor
43934897|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43934898|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934899|NCT00807209|Fentanyl|fentanyl|mesh-list
43934900|NCT00807209|Bupivacaine|bupivacaine|mesh-list
43934901|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
43934902|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
43934903|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934904|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934905|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
43934906|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934907|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43934908|NCT00807209|Narcotics|narcotics|mesh-ancestor
43934909|NCT00807209|Analgesics|analgesics|mesh-ancestor
43934910|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43766992|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
43766993|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766994|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766995|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43766996|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43766997|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
43766998|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766999|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43767000|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43571233|NCT00318656|Metformin|metformin|mesh-list
43934911|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43934912|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
43934913|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43934914|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43934915|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
43934916|NCT00807586|Prednisolone|prednisolone|mesh-list
43934917|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
43934918|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43934919|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
43934920|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43934936|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43934937|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934938|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
43934939|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
43934940|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
43934941|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934942|NCT00807989|Lamotrigine|lamotrigine|mesh-list
43934943|NCT00807989|Carbamazepine|carbamazepine|mesh-list
43934944|NCT00807989|Valproic Acid|valproic acid|mesh-list
43934945|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
43934946|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43934947|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43934948|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43934949|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43934950|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934951|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43934952|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43934953|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43934954|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43934955|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43934956|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934957|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
43934958|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934959|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
43934960|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43934961|NCT00807989|Analgesics|analgesics|mesh-ancestor
43934962|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
43934963|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43934983|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934984|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43934985|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43934986|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43934987|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43934988|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
43934989|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43934990|NCT00809185|Everolimus|everolimus|mesh-list
43934991|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43934992|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934993|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
43934994|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43934995|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
43934996|NCT00809276|Busulfan|busulfan|mesh-list
43934997|NCT00809276|Fludarabine|fludarabine|mesh-list
43934998|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43934999|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
43935000|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935001|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935002|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43935003|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
43935004|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935005|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935006|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43935007|NCT00809809|Zinc|zinc|mesh-list
43935008|NCT00809809|Trace Elements|trace elements|mesh-ancestor
43935009|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
43935010|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935011|NCT00809848|Bimatoprost|bimatoprost|mesh-list
43935012|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43935013|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43935014|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43935015|NCT00810303|Efavirenz|efavirenz|mesh-list
43935016|NCT00810303|Ezetimibe|ezetimibe|mesh-list
43935017|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43935018|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935019|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
44171259|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171260|NCT00284427|Protective Agents|protective agents|mesh-ancestor
44171261|NCT00284505|Thalidomide|thalidomide|mesh-list
43935020|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935021|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935022|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43935023|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935024|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935025|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
43935026|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935027|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43935028|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43935029|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43935030|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43935031|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43935032|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43935034|NCT00810576|Vorinostat|vorinostat|mesh-list
43935035|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935036|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43935037|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935038|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935039|NCT00810719|Gemcitabine|gemcitabine|mesh-list
43935040|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43935041|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43935042|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
43935043|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935044|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935045|NCT00810719|Antiviral Agents|antiviral agents|mesh-ancestor
43935046|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935047|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935048|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935049|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
43935050|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804623|NCT04942899|Letrozole|letrozole|mesh-list
44171262|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171263|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
44171264|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171265|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
44171266|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44171267|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171268|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43935051|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935052|NCT00810797|Exemestane|exemestane|mesh-list
43935053|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935054|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43935055|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43935056|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935057|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935058|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43935059|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
43935060|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935061|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935062|NCT00811434|Lactulose|lactulose|mesh-list
43935063|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935064|NCT00811564|Timolol|timolol|mesh-list
43935065|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43935066|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43935067|NCT00811564|Latanoprost|latanoprost|mesh-list
43935068|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43935069|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43935070|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43935071|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935072|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935073|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935074|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935075|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43935076|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43935077|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43804635|NCT04943146|Aspirin|aspirin|mesh-list
44171269|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44171270|NCT00284505|Growth Substances|growth substances|mesh-ancestor
44171271|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
44171272|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171274|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171275|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
44171276|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171277|NCT00284583|Lidocaine|lidocaine|mesh-list
44171278|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
44171279|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
44171286|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44171287|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171288|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171290|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
44171291|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44171292|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44171293|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171294|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935078|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43935079|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43935080|NCT00811850|Timolol|timolol|mesh-list
43935081|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43935082|NCT00811850|Dorzolamide|dorzolamide|mesh-list
43935083|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43935084|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43935085|NCT00811850|Maleic acid|maleic acid|mesh-list
43935086|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43935087|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43935088|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935089|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935090|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935091|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935092|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43935093|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43935094|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935095|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43935096|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43935097|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43935098|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43935099|NCT00812604|Analgesics|analgesics|mesh-list
43935100|NCT00812604|Petrolatum|petrolatum|mesh-list
43935101|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
43935102|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935103|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935104|NCT00812604|Emollients|emollients|mesh-ancestor
43935105|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935106|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
43935107|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43935108|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43935109|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43935110|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935111|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935112|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935113|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804673|NCT04942834|Amiodarone|amiodarone|mesh-list
44171295|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
43935114|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935115|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43935116|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935117|NCT00812877|Calcium|calcium|mesh-list
43935118|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43935119|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935120|NCT00813111|Epinephrine|epinephrine|mesh-list
43935121|NCT00813111|Bupivacaine|bupivacaine|mesh-list
43935122|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
43935123|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
43935124|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935125|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935126|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
43935127|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935128|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43935129|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43935130|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935131|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935132|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935133|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43935134|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43935135|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
43935136|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43935137|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
43935138|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
43935139|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
43935140|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44171296|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
44171297|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44171298|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
44171299|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44171300|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171301|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44171302|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44171303|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44171304|NCT00284765|Analgesics|analgesics|mesh-ancestor
44171305|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
44171306|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171307|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171308|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44171309|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171310|NCT00284778|Docetaxel|docetaxel|mesh-list
44171311|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171312|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44171313|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171314|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171315|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935141|NCT00814138|Methotrexate|methotrexate|mesh-list
43935142|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43935143|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
43935144|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935145|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935146|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43935147|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
43935148|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935149|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935150|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935151|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935152|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43935153|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935154|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
43935155|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935156|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935158|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
43935159|NCT00814255|Adalimumab|adalimumab|mesh-list
43935160|NCT00814255|Losartan|losartan|mesh-list
43935161|NCT00814255|Lisinopril|lisinopril|mesh-list
43935162|NCT00814255|Atorvastatin|atorvastatin|mesh-list
43935163|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43935164|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935165|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
43935166|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935167|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935168|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43935169|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935170|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935171|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935172|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43935173|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43935174|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43935175|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43935181|NCT00814671|Rifampin|rifampin|mesh-list
43935182|NCT00814671|Rifapentine|rifapentine|mesh-list
43935183|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43935184|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
43935185|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43935186|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935187|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
43935188|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935189|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935190|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935191|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43935192|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43935193|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43935194|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43935195|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43935196|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43935197|NCT00814788|Everolimus|everolimus|mesh-list
43935198|NCT00814788|Bicalutamide|bicalutamide|mesh-list
43935199|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935200|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935201|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
43935202|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935203|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
43935204|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
43935205|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935206|NCT00815347|Bosentan|bosentan|mesh-list
43935207|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43935208|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43935209|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935210|NCT00815360|Triamcinolone|triamcinolone|mesh-list
43935211|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43935212|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43935213|NCT00815360|Ranibizumab|ranibizumab|mesh-list
43935214|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43935218|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935219|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
43935220|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935221|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935261|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
43935262|NCT00817219|Calcipotriene|calcipotriene|mesh-list
43935263|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43935264|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935265|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
43935266|NCT00817219|Hormones|hormones|mesh-ancestor
43935267|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935268|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935269|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43935270|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
43935272|NCT00817843|Simvastatin|simvastatin|mesh-list
43935273|NCT00817843|Ezetimibe|ezetimibe|mesh-list
43935274|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43836084|NCT05003453|Hormones|hormones|mesh-ancestor
43935275|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935276|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
43935277|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935278|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935279|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43935280|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935281|NCT00817999|Clopidogrel|clopidogrel|mesh-list
43935282|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43935283|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43935284|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43935285|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43935286|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
43935287|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935288|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935289|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935290|NCT00818272|Infliximab|infliximab|mesh-list
43935291|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935292|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935293|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935303|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43935304|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43935305|NCT00818337|Analgesics|analgesics|mesh-ancestor
43935306|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
43935307|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935308|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935309|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935310|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935311|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43935312|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43935313|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935314|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43935315|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43935316|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935317|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
43935318|NCT00818363|Bupivacaine|bupivacaine|mesh-list
43935319|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
43935320|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
43935321|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935322|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935323|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
43935324|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935325|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43935326|NCT00818805|Tranilast|tranilast|mesh-list
43935327|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43935328|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43935329|NCT00818805|Analgesics|analgesics|mesh-ancestor
43935330|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
43935331|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935332|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935333|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935334|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935335|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43935336|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43804835|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
44171316|NCT00284791|Lamotrigine|lamotrigine|mesh-list
44171317|NCT00284791|Sertraline|sertraline|mesh-list
44171318|NCT00284791|Fluoxetine|fluoxetine|mesh-list
44171319|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
43935337|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43935338|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
43935339|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
43935340|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935341|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935342|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43935343|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935344|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43935345|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43935346|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
43935348|NCT00818961|Rituximab|rituximab|mesh-list
43935349|NCT00818961|Methotrexate|methotrexate|mesh-list
43935350|NCT00818961|Fludarabine|fludarabine|mesh-list
43935351|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
43935352|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
43935353|NCT00818961|Tacrolimus|tacrolimus|mesh-list
43935354|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935355|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
43935356|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935357|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935358|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43935359|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
43935360|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935361|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935362|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43935363|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935364|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43935365|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
43935366|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935367|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43935368|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
44171320|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171321|NCT00284791|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44171322|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44171323|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171324|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171325|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171327|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171328|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44171329|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44171330|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44171331|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935369|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935370|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935371|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43935372|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935373|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43935374|NCT00819403|Simvastatin|simvastatin|mesh-list
43935375|NCT00819403|Ezetimibe|ezetimibe|mesh-list
43935376|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
43935377|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43935378|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935379|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
43935380|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935381|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935382|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43935383|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935384|NCT00819507|Fluocinonide|fluocinonide|mesh-list
43935385|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935386|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
43935387|NCT00819507|Hormones|hormones|mesh-ancestor
43935388|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935389|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935390|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43935391|NCT00819637|Albuterol|albuterol|mesh-list
43935392|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
43935393|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43935394|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
43935395|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935396|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935397|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43935398|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
43935399|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43935400|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43935401|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43935402|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935403|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935404|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935407|NCT00820534|Penciclovir|penciclovir|mesh-list
43935408|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
43935409|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935410|NCT00820573|Metformin|metformin|mesh-list
43935411|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43935412|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43935413|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935414|NCT00820573|Incretins|incretins|mesh-ancestor
43935415|NCT00820573|Hormones|hormones|mesh-ancestor
43935416|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935417|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43935418|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
43935419|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935420|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935421|NCT00820612|Indomethacin|indomethacin|mesh-list
43935422|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43935423|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43935424|NCT00820612|Analgesics|analgesics|mesh-ancestor
43804892|NCT04939441|Tenofovir|tenofovir|mesh-list
44171332|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
44171333|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44171334|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44171335|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44171336|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44171337|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171338|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44171339|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
44171340|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44171341|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171342|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44171343|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
44171344|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44171345|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171346|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171371|NCT00285051|Ondansetron|ondansetron|mesh-list
44171372|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
44171373|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
44171374|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171375|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171376|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171377|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
44171378|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
44171379|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44171380|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
44171381|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171382|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171383|NCT00285051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44171384|NCT00285051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44171385|NCT00285051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171386|NCT00285051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171387|NCT00285051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44171388|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
44171389|NCT00285090|Vitamin D|vitamin d|mesh-list
44171390|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
43935425|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
43935426|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935427|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935428|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935429|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935430|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
43935431|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
43935432|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935433|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43935434|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935435|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935436|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43935437|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43935438|NCT00820664|Estradiol|estradiol|mesh-list
43935439|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43935440|NCT00820664|Estrogens|estrogens|mesh-ancestor
43935441|NCT00820664|Hormones|hormones|mesh-ancestor
43935442|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935443|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935444|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43935445|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
43935446|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935447|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43935448|NCT00820872|Carboplatin|carboplatin|mesh-list
43935449|NCT00820872|Docetaxel|docetaxel|mesh-list
43935450|NCT00820872|Trastuzumab|trastuzumab|mesh-list
44171391|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
44171392|NCT00285090|Vitamins|vitamins|mesh-list
44171393|NCT00285090|Calcium|calcium|mesh-list
44171394|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
44171395|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171396|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44171397|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171398|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
44171399|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171400|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171413|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44171415|NCT00285181|Simvastatin|simvastatin|mesh-list
44171416|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44171417|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43611825|NCT03169790|Leucovorin|leucovorin|mesh-list
44171418|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
44171419|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171420|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44171421|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44171422|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171423|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
44171424|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43935451|NCT00820872|Lapatinib|lapatinib|mesh-list
43935452|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935453|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
43767053|NCT02403687|Bupivacaine|bupivacaine|mesh-list
43767054|NCT02403687|Prilocaine|prilocaine|mesh-list
43767055|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
43935454|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
43935455|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
43935456|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935457|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935458|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935459|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935460|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
43935461|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43935462|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43935463|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935464|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935465|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935466|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935467|NCT00821184|Urological Agents|urological agents|mesh-ancestor
43935468|NCT05237115|Amoxicillin|amoxicillin|mesh-list
43935469|NCT05237115|Clarithromycin|clarithromycin|mesh-list
43935470|NCT05237115|Esomeprazole|esomeprazole|mesh-list
43935471|NCT05237115|Bismuth|bismuth|mesh-list
43935472|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43935473|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935474|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43935475|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935476|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43935477|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935478|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935479|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43935480|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44171425|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171426|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171427|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44171428|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44171429|NCT00285298|Protective Agents|protective agents|mesh-ancestor
44171430|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171431|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44171432|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44171433|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
44171434|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
44171435|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44171436|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171437|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43935481|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43935482|NCT05237115|Antacids|antacids|mesh-ancestor
43935483|NCT05236907|Midazolam|midazolam|mesh-list
43935484|NCT05236907|Melatonin|melatonin|mesh-list
43935485|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43935486|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43935487|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935488|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935489|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43935490|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43935491|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43935492|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43935493|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
43935494|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
43935495|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
43935496|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
43935497|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935498|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935499|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
43935500|NCT05236907|Protective Agents|protective agents|mesh-ancestor
43935501|NCT05236842|Sulthiame|sulthiame|mesh-list
43935502|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
43935503|NCT05236777|Natalizumab|natalizumab|mesh-list
43935504|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
44171438|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
44171439|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44171440|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171441|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171442|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171443|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44171444|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
44171445|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171446|NCT00285376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44171447|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44171448|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171449|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171450|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171451|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
44171452|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171453|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44171454|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44171455|NCT00285389|Dexamethasone|dexamethasone|mesh-list
44171456|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
44171457|NCT00285389|Melphalan|melphalan|mesh-list
44171471|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44171472|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44171473|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
44171474|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
44171475|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171476|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171477|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
44171478|NCT00285389|Hormones|hormones|mesh-ancestor
44171479|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935505|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935506|NCT05236634|Tadalafil|tadalafil|mesh-list
43935507|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43935508|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43935509|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
43935510|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43935511|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935512|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935513|NCT05236634|Urological Agents|urological agents|mesh-ancestor
43935514|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43935515|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43935516|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935517|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935518|NCT05236621|Dexamethasone|dexamethasone|mesh-list
43935519|NCT05236621|Pomalidomide|pomalidomide|mesh-list
43935520|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43935521|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
43935522|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
43935523|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935524|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935525|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935526|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
43935527|NCT05236621|Hormones|hormones|mesh-ancestor
43935528|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935529|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43679371|NCT02853864|Propofol|propofol|mesh-list
43935530|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935531|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
43935532|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43935533|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43935534|NCT05236621|Growth Substances|growth substances|mesh-ancestor
43935535|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
43935536|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
44171480|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171481|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44171482|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44171483|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171484|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171485|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44171486|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44171487|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43935537|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43935538|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43935539|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935541|NCT05236569|Coagulants|coagulants|mesh-ancestor
43935542|NCT05236504|Melatonin|melatonin|mesh-list
43935543|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
43935544|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935545|NCT05236504|Protective Agents|protective agents|mesh-ancestor
43935546|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935547|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935548|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
43935549|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
43935550|NCT05214196|Povidone|povidone|mesh-list
43935551|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
43935552|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
43935553|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43935554|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935555|NCT05209620|Pemetrexed|pemetrexed|mesh-list
43935556|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935557|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935558|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935559|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43935560|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935561|NCT05206812|Durvalumab|durvalumab|mesh-list
43935562|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935563|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140553|NCT00179751|Lenalidomide|lenalidomide|mesh-list
44140573|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140574|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140575|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140576|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44140578|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140579|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
44140580|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140581|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140582|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140583|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
44140584|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140585|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140586|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44140587|NCT00179881|Thalidomide|thalidomide|mesh-list
44140588|NCT00179881|Carboplatin|carboplatin|mesh-list
44140589|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140590|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140591|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
44140592|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140593|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
43935564|NCT05177198|Clindamycin|clindamycin|mesh-list
43935565|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
43935566|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
43935567|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43935568|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935569|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43935570|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935571|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935572|NCT05131152|Cyclosporine|cyclosporine|mesh-list
43935573|NCT05131152|Cyclosporins|cyclosporins|mesh-list
43935574|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935575|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935576|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651853|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43651854|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43651855|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767062|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935577|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
43935578|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935580|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935581|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
43935582|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935583|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43935584|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
43935585|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43935586|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935587|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935588|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935589|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935590|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935591|NCT05124704|Ropivacaine|ropivacaine|mesh-list
43935592|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
43935593|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
43935594|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935595|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935596|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
43935597|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935598|NCT05120505|Metformin|metformin|mesh-list
43935599|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43935600|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935601|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
43935602|NCT05000450|Fludarabine|fludarabine|mesh-list
43935603|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935605|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935606|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935607|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43935608|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
43935609|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935610|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935623|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935624|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43935625|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935626|NCT04900116|Bupivacaine|bupivacaine|mesh-list
43935627|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
43935628|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
43935629|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935630|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935631|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
43935632|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935633|NCT04894123|Trifluridine|trifluridine|mesh-list
43935634|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
43935635|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935636|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
43935637|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935638|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
43935639|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935640|NCT04857684|Bevacizumab|bevacizumab|mesh-list
43935641|NCT04857684|Atezolizumab|atezolizumab|mesh-list
43935642|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838014|NCT04876534|Hormones|hormones|mesh-ancestor
43935643|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935644|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43935645|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43935646|NCT04857684|Growth Substances|growth substances|mesh-ancestor
43935647|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935648|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
43935649|NCT04760275|Fluoxetine|fluoxetine|mesh-list
43935650|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43935651|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43935652|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935653|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935654|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935655|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
43935656|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935657|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43805019|NCT04937673|Paclitaxel|paclitaxel|mesh-list
44171488|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935658|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
43935659|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43935660|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43935661|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43935662|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935663|NCT04729725|Cemiplimab|cemiplimab|mesh-list
43935664|NCT04729725|Antibodies|antibodies|mesh-list
43935665|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43935666|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
43935667|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935668|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935669|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935670|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
43935671|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43935672|NCT04694976|Vitamin D|vitamin d|mesh-list
43935673|NCT04694976|Vitamins|vitamins|mesh-ancestor
43935674|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
43935675|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935676|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43935678|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43935679|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935680|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935681|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935682|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935683|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935684|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
43935685|NCT04645550|Aspirin|aspirin|mesh-list
43935686|NCT04645550|Heparin|heparin|mesh-list
43935687|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43935688|NCT04645550|Tinzaparin|tinzaparin|mesh-list
43935689|NCT04645550|Dalteparin|dalteparin|mesh-list
43935690|NCT04645550|Dipyridamole|dipyridamole|mesh-list
43935691|NCT04645550|Warfarin|warfarin|mesh-list
43935692|NCT04645550|Apixaban|apixaban|mesh-list
43935693|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43935694|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43935695|NCT04645550|Analgesics|analgesics|mesh-ancestor
43935700|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935701|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43935702|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43935703|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935704|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43935705|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43935706|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935707|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
43935708|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
43935709|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43935710|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
43935711|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43935712|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
43935713|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43935714|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
43935716|NCT04634071|Nicotine|nicotine|mesh-list
43935717|NCT04634071|Varenicline|varenicline|mesh-list
43935718|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43935719|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
43935720|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935721|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935722|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43935723|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43935724|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935725|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935726|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935727|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43935728|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
43935729|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43935730|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43935731|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43935733|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
43935744|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935745|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935746|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935748|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935749|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935750|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43935751|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935752|NCT04591925|Insulin|insulin|mesh-list
43935753|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43935754|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43935755|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935756|NCT04565730|Anesthetics|anesthetics|mesh-list
43935757|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935758|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935759|NCT04537156|Vaccines|vaccines|mesh-list
43935760|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
43935761|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935762|NCT04501718|Etoposide|etoposide|mesh-list
43935763|NCT04501718|Temozolomide|temozolomide|mesh-list
43935764|NCT04501718|Apatinib|apatinib|mesh-list
43935765|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43935766|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935767|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43935768|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43935769|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935770|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935771|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43935790|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
44140594|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44140595|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140596|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140597|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44140598|NCT00179881|Growth Substances|growth substances|mesh-ancestor
44140599|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
44140600|NCT00179920|Carboplatin|carboplatin|mesh-list
44140601|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140602|NCT00180011|Omalizumab|omalizumab|mesh-list
44140603|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44140604|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140605|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140606|NCT00180024|Irbesartan|irbesartan|mesh-list
44140607|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44140608|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44140609|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44140610|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140611|NCT00180037|Ubiquinone|ubiquinone|mesh-list
44140612|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
44140613|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
44140614|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140615|NCT00180037|Vitamins|vitamins|mesh-ancestor
44140616|NCT00180050|Budesonide|budesonide|mesh-list
44140617|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140618|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44140619|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
44140620|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140621|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140622|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140623|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140624|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
44140625|NCT00180050|Hormones|hormones|mesh-ancestor
44140626|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140627|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44140628|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140629|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171489|NCT00285415|Carboplatin|carboplatin|mesh-list
44171490|NCT00285415|Docetaxel|docetaxel|mesh-list
44140630|NCT00180076|Budesonide|budesonide|mesh-list
44140631|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140632|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44140633|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
44140634|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140635|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140636|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140637|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140638|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
44140639|NCT00180076|Hormones|hormones|mesh-ancestor
44140640|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140641|NCT00180089|Budesonide|budesonide|mesh-list
44140642|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140643|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44140644|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
44140645|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140646|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140647|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140648|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140649|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
44140650|NCT00180089|Hormones|hormones|mesh-ancestor
44140651|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44140652|NCT00180102|Cytarabine|cytarabine|mesh-list
44140653|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
44140654|NCT00180102|Amsacrine|amsacrine|mesh-list
44140655|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140656|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
44140657|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140658|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140659|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
44140660|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140661|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935795|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43935796|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43935797|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43935798|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43935799|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749425|NCT02510976|Laxatives|laxatives|mesh-ancestor
43935800|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
43935801|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935802|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935803|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43935804|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935805|NCT04267978|Irinotecan|irinotecan|mesh-list
43935806|NCT04267978|Temozolomide|temozolomide|mesh-list
43935807|NCT04267978|Endostatins|endostatins|mesh-list
43935808|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43935809|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43935810|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935811|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935812|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935813|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43935814|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
43935815|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43935816|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43935817|NCT04267978|Growth Substances|growth substances|mesh-ancestor
43935818|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935819|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
43935820|NCT04155164|Metformin|metformin|mesh-list
43935821|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43935822|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935823|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43935824|NCT04134663|Oxytocin|oxytocin|mesh-list
43935825|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
43935826|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935827|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935828|NCT04095221|Irinotecan|irinotecan|mesh-list
43935829|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43935830|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44171491|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935838|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935839|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43935840|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
43935841|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43935842|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43935843|NCT03936270|Letrozole|letrozole|mesh-list
43935844|NCT03936270|Palbociclib|palbociclib|mesh-list
43935845|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935846|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43935847|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43935848|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935849|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935850|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43935851|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
43935852|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43935853|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935854|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935860|NCT03839446|Etoposide|etoposide|mesh-list
43935861|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
43935862|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
43935863|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43935864|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935878|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
43935879|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935880|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935881|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935882|NCT03713645|Tacrolimus|tacrolimus|mesh-list
43935883|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935884|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
43935885|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935886|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43935887|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935888|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935889|NCT03690869|Cemiplimab|cemiplimab|mesh-list
43749447|NCT02510911|Caffeine|caffeine|mesh-list
43935890|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935891|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935892|NCT03641001|Micronutrients|micronutrients|mesh-list
43935893|NCT03641001|Trace Elements|trace elements|mesh-list
43935894|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935895|NCT03608696|Buprenorphine|buprenorphine|mesh-list
43935896|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43935897|NCT03608696|Narcotics|narcotics|mesh-ancestor
43935898|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43935899|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935900|NCT03608696|Analgesics|analgesics|mesh-ancestor
43935901|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
43935902|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43935903|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43935904|NCT03541486|Gemcitabine|gemcitabine|mesh-list
43935905|NCT03541486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935906|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43935907|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
43935908|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935909|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171492|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44171493|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44171494|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44171495|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171496|NCT00285428|Veltuzumab|veltuzumab|mesh-list
44171497|NCT00285428|Antibodies|antibodies|mesh-list
44171498|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
43935912|NCT03541486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935913|NCT03541486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935914|NCT03541486|Immunologic Factors|immunologic factors|mesh-ancestor
43935916|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
43935917|NCT03500731|Fludarabine|fludarabine|mesh-list
43935918|NCT03500731|Thiotepa|thiotepa|mesh-list
43935919|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
43935920|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43935921|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935922|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
43935923|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935924|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43935925|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935926|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935927|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171499|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171500|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171501|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44171502|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171503|NCT00285519|Doxazosin|doxazosin|mesh-list
44171504|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44171505|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44171506|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44171507|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44171508|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
44171509|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171510|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171511|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171512|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44171513|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44171514|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171515|NCT00285623|Thrombin|thrombin|mesh-list
44171516|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
44171517|NCT00285623|Coagulants|coagulants|mesh-ancestor
44171518|NCT00285662|Artesunate|artesunate|mesh-list
44171519|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
44171520|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
44171532|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44171533|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171534|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171535|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44171536|NCT00285662|Renal Agents|renal agents|mesh-ancestor
44171537|NCT00285675|Calcitriol|calcitriol|mesh-list
44171538|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44171539|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171540|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44171541|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171542|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171543|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44171544|NCT00285675|Vitamins|vitamins|mesh-ancestor
44171545|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
44171546|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171547|NCT00285727|Ropinirole|ropinirole|mesh-list
44171548|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44171549|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43935928|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
43935929|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43935930|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
43935931|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935932|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43935933|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
43935934|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43935935|NCT03493178|Glycine|glycine|mesh-list
43935936|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
43935937|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935938|NCT03493178|Expectorants|expectorants|mesh-ancestor
43935939|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
43935940|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43935941|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
43935942|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935943|NCT03493178|Protective Agents|protective agents|mesh-ancestor
43935944|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935945|NCT03493178|Antidotes|antidotes|mesh-ancestor
43935946|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
43935947|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43935948|NCT03414112|Oxytocin|oxytocin|mesh-list
43935949|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
43935950|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43935951|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935952|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
43935953|NCT03410030|Gemcitabine|gemcitabine|mesh-list
43935954|NCT03410030|Paclitaxel|paclitaxel|mesh-list
43935955|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43935956|NCT03410030|Cisplatin|cisplatin|mesh-list
43935957|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44171550|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
44171551|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
44171552|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171553|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171554|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171555|NCT00285766|Selegiline|selegiline|mesh-list
44171556|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
44171557|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171558|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44171559|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44171560|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44171561|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171562|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171563|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44171564|NCT00285766|Protective Agents|protective agents|mesh-ancestor
44171565|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171566|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
44171567|NCT00285805|Amiloride|amiloride|mesh-list
44171568|NCT00285805|Furosemide|furosemide|mesh-list
43935958|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935959|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
43935960|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
43935961|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
43935962|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935963|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43935964|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
43935965|NCT03410030|Antiviral Agents|antiviral agents|mesh-ancestor
43935966|NCT03410030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935967|NCT03410030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935968|NCT03410030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43935969|NCT03410030|Immunologic Factors|immunologic factors|mesh-ancestor
43935970|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43935971|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
43935972|NCT03410030|Protective Agents|protective agents|mesh-ancestor
43935973|NCT03410030|Vitamins|vitamins|mesh-ancestor
43935974|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
43935975|NCT03386240|Triclosan|triclosan|mesh-list
43935976|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43935977|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43935978|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43935979|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43935980|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
43935981|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43935982|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43935983|NCT03088930|Crizotinib|crizotinib|mesh-list
43935984|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43935985|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43935986|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43935987|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936003|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43936004|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43936005|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
43936006|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936007|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43936008|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
43936009|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936010|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936011|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43936012|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43936013|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
43936014|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936015|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44140669|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140670|NCT00180115|Cytarabine|cytarabine|mesh-list
44140671|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140672|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
44157464|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43936016|NCT02812615|Micronutrients|micronutrients|mesh-list
43936017|NCT02812615|Trace Elements|trace elements|mesh-list
43936018|NCT02812615|Albendazole|albendazole|mesh-list
43936019|NCT02812615|Pyrantel|pyrantel|mesh-list
43936020|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
43936021|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
43936022|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43936023|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936024|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
43936025|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43936026|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43936027|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936028|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936029|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936030|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936031|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936032|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936033|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
43936038|NCT02710851|Vaccines|vaccines|mesh-list
43936039|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
43936040|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936041|NCT02682888|Oxytocin|oxytocin|mesh-list
43936042|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
43936043|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936044|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936045|NCT02669186|Fentanyl|fentanyl|mesh-list
43936046|NCT02669186|Bupivacaine|bupivacaine|mesh-list
43936047|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
43936048|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
43936049|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936050|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936051|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
43936052|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936053|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936054|NCT02669186|Narcotics|narcotics|mesh-ancestor
43936055|NCT02669186|Analgesics|analgesics|mesh-ancestor
43936056|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43936057|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43936058|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
43936059|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
43936060|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
43936061|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936062|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936063|NCT02665117|Diuretics|diuretics|mesh-ancestor
43936064|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
43936065|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936066|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43936067|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936068|NCT02665117|Cathartics|cathartics|mesh-ancestor
43936069|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936070|NCT02646839|Biotin|biotin|mesh-list
43936071|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
43936072|NCT02646839|Vitamins|vitamins|mesh-ancestor
43936073|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
43936075|NCT02641236|Vancomycin|vancomycin|mesh-list
43936081|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
43936082|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936083|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936084|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
43936085|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43936086|NCT02348762|Glycine|glycine|mesh-list
43936087|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
43936088|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936089|NCT02348762|Expectorants|expectorants|mesh-ancestor
43936090|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
43936091|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43936092|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
43936093|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936094|NCT02348762|Protective Agents|protective agents|mesh-ancestor
43936095|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936096|NCT02348762|Antidotes|antidotes|mesh-ancestor
43936097|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
43767181|NCT02403284|Liraglutide|liraglutide|mesh-list
43767182|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936098|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936099|NCT02348359|Ranibizumab|ranibizumab|mesh-list
43936100|NCT02348359|Aflibercept|aflibercept|mesh-list
43936101|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936102|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936103|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936104|NCT02348359|Growth Substances|growth substances|mesh-ancestor
43936105|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936106|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936107|NCT02252432|Ketamine|ketamine|mesh-list
43936108|NCT02252432|Methadone|methadone|mesh-list
43936109|NCT02252432|Analgesics|analgesics|mesh-ancestor
43936110|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
43936111|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936112|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936113|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43936114|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43936115|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
43936116|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
43936117|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936118|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43936120|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936121|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936122|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936123|NCT02252432|Narcotics|narcotics|mesh-ancestor
43936124|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
43936125|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
43936126|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
43936127|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
43936128|NCT02224872|Fludarabine|fludarabine|mesh-list
43936129|NCT02224872|Tacrolimus|tacrolimus|mesh-list
43936130|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
43936131|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936132|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
43936133|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936134|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936135|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936136|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
43936137|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936138|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936139|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43936140|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43936141|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936142|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43936143|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43936144|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
43936145|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936146|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936148|NCT02187224|Progestins|progestins|mesh-ancestor
43936149|NCT02187224|Hormones|hormones|mesh-ancestor
43843098|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171569|NCT00285805|Diuretics|diuretics|mesh-ancestor
44171570|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
44171571|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171572|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44171573|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171574|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171575|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171576|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44171577|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44171578|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44171579|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44171580|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44171581|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171582|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171583|NCT00285883|Saquinavir|saquinavir|mesh-list
43936150|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936151|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936152|NCT01995669|Lenalidomide|lenalidomide|mesh-list
43936153|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
43936154|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
43936155|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936156|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571579|NCT00254904|Cisplatin|cisplatin|mesh-list
43936157|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936158|NCT01995669|Growth Substances|growth substances|mesh-ancestor
43936159|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936160|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936161|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936162|NCT01968109|Nivolumab|nivolumab|mesh-list
43936163|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936164|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936165|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43936166|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936167|NCT01905436|Ivermectin|ivermectin|mesh-list
43936168|NCT01905436|Albendazole|albendazole|mesh-list
43936169|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43936170|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936171|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
43936172|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
43936173|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43936174|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43936175|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936176|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936177|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936178|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936179|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936180|NCT01733693|Buprenorphine|buprenorphine|mesh-list
43936181|NCT01733693|Methadone|methadone|mesh-list
43936182|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936183|NCT01733693|Narcotics|narcotics|mesh-ancestor
43936184|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936185|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171600|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171601|NCT00285896|Incretins|incretins|mesh-ancestor
43936186|NCT01733693|Analgesics|analgesics|mesh-ancestor
43936187|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
43936188|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936189|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43936190|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
43936191|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
43936192|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
43936193|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43936254|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936255|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936256|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
43936257|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936258|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936259|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43936260|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936261|NCT00388921|Vitamin A|vitamin a|mesh-list
43936262|NCT00388921|Vitamins|vitamins|mesh-ancestor
43936263|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
43936264|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936265|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
43936266|NCT00142285|Astringents|astringents|mesh-ancestor
43936267|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936268|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936269|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
43936270|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936271|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936272|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43936273|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43936274|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936275|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936276|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936306|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43936307|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936308|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936309|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936310|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936311|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936312|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43936313|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
43936314|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936315|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
43936316|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43936317|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936318|NCT00822107|Diuretics|diuretics|mesh-ancestor
43936319|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
43936320|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936321|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43936322|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936323|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936324|NCT00822354|Tadalafil|tadalafil|mesh-list
43936325|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
43936326|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43936327|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43936328|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936329|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936330|NCT00822354|Urological Agents|urological agents|mesh-ancestor
43936331|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
43936332|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43936333|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43936334|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43936348|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936349|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43936350|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936351|NCT00823082|Antithrombins|antithrombins|mesh-list
43936352|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
43936353|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43936354|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
43936355|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936356|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936357|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
43936358|NCT00823303|Calcitriol|calcitriol|mesh-list
43936359|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43936360|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936361|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43936362|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936363|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936364|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43936365|NCT00823303|Vitamins|vitamins|mesh-ancestor
43936366|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
43936367|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43936368|NCT00823459|Everolimus|everolimus|mesh-list
43936369|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936370|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936371|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
43936372|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936373|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43936374|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936375|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
43936376|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936377|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936378|NCT00823966|Delavirdine|delavirdine|mesh-list
43936379|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43936380|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43936387|NCT00824044|Citalopram|citalopram|mesh-list
43936388|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43936389|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43936390|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936391|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936392|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936393|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
43936394|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936395|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43936396|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
43936397|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43936398|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
43936399|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
43936400|NCT00824070|Besifloxacin|besifloxacin|mesh-list
43936401|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43936402|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936403|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936404|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43936405|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43936406|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936407|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936408|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936437|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936438|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936439|NCT00824746|Gefitinib|gefitinib|mesh-list
43936440|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936441|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936442|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936443|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936444|NCT00824824|Timolol|timolol|mesh-list
43936445|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43936446|NCT00824824|Dorzolamide|dorzolamide|mesh-list
43936447|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43936448|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43936449|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43936450|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936451|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936452|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936453|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43936454|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936455|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43936456|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43936457|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43936458|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43936459|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936460|NCT00825266|Pioglitazone|pioglitazone|mesh-list
43936461|NCT00825266|Bosentan|bosentan|mesh-list
43936462|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936463|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936464|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936465|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43936466|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171602|NCT00286026|Azithromycin|azithromycin|mesh-list
44171603|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44171604|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171605|NCT00286052|Naloxone|naloxone|mesh-list
44171606|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44171607|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171608|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
44171609|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171610|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44171611|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171612|NCT00286117|Tamoxifen|tamoxifen|mesh-list
44171613|NCT00286117|Anastrozole|anastrozole|mesh-list
44171614|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43936468|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43936469|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680136|NCT05370898|Antacids|antacids|mesh-ancestor
43936470|NCT00825344|Analgesics|analgesics|mesh-ancestor
43936471|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
43936472|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936473|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936474|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936475|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936476|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936477|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936478|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
43936479|NCT00825370|Hydromorphone|hydromorphone|mesh-list
43936480|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936481|NCT00825370|Narcotics|narcotics|mesh-ancestor
43936482|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936483|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936484|NCT00825370|Analgesics|analgesics|mesh-ancestor
43936485|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
43936486|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171615|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
44171616|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171617|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171618|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171619|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171620|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44171621|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44171622|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171623|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44171624|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44171625|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171626|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171628|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
44171629|NCT00286130|Irinotecan|irinotecan|mesh-list
44171630|NCT00286130|Cetuximab|cetuximab|mesh-list
44171631|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171632|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44171633|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44171634|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171635|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171636|NCT00286130|Antidotes|antidotes|mesh-ancestor
44171637|NCT00286130|Protective Agents|protective agents|mesh-ancestor
44171638|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171639|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
44171640|NCT00286130|Vitamins|vitamins|mesh-ancestor
44171641|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
44171642|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44171648|NCT00286143|Analgesics|analgesics|mesh-ancestor
44171649|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
44171650|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171651|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44171652|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44171653|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
43936488|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43936489|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43936490|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936491|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936492|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43936493|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43936494|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
43936495|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936497|NCT00825565|Allantoin|allantoin|mesh-list
43936552|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43936553|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43936554|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
43936555|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936556|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936557|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936558|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
43936559|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43936560|NCT00827255|Cyclosporine|cyclosporine|mesh-list
43936561|NCT00827255|Cyclosporins|cyclosporins|mesh-list
43936562|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936563|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936564|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936565|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
43936566|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936567|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
43936568|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936569|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936570|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936571|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43936572|NCT00827983|Progesterone|progesterone|mesh-list
43936573|NCT00827983|Progestins|progestins|mesh-ancestor
43936574|NCT00827983|Hormones|hormones|mesh-ancestor
43936575|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936576|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140673|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140674|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140675|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
44140676|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44140693|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44140694|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140695|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140696|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140698|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
44140699|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140700|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
44140701|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44140702|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44140703|NCT00180141|Analgesics|analgesics|mesh-ancestor
44140704|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
44140705|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140706|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140707|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140708|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140709|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
44140710|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140711|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
44140712|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44140713|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140714|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140715|NCT00180310|Paclitaxel|paclitaxel|mesh-list
44140716|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43936577|NCT00828061|Prednisone|prednisone|mesh-list
43936578|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936579|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
43936580|NCT00828061|Hormones|hormones|mesh-ancestor
43936581|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936582|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936598|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936599|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936600|NCT00828295|Palonosetron|palonosetron|mesh-list
43936601|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
43936602|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
43936603|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936604|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936605|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936606|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43936607|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43936608|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
43936609|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936610|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936611|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
43936612|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43936613|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43936614|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936616|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
43936617|NCT00828412|Desonide|desonide|mesh-list
43936618|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936619|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43936620|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
43936621|NCT00828542|Desogestrel|desogestrel|mesh-list
43936622|NCT00828542|Etonogestrel|etonogestrel|mesh-list
43936623|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43936624|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43936625|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43936626|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
43936627|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43936628|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936629|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43936630|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43936633|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936639|NCT00828841|Cisplatin|cisplatin|mesh-list
43936640|NCT00828841|Carboplatin|carboplatin|mesh-list
43936641|NCT00828841|Cetuximab|cetuximab|mesh-list
43936642|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43936643|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936644|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936645|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936646|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936647|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936648|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43936649|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
43936650|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
43936651|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936652|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936653|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936654|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
43936655|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936656|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936657|NCT00829049|Adapalene|adapalene|mesh-list
43936658|NCT00829049|Tazarotene|tazarotene|mesh-list
43936659|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43936660|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43936661|NCT00829049|Analgesics|analgesics|mesh-ancestor
43936662|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
43936663|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936664|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936665|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936666|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936667|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936668|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
43936669|NCT00829738|Pantoprazole|pantoprazole|mesh-list
43936670|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43936671|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936672|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43936673|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805639|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171654|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
44171655|NCT00286208|Misoprostol|misoprostol|mesh-list
44171656|NCT00286208|Mifepristone|mifepristone|mesh-list
44171657|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44171658|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
43936674|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936675|NCT00830076|Metformin|metformin|mesh-list
43936676|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43936677|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936678|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936679|NCT00830076|Incretins|incretins|mesh-ancestor
43936680|NCT00830076|Hormones|hormones|mesh-ancestor
43936681|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936682|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43936683|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
43936684|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936685|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936686|NCT00830362|Propranolol|propranolol|mesh-list
43936687|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43936688|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43936689|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
43936690|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936691|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936692|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936693|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43936694|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43936695|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
43936696|NCT00830388|Ketoconazole|ketoconazole|mesh-list
43936697|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
43936698|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936699|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43936700|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43936701|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936702|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936703|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43936704|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
43936705|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936706|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936707|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43936708|NCT00831272|Naltrexone|naltrexone|mesh-list
43936709|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43936710|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43936711|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936712|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
43936713|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936714|NCT00831480|Everolimus|everolimus|mesh-list
43936715|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936716|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936717|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
43936718|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936719|NCT00831675|Vaccines|vaccines|mesh-list
43936720|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
43936721|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936722|NCT00831766|Cytarabine|cytarabine|mesh-list
43936723|NCT00831766|Lenalidomide|lenalidomide|mesh-list
43936724|NCT00831766|Idarubicin|idarubicin|mesh-list
43936725|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
43936726|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43680314|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
43936727|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
43936728|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936729|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
43936730|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936731|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936732|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
43936733|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936734|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43936735|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43936736|NCT00831766|Growth Substances|growth substances|mesh-ancestor
43936737|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
43936738|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43936739|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43936740|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43936741|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936742|NCT00831987|Vaccines|vaccines|mesh-list
43936743|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
43936745|NCT00832338|Dexamethasone|dexamethasone|mesh-list
43936748|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43936749|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
43936750|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
43936751|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936752|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936753|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43936754|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
43936755|NCT00832338|Hormones|hormones|mesh-ancestor
43936756|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936757|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43936758|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936759|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
43936760|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
43936761|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
43936762|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936763|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936764|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
43936765|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43936766|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936767|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
43936768|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43936769|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43936770|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936771|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936772|NCT00832390|Incretins|incretins|mesh-ancestor
43936773|NCT00832390|Hormones|hormones|mesh-ancestor
43936774|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936775|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43936776|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
43936777|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936778|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936779|NCT00832637|Gemcitabine|gemcitabine|mesh-list
43936780|NCT00832637|Cisplatin|cisplatin|mesh-list
43936781|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43936786|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
43936787|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936788|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936789|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43936790|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
43936791|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936792|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936793|NCT00832871|Mifepristone|mifepristone|mesh-list
43936794|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43936795|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
43936849|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936851|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936852|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936853|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
43936854|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
43936855|NCT00834210|Vitamins|vitamins|mesh-ancestor
43936856|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
43936857|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936858|NCT00834288|Tramadol|tramadol|mesh-list
43936859|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936860|NCT00834288|Narcotics|narcotics|mesh-ancestor
43936861|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936862|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936863|NCT00834288|Analgesics|analgesics|mesh-ancestor
43936864|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
43936865|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936866|NCT00834652|Metformin|metformin|mesh-list
43936867|NCT00834652|Sertraline|sertraline|mesh-list
44171659|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44171660|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171661|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44171662|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171663|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
44171664|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44171665|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44171666|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44171667|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44171668|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
44171669|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44171670|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44171671|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
44171672|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171673|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
44171674|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44171675|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44171676|NCT00286260|Levetiracetam|levetiracetam|mesh-list
44171677|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
44171678|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
44171679|NCT00286273|Heparin|heparin|mesh-list
44171680|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44171681|NCT00286273|Tinzaparin|tinzaparin|mesh-list
44171682|NCT00286273|Dalteparin|dalteparin|mesh-list
44171683|NCT00286273|Nadroparin|nadroparin|mesh-list
44171684|NCT00286273|Citric Acid|citric acid|mesh-list
44171685|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
44171686|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
44171687|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44171688|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
44171689|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
44171690|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171692|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44171693|NCT00286312|Atorvastatin|atorvastatin|mesh-list
44171694|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44171695|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44171696|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
44171697|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171698|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43936868|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936869|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936870|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
43936871|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43936872|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43936873|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43936874|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43936875|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936876|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936877|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
43936878|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43936879|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43936880|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936881|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43936882|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936883|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936884|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43936885|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
43936886|NCT00834808|Tramadol|tramadol|mesh-list
43936887|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43936888|NCT00834808|Narcotics|narcotics|mesh-ancestor
43936889|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43936890|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936891|NCT00834808|Analgesics|analgesics|mesh-ancestor
43936892|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
43936893|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936894|NCT00834886|Melatonin|melatonin|mesh-list
43936912|NCT00835185|Necitumumab|necitumumab|mesh-list
43936913|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
43936914|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43936915|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936916|NCT00835185|Antidotes|antidotes|mesh-ancestor
43936917|NCT00835185|Protective Agents|protective agents|mesh-ancestor
43936918|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936919|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
43936920|NCT00835185|Vitamins|vitamins|mesh-ancestor
43936921|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
43936922|NCT00835185|Hematinics|hematinics|mesh-ancestor
43936923|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936924|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
43936925|NCT00835198|Dapsone|dapsone|mesh-list
43936926|NCT00835198|Tretinoin|tretinoin|mesh-list
43936927|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936928|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
43936929|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
43936930|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936931|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
43936932|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43936933|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43936934|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43936935|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171699|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44171700|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171701|NCT00286351|Goserelin|goserelin|mesh-list
44171702|NCT00286351|Anastrozole|anastrozole|mesh-list
44171703|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171704|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171705|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44171706|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44171707|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171708|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171709|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44171710|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
44171711|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171712|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171713|NCT00286364|Androgens|androgens|mesh-list
44171714|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44171715|NCT00286364|Hormones|hormones|mesh-ancestor
44171744|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
44171745|NCT00286585|Anesthetics|anesthetics|mesh-list
44171746|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44171747|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171748|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171749|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
44171750|NCT00286611|Amifostine|amifostine|mesh-list
44171751|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44171752|NCT00286611|Protective Agents|protective agents|mesh-ancestor
44171753|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171754|NCT00286624|Cyclosporine|cyclosporine|mesh-list
44171755|NCT00286624|Everolimus|everolimus|mesh-list
44171756|NCT00286624|Cyclosporins|cyclosporins|mesh-list
44171757|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44171758|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936936|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936937|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
43936938|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43936939|NCT00835224|Midodrine|midodrine|mesh-list
43936940|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
43936941|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
43936942|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43936943|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936944|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43936945|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43936946|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43936947|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43936948|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
43936949|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936950|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936951|NCT00835510|Butenafine|butenafine|mesh-list
43936952|NCT00835510|Clotrimazole|clotrimazole|mesh-list
43936953|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
43936954|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43936955|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43936956|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43936957|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43936958|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43936959|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936960|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43936961|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
43936962|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43936963|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936964|NCT00835861|Insulin|insulin|mesh-list
43936965|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43936966|NCT00835861|Metformin|metformin|mesh-list
43936967|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
43936968|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
43936969|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43936974|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
43936975|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43936976|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936977|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936978|NCT00835926|Vaccines|vaccines|mesh-list
43936979|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
43936980|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936981|NCT00836407|Ipilimumab|ipilimumab|mesh-list
43936982|NCT00836407|Vaccines|vaccines|mesh-list
43936983|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
43936984|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936985|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936986|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936987|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43936988|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936989|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43936990|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
43936991|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43936992|NCT00836888|Nivolumab|nivolumab|mesh-list
43936993|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43936994|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43936995|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43936996|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43936997|NCT00837031|Gemcitabine|gemcitabine|mesh-list
43936998|NCT00837031|Lenalidomide|lenalidomide|mesh-list
43936999|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937000|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
43937001|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937002|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937003|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
43937004|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937005|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937006|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937007|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
43937008|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171759|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171760|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937009|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43937010|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43937011|NCT00837031|Growth Substances|growth substances|mesh-ancestor
43937012|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
43937013|NCT00837200|Doxorubicin|doxorubicin|mesh-list
43937014|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43937015|NCT00837200|Asparaginase|asparaginase|mesh-list
43937016|NCT00837200|Pegaspargase|pegaspargase|mesh-list
43937017|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43937018|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937019|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937020|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937021|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937022|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937023|NCT00837252|Finasteride|finasteride|mesh-list
43937024|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43937025|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43937026|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937027|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937028|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
43937029|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937030|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937031|NCT00837252|Urological Agents|urological agents|mesh-ancestor
43937032|NCT00837512|Insulin|insulin|mesh-list
43937033|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43937034|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937035|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937036|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43937037|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
43937038|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43937039|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43937051|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43937052|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
43937053|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
43937054|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937055|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937056|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43937057|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43937058|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43937059|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
43937060|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937061|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937064|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43937065|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43937066|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
43937067|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937068|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937069|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43937070|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43937071|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
43937072|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937073|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43937074|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43937075|NCT00838695|Phenylephrine|phenylephrine|mesh-list
43937076|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
43937077|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43937078|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
43937079|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
43937080|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937081|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937082|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
43937083|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43937084|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
43937085|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
43937086|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43937087|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43937088|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43937089|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
43937090|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937091|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937092|NCT00838695|Protective Agents|protective agents|mesh-ancestor
43937093|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43937094|NCT00839319|Testosterone|testosterone|mesh-list
43937095|NCT00839319|Acyline|acyline|mesh-list
43937096|NCT00839319|Androgens|androgens|mesh-ancestor
43937097|NCT00839319|Hormones|hormones|mesh-ancestor
43937098|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937099|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937100|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937101|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
43937102|NCT00839540|Caspofungin|caspofungin|mesh-list
43937103|NCT00839540|Micafungin|micafungin|mesh-list
43937104|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
43937105|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937106|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937107|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937108|NCT00839982|Cytarabine|cytarabine|mesh-list
43937109|NCT00839982|Clofarabine|clofarabine|mesh-list
43937110|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937111|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
43937112|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937113|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937114|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
43937115|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937116|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937117|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
43937118|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937119|NCT00841087|Insulin|insulin|mesh-list
43937120|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43937121|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
43937122|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
43937125|NCT00841204|Sulindac|sulindac|mesh-list
43937131|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937132|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937133|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937134|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937135|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43937136|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937137|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937138|NCT00841555|Temozolomide|temozolomide|mesh-list
43937139|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43937140|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
43937141|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937142|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937143|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
43937145|NCT00841828|Trastuzumab|trastuzumab|mesh-list
43937146|NCT00841828|Epirubicin|epirubicin|mesh-list
43937147|NCT00841828|Lapatinib|lapatinib|mesh-list
43937148|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937149|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
43937150|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937151|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937152|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43937153|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
43937154|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937155|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937156|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43937157|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
43937180|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43937181|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
43937182|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
43937183|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
43937184|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937185|NCT00842075|Pramlintide|pramlintide|mesh-list
43937186|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937187|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937188|NCT00842608|Haloperidol|haloperidol|mesh-list
43937189|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
43937190|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43937191|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
43937192|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
43937193|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937194|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937195|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43937196|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43937197|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43937199|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44157472|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44157473|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157475|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157476|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
44157477|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44157478|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44157479|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157480|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
44157481|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157482|NCT00234637|Memantine|memantine|mesh-list
44157483|NCT00234637|Rivastigmine|rivastigmine|mesh-list
44157484|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44157485|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44157486|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
44157487|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937259|NCT00845000|Carbidopa|carbidopa|mesh-list
43937260|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43937261|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43937262|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
43937263|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937264|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937265|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937266|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43937267|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937268|NCT00845039|Irinotecan|irinotecan|mesh-list
43937269|NCT00845039|Cetuximab|cetuximab|mesh-list
43937270|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43937271|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43937272|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937273|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937274|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937275|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937276|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43937277|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
43937278|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937279|NCT00845130|Vitamins|vitamins|mesh-list
43937280|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
43937281|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
43937282|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937283|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
43937284|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937285|NCT00845130|Protective Agents|protective agents|mesh-ancestor
43937286|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43937287|NCT00845195|Azelastine|azelastine|mesh-list
43937288|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43937289|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43937290|NCT00845195|Analgesics|analgesics|mesh-ancestor
43937291|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
43937298|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43937299|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
43937300|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
43937301|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937302|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937303|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43937304|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
43937305|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43937306|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
43937307|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43937308|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937309|NCT00845481|Calcitriol|calcitriol|mesh-list
43937310|NCT00845481|Betamethasone|betamethasone|mesh-list
43937311|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937312|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
43937313|NCT00845481|Hormones|hormones|mesh-ancestor
43937314|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937315|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171773|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44171774|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171775|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44171776|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
44171777|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44171778|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171779|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44171780|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44171781|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44171783|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767260|NCT02402725|Hormones|hormones|mesh-ancestor
44171784|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
44171785|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171786|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44171787|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171788|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171789|NCT00286923|Topiramate|topiramate|mesh-list
44171790|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
44171791|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171792|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171793|NCT00286936|Zolpidem|zolpidem|mesh-list
44171794|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44171795|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44171796|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171797|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171798|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44171800|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
44171801|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171802|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171803|NCT00286962|Insulin|insulin|mesh-list
44171804|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44171805|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171806|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171808|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
44171809|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171810|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171811|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
44171812|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171813|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43937317|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
43937318|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43937319|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43937320|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937321|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937322|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43937323|NCT00845481|Vitamins|vitamins|mesh-ancestor
43937324|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
43937325|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43937327|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937328|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937329|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43937330|NCT00845507|Incretins|incretins|mesh-ancestor
43937331|NCT00845507|Hormones|hormones|mesh-ancestor
43937332|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937333|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
43937334|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937335|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
43937336|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937337|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43937338|NCT00848016|Acetic Acid|acetic acid|mesh-list
43937339|NCT00848016|Retinol acetate|retinol acetate|mesh-list
43937340|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
43937341|NCT00848016|Gossypol|gossypol|mesh-list
43937342|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43937343|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937344|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43937345|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
43937346|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937347|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43937348|NCT00848016|Protective Agents|protective agents|mesh-ancestor
43806006|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
44171814|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171815|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171816|NCT00287066|Insulin|insulin|mesh-list
44171817|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44171818|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171819|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171820|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
44171821|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171822|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937349|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937350|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43937351|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
43937352|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937353|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43937357|NCT00848783|Cisplatin|cisplatin|mesh-list
43937419|NCT00850889|Lidocaine|lidocaine|mesh-list
43937420|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
43937421|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
43937422|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
43937423|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937424|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937425|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
43937426|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937427|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43937428|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43937429|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43937430|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937431|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937432|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43937433|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
43937434|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
43937435|NCT00850889|Protective Agents|protective agents|mesh-ancestor
43937436|NCT00851357|Nicotine|nicotine|mesh-list
43937437|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43937438|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
43937439|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140727|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
43937440|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937441|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43937442|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43937443|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806090|NCT04917250|Gemcitabine|gemcitabine|mesh-list
44171850|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
44171851|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171852|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
44171853|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44171854|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171855|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171856|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
44171857|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44171858|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171859|NCT00287209|Amiodarone|amiodarone|mesh-list
44171860|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44171861|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
44171862|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44171863|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171864|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171865|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44171866|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44171867|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44171888|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44171889|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
43937444|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937445|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937446|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43937447|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43937448|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937449|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
43937450|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937451|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43937452|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
43937453|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43937454|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43937455|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43937456|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937457|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937458|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43937459|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43937460|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937462|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937463|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
43937464|NCT00852761|Hormones|hormones|mesh-ancestor
43937465|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937466|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937467|NCT00853333|Midazolam|midazolam|mesh-list
43937468|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
43937469|NCT00853333|Propofol|propofol|mesh-list
43937470|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43937471|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937472|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937473|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43937475|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
43937476|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43937477|NCT00853333|Analgesics|analgesics|mesh-ancestor
43937478|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
43937484|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937485|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937486|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43937487|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43937488|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43937489|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43937490|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
43937491|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
43937492|NCT00853671|Adenosine|adenosine|mesh-list
43937493|NCT00853671|Analgesics|analgesics|mesh-ancestor
43937494|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
43937495|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937496|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937497|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43937498|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
43937499|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43937500|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
43937501|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
43937502|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937503|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937504|NCT00853840|Maraviroc|maraviroc|mesh-list
43937505|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43937506|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43937507|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43937508|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937509|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43937510|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43937511|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
43937512|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937513|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43937514|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
43937515|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43937516|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43806128|NCT04916899|Ethambutol|ethambutol|mesh-list
44171890|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44171891|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171892|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171893|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44171894|NCT00287300|Renal Agents|renal agents|mesh-ancestor
44171895|NCT00287313|Vitamin K|vitamin k|mesh-list
44171896|NCT00287313|Vitamins|vitamins|mesh-ancestor
43937517|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937518|NCT00853840|Urological Agents|urological agents|mesh-ancestor
43937519|NCT00854061|Prednisone|prednisone|mesh-list
43937520|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
43937521|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43937522|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
43937523|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43937524|NCT00854061|Prednisolone|prednisolone|mesh-list
43937525|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43937526|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
43937527|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43937528|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
43937529|NCT00854061|Hormones|hormones|mesh-ancestor
43937530|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937531|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937532|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43937533|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937534|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
43937535|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
43937536|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937537|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43937538|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43937539|NCT00854061|Protective Agents|protective agents|mesh-ancestor
43937540|NCT00855010|Pioglitazone|pioglitazone|mesh-list
43937541|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43937542|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937543|NCT00855413|Ritonavir|ritonavir|mesh-list
43937544|NCT00855413|Darunavir|darunavir|mesh-list
43937545|NCT00855413|Etravirine|etravirine|mesh-list
43937546|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43937547|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44171897|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
44171898|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171899|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44171900|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44171901|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171902|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
44171903|NCT00287313|Coagulants|coagulants|mesh-ancestor
44171904|NCT00287326|Clonidine|clonidine|mesh-list
44171905|NCT00287326|Morphine|morphine|mesh-list
44171906|NCT00287326|Bupivacaine|bupivacaine|mesh-list
44171907|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
44171908|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
44171909|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171910|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171911|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
44171912|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937548|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
43937549|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937550|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937551|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43937552|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43937553|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
43937554|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937555|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43937556|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43937557|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43937558|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43937559|NCT00856024|Ribavirin|ribavirin|mesh-list
43937560|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43937561|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
43937562|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937563|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
43937564|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937565|NCT00856050|Letrozole|letrozole|mesh-list
43937566|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937567|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43937568|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43937569|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937570|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937571|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43937572|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
43937573|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937574|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937575|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
43937576|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43937577|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44171913|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44171914|NCT00287326|Narcotics|narcotics|mesh-ancestor
44171915|NCT00287326|Analgesics|analgesics|mesh-ancestor
44171916|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44171917|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
44171918|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
44171919|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44171920|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44171921|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44171922|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44171923|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171924|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937578|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43937579|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937580|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937582|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937583|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937584|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43937585|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937586|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
43937587|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44140728|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
43937588|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937589|NCT00856791|ON 01910|on 01910|mesh-list
43937590|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937591|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937592|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171928|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
44171929|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171930|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171931|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171932|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44171933|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44171934|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171935|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171936|NCT00287352|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44171937|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44171938|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171939|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171940|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171941|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
44171942|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44171943|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44171944|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
44171945|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171946|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
44171947|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44171949|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
44171950|NCT00287378|Omalizumab|omalizumab|mesh-list
44171951|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44171952|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44171953|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
44171954|NCT00287391|Rabeprazole|rabeprazole|mesh-list
44171955|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44171956|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171957|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44171958|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171959|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171960|NCT00287430|Hormones|hormones|mesh-list
44171961|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171962|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171963|NCT00287443|Hormones|hormones|mesh-list
44171964|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171965|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171966|NCT00287456|Insulin|insulin|mesh-list
44171967|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43937593|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937594|NCT00857272|Bisacodyl|bisacodyl|mesh-list
43937595|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43937596|NCT00857272|Cathartics|cathartics|mesh-ancestor
43937597|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43937598|NCT00857272|Laxatives|laxatives|mesh-ancestor
43937599|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
43937600|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
43937601|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937602|NCT00857714|Lapatinib|lapatinib|mesh-list
43937603|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937604|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937605|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937606|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937607|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
43937608|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43937609|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43937610|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937611|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43937612|NCT00857727|Analgesics|analgesics|mesh-ancestor
43937613|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
43937614|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937615|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43937616|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43937617|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43937618|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
43937619|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937620|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937622|NCT00857961|Androgens|androgens|mesh-ancestor
43937623|NCT00857961|Hormones|hormones|mesh-ancestor
43937624|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937625|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937626|NCT00858013|Glimepiride|glimepiride|mesh-list
43937627|NCT00858013|Nateglinide|nateglinide|mesh-list
43937628|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43806211|NCT04915846|Tamoxifen|tamoxifen|mesh-list
44171968|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44171969|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937630|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937631|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937632|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
43937633|NCT00858468|Vaccines|vaccines|mesh-list
43937634|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
43937635|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937636|NCT00858689|Minocycline|minocycline|mesh-list
43937637|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43937638|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937639|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43937640|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43937641|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43937652|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
43937692|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937693|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937694|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937695|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937696|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43937697|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43937699|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43937700|NCT00859508|Estradiol|estradiol|mesh-list
43937701|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43937702|NCT00859508|Estrogens|estrogens|mesh-ancestor
43937703|NCT00859508|Hormones|hormones|mesh-ancestor
43937704|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937705|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937706|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43937707|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
43937708|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937709|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43937710|NCT00859651|Vitamin D|vitamin d|mesh-list
43937711|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
43937712|NCT00859651|Vitamins|vitamins|mesh-ancestor
43937713|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
43937714|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937715|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43937716|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43937717|NCT00859833|Adenosine|adenosine|mesh-list
43937718|NCT00859833|Regadenoson|regadenoson|mesh-list
43937719|NCT00859833|Analgesics|analgesics|mesh-ancestor
43937720|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
43937721|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937722|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937723|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43937724|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
43937735|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937736|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937737|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
43937738|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937739|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937740|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937742|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937743|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43937744|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43937745|NCT00860171|Iodine|iodine|mesh-list
43937746|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
43937747|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43937748|NCT00860171|Antibodies|antibodies|mesh-list
43937749|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
43937750|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43937751|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
43937752|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937753|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937754|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44171970|NCT00287495|Sorafenib|sorafenib|mesh-list
44171971|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171972|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44171973|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171974|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171975|NCT00287521|Timolol|timolol|mesh-list
44171976|NCT00287521|Latanoprost|latanoprost|mesh-list
44171977|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44171978|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44171979|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
44171980|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171981|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171982|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171983|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44171984|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44171985|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44171986|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44171987|NCT00287534|Tamoxifen|tamoxifen|mesh-list
44171988|NCT00287534|Anastrozole|anastrozole|mesh-list
44171989|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44171990|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
44171991|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171992|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171993|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171994|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171995|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44171996|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44172006|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44172007|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
44172008|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
44172009|NCT00287651|Insulin|insulin|mesh-list
44172010|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44172011|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172012|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172013|NCT00287664|Terlipressin|terlipressin|mesh-list
44172014|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44172015|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43937755|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937757|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
43937758|NCT00860379|Selenium|selenium|mesh-list
43937759|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
43937760|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937761|NCT00860379|Protective Agents|protective agents|mesh-ancestor
43937762|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937763|NCT00860379|Trace Elements|trace elements|mesh-ancestor
43937764|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
43937801|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43937802|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937803|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43937804|NCT00862745|Fesoterodine|fesoterodine|mesh-list
43937805|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43937806|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43937807|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
43937808|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937809|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937810|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937811|NCT00862745|Urological Agents|urological agents|mesh-ancestor
43937812|NCT00862784|Leucovorin|leucovorin|mesh-list
43937813|NCT00862784|Folic Acid|folic acid|mesh-list
43937814|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
43937815|NCT00862784|Fluorouracil|fluorouracil|mesh-list
43937816|NCT00862784|Ramucirumab|ramucirumab|mesh-list
43937817|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43937818|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
43937819|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937820|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
43937821|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937822|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937823|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937824|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
43937825|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937826|NCT00862784|Antidotes|antidotes|mesh-ancestor
43937827|NCT00862784|Protective Agents|protective agents|mesh-ancestor
43937828|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
43937829|NCT00862784|Vitamins|vitamins|mesh-ancestor
43937830|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
43937831|NCT00862784|Hematinics|hematinics|mesh-ancestor
43937847|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43937848|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43937849|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
43937850|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937851|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43937852|NCT00863356|Hemostatics|hemostatics|mesh-list
43937853|NCT00863356|Chitosan|chitosan|mesh-list
43937854|NCT00863356|Coagulants|coagulants|mesh-ancestor
43937855|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43937856|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43937857|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
43937858|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937859|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43937860|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
43937861|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
43937862|NCT00863434|Cytarabine|cytarabine|mesh-list
43937863|NCT00863434|Clofarabine|clofarabine|mesh-list
43937864|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43937865|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
43937866|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937867|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937868|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
43937869|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937870|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43937871|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
43937872|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172016|NCT00287677|Hormones|hormones|mesh-list
44172017|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172018|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172019|NCT00287742|Risperidone|risperidone|mesh-list
44172020|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44172021|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
44172022|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172023|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172024|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172025|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172026|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172027|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172028|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172029|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44172030|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
44172031|NCT00287768|Docetaxel|docetaxel|mesh-list
43612595|NCT03164304|Analgesics|analgesics|mesh-ancestor
44172032|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172033|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172034|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172035|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172036|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172037|NCT00287781|Lidocaine|lidocaine|mesh-list
44172038|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
43937874|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
43937875|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
43937876|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937877|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937878|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43937879|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43937880|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
43937881|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43937882|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937883|NCT00863551|Urological Agents|urological agents|mesh-ancestor
43937884|NCT00864032|Sorafenib|sorafenib|mesh-list
43937885|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937886|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43937887|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937888|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937889|NCT00864123|Cycloserine|cycloserine|mesh-list
43937890|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43937891|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937892|NCT00864123|Renal Agents|renal agents|mesh-ancestor
43937893|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43937894|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
43937895|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43937896|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
43937897|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172039|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
44172040|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172041|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172042|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
44172043|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172044|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44172045|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44172046|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44172047|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172048|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172049|NCT00287794|Diazepam|diazepam|mesh-list
44172050|NCT00287794|Melatonin|melatonin|mesh-list
44172051|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
44172052|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172053|NCT00287794|Protective Agents|protective agents|mesh-ancestor
44172054|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172055|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172056|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44172057|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
44172058|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
44172059|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
44172060|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43937898|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
43937899|NCT00864383|Rifampin|rifampin|mesh-list
43937900|NCT00864383|Isoniazid|isoniazid|mesh-list
43937901|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
43937902|NCT00864383|Ethambutol|ethambutol|mesh-list
43937903|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43937904|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43937905|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43937906|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43937907|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43937908|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937909|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937910|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43937911|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
43937912|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
43937913|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43937914|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43937915|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43937916|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43937917|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43937918|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43937919|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43937920|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43937921|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43937922|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
43937923|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43937924|NCT00864539|Vitamin D|vitamin d|mesh-list
43937925|NCT00864539|Calcium|calcium|mesh-list
43937926|NCT00864539|Vitamins|vitamins|mesh-ancestor
43937927|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
43937928|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937929|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43937930|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43937931|NCT00865202|Tryptophan|tryptophan|mesh-list
43937939|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43937940|NCT00866034|Cetrorelix|cetrorelix|mesh-list
43937941|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43937942|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
43937943|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43937944|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43937945|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
44140752|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43937946|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43937947|NCT00866749|Cytarabine|cytarabine|mesh-list
43938003|NCT00867139|Oseltamivir|oseltamivir|mesh-list
43938004|NCT00867139|Ribavirin|ribavirin|mesh-list
43938005|NCT00867139|Zanamivir|zanamivir|mesh-list
43938006|NCT00867139|Amantadine|amantadine|mesh-list
43938007|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
43938008|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
43938009|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938010|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938011|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938012|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
43938013|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43938014|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43938015|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
43938016|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938017|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938018|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938019|NCT00867139|Analgesics|analgesics|mesh-ancestor
43938020|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
43938021|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938022|NCT00867217|Vitamin D|vitamin d|mesh-list
43938024|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
43938025|NCT00867217|Vitamins|vitamins|mesh-list
43938026|NCT00867217|Letrozole|letrozole|mesh-list
43938027|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
43938028|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938029|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938030|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43938031|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938032|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43938033|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43938034|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938035|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938036|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43938039|NCT00867451|Melatonin|melatonin|mesh-list
43938046|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43938047|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938048|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
43938049|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938050|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938051|NCT00867659|Cetrorelix|cetrorelix|mesh-list
43938052|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43938053|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
43938054|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938055|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938056|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
43938057|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938059|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43938060|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
43938061|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43938062|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938063|NCT00867789|Renal Agents|renal agents|mesh-ancestor
43938102|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938103|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938104|NCT00868452|Valproic Acid|valproic acid|mesh-list
43938105|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
43938106|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43938107|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
43938108|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938109|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938110|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938111|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
43938112|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938113|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938114|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938115|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
43938116|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
43938117|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938118|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43938119|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43938120|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43938121|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43938122|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938123|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43938124|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43938125|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
43938126|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43938127|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43938128|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
43938129|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43938130|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43938131|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938132|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938133|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938134|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938135|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43938136|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43938137|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43938138|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938139|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938140|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938141|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43938142|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43938143|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
43938144|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43938145|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43938146|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
43938147|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43938148|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43938149|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938150|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938151|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938152|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938153|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43938154|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43938155|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43938156|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938157|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938158|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938159|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43938160|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43938161|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
43938162|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43938163|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43938164|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
43938165|NCT00869141|Timolol|timolol|mesh-list
43938166|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43938167|NCT00869141|Dorzolamide|dorzolamide|mesh-list
43938168|NCT00869141|Brinzolamide|brinzolamide|mesh-list
43938177|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43938178|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43938180|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43938181|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938183|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938184|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938185|NCT00869622|Vitamin D|vitamin d|mesh-list
43938186|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
43938187|NCT00869622|Calcium|calcium|mesh-list
43938188|NCT00869622|Vitamins|vitamins|mesh-ancestor
43938189|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
43938190|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938191|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44172061|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172062|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44172063|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44172064|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44172065|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44172066|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172067|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172068|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44172069|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
44172070|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
44172071|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
44172072|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
44172073|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172074|NCT00287820|Olanzapine|olanzapine|mesh-list
44172075|NCT00287820|Risperidone|risperidone|mesh-list
44172076|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44172077|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
44172078|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172079|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172080|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172081|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172082|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172083|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172084|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172085|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44172086|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
44172087|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
44172088|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
44172089|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172090|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172091|NCT00287820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44172092|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44172093|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172094|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
44172095|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172096|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44172097|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172098|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172099|NCT00287859|Topotecan|topotecan|mesh-list
44172100|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44172101|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172102|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172103|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172104|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172105|NCT00287885|Docetaxel|docetaxel|mesh-list
43612670|NCT03163693|Analgesics|analgesics|mesh-ancestor
44172106|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172107|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938192|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938193|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43938194|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43938195|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938196|NCT00869791|Levodopa|levodopa|mesh-list
43938197|NCT00869791|Carbidopa|carbidopa|mesh-list
43938198|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43938199|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43938200|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43938201|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
43938202|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938203|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938204|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938205|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43938206|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938207|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43938208|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
43938209|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
43938211|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43938212|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
43938213|NCT00870363|Maraviroc|maraviroc|mesh-list
43938214|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43938215|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938216|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938217|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
43938218|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938219|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43938220|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43938221|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43938222|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43938223|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43938224|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43806546|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
44172108|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172109|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172110|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172112|NCT00287911|Topotecan|topotecan|mesh-list
44172113|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938226|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43938227|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43938228|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43938229|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43938230|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43938231|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43938232|NCT00870467|Adalimumab|adalimumab|mesh-list
43938233|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938234|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938235|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
43938236|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43938237|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
43938238|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938239|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938240|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43750899|NCT02501941|Ketamine|ketamine|mesh-list
43938241|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938242|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
43938243|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43938244|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
43938245|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938246|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938247|NCT00871260|Regadenoson|regadenoson|mesh-list
43938248|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43938249|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43938250|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
43938251|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
43938252|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938253|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938254|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938255|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
43938256|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43938257|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938258|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938259|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938260|NCT00871624|Analgesics|analgesics|mesh-ancestor
43938261|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
43938262|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938263|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43938264|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43938265|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43938266|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938267|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938268|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938269|NCT00871689|Aldesleukin|aldesleukin|mesh-list
43938270|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
43938271|NCT00871689|Fludarabine|fludarabine|mesh-list
43938272|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
43938273|NCT00871689|Interleukin-2|interleukin-2|mesh-list
43938274|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938275|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
43938276|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938277|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938278|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43938279|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
43938280|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938281|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938282|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43938283|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938284|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
43938285|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
43938286|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938287|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938288|NCT00871689|Analgesics|analgesics|mesh-ancestor
43938289|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
43938305|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43938306|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938307|NCT00872534|Analgesics|analgesics|mesh-ancestor
43938308|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
43938309|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938310|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938311|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938312|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938313|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43938314|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43938315|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938316|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43938317|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43938318|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938319|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
43938320|NCT00872729|Cysteamine|cysteamine|mesh-list
43938321|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43938322|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938323|NCT00873327|Tazobactam|tazobactam|mesh-list
43938324|NCT00873327|Piperacillin|piperacillin|mesh-list
43938325|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43938326|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938327|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938328|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43938329|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938330|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938331|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43938332|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938333|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938334|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938335|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43938336|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
43938345|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938346|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938347|NCT00875212|Calcium|calcium|mesh-list
43938348|NCT00875212|Fluorides|fluorides|mesh-list
43938349|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
43938350|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43938351|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938352|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
43938353|NCT00875212|Protective Agents|protective agents|mesh-ancestor
43938355|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
43938356|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43938357|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
43938358|NCT00875277|Calcipotriene|calcipotriene|mesh-list
43938359|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43938360|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938361|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
43938362|NCT00875277|Hormones|hormones|mesh-ancestor
43938363|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938364|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938365|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43938366|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938367|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938368|NCT00875550|Fentanyl|fentanyl|mesh-list
43938369|NCT00875550|Midazolam|midazolam|mesh-list
43938370|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
43938371|NCT00875550|Morphine|morphine|mesh-list
43938372|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43938373|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938374|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938375|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938376|NCT00875550|Analgesics|analgesics|mesh-ancestor
43938377|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
43938378|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938379|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43938380|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43938381|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43938382|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938383|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938384|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938385|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43938386|NCT00875550|Narcotics|narcotics|mesh-ancestor
43938387|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43938388|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43938389|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
43938390|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
43938391|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43938392|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938393|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938394|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
43938395|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
43938396|NCT00875836|Buspirone|buspirone|mesh-list
43938397|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43938398|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938399|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938400|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938401|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140753|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44140754|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140755|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140756|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140757|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140758|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140759|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
44140760|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44140761|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140762|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
44140763|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140764|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
44140765|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140766|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44140767|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140768|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140769|NCT00180843|Bromides|bromides|mesh-list
44140770|NCT00180843|Albuterol|albuterol|mesh-list
44172114|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44172115|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172116|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172117|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172118|NCT00287924|Methotrexate|methotrexate|mesh-list
44172119|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44172120|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
44172121|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44172122|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172123|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44172124|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
44172125|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172126|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172127|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
44172128|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172129|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44172130|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172131|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
44172132|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172133|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44172134|NCT00287937|Paclitaxel|paclitaxel|mesh-list
44172145|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
44172146|NCT00287950|Cisplatin|cisplatin|mesh-list
44172147|NCT00287950|Carboplatin|carboplatin|mesh-list
44172148|NCT00287950|Etoposide|etoposide|mesh-list
44172149|NCT00287950|Vincristine|vincristine|mesh-list
44172150|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172151|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
44172152|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172153|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172154|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172155|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
44172156|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172157|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172158|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44172159|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172160|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140772|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
44140773|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44140774|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
44140775|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140776|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140777|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44140778|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44140779|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
44140780|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938440|NCT00878228|Ondansetron|ondansetron|mesh-list
43938441|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
43938442|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
43938443|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938444|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938445|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938446|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
43938447|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938448|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43938449|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
43938450|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938451|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938452|NCT00878228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43938453|NCT00878228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938454|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938455|NCT00878228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938479|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
43938480|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938481|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43938482|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43938483|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938484|NCT00879060|Spironolactone|spironolactone|mesh-list
43938485|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43938486|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
43938487|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938488|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938489|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43938490|NCT00879060|Diuretics|diuretics|mesh-ancestor
43938491|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
43938492|NCT00879190|Gentamicins|gentamicins|mesh-list
43938493|NCT00879190|Ampicillin|ampicillin|mesh-list
43938494|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43938495|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938496|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43938497|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938498|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938499|NCT00879359|Paclitaxel|paclitaxel|mesh-list
43938500|NCT00879359|Bevacizumab|bevacizumab|mesh-list
43938501|NCT00879359|Carboplatin|carboplatin|mesh-list
43938502|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43938503|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938504|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938505|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938506|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
43938507|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938508|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44172161|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172162|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172163|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172164|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172165|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172166|NCT00287963|Topotecan|topotecan|mesh-list
44172167|NCT00287963|Vinorelbine|vinorelbine|mesh-list
44172168|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44172169|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172170|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172171|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172172|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938510|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43938511|NCT00879359|Growth Substances|growth substances|mesh-ancestor
43938512|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938513|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
43938514|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
43938515|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938516|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43938517|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
43938518|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43938519|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43938520|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43938521|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938522|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938524|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43938525|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43938526|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43938527|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43938528|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938529|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172173|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172174|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172175|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172176|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172177|NCT00287976|Irinotecan|irinotecan|mesh-list
44172178|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44172179|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172180|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172181|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172182|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172183|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
44172185|NCT00288002|Capecitabine|capecitabine|mesh-list
44172186|NCT00288002|Trastuzumab|trastuzumab|mesh-list
44172187|NCT00288002|Epirubicin|epirubicin|mesh-list
44172188|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172189|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
44172190|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172191|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172192|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172193|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
44172194|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172195|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172196|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44172197|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172198|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172199|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172200|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44172204|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44172205|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172206|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172207|NCT00288028|Bortezomib|bortezomib|mesh-list
44172208|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938530|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938531|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938533|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
43938534|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938535|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
43938536|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938537|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938538|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938539|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43938540|NCT00882206|Cytarabine|cytarabine|mesh-list
43938541|NCT00882206|Prednisone|prednisone|mesh-list
43938542|NCT00882206|Doxorubicin|doxorubicin|mesh-list
43938543|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43938544|NCT00882206|Methotrexate|methotrexate|mesh-list
43938545|NCT00882206|Vincristine|vincristine|mesh-list
43938546|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
43938547|NCT00882206|Decitabine|decitabine|mesh-list
43938548|NCT00882206|Asparaginase|asparaginase|mesh-list
43938549|NCT00882206|Vorinostat|vorinostat|mesh-list
43938550|NCT00882206|Pegaspargase|pegaspargase|mesh-list
43938551|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43938552|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938553|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43938554|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43938555|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938556|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938557|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938558|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
43938559|NCT00882206|Hormones|hormones|mesh-ancestor
43938560|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938561|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806707|NCT04907747|Amoxicillin|amoxicillin|mesh-list
44172209|NCT00288041|Paclitaxel|paclitaxel|mesh-list
44172210|NCT00288041|Carboplatin|carboplatin|mesh-list
44172211|NCT00288041|Bortezomib|bortezomib|mesh-list
44172212|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172213|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172214|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172215|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172216|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172217|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172218|NCT00288158|Allopurinol|allopurinol|mesh-list
44172219|NCT00288158|Probenecid|probenecid|mesh-list
44172220|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
43938563|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43938564|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
43938565|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938566|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938567|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
43938568|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938569|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43938570|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938571|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
43938572|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938573|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43938574|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
43938575|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938576|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43938577|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938578|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938579|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43938580|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43938581|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43938582|NCT00882687|Lifitegrast|lifitegrast|mesh-list
43938583|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43938584|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43938585|NCT00883103|Lidocaine|lidocaine|mesh-list
43938586|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
43938587|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
43681652|NCT03198741|Aspirin|aspirin|mesh-list
43938588|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938589|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938590|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
43938591|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938592|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43938593|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43938594|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43938595|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43938596|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938598|NCT00883168|Xhance|xhance|mesh-list
43938599|NCT00883168|Azelastine|azelastine|mesh-list
43938600|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938601|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43938602|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
43938603|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938604|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938605|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43938606|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938607|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938608|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43938609|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43938610|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938611|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938612|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43938613|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43938614|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
43938615|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
43938616|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938617|NCT00883233|Adapalene|adapalene|mesh-list
43938618|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43938619|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938620|NCT00883233|Analgesics|analgesics|mesh-ancestor
43938621|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
43938622|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938623|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938624|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938625|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938626|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938627|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
43938646|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
43938647|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938648|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938649|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938650|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43938651|NCT00884897|Oxytocin|oxytocin|mesh-list
43938652|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
43938653|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938654|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938655|NCT00885079|Rebamipide|rebamipide|mesh-list
43938656|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43938657|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43938658|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43938659|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938660|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
43938661|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938662|NCT00885079|Protective Agents|protective agents|mesh-ancestor
43938663|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938664|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938665|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43938666|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43938667|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43938668|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938669|NCT00885638|Incretins|incretins|mesh-ancestor
43938670|NCT00885638|Hormones|hormones|mesh-ancestor
43938671|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938672|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43938693|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938694|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
43938695|NCT00886262|Vasopressins|vasopressins|mesh-list
43938696|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
43938697|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
43938698|NCT00886262|Coagulants|coagulants|mesh-ancestor
43938699|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43938700|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43938701|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
43938702|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938704|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43938705|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938706|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43938707|NCT00886626|Incretins|incretins|mesh-ancestor
43938709|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938710|NCT00887458|Itraconazole|itraconazole|mesh-list
43938711|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43938712|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
43938713|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938714|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43938715|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43938716|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938717|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938718|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43938719|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
43938720|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938721|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938722|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43938723|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43938724|NCT00887510|Trandolapril|trandolapril|mesh-list
43938725|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43938726|NCT00887510|Diuretics|diuretics|mesh-ancestor
43938727|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
43938728|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806802|NCT04906317|Midazolam|midazolam|mesh-list
43627897|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43938729|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43938730|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43938731|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938732|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43938733|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
43938734|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938735|NCT00887562|Ubiquinone|ubiquinone|mesh-list
43938736|NCT00887562|Idebenone|idebenone|mesh-list
43938737|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
43938738|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938739|NCT00887562|Protective Agents|protective agents|mesh-ancestor
43938740|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938741|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
43938743|NCT00887575|Carboplatin|carboplatin|mesh-list
43938744|NCT00887575|Sunitinib|sunitinib|mesh-list
43938745|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43938746|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938747|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938748|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938749|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
43938750|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938751|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43938752|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43938753|NCT00887575|Growth Substances|growth substances|mesh-ancestor
43938754|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938755|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
43938756|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43938757|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938758|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
43938759|NCT00887640|Promethazine|promethazine|mesh-list
43938760|NCT00887640|Sirolimus|sirolimus|mesh-list
43938773|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
43938774|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
43938775|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938777|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
43938778|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938779|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43938780|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
43938781|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
43938782|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938783|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938784|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43938785|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
43938786|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938787|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
43938788|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43938789|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43938790|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
43938791|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43938792|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43806810|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
44172221|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172222|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172223|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
44172224|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172225|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44172226|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
44172227|NCT00288158|Protective Agents|protective agents|mesh-ancestor
44172228|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172229|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
44172230|NCT00288158|Renal Agents|renal agents|mesh-ancestor
44172231|NCT00288171|Allopurinol|allopurinol|mesh-list
44172232|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
44172233|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172234|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172235|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
44172236|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172237|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44172238|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
44172239|NCT00288171|Protective Agents|protective agents|mesh-ancestor
44172240|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172241|NCT00288184|Allopurinol|allopurinol|mesh-list
44172242|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
44172243|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172244|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172245|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
44172246|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172247|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44172248|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
44172249|NCT00288184|Protective Agents|protective agents|mesh-ancestor
44172250|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172251|NCT00288197|Voriconazole|voriconazole|mesh-list
44172252|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
44172253|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172254|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44172255|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44172256|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172257|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938793|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43938794|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938795|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938796|NCT00887965|Denosumab|denosumab|mesh-list
43938797|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938798|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938799|NCT00888459|Nicotine|nicotine|mesh-list
43938800|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43938801|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
43938802|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938803|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938804|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43938805|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43938806|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
43938807|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938808|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938809|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43767276|NCT02402621|Fentanyl|fentanyl|mesh-list
43938810|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938811|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43938812|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938813|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681827|NCT02685605|Temozolomide|temozolomide|mesh-list
43938814|NCT00888628|Etanercept|etanercept|mesh-list
43938815|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43938816|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43938839|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938840|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938841|NCT00889200|Eszopiclone|eszopiclone|mesh-list
43938842|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43938843|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938844|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938845|NCT00889226|Atorvastatin|atorvastatin|mesh-list
43938846|NCT00889226|Pitavastatin|pitavastatin|mesh-list
43938847|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43938848|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43938849|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
43938850|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938851|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43938852|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43938853|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938854|NCT00889330|Alcaftadine|alcaftadine|mesh-list
43938855|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43938856|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
43938857|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
43938858|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938859|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938860|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938861|NCT00889915|Methylphenidate|methylphenidate|mesh-list
43938862|NCT00889915|Amphetamine|amphetamine|mesh-list
43938863|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43938864|NCT00889915|Adderall|adderall|mesh-list
43938865|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43938866|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938867|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43938868|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43938869|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43938870|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938871|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
44172258|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44172259|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
44172260|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172261|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938872|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938873|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
43938874|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
43938875|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938876|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938877|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43938878|NCT00890162|Omalizumab|omalizumab|mesh-list
43938879|NCT00890162|Epinephrine|epinephrine|mesh-list
43938880|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43938881|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43938882|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
43938883|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43938884|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938885|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938886|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43938887|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43938888|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
44172262|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44172263|NCT00288223|Telithromycin|telithromycin|mesh-list
44172264|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172265|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172267|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44172268|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44172269|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44172270|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172271|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172272|NCT00288236|Hormones|hormones|mesh-ancestor
44172273|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172274|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172275|NCT00288249|Sagopilone|sagopilone|mesh-list
44172278|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172279|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172280|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172281|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172282|NCT00288262|Melatonin|melatonin|mesh-list
44172283|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
44172284|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172285|NCT00288262|Protective Agents|protective agents|mesh-ancestor
44172286|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172287|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172288|NCT00288353|Aripiprazole|aripiprazole|mesh-list
44172289|NCT00288353|Ziprasidone|ziprasidone|mesh-list
44172290|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
44172291|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172292|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172293|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172294|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172295|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172296|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
44172297|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
44172298|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172299|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172300|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44172301|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44172302|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
44172303|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44172304|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43938889|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938890|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43938891|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938892|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
43938893|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
43938894|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43938895|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43938896|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
43938897|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938898|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
43938899|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938900|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938901|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43938902|NCT00890656|Dexamethasone|dexamethasone|mesh-list
43938903|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
43938904|NCT00890656|Doxorubicin|doxorubicin|mesh-list
43938905|NCT00890656|Methotrexate|methotrexate|mesh-list
43938906|NCT00890656|Vincristine|vincristine|mesh-list
43938907|NCT00890656|Asparaginase|asparaginase|mesh-list
43938908|NCT00890656|Pegaspargase|pegaspargase|mesh-list
43938909|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43938910|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
43938911|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938912|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43938913|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43938914|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
43938915|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938916|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938917|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43938918|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938919|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
43938920|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
43938921|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938922|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43938923|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
43938924|NCT00890656|Hormones|hormones|mesh-ancestor
43806891|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
44172305|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44172306|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44172307|NCT00288379|Budesonide|budesonide|mesh-list
43938925|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43938926|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43938927|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938928|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43938929|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43938930|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43938931|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43938932|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
43938933|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43938934|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938935|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
43938936|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938937|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43938938|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43938939|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43938940|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43938941|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43938942|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
43938943|NCT00890981|Denosumab|denosumab|mesh-list
43938944|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43938945|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938946|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43938947|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
43938948|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938949|NCT00891436|Fluticasone|fluticasone|mesh-list
43938950|NCT00891436|Xhance|xhance|mesh-list
43938951|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43938952|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43938953|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
43938954|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938955|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938956|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43938957|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938958|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938959|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43938960|NCT00891878|Capecitabine|capecitabine|mesh-list
43938961|NCT00891878|Sunitinib|sunitinib|mesh-list
43938962|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43938963|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
43938964|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43938965|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43938966|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43938967|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43938968|NCT00891878|Growth Substances|growth substances|mesh-ancestor
43938969|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938970|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
43938971|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43938972|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43938973|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
43938974|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
43938975|NCT00891995|Insulin|insulin|mesh-list
43938976|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43938977|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938978|NCT00892606|Morphine|morphine|mesh-list
43938979|NCT00892606|Methadone|methadone|mesh-list
43938980|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43938981|NCT00892606|Narcotics|narcotics|mesh-ancestor
43938982|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43938983|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43938984|NCT00892606|Analgesics|analgesics|mesh-ancestor
43938985|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
43938986|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43938987|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
43938988|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
43938989|NCT00892697|Ribavirin|ribavirin|mesh-list
43938990|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43938991|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
43938993|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
43939005|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939006|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939007|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43939008|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43939009|NCT00893074|Dronabinol|dronabinol|mesh-list
43939010|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
43939011|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939012|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939013|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939014|NCT00893074|Analgesics|analgesics|mesh-ancestor
43939015|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
43939016|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939017|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43939018|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43939019|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939020|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939021|NCT00893074|Hormones|hormones|mesh-ancestor
43939022|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939023|NCT00893984|Nebivolol|nebivolol|mesh-list
43939024|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939025|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
43939026|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43939027|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43939028|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43939029|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
43939030|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939031|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939032|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939033|NCT00893997|Vaccines|vaccines|mesh-list
43939034|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
43939035|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939036|NCT00894465|Midazolam|midazolam|mesh-list
43939045|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
43939046|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
43939047|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
43939048|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
43939049|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939050|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939051|NCT00894504|Gemcitabine|gemcitabine|mesh-list
43939052|NCT00894504|Carboplatin|carboplatin|mesh-list
43939053|NCT00894504|Panitumumab|panitumumab|mesh-list
43939054|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939055|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939056|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
43939057|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939058|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
43939059|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939060|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939061|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939062|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
43939063|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939064|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939065|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
43939066|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43939067|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43939068|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43939069|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939070|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939071|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
43939072|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939073|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939074|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43939075|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939076|NCT00894699|Sufentanil|sufentanil|mesh-list
43939077|NCT00894699|Triazolam|triazolam|mesh-list
43939078|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43939079|NCT00894699|Narcotics|narcotics|mesh-ancestor
43939080|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939081|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939083|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
43939084|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939085|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43939086|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43939087|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
43939088|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
43939089|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43767282|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
43939090|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43939091|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939092|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
43939093|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
43939094|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939095|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939096|NCT00895180|Ramucirumab|ramucirumab|mesh-list
43939097|NCT00895180|Olaratumab|olaratumab|mesh-list
43939098|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939099|NCT00895193|Aspirin|aspirin|mesh-list
43939100|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43939101|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939102|NCT00895193|Analgesics|analgesics|mesh-ancestor
43939103|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
43939104|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939105|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939106|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939107|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939108|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43939109|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43939110|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939111|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43939112|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43939113|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939114|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
44140781|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43939115|NCT00895232|Iron|iron|mesh-list
43939116|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43939117|NCT00895232|Trace Elements|trace elements|mesh-ancestor
44172308|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
44172309|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172310|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44172311|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
43939118|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
43939119|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939120|NCT00895232|Hematinics|hematinics|mesh-ancestor
43939121|NCT00895531|Morphine|morphine|mesh-list
43939122|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43939123|NCT00895531|Narcotics|narcotics|mesh-ancestor
43939124|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939125|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939126|NCT00895531|Analgesics|analgesics|mesh-ancestor
43939127|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
43939128|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939129|NCT00895752|Riluzole|riluzole|mesh-list
43939130|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
43939131|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43939132|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43939133|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939134|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939135|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939136|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43939137|NCT00895752|Protective Agents|protective agents|mesh-ancestor
43939138|NCT00895817|Fluticasone|fluticasone|mesh-list
43939139|NCT00895817|Esomeprazole|esomeprazole|mesh-list
43807022|NCT04902911|Antibodies|antibodies|mesh-list
44172312|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172313|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172314|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44172315|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
44172316|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
44172317|NCT00288379|Hormones|hormones|mesh-ancestor
44172318|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172319|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44172320|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44172321|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44172322|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612893|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612894|NCT03161509|Acetaminophen|acetaminophen|mesh-list
43612895|NCT03161509|Lamotrigine|lamotrigine|mesh-list
43612896|NCT03161509|Carbamazepine|carbamazepine|mesh-list
43612897|NCT03161509|Phenytoin|phenytoin|mesh-list
43612898|NCT03161509|Valproic Acid|valproic acid|mesh-list
43612899|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
43612900|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612901|NCT03161509|Analgesics|analgesics|mesh-ancestor
43612902|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
44172323|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172324|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172325|NCT00288431|Sirolimus|sirolimus|mesh-list
44172326|NCT00288431|Doxorubicin|doxorubicin|mesh-list
44172327|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172329|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44172330|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172331|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172332|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43629345|NCT03060070|Analgesics|analgesics|mesh-ancestor
43939140|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939141|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43939142|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
43939143|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939144|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939145|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43939146|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43939147|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939148|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43939149|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43939150|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939151|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43939152|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939153|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939154|NCT00895921|Olanzapine|olanzapine|mesh-list
43939155|NCT00895921|Aripiprazole|aripiprazole|mesh-list
43939156|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
43939157|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
43939158|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939159|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939160|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939161|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43939162|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43939163|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939164|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939165|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43939166|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43939167|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939168|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939169|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939170|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
43939171|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
43939172|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
43939173|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
43939174|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43939175|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44172333|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939176|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43939177|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43939178|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43939179|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43939180|NCT00895934|Azacitidine|azacitidine|mesh-list
43939181|NCT00895934|Vorinostat|vorinostat|mesh-list
43939182|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
43939183|NCT00895934|Calicheamicins|calicheamicins|mesh-list
43939184|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939185|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
43939186|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939187|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939188|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939189|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43939190|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939191|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939192|NCT00896012|Sirolimus|sirolimus|mesh-list
43939193|NCT00896012|Tacrolimus|tacrolimus|mesh-list
43939194|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939195|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
43939196|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939197|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43939198|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939199|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939200|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939201|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939202|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939203|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939204|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
43939205|NCT00896038|Aprepitant|aprepitant|mesh-list
43939206|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
43939207|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
43939208|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939209|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939214|NCT00896064|Vaccines|vaccines|mesh-list
43939215|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43939216|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
43939217|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939218|NCT00896181|Cisplatin|cisplatin|mesh-list
43939219|NCT00896181|Carboplatin|carboplatin|mesh-list
43939220|NCT00896181|Docetaxel|docetaxel|mesh-list
43939221|NCT00896181|Fluorouracil|fluorouracil|mesh-list
43939222|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939232|NCT00896441|Citalopram|citalopram|mesh-list
43939281|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939282|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939283|NCT00899574|Imiquimod|imiquimod|mesh-list
43939284|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43939285|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
43939286|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939287|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939288|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
43939289|NCT00899600|Ketamine|ketamine|mesh-list
43939290|NCT00899600|Analgesics|analgesics|mesh-ancestor
43939291|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
43939292|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939293|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939294|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43939295|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43939296|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
43939297|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
43939298|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939299|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43939300|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43939301|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939302|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939303|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
43939304|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939305|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
43939306|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
43939307|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939308|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43939309|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
43939310|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
43939311|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43939312|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43939313|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962692|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172334|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172335|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
44172336|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172337|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
44172338|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939314|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939315|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43939316|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43939317|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
43939318|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43939319|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43939320|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43939321|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939322|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939323|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
43939324|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939325|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939326|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43939327|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939328|NCT00901199|Deferasirox|deferasirox|mesh-list
43939329|NCT00901199|Deferoxamine|deferoxamine|mesh-list
43939330|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43939331|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
43939332|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
43939333|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939334|NCT00901199|Siderophores|siderophores|mesh-ancestor
43939335|NCT00901225|Plerixafor|plerixafor|mesh-list
43939336|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43939337|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43939338|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
43939339|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939340|NCT00902161|Propranolol|propranolol|mesh-list
43939341|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43939342|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43939343|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807129|NCT04901663|Amoxicillin|amoxicillin|mesh-list
44172339|NCT00288444|Docetaxel|docetaxel|mesh-list
44172340|NCT00288444|Lonafarnib|lonafarnib|mesh-list
44172341|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172342|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172343|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172344|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172345|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172346|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172347|NCT00288470|Hylan|hylan|mesh-list
44172348|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
44172349|NCT00288470|Protective Agents|protective agents|mesh-ancestor
44172350|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172351|NCT00288483|Policosanol|policosanol|mesh-list
44172352|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44172353|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43939344|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939345|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939346|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939347|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939348|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939349|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
43939350|NCT00902226|Citalopram|citalopram|mesh-list
43939351|NCT00902226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43939352|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43939353|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939354|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939355|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939356|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
43939357|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939358|NCT00902226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43939359|NCT00902226|Antidepressive Agents|antidepressive agents|mesh-ancestor
43939360|NCT00902226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939361|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
43939362|NCT00903162|Letrozole|letrozole|mesh-list
43939363|NCT00903162|Leuprolide|leuprolide|mesh-list
43939364|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939365|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43939366|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43939367|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939368|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939369|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43939370|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
43939371|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939387|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939389|NCT00904488|Furosemide|furosemide|mesh-list
43939390|NCT00904488|Diuretics|diuretics|mesh-ancestor
43939391|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
43939392|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939393|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43939394|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939395|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939396|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939397|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43939398|NCT00904618|Lidocaine|lidocaine|mesh-list
43939399|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
43939400|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
43939401|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939402|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939403|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
43939404|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939405|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939406|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43939407|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43939408|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939409|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939410|NCT00904826|Eculizumab|eculizumab|mesh-list
43939411|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43939412|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939414|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939415|NCT00904995|Voriconazole|voriconazole|mesh-list
44172354|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
44172355|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172356|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44172357|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44172358|NCT00288522|Lanreotide|lanreotide|mesh-list
44172359|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172360|NCT00288535|Sirolimus|sirolimus|mesh-list
44172361|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172362|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172363|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172364|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172365|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
44172366|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172367|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
44172368|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172369|NCT00288548|Metoprolol|metoprolol|mesh-list
44172370|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939416|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
43939417|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939418|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43939419|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43939420|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939421|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939422|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43939423|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
43939424|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939425|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939426|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43939427|NCT00905060|Temozolomide|temozolomide|mesh-list
43939428|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43939429|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
43939430|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939431|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939432|NCT00905268|Idebenone|idebenone|mesh-list
43939433|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
43939434|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939435|NCT00905268|Protective Agents|protective agents|mesh-ancestor
43939436|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939437|NCT00905515|Cyclosporine|cyclosporine|mesh-list
43939438|NCT00905515|Tacrolimus|tacrolimus|mesh-list
43939439|NCT00905515|Cyclosporins|cyclosporins|mesh-list
43939440|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939441|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
43939442|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939461|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43939462|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939463|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43939464|NCT00906503|Dexamethasone|dexamethasone|mesh-list
43939465|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43939466|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939467|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
43939468|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
43939469|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939470|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939471|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939472|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
43939473|NCT00906503|Hormones|hormones|mesh-ancestor
43939474|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939475|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43939476|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939477|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43939478|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939479|NCT00907426|Bimatoprost|bimatoprost|mesh-list
43939480|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43939481|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939482|NCT00908466|Sirolimus|sirolimus|mesh-list
43939483|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939484|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939485|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939486|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939487|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
43939488|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939489|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
43939490|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939492|NCT00909064|Fondaparinux|fondaparinux|mesh-list
43939493|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43939494|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
43939495|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43939496|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
44172371|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44172372|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
44172373|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
44172374|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172375|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939497|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939498|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939499|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
43939500|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43939501|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43939502|NCT00909155|Fluoxetine|fluoxetine|mesh-list
43939503|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43939504|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43939505|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43939508|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939560|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
43939561|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
43939562|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
43939563|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939564|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43939565|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
43939566|NCT00911586|Testosterone|testosterone|mesh-list
43939567|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
43939568|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
43939569|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43939570|NCT00911586|Androgens|androgens|mesh-ancestor
43939571|NCT00911586|Hormones|hormones|mesh-ancestor
43939572|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939573|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939574|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43939575|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939576|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
43939577|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43939578|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43939579|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43939580|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
43939582|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43939614|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43939615|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43939616|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939617|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939618|NCT00913068|Lidocaine|lidocaine|mesh-list
43939619|NCT00913068|Ropivacaine|ropivacaine|mesh-list
43939620|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
43939621|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
43939622|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939623|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939624|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
43939625|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939626|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43939627|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43939628|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43939629|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43939630|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939631|NCT00913081|Quercetin|quercetin|mesh-list
43939632|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
43939633|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939634|NCT00913081|Protective Agents|protective agents|mesh-ancestor
43939635|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939636|NCT00913133|Desirudin|desirudin|mesh-list
43939637|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
43939638|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43939639|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43939640|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939641|NCT00913263|Flutamide|flutamide|mesh-list
43939642|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
43939643|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
43939644|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
43939645|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939646|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939647|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43939648|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939649|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43939650|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
43939651|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939652|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939653|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939654|NCT00913627|Ibuprofen|ibuprofen|mesh-list
43939655|NCT00913627|Naproxen|naproxen|mesh-list
43939656|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43939657|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939658|NCT00913627|Analgesics|analgesics|mesh-ancestor
43939659|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
43939660|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939661|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939662|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939663|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939664|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43939665|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939666|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939667|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
43939668|NCT00913913|Bevacizumab|bevacizumab|mesh-list
43939669|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939670|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939671|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44140806|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140807|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44140808|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44140809|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140810|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140811|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44140812|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
43939677|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43939678|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939679|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43939680|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
43939681|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939682|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939683|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43939684|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
43939685|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
43939686|NCT00915538|Hormones|hormones|mesh-ancestor
43939687|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43939688|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43939689|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939690|NCT00915603|Paclitaxel|paclitaxel|mesh-list
43939691|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43939692|NCT00915603|Bevacizumab|bevacizumab|mesh-list
43939693|NCT00915603|Everolimus|everolimus|mesh-list
43939719|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43939720|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
43939721|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939722|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43939723|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43939724|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43939725|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43939726|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
43939727|NCT00915928|Perindopril|perindopril|mesh-list
43939728|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43939729|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
43939730|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939731|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939732|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43939733|NCT00915967|Vancomycin|vancomycin|mesh-list
43939734|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939735|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939736|NCT00916032|Factor VIII|factor viii|mesh-list
43939737|NCT00916032|Coagulants|coagulants|mesh-ancestor
43939738|NCT00916539|Calpastatin|calpastatin|mesh-list
43939739|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43939740|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
43939741|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939742|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939743|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
43939744|NCT00918723|Rituximab|rituximab|mesh-list
43939745|NCT00918723|Fludarabine|fludarabine|mesh-list
43939746|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
43939747|NCT00918723|Vorinostat|vorinostat|mesh-list
43939748|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939763|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939764|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939765|NCT00919035|Sirolimus|sirolimus|mesh-list
43939766|NCT00919035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939767|NCT00919035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939768|NCT00919035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939769|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939770|NCT00919035|Antifungal Agents|antifungal agents|mesh-ancestor
43939771|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939772|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
43939773|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939774|NCT00919126|Xenon|xenon|mesh-list
43939775|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43939776|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
43939777|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
43939778|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939779|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939780|NCT00919191|Adapalene|adapalene|mesh-list
43939781|NCT00919191|Tretinoin|tretinoin|mesh-list
43939782|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43939783|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939784|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43939785|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43939787|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
43939788|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939789|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939790|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43939791|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939792|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939793|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
43939794|NCT00919503|Cyclosporine|cyclosporine|mesh-list
43939795|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
43939796|NCT00919503|Methotrexate|methotrexate|mesh-list
43939797|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
44172376|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44172377|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44172378|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44172379|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172380|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172381|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612969|NCT03161041|Bevacizumab|bevacizumab|mesh-list
43612970|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
43939798|NCT00919503|Fludarabine|fludarabine|mesh-list
43939799|NCT00919503|Treosulfan|treosulfan|mesh-list
43939800|NCT00919503|Busulfan|busulfan|mesh-list
43939801|NCT00919503|Tacrolimus|tacrolimus|mesh-list
43939802|NCT00919503|Cyclosporins|cyclosporins|mesh-list
43939803|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
43939804|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43939805|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43939806|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
43939807|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43939808|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939809|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939810|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
43939811|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939812|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939813|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939814|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939815|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43939816|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939817|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
43939818|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939819|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43939820|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43939821|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
43939822|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939823|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939824|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43939825|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
43939826|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939827|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43939828|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
43939829|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43939830|NCT00919802|Oxytocin|oxytocin|mesh-list
43939831|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
43939832|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43939839|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939840|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43939841|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939842|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43939843|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43939844|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43939845|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939846|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43939847|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
43939848|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939849|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
43939850|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939851|NCT00921843|Methadone|methadone|mesh-list
43939852|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43939853|NCT00921843|Narcotics|narcotics|mesh-ancestor
43939854|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939855|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939856|NCT00921843|Analgesics|analgesics|mesh-ancestor
43939857|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
43939858|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939859|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
43939860|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
43939861|NCT00922194|Metformin|metformin|mesh-list
43939890|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43939891|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939893|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43939894|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43939895|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43939896|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
43939897|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
43939898|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
43939899|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
43939900|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43939901|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43939902|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
43682775|NCT02845804|Everolimus|everolimus|mesh-list
43939903|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
43939904|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43939905|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939906|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43939907|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
43939908|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43939909|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43939910|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
43939911|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939912|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939913|NCT00923949|Pioglitazone|pioglitazone|mesh-list
43939914|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43939915|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939916|NCT00924001|Aldesleukin|aldesleukin|mesh-list
43939917|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
43939918|NCT00924001|Fludarabine|fludarabine|mesh-list
43939919|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43939920|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
43939921|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939922|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43939923|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43939924|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
44172382|NCT00288561|Ranibizumab|ranibizumab|mesh-list
44172383|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44172384|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939925|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939926|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939927|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43939928|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43939929|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43939930|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
43939931|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43939932|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43939933|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939934|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43939935|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939936|NCT00924066|Epothilones|epothilones|mesh-list
43939937|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43939938|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43939939|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43939940|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939941|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939943|NCT00924209|Bevacizumab|bevacizumab|mesh-list
43939944|NCT00924209|Cisplatin|cisplatin|mesh-list
43939945|NCT00924209|Etoposide|etoposide|mesh-list
43939946|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43939947|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43939948|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44172385|NCT00288561|Growth Substances|growth substances|mesh-ancestor
44172386|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172387|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
44172388|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172389|NCT00288652|Reboxetine|reboxetine|mesh-list
44172390|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
44172391|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172392|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44172393|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44172394|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172395|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172396|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172397|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172398|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172399|NCT00288717|Telmisartan|telmisartan|mesh-list
44172400|NCT00288717|Candesartan|candesartan|mesh-list
44172401|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44172402|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44172403|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44172404|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172405|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44172406|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
44172407|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172408|NCT00288743|Insulin|insulin|mesh-list
44172409|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172410|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939949|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43939950|NCT00924209|Growth Substances|growth substances|mesh-ancestor
43939951|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43939952|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
43939953|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43939954|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
43939955|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43939956|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
43939957|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940013|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43940014|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
43940015|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940016|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940017|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43940018|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940085|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940086|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
43940087|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
43767324|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940088|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940089|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940090|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940091|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
43940092|NCT00928200|Hormones|hormones|mesh-ancestor
43940093|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940094|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43940095|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940096|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
43940097|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940098|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940099|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43940100|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43940101|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940102|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44172411|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
44172412|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
44172413|NCT00288769|Vitamins|vitamins|mesh-ancestor
44172414|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
44172435|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44172436|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
44172437|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44172438|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
44172439|NCT00288873|Vitamin D|vitamin d|mesh-list
44172440|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
44172441|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44172442|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172443|NCT00288873|Vitamins|vitamins|mesh-ancestor
44172444|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
44172445|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44172446|NCT00288951|Travoprost|travoprost|mesh-list
44172447|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44172448|NCT00289042|Enoxaparin|enoxaparin|mesh-list
44172449|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
44172450|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44172451|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44172452|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172453|NCT00289250|Artesunate|artesunate|mesh-list
44172454|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
44172455|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
44172456|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44172457|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
44172458|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44172459|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44172460|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172461|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172462|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
44172463|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
44172464|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44172465|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
44172466|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44172467|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172468|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940103|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
43940104|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940105|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43940106|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
43940107|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
43940108|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43940109|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940110|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
43940111|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940112|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43940113|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
43940114|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940115|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43940116|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
43940117|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
43940118|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
43940119|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43940120|NCT00928200|Protective Agents|protective agents|mesh-ancestor
43940121|NCT00928421|Polidocanol|polidocanol|mesh-list
43940122|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43940123|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43940124|NCT00928642|Gemcitabine|gemcitabine|mesh-list
43940125|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
43940126|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43682996|NCT02844803|Metformin|metformin|mesh-list
43940127|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
43940128|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940129|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940130|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
43940132|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940133|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940134|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
43940149|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940150|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43940151|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
43940152|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
43940153|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
43940154|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
43940155|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940156|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940157|NCT00928954|Gabapentin|gabapentin|mesh-list
43940158|NCT00928954|Memantine|memantine|mesh-list
43940159|NCT00928954|Analgesics|analgesics|mesh-ancestor
43940160|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
43940161|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940162|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940163|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
43940164|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43940166|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940167|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940168|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43940169|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43940170|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940171|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940172|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
43940173|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43940174|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43940175|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
43940176|NCT00929071|Lidocaine|lidocaine|mesh-list
43940177|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
43940178|NCT00929071|Anesthetics|anesthetics|mesh-list
43940179|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940180|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940181|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
43940182|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940183|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44172487|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
44172488|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
44172489|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172490|NCT00289406|Amlodipine|amlodipine|mesh-list
43940184|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43940185|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43940186|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940187|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140813|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44140814|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140815|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44140816|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
44140817|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
44140818|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44140819|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140820|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
44140821|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140822|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44140823|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44140824|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44140825|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
44140826|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
44140827|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140828|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44140829|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940188|NCT00929344|Pregabalin|pregabalin|mesh-list
43940189|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43940190|NCT00929344|Analgesics|analgesics|mesh-ancestor
43940191|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
43940192|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752329|NCT02492074|Analgesics|analgesics|mesh-ancestor
43940193|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940194|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
43940195|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43940196|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940197|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172491|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44172492|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44172493|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172494|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172495|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44172496|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172497|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
44172498|NCT00289419|Ketorolac|ketorolac|mesh-list
43940198|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43940199|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43940200|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940201|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940202|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940203|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43940204|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43940205|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940206|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
43940207|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
43940208|NCT00929383|Hemostatics|hemostatics|mesh-list
43940209|NCT00929383|Coagulants|coagulants|mesh-ancestor
43940210|NCT00929578|Fluphenazine|fluphenazine|mesh-list
43940211|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
43940212|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
43940213|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43940214|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940215|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940216|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940217|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940218|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43940219|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
43940220|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940221|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940222|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
43940223|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43940224|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43940225|NCT00929981|Prednisolone|prednisolone|mesh-list
43940226|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
44172499|NCT00289419|Epinephrine|epinephrine|mesh-list
44172500|NCT00289419|Racepinephrine|racepinephrine|mesh-list
44172501|NCT00289419|Morphine|morphine|mesh-list
44172502|NCT00289419|Ropivacaine|ropivacaine|mesh-list
44172503|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
44172504|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44172505|NCT00289419|Narcotics|narcotics|mesh-ancestor
44172506|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172507|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172508|NCT00289419|Analgesics|analgesics|mesh-ancestor
44172509|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
44172510|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172511|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
44172512|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
44172513|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44172514|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44172515|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940227|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43940228|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
43940229|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940230|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
43940231|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
43940232|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940233|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940234|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940235|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
43940236|NCT00929981|Hormones|hormones|mesh-ancestor
43940237|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940238|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43940239|NCT00929981|Protective Agents|protective agents|mesh-ancestor
43940240|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43940241|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940242|NCT00930293|Dexetimide|dexetimide|mesh-list
43940243|NCT00930293|Citalopram|citalopram|mesh-list
43940244|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43940245|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43940246|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940247|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940248|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940249|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
43940250|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940251|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43940276|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940277|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940278|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940279|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43940280|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43940281|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940282|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940283|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940284|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
43940285|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
43940286|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940287|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940288|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940289|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940290|NCT00931242|Growth Substances|growth substances|mesh-ancestor
43940291|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940292|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940293|NCT00931489|Ranibizumab|ranibizumab|mesh-list
43940294|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940295|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940297|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940298|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940299|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940300|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
43940301|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43940302|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940303|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940304|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940305|NCT00932022|Trospium chloride|trospium chloride|mesh-list
43940306|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
43940307|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
43940308|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172516|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172517|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44172518|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172519|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172520|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44172521|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44172522|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172523|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172524|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44172525|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43940309|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940310|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43940311|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43940312|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940313|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940314|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940315|NCT00932022|Urological Agents|urological agents|mesh-ancestor
43940316|NCT00932282|Omalizumab|omalizumab|mesh-list
43940317|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43940318|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43940319|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
43940320|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43940321|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43940322|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43940323|NCT00932321|Norethindrone|norethindrone|mesh-list
43940324|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
43940325|NCT00932321|Estradiol|estradiol|mesh-list
43940326|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43940327|NCT00932321|Estrogens|estrogens|mesh-ancestor
43940328|NCT00932321|Hormones|hormones|mesh-ancestor
43940329|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940330|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940331|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43940332|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
43940333|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940334|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43940335|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43940336|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43940337|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43940342|NCT00932438|Irinotecan|irinotecan|mesh-list
43940354|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
43940355|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43940356|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940357|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940358|NCT00932438|Antidotes|antidotes|mesh-ancestor
43940359|NCT00932438|Protective Agents|protective agents|mesh-ancestor
43940360|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
43940361|NCT00932438|Vitamins|vitamins|mesh-ancestor
43940362|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
43940363|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43940364|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
43940365|NCT00932477|Glycerol|glycerol|mesh-list
43940366|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43940367|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43940368|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43940416|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940417|NCT00935311|Acetaminophen|acetaminophen|mesh-list
43940418|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43940419|NCT00935311|Hydrocodone|hydrocodone|mesh-list
43940420|NCT00935311|Oxycodone|oxycodone|mesh-list
43940421|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940422|NCT00935311|Analgesics|analgesics|mesh-ancestor
43940423|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
43940424|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940425|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940426|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
43940427|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43940428|NCT00935311|Narcotics|narcotics|mesh-ancestor
43940429|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43940478|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940479|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43940480|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
43940481|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940482|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940483|NCT00936741|Mifepristone|mifepristone|mesh-list
43940484|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43940486|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43940487|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940488|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43940499|NCT00937235|Varenicline|varenicline|mesh-list
43940539|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43940540|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940541|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940542|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
43940606|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43940607|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43940608|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43940609|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940610|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940611|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43940612|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
43940613|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
43940614|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940615|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43940616|NCT00939705|Topiramate|topiramate|mesh-list
43940617|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
43940618|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43940619|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940620|NCT00939731|Crizotinib|crizotinib|mesh-list
43940621|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940622|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43940623|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940625|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
43940661|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43940662|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43940663|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43940664|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
43940665|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940666|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940667|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43940668|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43940669|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
43940670|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940726|NCT00942578|Lenalidomide|lenalidomide|mesh-list
43940727|NCT00942578|Docetaxel|docetaxel|mesh-list
43940728|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940729|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940730|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940731|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940732|NCT00942578|Growth Substances|growth substances|mesh-ancestor
43940733|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940734|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940735|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
43940736|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
43940737|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
43940738|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940739|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940741|NCT00942578|Hormones|hormones|mesh-ancestor
43940742|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940743|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43940744|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
43940745|NCT00942825|Cisplatin|cisplatin|mesh-list
44157490|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43940769|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
43940770|NCT00943800|Melphalan|melphalan|mesh-list
43940771|NCT00943800|Busulfan|busulfan|mesh-list
43940772|NCT00943800|Thiotepa|thiotepa|mesh-list
43940773|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43940774|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
43940775|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940776|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43940777|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
43940778|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940779|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940780|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
43940781|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940782|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
43940783|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940784|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940785|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
43940786|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43940787|NCT00943878|Vaccines|vaccines|mesh-list
43940788|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
43940789|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940790|NCT00944047|Paclitaxel|paclitaxel|mesh-list
43940791|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
43940792|NCT00944047|Doxorubicin|doxorubicin|mesh-list
43940793|NCT00944047|Trastuzumab|trastuzumab|mesh-list
43940794|NCT00944047|Mitogens|mitogens|mesh-list
43940795|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43940796|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940797|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
43940798|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
43940799|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
43940800|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172526|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
44172527|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44172528|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
44172533|NCT00289445|Folic Acid|folic acid|mesh-list
44172534|NCT00289445|Mitomycins|mitomycins|mesh-list
44172535|NCT00289445|Mitomycin|mitomycin|mesh-list
43940801|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940802|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
43940803|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940804|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940805|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940806|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
43940807|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43940808|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43940809|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43940810|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43940811|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940812|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940813|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43940814|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43940815|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940816|NCT00944450|Incretins|incretins|mesh-ancestor
43940818|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940819|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43940820|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
43940821|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940822|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940823|NCT00944554|Varenicline|varenicline|mesh-list
43940824|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43940825|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43940826|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940827|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940828|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940829|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940845|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940846|NCT00944710|Atropine|atropine|mesh-list
43940847|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43940848|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43940849|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43940850|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
43940851|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940852|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940853|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43940854|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
43940855|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
43940856|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
43940857|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43940858|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43940859|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940860|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940861|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940862|NCT00944749|Cyclosporine|cyclosporine|mesh-list
43940863|NCT00944749|Cyclosporins|cyclosporins|mesh-list
43940864|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940865|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940866|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940867|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
43940868|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940869|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
43940870|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940874|NCT00945139|Bevacizumab|bevacizumab|mesh-list
43940892|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940893|NCT00945282|Ritonavir|ritonavir|mesh-list
43940894|NCT00945282|Lopinavir|lopinavir|mesh-list
43940895|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43940896|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43940897|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
43940898|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940899|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940900|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43940901|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43940902|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
43940903|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940904|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43940905|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43940906|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
43940907|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43940908|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43940909|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43940910|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43940911|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940912|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
43940913|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940914|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940915|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43940916|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940917|NCT00945334|Rifaximin|rifaximin|mesh-list
43940918|NCT00945334|Neomycin|neomycin|mesh-list
43940919|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940920|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940921|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43940922|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43940923|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940924|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940932|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940933|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940935|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
43940936|NCT00946023|Rituximab|rituximab|mesh-list
43940937|NCT00946023|Fludarabine|fludarabine|mesh-list
43940938|NCT00946023|Tacrolimus|tacrolimus|mesh-list
43940939|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940940|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
43940941|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940942|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940943|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43940944|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
43940945|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940946|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940947|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43940948|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43940949|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43940950|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43940951|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43940952|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43940953|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
43940954|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940955|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940956|NCT00946270|Thalidomide|thalidomide|mesh-list
43940957|NCT00946270|Prednisone|prednisone|mesh-list
43940958|NCT00946270|Pomalidomide|pomalidomide|mesh-list
43940959|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940960|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
43940961|NCT00946270|Hormones|hormones|mesh-ancestor
43940962|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940963|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940964|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843703|NCT04434664|Metoprolol|metoprolol|mesh-list
44172536|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
44172537|NCT00289445|Antidotes|antidotes|mesh-ancestor
44172538|NCT00289445|Protective Agents|protective agents|mesh-ancestor
44172539|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172540|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
44172541|NCT00289445|Vitamins|vitamins|mesh-ancestor
44172542|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
44172543|NCT00289445|Hematinics|hematinics|mesh-ancestor
43940965|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43940966|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
43940967|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43940968|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43940969|NCT00946270|Growth Substances|growth substances|mesh-ancestor
43940970|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43940971|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43940972|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
43940973|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43940974|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43940975|NCT00946348|Dronabinol|dronabinol|mesh-list
43940976|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
43940977|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940978|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43940979|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940980|NCT00946348|Analgesics|analgesics|mesh-ancestor
43940981|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
43940982|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940983|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43940984|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43940985|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43940986|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43940987|NCT00946348|Hormones|hormones|mesh-ancestor
43940988|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43940989|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
43752787|NCT02488473|Analgesics|analgesics|mesh-ancestor
43940990|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43940991|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43940992|NCT00946478|Analgesics|analgesics|mesh-ancestor
43940993|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
43940994|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43940995|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43940996|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43940997|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43940998|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941004|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43941005|NCT00947167|Pertuzumab|pertuzumab|mesh-list
43941006|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941007|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43941008|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941009|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941010|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941011|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43941012|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941013|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
43941014|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
43941015|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43941016|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
43683687|NCT00816972|Loratadine|loratadine|mesh-list
43941068|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941069|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
43941070|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941071|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941072|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
43941073|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941074|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941075|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941076|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
43941077|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941078|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43941079|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43941080|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941081|NCT00949078|Omalizumab|omalizumab|mesh-list
43941082|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43941083|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43941084|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
43941085|NCT00949234|Ritonavir|ritonavir|mesh-list
43941086|NCT00949234|Lopinavir|lopinavir|mesh-list
43941087|NCT00949234|Tenofovir|tenofovir|mesh-list
43941088|NCT00949234|Emtricitabine|emtricitabine|mesh-list
43941089|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43941090|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43941091|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
43941092|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941093|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941094|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43941115|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941116|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43941117|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941118|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43941119|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43941120|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
43941121|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941123|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941124|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43941125|NCT00951561|Analgesics|analgesics|mesh-ancestor
43941126|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
43941127|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941128|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941129|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941130|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941131|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43941132|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941133|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941134|NCT00951899|Metformin|metformin|mesh-list
43941135|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43941152|NCT00952133|BB 1101|bb 1101|mesh-list
43941165|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941166|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941167|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43941168|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43941169|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
43941170|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941171|NCT00952653|Midazolam|midazolam|mesh-list
43941172|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43941173|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43941174|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43941175|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941176|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941177|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43941178|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43941179|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941180|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43941181|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
43941182|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
43941183|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
43941184|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
43941185|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941186|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941187|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43941188|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43941189|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941190|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
43941191|NCT00953121|Bevacizumab|bevacizumab|mesh-list
43941192|NCT00953121|Carboplatin|carboplatin|mesh-list
43941193|NCT00953121|Irinotecan|irinotecan|mesh-list
43941194|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941195|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941196|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43941197|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43941204|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941206|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43941207|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
43941208|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941209|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941210|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
43941211|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941212|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43941213|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43941214|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43941215|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941216|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941218|NCT00953212|Amiodarone|amiodarone|mesh-list
43941219|NCT00953212|Metoprolol|metoprolol|mesh-list
43941220|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43941221|NCT00953212|Vitamins|vitamins|mesh-ancestor
43941222|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
43941223|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941224|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
43941225|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941226|NCT00953212|Protective Agents|protective agents|mesh-ancestor
43941227|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43941228|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
43941229|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941230|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43941231|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
43941232|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43941233|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941234|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43941235|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43941236|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43941237|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941238|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43941242|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
43941243|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
43941244|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941245|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43941246|NCT00953849|Calcitriol|calcitriol|mesh-list
43941247|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43941248|NCT00953849|Vitamin D|vitamin d|mesh-list
43941249|NCT00953849|Celecoxib|celecoxib|mesh-list
43941250|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941251|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43941252|NCT00953849|Analgesics|analgesics|mesh-ancestor
43941253|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
43941254|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941255|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941256|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941257|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941258|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43941259|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43941260|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941261|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941262|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43941263|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43941264|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941265|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43941266|NCT00953849|Vitamins|vitamins|mesh-ancestor
43941267|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
43941268|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43941269|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43941270|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43941272|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941285|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43941286|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43941287|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43941288|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43941290|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941291|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941292|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941294|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43941295|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941296|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
43941297|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43941298|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
43941299|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941300|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941301|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43941302|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
43941303|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43941304|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
43941305|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941306|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941307|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43941308|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
43941309|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
43941310|NCT00955487|Protective Agents|protective agents|mesh-ancestor
43941311|NCT00955513|Diclofenac|diclofenac|mesh-list
43941312|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941313|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43941314|NCT00955513|Analgesics|analgesics|mesh-ancestor
43941315|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
43941316|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941317|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941318|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941324|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43941326|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
43941327|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941328|NCT00955877|Morphine|morphine|mesh-list
43941329|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43941330|NCT00955877|Narcotics|narcotics|mesh-ancestor
43941331|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941332|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941333|NCT00955877|Analgesics|analgesics|mesh-ancestor
43941334|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
43941335|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941336|NCT00955916|Cytarabine|cytarabine|mesh-list
43941337|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
43941338|NCT00955916|Cladribine|cladribine|mesh-list
43941339|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941340|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
43941341|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941342|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941343|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
43941344|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941345|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941346|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
43941347|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941348|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43941349|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941350|NCT00956085|Memantine|memantine|mesh-list
43941351|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43941352|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43941353|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
43941354|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941368|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43941369|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
43941370|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
43941371|NCT00956709|Ropivacaine|ropivacaine|mesh-list
43941372|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
43941373|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
43941374|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
43941375|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941376|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941377|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
43941378|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941379|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43941380|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
43941381|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43941382|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43941383|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941384|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941385|NCT00957242|Warfarin|warfarin|mesh-list
43941386|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
43941387|NCT00957333|Ketamine|ketamine|mesh-list
43941388|NCT00957333|Analgesics|analgesics|mesh-ancestor
43941389|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
43941390|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941391|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941392|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43941393|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43941394|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
43941395|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
43941398|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43941414|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941415|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43941416|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
43941417|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941418|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43941419|NCT00957593|Oxytocin|oxytocin|mesh-list
43941420|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
43941421|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43941422|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941423|NCT00957671|Hormones|hormones|mesh-list
43941424|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941425|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941426|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43941427|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
43941428|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43941429|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43941430|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941431|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140844|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140845|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
44140846|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683937|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
44140847|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
44140848|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941432|NCT00958035|Bimatoprost|bimatoprost|mesh-list
43941433|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43941454|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941455|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
43941456|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941457|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941458|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941459|NCT00959764|Calcitonin|calcitonin|mesh-list
43941460|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
43941461|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43941462|NCT00959764|Katacalcin|katacalcin|mesh-list
43941463|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43941464|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941465|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43941517|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
43941518|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941519|NCT00962039|Citalopram|citalopram|mesh-list
43941520|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43941521|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43941522|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941523|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941524|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941525|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
43941526|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941527|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43941528|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
43941529|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941530|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43941531|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43941532|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941533|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43941534|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941535|NCT00962871|Tenofovir|tenofovir|mesh-list
43941536|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43941537|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
43941538|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941539|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43941540|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941541|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941542|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941543|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43941544|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43941545|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
43941556|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43941557|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43941558|NCT00963105|Growth Substances|growth substances|mesh-ancestor
43941559|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
43941560|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941561|NCT00963508|Permethrin|permethrin|mesh-list
43941562|NCT00963508|Malathion|malathion|mesh-list
43941563|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941564|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941565|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43941566|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43941567|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941568|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941569|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
43941570|NCT00963872|Fludarabine|fludarabine|mesh-list
43941571|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
43941572|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941573|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
43941574|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941575|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941576|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43941577|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
43941578|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941579|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941581|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43941582|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
43941583|NCT00964353|Warfarin|warfarin|mesh-list
43941584|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
43941585|NCT00964431|Celecoxib|celecoxib|mesh-list
43941586|NCT00964431|Indomethacin|indomethacin|mesh-list
43941587|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43941588|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43941589|NCT00964431|Analgesics|analgesics|mesh-ancestor
43941590|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
43941591|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941597|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941598|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941599|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
43941601|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43941602|NCT00964496|Thalidomide|thalidomide|mesh-list
43941603|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
43941604|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941605|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
43941606|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941607|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
43941608|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43941609|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941610|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43941611|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43941612|NCT00964496|Growth Substances|growth substances|mesh-ancestor
43941613|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
43941614|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941615|NCT00964496|Hematinics|hematinics|mesh-ancestor
43941616|NCT00964548|Dantrolene|dantrolene|mesh-list
43941617|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43941618|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941621|NCT00966641|Naproxen|naproxen|mesh-list
43941650|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941651|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43941652|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43941653|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43941654|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941655|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941656|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43941657|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
43941658|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
43941659|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941660|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
43941661|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
43941662|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
43941664|NCT00967551|Trace Elements|trace elements|mesh-list
43941709|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
43941710|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941711|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43941712|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941713|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941714|NCT00970814|Levetiracetam|levetiracetam|mesh-list
43941715|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
43941716|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
43941717|NCT00971295|Metformin|metformin|mesh-list
43941718|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43941719|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43941720|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941721|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
43941722|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43941723|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43941724|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941725|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941726|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
43941727|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43941728|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43941729|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43941730|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43941731|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941732|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
43941733|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941734|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941735|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43941736|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941738|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
43941753|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43941754|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
43941755|NCT00971737|Trastuzumab|trastuzumab|mesh-list
43941756|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941757|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
43941758|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941759|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941760|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43941761|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
43941762|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941763|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941764|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43941765|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43941766|NCT00971789|Sirolimus|sirolimus|mesh-list
43941767|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43941768|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43941769|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941770|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43941771|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941772|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
43941773|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941774|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
43941775|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941776|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43941777|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941778|NCT00971841|Paclitaxel|paclitaxel|mesh-list
43941801|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941802|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
43941803|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684244|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
43941804|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
43941805|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43941806|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43941807|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43941808|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43941809|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43941810|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
43941811|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941812|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941813|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941814|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
43941816|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
43941817|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43941818|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941819|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43941820|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43941855|NCT00973752|Asparaginase|asparaginase|mesh-list
43941856|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
43941857|NCT00973752|Clofarabine|clofarabine|mesh-list
43941858|NCT00973752|Pegaspargase|pegaspargase|mesh-list
43941859|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43941860|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43941861|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43941862|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43941863|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941864|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941865|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43941866|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
43941867|NCT00973752|Hormones|hormones|mesh-ancestor
43941868|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43941869|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140872|NCT00181116|Levetiracetam|levetiracetam|mesh-list
44140873|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
44140874|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
44140876|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44140877|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
44140878|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140879|NCT00181181|Atorvastatin|atorvastatin|mesh-list
44140880|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44140881|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44140882|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
44140883|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140884|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44140885|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44140886|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140887|NCT00181220|Valproic Acid|valproic acid|mesh-list
44140888|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
44140889|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140890|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140891|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
44140892|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140893|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140894|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
44140895|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140896|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44140897|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44140898|NCT00181246|Fentanyl|fentanyl|mesh-list
44140899|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44140900|NCT00181246|Narcotics|narcotics|mesh-ancestor
44140901|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941893|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941894|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43941895|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
43941896|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941897|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43941898|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
43941899|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
43941900|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
43941901|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43941902|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43941903|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43941904|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
43941905|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43941906|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941907|NCT00974142|Cyclosporine|cyclosporine|mesh-list
43941908|NCT00974142|Cyclosporins|cyclosporins|mesh-list
43941909|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43941910|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43941911|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43941912|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
43941913|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941914|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
43941915|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941916|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
43941917|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43941918|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43941919|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43941920|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43941921|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
43941922|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941923|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941924|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43941925|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
43941930|NCT00974350|Bupivacaine|bupivacaine|mesh-list
43941932|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
43941933|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941934|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941935|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
43941936|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941937|NCT00974376|Gabapentin|gabapentin|mesh-list
43941938|NCT00974376|Analgesics|analgesics|mesh-ancestor
43941939|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
43941940|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43941941|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941942|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
43941943|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43941944|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43941945|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43941946|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43941947|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43941991|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43941993|NCT00976404|Maraviroc|maraviroc|mesh-list
43941994|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43941995|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43941996|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
43767365|NCT02402543|Ketamine|ketamine|mesh-list
43941997|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43941998|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43941999|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43942000|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942001|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942002|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43942003|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43942004|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43942005|NCT00976521|Abciximab|abciximab|mesh-list
43942006|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
43942007|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43942008|NCT00976599|Methotrexate|methotrexate|mesh-list
43942009|NCT00976599|Tofacitinib|tofacitinib|mesh-list
43942010|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43942011|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
43942012|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43942013|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942014|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43942015|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
43942016|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942017|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942018|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942019|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942020|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43942021|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942022|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
43942023|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942024|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43942025|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43942026|NCT00977171|Droxidopa|droxidopa|mesh-list
43809162|NCT03154580|Expectorants|expectorants|mesh-ancestor
43942028|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43942030|NCT00977769|Carbetocin|carbetocin|mesh-list
43942031|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
43942032|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43942033|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942034|NCT00979017|Bevacizumab|bevacizumab|mesh-list
43942035|NCT00979017|Irinotecan|irinotecan|mesh-list
43942036|NCT00979017|Temozolomide|temozolomide|mesh-list
43942037|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43942038|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942039|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43942040|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43942041|NCT00979017|Growth Substances|growth substances|mesh-ancestor
43942042|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942043|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
43942044|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43942045|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43942046|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942047|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942048|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942049|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
43942050|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43942051|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43942052|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942053|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
43942059|NCT00979615|Azelastine|azelastine|mesh-list
43942076|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
43942077|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43942078|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
43767373|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
43767399|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
43942079|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43942080|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942081|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
43942082|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43942083|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942084|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
43942085|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942086|NCT00979732|Protective Agents|protective agents|mesh-ancestor
43942087|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942088|NCT00979745|Afamelanotide|afamelanotide|mesh-list
43942089|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942090|NCT00979875|Insulin|insulin|mesh-list
43942091|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43942092|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
43942093|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
43942094|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
43942095|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43942096|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942097|NCT00979940|Atorvastatin|atorvastatin|mesh-list
43942098|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43942099|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942100|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
43942101|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942102|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942123|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942125|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43942126|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942127|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942128|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942129|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942130|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43942131|NCT00981045|Hematinics|hematinics|mesh-ancestor
43942132|NCT00981214|Pancrelipase|pancrelipase|mesh-list
43942133|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942134|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43942135|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
43942136|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43942137|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43942138|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942139|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942140|NCT00981435|Prednisolone|prednisolone|mesh-list
43942141|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
43942142|NCT00981435|Ketorolac|ketorolac|mesh-list
43942143|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
43942144|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942145|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
43942146|NCT00981435|Hormones|hormones|mesh-ancestor
43942147|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942148|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942149|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43942150|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942151|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942152|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43942153|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43942154|NCT00981435|Analgesics|analgesics|mesh-ancestor
43942155|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
43942156|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942157|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43942158|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942161|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43942162|NCT00981669|Vaccines|vaccines|mesh-list
43942163|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
43942164|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942165|NCT00981825|Listerine|listerine|mesh-list
43942166|NCT00981825|Triclosan|triclosan|mesh-list
43942167|NCT00981825|Fluorides|fluorides|mesh-list
43942168|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
43942169|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
43942170|NCT00981825|Protective Agents|protective agents|mesh-ancestor
43942171|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942172|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43942173|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942174|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43942175|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942176|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
43942177|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942178|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942179|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
43942180|NCT00982007|Hematinics|hematinics|mesh-ancestor
43942181|NCT00982072|Prednisolone|prednisolone|mesh-list
43942182|NCT00982072|Tacrolimus|tacrolimus|mesh-list
43942183|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942184|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
43942185|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942186|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43684530|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
43942187|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942188|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942189|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942190|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
43942191|NCT00982072|Hormones|hormones|mesh-ancestor
43942204|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43942205|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942206|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942207|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43942208|NCT00982189|Protective Agents|protective agents|mesh-ancestor
43942209|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942210|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43942211|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
43942212|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43942213|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43942214|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43942215|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942216|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942217|NCT00982423|Furosemide|furosemide|mesh-list
43942218|NCT00982423|Diuretics|diuretics|mesh-ancestor
43942219|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
43942220|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942221|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43942222|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942223|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942224|NCT00982553|Ribavirin|ribavirin|mesh-list
43942225|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
43942226|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
43942227|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942228|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
43942229|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942230|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942231|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942232|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43942233|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43942234|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942235|NCT00982592|Leucovorin|leucovorin|mesh-list
43942236|NCT00982592|Fluorouracil|fluorouracil|mesh-list
43942237|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
43942238|NCT00982592|Calcium|calcium|mesh-list
43942243|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942244|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43942245|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942246|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942247|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
43753399|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
43942249|NCT00982592|Protective Agents|protective agents|mesh-ancestor
43942250|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
43942251|NCT00982592|Vitamins|vitamins|mesh-ancestor
43942252|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
43942253|NCT00982865|Niacinamide|niacinamide|mesh-list
43942254|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
43942255|NCT00982865|Vitamins|vitamins|mesh-ancestor
43942256|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
43942257|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942258|NCT00983216|Ketoconazole|ketoconazole|mesh-list
43942259|NCT00983216|Colchicine|colchicine|mesh-list
43942260|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
43942261|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942262|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
43684611|NCT02840994|Nivolumab|nivolumab|mesh-list
43942263|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942264|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942265|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942266|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942267|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
43942268|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942269|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43942270|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43942271|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942272|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43942273|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
43942274|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942275|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942276|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43942277|NCT00983242|Colchicine|colchicine|mesh-list
43942282|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942283|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942284|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942285|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942286|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942287|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43942288|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942289|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43942290|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942291|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
43942292|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43942293|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942294|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43942295|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942296|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942297|NCT00983346|Bortezomib|bortezomib|mesh-list
43942298|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942299|NCT00983541|Gemcitabine|gemcitabine|mesh-list
43942300|NCT00983541|Fluorouracil|fluorouracil|mesh-list
43942301|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43942302|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
43942303|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942304|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942305|NCT00983541|Antiviral Agents|antiviral agents|mesh-ancestor
43942306|NCT00983541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942307|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942308|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942309|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
43942310|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942311|NCT00984139|Vaccines|vaccines|mesh-list
43942312|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
43942313|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942314|NCT00984334|Naloxone|naloxone|mesh-list
43942315|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43942317|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
43942321|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43942322|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43942323|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942324|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942325|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942326|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942327|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942328|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
43942329|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942330|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43942331|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43942332|NCT00985907|Bortezomib|bortezomib|mesh-list
43942333|NCT00985907|Melphalan|melphalan|mesh-list
43942334|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43942335|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942336|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942337|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
43942338|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942339|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43942340|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942341|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
43942342|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942343|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43942345|NCT00986401|Trospium chloride|trospium chloride|mesh-list
43942346|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43942347|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942348|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
43942349|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
43942350|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942351|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43942352|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43942353|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
43942356|NCT00986401|Urological Agents|urological agents|mesh-ancestor
43942362|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942364|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43942365|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942366|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43942367|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942368|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942369|NCT00987415|Allopurinol|allopurinol|mesh-list
43942370|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
43942371|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942372|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942373|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
43942374|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942375|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43942377|NCT00987415|Protective Agents|protective agents|mesh-ancestor
43942378|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942379|NCT00987480|Cyclosporine|cyclosporine|mesh-list
43942380|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
43942381|NCT00987480|Busulfan|busulfan|mesh-list
43942382|NCT00987480|Fludarabine|fludarabine|mesh-list
43942383|NCT00987480|Cyclosporins|cyclosporins|mesh-list
43942384|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942385|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
43942386|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942387|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942388|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942389|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
43942390|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942391|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942392|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43942393|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942394|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
43942395|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942396|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942404|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942405|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43942406|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942407|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
43942408|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43942409|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43942410|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942411|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43942412|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
43942413|NCT00987727|Glycerol|glycerol|mesh-list
43942414|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43942415|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
43942416|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942417|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
43942418|NCT00987727|Protective Agents|protective agents|mesh-ancestor
43942419|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43942420|NCT00987727|Laxatives|laxatives|mesh-ancestor
43942421|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942422|NCT00987948|Maraviroc|maraviroc|mesh-list
43942423|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43942424|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43942425|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942426|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942427|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942428|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
43942429|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942430|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44140921|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44140922|NCT00181532|Celecoxib|celecoxib|mesh-list
44140923|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44140924|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44140925|NCT00181532|Analgesics|analgesics|mesh-ancestor
44140926|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
44140927|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140928|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140929|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140930|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44140931|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44140932|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44140933|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140934|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140935|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
44140936|NCT00181558|Atrasentan|atrasentan|mesh-list
44140937|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44140938|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140939|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942462|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43942463|NCT00989586|Veltuzumab|veltuzumab|mesh-list
43942464|NCT00989586|Antibodies|antibodies|mesh-list
43942465|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
43942466|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43942467|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
43942468|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942469|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942470|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
43942471|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43942472|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43942473|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43942474|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942475|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942476|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
43942477|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942478|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942479|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43942480|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942482|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942483|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43942484|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942485|NCT00989989|Ranibizumab|ranibizumab|mesh-list
43942486|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43942487|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43942488|NCT00989989|Growth Substances|growth substances|mesh-ancestor
43942489|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942490|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
43942491|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942492|NCT00990236|Enoxaparin|enoxaparin|mesh-list
43942508|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942509|NCT00990769|Anesthetics|anesthetics|mesh-list
43942510|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942511|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942512|NCT00991029|Clopidogrel|clopidogrel|mesh-list
43753558|NCT02483715|Amoxicillin|amoxicillin|mesh-list
43942513|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43942514|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43942515|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43942516|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43684883|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
43942517|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
43942518|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942519|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942520|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942523|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43942524|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
43942525|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942526|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942527|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43942528|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43942529|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
43942530|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942531|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942532|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43942533|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
43942534|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43942535|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43942536|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43942537|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43942538|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
43942547|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942548|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
43942549|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942550|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
43942551|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942552|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942553|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942554|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43942555|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43942558|NCT00991809|Alfentanil|alfentanil|mesh-list
43942559|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43942560|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43942561|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942562|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942563|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
43942564|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
43942565|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
43942566|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942567|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
43942568|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
43942569|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942570|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43942571|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
43942572|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
43942573|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942574|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942575|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43942576|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
43942577|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942578|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43942579|NCT00991809|Narcotics|narcotics|mesh-ancestor
43942580|NCT00991809|Analgesics|analgesics|mesh-ancestor
43942581|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43942582|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
43942589|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43942590|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
43942591|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942592|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942593|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942594|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942595|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43942596|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942597|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
43942598|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942599|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43942600|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
43942601|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942602|NCT00993187|Metformin|metformin|mesh-list
43942603|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43942604|NCT00993187|Glimepiride|glimepiride|mesh-list
43942605|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43942606|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942607|NCT00993187|Incretins|incretins|mesh-ancestor
43942608|NCT00993187|Hormones|hormones|mesh-ancestor
43942609|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942610|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43942642|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43942643|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43942644|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43942645|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
43942646|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942647|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43942648|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43942649|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942650|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43942651|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942652|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942653|NCT00994175|Pioglitazone|pioglitazone|mesh-list
43942654|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43942655|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942656|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
43942657|NCT00994318|Hematinics|hematinics|mesh-ancestor
43942658|NCT00994760|Fentanyl|fentanyl|mesh-list
43942659|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43942660|NCT00994760|Narcotics|narcotics|mesh-ancestor
43942661|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942662|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942663|NCT00994760|Analgesics|analgesics|mesh-ancestor
43942664|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
43942665|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942666|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43942667|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43942668|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
43942669|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
43942689|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43942690|NCT00995475|Fluticasone|fluticasone|mesh-list
43942691|NCT00995475|Xhance|xhance|mesh-list
43942692|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942693|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43942694|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
43942695|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942696|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942697|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43942698|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
43942699|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
43942700|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43942701|NCT00995501|Insulin|insulin|mesh-list
43942702|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43942703|NCT00995501|Dexamethasone|dexamethasone|mesh-list
43942704|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
43942705|NCT00995501|Anesthetics|anesthetics|mesh-list
43942706|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
43942707|NCT00995501|BB 1101|bb 1101|mesh-list
43942709|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942710|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942711|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
43942712|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
43942713|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942714|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43942715|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
43942716|NCT00995501|Hormones|hormones|mesh-ancestor
43942717|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942718|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43942719|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942720|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942721|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942722|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942723|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942732|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942733|NCT00995761|Cisplatin|cisplatin|mesh-list
43942734|NCT00995761|Docetaxel|docetaxel|mesh-list
43942735|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942736|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
43942737|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942738|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942739|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942740|NCT00996346|Sirolimus|sirolimus|mesh-list
43942741|NCT00996346|Irinotecan|irinotecan|mesh-list
43942742|NCT00996346|Complement Factor H|complement factor h|mesh-list
43942743|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43942744|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43942745|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942746|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685038|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
43942747|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942748|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43942749|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942750|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43942751|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
43942752|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942753|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
43942754|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942755|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43942756|NCT00996931|Lenalidomide|lenalidomide|mesh-list
43942757|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
43942758|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942759|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43942760|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43942761|NCT00996931|Growth Substances|growth substances|mesh-ancestor
43942762|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
43942776|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942777|NCT00997139|Polymyxins|polymyxins|mesh-list
43942778|NCT00997139|Neomycin|neomycin|mesh-list
43942779|NCT00997139|Bacitracin|bacitracin|mesh-list
43942780|NCT00997139|Polymyxin B|polymyxin b|mesh-list
43942781|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
43942782|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43942783|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942784|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43942785|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942786|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942787|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43942788|NCT00997204|Icatibant|icatibant|mesh-list
43942789|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43942790|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43942791|NCT00997204|Analgesics|analgesics|mesh-ancestor
43942792|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
43942793|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942794|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942795|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942796|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942797|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43942798|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43942799|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942800|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43942801|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942802|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
43942820|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44140956|NCT00181597|Trilostane|trilostane|mesh-list
43942821|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43942822|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767413|NCT02401971|Irinotecan|irinotecan|mesh-list
43767415|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43942823|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
43942824|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
43942825|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43942826|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942827|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43942828|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43942829|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43942830|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43942831|NCT00998010|Temozolomide|temozolomide|mesh-list
43942832|NCT00998010|Bortezomib|bortezomib|mesh-list
43942833|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942834|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
43942835|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942836|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942837|NCT00998049|Plerixafor|plerixafor|mesh-list
43942838|NCT00998049|Lenograstim|lenograstim|mesh-list
43942839|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43942840|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
43942841|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942842|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942843|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942844|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
43942845|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942846|NCT00998205|Atropine|atropine|mesh-list
43942866|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43942867|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43942868|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
43942869|NCT00998205|Protective Agents|protective agents|mesh-ancestor
43942870|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
43942871|NCT00998426|Antibodies|antibodies|mesh-list
43942872|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
43942873|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43942874|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43942875|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
43942876|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
43942877|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942878|NCT00998582|Tenofovir|tenofovir|mesh-list
43942879|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
43942880|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942881|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43942882|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43942883|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942884|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942885|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942886|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942887|NCT00999037|Sevelamer|sevelamer|mesh-list
43942888|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
43942889|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
43942890|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942891|NCT00999102|Metoprolol|metoprolol|mesh-list
43942892|NCT00999102|Nebivolol|nebivolol|mesh-list
43942893|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43942894|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942895|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
43942896|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
43942913|NCT01000285|Etoposide|etoposide|mesh-list
43942914|NCT01000285|Vincristine|vincristine|mesh-list
43942915|NCT01000285|Bortezomib|bortezomib|mesh-list
43942916|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942917|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
43942918|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942919|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43942920|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43942921|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
43942922|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942923|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942924|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43942925|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43942926|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43942927|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43942928|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942929|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942930|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
43942931|NCT01000285|Hormones|hormones|mesh-ancestor
43942932|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43942933|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43942934|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43942935|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
43942936|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942937|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942938|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43942939|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942940|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
43942941|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942942|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43942943|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43942944|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
43942945|NCT01000818|Omeprazole|omeprazole|mesh-list
43942946|NCT01000818|Famotidine|famotidine|mesh-list
43942953|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43942955|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43942956|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43942957|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43942958|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43942959|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
43942960|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
43942961|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942962|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942963|NCT01000987|Varenicline|varenicline|mesh-list
43942964|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43942965|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43942966|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
43942967|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43942968|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942969|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43942970|NCT01001052|Colchicine|colchicine|mesh-list
43942971|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
43942972|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685271|NCT02837198|Dotinurad|dotinurad|mesh-list
43942973|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
43942974|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
43942975|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
43942976|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942977|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43942978|NCT01001195|Bimatoprost|bimatoprost|mesh-list
43942979|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43942980|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43942981|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43942982|NCT01001403|Nafamostat|nafamostat|mesh-list
43942983|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43942984|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43942985|NCT01001403|Analgesics|analgesics|mesh-ancestor
43942986|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
43942987|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43942989|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43942991|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
43942992|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
43942993|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43942994|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43942995|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43942996|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43942997|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43942998|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43942999|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
43943000|NCT01001442|Maytansine|maytansine|mesh-list
43943001|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943002|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943003|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943004|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943005|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943006|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943007|NCT01001559|Norepinephrine|norepinephrine|mesh-list
43943008|NCT01001559|Serotonin|serotonin|mesh-list
43943009|NCT01001559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43943010|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
43943011|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43943012|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43943013|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943014|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943015|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943016|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943017|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
43943018|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
43943019|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943020|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43943021|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44172544|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172545|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172546|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
44172547|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172548|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44172549|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172550|NCT00289510|Vaccines|vaccines|mesh-list
44172551|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
44172552|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172553|NCT00289588|Mupirocin|mupirocin|mesh-list
43943022|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
43943023|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43943024|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943025|NCT01001806|Ketorolac|ketorolac|mesh-list
43943026|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43943027|NCT01001806|Nepafenac|nepafenac|mesh-list
43943028|NCT01001806|Bromfenac|bromfenac|mesh-list
43943029|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43943030|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43943031|NCT01001806|Analgesics|analgesics|mesh-ancestor
43943032|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
43943033|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943034|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943035|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943036|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943037|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43943038|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943039|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943040|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
43943041|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43943042|NCT01001975|Protective Agents|protective agents|mesh-ancestor
43943043|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943044|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
43943045|NCT01002755|Lenalidomide|lenalidomide|mesh-list
43943046|NCT01002755|Ofatumumab|ofatumumab|mesh-list
43943047|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43943048|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
43943049|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943050|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943051|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943052|NCT01002755|Growth Substances|growth substances|mesh-ancestor
43943053|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943054|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943056|NCT01003080|Coagulants|coagulants|mesh-ancestor
43943057|NCT01003106|Ranibizumab|ranibizumab|mesh-list
43943058|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943063|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943065|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43943066|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43943067|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
43943068|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43943069|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
43943070|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140957|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44140958|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44140959|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
44140960|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44140961|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140962|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44140963|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140964|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140965|NCT00181636|Galantamine|galantamine|mesh-list
44140966|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44140967|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44140968|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44140969|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
44140970|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44140971|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140972|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44140973|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
44140974|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140994|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44140995|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44140996|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
44140997|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44140998|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
44140999|NCT00181688|Anastrozole|anastrozole|mesh-list
44141000|NCT00181688|Gefitinib|gefitinib|mesh-list
44141001|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141002|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141003|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44141004|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44141005|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141006|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141007|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43943071|NCT01003769|Acetic Acid|acetic acid|mesh-list
43943072|NCT01003769|Lenalidomide|lenalidomide|mesh-list
43943073|NCT01003769|Retinol acetate|retinol acetate|mesh-list
43943074|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
43943075|NCT01003769|Gossypol|gossypol|mesh-list
43943076|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
43943077|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943078|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943079|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943080|NCT01003769|Growth Substances|growth substances|mesh-ancestor
43943081|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943082|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943083|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943084|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943085|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43943086|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43943087|NCT01003769|Protective Agents|protective agents|mesh-ancestor
43943088|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43943089|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
43943090|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43943099|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943100|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943101|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43943102|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943103|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
43943104|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43943105|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43943106|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43943107|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943108|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943109|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
43943110|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943111|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943112|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43943113|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943114|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
43943115|NCT01004354|Vitamin D|vitamin d|mesh-list
43943116|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43943117|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943118|NCT01004354|Vitamins|vitamins|mesh-ancestor
43943119|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
43943120|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43943121|NCT01004393|Bromides|bromides|mesh-list
43943122|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
43943123|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
43943124|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43943125|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943126|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
43943127|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943128|NCT01004705|Aspirin|aspirin|mesh-list
43943129|NCT01004705|Ramipril|ramipril|mesh-list
43943130|NCT01004705|Simvastatin|simvastatin|mesh-list
43943131|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43943132|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43943133|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
44172554|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172555|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172556|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44172557|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172558|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943134|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943136|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43943137|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943138|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43943139|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43943140|NCT01004705|Analgesics|analgesics|mesh-ancestor
43943141|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
43943142|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943143|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943144|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943145|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943146|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43943147|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43943148|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43943149|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43943150|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
43943151|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43943152|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943153|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943154|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
43943155|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43943156|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43943157|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943158|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
43943159|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
43943160|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943161|NCT01004744|Anastrozole|anastrozole|mesh-list
43943162|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43943163|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943164|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43943165|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43943166|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943167|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943169|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
43943170|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943171|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943172|NCT01004939|PENTA|penta|mesh-list
43943173|NCT01004939|Fondaparinux|fondaparinux|mesh-list
43943174|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43943175|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
43943176|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43943177|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943178|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943179|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943180|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
43943181|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43943182|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43943183|NCT01004991|Prednisone|prednisone|mesh-list
43943184|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
43943185|NCT01004991|Rituximab|rituximab|mesh-list
43943186|NCT01004991|Doxorubicin|doxorubicin|mesh-list
43943187|NCT01004991|Vincristine|vincristine|mesh-list
43943188|NCT01004991|Azacitidine|azacitidine|mesh-list
43943189|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943190|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
43943191|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943192|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943193|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943194|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
43943195|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943196|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943197|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43943198|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943199|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943200|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43943201|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943202|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943203|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943204|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
43943205|NCT01004991|Hormones|hormones|mesh-ancestor
43810168|NCT04864366|Tenofovir|tenofovir|mesh-list
43943206|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943207|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43943208|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943209|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943210|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943211|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943212|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943213|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
43943214|NCT01005290|Ramipril|ramipril|mesh-list
43943215|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43943216|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943217|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943218|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943219|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943221|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943222|NCT01005407|Vaccines|vaccines|mesh-list
43943264|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943265|NCT01005810|Expectorants|expectorants|mesh-ancestor
43943266|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
43943267|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43943268|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
43573065|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943269|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943270|NCT01005810|Protective Agents|protective agents|mesh-ancestor
43943271|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943272|NCT01005810|Antidotes|antidotes|mesh-ancestor
43943273|NCT01005888|Complement C1s|complement c1s|mesh-list
43943274|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43943327|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43943328|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943329|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943330|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43943331|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943332|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43943333|NCT01008059|Alfentanil|alfentanil|mesh-list
43943334|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43943335|NCT01008059|Narcotics|narcotics|mesh-ancestor
43943336|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943337|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943338|NCT01008059|Analgesics|analgesics|mesh-ancestor
43943339|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
43943340|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943341|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43943342|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
43943343|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
43943344|NCT01008280|Baclofen|baclofen|mesh-list
43943345|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43943346|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943347|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43943348|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943349|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43943350|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
43943351|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
43943352|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943353|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943354|NCT01008319|Citric Acid|citric acid|mesh-list
44172559|NCT00289601|Eptifibatide|eptifibatide|mesh-list
44172560|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44172561|NCT00289627|Ipilimumab|ipilimumab|mesh-list
44172562|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44172563|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172564|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44172565|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172566|NCT00289809|Ifosfamide|ifosfamide|mesh-list
44172567|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172568|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
44172569|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172570|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172571|NCT00289835|Paclitaxel|paclitaxel|mesh-list
44172572|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44172573|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172574|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172575|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172576|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943355|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
43943356|NCT01008319|Clomiphene|clomiphene|mesh-list
43943357|NCT01008319|Enclomiphene|enclomiphene|mesh-list
43943358|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
43943359|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
43943360|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43943361|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
43943362|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
43943363|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943364|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43943365|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
43943366|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943367|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943368|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43754097|NCT02480400|Dexetimide|dexetimide|mesh-list
43943369|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
43943370|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44141008|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
43943371|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43943372|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43943373|NCT01008462|Cytarabine|cytarabine|mesh-list
43943374|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
43943375|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
43943376|NCT01008462|Melphalan|melphalan|mesh-list
43943377|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
43943378|NCT01008462|Carmustine|carmustine|mesh-list
43943379|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43943380|NCT01008462|Fludarabine|fludarabine|mesh-list
43943381|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
43943382|NCT01008462|Etoposide|etoposide|mesh-list
43943383|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
43943385|NCT01008462|Tacrolimus|tacrolimus|mesh-list
43943402|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943403|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43943404|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943405|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43943406|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
43943407|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943408|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
43943409|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
43943410|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943411|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943412|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943413|NCT01009619|Azithromycin|azithromycin|mesh-list
43943414|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943415|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943416|NCT01009918|Carvedilol|carvedilol|mesh-list
43943417|NCT01009918|Lisinopril|lisinopril|mesh-list
43943418|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43943419|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43943420|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943421|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943422|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943423|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943424|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943425|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
43943426|NCT01009918|Protective Agents|protective agents|mesh-ancestor
43943427|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43943428|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943429|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43943430|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
43943431|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43943432|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43943433|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43943434|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943435|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172577|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172578|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172579|NCT00289861|Risperidone|risperidone|mesh-list
44172580|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44172581|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
44172582|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943437|NCT01010009|Resveratrol|resveratrol|mesh-list
43943438|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
43943439|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943440|NCT01010009|Protective Agents|protective agents|mesh-ancestor
43943441|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943442|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943443|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43943444|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43943445|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
43943446|NCT01010282|Glycerol|glycerol|mesh-list
43943447|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43943448|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43943449|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43943450|NCT01010282|Protective Agents|protective agents|mesh-ancestor
43943451|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943453|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43943454|NCT01010399|Ritonavir|ritonavir|mesh-list
43943455|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
43943456|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43943457|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43943458|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
43943459|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943460|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943461|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43943462|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43943463|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
43943485|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943486|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43943487|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
43943488|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
43943489|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943490|NCT01010984|Doxorubicin|doxorubicin|mesh-list
43943491|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43943492|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943493|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43943494|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943495|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943496|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943498|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
43943499|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943500|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943501|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943502|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943503|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943504|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943505|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43943533|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
43943534|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943535|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943536|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943537|NCT01011894|Lenalidomide|lenalidomide|mesh-list
43943538|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
43943539|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943540|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943541|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943542|NCT01011894|Growth Substances|growth substances|mesh-ancestor
43943543|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943544|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943545|NCT01012089|Daptomycin|daptomycin|mesh-list
43943546|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943547|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943548|NCT01012297|Gemcitabine|gemcitabine|mesh-list
43943549|NCT01012297|Bevacizumab|bevacizumab|mesh-list
43943550|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43943551|NCT01012297|Docetaxel|docetaxel|mesh-list
43943552|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
43943553|NCT01012297|Antibodies|antibodies|mesh-list
43943554|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
43573132|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573133|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43573134|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43943555|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43943556|NCT01012297|Lenograstim|lenograstim|mesh-list
43943557|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
43943558|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943559|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943577|NCT01012336|Aprepitant|aprepitant|mesh-list
43943583|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943584|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43943585|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
43943586|NCT01012336|Hormones|hormones|mesh-ancestor
43943587|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943588|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43943589|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943590|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43943591|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943592|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943593|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43943594|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
43943595|NCT01012492|Abatacept|abatacept|mesh-list
43943596|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43943597|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943598|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943599|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943601|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943602|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943603|NCT01012661|Lidocaine|lidocaine|mesh-list
43943604|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
43943605|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
43943606|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943607|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943608|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
43943609|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943610|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43943611|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43943612|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43943613|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943616|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
43943624|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943625|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943626|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943627|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943628|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943629|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
43943630|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943631|NCT01014403|Enoxaparin|enoxaparin|mesh-list
43943632|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
43943633|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43943634|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43943635|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943636|NCT01014728|Propofol|propofol|mesh-list
43943637|NCT01014728|Sevoflurane|sevoflurane|mesh-list
43943638|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43943639|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943640|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943641|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43943642|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
43943643|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
43943644|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43943645|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43943646|NCT01014741|Ibutilide|ibutilide|mesh-list
43943647|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43943648|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
43943649|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43943650|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43943659|NCT01015170|Bupropion|bupropion|mesh-list
43943668|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943669|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943670|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43943671|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43943672|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943674|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943675|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
43943676|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943677|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943678|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943679|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
43943680|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943681|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943682|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43943683|NCT01015534|Temozolomide|temozolomide|mesh-list
43943684|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43943685|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
43943686|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943687|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943688|NCT01015586|Lamotrigine|lamotrigine|mesh-list
43943689|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
43943690|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43943691|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943692|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943693|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43943694|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943695|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43943696|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43943697|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43943698|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43943699|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43943700|NCT01015807|Clonidine|clonidine|mesh-list
43943701|NCT01015807|Bupivacaine|bupivacaine|mesh-list
43943703|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
43943706|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
43943707|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943708|NCT01015807|Analgesics|analgesics|mesh-ancestor
43943709|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43943710|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
43943711|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
43943712|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43943713|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43943714|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43943715|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943716|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943717|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943718|NCT01016483|Gemcitabine|gemcitabine|mesh-list
43943719|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943720|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
43943721|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943765|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943766|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943767|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141009|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141010|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141011|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44141012|NCT00181727|Valproic Acid|valproic acid|mesh-list
44141013|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
44141014|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141015|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141016|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
44141017|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141018|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141019|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
44141020|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141021|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141022|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141023|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44141024|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44141025|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141026|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141027|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141028|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
44141029|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141030|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141048|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44141050|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44141051|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141052|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141053|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43685988|NCT02831933|Valacyclovir|valacyclovir|mesh-list
43943768|NCT01017003|Colchicine|colchicine|mesh-list
43943769|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
43943770|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943771|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943772|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943773|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943774|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943775|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943776|NCT01017042|Colchicine|colchicine|mesh-list
43943777|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
43943778|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943779|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943780|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943781|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943782|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943783|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943784|NCT01017237|Midazolam|midazolam|mesh-list
43943785|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
43943813|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943814|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943815|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943816|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943817|NCT01017250|Growth Substances|growth substances|mesh-ancestor
43943818|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943819|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943820|NCT01017653|Irinotecan|irinotecan|mesh-list
43943821|NCT01017653|Panitumumab|panitumumab|mesh-list
43943822|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43943823|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43943824|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943825|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943826|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943827|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943828|NCT01018056|Riluzole|riluzole|mesh-list
43943829|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
43943830|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43943831|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43943832|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943833|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943834|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943835|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43943836|NCT01018056|Protective Agents|protective agents|mesh-ancestor
43943837|NCT01018095|Metronidazole|metronidazole|mesh-list
43943838|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943839|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43943840|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43943841|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43943842|NCT01018134|Desoximetasone|desoximetasone|mesh-list
43686070|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
43943844|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
43943845|NCT01018134|Hormones|hormones|mesh-ancestor
43943848|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
43943854|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943855|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943856|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943857|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
43943858|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43943859|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943860|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943861|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943862|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43943863|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43943864|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43943865|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43943866|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943867|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
43943868|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43943869|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943870|NCT01020006|Gemcitabine|gemcitabine|mesh-list
43943871|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943872|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
43943873|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943874|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943875|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
43943876|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43943877|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943878|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943879|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
43943902|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
43943903|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43943904|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
43943905|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
43943906|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43943907|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943908|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43943909|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
43943910|NCT05394909|Hormones|hormones|mesh-ancestor
43943911|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43943912|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43943913|NCT05394909|Protective Agents|protective agents|mesh-ancestor
43943914|NCT05394740|Leucovorin|leucovorin|mesh-list
43943915|NCT05394740|Fluorouracil|fluorouracil|mesh-list
43943916|NCT05394740|Capecitabine|capecitabine|mesh-list
43943917|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
43943918|NCT05394740|Nivolumab|nivolumab|mesh-list
43943919|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
43943920|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943921|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43943923|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943924|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
43943925|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943926|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943927|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43943955|NCT05394233|Pemetrexed|pemetrexed|mesh-list
43943956|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943957|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943958|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43943959|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43943960|NCT05394233|Growth Substances|growth substances|mesh-ancestor
43943961|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943962|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
43943963|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943964|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943965|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43943966|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43943968|NCT05388500|Trastuzumab|trastuzumab|mesh-list
43943969|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943970|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943971|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943972|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943973|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
43943974|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943975|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43943976|NCT05388487|Complement Factor H|complement factor h|mesh-list
43943977|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43943978|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43943979|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
43943980|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43943981|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43943982|NCT05386888|Paclitaxel|paclitaxel|mesh-list
43943983|NCT05386888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43943984|NCT05386888|Cisplatin|cisplatin|mesh-list
43943985|NCT05386888|Carboplatin|carboplatin|mesh-list
43943986|NCT05386888|Pemetrexed|pemetrexed|mesh-list
43943987|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43943988|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43943989|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
43943990|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
43943991|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172583|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943992|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43943993|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43943994|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43943995|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141054|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141055|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141056|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141057|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
44141058|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141059|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141060|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44141061|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44141062|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141063|NCT00181870|Carbamazepine|carbamazepine|mesh-list
44141064|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
44141065|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
44141066|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141067|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141068|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141069|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141070|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44141071|NCT00181870|Analgesics|analgesics|mesh-ancestor
44141072|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
44141073|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141074|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44141075|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141076|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141077|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44141078|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44141089|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141090|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44141091|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44141092|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141093|NCT00181922|Ziprasidone|ziprasidone|mesh-list
44141094|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141095|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
44141096|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141097|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141098|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141099|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141100|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141101|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141102|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141103|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44141104|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
44141105|NCT00181935|Olanzapine|olanzapine|mesh-list
44141106|NCT00181935|Risperidone|risperidone|mesh-list
44141107|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44141108|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
44141109|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141110|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141111|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141112|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141113|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141114|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141115|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141116|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43944006|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43944007|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43944008|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944009|NCT05022394|Nivolumab|nivolumab|mesh-list
43944010|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944011|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944012|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43944013|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944014|NCT05017584|Bupivacaine|bupivacaine|mesh-list
43944015|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
43944016|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
43944017|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944018|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944019|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
43944020|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944021|NCT04999332|Leucovorin|leucovorin|mesh-list
43944022|NCT04999332|Docetaxel|docetaxel|mesh-list
43944023|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
43944024|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
43944025|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944026|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
43944027|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
43944028|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944029|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944030|NCT04999332|Antidotes|antidotes|mesh-ancestor
43944031|NCT04999332|Protective Agents|protective agents|mesh-ancestor
43944032|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944033|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
43944034|NCT04999332|Vitamins|vitamins|mesh-ancestor
43944035|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
43944036|NCT04998617|Curcumin|curcumin|mesh-list
43944037|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944038|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944040|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
43944041|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810794|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
44172584|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172585|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172586|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43630811|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944042|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944043|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944044|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944045|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944046|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944047|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944048|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
43944049|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
43944050|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
43944051|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944052|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754477|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
43944053|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
43944054|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944055|NCT04468360|Pregnanolone|pregnanolone|mesh-list
43944056|NCT04468360|Brexanolone|brexanolone|mesh-list
43944057|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
43944058|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944059|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944060|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
43944061|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944062|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944063|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
43944064|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
43944065|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
43944066|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944067|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944068|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43944069|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
43944070|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43686337|NCT02829281|Hormones|hormones|mesh-ancestor
43944071|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944076|NCT04416269|Insulin|insulin|mesh-list
43944085|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944087|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43944088|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43944089|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944090|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
43944091|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944092|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944093|NCT04374903|Sirolimus|sirolimus|mesh-list
43944094|NCT04374903|Azithromycin|azithromycin|mesh-list
43944095|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
43944096|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43944097|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944098|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944099|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944100|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
43944101|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944102|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
43944103|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944104|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
43944105|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43944106|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43944107|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944108|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944109|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944110|NCT04341883|Paclitaxel|paclitaxel|mesh-list
43944111|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44172587|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172588|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172589|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44172590|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
44172591|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44172592|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44172593|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
44172594|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172595|NCT00289952|Valproic Acid|valproic acid|mesh-list
44172596|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
44172597|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172598|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172599|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
44172600|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172612|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172613|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172614|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44172615|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44172616|NCT00290030|Alfuzosin|alfuzosin|mesh-list
43630812|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43944112|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43944113|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944114|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
43944115|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
43944116|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944117|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944119|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
43944120|NCT04320342|Bromides|bromides|mesh-list
43944121|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
43944122|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43944123|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
43944124|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944125|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944126|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43944127|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
43944128|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43944129|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43944130|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43944131|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944132|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944133|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944134|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
43944135|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944136|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
43944137|NCT04320342|Hormones|hormones|mesh-ancestor
43944138|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944139|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43944140|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43944141|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43944142|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
43944143|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43944144|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944145|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844215|NCT04395222|Melphalan|melphalan|mesh-list
44172617|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44172618|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44172619|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44172620|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944146|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
43944148|NCT04225390|Dacarbazine|dacarbazine|mesh-list
43944149|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944150|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
43944151|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944152|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141125|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44141126|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44141127|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141128|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141129|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141130|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
44141131|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141132|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141133|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44141134|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
44141135|NCT00181974|Coagulants|coagulants|mesh-ancestor
44141136|NCT00181987|Methylphenidate|methylphenidate|mesh-list
44141137|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44141138|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141139|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44141140|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141141|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141142|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141143|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
44141144|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141145|NCT00182013|Olanzapine|olanzapine|mesh-list
44141146|NCT00182013|Risperidone|risperidone|mesh-list
44141147|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44141162|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141163|NCT00182013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141164|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141165|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141166|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141167|NCT00182039|Metoprolol|metoprolol|mesh-list
44141168|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44141169|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44141170|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
44141171|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
44141172|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141173|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141174|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44141175|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44141176|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44141177|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
44141178|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141179|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141180|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
44141181|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141182|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141183|NCT00182104|Warfarin|warfarin|mesh-list
44141184|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
44141185|NCT00182143|Heparin|heparin|mesh-list
44141186|NCT00182143|Calcium heparin|calcium heparin|mesh-list
44141187|NCT00182143|Dalteparin|dalteparin|mesh-list
44141188|NCT00182143|Tinzaparin|tinzaparin|mesh-list
44141189|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44141190|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
44141191|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44141192|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43944153|NCT04147416|Propofol|propofol|mesh-list
43944154|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43944155|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944156|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944157|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810898|NCT04851457|Tirofiban|tirofiban|mesh-list
44172621|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172622|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944159|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
43944160|NCT04101838|Vaccines|vaccines|mesh-list
43944161|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
43944162|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944163|NCT04098432|Nivolumab|nivolumab|mesh-list
43944164|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944165|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944166|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43944167|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944168|NCT04021264|Sufentanil|sufentanil|mesh-list
43944169|NCT04021264|Ropivacaine|ropivacaine|mesh-list
43944170|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
43944171|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
43944172|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944173|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944174|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
43944175|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944176|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43944177|NCT04021264|Narcotics|narcotics|mesh-ancestor
43944178|NCT04021264|Analgesics|analgesics|mesh-ancestor
43944179|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43944180|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43944181|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
43944182|NCT04005716|Cisplatin|cisplatin|mesh-list
43944183|NCT04005716|Carboplatin|carboplatin|mesh-list
43944184|NCT04005716|Etoposide|etoposide|mesh-list
43944185|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
43944209|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944210|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944211|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
43944212|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944213|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
43944214|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
43944215|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944216|NCT03442751|Riboflavin|riboflavin|mesh-list
43944217|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43944218|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43944219|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
43944220|NCT03442751|Vitamins|vitamins|mesh-ancestor
43944221|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
43944222|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944223|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43944224|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944225|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
43944226|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944227|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944228|NCT03404661|Secretin|secretin|mesh-list
43944229|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43944265|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944266|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43944267|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
43944268|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43944269|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43944270|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43944271|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
43944272|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43944273|NCT02847559|Bevacizumab|bevacizumab|mesh-list
43944274|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43944275|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
43944276|NCT02847559|Antibodies|antibodies|mesh-list
43944277|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
43944278|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43944279|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
43944280|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944281|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43944282|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43944283|NCT02847559|Growth Substances|growth substances|mesh-ancestor
43944284|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944285|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
43944286|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
43944287|NCT02808364|Vaccines|vaccines|mesh-list
43944288|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
43944289|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944314|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43944315|NCT02530697|Protective Agents|protective agents|mesh-ancestor
43944316|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944317|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
43944318|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43944320|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
43944321|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944322|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944323|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43944324|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43944325|NCT02466074|Acetazolamide|acetazolamide|mesh-list
43944326|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
43944327|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43944328|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944329|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944330|NCT02466074|Diuretics|diuretics|mesh-ancestor
43944331|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
43944332|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944333|NCT02406222|Dexamethasone|dexamethasone|mesh-list
43944334|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
43944335|NCT02406222|Pomalidomide|pomalidomide|mesh-list
43944336|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944337|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
43754664|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43944338|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944339|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944340|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944341|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
43944342|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944343|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944344|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43944345|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944347|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
43944348|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944355|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43944356|NCT02406222|Growth Substances|growth substances|mesh-ancestor
43944357|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
44141193|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141194|NCT00182169|Hormones|hormones|mesh-list
44141195|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141196|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141197|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
44141198|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44141199|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141200|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141201|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
44141202|NCT00182221|Coagulants|coagulants|mesh-ancestor
44141203|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44141204|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141205|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141206|NCT00182312|Caffeine|caffeine|mesh-list
44141207|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
44141208|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944385|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43944386|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43944387|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944388|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
43944389|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43944390|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43944391|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43944392|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
43944393|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944394|NCT02000596|Trastuzumab|trastuzumab|mesh-list
43944396|NCT02000596|Fulvestrant|fulvestrant|mesh-list
43944397|NCT02000596|Anastrozole|anastrozole|mesh-list
43944398|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944399|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944400|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43944401|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43944402|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43944403|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
43944404|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944405|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944406|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43944407|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43944408|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944409|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944410|NCT01884922|Vinblastine|vinblastine|mesh-list
43944411|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43944412|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944413|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
43944414|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
43944415|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944416|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944417|NCT01788020|Dexamethasone|dexamethasone|mesh-list
43944418|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
43944419|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
43944420|NCT01788020|Rituximab|rituximab|mesh-list
44172623|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944421|NCT01788020|Bortezomib|bortezomib|mesh-list
43944422|NCT01788020|BB 1101|bb 1101|mesh-list
43944423|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944424|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
43944425|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944426|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944427|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944428|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
43944429|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944430|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944431|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43944434|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
43944485|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944486|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944487|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944488|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944489|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43944490|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43944491|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944492|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43944493|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43944494|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944495|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
43944496|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
43944497|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
43944498|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43944499|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43944500|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944501|NCT00657241|Valsartan|valsartan|mesh-list
43944502|NCT00657241|Carvedilol|carvedilol|mesh-list
43944503|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43944504|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43944505|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43686609|NCT02826408|Rabeprazole|rabeprazole|mesh-list
43944506|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944507|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43944508|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43944509|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944510|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944511|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944512|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
43944513|NCT00657241|Protective Agents|protective agents|mesh-ancestor
43944514|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43944515|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43944516|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43944517|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
43944518|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43944520|NCT00478465|Valganciclovir|valganciclovir|mesh-list
43944522|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944523|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
43944524|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43944525|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944526|NCT00417664|Midazolam|midazolam|mesh-list
43944527|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
43944528|NCT00417664|Propofol|propofol|mesh-list
43944529|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43944530|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944531|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944532|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43944533|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
43944534|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
43944535|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944536|NCT00417664|Analgesics|analgesics|mesh-ancestor
43944537|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
43944538|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944539|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43944540|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43944541|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43944542|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
43944543|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944544|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944545|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43944546|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43944547|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43944548|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944549|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
43944550|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
43944566|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944567|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43944568|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
43944569|NCT01021761|Ketorolac|ketorolac|mesh-list
43944570|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43944571|NCT01021761|Nepafenac|nepafenac|mesh-list
43944572|NCT01021761|Bromfenac|bromfenac|mesh-list
43944573|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944574|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944575|NCT01021761|Analgesics|analgesics|mesh-ancestor
43944576|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
43944577|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944578|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944579|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944580|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944581|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43944582|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944583|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944584|NCT01022190|Etoricoxib|etoricoxib|mesh-list
43944585|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944586|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944621|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
43944622|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944623|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944624|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944626|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
43944627|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944628|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944629|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944630|NCT01023477|Filaricides|filaricides|mesh-ancestor
43767469|NCT02401425|Letrozole|letrozole|mesh-list
43944631|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
43944632|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
43944633|NCT01023711|Vaccines|vaccines|mesh-list
43944634|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
43944635|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944636|NCT01023724|Ketorolac|ketorolac|mesh-list
43944637|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43944638|NCT01023724|Bromfenac|bromfenac|mesh-list
43944639|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43944640|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944641|NCT01023724|Analgesics|analgesics|mesh-ancestor
43944642|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
43944643|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944644|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944645|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43944646|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944648|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944671|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43944672|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944673|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
43944674|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
43944675|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944676|NCT01024335|Naltrexone|naltrexone|mesh-list
43944677|NCT01024335|Dronabinol|dronabinol|mesh-list
43944678|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43944679|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43944680|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944681|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
43944682|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944683|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
43944684|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944685|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43944686|NCT01024335|Analgesics|analgesics|mesh-ancestor
43944687|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43944688|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43944689|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944690|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944691|NCT01024335|Hormones|hormones|mesh-ancestor
43944692|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944693|NCT01024686|Vaccines|vaccines|mesh-list
43944694|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
43944695|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944696|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
43944697|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43944698|NCT01024738|Triclosan|triclosan|mesh-list
43944699|NCT01024738|Fluorides|fluorides|mesh-list
43944700|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
43944701|NCT01024738|Protective Agents|protective agents|mesh-ancestor
43944702|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944703|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43944704|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944705|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
43944712|NCT01024972|Mannitol|mannitol|mesh-list
43944713|NCT01024972|Dantrolene|dantrolene|mesh-list
43944714|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43944715|NCT01024972|Diuretics|diuretics|mesh-ancestor
43944716|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
43944717|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944718|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43944719|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43944720|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944721|NCT01025427|Tenofovir|tenofovir|mesh-list
43944722|NCT01025427|Emtricitabine|emtricitabine|mesh-list
43944723|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
43944724|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
43944725|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944726|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43944727|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43944728|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944729|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944730|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43944731|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43944732|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43944733|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43944734|NCT01025453|Sirolimus|sirolimus|mesh-list
43944735|NCT01025453|Sorafenib|sorafenib|mesh-list
43944736|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944737|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43944738|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944739|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944740|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43944741|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944742|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944757|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43944758|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43944759|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43944760|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43944761|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
43944762|NCT01026623|Sirolimus|sirolimus|mesh-list
43944763|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43944764|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43944765|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944766|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944767|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944768|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
43944769|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944770|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
43944771|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944818|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944819|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944820|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43944821|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43944822|NCT01027468|Growth Substances|growth substances|mesh-ancestor
43944823|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944824|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
43944825|NCT01027559|Sertraline|sertraline|mesh-list
43944826|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
43944827|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944828|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43944829|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43944830|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43944831|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944832|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944833|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
43944834|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944835|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43944836|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944837|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43944838|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944839|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944840|NCT01027793|Tretinoin|tretinoin|mesh-list
43944841|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944842|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
43944843|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944844|NCT01027806|Montelukast|montelukast|mesh-list
43944845|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43944846|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
43944847|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43944848|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
43754823|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944849|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944850|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844303|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44172624|NCT00290030|Urological Agents|urological agents|mesh-ancestor
44172625|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
44172626|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43944851|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43944852|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43944853|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944854|NCT01027910|Doxorubicin|doxorubicin|mesh-list
43944855|NCT01027910|Abexinostat|abexinostat|mesh-list
43944856|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944857|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944858|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43944859|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43944860|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944861|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944862|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43944863|NCT01028677|Oxytocin|oxytocin|mesh-list
43944864|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
43944865|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43944866|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944867|NCT01028820|Aripiprazole|aripiprazole|mesh-list
43944868|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
43944906|NCT01029054|Growth Substances|growth substances|mesh-ancestor
43944907|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
43944908|NCT01029587|Eculizumab|eculizumab|mesh-list
43944909|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43944910|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944911|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
43944912|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944913|NCT01029730|Rituximab|rituximab|mesh-list
43944914|NCT01029730|Bortezomib|bortezomib|mesh-list
43944915|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43944916|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43944917|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944918|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
43944919|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944920|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944921|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43944922|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
43944923|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944924|NCT01030653|Voriconazole|voriconazole|mesh-list
43944925|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
43944926|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43944927|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43944928|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43944929|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944930|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944931|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43944932|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
43944933|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43944934|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944935|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43944937|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944938|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43944939|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944941|NCT01031043|Bethanechol|bethanechol|mesh-list
43944944|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43944945|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944946|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43944947|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43944948|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
43754890|NCT02476760|Tolazamide|tolazamide|mesh-list
43944949|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944950|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944951|NCT01031420|Doxorubicin|doxorubicin|mesh-list
43944952|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43944953|NCT01031420|Methotrexate|methotrexate|mesh-list
43944954|NCT01031420|Vinblastine|vinblastine|mesh-list
43944955|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43944956|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43944957|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43944958|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43944959|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43944960|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944961|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43944962|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
43944963|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43944964|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43944965|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43944966|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
43944967|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944968|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43944969|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43944970|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
43944971|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43944972|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43944973|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43944974|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43944975|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43944976|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43944984|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
43944985|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
43944986|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43944987|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
43944988|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43944989|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43944990|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43944991|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43944992|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43944993|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944994|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43944995|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43944996|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
43944997|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
43944998|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43944999|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43945000|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945001|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945002|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43945003|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43945004|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945005|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945006|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
43945007|NCT01031953|Aprepitant|aprepitant|mesh-list
43945008|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
43945009|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
43945010|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945011|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945012|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945013|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43945014|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945026|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43945027|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44141216|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141217|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
43945028|NCT01032850|Capecitabine|capecitabine|mesh-list
43945029|NCT01032850|Sorafenib|sorafenib|mesh-list
43945030|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945031|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
43945032|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945033|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945034|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43945035|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945036|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
43945037|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43945038|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945039|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945040|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
43945041|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945042|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945043|NCT01032993|Ubiquinone|ubiquinone|mesh-list
43945044|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
43945045|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
43945046|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945047|NCT01032993|Vitamins|vitamins|mesh-ancestor
43945048|NCT01033773|Metformin|metformin|mesh-list
43945049|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43945050|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945051|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
43945052|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43945053|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945054|NCT05593757|Quinidine|quinidine|mesh-list
43945055|NCT05593757|Verapamil|verapamil|mesh-list
43945056|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43945057|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44172627|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172628|NCT00290069|Sirolimus|sirolimus|mesh-list
44172629|NCT00290069|Tacrolimus|tacrolimus|mesh-list
44172630|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172631|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
44172632|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172633|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43945058|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945059|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945060|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43945061|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945062|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
43945063|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43945064|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43945065|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
43945066|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945067|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
43945068|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43945069|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43945070|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945071|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945072|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43945073|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43945074|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
43945075|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43945076|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43945077|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43945078|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945080|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
43945081|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945082|NCT05593731|Protective Agents|protective agents|mesh-ancestor
43945083|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945084|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945085|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43945086|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
43945087|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945088|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43945099|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
43945100|NCT05593627|Calcium|calcium|mesh-list
43945101|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43945102|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945103|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
43945104|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43945105|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945106|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945107|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
43945108|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43945109|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945110|NCT05593627|Antacids|antacids|mesh-ancestor
43945111|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945112|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
43945113|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945114|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
43945115|NCT05593341|Narcotics|narcotics|mesh-ancestor
43945116|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945117|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945118|NCT05593341|Analgesics|analgesics|mesh-ancestor
43945119|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
43945120|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945121|NCT05592951|Methamphetamine|methamphetamine|mesh-list
43945122|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43945123|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945124|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
43945125|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
43945126|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945127|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
43945128|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945129|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945142|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
43945143|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945144|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945145|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
43945147|NCT05583188|Paclitaxel|paclitaxel|mesh-list
43945148|NCT05583188|Vinorelbine|vinorelbine|mesh-list
43945149|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43945150|NCT05583188|Nivolumab|nivolumab|mesh-list
43945151|NCT05583188|Pemetrexed|pemetrexed|mesh-list
43945152|NCT05583188|Carboplatin|carboplatin|mesh-list
43945153|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43945154|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945155|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
43945156|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
43945157|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
43945158|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945159|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945160|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
43945161|NCT05583188|Antiviral Agents|antiviral agents|mesh-ancestor
43945162|NCT05583188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945163|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945164|NCT05583188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945165|NCT05583188|Immunologic Factors|immunologic factors|mesh-ancestor
43945166|NCT05583188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945167|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945168|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43945169|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43945194|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
43945195|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
43945196|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
43945197|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945198|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945199|NCT05536154|Cytarabine|cytarabine|mesh-list
43945200|NCT05536154|Etoposide|etoposide|mesh-list
43945201|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43945202|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945203|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43945204|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43945205|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945206|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945207|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945208|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
43945209|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
43945210|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945211|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945212|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
43945213|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945214|NCT05530278|Midazolam|midazolam|mesh-list
43945215|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43945216|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43945217|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945218|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945219|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43945220|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43945221|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43945222|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43945223|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
43945224|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
43945225|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
43945226|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
43945227|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945228|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172634|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172635|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141218|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44141219|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141220|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141221|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
44141222|NCT00182351|Coagulants|coagulants|mesh-ancestor
44141223|NCT00182364|Heparin|heparin|mesh-list
44141224|NCT00182364|Calcium heparin|calcium heparin|mesh-list
44141225|NCT00182364|Dalteparin|dalteparin|mesh-list
44141226|NCT00182364|Tinzaparin|tinzaparin|mesh-list
44141227|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44141228|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
44141229|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44141230|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141231|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157491|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44157492|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44157493|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157494|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44157495|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44157496|NCT00234637|Protective Agents|protective agents|mesh-ancestor
44157497|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44157498|NCT00234676|Estrogens|estrogens|mesh-ancestor
44157499|NCT00234676|Hormones|hormones|mesh-ancestor
44157500|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157501|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157502|NCT00234689|Naltrexone|naltrexone|mesh-list
43945229|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43945230|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945257|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945259|NCT05509634|Hormones|hormones|mesh-ancestor
43945260|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945261|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43945262|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945263|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
43945264|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945265|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945266|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43945267|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43945268|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
43945269|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945270|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43945271|NCT05503511|Bumetanide|bumetanide|mesh-list
43945272|NCT05503511|Diuretics|diuretics|mesh-ancestor
43945273|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
43945274|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945275|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43945276|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945277|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945285|NCT05498181|Valsartan|valsartan|mesh-list
43945290|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945291|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
43945292|NCT05463848|Temozolomide|temozolomide|mesh-list
43945293|NCT05463848|Olaparib|olaparib|mesh-list
43945294|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945295|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945296|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43945297|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
43945298|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945299|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43945300|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945301|NCT05461404|Emollients|emollients|mesh-list
43945302|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
43945303|NCT05449535|Omalizumab|omalizumab|mesh-list
43945304|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43945305|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43945306|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
43945307|NCT05427981|Buprenorphine|buprenorphine|mesh-list
43945308|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43945309|NCT05427981|Narcotics|narcotics|mesh-ancestor
43945310|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945311|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945312|NCT05427981|Analgesics|analgesics|mesh-ancestor
43945313|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
43945314|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945315|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43945316|NCT05407675|Nivolumab|nivolumab|mesh-list
43945317|NCT05407675|Ipilimumab|ipilimumab|mesh-list
43945318|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945319|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945320|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43945321|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945322|NCT05402826|Vitamin E|vitamin e|mesh-list
43945323|NCT05402826|Vitamins|vitamins|mesh-ancestor
43945324|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
43945362|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945363|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43945364|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945375|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43945376|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43945377|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43945378|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945379|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945380|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43945381|NCT05307003|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43945382|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43945383|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945384|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945385|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945386|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
43945387|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43945388|NCT05306028|Metformin|metformin|mesh-list
43945389|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43945390|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945391|NCT05276219|Furosemide|furosemide|mesh-list
43945392|NCT05276219|Isosorbide|isosorbide|mesh-list
43945393|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43945394|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43945395|NCT05276219|Diuretics|diuretics|mesh-ancestor
43945396|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
43945397|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945398|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43945399|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945400|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945401|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43945419|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945420|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43945421|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43945422|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945423|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43945424|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945426|NCT05224388|Enoxaparin|enoxaparin|mesh-list
43945427|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
43945428|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43945429|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945430|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945431|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
43945432|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43945433|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945434|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43945435|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945436|NCT05167175|Prednisone|prednisone|mesh-list
43945437|NCT05167175|Olaparib|olaparib|mesh-list
43945438|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
43945439|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945440|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
43945441|NCT05167175|Hormones|hormones|mesh-ancestor
43945471|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43945472|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945473|NCT05135858|Methotrexate|methotrexate|mesh-list
43945474|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43945475|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
43945476|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43945477|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945478|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945479|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
43945480|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945481|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945482|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
43945483|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945484|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43945485|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945486|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
43945487|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945488|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43945490|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945491|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141232|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44141233|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
44141234|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
44141235|NCT00182429|Metronidazole|metronidazole|mesh-list
44141236|NCT00182429|Rifampin|rifampin|mesh-list
44141237|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141238|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44141239|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44141255|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
44141256|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
44141257|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141258|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141259|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141260|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141261|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141262|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141263|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141264|NCT00182442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141265|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141266|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945492|NCT05081375|Enoxaparin|enoxaparin|mesh-list
43945493|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
43945494|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43945495|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945496|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945497|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
43945498|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43945499|NCT05070650|Acetaminophen|acetaminophen|mesh-list
43945500|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
43945501|NCT05070650|Phenylephrine|phenylephrine|mesh-list
43945535|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
43945536|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
43945537|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945538|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945539|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43945540|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
43945541|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43945542|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
43945543|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945544|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945545|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43945546|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
43945547|NCT04960202|Ritonavir|ritonavir|mesh-list
43945548|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43945549|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43945550|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
43945551|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945552|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945553|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43945554|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43945555|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
43945556|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945557|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43945558|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945559|NCT04828031|Vitamin D|vitamin d|mesh-list
43945560|NCT04828031|Vitamins|vitamins|mesh-ancestor
43945561|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
43945562|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945563|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43945564|NCT04817956|Trastuzumab|trastuzumab|mesh-list
43945565|NCT04817956|Pertuzumab|pertuzumab|mesh-list
43945566|NCT04817956|Atezolizumab|atezolizumab|mesh-list
43945567|NCT04817956|Vemurafenib|vemurafenib|mesh-list
43945568|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43945569|NCT04817956|Entrectinib|entrectinib|mesh-list
43945570|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945571|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945574|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43945575|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945576|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945577|NCT04814355|Celecoxib|celecoxib|mesh-list
43945578|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43945579|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43945580|NCT04814355|Analgesics|analgesics|mesh-ancestor
43945581|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
43945582|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945583|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945584|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945585|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945586|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43945587|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43945588|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945589|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945590|NCT04802876|Spartalizumab|spartalizumab|mesh-list
43945591|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43945592|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945593|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945594|NCT04780932|Macitentan|macitentan|mesh-list
43945595|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43945596|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43945597|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945598|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43945599|NCT04780061|Vitamin D|vitamin d|mesh-list
43945600|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
43945619|NCT04727242|Antiviral Agents|antiviral agents|mesh-ancestor
43945620|NCT04727242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945621|NCT04727242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945622|NCT04727242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945623|NCT04727242|Immunologic Factors|immunologic factors|mesh-ancestor
43945624|NCT04727242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945625|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43945626|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
43945627|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43945628|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43945629|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945630|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
43945631|NCT04582383|Doxycycline|doxycycline|mesh-list
43945632|NCT04582383|Spironolactone|spironolactone|mesh-list
43945633|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43945634|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945635|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
43945636|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43945637|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43945638|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43945639|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
43767551|NCT02400879|Sufentanil|sufentanil|mesh-list
43945640|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43945641|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945642|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43945643|NCT04582383|Diuretics|diuretics|mesh-ancestor
43945644|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
43945645|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
43945646|NCT04505878|Vitamins|vitamins|mesh-ancestor
43945647|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
43945648|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945649|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
43945650|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945651|NCT04505878|Protective Agents|protective agents|mesh-ancestor
43945652|NCT04478474|Ganciclovir|ganciclovir|mesh-list
43945653|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43945654|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
43945655|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945658|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945659|NCT04456517|Ranolazine|ranolazine|mesh-list
43945660|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43945661|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43945662|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141267|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141268|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141269|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
44141270|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
44141271|NCT00182455|Topiramate|topiramate|mesh-list
44141272|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
44141273|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141274|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141275|NCT00182494|Metformin|metformin|mesh-list
44141276|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141277|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141278|NCT00182507|Olanzapine|olanzapine|mesh-list
44141279|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
44141317|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
44141318|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141319|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44141320|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141322|NCT00182572|Buprenorphine|buprenorphine|mesh-list
44141323|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44141324|NCT00182572|Narcotics|narcotics|mesh-ancestor
43945663|NCT04433845|Psilocybin|psilocybin|mesh-list
43945664|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
43945665|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945666|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43945667|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
43945668|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43945669|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945670|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945671|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
43945672|NCT04410042|Coagulants|coagulants|mesh-ancestor
43945673|NCT04358133|Morphine|morphine|mesh-list
43945674|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43945675|NCT04358133|Narcotics|narcotics|mesh-ancestor
43945676|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945677|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945678|NCT04358133|Analgesics|analgesics|mesh-ancestor
43945679|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
43945680|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945681|NCT04323748|Rituximab|rituximab|mesh-list
43945682|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43945683|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945684|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
43945685|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945686|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945687|NCT04316910|Anesthetics|anesthetics|mesh-list
43945688|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
43945689|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812069|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
43755510|NCT02473198|Narcotics|narcotics|mesh-ancestor
44172636|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172637|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172638|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172639|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172640|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
44172641|NCT00290082|Midazolam|midazolam|mesh-list
44172642|NCT00290082|Loxapine|loxapine|mesh-list
43945690|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945692|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945693|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43945694|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945695|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945696|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
43945697|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43945698|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
43945699|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43945701|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
43945702|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43945703|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
43945704|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945705|NCT04291209|Protective Agents|protective agents|mesh-ancestor
43945707|NCT04291209|Antidotes|antidotes|mesh-ancestor
43945748|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43945750|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945751|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945752|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43945753|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43945754|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
43945755|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945756|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945757|NCT04130152|Letrozole|letrozole|mesh-list
43945758|NCT04130152|Palbociclib|palbociclib|mesh-list
43945759|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945760|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43945761|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43945769|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
43945808|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
43945809|NCT03913559|Methotrexate|methotrexate|mesh-list
43945810|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43945811|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43945812|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
44157504|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43945813|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43945814|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945815|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945816|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
43945817|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945818|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945819|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
43945820|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945821|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43945822|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43945823|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
43945824|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945825|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43945826|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
43945829|NCT03913559|Analgesics|analgesics|mesh-ancestor
43945862|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945863|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945864|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43945865|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43945866|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43945867|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43945868|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945869|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43945870|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43945871|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43945872|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
43945873|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43945874|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43945875|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43945876|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
43945877|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43945878|NCT03852797|Ketamine|ketamine|mesh-list
43945879|NCT03852797|Propofol|propofol|mesh-list
43945880|NCT03852797|Etomidate|etomidate|mesh-list
43945881|NCT03852797|Oxytocin|oxytocin|mesh-list
43945882|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43945883|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945884|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945885|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43945886|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
43945887|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
43945888|NCT03852797|Analgesics|analgesics|mesh-ancestor
43945889|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
43945890|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945907|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945908|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43945909|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43945911|NCT03850379|Renal Agents|renal agents|mesh-ancestor
43945981|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43945982|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945983|NCT03705559|Analgesics|analgesics|mesh-ancestor
43945984|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
43945985|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43945986|NCT03680508|Antibodies|antibodies|mesh-list
43945987|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
43945988|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
43945989|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945990|NCT03589833|Methotrexate|methotrexate|mesh-list
43945991|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43945992|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
43945993|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43945994|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43945995|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43945996|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
43945997|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43945998|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43945999|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946000|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946001|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43946002|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946003|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
43946004|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946005|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141325|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141326|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141327|NCT00182572|Analgesics|analgesics|mesh-ancestor
44141328|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
44141329|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141342|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141343|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141344|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
44141345|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141346|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141347|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141348|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
44141349|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141350|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141351|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44141352|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44141353|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
44141354|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141355|NCT00182663|Clarithromycin|clarithromycin|mesh-list
44141356|NCT00182663|Thalidomide|thalidomide|mesh-list
44141357|NCT00182663|Dexamethasone|dexamethasone|mesh-list
43687784|NCT02817477|Narcotics|narcotics|mesh-ancestor
43946006|NCT03587311|Paclitaxel|paclitaxel|mesh-list
43946007|NCT03587311|Maytansine|maytansine|mesh-list
43946008|NCT03587311|Bevacizumab|bevacizumab|mesh-list
43946009|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43946010|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43946011|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
43946012|NCT03587311|Antibodies|antibodies|mesh-list
43946013|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
43946014|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43946015|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
43946016|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43946017|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946018|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
43946019|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
43946020|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
43946021|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946022|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43946032|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946033|NCT03520790|Gemcitabine|gemcitabine|mesh-list
43946034|NCT03520790|Paclitaxel|paclitaxel|mesh-list
43946035|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43946036|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946037|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
43946038|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
43946039|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
43946040|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946041|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946042|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
43946043|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
43946044|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946045|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946046|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946047|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
43946048|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946049|NCT03484299|Gemcitabine|gemcitabine|mesh-list
43946050|NCT03484299|Folfirinox|folfirinox|mesh-list
43946051|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946052|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
43946053|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946054|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946055|NCT03484299|Antiviral Agents|antiviral agents|mesh-ancestor
43946056|NCT03484299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946057|NCT03484299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946058|NCT03484299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946059|NCT03484299|Immunologic Factors|immunologic factors|mesh-ancestor
43946060|NCT03484299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946061|NCT03442673|Gemcitabine|gemcitabine|mesh-list
43946062|NCT03442673|Vinorelbine|vinorelbine|mesh-list
43946078|NCT03295487|Hormones|hormones|mesh-ancestor
43946079|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946080|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946081|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43946082|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
43946083|NCT03080974|Nivolumab|nivolumab|mesh-list
43946084|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946085|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946086|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43946087|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946088|NCT03047135|Olaparib|olaparib|mesh-list
43946089|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43946090|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946091|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946092|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946093|NCT03022617|Apremilast|apremilast|mesh-list
43946094|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946095|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946096|NCT03022617|Analgesics|analgesics|mesh-ancestor
43946097|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
43946098|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946099|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946100|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946101|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946102|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43946103|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43946104|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946105|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946106|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
43946107|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946108|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946109|NCT03005444|Enoxaparin|enoxaparin|mesh-list
43946110|NCT03005444|Nadroparin|nadroparin|mesh-list
43946115|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
43946116|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946117|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946118|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
43946119|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43946120|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43946121|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43946122|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43946123|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946124|NCT02973737|Capecitabine|capecitabine|mesh-list
43946125|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946126|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
43946127|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946128|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946129|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
43946130|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946131|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946132|NCT02762669|Oxytocin|oxytocin|mesh-list
43946133|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
43946134|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43946135|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946136|NCT02740868|Xenon|xenon|mesh-list
43946137|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43946138|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
43946139|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
43946140|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946162|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946163|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946164|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
43946165|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946166|NCT02579473|Rotigotine|rotigotine|mesh-list
43946167|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
43946168|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
43946169|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946170|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946171|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946172|NCT02524405|Corticosterone|corticosterone|mesh-list
43946173|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946174|NCT02485184|Propranolol|propranolol|mesh-list
43946175|NCT02485184|Warfarin|warfarin|mesh-list
43946176|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43946177|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
43946178|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43946179|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
43946180|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946181|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946182|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946183|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43946184|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43946185|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
43946186|NCT02430103|Goserelin|goserelin|mesh-list
43946212|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
43946213|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946214|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946215|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
43946216|NCT01842672|Clofarabine|clofarabine|mesh-list
43946217|NCT01842672|Analgesics|analgesics|mesh-ancestor
43946218|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
44141360|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
44141361|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141362|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141363|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141364|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
44141365|NCT00182663|Hormones|hormones|mesh-ancestor
44141366|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141367|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141368|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141369|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44141370|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141371|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44141372|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141373|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141374|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44141375|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43755725|NCT02471963|Empagliflozin|empagliflozin|mesh-list
44141376|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141377|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
44141378|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
44141379|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44141380|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44141381|NCT00182663|Growth Substances|growth substances|mesh-ancestor
44141382|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
44141383|NCT00182702|Epothilones|epothilones|mesh-list
43946280|NCT01035333|Orlistat|orlistat|mesh-list
43946281|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946282|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946283|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43946284|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43946285|NCT01035346|Ibuprofen|ibuprofen|mesh-list
43946296|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946298|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43946299|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43946300|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946301|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43946302|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43946303|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946304|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946305|NCT01035749|Vaccines|vaccines|mesh-list
43946306|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
43946307|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946308|NCT01036802|Warfarin|warfarin|mesh-list
43946309|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
43946310|NCT01037192|Vancomycin|vancomycin|mesh-list
43946311|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946312|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946313|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
43946314|NCT01037452|Lansoprazole|lansoprazole|mesh-list
43946315|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
43946316|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
43946317|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43946318|NCT01037452|Calcium|calcium|mesh-list
43946319|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43946320|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946321|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43946322|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43946323|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946324|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43946325|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946327|NCT01037452|Antacids|antacids|mesh-ancestor
43946341|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946342|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946343|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946344|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
43946345|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43946346|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946347|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946348|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43946349|NCT01039207|Rilotumumab|rilotumumab|mesh-list
43946350|NCT01039207|Antibodies|antibodies|mesh-list
43946351|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
43946352|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43946353|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
43946354|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829031|NCT05453487|Vaccines|vaccines|mesh-list
43946355|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946356|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
43946357|NCT01039792|Vitamins|vitamins|mesh-ancestor
43946358|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
43946359|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946360|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
43946361|NCT01040819|Pioglitazone|pioglitazone|mesh-list
43946362|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43946363|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946364|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43946365|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946366|NCT01041274|Citalopram|citalopram|mesh-list
43946367|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43946368|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43946369|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43946370|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946371|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946372|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
43946373|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946375|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
43946379|NCT01041781|Carboplatin|carboplatin|mesh-list
43946380|NCT01041781|Pemetrexed|pemetrexed|mesh-list
43946381|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946382|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43946383|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
43946384|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946385|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
43946386|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946387|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946388|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946389|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
43946390|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946391|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43946392|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43946393|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946394|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946395|NCT01041781|Analgesics|analgesics|mesh-ancestor
43946396|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
43946397|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946398|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946399|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946400|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43946401|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946402|NCT01042145|Dexamethasone|dexamethasone|mesh-list
43946403|NCT01042145|Prednisone|prednisone|mesh-list
43946404|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946405|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
43946406|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
43946407|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946408|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946409|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946410|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
43946411|NCT01042145|Hormones|hormones|mesh-ancestor
43946412|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946420|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946421|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43946422|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43946423|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946424|NCT01042496|Lamotrigine|lamotrigine|mesh-list
43946425|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
43946426|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43946427|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43946428|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946429|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43946430|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946431|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43946432|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43946433|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946434|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43946435|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43946436|NCT01042509|Rituximab|rituximab|mesh-list
43946437|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
43946438|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946439|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946440|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
43946441|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946442|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946443|NCT01042795|Sunitinib|sunitinib|mesh-list
43946444|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946445|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43946446|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43946447|NCT01042795|Growth Substances|growth substances|mesh-ancestor
43946448|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946449|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
43946450|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43946451|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946452|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946453|NCT01043094|Pitavastatin|pitavastatin|mesh-list
43946454|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43767555|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43946458|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946459|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946460|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43946461|NCT01043393|Desoximetasone|desoximetasone|mesh-list
43946462|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946463|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
43946464|NCT01043393|Hormones|hormones|mesh-ancestor
43946465|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946466|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946467|NCT01043640|Cyclosporine|cyclosporine|mesh-list
43946468|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
43946469|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
43946470|NCT01043640|Busulfan|busulfan|mesh-list
43946471|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
43946472|NCT01043640|Cyclosporins|cyclosporins|mesh-list
43946473|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946474|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
43946475|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946476|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946477|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946478|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
43946479|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946480|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946481|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43946482|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946483|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
43946484|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946485|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946486|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43946487|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43946488|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43946489|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
43946490|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946492|NCT01043926|Suvorexant|suvorexant|mesh-list
43946497|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43946498|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946499|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946500|NCT01044212|Psyllium|psyllium|mesh-list
43946501|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
43946502|NCT01044212|Cathartics|cathartics|mesh-ancestor
43946503|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688209|NCT02813382|Bupivacaine|bupivacaine|mesh-list
43946504|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
43946505|NCT01044264|Clindamycin|clindamycin|mesh-list
43946506|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
43946507|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
43946508|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43946509|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43946510|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946511|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43946512|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946513|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946514|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946515|NCT01044693|Metoprolol|metoprolol|mesh-list
43946516|NCT01044693|Nebivolol|nebivolol|mesh-list
43946517|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
43946518|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43946519|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43946520|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43946521|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946522|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946523|NCT01044693|Urological Agents|urological agents|mesh-ancestor
43946524|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43946525|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43946526|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
43946527|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
43946528|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946533|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
43946538|NCT01044706|Bicalutamide|bicalutamide|mesh-list
43946539|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
43946540|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946541|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946542|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946543|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946544|NCT01044758|Levetiracetam|levetiracetam|mesh-list
43946545|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
43946546|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
43946547|NCT01044771|Tenofovir|tenofovir|mesh-list
43946548|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
43946549|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
43946550|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946551|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43946552|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43946553|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946554|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946555|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43946556|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43946557|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43946558|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43946559|NCT01044862|Letrozole|letrozole|mesh-list
43946560|NCT01044862|Clomiphene|clomiphene|mesh-list
43946561|NCT01044862|Enclomiphene|enclomiphene|mesh-list
43946562|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
43946563|NCT01044862|Hormones|hormones|mesh-list
43946564|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43946565|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43946566|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946567|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946568|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946569|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946570|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43946580|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946581|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
43946582|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946583|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946584|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
43946585|NCT01045122|Propofol|propofol|mesh-list
43946586|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43946587|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946588|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946589|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43946590|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
43946591|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
43946592|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946593|NCT01045122|Analgesics|analgesics|mesh-ancestor
43946594|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
43946595|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946596|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43946597|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43946598|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43946599|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43946600|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946601|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946602|NCT01045551|Apremilast|apremilast|mesh-list
43946603|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946604|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946605|NCT01045551|Analgesics|analgesics|mesh-ancestor
43946606|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
43946607|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946608|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946615|NCT01047189|Clindamycin|clindamycin|mesh-list
43946623|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946624|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946625|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
43946626|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946628|NCT01047241|Ketamine|ketamine|mesh-list
43946629|NCT01047241|Analgesics|analgesics|mesh-ancestor
43946630|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
43946631|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946632|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946633|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43946634|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43946635|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
43946636|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
43946684|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43946685|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
43946686|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946687|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946688|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946689|NCT01049243|Fluocinonide|fluocinonide|mesh-list
43946690|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946691|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
43946692|NCT01049243|Hormones|hormones|mesh-ancestor
43946693|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946694|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946695|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43946696|NCT01049945|Dexamethasone|dexamethasone|mesh-list
43946697|NCT01049945|Lenalidomide|lenalidomide|mesh-list
43946698|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43946699|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946700|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
43946701|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
43946702|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946703|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946704|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946705|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
43946706|NCT01049945|Hormones|hormones|mesh-ancestor
43946707|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946708|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43946709|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946710|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
43946711|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43946712|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43946713|NCT01049945|Growth Substances|growth substances|mesh-ancestor
43946728|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946729|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946730|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43946731|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43946732|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946733|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43946734|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946735|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946736|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
43946737|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
43946738|NCT01050582|Risperidone|risperidone|mesh-list
43946739|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
43946740|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43946741|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
43946742|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946743|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946744|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946745|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43946746|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946747|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43946748|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43946749|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
43946750|NCT01050647|Castor Oil|castor oil|mesh-list
43946751|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43946752|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43946753|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43946754|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946755|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946756|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946757|NCT01050647|Progestins|progestins|mesh-ancestor
43946758|NCT01050647|Hormones|hormones|mesh-ancestor
43946759|NCT01050647|Cathartics|cathartics|mesh-ancestor
43946760|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43946761|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43946762|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43946763|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43946766|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
43946767|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946768|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946769|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43946770|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43946771|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43946772|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43946773|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946774|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43946775|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43946776|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43946777|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946778|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
43946779|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946780|NCT01051570|Prednisone|prednisone|mesh-list
43946781|NCT01051570|Carboplatin|carboplatin|mesh-list
43946782|NCT01051570|Everolimus|everolimus|mesh-list
43946783|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946784|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946785|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
43946786|NCT01051570|Hormones|hormones|mesh-ancestor
43946787|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946792|NCT01051596|Temozolomide|temozolomide|mesh-list
43946816|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946817|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43946818|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946819|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946820|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
43946821|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
44141384|NCT00182702|Epothilone B|epothilone b|mesh-list
44141385|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141386|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141387|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
44141388|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141389|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141391|NCT00182715|Fluorouracil|fluorouracil|mesh-list
44141392|NCT00182715|Capecitabine|capecitabine|mesh-list
44141393|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
44141394|NCT00182715|Cetuximab|cetuximab|mesh-list
44141395|NCT00182715|Calcium|calcium|mesh-list
44141396|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
44141397|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44141398|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141399|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
44141400|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141401|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141402|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141429|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44141430|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141431|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44141432|NCT00182741|Vitamins|vitamins|mesh-ancestor
44141433|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
44141434|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44141435|NCT00182806|Gemcitabine|gemcitabine|mesh-list
44141436|NCT00182806|Irinotecan|irinotecan|mesh-list
44141437|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141438|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
44141439|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141440|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141441|NCT00182806|Antiviral Agents|antiviral agents|mesh-ancestor
43688551|NCT02811055|Aprepitant|aprepitant|mesh-list
43946823|NCT01052701|Abacavir|abacavir|mesh-list
43946824|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
43946825|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946826|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
43946827|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946828|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43946829|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43946830|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946831|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43946832|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43946833|NCT01052831|Naltrexone|naltrexone|mesh-list
43946834|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43946835|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43946836|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946837|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
43946838|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946839|NCT01053000|Tazarotene|tazarotene|mesh-list
43946840|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
43946841|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
43946852|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43946853|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946854|NCT01053507|Naproxen|naproxen|mesh-list
43946855|NCT01053507|Sumatriptan|sumatriptan|mesh-list
43946856|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946857|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946859|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
43946860|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946861|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946862|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946863|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946864|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
43946865|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43946866|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946867|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946868|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43946869|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43946870|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43946871|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
43946872|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946873|NCT01053819|Etanercept|etanercept|mesh-list
43946874|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43946875|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43946876|NCT01053819|Analgesics|analgesics|mesh-ancestor
43946877|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
43946878|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43946879|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946880|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946897|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946899|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946900|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946901|NCT01054742|Ribavirin|ribavirin|mesh-list
43946902|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43946903|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
43946904|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946905|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
43946906|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43946907|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
43946908|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
43946909|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
43946910|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946911|NCT01054768|Protective Agents|protective agents|mesh-ancestor
43946912|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946913|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
43946914|NCT01054768|Vitamins|vitamins|mesh-ancestor
43946915|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
43946916|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
43946917|NCT01054911|Sunitinib|sunitinib|mesh-list
43946918|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946919|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43946920|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43946921|NCT01054911|Growth Substances|growth substances|mesh-ancestor
43946922|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946923|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
43946924|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43946925|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946926|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946927|NCT01055171|Propranolol|propranolol|mesh-list
43946928|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43946929|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43946930|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43946931|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43946932|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946933|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946934|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43946935|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43946936|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
43946938|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
43946939|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946940|NCT01055223|Troglitazone|troglitazone|mesh-list
43946941|NCT01055223|Amiloride|amiloride|mesh-list
43946942|NCT01055223|Spironolactone|spironolactone|mesh-list
43767598|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
43946943|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43946944|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
43946945|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43946946|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946947|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43946948|NCT01055223|Diuretics|diuretics|mesh-ancestor
43946949|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
43946950|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43946951|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43946952|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43946953|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946954|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43946955|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43946956|NCT01055704|Naltrexone|naltrexone|mesh-list
43946957|NCT01055704|Codeine|codeine|mesh-list
43946958|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
43946959|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43946960|NCT01055704|Narcotics|narcotics|mesh-ancestor
43946961|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43946962|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946963|NCT01055704|Analgesics|analgesics|mesh-ancestor
43946979|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43946980|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43946981|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946982|NCT01057017|Panitumumab|panitumumab|mesh-list
43946983|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43946984|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946985|NCT01057225|Thalidomide|thalidomide|mesh-list
43946986|NCT01057225|Dexamethasone|dexamethasone|mesh-list
43946987|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
43946988|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43946989|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
43946990|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43946991|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43946992|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43946993|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
43946994|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43946995|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43946996|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43946997|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43946998|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
43946999|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
43947000|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947001|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947002|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
43947003|NCT01057225|Hormones|hormones|mesh-ancestor
43947004|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947005|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43947006|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
43947007|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947008|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947009|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43947010|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43947011|NCT01057225|Growth Substances|growth substances|mesh-ancestor
43947012|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
43947019|NCT01057381|Morphine|morphine|mesh-list
43947020|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43947021|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947022|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947023|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947024|NCT01057381|Analgesics|analgesics|mesh-ancestor
43947025|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
43947026|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947027|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43947028|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43947029|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43947030|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947031|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947032|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947033|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43947034|NCT01057381|Narcotics|narcotics|mesh-ancestor
43947035|NCT01058239|Rituximab|rituximab|mesh-list
43947036|NCT01058239|Bortezomib|bortezomib|mesh-list
43947037|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947038|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947039|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
43947040|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947041|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947042|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
44172643|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44172644|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44172645|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172646|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172647|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44172648|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172649|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172650|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44172651|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
44172653|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
44172654|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
44172655|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172656|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172657|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172658|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44172659|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
44172660|NCT00290108|Propofol|propofol|mesh-list
44172661|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44172662|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172663|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172664|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44172665|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
44172675|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172677|NCT00290121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43631327|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43947043|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
43947044|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947045|NCT01058941|Protective Agents|protective agents|mesh-ancestor
43947046|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947047|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
43947048|NCT01058941|Vitamins|vitamins|mesh-ancestor
43947049|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
43947050|NCT01058993|Plerixafor|plerixafor|mesh-list
43947051|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947052|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43947053|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
43947054|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947055|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43947056|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947057|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43947058|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947059|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947060|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
43947061|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43947062|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43947063|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
43947064|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947065|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43947066|NCT01059851|Suvorexant|suvorexant|mesh-list
43947067|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43947068|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43947069|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947091|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947092|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947093|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947094|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43947162|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947163|NCT01062165|Caspofungin|caspofungin|mesh-list
43947164|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
43947165|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947166|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947167|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947168|NCT01062230|Bortezomib|bortezomib|mesh-list
43947169|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947170|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
43947171|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43947172|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43947173|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
43767599|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43947174|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947175|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43947176|NCT01062568|Dexamethasone|dexamethasone|mesh-list
43947177|NCT01062568|Cosyntropin|cosyntropin|mesh-list
43947178|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43947179|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43947180|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
43947181|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947182|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
43947183|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
43947184|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947185|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947186|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947187|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
43947188|NCT01062568|Hormones|hormones|mesh-ancestor
43947189|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947190|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43947191|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947192|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813182|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
44172678|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44172679|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172680|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172681|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172682|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
44172683|NCT00290173|Ritodrine|ritodrine|mesh-list
44172684|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
44172685|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
44172686|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172687|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172688|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
43947193|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947194|NCT01063049|Bisacodyl|bisacodyl|mesh-list
43947195|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43947196|NCT01063049|Cathartics|cathartics|mesh-ancestor
43688874|NCT02808611|Propranolol|propranolol|mesh-list
43947197|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947198|NCT01063049|Laxatives|laxatives|mesh-ancestor
43947199|NCT01063075|Carboplatin|carboplatin|mesh-list
43947200|NCT01063075|Cetuximab|cetuximab|mesh-list
43947201|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947202|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947203|NCT01063829|Letermovir|letermovir|mesh-list
43947204|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43947205|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947206|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947207|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947208|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
43947209|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947210|NCT01063907|Bortezomib|bortezomib|mesh-list
43947211|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947212|NCT01064284|Factor VIII|factor viii|mesh-list
43947213|NCT01064284|Coagulants|coagulants|mesh-ancestor
43947214|NCT01064362|Heparin|heparin|mesh-list
43947215|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43947216|NCT01064362|Tinzaparin|tinzaparin|mesh-list
43947217|NCT01064362|Dalteparin|dalteparin|mesh-list
43947218|NCT01064362|PENTA|penta|mesh-list
43947219|NCT01064362|Fondaparinux|fondaparinux|mesh-list
43947220|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
43947221|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44172689|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44172690|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44172691|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44172692|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44172693|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172694|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172695|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172696|NCT00290264|Budesonide|budesonide|mesh-list
44172697|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
44172698|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172699|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44172700|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
44172701|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172702|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172703|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44172704|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
44172705|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
44172706|NCT00290264|Hormones|hormones|mesh-ancestor
44172707|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43631759|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43947222|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43947223|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947224|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43947225|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
43947226|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43947227|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947228|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947229|NCT01064830|Cyclosporine|cyclosporine|mesh-list
43947230|NCT01064830|Cyclosporins|cyclosporins|mesh-list
43947231|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947232|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947233|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947235|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947236|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
43947237|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947238|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947239|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947240|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43947280|NCT01066520|Analgesics|analgesics|mesh-ancestor
43947281|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
43947282|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947283|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947284|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947285|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947286|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43947287|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947288|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947289|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43947290|NCT01066624|Calcium|calcium|mesh-list
43947291|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43947292|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947293|NCT01068873|Ritonavir|ritonavir|mesh-list
43947294|NCT01068873|Lopinavir|lopinavir|mesh-list
43947295|NCT01068873|Maraviroc|maraviroc|mesh-list
43947296|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43947297|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43947298|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947299|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947300|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947301|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947302|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43947303|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
43947304|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947305|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43947306|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947307|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43947308|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43947309|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44141452|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141453|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141454|NCT00182845|Donepezil|donepezil|mesh-list
44141455|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44141456|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141457|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141458|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
44141459|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141460|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141461|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
44141462|NCT00182871|Testosterone|testosterone|mesh-list
44141463|NCT00182871|Androgens|androgens|mesh-ancestor
44141464|NCT00182871|Hormones|hormones|mesh-ancestor
44141465|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141466|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141467|NCT00182884|Donepezil|donepezil|mesh-list
44141468|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44141469|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573987|NCT03521167|Acetaminophen|acetaminophen|mesh-list
44141470|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141471|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
44141472|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141473|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141474|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
44141475|NCT00183001|Vitamin K|vitamin k|mesh-list
44141476|NCT00183001|Vitamins|vitamins|mesh-ancestor
44141477|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
44141478|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141479|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44141480|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141481|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947311|NCT01068964|Bimatoprost|bimatoprost|mesh-list
44172708|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44172709|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44172711|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172712|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172713|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172714|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
44172715|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172716|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172717|NCT00290420|Chloroquine|chloroquine|mesh-list
44172718|NCT00290420|Amebicides|amebicides|mesh-ancestor
44172719|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44172720|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43947312|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43947313|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43947314|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43947315|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43947316|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947317|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947318|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947319|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947320|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43947321|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947323|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
43947324|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
43947325|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947326|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947327|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
43947328|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947329|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43947330|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43947331|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43947332|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43947333|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947334|NCT01069510|Spironolactone|spironolactone|mesh-list
43947335|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43947336|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
43947337|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813265|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
44172721|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172722|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
44172723|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172724|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
44172725|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172726|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44172727|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172728|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172729|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
44172730|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44172731|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44172732|NCT00290602|Prednisolone|prednisolone|mesh-list
44172741|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172742|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
44172743|NCT00290602|Hormones|hormones|mesh-ancestor
44172744|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947338|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947339|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43947341|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
43947342|NCT01070810|Thiamine|thiamine|mesh-list
43947343|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
43947344|NCT01070810|Vitamins|vitamins|mesh-ancestor
43947345|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
43947346|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947347|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43947348|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43947349|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947350|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43947351|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43947352|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43947353|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947354|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
43947355|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947356|NCT01071538|Buprenorphine|buprenorphine|mesh-list
43947357|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43947358|NCT01071538|Narcotics|narcotics|mesh-ancestor
43947359|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947360|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947361|NCT01071538|Analgesics|analgesics|mesh-ancestor
43947362|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
43947363|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947364|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43947365|NCT01072136|Azithromycin|azithromycin|mesh-list
43947366|NCT01072136|Cefixime|cefixime|mesh-list
43947383|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947385|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
43947386|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947387|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43947388|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43947389|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43947390|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947391|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947392|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947393|NCT01072669|Ambrisentan|ambrisentan|mesh-list
43947394|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947395|NCT01072773|Dexamethasone|dexamethasone|mesh-list
43947396|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
43947397|NCT01072773|Bortezomib|bortezomib|mesh-list
43947398|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947399|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
43947400|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947401|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947402|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43947403|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
43947404|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947405|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947406|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43947407|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947408|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
43947409|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
43947410|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947411|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947412|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
43947413|NCT01072773|Hormones|hormones|mesh-ancestor
43947414|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947415|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43947417|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947418|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43947419|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947420|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947422|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
43947423|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947424|NCT01074463|Protective Agents|protective agents|mesh-ancestor
43947425|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947426|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43947427|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43947428|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
43947429|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
43947430|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947431|NCT01075087|Ropivacaine|ropivacaine|mesh-list
43947432|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
43947433|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
43947434|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947435|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947436|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
43947437|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947438|NCT01075204|Clarithromycin|clarithromycin|mesh-list
43947439|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947440|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947441|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43947442|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947443|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947444|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43947445|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947446|NCT01075399|Imidazole|imidazole|mesh-list
43947447|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947448|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947449|NCT01075971|Buprenorphine|buprenorphine|mesh-list
43947450|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43947451|NCT01075971|Narcotics|narcotics|mesh-ancestor
43947452|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172745|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44172746|NCT00290602|Protective Agents|protective agents|mesh-ancestor
44172747|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44172748|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172749|NCT00290628|Cyclosporine|cyclosporine|mesh-list
44172750|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
44172751|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
44172752|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
44172754|NCT00290628|Busulfan|busulfan|mesh-list
44172755|NCT00290628|Cyclosporins|cyclosporins|mesh-list
44172756|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43947453|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947454|NCT01075971|Analgesics|analgesics|mesh-ancestor
43947455|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
43947456|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947457|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43947458|NCT01076231|Cisplatin|cisplatin|mesh-list
43947459|NCT01076231|Etoposide|etoposide|mesh-list
43947460|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
43947461|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
43947462|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947463|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43947464|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43947465|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43947466|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947467|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947468|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
43947469|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947470|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
43947471|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
43947472|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
43947473|NCT01076270|Plerixafor|plerixafor|mesh-list
43947474|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947475|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43947476|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
43947477|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947478|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
43947479|NCT01076283|Baclofen|baclofen|mesh-list
43947480|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43947481|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947482|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43947483|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947484|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43947485|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
43947486|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
43947487|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947488|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947493|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
43947494|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
43947495|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43947496|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
43947497|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43947498|NCT01076504|Carboplatin|carboplatin|mesh-list
43947499|NCT01076504|Amrubicin|amrubicin|mesh-list
43947500|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947501|NCT01076972|Ritonavir|ritonavir|mesh-list
43947502|NCT01076972|Lopinavir|lopinavir|mesh-list
43947503|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43947504|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43947505|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947506|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947507|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947508|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947509|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43947510|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
43947511|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947512|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43947513|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947514|NCT01076985|Ritonavir|ritonavir|mesh-list
43947515|NCT01076985|Lopinavir|lopinavir|mesh-list
43947516|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43947517|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43947518|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947519|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947520|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947521|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43947522|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43947523|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
43947524|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947525|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43947537|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947538|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
43947539|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947540|NCT01077596|Bupropion|bupropion|mesh-list
43947541|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
43947542|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43947543|NCT01077596|Serotonin|serotonin|mesh-list
43947544|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43947545|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43947546|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43947547|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43947548|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43947549|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43947550|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947551|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
43947552|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947553|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947554|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43947555|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947556|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947557|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43947558|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
43947559|NCT01077921|Propranolol|propranolol|mesh-list
43947560|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43947585|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947586|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947587|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43947588|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43947589|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43947590|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947591|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43947593|NCT01078753|Coagulants|coagulants|mesh-ancestor
43947594|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43947595|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
43947596|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947597|NCT01079143|Cyclosporine|cyclosporine|mesh-list
43947598|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
43947599|NCT01079143|Everolimus|everolimus|mesh-list
43947600|NCT01079143|Cyclosporins|cyclosporins|mesh-list
43947601|NCT01079143|Basiliximab|basiliximab|mesh-list
43947602|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947603|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947604|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947605|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
44141482|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
43947606|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947607|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
43947608|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947609|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947610|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947611|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43947630|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43947631|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947632|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43947633|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947634|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947635|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43947636|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43947637|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
43947638|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947639|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43947640|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43947641|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
43947642|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43947643|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947644|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
43947646|NCT01081041|Carboplatin|carboplatin|mesh-list
43947647|NCT01081041|Fluorouracil|fluorouracil|mesh-list
43947648|NCT01081041|Cetuximab|cetuximab|mesh-list
43947649|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947650|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
43947651|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947652|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43947653|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947654|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
44172757|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172758|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
44172759|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172760|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172761|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172762|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
44172763|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172764|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172765|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44172766|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172767|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
44172768|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172769|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44172770|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44172771|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172772|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44172773|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
44172774|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172775|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172776|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
44172777|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
44172778|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172779|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947655|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947656|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947657|NCT01082380|Crizotinib|crizotinib|mesh-list
43947658|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947659|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43947660|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947661|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947662|NCT01082588|Pravastatin|pravastatin|mesh-list
43947663|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43947664|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43947665|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
43947666|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947667|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43947668|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43947669|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947670|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
43947671|NCT01082939|Rituximab|rituximab|mesh-list
43947672|NCT01082939|Fludarabine|fludarabine|mesh-list
43947673|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
43947674|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
43947675|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947676|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
43947677|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947678|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947679|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43689242|NCT02805842|Tacrolimus|tacrolimus|mesh-list
43947680|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
43947681|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947682|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947683|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43947684|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947685|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43947686|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
43947687|NCT01083368|Sirolimus|sirolimus|mesh-list
43947688|NCT01083368|Bevacizumab|bevacizumab|mesh-list
43947689|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43947692|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43947693|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947694|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43947695|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43947696|NCT01083368|Growth Substances|growth substances|mesh-ancestor
43947697|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947698|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
43947699|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
43947700|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947701|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947702|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43947703|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
43947704|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947706|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
43947707|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43947708|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43947709|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947710|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43947711|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947712|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947714|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43947715|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
43947716|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947717|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947718|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947719|NCT01083732|Dabigatran|dabigatran|mesh-list
43947720|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
44172780|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
44172781|NCT00290628|Hormones|hormones|mesh-ancestor
44172782|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172783|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44172784|NCT00290628|Protective Agents|protective agents|mesh-ancestor
44172785|NCT00290641|Cyclosporine|cyclosporine|mesh-list
44172786|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
44172787|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
44172788|NCT00290641|Fludarabine|fludarabine|mesh-list
44172789|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
44172790|NCT00290641|Cyclosporins|cyclosporins|mesh-list
44172791|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172792|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
44172793|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172794|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172795|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172796|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
44172797|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172798|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947721|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43947722|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947723|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947724|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947725|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
43947727|NCT01084148|Emollients|emollients|mesh-ancestor
43947728|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947729|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43947730|NCT01084265|Hormones|hormones|mesh-list
43947731|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43947732|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947733|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947734|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43947735|NCT01084278|Colchicine|colchicine|mesh-list
43947736|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
43947737|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947738|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
43947739|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
43947740|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
43947741|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947742|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947743|NCT01084499|Letrozole|letrozole|mesh-list
43947744|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947745|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43947770|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
43947771|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
43947772|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43947773|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43947775|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
43947791|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43947792|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43947793|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43947794|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947795|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43947796|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947797|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947798|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43947799|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43947800|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43947801|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43947802|NCT01085903|Modafinil|modafinil|mesh-list
43947803|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43947804|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947805|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43947806|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43947807|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43947808|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947809|NCT01086475|Cycloserine|cycloserine|mesh-list
43947810|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43947811|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947812|NCT01086475|Renal Agents|renal agents|mesh-ancestor
43947813|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43947814|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
43947815|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43947816|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
43947817|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947818|NCT01086605|Pixantrone|pixantrone|mesh-list
43947819|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43947820|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43813659|NCT04809532|Tramadol|tramadol|mesh-list
44172799|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44172800|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44172801|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
44172802|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172803|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
44172804|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172805|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947821|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947822|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947823|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947824|NCT01087931|Bupivacaine|bupivacaine|mesh-list
43947825|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
43947826|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
43947827|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947828|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947829|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
43947830|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947831|NCT01088295|Telmisartan|telmisartan|mesh-list
43947832|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43947833|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43947834|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43947835|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947836|NCT01088464|Necitumumab|necitumumab|mesh-list
43947837|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43947838|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43947839|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947840|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
43947841|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947842|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
43947843|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43947844|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
43947845|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
43947846|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947847|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947848|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947849|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947865|NCT01089569|Incretins|incretins|mesh-ancestor
43947866|NCT01089569|Hormones|hormones|mesh-ancestor
43947867|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947868|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
43947869|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947870|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43947871|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947884|NCT01090180|Dexamethasone|dexamethasone|mesh-list
43947927|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
43947928|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43947929|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
43947930|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947931|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43947932|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43947933|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
43947934|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
43947935|NCT01092559|Protective Agents|protective agents|mesh-ancestor
43947936|NCT01092676|Ibuprofen|ibuprofen|mesh-list
43947937|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43947938|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43947939|NCT01092676|Analgesics|analgesics|mesh-ancestor
43947940|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
43947941|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947942|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947943|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43947944|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947945|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43947946|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947947|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947948|NCT01092923|Sevoflurane|sevoflurane|mesh-list
43947949|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43947950|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43947951|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
43947952|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
43947953|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43947954|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947955|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
43947956|NCT01093183|Lenalidomide|lenalidomide|mesh-list
43947957|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43947958|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
43947959|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947960|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43947961|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43947964|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43947965|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43947966|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43947967|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43947968|NCT01093183|Growth Substances|growth substances|mesh-ancestor
43947969|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
43947971|NCT01093417|Vitamins|vitamins|mesh-ancestor
43947972|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
43947973|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947974|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43947975|NCT01093469|Decanoic acid|decanoic acid|mesh-list
43947976|NCT01093469|Petrolatum|petrolatum|mesh-list
43947977|NCT01093469|Emollients|emollients|mesh-ancestor
43947978|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
43947979|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
43947980|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43947981|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43947982|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43947983|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947984|NCT01093651|Incretins|incretins|mesh-ancestor
43947985|NCT01093651|Hormones|hormones|mesh-ancestor
43947986|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43947987|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43947988|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
43947989|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43947990|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43947991|NCT01093690|Metoclopramide|metoclopramide|mesh-list
43947992|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
43947993|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
43947994|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43947995|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43947996|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43947997|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43947998|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43947999|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
43948000|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948003|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43948004|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948005|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948006|NCT01093794|Incretins|incretins|mesh-ancestor
43948007|NCT01093794|Hormones|hormones|mesh-ancestor
43948008|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948009|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43948010|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
43948011|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948012|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948013|NCT01093976|Dronabinol|dronabinol|mesh-list
43948014|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
43948015|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948016|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43948017|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948018|NCT01093976|Analgesics|analgesics|mesh-ancestor
43948019|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
43948020|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948021|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43948022|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43948023|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948024|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948025|NCT01093976|Hormones|hormones|mesh-ancestor
43813773|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44172806|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44172807|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172808|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44172809|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
44172810|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44172812|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
44172813|NCT00290667|Rituximab|rituximab|mesh-list
44172814|NCT00290667|Doxorubicin|doxorubicin|mesh-list
44172815|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44172816|NCT00290667|Vincristine|vincristine|mesh-list
43613421|NCT05630183|Antiviral Agents|antiviral agents|mesh-ancestor
43613422|NCT05630183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613423|NCT05630183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613424|NCT05630183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613425|NCT05630183|Immunologic Factors|immunologic factors|mesh-ancestor
43613426|NCT05630183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613427|NCT05580250|Metformin|metformin|mesh-list
44172817|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44172818|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
44172819|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172820|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172821|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44172822|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
44172823|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172824|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172825|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43948026|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948027|NCT01094106|Ropivacaine|ropivacaine|mesh-list
43948028|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
43948029|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
43948030|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948031|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948032|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
43948033|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948034|NCT01094522|Morphine|morphine|mesh-list
43948035|NCT01094522|Methadone|methadone|mesh-list
43948036|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948037|NCT01094522|Narcotics|narcotics|mesh-ancestor
43948038|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948039|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948040|NCT01094522|Analgesics|analgesics|mesh-ancestor
43948041|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
43948042|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948043|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
43948044|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948045|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
43948046|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948047|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
43948048|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948049|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948050|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948051|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
43948052|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948053|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948054|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43948055|NCT01094574|Propranolol|propranolol|mesh-list
43948056|NCT01094574|Alfentanil|alfentanil|mesh-list
43948057|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43948058|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43948059|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
43948060|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948061|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172826|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948063|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43948064|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948065|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
43948066|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948067|NCT01094574|Narcotics|narcotics|mesh-ancestor
43948068|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948069|NCT01094574|Analgesics|analgesics|mesh-ancestor
43948070|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
43948071|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948072|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43948073|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
43948074|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
43948075|NCT01094717|Tazarotene|tazarotene|mesh-list
43948076|NCT01094717|Acitretin|acitretin|mesh-list
43948077|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948078|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
43948079|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43948080|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43948081|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948082|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
43948083|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948084|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43948085|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43948086|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948087|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
43948088|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948109|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948110|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948111|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
43948112|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948113|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43948114|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43948115|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43948116|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43948117|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43948118|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43948119|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43948120|NCT01096875|Atorvastatin|atorvastatin|mesh-list
43948121|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43948122|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43948123|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
43948124|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948125|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43948126|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43948127|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948128|NCT01096992|Rituximab|rituximab|mesh-list
43948129|NCT01096992|Fludarabine|fludarabine|mesh-list
43948130|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
43948131|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43948132|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948133|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948134|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
43948135|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948136|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948137|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43948138|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
43948150|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43948151|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
43948152|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948153|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948154|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948155|NCT01097395|Ribavirin|ribavirin|mesh-list
43948156|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
43948157|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948158|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
43948159|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948160|NCT01097460|Trastuzumab|trastuzumab|mesh-list
43948161|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948162|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948163|NCT01097642|Cetuximab|cetuximab|mesh-list
43948164|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948165|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948166|NCT01097785|Simvastatin|simvastatin|mesh-list
43948167|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43948206|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
43948207|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948208|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948210|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43948211|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948212|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948213|NCT01099618|Incretins|incretins|mesh-ancestor
43948214|NCT01099618|Hormones|hormones|mesh-ancestor
43948215|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948216|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43948217|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
43948218|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948219|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948220|NCT01099774|Bimatoprost|bimatoprost|mesh-list
43948221|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43948222|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43948223|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948224|NCT01100112|Budesonide|budesonide|mesh-list
43948225|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948226|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43948227|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
43948228|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948229|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948230|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43948231|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948232|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
43948233|NCT01100112|Hormones|hormones|mesh-ancestor
43948235|NCT01100242|Bortezomib|bortezomib|mesh-list
43948252|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43948253|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948254|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948255|NCT01100268|Methylphenidate|methylphenidate|mesh-list
43948256|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43948257|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948258|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43948259|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43948260|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948261|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948262|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
43948263|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141537|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141538|NCT00183404|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141539|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141540|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141541|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141542|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141543|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
44141544|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
44141545|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141546|NCT00183612|Olanzapine|olanzapine|mesh-list
44141547|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
44141548|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
44141549|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141550|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141551|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141552|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44141553|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44141554|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141555|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44141556|NCT00183612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141557|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141558|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43844749|NCT04340141|Fluorouracil|fluorouracil|mesh-list
44172827|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44141559|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141560|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141561|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
44141562|NCT00183742|Docetaxel|docetaxel|mesh-list
44141563|NCT00183742|Doxorubicin|doxorubicin|mesh-list
44141564|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43948265|NCT01100606|Pancreatin|pancreatin|mesh-list
43948266|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948267|NCT01100723|Vitamin D|vitamin d|mesh-list
43948268|NCT01100723|Calcitriol|calcitriol|mesh-list
43948269|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
43948270|NCT01100723|Cinacalcet|cinacalcet|mesh-list
43948271|NCT01100723|Vitamins|vitamins|mesh-ancestor
43948272|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
43948273|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948274|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43948275|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43948276|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43948277|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948278|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948279|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43948280|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43948281|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43948282|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948283|NCT01100931|Paclitaxel|paclitaxel|mesh-list
43948284|NCT01100931|Carboplatin|carboplatin|mesh-list
43948285|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43948286|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948287|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
43948288|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
43948291|NCT01101100|Brodalumab|brodalumab|mesh-list
43948303|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43948304|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
43948305|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948306|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948307|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
43948308|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948309|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948310|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
43948311|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948312|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
43948313|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
43948314|NCT01102218|Hematinics|hematinics|mesh-ancestor
43948369|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948370|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43948371|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948372|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43948373|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
43948374|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948375|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43948376|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948377|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948378|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43948379|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43948380|NCT01104025|Dexamethasone|dexamethasone|mesh-list
43948381|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
43948382|NCT01104025|Methotrexate|methotrexate|mesh-list
43948383|NCT01104025|Etoposide|etoposide|mesh-list
43948384|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
43948385|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948386|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
43948387|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
43948388|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948389|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948390|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948391|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
43948392|NCT01104025|Hormones|hormones|mesh-ancestor
43948393|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948394|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948395|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948396|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43948397|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
43948398|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43948399|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43948400|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
43948401|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948409|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43948410|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43948411|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43948413|NCT01105117|Tezosentan|tezosentan|mesh-list
43948414|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948415|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43948416|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
43948417|NCT01105312|Letrozole|letrozole|mesh-list
43948418|NCT01105312|Panobinostat|panobinostat|mesh-list
43948419|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948420|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43948421|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43948422|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948423|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948424|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43948425|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
43948426|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948427|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948428|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43948429|NCT01105650|Cyclosporine|cyclosporine|mesh-list
43948430|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
43948431|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43948432|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43948433|NCT01105650|Prednisolone|prednisolone|mesh-list
43948434|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
43948435|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
43948436|NCT01105650|Fludarabine|fludarabine|mesh-list
43948437|NCT01105650|Interleukin-2|interleukin-2|mesh-list
43948438|NCT01105650|Cyclosporins|cyclosporins|mesh-list
43948439|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43948440|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
43948441|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948442|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
43948443|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948444|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948448|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948449|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43948450|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948451|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
43948452|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948453|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948454|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43948455|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948456|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
43948457|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
43948458|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948459|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948460|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
43948461|NCT01105650|Hormones|hormones|mesh-ancestor
43948462|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948463|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43948464|NCT01105650|Protective Agents|protective agents|mesh-ancestor
43948465|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948466|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948467|NCT01105650|Analgesics|analgesics|mesh-ancestor
43948468|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
43948469|NCT01105702|Bevacizumab|bevacizumab|mesh-list
43948470|NCT01105702|Temozolomide|temozolomide|mesh-list
43948471|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
43948472|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948473|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948474|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948475|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948476|NCT01105702|Growth Substances|growth substances|mesh-ancestor
43948477|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948478|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948479|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948480|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
43948481|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948482|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
43948483|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43948484|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948486|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43948487|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948488|NCT01106833|Sirolimus|sirolimus|mesh-list
43948489|NCT01106833|Prednisone|prednisone|mesh-list
43948490|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43948491|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948492|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
43948493|NCT01106833|Hormones|hormones|mesh-ancestor
43948494|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948495|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948496|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948497|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948498|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43948499|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948500|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43948501|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
43948502|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948503|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
43948504|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948505|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948507|NCT01106859|Zopiclone|zopiclone|mesh-list
43948508|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43948509|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43948510|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948511|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948512|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43948513|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
43948514|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
43948515|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948533|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948534|NCT01107665|Paclitaxel|paclitaxel|mesh-list
43948535|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43948536|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948537|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
43948538|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
43948539|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
43948540|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948541|NCT01107730|Ascorbic Acid|ascorbic acid|mesh-list
43948542|NCT01107730|Vitamins|vitamins|mesh-ancestor
43948543|NCT01107730|Micronutrients|micronutrients|mesh-ancestor
43948544|NCT01107730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948545|NCT01107730|Antioxidants|antioxidants|mesh-ancestor
43948546|NCT01107730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948547|NCT01107730|Protective Agents|protective agents|mesh-ancestor
43948548|NCT01108445|Everolimus|everolimus|mesh-list
43948549|NCT01108445|Sunitinib|sunitinib|mesh-list
43948550|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948551|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948552|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
43948553|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948554|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948555|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948556|NCT01108445|Growth Substances|growth substances|mesh-ancestor
43948557|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948558|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43948559|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948581|NCT01110135|Dexamethasone|dexamethasone|mesh-list
43948582|NCT01110135|Etoposide|etoposide|mesh-list
43948583|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
43948584|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43948585|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948586|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
43948587|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
43948588|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948589|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948590|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43948591|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
43948592|NCT01110135|Hormones|hormones|mesh-ancestor
43948593|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948594|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948595|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948596|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43948597|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43948598|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43948600|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948601|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948602|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
43948603|NCT01110187|Lacosamide|lacosamide|mesh-list
43948604|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
43948605|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
43948606|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43948607|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43948608|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43948613|NCT01110421|Cefepime|cefepime|mesh-list
43948628|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948629|NCT01110876|Temozolomide|temozolomide|mesh-list
43948630|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43948631|NCT01110876|Vorinostat|vorinostat|mesh-list
43948632|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948633|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
43948634|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948635|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948636|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43948637|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948638|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43948639|NCT01111058|Everolimus|everolimus|mesh-list
43948640|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948641|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43948642|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
43690050|NCT02799316|Antibodies|antibodies|mesh-list
43948643|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948645|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43948646|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948647|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43948648|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948649|NCT01111331|Empagliflozin|empagliflozin|mesh-list
43948650|NCT01111331|Warfarin|warfarin|mesh-list
43948651|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
43948652|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43948678|NCT01112358|Hormones|hormones|mesh-ancestor
43948679|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43948680|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948686|NCT01112670|Atorvastatin|atorvastatin|mesh-list
43948749|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948750|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948751|NCT01114555|Growth Substances|growth substances|mesh-ancestor
43948752|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948753|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948754|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43948755|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43948756|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948757|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948758|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948759|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
43948760|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
43948761|NCT01114581|Guaifenesin|guaifenesin|mesh-list
43948762|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
43948763|NCT01114581|Expectorants|expectorants|mesh-ancestor
43948764|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948765|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43948766|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43948767|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43948768|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948769|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948770|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948771|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
43948772|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43948773|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
43948774|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
43948775|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948776|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
43948777|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44172828|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44172829|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172830|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172831|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172832|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
44172833|NCT00290667|Hormones|hormones|mesh-ancestor
44172834|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172835|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44172836|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172837|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172838|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172839|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43948778|NCT01114893|Travoprost|travoprost|mesh-list
43948779|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948780|NCT01114971|Labetalol|labetalol|mesh-list
43948781|NCT01114971|Fentanyl|fentanyl|mesh-list
43948782|NCT01114971|Esmolol|esmolol|mesh-list
43948783|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948784|NCT01114971|Narcotics|narcotics|mesh-ancestor
43948785|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948786|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948787|NCT01114971|Analgesics|analgesics|mesh-ancestor
43948788|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
43948789|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948790|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43948791|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43948792|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
43948793|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
43948794|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43948795|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43948796|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43948797|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
43948798|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948799|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948800|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43948801|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
43948802|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
43948803|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43948804|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43948805|NCT01114997|Lidocaine|lidocaine|mesh-list
43948806|NCT01114997|Esmolol|esmolol|mesh-list
43948807|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
43948808|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
43948809|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948810|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948811|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
43948812|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948813|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43948817|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948818|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43948819|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43948820|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43948821|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43948822|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948824|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948825|NCT01115101|Narcotics|narcotics|mesh-ancestor
43948826|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43948827|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948828|NCT01115101|Analgesics|analgesics|mesh-ancestor
43948829|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
43948830|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141565|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141566|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141567|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141568|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
44141569|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141570|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44141571|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44141572|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141573|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141574|NCT00183807|Celecoxib|celecoxib|mesh-list
44141575|NCT00183807|Cisplatin|cisplatin|mesh-list
44141576|NCT00183807|Irinotecan|irinotecan|mesh-list
44141577|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141578|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44141579|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141580|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141581|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141582|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814333|NCT04799184|Epinephrine|epinephrine|mesh-list
44172840|NCT00290680|Celecoxib|celecoxib|mesh-list
44172841|NCT00290680|Bortezomib|bortezomib|mesh-list
44172842|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172843|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44172844|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44172845|NCT00290680|Analgesics|analgesics|mesh-ancestor
44172846|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
43631760|NCT03041935|Narcotics|narcotics|mesh-ancestor
44141583|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44141584|NCT00183807|Analgesics|analgesics|mesh-ancestor
44141585|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
44141586|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141587|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141588|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44141589|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141590|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44141591|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44141592|NCT00183820|Gemcitabine|gemcitabine|mesh-list
44141593|NCT00183820|Paclitaxel|paclitaxel|mesh-list
44141594|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
44141595|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44141596|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141597|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141598|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141599|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
44141600|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141601|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43948831|NCT01115517|Bevacizumab|bevacizumab|mesh-list
43948832|NCT01115517|Mitomycins|mitomycins|mesh-list
43948833|NCT01115517|Mitomycin|mitomycin|mesh-list
43948834|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948835|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948836|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43948837|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43948838|NCT01115517|Growth Substances|growth substances|mesh-ancestor
43948839|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948840|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
43948841|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43948857|NCT01115673|Analgesics|analgesics|mesh-ancestor
43948859|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948860|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948861|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
43948862|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43948863|NCT01116401|Leuprolide|leuprolide|mesh-list
43948864|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43948865|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
43948866|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43948867|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948868|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43948869|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948870|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43948871|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
43948872|NCT01116986|Nicotine|nicotine|mesh-list
43948873|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43948874|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
43948875|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43948876|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948877|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43948878|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43948879|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
43948880|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43948881|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948882|NCT01117948|Lornoxicam|lornoxicam|mesh-list
43948883|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43948884|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948885|NCT01117948|Analgesics|analgesics|mesh-ancestor
43948886|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
43948887|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814402|NCT04797949|Analgesics|analgesics|mesh-ancestor
44172847|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172848|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172849|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172850|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172851|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44172852|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44172853|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172854|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172855|NCT00290719|Cisplatin|cisplatin|mesh-list
44172856|NCT00290719|Irinotecan|irinotecan|mesh-list
44172857|NCT00290719|Gefitinib|gefitinib|mesh-list
44172858|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172859|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43948888|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948889|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948890|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948892|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948893|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43948894|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43948895|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
43948896|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43948897|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
43948898|NCT01118273|Promethazine|promethazine|mesh-list
43948899|NCT01118273|Ibuprofen|ibuprofen|mesh-list
43948900|NCT01118273|Naproxen|naproxen|mesh-list
43948901|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948902|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43948903|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43948904|NCT01118273|Analgesics|analgesics|mesh-ancestor
43948905|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
43948906|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141602|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
43948907|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948908|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43948909|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948910|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43948911|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948912|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
43948913|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43948928|NCT01118624|Vitamins|vitamins|mesh-list
43948938|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43948939|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948940|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948941|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948943|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43948944|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43948945|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43948946|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948947|NCT01118845|Rituximab|rituximab|mesh-list
43948948|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43948949|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43948950|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948951|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
43948952|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43948953|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43948954|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43948955|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
43948956|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43948957|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
43948958|NCT01119222|Promethazine|promethazine|mesh-list
43948959|NCT01119222|Morphine|morphine|mesh-list
43948960|NCT01119222|Gabapentin|gabapentin|mesh-list
43948961|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43948962|NCT01119222|Narcotics|narcotics|mesh-ancestor
43948989|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
43948990|NCT01119794|Bortezomib|bortezomib|mesh-list
43948991|NCT01119794|Ofatumumab|ofatumumab|mesh-list
43948992|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43948993|NCT01120236|Leuprolide|leuprolide|mesh-list
43948994|NCT01120236|Goserelin|goserelin|mesh-list
43948995|NCT01120236|Bicalutamide|bicalutamide|mesh-list
43948996|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43948997|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43948998|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
43948999|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949000|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767605|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43767606|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949001|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949002|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949003|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
43949004|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
43949005|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949006|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
43949007|NCT01120405|Sevoflurane|sevoflurane|mesh-list
43949008|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43949009|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43949010|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
43949011|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
43949012|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949013|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949014|NCT01120639|Temozolomide|temozolomide|mesh-list
43949040|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949041|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949042|NCT01121939|Bevacizumab|bevacizumab|mesh-list
43949043|NCT01121939|Pertuzumab|pertuzumab|mesh-list
43949044|NCT01121939|Octreotide|octreotide|mesh-list
43949045|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949046|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949047|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43949048|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43949049|NCT01121939|Growth Substances|growth substances|mesh-ancestor
43949050|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949051|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
43949052|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949053|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949054|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43949055|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
43949056|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43949057|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43949058|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
43949059|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949060|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43949061|NCT01122160|Omeprazole|omeprazole|mesh-list
43949062|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43949063|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949064|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43949065|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949066|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949067|NCT01122238|Nicotine|nicotine|mesh-list
43949068|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43949069|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
43949070|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949082|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949083|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43949084|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43949085|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43949086|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949087|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949088|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949089|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949090|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43949091|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
43949092|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949093|NCT01124786|Gemcitabine|gemcitabine|mesh-list
43949094|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949095|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
43949096|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949097|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949098|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
43949099|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949100|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949101|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949102|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
43949103|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949104|NCT01125098|Amoxicillin|amoxicillin|mesh-list
43949105|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
43949106|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43949107|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43949108|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949109|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43949110|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949111|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949112|NCT01125163|Iron|iron|mesh-list
43949113|NCT01125163|Trace Elements|trace elements|mesh-ancestor
43949114|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
43949115|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949118|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949119|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949120|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949122|NCT05307835|Sargramostim|sargramostim|mesh-list
43949123|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
43949124|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949125|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949126|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43949127|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43949128|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949129|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949130|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
43949131|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949132|NCT05307718|Anticoagulants|anticoagulants|mesh-list
43949133|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
43949134|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43949135|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43949136|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
43949137|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43949138|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43949139|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
43949140|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949141|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949142|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44172860|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44172861|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172862|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172863|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44172864|NCT00290823|Albendazole|albendazole|mesh-list
44172865|NCT00290823|Dexamethasone|dexamethasone|mesh-list
44172866|NCT00290823|Omeprazole|omeprazole|mesh-list
44172867|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172868|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
44172869|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
44172877|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172878|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44172879|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44172880|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172881|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172882|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
44172883|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43949143|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43949144|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43949145|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
43949146|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949147|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949148|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
43949149|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43949150|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
43949152|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43949153|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43949154|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949155|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43949156|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43949157|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949158|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949159|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949160|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43949161|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
43949162|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949163|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949164|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43949165|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43949166|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43949168|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43949170|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43949171|NCT05307458|Narcotics|narcotics|mesh-ancestor
43949172|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949173|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949174|NCT05307458|Analgesics|analgesics|mesh-ancestor
43949175|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
43949176|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949177|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43949178|NCT05307341|Sufentanil|sufentanil|mesh-list
43949183|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949184|NCT05307341|Analgesics|analgesics|mesh-ancestor
43949185|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
43949186|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949187|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43949188|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43949189|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
43949190|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
43949191|NCT05307042|Vasopressins|vasopressins|mesh-list
43949192|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
43949193|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43949194|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
43949195|NCT05307042|Coagulants|coagulants|mesh-ancestor
43949196|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43949197|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43949198|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
43949199|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141603|NCT00183820|Antiviral Agents|antiviral agents|mesh-ancestor
44141604|NCT00183820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141605|NCT00183820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141606|NCT00183820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141607|NCT00183820|Immunologic Factors|immunologic factors|mesh-ancestor
44141608|NCT00183820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141609|NCT00183833|Capecitabine|capecitabine|mesh-list
44141610|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
44141611|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949200|NCT05306990|Atorvastatin|atorvastatin|mesh-list
43949201|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43949202|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43949203|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43949204|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
43949205|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949206|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43949207|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43949208|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949209|NCT05306587|Daratumumab|daratumumab|mesh-list
43844892|NCT04329065|Vaccines|vaccines|mesh-list
44172884|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172885|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
44172886|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43949210|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949211|NCT05306405|Misoprostol|misoprostol|mesh-list
43949212|NCT05306405|Estradiol|estradiol|mesh-list
43949213|NCT05306405|Estrogens|estrogens|mesh-ancestor
43949214|NCT05306405|Hormones|hormones|mesh-ancestor
43949215|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949216|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949217|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949218|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43949219|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
43949220|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43949222|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
43949223|NCT05305508|Mannitol|mannitol|mesh-list
43949224|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
43949225|NCT05305508|Calcium|calcium|mesh-list
43949226|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43949227|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949228|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43949229|NCT05305508|Diuretics|diuretics|mesh-ancestor
43949230|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
43949231|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
43949232|NCT05305508|Coagulants|coagulants|mesh-ancestor
43949233|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
43949234|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949235|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949236|NCT05296460|Dapsone|dapsone|mesh-list
43949237|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949238|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
43949239|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43949240|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43949241|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43949258|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949259|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949260|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43949261|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43949262|NCT05273320|Dronabinol|dronabinol|mesh-list
43949263|NCT05273320|Nabilone|nabilone|mesh-list
43949264|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
43949265|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
43949266|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949267|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949268|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949269|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43949270|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43949271|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949272|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949273|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
43949274|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949275|NCT05273320|Analgesics|analgesics|mesh-ancestor
43949276|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
43949277|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43949278|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43949279|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949280|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949281|NCT05273320|Hormones|hormones|mesh-ancestor
43949282|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949283|NCT05272397|Methylphenidate|methylphenidate|mesh-list
43949284|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43949285|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949286|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43949287|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43949288|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949289|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949290|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
44172887|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44172888|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172889|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172890|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172891|NCT00290836|Thrombin|thrombin|mesh-list
44172892|NCT00290836|Aprotinin|aprotinin|mesh-list
43949291|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949292|NCT05269628|Dronabinol|dronabinol|mesh-list
43949293|NCT05269628|Cannabidiol|cannabidiol|mesh-list
43949294|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
43949295|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
43949296|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949298|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949299|NCT05269628|Analgesics|analgesics|mesh-ancestor
43949300|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
43949301|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949302|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43949303|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43949304|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949305|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949306|NCT05269628|Hormones|hormones|mesh-ancestor
43949307|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949308|NCT05254418|Dulaglutide|dulaglutide|mesh-list
43949309|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949310|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949311|NCT05215067|Docetaxel|docetaxel|mesh-list
43949312|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949313|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
43949314|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
43949315|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
43949316|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949317|NCT05177510|Mifepristone|mifepristone|mesh-list
43949318|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43949319|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
43949320|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949321|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949322|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43949323|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44172893|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
44172894|NCT00290836|Coagulants|coagulants|mesh-ancestor
44172895|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44172896|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44172897|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
44172898|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172899|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172900|NCT00290849|Bivalirudin|bivalirudin|mesh-list
44172901|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
44172902|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43949324|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43949325|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
43949326|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43949327|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43949328|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
43949329|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949330|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
43949331|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43949332|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43949333|NCT05160987|Midazolam|midazolam|mesh-list
43949334|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43949335|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949336|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949337|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949338|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43949339|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43949340|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949341|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43949342|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
43949343|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
43949344|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
43949345|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
43949346|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949347|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949348|NCT05042648|Buprenorphine|buprenorphine|mesh-list
43949349|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43949371|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
43949373|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
43949374|NCT04974151|Vitamins|vitamins|mesh-ancestor
43949375|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
43949376|NCT04974138|Folic Acid|folic acid|mesh-list
43949377|NCT04974138|Amlodipine|amlodipine|mesh-list
43949378|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43949379|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43949380|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949381|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949382|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43949383|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949384|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
43949385|NCT04974138|Hematinics|hematinics|mesh-ancestor
43949386|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
43949387|NCT04974138|Vitamins|vitamins|mesh-ancestor
43949388|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
43949389|NCT04973982|Tacrolimus|tacrolimus|mesh-list
43949390|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949391|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
43949392|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949393|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43949394|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949395|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949396|NCT04944654|Emtricitabine|emtricitabine|mesh-list
43949397|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
44172903|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
44172904|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172905|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172906|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
44172907|NCT00290901|Celecoxib|celecoxib|mesh-list
44172908|NCT00290901|Tramadol|tramadol|mesh-list
44172909|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44172910|NCT00290901|Narcotics|narcotics|mesh-ancestor
44172911|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172912|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172913|NCT00290901|Analgesics|analgesics|mesh-ancestor
44172914|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
44172915|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172916|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44172917|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44172918|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172919|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172920|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44172921|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44172922|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172923|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172924|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44172925|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
44172926|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949398|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949399|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43949400|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43949401|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949402|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949403|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43949404|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43949405|NCT04822363|Aspirin|aspirin|mesh-list
43949406|NCT04822363|Clopidogrel|clopidogrel|mesh-list
43949407|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43949408|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949409|NCT04822363|Analgesics|analgesics|mesh-ancestor
43949410|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
43949411|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949412|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949413|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949414|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949415|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43949416|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43949417|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949418|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43949419|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43949420|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949421|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
43949422|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43949423|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43949424|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44172927|NCT00290914|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44172928|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44172929|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172930|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172931|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172932|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
44172933|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172934|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44172935|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44172936|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
44172945|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172947|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
44172948|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172949|NCT00291005|Docetaxel|docetaxel|mesh-list
44172950|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172951|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172952|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141621|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141622|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141624|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44141625|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141626|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141627|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141628|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141629|NCT00183885|Cisplatin|cisplatin|mesh-list
44141630|NCT00183885|Mitomycins|mitomycins|mesh-list
44141631|NCT00183885|Mitomycin|mitomycin|mesh-list
44141632|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141641|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
44141642|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141643|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141644|NCT00183911|Leucovorin|leucovorin|mesh-list
44141645|NCT00183911|Fluorouracil|fluorouracil|mesh-list
44141646|NCT00183911|Floxuridine|floxuridine|mesh-list
44141647|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
43757828|NCT02457650|Fludarabine|fludarabine|mesh-list
44141648|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141649|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141650|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141651|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44141652|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
44141653|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141654|NCT00183911|Antidotes|antidotes|mesh-ancestor
44141655|NCT00183911|Protective Agents|protective agents|mesh-ancestor
44141656|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
44141657|NCT00183911|Vitamins|vitamins|mesh-ancestor
44141658|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
44141659|NCT00183924|Carboplatin|carboplatin|mesh-list
44141660|NCT00183924|Docetaxel|docetaxel|mesh-list
44141661|NCT00183924|Estramustine|estramustine|mesh-list
44141662|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141663|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141664|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141665|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
44141666|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141667|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44141668|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
44141669|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141670|NCT00183937|Docetaxel|docetaxel|mesh-list
44141671|NCT00183937|Bortezomib|bortezomib|mesh-list
44141672|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141673|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141674|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141675|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690671|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
43949437|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43949438|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
44172953|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
43949440|NCT04573322|Protective Agents|protective agents|mesh-ancestor
43949441|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949442|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43949443|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949444|NCT04513145|Ropivacaine|ropivacaine|mesh-list
43949445|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
43949446|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
43949447|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949448|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949449|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
43949450|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949451|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
43949452|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
43949453|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949454|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949455|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949456|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949457|NCT04498351|Analgesics|analgesics|mesh-ancestor
43949458|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
43949459|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949460|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43949461|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43949462|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43949463|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43949464|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949465|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949466|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
43949467|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43949468|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
43949469|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43949470|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949471|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43949472|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
43949473|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949474|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
43949478|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43949479|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43949480|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949481|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949482|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949483|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949484|NCT04447534|Amebicides|amebicides|mesh-ancestor
43949485|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43949486|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949487|NCT04447534|Analgesics|analgesics|mesh-ancestor
43949488|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
43949489|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949490|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949491|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949492|NCT04447534|Filaricides|filaricides|mesh-ancestor
43949493|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
43949494|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
43949495|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43949496|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43949497|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43949498|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949499|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949500|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949501|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949502|NCT04395001|Analgesics|analgesics|mesh-ancestor
43949503|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
43949504|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949505|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
43949506|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43949507|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
43949508|NCT04391309|Remdesivir|remdesivir|mesh-list
43949509|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
43949510|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949512|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949513|NCT04361656|Lubiprostone|lubiprostone|mesh-list
43949516|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949517|NCT04312139|Lincomycin|lincomycin|mesh-list
43949518|NCT04312139|Calcium|calcium|mesh-list
43949519|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43949520|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949521|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43949522|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949523|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43949524|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949525|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949526|NCT04238637|Durvalumab|durvalumab|mesh-list
43949527|NCT04238637|Tremelimumab|tremelimumab|mesh-list
43949528|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949529|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949531|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
43949532|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
43949533|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949534|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949535|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
43949536|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949537|NCT04187352|Cisplatin|cisplatin|mesh-list
43949538|NCT04187352|Fluorouracil|fluorouracil|mesh-list
43949539|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949540|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
43949541|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949542|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949543|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949544|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
43949545|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949546|NCT04142892|Onapristone|onapristone|mesh-list
43949547|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949548|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43949549|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
43949550|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43949552|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
43949555|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949556|NCT04071977|Protective Agents|protective agents|mesh-ancestor
43949557|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949558|NCT04037241|Leucovorin|leucovorin|mesh-list
43949559|NCT04037241|Gemcitabine|gemcitabine|mesh-list
43949560|NCT04037241|Paclitaxel|paclitaxel|mesh-list
43949561|NCT04037241|Capecitabine|capecitabine|mesh-list
43949562|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43949563|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949564|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
43949565|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
43949566|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
43949567|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949568|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949569|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
43949570|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
43949571|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949572|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949573|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949574|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
43949575|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949576|NCT04037241|Antidotes|antidotes|mesh-ancestor
43949577|NCT04037241|Protective Agents|protective agents|mesh-ancestor
43949578|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
43949579|NCT04037241|Vitamins|vitamins|mesh-ancestor
43949580|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
43949581|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
43949582|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43949583|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949584|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43690816|NCT02792491|Hormones|hormones|mesh-ancestor
43949585|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949587|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
43949588|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
43949589|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949590|NCT03886649|Venetoclax|venetoclax|mesh-list
43949591|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949595|NCT03872947|Gemcitabine|gemcitabine|mesh-list
43949596|NCT03872947|Bevacizumab|bevacizumab|mesh-list
43949597|NCT03872947|Carboplatin|carboplatin|mesh-list
43949598|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
43949599|NCT03872947|Nivolumab|nivolumab|mesh-list
43949600|NCT03872947|Irinotecan|irinotecan|mesh-list
43949601|NCT03872947|Topotecan|topotecan|mesh-list
43949602|NCT03872947|Imiquimod|imiquimod|mesh-list
43949603|NCT03872947|Ramucirumab|ramucirumab|mesh-list
43949604|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949605|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949606|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949607|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43949608|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43949609|NCT03872947|Growth Substances|growth substances|mesh-ancestor
43949611|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
43949660|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43949661|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949662|NCT03709459|Doxycycline|doxycycline|mesh-list
43690891|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43949664|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949665|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
43949666|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43949667|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43949668|NCT03702374|Antioxidants|antioxidants|mesh-list
43949669|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949670|NCT03702374|Protective Agents|protective agents|mesh-ancestor
43949671|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949672|NCT03697356|Dexamethasone|dexamethasone|mesh-list
43949673|NCT03697356|Rituximab|rituximab|mesh-list
43949674|NCT03697356|Lenalidomide|lenalidomide|mesh-list
43949675|NCT03697356|Bortezomib|bortezomib|mesh-list
43949676|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949677|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949678|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
43949679|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949680|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949681|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949682|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
43949683|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
43949684|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949685|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949686|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
43949687|NCT03697356|Hormones|hormones|mesh-ancestor
43949688|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949689|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949690|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43949691|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43949692|NCT03697356|Growth Substances|growth substances|mesh-ancestor
43949693|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
43949694|NCT03683524|Dolutegravir|dolutegravir|mesh-list
43949695|NCT03683524|Darunavir|darunavir|mesh-list
43949696|NCT03683524|Cobicistat|cobicistat|mesh-list
43949697|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43814972|NCT04786470|Ropivacaine|ropivacaine|mesh-list
43949698|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43949699|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43949700|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949701|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949702|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43949703|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43949704|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
43949705|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949706|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43949707|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43949708|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
43949709|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43949710|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43949711|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
43949712|NCT03660683|Saxagliptin|saxagliptin|mesh-list
43949713|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43949714|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949715|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949716|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949717|NCT03660683|Incretins|incretins|mesh-ancestor
43949718|NCT03660683|Hormones|hormones|mesh-ancestor
43949719|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949720|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43949721|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
43949722|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949723|NCT03616782|Ixazomib|ixazomib|mesh-list
43949724|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949725|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
43949726|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949727|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949728|NCT03574571|Docetaxel|docetaxel|mesh-list
43949729|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949730|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
43949731|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
43949732|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814995|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44172954|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949733|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949735|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949736|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
43949737|NCT03465527|Hormones|hormones|mesh-ancestor
43690959|NCT02791256|Ribavirin|ribavirin|mesh-list
43949738|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949739|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949740|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141676|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141677|NCT00183950|Noscapine|noscapine|mesh-list
44141678|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
44141679|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141680|NCT00183976|Rituximab|rituximab|mesh-list
44141681|NCT00183976|Doxorubicin|doxorubicin|mesh-list
44141682|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44141683|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141684|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141685|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
44141686|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141687|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44141688|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44141689|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44141690|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141691|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141692|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141693|NCT00183989|Rituximab|rituximab|mesh-list
44141713|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44141714|NCT00184015|Growth Substances|growth substances|mesh-ancestor
44141715|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141716|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
44141717|NCT00184041|Cytarabine|cytarabine|mesh-list
44141718|NCT00184041|Prednisone|prednisone|mesh-list
44141719|NCT00184041|Methotrexate|methotrexate|mesh-list
44141720|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
44141721|NCT00184041|Vincristine|vincristine|mesh-list
44141722|NCT00184041|Daunorubicin|daunorubicin|mesh-list
44141723|NCT00184041|Asparaginase|asparaginase|mesh-list
44141724|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
44141725|NCT00184041|Thioguanine|thioguanine|mesh-list
44141726|NCT00184041|Pegaspargase|pegaspargase|mesh-list
44141727|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44141728|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
44141729|NCT00184041|Hormones|hormones|mesh-ancestor
44141730|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141731|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141732|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44141733|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44141734|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44141735|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
44141736|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44141737|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44141738|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
44141739|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141740|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
43949756|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43949757|NCT03399981|Natalizumab|natalizumab|mesh-list
43949758|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
43949759|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949760|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
43949761|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43949762|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43949763|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949764|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
43949765|NCT03385928|Coagulants|coagulants|mesh-ancestor
43949766|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
43949767|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43949768|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949769|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949770|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
43949771|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949772|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949773|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
43949774|NCT03375385|Propofol|propofol|mesh-list
43949775|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949776|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949777|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949778|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43949779|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
43949780|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
43949781|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43949782|NCT03375385|Analgesics|analgesics|mesh-ancestor
43949783|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
43949784|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949785|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43949786|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43949787|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43949788|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
43949789|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844968|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172955|NCT00291109|Letrozole|letrozole|mesh-list
44172956|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172957|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44172958|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43949790|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949792|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949793|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949794|NCT03112993|Neostigmine|neostigmine|mesh-list
43949795|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43949796|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949797|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949798|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
43949799|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949800|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949801|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43949802|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
43949803|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949804|NCT03110315|Suvorexant|suvorexant|mesh-list
43949805|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43949806|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949807|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949808|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172959|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172960|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172961|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44172962|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
44172963|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172964|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172965|NCT00291122|Celecoxib|celecoxib|mesh-list
43613575|NCT05357690|Bupivacaine|bupivacaine|mesh-list
43613576|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
43613577|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
44172966|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44172967|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44172969|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
44172970|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172971|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172972|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172973|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44172974|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44172975|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44172976|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172977|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172978|NCT00291148|Pregabalin|pregabalin|mesh-list
44172979|NCT00291148|Paroxetine|paroxetine|mesh-list
44172980|NCT00291148|Analgesics|analgesics|mesh-ancestor
44172981|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
44172982|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172983|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172984|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
44172985|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44172986|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44172987|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172988|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44172989|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44172990|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43949809|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43949810|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949811|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949812|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43949813|NCT03088137|Hormones|hormones|mesh-ancestor
43949814|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949815|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949816|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
43949817|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
43949818|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949820|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43949821|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
43949822|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43949823|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949824|NCT02926196|Avelumab|avelumab|mesh-list
43949825|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949826|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949827|NCT02819024|Alovudine|alovudine|mesh-list
43949828|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
43949829|NCT02819024|Dexamethasone|dexamethasone|mesh-list
43949830|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
43949831|NCT02819024|Ichthammol|ichthammol|mesh-list
43949832|NCT02819024|BB 1101|bb 1101|mesh-list
43949833|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949834|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
43949835|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
43949836|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949837|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949838|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949839|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
43949840|NCT02819024|Hormones|hormones|mesh-ancestor
43949841|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949842|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43949843|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949844|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
43949850|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
43949851|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43949852|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43949853|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43949854|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43949855|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949856|NCT02733185|Vitamins|vitamins|mesh-list
43949857|NCT02733185|Edetic Acid|edetic acid|mesh-list
43949858|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
43949859|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
43949860|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949861|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
43949862|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43949863|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
43949864|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
43949865|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949866|NCT02733185|Antidotes|antidotes|mesh-ancestor
43949867|NCT02733185|Protective Agents|protective agents|mesh-ancestor
43949868|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43949869|NCT02647437|Levetiracetam|levetiracetam|mesh-list
43949870|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
43949871|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
43949872|NCT02623426|Dexamethasone|dexamethasone|mesh-list
43949873|NCT02623426|Methotrexate|methotrexate|mesh-list
43949874|NCT02623426|Ranibizumab|ranibizumab|mesh-list
43949875|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949876|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
43949877|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
43949878|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949879|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949880|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43949881|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
43949894|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43949895|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949896|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
43949897|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43949898|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43949899|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43949900|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43949901|NCT02623426|Growth Substances|growth substances|mesh-ancestor
43949902|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
43949904|NCT02410512|Antibodies|antibodies|mesh-list
43949905|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
43949906|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43949907|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
43949908|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949909|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949910|NCT02390427|Paclitaxel|paclitaxel|mesh-list
43949911|NCT02390427|Maytansine|maytansine|mesh-list
43949912|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43949913|NCT02390427|Trastuzumab|trastuzumab|mesh-list
43949914|NCT02390427|Pertuzumab|pertuzumab|mesh-list
43949915|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43949916|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949917|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
43949918|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43949919|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43949920|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949921|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43949923|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43949924|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949925|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
43949927|NCT01924819|Leucovorin|leucovorin|mesh-list
43949941|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
43949942|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43949943|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43949944|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
43949945|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949946|NCT01924819|Antidotes|antidotes|mesh-ancestor
43949947|NCT01924819|Protective Agents|protective agents|mesh-ancestor
43949948|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
43949949|NCT01924819|Vitamins|vitamins|mesh-ancestor
43949950|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
43949951|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43949952|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43949953|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43949954|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43949955|NCT01126255|Clobetasol|clobetasol|mesh-list
43949956|NCT01126255|Progesterone|progesterone|mesh-list
43949957|NCT01126255|Progestins|progestins|mesh-ancestor
43949958|NCT01126255|Hormones|hormones|mesh-ancestor
43949959|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43949960|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949961|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43949962|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
43949963|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43949964|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43949965|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43949966|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43949967|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43949968|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
43949969|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43949970|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949971|NCT01126099|Prazosin|prazosin|mesh-list
43949984|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949985|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
43949986|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43949987|NCT01126671|Vitamin D|vitamin d|mesh-list
43949988|NCT01126671|Vitamins|vitamins|mesh-ancestor
43949989|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
43949990|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949991|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43949992|NCT01127438|Fospropofol|fospropofol|mesh-list
43949993|NCT01127438|Propofol|propofol|mesh-list
43949994|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43949995|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43949996|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43949997|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43949998|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
43949999|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
43950000|NCT01127581|Dinoprostone|dinoprostone|mesh-list
43950001|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
43950002|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950003|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950004|NCT01128192|Pasireotide|pasireotide|mesh-list
43950005|NCT01128192|Hormones|hormones|mesh-ancestor
43950006|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950007|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950008|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
43950009|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43950010|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950011|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950012|NCT01128972|Listerine|listerine|mesh-list
43950013|NCT01128972|Fluorides|fluorides|mesh-list
43950014|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
43950015|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
43950016|NCT01128972|Protective Agents|protective agents|mesh-ancestor
43950017|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950018|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43950019|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950020|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
43950024|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43950025|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43950026|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43950027|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950028|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43950029|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
43950030|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
43950031|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950032|NCT01129245|Celecoxib|celecoxib|mesh-list
43950033|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950088|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950089|NCT01132846|Protective Agents|protective agents|mesh-ancestor
43950090|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
43950092|NCT01133158|Rituximab|rituximab|mesh-list
43950093|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43950094|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
43950095|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43950096|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950097|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
43950098|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950099|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950100|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950101|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
43758231|NCT02455726|Pregabalin|pregabalin|mesh-list
43950102|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
43950103|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950104|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950105|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
43950106|NCT01133158|Hormones|hormones|mesh-ancestor
43950107|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950108|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950109|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43950110|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
43950111|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950136|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
43950137|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950138|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43950139|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950140|NCT01134575|Rituximab|rituximab|mesh-list
43950141|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43950142|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43950143|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950144|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
43950145|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950203|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43950204|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
43950205|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950206|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950207|NCT01136226|Leuprolide|leuprolide|mesh-list
43950208|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43950209|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
43950210|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950211|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950212|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950213|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950214|NCT01136798|Exenatide|exenatide|mesh-list
43950215|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950216|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950217|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43950218|NCT01136798|Incretins|incretins|mesh-ancestor
43950219|NCT01136798|Hormones|hormones|mesh-ancestor
43950220|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950221|NCT01137396|Modafinil|modafinil|mesh-list
43950222|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43950223|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950224|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43950225|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43950226|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43950227|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172991|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172992|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172993|NCT00291148|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44172994|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44172995|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172996|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
44172997|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44172998|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
44172999|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44173025|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44173026|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44173027|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173028|NCT00291382|Fluticasone|fluticasone|mesh-list
44173030|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44173031|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173032|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44173033|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
44173034|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173035|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950229|NCT01137890|Cocaine|cocaine|mesh-list
43950230|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
43950231|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43767641|NCT02400151|Vitamin D|vitamin d|mesh-list
43950232|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43950233|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950234|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43950235|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950236|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
43950237|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
43950238|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950239|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
43950240|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950241|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43950242|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43950243|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43950244|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
43950245|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950246|NCT01138124|Gabapentin|gabapentin|mesh-list
43950247|NCT01138124|Analgesics|analgesics|mesh-ancestor
43950248|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
43950249|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950250|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950251|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
43950252|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43950253|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950254|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950255|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950256|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43950257|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43950258|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950259|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950260|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
43950261|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
43950262|NCT01138475|Vitamin D|vitamin d|mesh-list
43950263|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43950264|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950265|NCT01138475|Vitamins|vitamins|mesh-ancestor
43950266|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
43950267|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43950268|NCT01138514|Clindamycin|clindamycin|mesh-list
43950269|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
43950270|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
43950271|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43950272|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950273|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950274|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43950275|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950276|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950277|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950278|NCT01138735|Adapalene|adapalene|mesh-list
43950279|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43950280|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43950281|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950282|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950283|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950284|NCT01138735|Analgesics|analgesics|mesh-ancestor
43950285|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
43950286|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950287|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950288|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950289|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950290|NCT01138969|Esomeprazole|esomeprazole|mesh-list
43950291|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43950292|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950293|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43950294|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950295|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950296|NCT01139190|Naproxen|naproxen|mesh-list
43950305|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
43950306|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43950307|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950308|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950310|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43950311|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
43950312|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950313|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950314|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950315|NCT01139801|Misoprostol|misoprostol|mesh-list
43950316|NCT01139801|Oxytocin|oxytocin|mesh-list
43950317|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
43950318|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950319|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950320|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43950321|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
43950322|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43950323|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950324|NCT01140191|Gentamicins|gentamicins|mesh-list
43950325|NCT01140191|Paromomycin|paromomycin|mesh-list
43950326|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950327|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950328|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43950329|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950330|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950331|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43950332|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43950333|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
43950334|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950335|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43950336|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950337|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950338|NCT01141049|Gabapentin|gabapentin|mesh-list
44173036|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44173037|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173038|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44173039|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44173040|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44173041|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43950339|NCT01141049|Analgesics|analgesics|mesh-ancestor
43950340|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
43950341|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950342|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950343|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
43950344|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43691502|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
43950345|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950346|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950347|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950348|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43950349|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43950350|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950351|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950352|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
43950354|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
43950355|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
43950356|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950357|NCT01141569|R04929097|r04929097|mesh-list
43950358|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950359|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950360|NCT01141595|Verapamil|verapamil|mesh-list
43950361|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43950362|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43950387|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950388|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950389|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43950390|NCT01142323|Fenofibrate|fenofibrate|mesh-list
43950391|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43950392|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
43950393|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950394|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43950395|NCT01142947|Beclomethasone|beclomethasone|mesh-list
43950396|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950397|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
43950398|NCT01142947|Hormones|hormones|mesh-ancestor
43950399|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950400|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950401|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43950402|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
43950403|NCT01143181|Brincidofovir|brincidofovir|mesh-list
43950404|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
43950405|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950406|NCT01143688|Albuterol|albuterol|mesh-list
43950407|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43950408|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
43950409|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950410|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950411|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43950412|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
43950413|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
43950414|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950415|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43950416|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43950417|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43950418|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950419|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950420|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173042|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44173043|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173044|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173045|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173047|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43950421|NCT01143766|Gabapentin|gabapentin|mesh-list
43950422|NCT01143766|Analgesics|analgesics|mesh-ancestor
43950423|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
43950424|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950425|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950426|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
43950427|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43950428|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950429|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950430|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950431|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43950432|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43950433|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950434|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950435|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
43950436|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
43950437|NCT01143818|Testosterone|testosterone|mesh-list
43950438|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
43950439|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
43950440|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43950441|NCT01143818|Androgens|androgens|mesh-ancestor
43950442|NCT01143818|Hormones|hormones|mesh-ancestor
43950443|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950444|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950445|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950446|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950447|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
43950448|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
43950449|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43950450|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43950466|NCT01144143|Protective Agents|protective agents|mesh-ancestor
43950467|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950468|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950469|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950470|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950472|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950473|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950474|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43950475|NCT01144338|Incretins|incretins|mesh-ancestor
43950476|NCT01144338|Hormones|hormones|mesh-ancestor
43950477|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950478|NCT01144442|Paclitaxel|paclitaxel|mesh-list
43950479|NCT01144442|Carboplatin|carboplatin|mesh-list
43950480|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43950481|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950482|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
43950483|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
43950484|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
43950485|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950486|NCT01144455|Gemcitabine|gemcitabine|mesh-list
43950487|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
43950488|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43950489|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
43950490|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950491|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950492|NCT01144455|Antiviral Agents|antiviral agents|mesh-ancestor
43950493|NCT01144455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950494|NCT01144455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950495|NCT01144455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950496|NCT01144455|Immunologic Factors|immunologic factors|mesh-ancestor
43950497|NCT01144455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950498|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43950499|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
43950500|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43950501|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
43950502|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43950503|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43950504|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43950505|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43950506|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950507|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950508|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950509|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950510|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43950511|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44141749|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44141750|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44141751|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44141752|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44141753|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44141754|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
44141755|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44141756|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44141757|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44141758|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44141759|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44141760|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44141761|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
44141762|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157505|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157506|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
44157507|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158392|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158394|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158395|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158396|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158397|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158398|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158399|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158402|NCT00236665|Topiramate|topiramate|mesh-list
44158404|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158405|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158406|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
44158407|NCT00236678|Hematinics|hematinics|mesh-ancestor
44158408|NCT00236691|Topiramate|topiramate|mesh-list
44158409|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
44158410|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158411|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158412|NCT00236704|Topiramate|topiramate|mesh-list
44158413|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
44158414|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158415|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158416|NCT00236717|Topiramate|topiramate|mesh-list
43691616|NCT02785978|Levodopa|levodopa|mesh-list
43950549|NCT01146457|Narcotics|narcotics|mesh-ancestor
43950550|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950551|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950552|NCT01146457|Analgesics|analgesics|mesh-ancestor
43950553|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
43950554|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950555|NCT01146600|Clarithromycin|clarithromycin|mesh-list
43950556|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950557|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950558|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43950559|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950560|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950561|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43950562|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43950563|NCT01146808|Adefovir|adefovir|mesh-list
43950564|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43950565|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
43950566|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950567|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43950568|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43950569|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950570|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950571|NCT01146834|Plerixafor|plerixafor|mesh-list
43950572|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
43950573|NCT01146834|Bortezomib|bortezomib|mesh-list
43950574|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950575|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
43950576|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950577|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950592|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43950593|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950595|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43950596|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43950597|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950598|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950599|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950600|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950601|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43950602|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43950603|NCT01147627|Insulin|insulin|mesh-list
43950604|NCT01147627|Pioglitazone|pioglitazone|mesh-list
43950605|NCT01147627|Exenatide|exenatide|mesh-list
43950606|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
43950607|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43950608|NCT01147627|Protamines|protamines|mesh-list
43950609|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950610|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950611|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43950612|NCT01147627|Incretins|incretins|mesh-ancestor
43950613|NCT01147627|Hormones|hormones|mesh-ancestor
43950614|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950615|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
43950616|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950618|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43950619|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
43950643|NCT01149434|Everolimus|everolimus|mesh-list
43950644|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950645|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950646|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
43950647|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950648|NCT01149616|Dexamethasone|dexamethasone|mesh-list
43950649|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950650|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
43950651|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
43950652|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950653|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950654|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950655|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
43950656|NCT01149616|Hormones|hormones|mesh-ancestor
43950657|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950658|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950659|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950660|NCT01149733|Tamsulosin|tamsulosin|mesh-list
43950661|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43950662|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43950663|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43950664|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950665|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950666|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950667|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950668|NCT01149733|Urological Agents|urological agents|mesh-ancestor
43950669|NCT01149759|Cyclosporine|cyclosporine|mesh-list
43950670|NCT01149759|Cyclosporins|cyclosporins|mesh-list
43950671|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950672|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950673|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950674|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
43950685|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43950686|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43950687|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950688|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950689|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43950691|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950692|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950693|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43950694|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950695|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43950696|NCT01149876|Tretinoin|tretinoin|mesh-list
43950697|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950698|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
43950699|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950700|NCT01150461|Losartan|losartan|mesh-list
43950701|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
43950702|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43950703|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43950704|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43950705|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43950706|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950707|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43950708|NCT01150500|Sirolimus|sirolimus|mesh-list
43950709|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950710|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950711|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43950712|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950713|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
43950714|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950727|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43950728|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950729|NCT01151046|Exemestane|exemestane|mesh-list
43950730|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950731|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43950732|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43950733|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950734|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950735|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43950736|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
44141763|NCT00184106|Paroxetine|paroxetine|mesh-list
43950737|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950738|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950739|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
43950740|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43950741|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
43950742|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950743|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
43950744|NCT01151436|Protective Agents|protective agents|mesh-ancestor
43950745|NCT01151449|R04929097|r04929097|mesh-list
43950746|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950747|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950748|NCT01151761|Gemcitabine|gemcitabine|mesh-list
43950749|NCT01151761|Cisplatin|cisplatin|mesh-list
43950750|NCT01151761|Carboplatin|carboplatin|mesh-list
43950751|NCT01151761|Fluorouracil|fluorouracil|mesh-list
43950752|NCT01151761|Capecitabine|capecitabine|mesh-list
43950753|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950754|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43950755|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
43950756|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950757|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
43950758|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950759|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950760|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950766|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
43950767|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950768|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950769|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950770|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
43950771|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950772|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43950773|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950774|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950775|NCT01152515|Remifentanil|remifentanil|mesh-list
43950776|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43950777|NCT01152515|Narcotics|narcotics|mesh-ancestor
43950778|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950779|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950780|NCT01152515|Analgesics|analgesics|mesh-ancestor
43950781|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
43950782|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950783|NCT01152697|Haloperidol|haloperidol|mesh-list
43950784|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
43950785|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
43950786|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
43950787|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950788|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950789|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950790|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43950791|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950792|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43950793|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950794|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43950795|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
43950796|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950797|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950800|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43950807|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950808|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950809|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43950811|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950812|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43950813|NCT01153581|Progestins|progestins|mesh-ancestor
43950814|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
43950815|NCT01153620|Polihexanide|polihexanide|mesh-list
43950816|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
43950817|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950818|NCT01153672|Letrozole|letrozole|mesh-list
43950819|NCT01153672|Anastrozole|anastrozole|mesh-list
43950820|NCT01153672|Vorinostat|vorinostat|mesh-list
43950821|NCT01153672|Exemestane|exemestane|mesh-list
43950822|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950823|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43950824|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43950825|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950826|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950827|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43950828|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
43950829|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950830|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950831|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950832|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43950833|NCT01153711|Ketoconazole|ketoconazole|mesh-list
43950834|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
43950835|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950851|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950852|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950853|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
43950854|NCT01154192|Hormones|hormones|mesh-ancestor
43950855|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43950856|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43950857|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950858|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43950859|NCT01155154|Clindamycin|clindamycin|mesh-list
43950860|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
43950861|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
43950862|NCT01155154|Cephalexin|cephalexin|mesh-list
43950863|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950864|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950865|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43950866|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950867|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950868|NCT01155999|Tobramycin|tobramycin|mesh-list
43950869|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950870|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950871|NCT01156571|Clopidogrel|clopidogrel|mesh-list
43950872|NCT01156571|Cangrelor|cangrelor|mesh-list
43950873|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43950874|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43950875|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43950876|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43950877|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
43950878|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950880|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950896|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
43950897|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950898|NCT01157429|Cycloserine|cycloserine|mesh-list
43950899|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43950900|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950901|NCT01157429|Renal Agents|renal agents|mesh-ancestor
43950902|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43950903|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
43950904|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43950905|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
43950906|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950907|NCT01158651|Everolimus|everolimus|mesh-list
43950908|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950909|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950910|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
43950911|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950913|NCT01158703|Clopidogrel|clopidogrel|mesh-list
43950914|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43950915|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950916|NCT01158703|Analgesics|analgesics|mesh-ancestor
43950917|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
43950918|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950919|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43950920|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43950921|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950922|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43950923|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43950935|NCT01158820|Fentanyl|fentanyl|mesh-list
43950942|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43950944|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
43950945|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43950946|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43950947|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43950948|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43950949|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
43950950|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43950951|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950952|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43950953|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43950954|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
43950955|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
43950956|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43950957|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43950958|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43950959|NCT01158820|Narcotics|narcotics|mesh-ancestor
43950960|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43950961|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43950962|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43950963|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43950964|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
43950965|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
43950966|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43950967|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
43950968|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
43950969|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
43950970|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43950971|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43950972|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
43950973|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
43950974|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43950975|NCT01158885|Cytarabine|cytarabine|mesh-list
43950976|NCT01158885|Methotrexate|methotrexate|mesh-list
43950977|NCT01158885|Clofarabine|clofarabine|mesh-list
43950983|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
43950984|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43950985|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43950986|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
43950987|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43950988|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43950989|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43950990|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
43950991|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43950992|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43950993|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
43950994|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43950996|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
43950997|NCT01159054|Niacinamide|niacinamide|mesh-list
43950998|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43950999|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
43951000|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951001|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43951002|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951003|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
43951004|NCT01159054|Vitamins|vitamins|mesh-ancestor
43951005|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
43951006|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951007|NCT01159067|Deferasirox|deferasirox|mesh-list
43951008|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43951009|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
43951010|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
43951011|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951012|NCT01159262|Fentanyl|fentanyl|mesh-list
43951013|NCT01159262|Midazolam|midazolam|mesh-list
43951014|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
43951015|NCT01159262|Morphine|morphine|mesh-list
43951016|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43951018|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951027|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951028|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951029|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43951030|NCT01159262|Narcotics|narcotics|mesh-ancestor
43951031|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43951032|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43951033|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
43951034|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
43951035|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43951036|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43951037|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951038|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
43951039|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
43951041|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43951042|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951043|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43951044|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43951045|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43951046|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951047|NCT01160445|Aldesleukin|aldesleukin|mesh-list
43951048|NCT01160445|Zanolimumab|zanolimumab|mesh-list
43951049|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951050|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43951051|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43951052|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
43951053|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951054|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44141764|NCT00184106|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44141765|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44141766|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141767|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141768|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141769|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
44173048|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
44141775|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44141776|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141777|NCT00184171|Budesonide|budesonide|mesh-list
44141778|NCT00184171|Bismuth|bismuth|mesh-list
44141779|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44141780|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44141781|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
44141782|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141783|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141784|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44141785|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141786|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
44141787|NCT00184171|Hormones|hormones|mesh-ancestor
44141788|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141789|NCT00184171|Antacids|antacids|mesh-ancestor
44141790|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141791|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141792|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
44141793|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44141794|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44141795|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141796|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
44141797|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141798|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141799|NCT00184496|Methadone|methadone|mesh-list
44141800|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44141801|NCT00184496|Narcotics|narcotics|mesh-ancestor
44141802|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141803|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141804|NCT00184496|Analgesics|analgesics|mesh-ancestor
44141805|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
44141818|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141820|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
44141821|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
44141822|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141823|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141824|NCT00184587|Candesartan|candesartan|mesh-list
43951055|NCT01160848|Ethanol|ethanol|mesh-list
43951056|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43951057|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951058|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951059|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951060|NCT01161121|Adenosine|adenosine|mesh-list
43951061|NCT01161121|Regadenoson|regadenoson|mesh-list
43951062|NCT01161121|Analgesics|analgesics|mesh-ancestor
43951063|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
43951064|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951065|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951066|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43951067|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951068|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43951069|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
43951074|NCT01161563|Leuprolide|leuprolide|mesh-list
43951102|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
43951103|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43951104|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951105|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951106|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
43951107|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951108|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951109|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
43951110|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951111|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43951112|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951113|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
43951114|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951115|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43951116|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951117|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951118|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43951119|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
44173049|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173050|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173052|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173053|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44173055|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173056|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173057|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44173058|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
44173059|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
44173060|NCT00291408|Protective Agents|protective agents|mesh-ancestor
44173062|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173063|NCT00291616|Interferons|interferons|mesh-list
44173064|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
44173065|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
44173066|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44173067|NCT00291616|Thymalfasin|thymalfasin|mesh-list
44173068|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173069|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
44173070|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173071|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
44173072|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173073|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44173074|NCT00291707|Pemetrexed|pemetrexed|mesh-list
44173075|NCT00291707|Cetuximab|cetuximab|mesh-list
44173076|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173077|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173078|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173079|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44173080|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44173081|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173082|NCT00291720|Spironolactone|spironolactone|mesh-list
44173083|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44173084|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173085|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951120|NCT01162733|Vancomycin|vancomycin|mesh-list
43951121|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951122|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951123|NCT01163097|Heparin|heparin|mesh-list
43951124|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
43951125|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43951126|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43951127|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951128|NCT01163214|Ropivacaine|ropivacaine|mesh-list
43951129|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
43951130|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
43951131|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951132|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951133|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
43951134|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951135|NCT01163604|Argatroban|argatroban|mesh-list
43951136|NCT01163604|Clopidogrel|clopidogrel|mesh-list
43951137|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951138|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951139|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43951140|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951174|NCT01165047|Protective Agents|protective agents|mesh-ancestor
43951175|NCT01165112|Rituximab|rituximab|mesh-list
43951176|NCT01165112|Carboplatin|carboplatin|mesh-list
43951177|NCT01165112|Etoposide|etoposide|mesh-list
43951178|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43951179|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951180|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951181|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
43951182|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951183|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951184|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43951185|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43951186|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43951187|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951188|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951189|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43951190|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
43951191|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43951192|NCT01165541|Mirtazapine|mirtazapine|mesh-list
43951193|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
43951194|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951195|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43951196|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43951197|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951198|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951199|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43951200|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
43951201|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
43951202|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951203|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951204|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44141825|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
43951205|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43951206|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43951207|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951208|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173086|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951209|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43951210|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43951212|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43951213|NCT01165840|Dapsone|dapsone|mesh-list
43951214|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951215|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
43951216|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43951217|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43951218|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43951219|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951220|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951221|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
43951222|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951271|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951272|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951273|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951274|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43951275|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43951276|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951277|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951278|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43951279|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
43951280|NCT01168687|Levetiracetam|levetiracetam|mesh-list
43951281|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
43951282|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
43951283|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
43951284|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951285|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43951286|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43951287|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951288|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951289|NCT01168908|Urological Agents|urological agents|mesh-ancestor
43951290|NCT01168934|Crizotinib|crizotinib|mesh-list
43951291|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951292|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43951293|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951294|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951295|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
43951296|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43951297|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173087|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44173088|NCT00291720|Diuretics|diuretics|mesh-ancestor
44173089|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
44173090|NCT00291733|Levetiracetam|levetiracetam|mesh-list
44173091|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
44173092|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
44173093|NCT00291746|Esomeprazole|esomeprazole|mesh-list
44173094|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44173095|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173096|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44173097|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173098|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173100|NCT00291759|Anastrozole|anastrozole|mesh-list
44173101|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44173102|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173103|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173104|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951298|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951300|NCT01169467|Analgesics|analgesics|mesh-ancestor
43951301|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
43951302|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951303|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43951304|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43951305|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43951306|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
43951307|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951308|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951309|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
43951310|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
43951311|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43951312|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43951313|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951314|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951315|NCT01169519|Urological Agents|urological agents|mesh-ancestor
43951316|NCT01170117|Olanzapine|olanzapine|mesh-list
43951317|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
43951318|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
43951319|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951320|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951321|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951322|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43951323|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43951324|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951325|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43951326|NCT01170117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43951327|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43951328|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43951329|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951330|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951331|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
43951332|NCT01170247|Ketamine|ketamine|mesh-list
43951334|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
43951335|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951336|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951337|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43951338|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43951339|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
43951340|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
43951341|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951342|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43951343|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43951344|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951345|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951346|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43951347|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43951348|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
43951349|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43951350|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43951351|NCT01170390|Estradiol|estradiol|mesh-list
43951352|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43951353|NCT01170390|Estrogens|estrogens|mesh-ancestor
43951354|NCT01170390|Hormones|hormones|mesh-ancestor
43951355|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951356|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951357|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43951358|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
43951359|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43951360|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43951361|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43951362|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43951363|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43951364|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43951366|NCT01170533|Pantoprazole|pantoprazole|mesh-list
43951373|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43951374|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43951376|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
43951377|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951378|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951379|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43951380|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951381|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951382|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951383|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
43951384|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43951385|NCT01170754|Laxatives|laxatives|mesh-ancestor
43951386|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951387|NCT01170884|Timolol|timolol|mesh-list
43951388|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43951389|NCT01170884|Bimatoprost|bimatoprost|mesh-list
43951390|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43951391|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43951392|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43951393|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951394|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
43951395|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951396|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951397|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951398|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43951399|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43951400|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43951401|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43951402|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43951403|NCT01170949|Miltefosine|miltefosine|mesh-list
43951404|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
43951405|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951406|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951407|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43951408|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43951409|NCT01171118|Physostigmine|physostigmine|mesh-list
43951410|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43951411|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951412|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951413|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
43951414|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951415|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951417|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
43951418|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951419|NCT01171690|Teriparatide|teriparatide|mesh-list
43951420|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951421|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951422|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43951423|NCT01171794|Ibuprofen|ibuprofen|mesh-list
43951424|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43951425|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43951426|NCT01171794|Analgesics|analgesics|mesh-ancestor
43951427|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
43951428|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951429|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951430|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43951431|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951432|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43951433|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951434|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951435|NCT01172145|Modafinil|modafinil|mesh-list
43951436|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43951437|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951438|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43951439|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43951440|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43951441|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951442|NCT01172197|Ropivacaine|ropivacaine|mesh-list
43951443|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
43951444|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
43951445|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
43951446|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951447|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951448|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
43951449|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951451|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
43951452|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43951453|NCT01172418|Daclizumab|daclizumab|mesh-list
43951454|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
43951455|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759035|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
43951456|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951457|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951458|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951459|NCT01172522|Fexofenadine|fexofenadine|mesh-list
43951460|NCT01172522|Terfenadine|terfenadine|mesh-list
43951461|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43951462|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43951463|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43951464|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
43951465|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
43951466|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951467|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951468|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951469|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
43951470|NCT01172600|Entonox|entonox|mesh-list
43951471|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43951472|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
43951473|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
43951474|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43951475|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951476|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43951477|NCT01172600|Analgesics|analgesics|mesh-ancestor
43951478|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
43951479|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951480|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43951481|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
43951482|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
43951483|NCT01173029|Diuretics|diuretics|mesh-list
43951484|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43631831|NCT03041948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43951485|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43951486|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
43951487|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43951488|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951489|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951490|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
43951491|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951492|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
43951493|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951494|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43951495|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
43951496|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951497|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43951498|NCT01173211|Vaccines|vaccines|mesh-list
43951499|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
43951500|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951501|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
43951502|NCT01173848|Vitamin D|vitamin d|mesh-list
43951503|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
43951504|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951505|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951506|NCT01173848|Vitamins|vitamins|mesh-ancestor
43951507|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
43951508|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43951509|NCT01174082|Vaccines|vaccines|mesh-list
43951532|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43951533|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43951534|NCT01175395|Ranibizumab|ranibizumab|mesh-list
43951535|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43951536|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43951537|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
43951538|NCT01175395|Hormones|hormones|mesh-ancestor
43951539|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951540|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951541|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951542|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
43951543|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951544|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951545|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43951546|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43951547|NCT01175395|Growth Substances|growth substances|mesh-ancestor
43951548|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
43951549|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951550|NCT01175798|Vitamin D|vitamin d|mesh-list
43951551|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
43951552|NCT01175798|Vitamins|vitamins|mesh-ancestor
43951553|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
43951554|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951555|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43951556|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43951557|NCT01175902|Timolol|timolol|mesh-list
43951558|NCT01175902|Dorzolamide|dorzolamide|mesh-list
43951559|NCT01175902|Latanoprost|latanoprost|mesh-list
43951560|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43951561|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951562|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
43951563|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951564|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951565|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951566|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43951571|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951573|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951574|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43951575|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951576|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141826|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
43951577|NCT01176435|Levodopa|levodopa|mesh-list
43951578|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43951579|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43951580|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
43951581|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951582|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951583|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951584|NCT01176591|Aprepitant|aprepitant|mesh-list
43951585|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
43951586|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
43951587|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
43951588|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951589|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951590|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951591|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43951592|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951593|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951594|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43951595|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
43951596|NCT01176981|Methotrexate|methotrexate|mesh-list
43951619|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951620|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951621|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951622|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43951623|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43951624|NCT01177189|Ascorbic Acid|ascorbic acid|mesh-list
43951625|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
43951626|NCT01177189|Vitamins|vitamins|mesh-ancestor
43951627|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
43951628|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951629|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
43951630|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951631|NCT01177189|Protective Agents|protective agents|mesh-ancestor
43951632|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
43951633|NCT01177709|Metformin|metformin|mesh-list
43951634|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951635|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951636|NCT01177735|Pomalidomide|pomalidomide|mesh-list
43951637|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
43951638|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951639|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43951640|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43951641|NCT01177735|Growth Substances|growth substances|mesh-ancestor
43951642|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
43951643|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951644|NCT01177956|Cisplatin|cisplatin|mesh-list
43951645|NCT01177956|Fluorouracil|fluorouracil|mesh-list
43951646|NCT01177956|Cetuximab|cetuximab|mesh-list
43951647|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951648|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
43767687|NCT02400112|Vancomycin|vancomycin|mesh-list
43951649|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951650|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43951651|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951652|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
43951653|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951654|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951656|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43951657|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951658|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
43951659|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951660|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951661|NCT01178281|Thalidomide|thalidomide|mesh-list
43951662|NCT01178281|Pomalidomide|pomalidomide|mesh-list
43951663|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
43951664|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951665|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43951666|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43951667|NCT01178281|Growth Substances|growth substances|mesh-ancestor
43951668|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
43951669|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951670|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951671|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
43951672|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951673|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951674|NCT01178528|Carvedilol|carvedilol|mesh-list
43951675|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43951676|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951677|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
43951682|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
43951709|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43951710|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43951711|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951712|NCT01179113|Esmolol|esmolol|mesh-list
43951713|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43951714|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43951715|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43951716|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
43951717|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951718|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951719|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951720|NCT01179490|Prednisolone|prednisolone|mesh-list
43951721|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43951722|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
43951723|NCT01179490|Hormones|hormones|mesh-ancestor
43951724|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43951725|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951726|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43951727|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951728|NCT01179568|Citalopram|citalopram|mesh-list
43951729|NCT01179568|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43951730|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43951731|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43951755|NCT01180894|Hematinics|hematinics|mesh-ancestor
43951756|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
43951757|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
43951758|NCT01181258|Rituximab|rituximab|mesh-list
43951759|NCT01181258|Fludarabine|fludarabine|mesh-list
43951760|NCT01181258|Interleukin-2|interleukin-2|mesh-list
43951761|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951762|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
43951764|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951826|NCT01183312|Protective Agents|protective agents|mesh-ancestor
43951827|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951828|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
43951829|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
43951830|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43951831|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951833|NCT01183481|Granisetron|granisetron|mesh-list
43951834|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
43951835|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
43951836|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43951837|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951838|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43951890|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43951891|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43951892|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43951893|NCT01184885|Sirolimus|sirolimus|mesh-list
43951894|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
43951895|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43951896|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43951897|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951898|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43951899|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43951900|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
43951901|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43951902|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
43951903|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951904|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43951950|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43951951|NCT01186406|Growth Substances|growth substances|mesh-ancestor
43951952|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43951953|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
43951954|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43951955|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
43951956|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43951957|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43951958|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43951959|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952009|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43952010|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952011|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952012|NCT01188369|Protective Agents|protective agents|mesh-ancestor
43952013|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952015|NCT01188421|Buprenorphine|buprenorphine|mesh-list
43952016|NCT01188421|Tramadol|tramadol|mesh-list
43952017|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43952018|NCT01188421|Naloxone|naloxone|mesh-list
43952019|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43952020|NCT01188421|Narcotics|narcotics|mesh-ancestor
43952023|NCT01188421|Analgesics|analgesics|mesh-ancestor
43952074|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
43952075|NCT01188928|Hormones|hormones|mesh-ancestor
43952076|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952077|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952078|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952079|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952080|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
43952081|NCT01189240|Bevacizumab|bevacizumab|mesh-list
43952082|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43952083|NCT01189240|Antibodies|antibodies|mesh-list
43952084|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
43952085|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43952086|NCT01189240|R04929097|r04929097|mesh-list
43952087|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952088|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952089|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952090|NCT01189240|Growth Substances|growth substances|mesh-ancestor
43952091|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952092|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
43952093|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
43952094|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952095|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952096|NCT01189279|Bimatoprost|bimatoprost|mesh-list
43952097|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43952098|NCT01189292|Dexamethasone|dexamethasone|mesh-list
43952099|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952100|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
43952101|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
43952102|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952103|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952104|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173105|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173106|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173107|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44173108|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43613723|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43613729|NCT05049525|Itraconazole|itraconazole|mesh-list
43613730|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43613731|NCT05049525|Terbinafine|terbinafine|mesh-list
43613732|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
43613743|NCT05041101|Halichondrin B|halichondrin b|mesh-list
44173109|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44173110|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44173111|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43952105|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
43952106|NCT01189292|Hormones|hormones|mesh-ancestor
44157508|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
43952107|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952108|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43952109|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952111|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952112|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43952113|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952114|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952115|NCT01189409|Sennosides|sennosides|mesh-list
43952116|NCT01189409|Laxatives|laxatives|mesh-ancestor
43952117|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44141856|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44141857|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141858|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44141859|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44141860|NCT00184795|Norethindrone|norethindrone|mesh-list
44141861|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
44141862|NCT00184795|Estradiol|estradiol|mesh-list
44141863|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44141864|NCT00184795|Estrogens|estrogens|mesh-ancestor
44141865|NCT00184795|Hormones|hormones|mesh-ancestor
44141866|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44141867|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141868|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44141869|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
44141870|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43952138|NCT01190878|Bromfenac|bromfenac|mesh-list
43952139|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43952140|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952141|NCT01190878|Analgesics|analgesics|mesh-ancestor
43952142|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
43952143|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952144|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952145|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952146|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952147|NCT01191255|Sevelamer|sevelamer|mesh-list
43952148|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
43952149|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
43952150|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952151|NCT01191320|Enclomiphene|enclomiphene|mesh-list
43952152|NCT01191320|Clomiphene|clomiphene|mesh-list
43952153|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
43952154|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43952155|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
43952156|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952157|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952162|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43952163|NCT01191398|Atropine|atropine|mesh-list
43952164|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
43952165|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43952166|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43952167|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43952168|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
43952169|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952170|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952171|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952173|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
43952226|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952227|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952228|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43952229|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43952230|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
43952231|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952233|NCT01194297|Vaccines|vaccines|mesh-list
43952295|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43952296|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952297|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952298|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952299|NCT01195116|Analgesics|analgesics|mesh-ancestor
43952300|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
43952301|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952302|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43952303|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43952304|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952305|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952306|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952307|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952308|NCT01195467|Tenofovir|tenofovir|mesh-list
43952309|NCT01195467|Emtricitabine|emtricitabine|mesh-list
43952352|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43952353|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
43952354|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952355|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952356|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43952357|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
43952358|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
43952359|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43952360|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43693091|NCT02776189|Midazolam|midazolam|mesh-list
43952361|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43952362|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952376|NCT01197612|Budesonide|budesonide|mesh-list
43952415|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43952416|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952417|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952418|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
43952419|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952420|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952421|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43952483|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952484|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952485|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43952486|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
43952487|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
43952488|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43952489|NCT01200433|Analgesics|analgesics|mesh-ancestor
43952490|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
43952491|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952492|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43952493|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43952494|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43952495|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952496|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952497|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952498|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43952499|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43952540|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952541|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43952542|NCT01203046|Ertapenem|ertapenem|mesh-list
43952543|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952544|NCT01203189|Ketoconazole|ketoconazole|mesh-list
43952545|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
43952546|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952547|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43952548|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43952549|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952604|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
43952605|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
43952606|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
43952607|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43952608|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952609|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
43952610|NCT01205503|Doxorubicin|doxorubicin|mesh-list
43952611|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43952612|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
43952613|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952614|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43952615|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43952616|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
43952617|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952618|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952619|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43952620|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43952621|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43952622|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43952623|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952624|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
44141893|NCT00184847|Adenosine|adenosine|mesh-list
44141894|NCT00184847|Acetylcholine|acetylcholine|mesh-list
43952635|NCT01206387|Desoximetasone|desoximetasone|mesh-list
43952636|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43952637|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
43952638|NCT01206387|Hormones|hormones|mesh-ancestor
43952639|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952640|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952699|NCT01206660|Hormones|hormones|mesh-ancestor
43952700|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43952701|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952702|NCT01207401|Lidocaine|lidocaine|mesh-list
43952703|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
43952704|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
43952705|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952706|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952707|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
43952708|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952709|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43952710|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43952711|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43952758|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952759|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952760|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
43952761|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43952762|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43952763|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43952764|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43952765|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43952766|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43952767|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952821|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
43952822|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43952823|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43952824|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43952825|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
43952826|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43952827|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952828|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952829|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43952830|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43952831|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43952832|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
43952833|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952834|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952835|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43952836|NCT01212952|Dexamethasone|dexamethasone|mesh-list
43952879|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952880|NCT01213576|Ivermectin|ivermectin|mesh-list
43952882|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43952883|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952884|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
43952885|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
43952886|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43952887|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43952888|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
43952889|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
43952890|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
43952891|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952892|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952943|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43952944|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43952945|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43759531|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
43952946|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43952947|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952948|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
43952949|NCT01214317|Analgesics|analgesics|mesh-ancestor
43952950|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
43952951|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43952952|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952953|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952954|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43952955|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43952956|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952957|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952958|NCT01214356|Vitamin D|vitamin d|mesh-list
43952959|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
43952960|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
43952961|NCT01214356|Vitamins|vitamins|mesh-list
43952962|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
43952963|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43952964|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43952965|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43952966|NCT01214759|Tenofovir|tenofovir|mesh-list
43952967|NCT01214759|Emtricitabine|emtricitabine|mesh-list
43952968|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
43952969|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43952970|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
43952971|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952972|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43952973|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43952974|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43952975|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43952976|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43952980|NCT01215110|Bedaquiline|bedaquiline|mesh-list
43952981|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
43952982|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43952983|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43952984|NCT01215123|Bevacizumab|bevacizumab|mesh-list
43952985|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43952986|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43952987|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43952988|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43952996|NCT01215292|Acyline|acyline|mesh-list
43953047|NCT01215344|Growth Substances|growth substances|mesh-ancestor
43953048|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
43953049|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953051|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43953052|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
43953053|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953054|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
43953055|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953056|NCT01215786|Timolol|timolol|mesh-list
43953057|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43953058|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43953059|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43953060|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43953061|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953062|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953063|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953064|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953065|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953066|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953067|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
43953068|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43953069|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953070|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43953071|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43953072|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953073|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953074|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
43953076|NCT01216241|Daptomycin|daptomycin|mesh-list
43953091|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
43953092|NCT01216410|Ondansetron|ondansetron|mesh-list
43953093|NCT01216410|Metoclopramide|metoclopramide|mesh-list
43953094|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
43953095|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
43953096|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953097|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953098|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953099|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
43953100|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953160|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953161|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953162|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43953163|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43953164|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43953166|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953167|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953168|NCT01217515|Diltiazem|diltiazem|mesh-list
43953169|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953170|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43953171|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953172|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953173|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953174|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953175|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
43953176|NCT01217749|Ofatumumab|ofatumumab|mesh-list
43953177|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953178|NCT01217840|Vitamin D|vitamin d|mesh-list
43953179|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
43953180|NCT01217840|Vitamins|vitamins|mesh-ancestor
43953181|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
43953182|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953183|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953184|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953185|NCT01218048|Cisplatin|cisplatin|mesh-list
43953209|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43953210|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43953211|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953212|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
43953213|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953214|NCT01218984|Naltrexone|naltrexone|mesh-list
43953215|NCT01218984|Hydromorphone|hydromorphone|mesh-list
43953216|NCT01218984|Naloxone|naloxone|mesh-list
43953217|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43953218|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43953219|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953220|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
43953222|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43953273|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43953274|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
43953275|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953276|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953277|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43953278|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
43953279|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
43953280|NCT01220687|Protective Agents|protective agents|mesh-ancestor
44141895|NCT00184847|Caffeine|caffeine|mesh-list
44141896|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44141897|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141898|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44141899|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953303|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43953304|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953305|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953306|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953307|NCT01221298|Ritonavir|ritonavir|mesh-list
43953308|NCT01221298|Ribavirin|ribavirin|mesh-list
43953309|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43953310|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43953311|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953312|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953314|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43953366|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43953367|NCT01222260|Dexamethasone|dexamethasone|mesh-list
43953368|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43767692|NCT02400021|Hormones|hormones|mesh-ancestor
43953369|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953370|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
43953371|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
43953372|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953373|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953374|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953432|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953434|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
43953435|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
43953436|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43953437|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953438|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
43953439|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953440|NCT01224210|Ambrisentan|ambrisentan|mesh-list
43953441|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953443|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953444|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953445|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43953446|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953447|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953448|NCT01224678|Vitamin D|vitamin d|mesh-list
43953449|NCT01224678|Vitamins|vitamins|mesh-ancestor
43953450|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
43953451|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953452|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953453|NCT01225055|Teriparatide|teriparatide|mesh-list
43953454|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953455|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953456|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953457|NCT01225068|Milnacipran|milnacipran|mesh-list
43953458|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
43953459|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43953460|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43953461|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43953462|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953463|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953464|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953474|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
43953475|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953476|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953477|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43953478|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43953479|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
43953480|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953481|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43953482|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43953483|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953485|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
43953486|NCT01225289|Vitamins|vitamins|mesh-ancestor
43953487|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
43953489|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
43953536|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953537|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953538|NCT01227655|Levodopa|levodopa|mesh-list
43953539|NCT01227655|Carbidopa|carbidopa|mesh-list
43953540|NCT01227655|Opicapone|opicapone|mesh-list
43953541|NCT01227655|Benserazide|benserazide|mesh-list
43953542|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43953543|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43953544|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
43953545|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953546|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953547|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953548|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43953549|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953550|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43953551|NCT01227993|Finasteride|finasteride|mesh-list
43953552|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43953553|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43953554|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759723|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43953555|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953556|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
43953557|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953558|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953559|NCT01227993|Urological Agents|urological agents|mesh-ancestor
43953560|NCT01228084|Sulforaphane|sulforaphane|mesh-list
43953561|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43953562|NCT01228084|Protective Agents|protective agents|mesh-ancestor
43953563|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953564|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953576|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953577|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
43953578|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953579|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43953580|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
43953581|NCT01228903|Protective Agents|protective agents|mesh-ancestor
43953582|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953583|NCT01229228|Naproxen|naproxen|mesh-list
43953584|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43953585|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43953586|NCT01229228|Analgesics|analgesics|mesh-ancestor
43953587|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
43953588|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953589|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953590|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953591|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953592|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
43953593|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43953594|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953595|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953596|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43953597|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953598|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43953599|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43953600|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43953601|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
43953602|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953603|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953604|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953605|NCT01229423|Bimatoprost|bimatoprost|mesh-list
43953606|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953607|NCT01229462|Timolol|timolol|mesh-list
43953609|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43953610|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43953616|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953617|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953618|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953619|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43953620|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43953621|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43953623|NCT01229527|Remifentanil|remifentanil|mesh-list
43953624|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43953625|NCT01229527|Narcotics|narcotics|mesh-ancestor
43953626|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43953681|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
43953682|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953683|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953684|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953686|NCT01230593|Hormones|hormones|mesh-ancestor
43953687|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953688|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43953689|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953690|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953691|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953748|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
43953749|NCT01231399|Everolimus|everolimus|mesh-list
43953750|NCT01231399|Calcium|calcium|mesh-list
43953751|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
43953752|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43953753|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953754|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43953755|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
43953756|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953757|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43953758|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953760|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
43953761|NCT01231399|Antidotes|antidotes|mesh-ancestor
43953762|NCT01231399|Protective Agents|protective agents|mesh-ancestor
43953763|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
43953764|NCT01231399|Vitamins|vitamins|mesh-ancestor
43953765|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
43953766|NCT01231412|Cyclosporine|cyclosporine|mesh-list
43953767|NCT01231412|Sirolimus|sirolimus|mesh-list
43953768|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
43953769|NCT01231412|Fludarabine|fludarabine|mesh-list
43953770|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
43953771|NCT01231412|Cyclosporins|cyclosporins|mesh-list
43953772|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953773|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43953774|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
43953775|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953776|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953777|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
43953778|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953779|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953780|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
43953781|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953794|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43953795|NCT01231633|Growth Substances|growth substances|mesh-ancestor
43953796|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953797|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
43953798|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43953799|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
43953800|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
43953801|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953802|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43953803|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
43953804|NCT01231633|Hormones|hormones|mesh-ancestor
43953805|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953806|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43953807|NCT01231841|Cyclosporine|cyclosporine|mesh-list
43953808|NCT01231841|Cyclosporins|cyclosporins|mesh-list
43953809|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
43953810|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43953811|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
43953812|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953813|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953850|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43953851|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953852|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
43953853|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953854|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43953855|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43953856|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43953857|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
43953858|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953859|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953860|NCT01232946|Insulin|insulin|mesh-list
43953861|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43953862|NCT01232946|Liraglutide|liraglutide|mesh-list
43953863|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
43953864|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43953865|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953866|NCT01232946|Incretins|incretins|mesh-ancestor
43953867|NCT01232946|Hormones|hormones|mesh-ancestor
43953868|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953869|NCT01233921|Mitogens|mitogens|mesh-list
43953870|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
43953871|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953872|NCT01234714|Liver Extracts|liver extracts|mesh-list
43953873|NCT01234714|Hematinics|hematinics|mesh-ancestor
43953874|NCT01234766|Rituximab|rituximab|mesh-list
43953875|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43953876|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43953877|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953878|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
43953879|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953880|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953881|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43953882|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
43953883|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141926|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43953887|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953888|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953889|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953890|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
43953891|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43953892|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
43953893|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
43953894|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953895|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953896|NCT01234922|Losartan|losartan|mesh-list
43953897|NCT01234922|Ramipril|ramipril|mesh-list
43953898|NCT01234922|Lisinopril|lisinopril|mesh-list
43953899|NCT01234922|Benazepril|benazepril|mesh-list
43953900|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43953901|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43953902|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43953903|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43953904|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953905|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43953906|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
43953907|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43953911|NCT01235195|Sertraline|sertraline|mesh-list
43953939|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43953940|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43953941|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43953942|NCT01236053|Gabapentin|gabapentin|mesh-list
43953943|NCT01236053|Analgesics|analgesics|mesh-ancestor
43953944|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
43953945|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43953946|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953947|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
43953948|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43953949|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43953950|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43953951|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43953952|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43953953|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43953954|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43953955|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43953956|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
43953957|NCT01236105|Charcoal|charcoal|mesh-list
43694303|NCT02769169|Ranibizumab|ranibizumab|mesh-list
43953958|NCT01236105|Antidotes|antidotes|mesh-ancestor
43953959|NCT01236105|Protective Agents|protective agents|mesh-ancestor
43953960|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953961|NCT01236378|Sirolimus|sirolimus|mesh-list
43953962|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43953963|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43953964|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43953965|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43953966|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
43953977|NCT01237041|Niacin|niacin|mesh-list
43953984|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
43953985|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
43953987|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
43953988|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953989|NCT01237197|Exenatide|exenatide|mesh-list
43953990|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43953991|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43953992|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43953993|NCT01237197|Incretins|incretins|mesh-ancestor
43953994|NCT01237197|Hormones|hormones|mesh-ancestor
43953995|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43953996|NCT01237353|Rabeprazole|rabeprazole|mesh-list
43953997|NCT01237353|Betaine|betaine|mesh-list
43953998|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43953999|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954000|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43954001|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954002|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954003|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
43954004|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43954005|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
43954006|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43954007|NCT01238471|Propranolol|propranolol|mesh-list
43954008|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43954009|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43954010|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
43954011|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954012|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954013|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954014|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954030|NCT01238536|Hormones|hormones|mesh-ancestor
43954031|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954032|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954033|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954034|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954035|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954036|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
43954037|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954038|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43954039|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43954040|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954041|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43954042|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954043|NCT01238640|Nicotine|nicotine|mesh-list
43954044|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43954045|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
43954046|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954047|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954048|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43954049|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43954050|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
43954051|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954052|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954053|NCT01239212|Levetiracetam|levetiracetam|mesh-list
43954054|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
43954055|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
43954056|NCT01241344|Brincidofovir|brincidofovir|mesh-list
43954057|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
43954058|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954059|NCT01241539|Dabigatran|dabigatran|mesh-list
43954060|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
43954061|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43954062|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
43954063|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954064|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954065|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
43954067|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43954068|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43954069|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
43954070|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954071|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43954072|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43954073|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954075|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43954076|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954077|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954078|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43954079|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
43954080|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
43954129|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
43954130|NCT01243333|Alovudine|alovudine|mesh-list
43954131|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
43954132|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43954133|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43954134|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954135|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
43954136|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
43954137|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954138|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43954139|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43954140|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954141|NCT01243450|Tretinoin|tretinoin|mesh-list
43954142|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954189|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43954190|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954191|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43954192|NCT01244451|Ofatumumab|ofatumumab|mesh-list
43954193|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43954194|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
43954195|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954196|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954197|NCT01244633|Ecopipam|ecopipam|mesh-list
43954198|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43954199|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43954200|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954201|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954202|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954203|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43954204|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
43954205|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954206|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954207|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43954208|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954209|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954210|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43954211|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43954212|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954213|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954214|NCT01244724|Citalopram|citalopram|mesh-list
43954215|NCT01244724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43954216|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954217|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954218|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954219|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954220|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
43954221|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954223|NCT01244724|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954226|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43954227|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
43954228|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954229|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954230|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43954231|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954232|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43954233|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43954234|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954235|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954236|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43954237|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43954238|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
43954239|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954240|NCT01245595|Protective Agents|protective agents|mesh-ancestor
43954241|NCT01245647|Naltrexone|naltrexone|mesh-list
43954242|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43954243|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43954244|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954245|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
43954246|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954247|NCT01246063|Dexamethasone|dexamethasone|mesh-list
43954248|NCT01246063|Doxorubicin|doxorubicin|mesh-list
43954249|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43954250|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954251|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
43954252|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
43954253|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954254|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954255|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954270|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43954271|NCT01246076|Growth Substances|growth substances|mesh-ancestor
43954272|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
43954273|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954274|NCT01246401|Naltrexone|naltrexone|mesh-list
43954275|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43954276|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43954277|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954278|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
43954279|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954280|NCT01246713|Acetaminophen|acetaminophen|mesh-list
43954281|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954283|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
43954284|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954285|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954286|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
43954287|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43954288|NCT01246791|Norethindrone|norethindrone|mesh-list
43954289|NCT01246791|Norinyl|norinyl|mesh-list
43954290|NCT01246791|Estradiol|estradiol|mesh-list
43954291|NCT01246791|Estrogens|estrogens|mesh-ancestor
43954292|NCT01246791|Hormones|hormones|mesh-ancestor
43954293|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954294|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954295|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43954296|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
43954297|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954319|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43954320|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954321|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954322|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43954323|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43954324|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954325|NCT01247285|Fluoxetine|fluoxetine|mesh-list
43954326|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43954327|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954328|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954329|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954330|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954331|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
43954332|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141928|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43954333|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43954334|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954335|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954336|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43954337|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43954338|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954340|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
43954341|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954342|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
43954343|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
43954344|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43954345|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43954346|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954347|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
43954348|NCT01248104|Coagulants|coagulants|mesh-ancestor
43954349|NCT01248416|Letrozole|letrozole|mesh-list
43954358|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954359|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43954360|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
43954361|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954362|NCT01248585|Dexamethasone|dexamethasone|mesh-list
43954363|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954364|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
43954365|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
43954366|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954367|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954368|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954369|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
43954370|NCT01248585|Hormones|hormones|mesh-ancestor
43954371|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954372|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954373|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954374|NCT01249027|Everolimus|everolimus|mesh-list
43954375|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954414|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43954415|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43954416|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43954417|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44141929|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44141931|NCT00184899|Calcium heparin|calcium heparin|mesh-list
44141932|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44141933|NCT00184899|Glycerol|glycerol|mesh-list
44141934|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
44141935|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44141936|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44141937|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141938|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44141939|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44141940|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44141941|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44141942|NCT00184899|Protective Agents|protective agents|mesh-ancestor
44141943|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141944|NCT00184912|Caffeine|caffeine|mesh-list
44141945|NCT00184912|Annexin A5|annexin a5|mesh-list
44141946|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44141947|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44141948|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44141949|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141950|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141951|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44141952|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44141953|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
44141954|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44141955|NCT00184938|Morphine|morphine|mesh-list
44141956|NCT00184938|Naloxone|naloxone|mesh-list
44141957|NCT00184938|Annexin A5|annexin a5|mesh-list
44141958|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44141959|NCT00184938|Narcotics|narcotics|mesh-ancestor
44141960|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44141963|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
44141964|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44141965|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44141966|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44141967|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141968|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44141969|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44141970|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44141971|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
44141972|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44141973|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44141975|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954452|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954453|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43954454|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43954455|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954456|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43954457|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954458|NCT01250899|Vitamin D|vitamin d|mesh-list
43954459|NCT01250899|Vitamins|vitamins|mesh-ancestor
43954460|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
43954461|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954462|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43954463|NCT01250977|Donepezil|donepezil|mesh-list
43954464|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43954465|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954466|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954467|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
43954468|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954469|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954470|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
43954471|NCT01250990|Niacin|niacin|mesh-list
43954472|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43954473|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
43954474|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954475|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43954476|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
43954477|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
43954478|NCT01250990|Vitamins|vitamins|mesh-ancestor
43954479|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
43767701|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
43767736|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954480|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954481|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
43954497|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
43954498|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954499|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954500|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43954501|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43954502|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
43954503|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954504|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954506|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43954507|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954508|NCT01251575|Cyclosporine|cyclosporine|mesh-list
43954509|NCT01251575|Sirolimus|sirolimus|mesh-list
43954510|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
43954511|NCT01251575|Fludarabine|fludarabine|mesh-list
43954512|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
43954513|NCT01251575|Cyclosporins|cyclosporins|mesh-list
43954514|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954515|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43954516|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
43954517|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954518|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43954519|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
43954520|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954521|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954522|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
43954523|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954524|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
43954525|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43954526|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43954527|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43954541|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954542|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
43954543|NCT01252745|Testosterone|testosterone|mesh-list
43954544|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
43954545|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
43954546|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43954547|NCT01252745|Androgens|androgens|mesh-ancestor
43954548|NCT01252745|Hormones|hormones|mesh-ancestor
43954549|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954550|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954551|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954552|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954553|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
43954604|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43954605|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43954606|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43954607|NCT01253902|Bimatoprost|bimatoprost|mesh-list
43954608|NCT01253902|Travoprost|travoprost|mesh-list
43954609|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43954610|NCT01253902|Latanoprost|latanoprost|mesh-list
43954611|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43954612|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43954613|NCT01253980|Amoxicillin|amoxicillin|mesh-list
43954614|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43954615|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954616|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
43954617|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
43954665|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43954666|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
43954667|NCT01256164|Coagulants|coagulants|mesh-ancestor
43954668|NCT01257087|Insulin|insulin|mesh-list
43954669|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43954670|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
43954671|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43954672|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954673|NCT01257802|Leuprolide|leuprolide|mesh-list
43954674|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43954675|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
43954676|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43954677|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954678|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43954679|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954680|NCT01258049|Artemether|artemether|mesh-list
43954681|NCT01258049|Quinine|quinine|mesh-list
43954682|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
43954683|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43954684|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43954685|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954686|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43954687|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954688|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43954689|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954690|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954691|NCT01258049|Analgesics|analgesics|mesh-ancestor
43954692|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
43954693|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43954694|NCT01258153|MEN 11420|men 11420|mesh-list
43954695|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43954696|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
43954697|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954698|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954699|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43954700|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
43954701|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
43954702|NCT01258374|Darunavir|darunavir|mesh-list
43954703|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43954705|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
43954706|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43954707|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43954708|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43954709|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954710|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954711|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43954712|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43954713|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
43954714|NCT01258387|Mitogens|mitogens|mesh-list
43954715|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
43954716|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954769|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43954770|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954771|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954772|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43954773|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
43954774|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
43954775|NCT01260662|Analgesics|analgesics|mesh-ancestor
43954776|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
43954777|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954778|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43954779|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43954780|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43954781|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954782|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954783|NCT01260688|Dasatinib|dasatinib|mesh-list
43954784|NCT01260688|Cediranib|cediranib|mesh-list
43954785|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954786|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43954787|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954788|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954789|NCT01260883|Ketorolac|ketorolac|mesh-list
43954790|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43954791|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43954792|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954818|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43954819|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43954820|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954821|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954822|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
43954823|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
43954824|NCT01263132|Vitamins|vitamins|mesh-ancestor
43954825|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
43954826|NCT01263717|Hormones|hormones|mesh-list
43954827|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43954828|NCT01263717|Tesamorelin|tesamorelin|mesh-list
43954829|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954830|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954831|NCT01263717|Growth Substances|growth substances|mesh-ancestor
43954832|NCT01263938|Atorvastatin|atorvastatin|mesh-list
43954833|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43954834|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43954835|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
43954836|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954837|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43954838|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43954839|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954840|NCT01264705|Sorafenib|sorafenib|mesh-list
43954841|NCT01264705|Bavituximab|bavituximab|mesh-list
43954842|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43954843|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954865|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43954866|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
43954867|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954868|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43954869|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43954870|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954871|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954872|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954873|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43954875|NCT01267136|Tramadol|tramadol|mesh-list
43954876|NCT01267136|Codeine|codeine|mesh-list
43954877|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954878|NCT01267136|Analgesics|analgesics|mesh-ancestor
43954879|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
43954880|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954881|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954882|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
43954883|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43954884|NCT01267136|Narcotics|narcotics|mesh-ancestor
43954885|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954886|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
43954887|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
44141995|NCT00184977|Protective Agents|protective agents|mesh-ancestor
44142022|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142023|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142024|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44142025|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142026|NCT00185094|Losartan|losartan|mesh-list
44142027|NCT00185094|Atenolol|atenolol|mesh-list
44142028|NCT00185094|Olmesartan|olmesartan|mesh-list
44142029|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142030|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43954921|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43954922|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43954923|NCT01267864|Analgesics|analgesics|mesh-ancestor
43954924|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
43954925|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954926|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954927|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43954928|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43954929|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43954930|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43954931|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954932|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
43954933|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
43954934|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954935|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
43954936|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43954937|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43954938|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954939|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
43954940|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
43954941|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43954942|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43954943|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43954944|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
43954945|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
43954946|NCT01268111|Vitamin D|vitamin d|mesh-list
43954947|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43954948|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954949|NCT01268111|Vitamins|vitamins|mesh-ancestor
43954950|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
43954951|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43954952|NCT01268527|Calcipotriene|calcipotriene|mesh-list
43954961|NCT01269047|Exenatide|exenatide|mesh-list
43954964|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954965|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43954966|NCT01269047|Incretins|incretins|mesh-ancestor
43954967|NCT01269047|Hormones|hormones|mesh-ancestor
43954968|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43954969|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
43954970|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43954971|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43954972|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43954973|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954974|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954975|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
43954976|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43954977|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954978|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43954979|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43954980|NCT01270542|Bevacizumab|bevacizumab|mesh-list
43954981|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43954982|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43954983|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43954984|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43954985|NCT01270542|Growth Substances|growth substances|mesh-ancestor
43954986|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43954987|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
43954988|NCT01270555|Bupropion|bupropion|mesh-list
43954989|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43954990|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
43954991|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43954992|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43954993|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43954994|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43954995|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43954996|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
43954997|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955000|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43955001|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955002|NCT01270659|Acetaminophen|acetaminophen|mesh-list
43955003|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43955004|NCT01270659|Fentanyl|fentanyl|mesh-list
43955005|NCT01270659|Oxycodone|oxycodone|mesh-list
43955006|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43955007|NCT01270659|Narcotics|narcotics|mesh-ancestor
43955008|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955009|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955065|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955066|NCT01272245|Cytarabine|cytarabine|mesh-list
43955067|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
43955068|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43955069|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
43955070|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955071|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955072|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
43955073|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955074|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955075|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
43955076|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955077|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43955078|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43955079|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955080|NCT01272388|Tadalafil|tadalafil|mesh-list
43955081|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
43955082|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43955083|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43955084|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955085|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955090|NCT01272583|Incretins|incretins|mesh-ancestor
43955116|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43955117|NCT01273766|Deferasirox|deferasirox|mesh-list
43955118|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43955119|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
43955120|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
43955121|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955122|NCT01274897|Lactitol|lactitol|mesh-list
43955123|NCT01274897|Cathartics|cathartics|mesh-ancestor
43955124|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955125|NCT01275300|Aspirin|aspirin|mesh-list
43955126|NCT01275300|Niacin|niacin|mesh-list
43955127|NCT01275300|Niacinamide|niacinamide|mesh-list
43955128|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
43955183|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955184|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955185|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43955186|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695316|NCT02762617|Tenofovir|tenofovir|mesh-list
43955187|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
43955188|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43955189|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
43955190|NCT01276301|Empagliflozin|empagliflozin|mesh-list
43955191|NCT01276301|Verapamil|verapamil|mesh-list
43955192|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43955194|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955245|NCT01277159|Narcotics|narcotics|mesh-ancestor
43955246|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955247|NCT01277159|Analgesics|analgesics|mesh-ancestor
43955248|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
43955249|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43955250|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
43955251|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43955252|NCT01279187|Teriparatide|teriparatide|mesh-list
43955253|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43955254|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955255|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43955256|NCT01279317|Acetic Acid|acetic acid|mesh-list
43955257|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43955258|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955260|NCT01280058|Carboplatin|carboplatin|mesh-list
43955261|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43955262|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43955263|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955264|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43955265|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43955266|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43955267|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955268|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43955269|NCT01280110|Laxatives|laxatives|mesh-ancestor
43955270|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955271|NCT01280123|Pioglitazone|pioglitazone|mesh-list
43955272|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955273|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955275|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955276|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955277|NCT01280604|Fenofibrate|fenofibrate|mesh-list
43955278|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43955279|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
43955280|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955281|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43955282|NCT01280695|Pioglitazone|pioglitazone|mesh-list
43955284|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955286|NCT01281007|Famciclovir|famciclovir|mesh-list
43955287|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
43955288|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955289|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43955290|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955291|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955292|NCT01281475|Levodopa|levodopa|mesh-list
43955293|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43955295|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
43955350|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955351|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955352|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43955353|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44142055|NCT00185120|Olmesartan|olmesartan|mesh-list
44142056|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44142057|NCT00185120|Benazepril|benazepril|mesh-list
44142058|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142059|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44142060|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142061|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142062|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44142110|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142111|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43695489|NCT02760888|Diclofenac|diclofenac|mesh-list
43955354|NCT01284296|Chrysarobin|chrysarobin|mesh-list
43955356|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
43955357|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
43955358|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955359|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955360|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
43955361|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955362|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43955363|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43955364|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43955365|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955366|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955367|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955368|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955369|NCT01284296|Analgesics|analgesics|mesh-ancestor
43955370|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955371|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955372|NCT01284335|Gemcitabine|gemcitabine|mesh-list
43955373|NCT01284335|Cisplatin|cisplatin|mesh-list
43955374|NCT01284335|Docetaxel|docetaxel|mesh-list
43955375|NCT01284335|Temozolomide|temozolomide|mesh-list
43955376|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43955377|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955378|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43955379|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
43955380|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955396|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955397|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955398|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43955399|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43955400|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43955401|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43955402|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
43955403|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955404|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955405|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43955406|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43955407|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
43955408|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43955409|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43955410|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
43955412|NCT01285050|Emtricitabine|emtricitabine|mesh-list
43955413|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
43955414|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43955415|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
43955416|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955417|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43955418|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43955419|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955420|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955421|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43955422|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43955423|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43955424|NCT01285635|Docetaxel|docetaxel|mesh-list
43955425|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955426|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
43955427|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
43955428|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
43955429|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955431|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44173112|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173113|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955432|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43955433|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955434|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955435|NCT01286402|Bupropion|bupropion|mesh-list
43767737|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955436|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43955437|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
43955438|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43955443|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
43955500|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955501|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955502|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43695623|NCT02760355|Ribavirin|ribavirin|mesh-list
43955503|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43955504|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955505|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955506|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955507|NCT01288521|Ketoconazole|ketoconazole|mesh-list
43955509|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955510|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
43955511|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955512|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43955513|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955514|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955515|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
43955516|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955517|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43955518|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43955519|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43955520|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
43955521|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955522|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43955523|NCT01288781|Acetazolamide|acetazolamide|mesh-list
43955524|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
43955525|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43955526|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955527|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955528|NCT01288781|Diuretics|diuretics|mesh-ancestor
43955529|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
43955530|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955531|NCT01288807|Milnacipran|milnacipran|mesh-list
43955532|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44173114|NCT00291772|Pramlintide|pramlintide|mesh-list
44173115|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44173116|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173117|NCT00291785|Leucovorin|leucovorin|mesh-list
44173118|NCT00291785|Folic Acid|folic acid|mesh-list
43955533|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43955534|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955535|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955536|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955537|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955538|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955539|NCT01288807|Analgesics|analgesics|mesh-ancestor
43955540|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
43955541|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955542|NCT01288859|Curcumin|curcumin|mesh-list
43955543|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43955544|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43955545|NCT01288859|Analgesics|analgesics|mesh-ancestor
43955546|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
43955547|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955548|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955549|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955550|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43955551|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955552|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955553|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955554|NCT01289067|Satraplatin|satraplatin|mesh-list
43955555|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955556|NCT01289275|Nicotine|nicotine|mesh-list
43955557|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43955558|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
43955559|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955560|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955561|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43760268|NCT02444559|Clonidine|clonidine|mesh-list
43955562|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43955563|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955564|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955565|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955566|NCT01289457|Cytarabine|cytarabine|mesh-list
43955571|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43955573|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955574|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695693|NCT02759861|Ledipasvir|ledipasvir|mesh-list
43955575|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
43955576|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955577|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
43955578|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955579|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43955580|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43955581|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43955582|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955583|NCT01289522|Cetuximab|cetuximab|mesh-list
43955584|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43955585|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955586|NCT01289912|Everolimus|everolimus|mesh-list
43955587|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955588|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43955589|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
43955590|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955591|NCT01290237|Vancomycin|vancomycin|mesh-list
43955592|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43955593|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955594|NCT01290445|Varenicline|varenicline|mesh-list
43955595|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43955596|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43955597|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955598|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955599|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955600|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955602|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
43955603|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43955604|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43955611|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43955612|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
43955613|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955614|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955615|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43955616|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
43955617|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43955618|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43955619|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43955620|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
43955621|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955622|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955623|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
43955624|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43955625|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955626|NCT01290913|Omalizumab|omalizumab|mesh-list
43955627|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43955628|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43955629|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
43955630|NCT01291056|Clomiphene|clomiphene|mesh-list
43955631|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43955632|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
43955633|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955634|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173119|NCT00291785|Fluorouracil|fluorouracil|mesh-list
44173120|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
44173121|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
44173137|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
44173138|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173139|NCT00291850|Paclitaxel|paclitaxel|mesh-list
44173140|NCT00291850|Cisplatin|cisplatin|mesh-list
44173141|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44173142|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173143|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
44173144|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173145|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
44173146|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173147|NCT00291863|Simvastatin|simvastatin|mesh-list
44173148|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44173149|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44173150|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
44173151|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173152|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44173153|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44173154|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173155|NCT00291915|Adalimumab|adalimumab|mesh-list
44173156|NCT00291915|Methotrexate|methotrexate|mesh-list
44173157|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44173158|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
44173159|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955635|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43955636|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
43955637|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955638|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43955639|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43955640|NCT01291108|Bimatoprost|bimatoprost|mesh-list
43955641|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43955642|NCT01291784|Antibodies|antibodies|mesh-list
43955643|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43955644|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
43955645|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955646|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
43955647|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43955648|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955649|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955650|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43955651|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43955652|NCT01292005|Protective Agents|protective agents|mesh-ancestor
43955653|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955654|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
43955655|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43955656|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
43955657|NCT01292252|Teriparatide|teriparatide|mesh-list
43955658|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
43955684|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43955685|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43955686|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
43955687|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955688|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955689|NCT01292798|Ranibizumab|ranibizumab|mesh-list
43955690|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43955691|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43955692|NCT01292798|Growth Substances|growth substances|mesh-ancestor
43955693|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955694|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
43955695|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955696|NCT01293396|Insulin|insulin|mesh-list
43955697|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43955698|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
43955699|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
43955700|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43955701|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
43955702|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955703|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955704|NCT01293825|Ziprasidone|ziprasidone|mesh-list
43955705|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43955706|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
43955707|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955708|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955709|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955710|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43955731|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43955732|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43955733|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43955734|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955735|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43955736|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955737|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955738|NCT01294319|Dexamethasone|dexamethasone|mesh-list
43955739|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
43955740|NCT01294319|Spironolactone|spironolactone|mesh-list
43955741|NCT01294319|Mifepristone|mifepristone|mesh-list
43955742|NCT01294319|BB 1101|bb 1101|mesh-list
43955743|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43955792|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
43955793|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955794|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43955795|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
43955797|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955798|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43955799|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
43955800|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955801|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955802|NCT01295515|Interferons|interferons|mesh-list
43955803|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
43955804|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
43955805|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43955806|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955807|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
43955808|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43955809|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
43955810|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955811|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
43955816|NCT01295879|Vitamin D|vitamin d|mesh-list
43955846|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955847|NCT01296763|Cisplatin|cisplatin|mesh-list
43955848|NCT01296763|Irinotecan|irinotecan|mesh-list
43955849|NCT01296763|Olaparib|olaparib|mesh-list
43955850|NCT01296763|Mitomycins|mitomycins|mesh-list
43955851|NCT01296763|Mitomycin|mitomycin|mesh-list
43955852|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955853|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43955854|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43955855|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955856|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955857|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43955858|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43955859|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
43955860|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43955861|NCT01296815|Bevacizumab|bevacizumab|mesh-list
43955862|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43955863|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955864|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43955865|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43955866|NCT01296815|Growth Substances|growth substances|mesh-ancestor
43955867|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955868|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
43955869|NCT01297335|Clonidine|clonidine|mesh-list
43955870|NCT01297335|Analgesics|analgesics|mesh-ancestor
43955871|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
43955872|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955873|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955874|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43955875|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
43955876|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
43955877|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43955878|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43955879|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43955880|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173160|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173161|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173162|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
44173163|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955881|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955882|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955883|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43955884|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43955885|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
43955886|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43955887|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
43955889|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
43955890|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
43955891|NCT01297348|Estradiol|estradiol|mesh-list
43955892|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43955893|NCT01297348|Estrogens|estrogens|mesh-ancestor
43955894|NCT01297348|Hormones|hormones|mesh-ancestor
43955895|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955896|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955897|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43955899|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43955900|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43955901|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43955902|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43955903|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
43955904|NCT01297595|Crizotinib|crizotinib|mesh-list
43955905|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955906|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43955907|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955908|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142112|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44142113|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44142127|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44142128|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44142129|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44142130|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44142131|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
44142132|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142133|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142134|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44142135|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44142136|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44142137|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44142138|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44142139|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44142141|NCT00185237|Estrogens|estrogens|mesh-ancestor
44142142|NCT00185237|Hormones|hormones|mesh-ancestor
44142143|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142144|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142145|NCT00185250|Interferons|interferons|mesh-list
44142146|NCT00185250|Interferon-beta|interferon-beta|mesh-list
44142147|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
43955938|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43955939|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955940|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43955942|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43955943|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43955944|NCT01301183|Growth Substances|growth substances|mesh-ancestor
43955945|NCT01301742|Empagliflozin|empagliflozin|mesh-list
43955946|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
43955947|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43955948|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955949|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955950|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955951|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43955952|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
43955953|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43955954|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43955955|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43955956|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955957|NCT01302379|Metformin|metformin|mesh-list
43955958|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955959|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955960|NCT01302483|Lidocaine|lidocaine|mesh-list
43955961|NCT01302483|Phenylephrine|phenylephrine|mesh-list
43955962|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
43955963|NCT01302483|Tetracaine|tetracaine|mesh-list
43955964|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
43955965|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
43955966|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43955967|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955968|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
43955969|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43955970|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43955971|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43955972|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44173164|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173165|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44173166|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955973|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43955974|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955975|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43955976|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43955977|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
43955978|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43955979|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
43955980|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
43955981|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
43955982|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43955983|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
43955984|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43955986|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43955987|NCT01302483|Protective Agents|protective agents|mesh-ancestor
43955988|NCT01302743|Metformin|metformin|mesh-list
43955989|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43955990|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43955991|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43955992|NCT01302808|Romidepsin|romidepsin|mesh-list
43955993|NCT01302808|Antiemetics|antiemetics|mesh-list
43955994|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43955995|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43955996|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43955997|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43955999|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
43956022|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43956023|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956024|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
43956025|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956026|NCT01304082|Lidocaine|lidocaine|mesh-list
43956027|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
43956028|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
43956029|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956030|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956031|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
43956032|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956033|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43956034|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43956035|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43956036|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956037|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956038|NCT01304238|PENTA|penta|mesh-list
43956039|NCT01304238|Lepirudin|lepirudin|mesh-list
43956040|NCT01304238|Danaparoid|danaparoid|mesh-list
43956041|NCT01304238|Fondaparinux|fondaparinux|mesh-list
43956042|NCT01304238|Argatroban|argatroban|mesh-list
43956043|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43956044|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
43956045|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43956046|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
43956047|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956048|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956049|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
43956050|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43956051|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43956052|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43956053|NCT01304407|Calcium|calcium|mesh-list
43956054|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43956055|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956056|NCT01304589|Milnacipran|milnacipran|mesh-list
43956057|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
43820025|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173167|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44173168|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956058|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43956059|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43956060|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956061|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956062|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956063|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956064|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43956066|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
43956067|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956068|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
43956069|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956070|NCT01304641|Atorvastatin|atorvastatin|mesh-list
43956071|NCT01304641|Simvastatin|simvastatin|mesh-list
43956072|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43956073|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43956074|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
43956075|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956076|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43956077|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43956078|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956080|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43956081|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
43956082|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
43956083|NCT01305213|Antibodies|antibodies|mesh-list
43956084|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
43956085|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43956086|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
43956087|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956088|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43956089|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956090|NCT01305213|Growth Substances|growth substances|mesh-ancestor
43956099|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43956100|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956101|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956102|NCT01305252|Urological Agents|urological agents|mesh-ancestor
43956103|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43956104|NCT01305772|Panitumumab|panitumumab|mesh-list
43956105|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956106|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956167|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
43956168|NCT01307956|Antibodies|antibodies|mesh-list
43956169|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
43956170|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43956171|NCT01307956|Calcium|calcium|mesh-list
43956172|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
43956173|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
43956174|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956237|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956238|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956239|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
43956240|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
43956241|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956242|NCT01309451|Dexamethasone|dexamethasone|mesh-list
43956243|NCT01309451|Bevacizumab|bevacizumab|mesh-list
43956244|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956245|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956246|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43956247|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956248|NCT01309451|Growth Substances|growth substances|mesh-ancestor
43956249|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956250|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
43956251|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956252|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
43956253|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
43956254|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956255|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956256|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
43956257|NCT01309451|Hormones|hormones|mesh-ancestor
43956258|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956259|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43956260|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
43956261|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43956262|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43956263|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43956264|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43767762|NCT02399657|Hormones|hormones|mesh-ancestor
43956265|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956266|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956267|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956268|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956269|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43956270|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956271|NCT01310179|Fludarabine|fludarabine|mesh-list
43956272|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
43956273|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956274|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956275|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
43956276|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956277|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956278|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
43956279|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956280|NCT01310231|Metformin|metformin|mesh-list
43956281|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43956282|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956283|NCT01310582|Sevoflurane|sevoflurane|mesh-list
43956284|NCT01310582|Desflurane|desflurane|mesh-list
43696340|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
43956285|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43956288|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
43956333|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956334|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956336|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
43956337|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956338|NCT01312038|Simethicone|simethicone|mesh-list
43956339|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
43956340|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956341|NCT01312038|Emollients|emollients|mesh-ancestor
43956342|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956343|NCT01312272|Oxytocin|oxytocin|mesh-list
43956344|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
43956345|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956346|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956347|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43956348|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43956349|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
43956350|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956351|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43956352|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
43956353|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956354|NCT01312766|Menotropins|menotropins|mesh-list
43956355|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43956356|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
43956357|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956358|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956359|NCT01312818|Dexamethasone|dexamethasone|mesh-list
43956360|NCT01312818|Methotrexate|methotrexate|mesh-list
43956361|NCT01312818|Bortezomib|bortezomib|mesh-list
43956362|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
43956364|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956365|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
43956366|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
43956367|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956368|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956375|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43956376|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
43956377|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956378|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956379|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
43956380|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956381|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956382|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956383|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43956384|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956385|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
43956386|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956387|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43956388|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956389|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43956390|NCT01312844|Scopolamine|scopolamine|mesh-list
43575870|NCT03504072|Etanercept|etanercept|mesh-list
43956391|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43956392|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43956393|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
43956394|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
43956395|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956396|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956397|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956398|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
43956399|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43956400|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956401|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956402|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956403|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43956404|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
43956405|NCT01313494|Albuterol|albuterol|mesh-list
43956406|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44173169|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
44173170|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173171|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44173172|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173173|NCT00291980|Vaccines|vaccines|mesh-list
44173174|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
44173175|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173176|NCT00292071|Caspofungin|caspofungin|mesh-list
44173177|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
44173178|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956407|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
43956408|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956409|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956410|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43956411|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
43956412|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
43956413|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956414|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43956415|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43956416|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43956417|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
43956418|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956419|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956420|NCT01313520|Infliximab|infliximab|mesh-list
43956421|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956422|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43956423|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956424|NCT01313897|Bortezomib|bortezomib|mesh-list
43956425|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956426|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43956431|NCT01314001|Nicotine|nicotine|mesh-list
44142155|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44142156|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142157|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142158|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142159|NCT00185315|Iloprost|iloprost|mesh-list
44142160|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44142161|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142162|NCT00185328|Estradiol|estradiol|mesh-list
44142163|NCT00185328|Estrogens|estrogens|mesh-ancestor
44142164|NCT00185328|Hormones|hormones|mesh-ancestor
44142165|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142166|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142167|NCT00185419|Desogestrel|desogestrel|mesh-list
44142168|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142169|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142170|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44142171|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44142172|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44142173|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
44142174|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44142175|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44142176|NCT00185419|Progestins|progestins|mesh-ancestor
44142177|NCT00185419|Hormones|hormones|mesh-ancestor
44142178|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142179|NCT00185445|Fludarabine|fludarabine|mesh-list
44142180|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
44142181|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142182|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142183|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
44142184|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142185|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142186|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
44142187|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142188|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
44142194|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44142195|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
44142196|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142197|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
44142198|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
44142199|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142200|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142201|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142202|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
43956515|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43956516|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956518|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956519|NCT01316770|Dexamethasone|dexamethasone|mesh-list
43956520|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956521|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
43956522|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
43956523|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956524|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956580|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956581|NCT01318967|Furosemide|furosemide|mesh-list
43956582|NCT01318967|Diuretics|diuretics|mesh-ancestor
43956583|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
43956584|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956585|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43956586|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956587|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956588|NCT01319045|Iloprost|iloprost|mesh-list
43956589|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43956590|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
43956591|NCT01319110|Ubiquinone|ubiquinone|mesh-list
43956592|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
43956593|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
43956594|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956595|NCT01319110|Vitamins|vitamins|mesh-ancestor
43956596|NCT01319773|Cyclosporine|cyclosporine|mesh-list
43956597|NCT01319773|Cyclosporins|cyclosporins|mesh-list
43956598|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956599|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956600|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956601|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
43956602|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956603|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
43956604|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956605|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956606|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956607|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43956608|NCT01319851|Alefacept|alefacept|mesh-list
43956609|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956610|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
43956611|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956612|NCT01321151|Resveratrol|resveratrol|mesh-list
43956613|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
43956619|NCT01321437|Axitinib|axitinib|mesh-list
43956622|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956623|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956624|NCT01321541|Gemcitabine|gemcitabine|mesh-list
43956625|NCT01321541|Rituximab|rituximab|mesh-list
43956626|NCT01321541|Pixantrone|pixantrone|mesh-list
43956627|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956628|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956629|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
43956630|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956631|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43956632|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956633|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
43956634|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956635|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
43956636|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43956637|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956638|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956639|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43956640|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43956642|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956643|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956644|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956645|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956646|NCT01322048|Propranolol|propranolol|mesh-list
43956647|NCT01322048|Clonidine|clonidine|mesh-list
43956648|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43956649|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43956650|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
43956651|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956652|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956653|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956654|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43956655|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43956656|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
43956657|NCT01322048|Analgesics|analgesics|mesh-ancestor
43956658|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
43956659|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956660|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
43956661|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
43956662|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43956663|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43956664|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43956665|NCT01322360|Morphine|morphine|mesh-list
43956666|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43956667|NCT01322360|Narcotics|narcotics|mesh-ancestor
43956668|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956669|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956670|NCT01322360|Analgesics|analgesics|mesh-ancestor
43956671|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
43956672|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956673|NCT01322815|Leucovorin|leucovorin|mesh-list
43956674|NCT01322815|Fluorouracil|fluorouracil|mesh-list
43956675|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
43956676|NCT01322815|Irinotecan|irinotecan|mesh-list
43956677|NCT01322815|Bevacizumab|bevacizumab|mesh-list
43956678|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
43956679|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
43956680|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956681|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43956682|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956683|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43956684|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
43956685|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956686|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43696659|NCT02753764|AZD7624|azd7624|mesh-list
43956687|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43956688|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956689|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43956690|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43956691|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43956701|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
43956702|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956703|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956704|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43956705|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
43956706|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
43956707|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43956708|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43956709|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43956710|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43956711|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
43956712|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956713|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956714|NCT01323140|Testosterone|testosterone|mesh-list
43956715|NCT01323140|Androgens|androgens|mesh-ancestor
43956716|NCT01323140|Hormones|hormones|mesh-ancestor
43956717|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956718|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956755|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956756|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956757|NCT01324128|Iron|iron|mesh-list
43956758|NCT01324128|Sevelamer|sevelamer|mesh-list
43956759|NCT01324128|Trace Elements|trace elements|mesh-ancestor
43956760|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
43956761|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956762|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
43956763|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
43956764|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956765|NCT01324700|Dexetimide|dexetimide|mesh-list
43956766|NCT01324700|Citalopram|citalopram|mesh-list
43956767|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43956768|NCT01324700|Serotonin|serotonin|mesh-list
43956769|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43956770|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956771|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956772|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956773|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
43956774|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956775|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43956776|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
43956777|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956778|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43956779|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43956780|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
43956797|NCT01325311|Vitamin D|vitamin d|mesh-list
43956805|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43956806|NCT01325311|Protective Agents|protective agents|mesh-ancestor
43956807|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43956808|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43956809|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956810|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956811|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
43956812|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43956813|NCT01325311|Estrogens|estrogens|mesh-ancestor
43956814|NCT01325311|Hormones|hormones|mesh-ancestor
43956815|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43956816|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
43956867|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43956868|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
43956869|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956870|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956871|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
43956872|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956873|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43956874|NCT01328782|Analgesics|analgesics|mesh-ancestor
43956875|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
43956876|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43956877|NCT01328782|Narcotics|narcotics|mesh-ancestor
43956878|NCT01328964|Fluticasone|fluticasone|mesh-list
43956879|NCT01328964|Xhance|xhance|mesh-list
43956880|NCT01328964|Budesonide|budesonide|mesh-list
43956881|NCT01328964|Montelukast|montelukast|mesh-list
43956882|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43956883|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43956884|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
43956885|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956886|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956887|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43956888|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
43956889|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
43956890|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43956891|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
43956907|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956908|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956909|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43956910|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43956911|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
43956912|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43956913|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956914|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43956915|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
43956916|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43956917|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43956918|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43956919|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956921|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43956922|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43956923|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43956924|NCT01330134|Lidocaine|lidocaine|mesh-list
43956925|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
43956926|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
43956927|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43956928|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956929|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
43956936|NCT01330290|Rotigotine|rotigotine|mesh-list
43956956|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43956957|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43956958|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
43956959|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43956960|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43956961|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43956962|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43956975|NCT01331694|Bromides|bromides|mesh-list
43957023|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957024|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957026|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
43957027|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957028|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957029|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957030|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957031|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957032|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957033|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957034|NCT01332357|Fluticasone|fluticasone|mesh-list
43957035|NCT01332357|Xhance|xhance|mesh-list
43957036|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43957037|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43957038|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957039|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43957040|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
43957041|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957042|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957043|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43957044|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957045|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957046|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43957047|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43957048|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43957049|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957050|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957051|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957052|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957053|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
43957054|NCT01332357|Hormones|hormones|mesh-ancestor
43957055|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957056|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
43957057|NCT01332461|Fluticasone|fluticasone|mesh-list
43957062|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
43957063|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957064|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957065|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43957066|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957067|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957068|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43957069|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43957070|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43957071|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957072|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957073|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957074|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957076|NCT01332500|Sumatriptan|sumatriptan|mesh-list
43957077|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957122|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43957123|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957124|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43957125|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43957126|NCT01332721|Growth Substances|growth substances|mesh-ancestor
43957127|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957128|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
43957129|NCT01333098|Mifepristone|mifepristone|mesh-list
43957130|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43957131|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
43957184|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
43957185|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43957186|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957187|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957188|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43957189|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957190|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957191|NCT01334723|Urological Agents|urological agents|mesh-ancestor
43957192|NCT01334944|Ibuprofen|ibuprofen|mesh-list
43957193|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957194|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957195|NCT01334944|Analgesics|analgesics|mesh-ancestor
43957196|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
43957243|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957244|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43957245|NCT01335789|Oxytocin|oxytocin|mesh-list
43957246|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
43957247|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957248|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957249|NCT01335867|Vigabatrin|vigabatrin|mesh-list
43957250|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
43957251|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957252|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957253|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
43957254|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957255|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957256|NCT01335932|Ganciclovir|ganciclovir|mesh-list
43957257|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43957258|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
43957259|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957260|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43957301|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43957302|NCT01337336|Ipratropium|ipratropium|mesh-list
43957303|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43957304|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957305|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43957306|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
43957307|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957308|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957309|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43957310|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957311|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957312|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43957313|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
43957314|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
43957315|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957316|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957317|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43957318|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43957319|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957320|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957321|NCT01337687|Oxytocin|oxytocin|mesh-list
43957322|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
43957323|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43957324|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957325|NCT01337700|Milnacipran|milnacipran|mesh-list
43957326|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
43957327|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43957328|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43957329|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957330|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957331|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957341|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43957342|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957343|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957344|NCT01339013|Anesthetics|anesthetics|mesh-list
43957345|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957346|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957347|NCT01339091|Vancomycin|vancomycin|mesh-list
43957349|NCT01339091|Dalbavancin|dalbavancin|mesh-list
43957350|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957351|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957352|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43957353|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957354|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957403|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43957404|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
43957405|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957406|NCT01339858|Protective Agents|protective agents|mesh-ancestor
43957407|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957408|NCT01339858|Antidotes|antidotes|mesh-ancestor
43957409|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43957411|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43957412|NCT01339936|Protective Agents|protective agents|mesh-ancestor
43957413|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957414|NCT01339936|Laxatives|laxatives|mesh-ancestor
43957415|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957416|NCT01340586|Apixaban|apixaban|mesh-list
43957417|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43957418|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
43957419|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43957420|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957421|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697302|NCT04876131|Penicillin G|penicillin g|mesh-list
43957422|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957423|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
43957424|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
43957425|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
43957426|NCT01341301|Tacrolimus|tacrolimus|mesh-list
43957427|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43957428|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
43957429|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957430|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957431|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43957432|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
43957433|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957434|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957435|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43957436|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43957437|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173179|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957441|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957442|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957445|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43957446|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43957447|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
43957448|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957449|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43957450|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43957451|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957452|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957453|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957454|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43957455|NCT01342029|Ranolazine|ranolazine|mesh-list
43957456|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43957457|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957458|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957459|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43957460|NCT01342172|Lenalidomide|lenalidomide|mesh-list
43957461|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
43957462|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957463|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43957464|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43957465|NCT01342172|Growth Substances|growth substances|mesh-ancestor
43957466|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
43957467|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957468|NCT01342523|Nicotine|nicotine|mesh-list
43957469|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43957470|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
43957471|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957472|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957473|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43957474|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43957475|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
43957476|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957480|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43957481|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43957482|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957483|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
43957484|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957485|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
43957486|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957487|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957488|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
43957489|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957490|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
43957491|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43957492|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957493|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43957494|NCT01342757|Temozolomide|temozolomide|mesh-list
43957495|NCT01342757|Vorinostat|vorinostat|mesh-list
43957496|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43957497|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
43957498|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957499|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957502|NCT01342770|Pioglitazone|pioglitazone|mesh-list
44142211|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142212|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44142213|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44142214|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44142215|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142216|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142217|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142218|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142219|NCT00185575|Analgesics|analgesics|mesh-ancestor
44142220|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
44142221|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142222|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
44142223|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142224|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
44142225|NCT00185705|Telmisartan|telmisartan|mesh-list
44142226|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44142230|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
43957553|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43957554|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957555|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957556|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43957557|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43957558|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43957559|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957560|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957561|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957562|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957563|NCT01347255|Betamethasone|betamethasone|mesh-list
43957564|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
43957565|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43957566|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
43957567|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43957568|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957569|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
43957570|NCT01347255|Hormones|hormones|mesh-ancestor
43957571|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957572|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957573|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43957574|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957575|NCT01348607|Methylphenidate|methylphenidate|mesh-list
43957576|NCT01348607|Modafinil|modafinil|mesh-list
43957577|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43957578|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957579|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43957580|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43957581|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957582|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957583|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
43957584|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957585|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43957588|NCT01349231|Ketamine|ketamine|mesh-list
43957591|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957592|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957593|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43957594|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43957596|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
43957597|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957598|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43957599|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43957600|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957601|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957602|NCT01349491|Ranolazine|ranolazine|mesh-list
43957603|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43957604|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957605|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957606|NCT01349920|Infliximab|infliximab|mesh-list
43957607|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
43957608|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43957609|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957610|NCT01349972|Cytarabine|cytarabine|mesh-list
43957611|NCT01349972|Daunorubicin|daunorubicin|mesh-list
43957612|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
43957613|NCT01349972|Alvocidib|alvocidib|mesh-list
43957614|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43957615|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
43957617|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957640|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43957641|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
43957642|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957643|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957644|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43957645|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43957646|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957647|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43957648|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43957649|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
43957650|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957651|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957652|NCT01350388|Febuxostat|febuxostat|mesh-list
43957701|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957702|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957703|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43957704|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43957706|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957707|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957708|NCT01352637|Cycloserine|cycloserine|mesh-list
43957709|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43957710|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957711|NCT01352637|Renal Agents|renal agents|mesh-ancestor
43957712|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43957713|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
43957714|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957715|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
43957716|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957717|NCT01353144|Aspirin|aspirin|mesh-list
43957718|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957719|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957720|NCT01353144|Analgesics|analgesics|mesh-ancestor
43957721|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
43957722|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957723|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957724|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43957725|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957726|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43821586|NCT03932409|Carboplatin|carboplatin|mesh-list
44173180|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173181|NCT00292110|Methadone|methadone|mesh-list
44173182|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44173183|NCT00292110|Narcotics|narcotics|mesh-ancestor
44173196|NCT00292123|Analgesics|analgesics|mesh-ancestor
44173197|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
44173198|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173199|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
44173200|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173201|NCT00292201|Atorvastatin|atorvastatin|mesh-list
44173202|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44173203|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44173204|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
44173205|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173206|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44173207|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44173208|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173209|NCT00292214|Acetaminophen|acetaminophen|mesh-list
44173210|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173211|NCT00292214|Analgesics|analgesics|mesh-ancestor
44173212|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
43957727|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43957728|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957729|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43957730|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43957731|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957733|NCT01353976|Econazole|econazole|mesh-list
43957734|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
43957735|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957736|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43957737|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43957738|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957739|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957740|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43957741|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
43957742|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957743|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957744|NCT01354145|Celecoxib|celecoxib|mesh-list
43957745|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957780|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957781|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43957782|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43957783|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43957784|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43957785|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957786|NCT01354990|Incretins|incretins|mesh-ancestor
43957787|NCT01354990|Hormones|hormones|mesh-ancestor
43957788|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43957789|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43957790|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957791|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957792|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957793|NCT01355588|Ketorolac|ketorolac|mesh-list
43957794|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43957795|NCT01355588|Lidocaine|lidocaine|mesh-list
43957796|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
43957797|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
43957798|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43957799|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957800|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
43957801|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957814|NCT01355705|Aspirin|aspirin|mesh-list
43957830|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43957831|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
43957832|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43957833|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957834|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43957835|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43957836|NCT01355705|Analgesics|analgesics|mesh-ancestor
43957837|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
43957838|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43957839|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43957843|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
43957895|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43957896|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957897|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957899|NCT01360450|Analgesics|analgesics|mesh-ancestor
43957900|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
43957901|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43957902|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43957903|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43957904|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
43957905|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
43957906|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43957907|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43957908|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43957909|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
43957910|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43957911|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43957912|NCT01361048|Metronidazole|metronidazole|mesh-list
43957913|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43957914|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43957915|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43957916|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43957917|NCT01361217|Midazolam|midazolam|mesh-list
43957918|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
43957919|NCT01361217|Caffeine|caffeine|mesh-list
43957920|NCT01361217|Fluoxetine|fluoxetine|mesh-list
43957921|NCT01361217|Omeprazole|omeprazole|mesh-list
43957944|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43957945|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43957946|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43957947|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
43957948|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43957949|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43957950|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43957951|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
43957952|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43957953|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
43957954|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43957955|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43957956|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
43957957|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
43957961|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43958002|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958003|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958004|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958005|NCT01362205|Analgesics|analgesics|mesh-ancestor
43958006|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
43958007|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958008|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43958009|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43958010|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958011|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958012|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958013|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958014|NCT01362686|Rivastigmine|rivastigmine|mesh-list
43958015|NCT01362686|Donepezil|donepezil|mesh-list
43958016|NCT01362686|Galantamine|galantamine|mesh-list
43958017|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43958018|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958019|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958020|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958021|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958022|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958023|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
43958024|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43958025|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
43958026|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958027|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43958028|NCT01362686|Protective Agents|protective agents|mesh-ancestor
43958029|NCT01362959|Nicotine|nicotine|mesh-list
43958030|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43958031|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
43958032|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958033|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958034|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43958035|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43958036|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958041|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958042|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958043|NCT01363050|Analgesics|analgesics|mesh-ancestor
43958044|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
43958045|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958046|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958047|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958048|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958049|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43958050|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958051|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958052|NCT01363128|Cytarabine|cytarabine|mesh-list
43958053|NCT01363128|Dexamethasone|dexamethasone|mesh-list
43958054|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
43958055|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
43958056|NCT01363128|Doxorubicin|doxorubicin|mesh-list
43958057|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43958058|NCT01363128|Methotrexate|methotrexate|mesh-list
43958059|NCT01363128|Vincristine|vincristine|mesh-list
43958060|NCT01363128|Ofatumumab|ofatumumab|mesh-list
43958061|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43958062|NCT01363128|BB 1101|bb 1101|mesh-list
43958063|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958064|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
43958066|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958092|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43958093|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
43958094|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958095|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43958096|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
43958097|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
43958098|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
43958099|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
44142248|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142249|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44142250|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
44142251|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
44142252|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
44142253|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142254|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44142255|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44142256|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44142257|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
44142258|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44142259|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142260|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44142261|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142262|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142263|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44142264|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142265|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142266|NCT00185952|Nifedipine|nifedipine|mesh-list
44142267|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44142268|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44142269|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142270|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44142271|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142272|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142273|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
44142276|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142277|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142278|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43958100|NCT01363479|Dexamethasone|dexamethasone|mesh-list
43958101|NCT01363479|Palonosetron|palonosetron|mesh-list
43958102|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958103|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
43958104|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
43958105|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958106|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958107|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958108|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
43958109|NCT01363479|Hormones|hormones|mesh-ancestor
43958119|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
43958161|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958162|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43958163|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43958164|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43958165|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43958166|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43958167|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43958168|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
43958201|NCT01365611|Xhance|xhance|mesh-list
43958228|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958229|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958230|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958231|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43958232|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958233|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958234|NCT01365650|Fluticasone|fluticasone|mesh-list
43958235|NCT01365650|Xhance|xhance|mesh-list
43958236|NCT01365650|Ketorolac|ketorolac|mesh-list
43958237|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43958238|NCT01365650|Phenylephrine|phenylephrine|mesh-list
43958239|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
43958240|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958241|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958242|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
43958243|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958244|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958245|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958246|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958247|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958248|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43958249|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958250|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958251|NCT01365650|Analgesics|analgesics|mesh-ancestor
43958252|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
43958253|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830090|NCT05384665|Sufentanil|sufentanil|mesh-list
43958254|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43958255|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958256|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958257|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43958258|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958259|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958260|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958261|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
43958262|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
43958263|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43958264|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43958267|NCT01365650|Protective Agents|protective agents|mesh-ancestor
43958268|NCT01365819|Varenicline|varenicline|mesh-list
43958269|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43958270|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43958271|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958272|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958273|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958274|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958276|NCT01366196|Analgesics|analgesics|mesh-ancestor
43958277|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
43958278|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958279|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958280|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
43958281|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43958282|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958283|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958284|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43958285|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43958286|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43958287|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958288|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43958289|NCT01366885|Vitamin D|vitamin d|mesh-list
43958290|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
43958291|NCT01366885|Vitamins|vitamins|mesh-ancestor
43958292|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
43958293|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958313|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958314|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958315|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958316|NCT01368653|Nicotine|nicotine|mesh-list
43958317|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43958318|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
43958319|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958320|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958321|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43958322|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43958323|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958324|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958325|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958326|NCT01368809|Fentanyl|fentanyl|mesh-list
43958327|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43958373|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958374|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43958375|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
43958376|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958377|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958378|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43958379|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43958380|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43958381|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
43958382|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958383|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
43958384|NCT01369888|Fludarabine|fludarabine|mesh-list
43958385|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958386|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
43958387|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958388|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958389|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43958390|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
43958391|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958392|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958393|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43958394|NCT01370369|Testosterone|testosterone|mesh-list
43958395|NCT01370369|Androgens|androgens|mesh-ancestor
43958396|NCT01370369|Hormones|hormones|mesh-ancestor
43958397|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958398|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958399|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
43958400|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43958401|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43958402|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958403|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
44173213|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173214|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173215|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
44173216|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
44173217|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44173218|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
44173219|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173220|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173221|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
44173222|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173223|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
43958405|NCT01370564|Diuretics|diuretics|mesh-list
43958406|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
43958407|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958408|NCT01371110|Midazolam|midazolam|mesh-list
43958409|NCT01371110|Ketamine|ketamine|mesh-list
43958410|NCT01371110|Analgesics|analgesics|mesh-ancestor
43958411|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
43958412|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958413|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958414|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43958415|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43958416|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
43958417|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
43958418|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958419|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43958420|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43958421|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958422|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958423|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43958424|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43958425|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43958426|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43958427|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43958428|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
43958429|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
43958430|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
43958431|NCT01371786|Ciclesonide|ciclesonide|mesh-list
43958432|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958433|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958434|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43958435|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
43958436|NCT01371786|Hormones|hormones|mesh-ancestor
43958437|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958447|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
43958448|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958449|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
43958450|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43958451|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958452|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
43958453|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958454|NCT01373450|Liraglutide|liraglutide|mesh-list
43958455|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43958456|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958457|NCT01373450|Incretins|incretins|mesh-ancestor
43958458|NCT01373450|Hormones|hormones|mesh-ancestor
43958459|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958460|NCT01374802|Ritonavir|ritonavir|mesh-list
43958461|NCT01374802|Darunavir|darunavir|mesh-list
43958462|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43958463|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43958464|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
43958465|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958466|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958467|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43958468|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43958469|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
43958470|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958471|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43958472|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43958473|NCT01375127|Tofacitinib|tofacitinib|mesh-list
43958474|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43958475|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958476|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958477|NCT01375140|Prednisone|prednisone|mesh-list
44173224|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44173225|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
44173226|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173227|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173228|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
44173229|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173230|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44173231|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44173232|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44173233|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44173234|NCT00292344|Rifaximin|rifaximin|mesh-list
44173235|NCT00292344|Loperamide|loperamide|mesh-list
43958478|NCT01375140|Lenalidomide|lenalidomide|mesh-list
43958479|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958480|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
43958481|NCT01375140|Hormones|hormones|mesh-ancestor
43958482|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958483|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958484|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958485|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958486|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
43958487|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43958541|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43958542|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958543|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958544|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958545|NCT01377623|Analgesics|analgesics|mesh-ancestor
43958546|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
43958547|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958548|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43958549|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43958550|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958551|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958552|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958553|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958554|NCT01377636|Isoproterenol|isoproterenol|mesh-list
43958555|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43958556|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958557|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958558|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958559|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958560|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958561|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958562|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
43958563|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958564|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958565|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958566|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43958567|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
43958568|NCT01377636|Protective Agents|protective agents|mesh-ancestor
43958569|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
43958570|NCT01378273|Hematinics|hematinics|mesh-ancestor
43958571|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
43958572|NCT01378299|Testosterone|testosterone|mesh-list
43958573|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
43958574|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
43958575|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43958576|NCT01378299|Androgens|androgens|mesh-ancestor
43958580|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958581|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958582|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
43958583|NCT01378377|Niacinamide|niacinamide|mesh-list
43958584|NCT01378377|Sirolimus|sirolimus|mesh-list
43958585|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43958586|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958587|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43958588|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958589|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
43958590|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958591|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
43958592|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958593|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
43958594|NCT01378377|Vitamins|vitamins|mesh-ancestor
43958595|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
43958596|NCT01378416|Decitabine|decitabine|mesh-list
43958597|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43958598|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
43958599|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958600|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958601|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958602|NCT01378520|Ketoconazole|ketoconazole|mesh-list
43958603|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
43958604|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958605|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43958606|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43958607|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958608|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958609|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43958610|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
43958611|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958612|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958613|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43958614|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
43958618|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958619|NCT01378988|Analgesics|analgesics|mesh-ancestor
43651889|NCT03005236|Tacrolimus|tacrolimus|mesh-list
43958620|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
43958621|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958622|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43958623|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43958624|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958625|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958626|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958627|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958628|NCT01379183|Erythromycin|erythromycin|mesh-list
43958629|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
43958630|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43958631|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
43958632|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43958633|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958634|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958635|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43958636|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958637|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958639|NCT01379664|Isoflurane|isoflurane|mesh-list
43958640|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43958641|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43958642|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
43958643|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
43958644|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958645|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958646|NCT01380106|Lenalidomide|lenalidomide|mesh-list
43958647|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
43958648|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958649|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43958650|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43958651|NCT01380106|Growth Substances|growth substances|mesh-ancestor
43958659|NCT01380197|Analgesics|analgesics|mesh-ancestor
43958660|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
43958661|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958663|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958664|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958665|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
43958666|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
43958667|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958668|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958669|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958670|NCT01381120|Acetaminophen|acetaminophen|mesh-list
43958671|NCT01381120|Oxycodone|oxycodone|mesh-list
43958672|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
43958673|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958674|NCT01381120|Analgesics|analgesics|mesh-ancestor
43958675|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
43958676|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958677|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958678|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
43958679|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43958680|NCT01381120|Narcotics|narcotics|mesh-ancestor
43958681|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43958682|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43958683|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43958684|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958685|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958686|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958687|NCT01381120|Urological Agents|urological agents|mesh-ancestor
43958688|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
43958689|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958690|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
43958691|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958692|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958693|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958694|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958695|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
44173236|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
43958697|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958698|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958699|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142279|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142280|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142282|NCT00186082|Cefotetan|cefotetan|mesh-list
44142283|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43958700|NCT01381471|Fluticasone|fluticasone|mesh-list
43958701|NCT01381471|Xhance|xhance|mesh-list
43958702|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43958703|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958704|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43958705|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
43958706|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958707|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958708|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958709|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958710|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958711|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43958712|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43958713|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43958714|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958715|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958716|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958718|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43958741|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43958742|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43958743|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958744|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958745|NCT01383759|Dexamethasone|dexamethasone|mesh-list
43958746|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
43958747|NCT01383759|Bortezomib|bortezomib|mesh-list
43958748|NCT01383759|BB 1101|bb 1101|mesh-list
43958749|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958750|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
43958751|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
43958752|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958753|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958754|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958755|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
43958756|NCT01383759|Hormones|hormones|mesh-ancestor
43958757|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43958758|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43958759|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958760|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
43958761|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958762|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958763|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
43958764|NCT01384539|Vitamin D|vitamin d|mesh-list
43958765|NCT01384539|Calcitriol|calcitriol|mesh-list
43958766|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43958767|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958768|NCT01384539|Vitamins|vitamins|mesh-ancestor
43958769|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
43958770|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43958771|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43958772|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43958773|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958774|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43958775|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
43958779|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43958780|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43958781|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43958782|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958784|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958785|NCT01384591|Expectorants|expectorants|mesh-ancestor
43958786|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958787|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43958788|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
43958789|NCT01384591|Protective Agents|protective agents|mesh-ancestor
43958790|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958791|NCT01384591|Antidotes|antidotes|mesh-ancestor
43958792|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43958793|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43958794|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
43958795|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958796|NCT01385189|Antacids|antacids|mesh-ancestor
43958797|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958798|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43958799|NCT01386983|Finasteride|finasteride|mesh-list
43958800|NCT01386983|Dutasteride|dutasteride|mesh-list
43958809|NCT01387139|Ketamine|ketamine|mesh-list
43958833|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958834|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958835|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43958836|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
43958837|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958838|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43958839|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
43958840|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43958841|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958842|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958843|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958844|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43958845|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43958846|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43958847|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958848|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
43958849|NCT01387464|Bromfenac|bromfenac|mesh-list
44157518|NCT00234845|Adalimumab|adalimumab|mesh-list
43958850|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43958851|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43958852|NCT01387464|Analgesics|analgesics|mesh-ancestor
43958853|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
43958854|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958855|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958856|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958857|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958858|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
43958859|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
43958860|NCT01387815|Adalimumab|adalimumab|mesh-list
43958861|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43958863|NCT01388946|Ropivacaine|ropivacaine|mesh-list
43958876|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43958878|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958879|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958880|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
43958881|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43958882|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43958883|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958884|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
43958885|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43958939|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43958940|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43958941|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43958942|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43958943|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
43958944|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43958945|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
43958947|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43958948|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958949|NCT01390870|Urological Agents|urological agents|mesh-ancestor
43958950|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43958951|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43958952|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43958953|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43958954|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958955|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
43958956|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
43958957|NCT01390909|Lactitol|lactitol|mesh-list
43958958|NCT01390909|Cathartics|cathartics|mesh-ancestor
43958993|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
43958994|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43958995|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43958996|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43958997|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43958998|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
43958999|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43959000|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43959001|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43959003|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959004|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959005|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959006|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959007|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43959008|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959009|NCT01391325|Allopurinol|allopurinol|mesh-list
43959010|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
43959011|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959012|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959013|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
43959014|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959015|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43959016|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
43959017|NCT01391325|Protective Agents|protective agents|mesh-ancestor
43959018|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959019|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43959020|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43959021|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
43959022|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43959023|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
43959024|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959025|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959026|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43959027|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959028|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43959030|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43959031|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
43959032|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959033|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959034|NCT01391858|Pregabalin|pregabalin|mesh-list
43959035|NCT01391858|Analgesics|analgesics|mesh-ancestor
43959036|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
43959037|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959038|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959039|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
43959040|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43959041|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959042|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959043|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959044|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43959045|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43959046|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959047|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43959048|NCT01392703|Dasatinib|dasatinib|mesh-list
43959049|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959050|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43959051|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959052|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959053|NCT01392859|Levocetirizine|levocetirizine|mesh-list
43959055|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43959077|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959078|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43959079|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
43959080|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959081|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43959082|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43959083|NCT01393392|Methadone|methadone|mesh-list
43959084|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43959085|NCT01393392|Narcotics|narcotics|mesh-ancestor
43959086|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959087|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959088|NCT01393392|Analgesics|analgesics|mesh-ancestor
43959089|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
43959090|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959091|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
43959092|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959093|NCT01393457|Levodopa|levodopa|mesh-list
43959094|NCT01393457|Carbidopa|carbidopa|mesh-list
43959095|NCT01393457|Ropinirole|ropinirole|mesh-list
43959096|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43959097|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43959098|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
43959099|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959100|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959101|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959102|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43959103|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959104|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
43959105|NCT01393704|Vasopressins|vasopressins|mesh-list
43959106|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
43959107|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
43959108|NCT01393704|Coagulants|coagulants|mesh-ancestor
43959109|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43959110|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43959121|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959123|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43959124|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
43959125|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959126|NCT01394510|Expectorants|expectorants|mesh-ancestor
43959127|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959128|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43959129|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
43959130|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959131|NCT01394510|Protective Agents|protective agents|mesh-ancestor
43959132|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959133|NCT01394510|Antidotes|antidotes|mesh-ancestor
43959134|NCT01394614|Vaccines|vaccines|mesh-list
43959135|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
43959136|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959137|NCT01395043|Epinephrine|epinephrine|mesh-list
43959138|NCT01395043|Bupivacaine|bupivacaine|mesh-list
43959139|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
43959140|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
43959141|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959142|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959143|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
43959144|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959145|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43959146|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43959147|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
43959148|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959149|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959150|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43959151|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43959153|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43959154|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959155|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
43959162|NCT01395329|BQ 788|bq 788|mesh-list
43959164|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43959165|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43959166|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
43959167|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
43959168|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959169|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959170|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43959171|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43959172|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43959173|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
43959174|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959175|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959176|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
43959177|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43959178|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43959179|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43959180|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43959181|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43959182|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959183|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43959184|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43959185|NCT01395537|Paclitaxel|paclitaxel|mesh-list
43959186|NCT01395537|Carboplatin|carboplatin|mesh-list
43959187|NCT01395537|Lapatinib|lapatinib|mesh-list
43959188|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43959189|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959190|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959191|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959192|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959193|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959196|NCT01395797|Pioglitazone|pioglitazone|mesh-list
43959208|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43959209|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43959210|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959211|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
43959212|NCT01398280|Coagulants|coagulants|mesh-ancestor
43959213|NCT01398943|Antioxidants|antioxidants|mesh-list
43959214|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959215|NCT01398943|Protective Agents|protective agents|mesh-ancestor
43959216|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959217|NCT01398982|Bupivacaine|bupivacaine|mesh-list
43959218|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
43959219|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
43959220|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43959221|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959222|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
43959223|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959224|NCT01399008|Colchicine|colchicine|mesh-list
43959225|NCT01399008|Allopurinol|allopurinol|mesh-list
43959226|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
43959227|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959228|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959229|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959230|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959231|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959232|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959233|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
43959234|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959235|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43959236|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
43959237|NCT01399008|Protective Agents|protective agents|mesh-ancestor
43959238|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142284|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142285|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
44142286|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44142293|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142294|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44142295|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
44142296|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142297|NCT00186277|Docetaxel|docetaxel|mesh-list
44142298|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
44142299|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142300|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142301|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142302|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142303|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142304|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44142305|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
44142306|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142307|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44142308|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
44142309|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142310|NCT00186420|Docetaxel|docetaxel|mesh-list
44142311|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142312|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142313|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142314|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142315|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142316|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44142317|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
44142318|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142319|NCT00186706|Selenium|selenium|mesh-list
44142320|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
44142321|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142322|NCT00186706|Protective Agents|protective agents|mesh-ancestor
44142323|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142324|NCT00186706|Trace Elements|trace elements|mesh-ancestor
44142325|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
44142326|NCT00186745|Tinzaparin|tinzaparin|mesh-list
44142327|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44142328|NCT00186745|Dalteparin|dalteparin|mesh-list
44142329|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
44142332|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142333|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
44142334|NCT00186797|Fludarabine|fludarabine|mesh-list
44142335|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142336|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
44142337|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142338|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142339|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142340|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
44142341|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142342|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142343|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142344|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
44142345|NCT00186810|Busulfan|busulfan|mesh-list
44142346|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959239|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
43959240|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959241|NCT01399827|Methylphenidate|methylphenidate|mesh-list
43959243|NCT01399827|Adderall|adderall|mesh-list
43959244|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
43959245|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43959246|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44173237|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173238|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173239|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173240|NCT00292409|Aripiprazole|aripiprazole|mesh-list
44173241|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
44173242|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44173243|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44173244|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44173245|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173246|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173247|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
44173248|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
44173249|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173250|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173251|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44173252|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44173253|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
44173254|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44173255|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44173256|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44173257|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44173258|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
44173259|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44173260|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
44173261|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173262|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173263|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44173264|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959247|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43959248|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959249|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43959250|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43959251|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959252|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959253|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
43959254|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959255|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43959256|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
43959257|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
43959258|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
43959259|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959260|NCT01399866|Cycloserine|cycloserine|mesh-list
43959261|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43959262|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959263|NCT01399866|Renal Agents|renal agents|mesh-ancestor
43959264|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43959265|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
43959266|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959267|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
43959268|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959269|NCT01400906|Fluticasone|fluticasone|mesh-list
43959270|NCT01400906|Xhance|xhance|mesh-list
43959271|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959294|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959295|NCT01401543|Urological Agents|urological agents|mesh-ancestor
43959296|NCT01401595|Dexetimide|dexetimide|mesh-list
43959297|NCT01401595|Citalopram|citalopram|mesh-list
43959298|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43959299|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43959300|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959301|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959302|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959303|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
43959304|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959305|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43959306|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
43959307|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43959308|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43959309|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43959352|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43959353|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
43959354|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959356|NCT01403376|Interferon-beta|interferon-beta|mesh-list
43959357|NCT01403376|Teriflunomide|teriflunomide|mesh-list
43959358|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
43959359|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959360|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
43959361|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959362|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43959363|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
43959364|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959365|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43959366|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959367|NCT01403376|Analgesics|analgesics|mesh-ancestor
43959368|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
43959369|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959370|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959371|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959372|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959373|NCT01404260|Gemcitabine|gemcitabine|mesh-list
43959374|NCT01404260|Carboplatin|carboplatin|mesh-list
43959375|NCT01404260|Gefitinib|gefitinib|mesh-list
43959376|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959377|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43959378|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
43959379|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959380|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
43959381|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959382|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959383|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959384|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
43959385|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959386|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43959392|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43959394|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959395|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959396|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959397|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959398|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43959399|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959400|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
43959401|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959402|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43959403|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43959404|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43959405|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43959406|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
43959407|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959408|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959409|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43959410|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43959411|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
43959412|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959413|NCT01404832|Lansoprazole|lansoprazole|mesh-list
43959414|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
43959415|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43959416|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959417|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43959418|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959419|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959420|NCT01404923|Mebeverine|mebeverine|mesh-list
43959440|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959441|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
43959442|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959443|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
43959444|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959445|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43959506|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
43959507|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959508|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43959510|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43959511|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43959512|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959513|NCT01410058|Efavirenz|efavirenz|mesh-list
43959514|NCT01410058|Nevirapine|nevirapine|mesh-list
43959515|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43959516|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43959517|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959518|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959519|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
43959520|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959521|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43959522|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43959527|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43959563|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959564|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959565|NCT01411501|Mosapride|mosapride|mesh-list
43959566|NCT01411501|Citric Acid|citric acid|mesh-list
43959567|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
43959568|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
43959569|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43959570|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
43959571|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
43959572|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959573|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959574|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43959575|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
43959576|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959577|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959578|NCT01411696|Dexamethasone|dexamethasone|mesh-list
43959579|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959580|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
43959581|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
43959582|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959583|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959584|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959585|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
43959586|NCT01411696|Hormones|hormones|mesh-ancestor
43959587|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959588|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43959589|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959590|NCT01412164|Sirolimus|sirolimus|mesh-list
43959591|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43959592|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959593|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43959594|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959595|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
43959596|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959597|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
43959603|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43959604|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959605|NCT01412372|Analgesics|analgesics|mesh-ancestor
43959606|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
43959607|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959608|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959609|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959610|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959612|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
43959613|NCT01412710|Vitamins|vitamins|mesh-ancestor
43959614|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
43959615|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959616|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43959617|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959618|NCT01413516|Varenicline|varenicline|mesh-list
43959619|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43959620|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43959621|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959622|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959623|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959624|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959625|NCT01413750|Paclitaxel|paclitaxel|mesh-list
43959626|NCT01413750|Carboplatin|carboplatin|mesh-list
43959627|NCT01413750|Vorinostat|vorinostat|mesh-list
43959628|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43959629|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959652|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959653|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
43959654|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
43959655|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959656|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959657|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959658|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
43959659|NCT01415583|Hormones|hormones|mesh-ancestor
43959660|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959661|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43959662|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959663|NCT01415960|Leuprolide|leuprolide|mesh-list
43959664|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43959665|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
43959666|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959667|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959668|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43959669|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142348|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142349|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142350|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142351|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
44142352|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142353|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142354|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142355|NCT00186823|Antibodies|antibodies|mesh-list
44142356|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
44142357|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142358|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
44142359|NCT00186849|Ifosfamide|ifosfamide|mesh-list
44142360|NCT00186849|Cisplatin|cisplatin|mesh-list
44163883|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163884|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163885|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44163887|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44163888|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44163889|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44163890|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44163891|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44163892|NCT00254202|Iloperidone|iloperidone|mesh-list
44163893|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163894|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44173265|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
44142361|NCT00186849|Carboplatin|carboplatin|mesh-list
44142362|NCT00186849|Doxorubicin|doxorubicin|mesh-list
44142363|NCT00186849|Etoposide|etoposide|mesh-list
44142364|NCT00186849|Topotecan|topotecan|mesh-list
44142365|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142366|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
44142367|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142368|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142369|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142370|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
44157519|NCT00234845|Methotrexate|methotrexate|mesh-list
43959671|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
43959672|NCT01416194|Diphosphonates|diphosphonates|mesh-list
43959673|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43959674|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
43959675|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959676|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959677|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43959678|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43959679|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43959681|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43959717|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959718|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
43959719|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959720|NCT01419795|Rituximab|rituximab|mesh-list
43959721|NCT01419795|Lenalidomide|lenalidomide|mesh-list
43959722|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43959723|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959724|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
43959725|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959726|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959727|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43959728|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43959729|NCT01419795|Growth Substances|growth substances|mesh-ancestor
43959730|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
43959731|NCT01419977|Dalteparin|dalteparin|mesh-list
43959732|NCT01419977|Tinzaparin|tinzaparin|mesh-list
43959733|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43959734|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
43959735|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43959736|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43959737|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959738|NCT01420146|Trastuzumab|trastuzumab|mesh-list
43959739|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43959740|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959741|NCT01420653|Acetaminophen|acetaminophen|mesh-list
43959742|NCT01420653|Ibuprofen|ibuprofen|mesh-list
43959743|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959744|NCT01420653|Analgesics|analgesics|mesh-ancestor
43959745|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
43959767|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959768|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43959769|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959770|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
43959771|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43959772|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43959773|NCT01421186|Growth Substances|growth substances|mesh-ancestor
43959774|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
43959775|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43959776|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43959777|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43959778|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
43959779|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959780|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959781|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43959782|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43959783|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
43959784|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959785|NCT01421472|Paclitaxel|paclitaxel|mesh-list
43959786|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43959787|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959788|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
43959789|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
43959790|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
43959791|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959792|NCT01421498|Lifitegrast|lifitegrast|mesh-list
44163895|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163896|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163898|NCT00254241|Risperidone|risperidone|mesh-list
44163899|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44163900|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163901|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
44163902|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163903|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163904|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163905|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163906|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163907|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163908|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163909|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163910|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
44163911|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
44163912|NCT00254254|Exenatide|exenatide|mesh-list
44163913|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44163914|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163915|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43959793|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43959794|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43959795|NCT01421589|Hormones|hormones|mesh-list
43959796|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959797|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959798|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
43959799|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959800|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959801|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
43959802|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43959803|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43959804|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959805|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959806|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43959807|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959808|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959809|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43959810|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959811|NCT01422200|Vaccines|vaccines|mesh-list
43959812|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
43959813|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959814|NCT01422226|Alprostadil|alprostadil|mesh-list
43959815|NCT01422226|Misoprostol|misoprostol|mesh-list
43959816|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43959817|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
43959818|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43959819|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959820|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43959821|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43959822|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
43959823|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43959824|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
43959825|NCT01422226|Urological Agents|urological agents|mesh-ancestor
43959826|NCT01422369|Ritonavir|ritonavir|mesh-list
43959827|NCT01422369|Darunavir|darunavir|mesh-list
43959828|NCT01422369|Pitavastatin|pitavastatin|mesh-list
43959831|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
43959832|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959833|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959834|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43959835|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43959836|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
43959837|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959838|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43959839|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43959840|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43959841|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43959842|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43959843|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
43959844|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43959846|NCT01422434|Betamethasone|betamethasone|mesh-list
43959847|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
43959848|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43959849|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
43959850|NCT01422434|Calcipotriene|calcipotriene|mesh-list
43959851|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43959852|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959853|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
43959854|NCT01422434|Hormones|hormones|mesh-ancestor
43959855|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959856|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959857|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43959858|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959859|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959860|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43959861|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43959862|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43959865|NCT01422434|Vitamins|vitamins|mesh-ancestor
43959871|NCT01423162|Protective Agents|protective agents|mesh-ancestor
43959872|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959874|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
43959875|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
43959876|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43671536|NCT04424602|Dimethoate|dimethoate|mesh-list
43959877|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
43959878|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959879|NCT01424033|Expectorants|expectorants|mesh-ancestor
43959880|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959881|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43959882|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
43959883|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959884|NCT01424033|Protective Agents|protective agents|mesh-ancestor
43959885|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959886|NCT01424033|Antidotes|antidotes|mesh-ancestor
43959887|NCT01425229|Bosentan|bosentan|mesh-list
43959888|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43959889|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43959890|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959891|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
43959892|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959893|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
43959894|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959895|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959896|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43959898|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43959899|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43959901|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
43959902|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43959903|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959904|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43959905|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959906|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43959907|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43959911|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43959912|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43959913|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
43959914|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959915|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43959916|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959917|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43959918|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43959919|NCT01426867|Brinzolamide|brinzolamide|mesh-list
43959920|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43959921|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43959922|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43959923|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43959924|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43959925|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
43959926|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43959927|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959928|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959929|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43959930|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959931|NCT01427504|Etravirine|etravirine|mesh-list
43959932|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44163916|NCT00254254|Incretins|incretins|mesh-ancestor
44163917|NCT00254254|Hormones|hormones|mesh-ancestor
44163918|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163919|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
44163920|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163921|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163922|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163923|NCT00254319|Bevacizumab|bevacizumab|mesh-list
44163924|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44163925|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163926|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44163927|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44163928|NCT00254319|Growth Substances|growth substances|mesh-ancestor
44163929|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163930|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
44163931|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44163932|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163933|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44163934|NCT00254345|Protective Agents|protective agents|mesh-ancestor
44163935|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163936|NCT00254371|Androgens|androgens|mesh-list
44163937|NCT00254371|Hormones|hormones|mesh-ancestor
44163938|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163939|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163940|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
44163941|NCT00254436|Hematinics|hematinics|mesh-ancestor
44163942|NCT00254449|Capsaicin|capsaicin|mesh-list
44163943|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
44163944|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959933|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43959934|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959935|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959936|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
43959937|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959938|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
43959939|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43959940|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
43959941|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959942|NCT01427517|Expectorants|expectorants|mesh-ancestor
43959943|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
43959944|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43959945|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
43959946|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959947|NCT01427517|Protective Agents|protective agents|mesh-ancestor
43959948|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959949|NCT01427517|Antidotes|antidotes|mesh-ancestor
43959950|NCT01427595|Metformin|metformin|mesh-list
43959951|NCT01427595|Progesterone|progesterone|mesh-list
43959952|NCT01427595|Estradiol|estradiol|mesh-list
43959953|NCT01427595|Estrogens|estrogens|mesh-list
43959954|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43959955|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959956|NCT01427595|Progestins|progestins|mesh-ancestor
43959957|NCT01427595|Hormones|hormones|mesh-ancestor
43959958|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43959959|NCT01427881|Cyclosporine|cyclosporine|mesh-list
43959960|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
43959961|NCT01427881|Busulfan|busulfan|mesh-list
43959962|NCT01427881|Fludarabine|fludarabine|mesh-list
43959963|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
43959964|NCT01427881|Cyclosporins|cyclosporins|mesh-list
43959965|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43959966|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
43959967|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43959968|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43959969|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43959970|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
44163945|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
43959971|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43959972|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43959973|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43959974|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43959975|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
43959976|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43959977|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
43959978|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43959979|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
43959980|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43959982|NCT01428245|Estrogens|estrogens|mesh-list
43959983|NCT01428245|Progesterone|progesterone|mesh-list
43959984|NCT01428245|Hormones|hormones|mesh-ancestor
43959993|NCT01428336|Hormones|hormones|mesh-ancestor
43960032|NCT01430182|Methadone|methadone|mesh-list
43960033|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43960034|NCT01430182|Narcotics|narcotics|mesh-ancestor
43960035|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960036|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960037|NCT01430182|Analgesics|analgesics|mesh-ancestor
43960038|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
43960039|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960040|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
43960041|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
43960042|NCT01430819|Vaccines|vaccines|mesh-list
43960043|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
43960044|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960045|NCT01431014|Dexamethasone|dexamethasone|mesh-list
43960046|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
43960047|NCT01431014|BB 1101|bb 1101|mesh-list
43960048|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960049|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
43960051|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960052|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960053|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960054|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
43960056|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960057|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960058|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960059|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
43960060|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960061|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960062|NCT01431105|Atorvastatin|atorvastatin|mesh-list
43960063|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43960064|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43960065|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
43960066|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960067|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43960068|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43960069|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163946|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960070|NCT01431170|Trimethoprim|trimethoprim|mesh-list
43960071|NCT01431170|Polymyxins|polymyxins|mesh-list
43960072|NCT01431170|Polymyxin B|polymyxin b|mesh-list
43960073|NCT01431170|Besifloxacin|besifloxacin|mesh-list
43960074|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
43960075|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43960076|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960077|NCT01431170|Renal Agents|renal agents|mesh-ancestor
43960078|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
43960079|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43960080|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43960081|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43960082|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960083|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960084|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43960085|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43960086|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43960087|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960088|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43960089|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43960090|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960091|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43960092|NCT01431339|Vancomycin|vancomycin|mesh-list
43960093|NCT01431339|Linezolid|linezolid|mesh-list
43960094|NCT01431339|Dalbavancin|dalbavancin|mesh-list
43960095|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960096|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960097|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43960098|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960099|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960100|NCT01431391|Leuprolide|leuprolide|mesh-list
43960101|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43960114|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960115|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960116|NCT01431794|Gemcitabine|gemcitabine|mesh-list
43960117|NCT01431794|Paclitaxel|paclitaxel|mesh-list
43960118|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43960119|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960120|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
43960121|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
43960122|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
43960123|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960124|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960125|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
43960126|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
43960127|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960174|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960175|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960176|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
43960177|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43960178|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43960179|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43960180|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960181|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960182|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
43960183|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960184|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960185|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43960186|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960187|NCT01432405|Pioglitazone|pioglitazone|mesh-list
43960188|NCT01432405|Exenatide|exenatide|mesh-list
43960189|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960190|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960191|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43960192|NCT01432405|Incretins|incretins|mesh-ancestor
43960193|NCT01432405|Hormones|hormones|mesh-ancestor
43960194|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960195|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43960196|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
43960197|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960198|NCT01432561|Cysteamine|cysteamine|mesh-list
43960200|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142371|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142372|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142373|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142374|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142375|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142376|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142377|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142378|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142380|NCT00186862|Interleukin-2|interleukin-2|mesh-list
44142382|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44142384|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
44142385|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142386|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142387|NCT00186940|Rasburicase|rasburicase|mesh-list
44142388|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
44142389|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142390|NCT00186966|Cytarabine|cytarabine|mesh-list
44142391|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
44142392|NCT00186966|Melphalan|melphalan|mesh-list
44142393|NCT00186966|Busulfan|busulfan|mesh-list
44142394|NCT00186966|Fludarabine|fludarabine|mesh-list
44142395|NCT00186966|Etoposide|etoposide|mesh-list
44142396|NCT00186966|Daunorubicin|daunorubicin|mesh-list
44142397|NCT00186966|Thioguanine|thioguanine|mesh-list
44142398|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142399|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
44142400|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142401|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142402|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142403|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
44142404|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142405|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142406|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142407|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142408|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
44142409|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142410|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142411|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163947|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163948|NCT00254475|Valsartan|valsartan|mesh-list
44163949|NCT00254475|Simvastatin|simvastatin|mesh-list
44163950|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44163951|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44163952|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
44163953|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163954|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44163955|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44163956|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163957|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44163958|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44163959|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44163960|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
44163961|NCT00254553|Testosterone|testosterone|mesh-list
44163962|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
44163963|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
44142412|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142413|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
44142414|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142415|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142416|NCT00186979|Cefixime|cefixime|mesh-list
44142417|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
44142418|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
44142419|NCT00186979|Irinotecan|irinotecan|mesh-list
44142420|NCT00186979|Vincristine|vincristine|mesh-list
44142421|NCT00186979|Gefitinib|gefitinib|mesh-list
44142422|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44142423|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142424|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142425|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142426|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142427|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142428|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142429|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142430|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142431|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44142432|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142433|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142434|NCT00187005|Cytarabine|cytarabine|mesh-list
44142435|NCT00187005|Dexamethasone|dexamethasone|mesh-list
44142436|NCT00187005|Prednisone|prednisone|mesh-list
44142437|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
44142438|NCT00187005|Methotrexate|methotrexate|mesh-list
44142439|NCT00187005|Etoposide|etoposide|mesh-list
44142440|NCT00187005|Vincristine|vincristine|mesh-list
44142441|NCT00187005|Daunorubicin|daunorubicin|mesh-list
44142442|NCT00187005|Asparaginase|asparaginase|mesh-list
44163964|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44163965|NCT00254553|Androgens|androgens|mesh-ancestor
44163966|NCT00254553|Hormones|hormones|mesh-ancestor
44163967|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163968|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163969|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44163970|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163971|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
44163972|NCT00254618|Mesalamine|mesalamine|mesh-list
43604029|NCT03241017|Durvalumab|durvalumab|mesh-list
44163973|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44163974|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44163975|NCT00254618|Analgesics|analgesics|mesh-ancestor
44163976|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
44163977|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163978|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163979|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163980|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44163982|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44142444|NCT00187005|Idarubicin|idarubicin|mesh-list
44142445|NCT00187005|Pegaspargase|pegaspargase|mesh-list
44142446|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142447|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
43960202|NCT01433081|Analgesics|analgesics|mesh-ancestor
43960203|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
43960204|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960205|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960206|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
43960207|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960208|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43960209|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
43960210|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43960211|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960212|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960213|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43960214|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
43767776|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
43767777|NCT02399462|Hormones|hormones|mesh-ancestor
43960215|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960216|NCT01433107|Terbinafine|terbinafine|mesh-list
43960217|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
43960218|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960219|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960220|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960221|NCT01433913|Metformin|metformin|mesh-list
43960222|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960223|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960224|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
43960225|NCT01434121|Vitamins|vitamins|mesh-ancestor
43960226|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
43960227|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960228|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
43960241|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960242|NCT01434342|Nicotine|nicotine|mesh-list
43960243|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43960244|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
43960245|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960246|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960247|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43960248|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43960249|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
43960250|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960251|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960252|NCT01434472|Vidarabine|vidarabine|mesh-list
43960253|NCT01434472|Cyclosporine|cyclosporine|mesh-list
43960254|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
43960255|NCT01434472|Rituximab|rituximab|mesh-list
43960256|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43960257|NCT01434472|Fludarabine|fludarabine|mesh-list
43960258|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
43960301|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43960302|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960303|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
43960304|NCT01436266|Hematinics|hematinics|mesh-ancestor
43960305|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
43960306|NCT01436279|Mifepristone|mifepristone|mesh-list
43960307|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43960308|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
43960309|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960310|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960311|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43960312|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43960313|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43960314|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
43960315|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43960316|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43960317|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
43960318|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960319|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
43960320|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43960321|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43960322|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
43960323|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43960324|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
43960325|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43960326|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
43960327|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960328|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960329|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
43960331|NCT01436799|Propofol|propofol|mesh-list
43960332|NCT01436799|Desflurane|desflurane|mesh-list
43960333|NCT01436799|Rocuronium|rocuronium|mesh-list
44163983|NCT00254631|Narcotics|narcotics|mesh-ancestor
44163984|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163985|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163986|NCT00254631|Analgesics|analgesics|mesh-ancestor
44163987|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
44163988|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163989|NCT00254657|Levetiracetam|levetiracetam|mesh-list
44163990|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
44163991|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
44163992|NCT00254670|Naltrexone|naltrexone|mesh-list
43960334|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43767815|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960335|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960336|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960337|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43960338|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
43960339|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
43960340|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43960341|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43960342|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43960343|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960344|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43960345|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43960346|NCT01436799|Narcotics|narcotics|mesh-ancestor
43960347|NCT01436799|Analgesics|analgesics|mesh-ancestor
43960348|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
43960349|NCT01437449|Cisplatin|cisplatin|mesh-list
43960350|NCT01437449|Carboplatin|carboplatin|mesh-list
43960351|NCT01437449|Docetaxel|docetaxel|mesh-list
43960352|NCT01437449|Cetuximab|cetuximab|mesh-list
43960393|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
43960394|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960395|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43960396|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960397|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960398|NCT01441037|Danazol|danazol|mesh-list
43960399|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43960400|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
43960401|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960402|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960403|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43960404|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960405|NCT01441245|Furosemide|furosemide|mesh-list
43960406|NCT01441245|Diuretics|diuretics|mesh-ancestor
43960407|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
43960408|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960409|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43960410|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960411|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960412|NCT01441401|Gabapentin|gabapentin|mesh-list
43960413|NCT01441401|Analgesics|analgesics|mesh-ancestor
43960414|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
43960415|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960416|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960417|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
43960418|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43960419|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43960437|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43960438|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
43960439|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960440|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960441|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
43960442|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43960443|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43960444|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43960445|NCT01441843|Lorazepam|lorazepam|mesh-list
43960446|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
43960447|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
43960448|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
43960449|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960450|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960451|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960452|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43960453|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960454|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43960455|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43960456|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960457|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
43960458|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
43960488|NCT01445028|Isotretinoin|isotretinoin|mesh-list
43960489|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960490|NCT01445626|Dexamethasone|dexamethasone|mesh-list
43960491|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960492|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
43960493|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
43960494|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960495|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960496|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960497|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
43960498|NCT01445626|Hormones|hormones|mesh-ancestor
43960499|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960500|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960501|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960502|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
43960503|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43960504|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
43960505|NCT01445821|Fludarabine|fludarabine|mesh-list
43960506|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
43960507|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960508|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
43960509|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960510|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960511|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43960512|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
43960513|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960514|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960515|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43960516|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960517|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
43960532|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960533|NCT01447225|Gemcitabine|gemcitabine|mesh-list
43960534|NCT01447225|Carboplatin|carboplatin|mesh-list
43960535|NCT01447225|Pemetrexed|pemetrexed|mesh-list
43960536|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960537|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960538|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
43960539|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960540|NCT01447225|Antiviral Agents|antiviral agents|mesh-ancestor
43960541|NCT01447225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960542|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960543|NCT01447225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960544|NCT01447225|Immunologic Factors|immunologic factors|mesh-ancestor
43960545|NCT01447225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960546|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43960547|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43960548|NCT01447511|Rifampin|rifampin|mesh-list
43960549|NCT01447511|Fluconazole|fluconazole|mesh-list
43960550|NCT01447511|Warfarin|warfarin|mesh-list
43960551|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
43960552|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43960553|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
43960554|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960555|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960556|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
43960581|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960583|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43960584|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960585|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960586|NCT01447888|Morphine|morphine|mesh-list
43960587|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43960588|NCT01447888|Narcotics|narcotics|mesh-ancestor
43960589|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960590|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960591|NCT01447888|Analgesics|analgesics|mesh-ancestor
43960592|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
43960593|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960594|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
43960639|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43960640|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
43960641|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960642|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
43960643|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960644|NCT01450319|Cetuximab|cetuximab|mesh-list
43960645|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43960646|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960647|NCT01450826|Ondansetron|ondansetron|mesh-list
43960648|NCT01450826|Aprepitant|aprepitant|mesh-list
43960649|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
43960650|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
43960651|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960652|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960653|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960654|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
43960655|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
43960656|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43960657|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
43960658|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960659|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960660|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43960661|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43960662|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960663|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960664|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43960665|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44142448|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142449|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142450|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142451|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
44142452|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142456|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
44142462|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142463|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142464|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142466|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142467|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142468|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
44142469|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142470|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142471|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142472|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142473|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142474|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142475|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142476|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
44142477|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142478|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142479|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142480|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142481|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142482|NCT00187031|Topotecan|topotecan|mesh-list
44142483|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44142484|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142485|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142487|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960668|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960669|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
43960670|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960671|NCT01451632|Irinotecan|irinotecan|mesh-list
43960672|NCT01451632|Cetuximab|cetuximab|mesh-list
43960673|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43960674|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43960675|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960676|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960677|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960678|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43960679|NCT01451775|Empagliflozin|empagliflozin|mesh-list
43960680|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43960681|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960682|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43960683|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960684|NCT01451996|Loratadine|loratadine|mesh-list
43960685|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
43960723|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960724|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960725|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43960726|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960727|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43960728|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960729|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960730|NCT01455519|Hydromorphone|hydromorphone|mesh-list
43960731|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43960732|NCT01455519|Narcotics|narcotics|mesh-ancestor
43960733|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960734|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960735|NCT01455519|Analgesics|analgesics|mesh-ancestor
43960736|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
43960737|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43960738|NCT01456143|Proflavine|proflavine|mesh-list
43960739|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43960740|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960741|NCT01456299|Remifentanil|remifentanil|mesh-list
43960742|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43960743|NCT01456299|Narcotics|narcotics|mesh-ancestor
43960775|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960776|NCT01457573|Tamsulosin|tamsulosin|mesh-list
43960777|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
43960778|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43960779|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43960780|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43960781|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
43960782|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43960783|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960784|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960785|NCT01457573|Urological Agents|urological agents|mesh-ancestor
43960786|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43960787|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43960788|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43960789|NCT01457885|Busulfan|busulfan|mesh-list
43960790|NCT01457885|Clofarabine|clofarabine|mesh-list
43960791|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
43960792|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960793|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960794|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
43960795|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960796|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43960797|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960798|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43960799|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960800|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
43960801|NCT01458418|Montelukast|montelukast|mesh-list
43960802|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43960803|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
43960804|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43960805|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
43960806|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43960807|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960808|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43960809|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43700073|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
43960811|NCT01458561|Thrombin|thrombin|mesh-list
43960812|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43960813|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
43960814|NCT01458561|Coagulants|coagulants|mesh-ancestor
43960815|NCT01458990|Omeprazole|omeprazole|mesh-list
43960816|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43960817|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960818|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43960819|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960820|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960821|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43960822|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43960823|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
43960824|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43960825|NCT01459588|Laxatives|laxatives|mesh-ancestor
43960826|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43960827|NCT01460225|Lubiprostone|lubiprostone|mesh-list
43960828|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43960829|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960830|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960831|NCT01460875|Interferons|interferons|mesh-list
43960832|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
43960833|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
43960834|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960835|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
43960836|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960837|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
43960838|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960839|NCT01460940|Lenalidomide|lenalidomide|mesh-list
43960840|NCT01460940|Panobinostat|panobinostat|mesh-list
43960841|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43960842|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
43960843|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960844|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43960852|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960853|NCT01461668|Retapamulin|retapamulin|mesh-list
43960854|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960855|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960856|NCT01461733|Amiodarone|amiodarone|mesh-list
43960857|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43960858|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
43960859|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43960860|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43960861|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960862|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43960863|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43960864|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43960865|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960866|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43960867|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43960868|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43960869|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43960870|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
43960871|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43960872|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43960873|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43960874|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
43960875|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960876|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960877|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43960878|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43960879|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43960880|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960881|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960891|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960892|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43960893|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43960894|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
43960896|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
43960897|NCT01462279|Vitamins|vitamins|mesh-ancestor
43960898|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
43960899|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960900|NCT01462565|Epoprostenol|epoprostenol|mesh-list
43960901|NCT01462565|Tezosentan|tezosentan|mesh-list
43960902|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43960903|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43960904|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
43960905|NCT01462773|Interferons|interferons|mesh-list
43960906|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
43960907|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
43960908|NCT01462773|Bortezomib|bortezomib|mesh-list
43960909|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960910|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
43960911|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960912|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
43960913|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960914|NCT01462812|Sumatriptan|sumatriptan|mesh-list
43960915|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43960916|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43960917|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43960918|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
43960941|NCT01463384|Tetracycline|tetracycline|mesh-list
43960942|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43960943|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43960944|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43960945|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43960946|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960947|NCT01464190|Sevelamer|sevelamer|mesh-list
43960948|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
43960949|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
43960950|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43960951|NCT01464229|Iloperidone|iloperidone|mesh-list
43960952|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43960953|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43960954|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43960955|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960956|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43960957|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
43960958|NCT01464359|Busulfan|busulfan|mesh-list
43960959|NCT01464359|Fludarabine|fludarabine|mesh-list
43960960|NCT01464359|Interleukin-2|interleukin-2|mesh-list
43960961|NCT01464359|Allopurinol|allopurinol|mesh-list
43960962|NCT01464359|Levetiracetam|levetiracetam|mesh-list
43960963|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960964|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
43960965|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960966|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43960967|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43960968|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
43960970|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960989|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
43960990|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43960991|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43960992|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43960993|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43960994|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43960995|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43960996|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43960997|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43960998|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43960999|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
43961000|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961002|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43961003|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43961004|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961005|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961006|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961007|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961008|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961009|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961010|NCT01468012|Levodopa|levodopa|mesh-list
43961011|NCT01468012|Carbidopa|carbidopa|mesh-list
43961012|NCT01468012|Entacapone|entacapone|mesh-list
43961013|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43961014|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43961015|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43961016|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
43961017|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961018|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961019|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961020|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43961027|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
43961028|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961029|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
43961030|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961031|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
43961032|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43961033|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43961034|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961035|NCT01468532|Prednisone|prednisone|mesh-list
43961036|NCT01468532|Docetaxel|docetaxel|mesh-list
43961037|NCT01468532|Pasireotide|pasireotide|mesh-list
43961038|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961039|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
43961040|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
43961041|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
43961042|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961043|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961044|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
43961046|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961047|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961048|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961049|NCT01468558|Ketoconazole|ketoconazole|mesh-list
43961050|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
43961051|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961052|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43961053|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43961054|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961055|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961056|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43961057|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
43961058|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961059|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961060|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43961061|NCT01468584|Ribavirin|ribavirin|mesh-list
43961062|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43961063|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
43961064|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961065|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
43961066|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961067|NCT01469234|Loratadine|loratadine|mesh-list
43961068|NCT01469234|Fexofenadine|fexofenadine|mesh-list
43961069|NCT01469234|Terfenadine|terfenadine|mesh-list
43961070|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
43961071|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961072|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43961073|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43961074|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43961075|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
43961076|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
43961077|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961078|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961079|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961080|NCT01469585|Doxycycline|doxycycline|mesh-list
43961081|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961082|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961083|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
43961084|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43961085|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43961086|NCT01469767|Fluocinonide|fluocinonide|mesh-list
43961087|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961088|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
43961089|NCT01469767|Hormones|hormones|mesh-ancestor
43961090|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961091|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961092|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43961093|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
43961094|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43961095|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
43961096|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961097|NCT01470027|Expectorants|expectorants|mesh-ancestor
43961107|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43961108|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43961109|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
43961110|NCT01470118|Alcaftadine|alcaftadine|mesh-list
43961111|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
43961113|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
43961114|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43961115|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961116|NCT01470118|Analgesics|analgesics|mesh-ancestor
43961117|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
43961118|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961119|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961120|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961121|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961122|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43961123|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43961124|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43961125|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
43961126|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
43961127|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961128|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961129|NCT01470170|Alfentanil|alfentanil|mesh-list
43961130|NCT01470170|Propofol|propofol|mesh-list
43961131|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961132|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961133|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961134|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43961135|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
43961136|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
43961137|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43961138|NCT01470170|Narcotics|narcotics|mesh-ancestor
43961139|NCT01470170|Analgesics|analgesics|mesh-ancestor
43961140|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
43961141|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961142|NCT01470196|Dexamethasone|dexamethasone|mesh-list
43961143|NCT01470196|Rituximab|rituximab|mesh-list
43961148|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961149|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961150|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
43961151|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
43961152|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961153|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961154|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
43961155|NCT01470196|Hormones|hormones|mesh-ancestor
43961156|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961157|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142509|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142510|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142511|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
43961180|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43961181|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
43961182|NCT01471639|Ketorolac|ketorolac|mesh-list
43961183|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43961184|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961185|NCT01471639|Analgesics|analgesics|mesh-ancestor
43961186|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
43961187|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961188|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961189|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961190|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961191|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43961192|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961193|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961194|NCT01472432|Vildagliptin|vildagliptin|mesh-list
43961195|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961196|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961197|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43961198|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
43961199|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961200|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961201|NCT01472445|Vitamin D|vitamin d|mesh-list
43961202|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
43961203|NCT01472445|Vitamins|vitamins|mesh-ancestor
43961204|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
43961205|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961206|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43961207|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43961208|NCT01472549|Ethanol|ethanol|mesh-list
43961209|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
43961210|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43961211|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961212|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961213|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961214|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
43961219|NCT01473368|Amoxicillin|amoxicillin|mesh-list
43961220|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
43961221|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
43961293|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
43961294|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961295|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961296|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43961297|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43961298|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961299|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43961300|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43961309|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
43961359|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
43961360|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961361|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961362|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
43961363|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43961364|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43961365|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
43961366|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961367|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43961368|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
43961369|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961370|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961371|NCT01476449|Ranibizumab|ranibizumab|mesh-list
43961372|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43961373|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43961374|NCT01476449|Growth Substances|growth substances|mesh-ancestor
43961420|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
43961421|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
43961422|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961423|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961424|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961425|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
43961426|NCT01478581|Hormones|hormones|mesh-ancestor
43961427|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961428|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961429|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961430|NCT01479127|Silicon|silicon|mesh-list
43961431|NCT01479127|Levodopa|levodopa|mesh-list
43961432|NCT01479127|Carbidopa|carbidopa|mesh-list
43961433|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43961434|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43961435|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
43961436|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961437|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961438|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961439|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43961443|NCT01479270|Epinephrine|epinephrine|mesh-list
43961473|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961474|NCT01480089|Ropivacaine|ropivacaine|mesh-list
43961475|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
43961476|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
43961477|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961478|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961479|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
43961480|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961481|NCT01480219|Voriconazole|voriconazole|mesh-list
43961482|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
43961483|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961484|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43961485|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43961486|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961487|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961488|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43961489|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
43961490|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961491|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961492|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43961493|NCT01480232|Nicotine|nicotine|mesh-list
43961494|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43961495|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
43961496|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961497|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961498|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43961499|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43961500|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
43961501|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961502|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961503|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43961504|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
43961505|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43961509|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961510|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961511|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43961512|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961513|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43961514|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961515|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961516|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
43961517|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961518|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961519|NCT01481545|Leucovorin|leucovorin|mesh-list
43961520|NCT01481545|Bevacizumab|bevacizumab|mesh-list
43961521|NCT01481545|Fluorouracil|fluorouracil|mesh-list
43961522|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
43961523|NCT01481545|Raltitrexed|raltitrexed|mesh-list
43961524|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
43961525|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43961526|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961527|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43961528|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43961529|NCT01481545|Growth Substances|growth substances|mesh-ancestor
43961530|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961531|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
43961532|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
43961533|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961560|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961561|NCT01481740|Protective Agents|protective agents|mesh-ancestor
43961562|NCT01482091|Fentanyl|fentanyl|mesh-list
43961563|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43961564|NCT01482091|Narcotics|narcotics|mesh-ancestor
43961565|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961566|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961567|NCT01482091|Analgesics|analgesics|mesh-ancestor
43961568|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
43961625|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961626|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961627|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
43961629|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961630|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961631|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961632|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43961633|NCT01485393|Analgesics|analgesics|mesh-ancestor
43961634|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
43961635|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961636|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43961637|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43961638|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961639|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961640|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961641|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961642|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43961643|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43961644|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
43961645|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
43961646|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
43961647|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
43961648|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961649|NCT01486043|Metformin|metformin|mesh-list
43961650|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961651|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961652|NCT01486615|Melatonin|melatonin|mesh-list
43961653|NCT01486615|Alprazolam|alprazolam|mesh-list
43961654|NCT01486615|Azaperone|azaperone|mesh-list
43961655|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
43961656|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961657|NCT01486615|Protective Agents|protective agents|mesh-ancestor
43961658|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961666|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961667|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43961668|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43961669|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
43961670|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43961671|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43961672|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961673|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43961674|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43961675|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43961676|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961677|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
43700721|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
43961678|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961679|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
43961680|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43961681|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
43961682|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961683|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961684|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43961685|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
43961686|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43961687|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43961688|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43961689|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
43961690|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961691|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961693|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
43961694|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961695|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43961697|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
43961707|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961708|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961709|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961710|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
43961711|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961712|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961713|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43961714|NCT01488279|Incretins|incretins|mesh-ancestor
43961715|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43961716|NCT01488318|Cetuximab|cetuximab|mesh-list
43961717|NCT01488318|Dasatinib|dasatinib|mesh-list
43961718|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43961719|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961720|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43961721|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961722|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961723|NCT01488409|Acipimox|acipimox|mesh-list
43961724|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43961725|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
43961726|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961727|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43961728|NCT01488877|Spironolactone|spironolactone|mesh-list
43961729|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43961730|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
43961731|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43961732|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961733|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43961734|NCT01488877|Diuretics|diuretics|mesh-ancestor
43961735|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
43961736|NCT01489670|Bimatoprost|bimatoprost|mesh-list
43961737|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43961738|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43961739|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43961746|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961747|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43961748|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43961749|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961750|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961751|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43961752|NCT01489826|Protective Agents|protective agents|mesh-ancestor
43961753|NCT01489969|Melatonin|melatonin|mesh-list
43961754|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
43961755|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961756|NCT01489969|Protective Agents|protective agents|mesh-ancestor
43961757|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961758|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961759|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
43961760|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44142538|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44142539|NCT00187070|Dexamethasone|dexamethasone|mesh-list
44142540|NCT00187070|Prednisone|prednisone|mesh-list
44142541|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
44142542|NCT00187070|Ifosfamide|ifosfamide|mesh-list
44142543|NCT00187070|Carboplatin|carboplatin|mesh-list
44142544|NCT00187070|Doxorubicin|doxorubicin|mesh-list
44142545|NCT00187070|Methotrexate|methotrexate|mesh-list
44142546|NCT00187070|Etoposide|etoposide|mesh-list
44142547|NCT00187070|Vincristine|vincristine|mesh-list
44142548|NCT00187070|Vinblastine|vinblastine|mesh-list
44142549|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44142550|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
44142551|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142552|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44142553|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142554|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
44142567|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44142568|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44142569|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44142570|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142571|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142572|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
44142573|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44142574|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44142575|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
44142576|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
44142577|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44142578|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44142579|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44142580|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
44142581|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142582|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
44142583|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
44142584|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
44142585|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44142586|NCT00187070|Renal Agents|renal agents|mesh-ancestor
44142587|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44142588|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
44142589|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44142590|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44142591|NCT00187083|Dexamethasone|dexamethasone|mesh-list
44142592|NCT00187083|Methotrexate|methotrexate|mesh-list
44142593|NCT00187083|Fludarabine|fludarabine|mesh-list
44142594|NCT00187083|Etoposide|etoposide|mesh-list
44142595|NCT00187083|Vincristine|vincristine|mesh-list
44142596|NCT00187083|Topotecan|topotecan|mesh-list
43961765|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
43961766|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43961767|NCT01490723|Tacrolimus|tacrolimus|mesh-list
43961768|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
43961769|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43961770|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43961771|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43961772|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961773|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
43961774|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961775|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961776|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43961777|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
43961778|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43961779|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43961780|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
43961781|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961782|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
43961783|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961784|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43961785|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961786|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43961787|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961788|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43961789|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43961790|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43961791|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
43961792|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961793|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961809|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43961810|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43961811|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43961879|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43961880|NCT01492673|Growth Substances|growth substances|mesh-ancestor
43961881|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
43961882|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43961883|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43961884|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961885|NCT01493180|Rebamipide|rebamipide|mesh-list
43961886|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43961887|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
43961888|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43961889|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43961890|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
43961891|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961892|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
43961893|NCT01493180|Protective Agents|protective agents|mesh-ancestor
43961894|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43961895|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43961896|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
43961897|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961898|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961899|NCT01493947|Metronidazole|metronidazole|mesh-list
43961900|NCT01493947|Ivermectin|ivermectin|mesh-list
43961901|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961902|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43961903|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43961904|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43961905|NCT01495481|Adenosine|adenosine|mesh-list
43961906|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
43961907|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43961908|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961909|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961911|NCT01495481|Analgesics|analgesics|mesh-ancestor
43961923|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
43961924|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
43961926|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
43961927|NCT01495572|Fludarabine|fludarabine|mesh-list
43961928|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961929|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
43961930|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961931|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961932|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961933|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
43961934|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961935|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961936|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43961937|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43961938|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43961939|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
43961940|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43961941|NCT01495585|Lonafarnib|lonafarnib|mesh-list
43961942|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43961943|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961944|NCT01495819|Nicotine|nicotine|mesh-list
43961945|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43961946|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
43961947|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961948|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961949|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43961950|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43961951|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
43961952|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961954|NCT01495858|Naproxen|naproxen|mesh-list
43961969|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
43961970|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43961971|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961972|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
43961973|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43961974|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43961975|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43961976|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43961977|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43961978|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43961979|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43961980|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961981|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
43961982|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
43961983|NCT01496131|Goserelin|goserelin|mesh-list
43961984|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
43961985|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43961986|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43961987|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43961988|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43961989|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
43961990|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43961991|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43961992|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43961993|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43961994|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
43961995|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43961996|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43961997|NCT01497496|Prednisolone|prednisolone|mesh-list
43961998|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
43961999|NCT01497496|Lenalidomide|lenalidomide|mesh-list
43962000|NCT01497496|Ofatumumab|ofatumumab|mesh-list
43962001|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43962002|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
43962003|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
43962004|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962006|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43962007|NCT01497496|Growth Substances|growth substances|mesh-ancestor
43962008|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
43962009|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962010|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43962011|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
43962012|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
43962013|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962014|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43962015|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
43962016|NCT01497496|Hormones|hormones|mesh-ancestor
43962017|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962018|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43962019|NCT01497496|Protective Agents|protective agents|mesh-ancestor
43962020|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43962021|NCT01497808|Ipilimumab|ipilimumab|mesh-list
43962022|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43962023|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962024|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43962025|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962026|NCT01497860|Vinorelbine|vinorelbine|mesh-list
43962027|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43962028|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962029|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
43962055|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962056|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962057|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43962058|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
44142612|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962059|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962060|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962061|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43962062|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43962063|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43962064|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43962065|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962066|NCT01498744|Clindamycin|clindamycin|mesh-list
43962067|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
43962068|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
43962069|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43962070|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962071|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43962072|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962073|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962074|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43962076|NCT01498978|Antibodies|antibodies|mesh-list
43962077|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
43962078|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43962079|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
43962080|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962081|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962082|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43962083|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962084|NCT01499147|Vidarabine|vidarabine|mesh-list
43962085|NCT01499147|Fludarabine|fludarabine|mesh-list
43962086|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
43962087|NCT01499147|Melphalan|melphalan|mesh-list
43962093|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962094|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962095|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
43962096|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962097|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
43962098|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962099|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43962100|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
43962101|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43962102|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
43962103|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
43962104|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43962146|NCT01502761|Analgesics|analgesics|mesh-ancestor
43962147|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
43962148|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962149|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962150|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
43962151|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962152|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43962153|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
43962154|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43962155|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962156|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962157|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43962158|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
43962207|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962209|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962210|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962211|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43962212|NCT01505179|Ranolazine|ranolazine|mesh-list
43962213|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43962214|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962215|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962216|NCT01505673|Liraglutide|liraglutide|mesh-list
43962217|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43962218|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962219|NCT01505673|Incretins|incretins|mesh-ancestor
43962220|NCT01505673|Hormones|hormones|mesh-ancestor
43962221|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962222|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
43962223|NCT01505933|Propofol|propofol|mesh-list
43962224|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962225|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962226|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962227|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43962228|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
43962229|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
43962230|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962231|NCT01505933|Analgesics|analgesics|mesh-ancestor
43962232|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
43962233|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962234|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43962235|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43962236|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643825|NCT04891809|Hormones|hormones|mesh-ancestor
43962248|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962249|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43962250|NCT01507181|Midazolam|midazolam|mesh-list
43962251|NCT01507181|Ketamine|ketamine|mesh-list
43962252|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
43962253|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
43962254|NCT01507181|Analgesics|analgesics|mesh-ancestor
43962255|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
43962256|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962257|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962258|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767964|NCT02398123|Bupivacaine|bupivacaine|mesh-list
43962259|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43962260|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
43962261|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
43962262|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962263|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43962264|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962265|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962266|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43962267|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962268|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43962269|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43962270|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43962271|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
43962272|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
43962273|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43962274|NCT01507220|Morphine|morphine|mesh-list
43962275|NCT01507220|Bupivacaine|bupivacaine|mesh-list
43962276|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962277|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
43962278|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962279|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962280|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
43962281|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962291|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962292|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962293|NCT01508455|Fentanyl|fentanyl|mesh-list
43962294|NCT01508455|Midazolam|midazolam|mesh-list
43962295|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
43962296|NCT01508455|Morphine|morphine|mesh-list
43962297|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962298|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962299|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962300|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962321|NCT01508832|Lidocaine|lidocaine|mesh-list
43962357|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962358|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962359|NCT01509638|Bupivacaine|bupivacaine|mesh-list
43962360|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962361|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
43962362|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962363|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962364|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
43962365|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962367|NCT01509807|Bupivacaine|bupivacaine|mesh-list
43962368|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
43962369|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
43962370|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962371|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962372|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
43962373|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962374|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43962375|NCT01509807|Narcotics|narcotics|mesh-ancestor
43962376|NCT01509807|Analgesics|analgesics|mesh-ancestor
44142614|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
44142648|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44142649|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
44142650|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142651|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44142652|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44142653|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44142655|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
44142656|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44142657|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44142658|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
44142659|NCT00187122|Hormones|hormones|mesh-ancestor
44142660|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44142661|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44142662|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44142663|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
43701361|NCT02724904|Methotrexate|methotrexate|mesh-list
43962377|NCT01510327|Aspirin|aspirin|mesh-list
43962378|NCT01510327|Everolimus|everolimus|mesh-list
43962379|NCT01510327|Ticlopidine|ticlopidine|mesh-list
43962380|NCT01510327|Clopidogrel|clopidogrel|mesh-list
43962381|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43962382|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962383|NCT01510327|Analgesics|analgesics|mesh-ancestor
43962384|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
43962385|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962386|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962387|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43962388|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962389|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43962390|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43962391|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962401|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43962402|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
43962403|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962404|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43962405|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43962406|NCT01510379|Promethazine|promethazine|mesh-list
43962407|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
43962408|NCT01510379|Ondansetron|ondansetron|mesh-list
43962409|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
43962410|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
43962411|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962412|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962413|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43962414|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
43962415|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
43962416|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43962417|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
43962418|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962419|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962420|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43962421|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43962456|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962457|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962458|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
43962459|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43962460|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962461|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962462|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43962463|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43962464|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43962465|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962466|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43962467|NCT01511809|Ritonavir|ritonavir|mesh-list
43962468|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43962469|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43962470|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43962471|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
43962472|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962473|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962474|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43962475|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43962476|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
43962477|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962478|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43962479|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43962480|NCT01511978|Amifampridine|amifampridine|mesh-list
43962481|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43962482|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962483|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962484|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43962487|NCT01512225|Domperidone|domperidone|mesh-list
43962498|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962500|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962501|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43962502|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962503|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962504|NCT01512446|Alendronate|alendronate|mesh-list
43962505|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43962506|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962507|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43962508|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43962509|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962510|NCT01512797|Incretins|incretins|mesh-ancestor
43962511|NCT01512797|Hormones|hormones|mesh-ancestor
43962512|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43962513|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43962557|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43962559|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962560|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962561|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
43962562|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43962563|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43962564|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43962565|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
43962566|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962567|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
43962568|NCT01515046|Protective Agents|protective agents|mesh-ancestor
43962569|NCT01515046|Vitamins|vitamins|mesh-ancestor
43962570|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
43962571|NCT01515176|Ofatumumab|ofatumumab|mesh-list
43962572|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43962573|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962574|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
43962575|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962576|NCT01515345|Clopidogrel|clopidogrel|mesh-list
43962577|NCT01515345|Ticagrelor|ticagrelor|mesh-list
43962578|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43962579|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43962580|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43962607|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43962608|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962609|NCT01515566|Fentanyl|fentanyl|mesh-list
43962610|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43962611|NCT01515566|Narcotics|narcotics|mesh-ancestor
43962612|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43962613|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962614|NCT01515566|Analgesics|analgesics|mesh-ancestor
43962615|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
43962616|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962617|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43962618|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43962619|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
43962620|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
43962621|NCT01515657|Aspirin|aspirin|mesh-list
43962622|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43962623|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43962624|NCT01515657|Analgesics|analgesics|mesh-ancestor
43962625|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
43962626|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962627|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962628|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43962629|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43962630|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43962697|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962698|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43962699|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43962700|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
43962701|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43962702|NCT01516684|Narcotics|narcotics|mesh-ancestor
43962703|NCT01516684|Analgesics|analgesics|mesh-ancestor
43962704|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43962705|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43962706|NCT01516957|Brodalumab|brodalumab|mesh-list
43962707|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43962763|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43962764|NCT01520207|Diuretics|diuretics|mesh-ancestor
43962765|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
43962766|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962767|NCT01520454|Heparin|heparin|mesh-list
43962768|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43962769|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
43962770|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43962771|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43962772|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962773|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43962774|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43962775|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43962826|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
43962827|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43962828|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962829|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43962830|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43962831|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
43962832|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962834|NCT01523496|Vitamin D|vitamin d|mesh-list
43962919|NCT01527045|Cyclosporine|cyclosporine|mesh-list
43962920|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
43962921|NCT01527045|Fludarabine|fludarabine|mesh-list
43962922|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
43962923|NCT01527045|Atorvastatin|atorvastatin|mesh-list
43962924|NCT01527045|Calcium|calcium|mesh-list
43962925|NCT01527045|Cyclosporins|cyclosporins|mesh-list
43962926|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43962927|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43962928|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43962929|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962930|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43962931|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
43962934|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
43962980|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
43962981|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43962982|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43962983|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43962984|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43962985|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
43963047|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43963048|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
43963049|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963050|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963051|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43963053|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43963114|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43963115|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43963116|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43963117|NCT01532141|Opicapone|opicapone|mesh-list
43963118|NCT01532141|Rasagiline|rasagiline|mesh-list
43963119|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43963120|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963121|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963122|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43963123|NCT01532141|Protective Agents|protective agents|mesh-ancestor
43963180|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963181|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
43963182|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
43963183|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
43963184|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43963185|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43963186|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43963187|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963189|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43963190|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43963245|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43963246|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43963247|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963248|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963249|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963250|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
43963251|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963252|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43963253|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
43963254|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43963267|NCT01535924|Gemcitabine|gemcitabine|mesh-list
43963306|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963307|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963308|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43963309|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43963310|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
43963311|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
43963312|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963313|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43963314|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43963315|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963369|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43963370|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43963371|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43963372|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43963373|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963374|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
43963375|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43963376|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
43963377|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963378|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
43963379|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
44142718|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
44142719|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44142720|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
44142721|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142722|NCT00187330|Expectorants|expectorants|mesh-ancestor
44142723|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
44142724|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44142725|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
44142726|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142727|NCT00187330|Protective Agents|protective agents|mesh-ancestor
44142728|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963477|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43963478|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43963479|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963480|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963481|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963482|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963483|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43963484|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43963485|NCT01542541|Rifaximin|rifaximin|mesh-list
43963486|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43963487|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963488|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963489|NCT01542645|Fentanyl|fentanyl|mesh-list
43963491|NCT01542645|Methadone|methadone|mesh-list
43963540|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43963541|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43963542|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963543|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963544|NCT01544998|Urological Agents|urological agents|mesh-ancestor
43963545|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
43963546|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963604|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963605|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
43963606|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963607|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43963608|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43963609|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43963610|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43963611|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963626|NCT01546402|Dexamethasone|dexamethasone|mesh-list
43963627|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
43963628|NCT01546402|BB 1101|bb 1101|mesh-list
43963629|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43963630|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
43963631|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
43963632|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43963633|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963634|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43963635|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
43963636|NCT01546402|Hormones|hormones|mesh-ancestor
43963638|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43963673|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43963674|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
43963750|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43963751|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963752|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43963753|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
43963754|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43963756|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
43767971|NCT02398136|Midazolam|midazolam|mesh-list
43963816|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
43963864|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43963865|NCT01556594|Incretins|incretins|mesh-ancestor
43963866|NCT01556633|Oseltamivir|oseltamivir|mesh-list
43963867|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
43963868|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963869|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963870|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963871|NCT01556724|Ropivacaine|ropivacaine|mesh-list
43963872|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
43963932|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43963933|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43963934|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43963935|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43963936|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43963937|NCT01558128|Amiodarone|amiodarone|mesh-list
43963938|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43963939|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
43963995|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43963996|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43963997|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43963998|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702665|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
43964000|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43964001|NCT01560923|Tryptophan|tryptophan|mesh-list
43964002|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43964003|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
43964004|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964005|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
43964006|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43964007|NCT01561053|Antibodies|antibodies|mesh-list
43964008|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
43964128|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
43964129|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964130|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43964131|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43964132|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43964133|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43964134|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964135|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964136|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43964193|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43964194|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
43964195|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
43964196|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964197|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964198|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
43964199|NCT01566539|Coagulants|coagulants|mesh-ancestor
43964200|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43964201|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43964262|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43964263|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43964264|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43964265|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964266|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964267|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
43964268|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964269|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44142773|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44142774|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44142775|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44142776|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44142777|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44142778|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
44142779|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44142780|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
43964325|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43964326|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964327|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43964328|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43964329|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
43964330|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43964331|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964333|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964334|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
43964335|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
43964336|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964337|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964340|NCT01571557|Hormones|hormones|mesh-ancestor
43964387|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43964461|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964462|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43964463|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43964464|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43964465|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
43964466|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964467|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964468|NCT01576809|Protective Agents|protective agents|mesh-ancestor
43964469|NCT01576809|Expectorants|expectorants|mesh-ancestor
43964470|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
43964471|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43964472|NCT01576874|Oxytocin|oxytocin|mesh-list
43964473|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
43964474|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43964475|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964476|NCT01576952|Bromfenac|bromfenac|mesh-list
43964520|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964521|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964522|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964523|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
43964524|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43964526|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
43964527|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964528|NCT01578707|Ofatumumab|ofatumumab|mesh-list
43964586|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43964587|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43964588|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964589|NCT01580592|Omalizumab|omalizumab|mesh-list
43964590|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43964591|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43964592|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964593|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964594|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
43964595|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964649|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
43964650|NCT01583543|Olaparib|olaparib|mesh-list
43964651|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43964652|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964653|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964654|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43964655|NCT01583686|Aldesleukin|aldesleukin|mesh-list
43964656|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
43964657|NCT01583686|Fludarabine|fludarabine|mesh-list
43964716|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964717|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964718|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
43964719|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43964720|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964721|NCT01585441|Urological Agents|urological agents|mesh-ancestor
44142827|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
44142828|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44142829|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44142830|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44142832|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
43964747|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43964748|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
43964749|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43964750|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
43964751|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
43964816|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43964817|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43964818|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964819|NCT01588418|Exenatide|exenatide|mesh-list
43964820|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43964821|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964886|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43964887|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43964888|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43964889|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964890|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43964891|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43964892|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43964893|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
43964951|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43964952|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
43964953|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43964954|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
43964955|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43964956|NCT01592851|Fluorides|fluorides|mesh-list
43964957|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
43964958|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
43964959|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
43964960|NCT01592851|Protective Agents|protective agents|mesh-ancestor
43964961|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964962|NCT01593215|Yohimbine|yohimbine|mesh-list
43964963|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
43964964|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
43964965|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43964966|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43964967|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43964968|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43965010|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965011|NCT01593748|Gemcitabine|gemcitabine|mesh-list
43965012|NCT01593748|Docetaxel|docetaxel|mesh-list
43965013|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965014|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
43965015|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965016|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965017|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
43965018|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965077|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43965078|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43965079|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
43965080|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965081|NCT01595854|Dabigatran|dabigatran|mesh-list
43965082|NCT01595854|Ticagrelor|ticagrelor|mesh-list
43965083|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43965084|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43965085|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43965086|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43965143|NCT05566665|Avibactam|avibactam|mesh-list
43965144|NCT05566665|Ceftolozane|ceftolozane|mesh-list
43965145|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
43965146|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
43965147|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43965148|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965149|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43965150|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965151|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965152|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43965153|NCT05566665|Renal Agents|renal agents|mesh-ancestor
43965154|NCT05566639|Vaccines|vaccines|mesh-list
43965155|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
43965157|NCT05566405|Anesthetics|anesthetics|mesh-list
44142894|NCT00188136|Melphalan|melphalan|mesh-list
43965206|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43965208|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965277|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
43965278|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965279|NCT05565274|Pentazocine|pentazocine|mesh-list
43965280|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43965281|NCT05565274|Narcotics|narcotics|mesh-ancestor
43965282|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965283|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965284|NCT05565274|Analgesics|analgesics|mesh-ancestor
43965347|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
43965348|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
43965349|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
43965350|NCT05562375|Coagulants|coagulants|mesh-ancestor
43965351|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
43577937|NCT03484962|Antibodies|antibodies|mesh-list
43965352|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965353|NCT05562089|Paclitaxel|paclitaxel|mesh-list
43965354|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43965355|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43965388|NCT05404919|Entecavir|entecavir|mesh-list
43965389|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
43965390|NCT05404919|Antibodies|antibodies|mesh-list
43965391|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
43965392|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43965458|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965460|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43965461|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
43965530|NCT05672537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43965531|NCT05672537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43965532|NCT05672537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43965533|NCT05672537|Immunologic Factors|immunologic factors|mesh-ancestor
43965534|NCT05672537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965535|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43965536|NCT05672524|Trastuzumab|trastuzumab|mesh-list
43965537|NCT05672524|Tucatinib|tucatinib|mesh-list
44142957|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44142958|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
44142959|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44142960|NCT00188552|Tocopherols|tocopherols|mesh-list
44142961|NCT00188552|Vitamin E|vitamin e|mesh-list
44142962|NCT00188552|Tocotrienols|tocotrienols|mesh-list
44142963|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
44142964|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
43965649|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
43965650|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
43965651|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43965652|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43965653|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43965654|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43965655|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965656|NCT05671822|Capecitabine|capecitabine|mesh-list
43965657|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
43965658|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965713|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43965714|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
43965715|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43965716|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43965717|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
43965718|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965719|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
43965781|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
43965782|NCT05607342|SR 142801|sr 142801|mesh-list
43965783|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43965784|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43965785|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44142974|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
44142975|NCT00188552|Vitamins|vitamins|mesh-ancestor
44142976|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
44142977|NCT00188565|Celecoxib|celecoxib|mesh-list
44142978|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44142979|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965875|NCT05558410|Analgesics|analgesics|mesh-ancestor
43965876|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
43965877|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43965878|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965879|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
43965880|NCT05557877|Aspirin|aspirin|mesh-list
43965882|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43965944|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43965945|NCT05511038|Aflibercept|aflibercept|mesh-list
43965946|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43965947|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43965948|NCT05511038|Growth Substances|growth substances|mesh-ancestor
43965949|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43965950|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
43965951|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966007|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43966008|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966009|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966010|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966011|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966012|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966013|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
43966014|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966073|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966074|NCT05322473|Adalimumab|adalimumab|mesh-list
43966075|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966076|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966077|NCT05281510|Vesatolimod|vesatolimod|mesh-list
43966078|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
43966079|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43966080|NCT05265299|Aspirin|aspirin|mesh-list
43966081|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43966082|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966083|NCT05265299|Analgesics|analgesics|mesh-ancestor
43966136|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43966137|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
43966138|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966139|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966141|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966142|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966143|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
43966144|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966145|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966146|NCT05106153|Zolpidem|zolpidem|mesh-list
43966148|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43966149|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43966151|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143056|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143057|NCT00188773|Expectorants|expectorants|mesh-ancestor
44143058|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44143059|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44143060|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
44143061|NCT00188773|Protective Agents|protective agents|mesh-ancestor
44143062|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143063|NCT00188773|Antidotes|antidotes|mesh-ancestor
44143064|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44143065|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44143066|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44143067|NCT00188812|Donepezil|donepezil|mesh-list
44143068|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44143069|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143070|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143071|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
44143072|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966194|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966195|NCT05019716|Cisplatin|cisplatin|mesh-list
43966196|NCT05019716|Etoposide|etoposide|mesh-list
43966197|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
43966198|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
43966199|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966200|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43966201|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43966202|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43966203|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966204|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966205|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
43966206|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
43966254|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966255|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43966256|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
43966257|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43966258|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43966259|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
43966260|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43966261|NCT04980482|Interferons|interferons|mesh-list
43966262|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
43966263|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
43966322|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
43966323|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966324|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966325|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
43966326|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966327|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43966328|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43966329|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43966348|NCT04763759|Antibodies|antibodies|mesh-list
43966389|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
43966390|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966391|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966392|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43966393|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43966394|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43966395|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43966396|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
43966397|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966455|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43966456|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43966457|NCT04526951|Analgesics|analgesics|mesh-ancestor
43966458|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
43966459|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966460|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966461|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143090|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143091|NCT00188877|Fluorouracil|fluorouracil|mesh-list
44143092|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
44143093|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143094|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143095|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143096|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143097|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
44143098|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143099|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
43966559|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43966560|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966562|NCT04398706|Vaccines|vaccines|mesh-list
43966632|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43966633|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43966634|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43966635|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43966636|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966637|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43966638|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43966639|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43966700|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966701|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966702|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966772|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966773|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966774|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966776|NCT03864042|Midazolam|midazolam|mesh-list
43966777|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
43966778|NCT03864042|Caffeine|caffeine|mesh-list
43966779|NCT03864042|Modafinil|modafinil|mesh-list
43966780|NCT03864042|Bupropion|bupropion|mesh-list
43966781|NCT03864042|Omeprazole|omeprazole|mesh-list
43966782|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43966792|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
43966837|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43966838|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
43966839|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966840|NCT03843541|Protective Agents|protective agents|mesh-ancestor
43966842|NCT03843541|Antidotes|antidotes|mesh-ancestor
43966896|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966897|NCT03404596|Nicotine|nicotine|mesh-list
43966898|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43966899|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
43966900|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43966901|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43966902|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43966903|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43966967|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43966968|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43966969|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43966970|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43966971|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43966972|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43966973|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
43966986|NCT03207347|Niraparib|niraparib|mesh-list
43967035|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43967036|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43967037|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
43967038|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
43967039|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
43967040|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
43967041|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967104|NCT02697344|Gossypol|gossypol|mesh-list
43967105|NCT02697344|BB 1101|bb 1101|mesh-list
43967106|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967107|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
43967108|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
43967109|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43967173|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43967175|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
43967247|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967248|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
43967249|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967250|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
43967252|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
43967312|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43967313|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
43967314|NCT01246869|Imidazole|imidazole|mesh-list
43967315|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967316|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967462|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
43967463|NCT04972513|Protective Agents|protective agents|mesh-ancestor
44143143|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
44143144|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44143145|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44143147|NCT00189007|Protective Agents|protective agents|mesh-ancestor
44143148|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143149|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44143150|NCT00189007|Diuretics|diuretics|mesh-ancestor
43967565|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43967566|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43967567|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43967568|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967638|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43967639|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
43967640|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967641|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43967642|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43967645|NCT04181996|Colchicine|colchicine|mesh-list
44143176|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143177|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143178|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
44143179|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44143180|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44143187|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
43967731|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
43967732|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967734|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967804|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
43967805|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
43967806|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967813|NCT03355560|Nivolumab|nivolumab|mesh-list
43967874|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43967875|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967876|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43967877|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43967878|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43967879|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
43967880|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43967941|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43967942|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43967943|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967944|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
43967945|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43967946|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143215|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143216|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
44143217|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
43967955|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43967956|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
43578102|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
43967957|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43967958|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43967959|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43967960|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43967961|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
43968022|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43968024|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
43968025|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968026|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43968027|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43968089|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
43968090|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43968091|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43968092|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
43968164|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968165|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43968166|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43968167|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968168|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43968169|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
43968170|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968171|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
43968229|NCT01605942|Hormones|hormones|mesh-ancestor
43968230|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968231|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43968232|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968233|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43968234|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
43968299|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968300|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968367|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968368|NCT01610154|Incretins|incretins|mesh-ancestor
43968369|NCT01610154|Hormones|hormones|mesh-ancestor
43968370|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43968371|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43968372|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
43968430|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43968431|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43968432|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968433|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968434|NCT01612884|Clopidogrel|clopidogrel|mesh-list
43968498|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43968499|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43968500|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968572|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43968573|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43968574|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
43968576|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43968577|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43968578|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43968579|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
43968580|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
43968583|NCT01620216|Sorafenib|sorafenib|mesh-list
43968641|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43968642|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43968643|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
43968714|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968715|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
43968716|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
43968717|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968786|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968787|NCT01625923|Olanzapine|olanzapine|mesh-list
43968788|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
43968789|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
43968790|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43968791|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43968792|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43968803|NCT01626092|Cyclosporine|cyclosporine|mesh-list
43968853|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43968854|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43968855|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
43968856|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43968857|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
43968859|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
43968951|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43968953|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43968954|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
43968955|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43968956|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43969019|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43969021|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43969095|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
43969096|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969097|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969099|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
43969167|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43969168|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
43969170|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43969171|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43969172|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969173|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
43969174|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
43969175|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43969310|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969311|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43969312|NCT01645098|Analgesics|analgesics|mesh-ancestor
43969313|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
43969314|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969315|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44143351|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44143352|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143353|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
44143354|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43969403|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43969404|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969411|NCT01651442|Zolpidem|zolpidem|mesh-list
43969473|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43969474|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969548|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43969550|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969551|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969552|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
43969553|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43969619|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43969620|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969767|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43969768|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43969842|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
43969843|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43969844|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43969845|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43969846|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44143402|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44143404|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44143405|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143406|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44143408|NCT00189722|Tacrolimus|tacrolimus|mesh-list
43969906|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43969907|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43969908|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43969909|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43969911|NCT01665508|Nebivolol|nebivolol|mesh-list
43969976|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43969977|NCT01667978|Ritonavir|ritonavir|mesh-list
43969978|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43969979|NCT01667978|Norethindrone|norethindrone|mesh-list
43969980|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
43969981|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
43969982|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43970046|NCT01669642|Ketamine|ketamine|mesh-list
43970047|NCT01669642|Analgesics|analgesics|mesh-ancestor
43970048|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
43767972|NCT02398136|Ketamine|ketamine|mesh-list
43970049|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970116|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43970117|NCT01673828|Pregnanolone|pregnanolone|mesh-list
43970118|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43970119|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
43970120|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970121|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970123|NCT01675297|Vitamin D|vitamin d|mesh-list
43970186|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43970187|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970188|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43970189|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
43970190|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
43970248|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
43970249|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970322|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
43970323|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970324|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970325|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43970326|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43970327|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970328|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43970389|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
43970390|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970391|NCT01687179|Sirolimus|sirolimus|mesh-list
43970392|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
43970393|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43970394|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43970395|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43970396|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970397|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
43970398|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43970399|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
43970400|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970401|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
43970453|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43970454|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970455|NCT01689324|Vaccines|vaccines|mesh-list
43970456|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
43970457|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970458|NCT01689441|Calcitriol|calcitriol|mesh-list
43970601|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43970602|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43970603|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43970604|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43970605|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
43970606|NCT01692756|Hormones|hormones|mesh-ancestor
43970607|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970613|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
43970669|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43970670|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43970671|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970672|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
43970673|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43970674|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
43970675|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43970676|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43970719|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970720|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970721|NCT01701037|Trametinib|trametinib|mesh-list
43970722|NCT01701037|Dabrafenib|dabrafenib|mesh-list
43970723|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43970724|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43970725|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43970726|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970789|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
43970790|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43970791|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970792|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43970793|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
43970794|NCT01702233|Hormones|hormones|mesh-ancestor
43970795|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43970856|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43970857|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
43970858|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43970859|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43970860|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970861|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43970862|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43970922|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43970923|NCT01706666|Growth Substances|growth substances|mesh-ancestor
43970924|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
43970925|NCT01706952|Epinephrine|epinephrine|mesh-list
43970926|NCT01706952|Racepinephrine|racepinephrine|mesh-list
43970927|NCT01706952|Cocaine|cocaine|mesh-list
43970993|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43970995|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43970996|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43970997|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43970998|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971003|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
43971066|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43971067|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
43971068|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
43971069|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971070|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971071|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43971072|NCT01709422|Narcotics|narcotics|mesh-ancestor
43971073|NCT01709422|Analgesics|analgesics|mesh-ancestor
43971074|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
43971075|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971132|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
43971133|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43971134|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
43971137|NCT01710839|Ranibizumab|ranibizumab|mesh-list
44143465|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143466|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143468|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143469|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143470|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
44143471|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971197|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
43971198|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43971199|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43971200|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971201|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
43971255|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43971256|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43971257|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971258|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971259|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
43971260|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971261|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971262|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43971263|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43971319|NCT01717898|Dactolisib|dactolisib|mesh-list
43971320|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43971321|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
43971322|NCT01717898|Hormones|hormones|mesh-ancestor
43971323|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43971324|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971325|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43971386|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971391|NCT01721603|Trametinib|trametinib|mesh-list
43971457|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
43971458|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971459|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
43971460|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
43971461|NCT01726621|Insulin|insulin|mesh-list
43971462|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43971463|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971464|NCT01726738|Trametinib|trametinib|mesh-list
43971465|NCT01726738|Dabrafenib|dabrafenib|mesh-list
43971523|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43971524|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43971525|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971526|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
43971595|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
43971596|NCT01729845|Decitabine|decitabine|mesh-list
43971597|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43971598|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971599|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43971600|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43971601|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971610|NCT01729845|Analgesics|analgesics|mesh-ancestor
43971663|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
43971664|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971665|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43971666|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43971667|NCT01730872|Protective Agents|protective agents|mesh-ancestor
43971668|NCT01731041|Ticagrelor|ticagrelor|mesh-list
43971669|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43971672|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44143476|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44143477|NCT00189982|Factor VIII|factor viii|mesh-list
44143478|NCT00189982|Coagulants|coagulants|mesh-ancestor
44143479|NCT00189995|Haloperidol|haloperidol|mesh-list
44143480|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
44143481|NCT00189995|Clozapine|clozapine|mesh-list
44143482|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
43971723|NCT05317039|Calcium|calcium|mesh-list
43971724|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43971725|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971726|NCT05316883|Clozapine|clozapine|mesh-list
43971727|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43971728|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
43971729|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43971737|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
43971786|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143608|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143609|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44143610|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143611|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143612|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
44143613|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143614|NCT00190333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44143615|NCT00190333|Antidepressive Agents|antidepressive agents|mesh-ancestor
43971933|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43971934|NCT05113186|Lenvatinib|lenvatinib|mesh-list
43971935|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43971936|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43971937|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43971938|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43971939|NCT05093140|Prednisone|prednisone|mesh-list
43971940|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
43971941|NCT05093140|Vincristine|vincristine|mesh-list
43971942|NCT05093140|Doxorubicin|doxorubicin|mesh-list
43971943|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43971944|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43971945|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
43971946|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43971993|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43971994|NCT04867135|Amikacin|amikacin|mesh-list
43971995|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43971996|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43971997|NCT04860661|Esketamine|esketamine|mesh-list
43971998|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
43971999|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972000|NCT04838717|Doxycycline|doxycycline|mesh-list
43972001|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972002|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972003|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
43972004|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43972005|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43972057|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43972058|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972059|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
43972060|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143616|NCT00190333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143617|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44143618|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972080|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972081|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
43972082|NCT04724772|Coagulants|coagulants|mesh-ancestor
43972083|NCT04721691|Cannabidiol|cannabidiol|mesh-list
43972084|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
43972085|NCT04642287|Fluorouracil|fluorouracil|mesh-list
43972086|NCT04642287|Calcipotriene|calcipotriene|mesh-list
43972087|NCT04642287|Petrolatum|petrolatum|mesh-list
43972088|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
43972089|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972148|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43972149|NCT04514653|Growth Substances|growth substances|mesh-ancestor
43972150|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972151|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
43972152|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972153|NCT04514393|Methotrexate|methotrexate|mesh-list
43972154|NCT04514393|Temozolomide|temozolomide|mesh-list
43972155|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43972214|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972215|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43972217|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
43972218|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43972219|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972220|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43972285|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972286|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
43972287|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43972288|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43972289|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
43972290|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43972291|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43972292|NCT04369365|Azithromycin|azithromycin|mesh-list
43972293|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43972391|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972392|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
43972393|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972394|NCT04090567|Olaparib|olaparib|mesh-list
43972395|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43972396|NCT04090567|Cediranib|cediranib|mesh-list
43972397|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972399|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972460|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43972461|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972462|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43972463|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43972464|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
43972465|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43972466|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43972467|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972468|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43972469|NCT03957304|Analgesics|analgesics|mesh-ancestor
43972470|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
43972471|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972472|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43972520|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43972521|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972592|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972593|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
43972594|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43972595|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43972596|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43972597|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43972598|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
43972599|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143668|NCT00190515|Protective Agents|protective agents|mesh-ancestor
44143669|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143670|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
44143671|NCT00190515|Vitamins|vitamins|mesh-ancestor
44143672|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
44143673|NCT00190554|Cisplatin|cisplatin|mesh-list
44143674|NCT00190554|Fluorouracil|fluorouracil|mesh-list
43972668|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43972669|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43972670|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43972671|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
43972672|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43972673|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43972674|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43972675|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972676|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
43972736|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43972737|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
43972738|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972739|NCT02866383|Nivolumab|nivolumab|mesh-list
43972740|NCT02866383|Ipilimumab|ipilimumab|mesh-list
43972741|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972746|NCT02865473|Miotics|miotics|mesh-ancestor
43972807|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43972816|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
43972882|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972883|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
43972884|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972885|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43972887|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43972927|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43972928|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972929|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43972930|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43972931|NCT01746238|Growth Substances|growth substances|mesh-ancestor
43972932|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43972933|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
43972995|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
43972996|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43972997|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43972998|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43972999|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43973000|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
43973001|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
43973005|NCT01091831|Hormones|hormones|mesh-ancestor
43973062|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43973063|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973064|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43973065|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
43973066|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973067|NCT01734525|Anidulafungin|anidulafungin|mesh-list
43973132|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43973133|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43973134|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43973135|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973136|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973273|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973274|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973275|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43973276|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43973277|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973278|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43973279|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973280|NCT01742832|Citalopram|citalopram|mesh-list
43973281|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43973282|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43973331|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973332|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43973334|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43973335|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143763|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44143764|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
44143765|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143766|NCT00190710|Antiviral Agents|antiviral agents|mesh-ancestor
44143767|NCT00190710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44143768|NCT00190710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44143769|NCT00190710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44143770|NCT00190710|Immunologic Factors|immunologic factors|mesh-ancestor
43973397|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973470|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973471|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
43973544|NCT01748799|Nabiximols|nabiximols|mesh-list
43973545|NCT01748799|Dronabinol|dronabinol|mesh-list
43973546|NCT01748799|Cannabidiol|cannabidiol|mesh-list
43973547|NCT01748799|Peppermint oil|peppermint oil|mesh-list
43973548|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43973549|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973615|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973616|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43973617|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43973618|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
43973619|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43973758|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43973760|NCT01753362|Hormones|hormones|mesh-ancestor
43973761|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43973762|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
43973763|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43973764|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
43973765|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43973828|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43973829|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43973830|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43973831|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43973899|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43973900|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43973901|NCT01760304|Budesonide|budesonide|mesh-list
43973902|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
43973903|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44143822|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44143823|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711162|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
43973949|NCT01762904|Ethanol|ethanol|mesh-list
43973950|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
43973952|NCT01762904|Triclosan|triclosan|mesh-list
43974018|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974019|NCT01764685|Topiramate|topiramate|mesh-list
43974020|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
43974021|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43974022|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974090|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43974091|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43974092|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974093|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43974162|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974163|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43974236|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43974237|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43974243|NCT01770483|Interferons|interferons|mesh-list
43974385|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43974455|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43974456|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43974457|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43974459|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43974526|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
43974527|NCT01783574|Testosterone|testosterone|mesh-list
43974601|NCT01785186|Rifampin|rifampin|mesh-list
43974602|NCT01785186|Isoniazid|isoniazid|mesh-list
43974603|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
43974673|NCT01786967|Urological Agents|urological agents|mesh-ancestor
43974674|NCT01787006|Cisplatin|cisplatin|mesh-list
43974675|NCT01787006|Fluorouracil|fluorouracil|mesh-list
43974676|NCT01787006|Cetuximab|cetuximab|mesh-list
43974677|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43974678|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
43974743|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974895|NCT01794741|Fluticasone|fluticasone|mesh-list
43974896|NCT01794741|Xhance|xhance|mesh-list
43974897|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43974898|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43974899|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
43974900|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43974901|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974902|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43974903|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
43974904|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
43974905|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44143865|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143866|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43974959|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
43974960|NCT01797822|Hormones|hormones|mesh-ancestor
43974961|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43975034|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43975035|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
43975036|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975037|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43975038|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975039|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
43975040|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
43975041|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43975042|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
43975102|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975103|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975107|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
43975174|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975175|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975176|NCT01808326|Chlorambucil|chlorambucil|mesh-list
43975178|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
43975179|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975180|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975181|NCT01808547|Bromfenac|bromfenac|mesh-list
43975182|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43975183|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975184|NCT01808547|Analgesics|analgesics|mesh-ancestor
43975185|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
43975186|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975204|NCT01809054|Aspirin|aspirin|mesh-list
43975237|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43975238|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43975239|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
43975311|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975312|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975313|NCT01812044|Lidocaine|lidocaine|mesh-list
43975314|NCT01812044|Bupivacaine|bupivacaine|mesh-list
43975315|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
43975316|NCT01812044|Anesthetics|anesthetics|mesh-list
43975317|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43975318|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975319|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
43975320|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975321|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43975376|NCT01815008|Clopidogrel|clopidogrel|mesh-list
43975377|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43975378|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975379|NCT01815008|Analgesics|analgesics|mesh-ancestor
43975380|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
43975381|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975382|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143899|NCT00190918|Pemetrexed|pemetrexed|mesh-list
44143937|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143938|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143939|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143940|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
44143941|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44143942|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44143943|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43712461|NCT02683564|Infliximab|infliximab|mesh-list
43975462|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975463|NCT01820754|Paclitaxel|paclitaxel|mesh-list
43975464|NCT01820754|Cisplatin|cisplatin|mesh-list
43975465|NCT01820754|Carboplatin|carboplatin|mesh-list
43975466|NCT01820754|Ipilimumab|ipilimumab|mesh-list
43975467|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43975468|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975469|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
43975470|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
43975471|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
43975527|NCT01823510|Clopidogrel|clopidogrel|mesh-list
43975528|NCT01823510|Ticagrelor|ticagrelor|mesh-list
43975529|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43975530|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43975531|NCT01823510|Analgesics|analgesics|mesh-ancestor
43975532|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
43975533|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43975534|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975535|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43975536|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43975537|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43975538|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43975539|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975540|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43975541|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43975542|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43975543|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
43975546|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43975583|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975584|NCT01825655|Cetirizine|cetirizine|mesh-list
43975593|NCT01825889|Evacetrapib|evacetrapib|mesh-list
43975655|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43975656|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975657|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975658|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975659|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
43975724|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975725|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975726|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
43975794|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
43975795|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975796|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975797|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
43975798|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43975799|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43975800|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43975801|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43975802|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975804|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43975805|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975806|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43975807|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143945|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975811|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975812|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43975887|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975960|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43975962|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
43975963|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43975964|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
43975965|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43975966|NCT01840345|Protective Agents|protective agents|mesh-ancestor
43975967|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43975968|NCT01840345|Antidotes|antidotes|mesh-ancestor
43976031|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976044|NCT01843920|Renal Agents|renal agents|mesh-ancestor
43976103|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
43976104|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
43976105|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43976106|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
43976107|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
43976108|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43976109|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976171|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43976245|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976246|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976247|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
44143983|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44143984|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44143985|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44143986|NCT00191061|Analgesics|analgesics|mesh-ancestor
44143987|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
44143988|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44143989|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
44143990|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44143991|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
44143992|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44143993|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44143994|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44143995|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157567|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976248|NCT01849068|Ezetimibe|ezetimibe|mesh-list
43976249|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43976250|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43976251|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
43976252|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976253|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43976254|NCT01849419|Oxytocin|oxytocin|mesh-list
43976255|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
43976256|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43976257|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976258|NCT01849692|Ranibizumab|ranibizumab|mesh-list
43976259|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43976260|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43976273|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43976274|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976275|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
43976276|NCT01850394|Coagulants|coagulants|mesh-ancestor
43976277|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43976278|NCT01852019|Cangrelor|cangrelor|mesh-list
43976279|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43976280|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43976281|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43976335|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43976336|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43976337|NCT01853553|Spironolactone|spironolactone|mesh-list
43976338|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43976339|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
43976340|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976341|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976405|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976407|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976479|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43976480|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976486|NCT01860807|Ibudilast|ibudilast|mesh-list
43976553|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
43976554|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43976555|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976556|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
43976567|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43976568|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43976569|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43976570|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976571|NCT01866592|Adalimumab|adalimumab|mesh-list
43976572|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43976573|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43976574|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
43976575|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43976576|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43976577|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976578|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
43976579|NCT01866943|Coagulants|coagulants|mesh-ancestor
43768015|NCT02398058|Olaparib|olaparib|mesh-list
43976580|NCT01868425|Acetaminophen|acetaminophen|mesh-list
43976581|NCT01868425|Ketamine|ketamine|mesh-list
43976582|NCT01868425|Gabapentin|gabapentin|mesh-list
43976583|NCT01868425|Bupivacaine|bupivacaine|mesh-list
43976584|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
43976585|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
43976586|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976587|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976588|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
43976622|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
43976623|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976624|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43976693|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43976694|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976695|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
43976696|NCT01874119|Aprepitant|aprepitant|mesh-list
43976697|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
43976698|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
43976699|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43976761|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43976762|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43976763|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43976764|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43976765|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43976766|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
43976767|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
43976772|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
44144071|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44144072|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144073|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144074|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144075|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144076|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43976917|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43976991|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43977063|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43977065|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43977066|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
43977067|NCT05300841|Estrogens|estrogens|mesh-ancestor
43977068|NCT05300841|Hormones|hormones|mesh-ancestor
43977069|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43977070|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977071|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44144110|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144111|NCT00191373|Gemcitabine|gemcitabine|mesh-list
44144112|NCT00191373|Trastuzumab|trastuzumab|mesh-list
44144113|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977144|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977146|NCT04923776|Etoposide|etoposide|mesh-list
43977147|NCT04923776|Atezolizumab|atezolizumab|mesh-list
43977148|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977149|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43977150|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43977151|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43977152|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977154|NCT04885712|Metformin|metformin|mesh-list
43977211|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43977213|NCT04807894|Androgens|androgens|mesh-ancestor
43977214|NCT04807894|Hormones|hormones|mesh-ancestor
43977217|NCT04795583|Prednisone|prednisone|mesh-list
44144166|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
44144167|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144168|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144169|NCT00191438|Antiviral Agents|antiviral agents|mesh-ancestor
44144170|NCT00191438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144171|NCT00191438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144172|NCT00191438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144173|NCT00191438|Immunologic Factors|immunologic factors|mesh-ancestor
44144174|NCT00191438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144175|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144232|NCT00191555|Olanzapine|olanzapine|mesh-list
43977352|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768025|NCT02397382|Caffeine|caffeine|mesh-list
43977353|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977355|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43977356|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
43977424|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43977425|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
43977426|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43977427|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977428|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977429|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
44144250|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
44144251|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44144252|NCT00191568|Gemcitabine|gemcitabine|mesh-list
44144253|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
44144254|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144255|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
44144256|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144257|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144258|NCT00191568|Antiviral Agents|antiviral agents|mesh-ancestor
43977481|NCT03021083|Fentanyl|fentanyl|mesh-list
43977535|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977536|NCT02813642|Mitogens|mitogens|mesh-list
43977607|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43977608|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
43977609|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43977610|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977612|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
43977679|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977680|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43977750|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43977751|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
43977752|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43977756|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
43977821|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977822|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
43977823|NCT01882868|Antidotes|antidotes|mesh-ancestor
43977824|NCT01882868|Protective Agents|protective agents|mesh-ancestor
43977866|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43977867|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
43977868|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977869|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43977870|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43977872|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
43977935|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43977936|NCT01890642|Lidocaine|lidocaine|mesh-list
43977937|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
43977938|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
43977939|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43977940|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43977948|NCT01891331|Fluconazole|fluconazole|mesh-list
43978004|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43978005|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43978006|NCT01893879|Analgesics|analgesics|mesh-ancestor
43978007|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
43978008|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43978009|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978010|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978011|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43978070|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43978071|NCT01897285|Laxatives|laxatives|mesh-ancestor
43978145|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978147|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978148|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43978149|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
43978150|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978153|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
43978213|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43978230|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978231|NCT01904864|Iron|iron|mesh-list
43978232|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
43978305|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
43978306|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43978307|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43978308|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43978309|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43978310|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
43978311|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978313|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
43978374|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43978375|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43978377|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43978378|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978379|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43978380|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43978444|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
43978516|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43978517|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43978588|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
43978589|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978591|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
43978671|NCT01921894|Vitamin D|vitamin d|mesh-list
44144348|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144349|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144350|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144351|NCT00191685|Analgesics|analgesics|mesh-ancestor
44144352|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
44144353|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44144354|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44144355|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44144356|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
44144357|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44144358|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44144359|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144360|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43978734|NCT01925469|Benzocaine|benzocaine|mesh-list
43978741|NCT01925781|Nicotine|nicotine|mesh-list
43978779|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43978780|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43978781|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
43978782|NCT01927718|Thalidomide|thalidomide|mesh-list
43978783|NCT01927718|Lenalidomide|lenalidomide|mesh-list
43978784|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
43978785|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978786|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43978787|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43978848|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43978849|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43978850|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43978851|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43978852|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978853|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43978915|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978916|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43978918|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43978919|NCT01930487|Protective Agents|protective agents|mesh-ancestor
43978920|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43978921|NCT01930747|Remifentanil|remifentanil|mesh-list
43978922|NCT01930747|Sevoflurane|sevoflurane|mesh-list
43978923|NCT01930747|Rocuronium|rocuronium|mesh-list
43978924|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43978925|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43978938|NCT01931163|Everolimus|everolimus|mesh-list
43978978|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43978979|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
43978987|NCT01933984|Fluticasone|fluticasone|mesh-list
43979054|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43979055|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
43979072|NCT01937026|Renal Agents|renal agents|mesh-ancestor
43979126|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979127|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
43979197|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43979199|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979200|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43979201|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979202|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979203|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43979204|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43979205|NCT01942668|Estradiol|estradiol|mesh-list
43979206|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43979239|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
43979240|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979312|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43979313|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979314|NCT01947946|Benralizumab|benralizumab|mesh-list
43979317|NCT01948141|Nintedanib|nintedanib|mesh-list
43979380|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979381|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715916|NCT02657603|Lidocaine|lidocaine|mesh-list
43979382|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
43979383|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43979384|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979385|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
43979386|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43979445|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43979446|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
43979447|NCT01951963|Ketamine|ketamine|mesh-list
43979448|NCT01951963|Morphine|morphine|mesh-list
43979449|NCT01951963|Analgesics|analgesics|mesh-ancestor
43979450|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
43979451|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979452|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979453|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43979454|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43979455|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
43979456|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
43979507|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43979508|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43979509|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43979510|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979511|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
43979512|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
43979513|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43979514|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
43979515|NCT01955382|Antidotes|antidotes|mesh-ancestor
43979516|NCT01955382|Protective Agents|protective agents|mesh-ancestor
43979517|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979518|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
43979519|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43979520|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
43979521|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979522|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979567|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979568|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979569|NCT01959490|Paclitaxel|paclitaxel|mesh-list
43979570|NCT01959490|Docetaxel|docetaxel|mesh-list
43979571|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
43979572|NCT01959490|Bevacizumab|bevacizumab|mesh-list
43979573|NCT01959490|Carboplatin|carboplatin|mesh-list
43979574|NCT01959490|Doxorubicin|doxorubicin|mesh-list
43979575|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43979576|NCT01959490|Trastuzumab|trastuzumab|mesh-list
43979577|NCT01959490|Pertuzumab|pertuzumab|mesh-list
43979578|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43979579|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43979580|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144391|NCT00191763|Cisplatin|cisplatin|mesh-list
43979666|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
43979668|NCT01962870|Coagulants|coagulants|mesh-ancestor
43979669|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43979670|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43979671|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
43979672|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979673|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
43979674|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43979675|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
43979734|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979735|NCT01965002|Aspirin|aspirin|mesh-list
43979736|NCT01965002|Enoxaparin|enoxaparin|mesh-list
43979737|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43979738|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43979739|NCT01965002|Analgesics|analgesics|mesh-ancestor
43979740|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
43979741|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43979742|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43979743|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979744|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43979745|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43979746|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43979747|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979748|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43979749|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43979750|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979751|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
43979752|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
43979753|NCT01965366|Dexamethasone|dexamethasone|mesh-list
43979754|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43979755|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
43979785|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
43979786|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43979787|NCT01966978|Liraglutide|liraglutide|mesh-list
43979859|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43979860|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
43979861|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43979868|NCT01968356|Ethanol|ethanol|mesh-list
43979929|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43979930|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43979931|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43979932|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43979933|NCT01970176|Urological Agents|urological agents|mesh-ancestor
43979939|NCT01971580|Ambrisentan|ambrisentan|mesh-list
43979997|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43979998|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43979999|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980000|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43980001|NCT01973413|Insulin|insulin|mesh-list
43980002|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43980003|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980004|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
43980005|NCT01974245|Vitamin D|vitamin d|mesh-list
43980006|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43980008|NCT01974245|Vitamins|vitamins|mesh-ancestor
44144450|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44144451|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44144452|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44144453|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44144454|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144455|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44144456|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144457|NCT00191919|Analgesics|analgesics|mesh-ancestor
44144458|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
44144459|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980061|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980062|NCT01976988|Heparin|heparin|mesh-list
43980063|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
43980134|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43980135|NCT01979276|Growth Substances|growth substances|mesh-ancestor
43980136|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
43980137|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43980138|NCT01979445|Clopidogrel|clopidogrel|mesh-list
43980139|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43980202|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980203|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
43980204|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980205|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43980206|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43980207|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43980208|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43980209|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980210|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43980211|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43980212|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
43980216|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
43980263|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980264|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980265|NCT01982643|Naltrexone|naltrexone|mesh-list
43980266|NCT01982643|Bupropion|bupropion|mesh-list
43980267|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43980268|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43980269|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980270|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
43980271|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980404|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
43716881|NCT02651441|Cisplatin|cisplatin|mesh-list
43980405|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980475|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980476|NCT01989910|Efavirenz|efavirenz|mesh-list
43980477|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
43980480|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980544|NCT01992172|Protective Agents|protective agents|mesh-ancestor
43980545|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980546|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
43980547|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
43980548|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43980549|NCT01992185|Protective Agents|protective agents|mesh-ancestor
43980550|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144513|NCT00192049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144514|NCT00192049|Immunologic Factors|immunologic factors|mesh-ancestor
44144515|NCT00192049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144516|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44144517|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
43980636|NCT01994993|Ampicillin|ampicillin|mesh-list
43980637|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43980638|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43980639|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43980640|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43980641|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43980642|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43980643|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980645|NCT01995045|Triamcinolone|triamcinolone|mesh-list
43980702|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43980774|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43980775|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980776|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43980777|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43980778|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
43980779|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
43980780|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43980781|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43980784|NCT02002767|Velpatasvir|velpatasvir|mesh-list
43980839|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43980840|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43980853|NCT02004990|Povidone|povidone|mesh-list
43980912|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43980913|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43980914|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
43980915|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
43980926|NCT02006108|Hematinics|hematinics|mesh-ancestor
43980983|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43980984|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43980985|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43980986|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43981041|NCT02014363|Amitriptyline|amitriptyline|mesh-list
43981042|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43981043|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
43981044|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43981045|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43981046|NCT02014363|Analgesics|analgesics|mesh-ancestor
43981047|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
43981108|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43981109|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43981179|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43981180|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871153|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
43981181|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981182|NCT02023411|Teriparatide|teriparatide|mesh-list
43981183|NCT02023411|Hormones|hormones|mesh-list
43981184|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
43981185|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981186|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981187|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43981241|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
43981242|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981243|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981244|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43981245|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
43981246|NCT02024724|Hormones|hormones|mesh-ancestor
43981248|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981311|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
43981312|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
43981313|NCT02028676|Trimethoprim|trimethoprim|mesh-list
43981314|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
43981382|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43981383|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981384|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
43981385|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43981386|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
43981387|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43981388|NCT02029872|Mupirocin|mupirocin|mesh-list
43981389|NCT02029872|Calcium|calcium|mesh-list
43981400|NCT02030574|Gemcitabine|gemcitabine|mesh-list
44157581|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157582|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157583|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157584|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
44157585|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157586|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44157587|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157588|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44157589|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157590|NCT00234923|Ritonavir|ritonavir|mesh-list
44157591|NCT00234923|Lopinavir|lopinavir|mesh-list
44157592|NCT00234923|Lamivudine|lamivudine|mesh-list
44157593|NCT00234923|Zidovudine|zidovudine|mesh-list
43981469|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43981470|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
43981471|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43981472|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981473|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981474|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981475|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
43981476|NCT02035345|Carboplatin|carboplatin|mesh-list
43981477|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981478|NCT02036424|Dexamethasone|dexamethasone|mesh-list
43981479|NCT02036424|Bevacizumab|bevacizumab|mesh-list
43981480|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43981481|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981482|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43981530|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
43981531|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981533|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
43981606|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981679|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
43981680|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981681|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981682|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43981683|NCT02044796|Cytarabine|cytarabine|mesh-list
43981684|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43981686|NCT02044796|Cladribine|cladribine|mesh-list
43981746|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44144556|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981836|NCT02051452|Methylphenidate|methylphenidate|mesh-list
43981838|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981908|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43981909|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981921|NCT02055638|SRX246|srx246|mesh-list
43981980|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43981981|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43981982|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43981983|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43981984|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43981985|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
43981986|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43981987|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43981988|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43981989|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
43981990|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
43981991|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43981992|NCT02059642|Metadoxine|metadoxine|mesh-list
43982040|NCT02061683|Bimatoprost|bimatoprost|mesh-list
43982041|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43982042|NCT02061774|Acetaminophen|acetaminophen|mesh-list
43982043|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982044|NCT02061774|Analgesics|analgesics|mesh-ancestor
43982045|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
43982046|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982047|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982048|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
43982049|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
43982050|NCT02061969|Linagliptin|linagliptin|mesh-list
43982051|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43982052|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982053|NCT02061969|Incretins|incretins|mesh-ancestor
43982055|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43982102|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
43982103|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43982104|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
43982105|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
43982106|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43982245|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982246|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982247|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44144653|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144654|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44144655|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44144656|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44144657|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44144658|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
44144659|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44144660|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44144661|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44144662|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44144663|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44144664|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43982321|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982322|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982325|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
43982391|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43982392|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982393|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43982394|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982395|NCT02073448|Adapalene|adapalene|mesh-list
43982396|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43982397|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43982398|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982458|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982459|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982529|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43982530|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43982600|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
43982601|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43982602|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982604|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
43982605|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
43982606|NCT02080273|Protective Agents|protective agents|mesh-ancestor
43982669|NCT02081638|Aspirin|aspirin|mesh-list
43982670|NCT02081638|Atorvastatin|atorvastatin|mesh-list
43982671|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43982672|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43982673|NCT02081638|Analgesics|analgesics|mesh-ancestor
43982674|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
43982740|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43982741|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
43982742|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43982743|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982744|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43982745|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43982747|NCT02083406|Artefenomel|artefenomel|mesh-list
43982748|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
43982749|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43982750|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43982751|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43982752|NCT02083679|Gemcitabine|gemcitabine|mesh-list
43982753|NCT02083679|Paclitaxel|paclitaxel|mesh-list
43982805|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43982806|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982807|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43982808|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43982809|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43982810|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43982873|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43982874|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43982875|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
43982876|NCT02086500|Coagulants|coagulants|mesh-ancestor
44144677|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144678|NCT00192712|Antiviral Agents|antiviral agents|mesh-ancestor
44144679|NCT00192712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144680|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43982879|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
43982939|NCT02090374|Vitamins|vitamins|mesh-ancestor
43982940|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
43982941|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43982942|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43983010|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983013|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
43983082|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
43983083|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43983157|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43983158|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43983159|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
43983231|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43983232|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43983233|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
43983234|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983235|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43983236|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
43983299|NCT02105324|Pancrelipase|pancrelipase|mesh-list
43983375|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983376|NCT02108171|Analgesics|analgesics|mesh-ancestor
43983449|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43983450|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983521|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43983522|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43983523|NCT02115750|Analgesics|analgesics|mesh-ancestor
43983592|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
43983593|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43983656|NCT02125292|Analgesics|analgesics|mesh-ancestor
43983657|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
43983732|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43983733|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43983734|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43983735|NCT02129075|Protective Agents|protective agents|mesh-ancestor
43983736|NCT02129426|Midazolam|midazolam|mesh-list
43983800|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43983801|NCT02130063|Trace Elements|trace elements|mesh-ancestor
43983802|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
43983803|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983804|NCT02130063|Hematinics|hematinics|mesh-ancestor
43983805|NCT02130635|Nemiralisib|nemiralisib|mesh-list
43983809|NCT02132169|Cetirizine|cetirizine|mesh-list
43983868|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
43983869|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43983870|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43983871|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43983872|NCT02134951|Ketamine|ketamine|mesh-list
43983873|NCT02134951|Analgesics|analgesics|mesh-ancestor
43983874|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
43983879|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
43983934|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
43983935|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43983937|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
43983938|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43983939|NCT02136498|Varenicline|varenicline|mesh-list
43983940|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43983941|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43984001|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144693|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144694|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44144695|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44144696|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
44144697|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144698|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44144699|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44144701|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144711|NCT00192842|Curcumin|curcumin|mesh-list
44144755|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144756|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144757|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144758|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
44144759|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144760|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44144761|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
43984003|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43984004|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
43984005|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43984006|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984007|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43984008|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984059|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
43984060|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43984061|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
43984062|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
43984063|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984064|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984066|NCT02139540|Analgesics|analgesics|mesh-ancestor
43984128|NCT02147899|Secnidazole|secnidazole|mesh-list
43984129|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43984130|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43984131|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984132|NCT02148588|Lidocaine|lidocaine|mesh-list
43984133|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
43984134|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
43984135|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984137|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
43984272|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43984273|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
43984274|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984275|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984276|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43984277|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
43984278|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43984279|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
43984340|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43984341|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
43984342|NCT02154243|Midodrine|midodrine|mesh-list
43984343|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
43984344|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
43984412|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43984413|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43984414|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43984415|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43984416|NCT02155335|Golimumab|golimumab|mesh-list
43984417|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43984418|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43984419|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43984477|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43984478|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43984509|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43984510|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43984511|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43984512|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43984513|NCT02159976|Antacids|antacids|mesh-ancestor
43984514|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
43984515|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43579012|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43984516|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43984517|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43984518|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984572|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43984573|NCT02162433|Analgesics|analgesics|mesh-ancestor
43984574|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
43871160|NCT02641782|Antibodies|antibodies|mesh-list
43984575|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984576|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43984577|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43984578|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43984579|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
43984582|NCT02162680|Lidocaine|lidocaine|mesh-list
43984636|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43984709|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
43984710|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
43984711|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43984712|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43984713|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43984714|NCT02168361|Interferons|interferons|mesh-list
43984715|NCT02168361|Ribavirin|ribavirin|mesh-list
43984716|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
43984717|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
43984718|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
43984720|NCT02168361|Simeprevir|simeprevir|mesh-list
43984777|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43984778|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984848|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43984849|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43984850|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984851|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43984852|NCT02170519|Iloprost|iloprost|mesh-list
43984853|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43984913|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43984914|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984915|NCT02173392|Brodalumab|brodalumab|mesh-list
43984985|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
43984986|NCT02175212|Estrogens|estrogens|mesh-ancestor
43984987|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43984988|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984989|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
43984990|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
43984991|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43984992|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43984993|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43984994|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43984995|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43984996|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43984997|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43984998|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
43985046|NCT02178540|Tobramycin|tobramycin|mesh-list
43985047|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43985048|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985096|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43985097|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985098|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
43985099|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
43985100|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985101|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
43985102|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43985103|NCT02179892|Analgesics|analgesics|mesh-ancestor
43985104|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
43985105|NCT02180100|Fluconazole|fluconazole|mesh-list
43985161|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985162|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43985163|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43985164|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43985165|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985166|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985167|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985168|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43985169|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
43985222|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985223|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43985224|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
43985225|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
43985226|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985227|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985228|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985229|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43985230|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43985231|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985233|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43985285|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985286|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
43985287|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
43985288|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43985289|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
43985291|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
43985292|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43985352|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985354|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43985356|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985357|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985358|NCT02193815|Calcitriol|calcitriol|mesh-list
43985359|NCT02193815|Calcipotriene|calcipotriene|mesh-list
43985360|NCT02193815|Tofacitinib|tofacitinib|mesh-list
43985361|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43985362|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985363|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985364|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
43985365|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43985366|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985367|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43985368|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43985369|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43985370|NCT02193815|Vitamins|vitamins|mesh-ancestor
43985371|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
43985409|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
43985410|NCT02195895|Antacids|antacids|mesh-list
43985411|NCT02195895|Calcium|calcium|mesh-list
43985412|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
43985413|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985414|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43985415|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43985416|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985417|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985418|NCT02195921|Antiemetics|antiemetics|mesh-list
43985419|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
43985420|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985421|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985422|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43985423|NCT02196168|Cisplatin|cisplatin|mesh-list
43985470|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43985471|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43985472|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
43985473|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43985474|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
43985475|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
43985476|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
43985477|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43985478|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43985538|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43985539|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43985540|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43985541|NCT02199496|Ustekinumab|ustekinumab|mesh-list
43985542|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43985543|NCT02199574|Bupivacaine|bupivacaine|mesh-list
43985584|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43985585|NCT02199964|Cyclosporine|cyclosporine|mesh-list
43985586|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
43985587|NCT02199964|Cyclosporins|cyclosporins|mesh-list
43985588|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43985589|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985590|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43985591|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
43985592|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985593|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
43985594|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43985595|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
43985649|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43985650|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985724|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43985725|NCT02205983|Narcotics|narcotics|mesh-ancestor
43985726|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43985727|NCT02206776|Midazolam|midazolam|mesh-list
43985728|NCT02206776|Ketamine|ketamine|mesh-list
43985729|NCT02206776|Analgesics|analgesics|mesh-ancestor
43985730|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
43985731|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985732|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985736|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
43985792|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985793|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43985794|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43985795|NCT02208466|Fluoxetine|fluoxetine|mesh-list
43985796|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43985797|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43985809|NCT02209272|Lidocaine|lidocaine|mesh-list
43985858|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
43985859|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43985860|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43985861|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43721493|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
43985863|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
43985864|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43985865|NCT02213289|Nivolumab|nivolumab|mesh-list
43985866|NCT02213289|Trastuzumab|trastuzumab|mesh-list
43985867|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
43985868|NCT02213289|Ramucirumab|ramucirumab|mesh-list
43985922|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43985923|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43985924|NCT02214628|Becaplermin|becaplermin|mesh-list
43985931|NCT02215070|Hormones|hormones|mesh-ancestor
43985992|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43985993|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
43985994|NCT02218320|Dolutegravir|dolutegravir|mesh-list
43985995|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43985996|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43985997|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
43985998|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144874|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44144875|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44144876|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44144879|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
43986079|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43986080|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986081|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43986082|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986083|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
43986147|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
43986148|NCT02223429|Oxytocin|oxytocin|mesh-list
43986149|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986150|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
43986151|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43986152|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
43986153|NCT02223429|Coagulants|coagulants|mesh-ancestor
43986154|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43986155|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43986217|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43986218|NCT02227316|Analgesics|analgesics|mesh-ancestor
43986219|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
43986220|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986221|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986222|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
43986223|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43986224|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986279|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43986280|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43986282|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43986283|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
43986284|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986286|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43986347|NCT02231086|Protective Agents|protective agents|mesh-ancestor
43986348|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
43986349|NCT02231086|Vitamins|vitamins|mesh-ancestor
43986350|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
43986351|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
43986352|NCT02231177|Olodaterol|olodaterol|mesh-list
43986353|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43986354|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
43986355|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986415|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43986416|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986418|NCT02234570|Oxfendazole|oxfendazole|mesh-list
43986419|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
43986420|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43986421|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986422|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
43986423|NCT02234752|Memantine|memantine|mesh-list
43986424|NCT02234752|Galantamine|galantamine|mesh-list
43986425|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43986426|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43986427|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
43986428|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986429|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986430|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986431|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43986432|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43986433|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43986434|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986437|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
43986468|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43986469|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43986470|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43986471|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43986472|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
43986473|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
43986474|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986475|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
43986476|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986477|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986478|NCT02237950|Metronidazole|metronidazole|mesh-list
43986479|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43986480|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43986481|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44144943|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144944|NCT00193323|Gemcitabine|gemcitabine|mesh-list
44144945|NCT00193323|Docetaxel|docetaxel|mesh-list
44144946|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144947|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
44144948|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44144949|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43986524|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43986525|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
43986526|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986527|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986528|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43986529|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43986594|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43986595|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
43986596|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43986597|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43986599|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
43986600|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986601|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986602|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43986603|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
43986604|NCT02242630|Hormones|hormones|mesh-ancestor
43986605|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43986606|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43986607|NCT02242630|Protective Agents|protective agents|mesh-ancestor
43986654|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986655|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43986656|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43986657|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
43986658|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43986659|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43986660|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43986661|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43986662|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986663|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
43986664|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986665|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986666|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43986667|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43986668|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43986669|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43986670|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43986671|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
43986672|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43986673|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
43986674|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43986705|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43986706|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
43986707|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986708|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986709|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43986710|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43986773|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43986774|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
43986775|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
43986776|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986777|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43986778|NCT02251938|Sirolimus|sirolimus|mesh-list
43986779|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43986780|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144983|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44144984|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
44144985|NCT00193362|Antiviral Agents|antiviral agents|mesh-ancestor
44144986|NCT00193362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44144987|NCT00193362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44144988|NCT00193362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44144989|NCT00193362|Immunologic Factors|immunologic factors|mesh-ancestor
44144990|NCT00193362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44144992|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43986950|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43986951|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43986952|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
43986953|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43986954|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43987020|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987021|NCT02265224|Antidotes|antidotes|mesh-ancestor
43987022|NCT02265341|Ponatinib|ponatinib|mesh-list
43987023|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987024|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43987025|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987026|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987027|NCT02265913|Acyclovir|acyclovir|mesh-list
43987028|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
43987030|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
43987087|NCT02270255|Ropivacaine|ropivacaine|mesh-list
43987088|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987089|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
43987090|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987091|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987092|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
43987093|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43987094|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43987095|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987096|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987097|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987098|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987147|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43987148|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43987149|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
43987150|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987151|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987152|NCT02277249|Digoxin|digoxin|mesh-list
43987153|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43987154|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43987155|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987159|NCT02277548|Pregabalin|pregabalin|mesh-list
43987178|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987179|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987180|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
43987181|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43987182|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43987183|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
43987184|NCT02279641|Protective Agents|protective agents|mesh-ancestor
43987185|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987241|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987242|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987243|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
43987244|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43987245|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
43722727|NCT02614937|Squalamine|squalamine|mesh-list
43987264|NCT02282514|Hormones|hormones|mesh-ancestor
43987308|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987309|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987310|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987311|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987312|NCT02284126|Vancomycin|vancomycin|mesh-list
43987313|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43987314|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987315|NCT02284386|Bupivacaine|bupivacaine|mesh-list
43987316|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987317|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
43987318|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987368|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987369|NCT02285283|Itraconazole|itraconazole|mesh-list
43987370|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
43987371|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43987372|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43987373|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43987381|NCT02285634|Lidocaine|lidocaine|mesh-list
43987435|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987436|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987437|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43987438|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
43987439|NCT02287350|Diclofenac|diclofenac|mesh-list
43987441|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43987503|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43987504|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43987505|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43987506|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43987507|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987571|NCT02292082|Dexamethasone|dexamethasone|mesh-list
43987572|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
43987573|NCT02292082|Midazolam|midazolam|mesh-list
43987574|NCT02292082|Morphine|morphine|mesh-list
43987575|NCT02292082|Bupivacaine|bupivacaine|mesh-list
43987576|NCT02292082|Propofol|propofol|mesh-list
43987577|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43987640|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43987642|NCT02295553|Propofol|propofol|mesh-list
43987643|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43987644|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145046|NCT00193544|Thalidomide|thalidomide|mesh-list
43987725|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43987726|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987727|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987728|NCT02299349|Epinephrine|epinephrine|mesh-list
43987729|NCT02299349|Racepinephrine|racepinephrine|mesh-list
43987730|NCT02299349|Morphine|morphine|mesh-list
43987731|NCT02299349|Bupivacaine|bupivacaine|mesh-list
43987732|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
43987733|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
43987734|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
43987735|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43987736|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43987791|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43987792|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
43987793|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43987794|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
43987795|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
43987861|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43987862|NCT02305277|Opicapone|opicapone|mesh-list
43987863|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43987864|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43987865|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43987929|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43987930|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988003|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988004|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988005|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43988006|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43988007|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988008|NCT02314546|Lidocaine|lidocaine|mesh-list
43988009|NCT02314546|Midazolam|midazolam|mesh-list
43988010|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43988019|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
43988068|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
43988069|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43988070|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988071|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43988072|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43988210|NCT02324543|Capecitabine|capecitabine|mesh-list
43988211|NCT02324543|Irinotecan|irinotecan|mesh-list
43988212|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988213|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43988214|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
43988281|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988282|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988283|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43988284|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
43988360|NCT02332902|Everolimus|everolimus|mesh-list
43988423|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43988424|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43988425|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145107|NCT00193661|Hormones|hormones|mesh-ancestor
44145108|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44145109|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145110|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
43988529|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43988530|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43988540|NCT02342327|Menthol|menthol|mesh-list
43988602|NCT02344238|Riboflavin|riboflavin|mesh-list
43988604|NCT02344238|Vitamins|vitamins|mesh-ancestor
43988678|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988679|NCT02348775|Antidotes|antidotes|mesh-ancestor
43988680|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
43988681|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43988682|NCT02348918|Bevacizumab|bevacizumab|mesh-list
43988750|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43988751|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43988752|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43988753|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43988820|NCT02353754|Morphine|morphine|mesh-list
43988821|NCT02353754|Bupivacaine|bupivacaine|mesh-list
43988893|NCT02354534|Artesunate|artesunate|mesh-list
43988894|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
43988895|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43988896|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43988897|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43988898|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43988949|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43988950|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43989021|NCT02358889|Ranibizumab|ranibizumab|mesh-list
43989022|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
43989023|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989024|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989025|NCT02358889|Growth Substances|growth substances|mesh-ancestor
43989026|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989091|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43989092|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43989093|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
43989162|NCT02363621|Ranibizumab|ranibizumab|mesh-list
43989163|NCT02363621|Aflibercept|aflibercept|mesh-list
43989164|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43989165|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43989166|NCT02363621|Growth Substances|growth substances|mesh-ancestor
43989170|NCT02363803|Lidocaine|lidocaine|mesh-list
43989232|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989236|NCT02366871|Enoxaparin|enoxaparin|mesh-list
43989307|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43989308|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43989309|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
43989377|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989378|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989379|NCT02373137|Ofloxacin|ofloxacin|mesh-list
43724607|NCT02603315|Mitogens|mitogens|mesh-list
43989447|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989522|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43989523|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43989524|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43989525|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43989526|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
43989592|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43989593|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989594|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989595|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43989596|NCT02384200|Renal Agents|renal agents|mesh-ancestor
43989597|NCT02385097|Ropivacaine|ropivacaine|mesh-list
43989598|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
43989599|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
43989600|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
43989601|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989614|NCT02386319|Melatonin|melatonin|mesh-list
43989657|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989658|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43989659|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43989660|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
43989661|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
43989662|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43989729|NCT02391714|Analgesics|analgesics|mesh-ancestor
44145177|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145178|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44145179|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
44145180|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44145181|NCT00193921|Antiviral Agents|antiviral agents|mesh-ancestor
44145182|NCT00193921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145183|NCT00193921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44145184|NCT00193921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43989803|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
43989804|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43989805|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989806|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
43989875|NCT02399345|Ribavirin|ribavirin|mesh-list
43989876|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
43989877|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43989878|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43989879|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
43989880|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43989881|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43989944|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43989945|NCT02403830|Analgesics|analgesics|mesh-ancestor
43989946|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
43990016|NCT02410382|Dexamethasone|dexamethasone|mesh-list
43990017|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990018|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
43990019|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
43990020|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990021|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990022|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990023|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
43990024|NCT02410382|Hormones|hormones|mesh-ancestor
43990027|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990084|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43990117|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43990118|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
43990119|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
43990120|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43990121|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43990122|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990187|NCT02419547|Sevoflurane|sevoflurane|mesh-list
43990188|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43990189|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990190|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990191|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990192|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
43990193|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
43990255|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990256|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
43990328|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43990329|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990331|NCT02424968|Cyclosporine|cyclosporine|mesh-list
43990403|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
43990404|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990405|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990406|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43990407|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43990472|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43990473|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43990474|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43990509|NCT02435901|Cyclosporins|cyclosporins|mesh-list
43990510|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43990511|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990512|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43990513|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
43990514|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990516|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990517|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
43990518|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43990519|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
43990574|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43990575|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
43990576|NCT02437669|Hydromorphone|hydromorphone|mesh-list
43990577|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990578|NCT02437669|Narcotics|narcotics|mesh-ancestor
43990647|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990648|NCT02441062|Edotreotide|edotreotide|mesh-list
43990649|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43990651|NCT02442700|Pitavastatin|pitavastatin|mesh-list
43990720|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43990721|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990722|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990723|NCT02448862|Fentanyl|fentanyl|mesh-list
43990724|NCT02448862|Analgesics|analgesics|mesh-list
43990725|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43990726|NCT02448862|Narcotics|narcotics|mesh-ancestor
43990729|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
43990787|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43990788|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43990789|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990790|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990791|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
43990792|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
43990793|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
43990794|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990857|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43990858|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990859|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
43990866|NCT02455167|Ribavirin|ribavirin|mesh-list
44145315|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
44145316|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44145317|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145318|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44145319|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43990924|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43990925|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43990926|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43990927|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43990928|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
43990929|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43990930|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43990931|NCT02461693|Caffeine|caffeine|mesh-list
43990935|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43990990|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43990991|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43990992|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43990993|NCT02464033|Analgesics|analgesics|mesh-ancestor
43991063|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43991064|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991065|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43991066|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
43991067|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
43991068|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991069|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43991132|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991133|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43991135|NCT02468830|Mirabegron|mirabegron|mesh-list
43991202|NCT02471651|Aflibercept|aflibercept|mesh-list
43991203|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991204|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43991206|NCT02471651|Growth Substances|growth substances|mesh-ancestor
43991274|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43991275|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43991276|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991277|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
43991278|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
43991279|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
43991303|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43991304|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991305|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
43991306|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43991376|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43991377|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43991378|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991379|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43991401|NCT02483000|Vitamins|vitamins|mesh-ancestor
43991447|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991448|NCT02486016|Fentanyl|fentanyl|mesh-list
43991449|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991450|NCT02486016|Narcotics|narcotics|mesh-ancestor
43991453|NCT02486016|Analgesics|analgesics|mesh-ancestor
43991521|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43991522|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
43991523|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
43991542|NCT02488070|Edetic Acid|edetic acid|mesh-list
43991594|NCT02492451|Progesterone|progesterone|mesh-list
43991595|NCT02492451|Progestins|progestins|mesh-ancestor
43991596|NCT02492451|Hormones|hormones|mesh-ancestor
43991597|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991666|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43991667|NCT02494180|Narcotics|narcotics|mesh-ancestor
43991699|NCT02494713|Docetaxel|docetaxel|mesh-list
43991738|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43991739|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
43991740|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991741|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991742|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
43991743|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
43991744|NCT02495779|Tenofovir|tenofovir|mesh-list
43991745|NCT02495779|Emtricitabine|emtricitabine|mesh-list
43991746|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
43991747|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43991802|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43991803|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145389|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44145390|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44145394|NCT00194935|Topotecan|topotecan|mesh-list
43991849|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991850|NCT02502487|Ropivacaine|ropivacaine|mesh-list
43991851|NCT02502487|Tetracaine|tetracaine|mesh-list
43991852|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
43991922|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43991923|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43991924|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43991925|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43991927|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43991928|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43991929|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43991930|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43991986|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43991987|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
43992064|NCT02509624|Selonsertib|selonsertib|mesh-list
43992138|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43992139|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43992140|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43992141|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43992142|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992143|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43992144|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43992205|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992206|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992207|NCT02513940|Progestins|progestins|mesh-ancestor
43992276|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992277|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43992349|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
43992350|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992351|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44145409|NCT00194948|Antidepressive Agents|antidepressive agents|mesh-ancestor
43992366|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992367|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
43992441|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
43992442|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
43992443|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992444|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43992513|NCT02530151|Analgesics|analgesics|mesh-ancestor
43992514|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
43992515|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992586|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
43992587|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43992657|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43992659|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43992661|NCT02534129|Emollients|emollients|mesh-ancestor
43992662|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
43992663|NCT02535611|Memantine|memantine|mesh-list
43992730|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43992802|NCT02538679|Racepinephrine|racepinephrine|mesh-list
43992803|NCT02538679|Bupivacaine|bupivacaine|mesh-list
43992804|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
43992805|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
43992806|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
43992807|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43992809|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
44145482|NCT00195195|Sirolimus|sirolimus|mesh-list
44145483|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44145484|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145485|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145486|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44145487|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
44145488|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43992854|NCT02541409|Ribavirin|ribavirin|mesh-list
43992855|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
43992856|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
43992858|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
43992914|NCT02541864|Clarithromycin|clarithromycin|mesh-list
43992915|NCT02541864|Tetracycline|tetracycline|mesh-list
43992916|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43992987|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43992988|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43993061|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993062|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993063|NCT02551432|Paclitaxel|paclitaxel|mesh-list
43993073|NCT02551744|Famotidine|famotidine|mesh-list
43993132|NCT02558374|Timolol|timolol|mesh-list
43993133|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43993134|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43993135|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43993143|NCT02558829|Insulin|insulin|mesh-list
43993203|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993204|NCT02561481|Sulforaphane|sulforaphane|mesh-list
43993276|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
44145489|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
44145491|NCT00195208|Pantoprazole|pantoprazole|mesh-list
43993320|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993321|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993391|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43993392|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43993393|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993394|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
43993395|NCT02569658|Coagulants|coagulants|mesh-ancestor
43993396|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
43993397|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43993398|NCT02570022|Bupivacaine|bupivacaine|mesh-list
43993399|NCT02570022|Ropivacaine|ropivacaine|mesh-list
43993400|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
43993401|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
43993402|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43993403|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993404|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
43993405|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993406|NCT02570139|Protective Agents|protective agents|mesh-list
43993451|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993452|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43993453|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
43993455|NCT02573857|Artefenomel|artefenomel|mesh-list
43993522|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43993523|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
43993595|NCT02581839|Dexamethasone|dexamethasone|mesh-list
43993596|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
43993597|NCT02581839|Ondansetron|ondansetron|mesh-list
43993598|NCT02581839|BB 1101|bb 1101|mesh-list
43993599|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993666|NCT02584725|Coagulants|coagulants|mesh-ancestor
43993667|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43993668|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
43993669|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
44145520|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157619|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
43993676|NCT02585843|Diuretics|diuretics|mesh-ancestor
43993677|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
43993678|NCT02587117|Prednisolone|prednisolone|mesh-list
43993679|NCT02587117|Lycopene|lycopene|mesh-list
43993680|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993681|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
43993682|NCT02587117|Hormones|hormones|mesh-ancestor
43993747|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43993748|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43993749|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993750|NCT05248152|Acetaminophen|acetaminophen|mesh-list
43993751|NCT05248152|Ibuprofen|ibuprofen|mesh-list
43993752|NCT05248152|Pregabalin|pregabalin|mesh-list
43993753|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43993754|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43993755|NCT05248152|Analgesics|analgesics|mesh-ancestor
43993756|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
43993759|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43993811|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43993812|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
43993813|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43993814|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43993815|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43993820|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
44145527|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145528|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44145529|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44145543|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44145544|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
44145545|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44145546|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
44145548|NCT00195416|Etanercept|etanercept|mesh-list
43993984|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
43993985|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43579537|NCT03470350|Capecitabine|capecitabine|mesh-list
43993986|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994058|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43994059|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
43994060|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145579|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44145580|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44145581|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994156|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994157|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994158|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43994228|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994229|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994230|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43994231|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43994302|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43994303|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
43994304|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994305|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43994306|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43994307|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994308|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43994309|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43994310|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994371|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994372|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43994418|NCT02592629|Lidocaine|lidocaine|mesh-list
43994442|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43994443|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43994444|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994490|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43994565|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43994566|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994569|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994639|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43994640|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994641|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43994705|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43994706|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
43994778|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
43994779|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43994780|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43994781|NCT04158362|Paclitaxel|paclitaxel|mesh-list
43994850|NCT03970252|Irinotecan|irinotecan|mesh-list
43994851|NCT03970252|Camptothecin|camptothecin|mesh-list
43994852|NCT03970252|Calcium|calcium|mesh-list
43994916|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
43994917|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
43994918|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43994919|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
43994987|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43994988|NCT03275285|Dexamethasone|dexamethasone|mesh-list
43994989|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43994990|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
43994991|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
43995057|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995129|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
43995130|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995131|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44145650|NCT00195689|Adalimumab|adalimumab|mesh-list
44145705|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44145706|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44145707|NCT00195780|Valproic Acid|valproic acid|mesh-list
44145708|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
44145709|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995147|NCT02597101|Metformin|metformin|mesh-list
43995199|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995200|NCT02600715|Morphine|morphine|mesh-list
43995274|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995275|NCT02605187|Acetaminophen|acetaminophen|mesh-list
43995276|NCT02605187|Ibuprofen|ibuprofen|mesh-list
43995277|NCT02605187|Morphine|morphine|mesh-list
43995278|NCT02605187|Gabapentin|gabapentin|mesh-list
43995279|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43995346|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43995347|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995348|NCT02608229|Gemcitabine|gemcitabine|mesh-list
43995349|NCT02608229|Paclitaxel|paclitaxel|mesh-list
43995350|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43995417|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43995418|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43995419|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43995420|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
43995421|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43995422|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995423|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995486|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995487|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43995488|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43995489|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43995490|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43995491|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995492|NCT02618772|Midazolam|midazolam|mesh-list
43995493|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43995497|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43995554|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
43995555|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43995556|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995561|NCT02620774|Renal Agents|renal agents|mesh-ancestor
44145742|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995625|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43995626|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43995705|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
43995706|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43995707|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43995708|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43995709|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
43995710|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43995711|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
43995712|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43995772|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43995773|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43995774|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43995843|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43995844|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43995845|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
43995853|NCT02631772|Ribavirin|ribavirin|mesh-list
43995908|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43995912|NCT02634073|Lamivudine|lamivudine|mesh-list
43995980|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43995981|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43995982|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43995984|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996050|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
43996051|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43996052|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996053|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43996055|NCT02641353|Growth Substances|growth substances|mesh-ancestor
43996122|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43996123|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
43996124|NCT05588869|Cyclosporine|cyclosporine|mesh-list
43996125|NCT05588869|Cyclosporins|cyclosporins|mesh-list
44145841|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43996140|NCT05588557|Bupivacaine|bupivacaine|mesh-list
43996141|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
43996142|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
43996143|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996148|NCT05588531|Avibactam|avibactam|mesh-list
43996212|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996213|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996284|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
43996358|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996359|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996360|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996361|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43579672|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
44145900|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996431|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43996432|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43996433|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43996434|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
43996435|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
43996436|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43996437|NCT05470465|Oxycodone|oxycodone|mesh-list
43996438|NCT05470465|Citalopram|citalopram|mesh-list
43996439|NCT05470465|Paroxetine|paroxetine|mesh-list
43996440|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43996441|NCT05470465|Narcotics|narcotics|mesh-ancestor
43996442|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43996443|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996444|NCT05470465|Analgesics|analgesics|mesh-ancestor
43996445|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
43996446|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996447|NCT05470465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43996448|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43996449|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43996450|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996451|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43996452|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
43996453|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43996454|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
43996455|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43996456|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43996457|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43996478|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
43996480|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996483|NCT05369351|Mirabegron|mirabegron|mesh-list
43996552|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
43996553|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
43996554|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
43996555|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996556|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996557|NCT05318573|Gemcitabine|gemcitabine|mesh-list
43996698|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43996738|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
43996739|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43996740|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43996741|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
43996742|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
43996809|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
43996810|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43996811|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996814|NCT04668144|Cangrelor|cangrelor|mesh-list
44145944|NCT00196625|Amprenavir|amprenavir|mesh-list
44145945|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44145946|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43996890|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996891|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43996892|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43996893|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
43996894|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43996960|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43996961|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
43996962|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997033|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43997034|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43997108|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43997109|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
43997110|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43997112|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
43768090|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768091|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768116|NCT02397486|Protective Agents|protective agents|mesh-ancestor
43768117|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43997184|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997185|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997186|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43997187|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
43997193|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
44146041|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146043|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44146044|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
44146045|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146046|NCT00196885|Expectorants|expectorants|mesh-ancestor
44146047|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
44146048|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44146049|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
43997293|NCT02055963|Minocycline|minocycline|mesh-list
43997294|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43997295|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997307|NCT00796263|Dolutegravir|dolutegravir|mesh-list
43997308|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43997309|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43997310|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997316|NCT02643615|Propofol|propofol|mesh-list
43997357|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997358|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997431|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997433|NCT02651584|Analgesics|analgesics|mesh-ancestor
43997507|NCT02653872|Diltiazem|diltiazem|mesh-list
43997508|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
43997509|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997512|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43997576|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
44157721|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157723|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
44157724|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157725|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997646|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
43997647|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
43997648|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
43997649|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43997650|NCT02658461|Trastuzumab|trastuzumab|mesh-list
43997651|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997652|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43997653|NCT02659501|Acetaminophen|acetaminophen|mesh-list
43997655|NCT02659501|Epinephrine|epinephrine|mesh-list
43997717|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997718|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
43997719|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
43997720|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997721|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
43997722|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997723|NCT02662036|Bupivacaine|bupivacaine|mesh-list
43997724|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
43997725|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
43997726|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997727|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997728|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
43997729|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43997730|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
43997731|NCT02664220|Povidone|povidone|mesh-list
43997732|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
43997733|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
43997734|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43997735|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43997736|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
43997737|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43997738|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43997739|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43997740|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
43997741|NCT02664909|Coagulants|coagulants|mesh-ancestor
43997742|NCT02664922|Ketamine|ketamine|mesh-list
43997743|NCT02664922|Remifentanil|remifentanil|mesh-list
43997744|NCT02664922|Propofol|propofol|mesh-list
43997745|NCT02664922|Sevoflurane|sevoflurane|mesh-list
43997746|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43997747|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43997748|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997749|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43997751|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
43997760|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43997761|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43997762|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43997763|NCT02664922|Narcotics|narcotics|mesh-ancestor
43997764|NCT02664961|Bevacizumab|bevacizumab|mesh-list
43997765|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43997785|NCT02666352|Ruzasvir|ruzasvir|mesh-list
43997832|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43997833|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43997848|NCT02669914|Durvalumab|durvalumab|mesh-list
43997905|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43997906|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
43997907|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43997918|NCT02677493|Vaccines|vaccines|mesh-list
44146097|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43997936|NCT02679911|Amorolfine|amorolfine|mesh-list
43998008|NCT02683707|Analgesics|analgesics|mesh-ancestor
43998009|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43998082|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43998083|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
43998084|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998085|NCT02689063|Acetaminophen|acetaminophen|mesh-list
43998087|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732033|NCT02552745|Parecoxib|parecoxib|mesh-list
43998088|NCT02689063|Analgesics|analgesics|mesh-ancestor
43998089|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
43998092|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
43998146|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998147|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998148|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43998150|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
43998217|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43998282|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998283|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43998354|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43998355|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998428|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998429|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43998498|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43998506|NCT02721017|Fentanyl|fentanyl|mesh-list
43998572|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998573|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43998651|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43998653|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
43998729|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43998730|NCT02731820|Diuretics|diuretics|mesh-ancestor
43998731|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
43998804|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998805|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43998806|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998807|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
43998808|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43998809|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43998810|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
43998811|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43998812|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
43998813|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43998814|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998825|NCT02735187|Vitamin D|vitamin d|mesh-list
43998863|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
43998864|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43998865|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998866|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43998868|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44146125|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146126|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146127|NCT00197548|Folic Acid|folic acid|mesh-list
44146128|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
44146129|NCT00197548|Vitamins|vitamins|mesh-ancestor
44146130|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
43998939|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43998940|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43999012|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43999013|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43999014|NCT05444374|Growth Substances|growth substances|mesh-ancestor
43999015|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999016|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
43999017|NCT05444218|Amoxicillin|amoxicillin|mesh-list
43999018|NCT05444218|Metronidazole|metronidazole|mesh-list
43999079|NCT05443178|Amebicides|amebicides|mesh-ancestor
43999080|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43999081|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43999082|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
43999152|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43999153|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999170|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999171|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
43999173|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43999174|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43999175|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999177|NCT05439564|Analgesics|analgesics|mesh-ancestor
43999237|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43999238|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999312|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
43999313|NCT05395195|Hematinics|hematinics|mesh-ancestor
43733101|NCT02546050|Metformin|metformin|mesh-list
43999314|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43999384|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43999385|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999386|NCT05335252|Hormones|hormones|mesh-ancestor
43999387|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43999388|NCT05303636|Drospirenone|drospirenone|mesh-list
43999452|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43999453|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43999454|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999523|NCT05109143|Indomethacin|indomethacin|mesh-list
43999524|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44146284|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
44146285|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146286|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44146287|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44146288|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44146289|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44146290|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
44146291|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
44146292|NCT00198120|Cycloserine|cycloserine|mesh-list
43999595|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999596|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999668|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43999670|NCT04868409|Succinylcholine|succinylcholine|mesh-list
43999671|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43999672|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43999673|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43999738|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43999739|NCT04744181|Hematinics|hematinics|mesh-ancestor
43999740|NCT04704453|Amitriptyline|amitriptyline|mesh-list
43999741|NCT04704453|Capsaicin|capsaicin|mesh-list
43999742|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
43999743|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
43999744|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
43999806|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43999807|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
43999808|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43999809|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43999810|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43999811|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43999872|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43999881|NCT04408625|Sirolimus|sirolimus|mesh-list
43999949|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
43999950|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43999951|NCT04344184|Protective Agents|protective agents|mesh-ancestor
43999952|NCT04315948|Interferons|interferons|mesh-list
44000055|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
44000056|NCT04127578|Rituximab|rituximab|mesh-list
44000064|NCT04127578|Hormones|hormones|mesh-ancestor
44000127|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000128|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000129|NCT04003987|Bupivacaine|bupivacaine|mesh-list
44000130|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
44000131|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
44000132|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44000194|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000195|NCT03649061|Etanercept|etanercept|mesh-list
44000196|NCT03649061|Leflunomide|leflunomide|mesh-list
44000197|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44000198|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44000199|NCT03649061|Analgesics|analgesics|mesh-ancestor
44000200|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
44000201|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44000236|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000237|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
44000238|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000239|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000240|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
44000241|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000242|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44000243|NCT03609008|Cromakalim|cromakalim|mesh-list
44000244|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44000306|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
44000310|NCT03417895|Apatinib|apatinib|mesh-list
44000380|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44000381|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000382|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000383|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
44000385|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
44000386|NCT02994784|Melphalan|melphalan|mesh-list
44000387|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44000388|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
44000389|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000390|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000391|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44000392|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000393|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
44000394|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000413|NCT02952534|Rucaparib|rucaparib|mesh-list
44000414|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44000415|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44000416|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000417|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000418|NCT02927067|Valganciclovir|valganciclovir|mesh-list
44000419|NCT02927067|Maribavir|maribavir|mesh-list
44000450|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000451|NCT02863055|Nintedanib|nintedanib|mesh-list
44000452|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000453|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146411|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146412|NCT00198445|Bromfenac|bromfenac|mesh-list
44146413|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44000479|NCT02514278|Capecitabine|capecitabine|mesh-list
44000480|NCT02514278|Folfirinox|folfirinox|mesh-list
44000481|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44000482|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
44000483|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000484|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000495|NCT02451111|Rituximab|rituximab|mesh-list
44000496|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44000497|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000498|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
44000546|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000547|NCT02340676|Interleukin-2|interleukin-2|mesh-list
44000548|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44000550|NCT02340676|Analgesics|analgesics|mesh-ancestor
44000620|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000621|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44000622|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44000623|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44000624|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44000625|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44000626|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44000627|NCT01871766|Protective Agents|protective agents|mesh-ancestor
44000628|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44000629|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
44000630|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44000631|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44000632|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
44000638|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
44000681|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44000755|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
44000756|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
44000757|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44000903|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44000904|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44000977|NCT05448885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44000978|NCT05448885|Immunologic Factors|immunologic factors|mesh-ancestor
44000980|NCT05448781|Paclitaxel|paclitaxel|mesh-list
44001045|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44001046|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
44001047|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
44001048|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
44001115|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
44001116|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001117|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001118|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
44001119|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44001120|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44001123|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44001182|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001183|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44001184|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44001222|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
44001223|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44001224|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
44001225|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001292|NCT05394142|Pioglitazone|pioglitazone|mesh-list
44001293|NCT05394142|Spironolactone|spironolactone|mesh-list
44001294|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44001295|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001297|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
44001363|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44001364|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44001365|NCT05364515|Clobetasol|clobetasol|mesh-list
44001366|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44001409|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44001410|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44001411|NCT05243953|Cromakalim|cromakalim|mesh-list
44001482|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
44001483|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44001486|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
44146487|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157758|NCT00235222|Stavudine|stavudine|mesh-list
44001568|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
44001569|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44001570|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44001571|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001578|NCT05062577|Buprenorphine|buprenorphine|mesh-list
44001635|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
44001636|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44001637|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
44001638|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44001639|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44001706|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001707|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
44001708|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44001778|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768130|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44001779|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44001804|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001805|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44001808|NCT04849377|Cisplatin|cisplatin|mesh-list
44001875|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
44001876|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44001878|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44001944|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44001945|NCT04715646|Brivaracetam|brivaracetam|mesh-list
44001946|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
44001947|NCT04704596|Anesthetics|anesthetics|mesh-list
44001950|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
44146566|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
44146567|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
44002013|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44002081|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
44002082|NCT04476628|Budesonide|budesonide|mesh-list
44002156|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44002157|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146572|NCT00199004|Cytarabine|cytarabine|mesh-list
44146573|NCT00199004|Dexamethasone|dexamethasone|mesh-list
44146574|NCT00199004|Prednisolone|prednisolone|mesh-list
44146575|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
44146576|NCT00199004|Rituximab|rituximab|mesh-list
44146577|NCT00199004|Methotrexate|methotrexate|mesh-list
44002159|NCT04267887|Prednisone|prednisone|mesh-list
44002160|NCT04267887|Cortisone|cortisone|mesh-list
44002163|NCT04267887|Hormones|hormones|mesh-list
44002219|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002221|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002294|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
44002295|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
44002296|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002297|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002367|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002371|NCT03929068|Levodopa|levodopa|mesh-list
44002439|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
44002441|NCT03871036|Durvalumab|durvalumab|mesh-list
44002442|NCT03871036|Tremelimumab|tremelimumab|mesh-list
44002502|NCT03754049|Dexamethasone|dexamethasone|mesh-list
44002503|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
44002504|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44002505|NCT03754049|BB 1101|bb 1101|mesh-list
44002506|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002507|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
44002508|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
44002576|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
44002577|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44002578|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002650|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44002651|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44002652|NCT03387670|Simvastatin|simvastatin|mesh-list
44002653|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44002654|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44002655|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
44002709|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44002784|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44002785|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44002860|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
44002861|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002862|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44002933|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44002934|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
44002935|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44002936|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44002937|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44002938|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44002939|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
44002940|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44002942|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
44002943|NCT03036488|Carboplatin|carboplatin|mesh-list
44002944|NCT03036488|Doxorubicin|doxorubicin|mesh-list
44002998|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44002999|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44003000|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43768136|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44003001|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44146615|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44146617|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003071|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
44003072|NCT02656511|Tenofovir|tenofovir|mesh-list
44003147|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003148|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44003149|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003219|NCT02278887|Interleukin-2|interleukin-2|mesh-list
44003220|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44003221|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
44003222|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003223|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003224|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44003225|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
44003227|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003284|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003285|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003286|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003287|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44003288|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44003289|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44003290|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44003293|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44003298|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003351|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44003352|NCT01438073|Hormones|hormones|mesh-list
44003353|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44003354|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003355|NCT01265030|Sirolimus|sirolimus|mesh-list
44003356|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44003357|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44003416|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44003417|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003418|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44003419|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003420|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44146673|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44003477|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44003478|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44003479|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003480|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003482|NCT05453851|Pancreatin|pancreatin|mesh-list
43736670|NCT05357872|Anesthetics|anesthetics|mesh-list
44003483|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44003484|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
44003544|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003545|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44003546|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44003547|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44003548|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
44003549|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44003550|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003610|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003611|NCT05443009|Lidocaine|lidocaine|mesh-list
44003612|NCT05443009|Carticaine|carticaine|mesh-list
44003613|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
44003614|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
44003615|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44003616|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003617|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
44003618|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44003619|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44003620|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44003621|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44003657|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003658|NCT05244993|Paclitaxel|paclitaxel|mesh-list
44003659|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44003660|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003661|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44003662|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003663|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44003664|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44003665|NCT05203562|Letrozole|letrozole|mesh-list
44003666|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44003675|NCT05132439|Metformin|metformin|mesh-list
44003721|NCT05057689|Midazolam|midazolam|mesh-list
44003722|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
44003727|NCT05057689|Analgesics|analgesics|mesh-ancestor
44003798|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44003799|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44003800|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
44003801|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
44003802|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44003803|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44003804|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
44003866|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
44003867|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
44003868|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
44003869|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44003870|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44003871|NCT04978584|Growth Substances|growth substances|mesh-ancestor
44003872|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
44003874|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44146706|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003998|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44003999|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44004000|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
44004001|NCT04527887|Hormones|hormones|mesh-ancestor
44004002|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004003|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44004004|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004005|NCT04516915|Oseltamivir|oseltamivir|mesh-list
44004006|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
44004007|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004063|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004064|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44004065|NCT04403711|Analgesics|analgesics|mesh-ancestor
44004066|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
44004067|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004070|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44004135|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004136|NCT04210037|Paclitaxel|paclitaxel|mesh-list
44004137|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44004138|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004139|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
44004140|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004141|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004142|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004143|NCT04184609|Bromides|bromides|mesh-list
44004200|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
44004201|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
44004202|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004203|NCT04000737|Sorafenib|sorafenib|mesh-list
44004204|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004205|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004206|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004207|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004215|NCT03920267|BMS-986165|bms-986165|mesh-list
44004216|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44004217|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44004218|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004219|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004220|NCT03758989|Prednisone|prednisone|mesh-list
44004221|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
44004222|NCT03758989|Rituximab|rituximab|mesh-list
44004223|NCT03758989|Doxorubicin|doxorubicin|mesh-list
44004224|NCT03758989|Vincristine|vincristine|mesh-list
44004241|NCT03758989|Hormones|hormones|mesh-ancestor
44004257|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
44004258|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44004259|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004260|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
44004261|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44004262|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44004263|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004296|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580063|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
44004297|NCT03559868|Protective Agents|protective agents|mesh-ancestor
44004298|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004299|NCT03540485|Melatonin|melatonin|mesh-list
44004300|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
44004365|NCT03058978|Etonogestrel|etonogestrel|mesh-list
44004366|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44004439|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44004440|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44004441|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004442|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44004510|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004511|NCT01190306|Riboflavin|riboflavin|mesh-list
44004512|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
44004513|NCT01190306|Vitamins|vitamins|mesh-ancestor
44004583|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44004584|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004585|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44004586|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44004587|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
44004588|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44004589|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44004590|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
44004594|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
44146739|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44146740|NCT00199069|Cytarabine|cytarabine|mesh-list
44146741|NCT00199069|Dexamethasone|dexamethasone|mesh-list
44004718|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
44004719|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44004791|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44004865|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004866|NCT02761252|Montelukast|montelukast|mesh-list
44004867|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44004868|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
44004869|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44004870|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737793|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
44004871|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44004872|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44004929|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44004930|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44004931|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44004932|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44004933|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
44004934|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
44004935|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
44004937|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
44004938|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
44004998|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44004999|NCT02768558|Cisplatin|cisplatin|mesh-list
44005000|NCT02768558|Nivolumab|nivolumab|mesh-list
44005001|NCT02768558|Etoposide|etoposide|mesh-list
44005002|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005003|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44005004|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44005011|NCT02769702|Hormones|hormones|mesh-ancestor
44146773|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146774|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146775|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
44146776|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146777|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44146778|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44146779|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44146780|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
44146781|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005074|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44005075|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44005076|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768142|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44005077|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005144|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
44005145|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
44005146|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005147|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005148|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44005149|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
44005150|NCT05349071|Hormones|hormones|mesh-ancestor
44005151|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005152|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44005153|NCT05349071|Protective Agents|protective agents|mesh-ancestor
44005154|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005155|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005156|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44005158|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005205|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
44005206|NCT05348239|Trace Elements|trace elements|mesh-ancestor
44005207|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
44005208|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005209|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44005210|NCT05348239|Protective Agents|protective agents|mesh-ancestor
44005211|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
44005212|NCT05348148|Cetirizine|cetirizine|mesh-list
44005213|NCT05348148|Phenylephrine|phenylephrine|mesh-list
44005214|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
44005215|NCT05348148|Levocetirizine|levocetirizine|mesh-list
44005216|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44005217|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
44005218|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44005222|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
44005250|NCT05334017|Xylometazoline|xylometazoline|mesh-list
44005324|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44005325|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005330|NCT05113901|Prednisolone|prednisolone|mesh-list
44005374|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
44005375|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44005376|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44005377|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44005378|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44005379|NCT05456022|Doxorubicin|doxorubicin|mesh-list
44005380|NCT05456022|Quercetin|quercetin|mesh-list
44005381|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44005382|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005390|NCT05455918|Paclitaxel|paclitaxel|mesh-list
44005446|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44005447|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44005448|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
44005449|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005450|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005451|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44005452|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44005509|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005510|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
44005512|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
44005513|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44005514|NCT05323721|Amodiaquine|amodiaquine|mesh-list
44146871|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
44146872|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44146873|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44146874|NCT00199160|Sorafenib|sorafenib|mesh-list
44146875|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44146876|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44146879|NCT00199186|Cytarabine|cytarabine|mesh-list
44005605|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005606|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005675|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44005676|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44005677|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44005678|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005679|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44005680|NCT04741620|Protective Agents|protective agents|mesh-ancestor
44005681|NCT04706507|Ganciclovir|ganciclovir|mesh-list
44005682|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44005683|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
44005739|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44005740|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44005741|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
44005742|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44005743|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005744|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44005753|NCT04066348|Etanercept|etanercept|mesh-list
44005806|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44005807|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44005808|NCT03837353|Docetaxel|docetaxel|mesh-list
44005809|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005810|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
44005811|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
44005812|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
44005877|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44005878|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44005879|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44005880|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44005881|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
44005882|NCT03339635|Testosterone|testosterone|mesh-list
44005883|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
44005884|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
44005885|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44005886|NCT03339635|Androgens|androgens|mesh-ancestor
44005887|NCT03339635|Hormones|hormones|mesh-ancestor
44005888|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44005889|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44146909|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
44146910|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44146911|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44146912|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
44146913|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
44146927|NCT00199212|Bortezomib|bortezomib|mesh-list
44005945|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44005946|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44005947|NCT02633397|Riociguat|riociguat|mesh-list
44005948|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
44006018|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44006019|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006020|NCT01972347|Trametinib|trametinib|mesh-list
44006021|NCT01972347|Dabrafenib|dabrafenib|mesh-list
44006022|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44006023|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44006026|NCT01674140|Tamoxifen|tamoxifen|mesh-list
44006088|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006089|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006090|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44006091|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
44006159|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006160|NCT05045937|Vitamin D|vitamin d|mesh-list
44006161|NCT05045937|Vitamins|vitamins|mesh-list
44006162|NCT05045937|Ivermectin|ivermectin|mesh-list
44006233|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44006234|NCT05029726|Analgesics|analgesics|mesh-ancestor
44006235|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44006236|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
44006237|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44006238|NCT04982237|Paclitaxel|paclitaxel|mesh-list
44147008|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44147009|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44147010|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44147011|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
44147012|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44006396|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
44006397|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44006398|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006399|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
44006400|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44006401|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44006402|NCT04755712|Narcotics|narcotics|mesh-ancestor
44006403|NCT04755712|Analgesics|analgesics|mesh-ancestor
44006404|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44006405|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44006406|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
44006407|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
44006408|NCT04751812|Narcotics|narcotics|mesh-ancestor
44006458|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43580225|NCT04092894|Suvorexant|suvorexant|mesh-list
44006532|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44006534|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44006535|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44006536|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44006537|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44006538|NCT04367090|Docetaxel|docetaxel|mesh-list
44006539|NCT04367090|Trastuzumab|trastuzumab|mesh-list
44006586|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44006587|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
44006602|NCT04260659|Lidocaine|lidocaine|mesh-list
44006658|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
44006659|NCT04231708|Yohimbine|yohimbine|mesh-list
44006660|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44006661|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
44006733|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
44006734|NCT04164069|Antibodies|antibodies|mesh-list
44006735|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
44006736|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44006737|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
44006738|NCT04164069|Calcium|calcium|mesh-list
44006739|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
44006805|NCT04040790|Protective Agents|protective agents|mesh-ancestor
44006806|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44006807|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44006808|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
44147049|NCT00199576|Prednisolone|prednisolone|mesh-list
44147050|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
44147060|NCT00199576|Hormones|hormones|mesh-ancestor
44006880|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
44006881|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44006887|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
44007023|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007025|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
44007026|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44007094|NCT02149277|Lenograstim|lenograstim|mesh-list
44007095|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44007096|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
44007097|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007098|NCT02062489|Tamoxifen|tamoxifen|mesh-list
44007099|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44007108|NCT02060721|Macitentan|macitentan|mesh-list
44007136|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44007137|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44007138|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
44007139|NCT01547468|Narcotics|narcotics|mesh-ancestor
44007207|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44007208|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44007210|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44007211|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007212|NCT02778113|Incretins|incretins|mesh-ancestor
44007277|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44007352|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007353|NCT02789033|Isosorbide|isosorbide|mesh-list
44007354|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44007356|NCT02789033|Chitosan|chitosan|mesh-list
44007427|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44007428|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007429|NCT02791906|Ascorbic Acid|ascorbic acid|mesh-list
44007430|NCT02791906|Vitamins|vitamins|mesh-ancestor
44147166|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44147167|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44007522|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007523|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007524|NCT02802241|Peppermint oil|peppermint oil|mesh-list
44007525|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
44007526|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
44007527|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007528|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007593|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007594|NCT02804594|Antidotes|antidotes|mesh-ancestor
44007595|NCT02805179|Temozolomide|temozolomide|mesh-list
44007596|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44007597|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
44007665|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44007666|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44007737|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
44007800|NCT02831569|Analgesics|analgesics|mesh-ancestor
44007801|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
44007802|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44007803|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007804|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44007869|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44007870|NCT02837237|Diuretics|diuretics|mesh-ancestor
44007943|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44007944|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44007945|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44007946|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44007949|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
44008012|NCT02860845|Clindamycin|clindamycin|mesh-list
44008013|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
44008014|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
44008072|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008073|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44008074|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44008075|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44008143|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008144|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
44008145|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44008146|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44008147|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008149|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
44008211|NCT02877095|Furosemide|furosemide|mesh-list
44008212|NCT02877095|Diuretics|diuretics|mesh-ancestor
44008213|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
44008214|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008216|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44008284|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44008285|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44008290|NCT02882633|Bupivacaine|bupivacaine|mesh-list
44008355|NCT02889393|Protective Agents|protective agents|mesh-ancestor
44008356|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008357|NCT02889510|Liraglutide|liraglutide|mesh-list
44008358|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44008359|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008360|NCT02889510|Incretins|incretins|mesh-ancestor
44008361|NCT02889510|Hormones|hormones|mesh-ancestor
44008362|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44008363|NCT02892110|Varenicline|varenicline|mesh-list
44147199|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
44008386|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
44008387|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
44008391|NCT02895035|Analgesics|analgesics|mesh-ancestor
44008462|NCT02902081|Cannabidiol|cannabidiol|mesh-list
44008465|NCT02902172|Ibuprofen|ibuprofen|mesh-list
44008534|NCT02903407|Analgesics|analgesics|mesh-ancestor
44008535|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
44008536|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44008537|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44008602|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44008603|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44008604|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44008605|NCT02907918|Trastuzumab|trastuzumab|mesh-list
44008606|NCT02907918|Letrozole|letrozole|mesh-list
44008607|NCT02907918|Palbociclib|palbociclib|mesh-list
44008673|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44008674|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44008675|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44008676|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44008744|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44008745|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44008817|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
44008818|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44008819|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44008891|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44147246|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147247|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44147248|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147250|NCT00200460|Nebivolol|nebivolol|mesh-list
44009019|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768224|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
44009020|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009022|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44009023|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44009026|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009088|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009089|NCT02934698|Ivacaftor|ivacaftor|mesh-list
44009090|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44009091|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009092|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009093|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
44009094|NCT02935699|Promethazine|promethazine|mesh-list
44009095|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44009155|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009156|NCT02937558|Glucagon|glucagon|mesh-list
44009157|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44009158|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009159|NCT02937558|Hormones|hormones|mesh-ancestor
44009160|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009223|NCT02946073|Narcotics|narcotics|mesh-ancestor
44009224|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009225|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009226|NCT02946073|Analgesics|analgesics|mesh-ancestor
44009227|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
44009228|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009229|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44009289|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
44009290|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009291|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009292|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44147254|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44147255|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44147256|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
44147257|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009319|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009321|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
44009322|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
44009323|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44009391|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44009392|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44009393|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009394|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44009395|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44009396|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
44009397|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44009398|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44009399|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
44009457|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009458|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
44009531|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44009532|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
44009533|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
44009534|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44009606|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44009607|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44009608|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
44009609|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44009610|NCT02968134|Posaconazole|posaconazole|mesh-list
44009611|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
44009673|NCT02970552|Progestins|progestins|mesh-ancestor
44009674|NCT02970552|Hormones|hormones|mesh-ancestor
44009675|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44009676|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009677|NCT02972554|Propranolol|propranolol|mesh-list
44009678|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44009743|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44009744|NCT02978339|Analgesics|analgesics|mesh-ancestor
44009745|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
44009746|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44009747|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009748|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44009749|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44009750|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44009751|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147345|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44147346|NCT00200590|Narcotics|narcotics|mesh-ancestor
44147347|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44147348|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147349|NCT00200590|Analgesics|analgesics|mesh-ancestor
44147350|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
44147351|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147352|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44147353|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
44147354|NCT00200603|Calcium|calcium|mesh-list
44009753|NCT02978508|Permethrin|permethrin|mesh-list
44009807|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
44009808|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44009809|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44009811|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44009812|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44009813|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
44009876|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44009877|NCT02989727|Lamotrigine|lamotrigine|mesh-list
44009878|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
44009879|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44009880|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44009881|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44009882|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44009945|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44009946|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
44009947|NCT02996591|Analgesics|analgesics|mesh-ancestor
44009948|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44009949|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44009950|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44009951|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44010011|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44010012|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
44010013|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
44010014|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
44010015|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44010017|NCT03001843|Narcotics|narcotics|mesh-list
44010018|NCT03001843|Analgesics|analgesics|mesh-ancestor
44010077|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
44010078|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010079|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010080|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010081|NCT03003949|Estradiol|estradiol|mesh-list
44010082|NCT03003949|Progesterone|progesterone|mesh-list
44010083|NCT03003949|Estrogens|estrogens|mesh-ancestor
44010145|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44010146|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44010147|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
44147359|NCT00200629|Adenosine|adenosine|mesh-list
44010171|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010172|NCT03012594|Lanreotide|lanreotide|mesh-list
44010173|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010174|NCT03015961|Bupivacaine|bupivacaine|mesh-list
44010175|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010176|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
44010243|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44010244|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44010246|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44010318|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
44010319|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010320|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010321|NCT03022526|Fentanyl|fentanyl|mesh-list
44010322|NCT03022526|Bupivacaine|bupivacaine|mesh-list
44010323|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
44010324|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
44010325|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010326|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010327|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
44010328|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010329|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44010330|NCT03022526|Narcotics|narcotics|mesh-ancestor
44010331|NCT03022526|Analgesics|analgesics|mesh-ancestor
44010332|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44010333|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010334|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
44010378|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010379|NCT03028025|Hemostatics|hemostatics|mesh-list
44010380|NCT03028025|Coagulants|coagulants|mesh-ancestor
44010381|NCT03028103|Repaglinide|repaglinide|mesh-list
44010382|NCT03028103|Fluconazole|fluconazole|mesh-list
44010449|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44010450|NCT03030638|Olodaterol|olodaterol|mesh-list
44010451|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44010452|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
44010453|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010454|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010455|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44010456|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
44010457|NCT03031795|Ketorolac|ketorolac|mesh-list
44010458|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44010459|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44010460|NCT03031795|Analgesics|analgesics|mesh-ancestor
44010461|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
44010462|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851542|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
44010463|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010464|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010465|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010466|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44010467|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44010468|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010469|NCT03032965|Adenosine|adenosine|mesh-list
44010470|NCT03032965|Isoproterenol|isoproterenol|mesh-list
44010471|NCT03032965|Analgesics|analgesics|mesh-ancestor
44010472|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
44010473|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010474|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010475|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44010496|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010498|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
44010499|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010570|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44010571|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44010572|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44010573|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44010574|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010577|NCT03038867|Analgesics|analgesics|mesh-ancestor
44147418|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147419|NCT00201305|Antidotes|antidotes|mesh-ancestor
44147420|NCT00201305|Protective Agents|protective agents|mesh-ancestor
44147421|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
44010641|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010642|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44010643|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44010644|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
44010645|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010646|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44010647|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44010648|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44010649|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
44010650|NCT03043105|Hormones|hormones|mesh-ancestor
44010651|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44010652|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44010653|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
44010654|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44010655|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44010656|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44010657|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44010658|NCT03043105|Growth Substances|growth substances|mesh-ancestor
44010659|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
44010660|NCT03043274|Cangrelor|cangrelor|mesh-list
44010661|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44010662|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44010663|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44010664|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44010688|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
43742796|NCT04989218|Cisplatin|cisplatin|mesh-list
44010689|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010690|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44010691|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44010692|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44010693|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44010694|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010753|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44010754|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44010755|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44010756|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
44010757|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
44010758|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010759|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44010820|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44010821|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
44010822|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44010823|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44010893|NCT03063255|Rocuronium|rocuronium|mesh-list
44010894|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44010895|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147479|NCT00201383|Cisplatin|cisplatin|mesh-list
44011009|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44011010|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44011011|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
44011012|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
44011013|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011077|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011078|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
44011079|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011151|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44011152|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011153|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44011154|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44011225|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
44011226|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
44011227|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
44011228|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011298|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44011299|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
44011373|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011374|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
44147510|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44147511|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44147512|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44011471|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
44011472|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44011473|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
44011474|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44011541|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44011542|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011617|NCT03117140|Narcotics|narcotics|mesh-ancestor
44011618|NCT03117140|Analgesics|analgesics|mesh-ancestor
44011619|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44011689|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
44011765|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
44147556|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147557|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44147558|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44147559|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44011848|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44011850|NCT03130738|Miconazole|miconazole|mesh-list
44011851|NCT03130738|Clotrimazole|clotrimazole|mesh-list
44011920|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44011921|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44011992|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44011996|NCT03159143|Docetaxel|docetaxel|mesh-list
44012064|NCT03168308|Neostigmine|neostigmine|mesh-list
44012065|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44012066|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44012067|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012068|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
44012069|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012070|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012071|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44012072|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
44012074|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44012080|NCT03170219|Furosemide|furosemide|mesh-list
44012081|NCT03170219|Diuretics|diuretics|mesh-ancestor
44012082|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
44012083|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012084|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44012085|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44012086|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012087|NCT03170661|Rocuronium|rocuronium|mesh-list
44012088|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44012089|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44012090|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44012091|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012092|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012139|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012148|NCT03179345|Pregabalin|pregabalin|mesh-list
44147665|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
44157781|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44157782|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44012344|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012345|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44012346|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012347|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
44012415|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012417|NCT04949477|Analgesics|analgesics|mesh-ancestor
44012418|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
44012419|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012420|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44012421|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44012422|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44012423|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
44012424|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44012425|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012426|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
44012427|NCT04941170|Bupivacaine|bupivacaine|mesh-list
44012479|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
44012480|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012481|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44012530|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012531|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44012532|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
44012533|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012534|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
44012535|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
44012536|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44012537|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012538|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
44012541|NCT05405439|Prednisone|prednisone|mesh-list
44012596|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44012597|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44147712|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44147713|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44147714|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012670|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012671|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44012673|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44012742|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012744|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44012816|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44012817|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44012818|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44012822|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44147770|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
44147771|NCT00202228|Vitamins|vitamins|mesh-ancestor
44147772|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
44012893|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44012894|NCT03744663|Analgesics|analgesics|mesh-ancestor
44012895|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
44012896|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44012897|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44012898|NCT03717155|Gemcitabine|gemcitabine|mesh-list
44012966|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44012968|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44012969|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44012970|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44012971|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44012972|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44012973|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44013031|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44013033|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013053|NCT02366819|Leucovorin|leucovorin|mesh-list
44013103|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
44013104|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
44013175|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013176|NCT04781673|Analgesics|analgesics|mesh-ancestor
44013177|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44147871|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013224|NCT04682574|Vitamins|vitamins|mesh-ancestor
44013274|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44013275|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44013276|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
44013277|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44013345|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013346|NCT04426500|Bupivacaine|bupivacaine|mesh-list
44013347|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
44013348|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
44013349|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44013350|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013351|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
44013352|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013353|NCT04372433|Azacitidine|azacitidine|mesh-list
44013354|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013355|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
44013356|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013357|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013358|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013359|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
44013360|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44013402|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013403|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013468|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44013545|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44013546|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
44013547|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013548|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013614|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44013615|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44013616|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
44013617|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44013618|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013686|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013687|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44013688|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
44013690|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
44013753|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44013754|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44013755|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013787|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44013788|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013789|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013858|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013859|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44013860|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44013861|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
44013862|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44013864|NCT03189589|Nemiralisib|nemiralisib|mesh-list
44013928|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
44013929|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
44013930|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013931|NCT03198221|Cathartics|cathartics|mesh-ancestor
44013932|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44013934|NCT03198221|Laxatives|laxatives|mesh-ancestor
44013935|NCT03198871|Acetaminophen|acetaminophen|mesh-list
44013936|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44013937|NCT03198871|Analgesics|analgesics|mesh-ancestor
44013938|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
44013939|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44013940|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44013941|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
44013942|NCT03198884|Dolutegravir|dolutegravir|mesh-list
44013943|NCT03198884|Darunavir|darunavir|mesh-list
44013944|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44013945|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44013946|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44013947|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44013987|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
44013988|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
44013989|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44013990|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44013991|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
44013992|NCT03203681|Hormones|hormones|mesh-ancestor
44014057|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44014058|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44014126|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014127|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44014128|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44014129|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44014130|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014193|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014269|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014270|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
44014273|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
44014342|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014343|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44014344|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014410|NCT03248947|Buprenorphine|buprenorphine|mesh-list
44014411|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44014412|NCT03248947|Naloxone|naloxone|mesh-list
44014413|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44014414|NCT03248947|Narcotics|narcotics|mesh-ancestor
44014417|NCT03248947|Analgesics|analgesics|mesh-ancestor
44014481|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44014482|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
44014546|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
44014547|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
44014548|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44014549|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44014550|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44014551|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
44014552|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014619|NCT03279731|Liraglutide|liraglutide|mesh-list
44014620|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44014621|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014622|NCT03279731|Incretins|incretins|mesh-ancestor
44014623|NCT03279731|Hormones|hormones|mesh-ancestor
44014624|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44014625|NCT03281200|Nintedanib|nintedanib|mesh-list
44014626|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
44014627|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
44014628|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44014629|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014630|NCT03282591|Serlopitant|serlopitant|mesh-list
44014631|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44014632|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014756|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
44014830|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
44014831|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44014832|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44014833|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44014834|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43580651|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
44014835|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44014837|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44014855|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44014857|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44014858|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44014859|NCT03303196|Pancrelipase|pancrelipase|mesh-list
44014926|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44014927|NCT03312023|Ledipasvir|ledipasvir|mesh-list
44014928|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
44014929|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44014996|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44014997|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44014998|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44014999|NCT03323801|Tretinoin|tretinoin|mesh-list
44015000|NCT03323801|Isotretinoin|isotretinoin|mesh-list
44015001|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015002|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
44015003|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015004|NCT03324451|Insulin|insulin|mesh-list
43746823|NCT02521831|Bupivacaine|bupivacaine|mesh-list
44015064|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015065|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44015066|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44015067|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
44015068|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015069|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015070|NCT03334734|Isoniazid|isoniazid|mesh-list
44015071|NCT03334734|Macozinone|macozinone|mesh-list
44015072|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
44015073|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015074|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015075|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44015076|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44015077|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
44015078|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015079|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44148022|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
44148023|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44148024|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
44015080|NCT03336450|Midazolam|midazolam|mesh-list
44015136|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015137|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
44015138|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015147|NCT03344510|Anesthetics|anesthetics|mesh-list
44015208|NCT03355820|Antibodies|antibodies|mesh-list
44015286|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44015287|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
44015288|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
44015289|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44015357|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015358|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015359|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44015360|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44015361|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44015426|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
44015427|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44015428|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44015429|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
44015432|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015489|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015490|NCT03384329|Protective Agents|protective agents|mesh-ancestor
44015491|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015492|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015493|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44015494|NCT03388268|Vancomycin|vancomycin|mesh-list
44015495|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44015559|NCT03398330|Narcotics|narcotics|mesh-ancestor
44015560|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015561|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015631|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015632|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44015633|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44015634|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
44015635|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015637|NCT03404648|Choline|choline|mesh-list
44015703|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015704|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015705|NCT03415581|Analgesics|analgesics|mesh-ancestor
44015727|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44015728|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44015729|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44015730|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015731|NCT03425097|Fexofenadine|fexofenadine|mesh-list
44015732|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44015733|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44015734|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44015735|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
44015736|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
44015737|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015789|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015790|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015791|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
44015792|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44015793|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44015794|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44015795|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44015813|NCT03441269|Ibuprofen|ibuprofen|mesh-list
44015858|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
44015859|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015860|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015861|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
44015862|NCT03448068|Ketamine|ketamine|mesh-list
44015863|NCT03448068|Analgesics|analgesics|mesh-ancestor
44015864|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
44015865|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015866|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015867|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44015868|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44015869|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
44015870|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
44015871|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015872|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44015873|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44015874|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015875|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015877|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44015878|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
44015879|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
44015880|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44015881|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
44015882|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44173278|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173279|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44173280|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
44173281|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173282|NCT00292708|Cefmetazole|cefmetazole|mesh-list
44173283|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173284|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173285|NCT00292721|Celecoxib|celecoxib|mesh-list
44173286|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173287|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173288|NCT00292721|Analgesics|analgesics|mesh-ancestor
44173289|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
44173290|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173291|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173292|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173293|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173294|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44173295|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173296|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173297|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173298|NCT00292734|Zolpidem|zolpidem|mesh-list
44173299|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44173300|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015883|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015884|NCT03450083|Benralizumab|benralizumab|mesh-list
44015885|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44173301|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173302|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173303|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44173304|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
44173305|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
44173306|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173307|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173308|NCT00292747|Ibuprofen|ibuprofen|mesh-list
44173309|NCT00292747|Drotaverin|drotaverin|mesh-list
44173310|NCT00292747|Papaverine|papaverine|mesh-list
44173311|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173312|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173313|NCT00292747|Analgesics|analgesics|mesh-ancestor
44173314|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
44173315|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173316|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173317|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173318|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173319|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173320|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173321|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173323|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
44173324|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
44173325|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44173326|NCT00292747|Urological Agents|urological agents|mesh-ancestor
44173327|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
44173328|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173329|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173330|NCT00292799|Metformin|metformin|mesh-list
44173331|NCT00292799|Orlistat|orlistat|mesh-list
44173332|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44173333|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173334|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173335|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173336|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44173337|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44173338|NCT00292838|Fluticasone|fluticasone|mesh-list
44173339|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173340|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44173341|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
44173342|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173343|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614027|NCT04540133|BB 1101|bb 1101|mesh-list
44173344|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44173345|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173346|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44173347|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44173348|NCT00292890|Insulin|insulin|mesh-list
44173349|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44173350|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173351|NCT00292929|Artesunate|artesunate|mesh-list
44173352|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
44173353|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44173354|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44173355|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173356|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173357|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
44173358|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
44173359|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44173360|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
44173361|NCT00292955|Cetuximab|cetuximab|mesh-list
44173362|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173363|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173364|NCT00293072|Rituximab|rituximab|mesh-list
44173365|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173366|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173367|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
44173368|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173369|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173370|NCT00293085|Docetaxel|docetaxel|mesh-list
44173371|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015886|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015887|NCT03453060|Thrombin|thrombin|mesh-list
44015888|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
44015889|NCT03453060|Coagulants|coagulants|mesh-ancestor
44015890|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
44015891|NCT03454048|Piperaquine|piperaquine|mesh-list
44015892|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
44015893|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44015894|NCT03454048|Atovaquone|atovaquone|mesh-list
44015895|NCT03454048|Proguanil|proguanil|mesh-list
44173372|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
44173373|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173374|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
44173375|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173376|NCT00293098|Deferiprone|deferiprone|mesh-list
44173377|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44173378|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
44173379|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
44173380|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173381|NCT00293111|Etodolac|etodolac|mesh-list
44173382|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173383|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173384|NCT00293111|Analgesics|analgesics|mesh-ancestor
44173385|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
44173386|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173387|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173388|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173389|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173390|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44173391|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173392|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173393|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173394|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
44173395|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173398|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173399|NCT00293150|Eplerenone|eplerenone|mesh-list
44173400|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44173401|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173402|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173403|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173404|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44173405|NCT00293150|Diuretics|diuretics|mesh-ancestor
44173406|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
44173407|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173408|NCT00293163|Hylan|hylan|mesh-list
44173409|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
44173410|NCT00293163|Protective Agents|protective agents|mesh-ancestor
44173411|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173412|NCT00293176|Donepezil|donepezil|mesh-list
44173413|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44173414|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173415|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173416|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
44173417|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173418|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173419|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
44173420|NCT00293228|Isoniazid|isoniazid|mesh-list
44173421|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
44173422|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173423|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173424|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44173425|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44173426|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
44173427|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173428|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44173429|NCT00293280|Lomustine|lomustine|mesh-list
44173430|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44015896|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44015897|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
44015898|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44015899|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44015900|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015901|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44015902|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015903|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015904|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44015905|NCT03454048|Renal Agents|renal agents|mesh-ancestor
44015906|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
44015907|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
44015908|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44015909|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
44015910|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768252|NCT02396108|Paclitaxel|paclitaxel|mesh-list
44015911|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015912|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44015913|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
44015914|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44015915|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
44015916|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015917|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015918|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44015919|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
44015920|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
44015921|NCT03455218|Protective Agents|protective agents|mesh-ancestor
44015922|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
44015923|NCT03459612|Promethazine|promethazine|mesh-list
44015924|NCT03459612|Lasmiditan|lasmiditan|mesh-list
43851991|NCT00895791|Umirolimus|umirolimus|mesh-list
44173431|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
44173432|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173433|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173434|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44173435|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173436|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173437|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173438|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44173439|NCT00293332|Bevacizumab|bevacizumab|mesh-list
44173440|NCT00293332|Carboplatin|carboplatin|mesh-list
44173441|NCT00293332|Docetaxel|docetaxel|mesh-list
44173442|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173443|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173444|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44173445|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44173446|NCT00293332|Growth Substances|growth substances|mesh-ancestor
44015926|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44015927|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44015928|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015929|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
44015930|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
44015931|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
44015932|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44015933|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
44015934|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
44015935|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015936|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44015937|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
44015938|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
44015939|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44015940|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015941|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44015942|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
44015943|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
44015944|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44015945|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
44015946|NCT03459794|Ivermectin|ivermectin|mesh-list
44015947|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44015948|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44015949|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
44015950|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44015951|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015952|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44015953|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44015954|NCT03460990|Ivacaftor|ivacaftor|mesh-list
44173447|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173448|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
44173449|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
44173450|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173451|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
44173452|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173453|NCT00293345|Gemcitabine|gemcitabine|mesh-list
44173454|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173455|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
44173456|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173457|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173458|NCT00293345|Antiviral Agents|antiviral agents|mesh-ancestor
43674405|NCT02893280|Enoxaparin|enoxaparin|mesh-list
44173459|NCT00293345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173460|NCT00293345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173461|NCT00293345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173462|NCT00293345|Immunologic Factors|immunologic factors|mesh-ancestor
44173463|NCT00293345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173464|NCT00293358|Cisplatin|cisplatin|mesh-list
44173465|NCT00293358|Carboplatin|carboplatin|mesh-list
44173466|NCT00293358|Etoposide|etoposide|mesh-list
44173467|NCT00293358|Ifosfamide|ifosfamide|mesh-list
44173470|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44173471|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44173472|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44173473|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173474|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173475|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44173476|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
44173478|NCT00293371|Docetaxel|docetaxel|mesh-list
44173479|NCT00293371|Vatalanib|vatalanib|mesh-list
44173480|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173481|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
44173482|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173483|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
44173484|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173485|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173486|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
44173487|NCT00293371|Hormones|hormones|mesh-ancestor
44173488|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173489|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173490|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173491|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44173492|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173493|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
44173494|NCT00293410|Clofarabine|clofarabine|mesh-list
44173495|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173496|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
44173497|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173498|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173499|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44173500|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
44173501|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173502|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173503|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44173504|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173505|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
44173506|NCT00293436|Celecoxib|celecoxib|mesh-list
44173507|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44173508|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173509|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44173510|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173511|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173512|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173513|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173514|NCT00293436|Analgesics|analgesics|mesh-ancestor
44173515|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
44173516|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173517|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173518|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173519|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173520|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44173521|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173522|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
44173523|NCT00293475|Rituximab|rituximab|mesh-list
44173524|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44173525|NCT00293475|Carboplatin|carboplatin|mesh-list
44173526|NCT00293475|Methotrexate|methotrexate|mesh-list
44173527|NCT00293475|Mannitol|mannitol|mesh-list
44173528|NCT00293475|Antibodies|antibodies|mesh-list
44173529|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
44173530|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44173531|NCT00293475|Antidotes|antidotes|mesh-list
44173532|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
44173533|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173534|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173535|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173536|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44173537|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
44173538|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44015956|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44015957|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44173539|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173540|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
44173544|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44173545|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173546|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44173547|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44173549|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
44173550|NCT00293475|Protective Agents|protective agents|mesh-ancestor
44173551|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
44173552|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
44173553|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173554|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173555|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
44173556|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
44173557|NCT00293501|Tinzaparin|tinzaparin|mesh-list
44173558|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44173559|NCT00293501|Dalteparin|dalteparin|mesh-list
44173560|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
44173561|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44173562|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44173563|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173564|NCT00293514|Thrombin|thrombin|mesh-list
44173565|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
44173566|NCT00293514|Coagulants|coagulants|mesh-ancestor
43614255|NCT04190433|Pravastatin|pravastatin|mesh-list
44173567|NCT00293527|Interferons|interferons|mesh-list
44173568|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
44173569|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
44173570|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173571|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
44173572|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173573|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
44173574|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173575|NCT00293592|Dexamethasone|dexamethasone|mesh-list
44173576|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173577|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
44173578|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
44173579|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173580|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173581|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173582|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
44173583|NCT00293592|Hormones|hormones|mesh-ancestor
44173584|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173585|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173586|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173587|NCT00293631|Ketorolac|ketorolac|mesh-list
44173588|NCT00293631|Lornoxicam|lornoxicam|mesh-list
44173589|NCT00293631|Piroxicam|piroxicam|mesh-list
44173590|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173591|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173592|NCT00293631|Analgesics|analgesics|mesh-ancestor
44173593|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
44173594|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173595|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173596|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173597|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173598|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173599|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173600|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173601|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
44173602|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
44173603|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
44173604|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173605|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173606|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173607|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44173608|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
44173609|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
44173610|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173611|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173612|NCT00293657|Lornoxicam|lornoxicam|mesh-list
44173613|NCT00293657|Piroxicam|piroxicam|mesh-list
44015958|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015959|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
44015960|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44015961|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44015962|NCT03463512|Racecadotril|racecadotril|mesh-list
44015963|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
44173614|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173615|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173616|NCT00293657|Analgesics|analgesics|mesh-ancestor
44173617|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
44173618|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173619|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173620|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173621|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173622|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173623|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173624|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173625|NCT00293670|Goserelin|goserelin|mesh-list
44173626|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173627|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173628|NCT00293696|Goserelin|goserelin|mesh-list
44173629|NCT00293696|Bicalutamide|bicalutamide|mesh-list
44173630|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173631|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173632|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
44173633|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173634|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173635|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173636|NCT00293735|Labetalol|labetalol|mesh-list
44173637|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44173638|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44173639|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173640|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173641|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173642|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173643|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173644|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
44173645|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
44173646|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173647|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44173648|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44173649|NCT00293761|Travoprost|travoprost|mesh-list
44173650|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173651|NCT00293787|Timolol|timolol|mesh-list
44173652|NCT00293787|Travoprost|travoprost|mesh-list
44173653|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44173654|NCT00293787|Latanoprost|latanoprost|mesh-list
44173655|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44173656|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44173657|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44173658|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173659|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173660|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173661|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173662|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44173663|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173664|NCT00293800|Timolol|timolol|mesh-list
44173665|NCT00293800|Travoprost|travoprost|mesh-list
44173666|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44173667|NCT00293800|Latanoprost|latanoprost|mesh-list
44173668|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44173669|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44173670|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44173671|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173672|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173673|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173674|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173675|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44015964|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44015965|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
44015966|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44015967|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44015968|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44015969|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44016010|NCT03468933|Plasminogen|plasminogen|mesh-list
44016011|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44016012|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44016013|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44016014|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016015|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
44016016|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016017|NCT03472469|Acetaminophen|acetaminophen|mesh-list
44016018|NCT03472469|Ketorolac|ketorolac|mesh-list
44016019|NCT03472469|Naproxen|naproxen|mesh-list
44016020|NCT03472469|Celecoxib|celecoxib|mesh-list
44016021|NCT03472469|Lidocaine|lidocaine|mesh-list
44016022|NCT03472469|Pregabalin|pregabalin|mesh-list
44016023|NCT03472469|Gabapentin|gabapentin|mesh-list
44016024|NCT03472469|Tramadol|tramadol|mesh-list
44016025|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016026|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
44016027|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016028|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016029|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
44016030|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016031|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44016032|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44016033|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44016034|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016035|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016036|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016037|NCT03472469|Analgesics|analgesics|mesh-ancestor
44016038|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
44016039|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
44016040|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44016041|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44016042|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44016043|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44016052|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016053|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016054|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016055|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016056|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
44173676|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173677|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44173678|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
44173679|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173681|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
44173682|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
44173683|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173684|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173685|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44173686|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44173687|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
44173704|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173705|NCT00293930|Tacrolimus|tacrolimus|mesh-list
44173706|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173707|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
44173708|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173709|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44173710|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173711|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173712|NCT00293969|Morphine|morphine|mesh-list
44173713|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44173714|NCT00293969|Narcotics|narcotics|mesh-ancestor
44173715|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173716|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173717|NCT00293969|Analgesics|analgesics|mesh-ancestor
44173718|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
44173719|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173720|NCT00294008|Risperidone|risperidone|mesh-list
44173721|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44173722|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
44173723|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173724|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768257|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173725|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173726|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44173727|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44173728|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173729|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44173730|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44173731|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
44173732|NCT00294086|Valsartan|valsartan|mesh-list
44173733|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173734|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44173735|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44173736|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173737|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44173738|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44173739|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
44173740|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173741|NCT00294099|Antacids|antacids|mesh-ancestor
44173742|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173743|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44173744|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
44173748|NCT00294164|Hormones|hormones|mesh-list
44173749|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173750|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173751|NCT00294190|Topotecan|topotecan|mesh-list
44173752|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44173753|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44173754|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173755|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173756|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173757|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
44173758|NCT00294203|Hematinics|hematinics|mesh-ancestor
44173760|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44173761|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
44173762|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173763|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173764|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173765|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44173766|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44173767|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173768|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44173769|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44173770|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
44173771|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44173772|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
44173773|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173774|NCT00294359|Bevacizumab|bevacizumab|mesh-list
44173775|NCT00294359|Capecitabine|capecitabine|mesh-list
44173776|NCT00294359|Mitomycins|mitomycins|mesh-list
44173777|NCT00294359|Mitomycin|mitomycin|mesh-list
44173778|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173779|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173780|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44173781|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44173782|NCT00294359|Growth Substances|growth substances|mesh-ancestor
44173783|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173784|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
44173785|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173786|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
44173787|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173788|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44173789|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
44173790|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44173791|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173792|NCT00294385|Gemcitabine|gemcitabine|mesh-list
44173793|NCT00294385|Docetaxel|docetaxel|mesh-list
44173794|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173795|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
44173796|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173797|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173798|NCT00294385|Antiviral Agents|antiviral agents|mesh-ancestor
44173799|NCT00294385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173800|NCT00294385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173801|NCT00294385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173802|NCT00294385|Immunologic Factors|immunologic factors|mesh-ancestor
44173803|NCT00294385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173804|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
44173805|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173806|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
44173807|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
44173808|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44173809|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173810|NCT00294463|Tibolone|tibolone|mesh-list
44173811|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44173812|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44173813|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44173814|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
44173815|NCT00294463|Estradiol|estradiol|mesh-list
44173816|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44173817|NCT00294463|Progesterone|progesterone|mesh-list
44173828|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173829|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173830|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173831|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173832|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44173833|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
44173834|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44173835|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44173837|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44173838|NCT00294502|Minocycline|minocycline|mesh-list
44173839|NCT00294502|Gentamicins|gentamicins|mesh-list
44173840|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173841|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173842|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016059|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016060|NCT03473665|Celecoxib|celecoxib|mesh-list
44016061|NCT03473665|Diclofenac|diclofenac|mesh-list
44016062|NCT03473665|Indomethacin|indomethacin|mesh-list
44016063|NCT03473665|Meloxicam|meloxicam|mesh-list
44016064|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016065|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016066|NCT03473665|Analgesics|analgesics|mesh-ancestor
44016067|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
44016068|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016069|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016070|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016071|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016072|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44016073|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016074|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016075|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016076|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
44016077|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
44016078|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44016079|NCT03478163|Clindamycin|clindamycin|mesh-list
44016080|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
44016081|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
44016082|NCT03478163|Cefazolin|cefazolin|mesh-list
44016083|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44016084|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016085|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44173843|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44173844|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173845|NCT00294567|Amlodipine|amlodipine|mesh-list
44173846|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
44173847|NCT00294567|Calcium|calcium|mesh-list
44173848|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44173849|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173850|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173851|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44173852|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173853|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
44173854|NCT00294580|Maloprim|maloprim|mesh-list
44173855|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
44173856|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44173857|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44173858|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173859|NCT00294593|Leucovorin|leucovorin|mesh-list
44173860|NCT00294593|Folic Acid|folic acid|mesh-list
44173861|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
44173862|NCT00294593|Antidotes|antidotes|mesh-ancestor
44173863|NCT00294593|Protective Agents|protective agents|mesh-ancestor
44173864|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016087|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016089|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44016090|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173865|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
44173866|NCT00294593|Vitamins|vitamins|mesh-ancestor
44173867|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
44173868|NCT00294593|Hematinics|hematinics|mesh-ancestor
44173869|NCT00294606|Phenylephrine|phenylephrine|mesh-list
44173870|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
44173871|NCT00294606|Norepinephrine|norepinephrine|mesh-list
44173872|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44173873|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
44173874|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
44173875|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173876|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173877|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
44173878|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44173879|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
44173880|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173881|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44173882|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44173883|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44173884|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173887|NCT00294606|Protective Agents|protective agents|mesh-ancestor
44173888|NCT00294619|Hormones|hormones|mesh-list
44173889|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173890|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173891|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44173892|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173893|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44173894|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173895|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173896|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
44173897|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44173898|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173899|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44173900|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44173901|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173902|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173903|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173904|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44173905|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44173906|NCT00294775|Candesartan|candesartan|mesh-list
44173907|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173908|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44173909|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44173910|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173911|NCT00294853|Calcium|calcium|mesh-list
44173912|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44173913|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173914|NCT00294892|Nevirapine|nevirapine|mesh-list
44173915|NCT00294892|Carbamazepine|carbamazepine|mesh-list
44173916|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44173917|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44173918|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173919|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173921|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173922|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44173923|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44173924|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44173925|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44173926|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
44173927|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
44016091|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016092|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44173928|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44173929|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173930|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173931|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44173932|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173933|NCT00294892|Analgesics|analgesics|mesh-ancestor
44173934|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
44173935|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173936|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44173937|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44173939|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173940|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173941|NCT00294931|Bevacizumab|bevacizumab|mesh-list
44173942|NCT00294931|Carboplatin|carboplatin|mesh-list
44173943|NCT00294931|Irinotecan|irinotecan|mesh-list
44173944|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44173945|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173946|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44173947|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44173948|NCT00294931|Growth Substances|growth substances|mesh-ancestor
44173949|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173950|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
44173951|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44173952|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44173953|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173959|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
44173960|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173961|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173962|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173963|NCT00294996|Doxorubicin|doxorubicin|mesh-list
44173964|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44173965|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173966|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44173967|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44173968|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173969|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173970|NCT00295035|Celecoxib|celecoxib|mesh-list
44173971|NCT00295035|Curcumin|curcumin|mesh-list
44173972|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44173973|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173974|NCT00295035|Analgesics|analgesics|mesh-ancestor
44173975|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
44173976|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173977|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173978|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173979|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44173980|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44173981|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44173982|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173983|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173984|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173985|NCT00295100|Tamoxifen|tamoxifen|mesh-list
44173986|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44173987|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
44173988|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173989|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173990|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44173991|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173992|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44173993|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44173994|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44173995|NCT00295165|Sargramostim|sargramostim|mesh-list
44173996|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
44173997|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173998|NCT00295178|Vancomycin|vancomycin|mesh-list
44173999|NCT00295178|Daptomycin|daptomycin|mesh-list
44174000|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174001|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016094|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016095|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
44016096|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
44016097|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016098|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016099|NCT03482583|Nicotine|nicotine|mesh-list
44016100|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44016101|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
44174002|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
44174003|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44174004|NCT00295243|Topotecan|topotecan|mesh-list
44174005|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44174006|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44174007|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174008|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174009|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174011|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44174012|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
44174013|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174014|NCT00295308|Clonidine|clonidine|mesh-list
44174015|NCT00295308|Analgesics|analgesics|mesh-ancestor
44174016|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
44174017|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174018|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174019|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44174020|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
44174021|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
44174032|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174034|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174035|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174036|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
44174037|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174038|NCT00295347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44174039|NCT00295347|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174040|NCT00295347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174041|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44174042|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174043|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174044|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44174045|NCT00295347|Diuretics|diuretics|mesh-ancestor
44174046|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
44174047|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174048|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44174049|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44174050|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44174051|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
44174052|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174053|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44174054|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44174055|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174056|NCT00295386|Zopiclone|zopiclone|mesh-list
44174057|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44174058|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174059|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174060|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44174061|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174062|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174063|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174064|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174065|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174066|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174067|NCT00295425|Cyclosporine|cyclosporine|mesh-list
44174068|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
44174069|NCT00295425|Cyclosporins|cyclosporins|mesh-list
44016102|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016103|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016104|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44016105|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44016106|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016107|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016108|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016109|NCT03482973|Bupivacaine|bupivacaine|mesh-list
44016110|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016111|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
44016112|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016113|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016114|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
44016115|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016116|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44016117|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
44016118|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016119|NCT03485976|Ixekizumab|ixekizumab|mesh-list
44016120|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
44016121|NCT03487276|Vilobelimab|vilobelimab|mesh-list
44016122|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44016123|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016124|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
44016125|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016126|NCT03489850|Ibudilast|ibudilast|mesh-list
44016127|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44016128|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
44016129|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016130|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016131|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44016132|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
44016133|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44016134|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016135|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016136|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44174070|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174071|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174072|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016137|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
44016138|NCT03490942|Glucagon|glucagon|mesh-list
44174073|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
44174074|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174075|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
44174076|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174077|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
44174078|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174079|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174080|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174081|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174082|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44174083|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
44174099|NCT00295542|Lisinopril|lisinopril|mesh-list
44174100|NCT00295542|Nebivolol|nebivolol|mesh-list
44174101|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
44174102|NCT00295542|Doxazosin|doxazosin|mesh-list
44174103|NCT00295542|Indapamide|indapamide|mesh-list
44174104|NCT00295542|Quinapril|quinapril|mesh-list
44174105|NCT00295542|Torsemide|torsemide|mesh-list
44174106|NCT00295542|Spirapril|spirapril|mesh-list
44174107|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44174108|NCT00295542|Diuretics|diuretics|mesh-list
44174109|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44174110|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44174111|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174112|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44174113|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
44174114|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174115|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174116|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
44174117|NCT00295542|Protective Agents|protective agents|mesh-ancestor
44174118|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44174119|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174120|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44174121|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
44174122|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44174123|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44174124|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44174125|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
44174126|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174127|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44174128|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
44174129|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44174130|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
44174131|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
44174132|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174133|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44174134|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44174135|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44174136|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44174137|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44174138|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44174139|NCT00295555|Doxazosin|doxazosin|mesh-list
44174140|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44174141|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44174142|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44174143|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44174144|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
44174145|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734405|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44174157|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
44174158|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174159|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174160|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174161|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174162|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174163|NCT00295672|Vinorelbine|vinorelbine|mesh-list
44174164|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44174165|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174166|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
44174167|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
44174168|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
44016139|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44016140|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016141|NCT03490942|Hormones|hormones|mesh-ancestor
44016142|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016143|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174169|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174170|NCT00295685|Antacids|antacids|mesh-list
44174171|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174172|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44174173|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
44174174|NCT00295698|Filaricides|filaricides|mesh-ancestor
44174175|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
44174176|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
44174177|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44174178|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174179|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44174180|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174181|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174182|NCT00295776|Lamotrigine|lamotrigine|mesh-list
44174183|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
44174184|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44174185|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174186|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174187|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44174188|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174189|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174190|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174191|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174192|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174193|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44174194|NCT00295789|Paclitaxel|paclitaxel|mesh-list
44174195|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44174196|NCT00295789|Cisplatin|cisplatin|mesh-list
44174197|NCT00295789|Carboplatin|carboplatin|mesh-list
44174198|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44174199|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174200|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
44174201|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
44174202|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44174203|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174204|NCT00295815|Lomustine|lomustine|mesh-list
44174205|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614942|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44174206|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
43734406|NCT02540395|Protective Agents|protective agents|mesh-ancestor
44174219|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174220|NCT00295893|Paclitaxel|paclitaxel|mesh-list
44174221|NCT00295893|Docetaxel|docetaxel|mesh-list
44174222|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
44174223|NCT00295893|Carboplatin|carboplatin|mesh-list
44174224|NCT00295893|Doxorubicin|doxorubicin|mesh-list
44174225|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44174226|NCT00295893|Trastuzumab|trastuzumab|mesh-list
44174227|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44174228|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174229|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
44174230|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
44174231|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
44174232|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174233|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174234|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
44174235|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174236|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174237|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174238|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
44174239|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174240|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174241|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44174242|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44174243|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016144|NCT03490942|Incretins|incretins|mesh-ancestor
44016145|NCT03493828|Bupivacaine|bupivacaine|mesh-list
44174244|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44174246|NCT00295919|Fenretinide|fenretinide|mesh-list
44174247|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
44174248|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174249|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44174250|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44174251|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174252|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174253|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44174254|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174255|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174256|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174257|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44174258|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174259|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44174260|NCT00295919|Protective Agents|protective agents|mesh-ancestor
44174261|NCT00295945|Fentanyl|fentanyl|mesh-list
44174262|NCT00295945|Hydromorphone|hydromorphone|mesh-list
44174263|NCT00295945|Ropivacaine|ropivacaine|mesh-list
44174264|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
44174265|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
44174266|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174267|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174268|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
44174269|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174282|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
44174284|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44174285|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174286|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174287|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
44174288|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174289|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174290|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
44174291|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174292|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174293|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
44174294|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174295|NCT00295984|Nicotine|nicotine|mesh-list
44174296|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44174297|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
44174298|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174299|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174300|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44174301|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44174302|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
44174303|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174304|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838054|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44174305|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
44174306|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
44174307|NCT00295997|Busulfan|busulfan|mesh-list
44174308|NCT00295997|Methotrexate|methotrexate|mesh-list
44174309|NCT00295997|Fludarabine|fludarabine|mesh-list
44174310|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
44174311|NCT00295997|Tacrolimus|tacrolimus|mesh-list
44174312|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44174313|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174314|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
44174315|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174316|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174317|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174318|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
43615085|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
44174319|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174320|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174321|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174322|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44174323|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
44174324|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174325|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174326|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
44174327|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
44016148|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016149|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016151|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016152|NCT03496324|Ibuprofen|ibuprofen|mesh-list
44016153|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44174328|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174329|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44174330|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44174331|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174332|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174333|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44174359|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
44174360|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44174361|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44174363|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
44174364|NCT00296023|Fludarabine|fludarabine|mesh-list
44174365|NCT00296023|Busulfan|busulfan|mesh-list
44174366|NCT00296023|Tacrolimus|tacrolimus|mesh-list
44174367|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44174368|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44174369|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
44174370|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174371|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174372|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174373|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
44174374|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174375|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174376|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
44174377|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174378|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44174379|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174380|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
44174381|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174398|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44174399|NCT00296062|Growth Substances|growth substances|mesh-ancestor
44174400|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174401|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
44174402|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174403|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
44174404|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174405|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44174406|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44174407|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174408|NCT00296127|Celecoxib|celecoxib|mesh-list
44174409|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44174410|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44174411|NCT00296127|Analgesics|analgesics|mesh-ancestor
44174412|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
44174413|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174414|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174415|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174416|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174417|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44174418|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44174419|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174420|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174421|NCT00296179|Zolpidem|zolpidem|mesh-list
44174422|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44174423|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44174424|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016156|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
44016157|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016158|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016159|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016160|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016161|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016162|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016163|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016164|NCT03496467|Nepafenac|nepafenac|mesh-list
44016165|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016166|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016167|NCT03496467|Analgesics|analgesics|mesh-ancestor
44016168|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
44016169|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174425|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174426|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44174427|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
44174428|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
44174429|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174430|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174431|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
44174432|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174433|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
44174434|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174435|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174436|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174437|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
44174438|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174439|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174453|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174454|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174455|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174456|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174457|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
44174459|NCT00296348|Daclizumab|daclizumab|mesh-list
44174460|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174461|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
44174462|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174463|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174464|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174465|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174466|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174467|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615235|NCT03158610|Capecitabine|capecitabine|mesh-list
44174468|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44174469|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
44174470|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174471|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174473|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174474|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
44174475|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174476|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174477|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016171|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016172|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016173|NCT03496545|Acetaminophen|acetaminophen|mesh-list
44016174|NCT03496545|Bromocriptine|bromocriptine|mesh-list
44016175|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016176|NCT03496545|Analgesics|analgesics|mesh-ancestor
44016177|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
44016178|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838055|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016179|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016180|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
44016181|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44016182|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44016183|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174478|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174479|NCT00296387|Atorvastatin|atorvastatin|mesh-list
44174480|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44174481|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44174482|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44174483|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
44174484|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174485|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44174486|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44174487|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174488|NCT00296465|Citric Acid|citric acid|mesh-list
44174489|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
44174491|NCT00296465|Enclomiphene|enclomiphene|mesh-list
44174492|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
44174493|NCT00296465|Hormones|hormones|mesh-list
44174494|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44174495|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
44174496|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44174497|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
44174498|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
44174499|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174509|NCT00296478|Progesterone|progesterone|mesh-list
44174510|NCT00296478|Progestins|progestins|mesh-ancestor
44174512|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174513|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174514|NCT00296530|Fluticasone|fluticasone|mesh-list
44174515|NCT00296530|Xhance|xhance|mesh-list
44174516|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44174517|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44174518|NCT00296530|Montelukast|montelukast|mesh-list
44174519|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174520|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44174521|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
44174522|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174523|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174524|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44174525|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
44174526|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
44174527|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44174528|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44174529|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44174530|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44174531|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
44174532|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174533|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016184|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016186|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
44016187|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016188|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016189|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44016190|NCT03496974|Antibodies|antibodies|mesh-list
44016191|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
44016192|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44016193|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
44016194|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016195|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016196|NCT03497845|Vaccines|vaccines|mesh-list
44016197|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
44016198|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016199|NCT03498196|Avelumab|avelumab|mesh-list
44016200|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016201|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016202|NCT03500289|Midazolam|midazolam|mesh-list
44016203|NCT03500289|Ketamine|ketamine|mesh-list
44016204|NCT03500289|Analgesics|analgesics|mesh-ancestor
44016205|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
44016206|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016207|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016208|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44016209|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44174534|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44174535|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174536|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174537|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44174538|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44174539|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
44174540|NCT00296530|Hormones|hormones|mesh-ancestor
44174541|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
43615311|NCT03153852|Glycolic acid|glycolic acid|mesh-list
44174542|NCT00296608|Leucovorin|leucovorin|mesh-list
44174543|NCT00296608|Fluorouracil|fluorouracil|mesh-list
44174544|NCT00296608|Calcium|calcium|mesh-list
44174545|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
44174546|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44174547|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174548|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
44174549|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174550|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174551|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174552|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174553|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
44174554|NCT00296608|Antidotes|antidotes|mesh-ancestor
44174555|NCT00296608|Protective Agents|protective agents|mesh-ancestor
44016210|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
44016211|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
44016212|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016213|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44016214|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44016215|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174556|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
44174557|NCT00296608|Vitamins|vitamins|mesh-ancestor
44174558|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
44174559|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44174560|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44174561|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
44174562|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174571|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174572|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174573|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174575|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174576|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174577|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174578|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44174579|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174580|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44174581|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174582|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174583|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44174584|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44174585|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174586|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174587|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174588|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174589|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174590|NCT00296699|Analgesics|analgesics|mesh-ancestor
44174591|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
44174592|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174593|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174594|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174595|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
44174596|NCT00296712|Dexetimide|dexetimide|mesh-list
44174597|NCT00296712|Citalopram|citalopram|mesh-list
44174598|NCT00296712|Bupropion|bupropion|mesh-list
44174599|NCT00296712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174600|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174601|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174602|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174603|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174604|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
44174605|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174606|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44174607|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174608|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174609|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44174610|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44174611|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
44174612|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
44174613|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174614|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43615386|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174615|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44174616|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
44174617|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44174618|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
44174619|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44174620|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44174621|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174622|NCT00296751|Fentanyl|fentanyl|mesh-list
44174623|NCT00296751|Meperidine|meperidine|mesh-list
44174624|NCT00296751|Bupivacaine|bupivacaine|mesh-list
44174625|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
44174635|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44174636|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
44174638|NCT00296777|Bupropion|bupropion|mesh-list
44174639|NCT00296777|Imipramine|imipramine|mesh-list
44174640|NCT00296777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174641|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174642|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174643|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174644|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174645|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
44174646|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174647|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44174648|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174649|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174650|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44174651|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
44174652|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44174653|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44174654|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174655|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44174656|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44174657|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44174658|NCT00296790|Zolpidem|zolpidem|mesh-list
44174659|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44174660|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44174661|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174662|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174663|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44174665|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
44174666|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174667|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174668|NCT00296803|Clopidogrel|clopidogrel|mesh-list
44174669|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44174670|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44174671|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44174672|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44174673|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
44174674|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174675|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174676|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174677|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
44174678|NCT00296868|Vitamins|vitamins|mesh-ancestor
44174679|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
44174680|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174681|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
44174682|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174683|NCT00296868|Protective Agents|protective agents|mesh-ancestor
44174684|NCT00296894|Adalimumab|adalimumab|mesh-list
44174685|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174686|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174687|NCT00296933|Citalopram|citalopram|mesh-list
44174688|NCT00296933|Bupropion|bupropion|mesh-list
44174689|NCT00296933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174690|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174691|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174697|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174699|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44174700|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
44174701|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44174702|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44174703|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174704|NCT00296946|Bromides|bromides|mesh-list
44174705|NCT00296946|Ipratropium|ipratropium|mesh-list
44174706|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
44174707|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44174708|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
44174709|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174710|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174711|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44174712|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44174713|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44016216|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016218|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44016219|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44016220|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44016221|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016222|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
44016223|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
44016224|NCT03500302|Evolocumab|evolocumab|mesh-list
44016225|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44016226|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44016227|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
44016228|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016229|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44016230|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44016231|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44016232|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016233|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016234|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016235|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016236|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016237|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44016238|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
44016239|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016240|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
44016241|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44016242|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
44016243|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
44016244|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016245|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016246|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016247|NCT03502915|Analgesics|analgesics|mesh-ancestor
44016248|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
44016249|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174714|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
44174715|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174716|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174717|NCT00296959|Topiramate|topiramate|mesh-list
44174718|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
44174719|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44016250|NCT03503292|Ondansetron|ondansetron|mesh-list
44016251|NCT03503292|Granisetron|granisetron|mesh-list
44174720|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174721|NCT00296972|Interferons|interferons|mesh-list
44174722|NCT00296972|Ribavirin|ribavirin|mesh-list
44174723|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174724|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
44174725|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174726|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
44174727|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174728|NCT00297011|Valacyclovir|valacyclovir|mesh-list
44174729|NCT00297011|Clobetasol|clobetasol|mesh-list
44174730|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
44174731|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174732|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174733|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
44174734|NCT00297011|Hormones|hormones|mesh-ancestor
43838058|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44174735|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174736|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174737|NCT00297050|Peramivir|peramivir|mesh-list
44174738|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
44174739|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174740|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174741|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174742|NCT00297076|Aplaviroc|aplaviroc|mesh-list
44174743|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44174744|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44174745|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174746|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44174747|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44174748|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
44174749|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174750|NCT00297128|Capecitabine|capecitabine|mesh-list
44174751|NCT00297128|Cetuximab|cetuximab|mesh-list
44174752|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174753|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
44174754|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174755|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174756|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44174757|NCT00297141|Capecitabine|capecitabine|mesh-list
44174758|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
44174759|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174767|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
44174768|NCT00297219|Calcium|calcium|mesh-list
44174769|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44174770|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174771|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44174772|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44174773|NCT00297284|Modafinil|modafinil|mesh-list
44174774|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44174775|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174776|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44174777|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44174778|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44174779|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174780|NCT00297323|Topiramate|topiramate|mesh-list
44174781|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
44174782|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44174783|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174784|NCT00297336|Topiramate|topiramate|mesh-list
44174785|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
44174786|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44174787|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174788|NCT00297349|Topiramate|topiramate|mesh-list
44174789|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
44174790|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44174791|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174792|NCT00297362|Galantamine|galantamine|mesh-list
44174793|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44174794|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174795|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174796|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
44174797|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016252|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
44016253|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
44016254|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016255|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016256|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016257|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
44016258|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
44016259|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44016260|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
44016261|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016262|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016263|NCT03503292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44016264|NCT03503292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44016265|NCT03503292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016266|NCT03503292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016267|NCT03503292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44016269|NCT03503578|Sevoflurane|sevoflurane|mesh-list
44016270|NCT03503578|Analgesics|analgesics|mesh-ancestor
44016271|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
44016272|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016273|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174798|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174799|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44174800|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
44174801|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174802|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
44174803|NCT00297375|Acetaminophen|acetaminophen|mesh-list
44174804|NCT00297375|Tramadol|tramadol|mesh-list
44174805|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44174806|NCT00297375|Analgesics|analgesics|mesh-ancestor
44174807|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
44174808|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174809|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174810|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
44174811|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44174812|NCT00297375|Narcotics|narcotics|mesh-ancestor
44174813|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174814|NCT00297388|Risperidone|risperidone|mesh-list
44174815|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44174816|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
44174817|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174818|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174819|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174820|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174821|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174822|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174823|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174824|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44174825|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
44174830|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174832|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44174833|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
44174834|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702557|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016274|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44016275|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44174835|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174836|NCT00297505|Citalopram|citalopram|mesh-list
44174837|NCT00297505|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174838|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174839|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615678|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44174840|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174841|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174842|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
44174843|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174844|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44174845|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174846|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174847|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
44174848|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
44174849|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44174850|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44174851|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174852|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174853|NCT00297544|Urological Agents|urological agents|mesh-ancestor
44174854|NCT00297570|Interferons|interferons|mesh-list
44174855|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
44174856|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174857|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
44174858|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174859|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44174860|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174861|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174862|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
44174863|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44174864|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174865|NCT00297661|Sirolimus|sirolimus|mesh-list
44174866|NCT00297661|Paclitaxel|paclitaxel|mesh-list
44174867|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44174868|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174869|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
44174870|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
44174871|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
44174872|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174873|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174874|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174875|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174876|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
44174877|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174878|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
44174879|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174880|NCT00297674|Clarithromycin|clarithromycin|mesh-list
44174881|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174882|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174883|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44174884|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174885|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174886|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44174887|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44174888|NCT00297739|Risperidone|risperidone|mesh-list
44174889|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44174890|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
44174891|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174892|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174893|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174903|NCT00297765|Tacrolimus|tacrolimus|mesh-list
44174904|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174905|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
44174906|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174907|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174908|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174909|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174910|NCT00297804|Paclitaxel|paclitaxel|mesh-list
44174912|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174913|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44174914|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44174915|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44174916|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174917|NCT00297817|Vaccines|vaccines|mesh-list
44174918|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
44174919|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174920|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44174921|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
44174922|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174923|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174924|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174925|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174926|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174928|NCT00297960|Ziprasidone|ziprasidone|mesh-list
44174929|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
44174930|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
44174931|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174932|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174933|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44174934|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174935|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174936|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174937|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174938|NCT00297960|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174939|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44174940|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174941|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174942|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174943|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
44174944|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44174945|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44174946|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
44174947|NCT00298012|Methotrexate|methotrexate|mesh-list
44174948|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44174949|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
44174950|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174951|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174952|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174953|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
44174954|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174955|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174956|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
44174957|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174958|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44174959|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174960|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
44174971|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174972|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44174973|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
44174974|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174975|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
44174976|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44174977|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
44174978|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174979|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174980|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174981|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
44174982|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174983|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
44174984|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44174985|NCT00298168|Protective Agents|protective agents|mesh-ancestor
44174986|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
44174987|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44174988|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
44174989|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174990|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174991|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174992|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
44174993|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174994|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
44174995|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44016276|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
44016277|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
44174996|NCT00298181|Protective Agents|protective agents|mesh-ancestor
44174998|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44174999|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175000|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175001|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
44175002|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175003|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175004|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44175005|NCT00298285|Enoxaparin|enoxaparin|mesh-list
44175006|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
44175007|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44175008|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44175009|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175010|NCT00298324|Cyclosporine|cyclosporine|mesh-list
44175011|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
44175012|NCT00298324|Prednisone|prednisone|mesh-list
44175013|NCT00298324|Cyclosporins|cyclosporins|mesh-list
44175014|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175015|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
44175016|NCT00298324|Hormones|hormones|mesh-ancestor
44175017|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175018|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175019|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44175020|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175022|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175023|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175024|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
44175025|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
44175026|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175027|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
44175045|NCT00298415|Carboplatin|carboplatin|mesh-list
44175046|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44175047|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44175048|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175049|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
44175050|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
44175051|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
44175052|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175053|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44175054|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
44175055|NCT00298415|Antiviral Agents|antiviral agents|mesh-ancestor
44175056|NCT00298415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175057|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175058|NCT00298415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175059|NCT00298415|Immunologic Factors|immunologic factors|mesh-ancestor
44175060|NCT00298415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175061|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44175063|NCT00298454|Diuretics|diuretics|mesh-ancestor
44175064|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
44175065|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175066|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44175067|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175068|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175069|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
44175070|NCT00298506|Tacrolimus|tacrolimus|mesh-list
44175071|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175072|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
44175073|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175074|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44175075|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175076|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175077|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175078|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175079|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175080|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175081|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175082|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175083|NCT00298545|Calcitriol|calcitriol|mesh-list
44175084|NCT00298545|Calcium|calcium|mesh-list
44175085|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44175086|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016278|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016279|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44016280|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44016281|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016282|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016283|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44016284|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44016285|NCT03506347|Vancomycin|vancomycin|mesh-list
44016286|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44016287|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016288|NCT03506724|Labetalol|labetalol|mesh-list
44016289|NCT03506724|Nifedipine|nifedipine|mesh-list
44016290|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44016291|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016292|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175095|NCT00298571|Bupivacaine|bupivacaine|mesh-list
44175096|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
44175097|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
44175098|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175099|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175100|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
44175101|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175102|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44175103|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44175104|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
44175105|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175106|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175107|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44175108|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44175109|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
44175110|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44175111|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175112|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
44175113|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
44175114|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44175115|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
44175116|NCT00298597|Hematinics|hematinics|mesh-ancestor
44175117|NCT00298636|Adenosine|adenosine|mesh-list
44175118|NCT00298636|Analgesics|analgesics|mesh-ancestor
44175119|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
44175120|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175121|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175122|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44175123|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
44175124|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44175125|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
44175126|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
44175127|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175128|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175129|NCT00298662|Interferons|interferons|mesh-list
44175130|NCT00298662|Interferon-beta|interferon-beta|mesh-list
44175131|NCT00298662|Tacrolimus|tacrolimus|mesh-list
44175132|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
44175133|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175134|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
44175135|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175136|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175137|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
44175138|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175139|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44016293|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44175140|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175141|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175142|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44175143|NCT00298675|Irinotecan|irinotecan|mesh-list
44175144|NCT00298675|Iniparib|iniparib|mesh-list
44175145|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44175146|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44175147|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175148|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175149|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175150|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44175151|NCT00298688|Gefitinib|gefitinib|mesh-list
44175152|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175153|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44175154|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175155|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175156|NCT00298714|Losartan|losartan|mesh-list
44175157|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44175158|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44175159|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44175160|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44175161|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175162|NCT00298779|Bortezomib|bortezomib|mesh-list
44175163|NCT00298779|Omeprazole|omeprazole|mesh-list
43615981|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
44175164|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175165|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44175166|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44175167|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44175168|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175169|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175170|NCT00298857|Valproic Acid|valproic acid|mesh-list
44175171|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
44175172|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175173|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175174|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
44175175|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175176|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175177|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
44175178|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44175179|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175180|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175181|NCT00298870|Isoniazid|isoniazid|mesh-list
44175182|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175183|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175184|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175185|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44175186|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44175187|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
44175188|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175189|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44175190|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
44175191|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175192|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175193|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175194|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175195|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175196|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175197|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175198|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175199|NCT00298909|Niacin|niacin|mesh-list
44175200|NCT00298909|Niacinamide|niacinamide|mesh-list
44175201|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
44175202|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44175203|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
44175204|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175205|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44175206|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
44175207|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
44175208|NCT00298909|Vitamins|vitamins|mesh-ancestor
44175209|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
44175210|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016294|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016295|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
44016296|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
44016297|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44016298|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44016299|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44175211|NCT00298922|Azithromycin|azithromycin|mesh-list
44175212|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175213|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175214|NCT00298974|Acetaminophen|acetaminophen|mesh-list
44175215|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44175216|NCT00298974|Hydrocodone|hydrocodone|mesh-list
44175217|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175218|NCT00298974|Analgesics|analgesics|mesh-ancestor
44175219|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
44175220|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175221|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175222|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
44175223|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44175224|NCT00298974|Narcotics|narcotics|mesh-ancestor
44175225|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175226|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
44175227|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175228|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175229|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175230|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175234|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44175236|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44175237|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
44175238|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175239|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
44175240|NCT00299013|Hormones|hormones|mesh-ancestor
43616056|NCT04873453|Cannabidiol|cannabidiol|mesh-list
44175241|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175242|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175243|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44175244|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175245|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
44175246|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
44175247|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175248|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44175249|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44175250|NCT00299013|Protective Agents|protective agents|mesh-ancestor
44175251|NCT00299026|Paclitaxel|paclitaxel|mesh-list
44175252|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44175253|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175254|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44175255|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44175256|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44175257|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175258|NCT00299039|Acetaminophen|acetaminophen|mesh-list
44175259|NCT00299039|Ibuprofen|ibuprofen|mesh-list
44175260|NCT00299039|Codeine|codeine|mesh-list
44175261|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175262|NCT00299039|Analgesics|analgesics|mesh-ancestor
44175263|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
44175264|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175265|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175266|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
44175267|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175268|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175269|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175270|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44175271|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175272|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175273|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44175274|NCT00299039|Narcotics|narcotics|mesh-ancestor
44175275|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175276|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
44016300|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
44175277|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175278|NCT00299065|Zileuton|zileuton|mesh-list
44175279|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175280|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175281|NCT00299065|Analgesics|analgesics|mesh-ancestor
44175282|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
44175283|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175284|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175285|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175286|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175287|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44175288|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175289|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175290|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44175291|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
44175292|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175293|NCT00299091|Efavirenz|efavirenz|mesh-list
44175294|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44175295|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44175296|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175297|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175298|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
44175299|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175300|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44175306|NCT00299208|Azithromycin|azithromycin|mesh-list
44175307|NCT00299208|Artesunate|artesunate|mesh-list
44175308|NCT00299208|Quinine|quinine|mesh-list
44175309|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175310|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175311|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
44175312|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44175313|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43616133|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
44175314|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175315|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
44175316|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
44175317|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44175318|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
44175319|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44175320|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175321|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44175322|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175323|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175324|NCT00299208|Analgesics|analgesics|mesh-ancestor
44175325|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
44175326|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44175327|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44175328|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175329|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175330|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175331|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44175332|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175333|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175334|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
44175335|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
44175336|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
44175337|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44175338|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44175339|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175340|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44175341|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175342|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175343|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44175344|NCT00299247|Renal Agents|renal agents|mesh-ancestor
44175345|NCT00299286|Lapatinib|lapatinib|mesh-list
44175346|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175347|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44175348|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175349|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175351|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175352|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175353|NCT00299364|Tibolone|tibolone|mesh-list
44016301|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175355|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
44175356|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175357|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175358|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44175359|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44175360|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175361|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44175362|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
44175363|NCT00299364|Hormones|hormones|mesh-ancestor
44175364|NCT00299377|Abciximab|abciximab|mesh-list
44175365|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
44175366|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44175367|NCT00299390|Sagopilone|sagopilone|mesh-list
44175368|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175369|NCT00299455|Amoxicillin|amoxicillin|mesh-list
44175377|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175380|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175381|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175382|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44175383|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175384|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175385|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44175386|NCT00299559|Camphor|camphor|mesh-list
44175387|NCT00299559|Menthol|menthol|mesh-list
44175388|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
44175389|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44175390|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44175391|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175392|NCT00299572|Alendronate|alendronate|mesh-list
44175393|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44175394|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175395|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44175396|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175397|NCT00299611|Levetiracetam|levetiracetam|mesh-list
44175398|NCT00299611|Sertraline|sertraline|mesh-list
44175399|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
44175400|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175401|NCT00299611|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44175402|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175403|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175404|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175405|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175406|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
44175407|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175408|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
44175409|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
44175410|NCT00299650|Cisatracurium|cisatracurium|mesh-list
44175411|NCT00299650|Atracurium|atracurium|mesh-list
44175412|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44175413|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44175414|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175415|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175416|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44175417|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44175418|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44175419|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
44175420|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175421|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175422|NCT00299676|Galantamine|galantamine|mesh-list
44175423|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44175424|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616280|NCT04356638|Midazolam|midazolam|mesh-list
44175425|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175426|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
44175427|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175428|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175429|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44175430|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
44175431|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175432|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
44175433|NCT00299754|Misoprostol|misoprostol|mesh-list
44175434|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44016302|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44016303|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
44016304|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
44016305|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016306|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44016307|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44148122|NCT00203359|Etanercept|etanercept|mesh-list
44148123|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44148124|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44148125|NCT00203359|Analgesics|analgesics|mesh-ancestor
44148126|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
44148127|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148128|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148129|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148130|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148131|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148132|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148133|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
44148134|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
44148135|NCT00203372|Bevacizumab|bevacizumab|mesh-list
44175435|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
44175442|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44175443|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
44175444|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175445|NCT00299845|Lansoprazole|lansoprazole|mesh-list
44175446|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
44175447|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44175448|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44175449|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44175450|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175451|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175452|NCT00299858|Theophylline|theophylline|mesh-list
44175453|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44175454|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
44175455|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175456|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175457|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44175458|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175459|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44175460|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175461|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175462|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
44175463|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44175464|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44175465|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
44175466|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175467|NCT00299871|Lixisenatide|lixisenatide|mesh-list
44175468|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44175469|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175470|NCT00299884|Atorvastatin|atorvastatin|mesh-list
44175471|NCT00299884|Ezetimibe|ezetimibe|mesh-list
44175472|NCT00299884|Fenofibrate|fenofibrate|mesh-list
44175473|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44175474|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44175475|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
44175476|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148136|NCT00203372|Docetaxel|docetaxel|mesh-list
44148137|NCT00203372|Doxorubicin|doxorubicin|mesh-list
44148138|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148139|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
44148140|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148141|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148142|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148143|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
44148144|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148145|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148146|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44148147|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44148148|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44148149|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44148150|NCT00203372|Growth Substances|growth substances|mesh-ancestor
44148151|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
44148152|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44148153|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44148154|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44148155|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148156|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44148157|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44148158|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148159|NCT00203385|Valproic Acid|valproic acid|mesh-list
44148170|NCT00203450|Zonisamide|zonisamide|mesh-list
44175478|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44175479|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175480|NCT00299910|Montelukast|montelukast|mesh-list
44175481|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44175482|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175483|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44175484|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
44175485|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175486|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175487|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44175488|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44175489|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175490|NCT00299923|Ribavirin|ribavirin|mesh-list
44175491|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44175492|NCT00299923|Amantadine|amantadine|mesh-list
44175493|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
44175494|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175495|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
44175496|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175497|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44175498|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44175499|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
44175501|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175502|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175503|NCT00299923|Analgesics|analgesics|mesh-ancestor
44175504|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
44175508|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
44175509|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175510|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
44175511|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175512|NCT00299962|Interferons|interferons|mesh-list
44175513|NCT00299962|Interferon-beta|interferon-beta|mesh-list
44175514|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175515|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
44175516|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175517|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
44175518|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175519|NCT00300014|Triamcinolone|triamcinolone|mesh-list
44175520|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175521|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
44175522|NCT00300014|Hormones|hormones|mesh-ancestor
44175523|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175524|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175525|NCT00300040|Chrysarobin|chrysarobin|mesh-list
44175526|NCT00300040|HBOC 201|hboc 201|mesh-list
44175527|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175528|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175529|NCT00300040|Analgesics|analgesics|mesh-ancestor
44175530|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
44175531|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175532|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175533|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175534|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175535|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
44175536|NCT00300079|Brinzolamide|brinzolamide|mesh-list
44175537|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44175538|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175539|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175540|NCT00300118|Budesonide|budesonide|mesh-list
44175541|NCT00300118|Mesalamine|mesalamine|mesh-list
44175542|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175543|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44175544|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
44175545|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175546|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175547|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44175548|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175549|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
44175550|NCT00300118|Hormones|hormones|mesh-ancestor
44175551|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175552|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175553|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175554|NCT00300118|Analgesics|analgesics|mesh-ancestor
44175555|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
44175557|NCT00300131|Everolimus|everolimus|mesh-list
44175558|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175559|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175560|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
44175561|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175562|NCT00300196|Ancrod|ancrod|mesh-list
44175563|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
44175564|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44175565|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44175566|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175567|NCT00300222|Capsaicin|capsaicin|mesh-list
44175568|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
44175569|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
44175570|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
44175571|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175572|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175573|NCT00300287|Vildagliptin|vildagliptin|mesh-list
44175574|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44175575|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175576|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44175577|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
44175578|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175586|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
44175587|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175588|NCT00300313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44175589|NCT00300313|Antidepressive Agents|antidepressive agents|mesh-ancestor
44175590|NCT00300313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175591|NCT00300339|Clopidogrel|clopidogrel|mesh-list
44175592|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44175593|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44175594|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44175595|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44175596|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
44175597|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175598|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175599|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175600|NCT00300352|Folic Acid|folic acid|mesh-list
44175601|NCT00300352|Hematinics|hematinics|mesh-ancestor
44175602|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
44175603|NCT00300352|Vitamins|vitamins|mesh-ancestor
44175604|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
44175605|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175606|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44175607|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44175608|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175609|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175610|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175611|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175612|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175613|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44175614|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175615|NCT00300404|Leucovorin|leucovorin|mesh-list
44175616|NCT00300404|Folic Acid|folic acid|mesh-list
44175617|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
44175618|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
44175619|NCT00300404|Antidotes|antidotes|mesh-ancestor
44175620|NCT00300404|Protective Agents|protective agents|mesh-ancestor
44175621|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175622|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
44175623|NCT00300404|Vitamins|vitamins|mesh-ancestor
44175624|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
44175625|NCT00300404|Hematinics|hematinics|mesh-ancestor
44175626|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
44175627|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44175628|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44175629|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175630|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44175631|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175632|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175633|NCT00300443|Bimatoprost|bimatoprost|mesh-list
44175634|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44175635|NCT00300508|Anastrozole|anastrozole|mesh-list
44175636|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44175637|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016317|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44016319|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016320|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016321|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
44016322|NCT03510481|Lumefantrine|lumefantrine|mesh-list
44016323|NCT03510481|Artemether|artemether|mesh-list
44016324|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
44016325|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44016326|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44016327|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016328|NCT03511521|Insulin|insulin|mesh-list
44016329|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44016330|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
44175638|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44175639|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44175640|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175641|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175642|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44175643|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
44175654|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
44175655|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175656|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44175657|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44175658|NCT00300586|Gemcitabine|gemcitabine|mesh-list
44175659|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44175660|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44175661|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
44175662|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175663|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175664|NCT00300586|Antiviral Agents|antiviral agents|mesh-ancestor
44175665|NCT00300586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175666|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175667|NCT00300586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175668|NCT00300586|Immunologic Factors|immunologic factors|mesh-ancestor
44175669|NCT00300586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175670|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44175671|NCT00300664|Hormones|hormones|mesh-list
44175672|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175673|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175674|NCT00300716|Memantine|memantine|mesh-list
44175675|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44175676|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44175677|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
44175678|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175679|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175680|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175681|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44175682|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44175683|NCT00300729|Celecoxib|celecoxib|mesh-list
44175684|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175685|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175686|NCT00300729|Analgesics|analgesics|mesh-ancestor
44175687|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
44175688|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838062|NCT04872608|Onapristone|onapristone|mesh-list
44175689|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175690|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175691|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175692|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44175693|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44175694|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702558|NCT02716129|Analgesics|analgesics|mesh-ancestor
44016332|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
44016333|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
44016334|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44016335|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016337|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
44016338|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
44016339|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
44016340|NCT03513757|Propofol|propofol|mesh-list
44016341|NCT03513757|Sevoflurane|sevoflurane|mesh-list
44016342|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016343|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
44016344|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175695|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175696|NCT00300794|Ketamine|ketamine|mesh-list
44175697|NCT00300794|Analgesics|analgesics|mesh-ancestor
44175698|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
44175699|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175700|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175701|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44175702|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44175703|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
44175704|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
44175705|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175714|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44175716|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
44175717|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175718|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44175719|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44175720|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175721|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175722|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
44175723|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
44175724|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175725|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175726|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44175727|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44175728|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
44175729|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44175730|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44175731|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44175732|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44175733|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
44175734|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44175735|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175736|NCT00300924|Acetaminophen|acetaminophen|mesh-list
44175737|NCT00300924|Rizatriptan|rizatriptan|mesh-list
44175738|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175739|NCT00300924|Analgesics|analgesics|mesh-ancestor
44175740|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
44175741|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175742|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175743|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
44175744|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44175745|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
44175746|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175747|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175748|NCT00300937|Ubiquinone|ubiquinone|mesh-list
44175749|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
44175750|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
44175751|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016351|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016352|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016353|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44016354|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44016355|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
44016356|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016357|NCT03513757|Analgesics|analgesics|mesh-ancestor
44175752|NCT00300937|Vitamins|vitamins|mesh-ancestor
44175753|NCT00300950|Gemcitabine|gemcitabine|mesh-list
44175754|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44175755|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
44175756|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175757|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175758|NCT00300950|Antiviral Agents|antiviral agents|mesh-ancestor
44175759|NCT00300950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175760|NCT00300950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175761|NCT00300950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44175762|NCT00300950|Immunologic Factors|immunologic factors|mesh-ancestor
44175763|NCT00300950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175764|NCT00301002|Alefacept|alefacept|mesh-list
44175765|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
44175766|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
44175767|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616876|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43617024|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617179|NCT03141632|Dulaglutide|dulaglutide|mesh-list
43619504|NCT03122041|Incretins|incretins|mesh-ancestor
43619717|NCT03120728|Hormones|hormones|mesh-ancestor
43620238|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
43620242|NCT05183126|Paclitaxel|paclitaxel|mesh-list
43620243|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43620244|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620316|NCT04791475|Hormones|hormones|mesh-ancestor
43620388|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43620536|NCT04098237|Pancrelipase|pancrelipase|mesh-list
43620765|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
43621064|NCT03119194|Opicapone|opicapone|mesh-list
43621803|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43622022|NCT03111420|Clopidogrel|clopidogrel|mesh-list
43622344|NCT03108833|Saruplase|saruplase|mesh-list
43622696|NCT03106610|Nivolumab|nivolumab|mesh-list
43622843|NCT03105765|Analgesics|analgesics|mesh-ancestor
43622992|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
43623068|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43623069|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43623070|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43623071|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623072|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623073|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623074|NCT05374499|Epinephrine|epinephrine|mesh-list
43623075|NCT05374499|Bupivacaine|bupivacaine|mesh-list
43623446|NCT04495868|Lidocaine|lidocaine|mesh-list
43623743|NCT03965728|Methotrexate|methotrexate|mesh-list
43623898|NCT02724410|Amoxicillin|amoxicillin|mesh-list
43624045|NCT01735461|Antacids|antacids|mesh-ancestor
43624120|NCT05403723|Cisplatin|cisplatin|mesh-list
43624423|NCT04670796|Trastuzumab|trastuzumab|mesh-list
43624572|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
43624647|NCT03472573|Hormones|hormones|mesh-ancestor
43624796|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
43624870|NCT00495508|Artemether|artemether|mesh-list
43624954|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
43625104|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
43625175|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
43625563|NCT03100604|Sevoflurane|sevoflurane|mesh-list
43625933|NCT03097211|Levodopa|levodopa|mesh-list
43626385|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
43626749|NCT03086174|Antibodies|antibodies|mesh-list
43627344|NCT03074448|Cathartics|cathartics|mesh-ancestor
43627651|NCT03072290|Hormones|hormones|mesh-ancestor
43630935|NCT03047538|Amlodipine|amlodipine|mesh-list
43631065|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
43631139|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
43631298|NCT03044626|Nivolumab|nivolumab|mesh-list
43631370|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
43631441|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
43631664|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43631741|NCT03041935|Ropivacaine|ropivacaine|mesh-list
43631750|NCT03041935|Hormones|hormones|mesh-ancestor
43632121|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
43632196|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632269|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43632419|NCT03036995|Analgesics|analgesics|mesh-ancestor
43632875|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
43633322|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
43633552|NCT05699876|Gabapentin|gabapentin|mesh-list
43633673|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633674|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633675|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43633676|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43633677|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43633678|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
43633680|NCT05699148|Elexacaftor|elexacaftor|mesh-list
43633681|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43633682|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43633684|NCT05699135|Avelumab|avelumab|mesh-list
43633748|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
43633749|NCT05698407|Ropivacaine|ropivacaine|mesh-list
43633750|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43633751|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43633752|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633753|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43633754|NCT05698407|Analgesics|analgesics|mesh-ancestor
43633755|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
43633756|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633757|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43633758|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43633759|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43633760|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
43633761|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43633762|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633763|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
43633764|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
43633765|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43633823|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43633824|NCT05697783|Analgesics|analgesics|mesh-ancestor
43633825|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
43633826|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016360|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44016361|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016362|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016363|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44016364|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44016365|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44016366|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43633827|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43633907|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
43633908|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43849477|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43849478|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849479|NCT03926130|Analgesics|analgesics|mesh-ancestor
43849480|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
43849481|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633961|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
43633962|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
43633963|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43633964|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43633965|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634411|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43634412|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
43634413|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634414|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43634415|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43634416|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
43634417|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634418|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634481|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43634482|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634483|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43634484|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43634485|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43634486|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634487|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
43634554|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634555|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634556|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
43634557|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
43634558|NCT05603754|Lorecivivint|lorecivivint|mesh-list
43634559|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43634561|NCT05602038|Bupivacaine|bupivacaine|mesh-list
43634562|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
43634708|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
43634710|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43634711|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43634712|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634713|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634714|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
43634715|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
43634716|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43634717|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
43634862|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634863|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634864|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
43634865|NCT05474183|Ketamine|ketamine|mesh-list
43634866|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43634867|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016368|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
44016369|NCT03514277|Bupivacaine|bupivacaine|mesh-list
44016370|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016371|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
44016372|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016373|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016374|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
44016375|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016376|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
44016377|NCT03519243|Hematinics|hematinics|mesh-ancestor
44016378|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
44016379|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
44016380|NCT03520348|Vitamins|vitamins|mesh-ancestor
44016381|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
44016382|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016383|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
44016384|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44016385|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
44016386|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016387|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
44016389|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44016390|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016391|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016392|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44016393|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
44016394|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
44016395|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634868|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634869|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43634870|NCT05474183|Analgesics|analgesics|mesh-ancestor
43634946|NCT05455320|Hormones|hormones|mesh-ancestor
43635013|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635014|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635015|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43635016|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43635017|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
43635018|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
43635019|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635088|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635089|NCT05389995|Diuretics|diuretics|mesh-ancestor
43635473|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
43635474|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
43635475|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43635482|NCT05286814|Gemcitabine|gemcitabine|mesh-list
43635483|NCT05286814|Dexamethasone|dexamethasone|mesh-list
43635484|NCT05286814|Fluorouracil|fluorouracil|mesh-list
43635485|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
43635486|NCT05286814|Irinotecan|irinotecan|mesh-list
44016396|NCT03521505|Analgesics|analgesics|mesh-ancestor
44016397|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
43635487|NCT05286814|Floxuridine|floxuridine|mesh-list
43635488|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43635489|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
43635490|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
43635491|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635492|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635493|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43635494|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
43635495|NCT05286814|Hormones|hormones|mesh-ancestor
43635496|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43635561|NCT05282121|Empagliflozin|empagliflozin|mesh-list
43635562|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43635563|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635564|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635565|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635778|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43635779|NCT05155293|Growth Substances|growth substances|mesh-ancestor
43635780|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635781|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
43635782|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635783|NCT05155033|Aldesleukin|aldesleukin|mesh-list
43635784|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
43635786|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849491|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635858|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43635859|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
43635867|NCT05140525|Macitentan|macitentan|mesh-list
43636151|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636152|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43636153|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
43636154|NCT05031078|Lidocaine|lidocaine|mesh-list
43636380|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636381|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
43636382|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43636383|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636384|NCT04938830|Palivizumab|palivizumab|mesh-list
43636540|NCT04887831|Cisplatin|cisplatin|mesh-list
43636541|NCT04887831|Carboplatin|carboplatin|mesh-list
43636542|NCT04887831|Avelumab|avelumab|mesh-list
43636543|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636544|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43636545|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
43636546|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636547|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
43636548|NCT04887831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43636549|NCT04887831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636756|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636889|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
43636890|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43636891|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
43636892|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43636893|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
43636894|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636895|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636896|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
43636897|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
43636898|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43636899|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
43636900|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43636901|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
43636902|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43636903|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636904|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
44016399|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44016400|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44016401|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44016402|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016403|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016404|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016406|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
44016407|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
44016408|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44016409|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016410|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43636905|NCT04742283|Timolol|timolol|mesh-list
43636906|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43636907|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43636908|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43636909|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43636912|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636913|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636915|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43636989|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43636990|NCT04714112|BB 1101|bb 1101|mesh-list
43636991|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43636992|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
43636998|NCT04714112|Hormones|hormones|mesh-ancestor
43637064|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637140|NCT04677543|Amikacin|amikacin|mesh-list
43637141|NCT04677543|Ethambutol|ethambutol|mesh-list
43637142|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43637143|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43637144|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
43637153|NCT04667663|Dexamethasone|dexamethasone|mesh-list
43637154|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
43637155|NCT04667663|Daratumumab|daratumumab|mesh-list
43637219|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
43637220|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637221|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637222|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637223|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637224|NCT04644068|Paclitaxel|paclitaxel|mesh-list
43637225|NCT04644068|Carboplatin|carboplatin|mesh-list
43637226|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637227|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637228|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637229|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637230|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637231|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637232|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
43637233|NCT04639245|Fludarabine|fludarabine|mesh-list
43637234|NCT04639245|Atezolizumab|atezolizumab|mesh-list
43637235|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43637236|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43637237|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43637238|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
43637239|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43637240|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43637241|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43637242|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
43637243|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637305|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016487|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
44016488|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016489|NCT03537404|Ritonavir|ritonavir|mesh-list
44016490|NCT03537404|Tenofovir|tenofovir|mesh-list
44016491|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
44016492|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44016493|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44016494|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
44016495|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016496|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016497|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44016498|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44016499|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
44016500|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016501|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44016502|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44016503|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44016504|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44016505|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44016506|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44016507|NCT03538808|Varenicline|varenicline|mesh-list
44016508|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43637306|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637307|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43637308|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637309|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637310|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
43637311|NCT04626479|Lenvatinib|lenvatinib|mesh-list
43637312|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637372|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
43637447|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
43637448|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637449|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637450|NCT04585958|Trastuzumab|trastuzumab|mesh-list
43637451|NCT04585958|Olaparib|olaparib|mesh-list
43637452|NCT04585958|Camptothecin|camptothecin|mesh-list
43637453|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43637454|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
43637455|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637456|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637457|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637458|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637459|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637460|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43637461|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637597|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
43637672|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637678|NCT04509791|Antibodies|antibodies|mesh-list
43637904|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
43637905|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
43637906|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637907|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43637908|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43637909|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43637910|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637911|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43637973|NCT04352101|Bupropion|bupropion|mesh-list
43637974|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43637975|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43637976|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43637978|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43638048|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43638049|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
43638050|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
43638051|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
43638052|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
43638053|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638054|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638055|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638056|NCT04311723|Anesthetics|anesthetics|mesh-list
43638057|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638058|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638059|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
43638060|NCT04305054|Lenvatinib|lenvatinib|mesh-list
43638061|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638062|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638063|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43638064|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638065|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638067|NCT04305041|Lenvatinib|lenvatinib|mesh-list
43638068|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638069|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638070|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43638071|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638072|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638111|NCT04300244|Nivolumab|nivolumab|mesh-list
43638112|NCT04300244|Ipilimumab|ipilimumab|mesh-list
43638113|NCT04300244|Sargramostim|sargramostim|mesh-list
43638114|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638115|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638116|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43638117|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016542|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016543|NCT03545893|Ibuprofen|ibuprofen|mesh-list
44016544|NCT03545893|Oxycodone|oxycodone|mesh-list
44016545|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016546|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016547|NCT03545893|Analgesics|analgesics|mesh-ancestor
44016548|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
44016549|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016550|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016551|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016552|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016553|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016554|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016555|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016556|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43638118|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
43638119|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638120|NCT04294784|Paclitaxel|paclitaxel|mesh-list
43638121|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43638124|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638125|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638126|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
43638127|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
43638128|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638129|NCT04294628|Trastuzumab|trastuzumab|mesh-list
43638130|NCT04294628|Camptothecin|camptothecin|mesh-list
43638131|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
43638132|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638133|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638134|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43638143|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
43638144|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638148|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
43638276|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638277|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43638278|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43638279|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43638433|NCT04141696|Ketamine|ketamine|mesh-list
43638434|NCT04141696|Analgesics|analgesics|mesh-ancestor
43638435|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
43638436|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638437|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638438|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43638518|NCT04099797|Cyclophosphamide|cyclophosphamide|mesh-list
43638519|NCT04099797|Fludarabine|fludarabine|mesh-list
43638520|NCT04099797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43638521|NCT04099797|Immunologic Factors|immunologic factors|mesh-ancestor
43638522|NCT04099797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638523|NCT04099797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43638524|NCT04099797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43638525|NCT04099797|Alkylating Agents|alkylating agents|mesh-ancestor
43638526|NCT04099797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638527|NCT04099797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638528|NCT04099797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43638529|NCT04097561|Belimumab|belimumab|mesh-list
43638818|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638892|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
44016557|NCT03545893|Narcotics|narcotics|mesh-ancestor
44016558|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016559|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44016560|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44016561|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016562|NCT03553940|Vaccines|vaccines|mesh-list
44016563|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
44016564|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016565|NCT03556761|Furosemide|furosemide|mesh-list
44016566|NCT03556761|Diuretics|diuretics|mesh-ancestor
43638893|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638894|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638895|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43638896|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
43638897|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
43638898|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43638907|NCT03725007|Upadacitinib|upadacitinib|mesh-list
43638908|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43639193|NCT03478865|Vitamin A|vitamin a|mesh-list
43639274|NCT03428958|Growth Substances|growth substances|mesh-ancestor
43639345|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43639346|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639347|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639348|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43639349|NCT03386500|Manganese|manganese|mesh-list
43639350|NCT03386500|Trace Elements|trace elements|mesh-ancestor
43639351|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
43639352|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639353|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43639422|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43639658|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
43639731|NCT03064126|Paclitaxel|paclitaxel|mesh-list
43639879|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43639880|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43639881|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43639955|NCT02923128|Sufentanil|sufentanil|mesh-list
43639956|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
43639957|NCT02923128|Dsuvia|dsuvia|mesh-list
43639958|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43640033|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640034|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43640035|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43640036|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43640037|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43640038|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43640039|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
43640040|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43640041|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640057|NCT02877303|Cytarabine|cytarabine|mesh-list
43640058|NCT02877303|Dexamethasone|dexamethasone|mesh-list
43640060|NCT02877303|Prednisone|prednisone|mesh-list
43640338|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640412|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43640413|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43640414|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43640415|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640490|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
43640491|NCT02339740|Protective Agents|protective agents|mesh-ancestor
43640492|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43640493|NCT02336815|Dexamethasone|dexamethasone|mesh-list
43640494|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43640495|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
43640496|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
43640497|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43640498|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43640499|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640500|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
43640501|NCT02336815|Hormones|hormones|mesh-ancestor
43640737|NCT02031419|Rituximab|rituximab|mesh-list
43640801|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43640802|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
43640803|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640804|NCT01937117|Trastuzumab|trastuzumab|mesh-list
43640805|NCT01937117|Pertuzumab|pertuzumab|mesh-list
43640806|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43640807|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43640808|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
43640809|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43640810|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43640811|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
43640812|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43640813|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43640814|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43640815|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641252|NCT01054196|Growth Substances|growth substances|mesh-ancestor
43641253|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
43641254|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641255|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43641256|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
43641257|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641258|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641398|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641399|NCT00458536|Molgramostim|molgramostim|mesh-list
43641400|NCT00458536|Sargramostim|sargramostim|mesh-list
43641401|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
43641402|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641403|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849698|NCT03898037|Metformin|metformin|mesh-list
44016570|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016571|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016573|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44016574|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
44016575|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
44016576|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016577|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016578|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016579|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016580|NCT03557333|Analgesics|analgesics|mesh-ancestor
44016581|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
44016582|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016583|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
44016584|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44016585|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148178|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
44148179|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148180|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157793|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
44157794|NCT00235248|Aspirin|aspirin|mesh-list
44157795|NCT00235248|Warfarin|warfarin|mesh-list
44157796|NCT00235248|Clopidogrel|clopidogrel|mesh-list
44157799|NCT00235248|Analgesics|analgesics|mesh-ancestor
44016652|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016653|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44016654|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
44016655|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016656|NCT03574818|Antiviral Agents|antiviral agents|mesh-ancestor
44016657|NCT03574818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016658|NCT03574818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016659|NCT03574818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016660|NCT03574818|Immunologic Factors|immunologic factors|mesh-ancestor
44016661|NCT03574818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016662|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016663|NCT03577171|Entecavir|entecavir|mesh-list
44016664|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
44016665|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016666|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
44016667|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44016668|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016669|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539017|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
43539018|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
43539019|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539020|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43539021|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43539022|NCT03952637|Protective Agents|protective agents|mesh-ancestor
43539023|NCT03944772|Cisplatin|cisplatin|mesh-list
43539024|NCT03944772|Carboplatin|carboplatin|mesh-list
43539025|NCT03944772|Etoposide|etoposide|mesh-list
43539098|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
43539163|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
43539164|NCT03653832|Propofol|propofol|mesh-list
43539165|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43539166|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539167|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016684|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44016685|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
44016686|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016687|NCT03581084|Protective Agents|protective agents|mesh-ancestor
44016688|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016689|NCT03581084|Antidotes|antidotes|mesh-ancestor
44016690|NCT03582553|Naringenin|naringenin|mesh-list
43545047|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
43546111|NCT03665610|Ozanimod|ozanimod|mesh-list
43546333|NCT03662763|Guanfacine|guanfacine|mesh-list
43546401|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546558|NCT03660917|Riluzole|riluzole|mesh-list
43546619|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
43546692|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43546768|NCT03658733|Renal Agents|renal agents|mesh-ancestor
43547071|NCT03656627|Nivolumab|nivolumab|mesh-list
43547215|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43547364|NCT03653052|Durvalumab|durvalumab|mesh-list
43547514|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43547667|NCT03650257|Temozolomide|temozolomide|mesh-list
43547759|NCT03649009|Thiamine|thiamine|mesh-list
43548192|NCT03644641|Propofol|propofol|mesh-list
43552601|NCT03602898|Cyclosporins|cyclosporins|mesh-list
43553206|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
43553287|NCT03587077|Isosorbide|isosorbide|mesh-list
43553356|NCT03586154|Analgesics|analgesics|mesh-ancestor
43553665|NCT03579004|Paclitaxel|paclitaxel|mesh-list
43553967|NCT03576456|Alprazolam|alprazolam|mesh-list
43554042|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
43554110|NCT03575078|Olaparib|olaparib|mesh-list
43554635|NCT03570541|Analgesics|analgesics|mesh-ancestor
43554867|NCT03567629|Vitamins|vitamins|mesh-ancestor
43555011|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43555237|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43555310|NCT03563365|Adapalene|adapalene|mesh-list
43555468|NCT03562585|Antibodies|antibodies|mesh-list
43556164|NCT03555071|Vaccines|vaccines|mesh-list
43556221|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43556299|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
43556383|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
43556447|NCT03552770|Growth Substances|growth substances|mesh-ancestor
43556529|NCT03552016|Riboflavin|riboflavin|mesh-list
43558260|NCT03535090|Hormones|hormones|mesh-ancestor
43558627|NCT05262465|Azacitidine|azacitidine|mesh-list
43558771|NCT05092841|Naltrexone|naltrexone|mesh-list
43559010|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
43559073|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43559233|NCT03957590|Paclitaxel|paclitaxel|mesh-list
43559897|NCT05633277|Polidocanol|polidocanol|mesh-list
43559975|NCT05436535|Hormones|hormones|mesh-ancestor
43560051|NCT05309928|Probenecid|probenecid|mesh-list
43560204|NCT05113940|Midazolam|midazolam|mesh-list
43560728|NCT03735966|Carboplatin|carboplatin|mesh-list
43560883|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43567427|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
43567958|NCT00684918|Obatoclax|obatoclax|mesh-list
43568359|NCT00649025|Xhance|xhance|mesh-list
43570714|NCT00388960|Cisplatin|cisplatin|mesh-list
44016771|NCT03593902|Hormones|hormones|mesh-ancestor
44016772|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016773|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44016774|NCT03593902|Protective Agents|protective agents|mesh-ancestor
44016775|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44016776|NCT03594045|Apixaban|apixaban|mesh-list
44016777|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44016778|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
44016779|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44016780|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
44016781|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016782|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016783|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
44016784|NCT03595449|Lidocaine|lidocaine|mesh-list
44016785|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016786|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
44016787|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016788|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016789|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
44016790|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016791|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44016792|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44016793|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44016794|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016795|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016796|NCT03595579|Bupropion|bupropion|mesh-list
44016797|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44016798|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
44016799|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44016800|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44016801|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44016802|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016803|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016807|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44016808|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44016809|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016810|NCT03596723|Prednisolone|prednisolone|mesh-list
44016811|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44016812|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
44016813|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44016814|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
44016815|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44016816|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
44016817|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016818|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
44016819|NCT03596723|Hormones|hormones|mesh-ancestor
44016820|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016821|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016822|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44016823|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016824|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
44016825|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
44016826|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016827|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016828|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44016829|NCT03596723|Protective Agents|protective agents|mesh-ancestor
44016830|NCT03597009|Nivolumab|nivolumab|mesh-list
44016831|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44016832|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44016833|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016834|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43582712|NCT03446625|Protective Agents|protective agents|mesh-ancestor
44016835|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016836|NCT03605914|Acetaminophen|acetaminophen|mesh-list
44016837|NCT03605914|Diclofenac|diclofenac|mesh-list
44016838|NCT03605914|Hydrocodone|hydrocodone|mesh-list
44016840|NCT03605914|Analgesics|analgesics|mesh-ancestor
44016850|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016851|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44016853|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016854|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
43570778|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43570851|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571153|NCT00327743|Capecitabine|capecitabine|mesh-list
43571753|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
43572046|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
43572578|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
43572890|NCT03531437|Progestins|progestins|mesh-ancestor
43573568|NCT03526224|Analgesics|analgesics|mesh-ancestor
43573640|NCT03525652|Vaccines|vaccines|mesh-list
43574022|NCT03521063|Budesonide|budesonide|mesh-list
43574095|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
43574540|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
43574909|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
43849070|NCT03967054|Ivermectin|ivermectin|mesh-list
43575433|NCT03507426|Ketamine|ketamine|mesh-list
43575656|NCT03506061|Ivacaftor|ivacaftor|mesh-list
43575736|NCT03505255|Neostigmine|neostigmine|mesh-list
43575806|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43575878|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43576194|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
43576266|NCT03500133|Cytarabine|cytarabine|mesh-list
43576333|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
43576479|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43577154|NCT03492138|Dexamethasone|dexamethasone|mesh-list
43577682|NCT03487406|Aspirin|aspirin|mesh-list
43577831|NCT03486353|Azacitidine|azacitidine|mesh-list
43577906|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43578288|NCT03481920|Avelumab|avelumab|mesh-list
43578431|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
43578737|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43578810|NCT03477136|Vitamin D|vitamin d|mesh-list
43579046|NCT03474939|Midazolam|midazolam|mesh-list
43579795|NCT05390736|Vitamin D|vitamin d|mesh-list
43579933|NCT05272683|Itraconazole|itraconazole|mesh-list
43580231|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580609|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
43580987|NCT03464968|Antidotes|antidotes|mesh-ancestor
43581063|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43581064|NCT03464058|Rabeprazole|rabeprazole|mesh-list
43581065|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43581066|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43581067|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43581070|NCT03463967|Lycopene|lycopene|mesh-list
43581593|NCT03452475|Lumefantrine|lumefantrine|mesh-list
43581893|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581967|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
43582426|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
43582575|NCT03448094|Resveratrol|resveratrol|mesh-list
43582651|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43582726|NCT03446547|Durvalumab|durvalumab|mesh-list
43583260|NCT03439787|Epinephrine|epinephrine|mesh-list
43583336|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
43583414|NCT03437707|Ibuprofen|ibuprofen|mesh-list
43583568|NCT03436303|Hormones|hormones|mesh-ancestor
43583788|NCT03434197|Analgesics|analgesics|mesh-ancestor
43584087|NCT03432273|Nicotine|nicotine|mesh-list
43584157|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43584459|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584846|NCT03425656|Docetaxel|docetaxel|mesh-list
43585224|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43585277|NCT03422510|CXA-10|cxa-10|mesh-list
43585454|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43585455|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585456|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43585457|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
43585458|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
43585459|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
43585460|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43585461|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43585462|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
43585463|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43585464|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43585751|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43585827|NCT03417427|Cytarabine|cytarabine|mesh-list
43589666|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
43589977|NCT03375463|Hormones|hormones|mesh-ancestor
43591018|NCT03365869|Sirolimus|sirolimus|mesh-list
43591195|NCT03364088|Oxycodone|oxycodone|mesh-list
43591245|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591474|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43591699|NCT03359837|Repaglinide|repaglinide|mesh-list
43591932|NCT03357822|Interferons|interferons|mesh-list
43592074|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
43592377|NCT03353857|Rifampin|rifampin|mesh-list
43592820|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
43592894|NCT03348735|Lidocaine|lidocaine|mesh-list
43593562|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43593715|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43593797|NCT03340701|Hormones|hormones|mesh-ancestor
43593862|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
43594009|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43594085|NCT03337282|Anesthetics|anesthetics|mesh-list
43594386|NCT03334981|Analgesics|analgesics|mesh-ancestor
43594464|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
43594543|NCT03332953|Nicotine|nicotine|mesh-list
43594693|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
43594770|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43595446|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43595603|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
43595677|NCT03323528|Benzocaine|benzocaine|mesh-list
43595752|NCT03322800|Ziresovir|ziresovir|mesh-list
43596120|NCT03319784|Analgesics|analgesics|mesh-ancestor
43596270|NCT03318744|Aspirin|aspirin|mesh-list
43596494|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
43596709|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
43849129|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43597157|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
43597234|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43597541|NCT03307902|Imiquimod|imiquimod|mesh-list
43597840|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
43669056|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
43669057|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
43669058|NCT02908152|Curcumin|curcumin|mesh-list
43669059|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669060|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669062|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
43669063|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669064|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669065|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669066|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669067|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669068|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834335|NCT05148000|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43669078|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669079|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669080|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669081|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669082|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
43669083|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669084|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
43669085|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826773|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43826774|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43826775|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826783|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826784|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43826785|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43826786|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
43826789|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826790|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826792|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826793|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826794|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826795|NCT05494385|Gabapentin|gabapentin|mesh-list
43826796|NCT05494385|Analgesics|analgesics|mesh-ancestor
43826797|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
43826798|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826799|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826800|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
43826801|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43826802|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43826803|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826804|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43826805|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43826806|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43826807|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826808|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826809|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
43826810|NCT05494307|Terbutaline|terbutaline|mesh-list
43826811|NCT05494307|Danazol|danazol|mesh-list
43826812|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43826813|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
43826814|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826815|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826816|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43826817|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
43826818|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
43669086|NCT02907749|Carvedilol|carvedilol|mesh-list
43669097|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669098|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669099|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669100|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43669101|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
43669102|NCT02907749|Protective Agents|protective agents|mesh-ancestor
43669103|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43669104|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43669105|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669106|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
43669107|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43669108|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43669110|NCT02907593|Calfactant|calfactant|mesh-list
43669111|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669112|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43669113|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
43669114|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669115|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669116|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43669117|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
43669118|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
43669119|NCT02907593|Hormones|hormones|mesh-ancestor
43669120|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669143|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
43669145|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669146|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669147|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669161|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43669162|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43669163|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669164|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669165|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43669166|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
43669167|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669168|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669169|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43669170|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43669171|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43669172|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43669173|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669174|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016857|NCT03608488|Vitamins|vitamins|mesh-ancestor
44016858|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
44016859|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669175|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669176|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669177|NCT02906722|Colistin|colistin|mesh-list
43669178|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669179|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669180|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
43669181|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669182|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669183|NCT02906995|Nicotine|nicotine|mesh-list
43669184|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43669185|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
43669186|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669187|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669189|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43669190|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
43669191|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669192|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669193|NCT02906800|Digoxin|digoxin|mesh-list
43669194|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43669195|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43669196|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669197|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669198|NCT02906800|Protective Agents|protective agents|mesh-ancestor
43669199|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669200|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43669201|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
43669202|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
43669203|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
43669204|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
43669205|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43669206|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669207|NCT02906150|Cisplatin|cisplatin|mesh-list
43669208|NCT02906150|Carboplatin|carboplatin|mesh-list
43669209|NCT02906150|Pemetrexed|pemetrexed|mesh-list
43669210|NCT02906150|Thymalfasin|thymalfasin|mesh-list
43669211|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669212|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669213|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669214|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43669215|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669216|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43669217|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
43669218|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669219|NCT02906059|Irinotecan|irinotecan|mesh-list
43669220|NCT02906059|Adavosertib|adavosertib|mesh-list
43669221|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43669222|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43669223|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669234|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
43669235|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669236|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669237|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43826819|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
43826820|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43826821|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43826822|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43826823|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43826824|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826825|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826826|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826827|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43826828|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702559|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
44016860|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44016862|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
44016863|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44016864|NCT03608839|BB 1101|bb 1101|mesh-list
44016865|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016866|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
44016867|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
44016868|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016869|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016870|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44016871|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
44016872|NCT03608839|Hormones|hormones|mesh-ancestor
44016873|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44016874|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44016875|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44016876|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
44016877|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016878|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016879|NCT03610399|Primaquine|primaquine|mesh-list
44016880|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
44016881|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44016882|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44016883|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016884|NCT03610464|Amphetamine|amphetamine|mesh-list
44016885|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44016886|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016887|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
44016888|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
44016889|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016890|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
44016891|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016892|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016893|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016894|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44016896|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148183|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148185|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148186|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148187|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148188|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148189|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148190|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148191|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148192|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148193|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
44148194|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
43826829|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826830|NCT05494281|Anesthetics|anesthetics|mesh-list
43826831|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
43826832|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826833|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826834|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
43826835|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826836|NCT05494060|Capecitabine|capecitabine|mesh-list
43826837|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
43826838|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826839|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
43669238|NCT02905994|Cytarabine|cytarabine|mesh-list
43669239|NCT02905994|Idarubicin|idarubicin|mesh-list
43669240|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669241|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
43669242|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669243|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669244|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
43669245|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669246|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669247|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
43669248|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669249|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669250|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43669251|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43669252|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669254|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
43669255|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
43669256|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43669257|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43669258|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43669259|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
43669260|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669261|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669273|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669274|NCT02905864|Liraglutide|liraglutide|mesh-list
43669275|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43669276|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669277|NCT02905864|Incretins|incretins|mesh-ancestor
43669278|NCT02905864|Hormones|hormones|mesh-ancestor
43669279|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148195|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148196|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
44148197|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
44148198|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44148199|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
44148200|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44148201|NCT00203554|Protective Agents|protective agents|mesh-ancestor
44148202|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148203|NCT00203567|Carbamazepine|carbamazepine|mesh-list
44148204|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
44148205|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
44148206|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148207|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148208|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148209|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148210|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44148211|NCT00203567|Analgesics|analgesics|mesh-ancestor
44148212|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
44148213|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148214|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44148215|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148216|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148217|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44148218|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44148219|NCT00203580|Tinzaparin|tinzaparin|mesh-list
44148220|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44148221|NCT00203580|Dalteparin|dalteparin|mesh-list
44148222|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
44148223|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44148224|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44148225|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148226|NCT00203606|Interferons|interferons|mesh-list
44148227|NCT00203606|Ribavirin|ribavirin|mesh-list
44148240|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148242|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44148243|NCT00203658|Dalteparin|dalteparin|mesh-list
44148244|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
44148245|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44016902|NCT03615534|Niacin|niacin|mesh-list
44016903|NCT03615534|Fenofibrate|fenofibrate|mesh-list
44016904|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44016905|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
44016906|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016907|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44016908|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
44016909|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
44016910|NCT03615534|Vitamins|vitamins|mesh-ancestor
44016911|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
43669280|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
43669281|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
43669282|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
43669283|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669284|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669285|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
43669286|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669287|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43669288|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
43669289|NCT02905682|Coagulants|coagulants|mesh-ancestor
43669290|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43669291|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669292|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669293|NCT02905708|Charcoal|charcoal|mesh-list
43669294|NCT02905708|Antidotes|antidotes|mesh-ancestor
43669295|NCT02905708|Protective Agents|protective agents|mesh-ancestor
43669296|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669297|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43669298|NCT02905539|Hematinics|hematinics|mesh-ancestor
43669299|NCT02905734|Nicotine|nicotine|mesh-list
43669300|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43669301|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
43669302|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669303|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669304|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43669305|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43669306|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
43669307|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669308|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669309|NCT02905760|Furosemide|furosemide|mesh-list
43669310|NCT02905760|Diuretics|diuretics|mesh-list
43669311|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669312|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669313|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43669314|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43669315|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669316|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
43669317|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669318|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669319|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
43669320|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669337|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
43669338|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43669339|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43669340|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
43669341|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669342|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669343|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669344|NCT02905058|Ketoprofen|ketoprofen|mesh-list
43669345|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669346|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669348|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
43669349|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669350|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669351|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669352|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669353|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43669354|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846777|NCT04173416|Narcotics|narcotics|mesh-ancestor
43669368|NCT02904772|Cyclosporine|cyclosporine|mesh-list
43669369|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
43669370|NCT02904772|Prednisolone|prednisolone|mesh-list
43669371|NCT02904772|Cyclosporins|cyclosporins|mesh-list
43669372|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669373|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669374|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669375|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
43669376|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669377|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
43669378|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669379|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
43669380|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669381|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43669382|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669383|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669384|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43669385|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
43669386|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669387|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669388|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
43669389|NCT02904772|Hormones|hormones|mesh-ancestor
43669390|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669391|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43669392|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43669393|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
43669394|NCT02904759|Coagulants|coagulants|mesh-ancestor
43669395|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43669396|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669397|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669398|NCT02904564|Fluorouracil|fluorouracil|mesh-list
43669399|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
43669400|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669401|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669402|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669403|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669404|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
43669405|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669406|NCT02904538|Dexamethasone|dexamethasone|mesh-list
43669407|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669408|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
43669409|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
43669410|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669411|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669412|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669413|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
43669414|NCT02904538|Hormones|hormones|mesh-ancestor
43669415|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669416|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43669417|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669418|NCT02904499|Dabigatran|dabigatran|mesh-list
43826841|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826842|NCT05494047|Vaccines|vaccines|mesh-list
43826843|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
43826844|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826845|NCT05493969|Lamivudine|lamivudine|mesh-list
43826846|NCT05493969|Dolutegravir|dolutegravir|mesh-list
43826847|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43826848|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826849|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826850|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826852|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826853|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43826854|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43826855|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43826856|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43846778|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846779|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846780|NCT04173416|Analgesics|analgesics|mesh-ancestor
43846786|NCT04172844|Pevonedistat|pevonedistat|mesh-list
43846787|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846788|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
43846789|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846790|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846791|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43846792|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846793|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846794|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846795|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846796|NCT04171726|Edoxaban|edoxaban|mesh-list
43846797|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43846798|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
43846799|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43846800|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
43846801|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846812|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846813|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846814|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846815|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846816|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
43846817|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846818|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846819|NCT04170517|Progesterone|progesterone|mesh-list
43846820|NCT04170517|Progestins|progestins|mesh-ancestor
43846821|NCT04170517|Hormones|hormones|mesh-ancestor
43846822|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846823|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846824|NCT04170465|Metformin|metformin|mesh-list
43846825|NCT04170465|Paclitaxel|paclitaxel|mesh-list
43846826|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
43846827|NCT04170465|Doxorubicin|doxorubicin|mesh-list
43846828|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43846829|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846830|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
43669436|NCT02904304|Phenylephrine|phenylephrine|mesh-list
43669437|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
43669438|NCT02904304|Desloratadine|desloratadine|mesh-list
43669439|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669440|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669441|NCT02904304|Analgesics|analgesics|mesh-ancestor
43669442|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
43669443|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669444|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669445|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669446|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669447|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43669448|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669449|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669450|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43669451|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
43669452|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
43669453|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
43669454|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43669455|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
43669456|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43669457|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43669458|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43669459|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43669460|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669461|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669462|NCT02904304|Protective Agents|protective agents|mesh-ancestor
43669463|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43669464|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
43669465|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43669466|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43669467|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
44016925|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44016926|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
44016928|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016929|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44016930|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44016931|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44016932|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016933|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44016934|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44016935|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
44016936|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44016937|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016938|NCT03626415|Abrocitinib|abrocitinib|mesh-list
44016939|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44016940|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016941|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016942|NCT03626714|Tacrolimus|tacrolimus|mesh-list
44016943|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44016944|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
44016945|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016946|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44016947|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016948|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016949|NCT03630198|Lidocaine|lidocaine|mesh-list
44016950|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
44016951|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
44016952|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44016953|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016954|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
44016955|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016956|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44016957|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44016958|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44016959|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44016960|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016961|NCT03631433|Acetaminophen|acetaminophen|mesh-list
44016963|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44016964|NCT03631433|Analgesics|analgesics|mesh-ancestor
44016965|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
44016966|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44016967|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016968|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
44016969|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44016970|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44016971|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44016972|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44016973|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016974|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016975|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
44016976|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44016977|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
44016978|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016979|NCT03632109|Gentamicins|gentamicins|mesh-list
44016980|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44016981|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44016982|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44016983|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44016984|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44016985|NCT03633344|Silicon|silicon|mesh-list
44016986|NCT03633344|Trace Elements|trace elements|mesh-ancestor
44016987|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
44016988|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016989|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
44016990|NCT03633448|Guaifenesin|guaifenesin|mesh-list
44016991|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44016992|NCT03633448|Expectorants|expectorants|mesh-ancestor
44016993|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
43669475|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669477|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669478|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669479|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
43669480|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669481|NCT02904031|Antidotes|antidotes|mesh-ancestor
43669528|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43669529|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669530|NCT02903485|Anesthetics|anesthetics|mesh-list
43669531|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669532|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669541|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
43669542|NCT02903537|Interferons|interferons|mesh-list
43669543|NCT02903537|Interferon-beta|interferon-beta|mesh-list
43669544|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669545|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
43669546|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669547|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
43669548|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669550|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
43669551|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43669552|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669554|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
43669555|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669556|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669557|NCT02903004|Gemcitabine|gemcitabine|mesh-list
43669558|NCT02903004|Paclitaxel|paclitaxel|mesh-list
43669559|NCT02903004|Carboplatin|carboplatin|mesh-list
43669560|NCT02903004|Doxorubicin|doxorubicin|mesh-list
43669561|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43669562|NCT02903004|Topotecan|topotecan|mesh-list
43669563|NCT02903004|Trabectedin|trabectedin|mesh-list
43669564|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43669565|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669566|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43669567|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43669568|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43669569|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669570|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669571|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
43669572|NCT02903004|Antiviral Agents|antiviral agents|mesh-ancestor
43669573|NCT02903004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669574|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669575|NCT02903004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669576|NCT02903004|Immunologic Factors|immunologic factors|mesh-ancestor
43669577|NCT02903004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44016995|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44016996|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
44016997|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669578|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669579|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43669580|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43669581|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43669582|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43669583|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
43669585|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43669586|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
43669587|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669588|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669589|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669590|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
43826858|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
43669591|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669592|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669593|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
43669594|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669595|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43669596|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669597|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
43669598|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669599|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669600|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
43669601|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43583008|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669611|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669612|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669613|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43669614|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669615|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
43669617|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669618|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669619|NCT02902666|Acetaminophen|acetaminophen|mesh-list
43669620|NCT02902666|Codeine|codeine|mesh-list
43669621|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669622|NCT02902666|Analgesics|analgesics|mesh-ancestor
43669623|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
43669624|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669625|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669626|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
43669627|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43669628|NCT02902666|Narcotics|narcotics|mesh-ancestor
43669629|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669630|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
43669632|NCT02902653|Misoprostol|misoprostol|mesh-list
43669633|NCT02902653|Dinoprostone|dinoprostone|mesh-list
43669634|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43669635|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
43669636|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669637|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669638|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43669639|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669640|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
43669641|NCT02902640|Trimethoprim|trimethoprim|mesh-list
43669642|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
43669643|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
43669644|NCT02902640|Guaifenesin|guaifenesin|mesh-list
43669645|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
43669646|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43669648|NCT02902640|Renal Agents|renal agents|mesh-ancestor
43669649|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
43669650|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43669651|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43669652|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43669653|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669654|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669655|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43669656|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43669662|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669663|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669664|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669665|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
43669666|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43669667|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
43669668|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
43669701|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669703|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
43669704|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669705|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43669706|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669707|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669708|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669709|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43669710|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43826859|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
43669716|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669718|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669719|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
43669720|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43669734|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669736|NCT02902289|Analgesics|analgesics|mesh-ancestor
43669737|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
43669738|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669739|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669740|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669741|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669742|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43669743|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676170|NCT02878265|Vitamin A|vitamin a|mesh-list
43669744|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669745|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
43669746|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669747|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669748|NCT02902133|Acetazolamide|acetazolamide|mesh-list
43669749|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
43669750|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43669752|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669753|NCT02902133|Diuretics|diuretics|mesh-ancestor
43669754|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669755|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669756|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43669757|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43669758|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669769|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43669770|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
43669771|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669772|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669773|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43669774|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
43669775|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43669776|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43669777|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43669778|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669779|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669780|NCT02901561|Misoprostol|misoprostol|mesh-list
43669781|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43669782|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
43669783|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669784|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669785|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43669786|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43669787|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
43669788|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
43669789|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
43669790|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669791|NCT02901366|Dotinurad|dotinurad|mesh-list
43669792|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
43669793|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
43669794|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669795|NCT02901366|Renal Agents|renal agents|mesh-ancestor
43669796|NCT02901379|Atorvastatin|atorvastatin|mesh-list
43669797|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43669798|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44017014|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017015|NCT03636061|Varenicline|varenicline|mesh-list
44017016|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44017017|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44017018|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017019|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017020|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017021|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017022|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44017023|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44017024|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44017025|NCT03638908|Fluoxetine|fluoxetine|mesh-list
44017026|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44017027|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43669799|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
43669800|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669801|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43669802|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43669803|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669804|NCT02901353|Sirolimus|sirolimus|mesh-list
43669805|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669806|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669807|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669808|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669809|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
43669810|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669811|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
43669812|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669813|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43669814|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
43669815|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669816|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
43669817|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669818|NCT02901288|Levofloxacin|levofloxacin|mesh-list
43669819|NCT02901288|Ofloxacin|ofloxacin|mesh-list
43669820|NCT02901288|Rifampin|rifampin|mesh-list
43669821|NCT02901288|Isoniazid|isoniazid|mesh-list
43669822|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
43669823|NCT02901288|Ethambutol|ethambutol|mesh-list
43669832|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669833|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43669834|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43669835|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43669836|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
43669837|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
43669838|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669839|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43669840|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43669841|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43669842|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43669843|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43669844|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43669845|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43669846|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43669848|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43669849|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
43669850|NCT02901145|Nivolumab|nivolumab|mesh-list
44017101|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43669852|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
43669853|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669854|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669855|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43669856|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
43669857|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669858|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669859|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43669860|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669861|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43669862|NCT02901301|Cisplatin|cisplatin|mesh-list
43669863|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
43669864|NCT02901301|Capecitabine|capecitabine|mesh-list
43669865|NCT02901301|Trastuzumab|trastuzumab|mesh-list
43669866|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669867|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669868|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669869|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
43669870|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669871|NCT02901236|Bevacizumab|bevacizumab|mesh-list
43669872|NCT02901236|Mitomycins|mitomycins|mesh-list
43669873|NCT02901236|Mitomycin|mitomycin|mesh-list
43669874|NCT02901236|Antimetabolites|antimetabolites|mesh-list
43669875|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669876|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669877|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43669878|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43669880|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669881|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
43669882|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669883|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
43669884|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669885|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669886|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669892|NCT02900729|Amlodipine|amlodipine|mesh-list
43669893|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43669894|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43669895|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43669896|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43669897|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669898|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669899|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669900|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
43669901|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43583143|NCT03441412|Metoprolol|metoprolol|mesh-list
43669902|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43669903|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43669905|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
43669906|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43826887|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43826888|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826889|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43826890|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43826891|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826892|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
43826893|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43826894|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43826895|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43826896|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
43826897|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826898|NCT05493618|Dexamethasone|dexamethasone|mesh-list
43826899|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
43826900|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826901|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
43826902|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
43826903|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826904|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017104|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44017105|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826905|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826906|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
43826907|NCT05493618|Hormones|hormones|mesh-ancestor
43826908|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826909|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826910|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826911|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826912|NCT05493371|Empagliflozin|empagliflozin|mesh-list
43826913|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43826914|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826915|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43826916|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826917|NCT05493332|Leucovorin|leucovorin|mesh-list
43826918|NCT05493332|Fluorouracil|fluorouracil|mesh-list
43826919|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
43826920|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
43826921|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826922|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826923|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826924|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826925|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
43826926|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826927|NCT05493332|Antidotes|antidotes|mesh-ancestor
43826928|NCT05493332|Protective Agents|protective agents|mesh-ancestor
43826929|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
43826930|NCT05493332|Vitamins|vitamins|mesh-ancestor
43826931|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
43826932|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
43826933|NCT05493267|Interleukin-2|interleukin-2|mesh-list
43826934|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826937|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
43826938|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826939|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826940|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43826941|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
43826942|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43826943|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826944|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826945|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43826947|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
43826948|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826949|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43826950|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43826951|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43826952|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826953|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826954|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826956|NCT05492968|Epinephrine|epinephrine|mesh-list
44017128|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017129|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
43669946|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43669947|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43669948|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669949|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669950|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43669951|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
43669952|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669953|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669954|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43669955|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43669956|NCT02900105|Letrozole|letrozole|mesh-list
43669957|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669958|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43669959|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43669960|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669961|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669962|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43669963|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
43669964|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669965|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669966|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43669967|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
43669968|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669969|NCT02899611|Valproic Acid|valproic acid|mesh-list
43669970|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
43669971|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669972|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669973|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
43669974|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43669975|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669976|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
43669977|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43669978|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669979|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43669980|NCT02899507|Amoxicillin|amoxicillin|mesh-list
43669981|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43669982|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
43669983|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
43669984|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669985|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669986|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43669987|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669988|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669989|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43669990|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44017132|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44017134|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
44017135|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43669991|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669992|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
43669994|NCT02899364|Protective Agents|protective agents|mesh-ancestor
43669995|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669997|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669998|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
43669999|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670000|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670001|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
43670002|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
43670003|NCT02899286|BCT-100|bct-100|mesh-list
43670004|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670005|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
43670006|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43670007|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
43670008|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
43670009|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670022|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670023|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670024|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670025|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43670026|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670027|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43670028|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670030|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43670031|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670032|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
43670033|NCT02899026|Hormones|hormones|mesh-ancestor
43670034|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670035|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670036|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43670037|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670038|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
43826958|NCT05492968|Norepinephrine|norepinephrine|mesh-list
43826959|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43826960|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43826961|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826962|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826963|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826964|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826965|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43826966|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43826967|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
43826968|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826969|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43826970|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
43826972|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
43826973|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43826974|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43826975|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
43826976|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43826977|NCT05492968|Protective Agents|protective agents|mesh-ancestor
43826978|NCT05492851|Hylan|hylan|mesh-list
43826979|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
43826980|NCT05492851|Protective Agents|protective agents|mesh-ancestor
43826981|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826982|NCT05492812|Melatonin|melatonin|mesh-list
43826983|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
43826984|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
44017136|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
44017137|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148246|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44148247|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148248|NCT00203684|Flunisolide|flunisolide|mesh-list
44148249|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44148250|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44148251|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148252|NCT00203697|Minocycline|minocycline|mesh-list
44148253|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148254|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148255|NCT00203723|Risperidone|risperidone|mesh-list
44148256|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148257|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
44148258|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148259|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148260|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148261|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148262|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148263|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148264|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148265|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148266|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
44148267|NCT00203736|Artesunate|artesunate|mesh-list
44148268|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
44148269|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
44148270|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44148271|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
44148272|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44148273|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44148274|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148275|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148276|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
44148277|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
44148278|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44148279|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
44148280|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44148286|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
44148287|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148288|NCT00203775|Risperidone|risperidone|mesh-list
44148289|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148290|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
44148291|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148292|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148293|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148294|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148295|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148296|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148297|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148298|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148299|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
44148300|NCT00203788|Risperidone|risperidone|mesh-list
44148301|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148302|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
44148303|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148304|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148305|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148306|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148307|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44017138|NCT03663101|Lidocaine|lidocaine|mesh-list
44017139|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
43826985|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
43826986|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826987|NCT05492812|Protective Agents|protective agents|mesh-ancestor
43826988|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670039|NCT02898961|Gentamicins|gentamicins|mesh-list
43670041|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670042|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670043|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43670105|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670106|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43670107|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43670108|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
43670109|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670110|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670111|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43670112|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43670113|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
43670114|NCT02898012|Bevacizumab|bevacizumab|mesh-list
43670144|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670145|NCT02897830|Dexamethasone|dexamethasone|mesh-list
43670146|NCT02897830|Lenalidomide|lenalidomide|mesh-list
43670147|NCT02897830|Ixazomib|ixazomib|mesh-list
43670148|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670149|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
43670150|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
44017141|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44017142|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017143|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
44017144|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017145|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017146|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
44017147|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017148|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017149|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017150|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017151|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017152|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670151|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670152|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670153|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670172|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670173|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43670174|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670175|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
43670177|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670179|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
43670180|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670181|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
43670182|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43826990|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
43826991|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
43826992|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43826993|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
43826994|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
43826995|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826996|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43826997|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
43826998|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
43826999|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827000|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
43827001|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827002|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827003|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43827004|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
43827005|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827006|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827007|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43827008|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827009|NCT05492669|Lidocaine|lidocaine|mesh-list
43827010|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
43827011|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
43827012|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827013|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827014|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
43827015|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827016|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43827030|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670183|NCT02897206|Imipenem|imipenem|mesh-list
43670184|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
43670186|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670187|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670188|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670189|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670190|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670191|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
43670192|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
44017156|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44017157|NCT03663283|Bupivacaine|bupivacaine|mesh-list
44017158|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017159|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
44017160|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017161|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017162|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
44017163|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017164|NCT03664544|Edaravone|edaravone|mesh-list
44017165|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44017166|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
43670193|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670194|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
43670195|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670196|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670197|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
43670198|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670199|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670200|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43670201|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670202|NCT02897076|Betamethasone|betamethasone|mesh-list
43670204|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43670206|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43670207|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670209|NCT02897076|Hormones|hormones|mesh-ancestor
43670210|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670211|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670212|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43670213|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
43670214|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
43670215|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670216|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43670217|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670218|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670219|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
43573424|NCT03527836|Lidocaine|lidocaine|mesh-list
43670220|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670221|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43670222|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670223|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670224|NCT02896803|Fluorouracil|fluorouracil|mesh-list
43670225|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
43670226|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
43670227|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670232|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670234|NCT02897037|Bivalirudin|bivalirudin|mesh-list
43670235|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
43670236|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43670237|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43670238|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670239|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
43670240|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43670241|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670242|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670244|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43670246|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43670247|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670248|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670250|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670251|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670253|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670254|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43670255|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670256|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
43670257|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670258|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670259|NCT02896621|Amlodipine|amlodipine|mesh-list
43670260|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
43670261|NCT02896621|Amiloride|amiloride|mesh-list
43670262|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43670263|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43670264|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43670265|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670266|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43670267|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670268|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
43670269|NCT02896621|Diuretics|diuretics|mesh-ancestor
43670270|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
43670271|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43670272|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43670273|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43670274|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43670275|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44017259|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44017261|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44017262|NCT03679975|Riluzole|riluzole|mesh-list
44017263|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
44017264|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017265|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017266|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017267|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017268|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017269|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44017270|NCT03679975|Protective Agents|protective agents|mesh-ancestor
44017271|NCT03684265|Meloxicam|meloxicam|mesh-list
43670277|NCT02896582|Dexamethasone|dexamethasone|mesh-list
43670278|NCT02896582|Etoposide|etoposide|mesh-list
43670279|NCT02896582|Melphalan|melphalan|mesh-list
43670280|NCT02896582|Cisplatin|cisplatin|mesh-list
43670281|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
43670282|NCT02896582|Carmustine|carmustine|mesh-list
43670283|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670284|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
43670285|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
43670286|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670287|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670288|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670289|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
43670290|NCT02896582|Hormones|hormones|mesh-ancestor
43670291|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670292|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43670293|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670294|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43670295|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43670296|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43670297|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670298|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670299|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670300|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
43670301|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
43670302|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670303|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670304|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
43670305|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43670306|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
43670307|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44017272|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017273|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017274|NCT03684265|Analgesics|analgesics|mesh-ancestor
44017275|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
44017276|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017277|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017278|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017279|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017280|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44017281|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44017282|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017283|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017284|NCT03685396|Hemostatics|hemostatics|mesh-list
44017285|NCT03685396|Coagulants|coagulants|mesh-ancestor
44017286|NCT03696758|Metoprolol|metoprolol|mesh-list
44017287|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
44017288|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
44017289|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44017290|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44017291|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017292|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670308|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670309|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
43670310|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43670311|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670312|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670313|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670314|NCT02896413|Analgesics|analgesics|mesh-ancestor
43670315|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
43670316|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670317|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43670318|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43670319|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43670320|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
43670321|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670322|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670323|NCT02896270|Valproic Acid|valproic acid|mesh-list
43670324|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
43670325|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670326|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670327|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
43670328|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670329|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670331|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43670332|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670350|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670351|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670352|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670353|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670354|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670355|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
43670356|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44017295|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44017297|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
44017298|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017299|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017300|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44017301|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44017302|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44017303|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017304|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017305|NCT03701061|Vaccines|vaccines|mesh-list
44017306|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
44017307|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017308|NCT03704376|Clonidine|clonidine|mesh-list
44017309|NCT03704376|Ropivacaine|ropivacaine|mesh-list
44017310|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017311|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
44017312|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017313|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017314|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
44017315|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017316|NCT03704376|Analgesics|analgesics|mesh-ancestor
43670357|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670358|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670359|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43670361|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670363|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43670364|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
43670365|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43670366|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670367|NCT02895659|Norepinephrine|norepinephrine|mesh-list
43670368|NCT02895659|Epinephrine|epinephrine|mesh-list
43670369|NCT02895659|Racepinephrine|racepinephrine|mesh-list
43670370|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
43670371|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43670372|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43670373|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
43670374|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670375|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670376|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670377|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
43670378|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
43670379|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670380|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43670381|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43670382|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43670383|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017318|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
44017319|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
44017320|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44017321|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44017322|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44017323|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017324|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017325|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017326|NCT03704467|Carboplatin|carboplatin|mesh-list
44017327|NCT03704467|Avelumab|avelumab|mesh-list
44017328|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017329|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44017330|NCT03705273|Dexamethasone|dexamethasone|mesh-list
44017331|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
44017332|NCT03705273|BB 1101|bb 1101|mesh-list
44017333|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017334|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
44017335|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
44017336|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670384|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
43670386|NCT02895529|Itraconazole|itraconazole|mesh-list
43670387|NCT02895529|Caspofungin|caspofungin|mesh-list
43670388|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
43670389|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670390|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43670391|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43670392|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670393|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670394|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43670395|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670396|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670397|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670398|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43670399|NCT02895672|Exenatide|exenatide|mesh-list
43670400|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670401|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670402|NCT02895672|Incretins|incretins|mesh-ancestor
43670403|NCT02895672|Hormones|hormones|mesh-ancestor
43670404|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670405|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43670406|NCT02895750|Metformin|metformin|mesh-list
43670407|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670408|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827031|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827032|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43827033|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43827034|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
43827035|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
43827036|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43827038|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43827039|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827040|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43827041|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44017338|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44017340|NCT03705273|Hormones|hormones|mesh-ancestor
44017341|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44017342|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44017343|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017344|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
44017345|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017346|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017347|NCT03706313|Bupivacaine|bupivacaine|mesh-list
44017348|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017349|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
44017350|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017351|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017352|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
44017353|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017354|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
44017355|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017356|NCT03711578|Tenalisib|tenalisib|mesh-list
44017357|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
43827042|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43827043|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827044|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827045|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
43827046|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43827047|NCT05492318|Clarithromycin|clarithromycin|mesh-list
43827048|NCT05492318|Midazolam|midazolam|mesh-list
43827049|NCT05492318|Dabigatran|dabigatran|mesh-list
43827050|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
43827051|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43827052|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43827053|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827054|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827055|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43827056|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43827057|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43827058|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43827060|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
43827061|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
43827062|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
43827063|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827064|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827065|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43827066|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827067|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43827068|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827069|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43827070|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43827071|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
43827072|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43827073|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
43748809|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44017358|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017359|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017360|NCT03714919|Acetaminophen|acetaminophen|mesh-list
44017361|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
44017362|NCT03714919|Ketamine|ketamine|mesh-list
44017363|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
44017364|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43871173|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
44017365|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017366|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017367|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017368|NCT03714919|Analgesics|analgesics|mesh-ancestor
44017369|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
44017370|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017371|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44017372|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44017373|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44017374|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
44017375|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017376|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017410|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
44017411|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017412|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017413|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
44017414|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017415|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017416|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017417|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017418|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017419|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017420|NCT03746002|Metolazone|metolazone|mesh-list
44017421|NCT03746002|Furosemide|furosemide|mesh-list
44017422|NCT03746002|Diuretics|diuretics|mesh-ancestor
43670452|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670453|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670454|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
43670455|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670458|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43670459|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43670460|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670461|NCT02894957|Varenicline|varenicline|mesh-list
43670462|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43670463|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43670464|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
43670465|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670466|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670467|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670470|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
43670471|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
43670472|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670473|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670474|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43670475|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43670476|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
43670477|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670478|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670479|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670480|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
43670481|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670482|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
43670483|NCT02894892|Esomeprazole|esomeprazole|mesh-list
43670484|NCT02894892|Bismuth|bismuth|mesh-list
43670485|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43670486|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670487|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43670488|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676587|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670489|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670490|NCT02894892|Antacids|antacids|mesh-ancestor
43670491|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
43670492|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
43670493|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670558|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670559|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670560|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43670561|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670563|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
43670564|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670565|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43670566|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
43670568|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670579|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670580|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43670581|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670582|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
43670583|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670584|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43670586|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670587|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670589|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43670590|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670591|NCT05428072|Analgesics|analgesics|mesh-ancestor
43670592|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
43670593|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670594|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670595|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670596|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670597|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43670598|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43670599|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670600|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43670601|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43670602|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670603|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
43670604|NCT05427942|Adalimumab|adalimumab|mesh-list
43670605|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43670606|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017466|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017467|NCT03889158|Protective Agents|protective agents|mesh-ancestor
44017468|NCT03889158|Vitamins|vitamins|mesh-ancestor
44017469|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
44017470|NCT03907033|Bupivacaine|bupivacaine|mesh-list
44017471|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017472|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
44017473|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017474|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017475|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
44017476|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017477|NCT03958071|Pirfenidone|pirfenidone|mesh-list
44017478|NCT03958071|Nintedanib|nintedanib|mesh-list
44017479|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017480|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44017481|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017482|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017483|NCT03958071|Analgesics|analgesics|mesh-ancestor
44017484|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
44017485|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017486|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017487|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44017488|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44017498|NCT03979807|Bromides|bromides|mesh-list
44017517|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017518|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43573508|NCT03527134|Analgesics|analgesics|mesh-ancestor
43768336|NCT02395458|Clarithromycin|clarithromycin|mesh-list
43768337|NCT02395458|Omeprazole|omeprazole|mesh-list
44017519|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44017520|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
44017522|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017523|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017524|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017525|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017526|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017527|NCT04032327|Bupivacaine|bupivacaine|mesh-list
44017528|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017529|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
44017530|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017531|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017532|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
44017533|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670607|NCT05427903|Epinephrine|epinephrine|mesh-list
43670608|NCT05427903|Anesthetics|anesthetics|mesh-list
43670609|NCT05427903|Carticaine|carticaine|mesh-list
43670611|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670612|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670613|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43670614|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43670615|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
43670616|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670617|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670618|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43670619|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43670620|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
43670621|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670622|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43670623|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
43670624|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
43670625|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
43670626|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43670627|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
43670628|NCT05427747|Meropenem|meropenem|mesh-list
43670629|NCT05427747|Cefotaxime|cefotaxime|mesh-list
43670630|NCT05427747|Cefoxitin|cefoxitin|mesh-list
43670631|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670632|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670633|NCT05427721|Thymol|thymol|mesh-list
43670634|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670635|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43670636|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
43670637|NCT05427617|Fulvestrant|fulvestrant|mesh-list
43670644|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670645|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670646|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670647|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827074|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
43827075|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43827076|NCT05492019|Doxycycline|doxycycline|mesh-list
43827077|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43827078|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827079|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
44017534|NCT04036292|Varenicline|varenicline|mesh-list
44017535|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44017536|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44017537|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017538|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017539|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017540|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017541|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
44017542|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44017543|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017544|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44017545|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44017546|NCT04085341|Sunitinib|sunitinib|mesh-list
44017547|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44017548|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44017549|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44017550|NCT04085341|Growth Substances|growth substances|mesh-ancestor
44017551|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017552|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
44017553|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44017554|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017555|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017556|NCT04103515|Cimetidine|cimetidine|mesh-list
44017557|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44017558|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44017559|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44017560|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
44017561|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
44017562|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017563|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017564|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017565|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43670658|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43670659|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670661|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670662|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670663|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670672|NCT05427305|Growth Substances|growth substances|mesh-ancestor
43670673|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670674|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670675|NCT05427175|Methotrexate|methotrexate|mesh-list
43670676|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43670677|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
43670678|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43827082|NCT05491928|Tempol|tempol|mesh-list
43670679|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670680|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670681|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
43670682|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670683|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670684|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670685|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670686|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43670687|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670688|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
43670689|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670690|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44017578|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44017579|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017580|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017581|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017582|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
44017583|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
44017584|NCT04184297|Olodaterol|olodaterol|mesh-list
44017585|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44017586|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
44017587|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017588|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017589|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017590|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017591|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
44017592|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44017593|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017594|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017595|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017596|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
44017597|NCT04211909|Velpatasvir|velpatasvir|mesh-list
44017598|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
44017599|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017600|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
44017601|NCT04223843|Olodaterol|olodaterol|mesh-list
44017602|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44017603|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
44017604|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017605|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017606|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44017607|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44017608|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
44017609|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44017610|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
44017611|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670692|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43670693|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670694|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670695|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017613|NCT04229303|Voriconazole|voriconazole|mesh-list
44017614|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
44017615|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017616|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44017617|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44017618|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017619|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017620|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44017621|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670697|NCT05426824|Asparaginase|asparaginase|mesh-list
43670698|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670699|NCT05426798|Azacitidine|azacitidine|mesh-list
43670701|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670702|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
43670703|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670704|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670705|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670707|NCT05426499|Isavuconazole|isavuconazole|mesh-list
43670708|NCT05426499|Anidulafungin|anidulafungin|mesh-list
43670709|NCT05426499|Meropenem|meropenem|mesh-list
43670710|NCT05426499|Cefotaxime|cefotaxime|mesh-list
43670711|NCT05426499|Cefoxitin|cefoxitin|mesh-list
43670712|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
43670713|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670714|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43670715|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43670716|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670717|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670718|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43670719|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670720|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670721|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670722|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43670723|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43670724|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670725|NCT05426486|Carboplatin|carboplatin|mesh-list
43670726|NCT05426486|Docetaxel|docetaxel|mesh-list
43670727|NCT05426486|Trastuzumab|trastuzumab|mesh-list
43670742|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670743|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43670744|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43670745|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43670746|NCT05425875|Dimercaprol|dimercaprol|mesh-list
43670747|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
43670748|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
43670749|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670750|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
43670752|NCT05425654|Carmustine|carmustine|mesh-list
43670753|NCT05425654|Rituximab|rituximab|mesh-list
43670754|NCT05425654|Methotrexate|methotrexate|mesh-list
43670755|NCT05425654|Vincristine|vincristine|mesh-list
43670756|NCT05425654|Lenalidomide|lenalidomide|mesh-list
43670757|NCT05425654|Procarbazine|procarbazine|mesh-list
43670758|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670759|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
43670760|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670761|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670762|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43670763|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
43670764|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670765|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670766|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44017629|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017630|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
44017631|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43583691|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44017632|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44017633|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017634|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44017635|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017636|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017637|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43670767|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670768|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43670769|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
43670770|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43670771|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670772|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
43670773|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670774|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670775|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43670776|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670777|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43670778|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
43670779|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670780|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670781|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670782|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43670783|NCT05425654|Growth Substances|growth substances|mesh-ancestor
43670784|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670786|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670787|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670789|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
43670790|NCT05425368|Protective Agents|protective agents|mesh-ancestor
43670791|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670792|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
43670801|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670802|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
43670803|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670804|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43670805|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43670806|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670807|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44017725|NCT04495712|Diuretics|diuretics|mesh-ancestor
44017726|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
43749128|NCT02513290|Loratadine|loratadine|mesh-list
44148311|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
44148312|NCT00203801|Artesunate|artesunate|mesh-list
44017727|NCT04490239|Heparin|heparin|mesh-list
44017728|NCT04490239|Calcium heparin|calcium heparin|mesh-list
44017729|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
44017730|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44017731|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44017732|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017733|NCT04467424|Lidocaine|lidocaine|mesh-list
44017734|NCT04467424|Ketamine|ketamine|mesh-list
44017735|NCT04467424|Propofol|propofol|mesh-list
44017736|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
44017737|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
44017738|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44017739|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017740|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
44017741|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017742|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017743|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44017744|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44017745|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44017746|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017747|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44017748|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44017749|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
44017750|NCT04467424|Analgesics|analgesics|mesh-ancestor
44017751|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44017752|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44017753|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44017754|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017755|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
44017756|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017757|NCT04459585|Dabigatran|dabigatran|mesh-list
43846927|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44017789|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017790|NCT04392362|Adenosine|adenosine|mesh-list
44017791|NCT04392362|Analgesics|analgesics|mesh-ancestor
44017792|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
44017793|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017794|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017795|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44017796|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
44017797|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44017798|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
44017799|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
44017800|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44017801|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017802|NCT04392141|Colchicine|colchicine|mesh-list
44017803|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
44017813|NCT04374500|Verapamil|verapamil|mesh-list
44017915|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44017916|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44017918|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
44017919|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
44017920|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017921|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
44017922|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
44017923|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44017924|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44017925|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017989|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44017990|NCT04290676|Dexamethasone|dexamethasone|mesh-list
44017991|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
44017992|NCT04290676|BB 1101|bb 1101|mesh-list
44017993|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44017994|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
44017995|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
44017996|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44017997|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44017998|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44017999|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
44018000|NCT04290676|Hormones|hormones|mesh-ancestor
44018001|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018002|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018003|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018004|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
44018005|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018006|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018007|NCT04290039|Atropine|atropine|mesh-list
44018008|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44018009|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44018010|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44018011|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44018012|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44018013|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
44018014|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018015|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018016|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44018017|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44148368|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018111|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44018112|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
44018113|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44018114|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
44018115|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018117|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
44018118|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018119|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018120|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018122|NCT04184999|Hormones|hormones|mesh-ancestor
44018123|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018124|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018125|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018126|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43583785|NCT03434197|Diclofenac|diclofenac|mesh-list
44018127|NCT04184999|Protective Agents|protective agents|mesh-ancestor
44018128|NCT04184271|Fluorides|fluorides|mesh-list
44018129|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
44018130|NCT04184271|Protective Agents|protective agents|mesh-ancestor
44018131|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018132|NCT04179474|Erenumab|erenumab|mesh-list
44018133|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44018134|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018135|NCT04179474|Analgesics|analgesics|mesh-ancestor
44018136|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
44018137|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018138|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018139|NCT04175262|Sunitinib|sunitinib|mesh-list
44018140|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018141|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44018142|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44018143|NCT04175262|Growth Substances|growth substances|mesh-ancestor
44018144|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018152|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44018153|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018154|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
44018155|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43647174|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43647175|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
43647176|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
43647177|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647178|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647179|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
43647180|NCT02303821|Hormones|hormones|mesh-ancestor
43647181|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647182|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43647183|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43647184|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
43647185|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43647186|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43647187|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
43647188|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
43647189|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647190|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43647191|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43647192|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
43647193|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647194|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43647195|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647196|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
43647197|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
43647257|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824085|NCT05515796|Trastuzumab|trastuzumab|mesh-list
43824086|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824087|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824088|NCT05515770|Cabotegravir|cabotegravir|mesh-list
43824089|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43824090|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43647459|NCT01362998|Narcotics|narcotics|mesh-ancestor
43647460|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647461|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647462|NCT01362998|Analgesics|analgesics|mesh-ancestor
43647463|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
43647464|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647465|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43647675|NCT05620641|Analgesics|analgesics|mesh-ancestor
43647676|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
43647677|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647678|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647679|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
43647680|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43647681|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43647682|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647683|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43647684|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43647685|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43768349|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43647686|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647687|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824222|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824223|NCT05514405|Propofol|propofol|mesh-list
43824224|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43648859|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43648860|NCT03033654|Protective Agents|protective agents|mesh-ancestor
43648861|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648862|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
43648863|NCT03033732|Buprenorphine|buprenorphine|mesh-list
43648864|NCT03033732|Methadone|methadone|mesh-list
43648865|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43648866|NCT03033732|Naloxone|naloxone|mesh-list
43648867|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43648868|NCT03033732|Narcotics|narcotics|mesh-ancestor
43648869|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648870|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648871|NCT03033732|Analgesics|analgesics|mesh-ancestor
43648872|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
43648873|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648874|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43648932|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
43649016|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43649017|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43649018|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43649019|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649020|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649021|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649022|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43649024|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649026|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43649027|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649028|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43649029|NCT03032458|Narcotics|narcotics|mesh-ancestor
43649030|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649031|NCT03032367|Bedaquiline|bedaquiline|mesh-list
43649032|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
43649330|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649331|NCT03031262|Cytarabine|cytarabine|mesh-list
43649332|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649333|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
43649334|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649335|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649336|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
43649337|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649338|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649339|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
43649340|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649341|NCT03030131|Durvalumab|durvalumab|mesh-list
43649342|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649343|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649344|NCT03030287|Paclitaxel|paclitaxel|mesh-list
43649345|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43649346|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43649347|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649348|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
43649349|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
43649350|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
43649351|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649352|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
43649726|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649727|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43649728|NCT03018665|Incretins|incretins|mesh-ancestor
43649729|NCT03018665|Hormones|hormones|mesh-ancestor
43649730|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649731|NCT03018626|Prednisone|prednisone|mesh-list
43649732|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
43649733|NCT03018626|Rituximab|rituximab|mesh-list
43649734|NCT03018626|Doxorubicin|doxorubicin|mesh-list
43649735|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43649736|NCT03018626|Etoposide|etoposide|mesh-list
43649754|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649755|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
43649756|NCT03018626|Hormones|hormones|mesh-ancestor
43583838|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43649757|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649758|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43649759|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43649760|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
43649761|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
43649762|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
43650093|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
43650094|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824435|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824436|NCT05512416|Letrozole|letrozole|mesh-list
43824437|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824438|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43824439|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43824440|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650143|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43650144|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650219|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650220|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43650221|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43650223|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
43650224|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650225|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43650226|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650227|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650228|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650229|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43650230|NCT03016039|Curcumin|curcumin|mesh-list
43650231|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650232|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650233|NCT03016039|Analgesics|analgesics|mesh-ancestor
43650234|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
43650235|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824534|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43651631|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651633|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
43651634|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651635|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43651636|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43651637|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
43651638|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
43651639|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651640|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651641|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44018228|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44018229|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
44018230|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018231|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018232|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
44018233|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018234|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018235|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018236|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44018237|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44018238|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44018239|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44018240|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44018241|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44018242|NCT04114058|Bupivacaine|bupivacaine|mesh-list
44018243|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651642|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43652534|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652535|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43652536|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43652537|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652538|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652539|NCT02991053|Ketamine|ketamine|mesh-list
43652540|NCT02991053|Analgesics|analgesics|mesh-ancestor
43652625|NCT02989467|Aprepitant|aprepitant|mesh-list
43652626|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
43652627|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
43768351|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
43652628|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652629|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652630|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652631|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43652632|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652633|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652634|NCT02989324|Misoprostol|misoprostol|mesh-list
43652635|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653044|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653045|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653077|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
43653078|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653079|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43653080|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653081|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
43653082|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653087|NCT02986451|Dexamethasone|dexamethasone|mesh-list
43653426|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
43653427|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43653428|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43653429|NCT02984722|Metformin|metformin|mesh-list
43653430|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653431|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653432|NCT02984696|Estradiol|estradiol|mesh-list
43653433|NCT02984696|Estrogens|estrogens|mesh-ancestor
43653434|NCT02984696|Hormones|hormones|mesh-ancestor
43653445|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653446|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653447|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
43653448|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
43653449|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653699|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653700|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43653701|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43653702|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43653703|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
43653704|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653705|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653706|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
43653707|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43653708|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653709|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653710|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
43653711|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653712|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653713|NCT02982161|Celecoxib|celecoxib|mesh-list
43653714|NCT02982161|Tramadol|tramadol|mesh-list
43653715|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653716|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653717|NCT02982161|Analgesics|analgesics|mesh-ancestor
43653718|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
43654014|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43654015|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
43654322|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
43654323|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654324|NCT02976571|Bupivacaine|bupivacaine|mesh-list
43654325|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654326|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
43654327|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654328|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654329|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
43654330|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654331|NCT02976623|Metronidazole|metronidazole|mesh-list
43654332|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655184|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
43656457|NCT02961608|Tacrolimus|tacrolimus|mesh-list
44018322|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44018323|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
44018324|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018325|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44018326|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43656458|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43656459|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
43656460|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656559|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656561|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656562|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
43656563|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
43656564|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
43656565|NCT02960126|Aspirin|aspirin|mesh-list
43656566|NCT02960126|Clopidogrel|clopidogrel|mesh-list
43656567|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656568|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656569|NCT02960126|Analgesics|analgesics|mesh-ancestor
43656570|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
43656571|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656572|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656573|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656574|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656575|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43656576|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43656577|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656578|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43656579|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656580|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656581|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
43656582|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43656583|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43656584|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43656585|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
43656586|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656587|NCT02959957|Cefotaxime|cefotaxime|mesh-list
43656617|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43656618|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656619|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
43656620|NCT02959762|Coagulants|coagulants|mesh-ancestor
43656621|NCT02959749|Bevacizumab|bevacizumab|mesh-list
43656622|NCT02959749|Docetaxel|docetaxel|mesh-list
43656623|NCT02959749|Osimertinib|osimertinib|mesh-list
43656624|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43656625|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656626|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43656627|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43656628|NCT02959749|Growth Substances|growth substances|mesh-ancestor
43656629|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656630|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
43656631|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43656632|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656671|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
43656672|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656673|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656674|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
43656744|NCT02958852|Fulvestrant|fulvestrant|mesh-list
43656745|NCT02958852|Atorvastatin|atorvastatin|mesh-list
43656746|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43656747|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656748|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
43656749|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656750|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656751|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43656752|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656753|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656754|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43656755|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43656756|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43656757|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
43656758|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43656759|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656760|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43656761|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43656762|NCT02958878|Tamsulosin|tamsulosin|mesh-list
43656763|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43656764|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43656765|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43656766|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656767|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656768|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656769|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656770|NCT02958878|Urological Agents|urological agents|mesh-ancestor
43825266|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825267|NCT05503706|Analgesics|analgesics|mesh-ancestor
43825268|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
43825269|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825270|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825271|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825272|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656799|NCT02958566|Acetaminophen|acetaminophen|mesh-list
43656800|NCT02958566|Ketorolac|ketorolac|mesh-list
43656801|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43656802|NCT02958566|Lidocaine|lidocaine|mesh-list
43656803|NCT02958566|Fentanyl|fentanyl|mesh-list
43656804|NCT02958566|Ketamine|ketamine|mesh-list
43656805|NCT02958566|Morphine|morphine|mesh-list
43656806|NCT02958566|Gabapentin|gabapentin|mesh-list
43656807|NCT02958566|Tramadol|tramadol|mesh-list
43656808|NCT02958566|Methadone|methadone|mesh-list
43656809|NCT02958566|Hydrocodone|hydrocodone|mesh-list
43656810|NCT02958566|Hydromorphone|hydromorphone|mesh-list
43656811|NCT02958566|Orphenadrine|orphenadrine|mesh-list
43656812|NCT02958566|Bupivacaine|bupivacaine|mesh-list
43656813|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656814|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
43656815|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656816|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656817|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
43656818|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656819|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43656820|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43656821|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43656846|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
43656847|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656848|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43656849|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43656850|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43656851|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43656852|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
43656853|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
43656854|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43656855|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43656856|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
43656857|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43656858|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43656859|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
43656860|NCT02958501|Vitamin D|vitamin d|mesh-list
43656861|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656862|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656863|NCT02958501|Vitamins|vitamins|mesh-ancestor
43656864|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
43656865|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43656866|NCT02958631|Losartan|losartan|mesh-list
44018331|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44148379|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148380|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148381|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44148382|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
44148383|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148384|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148385|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656867|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43656868|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43656869|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43656870|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43657028|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657029|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43657030|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43657032|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43657033|NCT02957630|Estrogens|estrogens|mesh-ancestor
43657034|NCT02957630|Hormones|hormones|mesh-ancestor
43584036|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653234|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43657035|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657036|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43657037|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
43657038|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43657039|NCT02957630|Diuretics|diuretics|mesh-ancestor
43657040|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
43657041|NCT02957474|Omeprazole|omeprazole|mesh-list
43657042|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43657043|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657044|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43657045|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657046|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657167|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43657168|NCT02955524|Lidocaine|lidocaine|mesh-list
43657169|NCT02955524|Tetracaine|tetracaine|mesh-list
43657170|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
43657171|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
43657172|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657173|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657174|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
43657175|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657176|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43657177|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43657178|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43657179|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657180|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657181|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43657182|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657183|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657184|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
43657185|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657186|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
43657187|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
43657188|NCT02955706|Vitamins|vitamins|mesh-ancestor
43657189|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
43657190|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657191|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
43657192|NCT02955641|Dexamethasone|dexamethasone|mesh-list
43659336|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43659337|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
43659338|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659339|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659340|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43659341|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659342|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43659343|NCT02939547|Betadex|betadex|mesh-list
43659344|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
43659345|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659346|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
44018408|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
44018409|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018410|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44018411|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018412|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018414|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
44018415|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44018416|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
44018417|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018418|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018419|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
44018420|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018421|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018422|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44018423|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
44018424|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018425|NCT04039412|Levofloxacin|levofloxacin|mesh-list
44018426|NCT04039412|Ofloxacin|ofloxacin|mesh-list
44018427|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44018428|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018429|NCT04039412|Renal Agents|renal agents|mesh-ancestor
44018430|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018431|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44018432|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44018433|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839233|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44018434|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018435|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018436|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44018438|NCT04024501|Verinurad|verinurad|mesh-list
43664037|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664038|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664039|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43664040|NCT05356104|Incretins|incretins|mesh-ancestor
43664041|NCT05356104|Hormones|hormones|mesh-ancestor
43664042|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664043|NCT05341167|Phenylephrine|phenylephrine|mesh-list
43664044|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
43664045|NCT05341167|Norepinephrine|norepinephrine|mesh-list
43664046|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43664047|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
43664048|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
43664049|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664050|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664051|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
43664077|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43664078|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43664079|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664080|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
43664081|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43664082|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43664083|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664084|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43664430|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
43664431|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664432|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664433|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664434|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
43664436|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664437|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664438|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664439|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
43664440|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664441|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43664470|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
43664471|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43664472|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
43664798|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018456|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44018457|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
44018458|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018459|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018460|NCT04029584|Rifampin|rifampin|mesh-list
44018461|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44018462|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
44018463|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44018464|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018465|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
44018466|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44018467|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018468|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018469|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44018470|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44018471|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44018472|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44018473|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44018474|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44018475|NCT04028960|Insulin|insulin|mesh-list
44018476|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44018477|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018478|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018479|NCT04023695|Lidocaine|lidocaine|mesh-list
44018480|NCT04023695|Epinephrine|epinephrine|mesh-list
44018481|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
44018482|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
44148387|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
44018483|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018484|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018485|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
44018486|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018487|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44018494|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664799|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664800|NCT03813875|Fentanyl|fentanyl|mesh-list
43664801|NCT03813875|Midazolam|midazolam|mesh-list
43664802|NCT03813875|Alfentanil|alfentanil|mesh-list
43664803|NCT03813875|Propofol|propofol|mesh-list
43664804|NCT03813875|Sevoflurane|sevoflurane|mesh-list
43664805|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43665024|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665025|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665026|NCT03374956|Incretins|incretins|mesh-ancestor
43665027|NCT03374956|Hormones|hormones|mesh-ancestor
43665028|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665063|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43665064|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665065|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826288|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43826289|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43826290|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665096|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665097|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665098|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
43665099|NCT03126591|Olaratumab|olaratumab|mesh-list
43665100|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665101|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665102|NCT03088410|Zidovudine|zidovudine|mesh-list
43665103|NCT03088410|Nevirapine|nevirapine|mesh-list
43665241|NCT01808820|Vaccines|vaccines|mesh-list
43665242|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
43665243|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665244|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665245|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665395|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
43665396|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43826311|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826312|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
43826313|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665454|NCT05469659|Metformin|metformin|mesh-list
43665455|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
43665456|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665457|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665458|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43665459|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665460|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
43665461|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43665462|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665463|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665464|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43665465|NCT05469529|Analgesics|analgesics|mesh-ancestor
43665466|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
43665467|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826339|NCT05498675|Valsartan|valsartan|mesh-list
43665468|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43768352|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824647|NCT05509569|Icatibant|icatibant|mesh-list
43665469|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43665577|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665578|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665579|NCT05468606|Imiquimod|imiquimod|mesh-list
43665580|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665581|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
43665639|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43665641|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665642|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665644|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665645|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665647|NCT05467852|Progestins|progestins|mesh-ancestor
43665648|NCT05467852|Hormones|hormones|mesh-ancestor
43665649|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665650|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665651|NCT05467826|Ribavirin|ribavirin|mesh-list
43665652|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
43665653|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43665654|NCT05467826|Velpatasvir|velpatasvir|mesh-list
43665655|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
43665656|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665657|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
43826411|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43826412|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826413|NCT05498090|Fenofibrate|fenofibrate|mesh-list
43826414|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43826415|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
43666047|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
43666048|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666049|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43666050|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43666051|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43666052|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666053|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826502|NCT05497596|Vitamin D|vitamin d|mesh-list
43826503|NCT05497596|Vitamins|vitamins|mesh-ancestor
43826504|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
43826505|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826506|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43826507|NCT05497570|Tenoxicam|tenoxicam|mesh-list
43826508|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43826509|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43826510|NCT05497570|Analgesics|analgesics|mesh-ancestor
43666269|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43666270|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710590|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43710591|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710592|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710593|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43710594|NCT02696330|Enoxaparin|enoxaparin|mesh-list
43710595|NCT02696330|Clopidogrel|clopidogrel|mesh-list
43710596|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43710597|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43710598|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43710599|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43710706|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831615|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43831616|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43831617|NCT05304949|Growth Substances|growth substances|mesh-ancestor
43831618|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831619|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
43831620|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831621|NCT05304871|Cefazolin|cefazolin|mesh-list
43831622|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43831623|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831624|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43831625|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
43831626|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831627|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43831628|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43831629|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831630|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831631|NCT05303792|Cytarabine|cytarabine|mesh-list
43831632|NCT05303792|Dexamethasone|dexamethasone|mesh-list
43831633|NCT05303792|Prednisone|prednisone|mesh-list
43831634|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
43831678|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
43831679|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43831680|NCT05303792|Protective Agents|protective agents|mesh-ancestor
43831682|NCT05302856|Testosterone|testosterone|mesh-list
43831683|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
43831684|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831685|NCT05302856|Androgens|androgens|mesh-ancestor
43831686|NCT05302856|Hormones|hormones|mesh-ancestor
43831687|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831688|NCT05302284|Gemcitabine|gemcitabine|mesh-list
43831689|NCT05302284|Cisplatin|cisplatin|mesh-list
43831690|NCT05302284|Carboplatin|carboplatin|mesh-list
43831691|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831692|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43831693|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
43710925|NCT02693574|Amoxicillin|amoxicillin|mesh-list
43710926|NCT02693574|Clarithromycin|clarithromycin|mesh-list
43710927|NCT02693574|Levofloxacin|levofloxacin|mesh-list
43710928|NCT02693574|Ofloxacin|ofloxacin|mesh-list
43710929|NCT02693574|Esomeprazole|esomeprazole|mesh-list
43710930|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710931|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710932|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43710933|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711103|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711104|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711105|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711106|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711404|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711406|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
43711407|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43711408|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711681|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711682|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711683|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43711684|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43711685|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711686|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43711687|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43711688|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
43711689|NCT02687971|Miltefosine|miltefosine|mesh-list
43711690|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
43711691|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711692|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711693|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43711694|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43711695|NCT02688023|Leucovorin|leucovorin|mesh-list
43711696|NCT02688023|Fluorouracil|fluorouracil|mesh-list
43711697|NCT02688023|Capecitabine|capecitabine|mesh-list
43711698|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
43711699|NCT02688023|Irinotecan|irinotecan|mesh-list
43711700|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
43711701|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711702|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43711703|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711932|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43711933|NCT02686476|Empagliflozin|empagliflozin|mesh-list
43711934|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43711935|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711936|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711937|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831789|NCT05297578|Vaccines|vaccines|mesh-list
43831790|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43831791|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
44018496|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44018497|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44018498|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
44018499|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44018500|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018501|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
44018502|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
44018503|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44018504|NCT04018664|Nalbuphine|nalbuphine|mesh-list
44018505|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44018506|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44018507|NCT04018664|Narcotics|narcotics|mesh-ancestor
44018508|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018509|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018510|NCT04018664|Analgesics|analgesics|mesh-ancestor
44018511|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
44018512|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018513|NCT04027803|Eculizumab|eculizumab|mesh-list
44018556|NCT04004481|Morphine|morphine|mesh-list
44018557|NCT04004481|Tramadol|tramadol|mesh-list
44018558|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44018559|NCT04004481|Narcotics|narcotics|mesh-ancestor
44018560|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018561|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018562|NCT04004481|Analgesics|analgesics|mesh-ancestor
44018563|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
44018564|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018565|NCT03997851|Acetaminophen|acetaminophen|mesh-list
44018566|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44018567|NCT03997851|Analgesics|analgesics|mesh-ancestor
44018568|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
44018569|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018570|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018571|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
44018572|NCT03989427|Listerine|listerine|mesh-list
44018573|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
44018574|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
44018575|NCT03989427|Protective Agents|protective agents|mesh-ancestor
44018576|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018577|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44018578|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018579|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
44018580|NCT03992482|Antibodies|antibodies|mesh-list
43847448|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712024|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712027|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712059|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43712060|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43712061|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712062|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
43712063|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
43712065|NCT02685657|Doxorubicin|doxorubicin|mesh-list
43712066|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712067|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
43712068|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712069|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712070|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43712102|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43712103|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
43712104|NCT02685397|Leuprolide|leuprolide|mesh-list
43712105|NCT02685397|Goserelin|goserelin|mesh-list
43712106|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43712107|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43712108|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
43712109|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712110|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712111|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712112|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712113|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
43712144|NCT02685306|Bavituximab|bavituximab|mesh-list
43712145|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43712146|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712147|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
43712148|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
43712173|NCT02685228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712175|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712176|NCT02685163|Protective Agents|protective agents|mesh-ancestor
43712177|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712178|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
43712179|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712180|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712181|NCT02685111|Lenograstim|lenograstim|mesh-list
43712182|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43712183|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
43712184|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712185|NCT02685150|Omeprazole|omeprazole|mesh-list
43712186|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43712187|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712188|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712189|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712190|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712191|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
43712192|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43712193|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43712194|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712195|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
43712196|NCT02684812|Coagulants|coagulants|mesh-ancestor
43712197|NCT02684786|Lidocaine|lidocaine|mesh-list
43712198|NCT02684786|Reserpine|reserpine|mesh-list
43712199|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712200|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
43712201|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712202|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712203|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
43712204|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712205|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712206|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43712207|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43712208|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43702560|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165304|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712209|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712210|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43712211|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43712212|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43712213|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43712214|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43712215|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43712258|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712259|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712261|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712262|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712263|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43712264|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
43712265|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712266|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43712267|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43712268|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712269|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712270|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712271|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
43712272|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712273|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712274|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
43712275|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712303|NCT02684487|Vitamins|vitamins|mesh-ancestor
43712317|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43712318|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712319|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
43712320|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712321|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
43712322|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
43712323|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43712324|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712340|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712341|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43712342|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
43712343|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712344|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
43712345|NCT02684071|Methotrexate|methotrexate|mesh-list
43712346|NCT02684071|Topotecan|topotecan|mesh-list
43712362|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712363|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43712364|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43712365|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43712366|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712367|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
43712368|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43712369|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712370|NCT02684084|Dexamethasone|dexamethasone|mesh-list
43712371|NCT02684084|Ranibizumab|ranibizumab|mesh-list
43712372|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712373|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
43712374|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
43712375|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712376|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712377|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712378|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
43712380|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712381|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712382|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712383|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43712384|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43712385|NCT02684084|Growth Substances|growth substances|mesh-ancestor
43712386|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
43712387|NCT02684305|Oxytocin|oxytocin|mesh-list
43712388|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
43712389|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43712390|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712391|NCT02684318|Olaparib|olaparib|mesh-list
43712392|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43712393|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712394|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712395|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712446|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712447|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712448|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712449|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712450|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712451|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712452|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712453|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
43712454|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712455|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712456|NCT02683655|Apatinib|apatinib|mesh-list
43712457|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712458|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43712459|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712460|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712462|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
43712463|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712491|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43712492|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43712493|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43712494|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712495|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
43712496|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43712497|NCT02683005|Ledipasvir|ledipasvir|mesh-list
43712498|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
43712499|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712500|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43712501|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43712502|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
43712503|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712504|NCT02683070|Tramadol|tramadol|mesh-list
43712505|NCT02683070|Ropivacaine|ropivacaine|mesh-list
43712506|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712507|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
43712508|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712509|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712536|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
43712537|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712538|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712539|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
43712540|NCT02682862|Bromides|bromides|mesh-list
44148411|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148412|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148413|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44148414|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
44148415|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44148416|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44148418|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148419|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
44148420|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148421|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44148422|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148423|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148424|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
44148425|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148426|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148427|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44148428|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
44148429|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148430|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148431|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018665|NCT03961295|Vedolizumab|vedolizumab|mesh-list
44018666|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018667|NCT03961100|Entrectinib|entrectinib|mesh-list
43712541|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
43712542|NCT02682862|Olodaterol|olodaterol|mesh-list
43712543|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831837|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831839|NCT05294328|Miotics|miotics|mesh-ancestor
43831840|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
43831852|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831853|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831855|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831856|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
43831857|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
43831858|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712570|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712571|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712572|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43712573|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
43712574|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43712575|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43712576|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43712577|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712578|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712579|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712580|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43712582|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43712583|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43712593|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712594|NCT02682524|Aceclofenac|aceclofenac|mesh-list
43712595|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712596|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712597|NCT02682524|Analgesics|analgesics|mesh-ancestor
43712598|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
43712599|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712600|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712601|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712602|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712603|NCT02682485|Metronidazole|metronidazole|mesh-list
43831875|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43831877|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
43712618|NCT02682186|Ropivacaine|ropivacaine|mesh-list
43712619|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712620|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
43712621|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712635|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
43712636|NCT02682134|Hormones|hormones|mesh-ancestor
43712637|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712638|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712639|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712668|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712669|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712670|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43712671|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43712672|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
43712673|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
43712674|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584494|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
43712675|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43712676|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43712677|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712678|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712679|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
43712680|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43712681|NCT02682121|Metformin|metformin|mesh-list
43712682|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712683|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712684|NCT02682017|Fucoidan|fucoidan|mesh-list
43712685|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712713|NCT02681913|Adenosine|adenosine|mesh-list
43712714|NCT02681913|Analgesics|analgesics|mesh-ancestor
43712742|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712743|NCT02681562|Olaparib|olaparib|mesh-list
43712744|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43712745|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712746|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712747|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712748|NCT02681705|Temozolomide|temozolomide|mesh-list
43712749|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43712750|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
43712751|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712752|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712753|NCT02681653|Atorvastatin|atorvastatin|mesh-list
43712754|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43712755|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43712756|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
44018668|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44018669|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712757|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712758|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43712795|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43712796|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43712797|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43712798|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712799|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43712800|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43712801|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
43712802|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712803|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43712804|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43712805|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43712806|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
43712807|NCT02681263|Temocillin|temocillin|mesh-list
43712808|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712809|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712810|NCT02680977|Levodopa|levodopa|mesh-list
43712811|NCT02680977|Benserazide|benserazide|mesh-list
43712812|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43712813|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43712814|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
43712815|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712830|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712831|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712832|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
43712833|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712834|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
43712835|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712836|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43712837|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712838|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43712839|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712840|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712841|NCT02680717|Clobetasol|clobetasol|mesh-list
43712842|NCT02680717|Calcipotriene|calcipotriene|mesh-list
43712843|NCT02680717|Tacrolimus|tacrolimus|mesh-list
43712844|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712845|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
43712846|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712847|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43712848|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712849|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712857|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43712858|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712859|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712860|NCT02680600|Cefepime|cefepime|mesh-list
43712861|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712862|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712863|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43831878|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831879|NCT05292066|Pregabalin|pregabalin|mesh-list
43831880|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43831881|NCT05292066|Analgesics|analgesics|mesh-ancestor
43831882|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
43831883|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831884|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712864|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
43712865|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43712866|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43712867|NCT02680548|Prednisolone|prednisolone|mesh-list
43712868|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
43712869|NCT02680548|Bupivacaine|bupivacaine|mesh-list
43712870|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43712871|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
43712908|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43712909|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43702561|NCT02716259|Fluorides|fluorides|mesh-list
44018670|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018671|NCT03960658|Ketamine|ketamine|mesh-list
44018672|NCT03960658|Analgesics|analgesics|mesh-ancestor
44018673|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
44018674|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018675|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712921|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712922|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
43712923|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712925|NCT02680379|Lovastatin|lovastatin|mesh-list
43712926|NCT02680379|L 647318|l 647318|mesh-list
43712927|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
43712928|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712929|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712930|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43712931|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43712932|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
43712933|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712934|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43712935|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43712936|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712937|NCT02680119|Esomeprazole|esomeprazole|mesh-list
43712938|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712939|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712940|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43712941|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712942|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712943|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
43712944|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43712945|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712946|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43712947|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43712948|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712949|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712950|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712951|NCT02680132|Esomeprazole|esomeprazole|mesh-list
43712952|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712953|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712954|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43712955|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713031|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713032|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43713033|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43713058|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
43713059|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43713060|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43713061|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
43713062|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713063|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
43713064|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43713065|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43713066|NCT02679040|Trastuzumab|trastuzumab|mesh-list
43713067|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713068|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713069|NCT02678949|Fluticasone|fluticasone|mesh-list
43713071|NCT02678949|Albuterol|albuterol|mesh-list
43713072|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713073|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43713074|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
43713075|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713076|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713077|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43713078|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
43713079|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
43713080|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43713179|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43713180|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713181|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
43713182|NCT02678208|Coagulants|coagulants|mesh-ancestor
43713214|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43713215|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43713216|NCT02678221|Urological Agents|urological agents|mesh-ancestor
43713217|NCT02678234|Acetaminophen|acetaminophen|mesh-list
43713218|NCT02678234|Ascorbic Acid|ascorbic acid|mesh-list
43713219|NCT02678234|Phenylephrine|phenylephrine|mesh-list
43713220|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
43713354|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713355|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713356|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
43713357|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713358|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713359|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43713420|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713421|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
43713422|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713431|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
43713432|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43713433|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713434|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713435|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713436|NCT02676154|Fesoterodine|fesoterodine|mesh-list
43713437|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43713438|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43713439|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713477|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43713479|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
43713517|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713518|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43713519|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
43713520|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
43713521|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
43713522|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43713523|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43713524|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713525|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713526|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713527|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43713528|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43713529|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43713530|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
43713531|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43713532|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
43713533|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713534|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713535|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43713536|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
43713559|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713560|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43713561|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713562|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
43713563|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
43713564|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713565|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43713566|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43713567|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713568|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713569|NCT02675400|Methylphenidate|methylphenidate|mesh-list
43713570|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43713602|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43713603|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43713604|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43713605|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713606|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713607|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43713608|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43713609|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713611|NCT02675335|Hormones|hormones|mesh-ancestor
43713612|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702562|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
44018678|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
43713613|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43713614|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
43713615|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713616|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713617|NCT02675205|Aspirin|aspirin|mesh-list
43713618|NCT02675205|Clopidogrel|clopidogrel|mesh-list
43713619|NCT02675205|Ticagrelor|ticagrelor|mesh-list
43713641|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43713642|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43713643|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
43713644|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713645|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43713646|NCT02675153|Sirolimus|sirolimus|mesh-list
43713647|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43713648|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713649|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43713650|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713651|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
43713652|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43713653|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
43713654|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713656|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43713657|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713658|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713659|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713660|NCT02675049|Analgesics|analgesics|mesh-ancestor
43713661|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
43713662|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713663|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43713664|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43713665|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713666|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713667|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713668|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713669|NCT02675140|Vitamins|vitamins|mesh-list
43713670|NCT02675140|Vitamin A|vitamin a|mesh-list
43713671|NCT02675140|Albendazole|albendazole|mesh-list
43713672|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
43713673|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
43713709|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713710|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43713726|NCT02674893|Incretins|incretins|mesh-ancestor
43713744|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43713745|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713746|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713747|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
43713748|NCT02674243|Povidone|povidone|mesh-list
43713749|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43713750|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
43713751|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
43713752|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713753|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713755|NCT02674139|Trace Elements|trace elements|mesh-ancestor
43713756|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
43713757|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713758|NCT02674113|Bupivacaine|bupivacaine|mesh-list
43713759|NCT02674113|Anesthetics|anesthetics|mesh-list
43713760|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713761|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713762|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713763|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
43713764|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713765|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43713766|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43713767|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
43713768|NCT02674191|Clindamycin|clindamycin|mesh-list
43713769|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
43713770|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
43713771|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
44018679|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
44018767|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44018768|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713780|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
43713781|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
43713782|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713783|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713784|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
43713785|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713786|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713787|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
43713788|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713789|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43713790|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43713791|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43713792|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713793|NCT02673866|Pregabalin|pregabalin|mesh-list
43713794|NCT02673866|DS-1971a|ds-1971a|mesh-list
43713795|NCT02673866|Analgesics|analgesics|mesh-ancestor
43713796|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
43713797|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713798|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713799|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
43713800|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43713801|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713802|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713803|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43713804|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43713805|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43713821|NCT02673814|Bavituximab|bavituximab|mesh-list
44018769|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43713822|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713823|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713824|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43713825|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43713827|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43713828|NCT02673606|Estrogens|estrogens|mesh-ancestor
43713829|NCT02673606|Hormones|hormones|mesh-ancestor
43713830|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713831|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713832|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43713841|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713842|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43713843|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43713844|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713846|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43713847|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
43713848|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713849|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713850|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43713851|NCT02673463|Diuretics|diuretics|mesh-ancestor
43713852|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
43713853|NCT02673359|Progesterone|progesterone|mesh-list
43713854|NCT02673359|Progestins|progestins|mesh-ancestor
43713855|NCT02673359|Hormones|hormones|mesh-ancestor
43713856|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713857|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713858|NCT02673229|Bacitracin|bacitracin|mesh-list
43713859|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43713860|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713861|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43713862|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
43713863|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43713870|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713871|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43713872|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831977|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43831978|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831979|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
43831980|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43831981|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
43831982|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831983|NCT05287724|Expectorants|expectorants|mesh-ancestor
43831984|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831985|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43831986|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
43831987|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831988|NCT05287724|Protective Agents|protective agents|mesh-ancestor
43831989|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831990|NCT05287724|Antidotes|antidotes|mesh-ancestor
43831991|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
43831992|NCT05287464|Nivolumab|nivolumab|mesh-list
43831993|NCT05287464|Ipilimumab|ipilimumab|mesh-list
43831994|NCT05287464|Avelumab|avelumab|mesh-list
43831995|NCT05287464|Atezolizumab|atezolizumab|mesh-list
43831996|NCT05287464|Lenvatinib|lenvatinib|mesh-list
43831997|NCT05287464|Axitinib|axitinib|mesh-list
43831998|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43831999|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832000|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43832001|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832002|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43832003|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832004|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
43832005|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43832006|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832007|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43702563|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
43847454|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43847455|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43847456|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847457|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847458|NCT04105946|Analgesics|analgesics|mesh-ancestor
43847459|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
43847460|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847461|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43713873|NCT02672839|Betadex|betadex|mesh-list
43713874|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
43713875|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713891|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
43713892|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43713893|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43713894|NCT02672527|Dexamethasone|dexamethasone|mesh-list
43713895|NCT02672527|Trabectedin|trabectedin|mesh-list
43713896|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43713897|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
43713898|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
43713899|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713900|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713901|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43713902|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
43713903|NCT02672527|Hormones|hormones|mesh-ancestor
43713904|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713905|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43713914|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713921|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713922|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713923|NCT02672345|Sevoflurane|sevoflurane|mesh-list
43713924|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43713925|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43713926|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
43713927|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
43713928|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713929|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713930|NCT02672358|Trametinib|trametinib|mesh-list
43713931|NCT02672358|Dabrafenib|dabrafenib|mesh-list
43713932|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713933|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43713939|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
43713940|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713941|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713943|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43713944|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713945|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713946|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43713947|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43713948|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43713949|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713950|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43713951|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43713952|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43713953|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713954|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
43713955|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
43713956|NCT02672241|Temozolomide|temozolomide|mesh-list
43713957|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
43713958|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44018771|NCT03928522|Tobramycin|tobramycin|mesh-list
44018772|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018773|NCT03910439|Avelumab|avelumab|mesh-list
44018774|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44018775|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713959|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
43713960|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713961|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713962|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43713963|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43713964|NCT02671864|Incretins|incretins|mesh-list
43713965|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713966|NCT02671864|Hormones|hormones|mesh-ancestor
43713967|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713968|NCT02671851|Acetaminophen|acetaminophen|mesh-list
43713969|NCT02671851|Dipyrone|dipyrone|mesh-list
43713970|NCT02671851|Fentanyl|fentanyl|mesh-list
43713971|NCT02671851|Tramadol|tramadol|mesh-list
43713972|NCT02671851|Bupivacaine|bupivacaine|mesh-list
43713973|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713974|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
43713975|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713976|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713977|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
43713978|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713979|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43713980|NCT02671851|Narcotics|narcotics|mesh-ancestor
43713981|NCT02671851|Analgesics|analgesics|mesh-ancestor
43713982|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43713983|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43713984|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
43713998|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
43713999|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714001|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43714002|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43714003|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714004|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714005|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714006|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714007|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
43714008|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
43714009|NCT02671708|Busulfan|busulfan|mesh-list
43714010|NCT02671708|Idarubicin|idarubicin|mesh-list
43714011|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714012|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
43714013|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714024|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
43714025|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43714026|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
43714027|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714028|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
43714029|NCT02671565|Protective Agents|protective agents|mesh-ancestor
43714030|NCT02671383|Lopinavir|lopinavir|mesh-list
43714031|NCT02671383|Darunavir|darunavir|mesh-list
43714032|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43714033|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43714034|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714035|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714036|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714037|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43714038|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43714039|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
43714040|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714041|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43714042|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43832025|NCT05284409|Acetaminophen|acetaminophen|mesh-list
43832026|NCT05284409|Dexamethasone|dexamethasone|mesh-list
43832027|NCT05284409|Meperidine|meperidine|mesh-list
44018779|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018780|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018781|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
44018782|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44018783|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832043|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43832044|NCT05284409|Narcotics|narcotics|mesh-ancestor
43832045|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832046|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43832047|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
43832048|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43832049|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832050|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832051|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832052|NCT05283083|Analgesics|analgesics|mesh-ancestor
43832053|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
43832054|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832055|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43832056|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43832057|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832058|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
43714044|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43714045|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714046|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43714047|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714048|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
43714049|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714050|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
43714051|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714052|NCT02671227|Bupivacaine|bupivacaine|mesh-list
43714053|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714054|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
43714055|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714056|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714061|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43714062|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43714063|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714065|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43714066|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43714067|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
43714068|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
43714069|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677300|NCT02868801|Pregabalin|pregabalin|mesh-list
43714070|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714071|NCT02671175|Piperaquine|piperaquine|mesh-list
43714072|NCT02671175|Artenimol|artenimol|mesh-list
43714088|NCT02670954|Tramadol|tramadol|mesh-list
43714089|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43714090|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714091|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714092|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714093|NCT02670954|Analgesics|analgesics|mesh-ancestor
43714094|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
43714095|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714096|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43714097|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43714098|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43714099|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
43714100|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714101|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714102|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43714103|NCT02670954|Narcotics|narcotics|mesh-ancestor
44018786|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43714110|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
43714111|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714112|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714113|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
43714114|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714115|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714116|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714117|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714118|NCT02670655|Lidocaine|lidocaine|mesh-list
43714119|NCT02670655|Prilocaine|prilocaine|mesh-list
43714120|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43714121|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714122|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
43714123|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714124|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714125|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
43714136|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714137|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714138|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
43714139|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714140|NCT02670785|Estradiol|estradiol|mesh-list
43714141|NCT02670785|Estrogens|estrogens|mesh-ancestor
43714142|NCT02670785|Hormones|hormones|mesh-ancestor
43714143|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714144|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714145|NCT02670616|Prednisolone|prednisolone|mesh-list
43714152|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714153|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714154|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714155|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
43714156|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714157|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714158|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714159|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714160|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43714161|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43714162|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43714163|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714164|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43714165|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
43714166|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
43714167|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
43714168|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714169|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
43584911|NCT03425448|Heparin|heparin|mesh-list
43714171|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714172|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714173|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43714174|NCT02670772|Tenofovir|tenofovir|mesh-list
43714175|NCT02670772|Stavudine|stavudine|mesh-list
43714176|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
43714177|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714178|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43714179|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43714180|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714181|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714182|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43714183|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43714184|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
43714185|NCT02670642|Esomeprazole|esomeprazole|mesh-list
43714186|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43714187|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714188|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44018857|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44018858|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44018859|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
44018860|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
44018861|NCT03885154|Valproic Acid|valproic acid|mesh-list
43714189|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714202|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714203|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714204|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714205|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43714206|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43714207|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43714208|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714209|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714210|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
43714212|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714213|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714214|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43714215|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
43714216|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
43714217|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
43714218|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714220|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43714221|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714222|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714223|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
43714224|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714245|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43714246|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43714247|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43714248|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
43714249|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714250|NCT02670018|Metformin|metformin|mesh-list
43714251|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43714274|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
43714275|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714276|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714277|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
43714278|NCT02670109|Busulfan|busulfan|mesh-list
43714279|NCT02670109|Carmustine|carmustine|mesh-list
43714280|NCT02670109|Carboplatin|carboplatin|mesh-list
43714281|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714282|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
43714283|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714284|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714285|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714286|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
43714287|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714288|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714289|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714290|NCT02669719|Carboplatin|carboplatin|mesh-list
43714291|NCT02669719|Pemetrexed|pemetrexed|mesh-list
43714292|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714293|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714294|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714295|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43714296|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43714297|NCT02669732|Firuglipel|firuglipel|mesh-list
43714298|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43714328|NCT02669303|Prednisolone|prednisolone|mesh-list
43714329|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
43714330|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43714331|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
43714332|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714333|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
43714345|NCT02669238|Etonogestrel|etonogestrel|mesh-list
43714346|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43714347|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
43714351|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43714352|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
43714353|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43714354|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
43714355|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714356|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
43714357|NCT02669368|Rocuronium|rocuronium|mesh-list
43714358|NCT02669368|Analgesics|analgesics|mesh-ancestor
43714359|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
43714360|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714361|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714362|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
43714363|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714364|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43714365|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
43714366|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43714367|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714368|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714369|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714370|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
43714371|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43714372|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43832071|NCT05281471|Bevacizumab|bevacizumab|mesh-list
43714373|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43714374|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43714375|NCT02669030|Suvorexant|suvorexant|mesh-list
43714376|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43714377|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43714378|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714379|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714380|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43714381|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714382|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714383|NCT02669004|Morphine|morphine|mesh-list
43714384|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43714385|NCT02669004|Narcotics|narcotics|mesh-ancestor
43714386|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714387|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714388|NCT02669004|Analgesics|analgesics|mesh-ancestor
43714389|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
43714390|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714440|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
43714441|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43714442|NCT02668536|Protective Agents|protective agents|mesh-ancestor
43714443|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714467|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714468|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714469|NCT02668159|Vitamin D|vitamin d|mesh-list
44018862|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
44018863|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018864|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018865|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
44018866|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44018867|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018868|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
44018869|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44018870|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018871|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44018872|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44018873|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
44018874|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
44018875|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44018876|NCT03885154|Analgesics|analgesics|mesh-ancestor
44018877|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
44018878|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018879|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
44018880|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44018881|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
44018882|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018883|NCT03881163|Expectorants|expectorants|mesh-ancestor
44018884|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018885|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44018886|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
44018887|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750071|NCT02506842|Leucovorin|leucovorin|mesh-list
44018888|NCT03881163|Protective Agents|protective agents|mesh-ancestor
44018889|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018891|NCT03848871|Betamethasone|betamethasone|mesh-list
44018892|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
44018893|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44018894|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
43714470|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
43714471|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
43714472|NCT02668159|Vitamins|vitamins|mesh-list
43714473|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
43714474|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714475|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43714476|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714477|NCT02668172|Pasireotide|pasireotide|mesh-list
43714478|NCT02668172|Hormones|hormones|mesh-ancestor
43714512|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
43714513|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714514|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018895|NCT03848871|Calcipotriene|calcipotriene|mesh-list
44018896|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44018897|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018898|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
44018899|NCT03848871|Hormones|hormones|mesh-ancestor
44018900|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018901|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018902|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44018903|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
44018904|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
44018905|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44018906|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44018907|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
44018908|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018909|NCT03879603|Antacids|antacids|mesh-ancestor
44018910|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018911|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018912|NCT03866434|Anagrelide|anagrelide|mesh-list
44018913|NCT03866434|Omeprazole|omeprazole|mesh-list
44018914|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44018915|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018916|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43714515|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
43714516|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714517|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714518|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714519|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43714520|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43714521|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714522|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714523|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
43714524|NCT02667743|Paclitaxel|paclitaxel|mesh-list
43714525|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43714526|NCT02667743|Cisplatin|cisplatin|mesh-list
43714527|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43714528|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714529|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
43714530|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
43714531|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
43714532|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714533|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
43714534|NCT02667561|Testosterone|testosterone|mesh-list
43714535|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
43714536|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
43714537|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43714538|NCT02667561|Androgens|androgens|mesh-ancestor
43714539|NCT02667561|Hormones|hormones|mesh-ancestor
43714540|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714541|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714542|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714543|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714544|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
43714545|NCT02667535|Isosorbide|isosorbide|mesh-list
44018917|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44018918|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018919|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43714546|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43714547|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43714548|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43714549|NCT02667535|Diuretics|diuretics|mesh-ancestor
43714550|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
43714551|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832081|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832082|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832083|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832084|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832085|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832086|NCT05281471|Growth Substances|growth substances|mesh-ancestor
43832087|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832088|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
43832089|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832090|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
43832091|NCT05281471|Antiviral Agents|antiviral agents|mesh-ancestor
43832092|NCT05281471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714555|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
43714556|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43714557|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43714558|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
43714559|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714560|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714561|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714562|NCT02667470|Urological Agents|urological agents|mesh-ancestor
43714563|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
43714564|NCT02667197|Narcotics|narcotics|mesh-ancestor
43714565|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714566|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714567|NCT02667197|Analgesics|analgesics|mesh-ancestor
43714578|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714579|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714580|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
43714581|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714582|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714583|NCT02667353|Anesthetics|anesthetics|mesh-list
43714585|NCT02667353|Succinylcholine|succinylcholine|mesh-list
43714586|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714587|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714588|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43714589|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43714590|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
43714591|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43714592|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43714593|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43714594|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714595|NCT02667496|Sargramostim|sargramostim|mesh-list
43714596|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
43714597|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714598|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
43714599|NCT02666898|Fludarabine|fludarabine|mesh-list
43714600|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
43714601|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714629|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714630|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714632|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
43714667|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714668|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714686|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
43714687|NCT02666209|Dexamethasone|dexamethasone|mesh-list
43714688|NCT02666209|Lenalidomide|lenalidomide|mesh-list
43714689|NCT02666209|Bortezomib|bortezomib|mesh-list
43714690|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714691|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
43714692|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
43702564|NCT02716259|Protective Agents|protective agents|mesh-ancestor
43714748|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43714758|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
43714759|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714760|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714761|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43714762|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
43714763|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
43714764|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43714765|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
43714767|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714768|NCT02666001|Fostemsavir|fostemsavir|mesh-list
43714769|NCT02666001|Buprenorphine|buprenorphine|mesh-list
43714770|NCT02666001|Methadone|methadone|mesh-list
43714771|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43714772|NCT02666001|Narcotics|narcotics|mesh-ancestor
43714773|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714774|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714775|NCT02666001|Analgesics|analgesics|mesh-ancestor
43714776|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
43714777|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714778|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44018940|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
44018941|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44018942|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44018943|NCT03852537|Prednisolone|prednisolone|mesh-list
43714779|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
43714780|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
43714781|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43714782|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43714783|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
43714784|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714785|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43714786|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43714787|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44018944|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
44018945|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44018946|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
44018947|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44018948|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
44018949|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
44018950|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018951|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018952|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44018953|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
44018954|NCT03852537|Hormones|hormones|mesh-ancestor
44018955|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44018956|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44018957|NCT03852537|Protective Agents|protective agents|mesh-ancestor
44018958|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44018959|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44018961|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
44018962|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44018963|NCT03861338|Buprenorphine|buprenorphine|mesh-list
44018964|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44018965|NCT03861338|Narcotics|narcotics|mesh-ancestor
44018966|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44018967|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018968|NCT03861338|Analgesics|analgesics|mesh-ancestor
44018969|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
44018970|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44018971|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44018973|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44018974|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148451|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148452|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714789|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
43714790|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
43714792|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714793|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
43714794|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
43714795|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714796|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714797|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714798|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
43714799|NCT02665936|Hormones|hormones|mesh-ancestor
43714800|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714801|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714811|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
43714812|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714813|NCT02665845|Mesalamine|mesalamine|mesh-list
43714814|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714815|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714816|NCT02665845|Analgesics|analgesics|mesh-ancestor
43714817|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
43714818|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714819|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714820|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714821|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714822|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
43714823|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43714824|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714825|NCT02665832|Amlodipine|amlodipine|mesh-list
43714826|NCT02665832|Olmesartan|olmesartan|mesh-list
43714827|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43714828|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43714829|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43714830|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714831|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714832|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714833|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714834|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
43714835|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43714836|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714837|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
43714838|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714839|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43714840|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714841|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43714850|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43714851|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
43714852|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714854|NCT02665702|Vinorelbine|vinorelbine|mesh-list
43714855|NCT02665702|Endostar protein|endostar protein|mesh-list
43714856|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714857|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43714858|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
43714859|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
43714860|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
43714861|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714862|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43714863|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43714864|NCT02665702|Growth Substances|growth substances|mesh-ancestor
43714865|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714866|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
43714869|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714870|NCT02665637|Trastuzumab|trastuzumab|mesh-list
44148453|NCT00204308|Tenofovir|tenofovir|mesh-list
44148454|NCT00204308|Emtricitabine|emtricitabine|mesh-list
43714871|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714872|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714873|NCT02665533|Dexamethasone|dexamethasone|mesh-list
43714874|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
43714875|NCT02665533|Diclofenac|diclofenac|mesh-list
43714876|NCT02665533|Codeine|codeine|mesh-list
43714877|NCT02665533|BB 1101|bb 1101|mesh-list
43714878|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714879|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
43714880|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
43714881|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714882|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714883|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714884|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
43714885|NCT02665533|Hormones|hormones|mesh-ancestor
43714886|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714887|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714888|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714889|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714890|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714891|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714958|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
43715168|NCT02663050|Analgesics|analgesics|mesh-ancestor
43715169|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
43715170|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715171|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715172|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715173|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715174|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43715175|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715176|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832153|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43832154|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
43832155|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832156|NCT05279703|Epinephrine|epinephrine|mesh-list
43832157|NCT05279703|Racepinephrine|racepinephrine|mesh-list
43832158|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
43832159|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43715457|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715459|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43715460|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715611|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715612|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715613|NCT02659657|Analgesics|analgesics|mesh-ancestor
43715614|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
43715615|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715616|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715617|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43715618|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
43715619|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715620|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43715621|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43715622|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715623|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43715651|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715653|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
43715654|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715655|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715656|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715657|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
43715658|NCT02659293|Hormones|hormones|mesh-ancestor
43715710|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43715743|NCT02658773|Lidocaine|lidocaine|mesh-list
43715756|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715757|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43715758|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
43715759|NCT02658760|Bupivacaine|bupivacaine|mesh-list
43715760|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715761|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
43715762|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715763|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715764|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
43715765|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715766|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43715789|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43715790|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43715791|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43715792|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715793|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715794|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43715795|NCT02658721|Narcotics|narcotics|mesh-ancestor
43715796|NCT02658721|Analgesics|analgesics|mesh-ancestor
43715797|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43715798|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43715799|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
43715800|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43715801|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43715802|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43715803|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43715804|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
43715805|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
43715806|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715807|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
43715808|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
43715809|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715810|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
43715811|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
43715812|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43715813|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
43715814|NCT02658721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43715815|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43715816|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43715817|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715818|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715819|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43715820|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715821|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43715822|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44148455|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
44148456|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148457|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44148458|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44148459|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715823|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
43715824|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
43715825|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
43715826|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43715827|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43715828|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
43715829|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43715830|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
43715831|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43715832|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
43715833|NCT02658422|Montelukast|montelukast|mesh-list
43715834|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43715835|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
43715836|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43715837|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
43715838|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715839|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715840|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43715841|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43715842|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715843|NCT02658526|Anesthetics|anesthetics|mesh-list
43715844|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715845|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715846|NCT02658435|Tafenoquine|tafenoquine|mesh-list
43715847|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
43715848|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43715849|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43715864|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43715865|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43715866|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715867|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715868|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
43715870|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715871|NCT02658214|Leucovorin|leucovorin|mesh-list
43715886|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
43715887|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
43715888|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715889|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715891|NCT02658214|Antiviral Agents|antiviral agents|mesh-ancestor
43715892|NCT02658214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715893|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715894|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715895|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
43715896|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715897|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43715898|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43715899|NCT02658214|Antidotes|antidotes|mesh-ancestor
43715900|NCT02658214|Protective Agents|protective agents|mesh-ancestor
43715901|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
43715903|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
43715904|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43715905|NCT02658214|Hematinics|hematinics|mesh-ancestor
43715906|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43715907|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43715908|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
43715909|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715910|NCT02658253|Antacids|antacids|mesh-ancestor
43715911|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715912|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715913|NCT02658292|Naftifine|naftifine|mesh-list
44148460|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148461|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44148462|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44148463|NCT00204321|Sirolimus|sirolimus|mesh-list
44148464|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148465|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148466|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44148467|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148468|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
44148469|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148470|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
44148471|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148472|NCT00204347|Risperidone|risperidone|mesh-list
44148473|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148474|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
44148475|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148476|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148477|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148478|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148479|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148480|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148481|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148482|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44148483|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
44148484|NCT00204386|Topiramate|topiramate|mesh-list
44148485|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
44148486|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148487|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715914|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
43715915|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832227|NCT05277896|Etomidate|etomidate|mesh-list
43832228|NCT05277896|Analgesics|analgesics|mesh-ancestor
43832229|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
43832230|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832231|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832232|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43832233|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43715924|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43715925|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43715926|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715927|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715928|NCT02657616|Vitamin K|vitamin k|mesh-list
43715929|NCT02657616|Anticoagulants|anticoagulants|mesh-list
43715930|NCT02657616|Vitamins|vitamins|mesh-ancestor
43715931|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
43715932|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715933|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43715996|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43715997|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43715998|NCT02657148|Progestins|progestins|mesh-ancestor
43715999|NCT02657148|Hormones|hormones|mesh-ancestor
43716000|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716019|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43716021|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716022|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716023|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43716024|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43716025|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43716026|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716027|NCT02656589|Capecitabine|capecitabine|mesh-list
43716028|NCT02656589|Trastuzumab|trastuzumab|mesh-list
43716029|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716030|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
43716031|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716032|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716033|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43716034|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
43716035|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
43716036|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43716037|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43716038|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716039|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
43716040|NCT02656472|Coagulants|coagulants|mesh-ancestor
43716041|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
43716042|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716043|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43716044|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716045|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716046|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
43716047|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716048|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716049|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43716050|NCT02656251|Ethanol|ethanol|mesh-list
43716051|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
43716052|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43716053|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43716054|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716094|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716095|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716096|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43716097|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716098|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
43832254|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832255|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832256|NCT05276830|Analgesics|analgesics|mesh-ancestor
43832257|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
43832258|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716289|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43716290|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716291|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
43716292|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43716293|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716294|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716295|NCT02655029|Diuretics|diuretics|mesh-ancestor
43716296|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
43716297|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43716298|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
43716299|NCT02654834|Anesthetics|anesthetics|mesh-list
43716300|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716301|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716302|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43716303|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
43716304|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716305|NCT02654834|Analgesics|analgesics|mesh-ancestor
43716306|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
43716307|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716308|NCT02654743|Sulforaphane|sulforaphane|mesh-list
43716309|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43716310|NCT02654743|Protective Agents|protective agents|mesh-ancestor
43716311|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716312|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716313|NCT02654561|Heparin|heparin|mesh-list
43716314|NCT02654561|Calcium heparin|calcium heparin|mesh-list
43716315|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
43716316|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43716317|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43702565|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716363|NCT02654093|Vitamin D|vitamin d|mesh-list
43832280|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832282|NCT05275426|Antiviral Agents|antiviral agents|mesh-ancestor
43832283|NCT05275426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832284|NCT05275426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832285|NCT05275426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832286|NCT05275426|Immunologic Factors|immunologic factors|mesh-ancestor
43716375|NCT02654106|Temozolomide|temozolomide|mesh-list
43716376|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43716377|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
43716378|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716405|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
43716406|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43716407|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43716408|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716409|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716410|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
43716411|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
43716412|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43716413|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
43716414|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716415|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716416|NCT02653833|Tadalafil|tadalafil|mesh-list
43716417|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
43716418|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43716419|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43716420|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716421|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716422|NCT02653833|Urological Agents|urological agents|mesh-ancestor
43716423|NCT02653703|Ethanol|ethanol|mesh-list
43716424|NCT02653703|Menthol|menthol|mesh-list
43716425|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43716426|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716427|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716428|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716429|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
43716430|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716431|NCT02653742|Ketorolac|ketorolac|mesh-list
43716456|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716458|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716459|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43716460|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43716461|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43716462|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716463|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716464|NCT02653651|Analgesics|analgesics|mesh-ancestor
43716465|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43716466|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716467|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
43716520|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43716606|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43716607|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43716608|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716609|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43716610|NCT02652650|Norethindrone|norethindrone|mesh-list
43716611|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
44018995|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44018996|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44018997|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44018998|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44018999|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
44019000|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44019001|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019002|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019003|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
44019004|NCT03856164|Coagulants|coagulants|mesh-ancestor
44019005|NCT03849690|Esomeprazole|esomeprazole|mesh-list
44019006|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44019007|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019008|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44019009|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019010|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019011|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
44019012|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44019013|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44165306|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43716612|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43716613|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43716614|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43716615|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
43716616|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43716617|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716618|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43716619|NCT02652650|Estrogens|estrogens|mesh-ancestor
43716621|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716622|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43716623|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
43716624|NCT02652806|Hematinics|hematinics|mesh-ancestor
43716625|NCT02652585|Naltrexone|naltrexone|mesh-list
43716626|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43716627|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43716628|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716629|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
43716630|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716631|NCT02652637|Metronidazole|metronidazole|mesh-list
43716632|NCT02652637|Neomycin|neomycin|mesh-list
43716633|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716634|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716659|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43716660|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
43716662|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019018|NCT03840278|Pancreatin|pancreatin|mesh-list
44019019|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019020|NCT03838874|Bupivacaine|bupivacaine|mesh-list
44019021|NCT03838874|Mepivacaine|mepivacaine|mesh-list
44019022|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019023|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
44019024|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716674|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716675|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43716676|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716677|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
43716679|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43716680|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43716681|NCT02652273|Abatacept|abatacept|mesh-list
43716682|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43716712|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43716713|NCT02652312|Narcotics|narcotics|mesh-ancestor
43716714|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43716715|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
43716716|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
43716717|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43716718|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
43716719|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
43716720|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43716721|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
43716722|NCT02652312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43716723|NCT02652312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43716724|NCT02652312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43716725|NCT02652312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43716726|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43716727|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716728|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716729|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43716730|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716762|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716763|NCT02652091|Interferons|interferons|mesh-list
43768457|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
43824651|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
43824652|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824653|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716764|NCT02652091|Interferon-beta|interferon-beta|mesh-list
43716765|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
43716788|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716789|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43716791|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
43716792|NCT02651792|Analgesics|analgesics|mesh-ancestor
43716793|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
43716794|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716795|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43716796|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43716797|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43716798|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716799|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716814|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43717077|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43717078|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43717079|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
43717080|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43832292|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832294|NCT05273827|Pemetrexed|pemetrexed|mesh-list
43832295|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832296|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832299|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832300|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717081|NCT02650388|Chrysarobin|chrysarobin|mesh-list
43717082|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43717083|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717084|NCT02650388|Analgesics|analgesics|mesh-ancestor
43717085|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
43717086|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717087|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717088|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717089|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717090|NCT02650245|Lactulose|lactulose|mesh-list
43717091|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717092|NCT02650206|Liraglutide|liraglutide|mesh-list
43717093|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717094|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717095|NCT02650206|Incretins|incretins|mesh-ancestor
43717096|NCT02650206|Hormones|hormones|mesh-ancestor
43717097|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717098|NCT02650102|Olanzapine|olanzapine|mesh-list
43717099|NCT02650102|Risperidone|risperidone|mesh-list
43717100|NCT02650102|Aripiprazole|aripiprazole|mesh-list
43717101|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43717102|NCT02650102|Ziprasidone|ziprasidone|mesh-list
43717103|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43717233|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717235|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43717236|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
43717237|NCT02649413|Prednisone|prednisone|mesh-list
43717537|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
43717538|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43717539|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717540|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717541|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43717542|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
43717543|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43717544|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43717545|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43717546|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
43717547|NCT02647047|Acetaminophen|acetaminophen|mesh-list
43717548|NCT02647047|Ketorolac|ketorolac|mesh-list
43717549|NCT02647047|Sufentanil|sufentanil|mesh-list
43717550|NCT02647047|Ropivacaine|ropivacaine|mesh-list
43717551|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
43717552|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
43717553|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717554|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717763|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717764|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717765|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717766|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43717767|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717770|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717771|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717772|NCT02645747|Growth Substances|growth substances|mesh-ancestor
43717773|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717889|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717890|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717891|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43717892|NCT02645461|Protective Agents|protective agents|mesh-ancestor
43717893|NCT02645461|Analgesics|analgesics|mesh-ancestor
43717894|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
43717895|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717896|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43717897|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717898|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717899|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43717900|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
43717901|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717902|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43717903|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43717904|NCT02645461|Hormones|hormones|mesh-ancestor
43834338|NCT05148000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717912|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43717913|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717914|NCT02645240|Heparin|heparin|mesh-list
43717915|NCT02645240|Calcium heparin|calcium heparin|mesh-list
43717916|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43717917|NCT02645240|Tinzaparin|tinzaparin|mesh-list
43717918|NCT02645240|Dalteparin|dalteparin|mesh-list
43717919|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
43717920|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43717921|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43717922|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717923|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43717924|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717925|NCT02645266|Aflibercept|aflibercept|mesh-list
43717926|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43717927|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717928|NCT02645266|Growth Substances|growth substances|mesh-ancestor
43717929|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717930|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717931|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717932|NCT02645279|Midazolam|midazolam|mesh-list
43717933|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43717934|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717935|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717936|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717937|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43717938|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717939|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717940|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717941|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
43717942|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
43717943|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
43717944|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
43717945|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832376|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43832377|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
43832378|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
43832379|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43832383|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43832384|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43832385|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43832386|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43832387|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43832388|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43832398|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832399|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832400|NCT05267743|Lansoprazole|lansoprazole|mesh-list
43832401|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
43832402|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43832403|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651898|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
43585443|NCT03421119|Hormones|hormones|mesh-ancestor
43832404|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43832405|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832406|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832407|NCT05266924|Hormones|hormones|mesh-list
43832408|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43832409|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832410|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832411|NCT05266859|Calcium|calcium|mesh-list
43832412|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43832413|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832414|NCT05266807|Vancomycin|vancomycin|mesh-list
43832415|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
43832416|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717962|NCT02644954|Metformin|metformin|mesh-list
43717963|NCT02644954|Calcipotriene|calcipotriene|mesh-list
43717964|NCT02644954|Coal Tar|coal tar|mesh-list
43717965|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717966|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717967|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
43717968|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
43717969|NCT02644785|Protamines|protamines|mesh-list
43717970|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
43717971|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717972|NCT02644785|Coagulants|coagulants|mesh-ancestor
43717973|NCT02644694|Dexamethasone|dexamethasone|mesh-list
43717974|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43717975|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43717976|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717977|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
43717978|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
43717979|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717980|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717981|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717982|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
43717983|NCT02644694|Hormones|hormones|mesh-ancestor
43718009|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43718010|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718011|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718012|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718013|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718014|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718356|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718357|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718358|NCT02643329|Gliclazide|gliclazide|mesh-list
43718359|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718360|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832434|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832435|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832436|NCT05265975|Growth Substances|growth substances|mesh-ancestor
43832437|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43832438|NCT05265728|Natalizumab|natalizumab|mesh-list
43832439|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
43832440|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832441|NCT05265546|Psilocybin|psilocybin|mesh-list
43832442|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
43832443|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832444|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832445|NCT05264870|Norepinephrine|norepinephrine|mesh-list
43832446|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43718381|NCT02643147|Diuretics|diuretics|mesh-list
43718382|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43718383|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
43718384|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718401|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718402|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
43718403|NCT02642900|Nystatin|nystatin|mesh-list
43718404|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43718405|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718406|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
43718407|NCT02642900|Ionophores|ionophores|mesh-ancestor
43718408|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43585491|NCT03420794|Analgesics|analgesics|mesh-list
43718409|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718410|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
43718447|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43718448|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43718478|NCT02642497|Analgesics|analgesics|mesh-ancestor
43718489|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718490|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718492|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
43718493|NCT02642484|Calcium|calcium|mesh-list
43718494|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718495|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718496|NCT02642484|Analgesics|analgesics|mesh-ancestor
43718497|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
43718498|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718499|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
43718500|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43718501|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43718502|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718503|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718504|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43718505|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43718506|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718519|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
43718520|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718521|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718522|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718523|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718524|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43718525|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43718526|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718527|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43718528|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718529|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
43718530|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43718531|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43718532|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43718549|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
43718550|NCT02642380|Hormones|hormones|mesh-ancestor
43718551|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718552|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43718553|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718554|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
43718555|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718556|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718558|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43718559|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718560|NCT02642601|Analgesics|analgesics|mesh-ancestor
43718561|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
43718562|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718563|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718564|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718565|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718566|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
43718567|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
43718568|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718569|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43718570|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718581|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
43718582|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718583|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718584|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718585|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718587|NCT02642250|Metronidazole|metronidazole|mesh-list
43718588|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43718589|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43768498|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
43768499|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768500|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718590|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43718591|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43718592|NCT02642263|Carbetocin|carbetocin|mesh-list
43718593|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
43718594|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718595|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718596|NCT02641990|Exenatide|exenatide|mesh-list
43718597|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718598|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834339|NCT05148000|Cholinergic Agents|cholinergic agents|mesh-ancestor
43718599|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43718600|NCT02641990|Incretins|incretins|mesh-ancestor
43718601|NCT02641990|Hormones|hormones|mesh-ancestor
43718602|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718603|NCT02642003|Lenograstim|lenograstim|mesh-list
43718604|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43718605|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
43718606|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718607|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
43718608|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43718609|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718610|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718611|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718612|NCT02641938|Analgesics|analgesics|mesh-ancestor
43718613|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
43718614|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718615|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43718616|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43718617|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43718618|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
43718619|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718620|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718621|NCT02641847|Gemcitabine|gemcitabine|mesh-list
43718622|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
43718623|NCT02641847|Cisplatin|cisplatin|mesh-list
43718624|NCT02641847|Docetaxel|docetaxel|mesh-list
43718625|NCT02641847|Doxorubicin|doxorubicin|mesh-list
43718650|NCT02641899|Lisinopril|lisinopril|mesh-list
43718651|NCT02641899|Warfarin|warfarin|mesh-list
43718655|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
43718656|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718657|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43718658|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43718659|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718660|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718661|NCT02641899|Analgesics|analgesics|mesh-ancestor
43718662|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
43718663|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718664|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718665|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
43718666|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
43718667|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43718668|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43718669|NCT02641899|Protective Agents|protective agents|mesh-ancestor
43718670|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43718671|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
43718672|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43718673|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718674|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43718675|NCT02641899|Incretins|incretins|mesh-ancestor
43718676|NCT02641899|Hormones|hormones|mesh-ancestor
43718677|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718678|NCT02641821|Nifedipine|nifedipine|mesh-list
43718679|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43718680|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718681|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718682|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43718683|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718684|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718685|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
43832462|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832463|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832464|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832466|NCT05263609|Axitinib|axitinib|mesh-list
43832467|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832477|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832478|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832479|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43832480|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
43832481|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43832482|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
43832483|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
43832484|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832485|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832486|NCT05262855|FAPI-46|fapi-46|mesh-list
43832487|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43832488|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718739|NCT02641288|Ropivacaine|ropivacaine|mesh-list
43718740|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
43718741|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
43718753|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718754|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43718755|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43718756|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
43718757|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
43718758|NCT02641132|Mitomycins|mitomycins|mesh-list
43718759|NCT02641132|Mitomycin|mitomycin|mesh-list
43718760|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43718761|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718762|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
43718763|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718764|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43718809|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43718810|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43718811|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
43718812|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718813|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718814|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718815|NCT02640833|Venetoclax|venetoclax|mesh-list
43718816|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718831|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43718832|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718833|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43718834|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43718835|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718836|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
43718866|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718894|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718896|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43718897|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
43718898|NCT02640300|Clozapine|clozapine|mesh-list
43718957|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
43718958|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718959|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
43718960|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718961|NCT02639741|Protective Agents|protective agents|mesh-ancestor
43718962|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718963|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
43718964|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43718965|NCT02639533|Pregabalin|pregabalin|mesh-list
43718966|NCT02639533|Analgesics|analgesics|mesh-ancestor
43718967|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
43718968|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718969|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718970|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
43718971|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43847480|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847482|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43847483|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43847484|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847485|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847486|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43847487|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
43847488|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847489|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847490|NCT04101721|Aflibercept|aflibercept|mesh-list
43847491|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43847492|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43847493|NCT04101721|Growth Substances|growth substances|mesh-ancestor
43719007|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43719008|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
43719009|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719010|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719011|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719013|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43719014|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719015|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43719016|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719017|NCT02639039|Cortisone|cortisone|mesh-list
43719018|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719019|NCT02639091|Cisplatin|cisplatin|mesh-list
43719020|NCT02639091|Pemetrexed|pemetrexed|mesh-list
43719021|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719052|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719053|NCT02638896|Analgesics|analgesics|mesh-ancestor
43719054|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
43719055|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719056|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719057|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43719058|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719059|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43719060|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43719061|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719062|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719071|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719072|NCT02638870|Analgesics|analgesics|mesh-ancestor
43719073|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
43719074|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719178|NCT02638233|Ledipasvir|ledipasvir|mesh-list
43719179|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
43719180|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719181|NCT02638376|Riboflavin|riboflavin|mesh-list
43719182|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43719183|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43719184|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
43719185|NCT02638376|Vitamins|vitamins|mesh-ancestor
43719186|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
43719187|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719188|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43719189|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
43719198|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43719199|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
43719271|NCT02637700|Antibodies|antibodies|mesh-list
43719272|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
43719273|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43719274|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
43719275|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832532|NCT05257655|Narcotics|narcotics|mesh-ancestor
43832533|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832534|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832535|NCT05257655|Analgesics|analgesics|mesh-ancestor
43832536|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
43832537|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832538|NCT05257083|Dexamethasone|dexamethasone|mesh-list
43832539|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
43832540|NCT05257083|Fludarabine|fludarabine|mesh-list
43832541|NCT05257083|Lenalidomide|lenalidomide|mesh-list
43832542|NCT05257083|Bortezomib|bortezomib|mesh-list
43832543|NCT05257083|Daratumumab|daratumumab|mesh-list
43832544|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832545|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
43832546|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832547|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43832548|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43832549|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
43832550|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832551|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832552|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43832567|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43832568|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832570|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
43832571|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832572|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832573|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832574|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43832575|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43719276|NCT02637466|Vortioxetine|vortioxetine|mesh-list
43719277|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
43719278|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719292|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43719293|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
43719294|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43719295|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
43719321|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719322|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719323|NCT02637167|Rifaximin|rifaximin|mesh-list
43719324|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719325|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719326|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719327|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
43719328|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43719329|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719330|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719331|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43719332|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719333|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719334|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719335|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719336|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719337|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43719338|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43719339|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019127|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43719340|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719341|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43719342|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
43719343|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719344|NCT02637128|Artesunate|artesunate|mesh-list
43719345|NCT02637128|Lumefantrine|lumefantrine|mesh-list
43719346|NCT02637128|Artemether|artemether|mesh-list
43719347|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43719348|NCT02637128|Amodiaquine|amodiaquine|mesh-list
43719349|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
43719350|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43719351|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43719352|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719412|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
43719413|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719414|NCT02636218|Ketamine|ketamine|mesh-list
43719415|NCT02636218|Analgesics|analgesics|mesh-ancestor
43719416|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
43719417|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719418|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719419|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43719420|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719421|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
43719426|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719427|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719428|NCT02636348|Vitamin D|vitamin d|mesh-list
43719429|NCT02636348|Calcium|calcium|mesh-list
43719430|NCT02636348|Vitamins|vitamins|mesh-ancestor
43719431|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
43719432|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719433|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43719434|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43719435|NCT02636101|Betamethasone|betamethasone|mesh-list
43719436|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
43847498|NCT04099888|Cisplatin|cisplatin|mesh-list
43719437|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43719438|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
43719454|NCT02635802|Remifentanil|remifentanil|mesh-list
43719455|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
43719456|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
43719457|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719458|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719459|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
43719460|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719461|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43719462|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43719463|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43719464|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43719465|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719466|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43719467|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43719468|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43719469|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719470|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719471|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719472|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
43719473|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
43719474|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
43719475|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719476|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43719477|NCT02635802|Narcotics|narcotics|mesh-ancestor
43719478|NCT02635802|Analgesics|analgesics|mesh-ancestor
43719479|NCT02635971|Gemcitabine|gemcitabine|mesh-list
43719480|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
43719481|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43719482|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
43719483|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719484|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019128|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019129|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019130|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019131|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44019132|NCT03809182|Narcotics|narcotics|mesh-ancestor
44019133|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44019134|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019135|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
44019136|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
44019137|NCT03805672|Enoxaparin|enoxaparin|mesh-list
44019138|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
44019139|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
44019140|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44019141|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019142|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019143|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44019144|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44019145|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
44019146|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019147|NCT03807245|Antacids|antacids|mesh-ancestor
44019148|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019149|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019150|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
44019151|NCT03805386|Narcotics|narcotics|mesh-ancestor
43677952|NCT02865018|Cetirizine|cetirizine|mesh-list
44019152|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019153|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019154|NCT03805386|Analgesics|analgesics|mesh-ancestor
44019155|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
44019156|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019157|NCT03802227|Oxycodone|oxycodone|mesh-list
44019158|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44019159|NCT03802227|Narcotics|narcotics|mesh-ancestor
44019160|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019161|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019162|NCT03802227|Analgesics|analgesics|mesh-ancestor
44019170|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
44019171|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019172|NCT03801265|Ropivacaine|ropivacaine|mesh-list
44019173|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019174|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
44019175|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019176|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019177|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
44019178|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019179|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
44019180|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019181|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019182|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019183|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019184|NCT03799783|Analgesics|analgesics|mesh-ancestor
44019185|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
44019186|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019187|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44019188|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44019189|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44019190|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019191|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019192|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019193|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
44019194|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
44019195|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44019196|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44019197|NCT03797872|Prednisolone|prednisolone|mesh-list
44019198|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
44019199|NCT03797872|Triamcinolone|triamcinolone|mesh-list
44019200|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44019201|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43719485|NCT02635971|Antiviral Agents|antiviral agents|mesh-ancestor
43719486|NCT02635971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719487|NCT02635971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719488|NCT02635971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719489|NCT02635971|Immunologic Factors|immunologic factors|mesh-ancestor
43719490|NCT02635971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719491|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43719495|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43719496|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
43719497|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43719498|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832577|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832578|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832580|NCT05256264|Analgesics|analgesics|mesh-ancestor
43832581|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
43832582|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832583|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832584|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43832585|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43832586|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
43832587|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
43832588|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43832589|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43832590|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43832591|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832623|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43832624|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43832625|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43832626|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
43832627|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43832628|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832629|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43832630|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43832631|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43719532|NCT02635243|Glucagon|glucagon|mesh-list
43719533|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719534|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719535|NCT02635243|Hormones|hormones|mesh-ancestor
43719536|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832721|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43832723|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
43832732|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832734|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832735|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832736|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720150|NCT02631668|Ascorbic Acid|ascorbic acid|mesh-list
43720187|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43720188|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43720189|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43834340|NCT05148000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722138|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
43722139|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722140|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43722141|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43722142|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43722143|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722144|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722145|NCT02618395|Hydrocodone|hydrocodone|mesh-list
43722146|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722147|NCT02618395|Narcotics|narcotics|mesh-ancestor
43722158|NCT02618603|Triamcinolone|triamcinolone|mesh-list
43722172|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
43722181|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43722182|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
43722183|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722184|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722185|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43722186|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722187|NCT02618499|Oxytocin|oxytocin|mesh-list
43722188|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
43722189|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43722190|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722321|NCT02617654|Hormones|hormones|mesh-ancestor
43722322|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722323|NCT02617485|Prednisone|prednisone|mesh-list
43722398|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43722399|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722400|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722401|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722627|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43722628|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
43722629|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834341|NCT05148000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722660|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43722661|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722662|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722663|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
43722664|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43838132|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722665|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43722666|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722667|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
43722668|NCT02615366|Coagulants|coagulants|mesh-ancestor
43722669|NCT02615223|Bicalutamide|bicalutamide|mesh-list
43722670|NCT02615223|Hormones|hormones|mesh-list
43722671|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43722672|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722673|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722674|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
43722733|NCT02614937|Growth Substances|growth substances|mesh-ancestor
43722734|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722735|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
43722736|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722737|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43722738|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723053|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723054|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723057|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723058|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723059|NCT02612272|Analgesics|analgesics|mesh-ancestor
43723060|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
43723087|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43723088|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
43723089|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43723090|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723091|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723092|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723094|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
43723095|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723096|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43723105|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723406|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
43723407|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723408|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
43723409|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723410|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
43723411|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
43723412|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43723413|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43723414|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
43644809|NCT04364620|Docetaxel|docetaxel|mesh-list
43723513|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
43723514|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723515|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723516|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723517|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723518|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
43723519|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43723589|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723590|NCT02609061|Alendronate|alendronate|mesh-list
43723591|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43723592|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723593|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43723594|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
43723595|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723623|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723624|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723626|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723627|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723628|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
43723629|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43723630|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723631|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723632|NCT02608788|Ketorolac|ketorolac|mesh-list
43723633|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723634|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723635|NCT02608788|Analgesics|analgesics|mesh-ancestor
43723636|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
43723647|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
43723648|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833138|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833139|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43833140|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
43833141|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833142|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833143|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833144|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833145|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43833146|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
43833148|NCT05235542|Docetaxel|docetaxel|mesh-list
43833149|NCT05235542|Cisplatin|cisplatin|mesh-list
43833150|NCT05235542|Capecitabine|capecitabine|mesh-list
43833151|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
43833152|NCT05235542|Irinotecan|irinotecan|mesh-list
43833153|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833154|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833155|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833156|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
43833157|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833158|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833159|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723675|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43723676|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43723677|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723678|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43723679|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723680|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
43723681|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43723682|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723683|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
43723684|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723706|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43723707|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43723708|NCT02608112|Methotrexate|methotrexate|mesh-list
43723709|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43723710|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
43723711|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43723712|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723730|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
43723731|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43723732|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723733|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723734|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723735|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723736|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723737|NCT02608034|Itraconazole|itraconazole|mesh-list
43723738|NCT02608034|Rifampin|rifampin|mesh-list
43723772|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
43723773|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43723774|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723775|NCT02607657|Eplerenone|eplerenone|mesh-list
43723776|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43723809|NCT02607579|Ropivacaine|ropivacaine|mesh-list
43723810|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
43723811|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
43723812|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723813|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723814|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
43723815|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723816|NCT02607540|Cisplatin|cisplatin|mesh-list
43723817|NCT02607540|Fluorouracil|fluorouracil|mesh-list
43723852|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723883|NCT02607423|Cisplatin|cisplatin|mesh-list
43723884|NCT02607423|Docetaxel|docetaxel|mesh-list
43723885|NCT02607423|Pemetrexed|pemetrexed|mesh-list
43723886|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43723887|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723888|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723937|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723938|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43723939|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723940|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723941|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
43723942|NCT02607202|Gemcitabine|gemcitabine|mesh-list
43723943|NCT02607202|Paclitaxel|paclitaxel|mesh-list
43723944|NCT02607202|Carboplatin|carboplatin|mesh-list
43723945|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43723946|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723947|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723948|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723949|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723950|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723951|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43723952|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
43723953|NCT02607202|Antiviral Agents|antiviral agents|mesh-ancestor
43723954|NCT02607202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43723955|NCT02607202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723956|NCT02607202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723957|NCT02607202|Immunologic Factors|immunologic factors|mesh-ancestor
43723988|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43833191|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724051|NCT02606448|Bupivacaine|bupivacaine|mesh-list
43724052|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
43724053|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
43724054|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724055|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724056|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
43724057|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724058|NCT02606552|Aspirin|aspirin|mesh-list
43724081|NCT02606539|Folic Acid|folic acid|mesh-list
43724082|NCT02606539|Methotrexate|methotrexate|mesh-list
43724083|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
43724084|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43724104|NCT02606539|Hematinics|hematinics|mesh-ancestor
43724105|NCT02606383|Ketoconazole|ketoconazole|mesh-list
43724106|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
43724107|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724108|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43724222|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724223|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43724224|NCT02605434|Levodopa|levodopa|mesh-list
43724225|NCT02605434|Carbidopa|carbidopa|mesh-list
43724251|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724252|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768585|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768586|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
43768588|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43724253|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
43724254|NCT02605356|Hormones|hormones|mesh-ancestor
43724255|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724256|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43724257|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724258|NCT02605213|Vancomycin|vancomycin|mesh-list
43724259|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43724260|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724261|NCT02605226|Bicalutamide|bicalutamide|mesh-list
43724262|NCT02605226|Hormones|hormones|mesh-list
43724263|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43724264|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724265|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724266|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
43724267|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
43724274|NCT02604992|Analgesics|analgesics|mesh-ancestor
43724275|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
43724342|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43724343|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833193|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43833194|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833195|NCT05228951|Trastuzumab|trastuzumab|mesh-list
43833196|NCT05228951|Letrozole|letrozole|mesh-list
43833197|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833198|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833199|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43833200|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43833201|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833202|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833203|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43833204|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833205|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833219|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
43833220|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833221|NCT05226754|Diacetylrhein|diacetylrhein|mesh-list
43833222|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833223|NCT05226429|Vaccines|vaccines|mesh-list
44019203|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43833225|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833226|NCT05225558|Vancomycin|vancomycin|mesh-list
43833227|NCT05225558|Delpazolid|delpazolid|mesh-list
43833228|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
43833229|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833230|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833231|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43724346|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43724347|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724348|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724350|NCT02604719|Coagulants|coagulants|mesh-ancestor
43724351|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
43724352|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43724353|NCT02604797|Sufentanil|sufentanil|mesh-list
43724368|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724369|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724370|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724372|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724373|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724374|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724375|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
43724376|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
43724377|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768614|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
43724378|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43724379|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
43724380|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724381|NCT02604784|Cisplatin|cisplatin|mesh-list
43724382|NCT02604784|Doxorubicin|doxorubicin|mesh-list
43724383|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43724384|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
43724390|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724392|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
43724393|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724394|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
43724395|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43724396|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724397|NCT02604615|Capecitabine|capecitabine|mesh-list
43724398|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
43724399|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43724400|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
43724401|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724402|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724403|NCT02604576|Bromopride|bromopride|mesh-list
43724404|NCT02604576|Metoclopramide|metoclopramide|mesh-list
43724405|NCT02604576|Simethicone|simethicone|mesh-list
43724406|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
43724407|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724408|NCT02604576|Emollients|emollients|mesh-ancestor
43724409|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
43724410|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
43724411|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
43724412|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724413|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724414|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43724415|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43724416|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
43724417|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724446|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724447|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43724448|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43724449|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43724450|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724451|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
43724709|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43724822|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724823|NCT02602002|Analgesics|analgesics|mesh-ancestor
43724824|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
43724825|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724826|NCT02602301|Oxytocin|oxytocin|mesh-list
43724827|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
43768657|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43768658|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43768659|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43768662|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43651901|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651902|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
43651903|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651904|NCT03004612|Metformin|metformin|mesh-list
43651905|NCT03004612|Linagliptin|linagliptin|mesh-list
43724828|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43724829|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724830|NCT02601989|Tadalafil|tadalafil|mesh-list
43724831|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
43724832|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43724833|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43724854|NCT02601911|Acetaminophen|acetaminophen|mesh-list
43724855|NCT02601911|Ketorolac|ketorolac|mesh-list
44019205|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44019206|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
44019207|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44019208|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
44019209|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44019210|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019211|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44019212|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
44019213|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019214|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019215|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
44019216|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019217|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44019218|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019219|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
44019264|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019266|NCT03796182|Abrocitinib|abrocitinib|mesh-list
44019267|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44019268|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019269|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44019270|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019271|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019272|NCT03796013|Entrectinib|entrectinib|mesh-list
44019273|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44019274|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019275|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750431|NCT02505048|Rucaparib|rucaparib|mesh-list
44019276|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
44019277|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019278|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019279|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019280|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019281|NCT03793751|Analgesics|analgesics|mesh-ancestor
44019282|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
44019283|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019284|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44019285|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44019286|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44019287|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019288|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019289|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724856|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43724857|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43724858|NCT02601911|Analgesics|analgesics|mesh-ancestor
43724859|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
43724860|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724861|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724862|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
43724863|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724864|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724865|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724866|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724867|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724868|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724869|NCT02601963|Minocycline|minocycline|mesh-list
43724870|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833280|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
43833281|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43833282|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833283|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
43833284|NCT05220293|Hormones|hormones|mesh-ancestor
43833285|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833286|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833287|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43833306|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724979|NCT02601235|Pyrilamine|pyrilamine|mesh-list
43724980|NCT02601235|Phenylephrine|phenylephrine|mesh-list
43724981|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
43724995|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43725005|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43725006|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
43725007|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43725008|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
43725009|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43725010|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725011|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43725012|NCT02600988|Vitamin D|vitamin d|mesh-list
43725013|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
43725014|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
43725015|NCT02600988|Vitamins|vitamins|mesh-list
43725016|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
43725077|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725079|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43725080|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
43725081|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
43725082|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
43725161|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43725162|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43725163|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725219|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725220|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
43725221|NCT02599571|Nicotine|nicotine|mesh-list
43725222|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43725223|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
43725224|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725285|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43725286|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
43725287|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725288|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725289|NCT02599077|Dienogest|dienogest|mesh-list
43725290|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
43725291|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43725292|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
43725293|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43725294|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768704|NCT02393144|Narcotics|narcotics|mesh-ancestor
43725295|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43725296|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43725297|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43725298|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43725299|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43725300|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
43725301|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725302|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43725303|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725304|NCT02598830|Vitamin D|vitamin d|mesh-list
43725305|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
43725399|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725400|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
43725424|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725425|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725426|NCT02598063|Lamivudine|lamivudine|mesh-list
43725427|NCT02598063|Adefovir|adefovir|mesh-list
43725428|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43725429|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43725446|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725447|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725448|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
43725473|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
43725474|NCT02597556|Albendazole|albendazole|mesh-list
43725475|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
43725476|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43725477|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725478|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
43725479|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43725480|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43833317|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43833318|NCT05217680|Growth Substances|growth substances|mesh-ancestor
43833319|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833320|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
43833322|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
43833323|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
43833324|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833325|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833326|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
43833327|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833328|NCT05216653|Capecitabine|capecitabine|mesh-list
43833329|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
43725508|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725509|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
43725510|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725511|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
43725524|NCT02597114|Insulin|insulin|mesh-list
43725525|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43725526|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43725527|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725528|NCT02597257|Lidocaine|lidocaine|mesh-list
43725529|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
43725560|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725562|NCT02597153|Analgesics|analgesics|mesh-ancestor
43725563|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
43725564|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725565|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725566|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725567|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43725568|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43725569|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725570|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725577|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725578|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725579|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725580|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725581|NCT02597036|Zansecimab|zansecimab|mesh-list
43725582|NCT02597036|Paclitaxel|paclitaxel|mesh-list
43725583|NCT02597036|Ramucirumab|ramucirumab|mesh-list
43725584|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43725585|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725586|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725587|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725588|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725589|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833364|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833366|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833367|NCT05215691|Morphine|morphine|mesh-list
43833368|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43833369|NCT05215691|Narcotics|narcotics|mesh-ancestor
43833370|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833371|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833372|NCT05215691|Analgesics|analgesics|mesh-ancestor
43833373|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
43833374|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833375|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43833376|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43833377|NCT05214573|Glucagon|glucagon|mesh-list
43833378|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43833379|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43725762|NCT02595476|Remifentanil|remifentanil|mesh-list
43725763|NCT02595476|Propofol|propofol|mesh-list
43725764|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43725765|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725766|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725767|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43725768|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
43725769|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
43725770|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43725771|NCT02595476|Narcotics|narcotics|mesh-ancestor
43725772|NCT02595476|Analgesics|analgesics|mesh-ancestor
43725773|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
43725774|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725775|NCT02595541|Milrinone|milrinone|mesh-list
43725776|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
43725777|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
43725778|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43725779|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43725780|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725781|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725782|NCT02595541|Urological Agents|urological agents|mesh-ancestor
43725783|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43725784|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43725785|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43725786|NCT02595541|Protective Agents|protective agents|mesh-ancestor
43725787|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725788|NCT02595268|Pitavastatin|pitavastatin|mesh-list
43725789|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43725790|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43725791|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43725792|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
44019297|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019298|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725793|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725794|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725795|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43725796|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43725797|NCT02595190|Gabapentin|gabapentin|mesh-list
43725798|NCT02595190|Tramadol|tramadol|mesh-list
43725799|NCT02595190|Analgesics|analgesics|mesh-ancestor
43725800|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
43725801|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725802|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725803|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
43725804|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43725805|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43644812|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725866|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725867|NCT02594358|Caffeine|caffeine|mesh-list
43725868|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43725869|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725870|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43725871|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725872|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725873|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43725891|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
43725892|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725893|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725894|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725895|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43725896|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43725897|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725898|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725899|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
43725900|NCT02594462|Etonogestrel|etonogestrel|mesh-list
43725901|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43725902|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725903|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43725904|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43725905|NCT02594241|Prednisolone|prednisolone|mesh-list
43725906|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43725908|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43725909|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
43725910|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43725911|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
43725912|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43725913|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
43725914|NCT02594241|Hormones|hormones|mesh-ancestor
43725915|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725916|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725917|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43725918|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725919|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
43725920|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
43725921|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725922|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43725923|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43725924|NCT02594241|Protective Agents|protective agents|mesh-ancestor
43725925|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
43725926|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43726005|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43726006|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43726007|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43726008|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726010|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43726011|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726012|NCT02593721|Analgesics|analgesics|mesh-ancestor
43726013|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
43726014|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726015|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726016|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726017|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726018|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43726019|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726040|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726041|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43726042|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43726043|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726044|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726045|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43726046|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43726047|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43726048|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43726049|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43726050|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
43726051|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
43726052|NCT02593669|Dexamethasone|dexamethasone|mesh-list
43726162|NCT02592980|Warfarin|warfarin|mesh-list
43726163|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
43726164|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43726165|NCT02593201|Cefazolin|cefazolin|mesh-list
43726166|NCT02593201|Ceftazidime|ceftazidime|mesh-list
43726167|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43726168|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726169|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
43726170|NCT02592941|Deflazacort|deflazacort|mesh-list
43726171|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726172|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726173|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
43726387|NCT02591667|Bevacizumab|bevacizumab|mesh-list
43726388|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726432|NCT02590874|Analgesics|analgesics|mesh-ancestor
43726433|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
43726434|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726435|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
43726436|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43726437|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
43726440|NCT02591017|Chitosan|chitosan|mesh-list
43726441|NCT02591017|Analgesics|analgesics|mesh-ancestor
43726442|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
43726452|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726453|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726454|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43726455|NCT02591017|Narcotics|narcotics|mesh-ancestor
43726456|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726457|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726458|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
43726459|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726460|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
43726461|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
43726462|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
43726463|NCT02591017|Coagulants|coagulants|mesh-ancestor
43726465|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726467|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43726468|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726469|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726470|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43726471|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726472|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
43726473|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
43726474|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726475|NCT02590653|Atorvastatin|atorvastatin|mesh-list
43726476|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726477|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726478|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
43726479|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726480|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726481|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726482|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726483|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
43726484|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726485|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
43726486|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43726487|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43726488|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726489|NCT02590536|Urological Agents|urological agents|mesh-ancestor
43726490|NCT02590705|Lidocaine|lidocaine|mesh-list
43726491|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
43726504|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43726505|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
43726506|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726507|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726508|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
43726509|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
43726510|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726511|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726512|NCT02590627|Lumefantrine|lumefantrine|mesh-list
43768798|NCT02392364|Aflibercept|aflibercept|mesh-list
44019309|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44019310|NCT03792191|Narcotics|narcotics|mesh-ancestor
44019311|NCT03792191|Analgesics|analgesics|mesh-ancestor
44019312|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44019313|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019314|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
44019315|NCT03789175|Niacinamide|niacinamide|mesh-list
44019317|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
44019318|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
44019319|NCT03789175|Vitamins|vitamins|mesh-ancestor
43726513|NCT02590627|Artemether|artemether|mesh-list
43726514|NCT02590627|Piperaquine|piperaquine|mesh-list
43726515|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43726516|NCT02590627|Artenimol|artenimol|mesh-list
43726517|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
43726518|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43726519|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43726534|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726535|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
43726536|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726537|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43726538|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726539|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
43726540|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726541|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726542|NCT02590263|Temozolomide|temozolomide|mesh-list
43726543|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43726544|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
43726545|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726546|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726547|NCT02590224|Glycine|glycine|mesh-list
43726548|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
43726549|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726550|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833459|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847516|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847517|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847518|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847519|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
43848969|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848970|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848971|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848972|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43848973|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43726600|NCT02589782|Clofazimine|clofazimine|mesh-list
43726601|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43726602|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726603|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43726604|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43726605|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726606|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726607|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726633|NCT02589678|Vaccines|vaccines|mesh-list
43726634|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
43726635|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726636|NCT02589652|Interferons|interferons|mesh-list
43726637|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
43726638|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
43726639|NCT02589652|Entecavir|entecavir|mesh-list
43726640|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43726641|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726642|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
43726643|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726644|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
43726645|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726646|NCT02589340|Buspirone|buspirone|mesh-list
43726647|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43726648|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43726649|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726650|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726651|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43726652|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43726653|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
43726654|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726655|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726656|NCT02589288|Ropivacaine|ropivacaine|mesh-list
43726673|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43726675|NCT02589158|Cobicistat|cobicistat|mesh-list
43726676|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43726677|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43726678|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726679|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726680|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726681|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43726682|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43726683|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
43726684|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726685|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43726686|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43726687|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
43726855|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43726960|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726961|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
43726962|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
43726963|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
43726964|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726966|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
43726967|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43726968|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726969|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
43833511|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833512|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43833513|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43833514|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833515|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
43833516|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43833517|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43833518|NCT05205473|Lidocaine|lidocaine|mesh-list
43833519|NCT05205473|Anesthetics|anesthetics|mesh-list
43833520|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
43833521|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833522|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727089|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727090|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727091|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43727092|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727093|NCT02585973|Cisplatin|cisplatin|mesh-list
43727094|NCT02585973|Adavosertib|adavosertib|mesh-list
43728510|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728511|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43728512|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
43728513|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
43728514|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728546|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43728547|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43728548|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728549|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728550|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
43728551|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43728552|NCT02576314|Ledipasvir|ledipasvir|mesh-list
43728553|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
43728554|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728555|NCT02576301|Cytarabine|cytarabine|mesh-list
43728556|NCT02576301|Combretastatin|combretastatin|mesh-list
43728557|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728558|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
43728559|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728591|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728592|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
43728593|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728594|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728595|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
43728596|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728597|NCT02576366|Rifampin|rifampin|mesh-list
43728598|NCT02576366|Voriconazole|voriconazole|mesh-list
43728599|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43728600|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
43730513|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730514|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730516|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
43730517|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730518|NCT02563951|Granisetron|granisetron|mesh-list
43730519|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
43730520|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
43730521|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730522|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732170|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732195|NCT02551796|Protective Agents|protective agents|mesh-ancestor
43732196|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732197|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732198|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732199|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43732200|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43732202|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43732203|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
43732204|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732205|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732206|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732207|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732208|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
43732209|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732210|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43732211|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43732212|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732213|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732263|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
43732264|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732445|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43732446|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43732447|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43732448|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733047|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733049|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
43733050|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43733051|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43733052|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733053|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43733084|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733091|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43733092|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43733093|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733094|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
43733095|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733096|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733097|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
43733098|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43733099|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
43733100|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
43733102|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43834350|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
43734374|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
43734375|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
43734376|NCT02540395|Prednisolone|prednisolone|mesh-list
43734377|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43734378|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
43834351|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834353|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834354|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43847614|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847615|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43847616|NCT04088305|Vancomycin|vancomycin|mesh-list
43847617|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43847618|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847619|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
43847620|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
43734477|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43734478|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43734480|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734510|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
43734511|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43734512|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43734514|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
43734515|NCT02539394|Hemostatics|hemostatics|mesh-list
43734516|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43734517|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
43734518|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734519|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
43734520|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
43834406|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43834408|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43834409|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
43834410|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
43834411|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834412|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834413|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834414|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834415|NCT05139043|Dexamethasone|dexamethasone|mesh-list
43834416|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
43834417|NCT05139043|Ichthammol|ichthammol|mesh-list
43734602|NCT02538367|Prucalopride|prucalopride|mesh-list
43734603|NCT02538367|YH12852|yh12852|mesh-list
43734604|NCT02538367|Laxatives|laxatives|mesh-ancestor
43734605|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43734606|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43734607|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43734608|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
43734609|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734610|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734611|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734612|NCT02538393|Sorafenib|sorafenib|mesh-list
43734613|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734614|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734615|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734616|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734644|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734645|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43734646|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43734648|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734649|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734650|NCT02538302|Urological Agents|urological agents|mesh-ancestor
43734651|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
43734652|NCT02538302|Coagulants|coagulants|mesh-ancestor
43734653|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43735152|NCT05298683|Pomalidomide|pomalidomide|mesh-list
43735153|NCT05298683|Ranitidine|ranitidine|mesh-list
43735154|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43735155|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43735156|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
43735157|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
43735158|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735159|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735160|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43735161|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
43735162|NCT05298683|Hormones|hormones|mesh-ancestor
43735163|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735242|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43735243|NCT05298020|Growth Substances|growth substances|mesh-ancestor
43735244|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
43735245|NCT05297994|Vaccines|vaccines|mesh-list
43735579|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735580|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
43735581|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735582|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735583|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43735584|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735585|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43735586|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
43735587|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735589|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43735590|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
43735591|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735592|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43735593|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735594|NCT03093480|Factor VIII|factor viii|mesh-list
43735595|NCT03093480|Coagulants|coagulants|mesh-ancestor
43735596|NCT03045653|Tamoxifen|tamoxifen|mesh-list
43735597|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43735598|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
43735599|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735630|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43735631|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735632|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43735633|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735634|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
43735710|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735712|NCT05301010|Docetaxel|docetaxel|mesh-list
43735713|NCT05301010|Trastuzumab|trastuzumab|mesh-list
43735714|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735715|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735716|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735717|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735718|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735719|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735720|NCT05300958|Deferoxamine|deferoxamine|mesh-list
43735721|NCT05300958|Siderophores|siderophores|mesh-ancestor
43735722|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44019340|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019341|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019342|NCT03782233|Bromides|bromides|mesh-list
44019343|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44019344|NCT03782233|Rocuronium|rocuronium|mesh-list
44019345|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
44019346|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44019347|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44019348|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019349|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019350|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148496|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
44019352|NCT03780010|Carboplatin|carboplatin|mesh-list
44019353|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44019354|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019355|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
44019356|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
44019357|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
44019358|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019359|NCT03774745|Mifepristone|mifepristone|mesh-list
44019360|NCT03774745|Progesterone|progesterone|mesh-list
44019361|NCT03774745|Progestins|progestins|mesh-ancestor
44019362|NCT03774745|Hormones|hormones|mesh-ancestor
44019363|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019364|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019365|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44019366|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
44019367|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43735723|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
43735724|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
43735725|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735726|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
43735727|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735728|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
43735729|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735730|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735731|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43735732|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
43735733|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735734|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735820|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43735822|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
43735823|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735824|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735825|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
43735826|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43735827|NCT05300009|Methotrexate|methotrexate|mesh-list
43735828|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43735829|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
43735830|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43735831|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735832|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43735833|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
43735834|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735835|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735836|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
43735837|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735838|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43735839|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735840|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
43735841|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735842|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43735843|NCT05299931|Ustekinumab|ustekinumab|mesh-list
43735844|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834481|NCT05132114|Coagulants|coagulants|mesh-ancestor
43847635|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43736144|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736145|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
43736146|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736147|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
43736148|NCT04928300|Ketamine|ketamine|mesh-list
43736149|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43736150|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736151|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736152|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736179|NCT04905901|Coagulants|coagulants|mesh-ancestor
43736180|NCT04855513|Metformin|metformin|mesh-list
43736181|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736182|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736183|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
43736184|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
43736306|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736308|NCT04488159|Protective Agents|protective agents|mesh-ancestor
43736309|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
43736310|NCT04488159|Vitamins|vitamins|mesh-ancestor
43736311|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
43736312|NCT04445246|Iloprost|iloprost|mesh-list
43736313|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43736314|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
43736315|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43736316|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
43736317|NCT04414761|Cetrorelix|cetrorelix|mesh-list
43736318|NCT04414761|Progesterone|progesterone|mesh-list
43736319|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
43736320|NCT04414761|Ganirelix|ganirelix|mesh-list
43736321|NCT04414761|Progestins|progestins|mesh-ancestor
43736322|NCT04414761|Hormones|hormones|mesh-ancestor
43736323|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736324|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736325|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43736359|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43736360|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
43736361|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43736362|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43736363|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736364|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
43736365|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43736366|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43736367|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736368|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43736369|NCT04388319|Zonisamide|zonisamide|mesh-list
43736370|NCT04388319|Bupropion|bupropion|mesh-list
43834566|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834569|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
43834570|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43834571|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43834572|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834573|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834574|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834575|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834576|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43834577|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43834578|NCT05119140|Analgesics|analgesics|mesh-ancestor
43834579|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
43834580|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834581|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834582|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834583|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
43834584|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834585|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834586|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834587|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834588|NCT05116254|AZD7648|azd7648|mesh-list
43736399|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43736400|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
43736401|NCT04377503|Hormones|hormones|mesh-ancestor
43736402|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736403|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43736404|NCT04377503|Protective Agents|protective agents|mesh-ancestor
43736405|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43736406|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736407|NCT04360070|Ketamine|ketamine|mesh-list
43736408|NCT04360070|Analgesics|analgesics|mesh-ancestor
43736409|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
43736410|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736411|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736412|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43736413|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43736667|NCT05357885|Antibodies|antibodies|mesh-list
43736668|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
43736669|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768914|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43736671|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736702|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43736703|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43736704|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736705|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43736706|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43736707|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
43736708|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736709|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736710|NCT05357456|Epinephrine|epinephrine|mesh-list
43736711|NCT05357456|Racepinephrine|racepinephrine|mesh-list
43736712|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
43736738|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43736739|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43736740|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43736742|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736743|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736744|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43736745|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
43736746|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
43736747|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
43736748|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43736749|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43736750|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
43736757|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736758|NCT05357196|Antiviral Agents|antiviral agents|mesh-ancestor
43736759|NCT05357196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736760|NCT05357196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736844|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
43736845|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736846|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736848|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
43736849|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736850|NCT05355337|Protective Agents|protective agents|mesh-ancestor
43736851|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736852|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43736887|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
43736889|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736890|NCT05347199|Amisulpride|amisulpride|mesh-list
43736891|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43736892|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43834663|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43834664|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834674|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
43834675|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43834676|NCT05109104|Protective Agents|protective agents|mesh-ancestor
43834677|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834678|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834680|NCT05108870|Carboplatin|carboplatin|mesh-list
43834681|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43834682|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736905|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43736906|NCT05345522|Antibodies|antibodies|mesh-list
43651915|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43736907|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
43736908|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43736909|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
43736910|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736911|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736912|NCT05343767|Metformin|metformin|mesh-list
43736913|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736941|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736942|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736943|NCT05325177|Ibuprofen|ibuprofen|mesh-list
43736944|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43736945|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736946|NCT05325177|Analgesics|analgesics|mesh-ancestor
43736947|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
43736948|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736949|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736950|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736951|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736952|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43736953|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736954|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736955|NCT05307198|Capecitabine|capecitabine|mesh-list
43736956|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
43736957|NCT05307198|Antibodies|antibodies|mesh-list
43736958|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43736959|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
43736960|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736961|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43736991|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736993|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834352|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019370|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44019371|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
43737342|NCT05014542|Analgesics|analgesics|mesh-list
43737404|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43737405|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
43737406|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
43737407|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43737408|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43737409|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43737410|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
43737411|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737442|NCT04854395|Bupivacaine|bupivacaine|mesh-list
43737443|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
43737444|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
43737445|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737446|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737447|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
43737448|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737449|NCT04853043|Cetuximab|cetuximab|mesh-list
43737450|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43737493|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737494|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43737495|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43737496|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43737497|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43737498|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737499|NCT04767841|Metformin|metformin|mesh-list
43737500|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43737501|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737537|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737539|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43737540|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737541|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737568|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737569|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
43737570|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
43737571|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43834732|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834733|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
43834734|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834735|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
43834736|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834737|NCT05102552|Huperzine A|huperzine a|mesh-list
43834738|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43834739|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834740|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834741|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
43834742|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737582|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737583|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737584|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43737585|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
43737586|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
43737587|NCT04688788|Fexofenadine|fexofenadine|mesh-list
43737588|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
43737620|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
43737747|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
43737761|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737762|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
43737763|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43737764|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
43834766|NCT05098210|Nivolumab|nivolumab|mesh-list
43834767|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43834768|NCT05098210|Poly ICLC|poly iclc|mesh-list
43834769|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834770|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834771|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43737809|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43737810|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43737811|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737812|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737813|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
43737814|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
43737815|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43737816|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
43737818|NCT04378621|Etanercept|etanercept|mesh-list
43737819|NCT04378621|Golimumab|golimumab|mesh-list
43737820|NCT04378621|Infliximab|infliximab|mesh-list
43737821|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
43737822|NCT04378621|Tofacitinib|tofacitinib|mesh-list
43737823|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43737824|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737825|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737826|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
43737827|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43737828|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43737908|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43737909|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43737911|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43737912|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43737948|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737949|NCT04271917|Analgesics|analgesics|mesh-ancestor
43737950|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
43737984|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43737985|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43737986|NCT04250064|Growth Substances|growth substances|mesh-ancestor
43737987|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737988|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
43737989|NCT04249544|Pramipexole|pramipexole|mesh-list
43737990|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
43737991|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737992|NCT04249544|Protective Agents|protective agents|mesh-ancestor
43737993|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737994|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43737995|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43737996|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
43737997|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
43737998|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737999|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
43738000|NCT04239092|Temozolomide|temozolomide|mesh-list
43738001|NCT04239092|Irinotecan|irinotecan|mesh-list
43738002|NCT04239092|Topotecan|topotecan|mesh-list
43738029|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738031|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
43738032|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43738033|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
43738034|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738035|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
43738036|NCT04202692|Protective Agents|protective agents|mesh-ancestor
43738037|NCT04202692|Antacids|antacids|mesh-ancestor
43738038|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738039|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738040|NCT04179864|Prednisone|prednisone|mesh-list
43738041|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738106|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738107|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43738108|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
43738109|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738110|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738111|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43738112|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43738113|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43738114|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43738115|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43738150|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738151|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
43738152|NCT03984188|Theophylline|theophylline|mesh-list
43738153|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43738154|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
43738155|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738156|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738157|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44019379|NCT03771560|Folic Acid|folic acid|mesh-list
44019380|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
44019381|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019382|NCT03771560|Antidotes|antidotes|mesh-ancestor
44019383|NCT03771560|Protective Agents|protective agents|mesh-ancestor
44019384|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
44019385|NCT03771560|Vitamins|vitamins|mesh-ancestor
44019386|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
44019387|NCT03771560|Hematinics|hematinics|mesh-ancestor
44019388|NCT03767738|Aflibercept|aflibercept|mesh-list
44019389|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44019390|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44019391|NCT03767738|Growth Substances|growth substances|mesh-ancestor
44019392|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019393|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
44019394|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019395|NCT03767062|Topiramate|topiramate|mesh-list
44019396|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
44019397|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44019398|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019399|NCT03765502|Glucagon|glucagon|mesh-list
44019400|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44019401|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019402|NCT03765502|Hormones|hormones|mesh-ancestor
44165309|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738190|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
43738191|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738192|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738193|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738194|NCT03926754|Urological Agents|urological agents|mesh-ancestor
43738195|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
44019406|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
44019408|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019409|NCT03763929|Protective Agents|protective agents|mesh-ancestor
44019410|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019411|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44019412|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019413|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
43834864|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834866|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43834867|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
43834868|NCT05095961|Hormones|hormones|mesh-ancestor
43834869|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43834870|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834871|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834872|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834873|NCT05095922|Valsartan|valsartan|mesh-list
43834874|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
43834875|NCT05095922|Calcium|calcium|mesh-list
43834876|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43834877|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834878|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43834879|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43834880|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43834881|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834882|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
43738291|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43738292|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43738293|NCT03746275|Analgesics|analgesics|mesh-ancestor
43738294|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
43738295|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738296|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738297|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738298|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738299|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43738300|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43738387|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738389|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738390|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
43738391|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738392|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738421|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738422|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738423|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
43738424|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738425|NCT03527043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43738426|NCT03527043|Antidepressive Agents|antidepressive agents|mesh-ancestor
43738427|NCT03527043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43738428|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
43738429|NCT03519997|Bavituximab|bavituximab|mesh-list
43738430|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738431|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738432|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
43738436|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738437|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
43738438|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43738439|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738481|NCT03369223|Nivolumab|nivolumab|mesh-list
43738482|NCT03369223|Ipilimumab|ipilimumab|mesh-list
43738483|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738936|NCT01682941|Hormones|hormones|mesh-ancestor
43738937|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43738938|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738939|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
43738940|NCT01608451|Vitamin D|vitamin d|mesh-list
43738941|NCT01608451|Progesterone|progesterone|mesh-list
43738942|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43768998|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43574288|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43769028|NCT02390843|Mitogens|mitogens|mesh-list
43769029|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769030|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
43769031|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769032|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769033|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769034|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
43769036|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739091|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43834971|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43834972|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834973|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
43739115|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739117|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
43739118|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
43739119|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739120|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
43739121|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43739122|NCT00004494|Protective Agents|protective agents|mesh-ancestor
43739123|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739125|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43739266|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739341|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739342|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739343|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739344|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43739346|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739347|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739458|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43739459|NCT01259648|Narcotics|narcotics|mesh-ancestor
43739460|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739461|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739462|NCT01259648|Analgesics|analgesics|mesh-ancestor
43739463|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
43739464|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739465|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
43739466|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739467|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
43739468|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739469|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739470|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43739471|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
43739472|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739473|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739474|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43739475|NCT00819546|Everolimus|everolimus|mesh-list
43739483|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739509|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43739510|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739512|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43739513|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739514|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
43739515|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44019415|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019416|NCT03758365|Triamcinolone|triamcinolone|mesh-list
44019417|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44019418|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44019419|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
44019420|NCT03758365|Betamethasone|betamethasone|mesh-list
44019421|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
44019422|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43739516|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43739517|NCT02535039|Prednisolone|prednisolone|mesh-list
43739518|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
43739519|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43739520|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
43739521|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739522|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
43739523|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
43739524|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739525|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739526|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739527|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
43739528|NCT02535039|Hormones|hormones|mesh-ancestor
43739529|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43739530|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43739531|NCT02535039|Protective Agents|protective agents|mesh-ancestor
43739532|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43739533|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739534|NCT02534870|Ritonavir|ritonavir|mesh-list
43739535|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43739587|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739588|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739589|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739590|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739591|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43739592|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43739593|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739594|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739595|NCT02534363|Aripiprazole|aripiprazole|mesh-list
43739596|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43739597|NCT02534363|Ziprasidone|ziprasidone|mesh-list
43739598|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
43739599|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43739600|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43739601|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43739602|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739603|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739604|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
43739605|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
43739606|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43739619|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
43739620|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739621|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43739622|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43739623|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739624|NCT02534636|Interferons|interferons|mesh-list
43739625|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
43739626|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
43739627|NCT02534636|BMS-986165|bms-986165|mesh-list
43739628|NCT02534636|Famotidine|famotidine|mesh-list
43739688|NCT02534623|Analgesics|analgesics|mesh-ancestor
43739689|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43739690|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43739728|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
43739729|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739794|NCT02533323|Pegaspargase|pegaspargase|mesh-list
43739795|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43739796|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
43739797|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739798|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739811|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739839|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
43739840|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43739841|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43739842|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739843|NCT02533076|Capsaicin|capsaicin|mesh-list
43739844|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
43739845|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
43739846|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
43739847|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739848|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835071|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835072|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835073|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
43835074|NCT05078879|Empagliflozin|empagliflozin|mesh-list
43835075|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43835076|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835103|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43835105|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835106|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43835107|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835123|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739906|NCT02532634|Palonosetron|palonosetron|mesh-list
43739907|NCT02532634|Ramosetron|ramosetron|mesh-list
43739908|NCT02532634|BB 1101|bb 1101|mesh-list
43739909|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43739910|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
43739911|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
43739912|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019428|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44019429|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019430|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
44019432|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019433|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019434|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019435|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
44019436|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019437|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019438|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44019439|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
44019440|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
44019441|NCT03756038|Lorazepam|lorazepam|mesh-list
44019442|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
44019443|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
44019444|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
44019445|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019446|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019447|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019448|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44019449|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019450|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44019451|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019452|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019453|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
44019454|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
44019455|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019456|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019457|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
44019458|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44019459|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
44019460|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44019461|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740356|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740357|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43740358|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740359|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740361|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740362|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740363|NCT02529982|Analgesics|analgesics|mesh-ancestor
43740364|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
43740365|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740366|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740367|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740421|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740637|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43740669|NCT02528201|Diclofenac|diclofenac|mesh-list
43740670|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43740671|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43740672|NCT02528201|Analgesics|analgesics|mesh-ancestor
43740673|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
43740674|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43740675|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740676|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43740677|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740678|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43740679|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43740680|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740681|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740682|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43740713|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
43740714|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
43740715|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019482|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
44019483|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019484|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019485|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019486|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
44019487|NCT03740659|Hormones|hormones|mesh-ancestor
44019488|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019489|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019490|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019491|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
44019492|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019493|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019494|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44019495|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019496|NCT03740659|Renal Agents|renal agents|mesh-ancestor
44019497|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019498|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44019499|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44019500|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44019501|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43750630|NCT02504177|Anticoagulants|anticoagulants|mesh-list
44019502|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
44019504|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44019505|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019506|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
44019507|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019508|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44019509|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019511|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43741176|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43741177|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43741208|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43741209|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741210|NCT02525302|Halofuginone|halofuginone|mesh-list
43741211|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741212|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
43741213|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43741214|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43741215|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741216|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43741217|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741218|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741219|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43741268|NCT02524964|Analgesics|analgesics|mesh-ancestor
43741269|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
43741270|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741271|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741272|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741273|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741274|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
43741275|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43741276|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741277|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741325|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43741326|NCT02524444|Renal Agents|renal agents|mesh-ancestor
43741327|NCT02524301|Diprenorphine|diprenorphine|mesh-list
43741328|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43741329|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741355|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43741356|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
43741357|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741358|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741359|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741360|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741373|NCT05671276|Clopidogrel|clopidogrel|mesh-list
43741374|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43741375|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43741376|NCT05671276|Analgesics|analgesics|mesh-ancestor
43741401|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
43741402|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741403|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741437|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
43741438|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741439|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741440|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741441|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
43741442|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
43741443|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43741477|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741479|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43741480|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43741481|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741482|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741483|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43741484|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43741485|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43741486|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43741487|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
43741709|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741710|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
43741711|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741712|NCT05665114|Cytarabine|cytarabine|mesh-list
43741713|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
43741714|NCT05665114|Fludarabine|fludarabine|mesh-list
43544427|NCT03682211|Fentanyl|fentanyl|mesh-list
43741715|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741716|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
43741717|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741718|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43741719|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43741720|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
43741721|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741722|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741723|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43741724|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43741725|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
43741726|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
43741727|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741728|NCT05665075|Cytarabine|cytarabine|mesh-list
43741729|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
43741730|NCT05665075|Fludarabine|fludarabine|mesh-list
43741753|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741754|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741755|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
43741756|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43741757|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43741758|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835364|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
43835365|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43835366|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43835367|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43835368|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43835369|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835370|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
43835371|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835372|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835373|NCT05059028|Oxytocin|oxytocin|mesh-list
43835374|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
43835405|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43835406|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43835407|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
43835408|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
43835411|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835412|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644816|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847749|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847750|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43544597|NCT03680404|Allopurinol|allopurinol|mesh-list
43741879|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
43741880|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741881|NCT05587998|Morphine|morphine|mesh-list
43741882|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43741883|NCT05587998|Narcotics|narcotics|mesh-ancestor
43741884|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741885|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741886|NCT05587998|Analgesics|analgesics|mesh-ancestor
43741887|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
43741888|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741889|NCT05581901|Methadone|methadone|mesh-list
43741890|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43741891|NCT05581901|Narcotics|narcotics|mesh-ancestor
43741892|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741893|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741952|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
43741953|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741954|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
43741955|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
43741956|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741957|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
43741958|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741959|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
43741960|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43741962|NCT05494866|Gemcitabine|gemcitabine|mesh-list
43741963|NCT05494866|Paclitaxel|paclitaxel|mesh-list
43741964|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43741965|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741966|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
43741967|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
43741968|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
43835413|NCT05056974|UB-421|ub-421|mesh-list
43835414|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43835415|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
43835416|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43835417|NCT05056883|Ivermectin|ivermectin|mesh-list
43742051|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43742052|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742053|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43742055|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43742056|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43742057|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43742058|NCT05449015|Atropine|atropine|mesh-list
43742059|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43742060|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43742061|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43742062|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
43742063|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742064|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742082|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742084|NCT05442515|Fludarabine|fludarabine|mesh-list
43742085|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742247|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742248|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742249|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43742250|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742251|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742252|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43742253|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43742254|NCT05311176|Paclitaxel|paclitaxel|mesh-list
43742255|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
43742256|NCT05311176|Ramucirumab|ramucirumab|mesh-list
43742257|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43742334|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43742335|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43742336|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43742337|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
43742338|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742339|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835510|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835511|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43835512|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835513|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
43835514|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43835515|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742457|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43742458|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43742459|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742460|NCT05194397|Niacinamide|niacinamide|mesh-list
43742462|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
43742463|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
43742556|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
43742557|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43742558|NCT05131204|Eculizumab|eculizumab|mesh-list
43742559|NCT05131204|Ravulizumab|ravulizumab|mesh-list
43742560|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43742561|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742562|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
43742563|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742564|NCT05130892|Tranilast|tranilast|mesh-list
43742565|NCT05130892|Colchicine|colchicine|mesh-list
43742566|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
43742567|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742568|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
43742569|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742570|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742571|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742572|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742573|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43742574|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43742575|NCT05130892|Analgesics|analgesics|mesh-ancestor
43742608|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43742634|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43742635|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
43742636|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742637|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742638|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742639|NCT05060315|Treprostinil|treprostinil|mesh-list
43742640|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43742854|NCT04949516|Analgesics|analgesics|mesh-ancestor
43742855|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
43742856|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742857|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742858|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43742859|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742860|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43742861|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43742862|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742863|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43742864|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43742865|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742866|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
43742867|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
43742868|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
43742869|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742870|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742871|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742872|NCT04942210|Vaccines|vaccines|mesh-list
43742873|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
43742874|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742875|NCT04941287|Atezolizumab|atezolizumab|mesh-list
43742876|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
43742877|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43742878|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
43742879|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742880|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
43742881|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742882|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
43742883|NCT04938817|Lenvatinib|lenvatinib|mesh-list
43742884|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43742885|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742886|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742887|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019555|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019556|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019557|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019558|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019559|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
44019560|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019561|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
44019562|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44019563|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44019564|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769043|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019565|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019566|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019567|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44019568|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44019569|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44019570|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
44019571|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
43742917|NCT04929223|Growth Substances|growth substances|mesh-ancestor
43742918|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742919|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
43743018|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43743019|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43743020|NCT04853875|Antacids|antacids|mesh-ancestor
43743021|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43743022|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43743023|NCT04853199|Quercetin|quercetin|mesh-list
43743024|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
43743025|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743026|NCT04853199|Protective Agents|protective agents|mesh-ancestor
43743203|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
43743204|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743205|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743206|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43743302|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43835653|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43835654|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43743778|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43743779|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43743780|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43743781|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
43743782|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43743783|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
43743784|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43743785|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743786|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43743787|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43743788|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43743789|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43743790|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43743791|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43743854|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43743855|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
43743856|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
43743857|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43743858|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43743859|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43743860|NCT04278404|Protective Agents|protective agents|mesh-ancestor
43743861|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43743862|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43743863|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43743933|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43743970|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43743971|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743973|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43743974|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743975|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743976|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
43743977|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743978|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
43743979|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43743980|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743982|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43743983|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43743984|NCT04128956|Analgesics|analgesics|mesh-ancestor
43743985|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
43743986|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743987|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743988|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43743989|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43743990|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43744033|NCT04071236|Avelumab|avelumab|mesh-list
43744034|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43744035|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744036|NCT04071236|Peposertib|peposertib|mesh-list
43744037|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744038|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744039|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
43744040|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744041|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744058|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744059|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43744341|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43744342|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744343|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43744344|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744345|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744346|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
43744347|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43744366|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744367|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744369|NCT03630991|Edetic Acid|edetic acid|mesh-list
43744370|NCT03630991|Calcium|calcium|mesh-list
43744371|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
43744372|NCT03630991|Succimer|succimer|mesh-list
43744373|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744374|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43744375|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43744667|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
43547708|NCT03649334|Ketorolac|ketorolac|mesh-list
43744668|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744669|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43744695|NCT03258554|Antibodies|antibodies|mesh-list
43744696|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
43744697|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744698|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
43744709|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744715|NCT03232073|Ponesimod|ponesimod|mesh-list
43744716|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43744848|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744850|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744854|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43744855|NCT02954510|Hematinics|hematinics|mesh-ancestor
43744856|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43744857|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43744858|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
43744859|NCT02936752|Entinostat|entinostat|mesh-list
43744860|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43744861|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43744862|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835726|NCT05025800|Antibodies|antibodies|mesh-list
43835727|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
43835728|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43835729|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
43835730|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835731|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835732|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43835733|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43769091|NCT02390258|S66913|s66913|mesh-list
43835734|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43835735|NCT05025800|Growth Substances|growth substances|mesh-ancestor
43835736|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43835737|NCT05025787|Celecoxib|celecoxib|mesh-list
43745221|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43745222|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43745224|NCT02568553|Blinatumomab|blinatumomab|mesh-list
43745262|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745263|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745264|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43745363|NCT02446600|Gemcitabine|gemcitabine|mesh-list
43745364|NCT02446600|Paclitaxel|paclitaxel|mesh-list
43745365|NCT02446600|Carboplatin|carboplatin|mesh-list
43745366|NCT02446600|Doxorubicin|doxorubicin|mesh-list
43745367|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43745368|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43745369|NCT02446600|Olaparib|olaparib|mesh-list
43745370|NCT02446600|Cediranib|cediranib|mesh-list
43745792|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43745793|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43745794|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745795|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43745796|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
43745797|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43745798|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745800|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
43745801|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43745888|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43745889|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745890|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
43745891|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43745892|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43745893|NCT01863550|Growth Substances|growth substances|mesh-ancestor
43745894|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
43745895|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
43745896|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745897|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745898|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
43745900|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019578|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019579|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019580|NCT03591458|Amitriptyline|amitriptyline|mesh-list
44019581|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44019582|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
44019583|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019584|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44019585|NCT03591458|Analgesics|analgesics|mesh-ancestor
44019586|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
44019587|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019588|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019589|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44019590|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44019591|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769127|NCT02389751|Carboplatin|carboplatin|mesh-list
44019592|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019593|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019594|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019595|NCT03565328|Niacinamide|niacinamide|mesh-list
44019597|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
44019598|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
44019599|NCT03565328|Vitamins|vitamins|mesh-ancestor
44019600|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
44019601|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019602|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44019603|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
44019604|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019605|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44019606|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
44019607|NCT03538015|Carvedilol|carvedilol|mesh-list
44019608|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43745901|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
43745939|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43746136|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746137|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746138|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
43746139|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746140|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
43746141|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43746142|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746143|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44019609|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44019611|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019612|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019613|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019614|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019615|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
44019616|NCT03538015|Protective Agents|protective agents|mesh-ancestor
44019617|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44019618|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019619|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44019620|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
44019621|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44019622|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44019623|NCT03490916|Acetazolamide|acetazolamide|mesh-list
44019624|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
44019625|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44019626|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019627|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019628|NCT03490916|Diuretics|diuretics|mesh-ancestor
44019629|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
44019630|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019631|NCT03465735|Heparin|heparin|mesh-list
44019632|NCT03465735|Enoxaparin|enoxaparin|mesh-list
44019633|NCT03465735|Dalteparin|dalteparin|mesh-list
44019634|NCT03465735|Warfarin|warfarin|mesh-list
43746197|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746198|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
43746202|NCT00602459|Lenalidomide|lenalidomide|mesh-list
43746203|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43746204|NCT00602459|Antibodies|antibodies|mesh-list
43769136|NCT02389868|L 647318|l 647318|mesh-list
43769137|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
43769138|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43769160|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
43769161|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43746205|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
43746206|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43746207|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746208|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
43746209|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746210|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746211|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43746212|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
43746213|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746214|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43746215|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43746216|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43746217|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
43746218|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43746219|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43746220|NCT00602459|Growth Substances|growth substances|mesh-ancestor
43746221|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
43746249|NCT00601003|Nifurtimox|nifurtimox|mesh-list
43746250|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
43746251|NCT00601003|Topotecan|topotecan|mesh-list
43746252|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43746253|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
43746254|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43746255|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43746450|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43746451|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43746452|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43746453|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
43746689|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43746690|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43746691|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43746692|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
43746693|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43746694|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
43746695|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
43746696|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
43747047|NCT02520817|Protective Agents|protective agents|mesh-ancestor
43747048|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747049|NCT02520219|Endostar protein|endostar protein|mesh-list
43747485|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43747486|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
43747488|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747489|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43747490|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747491|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
43747520|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747521|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747523|NCT05567068|Atorvastatin|atorvastatin|mesh-list
43747524|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747525|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747526|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
43747527|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747528|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769162|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43769163|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769164|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
43769165|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43769166|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
43587370|NCT03395132|Betamethasone|betamethasone|mesh-list
43839234|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839235|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839236|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43779730|NCT04895488|Vortioxetine|vortioxetine|mesh-list
43779731|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
43779732|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
43779733|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779734|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43779735|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43747529|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43747530|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747531|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43747532|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747533|NCT05567068|Analgesics|analgesics|mesh-ancestor
44019671|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44019672|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44019673|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019674|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
44019675|NCT03425799|Coagulants|coagulants|mesh-ancestor
44019676|NCT03370536|Ibutilide|ibutilide|mesh-list
44019677|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44019678|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
44019679|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44019680|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44148497|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44148498|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44148499|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44148500|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44148501|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44148502|NCT00204438|Progestins|progestins|mesh-ancestor
44148503|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
44148504|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44148505|NCT00204451|Estradiol|estradiol|mesh-list
44148506|NCT00204451|Estrogens|estrogens|mesh-ancestor
44148507|NCT00204451|Hormones|hormones|mesh-ancestor
44148508|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148509|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148510|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44148511|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
44148512|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43747534|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
43747535|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747536|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748256|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748257|NCT03143985|Growth Substances|growth substances|mesh-ancestor
43748258|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748259|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748260|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
43748261|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43748262|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43748263|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748264|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
43748265|NCT03128866|Coagulants|coagulants|mesh-ancestor
43748266|NCT03114319|Nazartinib|nazartinib|mesh-list
43748267|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748268|NCT03072147|Teriparatide|teriparatide|mesh-list
43748269|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43748270|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748271|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43748272|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
43748273|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748274|NCT03030261|Dexamethasone|dexamethasone|mesh-list
43748275|NCT03030261|Pomalidomide|pomalidomide|mesh-list
43748276|NCT03030261|Elotuzumab|elotuzumab|mesh-list
43748277|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748278|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
43836055|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
43836056|NCT05003570|Fentanyl|fentanyl|mesh-list
43836057|NCT05003570|Remifentanil|remifentanil|mesh-list
43836058|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43836059|NCT05003570|Narcotics|narcotics|mesh-ancestor
43836060|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836061|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748768|NCT02515734|Protective Agents|protective agents|mesh-ancestor
43748769|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
43748770|NCT02515734|Vitamins|vitamins|mesh-ancestor
43748771|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
43748844|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748846|NCT02515201|Heparin|heparin|mesh-list
43748847|NCT02515201|Calcium heparin|calcium heparin|mesh-list
43748880|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
43748881|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748882|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748883|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43748884|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748885|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748886|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43748888|NCT02514941|Acetaminophen|acetaminophen|mesh-list
43748914|NCT02514980|Analgesics|analgesics|mesh-ancestor
43748915|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43748916|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43748917|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
43748918|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43748919|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43748920|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748921|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748922|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
43748923|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748924|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748925|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
43748926|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43748927|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748928|NCT02514681|Gemcitabine|gemcitabine|mesh-list
43748929|NCT02514681|Paclitaxel|paclitaxel|mesh-list
43748930|NCT02514681|Vinorelbine|vinorelbine|mesh-list
43748931|NCT02514681|Docetaxel|docetaxel|mesh-list
43748932|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43748933|NCT02514681|Capecitabine|capecitabine|mesh-list
43748934|NCT02514681|Trastuzumab|trastuzumab|mesh-list
43748935|NCT02514681|Pertuzumab|pertuzumab|mesh-list
43748936|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43748937|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748938|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
43748939|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
43748940|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
43748941|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019746|NCT03150160|Brinzolamide|brinzolamide|mesh-list
44019747|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44019748|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44019749|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44019750|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44019751|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44019752|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019753|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019754|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750833|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
44019755|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019756|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44019759|NCT03109418|Analgesics|analgesics|mesh-ancestor
44019760|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
44019761|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019762|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019763|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43749138|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749139|NCT02513342|Cisplatin|cisplatin|mesh-list
43749188|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
43749189|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749190|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749191|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
43749299|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43749300|NCT02511613|Growth Substances|growth substances|mesh-ancestor
43749301|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749302|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
43749303|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749304|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43749305|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749306|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44019764|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44019765|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
44019766|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
44019767|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019768|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44019769|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44019770|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019771|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019772|NCT03109873|Metformin|metformin|mesh-list
44019773|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44019774|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019775|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
44019776|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44019777|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44019778|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44019779|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019780|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019781|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
44019782|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019783|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019784|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019785|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019786|NCT03042780|Folfirinox|folfirinox|mesh-list
44019787|NCT03042780|Lenograstim|lenograstim|mesh-list
44019788|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44019789|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
44019790|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019791|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019792|NCT03031340|Pregabalin|pregabalin|mesh-list
44019793|NCT03031340|Analgesics|analgesics|mesh-ancestor
44019794|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
44019795|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019796|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019797|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
44019798|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44019799|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019812|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019813|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
44019814|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44019815|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43749651|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43749653|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
43749654|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749655|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749656|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749657|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749658|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43749659|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
43749660|NCT02509351|Misoprostol|misoprostol|mesh-list
43749661|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43749662|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
43749663|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43749690|NCT02509234|Irinotecan|irinotecan|mesh-list
43749757|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749759|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749760|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749761|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
43749762|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43749763|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749764|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749765|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
43749766|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43749767|NCT02508922|Vitamin D|vitamin d|mesh-list
43553103|NCT03597945|Lidocaine|lidocaine|mesh-list
43749768|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
43749769|NCT02508922|Vitamins|vitamins|mesh-ancestor
43749780|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749781|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749782|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836209|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836210|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836211|NCT04988217|Interferons|interferons|mesh-list
43836212|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
43836213|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
43836214|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836215|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
43749829|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
43749830|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749831|NCT02508402|Dexamethasone|dexamethasone|mesh-list
43749832|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43749833|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
43749889|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749890|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43749891|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43749892|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749894|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43749895|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
43749896|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749897|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
43553260|NCT03590496|Calcium|calcium|mesh-list
43749898|NCT02507934|Protective Agents|protective agents|mesh-ancestor
43749899|NCT02507843|Vitamin D|vitamin d|mesh-list
43749900|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
43749901|NCT02507843|Vitamins|vitamins|mesh-ancestor
43749902|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
43749903|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836242|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836243|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750090|NCT02506842|Vitamins|vitamins|mesh-ancestor
43750091|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
43750092|NCT02506842|Hematinics|hematinics|mesh-ancestor
43750093|NCT02506699|Analgesics|analgesics|mesh-list
43750094|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
43750215|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750216|NCT02506140|Aspirin|aspirin|mesh-list
43750217|NCT02506140|Clopidogrel|clopidogrel|mesh-list
43750218|NCT02506140|Ticagrelor|ticagrelor|mesh-list
43750219|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43750220|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43750302|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
43750303|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
43750304|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
43750305|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750306|NCT02505880|Anesthetics|anesthetics|mesh-list
43750360|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750361|NCT02505477|Protective Agents|protective agents|mesh-ancestor
43750362|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750480|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43750482|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750483|NCT02505087|Protective Agents|protective agents|mesh-ancestor
43750484|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750485|NCT02505087|Antidotes|antidotes|mesh-ancestor
43750486|NCT02504801|Budesonide|budesonide|mesh-list
43750487|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43750488|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43750550|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43750552|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43750553|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750555|NCT02504359|Methotrexate|methotrexate|mesh-list
43750556|NCT02504359|Etoposide|etoposide|mesh-list
43750557|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
43750558|NCT02504359|Melphalan|melphalan|mesh-list
43750559|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
43750560|NCT02504359|Carmustine|carmustine|mesh-list
43750561|NCT02504359|Ixazomib|ixazomib|mesh-list
43750562|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
43750563|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43750593|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
43750651|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43750652|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750653|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
43750654|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43750655|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
43750656|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43651967|NCT03004014|Propofol|propofol|mesh-list
43751036|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751037|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43751309|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
43751310|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43751311|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43751349|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
43751350|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43751351|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
43751352|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751353|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43751354|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751355|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43751356|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
43751357|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019820|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019821|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019822|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44019823|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847840|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847841|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
43847842|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751799|NCT02495584|Vitamin D|vitamin d|mesh-list
43751800|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
43751801|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
43751802|NCT02495584|Vitamins|vitamins|mesh-list
43751803|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
43751804|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751805|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43751831|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43751832|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751833|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43751835|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
43751836|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
43751837|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751838|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751839|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43751840|NCT02495662|Protective Agents|protective agents|mesh-ancestor
43751841|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43751842|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43751843|NCT02496052|Estradiol|estradiol|mesh-list
43751844|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43751845|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
43751846|NCT02496052|Estrogens|estrogens|mesh-ancestor
43752000|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752002|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43752003|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752004|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43752005|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
43752006|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752032|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
43752033|NCT02494284|Aspirin|aspirin|mesh-list
43752034|NCT02494284|Clopidogrel|clopidogrel|mesh-list
43752035|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752036|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752037|NCT02494284|Analgesics|analgesics|mesh-ancestor
43752038|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
43752039|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752040|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752041|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836454|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
43836455|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43752082|NCT02493894|Cefazolin|cefazolin|mesh-list
43752083|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43651970|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752084|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752085|NCT02493725|Eculizumab|eculizumab|mesh-list
43752086|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43752087|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752088|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
43752089|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752090|NCT02493738|Itraconazole|itraconazole|mesh-list
43752091|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
43752092|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752093|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43752094|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43752095|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752096|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752097|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43752098|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
43752110|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43752111|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752112|NCT02493465|Everolimus|everolimus|mesh-list
43752113|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752114|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752119|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43752121|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752122|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752123|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43752124|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752125|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
43752126|NCT02493335|Hormones|hormones|mesh-ancestor
43752127|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752189|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752190|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752191|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752192|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43752193|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
43752194|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752195|NCT02492945|Lidocaine|lidocaine|mesh-list
43752196|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43752236|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
43752237|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752238|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
43752239|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752240|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43752241|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
43752242|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43752243|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43752244|NCT02492386|Everolimus|everolimus|mesh-list
43752245|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019840|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44019841|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44019842|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
44019843|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44019844|NCT02971839|Ivacaftor|ivacaftor|mesh-list
44019845|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44019846|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44019847|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019848|NCT02985840|Dexamethasone|dexamethasone|mesh-list
44019849|NCT02985840|Ondansetron|ondansetron|mesh-list
44019850|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44019851|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
44019852|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
44019853|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019854|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019855|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44019856|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
44019857|NCT02985840|Hormones|hormones|mesh-ancestor
44019858|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019859|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019860|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019861|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
44019862|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
44019863|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44019864|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
44019865|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019866|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019867|NCT02985840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44019868|NCT02985840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44019869|NCT02985840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019870|NCT02985840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44019871|NCT02985840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44019872|NCT02974803|Trametinib|trametinib|mesh-list
44019873|NCT02974803|Dabrafenib|dabrafenib|mesh-list
43752246|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752247|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
43752298|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752299|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43752300|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836472|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836473|NCT04970108|Empagliflozin|empagliflozin|mesh-list
43836475|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43836476|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836478|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836479|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836480|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43836481|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43836482|NCT04969510|Pramoxine|pramoxine|mesh-list
43836483|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
43836484|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
43836485|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43836486|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836487|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
43836488|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836489|NCT04969224|Ivacaftor|ivacaftor|mesh-list
43836490|NCT04969224|Elexacaftor|elexacaftor|mesh-list
43836491|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43836492|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43752316|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
43752317|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43752345|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752346|NCT02491736|Ketoprofen|ketoprofen|mesh-list
43752347|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752348|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752349|NCT02491736|Analgesics|analgesics|mesh-ancestor
43752350|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
43752355|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43752356|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752357|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752358|NCT02491970|Fluticasone|fluticasone|mesh-list
43752360|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
43752361|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43752362|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43752363|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752383|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43752384|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43752386|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
43752387|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752388|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752420|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752421|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43752422|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
43752423|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43752424|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43752425|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752426|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43752427|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
43752428|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43752429|NCT02491268|Protective Agents|protective agents|mesh-ancestor
43752430|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43752474|NCT02490982|Analgesics|analgesics|mesh-ancestor
43752475|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
43752476|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752477|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752478|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752479|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43752480|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752481|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
43752482|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43752483|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43752484|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752485|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43752486|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
43752487|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752488|NCT02490657|Iloprost|iloprost|mesh-list
43752489|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43752490|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
43752491|NCT02490592|Fluorides|fluorides|mesh-list
43752535|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752536|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43752537|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43752538|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836494|NCT04969120|Metoclopramide|metoclopramide|mesh-list
43836495|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
43836496|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
43836497|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836498|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836499|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836500|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43836501|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43836502|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
43836503|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836504|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836505|NCT04967664|Capsaicin|capsaicin|mesh-list
43836506|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
43836507|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
43836508|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
43836509|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43836510|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836511|NCT04967495|Sorafenib|sorafenib|mesh-list
43836512|NCT04967495|Lenvatinib|lenvatinib|mesh-list
43836513|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
43836514|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836515|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836516|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836517|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836518|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43836519|NCT04967495|Estrogens|estrogens|mesh-ancestor
43836520|NCT04967495|Hormones|hormones|mesh-ancestor
43836521|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752610|NCT02490098|Insulin|insulin|mesh-list
43752611|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43752612|NCT02490098|Glucagon|glucagon|mesh-list
43752613|NCT02490098|Hormones|hormones|mesh-list
43752614|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43752615|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752616|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752617|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836609|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43753145|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
43753146|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43753147|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
43753148|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753149|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753150|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
43753152|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43753153|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43753181|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753182|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43753183|NCT02486458|Listerine|listerine|mesh-list
43753184|NCT02486458|Fluorides|fluorides|mesh-list
43753185|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
43753237|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43753238|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
43753239|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753240|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753241|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43753242|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
43753243|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43753244|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43753245|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753284|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43753285|NCT02485873|Vitamin K|vitamin k|mesh-list
43753286|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
43753287|NCT02485873|Vitamins|vitamins|mesh-ancestor
43753288|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
43753289|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753290|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43753312|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753599|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43753617|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753644|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753899|NCT02482324|Analgesics|analgesics|mesh-ancestor
43753900|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
43753901|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753902|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753903|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753904|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753905|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43753906|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754075|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43754076|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754077|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
43754078|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
43754079|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
43754080|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754081|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
43754082|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43754116|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
43754117|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
43754118|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43754119|NCT02480387|Ledipasvir|ledipasvir|mesh-list
43754120|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
43754121|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754213|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43754214|NCT02479620|BB 1101|bb 1101|mesh-list
43754215|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754216|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
43754217|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
43754218|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754219|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754220|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754221|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
43754222|NCT02479620|Hormones|hormones|mesh-ancestor
43754223|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836691|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43836692|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836694|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836695|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
43836696|NCT04955743|Lenvatinib|lenvatinib|mesh-list
43836697|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836698|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754327|NCT02479347|Povidone|povidone|mesh-list
43754411|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43754412|NCT02479074|Protective Agents|protective agents|mesh-ancestor
43754581|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
43754582|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43754583|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754584|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43754585|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754586|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754587|NCT02477631|Deferiprone|deferiprone|mesh-list
43754588|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43754589|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
43754590|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
43754591|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754593|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
43754594|NCT02477514|Midazolam|midazolam|mesh-list
43754595|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43754596|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43754597|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43754598|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754854|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754855|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754856|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43754857|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754858|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754859|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754860|NCT02476760|Insulin|insulin|mesh-list
43754861|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43754862|NCT02476760|Metformin|metformin|mesh-list
43754863|NCT02476760|Pioglitazone|pioglitazone|mesh-list
43754864|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43754865|NCT02476760|Liraglutide|liraglutide|mesh-list
43754866|NCT02476760|Exenatide|exenatide|mesh-list
43754867|NCT02476760|Glimepiride|glimepiride|mesh-list
43754868|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
43754869|NCT02476760|Vildagliptin|vildagliptin|mesh-list
43754870|NCT02476760|Saxagliptin|saxagliptin|mesh-list
43754871|NCT02476760|Acarbose|acarbose|mesh-list
43754872|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43754873|NCT02476760|Repaglinide|repaglinide|mesh-list
43754874|NCT02476760|Gliclazide|gliclazide|mesh-list
43754875|NCT02476760|Glipizide|glipizide|mesh-list
43754876|NCT02476760|Biguanides|biguanides|mesh-list
43754877|NCT02476760|Voglibose|voglibose|mesh-list
43754878|NCT02476760|Tolbutamide|tolbutamide|mesh-list
43754879|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43754880|NCT02476760|Nateglinide|nateglinide|mesh-list
43754928|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43754930|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836883|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43836884|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836885|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836886|NCT04943224|Trametinib|trametinib|mesh-list
43836887|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836888|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836889|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836890|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836891|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43836892|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44019877|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019878|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
44019880|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019881|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44019882|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
44019883|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019884|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44019885|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44019886|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
44019887|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44019888|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44019889|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44019890|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019891|NCT02966184|Albuterol|albuterol|mesh-list
44019892|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44019893|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
44019894|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019895|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019896|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44019897|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
44019898|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
44019899|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44019900|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44019901|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44019902|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44019903|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
44019904|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019919|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019920|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019921|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44019922|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44019923|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44019924|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44019925|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
44019926|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
44019927|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44019928|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44019929|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019930|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
44019931|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
44019932|NCT02892500|Betamethasone|betamethasone|mesh-list
44019933|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
44019934|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44019935|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
44019936|NCT02892500|Bupivacaine|bupivacaine|mesh-list
44019937|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44019938|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019939|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
44019940|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44019941|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019942|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
44019946|NCT02892500|Hormones|hormones|mesh-ancestor
43755916|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43756079|NCT02468232|Enalaprilat|enalaprilat|mesh-list
43756080|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43756081|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43756082|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
43756083|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756084|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756085|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756086|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43756087|NCT02468206|Polidocanol|polidocanol|mesh-list
43756088|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43756089|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43756090|NCT02468128|Nalbuphine|nalbuphine|mesh-list
43756091|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43756131|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43756133|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43756134|NCT02467907|Growth Substances|growth substances|mesh-ancestor
43756135|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756136|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
43756138|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43756139|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756140|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43756141|NCT02467920|Incretins|incretins|mesh-ancestor
43756142|NCT02467920|Hormones|hormones|mesh-ancestor
43756143|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43756144|NCT02467647|Thalidomide|thalidomide|mesh-list
43756145|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43756146|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
43756147|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756148|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
43756149|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43756150|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756253|NCT02467517|Ketamine|ketamine|mesh-list
43756254|NCT02467517|Analgesics|analgesics|mesh-ancestor
43756337|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756338|NCT02467010|Dexamethasone|dexamethasone|mesh-list
43756339|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
43756341|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43756376|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43756377|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43756378|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43756413|NCT02466568|Vaccines|vaccines|mesh-list
43756414|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
43756415|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756416|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43756417|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756418|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43756419|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756449|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
43756450|NCT02466464|Coagulants|coagulants|mesh-ancestor
43836956|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43836957|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43756451|NCT02466373|Clonidine|clonidine|mesh-list
43756452|NCT02466373|Analgesics|analgesics|mesh-ancestor
43756453|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
43756454|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756455|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756497|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
43756498|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43756499|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43756500|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756501|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756502|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43756503|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43756504|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756505|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756506|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
43756541|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
43756542|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
43756543|NCT02466035|Caseins|caseins|mesh-list
43756544|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
43756545|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
43756546|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756547|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
43756633|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756634|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756635|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
43756636|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756637|NCT02465255|Acetaminophen|acetaminophen|mesh-list
43756639|NCT02465255|Tramadol|tramadol|mesh-list
43756640|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43756641|NCT02465255|Analgesics|analgesics|mesh-ancestor
43756642|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
43756643|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756644|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756645|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
43756646|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43756647|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43756648|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43756649|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43756650|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756679|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756681|NCT02464722|Narcotics|narcotics|mesh-ancestor
43756682|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43756683|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43756684|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
43756685|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43756686|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
43756687|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
43756688|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
43756689|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43756690|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43756691|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43756692|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43756693|NCT02464761|Verteporfin|verteporfin|mesh-list
43756694|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43756695|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43756696|NCT02464865|Thiamine|thiamine|mesh-list
43756697|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
43756698|NCT02464865|Vitamins|vitamins|mesh-ancestor
43836975|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43836976|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43836977|NCT04939844|Growth Substances|growth substances|mesh-ancestor
43836978|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
43836979|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836980|NCT04939792|Vitamin D|vitamin d|mesh-list
43836981|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
43836982|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
43836983|NCT04939792|Vitamins|vitamins|mesh-list
43836984|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
43837018|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837019|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43756772|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
43756773|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
43756774|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847992|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756775|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43756814|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
43756880|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
43756881|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43756882|NCT02463110|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43756910|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
43756911|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43756912|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43756913|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43756914|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43756915|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756916|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43756917|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43756918|NCT02463006|Methamphetamine|methamphetamine|mesh-list
43756919|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43756920|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756921|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
43757030|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43757032|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
43757033|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43757034|NCT02462369|Glimepiride|glimepiride|mesh-list
43757035|NCT02462369|Saxagliptin|saxagliptin|mesh-list
43757036|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43757037|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757038|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757039|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757040|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
43757182|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
43757183|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
43757184|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757185|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757186|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
43757187|NCT02461888|Hormones|hormones|mesh-ancestor
43757188|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757189|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43757190|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
43757228|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43757229|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
43757230|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
43757231|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757316|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757317|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43757319|NCT02460913|Morphine|morphine|mesh-list
43757320|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43757321|NCT02460913|Narcotics|narcotics|mesh-ancestor
43757322|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757323|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757324|NCT02460913|Analgesics|analgesics|mesh-ancestor
43757325|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
43757326|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757327|NCT02460497|Minoxidil|minoxidil|mesh-list
43757365|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757366|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757367|NCT02460640|Analgesics|analgesics|mesh-ancestor
43757402|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757404|NCT02460367|Tryptophan|tryptophan|mesh-list
43757405|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757406|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
43757407|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
43757408|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
43757409|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757410|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43757411|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
43757412|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43757413|NCT02460211|Vitamin D|vitamin d|mesh-list
43757414|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
44019981|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
44019982|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44019983|NCT02758132|Denosumab|denosumab|mesh-list
43757415|NCT02460211|Vitamins|vitamins|mesh-ancestor
43757416|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
43757417|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757446|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43757447|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757449|NCT02460133|Ribavirin|ribavirin|mesh-list
43757450|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43757451|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43757452|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
43757453|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757454|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757455|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43757456|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43757457|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
43757458|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757459|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43757460|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43757461|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
43757538|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
43757539|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43757540|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43757541|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
43757542|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757543|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757544|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
43757545|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43757546|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757547|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757548|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43757581|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757582|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43757583|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43757584|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
43757585|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43757586|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757587|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
43757588|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43757589|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837110|NCT04930900|Epinephrine|epinephrine|mesh-list
43837111|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43837112|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43837113|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837114|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837115|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837116|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837117|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43837118|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43837119|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
43837120|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757679|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
43757680|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757681|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43757682|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43757683|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43757684|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43757685|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43757686|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757695|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43757696|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43757697|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757700|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43757701|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
43757801|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43757802|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757803|NCT02457975|Ranibizumab|ranibizumab|mesh-list
43757804|NCT02457975|Aflibercept|aflibercept|mesh-list
43757814|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769291|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43757815|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757817|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43757818|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757819|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757820|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43757821|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43757857|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43757858|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
43757859|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43757860|NCT02457806|Protective Agents|protective agents|mesh-ancestor
43757954|NCT02456935|Esomeprazole|esomeprazole|mesh-list
43757955|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43757956|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757957|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43757958|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757959|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757960|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
43758021|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
43758022|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43758023|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758024|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758025|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44019987|NCT02758132|Hormones|hormones|mesh-ancestor
44019988|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44019989|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44019990|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44019991|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44019992|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44019993|NCT02734940|Lidocaine|lidocaine|mesh-list
44019994|NCT02734940|Fentanyl|fentanyl|mesh-list
43758026|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758027|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758028|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43758029|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
43758030|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
43758060|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758061|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758062|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43758063|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43758064|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758065|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758067|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758068|NCT02456454|Valproic Acid|valproic acid|mesh-list
43758069|NCT02456454|Risperidone|risperidone|mesh-list
43758070|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43758071|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
43758072|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758144|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758145|NCT02456428|Hormones|hormones|mesh-ancestor
43758146|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769333|NCT02387918|Hormones|hormones|mesh-ancestor
43758147|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
43758148|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758149|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758150|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43758151|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758152|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758153|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
43758154|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
43758155|NCT02456350|Fludarabine|fludarabine|mesh-list
43758156|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43758157|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
43758158|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758159|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758171|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43758172|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43758173|NCT02456363|Analgesics|analgesics|mesh-ancestor
43758174|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
43758205|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43758206|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
43758207|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43758208|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758209|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43758238|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
43758239|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43758240|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43758241|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758242|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43758243|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43758244|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43758245|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758246|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43758247|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758248|NCT02455726|Narcotics|narcotics|mesh-ancestor
43758250|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43758251|NCT02455908|Aldesleukin|aldesleukin|mesh-list
43758252|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758253|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43758254|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44019995|NCT02734940|Ketamine|ketamine|mesh-list
44019996|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
44019997|NCT02734940|Morphine|morphine|mesh-list
44019998|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
44019999|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
44020000|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020001|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020002|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
44020003|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020004|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44020005|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44020006|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44020007|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020008|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020009|NCT02734940|Analgesics|analgesics|mesh-ancestor
44020010|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44020011|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020012|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
44020013|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44020014|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44020015|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020016|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44020017|NCT02734940|Narcotics|narcotics|mesh-ancestor
44020018|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44020019|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44020020|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020021|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44020022|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44020023|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769344|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758255|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
43758282|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43758283|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758284|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43758285|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
43758286|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758287|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758288|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43758289|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
43758290|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
43758291|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
43758292|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43758293|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43758294|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
43758295|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758296|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758422|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43758423|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758426|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758427|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758428|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758429|NCT02454881|Narcotics|narcotics|mesh-ancestor
43758430|NCT02455115|Chromium|chromium|mesh-list
43758431|NCT02455115|Norepinephrine|norepinephrine|mesh-list
43758432|NCT02455115|Edetic Acid|edetic acid|mesh-list
43758433|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
43758434|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43758435|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43758436|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
43758437|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758464|NCT02454764|Interferons|interferons|mesh-list
43758466|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
43758467|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
43758468|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758469|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
43758470|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43758471|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43758472|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43758473|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758474|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758475|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43758476|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43758477|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
43758478|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758479|NCT02454751|Fentanyl|fentanyl|mesh-list
43758480|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758481|NCT02454751|Narcotics|narcotics|mesh-ancestor
43758482|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758483|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758484|NCT02454751|Analgesics|analgesics|mesh-ancestor
43758485|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
43758486|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758656|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43758657|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769356|NCT02387307|Interferons|interferons|mesh-list
43769357|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769358|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
43769359|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769360|NCT02387567|Lidocaine|lidocaine|mesh-list
43769361|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769362|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
43679120|NCT02856568|Ricolinostat|ricolinostat|mesh-list
43588146|NCT03390374|Nystatin|nystatin|mesh-list
43758658|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758694|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43758695|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
43758696|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43758697|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
43758792|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
43758793|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
43758809|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758811|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758812|NCT02452515|Fulacimstat|fulacimstat|mesh-list
43758813|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758814|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758815|NCT02452684|Eszopiclone|eszopiclone|mesh-list
44020026|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44020028|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44020029|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020030|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020031|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020032|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
44020033|NCT02749227|Pasireotide|pasireotide|mesh-list
44020034|NCT02749227|Hormones|hormones|mesh-ancestor
44020035|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020036|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020037|NCT02746263|Acetaminophen|acetaminophen|mesh-list
44020038|NCT02746263|Morphine|morphine|mesh-list
44020039|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44020040|NCT02746263|Narcotics|narcotics|mesh-ancestor
43758816|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43758817|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758818|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758819|NCT02452437|Oxycodone|oxycodone|mesh-list
43758820|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43758821|NCT02452437|Narcotics|narcotics|mesh-ancestor
43758822|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758823|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758824|NCT02452437|Analgesics|analgesics|mesh-ancestor
43758825|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
43758826|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758827|NCT02452606|Levodopa|levodopa|mesh-list
43758828|NCT02452606|Carbidopa|carbidopa|mesh-list
43758829|NCT02452606|Entacapone|entacapone|mesh-list
43758830|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43758831|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43758832|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
43758833|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43758834|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758835|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758836|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43758837|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758838|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43758839|NCT02452502|Atorvastatin|atorvastatin|mesh-list
43758840|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43758841|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43758842|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
43758843|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758844|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43758845|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43758846|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758847|NCT02452385|Vorolanib|vorolanib|mesh-list
43758848|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43758881|NCT02452307|Molgramostim|molgramostim|mesh-list
43758882|NCT02452307|Protamines|protamines|mesh-list
43563248|NCT01302249|Timolol|timolol|mesh-list
43758883|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43758884|NCT02452307|Sargramostim|sargramostim|mesh-list
43758885|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43758886|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
43758887|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020041|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020042|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020043|NCT02746263|Analgesics|analgesics|mesh-ancestor
44020044|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
44020045|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020046|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020047|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
44020049|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44020050|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44020051|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44020052|NCT02717949|Ribavirin|ribavirin|mesh-list
44020053|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
44020054|NCT02717949|Ledipasvir|ledipasvir|mesh-list
44020055|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
44020056|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020057|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
44020058|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020059|NCT02708849|Lamotrigine|lamotrigine|mesh-list
44020060|NCT02708849|Ketamine|ketamine|mesh-list
44020061|NCT02708849|Analgesics|analgesics|mesh-ancestor
44020062|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
44020063|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020064|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020065|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44020066|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44020067|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
44020068|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
44020069|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020070|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44020071|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44020072|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020085|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758888|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758923|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43758924|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43758925|NCT02452112|Lidocaine|lidocaine|mesh-list
43758926|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
43758927|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
43758928|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758929|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759116|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759117|NCT02450981|Bevacizumab|bevacizumab|mesh-list
43759118|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43759178|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
43759179|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43759180|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
43759181|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759182|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759185|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759186|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759187|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759214|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759215|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759216|NCT02450175|Everolimus|everolimus|mesh-list
43759217|NCT02450175|Letrozole|letrozole|mesh-list
43759218|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759219|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759312|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759313|NCT02449733|Tenofovir|tenofovir|mesh-list
43759314|NCT02449733|Emtricitabine|emtricitabine|mesh-list
43759315|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43759355|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
43759356|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43759357|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759358|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43759359|NCT02449603|Incretins|incretins|mesh-ancestor
43759360|NCT02449603|Hormones|hormones|mesh-ancestor
43759361|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759363|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
43759364|NCT02450058|Fluorouracil|fluorouracil|mesh-list
43759396|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759397|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759398|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
43759399|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759400|NCT02449265|Prednisone|prednisone|mesh-list
43759401|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
43759402|NCT02449265|Doxorubicin|doxorubicin|mesh-list
43759403|NCT02449265|Vincristine|vincristine|mesh-list
43759404|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759405|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
43759406|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759407|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43759432|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43759433|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43759434|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43563824|NCT01183949|Bortezomib|bortezomib|mesh-list
43759435|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43759436|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
43759437|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759438|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43759439|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43759440|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759441|NCT02449369|Acetaminophen|acetaminophen|mesh-list
43759445|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759446|NCT02449369|Analgesics|analgesics|mesh-ancestor
43759447|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
43759448|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759449|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759450|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
43759451|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43759452|NCT02449369|Narcotics|narcotics|mesh-ancestor
43759453|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759454|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43759455|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43759497|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
43759498|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
43759499|NCT02449070|Vitamins|vitamins|mesh-ancestor
43759500|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
43759591|NCT02448290|Docetaxel|docetaxel|mesh-list
43837257|NCT04920695|Protective Agents|protective agents|mesh-ancestor
43837259|NCT04920565|Polymyxin B|polymyxin b|mesh-list
43837260|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43837290|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43759614|NCT02448082|Ichthammol|ichthammol|mesh-list
43759615|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
43759616|NCT02448069|Argatroban|argatroban|mesh-list
43759617|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
43759618|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43759619|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
43759620|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759621|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43759622|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
43759623|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43759624|NCT02447965|Bupivacaine|bupivacaine|mesh-list
43759625|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
43759626|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
43759627|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759657|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43759658|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
43759659|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
43759660|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
43759661|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759662|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43759663|NCT02447757|Remifentanil|remifentanil|mesh-list
43759664|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43759665|NCT02447757|Narcotics|narcotics|mesh-ancestor
43759666|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759667|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759668|NCT02447757|Analgesics|analgesics|mesh-ancestor
43759669|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
43759670|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759700|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
43759701|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43759702|NCT02447796|Analgesics|analgesics|mesh-ancestor
43759703|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
43759704|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759705|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43847630|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760499|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760500|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
43760501|NCT00977483|Vitamins|vitamins|mesh-ancestor
43760502|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
43760503|NCT00777348|Reproterol|reproterol|mesh-list
43760504|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43760505|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43760638|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760640|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
43760641|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760642|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760643|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
43671010|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43671018|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43671019|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43671020|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43671021|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671111|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43671112|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671113|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671115|NCT05166876|Brequinar|brequinar|mesh-list
43671116|NCT05166876|Dipyridamole|dipyridamole|mesh-list
43671117|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43671118|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671119|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671120|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43671121|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
43671122|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671123|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671124|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
43671125|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671126|NCT05159050|Paclitaxel|paclitaxel|mesh-list
43769419|NCT02387086|Growth Substances|growth substances|mesh-ancestor
43671127|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43671172|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
43671173|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43671208|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671209|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43671210|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43671211|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671212|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671213|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671214|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43671215|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671216|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
43671217|NCT05005299|Fludarabine|fludarabine|mesh-list
43671218|NCT05005299|Venetoclax|venetoclax|mesh-list
43671219|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671220|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
43671221|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671222|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671289|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671290|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
43671291|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671292|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43671293|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671294|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
43671295|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
43671296|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
43671297|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
43671298|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
43671299|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
43671300|NCT04865731|Esomeprazole|esomeprazole|mesh-list
43671301|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43671302|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43671303|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43671304|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671305|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671306|NCT04864431|Vitamin D|vitamin d|mesh-list
43671364|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
43671365|NCT04713371|Ipilimumab|ipilimumab|mesh-list
43671366|NCT04713371|Sargramostim|sargramostim|mesh-list
43671367|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43671368|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
43671369|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671370|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671371|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43671372|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
43671395|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
43671396|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
43671397|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671398|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671399|NCT04675151|Phentolamine|phentolamine|mesh-list
43671400|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43671401|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43671402|NCT04675151|Pilocarpine|pilocarpine|mesh-list
43671403|NCT04675151|Miotics|miotics|mesh-ancestor
43671404|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
43671405|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671406|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671407|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43671408|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43671409|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671410|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671411|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671412|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43671413|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43671414|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
43671415|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43671416|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43671417|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
43671418|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43671420|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
43671421|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43671422|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
43671423|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671424|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671479|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43671480|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43671481|NCT04522167|Growth Substances|growth substances|mesh-ancestor
43671482|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671483|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
43671484|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671582|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43671583|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671584|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671585|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43671586|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
43671587|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671588|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671589|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
43671590|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43671591|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
43671592|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671593|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671737|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43671739|NCT03974100|Denosumab|denosumab|mesh-list
43671740|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43671741|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671742|NCT03911336|Acetaminophen|acetaminophen|mesh-list
43671743|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43671744|NCT03911336|Ketoprofen|ketoprofen|mesh-list
43671745|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671746|NCT03911336|Analgesics|analgesics|mesh-ancestor
43671747|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
43671748|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671749|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671750|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
43671751|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43671752|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846835|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
43671754|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827252|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
43827253|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827254|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827255|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827256|NCT05490082|Urological Agents|urological agents|mesh-ancestor
44020108|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
44020109|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020110|NCT02679560|Bupivacaine|bupivacaine|mesh-list
44020111|NCT02679560|Ropivacaine|ropivacaine|mesh-list
44020112|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
44020113|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
44020114|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020115|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020116|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
44020117|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020118|NCT02663752|Deferasirox|deferasirox|mesh-list
44020119|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44020120|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
44020121|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
44020122|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020123|NCT02658357|Risperidone|risperidone|mesh-list
44020124|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44020125|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
43848947|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43848948|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848950|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43848951|NCT03976362|Carboplatin|carboplatin|mesh-list
43848952|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
43848953|NCT03976362|Olaparib|olaparib|mesh-list
43671777|NCT03758287|Gefitinib|gefitinib|mesh-list
43671778|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671779|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43671780|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671781|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671782|NCT03733210|Panitumumab|panitumumab|mesh-list
43671783|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43671784|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671785|NCT03690921|Cisplatin|cisplatin|mesh-list
43671786|NCT03690921|Fluorouracil|fluorouracil|mesh-list
43671787|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671788|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
43671789|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672113|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43672114|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672115|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43827312|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827313|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827314|NCT05489796|Analgesics|analgesics|mesh-ancestor
43827315|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
43827316|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827317|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43827318|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43672276|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672277|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43672279|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672280|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
43672281|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43672282|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
43672283|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43672284|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43672285|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672286|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43672341|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672342|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43672343|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43672544|NCT02236195|Mocetinostat|mocetinostat|mesh-list
43672770|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43672771|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43672772|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
43672773|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
43672774|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
43672775|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672776|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43672777|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673100|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673101|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673102|NCT02032277|Paclitaxel|paclitaxel|mesh-list
43673103|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
43673104|NCT02032277|Carboplatin|carboplatin|mesh-list
43673105|NCT02032277|Doxorubicin|doxorubicin|mesh-list
43673106|NCT02032277|Veliparib|veliparib|mesh-list
43673107|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43673108|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673109|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
43673328|NCT01956812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673329|NCT01956812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673330|NCT01956812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673331|NCT01956812|Immunologic Factors|immunologic factors|mesh-ancestor
43673332|NCT01956812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673333|NCT01952990|Phenylephrine|phenylephrine|mesh-list
43673334|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
43673335|NCT01952990|Tetracaine|tetracaine|mesh-list
43673336|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
43673442|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673443|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
43673444|NCT01902381|Vitamins|vitamins|mesh-ancestor
43673445|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
43673456|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673457|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673458|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673459|NCT01877395|Vaccines|vaccines|mesh-list
43673460|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
43673461|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673462|NCT01874626|Ibuprofen|ibuprofen|mesh-list
43673463|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43673464|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43673465|NCT01874626|Analgesics|analgesics|mesh-ancestor
43673466|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
43673467|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827460|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827461|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43827462|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43827463|NCT05488327|Growth Substances|growth substances|mesh-ancestor
43827464|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
43827465|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846858|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
43846859|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846860|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43846861|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43846862|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673766|NCT01774578|Antiviral Agents|antiviral agents|mesh-ancestor
43673767|NCT01774578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43673768|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673769|NCT01774578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43673770|NCT01774578|Immunologic Factors|immunologic factors|mesh-ancestor
43673771|NCT01774578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673772|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
43673984|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673985|NCT01709214|Analgesics|analgesics|mesh-ancestor
43673986|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
43673987|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673988|NCT01704365|Vaccines|vaccines|mesh-list
43673989|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
43673990|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673991|NCT01699737|Glimepiride|glimepiride|mesh-list
43673992|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43673993|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43673994|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674004|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674005|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674163|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43674164|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43674166|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674167|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
43674181|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674234|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43674235|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674236|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43644820|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674238|NCT01303796|Sapacitabine|sapacitabine|mesh-list
43674239|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43674240|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
43674241|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674242|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674243|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674244|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
43674245|NCT01235923|Hematinics|hematinics|mesh-ancestor
43674246|NCT00896493|Cyclosporine|cyclosporine|mesh-list
43674247|NCT00896493|Cyclosporins|cyclosporins|mesh-list
43674248|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43674249|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674250|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674251|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43674252|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
43674253|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674254|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
43674255|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674256|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
43674257|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674258|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43674259|NCT00848328|Rituximab|rituximab|mesh-list
43674260|NCT00848328|Lenalidomide|lenalidomide|mesh-list
43674261|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43674262|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674272|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
43674273|NCT00712582|Carmustine|carmustine|mesh-list
43674297|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43674298|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674299|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43674300|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43674301|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
43674302|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43674303|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674305|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
44020132|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020133|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44020134|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
44020136|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44020137|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44020138|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
44020139|NCT02654639|Bevacizumab|bevacizumab|mesh-list
44020140|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020141|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020142|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44020143|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44020144|NCT02654639|Growth Substances|growth substances|mesh-ancestor
44020145|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020146|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
44020147|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
44020148|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020149|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
44020150|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020151|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020152|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44020153|NCT02634827|Decitabine|decitabine|mesh-list
44020154|NCT02634827|Midostaurin|midostaurin|mesh-list
44020155|NCT02634827|Staurosporine|staurosporine|mesh-list
44020156|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020157|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
44020158|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020159|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020160|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020161|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44020162|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
44020163|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44020164|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020165|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020174|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020175|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44020176|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
44020177|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020178|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020179|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44020180|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44020181|NCT02614586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020182|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020183|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44020184|NCT02589145|Pyridoxine|pyridoxine|mesh-list
44020185|NCT02589145|Gemcitabine|gemcitabine|mesh-list
44020186|NCT02589145|Dexamethasone|dexamethasone|mesh-list
44020187|NCT02589145|Rituximab|rituximab|mesh-list
44020188|NCT02589145|Lenalidomide|lenalidomide|mesh-list
44020189|NCT02589145|Melphalan|melphalan|mesh-list
44020190|NCT02589145|Busulfan|busulfan|mesh-list
44020191|NCT02589145|Vorinostat|vorinostat|mesh-list
44020192|NCT02589145|Enoxaparin|enoxaparin|mesh-list
44020193|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020194|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020195|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
44020196|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020197|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44020198|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020199|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
44020200|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
44020201|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020202|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020203|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
44020204|NCT02589145|Hormones|hormones|mesh-ancestor
44020205|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020206|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020207|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020208|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
44020209|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020210|NCT02589145|Antiviral Agents|antiviral agents|mesh-ancestor
44020211|NCT02589145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020212|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674306|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43674307|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43674308|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674309|NCT00373711|Trace Elements|trace elements|mesh-ancestor
43674310|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
43674311|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674312|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43674313|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674314|NCT00194714|Vaccines|vaccines|mesh-list
43674315|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
43674316|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674317|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43674318|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43674319|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43674320|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674321|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
43674322|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43674470|NCT02893371|Asenapine|asenapine|mesh-list
43674471|NCT02893371|Perphenazine|perphenazine|mesh-list
43674472|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
43674473|NCT02893371|Mirtazapine|mirtazapine|mesh-list
43674474|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
43674475|NCT02893371|Doxepin|doxepin|mesh-list
43674476|NCT02893371|Citalopram|citalopram|mesh-list
43674507|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43674509|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
43674512|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43674513|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43674514|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43674516|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
43674517|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
43674518|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
43674519|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43674651|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
43674652|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43674653|NCT02891278|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43674654|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43675076|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
43675078|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43675079|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43675080|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43675081|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
43675082|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43675083|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675084|NCT02887443|Midazolam|midazolam|mesh-list
43675179|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
43675180|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
43675181|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675182|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675183|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43675184|NCT02886351|Analgesics|analgesics|mesh-ancestor
43675185|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
43675186|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827542|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
43827543|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43827544|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43675280|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675281|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43675282|NCT02885558|Efonidipine|efonidipine|mesh-list
43675283|NCT02885558|Nifedipine|nifedipine|mesh-list
43675284|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43675285|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675286|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675287|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43675288|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675289|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
43675290|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
43675291|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675292|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43675293|NCT02885558|Diuretics|diuretics|mesh-ancestor
43675294|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
43675295|NCT02885545|Anticoagulants|anticoagulants|mesh-list
43675296|NCT02885454|Simeprevir|simeprevir|mesh-list
43827566|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827567|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827569|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43827570|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43827571|NCT05487521|Prednisolone|prednisolone|mesh-list
43827572|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
43675386|NCT02884713|Esomeprazole|esomeprazole|mesh-list
43675387|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43675388|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675389|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43675390|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675391|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675392|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43827583|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43827584|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43827585|NCT05487521|Protective Agents|protective agents|mesh-ancestor
43827586|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43827587|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827588|NCT05487508|Dexamethasone|dexamethasone|mesh-list
43827589|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827590|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
43827591|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
43827592|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020235|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020237|NCT02587650|Entrectinib|entrectinib|mesh-list
44020238|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020239|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44020240|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020241|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020242|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
44020243|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
43769484|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
44020244|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020245|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020246|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44020247|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
44020248|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
44020249|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020250|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020251|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020252|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44020253|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
44020254|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44020255|NCT02549716|Acetaminophen|acetaminophen|mesh-list
44020256|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44020257|NCT02549716|Analgesics|analgesics|mesh-ancestor
44020258|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
44020261|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
43675811|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43675812|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43675813|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675814|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675815|NCT02880995|Amisulpride|amisulpride|mesh-list
43675816|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43675942|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
43675943|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
43675944|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675945|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675946|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
43675947|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675948|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
43675949|NCT02879669|Cisplatin|cisplatin|mesh-list
43675950|NCT02879669|Carboplatin|carboplatin|mesh-list
43675951|NCT02879669|Pemetrexed|pemetrexed|mesh-list
43675952|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644821|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675953|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
43675954|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675988|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43675989|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43675990|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
43675991|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43675992|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43675993|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43675994|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43675995|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676019|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676020|NCT02879110|Sulforaphane|sulforaphane|mesh-list
43676021|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43676022|NCT02879110|Protective Agents|protective agents|mesh-ancestor
43676023|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676024|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676025|NCT02879097|Paclitaxel|paclitaxel|mesh-list
43676026|NCT02879097|Carboplatin|carboplatin|mesh-list
43676027|NCT02879097|Bevacizumab|bevacizumab|mesh-list
43676028|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43676029|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676030|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
43676063|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43676064|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
43676065|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
43676066|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
43676283|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43676285|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
43676286|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43676287|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676288|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43676289|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43676290|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
43676291|NCT02877173|Alprostadil|alprostadil|mesh-list
43676292|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43676308|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43676309|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676366|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676367|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676369|NCT02876549|Primaquine|primaquine|mesh-list
43676370|NCT02876549|Amebicides|amebicides|mesh-ancestor
43676371|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43676372|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43676373|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676374|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
43676375|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676376|NCT02876432|Diclofenac|diclofenac|mesh-list
44020274|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44020275|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
44020276|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44020277|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44020278|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020279|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020280|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44020281|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44020282|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
44020283|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44020284|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44020285|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020286|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44020287|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44020288|NCT02518750|Cytarabine|cytarabine|mesh-list
44020289|NCT02518750|Dexamethasone|dexamethasone|mesh-list
44020290|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
44020291|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
44020292|NCT02518750|Methotrexate|methotrexate|mesh-list
44020293|NCT02518750|Etoposide|etoposide|mesh-list
44020294|NCT02518750|Vincristine|vincristine|mesh-list
44020295|NCT02518750|Bortezomib|bortezomib|mesh-list
44020296|NCT02518750|Asparaginase|asparaginase|mesh-list
44020297|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
44020298|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
44020299|NCT02518750|Clofarabine|clofarabine|mesh-list
44020300|NCT02518750|Panobinostat|panobinostat|mesh-list
44020301|NCT02518750|Pegaspargase|pegaspargase|mesh-list
44020302|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020303|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
44020304|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020305|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676922|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676923|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43676924|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
43676925|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676926|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43676927|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43676928|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43676929|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43676930|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
43676931|NCT02871869|Hormones|hormones|mesh-ancestor
43676932|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43676933|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677038|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
43677039|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
43677040|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677305|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
43677306|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43677307|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43677308|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677309|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677310|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43677311|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43677312|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677313|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677314|NCT02868580|Lamivudine|lamivudine|mesh-list
43677315|NCT02868580|Abacavir|abacavir|mesh-list
43677316|NCT02868580|Dolutegravir|dolutegravir|mesh-list
43677317|NCT02868580|Triumeq|triumeq|mesh-list
43677318|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43677319|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43677320|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677321|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677322|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
43677323|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677324|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43677325|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43677326|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43677327|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43677451|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677452|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677453|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
43677510|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43677511|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
43677512|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
43677513|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677514|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
43677530|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
43677531|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
43677532|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43677533|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43677534|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
43677535|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43677536|NCT02867800|Narcotics|narcotics|mesh-ancestor
43677537|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43677538|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
43677539|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677540|NCT02867176|Ketorolac|ketorolac|mesh-list
43677541|NCT02867176|Gabapentin|gabapentin|mesh-list
43677542|NCT02867176|Analgesics|analgesics|mesh-ancestor
43677543|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
43677544|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677545|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677546|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
43677923|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
43677924|NCT02865174|Coagulants|coagulants|mesh-ancestor
43677999|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43678000|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
43678001|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43678002|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678003|NCT02864472|Ranibizumab|ranibizumab|mesh-list
43678004|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43678005|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43678006|NCT02864472|Growth Substances|growth substances|mesh-ancestor
44020399|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020400|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020401|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44020402|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
44020403|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020404|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44020405|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
44020406|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
44020407|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44020408|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44020409|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44020410|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44020411|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
44020412|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020413|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020414|NCT02504099|Ritonavir|ritonavir|mesh-list
44020415|NCT02504099|Ribavirin|ribavirin|mesh-list
44020416|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44020417|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44020418|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020419|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020420|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020421|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44020422|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44020423|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
44020424|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020438|NCT02468583|FX006|fx006|mesh-list
43679515|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679516|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020447|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020448|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020449|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43679517|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679518|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43679519|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679520|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
43679521|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769488|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
43827981|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43827982|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43827983|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
43827984|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827985|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827986|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43827987|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
43827988|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
43827989|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
43827990|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43827991|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43827992|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43827993|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43827994|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827995|NCT05483062|Fluorides|fluorides|mesh-list
43827996|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
43827997|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
43827998|NCT05483062|Protective Agents|protective agents|mesh-ancestor
43846990|NCT04152564|Bupivacaine|bupivacaine|mesh-list
43846991|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
43846992|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
43846993|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
43846994|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679640|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43679641|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43679642|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
43679643|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
43679644|NCT02851472|Protective Agents|protective agents|mesh-ancestor
43679772|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679773|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679774|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43679775|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43828015|NCT05482464|Caseins|caseins|mesh-list
43828016|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
43828017|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
43679779|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679781|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
43679782|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679783|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679784|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
43679785|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679892|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679893|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
43679894|NCT05380713|Durvalumab|durvalumab|mesh-list
43679895|NCT05380713|Tremelimumab|tremelimumab|mesh-list
43679896|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679897|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
43679898|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679899|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679900|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43679901|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
43679902|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679903|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679904|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43679905|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679906|NCT05380479|Megestrol|megestrol|mesh-list
43679907|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
43679931|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
43679932|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43679942|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43679943|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43679944|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43679945|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679946|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679947|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43679948|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43679949|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
43679950|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43679951|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43679952|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
43679953|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679954|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679955|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
43679956|NCT05379647|Rituximab|rituximab|mesh-list
43679957|NCT05379647|Fludarabine|fludarabine|mesh-list
43679958|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43679959|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
43679960|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679961|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43679962|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43679963|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
43679964|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680278|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43680279|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43680280|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43680281|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680282|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43680284|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43680285|NCT05180968|Analgesics|analgesics|mesh-ancestor
43680286|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
43680287|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43680288|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43680480|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43680481|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
43680482|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43680483|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
43680675|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680676|NCT04762082|Urological Agents|urological agents|mesh-ancestor
43828168|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
43828169|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
43828170|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43680810|NCT04619316|Dabrafenib|dabrafenib|mesh-list
43680811|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43680812|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43680813|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680814|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680815|NCT04612920|Acetaminophen|acetaminophen|mesh-list
43680953|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43680954|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43680955|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43680956|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680957|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43680958|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43680959|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43680960|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43680961|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43680962|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43680963|NCT04308863|Chitosan|chitosan|mesh-list
43680964|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43680965|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43680966|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43681092|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43681093|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681094|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
43681095|NCT04166877|Analgesics|analgesics|mesh-ancestor
43681096|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
43681097|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681098|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681099|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
43681100|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681101|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43828356|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43828357|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828358|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43828359|NCT05478356|Atropine|atropine|mesh-list
43828360|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43828361|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43828362|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43828363|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44020459|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020460|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020461|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
44020462|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44020463|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
44020464|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
44020465|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44020466|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44020467|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44020468|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
44020469|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020470|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020471|NCT02434146|Protective Agents|protective agents|mesh-ancestor
44020473|NCT02436265|Ropivacaine|ropivacaine|mesh-list
44020474|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020475|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
43681395|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828364|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43681396|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43681408|NCT03531073|Methotrexate|methotrexate|mesh-list
43681409|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43681410|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
43681411|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43681412|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681502|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43681503|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43681504|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43681505|NCT03464461|Analgesics|analgesics|mesh-ancestor
43681506|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
43681507|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681508|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681509|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43681510|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43681511|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43681512|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681513|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681514|NCT03409848|Nivolumab|nivolumab|mesh-list
43681515|NCT03409848|Ipilimumab|ipilimumab|mesh-list
44020476|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
44020477|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020478|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020479|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020480|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
44020481|NCT02436265|Hormones|hormones|mesh-ancestor
43681516|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681517|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681518|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681519|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681520|NCT03401047|Estradiol|estradiol|mesh-list
43681521|NCT03401047|Estrogens|estrogens|mesh-ancestor
43681522|NCT03401047|Hormones|hormones|mesh-ancestor
43681523|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43681524|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828365|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
43681544|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43681545|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43681546|NCT03396276|Narcotics|narcotics|mesh-ancestor
43681547|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43681548|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681549|NCT03396276|Analgesics|analgesics|mesh-ancestor
43681550|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
43681551|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681552|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43681642|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43681643|NCT03217669|Sirolimus|sirolimus|mesh-list
43681644|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43681645|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43681646|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43681647|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681648|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
43681649|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43681650|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
43681651|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681653|NCT03198741|Clopidogrel|clopidogrel|mesh-list
43681654|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43681655|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43681656|NCT03198741|Analgesics|analgesics|mesh-ancestor
43681657|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
43681658|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681754|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43681755|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43681756|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681757|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43681758|NCT02918955|Cisplatin|cisplatin|mesh-list
43681759|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681760|NCT02890212|Selenium|selenium|mesh-list
43681761|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
43681762|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681834|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43681835|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43681836|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43681837|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681838|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
43682055|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
43682056|NCT01730313|Phenytoin|phenytoin|mesh-list
43682057|NCT01730313|Valproic Acid|valproic acid|mesh-list
43682058|NCT01730313|Vitamins|vitamins|mesh-ancestor
43682059|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
43682060|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682061|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
43682062|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
43682063|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43682064|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682065|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
43682066|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682067|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
43682068|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43682069|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682718|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43682719|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43682720|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
43682846|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682848|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
43682849|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43682850|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43682851|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683089|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683092|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683093|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43683094|NCT05242419|Protective Agents|protective agents|mesh-ancestor
43683095|NCT05242133|Interferons|interferons|mesh-list
43683096|NCT05242133|Interferon-beta|interferon-beta|mesh-list
43683097|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
43683098|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683099|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
43683100|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683101|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
43683102|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683103|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43683104|NCT05242120|Anesthetics|anesthetics|mesh-list
43683105|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683106|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683107|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43683243|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683244|NCT04635241|Heparin|heparin|mesh-list
43683245|NCT04635241|Calcium heparin|calcium heparin|mesh-list
43683246|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
43683247|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43683263|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683264|NCT04570176|Epinephrine|epinephrine|mesh-list
43683265|NCT04570176|Racepinephrine|racepinephrine|mesh-list
43683372|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683373|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683468|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683469|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43683471|NCT03896880|Miconazole|miconazole|mesh-list
43683472|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
43683473|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683474|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43683475|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43683476|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43683477|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683486|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43683487|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43683488|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43683489|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683490|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683492|NCT03845582|Retinol acetate|retinol acetate|mesh-list
43683493|NCT03845582|Vitamins|vitamins|mesh-ancestor
43683494|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
43683495|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683496|NCT03845582|Protective Agents|protective agents|mesh-ancestor
43683497|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43683498|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683499|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43683621|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683622|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683623|NCT01615874|Prednisone|prednisone|mesh-list
43683624|NCT01615874|Prednisolone|prednisolone|mesh-list
43683625|NCT01615874|Montelukast|montelukast|mesh-list
43683626|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
43683627|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683628|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
43683629|NCT01615874|Hormones|hormones|mesh-ancestor
43683630|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683631|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683632|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43683633|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683634|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
43683635|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683636|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43683637|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
43683638|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43683639|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
43683640|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43683641|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43683642|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683643|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43683644|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
43683645|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43683646|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43683647|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683648|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683747|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43683749|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
43683750|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
44020505|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
44020506|NCT02413047|Azathioprine|azathioprine|mesh-list
44020507|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44020508|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
44020509|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44020510|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683751|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683752|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683753|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683754|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683755|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683756|NCT00783458|Fluticasone|fluticasone|mesh-list
43683757|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
43683758|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683759|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43683760|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
43683761|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683762|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683833|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
43683834|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683835|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683836|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683837|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43683838|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
43683839|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
43683840|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43683841|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
43683842|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43683843|NCT00726856|Ezetimibe|ezetimibe|mesh-list
43683844|NCT00726856|Fenofibrate|fenofibrate|mesh-list
43683845|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683846|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683847|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
43683848|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683849|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828565|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43828566|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43828567|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
43828568|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828569|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828570|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828571|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
43828572|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43828573|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
43828574|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828575|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43828576|NCT05476081|Aspirin|aspirin|mesh-list
43828577|NCT05476081|Clopidogrel|clopidogrel|mesh-list
43684019|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684157|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43684158|NCT00140959|Losartan|losartan|mesh-list
43684159|NCT00140959|Atenolol|atenolol|mesh-list
43684160|NCT00140959|Amlodipine|amlodipine|mesh-list
43684161|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43684162|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43684163|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43684164|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684165|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43684166|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684167|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
43684168|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684169|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43684170|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43684171|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684172|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684173|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
43684174|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684175|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
43684176|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43684177|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43684178|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43684179|NCT00140907|Losartan|losartan|mesh-list
43684180|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43684181|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43684182|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43684384|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
43684385|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684392|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
43684393|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684394|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43684396|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684397|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43684398|NCT02843490|Growth Substances|growth substances|mesh-ancestor
43684399|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684400|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
43684401|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684403|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43684414|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684415|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684416|NCT02843061|Rituximab|rituximab|mesh-list
43684417|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684418|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684419|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
43684420|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684421|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684482|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684484|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684485|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43684486|NCT02842580|Growth Substances|growth substances|mesh-ancestor
43684487|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684488|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
43684489|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684490|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
43684493|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43684494|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43684496|NCT02842580|Protective Agents|protective agents|mesh-ancestor
43684497|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
43684498|NCT02842580|Vitamins|vitamins|mesh-ancestor
43684499|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
43684500|NCT02842281|Levan|levan|mesh-list
43684501|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684502|NCT02842294|Bevacizumab|bevacizumab|mesh-list
43684503|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43684504|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684505|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43684506|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43684507|NCT02842294|Growth Substances|growth substances|mesh-ancestor
43684508|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684509|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
43684510|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
43684511|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43684512|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684513|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684514|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684515|NCT02842437|Analgesics|analgesics|mesh-ancestor
43684516|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
43684517|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684518|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43684519|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43684520|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43684521|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
43684522|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684523|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684524|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
43684588|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684589|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684590|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
43684761|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43684762|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43684763|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
43684764|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
43684765|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43684820|NCT02839668|Lidocaine|lidocaine|mesh-list
43684821|NCT02839668|Atropine|atropine|mesh-list
43828664|NCT05475613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828665|NCT05475561|Bupivacaine|bupivacaine|mesh-list
43828666|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
43828667|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
43828668|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828669|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828670|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
43828671|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828672|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
43828674|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43828675|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43828676|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43828677|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43684914|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43684915|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
43684916|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684917|NCT02839161|Antacids|antacids|mesh-ancestor
43684918|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684919|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43684920|NCT02839486|Vancomycin|vancomycin|mesh-list
43684921|NCT02839486|Cefoxitin|cefoxitin|mesh-list
43684922|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684923|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684924|NCT02839122|Tadalafil|tadalafil|mesh-list
43684925|NCT02839122|Dutasteride|dutasteride|mesh-list
43684942|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684943|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684945|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
43684946|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43684947|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
43684948|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43684949|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684950|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43684951|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
43684952|NCT02838823|Antibodies|antibodies|mesh-list
43684953|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43684954|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
43684955|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684956|NCT02838992|Cyclosporine|cyclosporine|mesh-list
43684957|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
43684958|NCT02838992|Cyclosporins|cyclosporins|mesh-list
43684959|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
43684960|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684961|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
43828721|NCT05472506|Nivolumab|nivolumab|mesh-list
43684962|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684963|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684964|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43684965|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
43684966|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020517|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44020518|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020519|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
44020520|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44020521|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44020522|NCT02411643|Calcipotriene|calcipotriene|mesh-list
44020523|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020524|NCT02389712|Lamotrigine|lamotrigine|mesh-list
44020525|NCT02389712|Fluoxetine|fluoxetine|mesh-list
44020526|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44020527|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44020528|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020529|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020530|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020531|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
44020532|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020533|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44020534|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
44020535|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020536|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44020537|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44020538|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020539|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
44020540|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44020541|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44020542|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44020543|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44020544|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020545|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44020546|NCT02382588|Ganciclovir|ganciclovir|mesh-list
44020547|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
44020562|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
44020563|NCT02369744|Tamsulosin|tamsulosin|mesh-list
44020564|NCT02369744|Silodosin|silodosin|mesh-list
44020565|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44020566|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44020567|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44020568|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
44020569|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020570|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684967|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684968|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43684969|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685073|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
43685074|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
43685075|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685076|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685077|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685078|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
43685079|NCT02838615|Hormones|hormones|mesh-ancestor
43685080|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685081|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685082|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685083|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
43685084|NCT02838225|Docetaxel|docetaxel|mesh-list
43685085|NCT02838225|Doxorubicin|doxorubicin|mesh-list
43685086|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43685087|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685088|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
43685108|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685109|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685110|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43685111|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
43685112|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685113|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685114|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43685115|NCT02837978|Methotrexate|methotrexate|mesh-list
43685116|NCT02837978|Tacrolimus|tacrolimus|mesh-list
43685117|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43685118|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
43685230|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
43685231|NCT02837770|Diclofenac|diclofenac|mesh-list
43685232|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43685233|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
43685234|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43685235|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43685236|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685237|NCT02837770|Analgesics|analgesics|mesh-ancestor
43685238|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
43685239|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685240|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685241|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685242|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685243|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43685244|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685245|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685270|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685272|NCT02837198|FYX-051|fyx-051|mesh-list
43685273|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
43685274|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
44020571|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020572|NCT02369744|Urological Agents|urological agents|mesh-ancestor
44020574|NCT02379585|Docetaxel|docetaxel|mesh-list
44020575|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
44020576|NCT02379585|Doxorubicin|doxorubicin|mesh-list
44020577|NCT02379585|Trastuzumab|trastuzumab|mesh-list
44020578|NCT02379585|Pertuzumab|pertuzumab|mesh-list
44020579|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020580|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020581|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020582|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020583|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020584|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020585|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020586|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
44020587|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020588|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44020589|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44020590|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
44020591|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44020592|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44020593|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44020594|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44020595|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020596|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020597|NCT02367170|Midazolam|midazolam|mesh-list
43685282|NCT02837003|Aspirin|aspirin|mesh-list
43769506|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43685283|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43685284|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685285|NCT02837003|Analgesics|analgesics|mesh-ancestor
43685299|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685300|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
43685301|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685302|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685303|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
43685304|NCT02836639|Etoposide|etoposide|mesh-list
43685305|NCT02836639|Busulfan|busulfan|mesh-list
43685306|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43685307|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43685308|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685309|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43685310|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43685311|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685312|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685313|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
43685314|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685315|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
43685316|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685317|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43685318|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43685319|NCT02836847|Trastuzumab|trastuzumab|mesh-list
43685320|NCT02836847|Cetuximab|cetuximab|mesh-list
43685321|NCT02836847|Everolimus|everolimus|mesh-list
43685322|NCT02836847|Sorafenib|sorafenib|mesh-list
43685323|NCT02836847|Lapatinib|lapatinib|mesh-list
43685324|NCT02836847|Gefitinib|gefitinib|mesh-list
43685325|NCT02836847|Crizotinib|crizotinib|mesh-list
43685326|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685327|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685328|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685329|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
43685330|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685331|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43685332|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685333|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685359|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685360|NCT02836743|Protective Agents|protective agents|mesh-ancestor
43685361|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685362|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685363|NCT02836704|Metformin|metformin|mesh-list
43685364|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
43685365|NCT02836704|Acarbose|acarbose|mesh-list
43685366|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43685367|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685368|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43685369|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685370|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685371|NCT02836795|Antibodies|antibodies|mesh-list
43685372|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43685381|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685434|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685437|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
43685438|NCT02836184|Vitamins|vitamins|mesh-ancestor
43685439|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
43685440|NCT02836184|Antacids|antacids|mesh-ancestor
43685441|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685442|NCT02836353|Rifaximin|rifaximin|mesh-list
43685443|NCT02836353|Somatostatin|somatostatin|mesh-list
43685444|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685472|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43685473|NCT02836028|Temozolomide|temozolomide|mesh-list
43685474|NCT02836028|Talazoparib|talazoparib|mesh-list
43685475|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43685476|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
43685477|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685478|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685479|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43685480|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685481|NCT02835833|Bevacizumab|bevacizumab|mesh-list
43685482|NCT02835833|Nintedanib|nintedanib|mesh-list
43685483|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43685484|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685485|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43685486|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43685487|NCT02835833|Growth Substances|growth substances|mesh-ancestor
43685488|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685489|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
43685490|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43685491|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685492|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685493|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
43685557|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
43685558|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
43685559|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
43685560|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685561|NCT02835521|Triamcinolone|triamcinolone|mesh-list
43685562|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43685563|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43685564|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43685565|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685608|NCT02834507|Entacapone|entacapone|mesh-list
43685609|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43685610|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43685611|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
43685612|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685613|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685614|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685615|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43685616|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685617|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43685618|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
43685619|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
43685620|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43685621|NCT02834546|Sorafenib|sorafenib|mesh-list
43685622|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685623|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43685624|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685625|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685626|NCT02834260|Dexamethasone|dexamethasone|mesh-list
43685710|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685749|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685769|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685771|NCT02833025|Thrombin|thrombin|mesh-list
43685772|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
43685773|NCT02833025|Coagulants|coagulants|mesh-ancestor
43685774|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
43685775|NCT02833038|Analgesics|analgesics|mesh-ancestor
43685776|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
43685777|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685778|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685779|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
43769556|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
43685780|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685781|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43685782|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
43685783|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43685784|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685785|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685786|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43685787|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
43685788|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43685789|NCT02833103|Pinaverium|pinaverium|mesh-list
43685790|NCT02833103|Bromides|bromides|mesh-list
43685805|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685823|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43685825|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43685826|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
43685828|NCT02832973|Bisoprolol|bisoprolol|mesh-list
43685829|NCT02832973|Amiloride|amiloride|mesh-list
43685830|NCT02832973|Furosemide|furosemide|mesh-list
43685831|NCT02832973|Spironolactone|spironolactone|mesh-list
43685832|NCT02832973|Diuretics|diuretics|mesh-list
43685833|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43685834|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
43685835|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685836|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43685837|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685838|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685839|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43685840|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
43685841|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685843|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
43685844|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685845|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43685846|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
43685847|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
43685848|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685849|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43685850|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43685851|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43685852|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
43685853|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43685854|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43685855|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43685856|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43685857|NCT02832778|Tenofovir|tenofovir|mesh-list
43685858|NCT02832778|Lamivudine|lamivudine|mesh-list
43685859|NCT02832778|Zidovudine|zidovudine|mesh-list
43685860|NCT02832778|Emtricitabine|emtricitabine|mesh-list
43685934|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685935|NCT02832336|Caffeine|caffeine|mesh-list
43685936|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
43685937|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686022|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686023|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686024|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
43686025|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686026|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686027|NCT02831543|Mosapride|mosapride|mesh-list
43686028|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686029|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686030|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43686031|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
43686032|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686033|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686034|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
43686035|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43686036|NCT02831478|Protective Agents|protective agents|mesh-ancestor
43686037|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686038|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686039|NCT02831361|Metformin|metformin|mesh-list
43686072|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43686073|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43686075|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686076|NCT02831491|Docetaxel|docetaxel|mesh-list
43686077|NCT02831491|Ramucirumab|ramucirumab|mesh-list
43686078|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686079|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
43686080|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
43686081|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
43686191|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43686192|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
43686193|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
43686194|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686195|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686246|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
43686247|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686248|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686249|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
43686490|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686491|NCT02827578|Urological Agents|urological agents|mesh-ancestor
43686495|NCT02827682|Anesthetics|anesthetics|mesh-list
43686496|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43686497|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686498|NCT02827487|Celecoxib|celecoxib|mesh-list
43686499|NCT02827487|Tramadol|tramadol|mesh-list
43686500|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43686501|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43686502|NCT02827487|Analgesics|analgesics|mesh-ancestor
43686503|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
43686504|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686505|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686506|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828847|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
43828848|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828856|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
44020624|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020625|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020627|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020628|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
44020629|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44020630|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44020631|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020632|NCT02345460|Antidotes|antidotes|mesh-ancestor
44020633|NCT02345460|Protective Agents|protective agents|mesh-ancestor
44020634|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
44020635|NCT02345460|Vitamins|vitamins|mesh-ancestor
44020636|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
44020637|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
44020638|NCT02351063|Diuretics|diuretics|mesh-list
44020639|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44020640|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
44020641|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44020642|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
44020643|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020644|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020645|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
44020646|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020647|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44020648|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
44020649|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828857|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43828858|NCT05466734|Protective Agents|protective agents|mesh-ancestor
43828859|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43828860|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43828861|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43828862|NCT05466500|Dexamethasone|dexamethasone|mesh-list
43828863|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
43828864|NCT05466500|Bupivacaine|bupivacaine|mesh-list
43828865|NCT05466500|BB 1101|bb 1101|mesh-list
43828866|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43828867|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
43828868|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
43828869|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43828870|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828871|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43828872|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
43828873|NCT05466500|Hormones|hormones|mesh-ancestor
43828874|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43828875|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828876|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828877|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
43644830|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828894|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
43686675|NCT02825914|Caseins|caseins|mesh-list
43686738|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43686739|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
43686740|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43686741|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686742|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43686743|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43686744|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686745|NCT02825342|Citalopram|citalopram|mesh-list
43686746|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43686747|NCT02825342|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43686748|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43686749|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43686750|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686751|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43686752|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
43686906|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43686907|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686908|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847045|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847047|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847048|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847049|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
43847050|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687216|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43687217|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687218|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43687219|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43687220|NCT02821559|Growth Substances|growth substances|mesh-ancestor
43687221|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687222|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
43687223|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43687224|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
43687225|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687289|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687290|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43687291|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43687292|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43687293|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687294|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43687295|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
43687569|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687570|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43687572|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43687573|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687574|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43687575|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
43687576|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
43687577|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43687578|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43687737|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
43687738|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43687777|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
43687778|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687779|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43687780|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43687781|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687782|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687783|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687786|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
43687880|NCT02817191|Dipivefrin|dipivefrin|mesh-list
43687944|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
43687945|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43687946|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687947|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43687948|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
43687949|NCT02816905|Hormones|hormones|mesh-ancestor
43687950|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43687951|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43687952|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687953|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43687954|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43687955|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
43687956|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847105|NCT04139304|Hormones|hormones|mesh-ancestor
43847106|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847107|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847108|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847109|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
43847110|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
43847111|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
43847112|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
43847113|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43847114|NCT04139213|Naltrexone|naltrexone|mesh-list
43847115|NCT04139213|Buprenorphine|buprenorphine|mesh-list
43847116|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43687980|NCT02816567|Sufentanil|sufentanil|mesh-list
43687981|NCT02816567|Propofol|propofol|mesh-list
43687982|NCT02816567|Cisatracurium|cisatracurium|mesh-list
43687983|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43687984|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43687985|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43687986|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43687987|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
43687988|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
43687989|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43687990|NCT02816567|Narcotics|narcotics|mesh-ancestor
43687991|NCT02816567|Analgesics|analgesics|mesh-ancestor
43687992|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
43688027|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
43688028|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688029|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43688030|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43688086|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43688087|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43688088|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43688089|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43688090|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688091|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688092|NCT02815111|Acetaminophen|acetaminophen|mesh-list
43688093|NCT02815111|Lidocaine|lidocaine|mesh-list
43688094|NCT02815111|Ketamine|ketamine|mesh-list
43688095|NCT02815111|Gabapentin|gabapentin|mesh-list
43688096|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688097|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
43688098|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688099|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688100|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
43688101|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688108|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43688132|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829033|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829046|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43829049|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688170|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43688171|NCT02814409|Plasminogen|plasminogen|mesh-list
43688172|NCT02814409|Tenecteplase|tenecteplase|mesh-list
43688173|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43688174|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43688175|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688176|NCT02814630|Omalizumab|omalizumab|mesh-list
43688177|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43688178|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43688179|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
43688180|NCT02814058|Zolpidem|zolpidem|mesh-list
43688181|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43688182|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688183|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688184|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688185|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43688186|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
43688187|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
43688188|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688189|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688190|NCT02814110|Lenograstim|lenograstim|mesh-list
43688191|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43688192|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
43688193|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688345|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
43688346|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43688364|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688365|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
43688366|NCT02812602|Lidocaine|lidocaine|mesh-list
43688367|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688368|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
43688399|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688400|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020675|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44020677|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020678|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020679|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020680|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44020681|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44020682|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
44020683|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
44020684|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
43688401|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43688402|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688403|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43688404|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
43688405|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
43688407|NCT02812199|Epinephrine|epinephrine|mesh-list
43688408|NCT02812199|Racepinephrine|racepinephrine|mesh-list
43688409|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
43688410|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
43688485|NCT02811692|Growth Substances|growth substances|mesh-ancestor
43688486|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688487|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
43688488|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688490|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43688491|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44020685|NCT02318901|Trastuzumab|trastuzumab|mesh-list
44020686|NCT02318901|Cetuximab|cetuximab|mesh-list
44020687|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44020688|NCT02318901|Maytansine|maytansine|mesh-list
44020689|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44020690|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020691|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020692|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020693|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020694|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020695|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020696|NCT02317276|Triamcinolone|triamcinolone|mesh-list
44020697|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44020698|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44020699|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44020700|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44020701|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
44020702|NCT02317276|Hormones|hormones|mesh-ancestor
44020703|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020704|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020705|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020706|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
44020707|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020708|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020709|NCT02297230|Paclitaxel|paclitaxel|mesh-list
44020710|NCT02297230|Capecitabine|capecitabine|mesh-list
44020711|NCT02297230|Trastuzumab|trastuzumab|mesh-list
44020742|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
44020743|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
44020744|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020745|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020746|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020747|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
44020748|NCT02266797|Hormones|hormones|mesh-ancestor
44020749|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44020750|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020751|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020752|NCT02253394|Ambrisentan|ambrisentan|mesh-list
44020753|NCT02253394|Spironolactone|spironolactone|mesh-list
44020754|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43688492|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
43688493|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688494|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688495|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688542|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688767|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43688768|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43688769|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688770|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43688771|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
43688772|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
43688773|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43688774|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43688775|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43688776|NCT02809378|Narcotics|narcotics|mesh-ancestor
43688777|NCT02809378|Analgesics|analgesics|mesh-ancestor
43688778|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
43688785|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
43688786|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688787|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688788|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
43688789|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
43688792|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688793|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43688794|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
43688795|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829087|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43829088|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847124|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43688797|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43688798|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43688799|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
43688800|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
43688801|NCT02809456|Vitamins|vitamins|mesh-ancestor
43829096|NCT05449392|Emollients|emollients|mesh-ancestor
43829097|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
43829113|NCT05447065|Vitamins|vitamins|mesh-ancestor
43829114|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
43829115|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829116|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43829117|NCT05446571|Valacyclovir|valacyclovir|mesh-list
43829118|NCT05446571|Letermovir|letermovir|mesh-list
43829119|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
43829120|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829121|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43829122|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829123|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829124|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829125|NCT05445609|Nivolumab|nivolumab|mesh-list
43829126|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829127|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689188|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689189|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689191|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689192|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689193|NCT02806128|Kallikreins|kallikreins|mesh-list
43689194|NCT02806128|Coagulants|coagulants|mesh-ancestor
43689230|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43689485|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43689486|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43689487|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43689488|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689489|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43689490|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689491|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689492|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43689595|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
43689596|NCT02802163|Dexamethasone|dexamethasone|mesh-list
43689597|NCT02802163|Lenalidomide|lenalidomide|mesh-list
43689598|NCT02802163|Panobinostat|panobinostat|mesh-list
43689599|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43689600|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
43689601|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
43689602|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689603|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689604|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43689605|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
43689606|NCT02802163|Hormones|hormones|mesh-ancestor
43689607|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43689738|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43689739|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43689740|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43689741|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43689876|NCT02800694|Analgesics|analgesics|mesh-ancestor
43689877|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
43689878|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43689879|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43689880|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43689881|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
43689882|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
43689883|NCT02800486|Cetuximab|cetuximab|mesh-list
43689884|NCT02800486|Mannitol|mannitol|mesh-list
43689885|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43689886|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689887|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43689888|NCT02800486|Diuretics|diuretics|mesh-ancestor
43689889|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
43689890|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689891|NCT02800252|Aspirin|aspirin|mesh-list
43689892|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43689925|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43689926|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690366|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
43690367|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43690368|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690369|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690370|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43690371|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43690372|NCT02796469|Protective Agents|protective agents|mesh-ancestor
43690373|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690374|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
43690408|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43690409|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690411|NCT02795949|Amoxicillin|amoxicillin|mesh-list
43690412|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
43690413|NCT02795949|Meropenem|meropenem|mesh-list
43690414|NCT02795949|Tazobactam|tazobactam|mesh-list
43690415|NCT02795949|Piperacillin|piperacillin|mesh-list
43690416|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
43690417|NCT02795949|Imipenem|imipenem|mesh-list
43690418|NCT02795949|Ceftazidime|ceftazidime|mesh-list
43690419|NCT02795949|Ampicillin|ampicillin|mesh-list
43690453|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690454|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690455|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690456|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43690457|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43690458|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43690459|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43690460|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
43690461|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
43690462|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690555|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690557|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43690558|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
43690559|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43690560|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43690561|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43690597|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43690599|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43690600|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
43690601|NCT02793986|Propofol|propofol|mesh-list
43690767|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43690768|NCT02792816|Artesunate|artesunate|mesh-list
43690769|NCT02792816|Artemether|artemether|mesh-list
43690770|NCT02792816|Piperaquine|piperaquine|mesh-list
43690771|NCT02792816|Artenimol|artenimol|mesh-list
43690772|NCT02792816|Mefloquine|mefloquine|mesh-list
43690773|NCT02792816|Antimalarials|antimalarials|mesh-list
43691280|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
43691281|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
43691282|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691283|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691284|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43691285|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43691286|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43691287|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691288|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691289|NCT02788877|Aflibercept|aflibercept|mesh-list
43691290|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43691291|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43691292|NCT02788877|Growth Substances|growth substances|mesh-ancestor
43691293|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691294|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
43691295|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691296|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
43691297|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43691298|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
43691299|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43691300|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43691301|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
43691302|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
43691303|NCT02788552|Vitamins|vitamins|mesh-list
43691304|NCT02788552|Thiamine|thiamine|mesh-list
43691305|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
43691306|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691307|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
43691308|NCT02788305|Misoprostol|misoprostol|mesh-list
43691355|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
43691356|NCT02787967|Hormones|hormones|mesh-ancestor
43547782|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43691357|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43691359|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43691360|NCT02787928|Narcotics|narcotics|mesh-ancestor
43691361|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691362|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691363|NCT02787928|Analgesics|analgesics|mesh-ancestor
43691364|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
43691365|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829380|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43829381|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691475|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691477|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
43691478|NCT02787018|Ropivacaine|ropivacaine|mesh-list
43691479|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43691480|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
43691481|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
43691482|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691483|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020764|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
44020765|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020766|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020767|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44020768|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
44020769|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
44020770|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44020771|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44020772|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44020773|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
44020774|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020775|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020777|NCT02234011|Analgesics|analgesics|mesh-ancestor
44020778|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
44020779|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020780|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020781|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44020782|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43691509|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
43691510|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43691511|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691512|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43691513|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
43691527|NCT02786732|Brodalumab|brodalumab|mesh-list
43691528|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43691529|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
43691530|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
43691531|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691532|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
43691533|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43691534|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43691535|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43691536|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43691622|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691623|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
43691624|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43691625|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43691626|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691627|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43691628|NCT02786212|Analgesics|analgesics|mesh-ancestor
43691629|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
43691630|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691631|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43691632|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43691633|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43691634|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
43691635|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691636|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691637|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43769651|NCT02385656|Modafinil|modafinil|mesh-list
43691638|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43691639|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43691727|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
43691728|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691729|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691730|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43691731|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
43691733|NCT02785146|Fluorouracil|fluorouracil|mesh-list
43691734|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
44020804|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44020805|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44020806|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020807|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44020808|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020809|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
44020810|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
44020811|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44020812|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44020813|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020814|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020815|NCT02162979|Urological Agents|urological agents|mesh-ancestor
44020817|NCT02152670|Methylphenidate|methylphenidate|mesh-list
44020818|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
44020819|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44020820|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020821|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44020822|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44020823|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020824|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020825|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
44020826|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020827|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44020828|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44020829|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020830|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44020831|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44020832|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020833|NCT02137096|Carboplatin|carboplatin|mesh-list
43691735|NCT02785146|Calcium|calcium|mesh-list
43691736|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
43691737|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43691738|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691766|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43691767|NCT02784899|Iloprost|iloprost|mesh-list
43691768|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43691782|NCT02785055|Hydromorphone|hydromorphone|mesh-list
43691783|NCT02785055|Bupivacaine|bupivacaine|mesh-list
43691784|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
43691785|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
43691823|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691824|NCT02785068|Antidotes|antidotes|mesh-ancestor
43691959|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691960|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43691961|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
43691962|NCT02784392|Metoclopramide|metoclopramide|mesh-list
43691963|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
43691964|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
43692108|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43692109|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43692110|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
43692111|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
43692112|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
43692113|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
43692114|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692115|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692116|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
43692117|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43692118|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692119|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43692120|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692121|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43692122|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43692123|NCT02783040|Protective Agents|protective agents|mesh-ancestor
43692124|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
43692186|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692188|NCT02782338|Diclofenac|diclofenac|mesh-list
43692190|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692191|NCT02782338|Analgesics|analgesics|mesh-ancestor
43692224|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
43692258|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43692259|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692260|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692261|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692262|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43692263|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692264|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692343|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692344|NCT02781909|Analgesics|analgesics|mesh-ancestor
43692345|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
43692346|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692347|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692392|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43692394|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692395|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692396|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43692397|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692398|NCT02781467|Analgesics|analgesics|mesh-ancestor
43692399|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
43692400|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692401|NCT02781415|Morphine|morphine|mesh-list
43692402|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43692403|NCT02781415|Narcotics|narcotics|mesh-ancestor
43692404|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692405|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692406|NCT02781415|Analgesics|analgesics|mesh-ancestor
43692407|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
43692408|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692409|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
43692410|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43692411|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692412|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692413|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692414|NCT02781246|Analgesics|analgesics|mesh-ancestor
43847221|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
43829502|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829503|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
43829504|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829505|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829506|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
43829507|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43829508|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43829509|NCT05422027|Growth Substances|growth substances|mesh-ancestor
43829510|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
43829511|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
43829512|NCT05421819|Vitamin D|vitamin d|mesh-list
43829513|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
43829514|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
43829515|NCT05421819|Vitamins|vitamins|mesh-list
43692469|NCT02780102|Methylphenidate|methylphenidate|mesh-list
43692470|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43692471|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692472|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43692505|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692597|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
43692772|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692773|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692774|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692775|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692776|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43692777|NCT02778425|Somatostatin|somatostatin|mesh-list
43692778|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43692779|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
43692780|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43692781|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692782|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692783|NCT02778425|Hormones|hormones|mesh-ancestor
43829592|NCT05416021|Dapivirine|dapivirine|mesh-list
43829593|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43829594|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43829595|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
43693015|NCT02776761|Vaccines|vaccines|mesh-list
43693016|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
43693017|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693129|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
43693130|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
43693131|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693132|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693322|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693323|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693324|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693325|NCT02774902|Clarithromycin|clarithromycin|mesh-list
43693326|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693327|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693328|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43693329|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693330|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693331|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43693332|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43693334|NCT02774837|Telbivudine|telbivudine|mesh-list
43693335|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
43693336|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693337|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43693451|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43693497|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693498|NCT02773602|Dexamethasone|dexamethasone|mesh-list
43693499|NCT02773602|Clonidine|clonidine|mesh-list
43693500|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693501|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
43693502|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
43693503|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693504|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693505|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693506|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
43693507|NCT02773602|Hormones|hormones|mesh-ancestor
43693508|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693509|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43693510|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693511|NCT02773602|Analgesics|analgesics|mesh-ancestor
43693512|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
43693513|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43693514|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
43693515|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43693516|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43693517|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43693518|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
43693519|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693562|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
43693563|NCT02773251|Protective Agents|protective agents|mesh-ancestor
43693565|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43693566|NCT02773407|Azithromycin|azithromycin|mesh-list
43693567|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43693568|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43693569|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693570|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43693571|NCT02773407|Renal Agents|renal agents|mesh-ancestor
43693572|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
43693573|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43693574|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43829600|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693709|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693710|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
43693711|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693712|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693713|NCT02772237|Riboflavin|riboflavin|mesh-list
43693714|NCT02772237|Vitamins|vitamins|mesh-ancestor
43693715|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
43693716|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693717|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
43693718|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43693725|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693778|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43829623|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
43693779|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693780|NCT02771834|Vitamin D|vitamin d|mesh-list
43644833|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44020848|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020850|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
44020851|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644834|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644835|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43644836|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644838|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
43644839|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644840|NCT04342039|Budesonide|budesonide|mesh-list
43644841|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644842|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43693781|NCT02771834|Vitamins|vitamins|mesh-ancestor
43693782|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
43693783|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693784|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43693785|NCT02771717|Budesonide|budesonide|mesh-list
43693786|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693787|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43693812|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43693813|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
43693814|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
43693815|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43693816|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693817|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
43693818|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693819|NCT02771509|Mitogens|mitogens|mesh-list
43693820|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
43693821|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693822|NCT02771379|Idebenone|idebenone|mesh-list
43693823|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
43693824|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693825|NCT02771379|Protective Agents|protective agents|mesh-ancestor
43693826|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829624|NCT05414877|Norepinephrine|norepinephrine|mesh-list
43829625|NCT05414877|Ephedrine|ephedrine|mesh-list
43829626|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43829627|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
43829628|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
43829629|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829630|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829631|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
43644843|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
43644844|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644845|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644846|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644847|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644848|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
43644849|NCT04342039|Hormones|hormones|mesh-ancestor
43693846|NCT02771743|Carboplatin|carboplatin|mesh-list
43693847|NCT02771743|Doxorubicin|doxorubicin|mesh-list
43693848|NCT02771743|Etoposide|etoposide|mesh-list
43693849|NCT02771743|Interleukin-2|interleukin-2|mesh-list
43693850|NCT02771743|Isotretinoin|isotretinoin|mesh-list
43693851|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693852|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
43693853|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693854|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693855|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43693856|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
43693857|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693860|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43693861|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43693890|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
43693891|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693892|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
43693893|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693894|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
43693895|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693896|NCT02771314|Osimertinib|osimertinib|mesh-list
43693897|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693898|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43693899|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693900|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693901|NCT02770950|Indomethacin|indomethacin|mesh-list
43693902|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43693903|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43693904|NCT02770950|Analgesics|analgesics|mesh-ancestor
43693905|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
43693906|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43693941|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43693942|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693943|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694038|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
43694039|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43644850|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644857|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644858|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43644859|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43644860|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694040|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
43694041|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
43694042|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43694043|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43694044|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43694045|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43694046|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43694047|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43694048|NCT02770261|Candesartan|candesartan|mesh-list
43694049|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
43694050|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43694051|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43694115|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43694116|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43694118|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43694119|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43694120|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
43694121|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694122|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694123|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694124|NCT02770105|Caffeine|caffeine|mesh-list
44020864|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
44020865|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020866|NCT02130622|Promethazine|promethazine|mesh-list
44020867|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
44020868|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
44020869|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
44020870|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44020871|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
44020872|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
44020873|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44020874|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020875|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020876|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43694125|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43694126|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694127|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43694128|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694129|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694130|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43694131|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43694132|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
43694133|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694134|NCT02769832|Gemcitabine|gemcitabine|mesh-list
43694135|NCT02769832|Paclitaxel|paclitaxel|mesh-list
43694136|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43694137|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43590178|NCT03373409|Albuterol|albuterol|mesh-list
43694138|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694139|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
43694140|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
43694141|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694185|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43694415|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
43694416|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43694417|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694418|NCT02768337|Afatinib|afatinib|mesh-list
43694419|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694420|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694454|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43547785|NCT03648697|Fludarabine|fludarabine|mesh-list
43644861|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43644862|NCT04341467|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43644863|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43644864|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644865|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020877|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44020878|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44020879|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020880|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
43644866|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644868|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43694461|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43694462|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694463|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43694464|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694465|NCT02768220|Incretins|incretins|mesh-ancestor
43694466|NCT02768220|Hormones|hormones|mesh-ancestor
43694467|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694468|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43694469|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
43694470|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694471|NCT02768168|Dezocine|dezocine|mesh-list
43694472|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43694473|NCT02768168|Narcotics|narcotics|mesh-ancestor
43694474|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43694475|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694476|NCT02768168|Analgesics|analgesics|mesh-ancestor
43694477|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
43694478|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43694479|NCT02768207|Vemurafenib|vemurafenib|mesh-list
43694480|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694481|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43694482|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694483|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694484|NCT02768116|Sirolimus|sirolimus|mesh-list
43694485|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43694486|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694487|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43829736|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43829757|NCT05408026|Dexamethasone|dexamethasone|mesh-list
43694582|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43694583|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
43694584|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43694585|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694586|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43694587|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43694588|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43694589|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
43694590|NCT02767674|Antiviral Agents|antiviral agents|mesh-ancestor
43694591|NCT02767674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43694592|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694593|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43694594|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
43694595|NCT02767674|Hormones|hormones|mesh-ancestor
43694596|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43694597|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43694598|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43694599|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43694600|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43694601|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644869|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
43644870|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43644871|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
43644872|NCT04341155|Dexamethasone|dexamethasone|mesh-list
43644873|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
43644874|NCT04341155|BB 1101|bb 1101|mesh-list
43644875|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644876|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
43644877|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
43694602|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
43694603|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
43694688|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
43829766|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43829767|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
43829768|NCT05408026|Hormones|hormones|mesh-ancestor
43829769|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829770|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829771|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43829772|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
43644878|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644879|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644880|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644882|NCT04341155|Hormones|hormones|mesh-ancestor
43644883|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644884|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644885|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43694963|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43694964|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695082|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43695083|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
43695084|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43695085|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43695086|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
43695087|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
43695088|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43695089|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695090|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
43695091|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695092|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44020883|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020884|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
44020885|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
44020886|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695093|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43695094|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43695095|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43695096|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43695097|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43695098|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43695099|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43695100|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43695101|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
43695102|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695103|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695104|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695105|NCT02763969|Interferons|interferons|mesh-list
43695106|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
43695107|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
43695138|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
43695139|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695140|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43695141|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43695142|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43695143|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644893|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644894|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
43644895|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644896|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644897|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644898|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43644899|NCT04339140|Zafirlukast|zafirlukast|mesh-list
43644900|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644901|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644902|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43644903|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
43644904|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644905|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644906|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
43695210|NCT02763059|Ibuprofen|ibuprofen|mesh-list
43695211|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43695212|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
43695213|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
43695214|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695215|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695216|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695217|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
43695218|NCT02763059|Hormones|hormones|mesh-ancestor
43695219|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43695220|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43695221|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695222|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43695223|NCT02763059|Analgesics|analgesics|mesh-ancestor
43695224|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
43695225|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
43695226|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695286|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
43695287|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695288|NCT02762942|Misoprostol|misoprostol|mesh-list
43695289|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43695290|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
43695291|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43695292|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695293|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44020891|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020892|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44020893|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44020894|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020895|NCT02134912|Pemetrexed|pemetrexed|mesh-list
44020896|NCT02134912|Crizotinib|crizotinib|mesh-list
44020897|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020898|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44020899|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020900|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44020901|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44020902|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44020903|NCT02110069|Sirolimus|sirolimus|mesh-list
44020904|NCT02110069|Vincristine|vincristine|mesh-list
44020905|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020906|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020907|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020908|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020909|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020910|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020911|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44020912|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44020913|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44020914|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
44020915|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020916|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
44020917|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644907|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
43644908|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43644909|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644910|NCT04338529|Vitamins|vitamins|mesh-ancestor
43644911|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
43644912|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43644913|NCT04338529|Antacids|antacids|mesh-ancestor
43644914|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020920|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
43644915|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43695424|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43695425|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43695426|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43695427|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695428|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43695429|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43695430|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695433|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43695434|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
43695435|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43695436|NCT02761577|Expectorants|expectorants|mesh-ancestor
43695437|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
43695438|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43829889|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
43829890|NCT05401214|Niraparib|niraparib|mesh-list
43829891|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43829892|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
43695580|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43695581|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695582|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695583|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695584|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43695585|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
43695586|NCT02760615|Losartan|losartan|mesh-list
43695587|NCT02760615|Midazolam|midazolam|mesh-list
43695588|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
43695589|NCT02760615|Caffeine|caffeine|mesh-list
43695590|NCT02760615|Omeprazole|omeprazole|mesh-list
43695591|NCT02760615|Vedolizumab|vedolizumab|mesh-list
43695592|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43644929|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644930|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644931|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644932|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644933|NCT04329325|Dexamethasone|dexamethasone|mesh-list
43695593|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43695594|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695595|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695596|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43695597|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43695598|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43695599|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43695600|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
43695601|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
43695602|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
43695603|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
43695604|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695605|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695606|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43695757|NCT02759614|Bevacizumab|bevacizumab|mesh-list
43695758|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43695759|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43695760|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695761|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43695794|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
43695795|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
43695796|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43695797|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695798|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43695799|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43695800|NCT02759224|Protective Agents|protective agents|mesh-ancestor
43695801|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43644936|NCT04329325|Blinatumomab|blinatumomab|mesh-list
43644937|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644938|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
43644939|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
43644940|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644941|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644942|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644943|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
43644944|NCT04329325|Hormones|hormones|mesh-ancestor
43644945|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644946|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644947|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696448|NCT02755311|Pirarubicin|pirarubicin|mesh-list
43696449|NCT02755311|Doxorubicin|doxorubicin|mesh-list
43696450|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43696451|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696452|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
43696453|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696454|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43696455|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696456|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
43696457|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696458|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43696459|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43696460|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43696461|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696462|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
43696463|NCT02755311|Coagulants|coagulants|mesh-ancestor
43696464|NCT02755259|Acetazolamide|acetazolamide|mesh-list
43696465|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
43696466|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43696467|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696468|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696469|NCT02755259|Diuretics|diuretics|mesh-ancestor
43696470|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
43696471|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696636|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43696637|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
43644951|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644952|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
43644953|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644954|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644955|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644956|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43644957|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644958|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
43644959|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644960|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644961|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43644963|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
43644964|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847264|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847265|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847266|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
43847267|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43847268|NCT04124367|Protective Agents|protective agents|mesh-ancestor
43847269|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847270|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
43847271|NCT04124198|Nimorazole|nimorazole|mesh-list
43847272|NCT04124198|Cisplatin|cisplatin|mesh-list
43847273|NCT04124198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847274|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43847275|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43847276|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43847277|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847278|NCT04123561|Dexamethasone|dexamethasone|mesh-list
43847279|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
43847280|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43847281|NCT04123561|BB 1101|bb 1101|mesh-list
43847282|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847283|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
43847284|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
43697016|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43697017|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697018|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43697030|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43697032|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
43697033|NCT02752412|Lixisenatide|lixisenatide|mesh-list
43769661|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697034|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697035|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697036|NCT02751593|Dexamethasone|dexamethasone|mesh-list
43697037|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697038|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
43697039|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
43697040|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697041|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697042|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43697043|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
43697044|NCT02751593|Hormones|hormones|mesh-ancestor
43697045|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697046|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697047|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697048|NCT02751632|Fluoxetine|fluoxetine|mesh-list
43697049|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
43697050|NCT02751632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43697051|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43697052|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697053|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697054|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697055|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
43697056|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697057|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43697058|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43697059|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43697060|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44020934|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
44020935|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44020936|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020937|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
43751674|NCT02496741|Amebicides|amebicides|mesh-ancestor
44020938|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44020939|NCT02074904|Topiramate|topiramate|mesh-list
44020940|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
44020941|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44020942|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020943|NCT02075021|Paclitaxel|paclitaxel|mesh-list
44020944|NCT02075021|Lenalidomide|lenalidomide|mesh-list
44020945|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44020946|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44020947|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44020948|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44020949|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44020950|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44020951|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
44020952|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44020953|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44020954|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44020955|NCT02075021|Growth Substances|growth substances|mesh-ancestor
44020956|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
44020957|NCT02057237|Mitotane|mitotane|mesh-list
43697063|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697097|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644975|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43644976|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
43644977|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644978|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644979|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644980|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644981|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43644982|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
43697098|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43697099|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
43697100|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697101|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697102|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43697103|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43697139|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43697140|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43697141|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697142|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43697143|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
43697144|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697145|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697174|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43697175|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697176|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43697177|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
43697178|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697179|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697180|NCT05429294|Paclitaxel|paclitaxel|mesh-list
43697181|NCT05429294|Trastuzumab|trastuzumab|mesh-list
43697182|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43697183|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697184|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697185|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697186|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697187|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697188|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697189|NCT05429151|Acyclovir|acyclovir|mesh-list
43697190|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
43697191|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697192|NCT05429086|Propofol|propofol|mesh-list
43697193|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43697194|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697230|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697231|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
43697232|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697233|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43697234|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43697235|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43697236|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697237|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697239|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44148571|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148572|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697240|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697241|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
43697242|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697243|NCT05271578|Nicotine|nicotine|mesh-list
43697244|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43697245|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
43697246|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697278|NCT04911062|Epinephrine|epinephrine|mesh-list
43697279|NCT04911062|Bupivacaine|bupivacaine|mesh-list
43697280|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697281|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
43697282|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697283|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697284|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
43697285|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697286|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43697287|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43697288|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43697289|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697290|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697291|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43697292|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43697293|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
43697294|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43697295|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
43697296|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
43697297|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
43697298|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43697299|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43697300|NCT04876131|Gentamicins|gentamicins|mesh-list
43697301|NCT04876131|Cephalexin|cephalexin|mesh-list
43769732|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43769767|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697303|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43697304|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
43697305|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697306|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43697307|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697336|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
43697337|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43697338|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
43697339|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697340|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697341|NCT04731025|Vancomycin|vancomycin|mesh-list
43697342|NCT04731025|Gentamicins|gentamicins|mesh-list
43697343|NCT04731025|Cefazolin|cefazolin|mesh-list
43697344|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43697345|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697346|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43697347|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697348|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697349|NCT04723004|Bevacizumab|bevacizumab|mesh-list
43697350|NCT04723004|Sorafenib|sorafenib|mesh-list
43697351|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697352|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697353|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43697384|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697386|NCT04529135|Narcotics|narcotics|mesh-ancestor
43697387|NCT04359979|Tamsulosin|tamsulosin|mesh-list
43697388|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43697389|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43697401|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43697402|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43697403|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697429|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43697431|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697432|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697433|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43697434|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
43697435|NCT04163406|Trace Elements|trace elements|mesh-ancestor
43697436|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
43697437|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830046|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43830047|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43830048|NCT05386095|Bupivacaine|bupivacaine|mesh-list
43830049|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
43830050|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
43830051|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830052|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830053|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
43830054|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830055|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
43830056|NCT05385432|Tacrolimus|tacrolimus|mesh-list
43830057|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43830058|NCT05385432|Basiliximab|basiliximab|mesh-list
43830059|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43830060|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
43697512|NCT03450018|Gemcitabine|gemcitabine|mesh-list
43697513|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697514|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
43697515|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697516|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697517|NCT03450018|Antiviral Agents|antiviral agents|mesh-ancestor
43697518|NCT03450018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697519|NCT03450018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697520|NCT03450018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697521|NCT03450018|Immunologic Factors|immunologic factors|mesh-ancestor
43697522|NCT03450018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697523|NCT03449459|Amikacin|amikacin|mesh-list
43697524|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43697525|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697526|NCT03211338|Progesterone|progesterone|mesh-list
43697527|NCT03211338|Mitogens|mitogens|mesh-list
43697528|NCT03211338|Progestins|progestins|mesh-ancestor
43697529|NCT03211338|Hormones|hormones|mesh-ancestor
43697530|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697531|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697532|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697533|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697534|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43697535|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43697536|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43697537|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148582|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148583|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
44148584|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148585|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148587|NCT00204633|Hematinics|hematinics|mesh-ancestor
44148588|NCT00204646|Carboplatin|carboplatin|mesh-list
44148589|NCT00204646|Etoposide|etoposide|mesh-list
44148590|NCT00204646|Doxorubicin|doxorubicin|mesh-list
44148591|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44148592|NCT00204646|Ifosfamide|ifosfamide|mesh-list
44148593|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148594|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44148595|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44148596|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44148597|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871175|NCT02641314|Celecoxib|celecoxib|mesh-list
44148598|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751751|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
43697538|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697576|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697577|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697578|NCT02772965|Methotrexate|methotrexate|mesh-list
43697579|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43697632|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697665|NCT02281981|Curcumin|curcumin|mesh-list
43697666|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43697667|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697668|NCT02281981|Analgesics|analgesics|mesh-ancestor
43697674|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697675|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697676|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697677|NCT02139852|Capsaicin|capsaicin|mesh-list
43697678|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
43697679|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697680|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
43697681|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697682|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697698|NCT02041234|Hormones|hormones|mesh-ancestor
43697699|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697700|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
43697701|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697702|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697703|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43697704|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43697705|NCT02022098|Cisplatin|cisplatin|mesh-list
43697706|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697707|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
43697708|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43697709|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
43697710|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43697711|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
43697712|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697713|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697714|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
43697715|NCT00783367|Dexamethasone|dexamethasone|mesh-list
43697723|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697724|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697725|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697726|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
43697727|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
43697728|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697729|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43697730|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
43697731|NCT00783367|Hormones|hormones|mesh-ancestor
43697732|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697733|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697734|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
43697735|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697736|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697737|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43697738|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43697739|NCT00783367|Growth Substances|growth substances|mesh-ancestor
43697740|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
43697741|NCT00716066|Cytarabine|cytarabine|mesh-list
43697742|NCT00716066|Prednisone|prednisone|mesh-list
43697743|NCT00716066|Cortisone|cortisone|mesh-list
43697744|NCT00716066|Etoposide|etoposide|mesh-list
43697745|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
43697746|NCT00716066|Melphalan|melphalan|mesh-list
43697768|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697769|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697770|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
43697771|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43697772|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
43697773|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43697774|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
43697775|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697776|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
43697777|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
43697778|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43697779|NCT02751268|Ropivacaine|ropivacaine|mesh-list
43697780|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697781|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
43697782|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697783|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697784|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
43697785|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697786|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43697787|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43697788|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
43697789|NCT02750904|Nicotine|nicotine|mesh-list
43697790|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43697791|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
43697792|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697793|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697794|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43644983|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644984|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644985|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43644986|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
43644987|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
43644988|NCT04312243|Protective Agents|protective agents|mesh-ancestor
43823943|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823945|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823946|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823947|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823948|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698031|NCT02749409|Narcotics|narcotics|mesh-ancestor
43698032|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698033|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698034|NCT02749409|Analgesics|analgesics|mesh-ancestor
43698035|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
43698036|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698037|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43698038|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43698039|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698040|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698041|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43698042|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43698043|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698044|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830081|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43830082|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
43830086|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830087|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43830088|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
43830089|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44020989|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021058|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44021059|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44021060|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44021061|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44021062|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44021063|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44021065|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44021067|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44021068|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021069|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43830092|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43830093|NCT05384665|Narcotics|narcotics|mesh-ancestor
43830094|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830095|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830096|NCT05384665|Analgesics|analgesics|mesh-ancestor
43830097|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
43698243|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43698339|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
43698340|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698341|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698342|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43698343|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43698344|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698345|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698346|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
43698347|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823949|NCT05517239|Gemcitabine|gemcitabine|mesh-list
43644989|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
43644990|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43644991|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
43644992|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
43644993|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644994|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644995|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43644996|NCT04305158|Analgesics|analgesics|mesh-ancestor
43644997|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
43644998|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644999|NCT04304040|Antibodies|antibodies|mesh-list
43645000|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645001|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
43645002|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645003|NCT04303780|Docetaxel|docetaxel|mesh-list
43645004|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645005|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43645006|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645007|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645008|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698348|NCT02746185|Heparin|heparin|mesh-list
43698349|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43698350|NCT02746185|Tinzaparin|tinzaparin|mesh-list
43698351|NCT02746185|Dalteparin|dalteparin|mesh-list
43698352|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
44021088|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021089|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021090|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43698648|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43645010|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
43645011|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
43645012|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645013|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645014|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43645015|NCT04299490|Analgesics|analgesics|mesh-list
43645016|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645017|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
43645018|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698649|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021091|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44021092|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021093|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021094|NCT01877564|Metformin|metformin|mesh-list
44021095|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698650|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698651|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698652|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698653|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43698654|NCT02744495|Betamethasone|betamethasone|mesh-list
43698655|NCT02744495|Droperidol|droperidol|mesh-list
43698656|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43698657|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
43698659|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698660|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698661|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43698890|NCT02742285|Artemether|artemether|mesh-list
43698891|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43698892|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
43698893|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43698920|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698921|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43698922|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698923|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
43698924|NCT02742467|Diuretics|diuretics|mesh-ancestor
43698925|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
43698926|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43698927|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43698928|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
43698929|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698930|NCT02742142|Fluorides|fluorides|mesh-list
43698931|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
43698932|NCT02742142|Protective Agents|protective agents|mesh-ancestor
43698933|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698934|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
43698935|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43698936|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698937|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
43698938|NCT02742051|Fluorouracil|fluorouracil|mesh-list
43698939|NCT02742051|Everolimus|everolimus|mesh-list
43698940|NCT02742051|Letrozole|letrozole|mesh-list
43698941|NCT02742051|Epirubicin|epirubicin|mesh-list
43698942|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698943|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
43698971|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43698972|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
43698973|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698974|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698975|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698976|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830227|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645024|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43645026|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645027|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645028|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43830231|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43830232|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43830233|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830234|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830235|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830236|NCT05377255|Naloxone|naloxone|mesh-list
43830237|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43830238|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699006|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43699008|NCT02741232|Lidocaine|lidocaine|mesh-list
43699009|NCT02741232|Epinephrine|epinephrine|mesh-list
43699015|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699016|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
43699017|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699018|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43699019|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43699020|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43699021|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699022|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699023|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43699024|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43699025|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699026|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699027|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43699290|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699292|NCT02739633|Paclitaxel|paclitaxel|mesh-list
43699293|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43699294|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699330|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43699331|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
43699332|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
43699333|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699334|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699335|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
43699336|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43699337|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
43645038|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
43645039|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645040|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645041|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
43645042|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43645043|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645044|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645045|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43645046|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43645047|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43645048|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43645049|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43645050|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43699493|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43699494|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699495|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021102|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
44021103|NCT01890577|Hematinics|hematinics|mesh-ancestor
44021104|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
44021105|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44021106|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
44021107|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021108|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
44021109|NCT01895959|Protective Agents|protective agents|mesh-ancestor
44021110|NCT01889420|Everolimus|everolimus|mesh-list
44021111|NCT01889420|Pomalidomide|pomalidomide|mesh-list
44021112|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021113|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021114|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
44021115|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021116|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021117|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44021118|NCT01889420|Growth Substances|growth substances|mesh-ancestor
44021119|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
44021120|NCT01881984|Glycerol|glycerol|mesh-list
44021121|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44021122|NCT01881984|Protective Agents|protective agents|mesh-ancestor
44021123|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699496|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
43699497|NCT02738073|Coagulants|coagulants|mesh-ancestor
43699498|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43699499|NCT02737943|Analgesics|analgesics|mesh-list
43699500|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699501|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
43699502|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699503|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699504|NCT02737709|Paclitaxel|paclitaxel|mesh-list
43699505|NCT02737709|Carboplatin|carboplatin|mesh-list
43699506|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43699507|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699508|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
43699509|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
43699510|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
43699511|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699512|NCT02737813|Bupivacaine|bupivacaine|mesh-list
43699513|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
43699514|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
43699515|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652038|NCT03003416|Hormones|hormones|mesh-ancestor
43699516|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699517|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
43645051|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43645052|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43645053|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
43645054|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43645055|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
43645056|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
43645057|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43645058|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43645059|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
43645060|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
43645062|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645063|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645064|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44021125|NCT01893359|Dextrans|dextrans|mesh-list
44021126|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44021127|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44021128|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
44021129|NCT01893359|Vitamins|vitamins|mesh-ancestor
44021130|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
44021131|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021132|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44021133|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021134|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
44021135|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
44021136|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
44021137|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
44021138|NCT01878786|Everolimus|everolimus|mesh-list
44021139|NCT01878786|Tacrolimus|tacrolimus|mesh-list
44021140|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021141|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
44021142|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021143|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44021144|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021145|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021146|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021147|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021148|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44021149|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
44021150|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44021151|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021152|NCT01851174|Gemcitabine|gemcitabine|mesh-list
44021153|NCT01851174|Paclitaxel|paclitaxel|mesh-list
44021154|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44021155|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021156|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
44021157|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
44021158|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
44021159|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021160|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021161|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
43699606|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699608|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699609|NCT02737228|Gemcitabine|gemcitabine|mesh-list
43699610|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43699611|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43699612|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
43699613|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699614|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699615|NCT02737228|Antiviral Agents|antiviral agents|mesh-ancestor
43699616|NCT02737228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699617|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699618|NCT02737228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43699619|NCT02737228|Immunologic Factors|immunologic factors|mesh-ancestor
43699620|NCT02737228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699621|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43699622|NCT02737124|Acetaminophen|acetaminophen|mesh-list
43699657|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
43699658|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838244|NCT04858269|Paclitaxel|paclitaxel|mesh-list
43699660|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43699661|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
43699662|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699663|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699664|NCT02736591|Hormones|hormones|mesh-list
43699738|NCT02736123|Ipilimumab|ipilimumab|mesh-list
43699739|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699740|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699741|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43699742|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830370|NCT05366868|Vildagliptin|vildagliptin|mesh-list
43830371|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43830372|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645066|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645067|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645068|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645069|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43645070|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645071|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645072|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43645073|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43645074|NCT04255277|Antidotes|antidotes|mesh-ancestor
43830373|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43830374|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
43830375|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830376|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830377|NCT05365451|Metformin|metformin|mesh-list
43830378|NCT05365451|Probenecid|probenecid|mesh-list
43830379|NCT05365451|Furosemide|furosemide|mesh-list
43830380|NCT05365451|Cimetidine|cimetidine|mesh-list
43830381|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43645078|NCT04255277|Hormones|hormones|mesh-ancestor
43645079|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645080|NCT04235686|Amphetamine|amphetamine|mesh-list
43645081|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
43645082|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43645083|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645084|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
43700123|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700124|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43700125|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700161|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700162|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
43700163|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700214|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700215|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700217|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43700218|NCT02732795|Narcotics|narcotics|mesh-ancestor
43700219|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700220|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700221|NCT02732795|Analgesics|analgesics|mesh-ancestor
43700370|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700371|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700372|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
43700373|NCT02731950|Bupivacaine|bupivacaine|mesh-list
43700374|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
43700375|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
43700376|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700377|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700378|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
44021180|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021181|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021182|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43700379|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700380|NCT02731950|Analgesics|analgesics|mesh-ancestor
43645085|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
43645086|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645087|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
43645088|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645089|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645090|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
43645091|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43645092|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43645093|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645094|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43645095|NCT04224545|Colchicine|colchicine|mesh-list
43700381|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700639|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
43700640|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43700641|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
43700642|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43830509|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43830510|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43830511|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43830512|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43830513|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43830514|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
43830515|NCT05358938|Ipilimumab|ipilimumab|mesh-list
43830516|NCT05358938|Avelumab|avelumab|mesh-list
43830517|NCT05358938|Cemiplimab|cemiplimab|mesh-list
43830518|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43830519|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830520|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830521|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830522|NCT05358834|Melatonin|melatonin|mesh-list
43830523|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
43830524|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830525|NCT05358834|Protective Agents|protective agents|mesh-ancestor
43830526|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645096|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
43645097|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645098|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
44021185|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021257|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44021259|NCT01797380|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44021260|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44021261|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021262|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021263|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021264|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
44021265|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021266|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44021267|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
44021268|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44021269|NCT01788475|Dexamethasone|dexamethasone|mesh-list
44021270|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
44021271|NCT01788475|BB 1101|bb 1101|mesh-list
44021272|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44021273|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
44021274|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
44021275|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021276|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021277|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021278|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
44021279|NCT01788475|Hormones|hormones|mesh-ancestor
44021280|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021281|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44021282|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021283|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
44021284|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021302|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
44021303|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021304|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44021305|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43645099|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645100|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645101|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645102|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645104|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645105|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645106|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645107|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645108|NCT04211090|Carboplatin|carboplatin|mesh-list
43830527|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830528|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
43830529|NCT05358522|Narcotics|narcotics|mesh-ancestor
43830530|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830531|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830532|NCT05358522|Analgesics|analgesics|mesh-ancestor
43830533|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
43700887|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700888|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43700889|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43700890|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830554|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
43830555|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830556|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
43701425|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701427|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43701428|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701429|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43701430|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701458|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43701459|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701460|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701461|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
43701462|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43701463|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701464|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645109|NCT04211090|Pemetrexed|pemetrexed|mesh-list
43645110|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645111|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645112|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645113|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43645114|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43645115|NCT04210349|Vaccines|vaccines|mesh-list
43701465|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701466|NCT02724098|Analgesics|analgesics|mesh-ancestor
43701467|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
43701468|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701469|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43701470|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43701606|NCT02723669|Antidotes|antidotes|mesh-ancestor
43701607|NCT02723513|Xenon|xenon|mesh-list
43701608|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43701880|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701915|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43701916|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701917|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701919|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701920|NCT02721329|Analgesics|analgesics|mesh-ancestor
43701921|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
43645116|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
43645117|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645118|NCT04209504|Bupivacaine|bupivacaine|mesh-list
43645119|NCT04209504|Ropivacaine|ropivacaine|mesh-list
43645120|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
43645121|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
43645122|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645123|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645135|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43645136|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645137|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43823950|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
43645138|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43645139|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43645140|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43645141|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43702071|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702072|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702073|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
43702074|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702075|NCT02720601|Capecitabine|capecitabine|mesh-list
43702138|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830701|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43702364|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
43702365|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702366|NCT02718079|Protective Agents|protective agents|mesh-ancestor
43702368|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43702369|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
43702370|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43702371|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702373|NCT02717923|Cetuximab|cetuximab|mesh-list
43702481|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43702482|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702483|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702484|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
43702485|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702486|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702487|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702489|NCT02717091|Antiviral Agents|antiviral agents|mesh-ancestor
43702490|NCT02717091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702491|NCT02717091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702566|NCT02716233|Pegaspargase|pegaspargase|mesh-list
43702567|NCT02716233|Asparaginase|asparaginase|mesh-list
43702568|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702569|NCT02716272|Nivolumab|nivolumab|mesh-list
43702570|NCT02716272|Ipilimumab|ipilimumab|mesh-list
43702571|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43702572|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702573|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43830758|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
44021335|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021336|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44021337|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021338|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021339|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
44021340|NCT01754987|Protective Agents|protective agents|mesh-ancestor
44021341|NCT01756560|Bupivacaine|bupivacaine|mesh-list
44021342|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021343|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
44021344|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021345|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021346|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
44021347|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021348|NCT01756573|Bupivacaine|bupivacaine|mesh-list
44021349|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021351|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752055|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
44021352|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702636|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702637|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
43702638|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702639|NCT02715492|Enoxaparin|enoxaparin|mesh-list
43702640|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
43702641|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43702642|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43702643|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702644|NCT02715531|Leucovorin|leucovorin|mesh-list
43702645|NCT02715531|Gemcitabine|gemcitabine|mesh-list
43702646|NCT02715531|Paclitaxel|paclitaxel|mesh-list
43702647|NCT02715531|Bevacizumab|bevacizumab|mesh-list
43702648|NCT02715531|Cisplatin|cisplatin|mesh-list
43702649|NCT02715531|Capecitabine|capecitabine|mesh-list
43702650|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
43645151|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
43702652|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43702653|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702654|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702655|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
43702656|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702657|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702728|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702729|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702730|NCT02715154|Analgesics|analgesics|mesh-ancestor
43702731|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
43702732|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702733|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43702734|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43702739|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43703026|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703027|NCT02713191|Analgesics|analgesics|mesh-ancestor
43703028|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
43703029|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703030|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43703031|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43703032|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43703033|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703034|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703035|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703036|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703037|NCT02713191|Narcotics|narcotics|mesh-ancestor
43703038|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703039|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703040|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
43703041|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
43703042|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43703043|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43703044|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43703045|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
43703046|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
43703123|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645160|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645161|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645162|NCT04183062|Gemcitabine|gemcitabine|mesh-list
43645163|NCT04183062|Docetaxel|docetaxel|mesh-list
43645164|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645165|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
43645166|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645167|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645168|NCT04183062|Antiviral Agents|antiviral agents|mesh-ancestor
43645169|NCT04183062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645170|NCT04183062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703178|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703179|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703180|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43703183|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43703184|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43703185|NCT02712125|Diuretics|diuretics|mesh-ancestor
43703186|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
43703187|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703188|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703189|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43703190|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703191|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43830838|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43830839|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
43830840|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830841|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
43830842|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645172|NCT04183062|Immunologic Factors|immunologic factors|mesh-ancestor
43645173|NCT04183062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645174|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
43645175|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645176|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645178|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
43645179|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
43645180|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43645181|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43830846|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830847|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43830849|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43830850|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43830851|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
43830852|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830853|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830854|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43830855|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43830856|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
43703279|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43703280|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703281|NCT02711592|Analgesics|analgesics|mesh-list
43703282|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
43703283|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703284|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703285|NCT02711410|Clopidogrel|clopidogrel|mesh-list
43703286|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703287|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43703288|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43703289|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43703290|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
43703291|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703292|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703293|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703294|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43703296|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43703297|NCT02711670|Diuretics|diuretics|mesh-ancestor
43703298|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
43703299|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703300|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43703301|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645186|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
43645187|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645188|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
43645189|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
43645190|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
43645191|NCT04173988|Fludarabine|fludarabine|mesh-list
43645192|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645193|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
43645194|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645195|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645196|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645197|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
43645198|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703542|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703543|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43703544|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43703545|NCT02710266|Gabexate|gabexate|mesh-list
43703546|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
43703547|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43703548|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
43703549|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703550|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703551|NCT02710305|Lidocaine|lidocaine|mesh-list
43703552|NCT02710305|Scopolamine|scopolamine|mesh-list
43703553|NCT02710305|Bromides|bromides|mesh-list
43703554|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43703555|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703556|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
43703705|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43703706|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43703707|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43703709|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
43703710|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43703711|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43703712|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43703713|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
43703714|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703715|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43703716|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43645199|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645200|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43645201|NCT04160936|Bupivacaine|bupivacaine|mesh-list
43645202|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
43645203|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
44021374|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021375|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44021377|NCT01718444|Enclomiphene|enclomiphene|mesh-list
44021378|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
44021379|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
44021380|NCT01718444|Progestins|progestins|mesh-list
44021454|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021455|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021457|NCT01691079|Ipratropium|ipratropium|mesh-list
44021458|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
43838254|NCT04857983|Memantine|memantine|mesh-list
43645204|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645205|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703906|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
43703907|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703908|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703909|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43703910|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43703911|NCT02707484|Growth Substances|growth substances|mesh-ancestor
43703912|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
43703913|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703914|NCT02707445|Clopidogrel|clopidogrel|mesh-list
43704260|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
43704261|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43704262|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43704263|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
43704264|NCT05244031|Narcotics|narcotics|mesh-ancestor
43704265|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704266|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704294|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704295|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704296|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43704297|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
43704298|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704299|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704300|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43704301|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704302|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43704303|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43704304|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
43704305|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704306|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704307|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704309|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43704310|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43704311|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704427|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43704428|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43704429|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704430|NCT04942067|Dexamethasone|dexamethasone|mesh-list
43645218|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645219|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
43645220|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
43645221|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645222|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645223|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43645224|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
43645226|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645227|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645228|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645229|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
43704465|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704467|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704468|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
43704469|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704470|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43704471|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704472|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43830944|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830945|NCT05335109|Xenon|xenon|mesh-list
43830946|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43704483|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43704484|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
43704485|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704486|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704487|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43704488|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704490|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704491|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43704492|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43704493|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43704494|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704495|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43704526|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704527|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43704528|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704529|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704530|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
43704531|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43704532|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704533|NCT04712071|Ketamine|ketamine|mesh-list
43704534|NCT04712071|Analgesics|analgesics|mesh-ancestor
43704535|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
43704536|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704537|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704538|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43645230|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43645231|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43645232|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
43645233|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
43645234|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645235|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645236|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43645237|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43645238|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704668|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704669|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
43704706|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
43704707|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704708|NCT04331145|Ticagrelor|ticagrelor|mesh-list
43704709|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43704743|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704744|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704745|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
43704746|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704747|NCT04291820|Anesthetics|anesthetics|mesh-list
43704748|NCT04291820|Sevoflurane|sevoflurane|mesh-list
43704749|NCT04291820|Desflurane|desflurane|mesh-list
43704750|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704751|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704788|NCT04230681|Analgesics|analgesics|mesh-ancestor
43704789|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
43704896|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
43704897|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43704898|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43645239|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43645240|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43645241|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43645242|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
43645243|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43645244|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43645245|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
43645246|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43645247|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
43645248|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43645249|NCT04155008|Analgesics|analgesics|mesh-ancestor
43704899|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43704900|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704901|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704902|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
43704903|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704904|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704906|NCT03792256|Prednisone|prednisone|mesh-list
43704907|NCT03792256|Prednisolone|prednisolone|mesh-list
43704908|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
43704909|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43704946|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43704947|NCT03787095|Cemiplimab|cemiplimab|mesh-list
44021461|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704948|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704949|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704950|NCT03779295|Clindamycin|clindamycin|mesh-list
43704951|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
43704952|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
43704953|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705037|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
43705038|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705039|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705040|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43705110|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
43705111|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705112|NCT03342456|Amoxicillin|amoxicillin|mesh-list
43705185|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
43705186|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705187|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705188|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
43705189|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
43705190|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705191|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705192|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
43705193|NCT05345119|Hormones|hormones|mesh-ancestor
43705194|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705195|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43705196|NCT05345119|Protective Agents|protective agents|mesh-ancestor
43705197|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705198|NCT05344742|Paclitaxel|paclitaxel|mesh-list
43705199|NCT05344742|Capecitabine|capecitabine|mesh-list
43705200|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
43705201|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43705383|NCT05244538|Narcotics|narcotics|mesh-ancestor
43705384|NCT05244538|Analgesics|analgesics|mesh-ancestor
43705385|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
43705427|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645251|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43645252|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43645253|NCT04154189|Etoposide|etoposide|mesh-list
43645254|NCT04154189|Ifosfamide|ifosfamide|mesh-list
43645255|NCT04154189|Lenvatinib|lenvatinib|mesh-list
43645256|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43645257|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645258|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43705456|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705457|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705458|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705459|NCT04827745|Blinatumomab|blinatumomab|mesh-list
43705460|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705461|NCT04811625|Aspirin|aspirin|mesh-list
43705462|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43705463|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43705464|NCT04811625|Analgesics|analgesics|mesh-ancestor
43705465|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
43705466|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705467|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705468|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705469|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705470|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43705471|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43705472|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705540|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831126|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43831127|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43831128|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831129|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43831130|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43831131|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831132|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021466|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
44021467|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021468|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021469|NCT01663285|Gemcitabine|gemcitabine|mesh-list
44021470|NCT01663285|Cisplatin|cisplatin|mesh-list
44021471|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021472|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021473|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
44021474|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021475|NCT01663285|Antiviral Agents|antiviral agents|mesh-ancestor
44021476|NCT01663285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021477|NCT01663285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021478|NCT01663285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021479|NCT01663285|Immunologic Factors|immunologic factors|mesh-ancestor
44021480|NCT01663285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021481|NCT01683864|Cisplatin|cisplatin|mesh-list
44021482|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021483|NCT01673061|Lidocaine|lidocaine|mesh-list
44021484|NCT01673061|Epinephrine|epinephrine|mesh-list
44021485|NCT01673061|Norflurane|norflurane|mesh-list
44021486|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
43831133|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43831134|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831135|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831136|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
43847406|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847407|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847408|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705568|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
43705569|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705570|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
43705571|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705572|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
43705608|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43705609|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
43705612|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43705634|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705635|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
43705636|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705637|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705638|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705639|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
44021492|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43705640|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
43705641|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645259|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43645260|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645261|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645262|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645263|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
43645264|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645265|NCT04151082|Prednisone|prednisone|mesh-list
43645266|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
43705642|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43705643|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
43705644|NCT04074187|Hormones|hormones|mesh-ancestor
43705645|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705646|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43705647|NCT04074187|Protective Agents|protective agents|mesh-ancestor
43705648|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705649|NCT04017546|Venetoclax|venetoclax|mesh-list
43705650|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705651|NCT04007991|Ecopipam|ecopipam|mesh-list
43705652|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43705653|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43705654|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705655|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705656|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43705688|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
43705689|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
43705690|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43705691|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705692|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705693|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705694|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705695|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705696|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705727|NCT03794336|Metformin|metformin|mesh-list
43705728|NCT03794336|Alogliptin|alogliptin|mesh-list
43705729|NCT03794336|Acarbose|acarbose|mesh-list
43705730|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705731|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705732|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43705733|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43705734|NCT03794336|Analgesics|analgesics|mesh-ancestor
43705735|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
43705736|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705737|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43705738|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831175|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831177|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43831178|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43831179|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831180|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831181|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43831182|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
43831183|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
43847417|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
43645270|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
43645272|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43645273|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
43645274|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645275|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
43645276|NCT04151082|Hormones|hormones|mesh-ancestor
43705873|NCT03492099|Narcotics|narcotics|mesh-ancestor
43705874|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705875|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705876|NCT03492099|Analgesics|analgesics|mesh-ancestor
43705877|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
43705878|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705879|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43705880|NCT03485547|Venetoclax|venetoclax|mesh-list
43705913|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43705914|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43705915|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
43705916|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43705917|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43705918|NCT03462069|Empagliflozin|empagliflozin|mesh-list
43705919|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43705920|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705956|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760759|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43706202|NCT02851290|Anesthetics|anesthetics|mesh-list
43706203|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706204|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706205|NCT02803203|Bevacizumab|bevacizumab|mesh-list
43706206|NCT02803203|Osimertinib|osimertinib|mesh-list
43706207|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706208|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706209|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43706210|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43706427|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706428|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43706429|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
43706430|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43706431|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43706432|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43706433|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
44021497|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44021498|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44021499|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43706434|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706435|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706436|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
43706437|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
43706438|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43706439|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706634|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831219|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831221|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
43831222|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
43831223|NCT05322538|Vitamins|vitamins|mesh-list
43831224|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43831225|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
43831226|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769863|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43831227|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43831228|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43831229|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43831230|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831231|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
43831232|NCT05322070|Hormones|hormones|mesh-ancestor
43831233|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831234|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706831|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43706833|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706834|NCT02704780|Misoprostol|misoprostol|mesh-list
43706835|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43706836|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
43706837|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43706838|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706839|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43706840|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706841|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
43706842|NCT02704546|Methylphenidate|methylphenidate|mesh-list
43706843|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43706844|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706845|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43706846|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43706847|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43706848|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706849|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
43706850|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706851|NCT02704481|Misoprostol|misoprostol|mesh-list
43706852|NCT02704481|Mifepristone|mifepristone|mesh-list
43706853|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43706854|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
43706855|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43706856|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706857|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43706858|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706859|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
43706860|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43706861|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43706863|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43706864|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
43645293|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645295|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
43706931|NCT02703896|Lafutidine|lafutidine|mesh-list
43706932|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43706933|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706934|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43706935|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706936|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706937|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43706938|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
44021500|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021501|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43706939|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
43706940|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706941|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706942|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43706943|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43706944|NCT02704013|Oxybutynin|oxybutynin|mesh-list
43706945|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
43706946|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
43706947|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706948|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706949|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43706950|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43706951|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
43706952|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706953|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706954|NCT02704013|Urological Agents|urological agents|mesh-ancestor
43707004|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43707005|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43707006|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43591616|NCT03360734|Cetuximab|cetuximab|mesh-list
43707007|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707008|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707009|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707011|NCT02703376|Prednisolone|prednisolone|mesh-list
43707012|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707013|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
43707014|NCT02703376|Hormones|hormones|mesh-ancestor
43707015|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707016|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707017|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707018|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707019|NCT02703415|Tramadol|tramadol|mesh-list
43707020|NCT02703415|Bupivacaine|bupivacaine|mesh-list
43707021|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707022|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
43707023|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707024|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707025|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
43707026|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707027|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43707028|NCT02703415|Narcotics|narcotics|mesh-ancestor
43707029|NCT02703415|Analgesics|analgesics|mesh-ancestor
43707030|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
43707031|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707032|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707044|NCT02703272|Rituximab|rituximab|mesh-list
43707045|NCT02703272|Carboplatin|carboplatin|mesh-list
43707046|NCT02703272|Etoposide|etoposide|mesh-list
43707047|NCT02703272|Vincristine|vincristine|mesh-list
43707048|NCT02703272|Ifosfamide|ifosfamide|mesh-list
43707049|NCT02703272|Idarubicin|idarubicin|mesh-list
43760763|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
43707068|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707069|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
43707070|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
43707071|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
43707072|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43707073|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
43707074|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43707075|NCT02703194|Prednisone|prednisone|mesh-list
43707076|NCT02703194|Prednisolone|prednisolone|mesh-list
43707077|NCT02703194|Leflunomide|leflunomide|mesh-list
43707078|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707079|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
43707080|NCT02703194|Hormones|hormones|mesh-ancestor
43707081|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707082|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707083|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707084|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707085|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707103|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707104|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43707105|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645304|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645306|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43645307|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
43645308|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43645309|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
43645310|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021515|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44021516|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021517|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707133|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
43707134|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707135|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707136|NCT02702817|Naproxen|naproxen|mesh-list
43707137|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707207|NCT02702323|Apatinib|apatinib|mesh-list
43707208|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707209|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43707210|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707211|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831284|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831285|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831286|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
43831287|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
43760764|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
43707218|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
43707219|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707220|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707221|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
43707222|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
43707223|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707224|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707225|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
43707226|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43707227|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43707228|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547787|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
43707315|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707316|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707318|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43707319|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
43707423|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707424|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
43707425|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707426|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707427|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
43707428|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707429|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707430|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43707431|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43707432|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707433|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707435|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43707436|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707437|NCT02700568|Axitinib|axitinib|mesh-list
43707438|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707439|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43707440|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707441|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707442|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43707443|NCT02700711|Methylphenidate|methylphenidate|mesh-list
43707444|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43707445|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707456|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
43707457|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43707458|NCT02700685|Methylphenidate|methylphenidate|mesh-list
43707459|NCT02700685|Pycnogenols|pycnogenols|mesh-list
43707464|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707465|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707467|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707468|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43707469|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
43707470|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
43707471|NCT02700685|Protective Agents|protective agents|mesh-ancestor
43707472|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43707473|NCT02700763|Dabrafenib|dabrafenib|mesh-list
43707474|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707475|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43707476|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707477|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707478|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
43707479|NCT02700347|Allopurinol|allopurinol|mesh-list
43707480|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
43707481|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707482|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707483|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
43707484|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707485|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43707486|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
43707487|NCT02700347|Protective Agents|protective agents|mesh-ancestor
43707488|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707489|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
43707490|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707491|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707492|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
43707493|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
43831314|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43831315|NCT05316935|Cyproterone|cyproterone|mesh-list
43831316|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43707494|NCT02700217|Remifentanil|remifentanil|mesh-list
43707495|NCT02700217|Heroin|heroin|mesh-list
43707534|NCT02699879|Analgesics|analgesics|mesh-ancestor
43707535|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
43707536|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707537|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707538|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707539|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707540|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707541|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707542|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707543|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
43707544|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
43707545|NCT02699827|Analgesics|analgesics|mesh-ancestor
43707546|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
43707547|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707548|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707549|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
43707550|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707551|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43707552|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
43707553|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43707588|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43645311|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645312|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
43823951|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823952|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
43823953|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823954|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707589|NCT02700022|Prednisone|prednisone|mesh-list
43707590|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
43707615|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
43707617|NCT02699658|Ofloxacin|ofloxacin|mesh-list
43707625|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707626|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707627|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43707628|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707630|NCT02699801|Propofol|propofol|mesh-list
43707631|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43707632|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707633|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707634|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43707635|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
43707636|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
43707637|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707638|NCT02699801|Analgesics|analgesics|mesh-ancestor
43707639|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
43823956|NCT05517239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823957|NCT05517239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823958|NCT05517239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823959|NCT05517239|Immunologic Factors|immunologic factors|mesh-ancestor
43707945|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708137|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708138|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708166|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708168|NCT05322681|Analgesics|analgesics|mesh-ancestor
43708169|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
43708170|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708171|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708172|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
43708173|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43708174|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769870|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
43708175|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708183|NCT05322603|Analgesics|analgesics|mesh-list
43708184|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43708185|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708186|NCT05322603|Narcotics|narcotics|mesh-ancestor
43708187|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708188|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708189|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
43708190|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708191|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43708192|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708193|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823960|NCT05517239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823962|NCT05517213|Etoposide|etoposide|mesh-list
43823963|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823964|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
43823965|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823966|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823967|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43823968|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
43823969|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823970|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823971|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43645313|NCT04111978|Letrozole|letrozole|mesh-list
43708194|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43708195|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708196|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708197|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
43708198|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708199|NCT05322564|Narcotics|narcotics|mesh-ancestor
43708200|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708201|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708202|NCT05322564|Analgesics|analgesics|mesh-ancestor
43708203|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
43708204|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708205|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43708206|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43708207|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708208|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708209|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708210|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708240|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702635|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021553|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021554|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44021555|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44021556|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021557|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44021558|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44021559|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021560|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
44021561|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43708289|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43708291|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708292|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708293|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708294|NCT05036226|Metformin|metformin|mesh-list
43708295|NCT05036226|Sirolimus|sirolimus|mesh-list
43708296|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
43708297|NCT05036226|Nelfinavir|nelfinavir|mesh-list
43708298|NCT05036226|Dasatinib|dasatinib|mesh-list
43708299|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43708300|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708301|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43708302|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645314|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645316|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43645317|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645318|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645319|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43645320|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
43708303|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43708304|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708305|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
43708306|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708307|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
43708308|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
43708309|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43708310|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43708311|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708312|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708313|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708314|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43708315|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43708316|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43708317|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
43708318|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43708319|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43708320|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
43708321|NCT05000658|Dexamethasone|dexamethasone|mesh-list
43708322|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43708323|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708324|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
43708325|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
43708326|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708327|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708328|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708329|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
43708330|NCT05000658|Hormones|hormones|mesh-ancestor
43702658|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708804|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708806|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43708807|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43708808|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645321|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645322|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645324|NCT04108481|Methamphetamine|methamphetamine|mesh-list
43645325|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43645326|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021568|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
44021569|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021570|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44021571|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021572|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021573|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44021574|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44021575|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
44148599|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44021576|NCT01608906|Heparin|heparin|mesh-list
44021577|NCT01608906|Calcium heparin|calcium heparin|mesh-list
44021578|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
44021579|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44021580|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44021581|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021582|NCT01621737|Oxytocin|oxytocin|mesh-list
44021583|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
44021584|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021585|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021586|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44021587|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44021588|NCT01607320|Clomiphene|clomiphene|mesh-list
44021589|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
44021590|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44021619|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021620|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
44021621|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021622|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021623|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
44021624|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708859|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708860|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43708861|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708862|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708863|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43708864|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43708865|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708866|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
43708867|NCT03735901|Levodopa|levodopa|mesh-list
43708868|NCT03735901|Carbidopa|carbidopa|mesh-list
43708869|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43708870|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43708871|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
43708872|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708873|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708874|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708875|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43708876|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708877|NCT03703856|Memantine|memantine|mesh-list
43708878|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43708879|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43708880|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
43708881|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708882|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708883|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708884|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708885|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708886|NCT03664180|Heparin|heparin|mesh-list
43708887|NCT03664180|Calcium heparin|calcium heparin|mesh-list
43708888|NCT03664180|Enoxaparin|enoxaparin|mesh-list
43708889|NCT03664180|Hirudins|hirudins|mesh-list
43708890|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
43708891|NCT03664180|Bivalirudin|bivalirudin|mesh-list
43708892|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
43708893|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43708894|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708895|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645327|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708962|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43708964|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708965|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708966|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708967|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43708968|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43708969|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
43709047|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709048|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
43709049|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709050|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43709051|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709052|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
43709053|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
43709054|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709055|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709056|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
43709057|NCT02471911|Hormones|hormones|mesh-ancestor
43709058|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709059|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43709062|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43709063|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709064|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709065|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43709066|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
43709067|NCT02432417|Chloroquine|chloroquine|mesh-list
43709068|NCT02432417|Amebicides|amebicides|mesh-ancestor
43709069|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43709070|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43709071|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709072|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
43709073|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43709074|NCT02407119|Amoxicillin|amoxicillin|mesh-list
43709075|NCT02407119|Clarithromycin|clarithromycin|mesh-list
43709076|NCT02407119|Omeprazole|omeprazole|mesh-list
43709077|NCT02407119|Rabeprazole|rabeprazole|mesh-list
43709078|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43709079|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709080|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709081|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43709082|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709083|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709084|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709085|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43709086|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43709087|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43709088|NCT02364713|Gemcitabine|gemcitabine|mesh-list
43709089|NCT02364713|Paclitaxel|paclitaxel|mesh-list
43709090|NCT02364713|Bevacizumab|bevacizumab|mesh-list
43709091|NCT02364713|Doxorubicin|doxorubicin|mesh-list
43709113|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709114|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
43709115|NCT02364713|Antiviral Agents|antiviral agents|mesh-ancestor
43709116|NCT02364713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709117|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709118|NCT02364713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709119|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43645328|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
43645329|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645330|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43645331|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
43645332|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
43645333|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645334|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
43645335|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645336|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645337|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709120|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43709121|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43709122|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43709123|NCT02358395|Sorafenib|sorafenib|mesh-list
43709124|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709125|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43709126|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709127|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831495|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
43831499|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
43709177|NCT01955980|Budesonide|budesonide|mesh-list
43709178|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709179|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43709180|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
43709181|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709182|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709183|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43709184|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
43709185|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
43709186|NCT01955980|Hormones|hormones|mesh-ancestor
43709187|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709188|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
43709189|NCT01953900|Fludarabine|fludarabine|mesh-list
43709190|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709191|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
43709192|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709193|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43709194|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43709195|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
43709196|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645338|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43645339|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43645340|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645341|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43645342|NCT04108156|Ranibizumab|ranibizumab|mesh-list
43645343|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43645344|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43645345|NCT04108156|Growth Substances|growth substances|mesh-ancestor
43709197|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709198|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43709199|NCT01946711|Budesonide|budesonide|mesh-list
43709200|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709201|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43709202|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
43709203|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709204|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709839|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44021633|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44021634|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021635|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44021636|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021637|NCT01602016|Leucovorin|leucovorin|mesh-list
44021638|NCT01602016|Folic Acid|folic acid|mesh-list
44021639|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
44021640|NCT01602016|Antidotes|antidotes|mesh-ancestor
44021641|NCT01602016|Protective Agents|protective agents|mesh-ancestor
44021642|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021643|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
44021644|NCT01602016|Vitamins|vitamins|mesh-ancestor
44021645|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
44021646|NCT01602016|Hematinics|hematinics|mesh-ancestor
44021647|NCT01598025|Fludarabine|fludarabine|mesh-list
44021648|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
44021649|NCT01598025|Melphalan|melphalan|mesh-list
44021650|NCT01598025|Thiotepa|thiotepa|mesh-list
44021651|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44021653|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021654|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
44021655|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021656|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021657|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
44021658|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709840|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
43709841|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
43709842|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709843|NCT04962841|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43709844|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43709845|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709846|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
43709986|NCT04551495|Letrozole|letrozole|mesh-list
43709987|NCT04551495|Goserelin|goserelin|mesh-list
43709988|NCT04551495|Entrectinib|entrectinib|mesh-list
43709989|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709990|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43709991|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44021659|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44021660|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
44021661|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44021662|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
44021663|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
43709992|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645348|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645349|NCT04102020|Azacitidine|azacitidine|mesh-list
43645350|NCT04102020|Venetoclax|venetoclax|mesh-list
43645351|NCT04102020|Cc-486|cc-486|mesh-list
43847434|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
43847435|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847436|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847437|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847438|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
43847439|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847440|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847441|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43847442|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43847443|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43847444|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847445|NCT04106115|Durvalumab|durvalumab|mesh-list
43847446|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43847447|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710000|NCT04494880|Bupivacaine|bupivacaine|mesh-list
43710001|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710002|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
43710003|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710004|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710005|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
43710006|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710007|NCT04489888|Paclitaxel|paclitaxel|mesh-list
43710008|NCT04489888|Carboplatin|carboplatin|mesh-list
43710009|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
43710010|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43710011|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831594|NCT05305066|Etanercept|etanercept|mesh-list
43831603|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
43831604|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831605|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831606|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831607|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831608|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
43831609|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43831610|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831611|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831612|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43831613|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43710291|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
43710292|NCT02580994|Etoposide|etoposide|mesh-list
43710293|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710294|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710295|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43710296|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710297|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43710298|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710299|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710302|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
43710304|NCT02436707|Cisplatin|cisplatin|mesh-list
43710305|NCT02436707|Etoposide|etoposide|mesh-list
43710306|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710307|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
43710308|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710309|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43710310|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43710311|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
43710312|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710313|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710314|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43710328|NCT02436707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710329|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710330|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43710331|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710332|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43710334|NCT02200978|Methotrexate|methotrexate|mesh-list
43710335|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
43710336|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
43710337|NCT02200978|Tretinoin|tretinoin|mesh-list
43710338|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
43710361|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
43710362|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43710363|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43710364|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43710365|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831614|NCT05304949|Ranibizumab|ranibizumab|mesh-list
44021670|NCT01583647|Niacinamide|niacinamide|mesh-list
44021671|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
44021672|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44021673|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
44021674|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710366|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710367|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43645356|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645357|NCT04091022|Eflornithine|eflornithine|mesh-list
43645358|NCT04091022|Diclofenac|diclofenac|mesh-list
43645359|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43645360|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43645361|NCT04091022|Analgesics|analgesics|mesh-ancestor
43710368|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710369|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710370|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
43710371|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710372|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
43710373|NCT02012114|Cysteamine|cysteamine|mesh-list
43710374|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43710375|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710376|NCT01979211|Cetuximab|cetuximab|mesh-list
43710377|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710378|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710379|NCT01880359|Nimorazole|nimorazole|mesh-list
43710380|NCT01880359|Cisplatin|cisplatin|mesh-list
43710381|NCT01880359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710382|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43710383|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43710384|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43710385|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710386|NCT01778946|Nicotine|nicotine|mesh-list
43710387|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43710388|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
43710389|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710390|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710391|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43710392|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43710393|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
43710394|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710395|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710396|NCT01706692|Cyclosporine|cyclosporine|mesh-list
43710397|NCT01706692|Adalimumab|adalimumab|mesh-list
43710398|NCT01706692|Etanercept|etanercept|mesh-list
43710399|NCT01706692|Methotrexate|methotrexate|mesh-list
43710400|NCT01706692|Infliximab|infliximab|mesh-list
43710401|NCT01706692|Ustekinumab|ustekinumab|mesh-list
43710402|NCT01706692|Cyclosporins|cyclosporins|mesh-list
43710403|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43710404|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
43710405|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43710406|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710407|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710493|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710494|NCT02696733|Cephalosporins|cephalosporins|mesh-list
43710495|NCT02696733|Lidocaine|lidocaine|mesh-list
43710496|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710497|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
43710498|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710499|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710500|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
43710501|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710502|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710503|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43710504|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43710507|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710508|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710509|NCT02696915|Fentanyl|fentanyl|mesh-list
43710510|NCT02696915|Bupivacaine|bupivacaine|mesh-list
44021676|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
44021677|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
44021679|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
44021680|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021681|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
44021682|NCT01570634|Loperamide|loperamide|mesh-list
44021683|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
44021684|NCT01570634|Calcium|calcium|mesh-list
43850026|NCT05702463|Aspirin|aspirin|mesh-list
43644238|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43644239|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43644240|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43644241|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43644242|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
43644243|NCT04687800|Dexamethasone|dexamethasone|mesh-list
43644244|NCT04687800|Difluprednate|difluprednate|mesh-list
43645362|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
43645363|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644245|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644246|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
43644247|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
43644248|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644249|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644250|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644251|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
43644252|NCT04687800|Hormones|hormones|mesh-ancestor
43644253|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644254|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644255|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823909|NCT05517928|Omeprazole|omeprazole|mesh-list
43823910|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43823911|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823912|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43823913|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823914|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823915|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43769916|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846318|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846319|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846320|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43846321|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43846322|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846323|NCT04205968|Antidotes|antidotes|mesh-ancestor
43846324|NCT04205968|Protective Agents|protective agents|mesh-ancestor
43846325|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
43846326|NCT04205968|Vitamins|vitamins|mesh-ancestor
43846327|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
43846328|NCT04205968|Hematinics|hematinics|mesh-ancestor
43846329|NCT04205552|Nivolumab|nivolumab|mesh-list
43846330|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43846331|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846332|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846333|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43846334|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846335|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
43846336|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43846337|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846338|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846339|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846340|NCT04205539|Analgesics|analgesics|mesh-ancestor
43846341|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
43846342|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846343|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43846344|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43846345|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43644263|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
44021687|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021688|NCT01566370|Zonisamide|zonisamide|mesh-list
44021689|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
44021690|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44021691|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021692|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644264|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644265|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644266|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644267|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
43644268|NCT04680988|Antiviral Agents|antiviral agents|mesh-ancestor
43644269|NCT04680988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644270|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644271|NCT04680988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644272|NCT04680988|Immunologic Factors|immunologic factors|mesh-ancestor
43644273|NCT04680988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644274|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43644275|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644276|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43644277|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43644278|NCT04677114|Buprenorphine|buprenorphine|mesh-list
43644305|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644307|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644308|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644309|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644310|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645364|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645365|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645366|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645367|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43645368|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644311|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644313|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
43644315|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43644316|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43644317|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
43644318|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644319|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644320|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644321|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644322|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43644323|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43644324|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43644325|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
43644344|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644345|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
43644346|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644347|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43644348|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644349|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644350|NCT04640376|Acetaminophen|acetaminophen|mesh-list
43644351|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43644352|NCT04640376|Analgesics|analgesics|mesh-ancestor
43644353|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
43644354|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644355|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644356|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
43644357|NCT04633577|Lidocaine|lidocaine|mesh-list
43644358|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
43644359|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
44021693|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44021694|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021695|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
44021697|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
43644360|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644361|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644362|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
43644363|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644364|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43644365|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43644366|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43644367|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43644368|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644369|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
43644370|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644371|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644372|NCT04624906|Rituximab|rituximab|mesh-list
43644373|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43644374|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
43644375|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644376|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644377|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
43644378|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644379|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644380|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43644381|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
43644416|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
43644417|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43644418|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
43644419|NCT04610476|Adalimumab|adalimumab|mesh-list
43644420|NCT04610476|Etanercept|etanercept|mesh-list
43644421|NCT04610476|Apremilast|apremilast|mesh-list
43644422|NCT04610476|Golimumab|golimumab|mesh-list
43644436|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644437|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644438|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
43645369|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645370|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645371|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43645372|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43645373|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43645374|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644439|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644440|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644441|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644442|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644443|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43644444|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644445|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
43644446|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644447|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43644448|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644449|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
43644450|NCT04610476|Hormones|hormones|mesh-ancestor
43644451|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644452|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644453|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
43644454|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
43644455|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644456|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644457|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43644458|NCT04610476|Protective Agents|protective agents|mesh-ancestor
43644459|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43644460|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43644461|NCT04610476|Analgesics|analgesics|mesh-ancestor
43644462|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
43644463|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644464|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44021698|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021699|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
44021700|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021701|NCT01555489|Protective Agents|protective agents|mesh-ancestor
44021702|NCT01549977|Febuxostat|febuxostat|mesh-list
44021703|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
44021704|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44021705|NCT01558492|Paclitaxel|paclitaxel|mesh-list
44021706|NCT01558492|Carboplatin|carboplatin|mesh-list
44021707|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44021708|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021709|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44021710|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44021711|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44021712|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021713|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44021714|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44021715|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021716|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
44021717|NCT01550510|Irinotecan|irinotecan|mesh-list
44021718|NCT01550510|Camptothecin|camptothecin|mesh-list
44021719|NCT01550510|Vitamins|vitamins|mesh-ancestor
44021720|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
44021721|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021722|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44021723|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44021724|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871177|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021725|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021726|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021727|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
44021728|NCT01550510|Protective Agents|protective agents|mesh-ancestor
44021729|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44021730|NCT01548651|Saxagliptin|saxagliptin|mesh-list
44021731|NCT01548651|Incretins|incretins|mesh-ancestor
43644465|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43644466|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43644467|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43644468|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644469|NCT04599790|Lenvatinib|lenvatinib|mesh-list
43644470|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021732|NCT01548651|Hormones|hormones|mesh-ancestor
44021733|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44021734|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021735|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44021736|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
44021737|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021738|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021739|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44021740|NCT01545648|Denosumab|denosumab|mesh-list
44021741|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44021742|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021743|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44021744|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
44021745|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644471|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43644472|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644473|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644474|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
43644475|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644476|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644477|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43644478|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
43644479|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
43644480|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43828176|NCT05480384|Trastuzumab|trastuzumab|mesh-list
43644481|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43644482|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644483|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823916|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
43644484|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644485|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43644486|NCT04589832|Entrectinib|entrectinib|mesh-list
43644493|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43644495|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644496|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644497|NCT04583488|Docetaxel|docetaxel|mesh-list
43644498|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644499|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644500|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644501|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644502|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644503|NCT04582669|Triamcinolone|triamcinolone|mesh-list
43644504|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43644505|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43644506|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43645375|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43645376|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
43645377|NCT04090190|Fesoterodine|fesoterodine|mesh-list
43645378|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43645379|NCT04090190|Oxybutynin|oxybutynin|mesh-list
43644510|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644511|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644512|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644514|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644515|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644516|NCT04582305|Bleomycin|bleomycin|mesh-list
43644517|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43644518|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644519|NCT04578886|Guanfacine|guanfacine|mesh-list
43644520|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44021746|NCT01533753|Gabapentin|gabapentin|mesh-list
44021747|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44021748|NCT01533753|Analgesics|analgesics|mesh-ancestor
44021749|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
44021750|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021751|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021752|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
44021753|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44021754|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021755|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644521|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43644522|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43644523|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43644524|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
43644525|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644526|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644527|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644528|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
43644529|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
43644530|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43644531|NCT04578691|Protective Agents|protective agents|mesh-ancestor
43644532|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644533|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644534|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43823917|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43823918|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43823919|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43823920|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43823921|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823922|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
43823923|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823924|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823925|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43823926|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823927|NCT05517499|Dexamethasone|dexamethasone|mesh-list
43823928|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
43823929|NCT05517499|BB 1101|bb 1101|mesh-list
43823930|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823931|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
43823932|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
43823933|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823934|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823935|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823936|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
43644544|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
43644545|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644546|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644548|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644549|NCT04572295|Fulvestrant|fulvestrant|mesh-list
43644550|NCT04572295|Exemestane|exemestane|mesh-list
43644551|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43644552|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644553|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43644554|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43644555|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
43644556|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644557|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645381|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43645382|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
43645383|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644558|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43644559|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43644560|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644561|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021756|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44021757|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44021758|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44021759|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021760|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021761|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
44021762|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44021763|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44021764|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021765|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44021766|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
44021767|NCT01534143|Sirolimus|sirolimus|mesh-list
44021768|NCT01534143|Fludarabine|fludarabine|mesh-list
44021769|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
44021770|NCT01534143|Bortezomib|bortezomib|mesh-list
44021771|NCT01534143|Busulfan|busulfan|mesh-list
44021772|NCT01534143|Tacrolimus|tacrolimus|mesh-list
44021773|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
44021774|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44021775|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
44021776|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021777|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44021778|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
44021779|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021780|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44021781|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
44021782|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644563|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644564|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644565|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43644566|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644567|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43644568|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43644569|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43644570|NCT04560166|Irinotecan|irinotecan|mesh-list
43644571|NCT04560166|Temozolomide|temozolomide|mesh-list
43644572|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43644573|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43644574|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644575|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644576|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644577|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43644578|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
43644579|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43644580|NCT04549116|Progesterone|progesterone|mesh-list
43644581|NCT04549116|Progestins|progestins|mesh-ancestor
43644582|NCT04549116|Hormones|hormones|mesh-ancestor
43645398|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
43645399|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645400|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645401|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
43645402|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021869|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021870|NCT01500109|Acetaminophen|acetaminophen|mesh-list
44021871|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44021872|NCT01500109|Analgesics|analgesics|mesh-ancestor
44021874|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021875|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021876|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
44021877|NCT01495988|Bevacizumab|bevacizumab|mesh-list
44021878|NCT01495988|Vemurafenib|vemurafenib|mesh-list
44021879|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021880|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44021881|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44021882|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44021883|NCT01495988|Growth Substances|growth substances|mesh-ancestor
44021884|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021885|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
44021886|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44021887|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44021888|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021889|NCT01483872|Tigecycline|tigecycline|mesh-list
44021890|NCT01483872|Heparin|heparin|mesh-list
44021891|NCT01483872|Calcium heparin|calcium heparin|mesh-list
44021892|NCT01483872|Anticoagulants|anticoagulants|mesh-list
44021893|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021894|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44021895|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44021896|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44021897|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44021942|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021943|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021944|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
44021945|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
44021946|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021947|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
44021948|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
44021949|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44021950|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44021951|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
44021952|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
44021953|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44021954|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021955|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44021956|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
44021957|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
44021958|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44021959|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44021960|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
44021961|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44021962|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44021963|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44021964|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44021965|NCT01401049|Lidocaine|lidocaine|mesh-list
44021966|NCT01401049|Propofol|propofol|mesh-list
44021967|NCT01401049|Fospropofol|fospropofol|mesh-list
44021968|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
44021969|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
44021970|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44021971|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44021972|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
44021973|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44021974|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44021975|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44021976|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44021977|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44021978|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44021979|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44021980|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44021981|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
44021982|NCT01402531|Bevacizumab|bevacizumab|mesh-list
44021983|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44021984|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022027|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022029|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44022030|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44022032|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44022033|NCT01385280|Estrogens|estrogens|mesh-ancestor
44022034|NCT01385280|Hormones|hormones|mesh-ancestor
44022035|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022036|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022037|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44022038|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
44022039|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44022040|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44022041|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022042|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44022043|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44022044|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022045|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022046|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44022047|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022048|NCT01379469|Carbamazepine|carbamazepine|mesh-list
44022049|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
44022050|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
44022051|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44022052|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44022053|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022114|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022156|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022157|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
44022158|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022159|NCT01303003|Dexamethasone|dexamethasone|mesh-list
44022160|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022161|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
44022162|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
44022163|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022164|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022165|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022166|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
44022167|NCT01303003|Hormones|hormones|mesh-ancestor
44022168|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022191|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
44022192|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022193|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44022194|NCT01280643|Leucovorin|leucovorin|mesh-list
44022195|NCT01280643|Bevacizumab|bevacizumab|mesh-list
44022196|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44022197|NCT01280643|Cetuximab|cetuximab|mesh-list
44022198|NCT01280643|Fluorouracil|fluorouracil|mesh-list
44022199|NCT01280643|Capecitabine|capecitabine|mesh-list
44022200|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
44022201|NCT01280643|Irinotecan|irinotecan|mesh-list
44022202|NCT01280643|Antibodies|antibodies|mesh-list
44022203|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
44022204|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44022205|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
44022206|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022207|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44022208|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44022209|NCT01280643|Growth Substances|growth substances|mesh-ancestor
44022210|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022211|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
44022212|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
44022213|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
44022214|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022215|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022216|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022217|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44022218|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44022219|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022220|NCT01280643|Antidotes|antidotes|mesh-ancestor
43645473|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
43645474|NCT03959241|Methotrexate|methotrexate|mesh-list
44022255|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44022256|NCT01269034|Incretins|incretins|mesh-ancestor
44022257|NCT01269034|Hormones|hormones|mesh-ancestor
44022258|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022259|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
44022260|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44022261|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44022262|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022263|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022264|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
44022265|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022266|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022267|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44022268|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022269|NCT01253668|Antibodies|antibodies|mesh-list
44022270|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44022271|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
44022272|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022273|NCT01240304|Gemcitabine|gemcitabine|mesh-list
44022274|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022275|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
44022354|NCT01211756|Oxytocin|oxytocin|mesh-list
44022355|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
44022356|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44022357|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022358|NCT01207726|Azacitidine|azacitidine|mesh-list
44022359|NCT01207726|Entinostat|entinostat|mesh-list
44022360|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44022361|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022362|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
44022363|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022364|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022365|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022366|NCT01206296|Gemcitabine|gemcitabine|mesh-list
44022367|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022368|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
44022369|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022370|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022371|NCT01206296|Antiviral Agents|antiviral agents|mesh-ancestor
44022372|NCT01206296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022373|NCT01206296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022374|NCT01206296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022375|NCT01206296|Immunologic Factors|immunologic factors|mesh-ancestor
44022376|NCT01206296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022377|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
44022378|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44022379|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022380|NCT01202110|Propranolol|propranolol|mesh-list
44022381|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44022382|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44022383|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022384|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022385|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644677|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644678|NCT04452214|Carboplatin|carboplatin|mesh-list
43644679|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
43644680|NCT04452214|Pemetrexed|pemetrexed|mesh-list
43644681|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644682|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645486|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
43645487|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645488|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645489|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
43645490|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645491|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022400|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022401|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022402|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
44022403|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44022404|NCT01194908|Tamoxifen|tamoxifen|mesh-list
44022405|NCT01194908|Decitabine|decitabine|mesh-list
44022406|NCT01194908|Panobinostat|panobinostat|mesh-list
44022407|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022408|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
44022409|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022410|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022411|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022412|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44022413|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
44022414|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022415|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022416|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022417|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44022418|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44022421|NCT01194856|Ritonavir|ritonavir|mesh-list
44022452|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44022453|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44022454|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022455|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022456|NCT01182610|Paclitaxel|paclitaxel|mesh-list
44022457|NCT01182610|Carboplatin|carboplatin|mesh-list
44022458|NCT01182610|Fluorouracil|fluorouracil|mesh-list
44022459|NCT01182610|Panitumumab|panitumumab|mesh-list
44022460|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44022461|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022462|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44022463|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44022464|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44022465|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022466|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
44022467|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44022468|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022469|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
44022470|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022471|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44022472|NCT01189071|Darifenacin|darifenacin|mesh-list
44022473|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44022474|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44022475|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
44022476|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022477|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022478|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022479|NCT01189071|Urological Agents|urological agents|mesh-ancestor
44022480|NCT01183416|Tretinoin|tretinoin|mesh-list
44022481|NCT01183416|Isotretinoin|isotretinoin|mesh-list
44022482|NCT01183416|Antibodies|antibodies|mesh-list
44022483|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44022489|NCT01183429|Tretinoin|tretinoin|mesh-list
44022513|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022514|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022515|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022516|NCT01166724|Sirolimus|sirolimus|mesh-list
44022517|NCT01166724|Tacrolimus|tacrolimus|mesh-list
44022518|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44022519|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
44022520|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022521|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44022522|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022523|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022524|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022525|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022526|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44022527|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022528|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
44022529|NCT01157533|Vancomycin|vancomycin|mesh-list
44022530|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022531|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022532|NCT01151904|Timolol|timolol|mesh-list
44022533|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44022534|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44022535|NCT01151904|Latanoprost|latanoprost|mesh-list
44022536|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44022537|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44022538|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44022539|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022540|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022541|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022542|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022567|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022569|NCT01139996|Analgesics|analgesics|mesh-ancestor
44022570|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
44022571|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022572|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022573|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44022574|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
44022575|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
44022576|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44022577|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44022578|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44022579|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022580|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022581|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022582|NCT01131884|Alendronate|alendronate|mesh-list
44022583|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44022584|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022585|NCT01133639|Ketorolac|ketorolac|mesh-list
44022586|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44022587|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44022588|NCT01133639|Analgesics|analgesics|mesh-ancestor
44022589|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
44022590|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022612|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
44022613|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022614|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44022615|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44022616|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44022617|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022618|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022619|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44022620|NCT01126957|Narcotics|narcotics|mesh-ancestor
44022621|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44022622|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
44022623|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022624|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022625|NCT01122511|Dexamethasone|dexamethasone|mesh-list
44022626|NCT01122511|Ranibizumab|ranibizumab|mesh-list
44022627|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44022628|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
44022629|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
44022630|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022631|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022632|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022633|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
44022634|NCT01122511|Hormones|hormones|mesh-ancestor
44022635|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022636|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022637|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022638|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44022639|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44022640|NCT01122511|Growth Substances|growth substances|mesh-ancestor
44022641|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
44022642|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
44022643|NCT01118013|Methotrexate|methotrexate|mesh-list
44022644|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
44022645|NCT01118013|Fludarabine|fludarabine|mesh-list
44022646|NCT01118013|Busulfan|busulfan|mesh-list
44022647|NCT01118013|Tacrolimus|tacrolimus|mesh-list
44022648|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44022669|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022670|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
44022671|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44022672|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44022673|NCT01108666|Nelfinavir|nelfinavir|mesh-list
44022674|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44022675|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44022676|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
44022677|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022678|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022679|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44022680|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44022681|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
44022682|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022683|NCT01115244|Dapsone|dapsone|mesh-list
44022684|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022685|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
44022686|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44022687|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44022688|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44022689|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022690|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022691|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
44022692|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44022693|NCT01090141|Micafungin|micafungin|mesh-list
44022694|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
44022695|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44022696|NCT01094561|Secretin|secretin|mesh-list
44022697|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022698|NCT01094561|Hormones|hormones|mesh-ancestor
44022699|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022700|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022701|NCT01078844|Memantine|memantine|mesh-list
44022702|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44022703|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44022704|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
44022705|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022710|NCT01085643|Lubiprostone|lubiprostone|mesh-list
44022748|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022749|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
44022750|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022751|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022752|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44022753|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753151|NCT02486510|Maraviroc|maraviroc|mesh-list
44022754|NCT01065051|Riociguat|riociguat|mesh-list
44022755|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
44022756|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022757|NCT01048125|Nitroprusside|nitroprusside|mesh-list
44022758|NCT01048125|Phenylephrine|phenylephrine|mesh-list
44022759|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
44022760|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44022761|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
44022762|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
44022763|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022764|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022765|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
44022766|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44022767|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
44022768|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
44022769|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44022770|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44022771|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44022772|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44022773|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022774|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022775|NCT01048125|Protective Agents|protective agents|mesh-ancestor
44022776|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44022777|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
44022778|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44022779|NCT01048723|Everolimus|everolimus|mesh-list
44022780|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022782|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
44022788|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022789|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022790|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
44022791|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
44022792|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
44022793|NCT01035944|Coagulants|coagulants|mesh-ancestor
44022794|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44022795|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44022796|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44022797|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022798|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022799|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022800|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022801|NCT01035073|Analgesics|analgesics|mesh-ancestor
44022802|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
44022803|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022804|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
44022806|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
44022858|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44022859|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022860|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022861|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
44022862|NCT01009931|Hormones|hormones|mesh-ancestor
44022863|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44022864|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44022865|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44022866|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
44022867|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022868|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022869|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
44022870|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44022871|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
44022872|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022917|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44022918|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44022919|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44022920|NCT00989937|Oxytocin|oxytocin|mesh-list
44022921|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
44022922|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43644692|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644693|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43644694|NCT04446039|Vortioxetine|vortioxetine|mesh-list
43644695|NCT04446039|Mirtazapine|mirtazapine|mesh-list
43644696|NCT04446039|Citalopram|citalopram|mesh-list
43644697|NCT04446039|Bupropion|bupropion|mesh-list
43645526|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43645527|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022934|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022935|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44022936|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44022937|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44022938|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
44022939|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022940|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022941|NCT00984490|Metformin|metformin|mesh-list
44022942|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44022943|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022944|NCT00986310|Fluoxetine|fluoxetine|mesh-list
44022945|NCT00986310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44022946|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44022947|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44022948|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44022949|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44022950|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
44022951|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44022953|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023042|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023043|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023044|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44023045|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44023046|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023047|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023048|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023049|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44023050|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44023051|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023052|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
44023053|NCT00947284|Nalbuphine|nalbuphine|mesh-list
44023054|NCT00947284|Naloxone|naloxone|mesh-list
44023055|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43753441|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
44023056|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023057|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
44023058|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023059|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44023060|NCT00947284|Narcotics|narcotics|mesh-ancestor
44023065|NCT00947791|Midazolam|midazolam|mesh-list
44023115|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44023116|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44023117|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023118|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023119|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
44023120|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023121|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
44023122|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44023125|NCT00924807|Bicalutamide|bicalutamide|mesh-list
44023126|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023127|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44023128|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023129|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023130|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44023131|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
44023132|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44023133|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023134|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44023135|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
44023136|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
44023137|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023138|NCT00911053|Melatonin|melatonin|mesh-list
44023139|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
44023140|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023141|NCT00911053|Protective Agents|protective agents|mesh-ancestor
44023142|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023143|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023144|NCT00907218|Varenicline|varenicline|mesh-list
44023145|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44023154|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023155|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44023157|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
44023158|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
44023159|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023160|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023161|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44023162|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44023163|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44023164|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
44023165|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023166|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023167|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
44023168|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44023169|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
44023170|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023171|NCT00896025|Expectorants|expectorants|mesh-ancestor
44023172|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023173|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44023174|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
44023175|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023176|NCT00896025|Protective Agents|protective agents|mesh-ancestor
44023177|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023178|NCT00896025|Antidotes|antidotes|mesh-ancestor
43702659|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023200|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
44023201|NCT00879619|Hormones|hormones|mesh-ancestor
44023202|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023203|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023204|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44023205|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023221|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
44023222|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44023223|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44023224|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44023225|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023226|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023227|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023228|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023229|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023230|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44023231|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023232|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
44023233|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44023234|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44023235|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44023236|NCT00850720|Vasopressins|vasopressins|mesh-list
44023237|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023238|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
44023239|NCT00850720|Coagulants|coagulants|mesh-ancestor
44023240|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44023241|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44023242|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
44023243|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023244|NCT00843310|Dexamethasone|dexamethasone|mesh-list
44023245|NCT00843310|Lenalidomide|lenalidomide|mesh-list
44023246|NCT00843310|Melphalan|melphalan|mesh-list
44023247|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023248|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
44023249|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
44023250|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023279|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023280|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023282|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023283|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023284|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44023285|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44023286|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44023287|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
44023288|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44023289|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44023290|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
44023291|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44023292|NCT00833859|Gemcitabine|gemcitabine|mesh-list
44023293|NCT00833859|Capecitabine|capecitabine|mesh-list
44023294|NCT00833859|Docetaxel|docetaxel|mesh-list
44023295|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44023296|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
44023297|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023298|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023299|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
44023300|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023301|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023302|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023303|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
44023304|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023336|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44023337|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44023338|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023339|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023340|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023341|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
44023342|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44023343|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
44023344|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023345|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023346|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44023348|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44023349|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
44023350|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023351|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023352|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44023353|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652042|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43652043|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43652044|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
43652045|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652046|NCT03003143|Vigabatrin|vigabatrin|mesh-list
43652047|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
43652048|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023354|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
44023355|NCT00823095|Protective Agents|protective agents|mesh-ancestor
44023356|NCT00825227|Modafinil|modafinil|mesh-list
44023357|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44023358|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023359|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44023360|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44023361|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44023388|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
44023389|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023390|NCT00808769|Omeprazole|omeprazole|mesh-list
44023391|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
44023392|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44023393|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44023394|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44023395|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023396|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023397|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
44023398|NCT00801931|Melphalan|melphalan|mesh-list
44023453|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023454|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023455|NCT00795665|Growth Substances|growth substances|mesh-ancestor
44023456|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023457|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023458|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44023459|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
44023460|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023462|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
44023463|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023464|NCT00790478|Protective Agents|protective agents|mesh-ancestor
44023465|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023466|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023467|NCT00791336|Nelfinavir|nelfinavir|mesh-list
44023468|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44023469|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44023470|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
44023471|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023472|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023473|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44023474|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44023475|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
44023476|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023477|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
44023478|NCT00786682|Docetaxel|docetaxel|mesh-list
44023479|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023480|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
44023481|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
44023482|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
44023483|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023484|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
44023485|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44023486|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44023487|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023488|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023489|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023490|NCT00791843|Hormones|hormones|mesh-list
43645615|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645616|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645617|NCT03911466|Buprenorphine|buprenorphine|mesh-list
43645618|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43645619|NCT03911466|Narcotics|narcotics|mesh-ancestor
43645620|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43645621|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645622|NCT03911466|Analgesics|analgesics|mesh-ancestor
43645623|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
43645624|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645625|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43645626|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
43645639|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645640|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645642|NCT03875378|Estrogens|estrogens|mesh-list
43645643|NCT03875378|Hormones|hormones|mesh-ancestor
43645644|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43592914|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43645645|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645646|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
43645647|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
43645648|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645649|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
43645650|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645651|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645652|NCT03850067|Cisplatin|cisplatin|mesh-list
43645653|NCT03850067|Carboplatin|carboplatin|mesh-list
43645654|NCT03850067|Nivolumab|nivolumab|mesh-list
43645655|NCT03850067|Etoposide|etoposide|mesh-list
43645693|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645695|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645696|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645697|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645698|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645699|NCT03815448|Methotrexate|methotrexate|mesh-list
43645700|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43645701|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
43645711|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645712|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
43645713|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645714|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43645715|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
43645716|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645717|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645718|NCT03814200|Rifampin|rifampin|mesh-list
43645719|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43645720|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
43645721|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43645722|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645723|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
43645724|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43645725|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645726|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645727|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43645728|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43645729|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43645730|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43645731|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43645732|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43645733|NCT03799445|Nivolumab|nivolumab|mesh-list
43645734|NCT03799445|Ipilimumab|ipilimumab|mesh-list
43645735|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645736|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645737|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645738|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645739|NCT03792958|Vorolanib|vorolanib|mesh-list
43645740|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43645741|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43645742|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023566|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
44023567|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023568|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023569|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44023570|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44023571|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023572|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44023573|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44023574|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
44023575|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44023576|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592988|NCT03347968|Warfarin|warfarin|mesh-list
43645792|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
43645793|NCT03769532|Azacitidine|azacitidine|mesh-list
43645794|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43645795|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023609|NCT00738972|Simvastatin|simvastatin|mesh-list
44023610|NCT00738972|Ezetimibe|ezetimibe|mesh-list
44023611|NCT00738972|Pravastatin|pravastatin|mesh-list
44023612|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44023613|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44023614|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
44023615|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023616|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44023645|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
44023646|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44023647|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44023648|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44023649|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645820|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
43645826|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
43645827|NCT03742986|Doxorubicin|doxorubicin|mesh-list
43645828|NCT03742986|Nivolumab|nivolumab|mesh-list
44023672|NCT00728845|Growth Substances|growth substances|mesh-ancestor
44023673|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023674|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023675|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
44023676|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44023677|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44023678|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023679|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023680|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023681|NCT00726830|Morphine|morphine|mesh-list
44023682|NCT00726830|Oxycodone|oxycodone|mesh-list
44023683|NCT00726830|Methadone|methadone|mesh-list
44023684|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44023685|NCT00726830|Narcotics|narcotics|mesh-ancestor
44023688|NCT00726830|Analgesics|analgesics|mesh-ancestor
44023698|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023699|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
44023700|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023701|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44023702|NCT00716807|Narcotics|narcotics|mesh-ancestor
44023703|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023704|NCT00716807|Analgesics|analgesics|mesh-ancestor
44023705|NCT00719914|Eptifibatide|eptifibatide|mesh-list
44023767|NCT00676026|Hormones|hormones|mesh-ancestor
44023768|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44023769|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023770|NCT00676026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44023771|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44023772|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023773|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023774|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023775|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
44023827|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44023828|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023829|NCT00684255|Fludarabine|fludarabine|mesh-list
43769941|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43769942|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769943|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43769945|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023831|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
44023832|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023833|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023834|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44023835|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
44023836|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023837|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
44023838|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44023839|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44023840|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44023841|NCT00669461|Lubiprostone|lubiprostone|mesh-list
44023842|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44023843|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023844|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023885|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023886|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44023887|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44023888|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
44023889|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44023890|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44023891|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44023892|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023893|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023894|NCT00656916|Fluticasone|fluticasone|mesh-list
44023895|NCT00656916|Xhance|xhance|mesh-list
44023896|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023897|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44023898|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
44023899|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023900|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023901|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44023902|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
44023903|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
44023904|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44023905|NCT00661466|Bupivacaine|bupivacaine|mesh-list
44023906|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
44023907|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
44023908|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44023938|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44023939|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44023940|NCT00642603|Growth Substances|growth substances|mesh-ancestor
44023941|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023942|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
44023943|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44023944|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
44023945|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023946|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44023947|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44023948|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023949|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
44023950|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44023951|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023952|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
44023953|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44023954|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
44023955|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023956|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
44023957|NCT00642382|Protective Agents|protective agents|mesh-ancestor
44023958|NCT00638222|Carvedilol|carvedilol|mesh-list
44023959|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44023960|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44023961|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
44023962|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44023963|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023964|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023965|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44023966|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
44023967|NCT00638222|Protective Agents|protective agents|mesh-ancestor
44023968|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44023969|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44023970|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44023974|NCT00634322|Leucovorin|leucovorin|mesh-list
44023978|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
44023979|NCT00634322|Vitamins|vitamins|mesh-ancestor
44023980|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
44023982|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
44023983|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44023984|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
44023985|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44023986|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44023987|NCT00634972|Ketorolac|ketorolac|mesh-list
44023988|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44023989|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44023990|NCT00634972|Analgesics|analgesics|mesh-ancestor
44023991|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
44023992|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44023993|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44023994|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44023995|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44023996|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44023997|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44023998|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024000|NCT00626444|Vitamins|vitamins|mesh-ancestor
44024001|NCT00626444|Micronutrients|micronutrients|mesh-ancestor
44024002|NCT00626444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024003|NCT00626444|Antioxidants|antioxidants|mesh-ancestor
44024004|NCT00626444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024005|NCT00626444|Protective Agents|protective agents|mesh-ancestor
44024006|NCT00623974|Teriparatide|teriparatide|mesh-list
44024007|NCT00623974|Calcitriol|calcitriol|mesh-list
44024008|NCT00623974|Calcium|calcium|mesh-list
44024009|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
44024042|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
44024043|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
44024044|NCT00624650|Diuretics|diuretics|mesh-ancestor
44024045|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
44024046|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44024047|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024048|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44024049|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
44024050|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44024051|NCT00624650|Protective Agents|protective agents|mesh-ancestor
44024052|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
44024053|NCT00624650|Coagulants|coagulants|mesh-ancestor
44024054|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44024055|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44024057|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024058|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024059|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44024060|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024061|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024062|NCT00619242|Sorafenib|sorafenib|mesh-list
44024063|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024064|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024065|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024066|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024067|NCT00616577|Ropivacaine|ropivacaine|mesh-list
44024068|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
44024069|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
44024089|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44024090|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
44024091|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
44024092|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44024094|NCT00608465|Ramipril|ramipril|mesh-list
44024095|NCT00608465|Eplerenone|eplerenone|mesh-list
44024096|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44024097|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
44024098|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024099|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024100|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024101|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44024102|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44024103|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024104|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024105|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44024106|NCT00608465|Diuretics|diuretics|mesh-ancestor
44024107|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
44024108|NCT00608777|Betamethasone|betamethasone|mesh-list
44024109|NCT00608777|Calcipotriene|calcipotriene|mesh-list
44024111|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
44024144|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024146|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024148|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
44024149|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024150|NCT00589550|Interferons|interferons|mesh-list
44024151|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
44024152|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
44024153|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44024154|NCT00589550|Sorafenib|sorafenib|mesh-list
44024155|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770068|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
44024156|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
44024157|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024158|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024159|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024160|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024161|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
44024162|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024163|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
44024164|NCT00586716|Antibodies|antibodies|mesh-list
44024165|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
44024209|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024210|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44024211|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44024212|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
44024213|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024214|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024216|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024217|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
44024218|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024219|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024220|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44024221|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
44024222|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024223|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
44024224|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024225|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024226|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44024227|NCT00577356|Docetaxel|docetaxel|mesh-list
44024228|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024229|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024230|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024231|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024232|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024233|NCT00569868|Bortezomib|bortezomib|mesh-list
44024234|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024235|NCT05600686|Prednisone|prednisone|mesh-list
44024236|NCT05600686|Cortisone|cortisone|mesh-list
44024237|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
44024238|NCT05600686|Rituximab|rituximab|mesh-list
44024239|NCT05600686|Doxorubicin|doxorubicin|mesh-list
44024240|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44024241|NCT05600686|Etoposide|etoposide|mesh-list
44024242|NCT05600686|Vincristine|vincristine|mesh-list
44024243|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
44024244|NCT05600686|Daunorubicin|daunorubicin|mesh-list
44024245|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
44024246|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44024247|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44024248|NCT05600686|Antibodies|antibodies|mesh-list
44024249|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
44024250|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44024251|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024252|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
44024253|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024254|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44024255|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44024256|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
44024257|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024258|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024259|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44024260|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44024261|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44024262|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44024263|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024264|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44024265|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
44024309|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44024310|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
44024311|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024312|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44024313|NCT05600023|Renal Agents|renal agents|mesh-ancestor
44024314|NCT05599971|Fluorouracil|fluorouracil|mesh-list
44024316|NCT05599971|Furosemide|furosemide|mesh-list
44024317|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
44024318|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024319|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024320|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024321|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024322|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
44024323|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024324|NCT05599971|Diuretics|diuretics|mesh-ancestor
44024325|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
44024326|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44024327|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024328|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44024329|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44024330|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024331|NCT05599971|Protective Agents|protective agents|mesh-ancestor
44024332|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
44024333|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44024334|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
44024335|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024336|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024337|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44024338|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
44024365|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024366|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024367|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024368|NCT05599555|Vaccines|vaccines|mesh-list
44024369|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
44024370|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024371|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
44024372|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024373|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024374|NCT05599347|Azithromycin|azithromycin|mesh-list
44024375|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024376|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024377|NCT05599243|Dutasteride|dutasteride|mesh-list
44024378|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44024379|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44024380|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024381|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024382|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
44024383|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024401|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44024402|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44024404|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
44024405|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024406|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024407|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44024408|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44024409|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024410|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44024411|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
44024412|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
44024413|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44024414|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
44024415|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44024416|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
44024417|NCT05594407|Lidocaine|lidocaine|mesh-list
44024418|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
44024419|NCT05594407|Ketamine|ketamine|mesh-list
44024420|NCT05594407|Remifentanil|remifentanil|mesh-list
44024421|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
44024422|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
44024423|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024424|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024425|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
44024426|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024427|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44024507|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
43823990|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
43823991|NCT05516862|Camphor|camphor|mesh-list
43823992|NCT05516862|Salicylates|salicylates|mesh-list
43823993|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
43823994|NCT05516862|Menthol|menthol|mesh-list
43823995|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43823996|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823997|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
43823998|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024508|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024509|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024510|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44024511|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44024512|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024513|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024514|NCT05507398|Metformin|metformin|mesh-list
44024515|NCT05507398|Atorvastatin|atorvastatin|mesh-list
44024516|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44024517|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024518|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024519|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024520|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
44024521|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024522|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024523|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024524|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024525|NCT05506046|Nicotine|nicotine|mesh-list
44024526|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44024527|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
44024528|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024529|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024530|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44024531|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44024532|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
44024533|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024534|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148696|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44148697|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
44148712|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148713|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148714|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148715|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148716|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44148717|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
44148719|NCT00205634|Clarithromycin|clarithromycin|mesh-list
44148720|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148721|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148722|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44148723|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44148724|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148725|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44148726|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44148727|NCT00205725|Olanzapine|olanzapine|mesh-list
44148728|NCT00205725|Ziprasidone|ziprasidone|mesh-list
44148729|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
44148730|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
44148731|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44148732|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148733|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148734|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44148735|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44148736|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44148737|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44148738|NCT00205725|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44148739|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44148740|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44148741|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148742|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44148743|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
44148744|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44148745|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44024536|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
44024537|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
44024538|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024539|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024540|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
44024541|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024542|NCT05403762|Protective Agents|protective agents|mesh-list
44024543|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024544|NCT05387941|Dexamethasone|dexamethasone|mesh-list
44024545|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44024546|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
44024547|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
44024548|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024549|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024550|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44024551|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
44024552|NCT05387941|Hormones|hormones|mesh-ancestor
44024553|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024554|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024555|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024556|NCT05383547|Bortezomib|bortezomib|mesh-list
44024557|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024558|NCT05342974|Misoprostol|misoprostol|mesh-list
44024559|NCT05342974|Atorvastatin|atorvastatin|mesh-list
44024560|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024561|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44024562|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
44024563|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024564|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44024565|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44024566|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024567|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44024568|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
44024569|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823999|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824000|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824001|NCT05516862|Analgesics|analgesics|mesh-ancestor
43824002|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
43824003|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824004|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024570|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024571|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44024572|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44024574|NCT05328895|Betahistine|betahistine|mesh-list
44024575|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024576|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
44024577|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
44024578|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024579|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024580|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024581|NCT05278975|Thiostrepton|thiostrepton|mesh-list
44024582|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024583|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024584|NCT05258565|Plasminogen|plasminogen|mesh-list
44024585|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44024586|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44024587|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44024588|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024589|NCT05243199|Valsartan|valsartan|mesh-list
44024590|NCT05243199|Irbesartan|irbesartan|mesh-list
44024591|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44024592|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024593|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44024594|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44024595|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024596|NCT05218668|Fasudil|fasudil|mesh-list
44024597|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44024598|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44024599|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024600|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43824005|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824006|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824007|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824008|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770147|NCT02382146|Dexamethasone|dexamethasone|mesh-list
43824009|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824010|NCT05516849|Oxandrolone|oxandrolone|mesh-list
43824011|NCT05516849|Androgens|androgens|mesh-ancestor
43824012|NCT05516849|Hormones|hormones|mesh-ancestor
43824013|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824014|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824015|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
43824016|NCT05516784|Clopidogrel|clopidogrel|mesh-list
43824017|NCT05516784|Ticagrelor|ticagrelor|mesh-list
43824018|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43645850|NCT03739996|Cabotegravir|cabotegravir|mesh-list
44024634|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024635|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024636|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
44024637|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44024638|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
44024639|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
44024640|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44024641|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44024642|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44024643|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024644|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024645|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024646|NCT05001048|Protective Agents|protective agents|mesh-ancestor
44024647|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
44024648|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44024649|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
44024650|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024651|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
44024652|NCT04972383|Protective Agents|protective agents|mesh-ancestor
44024653|NCT04961554|Anesthetics|anesthetics|mesh-list
44024654|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44024655|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024656|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44024657|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
44024659|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
44024660|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024661|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
44024662|NCT04941833|Desogestrel|desogestrel|mesh-list
44024663|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44024664|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44024665|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44024666|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
44024667|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43645851|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43645852|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43645853|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43645854|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702662|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645860|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44148775|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148776|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148777|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
44148778|NCT00205751|Hormones|hormones|mesh-ancestor
44148779|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44148780|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44148781|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148782|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148783|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
44148784|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148785|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44148786|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148787|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
44148788|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
44148789|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44148790|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44148791|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44148792|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44148793|NCT00205751|Growth Substances|growth substances|mesh-ancestor
44148794|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
44148795|NCT00205764|Melphalan|melphalan|mesh-list
44148796|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148797|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
43680942|NCT04329949|Paclitaxel|paclitaxel|mesh-list
44148798|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024705|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44024706|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44024707|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024708|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024709|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024710|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024711|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44024712|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44024713|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44024714|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44024715|NCT04816214|Cisplatin|cisplatin|mesh-list
44024716|NCT04816214|Carboplatin|carboplatin|mesh-list
44024717|NCT04816214|Pemetrexed|pemetrexed|mesh-list
44024718|NCT04816214|Osimertinib|osimertinib|mesh-list
44024719|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024720|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024721|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024722|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44024723|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44024724|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44024725|NCT04810572|Silymarin|silymarin|mesh-list
44024726|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
44024727|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024728|NCT04810572|Protective Agents|protective agents|mesh-ancestor
44024729|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024730|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
44024731|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44024732|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44024733|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
44024734|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024735|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024736|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44024737|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
44024746|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44024747|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44024748|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024749|NCT04585490|Paclitaxel|paclitaxel|mesh-list
44024750|NCT04585490|Cisplatin|cisplatin|mesh-list
44024751|NCT04585490|Carboplatin|carboplatin|mesh-list
44024752|NCT04585490|Pemetrexed|pemetrexed|mesh-list
44024753|NCT04585490|Durvalumab|durvalumab|mesh-list
44024754|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44024755|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44024756|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024757|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024758|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024759|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024760|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024761|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024762|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44024763|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44024764|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024765|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
44024766|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024767|NCT04575090|Simvastatin|simvastatin|mesh-list
44024768|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44024805|NCT04375631|Cyclosporins|cyclosporins|mesh-list
44024806|NCT04375631|Lenograstim|lenograstim|mesh-list
44024807|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024808|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
44024809|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024810|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44024811|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44024812|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
44024813|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024814|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024815|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43770165|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
43652054|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44024816|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44024817|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
44024818|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
44024819|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024820|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44024821|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024822|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
44024823|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44024824|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44024825|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44024826|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44024827|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
44024828|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024829|NCT04375631|Analgesics|analgesics|mesh-ancestor
44024830|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
44024831|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024832|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44024833|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43645865|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645866|NCT03732677|Gemcitabine|gemcitabine|mesh-list
43645869|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645870|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645871|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
44024844|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024845|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44024846|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024847|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44024848|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
44024849|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44024850|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44024851|NCT04298203|Topiramate|topiramate|mesh-list
44024852|NCT04298203|Phentermine|phentermine|mesh-list
44024853|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
44024854|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44024855|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024856|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44024857|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
44024858|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44024859|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
44024860|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
44024861|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44024862|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
44024863|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024864|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024865|NCT04285346|Ganaxolone|ganaxolone|mesh-list
44024866|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
44024867|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44024868|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024869|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024870|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
44024871|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
44024872|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44024873|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
44024875|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44024905|NCT04209855|Maytansine|maytansine|mesh-list
44024906|NCT04209855|Doxorubicin|doxorubicin|mesh-list
44024907|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44024908|NCT04209855|Topotecan|topotecan|mesh-list
44024909|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44024911|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44024912|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44024913|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44024914|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44024915|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44024916|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44024917|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44024918|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024919|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44024920|NCT04181203|Leuprolide|leuprolide|mesh-list
44024921|NCT04181203|Goserelin|goserelin|mesh-list
44024922|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44024923|NCT04181203|Hormones|hormones|mesh-list
44024924|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44024925|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024926|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44024927|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
44024928|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44024929|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44024930|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44024931|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
44024932|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44024933|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
44024934|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44024935|NCT04100772|Vaccines|vaccines|mesh-list
44024936|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
44024937|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024938|NCT04099303|Vaccines|vaccines|mesh-list
44024939|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
44024940|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024941|NCT04043520|Estradiol|estradiol|mesh-list
44148838|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148839|NCT00206063|Ximelagatran|ximelagatran|mesh-list
44148840|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
44148841|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44148842|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
44148843|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44024971|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
44024972|NCT03967223|Fludarabine|fludarabine|mesh-list
44024973|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44024974|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
44024975|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44024976|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025030|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025031|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645954|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025044|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
44025045|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44025046|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025048|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44025049|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025050|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025051|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44025052|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44025053|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44025054|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44025055|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43645955|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43645956|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645957|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
43645958|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43645959|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
43645960|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645961|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43645962|NCT03683069|Diuretics|diuretics|mesh-ancestor
43645963|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
43645965|NCT03681639|Chromium|chromium|mesh-list
43645966|NCT03681639|Trace Elements|trace elements|mesh-ancestor
43645967|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
43645968|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645969|NCT03676049|Cannabidiol|cannabidiol|mesh-list
43702666|NCT02715531|Antiviral Agents|antiviral agents|mesh-ancestor
44025056|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44025057|NCT03124355|Bromides|bromides|mesh-list
44025058|NCT03124355|Galantamine|galantamine|mesh-list
44025059|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
44025060|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
44025061|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44025062|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025063|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025064|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
44025065|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025066|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025067|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44025068|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
44025069|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025070|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
44025071|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
44025072|NCT03121001|Sirolimus|sirolimus|mesh-list
44025073|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
44025074|NCT03121001|Fludarabine|fludarabine|mesh-list
44025075|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
44025092|NCT03055247|Ibuprofen|ibuprofen|mesh-list
44025114|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025115|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025116|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
44025117|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
44025118|NCT02681211|Promethazine|promethazine|mesh-list
44025119|NCT02681211|Ketorolac|ketorolac|mesh-list
44025120|NCT02681211|Metoclopramide|metoclopramide|mesh-list
44025121|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44025122|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44025123|NCT02681211|Analgesics|analgesics|mesh-ancestor
44025124|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
44025125|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025126|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025127|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44025128|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025129|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44025130|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025131|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025132|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44025133|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44025134|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44025135|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
44025136|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
44025137|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
44025138|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
44025139|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44025140|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44025141|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
44025142|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
44025143|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025144|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44025145|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
44025156|NCT02598778|Protective Agents|protective agents|mesh-ancestor
44025157|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025158|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44025159|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025160|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
44025161|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025162|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44025163|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
44025164|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025165|NCT02500576|Aldesleukin|aldesleukin|mesh-list
44025166|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
44025167|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
44025168|NCT02500576|Fludarabine|fludarabine|mesh-list
44025169|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
44025170|NCT02500576|Interleukin-2|interleukin-2|mesh-list
44025171|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025172|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
44025173|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025174|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025175|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025176|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
44025177|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025178|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025207|NCT01807611|Melphalan|melphalan|mesh-list
44025212|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025213|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
44025214|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025215|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44025216|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44025217|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
44025218|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025219|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025233|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44025234|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44025235|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
44025236|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025237|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44025238|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44025239|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025240|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44025241|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44025242|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44025243|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44025244|NCT01692717|Diuretics|diuretics|mesh-ancestor
44025249|NCT01692171|Heparin|heparin|mesh-list
44025295|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
44025296|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
44025298|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025299|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025300|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025301|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025302|NCT00570531|Paclitaxel|paclitaxel|mesh-list
44025303|NCT00570531|Bevacizumab|bevacizumab|mesh-list
44025304|NCT00570531|Cisplatin|cisplatin|mesh-list
44025305|NCT00570531|Fluorouracil|fluorouracil|mesh-list
44025306|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44025307|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025308|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
44025309|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
44025310|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
44025311|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025312|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44025313|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44025314|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44025315|NCT00570531|Growth Substances|growth substances|mesh-ancestor
44025316|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025317|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
44025318|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
44025319|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025320|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025321|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
44025322|NCT00564876|Dasatinib|dasatinib|mesh-list
44025323|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025324|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44025325|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025326|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025327|NCT00558870|Morphine|morphine|mesh-list
44025328|NCT00558870|Methadone|methadone|mesh-list
44025329|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44025330|NCT00558870|Narcotics|narcotics|mesh-ancestor
44025334|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
44025335|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025336|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
44025337|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
44025338|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
44025406|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
44025407|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44025408|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44025409|NCT00542542|Narcotics|narcotics|mesh-ancestor
44025410|NCT00542542|Analgesics|analgesics|mesh-ancestor
44025411|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44025412|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44025413|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44025414|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44025415|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
44025416|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
44025417|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44025418|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025419|NCT00539617|Leucovorin|leucovorin|mesh-list
44025420|NCT00539617|Fluorouracil|fluorouracil|mesh-list
44025421|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
44025422|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44025423|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
44025424|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025433|NCT00539617|Vitamins|vitamins|mesh-ancestor
44025466|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
44025467|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44025468|NCT00523939|Cytarabine|cytarabine|mesh-list
44025469|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025470|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
44025471|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44025472|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025473|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
44025474|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025475|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025476|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
44025477|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025478|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
44025479|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44025486|NCT00523809|Melphalan|melphalan|mesh-list
44025682|NCT00421954|Ziprasidone|ziprasidone|mesh-list
44025908|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44025909|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44025910|NCT00268450|Growth Substances|growth substances|mesh-ancestor
44025911|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44025912|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
43755885|NCT02470676|Hormones|hormones|mesh-ancestor
44025913|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44025914|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
44025915|NCT00268450|Antiviral Agents|antiviral agents|mesh-ancestor
44025916|NCT00268450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44025917|NCT00268450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44025918|NCT00268450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44025919|NCT00268450|Immunologic Factors|immunologic factors|mesh-ancestor
44025920|NCT00218036|Dexetimide|dexetimide|mesh-list
44025921|NCT00218036|Modafinil|modafinil|mesh-list
44025922|NCT00218036|Citalopram|citalopram|mesh-list
44025923|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44025928|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
44025971|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
44026034|NCT00118053|Carboplatin|carboplatin|mesh-list
44026105|NCT00089128|Irinotecan|irinotecan|mesh-list
44026251|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44026252|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44026253|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
44026254|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
44026477|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44026478|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44026479|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
44026480|NCT00000198|Piracetam|piracetam|mesh-list
44026481|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026482|NCT00000198|Protective Agents|protective agents|mesh-ancestor
44026483|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44026484|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
44026485|NCT00000199|Piracetam|piracetam|mesh-list
44026486|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44026487|NCT00000199|Protective Agents|protective agents|mesh-ancestor
44026547|NCT00000207|Buprenorphine|buprenorphine|mesh-list
44026624|NCT00000217|Carbamazepine|carbamazepine|mesh-list
44026757|NCT00000232|Narcotics|narcotics|mesh-ancestor
44026835|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
44026836|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44026838|NCT00000241|Flupenthixol|flupenthixol|mesh-list
44026985|NCT00000263|Ethanol|ethanol|mesh-list
44027066|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
44027133|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44027135|NCT00000277|Mazindol|mazindol|mesh-list
44027136|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44027137|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027138|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027139|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027140|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027146|NCT00000278|Disulfiram|disulfiram|mesh-list
44027268|NCT00000293|Nefazodone|nefazodone|mesh-list
44027342|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027343|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027344|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44027346|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
44027347|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027348|NCT00000302|Buprenorphine|buprenorphine|mesh-list
44027349|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44027350|NCT00000302|Narcotics|narcotics|mesh-ancestor
44027351|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027352|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027353|NCT00000302|Analgesics|analgesics|mesh-ancestor
44027354|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
44148925|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44148926|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
44148927|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44148928|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44148929|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44148930|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44148931|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
44148932|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44027553|NCT00000326|Analgesics|analgesics|mesh-ancestor
44027627|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027702|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
44027703|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027704|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027706|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027707|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027708|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027709|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
44027710|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027711|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44027712|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44027713|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44027714|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
44027715|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44027716|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027717|NCT00000347|Risperidone|risperidone|mesh-list
44027718|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027759|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44027760|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027761|NCT00000353|Analgesics|analgesics|mesh-ancestor
44027762|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
44027763|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44027764|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027765|NCT00000354|Lofexidine|lofexidine|mesh-list
44027766|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44027767|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44027768|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44027769|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
44027822|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44027823|NCT00000372|Cycloserine|cycloserine|mesh-list
44027825|NCT00000372|Glycine|glycine|mesh-list
44027826|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44027827|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44027828|NCT00000372|Renal Agents|renal agents|mesh-ancestor
44027829|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44027830|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
44027831|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44027832|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
44027833|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027834|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44027835|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
44027838|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44027885|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027886|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44027887|NCT00000376|Desipramine|desipramine|mesh-list
44027888|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44027889|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
44027890|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44027891|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44027892|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44027893|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44027894|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44027896|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44028024|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028025|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028027|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44028028|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
44028029|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028030|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028031|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028032|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028033|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
44028034|NCT00000438|Naltrexone|naltrexone|mesh-list
44028035|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028036|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028037|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028038|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
44028039|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028040|NCT00000439|Valproic Acid|valproic acid|mesh-list
44028041|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
44028042|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028043|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028044|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
44028045|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028046|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028047|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
44028048|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44028049|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028050|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028051|NCT00000440|Naltrexone|naltrexone|mesh-list
44028052|NCT00000440|Sertraline|sertraline|mesh-list
44028053|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028054|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028055|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028122|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028123|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028125|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028126|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028127|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028128|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
44028129|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028130|NCT00000446|Sertraline|sertraline|mesh-list
44028131|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
44028132|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028133|NCT00000446|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44028134|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44028135|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028136|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028137|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028138|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
44028139|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028141|NCT00000447|Nicotine|nicotine|mesh-list
44028142|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44028143|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
44028144|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028145|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028146|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44028147|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44028148|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
44028149|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028150|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028151|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028152|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028153|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
44028154|NCT00000448|Naltrexone|naltrexone|mesh-list
44028155|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028156|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028157|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028158|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
44028159|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028160|NCT00000449|Naltrexone|naltrexone|mesh-list
44028161|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028162|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028163|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028164|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
44028165|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028166|NCT00000450|Naltrexone|naltrexone|mesh-list
44028167|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44028168|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44028169|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028170|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
44028171|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028172|NCT00000451|Naltrexone|naltrexone|mesh-list
44148983|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
44148984|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44148985|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
44148986|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148987|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44148988|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44148989|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
43770176|NCT02381964|Vitamins|vitamins|mesh-ancestor
44148990|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44148991|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44148992|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44148993|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
44148994|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44148995|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44148996|NCT00206414|Gefitinib|gefitinib|mesh-list
44148997|NCT00206414|Fulvestrant|fulvestrant|mesh-list
44148998|NCT00206414|Anastrozole|anastrozole|mesh-list
44148999|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149000|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44149001|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149002|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149003|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149004|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44149005|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44149006|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149007|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149008|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149009|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44149010|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44149011|NCT00206453|Docetaxel|docetaxel|mesh-list
44149012|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149013|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
44149014|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
44149015|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
44149037|NCT00206492|Tamoxifen|tamoxifen|mesh-list
44149038|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44149039|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
43646064|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646065|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646066|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646067|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028359|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
44028360|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44028361|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44028362|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
44028363|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
44028364|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028365|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028366|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44028367|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44028368|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44028369|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
44028370|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028371|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028372|NCT00000513|Diuretics|diuretics|mesh-ancestor
44028373|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
44028374|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44028375|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028398|NCT00000542|Pravastatin|pravastatin|mesh-list
44028399|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44028400|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44028401|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44028402|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44028403|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028404|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44028405|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028406|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028450|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028451|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028452|NCT00000577|Colchicine|colchicine|mesh-list
44028453|NCT00000577|Albuterol|albuterol|mesh-list
44028454|NCT00000577|Hormones|hormones|mesh-list
44028455|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
44028456|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
44028457|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44028458|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028459|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44028460|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
44028461|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44028462|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44028463|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
44028464|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
44028465|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44028466|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44028467|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44028468|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028469|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028470|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
44028471|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028472|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
44028473|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44028474|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44028475|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028476|NCT00000578|Beclomethasone|beclomethasone|mesh-list
44028477|NCT00000578|Theophylline|theophylline|mesh-list
44028478|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44028479|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
44028480|NCT00000578|Hormones|hormones|mesh-ancestor
43646134|NCT03430661|Ticagrelor|ticagrelor|mesh-list
43646135|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43646136|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43646137|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44028489|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028568|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028569|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028570|NCT00000621|Tretinoin|tretinoin|mesh-list
44028571|NCT00000621|Isotretinoin|isotretinoin|mesh-list
44028572|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028573|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
44028574|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
44028575|NCT00000623|Decitabine|decitabine|mesh-list
44028576|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
44028577|NCT00000623|Deferiprone|deferiprone|mesh-list
44028578|NCT00000623|Deferoxamine|deferoxamine|mesh-list
44028579|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44028580|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
44028581|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028582|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028583|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028584|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
44028585|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44028586|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44028587|NCT00000623|Urological Agents|urological agents|mesh-ancestor
44028588|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44028589|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
44028590|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
44028591|NCT00000623|Siderophores|siderophores|mesh-ancestor
44028592|NCT00000626|Doxorubicin|doxorubicin|mesh-list
44028593|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44028594|NCT00000626|Bleomycin|bleomycin|mesh-list
44028595|NCT00000626|Dacarbazine|dacarbazine|mesh-list
44028596|NCT00000626|Vinblastine|vinblastine|mesh-list
44028597|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44028598|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028599|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44028600|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44028601|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028602|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028635|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
44028636|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028637|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028638|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028639|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028640|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
44028641|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028642|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028643|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028644|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
44028645|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
44028646|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44028647|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028648|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
44028649|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44028650|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028651|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44028653|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
44028654|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028655|NCT00000634|Nevirapine|nevirapine|mesh-list
44028656|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028657|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028658|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028659|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028660|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
44028661|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028662|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028663|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028682|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44028683|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44028684|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44028685|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44028686|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028687|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
44028688|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44028689|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
44028690|NCT00000636|Vitamins|vitamins|mesh-ancestor
44028691|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
44028692|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028693|NCT00000638|Pyridoxine|pyridoxine|mesh-list
44028694|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
44028695|NCT00000638|Rifampin|rifampin|mesh-list
44028696|NCT00000638|Isoniazid|isoniazid|mesh-list
44028697|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
44028698|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44028699|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
44028700|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44028701|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028702|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
44028703|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028704|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028705|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028706|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44028707|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44028708|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44028709|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44028710|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44028711|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44028712|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44028713|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44028714|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
44028715|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43646191|NCT03393741|Docetaxel|docetaxel|mesh-list
43646192|NCT03393741|Epothilones|epothilones|mesh-list
43646193|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
43646194|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43646195|NCT03393741|Taxane|taxane|mesh-list
44028743|NCT00000649|Zidovudine|zidovudine|mesh-list
44028744|NCT00000649|Nevirapine|nevirapine|mesh-list
44028745|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
44028746|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028747|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028748|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028749|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028750|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
44028751|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028752|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028753|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028754|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44028755|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44028756|NCT00000650|Ditiocarb|ditiocarb|mesh-list
44028757|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44028758|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
44028759|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028805|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
44028806|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028807|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028808|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028809|NCT00000657|Zidovudine|zidovudine|mesh-list
44028810|NCT00000657|Didanosine|didanosine|mesh-list
44028811|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
43779736|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028812|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028813|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028814|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028815|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028816|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
44028817|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028818|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028819|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028820|NCT00000658|Leucovorin|leucovorin|mesh-list
44028821|NCT00000658|Cytarabine|cytarabine|mesh-list
44028822|NCT00000658|Dexamethasone|dexamethasone|mesh-list
44028823|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
44028824|NCT00000658|Doxorubicin|doxorubicin|mesh-list
44028825|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44028826|NCT00000658|Methotrexate|methotrexate|mesh-list
44028827|NCT00000658|Vincristine|vincristine|mesh-list
44028828|NCT00000658|Bleomycin|bleomycin|mesh-list
44028829|NCT00000658|Allopurinol|allopurinol|mesh-list
44028830|NCT00000658|Sargramostim|sargramostim|mesh-list
44028831|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
44028832|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44028833|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
44028834|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028835|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028836|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44028837|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
44028849|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44028851|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44028852|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44028853|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028854|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44028855|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
44028856|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44028857|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44028858|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
44028859|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
44028860|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44028861|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028862|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
44028863|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028864|NCT00000658|Antidotes|antidotes|mesh-ancestor
44028865|NCT00000658|Protective Agents|protective agents|mesh-ancestor
43646196|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646197|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646198|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646199|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646200|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646201|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646202|NCT03390010|Misoprostol|misoprostol|mesh-list
43646203|NCT03390010|Carboprost|carboprost|mesh-list
44028884|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028885|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028886|NCT00000660|Etoposide|etoposide|mesh-list
44028887|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44028888|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44028889|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44028890|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44028891|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028892|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028893|NCT00000661|Zidovudine|zidovudine|mesh-list
44028894|NCT00000661|Oxazepam|oxazepam|mesh-list
44028895|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
44028896|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028897|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028898|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028899|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028900|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
44028901|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028902|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028903|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028904|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44028905|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44028906|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44028907|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44028961|NCT00000670|Probenecid|probenecid|mesh-list
44028962|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
44028963|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028964|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028965|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028966|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028967|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
44028968|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028969|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44028970|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44028971|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
44028972|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
44028973|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44028974|NCT00000670|Renal Agents|renal agents|mesh-ancestor
44028975|NCT00000673|Ganciclovir|ganciclovir|mesh-list
44028976|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44028977|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
44028978|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44028979|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028980|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028981|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028982|NCT00000680|Zidovudine|zidovudine|mesh-list
44028983|NCT00000680|Aldesleukin|aldesleukin|mesh-list
44028984|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
44028985|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44028986|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44028987|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44028988|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44028989|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
43646231|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646233|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43646234|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646236|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
43646237|NCT03341156|Coagulants|coagulants|mesh-ancestor
43646238|NCT03337919|Nivolumab|nivolumab|mesh-list
43646239|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646240|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646241|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646242|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646243|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43646244|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
43646245|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
43646246|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646247|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43646248|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646249|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646250|NCT03311555|Docetaxel|docetaxel|mesh-list
43646251|NCT03311555|Androgens|androgens|mesh-list
43646252|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646253|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646254|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646255|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646256|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646257|NCT03311555|Hormones|hormones|mesh-ancestor
43646258|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646259|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029021|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029023|NCT00000693|Acyclovir|acyclovir|mesh-list
44029024|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
44029025|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029026|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029027|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029028|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029029|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
44029030|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029031|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029032|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029033|NCT00000694|Interferons|interferons|mesh-list
44029034|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
44029035|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
44029036|NCT00000694|Zidovudine|zidovudine|mesh-list
44029037|NCT00000694|Sargramostim|sargramostim|mesh-list
44029038|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029039|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
44029040|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029041|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
44029042|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029043|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
44029044|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029045|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029046|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029073|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029074|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029075|NCT00000698|Ganciclovir|ganciclovir|mesh-list
44029076|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44029077|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
44029078|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029079|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029080|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029081|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029082|NCT00000699|Ribavirin|ribavirin|mesh-list
44029083|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
44029084|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
44029085|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029086|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
44029087|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029088|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44029089|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
44029090|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029091|NCT00000700|Zidovudine|zidovudine|mesh-list
44029092|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
44029093|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029094|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029095|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029096|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029097|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
44029098|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029099|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029100|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029102|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
44029103|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029104|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029105|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029106|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029107|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
43646271|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646272|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646273|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43646274|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646275|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44029151|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44029152|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44029153|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44029154|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646304|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
43646305|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
43646306|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43646307|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029178|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44029179|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
44029180|NCT00000704|Zalcitabine|zalcitabine|mesh-list
44029181|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
44029182|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029183|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029184|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029185|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029186|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
44029187|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029188|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029189|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029191|NCT00000706|Quinine|quinine|mesh-list
44029192|NCT00000706|Probenecid|probenecid|mesh-list
44029193|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
44029194|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029195|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029196|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029197|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029198|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
44029199|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029200|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029201|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029202|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
44029203|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029204|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029205|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44029206|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029207|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44029208|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029209|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44029210|NCT00000706|Analgesics|analgesics|mesh-ancestor
43646357|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43646359|NCT03195478|Ipilimumab|ipilimumab|mesh-list
43646360|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646361|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646362|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646363|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824046|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
43824047|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824048|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43646365|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43646366|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646370|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646371|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44029287|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029288|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029289|NCT00000724|Leucovorin|leucovorin|mesh-list
44029290|NCT00000724|Trimetrexate|trimetrexate|mesh-list
44029291|NCT00000724|Calcium|calcium|mesh-list
44029292|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
44029293|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44029294|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029295|NCT00000724|Antidotes|antidotes|mesh-ancestor
44029296|NCT00000724|Protective Agents|protective agents|mesh-ancestor
44029297|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029298|NCT00000724|Vitamins|vitamins|mesh-ancestor
44029299|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
44029300|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
44029301|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029302|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029303|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
44029304|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029305|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029306|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029307|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029308|NCT00000725|Interferons|interferons|mesh-list
44029309|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
44029310|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
44029311|NCT00000725|Zidovudine|zidovudine|mesh-list
44029312|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029313|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
44029314|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029315|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
44029316|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029317|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
44029318|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029319|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029320|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029321|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029322|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029323|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029324|NCT00000727|Zidovudine|zidovudine|mesh-list
44149052|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157855|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43646377|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646378|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
43646379|NCT03182751|Coagulants|coagulants|mesh-ancestor
43646380|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
43646381|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770221|NCT02381717|Bupivacaine|bupivacaine|mesh-list
43646382|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646383|NCT03176134|Tedizolid|tedizolid|mesh-list
44029361|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029362|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029363|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029365|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44029366|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
44029367|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029368|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029369|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029370|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029371|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029372|NCT00000730|Leucovorin|leucovorin|mesh-list
44029373|NCT00000730|Trimethoprim|trimethoprim|mesh-list
44029398|NCT00000730|Renal Agents|renal agents|mesh-ancestor
44029399|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
44029400|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029401|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43646384|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
44029402|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029403|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029404|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029405|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44029406|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44029407|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029408|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
44029409|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44029410|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029411|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029412|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
44029413|NCT00000731|Acetaminophen|acetaminophen|mesh-list
44029414|NCT00000731|Zidovudine|zidovudine|mesh-list
44029415|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44029416|NCT00000731|Analgesics|analgesics|mesh-ancestor
44029417|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
44029418|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029419|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029420|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
44029421|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
44029422|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029423|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029424|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029425|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646385|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43646386|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646387|NCT03161912|Aflibercept|aflibercept|mesh-list
43646388|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43646389|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43646390|NCT03161912|Growth Substances|growth substances|mesh-ancestor
43646391|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646392|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
43646393|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646395|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646396|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646397|NCT03132532|Paclitaxel|paclitaxel|mesh-list
43646398|NCT03132532|Carboplatin|carboplatin|mesh-list
43646399|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646400|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646401|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646402|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646403|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646404|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646405|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
43646406|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43646407|NCT03112044|Velpatasvir|velpatasvir|mesh-list
43646408|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
43646409|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646410|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
43646411|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44029427|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029428|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029429|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029431|NCT00000732|Trimethoprim|trimethoprim|mesh-list
44029432|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
44029433|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44029434|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
44029435|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646412|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43646413|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646414|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43646415|NCT03109990|Analgesics|analgesics|mesh-ancestor
43646416|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
43646426|NCT03098485|Azithromycin|azithromycin|mesh-list
43646427|NCT03098485|Levofloxacin|levofloxacin|mesh-list
43646429|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
43646430|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
43646431|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43646432|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43646433|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43646434|NCT03098485|Renal Agents|renal agents|mesh-ancestor
43646435|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43646436|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43646437|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646438|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646439|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646440|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43646441|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43646442|NCT03071536|Furosemide|furosemide|mesh-list
43646443|NCT03071536|Diuretics|diuretics|mesh-ancestor
43646444|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
43646445|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646446|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43646447|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43646448|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646449|NCT03071406|Nivolumab|nivolumab|mesh-list
43646450|NCT03071406|Ipilimumab|ipilimumab|mesh-list
43646451|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43646452|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646453|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43646454|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646455|NCT03064867|Rituximab|rituximab|mesh-list
43646456|NCT03064867|Carboplatin|carboplatin|mesh-list
43646461|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646462|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
43646463|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646464|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646465|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646466|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43646467|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43646468|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646469|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646470|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646471|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
43646473|NCT03056755|Fulvestrant|fulvestrant|mesh-list
43646474|NCT03056755|Leuprolide|leuprolide|mesh-list
43646475|NCT03056755|Goserelin|goserelin|mesh-list
43646476|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646477|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43646478|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43646479|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646491|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43646492|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646493|NCT03047330|Leuprolide|leuprolide|mesh-list
43646494|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43646495|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
43646496|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43646497|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646498|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43646499|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646500|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
43646501|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43646502|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43646503|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
43646504|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43646505|NCT03043924|Estradiol|estradiol|mesh-list
43646506|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43646543|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43646544|NCT03038100|Paclitaxel|paclitaxel|mesh-list
43646545|NCT03038100|Bevacizumab|bevacizumab|mesh-list
43646546|NCT03038100|Carboplatin|carboplatin|mesh-list
43646547|NCT03038100|Atezolizumab|atezolizumab|mesh-list
43646548|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43646549|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646550|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029530|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029531|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029532|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44029533|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44029599|NCT00000769|Interleukin-4|interleukin-4|mesh-list
44029600|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44029601|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
44029602|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029603|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029604|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44029605|NCT00000770|Zidovudine|zidovudine|mesh-list
44029606|NCT00000770|Nevirapine|nevirapine|mesh-list
44029607|NCT00000770|Didanosine|didanosine|mesh-list
44029608|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
44029609|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029610|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029611|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029612|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029613|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
44029619|NCT00000771|Paromomycin|paromomycin|mesh-list
44029682|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44029683|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44029684|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029685|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029686|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029687|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44029688|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029689|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
44029690|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44029691|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44029692|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
44029693|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44029694|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
44029695|NCT00000778|Vitamins|vitamins|mesh-ancestor
44029696|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
44029697|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44029698|NCT00000781|Zidovudine|zidovudine|mesh-list
44029699|NCT00000781|Nevirapine|nevirapine|mesh-list
44029700|NCT00000781|Didanosine|didanosine|mesh-list
44029701|NCT00000781|Zalcitabine|zalcitabine|mesh-list
44029702|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
44029703|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029704|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44029724|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029725|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029726|NCT00000796|Pyridoxine|pyridoxine|mesh-list
44029727|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
44029728|NCT00000796|Levofloxacin|levofloxacin|mesh-list
44029729|NCT00000796|Cycloserine|cycloserine|mesh-list
44029730|NCT00000796|Rifampin|rifampin|mesh-list
44029731|NCT00000796|Isoniazid|isoniazid|mesh-list
44029732|NCT00000796|Amikacin|amikacin|mesh-list
44029733|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
44029734|NCT00000796|Ethambutol|ethambutol|mesh-list
44029735|NCT00000796|Clofazimine|clofazimine|mesh-list
44029736|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44029737|NCT00000796|Streptomycin|streptomycin|mesh-list
44029738|NCT00000796|Ethionamide|ethionamide|mesh-list
44029739|NCT00000796|Capreomycin|capreomycin|mesh-list
44029740|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44029741|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029742|NCT00000796|Renal Agents|renal agents|mesh-ancestor
44029743|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44029744|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44029745|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44029746|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029747|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029748|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029749|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44029750|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44029751|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44029752|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
43770223|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
44029753|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
44029754|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029755|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44029802|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
44029803|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029804|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44029805|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44029806|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44029808|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
44029809|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44029810|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44029811|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
44029812|NCT00000801|Hormones|hormones|mesh-ancestor
44029813|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44029814|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44029815|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44029816|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44029817|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44029818|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029819|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44029820|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
44029821|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
44029822|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029823|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44029824|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44029825|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44029826|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44029827|NCT00000802|Dapsone|dapsone|mesh-list
44029828|NCT00000802|Atovaquone|atovaquone|mesh-list
44029829|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029830|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
44029831|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44029832|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44029833|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44029834|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029835|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029836|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
44029844|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44029845|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029846|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
44029847|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029848|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029849|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029850|NCT00000804|Indinavir|indinavir|mesh-list
44029851|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44029852|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44029853|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44029854|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029855|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44029856|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029857|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44029858|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
44029859|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029860|NCT00000805|Ganciclovir|ganciclovir|mesh-list
44029861|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44029862|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
44029863|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44029865|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44029996|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44029997|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030000|NCT00000834|Methotrexate|methotrexate|mesh-list
44030001|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44030002|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
44030003|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44030004|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030005|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44030006|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
44030007|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030008|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030009|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44030010|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030011|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44030012|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44030013|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
44030014|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030015|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030016|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030017|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
44030018|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030019|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030020|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030021|NCT00000838|Lamivudine|lamivudine|mesh-list
44030022|NCT00000838|Zidovudine|zidovudine|mesh-list
44030023|NCT00000838|Didanosine|didanosine|mesh-list
44030024|NCT00000838|Stavudine|stavudine|mesh-list
44030069|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646671|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
43646672|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646673|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646674|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
43646675|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43646676|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43646677|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030095|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030096|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030097|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030098|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
44030099|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030100|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030101|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030102|NCT00000850|Indinavir|indinavir|mesh-list
44030103|NCT00000850|Sargramostim|sargramostim|mesh-list
44030104|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
44030105|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030106|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030107|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43759588|NCT02448264|Berotralstat|berotralstat|mesh-list
44030108|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030109|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030110|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030111|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030112|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030113|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
44030114|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030115|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44030116|NCT00000854|Nandrolone|nandrolone|mesh-list
44030117|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44030118|NCT00000854|Androgens|androgens|mesh-ancestor
44030119|NCT00000854|Hormones|hormones|mesh-ancestor
44030120|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44030154|NCT00000864|Zidovudine|zidovudine|mesh-list
44030155|NCT00000864|Abacavir|abacavir|mesh-list
44030156|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
44030157|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030158|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030159|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030160|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030161|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
44030162|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030163|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030164|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030165|NCT00000865|Lamivudine|lamivudine|mesh-list
44030166|NCT00000865|Zidovudine|zidovudine|mesh-list
44030167|NCT00000865|Abacavir|abacavir|mesh-list
44030168|NCT00000865|Didanosine|didanosine|mesh-list
44030169|NCT00000865|Stavudine|stavudine|mesh-list
44030170|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030171|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030172|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030173|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030174|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
44030175|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030176|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030177|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030178|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
44030179|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44030180|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44030181|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
44030182|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030183|NCT00000868|Antacids|antacids|mesh-ancestor
44030184|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030185|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44030186|NCT00000872|Lamivudine|lamivudine|mesh-list
44030187|NCT00000872|Zidovudine|zidovudine|mesh-list
44030188|NCT00000872|Nevirapine|nevirapine|mesh-list
44030189|NCT00000872|Abacavir|abacavir|mesh-list
44030190|NCT00000872|Stavudine|stavudine|mesh-list
44030191|NCT00000872|Nelfinavir|nelfinavir|mesh-list
44030192|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030201|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030202|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030203|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030204|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030205|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030206|NCT00000875|Acetaminophen|acetaminophen|mesh-list
44030207|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
44030208|NCT00000875|Promethazine|promethazine|mesh-list
44030209|NCT00000875|Lamivudine|lamivudine|mesh-list
44030210|NCT00000875|Zidovudine|zidovudine|mesh-list
44030211|NCT00000875|Aldesleukin|aldesleukin|mesh-list
44030212|NCT00000875|Indinavir|indinavir|mesh-list
44030213|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44030214|NCT00000875|Analgesics|analgesics|mesh-ancestor
44030215|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
44030216|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44030217|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030218|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
44030219|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030220|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030261|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
44030262|NCT00000880|Cyclosporine|cyclosporine|mesh-list
44030263|NCT00000880|Cyclosporins|cyclosporins|mesh-list
44030264|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030265|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030266|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44030267|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
44030268|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030269|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
44030270|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030271|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
44030272|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030273|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44030274|NCT00000881|Cidofovir|cidofovir|mesh-list
44030275|NCT00000881|Probenecid|probenecid|mesh-list
44030276|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
44030277|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
44030278|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030279|NCT00000881|Renal Agents|renal agents|mesh-ancestor
44030280|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
44030281|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030282|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030283|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149054|NCT00206544|Progesterone|progesterone|mesh-list
44149055|NCT00206544|Progestins|progestins|mesh-ancestor
44149056|NCT00206544|Hormones|hormones|mesh-ancestor
44149057|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149058|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149059|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44149060|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149061|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149062|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149063|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44149064|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44149065|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149066|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44149070|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149071|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149072|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44149073|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44149074|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44149075|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44149076|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44149077|NCT00206570|Estradiol|estradiol|mesh-list
44149078|NCT00206570|Estrogens|estrogens|mesh-ancestor
44149079|NCT00206570|Hormones|hormones|mesh-ancestor
44149080|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149081|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149082|NCT00206596|Sargramostim|sargramostim|mesh-list
44149083|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
44149084|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149085|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44149086|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44149087|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
44149088|NCT00206622|Estradiol|estradiol|mesh-list
44149089|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44149090|NCT00206622|Estrogens|estrogens|mesh-ancestor
44149091|NCT00206622|Hormones|hormones|mesh-ancestor
44149092|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149093|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149094|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44149095|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
44149096|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44149097|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44149098|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44149099|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44149100|NCT00206635|Interferons|interferons|mesh-list
44149101|NCT00206635|Interferon-beta|interferon-beta|mesh-list
44149102|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
44149103|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149104|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
44149105|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030290|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
44030291|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030292|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
44030293|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44030294|NCT00000884|Protective Agents|protective agents|mesh-ancestor
44030295|NCT00000885|Lamivudine|lamivudine|mesh-list
44030296|NCT00000885|Zidovudine|zidovudine|mesh-list
44030297|NCT00000885|Efavirenz|efavirenz|mesh-list
44030298|NCT00000885|Abacavir|abacavir|mesh-list
44030299|NCT00000885|Didanosine|didanosine|mesh-list
44030300|NCT00000885|Stavudine|stavudine|mesh-list
44030301|NCT00000885|Adefovir|adefovir|mesh-list
44030302|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44030303|NCT00000885|Nelfinavir|nelfinavir|mesh-list
44030304|NCT00000885|Indinavir|indinavir|mesh-list
44030305|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030306|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030307|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030308|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030309|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
44030310|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030311|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030312|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030313|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
44030314|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44030315|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030316|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44030317|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030318|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030319|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030320|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030321|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030322|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030323|NCT00000887|Lamivudine|lamivudine|mesh-list
44030344|NCT00000894|Ganciclovir|ganciclovir|mesh-list
44030345|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44030346|NCT00000894|Cidofovir|cidofovir|mesh-list
44030347|NCT00000894|Probenecid|probenecid|mesh-list
44030348|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
44030349|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030350|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030351|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030352|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030353|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
44030354|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
44030355|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44030356|NCT00000894|Renal Agents|renal agents|mesh-ancestor
44030357|NCT00000896|Lamivudine|lamivudine|mesh-list
44030358|NCT00000896|Zidovudine|zidovudine|mesh-list
44030359|NCT00000896|Nevirapine|nevirapine|mesh-list
44030360|NCT00000896|Stavudine|stavudine|mesh-list
43838278|NCT04855695|Venetoclax|venetoclax|mesh-list
44030361|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44030362|NCT00000896|Indinavir|indinavir|mesh-list
44030363|NCT00000896|Interleukin-12|interleukin-12|mesh-list
44030364|NCT00000896|Sargramostim|sargramostim|mesh-list
44030365|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030366|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030367|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030390|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030391|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030392|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030393|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
44030394|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030395|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030396|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030397|NCT00000901|Lamivudine|lamivudine|mesh-list
44030398|NCT00000901|Stavudine|stavudine|mesh-list
44030399|NCT00000901|Indinavir|indinavir|mesh-list
44030400|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030401|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030402|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030403|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030404|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
44030405|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030406|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030407|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43702673|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
44030440|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
44030441|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030443|NCT00000912|Abacavir|abacavir|mesh-list
44030444|NCT00000912|Adefovir|adefovir|mesh-list
44030445|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44030446|NCT00000912|Nelfinavir|nelfinavir|mesh-list
44030447|NCT00000912|Indinavir|indinavir|mesh-list
44030448|NCT00000912|Saquinavir|saquinavir|mesh-list
44030449|NCT00000912|Amprenavir|amprenavir|mesh-list
44030450|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030451|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030452|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030453|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030454|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
44030455|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030456|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44030457|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030458|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44030459|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030460|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030473|NCT00000913|Saquinavir|saquinavir|mesh-list
44030474|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030475|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030476|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030477|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030478|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030479|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030480|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030481|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
44030482|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030483|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030484|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030485|NCT00000914|Ritonavir|ritonavir|mesh-list
44030486|NCT00000914|Nelfinavir|nelfinavir|mesh-list
44030487|NCT00000914|Indinavir|indinavir|mesh-list
44030488|NCT00000914|Efavirenz|efavirenz|mesh-list
44030489|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030490|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030491|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030492|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030493|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030494|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030495|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030496|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
44030497|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030498|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030499|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030500|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030501|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030502|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44030551|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
44030552|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44030553|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44030554|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44030555|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44030556|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030557|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44030558|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
44030559|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030560|NCT00000920|Ritonavir|ritonavir|mesh-list
44030561|NCT00000920|Saquinavir|saquinavir|mesh-list
44030562|NCT00000920|Lamivudine|lamivudine|mesh-list
44030563|NCT00000920|Zidovudine|zidovudine|mesh-list
44030564|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44030565|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44030566|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
44030567|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030568|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030569|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030570|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030571|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
44030572|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030573|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44030574|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44030575|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030576|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030577|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
44030626|NCT00000929|Nonoxynol|nonoxynol|mesh-list
44030627|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44030628|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44030629|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030630|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44030654|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030655|NCT00000938|Doxycycline|doxycycline|mesh-list
44030656|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
44030657|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030721|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
44030722|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44030723|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44030724|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030725|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
44030726|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030727|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
44030728|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44030729|NCT00000946|Protective Agents|protective agents|mesh-ancestor
44030730|NCT00000947|Azithromycin|azithromycin|mesh-list
44030731|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030732|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030733|NCT00000948|Aldesleukin|aldesleukin|mesh-list
44030734|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030735|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030736|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030737|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
44030738|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030739|NCT00000949|Aldesleukin|aldesleukin|mesh-list
44030740|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44030741|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030742|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030743|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
44030744|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030745|NCT00000950|Pyridoxine|pyridoxine|mesh-list
44030746|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
44030747|NCT00000950|Rifampin|rifampin|mesh-list
44030748|NCT00000950|Isoniazid|isoniazid|mesh-list
44030749|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
44030750|NCT00000950|Ethambutol|ethambutol|mesh-list
44030751|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44030752|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
44030753|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44030754|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030755|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
44030756|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030757|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030758|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030761|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44030762|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44030763|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44030764|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44030765|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44030831|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
44030832|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030833|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030834|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030835|NCT00000964|Foscarnet|foscarnet|mesh-list
44030836|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44030945|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030946|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030947|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
44030948|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030949|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030950|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030951|NCT00000988|Stavudine|stavudine|mesh-list
44030952|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
44030953|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030954|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030955|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030956|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030957|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
44030958|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44030959|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44030960|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44030961|NCT00000989|Zidovudine|zidovudine|mesh-list
44030962|NCT00000989|Ganciclovir|ganciclovir|mesh-list
44030963|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44030964|NCT00000989|Sargramostim|sargramostim|mesh-list
44030965|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
44030966|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44030967|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44030968|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44030969|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44030970|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
44030971|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031000|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031001|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44031002|NCT00000991|Renal Agents|renal agents|mesh-ancestor
44031003|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
44031004|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031005|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031006|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44031007|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44031008|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44031009|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031010|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
44031011|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031012|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
44031013|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44031014|NCT00000992|Itraconazole|itraconazole|mesh-list
44031015|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
44031016|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031017|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44031018|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031019|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031020|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031021|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44031022|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
44031023|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031024|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031025|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44031026|NCT00000993|Zidovudine|zidovudine|mesh-list
44031027|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
44031028|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031031|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031054|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
44031055|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031056|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031057|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031058|NCT00000996|Doxorubicin|doxorubicin|mesh-list
44031059|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44031060|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031061|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031062|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44031063|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031064|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031065|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031066|NCT00000997|Zalcitabine|zalcitabine|mesh-list
44031067|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
44031068|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031069|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031070|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031071|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031072|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
44031073|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031074|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031075|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031076|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
44031077|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031078|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
44031103|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031104|NCT00001016|Antidotes|antidotes|mesh-ancestor
44031105|NCT00001016|Protective Agents|protective agents|mesh-ancestor
44031106|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
44031107|NCT00001016|Vitamins|vitamins|mesh-ancestor
44031108|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
44031109|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
44031110|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031111|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44031112|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
44031113|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031114|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031115|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44031116|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031117|NCT00001017|Fluconazole|fluconazole|mesh-list
44031118|NCT00001017|Amphotericin B|amphotericin b|mesh-list
44031119|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44031120|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
44031121|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031122|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44031123|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44031200|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44031201|NCT00001034|Ganciclovir|ganciclovir|mesh-list
44031202|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44031203|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
44031204|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031205|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031206|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031207|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031208|NCT00001035|Interferons|interferons|mesh-list
44031209|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
44031210|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
44031211|NCT00001035|Zidovudine|zidovudine|mesh-list
44031212|NCT00001035|Didanosine|didanosine|mesh-list
44031213|NCT00001035|Zalcitabine|zalcitabine|mesh-list
44031214|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031215|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
44031216|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031217|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
44031218|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031219|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
44031220|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031221|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031222|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031223|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031224|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031225|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031226|NCT00001039|Clarithromycin|clarithromycin|mesh-list
44031227|NCT00001039|Ethambutol|ethambutol|mesh-list
44031228|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031229|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031230|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44031231|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031267|NCT00001052|Antacids|antacids|mesh-ancestor
44149116|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149118|NCT00206674|Sargramostim|sargramostim|mesh-list
44149119|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
44149120|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149121|NCT00206700|Sargramostim|sargramostim|mesh-list
44149122|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
44149123|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149124|NCT00206713|Sargramostim|sargramostim|mesh-list
44149125|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
44149126|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149127|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
44149128|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
44149129|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
44149130|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44149131|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44149132|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44149133|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44149134|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149135|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149136|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44149144|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149145|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149146|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149147|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149148|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149149|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149150|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
44149151|NCT00206765|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44149152|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149153|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149154|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44149155|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149156|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44149157|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44149158|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149159|NCT00206778|Lamotrigine|lamotrigine|mesh-list
44149160|NCT00206778|Valproic Acid|valproic acid|mesh-list
44149161|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
44149162|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44149163|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149164|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149165|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44149166|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149167|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149168|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149169|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149170|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149171|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44149172|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149173|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
44149174|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149175|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
44149176|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44149177|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
44149178|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149180|NCT00206934|Citalopram|citalopram|mesh-list
44149181|NCT00206934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44157864|NCT00235313|Nicotine|nicotine|mesh-list
44031292|NCT00001057|Didanosine|didanosine|mesh-list
44031293|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
44031294|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031295|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031296|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031297|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031302|NCT00001058|Ritonavir|ritonavir|mesh-list
44031362|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031364|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031365|NCT00001065|Amphotericin B|amphotericin b|mesh-list
44031366|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44031367|NCT00001065|Amebicides|amebicides|mesh-ancestor
44031368|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031369|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031370|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031371|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031372|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
44031373|NCT00001067|Lamivudine|lamivudine|mesh-list
44031374|NCT00001067|Zidovudine|zidovudine|mesh-list
44031375|NCT00001067|Stavudine|stavudine|mesh-list
44031376|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031377|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031378|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031379|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031380|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
44031381|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031382|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031383|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031384|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
44031385|NCT00001068|Lamivudine|lamivudine|mesh-list
44031386|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031387|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031388|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031389|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031390|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
44031391|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031392|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031393|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031394|NCT00001070|Ascorbic Acid|ascorbic acid|mesh-list
44031395|NCT00001070|Vitamins|vitamins|mesh-ancestor
44031396|NCT00001070|Micronutrients|micronutrients|mesh-ancestor
44031397|NCT00001070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031398|NCT00001070|Antioxidants|antioxidants|mesh-ancestor
44031399|NCT00001070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031400|NCT00001070|Protective Agents|protective agents|mesh-ancestor
44031402|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44031403|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
44031404|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031405|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031406|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031407|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
44031408|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031409|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
44031410|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44031411|NCT00001072|Protective Agents|protective agents|mesh-ancestor
44031412|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
44031413|NCT00001079|Megestrol|megestrol|mesh-list
44031414|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
44031415|NCT00001079|Testosterone|testosterone|mesh-list
43646933|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646935|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43646936|NCT02654119|Paclitaxel|paclitaxel|mesh-list
43646937|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
43646938|NCT02654119|Trastuzumab|trastuzumab|mesh-list
43646939|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43646940|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43646942|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
43646943|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43646944|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43646945|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646946|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
43646947|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646948|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
43646949|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646950|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43646951|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
43646952|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646953|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43646954|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43646955|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
43646956|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43646957|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
43646958|NCT02638090|Vorinostat|vorinostat|mesh-list
44031539|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031541|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
44031542|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44031543|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031544|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
44031545|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44031546|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44031547|NCT00001104|Zidovudine|zidovudine|mesh-list
44031548|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
44031549|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031550|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031551|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031552|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031553|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
44031554|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031555|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031556|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031557|NCT00001106|Zidovudine|zidovudine|mesh-list
44031558|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
44031559|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031560|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031561|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031562|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031563|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
44031564|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031565|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031642|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44031643|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44031644|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
44031645|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031646|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031647|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
44031648|NCT00001123|Ribavirin|ribavirin|mesh-list
44031649|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
44031650|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031651|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
44031652|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031653|NCT00001126|Cidofovir|cidofovir|mesh-list
44031654|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
44031655|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031656|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031657|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031676|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031678|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031679|NCT00001132|Abacavir|abacavir|mesh-list
44031680|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031681|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031682|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031683|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031684|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
44031685|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031686|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031687|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031705|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031706|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
44031707|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031708|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031709|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031710|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44031711|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44031712|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
44031713|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031714|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
44031715|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031716|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44031717|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031718|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
44031719|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031720|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031721|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031723|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44031724|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
44031725|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031726|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031727|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031728|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44031729|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
44031730|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031731|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
44031732|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031733|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
44031734|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031735|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031736|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031746|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43761065|NCT02441673|Oxytocin|oxytocin|mesh-list
44031747|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
44031748|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031749|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031750|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44031751|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031752|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031753|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031754|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031755|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031756|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44031757|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031758|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031760|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031761|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
44031762|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031763|NCT00001237|Molgramostim|molgramostim|mesh-list
44031764|NCT00001237|Sargramostim|sargramostim|mesh-list
44031765|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
44031766|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031767|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031768|NCT00001249|Antibodies|antibodies|mesh-list
44031769|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
44031770|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031771|NCT00001256|Prednisone|prednisone|mesh-list
44031772|NCT00001256|Methotrexate|methotrexate|mesh-list
44031773|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44031774|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
44031775|NCT00001256|Hormones|hormones|mesh-ancestor
44031776|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44031777|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031778|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44031779|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031780|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44031781|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
44031866|NCT00001339|Mitotane|mitotane|mesh-list
44031867|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44031868|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031869|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44031870|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44031871|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031872|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031873|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44031874|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
44031875|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
44031876|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
44031877|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44031878|NCT00001354|Zidovudine|zidovudine|mesh-list
44031879|NCT00001354|Interleukin-2|interleukin-2|mesh-list
44031880|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031881|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44031882|NCT00001354|Analgesics|analgesics|mesh-ancestor
44031883|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
44031884|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031885|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44031886|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
44031887|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44031888|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44031889|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44031890|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44031891|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
44031892|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44031893|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44031894|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44031895|NCT00001357|Interleukin-2|interleukin-2|mesh-list
44031896|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44031897|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44031898|NCT00001357|Analgesics|analgesics|mesh-ancestor
44031899|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
44031900|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44031901|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032004|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032005|NCT00001440|Interleukin-2|interleukin-2|mesh-list
44032006|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032007|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032008|NCT00001440|Analgesics|analgesics|mesh-ancestor
44032009|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
44032010|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032011|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032012|NCT00001442|Paclitaxel|paclitaxel|mesh-list
44032013|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032014|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032015|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032016|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032017|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032018|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032019|NCT00001443|Indinavir|indinavir|mesh-list
44032020|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44032021|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44032022|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44032023|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032024|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032025|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032026|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032027|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
44032028|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032029|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44032030|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032031|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44032083|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032084|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032085|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
44032086|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032087|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032088|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44032089|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
44032090|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44032091|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44032092|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44032093|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44032094|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032095|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
44032096|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44032097|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44032098|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
44032099|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44032100|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032101|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44032102|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032103|NCT00001498|Antidotes|antidotes|mesh-ancestor
44032104|NCT00001498|Protective Agents|protective agents|mesh-ancestor
44032105|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
44032106|NCT00001498|Vitamins|vitamins|mesh-ancestor
44032107|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
44032108|NCT00001499|Paclitaxel|paclitaxel|mesh-list
44032109|NCT00001499|Cisplatin|cisplatin|mesh-list
44032110|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032111|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032112|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032113|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032114|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032115|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032116|NCT00001502|Carboplatin|carboplatin|mesh-list
44032117|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032145|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032146|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032147|NCT00001535|Analgesics|analgesics|mesh-ancestor
44032148|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
43647091|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647093|NCT02465736|Docetaxel|docetaxel|mesh-list
43647094|NCT02465736|Vinorelbine|vinorelbine|mesh-list
43647095|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647096|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647097|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032161|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032163|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032164|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032165|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032166|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032167|NCT00001570|Vinblastine|vinblastine|mesh-list
44032168|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032169|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032170|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
44032171|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
44032172|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
44032173|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032174|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
44032175|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032176|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
44032177|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032178|NCT00001577|Melphalan|melphalan|mesh-list
44032179|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44032180|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
44032181|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032182|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032183|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44032184|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032185|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
44032186|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032187|NCT00001579|Leucovorin|leucovorin|mesh-list
44032188|NCT00001579|Fluorouracil|fluorouracil|mesh-list
44032189|NCT00001579|Eniluracil|eniluracil|mesh-list
44032190|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
44032197|NCT00001579|Antidotes|antidotes|mesh-ancestor
44032206|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032207|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032208|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44032209|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032210|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
44032211|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032212|NCT00001599|Thalidomide|thalidomide|mesh-list
44032213|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032214|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
44032215|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032216|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
44032217|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032218|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032219|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032220|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44032221|NCT00001599|Growth Substances|growth substances|mesh-ancestor
44032222|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032223|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149193|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
44149194|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
44149195|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149196|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44149197|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44149198|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
44149199|NCT00206947|Ziprasidone|ziprasidone|mesh-list
44149200|NCT00206947|Donepezil|donepezil|mesh-list
44149201|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44149202|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149203|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149204|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
44149205|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149206|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149207|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
44149208|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149209|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
44149210|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149215|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
44149216|NCT00206960|Risperidone|risperidone|mesh-list
44149217|NCT00206960|Clopenthixol|clopenthixol|mesh-list
44149218|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149219|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
44149220|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149221|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149222|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149223|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149224|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149225|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149226|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149227|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44149228|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
44149229|NCT00206973|Mannitol|mannitol|mesh-list
44149230|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44032261|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44032262|NCT00001646|Voriconazole|voriconazole|mesh-list
44032263|NCT00001646|Amphotericin B|amphotericin b|mesh-list
44032264|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44032265|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
44032266|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032267|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032268|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032269|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032270|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032271|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032272|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032273|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032274|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032275|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44032276|NCT00001646|Amebicides|amebicides|mesh-ancestor
44032277|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032278|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032279|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032323|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032324|NCT00001698|Analgesics|analgesics|mesh-ancestor
44032325|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
44032326|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032327|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032328|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032329|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032330|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44032331|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032332|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032333|NCT00001713|Heparin|heparin|mesh-list
44032334|NCT00001713|Plasminogen|plasminogen|mesh-list
44032335|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44032336|NCT00001713|Warfarin|warfarin|mesh-list
44032337|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
44032338|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44032339|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44032340|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032341|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
44032342|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
44032343|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44032344|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
44032345|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647101|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
43647102|NCT02439450|Nivolumab|nivolumab|mesh-list
43647103|NCT02439450|Pemetrexed|pemetrexed|mesh-list
43647104|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647105|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647106|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43647107|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647108|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032346|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032347|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44032348|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
44032349|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44032350|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
44032351|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032352|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032353|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44032354|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44032355|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
44032356|NCT00001716|Protective Agents|protective agents|mesh-ancestor
44032357|NCT00001736|Cysteamine|cysteamine|mesh-list
44032358|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44032359|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032360|NCT00001737|Cyclosporine|cyclosporine|mesh-list
44032361|NCT00001737|Cyclosporins|cyclosporins|mesh-list
44032362|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032363|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032364|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032365|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
44032366|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032367|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
44032368|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032369|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032370|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032371|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44032372|NCT00001757|Voriconazole|voriconazole|mesh-list
44032373|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
44032374|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032375|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032376|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032377|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032378|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032379|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032385|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44032386|NCT00001768|Antibodies|antibodies|mesh-list
44032387|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
44032388|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44032389|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
44032390|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032391|NCT00001785|Interferons|interferons|mesh-list
44032392|NCT00001785|Interferon-beta|interferon-beta|mesh-list
44032393|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
44032394|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032395|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
44032396|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032397|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
44032398|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032399|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032400|NCT00001790|Micafungin|micafungin|mesh-list
44032401|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
44032402|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032403|NCT00001810|Voriconazole|voriconazole|mesh-list
44032404|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
44032405|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032406|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032407|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032408|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032409|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032410|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032411|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032412|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032413|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032414|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44032415|NCT00001812|Nystatin|nystatin|mesh-list
44032416|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032417|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032433|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
44032500|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44032501|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44032502|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
44032503|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032504|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032505|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44032506|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
44032507|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
44032508|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
44032509|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44032510|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44032511|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
44032512|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032513|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032514|NCT00001865|Daclizumab|daclizumab|mesh-list
44032515|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032516|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
44032574|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032575|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032576|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032577|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
44032578|NCT00001901|Etanercept|etanercept|mesh-list
44032579|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032580|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032581|NCT00001901|Analgesics|analgesics|mesh-ancestor
44032582|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
44032583|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032584|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032585|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032586|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032587|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032588|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032589|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
44032590|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
44032591|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44032592|NCT00001903|Antibodies|antibodies|mesh-list
44032593|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
44032594|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032595|NCT00001905|Interferons|interferons|mesh-list
44032596|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
44032597|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032598|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
44032599|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032600|NCT00001906|Interleukin-12|interleukin-12|mesh-list
44032601|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44032602|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032603|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
44032604|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032605|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032606|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44032607|NCT00001906|Growth Substances|growth substances|mesh-ancestor
44032608|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032609|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032610|NCT00001906|Antacids|antacids|mesh-ancestor
44032611|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032612|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032613|NCT00001911|Interleukin-12|interleukin-12|mesh-list
44032614|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44032615|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
44032616|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032617|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44032618|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44032619|NCT00001911|Growth Substances|growth substances|mesh-ancestor
44032620|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
44032621|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032622|NCT00001929|Eliprodil|eliprodil|mesh-list
44032623|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44032624|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44032625|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44032626|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032627|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032628|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44032629|NCT00001929|Protective Agents|protective agents|mesh-ancestor
44032630|NCT00001930|Amantadine|amantadine|mesh-list
44032631|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44032632|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44032633|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
44032689|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
44032690|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43595699|NCT03323372|Listerine|listerine|mesh-list
44032691|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032692|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032693|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032694|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44032695|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032696|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
44032697|NCT00001955|Celecoxib|celecoxib|mesh-list
44032698|NCT00001955|Etanercept|etanercept|mesh-list
44032699|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44032700|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032701|NCT00001955|Analgesics|analgesics|mesh-ancestor
44032702|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
44032703|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032704|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032705|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44032706|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032707|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44032714|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
44032744|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032745|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032746|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032747|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
44032748|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032749|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
44032750|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032751|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032752|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032753|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44032754|NCT00001965|Cyclosporine|cyclosporine|mesh-list
44032755|NCT00001965|Cyclosporins|cyclosporins|mesh-list
44032756|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032757|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032758|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44032759|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
44032760|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032761|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
44032762|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032763|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032764|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44032765|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44032766|NCT00001968|Ritonavir|ritonavir|mesh-list
44032767|NCT00001968|Amprenavir|amprenavir|mesh-list
44032768|NCT00001968|Lamivudine|lamivudine|mesh-list
44032769|NCT00001968|Abacavir|abacavir|mesh-list
44032770|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44032771|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44032772|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
44032773|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032790|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032791|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032792|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032793|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
44032794|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032795|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032796|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032797|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44032798|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
44032799|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44032800|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032801|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032802|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032803|NCT00001990|Atovaquone|atovaquone|mesh-list
44032804|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032805|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
44032806|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032807|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032808|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032810|NCT00001991|Atovaquone|atovaquone|mesh-list
44032817|NCT00001993|Miglustat|miglustat|mesh-list
44032848|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032849|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032850|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770295|NCT02381158|Beclomethasone|beclomethasone|mesh-list
43770298|NCT02381158|Hormones|hormones|mesh-ancestor
44032851|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
44032852|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44032854|NCT00001997|Didanosine|didanosine|mesh-list
44032855|NCT00001997|Interleukin-2|interleukin-2|mesh-list
44032856|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032857|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44032859|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
44032860|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032861|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032862|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
44032863|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032864|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44032865|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032866|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032867|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
44032868|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032869|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032870|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032871|NCT00001998|Nystatin|nystatin|mesh-list
44032872|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44032873|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032874|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
44032875|NCT00001998|Ionophores|ionophores|mesh-ancestor
44032876|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44032877|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032878|NCT00001999|Ganciclovir|ganciclovir|mesh-list
44032879|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44032880|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
44032881|NCT00001999|Antibodies|antibodies|mesh-list
44032882|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
44032883|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032884|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44032885|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032900|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032901|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
44032902|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032903|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44032904|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44032905|NCT00002002|Leucovorin|leucovorin|mesh-list
44032906|NCT00002002|Trimethoprim|trimethoprim|mesh-list
44032907|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
44032908|NCT00002002|Calcium|calcium|mesh-list
44032909|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
44032910|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44032911|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032912|NCT00002002|Antidotes|antidotes|mesh-ancestor
44032913|NCT00002002|Protective Agents|protective agents|mesh-ancestor
44032914|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
44032915|NCT00002002|Vitamins|vitamins|mesh-ancestor
44032916|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
44032917|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44032918|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032920|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
44032921|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44032922|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44032923|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44032924|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032925|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032926|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44032927|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44032928|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032929|NCT00002003|Etoposide|etoposide|mesh-list
44032930|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
44032931|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44032932|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032933|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44032934|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44032935|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032936|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032937|NCT00002003|Analgesics|analgesics|mesh-ancestor
44032938|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
44032939|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44032940|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149315|NCT00207402|Ribavirin|ribavirin|mesh-list
44149316|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
44149317|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149318|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
44032973|NCT00002010|Fluconazole|fluconazole|mesh-list
44032974|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
44032975|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032976|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44032977|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44032978|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44032979|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032980|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44032981|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44032982|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44032983|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032984|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44032985|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44032986|NCT00002011|Methoxsalen|methoxsalen|mesh-list
44032987|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44032988|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
44032989|NCT00002012|Interferons|interferons|mesh-list
44032990|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
44032991|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44032992|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
44032993|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44032994|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
44032995|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44032997|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
44032998|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44032999|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033000|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033001|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033002|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
44033003|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033004|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033005|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033006|NCT00002014|Zidovudine|zidovudine|mesh-list
44033007|NCT00002014|Didanosine|didanosine|mesh-list
44033008|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
44033009|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033010|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033011|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033012|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033013|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
44033014|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033015|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033016|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033017|NCT00002015|Ganciclovir|ganciclovir|mesh-list
44033028|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
44033029|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44033030|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033032|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
44033033|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033034|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
44033035|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033036|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
44033037|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033038|NCT00002019|Amphotericin B|amphotericin b|mesh-list
44033039|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44033040|NCT00002019|Amebicides|amebicides|mesh-ancestor
44033041|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033042|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033043|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033044|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033045|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
44033046|NCT00002020|Zidovudine|zidovudine|mesh-list
44033047|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
44033048|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033049|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033050|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033051|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033052|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
43652064|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44033053|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033054|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033055|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033056|NCT00002021|Foscarnet|foscarnet|mesh-list
44033057|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44033058|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
44033059|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033060|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033061|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033062|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033063|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033064|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
44033065|NCT00002022|Hematinics|hematinics|mesh-ancestor
44033072|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
44033073|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033074|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033075|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033076|NCT00002024|Ganciclovir|ganciclovir|mesh-list
44033077|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033078|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
44033079|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033080|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033081|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033082|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033083|NCT00002025|Ganciclovir|ganciclovir|mesh-list
44033084|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033085|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
44033086|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033087|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033088|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033089|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033090|NCT00002026|Acyclovir|acyclovir|mesh-list
44033091|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
44033092|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033093|NCT00002027|Diclazuril|diclazuril|mesh-list
44033094|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
44033095|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033096|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033097|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033098|NCT00002028|Didanosine|didanosine|mesh-list
44033099|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
44033100|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033101|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033102|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033116|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033117|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44033118|NCT00002032|Rifabutin|rifabutin|mesh-list
44033119|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033120|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033121|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44033122|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
44033123|NCT00002033|Zidovudine|zidovudine|mesh-list
44033124|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
44149319|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033125|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033126|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033127|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033128|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033129|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
44033130|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033131|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033132|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43647114|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
43647115|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033133|NCT00002034|Zidovudine|zidovudine|mesh-list
44033134|NCT00002034|Ganciclovir|ganciclovir|mesh-list
44033135|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033136|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
44033137|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033138|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033139|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033140|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033141|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
44033142|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033143|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033144|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033145|NCT00002035|Zidovudine|zidovudine|mesh-list
44033146|NCT00002035|Didanosine|didanosine|mesh-list
44033147|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
44033148|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033149|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033150|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033151|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033152|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
44033153|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033154|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033156|NCT00002036|Immune Sera|immune sera|mesh-list
44033203|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033204|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033205|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
44033206|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
44033207|NCT00002042|Hematinics|hematinics|mesh-ancestor
44033208|NCT00002043|Dapsone|dapsone|mesh-list
44033209|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033210|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
44033211|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033212|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033214|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033215|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033216|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
44033217|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033219|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
44033220|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033221|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033222|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033223|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033224|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
44033225|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033226|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033227|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033228|NCT00002045|Zidovudine|zidovudine|mesh-list
44033229|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
44033230|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033231|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033266|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033267|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033268|NCT00002049|Thymopentin|thymopentin|mesh-list
44033269|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033270|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
44033271|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033272|NCT00002050|Thymopentin|thymopentin|mesh-list
44033273|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033274|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
44033275|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033276|NCT00002051|Thymopentin|thymopentin|mesh-list
44033277|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033278|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
44033279|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033280|NCT00002052|Amoxicillin|amoxicillin|mesh-list
44033281|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
44033282|NCT00002052|Ampicillin|ampicillin|mesh-list
44033283|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033284|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033285|NCT00002053|Pentamidine|pentamidine|mesh-list
44033286|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
44033287|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033288|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033328|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033329|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
44033330|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033331|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
44033332|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033333|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
44033334|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43770301|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44033335|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
44033336|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033337|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
44033338|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033339|NCT00002062|Spiramycin|spiramycin|mesh-list
44033340|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033341|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033342|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
44033343|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033344|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033345|NCT00002063|Zidovudine|zidovudine|mesh-list
44033346|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
44033347|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033348|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033349|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43837530|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
44033350|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033351|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
44033352|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033353|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033354|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033355|NCT00002064|Clindamycin|clindamycin|mesh-list
44033356|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
44033357|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
44033358|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
44033359|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033360|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033361|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44033362|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033363|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033364|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
44033365|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033366|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033367|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44033368|NCT00002065|Disulfiram|disulfiram|mesh-list
44033369|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44033370|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44033371|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033372|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033373|NCT00002066|Thymopentin|thymopentin|mesh-list
44033374|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033375|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
44033376|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033377|NCT00002067|Megestrol|megestrol|mesh-list
44033378|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
44033379|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44033380|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44033381|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44033382|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
44033383|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44033407|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033408|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033409|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033410|NCT00002069|Ditiocarb|ditiocarb|mesh-list
44033411|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033412|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
44033479|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43770309|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
43770310|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770311|NCT02381145|Protective Agents|protective agents|mesh-ancestor
43770312|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770334|NCT02380898|Ketorolac|ketorolac|mesh-list
43770335|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43770336|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44033480|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033481|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033482|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033483|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033484|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033485|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033486|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033487|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033488|NCT00002077|Fluconazole|fluconazole|mesh-list
44033489|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
44033490|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033491|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033492|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033493|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033494|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033495|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033496|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033497|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033498|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149320|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
44033499|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033500|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033502|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
44033503|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033504|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
44033505|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033506|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
44033507|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033508|NCT00002079|Miglustat|miglustat|mesh-list
44033509|NCT00002079|Zidovudine|zidovudine|mesh-list
44033510|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
44033511|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033512|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033513|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033515|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
44033516|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033517|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033518|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033519|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44033520|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44033521|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033522|NCT00002080|Rifabutin|rifabutin|mesh-list
44033523|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033524|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033578|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
44033579|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44033580|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
44033581|NCT00002092|Cimetidine|cimetidine|mesh-list
44033582|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44033583|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44033584|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44033585|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
44033586|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
44033587|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44033588|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033589|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033590|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44033591|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033592|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033593|NCT00002093|Doxorubicin|doxorubicin|mesh-list
44033594|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44033595|NCT00002093|Daunorubicin|daunorubicin|mesh-list
44033596|NCT00002093|Bleomycin|bleomycin|mesh-list
44033597|NCT00002093|Vincristine|vincristine|mesh-list
44033598|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44033599|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033600|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44033601|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44033602|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033603|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033604|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44033605|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44033606|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44033625|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44033626|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
44033627|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033628|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033629|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033630|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033631|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
44033632|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033633|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033634|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033636|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033637|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033638|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
44033639|NCT00002097|Ionophores|ionophores|mesh-ancestor
44033640|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44033641|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033642|NCT00002098|Didanosine|didanosine|mesh-list
44033643|NCT00002098|Lentinan|lentinan|mesh-list
44033644|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
44033645|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033646|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033647|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033648|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033649|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
44033650|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033651|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033652|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033653|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44033671|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033672|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
44033673|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
44033674|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033675|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033676|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033677|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
44033678|NCT00002101|Clarithromycin|clarithromycin|mesh-list
44033679|NCT00002101|Ethambutol|ethambutol|mesh-list
44033680|NCT00002101|Rifabutin|rifabutin|mesh-list
44033681|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033682|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033683|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44033684|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033685|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033686|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44033687|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033688|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
44033689|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44033690|NCT00002102|Leucovorin|leucovorin|mesh-list
44033691|NCT00002102|Trimetrexate|trimetrexate|mesh-list
44033692|NCT00002102|Calcium|calcium|mesh-list
44033693|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
44033694|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44033695|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033726|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44033727|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033728|NCT00002104|Thalidomide|thalidomide|mesh-list
44033729|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44033730|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
44033731|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033732|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
44033733|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033734|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033735|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44033736|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44033737|NCT00002104|Growth Substances|growth substances|mesh-ancestor
44033738|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
44033739|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033740|NCT00002105|Doxorubicin|doxorubicin|mesh-list
44033741|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44033742|NCT00002105|Bleomycin|bleomycin|mesh-list
44033743|NCT00002105|Vincristine|vincristine|mesh-list
44033744|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44033745|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033746|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44033747|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44033748|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033749|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033750|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44033775|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033776|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
44033777|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033778|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033779|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033780|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
44033781|NCT00002109|Zidovudine|zidovudine|mesh-list
44033782|NCT00002109|Didanosine|didanosine|mesh-list
44033783|NCT00002109|Stavudine|stavudine|mesh-list
44033784|NCT00002109|Zalcitabine|zalcitabine|mesh-list
44033785|NCT00002109|Thymopentin|thymopentin|mesh-list
44033786|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
44033787|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033788|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033789|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033846|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033847|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033848|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033849|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033850|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033851|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033852|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44033853|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
44033854|NCT00002115|Adefovir|adefovir|mesh-list
44033855|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
44033856|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033857|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033858|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033859|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033860|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033861|NCT00002116|Cidofovir|cidofovir|mesh-list
44033901|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44033902|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033903|NCT00002120|Renal Agents|renal agents|mesh-ancestor
44033904|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
44033905|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44033906|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44033907|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44033908|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770392|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770393|NCT02380586|Anesthetics|anesthetics|mesh-list
43770425|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
43770426|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43770427|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43828412|NCT05477797|Lenalidomide|lenalidomide|mesh-list
44033909|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033910|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44033911|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44033912|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033913|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
44033914|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033915|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
44033916|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44033917|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
44033918|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033919|NCT00002122|Azithromycin|azithromycin|mesh-list
44033920|NCT00002122|Rifabutin|rifabutin|mesh-list
44033921|NCT00002122|Fluconazole|fluconazole|mesh-list
44033922|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44033923|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033924|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
44033925|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44033926|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44033927|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033928|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033929|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44033930|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
44033931|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44033932|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033933|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44033941|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033942|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033943|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033944|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
44033945|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033946|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033947|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033949|NCT00002124|Zidovudine|zidovudine|mesh-list
44033950|NCT00002124|Delavirdine|delavirdine|mesh-list
44033951|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033952|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033953|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033954|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033955|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
44033956|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033957|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44033958|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44033959|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
44033961|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44033962|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
44033963|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44033964|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44033965|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44033966|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44033967|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033968|NCT00002126|Lenograstim|lenograstim|mesh-list
44033984|NCT00002128|Adefovir|adefovir|mesh-list
44033991|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44033992|NCT00002129|Vesnarinone|vesnarinone|mesh-list
44033993|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43848027|NCT04060342|Paclitaxel|paclitaxel|mesh-list
44033994|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
44033995|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44033996|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44033997|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
44033998|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763163|NCT02428062|Dopamine|dopamine|mesh-list
44033999|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44034000|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44034001|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034002|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034003|NCT00002129|Protective Agents|protective agents|mesh-ancestor
44034004|NCT00002130|Vesnarinone|vesnarinone|mesh-list
44034005|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44034006|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
44034007|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034008|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034009|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
44034010|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034011|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44034012|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44034013|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034014|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034015|NCT00002130|Protective Agents|protective agents|mesh-ancestor
44034016|NCT00002131|Vesnarinone|vesnarinone|mesh-list
44034017|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44034018|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
44034019|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034020|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034021|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
44034022|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034023|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44034024|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44034025|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034026|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034028|NCT00002132|Itraconazole|itraconazole|mesh-list
44034029|NCT00002132|Fluconazole|fluconazole|mesh-list
44034030|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
44034031|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034032|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44034033|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034034|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034035|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034036|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44034037|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
44034038|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44034039|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034040|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034041|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44034042|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44034043|NCT00002133|Itraconazole|itraconazole|mesh-list
44034044|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
43848035|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770493|NCT02379715|Remifentanil|remifentanil|mesh-list
43770494|NCT02379715|Desflurane|desflurane|mesh-list
43770495|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43770496|NCT02379715|Narcotics|narcotics|mesh-ancestor
43770497|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770499|NCT02379715|Analgesics|analgesics|mesh-ancestor
44034045|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034046|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44034047|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034048|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034049|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034050|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44034051|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
44034052|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44034053|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034054|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034055|NCT00002134|Ganciclovir|ganciclovir|mesh-list
44034056|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44034068|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034069|NCT00002139|Azithromycin|azithromycin|mesh-list
44034070|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034071|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034072|NCT00002140|Azithromycin|azithromycin|mesh-list
44034073|NCT00002140|Clarithromycin|clarithromycin|mesh-list
44034074|NCT00002140|Ethambutol|ethambutol|mesh-list
44034075|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034076|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034077|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44034078|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034079|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034080|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034081|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034082|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034083|NCT00002141|Abacavir|abacavir|mesh-list
44034084|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034085|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034086|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034087|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034088|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
44034089|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034090|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034091|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034092|NCT00002142|Cidofovir|cidofovir|mesh-list
43763218|NCT02427295|Octreotide|octreotide|mesh-list
44034093|NCT00002142|Probenecid|probenecid|mesh-list
44034094|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
44034095|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
44034096|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44034097|NCT00002142|Renal Agents|renal agents|mesh-ancestor
44034098|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
44034099|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034100|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034110|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034111|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034112|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034113|NCT00002145|Foscarnet|foscarnet|mesh-list
44034114|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44034115|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
44034116|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034117|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034118|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034119|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034120|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034121|NCT00002146|Foscarnet|foscarnet|mesh-list
44034171|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44034172|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44034179|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
44034244|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44034245|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770540|NCT02379299|Hormones|hormones|mesh-list
44034246|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034248|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44034249|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44034250|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034251|NCT00002160|Ziconotide|ziconotide|mesh-list
44034252|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44034253|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44034254|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034255|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44034256|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034257|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44034258|NCT00002160|Protective Agents|protective agents|mesh-ancestor
44034259|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44034260|NCT00002160|Analgesics|analgesics|mesh-ancestor
44034261|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
44034262|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44034263|NCT00002161|Adefovir|adefovir|mesh-list
44034264|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44034265|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
44034266|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034267|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034268|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034269|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647119|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
43647120|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647121|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647122|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43647123|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
43647124|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
43647125|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647126|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
43647127|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647128|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647129|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43647130|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
43647131|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647132|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647133|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43647134|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647136|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43647137|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647138|NCT02344290|Pitavastatin|pitavastatin|mesh-list
44034270|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034272|NCT00002162|Zidovudine|zidovudine|mesh-list
44034273|NCT00002162|Didanosine|didanosine|mesh-list
44034274|NCT00002162|Stavudine|stavudine|mesh-list
44034275|NCT00002162|Zalcitabine|zalcitabine|mesh-list
44034276|NCT00002162|Saquinavir|saquinavir|mesh-list
44034277|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034278|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034279|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034280|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034281|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
44034282|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034283|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034284|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034285|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
44034286|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034287|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034288|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034327|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034328|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43770542|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770543|NCT02379000|Triamcinolone|triamcinolone|mesh-list
43770544|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43770545|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43770546|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44034329|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034330|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034331|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
44034332|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44034333|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
44034334|NCT00002168|Lamivudine|lamivudine|mesh-list
44034335|NCT00002168|Zidovudine|zidovudine|mesh-list
44034336|NCT00002168|Didanosine|didanosine|mesh-list
44034337|NCT00002168|Stavudine|stavudine|mesh-list
44034338|NCT00002168|Indinavir|indinavir|mesh-list
44034339|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034340|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034341|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034342|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034343|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
44034344|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034345|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034346|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034347|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
44034348|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034349|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034350|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034351|NCT00002169|Nelfinavir|nelfinavir|mesh-list
44034382|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44034383|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
44034384|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44034385|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
44034386|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034387|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034388|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44034389|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44034390|NCT00002174|Growth Substances|growth substances|mesh-ancestor
44034391|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
44034392|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034393|NCT00002176|Nelfinavir|nelfinavir|mesh-list
44034394|NCT00002176|Didanosine|didanosine|mesh-list
44034395|NCT00002176|Stavudine|stavudine|mesh-list
44034396|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
44034397|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034398|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
44034399|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034400|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034401|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034402|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034403|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034404|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034405|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034406|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034407|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
44034408|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034409|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
44034410|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034411|NCT00002177|Nelfinavir|nelfinavir|mesh-list
44034412|NCT00002177|Didanosine|didanosine|mesh-list
44034413|NCT00002177|Stavudine|stavudine|mesh-list
44034414|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
44034415|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034416|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
44034417|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647139|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43647140|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43647141|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43647142|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
44034419|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034420|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034421|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034423|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034424|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034425|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
44034426|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034427|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
44034428|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034429|NCT00002178|Ritonavir|ritonavir|mesh-list
44034430|NCT00002178|Nelfinavir|nelfinavir|mesh-list
44034431|NCT00002178|Saquinavir|saquinavir|mesh-list
43770550|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44034432|NCT00002178|Delavirdine|delavirdine|mesh-list
44034433|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034434|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034435|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034436|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034437|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034438|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034439|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034440|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
44034441|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034442|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034443|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034444|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034445|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034446|NCT00002179|Lamivudine|lamivudine|mesh-list
44034447|NCT00002179|Zidovudine|zidovudine|mesh-list
44034448|NCT00002179|Indinavir|indinavir|mesh-list
44034449|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034450|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034451|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647143|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647144|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647145|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44034452|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034453|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
44034454|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034455|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034456|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034457|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
44034458|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034459|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034460|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034462|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
44034463|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034464|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034465|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034466|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034467|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034468|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034469|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034470|NCT00002181|Cidofovir|cidofovir|mesh-list
44034471|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
44034472|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034473|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034474|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034475|NCT00002182|Megestrol|megestrol|mesh-list
44034476|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
44034477|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44034478|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44034479|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44034500|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034501|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
44034502|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034503|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034504|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034505|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034506|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034507|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034508|NCT00002184|Lamivudine|lamivudine|mesh-list
44034509|NCT00002184|Zidovudine|zidovudine|mesh-list
44034510|NCT00002184|Stavudine|stavudine|mesh-list
44034511|NCT00002184|Adefovir|adefovir|mesh-list
44034512|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44034513|NCT00002184|Nelfinavir|nelfinavir|mesh-list
44034514|NCT00002184|Saquinavir|saquinavir|mesh-list
44034565|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034566|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
44034567|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034568|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034569|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034570|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034571|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034572|NCT00002191|Albendazole|albendazole|mesh-list
44034573|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
44034574|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44034575|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034576|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
44034577|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44034578|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44034579|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
44034580|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
44034581|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
44034583|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034623|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034624|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034625|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034626|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
44034627|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034628|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034629|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034630|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034631|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44034632|NCT00002195|Lamivudine|lamivudine|mesh-list
44034633|NCT00002195|Zidovudine|zidovudine|mesh-list
44034634|NCT00002195|Amprenavir|amprenavir|mesh-list
44034635|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034636|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034637|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034638|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034639|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
44034640|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034641|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034642|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034643|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
44034644|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034645|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034646|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034650|NCT00002197|Abacavir|abacavir|mesh-list
44034674|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034675|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034676|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034677|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
44034678|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034679|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034680|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034681|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
44034682|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034683|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034684|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034685|NCT00002200|Abacavir|abacavir|mesh-list
44034686|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034687|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034688|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034689|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034690|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
44034691|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034692|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034693|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034694|NCT00002201|Ritonavir|ritonavir|mesh-list
44034695|NCT00002201|Nelfinavir|nelfinavir|mesh-list
44034696|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034697|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034698|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034699|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034700|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034702|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034703|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
44034704|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034705|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034720|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034721|NCT00002203|Lamivudine|lamivudine|mesh-list
44034722|NCT00002203|Zidovudine|zidovudine|mesh-list
44034723|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44034724|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034725|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034726|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034727|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034728|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
44034729|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034730|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034731|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034732|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
44034733|NCT00002205|Abacavir|abacavir|mesh-list
44149331|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44149332|NCT00207428|Analgesics|analgesics|mesh-ancestor
44149333|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
44149334|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149335|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44149336|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149337|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149338|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44149339|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44149340|NCT00207532|Folic Acid|folic acid|mesh-list
44149341|NCT00207532|Hematinics|hematinics|mesh-ancestor
44149342|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
44149343|NCT00207532|Vitamins|vitamins|mesh-ancestor
44149344|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
44149345|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149346|NCT00207558|Folic Acid|folic acid|mesh-list
44149347|NCT00207558|Hematinics|hematinics|mesh-ancestor
44149348|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
44149394|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44149395|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149396|NCT00207792|Lenograstim|lenograstim|mesh-list
44149397|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44149398|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
44149399|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149400|NCT00207831|Tegafur|tegafur|mesh-list
44149401|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44149402|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
44149403|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034782|NCT00002211|Nelfinavir|nelfinavir|mesh-list
44034783|NCT00002211|Didanosine|didanosine|mesh-list
44034784|NCT00002211|Stavudine|stavudine|mesh-list
44034785|NCT00002211|Delavirdine|delavirdine|mesh-list
44034786|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034787|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034788|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034789|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034790|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034791|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034792|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034793|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
44034794|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034795|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
43770665|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43770666|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44034796|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034797|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034798|NCT00002212|Bexarotene|bexarotene|mesh-list
44034799|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44034800|NCT00002213|Efavirenz|efavirenz|mesh-list
44034801|NCT00002213|Abacavir|abacavir|mesh-list
44034802|NCT00002213|Amprenavir|amprenavir|mesh-list
44034803|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034804|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034805|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034806|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034807|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
44034808|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034811|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44034812|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44034813|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034814|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034816|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034817|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034880|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44034881|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
44034882|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44034883|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034884|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034885|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034886|NCT00002219|Nelfinavir|nelfinavir|mesh-list
44034887|NCT00002219|Adefovir|adefovir|mesh-list
44034888|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44034889|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034890|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034891|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034892|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034893|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034894|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034895|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034896|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
44034897|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034898|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034899|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034900|NCT00002220|Efavirenz|efavirenz|mesh-list
44034901|NCT00002220|Adefovir|adefovir|mesh-list
44034902|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44034903|NCT00002220|Indinavir|indinavir|mesh-list
44034904|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44034905|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44034906|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034907|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44034908|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
44034909|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034910|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44034911|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034912|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44034913|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44034920|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034922|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
44034923|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034924|NCT00002223|Ritonavir|ritonavir|mesh-list
43770674|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770675|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
43770676|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770677|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
43838356|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838357|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838358|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44034925|NCT00002223|Indinavir|indinavir|mesh-list
44034926|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44034927|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44034928|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
44034929|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034930|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764012|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44034931|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44034932|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44034933|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
44034934|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44034935|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44034936|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034938|NCT00002225|Didanosine|didanosine|mesh-list
44034939|NCT00002225|Stavudine|stavudine|mesh-list
44034976|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44034977|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44034978|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44034979|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44034980|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44034981|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44034982|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
44034983|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
44035119|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44035120|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44035121|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035122|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035123|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035124|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035125|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035126|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
44035127|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035128|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44035129|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035130|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035131|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035132|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035133|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035134|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44035135|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44035136|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44035137|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44035181|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035182|NCT00002247|Ganciclovir|ganciclovir|mesh-list
44035183|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035184|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
44035185|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035186|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035187|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035188|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035189|NCT00002249|Levofloxacin|levofloxacin|mesh-list
44035190|NCT00002249|Ofloxacin|ofloxacin|mesh-list
44035191|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44035192|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035193|NCT00002249|Renal Agents|renal agents|mesh-ancestor
44035194|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035195|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44035196|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44035197|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035198|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035199|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838361|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43838362|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838363|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
43838364|NCT04844814|Hormones|hormones|mesh-ancestor
44035200|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44035201|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035202|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44035203|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
44035204|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035205|NCT00002251|Ganciclovir|ganciclovir|mesh-list
44035206|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44035207|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
44035208|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035209|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035210|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035211|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035212|NCT00002252|Octreotide|octreotide|mesh-list
44035213|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44035214|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44035215|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035216|NCT00002253|Octreotide|octreotide|mesh-list
44035217|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44035218|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44035219|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035220|NCT00002254|Alovudine|alovudine|mesh-list
44035221|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
44035222|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035223|NCT00002255|Zidovudine|zidovudine|mesh-list
44035224|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
44035225|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
44035227|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035261|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035262|NCT00002260|Alovudine|alovudine|mesh-list
44035263|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
44035264|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035265|NCT00002261|Vaccines|vaccines|mesh-list
44035266|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
44035267|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035268|NCT00002263|Zidovudine|zidovudine|mesh-list
44035269|NCT00002263|Sargramostim|sargramostim|mesh-list
44035270|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
44035271|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035272|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035273|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035274|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035275|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
44035276|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035277|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035278|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035279|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
44035280|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035281|NCT00002265|Zalcitabine|zalcitabine|mesh-list
44035282|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
44035283|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035284|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035286|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035312|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035313|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035314|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035315|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035316|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
44035317|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035318|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035319|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035379|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035380|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035381|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
43764354|NCT02420652|Aspirin|aspirin|mesh-list
44035382|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035383|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035385|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035386|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035387|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035388|NCT00002277|Fluconazole|fluconazole|mesh-list
44035389|NCT00002277|Amphotericin B|amphotericin b|mesh-list
44035390|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44035391|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
44035392|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035393|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035439|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
44035440|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035441|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035442|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035443|NCT00002281|Hematinics|hematinics|mesh-ancestor
44035444|NCT00002282|Fluconazole|fluconazole|mesh-list
44035445|NCT00002282|Clotrimazole|clotrimazole|mesh-list
44035446|NCT00002282|Miconazole|miconazole|mesh-list
44035447|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
44035448|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035449|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035450|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035451|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035452|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035500|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035501|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035502|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035503|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035504|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
44035505|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035506|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035507|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035509|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
44035510|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035511|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035512|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035513|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035514|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
44035515|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035516|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035517|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035518|NCT00002288|Zidovudine|zidovudine|mesh-list
44035557|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035558|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
44035559|NCT00002293|Ionophores|ionophores|mesh-ancestor
44035560|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44035561|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035562|NCT00002294|Fluconazole|fluconazole|mesh-list
44035563|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
44035564|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035565|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44035566|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44035692|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035693|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035694|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
44035695|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035696|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035697|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035698|NCT00002308|Stavudine|stavudine|mesh-list
44035699|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
44035700|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035701|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035702|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035703|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035704|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
44035705|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035706|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035743|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
44035744|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035745|NCT00002316|Amphotericin B|amphotericin b|mesh-list
44035746|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44035747|NCT00002316|Amebicides|amebicides|mesh-ancestor
44035748|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44035749|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44035750|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035751|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44035752|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
44035753|NCT00002317|Leucovorin|leucovorin|mesh-list
44035754|NCT00002317|Trimetrexate|trimetrexate|mesh-list
44035755|NCT00002317|Calcium|calcium|mesh-list
44035756|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
44035757|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44035758|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035759|NCT00002317|Antidotes|antidotes|mesh-ancestor
44035760|NCT00002317|Protective Agents|protective agents|mesh-ancestor
44035761|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
44035762|NCT00002317|Vitamins|vitamins|mesh-ancestor
44035763|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
44035764|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
44035765|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035766|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44035767|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
44035768|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035769|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035770|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44035771|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035772|NCT00002318|Doxorubicin|doxorubicin|mesh-list
44035773|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44035774|NCT00002318|Bleomycin|bleomycin|mesh-list
44035775|NCT00002318|Vincristine|vincristine|mesh-list
44035776|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44035777|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647146|NCT02327403|Abatacept|abatacept|mesh-list
44035787|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44035788|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44035789|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44035790|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44035791|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44035792|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035793|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035794|NCT00002320|Lamivudine|lamivudine|mesh-list
44035795|NCT00002320|Zidovudine|zidovudine|mesh-list
44035853|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035854|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035855|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44035856|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
44035857|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035858|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035859|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43770684|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44035860|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035861|NCT00002326|Zidovudine|zidovudine|mesh-list
44035862|NCT00002326|Adefovir|adefovir|mesh-list
44035863|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
43770686|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
44035864|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035865|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44035866|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44035867|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035868|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
44035869|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035870|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035871|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035908|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
44035909|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44035910|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44035911|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44035912|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44035975|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44035976|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44035977|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44035978|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44035979|NCT00002340|Atovaquone|atovaquone|mesh-list
44035980|NCT00002340|Pentamidine|pentamidine|mesh-list
44035981|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44035982|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
44036040|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036042|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036043|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036044|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036045|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036046|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036047|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036048|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036049|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036050|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036051|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036053|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036054|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036055|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036057|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
44036058|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036059|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036060|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036061|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036062|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
44036063|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036064|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036065|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036066|NCT00002351|Indinavir|indinavir|mesh-list
44036091|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
44036092|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036093|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036094|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036095|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036096|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036097|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036098|NCT00002355|Fomivirsen|fomivirsen|mesh-list
44036099|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
44036100|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036101|NCT00002356|Fomivirsen|fomivirsen|mesh-list
44036102|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
44036103|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036104|NCT00002357|Zidovudine|zidovudine|mesh-list
44036105|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
44036106|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036107|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036108|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036109|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036110|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
44036111|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036112|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036113|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036114|NCT00002358|Sorivudine|sorivudine|mesh-list
44036115|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
44036116|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036117|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036118|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036119|NCT00002360|Didanosine|didanosine|mesh-list
44036120|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
44036121|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036122|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036123|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036124|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036125|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
44036126|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036127|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43647147|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44036209|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036210|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036212|NCT00002369|Zidovudine|zidovudine|mesh-list
44036213|NCT00002369|Stavudine|stavudine|mesh-list
44036214|NCT00002369|Indinavir|indinavir|mesh-list
44036215|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036216|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036217|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036218|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036219|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
44036220|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036221|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036222|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036223|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
44036224|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036225|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036226|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036227|NCT00002370|Itraconazole|itraconazole|mesh-list
44036228|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
44036229|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036230|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44036231|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036232|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036233|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036234|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44036235|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
44036236|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44036237|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036238|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036239|NCT00002372|Nelfinavir|nelfinavir|mesh-list
44036240|NCT00002372|Indinavir|indinavir|mesh-list
44036241|NCT00002372|Saquinavir|saquinavir|mesh-list
44036242|NCT00002372|Amprenavir|amprenavir|mesh-list
43576283|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838404|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
43770753|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
43770791|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
44036243|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036244|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036245|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036246|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036247|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036248|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036249|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036250|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
44036251|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036252|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036253|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036254|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44036255|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036299|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036300|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036301|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036302|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
44036303|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036304|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036305|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036306|NCT00002377|Valganciclovir|valganciclovir|mesh-list
44036307|NCT00002377|Ganciclovir|ganciclovir|mesh-list
44036308|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44036309|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
44036310|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036311|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036312|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036313|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036314|NCT00002378|Ritonavir|ritonavir|mesh-list
44036315|NCT00002378|Nelfinavir|nelfinavir|mesh-list
44036316|NCT00002378|Saquinavir|saquinavir|mesh-list
44036317|NCT00002378|Lamivudine|lamivudine|mesh-list
44036318|NCT00002378|Zidovudine|zidovudine|mesh-list
44036319|NCT00002378|Stavudine|stavudine|mesh-list
44036320|NCT00002378|Delavirdine|delavirdine|mesh-list
44036321|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036322|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036323|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036354|NCT00002380|Saquinavir|saquinavir|mesh-list
44036355|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036356|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036357|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036358|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036359|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036361|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036362|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
44036363|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036364|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036365|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036366|NCT00002381|Nevirapine|nevirapine|mesh-list
44036367|NCT00002381|Stavudine|stavudine|mesh-list
44036368|NCT00002381|Nelfinavir|nelfinavir|mesh-list
44036369|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036370|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036371|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036372|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036373|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
44036374|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036375|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036376|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036408|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
44036409|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036410|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036411|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036412|NCT00002386|Lamivudine|lamivudine|mesh-list
44036413|NCT00002386|Zidovudine|zidovudine|mesh-list
44036414|NCT00002386|Didanosine|didanosine|mesh-list
44036415|NCT00002386|Stavudine|stavudine|mesh-list
44036416|NCT00002386|Zalcitabine|zalcitabine|mesh-list
44036417|NCT00002386|Indinavir|indinavir|mesh-list
44036418|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036419|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036420|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036471|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036472|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036473|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036474|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036475|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
44036476|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036477|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036478|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036480|NCT00002391|Zidovudine|zidovudine|mesh-list
44036481|NCT00002391|Abacavir|abacavir|mesh-list
44036482|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036483|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036484|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036485|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036486|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
44036487|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036488|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036489|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036602|NCT00002401|Zidovudine|zidovudine|mesh-list
44036603|NCT00002401|Delavirdine|delavirdine|mesh-list
44036604|NCT00002401|Indinavir|indinavir|mesh-list
44036605|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036606|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036607|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036608|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036609|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
44036610|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036611|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036612|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036613|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
44036614|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036615|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036616|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036617|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44036618|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44036619|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
44036620|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44036621|NCT00002402|Antacids|antacids|mesh-ancestor
44036622|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036623|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44036624|NCT00002404|Valacyclovir|valacyclovir|mesh-list
44036625|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
44036656|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036657|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036658|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036660|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036661|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036662|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036663|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036664|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036665|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
44036666|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036667|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036668|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036670|NCT00002409|Zidovudine|zidovudine|mesh-list
44036671|NCT00002409|Abacavir|abacavir|mesh-list
44036673|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036716|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036717|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
44036718|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036719|NCT00002415|Tenofovir|tenofovir|mesh-list
44036720|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
44036721|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036722|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036723|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43770820|NCT02376595|Bromides|bromides|mesh-list
44157901|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157902|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44157903|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157904|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
44157905|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157906|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44157907|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44157908|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44157909|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
44157910|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157911|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157912|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
44157913|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
44157914|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157915|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157916|NCT00235794|Sirolimus|sirolimus|mesh-list
44157917|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157918|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036739|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44036740|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
44036741|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44036742|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036743|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036744|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036745|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036746|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036747|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036748|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036749|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036750|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
44036751|NCT00002418|Nevirapine|nevirapine|mesh-list
44036763|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036764|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44036765|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44036766|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44036767|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
44036768|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
44036769|NCT00002419|Efavirenz|efavirenz|mesh-list
44036770|NCT00002419|Abacavir|abacavir|mesh-list
44036833|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036834|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036835|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036836|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
44036837|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036838|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036839|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036840|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
44036841|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036842|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036843|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036844|NCT00002425|Saquinavir|saquinavir|mesh-list
44036845|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036846|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036847|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036848|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036849|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036850|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036851|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036852|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
44036853|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036854|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44036855|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44036856|NCT00002426|Adefovir|adefovir|mesh-list
44036857|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44036858|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
44036884|NCT00002430|Indinavir|indinavir|mesh-list
44036885|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036886|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036887|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036888|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036889|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
44036890|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036891|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036892|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036893|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44036894|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44036895|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
44036896|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
44036897|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
44036898|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44036899|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44036903|NCT00002432|Foscarnet|foscarnet|mesh-list
44036944|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036945|NCT00002436|Lamivudine|lamivudine|mesh-list
44036946|NCT00002436|Zidovudine|zidovudine|mesh-list
44036947|NCT00002436|Zalcitabine|zalcitabine|mesh-list
44036948|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44036949|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44036950|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44036951|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44036952|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
44036953|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44036954|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44036955|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44036956|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
44036957|NCT00002437|Cidofovir|cidofovir|mesh-list
44036958|NCT00002437|Probenecid|probenecid|mesh-list
44037005|NCT00002442|Stavudine|stavudine|mesh-list
44037006|NCT00002442|Nelfinavir|nelfinavir|mesh-list
44037007|NCT00002442|Indinavir|indinavir|mesh-list
44037008|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037009|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037010|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037011|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037012|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
44037013|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037014|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037015|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037016|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037017|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037018|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037019|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
44037020|NCT00002443|Zidovudine|zidovudine|mesh-list
44037021|NCT00002443|Indinavir|indinavir|mesh-list
44037022|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
44037023|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037024|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44037025|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037026|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037027|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
44037028|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037029|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037030|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037031|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037032|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44037033|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037034|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
44037035|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44037036|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037037|NCT00002446|Fluconazole|fluconazole|mesh-list
44037038|NCT00002446|Posaconazole|posaconazole|mesh-list
44037039|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
44037040|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037045|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44037046|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
44037047|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037048|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037049|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44037050|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44037051|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44037109|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44037110|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44037112|NCT00002451|Indinavir|indinavir|mesh-list
44037113|NCT00002451|Lamivudine|lamivudine|mesh-list
44037114|NCT00002451|Stavudine|stavudine|mesh-list
44037115|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44037117|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
44037178|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037179|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037180|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037181|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44037182|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44037183|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44037184|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
44037185|NCT00002461|Carmustine|carmustine|mesh-list
44037186|NCT00002461|Cisplatin|cisplatin|mesh-list
44037187|NCT00002461|Etoposide|etoposide|mesh-list
44037202|NCT00002462|Cobalt|cobalt|mesh-list
44037245|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037246|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037247|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44037317|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037318|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
44037319|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037321|NCT00002471|Cytarabine|cytarabine|mesh-list
44037322|NCT00002471|Dexamethasone|dexamethasone|mesh-list
44037323|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
44037324|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
44037325|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44037326|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44037327|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44037385|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037386|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
44037462|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
44037463|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037464|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037465|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037466|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
43770936|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770938|NCT02375828|Glyburide|glyburide|mesh-list
44037467|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037468|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037469|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037529|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037530|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44037531|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
44037532|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037533|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037534|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
44037535|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44037536|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44037537|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44037538|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
44037594|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
44037596|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
44037597|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44037598|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44037599|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44037600|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44037601|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44037602|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44037603|NCT00002490|Mitomycins|mitomycins|mesh-list
44037604|NCT00002490|Mitomycin|mitomycin|mesh-list
44037605|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
44037606|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037607|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037608|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
44037609|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037610|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44037615|NCT00002492|Cisplatin|cisplatin|mesh-list
44037657|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037658|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44037659|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44037661|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
44037662|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44037663|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44037664|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
44037666|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44037667|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44037668|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44037669|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44037723|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037724|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44037725|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44037726|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
44037727|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44037728|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44037868|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037946|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
44037947|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44037948|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44037949|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44037950|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038018|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
44038095|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44038096|NCT00002524|Prednisolone|prednisolone|mesh-list
44038097|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
44038098|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
44038099|NCT00002524|Ifosfamide|ifosfamide|mesh-list
44038100|NCT00002524|Doxorubicin|doxorubicin|mesh-list
44038101|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038102|NCT00002524|Fluorouracil|fluorouracil|mesh-list
44038103|NCT00002524|Methotrexate|methotrexate|mesh-list
44038104|NCT00002524|Etoposide|etoposide|mesh-list
44038105|NCT00002524|Vincristine|vincristine|mesh-list
44038106|NCT00002524|Bleomycin|bleomycin|mesh-list
44038107|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44038108|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
44038109|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
44038110|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038111|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
44038112|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038113|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038114|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038115|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
44038117|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038154|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44038155|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44038156|NCT00002524|Renal Agents|renal agents|mesh-ancestor
44038157|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
44038158|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44038159|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44038160|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44038161|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44038162|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44038163|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44038164|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
44038165|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44038166|NCT00002526|Doxorubicin|doxorubicin|mesh-list
44038167|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44038168|NCT00002526|Ifosfamide|ifosfamide|mesh-list
44038169|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038170|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038171|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038172|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038173|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038174|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038204|NCT00002529|Toremifene|toremifene|mesh-list
44038205|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
44038206|NCT00002529|Doxorubicin|doxorubicin|mesh-list
44038279|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
44038280|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44038281|NCT00002531|Antidotes|antidotes|mesh-ancestor
44038282|NCT00002531|Protective Agents|protective agents|mesh-ancestor
44038283|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
44038284|NCT00002531|Vitamins|vitamins|mesh-ancestor
44038285|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
44038286|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038287|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038288|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038289|NCT00002531|Analgesics|analgesics|mesh-ancestor
44038290|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
44038291|NCT00002532|Leucovorin|leucovorin|mesh-list
44038347|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44149463|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
44149464|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149465|NCT00208130|Topiramate|topiramate|mesh-list
44038411|NCT00002536|Cisplatin|cisplatin|mesh-list
44038449|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038450|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038453|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767114|NCT02403713|Xhance|xhance|mesh-list
44038678|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
44038680|NCT00002554|Methotrexate|methotrexate|mesh-list
44038681|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44038682|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
44038683|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44038684|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44038685|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44038686|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
44038746|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44038822|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
44038823|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038824|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038825|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44038826|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44038827|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44038828|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44038829|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44038830|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44038831|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
44038833|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44038834|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44038835|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038836|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44038882|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038883|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44038884|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
44038885|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
44038886|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
44038888|NCT00002569|Vincristine|vincristine|mesh-list
44038954|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44038955|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44038956|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44038957|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
44038962|NCT00002571|Vitamins|vitamins|mesh-ancestor
44039024|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039025|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039026|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44039028|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
44039029|NCT00002578|Leucovorin|leucovorin|mesh-list
44039030|NCT00002578|Cytarabine|cytarabine|mesh-list
44039092|NCT00002580|Goserelin|goserelin|mesh-list
44039093|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039094|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
44039095|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039162|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
44039163|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039164|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039165|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039187|NCT00002583|Cisplatin|cisplatin|mesh-list
44039233|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
44039234|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039235|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44039236|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44039237|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
44039238|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44039239|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
44039240|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039241|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039242|NCT00002590|Leucovorin|leucovorin|mesh-list
44039243|NCT00002590|Cytarabine|cytarabine|mesh-list
44039244|NCT00002590|Prednisone|prednisone|mesh-list
44039245|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
44039246|NCT00002590|Doxorubicin|doxorubicin|mesh-list
44039247|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44039248|NCT00002590|Methotrexate|methotrexate|mesh-list
44039249|NCT00002590|Etoposide|etoposide|mesh-list
44039250|NCT00002590|Vincristine|vincristine|mesh-list
44039251|NCT00002590|Daunorubicin|daunorubicin|mesh-list
44039295|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039369|NCT00002598|Interferons|interferons|mesh-list
44039370|NCT00002598|Cytarabine|cytarabine|mesh-list
44039371|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
44039372|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
44039373|NCT00002598|Methotrexate|methotrexate|mesh-list
44039374|NCT00002598|Etoposide|etoposide|mesh-list
44039375|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
44039376|NCT00002598|Sargramostim|sargramostim|mesh-list
44039443|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44039444|NCT00002599|Protective Agents|protective agents|mesh-ancestor
44039445|NCT00002599|Trace Elements|trace elements|mesh-ancestor
44039446|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
44039447|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
44039448|NCT00002600|Carboplatin|carboplatin|mesh-list
44039449|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44039450|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
44039465|NCT00002608|Tamoxifen|tamoxifen|mesh-list
44039511|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039512|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039513|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
44039514|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039515|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039516|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039517|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44039518|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44039519|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44039576|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
44039577|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039578|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44039579|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44039580|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
44039581|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44039582|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039583|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44039584|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44039588|NCT00002618|Leucovorin|leucovorin|mesh-list
44039643|NCT00002620|Cobalt|cobalt|mesh-list
44039644|NCT00002620|Carmustine|carmustine|mesh-list
44039645|NCT00002620|Mitolactol|mitolactol|mesh-list
44039800|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
44039878|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44039879|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44039880|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44039881|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44039882|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44039948|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039949|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44040027|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040028|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
44040029|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
44040030|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040031|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44040032|NCT00002658|Analgesics|analgesics|mesh-ancestor
44040033|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
44040034|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44040035|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
44040036|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040058|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44040059|NCT00002665|Methotrexate|methotrexate|mesh-list
44040060|NCT00002665|Etoposide|etoposide|mesh-list
44040135|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040136|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040137|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040138|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040139|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040140|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
44040141|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
44040142|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040143|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040202|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040203|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040204|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040205|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040206|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040207|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
44040208|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040269|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
44040270|NCT00002680|Melphalan|melphalan|mesh-list
44040271|NCT00002680|Thiotepa|thiotepa|mesh-list
44040272|NCT00002680|Megestrol|megestrol|mesh-list
44040273|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
44040274|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44040275|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
44040276|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040277|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44040299|NCT00002681|Aldesleukin|aldesleukin|mesh-list
44040336|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
44040337|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
44040339|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040412|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44040413|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44040414|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040416|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040417|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040418|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
44040419|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040420|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040421|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040422|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44040476|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44040477|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44040478|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44040479|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
44040480|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040481|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040482|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040483|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44040484|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
44040485|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44040487|NCT00002697|Carboplatin|carboplatin|mesh-list
44040542|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44040543|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
44040621|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
44040696|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44040774|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44040775|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
44040776|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040777|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040844|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44040845|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
44040846|NCT00002720|Tamoxifen|tamoxifen|mesh-list
44040847|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44040848|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
44040917|NCT00002733|Cimetidine|cimetidine|mesh-list
44040918|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040919|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
44040920|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040921|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
44040922|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44040923|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44040924|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44040925|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44040926|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44040929|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
44040986|NCT00002738|Vitamins|vitamins|mesh-ancestor
44040987|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
44040988|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
44040989|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44040990|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44040991|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
44040992|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44040993|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040994|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041058|NCT00002744|Pegaspargase|pegaspargase|mesh-list
44041059|NCT00002744|Thioguanine|thioguanine|mesh-list
44041060|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041104|NCT00002747|Cobalt|cobalt|mesh-list
44041130|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041131|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041132|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041133|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041134|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
44041135|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041199|NCT00002756|Etoposide|etoposide|mesh-list
44041200|NCT00002756|Vincristine|vincristine|mesh-list
44041201|NCT00002756|Daunorubicin|daunorubicin|mesh-list
44041202|NCT00002756|Asparaginase|asparaginase|mesh-list
44041273|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041274|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041275|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041276|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041278|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041279|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041280|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041281|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041282|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
44041283|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041284|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
44041285|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
44041286|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
44041333|NCT00002761|Interferons|interferons|mesh-list
44041334|NCT00002761|Cytarabine|cytarabine|mesh-list
44041335|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
44041336|NCT00002761|Cyclosporine|cyclosporine|mesh-list
44041337|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
44041338|NCT00002761|Busulfan|busulfan|mesh-list
44041339|NCT00002761|Idarubicin|idarubicin|mesh-list
44041340|NCT00002761|Cyclosporins|cyclosporins|mesh-list
44041341|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041342|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
44041343|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041361|NCT00002763|Interferons|interferons|mesh-list
44041402|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041403|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
44041404|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041405|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44041406|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041407|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
44041408|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44041409|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44041410|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44041411|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44041412|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041413|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
44041414|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041418|NCT00002771|Interferons|interferons|mesh-list
44041464|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44041465|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44041466|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44041467|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44041468|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44041469|NCT00002773|Interferons|interferons|mesh-list
44041470|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
44041471|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
44041529|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44041530|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
44041531|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041603|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44041604|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44041605|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44041606|NCT00002785|Leucovorin|leucovorin|mesh-list
44041608|NCT00002785|Cytarabine|cytarabine|mesh-list
44041677|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44041678|NCT00002787|Aldesleukin|aldesleukin|mesh-list
44041679|NCT00002787|Interleukin-2|interleukin-2|mesh-list
44041680|NCT00002787|Vaccines|vaccines|mesh-list
44041681|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
44041682|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44041752|NCT00002790|Methotrexate|methotrexate|mesh-list
44041753|NCT00002790|Cyclosporins|cyclosporins|mesh-list
44041754|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44041755|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041756|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44041757|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041758|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44041759|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
44041796|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44041797|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
44041798|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44041799|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44041800|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44041802|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
44041865|NCT00002798|Aldesleukin|aldesleukin|mesh-list
44041866|NCT00002798|Dexamethasone|dexamethasone|mesh-list
44041867|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
44041868|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44041869|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44041870|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44041871|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
44041872|NCT00002798|Busulfan|busulfan|mesh-list
44041873|NCT00002798|Methotrexate|methotrexate|mesh-list
44041874|NCT00002798|Fludarabine|fludarabine|mesh-list
44041875|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
44041876|NCT00002798|Etoposide|etoposide|mesh-list
44041877|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
44041878|NCT00002798|Daunorubicin|daunorubicin|mesh-list
44041879|NCT00002798|Interleukin-2|interleukin-2|mesh-list
44041880|NCT00002798|Asparaginase|asparaginase|mesh-list
44041881|NCT00002798|Idarubicin|idarubicin|mesh-list
44041928|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44041929|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44041930|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042002|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042003|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042004|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042005|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042006|NCT00002804|Cobalt|cobalt|mesh-list
44042007|NCT00002804|Doxorubicin|doxorubicin|mesh-list
44042008|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042009|NCT00002804|Vincristine|vincristine|mesh-list
44042073|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042074|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042075|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042076|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042077|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
44042078|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
44042079|NCT00002809|Methotrexate|methotrexate|mesh-list
44042144|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
44042145|NCT00002812|Hormones|hormones|mesh-ancestor
44042146|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042218|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042219|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
44042220|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042294|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042368|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44042369|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042370|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042372|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042373|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44042374|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042436|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44042437|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44042438|NCT00002831|Protective Agents|protective agents|mesh-ancestor
44042439|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44042513|NCT00002835|Etoposide|etoposide|mesh-list
44042514|NCT00002835|Vincristine|vincristine|mesh-list
44042515|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
44042516|NCT00002835|Idarubicin|idarubicin|mesh-list
44042517|NCT00002835|Bleomycin|bleomycin|mesh-list
44042587|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44042589|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
44042590|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
44042591|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
44042592|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042593|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042594|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
44042595|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042596|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042597|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042598|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
44042599|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042600|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042605|NCT00002838|Fludarabine|fludarabine|mesh-list
44042645|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042647|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44042649|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042650|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44042651|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44042652|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
44042653|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44042716|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042788|NCT00002865|Leucovorin|leucovorin|mesh-list
44042789|NCT00002865|Cobalt|cobalt|mesh-list
44042790|NCT00002865|Cytarabine|cytarabine|mesh-list
44042791|NCT00002865|Dexamethasone|dexamethasone|mesh-list
44042792|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
44042793|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44042794|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44042795|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44042797|NCT00002865|Ifosfamide|ifosfamide|mesh-list
44042798|NCT00002865|Doxorubicin|doxorubicin|mesh-list
44042799|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44042800|NCT00002865|Methotrexate|methotrexate|mesh-list
44042801|NCT00002865|Etoposide|etoposide|mesh-list
44042802|NCT00002865|Vincristine|vincristine|mesh-list
44042803|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
44042854|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44042855|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44042856|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44042857|NCT00002868|Interferons|interferons|mesh-list
44042858|NCT00002868|Cytarabine|cytarabine|mesh-list
44042859|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
44042860|NCT00002868|Etoposide|etoposide|mesh-list
44042861|NCT00002868|Idarubicin|idarubicin|mesh-list
44042925|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44042926|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44042927|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
44042928|NCT00002875|Lomustine|lomustine|mesh-list
44042929|NCT00002875|Cisplatin|cisplatin|mesh-list
44042930|NCT00002875|Vincristine|vincristine|mesh-list
44042931|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44042932|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
44042933|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44042934|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44042935|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44042936|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
44042944|NCT00002876|Cisplatin|cisplatin|mesh-list
44042989|NCT00002881|Suramin|suramin|mesh-list
44042990|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
44043067|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043068|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043069|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043070|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043071|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043072|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
44043073|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44043074|NCT00002888|Paclitaxel|paclitaxel|mesh-list
44043075|NCT00002888|Cisplatin|cisplatin|mesh-list
44043076|NCT00002888|Fluorouracil|fluorouracil|mesh-list
44043077|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043078|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043133|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043135|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043136|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043137|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043138|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043204|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043205|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043206|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043207|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043208|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043274|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043275|NCT00002912|Etoposide|etoposide|mesh-list
44043276|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
44043277|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44043278|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043279|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043280|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043281|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44149532|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149533|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
44149534|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149535|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149536|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
44149537|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44149538|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44149539|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149540|NCT00208208|Ziprasidone|ziprasidone|mesh-list
44149541|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44149542|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
44149546|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44149596|NCT00208299|Analgesics|analgesics|mesh-ancestor
44149597|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
43771168|NCT02374567|Clozapine|clozapine|mesh-list
43771169|NCT02374567|Amisulpride|amisulpride|mesh-list
44149598|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149599|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149600|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44149601|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
44043403|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043404|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44043405|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043406|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043407|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043408|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043409|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
44043470|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043473|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
44043545|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44043546|NCT00002946|Penclomedine|penclomedine|mesh-list
44043547|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043548|NCT00002948|Topotecan|topotecan|mesh-list
44043549|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44043550|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44043551|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043553|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043614|NCT00002955|Fluorouracil|fluorouracil|mesh-list
44043615|NCT00002955|Calcium|calcium|mesh-list
44043616|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
44043617|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44043619|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
44043687|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043688|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
44043689|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043690|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44043708|NCT00002968|Edrecolomab|edrecolomab|mesh-list
44043755|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44043756|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
44043757|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043758|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043759|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44043760|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043761|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
44043762|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043821|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043822|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
44043823|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
44043824|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
44043825|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043826|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
44043827|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44043829|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
44043890|NCT00002989|Idarubicin|idarubicin|mesh-list
44043891|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043892|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
44043893|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44043904|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
44043961|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
44043962|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44043963|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
44043964|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043965|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44043966|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44043967|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
44043968|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044031|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44044032|NCT00003004|Paclitaxel|paclitaxel|mesh-list
44044033|NCT00003004|Cisplatin|cisplatin|mesh-list
44044034|NCT00003004|Alvocidib|alvocidib|mesh-list
44044035|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044036|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044037|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044038|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044101|NCT00003009|Aldesleukin|aldesleukin|mesh-list
44044102|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044103|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044104|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044105|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
44044107|NCT00003010|Marimastat|marimastat|mesh-list
44044172|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044173|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044174|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43771313|NCT02374008|Ropivacaine|ropivacaine|mesh-list
44044176|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44044177|NCT00003014|Carboplatin|carboplatin|mesh-list
44044178|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044179|NCT00003015|Carboplatin|carboplatin|mesh-list
44044180|NCT00003015|Vincristine|vincristine|mesh-list
44044181|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044182|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044183|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044184|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044187|NCT00003016|Tamoxifen|tamoxifen|mesh-list
44044233|NCT00003019|Methotrexate|methotrexate|mesh-list
44044234|NCT00003019|Vinblastine|vinblastine|mesh-list
44044235|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44044306|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044307|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044308|NCT00003029|Cisplatin|cisplatin|mesh-list
44044309|NCT00003029|Fluorouracil|fluorouracil|mesh-list
44044310|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044311|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
44044312|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044313|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44044314|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044315|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
44044369|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044370|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044371|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044372|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044373|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044374|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44044375|NCT00003035|Tamoxifen|tamoxifen|mesh-list
44149604|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
44149605|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149606|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044475|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44044476|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044477|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044478|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044479|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044480|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044481|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44044482|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
44044499|NCT00003052|Doxorubicin|doxorubicin|mesh-list
44044538|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
44044614|NCT00003063|Leucovorin|leucovorin|mesh-list
44044615|NCT00003063|Interferons|interferons|mesh-list
44044616|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
44044617|NCT00003063|Levamisole|levamisole|mesh-list
44044618|NCT00003063|Fluorouracil|fluorouracil|mesh-list
44044619|NCT00003063|Calcium|calcium|mesh-list
44044620|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
44044621|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44044622|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044623|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
44044683|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44044684|NCT00003067|Aldesleukin|aldesleukin|mesh-list
44044685|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44044686|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44044687|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44044688|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
44044689|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44044753|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044754|NCT00003078|Cisplatin|cisplatin|mesh-list
44044755|NCT00003078|Fluorouracil|fluorouracil|mesh-list
44044827|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
44044828|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
44044829|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
44044830|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44044831|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044832|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44044833|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44044834|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44044894|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
44044895|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44044896|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44044897|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44044898|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
44044899|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44044900|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44044965|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43771977|NCT02369133|Analgesics|analgesics|mesh-ancestor
44044966|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
44044967|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44044968|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045036|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045037|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045038|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
44045039|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045111|NCT00003116|Cyclosporins|cyclosporins|mesh-list
44045112|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045113|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
44045114|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045115|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44045181|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045182|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
44045183|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
44045184|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44045186|NCT00003125|Vaccines|vaccines|mesh-list
44045187|NCT00003125|Sargramostim|sargramostim|mesh-list
44045254|NCT00003133|Doxorubicin|doxorubicin|mesh-list
44045255|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045325|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44045326|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44045327|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045328|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045397|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44045398|NCT00003146|Melphalan|melphalan|mesh-list
44045399|NCT00003146|Busulfan|busulfan|mesh-list
44045400|NCT00003146|Thiotepa|thiotepa|mesh-list
44045471|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44045472|NCT00003151|Antacids|antacids|mesh-ancestor
44045473|NCT00003152|Interferons|interferons|mesh-list
44045475|NCT00003152|Prednisone|prednisone|mesh-list
44045540|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045541|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045542|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045543|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
44045544|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
44045545|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44045546|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045547|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045548|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
44045549|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045550|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045551|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
44045552|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045600|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44045601|NCT00003172|Fluorouracil|fluorouracil|mesh-list
44045602|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
44045603|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045604|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045605|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045606|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045607|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045608|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44045609|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44045610|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045611|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045612|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
44045613|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44045614|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045615|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
44045660|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44045661|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44045662|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045663|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045664|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44045665|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
44045666|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44045727|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
44045728|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045729|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045730|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44045731|NCT00003187|Cytarabine|cytarabine|mesh-list
44045732|NCT00003187|Cyclosporine|cyclosporine|mesh-list
44045733|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
44045734|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
44045735|NCT00003187|Methotrexate|methotrexate|mesh-list
44045795|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045796|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045797|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045798|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
44045799|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045800|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44045801|NCT00003193|Protective Agents|protective agents|mesh-ancestor
44045802|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045803|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
44045805|NCT00003194|Carboplatin|carboplatin|mesh-list
44045806|NCT00003194|Etoposide|etoposide|mesh-list
44045807|NCT00003194|Topotecan|topotecan|mesh-list
44045808|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44045809|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
44045858|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045859|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045860|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44045861|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
44045863|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045864|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44045865|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44045925|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44045926|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
44045927|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44045928|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045929|NCT00003206|Paclitaxel|paclitaxel|mesh-list
44045930|NCT00003206|Carboplatin|carboplatin|mesh-list
44045995|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045996|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44045997|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44046068|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44046069|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44046070|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44046071|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
44046139|NCT00003217|Doxorubicin|doxorubicin|mesh-list
44046140|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44046141|NCT00003217|Methotrexate|methotrexate|mesh-list
44046142|NCT00003217|Vincristine|vincristine|mesh-list
44046143|NCT00003217|Lenograstim|lenograstim|mesh-list
44046144|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046145|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
44046146|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046147|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44046148|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44046149|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
44046150|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046151|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046201|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046202|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046203|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44046204|NCT00003225|Protective Agents|protective agents|mesh-ancestor
44046205|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046206|NCT00003229|Aldesleukin|aldesleukin|mesh-list
44046207|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046271|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
44046344|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046345|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046346|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44046347|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44046348|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
44046349|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046350|NCT00003245|Irinotecan|irinotecan|mesh-list
44046351|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44046352|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046408|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046409|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046410|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046411|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44046412|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046413|NCT00003254|Fluorouracil|fluorouracil|mesh-list
44046414|NCT00003254|Eniluracil|eniluracil|mesh-list
44046415|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
44046416|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046417|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046418|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046419|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046472|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44046473|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44046475|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046476|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046477|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
44046478|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046479|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44046480|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44046539|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44046540|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44046541|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44046542|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046543|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
44046544|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44046545|NCT00003268|Cytarabine|cytarabine|mesh-list
44046546|NCT00003268|Idarubicin|idarubicin|mesh-list
44046547|NCT00003268|Amifostine|amifostine|mesh-list
44046565|NCT00003269|Etoposide|etoposide|mesh-list
44046606|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
44046607|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046608|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44046609|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44046610|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44046611|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046612|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046613|NCT00003273|Antidotes|antidotes|mesh-ancestor
44046614|NCT00003273|Protective Agents|protective agents|mesh-ancestor
44046615|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
44046616|NCT00003273|Vitamins|vitamins|mesh-ancestor
44046617|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
44046618|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
44046619|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
44046621|NCT00003274|Sargramostim|sargramostim|mesh-list
44046669|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44046670|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
44046671|NCT00003283|Hormones|hormones|mesh-ancestor
44046672|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44046722|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046723|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44046795|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046796|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046797|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44046865|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44046866|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44046867|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44046868|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44046869|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046870|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44046934|NCT00003323|Flutamide|flutamide|mesh-list
44046935|NCT00003323|Finasteride|finasteride|mesh-list
44046936|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44046937|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44046938|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44046939|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047004|NCT00003332|Immunologic Factors|immunologic factors|mesh-ancestor
44047005|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047006|NCT00003334|Paclitaxel|paclitaxel|mesh-list
44047007|NCT00003334|Doxorubicin|doxorubicin|mesh-list
44047008|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047009|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047010|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047011|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
44047074|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44047075|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047076|NCT00003338|Epratuzumab|epratuzumab|mesh-list
44047077|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44047078|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047079|NCT00003339|Interleukin-12|interleukin-12|mesh-list
44047080|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
44047081|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44047090|NCT00003340|Topotecan|topotecan|mesh-list
44047142|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047143|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047144|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44047145|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
44047146|NCT00003344|Irinotecan|irinotecan|mesh-list
44047147|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047148|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047149|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047150|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047151|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047153|NCT00003345|Irinotecan|irinotecan|mesh-list
44047154|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047155|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44047156|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047203|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047204|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047205|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047278|NCT00003364|Etoposide|etoposide|mesh-list
44047279|NCT00003364|Vincristine|vincristine|mesh-list
44047280|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047352|NCT00003376|Paclitaxel|paclitaxel|mesh-list
44047353|NCT00003376|Vinblastine|vinblastine|mesh-list
44047354|NCT00003376|Cisplatin|cisplatin|mesh-list
44047355|NCT00003376|Carboplatin|carboplatin|mesh-list
44047356|NCT00003376|Doxorubicin|doxorubicin|mesh-list
44047357|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44047358|NCT00003376|Methotrexate|methotrexate|mesh-list
44047359|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047360|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047421|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047497|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44047498|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
44047572|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
44047573|NCT00003397|Rituximab|rituximab|mesh-list
44047574|NCT00003397|Melphalan|melphalan|mesh-list
44047575|NCT00003397|Carmustine|carmustine|mesh-list
44047576|NCT00003397|Sargramostim|sargramostim|mesh-list
44047577|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44047578|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047579|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047580|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047643|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047644|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047645|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047646|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047647|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44047648|NCT00003400|Cisplatin|cisplatin|mesh-list
44047713|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047714|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047715|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
44047716|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44047717|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44047718|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047719|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
44047720|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047721|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44047722|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
44047723|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
44047724|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44047725|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047726|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
44047727|NCT00003402|Hormones|hormones|mesh-ancestor
44047728|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44047729|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44047730|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44047731|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44047770|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047771|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047772|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
44047814|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44047815|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
44047816|NCT00003412|Interleukin-12|interleukin-12|mesh-list
44047889|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047891|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44047892|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
44047893|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44047894|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
44047895|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047896|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44047897|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047898|NCT00003417|Carmustine|carmustine|mesh-list
44047900|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
44047955|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44047956|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44047957|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44047958|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44047959|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
44047960|NCT00003422|Antidotes|antidotes|mesh-ancestor
44047961|NCT00003422|Protective Agents|protective agents|mesh-ancestor
44047962|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
44047963|NCT00003422|Vitamins|vitamins|mesh-ancestor
44048021|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44048022|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
44048024|NCT00003425|Amifostine|amifostine|mesh-list
44048025|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44048026|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
44048027|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048028|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048029|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048030|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
44048031|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048032|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048033|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048034|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44048035|NCT00003425|Protective Agents|protective agents|mesh-ancestor
44048036|NCT00003426|Gemcitabine|gemcitabine|mesh-list
44048038|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
44048079|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44048080|NCT00003436|Methotrexate|methotrexate|mesh-list
44048081|NCT00003436|Etoposide|etoposide|mesh-list
44048082|NCT00003436|Daunorubicin|daunorubicin|mesh-list
44048083|NCT00003436|Asparaginase|asparaginase|mesh-list
44048084|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
44048085|NCT00003436|Amsacrine|amsacrine|mesh-list
44048086|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44048087|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048088|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048139|NCT00003437|Hormones|hormones|mesh-ancestor
44048147|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
44048148|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44048149|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048150|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
44048151|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048152|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048153|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048154|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
44048214|NCT00003446|Antidotes|antidotes|mesh-ancestor
44048215|NCT00003446|Protective Agents|protective agents|mesh-ancestor
44048216|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
44048218|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
44048288|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048289|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048290|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44048291|NCT00003463|Irinotecan|irinotecan|mesh-list
44048292|NCT00003463|Carmustine|carmustine|mesh-list
44048293|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44048294|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048295|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048354|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44048355|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048356|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048357|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
44048358|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
44048359|NCT00003493|Dexamethasone|dexamethasone|mesh-list
44048360|NCT00003493|Doxorubicin|doxorubicin|mesh-list
44048361|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44048362|NCT00003493|Vincristine|vincristine|mesh-list
44048421|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
44048422|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048423|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048493|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048497|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
44048567|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048568|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44048569|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44048570|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
44048571|NCT00003552|Fludarabine|fludarabine|mesh-list
44149732|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44149733|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44149734|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149735|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44149736|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
44048600|NCT00003555|Paclitaxel|paclitaxel|mesh-list
44048601|NCT00003555|Amifostine|amifostine|mesh-list
44048602|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048665|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048666|NCT00003564|Procarbazine|procarbazine|mesh-list
44048667|NCT00003564|Isotretinoin|isotretinoin|mesh-list
44048668|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048669|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
44048671|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048672|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
43774911|NCT02349945|Hormones|hormones|mesh-ancestor
44048733|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44048734|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44048735|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44048736|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44048738|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
44048805|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44048806|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048807|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
44048809|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44048877|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44048878|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44048952|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44048953|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44048954|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
44049024|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049025|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
44049026|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049027|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049028|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049097|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049098|NCT00003602|Cytarabine|cytarabine|mesh-list
44049171|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049172|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049173|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049174|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
44049176|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049241|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44049242|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049243|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
44049244|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049245|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44049248|NCT00003619|Vitamin E|vitamin e|mesh-list
44049313|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049314|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049315|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049316|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049317|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
44049318|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
44049384|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049459|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049460|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44049461|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
44049462|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44049532|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44049554|NCT00003650|Analgesics|analgesics|mesh-ancestor
44049606|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
44049607|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049608|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44049609|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049610|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
44049611|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049612|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049613|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049614|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44049615|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44049616|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049617|NCT00003661|Cyclosporine|cyclosporine|mesh-list
44049618|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
44049619|NCT00003661|Melphalan|melphalan|mesh-list
44049620|NCT00003661|Busulfan|busulfan|mesh-list
44049621|NCT00003661|Cyclosporins|cyclosporins|mesh-list
44049622|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44049623|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049624|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049625|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44049626|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
44049627|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44049628|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
44049660|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049661|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049662|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049664|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
44049665|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44049730|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44049731|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44049732|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049733|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44049734|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049735|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049736|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44049737|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
44049799|NCT00003674|Tinzaparin|tinzaparin|mesh-list
44049800|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44049802|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44049803|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44049804|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049805|NCT00003675|Topotecan|topotecan|mesh-list
44049806|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44049807|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44049864|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44049885|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
44049936|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44049937|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44049938|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44049939|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
44049940|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44049941|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44049942|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
44049943|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44049945|NCT00003686|Miotics|miotics|mesh-ancestor
44049946|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
44049947|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44049954|NCT00003687|Morphine|morphine|mesh-list
44049998|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44049999|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050000|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050147|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
44050148|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050149|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050150|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050151|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
44050152|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050153|NCT00003708|Temozolomide|temozolomide|mesh-list
44050154|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44050155|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
44050216|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050217|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050288|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050290|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
44050291|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050292|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050293|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44050294|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44050295|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050296|NCT00003728|Leucovorin|leucovorin|mesh-list
44050297|NCT00003728|Cytarabine|cytarabine|mesh-list
44050298|NCT00003728|Dexamethasone|dexamethasone|mesh-list
44050299|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
44050300|NCT00003728|Prednisolone|prednisolone|mesh-list
44050301|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
44050302|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44050303|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44050305|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
44050349|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
44050350|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050352|NCT00003728|Protective Agents|protective agents|mesh-ancestor
44050353|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050354|NCT00003728|Vitamins|vitamins|mesh-ancestor
44050355|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
44050356|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050357|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050418|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050419|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050420|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050421|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44050422|NCT00003734|Flutamide|flutamide|mesh-list
44050423|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
44050424|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44050425|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
44050487|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44050488|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44050489|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050560|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
44050561|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050633|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050634|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050635|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44050636|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050637|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050638|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050639|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
44050702|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050704|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050705|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050706|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050707|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050708|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050709|NCT00003780|Gemcitabine|gemcitabine|mesh-list
44050710|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050772|NCT00003783|Protective Agents|protective agents|mesh-ancestor
44050773|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
44050774|NCT00003783|Vitamins|vitamins|mesh-ancestor
44050775|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
44050776|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
44050777|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
44050778|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
44050779|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44050780|NCT00003784|Prednisone|prednisone|mesh-list
44050781|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
44050782|NCT00003784|Doxorubicin|doxorubicin|mesh-list
44050783|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44050784|NCT00003784|Vincristine|vincristine|mesh-list
44050785|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
44050836|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149740|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149741|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44149742|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44149743|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44149744|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44149745|NCT00208741|Tiagabine|tiagabine|mesh-list
44050849|NCT00003797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050850|NCT00003797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050851|NCT00003797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44050852|NCT00003797|Immunologic Factors|immunologic factors|mesh-ancestor
44050920|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44050921|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44050922|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44050923|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44050924|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44050925|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44050926|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44050927|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
44050928|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44050929|NCT00003809|Cisplatin|cisplatin|mesh-list
44050930|NCT00003809|Cetuximab|cetuximab|mesh-list
44050931|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44050932|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44050933|NCT00003810|Gemcitabine|gemcitabine|mesh-list
44050934|NCT00003810|Docetaxel|docetaxel|mesh-list
44050935|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44050936|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
44050948|NCT00003811|Cisplatin|cisplatin|mesh-list
44050979|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44050980|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44050981|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44050983|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051053|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051054|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051055|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44051056|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051058|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051123|NCT00003834|Protective Agents|protective agents|mesh-ancestor
44051124|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
44051125|NCT00003834|Vitamins|vitamins|mesh-ancestor
44051127|NCT00003835|Leucovorin|leucovorin|mesh-list
44051197|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051198|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
44051199|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051200|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
44051201|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44051202|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051203|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44051204|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44051267|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051268|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051269|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
44051280|NCT00003860|Carboplatin|carboplatin|mesh-list
44051339|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
44051340|NCT00003868|Methotrexate|methotrexate|mesh-list
44051342|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44051343|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051344|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
44051345|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051412|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051413|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051414|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051415|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051416|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051417|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051418|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051419|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
44051420|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051421|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051422|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051423|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
44051424|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051425|NCT00003878|Carmustine|carmustine|mesh-list
44051426|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051427|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
44051465|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051542|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051543|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051544|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051545|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051546|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
44051547|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051548|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051550|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
44051610|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051611|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051612|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051613|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
44051614|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051615|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051616|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051617|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44051618|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
44051619|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
44051620|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44051621|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44051622|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
44051623|NCT00003913|Hormones|hormones|mesh-ancestor
44051624|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44051625|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44051626|NCT00003913|Protective Agents|protective agents|mesh-ancestor
44051627|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
44051628|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051629|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44051630|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051663|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051664|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
44051665|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051666|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
44051667|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051668|NCT00003925|Leucovorin|leucovorin|mesh-list
44051669|NCT00003925|Gemcitabine|gemcitabine|mesh-list
44051670|NCT00003925|Tegafur|tegafur|mesh-list
44051671|NCT00003925|Calcium|calcium|mesh-list
44051672|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
44051673|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051674|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
44051675|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051676|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051677|NCT00003925|Antiviral Agents|antiviral agents|mesh-ancestor
44051678|NCT00003925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051679|NCT00003925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051680|NCT00003925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051681|NCT00003925|Immunologic Factors|immunologic factors|mesh-ancestor
44051682|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051683|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44051684|NCT00003925|Antidotes|antidotes|mesh-ancestor
44051685|NCT00003925|Protective Agents|protective agents|mesh-ancestor
44051686|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
44051687|NCT00003925|Vitamins|vitamins|mesh-ancestor
44051688|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
44051689|NCT00003926|Melphalan|melphalan|mesh-list
44051690|NCT00003926|Busulfan|busulfan|mesh-list
44051691|NCT00003926|Thiotepa|thiotepa|mesh-list
44051692|NCT00003926|Lenograstim|lenograstim|mesh-list
44051693|NCT00003926|Amifostine|amifostine|mesh-list
44051694|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44051695|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
44051696|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051697|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051698|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
44051699|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051705|NCT00003928|Gemcitabine|gemcitabine|mesh-list
44051706|NCT00003928|Cisplatin|cisplatin|mesh-list
44051707|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051708|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051709|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
44051710|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051711|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
44051712|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44051717|NCT00003929|Lomustine|lomustine|mesh-list
44051746|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44051747|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
44051748|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44051749|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051750|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44051751|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
44051752|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051753|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44051754|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
44051755|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051756|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44051757|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051807|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051808|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44051809|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44051810|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051811|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
44051812|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44051813|NCT00003937|Protective Agents|protective agents|mesh-ancestor
44051814|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44051815|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44051816|NCT00003938|Amphotericin B|amphotericin b|mesh-list
44051817|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44051818|NCT00003938|Amebicides|amebicides|mesh-ancestor
44051819|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44051871|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051872|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44051873|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
44051874|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44051875|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44051876|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44051877|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
44051878|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44051879|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44051881|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44051936|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44051937|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052010|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052085|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
44052086|NCT00003960|Busulfan|busulfan|mesh-list
44052087|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44052088|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
44052089|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052090|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
44052091|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052092|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052093|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052094|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
44052095|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052096|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052097|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44052098|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44052099|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
44052100|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
44052101|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44052102|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777702|NCT02330380|Adalimumab|adalimumab|mesh-list
44052142|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052143|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052214|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052215|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44052216|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052217|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
44052218|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052219|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
44052220|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
44052221|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44052222|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052223|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052278|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052279|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052280|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052281|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44052282|NCT00003994|Protective Agents|protective agents|mesh-ancestor
44052283|NCT00003995|Trastuzumab|trastuzumab|mesh-list
44052284|NCT00003995|Irinotecan|irinotecan|mesh-list
44052285|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052286|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052287|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44052289|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052343|NCT00004003|Fluorouracil|fluorouracil|mesh-list
44052344|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052345|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43771184|NCT02374567|Perazine|perazine|mesh-list
44052346|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
44052347|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052348|NCT00004003|Antiviral Agents|antiviral agents|mesh-ancestor
44052349|NCT00004003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052416|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
44052417|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052429|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
44052491|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052493|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44052494|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
44052564|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052565|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052566|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44052567|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052568|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44052569|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
44052570|NCT00004039|Hormones|hormones|mesh-ancestor
44052571|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44052572|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44052573|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
44052574|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44052575|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44052576|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
44052577|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
44052624|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44052625|NCT00004048|Doxorubicin|doxorubicin|mesh-list
44052626|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44052627|NCT00004048|Antibodies|antibodies|mesh-list
44052628|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
44052629|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44052630|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
44052631|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052632|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052633|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44052691|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052692|NCT00004059|Fluorouracil|fluorouracil|mesh-list
44149859|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44149860|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
44149861|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44149862|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44149863|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44149864|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44052772|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
44052773|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44052774|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44052775|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
44052776|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44052777|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44052778|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44052779|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
44052786|NCT00004068|Irinotecan|irinotecan|mesh-list
44052837|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44052838|NCT00004074|Carboplatin|carboplatin|mesh-list
44052839|NCT00004074|Trastuzumab|trastuzumab|mesh-list
44052840|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44052841|NCT00004074|Interleukin-12|interleukin-12|mesh-list
44052842|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44052843|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052844|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44052845|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
44052906|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44052980|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
44052982|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053056|NCT00004102|Antidotes|antidotes|mesh-ancestor
44053057|NCT00004102|Protective Agents|protective agents|mesh-ancestor
44053058|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053059|NCT00004102|Vitamins|vitamins|mesh-ancestor
44053060|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
44053130|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
44053131|NCT00004112|Rituximab|rituximab|mesh-list
44053132|NCT00004112|Doxorubicin|doxorubicin|mesh-list
44053133|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053134|NCT00004112|Vincristine|vincristine|mesh-list
44053135|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053136|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
44053137|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053138|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053139|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053140|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
44053141|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053142|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053194|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053195|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053196|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053197|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053198|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053199|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053200|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053201|NCT00004125|Tamoxifen|tamoxifen|mesh-list
44053202|NCT00004125|Paclitaxel|paclitaxel|mesh-list
44053203|NCT00004125|Docetaxel|docetaxel|mesh-list
44053204|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
44053205|NCT00004125|Doxorubicin|doxorubicin|mesh-list
44053206|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44053207|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44053209|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44053254|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
44053255|NCT00004127|Vitamins|vitamins|mesh-ancestor
44053256|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
44053257|NCT00004128|Cytarabine|cytarabine|mesh-list
44053327|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053329|NCT00004139|Docetaxel|docetaxel|mesh-list
44053330|NCT00004139|Irinotecan|irinotecan|mesh-list
44053331|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053332|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
44053398|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
44053399|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44053400|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053401|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
44053471|NCT00004162|Methotrexate|methotrexate|mesh-list
44053472|NCT00004162|Vincristine|vincristine|mesh-list
44053473|NCT00004162|Sargramostim|sargramostim|mesh-list
44053474|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053475|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053476|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053477|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053478|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053479|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053480|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44053481|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
44053535|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
44053536|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
44053537|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053538|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053539|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
44053540|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053541|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053542|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053601|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44053602|NCT00004184|Antibodies|antibodies|mesh-list
44053603|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44053604|NCT00004184|Sargramostim|sargramostim|mesh-list
44053605|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
44053606|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
44053607|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053608|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44053610|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053611|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44053612|NCT00004186|Carboplatin|carboplatin|mesh-list
44053669|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053670|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053743|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053744|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44053745|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
44053778|NCT00004200|Temozolomide|temozolomide|mesh-list
44053779|NCT00004200|Prinomastat|prinomastat|mesh-list
44053780|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44053851|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053852|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44053853|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053854|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44053855|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44053856|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44053857|NCT00004209|Cisplatin|cisplatin|mesh-list
44053858|NCT00004209|Mitomycins|mitomycins|mesh-list
44053859|NCT00004209|Mitomycin|mitomycin|mesh-list
44053860|NCT00004209|Vinblastine|vinblastine|mesh-list
44053917|NCT00004217|Sargramostim|sargramostim|mesh-list
44053918|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44053919|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
44053920|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053921|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44053922|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
44053923|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44053924|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44053925|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
44053983|NCT00004220|Immunologic Factors|immunologic factors|mesh-ancestor
44053984|NCT00004220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44053985|NCT00004221|Paclitaxel|paclitaxel|mesh-list
44053986|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
44053987|NCT00004221|Carboplatin|carboplatin|mesh-list
44053988|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44053989|NCT00004221|Topotecan|topotecan|mesh-list
44054053|NCT00004232|Prednisone|prednisone|mesh-list
44054054|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
44054055|NCT00004232|Cyclosporins|cyclosporins|mesh-list
44054129|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44054130|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44054131|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054132|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44054133|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44054134|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44054135|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44054136|NCT00004237|Analgesics|analgesics|mesh-ancestor
44054137|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
44054138|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44054139|NCT00004242|Gemcitabine|gemcitabine|mesh-list
44054140|NCT00004242|Fluorouracil|fluorouracil|mesh-list
44054141|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
44054142|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054191|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054192|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054193|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
44054263|NCT00004254|Raltitrexed|raltitrexed|mesh-list
44054264|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054265|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
44054266|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054267|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054268|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44054269|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054270|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
44054271|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
44054272|NCT00004255|Fludarabine|fludarabine|mesh-list
44054273|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
44054274|NCT00004255|Tacrolimus|tacrolimus|mesh-list
44054275|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44054276|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44054326|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
44054327|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054328|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44054329|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
44054330|NCT00004263|Cytarabine|cytarabine|mesh-list
44054331|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44054332|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44054333|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
44054334|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054335|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44054336|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
44054391|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44054467|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44054468|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44054469|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44054470|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44054471|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
44054472|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
44054473|NCT00004300|Bromocriptine|bromocriptine|mesh-list
44054475|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
44054476|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44054477|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44054501|NCT00004311|Leuprolide|leuprolide|mesh-list
44054532|NCT00004317|Calcium|calcium|mesh-list
44054533|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
44054534|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44054535|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054536|NCT00004317|Antidotes|antidotes|mesh-ancestor
44054537|NCT00004317|Protective Agents|protective agents|mesh-ancestor
44054538|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
44054539|NCT00004317|Vitamins|vitamins|mesh-ancestor
44054540|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
44054599|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
44054600|NCT00004330|Hormones|hormones|mesh-list
44054601|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054602|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44149923|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
44149924|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
44149925|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44149926|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44149927|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
44149928|NCT00209222|Hormones|hormones|mesh-ancestor
44149929|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44149930|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149931|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44149933|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44149981|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44149982|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44149983|NCT00209495|Analgesics|analgesics|mesh-ancestor
44149984|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
44149985|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
44054664|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
44054666|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44054737|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44054738|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44054739|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44054740|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054741|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054742|NCT00004380|Methocarbamol|methocarbamol|mesh-list
44054743|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44054744|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054802|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054803|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
44054806|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
44054876|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
44054877|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44054878|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054879|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44054880|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44054881|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054882|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
44054883|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44054884|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44054885|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44054886|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
44054937|NCT00004422|Antibodies|antibodies|mesh-list
44054938|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
44054939|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44054940|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44054941|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
44054942|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054943|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44054944|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
44054945|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44054946|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054947|NCT00004424|Fentanyl|fentanyl|mesh-list
44054948|NCT00004424|Midazolam|midazolam|mesh-list
44054949|NCT00004424|Propofol|propofol|mesh-list
44054950|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43682891|NCT02845388|Estradiol|estradiol|mesh-list
44054951|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44054952|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44054953|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44054998|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44054999|NCT00004433|Pergolide|pergolide|mesh-list
44055000|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
44055001|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
44055002|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055003|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055004|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055005|NCT00004436|Prednisone|prednisone|mesh-list
44055006|NCT00004436|Leuprolide|leuprolide|mesh-list
44055008|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
44055064|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055065|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44055066|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
44055067|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44055068|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44055069|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055070|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055071|NCT00004448|Prednisone|prednisone|mesh-list
44055072|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055129|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44055130|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055131|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44055132|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055133|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055134|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44055135|NCT00004468|Vitamins|vitamins|mesh-ancestor
44055136|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
44055193|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
44055194|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055195|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44055196|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
44055197|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
44055198|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055199|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44055200|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44157935|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
44157936|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157937|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157938|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157939|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157940|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44157941|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157942|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
44157943|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44055272|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44055273|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055274|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44055275|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
44055276|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055277|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055278|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44055279|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055280|NCT00004495|Folic Acid|folic acid|mesh-list
44055334|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44055335|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44055336|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44055337|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44055339|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055340|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055341|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
44055342|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44055343|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055344|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44055345|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
44055346|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055347|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055348|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055350|NCT00004573|Ganciclovir|ganciclovir|mesh-list
44055391|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44055392|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
44055393|NCT00004580|Ritonavir|ritonavir|mesh-list
44055394|NCT00004580|Lopinavir|lopinavir|mesh-list
44055395|NCT00004580|Nevirapine|nevirapine|mesh-list
44055396|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055397|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055398|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055399|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055400|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055401|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055402|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055403|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
44055404|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055405|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44055406|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44055407|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44055448|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055449|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055451|NCT00004583|Lopinavir|lopinavir|mesh-list
44055452|NCT00004583|Nelfinavir|nelfinavir|mesh-list
44055453|NCT00004583|Lamivudine|lamivudine|mesh-list
44055454|NCT00004583|Stavudine|stavudine|mesh-list
44055455|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44055456|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44055457|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
44055458|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055459|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055460|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44055461|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44055462|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
43780406|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780407|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43780408|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44055511|NCT00004644|Acyclovir|acyclovir|mesh-list
44055512|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
44055513|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055514|NCT00004646|Prednisone|prednisone|mesh-list
44055515|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44055516|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
44055517|NCT00004646|Hormones|hormones|mesh-ancestor
44055519|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055568|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44055569|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44055570|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44055571|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44055572|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44055573|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
44055574|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055575|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
44055635|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44055636|NCT00004689|Clarithromycin|clarithromycin|mesh-list
44055637|NCT00004689|Rifampin|rifampin|mesh-list
44055638|NCT00004689|Ethambutol|ethambutol|mesh-list
44055639|NCT00004689|Streptomycin|streptomycin|mesh-list
44055640|NCT00004689|Thioacetazone|thioacetazone|mesh-list
44055641|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44055642|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055643|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44055658|NCT00004690|Monolaurin|monolaurin|mesh-list
44055702|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44055703|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055704|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44055770|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44055772|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44055773|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44055774|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44055775|NCT00004734|Folic Acid|folic acid|mesh-list
44055776|NCT00004734|Pyridoxine|pyridoxine|mesh-list
44055777|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
44055778|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
44055779|NCT00004734|Hematinics|hematinics|mesh-ancestor
44055780|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
44055781|NCT00004734|Vitamins|vitamins|mesh-ancestor
44055782|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
44055784|NCT00004736|Lamivudine|lamivudine|mesh-list
44055838|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44055839|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44055840|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
44055903|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44055904|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44055905|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
44055906|NCT00004758|Vitamins|vitamins|mesh-ancestor
44055907|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
44055908|NCT00004758|Hormones|hormones|mesh-ancestor
44055909|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44055970|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
44055971|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44055972|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
44055973|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
44055974|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056043|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44056044|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
44056045|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44056046|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
44056047|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
44056048|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056049|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056050|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44056051|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
44056052|NCT00004785|Hormones|hormones|mesh-ancestor
44056110|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44056111|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44056112|NCT00004808|Fluconazole|fluconazole|mesh-list
44056113|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
44056179|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056180|NCT00004825|Growth Substances|growth substances|mesh-ancestor
44056181|NCT00004826|Clozapine|clozapine|mesh-list
44056182|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44056183|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
44056184|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44056185|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44056186|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056187|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44056188|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44056189|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44056242|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44056243|NCT00004845|Naproxen|naproxen|mesh-list
44056244|NCT00004845|Rofecoxib|rofecoxib|mesh-list
44056245|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44056246|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44056247|NCT00004845|Analgesics|analgesics|mesh-ancestor
44056248|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
44056249|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44056258|NCT00004852|Lamivudine|lamivudine|mesh-list
44056309|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
44056310|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056311|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44056312|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44056313|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44056314|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056315|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44056316|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44056317|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
44056375|NCT00004862|Cytarabine|cytarabine|mesh-list
44056448|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056449|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056451|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056452|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44056453|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44056454|NCT00004872|Growth Substances|growth substances|mesh-ancestor
44056455|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056519|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44056520|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
44056521|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44056522|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44056523|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
44056524|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44056525|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44056526|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44056527|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44056528|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44056529|NCT00004879|Panitumumab|panitumumab|mesh-list
44056530|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44056531|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056532|NCT00004880|Vaccines|vaccines|mesh-list
44056533|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
44056535|NCT00004883|Trastuzumab|trastuzumab|mesh-list
44056583|NCT00004887|Vinblastine|vinblastine|mesh-list
44056584|NCT00004887|Cisplatin|cisplatin|mesh-list
44056585|NCT00004887|Carboplatin|carboplatin|mesh-list
44056586|NCT00004887|Ifosfamide|ifosfamide|mesh-list
44056587|NCT00004887|Mitomycins|mitomycins|mesh-list
44056588|NCT00004887|Mitomycin|mitomycin|mesh-list
44056589|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44056590|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056591|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056592|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
44056622|NCT00004893|Interleukin-12|interleukin-12|mesh-list
44056623|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44056624|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
44056625|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056626|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44056627|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44056628|NCT00004893|Growth Substances|growth substances|mesh-ancestor
44056629|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
44056630|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44056631|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
44056632|NCT00004900|Thiotepa|thiotepa|mesh-list
44056765|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44056842|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056843|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781330|NCT05079672|Analgesics|analgesics|mesh-ancestor
44056917|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44056918|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44056988|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44056989|NCT00004981|Lamivudine|lamivudine|mesh-list
44057062|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057063|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
44057064|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44057065|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057066|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
43781418|NCT04951050|Sirolimus|sirolimus|mesh-list
44057067|NCT00004999|Lamivudine|lamivudine|mesh-list
44057068|NCT00004999|Zidovudine|zidovudine|mesh-list
44057069|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44057071|NCT00004999|Nelfinavir|nelfinavir|mesh-list
44057072|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44057073|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44057126|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44057127|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
44057128|NCT00005005|Alendronate|alendronate|mesh-list
44057129|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44057130|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057131|NCT00005006|Alendronate|alendronate|mesh-list
44057132|NCT00005006|Teriparatide|teriparatide|mesh-list
44057133|NCT00005006|Hormones|hormones|mesh-list
44057134|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
44057135|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44057136|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057137|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44057138|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44057187|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44057188|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44057189|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44057257|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44057258|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057259|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44057330|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
44057331|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057333|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057334|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057338|NCT00005030|Lonafarnib|lonafarnib|mesh-list
44057403|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057404|NCT00005041|Tipifarnib|tipifarnib|mesh-list
44057581|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057582|NCT00005076|Irinotecan|irinotecan|mesh-list
44057583|NCT00005076|Cetuximab|cetuximab|mesh-list
44057584|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44057585|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057587|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057588|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057652|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44057653|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
44057654|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057655|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057656|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057657|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44057658|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44057659|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44057660|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44057661|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44057662|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44057663|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
44057714|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44057715|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44057789|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057790|NCT00005108|Progestins|progestins|mesh-ancestor
44057792|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44057793|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44057808|NCT00005113|Sirolimus|sirolimus|mesh-list
44057865|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
44057905|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057906|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44057907|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44057908|NCT00005576|Analgesics|analgesics|mesh-ancestor
44057909|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
44057910|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44057911|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44057912|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44057913|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
44057914|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44057915|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
44057971|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058047|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44058049|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
44058199|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058200|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44058202|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44058203|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44058204|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
44058205|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
44058206|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44058207|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44058208|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44058209|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
44058210|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058211|NCT00005596|Antidotes|antidotes|mesh-ancestor
44058212|NCT00005596|Protective Agents|protective agents|mesh-ancestor
44058213|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
44058214|NCT00005596|Vitamins|vitamins|mesh-ancestor
44058259|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44058260|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
44058261|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
44058262|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058263|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058264|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
44058265|NCT00005601|Hormones|hormones|mesh-ancestor
44058267|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44058328|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44058329|NCT00005604|Analgesics|analgesics|mesh-ancestor
44058330|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
44058331|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44058332|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058402|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44058476|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
43782513|NCT05092945|Niacin|niacin|mesh-list
44058549|NCT00005641|Busulfan|busulfan|mesh-list
44058550|NCT00005641|Methotrexate|methotrexate|mesh-list
44058551|NCT00005641|Cyclosporins|cyclosporins|mesh-list
44058625|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058765|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44058766|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44058837|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44058838|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44058839|NCT00005779|Growth Substances|growth substances|mesh-ancestor
44058840|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
44058841|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058842|NCT00005782|Lenograstim|lenograstim|mesh-list
44058843|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44058844|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
44058845|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058905|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44058907|NCT00005796|Lomustine|lomustine|mesh-list
44058908|NCT00005796|Procarbazine|procarbazine|mesh-list
44058910|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058941|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
44058942|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44058943|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44058944|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44058945|NCT00005799|Cyclosporine|cyclosporine|mesh-list
44058946|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
44058947|NCT00005799|Fludarabine|fludarabine|mesh-list
44059010|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44059011|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44059012|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44059013|NCT00005802|Analgesics|analgesics|mesh-ancestor
44059014|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
44059082|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059083|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
44059153|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059154|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
44059155|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059156|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
44059157|NCT00005824|Busulfan|busulfan|mesh-list
44059158|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059223|NCT00005831|Gemcitabine|gemcitabine|mesh-list
44059224|NCT00005831|Paclitaxel|paclitaxel|mesh-list
44059225|NCT00005831|Carboplatin|carboplatin|mesh-list
44059226|NCT00005831|Trastuzumab|trastuzumab|mesh-list
44059227|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059228|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059229|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
44059230|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
44059231|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
44059232|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059242|NCT00005832|Tipifarnib|tipifarnib|mesh-list
44059289|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059290|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
44059291|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783138|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
44059292|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059293|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44059294|NCT00005835|Protective Agents|protective agents|mesh-ancestor
44059295|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
44059296|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059297|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
44059358|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059359|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059360|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059361|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059362|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
44059363|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059364|NCT00005848|Tipifarnib|tipifarnib|mesh-list
44059365|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059366|NCT00005849|Paclitaxel|paclitaxel|mesh-list
44059367|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
44059423|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
44059424|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
44059425|NCT00005852|Cyclosporins|cyclosporins|mesh-list
44059426|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44059427|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
44059428|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059429|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
44059430|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059431|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44059491|NCT00005855|Efaproxiral|efaproxiral|mesh-list
44059492|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44059493|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
44059494|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059495|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059496|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
44059497|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
44059498|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059499|NCT00005857|Docetaxel|docetaxel|mesh-list
44059559|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44059560|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44059561|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059562|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059563|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
44059631|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059632|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44059633|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44059634|NCT00005867|Analgesics|analgesics|mesh-ancestor
44059635|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
44059636|NCT00005868|Cisplatin|cisplatin|mesh-list
44059637|NCT00005868|Docetaxel|docetaxel|mesh-list
44059700|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059701|NCT00005874|Rubitecan|rubitecan|mesh-list
44059702|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059703|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44059704|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44059705|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059763|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059764|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059765|NCT00005886|Tamoxifen|tamoxifen|mesh-list
44059766|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44059767|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
44059768|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44059769|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059771|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059824|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44059825|NCT00005898|Cyclosporine|cyclosporine|mesh-list
44059826|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
44059827|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
44059828|NCT00005898|Fludarabine|fludarabine|mesh-list
44059829|NCT00005898|Cyclosporins|cyclosporins|mesh-list
44059830|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44059831|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44059832|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
44059834|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44150219|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150220|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150221|NCT00209859|Cyclosporine|cyclosporine|mesh-list
44150222|NCT00209859|Betamethasone|betamethasone|mesh-list
44150223|NCT00209859|Methotrexate|methotrexate|mesh-list
44150224|NCT00209859|Cyclosporins|cyclosporins|mesh-list
44150225|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44059883|NCT00005922|Hormones|hormones|mesh-ancestor
44059911|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44059912|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
44059913|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059914|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059915|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44059916|NCT00005931|Semaxinib|semaxinib|mesh-list
44059917|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44059918|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44059975|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44059976|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
44059977|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44059978|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059979|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
44059980|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
44059981|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44059982|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44059983|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44059984|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
44059985|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059986|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44059987|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44059988|NCT00005940|Trace Elements|trace elements|mesh-ancestor
44059989|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
44059990|NCT00005941|Cyclosporine|cyclosporine|mesh-list
44059991|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
44059992|NCT00005941|Fludarabine|fludarabine|mesh-list
44059993|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
44059994|NCT00005941|Cyclosporins|cyclosporins|mesh-list
44059995|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44059996|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44059997|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
44059998|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44059999|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060027|NCT00005944|Mitomycins|mitomycins|mesh-list
44060028|NCT00005944|Mitomycin|mitomycin|mesh-list
44060029|NCT00005944|Calcium|calcium|mesh-list
44060030|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
44060033|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
44060102|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060103|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
44060104|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060105|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060106|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060107|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44060108|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060109|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060110|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060111|NCT00005948|Interferons|interferons|mesh-list
44060112|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
44060113|NCT00005948|Aldesleukin|aldesleukin|mesh-list
44060114|NCT00005948|Busulfan|busulfan|mesh-list
44060115|NCT00005948|Sargramostim|sargramostim|mesh-list
44060116|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060117|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
44060118|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060119|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
44060120|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060121|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
44060122|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060123|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060124|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060125|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060126|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44060152|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060153|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060154|NCT00005954|Temozolomide|temozolomide|mesh-list
44060155|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060156|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
44060157|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783733|NCT05100719|Mebeverine|mebeverine|mesh-list
44060158|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060159|NCT00005955|Temozolomide|temozolomide|mesh-list
44060160|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44060161|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
44060162|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060163|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060164|NCT00005958|Gemcitabine|gemcitabine|mesh-list
44060165|NCT00005958|Docetaxel|docetaxel|mesh-list
44060166|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44060167|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
44060168|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060169|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060170|NCT00005958|Antiviral Agents|antiviral agents|mesh-ancestor
44060171|NCT00005958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060172|NCT00005958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060173|NCT00005958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44060174|NCT00005958|Immunologic Factors|immunologic factors|mesh-ancestor
44060175|NCT00005958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060176|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060177|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060178|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060179|NCT00005959|Prednisone|prednisone|mesh-list
44060180|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
44060181|NCT00005959|Rituximab|rituximab|mesh-list
44060182|NCT00005959|Doxorubicin|doxorubicin|mesh-list
44060183|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060184|NCT00005959|Vincristine|vincristine|mesh-list
44060192|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060193|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44060194|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44060195|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44060196|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060197|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060261|NCT00005963|Docetaxel|docetaxel|mesh-list
44060262|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060263|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060264|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060265|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060266|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060267|NCT00005964|Prednisone|prednisone|mesh-list
44060268|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
44060269|NCT00005964|Doxorubicin|doxorubicin|mesh-list
44060271|NCT00005964|Etoposide|etoposide|mesh-list
44060329|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
44060330|NCT00005970|Doxorubicin|doxorubicin|mesh-list
44060331|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44060332|NCT00005970|Trastuzumab|trastuzumab|mesh-list
44060333|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44060334|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
44060335|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44060336|NCT00005970|Antibodies|antibodies|mesh-list
44060337|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
44060365|NCT00005971|Alvocidib|alvocidib|mesh-list
44060394|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44060395|NCT00005975|Megestrol|megestrol|mesh-list
44060396|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
44060397|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44060398|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44060399|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44060400|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
44060401|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44060462|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44060463|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
44060464|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
44060465|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
44060535|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
44060536|NCT00005985|Carmustine|carmustine|mesh-list
44060537|NCT00005985|Etoposide|etoposide|mesh-list
44060538|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
44060609|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44060610|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060612|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
44060686|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44060687|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
44060688|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060689|NCT00005994|Ondansetron|ondansetron|mesh-list
44060690|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
44060691|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
44060692|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44060693|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060694|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44060695|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
44060707|NCT00005996|Cisplatin|cisplatin|mesh-list
44060751|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
44060752|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
44060753|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060754|NCT00006000|Cisplatin|cisplatin|mesh-list
44060755|NCT00006000|Irinotecan|irinotecan|mesh-list
44060756|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44060757|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44060758|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44060759|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060817|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44060818|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060819|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060823|NCT00006006|Interferons|interferons|mesh-list
44060891|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44060892|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44060893|NCT00006013|Growth Substances|growth substances|mesh-ancestor
44060900|NCT00006014|Semaxinib|semaxinib|mesh-list
44060962|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44060963|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
44060964|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
44060965|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
44060967|NCT00006021|Protective Agents|protective agents|mesh-ancestor
44061020|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
44061021|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061022|NCT00006028|Antiviral Agents|antiviral agents|mesh-ancestor
44061023|NCT00006028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061024|NCT00006028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061025|NCT00006028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44061026|NCT00006028|Immunologic Factors|immunologic factors|mesh-ancestor
44061027|NCT00006028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061029|NCT00006029|Doxorubicin|doxorubicin|mesh-list
44061030|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44061031|NCT00006029|Vinorelbine|vinorelbine|mesh-list
44061032|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44061049|NCT00006030|Tamoxifen|tamoxifen|mesh-list
44061080|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061081|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
44061157|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44061158|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061159|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44061232|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44061233|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44061234|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
44061235|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061236|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44061237|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44061238|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44150253|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
44150254|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
44150255|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44150256|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150257|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
44150258|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150259|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44150260|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44150261|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44150262|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44150318|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150319|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
44061296|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
44061297|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44061298|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061299|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
44061300|NCT05679453|Etodolac|etodolac|mesh-list
44061301|NCT05679453|Lornoxicam|lornoxicam|mesh-list
44061302|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44061303|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44061304|NCT05679453|Analgesics|analgesics|mesh-ancestor
44061305|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
44061358|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44061359|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44061360|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061361|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061362|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
44061363|NCT05679336|Rituximab|rituximab|mesh-list
44061375|NCT05678296|Analgesics|analgesics|mesh-list
44061425|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061426|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
44061427|NCT05660850|Mannitol|mannitol|mesh-list
44061428|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44061429|NCT05660850|Diuretics|diuretics|mesh-ancestor
44061430|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
44061431|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061432|NCT05660200|Iron|iron|mesh-list
44061433|NCT05660200|Trace Elements|trace elements|mesh-ancestor
44061434|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
44061435|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061436|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44061437|NCT05656027|Aceclidine|aceclidine|mesh-list
44061438|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44061439|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44061440|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44061441|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44061442|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061443|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061482|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
44061483|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
44061484|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061486|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
44061549|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44061550|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44061551|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
44061552|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44061553|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44061554|NCT05562713|Denatonium|denatonium|mesh-list
44061555|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
44061556|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061557|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
44061558|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061614|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44061615|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44061616|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061617|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
44061618|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44061619|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44061620|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44061621|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
44061622|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061623|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44061679|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
44061680|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44061681|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
44061682|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061683|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
44061684|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44061685|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44061686|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061687|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
44061688|NCT05470816|Coagulants|coagulants|mesh-ancestor
44061689|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
44061692|NCT05459571|Dexamethasone|dexamethasone|mesh-list
44061742|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44061743|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
44061744|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44061745|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061746|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44061747|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44061748|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44061750|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44061751|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44061752|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44061753|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44150372|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150373|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44150374|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
44150375|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150376|NCT00210041|Antiviral Agents|antiviral agents|mesh-ancestor
44150377|NCT00210041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44150378|NCT00210041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150379|NCT00210041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44150380|NCT00210041|Immunologic Factors|immunologic factors|mesh-ancestor
44150382|NCT00210132|Ropivacaine|ropivacaine|mesh-list
44061871|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44061872|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44061874|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44061875|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44061942|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
44061943|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44061944|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44061945|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44061946|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
44061947|NCT05147233|Hormones|hormones|mesh-ancestor
44061948|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062008|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
44062009|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062010|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
44062011|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
44062012|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062013|NCT04965493|Rituximab|rituximab|mesh-list
44062014|NCT04965493|Venetoclax|venetoclax|mesh-list
44062015|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062016|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062017|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
44062076|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
44062077|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062078|NCT04921722|Sirolimus|sirolimus|mesh-list
44062079|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44062080|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44062081|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44062082|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062083|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
44062113|NCT04899349|Metformin|metformin|mesh-list
44062114|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
44062115|NCT04899349|Fulvestrant|fulvestrant|mesh-list
44062116|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062117|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062118|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44062119|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062126|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
44062179|NCT04787991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062180|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44062181|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062182|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
44062252|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062253|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44062254|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062323|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
44062324|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062325|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
44062326|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
43785496|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
44062395|NCT04474223|Dexamethasone|dexamethasone|mesh-list
44062396|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44062397|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
44062398|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
44062399|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062400|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062401|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062402|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
44062403|NCT04474223|Hormones|hormones|mesh-ancestor
44062404|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062405|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44062406|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062407|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44062455|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062456|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062457|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
44062458|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062518|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062520|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
44062521|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44062522|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
44062523|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
44062524|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
44062525|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44062526|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44062586|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062587|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44062588|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062589|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062590|NCT04191187|Fludarabine|fludarabine|mesh-list
44062591|NCT04191187|Melphalan|melphalan|mesh-list
44062592|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062593|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062594|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062595|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
44062596|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062597|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44062598|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
44062599|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44062600|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
44062643|NCT04159519|Hormones|hormones|mesh-ancestor
44062644|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062645|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44062646|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44062647|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44062648|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
44062649|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062650|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062651|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
44062652|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44062654|NCT04083950|Vaccines|vaccines|mesh-list
44062655|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
44062656|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062657|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44062658|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44062659|NCT04083950|Analgesics|analgesics|mesh-ancestor
44062670|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
44062701|NCT04034927|Ipilimumab|ipilimumab|mesh-list
44062702|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44062703|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062704|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062705|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062706|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
44062707|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062769|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44062770|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44062771|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
44062772|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44062773|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
44062774|NCT03885830|Dasatinib|dasatinib|mesh-list
44062775|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44062777|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44062839|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44062840|NCT03786081|Growth Substances|growth substances|mesh-ancestor
44062841|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44062842|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
44062844|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44062845|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062846|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44062904|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44062905|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062906|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44062909|NCT03624517|Octreotide|octreotide|mesh-list
44150471|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44150473|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150474|NCT00210405|Micronutrients|micronutrients|mesh-list
44150475|NCT00210405|Trace Elements|trace elements|mesh-list
44150476|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150477|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
44150478|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44062991|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44062992|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44062994|NCT03297606|Trastuzumab|trastuzumab|mesh-list
44062995|NCT03297606|Ipilimumab|ipilimumab|mesh-list
44062996|NCT03297606|Pertuzumab|pertuzumab|mesh-list
44062997|NCT03297606|Sunitinib|sunitinib|mesh-list
44062998|NCT03297606|Dasatinib|dasatinib|mesh-list
44062999|NCT03297606|Olaparib|olaparib|mesh-list
44063000|NCT03297606|Palbociclib|palbociclib|mesh-list
44063001|NCT03297606|Axitinib|axitinib|mesh-list
44063002|NCT03297606|Vemurafenib|vemurafenib|mesh-list
44063003|NCT03297606|Crizotinib|crizotinib|mesh-list
44063004|NCT03297606|Tucatinib|tucatinib|mesh-list
44063006|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063057|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063058|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063059|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063060|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063061|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063062|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063066|NCT03080935|Evolocumab|evolocumab|mesh-list
44063124|NCT03000387|Nicotine|nicotine|mesh-list
44063125|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44063126|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
44063127|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063128|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063129|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44063130|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44063131|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
44063132|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44063190|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063191|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
44063192|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
44063193|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063194|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44063263|NCT02632760|Hematinics|hematinics|mesh-ancestor
44063264|NCT02632409|Nivolumab|nivolumab|mesh-list
44063265|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063266|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063267|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063268|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063269|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
44063270|NCT02595879|Cisplatin|cisplatin|mesh-list
44063271|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44063278|NCT02593110|Telmisartan|telmisartan|mesh-list
44063328|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063329|NCT02231749|Nivolumab|nivolumab|mesh-list
44063330|NCT02231749|Ipilimumab|ipilimumab|mesh-list
44063331|NCT02231749|Sunitinib|sunitinib|mesh-list
44063332|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063333|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063334|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44063335|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063336|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44063337|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44063338|NCT02231749|Growth Substances|growth substances|mesh-ancestor
44063339|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063340|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
44063341|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44063342|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063343|NCT02016924|Cobicistat|cobicistat|mesh-list
44063344|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44063345|NCT02016924|Emtricitabine|emtricitabine|mesh-list
44063346|NCT02016924|Tenofovir|tenofovir|mesh-list
44063347|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063348|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063349|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44063350|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44063351|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
44063352|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063353|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44063354|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44063355|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44063356|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44063357|NCT01959204|Oxycodone|oxycodone|mesh-list
44063358|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44063359|NCT01959204|Narcotics|narcotics|mesh-ancestor
44063360|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44063361|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063362|NCT01959204|Analgesics|analgesics|mesh-ancestor
44063368|NCT01853748|Trastuzumab|trastuzumab|mesh-list
44063369|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063370|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063371|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063372|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063373|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
44063374|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063375|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44063376|NCT01756248|Aflibercept|aflibercept|mesh-list
44063377|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44063378|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44063379|NCT01756248|Growth Substances|growth substances|mesh-ancestor
44063380|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063381|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
44063382|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063383|NCT00781612|Paclitaxel|paclitaxel|mesh-list
44063384|NCT00781612|Maytansine|maytansine|mesh-list
44063385|NCT00781612|Docetaxel|docetaxel|mesh-list
44063386|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44063387|NCT00781612|Trastuzumab|trastuzumab|mesh-list
44063388|NCT00781612|Atezolizumab|atezolizumab|mesh-list
44063389|NCT00781612|Pertuzumab|pertuzumab|mesh-list
44063390|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44063391|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063392|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
44063393|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
44063394|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
44150504|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150506|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44150507|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
44150508|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150509|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150510|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150511|NCT00210535|Topiramate|topiramate|mesh-list
44150513|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44150514|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150515|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44150529|NCT00210561|Acetaminophen|acetaminophen|mesh-list
44063413|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063414|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063415|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063416|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063417|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063418|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
44063419|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
44063422|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
44063482|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063483|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
44063484|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063485|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063486|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063487|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
44063488|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063489|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
44063500|NCT00006054|Prednisone|prednisone|mesh-list
44063549|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44063550|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
44063551|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063552|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063553|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44063554|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
44063555|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063556|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063617|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44063618|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44063619|NCT00006070|Analgesics|analgesics|mesh-ancestor
44063620|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
44063621|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44063622|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063623|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44063624|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44063685|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
44063686|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44063688|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063689|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44063914|NCT00006115|Protective Agents|protective agents|mesh-ancestor
44063915|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
44063916|NCT00006115|Vitamins|vitamins|mesh-ancestor
44063917|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
44063918|NCT00006116|Gemcitabine|gemcitabine|mesh-list
44063919|NCT00006116|Cisplatin|cisplatin|mesh-list
44063920|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44063921|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44063922|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
44063923|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063924|NCT00006116|Antiviral Agents|antiviral agents|mesh-ancestor
44063925|NCT00006116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44063982|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44063983|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44063984|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064132|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44064133|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44150555|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
44064241|NCT00006190|Lamivudine|lamivudine|mesh-list
44064243|NCT00006190|Stavudine|stavudine|mesh-list
44064244|NCT00006190|Nelfinavir|nelfinavir|mesh-list
44064245|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44064246|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44064247|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064248|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44064249|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
44064250|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064251|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44064252|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44064307|NCT00006199|Tipifarnib|tipifarnib|mesh-list
44064308|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44064309|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44064310|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064379|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
44064451|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44064453|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
44064454|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064455|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
44064456|NCT00006220|Tretinoin|tretinoin|mesh-list
44064457|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064458|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
44064520|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064522|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
44064593|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
44064596|NCT00006245|Paclitaxel|paclitaxel|mesh-list
44064668|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064742|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44064817|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064818|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
44064819|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064820|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44064821|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
44064822|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44064823|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44064824|NCT00006267|Rubitecan|rubitecan|mesh-list
44064825|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44064877|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44064878|NCT00006286|Fluoxetine|fluoxetine|mesh-list
44064879|NCT00006286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44064880|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44064898|NCT00006292|Infliximab|infliximab|mesh-list
44065023|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065101|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065177|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44065178|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44065179|NCT00006361|Growth Substances|growth substances|mesh-ancestor
44065180|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065181|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
44065182|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065183|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44065184|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065185|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065186|NCT00006362|Bortezomib|bortezomib|mesh-list
44065188|NCT00006363|Cytarabine|cytarabine|mesh-list
44065241|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065242|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065243|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
44065244|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44065310|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065311|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44150605|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44150610|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
44065430|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44065431|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
44065432|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
44065433|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065434|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
44065435|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065436|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44065437|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44065438|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
44065439|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065440|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065441|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44065442|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44065443|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
44065444|NCT00006391|Topotecan|topotecan|mesh-list
44065445|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065446|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44065447|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065448|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787943|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44065449|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150656|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
44065485|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44065715|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
44065797|NCT00006468|Vitamins|vitamins|mesh-ancestor
44065865|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065866|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44065867|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44065868|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44065869|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
44065870|NCT00006479|Antidotes|antidotes|mesh-ancestor
44065871|NCT00006479|Protective Agents|protective agents|mesh-ancestor
44065872|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
44065873|NCT00006479|Vitamins|vitamins|mesh-ancestor
44065874|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
44065932|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44065933|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44065934|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44065935|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44065936|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065937|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
44065938|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44065940|NCT00006508|Insulin|insulin|mesh-list
44066036|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066037|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
44066038|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066039|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066040|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066041|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066042|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066043|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066044|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066101|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066102|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066103|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
44066104|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
44066105|NCT00006734|Ifosfamide|ifosfamide|mesh-list
44066106|NCT00006734|Doxorubicin|doxorubicin|mesh-list
44066107|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44066108|NCT00006734|Etoposide|etoposide|mesh-list
44066109|NCT00006734|Vincristine|vincristine|mesh-list
44066110|NCT00006734|Lenograstim|lenograstim|mesh-list
44066111|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066129|NCT00006747|Cytarabine|cytarabine|mesh-list
44066167|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066168|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066169|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
44066170|NCT00006773|Bortezomib|bortezomib|mesh-list
44066171|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066172|NCT00006786|Leucovorin|leucovorin|mesh-list
44066173|NCT00006786|Bevacizumab|bevacizumab|mesh-list
44066175|NCT00006786|Irinotecan|irinotecan|mesh-list
44066176|NCT00006786|Calcium|calcium|mesh-list
44066177|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
44066178|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44066179|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066180|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44066182|NCT00006786|Growth Substances|growth substances|mesh-ancestor
44066231|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44066232|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
44066233|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066234|NCT00006877|Temozolomide|temozolomide|mesh-list
44066235|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066236|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
44066238|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066299|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066300|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066301|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
44066302|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066303|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44066304|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
44066305|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44066306|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44066307|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066363|NCT00007358|Hormones|hormones|mesh-ancestor
44066364|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066365|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066366|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066367|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
44066368|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44066369|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
44066370|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066371|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066426|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
44066427|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
44066428|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066429|NCT00007631|Tretinoin|tretinoin|mesh-list
44066430|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066431|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
44066432|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066433|NCT00007670|Lamotrigine|lamotrigine|mesh-list
44066434|NCT00007670|Carbamazepine|carbamazepine|mesh-list
44066435|NCT00007670|Gabapentin|gabapentin|mesh-list
44066436|NCT00007670|Analgesics|analgesics|mesh-ancestor
44066493|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44066494|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066495|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771201|NCT02374567|Mianserin|mianserin|mesh-list
44066496|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44066497|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44066498|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44066499|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44066500|NCT00007774|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44066501|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44066560|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066561|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44066562|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066563|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066564|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066566|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066630|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066631|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44066632|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
44066633|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066634|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066635|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066636|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066637|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066638|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44150774|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44150775|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44066714|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066715|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44066716|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
44066717|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44066718|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
44066719|NCT00008008|Thiotepa|thiotepa|mesh-list
44066720|NCT00008008|Sargramostim|sargramostim|mesh-list
44066721|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066722|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
44066723|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066724|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066781|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066782|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
44066783|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066784|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
44066785|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066786|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44066787|NCT00008060|Leucovorin|leucovorin|mesh-list
44066788|NCT00008060|Fluorouracil|fluorouracil|mesh-list
44066789|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
44066790|NCT00008060|Irinotecan|irinotecan|mesh-list
44066849|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44066850|NCT00008151|Cyclosporine|cyclosporine|mesh-list
44066851|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
44066852|NCT00008151|Methotrexate|methotrexate|mesh-list
44066853|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
44066854|NCT00008151|Fludarabine|fludarabine|mesh-list
44066855|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
44066856|NCT00008151|Cyclosporins|cyclosporins|mesh-list
44066857|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44066858|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
44066859|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44066860|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066861|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44066862|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
44066863|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44066864|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066865|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
44066909|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
44066910|NCT00008190|Aldesleukin|aldesleukin|mesh-list
44066911|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
44066912|NCT00008190|Melphalan|melphalan|mesh-list
44066913|NCT00008190|Busulfan|busulfan|mesh-list
44066914|NCT00008190|Etoposide|etoposide|mesh-list
44066915|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44066916|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
44066917|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44066918|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44066920|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
44066978|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44066979|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44066980|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44066981|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44066982|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44066983|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44066984|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44066986|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067044|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44067045|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
44067046|NCT00008294|Antidotes|antidotes|mesh-ancestor
44067047|NCT00008294|Protective Agents|protective agents|mesh-ancestor
44067048|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
44067049|NCT00008294|Vitamins|vitamins|mesh-ancestor
44067050|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
44067051|NCT00008307|Cyclosporine|cyclosporine|mesh-list
44067052|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
44067115|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
44067116|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
44067117|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067119|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44067120|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44067121|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067122|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067123|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067182|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
44067183|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067184|NCT00008554|Lamivudine|lamivudine|mesh-list
44067185|NCT00008554|Abacavir|abacavir|mesh-list
44067186|NCT00008554|Nelfinavir|nelfinavir|mesh-list
44067188|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44067189|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44067190|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067191|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067192|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
44067193|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067248|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
44067249|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
44067250|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067251|NCT05636566|Analgesics|analgesics|mesh-ancestor
44067252|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
44067253|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067254|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44067255|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44067256|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44067257|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
44067258|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150832|NCT00211471|Growth Substances|growth substances|mesh-ancestor
44150833|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150834|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150835|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150836|NCT00211484|Anecortave|anecortave|mesh-list
44150837|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44150838|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44150839|NCT00211484|Growth Substances|growth substances|mesh-ancestor
44150840|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150841|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
44150842|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44150843|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
44150847|NCT00211562|Vitamin E|vitamin e|mesh-list
44067299|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44067300|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44067301|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44067302|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067303|NCT05637281|Indomethacin|indomethacin|mesh-list
44067304|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44067305|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067306|NCT05637281|Analgesics|analgesics|mesh-ancestor
44067307|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
44067308|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067309|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067363|NCT05638217|Fluorides|fluorides|mesh-list
44067364|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
44067365|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
44067366|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
44067367|NCT05638217|Protective Agents|protective agents|mesh-ancestor
44067368|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067369|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44067370|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44067371|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44067372|NCT05638295|Panitumumab|panitumumab|mesh-list
44067373|NCT05638295|Antibodies|antibodies|mesh-list
44067428|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067429|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067430|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067431|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
44067432|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
44067433|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067434|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44067435|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44150866|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
44067445|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44067446|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44067447|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44067448|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
44067449|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44067450|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067451|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44067452|NCT05638867|Aspirin|aspirin|mesh-list
44067509|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44067510|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067511|NCT05639257|Mexiletine|mexiletine|mesh-list
44067512|NCT05639257|Lamotrigine|lamotrigine|mesh-list
44067513|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
44067514|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44067515|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44067516|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067517|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44067518|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067574|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067575|NCT00000114|Protective Agents|protective agents|mesh-ancestor
44067576|NCT00000115|Acetazolamide|acetazolamide|mesh-list
44067577|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
44067578|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44067579|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44067580|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067581|NCT00000115|Diuretics|diuretics|mesh-ancestor
44067582|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
44067641|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067642|NCT00000145|Zinc|zinc|mesh-list
44067643|NCT00000145|Antioxidants|antioxidants|mesh-list
44067644|NCT00000145|Trace Elements|trace elements|mesh-ancestor
44067645|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
44067646|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067647|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067648|NCT00000145|Protective Agents|protective agents|mesh-ancestor
44067649|NCT00000146|Prednisone|prednisone|mesh-list
44067650|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
44067651|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44067652|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44067653|NCT00000146|Prednisolone|prednisolone|mesh-list
44067654|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
44067655|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44067656|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
44067657|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067658|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
44067701|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
44067702|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067703|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067704|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44067705|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44067706|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44067707|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44067708|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067709|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44067710|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44150917|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
44150918|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44150919|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44150920|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44150921|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43628193|NCT03068065|Metformin|metformin|mesh-list
44150922|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44150923|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
44150924|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44150925|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150926|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44150927|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150929|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
44067763|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44067764|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44067765|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
44067766|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067767|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067768|NCT00000171|Melatonin|melatonin|mesh-list
44067769|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
44067770|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067771|NCT00000171|Protective Agents|protective agents|mesh-ancestor
44067772|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067773|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067828|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44067829|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44067830|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44067831|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44067832|NCT00000179|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44067833|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44067834|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44067835|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
44067836|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44067837|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
44067838|NCT00000187|Ritanserin|ritanserin|mesh-list
44067890|NCT00000216|Analgesics|analgesics|mesh-ancestor
44067891|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
44067892|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067893|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44067894|NCT00000220|Buprenorphine|buprenorphine|mesh-list
44067895|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44067896|NCT00000220|Narcotics|narcotics|mesh-ancestor
44067897|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067898|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067899|NCT00000220|Analgesics|analgesics|mesh-ancestor
44067900|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
44067901|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44067954|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
44067955|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44067956|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
44067957|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
44067958|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44067959|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44067960|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44067961|NCT00000257|Analgesics|analgesics|mesh-ancestor
44067962|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
44067963|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068016|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068017|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068019|NCT00000378|Nortriptyline|nortriptyline|mesh-list
44068020|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068021|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068022|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44068023|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068024|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068025|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068027|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
44068080|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068081|NCT00000419|Estrogens|estrogens|mesh-ancestor
44068082|NCT00000419|Hormones|hormones|mesh-ancestor
44068083|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44068084|NCT00000420|Norinyl|norinyl|mesh-list
44068085|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44068086|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44068087|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44068088|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
44068089|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44068090|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068091|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44068092|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44068093|NCT00000421|Prednisone|prednisone|mesh-list
44068094|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068096|NCT00000421|Hormones|hormones|mesh-ancestor
44068138|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44068139|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068140|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
44068141|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068142|NCT00000457|Bupropion|bupropion|mesh-list
44068143|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44068144|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
44068145|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068156|NCT00000461|Niacin|niacin|mesh-list
44068202|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068203|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44068274|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068275|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
44068276|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
44068277|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068278|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44068279|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44068280|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068281|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068282|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068283|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44068340|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068341|NCT00000491|Analgesics|analgesics|mesh-ancestor
44068342|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
44068343|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068344|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068345|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068346|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068347|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068406|NCT00000499|Diuretics|diuretics|mesh-ancestor
44068407|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
44068408|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44068409|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068410|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068411|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44068412|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44068413|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44068414|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44068415|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068416|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068417|NCT00000500|Aspirin|aspirin|mesh-list
44068418|NCT00000500|Carotenoids|carotenoids|mesh-list
44068419|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44068420|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068421|NCT00000500|Analgesics|analgesics|mesh-ancestor
44068422|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
44068423|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068424|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068425|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44068426|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068427|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44068428|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44068429|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068430|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44068431|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44068432|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44068454|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44068455|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44068456|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
44068457|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068458|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44150968|NCT00211952|Analgesics|analgesics|mesh-ancestor
44150969|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
44150970|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44150971|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068477|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068478|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44068479|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44068550|NCT00000522|Enalapril|enalapril|mesh-list
44068551|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
44068552|NCT00000522|Doxazosin|doxazosin|mesh-list
44068553|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068554|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44068555|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068557|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068618|NCT00000527|Dipyridamole|dipyridamole|mesh-list
44068619|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44068620|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44068621|NCT00000527|Analgesics|analgesics|mesh-ancestor
44068622|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
44068687|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068688|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
44068689|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
44068690|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068691|NCT00000539|Protective Agents|protective agents|mesh-ancestor
44068692|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44068761|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44068762|NCT00000556|Protective Agents|protective agents|mesh-ancestor
44068763|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068764|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
44068765|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44068766|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44068767|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44068768|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44068769|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44068770|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44068771|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44068772|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44068773|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44068774|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44068775|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44068776|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44068777|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068778|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
44068779|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
44068780|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44068781|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44068782|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44068783|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
44068784|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44068785|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44068786|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44068787|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44068804|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44068805|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44068806|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44068807|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44068808|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44068809|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44068810|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44068811|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
44068812|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44068813|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44068867|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44068868|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
44068869|NCT00000579|Ketoconazole|ketoconazole|mesh-list
44068870|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
44068871|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44068872|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44068873|NCT00000579|Prednisolone|prednisolone|mesh-list
44068874|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
44068875|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44068876|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
44068931|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
44068932|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44068933|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44068934|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44068935|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
44068937|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069001|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44069002|NCT00000612|Hormones|hormones|mesh-ancestor
44069003|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069004|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069005|NCT00000620|Insulin|insulin|mesh-list
44069006|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44069007|NCT00000620|Metformin|metformin|mesh-list
44069008|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
44069009|NCT00000620|Pioglitazone|pioglitazone|mesh-list
44069010|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
44069011|NCT00000620|Glimepiride|glimepiride|mesh-list
44069012|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
44069068|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
44069069|NCT00000620|Protective Agents|protective agents|mesh-ancestor
44069070|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44069071|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44069072|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44069073|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
44069074|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44069075|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44069076|NCT00000620|Urological Agents|urological agents|mesh-ancestor
44069132|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44069133|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069134|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44069135|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44069136|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44069137|NCT00000639|Amebicides|amebicides|mesh-ancestor
44069138|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069139|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069140|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069141|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
44069142|NCT00000640|Clindamycin|clindamycin|mesh-list
44069143|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
44069144|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
44069145|NCT00000640|Dapsone|dapsone|mesh-list
44069147|NCT00000640|Primaquine|primaquine|mesh-list
44069190|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44069191|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44069192|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
44069193|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069194|NCT00000643|Leucovorin|leucovorin|mesh-list
44069195|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
44069196|NCT00000643|Calcium|calcium|mesh-list
44069197|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
44069198|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44069199|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069200|NCT00000643|Antidotes|antidotes|mesh-ancestor
44069201|NCT00000643|Protective Agents|protective agents|mesh-ancestor
44069202|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
44069256|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069257|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069258|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069259|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069260|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
44069261|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069262|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069263|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069264|NCT00000665|Ganciclovir|ganciclovir|mesh-list
44069265|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44069266|NCT00000665|Foscarnet|foscarnet|mesh-list
44069267|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
44069268|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
44069269|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069270|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069317|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069318|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069319|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44069320|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069321|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069322|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
44069323|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069384|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44069385|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44069386|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44069387|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
44069388|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069389|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069390|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
44069391|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069429|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069430|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
44069431|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069432|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069433|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069434|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069435|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069436|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069437|NCT00000688|Ganciclovir|ganciclovir|mesh-list
44069438|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44069439|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
44069440|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069494|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
44069495|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
44069497|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
44069498|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
44069499|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
44069500|NCT00000696|Interferons|interferons|mesh-list
44069501|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
44069502|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
44069503|NCT00000696|Zidovudine|zidovudine|mesh-list
44069504|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44069505|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
44069506|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069507|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
44069508|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069509|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
44069510|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069511|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069512|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069551|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069552|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
44069553|NCT00000710|Didanosine|didanosine|mesh-list
44069554|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
44069555|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069556|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069557|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069558|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069618|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
44069619|NCT00000717|Primaquine|primaquine|mesh-list
44069620|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069621|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069622|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44069623|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069624|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069625|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
44069628|NCT00000718|Zidovudine|zidovudine|mesh-list
44069687|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44069688|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
44069689|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44069690|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44069691|NCT00000741|Prednisolone|prednisolone|mesh-list
44069692|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
44069693|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44069694|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
44069695|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44069696|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
44069697|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
44069698|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069702|NCT00000741|Hormones|hormones|mesh-ancestor
44069748|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44069749|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
44069750|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44069751|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069752|NCT00000748|Renal Agents|renal agents|mesh-ancestor
44069753|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
44069754|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44069755|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44069756|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44069815|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069816|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44069817|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069818|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069819|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
44069820|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069821|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44069822|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44069823|NCT00000754|Interferons|interferons|mesh-list
44069824|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
44069825|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
44069826|NCT00000754|Zidovudine|zidovudine|mesh-list
44069827|NCT00000754|Zalcitabine|zalcitabine|mesh-list
44069840|NCT00000755|Zidovudine|zidovudine|mesh-list
44069878|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44069879|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069880|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069881|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44069882|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44069883|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
44069884|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069885|NCT00000779|Antacids|antacids|mesh-ancestor
44069886|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069887|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44069888|NCT00000788|Fluconazole|fluconazole|mesh-list
44069889|NCT00000788|Methadone|methadone|mesh-list
44069890|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44069891|NCT00000788|Narcotics|narcotics|mesh-ancestor
44069938|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44069939|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44069940|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44069941|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44069942|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
44069943|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44069945|NCT00000793|Amitriptyline|amitriptyline|mesh-list
44069946|NCT00000793|Benztropine|benztropine|mesh-list
44069947|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44069948|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
44069949|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44069950|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44069951|NCT00000793|Analgesics|analgesics|mesh-ancestor
44069952|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
44069953|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44069959|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
44069998|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
44069999|NCT00000799|Cidofovir|cidofovir|mesh-list
44070000|NCT00000799|Probenecid|probenecid|mesh-list
44070001|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
44070002|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
44070003|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44070004|NCT00000799|Renal Agents|renal agents|mesh-ancestor
44070005|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
44070006|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070007|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070008|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070009|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
44070010|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44070062|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070063|NCT00000822|Ritonavir|ritonavir|mesh-list
44070064|NCT00000822|Didanosine|didanosine|mesh-list
44070065|NCT00000822|Stavudine|stavudine|mesh-list
44070066|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070067|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070068|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070069|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070070|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070128|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
44070129|NCT00000849|Aldesleukin|aldesleukin|mesh-list
44070130|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070131|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070132|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070133|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
44070134|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070135|NCT00000851|Didanosine|didanosine|mesh-list
44070136|NCT00000851|Stavudine|stavudine|mesh-list
44070137|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
44070138|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070146|NCT00000855|Zidovudine|zidovudine|mesh-list
44070192|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070193|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
44070194|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070195|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070196|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070197|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070198|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070199|NCT00000870|Lamivudine|lamivudine|mesh-list
44070200|NCT00000870|Zidovudine|zidovudine|mesh-list
44070201|NCT00000870|Didanosine|didanosine|mesh-list
44070202|NCT00000870|Stavudine|stavudine|mesh-list
44070203|NCT00000870|Aldesleukin|aldesleukin|mesh-list
44070204|NCT00000870|Indinavir|indinavir|mesh-list
44070205|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070218|NCT00000877|Indinavir|indinavir|mesh-list
44070257|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44070258|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070259|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070260|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070261|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070262|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
44070263|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070264|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44070265|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070268|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
44070322|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070323|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44070324|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44070396|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070397|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
44070398|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070399|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44070400|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44070401|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44070402|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070403|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070464|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070465|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070466|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
44070467|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44070468|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44070469|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44070470|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44070471|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44070472|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070530|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44070531|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
44070532|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44070533|NCT00000941|Ritonavir|ritonavir|mesh-list
44070534|NCT00000941|Nelfinavir|nelfinavir|mesh-list
44070535|NCT00000941|Saquinavir|saquinavir|mesh-list
44070536|NCT00000941|Atorvastatin|atorvastatin|mesh-list
44070537|NCT00000941|Simvastatin|simvastatin|mesh-list
44070538|NCT00000941|Pravastatin|pravastatin|mesh-list
44070539|NCT00000941|Calcium|calcium|mesh-list
44151042|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151043|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151044|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
44070624|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070625|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070626|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070627|NCT00000966|Leucovorin|leucovorin|mesh-list
44070628|NCT00000966|Azithromycin|azithromycin|mesh-list
44070629|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
44070630|NCT00000966|Calcium|calcium|mesh-list
44070631|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
44070632|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070633|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070634|NCT00000966|Antidotes|antidotes|mesh-ancestor
44070635|NCT00000966|Protective Agents|protective agents|mesh-ancestor
44070689|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070690|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070691|NCT00000973|Antidotes|antidotes|mesh-ancestor
44070692|NCT00000973|Protective Agents|protective agents|mesh-ancestor
44070693|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070694|NCT00000973|Vitamins|vitamins|mesh-ancestor
44070695|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
44070696|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
44070697|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070755|NCT00000998|Leucovorin|leucovorin|mesh-list
44070756|NCT00000998|Trimetrexate|trimetrexate|mesh-list
44070757|NCT00000998|Calcium|calcium|mesh-list
44070758|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
44070759|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44070760|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44070761|NCT00000998|Antidotes|antidotes|mesh-ancestor
44070762|NCT00000998|Protective Agents|protective agents|mesh-ancestor
44070763|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
44070824|NCT00001004|Interferons|interferons|mesh-list
44070825|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
44070826|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44070827|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
44070828|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070830|NCT00001005|Aldesleukin|aldesleukin|mesh-list
44070831|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
44070832|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070833|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070835|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070890|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44070891|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44070892|NCT00001013|Leucovorin|leucovorin|mesh-list
44070893|NCT00001013|Trimethoprim|trimethoprim|mesh-list
44070894|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44070895|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
44070896|NCT00001013|Pentamidine|pentamidine|mesh-list
44070897|NCT00001013|Trimetrexate|trimetrexate|mesh-list
44070960|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44070961|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44070962|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44070963|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44070964|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
44070965|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44070966|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071027|NCT00001036|Interleukin-2|interleukin-2|mesh-list
44071028|NCT00001036|Thymalfasin|thymalfasin|mesh-list
44071029|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071030|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44071031|NCT00001036|Analgesics|analgesics|mesh-ancestor
44071032|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
44071033|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071034|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071035|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
44071036|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071094|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44071095|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
44071096|NCT00001048|Cytarabine|cytarabine|mesh-list
44071169|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071170|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
44071171|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44071172|NCT00001076|Protective Agents|protective agents|mesh-ancestor
44071173|NCT00001083|Ritonavir|ritonavir|mesh-list
44071174|NCT00001083|Indinavir|indinavir|mesh-list
44071175|NCT00001083|Lamivudine|lamivudine|mesh-list
44071176|NCT00001083|Zidovudine|zidovudine|mesh-list
44071177|NCT00001083|Nevirapine|nevirapine|mesh-list
44071238|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44071239|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071240|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44071241|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44071242|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44071243|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44071249|NCT00001087|Ritonavir|ritonavir|mesh-list
44071306|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071307|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071308|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071309|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071310|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071311|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071312|NCT00001114|Interferons|interferons|mesh-list
44071313|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
44071314|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
44071315|NCT00001114|Didanosine|didanosine|mesh-list
44071316|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071317|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
44071318|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071319|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
44071320|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071366|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44071367|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
44071368|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44071369|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44071370|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44071435|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071436|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44071437|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44071438|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
44071439|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071440|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071441|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44071442|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44071443|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
44071445|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151126|NCT00212342|Hormones|hormones|mesh-ancestor
44151127|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44151128|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44151129|NCT00212472|Factor VIII|factor viii|mesh-list
44151130|NCT00212472|Coagulants|coagulants|mesh-ancestor
44151131|NCT00212589|Leucovorin|leucovorin|mesh-list
44151132|NCT00212589|Folic Acid|folic acid|mesh-list
44151133|NCT00212589|Fluorouracil|fluorouracil|mesh-list
43792771|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
44151134|NCT00212589|Capecitabine|capecitabine|mesh-list
44151135|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
44151136|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
44071455|NCT00001221|Hormones|hormones|mesh-list
44071510|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071511|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44071512|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
44071514|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071580|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071581|NCT00001341|Raltitrexed|raltitrexed|mesh-list
44071582|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44071583|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
44071584|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071585|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071586|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44071587|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071588|NCT00001343|Oxandrolone|oxandrolone|mesh-list
44071589|NCT00001343|Androgens|androgens|mesh-ancestor
44071590|NCT00001343|Hormones|hormones|mesh-ancestor
44071591|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44071640|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44071641|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44071642|NCT00001457|Lamivudine|lamivudine|mesh-list
44071643|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44071644|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44071645|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071646|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071707|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44071708|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44071709|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071710|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44071738|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44071739|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44071740|NCT00001524|Growth Substances|growth substances|mesh-ancestor
44071741|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44071742|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44071743|NCT00001533|Cyclosporine|cyclosporine|mesh-list
44071744|NCT00001533|Cyclosporins|cyclosporins|mesh-list
44071745|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071804|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071805|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44071807|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44071808|NCT00001576|Leucovorin|leucovorin|mesh-list
44071809|NCT00001576|Melphalan|melphalan|mesh-list
44071810|NCT00001576|Floxuridine|floxuridine|mesh-list
44071811|NCT00001576|Antidotes|antidotes|mesh-ancestor
44071812|NCT00001576|Protective Agents|protective agents|mesh-ancestor
44071813|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071870|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44071871|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44071872|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
44071873|NCT00001649|Valacyclovir|valacyclovir|mesh-list
44071874|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
44071875|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071876|NCT00001656|Olanzapine|olanzapine|mesh-list
44071877|NCT00001656|Clozapine|clozapine|mesh-list
44071878|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
44071879|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
44071880|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44071881|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44071882|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44071883|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44071884|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44071885|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44071886|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44071887|NCT00001656|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44071888|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44071889|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071890|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071891|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071892|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
44071893|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44071894|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
44071895|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
44071896|NCT00001666|Methamphetamine|methamphetamine|mesh-list
44071919|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44071920|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071921|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44071922|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44071923|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
44071924|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44071925|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44071932|NCT00001693|Celecoxib|celecoxib|mesh-list
44071984|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
44071985|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44071986|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44071987|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44071988|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44071990|NCT00001728|Alendronate|alendronate|mesh-list
44072046|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44072047|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44072048|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44072049|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44072050|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44072051|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
44072052|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44072053|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44072054|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44072055|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
44072056|NCT00001763|Interleukin-12|interleukin-12|mesh-list
44072057|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44072058|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
44072059|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072106|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072107|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072108|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
44072109|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072110|NCT00001784|Mexiletine|mexiletine|mesh-list
44072111|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44072112|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44072169|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072170|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072171|NCT05641376|Analgesics|analgesics|mesh-ancestor
44072172|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
44072173|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072238|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44072239|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44072240|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
44072311|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072312|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44072385|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072387|NCT05640479|Analgesics|analgesics|mesh-ancestor
44072408|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44072409|NCT05640453|Analgesics|analgesics|mesh-ancestor
44072410|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
43652076|NCT03002831|Tegafur|tegafur|mesh-list
44072411|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072412|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44072413|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072414|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072415|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072416|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072417|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072418|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
44072419|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44072420|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44072467|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072468|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072469|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072470|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072472|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44072473|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072474|NCT05637606|Etilefrine|etilefrine|mesh-list
44072475|NCT05637606|Norepinephrine|norepinephrine|mesh-list
44072476|NCT05637606|Ephedrine|ephedrine|mesh-list
44072477|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
44072478|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44072479|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072484|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
44072529|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44072530|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44072531|NCT05636787|Melphalan|melphalan|mesh-list
44072532|NCT05636787|Treosulfan|treosulfan|mesh-list
44072533|NCT05636787|Busulfan|busulfan|mesh-list
44072601|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
44072602|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072603|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072604|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44072605|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44072606|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44072607|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072608|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072609|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44072666|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072667|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072668|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072669|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
44072670|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072671|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072672|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44151203|NCT00213096|ST 1435|st 1435|mesh-list
44072704|NCT05604222|Mirabegron|mirabegron|mesh-list
44072705|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44072706|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44072707|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44072708|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
44072709|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072710|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072711|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072774|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44072775|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44072776|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
44072777|NCT05545280|Neostigmine|neostigmine|mesh-list
44072778|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44072779|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44072780|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072781|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
44072782|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44072783|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072784|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44072785|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
44072786|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44072787|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44072788|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44072789|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44072790|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44072794|NCT05519683|Citalopram|citalopram|mesh-list
44072827|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
44072828|NCT05482542|Rituximab|rituximab|mesh-list
44072829|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072830|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
44072831|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44072832|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44072833|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44072834|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
44072835|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072836|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072837|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44072838|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44072889|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
44072890|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072891|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
44072892|NCT05428488|Abatacept|abatacept|mesh-list
44072893|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44072894|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44072895|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44072896|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44072954|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44072955|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44072956|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44072957|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
44072958|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
44072959|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
44072960|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44072961|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44072962|NCT05371093|Growth Substances|growth substances|mesh-ancestor
44073017|NCT05321160|Esketamine|esketamine|mesh-list
44073018|NCT05321160|Analgesics|analgesics|mesh-ancestor
44073019|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
44073020|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073021|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073022|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44073023|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44073024|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
44073070|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073071|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073073|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073074|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073075|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073076|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073077|NCT05223673|Trifluridine|trifluridine|mesh-list
44073078|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
44073083|NCT05219435|Nivolumab|nivolumab|mesh-list
44151251|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151253|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44151254|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
44151255|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44151256|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
44151257|NCT00213252|Montelukast|montelukast|mesh-list
44151258|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44151259|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
44151260|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44073143|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073144|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073216|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073217|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44073289|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073290|NCT04999241|Mesalamine|mesalamine|mesh-list
44073291|NCT04999241|Infliximab|infliximab|mesh-list
44073292|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073293|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44073294|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44073295|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44073296|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44073297|NCT04999241|Analgesics|analgesics|mesh-ancestor
44073333|NCT04908371|Racepinephrine|racepinephrine|mesh-list
44073334|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
44073335|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
44073336|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
44073337|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
44073338|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44073339|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073340|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
44073341|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073342|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44073343|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44073348|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44073395|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44073396|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073397|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073398|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073400|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
44073401|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073402|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
44073403|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44073404|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
44073405|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
44073406|NCT04862221|Promethazine|promethazine|mesh-list
44073407|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
44073408|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44073457|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073458|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
44073459|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073460|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073461|NCT04827953|Gemcitabine|gemcitabine|mesh-list
44073462|NCT04827953|Paclitaxel|paclitaxel|mesh-list
44073463|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44073464|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073465|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44073466|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44073467|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44073468|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073469|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44073518|NCT04784637|Insulin|insulin|mesh-list
44073519|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44073520|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073522|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073523|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073524|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
44073525|NCT04767776|Charcoal|charcoal|mesh-list
44073536|NCT04762953|Leucovorin|leucovorin|mesh-list
44073589|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
44073590|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073591|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073592|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
44073593|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
44073594|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073595|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44073647|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073648|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073649|NCT04619706|Palmidrol|palmidrol|mesh-list
44073650|NCT04619706|Analgesics|analgesics|mesh-ancestor
44073651|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
44073652|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073653|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073654|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44073718|NCT04551482|Oxytocin|oxytocin|mesh-list
44073719|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
44073720|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44073721|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073722|NCT04547530|Vitamin D|vitamin d|mesh-list
44073723|NCT04547530|Vitamins|vitamins|mesh-ancestor
44073724|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
44073725|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073726|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44073786|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44073787|NCT04476030|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44073788|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44073789|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44073790|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073791|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073854|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073856|NCT04340076|Brodalumab|brodalumab|mesh-list
44073857|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
44151337|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151338|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44151339|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44158016|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44073859|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073860|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44073861|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44073862|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073864|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44073865|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44073866|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44073924|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073925|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44073926|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44073927|NCT04226690|Analgesics|analgesics|mesh-ancestor
44073928|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
44073929|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44073930|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44073931|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44073932|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44073933|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44073934|NCT04226690|Hormones|hormones|mesh-ancestor
44073935|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44073936|NCT04205812|Paclitaxel|paclitaxel|mesh-list
44073937|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44073938|NCT04205812|Cisplatin|cisplatin|mesh-list
44073940|NCT04205812|Pemetrexed|pemetrexed|mesh-list
44073982|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
44073983|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44073993|NCT04071756|Tazarotene|tazarotene|mesh-list
44073994|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44073995|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
44073996|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
44073997|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44073998|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44073999|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44074000|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44074001|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074002|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
44074003|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074004|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074005|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44074006|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074007|NCT04062708|Durvalumab|durvalumab|mesh-list
44074008|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074009|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074010|NCT04061798|Heparin|heparin|mesh-list
44074037|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074038|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074040|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44074041|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44074042|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074043|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
44074044|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44074045|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074104|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
44074106|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074107|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074108|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074109|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074115|NCT03991741|Interleukin-2|interleukin-2|mesh-list
44074158|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44074159|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44074160|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44074161|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44074162|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44074163|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
44074164|NCT03890666|Albuterol|albuterol|mesh-list
44074165|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44074166|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
44074167|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074168|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074169|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44074170|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44074171|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
44074172|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44074173|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44074174|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44074175|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44074176|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
44074177|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44074178|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074179|NCT03879408|Acetaminophen|acetaminophen|mesh-list
44074180|NCT03879408|Naproxen|naproxen|mesh-list
44074181|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44074182|NCT03879408|Hydrocodone|hydrocodone|mesh-list
44074183|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074184|NCT03879408|Analgesics|analgesics|mesh-ancestor
43572265|NCT00028639|Bortezomib|bortezomib|mesh-list
44074205|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074206|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074207|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074208|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
44074210|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074211|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44074273|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074274|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44074275|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44074276|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074277|NCT03837977|Antidotes|antidotes|mesh-ancestor
44074278|NCT03837977|Protective Agents|protective agents|mesh-ancestor
44074279|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
44074280|NCT03837977|Vitamins|vitamins|mesh-ancestor
44074404|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
44074406|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074476|NCT03593018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074477|NCT03593018|Immunologic Factors|immunologic factors|mesh-ancestor
44074478|NCT03593018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074479|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074480|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
44074481|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074482|NCT03588767|Vitamin D|vitamin d|mesh-list
44074483|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
44074548|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074549|NCT03555149|Bevacizumab|bevacizumab|mesh-list
44074550|NCT03555149|Atezolizumab|atezolizumab|mesh-list
44074551|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074552|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074553|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44074554|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44074555|NCT03555149|Growth Substances|growth substances|mesh-ancestor
44074557|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
44074595|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074596|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074597|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44074598|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
44074599|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074600|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771249|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
44074601|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44074602|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44074603|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44074604|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44074605|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44074657|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074659|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074661|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44074662|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44074663|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074664|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074665|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074666|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44074667|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44074669|NCT03272295|Menthol|menthol|mesh-list
44074722|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44074723|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44074724|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44074725|NCT03128021|Analgesics|analgesics|mesh-ancestor
44074726|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
44074727|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
44074728|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
44074730|NCT03096782|Busulfan|busulfan|mesh-list
44074791|NCT03087071|Antibodies|antibodies|mesh-list
44074792|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
44074793|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44074794|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
44074795|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074796|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074797|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44074798|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44074799|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074800|NCT03081143|Paclitaxel|paclitaxel|mesh-list
44074801|NCT03081143|Ramucirumab|ramucirumab|mesh-list
44074802|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44074803|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074804|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
44074805|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795440|NCT03865082|Nivolumab|nivolumab|mesh-list
44074850|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074863|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44074864|NCT02939365|Abatacept|abatacept|mesh-list
44074865|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44074866|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44074867|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44074868|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44074869|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
44074870|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44074871|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44074872|NCT02909322|Hydromorphone|hydromorphone|mesh-list
44151432|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151433|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
44151434|NCT00214266|Rituximab|rituximab|mesh-list
44151435|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
44151436|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44151449|NCT00214318|Carvedilol|carvedilol|mesh-list
44074997|NCT02723994|Hormones|hormones|mesh-ancestor
44074998|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44074999|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44075000|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44075001|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075002|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075003|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075004|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44075005|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
44075006|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44075062|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
44075063|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075064|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44075065|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075066|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
44075067|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075068|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075069|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44075070|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075072|NCT02693821|Analgesics|analgesics|mesh-ancestor
44075073|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
44075074|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44075075|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075076|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
44075077|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44075078|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44075079|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44075080|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44075081|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44075082|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44075083|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075084|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075113|NCT02627443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075114|NCT02627443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075115|NCT02627443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075116|NCT02627443|Immunologic Factors|immunologic factors|mesh-ancestor
44075117|NCT02627443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075118|NCT02621151|Gemcitabine|gemcitabine|mesh-list
44075119|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
44075120|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44075121|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
44075122|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075180|NCT02419495|Camptothecin|camptothecin|mesh-list
44075181|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
44075182|NCT02419495|Carboplatin|carboplatin|mesh-list
44075183|NCT02419495|Doxorubicin|doxorubicin|mesh-list
44075184|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44075185|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
44075186|NCT02419495|Fluorouracil|fluorouracil|mesh-list
44075187|NCT02419495|Capecitabine|capecitabine|mesh-list
44075188|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
44075189|NCT02419495|Nivolumab|nivolumab|mesh-list
44075190|NCT02419495|Irinotecan|irinotecan|mesh-list
44075191|NCT02419495|Pemetrexed|pemetrexed|mesh-list
44075192|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44075193|NCT02419495|Ipilimumab|ipilimumab|mesh-list
44075194|NCT02419495|Daunorubicin|daunorubicin|mesh-list
44075195|NCT02419495|Topotecan|topotecan|mesh-list
43795758|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
44075196|NCT02419495|Olaparib|olaparib|mesh-list
44075197|NCT02419495|Calcium|calcium|mesh-list
44075198|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
44075199|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075200|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075240|NCT02159066|Infigratinib|infigratinib|mesh-list
44075241|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075242|NCT02157077|Aflibercept|aflibercept|mesh-list
44075315|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075316|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075317|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075318|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44075319|NCT01902173|Protective Agents|protective agents|mesh-ancestor
44075320|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075321|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44075323|NCT01889992|Sirolimus|sirolimus|mesh-list
44075324|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44075325|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075379|NCT00819780|Bevacizumab|bevacizumab|mesh-list
44075380|NCT00819780|Panitumumab|panitumumab|mesh-list
44075381|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44075382|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075383|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44075384|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44075385|NCT00819780|Growth Substances|growth substances|mesh-ancestor
44075386|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075387|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
44075389|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075390|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44075391|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075392|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075393|NCT00700258|Sirolimus|sirolimus|mesh-list
44075394|NCT00700258|Sunitinib|sunitinib|mesh-list
44075395|NCT00700258|Axitinib|axitinib|mesh-list
44075396|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075397|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44075398|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44075399|NCT00700258|Growth Substances|growth substances|mesh-ancestor
44075400|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075421|NCT00062816|Ribavirin|ribavirin|mesh-list
44075435|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44075436|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44075437|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44075438|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075440|NCT00001832|Fludarabine|fludarabine|mesh-list
44075441|NCT00001832|Interleukin-2|interleukin-2|mesh-list
44075442|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44075443|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44075444|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
44075445|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075446|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44075447|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44075448|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
44075449|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075450|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075494|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44075495|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44075496|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44075497|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44075498|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44075499|NCT00009178|Fluoxetine|fluoxetine|mesh-list
44075500|NCT00009178|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44075501|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44075502|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44151494|NCT00214370|Propofol|propofol|mesh-list
44151495|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44151496|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44151497|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151498|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44151499|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
44151500|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
44151501|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44151502|NCT00214370|Narcotics|narcotics|mesh-ancestor
44075587|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44075588|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44075589|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075590|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
44075591|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
44075592|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44075593|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44075594|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44075595|NCT00009646|Indomethacin|indomethacin|mesh-list
44075596|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44075597|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44075650|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
44075651|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44075652|NCT00009750|Cyclosporins|cyclosporins|mesh-list
44075653|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075723|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44075724|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44075725|NCT00009802|Vitamins|vitamins|mesh-ancestor
44075726|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
44075727|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44075728|NCT00009815|Leucovorin|leucovorin|mesh-list
44075729|NCT00009815|Etoposide|etoposide|mesh-list
44075730|NCT00009815|Tegafur|tegafur|mesh-list
44075731|NCT00009815|Calcium|calcium|mesh-list
44075732|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
44075733|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44075734|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44075735|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44075736|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075737|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44075738|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44075739|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44075740|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44075741|NCT00009815|Antidotes|antidotes|mesh-ancestor
44075742|NCT00009815|Protective Agents|protective agents|mesh-ancestor
44075743|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
44075744|NCT00009815|Vitamins|vitamins|mesh-ancestor
44075745|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
44075778|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
44075780|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075854|NCT00009971|Fenretinide|fenretinide|mesh-list
44075855|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075927|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076004|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076005|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076006|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076007|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44076008|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44076009|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44076010|NCT00010153|Fulvestrant|fulvestrant|mesh-list
44076011|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44076012|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076067|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44076139|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44076140|NCT00010426|Cysteamine|cysteamine|mesh-list
44076252|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
44076324|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076326|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076327|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
44076328|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076329|NCT00011960|Paclitaxel|paclitaxel|mesh-list
44076330|NCT00011960|Cisplatin|cisplatin|mesh-list
44076331|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44076332|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076333|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
44076334|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
44076335|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
44076336|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44076337|NCT00011973|Fenretinide|fenretinide|mesh-list
44076338|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076339|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44076340|NCT00011973|Protective Agents|protective agents|mesh-ancestor
44076341|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076342|NCT00011999|Paclitaxel|paclitaxel|mesh-list
44076343|NCT00011999|Cisplatin|cisplatin|mesh-list
44076456|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
44076457|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076533|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
44076534|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44076535|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44076536|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
44076537|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44076542|NCT00012324|Doxorubicin|doxorubicin|mesh-list
44076604|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
44076605|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44076606|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076607|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44076608|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44076609|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44076610|NCT00012467|Amebicides|amebicides|mesh-ancestor
44076611|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44076612|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44076613|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44076614|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
44076615|NCT00012506|Etanercept|etanercept|mesh-list
44076616|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44076617|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44076618|NCT00012506|Analgesics|analgesics|mesh-ancestor
44076619|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
44076620|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076621|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44076622|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44076623|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796949|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
44076624|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44076627|NCT00012519|Ritonavir|ritonavir|mesh-list
44076655|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44076656|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44076721|NCT00013520|Lamivudine|lamivudine|mesh-list
44076722|NCT00013520|Zidovudine|zidovudine|mesh-list
44076824|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
44076825|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
44076826|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44076827|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44076828|NCT00014001|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44076829|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44076969|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
44077043|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077044|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
44077045|NCT00014352|Ketoconazole|ketoconazole|mesh-list
44077046|NCT00014352|Docetaxel|docetaxel|mesh-list
44077047|NCT00014352|Doxorubicin|doxorubicin|mesh-list
44077113|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077114|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077115|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077116|NCT00014469|Methotrexate|methotrexate|mesh-list
44077117|NCT00014469|Melphalan|melphalan|mesh-list
44077118|NCT00014469|Busulfan|busulfan|mesh-list
44077119|NCT00014469|Tacrolimus|tacrolimus|mesh-list
44077120|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44077121|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
44077122|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44077181|NCT00014573|Aldesleukin|aldesleukin|mesh-list
44077182|NCT00014573|Paclitaxel|paclitaxel|mesh-list
44077255|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
44077256|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44077257|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44077258|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
44077259|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077260|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44077261|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077262|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
44077263|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077264|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077265|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077266|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077267|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
44077270|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44077389|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077462|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44077463|NCT00015301|Methylphenidate|methylphenidate|mesh-list
44077464|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44077465|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44077466|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44077467|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44077468|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44077469|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077470|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
44077471|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44077472|NCT00015340|Buprenorphine|buprenorphine|mesh-list
44077473|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44077474|NCT00015340|Naloxone|naloxone|mesh-list
44077475|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44077476|NCT00015340|Narcotics|narcotics|mesh-ancestor
44077589|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077665|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077667|NCT00015938|Vinorelbine|vinorelbine|mesh-list
44077668|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077669|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
44077670|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44077671|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44077672|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077673|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44077674|NCT00015951|Cytarabine|cytarabine|mesh-list
44077675|NCT00015951|Bevacizumab|bevacizumab|mesh-list
44077808|NCT00016133|Leucovorin|leucovorin|mesh-list
44077883|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
44077884|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44077960|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44077961|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
44077962|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44077963|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44077964|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44077965|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44077966|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
44077967|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
44078027|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44078028|NCT00016341|Megestrol|megestrol|mesh-list
44078058|NCT00016367|Cisplatin|cisplatin|mesh-list
44078098|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078099|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078100|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078101|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078102|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078103|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078104|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078105|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
44078106|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078108|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44078109|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
44078110|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078111|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44078112|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078113|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078114|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44078115|NCT00016419|Cyclosporine|cyclosporine|mesh-list
44078116|NCT00016419|Cyclosporins|cyclosporins|mesh-list
44078117|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44078224|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078306|NCT00016926|Capecitabine|capecitabine|mesh-list
44078377|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
44078378|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078379|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078381|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
44078382|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44078383|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
44078384|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
44078385|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44078386|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078387|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44078388|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
44078389|NCT00017069|Hormones|hormones|mesh-ancestor
44078390|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44078391|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44078392|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078393|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
44078394|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078395|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
44078396|NCT00017095|Docetaxel|docetaxel|mesh-list
44078397|NCT00017095|Fluorouracil|fluorouracil|mesh-list
44078398|NCT00017095|Epirubicin|epirubicin|mesh-list
44078399|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078400|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
44078401|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44078411|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
44078431|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
44078506|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44078561|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078562|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078563|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44078564|NCT00017303|Paclitaxel|paclitaxel|mesh-list
44078565|NCT00017303|Carboplatin|carboplatin|mesh-list
44078566|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44078567|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44078568|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
44078569|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
44078570|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
44078571|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44078572|NCT00017316|Thalidomide|thalidomide|mesh-list
44078573|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44078574|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
44078584|NCT00017329|Bortezomib|bortezomib|mesh-list
44078624|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44078699|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
44078773|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44078867|NCT00017784|Valganciclovir|valganciclovir|mesh-list
44078923|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
44078924|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44078996|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44078997|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079069|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079070|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
44079071|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44079072|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44079073|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079074|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079075|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44079076|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44079077|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079078|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079079|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
44079080|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44079081|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
44079132|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079133|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44079134|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
44079315|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079367|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44079372|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44079444|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44079446|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
44079447|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079448|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44079449|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44079450|NCT05560230|Clonidine|clonidine|mesh-list
44079451|NCT05560230|Analgesics|analgesics|mesh-ancestor
44079452|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
44079453|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079454|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079456|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
44079457|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
44079458|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44079459|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44079460|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44079461|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
44079462|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44079463|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44079464|NCT05558137|Mivacurium|mivacurium|mesh-list
44079465|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44079466|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44079467|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44079468|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44079469|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079470|NCT05557643|Psilocybin|psilocybin|mesh-list
44079471|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
44079472|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079473|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44079474|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44079475|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44079476|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43577809|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
44079477|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44079478|NCT05551871|Simvastatin|simvastatin|mesh-list
44079551|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44151748|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44151749|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44151750|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
44151751|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
44151752|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44151753|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44151754|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151755|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151756|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151757|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151758|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151759|NCT00215345|Celecoxib|celecoxib|mesh-list
44151760|NCT00215345|Docetaxel|docetaxel|mesh-list
44151761|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44151762|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
44151763|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
44151764|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
44151765|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44151766|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44151767|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44151768|NCT00215345|Analgesics|analgesics|mesh-ancestor
44151769|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
44151770|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44151771|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44151772|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44151773|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44079731|NCT05223582|Prednisone|prednisone|mesh-list
44079750|NCT05171179|Bupivacaine|bupivacaine|mesh-list
44079751|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
44079752|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
44079753|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44079754|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44079820|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
44079972|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080009|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44080082|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44080083|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
44080084|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080090|NCT04623775|Paclitaxel|paclitaxel|mesh-list
44080091|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44080092|NCT04623775|Cisplatin|cisplatin|mesh-list
44080093|NCT04623775|Carboplatin|carboplatin|mesh-list
44080155|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44080156|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44080229|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080232|NCT04477304|Narcotics|narcotics|mesh-ancestor
44080303|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
44080304|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080305|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
44080306|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080307|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080308|NCT04022876|Carboplatin|carboplatin|mesh-list
44080309|NCT04022876|Pemetrexed|pemetrexed|mesh-list
44080310|NCT04022876|Topotecan|topotecan|mesh-list
44080311|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080312|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080313|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080314|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44080315|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44080364|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080490|NCT03959332|Baloxavir|baloxavir|mesh-list
44080559|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
44080560|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44080561|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
44080562|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080564|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
44080565|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44080566|NCT03958721|Capecitabine|capecitabine|mesh-list
44080567|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44080569|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44080570|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080571|NCT03958708|Rifaximin|rifaximin|mesh-list
44080572|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44080623|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44080697|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
44080698|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44080701|NCT03852407|Melphalan|melphalan|mesh-list
44080792|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44080793|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
44080794|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44080795|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44080796|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44080797|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
44080798|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44080799|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
44080800|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44080803|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
44080858|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44080859|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44080931|NCT03432091|Protective Agents|protective agents|mesh-ancestor
44081007|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081008|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081009|NCT03151876|Antiviral Agents|antiviral agents|mesh-ancestor
44081075|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44081146|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081147|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081148|NCT03151460|Protective Agents|protective agents|mesh-ancestor
44081149|NCT03151434|Hydromorphone|hydromorphone|mesh-list
44081150|NCT03151434|Bupivacaine|bupivacaine|mesh-list
44081151|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
44081152|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
44081153|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44081154|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081155|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
44081156|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44081157|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44081158|NCT03151434|Narcotics|narcotics|mesh-ancestor
44081159|NCT03151434|Analgesics|analgesics|mesh-ancestor
44081160|NCT03151382|Tandospirone|tandospirone|mesh-list
44081161|NCT03151382|Donepezil|donepezil|mesh-list
44081162|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081163|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44081164|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081203|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44081280|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
44081281|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081354|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44081356|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
44081427|NCT03150316|Dexamethasone|dexamethasone|mesh-list
44081469|NCT03083665|Brivaracetam|brivaracetam|mesh-list
44081544|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081545|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44081546|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44081547|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44081548|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081549|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44081687|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44081760|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44081765|NCT01807429|Midazolam|midazolam|mesh-list
44081835|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
44081863|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44081864|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081865|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44081866|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44081867|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44081868|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
44081869|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44081870|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
44081871|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44081872|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44081873|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44081874|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44081924|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44081925|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
44081995|NCT01806272|Hematinics|hematinics|mesh-ancestor
44081996|NCT01806259|Ketorolac|ketorolac|mesh-list
44082142|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44082143|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
44082144|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082145|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082146|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
44082148|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44082155|NCT01805453|Losartan|losartan|mesh-list
44152003|NCT00215982|Irinotecan|irinotecan|mesh-list
44082222|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082374|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44082447|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082448|NCT01465503|Heparin|heparin|mesh-list
44082449|NCT01465503|Calcium heparin|calcium heparin|mesh-list
44082450|NCT01465503|Hirudins|hirudins|mesh-list
44082451|NCT01465503|Bivalirudin|bivalirudin|mesh-list
44082452|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
44082453|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082454|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082455|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082456|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
44082457|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44152034|NCT00216034|Tegafur|tegafur|mesh-list
44082549|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44082701|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44082702|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44082703|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44082704|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44082705|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44082706|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44082707|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082708|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
44082709|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44082710|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
44082711|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44082712|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
44152076|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
44082858|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44082859|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44082929|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44082930|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
44082931|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44082932|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083000|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
44083001|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44083002|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44083072|NCT00846508|Cisplatin|cisplatin|mesh-list
44083073|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083146|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
44083152|NCT00846144|Emetics|emetics|mesh-ancestor
44083220|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44083222|NCT00680628|Enoxaparin|enoxaparin|mesh-list
44083417|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44083491|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44083567|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
44083568|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
44083569|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
44083570|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44083571|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44083572|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
44083574|NCT00276640|Etoposide|etoposide|mesh-list
44083804|NCT00276055|Docetaxel|docetaxel|mesh-list
44083865|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
44083867|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
44083936|NCT00275639|Losartan|losartan|mesh-list
44083937|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44083938|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084053|NCT00275249|Narcotics|narcotics|mesh-ancestor
44084129|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44084130|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
44084204|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084205|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44084206|NCT00275015|Cytarabine|cytarabine|mesh-list
44084207|NCT00275015|Dexamethasone|dexamethasone|mesh-list
44084208|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
44084275|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44084346|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44084421|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44084422|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
44084423|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084495|NCT00129922|Epirubicin|epirubicin|mesh-list
44084569|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
44084570|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44084642|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44084644|NCT00129363|Protective Agents|protective agents|mesh-ancestor
44152187|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152188|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084700|NCT00129207|Bortezomib|bortezomib|mesh-list
44084701|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084702|NCT00129181|Levodopa|levodopa|mesh-list
44084703|NCT00129181|Carbidopa|carbidopa|mesh-list
44084704|NCT00129181|Cabergoline|cabergoline|mesh-list
44084705|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44084706|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44084707|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44084708|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
44084709|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44084710|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084711|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084712|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44084713|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084714|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
44084715|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44084716|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
44084717|NCT00129168|Cytarabine|cytarabine|mesh-list
44084718|NCT00129168|Daunorubicin|daunorubicin|mesh-list
44084719|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44084750|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084899|NCT00128557|Vitamin A|vitamin a|mesh-list
44084900|NCT00128557|Vitamins|vitamins|mesh-ancestor
44084901|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
44084902|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084903|NCT00128544|Telbivudine|telbivudine|mesh-list
44084904|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
44084905|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084906|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44084907|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084908|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084909|NCT00128531|Leuprolide|leuprolide|mesh-list
44084911|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
44084960|NCT00128466|Gentamicins|gentamicins|mesh-list
44084961|NCT00128466|Streptomycin|streptomycin|mesh-list
44084962|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44084963|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44084964|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44084965|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44084966|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084967|NCT00128453|Colchicine|colchicine|mesh-list
44084968|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
44084969|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44084970|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
44084971|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
44084972|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
44084973|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44084974|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44084975|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
44084976|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44084977|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
44084978|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44084979|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44084980|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44084981|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
44084982|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
44084983|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44084984|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
44085009|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44085010|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
44085233|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
44085234|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
44085235|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44085236|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44085237|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44085238|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
44085239|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085240|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
44085241|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
44085300|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44085402|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
44085403|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085474|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085475|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44085476|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085477|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085478|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
44085479|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085480|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
44085481|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085482|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
44085483|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085484|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44085485|NCT00019487|Aldesleukin|aldesleukin|mesh-list
44085486|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
44085487|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085488|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085489|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085490|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
44085531|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085532|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
44085533|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44085534|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
44085535|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
44085536|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44085537|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085539|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085540|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
44085542|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085675|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085750|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44085751|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085752|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085753|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44085754|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44085755|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44085756|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085757|NCT00020150|Temozolomide|temozolomide|mesh-list
44085758|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44085759|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44085760|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
44085761|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44085813|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44085814|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085815|NCT00020254|Aldesleukin|aldesleukin|mesh-list
44085816|NCT00020254|Nilutamide|nilutamide|mesh-list
44085817|NCT00020254|Vaccines|vaccines|mesh-list
44085818|NCT00020254|Sargramostim|sargramostim|mesh-list
44085819|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
44085820|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085821|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085822|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44085823|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44085824|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
44085825|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085826|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
44085827|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
44085828|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44085829|NCT00020267|Interleukin-2|interleukin-2|mesh-list
44085830|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44085831|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44085832|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44085833|NCT00020267|Analgesics|analgesics|mesh-ancestor
44085839|NCT00020332|Docetaxel|docetaxel|mesh-list
44085869|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44085948|NCT00020501|Irinotecan|irinotecan|mesh-list
44086024|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086025|NCT00020618|Analgesics|analgesics|mesh-ancestor
44086026|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
44086027|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086028|NCT00020631|Pirfenidone|pirfenidone|mesh-list
44086029|NCT00020631|Analgesics|analgesics|mesh-ancestor
44086030|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
44086031|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086032|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086033|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44086092|NCT00020735|Toremifene|toremifene|mesh-list
44086101|NCT00020748|Irinotecan|irinotecan|mesh-list
44086166|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43804573|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44086235|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44086236|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086237|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44086238|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086239|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
44086240|NCT00020943|Hormones|hormones|mesh-ancestor
44086241|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086242|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086243|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44086244|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
44086245|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44086246|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44086247|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
44086257|NCT00020943|Vitamins|vitamins|mesh-ancestor
44152273|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44152274|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152275|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152276|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152277|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44152279|NCT00216567|Topiramate|topiramate|mesh-list
44152280|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
44152281|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44152282|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152283|NCT00216580|Risperidone|risperidone|mesh-list
44086311|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
44086387|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44086448|NCT00021346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086449|NCT00021359|Dexamethasone|dexamethasone|mesh-list
44086450|NCT00021359|Isotretinoin|isotretinoin|mesh-list
44086451|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44086452|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
44086453|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
44086454|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44086455|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44086456|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44086457|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
44086458|NCT00021359|Hormones|hormones|mesh-ancestor
44086459|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44086460|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44086461|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086462|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44086463|NCT00021372|Paclitaxel|paclitaxel|mesh-list
44086464|NCT00021372|Estramustine|estramustine|mesh-list
44086465|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086466|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086467|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086468|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086469|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804757|NCT04941872|FAPI-46|fapi-46|mesh-list
44086577|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
44086578|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44086579|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44086580|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44086581|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44086582|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
44086583|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44086584|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44086644|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44086645|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44086717|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44086793|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086795|NCT00022165|Selenium|selenium|mesh-list
44086870|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
44086871|NCT00022230|Doxorubicin|doxorubicin|mesh-list
44086872|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44086873|NCT00022230|Sargramostim|sargramostim|mesh-list
44086874|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44086875|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44086876|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
44086877|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
44086878|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
44086937|NCT00022438|Aldesleukin|aldesleukin|mesh-list
44087116|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
44087117|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087118|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087119|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
44087121|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
44087122|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087125|NCT00022932|Antibodies|antibodies|mesh-list
44087186|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43771292|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43771293|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43771294|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43629801|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
44087187|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44087188|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
43843081|NCT04488874|Mannitol|mannitol|mesh-list
44087189|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087257|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
44087331|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44087332|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
44087333|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087334|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44087335|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44087336|NCT00023361|Rifabutin|rifabutin|mesh-list
44087337|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44087338|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087339|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43805394|NCT04930562|Belumosudil|belumosudil|mesh-list
44087340|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
44087393|NCT00023413|Efavirenz|efavirenz|mesh-list
44087466|NCT00023634|Sargramostim|sargramostim|mesh-list
44087540|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
44087541|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087617|NCT00023868|Protective Agents|protective agents|mesh-ancestor
44087618|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
44087619|NCT00023868|Vitamins|vitamins|mesh-ancestor
44087620|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
44087621|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
44087622|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44087623|NCT00023881|Bortezomib|bortezomib|mesh-list
44087624|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44087625|NCT00023894|Alvocidib|alvocidib|mesh-list
44087633|NCT00023907|Paclitaxel|paclitaxel|mesh-list
44087686|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44087687|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
44087688|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
44087689|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
44087710|NCT00023998|Leucovorin|leucovorin|mesh-list
44087759|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44087824|NCT00024180|Romidepsin|romidepsin|mesh-list
44087978|NCT00024427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44087979|NCT00024427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44087984|NCT00024440|Fludarabine|fludarabine|mesh-list
44088052|NCT00025038|Fludarabine|fludarabine|mesh-list
44088053|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
44088054|NCT00025038|Tipifarnib|tipifarnib|mesh-list
44088055|NCT00025038|Isotretinoin|isotretinoin|mesh-list
44088056|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
44088057|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44088058|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
44088059|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088123|NCT00025077|Carboplatin|carboplatin|mesh-list
44088124|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088125|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
44088126|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088127|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088128|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088129|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
44088130|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088131|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088132|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088133|NCT00025090|Cisplatin|cisplatin|mesh-list
44088134|NCT00025090|Fluorouracil|fluorouracil|mesh-list
44088135|NCT00025090|Mitomycins|mitomycins|mesh-list
44088136|NCT00025090|Mitomycin|mitomycin|mesh-list
44088137|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088138|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
44088139|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088140|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088141|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088142|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
44088143|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088144|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088251|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088252|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088254|NCT00025272|Carboplatin|carboplatin|mesh-list
44088327|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088328|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088404|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44088405|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44088406|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
44088407|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088408|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088409|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44088410|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44088411|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44088412|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44088413|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088414|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
44088415|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088416|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088417|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
44088418|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44088419|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
44088420|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44088421|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
44088422|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088537|NCT00025545|Methotrexate|methotrexate|mesh-list
44088612|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
44088613|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
44088614|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
44088688|NCT00025649|Etoposide|etoposide|mesh-list
44152360|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44152361|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44152362|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
44152363|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44152364|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44152365|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44152366|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44152368|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152369|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152370|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
44152371|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152372|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44152373|NCT00216775|Interferons|interferons|mesh-list
44088795|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088802|NCT00026091|Fenretinide|fenretinide|mesh-list
44088871|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44088873|NCT00026182|Growth Substances|growth substances|mesh-ancestor
44088945|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44088946|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088947|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
44088948|NCT00026299|Gefitinib|gefitinib|mesh-list
44088949|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088950|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088951|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088952|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088953|NCT00026338|Gemcitabine|gemcitabine|mesh-list
44088954|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44088955|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44088956|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
44088957|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44088958|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44088959|NCT00026338|Antiviral Agents|antiviral agents|mesh-ancestor
44088960|NCT00026338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44088961|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44088962|NCT00026338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44088963|NCT00026338|Immunologic Factors|immunologic factors|mesh-ancestor
44088964|NCT00026338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44088965|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44088966|NCT00026351|Rituximab|rituximab|mesh-list
44088967|NCT00026351|Pentostatin|pentostatin|mesh-list
44088968|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44089069|NCT00026520|Interferons|interferons|mesh-list
44089219|NCT00027287|Vitamin E|vitamin e|mesh-list
44089220|NCT00027287|Vitamins|vitamins|mesh-ancestor
44089221|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
43652077|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652078|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
43652079|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652080|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684065|NCT00156117|Asenapine|asenapine|mesh-list
44089222|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089223|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
44089224|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089225|NCT00027287|Protective Agents|protective agents|mesh-ancestor
44089226|NCT00027300|Natalizumab|natalizumab|mesh-list
44089227|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
44089228|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089229|NCT00027339|Ritonavir|ritonavir|mesh-list
44089230|NCT00027339|Lopinavir|lopinavir|mesh-list
44089231|NCT00027339|Indinavir|indinavir|mesh-list
44089232|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
44089233|NCT00027339|Tenofovir|tenofovir|mesh-list
44089234|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44089235|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44089236|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
44089237|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089239|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44089276|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
44089277|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44089278|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44089279|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44089280|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152383|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089281|NCT00027443|Cyclosporine|cyclosporine|mesh-list
44089294|NCT00027495|Curcumin|curcumin|mesh-list
44089343|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
44089344|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44089345|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44089346|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44089347|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
44089348|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44089350|NCT00027573|Methotrexate|methotrexate|mesh-list
44089351|NCT00027573|Fludarabine|fludarabine|mesh-list
44089352|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
44089353|NCT00027573|Tacrolimus|tacrolimus|mesh-list
44089354|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089367|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
44089405|NCT00027638|Thalidomide|thalidomide|mesh-list
44089406|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089407|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
44089408|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089409|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
44089414|NCT00027638|Growth Substances|growth substances|mesh-ancestor
44089478|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
44089479|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089480|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44089481|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
44089482|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089483|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
44089485|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
44089549|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089550|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089551|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44089552|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44089553|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
44089554|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089618|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
44089620|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089692|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089693|NCT00027989|Antiviral Agents|antiviral agents|mesh-ancestor
44089694|NCT00027989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44089695|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089696|NCT00027989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089697|NCT00027989|Immunologic Factors|immunologic factors|mesh-ancestor
44089763|NCT00028327|Efavirenz|efavirenz|mesh-list
44089764|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44089765|NCT00028327|Nelfinavir|nelfinavir|mesh-list
44089766|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44089768|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44089830|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44089831|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
44089832|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44089833|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
44089843|NCT00028496|Vaccines|vaccines|mesh-list
44089905|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
44089906|NCT00028600|Tacrolimus|tacrolimus|mesh-list
44089907|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089908|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
44089926|NCT00028613|Antibodies|antibodies|mesh-list
44089975|NCT00028717|Vincristine|vincristine|mesh-list
44089976|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44089977|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
44089978|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44089979|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44089980|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090045|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090046|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090047|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44090048|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
44090049|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44090050|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090051|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44090052|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44090053|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44090110|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44090111|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090112|NCT00028860|Gemcitabine|gemcitabine|mesh-list
44090113|NCT00028860|Paclitaxel|paclitaxel|mesh-list
44090114|NCT00028860|Carboplatin|carboplatin|mesh-list
44090115|NCT00028860|Ifosfamide|ifosfamide|mesh-list
44090116|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44090117|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090118|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
44090179|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44090180|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44090181|NCT00028886|Growth Substances|growth substances|mesh-ancestor
44090182|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
44090183|NCT00028899|Cytarabine|cytarabine|mesh-list
44090184|NCT00028899|Asparaginase|asparaginase|mesh-list
44090185|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
44090186|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
44090187|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44090249|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090250|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44090251|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44090252|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44090253|NCT00028990|Growth Substances|growth substances|mesh-ancestor
43771399|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771400|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43771402|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771445|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771446|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771447|NCT02373033|Folic Acid|folic acid|mesh-list
43771448|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
43771449|NCT02373033|Hematinics|hematinics|mesh-ancestor
43771450|NCT02373033|Vitamins|vitamins|mesh-ancestor
43771451|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
43771456|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
44090254|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090255|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44090310|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090311|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
44090312|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090313|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090314|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090315|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090316|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
44090317|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44090318|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
44090373|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44090374|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090375|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44090376|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090377|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090379|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
44090380|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
44090381|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090382|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090436|NCT00029848|Hormones|hormones|mesh-ancestor
44090437|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44090438|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090439|NCT00029861|Rimonabant|rimonabant|mesh-list
44090440|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44090441|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44090442|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44090443|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44090445|NCT00029861|Hormones|hormones|mesh-ancestor
44090500|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090501|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090502|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44090503|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44090504|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
44090505|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090506|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44090507|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090566|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44090567|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44090569|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
44090570|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44090571|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090572|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44090635|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090636|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807781|NCT04892654|Dolutegravir|dolutegravir|mesh-list
44090637|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090649|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
44090702|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
44090703|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44090704|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152412|NCT00216840|Hormones|hormones|mesh-ancestor
44152413|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44152414|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44090815|NCT00030784|Ifosfamide|ifosfamide|mesh-list
44090816|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44090817|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090818|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44090819|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44090820|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44090821|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771461|NCT02373280|Amoxicillin|amoxicillin|mesh-list
44090822|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44090823|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
44090878|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44090879|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44090880|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090881|NCT00030966|Natalizumab|natalizumab|mesh-list
44090882|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
44090884|NCT00030979|Donepezil|donepezil|mesh-list
44090949|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44090950|NCT00031083|Interferons|interferons|mesh-list
44090951|NCT00031083|Interferon-beta|interferon-beta|mesh-list
44090952|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44090953|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
44091020|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44091021|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44091022|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44091023|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091024|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
44091025|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
44091026|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44091027|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
44091028|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44091089|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091090|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091091|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091092|NCT00031616|Brivudine|brivudine|mesh-list
44091160|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44091161|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091162|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091163|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
44091164|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44091165|NCT00031720|Tamoxifen|tamoxifen|mesh-list
44091166|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44091226|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091230|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44091303|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091304|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091305|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091306|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
44091307|NCT00031889|Exemestane|exemestane|mesh-list
44091308|NCT00031889|Bicalutamide|bicalutamide|mesh-list
44091309|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091310|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44091311|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44091312|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091313|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091314|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44091315|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
44091316|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091317|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091318|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
44091319|NCT00031902|Prednisolone|prednisolone|mesh-list
44091320|NCT00031902|Rituximab|rituximab|mesh-list
44091321|NCT00031902|Vincristine|vincristine|mesh-list
44091322|NCT00031902|Bleomycin|bleomycin|mesh-list
44091323|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44091324|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091325|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
44091326|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091327|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091328|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44091329|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091330|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091331|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091332|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091333|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44091334|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
44091335|NCT00031902|Hormones|hormones|mesh-ancestor
44091336|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44091337|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091338|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44091339|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
44091340|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091400|NCT00032019|Doxorubicin|doxorubicin|mesh-list
44091401|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44091402|NCT00032019|Etoposide|etoposide|mesh-list
44091403|NCT00032019|Vincristine|vincristine|mesh-list
44091405|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
44091470|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091471|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091472|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091473|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091474|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44091475|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091476|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44091477|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091536|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44091537|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
44091538|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091539|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091540|NCT00032175|Antiviral Agents|antiviral agents|mesh-ancestor
44091590|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091591|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44091592|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091593|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091594|NCT00032786|Natalizumab|natalizumab|mesh-list
44091595|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
44091596|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091597|NCT00032799|Natalizumab|natalizumab|mesh-list
44091598|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
44091599|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091600|NCT00032812|Raclopride|raclopride|mesh-list
44091601|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44091602|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44091603|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44091648|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44091649|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44091650|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091651|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091653|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
44091654|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091655|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44091656|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44091657|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44091658|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091659|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091660|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44091661|NCT00032929|Protective Agents|protective agents|mesh-ancestor
44091663|NCT00032942|Lofexidine|lofexidine|mesh-list
44091706|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091707|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091708|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44091709|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44091711|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43824665|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652081|NCT03002961|Buprenorphine|buprenorphine|mesh-list
43771506|NCT02373163|Diuretics|diuretics|mesh-ancestor
43771507|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
44091712|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44091713|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44091714|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44091715|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44091717|NCT00033059|Tolcapone|tolcapone|mesh-list
44091770|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091771|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091772|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44091773|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44091775|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
44091776|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091777|NCT00033176|Protective Agents|protective agents|mesh-ancestor
44091839|NCT00033319|Hematinics|hematinics|mesh-ancestor
44091840|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
44091841|NCT00033319|Vitamins|vitamins|mesh-ancestor
44091842|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
44091912|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091913|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091914|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091915|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091916|NCT00033423|Rituximab|rituximab|mesh-list
44091917|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44091918|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091919|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
44091921|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44091979|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
44091980|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44091981|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44091982|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44091983|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44091984|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
44091985|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44091986|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44091987|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44091988|NCT00033605|Octreotide|octreotide|mesh-list
44091989|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44091990|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44091991|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091992|NCT00033618|Epothilones|epothilones|mesh-list
44091993|NCT00033618|Epothilone B|epothilone b|mesh-list
44091994|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44091995|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44091996|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44091997|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44091998|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44091999|NCT00033644|Cisplatin|cisplatin|mesh-list
44092000|NCT00033644|Doxorubicin|doxorubicin|mesh-list
44092001|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44092002|NCT00033644|Mitomycins|mitomycins|mesh-list
44092003|NCT00033644|Mitomycin|mitomycin|mesh-list
44092029|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092030|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092031|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44092032|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092100|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092101|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44092102|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092103|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44092104|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
44092105|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092106|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44092107|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
44092108|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44092109|NCT00033748|Antibodies|antibodies|mesh-list
43577063|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
43771519|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092110|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
44152478|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152479|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44092125|NCT00033891|Infliximab|infliximab|mesh-list
44092126|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
44092127|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44092128|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44092129|NCT00033982|Posaconazole|posaconazole|mesh-list
44092130|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
44092143|NCT00034047|Nafarelin|nafarelin|mesh-list
44092190|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092191|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44092192|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092193|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44092194|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44092257|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092258|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
44092332|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
44092333|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
44092334|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
44092340|NCT00034593|Gemcitabine|gemcitabine|mesh-list
44092402|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092403|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092404|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092405|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44092406|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092469|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44092470|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
44092471|NCT00034775|Risperidone|risperidone|mesh-list
44092472|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44092473|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
44092474|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092540|NCT00034879|Gefitinib|gefitinib|mesh-list
44092541|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092611|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44092612|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44092613|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092681|NCT00035100|Epothilone B|epothilone b|mesh-list
44092682|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092683|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092684|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092685|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092686|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092687|NCT00035113|Epothilones|epothilones|mesh-list
44092688|NCT00035113|Epothilone B|epothilone b|mesh-list
44092689|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092690|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092691|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092692|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092693|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092694|NCT00035126|Epothilones|epothilones|mesh-list
44092695|NCT00035126|Epothilone B|epothilone b|mesh-list
44092696|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
44092697|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
44092698|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
44092699|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092700|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092701|NCT00035139|Methylphenidate|methylphenidate|mesh-list
44092735|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44092736|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092737|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
44092738|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44092739|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092740|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44092741|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
44092742|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44092743|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
44092768|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44092769|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092770|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44092771|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44092772|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
44092773|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44092776|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44092833|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44092834|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44092835|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44092836|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44092838|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
44092839|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44092840|NCT00035425|Vancomycin|vancomycin|mesh-list
44092899|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44092900|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
44092901|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092902|NCT00035802|Topiramate|topiramate|mesh-list
44092903|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
44092904|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44092905|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092906|NCT00035854|Linezolid|linezolid|mesh-list
44092907|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44092965|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44092966|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44092967|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
44093036|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093037|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44093038|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44093039|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
44093040|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44093041|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44093042|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44093101|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44093102|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44093103|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093171|NCT00036439|Infliximab|infliximab|mesh-list
44093172|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093173|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093174|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44093175|NCT00036452|Ritonavir|ritonavir|mesh-list
44093176|NCT00036452|Lopinavir|lopinavir|mesh-list
44093177|NCT00036452|Tenofovir|tenofovir|mesh-list
44093241|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093242|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093243|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093244|NCT00036764|Epothilones|epothilones|mesh-list
44093245|NCT00036764|Epothilone B|epothilone b|mesh-list
44093246|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
44093247|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
44093248|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
44093302|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093303|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093304|NCT00036894|Lenalidomide|lenalidomide|mesh-list
44093305|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
44093306|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093375|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44093376|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093377|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093378|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
44093379|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093380|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093381|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44093382|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093441|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093442|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44093443|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44093444|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093445|NCT00037180|Antidotes|antidotes|mesh-ancestor
44093446|NCT00037180|Protective Agents|protective agents|mesh-ancestor
44093447|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
44093510|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093511|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093512|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44093513|NCT00037609|Protective Agents|protective agents|mesh-ancestor
43771528|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
44093514|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093515|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093516|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093517|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44093518|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44093520|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
44093533|NCT00037635|Cinacalcet|cinacalcet|mesh-list
44093572|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093573|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093574|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093575|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44093576|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
44093577|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093640|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093641|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093642|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093643|NCT00038090|Growth Substances|growth substances|mesh-ancestor
44093644|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093645|NCT00038116|Dopamine|dopamine|mesh-list
44093646|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44093647|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
44093709|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44093710|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44093711|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44093712|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44093713|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44093714|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44093715|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44093716|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44152521|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44152522|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152523|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44152524|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44152525|NCT00217282|Growth Substances|growth substances|mesh-ancestor
44152526|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093717|NCT00038233|Thalidomide|thalidomide|mesh-list
44093718|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44093719|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
44093720|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093721|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
44093722|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093723|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093724|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44093725|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44093726|NCT00038233|Growth Substances|growth substances|mesh-ancestor
44093727|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
44093750|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093752|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093753|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44093754|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44093755|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
44093756|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093757|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
44093758|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44093759|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093760|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44093761|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
44093762|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44093763|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44093811|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
44093812|NCT05432934|Hormones|hormones|mesh-ancestor
44093813|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093814|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093815|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093816|NCT05432778|Letermovir|letermovir|mesh-list
44093818|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093879|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44093880|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093893|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44093894|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093895|NCT05195242|Dexamethasone|dexamethasone|mesh-list
44093896|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44093897|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
44093898|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
44093899|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44093900|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093901|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44093902|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
44093903|NCT05195242|Hormones|hormones|mesh-ancestor
44093904|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44093905|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44093955|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44093956|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44093957|NCT05019794|Infigratinib|infigratinib|mesh-list
44093958|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44093959|NCT04941521|Exenatide|exenatide|mesh-list
44093963|NCT04941521|Incretins|incretins|mesh-ancestor
44094023|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44094024|NCT04393389|Paclitaxel|paclitaxel|mesh-list
44094025|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094026|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094027|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094028|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
43810511|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44152551|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152552|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44152553|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44152555|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44152556|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44152557|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44152559|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
44094077|NCT04149210|Fluorometholone|fluorometholone|mesh-list
44094132|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44094133|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44094134|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
44094135|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094136|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
44094137|NCT03668431|Trametinib|trametinib|mesh-list
44094138|NCT03668431|Dabrafenib|dabrafenib|mesh-list
44094139|NCT03668431|Spartalizumab|spartalizumab|mesh-list
44094140|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094198|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44094199|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44094200|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44094201|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44094202|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44094203|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
44094204|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44094206|NCT03336333|Venetoclax|venetoclax|mesh-list
44094207|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44094208|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
44094209|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094210|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094211|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
44094212|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094213|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094214|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094215|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
44094216|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094217|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094254|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44094255|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44094256|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44094257|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
44094258|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44094259|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
44094260|NCT03058289|Ipilimumab|ipilimumab|mesh-list
44094261|NCT03058289|Antibodies|antibodies|mesh-list
44094262|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
44094263|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
44094264|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094266|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094318|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44094319|NCT01331018|Plerixafor|plerixafor|mesh-list
44094320|NCT01331018|Prednisone|prednisone|mesh-list
44094321|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
44094322|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44094323|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44094324|NCT01331018|Prednisolone|prednisolone|mesh-list
44094325|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
44094326|NCT01331018|Cortisone|cortisone|mesh-list
44094385|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
44094386|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44094387|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094388|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094389|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
44094390|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
44094391|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44094392|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094393|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
44094394|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094398|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
44094449|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094450|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094451|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
44094452|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094453|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
44094454|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094455|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094456|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44152624|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44152625|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
44152626|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44152627|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44152629|NCT00217516|Selenium|selenium|mesh-list
44094516|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44094517|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44094518|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
44094519|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094520|NCT00038532|Ritonavir|ritonavir|mesh-list
44094521|NCT00038532|Saquinavir|saquinavir|mesh-list
44094522|NCT00038532|Amprenavir|amprenavir|mesh-list
44094582|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094583|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094584|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
44094585|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094586|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094587|NCT00038636|Ritonavir|ritonavir|mesh-list
44094588|NCT00038636|Lopinavir|lopinavir|mesh-list
44094589|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44094590|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44094591|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
44094592|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094646|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094647|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
44094648|NCT00038844|Rituximab|rituximab|mesh-list
44094649|NCT00038844|Fludarabine|fludarabine|mesh-list
44094650|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
44094651|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
44094652|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094653|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
43838458|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094654|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094655|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094656|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094657|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
44094658|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094659|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094660|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094661|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094705|NCT00039026|Exenatide|exenatide|mesh-list
44094706|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44094707|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094708|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44094709|NCT00039026|Incretins|incretins|mesh-ancestor
44094710|NCT00039026|Hormones|hormones|mesh-ancestor
44094711|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44094712|NCT00039039|Paclitaxel|paclitaxel|mesh-list
44094713|NCT00039039|Cisplatin|cisplatin|mesh-list
44094714|NCT00039039|Carboplatin|carboplatin|mesh-list
44094715|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094716|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094728|NCT00039091|Ipilimumab|ipilimumab|mesh-list
44094771|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44094772|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094773|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
44094774|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094775|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094776|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094777|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094778|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
44094779|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44094780|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094781|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094782|NCT00039208|Antidotes|antidotes|mesh-ancestor
44094783|NCT00039208|Protective Agents|protective agents|mesh-ancestor
44094835|NCT00039390|Gefitinib|gefitinib|mesh-list
44094836|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094837|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
44094838|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094839|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094840|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094841|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094842|NCT00039403|Gemcitabine|gemcitabine|mesh-list
44094843|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44094844|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094845|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
44094846|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094847|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094848|NCT00039403|Antiviral Agents|antiviral agents|mesh-ancestor
44094849|NCT00039403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652087|NCT03002961|Analgesics|analgesics|mesh-ancestor
44094850|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094851|NCT00039403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094852|NCT00039403|Immunologic Factors|immunologic factors|mesh-ancestor
44094853|NCT00039403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094854|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094855|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
44094856|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094857|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094858|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094859|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094861|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094862|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44094863|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44094864|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094865|NCT00039442|Capecitabine|capecitabine|mesh-list
44094866|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094867|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
43594289|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44094868|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094869|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094870|NCT00039455|Trastuzumab|trastuzumab|mesh-list
44094871|NCT00039455|Alvocidib|alvocidib|mesh-list
44094872|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44094873|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094874|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
44094875|NCT00039455|Growth Substances|growth substances|mesh-ancestor
44094876|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094877|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094878|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094879|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094880|NCT00039468|Thalidomide|thalidomide|mesh-list
44094881|NCT00039468|Irinotecan|irinotecan|mesh-list
44094882|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44094883|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094884|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094885|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094886|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094887|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44094888|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
44094889|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094890|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
44094891|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44094930|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094931|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094932|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094933|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094934|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094935|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44094936|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094937|NCT00039520|Analgesics|analgesics|mesh-ancestor
44094938|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
44094939|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44094940|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094941|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44094942|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094943|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44094944|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094945|NCT00039546|Gemcitabine|gemcitabine|mesh-list
44094946|NCT00039546|Paclitaxel|paclitaxel|mesh-list
44094947|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
44094949|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44094950|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094951|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
44094952|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
44094953|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
44094954|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094955|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838488|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44094956|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
44094957|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44094958|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44094959|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44094960|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
44094961|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44094962|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44094963|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
44094964|NCT00039546|Antiviral Agents|antiviral agents|mesh-ancestor
44094965|NCT00039546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44094966|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44094967|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44094968|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44094969|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44094970|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
44094971|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44094972|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44094975|NCT00039611|Leucovorin|leucovorin|mesh-list
44094998|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44094999|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44095000|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
44095001|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095092|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44095093|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
44095094|NCT00040027|Thymalfasin|thymalfasin|mesh-list
44095095|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
44095096|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095097|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
44095098|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095099|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44095100|NCT00040040|Bupropion|bupropion|mesh-list
44095101|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44095102|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
44095103|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44095104|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44095105|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44095106|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095107|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095108|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
44095109|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095110|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095111|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44095112|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44095113|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095114|NCT00040053|Ondansetron|ondansetron|mesh-list
44095115|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
44095116|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
44095117|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095118|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095145|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
44095146|NCT00040105|Tipifarnib|tipifarnib|mesh-list
44095147|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152650|NCT00217542|Amifostine|amifostine|mesh-list
44095154|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095155|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095156|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
44095157|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095158|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44095159|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44095160|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
44095161|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44095162|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095163|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095220|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095221|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
44095222|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095223|NCT00040378|Protective Agents|protective agents|mesh-ancestor
43811375|NCT04845607|Amiodarone|amiodarone|mesh-list
44095224|NCT00040378|Trace Elements|trace elements|mesh-ancestor
44095225|NCT00040391|Leucovorin|leucovorin|mesh-list
44095226|NCT00040391|Fluorouracil|fluorouracil|mesh-list
44095238|NCT00040391|Antidotes|antidotes|mesh-ancestor
44095288|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44095289|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095290|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095361|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095362|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
44095363|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095364|NCT00040690|Antidotes|antidotes|mesh-ancestor
44095437|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095438|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095439|NCT00040885|Docetaxel|docetaxel|mesh-list
44095440|NCT00040885|Infliximab|infliximab|mesh-list
44095441|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095442|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095443|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095444|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095445|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095446|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44095447|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44095448|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095449|NCT00040950|Rituximab|rituximab|mesh-list
44095450|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44095451|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095452|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
44095453|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811521|NCT04843007|Pemetrexed|pemetrexed|mesh-list
44095454|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095455|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44095456|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095457|NCT00041015|Cisplatin|cisplatin|mesh-list
44095458|NCT00041015|Etoposide|etoposide|mesh-list
44095459|NCT00041015|Topotecan|topotecan|mesh-list
44095460|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095461|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095462|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44095463|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095464|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095465|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095466|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095467|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
44095478|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44095479|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095480|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095481|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44095482|NCT00041054|Protective Agents|protective agents|mesh-ancestor
44095483|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095484|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44095486|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44095546|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095547|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095548|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44095549|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
44095618|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44095620|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
44095621|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44095622|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44095623|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44095624|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
44095626|NCT00041314|Gemcitabine|gemcitabine|mesh-list
44095687|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
44095688|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
44095689|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095690|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44095691|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095692|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095694|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095695|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095696|NCT00041483|Anecortave|anecortave|mesh-list
44095697|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44095698|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44095699|NCT00041483|Growth Substances|growth substances|mesh-ancestor
44095700|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095701|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
44095746|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095747|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095748|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44095749|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
44095750|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44095751|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
44095752|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152722|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
44152723|NCT00217711|Irinotecan|irinotecan|mesh-list
44152724|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44152725|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
44152726|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152727|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44152728|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44095842|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44095843|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095844|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44095845|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44095846|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44095847|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44095848|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095849|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095851|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44095852|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44095853|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44095854|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095855|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44095856|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
44095857|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
44095858|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095859|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095860|NCT00042172|Donepezil|donepezil|mesh-list
44095861|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44095862|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44095863|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095864|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
44095865|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095866|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44095867|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
44095868|NCT00042302|Paclitaxel|paclitaxel|mesh-list
44095869|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44095870|NCT00042302|Carboplatin|carboplatin|mesh-list
44095871|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44095872|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095873|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095874|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095875|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095877|NCT00042315|Vinorelbine|vinorelbine|mesh-list
44095879|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44095880|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44095881|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44095882|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44095883|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44095884|NCT00042328|Valacyclovir|valacyclovir|mesh-list
44095946|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44095947|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44095948|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44095949|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096013|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096014|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44096016|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44096085|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
44096086|NCT00042861|Vitamins|vitamins|mesh-ancestor
44096087|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
44096088|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44096089|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096090|NCT00042874|Leucovorin|leucovorin|mesh-list
44096091|NCT00042874|Fluorouracil|fluorouracil|mesh-list
44096092|NCT00042874|Irinotecan|irinotecan|mesh-list
44096093|NCT00042874|Alvocidib|alvocidib|mesh-list
44096094|NCT00042874|Calcium|calcium|mesh-list
44096155|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096156|NCT00043004|Leucovorin|leucovorin|mesh-list
44096157|NCT00043004|Bevacizumab|bevacizumab|mesh-list
44096158|NCT00043004|Fluorouracil|fluorouracil|mesh-list
44096159|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
44096160|NCT00043004|Calcium|calcium|mesh-list
44096161|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
44096162|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096163|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096224|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096225|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096226|NCT00043095|Antiviral Agents|antiviral agents|mesh-ancestor
44096227|NCT00043095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096228|NCT00043095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096294|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44096295|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44096296|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44096297|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44096298|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44096300|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
44096301|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44152769|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44152770|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152771|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
44152772|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152774|NCT00218075|Levodopa|levodopa|mesh-list
44096371|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
44096372|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096373|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096374|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
44096375|NCT00043654|Mifepristone|mifepristone|mesh-list
44096376|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44096377|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
44096438|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096439|NCT00043810|Fludarabine|fludarabine|mesh-list
44096440|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
44096441|NCT00043810|Busulfan|busulfan|mesh-list
44096442|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
44096578|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096579|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44096580|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44096581|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
44096582|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096583|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44096584|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44096642|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096643|NCT00044382|Lenalidomide|lenalidomide|mesh-list
44096644|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
44096645|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096646|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44096708|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771706|NCT02371993|Choline|choline|mesh-list
44096709|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096710|NCT00044525|Taxane|taxane|mesh-list
44096712|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096713|NCT00044538|Taxane|taxane|mesh-list
44096714|NCT00044538|IDN 5109|idn 5109|mesh-list
44096715|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096779|NCT00044668|Hormones|hormones|mesh-ancestor
44152804|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
44096780|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44096781|NCT00044681|Risperidone|risperidone|mesh-list
44096848|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44096849|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
44096850|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096851|NCT00044785|Antidotes|antidotes|mesh-ancestor
44096852|NCT00044785|Protective Agents|protective agents|mesh-ancestor
43812650|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44096853|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
44096854|NCT00044785|Vitamins|vitamins|mesh-ancestor
44096855|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
44096856|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44096911|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44096912|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096913|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44096914|NCT00044889|Clofarabine|clofarabine|mesh-list
44096915|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44096916|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
44096917|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096918|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096919|NCT00044902|Epratuzumab|epratuzumab|mesh-list
44096920|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44096921|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44096922|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
44096923|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44096924|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44096925|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
44096926|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44096927|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096928|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44096929|NCT00044928|Tazobactam|tazobactam|mesh-list
44096930|NCT00044928|Piperacillin|piperacillin|mesh-list
44096931|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44096932|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44096933|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44096934|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44096935|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44096936|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096938|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
44096957|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
44096958|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44152805|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152806|NCT00218127|Narcotics|narcotics|mesh-ancestor
44152807|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152808|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152809|NCT00218127|Analgesics|analgesics|mesh-ancestor
44152810|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
44152811|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152813|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44152814|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
44152815|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152816|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152817|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44152818|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44096975|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096976|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44096977|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44096978|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096979|NCT00045136|Melphalan|melphalan|mesh-list
44096980|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44096981|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
44096982|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096983|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097040|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097041|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630671|NCT03050437|Cisplatin|cisplatin|mesh-list
44097042|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097043|NCT00045370|Interferons|interferons|mesh-list
44097044|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
44097045|NCT00045370|Sirolimus|sirolimus|mesh-list
44097046|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097047|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
44097055|NCT00045396|Tipifarnib|tipifarnib|mesh-list
44097107|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097108|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097109|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097110|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44097179|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44097181|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44097182|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097183|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097184|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
44097185|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097186|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097244|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44097245|NCT00045812|Ezetimibe|ezetimibe|mesh-list
44097246|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44097252|NCT00045864|Rituximab|rituximab|mesh-list
44097314|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44097315|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44097316|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097317|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097318|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097319|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097320|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097321|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44097322|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097323|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097324|NCT00046033|Ritonavir|ritonavir|mesh-list
44097375|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097377|NCT00046176|Abacavir|abacavir|mesh-list
44097378|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
44097379|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44097445|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097446|NCT00046384|Aripiprazole|aripiprazole|mesh-list
44097447|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097448|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097449|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44097450|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44097451|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44097452|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097453|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
44097454|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
44097455|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097456|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097457|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44097458|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44097459|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
44097460|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44097461|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44097501|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097503|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
44097504|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097505|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44097506|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44097507|NCT00046735|Growth Substances|growth substances|mesh-ancestor
44097508|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097509|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097526|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097527|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097528|NCT00046826|Thalidomide|thalidomide|mesh-list
44097529|NCT00046826|Docetaxel|docetaxel|mesh-list
44097530|NCT00046826|Estramustine|estramustine|mesh-list
44097531|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097532|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097533|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097534|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
43684528|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097535|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097591|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097592|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097594|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097595|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44097596|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44097597|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097598|NCT00046969|Cisplatin|cisplatin|mesh-list
44097663|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44097664|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
44097665|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097666|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44097667|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44097668|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
44097729|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097730|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
44097731|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097732|NCT00047190|Tipifarnib|tipifarnib|mesh-list
44097733|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097734|NCT00047203|Alvocidib|alvocidib|mesh-list
44097735|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097736|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44097737|NCT00047203|Growth Substances|growth substances|mesh-ancestor
44097738|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097739|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44097740|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097794|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097795|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44097796|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44097865|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44097866|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097867|NCT00047450|Citalopram|citalopram|mesh-list
44097868|NCT00047450|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44097869|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44097870|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44097871|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097872|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44097873|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
44097874|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44097875|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44097876|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
44097877|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44097924|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097925|NCT00047645|Interferons|interferons|mesh-list
44097926|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
44097927|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44097928|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
44097929|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44097992|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
44097993|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
44097994|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098066|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44098067|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098068|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098073|NCT00048230|Bortezomib|bortezomib|mesh-list
44152899|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
44152900|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152901|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152902|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44152903|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44152904|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
44152905|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152906|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152907|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
44098141|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44098142|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44098143|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098144|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098145|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
44098146|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098147|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44098148|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098203|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44098204|NCT00048776|Protective Agents|protective agents|mesh-ancestor
44098205|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44098206|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44098208|NCT00048802|Valproic Acid|valproic acid|mesh-list
44098275|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098277|NCT00049023|Edotreotide|edotreotide|mesh-list
44098278|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098281|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44098363|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098364|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098365|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098366|NCT00049179|Cytarabine|cytarabine|mesh-list
44098367|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
44098368|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098369|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
44098370|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098371|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098372|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
44098373|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098374|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098375|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
43598118|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43647148|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098376|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098377|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098379|NCT00049192|Oblimersen|oblimersen|mesh-list
44098380|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098381|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44098382|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098383|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098384|NCT00049218|Carboplatin|carboplatin|mesh-list
44098385|NCT00049218|Etoposide|etoposide|mesh-list
44098386|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098387|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44098388|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44098389|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098390|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098391|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098392|NCT00049244|Capecitabine|capecitabine|mesh-list
44098393|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098394|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
44098395|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098396|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098397|NCT00049283|Docetaxel|docetaxel|mesh-list
44098398|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44098427|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098428|NCT00049348|Gemcitabine|gemcitabine|mesh-list
44098430|NCT00049348|Fluorouracil|fluorouracil|mesh-list
44098431|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
44098432|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098433|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098434|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
44098435|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098497|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098498|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098499|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44098500|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098501|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
44098502|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098503|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
44098505|NCT00049439|Etoposide|etoposide|mesh-list
44098506|NCT00049439|Procarbazine|procarbazine|mesh-list
44098507|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44098508|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
44098509|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098510|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098511|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098512|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
44098513|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098514|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098515|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44098516|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44098517|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44098518|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098519|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098520|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
44098550|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
44098551|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098552|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098553|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44098554|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44098555|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44098556|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098557|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098558|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098559|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
44098560|NCT00049569|Hormones|hormones|mesh-ancestor
44098561|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098562|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098563|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44098564|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
44098565|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44098566|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098567|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
44098568|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44098607|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
44098608|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098609|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098610|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098611|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
44098612|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098613|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098614|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44098615|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44098616|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
44098617|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44098618|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098620|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
44098621|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098622|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44098623|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44098624|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
44098625|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098626|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44098627|NCT00049660|Capecitabine|capecitabine|mesh-list
44098628|NCT00049660|Vinorelbine|vinorelbine|mesh-list
44098629|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44098630|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
44098631|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098632|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098633|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44098634|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098635|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098653|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44098654|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44098655|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098656|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44098658|NCT00049790|Carboplatin|carboplatin|mesh-list
44098659|NCT00049790|Angiostatins|angiostatins|mesh-list
44098660|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44098661|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098662|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098663|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098664|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098665|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098666|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44098667|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44098668|NCT00049790|Growth Substances|growth substances|mesh-ancestor
44098669|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098670|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44098671|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
44098672|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44098673|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44098674|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
44098675|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
44098676|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098677|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098678|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
44098679|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44098680|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098700|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098701|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44098702|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
44098703|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44098704|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44098705|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44098706|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098707|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
44098708|NCT00049985|Hematinics|hematinics|mesh-ancestor
44098709|NCT00049998|Topotecan|topotecan|mesh-list
44098710|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44098711|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098712|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098713|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098714|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098716|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098717|NCT00050154|Tipifarnib|tipifarnib|mesh-list
44098759|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098760|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098761|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
44098762|NCT00050245|Rituximab|rituximab|mesh-list
44098763|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098764|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098765|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
44098766|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098767|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44098768|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
44098769|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
44098770|NCT00050271|Vitamins|vitamins|mesh-ancestor
44098771|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
44098772|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098773|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
44152950|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44152951|NCT00218361|Narcotics|narcotics|mesh-ancestor
44152952|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152953|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152954|NCT00218361|Analgesics|analgesics|mesh-ancestor
44152955|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
44152956|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152957|NCT00218374|Gabapentin|gabapentin|mesh-list
44152958|NCT00218374|Analgesics|analgesics|mesh-ancestor
44152959|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
44152960|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44152961|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152962|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
44152963|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44152964|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44152965|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44152966|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152967|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44152968|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44152969|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44152970|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44152975|NCT00218504|Dronabinol|dronabinol|mesh-list
44152976|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
44152977|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44152978|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44152979|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44098774|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
44098775|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44098776|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098777|NCT00050336|Lonafarnib|lonafarnib|mesh-list
44098778|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098779|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098780|NCT00050349|Epothilones|epothilones|mesh-list
44098781|NCT00050349|Epothilone B|epothilone b|mesh-list
44098782|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
44098783|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
44098784|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098785|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098786|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098787|NCT00050362|Rofecoxib|rofecoxib|mesh-list
44098788|NCT00050362|Bupivacaine|bupivacaine|mesh-list
44098790|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
44098822|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44098823|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098824|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098825|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098826|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
44098827|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098828|NCT00050427|Trabectedin|trabectedin|mesh-list
44098829|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44098842|NCT00050440|Hormones|hormones|mesh-ancestor
44098886|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
44098887|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098888|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44098889|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44098890|NCT00050609|Tadalafil|tadalafil|mesh-list
44098891|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
44098892|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44098893|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44098894|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44098895|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098896|NCT00050609|Urological Agents|urological agents|mesh-ancestor
44098897|NCT00050635|Octreotide|octreotide|mesh-list
44098898|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44098899|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44098900|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44098901|NCT00050648|Cyclosporine|cyclosporine|mesh-list
44098902|NCT00050648|Cyclosporins|cyclosporins|mesh-list
44098903|NCT00050648|Daclizumab|daclizumab|mesh-list
44098945|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098947|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098948|NCT00050817|Clopidogrel|clopidogrel|mesh-list
44098949|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44098950|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44098951|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44098952|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44098953|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
44098954|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44098955|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44098956|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098957|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
44098958|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
44098959|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
44098960|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44098961|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098962|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
44099002|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099003|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44099004|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099005|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099006|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099008|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44099068|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099069|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44099070|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099071|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44099072|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44099073|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44099074|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44099075|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
44099076|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
44099077|NCT00051116|Lenalidomide|lenalidomide|mesh-list
44099078|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
44099079|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099080|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099081|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099082|NCT00051116|Growth Substances|growth substances|mesh-ancestor
44099085|NCT00051142|Travoprost|travoprost|mesh-list
44099124|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
44099125|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44099126|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44099127|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44099128|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44099129|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099130|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
44099131|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099132|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099133|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44099134|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099137|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44099138|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
44099139|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44099140|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44099141|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099142|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099143|NCT00051285|Protective Agents|protective agents|mesh-ancestor
44099145|NCT00051298|Olanzapine|olanzapine|mesh-list
44099178|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099179|NCT00051545|Seocalcitol|seocalcitol|mesh-list
44099180|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099181|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099182|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
44099183|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099184|NCT00051571|Docetaxel|docetaxel|mesh-list
44099185|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099186|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099246|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44099247|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
44099248|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099249|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099250|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44099251|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44099252|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
44099253|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099254|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44099255|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44099256|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099257|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099258|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44099259|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44099260|NCT00051844|Capravirine|capravirine|mesh-list
44099261|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099262|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099273|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099274|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
44099275|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44099276|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099277|NCT00051974|Bortezomib|bortezomib|mesh-list
44099278|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099279|NCT00051987|Bortezomib|bortezomib|mesh-list
44099280|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099281|NCT00052000|Antibodies|antibodies|mesh-list
44099282|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44099283|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
44099284|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099285|NCT00052013|Vatalanib|vatalanib|mesh-list
44099286|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099287|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099288|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099333|NCT00052169|Gefitinib|gefitinib|mesh-list
44099334|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099335|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099336|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099337|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099338|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099339|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099340|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099341|NCT00052208|Gefitinib|gefitinib|mesh-list
44099342|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099343|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099344|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099345|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099346|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
44099347|NCT00052221|Hematinics|hematinics|mesh-ancestor
44099348|NCT00052273|Capecitabine|capecitabine|mesh-list
44099349|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099392|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099393|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44099394|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099395|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099396|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099397|NCT00052338|Gemcitabine|gemcitabine|mesh-list
44099398|NCT00052338|Carboplatin|carboplatin|mesh-list
44099399|NCT00052338|Bortezomib|bortezomib|mesh-list
44099400|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099401|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099402|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
44099403|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099404|NCT00052338|Antiviral Agents|antiviral agents|mesh-ancestor
44099405|NCT00052338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099406|NCT00052338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099407|NCT00052338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099408|NCT00052338|Immunologic Factors|immunologic factors|mesh-ancestor
44099409|NCT00052338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099410|NCT00052351|Metronidazole|metronidazole|mesh-list
44099411|NCT00052351|Paclitaxel|paclitaxel|mesh-list
44099412|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
44099413|NCT00052351|Doxorubicin|doxorubicin|mesh-list
44099414|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44099415|NCT00052351|Vaccines|vaccines|mesh-list
44099416|NCT00052351|Sargramostim|sargramostim|mesh-list
44099417|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
44099418|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099419|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099420|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099421|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099422|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099423|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099424|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099425|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099426|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099434|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099435|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099436|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44099437|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44099438|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
44099439|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099440|NCT00052377|Aldesleukin|aldesleukin|mesh-list
44099441|NCT00052377|Interleukin-2|interleukin-2|mesh-list
44099442|NCT00052377|Interleukin-12|interleukin-12|mesh-list
44099443|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099444|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44099445|NCT00052377|Analgesics|analgesics|mesh-ancestor
44099446|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
44099500|NCT00052455|Procarbazine|procarbazine|mesh-list
44099501|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099502|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099503|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099504|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099505|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099506|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099507|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099508|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
44099509|NCT00052468|Gemcitabine|gemcitabine|mesh-list
44099510|NCT00052468|Paclitaxel|paclitaxel|mesh-list
44099511|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44099512|NCT00052468|Carboplatin|carboplatin|mesh-list
44099513|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099514|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099515|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099516|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099517|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099518|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099519|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099520|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
44099521|NCT00052468|Antiviral Agents|antiviral agents|mesh-ancestor
44099522|NCT00052468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099523|NCT00052468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099524|NCT00052468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099525|NCT00052468|Immunologic Factors|immunologic factors|mesh-ancestor
44099527|NCT00052494|Cisplatin|cisplatin|mesh-list
44099554|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099555|NCT00052585|Leucovorin|leucovorin|mesh-list
44099556|NCT00052585|Fluorouracil|fluorouracil|mesh-list
44099557|NCT00052585|Irinotecan|irinotecan|mesh-list
44099558|NCT00052585|Gefitinib|gefitinib|mesh-list
44099559|NCT00052585|Calcium|calcium|mesh-list
44099560|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
44099561|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44099562|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099563|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
44099564|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099565|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099566|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099567|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099568|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
44099569|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44099570|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099571|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814652|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
44099572|NCT00052585|Antidotes|antidotes|mesh-ancestor
44099573|NCT00052585|Protective Agents|protective agents|mesh-ancestor
44099574|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
44099575|NCT00052585|Vitamins|vitamins|mesh-ancestor
44099576|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
44099577|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44099578|NCT00052611|Celecoxib|celecoxib|mesh-list
44099579|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44099580|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44099581|NCT00052611|Analgesics|analgesics|mesh-ancestor
44099582|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
43647149|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647150|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647151|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
44099583|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099584|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099585|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099586|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099587|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44099588|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44099589|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099590|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099591|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44099592|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44099593|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099594|NCT00052689|Gemcitabine|gemcitabine|mesh-list
44099595|NCT00052689|Bortezomib|bortezomib|mesh-list
44099596|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099597|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
43771831|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099598|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099599|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099600|NCT00052689|Antiviral Agents|antiviral agents|mesh-ancestor
44099601|NCT00052689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099602|NCT00052689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099603|NCT00052689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099604|NCT00052689|Immunologic Factors|immunologic factors|mesh-ancestor
44099605|NCT00052689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099606|NCT00052728|Tamoxifen|tamoxifen|mesh-list
44099607|NCT00052728|Tipifarnib|tipifarnib|mesh-list
44099608|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44099609|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
44099611|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099629|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44099630|NCT00052832|Vitamins|vitamins|mesh-ancestor
44099631|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
44099632|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099633|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44099634|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
44099635|NCT00052845|Docetaxel|docetaxel|mesh-list
44099636|NCT00052845|Estramustine|estramustine|mesh-list
44099637|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099638|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44099639|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44099640|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44099641|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099642|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099643|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
44099644|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44099645|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44099646|NCT00052845|Protective Agents|protective agents|mesh-ancestor
44099647|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099648|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44099649|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099650|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44099651|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44099652|NCT00052845|Analgesics|analgesics|mesh-ancestor
44099653|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
44099654|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44099655|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44099656|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099657|NCT00052884|Melphalan|melphalan|mesh-list
44099658|NCT00052884|Amifostine|amifostine|mesh-list
44099659|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
44099660|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099661|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099662|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
44099663|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099666|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099667|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44099668|NCT00052884|Protective Agents|protective agents|mesh-ancestor
44099669|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
44099670|NCT00052923|Carmustine|carmustine|mesh-list
44099671|NCT00052923|Rituximab|rituximab|mesh-list
44099672|NCT00052923|Etoposide|etoposide|mesh-list
44099673|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099674|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
44099675|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099676|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099677|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099678|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
44099679|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099680|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099681|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099682|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44099683|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099684|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099685|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099722|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
44099723|NCT00053001|Hematinics|hematinics|mesh-ancestor
44153008|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44099724|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099725|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
44099726|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099727|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
44099728|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099729|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099730|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099731|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099787|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44099788|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44099789|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099790|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099791|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099792|NCT00053131|Cytarabine|cytarabine|mesh-list
44099793|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
44099794|NCT00053131|Sargramostim|sargramostim|mesh-list
44099795|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099796|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
44099797|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099798|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099799|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
44099800|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099801|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099802|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
44099803|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099845|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44099846|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099847|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
44099848|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44099849|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099850|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44099851|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44099852|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44099853|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
44099854|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099855|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099856|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
44099857|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44099858|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44099859|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
44099860|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44099861|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
44099862|NCT00053196|Protective Agents|protective agents|mesh-ancestor
44099863|NCT00053209|Gemcitabine|gemcitabine|mesh-list
44099864|NCT00053209|Pemetrexed|pemetrexed|mesh-list
44099865|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44099866|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
44099868|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44099898|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44099899|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099900|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
44099901|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099902|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099903|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44099904|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44099905|NCT00053287|Growth Substances|growth substances|mesh-ancestor
44099906|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
44099908|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44099909|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
44099910|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099911|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
44099912|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44099924|NCT00053339|Tamoxifen|tamoxifen|mesh-list
44099958|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
44099959|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099960|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44099961|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44099962|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44099963|NCT00053612|Vitamin A|vitamin a|mesh-list
44099964|NCT00053612|Vitamins|vitamins|mesh-ancestor
44099965|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
44099966|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44099967|NCT00053638|Tenofovir|tenofovir|mesh-list
44099968|NCT00053638|Lamivudine|lamivudine|mesh-list
44099969|NCT00053638|Efavirenz|efavirenz|mesh-list
44099970|NCT00053638|Abacavir|abacavir|mesh-list
44099971|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
44099972|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44099973|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44099974|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44099975|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153042|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44153043|NCT00218855|Thalidomide|thalidomide|mesh-list
44153045|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
44100051|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100052|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100053|NCT00053872|Cisplatin|cisplatin|mesh-list
44100054|NCT00053872|Vincristine|vincristine|mesh-list
44100055|NCT00053872|Lomustine|lomustine|mesh-list
44100056|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100057|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44100058|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
44100059|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
44100060|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
44100061|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100062|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44100063|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
44100064|NCT00053885|Vatalanib|vatalanib|mesh-list
44100065|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44100066|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100067|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100068|NCT00053911|Tamoxifen|tamoxifen|mesh-list
44100069|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
44100070|NCT00053911|Docetaxel|docetaxel|mesh-list
44100071|NCT00053911|Fluorouracil|fluorouracil|mesh-list
44100072|NCT00053911|Epirubicin|epirubicin|mesh-list
44100105|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44100106|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100107|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44100412|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100413|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
44100571|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100572|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
44100573|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
44100574|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100575|NCT00055198|Daptomycin|daptomycin|mesh-list
44100576|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44100577|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100578|NCT00055250|Gemcitabine|gemcitabine|mesh-list
44100579|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44100580|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
44100581|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100582|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100583|NCT00055250|Antiviral Agents|antiviral agents|mesh-ancestor
44100584|NCT00055250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100585|NCT00055250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100586|NCT00055250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44100587|NCT00055250|Immunologic Factors|immunologic factors|mesh-ancestor
44100588|NCT00055250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44100589|NCT00055302|Anastrozole|anastrozole|mesh-list
44100590|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44100591|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44100592|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44100593|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44100594|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100595|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100596|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44100597|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
44100600|NCT00055341|Ribavirin|ribavirin|mesh-list
44100682|NCT00055614|Topotecan|topotecan|mesh-list
44100739|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44100740|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
44100743|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
44100823|NCT00055822|Leucovorin|leucovorin|mesh-list
44101200|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101201|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101202|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
44101203|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
44101204|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101205|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
44101206|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101207|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43684885|NCT02839408|Azithromycin|azithromycin|mesh-list
44101208|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44101209|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
44101210|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101211|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101212|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44101213|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101243|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
44101532|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101533|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44101534|NCT00058201|Antidotes|antidotes|mesh-ancestor
44101535|NCT00058201|Protective Agents|protective agents|mesh-ancestor
44101536|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
44101538|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
44101539|NCT00058227|Rituximab|rituximab|mesh-list
44101540|NCT00058227|Fludarabine|fludarabine|mesh-list
44101541|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
44101542|NCT00058227|Alvocidib|alvocidib|mesh-list
44101543|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101544|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101545|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
44101546|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101547|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44101548|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44101549|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
44101550|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101551|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44101552|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
44101553|NCT00058227|Growth Substances|growth substances|mesh-ancestor
44101554|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44101555|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101556|NCT00058253|Docetaxel|docetaxel|mesh-list
44101557|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101558|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
44101559|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
44101560|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
44101561|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101562|NCT00058279|Aldesleukin|aldesleukin|mesh-list
44101563|NCT00058279|Ipilimumab|ipilimumab|mesh-list
44101564|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101565|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101566|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44101567|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44101576|NCT00058292|Melphalan|melphalan|mesh-list
44101577|NCT00058292|Carmustine|carmustine|mesh-list
44101651|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101652|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
44101653|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101723|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101724|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
44101725|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44101726|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44101733|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
44153097|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153098|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
44153099|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153100|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153101|NCT00219388|Simendan|simendan|mesh-list
44153102|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44153103|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
44153104|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44153105|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44153106|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153108|NCT00219388|Protective Agents|protective agents|mesh-ancestor
44101808|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44101809|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
44101810|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44101811|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44101812|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44101813|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
44101814|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44101815|NCT00059358|Interferons|interferons|mesh-list
44101816|NCT00059358|Ribavirin|ribavirin|mesh-list
44101817|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
44101818|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
44101819|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44101820|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101872|NCT00059813|Interferons|interferons|mesh-list
44101873|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
44101874|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
44101875|NCT00059813|Oblimersen|oblimersen|mesh-list
44101876|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101877|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
44101878|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44101879|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
44101880|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44101881|NCT00059826|Interferons|interferons|mesh-list
44101939|NCT00059904|Rituximab|rituximab|mesh-list
44101940|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44101941|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44101942|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
44101943|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102012|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102013|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
44102014|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102015|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102016|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44102017|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102081|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102082|NCT00060398|Hematinics|hematinics|mesh-ancestor
44102083|NCT00060411|Leucovorin|leucovorin|mesh-list
44102084|NCT00060411|Bevacizumab|bevacizumab|mesh-list
44102085|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44102086|NCT00060411|Fluorouracil|fluorouracil|mesh-list
44102152|NCT00060502|Infliximab|infliximab|mesh-list
44102153|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102154|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
43816818|NCT03995628|Hormones|hormones|mesh-ancestor
44153129|NCT00219466|Vitamins|vitamins|mesh-ancestor
44102155|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102222|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102223|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102224|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44102225|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
44102226|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
44102227|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153184|NCT00219713|Analgesics|analgesics|mesh-ancestor
44153185|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
44153186|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153187|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
44153188|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153189|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44153190|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153191|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153192|NCT00219739|Interferons|interferons|mesh-list
44153193|NCT00219739|Cytarabine|cytarabine|mesh-list
44153194|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
44153195|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153196|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
44102288|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44102289|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44102290|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44102291|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44102292|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102293|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102294|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
44102295|NCT00060931|Protective Agents|protective agents|mesh-ancestor
44102296|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44102297|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102298|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44102299|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102300|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44102301|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43652098|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
44102302|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
44102303|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44102304|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44102305|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44102306|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102307|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102308|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
44102309|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102310|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102313|NCT00060996|Treprostinil|treprostinil|mesh-list
44102336|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44102337|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102339|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44102340|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44102341|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
44102342|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44102343|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44102400|NCT00061308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102401|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44102402|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102408|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
44102471|NCT00061477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102472|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102473|NCT00061477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102474|NCT00061477|Immunologic Factors|immunologic factors|mesh-ancestor
44102475|NCT00061477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102476|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44102477|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44102478|NCT00061503|Travoprost|travoprost|mesh-list
44102536|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44102538|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
44102539|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102540|NCT00061776|Capsaicin|capsaicin|mesh-list
44102608|NCT00061919|Carboplatin|carboplatin|mesh-list
44102609|NCT00061919|Etoposide|etoposide|mesh-list
44102610|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
44102611|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102612|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44102613|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44102614|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44102615|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102616|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102617|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44102674|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102675|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44102676|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44102677|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
44102678|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102679|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102680|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44102681|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102682|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
44102683|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44102684|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44102738|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
44102739|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44102740|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44102741|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44102809|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102810|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102812|NCT00062270|Cisplatin|cisplatin|mesh-list
44102813|NCT00062270|Docetaxel|docetaxel|mesh-list
44102814|NCT00062270|Gefitinib|gefitinib|mesh-list
44102815|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44102816|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44102817|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
44153220|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153221|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
44153222|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44102894|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
44102895|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
44102897|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
44102901|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44102966|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
44102967|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44102968|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44102969|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44102970|NCT00062842|Irinotecan|irinotecan|mesh-list
44103036|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44103037|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
44103038|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103039|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44103108|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103110|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44103111|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
44103112|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103113|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44103114|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44103115|NCT00063869|Etanercept|etanercept|mesh-list
44103116|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103117|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44103118|NCT00063869|Analgesics|analgesics|mesh-ancestor
44103173|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103174|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
44103223|NCT00064181|Fluorouracil|fluorouracil|mesh-list
44103224|NCT00064181|Capecitabine|capecitabine|mesh-list
44103225|NCT00064181|Irinotecan|irinotecan|mesh-list
44103226|NCT00064181|Calcium|calcium|mesh-list
44103298|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
44103299|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103300|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103301|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44103367|NCT00064623|Capsaicin|capsaicin|mesh-list
44103368|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
44103369|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
44103370|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
44103371|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44103372|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103373|NCT00064636|Bortezomib|bortezomib|mesh-list
44103439|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44103440|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
44103441|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103442|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103509|NCT00065455|Vitamins|vitamins|mesh-ancestor
44103511|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103512|NCT00065533|Pemetrexed|pemetrexed|mesh-list
44103513|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103518|NCT00065546|Choline|choline|mesh-list
44153289|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
44153290|NCT00219908|Analgesics|analgesics|mesh-ancestor
44153291|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
44103568|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
44103638|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44103639|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
44103642|NCT00066157|Progestins|progestins|mesh-ancestor
44103713|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103714|NCT00066378|Gefitinib|gefitinib|mesh-list
44103715|NCT00066378|Anastrozole|anastrozole|mesh-list
44103716|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44103717|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44103786|NCT00066482|Etoposide|etoposide|mesh-list
44103787|NCT00066482|Bleomycin|bleomycin|mesh-list
44103788|NCT00066482|Lenograstim|lenograstim|mesh-list
44103789|NCT00066482|Mesna|mesna|mesh-list
44103790|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103791|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
44103792|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103793|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103855|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44103856|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44103857|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103858|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44103859|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652106|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652107|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652108|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43652109|NCT03002675|Incretins|incretins|mesh-ancestor
44103860|NCT00066716|Analgesics|analgesics|mesh-ancestor
44103861|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
44103923|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
44103924|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44103925|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
44103926|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44103928|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44103995|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
44103996|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44103997|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
44103998|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44103999|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44104066|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104067|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
44104068|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153295|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44153296|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153297|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153298|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153300|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44153301|NCT00219921|Narcotics|narcotics|mesh-ancestor
44104163|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104164|NCT00067899|Protective Agents|protective agents|mesh-ancestor
44104165|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44104166|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44104167|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44104168|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104169|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104170|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104171|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104172|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104173|NCT00067912|Analgesics|analgesics|mesh-ancestor
44104174|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
44104175|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44104222|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
44104223|NCT00068276|Vitamin D|vitamin d|mesh-list
44104224|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44104225|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104226|NCT00068276|Vitamins|vitamins|mesh-ancestor
44104227|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
44104228|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44104229|NCT00068289|Bortezomib|bortezomib|mesh-list
44104230|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104231|NCT00068302|Sirolimus|sirolimus|mesh-list
44104289|NCT00068497|Gefitinib|gefitinib|mesh-list
44104290|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104294|NCT00068523|Cyclosporine|cyclosporine|mesh-list
44104361|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44104362|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
44104363|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104364|NCT00068731|Protective Agents|protective agents|mesh-ancestor
44104366|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44104431|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
44104432|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44104433|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44104434|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104435|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104436|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104437|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
44104438|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104439|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771914|NCT02369965|Lamivudine|lamivudine|mesh-list
43771915|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43771916|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43771917|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
43771918|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771919|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104440|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44104441|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44104442|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104443|NCT00069355|Propranolol|propranolol|mesh-list
44104444|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44104445|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44104446|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44104447|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104448|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104449|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153339|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153340|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153341|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
44153342|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153343|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44153344|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104529|NCT00069927|Adderall|adderall|mesh-list
44104530|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
44104531|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44104532|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104533|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44104534|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44104535|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44104536|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104593|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
44104594|NCT00070083|Rituximab|rituximab|mesh-list
44104595|NCT00070083|Doxorubicin|doxorubicin|mesh-list
44104596|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44104597|NCT00070083|Vincristine|vincristine|mesh-list
44104598|NCT00070083|Oblimersen|oblimersen|mesh-list
44104599|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104600|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
44104601|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104662|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44104663|NCT00070148|Androgens|androgens|mesh-ancestor
44104665|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104666|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
44104667|NCT00070161|Donepezil|donepezil|mesh-list
44104668|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44104669|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104670|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104671|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
44104672|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44104673|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104674|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
44104675|NCT00070174|Cytarabine|cytarabine|mesh-list
44104726|NCT00070187|Lenograstim|lenograstim|mesh-list
44104727|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104728|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104729|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44104730|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44104731|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44104732|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44104733|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
44104734|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44104793|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44104794|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104795|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
44104796|NCT00070213|Antidotes|antidotes|mesh-ancestor
44104797|NCT00070213|Protective Agents|protective agents|mesh-ancestor
44104798|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
44104800|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
44104801|NCT00070239|Alvocidib|alvocidib|mesh-list
44104802|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44104862|NCT00070304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44104863|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
44104864|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44104865|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44104866|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44104867|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
44104868|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104869|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104870|NCT00070343|Dacarbazine|dacarbazine|mesh-list
44104871|NCT00070343|Oblimersen|oblimersen|mesh-list
44104872|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44104876|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
44104928|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
44104929|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
44104930|NCT00070473|Pemetrexed|pemetrexed|mesh-list
44104931|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105001|NCT00070655|Warfarin|warfarin|mesh-list
44105002|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
44105003|NCT00070655|Idraparinux|idraparinux|mesh-list
44105004|NCT00070655|Vitamins|vitamins|mesh-ancestor
44105005|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
44105006|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105007|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
44105008|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44105009|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44105010|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105011|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
44105012|NCT00070655|Coagulants|coagulants|mesh-ancestor
44105013|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44105014|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
44105015|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44105016|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
44105017|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105018|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
44105019|NCT00070733|Testosterone|testosterone|mesh-list
44105020|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
44105022|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44105023|NCT00070733|Androgens|androgens|mesh-ancestor
44105024|NCT00070733|Hormones|hormones|mesh-ancestor
44105025|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44105026|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105027|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44105028|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105029|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
44105030|NCT00070759|Daclizumab|daclizumab|mesh-list
44105031|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105032|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
44105033|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105034|NCT00070837|Antibodies|antibodies|mesh-list
44105035|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44105036|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
44105037|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105038|NCT00071071|Zanolimumab|zanolimumab|mesh-list
44105040|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105042|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44105043|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105044|NCT00071097|Darunavir|darunavir|mesh-list
44105045|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44105046|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44105055|NCT00071136|Pemetrexed|pemetrexed|mesh-list
44105112|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105113|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105114|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105158|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105159|NCT00071643|Citalopram|citalopram|mesh-list
44105160|NCT00071643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44105161|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44105162|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44105163|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105226|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105227|NCT00071994|Gefitinib|gefitinib|mesh-list
44105228|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105229|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105230|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105231|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105293|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44105294|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44105295|NCT00072072|Analgesics|analgesics|mesh-ancestor
44105296|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
44105297|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44105298|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105299|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105300|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44105301|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44105302|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44105303|NCT00072085|Aldesleukin|aldesleukin|mesh-list
44105304|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
44105305|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105306|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44105307|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44105308|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
44105309|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105310|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44105311|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
44105312|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105313|NCT00072098|Interleukin-12|interleukin-12|mesh-list
44105314|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44105347|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105348|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105349|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105350|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
44105351|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105352|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
44105353|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44105354|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105355|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44105356|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44105357|NCT00072163|Growth Substances|growth substances|mesh-ancestor
44105358|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44105359|NCT00072215|Paclitaxel|paclitaxel|mesh-list
44105360|NCT00072215|Vinblastine|vinblastine|mesh-list
44105361|NCT00072215|Cisplatin|cisplatin|mesh-list
44105362|NCT00072215|Ifosfamide|ifosfamide|mesh-list
44105363|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105364|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105365|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105366|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
44105367|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
44105368|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105369|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44105370|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
44105372|NCT00072228|Soblidotin|soblidotin|mesh-list
44105373|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44105374|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
44105375|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105376|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105377|NCT00072228|Antiviral Agents|antiviral agents|mesh-ancestor
44105378|NCT00072228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44105379|NCT00072228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105380|NCT00072228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44105381|NCT00072228|Immunologic Factors|immunologic factors|mesh-ancestor
44105389|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105390|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44105391|NCT00072319|Paclitaxel|paclitaxel|mesh-list
44105392|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
44105393|NCT00072319|Epirubicin|epirubicin|mesh-list
44105394|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44105395|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105396|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
44105457|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44105458|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44105532|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44105606|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105607|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44105608|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
44105609|NCT00072930|Hormones|hormones|mesh-ancestor
44105611|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105638|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44105639|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105640|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105703|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105704|NCT00073411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44105705|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
44105706|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44105775|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44105776|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
44105777|NCT00073710|Calcitriol|calcitriol|mesh-list
44105778|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44105779|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44105780|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44105843|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44105844|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
44105845|NCT00073879|Fludarabine|fludarabine|mesh-list
44105846|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
44105847|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
44105914|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105917|NCT00074139|Docetaxel|docetaxel|mesh-list
44105989|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44105990|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44105991|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
44106062|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106063|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
44106064|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106065|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
44106066|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106067|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44106132|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44106133|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44106134|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819830|NCT03340506|Trametinib|trametinib|mesh-list
44153471|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153472|NCT00220350|Leuprolide|leuprolide|mesh-list
44153473|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44153474|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
44153475|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44153476|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153477|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44158132|NCT00236275|Telbivudine|telbivudine|mesh-list
44106196|NCT00075205|Rimonabant|rimonabant|mesh-list
44106197|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44106198|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44106199|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44106200|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106201|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106265|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106266|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106341|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
44106342|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106343|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106344|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44106351|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
44106411|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106412|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106413|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106414|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106415|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106416|NCT00075738|Leucovorin|leucovorin|mesh-list
44106484|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106485|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44106486|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44106487|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
44106488|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106489|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44106490|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44106491|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106492|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106493|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43820289|NCT05677126|Copper|copper|mesh-list
44106545|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106546|NCT00076232|Acyclovir|acyclovir|mesh-list
44106621|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106622|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106623|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44106624|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106625|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44106684|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
44106685|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106686|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106757|NCT00077168|Anastrozole|anastrozole|mesh-list
44106758|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106907|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106908|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106909|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106910|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106911|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106914|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106976|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106977|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107051|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107052|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107054|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107122|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44107123|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
44153488|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107255|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107257|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44107327|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107328|NCT00079079|Gemcitabine|gemcitabine|mesh-list
44107329|NCT00079079|Cisplatin|cisplatin|mesh-list
44107330|NCT00079079|Carboplatin|carboplatin|mesh-list
44107331|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107332|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107333|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
44107356|NCT00079105|Etoposide|etoposide|mesh-list
44107397|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107398|NCT00079131|Oblimersen|oblimersen|mesh-list
44107399|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107400|NCT00079144|Aldesleukin|aldesleukin|mesh-list
44107401|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
44107402|NCT00079144|Fludarabine|fludarabine|mesh-list
44107403|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
44107404|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
44107405|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107467|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107468|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
44107469|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107540|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107542|NCT00079365|Fluorouracil|fluorouracil|mesh-list
44107543|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107544|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
44107546|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107612|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44107613|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
44107614|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107615|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44107616|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44107617|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44107619|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
44107679|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107680|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107681|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44107682|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107683|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107684|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
44107746|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44107747|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107748|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107749|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
44107750|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107751|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44107752|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107753|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
44107754|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107755|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44107810|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44107811|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44107812|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107813|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44107814|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
44107815|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107816|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44107817|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107818|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107820|NCT00080275|Simvastatin|simvastatin|mesh-list
44107821|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44107822|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44107823|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
44107824|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107825|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44107867|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44107868|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44107869|NCT00080340|Gefitinib|gefitinib|mesh-list
44107870|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107871|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107872|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821436|NCT04298528|Hormones|hormones|mesh-ancestor
44107873|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107874|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44107875|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44153556|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153557|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153558|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153559|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
44153560|NCT00220766|Antibodies|antibodies|mesh-list
44107933|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107934|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
44107935|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107936|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107937|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107938|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107939|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107941|NCT00080522|Lopinavir|lopinavir|mesh-list
44107942|NCT00080522|Lamivudine|lamivudine|mesh-list
44107943|NCT00080522|Zidovudine|zidovudine|mesh-list
44107944|NCT00080522|Didanosine|didanosine|mesh-list
44107945|NCT00080522|Stavudine|stavudine|mesh-list
44107946|NCT00080522|Efavirenz|efavirenz|mesh-list
44107947|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44107948|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44107993|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
44107994|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107995|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107996|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107997|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107998|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107999|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108000|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108001|NCT00080743|Tamoxifen|tamoxifen|mesh-list
44108002|NCT00080743|Gefitinib|gefitinib|mesh-list
44108003|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108004|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44108005|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
44108055|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
44108056|NCT00080808|Alprostadil|alprostadil|mesh-list
44108057|NCT00080808|Papaverine|papaverine|mesh-list
44108058|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108059|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44108060|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44108061|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44108062|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108063|NCT00080808|Urological Agents|urological agents|mesh-ancestor
44108064|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44108065|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44108066|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
44108118|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108119|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108120|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
44108121|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
44108122|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108123|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108124|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108127|NCT00080925|Cytarabine|cytarabine|mesh-list
44108188|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
44108189|NCT00080951|Vitamins|vitamins|mesh-ancestor
44108190|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
44108191|NCT00080977|Aldesleukin|aldesleukin|mesh-list
44108192|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108193|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44108194|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44108195|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
44108196|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108197|NCT00080990|Leucovorin|leucovorin|mesh-list
44108257|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44108258|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44153576|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
44108273|NCT00081172|Antibodies|antibodies|mesh-list
44108331|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108332|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
44108333|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821931|NCT03099174|Letrozole|letrozole|mesh-list
44108334|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108335|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
44108336|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108338|NCT00081575|Ofloxacin|ofloxacin|mesh-list
44108342|NCT00081575|Renal Agents|renal agents|mesh-ancestor
44108396|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108398|NCT00081822|Clofarabine|clofarabine|mesh-list
44108399|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108400|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
44108401|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108402|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108464|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108465|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108467|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44108468|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
44108469|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108470|NCT00082095|Doxorubicin|doxorubicin|mesh-list
44108471|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108472|NCT00082095|Capecitabine|capecitabine|mesh-list
44108509|NCT00082251|Niacin|niacin|mesh-list
44153583|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44153584|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153585|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153586|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153587|NCT00220844|Analgesics|analgesics|mesh-ancestor
44153588|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
44153589|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44153590|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153591|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44108560|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108561|NCT00082472|Cisplatin|cisplatin|mesh-list
44108562|NCT00082472|Docetaxel|docetaxel|mesh-list
44108563|NCT00082472|Doxorubicin|doxorubicin|mesh-list
43772002|NCT02369081|Diuretics|diuretics|mesh-ancestor
44108564|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108565|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108632|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44108633|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
44108634|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108635|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108636|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44108637|NCT00082589|Diuretics|diuretics|mesh-ancestor
44108638|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
44108639|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44108640|NCT00082602|Galantamine|galantamine|mesh-list
44108641|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44108642|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108643|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108696|NCT00082797|Vitamins|vitamins|mesh-ancestor
44108697|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
44108698|NCT00082823|Aflibercept|aflibercept|mesh-list
44108699|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108700|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108701|NCT00082823|Growth Substances|growth substances|mesh-ancestor
44108702|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108703|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108704|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108705|NCT00082836|Rituximab|rituximab|mesh-list
44108761|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108762|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108763|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
44108764|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108833|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108834|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44108835|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44108836|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44108837|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108842|NCT00083148|Irinotecan|irinotecan|mesh-list
44108903|NCT00083408|Growth Substances|growth substances|mesh-ancestor
44108904|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108906|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44108978|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108979|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108980|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108981|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108982|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108983|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108984|NCT00083577|Growth Substances|growth substances|mesh-ancestor
44108985|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109045|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109047|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109048|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
44109049|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44109050|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109051|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44109052|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44109053|NCT00083694|Growth Substances|growth substances|mesh-ancestor
44109054|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109055|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109057|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109058|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
44109059|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109060|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
44109061|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44109062|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109063|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44109064|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44109065|NCT00083707|Growth Substances|growth substances|mesh-ancestor
44153611|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
44153612|NCT00220909|Lansoprazole|lansoprazole|mesh-list
44153613|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
44153614|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44153615|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153616|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44153617|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153619|NCT00220922|Ethanol|ethanol|mesh-list
44109135|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109208|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44109209|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109210|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109279|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
44109280|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44109281|NCT04984070|Diuretics|diuretics|mesh-ancestor
44109282|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
44109283|NCT04943627|Gemcitabine|gemcitabine|mesh-list
44109284|NCT04943627|Irinotecan|irinotecan|mesh-list
44109285|NCT04943627|Pemetrexed|pemetrexed|mesh-list
44109286|NCT04943627|Topotecan|topotecan|mesh-list
44109287|NCT04943627|Vinorelbine|vinorelbine|mesh-list
44109288|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44109289|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
44109291|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109346|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
44109347|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44109348|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
44109349|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109350|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109351|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44109352|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
44109414|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44109415|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109416|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44109417|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44109418|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109419|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109420|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
44109433|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44109505|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109506|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109507|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44109508|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109509|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109510|NCT04493619|Carboplatin|carboplatin|mesh-list
44109511|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109512|NCT04420533|Mirabegron|mirabegron|mesh-list
44109513|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44109514|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44109515|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44109516|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
44109517|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109518|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109519|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109520|NCT04420533|Urological Agents|urological agents|mesh-ancestor
44109521|NCT04379713|Vaccines|vaccines|mesh-list
44109522|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44109523|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
44109524|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109525|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
44109526|NCT04332211|Ephedrine|ephedrine|mesh-list
44109527|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44109528|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
44109529|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109530|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109540|NCT04328285|Ritonavir|ritonavir|mesh-list
44109551|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109552|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44109553|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109554|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
44109555|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44109556|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44109557|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109558|NCT04230499|Sirolimus|sirolimus|mesh-list
44109559|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44109567|NCT04166383|Nivolumab|nivolumab|mesh-list
44109617|NCT04030026|Narcotics|narcotics|mesh-ancestor
44109618|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109619|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109690|NCT03883919|Antidotes|antidotes|mesh-ancestor
44109691|NCT03883919|Protective Agents|protective agents|mesh-ancestor
44109692|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
44109693|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
44109694|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109695|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109696|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
44109697|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109698|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44109699|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44109700|NCT03847311|Analgesics|analgesics|mesh-ancestor
44109701|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
44109702|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109703|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109704|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109705|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109706|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109707|NCT03839459|Denosumab|denosumab|mesh-list
44109708|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44109709|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109710|NCT03816774|Simethicone|simethicone|mesh-list
44109711|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
44109712|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109713|NCT03816774|Emollients|emollients|mesh-ancestor
44109714|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
44109715|NCT03815643|Avelumab|avelumab|mesh-list
44109716|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109717|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109718|NCT03784014|Durvalumab|durvalumab|mesh-list
44109719|NCT03784014|Olaparib|olaparib|mesh-list
44109721|NCT03784014|Palbociclib|palbociclib|mesh-list
44109722|NCT03784014|Trametinib|trametinib|mesh-list
44109723|NCT03784014|Dabrafenib|dabrafenib|mesh-list
44109724|NCT03784014|Ceritinib|ceritinib|mesh-list
44109725|NCT03784014|Futibatinib|futibatinib|mesh-list
44109726|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109727|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109729|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109731|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44109732|NCT03731832|Dexamethasone|dexamethasone|mesh-list
44109733|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
44109734|NCT03731832|Pomalidomide|pomalidomide|mesh-list
44109735|NCT03731832|Ixazomib|ixazomib|mesh-list
44109736|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109737|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
44109738|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109751|NCT03731832|Hormones|hormones|mesh-ancestor
44109800|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44109801|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109802|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44109803|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
44109804|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
44109805|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109806|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109807|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109808|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44109809|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109810|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153691|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
44153692|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153695|NCT00221416|Aripiprazole|aripiprazole|mesh-list
44153738|NCT00221481|Valproic Acid|valproic acid|mesh-list
44153739|NCT00221481|Olanzapine|olanzapine|mesh-list
43772065|NCT02368717|Mesalamine|mesalamine|mesh-list
44153740|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
44153741|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
44153745|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44109871|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44109872|NCT03238365|Nivolumab|nivolumab|mesh-list
44109873|NCT03238365|Tadalafil|tadalafil|mesh-list
44109874|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109875|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109876|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44109877|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109878|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
44109883|NCT02966665|Vitamins|vitamins|mesh-list
44109940|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109941|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109946|NCT02832544|Vitamin K|vitamin k|mesh-list
44110013|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110014|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44110015|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44110083|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
44110084|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44110085|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110086|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110156|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44110157|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44110158|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110159|NCT00084240|Amebicides|amebicides|mesh-ancestor
44110160|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44110161|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44110162|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
44110224|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110225|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110226|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110227|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110228|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110229|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110230|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110231|NCT00084448|Analgesics|analgesics|mesh-ancestor
44110232|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
44110233|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44110234|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110235|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44110236|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44110237|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44110238|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44110239|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110240|NCT00084461|Romidepsin|romidepsin|mesh-list
44110241|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110242|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110243|NCT00084513|Trastuzumab|trastuzumab|mesh-list
44110244|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
44110245|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110246|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110247|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110248|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110249|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110250|NCT00084565|Paclitaxel|paclitaxel|mesh-list
44110251|NCT00084565|Topotecan|topotecan|mesh-list
44110252|NCT00084565|Estramustine|estramustine|mesh-list
44110253|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44110254|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110255|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110256|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110264|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44110265|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
44110266|NCT00084578|Celecoxib|celecoxib|mesh-list
44110267|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44110268|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44110269|NCT00084578|Analgesics|analgesics|mesh-ancestor
44110333|NCT00084695|Melphalan|melphalan|mesh-list
44110334|NCT00084695|Busulfan|busulfan|mesh-list
44110335|NCT00084695|Fludarabine|fludarabine|mesh-list
44110407|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110408|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110409|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
44110410|NCT00084773|Fluorouracil|fluorouracil|mesh-list
44153754|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
44153755|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
44153756|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153757|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
44153758|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
44110539|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110615|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110616|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110617|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110618|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44110619|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44110620|NCT00085358|Growth Substances|growth substances|mesh-ancestor
44110621|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110622|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
44110623|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
44110624|NCT00085384|Interferons|interferons|mesh-list
44110625|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
44110626|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
44110627|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44110628|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110630|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110631|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
44110632|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110674|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44110675|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
44110676|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44110677|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44110678|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
44110679|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44110680|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
44110681|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110682|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44110683|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44110684|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110685|NCT00085501|Paclitaxel|paclitaxel|mesh-list
44110686|NCT00085501|Carboplatin|carboplatin|mesh-list
44110687|NCT00085501|Cetuximab|cetuximab|mesh-list
44110688|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44110689|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110690|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
44110691|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
44110692|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
44110693|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110694|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110695|NCT00085527|Romidepsin|romidepsin|mesh-list
44110696|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44110697|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110698|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44110699|NCT00085553|Tipifarnib|tipifarnib|mesh-list
44110725|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44110726|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44110727|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44110728|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
44110729|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110730|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44110794|NCT00086099|Protective Agents|protective agents|mesh-ancestor
44110795|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44110796|NCT00086112|Risperidone|risperidone|mesh-list
44110797|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44110798|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
44110799|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44110863|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44110938|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44110939|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
44110940|NCT00086632|Oregovomab|oregovomab|mesh-list
44110941|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44110942|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44110943|NCT00086645|Dexetimide|dexetimide|mesh-list
44111007|NCT00086801|Antiviral Agents|antiviral agents|mesh-ancestor
44111008|NCT00086801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111009|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111010|NCT00086801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111081|NCT00087009|Rituximab|rituximab|mesh-list
43642433|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
44111082|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44111084|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
44153807|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
44153808|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153809|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44153811|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
44111172|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44111247|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111248|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111249|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44111250|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44111251|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44111252|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44111254|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44111255|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44111256|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44111257|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44111310|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44111311|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44111312|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111313|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111314|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111315|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44111316|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
44111379|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44111450|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44111451|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
44111602|NCT00088894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153844|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153845|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44153846|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
44153847|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153848|NCT00221754|Pravastatin|pravastatin|mesh-list
44153849|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44111746|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44111747|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44111748|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44111749|NCT00089167|Growth Substances|growth substances|mesh-ancestor
44111750|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
44111756|NCT00089206|Sargramostim|sargramostim|mesh-list
44111816|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
44111818|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111888|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44111889|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111890|NCT00089700|Ibalizumab|ibalizumab|mesh-list
44111960|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44111961|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
44111962|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111963|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44111964|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
44111965|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44111966|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112028|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
44112029|NCT00090194|Antibodies|antibodies|mesh-list
44112030|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
44112031|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44112032|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44112033|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
44112034|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112099|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
44112107|NCT00090675|Gefitinib|gefitinib|mesh-list
44112175|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44112176|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
44112177|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686042|NCT02831374|Anesthetics|anesthetics|mesh-list
44112248|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112249|NCT00091312|Antidotes|antidotes|mesh-ancestor
44112250|NCT00091312|Protective Agents|protective agents|mesh-ancestor
44112251|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
44112252|NCT00091312|Vitamins|vitamins|mesh-ancestor
44112253|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
44112254|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44112255|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
44112256|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112257|NCT00091325|Protective Agents|protective agents|mesh-ancestor
44112258|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112259|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44112275|NCT00091429|Ranolazine|ranolazine|mesh-list
44112276|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44112277|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44112278|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112345|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
44112346|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112348|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44153875|NCT00221962|Aripiprazole|aripiprazole|mesh-list
44112349|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44112413|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112414|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
44112415|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112480|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112481|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112553|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112554|NCT00092365|Celecoxib|celecoxib|mesh-list
44112555|NCT00092365|Rofecoxib|rofecoxib|mesh-list
44112556|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44112557|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44112558|NCT00092365|Analgesics|analgesics|mesh-ancestor
44112559|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
44112560|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112561|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112562|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112563|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112564|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112568|NCT00092378|Diclofenac|diclofenac|mesh-list
44112615|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44112616|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112617|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44112688|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112689|NCT00093288|Bupropion|bupropion|mesh-list
44112690|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44112691|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
44112692|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44112758|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112759|NCT00093457|Sorafenib|sorafenib|mesh-list
44112760|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112761|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44112762|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112763|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112764|NCT00093483|Cytarabine|cytarabine|mesh-list
44112765|NCT00093483|Idarubicin|idarubicin|mesh-list
44112766|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
44112767|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44112768|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
44112769|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112770|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44112771|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
44112782|NCT00093509|Ifosfamide|ifosfamide|mesh-list
44112820|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
44112821|NCT00093587|Busulfan|busulfan|mesh-list
44112822|NCT00093587|Cyclosporins|cyclosporins|mesh-list
44112838|NCT00093600|Cytarabine|cytarabine|mesh-list
44153880|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153881|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153882|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
44153883|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
44153884|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153885|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153886|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44153887|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44153888|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
44153889|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44153890|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44153891|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44153892|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44153893|NCT00221975|Lamotrigine|lamotrigine|mesh-list
44153894|NCT00221975|Valproic Acid|valproic acid|mesh-list
44153895|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153896|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153897|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153898|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
44153902|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
44112893|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
44112894|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44112895|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44112896|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44112897|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44112898|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44112899|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44112900|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44112961|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44112962|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113033|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113034|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113035|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44113036|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113037|NCT00094120|Growth Substances|growth substances|mesh-ancestor
44113038|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113039|NCT00094146|Octreotide|octreotide|mesh-list
44113100|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
44113101|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113102|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113172|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113173|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113174|NCT00094627|Gaboxadol|gaboxadol|mesh-list
44113175|NCT00094627|Analgesics|analgesics|mesh-ancestor
44113244|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113245|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113246|NCT00094978|Growth Substances|growth substances|mesh-ancestor
44113247|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113248|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44113249|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113250|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113313|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44113314|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44113315|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44113387|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
44113428|NCT00095654|Ramipril|ramipril|mesh-list
44153949|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153950|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44113486|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113487|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113488|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44113489|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44113490|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
44113491|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44113552|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
44113553|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
44113554|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44113555|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
44113557|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44113623|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44113624|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
44113625|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113626|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113633|NCT00096083|Melphalan|melphalan|mesh-list
44113695|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113696|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44113697|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44113764|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113765|NCT00096473|Donepezil|donepezil|mesh-list
44113766|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44113767|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44113768|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44113769|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44113770|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44113832|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44113833|NCT00096720|Levodopa|levodopa|mesh-list
44113834|NCT00096720|Pramipexole|pramipexole|mesh-list
44113835|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44113904|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44113905|NCT00096967|Growth Substances|growth substances|mesh-ancestor
44113906|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113907|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
44113908|NCT00097019|Bevacizumab|bevacizumab|mesh-list
44113977|NCT00097227|Carboplatin|carboplatin|mesh-list
44113978|NCT00097227|Cetuximab|cetuximab|mesh-list
44113979|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44113980|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44113981|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44113982|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44113983|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44114047|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114048|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44114052|NCT00097435|Ribavirin|ribavirin|mesh-list
44114059|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114060|NCT00097760|Natalizumab|natalizumab|mesh-list
44114061|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
44114062|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114130|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44114131|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
44114132|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114197|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
44114198|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44114199|NCT00098384|Rifaximin|rifaximin|mesh-list
44114349|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154087|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44154088|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44154089|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
44154090|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
44154091|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154092|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44154093|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44154094|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44154095|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
44114449|NCT00099489|Interferons|interferons|mesh-list
44114450|NCT00099489|Interferon-beta|interferon-beta|mesh-list
44114451|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
44114452|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114453|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
44114454|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114455|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
44114456|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114457|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44114458|NCT00099502|Interferons|interferons|mesh-list
44114459|NCT00099502|Interferon-beta|interferon-beta|mesh-list
44114460|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
44114461|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
44114462|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114463|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
44114464|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114465|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
44114466|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114467|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44114468|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114476|NCT00099554|Analgesics|analgesics|mesh-ancestor
44114488|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114489|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114490|NCT00099619|Insulin|insulin|mesh-list
44114492|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
44114558|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114559|NCT00099788|Ranolazine|ranolazine|mesh-list
44114560|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44114561|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44114562|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114563|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44114564|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44114565|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114566|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114567|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
44114568|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114569|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44114570|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114571|NCT00099866|Metformin|metformin|mesh-list
44114614|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44114615|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
44114616|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114617|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114681|NCT00100126|Amoxicillin|amoxicillin|mesh-list
44114682|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44114683|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44114684|NCT00100139|Paclitaxel|paclitaxel|mesh-list
44114685|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44114686|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44114687|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114748|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44114749|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44114750|NCT00100477|Analgesics|analgesics|mesh-ancestor
44114751|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
44114752|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44114806|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44114807|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44114809|NCT00100594|Zidovudine|zidovudine|mesh-list
44114810|NCT00100594|Efavirenz|efavirenz|mesh-list
44114812|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44114877|NCT00100750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44114878|NCT00100750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44114879|NCT00100750|Immunologic Factors|immunologic factors|mesh-ancestor
44114880|NCT00100750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114881|NCT00100776|Olanzapine|olanzapine|mesh-list
44114882|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
44114947|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44114948|NCT00100958|Protective Agents|protective agents|mesh-ancestor
44114949|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114950|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44114952|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
44114953|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44114954|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
44114955|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44154097|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44114956|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44114958|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44154125|NCT00222820|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44154126|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154127|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44115036|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115037|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
44115038|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115040|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
44115108|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44115109|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115110|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115111|NCT00101348|Bevacizumab|bevacizumab|mesh-list
44115112|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44115113|NCT00101348|Cetuximab|cetuximab|mesh-list
44115114|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44115115|NCT00101348|Antibodies|antibodies|mesh-list
44115116|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
44115117|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44115118|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115119|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44115120|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44115121|NCT00101348|Growth Substances|growth substances|mesh-ancestor
44115122|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115123|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
44115124|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
43558846|NCT04961619|Trametinib|trametinib|mesh-list
44115125|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115126|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115127|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115159|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115160|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44115161|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44115162|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44115163|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
44115164|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115165|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115166|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44115167|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44115168|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
44115169|NCT00101673|Vildagliptin|vildagliptin|mesh-list
44115170|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115171|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115172|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44115173|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115174|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115175|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115176|NCT00101712|Vildagliptin|vildagliptin|mesh-list
44115177|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44115178|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115179|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44115180|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
44115181|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115182|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115183|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
44115184|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44115185|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115186|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44115187|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
44115188|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44115189|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115190|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115191|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115192|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
44115197|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44115271|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44115273|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
44115274|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44115275|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44115277|NCT00102154|Analgesics|analgesics|mesh-ancestor
44115278|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
44115286|NCT00102167|Gaboxadol|gaboxadol|mesh-list
44115342|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115343|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44115344|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44115345|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44115346|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44115347|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44115409|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
44115410|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44115411|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44115412|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43772108|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772109|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772110|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772111|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115481|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115482|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115483|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
44115553|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
44154180|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44154181|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154182|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154183|NCT00223028|Sirolimus|sirolimus|mesh-list
44154184|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44115633|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
44115634|NCT00102882|Hormones|hormones|mesh-ancestor
44115635|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44115640|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
44115705|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
44115706|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115707|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44115708|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115719|NCT00103246|Silicon|silicon|mesh-list
44115779|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44115780|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44115781|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115782|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44115847|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44115848|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
44115849|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44115850|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44115851|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44115852|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
44115853|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115854|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44115855|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44115856|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44115857|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44115858|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
44115859|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44115860|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44115906|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
44115907|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
44115908|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
44115909|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
44115910|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44115912|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
44115976|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44115977|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44115979|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
44116049|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
44116050|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116051|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116052|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44116062|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44116064|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44116065|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116066|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44116067|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44116068|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116069|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
44116070|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
44116071|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44116072|NCT00104767|Celecoxib|celecoxib|mesh-list
44116073|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44116124|NCT00104949|Trastuzumab|trastuzumab|mesh-list
44116125|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44116126|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116127|NCT00104962|Lenalidomide|lenalidomide|mesh-list
44116128|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
44116194|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116195|NCT00105209|Aspirin|aspirin|mesh-list
44116196|NCT00105209|Clopidogrel|clopidogrel|mesh-list
44116266|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44116267|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
44116268|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
44116339|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44116340|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116343|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
44116412|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44116413|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116414|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44116415|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
44116416|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116417|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116418|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44116419|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116420|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44116466|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116467|NCT00106613|Romidepsin|romidepsin|mesh-list
44116468|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44116469|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116470|NCT00106691|Toremifene|toremifene|mesh-list
44116539|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44116540|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116541|NCT00107107|Pramlintide|pramlintide|mesh-list
44116542|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44116609|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116610|NCT00107458|Valproic Acid|valproic acid|mesh-list
44116611|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
44116612|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44116614|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
44116680|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44116681|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44116682|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44116750|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
44116751|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116752|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116753|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44116754|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
44116765|NCT00108186|Celecoxib|celecoxib|mesh-list
44116819|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116820|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44116826|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
44116855|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44116856|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44116857|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44116858|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44116859|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44116860|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44116861|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44116919|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44116920|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44116993|NCT00108979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44116994|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44116998|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
44117058|NCT00109135|Hormones|hormones|mesh-ancestor
44117059|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44117060|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117062|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44117107|NCT00109356|AQ4N|aq4n|mesh-list
44117127|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44117128|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44117129|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44117130|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
44117133|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44117199|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117200|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
44117201|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44117202|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44117203|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44117272|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
44117273|NCT00109993|Tacrolimus|tacrolimus|mesh-list
44117274|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44117275|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
44117346|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
44117347|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117348|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
44117349|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117350|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117351|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
44117417|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44117418|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154297|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154298|NCT00223626|Topiramate|topiramate|mesh-list
44154299|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
44117477|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
44117478|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44117479|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117480|NCT00110669|Prednisone|prednisone|mesh-list
44117548|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117549|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44117550|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44117617|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
44117619|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117620|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44117621|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117622|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117623|NCT00111046|Ibuprofen|ibuprofen|mesh-list
44117624|NCT00111046|Tramadol|tramadol|mesh-list
44117625|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44117626|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44117627|NCT00111046|Analgesics|analgesics|mesh-ancestor
44117628|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
44117629|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44117630|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44117631|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117637|NCT00111046|Narcotics|narcotics|mesh-ancestor
44117676|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
44117677|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
44117678|NCT00111137|Hematinics|hematinics|mesh-ancestor
44117679|NCT00111150|Tenofovir|tenofovir|mesh-list
44117680|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
44117681|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117682|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44117683|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44117684|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117685|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117686|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44117687|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44117688|NCT00111163|Artesunate|artesunate|mesh-list
44117689|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
44117690|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
44117691|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44117692|NCT00111163|Amodiaquine|amodiaquine|mesh-list
44117693|NCT00111163|Dapsone|dapsone|mesh-list
44117694|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
44117695|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
44117696|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44117697|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44117698|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117699|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117700|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
44117701|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
44117702|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44117703|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
44117704|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44117705|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117706|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117707|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44117721|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117722|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44117723|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44117724|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
43652113|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43652114|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
43652115|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43652116|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44117725|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44117726|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
44117727|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44117728|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44117788|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44117789|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44117793|NCT00111449|Etanercept|etanercept|mesh-list
44117863|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
44117864|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
44117865|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
44117866|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44117867|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44117868|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44154360|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44154361|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44154362|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44154363|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44117938|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44117939|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
44117940|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44117941|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44117942|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44118009|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
44118010|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118011|NCT00112476|Sirolimus|sirolimus|mesh-list
44118012|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
44118013|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44118014|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44118015|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44118016|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118074|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118075|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118076|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
44118084|NCT00112645|Melphalan|melphalan|mesh-list
44118148|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118149|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44118150|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118221|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44118222|NCT00112879|Growth Substances|growth substances|mesh-ancestor
44118223|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
44118225|NCT00112879|Protective Agents|protective agents|mesh-ancestor
44118226|NCT00112879|Vitamins|vitamins|mesh-ancestor
44118293|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118294|NCT00113165|Lamotrigine|lamotrigine|mesh-list
44118295|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
44118363|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
44118364|NCT00113685|Dextrans|dextrans|mesh-list
44118365|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44118366|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
44118367|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
44118368|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
44118433|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44118434|NCT00113971|Epratuzumab|epratuzumab|mesh-list
44118435|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44118436|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118467|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
44118468|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118469|NCT00114179|Gemcitabine|gemcitabine|mesh-list
44118470|NCT00114179|Bevacizumab|bevacizumab|mesh-list
44118471|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44118472|NCT00114179|Capecitabine|capecitabine|mesh-list
44118473|NCT00114179|Antibodies|antibodies|mesh-list
44118474|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
44118534|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118535|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44118536|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118538|NCT00114361|Ribavirin|ribavirin|mesh-list
44118607|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44118608|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
44118609|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118616|NCT00114569|Lorazepam|lorazepam|mesh-list
44118681|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
44118682|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118683|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118684|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44118685|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44118686|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
44118698|NCT00115011|Citalopram|citalopram|mesh-list
44118750|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44118751|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118752|NCT00115115|Protective Agents|protective agents|mesh-ancestor
44118753|NCT00115128|Lenograstim|lenograstim|mesh-list
44118819|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
44118820|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118821|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44118822|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44118891|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44118892|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44118893|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118894|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44118895|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44118902|NCT00115622|Fluticasone|fluticasone|mesh-list
44154464|NCT00223717|Diuretics|diuretics|mesh-ancestor
44154465|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
44154466|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44154467|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154468|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
44118965|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44118966|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44118967|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44118968|NCT00115752|Analgesics|analgesics|mesh-ancestor
44118969|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
44118970|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44118971|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44118991|NCT00115908|Ribavirin|ribavirin|mesh-list
44119032|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44119033|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44119034|NCT00116181|Analgesics|analgesics|mesh-ancestor
44119035|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
44119036|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119037|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119038|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44119039|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44119096|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119097|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119098|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44119099|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119100|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
44119165|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44119166|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119168|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
44119169|NCT00116623|Analgesics|analgesics|mesh-ancestor
44119170|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
44119171|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119233|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119234|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44119235|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44119236|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44119237|NCT00116961|Dexamethasone|dexamethasone|mesh-list
44119238|NCT00116961|Bortezomib|bortezomib|mesh-list
44119306|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44119307|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
44119308|NCT00117182|Hormones|hormones|mesh-ancestor
44119310|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
44154490|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44154492|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44154493|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44154494|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44154495|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
44154496|NCT00223717|Coagulants|coagulants|mesh-ancestor
44119375|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44119376|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44119448|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44119449|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44119450|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44119451|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
44119520|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44119521|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
44119522|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44119523|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119590|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119591|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
44119592|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119595|NCT00118170|Sorafenib|sorafenib|mesh-list
44119665|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44119666|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
44119667|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119668|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44119737|NCT00118794|Dapsone|dapsone|mesh-list
44119738|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
44119739|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44119740|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
44119811|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44119812|NCT00119119|Protective Agents|protective agents|mesh-ancestor
44119813|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44119814|NCT00119119|Vitamins|vitamins|mesh-ancestor
44119884|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
44119885|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44119886|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154555|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154556|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154558|NCT00224302|Analgesics|analgesics|mesh-ancestor
44119999|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44120000|NCT00119652|Paroxetine|paroxetine|mesh-list
44120001|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
44120002|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44120003|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44120004|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44120005|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44120065|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120066|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120067|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44120068|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44120069|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120070|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
44120132|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120134|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120135|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120136|NCT00120237|Misoprostol|misoprostol|mesh-list
44120137|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44120203|NCT00120432|Phenylephrine|phenylephrine|mesh-list
44120204|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
44120205|NCT00120432|Tropicamide|tropicamide|mesh-list
44120206|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44120207|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
44120275|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
44120276|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120277|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44120278|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44120283|NCT00120640|Progestins|progestins|mesh-ancestor
44120348|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44120349|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44120350|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44120351|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772112|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43772113|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43772114|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772115|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
43772116|NCT02368561|Hylan|hylan|mesh-list
43772143|NCT02368054|Racepinephrine|racepinephrine|mesh-list
44120352|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120353|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44154585|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154587|NCT00224393|Etanercept|etanercept|mesh-list
44154588|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44120427|NCT00121017|Ritonavir|ritonavir|mesh-list
44120428|NCT00121017|Lopinavir|lopinavir|mesh-list
44120429|NCT00121017|Tenofovir|tenofovir|mesh-list
44120430|NCT00121017|Emtricitabine|emtricitabine|mesh-list
44120496|NCT00121277|Capecitabine|capecitabine|mesh-list
44120497|NCT00121277|Vorinostat|vorinostat|mesh-list
44120498|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44120499|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
44120501|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120567|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
44120568|NCT00121407|Verteporfin|verteporfin|mesh-list
44120639|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44120640|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44120641|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44120642|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44120643|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44120644|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44120645|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44120646|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44120647|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44120702|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44120703|NCT00121615|Analgesics|analgesics|mesh-ancestor
44120704|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
44120705|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44120706|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120707|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44120708|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44120709|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44120767|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44120768|NCT00121979|Racivir|racivir|mesh-list
44120769|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120840|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44120841|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
44120910|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120911|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44120912|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44154644|NCT00224510|Lamotrigine|lamotrigine|mesh-list
44154645|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
44154646|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44154647|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154648|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121024|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121025|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44121026|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44121027|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44121028|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
44121094|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121095|NCT00122824|Analgesics|analgesics|mesh-ancestor
44121096|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
44121162|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44121163|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44121165|NCT00122941|Trace Elements|trace elements|mesh-list
44121166|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121167|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
44121168|NCT00123149|Hematinics|hematinics|mesh-ancestor
44121169|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44121170|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
44121171|NCT00123175|Progestins|progestins|mesh-list
44121229|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121230|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121231|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
44121232|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121299|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
44121300|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
44121301|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
44121302|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121303|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121304|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44121305|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44121306|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121307|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44121308|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44121309|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44121310|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
44121311|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
44121312|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44121313|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121314|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44121315|NCT00123656|Fluticasone|fluticasone|mesh-list
44121316|NCT00123656|Esomeprazole|esomeprazole|mesh-list
44121317|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44121335|NCT00123669|Hormones|hormones|mesh-ancestor
44121355|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44121358|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121429|NCT00124111|Methotrexate|methotrexate|mesh-list
44121430|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121431|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
44121473|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44121474|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121475|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121476|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
44121477|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44121542|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44158167|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44121543|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44121545|NCT00124436|Alitretinoin|alitretinoin|mesh-list
44121546|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121547|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121548|NCT00124475|Alitretinoin|alitretinoin|mesh-list
44121549|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44121550|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44121608|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44121609|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
44121682|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44121683|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44121684|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44121753|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44121754|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44121825|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44121899|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44121900|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44121901|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44121902|NCT00125645|Irbesartan|irbesartan|mesh-list
44121903|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44121904|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44121905|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44121907|NCT00125671|Warfarin|warfarin|mesh-list
44121966|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44121967|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122033|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44122034|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44122035|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
43772146|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
44122036|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122037|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44122106|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122107|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44122109|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122110|NCT00126269|Antiviral Agents|antiviral agents|mesh-ancestor
44122116|NCT00126282|Cycloserine|cycloserine|mesh-list
44122174|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44122175|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122177|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44122178|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122179|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
44122243|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122244|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44122245|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44122246|NCT00126633|Growth Substances|growth substances|mesh-ancestor
44122247|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122248|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
44122257|NCT00126646|Antibodies|antibodies|mesh-list
44122312|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
44122313|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44122314|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44122315|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44122316|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
44122317|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
44122318|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
44122327|NCT00126971|Dapsone|dapsone|mesh-list
44122384|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122385|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44122386|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122454|NCT00127569|Rituximab|rituximab|mesh-list
44122455|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122456|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122457|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
44122507|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44122508|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122509|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122510|NCT00127868|Selenium|selenium|mesh-list
44122511|NCT00127868|Ketoconazole|ketoconazole|mesh-list
44122512|NCT00127868|Ciclopirox|ciclopirox|mesh-list
44122513|NCT00127868|Griseofulvin|griseofulvin|mesh-list
44122514|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
44122577|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44122653|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44122654|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
44122655|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122656|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44122725|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44122726|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44122727|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122789|NCT05556356|Analgesics|analgesics|mesh-ancestor
44122790|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
44122791|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44122792|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122793|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
44122860|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44122861|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44122862|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44122863|NCT05533164|Rituximab|rituximab|mesh-list
44122864|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44122865|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122866|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
44122867|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44122868|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44122870|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44122871|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44122872|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44122873|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44122874|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
44122875|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44122876|NCT05516628|Bevacizumab|bevacizumab|mesh-list
44122921|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44122922|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44122925|NCT05361824|Acetaminophen|acetaminophen|mesh-list
44122992|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44122993|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44122994|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
44122995|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
44122996|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44122997|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
44122998|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
44122999|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123000|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123001|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44123002|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
44123003|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123004|NCT05284552|Tinzaparin|tinzaparin|mesh-list
44123062|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123063|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123067|NCT05102409|Lifitegrast|lifitegrast|mesh-list
44123114|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123115|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
44123116|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123117|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44123118|NCT04952519|Amantadine|amantadine|mesh-list
44123119|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44123120|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44123121|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
44123122|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123123|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
44123124|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123125|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123126|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123127|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44123128|NCT04952519|Analgesics|analgesics|mesh-ancestor
44123129|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
44123130|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44123131|NCT04938466|Hormones|hormones|mesh-list
44123132|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44123133|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123134|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44123135|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44123138|NCT04635683|Lenalidomide|lenalidomide|mesh-list
44123163|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123164|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123165|NCT04539236|Lenalidomide|lenalidomide|mesh-list
44123166|NCT04539236|Luspatercept|luspatercept|mesh-list
44123227|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44123228|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123229|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44123230|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123231|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44123232|NCT04321408|Protective Agents|protective agents|mesh-ancestor
44123296|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44123297|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
44123298|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44123300|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123368|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123369|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123370|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44123371|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44123372|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123373|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123374|NCT04050462|Nivolumab|nivolumab|mesh-list
44123375|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123379|NCT03990467|Tazobactam|tazobactam|mesh-list
44123432|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123433|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123434|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44123435|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
44123501|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123502|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44158174|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
44158175|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
44158176|NCT00236353|Risperidone|risperidone|mesh-list
44158177|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158178|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
44158179|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158181|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123577|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44123579|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
44123580|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44123581|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123582|NCT02599363|Paclitaxel|paclitaxel|mesh-list
44123583|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44123584|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123585|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
44123586|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
44123587|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
44123588|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123638|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
44123639|NCT01731236|Aspirin|aspirin|mesh-list
44123640|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44123641|NCT01731236|Vancomycin|vancomycin|mesh-list
44123642|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
44123715|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123716|NCT01409161|Protective Agents|protective agents|mesh-ancestor
44123717|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44123718|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44123719|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44123720|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
44123721|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44123722|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
44123723|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44123724|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
44123725|NCT00130468|Protective Agents|protective agents|mesh-ancestor
44123726|NCT00130481|Atorvastatin|atorvastatin|mesh-list
44123727|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44123728|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44123774|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44123775|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
44123776|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44123777|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772347|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123778|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123779|NCT00130585|Folic Acid|folic acid|mesh-list
44123780|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
44123781|NCT00130585|Hematinics|hematinics|mesh-ancestor
44123782|NCT00130585|Vitamins|vitamins|mesh-ancestor
44123783|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
44123785|NCT00130676|Mifepristone|mifepristone|mesh-list
44123838|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123839|NCT00130871|Simendan|simendan|mesh-list
44123911|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
44123912|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44123913|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44123914|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44123915|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44123916|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
44123917|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
43772353|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772355|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
44123981|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44123982|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
44123983|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
44123984|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44123985|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44123987|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
44154854|NCT00225173|Hormones|hormones|mesh-ancestor
44158190|NCT00236366|Narcotics|narcotics|mesh-ancestor
44124006|NCT00131261|Belinostat|belinostat|mesh-list
44124007|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124008|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
44124070|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124072|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44124074|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124143|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
44124144|NCT00131768|Protective Agents|protective agents|mesh-ancestor
44124145|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124146|NCT00131846|Diuretics|diuretics|mesh-list
44124147|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44124148|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
44124211|NCT00132158|Irinotecan|irinotecan|mesh-list
44124212|NCT00132158|Gefitinib|gefitinib|mesh-list
44124213|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44124214|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44124270|NCT00132444|UC-781|uc-781|mesh-list
44124286|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124287|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44124288|NCT00132535|Renal Agents|renal agents|mesh-ancestor
44124289|NCT00132548|Artesunate|artesunate|mesh-list
44124290|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
44124291|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
44124292|NCT00132548|Amodiaquine|amodiaquine|mesh-list
44124293|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44124359|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44124360|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44154902|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154903|NCT00225381|Anesthetics|anesthetics|mesh-list
44154904|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44124401|NCT00132886|Tolvaptan|tolvaptan|mesh-list
44124402|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44124403|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647152|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647153|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647154|NCT02303821|Cytarabine|cytarabine|mesh-list
43647155|NCT02303821|Dexamethasone|dexamethasone|mesh-list
43647156|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
44124419|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
44124420|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124421|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44124422|NCT00132912|Vorapaxar|vorapaxar|mesh-list
44124423|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44124424|NCT00132925|Triamcinolone|triamcinolone|mesh-list
44124425|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124426|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
44124427|NCT00132925|Hormones|hormones|mesh-ancestor
44124428|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124429|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124430|NCT00132938|Telithromycin|telithromycin|mesh-list
44124431|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124432|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124433|NCT00132951|Azithromycin|azithromycin|mesh-list
44124434|NCT00132951|Telithromycin|telithromycin|mesh-list
44124435|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124436|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124437|NCT00133003|Abciximab|abciximab|mesh-list
44124438|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
43652170|NCT03001687|Vitamin D|vitamin d|mesh-list
43652171|NCT03001687|Vitamins|vitamins|mesh-ancestor
43652172|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
43652175|NCT03001739|Urapidil|urapidil|mesh-list
44124439|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44124440|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44124441|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124442|NCT00133042|Omalizumab|omalizumab|mesh-list
44124443|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44124444|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44124445|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
44124446|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
44124447|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
44124448|NCT00133172|Prednisone|prednisone|mesh-list
44124449|NCT00133172|Tacrolimus|tacrolimus|mesh-list
44124450|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124451|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
44124452|NCT00133172|Hormones|hormones|mesh-ancestor
44124453|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124474|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124475|NCT00133185|Diuretics|diuretics|mesh-ancestor
44124476|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
44124477|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124478|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44124479|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124481|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
44124482|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124483|NCT00133198|Protective Agents|protective agents|mesh-ancestor
44124484|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124485|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44124486|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44124487|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
44124488|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
44124489|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124490|NCT00133224|Prednisone|prednisone|mesh-list
44124491|NCT00133224|Docetaxel|docetaxel|mesh-list
44124492|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124493|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124494|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124495|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124496|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124497|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124498|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
44124499|NCT00133224|Hormones|hormones|mesh-ancestor
44124500|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44124501|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124502|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44124503|NCT00133237|Sirolimus|sirolimus|mesh-list
44124504|NCT00133237|Paclitaxel|paclitaxel|mesh-list
44124505|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44124506|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124507|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124508|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124509|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124510|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124511|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44124512|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124513|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44124514|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
44124547|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
44124548|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124549|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124550|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44124551|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
44124553|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124554|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44124555|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44124556|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124557|NCT00133341|Parthenolide|parthenolide|mesh-list
44124558|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772643|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
43772644|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
43772645|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124559|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44124560|NCT00133341|Analgesics|analgesics|mesh-ancestor
44124561|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
44124562|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124563|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124564|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124565|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124566|NCT00133354|Anastrozole|anastrozole|mesh-list
44124567|NCT00133354|Hormones|hormones|mesh-list
43647163|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
43647164|NCT02303821|Pegaspargase|pegaspargase|mesh-list
43647165|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647166|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
43647167|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647168|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647169|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43647170|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
43647171|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647172|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647198|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43647199|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44124572|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44124573|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44124648|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124649|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124650|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124651|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124653|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
44124654|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124655|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44124656|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
44124657|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124658|NCT00133562|Glycine|glycine|mesh-list
44124659|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
44124660|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124661|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124662|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124663|NCT00133627|Ketotifen|ketotifen|mesh-list
44124664|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
44124665|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124666|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44124667|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
44124668|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
44124669|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124670|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124671|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124672|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44124673|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
44124674|NCT00133640|Vitamin D|vitamin d|mesh-list
44124675|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44124676|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124677|NCT00133640|Vitamins|vitamins|mesh-ancestor
44124678|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
44124679|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44124680|NCT00133692|Atenolol|atenolol|mesh-list
44124681|NCT00133692|Verapamil|verapamil|mesh-list
44124682|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44124683|NCT00133692|Trandolapril|trandolapril|mesh-list
44124684|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124685|NCT00133692|Diuretics|diuretics|mesh-ancestor
43702680|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124704|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44124705|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124706|NCT00133731|Heparin|heparin|mesh-list
44124707|NCT00133731|Calcium heparin|calcium heparin|mesh-list
44124708|NCT00133731|Otamixaban|otamixaban|mesh-list
44124709|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
44124710|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44124711|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44124712|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124713|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44124714|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
44124715|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44124716|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
44124717|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124718|NCT00133744|Folic Acid|folic acid|mesh-list
44124719|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
44124720|NCT00133744|Vitamins|vitamins|mesh-ancestor
44124721|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
44124722|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124723|NCT00133744|Hematinics|hematinics|mesh-ancestor
44124724|NCT00133757|Bupropion|bupropion|mesh-list
44124823|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
44124824|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124825|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44124826|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44124827|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
44124828|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44124829|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44124830|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
44124831|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
44124832|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
44124833|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
44124834|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124835|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44124836|NCT00134069|Cetuximab|cetuximab|mesh-list
44124837|NCT00134069|Irinotecan|irinotecan|mesh-list
44124838|NCT00134069|Sorafenib|sorafenib|mesh-list
44124839|NCT00134069|Antibodies|antibodies|mesh-list
44124840|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
44124841|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44124842|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
44124843|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124844|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124845|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44124846|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44124847|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124850|NCT00134095|Irinotecan|irinotecan|mesh-list
44124885|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44124886|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44124887|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
44124888|NCT00134199|Sibutramine|sibutramine|mesh-list
44124889|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
44124890|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44124891|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
44124892|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44124893|NCT00134212|Epinephrine|epinephrine|mesh-list
44124894|NCT00134212|Norepinephrine|norepinephrine|mesh-list
44124895|NCT00134212|Dopexamine|dopexamine|mesh-list
44124896|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44124897|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44124898|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
44124899|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44124900|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124901|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124902|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44124903|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44124904|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
44124905|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124906|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44124907|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
44124908|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
44124909|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
44124910|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44124911|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
44124912|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
44124913|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
44124914|NCT00134290|Metformin|metformin|mesh-list
44124915|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44124916|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647203|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
43647204|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43647205|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43647206|NCT02283996|Prednisolone|prednisolone|mesh-list
43647207|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
43647208|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43647209|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
43647210|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124939|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124940|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124941|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44124942|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44124943|NCT00134394|Analgesics|analgesics|mesh-ancestor
44124944|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
44124945|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124946|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44124947|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44124948|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44124949|NCT00134420|Clonidine|clonidine|mesh-list
44124950|NCT00134420|Mitogens|mitogens|mesh-list
44124951|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44124952|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
44124953|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124954|NCT00134420|Analgesics|analgesics|mesh-ancestor
44124955|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
44124956|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44124957|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44124958|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
44124959|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
44124960|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44124961|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44124962|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44154913|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44154914|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154915|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154916|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154917|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154918|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154919|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44154920|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154921|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154922|NCT00225511|Milnacipran|milnacipran|mesh-list
44154923|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44154924|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
44154925|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44154926|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154927|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44154928|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154929|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44154930|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44154931|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44154932|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
44154933|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44154934|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44154935|NCT00225511|Analgesics|analgesics|mesh-ancestor
44154936|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
44154937|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44154938|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44154939|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44154940|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44154941|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44124965|NCT00134485|Atorvastatin|atorvastatin|mesh-list
44124966|NCT00134485|Torcetrapib|torcetrapib|mesh-list
44124967|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124968|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124969|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
44124970|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124971|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124972|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44124973|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44124974|NCT00134498|Atorvastatin|atorvastatin|mesh-list
44124975|NCT00134498|Torcetrapib|torcetrapib|mesh-list
44124976|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44124977|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44124978|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
44124979|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44124980|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44124981|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44124982|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125021|NCT00134667|Verteporfin|verteporfin|mesh-list
44125022|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44125023|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125024|NCT00134680|Trastuzumab|trastuzumab|mesh-list
44125025|NCT00134680|Letrozole|letrozole|mesh-list
44125026|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125032|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44125033|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
44125034|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125035|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125036|NCT00134693|Prednisolone|prednisolone|mesh-list
44125037|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44125038|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
44125039|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44125040|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
44125041|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44125042|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
44125043|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125044|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
44125045|NCT00134693|Hormones|hormones|mesh-ancestor
44125046|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125047|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125048|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125049|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125050|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
44125051|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
44125052|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125053|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44125054|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44125055|NCT00134693|Protective Agents|protective agents|mesh-ancestor
44125056|NCT00134706|Carboplatin|carboplatin|mesh-list
44125057|NCT00134706|Docetaxel|docetaxel|mesh-list
44125058|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125059|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44125060|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
43647248|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125100|NCT00134888|Analgesics|analgesics|mesh-ancestor
44125101|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
44125102|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125103|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44125104|NCT00134914|Buprenorphine|buprenorphine|mesh-list
44125105|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44125106|NCT00134914|Narcotics|narcotics|mesh-ancestor
44125107|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44125108|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125109|NCT00134914|Analgesics|analgesics|mesh-ancestor
43824095|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
43824096|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824097|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43824098|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43824099|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44125111|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125112|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44125114|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44125115|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125116|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125117|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
44125118|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125119|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125180|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125181|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44125182|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44125183|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125184|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125185|NCT00135057|Insulin|insulin|mesh-list
44125186|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44125187|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
44125188|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
44125189|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125190|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125191|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
44125192|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125193|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125194|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
44125195|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125196|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125197|NCT00135096|Insulin|insulin|mesh-list
44125198|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44125199|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
44125200|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
44125201|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44125202|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125243|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125244|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
44125245|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125246|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44125247|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
44125248|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
44125249|NCT00135187|Dexamethasone|dexamethasone|mesh-list
44125250|NCT00135187|Bortezomib|bortezomib|mesh-list
44125251|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125252|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
44125253|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
44125254|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125255|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125256|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824100|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43824101|NCT05515354|Nicotine|nicotine|mesh-list
43824102|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43824103|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
43824104|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824105|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125257|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
44125258|NCT00135187|Hormones|hormones|mesh-ancestor
44125259|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125260|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44125261|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125262|NCT00135304|Vitamin D|vitamin d|mesh-list
44125263|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44125264|NCT00135304|Cinacalcet|cinacalcet|mesh-list
44125265|NCT00135304|Vitamins|vitamins|mesh-ancestor
44125266|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
44125267|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125268|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44125269|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44125270|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44125271|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
44125272|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125273|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
44125274|NCT00135317|Hematinics|hematinics|mesh-ancestor
44125275|NCT00135408|Budesonide|budesonide|mesh-list
44125276|NCT00135408|Ipilimumab|ipilimumab|mesh-list
44125277|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44125278|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125279|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44125280|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125281|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125282|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44125283|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
44125284|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44125305|NCT00135473|Insulin|insulin|mesh-list
44125383|NCT00135668|Nitroprusside|nitroprusside|mesh-list
44125452|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44125453|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
44125459|NCT00135811|Hormones|hormones|mesh-ancestor
44125600|NCT00136175|Antiviral Agents|antiviral agents|mesh-ancestor
44125601|NCT00136175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44125602|NCT00136175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125603|NCT00136175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44125604|NCT00136175|Immunologic Factors|immunologic factors|mesh-ancestor
44125671|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
44125672|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44125673|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44125674|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
44125675|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125676|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44125677|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44125678|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125679|NCT00136448|Cytarabine|cytarabine|mesh-list
44125680|NCT00136448|Interleukin-2|interleukin-2|mesh-list
44125681|NCT00136448|Daunorubicin|daunorubicin|mesh-list
44125682|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44125683|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
44125684|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125685|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44125699|NCT00136461|Tretinoin|tretinoin|mesh-list
44125732|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44125733|NCT00136526|Estrogens|estrogens|mesh-ancestor
44125734|NCT00136526|Hormones|hormones|mesh-ancestor
44125735|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44125873|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44125874|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44125928|NCT00137007|Ampicillin|ampicillin|mesh-list
44125939|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44125940|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126013|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126085|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44126086|NCT00137514|Chloroquine|chloroquine|mesh-list
44126087|NCT00137514|Amodiaquine|amodiaquine|mesh-list
44126088|NCT00137514|Amebicides|amebicides|mesh-ancestor
44126092|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
44126122|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
44126123|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44126124|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126194|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44126195|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126205|NCT00137813|Bevacizumab|bevacizumab|mesh-list
44126268|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126339|NCT00138216|Temozolomide|temozolomide|mesh-list
44126340|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44126412|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44126413|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
44126416|NCT00138567|Vildagliptin|vildagliptin|mesh-list
44126482|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126483|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44126484|NCT00138944|Eplerenone|eplerenone|mesh-list
44126485|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44126486|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
44126487|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44126488|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126489|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44126490|NCT00138944|Diuretics|diuretics|mesh-ancestor
44126491|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
44126492|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44126493|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
44126494|NCT00138970|Cyclosporine|cyclosporine|mesh-list
44126495|NCT00138970|Prednisolone|prednisolone|mesh-list
44126496|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44126497|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
44126499|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
44126541|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126542|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
44126543|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126544|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
44126545|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44126546|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44126547|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44126548|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44126549|NCT00139035|Cyclosporine|cyclosporine|mesh-list
44126550|NCT00139035|Cyclosporins|cyclosporins|mesh-list
44126551|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126552|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44154990|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
44154991|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44126626|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
44126627|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126628|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44126629|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44126699|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44126700|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126701|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44126702|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44126703|NCT00139360|Growth Substances|growth substances|mesh-ancestor
44126704|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126705|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
44126706|NCT00139373|Donepezil|donepezil|mesh-list
43632364|NCT03037892|Narcotics|narcotics|mesh-ancestor
44126707|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44126762|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126764|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44126765|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44126766|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44126767|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126828|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44126829|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
44126830|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44126831|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44126832|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44126833|NCT00139815|Enoxaparin|enoxaparin|mesh-list
44126834|NCT00139815|PENTA|penta|mesh-list
44126835|NCT00139815|Fondaparinux|fondaparinux|mesh-list
44126836|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
44126837|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44126841|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
44126892|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
44126968|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44127043|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127044|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
44127045|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127114|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
44127115|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155050|NCT00226044|Omeprazole|omeprazole|mesh-list
44155051|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44155052|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127167|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44127168|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44127169|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
44127170|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
44127171|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127172|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127173|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127174|NCT00140725|Interferons|interferons|mesh-list
44127175|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
44127176|NCT00140725|Lamivudine|lamivudine|mesh-list
44127177|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
44127178|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127225|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44127226|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127227|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127228|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44127229|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44127230|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44127231|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127232|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
44127233|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
44127234|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44127235|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44127236|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44127237|NCT00140894|Rofecoxib|rofecoxib|mesh-list
44127238|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127239|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127240|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127281|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44127351|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127352|NCT00141193|Analgesics|analgesics|mesh-ancestor
44127353|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
44127354|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127355|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127356|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127357|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127358|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44127359|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44127360|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127361|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127362|NCT00141206|Varenicline|varenicline|mesh-list
44127363|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44127410|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44127411|NCT00141310|Urological Agents|urological agents|mesh-ancestor
44127413|NCT00141336|Analgesics|analgesics|mesh-ancestor
44127426|NCT00141362|Pregabalin|pregabalin|mesh-list
44127479|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44127480|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44127481|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44127483|NCT00141414|Analgesics|analgesics|mesh-ancestor
44127484|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
44127485|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127486|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127496|NCT00141427|Pregabalin|pregabalin|mesh-list
44127547|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
44127548|NCT00141570|Estrogens|estrogens|mesh-list
44127554|NCT00141570|Hormones|hormones|mesh-ancestor
44127620|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44127621|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44127622|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127623|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44127624|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44127625|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
44127626|NCT00141791|Etanercept|etanercept|mesh-list
44127627|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44127628|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44127629|NCT00141791|Analgesics|analgesics|mesh-ancestor
44127630|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
44127631|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44127681|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
44127682|NCT00141908|Castor Oil|castor oil|mesh-list
44127683|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44127684|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44127685|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44127686|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
44127752|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44127753|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44127754|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
44127755|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44155067|NCT00226096|Glycerol|glycerol|mesh-list
44155068|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44155069|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44155070|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
44155071|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
44127878|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
44127879|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
44127880|NCT00142545|Apomorphine|apomorphine|mesh-list
44128024|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128025|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128026|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128027|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44128028|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128029|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44128031|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
44128088|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44128089|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44128090|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44128091|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128092|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44128094|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44128095|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44128096|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128097|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128098|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44128099|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44128100|NCT00143169|Analgesics|analgesics|mesh-ancestor
44128101|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
44128102|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128103|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128104|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44128142|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128143|NCT00143260|Urological Agents|urological agents|mesh-ancestor
44128144|NCT00143286|Varenicline|varenicline|mesh-list
44128214|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128215|NCT00143481|Urological Agents|urological agents|mesh-ancestor
44128216|NCT00143520|Pioglitazone|pioglitazone|mesh-list
44128217|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44128218|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128219|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
44128220|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
44128222|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44128223|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128224|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128225|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128226|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128227|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44128228|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128229|NCT00143546|Defibrotide|defibrotide|mesh-list
44128230|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44128234|NCT00143559|Antibodies|antibodies|mesh-list
44128271|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128272|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
44128273|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128274|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128275|NCT00143702|Riboflavin|riboflavin|mesh-list
44128276|NCT00143702|Thiamine|thiamine|mesh-list
44128277|NCT00143702|Abacavir|abacavir|mesh-list
44128287|NCT00143702|Vitamins|vitamins|mesh-ancestor
44128342|NCT00143949|Enalapril|enalapril|mesh-list
44128343|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44128344|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128345|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44128346|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44128347|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128348|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44128349|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
44128350|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128352|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
44128353|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
44128354|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44128355|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
44128356|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128357|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128358|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
44155102|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
44155103|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155104|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155105|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44155106|NCT00226109|Diuretics|diuretics|mesh-ancestor
44155107|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
44155108|NCT00226122|Indomethacin|indomethacin|mesh-list
44128370|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44128371|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44128372|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128431|NCT00144183|Nevirapine|nevirapine|mesh-list
44128432|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
44128433|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128434|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44128435|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128436|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128437|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
44128438|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128439|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44128440|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44128441|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44128442|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44128443|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
44128444|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44128445|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
44128446|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128447|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128448|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44128449|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
44128450|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
44128451|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44128452|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
44128453|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128454|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128456|NCT00144209|Pramipexole|pramipexole|mesh-list
44128457|NCT00144209|Benserazide|benserazide|mesh-list
44128475|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44128476|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128544|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128546|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
44128547|NCT00144417|Rifampin|rifampin|mesh-list
44128548|NCT00144417|Isoniazid|isoniazid|mesh-list
44128549|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
44128550|NCT00144417|Ethambutol|ethambutol|mesh-list
44128551|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44128552|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128553|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44128554|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44128555|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128557|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128607|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128608|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44128609|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
44128611|NCT05594849|Hormones|hormones|mesh-ancestor
44128612|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128613|NCT05594784|Prednisone|prednisone|mesh-list
44128614|NCT05594784|Vincristine|vincristine|mesh-list
44128615|NCT05594784|Venetoclax|venetoclax|mesh-list
44128616|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44128617|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
44128618|NCT05594784|Hormones|hormones|mesh-ancestor
44128619|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128620|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128621|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44128622|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44128667|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44128668|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44128669|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44128670|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158191|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44128671|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128672|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44128673|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
44128712|NCT05594459|Analgesics|analgesics|mesh-list
44128730|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44128731|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128732|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44128733|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44128734|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44128735|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
44128736|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128737|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128738|NCT05594342|Protective Agents|protective agents|mesh-ancestor
44128739|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
44128740|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
44155136|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44155137|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44155138|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
44155139|NCT00226317|Aripiprazole|aripiprazole|mesh-list
44155140|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
44155141|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155142|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44155143|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155144|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155145|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155146|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
44155147|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
44128804|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44128805|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128807|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
44128808|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44128809|NCT05586724|Norethindrone|norethindrone|mesh-list
44128810|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
44128811|NCT05586724|Progesterone|progesterone|mesh-list
44128812|NCT05586724|Estrogens|estrogens|mesh-list
44128813|NCT05586724|Progestins|progestins|mesh-ancestor
44128814|NCT05586724|Hormones|hormones|mesh-ancestor
44128815|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44128870|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44128871|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44128872|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44128873|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44128943|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
44128944|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
44128945|NCT05436678|Celecoxib|celecoxib|mesh-list
44155178|NCT00226382|Interferons|interferons|mesh-list
44155179|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
44155180|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
44155181|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44155182|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155183|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
44155184|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155185|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
44155186|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155187|NCT00226395|Oxymorphone|oxymorphone|mesh-list
44155188|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44155189|NCT00226395|Narcotics|narcotics|mesh-ancestor
44155190|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155191|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155192|NCT00226395|Analgesics|analgesics|mesh-ancestor
44155193|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
44155196|NCT00226408|Interferons|interferons|mesh-list
44129005|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129007|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
44129008|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129009|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44129010|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44129011|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
44129012|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
44129013|NCT05350592|Dobutamine|dobutamine|mesh-list
44129014|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44129015|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
44129016|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
44129017|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129018|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129019|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44129020|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44129021|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44129022|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44129023|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129024|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129025|NCT05350592|Protective Agents|protective agents|mesh-ancestor
44129026|NCT05334056|Cocaine|cocaine|mesh-list
44129027|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
44129028|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
44129029|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129057|NCT05281406|Osimertinib|osimertinib|mesh-list
44129058|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129059|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129060|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129061|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44129062|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44129063|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44129064|NCT05262452|Folfirinox|folfirinox|mesh-list
44129065|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129066|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44129067|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
44129068|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44129069|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129070|NCT05236998|Incretins|incretins|mesh-ancestor
44129071|NCT05236998|Hormones|hormones|mesh-ancestor
44129072|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129073|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44129074|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44129075|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158193|NCT00236366|Analgesics|analgesics|mesh-ancestor
44129076|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129077|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44129106|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44129107|NCT05227456|Progestins|progestins|mesh-ancestor
44129108|NCT05227456|Hormones|hormones|mesh-ancestor
44129109|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129110|NCT05197075|Darunavir|darunavir|mesh-list
44129111|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44129112|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44129113|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
44129120|NCT05184101|Heparin|heparin|mesh-list
44129172|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129173|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44129174|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44129176|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44129177|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129178|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44129179|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44129180|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44129181|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44129182|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44129183|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44129184|NCT05071313|Vaccines|vaccines|mesh-list
44129185|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
44129186|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129187|NCT05065567|Droperidol|droperidol|mesh-list
44129230|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
44129231|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44129232|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
44129233|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
44129234|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
44129235|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44129261|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44129262|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44129263|NCT04988282|Prednisolone|prednisolone|mesh-list
44129264|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
44129265|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44129266|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
44129267|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44129268|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
44129269|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
44129270|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129271|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129272|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44129273|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
44129274|NCT04988282|Hormones|hormones|mesh-ancestor
44129275|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129276|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44129277|NCT04988282|Protective Agents|protective agents|mesh-ancestor
44129278|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44129279|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129280|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
44129281|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44129282|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44129283|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44129284|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44129285|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129286|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
44129287|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129288|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129289|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44129290|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129291|NCT04981067|Ropivacaine|ropivacaine|mesh-list
44129292|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
44129293|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
44129299|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44129300|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129301|NCT04957329|Latanoprost|latanoprost|mesh-list
44129302|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44129303|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44129304|NCT04953754|Melatonin|melatonin|mesh-list
44129305|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
44129306|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129307|NCT04953754|Protective Agents|protective agents|mesh-ancestor
44129308|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129309|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129310|NCT04930887|Bupivacaine|bupivacaine|mesh-list
44129311|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
44129312|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
44129313|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129314|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129315|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
44129316|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129357|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
44129358|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129359|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129360|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44129361|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44129362|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
44129363|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
44129364|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129365|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44129366|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44129367|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129368|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129369|NCT04846855|Anesthetics|anesthetics|mesh-list
44129370|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
44129371|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129372|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129373|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
44129414|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
44129415|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129417|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44129418|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44129419|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44129420|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129421|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129422|NCT04713319|Calcium|calcium|mesh-list
44129423|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44129424|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129425|NCT04665765|Rituximab|rituximab|mesh-list
44129426|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44129427|NCT04665765|Carboplatin|carboplatin|mesh-list
44129428|NCT04665765|Etoposide|etoposide|mesh-list
44129429|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
44155282|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44155284|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
44155285|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44129521|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129522|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44129596|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129597|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44129598|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
44129600|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129601|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44129602|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129603|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44158208|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158209|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158210|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158211|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158212|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
44158213|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
44158214|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
44158215|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158216|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158217|NCT00236379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44129673|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129675|NCT03879122|Nivolumab|nivolumab|mesh-list
44129676|NCT03879122|Ipilimumab|ipilimumab|mesh-list
44129677|NCT03879122|Androgens|androgens|mesh-list
44129678|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129679|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
44129680|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
44129681|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
44129682|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129683|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44129684|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44129685|NCT03879122|Hormones|hormones|mesh-ancestor
44129686|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44129687|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129688|NCT03868722|Venetoclax|venetoclax|mesh-list
44129689|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
44129690|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129691|NCT03845348|Ketoconazole|ketoconazole|mesh-list
44129692|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
43847079|NCT04139304|Prednisone|prednisone|mesh-list
44129693|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129694|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44129726|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44129727|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
44129728|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
44129729|NCT03734731|Narcotics|narcotics|mesh-ancestor
44129730|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44129731|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129732|NCT03734731|Analgesics|analgesics|mesh-ancestor
44129733|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
44129734|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44129735|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
44129736|NCT03721497|Testosterone|testosterone|mesh-list
44129737|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
44129738|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
44129739|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44129787|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129788|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129789|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
44129790|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44129791|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44129792|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
44129793|NCT03648996|Protective Agents|protective agents|mesh-ancestor
44129922|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44129923|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129924|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
44129925|NCT03184935|Decitabine|decitabine|mesh-list
44129926|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44129927|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
44129928|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44129929|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44129930|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129931|NCT03176498|Aspirin|aspirin|mesh-list
44129932|NCT03176498|Atorvastatin|atorvastatin|mesh-list
44129933|NCT03176498|Calcium|calcium|mesh-list
44129934|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44129935|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44129936|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44129937|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44129938|NCT03176498|Analgesics|analgesics|mesh-ancestor
44129977|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44129978|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44129979|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44129981|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130028|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130029|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44130030|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130034|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130098|NCT02358187|Poly ICLC|poly iclc|mesh-list
44130099|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
44130100|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
44130101|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130102|NCT02333370|Tamoxifen|tamoxifen|mesh-list
44130103|NCT02333370|Letrozole|letrozole|mesh-list
44130104|NCT02333370|Fulvestrant|fulvestrant|mesh-list
44130105|NCT02333370|Goserelin|goserelin|mesh-list
44130106|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130107|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44130108|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44130109|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130110|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130111|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44130112|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
44130157|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130158|NCT01154439|Cytarabine|cytarabine|mesh-list
44130159|NCT01154439|Etoposide|etoposide|mesh-list
44130160|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
44130161|NCT01154439|Idarubicin|idarubicin|mesh-list
44130162|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
44130163|NCT01154439|Everolimus|everolimus|mesh-list
44130164|NCT01154439|Ifosfamide|ifosfamide|mesh-list
44130165|NCT01154439|Carboplatin|carboplatin|mesh-list
44130166|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130167|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130168|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44130169|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44130170|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130171|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130172|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130173|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
44130174|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
44130175|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130176|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44130177|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
44130178|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130179|NCT01154439|Analgesics|analgesics|mesh-ancestor
44130180|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
44130181|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130182|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130183|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44130184|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
44130185|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
44130186|NCT00144495|Hematinics|hematinics|mesh-ancestor
44130187|NCT00144677|Sirolimus|sirolimus|mesh-list
44130188|NCT00144677|Tacrolimus|tacrolimus|mesh-list
44130203|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
44130204|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130205|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44130206|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130207|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130208|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44130209|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130210|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44130269|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130270|NCT00144872|Lamotrigine|lamotrigine|mesh-list
44130271|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
44130272|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44130273|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130274|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130275|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44130276|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130277|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44130278|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44130282|NCT00144911|Fluticasone|fluticasone|mesh-list
44130333|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130335|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130336|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44130337|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
44130338|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
44130339|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44130340|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130341|NCT00145184|Vitamins|vitamins|mesh-list
44130342|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
44130343|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
44130344|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155327|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155329|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130373|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
44130374|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44130375|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130376|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
44130383|NCT00145301|Analgesics|analgesics|mesh-ancestor
44130446|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44130447|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44130519|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130520|NCT00145847|Naltrexone|naltrexone|mesh-list
44130521|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44130522|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44130523|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130524|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
44130525|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130526|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44130527|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
44130528|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130529|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
44130530|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130531|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44130532|NCT00145925|Gliclazide|gliclazide|mesh-list
44130580|NCT00146042|Erythromycin|erythromycin|mesh-list
44130581|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
43687155|NCT02822157|Paclitaxel|paclitaxel|mesh-list
44130582|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44130652|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44130653|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44130654|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130655|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44130656|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44130657|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
44130658|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44130659|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
44130660|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
44130661|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44130662|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130663|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44130664|NCT00146250|Analgesics|analgesics|mesh-ancestor
44130665|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
44130666|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130667|NCT00146276|Gemcitabine|gemcitabine|mesh-list
44130668|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44130669|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
44130670|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130671|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130672|NCT00146276|Antiviral Agents|antiviral agents|mesh-ancestor
44130673|NCT00146276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44130702|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44130703|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44130704|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44130705|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
44130706|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44130707|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44130708|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130709|NCT00146471|Levetiracetam|levetiracetam|mesh-list
44130710|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
44130711|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
44130713|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44130714|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130715|NCT00146497|Budesonide|budesonide|mesh-list
44130716|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44130717|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44130718|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44130719|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
44130720|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44130721|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130722|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44130723|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
44130724|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
44130725|NCT00146497|Hormones|hormones|mesh-ancestor
44130726|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130727|NCT00146523|Mifepristone|mifepristone|mesh-list
44130728|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44130729|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
44130730|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44130731|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130732|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44130733|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44130734|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44130735|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
44130736|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44130740|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
44130741|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44130742|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44130744|NCT00146549|Vinorelbine|vinorelbine|mesh-list
44130745|NCT00146549|Docetaxel|docetaxel|mesh-list
44130811|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130812|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44130813|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44130814|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
44130815|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44130816|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130817|NCT00146614|Sirolimus|sirolimus|mesh-list
44130818|NCT00146614|Methotrexate|methotrexate|mesh-list
44130819|NCT00146614|Tacrolimus|tacrolimus|mesh-list
44130820|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44130821|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
44130877|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44130878|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
44130879|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155347|NCT00226746|Antiviral Agents|antiviral agents|mesh-ancestor
44155348|NCT00226746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155349|NCT00226746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155350|NCT00226746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155351|NCT00226746|Immunologic Factors|immunologic factors|mesh-ancestor
44155352|NCT00226746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155353|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
44155354|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44155407|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44155409|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44130947|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44130948|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130949|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
44130950|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44130951|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44130953|NCT00147160|Cisplatin|cisplatin|mesh-list
44131014|NCT00147381|Tacrolimus|tacrolimus|mesh-list
44131015|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131016|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
44131017|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131018|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44131019|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131020|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131021|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131023|NCT00147394|Risperidone|risperidone|mesh-list
44131078|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44131080|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
44131081|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44131082|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
44131083|NCT00147628|Citric Acid|citric acid|mesh-list
44131084|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
44131085|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
44131086|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44131087|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
44131088|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
44131089|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131090|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
44131091|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44131092|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44131093|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131094|NCT00147628|Urological Agents|urological agents|mesh-ancestor
44131095|NCT00147654|Tamsulosin|tamsulosin|mesh-list
44131136|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131211|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44131212|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131213|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44131214|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131215|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131216|NCT00147953|Rituximab|rituximab|mesh-list
44131217|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131278|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44131279|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
44131280|NCT00148135|Gemcitabine|gemcitabine|mesh-list
44131281|NCT00148135|Carboplatin|carboplatin|mesh-list
44131282|NCT00148135|Capecitabine|capecitabine|mesh-list
44131293|NCT00148148|Amphotericin B|amphotericin b|mesh-list
44131350|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
44131425|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131426|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
44155418|NCT00226967|Octreotide|octreotide|mesh-list
44131448|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131449|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131450|NCT00148564|Olanzapine|olanzapine|mesh-list
44131451|NCT00148564|Ziprasidone|ziprasidone|mesh-list
44131452|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
44131453|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
44131454|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131455|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131510|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
44131511|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131512|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131521|NCT00148694|Cisplatin|cisplatin|mesh-list
44131583|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
44131658|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131659|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44131660|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131661|NCT00149110|Analgesics|analgesics|mesh-ancestor
44131662|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
44131663|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131664|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
44131665|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44131666|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
44131667|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
44131668|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131669|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
44131670|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131671|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44131672|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44131673|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44131674|NCT00149149|Polaprezinc|polaprezinc|mesh-list
44131675|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44131676|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44131677|NCT00149162|Aldesleukin|aldesleukin|mesh-list
44131678|NCT00149162|Interleukin-2|interleukin-2|mesh-list
44131679|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131680|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44131681|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44131682|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
44131683|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44131684|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131707|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131708|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44131709|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131710|NCT00149253|Etoricoxib|etoricoxib|mesh-list
44131711|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131712|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44131713|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131714|NCT00149253|Analgesics|analgesics|mesh-ancestor
44131715|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
44131716|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131717|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131718|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131723|NCT00149292|Olanzapine|olanzapine|mesh-list
44131768|NCT00149578|Immunologic Factors|immunologic factors|mesh-ancestor
44131769|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131770|NCT00149578|Antidotes|antidotes|mesh-ancestor
44131771|NCT00149578|Protective Agents|protective agents|mesh-ancestor
44131772|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
44131773|NCT00149578|Vitamins|vitamins|mesh-ancestor
44131774|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
44131775|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44131776|NCT00149604|Estrogens|estrogens|mesh-list
44131777|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44131778|NCT00149604|Hormones|hormones|mesh-ancestor
44131779|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44131780|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131781|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44131786|NCT00149617|Buspirone|buspirone|mesh-list
44131828|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44131829|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131831|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
44131899|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131901|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44131902|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44131903|NCT00150059|Analgesics|analgesics|mesh-ancestor
44131904|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
44131905|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44131906|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131907|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44131908|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131909|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
44131910|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44131911|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
44131934|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44131935|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44131936|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
44131937|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44131938|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44131939|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
44132001|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132002|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44132003|NCT00150293|Pregabalin|pregabalin|mesh-list
44132004|NCT00150293|Analgesics|analgesics|mesh-ancestor
44132005|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
44132006|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132007|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132008|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
44132009|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44132010|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132013|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44132062|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132063|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132064|NCT00150410|Insulin|insulin|mesh-list
44132065|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44132066|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132067|NCT00150423|Pregabalin|pregabalin|mesh-list
44132068|NCT00150423|Analgesics|analgesics|mesh-ancestor
44132125|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132126|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132127|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
44132130|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132194|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132195|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
44132196|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132197|NCT00150657|Antiviral Agents|antiviral agents|mesh-ancestor
44132198|NCT00150657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132199|NCT00150657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132200|NCT00150657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44132201|NCT00150657|Immunologic Factors|immunologic factors|mesh-ancestor
44132259|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44132260|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
44132261|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
44132332|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44132333|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
44132334|NCT00151034|Antiviral Agents|antiviral agents|mesh-ancestor
44132405|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
44132406|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
44132407|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132408|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44132478|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44132479|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
44132480|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
44132481|NCT00151294|Dexetimide|dexetimide|mesh-list
44132482|NCT00151294|Citalopram|citalopram|mesh-list
44132483|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
44132484|NCT00151294|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44132485|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44132486|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132487|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132488|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132489|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
44132490|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132491|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44132492|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44132493|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44132501|NCT00151346|Fentanyl|fentanyl|mesh-list
44132535|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
44132536|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132537|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
44132538|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44132539|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44132540|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132541|NCT00151463|Urological Agents|urological agents|mesh-ancestor
44132542|NCT00151489|Pregabalin|pregabalin|mesh-list
44132601|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44132602|NCT00151567|Tamsulosin|tamsulosin|mesh-list
44132603|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44132611|NCT00151580|Ribavirin|ribavirin|mesh-list
44132629|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44132630|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132631|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132638|NCT00151684|Diazoxide|diazoxide|mesh-list
44132699|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44132701|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44132844|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44132845|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
44132846|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
44132847|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44132848|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
44132849|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44132850|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44132851|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44132852|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44132853|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44132856|NCT00152204|Renal Agents|renal agents|mesh-ancestor
44132909|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
44132910|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
44132911|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44132912|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132913|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132914|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
44132916|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
44132973|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
44132974|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44132975|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
44132976|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44132977|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
44132978|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
44132979|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132980|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44132981|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44132982|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
44132983|NCT00152620|Hormones|hormones|mesh-ancestor
44132984|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44132985|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44132986|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44132987|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44132988|NCT00152620|Protective Agents|protective agents|mesh-ancestor
44132990|NCT00152633|Metoprolol|metoprolol|mesh-list
44132991|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44132992|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44132993|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44132994|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44132995|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44132996|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
44132997|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
44132998|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44132999|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133014|NCT00152698|Irbesartan|irbesartan|mesh-list
44133019|NCT00152724|Aspirin|aspirin|mesh-list
44133020|NCT00152724|Celecoxib|celecoxib|mesh-list
44133021|NCT00152724|Indomethacin|indomethacin|mesh-list
44133022|NCT00152724|Nitroprusside|nitroprusside|mesh-list
44133023|NCT00152724|Acetylcholine|acetylcholine|mesh-list
44133024|NCT00152724|Capsaicin|capsaicin|mesh-list
44133025|NCT00152724|Clopidogrel|clopidogrel|mesh-list
44133027|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43852039|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43852040|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
43852041|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
43852042|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852110|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43852111|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43852112|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
43852113|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
43852179|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
43852180|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852181|NCT03866772|Misoprostol|misoprostol|mesh-list
43852252|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852253|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852254|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
43852256|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852286|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43852287|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
43852288|NCT03861390|Hormones|hormones|mesh-ancestor
43852289|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43852430|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852431|NCT03841357|Abatacept|abatacept|mesh-list
43852505|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852506|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44133093|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133121|NCT00152893|Niacin|niacin|mesh-list
43852514|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43852515|NCT03832361|Maytansine|maytansine|mesh-list
43852516|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43852588|NCT03825796|Daunorubicin|daunorubicin|mesh-list
43852589|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43852590|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
43852591|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852662|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43852664|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43852666|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
43852734|NCT03818672|Rifaximin|rifaximin|mesh-list
43852812|NCT03814109|Indapamide|indapamide|mesh-list
43852813|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43852814|NCT03814109|Diuretics|diuretics|mesh-ancestor
43852815|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
43852887|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852888|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43852889|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43852890|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43852891|NCT03805607|Ketorolac|ketorolac|mesh-list
43852892|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44133182|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133183|NCT00152997|Protective Agents|protective agents|mesh-ancestor
43852990|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43852991|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43852992|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
43853062|NCT03788759|Vitamins|vitamins|mesh-ancestor
43853138|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43853139|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853212|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
43853213|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853214|NCT03777813|Leucovorin|leucovorin|mesh-list
43853215|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
43853216|NCT03777813|Durvalumab|durvalumab|mesh-list
43853217|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
44155576|NCT00227656|Capecitabine|capecitabine|mesh-list
44155577|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44155578|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
44155585|NCT00227669|Gemcitabine|gemcitabine|mesh-list
43853288|NCT03774732|Carboplatin|carboplatin|mesh-list
43853289|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
43853290|NCT03774732|Pemetrexed|pemetrexed|mesh-list
43853291|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43853292|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853293|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
43853294|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
43853295|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
43853296|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853297|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853298|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853299|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43853300|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43853301|NCT03774654|Cyclophosphamide|cyclophosphamide|mesh-list
43853302|NCT03774654|Fludarabine|fludarabine|mesh-list
43853359|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43853360|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43853361|NCT03770286|Fluorides|fluorides|mesh-list
43853362|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
43853363|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
43853364|NCT03770286|Protective Agents|protective agents|mesh-ancestor
43853365|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853425|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853427|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
43853428|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853429|NCT03754933|Fludarabine|fludarabine|mesh-list
43853430|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
43853498|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43853499|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43853500|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
43853514|NCT03749018|Hormones|hormones|mesh-ancestor
43853570|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853572|NCT03745729|Allopurinol|allopurinol|mesh-list
43853573|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
43853574|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853575|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853576|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
43853577|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43853578|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43853579|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
43853580|NCT03745729|Protective Agents|protective agents|mesh-ancestor
43853581|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853582|NCT03745430|Ramucirumab|ramucirumab|mesh-list
43853583|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853584|NCT03745170|Capecitabine|capecitabine|mesh-list
43853608|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853609|NCT03742297|Dexamethasone|dexamethasone|mesh-list
43853611|NCT03742297|Lenalidomide|lenalidomide|mesh-list
43853612|NCT03742297|Bortezomib|bortezomib|mesh-list
43853613|NCT03742297|Melphalan|melphalan|mesh-list
43853614|NCT03742297|Daratumumab|daratumumab|mesh-list
43853615|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43853675|NCT03739619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43853676|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43853680|NCT03738917|Bromides|bromides|mesh-list
43853830|NCT03726268|Hydromorphone|hydromorphone|mesh-list
43853831|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43853902|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43853903|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43853904|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43853905|NCT03721653|Leucovorin|leucovorin|mesh-list
43853906|NCT03721653|Bevacizumab|bevacizumab|mesh-list
43853907|NCT03721653|Fluorouracil|fluorouracil|mesh-list
43853908|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
43854018|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
43854019|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854020|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854021|NCT03715244|Anesthetics|anesthetics|mesh-list
43854088|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43854092|NCT03710122|Vancomycin|vancomycin|mesh-list
43854165|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854240|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43854242|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
43854245|NCT03693781|Colchicine|colchicine|mesh-list
44133285|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44133286|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133287|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
44133288|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44133289|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44133290|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44133291|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43580759|NCT03466775|Giapreza|giapreza|mesh-list
44133292|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44133293|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44133294|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155597|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
43854275|NCT03686124|Nivolumab|nivolumab|mesh-list
43854276|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854277|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854278|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43854318|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43854319|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
43854320|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854321|NCT03683810|Lactoferrin|lactoferrin|mesh-list
43854389|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854395|NCT03676192|Bevacizumab|bevacizumab|mesh-list
43854463|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43854464|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43854465|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854466|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43854467|NCT03671967|Meropenem|meropenem|mesh-list
43854468|NCT03671967|Tazobactam|tazobactam|mesh-list
43854533|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854534|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854535|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
43854536|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854543|NCT03662022|Rifampin|rifampin|mesh-list
44133309|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44133310|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133311|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44133312|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44133313|NCT00153491|Lumefantrine|lumefantrine|mesh-list
44133314|NCT00153491|Artemether|artemether|mesh-list
43854611|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43854612|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43854628|NCT03656549|Pemetrexed|pemetrexed|mesh-list
43854762|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43854763|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43854764|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43854765|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43854766|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43854767|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
43854768|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43854769|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43854770|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43854771|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43854772|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43854773|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854774|NCT03643107|Prednisolone|prednisolone|mesh-list
43854775|NCT03643107|Irofulven|irofulven|mesh-list
43854776|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43854777|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
43854778|NCT03643107|Hormones|hormones|mesh-ancestor
43854779|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854780|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854815|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43854816|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854818|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
44133356|NCT00153634|Ceftazidime|ceftazidime|mesh-list
43854890|NCT03627741|Hormones|hormones|mesh-ancestor
43854891|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43854892|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43854893|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855042|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855043|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
43855044|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
43855045|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855046|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855047|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43855048|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
43855111|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855112|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855113|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43855114|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
43855115|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
43855116|NCT03602781|Protective Agents|protective agents|mesh-ancestor
43855118|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855119|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
43855120|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855121|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855122|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
43855123|NCT03600649|Topotecan|topotecan|mesh-list
43855171|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
43855172|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43855173|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43855174|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44133423|NCT00153881|Carboplatin|carboplatin|mesh-list
43855218|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855219|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855220|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43855221|NCT03593408|Analgesics|analgesics|mesh-ancestor
43855222|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
43855223|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43855224|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43855225|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43855226|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43855227|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
43855228|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855229|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855230|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43855278|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43855279|NCT03584373|Narcotics|narcotics|mesh-ancestor
43855280|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855281|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43855282|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43855283|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855284|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43855285|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855286|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855287|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43855288|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43855289|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855291|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855292|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855293|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43855294|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855295|NCT03582722|Orlistat|orlistat|mesh-list
43855296|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855297|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855298|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43855331|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855332|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855333|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43855400|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
43855401|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43855402|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44133477|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44133478|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855448|NCT03568383|Pyridoxine|pyridoxine|mesh-list
43855449|NCT03568383|Pyridoxal|pyridoxal|mesh-list
43855520|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43855521|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855522|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43855523|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
43855524|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855525|NCT03559348|Antidotes|antidotes|mesh-ancestor
43855526|NCT03559348|Protective Agents|protective agents|mesh-ancestor
43855527|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
43855528|NCT03559348|Vitamins|vitamins|mesh-ancestor
43855529|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
43855530|NCT03558867|Metformin|metformin|mesh-list
43855531|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43855532|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855533|NCT03557385|Adenosine|adenosine|mesh-list
43855534|NCT03557385|Analgesics|analgesics|mesh-ancestor
43855535|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
43855545|NCT03557008|Metronidazole|metronidazole|mesh-list
43855582|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855583|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43582348|NCT02099188|Vitamins|vitamins|mesh-ancestor
43855656|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43855657|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43855659|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133520|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133522|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
43855734|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855807|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43855808|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43855809|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
43855810|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855811|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43855813|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43855814|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43855815|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
43855816|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855817|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43855825|NCT03525574|Ivacaftor|ivacaftor|mesh-list
43855877|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43855878|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
43855879|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43855880|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43855894|NCT03519646|Eliglustat|eliglustat|mesh-list
43855949|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43855950|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43856023|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43856089|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
43856090|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856093|NCT03492437|Tepotinib|tepotinib|mesh-list
43856162|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43856163|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43856164|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
43856165|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43856232|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43856233|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43856235|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
43856304|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856305|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856306|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856307|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43856334|NCT03458455|Nivolumab|nivolumab|mesh-list
43856335|NCT03458455|Ipilimumab|ipilimumab|mesh-list
43856336|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43632975|NCT05614544|Propofol|propofol|mesh-list
43856401|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
43856402|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43856403|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43856404|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43856405|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43856472|NCT03447808|Daratumumab|daratumumab|mesh-list
43856473|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856475|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43856476|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856477|NCT03447379|Analgesics|analgesics|mesh-ancestor
43856542|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856619|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43856620|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43856621|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
43856622|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43856624|NCT03434678|Analgesics|analgesics|mesh-ancestor
43856638|NCT03432650|Hormones|hormones|mesh-ancestor
43856690|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43856691|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
43856692|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856728|NCT03422523|Gemcitabine|gemcitabine|mesh-list
43856730|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
43856731|NCT03422523|Atezolizumab|atezolizumab|mesh-list
43856732|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856733|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856799|NCT03406650|Durvalumab|durvalumab|mesh-list
43856800|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43856801|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43856802|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
43856803|NCT03404180|Propofol|propofol|mesh-list
43856804|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43856805|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43856806|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43856807|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43856808|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
43856809|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
43856810|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43856811|NCT03404180|Analgesics|analgesics|mesh-ancestor
43856812|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
43856813|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43856814|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43856858|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43856859|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43856924|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43856925|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43856926|NCT03395899|Growth Substances|growth substances|mesh-ancestor
43857071|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857072|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43857073|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43857143|NCT03366766|Cisplatin|cisplatin|mesh-list
43857144|NCT03366766|Nivolumab|nivolumab|mesh-list
43857145|NCT03366766|Pemetrexed|pemetrexed|mesh-list
43857146|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857147|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43857148|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
43857149|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857150|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
43857151|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857152|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43857153|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43857154|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
43857208|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43857209|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857210|NCT03358563|Hematinics|hematinics|mesh-ancestor
43857211|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43857330|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
43857331|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857332|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857333|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43857334|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43857335|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
43857336|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
43857399|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857400|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857401|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
43857402|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43857468|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857470|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43857473|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43857539|NCT03321981|Fulvestrant|fulvestrant|mesh-list
43857540|NCT03321981|Exemestane|exemestane|mesh-list
43857542|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44133664|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44133665|NCT00154336|Methotrexate|methotrexate|mesh-list
44133666|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
44133667|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43857616|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857617|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857618|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43857620|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43857625|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
43857685|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857686|NCT03298802|Diuretics|diuretics|mesh-ancestor
43857687|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
43857688|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857756|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43857757|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43857758|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43857759|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43857760|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
43857763|NCT03288974|Pomalidomide|pomalidomide|mesh-list
43857828|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857830|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43857831|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155658|NCT00227773|Mitogens|mitogens|mesh-list
44155659|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44155660|NCT00227773|Vatalanib|vatalanib|mesh-list
43857835|NCT03284307|Midazolam|midazolam|mesh-list
43857836|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
43857837|NCT03284307|Ketamine|ketamine|mesh-list
43857838|NCT03284307|Propofol|propofol|mesh-list
43857839|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43857840|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43857841|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43857842|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43857843|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
43857844|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
43857897|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
43857969|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43857970|NCT03267836|Avelumab|avelumab|mesh-list
43857971|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857972|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43857973|NCT03267680|Indomethacin|indomethacin|mesh-list
43857974|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
43858038|NCT03259503|Gemcitabine|gemcitabine|mesh-list
43858039|NCT03259503|Rituximab|rituximab|mesh-list
43858114|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43858115|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43858116|NCT03249558|Narcotics|narcotics|mesh-ancestor
43858117|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43858118|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858119|NCT03249558|Analgesics|analgesics|mesh-ancestor
43858120|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
43858126|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43858182|NCT03245541|Durvalumab|durvalumab|mesh-list
43858183|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858184|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858185|NCT03245437|Oxytocin|oxytocin|mesh-list
43858186|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
43858238|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
43858239|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43858240|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
43858242|NCT03238300|Protective Agents|protective agents|mesh-ancestor
43858310|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43858333|NCT03229174|Droxidopa|droxidopa|mesh-list
43858385|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858386|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
43858387|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43858388|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858389|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
43858390|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858391|NCT03221426|Antidotes|antidotes|mesh-ancestor
43858392|NCT03221426|Protective Agents|protective agents|mesh-ancestor
43858460|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43858461|NCT03216967|Everolimus|everolimus|mesh-list
43858466|NCT03215017|Loperamide|loperamide|mesh-list
43858527|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858528|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858529|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43858530|NCT03197662|Oxytocin|oxytocin|mesh-list
43858531|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
43858534|NCT03194932|Cytarabine|cytarabine|mesh-list
43858597|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43858598|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
43858599|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43858602|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43858668|NCT03175432|Atezolizumab|atezolizumab|mesh-list
43858669|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
43858671|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
43858672|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43858741|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858742|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43858743|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
43858744|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43858893|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
43858894|NCT03138889|Pemetrexed|pemetrexed|mesh-list
43858895|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43858896|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43858897|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
43858965|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
43858966|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
43858967|NCT03135860|Protective Agents|protective agents|mesh-ancestor
43859037|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859038|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
43859114|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43859115|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43859116|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43859117|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859118|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
43859119|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43859120|NCT03118674|Ledipasvir|ledipasvir|mesh-list
43859121|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
43859122|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43859123|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
43859124|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
43859125|NCT03118492|Melphalan|melphalan|mesh-list
43859126|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
43859127|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43859128|NCT03118492|Fludarabine|fludarabine|mesh-list
43859129|NCT03118492|Tacrolimus|tacrolimus|mesh-list
43859130|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859131|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
43859132|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859133|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859134|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43859135|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
43859136|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43586205|NCT03413059|Analgesics|analgesics|mesh-ancestor
43859137|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859138|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43859139|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43859140|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859141|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43859162|NCT03115151|Bupivacaine|bupivacaine|mesh-list
43859163|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
43859164|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
43859166|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133770|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
44133771|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44133772|NCT00154739|Gemcitabine|gemcitabine|mesh-list
44133773|NCT00154739|Cisplatin|cisplatin|mesh-list
43859263|NCT03100253|Infliximab|infliximab|mesh-list
43859264|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
43859265|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43859266|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43859336|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859337|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859338|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43859339|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43859412|NCT03087708|Naloxegol|naloxegol|mesh-list
43859484|NCT03074045|Drospirenone|drospirenone|mesh-list
43859485|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
43859486|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43859487|NCT03074045|Estradiol|estradiol|mesh-list
43859488|NCT03074045|Estrogens|estrogens|mesh-ancestor
43859489|NCT03074045|Hormones|hormones|mesh-ancestor
43859502|NCT03074045|Diuretics|diuretics|mesh-ancestor
44133805|NCT00154791|Immunologic Factors|immunologic factors|mesh-ancestor
44133806|NCT00154791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44133807|NCT00154804|Paclitaxel|paclitaxel|mesh-list
44133808|NCT00154804|Cisplatin|cisplatin|mesh-list
44133809|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44133815|NCT00154843|Lycopene|lycopene|mesh-list
43859577|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43859578|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43859579|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43859580|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43859582|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
43859583|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43859645|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43859646|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43859647|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43859648|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
43859649|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
43859650|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859651|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
43859652|NCT03056339|Fludarabine|fludarabine|mesh-list
43859653|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
43859654|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43859710|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43859783|NCT03036904|Doxorubicin|doxorubicin|mesh-list
43859784|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43859785|NCT03036904|Etoposide|etoposide|mesh-list
43859786|NCT03036904|Vincristine|vincristine|mesh-list
43859787|NCT03036904|Venetoclax|venetoclax|mesh-list
43859840|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43859841|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
43859842|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859901|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43859902|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43859903|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43859904|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43859911|NCT03028857|Choline|choline|mesh-list
44133887|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44133888|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44133889|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44133890|NCT00155272|Growth Substances|growth substances|mesh-ancestor
43860053|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43860054|NCT03008382|Metoprolol|metoprolol|mesh-list
43860055|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43860056|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43860057|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
43860058|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
43860120|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43860121|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860123|NCT03007147|Cytarabine|cytarabine|mesh-list
43860124|NCT03007147|Dexamethasone|dexamethasone|mesh-list
43860195|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860196|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
43860197|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860198|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860265|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
43860266|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43860267|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860268|NCT03004001|Atorvastatin|atorvastatin|mesh-list
43860337|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
43860338|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43860341|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
43860412|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860413|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
43860414|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43860425|NCT02974725|Trametinib|trametinib|mesh-list
43860485|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860486|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860487|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860488|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860490|NCT02967133|Paclitaxel|paclitaxel|mesh-list
43860549|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860550|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860551|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43860552|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43860553|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860554|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860617|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860618|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
43860619|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43860620|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860712|NCT02937272|Gemcitabine|gemcitabine|mesh-list
43860714|NCT02937272|Cisplatin|cisplatin|mesh-list
43860715|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860716|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860717|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860718|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860719|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860720|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860722|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
43860756|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43860757|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
43860758|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860759|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860760|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
43860761|NCT02932475|Metformin|metformin|mesh-list
43860762|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43860763|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860764|NCT02930902|Gemcitabine|gemcitabine|mesh-list
43860765|NCT02930902|Paclitaxel|paclitaxel|mesh-list
43860766|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43860767|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
43860768|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43860769|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43860770|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860771|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860772|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
43860773|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860774|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43860775|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
43860776|NCT02930902|Antiviral Agents|antiviral agents|mesh-ancestor
43860777|NCT02930902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43860778|NCT02930902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43860779|NCT02930902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43860780|NCT02930902|Immunologic Factors|immunologic factors|mesh-ancestor
43860781|NCT02930902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43860782|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43860783|NCT02926222|Lomustine|lomustine|mesh-list
43860784|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43860785|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
43860786|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860788|NCT02925650|Phenserine|phenserine|mesh-list
43860797|NCT02925234|Nivolumab|nivolumab|mesh-list
43860798|NCT02925234|Trastuzumab|trastuzumab|mesh-list
43860799|NCT02925234|Ipilimumab|ipilimumab|mesh-list
43860800|NCT02925234|Durvalumab|durvalumab|mesh-list
43860801|NCT02925234|Pertuzumab|pertuzumab|mesh-list
43860802|NCT02925234|Panitumumab|panitumumab|mesh-list
43860803|NCT02925234|Sunitinib|sunitinib|mesh-list
43860874|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43860875|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43860876|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43860877|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
43860878|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
43860933|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
43860934|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
43860935|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861079|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861080|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43861081|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
43861082|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43861084|NCT02880982|Vitamin D|vitamin d|mesh-list
43861147|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43861148|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43861149|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43861150|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43861255|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861256|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43861257|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
43861327|NCT02827201|Paclitaxel|paclitaxel|mesh-list
43861328|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861330|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861401|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43861402|NCT02809690|Clevudine|clevudine|mesh-list
43861403|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
43861441|NCT02792257|Analgesics|analgesics|mesh-ancestor
43861442|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
43861443|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43861444|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43861587|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861589|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861599|NCT02766465|Sirolimus|sirolimus|mesh-list
43861659|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861660|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861661|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43861662|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861663|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
43861664|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
43861727|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43861728|NCT02752685|Paclitaxel|paclitaxel|mesh-list
43861729|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
43861730|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43861731|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861732|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
43861733|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
43861734|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
43861735|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861736|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43861737|NCT02749526|Cisplatin|cisplatin|mesh-list
43861738|NCT02749526|Tegafur|tegafur|mesh-list
43861739|NCT02749526|Endostar protein|endostar protein|mesh-list
43861740|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43861741|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43861742|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
43861743|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861744|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43861745|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43861746|NCT02749526|Growth Substances|growth substances|mesh-ancestor
43861748|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44133981|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
43861830|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43861831|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861906|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43861908|NCT02725424|Docetaxel|docetaxel|mesh-list
43862057|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
43862058|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862059|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862129|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43862130|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
43862131|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43862132|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43862133|NCT02712723|Letrozole|letrozole|mesh-list
43862134|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862135|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43862136|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43862137|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862197|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862198|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
43862270|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862271|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
43862272|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134006|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134007|NCT00156325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44134010|NCT00156377|Mupirocin|mupirocin|mesh-list
43862367|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862368|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43862369|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862440|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
43862441|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43862442|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862443|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862444|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862510|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
43862511|NCT02661503|Hormones|hormones|mesh-ancestor
43862512|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862513|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862514|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43862515|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43862516|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43862517|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862518|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43862519|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
43862574|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43862575|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43862576|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862577|NCT02649764|Cytarabine|cytarabine|mesh-list
43862645|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862646|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43862648|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
43862649|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43862650|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862651|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
43862652|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862653|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43862711|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43862712|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
43862713|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43862714|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862715|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43862716|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43862717|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
43862718|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43862720|NCT02627846|Epinephrine|epinephrine|mesh-list
43862721|NCT02627846|Racepinephrine|racepinephrine|mesh-list
43862722|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43862723|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
43862724|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
43862725|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
43862726|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
43862727|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43862728|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862769|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43862770|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862771|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862772|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43862774|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43862775|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134098|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134099|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134100|NCT00157066|Vitamins|vitamins|mesh-ancestor
43862853|NCT02608268|Decitabine|decitabine|mesh-list
43862914|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43862915|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43862916|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862917|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43862919|NCT02596685|Nicotine|nicotine|mesh-list
43862987|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43862988|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
43862989|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43862990|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43862991|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43862992|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43862993|NCT02588105|Antidotes|antidotes|mesh-ancestor
43862994|NCT02588105|Protective Agents|protective agents|mesh-ancestor
43863057|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
43863058|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
43863059|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43863060|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863061|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
43863128|NCT02552641|Clarithromycin|clarithromycin|mesh-list
43863129|NCT02552641|Esomeprazole|esomeprazole|mesh-list
43863130|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43863202|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
43863203|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43863204|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134143|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44134145|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
43863281|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43863282|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
43863283|NCT02531308|Hormones|hormones|mesh-ancestor
43863290|NCT02530034|Antibodies|antibodies|mesh-list
43863355|NCT02520778|Osimertinib|osimertinib|mesh-list
43863356|NCT02520778|Navitoclax|navitoclax|mesh-list
43863430|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
43863431|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863432|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
43863433|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43863434|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863435|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43863436|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43863437|NCT02507336|Growth Substances|growth substances|mesh-ancestor
43863438|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
43863439|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863440|NCT02504489|Docetaxel|docetaxel|mesh-list
43863441|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863442|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
43863443|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
43863444|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
43863445|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772778|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43772779|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772780|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43772781|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824678|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824679|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43824680|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43687730|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43863446|NCT02503358|Paclitaxel|paclitaxel|mesh-list
43863447|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43863487|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863488|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43863489|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
43863490|NCT02495896|Antiviral Agents|antiviral agents|mesh-ancestor
43863491|NCT02495896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863492|NCT02495896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43863557|NCT02483936|Olmesartan|olmesartan|mesh-list
43863558|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43863559|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
43863560|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43863561|NCT02483936|Diuretics|diuretics|mesh-ancestor
43863624|NCT02464696|Protective Agents|protective agents|mesh-ancestor
43863625|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43863626|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43863627|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
43863628|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43863629|NCT02462421|Canagliflozin|canagliflozin|mesh-list
43863694|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
43863695|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
43863696|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863697|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863698|NCT02455687|Budesonide|budesonide|mesh-list
44134223|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44134224|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134228|NCT00157586|Manidipine|manidipine|mesh-list
43863789|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43863790|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43863791|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43863863|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43863937|NCT02415413|Growth Substances|growth substances|mesh-ancestor
43863938|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
43863939|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43863940|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
43863941|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864006|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864007|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864008|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
43864009|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
43864081|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864082|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864083|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
43864156|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43864157|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864158|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43864220|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864221|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
43864222|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43864223|NCT02358967|Protective Agents|protective agents|mesh-ancestor
43864224|NCT02354131|Bevacizumab|bevacizumab|mesh-list
43864225|NCT02354131|Niraparib|niraparib|mesh-list
43864226|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43864227|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864228|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864229|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864288|NCT02344472|Letrozole|letrozole|mesh-list
43864289|NCT02344472|Fulvestrant|fulvestrant|mesh-list
43864361|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864362|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
43864363|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43864364|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43864432|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43864433|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
43864434|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43864435|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
43864505|NCT02278965|Metformin|metformin|mesh-list
43864561|NCT02264678|Olaparib|olaparib|mesh-list
43864562|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864633|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
43864634|NCT02248597|Busulfan|busulfan|mesh-list
43864635|NCT02248597|Fludarabine|fludarabine|mesh-list
43864636|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
43864637|NCT02248597|Tacrolimus|tacrolimus|mesh-list
43864639|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
43864706|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43864707|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43864708|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
43864709|NCT02226159|Hormones|hormones|mesh-ancestor
43864713|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
43864777|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
43864778|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43864780|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
43864848|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43864849|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43864850|NCT02180711|Rituximab|rituximab|mesh-list
43864851|NCT02180711|Lenalidomide|lenalidomide|mesh-list
43864852|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
43864854|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43864901|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
43864902|NCT02166463|Cortisone|cortisone|mesh-list
43864903|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
43864904|NCT02166463|Doxorubicin|doxorubicin|mesh-list
43864976|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
43864977|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43864978|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43864979|NCT02159989|Growth Substances|growth substances|mesh-ancestor
43864980|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865046|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43865047|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865048|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
43865049|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865050|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865051|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865052|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865116|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43865117|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
44134277|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865118|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43865121|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
43865185|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
43865186|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865187|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865259|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43865260|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43865261|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
43865262|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
43865263|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865264|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43865265|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43865266|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43865267|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865268|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43865269|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
43865270|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865271|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
43865272|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43865273|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44134304|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
44134305|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44134306|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
43865390|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43865391|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43865392|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
43865393|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865394|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
43865395|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865396|NCT02068092|Protective Agents|protective agents|mesh-ancestor
43865399|NCT02064673|Curcumin|curcumin|mesh-list
43865457|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43865458|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43865459|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
43865460|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43865461|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43865527|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865528|NCT02043457|Hormones|hormones|mesh-list
43865531|NCT02042391|Cytarabine|cytarabine|mesh-list
43865601|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43865602|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43865603|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43865607|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
43865671|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
43865672|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43865674|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
43865680|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43865742|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43865743|NCT01976585|Poly ICLC|poly iclc|mesh-list
43865744|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
43865745|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
43865746|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43865747|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43865748|NCT01976065|Metronidazole|metronidazole|mesh-list
43865749|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
43865750|NCT01976065|Minocycline|minocycline|mesh-list
43865751|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43865752|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43865753|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43865754|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43865755|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44134353|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44134354|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43865928|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
43865929|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
43866003|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43866004|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866006|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866007|NCT01906853|Vaccines|vaccines|mesh-list
43866008|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
43866009|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
43866010|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866011|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43866012|NCT01905046|Metformin|metformin|mesh-list
43866071|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866073|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866074|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866075|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866076|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
43866077|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43866078|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43866140|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866141|NCT01879085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866142|NCT01879085|Immunologic Factors|immunologic factors|mesh-ancestor
43866143|NCT01879085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866148|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
43866213|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866214|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43866215|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43866216|NCT01865110|Growth Substances|growth substances|mesh-ancestor
43866217|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866218|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44134370|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44134371|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134372|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134373|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44134374|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44134375|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
44134376|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134377|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
44134378|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44134379|NCT00158132|Analgesics|analgesics|mesh-ancestor
44134380|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
44134381|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134382|NCT00158158|Nicotine|nicotine|mesh-list
44134383|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44134384|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
44134385|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772782|NCT02363751|Growth Substances|growth substances|mesh-ancestor
43772783|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772784|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
43772785|NCT02363556|Misoprostol|misoprostol|mesh-list
43687869|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134386|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134387|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44134388|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43866294|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
43866295|NCT01824836|Anastrozole|anastrozole|mesh-list
43866296|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43866297|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866298|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43866299|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43866300|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866364|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43866365|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866367|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866368|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43866369|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866433|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866434|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43866436|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866438|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866505|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43866506|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866507|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866508|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43866509|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
43866511|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43866574|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866575|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866576|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43866579|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
43866646|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866647|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866648|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866649|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134461|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
44134462|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44134463|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44134464|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44134465|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44134466|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43866724|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
43866725|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43866726|NCT01673217|Doxorubicin|doxorubicin|mesh-list
43866727|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43866728|NCT01673217|Decitabine|decitabine|mesh-list
43866729|NCT01673217|Azacitidine|azacitidine|mesh-list
43866794|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
43866795|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43866796|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43866858|NCT01624285|Sorafenib|sorafenib|mesh-list
43866859|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866860|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866861|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866862|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866863|NCT01621906|Alovudine|alovudine|mesh-list
43866864|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
43866925|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43866926|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
43866927|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43866928|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43866929|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43866930|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43866931|NCT01573780|Gemcitabine|gemcitabine|mesh-list
43866932|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43866933|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
43866936|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
43866990|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43866991|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
43772787|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
43866992|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867065|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867068|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
43867138|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867139|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
43867140|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867141|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867142|NCT01514344|Rituximab|rituximab|mesh-list
43867143|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867144|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867145|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
43867146|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867147|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134474|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134475|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134476|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44134477|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44134478|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44134479|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134480|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44134481|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44134482|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44134483|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44134484|NCT00158470|Lamivudine|lamivudine|mesh-list
44134485|NCT00158470|Efavirenz|efavirenz|mesh-list
44134486|NCT00158470|Didanosine|didanosine|mesh-list
44134487|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43867150|NCT01506856|Carboplatin|carboplatin|mesh-list
43867151|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43867152|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867153|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867154|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867223|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43867224|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43867299|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867300|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
43595149|NCT03327454|Etanercept|etanercept|mesh-list
43867301|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867370|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43867371|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43867372|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43867373|NCT01419834|Antibodies|antibodies|mesh-list
43867374|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43867375|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
43867437|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867438|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
43867439|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
43867509|NCT01319981|Dexamethasone|dexamethasone|mesh-list
43867510|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
43867511|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43867512|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43867580|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
43867581|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
43867582|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134542|NCT00158548|Amebicides|amebicides|mesh-ancestor
44134543|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134544|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
43867676|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
43867677|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43867686|NCT01229943|Everolimus|everolimus|mesh-list
43867752|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43867753|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
43867754|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43867755|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43867756|NCT01209364|Prednisolone|prednisolone|mesh-list
43867757|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
43867761|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
43867820|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43867821|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43867822|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867895|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43867896|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
43867897|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43867967|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43867968|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
43868025|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43868026|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868027|NCT00936832|Antidotes|antidotes|mesh-ancestor
43868028|NCT00936832|Protective Agents|protective agents|mesh-ancestor
43868029|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
43868030|NCT00936832|Vitamins|vitamins|mesh-ancestor
43868031|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
43868098|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868099|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
43868107|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43868170|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868171|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868172|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
43868242|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868243|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43868244|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
43868245|NCT00813423|Sunitinib|sunitinib|mesh-list
43868246|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868314|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43868315|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
43868316|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868318|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868387|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868388|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868389|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
43868390|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868391|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43868429|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
43868430|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43868431|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
43868432|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43868433|NCT00637624|Expectorants|expectorants|mesh-ancestor
43868499|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
43868500|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
43868501|NCT00547196|Melphalan|melphalan|mesh-list
43868502|NCT00547196|Busulfan|busulfan|mesh-list
43868571|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43868572|NCT00472966|Tretinoin|tretinoin|mesh-list
43868573|NCT00472966|Glycolic acid|glycolic acid|mesh-list
43868574|NCT00472966|Hydroquinone|hydroquinone|mesh-list
43868575|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868576|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
43868577|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
43868580|NCT00472966|Hormones|hormones|mesh-ancestor
43868642|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43868643|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
43868644|NCT00437255|Clobetasol|clobetasol|mesh-list
43868649|NCT00437255|Hormones|hormones|mesh-ancestor
43868713|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868714|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
43868715|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868716|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
43868717|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
43868718|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43868719|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43868720|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
43868721|NCT00410956|Hormones|hormones|mesh-ancestor
43868722|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43868773|NCT00338377|Mesna|mesna|mesh-list
43868778|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43868779|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
43868780|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43868781|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868782|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44134652|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134653|NCT00158847|Fluticasone|fluticasone|mesh-list
44134654|NCT00158847|Xhance|xhance|mesh-list
44134655|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44134656|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43868853|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43868854|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43868855|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43868924|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43868925|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
43868926|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868927|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868929|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43868995|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
43868996|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
43868997|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43868998|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43868999|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43869069|NCT00163566|Androgens|androgens|mesh-ancestor
43869070|NCT00163566|Hormones|hormones|mesh-ancestor
43869071|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43869072|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869073|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43869074|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43869075|NCT00160173|Estradiol|estradiol|mesh-list
43869076|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43869137|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869138|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43869139|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43869140|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
43869141|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43869142|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869143|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43869144|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43869145|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
43869146|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43869147|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
43869148|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
43869149|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
43869150|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43869151|NCT04784000|Carbamazepine|carbamazepine|mesh-list
43869194|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869195|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869196|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869197|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43869240|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43869241|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43869242|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869313|NCT04781686|Docetaxel|docetaxel|mesh-list
43869314|NCT04781686|Apatinib|apatinib|mesh-list
43869315|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43869316|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
43869317|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
43869385|NCT04780412|Misoprostol|misoprostol|mesh-list
43869386|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43869387|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
43869396|NCT04780347|Paclitaxel|paclitaxel|mesh-list
44134729|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44134730|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134731|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134732|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43869433|NCT04779762|Ustekinumab|ustekinumab|mesh-list
43869434|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
43869435|NCT04779255|Acetaminophen|acetaminophen|mesh-list
43869500|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869579|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43869580|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43869581|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
43869582|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43869583|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43869584|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
43869585|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44134743|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
44134744|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
44134745|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
44134746|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134747|NCT00159107|Acamprosate|acamprosate|mesh-list
43869689|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43869690|NCT04776655|Growth Substances|growth substances|mesh-ancestor
43869691|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869694|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
43869762|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869763|NCT04774822|Mydriatics|mydriatics|mesh-list
43869764|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
43869765|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869828|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869829|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
43869830|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43869831|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43869832|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43869833|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43869834|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43869895|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
43869896|NCT04772287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43869899|NCT04772352|Febuxostat|febuxostat|mesh-list
44155681|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44155682|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155684|NCT00227942|Estrogens|estrogens|mesh-list
43869971|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43869972|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
43869973|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869974|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43869975|NCT04769908|Lenvatinib|lenvatinib|mesh-list
43870042|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43870043|NCT05605925|Ivermectin|ivermectin|mesh-list
43870044|NCT05605925|Lumefantrine|lumefantrine|mesh-list
43871212|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871213|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
43871214|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
43871215|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871219|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
43871220|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871221|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871222|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871290|NCT01575925|Growth Substances|growth substances|mesh-ancestor
43871364|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871366|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44135036|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
44135037|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135038|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135039|NCT00159770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43871486|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
43871487|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871558|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43871564|NCT04766021|Mirabegron|mirabegron|mesh-list
44135059|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
44135060|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135061|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
43871669|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43871670|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871671|NCT04764227|Paclitaxel|paclitaxel|mesh-list
43871672|NCT04764227|Carboplatin|carboplatin|mesh-list
43871673|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43871674|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871739|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43871740|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
43871798|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43871799|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871800|NCT04763096|Tacrolimus|tacrolimus|mesh-list
43871801|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43871867|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
43871868|NCT04762901|Carboplatin|carboplatin|mesh-list
43871869|NCT04762901|Doxorubicin|doxorubicin|mesh-list
43871873|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
43871927|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872002|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872070|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872071|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43872072|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
43872141|NCT04758000|Metformin|metformin|mesh-list
43872142|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43872143|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135101|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
44135102|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
44135103|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
44135104|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135105|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135106|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872228|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872229|NCT04756622|Protective Agents|protective agents|mesh-ancestor
43872230|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872232|NCT04756492|Cyclosporine|cyclosporine|mesh-list
43872233|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
43872297|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43872370|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872371|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872378|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
43872405|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43872406|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
43872407|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43872408|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872409|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
43872410|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
43872472|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
43872473|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
43872542|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
43872543|NCT04751175|Dexamethasone|dexamethasone|mesh-list
43872544|NCT04751175|Ketamine|ketamine|mesh-list
44155723|NCT00228020|Cyclosporine|cyclosporine|mesh-list
43872580|NCT04750603|Fluticasone|fluticasone|mesh-list
43872583|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872584|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43872585|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
43872653|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
43872654|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872655|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43872656|NCT04750135|Metformin|metformin|mesh-list
43872657|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43872658|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872659|NCT04750083|Cisplatin|cisplatin|mesh-list
43872719|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43872721|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
43872722|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43872723|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43872724|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43872725|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
43872726|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43872784|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43872785|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872786|NCT04746430|Dexamethasone|dexamethasone|mesh-list
43872857|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43872858|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43872859|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43872860|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
43872861|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
44155760|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155761|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44155762|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44155763|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44155764|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155765|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
44155766|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155774|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
43872932|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43872933|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43872934|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43872935|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43872936|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43872937|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
43872938|NCT04744623|Dapsone|dapsone|mesh-list
43872939|NCT04744623|Prednisolone|prednisolone|mesh-list
43872940|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43872941|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
43872942|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43772793|NCT02363452|Lamivudine|lamivudine|mesh-list
43872943|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
43872944|NCT04744623|Triamcinolone|triamcinolone|mesh-list
43872945|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43872946|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43872947|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43872948|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43872949|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
43872989|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43872990|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43872991|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43872996|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873059|NCT04743011|Calcium heparin|calcium heparin|mesh-list
43873060|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43873061|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
44135238|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135239|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44135240|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43873133|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
43873134|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43873135|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43873136|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43873140|NCT04741464|Tinzaparin|tinzaparin|mesh-list
43873202|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873203|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873204|NCT04739774|Itraconazole|itraconazole|mesh-list
43873205|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
43873206|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43873256|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
43873257|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43873258|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873330|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873331|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
43873332|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873396|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43873397|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873398|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135347|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44135348|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44135349|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44135350|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44135351|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135352|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135353|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44135354|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
44135355|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
44135356|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44135357|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135358|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
44135359|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43873436|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
43873485|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
43873486|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43873487|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
43873488|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43873489|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873490|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873491|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873492|NCT04736433|Valsartan|valsartan|mesh-list
43873493|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43873494|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43873548|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873549|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43873550|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873551|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873552|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
43873554|NCT04736225|Insulin|insulin|mesh-list
44135360|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
44135361|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44135362|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873647|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
43873648|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873650|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873719|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43873720|NCT05313477|Vitamins|vitamins|mesh-ancestor
43873721|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
43873722|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43873723|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43873724|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43873789|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43873790|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43873791|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
43873792|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
43873793|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44135409|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135410|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44135411|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135412|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43873862|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43873863|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43873864|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
43873865|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43873866|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873934|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43873935|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
43873936|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43873937|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
43873938|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43873939|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43873940|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
43873941|NCT04609423|Vitamin D|vitamin d|mesh-list
43873942|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
43873943|NCT04609423|Vitamins|vitamins|mesh-ancestor
43873944|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
43873945|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873946|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43873947|NCT04593459|Metformin|metformin|mesh-list
43873948|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43873949|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873950|NCT04579640|Vitamin D|vitamin d|mesh-list
43873951|NCT04579640|Vitamins|vitamins|mesh-ancestor
43873952|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
43873953|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43873954|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43873955|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
43873956|NCT04555603|Avelumab|avelumab|mesh-list
43873957|NCT04555603|Axitinib|axitinib|mesh-list
43873958|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43873959|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43873961|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135480|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
43874032|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43874033|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874034|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874035|NCT04275232|Plasminogen|plasminogen|mesh-list
43874036|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43874037|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43874039|NCT04225819|Vitamin D|vitamin d|mesh-list
43874099|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874101|NCT03996148|Remifentanil|remifentanil|mesh-list
43874102|NCT03996148|Propofol|propofol|mesh-list
43874103|NCT03996148|Desflurane|desflurane|mesh-list
43874104|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43874105|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874169|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43874170|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874171|NCT03834909|Tenofovir|tenofovir|mesh-list
43874172|NCT03834909|Emtricitabine|emtricitabine|mesh-list
43874173|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43874174|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
43874175|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874176|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43874177|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43874213|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43874214|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874215|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43874283|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
43874284|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43874285|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874286|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43874287|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874288|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43874289|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43874290|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43874291|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874292|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874293|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874294|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
43874350|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874351|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
43874352|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874353|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874354|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874355|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
43874356|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874357|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874358|NCT02888067|Bromides|bromides|mesh-list
43874359|NCT02888067|Rocuronium|rocuronium|mesh-list
43874392|NCT02235857|Dextrans|dextrans|mesh-list
43874393|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
43874394|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
43874395|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
43874396|NCT02192398|Guanfacine|guanfacine|mesh-list
43874397|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43874463|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874464|NCT01791816|Phenylephrine|phenylephrine|mesh-list
43874465|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
43874466|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43874467|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43874468|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
43874469|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
43874472|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
43874533|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874534|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
43874535|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43874536|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43874537|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874600|NCT01140516|Trimethoprim|trimethoprim|mesh-list
43874601|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43874602|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43874603|NCT01140516|Renal Agents|renal agents|mesh-ancestor
43874604|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
43874669|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874670|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44135561|NCT00161720|Protein C|protein c|mesh-list
44135562|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
44135563|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44135564|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44135565|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135566|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44135567|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
43838600|NCT04833582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838601|NCT04833582|Immunologic Factors|immunologic factors|mesh-ancestor
43772813|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43772814|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772815|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772816|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
43772817|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772818|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43772819|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
44135568|NCT00161733|Coagulants|coagulants|mesh-ancestor
44135569|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44135570|NCT00161759|Thrombin|thrombin|mesh-list
43874779|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43874781|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
43874782|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43874783|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874784|NCT04732364|Bupivacaine|bupivacaine|mesh-list
43874785|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
43874786|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
43874787|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43874843|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
43874844|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
43874845|NCT04731740|Lenvatinib|lenvatinib|mesh-list
43874846|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43874847|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874848|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43874849|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43874850|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135581|NCT00161902|Coagulants|coagulants|mesh-ancestor
44135582|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44135583|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
44135584|NCT00161915|Coagulants|coagulants|mesh-ancestor
44135585|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44135586|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
44135587|NCT00161980|Coagulants|coagulants|mesh-ancestor
44135588|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
43874935|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43874936|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43874937|NCT04730674|Tetracycline|tetracycline|mesh-list
43874938|NCT04730674|Lidocaine|lidocaine|mesh-list
43874939|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
43875006|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
43875007|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
43875008|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
43875009|NCT04729556|Coagulants|coagulants|mesh-ancestor
43875078|NCT04728750|Pancrelipase|pancrelipase|mesh-list
43875079|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875080|NCT04728516|Amoxicillin|amoxicillin|mesh-list
43875081|NCT04728516|Pantoprazole|pantoprazole|mesh-list
43875082|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875083|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875084|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43875085|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43875112|NCT04728659|Ganirelix|ganirelix|mesh-list
43875147|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875148|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
43875149|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43875151|NCT04729140|Doxycycline|doxycycline|mesh-list
43875192|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43669347|NCT02905058|Analgesics|analgesics|mesh-ancestor
43875194|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875199|NCT04727684|Menotropins|menotropins|mesh-list
43669358|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875262|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43875263|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43875264|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875265|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875266|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
43875267|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875268|NCT04726982|Acetazolamide|acetazolamide|mesh-list
43875269|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
43875328|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875329|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875330|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
43875331|NCT04726553|Antimalarials|antimalarials|mesh-list
43875396|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875397|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875399|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43875400|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875401|NCT04725682|Tacrolimus|tacrolimus|mesh-list
43875415|NCT04725448|Paclitaxel|paclitaxel|mesh-list
43875463|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43875464|NCT04725357|Analgesics|analgesics|mesh-ancestor
43875465|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
44135669|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
44135670|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135671|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44135672|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44135673|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44135674|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44135675|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43875564|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
43875565|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
43875566|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43875567|NCT04724148|Fentanyl|fentanyl|mesh-list
43875568|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43875569|NCT04724148|Narcotics|narcotics|mesh-ancestor
43875634|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875635|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875636|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44158244|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158245|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
44158246|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158247|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158248|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158249|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43875711|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875712|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43875713|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43875714|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43875715|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43875716|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875717|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43875774|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875776|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43875777|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43875778|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875779|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
43875780|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875781|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875782|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43875783|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
43875784|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875838|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43875839|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43875840|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
43875860|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43875861|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43875862|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43875863|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43875864|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43875865|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
43875866|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43875876|NCT04719104|Bilirubin|bilirubin|mesh-list
43875924|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43875996|NCT04717908|Clofazimine|clofazimine|mesh-list
43875997|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43875998|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43875999|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43876000|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876001|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876002|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43876003|NCT04717908|Renal Agents|renal agents|mesh-ancestor
43876004|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43876005|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
43876006|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
43772820|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
43876007|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43876008|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
43876009|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
43876010|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43876054|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876055|NCT04716894|Itraconazole|itraconazole|mesh-list
43876056|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
43876120|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
43876121|NCT04715620|Niraparib|niraparib|mesh-list
43876122|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43876123|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876124|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876125|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876126|NCT04715568|Losartan|losartan|mesh-list
43876127|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
43876128|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
43876129|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43876130|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43876131|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43876144|NCT04715269|Alprazolam|alprazolam|mesh-list
43876183|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
43876184|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43876185|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135773|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
44135774|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44135775|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44135776|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44135777|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135780|NCT00162487|Albuterol|albuterol|mesh-list
43876261|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43876262|NCT04714242|Growth Substances|growth substances|mesh-ancestor
43876263|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876264|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
43876332|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876333|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43876407|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876479|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
43876480|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
43876481|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43876482|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
43876484|NCT04712435|Expectorants|expectorants|mesh-ancestor
44135826|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135828|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
44135829|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44135830|NCT00162604|Cefuroxime|cefuroxime|mesh-list
44135831|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
43876546|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43876547|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876548|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43876549|NCT04711863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43876550|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43876551|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43876552|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876553|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876554|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
43876561|NCT04712058|Tenofovir|tenofovir|mesh-list
43876607|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876608|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876609|NCT04711265|Vaccines|vaccines|mesh-list
43876610|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
43876611|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43876612|NCT04711434|Antibodies|antibodies|mesh-list
43876613|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
43876674|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43876675|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876677|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
43876745|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43876746|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44135887|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44135888|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44135889|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44135890|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44135891|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
44135892|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
44135893|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
44135894|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
44135895|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44135896|NCT00162721|Cisplatin|cisplatin|mesh-list
44135897|NCT00162721|Doxorubicin|doxorubicin|mesh-list
43876793|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43876794|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43876795|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43876796|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43876797|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
43876799|NCT04709081|Digoxin|digoxin|mesh-list
43876800|NCT04709081|Midazolam|midazolam|mesh-list
43876801|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43876802|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43876810|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
43876858|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876859|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43876860|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43876861|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43876862|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43876863|NCT04708821|Analgesics|analgesics|mesh-ancestor
43876864|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
43876865|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43876866|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43876867|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43876868|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
43876869|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
43876922|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43876923|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
43876924|NCT04707742|Povidone|povidone|mesh-list
43876925|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
43876926|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
43876927|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43876928|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876929|NCT04707560|Heparin|heparin|mesh-list
43876930|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
43876934|NCT04707547|Nivolumab|nivolumab|mesh-list
43876987|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43876988|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43876989|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43876990|NCT04706806|Acetic Acid|acetic acid|mesh-list
43876991|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43876992|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43876993|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
43669682|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
43876996|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43877003|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43877004|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877005|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877006|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
43877007|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877008|NCT04706949|Carboplatin|carboplatin|mesh-list
43877009|NCT04706949|Pemetrexed|pemetrexed|mesh-list
43877010|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877011|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43877068|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43877069|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43877070|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43877071|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877072|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43877073|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877074|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877077|NCT04705948|Analgesics|analgesics|mesh-ancestor
43877078|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
43877079|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877080|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877081|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43877082|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43877125|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877126|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
43877198|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877199|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43877201|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
43877202|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877203|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43877204|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877205|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877206|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877265|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
43877266|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877267|NCT04704245|Emollients|emollients|mesh-ancestor
43877268|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
44135949|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44135950|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
44135951|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44135952|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
44135953|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44135954|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44135955|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44135956|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43877297|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43877298|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43877299|NCT04703608|Ivermectin|ivermectin|mesh-list
43877300|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43877301|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43877302|NCT04702906|Trimetazidine|trimetazidine|mesh-list
43877303|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877304|NCT04703127|Lidocaine|lidocaine|mesh-list
43877305|NCT04703127|Tadalafil|tadalafil|mesh-list
43877351|NCT04702698|Peposertib|peposertib|mesh-list
43877364|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877365|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43877366|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877436|NCT04701320|Methamphetamine|methamphetamine|mesh-list
43877437|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43877438|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877439|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
43877440|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
43877441|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877442|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
43877443|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43877462|NCT04700670|Coagulants|coagulants|mesh-ancestor
43877463|NCT04700592|Ketamine|ketamine|mesh-list
43877464|NCT04700592|Gabapentin|gabapentin|mesh-list
43877465|NCT04700592|Analgesics|analgesics|mesh-ancestor
43877466|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
43877467|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877534|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
43877535|NCT04700046|Mexiletine|mexiletine|mesh-list
43877607|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877608|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43877609|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43877610|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
43877611|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43877612|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43877636|NCT04698772|Ketamine|ketamine|mesh-list
43877663|NCT04698213|Axitinib|axitinib|mesh-list
43877664|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43877665|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43877669|NCT04698317|Mitogens|mitogens|mesh-list
43877733|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
43877734|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43877735|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43877736|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43877737|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
43877739|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43877870|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43877871|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
43877872|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43877873|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43877874|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43877875|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43877876|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43877934|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
43877935|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
43878007|NCT04693312|Hormones|hormones|mesh-ancestor
43878008|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878009|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43878010|NCT04693312|Protective Agents|protective agents|mesh-ancestor
43878011|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43878012|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136032|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44136033|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43878055|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878056|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
43878057|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43878058|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43878123|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878124|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878125|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43878126|NCT04690920|Remdesivir|remdesivir|mesh-list
43878127|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878128|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136050|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136051|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
44136052|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136053|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43878220|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878222|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
43878223|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878224|NCT04689412|Protective Agents|protective agents|mesh-ancestor
43878225|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878226|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878227|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43878228|NCT04689191|Vaccines|vaccines|mesh-list
43878229|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
43878230|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878231|NCT04689100|Leucovorin|leucovorin|mesh-list
43878232|NCT04689100|Fluorouracil|fluorouracil|mesh-list
43878285|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878287|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878288|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878289|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44136097|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136098|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44136100|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
44136101|NCT00163345|Hormones|hormones|mesh-ancestor
44136103|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878349|NCT04687878|Insulin|insulin|mesh-list
43878350|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43878351|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43878352|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878353|NCT04687566|Memantine|memantine|mesh-list
43878420|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878421|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878422|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878443|NCT04686643|Niacin|niacin|mesh-list
43878492|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43878493|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878494|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878496|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43878497|NCT04685642|Aspirin|aspirin|mesh-list
43878498|NCT04685642|Atorvastatin|atorvastatin|mesh-list
44136207|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878575|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669931|NCT02900417|Incretins|incretins|mesh-ancestor
43878578|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878645|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878646|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43878647|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43878648|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43878649|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
43878650|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43878651|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43878652|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43878653|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155794|NCT00228267|Propofol|propofol|mesh-list
43878701|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878702|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43878703|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
43878704|NCT04681937|Hormones|hormones|mesh-ancestor
43878705|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43878706|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43878707|NCT04681937|Protective Agents|protective agents|mesh-ancestor
43878708|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43878709|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878710|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43878711|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
43878712|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
43878765|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
43878766|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43878767|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43878768|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
43878769|NCT04681911|Antiviral Agents|antiviral agents|mesh-ancestor
43878770|NCT04681911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43878771|NCT04681911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878772|NCT04681911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43878773|NCT04681911|Immunologic Factors|immunologic factors|mesh-ancestor
43878774|NCT04681911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878775|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
43878776|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43878777|NCT04682041|Antibodies|antibodies|mesh-list
43878778|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
43878779|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878780|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
43878823|NCT04680650|Propofol|propofol|mesh-list
43878824|NCT04680650|Sevoflurane|sevoflurane|mesh-list
43878825|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878826|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878827|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878828|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878829|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
43878830|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43878862|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43878863|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43878864|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43878865|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43878866|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43878867|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43878868|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43878869|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
43878870|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
43878871|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
43878872|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
43878928|NCT04679506|Cladribine|cladribine|mesh-list
43878929|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43878930|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43878931|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43878932|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43878933|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43878936|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
43879059|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879060|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44136237|NCT00163969|Ketamine|ketamine|mesh-list
43879115|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879116|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879117|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
43879118|NCT04676776|Mifepristone|mifepristone|mesh-list
43879183|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43879185|NCT04676035|Coagulants|coagulants|mesh-ancestor
43879186|NCT04676035|Vitamins|vitamins|mesh-ancestor
43879187|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
43879254|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
43879255|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879256|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43879257|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43879258|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43879259|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
43879260|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43879261|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879262|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43879263|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43879264|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43879318|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
43879319|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
43879331|NCT04674137|Histamine|histamine|mesh-list
43879391|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
43879392|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879393|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879394|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
43879395|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879396|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879397|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43879398|NCT04672759|Durvalumab|durvalumab|mesh-list
43879434|NCT04671563|Tenofovir|tenofovir|mesh-list
43879435|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
43879436|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879437|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43879438|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43879504|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43879505|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43879506|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879507|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43879508|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879510|NCT04670497|Racepinephrine|racepinephrine|mesh-list
44136284|NCT00164112|Levofloxacin|levofloxacin|mesh-list
44136285|NCT00164112|Ofloxacin|ofloxacin|mesh-list
44136286|NCT00164112|Telithromycin|telithromycin|mesh-list
44136287|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136288|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136289|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44136290|NCT00164112|Renal Agents|renal agents|mesh-ancestor
44136291|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136292|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136293|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136295|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136351|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44136352|NCT00164359|Artesunate|artesunate|mesh-list
44136353|NCT00164359|Amodiaquine|amodiaquine|mesh-list
43879567|NCT04668976|Gemcitabine|gemcitabine|mesh-list
43879568|NCT04668976|Fluorouracil|fluorouracil|mesh-list
43879569|NCT04668976|Floxuridine|floxuridine|mesh-list
43879570|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
43879571|NCT04668976|Irinotecan|irinotecan|mesh-list
43879572|NCT04668976|Cetuximab|cetuximab|mesh-list
43879573|NCT04668976|Panitumumab|panitumumab|mesh-list
43879574|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43879575|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
43879576|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879629|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43879630|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879631|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879632|NCT04668469|Acetaminophen|acetaminophen|mesh-list
43879704|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43879705|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879706|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43879707|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43879708|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43879709|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43879710|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43879711|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879712|NCT04667299|Antacids|antacids|mesh-ancestor
43879713|NCT04667299|Diuretics|diuretics|mesh-ancestor
44136379|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136380|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136381|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136382|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44136383|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136384|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
44136385|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136386|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44136387|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44136388|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136389|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
44136390|NCT00164463|Isoniazid|isoniazid|mesh-list
44136391|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136392|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136393|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136394|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136395|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136396|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136397|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136398|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136399|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44136400|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44136401|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
44136402|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44155819|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155820|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43879748|NCT04666324|Simethicone|simethicone|mesh-list
43879749|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
43879750|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879751|NCT04666324|Emollients|emollients|mesh-ancestor
43879752|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
43879753|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
43879754|NCT04666168|Fludarabine|fludarabine|mesh-list
43879755|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43879761|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879763|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43879764|NCT04665895|Fluticasone|fluticasone|mesh-list
43879766|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43879767|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43879768|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
43879769|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43879771|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43879828|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879829|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879830|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43879831|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43879832|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
43879833|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879835|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43879836|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43879895|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
43879896|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
43879897|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
43826971|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
43879898|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879899|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43879900|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
43879901|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43879902|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
43879903|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155854|NCT00228475|Budesonide|budesonide|mesh-list
43879988|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43879989|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43879990|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43879991|NCT04662476|Vitamin D|vitamin d|mesh-list
43879992|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
43879993|NCT04662476|Vitamins|vitamins|mesh-ancestor
43879994|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
43879995|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43879996|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43879998|NCT04662658|Xenon|xenon|mesh-list
43880053|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43880054|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43880055|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
43880056|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880057|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
43880058|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880059|NCT04662242|Selenium|selenium|mesh-list
43880060|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
43880062|NCT04662242|Protective Agents|protective agents|mesh-ancestor
43880122|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
43880123|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
43880124|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
43880125|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880126|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
43880128|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880129|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880130|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880131|NCT04661475|Analgesics|analgesics|mesh-ancestor
43880132|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
43880133|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880134|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880171|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880172|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
43880173|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880175|NCT04660461|Lansoprazole|lansoprazole|mesh-list
43880243|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43880244|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43880314|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880315|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880383|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880384|NCT04657939|Incretins|incretins|mesh-ancestor
43880385|NCT04657939|Hormones|hormones|mesh-ancestor
43880456|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880457|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880507|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
43880510|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43880576|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880649|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880711|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
43880712|NCT04652739|Hormones|hormones|mesh-ancestor
43880783|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880857|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880858|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43880859|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43880860|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880880|NCT04649892|Naltrexone|naltrexone|mesh-list
43880881|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43880882|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43880883|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880949|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
43880950|NCT04648358|Hormones|hormones|mesh-ancestor
43880951|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880952|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880953|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880954|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
43880955|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
43880956|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880957|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
43880958|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
44155990|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155991|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44155992|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
44155993|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
44155994|NCT00229138|Tacrolimus|tacrolimus|mesh-list
44155995|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155996|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
44155997|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155998|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43881049|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
43881050|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881051|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
43881052|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881053|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
43881054|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881055|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43881115|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
43881116|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881118|NCT04646694|Ketamine|ketamine|mesh-list
43881185|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881187|NCT04645745|Inositol|inositol|mesh-list
43881188|NCT04645745|Hematinics|hematinics|mesh-ancestor
43881189|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
43881190|NCT04645745|Vitamins|vitamins|mesh-ancestor
43881231|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881232|NCT04644094|Dexamethasone|dexamethasone|mesh-list
43881233|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881234|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
43881235|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
43881236|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881237|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881238|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881239|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
43881240|NCT04644094|Hormones|hormones|mesh-ancestor
43881297|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881298|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881299|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43881360|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
43881361|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881362|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43881363|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
43881433|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881434|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881435|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43881436|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43881437|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
43881476|NCT04639271|Trastuzumab|trastuzumab|mesh-list
43881477|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43881478|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881547|NCT04638439|Entecavir|entecavir|mesh-list
43881548|NCT04638439|Nivolumab|nivolumab|mesh-list
43881549|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881550|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881551|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43881552|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881553|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
43881575|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881576|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
43881577|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881578|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
43881579|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881580|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43881581|NCT04637204|Axitinib|axitinib|mesh-list
43881582|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881583|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881642|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881643|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881644|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
43881645|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881647|NCT04635176|Epinephrine|epinephrine|mesh-list
43881648|NCT04635176|Bupivacaine|bupivacaine|mesh-list
43881711|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
43881712|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43881713|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881714|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43881715|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881716|NCT04634721|Bupivacaine|bupivacaine|mesh-list
44156160|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44156161|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44156162|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156164|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156165|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44156166|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156167|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156168|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44156169|NCT00229775|Renal Agents|renal agents|mesh-ancestor
44158283|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
43881776|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43881777|NCT04632693|Ascorbic Acid|ascorbic acid|mesh-list
43881778|NCT04632693|Vitamins|vitamins|mesh-ancestor
43881779|NCT04632693|Micronutrients|micronutrients|mesh-ancestor
43881780|NCT04632693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881784|NCT04632758|Crizotinib|crizotinib|mesh-list
44156177|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156178|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156179|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156180|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
44156181|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156182|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156183|NCT00229944|Azithromycin|azithromycin|mesh-list
44156184|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156185|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156186|NCT00229996|Leuprolide|leuprolide|mesh-list
44156187|NCT00229996|Norethindrone|norethindrone|mesh-list
44156188|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
44156189|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
44156190|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
44156191|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44156192|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
44156193|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44156194|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156195|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44156196|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156197|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44156198|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44156199|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44156200|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44156201|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
44156202|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
44156203|NCT00230035|Rituximab|rituximab|mesh-list
43881841|NCT04631315|Prednisolone|prednisolone|mesh-list
43881842|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43881843|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
43881844|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43881845|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
43881846|NCT04631315|Phenylephrine|phenylephrine|mesh-list
43881847|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
43881848|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43881851|NCT04631315|Difluprednate|difluprednate|mesh-list
43881854|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
43881856|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881857|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881858|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881859|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881860|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
43881861|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
43881862|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881863|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881864|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43881865|NCT04631315|Protective Agents|protective agents|mesh-ancestor
43881866|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43881867|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
43881868|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
43881869|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43881870|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
43881871|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
43881872|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43881873|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881874|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881875|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881876|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881905|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43881906|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881907|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881908|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881909|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43881910|NCT04630444|Protective Agents|protective agents|mesh-ancestor
43881911|NCT04630548|Copper|copper|mesh-list
43881912|NCT04630548|Trace Elements|trace elements|mesh-ancestor
43881972|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43881973|NCT04628559|Analgesics|analgesics|mesh-ancestor
43881974|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
43881975|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881976|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43881977|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881978|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881979|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881980|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881981|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881982|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43881983|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43881984|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
43881985|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
43881986|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43881987|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43882027|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882028|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882029|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882030|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882031|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
43882032|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
43882033|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882034|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
43882035|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43882094|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43882095|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43882096|NCT04627363|Growth Substances|growth substances|mesh-ancestor
43882097|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882162|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
43882163|NCT04626726|Fludarabine|fludarabine|mesh-list
43882223|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882224|NCT04625985|Metformin|metformin|mesh-list
43882225|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882226|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882295|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882297|NCT04624360|Dexamethasone|dexamethasone|mesh-list
43882298|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882299|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
43882300|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
43882301|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882346|NCT04623840|Urological Agents|urological agents|mesh-ancestor
43882347|NCT04623086|Insulin|insulin|mesh-list
43882352|NCT04623385|Tretinoin|tretinoin|mesh-list
43882419|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
43882420|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43882421|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882422|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43882423|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
43882424|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882425|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882426|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882427|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882428|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43882429|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882430|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
43882431|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882432|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43882433|NCT04622891|Azithromycin|azithromycin|mesh-list
43882477|NCT04622202|Pregabalin|pregabalin|mesh-list
43882478|NCT04622202|Analgesics|analgesics|mesh-ancestor
43882479|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
43882480|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882552|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43882553|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882554|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882557|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44156242|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44156243|NCT00230035|Protective Agents|protective agents|mesh-ancestor
44156244|NCT00230204|Antibodies|antibodies|mesh-list
44156245|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
44156246|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156247|NCT00230217|Rasburicase|rasburicase|mesh-list
44156248|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
43882674|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
43882675|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43882676|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43882677|NCT04620967|Insulin|insulin|mesh-list
43882678|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43882679|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
43882680|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
43882681|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43882743|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882744|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882745|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43882746|NCT04619758|Emollients|emollients|mesh-list
43882814|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882815|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43882816|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
44156296|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156297|NCT00230464|Vildagliptin|vildagliptin|mesh-list
44156298|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156299|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156300|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43882880|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
43882881|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
43882882|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882955|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882956|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43882957|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
43882958|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43882959|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43882960|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882961|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43882962|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
43882963|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43882964|NCT04617795|Insulin|insulin|mesh-list
43882965|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883022|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883093|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43883095|NCT04615702|Secretin|secretin|mesh-list
43883096|NCT04615702|Bilirubin|bilirubin|mesh-list
43883097|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883098|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883099|NCT04615702|Analgesics|analgesics|mesh-ancestor
43883162|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883163|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
43883164|NCT04614727|Protective Agents|protective agents|mesh-ancestor
43883165|NCT04614584|Mirtazapine|mirtazapine|mesh-list
43883166|NCT04614584|Methamphetamine|methamphetamine|mesh-list
43883167|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
43883168|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883169|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43883170|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
43883171|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
43883172|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883225|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883226|NCT04613700|Hormones|hormones|mesh-ancestor
43883227|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883228|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883296|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883297|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43883298|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43883299|NCT04613284|Growth Substances|growth substances|mesh-ancestor
43883300|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883301|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44156330|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156390|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44156391|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156392|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156393|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156394|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43883302|NCT04612998|Atropine|atropine|mesh-list
43883303|NCT04612998|Ephedrine|ephedrine|mesh-list
43883304|NCT04612998|Metoclopramide|metoclopramide|mesh-list
43883360|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
43883361|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883362|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883363|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883433|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883435|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
43883436|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883437|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43883438|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
43883439|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
43883440|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
43883441|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43883442|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883443|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883499|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
43883500|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
43883501|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
43883502|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43883503|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883564|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
43883565|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883566|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
43883567|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
43883568|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883571|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
43883634|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43883636|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883637|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883638|NCT04609176|Apatinib|apatinib|mesh-list
43883639|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883640|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43883641|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883642|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883643|NCT04608734|Midazolam|midazolam|mesh-list
43883644|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43883645|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43883646|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883647|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883648|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43883691|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883692|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43883693|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883694|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883695|NCT04608669|Acetaminophen|acetaminophen|mesh-list
43883696|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883697|NCT04608669|Analgesics|analgesics|mesh-ancestor
43883698|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
43883699|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883700|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883716|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883717|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883719|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883720|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43883721|NCT04608006|Narcotics|narcotics|mesh-ancestor
43883722|NCT04608006|Analgesics|analgesics|mesh-ancestor
43883723|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43883724|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43883726|NCT04607733|Mirikizumab|mirikizumab|mesh-list
43883782|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883783|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43883784|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43883785|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883786|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
43883787|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43883788|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883789|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883844|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43883845|NCT04606212|Losartan|losartan|mesh-list
43883846|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883847|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883848|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43883849|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43883850|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883851|NCT04606225|Losartan|losartan|mesh-list
43883852|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883907|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
43883908|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156440|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156441|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772850|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156442|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156443|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44156444|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
44156445|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156446|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
43883947|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883948|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43883949|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43883950|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883951|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883952|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43883953|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
43883954|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883955|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883957|NCT04604509|Bupropion|bupropion|mesh-list
43884009|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
43884010|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884011|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
43884012|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
43884013|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884014|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884015|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884016|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
43884017|NCT04603729|Hormones|hormones|mesh-ancestor
43884018|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884075|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884076|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884077|NCT04603131|Vaccines|vaccines|mesh-list
43884078|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
43884079|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884080|NCT04603066|Ondansetron|ondansetron|mesh-list
43884081|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
43884082|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
43884083|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884084|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884126|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884127|NCT04602247|Fesoterodine|fesoterodine|mesh-list
43884128|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43884129|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43884130|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
43884131|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884132|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884133|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884134|NCT04602247|Urological Agents|urological agents|mesh-ancestor
43884135|NCT04602143|Testosterone|testosterone|mesh-list
43884136|NCT04602143|Androgens|androgens|mesh-ancestor
43884138|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884189|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884190|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
43884192|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884194|NCT04601675|Dexamethasone|dexamethasone|mesh-list
43884261|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884262|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884263|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884264|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884265|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43884266|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884267|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884327|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43884329|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884330|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884331|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
43884332|NCT04600414|Narcotics|narcotics|mesh-ancestor
43884333|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884334|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884335|NCT04600414|Analgesics|analgesics|mesh-ancestor
43772862|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
43884336|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
43884337|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884338|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
43884339|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156496|NCT00231218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156497|NCT00231218|Protective Agents|protective agents|mesh-ancestor
44156498|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156499|NCT00231244|Sirolimus|sirolimus|mesh-list
44156500|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156501|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156502|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156503|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884406|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43884407|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884408|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
43884409|NCT04598542|Hormones|hormones|mesh-ancestor
43884410|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884411|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884412|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884413|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
43884470|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884471|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
43884472|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43884502|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884503|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884504|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43884505|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43884506|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43884507|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43884508|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
43884572|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
44156570|NCT00231517|Narcotics|narcotics|mesh-ancestor
44156571|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156573|NCT00231517|Analgesics|analgesics|mesh-ancestor
43884584|NCT04593706|Triamcinolone|triamcinolone|mesh-list
43884585|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43884586|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43884587|NCT04593706|Betamethasone|betamethasone|mesh-list
43884588|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
43884589|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43884590|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
43884591|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
43884653|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
43884654|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884655|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884656|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
43884725|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
43884726|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
43884796|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156584|NCT00231569|Mipomersen|mipomersen|mesh-list
43884802|NCT04592029|Bevacizumab|bevacizumab|mesh-list
44156636|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156637|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156638|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44156639|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44156640|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44156641|NCT00231764|Daclizumab|daclizumab|mesh-list
44156642|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884879|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43884880|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43884881|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884882|NCT04590612|Levodopa|levodopa|mesh-list
43884883|NCT04590612|Carbidopa|carbidopa|mesh-list
43884884|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43884885|NCT04590612|Citalopram|citalopram|mesh-list
43885020|NCT04589234|Folfirinox|folfirinox|mesh-list
43772863|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43772864|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772865|NCT02363127|Progesterone|progesterone|mesh-list
43689049|NCT02807194|Anesthetics|anesthetics|mesh-list
43885021|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44156685|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156686|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156687|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156688|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156689|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
44156690|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44156691|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156692|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885095|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885168|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885169|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885170|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885171|NCT04587505|Morphine|morphine|mesh-list
43885241|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43885242|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
44156728|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156729|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
44156730|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156731|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
44156732|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156733|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156734|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156735|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44156736|NCT00232076|Cyclosporine|cyclosporine|mesh-list
43885323|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885324|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885326|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885391|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43885392|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43885393|NCT04584580|Heparin|heparin|mesh-list
43885394|NCT04584580|Enoxaparin|enoxaparin|mesh-list
43885395|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43885396|NCT04584580|Tinzaparin|tinzaparin|mesh-list
43885397|NCT04584580|Dalteparin|dalteparin|mesh-list
43885398|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
43885399|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43885400|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43885401|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885402|NCT04584710|Dactolisib|dactolisib|mesh-list
43885403|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885404|NCT04584671|Xenon|xenon|mesh-list
43885405|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43885406|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
43885407|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
43885410|NCT04584736|Ezetimibe|ezetimibe|mesh-list
43885449|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885450|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43885451|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885452|NCT04583410|Nicotine|nicotine|mesh-list
43885453|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43885454|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
43885457|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43885492|NCT04583137|Lidocaine|lidocaine|mesh-list
43885493|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
43885494|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
43885495|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885496|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885497|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
43885498|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885557|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43885558|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156801|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
44156802|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44156803|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44156804|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156805|NCT00232284|Sertraline|sertraline|mesh-list
43885623|NCT04580355|Amoxicillin|amoxicillin|mesh-list
43885624|NCT04580355|Metronidazole|metronidazole|mesh-list
43885686|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
43689075|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
43885687|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885688|NCT04579133|Durvalumab|durvalumab|mesh-list
43885689|NCT04579133|Olaparib|olaparib|mesh-list
43885690|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43885691|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885692|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43885693|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885694|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885695|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
43885696|NCT04578847|Dasatinib|dasatinib|mesh-list
43885697|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156814|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156815|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44156816|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156817|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156818|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156819|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156820|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156821|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156822|NCT00232349|Galantamine|galantamine|mesh-list
44156823|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43885782|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885783|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43885784|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43885785|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
43885786|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
43885787|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43885788|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43670567|NCT02894645|Hormones|hormones|mesh-ancestor
43885921|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885922|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885923|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43885924|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670577|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43885925|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885926|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43885927|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43885928|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43670585|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885983|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885985|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43885986|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885987|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885988|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885990|NCT04574960|Cisplatin|cisplatin|mesh-list
43885991|NCT04574960|Carboplatin|carboplatin|mesh-list
43885992|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886012|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886013|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886014|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
43886015|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43886016|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43886017|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
43886018|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
43886080|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43886081|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578587|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886082|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886083|NCT04573049|Protective Agents|protective agents|mesh-ancestor
43886084|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886085|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
43886086|NCT04572698|Growth Substances|growth substances|mesh-ancestor
43886087|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886089|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
43886090|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886105|NCT04572724|Valsartan|valsartan|mesh-list
43886142|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43886143|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43886144|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43886208|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
43886209|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
43886210|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886211|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886212|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886213|NCT04571151|Halobetasol|halobetasol|mesh-list
43886214|NCT04571151|Calcipotriene|calcipotriene|mesh-list
43886275|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886276|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43886277|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43886278|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886279|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
43886280|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43886344|NCT04569916|Antibodies|antibodies|mesh-list
43886345|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
43886346|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886347|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43886348|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43886349|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886350|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886351|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156910|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156911|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44156912|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
44156913|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156914|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156915|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44156916|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
44156917|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
44156918|NCT00232674|Hormones|hormones|mesh-ancestor
44156920|NCT00232687|Aripiprazole|aripiprazole|mesh-list
44156938|NCT00232700|Citalopram|citalopram|mesh-list
43886486|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886487|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886488|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886489|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886490|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43886491|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43886492|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43886493|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
43886495|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
44156951|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156952|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156953|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156954|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
44156955|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156956|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
44156957|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156959|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44156960|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
44156963|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43886627|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886700|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886701|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43886702|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886718|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886719|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
43886794|NCT04561921|Analgesics|analgesics|mesh-ancestor
43886867|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886868|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
43886881|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43886882|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886954|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43887030|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43887032|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887033|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43887034|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
43887035|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
43887036|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
43887037|NCT04559165|Coagulants|coagulants|mesh-ancestor
43887038|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
43887039|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43887092|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887094|NCT04558268|Prednisone|prednisone|mesh-list
43887095|NCT04558268|Progesterone|progesterone|mesh-list
43887172|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887174|NCT04557137|Hormones|hormones|mesh-ancestor
43887175|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887176|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887177|NCT04557202|Tamsulosin|tamsulosin|mesh-list
43887178|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43887179|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43887237|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887239|NCT04556279|Diuretics|diuretics|mesh-ancestor
43887309|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887310|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887367|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43887368|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887369|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887370|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887371|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887372|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887373|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887375|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43887376|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43887377|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43887378|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157151|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157152|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44158487|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44158488|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44158489|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44158560|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158561|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158562|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158563|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158567|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
44158629|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44158630|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
44158631|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158632|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158633|NCT00237224|Letrozole|letrozole|mesh-list
44158634|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158635|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44158636|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44158637|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158638|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158639|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44158640|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
44158769|NCT00237575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158770|NCT00237575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44158771|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
44158772|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158773|NCT00237588|Losartan|losartan|mesh-list
44158774|NCT00237588|Amlodipine|amlodipine|mesh-list
44158775|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44158785|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
44158836|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158837|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158838|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158839|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158840|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158841|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158842|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158843|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
44158844|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
44158903|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158904|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
44158906|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
44158907|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158908|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158909|NCT00237913|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44158910|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158912|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158972|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158973|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158974|NCT00238082|Beclomethasone|beclomethasone|mesh-list
44158975|NCT00238082|Norflurane|norflurane|mesh-list
44158976|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158977|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
44158978|NCT00238082|Hormones|hormones|mesh-ancestor
44158983|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
44159042|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159043|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
44159044|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
44159045|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
44159046|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159047|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44159048|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159109|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159110|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159111|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44159112|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
44159113|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159114|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159177|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
44159178|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
44159179|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
44159180|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
44159181|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
44159182|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159183|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159184|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44159185|NCT00238368|Protective Agents|protective agents|mesh-ancestor
44159186|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44159244|NCT00238667|Dalteparin|dalteparin|mesh-list
44159245|NCT00238667|Dipyridamole|dipyridamole|mesh-list
44159246|NCT00238667|Warfarin|warfarin|mesh-list
44159247|NCT00238667|Anticoagulants|anticoagulants|mesh-list
44159248|NCT00238667|Clopidogrel|clopidogrel|mesh-list
44159249|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44159250|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44159251|NCT00238667|Analgesics|analgesics|mesh-ancestor
44159252|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
44159253|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159256|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159381|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159382|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159383|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159451|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
44159452|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159453|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159454|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159455|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44159456|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44159457|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44159458|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44159459|NCT00239109|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44159514|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159515|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159516|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44159517|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44159518|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159519|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159520|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159521|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159522|NCT00239291|Gefitinib|gefitinib|mesh-list
44159523|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159524|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159525|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159526|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159573|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44159574|NCT00239395|Analgesics|analgesics|mesh-ancestor
44159575|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
44159576|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159577|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159578|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159579|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159580|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44159581|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44159582|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159637|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159710|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159711|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159712|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159713|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159714|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44159715|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159716|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159773|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
44159774|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159775|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159776|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44159777|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159778|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159779|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
44159780|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159781|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159832|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44159833|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159834|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
44159835|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
44159836|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44159837|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
44159838|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159839|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159840|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159897|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159898|NCT00240058|Protective Agents|protective agents|mesh-ancestor
44159899|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159900|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159901|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44159902|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
44159904|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
44159965|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44159966|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159967|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159968|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159969|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159970|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
44159971|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159972|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44160028|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44160029|NCT00240448|Telmisartan|telmisartan|mesh-list
44160030|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160031|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160032|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160033|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160034|NCT00240448|Diuretics|diuretics|mesh-ancestor
44160035|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
44160036|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160037|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44160038|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160039|NCT00240474|Amlodipine|amlodipine|mesh-list
44160040|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44160041|NCT00240474|Telmisartan|telmisartan|mesh-list
44160042|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160049|NCT00240474|Diuretics|diuretics|mesh-ancestor
44160086|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160087|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160088|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44160089|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44160090|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44160091|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
44160092|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160093|NCT00240630|Naproxen|naproxen|mesh-list
44160094|NCT00240630|Sumatriptan|sumatriptan|mesh-list
44160095|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160148|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160149|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44160150|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
44160151|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160152|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
44160153|NCT00240708|Risperidone|risperidone|mesh-list
44160219|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160220|NCT00240812|Analgesics|analgesics|mesh-ancestor
44160221|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
44160222|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160223|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160240|NCT00240825|Ibuprofen|ibuprofen|mesh-list
44160289|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160290|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44160291|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160293|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160355|NCT00241124|Valsartan|valsartan|mesh-list
44160356|NCT00241124|Lisinopril|lisinopril|mesh-list
44160357|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160358|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160359|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160360|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160361|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44160422|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
44160423|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44160424|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
44160425|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160426|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
44160427|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160428|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160429|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44160430|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
44160487|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160488|NCT00241449|Tamoxifen|tamoxifen|mesh-list
44160489|NCT00241449|Fulvestrant|fulvestrant|mesh-list
44160490|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44160491|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
43772901|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160492|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160493|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160554|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
44160555|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160556|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
44160557|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160558|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44160559|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44160560|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160561|NCT00241722|Alvimopan|alvimopan|mesh-list
44160562|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160563|NCT00241982|Prednisolone|prednisolone|mesh-list
44160619|NCT00242346|Candesartan|candesartan|mesh-list
44160620|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
44160621|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160623|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160691|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44160692|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160693|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160695|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160758|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160759|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160760|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160761|NCT00242814|Amlodipine|amlodipine|mesh-list
44160762|NCT00242814|Telmisartan|telmisartan|mesh-list
44160763|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160764|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44160765|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160766|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160767|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44160768|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160769|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
44160770|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160771|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160772|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
44160815|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44160817|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
43600651|NCT04239040|Vaccines|vaccines|mesh-list
44160818|NCT00242996|Carmustine|carmustine|mesh-list
44160819|NCT00242996|Rituximab|rituximab|mesh-list
44160820|NCT00242996|Etoposide|etoposide|mesh-list
44160821|NCT00242996|Sargramostim|sargramostim|mesh-list
44160822|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160823|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
44160824|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160858|NCT00243035|Bortezomib|bortezomib|mesh-list
44160880|NCT00243178|Clopidogrel|clopidogrel|mesh-list
44160953|NCT00243711|Protective Agents|protective agents|mesh-ancestor
44160954|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160955|NCT00243711|Laxatives|laxatives|mesh-ancestor
44160956|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160957|NCT00243724|Esomeprazole|esomeprazole|mesh-list
44160958|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160959|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160960|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160961|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160963|NCT00243737|Artesunate|artesunate|mesh-list
44161020|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
44161096|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44161097|NCT00244153|Narcotics|narcotics|mesh-ancestor
44161098|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161099|NCT00244153|Analgesics|analgesics|mesh-ancestor
44161100|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
44161101|NCT00244166|Prednisolone|prednisolone|mesh-list
44161102|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161103|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
44161104|NCT00244166|Hormones|hormones|mesh-ancestor
44161105|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161234|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161235|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772924|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43772925|NCT02362308|Diuretics|diuretics|mesh-ancestor
44161236|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44161237|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
44161249|NCT00244556|Analgesics|analgesics|mesh-ancestor
44161306|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
44161379|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161380|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161381|NCT00245089|Dactinomycin|dactinomycin|mesh-list
44161382|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
44161383|NCT00245089|Vincristine|vincristine|mesh-list
44161384|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161385|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
44161386|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161387|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161388|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161389|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
44161390|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161391|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161392|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44161393|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161394|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161395|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161396|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44161397|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161398|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161399|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44161400|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44161404|NCT00245115|Busulfan|busulfan|mesh-list
44161429|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
44161430|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161431|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161432|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44161433|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44161434|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161435|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44161436|NCT00245154|Paclitaxel|paclitaxel|mesh-list
44161437|NCT00245154|Carboplatin|carboplatin|mesh-list
44161438|NCT00245154|Cediranib|cediranib|mesh-list
44161495|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161571|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161572|NCT00245661|Temazepam|temazepam|mesh-list
44161573|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44161574|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161575|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161576|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44161577|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161638|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44161639|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44161712|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44161713|NCT00246168|Narcotics|narcotics|mesh-ancestor
44161714|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161715|NCT00246194|Risperidone|risperidone|mesh-list
44161716|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44161717|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
44161779|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44161780|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
44161781|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161782|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161783|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161784|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161785|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161786|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161845|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44161846|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
44161847|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161848|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44161849|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161850|NCT00246636|Fenofibrate|fenofibrate|mesh-list
44161851|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43634513|NCT05627271|Ofatumumab|ofatumumab|mesh-list
44161852|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
44161853|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161854|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44161856|NCT00246675|Diuretics|diuretics|mesh-ancestor
44161857|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
44161858|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161859|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44161860|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161904|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161905|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162051|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44162052|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162053|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162054|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44162055|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
44162056|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
44162118|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162119|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
44162120|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162121|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162122|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44162123|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162124|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162126|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162127|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44162128|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162129|NCT00248144|Famciclovir|famciclovir|mesh-list
44162130|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
44162135|NCT00248157|Octreotide|octreotide|mesh-list
44162176|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162177|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
44162178|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162179|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162180|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162181|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162182|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162183|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162184|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
44162186|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44162187|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162189|NCT00248313|Sirolimus|sirolimus|mesh-list
44162243|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44162244|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162245|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162246|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162247|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44162248|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162249|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
44162250|NCT00248716|Hematinics|hematinics|mesh-ancestor
44162310|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162311|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
44162312|NCT00249132|Risperidone|risperidone|mesh-list
44162313|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162314|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
44162315|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162316|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162317|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162318|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162319|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162320|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162372|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162375|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44162376|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652216|NCT03001193|Oxytocin|oxytocin|mesh-list
43652217|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
43652218|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652219|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634525|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162377|NCT00249210|Renal Agents|renal agents|mesh-ancestor
44162378|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162440|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162441|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
44162442|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162443|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162444|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162445|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162446|NCT00249431|Sertraline|sertraline|mesh-list
44162447|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162448|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162502|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
44162503|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162575|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162576|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162577|NCT00249899|Atorvastatin|atorvastatin|mesh-list
44162578|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44162579|NCT00249899|Simvastatin|simvastatin|mesh-list
44162580|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44162581|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44162582|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44162583|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
44162584|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162585|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44162586|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162587|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44162588|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44162589|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44162590|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
44162591|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162592|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44162593|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44162594|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162595|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44162596|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44162597|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44162598|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
44162599|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162600|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44162601|NCT00249964|Paclitaxel|paclitaxel|mesh-list
44162602|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44162603|NCT00249964|Carboplatin|carboplatin|mesh-list
44162604|NCT00249964|Temozolomide|temozolomide|mesh-list
44162605|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162606|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162607|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
44162608|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
44173269|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173271|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44173272|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
44173273|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173274|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162609|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162610|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162611|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44162612|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
44162614|NCT00249977|Capecitabine|capecitabine|mesh-list
44162615|NCT00249977|Irinotecan|irinotecan|mesh-list
44162616|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162617|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44162618|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
44162619|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162620|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44162621|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162622|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162670|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
44162671|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44162672|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162673|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162674|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162675|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162676|NCT00250237|Haloperidol|haloperidol|mesh-list
44162677|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
44162678|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
44162679|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
44162680|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162681|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162682|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162683|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162684|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162685|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162686|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162687|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162688|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
44162689|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162690|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162691|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44162692|NCT00250315|Dobutamine|dobutamine|mesh-list
44162720|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162721|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162722|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162723|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162724|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162725|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162726|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162727|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162728|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
44162729|NCT00250393|Istradefylline|istradefylline|mesh-list
44162730|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44162731|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44162732|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44162733|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
44162734|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162735|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162736|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162737|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44162739|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44162740|NCT00250536|Androgens|androgens|mesh-ancestor
44162741|NCT00250536|Hormones|hormones|mesh-ancestor
44162772|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
44162773|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44162774|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
44162775|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
44162776|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162777|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162778|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44162779|NCT00250692|Analgesics|analgesics|mesh-ancestor
44162780|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
44162781|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162839|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162840|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162841|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162842|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44162843|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44162844|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162871|NCT00251017|Vancomycin|vancomycin|mesh-list
44162908|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162909|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162910|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44162911|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162912|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162913|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162914|NCT00251186|Capecitabine|capecitabine|mesh-list
44162915|NCT00251186|Cetuximab|cetuximab|mesh-list
44162916|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44162917|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
44162918|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162919|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162920|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162921|NCT00251277|Rituximab|rituximab|mesh-list
44162922|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162923|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162924|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
44162925|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162926|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162927|NCT00251355|Gemcitabine|gemcitabine|mesh-list
44162928|NCT00251355|Fluorouracil|fluorouracil|mesh-list
44162929|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44162930|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
44162932|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162957|NCT00251459|Ranibizumab|ranibizumab|mesh-list
44162964|NCT00251472|Paclitaxel|paclitaxel|mesh-list
44163032|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163034|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44163035|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163036|NCT00251706|Amiodarone|amiodarone|mesh-list
44163037|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44163038|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163039|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44163050|NCT00251732|Nortriptyline|nortriptyline|mesh-list
44163095|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163096|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
44163097|NCT00251888|Cisplatin|cisplatin|mesh-list
44163098|NCT00251888|Irinotecan|irinotecan|mesh-list
44163099|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163100|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44163101|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163102|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163103|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163104|NCT00251901|Esomeprazole|esomeprazole|mesh-list
44163157|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44163158|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
44163159|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163160|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163161|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163162|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163163|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163164|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44163165|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44163166|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44163167|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163168|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163169|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163170|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163171|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163172|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
44163173|NCT00252291|Miotics|miotics|mesh-ancestor
44163174|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
44163175|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163176|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163177|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163178|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44163179|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
44163207|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163208|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163209|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163210|NCT00252356|Amibegron|amibegron|mesh-list
44163211|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163212|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163213|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163214|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163215|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163269|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
44163270|NCT00252668|Etanercept|etanercept|mesh-list
44163271|NCT00252668|Methotrexate|methotrexate|mesh-list
44163272|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44163273|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
44163274|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44163275|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163276|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44163277|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
44163278|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163279|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163280|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163281|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163282|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44163283|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163284|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
44163285|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44163286|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44163287|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44163288|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44163289|NCT00252668|Analgesics|analgesics|mesh-ancestor
44163290|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
44163291|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163292|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163293|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163294|NCT00252707|Docetaxel|docetaxel|mesh-list
44163295|NCT00252707|Gefitinib|gefitinib|mesh-list
44163296|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163315|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163317|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163386|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163387|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163388|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163389|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163390|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163391|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
44163392|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44163393|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44163394|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
44163395|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44163396|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44163397|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44163398|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163399|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163400|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44163401|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44163403|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
43603423|NCT03246399|Lorecivivint|lorecivivint|mesh-list
44163404|NCT00252889|Doxorubicin|doxorubicin|mesh-list
44163405|NCT00252889|Topotecan|topotecan|mesh-list
44163406|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
44163407|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44163408|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163409|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44163410|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163411|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163412|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163413|NCT00252928|Troclosene|troclosene|mesh-list
44163414|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
44163415|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163430|NCT00253110|Haloperidol|haloperidol|mesh-list
44163431|NCT00253110|Risperidone|risperidone|mesh-list
44163432|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
44163433|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163434|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
44163501|NCT00253188|Galantamine|galantamine|mesh-list
44163502|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44163503|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163504|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163505|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163506|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163507|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163508|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163509|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
44163510|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163511|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
44163512|NCT00253201|Galantamine|galantamine|mesh-list
44163513|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44163514|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163515|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163516|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163517|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163518|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163519|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163520|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
44163554|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44163555|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163556|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163558|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44163559|NCT00253305|Terbinafine|terbinafine|mesh-list
44163561|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
44163562|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163563|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163564|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163565|NCT00253318|Dexamethasone|dexamethasone|mesh-list
44163566|NCT00253318|Docetaxel|docetaxel|mesh-list
44163567|NCT00253318|Everolimus|everolimus|mesh-list
44163569|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
44163616|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163617|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44163618|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44163619|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163620|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163621|NCT00253461|Topotecan|topotecan|mesh-list
44163622|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44163623|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44163624|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163625|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163682|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163683|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163684|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44163685|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163686|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44163687|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44163688|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44163689|NCT00253552|Cyclosporine|cyclosporine|mesh-list
44163690|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
44163691|NCT00253552|Busulfan|busulfan|mesh-list
44163692|NCT00253552|Methotrexate|methotrexate|mesh-list
44163693|NCT00253552|Etoposide|etoposide|mesh-list
44163694|NCT00253552|Cyclosporins|cyclosporins|mesh-list
44163695|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163696|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
44163697|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652234|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603723|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603724|NCT03243604|Hormones|hormones|mesh-list
43603725|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163729|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163730|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163731|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163732|NCT00253591|Cisplatin|cisplatin|mesh-list
44163733|NCT00253591|Vinorelbine|vinorelbine|mesh-list
44163734|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163735|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44163736|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
44163737|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
44163738|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163739|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163795|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163796|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44163797|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163798|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44163799|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
44163800|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44163801|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44163802|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44163803|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163804|NCT00253955|Levofloxacin|levofloxacin|mesh-list
44163805|NCT00253955|Ofloxacin|ofloxacin|mesh-list
44163806|NCT00253955|Tazobactam|tazobactam|mesh-list
44163807|NCT00253955|Piperacillin|piperacillin|mesh-list
44163808|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44163809|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44163853|NCT00254046|Etravirine|etravirine|mesh-list
44163854|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44163855|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44163856|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163857|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163858|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
44163859|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163860|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
44163861|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44163862|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163863|NCT00254137|Capecitabine|capecitabine|mesh-list
44163864|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
44163865|NCT00254137|Irinotecan|irinotecan|mesh-list
44163866|NCT00254137|Cetuximab|cetuximab|mesh-list
44163867|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44163868|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
44163869|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163870|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163871|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44163872|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163873|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163874|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44163875|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
44163876|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44163877|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44163878|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
44163879|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44163880|NCT00254189|Estradiol|estradiol|mesh-list
44163881|NCT00254189|Estrogens|estrogens|mesh-ancestor
44163882|NCT00254189|Hormones|hormones|mesh-ancestor
44163886|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
44163897|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43603950|NCT03241563|Triamcinolone|triamcinolone|mesh-list
44164046|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164047|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164048|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164049|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164050|NCT00254800|Exenatide|exenatide|mesh-list
44164051|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44164052|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44164053|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
44164113|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44164114|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
44164116|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
44164117|NCT00254956|Hormones|hormones|mesh-ancestor
44164118|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164119|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164120|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44164121|NCT00255073|Baclofen|baclofen|mesh-list
44164122|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44164123|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164124|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44164125|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164126|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44164127|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
44164128|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
44164172|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44164173|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44164174|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44164176|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44164177|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44164178|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44164179|NCT00255450|Hematinics|hematinics|mesh-ancestor
44164180|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44164181|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44164182|NCT00255463|Gefitinib|gefitinib|mesh-list
44164195|NCT00255476|Cisplatin|cisplatin|mesh-list
44164234|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44164235|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44164236|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
44164237|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164238|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164240|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44164242|NCT00255554|Citalopram|citalopram|mesh-list
44164301|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164302|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164303|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44164304|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
44164305|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164306|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164307|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44164308|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44164367|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44164368|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
44164369|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164370|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164371|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164372|NCT00255996|Linezolid|linezolid|mesh-list
44164373|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164374|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164375|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44164376|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164378|NCT00256009|Misoprostol|misoprostol|mesh-list
44164431|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44164432|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44164433|NCT00256321|Analgesics|analgesics|mesh-ancestor
44164434|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
44164435|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164436|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164437|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164438|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164439|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44164440|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44164441|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164443|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
44164444|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164445|NCT00256334|Protective Agents|protective agents|mesh-ancestor
44164446|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164447|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164490|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43689578|NCT02802540|Nabilone|nabilone|mesh-list
44164491|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164492|NCT00256828|Lamivudine|lamivudine|mesh-list
44164493|NCT00256828|Efavirenz|efavirenz|mesh-list
44164494|NCT00256828|Didanosine|didanosine|mesh-list
44164495|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44164496|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44164497|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164498|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164499|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
44164500|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164501|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44164552|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164553|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164554|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164555|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164556|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164557|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164558|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164617|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164619|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44164620|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164621|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164622|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164623|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44164624|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44164625|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164626|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164627|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
44164628|NCT00257348|Docetaxel|docetaxel|mesh-list
44164679|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
44164680|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164681|NCT00257465|Vaccines|vaccines|mesh-list
44164682|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
43604773|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
44164683|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164685|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44164686|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44164687|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44164688|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164689|NCT00257530|Imiquimod|imiquimod|mesh-list
44164690|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44164691|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
44164692|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164693|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164694|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
44164695|NCT00257569|Cetirizine|cetirizine|mesh-list
44164704|NCT00257582|Cetirizine|cetirizine|mesh-list
44164735|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164736|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
44164737|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
44164738|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164739|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164740|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164741|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
44164742|NCT00257634|Hormones|hormones|mesh-ancestor
44164743|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164744|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164746|NCT00257699|Metronidazole|metronidazole|mesh-list
44164799|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164800|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164801|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44164802|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164803|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164804|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164805|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164806|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164807|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44164808|NCT00257868|Rivastigmine|rivastigmine|mesh-list
44164809|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44164810|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164811|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164812|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
44164813|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164814|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164854|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164855|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44164857|NCT00258050|Lapatinib|lapatinib|mesh-list
44164858|NCT00258050|Midazolam|midazolam|mesh-list
44164859|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44164860|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44164861|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164862|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164863|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44164864|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164865|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164866|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44164867|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
44164868|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
44164869|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
44164914|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164915|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164916|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164917|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164918|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44164919|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44164920|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44164921|NCT00258115|Analgesics|analgesics|mesh-ancestor
44164922|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
44164923|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164924|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164925|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164926|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164927|NCT00258193|Linaclotide|linaclotide|mesh-list
44164928|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44164929|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
44164930|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164931|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164932|NCT00258232|Celecoxib|celecoxib|mesh-list
44164968|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164969|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164970|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
44164971|NCT00258245|Hormones|hormones|mesh-ancestor
44164972|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164973|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164974|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164975|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
44164976|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164977|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164978|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44164979|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44164980|NCT00258245|Analgesics|analgesics|mesh-ancestor
44164981|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
44164982|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164983|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44164987|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
44165025|NCT00258297|Gefitinib|gefitinib|mesh-list
44165026|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44165027|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165028|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165029|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165030|NCT00258323|Cisplatin|cisplatin|mesh-list
44165031|NCT00258323|Fluorouracil|fluorouracil|mesh-list
44165032|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165033|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
44165034|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165035|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165039|NCT00258336|Rituximab|rituximab|mesh-list
44165089|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44165090|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165092|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165093|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
44165094|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165095|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
44165096|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44165097|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44165098|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44165099|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165100|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165101|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
44165102|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165103|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165104|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44165105|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165106|NCT00258622|Lidocaine|lidocaine|mesh-list
44165107|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
44165108|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
44165109|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165110|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165111|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
44165112|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165113|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44165114|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44165115|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44165116|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165134|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
44165135|NCT00258765|Docetaxel|docetaxel|mesh-list
44165136|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165137|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165138|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165139|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165140|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165141|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44165142|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165143|NCT00258791|Ibuprofen|ibuprofen|mesh-list
44165144|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44165145|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165146|NCT00258791|Analgesics|analgesics|mesh-ancestor
44165147|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
44165148|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165149|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165150|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165151|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165152|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44165153|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165154|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165158|NCT00258843|Vaccines|vaccines|mesh-list
44165185|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165186|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165187|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165188|NCT00259142|Chloroquine|chloroquine|mesh-list
43772965|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
44165189|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
44165190|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
44165191|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44165192|NCT00259142|Amebicides|amebicides|mesh-ancestor
44165193|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44165194|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44165195|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165196|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
44165197|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165198|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44165199|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165200|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165201|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44165202|NCT00259142|Renal Agents|renal agents|mesh-ancestor
44165203|NCT00259155|Rifaximin|rifaximin|mesh-list
44165204|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165205|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165206|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165207|NCT00259168|Nateglinide|nateglinide|mesh-list
44165208|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44165209|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165210|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
44165211|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44165212|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
44165213|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44165214|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165215|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
44165216|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44165217|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
44165218|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44165219|NCT00259181|Protective Agents|protective agents|mesh-ancestor
44165220|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165221|NCT00259220|Erythromycin|erythromycin|mesh-list
44173275|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44173276|NCT00292695|Cisplatin|cisplatin|mesh-list
44173277|NCT00292695|Ifosfamide|ifosfamide|mesh-list
44165222|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
44165223|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44165224|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
44165225|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165226|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165227|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165228|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44165392|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44165393|NCT00259896|Incretins|incretins|mesh-ancestor
44165394|NCT00259896|Hormones|hormones|mesh-ancestor
44165395|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165396|NCT00259922|Alvimopan|alvimopan|mesh-list
44165397|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165398|NCT00259935|Topotecan|topotecan|mesh-list
44165399|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44165400|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44165401|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165402|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165403|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165404|NCT00259974|Rituximab|rituximab|mesh-list
44165405|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165406|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165407|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
44165408|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165409|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165410|NCT00259987|Lapatinib|lapatinib|mesh-list
44165411|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165412|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165413|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165414|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165415|NCT00260026|Docetaxel|docetaxel|mesh-list
44165416|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165417|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165418|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165419|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165421|NCT00260039|Vaccines|vaccines|mesh-list
44165442|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44165443|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165444|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165445|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44165446|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165447|NCT00260247|Analgesics|analgesics|mesh-ancestor
44165448|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
44165449|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165450|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44165451|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165452|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165453|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44165454|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44165455|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44165456|NCT00260260|Oxycodone|oxycodone|mesh-list
44165457|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44165458|NCT00260260|Narcotics|narcotics|mesh-ancestor
44165459|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165460|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165461|NCT00260260|Analgesics|analgesics|mesh-ancestor
44165462|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
44165463|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165464|NCT00260325|Valdecoxib|valdecoxib|mesh-list
44165465|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44165466|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44165467|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165468|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165469|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44165470|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44165471|NCT00260325|Analgesics|analgesics|mesh-ancestor
44165472|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
44165473|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165474|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165482|NCT00260364|Capecitabine|capecitabine|mesh-list
44165483|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44165484|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165485|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165558|NCT00261027|Exemestane|exemestane|mesh-list
44165626|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44165627|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44165628|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165629|NCT00261261|Midazolam|midazolam|mesh-list
44165630|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44165631|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44165695|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165696|NCT00261469|Topiramate|topiramate|mesh-list
44165697|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
44165698|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44165699|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165700|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44165701|NCT00261482|Norelgestromin|norelgestromin|mesh-list
44165702|NCT00261482|Estradiol|estradiol|mesh-list
44165703|NCT00261482|Estrogens|estrogens|mesh-ancestor
44165704|NCT00261482|Hormones|hormones|mesh-ancestor
43605949|NCT03222960|Propolis|propolis|mesh-list
44165705|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165706|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165707|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44165708|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
44165709|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44165710|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44165711|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44165712|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44165713|NCT00261508|Risperidone|risperidone|mesh-list
44165714|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44165715|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
44165828|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44165829|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165831|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165899|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44165901|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165902|NCT00261976|Infliximab|infliximab|mesh-list
44165903|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
44165904|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165906|NCT00262015|Vaccines|vaccines|mesh-list
44165907|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
44165908|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165909|NCT00262054|Heparin|heparin|mesh-list
44165910|NCT00262054|Calcium heparin|calcium heparin|mesh-list
44165911|NCT00262054|Bivalirudin|bivalirudin|mesh-list
44166037|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44166038|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166039|NCT00262561|Aspirin|aspirin|mesh-list
44166040|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166041|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166042|NCT00262561|Analgesics|analgesics|mesh-ancestor
44166043|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
44166105|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
44166106|NCT00262808|Vitamins|vitamins|mesh-ancestor
44166107|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
44166108|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
44166109|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
44166174|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
44166175|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
44166176|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44166177|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166178|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166179|NCT00263094|Rofecoxib|rofecoxib|mesh-list
44166180|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44166181|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44166182|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166183|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166184|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44166185|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44166186|NCT00263094|Analgesics|analgesics|mesh-ancestor
44166187|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
44166310|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166311|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166312|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166313|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
44166314|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166315|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166316|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44166317|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
44166318|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
44166319|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44166320|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166321|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44166322|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44166323|NCT00263484|Growth Substances|growth substances|mesh-ancestor
44166324|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
44166325|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44166326|NCT00263705|Capecitabine|capecitabine|mesh-list
44166327|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166328|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
44166329|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166330|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44166331|NCT00263718|Betamethasone|betamethasone|mesh-list
44166332|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
44166333|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44166334|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
44166335|NCT00263718|Calcipotriene|calcipotriene|mesh-list
44166336|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44166337|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166338|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
44166339|NCT00263718|Hormones|hormones|mesh-ancestor
44166340|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44166341|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166342|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44166343|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
44166425|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44166426|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166427|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166428|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44166429|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44166430|NCT00264225|Codeine|codeine|mesh-list
44166431|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44166432|NCT00264225|Narcotics|narcotics|mesh-ancestor
44166433|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166434|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166563|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166638|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44166639|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44166708|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44166718|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
44166781|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
44166782|NCT00265746|Metformin|metformin|mesh-list
44166783|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44166784|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166785|NCT00265772|Prednisolone|prednisolone|mesh-list
44166786|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44166787|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
44166788|NCT00265772|Hormones|hormones|mesh-ancestor
44166849|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44166852|NCT00265993|Enoxaparin|enoxaparin|mesh-list
44166920|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44166921|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
44166922|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
43607194|NCT03204578|Midazolam|midazolam|mesh-list
44166923|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44166924|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44166925|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44166926|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44166928|NCT00266149|Lamotrigine|lamotrigine|mesh-list
44166929|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
44166930|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44166931|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44166932|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44166933|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44166934|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44166935|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43773029|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773030|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43838613|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838614|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
43838615|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838616|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773063|NCT02361502|Mirabegron|mirabegron|mesh-list
44166936|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44166937|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44166938|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44166939|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44166972|NCT00266344|Analgesics|analgesics|mesh-ancestor
44166976|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
44167347|NCT00268255|Gefitinib|gefitinib|mesh-list
44167422|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167423|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167424|NCT00268411|Antiviral Agents|antiviral agents|mesh-ancestor
44167425|NCT00268411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44167426|NCT00268411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167427|NCT00268411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44167428|NCT00268411|Immunologic Factors|immunologic factors|mesh-ancestor
44167429|NCT00268411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167430|NCT00268489|Bevacizumab|bevacizumab|mesh-list
44167561|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
44167562|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
44167563|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167564|NCT00268723|Albuterol|albuterol|mesh-list
44167565|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44167566|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
44167567|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167568|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167569|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44167629|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167630|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44167631|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167632|NCT00268957|Sevelamer|sevelamer|mesh-list
44167633|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
44167634|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
44167636|NCT00268970|Paclitaxel|paclitaxel|mesh-list
44167699|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44167700|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
44167701|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167702|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44167703|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44167704|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167705|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
44167706|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
44167707|NCT00269217|Vitamins|vitamins|mesh-ancestor
44167708|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
44167709|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167710|NCT00269243|Quinapril|quinapril|mesh-list
44167711|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44167712|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
44167713|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167714|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167715|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44167716|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
44167717|NCT00269334|Paroxetine|paroxetine|mesh-list
44167718|NCT00269334|Citalopram|citalopram|mesh-list
44167719|NCT00269334|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44167720|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44167721|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44167722|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167750|NCT00269542|Hematinics|hematinics|mesh-ancestor
44167751|NCT00269542|Vitamins|vitamins|mesh-ancestor
44167752|NCT00269555|Genistein|genistein|mesh-list
44167753|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44167754|NCT00269555|Protective Agents|protective agents|mesh-ancestor
44167755|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167756|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167757|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44167758|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44167759|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44167760|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
44167761|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44167762|NCT00269555|Estrogens|estrogens|mesh-ancestor
44167763|NCT00269555|Hormones|hormones|mesh-ancestor
44167764|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44167765|NCT00269568|Misoprostol|misoprostol|mesh-list
44167766|NCT00269568|Mifepristone|mifepristone|mesh-list
44167767|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44167768|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
44167769|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44167771|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44167799|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44167800|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44167801|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167802|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
44167803|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44167804|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44167805|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44167806|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44167807|NCT00269620|Etonogestrel|etonogestrel|mesh-list
44167808|NCT00269620|NuvaRing|nuvaring|mesh-list
44167809|NCT00269620|Norelgestromin|norelgestromin|mesh-list
44167867|NCT00269750|Urological Agents|urological agents|mesh-ancestor
44167868|NCT00269763|Fentanyl|fentanyl|mesh-list
44167869|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44167870|NCT00269763|Narcotics|narcotics|mesh-ancestor
44167871|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44167872|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44167873|NCT00269763|Analgesics|analgesics|mesh-ancestor
44167927|NCT00269841|Antibodies|antibodies|mesh-list
44167928|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
44167929|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44167930|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
44167931|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652260|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44167932|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44167933|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
44167934|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44167935|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168020|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168021|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168022|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
44168023|NCT00270166|Hematinics|hematinics|mesh-ancestor
44168024|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
44168025|NCT00270179|Hematinics|hematinics|mesh-ancestor
44168026|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
44168027|NCT00270270|Hematinics|hematinics|mesh-ancestor
44168028|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
44168029|NCT00270283|Hematinics|hematinics|mesh-ancestor
44168030|NCT00270322|Fentanyl|fentanyl|mesh-list
44168031|NCT00270322|Morphine|morphine|mesh-list
44168032|NCT00270322|Bupivacaine|bupivacaine|mesh-list
44168033|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44168034|NCT00270322|Narcotics|narcotics|mesh-ancestor
44168035|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168036|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168037|NCT00270322|Analgesics|analgesics|mesh-ancestor
44168038|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
44168039|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168040|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44168041|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44168042|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
44168043|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
44168044|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
44168045|NCT00270335|Propofol|propofol|mesh-list
44168046|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44168047|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168048|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168049|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44168050|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
44168052|NCT00270348|Ciclesonide|ciclesonide|mesh-list
44168053|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
44168054|NCT00270348|Hormones|hormones|mesh-ancestor
44168070|NCT00270426|Benazepril|benazepril|mesh-list
44168082|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168083|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44168085|NCT00270491|Capecitabine|capecitabine|mesh-list
44168086|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44168087|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168088|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168089|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168090|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168091|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168092|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168093|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
44168094|NCT00270517|Telithromycin|telithromycin|mesh-list
44168095|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44168096|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168097|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
44168143|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168144|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
44168145|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168146|NCT00270582|Antiviral Agents|antiviral agents|mesh-ancestor
44168147|NCT00270582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168148|NCT00270582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168149|NCT00270582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168150|NCT00270582|Immunologic Factors|immunologic factors|mesh-ancestor
44168151|NCT00270582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168152|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168153|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168154|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168155|NCT00270647|Vitamins|vitamins|mesh-list
44168156|NCT00270647|Ascorbic Acid|ascorbic acid|mesh-list
44168157|NCT00270647|Vitamin E|vitamin e|mesh-list
44168158|NCT00270647|Beta Carotene|beta carotene|mesh-list
44168159|NCT00270647|Carotenoids|carotenoids|mesh-list
44168160|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
44168161|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168162|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
44168163|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168164|NCT00270647|Protective Agents|protective agents|mesh-ancestor
44168165|NCT00270647|Provitamins|provitamins|mesh-ancestor
44168198|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44168199|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168200|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
44168202|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
44168203|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
44168204|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168205|NCT00270816|Interferons|interferons|mesh-list
44168206|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168207|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
44168208|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168209|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44168210|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
44168211|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168212|NCT00270881|Cytarabine|cytarabine|mesh-list
44168213|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
44168214|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44168215|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
44168216|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168217|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168218|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44168220|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168221|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168222|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44168223|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168224|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
44168225|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
44168226|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168227|NCT00270907|Gemcitabine|gemcitabine|mesh-list
44168246|NCT00271206|Progestins|progestins|mesh-ancestor
44168247|NCT00271206|Hormones|hormones|mesh-ancestor
44168248|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168249|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168250|NCT00271245|Selenium|selenium|mesh-list
44168251|NCT00271245|Selenic Acid|selenic acid|mesh-list
44168252|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
44168253|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168254|NCT00271245|Protective Agents|protective agents|mesh-ancestor
44168255|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168256|NCT00271245|Trace Elements|trace elements|mesh-ancestor
44168257|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
44168258|NCT00271271|Gemcitabine|gemcitabine|mesh-list
44168259|NCT00271271|Vinorelbine|vinorelbine|mesh-list
44168260|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
44168261|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44168262|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
44168263|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168264|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168265|NCT00271271|Antiviral Agents|antiviral agents|mesh-ancestor
44168300|NCT00271349|Budesonide|budesonide|mesh-list
44168301|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168302|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44168303|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
44168304|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168305|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168306|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168307|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168308|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
44168309|NCT00271349|Hormones|hormones|mesh-ancestor
44168310|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168311|NCT00271401|Heparin|heparin|mesh-list
44168312|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
44168313|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44168314|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44168315|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168316|NCT00271414|Fentanyl|fentanyl|mesh-list
44168317|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44168318|NCT00271414|Narcotics|narcotics|mesh-ancestor
44168319|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168320|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168321|NCT00271414|Analgesics|analgesics|mesh-ancestor
44168375|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44168376|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
44168377|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43648418|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43648419|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
43648420|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168378|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168379|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44168380|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44168381|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44168382|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
44168383|NCT00271635|Vitamins|vitamins|mesh-ancestor
44168384|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
44168385|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168386|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
44168387|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168390|NCT00271713|Vitamin D|vitamin d|mesh-list
44168443|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
44168444|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44168445|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168446|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
44168516|NCT00272428|Provitamins|provitamins|mesh-ancestor
44168517|NCT00272454|Aspirin|aspirin|mesh-list
44168518|NCT00272454|Cilostazol|cilostazol|mesh-list
44168519|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44168520|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44168521|NCT00272454|Analgesics|analgesics|mesh-ancestor
44168522|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
44168523|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168524|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168525|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168526|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168527|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44168528|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44168529|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168578|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168579|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168580|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168581|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44168582|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44168583|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44168584|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44168585|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44168714|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168715|NCT00272909|Piclozotan|piclozotan|mesh-list
44168716|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44168717|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44168718|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
43773152|NCT02361528|Sargramostim|sargramostim|mesh-list
44168719|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168720|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168721|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168722|NCT00272935|Estrogens|estrogens|mesh-list
44168723|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44168724|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
44168725|NCT00272935|Hormones|hormones|mesh-ancestor
44168726|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168727|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168729|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44168730|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44168731|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168732|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44168733|NCT00273013|Montelukast|montelukast|mesh-list
44168734|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44168735|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168736|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44168737|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
44168738|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168739|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168740|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44168758|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168759|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168760|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168761|NCT00273039|Paroxetine|paroxetine|mesh-list
44168762|NCT00273039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44168763|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44168764|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168765|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168766|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168767|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
44168768|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168769|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44168770|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
44168771|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44168772|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44168773|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44168774|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168775|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
44168776|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44168777|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44168780|NCT00273247|Interferons|interferons|mesh-list
44168810|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168811|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168812|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44168813|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168814|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44168815|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168816|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44168817|NCT00273338|Vitamins|vitamins|mesh-ancestor
44168818|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
44168819|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44168820|NCT00273377|Dexamethasone|dexamethasone|mesh-list
44168821|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44168822|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
44168823|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
44168824|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44168825|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168826|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168827|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
44168828|NCT00273377|Hormones|hormones|mesh-ancestor
44168829|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44168830|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44168831|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168832|NCT00273390|Infliximab|infliximab|mesh-list
44168833|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
44168834|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44168835|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44168836|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
44168837|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
44168838|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44168839|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44168840|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168841|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168842|NCT00273416|Urological Agents|urological agents|mesh-ancestor
44168843|NCT00273429|Timolol|timolol|mesh-list
44168844|NCT00273429|Dorzolamide|dorzolamide|mesh-list
44168845|NCT00273429|Latanoprost|latanoprost|mesh-list
44168848|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44168849|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168850|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168851|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168852|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168853|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44168854|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168855|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168856|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44168857|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44168859|NCT00273442|Timolol|timolol|mesh-list
44168912|NCT00273507|Carboplatin|carboplatin|mesh-list
44168913|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44168914|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168915|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168916|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
44168917|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
44168918|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168919|NCT00273520|Telithromycin|telithromycin|mesh-list
44168920|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44168921|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168922|NCT00273533|Ramipril|ramipril|mesh-list
44168923|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44168924|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
44168925|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44168926|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168927|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44168928|NCT00273546|Docetaxel|docetaxel|mesh-list
44168929|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44168930|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
44168966|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44168967|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44168968|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44168969|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44168970|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
44168971|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44168972|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
44168973|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44168974|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
44168975|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44168976|NCT00273702|Expectorants|expectorants|mesh-ancestor
43652266|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44168977|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
44168978|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44168979|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
44168980|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168981|NCT00273702|Protective Agents|protective agents|mesh-ancestor
44168982|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168983|NCT00273702|Antidotes|antidotes|mesh-ancestor
44168984|NCT00273741|Methylphenidate|methylphenidate|mesh-list
44168985|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44168986|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44168987|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44168988|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44168989|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44168990|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44168991|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
44168993|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
44169013|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169014|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
44169015|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169016|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169017|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
44169018|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169019|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169020|NCT00273949|Lactulose|lactulose|mesh-list
44169021|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169022|NCT00273962|Albuterol|albuterol|mesh-list
44169023|NCT00273962|Ipratropium|ipratropium|mesh-list
44169024|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169025|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
44169026|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169074|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44169075|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44169076|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
44169077|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169078|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
44169079|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169080|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169081|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169140|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169141|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
44169142|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
44169143|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44169144|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44169145|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44169146|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44169147|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
44169148|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
44169149|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169150|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
44169151|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169152|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169153|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169154|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169155|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
44169160|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
44169196|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169197|NCT00274144|Telmisartan|telmisartan|mesh-list
44169198|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44169199|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44169200|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44169201|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169202|NCT00274170|Octreotide|octreotide|mesh-list
44169203|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169204|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44169205|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169206|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
44169207|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
44169208|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44169209|NCT00274235|Mefloquine|mefloquine|mesh-list
44169210|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
44169211|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44169212|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44169213|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169214|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44169215|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169216|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169217|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44169218|NCT00274235|Renal Agents|renal agents|mesh-ancestor
44169249|NCT00274404|Valacyclovir|valacyclovir|mesh-list
44169250|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
44169251|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169252|NCT00274417|Dutasteride|dutasteride|mesh-list
44169253|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44169301|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169302|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169303|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169305|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
44169306|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44169307|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
44169308|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169309|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169310|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44169311|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
44169312|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
44169313|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44169314|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169315|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169316|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169317|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
44169356|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
44169357|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169358|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169359|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44169360|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44169361|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44169363|NCT00274573|Bromides|bromides|mesh-list
44169421|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44169422|NCT00274690|Casopitant|casopitant|mesh-list
44169423|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
44169424|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
44169425|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169426|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169427|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44169428|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44169429|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44169488|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
44169489|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169490|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169491|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44169492|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169494|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
44169495|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169496|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
44169497|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169498|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169499|NCT00274859|Antiviral Agents|antiviral agents|mesh-ancestor
44169500|NCT00274859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44169501|NCT00274859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169502|NCT00274859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44169503|NCT00274859|Immunologic Factors|immunologic factors|mesh-ancestor
44169504|NCT00274859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169506|NCT00274872|Fluorouracil|fluorouracil|mesh-list
44169507|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
44169508|NCT00274872|Calcium|calcium|mesh-list
44169509|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
44169510|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44169511|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169512|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
44169513|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169514|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169515|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169537|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169538|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44169539|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44169540|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44169541|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44169542|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44169543|NCT00274911|Cisplatin|cisplatin|mesh-list
44169544|NCT00274911|Vincristine|vincristine|mesh-list
44169545|NCT00274911|Lomustine|lomustine|mesh-list
44169546|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169547|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169601|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44169602|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44169603|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
44169611|NCT00277511|Levofloxacin|levofloxacin|mesh-list
44169668|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44169669|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44169670|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44169671|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44169672|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44169673|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
44169674|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44169675|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
44169738|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44169809|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
44169810|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44169811|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169812|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44169813|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
44169814|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44169815|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169816|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
44169876|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44169877|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44169878|NCT00278369|Analgesics|analgesics|mesh-ancestor
44169879|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
44169880|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44169881|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44169945|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44169946|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
44170019|NCT00279045|Metformin|metformin|mesh-list
44170020|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
44170021|NCT00279045|Glyburide|glyburide|mesh-list
44170022|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44170023|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170024|NCT00279084|Chrysarobin|chrysarobin|mesh-list
44170025|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
44170026|NCT00279084|Hematinics|hematinics|mesh-ancestor
44170027|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44170028|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44170029|NCT00279084|Analgesics|analgesics|mesh-ancestor
44170030|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
44170036|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
44170086|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
44170087|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
44170088|NCT00279383|Thrombin|thrombin|mesh-list
44170089|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
44170090|NCT00279383|Coagulants|coagulants|mesh-ancestor
44170091|NCT00279422|Visilizumab|visilizumab|mesh-list
44170092|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
44170158|NCT00279565|Analgesics|analgesics|mesh-ancestor
44170159|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
44170160|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170161|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44170229|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170230|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44170231|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170232|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170233|NCT00280007|Bevacizumab|bevacizumab|mesh-list
44170234|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44170235|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170236|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44170237|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44170238|NCT00280007|Growth Substances|growth substances|mesh-ancestor
44170239|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170240|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
44170241|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44170291|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
44170292|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
44170293|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170294|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170295|NCT00280358|Fluticasone|fluticasone|mesh-list
44170296|NCT00280358|Xhance|xhance|mesh-list
44170297|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
44170298|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170299|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44170300|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
44170301|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170302|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170303|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44170304|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
44170305|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
44170306|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44170307|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44170308|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44170309|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44170310|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44170311|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170312|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170313|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
44170342|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170343|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170413|NCT00280774|Memantine|memantine|mesh-list
44170414|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44170415|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44170416|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
44170417|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44170418|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170419|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170422|NCT00280787|Paclitaxel|paclitaxel|mesh-list
44170481|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170482|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
44170483|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44170555|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44170556|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
44170557|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170558|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44170559|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44170560|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44170561|NCT00281489|Anesthetics|anesthetics|mesh-list
44170562|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170620|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44170621|NCT00281710|Prednisolone|prednisolone|mesh-list
44170622|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
44170623|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44170624|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
44170625|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44170626|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
44170627|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
44170628|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44170629|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170630|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44170631|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
44170632|NCT00281710|Hormones|hormones|mesh-ancestor
44170633|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44170634|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44170635|NCT00281710|Protective Agents|protective agents|mesh-ancestor
44170636|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44170637|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170638|NCT00281788|Paclitaxel|paclitaxel|mesh-list
44170639|NCT00281788|Carboplatin|carboplatin|mesh-list
44170640|NCT00281788|Capecitabine|capecitabine|mesh-list
44170641|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44170648|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
44170673|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170674|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44170675|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44170676|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
44170677|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44170678|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44170679|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44170680|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44170681|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
44170682|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44170738|NCT00281983|Rituximab|rituximab|mesh-list
44170739|NCT00281983|Methotrexate|methotrexate|mesh-list
44170812|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44170813|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44170814|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
44170815|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44170816|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44170817|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44170818|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43611228|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
44170876|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
44170877|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44170878|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44170879|NCT00282503|Prednisolone|prednisolone|mesh-list
44170947|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170948|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
44170949|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44170950|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44170951|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652288|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
44170952|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44170953|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44170954|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44170955|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44170956|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44170957|NCT00283036|Irbesartan|irbesartan|mesh-list
44171009|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44171010|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
44171011|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171078|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
44171079|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44171080|NCT00283660|Protective Agents|protective agents|mesh-ancestor
44171081|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171082|NCT00283699|Albendazole|albendazole|mesh-list
44171150|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171151|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171152|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44171153|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
44171154|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44171155|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44171156|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
44171157|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171158|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
44171159|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171160|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44171161|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171162|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
44171163|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171211|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
44171212|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171213|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171214|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44171215|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44171216|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
44171217|NCT00284271|Hormones|hormones|mesh-ancestor
44171226|NCT00284323|Adenosine|adenosine|mesh-list
44171280|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171281|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171282|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
44171283|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171284|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44171285|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44171347|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171349|NCT00284947|Prednisolone|prednisolone|mesh-list
44171350|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
44171351|NCT00284947|Basiliximab|basiliximab|mesh-list
44171352|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44171353|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
44171354|NCT00284947|Hormones|hormones|mesh-ancestor
44171355|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171356|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171357|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44171358|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171359|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
44171360|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
44171361|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171362|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171363|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44171364|NCT00284947|Protective Agents|protective agents|mesh-ancestor
44171365|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171366|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
44171367|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44171368|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44171369|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
44171370|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171402|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44171403|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
44171404|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44171405|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44171406|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44171407|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171408|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171409|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
44171410|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171411|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171412|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44171414|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171458|NCT00285389|Chlorambucil|chlorambucil|mesh-list
44171459|NCT00285389|Rituximab|rituximab|mesh-list
44171460|NCT00285389|Vincristine|vincristine|mesh-list
44171461|NCT00285389|Doxorubicin|doxorubicin|mesh-list
44171462|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44171463|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
44171464|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171465|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171466|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44171467|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
44171468|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171469|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171470|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44171521|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44171522|NCT00285662|Amodiaquine|amodiaquine|mesh-list
44171523|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
44171524|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44171525|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44171526|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171527|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171528|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
44171529|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
44171530|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44171531|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
44171584|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44171585|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44171586|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
44171587|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171588|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171589|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44171590|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44171591|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
44171592|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171593|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44171594|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44171595|NCT00285896|Glucagon|glucagon|mesh-list
44171596|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44171597|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44171598|NCT00285896|Hormones|hormones|mesh-ancestor
44171599|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171644|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44171645|NCT00286143|Narcotics|narcotics|mesh-ancestor
44171646|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44171647|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171716|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171717|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171718|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44171719|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171720|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171721|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44171722|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
44171724|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171725|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44171726|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
44171727|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
44171728|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
44171729|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171730|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171731|NCT00286416|Omalizumab|omalizumab|mesh-list
44171732|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44171733|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44171734|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
44171735|NCT00286481|Simvastatin|simvastatin|mesh-list
44171736|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44171737|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44171738|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
44171739|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171740|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44171741|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44171742|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171743|NCT00286585|Propofol|propofol|mesh-list
44171762|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171763|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
44171764|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171765|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
44171766|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44171767|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44171768|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171769|NCT00286689|Hormones|hormones|mesh-list
44171770|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44171771|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171772|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
44171782|NCT00286871|Tacrolimus|tacrolimus|mesh-list
44171823|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171824|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171825|NCT00287157|Tizanidine|tizanidine|mesh-list
44171826|NCT00287157|Analgesics|analgesics|mesh-ancestor
44171827|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
44171828|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44171829|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171830|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
44171831|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44171832|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44171833|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
44171834|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
44171835|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44171836|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44171837|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44171838|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44171839|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44171840|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171841|NCT00287170|Calcitriol|calcitriol|mesh-list
44171842|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
44171843|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44171844|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171845|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44171846|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44171847|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44171848|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44171849|NCT00287170|Vitamins|vitamins|mesh-ancestor
44171868|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44171869|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44171870|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44171871|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44171872|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
44171873|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171874|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44171875|NCT00287300|Azithromycin|azithromycin|mesh-list
44171876|NCT00287300|Artesunate|artesunate|mesh-list
44171877|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
44171878|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
44171879|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44171880|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44171881|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44171882|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
44171883|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44171884|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44171885|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44171886|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
44171887|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
44171926|NCT00287352|Olanzapine|olanzapine|mesh-list
44171927|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
44171948|NCT00287352|Analgesics|analgesics|mesh-ancestor
44171997|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44171998|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44171999|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44172000|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172001|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172003|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44172004|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172005|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172135|NCT00287937|Carboplatin|carboplatin|mesh-list
44172136|NCT00287937|Vorinostat|vorinostat|mesh-list
44172137|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172138|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172139|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172140|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172141|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172142|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172143|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44172144|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44172202|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44172203|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44172276|NCT00288249|Epothilones|epothilones|mesh-list
44172277|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172415|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172416|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
44172417|NCT00288769|Hematinics|hematinics|mesh-ancestor
44172418|NCT00288782|Mirtazapine|mirtazapine|mesh-list
44172419|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
44172420|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172421|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44172422|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
44172423|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
44172424|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44172425|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172426|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172427|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44172428|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172429|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172430|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44172431|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44172432|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44172433|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
44172434|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44172469|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44172471|NCT00289263|Paclitaxel|paclitaxel|mesh-list
44172472|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44172473|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172474|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
44172475|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
44172476|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
44172477|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172478|NCT00289354|Chromium|chromium|mesh-list
44172480|NCT00289354|Picolinic acid|picolinic acid|mesh-list
44172481|NCT00289354|Trace Elements|trace elements|mesh-ancestor
43773271|NCT02360423|Sirolimus|sirolimus|mesh-list
43773272|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773273|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44172482|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
44172483|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172484|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
44172485|NCT00289354|Vitamins|vitamins|mesh-ancestor
44172486|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44172529|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
44172530|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
44172531|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43613120|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
44172532|NCT00289445|Leucovorin|leucovorin|mesh-list
44172602|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
44172603|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172604|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44172605|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172606|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
44172607|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172608|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44172609|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
44172610|NCT00290017|Pemetrexed|pemetrexed|mesh-list
44172611|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172666|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
44172667|NCT00290121|Olanzapine|olanzapine|mesh-list
44172668|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
44172669|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
44172670|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172671|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172672|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172673|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44172674|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44172676|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44172733|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
44172734|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44172735|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
44172736|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44172738|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
44172739|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172740|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172811|NCT00290667|Prednisone|prednisone|mesh-list
44172870|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44172871|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172872|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44172873|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
44172875|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44172876|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44172937|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172938|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172940|NCT00290940|Pioglitazone|pioglitazone|mesh-list
44172941|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172942|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44172943|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
44172944|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44172946|NCT00290992|Rasburicase|rasburicase|mesh-list
44173000|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44173001|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173002|NCT00291213|Levetiracetam|levetiracetam|mesh-list
44173003|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
44173004|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
44173005|NCT00291369|Interferons|interferons|mesh-list
44173006|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
44173007|NCT00291369|Interleukin-2|interleukin-2|mesh-list
44173008|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44173009|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
44173010|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173011|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
44173012|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173013|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
44173014|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173015|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44173016|NCT00291369|Analgesics|analgesics|mesh-ancestor
44173017|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
44173018|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773280|NCT02360592|Interferons|interferons|mesh-list
44173019|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44173020|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44173021|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44173022|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
44173023|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44173024|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44173051|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44173061|NCT00291538|Bortezomib|bortezomib|mesh-list
44173122|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173123|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44173124|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173125|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173126|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
44173127|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173128|NCT00291785|Antidotes|antidotes|mesh-ancestor
44173129|NCT00291785|Protective Agents|protective agents|mesh-ancestor
44173130|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
44173131|NCT00291785|Vitamins|vitamins|mesh-ancestor
44173132|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
44173133|NCT00291785|Hematinics|hematinics|mesh-ancestor
44173134|NCT00291811|Plerixafor|plerixafor|mesh-list
44173135|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44173136|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44173184|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173185|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173186|NCT00292110|Analgesics|analgesics|mesh-ancestor
44173187|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
44173188|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44173189|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
44173190|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
44173191|NCT00292123|Methadone|methadone|mesh-list
44173192|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44173193|NCT00292123|Narcotics|narcotics|mesh-ancestor
44173194|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44173195|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173322|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
44173396|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44173397|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173468|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
44173469|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44173477|NCT00293371|Prednisone|prednisone|mesh-list
44173541|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173542|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44173543|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173688|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173689|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173690|NCT00293839|Urological Agents|urological agents|mesh-ancestor
44173691|NCT00293891|Tacrolimus|tacrolimus|mesh-list
44173692|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173693|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
44173694|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173695|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44173696|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173697|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173698|NCT00293917|Tacrolimus|tacrolimus|mesh-list
44173699|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44173700|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
44173701|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173702|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44173703|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44173745|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44173746|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
44173747|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44173818|NCT00294463|Estrogens|estrogens|mesh-ancestor
44173819|NCT00294463|Hormones|hormones|mesh-ancestor
44173820|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44173821|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44173822|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44173823|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
44173824|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44173825|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44173826|NCT00294463|Progestins|progestins|mesh-ancestor
44173827|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
44173885|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44173886|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173954|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44173956|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44173957|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44173958|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44174022|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44174023|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44174024|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44174025|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
44174026|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174027|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174028|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
44174029|NCT00295347|Spironolactone|spironolactone|mesh-list
44174030|NCT00295347|Citalopram|citalopram|mesh-list
44174031|NCT00295347|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44174033|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44174084|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174085|NCT00295464|Betamethasone|betamethasone|mesh-list
44174086|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44174087|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
44174088|NCT00295464|Hormones|hormones|mesh-ancestor
44174089|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174090|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174091|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44174092|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44174093|NCT00295542|Atenolol|atenolol|mesh-list
44174094|NCT00295542|Valsartan|valsartan|mesh-list
44174095|NCT00295542|Telmisartan|telmisartan|mesh-list
44174096|NCT00295542|Carvedilol|carvedilol|mesh-list
44174097|NCT00295542|Olmesartan|olmesartan|mesh-list
44174098|NCT00295542|Enalapril|enalapril|mesh-list
44174146|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174147|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174148|NCT00295594|Tacrolimus|tacrolimus|mesh-list
44174149|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174150|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
44174151|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174152|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174153|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174154|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174155|NCT00295607|Antibodies|antibodies|mesh-list
44174156|NCT00295607|Tacrolimus|tacrolimus|mesh-list
44174207|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174208|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174209|NCT00295841|Cytarabine|cytarabine|mesh-list
44174210|NCT00295841|Clofarabine|clofarabine|mesh-list
44174211|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174212|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
44174213|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174214|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174215|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
44174216|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773283|NCT02360592|Entecavir|entecavir|mesh-list
44174217|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174218|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
44174270|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44174271|NCT00295945|Narcotics|narcotics|mesh-ancestor
44174272|NCT00295945|Analgesics|analgesics|mesh-ancestor
44174273|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44174274|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44174275|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
44174276|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
44174277|NCT00295958|Immunotoxins|immunotoxins|mesh-list
44174278|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44174279|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
44174280|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174281|NCT00295971|Fludarabine|fludarabine|mesh-list
44174334|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
44174335|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174336|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174337|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
44174339|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44174340|NCT00296010|Methotrexate|methotrexate|mesh-list
44174341|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174342|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
44174343|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174344|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44174345|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174346|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
44174347|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174348|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174349|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174350|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44174351|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44174352|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44174353|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44174354|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44174355|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
44174356|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174357|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44174358|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
44174362|NCT00296023|Methotrexate|methotrexate|mesh-list
44174382|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44174383|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44174384|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
44174385|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44174386|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174387|NCT00296049|Vancomycin|vancomycin|mesh-list
44174388|NCT00296049|Daptomycin|daptomycin|mesh-list
44174389|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44174390|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174391|NCT00296062|Bevacizumab|bevacizumab|mesh-list
44174392|NCT00296062|Capecitabine|capecitabine|mesh-list
44174393|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
44174394|NCT00296062|Irinotecan|irinotecan|mesh-list
44174395|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44174396|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174397|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44174440|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44174442|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44174443|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44174444|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44174445|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174446|NCT00296257|Rimacalib|rimacalib|mesh-list
44174447|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44174448|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773301|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
44174449|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174450|NCT00296309|Tacrolimus|tacrolimus|mesh-list
44174451|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44174452|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
44174458|NCT00296348|Tacrolimus|tacrolimus|mesh-list
44174500|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174501|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174502|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44174503|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
44174504|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44174505|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
44174506|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44174507|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44174508|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44174511|NCT00296478|Hormones|hormones|mesh-ancestor
44174563|NCT00296634|Antacids|antacids|mesh-ancestor
44174564|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174565|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44174566|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
44174567|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
44174568|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44174569|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174570|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44174574|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
44174626|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
44174627|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174628|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174629|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
44174630|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174631|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44174632|NCT00296751|Narcotics|narcotics|mesh-ancestor
44174633|NCT00296751|Analgesics|analgesics|mesh-ancestor
44174634|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44174637|NCT00296777|Citalopram|citalopram|mesh-list
44174692|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44174693|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44174694|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
44174695|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44174696|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44174698|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174761|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773313|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174762|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44174763|NCT00297206|Valacyclovir|valacyclovir|mesh-list
44174764|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
44174765|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174766|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
44174826|NCT00297466|Nicotine|nicotine|mesh-list
44174827|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44174828|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
44174829|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44174831|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44174894|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44174895|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44174896|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44174897|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44174898|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44174899|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
44174900|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
44174901|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44174902|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44174962|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44174963|NCT00298025|Cetrorelix|cetrorelix|mesh-list
44174964|NCT00298025|Menotropins|menotropins|mesh-list
44174965|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44174966|NCT00298025|Hormones|hormones|mesh-list
44174967|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44174968|NCT00298025|Ganirelix|ganirelix|mesh-list
44174969|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44174970|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175028|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175029|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44175030|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175031|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175032|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175033|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175034|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
44175035|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
44175036|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175037|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175038|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44175039|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44175040|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
44175041|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175042|NCT00298415|Gemcitabine|gemcitabine|mesh-list
44175043|NCT00298415|Paclitaxel|paclitaxel|mesh-list
44175044|NCT00298415|Vinorelbine|vinorelbine|mesh-list
44175087|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44175088|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175089|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175090|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44175092|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
44175093|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44175094|NCT00298571|Epinephrine|epinephrine|mesh-list
44175231|NCT00299013|Prednisolone|prednisolone|mesh-list
44175232|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44175233|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
44175235|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
44175301|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44175302|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44175303|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44175304|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44175305|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44175370|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
44175371|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
44175372|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44175373|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175374|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175375|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44175376|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175378|NCT00299520|Linezolid|linezolid|mesh-list
44175379|NCT00299520|Iclaprim|iclaprim|mesh-list
44175436|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44175437|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175438|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44175439|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44175440|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
44175441|NCT00299819|Sifalimumab|sifalimumab|mesh-list
44175505|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175506|NCT00299936|Ribavirin|ribavirin|mesh-list
44175507|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44175579|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175581|NCT00300313|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44175582|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175583|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175584|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175585|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175644|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175645|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175647|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175648|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175650|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44175651|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44175652|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175653|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175706|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44175707|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44175708|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175709|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175710|NCT00300833|Tirofiban|tirofiban|mesh-list
44175711|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44175712|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44175713|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175715|NCT00300846|Aripiprazole|aripiprazole|mesh-list
43617253|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
43617326|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
43617402|NCT03140033|Misoprostol|misoprostol|mesh-list
43617553|NCT03138785|Itraconazole|itraconazole|mesh-list
43617702|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
43617794|NCT03136406|Leucovorin|leucovorin|mesh-list
43618158|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
43618234|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
43618381|NCT03131973|Leucovorin|leucovorin|mesh-list
43618534|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619210|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43619359|NCT03123016|Apremilast|apremilast|mesh-list
43619432|NCT03122353|Hormones|hormones|mesh-ancestor
43628159|NCT03068533|Calcium|calcium|mesh-list
43628612|NCT03065998|Baclofen|baclofen|mesh-list
43628881|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43628956|NCT03063359|Analgesics|analgesics|mesh-ancestor
43629866|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630092|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
43630239|NCT03053856|Paclitaxel|paclitaxel|mesh-list
43630465|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43630767|NCT03049293|Midazolam|midazolam|mesh-list
43633967|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43634039|NCT05696613|Rituximab|rituximab|mesh-list
43634040|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43634111|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43634407|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43634408|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
43634409|NCT05653271|Fludarabine|fludarabine|mesh-list
43634410|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
43634560|NCT05602038|Morphine|morphine|mesh-list
43635093|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43635094|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43635095|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
43635096|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
43635097|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43635098|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
43635099|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635100|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
43635101|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43635102|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43635103|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43635104|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43635139|NCT05383352|Leucovorin|leucovorin|mesh-list
43635140|NCT05383352|Folic Acid|folic acid|mesh-list
43635141|NCT05383352|Fluorouracil|fluorouracil|mesh-list
43635142|NCT05383352|Irinotecan|irinotecan|mesh-list
43635143|NCT05383352|Camptothecin|camptothecin|mesh-list
43635144|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
43635145|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
43635146|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635147|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43635148|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635149|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43635150|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
43635151|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635152|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43635153|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43635154|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635241|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43635242|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43635243|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43635244|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635245|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635246|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43635247|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43635248|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43635249|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
43635250|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635252|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
43635323|NCT05326776|Oxytocin|oxytocin|mesh-list
43635395|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635471|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43635472|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636155|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43636156|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
43636157|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
43636158|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43636159|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
43636160|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43636161|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43636162|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43636163|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43636164|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636165|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636166|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
43636167|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43636168|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43636169|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43636378|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43636379|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43636388|NCT04937062|Glycerol|glycerol|mesh-list
43636910|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
43636911|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43636914|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43637823|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637897|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
43637898|NCT04380636|Pemetrexed|pemetrexed|mesh-list
43637899|NCT04380636|Durvalumab|durvalumab|mesh-list
43637900|NCT04380636|Olaparib|olaparib|mesh-list
43637901|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43637902|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637903|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
43638135|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43638136|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43638137|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43638138|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43638139|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
43638140|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638141|NCT04285450|Vitamin K|vitamin k|mesh-list
43638142|NCT04285450|Vitamins|vitamins|mesh-ancestor
43638432|NCT04141696|Midazolam|midazolam|mesh-list
43640032|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851548|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851549|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851550|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
43851563|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541220|NCT00620464|Progestins|progestins|mesh-ancestor
43541294|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541519|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542044|NCT02636270|Growth Substances|growth substances|mesh-ancestor
43542121|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
43542280|NCT03703596|Docetaxel|docetaxel|mesh-list
43542422|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
43542572|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
43542647|NCT03701126|Bupivacaine|bupivacaine|mesh-list
43542874|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
43542947|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543022|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
43551836|NCT03609970|Vitamin D|vitamin d|mesh-list
43552094|NCT03607643|Temozolomide|temozolomide|mesh-list
43552243|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552384|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43552461|NCT03603899|Xenon|xenon|mesh-list
43552524|NCT03603418|BB 1101|bb 1101|mesh-list
43552857|NCT03601533|Phenol|phenol|mesh-list
43561048|NCT02358031|Cisplatin|cisplatin|mesh-list
43561105|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
43561186|NCT03094416|Omeprazole|omeprazole|mesh-list
43561255|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
43561629|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562230|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562313|NCT01489046|Tenofovir|tenofovir|mesh-list
43562379|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43562380|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43562381|NCT01481051|Latanoprost|latanoprost|mesh-list
43562384|NCT01480583|Alovudine|alovudine|mesh-list
43562512|NCT01443728|Vitamins|vitamins|mesh-list
43562588|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562737|NCT01397968|Cenobamate|cenobamate|mesh-list
43562888|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43563034|NCT01344187|Riboflavin|riboflavin|mesh-list
43563105|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43563330|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
43563912|NCT01168713|Ofloxacin|ofloxacin|mesh-list
43563913|NCT01168713|Solithromycin|solithromycin|mesh-list
43564061|NCT01130142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564062|NCT01130142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564063|NCT01130142|Immunologic Factors|immunologic factors|mesh-ancestor
43564064|NCT01130142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564065|NCT01129674|Olanzapine|olanzapine|mesh-list
43564066|NCT01129674|Risperidone|risperidone|mesh-list
43564067|NCT01129674|Aripiprazole|aripiprazole|mesh-list
43564068|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43564069|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43564071|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43564283|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564980|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43565803|NCT00863369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43565895|NCT00851045|Vitamins|vitamins|mesh-ancestor
43566107|NCT00838799|Pregabalin|pregabalin|mesh-list
43566171|NCT00836706|Clarithromycin|clarithromycin|mesh-list
43566243|NCT00835666|Finasteride|finasteride|mesh-list
43566316|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
43566464|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
43566689|NCT00830024|Alprazolam|alprazolam|mesh-list
43566918|NCT00810732|Nifedipine|nifedipine|mesh-list
43566982|NCT00803114|Analgesics|analgesics|mesh-ancestor
43567060|NCT00788541|Anecortave|anecortave|mesh-list
43568395|NCT00643383|Acetaminophen|acetaminophen|mesh-list
43568467|NCT00626704|Conatumumab|conatumumab|mesh-list
43568761|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569356|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
43569427|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569956|NCT00460317|Paclitaxel|paclitaxel|mesh-list
43570029|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
43585465|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43585466|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43585467|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43585612|NCT03419923|Citric Acid|citric acid|mesh-list
43585677|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43669069|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669071|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
43669072|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669073|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669074|NCT02907957|Anesthetics|anesthetics|mesh-list
43669075|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669076|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669077|NCT02908035|Sirolimus|sirolimus|mesh-list
43826788|NCT05494411|Mitomycin|mitomycin|mesh-list
43669089|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
43669090|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669091|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669092|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43669095|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43669096|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43669224|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669225|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669226|NCT02906176|Voriconazole|voriconazole|mesh-list
43669227|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
43669228|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669229|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43669230|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43669231|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669232|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669233|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43669262|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43669263|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43669265|NCT02906163|Afatinib|afatinib|mesh-list
43669266|NCT02906163|Thymalfasin|thymalfasin|mesh-list
43669267|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43669268|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43635821|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
43669269|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669270|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669271|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43669272|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
43669355|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669357|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669359|NCT02905045|Analgesics|analgesics|mesh-ancestor
43669360|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
43669361|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669362|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669363|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669364|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669365|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43669366|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669367|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669419|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
43669420|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43669421|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
43669422|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669423|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669424|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
43669425|NCT02904369|Tenofovir|tenofovir|mesh-list
43669426|NCT02904369|Emtricitabine|emtricitabine|mesh-list
43669427|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
43669428|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669429|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43669430|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669431|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669432|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669433|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43669434|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43826840|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846802|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846804|NCT04171700|Rucaparib|rucaparib|mesh-list
43846805|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43846806|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846807|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846808|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846809|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
43846810|NCT04171622|Lenvatinib|lenvatinib|mesh-list
43846811|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43669470|NCT02904031|Fluorouracil|fluorouracil|mesh-list
43669471|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
43669472|NCT02904031|Panitumumab|panitumumab|mesh-list
43669473|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
43669474|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
43669476|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43669533|NCT02903719|Ropivacaine|ropivacaine|mesh-list
43669534|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
43669535|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
43669536|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43669537|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669538|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
43669539|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669549|NCT02903537|Vitamins|vitamins|mesh-ancestor
43669602|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43669603|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669606|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43669607|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669608|NCT02903069|Temozolomide|temozolomide|mesh-list
43669609|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43669610|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
43669669|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669671|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43669673|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43669674|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43669675|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669676|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43669677|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669678|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
43635889|NCT05131698|Lenvatinib|lenvatinib|mesh-list
43669679|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
43669680|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43669681|NCT02902315|Vitamins|vitamins|mesh-list
43669683|NCT02902315|Tocopherols|tocopherols|mesh-list
43669684|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
43669685|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
43669686|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669687|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
43669688|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669689|NCT02902315|Protective Agents|protective agents|mesh-ancestor
43669690|NCT02902302|Ibuprofen|ibuprofen|mesh-list
43669691|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43669692|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669693|NCT02902302|Analgesics|analgesics|mesh-ancestor
43669694|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
43669695|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669696|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669697|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43669698|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43669699|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43669700|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669702|NCT02902523|Tenofovir|tenofovir|mesh-list
43826862|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
43826863|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826864|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43826865|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43826866|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43826867|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43826868|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826869|NCT05493709|Leuprolide|leuprolide|mesh-list
43826870|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43826871|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
43826872|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43826873|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826874|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826875|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826876|NCT05493657|Aspirin|aspirin|mesh-list
43826877|NCT05493657|Clopidogrel|clopidogrel|mesh-list
43826878|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43826879|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43826880|NCT05493657|Analgesics|analgesics|mesh-ancestor
43826881|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
43826882|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826883|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826884|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826885|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826886|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43669711|NCT02902432|Endostar protein|endostar protein|mesh-list
43669713|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43669714|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43669715|NCT02902432|Growth Substances|growth substances|mesh-ancestor
43669722|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669724|NCT02902380|Analgesics|analgesics|mesh-ancestor
43669759|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669760|NCT02901977|Ramipril|ramipril|mesh-list
43669761|NCT02901977|Doxazosin|doxazosin|mesh-list
43669762|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43669763|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
43669764|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669765|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669766|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43669767|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43669768|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43669824|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43669825|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669826|NCT02901288|Renal Agents|renal agents|mesh-ancestor
43669827|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43669828|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43669829|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43669830|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669831|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43669887|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43669888|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43669889|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669890|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
43669891|NCT02900729|Losartan|losartan|mesh-list
43826935|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43669916|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43669917|NCT02900742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43669918|NCT02900742|Immunologic Factors|immunologic factors|mesh-ancestor
43669919|NCT02900742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669920|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
43669921|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
43669922|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
43669923|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43669924|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43669926|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43669927|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669928|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43669929|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43669944|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669945|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43670010|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670011|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670012|NCT02899182|Analgesics|analgesics|mesh-ancestor
43670013|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
43670014|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670015|NCT02899169|Tretinoin|tretinoin|mesh-list
43670016|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
43670017|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
43670018|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670019|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
43670020|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
43670021|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
43670049|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670050|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670051|NCT02898792|Analgesics|analgesics|mesh-ancestor
43670052|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
43670053|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670054|NCT02898779|Primaquine|primaquine|mesh-list
43670055|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
43670056|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43670057|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43670058|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670059|NCT02898571|Ascorbic Acid|ascorbic acid|mesh-list
43670060|NCT02898571|Vitamins|vitamins|mesh-ancestor
43670061|NCT02898571|Micronutrients|micronutrients|mesh-ancestor
43670062|NCT02898571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670063|NCT02898571|Antioxidants|antioxidants|mesh-ancestor
43670064|NCT02898571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670065|NCT02898571|Protective Agents|protective agents|mesh-ancestor
43670066|NCT02898376|Tocopherols|tocopherols|mesh-list
43670067|NCT02898376|Vitamin E|vitamin e|mesh-list
43670068|NCT02898376|Tocotrienols|tocotrienols|mesh-list
43670069|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
43670070|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
43670071|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43670072|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670073|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670074|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43670075|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43670076|NCT02898376|Protective Agents|protective agents|mesh-ancestor
43670077|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670078|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
43670079|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43670081|NCT02898376|Vitamins|vitamins|mesh-ancestor
43670082|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
43670083|NCT02898610|Colchicine|colchicine|mesh-list
43670084|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
43670085|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670086|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43670087|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670088|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670089|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670090|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670091|NCT02897934|Bupivacaine|bupivacaine|mesh-list
43670092|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670093|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
43670094|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670095|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670096|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
43670097|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670098|NCT02897986|Vinorelbine|vinorelbine|mesh-list
43670099|NCT02897986|Propranolol|propranolol|mesh-list
43670100|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43670101|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670102|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
43670103|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670104|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670154|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
43670155|NCT02897830|Hormones|hormones|mesh-ancestor
43670156|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43670157|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43670158|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670159|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
43670160|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670161|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43670162|NCT02897830|Growth Substances|growth substances|mesh-ancestor
43670163|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670164|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670165|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670166|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670167|NCT02897765|Nivolumab|nivolumab|mesh-list
43670168|NCT02897765|Poly ICLC|poly iclc|mesh-list
43670169|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
43670170|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670171|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670178|NCT02897596|Grazoprevir|grazoprevir|mesh-list
43827017|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43827018|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43827019|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43827020|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827021|NCT05492591|Valacyclovir|valacyclovir|mesh-list
43827022|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
43827023|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827024|NCT05492565|Tenofovir|tenofovir|mesh-list
43827025|NCT05492565|Emtricitabine|emtricitabine|mesh-list
43827026|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
43827027|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827028|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43827029|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670333|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43670334|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
43670335|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43670336|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670337|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43670338|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
43670339|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43670340|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670341|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670342|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670343|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
43670345|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43670346|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43670347|NCT02896101|Analgesics|analgesics|mesh-ancestor
43670348|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
43670349|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670360|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
43670434|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43670435|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670436|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
43670437|NCT02895321|Listerine|listerine|mesh-list
43670438|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
43670439|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
43670440|NCT02895321|Protective Agents|protective agents|mesh-ancestor
43670441|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670442|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43670443|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670444|NCT02894983|Calpastatin|calpastatin|mesh-list
43670445|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43670446|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
43670447|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670448|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670449|NCT02895022|Lidocaine|lidocaine|mesh-list
43670509|NCT02894593|Protective Agents|protective agents|mesh-ancestor
43670510|NCT02894554|Lamivudine|lamivudine|mesh-list
43670511|NCT02894554|Telbivudine|telbivudine|mesh-list
43670512|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43670513|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43670514|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670515|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670516|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
43670517|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670518|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43670519|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43670520|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
43670521|NCT02894606|Basiliximab|basiliximab|mesh-list
43670522|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
43670523|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670524|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670525|NCT02894684|Aztreonam|aztreonam|mesh-list
43670527|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43670528|NCT02894710|Lidocaine|lidocaine|mesh-list
43670529|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670530|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
43670531|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670532|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670533|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
43670534|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670535|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43670536|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43670537|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43670538|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43670539|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670540|NCT02894645|Cytarabine|cytarabine|mesh-list
43670541|NCT02894645|Dexamethasone|dexamethasone|mesh-list
43670542|NCT02894645|Prednisolone|prednisolone|mesh-list
43670543|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
43670544|NCT02894645|Doxorubicin|doxorubicin|mesh-list
43670545|NCT02894645|Methotrexate|methotrexate|mesh-list
43670546|NCT02894645|Fludarabine|fludarabine|mesh-list
43670547|NCT02894645|Vincristine|vincristine|mesh-list
43670548|NCT02894645|Daunorubicin|daunorubicin|mesh-list
43670549|NCT02894645|Asparaginase|asparaginase|mesh-list
43670550|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
43670551|NCT02894645|Thioguanine|thioguanine|mesh-list
43670552|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43670553|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
43670554|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670555|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43670556|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43670557|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
43670569|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43670570|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43670571|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43670572|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43670573|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43670574|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43670575|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
43670576|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43670588|NCT05428072|Aspirin|aspirin|mesh-list
43670638|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43670639|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43670640|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670641|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43670642|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43670643|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670666|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773387|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
43670667|NCT05427305|Bevacizumab|bevacizumab|mesh-list
43670668|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670669|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670670|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670671|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43670728|NCT05426486|Pertuzumab|pertuzumab|mesh-list
43670729|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670730|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
43670731|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
43670732|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
43670733|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670734|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43670735|NCT05426044|Metformin|metformin|mesh-list
43670736|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43670737|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670738|NCT05425914|Vitamin D|vitamin d|mesh-list
43670739|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
43670740|NCT05425914|Vitamins|vitamins|mesh-ancestor
43670741|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
43670794|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
43670795|NCT05424692|Irinotecan|irinotecan|mesh-list
43670796|NCT05424692|Cetuximab|cetuximab|mesh-list
43670797|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
43670798|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670799|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43670800|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646265|NCT03292861|Tacrolimus|tacrolimus|mesh-list
43646266|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
43646267|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43647467|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
43647468|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
43647469|NCT01269853|Bevacizumab|bevacizumab|mesh-list
43647470|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647471|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647472|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43647473|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647672|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647674|NCT05620641|Ondansetron|ondansetron|mesh-list
43846401|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43846402|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846403|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846404|NCT04201197|Hormones|hormones|mesh-ancestor
43846405|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846406|NCT04200066|Tamoxifen|tamoxifen|mesh-list
43846407|NCT04200066|Temozolomide|temozolomide|mesh-list
43846408|NCT04200066|Maprotiline|maprotiline|mesh-list
43649013|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649014|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
43649025|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650095|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650096|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
43650097|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650098|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
43650099|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824428|NCT05512481|Temozolomide|temozolomide|mesh-list
43824430|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824431|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
43824432|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824433|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824434|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652541|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
43652542|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652543|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652544|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43652545|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652546|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
43652547|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
43652548|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652549|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43652550|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43652551|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652619|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
43652620|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43652621|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43652623|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
43652624|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653435|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653436|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653437|NCT02984657|Anesthetics|anesthetics|mesh-list
43653438|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653439|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653441|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
43653442|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
43653443|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653444|NCT02984475|Metformin|metformin|mesh-list
43656412|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656413|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656415|NCT02961816|Gemcitabine|gemcitabine|mesh-list
43656416|NCT02961816|Dexamethasone|dexamethasone|mesh-list
43656417|NCT02961816|Rituximab|rituximab|mesh-list
43656418|NCT02961816|Melphalan|melphalan|mesh-list
43656453|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656455|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
43656456|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656676|NCT02959255|Esomeprazole|esomeprazole|mesh-list
43656677|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43656678|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656679|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43656680|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656681|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656682|NCT02959229|Lactoferrin|lactoferrin|mesh-list
43656683|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656684|NCT02959359|Ribavirin|ribavirin|mesh-list
43656685|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
43656686|NCT02959359|Ledipasvir|ledipasvir|mesh-list
43656687|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
43656688|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656689|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
43656742|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43656743|NCT02958852|Letrozole|letrozole|mesh-list
43656796|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656797|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
43656798|NCT02958761|Protective Agents|protective agents|mesh-ancestor
43656969|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43656970|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43656971|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656972|NCT02957890|Vaccines|vaccines|mesh-list
43656973|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
43656974|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656975|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
43656976|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43656977|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
43656978|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
43656979|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656980|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656981|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656982|NCT02957851|Analgesics|analgesics|mesh-ancestor
43656983|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
43656984|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656985|NCT02957643|Iron|iron|mesh-list
43656986|NCT02957643|Trace Elements|trace elements|mesh-ancestor
43656987|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
43656988|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656989|NCT02957604|Evolocumab|evolocumab|mesh-list
43656990|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43656991|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656992|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
43656993|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656994|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656995|NCT02957435|Eplerenone|eplerenone|mesh-list
43656996|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43656997|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825275|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657021|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657022|NCT02957630|Drospirenone|drospirenone|mesh-list
43657023|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
43657024|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43657025|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43657026|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
43657027|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43657031|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43657697|NCT02951234|Aspirin|aspirin|mesh-list
43657698|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43657699|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
43657700|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43657701|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43657702|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657795|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
43657796|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657797|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43657798|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
43657799|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657800|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43657801|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
43657802|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
43657803|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43657804|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657805|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
43657806|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
43657807|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657808|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657809|NCT02950168|Edoxaban|edoxaban|mesh-list
43657810|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43657811|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
43657924|NCT02949349|Prednisolone|prednisolone|mesh-list
43657925|NCT02949349|Azathioprine|azathioprine|mesh-list
43825474|NCT05499897|Anesthetics|anesthetics|mesh-list
43657926|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43657927|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657928|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43657929|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
43657930|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43657931|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657932|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665137|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43665138|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43665139|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
43665140|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665141|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43665142|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43665143|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665144|NCT02521753|Metformin|metformin|mesh-list
43665145|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665146|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665147|NCT02500147|Metformin|metformin|mesh-list
43665148|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665149|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665150|NCT02496585|Prednisone|prednisone|mesh-list
43665151|NCT02496585|Nintedanib|nintedanib|mesh-list
43665591|NCT05468372|Amebicides|amebicides|mesh-ancestor
43665592|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43665593|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43665594|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665595|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665596|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
43665646|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
43826416|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826417|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43826419|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666040|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
43666041|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666043|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
43666044|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
43666045|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666046|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831670|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831671|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43831672|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43831674|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831675|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43831676|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
43831677|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
43831681|NCT05302856|Antibodies|antibodies|mesh-list
43711409|NCT02689843|Metformin|metformin|mesh-list
43711410|NCT02689843|Pioglitazone|pioglitazone|mesh-list
43711411|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
43711412|NCT02689843|Spironolactone|spironolactone|mesh-list
43711413|NCT02689843|Cyproterone|cyproterone|mesh-list
43711414|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43711415|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711416|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43711417|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711418|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711419|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43711420|NCT02689843|Diuretics|diuretics|mesh-ancestor
43711673|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711674|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43711676|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711677|NCT02687984|Risperidone|risperidone|mesh-list
43711678|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43711679|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
43711680|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831792|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831793|NCT05297448|Rifaximin|rifaximin|mesh-list
43831794|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43831795|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831796|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831797|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
43831798|NCT05297396|Narcotics|narcotics|mesh-ancestor
43831799|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831800|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831801|NCT05297396|Analgesics|analgesics|mesh-ancestor
43831802|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
43831803|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831804|NCT05296577|Vinorelbine|vinorelbine|mesh-list
43831805|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43831806|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831807|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
43831808|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
43831809|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712149|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712150|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712151|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43712152|NCT02685449|Insulin|insulin|mesh-list
43712153|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43712154|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
43712155|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
43712156|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
43712157|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43712158|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712159|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43712170|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712171|NCT02685228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712172|NCT02685228|Immunologic Factors|immunologic factors|mesh-ancestor
43712174|NCT02685163|Antioxidants|antioxidants|mesh-list
43712216|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
43712217|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712219|NCT02684799|Omeprazole|omeprazole|mesh-list
43712220|NCT02684799|Famotidine|famotidine|mesh-list
43712221|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43712222|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712223|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43712224|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712250|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
43712251|NCT02685059|Durvalumab|durvalumab|mesh-list
43712252|NCT02685059|Epirubicin|epirubicin|mesh-list
43712253|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43712254|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712255|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
43712256|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
43712257|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712260|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
43712327|NCT02684019|Analgesics|analgesics|mesh-ancestor
43712328|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
43712329|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712330|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43712331|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43712332|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43712333|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
43712334|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712335|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712336|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
43712337|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43712338|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
43712339|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43712424|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712426|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
43712427|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712428|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712429|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712430|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712431|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712432|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712433|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712434|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43712436|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712437|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
43712438|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712439|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
43712440|NCT02683733|Curcumin|curcumin|mesh-list
43712441|NCT02683733|Mesalamine|mesalamine|mesh-list
43712442|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43712443|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43712444|NCT02683733|Analgesics|analgesics|mesh-ancestor
43712445|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
43831841|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831843|NCT05294146|Clofazimine|clofazimine|mesh-list
43831844|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831845|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
43831846|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43831847|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831848|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43831849|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
43831850|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831851|NCT05293288|Anesthetics|anesthetics|mesh-list
43831854|NCT05293210|Dexamethasone|dexamethasone|mesh-list
43712622|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712623|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
43712624|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712625|NCT02682134|Dexamethasone|dexamethasone|mesh-list
43712626|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
43712628|NCT02682134|BB 1101|bb 1101|mesh-list
43712629|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43712630|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
43712631|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
43712632|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712633|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712634|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712759|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43712760|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712761|NCT02681471|Mannitol|mannitol|mesh-list
43712782|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
43712783|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712784|NCT02681198|Lofexidine|lofexidine|mesh-list
43712785|NCT02681198|Paroxetine|paroxetine|mesh-list
43712786|NCT02681198|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43712787|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43712788|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712789|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712790|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712791|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
43712792|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712793|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43712794|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
43712853|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712854|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
43712855|NCT02680795|Belinostat|belinostat|mesh-list
43712856|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713019|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43713021|NCT02678975|Copper|copper|mesh-list
43713022|NCT02678975|Temozolomide|temozolomide|mesh-list
43713023|NCT02678975|Lomustine|lomustine|mesh-list
43713024|NCT02678975|Disulfiram|disulfiram|mesh-list
43713025|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
43713026|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43713027|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713028|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713029|NCT02678975|Trace Elements|trace elements|mesh-ancestor
43713030|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
43713116|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43713118|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
43713119|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
43713120|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43713121|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43713122|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43713123|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713124|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713125|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43713126|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43713127|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713128|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713129|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713130|NCT02678650|Anesthetics|anesthetics|mesh-list
43713131|NCT02678650|Propofol|propofol|mesh-list
43713132|NCT02678650|Isoflurane|isoflurane|mesh-list
43713133|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713162|NCT02678585|Nalbuphine|nalbuphine|mesh-list
43713163|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713164|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
43713301|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
43713302|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43713303|NCT02677571|Narcotics|narcotics|mesh-ancestor
43713304|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713305|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713306|NCT02677571|Analgesics|analgesics|mesh-ancestor
43713307|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
43713308|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713309|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713310|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
43713311|NCT02677532|Acetaminophen|acetaminophen|mesh-list
43713312|NCT02677532|Sufentanil|sufentanil|mesh-list
43713313|NCT02677532|Morphine|morphine|mesh-list
43713314|NCT02677532|Dsuvia|dsuvia|mesh-list
43713315|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
43713316|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43713317|NCT02677532|Narcotics|narcotics|mesh-ancestor
43713318|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713353|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
43713478|NCT02676336|Iodine|iodine|mesh-list
43713500|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43713501|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713502|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713503|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713504|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713505|NCT02675868|Protective Agents|protective agents|mesh-ancestor
43713508|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43713509|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
43713511|NCT02676011|Succinylcholine|succinylcholine|mesh-list
43713512|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43713513|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43713514|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43713515|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
43713516|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713571|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43713596|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
43713597|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
43713598|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713599|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713600|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
43713601|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713610|NCT02675335|Incretins|incretins|mesh-ancestor
43713727|NCT02674893|Hormones|hormones|mesh-ancestor
43713728|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713729|NCT02674581|Fostemsavir|fostemsavir|mesh-list
43713730|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43713731|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43713732|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
43713733|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43713734|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43713735|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43713736|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713737|NCT02674295|Esketamine|esketamine|mesh-list
43713738|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
43713739|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43713740|NCT02674308|Vedolizumab|vedolizumab|mesh-list
43713741|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43713742|NCT02674555|Naquotinib|naquotinib|mesh-list
43713743|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713834|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43713835|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43713836|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43713837|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
43713838|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43713839|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
43713840|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43832011|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
43832012|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832013|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
43832014|NCT05286320|Lenvatinib|lenvatinib|mesh-list
43832015|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832016|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832017|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43713934|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43713935|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713936|NCT02672202|Pregabalin|pregabalin|mesh-list
43713937|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43713938|NCT02672202|Analgesics|analgesics|mesh-ancestor
43713942|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
43714014|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714015|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714016|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
43714017|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714018|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714019|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714020|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43714021|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43714022|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43714023|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714057|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
43714058|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714059|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
43714060|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43714064|NCT02671084|Sevoflurane|sevoflurane|mesh-list
43714146|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
43714147|NCT02670616|Rituximab|rituximab|mesh-list
43714148|NCT02670616|Doxorubicin|doxorubicin|mesh-list
43714149|NCT02670616|Vincristine|vincristine|mesh-list
43714150|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714151|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
43714170|NCT02670616|Hormones|hormones|mesh-ancestor
43714226|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714227|NCT02670304|Aspirin|aspirin|mesh-list
43714228|NCT02670304|Letrozole|letrozole|mesh-list
43714229|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43714230|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714231|NCT02670304|Analgesics|analgesics|mesh-ancestor
43714232|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
43714233|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714234|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714235|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714236|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43714237|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43714238|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43714239|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714240|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43714241|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43714242|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714243|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
43714244|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714299|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714301|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
43714302|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714317|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43714318|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43714319|NCT02669459|Imiquimod|imiquimod|mesh-list
43714320|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43714321|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
43714322|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714323|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714324|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
43832059|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43832060|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832061|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
43832062|NCT05282901|Lenvatinib|lenvatinib|mesh-list
43832063|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832064|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832065|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43832066|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832067|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832068|NCT05281471|Gemcitabine|gemcitabine|mesh-list
43832069|NCT05281471|Paclitaxel|paclitaxel|mesh-list
43832070|NCT05281471|Docetaxel|docetaxel|mesh-list
43714325|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
43714326|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43714327|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43714391|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43714414|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
43714415|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
43714416|NCT02668861|Hormones|hormones|mesh-ancestor
43714417|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714418|NCT02668926|Amphetamine|amphetamine|mesh-list
43714419|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43714420|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
43714421|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43714422|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714423|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
43714424|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
43714425|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714426|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
43714427|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714428|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714429|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
43714430|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43714431|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43714432|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714433|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43714434|NCT02668679|Hormones|hormones|mesh-list
43714435|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714436|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714437|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43714438|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43714439|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714479|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714480|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714481|NCT02667925|Cisplatin|cisplatin|mesh-list
43714482|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714483|NCT02668094|Lidocaine|lidocaine|mesh-list
43714484|NCT02668094|Pregabalin|pregabalin|mesh-list
43714485|NCT02668094|Propofol|propofol|mesh-list
43714486|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714487|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
43714488|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714489|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714490|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
43714491|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714492|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43714510|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43714511|NCT02667730|Analgesics|analgesics|mesh-ancestor
43714603|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714605|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43714606|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
43714607|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714608|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714609|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43714610|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43714611|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
43714612|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43714613|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43714614|NCT02666703|Prednisolone|prednisolone|mesh-list
43714615|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
43714616|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43714617|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
43714618|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714619|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
43714620|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
43714621|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714622|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714623|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714624|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
43714625|NCT02666703|Hormones|hormones|mesh-ancestor
43714626|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714627|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43714628|NCT02666703|Protective Agents|protective agents|mesh-ancestor
43714631|NCT02667054|Anesthetics|anesthetics|mesh-list
43714716|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714717|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714723|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714724|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714725|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714730|NCT02666092|Antibodies|antibodies|mesh-list
43714749|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43714750|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714751|NCT02666040|Anesthetics|anesthetics|mesh-list
43714752|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714753|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714754|NCT02665806|Fluticasone|fluticasone|mesh-list
43714755|NCT02665806|Ciclesonide|ciclesonide|mesh-list
43714756|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714757|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43714842|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43714843|NCT02666014|Neostigmine|neostigmine|mesh-list
43714844|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43714845|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714846|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714847|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
43714848|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714849|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714853|NCT02665702|Cisplatin|cisplatin|mesh-list
43715178|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43715179|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43715250|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715252|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715253|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715326|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715327|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715328|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832152|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
43715659|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715661|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715662|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
43715663|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43715664|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43715665|NCT02659293|Growth Substances|growth substances|mesh-ancestor
43652337|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
43715666|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
43715667|NCT02659085|Ketamine|ketamine|mesh-list
43715668|NCT02659085|Analgesics|analgesics|mesh-ancestor
43715669|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
43715700|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43715702|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715703|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715704|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715705|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43715706|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
43715707|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43715708|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715709|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43715745|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43715746|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715747|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
43715748|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715749|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715750|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
43715751|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715752|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43715753|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43715754|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43715755|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715872|NCT02658214|Folic Acid|folic acid|mesh-list
43715873|NCT02658214|Gemcitabine|gemcitabine|mesh-list
43715874|NCT02658214|Paclitaxel|paclitaxel|mesh-list
43715875|NCT02658214|Etoposide|etoposide|mesh-list
43715876|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43715877|NCT02658214|Carboplatin|carboplatin|mesh-list
43715878|NCT02658214|Fluorouracil|fluorouracil|mesh-list
43715879|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
43715880|NCT02658214|Durvalumab|durvalumab|mesh-list
43715881|NCT02658214|Tremelimumab|tremelimumab|mesh-list
43715882|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
43715883|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43715884|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715885|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
43715890|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
43715936|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
43715937|NCT02657616|Coagulants|coagulants|mesh-ancestor
43715938|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
43715939|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43715940|NCT02657694|Ledipasvir|ledipasvir|mesh-list
43715941|NCT02657694|Velpatasvir|velpatasvir|mesh-list
43715942|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
43715943|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715944|NCT02657460|Cisplatin|cisplatin|mesh-list
43715945|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715946|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43715947|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
43715948|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
43715974|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715976|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43715977|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43715978|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43715979|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715980|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715981|NCT02657213|Insulin|insulin|mesh-list
43715982|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43715983|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43715984|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715985|NCT02657161|Vaccines|vaccines|mesh-list
43715986|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
43715987|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715988|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
43715989|NCT02657148|Etonogestrel|etonogestrel|mesh-list
43715990|NCT02657148|Desogestrel|desogestrel|mesh-list
43715991|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43715992|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715993|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43715994|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43715995|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43832269|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832270|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
43832271|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
43832272|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43832273|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43832274|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832275|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832276|NCT05275725|Urological Agents|urological agents|mesh-ancestor
43832277|NCT05275426|Gemcitabine|gemcitabine|mesh-list
43832278|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832279|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
43832281|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716468|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43716469|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43716470|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716472|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43716473|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716474|NCT02653638|Analgesics|analgesics|mesh-ancestor
43716475|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
43716476|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716477|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716478|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716479|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716515|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716516|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43716517|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43716518|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
43716519|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716521|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
43716663|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716664|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716665|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43716666|NCT02652507|Analgesics|analgesics|mesh-ancestor
43716667|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
43716668|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716669|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43716670|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716671|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43716672|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
43716673|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716800|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43716801|NCT02651792|Narcotics|narcotics|mesh-ancestor
43716802|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43716803|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
43716804|NCT02651753|Atorvastatin|atorvastatin|mesh-list
43716805|NCT02651753|Fenofibrate|fenofibrate|mesh-list
43716806|NCT02651753|Calcium|calcium|mesh-list
43716807|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43716808|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716809|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43716810|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43716811|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43716812|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
43716813|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832293|NCT05273827|Paclitaxel|paclitaxel|mesh-list
43717240|NCT02649413|Hormones|hormones|mesh-ancestor
43717241|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717242|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717243|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717244|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717245|NCT02649140|Acetic Acid|acetic acid|mesh-list
43717361|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717362|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717363|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
43717364|NCT02648490|Hormones|hormones|mesh-ancestor
43717365|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717366|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717367|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717368|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717369|NCT02648490|Analgesics|analgesics|mesh-ancestor
43717370|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
43717371|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
43717399|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
43717400|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717401|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717402|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
43717403|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717404|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717405|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717406|NCT02648659|Amoxicillin|amoxicillin|mesh-list
43717407|NCT02648659|Metronidazole|metronidazole|mesh-list
43717408|NCT02648659|Clarithromycin|clarithromycin|mesh-list
43717409|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717410|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717411|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43717412|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43717413|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43717414|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717415|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717416|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43717417|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43717418|NCT02648412|Ketamine|ketamine|mesh-list
43717419|NCT02648412|Analgesics|analgesics|mesh-ancestor
43717420|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
43717530|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717531|NCT02647268|Analgesics|analgesics|mesh-ancestor
43717532|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
43717533|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717534|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
43717535|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717536|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43717905|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717906|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43717907|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43717908|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43717909|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
43717910|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717911|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43832390|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43832391|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43832392|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43832393|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43832394|NCT05268003|Venetoclax|venetoclax|mesh-list
43832395|NCT05268003|Ponatinib|ponatinib|mesh-list
43832396|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832397|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43718015|NCT02644629|Ketamine|ketamine|mesh-list
43718016|NCT02644629|Analgesics|analgesics|mesh-ancestor
43718017|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
43718018|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718019|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773452|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718020|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43718021|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43718022|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
43718023|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
43718024|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718025|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43718026|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43718027|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718028|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718029|NCT02644915|Edaravone|edaravone|mesh-list
43718030|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43718031|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
43718368|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718369|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43718370|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43718371|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43718372|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
43718373|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718374|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718376|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
43718377|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718378|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718379|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
43718380|NCT02643147|Furosemide|furosemide|mesh-list
43718385|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718386|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718387|NCT02643186|Misoprostol|misoprostol|mesh-list
43718388|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43718389|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
43718390|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43718391|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718392|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43718393|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718394|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
43718395|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
43718396|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43718397|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
43718398|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43718399|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
43718400|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718483|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43718484|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
43718485|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
43718486|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718487|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43718488|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43718491|NCT02642484|Gabapentin|gabapentin|mesh-list
43718533|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
43718534|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718535|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43718536|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
43718537|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43718538|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
43718539|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
43718540|NCT02642380|Dexamethasone|dexamethasone|mesh-list
43718541|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
43718542|NCT02642380|BB 1101|bb 1101|mesh-list
43718543|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718544|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
43718545|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
43718546|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718547|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718548|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718694|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718695|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
43718696|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718697|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
43718698|NCT02641639|Combretastatin|combretastatin|mesh-list
43718699|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43718700|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718728|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43718729|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718730|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718742|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718743|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718744|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
43718745|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718747|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43718748|NCT02641340|Narcotics|narcotics|mesh-ancestor
43718749|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718750|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718751|NCT02641340|Analgesics|analgesics|mesh-ancestor
43718752|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
43718817|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43718818|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
43718819|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718820|NCT02640794|Aspirin|aspirin|mesh-list
43718821|NCT02640794|Clopidogrel|clopidogrel|mesh-list
43718822|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43718823|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718824|NCT02640794|Analgesics|analgesics|mesh-ancestor
43718825|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
43718826|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718827|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718828|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718829|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718830|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43718901|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718902|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718903|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718904|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43718905|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43718906|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718907|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43718908|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
43718909|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
43718910|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
43718911|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43718912|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
43718913|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718914|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
43718915|NCT02640144|Protective Agents|protective agents|mesh-ancestor
43718916|NCT02640118|Lixisenatide|lixisenatide|mesh-list
43718917|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43718918|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718919|NCT02639858|Docetaxel|docetaxel|mesh-list
43718920|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718921|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
43718922|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
43718923|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
43718924|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718925|NCT02639767|Cisplatin|cisplatin|mesh-list
43718950|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718951|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43718952|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43718972|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43718973|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718974|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43832497|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43832498|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43832499|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43832528|NCT05258292|Insulin|insulin|mesh-list
43832529|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832530|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847475|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
43847476|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847477|NCT04102618|Trastuzumab|trastuzumab|mesh-list
43847478|NCT04102618|Atezolizumab|atezolizumab|mesh-list
43847479|NCT04102618|Letrozole|letrozole|mesh-list
43847481|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719075|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832531|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
43719076|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43719077|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43719078|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43719079|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719080|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
43719081|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719082|NCT02638857|Epirubicin|epirubicin|mesh-list
43719083|NCT02638857|Mitomycins|mitomycins|mesh-list
43719084|NCT02638857|Mitomycin|mitomycin|mesh-list
43719085|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
43719086|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43719087|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719088|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43719089|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43719103|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43719104|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43719105|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
43719106|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719107|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719127|NCT02638506|Fentanyl|fentanyl|mesh-list
43719128|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43719129|NCT02638506|Narcotics|narcotics|mesh-ancestor
43719138|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
43719139|NCT02638389|Sirolimus|sirolimus|mesh-list
43719140|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43719141|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719142|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43719143|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719144|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
43719145|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719146|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
43719147|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719148|NCT02638428|Cytarabine|cytarabine|mesh-list
43719149|NCT02638428|Carboplatin|carboplatin|mesh-list
43719150|NCT02638428|Trastuzumab|trastuzumab|mesh-list
43719151|NCT02638428|Fludarabine|fludarabine|mesh-list
43719152|NCT02638428|Etoposide|etoposide|mesh-list
43719153|NCT02638428|Everolimus|everolimus|mesh-list
43719154|NCT02638428|Sorafenib|sorafenib|mesh-list
43719155|NCT02638428|Dasatinib|dasatinib|mesh-list
43719156|NCT02638428|Ifosfamide|ifosfamide|mesh-list
43719157|NCT02638428|Axitinib|axitinib|mesh-list
43719158|NCT02638428|Vemurafenib|vemurafenib|mesh-list
43719159|NCT02638428|Crizotinib|crizotinib|mesh-list
43719160|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719200|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719233|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43719234|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719235|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43719236|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719237|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719238|NCT02637973|Empagliflozin|empagliflozin|mesh-list
43719239|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43719261|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719262|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
43719263|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
43719264|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43719265|NCT02637726|Narcotics|narcotics|mesh-ancestor
43719266|NCT02637726|Analgesics|analgesics|mesh-ancestor
43719267|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
43719268|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719269|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
43719270|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43719280|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719281|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719282|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719283|NCT02637466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43719284|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43719296|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719297|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
43719298|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719299|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43719301|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43652367|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652368|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652369|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
43652370|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
43719302|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719303|NCT02637375|Paclitaxel|paclitaxel|mesh-list
43719304|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
43719305|NCT02637375|Doxorubicin|doxorubicin|mesh-list
43719310|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
43719311|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719312|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719313|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
43719314|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719315|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43719316|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43719317|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
43719318|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43719319|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43719320|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43719370|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
43719371|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
43719372|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
43719373|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719374|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719375|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
43719376|NCT02636829|Calcium|calcium|mesh-list
43719388|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
43719389|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719390|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719391|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43719392|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43719393|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
43719394|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43719395|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43719396|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43719397|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43719399|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43719400|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43719401|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719402|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719403|NCT02636491|Insulin|insulin|mesh-list
43719404|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43719405|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43719406|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719407|NCT02636231|Endostatins|endostatins|mesh-list
43719408|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43719409|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43719410|NCT02636231|Growth Substances|growth substances|mesh-ancestor
43719411|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832733|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722135|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
43722137|NCT02618668|Analgesics|analgesics|mesh-ancestor
43722148|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722149|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722150|NCT02618395|Analgesics|analgesics|mesh-ancestor
43722151|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
43722152|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722153|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
43722154|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
43722155|NCT02618564|Sennosides|sennosides|mesh-list
43722156|NCT02618564|Laxatives|laxatives|mesh-ancestor
43722157|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722622|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722623|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722624|NCT02615782|Urological Agents|urological agents|mesh-ancestor
43722625|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43722626|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43722656|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722657|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722658|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722659|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43723043|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723044|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723045|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723046|NCT02612363|Analgesics|analgesics|mesh-ancestor
43723047|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
43723048|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43723049|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43723050|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43723051|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43723052|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723056|NCT02612272|Betamethasone|betamethasone|mesh-list
43833115|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833117|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723395|NCT02610088|Gliclazide|gliclazide|mesh-list
43723396|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43723397|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723398|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43723399|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723400|NCT02610127|Factor VIII|factor viii|mesh-list
43723401|NCT02610127|Coagulants|coagulants|mesh-ancestor
43723402|NCT02610075|Adavosertib|adavosertib|mesh-list
43723403|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723404|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723405|NCT02609932|Interferons|interferons|mesh-list
43723640|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723641|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723642|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723646|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723717|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
43723718|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723719|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43723720|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43723721|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
43723722|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43723723|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43723725|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43723726|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
43723727|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43723728|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723729|NCT02607982|Paclitaxel|paclitaxel|mesh-list
43723896|NCT02607423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723992|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
43723994|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
43723995|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
43723996|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723997|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723998|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
43723999|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724000|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43724033|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
43833188|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833190|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
43724085|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
43724086|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43724087|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724088|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43724089|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
43724090|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652371|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652372|NCT02999126|Narcotics|narcotics|mesh-ancestor
43652373|NCT02999126|Analgesics|analgesics|mesh-ancestor
43652376|NCT02998970|Empagliflozin|empagliflozin|mesh-list
43724091|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43724092|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
43724093|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724094|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43724095|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43724096|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
43724097|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724098|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43724099|NCT02606539|Antidotes|antidotes|mesh-ancestor
43724100|NCT02606539|Protective Agents|protective agents|mesh-ancestor
43724101|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
43724102|NCT02606539|Vitamins|vitamins|mesh-ancestor
43724103|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
43833206|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833207|NCT05228613|Vaccines|vaccines|mesh-list
43833208|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
43833209|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833210|NCT05227937|Amikacin|amikacin|mesh-list
43833211|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43833212|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833213|NCT05227664|Paclitaxel|paclitaxel|mesh-list
43833214|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43833215|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43833216|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833217|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
43833218|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
43724470|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724471|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724472|NCT02604004|Lamivudine|lamivudine|mesh-list
43724473|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43724474|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43724475|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724476|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724477|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
43724478|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724479|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43724480|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43724482|NCT02603965|Trace Elements|trace elements|mesh-ancestor
43724483|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
43724484|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724485|NCT02603757|Vitamin D|vitamin d|mesh-list
43724515|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724516|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43724517|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43724518|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43724519|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724521|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
43724522|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
43724523|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
43724711|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43724712|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724713|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773488|NCT02359136|Ropivacaine|ropivacaine|mesh-list
43773489|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773490|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773491|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773492|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
43773493|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773494|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43652377|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43824681|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
43724714|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43724715|NCT02602743|Narcotics|narcotics|mesh-ancestor
43724716|NCT02602652|Vaccines|vaccines|mesh-list
43724750|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724751|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724752|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724754|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43724816|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43724817|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43724818|NCT02602002|Remifentanil|remifentanil|mesh-list
43724819|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43724820|NCT02602002|Narcotics|narcotics|mesh-ancestor
43724821|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43724982|NCT02601235|Naphazoline|naphazoline|mesh-list
43724983|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724984|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43724985|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43724986|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
43724987|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724988|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724989|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
43724990|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
43724991|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724992|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
43724993|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43724994|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
43724996|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
43725151|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725152|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725153|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43725155|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43725156|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43725157|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43725158|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43725159|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43725160|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725210|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43725211|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725212|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725213|NCT02599532|Apixaban|apixaban|mesh-list
43725214|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43725215|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
43725216|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43725217|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
43725218|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725225|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725226|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43725274|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725275|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725276|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43725277|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
43725279|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43725280|NCT02599168|Analgesics|analgesics|mesh-ancestor
43725281|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
43725282|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43725283|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43725284|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43725430|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43725431|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43725432|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725433|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725434|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
43725435|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725436|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43725437|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43725438|NCT02598011|Flucytosine|flucytosine|mesh-list
43725439|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
43725440|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725441|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
43725442|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725443|NCT02597868|Capecitabine|capecitabine|mesh-list
43725444|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43725445|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
43725512|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725514|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
43725515|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725516|NCT02597231|Protective Agents|protective agents|mesh-ancestor
43725517|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725518|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725519|NCT02597309|Canagliflozin|canagliflozin|mesh-list
43725520|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43725521|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725522|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43725523|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725646|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725683|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43725684|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
43725685|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725686|NCT02596243|Vaccines|vaccines|mesh-list
43725732|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725733|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725734|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
43833342|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
43833343|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
43833344|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833345|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833346|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43833347|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
43833348|NCT05216055|Hormones|hormones|mesh-ancestor
43833349|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833350|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43833351|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833352|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
43833353|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
43833354|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725861|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43725862|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
43725863|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725864|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43725865|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43725927|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725928|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
43725929|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43725930|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833409|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833411|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43833412|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
43833413|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
43833414|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833415|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833416|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43725996|NCT02593695|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43725997|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43725998|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725999|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726009|NCT02593721|Ibuprofen|ibuprofen|mesh-list
43726058|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726060|NCT02593669|Hormones|hormones|mesh-ancestor
43726061|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726062|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43726063|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726064|NCT02593500|Budesonide|budesonide|mesh-list
43726065|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726066|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726152|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
43726153|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
43726154|NCT02593019|Adavosertib|adavosertib|mesh-list
43726155|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726156|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726157|NCT02593162|Ribavirin|ribavirin|mesh-list
43726158|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
43726159|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726160|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
43726161|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726195|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43726196|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
43726197|NCT02592772|Menthol|menthol|mesh-list
43726198|NCT02592772|Nicotine|nicotine|mesh-list
43726199|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43726200|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
43726265|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726267|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43726268|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43726269|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43726270|NCT02592226|Anesthetics|anesthetics|mesh-list
43726271|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43726272|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726273|NCT02592395|Folfirinox|folfirinox|mesh-list
43726274|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726275|NCT02592278|Listerine|listerine|mesh-list
43726276|NCT02592278|Fluorides|fluorides|mesh-list
43726277|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
43726278|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
43726305|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726306|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
43726307|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726308|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726309|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726310|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726311|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
43726312|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726313|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43726314|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43726315|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43726391|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43726392|NCT02591667|Growth Substances|growth substances|mesh-ancestor
43726393|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726394|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
43726395|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
43726396|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43726397|NCT02591628|Diuretics|diuretics|mesh-ancestor
43726398|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
43726399|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726400|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43726401|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726421|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43726422|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
43726423|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726424|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726425|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43726426|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43726427|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43726428|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43726429|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726430|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726431|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726520|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726521|NCT02590614|Vitamin D|vitamin d|mesh-list
43726522|NCT02590614|Vitamins|vitamins|mesh-ancestor
43726523|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
43726524|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726525|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43726526|NCT02590510|Methotrexate|methotrexate|mesh-list
43726527|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43726528|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
43726529|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726530|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726531|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43726532|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
43726533|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726559|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726587|NCT02590055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726588|NCT02590055|Immunologic Factors|immunologic factors|mesh-ancestor
43726589|NCT02590055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726590|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
43726591|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
43726592|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
43726593|NCT02590016|Insulin|insulin|mesh-list
43726594|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
43726595|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43726596|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726597|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
43726598|NCT02589782|Linezolid|linezolid|mesh-list
43726599|NCT02589782|Bedaquiline|bedaquiline|mesh-list
43726697|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
43726698|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726699|NCT02588937|Entecavir|entecavir|mesh-list
43726700|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
43726701|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726702|NCT02588534|Etanercept|etanercept|mesh-list
43726703|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43726704|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43726705|NCT02588534|Analgesics|analgesics|mesh-ancestor
43726706|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
43726707|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726708|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726709|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726710|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43726711|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773503|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773505|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
43773506|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43773507|NCT02359162|Gemcitabine|gemcitabine|mesh-list
43773508|NCT02359162|Prednisone|prednisone|mesh-list
43773509|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
43773510|NCT02359162|Doxorubicin|doxorubicin|mesh-list
43773511|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
43773512|NCT02359162|Etoposide|etoposide|mesh-list
43773513|NCT02359162|Vincristine|vincristine|mesh-list
43773514|NCT02359162|Pegaspargase|pegaspargase|mesh-list
43773515|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773516|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
43773517|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773518|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773519|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43773520|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
43773521|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773522|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726712|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726713|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
43726714|NCT02588547|Granisetron|granisetron|mesh-list
43726715|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
43726783|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726784|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726785|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726786|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
43726788|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726821|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43726822|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43726823|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
43726824|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726825|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
43726826|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726827|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726837|NCT02587533|Protective Agents|protective agents|mesh-ancestor
43726838|NCT02587416|Atorvastatin|atorvastatin|mesh-list
43726839|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726840|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726841|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
43726842|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726843|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726844|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726845|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726846|NCT02587390|Simvastatin|simvastatin|mesh-list
43726847|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43726848|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43726849|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
43726850|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644813|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
43726851|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43726852|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43726853|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726854|NCT02587273|Fentanyl|fentanyl|mesh-list
43726856|NCT02587273|Narcotics|narcotics|mesh-ancestor
43726863|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43726864|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
43726865|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
43726891|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726921|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726922|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43726923|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43726924|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726925|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726926|NCT02586987|Durvalumab|durvalumab|mesh-list
43726927|NCT02586987|Tremelimumab|tremelimumab|mesh-list
43726928|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43726929|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726930|NCT02586961|Betamethasone|betamethasone|mesh-list
43726931|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
43726932|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43726933|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
43726934|NCT02586961|Epinephrine|epinephrine|mesh-list
43726935|NCT02586961|Racepinephrine|racepinephrine|mesh-list
43728343|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
43728344|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728345|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728346|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43728347|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
43728348|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
43728349|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43728350|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
43833718|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833719|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
43833720|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833721|NCT05191004|Fulvestrant|fulvestrant|mesh-list
43833722|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43833723|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728422|NCT02576782|BB 1101|bb 1101|mesh-list
43773541|NCT02358707|Ibuprofen|ibuprofen|mesh-list
43728423|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728424|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
43728425|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
43728426|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728427|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728428|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728429|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
43728430|NCT02576782|Hormones|hormones|mesh-ancestor
43728461|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43728462|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43728463|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43728464|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
43728465|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43728469|NCT02576808|Loratadine|loratadine|mesh-list
43728470|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
43728471|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
43728472|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43728473|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43728507|NCT02576600|Propofol|propofol|mesh-list
43728508|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43728509|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729401|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729402|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729403|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
43729404|NCT02571842|Hormones|hormones|mesh-ancestor
43729405|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729406|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43729407|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43729408|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
43729409|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729410|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729412|NCT02571959|Amoxicillin|amoxicillin|mesh-list
43729568|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729599|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729601|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
43729602|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43729603|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729604|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43729605|NCT02570841|Capsaicin|capsaicin|mesh-list
43729606|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
43729607|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
43729608|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
43729609|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729611|NCT02570789|Sunitinib|sunitinib|mesh-list
43648508|NCT02748018|Insulin|insulin|mesh-list
43648509|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43648510|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648511|NCT02720445|Nicotine|nicotine|mesh-list
43648512|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43648513|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
43648514|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648515|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648516|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43729860|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43729861|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43729862|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43729863|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729864|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729865|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43729866|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43729867|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
43729868|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43729869|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43729870|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43729872|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43729873|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
43729874|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
43729875|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
43729876|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43729877|NCT02568943|Panobinostat|panobinostat|mesh-list
43729956|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
43729957|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43729958|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43729959|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729960|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43729961|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43730380|NCT02565836|Coagulants|coagulants|mesh-ancestor
43730381|NCT02565641|Gemcitabine|gemcitabine|mesh-list
43730382|NCT02565641|Capecitabine|capecitabine|mesh-list
43730383|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43730384|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
43730385|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730386|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730387|NCT02565641|Antiviral Agents|antiviral agents|mesh-ancestor
43730388|NCT02565641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730389|NCT02565641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730390|NCT02565641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43730391|NCT02565641|Immunologic Factors|immunologic factors|mesh-ancestor
43730392|NCT02565641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730393|NCT02565693|Aspirin|aspirin|mesh-list
43730394|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
43730395|NCT02565693|Dipyridamole|dipyridamole|mesh-list
43730396|NCT02565693|Apixaban|apixaban|mesh-list
43730397|NCT02565693|Clopidogrel|clopidogrel|mesh-list
43730398|NCT02565693|Calcium|calcium|mesh-list
43730399|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43730400|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730401|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43730402|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43730500|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730501|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730503|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
43730504|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730506|NCT02564094|Hematinics|hematinics|mesh-ancestor
43730507|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
43730508|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43730509|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730510|NCT02564003|Oxycodone|oxycodone|mesh-list
43730511|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43730512|NCT02564003|Narcotics|narcotics|mesh-ancestor
43730890|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43730892|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43730893|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43730894|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
43730895|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730896|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43730897|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43730898|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730899|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
43731698|NCT02556008|Cannabidiol|cannabidiol|mesh-list
43731699|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
43731700|NCT02556060|Lamotrigine|lamotrigine|mesh-list
43731701|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
43731702|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43731703|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731704|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731705|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43731706|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731707|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43731708|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43731709|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731710|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43731711|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43731713|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
43731714|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731715|NCT02555943|Ritonavir|ritonavir|mesh-list
43731716|NCT02555943|Tenofovir|tenofovir|mesh-list
43731717|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
43731718|NCT02555943|Entecavir|entecavir|mesh-list
43731719|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43731720|NCT02555943|Ledipasvir|ledipasvir|mesh-list
43731721|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43731722|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43731723|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
43731724|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648520|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731883|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
43731884|NCT02554955|Daclizumab|daclizumab|mesh-list
43731885|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43731886|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731887|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43731888|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
43731889|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731890|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732019|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
43732020|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732021|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732022|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43732023|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
43732024|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732025|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732026|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732027|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732028|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43732029|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43732030|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
43732031|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732032|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43732034|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43732035|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43732036|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732037|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732038|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43732039|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732040|NCT02552745|Analgesics|analgesics|mesh-ancestor
43732041|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
43732042|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732043|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732122|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43732123|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43732124|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732125|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732126|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
43732155|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43732156|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43732157|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43732159|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
43732254|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732256|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43732257|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
43732258|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732259|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732260|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43732261|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732262|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43732443|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732444|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
43732452|NCT02550249|Nivolumab|nivolumab|mesh-list
43732836|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43732837|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732838|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732839|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732840|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732842|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
43732883|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
43732884|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732886|NCT02547844|Efavirenz|efavirenz|mesh-list
43732887|NCT02547844|Emtricitabine|emtricitabine|mesh-list
43732888|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
43732889|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732890|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43732986|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43732987|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43732988|NCT02546843|Rocuronium|rocuronium|mesh-list
43732989|NCT02546843|Atracurium|atracurium|mesh-list
43732990|NCT02546843|Cisatracurium|cisatracurium|mesh-list
43732991|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43732992|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43732993|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43732994|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732995|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732996|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43732997|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43732998|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
43732999|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43733000|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733002|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733003|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43733004|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733029|NCT02546531|Antiviral Agents|antiviral agents|mesh-ancestor
43733030|NCT02546531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43733031|NCT02546531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733032|NCT02546531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733033|NCT02546531|Immunologic Factors|immunologic factors|mesh-ancestor
43733034|NCT02546531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733035|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43733036|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43733037|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
43733038|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733039|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
43733040|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733041|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
43733042|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43733043|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733044|NCT02546141|Caseins|caseins|mesh-list
43733045|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
43733046|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
43733048|NCT02546349|Fluticasone|fluticasone|mesh-list
43648565|NCT01013649|Gemcitabine|gemcitabine|mesh-list
43648566|NCT01013649|Fluorouracil|fluorouracil|mesh-list
43733816|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
43733817|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733818|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733819|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43733820|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733821|NCT03955861|Analgesics|analgesics|mesh-ancestor
43733822|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
43733823|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733996|NCT02542254|Albuterol|albuterol|mesh-list
43733997|NCT02542254|Ipratropium|ipratropium|mesh-list
43733998|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43733999|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
43734000|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734001|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734002|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43734018|NCT02542124|Interleukin-12|interleukin-12|mesh-list
43734019|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43734020|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
43734021|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734022|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43734023|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43734024|NCT02542124|Growth Substances|growth substances|mesh-ancestor
43834378|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
43834379|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834380|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834407|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
43735164|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43735166|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735167|NCT05298683|Analgesics|analgesics|mesh-ancestor
43735222|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43735223|NCT05298020|Gemcitabine|gemcitabine|mesh-list
43735224|NCT05298020|Paclitaxel|paclitaxel|mesh-list
43735225|NCT05298020|Endostar protein|endostar protein|mesh-list
43735226|NCT05298020|Endostatins|endostatins|mesh-list
43735227|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43735228|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735229|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
43735230|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
43735231|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
43735232|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735233|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43735234|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
43735235|NCT05298020|Antiviral Agents|antiviral agents|mesh-ancestor
43735236|NCT05298020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735237|NCT05298020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735238|NCT05298020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735239|NCT05298020|Immunologic Factors|immunologic factors|mesh-ancestor
43735240|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735241|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43735304|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735305|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43735306|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43735307|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43735308|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735309|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735310|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735558|NCT03547427|Acetaminophen|acetaminophen|mesh-list
43735560|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43735561|NCT03547427|Pramlintide|pramlintide|mesh-list
43735562|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43735563|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735564|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43735565|NCT03547427|Analgesics|analgesics|mesh-ancestor
43735566|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
43735567|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43735568|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
43735569|NCT03489525|Antibodies|antibodies|mesh-list
43735570|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
43735571|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
43735572|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
43648596|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648597|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648598|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648599|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648600|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648601|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648602|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
43648603|NCT00670358|Hormones|hormones|mesh-ancestor
43735703|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43735704|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43735705|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43735706|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43735707|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43735708|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43735709|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735711|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
43736267|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736270|NCT04614493|Temozolomide|temozolomide|mesh-list
43736271|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43736272|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
43736273|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736274|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736276|NCT04573673|Cathartics|cathartics|mesh-ancestor
43736305|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
43736307|NCT04488159|Antidotes|antidotes|mesh-ancestor
43736419|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43736420|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736421|NCT04295486|Aspirin|aspirin|mesh-list
43736422|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43736423|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43736424|NCT04295486|Analgesics|analgesics|mesh-ancestor
43736425|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
43736426|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736427|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736428|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43736429|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43736430|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43736431|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43736432|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736648|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43736649|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43736650|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736651|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736652|NCT05359341|Incretins|incretins|mesh-ancestor
43736653|NCT05359341|Hormones|hormones|mesh-ancestor
43736654|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736655|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
43736656|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736657|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736658|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
43736659|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43736660|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736661|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43736662|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
43736663|NCT05358977|Coagulants|coagulants|mesh-ancestor
43736664|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43736665|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
43736666|NCT05358509|Hematinics|hematinics|mesh-ancestor
43736761|NCT05357196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43736762|NCT05357196|Immunologic Factors|immunologic factors|mesh-ancestor
43736763|NCT05357196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736764|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
43736765|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43834646|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834647|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
43834648|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834649|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834650|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834651|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43834652|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847658|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736786|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736787|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
43736833|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43736834|NCT05355467|Tenofovir|tenofovir|mesh-list
43736835|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
43736836|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736837|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43736838|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43736839|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736840|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736841|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43736842|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43736843|NCT05355441|Analgesics|analgesics|mesh-list
43736888|NCT05348200|Hormones|hormones|mesh-ancestor
43834670|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834671|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834672|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834673|NCT05109364|Urological Agents|urological agents|mesh-ancestor
43834679|NCT05108870|Paclitaxel|paclitaxel|mesh-list
43737002|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43648611|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43737296|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43737297|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43737298|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43737300|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43737301|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43737302|NCT05071937|Talazoparib|talazoparib|mesh-list
43737336|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
43737337|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737338|NCT05021900|Tenalisib|tenalisib|mesh-list
43737339|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
43737340|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737341|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737481|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
43737482|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737483|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43737484|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43737485|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43737486|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43737488|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
43737489|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
43737490|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43737491|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737492|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
43847681|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43539678|NCT00092222|Zidovudine|zidovudine|mesh-list
43737572|NCT04718220|Antibodies|antibodies|mesh-list
43737573|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
43737574|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737575|NCT04713709|Naloxone|naloxone|mesh-list
43737576|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43737577|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737578|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
43737579|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737580|NCT04711837|Propofol|propofol|mesh-list
43737581|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43737704|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43737705|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737706|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
43737707|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737708|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
43737709|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43737710|NCT04535882|Protective Agents|protective agents|mesh-ancestor
43737727|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
43737728|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43737729|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43737730|NCT04502095|Renal Agents|renal agents|mesh-ancestor
43737731|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43737732|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43737733|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43737734|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737735|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737736|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737737|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43737738|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43737739|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43737740|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
43737741|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43737742|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43737743|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43737744|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43737745|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43737746|NCT04492254|Enoxaparin|enoxaparin|mesh-list
43737748|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43737749|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43737750|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737751|NCT04485130|Disulfiram|disulfiram|mesh-list
43737752|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43737753|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43737754|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737755|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737756|NCT04475835|Heparin|heparin|mesh-list
43737757|NCT04475835|Bivalirudin|bivalirudin|mesh-list
43737758|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
43737759|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43737760|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43737829|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737831|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
43737832|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43737902|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43737903|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
43737904|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737905|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43737906|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
43737907|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43737910|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
43738102|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738103|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43738104|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43738105|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648613|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648614|NCT00669734|Metronidazole|metronidazole|mesh-list
43648615|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
43648616|NCT00669734|Vaccines|vaccines|mesh-list
43648617|NCT00669734|Sargramostim|sargramostim|mesh-list
43738288|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834861|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834862|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834863|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834865|NCT05095961|Prednisone|prednisone|mesh-list
43738301|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738302|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43738303|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43738304|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738306|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43738307|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
43738308|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43738309|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
43738310|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
43738345|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738347|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43738348|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
43738379|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738380|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
43738381|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
43738382|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738383|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738384|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738385|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
43738386|NCT03567473|Hormones|hormones|mesh-ancestor
43738388|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834908|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43834909|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834941|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43834942|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834943|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834944|NCT05086627|Capecitabine|capecitabine|mesh-list
43834945|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
43738692|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43738693|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738694|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
43738695|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43738696|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43738697|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738698|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43738986|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
43738987|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738989|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43738990|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738991|NCT01033032|Amrubicin|amrubicin|mesh-list
43738992|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738993|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43738994|NCT00750698|Entinostat|entinostat|mesh-list
43738995|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738996|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43738997|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739084|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
43739085|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
43739086|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739087|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
43739088|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739089|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
43739090|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43739124|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
43739477|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739478|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43739479|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
43739480|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739481|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43739482|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739678|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
43739679|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43739680|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739681|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
43739682|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43739683|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43739684|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43739685|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
43739686|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43835108|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43835109|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
43835110|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
43835111|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43835112|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
43835113|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43835114|NCT05076006|PF-06700841|pf-06700841|mesh-list
43835115|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43835116|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835117|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835118|NCT05075993|Paclitaxel|paclitaxel|mesh-list
43835119|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43835120|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
43835121|NCT05075993|Bevacizumab|bevacizumab|mesh-list
43835122|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43739951|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
43739952|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739953|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43739954|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43739955|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43739956|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
43739957|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739958|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43739959|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43739960|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43739961|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43739962|NCT02532335|Cathartics|cathartics|mesh-ancestor
43739963|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43739964|NCT02532114|Niclosamide|niclosamide|mesh-list
43739965|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
43739966|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43740096|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43740097|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
43740098|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43740099|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43740100|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
43740424|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43740425|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
43740426|NCT02529787|Lansoprazole|lansoprazole|mesh-list
43740427|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43740428|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43740429|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43740550|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43740584|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
43740585|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740586|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43740587|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740588|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740589|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740590|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43740591|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
43740623|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
43740625|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
43740626|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740628|NCT02528461|Liver Extracts|liver extracts|mesh-list
43740629|NCT02528461|Hematinics|hematinics|mesh-ancestor
43740630|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
43740631|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740632|NCT02528513|Fentanyl|fentanyl|mesh-list
43740633|NCT02528513|Midazolam|midazolam|mesh-list
43740634|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
43740635|NCT02528513|Propofol|propofol|mesh-list
43740636|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43740716|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740718|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
43740719|NCT02528123|Hormones|hormones|mesh-ancestor
43740720|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740721|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43740722|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740723|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43740724|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43740725|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43740726|NCT02528123|Renal Agents|renal agents|mesh-ancestor
43740727|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740728|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740759|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740760|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43740761|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
43740762|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740763|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740764|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43740776|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740777|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
43740778|NCT02527746|Epirubicin|epirubicin|mesh-list
43740779|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43740780|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
43740781|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740782|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43740783|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43740784|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
43740785|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740786|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740787|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43740788|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43740789|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43740790|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740791|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43740792|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
43740793|NCT02527785|Irinotecan|irinotecan|mesh-list
43740794|NCT02527785|Tegafur|tegafur|mesh-list
43740795|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43740796|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43740797|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43740829|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43740830|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
43740831|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43740832|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741033|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
43741034|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43741035|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741097|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
43741098|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
43741099|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43741100|NCT02526030|Aripiprazole|aripiprazole|mesh-list
43741101|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43741103|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
43741106|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43835210|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43835212|NCT05066607|Hormones|hormones|mesh-ancestor
43835213|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835214|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43835215|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43637387|NCT04604704|Vitamins|vitamins|mesh-ancestor
43835216|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
43741124|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
43741125|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
43741126|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43741127|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741128|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43741129|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
43741156|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43741157|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43741159|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43741160|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43741161|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
43741162|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741163|NCT02525211|Ropivacaine|ropivacaine|mesh-list
43741164|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
43741165|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
43741166|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43741361|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43741362|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43741363|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741364|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43741365|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
43741366|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43741367|NCT05671497|Protective Agents|protective agents|mesh-ancestor
43741368|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43741369|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43741370|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43741371|NCT05671276|Aspirin|aspirin|mesh-list
43741372|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
43741527|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741529|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43741530|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43741531|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43741532|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43741533|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43741677|NCT05667805|Thrombin|thrombin|mesh-list
43742087|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742088|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742089|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43742090|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
43742091|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742202|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
43742204|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43742205|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
43742206|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742207|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43742208|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43742209|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
43742210|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742211|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43742212|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43742244|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742245|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43742352|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742424|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
43742425|NCT05201248|Rituximab|rituximab|mesh-list
43742444|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
43742446|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43742447|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43742448|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43742449|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43742450|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43742451|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43742452|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43742453|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43742454|NCT05201248|Growth Substances|growth substances|mesh-ancestor
43742455|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
43742456|NCT05199662|Tenecteplase|tenecteplase|mesh-list
43742461|NCT05194397|Niacin|niacin|mesh-list
43835595|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43835596|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
43835597|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
43835598|NCT05037500|Decitabine|decitabine|mesh-list
43835599|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43835600|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
43835601|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835602|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835603|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835604|NCT05036798|Lenvatinib|lenvatinib|mesh-list
43743148|NCT04629976|Tenofovir|tenofovir|mesh-list
43743149|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
43743150|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648618|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
43648619|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648620|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743152|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43743153|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743154|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743155|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43743156|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43743157|NCT04624230|Tofacitinib|tofacitinib|mesh-list
43743158|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743159|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743160|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743161|NCT04620187|Cisplatin|cisplatin|mesh-list
43743195|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
43743196|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
43743197|NCT04608487|Fludarabine|fludarabine|mesh-list
43743935|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43743936|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43743939|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43743940|NCT04175600|Selexipag|selexipag|mesh-list
43743941|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43743942|NCT04172532|Peposertib|peposertib|mesh-list
43743943|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43743944|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43743945|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744063|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
43744064|NCT04068103|Vitamins|vitamins|mesh-ancestor
43744065|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
43744066|NCT04068103|Hematinics|hematinics|mesh-ancestor
43744067|NCT04064060|Luspatercept|luspatercept|mesh-list
43744068|NCT04064060|Hematinics|hematinics|mesh-ancestor
43744097|NCT04052880|Hormones|hormones|mesh-ancestor
43744098|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744099|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43744100|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744101|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
43744102|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43744103|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43744104|NCT04052880|Growth Substances|growth substances|mesh-ancestor
43744105|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
43744106|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43744107|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744108|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835661|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43835662|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43835663|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835664|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43835665|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43835666|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
43835667|NCT05031481|Butoconazole|butoconazole|mesh-list
43835668|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
43835669|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847752|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43744215|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43744220|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744221|NCT03907488|Lenograstim|lenograstim|mesh-list
43744222|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
43744223|NCT03907488|Imidazole|imidazole|mesh-list
43744224|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
43744225|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744226|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744227|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43744228|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43744229|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43744230|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744231|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744339|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43744340|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744376|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
43744377|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43744378|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
43744379|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
43744380|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744506|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744507|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744508|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744573|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744575|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43744576|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
43744654|NCT03263572|Ponatinib|ponatinib|mesh-list
43744655|NCT03263572|Antibodies|antibodies|mesh-list
43744656|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
43744657|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43744658|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
43744659|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43744660|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
43744661|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43744662|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744663|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43744664|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
43744665|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43744666|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43744843|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43744844|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43744845|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43744846|NCT02964273|Tolvaptan|tolvaptan|mesh-list
43744847|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43744849|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
43835738|NCT05025787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43835739|NCT05025787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43835741|NCT05025787|Sensory System Agents|sensory system agents|mesh-ancestor
43835742|NCT05025787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43745210|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773617|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43745211|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43745212|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
43745213|NCT02576574|Antiviral Agents|antiviral agents|mesh-ancestor
43745214|NCT02576574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43745215|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43745216|NCT02576574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43745217|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
43745218|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43745219|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43745220|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43745223|NCT02568553|Lenalidomide|lenalidomide|mesh-list
43745627|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43745629|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43745808|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
43745809|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
43745810|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43747444|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
43747445|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43747446|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43747447|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
43747448|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
43747480|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747482|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
43747483|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747484|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748150|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748151|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748152|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
43748153|NCT03860038|Hormones|hormones|mesh-ancestor
43748154|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748212|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
43748213|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748214|NCT03425331|Nivolumab|nivolumab|mesh-list
43748215|NCT03425331|Ipilimumab|ipilimumab|mesh-list
43748216|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748217|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748218|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43748219|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748220|NCT03387423|Tofacitinib|tofacitinib|mesh-list
43748221|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43748222|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748223|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748224|NCT03297593|Nivolumab|nivolumab|mesh-list
43748225|NCT03297593|Ipilimumab|ipilimumab|mesh-list
43748226|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748227|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748228|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43748229|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748230|NCT03218137|Adenosine|adenosine|mesh-list
43748315|NCT02911142|Hormones|hormones|mesh-ancestor
43748316|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43748317|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43748318|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43748319|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
43748320|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
43748321|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
43748322|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551515|NCT03612947|Analgesics|analgesics|mesh-ancestor
43748323|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43748324|NCT02911142|Growth Substances|growth substances|mesh-ancestor
43748325|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748326|NCT02546661|Durvalumab|durvalumab|mesh-list
43748327|NCT02546661|Olaparib|olaparib|mesh-list
43748328|NCT02546661|Adavosertib|adavosertib|mesh-list
43748329|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43748330|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43748331|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43748332|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748334|NCT02437370|Gemcitabine|gemcitabine|mesh-list
43836043|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43836044|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43836045|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43748773|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43748774|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
43748775|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748841|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748842|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43748843|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43748845|NCT02515201|Taurolidine|taurolidine|mesh-list
43749164|NCT02513147|Darunavir|darunavir|mesh-list
43749165|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
43749166|NCT02513147|Dolutegravir|dolutegravir|mesh-list
43749167|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43749168|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43749169|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
43749170|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749171|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749172|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43749173|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43749174|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
43749175|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43749176|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43749177|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43749178|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43749179|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43749180|NCT02513069|Nicotine|nicotine|mesh-list
43749181|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
43749182|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43749183|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
43749184|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749185|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749186|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43749187|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43749464|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749465|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749466|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
43749467|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
43749468|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749470|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43749471|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43749472|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
43749473|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
43749474|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43749475|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749476|NCT02510534|Menotropins|menotropins|mesh-list
43749477|NCT02510534|Progesterone|progesterone|mesh-list
43749478|NCT02510534|Progestins|progestins|mesh-ancestor
43749479|NCT02510534|Hormones|hormones|mesh-ancestor
43749480|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43749481|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749482|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43749484|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43836135|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43836136|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
43836137|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836138|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836139|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43836140|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836141|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43836142|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836143|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836144|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
43749650|NCT02509559|Propranolol|propranolol|mesh-list
43749652|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43749672|NCT02509286|Fluorouracil|fluorouracil|mesh-list
43749673|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
43749674|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43749675|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749676|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749677|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749678|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749679|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749680|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
43749681|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43749682|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43749683|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
43749684|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749685|NCT02509286|Antidotes|antidotes|mesh-ancestor
43749686|NCT02509286|Protective Agents|protective agents|mesh-ancestor
43749687|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
43749688|NCT02509286|Vitamins|vitamins|mesh-ancestor
43749689|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
43749770|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
43749771|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749772|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749773|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43749774|NCT02508805|Diclofenac|diclofenac|mesh-list
43749775|NCT02508805|Tizanidine|tizanidine|mesh-list
43749776|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43749777|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749778|NCT02508805|Analgesics|analgesics|mesh-ancestor
43749779|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
43836208|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
43749958|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749959|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
43749960|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749961|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749962|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43749963|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43749964|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749965|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836230|NCT04987775|Antidotes|antidotes|mesh-ancestor
43836231|NCT04987463|Sirolimus|sirolimus|mesh-list
43836232|NCT04987463|Vigabatrin|vigabatrin|mesh-list
43836233|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43836234|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836235|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43836236|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836237|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
43836238|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43836239|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
43836240|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836241|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
43836244|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
43836245|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847813|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847814|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43847815|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43847816|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847817|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43847818|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43847819|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847820|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
43847821|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847822|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
43847823|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847824|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847825|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
43847826|NCT04075149|Spironolactone|spironolactone|mesh-list
43847827|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43750073|NCT02506842|Gemcitabine|gemcitabine|mesh-list
43750074|NCT02506842|Fluorouracil|fluorouracil|mesh-list
43750075|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
43750076|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
43750077|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750078|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750079|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43750080|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
43750081|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
43750082|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43750083|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750084|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43750085|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
43750086|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750087|NCT02506842|Antidotes|antidotes|mesh-ancestor
43750088|NCT02506842|Protective Agents|protective agents|mesh-ancestor
43750089|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
43750364|NCT02505516|Metformin|metformin|mesh-list
43750365|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750366|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750367|NCT02505568|Infliximab|infliximab|mesh-list
43750368|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
43750369|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43750407|NCT02505282|Coagulants|coagulants|mesh-ancestor
43750408|NCT02505399|Clopidogrel|clopidogrel|mesh-list
43750409|NCT02505399|Ticagrelor|ticagrelor|mesh-list
43836256|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
43836257|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836258|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43836259|NCT04985760|Antacids|antacids|mesh-ancestor
43836260|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750605|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750606|NCT02504346|Osimertinib|osimertinib|mesh-list
43750607|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750608|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43750638|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750639|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43750640|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
43750641|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
43750642|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
43750643|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
43750644|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750645|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750646|NCT02504138|Anesthetics|anesthetics|mesh-list
43750647|NCT02504138|Propofol|propofol|mesh-list
43750648|NCT02504138|Desflurane|desflurane|mesh-list
43750649|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750650|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750709|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750710|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43750711|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43750712|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
43750713|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43750714|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
43750715|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
43750716|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
43750717|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43750718|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43750719|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43750720|NCT02503943|Metformin|metformin|mesh-list
43750721|NCT02503943|Liraglutide|liraglutide|mesh-list
43750722|NCT02503943|Mitiglinide|mitiglinide|mesh-list
43750723|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43750829|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43750830|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43554304|NCT03572829|Dexamethasone|dexamethasone|mesh-list
43750831|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43750832|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43750834|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
43750835|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750836|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750864|NCT02502175|Narcotics|narcotics|mesh-ancestor
43750865|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43750866|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43750867|NCT02502175|Analgesics|analgesics|mesh-ancestor
43750868|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
43750869|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43750911|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43750912|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43750913|NCT02501837|Oxytocin|oxytocin|mesh-list
43751157|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751158|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
43751159|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
43751160|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751161|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
43751162|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751163|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751164|NCT02500251|Rituximab|rituximab|mesh-list
43751165|NCT02500251|Bortezomib|bortezomib|mesh-list
43751166|NCT02500251|Belimumab|belimumab|mesh-list
43751167|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43751168|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43751169|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
43751170|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751171|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43751172|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43751173|NCT02500069|Caseins|caseins|mesh-list
43751174|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
43751301|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
43751302|NCT02499393|Analgesics|analgesics|mesh-ancestor
43751303|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
43751304|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751305|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751306|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
43751307|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43751308|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43751743|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43751780|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43751781|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
43751782|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
43751783|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43751784|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847832|NCT04075149|Diuretics|diuretics|mesh-ancestor
43847833|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
43847835|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
43847836|NCT04074746|Fludarabine|fludarabine|mesh-list
43847837|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
43751947|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43751948|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751949|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43751950|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43751951|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751953|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43751954|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43751955|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43751956|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
43751957|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43751958|NCT02494856|Naproxen|naproxen|mesh-list
43751959|NCT02494856|Esomeprazole|esomeprazole|mesh-list
43751960|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43751961|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43751962|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43751963|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43751964|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751965|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43751995|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43751996|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43751998|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43751999|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43752001|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
43752046|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43752047|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43752048|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43752049|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
43752050|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43752051|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43836451|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836452|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836453|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43752144|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43752145|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43752146|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43752147|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43752148|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43752149|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43752150|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
43752151|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43752152|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752153|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43752154|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752156|NCT02493192|Analgesics|analgesics|mesh-ancestor
43752157|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
43752158|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43752159|NCT02493283|Dapsone|dapsone|mesh-list
43752160|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752161|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
43752162|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752188|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
43752248|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752249|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43752250|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
43752251|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752252|NCT02492581|Nalmefene|nalmefene|mesh-list
43752280|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
43752281|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43752282|NCT02492282|Narcotics|narcotics|mesh-ancestor
43752283|NCT02492282|Analgesics|analgesics|mesh-ancestor
43752284|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
43752285|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752286|NCT02492126|Citric Acid|citric acid|mesh-list
43752287|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
43752288|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
43752289|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43752290|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
43752291|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
43752292|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752294|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
43752295|NCT02492178|Artesunate|artesunate|mesh-list
43752296|NCT02492178|Quinine|quinine|mesh-list
43752297|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
43752529|NCT02490839|Antacids|antacids|mesh-ancestor
43752530|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43752531|NCT02490527|Simvastatin|simvastatin|mesh-list
43752532|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43752533|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43752534|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
43648682|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
43648683|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
43648684|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648685|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648686|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
43648687|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648688|NCT03035357|Daratumumab|daratumumab|mesh-list
43648689|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648690|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
43648691|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
43648692|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43648693|NCT03035305|Amodiaquine|amodiaquine|mesh-list
43648694|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
43648695|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43648696|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43648697|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648698|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43648699|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648700|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648701|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43648702|NCT03035305|Renal Agents|renal agents|mesh-ancestor
43648703|NCT03035214|Dexamethasone|dexamethasone|mesh-list
43752939|NCT02487680|Trace Elements|trace elements|mesh-ancestor
43752940|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
43752941|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43752942|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43752943|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
43752944|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
43752945|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43752946|NCT02487706|Dolutegravir|dolutegravir|mesh-list
43753038|NCT02487316|Crizotinib|crizotinib|mesh-list
43753039|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753040|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43753041|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753042|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753044|NCT02487212|Petrolatum|petrolatum|mesh-list
43753076|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43753077|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
43753078|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43753080|NCT02487082|Donepezil|donepezil|mesh-list
43753081|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
43753082|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753083|NCT02487082|Protective Agents|protective agents|mesh-ancestor
43753084|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753085|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753086|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43753087|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836594|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43836595|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836596|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836597|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43836598|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
43836599|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43836600|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43836601|NCT04964505|Azacitidine|azacitidine|mesh-list
43836602|NCT04964505|Venetoclax|venetoclax|mesh-list
43836603|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43836604|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
43836605|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836606|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836607|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836608|NCT04964427|Methylphenidate|methylphenidate|mesh-list
43753144|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43753186|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
43753187|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
43753188|NCT02486458|Protective Agents|protective agents|mesh-ancestor
43753189|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753190|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43753191|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753192|NCT02486484|Aflibercept|aflibercept|mesh-list
43753193|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43753194|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43753195|NCT02486484|Growth Substances|growth substances|mesh-ancestor
43753196|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753197|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
43753198|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753199|NCT02486341|Insulin|insulin|mesh-list
43753200|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43753201|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753202|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
43753231|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
43753233|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
43753234|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753235|NCT02486276|Cilostazol|cilostazol|mesh-list
43753236|NCT02486276|Sumatriptan|sumatriptan|mesh-list
43753356|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43753357|NCT02485249|BB 1101|bb 1101|mesh-list
43753358|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753435|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43753436|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
43753437|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43753438|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753439|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753440|NCT02485067|Urological Agents|urological agents|mesh-ancestor
43753467|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753469|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753470|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43753471|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753472|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836610|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836611|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43836612|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43836613|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836614|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753490|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753491|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753492|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43753493|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43753494|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
43753497|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43753498|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753499|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753500|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43753501|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43753502|NCT02484300|Melatonin|melatonin|mesh-list
43753503|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
43753504|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753505|NCT02484300|Protective Agents|protective agents|mesh-ancestor
43753506|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753507|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753508|NCT02484352|Oxycodone|oxycodone|mesh-list
43753509|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43753510|NCT02484352|Narcotics|narcotics|mesh-ancestor
43753511|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753512|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753513|NCT02484352|Analgesics|analgesics|mesh-ancestor
43753514|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
43753515|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753516|NCT02484170|Mannitol|mannitol|mesh-list
43753591|NCT02483897|Tetracaine|tetracaine|mesh-list
43753592|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43753593|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
43753594|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
43753595|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753596|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753597|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
43753598|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753720|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43753721|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43753722|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
43753723|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43753724|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
43753725|NCT02483156|Ribavirin|ribavirin|mesh-list
43753726|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
43753727|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
43753728|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836651|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43836652|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43836653|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836654|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836655|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
43836656|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836657|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43847863|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43847864|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847865|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
43847866|NCT04072822|Hormones|hormones|mesh-ancestor
43753985|NCT02481193|Cisatracurium|cisatracurium|mesh-list
43753986|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43753987|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43753988|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754066|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754067|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754068|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
43754069|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43754070|NCT02480543|Misoprostol|misoprostol|mesh-list
43754071|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43754072|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
43754073|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43754074|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754231|NCT02479490|Prednisone|prednisone|mesh-list
43754232|NCT02479490|Everolimus|everolimus|mesh-list
43754233|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754234|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
43754235|NCT02479490|Hormones|hormones|mesh-ancestor
43754236|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754237|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836679|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836681|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
43836682|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836683|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836684|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
43836685|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836686|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43836687|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
43836688|NCT04956432|Protective Agents|protective agents|mesh-ancestor
43836689|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836690|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
43836693|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43754398|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43754399|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
43754400|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43754401|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
43754402|NCT02479074|Hormones|hormones|mesh-ancestor
43754403|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754404|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754405|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43754406|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754407|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
43754408|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
43754409|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43754410|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43754542|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43754543|NCT02477969|Metformin|metformin|mesh-list
43754544|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43754545|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754546|NCT02477995|Vaccines|vaccines|mesh-list
43754547|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
43754548|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754549|NCT02477891|Daratumumab|daratumumab|mesh-list
43754550|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836737|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
43836738|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836739|NCT04953104|Nivolumab|nivolumab|mesh-list
43836740|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43836741|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836742|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43836743|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754551|NCT02477852|Rifampin|rifampin|mesh-list
43754552|NCT02477852|Isoniazid|isoniazid|mesh-list
43754578|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43754579|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
43754934|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43754935|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754936|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43754937|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754938|NCT02476045|Leucovorin|leucovorin|mesh-list
43754939|NCT02476045|Fluorouracil|fluorouracil|mesh-list
43754940|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
43754941|NCT02476045|Panitumumab|panitumumab|mesh-list
43754942|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
43754943|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
43754944|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754945|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43754946|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754947|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43754948|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
43754949|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754950|NCT02476045|Antidotes|antidotes|mesh-ancestor
43754951|NCT02476045|Protective Agents|protective agents|mesh-ancestor
43754952|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
43754953|NCT02476045|Vitamins|vitamins|mesh-ancestor
43754954|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
43754992|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43754993|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
43754994|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43755029|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43755030|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755031|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43755032|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43755033|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43755154|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755155|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43755198|NCT02474654|Bupivacaine|bupivacaine|mesh-list
43755199|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
43755200|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
43755201|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
43755202|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755203|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755256|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755257|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755258|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
43755259|NCT02474628|Calcium|calcium|mesh-list
43755260|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43755261|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755262|NCT02474628|Antacids|antacids|mesh-ancestor
43755263|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648720|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43648721|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
43648722|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648761|NCT03035045|Analgesics|analgesics|mesh-ancestor
43648762|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
43648763|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648764|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648765|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
43648766|NCT03034733|Dexamethasone|dexamethasone|mesh-list
43648767|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648768|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
43648769|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
43648770|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648771|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648772|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648773|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
43648775|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648776|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648777|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824260|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824261|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824262|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824263|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
43755481|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43755512|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43755513|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43755514|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43755515|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43755516|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43755517|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755518|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755519|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
43755520|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43755521|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824274|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824275|NCT05513976|Febuxostat|febuxostat|mesh-list
43824276|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
43824277|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824278|NCT05513937|Amlodipine|amlodipine|mesh-list
43824279|NCT05513937|Nebivolol|nebivolol|mesh-list
43824280|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43824281|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43824282|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846394|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648778|NCT03034707|Biotin|biotin|mesh-list
43648779|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
43648780|NCT03034707|Vitamins|vitamins|mesh-ancestor
43836818|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836819|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836820|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
43836821|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43836822|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43836823|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
43836824|NCT04947254|Protective Agents|protective agents|mesh-ancestor
43836855|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836857|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43836858|NCT04944290|Brinzolamide|brinzolamide|mesh-list
43836859|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836860|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43836861|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43836863|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
43836864|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836865|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836866|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836867|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43836868|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755750|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
43755751|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43755752|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43755753|NCT02471820|Growth Substances|growth substances|mesh-ancestor
43755754|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
43755755|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43755756|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43755821|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755823|NCT02470858|Asunaprevir|asunaprevir|mesh-list
43755824|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
43755825|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755826|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755827|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43755828|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43755829|NCT02470780|Rifaximin|rifaximin|mesh-list
43755830|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755831|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755832|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43755833|NCT02470767|Anticoagulants|anticoagulants|mesh-list
43755834|NCT02470611|Alendronate|alendronate|mesh-list
43755835|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43755836|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755837|NCT02470559|Aldesleukin|aldesleukin|mesh-list
43755838|NCT02470559|Interleukin-2|interleukin-2|mesh-list
43755839|NCT02470559|Sargramostim|sargramostim|mesh-list
43755877|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43755878|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43755880|NCT02470702|Oritavancin|oritavancin|mesh-list
43755881|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43755882|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43755883|NCT02470676|Progesterone|progesterone|mesh-list
43755884|NCT02470676|Progestins|progestins|mesh-ancestor
43755886|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43755887|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755888|NCT02470442|Sevoflurane|sevoflurane|mesh-list
43755889|NCT02470442|Desflurane|desflurane|mesh-list
43652443|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
43755890|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43755891|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43755892|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
43755893|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
43755894|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755895|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755896|NCT02470455|Atorvastatin|atorvastatin|mesh-list
43755897|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43755898|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43755899|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
43755900|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836950|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43836951|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43836952|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43836953|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
43836954|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
43560233|NCT05081102|Ibuprofen|ibuprofen|mesh-list
43756092|NCT02468128|Narcotics|narcotics|mesh-ancestor
43756093|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43756094|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756095|NCT02468128|Analgesics|analgesics|mesh-ancestor
43756096|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
43756097|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756098|NCT02468063|Terlipressin|terlipressin|mesh-list
43756099|NCT02468063|Norepinephrine|norepinephrine|mesh-list
43756100|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756101|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43756102|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43756130|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43756132|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43756456|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43756457|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
43756458|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
43756459|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43756460|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43756461|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43756462|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
43756463|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756495|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43756496|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836964|NCT04939883|Protective Agents|protective agents|mesh-ancestor
43836965|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43836966|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836967|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43836968|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836969|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43836970|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43836971|NCT04939844|Lenalidomide|lenalidomide|mesh-list
43836972|NCT04939844|Bortezomib|bortezomib|mesh-list
43836973|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
43836974|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43756925|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756976|NCT02462837|Urological Agents|urological agents|mesh-ancestor
43837026|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
43837027|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837028|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837029|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837030|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43837031|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43837032|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43837033|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837034|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43837067|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837068|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837069|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
43837070|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837071|NCT04934748|Phenylephrine|phenylephrine|mesh-list
43837072|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
43652444|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773643|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43837073|NCT04934748|Norepinephrine|norepinephrine|mesh-list
43837074|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43837075|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
43837076|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
43837077|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43757028|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757029|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757031|NCT02462499|Diuretics|diuretics|mesh-ancestor
43757042|NCT02462369|Hormones|hormones|mesh-ancestor
43757043|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43757044|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43757045|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
43757046|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43757047|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757048|NCT02462304|Bevacizumab|bevacizumab|mesh-list
43757049|NCT02462304|Ranibizumab|ranibizumab|mesh-list
43757050|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43757118|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757119|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43757120|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
43757121|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757122|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
43757123|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43757124|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
43757178|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43757180|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43757181|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837092|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43837093|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43757395|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
43757396|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43757397|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
43757398|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757399|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757400|NCT02460354|Metformin|metformin|mesh-list
43757401|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43757403|NCT02460367|Docetaxel|docetaxel|mesh-list
43757592|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43757805|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43757806|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43757807|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43757808|NCT02457975|Growth Substances|growth substances|mesh-ancestor
43757809|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43757810|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43757812|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43757813|NCT02458118|Hormones|hormones|mesh-ancestor
43757816|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
43758160|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43758161|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
43758162|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758163|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758164|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43758165|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
43758166|NCT02456363|Adalimumab|adalimumab|mesh-list
43758167|NCT02456363|Etanercept|etanercept|mesh-list
43758168|NCT02456363|Golimumab|golimumab|mesh-list
43758169|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43758170|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43758249|NCT02455726|Antacids|antacids|mesh-ancestor
43758313|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43758314|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758315|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
43758388|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758389|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
43758390|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758391|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758392|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43758785|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758786|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758787|NCT02452879|Urological Agents|urological agents|mesh-ancestor
43758788|NCT02453009|Prednisone|prednisone|mesh-list
43758789|NCT02453009|Docetaxel|docetaxel|mesh-list
43758790|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43758791|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
43758930|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
43758931|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43758957|NCT02451787|Vitamin D|vitamin d|mesh-list
43563326|NCT01266525|Donepezil|donepezil|mesh-list
43758958|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
43758960|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
43758961|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758962|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43758963|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43758964|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
43758965|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43758966|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43758967|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43758968|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43758969|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43758970|NCT02451774|Protective Agents|protective agents|mesh-ancestor
43758971|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758972|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
43758973|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43758974|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
43758975|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
43758976|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43758977|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
43758978|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43759014|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
43759015|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43759016|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43759017|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43759184|NCT02450656|Afatinib|afatinib|mesh-list
43759228|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759229|NCT02450279|Edetic Acid|edetic acid|mesh-list
43759230|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
43759231|NCT02450279|Antidotes|antidotes|mesh-ancestor
43759232|NCT02450279|Protective Agents|protective agents|mesh-ancestor
43759233|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759234|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
43837228|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
43837229|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837230|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43837231|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
43837232|NCT04922827|Infliximab|infliximab|mesh-list
43837233|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
43837234|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837235|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43837236|NCT04922658|Vinorelbine|vinorelbine|mesh-list
43759309|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43759310|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43759311|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
43759344|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759345|NCT02449720|Ropivacaine|ropivacaine|mesh-list
43759346|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
43759347|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
43759348|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43759349|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759350|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
43759351|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43759352|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
43759353|NCT02449603|Exenatide|exenatide|mesh-list
43759354|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
43759456|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43759488|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759489|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43759490|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43759491|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
43759492|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
43759493|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
43759494|NCT02449070|Nicorandil|nicorandil|mesh-list
43759495|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43759496|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43759706|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43759707|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43759708|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
43759709|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43759710|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760018|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43760019|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43760020|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43760021|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43760022|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43760263|NCT02444572|Enoxaparin|enoxaparin|mesh-list
43760264|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
43760265|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43760348|NCT03241940|Fludarabine|fludarabine|mesh-list
43760349|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
43760492|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
43760494|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43760495|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
43760496|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
43760497|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760498|NCT00977483|Protective Agents|protective agents|mesh-ancestor
43671011|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43671012|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43671013|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671014|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43671015|NCT05349448|Analgesics|analgesics|mesh-ancestor
43671016|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
43671017|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671174|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827153|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43827154|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827155|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
43827156|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827157|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
43827158|NCT05491460|Apixaban|apixaban|mesh-list
43827159|NCT05491460|Edoxaban|edoxaban|mesh-list
43827160|NCT05491460|Dabigatran|dabigatran|mesh-list
43671205|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671206|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
43671207|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43827169|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
43827170|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43827171|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43827172|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43827173|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
43827174|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43827175|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671361|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
43671844|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43671845|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
43671846|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43671847|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671848|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43671849|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43671850|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
43671851|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43671852|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671853|NCT03617679|Rucaparib|rucaparib|mesh-list
43671854|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43671855|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43671856|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671857|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43671858|NCT03603808|Vaccines|vaccines|mesh-list
43671859|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
43671860|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43671861|NCT03570983|Cytarabine|cytarabine|mesh-list
43671966|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
43672320|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
43672321|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43672322|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
43672323|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43672324|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672325|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43672326|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
43672327|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
43672328|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43672329|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
43672330|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43672545|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43672546|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43672547|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43672548|NCT02236156|Metronidazole|metronidazole|mesh-list
43672762|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43672763|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43672764|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43672766|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
43672767|NCT02106546|Paclitaxel|paclitaxel|mesh-list
43672768|NCT02106546|Carboplatin|carboplatin|mesh-list
43672769|NCT02106546|Veliparib|veliparib|mesh-list
43672779|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43672913|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43672914|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43672915|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
43827329|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827376|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827377|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
43827378|NCT05489185|Coagulants|coagulants|mesh-ancestor
43827379|NCT05488990|Calcitriol|calcitriol|mesh-list
43827380|NCT05488990|Calcipotriene|calcipotriene|mesh-list
43827381|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
43827382|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43827383|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827384|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43827385|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43827386|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827387|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43827388|NCT05488990|Vitamins|vitamins|mesh-ancestor
43827389|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
43827390|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43827391|NCT05488925|Vitamin E|vitamin e|mesh-list
43827392|NCT05488925|Diclofenac|diclofenac|mesh-list
43827393|NCT05488925|Piroxicam|piroxicam|mesh-list
43827394|NCT05488925|Tramadol|tramadol|mesh-list
43673094|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43673095|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
43673096|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43673097|NCT02042378|Rucaparib|rucaparib|mesh-list
43673099|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673468|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673469|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43673470|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43673580|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43673581|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43673583|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43673584|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43827459|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
43674168|NCT01632137|Rebamipide|rebamipide|mesh-list
43674169|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43674170|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43674171|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
43674172|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43674173|NCT01632137|Protective Agents|protective agents|mesh-ancestor
43674174|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674175|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674176|NCT01628094|Ritonavir|ritonavir|mesh-list
43674177|NCT01628094|Ribavirin|ribavirin|mesh-list
43674178|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43674179|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43674180|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
43674237|NCT01303796|Decitabine|decitabine|mesh-list
43674265|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43674266|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43674267|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43674268|NCT00848328|Growth Substances|growth substances|mesh-ancestor
43674269|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
43674270|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
43674271|NCT00712582|Ifosfamide|ifosfamide|mesh-list
43675361|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43675362|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43675363|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675364|NCT02884921|Acetaminophen|acetaminophen|mesh-list
43675365|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43675366|NCT02884921|Analgesics|analgesics|mesh-ancestor
43675367|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
43675368|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827562|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43827564|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43827565|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
43827568|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
43675623|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675625|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43675626|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43675627|NCT02882737|Hormones|hormones|mesh-ancestor
43675817|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43675928|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43675929|NCT02880085|Lidocaine|lidocaine|mesh-list
43675930|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
43675931|NCT02880085|Anesthetics|anesthetics|mesh-list
43675932|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43675933|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675934|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
43675935|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675936|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43675937|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43675938|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43675939|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43675940|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43675941|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
43676016|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652445|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43652446|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43652447|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652449|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
43676017|NCT02879227|Cisplatin|cisplatin|mesh-list
43676018|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
43676298|NCT02877277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676299|NCT02877277|Antioxidants|antioxidants|mesh-ancestor
43676300|NCT02877277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676301|NCT02877277|Protective Agents|protective agents|mesh-ancestor
43676302|NCT02876991|Listerine|listerine|mesh-list
43676303|NCT02876991|Fluorides|fluorides|mesh-list
43676304|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
43676305|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
43676306|NCT02876991|Protective Agents|protective agents|mesh-ancestor
43676307|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676417|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43676418|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
43676419|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676420|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
43676421|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676422|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
43676423|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43676424|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43676425|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43676426|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43676427|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43676482|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43676483|NCT02875821|Metformin|metformin|mesh-list
43676484|NCT02875821|Pioglitazone|pioglitazone|mesh-list
43676485|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
43676486|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43676633|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43676634|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43676635|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676636|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
43676637|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
43676638|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
43676639|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
43676700|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43676702|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43676703|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43676704|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827705|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43827706|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43827707|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
43827708|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
43827709|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846941|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43846942|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43846943|NCT04157036|Prednisolone|prednisolone|mesh-list
43846944|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
43846945|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43846946|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
43677041|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677042|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43677043|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
43677045|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677046|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43677295|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43677296|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43677297|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43677298|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677299|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43677301|NCT02868801|Analgesics|analgesics|mesh-ancestor
43677302|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
43677303|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43677304|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677364|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677365|NCT02868151|Protective Agents|protective agents|mesh-ancestor
43677367|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
43677370|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677372|NCT02867956|Apatinib|apatinib|mesh-list
43677373|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43677374|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677375|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43677376|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43677377|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677378|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43677515|NCT02867800|Hormones|hormones|mesh-ancestor
43677516|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43677517|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43677518|NCT02867800|Protective Agents|protective agents|mesh-ancestor
43677519|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43677520|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
43677521|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43677522|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43677523|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43677524|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43677525|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43677526|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43677527|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
43677528|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
43677529|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43677555|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
43827822|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43827823|NCT05485064|Narcotics|narcotics|mesh-ancestor
43677589|NCT02867280|Sorafenib|sorafenib|mesh-list
43677590|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677591|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43677592|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43677896|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
43677897|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677898|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
43677899|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43677900|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
43677901|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43677902|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43677903|NCT02865304|Endostar protein|endostar protein|mesh-list
43677904|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43677905|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43677906|NCT02865304|Growth Substances|growth substances|mesh-ancestor
43677910|NCT02865174|Heparin|heparin|mesh-list
43678162|NCT02863705|Bimatoprost|bimatoprost|mesh-list
43678163|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43678164|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43678165|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43678166|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43678167|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
43678168|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43678169|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43678170|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678171|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43678172|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43678173|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43678174|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43678175|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43678176|NCT02863471|Gemcitabine|gemcitabine|mesh-list
43678177|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43678178|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
43678201|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43679026|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
43679225|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679226|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679228|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
43679230|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
43679363|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679522|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43679523|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679524|NCT02852720|Anesthetics|anesthetics|mesh-list
43679525|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
43679526|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679527|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679528|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
43679529|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
43679530|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679531|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
43679532|NCT02852564|Diuretics|diuretics|mesh-ancestor
43679623|NCT02851745|Incretins|incretins|mesh-ancestor
43679624|NCT02851745|Hormones|hormones|mesh-ancestor
43679625|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679626|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43679627|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
43679628|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43679629|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43827973|NCT05483439|Trastuzumab|trastuzumab|mesh-list
43827974|NCT05483439|Epirubicin|epirubicin|mesh-list
43827975|NCT05483439|Pertuzumab|pertuzumab|mesh-list
43827976|NCT05483439|Antibodies|antibodies|mesh-list
43827977|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43827978|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43827979|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
43827980|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846997|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846998|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
43846999|NCT04151680|Apixaban|apixaban|mesh-list
43847000|NCT04151680|Edoxaban|edoxaban|mesh-list
43847001|NCT04151680|Dabigatran|dabigatran|mesh-list
43847002|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847003|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
43847004|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847005|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847006|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847007|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847008|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
43847009|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
43847010|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679630|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
43679631|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43679632|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
43679633|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43679634|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679635|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43679636|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
43679637|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43679638|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
43679639|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43679787|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43679788|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
43679789|NCT05381558|Hormones|hormones|mesh-ancestor
43638350|NCT04198766|Antibodies|antibodies|mesh-list
43679790|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43679791|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679792|NCT05381428|Indomethacin|indomethacin|mesh-list
43679793|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43679794|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43679795|NCT05381428|Analgesics|analgesics|mesh-ancestor
43679890|NCT05380778|Anesthetics|anesthetics|mesh-list
43679891|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43679965|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43679966|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43679967|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43679968|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
43828093|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43828094|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43828095|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43828096|NCT05481970|Narcotics|narcotics|mesh-ancestor
43828097|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43828098|NCT05481957|Vortioxetine|vortioxetine|mesh-list
43680277|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828207|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43828208|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828209|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43828210|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43680809|NCT04619316|Trametinib|trametinib|mesh-list
43681399|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43681400|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43681401|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681402|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681404|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43681405|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681406|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43681407|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43681744|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681745|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43681746|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43681748|NCT02962063|Carboplatin|carboplatin|mesh-list
43681749|NCT02962063|Durvalumab|durvalumab|mesh-list
43681750|NCT02962063|Tremelimumab|tremelimumab|mesh-list
43681751|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43681752|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43681753|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43682235|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682236|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43682237|NCT02850445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43682238|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43682239|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43682240|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682241|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43682242|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
43682243|NCT02850211|Ibuprofen|ibuprofen|mesh-list
43682244|NCT02850211|Celecoxib|celecoxib|mesh-list
43682245|NCT02850211|Tramadol|tramadol|mesh-list
43682246|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43682247|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43682855|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
43682856|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43682857|NCT02845778|Melatonin|melatonin|mesh-list
43682858|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
43682859|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43682860|NCT02845778|Protective Agents|protective agents|mesh-ancestor
43682861|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43682862|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43682863|NCT02845713|Ivermectin|ivermectin|mesh-list
43682864|NCT02845713|Albendazole|albendazole|mesh-list
43682865|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
43682866|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43682867|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43683248|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43683249|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683250|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
43683251|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43683252|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43683253|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683254|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43683255|NCT04628663|Analgesics|analgesics|mesh-ancestor
43683256|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
43683257|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43683258|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43683259|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43683260|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43683261|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
43683262|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43683478|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683479|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43683481|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43683482|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43683483|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43683484|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43683485|NCT03866668|Esomeprazole|esomeprazole|mesh-list
43683491|NCT03845582|Vitamin A|vitamin a|mesh-list
43683649|NCT01236430|Atorvastatin|atorvastatin|mesh-list
43683650|NCT01236430|Ezetimibe|ezetimibe|mesh-list
43683651|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43683652|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43683653|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
43683654|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43683655|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43683656|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43683657|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43683658|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
43828580|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43828581|NCT05476081|Analgesics|analgesics|mesh-ancestor
43828582|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
43684342|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684345|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43684346|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684347|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43684348|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684349|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
43684350|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43684351|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
43684352|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684353|NCT02843984|Lactoferrin|lactoferrin|mesh-list
43684354|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43684355|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
43684381|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43684382|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43684383|NCT02843698|Analgesics|analgesics|mesh-ancestor
43684395|NCT02843490|Ranibizumab|ranibizumab|mesh-list
43684822|NCT02839668|Tramadol|tramadol|mesh-list
43684823|NCT02839668|Sevoflurane|sevoflurane|mesh-list
43684824|NCT02839668|Neostigmine|neostigmine|mesh-list
43684825|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
43684877|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43684878|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
43684879|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43684880|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43684881|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
43684882|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
43684884|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43652477|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43652478|NCT02995083|Protective Agents|protective agents|mesh-ancestor
43652479|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43828673|NCT05475444|Chitosan|chitosan|mesh-list
43684972|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
43684973|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43684974|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
43684975|NCT02839044|Vitamin K|vitamin k|mesh-list
43684976|NCT02839044|Vitamin MK 7|vitamin mk 7|mesh-list
43684977|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43684978|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43684979|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684980|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
43684981|NCT02839044|Coagulants|coagulants|mesh-ancestor
43684982|NCT02839044|Vitamins|vitamins|mesh-ancestor
43685064|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43685066|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685067|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685068|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43685069|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
43685070|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685071|NCT02838615|Dexamethasone|dexamethasone|mesh-list
43685072|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685119|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43685120|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685121|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43685186|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43685187|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685188|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
43685189|NCT02837835|Ceftazidime|ceftazidime|mesh-list
43685190|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43685191|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43685192|NCT02837614|Acetaminophen|acetaminophen|mesh-list
43685193|NCT02837614|Amoxicillin|amoxicillin|mesh-list
43685194|NCT02837614|Dexamethasone|dexamethasone|mesh-list
43685195|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
43685197|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43685198|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
43685199|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
43685200|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685229|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
43685290|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43685373|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
43685374|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685375|NCT02836509|Acetaminophen|acetaminophen|mesh-list
43685376|NCT02836509|Ibuprofen|ibuprofen|mesh-list
43685377|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43685378|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43685379|NCT02836509|Analgesics|analgesics|mesh-ancestor
43685380|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
43685436|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
43685567|NCT02835521|Hormones|hormones|mesh-ancestor
43685568|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43685569|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685570|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43685571|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
43685572|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685596|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43685598|NCT02834845|Desflurane|desflurane|mesh-list
43685599|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43685600|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43685601|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
43685602|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
43685603|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43685604|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685605|NCT02834507|Levodopa|levodopa|mesh-list
43685606|NCT02834507|Carbidopa|carbidopa|mesh-list
43685607|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43685792|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43685793|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43685794|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43685795|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43685796|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43685797|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
43685798|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
43685799|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43685800|NCT02833155|Exemestane|exemestane|mesh-list
43685801|NCT02833155|Entinostat|entinostat|mesh-list
43685802|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43685803|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43685804|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43685827|NCT02832973|Ramipril|ramipril|mesh-list
43685940|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43685941|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43685984|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
43686005|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
43686006|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686007|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
43686008|NCT02831712|Trace Elements|trace elements|mesh-ancestor
43686009|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
43686010|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686011|NCT02831686|Dexamethasone|dexamethasone|mesh-list
43686012|NCT02831686|Ixazomib|ixazomib|mesh-list
43686013|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43686014|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
43686015|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
43686016|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43686017|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686018|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43686019|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
43686020|NCT02831686|Hormones|hormones|mesh-ancestor
43686021|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43686084|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43828790|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828791|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43828792|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43828793|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43828794|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
43828795|NCT05470283|Diuretics|diuretics|mesh-ancestor
43828796|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
43828797|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43828798|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43828799|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
43828800|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43686185|NCT02830230|Cefixime|cefixime|mesh-list
43686186|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43686187|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43686188|NCT02830243|Sevoflurane|sevoflurane|mesh-list
43686189|NCT02830243|Desflurane|desflurane|mesh-list
43686190|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43828849|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43828850|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43828851|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
43828852|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43828853|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43828854|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43828855|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43686596|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686597|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43686598|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
43686599|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43686600|NCT02826837|Bevacizumab|bevacizumab|mesh-list
43686601|NCT02826837|Cetuximab|cetuximab|mesh-list
43686602|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43686603|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43686604|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43686605|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43686606|NCT02826837|Growth Substances|growth substances|mesh-ancestor
43686607|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43686681|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43686682|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686683|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686724|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43686726|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43686727|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43686728|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43686729|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
43686730|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686731|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43686732|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847051|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847052|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43847053|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
43847054|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847055|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847056|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
43847057|NCT04141904|Tofacitinib|tofacitinib|mesh-list
43847058|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847059|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847060|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847061|NCT04141020|Sirolimus|sirolimus|mesh-list
43847062|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43847063|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847064|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43687412|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43687413|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43687443|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
43829034|NCT05452174|Mirtazapine|mirtazapine|mesh-list
43829035|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
43829036|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43829037|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43829038|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
43829039|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
43829040|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43829041|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829042|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829043|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829044|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43829045|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43829047|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43688348|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43688349|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688350|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688351|NCT02812641|Bevacizumab|bevacizumab|mesh-list
43688352|NCT02812641|Cisplatin|cisplatin|mesh-list
43688353|NCT02812641|Fluorouracil|fluorouracil|mesh-list
43688354|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43688355|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43688356|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43688357|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43688358|NCT02812641|Growth Substances|growth substances|mesh-ancestor
43688359|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688360|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
43688361|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
43688362|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688363|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43688497|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43688537|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688538|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43688539|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
43688540|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43688541|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
43829098|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43829099|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43829100|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43829101|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
43829102|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43829103|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43829104|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43829105|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
43829106|NCT05448456|Coagulants|coagulants|mesh-ancestor
43829107|NCT05448378|Inositol|inositol|mesh-list
43829108|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
43829109|NCT05448378|Vitamins|vitamins|mesh-ancestor
43829110|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
43829111|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829112|NCT05447065|Vitamin D|vitamin d|mesh-list
43847137|NCT04138212|Cisplatin|cisplatin|mesh-list
43847138|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43847139|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847140|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
43847141|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
43847142|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690182|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
43690183|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
43690186|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847166|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847167|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
43847168|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43690550|NCT02794714|Rocuronium|rocuronium|mesh-list
43690551|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43690552|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43690553|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43690554|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690556|NCT02794610|Tacrolimus|tacrolimus|mesh-list
43691199|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
43691200|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43691514|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43691515|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43691517|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
43691518|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
43691519|NCT02786823|Metformin|metformin|mesh-list
43691520|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43691521|NCT02786823|Vitamins|vitamins|mesh-ancestor
43691522|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
43691523|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691524|NCT02786823|Hematinics|hematinics|mesh-ancestor
43691525|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
43691526|NCT02786732|Ustekinumab|ustekinumab|mesh-list
43692038|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
43692039|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43692040|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692041|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692042|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43692094|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
43692095|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692096|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692097|NCT02783040|Digoxin|digoxin|mesh-list
43692098|NCT02783040|Midazolam|midazolam|mesh-list
43692099|NCT02783040|BI 425809|bi 425809|mesh-list
43692100|NCT02783040|Omeprazole|omeprazole|mesh-list
43692101|NCT02783040|Warfarin|warfarin|mesh-list
43692102|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43692103|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43692104|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692105|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692106|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43692107|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43692125|NCT02783183|Pregabalin|pregabalin|mesh-list
43692126|NCT02783183|Analgesics|analgesics|mesh-ancestor
43692127|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
43692128|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692129|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692130|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
43692131|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43692132|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43692133|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692134|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43829495|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829496|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829498|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
43829499|NCT05422027|Hormones|hormones|mesh-ancestor
43829500|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43829501|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43692513|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43692573|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
43692574|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692575|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43692576|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43692577|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
43692578|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692579|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43692580|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43692581|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43692583|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
43692584|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43692585|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43692586|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
43692587|NCT02779283|Hormones|hormones|mesh-ancestor
43692588|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693490|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43693491|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43693492|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693493|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
43693494|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43693495|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693496|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43693520|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693521|NCT02773459|Capecitabine|capecitabine|mesh-list
43693522|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43693523|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
43693547|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43693549|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43693550|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43693719|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
43693720|NCT02772211|Cycloserine|cycloserine|mesh-list
43693721|NCT02772211|Ketamine|ketamine|mesh-list
43693722|NCT02772211|Analgesics|analgesics|mesh-ancestor
43693723|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
43693724|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43829632|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43829633|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
43829634|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
43829635|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43693836|NCT02771704|Protective Agents|protective agents|mesh-ancestor
43693837|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693838|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43693839|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43693841|NCT02771704|Trace Elements|trace elements|mesh-ancestor
43693842|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
43693843|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
43693844|NCT02771743|Ifosfamide|ifosfamide|mesh-list
43693845|NCT02771743|Cisplatin|cisplatin|mesh-list
43644852|NCT04341467|Amisulpride|amisulpride|mesh-list
43644853|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
43644854|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
43644855|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644856|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694455|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43694456|NCT02768389|Growth Substances|growth substances|mesh-ancestor
43694457|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694458|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
43694459|NCT02768220|Empagliflozin|empagliflozin|mesh-list
43694460|NCT02768220|Linagliptin|linagliptin|mesh-list
43644888|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644889|NCT04340843|Decitabine|decitabine|mesh-list
43644890|NCT04340843|Azacitidine|azacitidine|mesh-list
43644891|NCT04340843|Belinostat|belinostat|mesh-list
43644892|NCT04340843|Guadecitabine|guadecitabine|mesh-list
43695144|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695146|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
43695147|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43695148|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43695149|NCT02763761|Prednisolone|prednisolone|mesh-list
43695150|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
43695151|NCT02763761|Infliximab|infliximab|mesh-list
43695203|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43695204|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43695205|NCT02763098|Analgesics|analgesics|mesh-ancestor
43695206|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
43695207|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43695208|NCT02763059|Acetaminophen|acetaminophen|mesh-list
43695209|NCT02763059|Dexamethasone|dexamethasone|mesh-list
43695803|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
43829907|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
43644973|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644974|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
43697247|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697248|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43697249|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43697250|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
43697251|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697252|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697253|NCT05246111|Topotecan|topotecan|mesh-list
43697254|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43697354|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43697356|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697383|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697385|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43697717|NCT00783367|Rituximab|rituximab|mesh-list
43697718|NCT00783367|Lenalidomide|lenalidomide|mesh-list
43697719|NCT00783367|BB 1101|bb 1101|mesh-list
43697720|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697721|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697722|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
43830083|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830084|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830085|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830091|NCT05384665|Remifentanil|remifentanil|mesh-list
43698641|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698642|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
43698643|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698644|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
43698645|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698646|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43698647|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
43645009|NCT04303195|Metopimazine|metopimazine|mesh-list
43830228|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830229|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830230|NCT05378737|Exatecan|exatecan|mesh-list
43645019|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43645020|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43645021|NCT04281108|Fluticasone|fluticasone|mesh-list
43645023|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43645025|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
43645029|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
43645030|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
43645031|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43645032|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43645034|NCT04260477|Isoniazid|isoniazid|mesh-list
43645035|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
43645036|NCT04260477|Ethambutol|ethambutol|mesh-list
43645037|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43699600|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699959|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
43699960|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
43699961|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
43699962|NCT02734420|Coagulants|coagulants|mesh-ancestor
43699963|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
43700623|NCT02730117|Milrinone|milrinone|mesh-list
43700624|NCT02730117|Norepinephrine|norepinephrine|mesh-list
43700625|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43700626|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43700627|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43700628|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700629|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700630|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700631|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700632|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
43700633|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
43700634|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700635|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43830490|NCT05359055|Itraconazole|itraconazole|mesh-list
43700636|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43700637|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43824700|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
43700638|NCT02730117|Protective Agents|protective agents|mesh-ancestor
43830536|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43700885|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700886|NCT02728466|Protective Agents|protective agents|mesh-ancestor
43645142|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
43645143|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43645144|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645145|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
43645146|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
43645147|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645148|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
43645149|NCT04187898|Docetaxel|docetaxel|mesh-list
43645150|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702372|NCT02717923|Capecitabine|capecitabine|mesh-list
43645152|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645153|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43645154|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43645155|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
43645156|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645157|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645158|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43645159|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702651|NCT02715531|Atezolizumab|atezolizumab|mesh-list
43645182|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43645183|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43645184|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645185|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830843|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830844|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43830845|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
43830848|NCT05341609|Ritonavir|ritonavir|mesh-list
43703541|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43703720|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43703753|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703754|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43703756|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
43703757|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703758|NCT02708628|Heparin|heparin|mesh-list
43703759|NCT02708628|Allantoin|allantoin|mesh-list
43703760|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
43703761|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43703762|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43703763|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703896|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
43703897|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703898|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43703899|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
43703900|NCT02707458|Protective Agents|protective agents|mesh-ancestor
43703901|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703902|NCT02707484|Thalidomide|thalidomide|mesh-list
43703903|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703904|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
43703905|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645213|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
43645214|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645215|NCT04155008|Dexamethasone|dexamethasone|mesh-list
43704103|NCT02706470|Progestins|progestins|mesh-ancestor
43704104|NCT02706470|Hormones|hormones|mesh-ancestor
43648894|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43648895|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43648896|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43830947|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
43830948|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
43830949|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830950|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830951|NCT05334654|Enoxaparin|enoxaparin|mesh-list
43830952|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
43830953|NCT05334654|Bivalirudin|bivalirudin|mesh-list
43830954|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
43830955|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43705611|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43547786|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645277|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43645278|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645279|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43645280|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43645282|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
43645283|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43645284|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706440|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43706865|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43706866|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43706867|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
43645285|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43645286|NCT04151082|Protective Agents|protective agents|mesh-ancestor
43645289|NCT04150640|Trastuzumab|trastuzumab|mesh-list
43645290|NCT04150640|Fluorouracil|fluorouracil|mesh-list
43645291|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
43645294|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707034|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43707035|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
43645296|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43645297|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43645298|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645299|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
43645300|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645301|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43645302|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43707036|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
43707037|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707038|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707039|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707040|NCT02703233|Analgesics|analgesics|mesh-ancestor
43707041|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
43707042|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707043|NCT02703272|Dexamethasone|dexamethasone|mesh-list
43707532|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707533|NCT02699879|Pirfenidone|pirfenidone|mesh-list
43831497|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43831498|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831502|NCT05308901|Lenvatinib|lenvatinib|mesh-list
43710300|NCT02436707|Gemcitabine|gemcitabine|mesh-list
43710301|NCT02436707|Dexamethasone|dexamethasone|mesh-list
43710303|NCT02436707|Rituximab|rituximab|mesh-list
43710505|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710506|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644507|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644508|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
43644513|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
43644671|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43645579|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43645834|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
43645835|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
43645837|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43645934|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
43646139|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43646211|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43646212|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43646213|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
43646214|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
43646215|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646216|NCT03365622|Acetaminophen|acetaminophen|mesh-list
43646367|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43646368|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646372|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646417|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43646418|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43646423|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646424|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43646425|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43646845|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
43646898|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43646899|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
43646900|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43646901|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43646902|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43646903|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824705|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43646907|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43646908|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43646909|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
43647020|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43647099|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647135|NCT02347865|Denosumab|denosumab|mesh-list
43647218|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647219|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43647220|NCT02283996|Protective Agents|protective agents|mesh-ancestor
43647227|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647275|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647276|NCT02126553|Growth Substances|growth substances|mesh-ancestor
43647279|NCT02117141|Hydrocodone|hydrocodone|mesh-list
43647288|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647289|NCT02112734|Vitamin D|vitamin d|mesh-list
43647290|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
43647291|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
43647375|NCT01782443|Aflibercept|aflibercept|mesh-list
43647382|NCT01667120|Ketorolac|ketorolac|mesh-list
43647410|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43647411|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647413|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647518|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
43824124|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824176|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824194|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43647835|NCT05417100|Narcotics|narcotics|mesh-ancestor
43647836|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647841|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
43647842|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647843|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
43647844|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647845|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647846|NCT05332483|Megestrol|megestrol|mesh-list
43647847|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
43647848|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43647886|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647887|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43647888|NCT05153590|Liraglutide|liraglutide|mesh-list
43647889|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43647890|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647891|NCT05153590|Incretins|incretins|mesh-ancestor
43647910|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
43647911|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647912|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43647913|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824228|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
43824236|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648165|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43648166|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
43648167|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
43648168|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
43648169|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43648170|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43648240|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
43648241|NCT03988933|Rifampin|rifampin|mesh-list
43648250|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43648286|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648287|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43648288|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648290|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43648434|NCT03439293|Hormones|hormones|mesh-ancestor
43648575|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648665|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648666|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43648667|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648848|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
43598588|NCT03298347|Caffeine|caffeine|mesh-list
43598610|NCT03298191|Analgesics|analgesics|mesh-ancestor
43598692|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
43598785|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599018|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43599023|NCT03294486|Flucytosine|flucytosine|mesh-list
43599141|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599145|NCT03293407|Iloprost|iloprost|mesh-list
43693051|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
43648904|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648905|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599255|NCT03292185|Insulin|insulin|mesh-list
43599552|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
43599553|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599843|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43600085|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
43600342|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
43600343|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43649060|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43649104|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600784|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43601224|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
43601366|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43601367|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598283|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43598284|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
43601861|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43601862|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
43598285|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43598286|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43598287|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43602098|NCT03258372|Rifampin|rifampin|mesh-list
43598288|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43598289|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43598290|NCT03301207|Estrogens|estrogens|mesh-ancestor
43598291|NCT03301207|Hormones|hormones|mesh-ancestor
43598292|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598293|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43598294|NCT03301181|Itraconazole|itraconazole|mesh-list
43598295|NCT03301181|Rifampin|rifampin|mesh-list
43598296|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
43598297|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
43598298|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598299|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43598319|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598320|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43598322|NCT03301025|Analgesics|analgesics|mesh-ancestor
43598323|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
43602523|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43649215|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649216|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598324|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598325|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598326|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
43598327|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43598328|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598329|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603139|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603180|NCT03248427|Paclitaxel|paclitaxel|mesh-list
43598330|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598331|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43598332|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43598333|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598334|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43598335|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43598336|NCT03300960|Ganirelix|ganirelix|mesh-list
43603589|NCT03244592|Minocycline|minocycline|mesh-list
43603619|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603783|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43603891|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43603910|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43598337|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43598338|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
43849154|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43598339|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43824706|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
43824707|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598340|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598341|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43598342|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43598343|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43598344|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598345|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
43649237|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43598377|NCT03300609|Protective Agents|protective agents|mesh-ancestor
43598378|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
43598379|NCT03300609|Vitamins|vitamins|mesh-ancestor
43598380|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
43598381|NCT03300609|Hematinics|hematinics|mesh-ancestor
43598382|NCT03300531|Betamethasone|betamethasone|mesh-list
43648912|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
43648913|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43648914|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648915|NCT03033199|Dexamethasone|dexamethasone|mesh-list
43648916|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648917|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
43648918|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
43604201|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648919|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648920|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648921|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648922|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
43648924|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648925|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43648926|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648927|NCT03033368|Rilpivirine|rilpivirine|mesh-list
43648928|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43648929|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43604295|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604296|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43598384|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
43598385|NCT03300531|Hormones|hormones|mesh-ancestor
43598386|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598387|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598388|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43598389|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
43598392|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
43598393|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
43598394|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598395|NCT03300362|Vaccines|vaccines|mesh-list
43598396|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
43598397|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598398|NCT03300115|Abivertinib|abivertinib|mesh-list
43598399|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43598400|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598434|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598435|NCT03299517|Lidocaine|lidocaine|mesh-list
43598436|NCT03299517|Amiodarone|amiodarone|mesh-list
43598437|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43598463|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43598464|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598465|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598466|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43598467|NCT03299387|Renal Agents|renal agents|mesh-ancestor
43598468|NCT03299296|Enoxaparin|enoxaparin|mesh-list
43598469|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
43598470|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43598471|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
43598472|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43598473|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
43598474|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838653|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824708|NCT05509153|Protective Agents|protective agents|mesh-ancestor
43824709|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824710|NCT05508815|Methotrexate|methotrexate|mesh-list
43824711|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43598475|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598476|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
43598477|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43598478|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43598479|NCT03299257|Donepezil|donepezil|mesh-list
43598480|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43598481|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598482|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598483|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
43598496|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598497|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43598498|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598499|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
43598500|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649307|NCT03030560|Lidocaine|lidocaine|mesh-list
43604682|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43604683|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604684|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43604685|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
43604704|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598501|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
43598502|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598504|NCT03298906|Esketamine|esketamine|mesh-list
43598505|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
43598506|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43598507|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43598508|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43598509|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598510|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43598511|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43598512|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43598513|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43598514|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
43598515|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598516|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598519|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598520|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
43598521|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43605180|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824379|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
43598522|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598523|NCT03298698|Prednisone|prednisone|mesh-list
43598524|NCT03298698|Prednisolone|prednisolone|mesh-list
43598525|NCT03298698|Rituximab|rituximab|mesh-list
43598526|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605745|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
43605943|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43605946|NCT03223025|Hormones|hormones|mesh-list
43598527|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598528|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
43598529|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598530|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598531|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598532|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
43606022|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
43598534|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598535|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43598536|NCT03298646|Diclofenac|diclofenac|mesh-list
43598537|NCT03298646|Lidocaine|lidocaine|mesh-list
43598538|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
43598539|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
43598540|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598541|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598542|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
43598543|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598544|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598545|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43598546|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43598573|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598574|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598575|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598576|NCT03298464|Pioglitazone|pioglitazone|mesh-list
43598577|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43598578|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598579|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
43598580|NCT03298373|Nandrolone|nandrolone|mesh-list
43606455|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598581|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
43598582|NCT03298373|Androgens|androgens|mesh-ancestor
43598583|NCT03298373|Hormones|hormones|mesh-ancestor
43598584|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598585|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598586|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
43649547|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606979|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606980|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598587|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43598589|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43598590|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598591|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43598608|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598611|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
43598612|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598613|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
43598614|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598615|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43598616|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
43598617|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598618|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607214|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598619|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
43598620|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43598621|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
43598622|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
43607401|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
43598625|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43598626|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43598627|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598628|NCT03298074|Etoposide|etoposide|mesh-list
43598629|NCT03298074|Apatinib|apatinib|mesh-list
43607978|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43608085|NCT03198130|Cemiplimab|cemiplimab|mesh-list
43598630|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849280|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
43608565|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608566|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649701|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649702|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598631|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598632|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43598633|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43598634|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849157|NCT03955783|Venetoclax|venetoclax|mesh-list
43598635|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598636|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43849310|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43609116|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43609117|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598637|NCT03298009|Canagliflozin|canagliflozin|mesh-list
43598638|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43598639|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598640|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609284|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
43609533|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43609696|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
43598641|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598643|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598645|NCT03297879|Exenatide|exenatide|mesh-list
43649820|NCT03018418|Mitomycins|mitomycins|mesh-list
43598646|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43598647|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610297|NCT03181178|Micronutrients|micronutrients|mesh-list
43610418|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43610419|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
43598663|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43598664|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
43610716|NCT03177980|Fentanyl|fentanyl|mesh-list
43610815|NCT03177109|Protective Agents|protective agents|mesh-ancestor
43598665|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43598666|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598667|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598669|NCT03297463|Interleukin-2|interleukin-2|mesh-list
43598670|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43598671|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598672|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43598673|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598674|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598675|NCT03297463|Analgesics|analgesics|mesh-ancestor
43598676|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
43611204|NCT03173898|Anesthetics|anesthetics|mesh-list
43611205|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611207|NCT03173781|Droxidopa|droxidopa|mesh-list
43611311|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611312|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611600|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598680|NCT03297359|Tinzaparin|tinzaparin|mesh-list
43598681|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43598682|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
43598683|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43598684|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43598685|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598686|NCT03297073|Acetaminophen|acetaminophen|mesh-list
43598687|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611876|NCT03169777|Nivolumab|nivolumab|mesh-list
43598688|NCT03297073|Analgesics|analgesics|mesh-ancestor
43598689|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
43598690|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598691|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598693|NCT03296982|Enoxaparin|enoxaparin|mesh-list
43598694|NCT03296982|Edoxaban|edoxaban|mesh-list
43598695|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
43598696|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43598697|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43598698|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598699|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43598700|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
43598701|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43598702|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
43612052|NCT03168191|Menthol|menthol|mesh-list
43598703|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43598704|NCT03296930|Ritonavir|ritonavir|mesh-list
43598705|NCT03296930|Ribavirin|ribavirin|mesh-list
43612397|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
43598707|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43598708|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43598740|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
43598741|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43650014|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
43650015|NCT03017430|Ketorolac|ketorolac|mesh-list
43650037|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613363|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613364|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43613365|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613366|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
43613367|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613368|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613403|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
43613404|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613405|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613406|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613407|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613409|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
43613410|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613558|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614382|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
43614677|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
43615089|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
43650196|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43650244|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43650246|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
43615705|NCT03146871|Azacitidine|azacitidine|mesh-list
43615964|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615965|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616143|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
43616147|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
43616369|NCT03117933|Cediranib|cediranib|mesh-list
43616370|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616401|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
43616851|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616997|NCT03142880|Ropivacaine|ropivacaine|mesh-list
43616998|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617622|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617623|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
43618023|NCT03134612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43618362|NCT03131700|Growth Substances|growth substances|mesh-ancestor
43618761|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43619080|NCT03126084|Acetaminophen|acetaminophen|mesh-list
43648936|NCT03033147|Amoxicillin|amoxicillin|mesh-list
43598742|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43598743|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619156|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619263|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619361|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619443|NCT03122353|Vitamins|vitamins|mesh-ancestor
43619545|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619625|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43619626|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43619627|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619628|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619629|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619630|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43598744|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43598745|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
43598746|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43648937|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
43648938|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
43619798|NCT03120637|Methylene Blue|methylene blue|mesh-list
43619828|NCT03120247|Analgesics|analgesics|mesh-ancestor
43620065|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648939|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43648940|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43648941|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620247|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620251|NCT05128734|Olaparib|olaparib|mesh-list
43620397|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
43648942|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43598747|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43598748|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
43598749|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43598750|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
43598751|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43598752|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43598780|NCT03296410|Vaccines|vaccines|mesh-list
43598781|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
43598782|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598783|NCT03296358|Dexamethasone|dexamethasone|mesh-list
43598784|NCT03296358|Prednisolone|prednisolone|mesh-list
43598786|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
43598787|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
43598788|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620607|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620608|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620609|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43620610|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
43620611|NCT03946969|Paclitaxel|paclitaxel|mesh-list
43620612|NCT03946969|Cisplatin|cisplatin|mesh-list
43620677|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620678|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
43620744|NCT02945852|Apatinib|apatinib|mesh-list
43620745|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620856|NCT01552434|Sirolimus|sirolimus|mesh-list
43598789|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621000|NCT03119532|Metronidazole|metronidazole|mesh-list
43621088|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
43621168|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598790|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43621330|NCT03116893|Rifampin|rifampin|mesh-list
43598791|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
43598792|NCT03296358|Hormones|hormones|mesh-ancestor
43598793|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43598794|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43598795|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598796|NCT03296306|Cisplatin|cisplatin|mesh-list
43598797|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598798|NCT03296189|Dexamethasone|dexamethasone|mesh-list
43598799|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
43598800|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
43598801|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43598803|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43598830|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43598831|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
43598832|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621998|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43622000|NCT03111511|Hormones|hormones|mesh-ancestor
43622104|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622105|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
43622106|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43598833|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598834|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43598835|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43598836|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43598837|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43598838|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
43598839|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43650533|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598840|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43598841|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
43598842|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598843|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
43598844|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43598845|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
43598846|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43598847|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598848|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43598850|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43598851|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598852|NCT03295968|Analgesics|analgesics|mesh-ancestor
43598871|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
43598872|NCT03295851|Iron|iron|mesh-list
43598873|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
43622757|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650636|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598874|NCT03295851|Trace Elements|trace elements|mesh-ancestor
43598875|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
43598876|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598877|NCT03295825|Heparin|heparin|mesh-list
43598878|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
43598879|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43598880|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43648943|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623249|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623285|NCT04832009|Vitamins|vitamins|mesh-ancestor
43648944|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598881|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598882|NCT03295786|Dopamine|dopamine|mesh-list
43824515|NCT05511441|Aspirin|aspirin|mesh-list
43598883|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43598884|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
43849161|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849162|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849163|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43849164|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43849165|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
43623955|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623997|NCT02002819|Levetiracetam|levetiracetam|mesh-list
43624095|NCT05404516|Idarubicin|idarubicin|mesh-list
43624096|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624097|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
43624100|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
43849166|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43693440|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
43849167|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43849168|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849170|NCT03954314|Coagulants|coagulants|mesh-ancestor
43849171|NCT03953261|Curcumin|curcumin|mesh-list
43849172|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43624638|NCT03472573|Dexamethasone|dexamethasone|mesh-list
43849173|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849174|NCT03953261|Analgesics|analgesics|mesh-ancestor
43849175|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
43849176|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849177|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849179|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598885|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
43598886|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651012|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
43824575|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43824576|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
43824577|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
43824578|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43824579|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
43824580|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824581|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
43824583|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43598887|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598912|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598914|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43598915|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43598916|NCT03295214|Acetaminophen|acetaminophen|mesh-list
43598917|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43598918|NCT03295214|Analgesics|analgesics|mesh-ancestor
43625575|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625576|NCT03100734|Analgesics|analgesics|mesh-ancestor
43625577|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
43625578|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625579|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625580|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625581|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625582|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625583|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625584|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
43625585|NCT03100565|Lidocaine|lidocaine|mesh-list
43625586|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
43625587|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
43625588|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625589|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625702|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43625703|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625705|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
43625706|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625707|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625708|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43625709|NCT03099122|Protective Agents|protective agents|mesh-ancestor
43625710|NCT03099408|Metronidazole|metronidazole|mesh-list
43824611|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626049|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626050|NCT03096184|Apatinib|apatinib|mesh-list
43626051|NCT03096184|Tegafur|tegafur|mesh-list
43626052|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626053|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651066|NCT03009643|Protective Agents|protective agents|mesh-ancestor
43651067|NCT03009604|Simethicone|simethicone|mesh-list
43626183|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626185|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626186|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626187|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626188|NCT03095079|Endostatins|endostatins|mesh-list
43626189|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43651068|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
43651069|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651070|NCT03009604|Emollients|emollients|mesh-ancestor
43651071|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651072|NCT03009682|Olaparib|olaparib|mesh-list
43651073|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43651078|NCT03009799|Laxatives|laxatives|mesh-ancestor
43651092|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43651093|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
43651094|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651095|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
43651096|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651097|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651098|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
43651099|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651100|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43626401|NCT03092986|Paclitaxel|paclitaxel|mesh-list
43626572|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626573|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626574|NCT03091075|Oxandrolone|oxandrolone|mesh-list
43626575|NCT03091075|Androgens|androgens|mesh-ancestor
43626577|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626712|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
43626713|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43626714|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
43626715|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43626716|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
43626717|NCT03087890|Trimethoprim|trimethoprim|mesh-list
43626718|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43626719|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
43626720|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43626721|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626722|NCT03087890|Renal Agents|renal agents|mesh-ancestor
43626895|NCT03079219|Olanzapine|olanzapine|mesh-list
43626896|NCT03079219|Aprepitant|aprepitant|mesh-list
43626897|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
43626898|NCT03079219|BB 1101|bb 1101|mesh-list
43626899|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626900|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
43651212|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
43651213|NCT03009058|Hematinics|hematinics|mesh-ancestor
43651214|NCT03009409|Ketamine|ketamine|mesh-list
43651215|NCT03009409|Analgesics|analgesics|mesh-ancestor
43651216|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
43651217|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651218|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651219|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43651220|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43626972|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
43651222|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
43627351|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
43627352|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627353|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
43627354|NCT03074344|Protective Agents|protective agents|mesh-ancestor
43627355|NCT03074097|Bupivacaine|bupivacaine|mesh-list
43627356|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627357|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
43627358|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627418|NCT03073343|Betaine|betaine|mesh-list
43651253|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43651254|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651255|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
43651256|NCT03008655|Coagulants|coagulants|mesh-ancestor
43651257|NCT03008512|Paclitaxel|paclitaxel|mesh-list
43651258|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43761439|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761440|NCT02438761|Gedatolisib|gedatolisib|mesh-list
43761441|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43761474|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
43651297|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
43651298|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651299|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
43651300|NCT03008109|Endostatins|endostatins|mesh-list
43651332|NCT03007810|Hemay005|hemay005|mesh-list
43761820|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43761821|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651367|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43762060|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43762097|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43762175|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43762176|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43762177|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43762178|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762179|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651414|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
43651415|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
43651448|NCT03007121|Bupivacaine|bupivacaine|mesh-list
43651449|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651450|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
43651451|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651452|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762271|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43762272|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43762273|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43762274|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
43849180|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598919|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
43598920|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598921|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598922|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
43598923|NCT03295162|Melatonin|melatonin|mesh-list
43598924|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
43598925|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598926|NCT03295162|Protective Agents|protective agents|mesh-ancestor
43598927|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43598928|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43598929|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43598930|NCT03295084|Capecitabine|capecitabine|mesh-list
43598931|NCT03295084|Irinotecan|irinotecan|mesh-list
43598932|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43598933|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
43763248|NCT02427308|Miltefosine|miltefosine|mesh-list
43598934|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598935|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598936|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43598966|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
43598967|NCT03294707|Coal Tar|coal tar|mesh-list
43598968|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
43598969|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
43598970|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
43598971|NCT03294577|Docetaxel|docetaxel|mesh-list
43598972|NCT03294577|Doxorubicin|doxorubicin|mesh-list
43763274|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43763275|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43763276|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43763277|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
43763278|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763279|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763280|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43763281|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
43763501|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
43837610|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837611|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837612|NCT04901702|Irinotecan|irinotecan|mesh-list
43837613|NCT04901702|Temozolomide|temozolomide|mesh-list
43837614|NCT04901702|Talazoparib|talazoparib|mesh-list
43763994|NCT02422901|Vitamins|vitamins|mesh-ancestor
43763995|NCT02422901|Micronutrients|micronutrients|mesh-ancestor
43763996|NCT02422901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763997|NCT02422901|Antioxidants|antioxidants|mesh-ancestor
43763998|NCT02422901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763999|NCT02422901|Protective Agents|protective agents|mesh-ancestor
43651685|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
43651686|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651687|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651688|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43651689|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651690|NCT03005496|Trace Elements|trace elements|mesh-ancestor
43651691|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43824720|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651692|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43651693|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
43651694|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
43764112|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764113|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43764114|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764115|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764116|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43764117|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43764118|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43764119|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43764120|NCT02422706|Renal Agents|renal agents|mesh-ancestor
43764122|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43764261|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43764262|NCT02420938|Rituximab|rituximab|mesh-list
43764263|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43764264|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764265|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
43764266|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764267|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764268|NCT02421042|Lenvatinib|lenvatinib|mesh-list
43764269|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651722|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43651723|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
43651724|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
43651725|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651726|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
43651727|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651728|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651729|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
43651730|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43651737|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43651738|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43651740|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
43651741|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651742|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43598980|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598981|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43598982|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
43598983|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648946|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43648947|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43598984|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
43764829|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764830|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764831|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43764832|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
43764833|NCT02416869|Hormones|hormones|mesh-ancestor
43651799|NCT03005353|Clotrimazole|clotrimazole|mesh-list
43651805|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43765716|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766052|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766081|NCT02409407|Urological Agents|urological agents|mesh-ancestor
43766082|NCT02409563|Budesonide|budesonide|mesh-list
43766083|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766084|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43766085|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
43766086|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766102|NCT02409017|Insulin|insulin|mesh-list
43837930|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
43837931|NCT04877834|Lansoprazole|lansoprazole|mesh-list
43837932|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43837933|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766224|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766261|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
43766262|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
43766297|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43766298|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
43766299|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
43766300|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766301|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766340|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
43599001|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
43599002|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599003|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43837979|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767056|NCT02403687|Baclofen|baclofen|mesh-list
43767057|NCT02403687|Capsaicin|capsaicin|mesh-list
43767058|NCT02403687|Menthol|menthol|mesh-list
43767059|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767060|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
43767061|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651848|NCT03005184|Icatibant|icatibant|mesh-list
43599004|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599005|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599006|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43599008|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
43599009|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
43599010|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43599019|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
43767401|NCT02402179|Tryptophan|tryptophan|mesh-list
43599020|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43599021|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43599022|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43599024|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
43599025|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599026|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
43599027|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651881|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767685|NCT02400255|Crenolanib|crenolanib|mesh-list
43627422|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
43768037|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
43768038|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
43768039|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
43768040|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768041|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768042|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
43768043|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43768044|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599028|NCT03294395|Gentamicins|gentamicins|mesh-list
43599029|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
43599030|NCT03294395|Ertapenem|ertapenem|mesh-list
43599031|NCT03294395|Fosfomycin|fosfomycin|mesh-list
43599032|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43599033|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599034|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43599035|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599036|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599037|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
43768246|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43768450|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43838138|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
43838139|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43768661|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
43599038|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43599039|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43599040|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43599041|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599042|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769207|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769208|NCT02389231|Interleukin-2|interleukin-2|mesh-list
43769330|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651975|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43769332|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
43599069|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599070|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769594|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769733|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
43769734|NCT02385435|Bupivacaine|bupivacaine|mesh-list
43769769|NCT02385058|Mebendazole|mebendazole|mesh-list
43599071|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
43599072|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599073|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
43599074|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43599075|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43599076|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599078|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43599079|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43599080|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599081|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652057|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652059|NCT03002844|Gemcitabine|gemcitabine|mesh-list
43770593|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43599082|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599084|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
43599085|NCT03293992|Latanoprost|latanoprost|mesh-list
43599086|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43599087|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43599088|NCT03293927|Fentanyl|fentanyl|mesh-list
43599089|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
43599090|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43771108|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
43771296|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43771297|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
43771462|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
43771464|NCT02373280|Clarithromycin|clarithromycin|mesh-list
43771497|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43599091|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599092|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771984|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43772198|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772199|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772200|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43772201|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43772202|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
43772203|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43772204|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43772205|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772206|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43772209|NCT02367937|Analgesics|analgesics|mesh-ancestor
43599094|NCT03293927|Analgesics|analgesics|mesh-ancestor
43648950|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648952|NCT03032978|Calcium|calcium|mesh-list
43648953|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43648954|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648955|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43648956|NCT03033160|Estradiol|estradiol|mesh-list
43772399|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43772400|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772401|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772402|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772403|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43772404|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
43772405|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652123|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43652124|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43652125|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43652126|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43652127|NCT03002428|Teriparatide|teriparatide|mesh-list
43652128|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43652129|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652130|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43652147|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652148|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
43652149|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
43652150|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
43652151|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652152|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
43652153|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652154|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652155|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
43652156|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652158|NCT03002090|Trace Elements|trace elements|mesh-ancestor
43652159|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
43652160|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652161|NCT03001960|Clopidogrel|clopidogrel|mesh-list
43772573|NCT02365272|Amikacin|amikacin|mesh-list
43772574|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772575|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772650|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43652210|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43648957|NCT03033160|Estrogens|estrogens|mesh-ancestor
43648958|NCT03033160|Hormones|hormones|mesh-ancestor
43763496|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43648959|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648960|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648961|NCT03033316|Dexamethasone|dexamethasone|mesh-list
43648962|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43648963|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
43648964|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
43648965|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648966|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824286|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
43824287|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43824288|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43824289|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43824290|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43824291|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824292|NCT05513924|Fluorouracil|fluorouracil|mesh-list
43824293|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43824294|NCT05513924|Latanoprost|latanoprost|mesh-list
43824295|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
43824296|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763497|NCT02425813|Prednisolone|prednisolone|mesh-list
43652308|NCT03000127|Hormones|hormones|mesh-ancestor
43652311|NCT03000218|Metformin|metformin|mesh-list
43773386|NCT02359370|Analgesics|analgesics|mesh-ancestor
43773449|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773581|NCT02358304|Calcitonin|calcitonin|mesh-list
43824297|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43599122|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599123|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599124|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43599125|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43599126|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599128|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
43652456|NCT02995083|Lidocaine|lidocaine|mesh-list
43599129|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
43599130|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43599131|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43599132|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
43599133|NCT03293511|Oxytocin|oxytocin|mesh-list
43599134|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
43599135|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43599136|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599137|NCT03293472|Bupivacaine|bupivacaine|mesh-list
43599138|NCT03293472|Ropivacaine|ropivacaine|mesh-list
43599139|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
43599140|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
43773799|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652598|NCT02989623|Copper|copper|mesh-list
43773862|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
43773863|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
43599142|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599143|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
43599144|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599162|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599163|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599164|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599165|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599166|NCT03293277|Analgesics|analgesics|mesh-ancestor
43599167|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
43599168|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599169|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43599171|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599172|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599173|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599174|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599175|NCT03293108|Vitamin D|vitamin d|mesh-list
43774521|NCT02352025|Equol|equol|mesh-list
43599177|NCT03293108|Calcium|calcium|mesh-list
43599178|NCT03293108|Vitamins|vitamins|mesh-ancestor
43599179|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
43599180|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599181|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599182|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43599184|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
43599185|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
43599186|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599187|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
43599188|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599189|NCT03293004|Protective Agents|protective agents|mesh-ancestor
43599190|NCT03292965|Neostigmine|neostigmine|mesh-list
43824298|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824299|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824300|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
43824301|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824302|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43824303|NCT05513872|Nicotine|nicotine|mesh-list
43599191|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43599192|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599193|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775209|NCT02347046|Dotinurad|dotinurad|mesh-list
43775283|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775285|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
43775606|NCT02344511|Vancomycin|vancomycin|mesh-list
43775607|NCT02344511|Cefazolin|cefazolin|mesh-list
43775608|NCT02344511|Dalbavancin|dalbavancin|mesh-list
43775609|NCT02344511|Oxacillin|oxacillin|mesh-list
43775610|NCT02344511|Nafcillin|nafcillin|mesh-list
43775611|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775612|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775613|NCT02344550|Everolimus|everolimus|mesh-list
43599194|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
43599195|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599196|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599197|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43599198|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
43599199|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599200|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
43599201|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
43599202|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599203|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599221|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43599222|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43775800|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775801|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
43775982|NCT02342093|Drospirenone|drospirenone|mesh-list
43599223|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599225|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
43599226|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43776056|NCT02341729|Ticagrelor|ticagrelor|mesh-list
43776200|NCT02340988|Oritavancin|oritavancin|mesh-list
43776340|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43599227|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43599228|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43599229|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43599230|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
43599231|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599232|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599233|NCT03292731|Progestins|progestins|mesh-ancestor
43599236|NCT03292315|Exenatide|exenatide|mesh-list
43599237|NCT03292315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43599238|NCT03292315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599239|NCT03292315|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43599241|NCT03292315|Hormones|hormones|mesh-ancestor
43599242|NCT03292315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599243|NCT03292263|Nivolumab|nivolumab|mesh-list
43599244|NCT03292263|Melphalan|melphalan|mesh-list
43599245|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838900|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
43599246|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599247|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43599248|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599249|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43599250|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
43599251|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43599252|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43599253|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
43599254|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777797|NCT02329795|Temozolomide|temozolomide|mesh-list
43599256|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43599257|NCT03292185|Liraglutide|liraglutide|mesh-list
43599258|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
43599259|NCT03292185|Xultophy|xultophy|mesh-list
43599260|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43778480|NCT02325986|Cisplatin|cisplatin|mesh-list
43599261|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599263|NCT03292185|Hormones|hormones|mesh-ancestor
43599264|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599297|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599298|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599299|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599300|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
43599301|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43599302|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599303|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824304|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43824305|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
43824306|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824307|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824308|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43824309|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43824311|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824312|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824314|NCT05513729|Canagliflozin|canagliflozin|mesh-list
43779294|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43824315|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824316|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824317|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43824318|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846395|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779389|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
43779467|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846396|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846397|NCT04201197|Analgesics|analgesics|mesh-ancestor
43846398|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
43846399|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846400|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43846409|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846411|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763499|NCT02425813|Budesonide|budesonide|mesh-list
43763500|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43779957|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846412|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780019|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43780020|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780168|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
43846413|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43599305|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599306|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599307|NCT03291314|Avelumab|avelumab|mesh-list
43599341|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599342|NCT03290963|Ketamine|ketamine|mesh-list
43599343|NCT03290963|Analgesics|analgesics|mesh-ancestor
43780276|NCT05392790|Calcium|calcium|mesh-list
43839404|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599374|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599376|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599377|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43599378|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43599379|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599380|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43599381|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43599382|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599384|NCT03290703|Rabeprazole|rabeprazole|mesh-list
43599385|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43599386|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599387|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43599420|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599421|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43599422|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43599424|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780729|NCT03519893|Losartan|losartan|mesh-list
43780948|NCT01828697|Dalteparin|dalteparin|mesh-list
43599426|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599427|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
43781064|NCT03910738|Testosterone|testosterone|mesh-list
43599456|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
43599457|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599458|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43599459|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599460|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599461|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599462|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599464|NCT03290417|Protective Agents|protective agents|mesh-ancestor
43599466|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43781268|NCT05085912|Ethanol|ethanol|mesh-list
43781413|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781414|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781415|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839525|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
43839526|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43839527|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
43839528|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839529|NCT04766450|Expectorants|expectorants|mesh-ancestor
43839530|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
43839531|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43839532|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
43839533|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839534|NCT04766450|Protective Agents|protective agents|mesh-ancestor
43839535|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839536|NCT04766450|Antidotes|antidotes|mesh-ancestor
43839537|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43653375|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
43599467|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
43599468|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599469|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
43599470|NCT03290365|Protective Agents|protective agents|mesh-ancestor
43599471|NCT03290196|Bupivacaine|bupivacaine|mesh-list
43599472|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
43599473|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
43839558|NCT04763577|Bradykinin|bradykinin|mesh-list
43599474|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599475|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599506|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
43599507|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
43599508|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599509|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599510|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43599511|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43599512|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599513|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
43599514|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839585|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
43781679|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781684|NCT03630835|Annexin A5|annexin a5|mesh-list
43839655|NCT04755764|Atenolol|atenolol|mesh-list
43599515|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599516|NCT03289728|Protective Agents|protective agents|mesh-ancestor
43599517|NCT03289637|Vitamin D|vitamin d|mesh-list
43782023|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43599518|NCT03289637|Vitamins|vitamins|mesh-ancestor
43599519|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
43599520|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846414|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
43846415|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653518|NCT02983214|Cilostazol|cilostazol|mesh-list
43599545|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43839753|NCT04751929|Atezolizumab|atezolizumab|mesh-list
43782552|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43782553|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43782565|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
43782650|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43599547|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599548|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43599549|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43599550|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599551|NCT03289429|Analgesics|analgesics|mesh-ancestor
43599554|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599556|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599557|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43599558|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
43599559|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43599560|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599561|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43599562|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
43599563|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43599564|NCT03289390|Acetaminophen|acetaminophen|mesh-list
43599565|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599566|NCT03289390|Analgesics|analgesics|mesh-ancestor
43599567|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
43599595|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
43599596|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782957|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
43783033|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43599597|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599598|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
43599600|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43599601|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599602|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
43599603|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599604|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599605|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43783140|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783141|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783142|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43599607|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599608|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599609|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43599610|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599611|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599613|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599614|NCT03289026|Aripiprazole|aripiprazole|mesh-list
43783268|NCT05097950|Acetaminophen|acetaminophen|mesh-list
43599645|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599646|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43599647|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599649|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43599650|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43599651|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
43599652|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599653|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599654|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43599655|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43599682|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599684|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43599685|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599686|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43599687|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599688|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840024|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783821|NCT05099575|Oxytocin|oxytocin|mesh-list
43599690|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43599691|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
43846417|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846418|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43846419|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43840061|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43648979|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43648980|NCT03032666|Velpatasvir|velpatasvir|mesh-list
43599692|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599693|NCT03288350|Avelumab|avelumab|mesh-list
43599694|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784222|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
43599695|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599696|NCT03288259|Anesthetics|anesthetics|mesh-list
43599698|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599699|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599700|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
43599701|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599702|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
43599703|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
43599704|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599728|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43599730|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43599731|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43784303|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
43784306|NCT04316143|Zamicastat|zamicastat|mesh-list
43599732|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
43599733|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599734|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43599735|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43599736|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599737|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
43599738|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
43599739|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599740|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599742|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
43599743|NCT03287882|Micronutrients|micronutrients|mesh-list
43599744|NCT03287882|Trace Elements|trace elements|mesh-list
43599745|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599746|NCT03287609|Evolocumab|evolocumab|mesh-list
43599747|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43599749|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
43784423|NCT02675842|Dronabinol|dronabinol|mesh-list
43653790|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43784710|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
43784796|NCT05106179|Atenolol|atenolol|mesh-list
43784894|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
43785011|NCT03164564|Emtricitabine|emtricitabine|mesh-list
43785191|NCT04695106|Aspirin|aspirin|mesh-list
43599750|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599751|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43599752|NCT03287505|Aripiprazole|aripiprazole|mesh-list
43599753|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
43599754|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599755|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43599756|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43599757|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840309|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43785530|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43785531|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599780|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599781|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785802|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43785966|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
43786116|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43786203|NCT05114499|Donepezil|donepezil|mesh-list
43599782|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
43599783|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599784|NCT03287180|Buprenorphine|buprenorphine|mesh-list
43599785|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43599787|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43599788|NCT03287180|Narcotics|narcotics|mesh-ancestor
43599789|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786723|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786819|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
43840487|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786917|NCT04753437|Clarithromycin|clarithromycin|mesh-list
43599790|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599792|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
43787213|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43599793|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787287|NCT03906617|Dexamethasone|dexamethasone|mesh-list
43599794|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43787561|NCT04752527|Venetoclax|venetoclax|mesh-list
43787562|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787563|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43787564|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787565|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787566|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43787567|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
43787568|NCT04640571|Metformin|metformin|mesh-list
43787569|NCT04640571|Valacyclovir|valacyclovir|mesh-list
43787570|NCT04640571|Enalaprilat|enalaprilat|mesh-list
43787571|NCT04640571|Enalapril|enalapril|mesh-list
43787572|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43787573|NCT04640571|Pravastatin|pravastatin|mesh-list
43787574|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43599795|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
43599796|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654065|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
43654066|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
43599797|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648981|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
43648982|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43648984|NCT03032536|Entecavir|entecavir|mesh-list
43648985|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
43648986|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599799|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43787991|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599800|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599801|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43599802|NCT03287076|Incretins|incretins|mesh-ancestor
43599803|NCT03287076|Hormones|hormones|mesh-ancestor
43840589|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43599804|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43599805|NCT03287011|Listerine|listerine|mesh-list
43599806|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
43599807|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
43599808|NCT03287011|Protective Agents|protective agents|mesh-ancestor
43599809|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599810|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43599839|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599840|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
43599844|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
43599845|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599847|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43599848|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599849|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
43599850|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
43599851|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
43599852|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788776|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
43599854|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43599855|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43599856|NCT03285906|Apatinib|apatinib|mesh-list
43599857|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599858|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43599926|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43599927|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
43599929|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
43599930|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43599931|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43599932|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43599934|NCT03285087|Analgesics|analgesics|mesh-ancestor
43599935|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
43599936|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43599937|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43789278|NCT04563559|Prednisolone|prednisolone|mesh-list
43789279|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43789394|NCT03872791|Paclitaxel|paclitaxel|mesh-list
43599938|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43599939|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43599969|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43789559|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
43789563|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
43789714|NCT05089942|Insulin|insulin|mesh-list
43789847|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
43789976|NCT04413526|Hormones|hormones|mesh-ancestor
43654233|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43654235|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654236|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654237|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654238|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599970|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43599971|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43599972|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43599973|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43599974|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43599976|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43599977|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
43790094|NCT03277924|Ifosfamide|ifosfamide|mesh-list
43599978|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43599979|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43599980|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43599981|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
43599982|NCT03284294|Vitamin D|vitamin d|mesh-list
43599983|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43790180|NCT02824952|Osimertinib|osimertinib|mesh-list
43599984|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840830|NCT04669171|Rituximab|rituximab|mesh-list
43790675|NCT01794520|Hormones|hormones|mesh-ancestor
43790884|NCT04529902|Abatacept|abatacept|mesh-list
43600022|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600023|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648987|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43648988|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43648989|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648990|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648991|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43648992|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43648993|NCT03032484|Bevacizumab|bevacizumab|mesh-list
43648994|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791102|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43791290|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791291|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43791292|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43654338|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654339|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654340|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654341|NCT02976272|Bortezomib|bortezomib|mesh-list
43654342|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654343|NCT02976259|Dolutegravir|dolutegravir|mesh-list
43654344|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43791452|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791460|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791461|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
43791462|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43791463|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43791464|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43791525|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43791526|NCT05135286|Analgesics|analgesics|mesh-ancestor
43791527|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
43791528|NCT05135286|Protective Agents|protective agents|mesh-ancestor
43848406|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848407|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
43848408|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791954|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792025|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43792026|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43792027|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43792028|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792121|NCT05137288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43792122|NCT05137288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792123|NCT05137288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43792124|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43600024|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
43600060|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
43600061|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792313|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
43792566|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792567|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792569|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792570|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43792571|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792572|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792573|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43792574|NCT05281549|Tenecteplase|tenecteplase|mesh-list
43792575|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43792576|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43792577|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792578|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
43792579|NCT05265507|Ondansetron|ondansetron|mesh-list
43792580|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
43792741|NCT05097274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43792742|NCT05097274|Antimetabolites|antimetabolites|mesh-ancestor
43792743|NCT05097274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792850|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43792851|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43792852|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43792853|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43600062|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600063|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600064|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
43600065|NCT03283046|Hormones|hormones|mesh-ancestor
43600066|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600067|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600078|NCT03283020|Remifentanil|remifentanil|mesh-list
43600079|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
43600080|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43600081|NCT03283020|Narcotics|narcotics|mesh-ancestor
43600082|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600083|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600084|NCT03283020|Analgesics|analgesics|mesh-ancestor
43600086|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600087|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43600088|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43600089|NCT03282838|Celecoxib|celecoxib|mesh-list
43841197|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841198|NCT04645004|Aspirin|aspirin|mesh-list
43601694|NCT03262363|Curcumin|curcumin|mesh-list
43793061|NCT04529278|Hormones|hormones|mesh-ancestor
43793062|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846539|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846541|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
43846542|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846543|NCT04192773|Lidocaine|lidocaine|mesh-list
43793134|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43793135|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793136|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793137|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43793276|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43793277|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43793278|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
43793279|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
43793280|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793281|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43793282|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43793283|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846556|NCT04192136|Niacin|niacin|mesh-list
43600090|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43600092|NCT03282838|Analgesics|analgesics|mesh-ancestor
43600093|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
43600094|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600095|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600096|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600097|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846564|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846565|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43846566|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794080|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43794081|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43794082|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43794083|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794084|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794085|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794086|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43794087|NCT03938831|Narcotics|narcotics|mesh-ancestor
43794088|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43794165|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794167|NCT03841201|Lenvatinib|lenvatinib|mesh-list
43794168|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794169|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794170|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43794671|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794672|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
43600100|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600101|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600102|NCT03282825|Paclitaxel|paclitaxel|mesh-list
43600103|NCT03282825|Decitabine|decitabine|mesh-list
43600104|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43600105|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600106|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
43794912|NCT05042700|Protective Agents|protective agents|mesh-ancestor
43794913|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794914|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794915|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
43794916|NCT05033483|Trace Elements|trace elements|mesh-ancestor
43794917|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
43794918|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841479|NCT04613960|Analgesics|analgesics|mesh-ancestor
43841480|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
43841481|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841482|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841483|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
43795012|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43795088|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43795089|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795090|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795091|NCT05243446|Losartan|losartan|mesh-list
43795092|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43795093|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43795094|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43795095|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43795105|NCT05243290|Niacin|niacin|mesh-list
43795462|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795463|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795464|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43795465|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600107|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
43600108|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
43600109|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600110|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600112|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600113|NCT03282643|Heparin|heparin|mesh-list
43600114|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43600115|NCT03282643|Tinzaparin|tinzaparin|mesh-list
43600116|NCT03282643|Dalteparin|dalteparin|mesh-list
43600117|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
43600118|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
43600119|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43600120|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43600121|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600122|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43600123|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
43600124|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43795872|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
43795873|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
43795874|NCT00751075|Amoxicillin|amoxicillin|mesh-list
43795875|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43795876|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795877|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795878|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795879|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795880|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
43795881|NCT00750750|Amoxicillin|amoxicillin|mesh-list
43795882|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654441|NCT02975440|Midazolam|midazolam|mesh-list
43654446|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43654447|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654448|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654449|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43654450|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
43654452|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
43654453|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
43654454|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654455|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796317|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796318|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43796319|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796321|NCT05070598|Tegafur|tegafur|mesh-list
43796322|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43796323|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796324|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
43796325|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
43796326|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
43796327|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796328|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796329|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
43654466|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43654467|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43654468|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43654469|NCT02975583|Vorapaxar|vorapaxar|mesh-list
43654470|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43654471|NCT02975570|Levofloxacin|levofloxacin|mesh-list
43654472|NCT02975570|Ofloxacin|ofloxacin|mesh-list
43654474|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
43654475|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43796677|NCT05061732|Levofloxacin|levofloxacin|mesh-list
43796678|NCT05061732|Tetracycline|tetracycline|mesh-list
43796679|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
43796680|NCT05061732|Rabeprazole|rabeprazole|mesh-list
43796681|NCT05061732|Bismuth|bismuth|mesh-list
43796682|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796683|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796684|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796685|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43841823|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841824|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841826|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43654500|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43654501|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
43654502|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
43654503|NCT02975258|Protective Agents|protective agents|mesh-ancestor
43796999|NCT05052515|Ascorbic Acid|ascorbic acid|mesh-list
43797000|NCT05052515|Choline|choline|mesh-list
43797001|NCT05052515|Vitamins|vitamins|mesh-ancestor
43797071|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
43797072|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797073|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797074|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797075|NCT05051163|Gentamicins|gentamicins|mesh-list
43797076|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
43797077|NCT05051163|Ampicillin|ampicillin|mesh-list
43797078|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43797079|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797080|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43797081|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797083|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43797098|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797099|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
43797100|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797101|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797102|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43797137|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43797138|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654504|NCT02975258|Miotics|miotics|mesh-ancestor
43654505|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43654506|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43654507|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43654508|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43654509|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
43654510|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43654511|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43848541|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797149|NCT05049473|Cytarabine|cytarabine|mesh-list
43797150|NCT05049473|Dexamethasone|dexamethasone|mesh-list
43797257|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
43797922|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797923|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
43797924|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
43797925|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
43797926|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43797927|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797928|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797929|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797930|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798049|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798050|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
43798051|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43841965|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841966|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43841967|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43841968|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
43841969|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841970|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649000|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
43649001|NCT03032614|Carboplatin|carboplatin|mesh-list
43649002|NCT03032614|Veliparib|veliparib|mesh-list
43649004|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43649005|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649006|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649007|NCT03032458|Ketorolac|ketorolac|mesh-list
43649008|NCT03032458|Lidocaine|lidocaine|mesh-list
43649009|NCT03032458|Meperidine|meperidine|mesh-list
43649010|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649011|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
43798313|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
43798453|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
43798454|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
43798455|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798456|NCT05024084|Anesthetics|anesthetics|mesh-list
43798457|NCT05024084|Sevoflurane|sevoflurane|mesh-list
43798458|NCT05024084|Desflurane|desflurane|mesh-list
43798462|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43798639|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43798838|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649012|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649023|NCT03032458|Analgesics|analgesics|mesh-ancestor
43649033|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649034|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649035|NCT03032419|Vaccines|vaccines|mesh-list
43649036|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
43799224|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
43799228|NCT05009017|Bevacizumab|bevacizumab|mesh-list
43654585|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654586|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654587|NCT02974920|Analgesics|analgesics|mesh-ancestor
43654588|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
43654589|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654590|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799283|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
43799284|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799522|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43799523|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
43799525|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
43799526|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799527|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
43799528|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43799529|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43799531|NCT05005494|Analgesics|analgesics|mesh-ancestor
43600125|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600126|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600128|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600129|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600130|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600131|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
43600132|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600133|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
43600157|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43600158|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
43600159|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43800138|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
43800139|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800140|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800141|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
43800142|NCT04996550|Protective Agents|protective agents|mesh-ancestor
43800143|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43800144|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800145|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43800146|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
43600170|NCT03281928|Diuretics|diuretics|mesh-ancestor
43600171|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
43600172|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600173|NCT03281928|Expectorants|expectorants|mesh-ancestor
43600174|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
43600175|NCT03281863|Antibodies|antibodies|mesh-list
43600176|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
43600177|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
43842346|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842347|NCT04535505|Erythromycin|erythromycin|mesh-list
43654655|NCT02974504|Hormones|hormones|mesh-ancestor
43654656|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654657|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43654658|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
43654659|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654660|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801505|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43801742|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
43801743|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43801744|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43801745|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43801746|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
43801747|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600178|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600180|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43600181|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
43600182|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801966|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802278|NCT02394834|Vitamins|vitamins|mesh-ancestor
43802279|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
43802280|NCT02329834|Furosemide|furosemide|mesh-list
43802281|NCT02329834|Diuretics|diuretics|mesh-ancestor
43802282|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
43802283|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802400|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802401|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43802600|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802601|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802602|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43825022|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
43825023|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43825024|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43825025|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43825027|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43825028|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825029|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43802836|NCT04977336|Analgesics|analgesics|mesh-ancestor
43802841|NCT04977544|Sertraline|sertraline|mesh-list
43802902|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
43802903|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43802904|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802905|NCT04976088|Analgesics|analgesics|mesh-ancestor
43802906|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
43802907|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802908|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802909|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802910|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802973|NCT04974827|Cisplatin|cisplatin|mesh-list
43600183|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600184|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43600185|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43600220|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
43600221|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600222|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600223|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43600224|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600286|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600288|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43600289|NCT03280095|Narcotics|narcotics|mesh-ancestor
43600290|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600291|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
43600298|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43803242|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803243|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
43803244|NCT04970329|Dextrans|dextrans|mesh-list
43803245|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
43803246|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
43803247|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
43803248|NCT04970238|Simendan|simendan|mesh-list
43803249|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43842742|NCT04513951|Irinotecan|irinotecan|mesh-list
43803377|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
43803378|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43842803|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43842804|NCT04512365|Analgesics|analgesics|mesh-ancestor
43842805|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
43842806|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842807|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43842808|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43842809|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842810|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600300|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600301|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600302|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43600303|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
43600304|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43600305|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600306|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43654674|NCT02974244|Exenatide|exenatide|mesh-list
43654675|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43848061|NCT04055909|Nangibotide|nangibotide|mesh-list
43654676|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654677|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43654678|NCT02974244|Incretins|incretins|mesh-ancestor
43654679|NCT02974244|Hormones|hormones|mesh-ancestor
43654680|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803562|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803563|NCT04963595|Vinorelbine|vinorelbine|mesh-list
43803564|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43803565|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803566|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
43803567|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
43803568|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803569|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803570|NCT04963257|Aripiprazole|aripiprazole|mesh-list
43803571|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
43803572|NCT04963257|Sertraline|sertraline|mesh-list
43803573|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
43803574|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803575|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43803576|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43803577|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803578|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803579|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
43803580|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
43803581|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803582|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803583|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43803584|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43803585|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
43803586|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43803587|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43654682|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654683|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600308|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43600309|NCT03279796|Betamethasone|betamethasone|mesh-list
43803774|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803775|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803938|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803939|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
43803940|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43803941|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
43803942|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803943|NCT04951856|Evolocumab|evolocumab|mesh-list
43803944|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43803945|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43804199|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804200|NCT04947956|Apatinib|apatinib|mesh-list
43804201|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804355|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
43804356|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804357|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43804358|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
43804359|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43804360|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804361|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43804362|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43804363|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804390|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
43649039|NCT03032042|Albendazole|albendazole|mesh-list
43649040|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649041|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649042|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
43649043|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43600312|NCT03279796|Hormones|hormones|mesh-ancestor
43804517|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
43804518|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43804519|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
43804520|NCT04945096|Protective Agents|protective agents|mesh-ancestor
43804521|NCT04944966|Lumefantrine|lumefantrine|mesh-list
43804522|NCT04944966|Artemether|artemether|mesh-list
43804523|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43804524|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
43804525|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43804526|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43654690|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654691|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600335|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43600336|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43654704|NCT02974348|Analgesics|analgesics|mesh-ancestor
43654705|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
43654706|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805341|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805342|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805343|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
43805413|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805537|NCT04928586|Analgesics|analgesics|mesh-ancestor
43805538|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
43805539|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805540|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805541|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43805542|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805543|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848693|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848695|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43848696|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
43848697|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848698|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848699|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
43848700|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805754|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43843249|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843250|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843251|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43806027|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43600337|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43600338|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43600339|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43600340|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43600341|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43600344|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43600345|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43600346|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43600347|NCT03277573|Analgesics|analgesics|mesh-ancestor
43600351|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600352|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600353|NCT03277391|Droperidol|droperidol|mesh-list
43600354|NCT03277391|Morphine|morphine|mesh-list
43600355|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43600356|NCT03277391|Narcotics|narcotics|mesh-ancestor
43600357|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600358|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600359|NCT03277391|Analgesics|analgesics|mesh-ancestor
43806326|NCT04913987|Cimetidine|cimetidine|mesh-list
43806327|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43806328|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843295|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843296|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843297|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843298|NCT04465864|Dexamethasone|dexamethasone|mesh-list
43843299|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843300|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
43654762|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654763|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654764|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843301|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
43843302|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843303|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843304|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843305|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
43843306|NCT04465864|Hormones|hormones|mesh-ancestor
43806636|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806637|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
43654765|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43806841|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806842|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848988|NCT03976258|Analgesics|analgesics|mesh-ancestor
43806844|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806845|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
43600360|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
43600361|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600378|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
43654811|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43807429|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43600379|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43600380|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
43600381|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43600382|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600383|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600384|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600385|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
43600386|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43600387|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43600388|NCT03276598|Losartan|losartan|mesh-list
43600389|NCT03276598|Amlodipine|amlodipine|mesh-list
43600390|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43600391|NCT03276598|Bisoprolol|bisoprolol|mesh-list
43600392|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43600393|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43600394|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600395|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600396|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43600397|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600398|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
43807692|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600399|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43600400|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43600401|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43600402|NCT03276598|Diuretics|diuretics|mesh-ancestor
43843629|NCT04437888|Ketamine|ketamine|mesh-list
43808117|NCT04887649|Analgesics|analgesics|mesh-ancestor
43808118|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
43808178|NCT04886752|Vitamins|vitamins|mesh-list
43600403|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
43600404|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43600405|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
43600406|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
43600407|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600408|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43600410|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43649044|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
43649045|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43649046|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43649047|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
43649048|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43649049|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43600411|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
43600412|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600413|NCT03275090|SMOFlipid|smoflipid|mesh-list
43600414|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43600415|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43808711|NCT05256693|Vancomycin|vancomycin|mesh-list
43600416|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43600417|NCT03274596|Vitamin E|vitamin e|mesh-list
43600418|NCT03274596|Vitamins|vitamins|mesh-ancestor
43600419|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
43600420|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600421|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
43809034|NCT04309916|Esomeprazole|esomeprazole|mesh-list
43600455|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43600456|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43600457|NCT05075460|Azacitidine|azacitidine|mesh-list
43600458|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600459|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
43600460|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809583|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43809584|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43600480|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
43600482|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600483|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600485|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43600486|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600487|NCT05074628|Renal Agents|renal agents|mesh-ancestor
43600488|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600489|NCT05074602|Fluconazole|fluconazole|mesh-list
43600490|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
43600491|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600492|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43600493|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43600494|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809761|NCT04870671|Tenofovir|tenofovir|mesh-list
43809762|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
43810235|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600495|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600496|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43600497|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
43600498|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600499|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600500|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43600505|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
43600506|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
43600507|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600508|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600509|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600510|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600511|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
43600512|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600513|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43600514|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43810994|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43623231|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
43600515|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600516|NCT05074589|Antidotes|antidotes|mesh-ancestor
43600551|NCT04962022|Itraconazole|itraconazole|mesh-list
43600552|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43600553|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43600554|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
43600555|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600556|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600557|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43600558|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43811226|NCT04847895|Ranibizumab|ranibizumab|mesh-list
43811324|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43600602|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43600603|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
43600604|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43811400|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654981|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43811888|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812388|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
43655061|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43655062|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
43812579|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844585|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844586|NCT04360889|Protective Agents|protective agents|mesh-ancestor
43844587|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844588|NCT04360889|Vitamins|vitamins|mesh-ancestor
43844589|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
43844590|NCT04360135|Acetaminophen|acetaminophen|mesh-list
43844591|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844592|NCT04360135|Analgesics|analgesics|mesh-ancestor
43844593|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
43844594|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844595|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844596|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
43812876|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813124|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649050|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649052|NCT03032315|Amlodipine|amlodipine|mesh-list
43649053|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43649054|NCT03032315|Telmisartan|telmisartan|mesh-list
43649055|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43649056|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43649057|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43649058|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813231|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813233|NCT04816461|Piperaquine|piperaquine|mesh-list
43649059|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649062|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
43649064|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
43649065|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43649066|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43649067|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43649068|NCT03031834|Quinapril|quinapril|mesh-list
43649069|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43649070|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813391|NCT04814381|Ketamine|ketamine|mesh-list
43649071|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649072|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649073|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43649074|NCT03031691|Trifluridine|trifluridine|mesh-list
43649075|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
43649076|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600605|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43814093|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43814094|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
43814095|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814096|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
43814268|NCT04801017|Artemisinin|artemisinin|mesh-list
43649078|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649080|NCT03031808|Rocuronium|rocuronium|mesh-list
43649081|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649082|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
43649083|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814465|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
43814615|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43814939|NCT04787276|Rifaximin|rifaximin|mesh-list
43815228|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815394|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649084|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649085|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
43649086|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649087|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43649088|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43815989|NCT02414724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815990|NCT02414724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815991|NCT02414724|Immunologic Factors|immunologic factors|mesh-ancestor
43815992|NCT02414724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815993|NCT02413138|Hormones|hormones|mesh-list
43815994|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816024|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816025|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816026|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816027|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
43649089|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43649090|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649091|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649092|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43649093|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43649094|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43649095|NCT03031756|Glycine|glycine|mesh-list
43825094|NCT05504603|Rituximab|rituximab|mesh-list
43629759|NCT03057509|Octreotide|octreotide|mesh-list
43825126|NCT05504382|Naproxen|naproxen|mesh-list
43825127|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43825128|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825129|NCT05504382|Analgesics|analgesics|mesh-ancestor
43816782|NCT04089072|Methylene Blue|methylene blue|mesh-list
43816783|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43816796|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816797|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816798|NCT04089072|Protective Agents|protective agents|mesh-ancestor
43816799|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816800|NCT04062695|Tofacitinib|tofacitinib|mesh-list
43816801|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816802|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816803|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816804|NCT04053140|Penicillins|penicillins|mesh-list
43816940|NCT03085680|Curcumin|curcumin|mesh-list
43600639|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43600640|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43600641|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43600642|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43817174|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
43600643|NCT04431466|Ivermectin|ivermectin|mesh-list
43600644|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43600645|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600646|NCT04416282|Terlipressin|terlipressin|mesh-list
43600647|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43600667|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600669|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43600670|NCT03821883|Aspirin|aspirin|mesh-list
43763502|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43630555|NCT03051373|Gemcitabine|gemcitabine|mesh-list
43817467|NCT05555576|Vitamins|vitamins|mesh-ancestor
43763503|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
43817555|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
43600671|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43600673|NCT03821883|Analgesics|analgesics|mesh-ancestor
43600674|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
43818263|NCT05546853|Calcium|calcium|mesh-list
43600675|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600676|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600677|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649097|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649098|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649099|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845490|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649102|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
43649103|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649105|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43600678|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600679|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43600680|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43600681|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600682|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43600683|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43600684|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600685|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
43600686|NCT03536520|Acetazolamide|acetazolamide|mesh-list
43600687|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
43600688|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43600689|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818503|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600690|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600692|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
43600693|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600694|NCT03536455|Acetazolamide|acetazolamide|mesh-list
43600695|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
43600696|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43600697|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600698|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600699|NCT03536455|Diuretics|diuretics|mesh-ancestor
43600700|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
43600701|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600717|NCT03475134|Interleukin-2|interleukin-2|mesh-list
43600718|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600719|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
43600720|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600721|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43600722|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43818825|NCT05539872|Insulin|insulin|mesh-list
43600723|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
43600724|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600725|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600726|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43600727|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43600728|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43600729|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818849|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43818850|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
43845702|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845703|NCT04259944|Capecitabine|capecitabine|mesh-list
43600730|NCT03475134|Analgesics|analgesics|mesh-ancestor
43600731|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
43600732|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600734|NCT03384212|Fludarabine|fludarabine|mesh-list
43600735|NCT03384212|Busulfan|busulfan|mesh-list
43600736|NCT03384212|Cladribine|cladribine|mesh-list
43600737|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600738|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600739|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
43600740|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819119|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
43819250|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
43845751|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600741|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600742|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
43600743|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649106|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43649107|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819532|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
43819722|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
43652557|NCT02990962|Hormones|hormones|mesh-ancestor
43600745|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600746|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
43600747|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43600748|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43600749|NCT03384225|Cytarabine|cytarabine|mesh-list
43600750|NCT03384225|Fludarabine|fludarabine|mesh-list
43820022|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43820148|NCT05678335|Tacrolimus|tacrolimus|mesh-list
43600751|NCT03384225|Busulfan|busulfan|mesh-list
43600753|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600754|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43600755|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
43600756|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600757|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43600758|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
43600759|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600760|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
43600761|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600762|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
43600783|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600785|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43600786|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
43600787|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
43600788|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43600789|NCT03269929|Midazolam|midazolam|mesh-list
43820510|NCT05577000|Fludarabine|fludarabine|mesh-list
43820511|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820656|NCT05372367|Rifampin|rifampin|mesh-list
43600790|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43600791|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600792|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600793|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600794|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43600795|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43600796|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820758|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
43845945|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43845948|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
43820930|NCT05051449|Ketamine|ketamine|mesh-list
43820931|NCT05051449|Analgesics|analgesics|mesh-ancestor
43600797|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43600798|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
43600800|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
43600801|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
43600802|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43600803|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600804|NCT03269760|Zolpidem|zolpidem|mesh-list
43600805|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43600806|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43600807|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600808|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600809|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43600810|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
43600811|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
43600812|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821259|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821260|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43821261|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821262|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821263|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821264|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
43821272|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
43821415|NCT04303845|Erenumab|erenumab|mesh-list
43821416|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43821417|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821418|NCT04303845|Analgesics|analgesics|mesh-ancestor
43821424|NCT04298528|Dronabinol|dronabinol|mesh-list
43600813|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600814|NCT03269786|Bilirubin|bilirubin|mesh-list
43600815|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
43821655|NCT03597347|Molgramostim|molgramostim|mesh-list
43821732|NCT03547973|Carboplatin|carboplatin|mesh-list
43821848|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
43822028|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600816|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600817|NCT03269786|Protective Agents|protective agents|mesh-ancestor
43600818|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600853|NCT03269747|Prednisone|prednisone|mesh-list
43600854|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43600855|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
43600856|NCT03269747|Hormones|hormones|mesh-ancestor
43600857|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43600858|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822501|NCT05534620|Treosulfan|treosulfan|mesh-list
43600886|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600887|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43600888|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43655565|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822925|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43600889|NCT03269591|Analgesics|analgesics|mesh-ancestor
43600890|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
43600891|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600892|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823350|NCT05525351|Narcotics|narcotics|mesh-ancestor
43823351|NCT05525247|Gemcitabine|gemcitabine|mesh-list
43823352|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823353|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
43600893|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649109|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
43649110|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43649111|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649112|NCT03031444|Leucovorin|leucovorin|mesh-list
43649113|NCT03031444|Cetuximab|cetuximab|mesh-list
43649114|NCT03031444|Fluorouracil|fluorouracil|mesh-list
43649115|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
43649116|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649117|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641704|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
43641705|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
43641718|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649119|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649120|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43649121|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649122|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
43649123|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600894|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43600895|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600896|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600897|NCT03269383|Bupivacaine|bupivacaine|mesh-list
43600898|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
43642206|NCT05482334|Sargramostim|sargramostim|mesh-list
43642210|NCT05480046|Risperidone|risperidone|mesh-list
43642517|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43642519|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600900|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43600901|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600902|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
43600903|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600904|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
43600905|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43600906|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600934|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43600935|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43600936|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
43600937|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43600938|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600939|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43600940|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600941|NCT03269318|Theophylline|theophylline|mesh-list
43600942|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43600943|NCT03269318|Montelukast|montelukast|mesh-list
43600944|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43600945|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
43600946|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43600947|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600948|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43849183|NCT03950609|Everolimus|everolimus|mesh-list
43600949|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
43643720|NCT04925167|Calcium heparin|calcium heparin|mesh-list
43643801|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600950|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43600964|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43600965|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43600966|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
43600968|NCT03268733|Hematinics|hematinics|mesh-ancestor
43600969|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
43600970|NCT03268733|Vitamins|vitamins|mesh-ancestor
43600971|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
43600972|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600973|NCT03269162|Cisplatin|cisplatin|mesh-list
43600974|NCT03269162|Docetaxel|docetaxel|mesh-list
43600975|NCT03269162|Pemetrexed|pemetrexed|mesh-list
43600976|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43600977|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
43600978|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
43600979|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
43649124|NCT03031444|Antidotes|antidotes|mesh-ancestor
43600980|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600981|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600982|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43600983|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43600984|NCT03268902|Niacinamide|niacinamide|mesh-list
43644216|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644217|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644218|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644219|NCT04693715|RNS60|rns60|mesh-list
43644220|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43644221|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43644222|NCT04693715|Analgesics|analgesics|mesh-ancestor
43644223|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
43644224|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43644225|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644226|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655714|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655732|NCT02967224|Insulin|insulin|mesh-list
43655733|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43655734|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
43655735|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
43655736|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
43655737|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
43655738|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
43655739|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655741|NCT02966847|Anesthetics|anesthetics|mesh-list
43655743|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825164|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43825166|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825167|NCT05504278|Carboplatin|carboplatin|mesh-list
43825168|NCT05504278|Pemetrexed|pemetrexed|mesh-list
43825169|NCT05504278|Cetuximab|cetuximab|mesh-list
43825170|NCT05504278|Cisplatin|cisplatin|mesh-list
43825171|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825181|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825182|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825183|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43825184|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825185|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825187|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43825188|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600987|NCT03268902|Azithromycin|azithromycin|mesh-list
43600988|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
43600989|NCT03268902|Vitamins|vitamins|mesh-ancestor
43600990|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
43600991|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43600992|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43600993|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600994|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
43600995|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43600996|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
43600997|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846587|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
43846588|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43846589|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846590|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43846591|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
43846592|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846593|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846594|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43846595|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850116|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43850117|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850118|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850119|NCT05701969|Melatonin|melatonin|mesh-list
43850120|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
43850121|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850122|NCT05701969|Protective Agents|protective agents|mesh-ancestor
43601005|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601007|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
43846596|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
43846598|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846599|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43846600|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43846601|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43846602|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846603|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846604|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846605|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
43655744|NCT02966717|Rituximab|rituximab|mesh-list
43655745|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43655746|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655747|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
43655748|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655749|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655750|NCT02966522|Thalidomide|thalidomide|mesh-list
43655751|NCT02966522|Dexamethasone|dexamethasone|mesh-list
43655752|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655753|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
43655754|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
43655755|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655756|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655757|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655758|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
43655759|NCT02966522|Hormones|hormones|mesh-ancestor
43655760|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655761|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43655762|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655763|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655764|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
43655765|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
43655766|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43655767|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850123|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601093|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601124|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601125|NCT03266965|Carbidopa|carbidopa|mesh-list
43601126|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43601127|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43601128|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
43601129|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601130|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601131|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655787|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655789|NCT02966743|Analgesics|analgesics|mesh-ancestor
43655790|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
43655791|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655792|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43655793|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43655794|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43655795|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655796|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655816|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43655817|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655818|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
43655819|NCT02966288|Ibuprofen|ibuprofen|mesh-list
43655820|NCT02966288|Ketorolac|ketorolac|mesh-list
43655821|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43655822|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43655823|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43655825|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
43655826|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655827|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655828|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655829|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655830|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43655831|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601132|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43601133|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601134|NCT03266926|Bupivacaine|bupivacaine|mesh-list
43601135|NCT03266926|Estrogens|estrogens|mesh-list
43601136|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43601166|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601167|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43601168|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43601169|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601170|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43601171|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43601172|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601173|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
43601174|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43601175|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43601176|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43601177|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
43649126|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
43601200|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43601201|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601202|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601203|NCT03266159|Trametinib|trametinib|mesh-list
43601204|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601205|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601206|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601207|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601208|NCT03266250|Anesthetics|anesthetics|mesh-list
43601209|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601210|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601211|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
43655836|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655837|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
43655838|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43655839|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43655840|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655841|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
43655842|NCT02966236|Coagulants|coagulants|mesh-ancestor
43655843|NCT02966067|Anesthetics|anesthetics|mesh-list
43655845|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655846|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655847|NCT02966041|Ondansetron|ondansetron|mesh-list
43655849|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
43655850|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655851|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850126|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43655852|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655853|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
43655854|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
43601212|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43601213|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43601215|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
43601216|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43601217|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
43601218|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601219|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
43601220|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
43601221|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601222|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601223|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43601225|NCT03266146|Hormones|hormones|mesh-ancestor
43601226|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43601227|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43601253|NCT03265782|Acetaminophen|acetaminophen|mesh-list
43601255|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601256|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43601257|NCT03265782|Analgesics|analgesics|mesh-ancestor
43601258|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
43601259|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601260|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601261|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43601262|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601263|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43601264|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601265|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601266|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
43601267|NCT03265470|Fentanyl|fentanyl|mesh-list
43601268|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
43601269|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43601270|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655856|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
43601273|NCT03265470|Analgesics|analgesics|mesh-ancestor
43601274|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
43601275|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601276|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43601277|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43601306|NCT03265288|Fenretinide|fenretinide|mesh-list
43601307|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601308|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43601309|NCT03265288|Protective Agents|protective agents|mesh-ancestor
43655857|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655858|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655859|NCT02966041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43655860|NCT02966041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43655861|NCT02966041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655862|NCT02966041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655863|NCT02966041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43850127|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43655864|NCT02965911|Fenofibrate|fenofibrate|mesh-list
43655865|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43655866|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
43655867|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655868|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43655869|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
43655870|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
43655871|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
43601312|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43601313|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43601314|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601315|NCT03265223|Ropivacaine|ropivacaine|mesh-list
43601316|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601317|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
43601318|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601319|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601320|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
43655872|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655873|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655874|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
43655875|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655876|NCT02966080|Heparin|heparin|mesh-list
43655877|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
43655878|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43655879|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43655880|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655881|NCT02965859|Adefovir|adefovir|mesh-list
43655882|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43655883|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
43655888|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850128|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850129|NCT05701917|Heparin|heparin|mesh-list
43850177|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
43850178|NCT05701436|Raltitrexed|raltitrexed|mesh-list
43601357|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601358|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601359|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601360|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601362|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43601363|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43601364|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43601365|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
43850192|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
43655903|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655904|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655905|NCT02965443|Incretins|incretins|mesh-ancestor
43655906|NCT02965443|Hormones|hormones|mesh-ancestor
43655907|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655908|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43655909|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655910|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655911|NCT02965053|Sevelamer|sevelamer|mesh-list
43655912|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
43655913|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
43601410|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
43601411|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601412|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850194|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
43655924|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655925|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43655926|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655927|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
43655928|NCT02965248|Leucovorin|leucovorin|mesh-list
43655929|NCT02965248|Capecitabine|capecitabine|mesh-list
43601414|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601415|NCT03264430|Analgesics|analgesics|mesh-ancestor
43601416|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43601417|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43601418|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
43601419|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43601420|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43601421|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43601455|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655941|NCT02965248|Antidotes|antidotes|mesh-ancestor
43655942|NCT02965248|Protective Agents|protective agents|mesh-ancestor
43655943|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
43655944|NCT02965248|Vitamins|vitamins|mesh-ancestor
43655945|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
43655946|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43655947|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655948|NCT02965274|Fluoxetine|fluoxetine|mesh-list
43655949|NCT02965274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43655950|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649136|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
43649137|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601495|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601496|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43601497|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43601498|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601499|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
43601500|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43601501|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43601531|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
43655951|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655952|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655953|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655954|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
43655955|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655956|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43655957|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
43655958|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655959|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43655960|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43601532|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43601533|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
43601534|NCT03263208|Fludarabine|fludarabine|mesh-list
43601535|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43601536|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
43601537|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601538|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43601539|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43850196|NCT05701423|Natalizumab|natalizumab|mesh-list
43850197|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
43655963|NCT02965261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43655964|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43655965|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43601540|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
43601541|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601542|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601543|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43601544|NCT03262857|Lidocaine|lidocaine|mesh-list
43601545|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
43601546|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601547|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
43601606|NCT03262545|Apatinib|apatinib|mesh-list
43601607|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601608|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601609|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601610|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601611|NCT03262688|Bupivacaine|bupivacaine|mesh-list
43601612|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
43601613|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
43601614|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601615|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601616|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
43601617|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43601618|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43601619|NCT03262740|Norethindrone|norethindrone|mesh-list
43601620|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
43651602|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850198|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850199|NCT05701384|Lazertinib|lazertinib|mesh-list
43655966|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655967|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655968|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
43655972|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655973|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43850200|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43850201|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850203|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
43850204|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43850205|NCT05701332|Gemcitabine|gemcitabine|mesh-list
43655978|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655979|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655980|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825190|NCT05504213|Fulvestrant|fulvestrant|mesh-list
43825191|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825192|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702892|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
43850209|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850211|NCT05701332|Antiviral Agents|antiviral agents|mesh-ancestor
43850212|NCT05701332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850213|NCT05701332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850214|NCT05701332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850215|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
43850216|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850217|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43850218|NCT05701241|Octreotide|octreotide|mesh-list
43850219|NCT05701241|Lanreotide|lanreotide|mesh-list
43850220|NCT05701241|Somatostatin|somatostatin|mesh-list
43850232|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
43827084|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850233|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43850234|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
43850235|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601653|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43601654|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43601655|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43601656|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43601657|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
43601658|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43601659|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601660|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601661|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43825196|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825197|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825199|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
43825200|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
43601662|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
43601664|NCT03262142|Tazobactam|tazobactam|mesh-list
43649138|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649139|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
43649140|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649141|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
43649142|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
43649143|NCT03031184|Mirtazapine|mirtazapine|mesh-list
43825206|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43655982|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43649148|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
43649149|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649150|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649151|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655984|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43655985|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655986|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655987|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655988|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
43655989|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
43655990|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43655991|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43655992|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43655993|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655994|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655995|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
43655996|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655997|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655998|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43655999|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649153|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43649154|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43601665|NCT03262142|Piperacillin|piperacillin|mesh-list
43601666|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43601667|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43601668|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601669|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43601670|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43601671|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601672|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601673|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601674|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43601675|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43601676|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43601677|NCT03262077|Methylene Blue|methylene blue|mesh-list
43601678|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656002|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656003|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656004|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656005|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43656006|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43850243|NCT05701059|Meloxicam|meloxicam|mesh-list
43850244|NCT05701059|Cimetidine|cimetidine|mesh-list
43656009|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656010|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
43656011|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656012|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
43656013|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656014|NCT02964572|Empagliflozin|empagliflozin|mesh-list
43656015|NCT02964572|Glimepiride|glimepiride|mesh-list
43656016|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43850247|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43656022|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
43601715|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
43601716|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43601717|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43601718|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656023|NCT02964195|Rifaximin|rifaximin|mesh-list
43656024|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43656025|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850248|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
43850249|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
43850250|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850251|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601728|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43601729|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601730|NCT03261921|Dexamethasone|dexamethasone|mesh-list
43649155|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43850252|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850253|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43850254|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43656034|NCT02964403|Analgesics|analgesics|mesh-ancestor
43656035|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
43656036|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656037|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656038|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656039|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656043|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656044|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649157|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43649159|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43649160|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43649161|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
43601767|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601768|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656045|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656046|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
43656047|NCT02964091|Ledipasvir|ledipasvir|mesh-list
43656049|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656050|NCT02963779|Apremilast|apremilast|mesh-list
43656051|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656052|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656054|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
43601823|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601824|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43601858|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601860|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850258|NCT05701059|Analgesics|analgesics|mesh-ancestor
43850259|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
43850260|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850265|NCT05698771|Niacinamide|niacinamide|mesh-list
43850267|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
43850268|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
43850269|NCT05698771|Vitamins|vitamins|mesh-ancestor
43850270|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
43850271|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850272|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656065|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656066|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43656067|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656068|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702759|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43702760|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43702761|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43702762|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43702763|NCT02715167|Budesonide|budesonide|mesh-list
43702764|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702765|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43702766|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
43702767|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702768|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702769|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43702770|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43702771|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
43702772|NCT02715167|Hormones|hormones|mesh-ancestor
43702773|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702774|NCT02714959|Aldesleukin|aldesleukin|mesh-list
43702775|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702776|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43702777|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43702778|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
43702779|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702780|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
43702782|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43702783|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702784|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702785|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43702786|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
43702787|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
43702788|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702789|NCT02714725|Analgesics|analgesics|mesh-ancestor
43702790|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
43656070|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656071|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656074|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43656082|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
43702893|NCT02714179|Acetaminophen|acetaminophen|mesh-list
43702894|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702895|NCT02714179|Analgesics|analgesics|mesh-ancestor
43702909|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
43702910|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702911|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702912|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43702913|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656083|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
43656084|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656085|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43656086|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43656087|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43656094|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656096|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43656097|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656098|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656099|NCT02963194|Oxytocin|oxytocin|mesh-list
43656100|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
43656101|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43656102|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656103|NCT02963129|Mupirocin|mupirocin|mesh-list
43656104|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43656105|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656106|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43656107|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656108|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656109|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
43656110|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43601891|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43601892|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43601893|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
43601896|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
43601897|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
43601898|NCT03260166|Vitamins|vitamins|mesh-ancestor
43601899|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
43601900|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601901|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43601902|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
43850275|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656116|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656117|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
43656118|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656119|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
43601903|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649162|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43649163|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43601904|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43601905|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
43601907|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43601908|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601909|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
43601910|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43601911|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
43601912|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43601913|NCT03260088|Antibodies|antibodies|mesh-list
43601914|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
43601915|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
43601916|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601917|NCT03259919|Metformin|metformin|mesh-list
43601918|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43601919|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43601920|NCT03259958|Donepezil|donepezil|mesh-list
43850276|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
43656124|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656125|NCT02963181|Protective Agents|protective agents|mesh-ancestor
43656126|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656127|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656129|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
43656130|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656131|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43656132|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43656133|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43656153|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656154|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43656156|NCT02963103|Tacrolimus|tacrolimus|mesh-list
43656157|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43656158|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
43656159|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656160|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43656161|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656163|NCT02962999|Ketamine|ketamine|mesh-list
43601974|NCT03259516|Urological Agents|urological agents|mesh-ancestor
43601975|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
43601976|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
43656177|NCT02962986|Phenylephrine|phenylephrine|mesh-list
43656178|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
43656179|NCT02962986|Norepinephrine|norepinephrine|mesh-list
43656180|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43850280|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702793|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43702794|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43702795|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702796|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702797|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702799|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702800|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702801|NCT02714842|Analgesics|analgesics|mesh-ancestor
43702802|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
43702803|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702804|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702805|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702806|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702807|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43702808|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702809|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702810|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43702811|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
43702812|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702813|NCT02714699|Diclofenac|diclofenac|mesh-list
43702814|NCT02714699|Scopolamine|scopolamine|mesh-list
43702815|NCT02714699|Bromides|bromides|mesh-list
43702819|NCT02714699|Analgesics|analgesics|mesh-ancestor
43702820|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
43702821|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656186|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43656188|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656189|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43656190|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43656191|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43656192|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656198|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656200|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43651604|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43651606|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651607|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43651608|NCT03006107|Analgesics|analgesics|mesh-ancestor
43651609|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
43651610|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651611|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656201|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43656202|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656203|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656204|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651613|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651614|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43651615|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651616|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651618|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43651619|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43651620|NCT03006081|Growth Substances|growth substances|mesh-ancestor
43651621|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652579|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
43651622|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
43656205|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656206|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43656207|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43656208|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
43656209|NCT02962804|Nivolumab|nivolumab|mesh-list
43602017|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
43602018|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43602019|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43602020|NCT03259152|Denosumab|denosumab|mesh-list
43602056|NCT03258684|Antioxidants|antioxidants|mesh-ancestor
43602057|NCT03258684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602058|NCT03258684|Protective Agents|protective agents|mesh-ancestor
43649164|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
43649165|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43649166|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43649167|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
43649168|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649169|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
43602059|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
43602070|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
43602071|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602072|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656213|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825207|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43825208|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
43825209|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825210|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
43825211|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825212|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825213|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825214|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825215|NCT05504057|Analgesics|analgesics|mesh-ancestor
43825216|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
43825217|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825218|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
43825219|NCT05503901|Timolol|timolol|mesh-list
43825220|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43825221|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43825222|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43825223|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43602078|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602079|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43602080|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
43602081|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43602082|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43602083|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43602084|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
43825229|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43825230|NCT05503875|Adalimumab|adalimumab|mesh-list
43825231|NCT05503875|Methotrexate|methotrexate|mesh-list
43825232|NCT05503875|Ixekizumab|ixekizumab|mesh-list
43825233|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43602096|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602099|NCT03258372|Mifepristone|mifepristone|mesh-list
43602100|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43602101|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
43602102|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602103|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602104|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
43602105|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43602106|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602107|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602108|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43602109|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43602110|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43602111|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43602112|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43602113|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43602114|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43602115|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
43825235|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
43825236|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43825237|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825238|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43825239|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
43825240|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825241|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602117|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602118|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43602119|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43602120|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43602121|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
43602140|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602142|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649172|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43649173|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
43649174|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43850283|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43602169|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602170|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602172|NCT03257722|Idelalisib|idelalisib|mesh-list
43602173|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602174|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602201|NCT03257800|Ketamine|ketamine|mesh-list
43602202|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
43602203|NCT03257800|Sevoflurane|sevoflurane|mesh-list
43602204|NCT03257800|Analgesics|analgesics|mesh-ancestor
43602205|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
43602206|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602207|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602208|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43825245|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825246|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
43825247|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825248|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43825250|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602209|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43602210|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
43602211|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
43602212|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602213|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43602214|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43602215|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602216|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602217|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43850284|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43825251|NCT05503706|Selenium|selenium|mesh-list
43825252|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
43825253|NCT05503706|Salicylates|salicylates|mesh-list
43602219|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43602220|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
43602221|NCT03257423|Metronidazole|metronidazole|mesh-list
43602222|NCT03257423|Levofloxacin|levofloxacin|mesh-list
43602239|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602240|NCT03257319|Narcotics|narcotics|mesh-ancestor
43602241|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602242|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602243|NCT03257319|Analgesics|analgesics|mesh-ancestor
43825254|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
43825255|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
43825256|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656214|NCT02962830|Sufentanil|sufentanil|mesh-list
43656215|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43656216|NCT02962830|Narcotics|narcotics|mesh-ancestor
43602244|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
43602245|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602246|NCT03257241|Cytarabine|cytarabine|mesh-list
43602247|NCT03257241|Fludarabine|fludarabine|mesh-list
43602248|NCT03257241|Daunorubicin|daunorubicin|mesh-list
43602249|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
43602250|NCT03257241|Idarubicin|idarubicin|mesh-list
43602251|NCT03257241|Cladribine|cladribine|mesh-list
43602252|NCT03257241|Lenograstim|lenograstim|mesh-list
43602253|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602254|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602255|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
43695133|NCT02763592|Lidocaine|lidocaine|mesh-list
43602256|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656224|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
43656226|NCT02962921|Insulin|insulin|mesh-list
43850285|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
43656227|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43656228|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
43656229|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43656230|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656231|NCT02962232|Paclitaxel|paclitaxel|mesh-list
43656232|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43656233|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850286|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43656234|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
43656235|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656236|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
43656237|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656238|NCT02962388|Anagrelide|anagrelide|mesh-list
43656239|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43649178|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
43649179|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
43649180|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43649181|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
43649182|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649183|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
43649184|NCT03031054|Protective Agents|protective agents|mesh-ancestor
43649185|NCT03030911|Fentanyl|fentanyl|mesh-list
43649186|NCT03030911|Midazolam|midazolam|mesh-list
43649187|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
43649188|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43649189|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649190|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649191|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43649192|NCT03030911|Analgesics|analgesics|mesh-ancestor
43649193|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
43649194|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649195|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43649196|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43656240|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43656241|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656242|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43656244|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43656245|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43656246|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43656247|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656248|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656249|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656250|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602260|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
43602261|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602262|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43602263|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43602264|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43602265|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43850288|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
43656260|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656261|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43656262|NCT02962492|Incretins|incretins|mesh-ancestor
43656263|NCT02962492|Hormones|hormones|mesh-ancestor
43827086|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656264|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43656266|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656267|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
43656268|NCT02962518|Hormones|hormones|mesh-ancestor
43656269|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602266|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602268|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
43602269|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602270|NCT03257215|Vitamin D|vitamin d|mesh-list
43602271|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
43602272|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
43602273|NCT03257215|Vitamins|vitamins|mesh-list
43602274|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
43602275|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602276|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43602277|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656270|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656271|NCT02962336|Amlodipine|amlodipine|mesh-list
43656272|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43656273|NCT02962336|Olmesartan|olmesartan|mesh-list
43656279|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656280|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656281|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
43656282|NCT02962336|Diuretics|diuretics|mesh-ancestor
43656283|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
43656284|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43656285|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43656286|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43656287|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43656292|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656294|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656295|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656296|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43656297|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656298|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43656299|NCT02962323|Calcium|calcium|mesh-list
43656300|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656301|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656304|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
43656305|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656306|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656307|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43656308|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656309|NCT02962141|Paclitaxel|paclitaxel|mesh-list
43656310|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43656311|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656312|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
43656313|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656314|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
43656315|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656316|NCT02961855|Diclofenac|diclofenac|mesh-list
43602311|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602312|NCT03256487|Morphine|morphine|mesh-list
43602313|NCT03256487|Buprenorphine|buprenorphine|mesh-list
43602314|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602315|NCT03256487|Narcotics|narcotics|mesh-ancestor
43602316|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602317|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602318|NCT03256487|Analgesics|analgesics|mesh-ancestor
43602319|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
43602320|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656318|NCT02961855|Lidocaine|lidocaine|mesh-list
43656319|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656320|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
43656321|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656322|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656323|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
43656324|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656325|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43656326|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43656327|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43656328|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656329|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656330|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656333|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656334|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656335|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656336|NCT02961998|Celecoxib|celecoxib|mesh-list
43656337|NCT02961998|Sorafenib|sorafenib|mesh-list
43656338|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656339|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43656340|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656341|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656342|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656343|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656344|NCT02961998|Analgesics|analgesics|mesh-ancestor
43656348|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656349|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656350|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43656351|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656352|NCT02961829|Niacinamide|niacinamide|mesh-list
43656353|NCT02961829|Maraviroc|maraviroc|mesh-list
43656354|NCT02961829|Dolutegravir|dolutegravir|mesh-list
43656355|NCT02961829|Auranofin|auranofin|mesh-list
43656356|NCT02961829|Vaccines|vaccines|mesh-list
43656357|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43656358|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
43656359|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656360|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43602321|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43602322|NCT03256071|Decitabine|decitabine|mesh-list
43602323|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43602324|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
43602325|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602326|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602327|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602328|NCT03256292|Testosterone|testosterone|mesh-list
43602329|NCT03256292|Androgens|androgens|mesh-ancestor
43602330|NCT03256292|Hormones|hormones|mesh-ancestor
43602331|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602332|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602333|NCT03255811|Apatinib|apatinib|mesh-list
43602334|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602335|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602336|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656377|NCT02961842|Bupivacaine|bupivacaine|mesh-list
43656378|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656379|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
43656380|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656381|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656382|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
43656383|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656384|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43656385|NCT02961842|Narcotics|narcotics|mesh-ancestor
43656386|NCT02961842|Analgesics|analgesics|mesh-ancestor
43656387|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43656388|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43656389|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
43656390|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43656391|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
43656392|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
43656393|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43656394|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656395|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656397|NCT02962024|Morphine|morphine|mesh-list
43656424|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656425|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656426|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656427|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
43656428|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
43656429|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656430|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656431|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
43602337|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602338|NCT03255642|Clonazepam|clonazepam|mesh-list
43602339|NCT03255642|Melatonin|melatonin|mesh-list
43602340|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
43602341|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602342|NCT03255642|Protective Agents|protective agents|mesh-ancestor
43602343|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602344|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602345|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
43602346|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
43602347|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
43602348|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602349|NCT03255226|Tolvaptan|tolvaptan|mesh-list
43602364|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656491|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43656492|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656493|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656494|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656495|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656496|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
43656497|NCT02961101|Decitabine|decitabine|mesh-list
43656498|NCT02961101|Antibodies|antibodies|mesh-list
43656499|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
43656500|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656501|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43656502|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
43656503|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656504|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656506|NCT02961075|Anesthetics|anesthetics|mesh-list
43602367|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43602368|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602369|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602370|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
43602371|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43602372|NCT03255330|Narcotics|narcotics|mesh-ancestor
43602373|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43602374|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43602375|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43602376|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825265|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656510|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
43656511|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43656512|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
43656513|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43656514|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
43656515|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656516|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656517|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
43656519|NCT02960906|Ipilimumab|ipilimumab|mesh-list
43656520|NCT02960906|Sunitinib|sunitinib|mesh-list
43656521|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43656522|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656523|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43656524|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656525|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43656526|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43656527|NCT02960906|Growth Substances|growth substances|mesh-ancestor
43656528|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656529|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
43656530|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43656531|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656532|NCT02960919|Amoxicillin|amoxicillin|mesh-list
43656533|NCT02960919|Gentamicins|gentamicins|mesh-list
43656534|NCT02960919|Penicillins|penicillins|mesh-list
43656535|NCT02960919|Ampicillin|ampicillin|mesh-list
43656536|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43602378|NCT03255473|Dexamethasone|dexamethasone|mesh-list
43602379|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
43649202|NCT03030911|Narcotics|narcotics|mesh-ancestor
43649203|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649204|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649205|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
43649206|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
43649207|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43649208|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43602381|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43656537|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656538|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43656539|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656540|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656541|NCT02960815|Imiquimod|imiquimod|mesh-list
43656542|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43656543|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
43656544|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656545|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656546|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
43656547|NCT02960503|Azithromycin|azithromycin|mesh-list
43656548|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43656549|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656550|NCT02960412|Furosemide|furosemide|mesh-list
43656551|NCT02960412|Diuretics|diuretics|mesh-ancestor
43656552|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
43656553|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656554|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43656555|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656556|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656557|NCT02960711|Metformin|metformin|mesh-list
43656558|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43656560|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
43602391|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43602392|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43602393|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602394|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
43602395|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602396|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602397|NCT03255148|Oxytocin|oxytocin|mesh-list
43602398|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
43602399|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602400|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656644|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43656645|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656646|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43656647|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656648|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43656649|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43656650|NCT02959554|Growth Substances|growth substances|mesh-ancestor
43656651|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656652|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
43656653|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43656654|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656655|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
43656656|NCT02959606|Clopidogrel|clopidogrel|mesh-list
43656657|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43656658|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43656659|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43656660|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43656661|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
43656662|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656663|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656664|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656665|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43656666|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43656667|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43656668|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
43656669|NCT02959476|Ropivacaine|ropivacaine|mesh-list
43656670|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656691|NCT02959411|Tolvaptan|tolvaptan|mesh-list
43602401|NCT03254849|Empagliflozin|empagliflozin|mesh-list
43602402|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43602403|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602404|NCT03254849|Diuretics|diuretics|mesh-ancestor
43602405|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
43602406|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602407|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43651624|NCT03005860|Fentanyl|fentanyl|mesh-list
43656720|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
43656721|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656722|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656723|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
43656724|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
43656725|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602408|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602409|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602446|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43602447|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43602448|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43602449|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656839|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43656840|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
43656841|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656842|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656843|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656844|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43656845|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656872|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
43656873|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43656874|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
43656875|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656876|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656877|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656916|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656917|NCT02958215|Phenylephrine|phenylephrine|mesh-list
43656918|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
43656919|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43656920|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
43656921|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
43656922|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656923|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656924|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
43656925|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43656926|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
43656927|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656928|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43656929|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43656930|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43656931|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656932|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656933|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656934|NCT02958215|Protective Agents|protective agents|mesh-ancestor
43602481|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602482|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602483|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43602484|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
43602485|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602486|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602487|NCT03253887|Ethanol|ethanol|mesh-list
43602488|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43602489|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602490|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656943|NCT02957864|Abacavir|abacavir|mesh-list
43656944|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
43656945|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656946|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43656947|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43656948|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656949|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656950|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43656951|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43656952|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
43656953|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656954|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
43656955|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656956|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656957|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43656958|NCT02957786|Varenicline|varenicline|mesh-list
43656959|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43656960|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43656961|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
43602491|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602493|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43602494|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
43602519|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43602521|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849185|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602524|NCT03253250|Entecavir|entecavir|mesh-list
43602525|NCT03253250|Adefovir|adefovir|mesh-list
43602526|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
43602527|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602528|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43651625|NCT03005860|Propofol|propofol|mesh-list
43656962|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656963|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656964|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656965|NCT02957877|Heparin|heparin|mesh-list
43656998|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43656999|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657000|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43657002|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
43657003|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43602529|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43649211|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
43649212|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
43649213|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43649214|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602530|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602531|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602532|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43602533|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43602534|NCT03253562|Metformin|metformin|mesh-list
43602535|NCT03253562|Vildagliptin|vildagliptin|mesh-list
43602536|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657069|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
43657070|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657071|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
43657072|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43657126|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
43657127|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657128|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657129|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43657130|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657131|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
43657132|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
43657133|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657134|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657135|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
43602537|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602538|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43602540|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602541|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602542|NCT03253198|Bupivacaine|bupivacaine|mesh-list
43602543|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
43602544|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
43602579|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651626|NCT03005860|Sevoflurane|sevoflurane|mesh-list
43657146|NCT02955732|Analgesics|analgesics|mesh-ancestor
43657147|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
43657148|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657149|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43657150|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43657151|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43657152|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
43657153|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657154|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657155|NCT02955719|Sertraline|sertraline|mesh-list
43657156|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43657157|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
43657158|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43657159|NCT02955719|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43657160|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43657161|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657162|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657163|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657164|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
43657165|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657194|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43602590|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
43602621|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
43602622|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602623|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43850292|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43850293|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43602707|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43602708|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602709|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602710|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43602711|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
43602712|NCT03251040|Coagulants|coagulants|mesh-ancestor
43602713|NCT03250923|Acemannan|acemannan|mesh-list
43602714|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43602715|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
43602716|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657217|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43657218|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
43657219|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657220|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657221|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43657222|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
43657223|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
43657224|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
43657225|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43657226|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43649219|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649220|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43649221|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43649222|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43649223|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
43649224|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657229|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825278|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43825279|NCT05503667|Growth Substances|growth substances|mesh-ancestor
43825280|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825281|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
43825282|NCT05503355|Venetoclax|venetoclax|mesh-list
43825283|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825284|NCT05503225|Colchicine|colchicine|mesh-list
43825285|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
43825286|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825287|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
43825288|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
43825289|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
43825290|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825291|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825292|NCT05503147|Nabiximols|nabiximols|mesh-list
43825293|NCT05503147|Analgesics|analgesics|mesh-ancestor
43825294|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
43825295|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825296|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850297|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43825297|NCT05503043|Lidocaine|lidocaine|mesh-list
43825298|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
43825299|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
43825300|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825301|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825302|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
43825303|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825304|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43562872|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602753|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43602754|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43602755|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43602756|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43602757|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
43602758|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602759|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602760|NCT03250910|Ribavirin|ribavirin|mesh-list
43602794|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602795|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
43825305|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43825307|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43825308|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825309|NCT05502991|Bevacizumab|bevacizumab|mesh-list
43825310|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825311|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825312|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43825313|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43825314|NCT05502991|Growth Substances|growth substances|mesh-ancestor
43825315|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825316|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
43602796|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602797|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602798|NCT03250481|Oxycodone|oxycodone|mesh-list
43602799|NCT03250481|Propofol|propofol|mesh-list
43602800|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43602801|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43602834|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43602835|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43602836|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602837|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43602838|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43602839|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602840|NCT03250143|Cyclosporine|cyclosporine|mesh-list
43602841|NCT03250143|Azathioprine|azathioprine|mesh-list
43602842|NCT03250143|Cyclosporins|cyclosporins|mesh-list
43825324|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825325|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
43825326|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43825327|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
43825328|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43825329|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43825330|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825331|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
43602843|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602844|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602870|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43602871|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43602872|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602873|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43602875|NCT03249740|Aflibercept|aflibercept|mesh-list
43602876|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43602877|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43602878|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43602879|NCT03249740|Growth Substances|growth substances|mesh-ancestor
43825332|NCT05502731|Adalimumab|adalimumab|mesh-list
43825333|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825334|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825335|NCT05502705|Lidocaine|lidocaine|mesh-list
43825336|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
43825337|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
43825338|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825339|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825340|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
43825341|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825342|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43657230|NCT02955056|Teriparatide|teriparatide|mesh-list
43562873|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
43602884|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602885|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
43602886|NCT03249506|Empagliflozin|empagliflozin|mesh-list
43602887|NCT03249506|Canagliflozin|canagliflozin|mesh-list
43602888|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43602889|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43602891|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43602892|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43649225|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824319|NCT05513664|Osimertinib|osimertinib|mesh-list
43651627|NCT03005860|Atracurium|atracurium|mesh-list
43657242|NCT02955251|Nivolumab|nivolumab|mesh-list
43657243|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657244|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657245|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43657246|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657247|NCT02954913|Liver Extracts|liver extracts|mesh-list
43657248|NCT02954913|Hematinics|hematinics|mesh-ancestor
43657249|NCT02954692|Metformin|metformin|mesh-list
43657250|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
43657251|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
43657252|NCT02954692|Meglitinide|meglitinide|mesh-list
43657253|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
43824323|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824325|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
43824326|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824327|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824328|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824329|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
43824330|NCT05513612|Fludarabine|fludarabine|mesh-list
43824331|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824332|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
43824333|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824334|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657254|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657255|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657256|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657257|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657258|NCT02954822|Glimepiride|glimepiride|mesh-list
43657259|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43657260|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657262|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657264|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
43657265|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
43657266|NCT02954588|Vitamins|vitamins|mesh-ancestor
43657267|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
43602929|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43657268|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657269|NCT02954549|Vitamin D|vitamin d|mesh-list
43657270|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
43657271|NCT02954549|Vitamins|vitamins|mesh-ancestor
43657272|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
43657273|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657274|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43657275|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43657276|NCT02954393|Amoxicillin|amoxicillin|mesh-list
43657277|NCT02954393|Metronidazole|metronidazole|mesh-list
43657278|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43657279|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43602930|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43602931|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602932|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602933|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43602961|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43602962|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43602964|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657281|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43657282|NCT02954276|Sumatriptan|sumatriptan|mesh-list
43657283|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43657284|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43602969|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
43602970|NCT03249259|Choline|choline|mesh-list
43602971|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
43602972|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43602973|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
43657285|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43657286|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
43657287|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827089|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43657288|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657289|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657291|NCT02954484|Etoricoxib|etoricoxib|mesh-list
43657292|NCT02954484|Pregabalin|pregabalin|mesh-list
43657293|NCT02954484|Morphine|morphine|mesh-list
43603017|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43603019|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657298|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603053|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603054|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603055|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
43603056|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603057|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43603058|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
43603059|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
43603060|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
43603061|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43603062|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
43603063|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43603064|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43603065|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43603066|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43603067|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603068|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603069|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603070|NCT03248817|Protective Agents|protective agents|mesh-ancestor
43603071|NCT03248713|Mifepristone|mifepristone|mesh-list
43603072|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43603073|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
43603074|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603075|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603076|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43603077|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43603078|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43603079|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
43603080|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43603081|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43603082|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
43824345|NCT05513365|Dutasteride|dutasteride|mesh-list
43824346|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43824347|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824348|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
43603103|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651629|NCT03005860|Narcotics|narcotics|mesh-ancestor
43651630|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651632|NCT03005860|Analgesics|analgesics|mesh-ancestor
43651643|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43651645|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43651646|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43651647|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
43651648|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651649|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43651650|NCT03006042|Bupivacaine|bupivacaine|mesh-list
43651651|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651652|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
43657308|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657309|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657310|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43657311|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43657312|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43603105|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
43603106|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603108|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
43603109|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
43603110|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
43603111|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43603112|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
43603113|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850300|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657313|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43657314|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43657315|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657316|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657317|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43657318|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43657319|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603114|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43603115|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43603116|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43603117|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603118|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603119|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603120|NCT03248791|Protective Agents|protective agents|mesh-ancestor
43603121|NCT03248700|Vitamins|vitamins|mesh-list
43603122|NCT03248700|Vitamin A|vitamin a|mesh-list
43603123|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
43603124|NCT03248700|Retinol acetate|retinol acetate|mesh-list
43603125|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
43603126|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657321|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
43657322|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43657323|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657324|NCT02954029|Hemostatics|hemostatics|mesh-list
43657325|NCT02954029|Coagulants|coagulants|mesh-ancestor
43657326|NCT02953847|Rifampin|rifampin|mesh-list
43657327|NCT02953847|Isoniazid|isoniazid|mesh-list
43657328|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43657329|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
43657330|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43850301|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43603133|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
43603134|NCT03248648|Ketamine|ketamine|mesh-list
43603135|NCT03248648|Neostigmine|neostigmine|mesh-list
43603136|NCT03248648|Analgesics|analgesics|mesh-ancestor
43603137|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
43603138|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603140|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43603141|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43603174|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
43603175|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603176|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43603177|NCT03248401|Protective Agents|protective agents|mesh-ancestor
43603178|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43657331|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657332|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
43657333|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43657334|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657349|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657350|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657351|NCT02953522|Folic Acid|folic acid|mesh-list
43657352|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
43657353|NCT02953522|Hematinics|hematinics|mesh-ancestor
43657354|NCT02953522|Vitamins|vitamins|mesh-ancestor
43657355|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
43657356|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657357|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
43657358|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
43657359|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657360|NCT02953405|Clopidogrel|clopidogrel|mesh-list
43657364|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43603179|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43603181|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
43603182|NCT03248427|Doxorubicin|doxorubicin|mesh-list
43603183|NCT03248427|Letrozole|letrozole|mesh-list
43603203|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43603204|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
43603205|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603206|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43603207|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603209|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43603210|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43603216|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603217|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43603218|NCT03247998|Narcotics|narcotics|mesh-ancestor
43657462|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43657463|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
43657464|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
43657466|NCT02953106|Azelastine|azelastine|mesh-list
43657467|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657468|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43850310|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43850311|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43850312|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
43850313|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657469|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
43657470|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657471|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657472|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43657473|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
43657474|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657475|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43657478|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657479|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43657480|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43657482|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
43657483|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657484|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
43657485|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657486|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825343|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43562874|NCT01366014|Oxycodone|oxycodone|mesh-list
43850314|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825346|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825348|NCT05502458|Desflurane|desflurane|mesh-list
43825349|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825350|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603228|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
43603229|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603230|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43603231|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43603232|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
43603233|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
43603234|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43603235|NCT03247920|Amoxicillin|amoxicillin|mesh-list
43603236|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
43603237|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
43850316|NCT05688332|Glyburide|glyburide|mesh-list
43850317|NCT05688332|Voglibose|voglibose|mesh-list
43850318|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43850319|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850320|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43850321|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825351|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825352|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825353|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
43825354|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
43825355|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43846607|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846608|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850322|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850323|NCT05683392|Insulin|insulin|mesh-list
43850324|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43850325|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850326|NCT05681377|Flumazenil|flumazenil|mesh-list
43846609|NCT04191096|Hormones|hormones|mesh-ancestor
43846610|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846611|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603267|NCT03247140|Telmisartan|telmisartan|mesh-list
43603268|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43603269|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43603270|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603271|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43603272|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603273|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850332|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603285|NCT03247400|Atorvastatin|atorvastatin|mesh-list
43603286|NCT03247400|Simvastatin|simvastatin|mesh-list
43603288|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603289|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603290|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43824362|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824363|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
43848938|NCT03976375|Docetaxel|docetaxel|mesh-list
43848939|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
43848940|NCT03976375|Lenvatinib|lenvatinib|mesh-list
43848941|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848942|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848943|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
43657487|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
43657488|NCT02953041|Bromides|bromides|mesh-list
43657489|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
43657490|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43562875|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43603326|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43603327|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43850342|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850343|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657496|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657497|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43657499|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43657500|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657501|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603328|NCT03246919|Oxytocin|oxytocin|mesh-list
43603329|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
43603330|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603331|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603332|NCT03246776|Triclosan|triclosan|mesh-list
43603333|NCT03246776|Halometasone|halometasone|mesh-list
43603334|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43603335|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603336|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43603337|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43603365|NCT03246555|Diuretics|diuretics|mesh-ancestor
43603366|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
43657502|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43850344|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657503|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657504|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657505|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43657506|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657507|NCT02953184|Vitamins|vitamins|mesh-list
43657508|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
43657509|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
43657510|NCT02953184|Docetaxel|docetaxel|mesh-list
43657511|NCT02953184|Doxorubicin|doxorubicin|mesh-list
43657512|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43603369|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603370|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657514|NCT02953184|Razoxane|razoxane|mesh-list
43657515|NCT02953184|Pirarubicin|pirarubicin|mesh-list
43657516|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657517|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
43603373|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603374|NCT03246659|Polygeline|polygeline|mesh-list
43603375|NCT03246659|Gastrins|gastrins|mesh-list
43603376|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
43603377|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
43603378|NCT03246659|Hormones|hormones|mesh-ancestor
43603379|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603380|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603381|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
43603382|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657518|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657519|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657520|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43657521|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
43657522|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657523|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657524|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43657525|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
43657526|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
43562876|NCT01366014|Narcotics|narcotics|mesh-ancestor
43603412|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603414|NCT03246360|Cloxacillin|cloxacillin|mesh-list
43603415|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603416|NCT03246295|Insulin|insulin|mesh-list
43603417|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43603418|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603419|NCT03246009|Lenograstim|lenograstim|mesh-list
43603420|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43603421|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
43657527|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
43657528|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
43657529|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43657530|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43603460|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43603461|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43603463|NCT03245996|Nebivolol|nebivolol|mesh-list
43603464|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603465|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603466|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
43603467|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
43603468|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657534|NCT02953184|Protective Agents|protective agents|mesh-ancestor
43657535|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43657536|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43657537|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43657538|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43657539|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
43657540|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657541|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43657542|NCT02952963|Cathartics|cathartics|mesh-ancestor
43657543|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657544|NCT02952573|Dexamethasone|dexamethasone|mesh-list
43657545|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
43657546|NCT02952573|BB 1101|bb 1101|mesh-list
43657547|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657548|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
43850361|NCT05633563|Trimetazidine|trimetazidine|mesh-list
43657559|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827091|NCT05491902|Flutemetamol|flutemetamol|mesh-list
43562877|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603478|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43603479|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43603480|NCT03245658|Nabiximols|nabiximols|mesh-list
43603481|NCT03245658|Analgesics|analgesics|mesh-ancestor
43603482|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
43603483|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43603484|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603485|NCT03245671|Dexamethasone|dexamethasone|mesh-list
43603486|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
43603487|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43603488|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43603489|NCT03245671|BB 1101|bb 1101|mesh-list
43603515|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603516|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603517|NCT03245554|Propranolol|propranolol|mesh-list
43603518|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43603519|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43603520|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
43603521|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603522|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603523|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603524|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43603525|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43603526|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
43603527|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
43603528|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850374|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43850375|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657564|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43657565|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
43850379|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43850380|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
43850381|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
43657566|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657567|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657568|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
43603533|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603535|NCT03245307|Apatinib|apatinib|mesh-list
43603536|NCT03245307|Nifedipine|nifedipine|mesh-list
43603537|NCT03245307|Warfarin|warfarin|mesh-list
43603538|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
43657569|NCT02952807|Misoprostol|misoprostol|mesh-list
43657570|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43657571|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
43657572|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43657573|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657586|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
43657587|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
43850394|NCT05613608|Cannabidiol|cannabidiol|mesh-list
43850395|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
43850396|NCT05602207|Abrocitinib|abrocitinib|mesh-list
43850397|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43657588|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657589|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657590|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
43603573|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
43603574|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
43603575|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
43603576|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603577|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
43603578|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43603579|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603580|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
43603581|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603582|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43850398|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850399|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850406|NCT05590728|Apramycin|apramycin|mesh-list
43850407|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43850408|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850413|NCT05576207|Micronutrients|micronutrients|mesh-list
43657591|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657592|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43657593|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43603587|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
43603588|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603620|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603621|NCT03244553|Prucalopride|prucalopride|mesh-list
43603622|NCT03244553|Laxatives|laxatives|mesh-ancestor
43603623|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43603624|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43603625|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43603626|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
43850414|NCT05576207|Trace Elements|trace elements|mesh-list
43850415|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850416|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43657595|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657596|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657597|NCT02951754|Methylphenidate|methylphenidate|mesh-list
43657598|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43657599|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657600|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43657601|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43657602|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657603|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657604|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
43657605|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657606|NCT02951728|Prednisone|prednisone|mesh-list
43657607|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
43657608|NCT02951728|Rituximab|rituximab|mesh-list
43603628|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603629|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603631|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43603632|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43603633|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603634|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
43603635|NCT03244423|Coagulants|coagulants|mesh-ancestor
43603636|NCT03244358|Epalrestat|epalrestat|mesh-list
43603637|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603669|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43603670|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43603671|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43603672|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43603673|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603674|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657609|NCT02951728|Doxorubicin|doxorubicin|mesh-list
43657610|NCT02951728|Vincristine|vincristine|mesh-list
43657611|NCT02951728|Decitabine|decitabine|mesh-list
43657612|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657613|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
43657614|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657615|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657616|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43657617|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
43850418|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657618|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657619|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850419|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
43850420|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43850421|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
43850422|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850423|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
43850424|NCT05561179|Protective Agents|protective agents|mesh-ancestor
43657646|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657647|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850431|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43850432|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850433|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
43850434|NCT05547750|Coagulants|coagulants|mesh-ancestor
43603776|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
43603777|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43603778|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
43603779|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603780|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
43603781|NCT03242707|Protective Agents|protective agents|mesh-ancestor
43603782|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
43603784|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603785|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603786|NCT03242460|Dexamethasone|dexamethasone|mesh-list
43603787|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
43603788|NCT03242460|Pomalidomide|pomalidomide|mesh-list
43657650|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43657651|NCT02951806|Narcotics|narcotics|mesh-ancestor
43657652|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657653|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850456|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850457|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603816|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
43603817|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603818|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43603819|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43603820|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603821|NCT03242616|Pemetrexed|pemetrexed|mesh-list
43603822|NCT03242616|Vinorelbine|vinorelbine|mesh-list
43603823|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603824|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657658|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43657659|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
43657660|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
43657663|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43657664|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43657665|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43657666|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43657667|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657668|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657669|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43657670|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657671|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
43850462|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
43850463|NCT05504291|Melphalan|melphalan|mesh-list
43850464|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
43850465|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
43850466|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43850467|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850468|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825360|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
43825361|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825362|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
43825363|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825364|NCT05502068|Vitamin D|vitamin d|mesh-list
43850469|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43850470|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43603861|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43603862|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603863|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43603864|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43603865|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43603866|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43603867|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43603868|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43603869|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43603870|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603871|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
43603873|NCT03241901|Artemether|artemether|mesh-list
43603874|NCT03241901|Primaquine|primaquine|mesh-list
43603875|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43603876|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
43603877|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43603878|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43603879|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43603880|NCT03241914|Megestrol|megestrol|mesh-list
43603881|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
43603882|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
43603883|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43603884|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
43825365|NCT05502068|Vitamins|vitamins|mesh-ancestor
43825366|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
43825367|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825368|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43825369|NCT05501704|Tamoxifen|tamoxifen|mesh-list
43825370|NCT05501704|Anastrozole|anastrozole|mesh-list
43825371|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43825372|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825373|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825374|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825375|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825376|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825377|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43773797|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773798|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
43825378|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43825379|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43825380|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43825381|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43825382|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825383|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825384|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
43825385|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43825386|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
43825387|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825388|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825389|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43825390|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825391|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
43825392|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43825393|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
43825394|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43603885|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603886|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603887|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43603888|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43603889|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43603890|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43603911|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657722|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657723|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657724|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43657725|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43657726|NCT02951299|Protective Agents|protective agents|mesh-ancestor
43657727|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657728|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
43657729|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43657730|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
43657731|NCT02950948|Progesterone|progesterone|mesh-list
43657732|NCT02950948|Progestins|progestins|mesh-ancestor
43657734|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603913|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
43603914|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43603915|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
43603916|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603917|NCT03241888|Megestrol|megestrol|mesh-list
43603918|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
43603919|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
43603920|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43603921|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
43603922|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603923|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603927|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43603928|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43603929|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603931|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43603932|NCT03241472|Letrozole|letrozole|mesh-list
43603933|NCT03241472|Clomiphene|clomiphene|mesh-list
43603934|NCT03241472|Enclomiphene|enclomiphene|mesh-list
43603935|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
43603936|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773804|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773805|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652590|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
43603937|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43603938|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43603939|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43603940|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603941|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43603942|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
43603943|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43603944|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603945|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43603946|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
43603947|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43603981|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603982|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43603983|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43603984|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43657773|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43657774|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43657775|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
43657776|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
43657777|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
43657778|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43657779|NCT02950623|Protective Agents|protective agents|mesh-ancestor
43657780|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657781|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657782|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43657783|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
43657784|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
43657785|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43657786|NCT02950584|Protective Agents|protective agents|mesh-ancestor
43657787|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657790|NCT02950441|Niacinamide|niacinamide|mesh-list
43603986|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
43604015|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43604016|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604017|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
43604018|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604019|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43649238|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43649239|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649240|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825449|NCT05500690|Hematinics|hematinics|mesh-ancestor
43604026|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43604027|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604028|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604030|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604031|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604032|NCT03240822|Antibodies|antibodies|mesh-list
43604033|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43604034|NCT03240822|Tacrolimus|tacrolimus|mesh-list
43657897|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657898|NCT02949232|Prednisolone|prednisolone|mesh-list
43657899|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657900|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
43657901|NCT02949232|Hormones|hormones|mesh-ancestor
43657902|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657903|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657904|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657905|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657906|NCT02949466|Triamcinolone|triamcinolone|mesh-list
43657907|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
43657908|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657909|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
43657910|NCT02949466|Hormones|hormones|mesh-ancestor
43657911|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657913|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
43657939|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657940|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
43604068|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604069|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
43657974|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657975|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657976|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43657977|NCT02948998|Diuretics|diuretics|mesh-ancestor
43657978|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
43657979|NCT02948920|Ephedrine|ephedrine|mesh-list
43657980|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43657981|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657982|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
43657986|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
43657987|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657988|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657989|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
43657990|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43657991|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658017|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43658018|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
43658019|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
43658020|NCT02948101|Antibodies|antibodies|mesh-list
43658021|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43658022|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658023|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
43658024|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658029|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658030|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43658031|NCT02948075|Paclitaxel|paclitaxel|mesh-list
43658032|NCT02948075|Carboplatin|carboplatin|mesh-list
43658033|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658034|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658035|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
43850490|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850491|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
43850492|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850493|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
43850518|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
43658050|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
43658051|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658052|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658053|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658054|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
43658055|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
43658056|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43658057|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43658059|NCT02947880|Diuretics|diuretics|mesh-ancestor
43658060|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
43604157|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604160|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
43604161|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43604162|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604190|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
43604191|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604192|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604193|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604194|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
43604195|NCT03239314|Hormones|hormones|mesh-ancestor
43604196|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604197|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43658061|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658062|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43658063|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658064|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658065|NCT02947711|Diltiazem|diltiazem|mesh-list
43658066|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43658067|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43658068|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658069|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658070|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43658071|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658072|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658074|NCT02947620|Atorvastatin|atorvastatin|mesh-list
43658075|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658076|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658077|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43658078|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43658079|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
43658080|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658081|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658082|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43604199|NCT03239353|Entecavir|entecavir|mesh-list
43604200|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
43604202|NCT03239236|Anesthetics|anesthetics|mesh-list
43604203|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649244|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649245|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
43649246|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649247|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649248|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43649249|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
43649250|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649251|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649252|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43649253|NCT03030690|Methamphetamine|methamphetamine|mesh-list
43604204|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604205|NCT03239457|Mitogens|mitogens|mesh-list
43604206|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
43604207|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604208|NCT03239080|Denosumab|denosumab|mesh-list
43604209|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604210|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604238|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43604239|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
43604240|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604241|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604242|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43604245|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604246|NCT03238625|Lidocaine|lidocaine|mesh-list
43604247|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
43604248|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
43604249|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604250|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604251|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
43604252|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604253|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43825481|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604255|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43604256|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604257|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604258|NCT03238482|Fluticasone|fluticasone|mesh-list
43604288|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43604289|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43850522|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43850523|NCT05409066|Growth Substances|growth substances|mesh-ancestor
43850524|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
43850525|NCT05409027|Cortisone|cortisone|mesh-list
43850526|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43850527|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
43850528|NCT05409027|Hormones|hormones|mesh-ancestor
43850529|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658148|NCT02947113|Cisplatin|cisplatin|mesh-list
43658149|NCT02947113|Etoposide|etoposide|mesh-list
43658150|NCT02947113|Pemetrexed|pemetrexed|mesh-list
43658151|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658152|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658153|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43658154|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43658155|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658156|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658157|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43658158|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43658159|NCT02947334|Bococizumab|bococizumab|mesh-list
43658160|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43658161|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43658162|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
43850530|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850531|NCT05403385|Carboplatin|carboplatin|mesh-list
43658167|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43658168|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43658169|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43658170|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
43658171|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658172|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658173|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658174|NCT02947243|Morphine|morphine|mesh-list
43658175|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43658176|NCT02947243|Narcotics|narcotics|mesh-ancestor
43658177|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658178|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658179|NCT02947243|Analgesics|analgesics|mesh-ancestor
43658180|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
43658200|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43658201|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658202|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43604298|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604299|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43604325|NCT03238092|Testosterone|testosterone|mesh-list
43604326|NCT03238092|Estrogens|estrogens|mesh-ancestor
43850576|NCT05384691|Luspatercept|luspatercept|mesh-list
43850577|NCT05384691|Hematinics|hematinics|mesh-ancestor
43850578|NCT05384015|Carboplatin|carboplatin|mesh-list
43850579|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
43850580|NCT05384015|Etoposide|etoposide|mesh-list
43850581|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
43850582|NCT05384015|Lenvatinib|lenvatinib|mesh-list
43850583|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850584|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850585|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658217|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
43773845|NCT02356913|Nicotine|nicotine|mesh-list
43658218|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658219|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658220|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43658221|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658222|NCT02946684|Letrozole|letrozole|mesh-list
43658223|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43658224|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658225|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43658226|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658227|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658231|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658232|NCT02946801|Listerine|listerine|mesh-list
43658233|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
43658234|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43658235|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658236|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
43658237|NCT02946801|Protective Agents|protective agents|mesh-ancestor
43658238|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658239|NCT02946359|Bevacizumab|bevacizumab|mesh-list
43658240|NCT02946359|Crizotinib|crizotinib|mesh-list
43658252|NCT02946437|Propofol|propofol|mesh-list
43658253|NCT02946437|Sevoflurane|sevoflurane|mesh-list
43658254|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43658255|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658256|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658257|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43658258|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
43658259|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
43658260|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43658261|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43850602|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43850603|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43850604|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
43850605|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658302|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658303|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
43658304|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658305|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43658306|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43658307|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
43658308|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658309|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658310|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43604348|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
43604349|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604367|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43604368|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43604369|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
43649280|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43658324|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658326|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
43649281|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43649282|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
43649283|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649284|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43649285|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43649286|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649287|NCT03030430|Bevacizumab|bevacizumab|mesh-list
43649288|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604371|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
43604372|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604373|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43604375|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
43604376|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604377|NCT03237715|Protective Agents|protective agents|mesh-ancestor
43604378|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604379|NCT03237741|Rabeprazole|rabeprazole|mesh-list
43604380|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43604381|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43604382|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43604383|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604384|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604385|NCT03237533|Promethazine|promethazine|mesh-list
43658327|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658328|NCT02946060|Protective Agents|protective agents|mesh-ancestor
43658329|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658330|NCT02945982|Entecavir|entecavir|mesh-list
43658331|NCT02945982|Carvedilol|carvedilol|mesh-list
43658332|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
43658333|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658334|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43658335|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43658336|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
43658353|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658354|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
43658355|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658356|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658357|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
43658358|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658359|NCT02945839|Topiramate|topiramate|mesh-list
43658360|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
43658361|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658362|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825490|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825491|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43825492|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825493|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
43825494|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43825495|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
43658385|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
43658386|NCT02945527|Hormones|hormones|mesh-ancestor
43658387|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658388|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43658389|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658390|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
43658391|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43604398|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43604399|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43604400|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604401|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604402|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604403|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604404|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
43604405|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43604406|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43604407|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
43604408|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
43604432|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658392|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658393|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658394|NCT02945527|Diuretics|diuretics|mesh-ancestor
43658395|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
43658396|NCT02945293|Oxycodone|oxycodone|mesh-list
43658397|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43658398|NCT02945293|Narcotics|narcotics|mesh-ancestor
43658399|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658400|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658401|NCT02945293|Analgesics|analgesics|mesh-ancestor
43658402|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
43604433|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604434|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604435|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43604436|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43604437|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43604438|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
43604439|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
43604440|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
43604441|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
43604442|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604443|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604444|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
43604445|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43604446|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
43604447|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604448|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
43604449|NCT03237546|Anesthetics|anesthetics|mesh-list
43604450|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649290|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43649291|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43649292|NCT03030430|Growth Substances|growth substances|mesh-ancestor
43649293|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649294|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
43649295|NCT03030703|Inositol|inositol|mesh-list
43649296|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
43649297|NCT03030703|Vitamins|vitamins|mesh-ancestor
43649298|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
43649299|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649300|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
43649301|NCT03030469|Analgesics|analgesics|mesh-list
43649302|NCT03030469|Narcotics|narcotics|mesh-ancestor
43649303|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824370|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43649304|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604451|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604453|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43604454|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43604455|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
43604456|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604457|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43604458|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
43604459|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
43604460|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
43604461|NCT03237624|Coagulants|coagulants|mesh-ancestor
43604462|NCT03237117|Hormones|hormones|mesh-list
43604490|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43604491|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
43604492|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658403|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658405|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43658406|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
43658407|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43658408|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
43658409|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658410|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658411|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
43658412|NCT02945267|Tegafur|tegafur|mesh-list
43658413|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
43658414|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658415|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
43604497|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43604498|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
43604499|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604500|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
43604501|NCT03236961|Metronidazole|metronidazole|mesh-list
43604502|NCT03236961|Levofloxacin|levofloxacin|mesh-list
43604503|NCT03236961|Ertapenem|ertapenem|mesh-list
43604504|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604505|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604506|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43604507|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43604508|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604535|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43604536|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604537|NCT03236740|Estrogens|estrogens|mesh-ancestor
43604538|NCT03236740|Hormones|hormones|mesh-ancestor
43651653|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658416|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658417|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658418|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658420|NCT02945241|Cystatins|cystatins|mesh-list
43658421|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658422|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658423|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43658424|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
43604540|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43604541|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
43604542|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43604543|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43604544|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43604545|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43604546|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
43604547|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43604548|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649306|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658425|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658426|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658428|NCT02945163|Lamivudine|lamivudine|mesh-list
43658429|NCT02945163|Efavirenz|efavirenz|mesh-list
43658430|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
43658431|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658432|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43658433|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43658440|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43604550|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43604551|NCT03236727|Analgesics|analgesics|mesh-ancestor
43604552|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
43604553|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43604554|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43604555|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43604556|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43604589|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604590|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43604591|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43604592|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604593|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604594|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43604595|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43604630|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604631|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604633|NCT03236155|Narcotics|narcotics|mesh-ancestor
43604634|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604635|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658442|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43658443|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43658444|NCT02945215|Rituximab|rituximab|mesh-list
43658445|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658446|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658447|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
43658448|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658449|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658450|NCT02945072|Sevoflurane|sevoflurane|mesh-list
43658451|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658452|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43658453|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
43658454|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
43658455|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658456|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658457|NCT02944942|Anesthetics|anesthetics|mesh-list
43850619|NCT05357482|Sirolimus|sirolimus|mesh-list
43850620|NCT05357482|Plerixafor|plerixafor|mesh-list
43850621|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
43850622|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
43850623|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
43850624|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604665|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43604666|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43604667|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43604668|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604669|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604671|NCT03235609|Narcotics|narcotics|mesh-ancestor
43604672|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43604673|NCT03235531|Valproic Acid|valproic acid|mesh-list
43604674|NCT03235531|Lorazepam|lorazepam|mesh-list
43604675|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
43604676|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604677|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658458|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658459|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658461|NCT02945020|Odalasvir|odalasvir|mesh-list
43658462|NCT02945020|Dabigatran|dabigatran|mesh-list
43658463|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
43658464|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43658465|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
43850625|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43850626|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850627|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43850628|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850629|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
43850630|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850631|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658466|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658467|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658468|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
43658469|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
43658470|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658472|NCT02944981|Analgesics|analgesics|mesh-ancestor
43658473|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
43658474|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658475|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658476|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
43658477|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43604711|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43604712|NCT03235778|Analgesics|analgesics|mesh-ancestor
43604713|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
43649315|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43649316|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43649317|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649318|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649319|NCT03030677|Lidocaine|lidocaine|mesh-list
43649320|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649321|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
43649322|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649323|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649324|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
43658478|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43658479|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649353|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649354|NCT03030300|Metformin|metformin|mesh-list
43649355|NCT03030300|Pioglitazone|pioglitazone|mesh-list
43649356|NCT03030300|Insulin|insulin|mesh-list
43649357|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43649358|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649359|NCT03030001|Antibodies|antibodies|mesh-list
43649360|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
43649361|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649362|NCT03030196|Denosumab|denosumab|mesh-list
43649363|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43658480|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43658481|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43658482|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43658483|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658484|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658485|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
43658486|NCT02945033|Aspirin|aspirin|mesh-list
43658487|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43850632|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
43658488|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658489|NCT02945033|Analgesics|analgesics|mesh-ancestor
43658490|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
43658491|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658492|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658493|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658494|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658495|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43658496|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43658497|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850634|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850635|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43850636|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43850637|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43850638|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
43850639|NCT05353062|Epinephrine|epinephrine|mesh-list
43658521|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43658522|NCT02944734|Amlodipine|amlodipine|mesh-list
43658523|NCT02944734|Candesartan|candesartan|mesh-list
43658524|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
43658525|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43658526|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43658527|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658528|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658529|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43658530|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658531|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658532|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43658533|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43658534|NCT02944227|Ranibizumab|ranibizumab|mesh-list
43658535|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43658536|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43604729|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604731|NCT03235141|Azithromycin|azithromycin|mesh-list
43604732|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43604733|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604734|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604735|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43604736|NCT03234816|Norepinephrine|norepinephrine|mesh-list
43604758|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604759|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
43604760|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
43604761|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
43604762|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604763|NCT03234673|Calcipotriene|calcipotriene|mesh-list
43658545|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43658546|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
43658547|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
43658548|NCT02944357|Gemcitabine|gemcitabine|mesh-list
43658549|NCT02944357|Cisplatin|cisplatin|mesh-list
43658550|NCT02944357|Vaccines|vaccines|mesh-list
43658551|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696381|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
43658552|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658553|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
43658554|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658555|NCT02944357|Antiviral Agents|antiviral agents|mesh-ancestor
43658556|NCT02944357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658557|NCT02944357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658558|NCT02944357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658559|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
43658560|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850641|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43850642|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43850643|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43850644|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850645|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850646|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850647|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43658562|NCT02944214|Benzbromarone|benzbromarone|mesh-list
43658563|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
43658564|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658565|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
43658566|NCT02944214|Renal Agents|renal agents|mesh-ancestor
43658567|NCT02944396|Paclitaxel|paclitaxel|mesh-list
43658568|NCT02944396|Carboplatin|carboplatin|mesh-list
43658569|NCT02944396|Nivolumab|nivolumab|mesh-list
43658570|NCT02944396|Pemetrexed|pemetrexed|mesh-list
43658571|NCT02944396|Veliparib|veliparib|mesh-list
43658572|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658573|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658574|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
43658575|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
43658576|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
43658577|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658578|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43604772|NCT03234517|Clindamycin|clindamycin|mesh-list
43658590|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658592|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658593|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658594|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
43658595|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658596|NCT02944500|Liraglutide|liraglutide|mesh-list
43658597|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658598|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658599|NCT02944500|Incretins|incretins|mesh-ancestor
43658600|NCT02944500|Hormones|hormones|mesh-ancestor
43658601|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850655|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43604774|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
43604775|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604776|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604777|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43604778|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43604779|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604780|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
43649369|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649370|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649371|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
43604782|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
43604783|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43604784|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604785|NCT03234244|Vitamins|vitamins|mesh-ancestor
43604786|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
43604787|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604788|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43604789|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43604790|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
43696407|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43604819|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43604820|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604822|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43604823|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43604824|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
43604825|NCT03234400|Dapivirine|dapivirine|mesh-list
43604826|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43604827|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43604828|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
43658603|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43658604|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43658605|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
43658606|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658607|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658608|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658609|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43658610|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
43658611|NCT02944201|Protective Agents|protective agents|mesh-ancestor
43658612|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43658613|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604834|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43604835|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658614|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43658615|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658616|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43658617|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43658618|NCT02944123|Clopidogrel|clopidogrel|mesh-list
43658619|NCT02944123|Ticagrelor|ticagrelor|mesh-list
43658620|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43658621|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658622|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43658623|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43658624|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43604837|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604872|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604873|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
43604874|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43604875|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
43604876|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604891|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43604892|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604894|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43604895|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43604897|NCT03233815|Sevoflurane|sevoflurane|mesh-list
43604898|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43658625|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
43658626|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658627|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658628|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658629|NCT02944175|Neostigmine|neostigmine|mesh-list
43658630|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43658631|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658632|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658633|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
43658634|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658635|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658636|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43658637|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
43658638|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658639|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
43658640|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43658641|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43658642|NCT02944045|Prednisolone|prednisolone|mesh-list
43658643|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
43658644|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43658645|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
43658646|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658647|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
43604905|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43604906|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
43604907|NCT03233893|Calcium|calcium|mesh-list
43604908|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43604909|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604910|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43604911|NCT03234153|Durvalumab|durvalumab|mesh-list
43604912|NCT03234153|Tremelimumab|tremelimumab|mesh-list
43604913|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
43604914|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658648|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
43658649|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658650|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658651|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43658652|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
43658654|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658655|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43658656|NCT02944045|Protective Agents|protective agents|mesh-ancestor
43658657|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43658658|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825496|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825497|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825498|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43825499|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825500|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43825501|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
43825502|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825503|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604927|NCT03233412|Imiquimod|imiquimod|mesh-list
43649372|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649373|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825516|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825517|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825518|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
43825520|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825521|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825522|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825523|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43825524|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649375|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649376|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
43649377|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
43649378|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649379|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43649380|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
43604928|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43604929|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
43604930|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604931|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43604932|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
43604933|NCT03233295|Vitamin D|vitamin d|mesh-list
43604934|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
43604935|NCT03233295|Vitamins|vitamins|mesh-ancestor
43604936|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
43604971|NCT03232957|Analgesics|analgesics|mesh-ancestor
43604972|NCT03232632|Flutemetamol|flutemetamol|mesh-list
43604973|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43604974|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604975|NCT03232710|Aripiprazole|aripiprazole|mesh-list
43604989|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43604990|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43604991|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43604992|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43604993|NCT03232554|Iron|iron|mesh-list
43604994|NCT03232554|Trace Elements|trace elements|mesh-ancestor
43604995|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
43604996|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604997|NCT03232450|Aspirin|aspirin|mesh-list
43604998|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43604999|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605000|NCT03232450|Analgesics|analgesics|mesh-ancestor
43605001|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
43773896|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605002|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605003|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605028|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
43605029|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43605030|NCT03232307|BB 1101|bb 1101|mesh-list
43605031|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
43605032|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605033|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649388|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649390|NCT03029455|VX-659|vx-659|mesh-list
43649391|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43649392|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649393|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649394|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
43649395|NCT03029494|Vitamins|vitamins|mesh-ancestor
43649396|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
43649397|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649398|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
43649399|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649400|NCT03029494|Protective Agents|protective agents|mesh-ancestor
43649401|NCT03029442|Denosumab|denosumab|mesh-list
43658715|NCT02943655|Hormones|hormones|mesh-ancestor
43658716|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658717|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
43658718|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658719|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658720|NCT02943369|Ticagrelor|ticagrelor|mesh-list
43658721|NCT02943369|Cangrelor|cangrelor|mesh-list
43658722|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658723|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43658724|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43850688|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649402|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43649403|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605034|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605035|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605036|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
43605037|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
43605038|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605062|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43605063|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43850703|NCT05312645|Analgesics|analgesics|mesh-ancestor
43850704|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
43850705|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850706|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850707|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658725|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43605068|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43605069|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43649405|NCT03028532|Enclomiphene|enclomiphene|mesh-list
43649406|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
43649407|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43649408|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
43847632|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649409|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649410|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658742|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658743|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658744|NCT02943356|Urological Agents|urological agents|mesh-ancestor
43658746|NCT02943252|Tegafur|tegafur|mesh-list
43658747|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658748|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43658749|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658750|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658751|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658752|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
43658753|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
43658754|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43649412|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
43649413|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43605070|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605071|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773899|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
43605072|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605073|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605074|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
43605076|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43605077|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605078|NCT03232125|Ramosetron|ramosetron|mesh-list
43605079|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
43605080|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
43605081|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605082|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605083|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605084|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43605085|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
43605086|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605087|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605088|NCT03232021|Pregabalin|pregabalin|mesh-list
43605125|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43605126|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43605144|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605145|NCT03231215|Dexamethasone|dexamethasone|mesh-list
43658755|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658757|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658758|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
43658759|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658760|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658761|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
43658762|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605154|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605155|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605156|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605157|NCT03231033|Pioglitazone|pioglitazone|mesh-list
43605158|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658763|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43658764|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43658765|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43658766|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658767|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658768|NCT02942888|Niacinamide|niacinamide|mesh-list
43658770|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
43658771|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
43658773|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
43658774|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658775|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43658776|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
43658777|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658778|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658779|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658780|NCT02942810|Cefepime|cefepime|mesh-list
43658781|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658782|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658783|NCT02942680|Aspirin|aspirin|mesh-list
43658784|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43658785|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658786|NCT02942680|Analgesics|analgesics|mesh-ancestor
43658787|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
43658788|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658789|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658790|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658791|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658792|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43605167|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43605168|NCT03230851|Aspirin|aspirin|mesh-list
43605169|NCT03230851|Indobufen|indobufen|mesh-list
43605170|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605171|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605172|NCT03230851|Analgesics|analgesics|mesh-ancestor
43605173|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
43605174|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658803|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658804|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
43658806|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43658807|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658808|NCT02942732|Vitamins|vitamins|mesh-ancestor
43658809|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
43658810|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43658811|NCT02942758|Pioglitazone|pioglitazone|mesh-list
43658812|NCT02942758|Azacitidine|azacitidine|mesh-list
43658813|NCT02942758|Tretinoin|tretinoin|mesh-list
43658814|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43850727|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
43658815|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
43658816|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658817|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658828|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658829|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658830|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43658831|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43658832|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658834|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43658835|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658836|NCT02942420|Analgesics|analgesics|mesh-ancestor
43658837|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
43658838|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658839|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658840|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658841|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658842|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
43658843|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605209|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605210|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605212|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
43605213|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850735|NCT05283720|Rituximab|rituximab|mesh-list
43850736|NCT05283720|Doxorubicin|doxorubicin|mesh-list
43658844|NCT02942420|Protective Agents|protective agents|mesh-ancestor
43658846|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658847|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658848|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
43658849|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
43658850|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43658851|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43658852|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605218|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605219|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605221|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605222|NCT03230162|Heparin|heparin|mesh-list
43605223|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43605224|NCT03230162|Tinzaparin|tinzaparin|mesh-list
43605225|NCT03230162|Dalteparin|dalteparin|mesh-list
43605226|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
43605227|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
43605228|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43605229|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43605230|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605231|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
43605232|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43605233|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43605234|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605235|NCT03230162|Urological Agents|urological agents|mesh-ancestor
43605271|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43658853|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658854|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658855|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658856|NCT02942550|Bromides|bromides|mesh-list
43658857|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
43658858|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
43658859|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43658860|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658861|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
43658862|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850737|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43850738|NCT05283720|Lenalidomide|lenalidomide|mesh-list
43850739|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850740|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
43850741|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850742|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43850743|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43850744|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
43850745|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658869|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658870|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658871|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43658872|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658873|NCT02942329|Apatinib|apatinib|mesh-list
43658874|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658875|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43658876|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658877|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658878|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43658879|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43658880|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658881|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605304|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605306|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43605307|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43605308|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43605309|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
43605310|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658882|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
43658883|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658884|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658885|NCT02942212|Nicotine|nicotine|mesh-list
43658886|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43658887|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
43658888|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658889|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658890|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43658891|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43658892|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
43658893|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658894|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825525|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825526|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43825527|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43825528|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
43825529|NCT05563961|Acetaminophen|acetaminophen|mesh-list
43825530|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605321|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605322|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605323|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43649418|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649419|NCT03025750|Vaccines|vaccines|mesh-list
43649420|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
43605324|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43825531|NCT05563961|Analgesics|analgesics|mesh-ancestor
43825532|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
43825533|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825534|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825535|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
43825536|NCT05563610|Amoxicillin|amoxicillin|mesh-list
43825537|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43825538|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825539|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43825540|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
43825541|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43605369|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
43605370|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605372|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43605373|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
43605374|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43605375|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605376|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658895|NCT02942043|Bevacizumab|bevacizumab|mesh-list
43773903|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
43658896|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658897|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605379|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43605380|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605381|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43605382|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43605383|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43605385|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43605386|NCT03228732|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43605406|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43605407|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605408|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605409|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43658898|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43658899|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43658900|NCT02942043|Growth Substances|growth substances|mesh-ancestor
43658901|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658902|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
43658903|NCT02941913|Palonosetron|palonosetron|mesh-list
43658904|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
43658905|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
43825547|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658906|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658907|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658908|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850766|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43850767|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43850768|NCT05220319|Prednisolone|prednisolone|mesh-list
43850769|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
43850770|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43850771|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
43850772|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658909|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43658922|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658924|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43658925|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43658926|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658927|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43658928|NCT02941562|Leucovorin|leucovorin|mesh-list
43658929|NCT02941562|Fluorouracil|fluorouracil|mesh-list
43658930|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
43658931|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
43658932|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658933|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658934|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658935|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658936|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
43658937|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658943|NCT02941731|Oseltamivir|oseltamivir|mesh-list
43658944|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
43658945|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658946|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658947|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824373|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824374|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43824375|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43824376|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658964|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43658965|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
43658966|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658967|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658968|NCT02941510|Budesonide|budesonide|mesh-list
43658969|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658970|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43658971|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
43658972|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658973|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658974|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43850773|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
43658975|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
43658977|NCT02941510|Hormones|hormones|mesh-ancestor
43658978|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658979|NCT02941601|Gemcitabine|gemcitabine|mesh-list
43658980|NCT02941601|Carboplatin|carboplatin|mesh-list
43658982|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658983|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658984|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
43605420|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605422|NCT03228576|Tacrolimus|tacrolimus|mesh-list
43605423|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605424|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
43605425|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605426|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43658985|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658986|NCT02941601|Antiviral Agents|antiviral agents|mesh-ancestor
43658987|NCT02941601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658988|NCT02941601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658989|NCT02941601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658990|NCT02941601|Immunologic Factors|immunologic factors|mesh-ancestor
43658991|NCT02941601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658992|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658993|NCT02941367|Metformin|metformin|mesh-list
43658994|NCT02941367|Lixisenatide|lixisenatide|mesh-list
43659012|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43659013|NCT02941315|Diuretics|diuretics|mesh-ancestor
43659014|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
43659015|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43659016|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
43605465|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43605466|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43605467|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605469|NCT03228238|Protective Agents|protective agents|mesh-ancestor
43605470|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659023|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43659024|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659026|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43659027|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659028|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43659029|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659030|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
43659031|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659032|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
43659033|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659034|NCT02941198|Copper|copper|mesh-list
43659035|NCT02941198|Trace Elements|trace elements|mesh-ancestor
43659036|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
43659037|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659038|NCT02940990|Gemcitabine|gemcitabine|mesh-list
43659039|NCT02940990|Paclitaxel|paclitaxel|mesh-list
43659040|NCT02940990|Etoposide|etoposide|mesh-list
43659041|NCT02940990|Vinorelbine|vinorelbine|mesh-list
43659042|NCT02940990|Docetaxel|docetaxel|mesh-list
43659043|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43641196|NCT01281176|Vorinostat|vorinostat|mesh-list
43605474|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
43605475|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605476|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824382|NCT05512728|Midazolam|midazolam|mesh-list
43824383|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43824384|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43659044|NCT02940990|Cisplatin|cisplatin|mesh-list
43659045|NCT02940990|Carboplatin|carboplatin|mesh-list
43659046|NCT02940990|Pemetrexed|pemetrexed|mesh-list
43659047|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43659048|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659049|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
43659050|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
43659051|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
43659052|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659053|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659054|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
43659055|NCT02940990|Antiviral Agents|antiviral agents|mesh-ancestor
43659056|NCT02940990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659057|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659058|NCT02940990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659059|NCT02940990|Immunologic Factors|immunologic factors|mesh-ancestor
43659060|NCT02940990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659061|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43659062|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43824396|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605477|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43605478|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
43605479|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
43605480|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
43659063|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43659064|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43659065|NCT02940925|Cisplatin|cisplatin|mesh-list
43659066|NCT02940925|Fluorouracil|fluorouracil|mesh-list
43659067|NCT02940925|Capecitabine|capecitabine|mesh-list
43659068|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659069|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
43659070|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659071|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659073|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
43659074|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659075|NCT02941016|Evolocumab|evolocumab|mesh-list
43659076|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43659077|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43659078|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
43659079|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605487|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43605488|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
43605490|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
43605491|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43659090|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659092|NCT02940821|Fluorides|fluorides|mesh-list
43659093|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
43659094|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
43659095|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
43659096|NCT02940821|Protective Agents|protective agents|mesh-ancestor
43659097|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659098|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43659099|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605529|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605530|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605532|NCT03227679|Nicotine|nicotine|mesh-list
43605533|NCT03227679|Varenicline|varenicline|mesh-list
43605534|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43605535|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
43659148|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43659150|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43659151|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659152|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43659153|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696657|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
43827093|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850789|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850790|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
43850792|NCT05189457|Leuprolide|leuprolide|mesh-list
43659159|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43827094|NCT05491811|Bevacizumab|bevacizumab|mesh-list
43850799|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
43850800|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
43850801|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605548|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605549|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
43605572|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43605573|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43605574|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43605575|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43605576|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43659160|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659161|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43659162|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43659163|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43659164|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43659165|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
43659190|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43659191|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43659192|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659193|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43659194|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
43850821|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605579|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43605580|NCT03227484|Empagliflozin|empagliflozin|mesh-list
43605581|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43605582|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605583|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43605584|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605586|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43605587|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659196|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43659197|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
43659198|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659199|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659200|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659201|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
43659202|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659203|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659204|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
43659205|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659206|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43659207|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850823|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850824|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
43850825|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43850826|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43850827|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43850828|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43850829|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850830|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
43850831|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850832|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850833|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43825549|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825550|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825551|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
43605590|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
43605591|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605592|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605593|NCT03227432|Dexamethasone|dexamethasone|mesh-list
43605594|NCT03227432|Nivolumab|nivolumab|mesh-list
43605595|NCT03227432|Pomalidomide|pomalidomide|mesh-list
43605596|NCT03227432|Elotuzumab|elotuzumab|mesh-list
43605597|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605598|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
43605599|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
43605600|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605601|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605634|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
43605635|NCT03226522|Bupropion|bupropion|mesh-list
43605636|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43605637|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
43605638|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43605639|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43605640|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43605661|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43605662|NCT03226340|Diuretics|diuretics|mesh-ancestor
43605663|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
43605664|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43605665|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43605666|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
43850834|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850835|NCT05111626|Nivolumab|nivolumab|mesh-list
43850836|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
43850837|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850838|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850839|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43850840|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825552|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825553|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43825554|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43825555|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43825556|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43825557|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825558|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825559|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
43605667|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43605668|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
43605669|NCT03226340|Vitamins|vitamins|mesh-ancestor
43605670|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
43605671|NCT03226210|Insulin|insulin|mesh-list
43605672|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
43605673|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43605674|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605675|NCT03225937|Trastuzumab|trastuzumab|mesh-list
43605676|NCT03225937|Pertuzumab|pertuzumab|mesh-list
43605677|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43605678|NCT03225937|Lapatinib|lapatinib|mesh-list
43605679|NCT03225937|Maytansine|maytansine|mesh-list
43605680|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605681|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605682|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605683|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605684|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605685|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43649427|NCT03023527|Pomalidomide|pomalidomide|mesh-list
43649428|NCT03023527|Elotuzumab|elotuzumab|mesh-list
43649429|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649430|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
43649431|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
43649432|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649433|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649434|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605686|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
43605687|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
43605688|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
43605689|NCT03226080|Rocuronium|rocuronium|mesh-list
43605690|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43605691|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43605692|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43605693|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825561|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825562|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
43825563|NCT05563571|Hormones|hormones|mesh-ancestor
43825564|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825565|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43825566|NCT05563571|Protective Agents|protective agents|mesh-ancestor
43825567|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825568|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825569|NCT05563558|Carboplatin|carboplatin|mesh-list
43825570|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
43825571|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825572|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846621|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846622|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43605716|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43605717|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43605719|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605720|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
43605721|NCT03225924|Hormones|hormones|mesh-ancestor
43605722|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43605723|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43605724|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43605725|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
43605726|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
43605727|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
43605728|NCT03226145|Scopolamine|scopolamine|mesh-list
43605729|NCT03226145|Bisacodyl|bisacodyl|mesh-list
43605730|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43605731|NCT03226145|Cathartics|cathartics|mesh-ancestor
43605732|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43605733|NCT03226145|Laxatives|laxatives|mesh-ancestor
43850841|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
43846623|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43846625|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846626|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846627|NCT04188223|Vaccines|vaccines|mesh-list
43846628|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
43846629|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846630|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
43850842|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850843|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850844|NCT05061524|Omalizumab|omalizumab|mesh-list
43850845|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43850846|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43850847|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850848|NCT05050916|Vitamin D|vitamin d|mesh-list
43605734|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43605735|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
43605736|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
43605737|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605738|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605739|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
43605740|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43605741|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
43605742|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605743|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605744|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43605767|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605769|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
43850849|NCT05050916|Vitamins|vitamins|mesh-ancestor
43850850|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
43850851|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846631|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846632|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846634|NCT04187703|Decitabine|decitabine|mesh-list
43846635|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846636|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
43846637|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846638|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846639|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846640|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
43846641|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
43846642|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846643|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846644|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846645|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
43846646|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
43846647|NCT04185402|Azithromycin|azithromycin|mesh-list
43827095|NCT05491811|Ensartinib|ensartinib|mesh-list
43846656|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846657|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43605771|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605772|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605773|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605774|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43605775|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43605776|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605777|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43605778|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43605779|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846666|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
43846667|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846668|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846669|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43850853|NCT05033808|Epirubicin|epirubicin|mesh-list
43850854|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43850855|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850856|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43850857|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43659220|NCT02940366|Pitavastatin|pitavastatin|mesh-list
43659221|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43659222|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43659223|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
43659224|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659225|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43659226|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43659227|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659228|NCT02940405|Ketorolac|ketorolac|mesh-list
43850858|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850859|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659229|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43659230|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43659231|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43659232|NCT02940405|Analgesics|analgesics|mesh-ancestor
43659233|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
43659234|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659235|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659236|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605780|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
43605781|NCT03225326|Carticaine|carticaine|mesh-list
43605782|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
43605783|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
43605784|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43605785|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605786|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
43605787|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605788|NCT03224923|Aspirin|aspirin|mesh-list
43659238|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43659239|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659240|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659241|NCT02940444|Heparin|heparin|mesh-list
43659242|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
43659243|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43659244|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43659245|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659246|NCT02940483|Azacitidine|azacitidine|mesh-list
43649450|NCT03023514|Progestins|progestins|mesh-ancestor
43649451|NCT03023514|Hormones|hormones|mesh-ancestor
43649452|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649453|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649454|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
43659247|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659248|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
43659249|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659250|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659251|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659252|NCT02940262|Edetic Acid|edetic acid|mesh-list
43659253|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43659254|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
43659255|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
43641360|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
43659256|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659257|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
43659258|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43659259|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43659260|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43659261|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43659262|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659263|NCT02940184|Incretins|incretins|mesh-ancestor
43659264|NCT02940184|Hormones|hormones|mesh-ancestor
43659265|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659267|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
43605792|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605793|NCT03224923|Analgesics|analgesics|mesh-ancestor
43605794|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
43605795|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43605796|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605797|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43605798|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43605799|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43605800|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43849208|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849209|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605838|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43649455|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659273|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659274|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
43659275|NCT02940002|Hormones|hormones|mesh-ancestor
43659276|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659277|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659278|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43659279|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
43659280|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
43659281|NCT02939833|Ropivacaine|ropivacaine|mesh-list
43659282|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
43659283|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
43659284|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659285|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659286|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
43659287|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659288|NCT02939898|Letrozole|letrozole|mesh-list
43850881|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
43850882|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43850883|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
43850884|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850885|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850886|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43850887|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43850888|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43850889|NCT04964050|Diuretics|diuretics|mesh-ancestor
43850890|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
43850891|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850892|NCT04951206|Clobetasol|clobetasol|mesh-list
43850894|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
43605852|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605853|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605867|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605868|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43605869|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
43605870|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605871|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43605872|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43605873|NCT03224039|Sufentanil|sufentanil|mesh-list
43605874|NCT03224039|Morphine|morphine|mesh-list
43849212|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849213|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849214|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
43849215|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43849216|NCT03949764|Velpatasvir|velpatasvir|mesh-list
43849217|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
43849218|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849219|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
43849220|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43605892|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43605893|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605894|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43605895|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43605896|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43605897|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605898|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
43605899|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43605900|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
43605901|NCT03223961|Hematinics|hematinics|mesh-ancestor
43605902|NCT03223506|Acetaminophen|acetaminophen|mesh-list
43605903|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43605904|NCT03223506|Analgesics|analgesics|mesh-ancestor
43605905|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
43659293|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659295|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659296|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659297|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659298|NCT02939846|Trametinib|trametinib|mesh-list
43659299|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659300|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43659301|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659302|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659303|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
43659304|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
43850923|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850924|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850925|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850926|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43850927|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43659305|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43659306|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43659307|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659308|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659309|NCT02939495|Urological Agents|urological agents|mesh-ancestor
43659311|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43659365|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659376|NCT02938988|Methylene Blue|methylene blue|mesh-list
43659377|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773907|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659378|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659379|NCT02939235|Morphine|morphine|mesh-list
43659380|NCT02939235|Metoclopramide|metoclopramide|mesh-list
43659381|NCT02939235|Ticagrelor|ticagrelor|mesh-list
43850942|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43605936|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605938|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43605939|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43605940|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43605941|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43605942|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43605944|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43605945|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659386|NCT02939235|Analgesics|analgesics|mesh-ancestor
43659387|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
43659388|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659389|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43659390|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43825573|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
43659391|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43659393|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
43659394|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659395|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659396|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
43659397|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
43659398|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659399|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43659400|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43659401|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
43850973|NCT04878315|Captopril|captopril|mesh-list
43850974|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43850975|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
43850976|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659402|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
43659403|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43659404|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43652607|NCT02989558|Analgesics|analgesics|mesh-ancestor
43652608|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
43652609|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696800|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696801|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43696802|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43696803|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43696804|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659405|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659406|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
43659407|NCT02938962|Coagulants|coagulants|mesh-ancestor
43659408|NCT02938975|Permethrin|permethrin|mesh-list
43659409|NCT02938975|Insect Repellents|insect repellents|mesh-list
43605956|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651654|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659414|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
43659415|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43659416|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659417|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
43659418|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
43659419|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
43659420|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659421|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850985|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
43850986|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850987|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850988|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850989|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43850990|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659422|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43659423|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43659427|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659428|NCT02938468|Dexamethasone|dexamethasone|mesh-list
43659429|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659430|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
43659431|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
43659432|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659433|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659434|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659435|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
43659437|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659438|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43659439|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659440|NCT02938507|Solabegron|solabegron|mesh-list
43659441|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43659442|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43605968|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43605969|NCT03222687|Prednisone|prednisone|mesh-list
43850992|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850993|NCT04804540|Vedolizumab|vedolizumab|mesh-list
43850994|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850995|NCT04781855|Nivolumab|nivolumab|mesh-list
43850996|NCT04781855|Ipilimumab|ipilimumab|mesh-list
43850997|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850998|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659444|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659445|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659446|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659447|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825574|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825575|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825576|NCT05563350|Midazolam|midazolam|mesh-list
43652610|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652611|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652612|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652613|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43652614|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43652615|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652616|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43696826|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
43825577|NCT05563350|Omeprazole|omeprazole|mesh-list
43825578|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43825579|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825580|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825581|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825582|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43825583|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43825584|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825585|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825586|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
43825587|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
43825588|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
43825589|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
43825590|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825591|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825592|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43659449|NCT02938260|Diltiazem|diltiazem|mesh-list
43659450|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43659452|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
43851000|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851002|NCT04759586|Prednisolone|prednisolone|mesh-list
43851003|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43851004|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
43851005|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43851006|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
43851007|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
43659482|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43659483|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
43659484|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
43659485|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
43659486|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43659487|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
43659488|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
43659489|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659490|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
43659491|NCT02938182|Clopidogrel|clopidogrel|mesh-list
43659492|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43851008|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43851009|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43851010|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43605998|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43605999|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606000|NCT03222206|Analgesics|analgesics|mesh-ancestor
43606001|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
43606002|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606003|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606004|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606005|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606006|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
43606007|NCT03222323|Ropivacaine|ropivacaine|mesh-list
43606008|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43606009|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606010|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606011|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606012|NCT03222323|Analgesics|analgesics|mesh-ancestor
43606013|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
43606014|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606015|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43606016|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43606017|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43606018|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606019|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649462|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606020|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606023|NCT03222089|Leucovorin|leucovorin|mesh-list
43606024|NCT03222089|Fluorouracil|fluorouracil|mesh-list
43606025|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
43606026|NCT03222089|Irinotecan|irinotecan|mesh-list
43606027|NCT03222089|Interleukin-2|interleukin-2|mesh-list
43606028|NCT03222089|Molgramostim|molgramostim|mesh-list
43606029|NCT03222089|Sargramostim|sargramostim|mesh-list
43606030|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
43606031|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
43606032|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606056|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606057|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43851012|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
43851013|NCT04759586|Rituximab|rituximab|mesh-list
43851014|NCT04759586|Doxorubicin|doxorubicin|mesh-list
43851015|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43851016|NCT04759586|Nivolumab|nivolumab|mesh-list
43851017|NCT04759586|Etoposide|etoposide|mesh-list
43851018|NCT04759586|Vincristine|vincristine|mesh-list
43851019|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
43606064|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
43606065|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606067|NCT03221816|Pyridoxine|pyridoxine|mesh-list
43606068|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
43606069|NCT03221816|Hematinics|hematinics|mesh-ancestor
43606070|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
43606071|NCT03221816|Vitamins|vitamins|mesh-ancestor
43606072|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
43606073|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606074|NCT03221855|Domperidone|domperidone|mesh-list
43606075|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
43606076|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
43606077|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606078|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606079|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606080|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43606081|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
43606082|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851020|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43851021|NCT04759586|Antibodies|antibodies|mesh-list
43851022|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
43851023|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851024|NCT04759586|Lenograstim|lenograstim|mesh-list
43851025|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43851026|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
43851027|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659505|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659506|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43659507|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43659508|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
43659509|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659510|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659511|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43659512|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659513|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
43659514|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
43659515|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659516|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43659517|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43659518|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43659519|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659520|NCT02937857|Antipyretics|antipyretics|mesh-list
43606104|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
43606105|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649475|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
43659543|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659544|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649486|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43659558|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
43659559|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659560|NCT02937779|Tenofovir|tenofovir|mesh-list
43659561|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
43659562|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696874|NCT02752646|Analgesics|analgesics|mesh-ancestor
43659563|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43659564|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43659565|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659566|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659567|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43659568|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43659578|NCT02937415|Protective Agents|protective agents|mesh-ancestor
43659579|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659580|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
43659581|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
43659582|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659583|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
43659584|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
43659585|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659586|NCT02937363|Protective Agents|protective agents|mesh-ancestor
43659587|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659588|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
43659589|NCT02937363|Vitamins|vitamins|mesh-ancestor
43659590|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
43659591|NCT02937285|Interferons|interferons|mesh-list
43659592|NCT02937285|Interferon-beta|interferon-beta|mesh-list
43659593|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
43659594|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
43659595|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659596|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
43659597|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659598|NCT02937285|Analgesics|analgesics|mesh-ancestor
43659599|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
43659600|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659601|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659602|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43659603|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43659604|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827096|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43606119|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43606120|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606121|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606123|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652617|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43659622|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43659623|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659624|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43659625|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
43659626|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659627|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43659628|NCT02936895|Vitamin D|vitamin d|mesh-list
43659629|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
43659630|NCT02936895|Vitamins|vitamins|mesh-ancestor
43659631|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
43659632|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851061|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851062|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
43851063|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851067|NCT04685980|Morphine|morphine|mesh-list
43851068|NCT04685980|Anesthetics|anesthetics|mesh-list
43851069|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
43851070|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851071|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851072|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43851073|NCT04685980|Narcotics|narcotics|mesh-ancestor
43851074|NCT04685980|Analgesics|analgesics|mesh-ancestor
43851075|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
43851076|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851091|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
43659633|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43659634|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43659639|NCT02936830|Glycerol|glycerol|mesh-list
43659640|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
43659641|NCT02936830|Protective Agents|protective agents|mesh-ancestor
43659642|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659643|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43659644|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851092|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43851093|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43851094|NCT04628767|Gemcitabine|gemcitabine|mesh-list
43851095|NCT04628767|Cisplatin|cisplatin|mesh-list
43851096|NCT04628767|Doxorubicin|doxorubicin|mesh-list
43851097|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43851098|NCT04628767|Methotrexate|methotrexate|mesh-list
43851099|NCT04628767|Durvalumab|durvalumab|mesh-list
43851100|NCT04628767|Vinblastine|vinblastine|mesh-list
43851101|NCT04628767|Lenograstim|lenograstim|mesh-list
43606143|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606144|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43606175|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606176|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
43659674|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659675|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659676|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
43659677|NCT02936375|Azathioprine|azathioprine|mesh-list
43659678|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659679|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
43659681|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606180|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606181|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43606182|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43606183|NCT03221166|Growth Substances|growth substances|mesh-ancestor
43606184|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606185|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606186|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
43606187|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43606188|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
43606189|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606190|NCT03221231|Expectorants|expectorants|mesh-ancestor
43606210|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606211|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606212|NCT03220815|Methamphetamine|methamphetamine|mesh-list
43606213|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43606214|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606215|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
43606216|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
43606217|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606218|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
43606219|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606220|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606221|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
43851115|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851116|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43659684|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659685|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659686|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43659687|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
43659688|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659689|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
43659695|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
43659696|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
43659697|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659698|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659699|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
43659700|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606227|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606228|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606229|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
43606230|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43606231|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851129|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
43659701|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43659702|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43659703|NCT02935933|Analgesics|analgesics|mesh-ancestor
43659704|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43659705|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43659706|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43659707|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659708|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659709|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659715|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659716|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659717|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43659718|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43659719|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
43659720|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
43659721|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659722|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43659723|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43851130|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851131|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
43851132|NCT04613596|Pemetrexed|pemetrexed|mesh-list
43851133|NCT04613596|Adagrasib|adagrasib|mesh-list
43851134|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851135|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851136|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851137|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851138|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43851139|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43851140|NCT04579380|Trastuzumab|trastuzumab|mesh-list
43606246|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606266|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43606267|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43851141|NCT04579380|Fulvestrant|fulvestrant|mesh-list
43851143|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851144|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851145|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43851146|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43851147|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43851148|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659724|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659725|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659727|NCT02935764|Fluorouracil|fluorouracil|mesh-list
43851150|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851152|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851153|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851154|NCT04576117|Vinblastine|vinblastine|mesh-list
43851155|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851156|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606274|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606275|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
43606276|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606277|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43606278|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43606279|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43606280|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606281|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606282|NCT03220256|Lamotrigine|lamotrigine|mesh-list
43606283|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
43606284|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606285|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606286|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659736|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43659737|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43659738|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659739|NCT02935764|Antidotes|antidotes|mesh-ancestor
43659740|NCT02935764|Protective Agents|protective agents|mesh-ancestor
43659741|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
43659742|NCT02935764|Vitamins|vitamins|mesh-ancestor
43659743|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
43659744|NCT02935751|Apixaban|apixaban|mesh-list
43659745|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43851158|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851159|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851161|NCT04551196|Acetaminophen|acetaminophen|mesh-list
43606289|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43606290|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43606291|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606292|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43606293|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43606294|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
43606295|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
43851172|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43851173|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851174|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851175|NCT04543591|Ravulizumab|ravulizumab|mesh-list
43851176|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43851177|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851178|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
43851179|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851180|NCT04536298|Vitamin D|vitamin d|mesh-list
43659757|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659758|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43659759|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43659760|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659761|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43659762|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43659763|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
43659765|NCT02935790|Ipilimumab|ipilimumab|mesh-list
43659766|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43659767|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659768|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43659769|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659770|NCT02935829|Locust bean gum|locust bean gum|mesh-list
43659771|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
43659772|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659773|NCT02935959|Midazolam|midazolam|mesh-list
43659774|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
43659775|NCT02935959|Ketamine|ketamine|mesh-list
43659776|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43659777|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606331|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43606332|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43606333|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606334|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606335|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659778|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659779|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43659780|NCT02935959|Analgesics|analgesics|mesh-ancestor
43659781|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
43659782|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659783|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43659784|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43659785|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43659786|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
43851181|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
43851182|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
43851183|NCT04536298|Vitamins|vitamins|mesh-list
43851184|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
43851185|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851186|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43851187|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43851188|NCT04472598|Navitoclax|navitoclax|mesh-list
43851189|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659788|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659789|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43659790|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43659791|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
43659793|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43606345|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606354|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606356|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606357|NCT03220126|Mirikizumab|mirikizumab|mesh-list
43606358|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43606359|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606360|NCT03220126|Analgesics|analgesics|mesh-ancestor
43606361|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
43606362|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606363|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606364|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606365|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606366|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606367|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606368|NCT03220191|Palbociclib|palbociclib|mesh-list
43606369|NCT03220191|Rabeprazole|rabeprazole|mesh-list
43606370|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606371|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43606372|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606373|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606374|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606375|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606376|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43606377|NCT03220113|Thiamine|thiamine|mesh-list
43606378|NCT03220113|Dexamethasone|dexamethasone|mesh-list
43606379|NCT03220113|Lidocaine|lidocaine|mesh-list
43606380|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606381|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
43606382|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
43606383|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652643|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606384|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606385|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606386|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
43659821|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43659822|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43659823|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43659824|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43659825|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43659826|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
43659827|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
43659828|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
43659829|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606388|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606390|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606391|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43606393|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606394|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
43606395|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43606396|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43851208|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
43827097|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43827098|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43827099|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43827100|NCT05491811|Growth Substances|growth substances|mesh-ancestor
43827101|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43827102|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
43670811|NCT05424445|Misoprostol|misoprostol|mesh-list
43606407|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43606408|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851209|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
43659841|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659843|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43659844|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43659845|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659846|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
43659847|NCT02935985|Coagulants|coagulants|mesh-ancestor
43659848|NCT02935647|Propofol|propofol|mesh-list
43659849|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43659850|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659851|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659875|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43659876|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659877|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
43659878|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43659879|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
43659880|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659881|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43659882|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43659902|NCT02935335|Menotropins|menotropins|mesh-list
43659903|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43659923|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43659924|NCT02935101|Prednisolone|prednisolone|mesh-list
43659925|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43659926|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
43659927|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43659928|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
43659929|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43659930|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
43659931|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659933|NCT02935101|Hormones|hormones|mesh-ancestor
43659934|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659935|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659936|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43659937|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659939|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
43659940|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659941|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659942|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43659943|NCT02935101|Protective Agents|protective agents|mesh-ancestor
43659944|NCT02934945|Budesonide|budesonide|mesh-list
43659945|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
43606436|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43606437|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43606438|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606439|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43606440|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43606441|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43851216|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
43851217|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659956|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43659957|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43659958|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43659959|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659960|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659961|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659962|NCT02934919|Nalmefene|nalmefene|mesh-list
43659963|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43659964|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606443|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43606444|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43606445|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
43606446|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43606447|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43606448|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606449|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
43606450|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
43606451|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43606452|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
43606453|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606454|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43606456|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
43606457|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606458|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
43606459|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43606460|NCT03217916|Protective Agents|protective agents|mesh-ancestor
43606461|NCT03216356|Cycloserine|cycloserine|mesh-list
43659965|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
43659966|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659967|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
43659968|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
43659969|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43659970|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659971|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659972|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43659973|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
43659974|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43659976|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
43659977|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43659978|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
43659979|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659980|NCT02935010|Amoxicillin|amoxicillin|mesh-list
43659981|NCT02935010|Metronidazole|metronidazole|mesh-list
43659982|NCT02935010|Clarithromycin|clarithromycin|mesh-list
43659983|NCT02935010|Levofloxacin|levofloxacin|mesh-list
43659984|NCT02935010|Ofloxacin|ofloxacin|mesh-list
43659985|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
43659986|NCT02935010|Esomeprazole|esomeprazole|mesh-list
43659987|NCT02935010|Bismuth|bismuth|mesh-list
43659990|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659991|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43659992|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43659993|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43606509|NCT03213769|Vitamins|vitamins|mesh-ancestor
43606510|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
43606511|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43606512|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606513|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606514|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606515|NCT03213743|Analgesics|analgesics|mesh-ancestor
43606516|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
43606517|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606518|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43606519|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43606520|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43606521|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606522|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606537|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606539|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43606540|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
43660005|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43660006|NCT02935010|Antacids|antacids|mesh-ancestor
43660007|NCT02935010|Diuretics|diuretics|mesh-ancestor
43660008|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
43660009|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660010|NCT02935010|Expectorants|expectorants|mesh-ancestor
43660011|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
43660012|NCT02934763|Propranolol|propranolol|mesh-list
43660013|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43660014|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43851219|NCT04417192|Olaparib|olaparib|mesh-list
43851220|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43660015|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606542|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43606543|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606544|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606545|NCT03212352|Misoprostol|misoprostol|mesh-list
43606546|NCT03212352|Mifepristone|mifepristone|mesh-list
43606547|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43849222|NCT03948074|Dronabinol|dronabinol|mesh-list
43849223|NCT03948074|Cannabidiol|cannabidiol|mesh-list
43849224|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
43849225|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
43849226|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849227|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43849228|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825612|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825614|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43825615|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825616|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825617|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825618|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
43851221|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851222|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43825619|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825620|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825621|NCT05561205|Methylphenidate|methylphenidate|mesh-list
43825622|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43825623|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849235|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606548|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
43606549|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43851224|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851225|NCT04402788|Atezolizumab|atezolizumab|mesh-list
43851226|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851227|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825643|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825644|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825645|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825646|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
43825647|NCT05560542|Hormones|hormones|mesh-ancestor
43846670|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
43846671|NCT04182984|Prednisone|prednisone|mesh-list
43660022|NCT02934464|Leucovorin|leucovorin|mesh-list
43660023|NCT02934464|Paclitaxel|paclitaxel|mesh-list
43660024|NCT02934464|Ramucirumab|ramucirumab|mesh-list
43660025|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
43660026|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
43660027|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43660028|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660029|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
43660030|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
43660031|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
43660032|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660033|NCT02934464|Antidotes|antidotes|mesh-ancestor
43606599|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43606600|NCT03209856|Vitamin D|vitamin d|mesh-list
43606601|NCT03209856|Calcitriol|calcitriol|mesh-list
43606602|NCT03209856|Vitamins|vitamins|mesh-ancestor
43606603|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
43606604|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606605|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43606606|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43606607|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43606608|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849236|NCT03948074|Hormones|hormones|mesh-ancestor
43847634|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43849237|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649521|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43851234|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660043|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
43660044|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43660045|NCT02934035|Citalopram|citalopram|mesh-list
43660046|NCT02934035|Fluoxetine|fluoxetine|mesh-list
43660047|NCT02934035|Paroxetine|paroxetine|mesh-list
43660048|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43660049|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
43660050|NCT02934035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43660051|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43660052|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660053|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849239|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43849240|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849242|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43849243|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849244|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849245|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
43849246|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849247|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
43849248|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43849249|NCT03945656|Insulin|insulin|mesh-list
43849250|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43849251|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
43849252|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43849253|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606609|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606610|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43606612|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43606625|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
43606626|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606627|NCT03209427|Morphine|morphine|mesh-list
43606628|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43606629|NCT03209427|Narcotics|narcotics|mesh-ancestor
43652660|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
43606630|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606631|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606632|NCT03209427|Analgesics|analgesics|mesh-ancestor
43606633|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
43660054|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660055|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
43660056|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660057|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43660058|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660059|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660060|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43660062|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
43660063|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
43606639|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606640|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606642|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43606643|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
43606644|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606645|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606646|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
43606647|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606648|NCT03209648|Itraconazole|itraconazole|mesh-list
43606649|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
43606650|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606651|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43660064|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43660065|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43660067|NCT02934152|Amoxicillin|amoxicillin|mesh-list
43660068|NCT02934152|Clarithromycin|clarithromycin|mesh-list
43660069|NCT02934152|Rabeprazole|rabeprazole|mesh-list
43660070|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660071|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660072|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43660073|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660074|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660075|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43660076|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43660077|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43660078|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838676|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838677|NCT04830982|Diazoxide|diazoxide|mesh-list
43838678|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43838679|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
43838680|NCT04830735|Dasatinib|dasatinib|mesh-list
43773928|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
43773929|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773931|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
43697539|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
43697540|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43697541|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660079|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43660081|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
43660082|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660084|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43660085|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43660086|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660087|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43660088|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43660089|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
43606656|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
43606657|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43606658|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606659|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43606660|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43606661|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
43606662|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851235|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
43606669|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606670|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43649527|NCT03022253|Ibuprofen|ibuprofen|mesh-list
43660123|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43660124|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43660125|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660126|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660128|NCT02934217|Cyclosporins|cyclosporins|mesh-list
43649528|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649529|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43649531|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
43606671|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
43606672|NCT03209180|Protective Agents|protective agents|mesh-ancestor
43606673|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606689|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43606690|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43606691|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660136|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
43660137|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660138|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43660139|NCT02933905|Ranibizumab|ranibizumab|mesh-list
43660140|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43660141|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43660142|NCT02933905|Growth Substances|growth substances|mesh-ancestor
43660143|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652664|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
43652665|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697558|NCT02983682|Lidocaine|lidocaine|mesh-list
43697559|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697560|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
43697561|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697562|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660144|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
43660145|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660146|NCT02933814|Bupivacaine|bupivacaine|mesh-list
43660147|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660148|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
43660149|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660150|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660151|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
43660152|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660153|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
43660154|NCT02933775|Fludarabine|fludarabine|mesh-list
43660155|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660156|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
43660157|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660158|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660159|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43660160|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
43660161|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606692|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
43606693|NCT03209193|Sevoflurane|sevoflurane|mesh-list
43606694|NCT03209193|Desflurane|desflurane|mesh-list
43606695|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43606696|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43606697|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
43606698|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
43606699|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43606700|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606701|NCT03209219|Interferons|interferons|mesh-list
43606702|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
43606703|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
43606704|NCT03209219|Cyclosporine|cyclosporine|mesh-list
43606705|NCT03209219|Cyclosporins|cyclosporins|mesh-list
43660162|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660163|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43660164|NCT02933788|Aspirin|aspirin|mesh-list
43660165|NCT02933788|Cilostazol|cilostazol|mesh-list
43660166|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43660167|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43606707|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
43606708|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606709|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606710|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606711|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43606712|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
43606713|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606714|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
43606715|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606716|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606717|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43606718|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
43660199|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660200|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660201|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660202|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
43660203|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43660204|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43660205|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
43660206|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43660207|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43660208|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660209|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43660210|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43660211|NCT02933593|Hydralazine|hydralazine|mesh-list
43660212|NCT02933593|Labetalol|labetalol|mesh-list
43660213|NCT02933593|Nifedipine|nifedipine|mesh-list
43660214|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43606720|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43606721|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
43606722|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606724|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606725|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43606726|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43606727|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43606728|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606729|NCT03209232|Infliximab|infliximab|mesh-list
43606730|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
43606731|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606732|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43606733|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43606758|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43606759|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43606760|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606762|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606763|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43660230|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43660231|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43660232|NCT02933853|Insulin|insulin|mesh-list
43660233|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43660234|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
43660235|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
43660236|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43660237|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660238|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606811|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43606812|NCT03208218|Lenalidomide|lenalidomide|mesh-list
43660247|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43660248|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
43660249|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660250|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
43660251|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660252|NCT02933333|Molgramostim|molgramostim|mesh-list
43660253|NCT02933333|Lenograstim|lenograstim|mesh-list
43660254|NCT02933333|Sargramostim|sargramostim|mesh-list
43851239|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851240|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
43851241|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
43660255|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43660256|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
43660257|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660258|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660260|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660261|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43660262|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43660263|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660264|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660265|NCT02932930|Ropivacaine|ropivacaine|mesh-list
43660266|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660267|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
43660268|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660269|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606820|NCT03208413|Thalidomide|thalidomide|mesh-list
43606821|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660285|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660286|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
43660287|NCT02933099|Hormones|hormones|mesh-ancestor
43660288|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660289|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43660290|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660291|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
43660293|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660294|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43660295|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660296|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43660297|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43660298|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
43825648|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851244|NCT04393298|Protective Agents|protective agents|mesh-ancestor
43606843|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
43851245|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
43825649|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825650|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825651|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43825652|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43825653|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43825654|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43825655|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825657|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
43606846|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
43606847|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
43606848|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43606849|NCT03208426|Amoxicillin|amoxicillin|mesh-list
43606850|NCT03208426|Metronidazole|metronidazole|mesh-list
43606851|NCT03208426|Clarithromycin|clarithromycin|mesh-list
43606852|NCT03208426|Tetracycline|tetracycline|mesh-list
43606853|NCT03208426|Esomeprazole|esomeprazole|mesh-list
43851246|NCT04393298|Vitamins|vitamins|mesh-ancestor
43825658|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43825659|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43825660|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
43825661|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825662|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825663|NCT05560308|Trastuzumab|trastuzumab|mesh-list
43825664|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43825665|NCT05560308|Maytansine|maytansine|mesh-list
43825666|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825669|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43825670|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43825671|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43825672|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43825673|NCT05491616|Nivolumab|nivolumab|mesh-list
43825674|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825675|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825678|NCT05448807|Phentolamine|phentolamine|mesh-list
43825679|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43825680|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43825681|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
43825682|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825683|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825684|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606865|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43606867|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
43606868|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606869|NCT03208361|Amoxicillin|amoxicillin|mesh-list
43830077|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43830078|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
43830079|NCT05384756|Antibodies|antibodies|mesh-list
43830080|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
43697799|NCT02750969|Lidocaine|lidocaine|mesh-list
43697800|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697801|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
43697802|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697803|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697804|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
43697805|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697806|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43697807|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43606870|NCT03208361|Penicillins|penicillins|mesh-list
43606871|NCT03208361|Penicillin V|penicillin v|mesh-list
43606872|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43606873|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825694|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
43825695|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825696|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
43825697|NCT05325762|Propofol|propofol|mesh-list
43825698|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825699|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660299|NCT02932722|Anesthetics|anesthetics|mesh-list
43660300|NCT02932722|Propofol|propofol|mesh-list
43660301|NCT02932722|Sevoflurane|sevoflurane|mesh-list
43660302|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660303|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660304|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660305|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660306|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
43660307|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43660308|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43660310|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43660311|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660312|NCT02932774|Cetirizine|cetirizine|mesh-list
43660313|NCT02932774|Loratadine|loratadine|mesh-list
43660314|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43660315|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43660316|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43660317|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
43660318|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
43851247|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
43606879|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649536|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43649537|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649538|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649540|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
43649541|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43649542|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649543|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43649544|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43649545|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649546|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649548|NCT03021694|Caseins|caseins|mesh-list
43649549|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
43649550|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
43649551|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649552|NCT03020680|Ubiquinone|ubiquinone|mesh-list
43649553|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
43649554|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
43773973|NCT02355522|Lidocaine|lidocaine|mesh-list
43649555|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606880|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
43606881|NCT03207698|Metformin|metformin|mesh-list
43606882|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43606883|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649557|NCT03020329|Paclitaxel|paclitaxel|mesh-list
43649558|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43649559|NCT03020329|Cisplatin|cisplatin|mesh-list
43606884|NCT03207308|Vitamin A|vitamin a|mesh-list
43606906|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
43606907|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43606908|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
43606909|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
43606910|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606911|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43606912|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43660319|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660320|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660321|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660323|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
43660324|NCT02932605|Cannabidiol|cannabidiol|mesh-list
43660325|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
43660326|NCT02932488|Sumatriptan|sumatriptan|mesh-list
43660327|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43660328|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43660329|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43606913|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43606914|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43606915|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
43606916|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43606917|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606918|NCT03207165|Protective Agents|protective agents|mesh-ancestor
43606919|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43606920|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
43660330|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
43660331|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774005|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660332|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660333|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660334|NCT02932397|Propofol|propofol|mesh-list
43660335|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660336|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660337|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660338|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660339|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
43660340|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
43660341|NCT02932566|Pirfenidone|pirfenidone|mesh-list
43660342|NCT02932566|Analgesics|analgesics|mesh-ancestor
43660343|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
43660344|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660345|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660346|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43660347|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660348|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660349|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660350|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660351|NCT02932644|Vitamin D|vitamin d|mesh-list
43660352|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
43660353|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
43660354|NCT02932644|Vitamins|vitamins|mesh-list
43660356|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660357|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43660358|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660359|NCT02932436|Empagliflozin|empagliflozin|mesh-list
43660360|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43660361|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660362|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660363|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660364|NCT02932007|Chloroquine|chloroquine|mesh-list
43660365|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43660366|NCT02932007|Amebicides|amebicides|mesh-ancestor
43660367|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43660368|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43660369|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43606938|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
43606950|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606954|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43606955|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43606956|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606957|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43606958|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43606959|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606961|NCT03206931|Selitrectinib|selitrectinib|mesh-list
43606962|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43606963|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606964|NCT03206671|Cytarabine|cytarabine|mesh-list
43606965|NCT03206671|Dexamethasone|dexamethasone|mesh-list
43606966|NCT03206671|Prednisolone|prednisolone|mesh-list
43606967|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
43606968|NCT03206671|Ifosfamide|ifosfamide|mesh-list
43606969|NCT03206671|Rituximab|rituximab|mesh-list
43606970|NCT03206671|Doxorubicin|doxorubicin|mesh-list
43606971|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43606972|NCT03206671|Methotrexate|methotrexate|mesh-list
43606973|NCT03206671|Etoposide|etoposide|mesh-list
43606974|NCT03206671|Vincristine|vincristine|mesh-list
43606975|NCT03206671|Vindesine|vindesine|mesh-list
43606976|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660375|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
43660376|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846672|NCT04182984|Azathioprine|azathioprine|mesh-list
43660377|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660378|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660379|NCT02932007|Filaricides|filaricides|mesh-ancestor
43660380|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
43660381|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
43660382|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43851267|NCT04329494|Leucovorin|leucovorin|mesh-list
43851268|NCT04329494|Cisplatin|cisplatin|mesh-list
43851269|NCT04329494|Doxorubicin|doxorubicin|mesh-list
43851270|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43851271|NCT04329494|Fluorouracil|fluorouracil|mesh-list
43851272|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
43851273|NCT04329494|Irinotecan|irinotecan|mesh-list
43851274|NCT04329494|Daunorubicin|daunorubicin|mesh-list
43606981|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
43606982|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43606983|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606984|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43606985|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43606986|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649560|NCT03020329|Fluorouracil|fluorouracil|mesh-list
43649561|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43649562|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43649563|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
43649564|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851275|NCT04329494|Mitomycins|mitomycins|mesh-list
43660383|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
43660384|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43660385|NCT02932020|Prednisolone|prednisolone|mesh-list
43660386|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
43660387|NCT02932020|Bupivacaine|bupivacaine|mesh-list
43660388|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43660389|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
43660390|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660391|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
43660392|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660393|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660394|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
43660395|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660396|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660397|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
43660398|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
43660399|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660400|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
43851276|NCT04329494|Mitomycin|mitomycin|mesh-list
43851277|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851278|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851279|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43851280|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851281|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851289|NCT04329494|Antidotes|antidotes|mesh-ancestor
43851291|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
43851292|NCT04329494|Vitamins|vitamins|mesh-ancestor
43660401|NCT02932020|Hormones|hormones|mesh-ancestor
43660402|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660403|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43660404|NCT02932020|Protective Agents|protective agents|mesh-ancestor
43660405|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43660406|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660407|NCT02932137|Interleukin-2|interleukin-2|mesh-list
43660408|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606988|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
43606989|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43606990|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43606991|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
43660428|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43660429|NCT02931786|Ketamine|ketamine|mesh-list
43660430|NCT02931786|Propofol|propofol|mesh-list
43660431|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660432|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660433|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660434|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660435|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
43851293|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
43851294|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
43851295|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43851296|NCT04301076|Prednisone|prednisone|mesh-list
43851297|NCT04301076|Cortisone|cortisone|mesh-list
43851298|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
43851299|NCT04301076|Doxorubicin|doxorubicin|mesh-list
43851300|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43851301|NCT04301076|Etoposide|etoposide|mesh-list
43851302|NCT04301076|Vincristine|vincristine|mesh-list
43851303|NCT04301076|Lenalidomide|lenalidomide|mesh-list
43851304|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
43851305|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
43851306|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851307|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
43660436|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
43660437|NCT02931786|Analgesics|analgesics|mesh-ancestor
43660438|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
43607001|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607027|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
43607028|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607029|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607030|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43607031|NCT03206658|Diuretics|diuretics|mesh-ancestor
43607032|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
43607033|NCT03206554|Ropivacaine|ropivacaine|mesh-list
43607034|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
43607035|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
43607036|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607037|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607038|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
43607039|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43670812|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43851308|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851309|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851321|NCT04301076|Hormones|hormones|mesh-ancestor
43851326|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851327|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851328|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670813|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
43670814|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43670815|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670816|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43851329|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43851330|NCT04301076|Growth Substances|growth substances|mesh-ancestor
43851331|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
43851332|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
43851333|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
43851335|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43851336|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43851337|NCT04296006|Amphetamine|amphetamine|mesh-list
43851338|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
43851339|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43851340|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607044|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
43607045|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607046|NCT03206138|Imiquimod|imiquimod|mesh-list
43607047|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43607048|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
43607049|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607050|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607079|NCT03206021|Azacitidine|azacitidine|mesh-list
43607080|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607081|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607082|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
43607083|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607084|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607085|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
43607086|NCT03206008|Analgesics|analgesics|mesh-ancestor
43607087|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
43607088|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607089|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607090|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
43649571|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649572|NCT03019822|Amphetamine|amphetamine|mesh-list
43649573|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
43649574|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43649575|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43649576|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43649577|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649578|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
43649579|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
43649580|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649581|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
43649582|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649583|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649584|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
43649585|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43649586|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649587|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660454|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43660456|NCT02931591|Hormones|hormones|mesh-list
43660457|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660458|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660459|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660460|NCT02931383|Liraglutide|liraglutide|mesh-list
43660461|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660462|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660463|NCT02931383|Incretins|incretins|mesh-ancestor
43660464|NCT02931383|Hormones|hormones|mesh-ancestor
43660465|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660466|NCT02931474|Tesamorelin|tesamorelin|mesh-list
43660467|NCT02931474|Growth Substances|growth substances|mesh-ancestor
43607095|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607128|NCT03204929|Trace Elements|trace elements|mesh-ancestor
43607129|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
43607130|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607132|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
43607133|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607134|NCT03205033|Protective Agents|protective agents|mesh-ancestor
43607135|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607136|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851341|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
43851342|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
43851343|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851344|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
43851345|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851346|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851347|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
43851348|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43660468|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660469|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
43660470|NCT02931357|Lidocaine|lidocaine|mesh-list
43660471|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
43660472|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660473|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
43660474|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660475|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660476|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
43607168|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
43607169|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607170|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43774053|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
43774054|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774055|NCT02355054|Choline|choline|mesh-list
43774056|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
43774057|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43774058|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
43774062|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
43607171|NCT03204669|Trace Elements|trace elements|mesh-list
43607172|NCT03204669|Micronutrients|micronutrients|mesh-list
43607173|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607174|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43607175|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43607176|NCT03204331|Norethindrone|norethindrone|mesh-list
43607177|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
43607178|NCT03204331|Estradiol|estradiol|mesh-list
43660477|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660478|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660479|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43660480|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43660481|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660482|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660483|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43660485|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
43660486|NCT02931357|Protective Agents|protective agents|mesh-ancestor
43660487|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43660488|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660489|NCT02931526|Tigecycline|tigecycline|mesh-list
43660490|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660491|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851349|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649595|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43649596|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43649597|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
43649598|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649599|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649600|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43607179|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43607180|NCT03204331|Relugolix|relugolix|mesh-list
43607181|NCT03204331|Estrogens|estrogens|mesh-ancestor
43607182|NCT03204331|Hormones|hormones|mesh-ancestor
43607183|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607184|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660492|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43660493|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660494|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660495|NCT02931123|Rifaximin|rifaximin|mesh-list
43660496|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660497|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660498|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660499|NCT02931136|Huperzine A|huperzine a|mesh-list
43660500|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43660501|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660502|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660503|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
43660504|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660505|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660506|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43660507|NCT02931136|Protective Agents|protective agents|mesh-ancestor
43660508|NCT02931188|Anacetrapib|anacetrapib|mesh-list
43851350|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43851351|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43660510|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43660511|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
43660512|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660513|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43660514|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43660515|NCT02931175|Hormones|hormones|mesh-ancestor
43660516|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660517|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825706|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
43825707|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846673|NCT04182984|Bromides|bromides|mesh-list
43607239|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
43607240|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
43607241|NCT03204097|Alendronate|alendronate|mesh-list
43607268|NCT03204032|Tegafur|tegafur|mesh-list
43607269|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43607270|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
43607271|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607272|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607273|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607274|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
43607275|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607276|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
43607277|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607278|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607279|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43607280|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43607281|NCT03204032|Growth Substances|growth substances|mesh-ancestor
43607282|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
43607283|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607284|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
43649602|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
43649603|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649604|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43649605|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43607285|NCT03204045|Fentanyl|fentanyl|mesh-list
43607286|NCT03204045|Oxycodone|oxycodone|mesh-list
43607287|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43607288|NCT03204045|Narcotics|narcotics|mesh-ancestor
43607289|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607290|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607291|NCT03204045|Analgesics|analgesics|mesh-ancestor
43660522|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607327|NCT03204019|Growth Substances|growth substances|mesh-ancestor
43607328|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
43607329|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43607330|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
43607331|NCT03203746|Lycopene|lycopene|mesh-list
43607368|NCT03203616|Trastuzumab|trastuzumab|mesh-list
43607369|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43607398|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607400|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607402|NCT03202836|Progesterone|progesterone|mesh-list
43607403|NCT03202836|Progestins|progestins|mesh-ancestor
43607404|NCT03202836|Hormones|hormones|mesh-ancestor
43607405|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43607406|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607407|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607408|NCT03202979|Trazodone|trazodone|mesh-list
43607409|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43660523|NCT02930733|Bupivacaine|bupivacaine|mesh-list
43660524|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660525|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
43660526|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660527|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660528|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
43660529|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660530|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
43607453|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43607454|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607455|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43607482|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43607483|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607484|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607485|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43607486|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43607487|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43607488|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774069|NCT02354768|Lanreotide|lanreotide|mesh-list
43607489|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660531|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
43660532|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43660533|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43660534|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660535|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660536|NCT02930811|Urological Agents|urological agents|mesh-ancestor
43660539|NCT02930954|Carboplatin|carboplatin|mesh-list
43660540|NCT02930954|Pemetrexed|pemetrexed|mesh-list
43660541|NCT02930954|Gefitinib|gefitinib|mesh-list
43660557|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43660558|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43660559|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43660560|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43660561|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43660563|NCT02930551|Lidocaine|lidocaine|mesh-list
43607498|NCT03202407|Sevelamer|sevelamer|mesh-list
43607499|NCT03202407|Calcium acetate|calcium acetate|mesh-list
43607500|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43607501|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607502|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
43607528|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607530|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43607531|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660569|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660570|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660571|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43660572|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43660573|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660574|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660575|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
43660576|NCT02930707|Bupivacaine|bupivacaine|mesh-list
43660577|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660578|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
43660579|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660580|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660581|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
43660582|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660583|NCT02930707|Analgesics|analgesics|mesh-ancestor
43660584|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660585|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
43660586|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43660587|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660588|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649612|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660589|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660590|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
43660591|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43660592|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
43660593|NCT02930434|Vitamin D|vitamin d|mesh-list
43660594|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
43660595|NCT02930434|Vitamins|vitamins|mesh-ancestor
43660596|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
43660597|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660598|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43660599|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660600|NCT02930317|Factor VIII|factor viii|mesh-list
43660601|NCT02930317|Coagulants|coagulants|mesh-ancestor
43660602|NCT02930057|Betamethasone|betamethasone|mesh-list
43660603|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660604|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
43660605|NCT02930057|Hormones|hormones|mesh-ancestor
43660606|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660607|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660608|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43660609|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
43660610|NCT02930109|Cytarabine|cytarabine|mesh-list
43660611|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660612|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
43660613|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660614|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660615|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
43607536|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43607537|NCT03201861|Cisplatin|cisplatin|mesh-list
43607538|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43607539|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607540|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
43607541|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
43607542|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
43660618|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
43660619|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660621|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43660622|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
43660623|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660624|NCT02930031|Expectorants|expectorants|mesh-ancestor
43660625|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
43660626|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43660627|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
43660628|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660629|NCT02930031|Protective Agents|protective agents|mesh-ancestor
43660630|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660631|NCT02930031|Antidotes|antidotes|mesh-ancestor
43660632|NCT02930265|Liraglutide|liraglutide|mesh-list
43660633|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660634|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660635|NCT02930265|Incretins|incretins|mesh-ancestor
43660636|NCT02930265|Hormones|hormones|mesh-ancestor
43660637|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660638|NCT02929797|Gemcitabine|gemcitabine|mesh-list
43660639|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660640|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
43660641|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607548|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607549|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43607550|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
43607551|NCT03201913|Estrogens|estrogens|mesh-list
43607552|NCT03201913|Hormones|hormones|mesh-ancestor
43607575|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607576|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
43607577|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
43607578|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43607579|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
43607580|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
43607581|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
43607582|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43607583|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607584|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607585|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
43660650|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43660651|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660652|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43660653|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660654|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660657|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
43660658|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660659|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
43607593|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607594|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43607595|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43660674|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660675|NCT02929719|Dapsone|dapsone|mesh-list
43660676|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660677|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
43660678|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43660679|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43660680|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43660681|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660690|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43660691|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660692|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
43660693|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
43660700|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43660701|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660702|NCT02929888|Analgesics|analgesics|mesh-ancestor
43660703|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
43660704|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660705|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660706|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660707|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660708|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43660709|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43660710|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660711|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43660712|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43607643|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43607644|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
43607645|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43607646|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
43607651|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607652|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607654|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
43607655|NCT03200938|Trace Elements|trace elements|mesh-ancestor
43607656|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
43660719|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660720|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660721|NCT02929459|Vitamins|vitamins|mesh-list
43660722|NCT02929459|Riboflavin|riboflavin|mesh-list
43660723|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
43660724|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
43660725|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660726|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43660727|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
43825708|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43825709|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43825710|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43607692|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43607693|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
43607694|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607695|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607697|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
43607698|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
43607699|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43825711|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
43825712|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825713|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825715|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
43825716|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825717|NCT05285124|Protective Agents|protective agents|mesh-ancestor
43825718|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825719|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825720|NCT05284643|Bevacizumab|bevacizumab|mesh-list
43660729|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43660730|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660731|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
43660732|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
43660733|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
43660734|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660735|NCT02929121|Doxycycline|doxycycline|mesh-list
43660736|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660737|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660752|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660753|NCT02929147|Analgesics|analgesics|mesh-ancestor
43660754|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
43660755|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607774|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607775|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43607776|NCT03200236|Nicotine|nicotine|mesh-list
43607777|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43607778|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
43607779|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607780|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607781|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43607782|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43660756|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43660757|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660758|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660759|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660761|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660762|NCT02929212|Analgesics|analgesics|mesh-ancestor
43660763|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
43660764|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660765|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660766|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
43660767|NCT02929251|Adalimumab|adalimumab|mesh-list
43660768|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43660769|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660770|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660771|NCT02929394|Trabectedin|trabectedin|mesh-list
43660786|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
43660787|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660788|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43660789|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43660790|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43660791|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
43660792|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660793|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660794|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43660795|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43660796|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43660797|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660798|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43607797|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849258|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849259|NCT03945513|Dienogest|dienogest|mesh-list
43849260|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43849261|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43851376|NCT04265651|Infigratinib|infigratinib|mesh-list
43660800|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
43660801|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
43660802|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
43660803|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43660804|NCT02929095|Narcotics|narcotics|mesh-ancestor
43660805|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43660806|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43660807|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660808|NCT02928965|Minocycline|minocycline|mesh-list
43660809|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849265|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849266|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607798|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
43607819|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
43607820|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660811|NCT02928692|Minocycline|minocycline|mesh-list
43660812|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660813|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660814|NCT02928991|Vidarabine|vidarabine|mesh-list
43660815|NCT02928991|Fludarabine|fludarabine|mesh-list
43660816|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
43660817|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660818|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660819|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
43660820|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660821|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660822|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
43660823|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851377|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43607822|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43607823|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
43607824|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607825|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43607826|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
43607827|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43607828|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
43660825|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660826|NCT02928679|Liraglutide|liraglutide|mesh-list
43660827|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660828|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660829|NCT02928679|Incretins|incretins|mesh-ancestor
43660830|NCT02928679|Hormones|hormones|mesh-ancestor
43660831|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660832|NCT02928510|Idelalisib|idelalisib|mesh-list
43660833|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660834|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660835|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660836|NCT02928419|Lenalidomide|lenalidomide|mesh-list
43660837|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
43660838|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660839|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43660840|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43660841|NCT02928419|Growth Substances|growth substances|mesh-ancestor
43660842|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
43660843|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660844|NCT02928614|Liraglutide|liraglutide|mesh-list
43660857|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
43607833|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607834|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43607835|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43607836|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43607837|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
43607838|NCT03199664|Tacrolimus|tacrolimus|mesh-list
43660858|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43660859|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
43660860|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660861|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660862|NCT02928601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43660863|NCT02928601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43660864|NCT02928601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649635|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649636|NCT03019809|Plerixafor|plerixafor|mesh-list
43649637|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43660865|NCT02928601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660866|NCT02928601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43774146|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43774147|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43774148|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43774149|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774150|NCT02354313|Lenalidomide|lenalidomide|mesh-list
43660867|NCT02928575|Temozolomide|temozolomide|mesh-list
43774151|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
43660869|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43660870|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
43660871|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660872|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660873|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43660874|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43660875|NCT02928575|Growth Substances|growth substances|mesh-ancestor
43660876|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660877|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
43607849|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43607850|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607851|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
43607852|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43607853|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43607854|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607886|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43607888|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
43607889|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43607890|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
43607891|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43607892|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607893|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43607922|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43607923|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
43660878|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43660879|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660880|NCT02928328|Lidocaine|lidocaine|mesh-list
43660881|NCT02928328|Lorazepam|lorazepam|mesh-list
43660882|NCT02928328|Capsaicin|capsaicin|mesh-list
43660883|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
43660884|NCT02928328|Butyric Acid|butyric acid|mesh-list
43660885|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660886|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
43660887|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660888|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607932|NCT03199261|Hormones|hormones|mesh-ancestor
43660889|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
43660890|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660891|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660892|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43660893|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43660894|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660895|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660896|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
43660897|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
43660898|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
43660899|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
43660900|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
43660901|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660902|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660903|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43660905|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660906|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
43660907|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
43660908|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660909|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
43660910|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
43660911|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
43660912|NCT02928315|Analgesics|analgesics|mesh-ancestor
43607935|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43607937|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
43607938|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607939|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607940|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43607972|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43607973|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43607974|NCT03199170|Analgesics|analgesics|mesh-ancestor
43607975|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
43660937|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43660938|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660939|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660940|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
43660941|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43660942|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660943|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660944|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
43660945|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660946|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825721|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825722|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825728|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
43608024|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608025|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43608036|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43608037|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608038|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608039|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649653|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43649654|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
43649655|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649657|NCT03019562|Oxycodone|oxycodone|mesh-list
43649658|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43608040|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43608041|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43608042|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
43608043|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43608044|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
43608045|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
43608046|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
43608047|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43608048|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43608049|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43608050|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608051|NCT03198949|Everolimus|everolimus|mesh-list
43608052|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608053|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660947|NCT02927587|Propofol|propofol|mesh-list
43660948|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660949|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660950|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660951|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660952|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
43608078|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608079|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608080|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43608081|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
43608082|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608083|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608084|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43608086|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608087|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608088|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
43608089|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43849268|NCT03945513|Estrogens|estrogens|mesh-ancestor
43608090|NCT03197961|Tenofovir|tenofovir|mesh-list
43608125|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43608126|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43660953|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
43660954|NCT02927405|Gabapentin|gabapentin|mesh-list
43660955|NCT02927405|Analgesics|analgesics|mesh-ancestor
43660956|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
43660957|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774159|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
43774160|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43660958|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660959|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
43660960|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43660961|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43660962|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660963|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43660964|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43660965|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43660966|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660967|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660968|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
43660969|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
43660970|NCT02927379|Ketamine|ketamine|mesh-list
43660971|NCT02927379|Bupivacaine|bupivacaine|mesh-list
43660972|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608159|NCT03197571|Capecitabine|capecitabine|mesh-list
43608160|NCT03197571|Fulvestrant|fulvestrant|mesh-list
43608161|NCT03197571|Avelumab|avelumab|mesh-list
43608162|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43608163|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608164|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
43608165|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
43608166|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
43608167|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608168|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43608169|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
43608170|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608171|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608172|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43660973|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
43660974|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660975|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660976|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
43660977|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660978|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660979|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660981|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43660982|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43660983|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43660984|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
43660985|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660986|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660987|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43660988|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660989|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
43608216|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43608217|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608218|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43608219|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43608220|NCT03197584|Growth Substances|growth substances|mesh-ancestor
43660999|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661000|NCT02927353|Adalimumab|adalimumab|mesh-list
43661001|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661002|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661003|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43661004|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
43661005|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661006|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43661007|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661008|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661009|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851384|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43661010|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661011|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661012|NCT02927522|Donepezil|donepezil|mesh-list
43661013|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43661014|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661015|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661026|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661027|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661028|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661029|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43661030|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43661040|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43661041|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
43661042|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661044|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
43661045|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
43661046|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
43851385|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661047|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43661048|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43661049|NCT02926885|Liver Extracts|liver extracts|mesh-list
43661050|NCT02926885|Hematinics|hematinics|mesh-ancestor
43661051|NCT02927015|Iproplatin|iproplatin|mesh-list
43661052|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661053|NCT02926846|Vancomycin|vancomycin|mesh-list
43661054|NCT02926846|Gentamicins|gentamicins|mesh-list
43661055|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661056|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661057|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43608262|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43608263|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43608265|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
43608266|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608267|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608268|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608269|NCT03197207|Camphor|camphor|mesh-list
43608300|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
43608301|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608302|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
43608303|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608304|NCT03197233|Protective Agents|protective agents|mesh-ancestor
43608305|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43608306|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608307|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43608308|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
43608309|NCT03197077|Desogestrel|desogestrel|mesh-list
43608310|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
43661059|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661060|NCT02926248|Colchicine|colchicine|mesh-list
43661061|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
43661062|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661063|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661064|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661065|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661066|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661067|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661068|NCT02926326|Azithromycin|azithromycin|mesh-list
43661069|NCT02926326|Acumapimod|acumapimod|mesh-list
43661070|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661071|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661072|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43661073|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661095|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
43661096|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661097|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661098|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
43851386|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661099|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
43661100|NCT02926053|Fludarabine|fludarabine|mesh-list
43661101|NCT02926053|Interleukin-2|interleukin-2|mesh-list
43661102|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661103|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
43661104|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661105|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661106|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43661107|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
43661108|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608357|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
43608358|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43608359|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
43608360|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608361|NCT03197103|Protective Agents|protective agents|mesh-ancestor
43608362|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608363|NCT03197103|Antidotes|antidotes|mesh-ancestor
43608364|NCT03196817|Betamethasone|betamethasone|mesh-list
43608365|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
43608388|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608389|NCT03196882|Iron|iron|mesh-list
43608390|NCT03196882|Trace Elements|trace elements|mesh-ancestor
43849270|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849271|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43849272|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849273|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849274|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849276|NCT03944434|Goserelin|goserelin|mesh-list
43608391|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
43661109|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661110|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43661111|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661112|NCT02926053|Analgesics|analgesics|mesh-ancestor
43661113|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
43661114|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661115|NCT02925832|Bupivacaine|bupivacaine|mesh-list
43661116|NCT02925832|Ropivacaine|ropivacaine|mesh-list
43661117|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
43661118|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
43661119|NCT02925832|Anesthetics|anesthetics|mesh-list
43661120|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849286|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849287|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849288|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43849289|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
43608427|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
43608428|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608429|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608431|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43608432|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608433|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608434|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43608435|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43608436|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43608440|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
43608441|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43608442|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43608443|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608444|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
43608477|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43838724|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661127|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661128|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661129|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661130|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661131|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661132|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
43661133|NCT02925975|Protective Agents|protective agents|mesh-ancestor
43851387|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608480|NCT03196531|Loratadine|loratadine|mesh-list
43608481|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
43608482|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
43608483|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43608512|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43608513|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43608514|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
43608515|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43608516|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43608517|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608518|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
43608519|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
43608520|NCT03195569|Paclitaxel|paclitaxel|mesh-list
43608521|NCT03195569|Bevacizumab|bevacizumab|mesh-list
43608522|NCT03195569|Carboplatin|carboplatin|mesh-list
43608523|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43608524|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608525|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
43608526|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
43608527|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661134|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43661135|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661136|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661137|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
43661138|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43661139|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43661140|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43661141|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825729|NCT05244070|Fludarabine|fludarabine|mesh-list
43661143|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43661144|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
43661145|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661146|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661148|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661149|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661150|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
43661151|NCT02925559|Gliclazide|gliclazide|mesh-list
43608557|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608559|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
43608560|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608561|NCT03195543|Thrombin|thrombin|mesh-list
43608562|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
43649670|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43649671|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43649672|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
43649673|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43649674|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43649675|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649676|NCT03019081|Isoproterenol|isoproterenol|mesh-list
43649677|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43851388|NCT04166409|Carboplatin|carboplatin|mesh-list
43851389|NCT04166409|Vincristine|vincristine|mesh-list
43661162|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661163|NCT02924922|Mannitol|mannitol|mesh-list
43661164|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43661165|NCT02924922|Diuretics|diuretics|mesh-ancestor
43661166|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
43661167|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661168|NCT02925026|Lactoferrin|lactoferrin|mesh-list
43661169|NCT02925026|Muramidase|muramidase|mesh-list
43661170|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661171|NCT02925130|Albuterol|albuterol|mesh-list
43661172|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43661173|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
43608568|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608569|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
43608571|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
43608572|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43608573|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43608574|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43608576|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608577|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43608578|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43608579|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608600|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43608601|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43608602|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608603|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43608604|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43608605|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
43608606|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608607|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43608608|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43608609|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
43661174|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661175|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661176|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43661177|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
43661178|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
43661179|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661180|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43661181|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43608610|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43608611|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
43608612|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
43608613|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
43608614|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43608615|NCT03195205|Antibodies|antibodies|mesh-list
43608616|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
43608617|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608618|NCT03195257|Glucagon|glucagon|mesh-list
43608619|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
43608620|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43608621|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608622|NCT03195257|Hormones|hormones|mesh-ancestor
43608623|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608660|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43608661|NCT03195309|Narcotics|narcotics|mesh-ancestor
43608691|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43608692|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608693|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
43661182|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43661183|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661184|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661185|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661186|NCT02925000|Vinorelbine|vinorelbine|mesh-list
43661187|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43661188|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661189|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661190|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
43774226|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
43774227|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661191|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661192|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661193|NCT02924987|Aflibercept|aflibercept|mesh-list
43661194|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43661195|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43661196|NCT02924987|Growth Substances|growth substances|mesh-ancestor
43661197|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661198|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
43661199|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661200|NCT02924974|Lidocaine|lidocaine|mesh-list
43661201|NCT02924974|Morphine|morphine|mesh-list
43661202|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
43608695|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608697|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
43608698|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43608699|NCT03194620|Procyanidin|procyanidin|mesh-list
43608700|NCT03194620|Theaflavin|theaflavin|mesh-list
43608701|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
43608702|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608703|NCT03194620|Protective Agents|protective agents|mesh-ancestor
43661216|NCT02924909|Paclitaxel|paclitaxel|mesh-list
43661217|NCT02924909|Carboplatin|carboplatin|mesh-list
43661218|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43661219|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661220|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661221|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661222|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661223|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661224|NCT02924857|Paclitaxel|paclitaxel|mesh-list
43661225|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43661226|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851390|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661228|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661229|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661230|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661231|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
43661232|NCT02924753|Fludarabine|fludarabine|mesh-list
43661233|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661234|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
43661235|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661236|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661237|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43661238|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
43608704|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649680|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649681|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649682|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649683|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43649684|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
43649685|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649686|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43649687|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
43649688|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43649689|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
43661239|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661241|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43661243|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
43661244|NCT02924766|Niraparib|niraparib|mesh-list
43661245|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661246|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
43661247|NCT02924766|Hormones|hormones|mesh-ancestor
43661248|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661249|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661250|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43661251|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661252|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43661253|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661254|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661255|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
43661256|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43661257|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43661258|NCT02924675|Pregabalin|pregabalin|mesh-list
43661259|NCT02924675|Analgesics|analgesics|mesh-ancestor
43661260|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
43661261|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661262|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661263|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
43661272|NCT02924532|Hormones|hormones|mesh-list
43649691|NCT03019120|Vitamin D|vitamin d|mesh-list
43649692|NCT03019120|Vitamins|vitamins|mesh-ancestor
43649693|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
43649694|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698531|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
43649695|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43649696|NCT03018899|Anesthetics|anesthetics|mesh-list
43649697|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649698|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649699|NCT03018990|Ethanol|ethanol|mesh-list
43661273|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
43661274|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661275|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661276|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661277|NCT02924506|Meloxicam|meloxicam|mesh-list
43661278|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661279|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661280|NCT02924506|Analgesics|analgesics|mesh-ancestor
43661281|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
43661282|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661283|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661284|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661285|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661286|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43661287|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43661288|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608779|NCT03194139|Protective Agents|protective agents|mesh-ancestor
43661292|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43661293|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661294|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43661295|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43661296|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661297|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43661298|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
43661299|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661301|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43661302|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43661303|NCT02924311|Growth Substances|growth substances|mesh-ancestor
43661304|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661305|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
43661306|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851392|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661308|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661309|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
43661310|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43824408|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824409|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824410|NCT05512546|Analgesics|analgesics|mesh-ancestor
43608786|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
43608787|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43608788|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43608789|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
43661313|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43661314|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43661315|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43661316|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661317|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43661318|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43661319|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43698533|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43698534|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43698535|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
43661320|NCT02924454|Metoprolol|metoprolol|mesh-list
43661321|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43661322|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43661323|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43661324|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661325|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661326|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
43661327|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
43661328|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661329|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661330|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43661331|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43661332|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661333|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661334|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661335|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661336|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43661337|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
43661338|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661339|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43608790|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608792|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608793|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
43608794|NCT03194061|Cisplatin|cisplatin|mesh-list
43608795|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608796|NCT03194074|Propofol|propofol|mesh-list
43608797|NCT03194074|Desflurane|desflurane|mesh-list
43608798|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43608822|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
43608823|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608824|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43608825|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43608826|NCT03193957|Etanercept|etanercept|mesh-list
43608827|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43608828|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43608829|NCT03193957|Analgesics|analgesics|mesh-ancestor
43608830|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
43608831|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608832|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608833|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608834|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43608835|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43608836|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43608837|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
43608838|NCT03193814|Apatinib|apatinib|mesh-list
43608839|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608840|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43608841|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608842|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608843|NCT03193788|Folic Acid|folic acid|mesh-list
43608844|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
43608845|NCT03193788|Hydroxocobalamin|hydroxocobalamin|mesh-list
43608846|NCT03193788|Dexamethasone|dexamethasone|mesh-list
43608847|NCT03193788|Pemetrexed|pemetrexed|mesh-list
43608848|NCT03193788|Vitamins|vitamins|mesh-ancestor
43608849|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
43608850|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608875|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608876|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43608877|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
43608878|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
43608879|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43608880|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43608881|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43608882|NCT03193710|Narcotics|narcotics|mesh-ancestor
43608883|NCT03193710|Analgesics|analgesics|mesh-ancestor
43608884|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
43608885|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608886|NCT03193918|Paclitaxel|paclitaxel|mesh-list
43608887|NCT03193918|Ramucirumab|ramucirumab|mesh-list
43608888|NCT03193918|Crenolanib|crenolanib|mesh-list
43608889|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43608890|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608891|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851393|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661340|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43661341|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43661342|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824411|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
43824412|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824413|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824414|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824415|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661343|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661344|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661346|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43661347|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661348|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43661349|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661350|NCT02923986|Dasatinib|dasatinib|mesh-list
43661351|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661352|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43661353|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661354|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661371|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661372|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43661374|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661375|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661376|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43661377|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43661379|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
43661380|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43608925|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608926|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608927|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43608928|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608929|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
43608930|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43608931|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43608932|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43851394|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661392|NCT02923869|Bupivacaine|bupivacaine|mesh-list
43661393|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
43661394|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
43661395|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
43661396|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661397|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661398|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
43661399|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661400|NCT02923791|Lenograstim|lenograstim|mesh-list
43661401|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43608934|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608935|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
43608936|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608937|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608938|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43608939|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43608940|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43661402|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
43661403|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825730|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825731|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
43825732|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825733|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825734|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43825735|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
43825736|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825737|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825738|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43825739|NCT05243862|Atezolizumab|atezolizumab|mesh-list
43825740|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608941|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43608943|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43608944|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43608945|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608946|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43608947|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
43608948|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43608949|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825742|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825743|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846675|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43652693|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846676|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43851395|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849307|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849308|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849309|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43849312|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43846677|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846680|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846681|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846682|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846683|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846684|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
43846685|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43846686|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652694|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652695|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851396|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43846687|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846688|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43824423|NCT05512520|Capecitabine|capecitabine|mesh-list
43849316|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846689|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43846690|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
43846691|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43824728|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43774309|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43774310|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43774311|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846692|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846693|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
43846694|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
43846695|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846696|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846697|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43846698|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
43846699|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846701|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
43846702|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846703|NCT04182555|Protective Agents|protective agents|mesh-ancestor
43846704|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609045|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609047|NCT03192644|Cisplatin|cisplatin|mesh-list
43609048|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
43609049|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
43609050|NCT03192644|Epirubicin|epirubicin|mesh-list
43609051|NCT03192644|Calcium|calcium|mesh-list
43609052|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
43609053|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609054|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43609055|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609056|NCT03192644|Antidotes|antidotes|mesh-ancestor
43609057|NCT03192644|Protective Agents|protective agents|mesh-ancestor
43609058|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
43609059|NCT03192644|Vitamins|vitamins|mesh-ancestor
43609060|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
43851397|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43851398|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
43846705|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
43846706|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846707|NCT04177810|Plerixafor|plerixafor|mesh-list
43846708|NCT04177810|Cemiplimab|cemiplimab|mesh-list
43846709|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43846710|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43846711|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
43846712|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846713|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846714|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846715|NCT04177498|ON 01910|on 01910|mesh-list
43609065|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609066|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43609067|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
43609068|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43609069|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
43609070|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43609071|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609072|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43609092|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609093|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609094|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
43609095|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609097|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
43609098|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609099|NCT03192111|Entinostat|entinostat|mesh-list
43609100|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846716|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846717|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846718|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661405|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43661406|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661407|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661408|NCT02923687|Analgesics|analgesics|mesh-ancestor
43661409|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
43661415|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661416|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661417|NCT02923557|Pirarubicin|pirarubicin|mesh-list
43661418|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661419|NCT02923583|Abatacept|abatacept|mesh-list
43661420|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43661421|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661422|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661423|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661424|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
43661425|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661426|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661427|NCT02923388|Vitamins|vitamins|mesh-list
43661428|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
43661429|NCT02923388|Pyridoxine|pyridoxine|mesh-list
43661430|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
43661431|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
43661432|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
43661433|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609107|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609108|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609109|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43661434|NCT02923258|Docetaxel|docetaxel|mesh-list
43661435|NCT02923258|Cisplatin|cisplatin|mesh-list
43661436|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661437|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661438|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661439|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661440|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661442|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43661443|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661444|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661445|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774312|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562910|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661446|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661447|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661448|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661450|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
43661484|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661485|NCT02922712|Nimesulide|nimesulide|mesh-list
43661486|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661487|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661488|NCT02922712|Analgesics|analgesics|mesh-ancestor
43649710|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649712|NCT03019198|Coagulants|coagulants|mesh-ancestor
43649713|NCT03018821|Tenofovir|tenofovir|mesh-list
43649714|NCT03018821|Entecavir|entecavir|mesh-list
43649715|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
43649716|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649717|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43609126|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609127|NCT03192059|Aspirin|aspirin|mesh-list
43609146|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43609147|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609148|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609149|NCT03192059|Analgesics|analgesics|mesh-ancestor
43609150|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
43609151|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609152|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609153|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43609154|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43609155|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43609156|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609157|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609158|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
43609159|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43609160|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609161|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43609162|NCT03192033|Hemostatics|hemostatics|mesh-list
43609163|NCT03192033|Coagulants|coagulants|mesh-ancestor
43609169|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609170|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609171|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43849320|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43609172|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
43609173|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609174|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609175|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43609176|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609177|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43609178|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43609180|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
43609181|NCT03191903|Triamcinolone|triamcinolone|mesh-list
43774313|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774314|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43774315|NCT02353182|Narcotics|narcotics|mesh-ancestor
43774316|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43774317|NCT02353507|Laxatives|laxatives|mesh-ancestor
43774318|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774319|NCT02353429|Toremifene|toremifene|mesh-list
43774320|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43609182|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43609183|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43609184|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43609203|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
43609204|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609205|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43609206|NCT03191539|Apremilast|apremilast|mesh-list
43609207|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609208|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609209|NCT03191539|Analgesics|analgesics|mesh-ancestor
43661489|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
43661490|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661491|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661492|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661493|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661494|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43661495|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661496|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661497|NCT02922699|Omeprazole|omeprazole|mesh-list
43661498|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43661499|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43661500|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43661501|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661502|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661503|NCT02922673|Aspirin|aspirin|mesh-list
43661504|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661505|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661514|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661516|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43661517|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661518|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
43661519|NCT02922660|Remifentanil|remifentanil|mesh-list
43661520|NCT02922660|Anesthetics|anesthetics|mesh-list
43661521|NCT02922660|Propofol|propofol|mesh-list
43661522|NCT02922660|Desflurane|desflurane|mesh-list
43661523|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774321|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774322|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43774323|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43774324|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774325|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774326|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774327|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43774328|NCT02353130|Memantine|memantine|mesh-list
43774329|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43774330|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43774365|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661524|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661525|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43661526|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43661527|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
43661528|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43661529|NCT02922660|Narcotics|narcotics|mesh-ancestor
43661530|NCT02922660|Analgesics|analgesics|mesh-ancestor
43661531|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
43661532|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661533|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43661534|NCT02922465|Clopidogrel|clopidogrel|mesh-list
43661535|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43661536|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43661537|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43661538|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43661539|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
43661540|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774366|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774367|NCT02352714|Lidocaine|lidocaine|mesh-list
43774368|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774369|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
43774370|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774371|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774372|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
43774398|NCT02352597|Hormones|hormones|mesh-ancestor
43774399|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830224|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43830225|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43698711|NCT02743975|Bevacizumab|bevacizumab|mesh-list
43698712|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698713|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698714|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43698715|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43698716|NCT02743975|Growth Substances|growth substances|mesh-ancestor
43698717|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698718|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43698719|NCT02743663|Albuterol|albuterol|mesh-list
43698720|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
43698721|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
43698722|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698723|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698724|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43698725|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
43609239|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
43609240|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609260|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
43609261|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43609262|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609263|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609264|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609265|NCT03190603|Celecoxib|celecoxib|mesh-list
43609266|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609267|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609268|NCT03190603|Analgesics|analgesics|mesh-ancestor
43661543|NCT02922426|Olanzapine|olanzapine|mesh-list
43661544|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
43661545|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
43774400|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774401|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43774402|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
43774403|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43774404|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43774405|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43774406|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774407|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43774408|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
43774409|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43774410|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43774411|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43774412|NCT02352519|Anesthetics|anesthetics|mesh-list
43774413|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
43698726|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
43698727|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698728|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43698729|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43698730|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43698731|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
43698732|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698733|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698734|NCT02743572|Iron|iron|mesh-list
43698735|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43698736|NCT02743572|Trace Elements|trace elements|mesh-ancestor
43698737|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
43698738|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698739|NCT02743572|Hematinics|hematinics|mesh-ancestor
43698740|NCT02743260|Metformin|metformin|mesh-list
43661546|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661547|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661548|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43661549|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43661550|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43851407|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851408|NCT04120766|Nicorandil|nicorandil|mesh-list
43661559|NCT02922491|Vitamin E|vitamin e|mesh-list
43661560|NCT02922491|Vitamins|vitamins|mesh-ancestor
43661561|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
43661562|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661563|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
43661564|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661565|NCT02922491|Protective Agents|protective agents|mesh-ancestor
43661566|NCT02922179|Insulin|insulin|mesh-list
43661567|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
43661568|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661569|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609280|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43609282|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
43609283|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43609285|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661581|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661582|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43661583|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
43661584|NCT02922166|SRX246|srx246|mesh-list
43661585|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43661586|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661587|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
43661588|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661589|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43661590|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43661591|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43661592|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
43661593|NCT02922348|Norgestimate|norgestimate|mesh-list
43661594|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
43661595|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
43661596|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43661597|NCT02922348|Hormones|hormones|mesh-list
43661598|NCT02922348|Estradiol|estradiol|mesh-list
43661599|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43609287|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
43609288|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609289|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609290|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609291|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
43609292|NCT03190642|Hormones|hormones|mesh-ancestor
43609293|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851409|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43851410|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661601|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661602|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661603|NCT02922348|Estrogens|estrogens|mesh-ancestor
43661604|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43661605|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661606|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43661607|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43661608|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43661609|NCT02922387|Varenicline|varenicline|mesh-list
43661610|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43661611|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43661612|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
43661613|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661614|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661615|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661616|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
43661617|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
43661618|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
43661619|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43609313|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609314|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609315|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43609317|NCT03189953|Hormones|hormones|mesh-ancestor
43609318|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609319|NCT03190239|Pemetrexed|pemetrexed|mesh-list
43609320|NCT03190239|Apatinib|apatinib|mesh-list
43609321|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609322|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609323|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609324|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43609325|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43609326|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43609327|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43609328|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609330|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43609331|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609332|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
43609333|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609334|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609335|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
43609336|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609337|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
43609338|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
43609339|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
43609345|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609346|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609347|NCT03189901|Protective Agents|protective agents|mesh-ancestor
43609348|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609349|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
43609350|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
43609351|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609352|NCT03189732|Metformin|metformin|mesh-list
43609353|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609354|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609355|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
43609356|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43609357|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
43609393|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43609394|NCT03188835|Protective Agents|protective agents|mesh-ancestor
43609395|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609396|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
43609397|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
43609398|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43609428|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609429|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609430|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609432|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43609433|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609434|NCT03188198|Prednisone|prednisone|mesh-list
43609435|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
43851411|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
43851412|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
43851413|NCT04120766|Vitamins|vitamins|mesh-ancestor
43851414|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
43851415|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661636|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
43661637|NCT02921659|Vitamins|vitamins|mesh-ancestor
43661638|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
43661639|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825744|NCT05095116|Fluticasone|fluticasone|mesh-list
43825746|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825747|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43698778|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
43825748|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
43698779|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43825749|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825750|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825751|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43825752|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825753|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
43609436|NCT03188198|Rituximab|rituximab|mesh-list
43609437|NCT03188198|Doxorubicin|doxorubicin|mesh-list
43609438|NCT03188198|Etoposide|etoposide|mesh-list
43609439|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
43609440|NCT03188198|Vincristine|vincristine|mesh-list
43609441|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609442|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
43609443|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609444|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609484|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609485|NCT03188159|Vinorelbine|vinorelbine|mesh-list
43609486|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43609487|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609488|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
43609489|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
43825754|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43825755|NCT05093959|Metformin|metformin|mesh-list
43825756|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43825757|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825758|NCT05092373|Paclitaxel|paclitaxel|mesh-list
43825759|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43825760|NCT05092373|Atezolizumab|atezolizumab|mesh-list
43825761|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43825762|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43825763|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825764|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
43825765|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
43825766|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
43825767|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825768|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
43825769|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825770|NCT05076682|Efavirenz|efavirenz|mesh-list
43825771|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
43825772|NCT05076682|Choline|choline|mesh-list
43825773|NCT05076682|Antibodies|antibodies|mesh-list
43825774|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
43825775|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661654|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
43661655|NCT02921282|Dopamine|dopamine|mesh-list
43661656|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43661657|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
43661658|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
43661659|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661660|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661661|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
43774414|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774415|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774416|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
43774417|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774418|NCT02352701|Amoxicillin|amoxicillin|mesh-list
43774419|NCT02352701|Levofloxacin|levofloxacin|mesh-list
43838740|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
43838741|NCT04824092|Rituximab|rituximab|mesh-list
43661662|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661663|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661691|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43661692|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43661693|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
43661694|NCT02921165|Aspirin|aspirin|mesh-list
43661695|NCT02921165|Analgesics|analgesics|mesh-list
43661699|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661700|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661701|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661702|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661703|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43661704|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43661705|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825788|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
43661710|NCT02920931|Tenofovir|tenofovir|mesh-list
43661732|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
43661733|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661734|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661735|NCT02920905|Lidocaine|lidocaine|mesh-list
43661736|NCT02920905|Atracurium|atracurium|mesh-list
43661751|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43661752|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43661753|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
43661754|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661759|NCT02920515|Leuprolide|leuprolide|mesh-list
43661775|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
43661776|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43661777|NCT02920593|Vitamin D|vitamin d|mesh-list
43661778|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
43661779|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
43609619|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43609644|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43609645|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609646|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43609648|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
43609649|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43609651|NCT03186664|Analgesics|analgesics|mesh-ancestor
43609652|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
43609653|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838742|NCT04824092|Doxorubicin|doxorubicin|mesh-list
43609654|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609655|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
43661780|NCT02920593|Vitamins|vitamins|mesh-list
43661781|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
43661782|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661783|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43661784|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661785|NCT02920658|Betamethasone|betamethasone|mesh-list
43661786|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
43661787|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43661788|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
43661789|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43661790|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661791|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
43609662|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43609663|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43609664|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43609665|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43609666|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609667|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
43609668|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609669|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609670|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43649767|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
43649770|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43649771|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
43649772|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43649773|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
43649774|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649775|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649776|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43649777|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
43609671|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609672|NCT03186482|Rifampin|rifampin|mesh-list
43609687|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43609688|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
43609689|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43609690|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43661792|NCT02920658|Hormones|hormones|mesh-ancestor
43661793|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43661794|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661795|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43661796|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
43661797|NCT02920359|Leuprolide|leuprolide|mesh-list
43661798|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43661799|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
43562913|NCT01359566|Baclofen|baclofen|mesh-list
43609697|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609698|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
43609699|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43609700|NCT03186053|Protective Agents|protective agents|mesh-ancestor
43661800|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661801|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851436|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851437|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851438|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851442|NCT04040452|Ketorolac|ketorolac|mesh-list
43851443|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661802|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43661803|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661804|NCT02920489|Sufentanil|sufentanil|mesh-list
43661805|NCT02920489|Dsuvia|dsuvia|mesh-list
43661806|NCT02920489|Ropivacaine|ropivacaine|mesh-list
43661807|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
43661808|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
43661809|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661810|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661811|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
43661812|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661813|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43661814|NCT02920489|Narcotics|narcotics|mesh-ancestor
43661815|NCT02920489|Analgesics|analgesics|mesh-ancestor
43661816|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43661817|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43661840|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661841|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661844|NCT02920190|Liraglutide|liraglutide|mesh-list
43609794|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609795|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
43609796|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43609797|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43609798|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609799|NCT03185364|Urological Agents|urological agents|mesh-ancestor
43609800|NCT03185403|Sufentanil|sufentanil|mesh-list
43609801|NCT03185403|Ropivacaine|ropivacaine|mesh-list
43661850|NCT02920060|Levetiracetam|levetiracetam|mesh-list
43661851|NCT02920060|Valproic Acid|valproic acid|mesh-list
43661852|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
43661853|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
43661854|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661855|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661856|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
43661859|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
43661860|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43661861|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661862|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43661863|NCT02919878|Gemcitabine|gemcitabine|mesh-list
43661864|NCT02919878|Capecitabine|capecitabine|mesh-list
43661865|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43661866|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
43661867|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661868|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661869|NCT02919878|Antiviral Agents|antiviral agents|mesh-ancestor
43661870|NCT02919878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661871|NCT02919878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661872|NCT02919878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661873|NCT02919878|Immunologic Factors|immunologic factors|mesh-ancestor
43661874|NCT02919878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661875|NCT02919605|Pentamidine|pentamidine|mesh-list
43661876|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
43609841|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609842|NCT03185156|Propofol|propofol|mesh-list
43609843|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43609844|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609845|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609846|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43609847|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
43609848|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
43609849|NCT03184844|Thalidomide|thalidomide|mesh-list
43609850|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43609851|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
43609852|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609853|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
43609854|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661892|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661893|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661894|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
43661895|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43698832|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
43661896|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43661897|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43661898|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43661900|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
43661901|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43851453|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851454|NCT04027894|Rifamycins|rifamycins|mesh-list
43851455|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
43851456|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43851457|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851458|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851459|NCT04026984|Rifamycins|rifamycins|mesh-list
43851460|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
43609888|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
43609889|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609890|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
43609891|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
43609892|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43609893|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43609894|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
43609895|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
43609896|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661902|NCT02919462|Cisplatin|cisplatin|mesh-list
43661903|NCT02919462|Pemetrexed|pemetrexed|mesh-list
43661904|NCT02919462|Vinorelbine|vinorelbine|mesh-list
43661905|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661906|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661907|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661908|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43661909|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43661910|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43661911|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661912|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661913|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661914|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
43661915|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43661916|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43661917|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851461|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43851462|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851463|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851464|NCT04022096|Lansoprazole|lansoprazole|mesh-list
43851465|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
43851466|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43851467|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43851468|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43851469|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609903|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43609904|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43609905|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
43851470|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851471|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43661918|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
43661919|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
43661920|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661922|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
43661923|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661924|NCT02919371|Bevacizumab|bevacizumab|mesh-list
43661925|NCT02919371|Sunitinib|sunitinib|mesh-list
43661926|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43661927|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661928|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43661929|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43661930|NCT02919371|Growth Substances|growth substances|mesh-ancestor
43661931|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661932|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
43661933|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43661934|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661935|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661936|NCT02919202|Listerine|listerine|mesh-list
43661937|NCT02919202|Fluorides|fluorides|mesh-list
43661938|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
43661939|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
43661940|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
43661941|NCT02919202|Protective Agents|protective agents|mesh-ancestor
43661942|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609938|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609939|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43609941|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609942|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609943|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43609944|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
43609945|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
43609946|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43609947|NCT03184493|Metformin|metformin|mesh-list
43609948|NCT03184493|Celecoxib|celecoxib|mesh-list
43609949|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43609950|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609951|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43609974|NCT03184766|Ephedrine|ephedrine|mesh-list
43609975|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43649781|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649782|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43649783|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
43851472|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
43851473|NCT03989466|Antibodies|antibodies|mesh-list
43851474|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
43661943|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43661944|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661945|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
43661946|NCT02919345|Glyburide|glyburide|mesh-list
43661947|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43661948|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661949|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661950|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661951|NCT02919449|Atezolizumab|atezolizumab|mesh-list
43661952|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661953|NCT02919176|Pioglitazone|pioglitazone|mesh-list
43661954|NCT02919176|Mirabegron|mirabegron|mesh-list
43661955|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43649789|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649790|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43649792|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43649793|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
43649794|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43609976|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43609977|NCT03184766|Analgesics|analgesics|mesh-ancestor
43609978|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
43609979|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609980|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43609981|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609982|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43609983|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609984|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609985|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609986|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43609987|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
43609988|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43609989|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
43609990|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
43609991|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43609992|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43609993|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
43609994|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830239|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
43830240|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661956|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661957|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43661958|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43661959|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43661960|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43661961|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610000|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610001|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610002|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
43610016|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43610017|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610019|NCT03183843|Dabigatran|dabigatran|mesh-list
43661962|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661963|NCT02919176|Urological Agents|urological agents|mesh-ancestor
43661964|NCT02919072|Ropivacaine|ropivacaine|mesh-list
43661965|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
43661966|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
43661967|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
43661968|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661969|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851475|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851476|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
43851477|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661970|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
43661971|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661972|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
43661973|NCT02919059|Glimepiride|glimepiride|mesh-list
43661974|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43661975|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661976|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661977|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661978|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661979|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661980|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
43661981|NCT02918812|Diclofenac|diclofenac|mesh-list
43661982|NCT02918812|Lidocaine|lidocaine|mesh-list
43661983|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610025|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610026|NCT03183674|Oxytocin|oxytocin|mesh-list
43610027|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
43661984|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
43661985|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661986|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661987|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
43661988|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661989|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43661990|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43661991|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43661992|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661993|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661994|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661995|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610034|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
43610035|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851478|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851479|NCT03975647|Tucatinib|tucatinib|mesh-list
43851480|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851481|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851482|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851483|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830269|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830270|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661996|NCT02918812|Analgesics|analgesics|mesh-ancestor
43661997|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43661998|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661999|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43662000|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662001|NCT02918825|Olanzapine|olanzapine|mesh-list
43662002|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43662003|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
43662004|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
43662005|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662006|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662007|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662008|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43662009|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43649799|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649801|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43649802|NCT03018756|Narcotics|narcotics|mesh-ancestor
43649803|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649804|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649805|NCT03018756|Analgesics|analgesics|mesh-ancestor
43649806|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
43649807|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649808|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649809|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649810|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
43610036|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610037|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610038|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
43610039|NCT03183596|Hormones|hormones|mesh-ancestor
43610040|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610041|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43610042|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610043|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610044|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
43610045|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610046|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
43610047|NCT03183557|Vitamin D|vitamin d|mesh-list
43610048|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
43610049|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
43610050|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43610051|NCT03183557|Vitamins|vitamins|mesh-ancestor
43610052|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
43610053|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610054|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43610055|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
43610056|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610057|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
43610058|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610059|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610060|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43610061|NCT03183297|Fexofenadine|fexofenadine|mesh-list
43610062|NCT03183297|Naproxen|naproxen|mesh-list
43610063|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610064|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43610065|NCT03183297|Analgesics|analgesics|mesh-ancestor
43662010|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662011|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662012|NCT02918825|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43662013|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43662014|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662023|NCT02918760|Gabapentin|gabapentin|mesh-list
43610067|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610068|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610102|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
43610103|NCT03182894|Azacitidine|azacitidine|mesh-list
43610104|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43649811|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
43649812|NCT03018444|Atorvastatin|atorvastatin|mesh-list
43649813|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43649814|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43649815|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
43610105|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610106|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610107|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
43610108|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610128|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43610129|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610130|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838751|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838752|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838753|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43774440|NCT02352285|Tolvaptan|tolvaptan|mesh-list
43774441|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43774442|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774443|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
43774468|NCT02351973|Amiloride|amiloride|mesh-list
43774469|NCT02351973|Diuretics|diuretics|mesh-ancestor
43774470|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
43774471|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699058|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43699059|NCT02741414|Renal Agents|renal agents|mesh-ancestor
43699060|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43699061|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699062|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699063|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43699064|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43699065|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43699066|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43699067|NCT02741219|Sufentanil|sufentanil|mesh-list
43699068|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
43699070|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43699071|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699072|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610131|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610132|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43610133|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43610134|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43662027|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662029|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43662030|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43662031|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662032|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662033|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43610142|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610143|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610144|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
43610146|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43610147|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610148|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43610149|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43610150|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43610151|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610152|NCT03182504|Meropenem|meropenem|mesh-list
43662034|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43662035|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662036|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662037|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
43662038|NCT02918747|Gemcitabine|gemcitabine|mesh-list
43662039|NCT02918747|Dexamethasone|dexamethasone|mesh-list
43662040|NCT02918747|Prednisone|prednisone|mesh-list
43662041|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
43662042|NCT02918747|Doxorubicin|doxorubicin|mesh-list
43662043|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
43662044|NCT02918747|Vincristine|vincristine|mesh-list
43662045|NCT02918747|Pegaspargase|pegaspargase|mesh-list
43662046|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662047|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
43662048|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662049|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662050|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43662051|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
43662052|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662053|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662056|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
43662076|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43662080|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43662081|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662082|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662083|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662084|NCT02918331|Dexamethasone|dexamethasone|mesh-list
43662085|NCT02918331|Lenalidomide|lenalidomide|mesh-list
43662086|NCT02918331|Daratumumab|daratumumab|mesh-list
43662087|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662088|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
43662089|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
43662090|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662091|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662094|NCT02918331|Hormones|hormones|mesh-ancestor
43610188|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
43610189|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610190|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610191|NCT03182088|Norepinephrine|norepinephrine|mesh-list
43610192|NCT03182088|Bupivacaine|bupivacaine|mesh-list
43662095|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662096|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662097|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662098|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
43662099|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43662100|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43662101|NCT02918331|Growth Substances|growth substances|mesh-ancestor
43662102|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
43662103|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
43662104|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
43662105|NCT02918045|Coagulants|coagulants|mesh-ancestor
43662106|NCT02918136|Cortisone|cortisone|mesh-list
43662107|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610199|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43610200|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43610201|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
43610202|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610203|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610204|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
43610205|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
43610206|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43610207|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
43610208|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43610209|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
43662109|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43662110|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
43662111|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43774485|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43662112|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662113|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43662114|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662115|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
43662116|NCT02917889|Caffeine|caffeine|mesh-list
43649825|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649826|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43649827|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43649829|NCT03018171|Sufentanil|sufentanil|mesh-list
43649830|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43649831|NCT03018171|Narcotics|narcotics|mesh-ancestor
43610210|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43610211|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610212|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43610213|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43610247|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
43610248|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43610249|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
43610250|NCT03181685|Cetrorelix|cetrorelix|mesh-list
43610251|NCT03181685|Progesterone|progesterone|mesh-list
43610252|NCT03181685|Progestins|progestins|mesh-ancestor
43610266|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849345|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43610267|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43610268|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43610269|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43610270|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43610271|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610285|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610286|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610288|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649832|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649833|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649834|NCT03018171|Analgesics|analgesics|mesh-ancestor
43649835|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
43649836|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649837|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43649843|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
43649844|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43649845|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43649846|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43649847|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662121|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662122|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43662123|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43662124|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
43662125|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662126|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
43662127|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43662128|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43562914|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43610290|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
43610291|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610292|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43610293|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43610294|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43610295|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610296|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43610298|NCT03181178|Trace Elements|trace elements|mesh-list
43662129|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662131|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662132|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662133|NCT02917746|Imiquimod|imiquimod|mesh-list
43662134|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43662135|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
43662136|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662137|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662138|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
43825796|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43825797|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825798|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
43662139|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43662140|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43662141|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662142|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
43662143|NCT02917512|Cyclosporine|cyclosporine|mesh-list
43662144|NCT02917512|Cyclosporins|cyclosporins|mesh-list
43662145|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662148|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
43662149|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662150|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
43662151|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662152|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
43662153|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662154|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43662157|NCT02917525|Vitamins|vitamins|mesh-ancestor
43662158|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
43662159|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662160|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43662161|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43662162|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662163|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
43610341|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849348|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
43849349|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849350|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849351|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
43849352|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43849353|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43662164|NCT02917525|Coagulants|coagulants|mesh-ancestor
43662165|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
43662166|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662167|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662168|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662169|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43662170|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662171|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662172|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662173|NCT02917005|Palbociclib|palbociclib|mesh-list
43662174|NCT02917005|Exemestane|exemestane|mesh-list
43662175|NCT02917005|Goserelin|goserelin|mesh-list
43662176|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662177|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43662178|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662179|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662180|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43662181|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43662182|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43662183|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662184|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662185|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662186|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662187|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
43649849|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649850|NCT03018301|Ketamine|ketamine|mesh-list
43649851|NCT03018301|Analgesics|analgesics|mesh-ancestor
43649852|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
43649853|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610344|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610345|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
43610346|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43610347|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
43610376|NCT03180593|Valsartan|valsartan|mesh-list
43610377|NCT03180593|Nebivolol|nebivolol|mesh-list
43610378|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43610379|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43610380|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43610381|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610382|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
43610383|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43610384|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43610385|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43610386|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662188|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43662189|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662190|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662191|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662192|NCT02917018|Analgesics|analgesics|mesh-ancestor
43662193|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
43662194|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662195|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43662196|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43662197|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43662198|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662199|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662200|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662201|NCT02917057|Exenatide|exenatide|mesh-list
43662202|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662203|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662204|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43610392|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610393|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610394|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610412|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610413|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43610414|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43610415|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43610416|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43610417|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610421|NCT03180125|Protective Agents|protective agents|mesh-ancestor
43662206|NCT02917057|Hormones|hormones|mesh-ancestor
43662207|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662208|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43662209|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662210|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
43662211|NCT02916940|Hormones|hormones|mesh-ancestor
43825799|NCT05068791|Psilocybin|psilocybin|mesh-list
43662212|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662213|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662214|NCT02916654|Iron|iron|mesh-list
43662215|NCT02916654|Trace Elements|trace elements|mesh-ancestor
43662216|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
43662217|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662218|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43662219|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662220|NCT02916420|Dexamethasone|dexamethasone|mesh-list
43662221|NCT02916420|Pomalidomide|pomalidomide|mesh-list
43662222|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610428|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610429|NCT03180281|Incretins|incretins|mesh-ancestor
43651656|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662223|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
43662224|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
43662225|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662226|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662227|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662228|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
43662229|NCT02916420|Hormones|hormones|mesh-ancestor
43662230|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662231|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662232|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662233|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
43662234|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43662235|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43662236|NCT02916420|Growth Substances|growth substances|mesh-ancestor
43662237|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
43662238|NCT02916511|Paclitaxel|paclitaxel|mesh-list
43662239|NCT02916511|Carboplatin|carboplatin|mesh-list
43610432|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43610433|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
43610434|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610435|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610436|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43610437|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662253|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
43662254|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662257|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
43662258|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43662259|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43662260|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662261|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662262|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43610443|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
43610444|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
43610445|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610446|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610447|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610448|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
43662263|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662264|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
43662265|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43662266|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43662267|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43662268|NCT02916602|Diuretics|diuretics|mesh-ancestor
43662269|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
43662270|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43662271|NCT02916381|Anesthetics|anesthetics|mesh-list
43662272|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662273|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662274|NCT02916251|Glucagon|glucagon|mesh-list
43662275|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43662276|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662277|NCT02916251|Hormones|hormones|mesh-ancestor
43699186|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699187|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43699188|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662278|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610480|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43649854|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649855|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43649856|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649857|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
43649858|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
43649859|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649860|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43649861|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43649862|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610481|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43610487|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43610488|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
43610489|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610490|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
43610491|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43610527|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43610528|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
43610529|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610530|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849363|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
43849364|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610552|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
43610553|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662279|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662280|NCT02916251|Incretins|incretins|mesh-ancestor
43662281|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43662282|NCT02916173|Hormones|hormones|mesh-list
43662283|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662284|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662285|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662286|NCT02916238|Fluoxetine|fluoxetine|mesh-list
43662287|NCT02916238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43662288|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43662289|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662290|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662291|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662293|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662294|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43662295|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
43662296|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662297|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43662298|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610555|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610556|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43610557|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610558|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43610559|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
43610561|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610562|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43610563|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610564|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610565|NCT03178721|Calcium|calcium|mesh-list
43610566|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43610567|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610568|NCT03178643|Piperaquine|piperaquine|mesh-list
43610569|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
43610570|NCT03178643|Amodiaquine|amodiaquine|mesh-list
43610571|NCT03178643|Artenimol|artenimol|mesh-list
43610572|NCT03178643|Proguanil|proguanil|mesh-list
43610573|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
43610574|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43610575|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43610576|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610599|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662302|NCT02916160|Valsartan|valsartan|mesh-list
43662303|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43662304|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43662305|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43662306|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43662307|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662309|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
43662310|NCT02916121|Vitamins|vitamins|mesh-ancestor
43662311|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
43774530|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43774531|NCT02351908|Dolutegravir|dolutegravir|mesh-list
43824744|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43824745|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824746|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
43824747|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824748|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
43824749|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824750|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43699230|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
43699231|NCT02739958|Propofol|propofol|mesh-list
43699232|NCT02739958|Isoflurane|isoflurane|mesh-list
43699233|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43699234|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699235|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699236|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43699237|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
43699238|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
43699239|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43830283|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43830284|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43830285|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43830286|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43830287|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830288|NCT05371015|Ropivacaine|ropivacaine|mesh-list
43662312|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662313|NCT02916121|Hematinics|hematinics|mesh-ancestor
43662314|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
43825800|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
43825801|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
43610603|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610604|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43610605|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43610606|NCT03178422|Nicotine|nicotine|mesh-list
43610607|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43610608|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
43610609|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610610|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610611|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43649863|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649865|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
43649866|NCT03018236|Cocaine|cocaine|mesh-list
43825802|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43825803|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43825804|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825805|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825806|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825807|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
43825808|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825809|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
43851505|NCT03871361|Abatacept|abatacept|mesh-list
43851506|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43825810|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
43825811|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43825812|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43825813|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825814|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825815|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825816|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825817|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
43825818|NCT04947553|Bupropion|bupropion|mesh-list
43825819|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43825820|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
43825821|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825822|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43825823|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43825824|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43825825|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825826|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
43825827|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825828|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825829|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43825830|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43825831|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825832|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
43825833|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825834|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43649867|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43649868|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43610612|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43610613|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
43830290|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
43610614|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43610615|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610616|NCT03178396|Melatonin|melatonin|mesh-list
43610617|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
43610618|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610619|NCT03178396|Protective Agents|protective agents|mesh-ancestor
43610620|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610621|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610622|NCT03178409|Liver Extracts|liver extracts|mesh-list
43610623|NCT03178409|Hematinics|hematinics|mesh-ancestor
43610624|NCT03178539|Diclofenac|diclofenac|mesh-list
43851507|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662322|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
43662323|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43662324|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43662326|NCT02915731|Vitamins|vitamins|mesh-ancestor
43662327|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
43662328|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662329|NCT02915666|Trametinib|trametinib|mesh-list
43662330|NCT02915666|Dabrafenib|dabrafenib|mesh-list
43662331|NCT02915666|Digoxin|digoxin|mesh-list
43662332|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662333|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43662334|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662335|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662336|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43662337|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43662338|NCT02915666|Protective Agents|protective agents|mesh-ancestor
43662339|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662340|NCT02915809|Vaccines|vaccines|mesh-list
43662341|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
43662342|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662343|NCT02915796|Lenograstim|lenograstim|mesh-list
43662344|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43662345|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
43662346|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662347|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
43662348|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662349|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662350|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
43662372|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43662373|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662375|NCT02915172|Lenvatinib|lenvatinib|mesh-list
43662376|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43662377|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
43662378|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662379|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662380|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43662381|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662382|NCT02915055|Acetaminophen|acetaminophen|mesh-list
43662383|NCT02915055|Ibuprofen|ibuprofen|mesh-list
43662384|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43662386|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662388|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
43662389|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662390|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662391|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
43662392|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610701|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43610702|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610703|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610704|NCT03177837|Diuretics|diuretics|mesh-ancestor
43610705|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
43610706|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610707|NCT03177811|Acetazolamide|acetazolamide|mesh-list
43610708|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
43610709|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43610710|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610711|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610712|NCT03177811|Diuretics|diuretics|mesh-ancestor
43610713|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
43610714|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610717|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43610718|NCT03177980|Narcotics|narcotics|mesh-ancestor
43610719|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610720|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610721|NCT03177980|Analgesics|analgesics|mesh-ancestor
43610722|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
43610736|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610737|NCT03177850|Acetazolamide|acetazolamide|mesh-list
43610738|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
43610739|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43610740|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662396|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825844|NCT04916613|Hormones|hormones|mesh-ancestor
43662397|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662398|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662399|NCT02915055|Narcotics|narcotics|mesh-ancestor
43662400|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662401|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
43662402|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43662403|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662404|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610741|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610743|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
43649870|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649871|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649872|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
43649873|NCT03018236|Expectorants|expectorants|mesh-ancestor
43649874|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
43649875|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43649876|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
43649877|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649878|NCT03018236|Protective Agents|protective agents|mesh-ancestor
43649879|NCT03018236|Antidotes|antidotes|mesh-ancestor
43649880|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
43649881|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
43610744|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610745|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
43610746|NCT03177720|Imipenem|imipenem|mesh-list
43610747|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43610748|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610749|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43610750|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43610751|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43610752|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610753|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610754|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43651657|NCT03005639|Vemurafenib|vemurafenib|mesh-list
43662417|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662418|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662419|NCT02914652|Albuterol|albuterol|mesh-list
43662420|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43662421|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
43662422|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662423|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610759|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610761|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43610762|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
43610763|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43610764|NCT03177434|Lactulose|lactulose|mesh-list
43610765|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610766|NCT03177174|Cisplatin|cisplatin|mesh-list
43610767|NCT03177174|Docetaxel|docetaxel|mesh-list
43610768|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610769|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
43610770|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
43662424|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43662425|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
43662426|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
43662427|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662428|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43662429|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43662430|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43662431|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662432|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662433|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662434|NCT02914678|Fentanyl|fentanyl|mesh-list
43662435|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662436|NCT02914678|Narcotics|narcotics|mesh-ancestor
43662437|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662438|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662439|NCT02914678|Analgesics|analgesics|mesh-ancestor
43662440|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
43662441|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851512|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662442|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43662443|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43662446|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43662447|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43662448|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43662449|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43662450|NCT02914626|Ranibizumab|ranibizumab|mesh-list
43662451|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43662452|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43662453|NCT02914626|Growth Substances|growth substances|mesh-ancestor
43662454|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662455|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
43662456|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662467|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662468|NCT02914054|Dexamethasone|dexamethasone|mesh-list
43662469|NCT02914054|Prednisone|prednisone|mesh-list
43662470|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662471|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
43662472|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
43848944|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
43662473|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662474|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662475|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43610772|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610774|NCT03177252|Bupivacaine|bupivacaine|mesh-list
43610775|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
43610776|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
43610777|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610778|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610779|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
43610780|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610781|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43610782|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43610783|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43610784|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662496|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
43662497|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662498|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662499|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
43662500|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662501|NCT02914028|Narcotics|narcotics|mesh-ancestor
43662502|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662503|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
43662504|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662505|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662506|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825845|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825846|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825848|NCT04904562|Giapreza|giapreza|mesh-list
43825849|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
43825850|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43825851|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43825852|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
43825853|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825854|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825855|NCT04740099|Naloxone|naloxone|mesh-list
43825856|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43825870|NCT04596579|Antibodies|antibodies|mesh-list
43610818|NCT03177083|Interferon-beta|interferon-beta|mesh-list
43649882|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
43649883|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649884|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43649885|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43649886|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43649887|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43649888|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
43649889|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649891|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43610819|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
43610820|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
43610821|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610822|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
43610823|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43610824|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
43610825|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825874|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
43825875|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825876|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825877|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825878|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825879|NCT04542304|Metolazone|metolazone|mesh-list
43825880|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43825881|NCT04542304|Diuretics|diuretics|mesh-ancestor
43825882|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
43825883|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825884|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43825885|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43825886|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662507|NCT02913768|Ondansetron|ondansetron|mesh-list
43699307|NCT02739477|Favipiravir|favipiravir|mesh-list
43699308|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
43699309|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662508|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
43662509|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
43662510|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662511|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610827|NCT03176758|Anesthetics|anesthetics|mesh-list
43610828|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
43610829|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610830|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610831|NCT03176693|Doxazosin|doxazosin|mesh-list
43610832|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
43610833|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43610857|NCT03176264|Bevacizumab|bevacizumab|mesh-list
43610858|NCT03176264|Spartalizumab|spartalizumab|mesh-list
43610859|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43610860|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610861|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43610862|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43610863|NCT03176264|Growth Substances|growth substances|mesh-ancestor
43610864|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610865|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
43610866|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43610867|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610868|NCT03176563|Fosfomycin|fosfomycin|mesh-list
43610869|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662516|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
43662517|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662518|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662519|NCT02913768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43662520|NCT02913768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43662521|NCT02913768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662522|NCT02913768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662523|NCT02913768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43662524|NCT02913417|Nivolumab|nivolumab|mesh-list
43662525|NCT02913417|Ipilimumab|ipilimumab|mesh-list
43662526|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43662528|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43662529|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662530|NCT02913573|Bupivacaine|bupivacaine|mesh-list
43662531|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
43662532|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
43662533|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662534|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662535|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
43662536|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610872|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43610873|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610874|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
43610875|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610876|NCT03176446|Anesthetics|anesthetics|mesh-list
43610877|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
43610878|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43610879|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610880|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
43610881|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610882|NCT03176537|Testosterone|testosterone|mesh-list
43610883|NCT03176537|Androgens|androgens|mesh-ancestor
43610912|NCT03175939|Fluorouracil|fluorouracil|mesh-list
43610913|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43610914|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
43824751|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43824752|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43824753|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774532|NCT02351908|Cobicistat|cobicistat|mesh-list
43774534|NCT02351908|Elvitegravir|elvitegravir|mesh-list
43774535|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
43610915|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43610916|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610917|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43610918|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
43610919|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610920|NCT03175926|Budesonide|budesonide|mesh-list
43610921|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610922|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43610923|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
43649892|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662537|NCT02913430|Tamoxifen|tamoxifen|mesh-list
43662538|NCT02913430|Fulvestrant|fulvestrant|mesh-list
43662539|NCT02913430|Palbociclib|palbociclib|mesh-list
43662540|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43662541|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662542|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662543|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662544|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662545|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662546|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43662547|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43662548|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43662549|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43662550|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43662551|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662552|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662554|NCT02913469|Metoclopramide|metoclopramide|mesh-list
43662555|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662556|NCT02913469|Narcotics|narcotics|mesh-ancestor
43649896|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610924|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43610925|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610926|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43662560|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
43662561|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662562|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
43662563|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
43662564|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662565|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43662566|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43662567|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
43662568|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662569|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662570|NCT02913508|Vedolizumab|vedolizumab|mesh-list
43662571|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662572|NCT02913300|Lidocaine|lidocaine|mesh-list
43662573|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43662574|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
43662575|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
43662598|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662599|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662601|NCT02913118|Azithromycin|azithromycin|mesh-list
43662602|NCT02913118|Doxycycline|doxycycline|mesh-list
43662603|NCT02913118|Minocycline|minocycline|mesh-list
43662604|NCT02913118|Cephalosporins|cephalosporins|mesh-list
43662605|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
43662607|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662608|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
43662609|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43662610|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43662611|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43662612|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662613|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774653|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774654|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43774655|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43610968|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
43610969|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43610970|NCT03175666|Antidotes|antidotes|mesh-ancestor
43610971|NCT03175666|Protective Agents|protective agents|mesh-ancestor
43610972|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
43611039|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43611040|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43611041|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611042|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611043|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611045|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43662617|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
43662618|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662619|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
43662620|NCT02912663|Verapamil|verapamil|mesh-list
43662621|NCT02912663|Analgesics|analgesics|mesh-ancestor
43662622|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
43662623|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662624|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662625|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
43611051|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
43611052|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611053|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662626|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662627|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43662629|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43662630|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662631|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662632|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43662633|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
43662634|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662635|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
43662637|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43662638|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
43662639|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
43662640|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662641|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662643|NCT02912910|Nifedipine|nifedipine|mesh-list
43662644|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43662645|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662646|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662647|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43662648|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662649|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
43662675|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
43662676|NCT02912702|Hormones|hormones|mesh-ancestor
43662677|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662678|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662679|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662680|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43825887|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
43662681|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662682|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43662683|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851521|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
43662685|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43662686|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43662687|NCT02912702|Protective Agents|protective agents|mesh-ancestor
43699419|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43662689|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
43662690|NCT02912676|Thioguanine|thioguanine|mesh-list
43662691|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43662692|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
43662693|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662694|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662696|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
43662706|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
43662707|NCT02912494|Hematinics|hematinics|mesh-ancestor
43662708|NCT02912156|Voriconazole|voriconazole|mesh-list
43662709|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
43662710|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662711|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43662712|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43662713|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662714|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662715|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43662716|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662717|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662718|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662724|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662725|NCT02912182|Prednisolone|prednisolone|mesh-list
43662726|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43662727|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
43662728|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43611101|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
43611102|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
43611103|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43611104|NCT03174457|Micafungin|micafungin|mesh-list
43611105|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
43611106|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611107|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
43611108|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43611109|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774656|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43774657|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774658|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774659|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774660|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774661|NCT02351440|Analgesics|analgesics|mesh-ancestor
43774662|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
43774663|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774664|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
43774665|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43774666|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
43774667|NCT02351128|Lanreotide|lanreotide|mesh-list
43662735|NCT02912182|Hormones|hormones|mesh-ancestor
43662736|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662737|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662738|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662739|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662740|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
43662741|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
43662742|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662743|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662744|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43662745|NCT02912182|Protective Agents|protective agents|mesh-ancestor
43662746|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43662747|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825888|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611113|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
43611114|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611115|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611116|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611117|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611118|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
43611119|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825889|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825890|NCT04528004|Niacinamide|niacinamide|mesh-list
43825891|NCT04528004|Niacin|niacin|mesh-list
43851522|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825892|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
43825893|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
43825895|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
43662748|NCT02912247|Adalimumab|adalimumab|mesh-list
43662749|NCT02912247|Antibodies|antibodies|mesh-list
43662750|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43662751|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
43662752|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662753|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662754|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662755|NCT02912234|Clarithromycin|clarithromycin|mesh-list
43662756|NCT02912234|Apixaban|apixaban|mesh-list
43662757|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662758|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662759|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43662760|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851523|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
43611156|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611157|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611159|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
43611160|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611161|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43611162|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43611163|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
43611176|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43611177|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43611178|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43611179|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611180|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43611181|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43611182|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43851524|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662761|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662762|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43662763|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43662764|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43662765|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
43662766|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43662767|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
43699453|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43699454|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662768|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
43662770|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
43662771|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851525|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662785|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662786|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662787|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
43662788|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43662789|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43662790|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662791|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
43662792|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
43662794|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
43662795|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662796|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662797|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43662798|NCT02911662|Renal Agents|renal agents|mesh-ancestor
43662799|NCT02911701|Acetaminophen|acetaminophen|mesh-list
43662800|NCT02911701|Ibuprofen|ibuprofen|mesh-list
43662801|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662802|NCT02911701|Analgesics|analgesics|mesh-ancestor
43662803|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
43662804|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662805|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611191|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43611192|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
43611193|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43611194|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43611195|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611196|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
43611197|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611198|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43611199|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43611200|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43611201|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
43611202|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43611203|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43662813|NCT02911597|Naltrexone|naltrexone|mesh-list
43662814|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43662815|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43662816|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662817|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
43662818|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662819|NCT02911298|Metronidazole|metronidazole|mesh-list
43662820|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662821|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662822|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43662823|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43662824|NCT02911350|Paclitaxel|paclitaxel|mesh-list
43611211|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43611212|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611213|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43611214|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611215|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
43611217|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611218|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
43699462|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43662853|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43662854|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43662855|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
43662856|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662857|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662858|NCT02910882|Gemcitabine|gemcitabine|mesh-list
43662859|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43662860|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
43662861|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662862|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662863|NCT02910882|Antiviral Agents|antiviral agents|mesh-ancestor
43662864|NCT02910882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662865|NCT02910882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662866|NCT02910882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662867|NCT02910882|Immunologic Factors|immunologic factors|mesh-ancestor
43662868|NCT02910882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662869|NCT02910817|Metformin|metformin|mesh-list
43662890|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662892|NCT02910518|Hormones|hormones|mesh-ancestor
43611258|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43611259|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611260|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611261|NCT03173508|Diuretics|diuretics|mesh-ancestor
43851526|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43851527|NCT03805932|Rituximab|rituximab|mesh-list
43662893|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662894|NCT02910596|Bethanechol|bethanechol|mesh-list
43662895|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43662896|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
43662897|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611395|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
43611396|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43611397|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43611398|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
43611399|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611400|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
43611401|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611402|NCT03171974|Dexamethasone|dexamethasone|mesh-list
43662906|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662907|NCT02910570|Incretins|incretins|mesh-ancestor
43662908|NCT02910570|Hormones|hormones|mesh-ancestor
43662909|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662910|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
43662911|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
43662912|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43662913|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43662914|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662915|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662916|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662917|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774669|NCT02351102|Valacyclovir|valacyclovir|mesh-list
43662918|NCT02910141|Insulin|insulin|mesh-list
43662919|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43662920|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662921|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662922|NCT02910115|Oxytocin|oxytocin|mesh-list
43662923|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
43662924|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662925|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662926|NCT02910206|Sufentanil|sufentanil|mesh-list
43662927|NCT02910206|Propofol|propofol|mesh-list
43662928|NCT02910206|Etomidate|etomidate|mesh-list
43662929|NCT02910206|Cisatracurium|cisatracurium|mesh-list
43662930|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43662931|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851530|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662932|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662933|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43662934|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
43662936|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662937|NCT02910206|Narcotics|narcotics|mesh-ancestor
43662938|NCT02910206|Analgesics|analgesics|mesh-ancestor
43662939|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
43611409|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
43611438|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43611439|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43611440|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611441|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
43611442|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43662948|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662949|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
43662950|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662951|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662952|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
43662953|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825896|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825897|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43825898|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
43825899|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825900|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43825901|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
43825903|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825904|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825905|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774675|NCT02351024|Naproxen|naproxen|mesh-list
43774678|NCT02351024|Analgesics|analgesics|mesh-ancestor
43825906|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825907|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
43825908|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
43825915|NCT04426669|Aldesleukin|aldesleukin|mesh-list
43825916|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
43825917|NCT04426669|Fludarabine|fludarabine|mesh-list
43825918|NCT04426669|Interleukin-2|interleukin-2|mesh-list
43825919|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825920|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
43825921|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825922|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825923|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43825924|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
43825925|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825926|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825927|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43825928|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825929|NCT04426669|Analgesics|analgesics|mesh-ancestor
43825930|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
43825931|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825936|NCT04356950|Thrombin|thrombin|mesh-list
43611445|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43611446|NCT03172065|Analgesics|analgesics|mesh-ancestor
43611447|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
43611448|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43611449|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43611450|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43611451|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43611452|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662965|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662966|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662967|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662968|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
43662970|NCT02909933|Liraglutide|liraglutide|mesh-list
43662971|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43662972|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662973|NCT02909933|Incretins|incretins|mesh-ancestor
43662974|NCT02909933|Hormones|hormones|mesh-ancestor
43662975|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662976|NCT02910245|Prednisone|prednisone|mesh-list
43662977|NCT02910245|Mesalamine|mesalamine|mesh-list
43662978|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
43662979|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662980|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
43662981|NCT02910245|Hormones|hormones|mesh-ancestor
43662982|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662983|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662984|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662985|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662986|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
43830356|NCT05367401|Magrolimab|magrolimab|mesh-list
43662987|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662988|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43662989|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662990|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
43662991|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43662992|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663004|NCT02909751|Trastuzumab|trastuzumab|mesh-list
43663005|NCT02909751|Epirubicin|epirubicin|mesh-list
43663006|NCT02909751|Pertuzumab|pertuzumab|mesh-list
43663007|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663008|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43611493|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
43611494|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43611495|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43611496|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663018|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43663019|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663020|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43663021|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43663022|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43663023|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663024|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
43663025|NCT02909751|Protective Agents|protective agents|mesh-ancestor
43663026|NCT02909751|Vitamins|vitamins|mesh-ancestor
43663027|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
43663028|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
43663029|NCT02909712|Piperaquine|piperaquine|mesh-list
43663030|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
43663031|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43663032|NCT02909712|Artenimol|artenimol|mesh-list
43663033|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
43663034|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43663035|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43663036|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774722|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43774723|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774725|NCT02350712|Carboplatin|carboplatin|mesh-list
43774759|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774760|NCT02350673|Atezolizumab|atezolizumab|mesh-list
43774761|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774762|NCT02350361|Endostatins|endostatins|mesh-list
43774763|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774764|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43663039|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663040|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43663042|NCT02909465|Midazolam|midazolam|mesh-list
43663043|NCT02909465|Ketamine|ketamine|mesh-list
43663044|NCT02909465|Haloperidol|haloperidol|mesh-list
43663045|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
43663046|NCT02909465|Analgesics|analgesics|mesh-ancestor
43611601|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611602|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43611603|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651658|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663055|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43663056|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43663057|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663058|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663059|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43663060|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663061|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43663062|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663063|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663064|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
43663065|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
43663066|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
43663067|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
43663068|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663069|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43663070|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43663071|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
43663072|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43663073|NCT02909413|Sevoflurane|sevoflurane|mesh-list
43663075|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663076|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43663077|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
43663078|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
43663083|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663084|NCT02909400|Protective Agents|protective agents|mesh-ancestor
43663085|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663086|NCT02909257|Bupivacaine|bupivacaine|mesh-list
43663087|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
43663088|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
43663089|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663090|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663091|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
43663092|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663093|NCT02909478|Dexamethasone|dexamethasone|mesh-list
43663094|NCT02909478|Aprepitant|aprepitant|mesh-list
43663095|NCT02909478|Tropisetron|tropisetron|mesh-list
43663096|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663097|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
43663098|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
43611610|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
43611611|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611612|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663099|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663100|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663101|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663102|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
43663103|NCT02909478|Hormones|hormones|mesh-ancestor
43851531|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
43663104|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663105|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663106|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699563|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
43663107|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43663108|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43611656|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611658|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611659|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
43611660|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611661|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
43611662|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611722|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611723|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43851532|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851533|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663112|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
43663113|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
43663114|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663115|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663116|NCT02908945|Ketamine|ketamine|mesh-list
43663117|NCT02908945|Analgesics|analgesics|mesh-ancestor
43663118|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
43663119|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663120|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663121|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43663122|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663123|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
43663124|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
43663125|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663126|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43663127|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43611777|NCT03169738|Leucovorin|leucovorin|mesh-list
43611778|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
43611779|NCT03169738|Bevacizumab|bevacizumab|mesh-list
43611780|NCT03169738|Fluorouracil|fluorouracil|mesh-list
43611781|NCT03169738|Capecitabine|capecitabine|mesh-list
43611782|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
43611783|NCT03169738|Nivolumab|nivolumab|mesh-list
43611784|NCT03169738|Fulvestrant|fulvestrant|mesh-list
43611785|NCT03169738|Avelumab|avelumab|mesh-list
43611786|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43611787|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611788|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43611789|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
43611790|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611820|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43611821|NCT03169933|Androgens|androgens|mesh-list
43611822|NCT03169933|Hormones|hormones|mesh-ancestor
43611823|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849368|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43611824|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611826|NCT03169790|Paclitaxel|paclitaxel|mesh-list
43611827|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
43663150|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43663151|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43663152|NCT05311774|Narcotics|narcotics|mesh-ancestor
43663153|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663154|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663155|NCT05311774|Analgesics|analgesics|mesh-ancestor
43663156|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
43663157|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663158|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43663159|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43663160|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663161|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663162|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663163|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
43663164|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663165|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
43663166|NCT05296213|Calcium|calcium|mesh-list
43663182|NCT05276206|Anesthetics|anesthetics|mesh-list
43663183|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
43699574|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
43663184|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663203|NCT05247268|Letrozole|letrozole|mesh-list
43611836|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
43611865|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611866|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611867|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611868|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611869|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663224|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43663225|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663227|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43825941|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825942|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825943|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825944|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
43825945|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43825946|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825947|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825949|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
43825950|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825951|NCT04222062|Carmustine|carmustine|mesh-list
43825952|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43825953|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
43825954|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825955|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825956|NCT04158934|Factor VIII|factor viii|mesh-list
43825957|NCT04158934|BAX 855|bax 855|mesh-list
43825958|NCT04158934|Coagulants|coagulants|mesh-ancestor
43851543|NCT03732352|Osimertinib|osimertinib|mesh-list
43851544|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43825961|NCT04151667|Bortezomib|bortezomib|mesh-list
43825962|NCT04151667|Daratumumab|daratumumab|mesh-list
43825963|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825964|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
43825965|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
43825966|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846723|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
43846724|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846725|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43846726|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
43846727|NCT04177004|Sirolimus|sirolimus|mesh-list
43846728|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
43846729|NCT04177004|Etoposide|etoposide|mesh-list
43846730|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
43846731|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
43846732|NCT04177004|Tacrolimus|tacrolimus|mesh-list
43774791|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774792|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774801|NCT02350543|Aspirin|aspirin|mesh-list
43846733|NCT04177004|Mitogens|mitogens|mesh-list
43851556|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
43851557|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43851558|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846734|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846735|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
43846736|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846737|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846738|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846739|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
43846740|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851559|NCT03598257|Olaparib|olaparib|mesh-list
43851560|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43851561|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846741|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846742|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43846743|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663228|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
43663229|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43663230|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663233|NCT05189717|Everolimus|everolimus|mesh-list
43651663|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
43651664|NCT03005496|Beta Carotene|beta carotene|mesh-list
43651665|NCT03005496|Zinc|zinc|mesh-list
43651666|NCT03005496|Dexamethasone|dexamethasone|mesh-list
43763268|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763269|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763270|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43763271|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
43763272|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
43763273|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763282|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763283|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
43763341|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763343|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
43763344|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43763345|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43763346|NCT02426723|Growth Substances|growth substances|mesh-ancestor
43763347|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
43763348|NCT02426736|Dexamethasone|dexamethasone|mesh-list
43763349|NCT02426736|Bupivacaine|bupivacaine|mesh-list
43763350|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663250|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663251|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663252|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
43663254|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663255|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663256|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663257|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
43663258|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663259|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663260|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663261|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663262|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43663263|NCT05124067|Analgesics|analgesics|mesh-ancestor
43663264|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
43663265|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43663266|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43663267|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43663268|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
43663269|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663275|NCT05124067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663276|NCT05124067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663277|NCT05124067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43663278|NCT05123040|Prednisone|prednisone|mesh-list
43663279|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
43663280|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663281|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
43663282|NCT05123040|Hormones|hormones|mesh-ancestor
43699597|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611910|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43611911|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43611912|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611913|NCT03169582|Urological Agents|urological agents|mesh-ancestor
43611914|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
43611915|NCT03169348|Ledipasvir|ledipasvir|mesh-list
43611916|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43611917|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
43611918|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43611919|NCT03169504|Fluticasone|fluticasone|mesh-list
43611921|NCT03169504|Bromides|bromides|mesh-list
43611922|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
43663304|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
43663305|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
43611976|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611977|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43611978|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43611979|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43611980|NCT03169335|Growth Substances|growth substances|mesh-ancestor
43611981|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611982|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
43611983|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
43611984|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43611985|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611986|NCT03168997|Memantine|memantine|mesh-list
43612018|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
43612019|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
43663306|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663307|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43663308|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43663309|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663310|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663311|NCT05056584|Glucagon|glucagon|mesh-list
43663312|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663313|NCT05056584|Hormones|hormones|mesh-ancestor
43663314|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663315|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663316|NCT05046535|Nicotine|nicotine|mesh-list
43663317|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43663318|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
43663319|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663332|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663333|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43663334|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663335|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
43663355|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663356|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663357|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663358|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
43663359|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43663360|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851568|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851569|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43663386|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43663387|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663388|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663389|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
43663390|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
43612056|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612057|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612058|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43612059|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43612060|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
43612061|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663412|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
43663413|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663414|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663415|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663416|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663417|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663418|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43663419|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43663420|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43663421|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663422|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663423|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663424|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
43663425|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
43663426|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
43663427|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
43663428|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825983|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43825984|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43825985|NCT03914443|Cisplatin|cisplatin|mesh-list
43825986|NCT03914443|Docetaxel|docetaxel|mesh-list
43825987|NCT03914443|Fluorouracil|fluorouracil|mesh-list
43825988|NCT03914443|Nivolumab|nivolumab|mesh-list
43825989|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825990|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
43825991|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
43825992|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
43825993|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612074|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612076|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612077|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43612078|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825994|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
43825995|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43825996|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825997|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
43825998|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825999|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826000|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43826001|NCT03810066|Osimertinib|osimertinib|mesh-list
43826002|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826003|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851571|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43826004|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826005|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826006|NCT03760458|Lamivudine|lamivudine|mesh-list
43826019|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43826020|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43826021|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
43826022|NCT03719768|Avelumab|avelumab|mesh-list
43612122|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
43612123|NCT03167853|Antibodies|antibodies|mesh-list
43612124|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43612125|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
43612126|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649898|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43649899|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43851572|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826023|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826024|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826026|NCT03699956|Carboplatin|carboplatin|mesh-list
43826027|NCT03699956|Etoposide|etoposide|mesh-list
43826028|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663436|NCT04790045|Venetoclax|venetoclax|mesh-list
43663437|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663438|NCT04772274|Ustekinumab|ustekinumab|mesh-list
43663439|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
43663440|NCT04758975|Rituximab|rituximab|mesh-list
43663441|NCT04758975|Venetoclax|venetoclax|mesh-list
43663442|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663443|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663444|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
43663445|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774804|NCT02350543|Analgesics|analgesics|mesh-ancestor
43663446|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663447|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
43663448|NCT04669210|Tacrolimus|tacrolimus|mesh-list
43612156|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43612157|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
43612158|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
43612159|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612160|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612161|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612162|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43612163|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
43663449|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663450|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
43663451|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663452|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43663453|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663454|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663455|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43663456|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663459|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663460|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663462|NCT04660760|Paclitaxel|paclitaxel|mesh-list
43663463|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43663464|NCT04660760|Ramucirumab|ramucirumab|mesh-list
43612167|NCT03166956|Ascorbic Acid|ascorbic acid|mesh-list
43612168|NCT03166956|Vitamins|vitamins|mesh-ancestor
43612169|NCT03166956|Micronutrients|micronutrients|mesh-ancestor
43612170|NCT03166956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612171|NCT03166956|Antioxidants|antioxidants|mesh-ancestor
43612172|NCT03166956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612173|NCT03166956|Protective Agents|protective agents|mesh-ancestor
43612174|NCT03167164|Leucovorin|leucovorin|mesh-list
43612175|NCT03167164|Paclitaxel|paclitaxel|mesh-list
43612176|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
43612177|NCT03167164|Bevacizumab|bevacizumab|mesh-list
43612178|NCT03167164|Cisplatin|cisplatin|mesh-list
43612179|NCT03167164|Fluorouracil|fluorouracil|mesh-list
43612180|NCT03167164|Capecitabine|capecitabine|mesh-list
43612181|NCT03167164|Avelumab|avelumab|mesh-list
43612182|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663467|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
43663468|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43663469|NCT04660760|Lexatumumab|lexatumumab|mesh-list
43663470|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663471|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774808|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774809|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824759|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824760|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
43824761|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699743|NCT02736019|Celecoxib|celecoxib|mesh-list
43699744|NCT02736019|Tramadol|tramadol|mesh-list
43699745|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43699746|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699747|NCT02736019|Analgesics|analgesics|mesh-ancestor
43663472|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
43663473|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851573|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663475|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663476|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
43663477|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663478|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
43663479|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
43663480|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663481|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
43663482|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663483|NCT04656951|Daratumumab|daratumumab|mesh-list
43663497|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663498|NCT04607252|Metformin|metformin|mesh-list
43663499|NCT04607252|Megestrol|megestrol|mesh-list
43663500|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
43663501|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663502|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663503|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43663504|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43663505|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43663506|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
43663507|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43663508|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43663509|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43663510|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663511|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612276|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43612277|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43612307|NCT03166254|Poly ICLC|poly iclc|mesh-list
43612308|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
43612312|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
43612313|NCT03166306|Bevacizumab|bevacizumab|mesh-list
43612314|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43612315|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612316|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43612317|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826029|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663517|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663518|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43663519|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663520|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663521|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663523|NCT04567160|Sevoflurane|sevoflurane|mesh-list
43663524|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663525|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663526|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663527|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663528|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
43663530|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663531|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43663532|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43663533|NCT04566250|Analgesics|analgesics|mesh-ancestor
43663534|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
43663535|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663536|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663537|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
43851575|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
43851576|NCT03589547|Durvalumab|durvalumab|mesh-list
43612318|NCT03166306|Growth Substances|growth substances|mesh-ancestor
43612319|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612320|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
43612322|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
43612323|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612324|NCT03166605|Emollients|emollients|mesh-ancestor
43612325|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
43612326|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
43612327|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612328|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
43612329|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
43612330|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612365|NCT03165890|Acetazolamide|acetazolamide|mesh-list
43612366|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
43612367|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43612368|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612369|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663538|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663539|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
43663540|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663541|NCT04545866|Budesonide|budesonide|mesh-list
43663542|NCT04545866|Poractant alfa|poractant alfa|mesh-list
43663543|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43663544|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663545|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43663546|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
43663547|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663548|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663549|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43663550|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
43663551|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
43663552|NCT04545866|Hormones|hormones|mesh-ancestor
43663553|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663554|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
43663555|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663556|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
43663557|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43649917|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43649918|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
43649919|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43649920|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649921|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43649922|NCT03017703|Diuretics|diuretics|mesh-ancestor
43649923|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612385|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612386|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43612387|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663577|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
43663578|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663579|NCT04366713|Capecitabine|capecitabine|mesh-list
43663580|NCT04366713|Loperamide|loperamide|mesh-list
43663581|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
43663582|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43663583|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
43663584|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663585|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663586|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663587|NCT04356326|Aspirin|aspirin|mesh-list
43663588|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43663589|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43663590|NCT04356326|Analgesics|analgesics|mesh-ancestor
43663591|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
43663592|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663593|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663594|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663595|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663596|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43663597|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43663598|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663599|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663600|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43663601|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612394|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612395|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612396|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43612398|NCT03165825|Hormones|hormones|mesh-ancestor
43663603|NCT04322123|Azithromycin|azithromycin|mesh-list
43663604|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
43663605|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663606|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663607|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
43663608|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43663609|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43663610|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663611|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663612|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663614|NCT04299880|Gemcitabine|gemcitabine|mesh-list
43663615|NCT04299880|Paclitaxel|paclitaxel|mesh-list
43663616|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43663617|NCT04299880|Bevacizumab|bevacizumab|mesh-list
43663618|NCT04299880|Fluorouracil|fluorouracil|mesh-list
43663619|NCT04299880|Nivolumab|nivolumab|mesh-list
43663620|NCT04299880|Irinotecan|irinotecan|mesh-list
43663637|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663643|NCT04299880|Antidotes|antidotes|mesh-ancestor
43663644|NCT04299880|Protective Agents|protective agents|mesh-ancestor
43663645|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
43663646|NCT04299880|Vitamins|vitamins|mesh-ancestor
43663647|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
43663648|NCT04268706|Fludarabine|fludarabine|mesh-list
43663649|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43663650|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663651|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663652|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43663653|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
43663654|NCT04259138|Vedolizumab|vedolizumab|mesh-list
43663666|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663667|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663668|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
43663669|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
43663670|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663671|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663672|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663673|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
43826040|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826041|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
43826043|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826044|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826045|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
43826046|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826047|NCT03618550|Gemcitabine|gemcitabine|mesh-list
43699810|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43826048|NCT03618550|Doxorubicin|doxorubicin|mesh-list
43826049|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43826050|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
43826051|NCT03618550|Vinorelbine|vinorelbine|mesh-list
43826056|NCT03618550|Antiviral Agents|antiviral agents|mesh-ancestor
43826057|NCT03618550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826058|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826059|NCT03618550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826060|NCT03618550|Immunologic Factors|immunologic factors|mesh-ancestor
43826061|NCT03618550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826062|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826063|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826064|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826065|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826066|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826068|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
43826069|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826079|NCT03607539|Pemetrexed|pemetrexed|mesh-list
43826080|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826081|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826082|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826085|NCT03542461|Nivolumab|nivolumab|mesh-list
43826086|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826087|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826089|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663703|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663704|NCT03984565|Cannabidiol|cannabidiol|mesh-list
43663705|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
43663706|NCT03974139|Metformin|metformin|mesh-list
43663707|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663708|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663709|NCT03936998|Vancomycin|vancomycin|mesh-list
43826090|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
43663710|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663711|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663713|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43649926|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43649927|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
43649928|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649929|NCT03017807|Antibodies|antibodies|mesh-list
43649930|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
43649931|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649932|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
43649933|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43649934|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43649935|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43649936|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663715|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43663751|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663753|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
43663754|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43663755|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663756|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663757|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663758|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43663759|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
43851581|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663760|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663764|NCT03719092|Vitamin A|vitamin a|mesh-list
43663822|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663823|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
43663824|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43663825|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43663826|NCT02817451|Vaccines|vaccines|mesh-list
43663827|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
43663828|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699829|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43699830|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663829|NCT02716012|Sorafenib|sorafenib|mesh-list
43663830|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663831|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43663832|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663833|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663834|NCT05467709|Midazolam|midazolam|mesh-list
43663835|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43663836|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663837|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663838|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663839|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43649961|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
43612469|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43612470|NCT03165396|Propofol|propofol|mesh-list
43612471|NCT03165396|Sevoflurane|sevoflurane|mesh-list
43612472|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612473|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612474|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612475|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43612476|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
43612477|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
43612478|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43612479|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43612480|NCT03165253|Amoxicillin|amoxicillin|mesh-list
43612481|NCT03165253|Clarithromycin|clarithromycin|mesh-list
43612482|NCT03165253|Omeprazole|omeprazole|mesh-list
43612509|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43612510|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
43612511|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612512|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612513|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43612514|NCT03165240|Diuretics|diuretics|mesh-ancestor
43663840|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663841|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824762|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
43824763|NCT05508178|Vaccines|vaccines|mesh-list
43824764|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
43824765|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824766|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43663874|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43663876|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43663878|NCT05467189|Paclitaxel|paclitaxel|mesh-list
43612515|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
43612516|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43612517|NCT03165097|ACT-709478|act-709478|mesh-list
43612518|NCT03165097|Midazolam|midazolam|mesh-list
43612519|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43612520|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612521|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612522|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612523|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43612524|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663885|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
43663886|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663887|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
43663888|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
43663889|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663890|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612526|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43612527|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
43612528|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
43612529|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
43612530|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
43612557|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
43612559|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612560|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612561|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
43612562|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612563|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43580784|NCT03466632|Propofol|propofol|mesh-list
43774836|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774837|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774838|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
43774839|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43774868|NCT02350023|Latanoprost|latanoprost|mesh-list
43774869|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43774870|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43774871|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43774872|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
43774873|NCT02350023|Hormones|hormones|mesh-ancestor
43774874|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774875|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699881|NCT02735317|Vitamins|vitamins|mesh-ancestor
43699882|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
43612564|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43612565|NCT03164590|Analgesics|analgesics|mesh-ancestor
43612566|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43612567|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43612568|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43612569|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612570|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612571|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664014|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43664015|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664016|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664017|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826092|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43826093|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43826094|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826096|NCT03364244|Urological Agents|urological agents|mesh-ancestor
43612572|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43612574|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
43612575|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43612576|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43612577|NCT03164668|Menthol|menthol|mesh-list
43612578|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
43612606|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43612607|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
43612608|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43612609|NCT03164382|Sorafenib|sorafenib|mesh-list
43612610|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664198|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43664199|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664200|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664201|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664202|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664203|NCT05209035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664204|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43664207|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612611|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43649962|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43649963|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43649964|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43649965|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
43649966|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
43649967|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43649968|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
43649969|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612612|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826150|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826151|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826152|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43826153|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43664212|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43664213|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664214|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664215|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43664216|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
43664217|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
43664218|NCT05191667|Paclitaxel|paclitaxel|mesh-list
43664219|NCT05191667|Carboplatin|carboplatin|mesh-list
43664220|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43664221|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664222|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
43664223|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
43664224|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
43664225|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664226|NCT05177146|Ketamine|ketamine|mesh-list
43664227|NCT05177146|Analgesics|analgesics|mesh-ancestor
43664228|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
43664229|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664230|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664231|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43664232|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43664233|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
43664234|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
43664240|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
43612616|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612617|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43612618|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
43612619|NCT03164096|Bupivacaine|bupivacaine|mesh-list
43612620|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
43612621|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
43612622|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664244|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664245|NCT05152004|Amoxicillin|amoxicillin|mesh-list
43664246|NCT05152004|Metronidazole|metronidazole|mesh-list
43664247|NCT05152004|Clarithromycin|clarithromycin|mesh-list
43664248|NCT05152004|Rabeprazole|rabeprazole|mesh-list
43664249|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43664250|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664251|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43664252|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43664253|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43664255|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664256|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43664257|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43664258|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43664259|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664260|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43664261|NCT05136066|Peppermint oil|peppermint oil|mesh-list
43664262|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
43664263|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
43664264|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664265|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664266|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699924|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
43851584|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664267|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
43664269|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43664270|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664271|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
43664272|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43664273|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43664274|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664275|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664280|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43664282|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
43664283|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664284|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43664289|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43664290|NCT05104229|Analgesics|analgesics|mesh-ancestor
43664291|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
43664292|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664293|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664294|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664295|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664296|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43664297|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43664298|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664299|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664300|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43664301|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664302|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
43664303|NCT05103306|Empagliflozin|empagliflozin|mesh-list
43664304|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664305|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664306|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43664307|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664308|NCT05080959|Ropivacaine|ropivacaine|mesh-list
43664309|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664310|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
43664311|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664312|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612657|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
43612658|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
43612659|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
43612660|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43612661|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43612662|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
43664315|NCT05060068|Ketamine|ketamine|mesh-list
43664316|NCT05060068|Esketamine|esketamine|mesh-list
43664317|NCT05060068|Analgesics|analgesics|mesh-ancestor
43664318|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
43664319|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664320|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664321|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43664322|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43664323|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
43664324|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
43664325|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664326|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43664327|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43664328|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664329|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664330|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
43664331|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664332|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
43664333|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664334|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664335|NCT05047952|Vortioxetine|vortioxetine|mesh-list
43664336|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
43664337|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664338|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43612666|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612667|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612668|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612669|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43664339|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664340|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664341|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664342|NCT05047952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664343|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43664344|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664345|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664346|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664347|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
43664348|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43664349|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43664350|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43664351|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43612674|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43612675|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43612676|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612677|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612678|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612679|NCT03163680|Omeprazole|omeprazole|mesh-list
43612680|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43612705|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
43612706|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612707|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612708|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
43612709|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612710|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43612711|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612712|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
43612713|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612714|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43612715|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
43649970|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649971|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43649972|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43649973|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649974|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43649975|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43649977|NCT03017248|Morphine|morphine|mesh-list
43649978|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43649979|NCT03017248|Analgesics|analgesics|mesh-ancestor
43649980|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
43664352|NCT05044637|Primaquine|primaquine|mesh-list
43664353|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
43664354|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43664355|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43664356|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664357|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
43664358|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43664359|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664360|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
43664361|NCT04959825|Melatonin|melatonin|mesh-list
43664362|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
43851586|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851587|NCT03497975|Nalbuphine|nalbuphine|mesh-list
43649983|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43649984|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43649985|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
43612716|NCT03163589|Hematinics|hematinics|mesh-ancestor
43612717|NCT03163277|Emtricitabine|emtricitabine|mesh-list
43612718|NCT03163277|Maraviroc|maraviroc|mesh-list
43612719|NCT03163277|Darunavir|darunavir|mesh-list
43612720|NCT03163277|Cobicistat|cobicistat|mesh-list
43664363|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664364|NCT04959825|Protective Agents|protective agents|mesh-ancestor
43664365|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664366|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664367|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
43664368|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
43664370|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43664371|NCT04942730|Fludarabine|fludarabine|mesh-list
43664372|NCT04942730|Tacrolimus|tacrolimus|mesh-list
43664373|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664374|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
43664375|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664376|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664377|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43664378|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
43664379|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664380|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664381|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43664382|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43664383|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664384|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43664385|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43664386|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
43664387|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43664388|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664390|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43664391|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43664392|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43664393|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664394|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664395|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
43664396|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664397|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664398|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43851588|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43664399|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664400|NCT04914247|Selexipag|selexipag|mesh-list
43664401|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43826155|NCT02489903|Paclitaxel|paclitaxel|mesh-list
43826156|NCT02489903|Etoposide|etoposide|mesh-list
43826157|NCT02489903|Vinorelbine|vinorelbine|mesh-list
43826158|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43826159|NCT02489903|Carboplatin|carboplatin|mesh-list
43612721|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43612722|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
43612723|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612724|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43612725|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43612726|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612727|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612728|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43826167|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826168|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826169|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826170|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
43826171|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
43826172|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826173|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826174|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826175|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
43826176|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826177|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43826178|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826179|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826180|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43826181|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826182|NCT02403310|Cytarabine|cytarabine|mesh-list
43826183|NCT02403310|Daunorubicin|daunorubicin|mesh-list
43826184|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826185|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
43700050|NCT02733705|Fentanyl|fentanyl|mesh-list
43826186|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826187|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826188|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
43826189|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826190|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43612755|NCT03163420|Analgesics|analgesics|mesh-ancestor
43612756|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
43612757|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43612758|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612759|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43612760|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664474|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664475|NCT04788823|Prednisone|prednisone|mesh-list
43664476|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664477|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
43664478|NCT04788823|Hormones|hormones|mesh-ancestor
43664479|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664480|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664483|NCT04752033|Morphine|morphine|mesh-list
43664523|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
43664524|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664525|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664526|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43664527|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
43664528|NCT04691817|Atezolizumab|atezolizumab|mesh-list
43664529|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664530|NCT04622813|Acetaminophen|acetaminophen|mesh-list
43664531|NCT04622813|Ketoprofen|ketoprofen|mesh-list
43664532|NCT04622813|Nefopam|nefopam|mesh-list
43664534|NCT04622813|Analgesics|analgesics|mesh-ancestor
43612761|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43612762|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612763|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612764|NCT03163407|Norepinephrine|norepinephrine|mesh-list
43612766|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43612767|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43612768|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
43612769|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612770|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612771|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612772|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
43612773|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
43612803|NCT03162861|Propofol|propofol|mesh-list
43612804|NCT03162861|Sevoflurane|sevoflurane|mesh-list
43612805|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43612806|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612807|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43612808|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43612809|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
43612810|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664535|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
43664536|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664537|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664538|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
43664539|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43664540|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664541|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664542|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43664543|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664544|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43649987|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43649988|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43649989|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43649990|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43649991|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612813|NCT03162653|Mannitol|mannitol|mesh-list
43612814|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
43612815|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612816|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612817|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
43612818|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43612844|NCT03162562|Poly ICLC|poly iclc|mesh-list
43612845|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
43612846|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
43612847|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664545|NCT04614610|Lidocaine|lidocaine|mesh-list
43664546|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664547|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
43664548|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664549|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664550|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
43664551|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664552|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664553|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43664554|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43664555|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612852|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43612853|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43612854|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43612855|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43612857|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43612859|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664556|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664557|NCT04575844|Liraglutide|liraglutide|mesh-list
43664558|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664559|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664560|NCT04575844|Incretins|incretins|mesh-ancestor
43664561|NCT04575844|Hormones|hormones|mesh-ancestor
43664562|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664563|NCT04562441|Avelumab|avelumab|mesh-list
43664564|NCT04562441|Axitinib|axitinib|mesh-list
43664565|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664566|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664567|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43664568|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664569|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664570|NCT04547153|Docetaxel|docetaxel|mesh-list
43664571|NCT04547153|Fluorouracil|fluorouracil|mesh-list
43664572|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664573|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
43664574|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
43664575|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851589|NCT03497975|Narcotics|narcotics|mesh-ancestor
43612860|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43612861|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43612862|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612863|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612864|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
43612865|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612866|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43612867|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
43612868|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43612869|NCT03162120|Metoprolol|metoprolol|mesh-list
43612870|NCT03162120|Flecainide|flecainide|mesh-list
43612871|NCT03162120|Ranolazine|ranolazine|mesh-list
43612912|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826213|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826214|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826215|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
43826216|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826217|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
43826218|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826219|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43826220|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826221|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826222|NCT00950430|Corticosterone|corticosterone|mesh-list
43826223|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826224|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
43826225|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
43826226|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826227|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43826228|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43826229|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
43612917|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43612918|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
43612919|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43612920|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43612953|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43612954|NCT03160872|Hormones|hormones|mesh-list
43612955|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43612956|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43612957|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43826230|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
43851591|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826231|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826232|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826233|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826234|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826235|NCT00560495|Growth Substances|growth substances|mesh-ancestor
43826236|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826237|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
43826238|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826239|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43826240|NCT00054158|Thalidomide|thalidomide|mesh-list
43826241|NCT00054158|Dexamethasone|dexamethasone|mesh-list
43826242|NCT00054158|Doxorubicin|doxorubicin|mesh-list
43826243|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43826244|NCT00054158|Vincristine|vincristine|mesh-list
43700206|NCT02733341|Ticagrelor|ticagrelor|mesh-list
43826245|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826246|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
43613044|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613047|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613049|NCT05676463|Vitamins|vitamins|mesh-ancestor
43613050|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
43613051|NCT05676463|Estrogens|estrogens|mesh-ancestor
43613052|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613053|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613079|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
43649992|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43649993|NCT03017248|Narcotics|narcotics|mesh-ancestor
43649994|NCT03017391|Dexamethasone|dexamethasone|mesh-list
43649995|NCT03017391|Metoclopramide|metoclopramide|mesh-list
43826247|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
43826248|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846751|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
43664585|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
43664586|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43664587|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
43664588|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43664589|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664590|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664591|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664592|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
43664593|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
43664594|NCT04484610|Narcotics|narcotics|mesh-ancestor
43664595|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664596|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664597|NCT04484610|Analgesics|analgesics|mesh-ancestor
43664598|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
43664601|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
43664602|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664604|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
43664605|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650010|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
43650011|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650012|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650013|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43650016|NCT03017430|Phenazepam|phenazepam|mesh-list
43650017|NCT03017430|Clonidine|clonidine|mesh-list
43650018|NCT03017430|Pregabalin|pregabalin|mesh-list
43774970|NCT02349607|Ibuprofen|ibuprofen|mesh-list
43650019|NCT03017430|Metoclopramide|metoclopramide|mesh-list
43613080|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
43664629|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
43664630|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664631|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664632|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664633|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43664634|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664635|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664636|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664637|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43664638|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
43664640|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
43664641|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664642|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664643|NCT04312503|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664644|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43664645|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664646|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
43664647|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
43613084|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613085|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43824769|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
43824770|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43824771|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43824772|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824773|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43824774|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824775|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846513|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846514|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846515|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
43846516|NCT04195568|Antacids|antacids|mesh-ancestor
43700279|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43700280|NCT02732197|Thiopental|thiopental|mesh-list
43700281|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
43700282|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700283|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700285|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43613086|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
43613088|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613089|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664670|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664671|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43664672|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
43664673|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43664674|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
43664675|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664676|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43664677|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43664678|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43664679|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664680|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664682|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664683|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664684|NCT04166396|Resveratrol|resveratrol|mesh-list
43664685|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
43664686|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664687|NCT04166396|Protective Agents|protective agents|mesh-ancestor
43664688|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664689|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664690|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664691|NCT04156828|Gemcitabine|gemcitabine|mesh-list
43664692|NCT04156828|Dexamethasone|dexamethasone|mesh-list
43650025|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650026|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
43650027|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43650028|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43650029|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650030|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43650031|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43650032|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43650033|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650034|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43650035|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43613090|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43613091|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
43613092|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
43613093|NCT05676203|Docetaxel|docetaxel|mesh-list
43613094|NCT05676203|Androgens|androgens|mesh-list
43613095|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664694|NCT04156828|Rituximab|rituximab|mesh-list
43664695|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43664696|NCT04156828|Carboplatin|carboplatin|mesh-list
43664697|NCT04156828|Antibodies|antibodies|mesh-list
43664698|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
43664699|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43664700|NCT04156828|Lenograstim|lenograstim|mesh-list
43664701|NCT04156828|BB 1101|bb 1101|mesh-list
43664702|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
43851592|NCT03497975|Analgesics|analgesics|mesh-ancestor
43613097|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613098|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613099|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613100|NCT05676203|Hormones|hormones|mesh-ancestor
43613101|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613102|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613133|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43613134|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613135|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613136|NCT05675644|Drospirenone|drospirenone|mesh-list
43613137|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43664703|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664704|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664705|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664706|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664707|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
43664708|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
43664709|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664710|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664711|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
43664712|NCT04156828|Hormones|hormones|mesh-ancestor
43664713|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664714|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664715|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43664716|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
43664717|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664718|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
43851593|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
43613140|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613141|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43613142|NCT05675644|Diuretics|diuretics|mesh-ancestor
43613143|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
43613144|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
43664719|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664720|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664721|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664722|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43664723|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664725|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43664726|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43664727|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664728|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664729|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43664730|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664731|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
43664732|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
43664733|NCT04106830|Azathioprine|azathioprine|mesh-list
43664734|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846517|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775006|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
43847344|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
43847345|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
43847346|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847347|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43847348|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43664735|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
43664736|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664737|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664738|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43664739|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43664740|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
43664741|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43664742|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664743|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664744|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664755|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
43664756|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664757|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664758|NCT04083365|Capecitabine|capecitabine|mesh-list
43664759|NCT04083365|Durvalumab|durvalumab|mesh-list
43664760|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43664761|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
43664762|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664763|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664764|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826249|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826264|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826265|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826266|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
43826267|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
43826268|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826269|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826270|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826271|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826272|NCT00054158|Growth Substances|growth substances|mesh-ancestor
43826273|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
43826275|NCT05499234|Meperidine|meperidine|mesh-list
43826276|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43826277|NCT05499234|Analgesics|analgesics|mesh-ancestor
43826278|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
43826279|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826280|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826281|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
43826286|NCT05499117|Fluoxetine|fluoxetine|mesh-list
43664835|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664836|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664837|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664838|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
43664839|NCT03809442|Hormones|hormones|mesh-ancestor
43664840|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664841|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664842|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664843|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43664844|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664845|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43613145|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613178|NCT05675410|Procarbazine|procarbazine|mesh-list
43613179|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43613180|NCT05675410|Antibodies|antibodies|mesh-list
43613181|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
43613182|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43613183|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
43613184|NCT05675410|Imidazole|imidazole|mesh-list
43613185|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43613186|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
43613187|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43613188|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613189|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
43613190|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613191|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613192|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43650036|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650038|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650039|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650040|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650041|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43664872|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664873|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664874|NCT03748810|Metformin|metformin|mesh-list
43664875|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
43664876|NCT03748810|Empagliflozin|empagliflozin|mesh-list
43664877|NCT03748810|Glimepiride|glimepiride|mesh-list
43664878|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43664879|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43664880|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664881|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43650043|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
43650044|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43650045|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43650046|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650047|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650048|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650049|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
43664914|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
43664915|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664916|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43664918|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43664919|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664920|NCT03554174|Psilocybin|psilocybin|mesh-list
43664921|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
43664922|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664923|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664924|NCT03527576|Dexamethasone|dexamethasone|mesh-list
43664925|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43664926|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
43664927|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
43664928|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664929|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664930|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664931|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
43664932|NCT03527576|Hormones|hormones|mesh-ancestor
43664933|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664934|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664935|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664936|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
43664937|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43650051|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43613193|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
43613194|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613223|NCT05675319|Dexamethasone|dexamethasone|mesh-list
43613224|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
43613225|NCT05675319|Lenalidomide|lenalidomide|mesh-list
43613226|NCT05675319|Bortezomib|bortezomib|mesh-list
43613227|NCT05675319|Daratumumab|daratumumab|mesh-list
43613228|NCT05675319|Pomalidomide|pomalidomide|mesh-list
43613229|NCT05675319|Ixazomib|ixazomib|mesh-list
43613230|NCT05675319|Elotuzumab|elotuzumab|mesh-list
43613231|NCT05675319|BB 1101|bb 1101|mesh-list
43613232|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43613233|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613234|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
43613235|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
43664956|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664957|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664958|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43664959|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43664960|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
43664961|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43664962|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43664963|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
43664965|NCT03436992|Antioxidants|antioxidants|mesh-list
43664966|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664967|NCT03436992|Protective Agents|protective agents|mesh-ancestor
43664968|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664969|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664970|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664971|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43664972|NCT03429946|Spironolactone|spironolactone|mesh-list
43664973|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43664974|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
43664975|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664976|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664977|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43664978|NCT03429946|Diuretics|diuretics|mesh-ancestor
43613236|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613237|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613238|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613239|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
43613240|NCT05675319|Hormones|hormones|mesh-ancestor
43613241|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613242|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43613243|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613279|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43664989|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
43664990|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664991|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43664992|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43664993|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43664994|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664995|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664996|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664997|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664998|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
43664999|NCT03377543|Aspirin|aspirin|mesh-list
43665000|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43665001|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43613280|NCT05674877|Analgesics|analgesics|mesh-ancestor
43613313|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613314|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613315|NCT05672212|Analgesics|analgesics|mesh-ancestor
43613316|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
43613317|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700391|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
43700392|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
43700393|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700394|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700395|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700396|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
43700397|NCT02731911|Hormones|hormones|mesh-ancestor
43700398|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700399|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700400|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613318|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43613319|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43613320|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
43613321|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
43613349|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613350|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
43613351|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613352|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43613354|NCT05665699|Protective Agents|protective agents|mesh-ancestor
43613355|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613356|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43613357|NCT05661552|Ezetimibe|ezetimibe|mesh-list
43613358|NCT05661552|Evolocumab|evolocumab|mesh-list
43613359|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43650052|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43665045|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
43665046|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
43665047|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
43665048|NCT03370783|Ethanol|ethanol|mesh-list
43665049|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43665050|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665051|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665052|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665053|NCT03358693|Infliximab|infliximab|mesh-list
43665054|NCT03358693|Upadacitinib|upadacitinib|mesh-list
43665055|NCT03358693|Ustekinumab|ustekinumab|mesh-list
43665056|NCT03358693|Ixekizumab|ixekizumab|mesh-list
43665057|NCT03358693|Brodalumab|brodalumab|mesh-list
43665058|NCT03358693|Abrocitinib|abrocitinib|mesh-list
43826300|NCT05499065|Cetuximab|cetuximab|mesh-list
43650054|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43650055|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
43650056|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43650058|NCT03017352|Exenatide|exenatide|mesh-list
43650059|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43650060|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650061|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43650062|NCT03017352|Incretins|incretins|mesh-ancestor
43650063|NCT03017352|Hormones|hormones|mesh-ancestor
43650064|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650065|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
43613360|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613361|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
43613362|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613442|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
43613443|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
43665116|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
43665117|NCT02690064|Vitamin E|vitamin e|mesh-list
43665118|NCT02690064|Tocopherols|tocopherols|mesh-list
43665119|NCT02690064|Tocotrienols|tocotrienols|mesh-list
43665120|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
43665121|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
43665122|NCT02690064|Ubiquinone|ubiquinone|mesh-list
43665123|NCT02690064|Resveratrol|resveratrol|mesh-list
43665124|NCT02690064|Antioxidants|antioxidants|mesh-list
43665125|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
43665126|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665127|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665128|NCT02690064|Protective Agents|protective agents|mesh-ancestor
43665129|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665130|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43665131|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
43665132|NCT02627092|Copper|copper|mesh-list
43665133|NCT02627092|Trace Elements|trace elements|mesh-ancestor
43665134|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
43665152|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43665153|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
43665156|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665174|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665175|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43665176|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
43665177|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665178|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
43665179|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
43665181|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43665182|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43665183|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665184|NCT02115724|Vitamins|vitamins|mesh-list
43665185|NCT02115724|Vitamin E|vitamin e|mesh-list
43665186|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
43613451|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43613452|NCT05561660|Analgesics|analgesics|mesh-ancestor
43613453|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
43613454|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613455|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613456|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613457|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613458|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43650067|NCT03017404|Doxorubicin|doxorubicin|mesh-list
43650068|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43650069|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650070|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
43650071|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650072|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665187|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
43665188|NCT02115724|Antioxidants|antioxidants|mesh-list
43665189|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
43665190|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665191|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665192|NCT02115724|Protective Agents|protective agents|mesh-ancestor
43665193|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
43665194|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
43665195|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
43665196|NCT02081755|Everolimus|everolimus|mesh-list
43665197|NCT02081755|Azathioprine|azathioprine|mesh-list
43665198|NCT02081755|Tacrolimus|tacrolimus|mesh-list
43775029|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43775030|NCT02349113|Hormones|hormones|mesh-ancestor
43775031|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775032|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775033|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43700457|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43665199|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665200|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
43665201|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665202|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43665203|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665204|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665205|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665206|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43665207|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43665208|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
43650073|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43650074|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
43650075|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613459|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43613460|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613461|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43613462|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43613463|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665209|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665210|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665211|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
43665212|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43665213|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665214|NCT02071862|Paclitaxel|paclitaxel|mesh-list
43665226|NCT02021474|Phenol|phenol|mesh-list
43613464|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
43613507|NCT05457998|Flutemetamol|flutemetamol|mesh-list
43613508|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43613509|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613546|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613547|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613548|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613549|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613550|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613551|NCT05382559|Cetuximab|cetuximab|mesh-list
43613552|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665276|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665277|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43665278|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43775034|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
43775035|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43775036|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43665279|NCT01468896|Growth Substances|growth substances|mesh-ancestor
43665280|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
43665281|NCT01462890|Paclitaxel|paclitaxel|mesh-list
43665282|NCT01462890|Bevacizumab|bevacizumab|mesh-list
43665283|NCT01462890|Carboplatin|carboplatin|mesh-list
43665284|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43665285|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665286|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
43665287|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665288|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
43665289|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613601|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613602|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613603|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613604|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
43613605|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
43613606|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
43613607|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43613633|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43613634|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43613635|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613637|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613638|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43613639|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613640|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613641|NCT05185089|Maleic acid|maleic acid|mesh-list
43650076|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650077|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43665325|NCT05471453|Tocotrienols|tocotrienols|mesh-list
43665326|NCT05471453|Vitamin E|vitamin e|mesh-list
43665327|NCT05471453|Tocopherols|tocopherols|mesh-list
43665328|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43613645|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
43613647|NCT05177796|Doxorubicin|doxorubicin|mesh-list
43613648|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43613649|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
43613650|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43613651|NCT05177796|Daunorubicin|daunorubicin|mesh-list
43613652|NCT05177796|Panitumumab|panitumumab|mesh-list
43613653|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43613654|NCT05177796|Antibodies|antibodies|mesh-list
43613655|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
43613656|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43613657|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43613685|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43613686|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851601|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43665331|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665333|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665334|NCT05471453|Protective Agents|protective agents|mesh-ancestor
43665335|NCT05471453|Vitamins|vitamins|mesh-ancestor
43665336|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
43665337|NCT05471427|Docetaxel|docetaxel|mesh-list
43665338|NCT05471427|Taxane|taxane|mesh-list
43665339|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665340|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
43665341|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665342|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43665343|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665344|NCT05471063|Fluconazole|fluconazole|mesh-list
43665345|NCT05471063|Amphotericin B|amphotericin b|mesh-list
43665346|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43665347|NCT05471063|Flucytosine|flucytosine|mesh-list
43665348|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
43665349|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
43665353|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613693|NCT05171647|Antiviral Agents|antiviral agents|mesh-ancestor
43613694|NCT05171647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613695|NCT05171647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613696|NCT05171647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613697|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43613698|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613699|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613700|NCT05149365|Incretins|incretins|mesh-ancestor
43613701|NCT05149365|Hormones|hormones|mesh-ancestor
43613702|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613703|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43613704|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
43826333|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43826334|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826335|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826336|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826337|NCT05498714|Lactulose|lactulose|mesh-list
43826338|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665397|NCT05470647|Interleukin-4|interleukin-4|mesh-list
43665398|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665399|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
43665400|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665401|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665402|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665404|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665405|NCT05470582|Vaccines|vaccines|mesh-list
43665406|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
43665407|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665408|NCT05470530|Dexamethasone|dexamethasone|mesh-list
43665409|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43665410|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
43665411|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
43665412|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665413|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665414|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665415|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
43665416|NCT05470530|Hormones|hormones|mesh-ancestor
43613750|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613751|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
43613752|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613753|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613755|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
43613756|NCT05003713|Prednisone|prednisone|mesh-list
43613757|NCT05003713|Cortisone|cortisone|mesh-list
43613758|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43613788|NCT04927780|Fluorouracil|fluorouracil|mesh-list
43613789|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
43613790|NCT04927780|Irinotecan|irinotecan|mesh-list
43613791|NCT04927780|Calcium|calcium|mesh-list
43613792|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
43613793|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43665428|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43665429|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43665430|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665431|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665432|NCT05469984|Gentamicins|gentamicins|mesh-list
43665433|NCT05469984|Ampicillin|ampicillin|mesh-list
43665434|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665435|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665436|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43665437|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665438|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613830|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43613831|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
43613832|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613833|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43613834|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43613835|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
43613836|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851602|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43851603|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851604|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851605|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43665493|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43665494|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665495|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665496|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
43665497|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665499|NCT05469204|Digoxin|digoxin|mesh-list
43665500|NCT05469204|Midazolam|midazolam|mesh-list
43665501|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43613838|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43613840|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613841|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43613842|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43613843|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43613844|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613845|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43613846|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
43613847|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613848|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613849|NCT04861584|Gemcitabine|gemcitabine|mesh-list
43613850|NCT04861584|Cisplatin|cisplatin|mesh-list
43613851|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613883|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
43613884|NCT04787471|Vitamins|vitamins|mesh-ancestor
43613885|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
43665502|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43665503|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43665504|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665505|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665506|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43665507|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43665508|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43665509|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43665510|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
43665511|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
43665512|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
43665513|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
43665514|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665515|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665516|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43613920|NCT04715230|Haloperidol|haloperidol|mesh-list
43613921|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
43613922|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
43613923|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
43613924|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613925|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613926|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43613927|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43613928|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43613929|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851606|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43665524|NCT05469204|Protective Agents|protective agents|mesh-ancestor
43665525|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
43665526|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
43665527|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
43665528|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665529|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43665530|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
43665531|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
43665532|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846754|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
43665533|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665534|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665535|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43665536|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
43665537|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43665538|NCT05469113|Repaglinide|repaglinide|mesh-list
43665539|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613930|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43613931|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43613932|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
43613933|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613934|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700589|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
43613935|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43613936|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
43613937|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43613938|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43613939|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
43613940|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
43613942|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43613943|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613968|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
43613969|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43613970|NCT04600427|Anesthetics|anesthetics|mesh-list
43613971|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43613972|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613973|NCT04595981|Cisplatin|cisplatin|mesh-list
43613974|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613975|NCT04553692|Leucovorin|leucovorin|mesh-list
43613976|NCT04553692|Gemcitabine|gemcitabine|mesh-list
43613977|NCT04553692|Bevacizumab|bevacizumab|mesh-list
43613978|NCT04553692|Docetaxel|docetaxel|mesh-list
43613979|NCT04553692|Fluorouracil|fluorouracil|mesh-list
43613980|NCT04553692|Irinotecan|irinotecan|mesh-list
43613981|NCT04553692|Azacitidine|azacitidine|mesh-list
43613982|NCT04553692|Venetoclax|venetoclax|mesh-list
43613983|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665549|NCT05469022|Lazertinib|lazertinib|mesh-list
43665550|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43665553|NCT05468879|Glimepiride|glimepiride|mesh-list
43613992|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614018|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
43614019|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614020|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614021|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614022|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
43614023|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43614025|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
43614026|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43614028|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614029|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
43665628|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
43826340|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43826341|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43826342|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43826343|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43826344|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826345|NCT05498636|Prednisone|prednisone|mesh-list
43826346|NCT05498636|Etoposide|etoposide|mesh-list
43838770|NCT04824092|Growth Substances|growth substances|mesh-ancestor
43838771|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
43838772|NCT04824053|Selenium|selenium|mesh-list
43775039|NCT02348788|Artemether|artemether|mesh-list
43775040|NCT02348788|Primaquine|primaquine|mesh-list
43775041|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43775042|NCT02348788|Amebicides|amebicides|mesh-ancestor
43775043|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43846518|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846519|NCT04194424|Metformin|metformin|mesh-list
43846520|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43846521|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846522|NCT04193878|Budesonide|budesonide|mesh-list
43846523|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
43826347|NCT05498636|Lenalidomide|lenalidomide|mesh-list
43826348|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846524|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846525|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43826349|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
43826350|NCT05498636|Hormones|hormones|mesh-ancestor
43826351|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826352|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826353|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826354|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826355|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826356|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826357|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826358|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826359|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826360|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
43826361|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826379|NCT05498337|Calcium|calcium|mesh-list
43614031|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614032|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614033|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614035|NCT04540133|Hormones|hormones|mesh-ancestor
43614036|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614037|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614038|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614039|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
43614040|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614041|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614042|NCT04493060|Niraparib|niraparib|mesh-list
43614043|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
43665663|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43665664|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665665|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
43665667|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665668|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665669|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665670|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665671|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
43665672|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
43665673|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
43665674|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665675|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665676|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
43665677|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665678|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43665679|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
43665680|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43665681|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43851608|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43851609|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
43665682|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665683|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665684|NCT05567367|Urological Agents|urological agents|mesh-ancestor
43665685|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
43665686|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665687|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
43846526|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
43846527|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846528|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846529|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43846530|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
43846531|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
43846532|NCT04193878|Hormones|hormones|mesh-ancestor
43665688|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665690|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614044|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
43614045|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
43614046|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614077|NCT04404439|Paroxetine|paroxetine|mesh-list
43614078|NCT04404439|Nortriptyline|nortriptyline|mesh-list
43614079|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
43614080|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43614081|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614082|NCT04404439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43614083|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43614084|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614085|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614086|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43614087|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
43614088|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43614089|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
43614090|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43614091|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43614102|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614104|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665691|NCT05546242|Dolutegravir|dolutegravir|mesh-list
43665692|NCT05546242|Cabotegravir|cabotegravir|mesh-list
43665693|NCT05546242|Rilpivirine|rilpivirine|mesh-list
43665694|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43665695|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43665696|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43665697|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665698|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665699|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43665700|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
43665701|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665702|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43665703|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43665704|NCT05527470|Gemcitabine|gemcitabine|mesh-list
43665705|NCT05527470|Cisplatin|cisplatin|mesh-list
43665706|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665707|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43665708|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
43665709|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665710|NCT05527470|Antiviral Agents|antiviral agents|mesh-ancestor
43665732|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665733|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665734|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
43665735|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43665736|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665737|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43665738|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
43665739|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665740|NCT05478707|Dulaglutide|dulaglutide|mesh-list
43665741|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665742|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826393|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826394|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
43826395|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
43826396|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826397|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826398|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43826423|NCT05498025|Charcoal|charcoal|mesh-list
43614105|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614106|NCT04386746|Gemcitabine|gemcitabine|mesh-list
43614107|NCT04386746|Docetaxel|docetaxel|mesh-list
43614108|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614109|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
43614110|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614111|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614112|NCT04386746|Antiviral Agents|antiviral agents|mesh-ancestor
43614113|NCT04386746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614114|NCT04386746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614115|NCT04386746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614116|NCT04386746|Immunologic Factors|immunologic factors|mesh-ancestor
43614117|NCT04386746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614118|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
43826435|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43826436|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826437|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826439|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
43826440|NCT05497804|Lenalidomide|lenalidomide|mesh-list
43826441|NCT05497804|Daratumumab|daratumumab|mesh-list
43826442|NCT05497804|Ichthammol|ichthammol|mesh-list
43826443|NCT05497804|BB 1101|bb 1101|mesh-list
43826444|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826445|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
43826446|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
43826447|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826448|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826449|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826450|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
43826451|NCT05497804|Hormones|hormones|mesh-ancestor
43826452|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826453|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826454|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826455|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
43826456|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614123|NCT04382404|Velpatasvir|velpatasvir|mesh-list
43614124|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
43614125|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614126|NCT04381936|Aspirin|aspirin|mesh-list
43826457|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826458|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
43826459|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826460|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826461|NCT05497804|Growth Substances|growth substances|mesh-ancestor
43665743|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43665744|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43665745|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665747|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43700696|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665748|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665749|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43700697|NCT02729766|Empagliflozin|empagliflozin|mesh-list
43665750|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43665751|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665752|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665753|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
43665754|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665755|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43665756|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43665757|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665758|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
43665759|NCT05381623|Hemostatics|hemostatics|mesh-list
43665760|NCT05381623|Coagulants|coagulants|mesh-ancestor
43665761|NCT05339256|Buprenorphine|buprenorphine|mesh-list
43665762|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43665763|NCT05339256|Narcotics|narcotics|mesh-ancestor
43665764|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665765|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665767|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
43665768|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665769|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43665771|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665772|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665773|NCT05336812|Venetoclax|venetoclax|mesh-list
43665774|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
43665775|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
43665776|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665777|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665778|NCT05329116|Lidocaine|lidocaine|mesh-list
43665785|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665786|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43665787|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43665788|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43665789|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665790|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665791|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43665792|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665793|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43665794|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43665795|NCT05329116|Protective Agents|protective agents|mesh-ancestor
43665796|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
43665797|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43665798|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
43665799|NCT05328908|Trifluridine|trifluridine|mesh-list
43665801|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614142|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
43614143|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614144|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614146|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43614147|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43614148|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614149|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43614150|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43614151|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614152|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
43614153|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43614154|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43614155|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
43665817|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665818|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43665819|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
43665820|NCT05264142|Voriconazole|voriconazole|mesh-list
43665821|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
43665822|NCT05264142|Omeprazole|omeprazole|mesh-list
43665823|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43665824|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665825|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43665826|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665827|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665828|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
43665829|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665830|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43665831|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43665832|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43665833|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665840|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43665841|NCT05264142|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43665842|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43665843|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665844|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665845|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
43665846|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43665847|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
43665848|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43665849|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43665850|NCT05239182|Gemcitabine|gemcitabine|mesh-list
43665851|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43665852|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43614197|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43614198|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614199|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614200|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614201|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43614202|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43614203|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
43614204|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43614235|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
43614236|NCT04205838|Fludarabine|fludarabine|mesh-list
43614237|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
43614238|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43614239|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614240|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
43614241|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614242|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614243|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614244|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
43614245|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614246|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614247|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43665867|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665868|NCT05220046|Psilocybin|psilocybin|mesh-list
43665869|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
43665870|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665871|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43665873|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43700787|NCT02729324|Protective Agents|protective agents|mesh-list
43665874|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
43665875|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665876|NCT05169229|Vancomycin|vancomycin|mesh-list
43665877|NCT05169229|Tobramycin|tobramycin|mesh-list
43665878|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665879|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665880|NCT05161208|Varenicline|varenicline|mesh-list
43665881|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43665882|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43665883|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
43826464|NCT05497765|Silybin|silybin|mesh-list
43851614|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826470|NCT05497700|Ephedrine|ephedrine|mesh-list
43826471|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43826472|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43826473|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826474|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826475|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846755|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43846756|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846757|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43846758|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43846759|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846761|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
43846762|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
43846763|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
43614275|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43614276|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43614278|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43846767|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43846768|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43846769|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846770|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846771|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43846772|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
43846773|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846774|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665888|NCT05119439|Mifepristone|mifepristone|mesh-list
43665889|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43614280|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43614281|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43614282|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614283|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43614284|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
43614285|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43614286|NCT04190056|Tamoxifen|tamoxifen|mesh-list
43614287|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
43614288|NCT04190056|Vorinostat|vorinostat|mesh-list
43614289|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614290|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614291|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43665896|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43665897|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43665898|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43665899|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43665900|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
43665901|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43665902|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43665903|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665905|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
43665944|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665945|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665946|NCT05001776|PENTA|penta|mesh-list
43665947|NCT05001776|Fondaparinux|fondaparinux|mesh-list
43665948|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43665949|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
43665950|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43665951|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
43665952|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665957|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
43665959|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665960|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665961|NCT04983238|Antidotes|antidotes|mesh-ancestor
43775094|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775095|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775129|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775130|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775131|NCT02348398|Topotecan|topotecan|mesh-list
43775132|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43775133|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43775134|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700831|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43700832|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700833|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43700834|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
43700835|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700836|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700837|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700838|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700839|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
43700840|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700841|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
43700842|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700843|NCT02728453|Empagliflozin|empagliflozin|mesh-list
43665962|NCT04983238|Protective Agents|protective agents|mesh-ancestor
43665963|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665964|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
43665965|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665966|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
43614293|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614294|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614295|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614296|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43614297|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43614298|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43665970|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
43665971|NCT04974385|Bupivacaine|bupivacaine|mesh-list
43665972|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
43665973|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
43665974|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665975|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665976|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
43665977|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665978|NCT04972617|Furosemide|furosemide|mesh-list
43665979|NCT04972617|Diuretics|diuretics|mesh-ancestor
43665980|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
43665981|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665982|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43665983|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665984|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665985|NCT04939480|Atezolizumab|atezolizumab|mesh-list
43665986|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665987|NCT04933383|Budesonide|budesonide|mesh-list
43665988|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43665989|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43665990|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
43665991|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665992|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665993|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43665994|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
43665995|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
43650104|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43650105|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43650106|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43650107|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614425|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614426|NCT03933904|Sirolimus|sirolimus|mesh-list
43614427|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43614428|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614429|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43614430|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614431|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
43614432|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614433|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
43614458|NCT03873402|Nivolumab|nivolumab|mesh-list
43614459|NCT03873402|Ipilimumab|ipilimumab|mesh-list
43614460|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614461|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700844|NCT02728453|Glimepiride|glimepiride|mesh-list
43700845|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43700846|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700847|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43700848|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700849|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700850|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700851|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
43614462|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614463|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614464|NCT03861871|Fenfluramine|fenfluramine|mesh-list
43614465|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43614466|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43614467|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614468|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614469|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43614470|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
43614471|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614472|NCT03860233|Oxytocin|oxytocin|mesh-list
43614473|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
43614474|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43614475|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614476|NCT03794583|Treprostinil|treprostinil|mesh-list
43614477|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43614478|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
43614479|NCT03785249|Cetuximab|cetuximab|mesh-list
43614480|NCT03785249|Afatinib|afatinib|mesh-list
43614481|NCT03785249|Adagrasib|adagrasib|mesh-list
43614482|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614483|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665996|NCT04933383|Hormones|hormones|mesh-ancestor
43665997|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665998|NCT04923542|Hormones|hormones|mesh-list
43665999|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666000|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666001|NCT04922424|Atorvastatin|atorvastatin|mesh-list
43666002|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43666003|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43614484|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614513|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614514|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
43614515|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614516|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614517|NCT03656718|Nivolumab|nivolumab|mesh-list
43614518|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614519|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614520|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614521|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614522|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
43614523|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666004|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
43666005|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666006|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43666007|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43666008|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666009|NCT04913220|Cemiplimab|cemiplimab|mesh-list
43666010|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666012|NCT04902495|Pemetrexed|pemetrexed|mesh-list
43666013|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666014|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666015|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666016|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666017|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43666018|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
43666019|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43614524|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614526|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614555|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614556|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614557|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614558|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614559|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
43700875|NCT02728687|Menthol|menthol|mesh-list
43614560|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
43614561|NCT03541850|Hormones|hormones|mesh-list
43614562|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43614563|NCT03541850|Androgens|androgens|mesh-list
43614564|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
43614565|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614566|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650110|NCT03016806|Busulfan|busulfan|mesh-list
43650111|NCT03016806|Fludarabine|fludarabine|mesh-list
43666036|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43666037|NCT04898231|Protective Agents|protective agents|mesh-ancestor
43666038|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666039|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666042|NCT04891419|Lidocaine|lidocaine|mesh-list
43826512|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826513|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826514|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826515|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826516|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43826517|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826518|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826519|NCT05497492|Lidocaine|lidocaine|mesh-list
43826520|NCT05497492|Sufentanil|sufentanil|mesh-list
43826521|NCT05497492|Propofol|propofol|mesh-list
43826522|NCT05497492|Esketamine|esketamine|mesh-list
43826523|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
43826524|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
43826525|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666054|NCT04776993|Methimazole|methimazole|mesh-list
43666055|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
43851620|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
43851621|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
43666056|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
43666057|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666058|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666059|NCT04768010|Misoprostol|misoprostol|mesh-list
43666061|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
43666062|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666063|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666064|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43666065|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666066|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
43666067|NCT04741997|Nivolumab|nivolumab|mesh-list
43666068|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666069|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666070|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43650113|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650114|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
43614567|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
43614568|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614569|NCT03541850|Protective Agents|protective agents|mesh-ancestor
43614570|NCT03541850|Vitamins|vitamins|mesh-ancestor
43614571|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
43614572|NCT03541850|Estrogens|estrogens|mesh-ancestor
43614573|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614574|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614575|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
43830588|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830589|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43830590|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830591|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830592|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43700891|NCT02728492|Gemcitabine|gemcitabine|mesh-list
43700892|NCT02728492|Paclitaxel|paclitaxel|mesh-list
43700893|NCT02728492|Cisplatin|cisplatin|mesh-list
43614576|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
43614600|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
43614601|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43614602|NCT03498521|Gemcitabine|gemcitabine|mesh-list
43614603|NCT03498521|Bevacizumab|bevacizumab|mesh-list
43614604|NCT03498521|Carboplatin|carboplatin|mesh-list
43614605|NCT03498521|Trastuzumab|trastuzumab|mesh-list
43614606|NCT03498521|Atezolizumab|atezolizumab|mesh-list
43614607|NCT03498521|Olaparib|olaparib|mesh-list
43614608|NCT03498521|Pertuzumab|pertuzumab|mesh-list
43614609|NCT03498521|Vemurafenib|vemurafenib|mesh-list
43666081|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666082|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666083|NCT04653337|Norepinephrine|norepinephrine|mesh-list
43666084|NCT04653337|Serotonin|serotonin|mesh-list
43666085|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
43666086|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43666087|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43666089|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666090|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775135|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775136|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775137|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
43775138|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43775139|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43775174|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43775175|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700897|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
43700898|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
43700899|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
43700900|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700901|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43700902|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
43700903|NCT02728492|Antiviral Agents|antiviral agents|mesh-ancestor
43700904|NCT02728492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700905|NCT02728492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700906|NCT02728492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43700907|NCT02728492|Immunologic Factors|immunologic factors|mesh-ancestor
43700908|NCT02728492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700909|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43700910|NCT02728440|Menotropins|menotropins|mesh-list
43700911|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700912|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700913|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43666091|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666093|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
43666094|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666095|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43666096|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43666097|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
43666098|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43614622|NCT03498521|Antiviral Agents|antiviral agents|mesh-ancestor
43614623|NCT03498521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43614624|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43614625|NCT03498521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43614626|NCT03498521|Immunologic Factors|immunologic factors|mesh-ancestor
43614627|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43614628|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43614629|NCT03496623|Treprostinil|treprostinil|mesh-list
43614630|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43614631|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43614632|NCT03408886|Vancomycin|vancomycin|mesh-list
43614658|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614660|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
43614661|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614662|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614676|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43614678|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
43614679|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43614680|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614681|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43650115|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650116|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666099|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666100|NCT04652089|Simvastatin|simvastatin|mesh-list
43666101|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43666102|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43666103|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
43666104|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666105|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43666106|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43666107|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666108|NCT04610658|Nivolumab|nivolumab|mesh-list
43666109|NCT04610658|Ipilimumab|ipilimumab|mesh-list
43650118|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
43650119|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650120|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650121|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43650122|NCT03016806|Protective Agents|protective agents|mesh-ancestor
43650124|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650125|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650126|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43650127|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650128|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
43650129|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650130|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
43650131|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650133|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
43650134|NCT03016741|Prednisone|prednisone|mesh-list
43650135|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
43666110|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666111|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666112|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43666113|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666114|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43666115|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43666116|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650137|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
43700914|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
43700915|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
43700916|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
43700917|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
43650138|NCT03016741|Hormones|hormones|mesh-ancestor
43650139|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650140|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650141|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43650142|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650145|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650146|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
43666117|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43666118|NCT04608539|Hematinics|hematinics|mesh-ancestor
43666119|NCT04598815|Sirolimus|sirolimus|mesh-list
43666120|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43666121|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666122|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666123|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666124|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
43666125|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666126|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
43666127|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666128|NCT04595565|Cisplatin|cisplatin|mesh-list
43666129|NCT04595565|Carboplatin|carboplatin|mesh-list
43666130|NCT04595565|Capecitabine|capecitabine|mesh-list
43650147|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43650150|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43614705|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775176|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775177|NCT02347891|Belimumab|belimumab|mesh-list
43775178|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775179|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
43775180|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775181|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43775207|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43846535|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43846536|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43652696|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
43652697|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
43700933|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700934|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700935|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
43700937|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700939|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43614706|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614707|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
43614708|NCT03323476|Hormones|hormones|mesh-ancestor
43614709|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614710|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614711|NCT03279471|Sertraline|sertraline|mesh-list
43614712|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
43614713|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43614714|NCT03279471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43614715|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43614716|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614717|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614718|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851629|NCT03366155|Irinotecan|irinotecan|mesh-list
43851630|NCT03366155|Cetuximab|cetuximab|mesh-list
43851631|NCT03366155|Panitumumab|panitumumab|mesh-list
43851632|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851633|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43851634|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851635|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851636|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851637|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851638|NCT03355976|Nivolumab|nivolumab|mesh-list
43666131|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666132|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666133|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
43666134|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666135|NCT04543682|Iloprost|iloprost|mesh-list
43666136|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43666137|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
43666138|NCT04513015|Antioxidants|antioxidants|mesh-list
43652698|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43652699|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
43652700|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652701|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652702|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43652703|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
43652704|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43652705|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43652706|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43652707|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
43652708|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849546|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700955|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43700956|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43700957|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700958|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700959|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700960|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666139|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666140|NCT04513015|Protective Agents|protective agents|mesh-ancestor
43666141|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666142|NCT04423029|Nivolumab|nivolumab|mesh-list
43666143|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666144|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666145|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43666146|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666148|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666149|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666168|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666169|NCT04362527|Protective Agents|protective agents|mesh-ancestor
43666170|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666172|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
43666173|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666174|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666175|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666176|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666177|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666178|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826526|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826527|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
43826528|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826529|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43851653|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
43851654|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826530|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43826531|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43666190|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666193|NCT04255160|Hormones|hormones|mesh-ancestor
43666194|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666195|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666196|NCT04233034|Verapamil|verapamil|mesh-list
43666197|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43666198|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43666199|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43614764|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614765|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614766|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614767|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
43614768|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614769|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666218|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666219|NCT04173533|Azacitidine|azacitidine|mesh-list
43666220|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666221|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
43666222|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666223|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666224|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652709|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775208|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775210|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
43775211|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
43775212|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775213|NCT02347046|Renal Agents|renal agents|mesh-ancestor
43775214|NCT02347059|Dopamine|dopamine|mesh-list
43775215|NCT02347059|Levodopa|levodopa|mesh-list
43775216|NCT02347059|Pramipexole|pramipexole|mesh-list
43775217|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
43775244|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
43666225|NCT04165096|Acetaminophen|acetaminophen|mesh-list
43666226|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
43666227|NCT04165096|Promethazine|promethazine|mesh-list
43666228|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
43666229|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666230|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666231|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43666232|NCT04165096|Analgesics|analgesics|mesh-ancestor
43614774|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614775|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614776|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43614777|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614778|NCT03029702|Metformin|metformin|mesh-list
43614780|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43614781|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614782|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
43614783|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43614784|NCT02958917|Pirfenidone|pirfenidone|mesh-list
43614820|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
43614821|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614822|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43614823|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43614824|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
43666234|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666235|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666236|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
43666237|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43666238|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43666239|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666240|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
43666241|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
43666242|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
43666243|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
43666244|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666245|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43666246|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
43666247|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
43666248|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666249|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666250|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43666251|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
43666252|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
43666253|NCT04158440|Paclitaxel|paclitaxel|mesh-list
43666254|NCT04158440|Docetaxel|docetaxel|mesh-list
43702822|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702823|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702824|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702825|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43702826|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702827|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702828|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
43614895|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43775245|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614896|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
43614897|NCT02769689|Natalizumab|natalizumab|mesh-list
43614898|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43614899|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
43614900|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
43614901|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43614902|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614903|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43614904|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
43614905|NCT02769689|Hormones|hormones|mesh-ancestor
43614906|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43614907|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43614908|NCT02769689|Protective Agents|protective agents|mesh-ancestor
43614909|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43614955|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
43614956|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43614957|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43614958|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43614959|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43614960|NCT02437110|Ritonavir|ritonavir|mesh-list
43614961|NCT02437110|Darunavir|darunavir|mesh-list
43614962|NCT02437110|Tenofovir|tenofovir|mesh-list
43614963|NCT02437110|Dolutegravir|dolutegravir|mesh-list
43614964|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43734424|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
43666275|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666276|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666277|NCT04137107|Analgesics|analgesics|mesh-ancestor
43666278|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
43666279|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666280|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
43666281|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43666282|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
43666283|NCT04116528|Ketamine|ketamine|mesh-list
43666284|NCT04116528|Buprenorphine|buprenorphine|mesh-list
43666285|NCT04116528|Analgesics|analgesics|mesh-ancestor
43666286|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
43666287|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666288|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666289|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43666290|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43666291|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
43666292|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
43650157|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650158|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650159|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650160|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650161|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650163|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43650164|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43650165|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43650166|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43851655|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666294|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43666295|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43666296|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666297|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666298|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43666299|NCT04116528|Narcotics|narcotics|mesh-ancestor
43666300|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43666301|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
43666302|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43666303|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666304|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666305|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43666306|NCT04106999|Analgesics|analgesics|mesh-ancestor
43666307|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
43666308|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666309|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43666310|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43666311|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43666312|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
43666313|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666314|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666315|NCT04095364|Paclitaxel|paclitaxel|mesh-list
43666316|NCT04095364|Carboplatin|carboplatin|mesh-list
43666317|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43666318|NCT04095364|Letrozole|letrozole|mesh-list
43615027|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615028|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615029|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
43615030|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615031|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615032|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43615033|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43615034|NCT01938001|Growth Substances|growth substances|mesh-ancestor
43615035|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
43615036|NCT01838187|Vorinostat|vorinostat|mesh-list
43615037|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43615038|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666325|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43666326|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43666327|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666328|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43666329|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
43666330|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666331|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666332|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
43666333|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43666334|NCT04044690|Antibodies|antibodies|mesh-list
43615039|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43615040|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615041|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615042|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43615043|NCT01799538|Albuterol|albuterol|mesh-list
43615044|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43615045|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
43615046|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615047|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615048|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43615049|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
43615050|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
43615051|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615052|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43615080|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
43615081|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
43849386|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615082|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
43615083|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615084|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851657|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
43666335|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
43666336|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
43666337|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666338|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43666339|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666340|NCT04015414|Varenicline|varenicline|mesh-list
43615087|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615088|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43615090|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43615091|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615092|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43615093|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43615094|NCT00773695|Growth Substances|growth substances|mesh-ancestor
43615095|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
43615096|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
43615097|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666341|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43666342|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43666343|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
43666344|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666345|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666346|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666347|NCT04005690|Olaparib|olaparib|mesh-list
43666348|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43666349|NCT04005690|Onvansertib|onvansertib|mesh-list
43666350|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666351|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666352|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666353|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43666354|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
43615099|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615100|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43615101|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
43615102|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615128|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43615129|NCT00014443|Growth Substances|growth substances|mesh-ancestor
43650167|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43650168|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
43650169|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650170|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650171|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615130|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
43615131|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
43615132|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43615133|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43615134|NCT03160651|Prednisolone|prednisolone|mesh-list
43615135|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
43615136|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43615137|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
43615138|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615139|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
43615140|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
43615141|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615142|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615143|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615144|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
43615146|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615147|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43615148|NCT03160651|Protective Agents|protective agents|mesh-ancestor
43615149|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43615150|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615151|NCT03160339|Vaccines|vaccines|mesh-list
43615152|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
43615153|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615187|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615188|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666356|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
43666357|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666358|NCT04005053|Expectorants|expectorants|mesh-ancestor
43666359|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
43666360|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43666361|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
43666362|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666363|NCT04005053|Protective Agents|protective agents|mesh-ancestor
43666364|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666365|NCT04005053|Antidotes|antidotes|mesh-ancestor
43666366|NCT04003805|Nicotine|nicotine|mesh-list
43666367|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43615190|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43615191|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615192|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43615193|NCT03160261|Incretins|incretins|mesh-ancestor
43615194|NCT03160261|Hormones|hormones|mesh-ancestor
43615195|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43615229|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615231|NCT03159078|Polymyxins|polymyxins|mesh-list
43615232|NCT03159078|Polymyxin B|polymyxin b|mesh-list
43615233|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615234|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615236|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43615237|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
43615268|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615269|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
43615270|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
43615271|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615272|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615273|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615274|NCT03156062|Analgesics|analgesics|mesh-ancestor
43615275|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
43666368|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
43666369|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666370|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666371|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43666372|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43666373|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
43615276|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615277|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615278|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615279|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615280|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615281|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615308|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43615309|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43615312|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
43615313|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
43615315|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
43615316|NCT03153436|Vitamins|vitamins|mesh-ancestor
43615317|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
43615318|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615319|NCT03152877|Bupivacaine|bupivacaine|mesh-list
43666374|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666375|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666376|NCT04001777|Osimertinib|osimertinib|mesh-list
43666377|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666378|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43666379|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701124|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
43650174|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615321|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
43615322|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615323|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615324|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
43615325|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615326|NCT03150134|Cyclosporine|cyclosporine|mesh-list
43615327|NCT03150134|Cyclosporins|cyclosporins|mesh-list
43615328|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43615329|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615354|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615355|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
43615356|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615358|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43615359|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43615360|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43615362|NCT03149432|Analgesics|analgesics|mesh-ancestor
43615363|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
43615364|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615365|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615366|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
43615367|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43615368|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43615369|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615370|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43615371|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43615372|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43615373|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615374|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666380|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666382|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43666383|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
43666384|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666385|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615376|NCT03149419|Paroxetine|paroxetine|mesh-list
43615377|NCT03149419|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43615378|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43615379|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615400|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
43615401|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615402|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
43615403|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615404|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615405|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43615406|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
43615407|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615408|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615409|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43615410|NCT03149575|Carboplatin|carboplatin|mesh-list
43615411|NCT03149575|Temozolomide|temozolomide|mesh-list
43615412|NCT03149575|Lomustine|lomustine|mesh-list
43615413|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
43615414|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615415|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43830609|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615416|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
43615417|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615418|NCT03149445|Metoprolol|metoprolol|mesh-list
43615419|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43615420|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43615421|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
43615422|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
43615423|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615424|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615425|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43666386|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43666387|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43666388|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
43666389|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666390|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666391|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
43615427|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43615428|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
43615429|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615430|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615431|NCT03149393|Mosapride|mosapride|mesh-list
43615432|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650175|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650176|NCT03016260|Adalimumab|adalimumab|mesh-list
43666392|NCT03970330|Naltrexone|naltrexone|mesh-list
43666393|NCT03970330|Norethindrone|norethindrone|mesh-list
43666394|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
43666395|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43666396|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43666397|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666398|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
43666399|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666400|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43650180|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
43650181|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650182|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650183|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
43650184|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615433|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615461|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43615462|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615464|NCT03148704|Palonosetron|palonosetron|mesh-list
43615465|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
43615466|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
43615467|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615468|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615469|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615470|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43615471|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43615472|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
43615473|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615474|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666401|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43666402|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43666403|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
43615477|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
43615478|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615479|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615480|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43615500|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615501|NCT03148509|Risperidone|risperidone|mesh-list
43615502|NCT03148509|Aripiprazole|aripiprazole|mesh-list
43615503|NCT03148509|Bupropion|bupropion|mesh-list
43615504|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43615505|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
43615506|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666404|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666405|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43666406|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43666407|NCT03959085|Leucovorin|leucovorin|mesh-list
43666408|NCT03959085|Cytarabine|cytarabine|mesh-list
43666409|NCT03959085|Dexamethasone|dexamethasone|mesh-list
43666410|NCT03959085|Prednisolone|prednisolone|mesh-list
43666411|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
43666412|NCT03959085|Doxorubicin|doxorubicin|mesh-list
43666413|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43666414|NCT03959085|Methotrexate|methotrexate|mesh-list
43615511|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615512|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43615513|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43615514|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
43615515|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43615516|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
43615517|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43615518|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43650185|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650186|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650187|NCT03016260|Analgesics|analgesics|mesh-ancestor
43650188|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
43650189|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650190|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666415|NCT03959085|Vincristine|vincristine|mesh-list
43666416|NCT03959085|Daunorubicin|daunorubicin|mesh-list
43666417|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
43666418|NCT03959085|Pegaspargase|pegaspargase|mesh-list
43666419|NCT03959085|Thioguanine|thioguanine|mesh-list
43666420|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43666421|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
43666422|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666423|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
43650191|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650192|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
43650193|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43650195|NCT03016234|Desflurane|desflurane|mesh-list
43650197|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650198|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650199|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43650200|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
43650201|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
43650202|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43650203|NCT03016468|Treprostinil|treprostinil|mesh-list
43615519|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615520|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43615521|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43666424|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666425|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666426|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43615523|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
43615524|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43615525|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43615526|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43615527|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43615528|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43615529|NCT03148522|Mirtazapine|mirtazapine|mesh-list
43615530|NCT03148522|Citalopram|citalopram|mesh-list
43615531|NCT03148522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43615532|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43615533|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615534|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615554|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43775279|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43615555|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
43615556|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43615557|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43615558|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43615559|NCT03148444|Cephalexin|cephalexin|mesh-list
43615560|NCT03148444|Roxithromycin|roxithromycin|mesh-list
43615561|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615562|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615563|NCT03148132|Bevacizumab|bevacizumab|mesh-list
43615564|NCT03148132|Ranibizumab|ranibizumab|mesh-list
43851658|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650216|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650217|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
43650218|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650222|NCT03016000|Growth Substances|growth substances|mesh-ancestor
43650236|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650237|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650238|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650239|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650240|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650241|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650242|NCT03015818|Calcium|calcium|mesh-list
43650243|NCT03015818|Fluorides|fluorides|mesh-list
43650245|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650247|NCT03015818|Protective Agents|protective agents|mesh-ancestor
43650248|NCT03015857|Phenylephrine|phenylephrine|mesh-list
43650249|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
43650250|NCT03015857|Norepinephrine|norepinephrine|mesh-list
43615566|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615567|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43615568|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43615569|NCT03148132|Growth Substances|growth substances|mesh-ancestor
43615570|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615571|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
43615572|NCT03148314|Misoprostol|misoprostol|mesh-list
43615573|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43615574|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
43615575|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666435|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666436|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
43666437|NCT03959085|Hormones|hormones|mesh-ancestor
43666438|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666439|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666440|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666441|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666442|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666443|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666444|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43666445|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
43666446|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43615613|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
43615614|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615615|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615616|NCT03147404|Avelumab|avelumab|mesh-list
43615617|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615618|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615619|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
43615620|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
43615621|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615622|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615624|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43615625|NCT03147066|Dezocine|dezocine|mesh-list
43615626|NCT03147066|Analgesics|analgesics|mesh-ancestor
43615627|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
43615628|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650252|NCT03015857|Bupivacaine|bupivacaine|mesh-list
43650253|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
43650254|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
43650255|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615629|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615631|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615632|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615634|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615635|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615636|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615637|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43615638|NCT03147066|Narcotics|narcotics|mesh-ancestor
43615697|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
43615698|NCT03147157|Tacrolimus|tacrolimus|mesh-list
43615699|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615700|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
43615701|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615702|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43615703|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615704|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615706|NCT03146871|Decitabine|decitabine|mesh-list
43615707|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851659|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851660|NCT03161132|Doxorubicin|doxorubicin|mesh-list
43851661|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43851662|NCT03161132|Olaparib|olaparib|mesh-list
43851663|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851664|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851665|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666447|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701274|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43701275|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
43701276|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701277|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701278|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43701279|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
43701280|NCT02725255|Albendazole|albendazole|mesh-list
43701281|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
43666449|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
43666450|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666451|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43666452|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
43666453|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666454|NCT03959085|Antidotes|antidotes|mesh-ancestor
43666455|NCT03959085|Protective Agents|protective agents|mesh-ancestor
43666456|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
43666457|NCT03959085|Vitamins|vitamins|mesh-ancestor
43666458|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
43666459|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666460|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666461|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666462|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666463|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666464|NCT03954483|Triazolam|triazolam|mesh-list
43615751|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615752|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615754|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615755|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666465|NCT03954483|Buspirone|buspirone|mesh-list
43666466|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43666467|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43851666|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851667|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851668|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851669|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43851670|NCT03126331|Nivolumab|nivolumab|mesh-list
43851671|NCT03126331|Ipilimumab|ipilimumab|mesh-list
43666468|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615757|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615759|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
43615760|NCT03146377|Irinotecan|irinotecan|mesh-list
43615761|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43615762|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
43615763|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615764|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615765|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43615766|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43615767|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615768|NCT03146390|Listerine|listerine|mesh-list
43615769|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
43615770|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43615771|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615772|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
43615773|NCT03146390|Protective Agents|protective agents|mesh-ancestor
43615774|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43615775|NCT03146247|Apremilast|apremilast|mesh-list
43650256|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650257|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
43650258|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650259|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43650260|NCT03015857|Narcotics|narcotics|mesh-ancestor
43650261|NCT03015857|Analgesics|analgesics|mesh-ancestor
43650262|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43650263|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43615803|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43615804|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615805|NCT03146000|Analgesics|analgesics|mesh-ancestor
43615806|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43615807|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43615808|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43615809|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615810|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615811|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43615812|NCT03146325|Metronidazole|metronidazole|mesh-list
43615813|NCT03146325|Tetracycline|tetracycline|mesh-list
43615814|NCT03146325|Omeprazole|omeprazole|mesh-list
43666469|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666470|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43666471|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43666472|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
43666473|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666474|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851673|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851674|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851675|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851676|NCT03036930|Vaccines|vaccines|mesh-list
43851677|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
43851678|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775407|NCT02345746|Folic Acid|folic acid|mesh-list
43775408|NCT02345746|Fluorouracil|fluorouracil|mesh-list
43775482|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43775483|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
43775484|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43775485|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
43775486|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775533|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701347|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701348|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701349|NCT02725164|Analgesics|analgesics|mesh-ancestor
43701350|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
43701351|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701352|NCT02725099|Ticagrelor|ticagrelor|mesh-list
43701353|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43701357|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
43666475|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43666476|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
43666477|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
43666478|NCT03950739|Treprostinil|treprostinil|mesh-list
43666479|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43666480|NCT03911414|Inositol|inositol|mesh-list
43666482|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43666485|NCT03911414|Expectorants|expectorants|mesh-ancestor
43615851|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43615852|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43615854|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
43615855|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615856|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615859|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
43615860|NCT03145610|Protective Agents|protective agents|mesh-ancestor
43615861|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666488|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
43666489|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666490|NCT03911414|Protective Agents|protective agents|mesh-ancestor
43666491|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666492|NCT03911414|Antidotes|antidotes|mesh-ancestor
43666493|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
43666494|NCT03911414|Vitamins|vitamins|mesh-ancestor
43666495|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
43666496|NCT03872180|Venetoclax|venetoclax|mesh-list
43851680|NCT03032328|Vitamins|vitamins|mesh-ancestor
43851681|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
43851682|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851683|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43851684|NCT03018080|Paclitaxel|paclitaxel|mesh-list
43851685|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
43615871|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43615872|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615899|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
43615900|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615902|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43615903|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43615904|NCT05255523|Capecitabine|capecitabine|mesh-list
43615905|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43615906|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
43615907|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615908|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43615909|NCT05255211|Propofol|propofol|mesh-list
43615910|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43615911|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666497|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43666498|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
43666499|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666500|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666501|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
43666502|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666503|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826533|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826534|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43826535|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43826536|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
43826537|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43826538|NCT05497492|Narcotics|narcotics|mesh-ancestor
43826539|NCT05497492|Analgesics|analgesics|mesh-ancestor
43826540|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43615915|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
43615916|NCT05254899|Gemcitabine|gemcitabine|mesh-list
43851686|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851687|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851688|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851689|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851690|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851691|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851692|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851693|NCT03000439|Tofacitinib|tofacitinib|mesh-list
43851694|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851695|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851696|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851697|NCT02993523|Azacitidine|azacitidine|mesh-list
43851698|NCT02993523|Venetoclax|venetoclax|mesh-list
43851699|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851700|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
43851701|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851702|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851703|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851704|NCT02933255|Nivolumab|nivolumab|mesh-list
43851705|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851706|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851707|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43615923|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43615946|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615947|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43615948|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43615949|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43615950|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615951|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43826541|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
43826542|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43826543|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43826544|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826545|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826547|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43826548|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615959|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43615960|NCT05254574|Analgesics|analgesics|mesh-ancestor
43615961|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
43615962|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43615963|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826549|NCT05497323|Analgesics|analgesics|mesh-ancestor
43826550|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
43826551|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826552|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826553|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826554|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826555|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
43826556|NCT05497232|Pancrelipase|pancrelipase|mesh-list
43826557|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43615966|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43615967|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43615968|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615969|NCT05254405|Brexanolone|brexanolone|mesh-list
43615970|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
43615971|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615972|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43615973|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826558|NCT05497206|Metronidazole|metronidazole|mesh-list
43826559|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826560|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826561|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43826562|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43826563|NCT05497102|Lenalidomide|lenalidomide|mesh-list
43826564|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
43851708|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616009|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
43616010|NCT05166304|Rebamipide|rebamipide|mesh-list
43616011|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43616012|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826565|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826566|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826567|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826568|NCT05497102|Growth Substances|growth substances|mesh-ancestor
43826569|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
43826570|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826571|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
43826572|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
43826573|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
43826574|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43826575|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43826576|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826577|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43826578|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826579|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826580|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43826581|NCT05497063|Renal Agents|renal agents|mesh-ancestor
43826582|NCT05496764|Dexamethasone|dexamethasone|mesh-list
43826583|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826584|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
43666511|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666512|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
43666513|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666514|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616053|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616054|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43775570|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43838814|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838815|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43838816|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
43652718|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
43652719|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616055|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43616058|NCT04852367|Doxorubicin|doxorubicin|mesh-list
43616059|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43616060|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616061|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43616062|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43616063|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616064|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616065|NCT04850495|Prednisone|prednisone|mesh-list
43616066|NCT04850495|Cortisone|cortisone|mesh-list
43616067|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
43616068|NCT04850495|Rituximab|rituximab|mesh-list
43616069|NCT04850495|Doxorubicin|doxorubicin|mesh-list
43616070|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43616071|NCT04850495|Vincristine|vincristine|mesh-list
43616072|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
43616073|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43616074|NCT04850495|Antibodies|antibodies|mesh-list
43616111|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
43616112|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
43616137|NCT04762459|Pemetrexed|pemetrexed|mesh-list
43616138|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616139|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616140|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616141|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43616142|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43616144|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43616145|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43616146|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616148|NCT04754230|Coagulants|coagulants|mesh-ancestor
43616149|NCT04718415|Paclitaxel|paclitaxel|mesh-list
43616150|NCT04718415|Carboplatin|carboplatin|mesh-list
43616151|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43616152|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616153|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616154|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616155|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616156|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616157|NCT04718025|Aspirin|aspirin|mesh-list
43616158|NCT04718025|Ticagrelor|ticagrelor|mesh-list
43616159|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616160|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616161|NCT04718025|Analgesics|analgesics|mesh-ancestor
43616162|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
43616163|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616164|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851709|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43851710|NCT02879695|Nivolumab|nivolumab|mesh-list
43851711|NCT02879695|Ipilimumab|ipilimumab|mesh-list
43851712|NCT02879695|Blinatumomab|blinatumomab|mesh-list
43851713|NCT02879695|Antibodies|antibodies|mesh-list
43851714|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
43616166|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43616167|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43616201|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
43616202|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43616203|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43616204|NCT04636437|Tenofovir|tenofovir|mesh-list
43616205|NCT04636437|Lamivudine|lamivudine|mesh-list
43616206|NCT04636437|Emtricitabine|emtricitabine|mesh-list
43650276|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650277|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650278|NCT03015857|Protective Agents|protective agents|mesh-ancestor
43650279|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
43650280|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650281|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650282|NCT03015922|Lenalidomide|lenalidomide|mesh-list
43650283|NCT03015922|Pomalidomide|pomalidomide|mesh-list
43616207|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
43616235|NCT04594746|Amiodarone|amiodarone|mesh-list
43616236|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616237|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
43616238|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43616239|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616240|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616241|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43616242|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43616243|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616244|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616245|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43616246|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43616247|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43616248|NCT04592237|Carboplatin|carboplatin|mesh-list
43616249|NCT04592237|Niraparib|niraparib|mesh-list
43616250|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616251|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43616283|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616284|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616285|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616286|NCT04356638|Analgesics|analgesics|mesh-ancestor
43616287|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
43616288|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616289|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43616290|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616291|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616292|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
43616293|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616331|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616332|NCT04031729|Aspirin|aspirin|mesh-list
43616333|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43616367|NCT03117933|Paclitaxel|paclitaxel|mesh-list
43666516|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
43666517|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43666518|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
43666519|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666520|NCT03757585|Expectorants|expectorants|mesh-ancestor
43666521|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
43666522|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43666523|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
43616398|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616400|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43616402|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616403|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616404|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43616405|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
43616406|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43616407|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
43616408|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616409|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616410|NCT03049540|Tadalafil|tadalafil|mesh-list
43616411|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
43616412|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43666533|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
43666534|NCT03757403|DMP 777|dmp 777|mesh-list
43666535|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
43666536|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
43666537|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43666538|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666539|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666540|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666541|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666548|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666549|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670817|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43851716|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
43666558|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666559|NCT03712943|Nivolumab|nivolumab|mesh-list
43666560|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666561|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666563|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666566|NCT03541447|Octreotide|octreotide|mesh-list
43666567|NCT03541447|Tolvaptan|tolvaptan|mesh-list
43666569|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666571|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43666572|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666573|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
43666574|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666576|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43666577|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43666578|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666579|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616531|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
43616532|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43670818|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
43666583|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666584|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666585|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666586|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
43666587|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43666588|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
43666589|NCT03516604|Citalopram|citalopram|mesh-list
43666590|NCT03516604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43666591|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43666592|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43670819|NCT05424393|Etanercept|etanercept|mesh-list
43666593|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666594|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43666595|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
43666596|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666597|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43666598|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
43616633|NCT00069238|Doxorubicin|doxorubicin|mesh-list
43851740|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43851741|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
43666603|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666604|NCT03511196|Hormones|hormones|mesh-ancestor
43666605|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666606|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666607|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666608|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666609|NCT03466151|Sirolimus|sirolimus|mesh-list
43666610|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650311|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43650313|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43650314|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
43851742|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851743|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851744|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851745|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851746|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666611|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666612|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666613|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666614|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
43666615|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666616|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
43666617|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666618|NCT03434158|Olaparib|olaparib|mesh-list
43851751|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
43851752|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43666619|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43666620|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666632|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666633|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666634|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666635|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666636|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666637|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666638|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
43666639|NCT03421353|Antiviral Agents|antiviral agents|mesh-ancestor
43666640|NCT03421353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666641|NCT03421353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666642|NCT03421353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666643|NCT03421353|Immunologic Factors|immunologic factors|mesh-ancestor
43666644|NCT03421353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666645|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666647|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
43666648|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
43666649|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666650|NCT03318952|Lidocaine|lidocaine|mesh-list
43666651|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
43666652|NCT03318952|Carticaine|carticaine|mesh-list
43666653|NCT03318952|Anesthetics|anesthetics|mesh-list
43851756|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851757|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
43851758|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43851759|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43851760|NCT02510300|Ledipasvir|ledipasvir|mesh-list
43851761|NCT02510300|Velpatasvir|velpatasvir|mesh-list
43851762|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
43851763|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616669|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43616671|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616672|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616673|NCT03145584|Bupivacaine|bupivacaine|mesh-list
43616674|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
43616675|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
43616676|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616677|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616678|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
43616679|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616680|NCT03145194|Ticagrelor|ticagrelor|mesh-list
43616681|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43616682|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43616683|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43616684|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43616685|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
43616686|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616687|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616688|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616689|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
43616721|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616722|NCT03144596|Urological Agents|urological agents|mesh-ancestor
43616723|NCT03145012|Ranitidine|ranitidine|mesh-list
43616724|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43616725|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43666654|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666655|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666656|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
43666657|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666658|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43616728|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
43616729|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
43616730|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616731|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616762|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616764|NCT03144856|Apatinib|apatinib|mesh-list
43616765|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43616766|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43616767|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43616768|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616769|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
43616770|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43616771|NCT03144882|Curcumin|curcumin|mesh-list
43851767|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43851768|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43666659|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43666660|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43666661|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666662|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666663|NCT03230565|Ropivacaine|ropivacaine|mesh-list
43666664|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
43666665|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
43666666|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666667|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838825|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838826|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775600|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
43775601|NCT02344810|Antidotes|antidotes|mesh-ancestor
43775602|NCT02344810|Protective Agents|protective agents|mesh-ancestor
43775603|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
43775604|NCT02344810|Vitamins|vitamins|mesh-ancestor
43775614|NCT02344550|Letrozole|letrozole|mesh-list
43775615|NCT02344550|Leuprolide|leuprolide|mesh-list
43666668|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
43666669|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666670|NCT03220022|Prednisone|prednisone|mesh-list
43666671|NCT03220022|Cortisone|cortisone|mesh-list
43666672|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
43666673|NCT03220022|Rituximab|rituximab|mesh-list
43666674|NCT03220022|Doxorubicin|doxorubicin|mesh-list
43666675|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43666676|NCT03220022|Etoposide|etoposide|mesh-list
43666677|NCT03220022|Vincristine|vincristine|mesh-list
43616774|NCT03144882|Analgesics|analgesics|mesh-ancestor
43616775|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
43616809|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43616810|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616811|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43616812|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43616813|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
43616815|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
43616816|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666678|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
43666679|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
43666680|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43666682|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
43666683|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43666684|NCT03220022|Lenograstim|lenograstim|mesh-list
43666685|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666686|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
43851769|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734425|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666687|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666688|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666689|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666690|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
43666691|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666692|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666693|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666694|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666695|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666696|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666697|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650319|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
43650320|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43650321|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43650322|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
43650324|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
43650325|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650326|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
43616843|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43616844|NCT03143998|Grazoprevir|grazoprevir|mesh-list
43616845|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
43616846|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43616847|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
43616848|NCT03143972|Remifentanil|remifentanil|mesh-list
43616849|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43616850|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616852|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43616853|NCT03143972|Analgesics|analgesics|mesh-ancestor
43616854|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
43616855|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616856|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43616857|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616858|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43616859|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
43775617|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775618|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
43775619|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775620|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43616860|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43616861|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616863|NCT03143972|Narcotics|narcotics|mesh-ancestor
43616864|NCT03143530|Ropivacaine|ropivacaine|mesh-list
43616865|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
43666698|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666699|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
43666700|NCT03220022|Hormones|hormones|mesh-ancestor
43666701|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666702|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666703|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666704|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43666705|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666706|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666707|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666708|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
43666709|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
43666710|NCT03181100|Paclitaxel|paclitaxel|mesh-list
43666711|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43666712|NCT03181100|Bevacizumab|bevacizumab|mesh-list
43666713|NCT03181100|Atezolizumab|atezolizumab|mesh-list
43666714|NCT03181100|Vemurafenib|vemurafenib|mesh-list
43616867|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616868|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616890|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
43616891|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
43616892|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43616894|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
43616895|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43616896|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43666715|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43666716|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
43666717|NCT03181100|Antibodies|antibodies|mesh-list
43666718|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
43666719|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43666720|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
43616906|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
43775647|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666721|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666722|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666723|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666724|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666725|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666726|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666727|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43666728|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43666729|NCT03181100|Growth Substances|growth substances|mesh-ancestor
43666730|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666731|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666732|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
43666733|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43666734|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666735|NCT03177291|Pirfenidone|pirfenidone|mesh-list
43851770|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43851771|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851776|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
43616908|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616909|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616910|NCT03143244|Ketorolac|ketorolac|mesh-list
43616911|NCT03143244|Midazolam|midazolam|mesh-list
43616912|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
43616913|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43616914|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43616915|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616916|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650327|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650328|NCT03015675|Protective Agents|protective agents|mesh-ancestor
43650329|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
43650330|NCT03015519|Incretins|incretins|mesh-ancestor
43650331|NCT03015519|Hormones|hormones|mesh-ancestor
43616917|NCT03143244|Analgesics|analgesics|mesh-ancestor
43616918|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
43616919|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43616920|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43616921|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43616922|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43666736|NCT03177291|Paclitaxel|paclitaxel|mesh-list
43666737|NCT03177291|Carboplatin|carboplatin|mesh-list
43666738|NCT03177291|Pemetrexed|pemetrexed|mesh-list
43666739|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666740|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666741|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666742|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
43616961|NCT03143036|Growth Substances|growth substances|mesh-ancestor
43616962|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666745|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666746|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666747|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43666748|NCT03177291|Analgesics|analgesics|mesh-ancestor
43666749|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
43666750|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666751|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851780|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43851781|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43851782|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43851783|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851784|NCT02203526|Cytarabine|cytarabine|mesh-list
43851785|NCT02203526|Isavuconazole|isavuconazole|mesh-list
43851786|NCT02203526|Rituximab|rituximab|mesh-list
43851787|NCT02203526|Methotrexate|methotrexate|mesh-list
43666752|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43666753|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43666754|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666755|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666756|NCT03147612|Cytarabine|cytarabine|mesh-list
43666757|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
43616994|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43616995|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43616996|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43616999|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
43617000|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617001|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617002|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
43617003|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617004|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
43617005|NCT03142646|Fludarabine|fludarabine|mesh-list
43617006|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43617007|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
43617008|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617009|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617010|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43617011|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
43617012|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617013|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617050|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
43617051|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43617052|NCT03142607|Metronidazole|metronidazole|mesh-list
43617053|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617054|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775670|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
43775691|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
43775692|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617055|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
43851796|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666776|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666778|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666779|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43666780|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
43666781|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666782|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666783|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
43666784|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617091|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
43617092|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
43617093|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617094|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
43666785|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666786|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666787|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43666788|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
43666789|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666790|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43666791|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666792|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666793|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666794|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666795|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617103|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
43617104|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617123|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617125|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617126|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617128|NCT03141970|Prednisolone|prednisolone|mesh-list
43617129|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617130|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
43617131|NCT03141970|Hormones|hormones|mesh-ancestor
43617132|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617133|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617134|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617135|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666821|NCT02871219|Lenalidomide|lenalidomide|mesh-list
43666822|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
43666823|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
43666824|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666825|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43666826|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43666827|NCT02871219|Growth Substances|growth substances|mesh-ancestor
43666828|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666829|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666830|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666837|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617144|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
43617145|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617146|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43617147|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43617148|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617149|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617150|NCT03141645|Ondansetron|ondansetron|mesh-list
43617151|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
43617152|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
43617153|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617154|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617155|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617156|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
43617157|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43617158|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43652728|NCT02988700|Bupivacaine|bupivacaine|mesh-list
43775697|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617191|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617193|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666840|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666841|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666842|NCT02812420|Durvalumab|durvalumab|mesh-list
43666843|NCT02812420|Ipilimumab|ipilimumab|mesh-list
43666844|NCT02812420|Tremelimumab|tremelimumab|mesh-list
43666845|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
43666846|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43666847|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
43666848|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666849|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666850|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
43666851|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666857|NCT02605421|Melphalan|melphalan|mesh-list
43617196|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617197|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617198|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
43617199|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
43617200|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43617201|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617202|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
43617203|NCT03141125|Ethanol|ethanol|mesh-list
43617239|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
43666862|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666863|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
43666864|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666865|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666866|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666867|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
43666868|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666869|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666870|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666871|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666872|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666873|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666874|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666875|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43666877|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
43666878|NCT02556931|Fludarabine|fludarabine|mesh-list
43666879|NCT02556931|Tacrolimus|tacrolimus|mesh-list
43851803|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43851804|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
43851805|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851806|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
43617242|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617268|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617269|NCT03140826|Meropenem|meropenem|mesh-list
43617270|NCT03140826|Tazobactam|tazobactam|mesh-list
43617271|NCT03140826|Piperacillin|piperacillin|mesh-list
43617272|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43666880|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666881|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
43666882|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666883|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666884|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666885|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
43666886|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666887|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666888|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666889|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43666890|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666891|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666892|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43666893|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
43666894|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43666895|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666897|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
43666898|NCT02529852|Doxorubicin|doxorubicin|mesh-list
43666899|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43666900|NCT02529852|Vincristine|vincristine|mesh-list
43666901|NCT02529852|Lenalidomide|lenalidomide|mesh-list
43666902|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
43666903|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666904|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
43666905|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666906|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666907|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666908|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
43666909|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666910|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666919|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666920|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666921|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666922|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666923|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666924|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666925|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43666926|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43666927|NCT02529852|Growth Substances|growth substances|mesh-ancestor
43666928|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666929|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666930|NCT02525757|Paclitaxel|paclitaxel|mesh-list
43666931|NCT02525757|Carboplatin|carboplatin|mesh-list
43666932|NCT02525757|Atezolizumab|atezolizumab|mesh-list
43666933|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666934|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666935|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666936|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666937|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666939|NCT02465268|Molgramostim|molgramostim|mesh-list
43617279|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617280|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
43617281|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617282|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617283|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
43617284|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617285|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43581742|NCT05320874|Antibodies|antibodies|mesh-list
43775698|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838828|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43775715|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775716|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775717|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
43701968|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701969|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
43701970|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
43701971|NCT02721186|Piperaquine|piperaquine|mesh-list
43701972|NCT02721186|Primaquine|primaquine|mesh-list
43701973|NCT02721186|Artenimol|artenimol|mesh-list
43701974|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
43701975|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43617286|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43617287|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43666951|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666952|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
43666953|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666954|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666955|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666956|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666957|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
43666958|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
43666959|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666960|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666961|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
43617289|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617291|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43617292|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
43617318|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43617319|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617320|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43666962|NCT02203643|Hormones|hormones|mesh-ancestor
43666963|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666964|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666965|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43666966|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43666967|NCT02203643|Growth Substances|growth substances|mesh-ancestor
43666968|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
43666969|NCT02188745|Letrozole|letrozole|mesh-list
43666970|NCT02188745|Anastrozole|anastrozole|mesh-list
43666971|NCT02188745|Exemestane|exemestane|mesh-list
43666972|NCT02188745|Estradiol|estradiol|mesh-list
43666973|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43666974|NCT02188745|Estrogens|estrogens|mesh-ancestor
43666976|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666977|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666978|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666979|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43666980|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666981|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617330|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
43617333|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43617334|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43666984|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666986|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43666987|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826587|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826588|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826589|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
43826590|NCT05496764|Hormones|hormones|mesh-ancestor
43826591|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826592|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826593|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826594|NCT05496725|Micafungin|micafungin|mesh-list
43826595|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
43826596|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826597|NCT05496530|Triamcinolone|triamcinolone|mesh-list
43826598|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43826599|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43826600|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43826601|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826602|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
43826603|NCT05496530|Hormones|hormones|mesh-ancestor
43826604|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826605|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826606|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43701997|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43826607|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
43826608|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826609|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826610|NCT05496192|Nivolumab|nivolumab|mesh-list
43826611|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826612|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826613|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43826615|NCT05496179|Metoclopramide|metoclopramide|mesh-list
43617340|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
43617341|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
43617342|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617343|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617368|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617369|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43826618|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
43826619|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826620|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826621|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826622|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43826623|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43826624|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
43826625|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826626|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826627|NCT05496179|Laxatives|laxatives|mesh-ancestor
43666988|NCT01962636|Cyclosporine|cyclosporine|mesh-list
43666989|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
43666990|NCT01962636|Fludarabine|fludarabine|mesh-list
43666991|NCT01962636|Cyclosporins|cyclosporins|mesh-list
43666992|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666993|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
43666994|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666995|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666996|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667001|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667002|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
43667003|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617379|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
43617380|NCT03139708|Tropicamide|tropicamide|mesh-list
43617381|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43617382|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
43617383|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
43617384|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617385|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617386|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
43617387|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43667004|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
43667005|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43851842|NCT02077959|Pidilizumab|pidilizumab|mesh-list
43851843|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
43851844|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851845|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667006|NCT01731782|Bupivacaine|bupivacaine|mesh-list
43667007|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43667008|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
43667009|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667010|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667011|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
43667012|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667013|NCT01722240|Liraglutide|liraglutide|mesh-list
43667014|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702029|NCT02720783|Econazole|econazole|mesh-list
43667015|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667016|NCT01722240|Incretins|incretins|mesh-ancestor
43667018|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667019|NCT01666080|Fludarabine|fludarabine|mesh-list
43667022|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667023|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667024|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43667026|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667027|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
43667035|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667037|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667038|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667039|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43667040|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43667041|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43667042|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667043|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
43667044|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667045|NCT01269190|Proflavine|proflavine|mesh-list
43667046|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43851848|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
43851849|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667047|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617437|NCT03139253|Levofloxacin|levofloxacin|mesh-list
43617438|NCT03139253|Ofloxacin|ofloxacin|mesh-list
43617439|NCT03139253|Tetracycline|tetracycline|mesh-list
43617440|NCT03139253|Tinidazole|tinidazole|mesh-list
43617441|NCT03139253|Furazolidone|furazolidone|mesh-list
43617442|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43617463|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617464|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
43617465|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
43617466|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617467|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617468|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43617469|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
43617471|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617472|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617473|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667048|NCT01229072|Heparin|heparin|mesh-list
43667049|NCT01229072|Calcium heparin|calcium heparin|mesh-list
43667050|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
43667051|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667052|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667053|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667054|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
43667055|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
43667056|NCT01228656|Salicylates|salicylates|mesh-list
43667057|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667058|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
43851850|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851851|NCT01988883|Propranolol|propranolol|mesh-list
43851852|NCT01988883|Modafinil|modafinil|mesh-list
43851853|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43851854|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43851855|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
43851856|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667059|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43667060|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667061|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
43667062|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
43667063|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667064|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667065|NCT01228656|Analgesics|analgesics|mesh-ancestor
43617478|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43617479|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43617480|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43617481|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617482|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617483|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
43667070|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667071|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667072|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667073|NCT01199978|Losartan|losartan|mesh-list
43617486|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
43617487|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
43617488|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
43617489|NCT03139422|Calcium|calcium|mesh-list
43617490|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43617491|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617492|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43617493|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43617494|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617519|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43617520|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43617521|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
43617522|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
43617523|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
43617524|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
43617525|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617526|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617528|NCT03139331|Temozolomide|temozolomide|mesh-list
43617529|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43617530|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43617531|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617532|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617533|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617534|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43617535|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
43667101|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
43667102|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667103|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43667104|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
43667105|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
43667106|NCT01099449|Calcium|calcium|mesh-list
43667107|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43667108|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667109|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667110|NCT01099449|Analgesics|analgesics|mesh-ancestor
43667111|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
43667112|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667113|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
43667114|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667115|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43667116|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
43667117|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43667118|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667119|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702179|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667120|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
43667121|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43667122|NCT00871013|Thalidomide|thalidomide|mesh-list
43667123|NCT00871013|Dexamethasone|dexamethasone|mesh-list
43667124|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
43667125|NCT00871013|Melphalan|melphalan|mesh-list
43667126|NCT00871013|Cisplatin|cisplatin|mesh-list
43667127|NCT00871013|Doxorubicin|doxorubicin|mesh-list
43617547|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
43667149|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851861|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
43851862|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43851863|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43851864|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43851865|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43851866|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43851867|NCT01935921|Cetuximab|cetuximab|mesh-list
43851868|NCT01935921|Ipilimumab|ipilimumab|mesh-list
43851869|NCT01935921|Antibodies|antibodies|mesh-list
43851870|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
43851874|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851875|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43667150|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43667151|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43667152|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667153|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43667154|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
43667155|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667156|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702180|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667157|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43617581|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43617582|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43617583|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617584|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43617585|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617586|NCT03138447|Insulin|insulin|mesh-list
43617587|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43617588|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617610|NCT03137927|Vaccines|vaccines|mesh-list
43617611|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
43617612|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851877|NCT01923649|Lanreotide|lanreotide|mesh-list
43851878|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851879|NCT01810913|Cisplatin|cisplatin|mesh-list
43851880|NCT01810913|Docetaxel|docetaxel|mesh-list
43851881|NCT01810913|Cetuximab|cetuximab|mesh-list
43851882|NCT01810913|Atezolizumab|atezolizumab|mesh-list
43851883|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43851884|NCT01810913|Antibodies|antibodies|mesh-list
43851885|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
43851886|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851887|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
43667158|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667159|NCT00871013|Growth Substances|growth substances|mesh-ancestor
43667160|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667162|NCT00717652|Tretinoin|tretinoin|mesh-list
43667163|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667164|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
43667165|NCT00717652|Hormones|hormones|mesh-ancestor
43667166|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667167|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667168|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667169|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
43667170|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
43667171|NCT00445965|Antibodies|antibodies|mesh-list
43667172|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43667173|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
43667174|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702182|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
43851888|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617620|NCT03137498|Lidocaine|lidocaine|mesh-list
43617621|NCT03137498|Prilocaine|prilocaine|mesh-list
43617624|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617625|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617626|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
43617627|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617628|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43617629|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43617630|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43617631|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617632|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617633|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43617634|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43617635|NCT03137498|Analgesics|analgesics|mesh-ancestor
43617636|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43617637|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617638|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667175|NCT00436254|Molgramostim|molgramostim|mesh-list
43667176|NCT00436254|Sargramostim|sargramostim|mesh-list
43667177|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
43667178|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667179|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667181|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
43667182|NCT00066040|Fluorides|fluorides|mesh-list
43667183|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
43667184|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
43667185|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
43667186|NCT00066040|Protective Agents|protective agents|mesh-ancestor
43667187|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667188|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43667189|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667190|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
43667191|NCT05461131|Azithromycin|azithromycin|mesh-list
43617714|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43617715|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617716|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617718|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617719|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43617720|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43617721|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43617722|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617723|NCT03136666|Candesartan|candesartan|mesh-list
43617724|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
43617725|NCT03136666|Nifedipine|nifedipine|mesh-list
43617756|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43851890|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
43617757|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
43617758|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617759|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617760|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
43617761|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43617762|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43617763|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43617764|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43617765|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667193|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667195|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43617768|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617769|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43617835|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43617836|NCT03135912|Terbinafine|terbinafine|mesh-list
43617837|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
43617838|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43617839|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617840|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617841|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43617842|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
43617843|NCT03136003|Coagulants|coagulants|mesh-ancestor
43617844|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43617845|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
43617846|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667196|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851891|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
43667204|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
43667205|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
43667206|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
43667207|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
43667208|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617851|NCT03135795|Dsuvia|dsuvia|mesh-list
43617852|NCT03135795|Bromides|bromides|mesh-list
43617853|NCT03135795|Propofol|propofol|mesh-list
43617854|NCT03135795|Sevoflurane|sevoflurane|mesh-list
43617855|NCT03135795|Citric Acid|citric acid|mesh-list
43617856|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
43617857|NCT03135795|Rocuronium|rocuronium|mesh-list
43617858|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43617888|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43617889|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43617890|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43617891|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667209|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667210|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667212|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43667213|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667215|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43851893|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851895|NCT01745757|Bevacizumab|bevacizumab|mesh-list
43851896|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851897|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775736|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
43775737|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775738|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
43775739|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775740|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43775741|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
43775742|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
43775743|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
43775744|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702191|NCT02719132|Metformin|metformin|mesh-list
43702192|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
43702193|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702194|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702195|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43702196|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702197|NCT02718820|Docetaxel|docetaxel|mesh-list
43702198|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
43851898|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851899|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
43617902|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43617935|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43617936|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617937|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43617962|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617963|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
43617964|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43617965|NCT03134651|Propofol|propofol|mesh-list
43617966|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43617967|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43617968|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667230|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43667231|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667232|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667233|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43667234|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667235|NCT05409885|Anesthetics|anesthetics|mesh-list
43667236|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667237|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667238|NCT05408312|Vaccines|vaccines|mesh-list
43667239|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
43667240|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667241|NCT05371899|Chiauranib|chiauranib|mesh-list
43617969|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43617970|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
43617971|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
43617972|NCT03134638|Carboplatin|carboplatin|mesh-list
43617973|NCT03134638|Fulvestrant|fulvestrant|mesh-list
43617974|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43617975|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43617976|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43617977|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43617978|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
43617979|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851903|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667257|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667258|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43650336|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43650338|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
43650339|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
43618024|NCT03134612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43618025|NCT03134612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43618026|NCT03134612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43618027|NCT03134573|Interferons|interferons|mesh-list
43618028|NCT03134573|Interferon-beta|interferon-beta|mesh-list
43618029|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
43618030|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618031|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
43618032|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851904|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667261|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667262|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667263|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
43667264|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43667265|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43667266|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43667267|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
43667268|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667269|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43667270|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
43667271|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43667272|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
43667273|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
43667274|NCT05346601|Chiauranib|chiauranib|mesh-list
43667275|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667276|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618034|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618057|NCT03134846|Cetuximab|cetuximab|mesh-list
43618058|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618059|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618060|NCT03134339|Nicotine|nicotine|mesh-list
43618061|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43618062|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
43618063|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667277|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775745|NCT02343692|Pancrelipase|pancrelipase|mesh-list
43775746|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775747|NCT02343666|Plerixafor|plerixafor|mesh-list
43775748|NCT02343666|Carmustine|carmustine|mesh-list
43667278|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667279|NCT05345613|Epinephrine|epinephrine|mesh-list
43667280|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
43851905|NCT01745757|Growth Substances|growth substances|mesh-ancestor
43618064|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618066|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43618067|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
43618068|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618069|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618070|NCT03133975|Vitamin D|vitamin d|mesh-list
43618071|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
43618072|NCT03133975|Vitamins|vitamins|mesh-ancestor
43618073|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
43618074|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618075|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43618076|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618077|NCT03133832|Praziquantel|praziquantel|mesh-list
43618078|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
43618079|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618080|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618082|NCT03133845|Midazolam|midazolam|mesh-list
43618083|NCT03133845|Morphine|morphine|mesh-list
43618084|NCT03133845|Anesthetics|anesthetics|mesh-list
43618085|NCT03133845|Propofol|propofol|mesh-list
43618086|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618087|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618088|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43667281|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43667282|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43618089|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618090|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
43618127|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
43618128|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618129|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618130|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43618131|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618172|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618200|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667283|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667284|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
43667285|NCT05345613|Coagulants|coagulants|mesh-ancestor
43667286|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43618201|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618202|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618203|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618204|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618205|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618206|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
43618207|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43618208|NCT03132714|Amoxicillin|amoxicillin|mesh-list
43667288|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
43667289|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667290|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618209|NCT03132714|Metronidazole|metronidazole|mesh-list
43618210|NCT03132714|Clarithromycin|clarithromycin|mesh-list
43618211|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618212|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618213|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618214|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618215|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43650340|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650341|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824455|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43824456|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
43824457|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702256|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43618217|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618218|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43618219|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43618253|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618254|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618255|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667291|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43667292|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43667293|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
43667294|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618258|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618259|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43618260|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618281|NCT03132142|Capsaicin|capsaicin|mesh-list
43618282|NCT03132142|Menthol|menthol|mesh-list
43618283|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
43667295|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43667296|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
43667297|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
43618284|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618285|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
43618286|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618287|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618288|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43618289|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618290|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43618291|NCT03132142|Protective Agents|protective agents|mesh-ancestor
43618292|NCT03132194|Dapsone|dapsone|mesh-list
43618293|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618294|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
43618295|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43652738|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43702303|NCT02718482|Docetaxel|docetaxel|mesh-list
43618296|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43618297|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43618298|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618299|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618300|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
43618301|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43618303|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
43618304|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
43618305|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618306|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
43618307|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43618308|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618309|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618310|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618311|NCT03132259|Analgesics|analgesics|mesh-ancestor
43618312|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
43618313|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618314|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43618315|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43618316|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43618344|NCT03132051|Triamcinolone|triamcinolone|mesh-list
43667298|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
43667299|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43667300|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
43667301|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43618345|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43618346|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43618347|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43618348|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618349|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
43618350|NCT03132051|Hormones|hormones|mesh-ancestor
43618351|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618352|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618353|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618354|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
43618355|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618356|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824458|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824459|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43824460|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43824461|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43667302|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667303|NCT05317364|Estradiol|estradiol|mesh-list
43667304|NCT05317364|Estrogens|estrogens|mesh-ancestor
43667305|NCT05317364|Hormones|hormones|mesh-ancestor
43618358|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618359|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618360|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43618361|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43618429|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43618430|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
43618431|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43618432|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
43618433|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43618434|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
43618435|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43618436|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43618437|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43618438|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43618439|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43618440|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43618441|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43618442|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43618443|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43618444|NCT03131973|Analgesics|analgesics|mesh-ancestor
43618445|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
43618446|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618447|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618467|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
43618468|NCT03131882|Protective Agents|protective agents|mesh-ancestor
43618469|NCT03131622|Coal Tar|coal tar|mesh-list
43618470|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
43618471|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
43618472|NCT03131583|Colchicine|colchicine|mesh-list
43618473|NCT03131583|Febuxostat|febuxostat|mesh-list
43618474|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
43618475|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618476|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
43618477|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
43618478|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851906|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851907|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
43851908|NCT01711541|Paclitaxel|paclitaxel|mesh-list
43851909|NCT01711541|Cisplatin|cisplatin|mesh-list
43851910|NCT01711541|Carboplatin|carboplatin|mesh-list
43851911|NCT01711541|Fluorouracil|fluorouracil|mesh-list
43851912|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43851913|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
43851914|NCT01711541|Veliparib|veliparib|mesh-list
43851915|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826629|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43826630|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
43826631|NCT05496075|Orlistat|orlistat|mesh-list
43826632|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826633|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702829|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43702830|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
43702831|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
43702832|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702833|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
43702834|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43702835|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702836|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702837|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43702838|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
43702839|NCT02714855|Apixaban|apixaban|mesh-list
43851920|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851921|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
43851922|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851923|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851924|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
43851925|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618586|NCT03130452|Metronidazole|metronidazole|mesh-list
43618587|NCT03130452|Clarithromycin|clarithromycin|mesh-list
43618588|NCT03130452|Lansoprazole|lansoprazole|mesh-list
43618617|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43618618|NCT03130517|Antibodies|antibodies|mesh-list
43618619|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
43618624|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
43618625|NCT03130348|Bortezomib|bortezomib|mesh-list
43618626|NCT03130348|Ichthammol|ichthammol|mesh-list
43618627|NCT03130348|BB 1101|bb 1101|mesh-list
43618628|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618629|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
43618630|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
43618631|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618632|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618633|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618634|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
43851926|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
43618656|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
43618657|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618658|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618659|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43618660|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43618661|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618663|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
43618664|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
43618665|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618666|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618667|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618668|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
43618670|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
43618671|NCT03130153|Salicylates|salicylates|mesh-list
43618672|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43618673|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43618674|NCT03130153|Analgesics|analgesics|mesh-ancestor
43667308|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43667310|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43618675|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
43618676|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618677|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618678|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618679|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618680|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43618681|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43618682|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618683|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43849399|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618684|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43618685|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618686|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
43618687|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618717|NCT03129594|Hormones|hormones|mesh-ancestor
43618718|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851927|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667311|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43667312|NCT05292755|Laxatives|laxatives|mesh-ancestor
43667313|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667315|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
43667316|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
43667317|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667318|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667319|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
43667320|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702428|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
43667321|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43667322|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43775803|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667323|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43618720|NCT03129594|Incretins|incretins|mesh-ancestor
43618721|NCT03129698|Apatinib|apatinib|mesh-list
43618722|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618723|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43618724|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618725|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618726|NCT03129347|Nalmefene|nalmefene|mesh-list
43618727|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43618728|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618729|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
43667324|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667325|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667327|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43667328|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667329|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
43667330|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43667331|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43618734|NCT03129490|Dabigatran|dabigatran|mesh-list
43618735|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43618736|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
43618737|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43618738|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
43618758|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43618759|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43667332|NCT05209412|Aspirin|aspirin|mesh-list
43667333|NCT05209412|Paclitaxel|paclitaxel|mesh-list
43667334|NCT05209412|Clopidogrel|clopidogrel|mesh-list
43667335|NCT05209412|Ticagrelor|ticagrelor|mesh-list
43667336|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43667337|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667338|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
43667339|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
43667340|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
43618771|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43618772|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
43667341|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667342|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667343|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667345|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
43667346|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667347|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667348|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667349|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667350|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667351|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667352|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43667353|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43775804|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775805|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43775806|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
43775826|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43775828|NCT02343614|Analgesics|analgesics|mesh-ancestor
43775829|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
43667354|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667356|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43667357|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43667358|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43667359|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
43702840|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43702841|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
43618774|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618775|NCT03129022|Anesthetics|anesthetics|mesh-list
43618776|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618777|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618778|NCT03129009|Anesthetics|anesthetics|mesh-list
43618779|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618780|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851929|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43851930|NCT01695941|Rituximab|rituximab|mesh-list
43851931|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43851932|NCT01695941|Bortezomib|bortezomib|mesh-list
43851933|NCT01695941|Antibodies|antibodies|mesh-list
43851934|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
43851935|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851936|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
43851937|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851938|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851939|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851940|NCT01244789|Paclitaxel|paclitaxel|mesh-list
43667360|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667361|NCT05208307|Dexamethasone|dexamethasone|mesh-list
43667362|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
43667363|NCT05208307|Pomalidomide|pomalidomide|mesh-list
43667364|NCT05208307|Ichthammol|ichthammol|mesh-list
43667365|NCT05208307|BB 1101|bb 1101|mesh-list
43667366|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667367|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
43667368|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
43667369|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667370|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851941|NCT01244789|Carboplatin|carboplatin|mesh-list
43667371|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775830|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775831|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775832|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775833|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775834|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43775835|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43775836|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775837|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702443|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43702444|NCT02717780|Fentanyl|fentanyl|mesh-list
43702445|NCT02717780|Remifentanil|remifentanil|mesh-list
43702446|NCT02717780|Sevoflurane|sevoflurane|mesh-list
43702447|NCT02717780|Desflurane|desflurane|mesh-list
43702448|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43702449|NCT02717780|Narcotics|narcotics|mesh-ancestor
43702450|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702451|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702452|NCT02717780|Analgesics|analgesics|mesh-ancestor
43667372|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
43667373|NCT05208307|Hormones|hormones|mesh-ancestor
43667374|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667375|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667376|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667377|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
43667378|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667379|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667380|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
43618783|NCT03128736|Lansoprazole|lansoprazole|mesh-list
43618784|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43618785|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43618786|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43618787|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618788|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618789|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
43618790|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618791|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
43618792|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618793|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667381|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667382|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667383|NCT05208307|Growth Substances|growth substances|mesh-ancestor
43667384|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667385|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
43667386|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
43667387|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43667388|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667389|NCT05189223|Buprenorphine|buprenorphine|mesh-list
43667390|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43667391|NCT05189223|Narcotics|narcotics|mesh-ancestor
43667392|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667393|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667394|NCT05189223|Analgesics|analgesics|mesh-ancestor
43667395|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
43667397|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43667398|NCT05186675|Epinephrine|epinephrine|mesh-list
43667399|NCT05186675|Racepinephrine|racepinephrine|mesh-list
43667400|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
43667401|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43618794|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43618821|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618822|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618823|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43618824|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43618825|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43618826|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618827|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43618828|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667403|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
43667404|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667405|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667406|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667407|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43667408|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43667409|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
43775838|NCT02343393|Hydralazine|hydralazine|mesh-list
43667410|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667411|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43667412|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
43667414|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
43667415|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43667416|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43667417|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618829|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618830|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
43618831|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43618832|NCT03128346|Narcotics|narcotics|mesh-ancestor
43618833|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618834|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43618835|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43618836|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
43618837|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
43618838|NCT03128203|Oxytocin|oxytocin|mesh-list
43618839|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
43618840|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849400|NCT03931642|Blinatumomab|blinatumomab|mesh-list
43618841|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667418|NCT05172531|Cisatracurium|cisatracurium|mesh-list
43667419|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43667420|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43667421|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667422|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667423|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43667424|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667425|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667426|NCT05163106|Letrozole|letrozole|mesh-list
43667427|NCT05163106|Goserelin|goserelin|mesh-list
43667428|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667429|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43667430|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43667431|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667432|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667433|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43667434|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
43667435|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667436|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667437|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667438|NCT05153317|Ivacaftor|ivacaftor|mesh-list
43618842|NCT03127800|Morphine|morphine|mesh-list
43618843|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43618844|NCT03127800|Narcotics|narcotics|mesh-ancestor
43824464|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824465|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824466|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824467|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43618845|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43618846|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618914|NCT03127124|Fluorouracil|fluorouracil|mesh-list
43618915|NCT03127124|Bevacizumab|bevacizumab|mesh-list
43618916|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
43618917|NCT03127124|Calcium|calcium|mesh-list
43618918|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
43618919|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43618920|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618921|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
43618950|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652746|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
43618951|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43618952|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667439|NCT05153317|Elexacaftor|elexacaftor|mesh-list
43667440|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43667441|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667442|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667443|NCT05120141|Listerine|listerine|mesh-list
43618953|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43618954|NCT03126877|Mitomycins|mitomycins|mesh-list
43618955|NCT03126877|Mitomycin|mitomycin|mesh-list
43618956|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43618957|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43618958|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
43618959|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618960|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43618961|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43618962|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
43667444|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43667445|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667446|NCT05117398|Dalbavancin|dalbavancin|mesh-list
43667447|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667448|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667449|NCT05098470|Metformin|metformin|mesh-list
43667450|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
43618964|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
43618965|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43618966|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
43618967|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43618968|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619009|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43619010|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619011|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43619012|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
43619014|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
43667451|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43667452|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667453|NCT05093205|Midazolam|midazolam|mesh-list
43667454|NCT05093205|Atorvastatin|atorvastatin|mesh-list
43667455|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
43619016|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619017|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619018|NCT03126708|Paclitaxel|paclitaxel|mesh-list
43619019|NCT03126708|Cisplatin|cisplatin|mesh-list
43619020|NCT03126708|Cetuximab|cetuximab|mesh-list
43619021|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43619022|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667456|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43667457|NCT05093205|Estradiol|estradiol|mesh-list
43667458|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43667459|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43667460|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667461|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667462|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43667463|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43667464|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43667465|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43667466|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
43667467|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
43667468|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
43667469|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
43667470|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851942|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43619024|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43619025|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702538|NCT02716415|Protective Agents|protective agents|mesh-ancestor
43619026|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619027|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619029|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43619030|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43775857|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43619031|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43619032|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43619033|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
43619034|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619035|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619036|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619037|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
43667471|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667472|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43667473|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43667474|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
43667475|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43667476|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43667477|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667478|NCT05093205|Estrogens|estrogens|mesh-ancestor
43667479|NCT05093205|Hormones|hormones|mesh-ancestor
43667480|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667481|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43667482|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
43667483|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43667484|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43667485|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43667486|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43667487|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43667489|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
43667490|NCT05080530|Vitamins|vitamins|mesh-ancestor
43667491|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
43667492|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619038|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43775858|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775859|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43775860|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775861|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619039|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619040|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619041|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619042|NCT03126422|Analgesics|analgesics|mesh-ancestor
43619043|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
43619044|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619045|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43824468|NCT05512351|Growth Substances|growth substances|mesh-ancestor
43824469|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824470|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
43824471|NCT05512325|Bevacizumab|bevacizumab|mesh-list
43667493|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43667494|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43667495|NCT05077969|Celecoxib|celecoxib|mesh-list
43667496|NCT05077969|Famotidine|famotidine|mesh-list
43667497|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667498|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667499|NCT05077969|Analgesics|analgesics|mesh-ancestor
43667500|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
43667501|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667502|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667503|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667504|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667505|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43667506|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667507|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667508|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667509|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43824472|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824474|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824475|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824476|NCT05512325|Growth Substances|growth substances|mesh-ancestor
43619046|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43619047|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43619048|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619049|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619050|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619051|NCT03126461|Nivolumab|nivolumab|mesh-list
43667510|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667511|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43667512|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
43667514|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667515|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
43667516|NCT05073627|Dabigatran|dabigatran|mesh-list
43667517|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
43667518|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43667519|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
43667520|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667521|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667522|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
43667530|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851943|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851944|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
43775869|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43851945|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851946|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851947|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851949|NCT01126190|Doxorubicin|doxorubicin|mesh-list
43851950|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667532|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667533|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667534|NCT05063734|Growth Substances|growth substances|mesh-ancestor
43667535|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619070|NCT03126123|Acetic Acid|acetic acid|mesh-list
43619071|NCT03126123|Retinol acetate|retinol acetate|mesh-list
43619072|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43619073|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619074|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43619075|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
43619076|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619077|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43619078|NCT03126123|Protective Agents|protective agents|mesh-ancestor
43619079|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619081|NCT03126084|Tramadol|tramadol|mesh-list
43619082|NCT03126084|Bupivacaine|bupivacaine|mesh-list
43619083|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619084|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
43619085|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619087|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
43619088|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619089|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619090|NCT03126084|Analgesics|analgesics|mesh-ancestor
43619091|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
43619092|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619093|NCT03126084|Narcotics|narcotics|mesh-ancestor
43619094|NCT03125980|Capecitabine|capecitabine|mesh-list
43619095|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
43619096|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619097|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
43619098|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619099|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619100|NCT03126097|Drospirenone|drospirenone|mesh-list
43619101|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43619102|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43619103|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43619104|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43619105|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43619106|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
43619107|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43826647|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43851954|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851955|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851956|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43851957|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851958|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851959|NCT01065532|Paclitaxel|paclitaxel|mesh-list
43851960|NCT01065532|Everolimus|everolimus|mesh-list
43851965|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851966|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851967|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619122|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619123|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619124|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43619125|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43619126|NCT03126071|Growth Substances|growth substances|mesh-ancestor
43619127|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619128|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
43619129|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43619130|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43619131|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619132|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826648|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
43826649|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
43826650|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
43826651|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
43851968|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
43824477|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824479|NCT05512130|Empagliflozin|empagliflozin|mesh-list
43846420|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43650342|NCT03015246|Morphine|morphine|mesh-list
43619133|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619134|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
43619135|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43619136|NCT03125772|Paclitaxel|paclitaxel|mesh-list
43619137|NCT03125772|Everolimus|everolimus|mesh-list
43619138|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43619139|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619140|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
43619141|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
43619142|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
43619143|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775890|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775891|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775892|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775893|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
43775912|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775913|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43775914|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775915|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775916|NCT02342587|Lapatinib|lapatinib|mesh-list
43775917|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775918|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43775919|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830788|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43830789|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
43619144|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619145|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
43619146|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826652|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826653|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
43826654|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826655|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826656|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43826657|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
43826658|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826659|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619152|NCT03125694|Hormones|hormones|mesh-ancestor
43619153|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619154|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43619155|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
43619157|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619158|NCT03125746|Exemestane|exemestane|mesh-list
43619159|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619160|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43826660|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43851969|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667538|NCT05007132|Trifluridine|trifluridine|mesh-list
43667539|NCT05007132|Bevacizumab|bevacizumab|mesh-list
43667540|NCT05007132|Panitumumab|panitumumab|mesh-list
43619163|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619165|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619166|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619167|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619169|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
43667541|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43667542|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667543|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667544|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667545|NCT05007132|Growth Substances|growth substances|mesh-ancestor
43667546|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667547|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667548|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
43667549|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667550|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
43652747|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43652748|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43652749|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652750|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652751|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652752|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652753|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
43652754|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43830812|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
43830813|NCT05344404|Vitamins|vitamins|mesh-ancestor
43830814|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
43667551|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667552|NCT04977232|Citalopram|citalopram|mesh-list
43619200|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43619202|NCT03124524|Hormones|hormones|mesh-ancestor
43619203|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619204|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619205|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43619206|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
43619207|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619208|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43619209|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43619211|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43619212|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619213|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43619214|NCT03124524|Diuretics|diuretics|mesh-ancestor
43619215|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
43619216|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43619217|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775920|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775922|NCT02342509|Desflurane|desflurane|mesh-list
43775923|NCT02342509|Isoflurane|isoflurane|mesh-list
43775924|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43775925|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43775926|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
43775927|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
43775928|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775929|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775930|NCT02342574|Olorofim|olorofim|mesh-list
43775931|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
43775932|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775933|NCT02342392|Ranibizumab|ranibizumab|mesh-list
43775934|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43619230|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43619231|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43619232|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43619233|NCT03124082|Lidocaine|lidocaine|mesh-list
43851970|NCT01059786|Rituximab|rituximab|mesh-list
43851971|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43667553|NCT04977232|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43667554|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43667555|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619240|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775935|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43775936|NCT02342392|Growth Substances|growth substances|mesh-ancestor
43702686|NCT02715336|Leuprolide|leuprolide|mesh-list
43702687|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43702688|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
43702689|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619241|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
43619242|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619250|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43619251|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
43619252|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43619253|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43619254|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619255|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619256|NCT03124082|Narcotics|narcotics|mesh-ancestor
43619257|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619258|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
43619259|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
43619260|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43619261|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43619262|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43619264|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
43619266|NCT03123770|Doxorubicin|doxorubicin|mesh-list
43619267|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43619268|NCT03123770|Epirubicin|epirubicin|mesh-list
43851972|NCT01059786|Pentostatin|pentostatin|mesh-list
43619270|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
43619271|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775937|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775938|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
43619272|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619273|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43619274|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
43619275|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619276|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619277|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43619278|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
43619290|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43619291|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619293|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619294|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43619295|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851973|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851974|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851975|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
43851976|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851977|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851978|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43851979|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
43619299|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
43619300|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619301|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619302|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619303|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
43619304|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619305|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619306|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
43619307|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619308|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43619309|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619310|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
43650350|NCT03015246|Analgesics|analgesics|mesh-ancestor
43650351|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
43619311|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619312|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43619313|NCT03123406|Cinacalcet|cinacalcet|mesh-list
43619314|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43619315|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619316|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43619317|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619318|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619319|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43619320|NCT03123484|Gefitinib|gefitinib|mesh-list
43619321|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619322|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43619323|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619324|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619325|NCT03123289|Gallium citrate|gallium citrate|mesh-list
43619326|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619327|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43619328|NCT03123445|Gemcitabine|gemcitabine|mesh-list
43619329|NCT03123445|Cisplatin|cisplatin|mesh-list
43619330|NCT03123445|Endostar protein|endostar protein|mesh-list
43667556|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667557|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667558|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
43619334|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
43619350|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619352|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
43619353|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849405|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
43619354|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619355|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619356|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
43619357|NCT03123276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619358|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619360|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43619362|NCT03123016|Analgesics|analgesics|mesh-ancestor
43619363|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
43619364|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619365|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619366|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619367|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619368|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43619369|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43619370|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619371|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619372|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
43619374|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
43702842|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43702843|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
43702844|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702845|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702846|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
43702847|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
43702848|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
43702849|NCT02714543|Antioxidants|antioxidants|mesh-list
43702850|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702851|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43702852|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
43702853|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702854|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
43702855|NCT02714543|Protective Agents|protective agents|mesh-ancestor
43702856|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702857|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43702858|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702859|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43702860|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702861|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702862|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
43847350|NCT04115878|Urological Agents|urological agents|mesh-ancestor
43702863|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43702864|NCT02714166|Protective Agents|protective agents|mesh-ancestor
43702873|NCT02714231|Analgesics|analgesics|mesh-ancestor
43775976|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775977|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43775978|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43702874|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
43702875|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702876|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702877|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702878|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43702879|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43702880|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702881|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702882|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
43702883|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43702884|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
43702885|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
43702886|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702887|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
43702888|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43702889|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
43702890|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702891|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43619375|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619376|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
43619377|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619378|NCT03123107|Protective Agents|protective agents|mesh-ancestor
43619379|NCT03122938|Lactoferrin|lactoferrin|mesh-list
43619380|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619381|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
43619382|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43619383|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43619384|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619385|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
43619386|NCT03122782|Coagulants|coagulants|mesh-ancestor
43619387|NCT03122561|Acetaminophen|acetaminophen|mesh-list
43619388|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619389|NCT03122561|Analgesics|analgesics|mesh-ancestor
43619390|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
43619391|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619392|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619393|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
43619403|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667559|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667560|NCT04977232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43667561|NCT04977232|Antidepressive Agents|antidepressive agents|mesh-ancestor
43667563|NCT04974814|Atorvastatin|atorvastatin|mesh-list
43667564|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43667565|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43667566|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43667567|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
43667568|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667569|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43667570|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43667571|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667573|NCT04971356|Ticagrelor|ticagrelor|mesh-list
43667574|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667575|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667577|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
43667578|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667579|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667580|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667581|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667582|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667583|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667584|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619404|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
43650352|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650353|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43650354|NCT03014947|Adalimumab|adalimumab|mesh-list
43650355|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650356|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619405|NCT03122756|Hormones|hormones|mesh-ancestor
43619406|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619407|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667608|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43667609|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
43667610|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
43667611|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43667612|NCT04899778|Estradiol|estradiol|mesh-list
43667613|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43667614|NCT04899778|Trace Elements|trace elements|mesh-ancestor
43667615|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
43619408|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619410|NCT03122678|Vitamins|vitamins|mesh-ancestor
43619411|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
43619412|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619413|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
43619415|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619416|NCT03122665|Analgesics|analgesics|mesh-ancestor
43619417|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
43619418|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619419|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619420|NCT03122769|Metformin|metformin|mesh-list
43619421|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619422|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619423|NCT03122353|Calcitriol|calcitriol|mesh-list
43619424|NCT03122353|Betamethasone|betamethasone|mesh-list
43667616|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667618|NCT04899778|Hormones|hormones|mesh-ancestor
43667619|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619425|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
43619426|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43619427|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
43619428|NCT03122353|Calcipotriene|calcipotriene|mesh-list
43619429|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43619430|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619431|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
43619433|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619434|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619435|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43619436|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
43667620|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43619459|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43619461|NCT03121963|Gabapentin|gabapentin|mesh-list
43619483|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43619484|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43619485|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619486|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
43619487|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
43619488|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
43619489|NCT03122132|Ritonavir|ritonavir|mesh-list
43619490|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43619491|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43650357|NCT03015168|Capecitabine|capecitabine|mesh-list
43650358|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43667626|NCT04878211|Interferons|interferons|mesh-list
43667627|NCT04878211|Ofatumumab|ofatumumab|mesh-list
43667628|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
43667629|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
43667630|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667631|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
43667632|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667633|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43667634|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
43619500|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43619501|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43619502|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619503|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619505|NCT03122041|Hormones|hormones|mesh-ancestor
43619506|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619507|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43619508|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
43619509|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619510|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619511|NCT03121846|Apatinib|apatinib|mesh-list
43619512|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619513|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43619514|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619524|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43619525|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619526|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43619527|NCT03122067|Oxytocin|oxytocin|mesh-list
43702867|NCT02714231|Diclofenac|diclofenac|mesh-list
43619528|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
43619529|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619530|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619531|NCT03121833|Endostar protein|endostar protein|mesh-list
43619532|NCT03121833|Endostatins|endostatins|mesh-list
43619533|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43619534|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43619535|NCT03121833|Growth Substances|growth substances|mesh-ancestor
43667637|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667638|NCT04863950|Lomustine|lomustine|mesh-list
43667639|NCT04863950|Imipramine|imipramine|mesh-list
43619536|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619537|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
43619538|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619540|NCT03121807|Fluorouracil|fluorouracil|mesh-list
43619541|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
43619542|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
43619543|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619544|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619546|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619547|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
43619548|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619549|NCT03121807|Antidotes|antidotes|mesh-ancestor
43619550|NCT03121807|Protective Agents|protective agents|mesh-ancestor
43619551|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
43619552|NCT03121807|Vitamins|vitamins|mesh-ancestor
43619553|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
43619554|NCT03121521|Melatonin|melatonin|mesh-list
43619555|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
43619556|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619557|NCT03121521|Protective Agents|protective agents|mesh-ancestor
43619558|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667640|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667641|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
43667642|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667643|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667644|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43667645|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
43667646|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43667647|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43667648|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43667649|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667650|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
43667651|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667652|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667653|NCT04831593|Anesthetics|anesthetics|mesh-list
43667654|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667655|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667656|NCT04824911|Aspirin|aspirin|mesh-list
43667658|NCT04824911|Atorvastatin|atorvastatin|mesh-list
43667659|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43734426|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43619559|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619560|NCT03121664|Itraconazole|itraconazole|mesh-list
43619561|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
43619562|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619563|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43619564|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43619565|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619566|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619567|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43619568|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
43619569|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667660|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667661|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667663|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
43667664|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667665|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667666|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667667|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667668|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43667669|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667670|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667671|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43667672|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667673|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667674|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
43667675|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43667676|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43667677|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
43667678|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43667679|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43667680|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43667681|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43667685|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
43667698|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43667699|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
43667700|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667701|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667703|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43667704|NCT04800302|Narcotics|narcotics|mesh-ancestor
43667705|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776007|NCT02342002|Mifepristone|mifepristone|mesh-list
43776034|NCT02341963|Ketamine|ketamine|mesh-list
43667706|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667707|NCT04800302|Analgesics|analgesics|mesh-ancestor
43667708|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
43667709|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667710|NCT04784754|Melatonin|melatonin|mesh-list
43667711|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
43667712|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667713|NCT04784754|Protective Agents|protective agents|mesh-ancestor
43667714|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619591|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43619593|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619596|NCT03121352|Carboplatin|carboplatin|mesh-list
43619597|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
43619598|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43619599|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619600|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
43619601|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
43619602|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
43619603|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619604|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43619605|NCT03121599|Alovudine|alovudine|mesh-list
43619606|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
43619607|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619608|NCT03121690|Prednisone|prednisone|mesh-list
43619609|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619610|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
43619611|NCT03121690|Hormones|hormones|mesh-ancestor
43619612|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619613|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619614|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43619615|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619619|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43776039|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43776040|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43776041|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
43776042|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
43619621|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619622|NCT03121547|Analgesics|analgesics|mesh-ancestor
43619623|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
43619624|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619632|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
43619633|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619634|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
43619635|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43619636|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
43619637|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619638|NCT03121222|Expectorants|expectorants|mesh-ancestor
43619639|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650367|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
43650368|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43619654|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
43619655|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619656|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
43619657|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43619658|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43619659|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619660|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43619661|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43619662|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619663|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619664|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
43619665|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
43619674|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43619676|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619677|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43619678|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43619679|NCT03121079|Interferons|interferons|mesh-list
43619680|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
43619681|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619682|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
43619683|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619684|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
43619685|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619686|NCT03120923|Triamcinolone|triamcinolone|mesh-list
43619701|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619702|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619703|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
43619705|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619706|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619707|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
43619708|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619709|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43619710|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619711|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43619712|NCT03120728|Etonogestrel|etonogestrel|mesh-list
43619713|NCT03120728|NuvaRing|nuvaring|mesh-list
43619714|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
43619715|NCT03120728|Estradiol|estradiol|mesh-list
43619716|NCT03120728|Estrogens|estrogens|mesh-ancestor
43619718|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619719|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851980|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851981|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43619721|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43619722|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43619723|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43619724|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43619725|NCT03120442|Fentanyl|fentanyl|mesh-list
43619726|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
43619727|NCT03120442|Propofol|propofol|mesh-list
43619728|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619729|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619730|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619731|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43619732|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
43667722|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667723|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667724|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
43667726|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667727|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43650369|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650370|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
43650371|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619734|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619735|NCT03120442|Analgesics|analgesics|mesh-ancestor
43619736|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
43619737|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619738|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43619739|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43619740|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43619741|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619742|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619743|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619744|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43619745|NCT03120442|Narcotics|narcotics|mesh-ancestor
43619746|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43619747|NCT03120468|Topiramate|topiramate|mesh-list
43619766|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43619767|NCT03120715|Progesterone|progesterone|mesh-list
43619768|NCT03120715|Estrogens|estrogens|mesh-list
43619769|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
43619770|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43619771|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43619772|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619773|NCT03120715|Progestins|progestins|mesh-ancestor
43619774|NCT03120715|Hormones|hormones|mesh-ancestor
43667728|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667729|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43667730|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
43667731|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
43667732|NCT04766853|Protective Agents|protective agents|mesh-ancestor
43667733|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43667734|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
43667735|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667737|NCT04743934|Hormones|hormones|mesh-ancestor
43667738|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667739|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776059|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43776060|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43776061|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
43776080|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
43652764|NCT02988089|Metronidazole|metronidazole|mesh-list
43667740|NCT04742959|Paclitaxel|paclitaxel|mesh-list
43667741|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43667742|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667743|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
43667744|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
43667745|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667746|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619791|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619792|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43667747|NCT04730258|Azacitidine|azacitidine|mesh-list
43667748|NCT04730258|Decitabine|decitabine|mesh-list
43667749|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43667750|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
43667751|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667752|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667753|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667754|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
43667755|NCT04721457|Listerine|listerine|mesh-list
43667756|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43667757|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
43667758|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43667760|NCT04721457|Povidone|povidone|mesh-list
43667761|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43667762|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
43667763|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
43667764|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
43667765|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43667766|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667767|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
43667768|NCT04721457|Protective Agents|protective agents|mesh-ancestor
43849406|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849407|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849408|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43849409|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
43849410|NCT03929640|Acetaminophen|acetaminophen|mesh-list
43849411|NCT03929640|Ibuprofen|ibuprofen|mesh-list
43849412|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619794|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619795|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619796|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43619797|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43619799|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619800|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619820|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43667769|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667770|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
43667771|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
43667772|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43667773|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
43667774|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667775|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
43667776|NCT04711304|Protective Agents|protective agents|mesh-ancestor
43667777|NCT04710719|Triamcinolone|triamcinolone|mesh-list
43667778|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43619822|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619823|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
43619824|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619825|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619826|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619827|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43619829|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
43776085|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
43619830|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619831|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43667780|NCT04710719|Fluorouracil|fluorouracil|mesh-list
43667781|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43667782|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
43667783|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667784|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43667785|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667786|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650373|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43650374|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
43650375|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650376|NCT03014882|Expectorants|expectorants|mesh-ancestor
43650377|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650378|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43619832|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43619833|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43619834|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619835|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619836|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619838|NCT05465330|Desflurane|desflurane|mesh-list
43619839|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43619840|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619841|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667787|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
43667788|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667789|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667790|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
43667791|NCT04710719|Hormones|hormones|mesh-ancestor
43667792|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619842|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43619843|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
43619844|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
43619845|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43619846|NCT05465135|Artenimol|artenimol|mesh-list
43619847|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
43619848|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43619849|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43776098|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
43776099|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776100|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776101|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776102|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776103|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43776104|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43776105|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619850|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619851|NCT05465031|Valsartan|valsartan|mesh-list
43667793|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667794|NCT04704271|Dronabinol|dronabinol|mesh-list
43667795|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
43667796|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667797|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43667798|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667799|NCT04704271|Analgesics|analgesics|mesh-ancestor
43667800|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
43667801|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667802|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43667803|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43667804|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667805|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619852|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43619853|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619854|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43619855|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43619856|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619857|NCT05464979|Fentanyl|fentanyl|mesh-list
43619888|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43619889|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43619890|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43619891|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43619892|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
43619893|NCT05464953|Hormones|hormones|mesh-ancestor
43619894|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619895|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619896|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43619897|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
43619898|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619899|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619900|NCT05464862|Lidocaine|lidocaine|mesh-list
43619901|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619902|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
43619922|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43619923|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43619925|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43619926|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619927|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
43619928|NCT05464433|Analgesics|analgesics|mesh-ancestor
43619929|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
43619930|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619931|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619932|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43619933|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43619934|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776106|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43776107|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43703136|NCT02712528|Sufentanil|sufentanil|mesh-list
43619935|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619936|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619937|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
43619938|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43619939|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43619940|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619941|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
43650380|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650381|NCT03014882|Protective Agents|protective agents|mesh-ancestor
43650382|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650383|NCT03014882|Antidotes|antidotes|mesh-ancestor
43650384|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
43650385|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
43650386|NCT03014713|Dezocine|dezocine|mesh-list
43650387|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43650388|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650389|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650390|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650391|NCT03014713|Analgesics|analgesics|mesh-ancestor
43650392|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
43650393|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619942|NCT05464394|Coagulants|coagulants|mesh-ancestor
43619943|NCT05464303|Antibodies|antibodies|mesh-list
43619944|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43619945|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
43619946|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43619947|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
43619948|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619949|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43619950|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43619951|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619952|NCT05463861|Lemborexant|lemborexant|mesh-list
43619953|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43619954|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619965|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619966|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
43619967|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619968|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619969|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43619970|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619972|NCT05463809|Analgesics|analgesics|mesh-list
43619973|NCT05463809|Ropivacaine|ropivacaine|mesh-list
43619974|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
43619975|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
43667869|NCT04561739|Ticagrelor|ticagrelor|mesh-list
43619977|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619978|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
43619979|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619981|NCT05463809|Narcotics|narcotics|mesh-ancestor
43619982|NCT05463627|Metformin|metformin|mesh-list
43619983|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43619984|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619985|NCT05463614|Propranolol|propranolol|mesh-list
43619986|NCT05463614|Propafenone|propafenone|mesh-list
43619987|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43619988|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43619989|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
43619990|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43619991|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43619992|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43619993|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43619994|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43619995|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
43619996|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43619997|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43650394|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43650395|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43650396|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650397|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650398|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650399|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650400|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43650401|NCT03014713|Narcotics|narcotics|mesh-ancestor
43650402|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650403|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650404|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650405|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650406|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650407|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43619998|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620001|NCT05463601|Fulvestrant|fulvestrant|mesh-list
43620002|NCT05463601|Exemestane|exemestane|mesh-list
43620003|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620004|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43620005|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43620006|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620007|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620008|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43620009|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
43620010|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43620011|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620012|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43620014|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43620015|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43620023|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
43620024|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620025|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620026|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
43620027|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43620028|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43620029|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620030|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43620031|NCT05463393|Xanthohumol|xanthohumol|mesh-list
43620032|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620033|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620034|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43620035|NCT05463393|Growth Substances|growth substances|mesh-ancestor
43620036|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620037|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620038|NCT05463367|Acetaminophen|acetaminophen|mesh-list
43620039|NCT05463367|Naproxen|naproxen|mesh-list
43620040|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43620041|NCT05463367|Oxymorphone|oxymorphone|mesh-list
43620042|NCT05463367|Morphine|morphine|mesh-list
43620043|NCT05463367|Oxycodone|oxycodone|mesh-list
43620044|NCT05463367|Tramadol|tramadol|mesh-list
43620045|NCT05463367|Hydrocodone|hydrocodone|mesh-list
43620046|NCT05463367|Codeine|codeine|mesh-list
43620047|NCT05463367|Levodopa|levodopa|mesh-list
43620048|NCT05463367|Carbidopa|carbidopa|mesh-list
43620049|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43620050|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43620051|NCT05463367|Narcotics|narcotics|mesh-ancestor
43650409|NCT03014687|Cephalosporins|cephalosporins|mesh-list
43650410|NCT03014687|Trimethoprim|trimethoprim|mesh-list
43650411|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
43650412|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650413|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43650414|NCT03014687|Renal Agents|renal agents|mesh-ancestor
43650415|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
43650416|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43620052|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620053|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620054|NCT05463367|Analgesics|analgesics|mesh-ancestor
43620055|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
43620056|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620057|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620058|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
43620059|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43620060|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620061|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620062|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
43620063|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43620064|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620066|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43620067|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43620068|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
43620069|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620070|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43620071|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
43620072|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
43620073|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620074|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
43620075|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
43620076|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43620077|NCT05463354|Vaccines|vaccines|mesh-list
43620078|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
43620079|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620080|NCT05462470|Liver Extracts|liver extracts|mesh-list
43620081|NCT05462470|Hematinics|hematinics|mesh-ancestor
43620082|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43620083|NCT05461339|Ranibizumab|ranibizumab|mesh-list
43620084|NCT05461339|Antibodies|antibodies|mesh-list
43620085|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43620104|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
43620105|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620106|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620107|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
43620108|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620109|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620110|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
43620111|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620112|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620113|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43620115|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620116|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620117|NCT05437835|Ropivacaine|ropivacaine|mesh-list
43620118|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
43620119|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
43620120|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620121|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620122|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
43650425|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650426|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650427|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43620127|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620128|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620129|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620130|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43620131|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
43620132|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620133|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620134|NCT05429489|Morphine|morphine|mesh-list
43667995|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
43620135|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43620136|NCT05429489|Narcotics|narcotics|mesh-ancestor
43620137|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620138|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620140|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
43620141|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620142|NCT05397600|Bimatoprost|bimatoprost|mesh-list
43620143|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43620144|NCT05395507|Interferons|interferons|mesh-list
43620156|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620157|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620158|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
43620159|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620160|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43620161|NCT05373225|Protective Agents|protective agents|mesh-ancestor
43620162|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620164|NCT05341323|Bupivacaine|bupivacaine|mesh-list
43620165|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
43620166|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
43620167|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620168|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620169|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
43620170|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620171|NCT05341323|Analgesics|analgesics|mesh-ancestor
43620172|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43620173|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43620174|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
43620175|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43620176|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43620177|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620178|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620179|NCT05336266|Ketorolac|ketorolac|mesh-list
43620180|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43620181|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43620182|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620183|NCT05336266|Analgesics|analgesics|mesh-ancestor
43620184|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
43620185|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620186|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620187|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620188|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620189|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43620190|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650428|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650429|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
43650430|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43703329|NCT02711176|Clarithromycin|clarithromycin|mesh-list
43703330|NCT02711176|Tinidazole|tinidazole|mesh-list
43703331|NCT02711176|Esomeprazole|esomeprazole|mesh-list
43703332|NCT02711176|Lansoprazole|lansoprazole|mesh-list
43703333|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703334|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703335|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43703336|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650431|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
43650432|NCT03014778|Povidone|povidone|mesh-list
43650433|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43650434|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650435|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
43650436|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
43650437|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
43650438|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
43620191|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620192|NCT05305794|Insulin|insulin|mesh-list
43620193|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43620194|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43620195|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620196|NCT05291325|Linaclotide|linaclotide|mesh-list
43620197|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43620198|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
43620199|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620200|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620202|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43620203|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
43620204|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620205|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620206|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43620207|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43620208|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620209|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620229|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
43620230|NCT05262322|Apixaban|apixaban|mesh-list
43620231|NCT05262322|Edoxaban|edoxaban|mesh-list
43620232|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43620233|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
43620234|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43620235|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620236|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620237|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849413|NCT03929640|Analgesics|analgesics|mesh-ancestor
43620245|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620246|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620248|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620249|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620250|NCT05128734|Temozolomide|temozolomide|mesh-list
43620252|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43620253|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
43620254|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620255|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620256|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43620257|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620258|NCT05120960|Osimertinib|osimertinib|mesh-list
43620259|NCT05120960|Tepotinib|tepotinib|mesh-list
43620260|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620261|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43620262|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620263|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620264|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
43620265|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43620266|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620267|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620268|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620269|NCT05031026|Analgesics|analgesics|mesh-ancestor
43650439|NCT03014440|Cannabidiol|cannabidiol|mesh-list
43650440|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
43650441|NCT03014323|Galantamine|galantamine|mesh-list
43650442|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43650443|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650444|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650445|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
43650446|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650447|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650448|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43620300|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620302|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620303|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620304|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43620305|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620306|NCT04791475|Dexamethasone|dexamethasone|mesh-list
43620307|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
43620308|NCT04791475|Bupivacaine|bupivacaine|mesh-list
43620309|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620310|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
43620311|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
43620312|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620336|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620337|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620338|NCT04727307|Bevacizumab|bevacizumab|mesh-list
43620339|NCT04727307|Atezolizumab|atezolizumab|mesh-list
43620340|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43620341|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620342|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620343|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620344|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43620345|NCT04727307|Growth Substances|growth substances|mesh-ancestor
43620346|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620347|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
43620349|NCT04718805|Darunavir|darunavir|mesh-list
43620350|NCT04718805|Cobicistat|cobicistat|mesh-list
43620351|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43620352|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43620353|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43620354|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
43620355|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620356|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620357|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43620358|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43620359|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
43620360|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620362|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43620363|NCT04677049|Niacin|niacin|mesh-list
43620364|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
43620398|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
43620399|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620400|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620401|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620402|NCT04608474|Evolocumab|evolocumab|mesh-list
43620403|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43620404|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43620405|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43620406|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
43620407|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620408|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43620409|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620440|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43650449|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
43650450|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650453|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
43652776|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43776201|NCT02340988|Warfarin|warfarin|mesh-list
43776202|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
43776203|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776204|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776205|NCT02340455|Pregabalin|pregabalin|mesh-list
43776206|NCT02340455|Analgesics|analgesics|mesh-ancestor
43650454|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650455|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650456|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
43650457|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650458|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43650459|NCT03014076|Trastuzumab|trastuzumab|mesh-list
43650460|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620441|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620442|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
43620443|NCT04488367|Coagulants|coagulants|mesh-ancestor
43620444|NCT04415840|Acetic Acid|acetic acid|mesh-list
43620445|NCT04415840|Retinol acetate|retinol acetate|mesh-list
43620446|NCT04415840|Lugol's solution|lugol's solution|mesh-list
43620447|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43620449|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620450|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
43620451|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620452|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43620453|NCT04415840|Protective Agents|protective agents|mesh-ancestor
43620454|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620455|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
43620456|NCT04415840|Coagulants|coagulants|mesh-ancestor
43620489|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620490|NCT04239339|Citalopram|citalopram|mesh-list
43620491|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43620492|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43620493|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620494|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620495|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620496|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
43620510|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43620511|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43620512|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43620513|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620514|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620515|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43620516|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620517|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620518|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620519|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620520|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43620521|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620522|NCT04157751|Empagliflozin|empagliflozin|mesh-list
43620523|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43620524|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620525|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43776211|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43776212|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776213|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776214|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776215|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43776247|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
43776248|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
43776249|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776250|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
43703439|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43620526|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620527|NCT04135846|Doxazosin|doxazosin|mesh-list
43620528|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43620529|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43620530|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43620531|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43620533|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620534|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650462|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
43650463|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650464|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650465|NCT03013959|Analgesics|analgesics|mesh-ancestor
43650466|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
43650467|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650468|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650469|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650470|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650471|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
43776251|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43776252|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650473|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620535|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620537|NCT04098237|Pancreatin|pancreatin|mesh-list
43620538|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43620539|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
43620540|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43620541|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43620542|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
43620543|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620544|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43620545|NCT03989609|Midazolam|midazolam|mesh-list
43620546|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
43776253|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43776254|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43620547|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43620548|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43620549|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620550|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620551|NCT03989609|Analgesics|analgesics|mesh-ancestor
43620552|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
43620553|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620554|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43620555|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43620576|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620578|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620579|NCT03984955|Mannitol|mannitol|mesh-list
43620580|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
43620581|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43620582|NCT03984955|Diuretics|diuretics|mesh-ancestor
43620583|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
43620584|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620585|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43620586|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
43620587|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
43620588|NCT03984955|Protective Agents|protective agents|mesh-ancestor
43620589|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
43620590|NCT03970746|Pemetrexed|pemetrexed|mesh-list
43620591|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620592|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620593|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620594|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620595|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43620596|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43620597|NCT03965962|Vaccines|vaccines|mesh-list
43620598|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
43620599|NCT03965962|Antibodies|antibodies|mesh-list
43620600|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
43620601|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43776299|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43620602|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43620603|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
43620604|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620605|NCT03961919|Fludarabine|fludarabine|mesh-list
43650474|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650475|NCT03013751|Udenafil|udenafil|mesh-list
43650476|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43650477|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43650478|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650479|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650480|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43650481|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43650482|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43650483|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
43650484|NCT03013790|Melatonin|melatonin|mesh-list
43650485|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
43620606|NCT03961919|Treosulfan|treosulfan|mesh-list
43620679|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
43620680|NCT03573960|Lenvatinib|lenvatinib|mesh-list
43620681|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620682|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43620683|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620684|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620685|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
43620686|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620687|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620688|NCT03517969|Carboplatin|carboplatin|mesh-list
43620689|NCT03517969|Docetaxel|docetaxel|mesh-list
43620690|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620691|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620692|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620693|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620694|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620695|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
43620696|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43620697|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43620698|NCT03511625|Prednisolone|prednisolone|mesh-list
43620719|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620720|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620722|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
43620723|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620733|NCT03176472|Ricolinostat|ricolinostat|mesh-list
43620734|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620735|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43620736|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620737|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620738|NCT03147040|Carboplatin|carboplatin|mesh-list
43620739|NCT03147040|Atezolizumab|atezolizumab|mesh-list
43620740|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620741|NCT03094247|Amoxicillin|amoxicillin|mesh-list
43650486|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650487|NCT03013790|Protective Agents|protective agents|mesh-ancestor
43650488|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650489|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650490|NCT03013335|Nivolumab|nivolumab|mesh-list
43650491|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650492|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620742|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43620743|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620746|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43620747|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620748|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620749|NCT02832531|Aspirin|aspirin|mesh-list
43620750|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
43620751|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43620752|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620753|NCT02832531|Analgesics|analgesics|mesh-ancestor
43620754|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
43620775|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620776|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
43620777|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43620778|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
43620779|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43620780|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620781|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43620782|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43620783|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43620785|NCT02425891|Atezolizumab|atezolizumab|mesh-list
43620786|NCT02425891|Antibodies|antibodies|mesh-list
43620787|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43620788|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620789|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620790|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620791|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620792|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620793|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620794|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
43620795|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620796|NCT02420847|Gemcitabine|gemcitabine|mesh-list
43620797|NCT02420847|Doxorubicin|doxorubicin|mesh-list
43620798|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43620799|NCT02420847|Ixazomib|ixazomib|mesh-list
43620800|NCT02420847|Glycine|glycine|mesh-list
43620801|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43620802|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
43620803|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620804|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620805|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
43620806|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620807|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620808|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43620809|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
43776336|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43776337|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776338|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703569|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
43703570|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703571|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
43703572|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43703573|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620810|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620811|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43620838|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43620839|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43620840|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
43620841|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620842|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43620843|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43620844|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
43620845|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
43650493|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43650494|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824480|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43824481|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824482|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824483|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824484|NCT05512013|Ibuprofen|ibuprofen|mesh-list
43824485|NCT05512013|Celecoxib|celecoxib|mesh-list
43824486|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
43824487|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824488|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620846|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43620847|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43620848|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620851|NCT01991977|Temozolomide|temozolomide|mesh-list
43620852|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43620853|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
43734408|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43620854|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620855|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620857|NCT01552434|Bevacizumab|bevacizumab|mesh-list
43620858|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43620859|NCT01552434|Cetuximab|cetuximab|mesh-list
43620860|NCT01552434|Valproic Acid|valproic acid|mesh-list
43620894|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620896|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
43620897|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
43620898|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620899|NCT01191697|Bevacizumab|bevacizumab|mesh-list
43620900|NCT01191697|Trastuzumab|trastuzumab|mesh-list
43620901|NCT01191697|Capecitabine|capecitabine|mesh-list
43620902|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
43620903|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43620923|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
43620924|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43620926|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
43620927|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43620928|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43620929|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43620930|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
43620931|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
43620932|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
43620933|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620934|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
43620935|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620937|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43620938|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43620939|NCT03120221|Trace Elements|trace elements|mesh-ancestor
43620940|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
43620941|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620942|NCT03120234|Fentanyl|fentanyl|mesh-list
43620943|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
43620944|NCT03120234|Ketamine|ketamine|mesh-list
43620945|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43620946|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830869|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43830874|NCT05339529|Glycine|glycine|mesh-list
43620947|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620948|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620949|NCT03120234|Analgesics|analgesics|mesh-ancestor
43620950|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
43824490|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
43824492|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824493|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824494|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824495|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43776341|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
43776342|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776343|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43776344|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43776345|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776346|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776347|NCT02339844|Aripiprazole|aripiprazole|mesh-list
43776348|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
43776349|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824496|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620951|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620952|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43620953|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43620954|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43620974|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43620975|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43620976|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620977|NCT03120182|Aspirin|aspirin|mesh-list
43620978|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43620979|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43620980|NCT03120182|Analgesics|analgesics|mesh-ancestor
43620981|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
43620982|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43620983|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43620984|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43620985|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43620986|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43620987|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43620988|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849416|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776350|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43620989|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43620990|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43620991|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43620992|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
43620993|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
43620994|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43620995|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43620996|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43620997|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
43620998|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620999|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621001|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621002|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621003|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43621004|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43621006|NCT03119623|Enalapril|enalapril|mesh-list
43621007|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43621022|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43621023|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
43621025|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43621026|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43621027|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
43621028|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621029|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621030|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621031|NCT03119714|Pemirolast|pemirolast|mesh-list
43621032|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
43621034|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621035|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621036|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621037|NCT03119428|Nivolumab|nivolumab|mesh-list
43824497|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824499|NCT05511948|Hydroquinone|hydroquinone|mesh-list
43824500|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
43824501|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824502|NCT05511948|Protective Agents|protective agents|mesh-ancestor
43824503|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824504|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43824505|NCT05511831|Ketotifen|ketotifen|mesh-list
43824506|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
43824507|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621039|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621040|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43621041|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621042|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
43621043|NCT03119116|Apixaban|apixaban|mesh-list
43621044|NCT03119116|Dabigatran|dabigatran|mesh-list
43621045|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43621046|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
43621047|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43621048|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
43621049|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621050|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621052|NCT03119077|Itraconazole|itraconazole|mesh-list
43621053|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
43621054|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621055|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43621056|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621057|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621058|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621059|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621060|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849417|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
43621061|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703612|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
43621081|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621082|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43621083|NCT03118830|Cetrorelix|cetrorelix|mesh-list
43621084|NCT03118830|Hormones|hormones|mesh-list
43621085|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43621086|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621087|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621089|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43621090|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
43621091|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621092|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43621093|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621094|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621095|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43621096|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
43621097|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621098|NCT03118713|Metformin|metformin|mesh-list
43621099|NCT03118713|Glimepiride|glimepiride|mesh-list
43621100|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
43621101|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621102|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621103|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43621104|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43621105|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
43824508|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43776353|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776354|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
43776355|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
43776356|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776365|NCT02339350|Methotrexate|methotrexate|mesh-list
43776366|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43703644|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703645|NCT02709590|Analgesics|analgesics|mesh-ancestor
43703646|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43703647|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703648|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43703649|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703650|NCT02709603|Scopolamine|scopolamine|mesh-list
43703651|NCT02709603|Bromides|bromides|mesh-list
43703652|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43703653|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
43703654|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703655|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
43703656|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
43824509|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
43824510|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
43824511|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824512|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824513|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824514|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43846421|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43846422|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
43846423|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43621106|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43621107|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621108|NCT03118479|Anastrozole|anastrozole|mesh-list
43621109|NCT03118479|Testosterone|testosterone|mesh-list
43621110|NCT03118479|Androgens|androgens|mesh-ancestor
43621111|NCT03118479|Hormones|hormones|mesh-ancestor
43621112|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621113|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621114|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621115|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621116|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43621136|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621137|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621138|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621139|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
43621140|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
43621141|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621142|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621143|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
43621144|NCT03118076|Ropivacaine|ropivacaine|mesh-list
43621145|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621146|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621147|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621148|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621149|NCT03118076|Analgesics|analgesics|mesh-ancestor
43621150|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
43621151|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621152|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43536676|NCT04503993|Antibodies|antibodies|mesh-list
43621153|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43621154|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43621155|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621156|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621157|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621158|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
43621159|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
43621160|NCT03118128|Metformin|metformin|mesh-list
43621161|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621162|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621163|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
43621164|NCT03117790|Morphine|morphine|mesh-list
43621165|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621166|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621167|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621169|NCT03117790|Analgesics|analgesics|mesh-ancestor
43621188|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621189|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536777|NCT04067609|Hormones|hormones|mesh-ancestor
43621190|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621192|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
43621193|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43621194|NCT03117894|Narcotics|narcotics|mesh-ancestor
43621195|NCT03117894|Analgesics|analgesics|mesh-ancestor
43536843|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
43846424|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43846425|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43846426|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846427|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
43536913|NCT03569293|Upadacitinib|upadacitinib|mesh-list
43846428|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846430|NCT04199572|Diclofenac|diclofenac|mesh-list
43846431|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846432|NCT04199572|Analgesics|analgesics|mesh-ancestor
43846433|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
43846434|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621196|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
43621197|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621198|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
43621199|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621200|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
43621201|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
43621202|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
43621203|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43621204|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
43621205|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621206|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43621207|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
43621208|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621209|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621210|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43621211|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43621212|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43621213|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43621214|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621215|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621216|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621217|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43621218|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621219|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621220|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
43621221|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43621222|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
43537072|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621223|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621224|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621225|NCT03117855|Capecitabine|capecitabine|mesh-list
43621226|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43621227|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
43621241|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621243|NCT03117595|Narcotics|narcotics|mesh-ancestor
43621244|NCT03117595|Analgesics|analgesics|mesh-ancestor
43621245|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43621246|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621247|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
43621248|NCT03117335|Endostatins|endostatins|mesh-list
43621249|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621250|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43621251|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43621252|NCT03117335|Growth Substances|growth substances|mesh-ancestor
43621253|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621254|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
43621255|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
43621258|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621259|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43621260|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43776375|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621261|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621262|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846435|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846436|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
43846437|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43846438|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846439|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43846440|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43846441|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846442|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846443|NCT04199468|Ketamine|ketamine|mesh-list
43846444|NCT04199468|Dronabinol|dronabinol|mesh-list
43846445|NCT04199468|Analgesics|analgesics|mesh-ancestor
43846446|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
43621263|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621264|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621265|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621266|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621267|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621268|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43621269|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43621270|NCT03117530|Minocycline|minocycline|mesh-list
43621271|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621272|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621273|NCT03117725|Melatonin|melatonin|mesh-list
43621274|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
43621275|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621276|NCT03117725|Protective Agents|protective agents|mesh-ancestor
43621277|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621278|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621279|NCT03117257|Cisplatin|cisplatin|mesh-list
43621280|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621281|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
43621282|NCT03117192|Astringents|astringents|mesh-ancestor
43621283|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621284|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621285|NCT03117166|Lidocaine|lidocaine|mesh-list
43621286|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
43621287|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
43621288|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537267|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43537268|NCT05692570|Ritonavir|ritonavir|mesh-list
43776379|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776410|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
43776411|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776412|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776413|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
43621289|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621306|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43621307|NCT03116945|Gallium citrate|gallium citrate|mesh-list
43621308|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621309|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43621310|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
43621311|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43621312|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621313|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621314|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621315|NCT03117023|Analgesics|analgesics|mesh-ancestor
43621316|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
43621317|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621318|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43621319|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43621320|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43621321|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621322|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621323|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621324|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
43621325|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621326|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
43846447|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846448|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846449|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43846450|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43846451|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
43846452|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
43846453|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846454|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43846455|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43846456|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846457|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621327|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
43621328|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621329|NCT03116893|Itraconazole|itraconazole|mesh-list
43621331|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
43621332|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621333|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43621334|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43621335|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621336|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621337|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43621338|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621339|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621340|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621341|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43621342|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43621343|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
43621344|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621362|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43621363|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
43537408|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776418|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43830887|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830888|NCT05339295|Levofloxacin|levofloxacin|mesh-list
43830889|NCT05339295|Ofloxacin|ofloxacin|mesh-list
43830890|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43830891|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830892|NCT05339295|Renal Agents|renal agents|mesh-ancestor
43830893|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43537409|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43537410|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537411|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43537486|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537487|NCT05614609|Lidocaine|lidocaine|mesh-list
43537488|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
43668177|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
43668178|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537489|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
43537490|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537499|NCT05603832|Acetaminophen|acetaminophen|mesh-list
43703859|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703860|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703861|NCT02707874|Ropivacaine|ropivacaine|mesh-list
43703862|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703863|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
43703864|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703865|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703866|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
43703867|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703868|NCT02707913|Amlodipine|amlodipine|mesh-list
43621365|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621366|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621367|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
43621368|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621369|NCT03116659|Doxycycline|doxycycline|mesh-list
43621370|NCT03116659|Imiquimod|imiquimod|mesh-list
43621371|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43621372|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621373|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
43621374|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43621375|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43621376|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43621377|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
43621378|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621379|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621380|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
43621381|NCT03116672|Diclofenac|diclofenac|mesh-list
43621382|NCT03116672|Ketorolac|ketorolac|mesh-list
43621383|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621384|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621385|NCT03116672|Analgesics|analgesics|mesh-ancestor
43621386|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
43621387|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621390|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621391|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621392|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621393|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621394|NCT03116490|Anesthetics|anesthetics|mesh-list
43650495|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43650497|NCT03013387|Octreotide|octreotide|mesh-list
43650498|NCT03013387|Edotreotide|edotreotide|mesh-list
43650499|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650500|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43650501|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650502|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43650503|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537651|NCT05425732|Vaccines|vaccines|mesh-list
43621397|NCT03116542|Alovudine|alovudine|mesh-list
43621398|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
43621399|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621400|NCT03116555|Irinotecan|irinotecan|mesh-list
43621401|NCT03116555|Apatinib|apatinib|mesh-list
43621416|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
43621417|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43621418|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43621419|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
43621420|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43621421|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43621422|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621424|NCT03116269|Cilostazol|cilostazol|mesh-list
43621425|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621426|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621427|NCT03116269|Analgesics|analgesics|mesh-ancestor
43621428|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
43621429|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776419|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776420|NCT02339428|Analgesics|analgesics|mesh-ancestor
43776421|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
43776422|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703876|NCT02707666|Cisplatin|cisplatin|mesh-list
43621430|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621431|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621432|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621433|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43621434|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43621435|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621436|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43621437|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621438|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621439|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
43621440|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43621441|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
43621442|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43537716|NCT05374512|Capecitabine|capecitabine|mesh-list
43537717|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537718|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537719|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537720|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
43537721|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
43537722|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537723|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43621443|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
43621444|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
43621445|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43621446|NCT03116269|Protective Agents|protective agents|mesh-ancestor
43776458|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43621447|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43621448|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43621449|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43621450|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
43621451|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43621452|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43621453|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43537855|NCT05244460|Droperidol|droperidol|mesh-list
43621494|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
43621495|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621496|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43621497|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43621498|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621499|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621500|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43621501|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43621552|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621553|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621554|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621555|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621558|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43621559|NCT03115255|Growth Substances|growth substances|mesh-ancestor
43621560|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621561|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
43621562|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621563|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
43621564|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43621565|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43621566|NCT03115034|Melatonin|melatonin|mesh-list
43621567|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
43621568|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621569|NCT03115034|Protective Agents|protective agents|mesh-ancestor
43621570|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621571|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621572|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43621573|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621574|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621575|NCT03115073|Clotrimazole|clotrimazole|mesh-list
43621576|NCT03115073|Miconazole|miconazole|mesh-list
43621577|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43621578|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538231|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538232|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538233|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538234|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538235|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
43538236|NCT04933617|Hormones|hormones|mesh-ancestor
43538237|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538238|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538243|NCT04924101|Cisplatin|cisplatin|mesh-list
43621586|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621588|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43621589|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43621590|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43621591|NCT03115099|Liraglutide|liraglutide|mesh-list
43621592|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621616|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43621617|NCT03114371|Oxytocin|oxytocin|mesh-list
43621618|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
43621619|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621620|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621621|NCT03114280|Carboplatin|carboplatin|mesh-list
43621622|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621623|NCT03114228|Midostaurin|midostaurin|mesh-list
43621624|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621625|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43621626|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538298|NCT04862975|Tenofovir|tenofovir|mesh-list
43538299|NCT04862975|Emtricitabine|emtricitabine|mesh-list
43538300|NCT04862975|Efavirenz|efavirenz|mesh-list
43621627|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621629|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43621630|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621631|NCT03114085|Capecitabine|capecitabine|mesh-list
43621632|NCT03114085|Apatinib|apatinib|mesh-list
43621633|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43621634|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
43621635|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621636|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621637|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43621638|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621639|NCT03114072|Methamphetamine|methamphetamine|mesh-list
43621664|NCT03114020|Protective Agents|protective agents|mesh-ancestor
43621665|NCT03113851|Molgramostim|molgramostim|mesh-list
43621666|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621667|NCT03113773|Aldesleukin|aldesleukin|mesh-list
43621668|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621669|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43621670|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43621671|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
43621672|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621673|NCT03113448|Capsaicin|capsaicin|mesh-list
43621674|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
43621675|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43621676|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
43538341|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538381|NCT04826237|Hormones|hormones|mesh-ancestor
43621687|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621688|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621689|NCT03113708|Heparin|heparin|mesh-list
43621690|NCT03113708|Calcium heparin|calcium heparin|mesh-list
43621691|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
43621727|NCT03113110|Empagliflozin|empagliflozin|mesh-list
43621728|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43621729|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621730|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43621731|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621732|NCT03113162|Cytarabine|cytarabine|mesh-list
43621733|NCT03113162|Etoposide|etoposide|mesh-list
43621734|NCT03113162|Melphalan|melphalan|mesh-list
43621735|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43621736|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621761|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43621762|NCT03112707|Aspirin|aspirin|mesh-list
43621763|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43621764|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621765|NCT03112707|Analgesics|analgesics|mesh-ancestor
43621766|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
43621767|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621768|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621769|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621770|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43621771|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43621772|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43621773|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538508|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43621774|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43621775|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621776|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621777|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
43621778|NCT03112642|Anesthetics|anesthetics|mesh-list
43621779|NCT03112642|Bupivacaine|bupivacaine|mesh-list
43621780|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
43621781|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621782|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621783|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
43621813|NCT03112551|Analgesics|analgesics|mesh-ancestor
43621814|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
43621815|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621816|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621817|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
43621818|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43621819|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43538585|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621820|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
43621821|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43621822|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43621823|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621824|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43621825|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
43538661|NCT04531059|Esomeprazole|esomeprazole|mesh-list
43621826|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43621827|NCT03112564|Fentanyl|fentanyl|mesh-list
43621828|NCT03112564|Sevoflurane|sevoflurane|mesh-list
43621829|NCT03112564|Rocuronium|rocuronium|mesh-list
43621830|NCT03112564|Cisatracurium|cisatracurium|mesh-list
43621861|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43621862|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43704011|NCT02707263|Heparin|heparin|mesh-list
43621863|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538734|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538745|NCT04332068|Ivermectin|ivermectin|mesh-list
43621864|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
43621865|NCT03112135|Coagulants|coagulants|mesh-ancestor
43621866|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43621867|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43621868|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
43621869|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621870|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538819|NCT04241185|Cisplatin|cisplatin|mesh-list
43650505|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43650506|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
43650507|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
43650508|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650509|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43650510|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43621873|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
43621874|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621875|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43621901|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621902|NCT03112005|Mydriatics|mydriatics|mesh-list
43621903|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
43621904|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621905|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621906|NCT03111966|Grazoprevir|grazoprevir|mesh-list
43621907|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43621908|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
43621909|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621910|NCT03112031|Tamoxifen|tamoxifen|mesh-list
43621911|NCT03112031|Fluconazole|fluconazole|mesh-list
43621912|NCT03112031|Amphotericin B|amphotericin b|mesh-list
43621913|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43621914|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43776534|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776535|NCT02338622|Olaparib|olaparib|mesh-list
43776536|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43776537|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776538|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776539|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776540|NCT02338466|Tenecteplase|tenecteplase|mesh-list
43621915|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
43621916|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621917|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621918|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621919|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621939|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621940|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43621942|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
43538887|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
43621943|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621944|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621945|NCT03111797|Morphine|morphine|mesh-list
43621946|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43621947|NCT03111797|Narcotics|narcotics|mesh-ancestor
43621948|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849421|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43621949|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621950|NCT03111797|Analgesics|analgesics|mesh-ancestor
43621951|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
43621952|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621953|NCT03111810|Prednisolone|prednisolone|mesh-list
43621954|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43621955|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
43621956|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43621957|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
43621958|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43538923|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
43621959|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
43621960|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43621961|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
43621962|NCT03111810|Hormones|hormones|mesh-ancestor
43621963|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43621964|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621965|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43621966|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43621967|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
43621968|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
43621969|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43621970|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43621971|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43621999|NCT03111511|Estrogens|estrogens|mesh-ancestor
43650511|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650512|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650513|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43650514|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43650515|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
43650516|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622001|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622002|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43622003|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
43622004|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43622005|NCT03111511|Diuretics|diuretics|mesh-ancestor
43622006|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
43622007|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
43622008|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622009|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
43622011|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622012|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
43622013|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622014|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622015|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
43622016|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622017|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622018|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43776544|NCT02338323|Febuxostat|febuxostat|mesh-list
43776545|NCT02338323|Benzbromarone|benzbromarone|mesh-list
43776546|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
43622019|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43622020|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622051|NCT03111186|Oxycodone|oxycodone|mesh-list
43622052|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622053|NCT03111186|Analgesics|analgesics|mesh-ancestor
43622054|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
43622055|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622056|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622057|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
43622058|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43622059|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622060|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622061|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43622062|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622063|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622081|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
43622083|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
43622084|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622085|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
43622086|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622087|NCT03110952|Protective Agents|protective agents|mesh-ancestor
43622089|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
43622090|NCT03111069|Doxorubicin|doxorubicin|mesh-list
43622091|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43622092|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43622093|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622094|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43622095|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43622096|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622097|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622098|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43622099|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43622100|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
43622101|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622102|NCT03110757|Antacids|antacids|mesh-ancestor
43622103|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622107|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43622108|NCT03110848|Prednisolone|prednisolone|mesh-list
43539124|NCT03767933|Analgesics|analgesics|mesh-ancestor
43650518|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43650519|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43650520|NCT03013205|Lidocaine|lidocaine|mesh-list
43650521|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43650522|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650523|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
43650524|NCT03013205|Hormones|hormones|mesh-ancestor
43650525|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650526|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622109|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
43622110|NCT03110848|Atorvastatin|atorvastatin|mesh-list
43622111|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43622112|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
43622113|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
43622114|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43622115|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43622116|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
43622117|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622118|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43622119|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43539173|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
43539174|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539177|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622145|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622146|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622147|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43622148|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
43622149|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622150|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622151|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43622152|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
43539241|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43622153|NCT03110341|Hematinics|hematinics|mesh-ancestor
43622154|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
43622155|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43622156|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
43622157|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622158|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
43622159|NCT03110679|Protective Agents|protective agents|mesh-ancestor
43622160|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
43539310|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
43622161|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43622162|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622163|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
43652779|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43652780|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43652781|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43652783|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652784|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43652785|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652786|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43652787|NCT02988089|Antacids|antacids|mesh-ancestor
43652788|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43704155|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
43704156|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
43830924|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830925|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830926|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830927|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43830928|NCT05337566|Azithromycin|azithromycin|mesh-list
43830930|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
43830931|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830932|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847353|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43847354|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
43847355|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847356|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622164|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622165|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622166|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
43622167|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622168|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43622169|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43622204|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43622205|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
43622206|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622207|NCT03109691|Dexamethasone|dexamethasone|mesh-list
43622208|NCT03109691|Bupivacaine|bupivacaine|mesh-list
43622209|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539465|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
43622210|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
43622238|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622239|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622240|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
43622241|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
43622242|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
43622243|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622244|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622245|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
43650527|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43650528|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
43650529|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650530|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650531|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622246|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622247|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622249|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43622250|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
43622251|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622252|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
43622253|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43622254|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43622255|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622256|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
43622257|NCT03109652|Coagulants|coagulants|mesh-ancestor
43622290|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622292|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
43622293|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43622294|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
43622295|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
43622296|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622297|NCT03109158|Cetuximab|cetuximab|mesh-list
43622326|NCT03108846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43622327|NCT03108846|Antidepressive Agents|antidepressive agents|mesh-ancestor
43622328|NCT03108846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43540221|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540288|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622329|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
43622330|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622331|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622332|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622333|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622334|NCT03108937|Analgesics|analgesics|mesh-ancestor
43622335|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
43622336|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622337|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43622338|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43622339|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622340|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622341|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622372|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
43540434|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
43540680|NCT04808973|Lamivudine|lamivudine|mesh-list
43540681|NCT04808973|Dolutegravir|dolutegravir|mesh-list
43622373|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43622374|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622375|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
43652798|NCT02987985|Lidocaine|lidocaine|mesh-list
43622376|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43622378|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622379|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
43622380|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43622381|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43622382|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622383|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
43622384|NCT03108807|Coagulants|coagulants|mesh-ancestor
43540758|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
43622385|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43622386|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
43622387|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43622388|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43622389|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622416|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43622417|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622418|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43622419|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43650534|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
43650535|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650536|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43650537|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43541060|NCT01498770|Olanzapine|olanzapine|mesh-list
43668294|NCT03689946|Evolocumab|evolocumab|mesh-list
43650539|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43650541|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650542|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650544|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
43650545|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622420|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622421|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622422|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43622423|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43652808|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
43652809|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652810|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652811|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652812|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
43838850|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
43838852|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838853|NCT04814537|Bupivacaine|bupivacaine|mesh-list
43838854|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838855|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
43838856|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838857|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838858|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
43838859|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838860|NCT04813991|Ibuprofen|ibuprofen|mesh-list
43838861|NCT04813991|Oxycodone|oxycodone|mesh-list
43704181|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704182|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
43622424|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622425|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622426|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622427|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622428|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43622429|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
43541290|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541291|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
43541292|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541295|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
43541296|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541297|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43541298|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541307|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43541308|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
43668300|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43668301|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668302|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43668303|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43668304|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
43541311|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541312|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
43541313|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
43541318|NCT05563155|Hormones|hormones|mesh-ancestor
43622431|NCT03108326|Ustekinumab|ustekinumab|mesh-list
43622432|NCT03108326|Vedolizumab|vedolizumab|mesh-list
43622433|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622434|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
43622435|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622436|NCT03108365|Hemostatics|hemostatics|mesh-list
43622467|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43622468|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43622470|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849422|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622471|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43622472|NCT03108287|Antacids|antacids|mesh-ancestor
43622473|NCT03108274|Fexofenadine|fexofenadine|mesh-list
43622474|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
43622475|NCT03108274|Midazolam|midazolam|mesh-list
43622476|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43622477|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43541357|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43541416|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43541423|NCT05472792|Tamoxifen|tamoxifen|mesh-list
43622478|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622479|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541581|NCT05289349|Sevoflurane|sevoflurane|mesh-list
43541657|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43541734|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622480|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43622481|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43622504|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43622505|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622506|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622507|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541814|NCT04247165|Nivolumab|nivolumab|mesh-list
43622508|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622509|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622510|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
43622511|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
43622512|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622513|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43704192|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622514|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43622515|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
43541979|NCT03122613|Curcumin|curcumin|mesh-list
43622516|NCT03107858|Protective Agents|protective agents|mesh-ancestor
43622518|NCT03107962|Antibodies|antibodies|mesh-list
43622519|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
43622520|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
43622521|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622522|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650546|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650547|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650548|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650549|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43542182|NCT03704909|Racepinephrine|racepinephrine|mesh-list
43542183|NCT03704909|Ephedrine|ephedrine|mesh-list
43650550|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650551|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
43650552|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650553|NCT03013400|Protective Agents|protective agents|mesh-ancestor
43650554|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650555|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650556|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43650557|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
43650558|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43650559|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650560|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650561|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650562|NCT03013634|Analgesics|analgesics|mesh-ancestor
43650563|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
43622523|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622524|NCT03107884|Metformin|metformin|mesh-list
43622525|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43622526|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622527|NCT03107923|Dobutamine|dobutamine|mesh-list
43622528|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43622529|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
43622530|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
43622531|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622532|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622533|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43622534|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43622535|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622548|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622549|NCT03107481|Acetaminophen|acetaminophen|mesh-list
43542578|NCT03701698|Hormones|hormones|mesh-ancestor
43622550|NCT03107481|Hydromorphone|hydromorphone|mesh-list
43622551|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622552|NCT03107481|Analgesics|analgesics|mesh-ancestor
43622553|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
43622554|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622555|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622556|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
43622557|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43622558|NCT03107481|Narcotics|narcotics|mesh-ancestor
43622559|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622560|NCT03107429|Acetazolamide|acetazolamide|mesh-list
43622561|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
43622562|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43622563|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622564|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622565|NCT03107429|Diuretics|diuretics|mesh-ancestor
43622566|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
43622567|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622568|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43622569|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43622570|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622571|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
43622572|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43622573|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650564|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650565|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43650566|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43650567|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650568|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650569|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650570|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650571|NCT03013322|Physostigmine|physostigmine|mesh-list
43650572|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43650573|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650574|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650575|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
43650576|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622574|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43622575|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43622576|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622577|NCT03107338|Analgesics|analgesics|mesh-ancestor
43542837|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622579|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622580|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622581|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622582|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622583|NCT03107507|Levetiracetam|levetiracetam|mesh-list
43622586|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
43622587|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622588|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622589|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622590|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43622591|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43622592|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622593|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622594|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
43622595|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
43622609|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43543130|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
43622610|NCT03107078|Protective Agents|protective agents|mesh-ancestor
43622611|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
43622612|NCT03106948|Penicillamine|penicillamine|mesh-list
43622613|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
43776630|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43622614|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622615|NCT03106948|Protective Agents|protective agents|mesh-ancestor
43622616|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622617|NCT03106948|Vitamins|vitamins|mesh-ancestor
43622618|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
43622619|NCT03106948|Antidotes|antidotes|mesh-ancestor
43622620|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
43622621|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
43622622|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622623|NCT03107169|Vancomycin|vancomycin|mesh-list
43622624|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622625|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622626|NCT03106831|Norepinephrine|norepinephrine|mesh-list
43622627|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43622628|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622629|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622630|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622631|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622632|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650577|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650578|NCT03013322|Miotics|miotics|mesh-ancestor
43650579|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
43650580|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650581|NCT03013361|Bupivacaine|bupivacaine|mesh-list
43650582|NCT03013361|Ropivacaine|ropivacaine|mesh-list
43650583|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
43650584|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
43650585|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650586|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650587|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
43650588|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650589|NCT03013036|Fentanyl|fentanyl|mesh-list
43650590|NCT03013036|Midazolam|midazolam|mesh-list
43650591|NCT03013036|Propofol|propofol|mesh-list
43650592|NCT03013036|Sevoflurane|sevoflurane|mesh-list
43650593|NCT03013036|Rocuronium|rocuronium|mesh-list
43650594|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43650595|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650596|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668435|NCT03249012|Calcium|calcium|mesh-list
43543630|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650597|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43650598|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
43650599|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
43650600|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43650601|NCT03013036|Narcotics|narcotics|mesh-ancestor
43622633|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
43622634|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
43622635|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622636|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43622637|NCT03106740|Minocycline|minocycline|mesh-list
43622638|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622639|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622640|NCT03106597|Amlodipine|amlodipine|mesh-list
43622641|NCT03106597|Manidipine|manidipine|mesh-list
43622642|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43622643|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43622644|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622645|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668524|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43622646|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43622647|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622648|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
43622649|NCT03106818|Ketorolac|ketorolac|mesh-list
43622650|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
43622651|NCT03106818|Bupivacaine|bupivacaine|mesh-list
43622652|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
43622653|NCT03106818|Anesthetics|anesthetics|mesh-list
43622654|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622655|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622656|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
43622657|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622669|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622670|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43622671|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
43650602|NCT03013036|Analgesics|analgesics|mesh-ancestor
43650603|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
43650604|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650605|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43650606|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43650607|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43650608|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43650609|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
43650610|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
43650611|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544088|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622672|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43622673|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
43622674|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826729|NCT05494710|Bleomycin|bleomycin|mesh-list
43622675|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
43622676|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622677|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622678|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43622679|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
43622680|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622681|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622682|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43544277|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
43622683|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
43622685|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43668591|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43544551|NCT03680612|Cefepime|cefepime|mesh-list
43622686|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43622687|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
43622688|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622689|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622690|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622691|NCT03106623|Urological Agents|urological agents|mesh-ancestor
43622692|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43622693|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43622694|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43622695|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622697|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43622698|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622699|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43776677|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622700|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622701|NCT03106571|Methamphetamine|methamphetamine|mesh-list
43622702|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43622703|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622704|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
43622705|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
43622706|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622707|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
43622708|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622709|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622710|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
43622711|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43622712|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43622713|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622714|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43622715|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43622716|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43622717|NCT03106545|Bupivacaine|bupivacaine|mesh-list
43622718|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622719|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
43622752|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
43776678|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776679|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
43776680|NCT02337127|Lamivudine|lamivudine|mesh-list
43776681|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43776682|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43776683|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776718|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
43776719|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776720|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43776721|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776723|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43544651|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43622753|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622754|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43622755|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43622758|NCT03106363|Hormones|hormones|mesh-ancestor
43650612|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650613|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43650614|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43650615|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43650616|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43650617|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43650618|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
43650619|NCT03013010|Tegafur|tegafur|mesh-list
43650620|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650621|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43650622|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
43650623|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650624|NCT03012945|Anesthetics|anesthetics|mesh-list
43622759|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622760|NCT03106519|Bupivacaine|bupivacaine|mesh-list
43544711|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43544765|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622761|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622762|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
43622774|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
43622775|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43622776|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43622777|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622778|NCT03106402|Bromfenac|bromfenac|mesh-list
43622779|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43622780|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622781|NCT03106402|Analgesics|analgesics|mesh-ancestor
43622782|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
43622783|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622784|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622785|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622786|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622787|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43622788|NCT03106298|Hematinics|hematinics|mesh-ancestor
43622789|NCT03105830|Acetaminophen|acetaminophen|mesh-list
43622790|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43622791|NCT03105830|Analgesics|analgesics|mesh-ancestor
43622792|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
43622793|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622794|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622795|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
43622796|NCT03105986|Probenecid|probenecid|mesh-list
43622797|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
43544921|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
43622798|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
43622799|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622800|NCT03105986|Renal Agents|renal agents|mesh-ancestor
43622801|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
43622802|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43622803|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622804|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
43622805|NCT03105661|Atenolol|atenolol|mesh-list
43622806|NCT03105661|Labetalol|labetalol|mesh-list
43622807|NCT03105661|Nifedipine|nifedipine|mesh-list
43622808|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43622809|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622810|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622811|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776745|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776746|NCT02336568|Oxytocin|oxytocin|mesh-list
43776747|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
43776748|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776750|NCT02336529|Bupivacaine|bupivacaine|mesh-list
43622812|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622813|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
43622814|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
43622815|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43545102|NCT03675555|Dexamethasone|dexamethasone|mesh-list
43545173|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545174|NCT03674606|Aspirin|aspirin|mesh-list
43545308|NCT03673735|Durvalumab|durvalumab|mesh-list
43545455|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545603|NCT03670095|Memantine|memantine|mesh-list
43668772|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43622816|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622817|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43622818|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
43650625|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650626|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650627|NCT03013140|Anesthetics|anesthetics|mesh-list
43650628|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650629|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545816|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
43650630|NCT03013075|Morphine|morphine|mesh-list
43650631|NCT03013075|Bupivacaine|bupivacaine|mesh-list
43650632|NCT03013075|Anesthetics|anesthetics|mesh-list
43650633|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
43650634|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
43650635|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650637|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
43622819|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
43622820|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622821|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43622822|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43622838|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622839|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622840|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
43622841|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622844|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
43622845|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622846|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622847|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43622848|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622849|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
43622850|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
43622851|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622852|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43622853|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43622854|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622855|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622856|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
43622857|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43622858|NCT03105505|Permethrin|permethrin|mesh-list
43622859|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43622860|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622861|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622862|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622863|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545930|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545931|NCT03666949|Anesthetics|anesthetics|mesh-list
43622864|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43622866|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
43622867|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
43622868|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622869|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622870|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
43546175|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43622871|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622872|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43622873|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43622874|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43622875|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43622876|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622877|NCT03105310|Interferons|interferons|mesh-list
43622878|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
43622879|NCT03105310|Ezetimibe|ezetimibe|mesh-list
43622880|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546245|NCT03664063|Ivermectin|ivermectin|mesh-list
43546246|NCT03664063|Albendazole|albendazole|mesh-list
43650638|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650639|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43650641|NCT03013075|Analgesics|analgesics|mesh-ancestor
43650642|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
43650643|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650644|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650645|NCT03013101|Antibodies|antibodies|mesh-list
43650646|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43650647|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
43650648|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650649|NCT03013114|Bortezomib|bortezomib|mesh-list
43650650|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546381|NCT03662516|Estrogens|estrogens|mesh-ancestor
43650651|NCT03012646|Treprostinil|treprostinil|mesh-list
43650652|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43650653|NCT03012763|Acetaminophen|acetaminophen|mesh-list
43650654|NCT03012763|Fexofenadine|fexofenadine|mesh-list
43650655|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
43650656|NCT03012763|Valsartan|valsartan|mesh-list
43650657|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43650658|NCT03012763|Analgesics|analgesics|mesh-ancestor
43650659|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
43622881|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
43622915|NCT03105349|Ribavirin|ribavirin|mesh-list
43622916|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
43622917|NCT03105349|Grazoprevir|grazoprevir|mesh-list
43622918|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43622919|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
43622920|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622921|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
43622922|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622923|NCT03105245|Thiopental|thiopental|mesh-list
43622924|NCT03105245|Anesthetics|anesthetics|mesh-list
43622925|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622941|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
43622943|NCT03105466|Tacrolimus|tacrolimus|mesh-list
43622944|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43622945|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
43622946|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546708|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622947|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43622948|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43622949|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622950|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43668948|NCT01325441|Paclitaxel|paclitaxel|mesh-list
43622951|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43622952|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43622953|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43622954|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
43622955|NCT03105466|Hormones|hormones|mesh-ancestor
43622956|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43622957|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
43622958|NCT05378061|Growth Substances|growth substances|mesh-ancestor
43622959|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622960|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
43622961|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622962|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622963|NCT05377619|Buspirone|buspirone|mesh-list
43650660|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650661|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546970|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546973|NCT03657420|Dexamethasone|dexamethasone|mesh-list
43650662|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
43650663|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43650664|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43650665|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43650666|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650667|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43650668|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43650669|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43650670|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
43650671|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
43650672|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650673|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650674|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650675|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650676|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43622964|NCT05377619|Prucalopride|prucalopride|mesh-list
43622965|NCT05377619|Laxatives|laxatives|mesh-ancestor
43622966|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43622967|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43622968|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43622969|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
43547031|NCT03656783|Emtricitabine|emtricitabine|mesh-list
43547033|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
43622970|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43622971|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43622972|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622973|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43622974|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43622975|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622976|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43622977|NCT05377606|Temazepam|temazepam|mesh-list
43622978|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622979|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43622980|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43622981|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43622982|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43622996|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43622998|NCT05376865|Vitamins|vitamins|mesh-ancestor
43622999|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
43623000|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623001|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43623002|NCT05376670|Gentamicins|gentamicins|mesh-list
43623003|NCT05376670|Tobramycin|tobramycin|mesh-list
43623004|NCT05376670|Amikacin|amikacin|mesh-list
43623005|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623006|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623007|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43623008|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547615|NCT03650543|Amoxicillin|amoxicillin|mesh-list
43547616|NCT03650543|Clarithromycin|clarithromycin|mesh-list
43547704|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623011|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623013|NCT05376189|Vitamin D|vitamin d|mesh-list
43623014|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
43623015|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
43623016|NCT05376189|Vitamins|vitamins|mesh-list
43650677|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547775|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547776|NCT03648970|Pravastatin|pravastatin|mesh-list
43547777|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43547778|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43547779|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
43547780|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547781|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43710566|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43650678|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43650679|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43710583|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
43650680|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43548046|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
43548047|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
43548048|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548049|NCT03646370|Tenofovir|tenofovir|mesh-list
43548050|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
43548051|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548052|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43548053|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43548054|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548055|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650681|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650682|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650683|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
43650684|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650685|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43650686|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43650687|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
43650688|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43650689|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650690|NCT03012321|Prednisone|prednisone|mesh-list
43650691|NCT03012321|Olaparib|olaparib|mesh-list
43548107|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650692|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
43650693|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650694|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
43548222|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
43548223|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710722|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43710723|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43710724|NCT02695641|Growth Substances|growth substances|mesh-ancestor
43710725|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710726|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
43710727|NCT02695745|Celecoxib|celecoxib|mesh-list
43710728|NCT02695745|Capsaicin|capsaicin|mesh-list
43710730|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548262|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548263|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43548264|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43548265|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
43548266|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
43548267|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43548268|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43548269|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650695|NCT03012321|Hormones|hormones|mesh-ancestor
43650696|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650697|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650698|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43650699|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650700|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43623017|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
43548321|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548322|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
43548323|NCT03643588|Protective Agents|protective agents|mesh-ancestor
43548324|NCT03643549|Temozolomide|temozolomide|mesh-list
43548449|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710780|NCT02695355|Methylphenidate|methylphenidate|mesh-list
43548515|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43623018|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623019|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43623020|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43623021|NCT05375916|Hydromorphone|hydromorphone|mesh-list
43623022|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623023|NCT05375916|Narcotics|narcotics|mesh-ancestor
43623024|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623025|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623026|NCT05375916|Analgesics|analgesics|mesh-ancestor
43623027|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
43623028|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623029|NCT05375630|Vitamin K|vitamin k|mesh-list
43623030|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
43623031|NCT05375630|Vitamins|vitamins|mesh-ancestor
43623032|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
43623033|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623034|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43623035|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43548605|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43548606|NCT03640247|Analgesics|analgesics|mesh-ancestor
43548607|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
43548608|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548609|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548610|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
43548644|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548705|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
43548706|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
43548707|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548708|NCT03639519|Protective Agents|protective agents|mesh-ancestor
43548709|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548758|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43548759|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43548760|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43548761|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
43548763|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
43548764|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
43548765|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548769|NCT03639415|Narcotics|narcotics|mesh-ancestor
43548812|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43623036|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623037|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
43623038|NCT05375630|Coagulants|coagulants|mesh-ancestor
43623039|NCT05375305|Morphine|morphine|mesh-list
43710894|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
43710895|NCT02694224|Epirubicin|epirubicin|mesh-list
43710896|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43710897|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710898|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
43710899|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
43710900|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
43760765|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43548918|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43548919|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
43548920|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43548921|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548922|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
43548923|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43548924|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548925|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710923|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
43710924|NCT02693808|Protective Agents|protective agents|mesh-ancestor
43831652|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831653|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
43831654|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
43831655|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831656|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43831657|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
43831658|NCT05303792|Hormones|hormones|mesh-ancestor
43831659|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831660|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710941|NCT02693574|Renal Agents|renal agents|mesh-ancestor
43710952|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710953|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
43710954|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710955|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43710956|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623040|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623042|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650701|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650702|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650703|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43650704|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
43549053|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
43549140|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549141|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43549142|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
43549143|NCT03635398|Midazolam|midazolam|mesh-list
43549144|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43549145|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43549146|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549147|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549148|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43650705|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43650706|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
43650707|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43650708|NCT03012347|Protective Agents|protective agents|mesh-ancestor
43650709|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650710|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623043|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623045|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
43623046|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623047|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
43549246|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549247|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43549248|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776777|NCT02336386|Bortezomib|bortezomib|mesh-list
43549250|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549251|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549252|NCT03634345|Fluconazole|fluconazole|mesh-list
43549253|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
43549254|NCT03634345|Abrocitinib|abrocitinib|mesh-list
43549255|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
43710993|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710994|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710997|NCT02692989|Anesthetics|anesthetics|mesh-list
43549319|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
43549376|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549377|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549379|NCT03633552|Temozolomide|temozolomide|mesh-list
43623048|NCT05375240|Propranolol|propranolol|mesh-list
43623049|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43623065|NCT05375188|Analgesics|analgesics|mesh-ancestor
43623066|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
43549513|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43549514|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549515|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
43711072|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
43711097|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711098|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43711123|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549669|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43623067|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623083|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43549742|NCT03630042|Rituximab|rituximab|mesh-list
43549870|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43549871|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
43549872|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43549873|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43549874|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43549876|NCT03628521|Gemcitabine|gemcitabine|mesh-list
43549877|NCT03628521|Carboplatin|carboplatin|mesh-list
43549930|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43549931|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
43549932|NCT03628079|Mebendazole|mebendazole|mesh-list
43549933|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
43711172|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
43711173|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
43549975|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43549977|NCT03626831|Evolocumab|evolocumab|mesh-list
43711230|NCT02690870|Tamoxifen|tamoxifen|mesh-list
43550244|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43550245|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550246|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550248|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43623084|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623085|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623086|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623087|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43623088|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43623089|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
43623090|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43550389|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
43623091|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
43623093|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
43623094|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43623095|NCT05374356|Morphine|morphine|mesh-list
43623096|NCT05374356|Bupivacaine|bupivacaine|mesh-list
43623097|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623098|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
43623099|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623100|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550436|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
43623101|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
43623102|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623103|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623104|NCT05374356|Narcotics|narcotics|mesh-ancestor
43623105|NCT05374356|Analgesics|analgesics|mesh-ancestor
43623106|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43623107|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623108|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623125|NCT05371600|Midazolam|midazolam|mesh-list
43711312|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
43711313|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711314|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43711315|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
43711316|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43711317|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
43550491|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43550492|NCT03622827|Growth Substances|growth substances|mesh-ancestor
43550493|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550494|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
43623126|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43623127|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623128|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623129|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623130|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43623131|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43711339|NCT02689882|Niacin|niacin|mesh-list
43550591|NCT03621995|Protective Agents|protective agents|mesh-ancestor
43550650|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43550651|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623132|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43623133|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43623134|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
43623135|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
43623136|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
43623137|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
43623144|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43550827|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
43550829|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43550830|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550831|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43623145|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
43623146|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623147|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623148|NCT05331807|Vitamin D|vitamin d|mesh-list
43650711|NCT03011970|Oxytocin|oxytocin|mesh-list
43650712|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
43650713|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43650714|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650715|NCT03011905|Acetaminophen|acetaminophen|mesh-list
43650716|NCT03011905|Dexamethasone|dexamethasone|mesh-list
43711448|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711449|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711450|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550958|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43650718|NCT03011905|Oxycodone|oxycodone|mesh-list
43650719|NCT03011905|Ropivacaine|ropivacaine|mesh-list
43650720|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650721|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
43650722|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
43623149|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
43623150|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
43623151|NCT05331807|Vitamins|vitamins|mesh-list
43623152|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
43623153|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623154|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43623155|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43623156|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43623157|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623158|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623159|NCT05286996|Anesthetics|anesthetics|mesh-list
43623160|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
43623161|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623162|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623163|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
43623164|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623165|NCT05283382|Cannabidiol|cannabidiol|mesh-list
43623166|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
43623168|NCT05261464|Diltiazem|diltiazem|mesh-list
43623169|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623170|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43623171|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
43623172|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
43623173|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623174|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623175|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43623176|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43623177|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43623178|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
43623179|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623180|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623181|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43623182|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623183|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43623184|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
43623185|NCT05164367|Atropine|atropine|mesh-list
43623186|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43623187|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623188|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43623189|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
43711532|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711533|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43711534|NCT02689024|Narcotics|narcotics|mesh-ancestor
43711535|NCT02689024|Analgesics|analgesics|mesh-ancestor
43711536|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43711537|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43711538|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
43711539|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711540|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
43711541|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43711542|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711543|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711544|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43711545|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711546|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711547|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
43711548|NCT02689037|Aspirin|aspirin|mesh-list
43711549|NCT02689037|Clopidogrel|clopidogrel|mesh-list
43623190|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623191|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623192|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43623193|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
43623194|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
43623195|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
43623196|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43623197|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43623198|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
43623199|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623200|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623201|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43650723|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650724|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650725|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650726|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
43650728|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650729|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43551130|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551131|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551132|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43551133|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43650730|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650731|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623202|NCT05164081|Clindamycin|clindamycin|mesh-list
43623226|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
43623227|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623228|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
43623229|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43623230|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
43623232|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43623233|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
43623234|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43551176|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623235|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623236|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623237|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
43623238|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623239|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623240|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43623241|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
43623242|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
43623243|NCT05012566|Protective Agents|protective agents|mesh-ancestor
43623244|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43623245|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623248|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623250|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43623286|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
43623287|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43623288|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43551234|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623321|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623323|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623324|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623325|NCT04670471|Analgesics|analgesics|mesh-ancestor
43623326|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
43623327|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623328|NCT04669197|Gemcitabine|gemcitabine|mesh-list
43776824|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43623329|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
43623330|NCT04669197|Paclitaxel|paclitaxel|mesh-list
43623331|NCT04669197|Cisplatin|cisplatin|mesh-list
43623332|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43623369|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43623370|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43623371|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43623372|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
43623409|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43623410|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623432|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623433|NCT04551040|Urological Agents|urological agents|mesh-ancestor
43623434|NCT04542837|Lenvatinib|lenvatinib|mesh-list
43623435|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623436|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43623437|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551270|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
43623443|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623444|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623445|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623447|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
43623448|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
43623449|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623450|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623451|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
43623452|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623453|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43623454|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43623455|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623456|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623457|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623458|NCT04472611|Colchicine|colchicine|mesh-list
43623459|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43551327|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43551328|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43551329|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
43551330|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43551331|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551377|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551378|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551379|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551380|NCT03614052|Urological Agents|urological agents|mesh-ancestor
43551381|NCT03613974|Lidocaine|lidocaine|mesh-list
43551382|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
43551383|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
43551384|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551385|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551386|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
43551387|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551388|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551389|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43551390|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623460|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43623461|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43623463|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623464|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43623499|NCT04323566|Rituximab|rituximab|mesh-list
43623500|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623501|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623502|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
43623503|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623504|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623505|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
43623506|NCT04319328|Cefazolin|cefazolin|mesh-list
43623507|NCT04319328|Ceftazidime|ceftazidime|mesh-list
43623508|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623532|NCT04303000|Narcotics|narcotics|mesh-ancestor
43623533|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623534|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623535|NCT04303000|Analgesics|analgesics|mesh-ancestor
43623536|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
43650739|NCT03011905|Narcotics|narcotics|mesh-ancestor
43650740|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650741|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43711625|NCT02688595|Anesthetics|anesthetics|mesh-list
43650743|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650744|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650745|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650746|NCT03011918|Vitamin D|vitamin d|mesh-list
43650747|NCT03011918|Vitamins|vitamins|mesh-ancestor
43650748|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
43650749|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650750|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43650751|NCT03012009|Lidocaine|lidocaine|mesh-list
43650752|NCT03012009|Epinephrine|epinephrine|mesh-list
43650753|NCT03012009|Racepinephrine|racepinephrine|mesh-list
43650754|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
43650755|NCT03012009|Anesthetics|anesthetics|mesh-list
43650756|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43650757|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
43650758|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650759|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650760|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
43650761|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650762|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43650763|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43650764|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43650765|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43650766|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650767|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43650768|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650769|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650770|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650771|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43623537|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623538|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43623539|NCT04302870|Memantine|memantine|mesh-list
43623540|NCT04302870|Trazodone|trazodone|mesh-list
43623541|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43623542|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43652819|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652820|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
43652821|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652822|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652823|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623543|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43650772|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43551462|NCT03613545|Rifaximin|rifaximin|mesh-list
43831771|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831772|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
43831773|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831774|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831775|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831776|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831777|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831778|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43551511|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43831780|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43831781|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
43831782|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650773|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
43650774|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43650775|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650776|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
43650777|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
43650778|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43650779|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43650780|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
43650781|NCT03012113|Mirabegron|mirabegron|mesh-list
43650782|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43650783|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43650784|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43650785|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650786|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650787|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650788|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650789|NCT03012113|Urological Agents|urological agents|mesh-ancestor
43824516|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824517|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824518|NCT05511441|Analgesics|analgesics|mesh-ancestor
43824519|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
43824520|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824521|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824522|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824523|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824524|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43824525|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824526|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824527|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43824528|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824529|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824530|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
43824531|NCT05511337|Citric Acid|citric acid|mesh-list
43824532|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
43824537|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824538|NCT05511246|Ethanol|ethanol|mesh-list
43824539|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43824540|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824541|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824542|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824543|NCT05510986|Fentanyl|fentanyl|mesh-list
43824544|NCT05510986|Oxycodone|oxycodone|mesh-list
43824545|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43824546|NCT05510986|Narcotics|narcotics|mesh-ancestor
43824547|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824548|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824549|NCT05510986|Analgesics|analgesics|mesh-ancestor
43824550|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
43824551|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650790|NCT03011931|Simvastatin|simvastatin|mesh-list
43650791|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43650792|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43650793|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
43650794|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650795|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43650796|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43711730|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43711731|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43711732|NCT02687841|Protective Agents|protective agents|mesh-ancestor
43551555|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43551556|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623544|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
43623545|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623546|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623547|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623548|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43623549|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43623550|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43623551|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43623552|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623553|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43623554|NCT04302870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43623555|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43623556|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623592|NCT04189588|Paclitaxel|paclitaxel|mesh-list
43623593|NCT04189588|Rituximab|rituximab|mesh-list
43623594|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43623595|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551594|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551595|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
43551596|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711733|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623596|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
43623597|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623627|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43623628|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43623629|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623630|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43650797|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650798|NCT03011996|Amoxicillin|amoxicillin|mesh-list
43650799|NCT03011996|Clarithromycin|clarithromycin|mesh-list
43650800|NCT03011996|Pantoprazole|pantoprazole|mesh-list
43650801|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650802|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650803|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43650804|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650805|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650806|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43650807|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43650808|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43711752|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650809|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650810|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43650812|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43650813|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650814|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650815|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
43650816|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650817|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650818|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
43650819|NCT03011463|Clarithromycin|clarithromycin|mesh-list
43650821|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43650822|NCT03011463|Trospium chloride|trospium chloride|mesh-list
43652826|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43652827|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652828|NCT02987985|Analgesics|analgesics|mesh-ancestor
43652829|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43652830|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43623631|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43623632|NCT04175470|Tocotrienols|tocotrienols|mesh-list
43623633|NCT04175470|Vitamin E|vitamin e|mesh-list
43623634|NCT04175470|Tocopherols|tocopherols|mesh-list
43623635|NCT04175470|Bevacizumab|bevacizumab|mesh-list
43623636|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43623637|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623638|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43623639|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43623640|NCT04175470|Growth Substances|growth substances|mesh-ancestor
43623641|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623642|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
43623673|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43623674|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43623675|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43623676|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623677|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
43623678|NCT04021550|Protective Agents|protective agents|mesh-ancestor
43623679|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623714|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551656|NCT03611504|Hemostatics|hemostatics|mesh-list
43711773|NCT02687854|Coagulants|coagulants|mesh-ancestor
43711774|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43711775|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711776|NCT02687347|Morphine|morphine|mesh-list
43711777|NCT02687347|Methadone|methadone|mesh-list
43623715|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43623716|NCT03994731|Protective Agents|protective agents|mesh-ancestor
43623717|NCT03994731|Hematinics|hematinics|mesh-ancestor
43650823|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43650824|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43650825|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43650826|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650827|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650828|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43650829|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43650830|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43551687|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551688|NCT03611179|Growth Substances|growth substances|mesh-ancestor
43650831|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650832|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43650833|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
43831095|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
43831096|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
43831097|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
43831098|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831099|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43705133|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
43705134|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43705135|NCT03322280|Estrogens|estrogens|mesh-ancestor
43705137|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705138|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705139|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43705140|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705141|NCT05345327|Metformin|metformin|mesh-list
43705142|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
43650834|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
43650835|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650836|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650837|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
43650838|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
43650839|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650840|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43650841|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43650842|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
43650843|NCT03011463|Urological Agents|urological agents|mesh-ancestor
43650844|NCT03011645|Ziprasidone|ziprasidone|mesh-list
43650845|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43650846|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
43551728|NCT03610932|Ascorbic Acid|ascorbic acid|mesh-list
43650847|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650848|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650849|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650850|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43650851|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43623718|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
43623719|NCT03994731|Vitamins|vitamins|mesh-ancestor
43623720|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
43623721|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43623722|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43623756|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623757|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
43623758|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43623759|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43623760|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43623761|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623762|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623763|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43623778|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
43623779|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43650852|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650853|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43650854|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43650855|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
43650856|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
43650857|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650858|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
43650859|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43650860|NCT03011567|Acetaminophen|acetaminophen|mesh-list
43650861|NCT03011567|Ibuprofen|ibuprofen|mesh-list
43551760|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
43650863|NCT03011567|Analgesics|analgesics|mesh-ancestor
43650864|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
43650865|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650866|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650868|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43650869|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43650870|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43650871|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43650872|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650873|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650874|NCT03011281|Tofacitinib|tofacitinib|mesh-list
43650875|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43650876|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650877|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650878|NCT03011177|Linagliptin|linagliptin|mesh-list
43650879|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705168|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
43650880|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650881|NCT03011177|Incretins|incretins|mesh-ancestor
43650882|NCT03011177|Hormones|hormones|mesh-ancestor
43623780|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43623782|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623783|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43623784|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
43623785|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623786|NCT03954613|Memantine|memantine|mesh-list
43623787|NCT03954613|Donepezil|donepezil|mesh-list
43551774|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
43623788|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43623789|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623790|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623791|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
43623792|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623793|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623794|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
43650883|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650884|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43650886|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650887|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650888|NCT03010865|Butyric Acid|butyric acid|mesh-list
43650889|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
43650890|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
43650891|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650892|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650893|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650894|NCT03011008|Liraglutide|liraglutide|mesh-list
43650895|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43650896|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650897|NCT03011008|Incretins|incretins|mesh-ancestor
43650898|NCT03011008|Hormones|hormones|mesh-ancestor
43650899|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650900|NCT03010995|Prazosin|prazosin|mesh-list
43650901|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43650902|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43650903|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43650904|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43650905|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
43650906|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43650907|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650908|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623795|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43623796|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43623797|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
43623798|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43623799|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43623800|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
43623801|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43623802|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623803|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
43623805|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43623806|NCT03906721|Narcotics|narcotics|mesh-ancestor
43623807|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623808|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623809|NCT03906721|Analgesics|analgesics|mesh-ancestor
43623810|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
43623811|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43623812|NCT03905811|Terazosin|terazosin|mesh-list
43623813|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43623814|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43650910|NCT03011125|Lansoprazole|lansoprazole|mesh-list
43650911|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43650912|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43650913|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43650914|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650915|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650916|NCT03011060|Capecitabine|capecitabine|mesh-list
43650917|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43650918|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
43650919|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650920|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650921|NCT03010670|Oxytocin|oxytocin|mesh-list
43650936|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650937|NCT03010761|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43650938|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
43623815|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43623861|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
43623862|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43623863|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43623864|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623865|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623866|NCT03177746|Urological Agents|urological agents|mesh-ancestor
43623868|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43551914|NCT03609294|Linagliptin|linagliptin|mesh-list
43623869|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43623870|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43623901|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43623903|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43623904|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43623905|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43623906|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623907|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623908|NCT02672475|Paclitaxel|paclitaxel|mesh-list
43623909|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43712008|NCT02686047|Hylan|hylan|mesh-list
43623949|NCT02398656|Clopidogrel|clopidogrel|mesh-list
43623950|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43623951|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43623952|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43623953|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43623954|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
43623956|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623957|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43623958|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43623959|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43703391|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705290|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43705291|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705292|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705293|NCT05343169|Naloxone|naloxone|mesh-list
43705294|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43705295|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705296|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
43623988|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
43623989|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623990|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623992|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43623993|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43623994|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43623995|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43623996|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43623998|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
43623999|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
43624000|NCT01979796|Nicotine|nicotine|mesh-list
43624001|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43624002|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
43624003|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624027|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624028|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
43624029|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624030|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624031|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624032|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
43624033|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624034|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624041|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
43624043|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43624044|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624046|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624047|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624048|NCT01715285|Prednisone|prednisone|mesh-list
43624049|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
43624050|NCT01715285|Androgens|androgens|mesh-list
43624051|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43624052|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
43624053|NCT01715285|Hormones|hormones|mesh-ancestor
43624054|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624055|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624084|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43624085|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43624086|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624087|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43624088|NCT05405049|Narcotics|narcotics|mesh-ancestor
43624089|NCT05405049|Analgesics|analgesics|mesh-ancestor
43624090|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43624091|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43624092|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
43624093|NCT05404516|Cytarabine|cytarabine|mesh-list
43624098|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624099|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624101|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624102|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624124|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624125|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43624126|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624127|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624128|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624129|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624130|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650941|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650942|NCT03011021|Liraglutide|liraglutide|mesh-list
43624134|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624136|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
43624137|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624138|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43624139|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
43624140|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43624141|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624142|NCT05403281|Incretins|incretins|mesh-ancestor
43624143|NCT05403281|Hormones|hormones|mesh-ancestor
43712415|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624144|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624145|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43624146|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
43624147|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624148|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624149|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43624150|NCT05403125|Listerine|listerine|mesh-list
43624151|NCT05403125|Fluorides|fluorides|mesh-list
43624152|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
43624153|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
43624154|NCT05403125|Protective Agents|protective agents|mesh-ancestor
43624155|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624156|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43624157|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624182|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
43624183|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624184|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43650943|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43650944|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650945|NCT03011021|Incretins|incretins|mesh-ancestor
43650946|NCT03011021|Hormones|hormones|mesh-ancestor
43650947|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650948|NCT03010540|Fentanyl|fentanyl|mesh-list
43650949|NCT03010540|Morphine|morphine|mesh-list
43831830|NCT05294328|Aceclidine|aceclidine|mesh-list
43650951|NCT03010540|Narcotics|narcotics|mesh-ancestor
43650952|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43650953|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650954|NCT03010540|Analgesics|analgesics|mesh-ancestor
43650955|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
43650956|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43650957|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43650958|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43650959|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
43650960|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
43650961|NCT03010475|Furosemide|furosemide|mesh-list
43650962|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43624185|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624186|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624187|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624188|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43624189|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43624190|NCT05399290|Doxycycline|doxycycline|mesh-list
43624191|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43624192|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624193|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
43624194|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43624195|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43624196|NCT05387148|Cannabidiol|cannabidiol|mesh-list
43624197|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
43624198|NCT05344365|Iloperidone|iloperidone|mesh-list
43624199|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43624200|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624201|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624202|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624203|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43583014|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
43776855|NCT02335684|Methamphetamine|methamphetamine|mesh-list
43776856|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43624204|NCT05328440|Fulvestrant|fulvestrant|mesh-list
43624205|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43624206|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624207|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43624208|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43624209|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
43624210|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624211|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624212|NCT05323175|Ropivacaine|ropivacaine|mesh-list
43624213|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
43624214|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
43624240|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624241|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624242|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43624243|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624244|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43650963|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43650964|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43650965|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
43650966|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650967|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43650968|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43650969|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43650970|NCT03010475|Diuretics|diuretics|mesh-ancestor
43650971|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
43650972|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650973|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43650974|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43624245|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43624246|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
43624247|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
43624248|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
43624249|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
43624250|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624251|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624252|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
43624254|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
43624255|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
43624256|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624257|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624258|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
43624259|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624260|NCT05220514|PK 11195|pk 11195|mesh-list
43624261|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624262|NCT05161754|Hemostatics|hemostatics|mesh-list
43624263|NCT05161754|Coagulants|coagulants|mesh-ancestor
43624264|NCT05137262|Cisplatin|cisplatin|mesh-list
43624299|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
43624300|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
43624301|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624302|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624303|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
43624341|NCT05011812|Ritonavir|ritonavir|mesh-list
43624342|NCT05011812|Midazolam|midazolam|mesh-list
43624378|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43624379|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624380|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
43624381|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
43624382|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43624405|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
43624406|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624407|NCT04712734|Iloperidone|iloperidone|mesh-list
43624408|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43624409|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624410|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624411|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624412|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43624413|NCT04695704|Montelukast|montelukast|mesh-list
43624414|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43624415|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43624416|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
43624417|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
43712732|NCT02681679|Bromfenac|bromfenac|mesh-list
43624418|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624419|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624420|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43624421|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43650976|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43650977|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
43650978|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
43650979|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650980|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650981|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43650982|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43650983|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
43650984|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650985|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650986|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43650987|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43650988|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43650989|NCT03010202|Dexamethasone|dexamethasone|mesh-list
43650990|NCT03010202|Rituximab|rituximab|mesh-list
43650991|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43650992|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43650993|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
43650994|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43650995|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624422|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624424|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624425|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624426|NCT04592159|Nabiximols|nabiximols|mesh-list
43624427|NCT04592159|Analgesics|analgesics|mesh-ancestor
43624428|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
43624429|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624430|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624431|NCT04585776|Insulin|insulin|mesh-list
43624432|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43624503|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712924|NCT02680379|Minocycline|minocycline|mesh-list
43624505|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624516|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
43624517|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
43624518|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43624519|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43624520|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
43624521|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
43624522|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624523|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624524|NCT03995004|Dexamethasone|dexamethasone|mesh-list
43624525|NCT03995004|Melatonin|melatonin|mesh-list
43624526|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
43624527|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43624528|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
43624529|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
43624530|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624531|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624532|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624533|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
43624534|NCT03995004|Hormones|hormones|mesh-ancestor
43624535|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43650997|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
43650998|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
43650999|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651000|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651001|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
43651002|NCT03010202|Hormones|hormones|mesh-ancestor
43624536|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43624537|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624539|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624540|NCT03995004|Protective Agents|protective agents|mesh-ancestor
43624541|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624542|NCT03995004|Cathartics|cathartics|mesh-ancestor
43624543|NCT03957876|Cytarabine|cytarabine|mesh-list
43624544|NCT03957876|Daunorubicin|daunorubicin|mesh-list
43624545|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624546|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
43624547|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624548|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624549|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
43624550|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624551|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624552|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
43624553|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624554|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624555|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624556|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624557|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624558|NCT03955575|Liraglutide|liraglutide|mesh-list
43624559|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43624560|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43624561|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624562|NCT03955575|Incretins|incretins|mesh-ancestor
43624563|NCT03955575|Hormones|hormones|mesh-ancestor
43624564|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624565|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43624566|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43624567|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
43624568|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624569|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43624570|NCT03919435|Trimethoprim|trimethoprim|mesh-list
43624603|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43624604|NCT03738878|Valsartan|valsartan|mesh-list
43624605|NCT03738878|Bradykinin|bradykinin|mesh-list
43713137|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
43624607|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43624608|NCT03738878|Substance P|substance p|mesh-list
43624609|NCT03738878|Neurokinin A|neurokinin a|mesh-list
43624610|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43624631|NCT03530267|Aflibercept|aflibercept|mesh-list
43624632|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43624633|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43624634|NCT03530267|Growth Substances|growth substances|mesh-ancestor
43624635|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624636|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
43624637|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624639|NCT03472573|Palbociclib|palbociclib|mesh-list
43624640|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43624643|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624644|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624645|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624646|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
43624648|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43624649|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43624650|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651003|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651004|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651005|NCT03010098|Remifentanil|remifentanil|mesh-list
43624651|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624652|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624653|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624654|NCT03384784|Galantamine|galantamine|mesh-list
43624655|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43624656|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624657|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624658|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
43624659|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624660|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624661|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43624681|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
43624682|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43624683|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624684|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624686|NCT03337087|Protective Agents|protective agents|mesh-ancestor
43624687|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
43624689|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
43624690|NCT03337087|Hematinics|hematinics|mesh-ancestor
43624691|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43624692|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
43624693|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624694|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624695|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
43624696|NCT03299088|Trametinib|trametinib|mesh-list
43624697|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624698|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624699|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43624700|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624701|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624702|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
43624703|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
43624704|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624705|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43624706|NCT02970318|Rituximab|rituximab|mesh-list
43624707|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43624708|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
43624709|NCT02970318|Idelalisib|idelalisib|mesh-list
43624710|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624711|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624712|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
43831931|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624713|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624714|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624715|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624716|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
43624717|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624718|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624719|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43624720|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43624754|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624755|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624756|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43624757|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624758|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624759|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43624760|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
43624762|NCT02710669|Propafenone|propafenone|mesh-list
43624763|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43624797|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43624798|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43624799|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
43624800|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43651006|NCT03010098|Propofol|propofol|mesh-list
43651007|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43651008|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651009|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624801|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43624802|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
43624803|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
43624804|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624805|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43624806|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624826|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
43624827|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
43624828|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624829|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624830|NCT02514031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624831|NCT02514031|Immunologic Factors|immunologic factors|mesh-ancestor
43624832|NCT02514031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624833|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43624834|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43624835|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43624836|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43624837|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624838|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
43624839|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624840|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624841|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43624842|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43624844|NCT02449005|Coagulants|coagulants|mesh-ancestor
43624845|NCT02332928|Melatonin|melatonin|mesh-list
43624846|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
43624847|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624848|NCT02332928|Protective Agents|protective agents|mesh-ancestor
43624849|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624850|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624851|NCT01868451|Doxorubicin|doxorubicin|mesh-list
43624852|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43624853|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43624854|NCT01868451|Dacarbazine|dacarbazine|mesh-list
43624855|NCT01868451|Vinblastine|vinblastine|mesh-list
43624856|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624857|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624858|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43624859|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43624860|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624861|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624889|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776917|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
43624890|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624891|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
43624892|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624893|NCT01506986|Metronidazole|metronidazole|mesh-list
43624894|NCT01506986|Clarithromycin|clarithromycin|mesh-list
43624895|NCT01506986|Lansoprazole|lansoprazole|mesh-list
43624896|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
43624897|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43624898|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43624899|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43624900|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43624901|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43624902|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43624903|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624904|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43624905|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43624906|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43624907|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624908|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43624910|NCT01295944|Carboplatin|carboplatin|mesh-list
43624937|NCT01228331|Daunorubicin|daunorubicin|mesh-list
43624938|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
43624939|NCT01228331|Clofarabine|clofarabine|mesh-list
43624940|NCT01228331|Pegaspargase|pegaspargase|mesh-list
43624941|NCT01228331|Thioguanine|thioguanine|mesh-list
43651010|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43651011|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
43624942|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
43624943|NCT01228331|Amsacrine|amsacrine|mesh-list
43624944|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624945|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
43624946|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624947|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43624948|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43624949|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
43624950|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624951|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624952|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43624953|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43624955|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
43624956|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43624957|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43624958|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
43624959|NCT01228331|Hormones|hormones|mesh-ancestor
43624960|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43713991|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43624961|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43624962|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43624984|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
43624985|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43624986|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624987|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624988|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43624989|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43624990|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43624991|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43624992|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43624993|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
43624995|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
43624996|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
43624997|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624998|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
43624999|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625000|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625001|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625002|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
43625003|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625004|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625005|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43776958|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
43776959|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43625006|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43625007|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625008|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43625009|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
43625010|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43625011|NCT00964002|Efavirenz|efavirenz|mesh-list
43625012|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43625013|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43625014|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625045|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
43625046|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625047|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625048|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43625049|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625050|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43625051|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625052|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625072|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
43625073|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43625074|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625075|NCT00432094|Protective Agents|protective agents|mesh-ancestor
43625077|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43625078|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
43625079|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625080|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625081|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
43651013|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651014|NCT03010098|Narcotics|narcotics|mesh-ancestor
43651015|NCT03010098|Analgesics|analgesics|mesh-ancestor
43651016|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
43651017|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625082|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43625083|NCT00072358|Irinotecan|irinotecan|mesh-list
43625084|NCT00072358|Temozolomide|temozolomide|mesh-list
43625085|NCT00072358|Molgramostim|molgramostim|mesh-list
43625086|NCT00072358|Isotretinoin|isotretinoin|mesh-list
43625087|NCT00072358|Antibodies|antibodies|mesh-list
43625088|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
43625089|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43625090|NCT00072358|Sargramostim|sargramostim|mesh-list
43625091|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
43625092|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
43625093|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625094|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625095|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43625096|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43625097|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625098|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625099|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43625100|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
43625101|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
43625102|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625103|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625105|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43625106|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
43625107|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625108|NCT03104959|Expectorants|expectorants|mesh-ancestor
43625109|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625110|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43625111|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
43625134|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625135|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625136|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43625137|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
43625138|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43625139|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43625140|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43625141|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43625142|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625143|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625144|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
43625145|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
43625146|NCT03104426|Hematinics|hematinics|mesh-ancestor
43625147|NCT03104335|Apatinib|apatinib|mesh-list
43625148|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625149|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43625150|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625151|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625152|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
43625153|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43625154|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
43625155|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43625156|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625157|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43625158|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43625159|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43625160|NCT03104140|Ketamine|ketamine|mesh-list
43625161|NCT03104140|Thiopental|thiopental|mesh-list
43625162|NCT03104140|Analgesics|analgesics|mesh-ancestor
43625163|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
43625164|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625165|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625199|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625200|NCT03103867|Insulin|insulin|mesh-list
43625201|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43651019|NCT03010072|Hematinics|hematinics|mesh-ancestor
43824552|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43824553|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43824554|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
43824555|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
43824556|NCT05510895|Cetuximab|cetuximab|mesh-list
43824557|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824558|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824559|NCT05510778|Charcoal|charcoal|mesh-list
43824560|NCT05510778|Antidotes|antidotes|mesh-ancestor
43824561|NCT05510778|Protective Agents|protective agents|mesh-ancestor
43625202|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625203|NCT03103685|Clopidogrel|clopidogrel|mesh-list
43625204|NCT03103685|Ticagrelor|ticagrelor|mesh-list
43625205|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43625206|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625207|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43625242|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
43625243|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
43625244|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625245|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43625281|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43625282|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
43625283|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625306|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
43625307|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
43625308|NCT03103152|Vitamins|vitamins|mesh-list
43625309|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
43625310|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625311|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43625312|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43625313|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625314|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625315|NCT03103152|Analgesics|analgesics|mesh-ancestor
43625316|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
43625320|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43625321|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43705790|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
43705795|NCT03739554|Venetoclax|venetoclax|mesh-list
43625322|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625323|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43625324|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43625325|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625327|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43625328|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43625329|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43625330|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43625331|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625332|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
43625333|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625361|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625363|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43625364|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625365|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
43625366|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43625367|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625368|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625369|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625370|NCT03102359|Analgesics|analgesics|mesh-ancestor
43625371|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
43824562|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824564|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43824565|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43824566|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
43824567|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824568|NCT05510505|Antibodies|antibodies|mesh-list
43824569|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43824570|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
43824571|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824572|NCT05510323|Prednisolone|prednisolone|mesh-list
43824573|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43824574|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
43824582|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824584|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824585|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
43824586|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824587|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824588|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824589|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824590|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
43824591|NCT05510323|Hormones|hormones|mesh-ancestor
43824592|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824593|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43824594|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
43824595|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
43824596|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625372|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625373|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43625374|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43832098|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43832099|NCT05281341|Hormones|hormones|mesh-list
43832100|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832101|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625375|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43625376|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
43824597|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824598|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43824599|NCT05510323|Protective Agents|protective agents|mesh-ancestor
43824600|NCT05510310|Oxytocin|oxytocin|mesh-list
43824601|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
43824602|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43824603|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625377|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625378|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625379|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
43625380|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
43625381|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43625382|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43625414|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625415|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43625416|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625417|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625418|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
43625419|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43625420|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
43625421|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625422|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
43625423|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625424|NCT03101423|Interleukin-2|interleukin-2|mesh-list
43625425|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625426|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43625427|NCT03101423|Analgesics|analgesics|mesh-ancestor
43625428|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
43625429|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625568|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
43625569|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625570|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625571|NCT03100513|Lactulose|lactulose|mesh-list
43625572|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625573|NCT03100734|Etanercept|etanercept|mesh-list
43625574|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43625590|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
43625591|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625592|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43625593|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43625594|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43824604|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
43824605|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824606|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824607|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
43824608|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43824609|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
43824610|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
43625595|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43625596|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625679|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43625680|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
43625681|NCT03099122|Prednisone|prednisone|mesh-list
43625682|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
43625683|NCT03099122|Tacrolimus|tacrolimus|mesh-list
43625684|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
43625685|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43625686|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
43625687|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625688|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
43625689|NCT03099122|Hormones|hormones|mesh-ancestor
43551953|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625690|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625691|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625692|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625693|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625694|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43625695|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
43625696|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43625697|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625698|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625699|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43776961|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43776962|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43776963|NCT02334501|Lansoprazole|lansoprazole|mesh-list
43776964|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
43625700|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43625701|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
43824612|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625922|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625923|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43625925|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43625926|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
43849432|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
43625927|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43625928|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43625929|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43625930|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43625931|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625932|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626040|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
43626041|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43626043|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626044|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626045|NCT03096223|KHK4083|khk4083|mesh-list
43626046|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
43626047|NCT03095872|Petrolatum|petrolatum|mesh-list
43626048|NCT03095872|Emollients|emollients|mesh-ancestor
43626054|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626055|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626056|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43626057|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
43626058|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
43626059|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
43626060|NCT03096028|Vitamins|vitamins|mesh-ancestor
43626131|NCT03095209|Paclitaxel|paclitaxel|mesh-list
43824613|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824615|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
43824616|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824617|NCT05510115|Empagliflozin|empagliflozin|mesh-list
43824618|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43824619|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824620|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43824621|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824622|NCT05509946|Celecoxib|celecoxib|mesh-list
43824623|NCT05509946|Pregabalin|pregabalin|mesh-list
43824624|NCT05509946|Analgesics|analgesics|mesh-ancestor
43824625|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
43824626|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824627|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651020|NCT03009877|Fentanyl|fentanyl|mesh-list
43651021|NCT03009877|Midazolam|midazolam|mesh-list
43651022|NCT03009877|Propofol|propofol|mesh-list
43651023|NCT03009877|Rocuronium|rocuronium|mesh-list
43651024|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43651025|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651026|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651028|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
43651029|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
43651030|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651031|NCT03009877|Narcotics|narcotics|mesh-ancestor
43651032|NCT03009877|Analgesics|analgesics|mesh-ancestor
43651033|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
43651034|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651035|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43651036|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43651037|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43651038|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43651039|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
43651040|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
43651041|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651042|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651043|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43651044|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43651045|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43651046|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43651047|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43651048|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651049|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
43651050|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651051|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43651052|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
43651053|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43651054|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
43651055|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651056|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651057|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651058|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
43651059|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43651060|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
43551973|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43551974|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43551975|NCT03608501|Thalidomide|thalidomide|mesh-list
43551976|NCT03608501|Dexamethasone|dexamethasone|mesh-list
43551977|NCT03608501|Ixazomib|ixazomib|mesh-list
43551978|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551988|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551989|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551990|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551991|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
43651062|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651063|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43651064|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
43651074|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651075|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651076|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651077|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43651079|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43714928|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43714930|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714931|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551995|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43551996|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43551997|NCT03608501|Growth Substances|growth substances|mesh-ancestor
43551998|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551999|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
43552000|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552001|NCT03608306|Methamphetamine|methamphetamine|mesh-list
43552002|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43552003|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552004|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
43552005|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
43552006|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552007|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
43552008|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552009|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552010|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552011|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43552012|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552013|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552014|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43552015|NCT03608293|Dimercaprol|dimercaprol|mesh-list
43552016|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
43552017|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
43651084|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651085|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
43651086|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43651087|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43651088|NCT03009500|Prednisolone|prednisolone|mesh-list
43651089|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
43626190|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43626191|NCT03095079|Growth Substances|growth substances|mesh-ancestor
43626192|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626193|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
43626194|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626195|NCT03095040|Everolimus|everolimus|mesh-list
43626196|NCT03095040|Vorolanib|vorolanib|mesh-list
43626197|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626198|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626199|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
43552018|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552019|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43552020|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
43552021|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
43626200|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626201|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43626202|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626203|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626204|NCT03095001|Paclitaxel|paclitaxel|mesh-list
43626205|NCT03095001|Bevacizumab|bevacizumab|mesh-list
43626206|NCT03095001|Carboplatin|carboplatin|mesh-list
43626239|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626240|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
43626241|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
43626242|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626243|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
43626244|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43626245|NCT03094663|Protective Agents|protective agents|mesh-ancestor
43626246|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43626247|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43626248|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
43626397|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43626398|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626400|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626402|NCT03092986|Vinblastine|vinblastine|mesh-list
43626403|NCT03092986|Cisplatin|cisplatin|mesh-list
43626404|NCT03092986|Carboplatin|carboplatin|mesh-list
43626523|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626524|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
43849433|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626525|NCT03091569|Coagulants|coagulants|mesh-ancestor
43714938|NCT02665039|Carboplatin|carboplatin|mesh-list
43626586|NCT03090971|Diclofenac|diclofenac|mesh-list
43626587|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43626588|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626589|NCT03090971|Analgesics|analgesics|mesh-ancestor
43626590|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
43626591|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626592|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626593|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626594|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552077|NCT03607903|Adalimumab|adalimumab|mesh-list
43626602|NCT03090698|Hormones|hormones|mesh-ancestor
43626603|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626604|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626605|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
43626606|NCT03090698|Protective Agents|protective agents|mesh-ancestor
43626607|NCT03090503|Risperidone|risperidone|mesh-list
43626608|NCT03090503|Aripiprazole|aripiprazole|mesh-list
43626666|NCT03090048|Protective Agents|protective agents|mesh-ancestor
43626667|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43626668|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626669|NCT03090035|Interferons|interferons|mesh-list
43626670|NCT03090035|Ribavirin|ribavirin|mesh-list
43626671|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626672|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
43626673|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626674|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
43626675|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626676|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
43651108|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651109|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
43651110|NCT03009500|Hormones|hormones|mesh-ancestor
43651111|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651112|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43651113|NCT03009500|Protective Agents|protective agents|mesh-ancestor
43714949|NCT02664857|Vitamin D|vitamin d|mesh-list
43651114|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651115|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651117|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43651118|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626677|NCT03090009|Analgesics|analgesics|mesh-ancestor
43626678|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
43626679|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626680|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626681|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43626682|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43626683|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43626684|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43626685|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43626686|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626710|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
43626711|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714964|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626723|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
43626724|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43626725|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43626726|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43626727|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626728|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626729|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43626730|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43626731|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43626732|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43626733|NCT03087201|Nabiximols|nabiximols|mesh-list
43626734|NCT03087201|Analgesics|analgesics|mesh-ancestor
43626735|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
43626736|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626737|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651119|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651120|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651121|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
43651122|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
43651123|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43552140|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651124|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43651125|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651126|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
43651127|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651128|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43651129|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43651130|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651131|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43651132|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
43651133|NCT03009526|Piperaquine|piperaquine|mesh-list
43651134|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
43651135|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43651136|NCT03009526|Artenimol|artenimol|mesh-list
43651137|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
43651138|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43651139|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43651140|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651141|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43651142|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651143|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651144|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43651145|NCT03009526|Renal Agents|renal agents|mesh-ancestor
43651146|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
43651147|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43651148|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43651149|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626893|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
43626894|NCT03079219|Ondansetron|ondansetron|mesh-list
43651150|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
43651151|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43651152|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
43651153|NCT03009292|Lenvatinib|lenvatinib|mesh-list
43651154|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651155|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651156|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715004|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651157|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651159|NCT03009578|Hematinics|hematinics|mesh-ancestor
43651160|NCT03009097|Atorvastatin|atorvastatin|mesh-list
43651161|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43651162|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651163|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
43651164|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651165|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43651166|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43651167|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651168|NCT03009045|Tedizolid|tedizolid|mesh-list
43651169|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
43651170|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
43651171|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43651172|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651173|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43651174|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651175|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651176|NCT03009058|Leucovorin|leucovorin|mesh-list
43651177|NCT03009058|Folic Acid|folic acid|mesh-list
43651178|NCT03009058|Gemcitabine|gemcitabine|mesh-list
43651179|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
43651180|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
43651181|NCT03009058|Fluorouracil|fluorouracil|mesh-list
43651182|NCT03009058|Capecitabine|capecitabine|mesh-list
43651183|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
43651184|NCT03009058|Nivolumab|nivolumab|mesh-list
43626965|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
43626966|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626967|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626968|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
43626969|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626971|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43651185|NCT03009058|Irinotecan|irinotecan|mesh-list
43651186|NCT03009058|Cetuximab|cetuximab|mesh-list
43651187|NCT03009058|Ipilimumab|ipilimumab|mesh-list
43651188|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43651189|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
43651190|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651191|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
43651192|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651193|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651194|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43651195|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
43651196|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651197|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651198|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43651199|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43651200|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
43651201|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
43651202|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651203|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552235|NCT03606590|Sorafenib|sorafenib|mesh-list
43552236|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552237|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552238|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552239|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552240|NCT03606577|Dexamethasone|dexamethasone|mesh-list
43552241|NCT03606577|Lenalidomide|lenalidomide|mesh-list
43552242|NCT03606577|Daratumumab|daratumumab|mesh-list
43552244|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
43715039|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715040|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43715043|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43552248|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43552249|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
43552250|NCT03606577|Hormones|hormones|mesh-ancestor
43552251|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43552252|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43552253|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552254|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
43552255|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43651204|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43651205|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43651206|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43651207|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43651208|NCT03009058|Antidotes|antidotes|mesh-ancestor
43651209|NCT03009058|Protective Agents|protective agents|mesh-ancestor
43651210|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
43626973|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651223|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651224|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43651225|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43651226|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651227|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651228|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
43651229|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
43651230|NCT03009006|Calcium|calcium|mesh-list
43627086|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43627087|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43627088|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627089|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552301|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552315|NCT03606018|Insulin|insulin|mesh-list
43627090|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43627153|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627155|NCT03077009|Protective Agents|protective agents|mesh-ancestor
43627156|NCT03076905|Olorofim|olorofim|mesh-list
43627157|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
43627158|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627159|NCT03076710|Bupivacaine|bupivacaine|mesh-list
43627160|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627161|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
43627162|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627163|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627164|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
43627165|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627166|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43627167|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43627276|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627278|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
43651231|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651232|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651233|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43552355|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43552356|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
43552357|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
43552358|NCT03605056|Dexamethasone|dexamethasone|mesh-list
43552359|NCT03605056|Lenalidomide|lenalidomide|mesh-list
43552360|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552361|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
43552362|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
43552363|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552364|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552365|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777100|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43552366|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
43552367|NCT03605056|Hormones|hormones|mesh-ancestor
43651235|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651237|NCT03008876|Acetaminophen|acetaminophen|mesh-list
43651238|NCT03008876|Ibuprofen|ibuprofen|mesh-list
43651239|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43651240|NCT03008876|Analgesics|analgesics|mesh-ancestor
43651241|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
43627279|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627280|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627281|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
43627282|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627283|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43552398|NCT03604575|Insulin|insulin|mesh-list
43627284|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627285|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43627286|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627287|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627288|NCT03075241|Zolpidem|zolpidem|mesh-list
43627289|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43627290|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43627291|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627292|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627293|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43627294|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
43627295|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
43627296|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627297|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627298|NCT03074825|Chiauranib|chiauranib|mesh-list
43627299|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43627300|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43627301|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627302|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627303|NCT03074773|Dexamethasone|dexamethasone|mesh-list
43627304|NCT03074773|Bupivacaine|bupivacaine|mesh-list
43627305|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627306|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
43627307|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
43715103|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
43715105|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
43627308|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627309|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627310|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43627311|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
43627331|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43627333|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43627334|NCT03074591|Hematinics|hematinics|mesh-ancestor
43627335|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43552488|NCT03603756|Apatinib|apatinib|mesh-list
43552489|NCT03603756|Nedaplatin|nedaplatin|mesh-list
43552492|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
43552544|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552545|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552546|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552547|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43552548|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43552549|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43552550|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552551|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43552552|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43552553|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552555|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
43552556|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552557|NCT03603249|Trimetazidine|trimetazidine|mesh-list
43552558|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
43552559|NCT03603119|Dexamethasone|dexamethasone|mesh-list
43552560|NCT03603119|Midazolam|midazolam|mesh-list
43552561|NCT03603119|Ondansetron|ondansetron|mesh-list
43552562|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43552563|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
43552564|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
43552576|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43627346|NCT03074435|Ivermectin|ivermectin|mesh-list
43627347|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43627348|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627349|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
43651242|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651243|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651245|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627359|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627360|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
43552593|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552594|NCT03602898|Cyclosporine|cyclosporine|mesh-list
43552595|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
43552596|NCT03602898|Busulfan|busulfan|mesh-list
43552597|NCT03602898|Methotrexate|methotrexate|mesh-list
43552598|NCT03602898|Fludarabine|fludarabine|mesh-list
43552599|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
43627361|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627362|NCT03074123|Cosyntropin|cosyntropin|mesh-list
43627363|NCT03074123|Hormones|hormones|mesh-ancestor
43627364|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627365|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627366|NCT03073928|Ropivacaine|ropivacaine|mesh-list
43760797|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
43760798|NCT02443012|Nepafenac|nepafenac|mesh-list
43760799|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43760800|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760801|NCT02443012|Analgesics|analgesics|mesh-ancestor
43760802|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
43552627|NCT03602690|Darunavir|darunavir|mesh-list
43552628|NCT03602690|Dolutegravir|dolutegravir|mesh-list
43552629|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43552630|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43552631|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
43552632|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777152|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43552633|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552634|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43552639|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43552640|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43552641|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43552642|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43761194|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
43761195|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43761196|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761197|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43761264|NCT02440256|Analgesics|analgesics|mesh-ancestor
43761265|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
43761266|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837401|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837402|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837406|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837407|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837408|NCT04910503|Dexamethasone|dexamethasone|mesh-list
43837409|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43651246|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651247|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651248|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43651249|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651250|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651251|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
43651259|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715188|NCT02662959|Irinotecan|irinotecan|mesh-list
43651260|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
43651261|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
43651262|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
43651263|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651265|NCT03008551|Empagliflozin|empagliflozin|mesh-list
43651266|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43651267|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651268|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43651269|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824628|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
43824629|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43824630|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43824631|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824632|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651270|NCT03008317|Chromium|chromium|mesh-list
43651271|NCT03008317|Trace Elements|trace elements|mesh-ancestor
43651272|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
43651273|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651274|NCT03008252|Caseins|caseins|mesh-list
43651275|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
43651276|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
43651277|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651278|NCT03008148|Temozolomide|temozolomide|mesh-list
43651279|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43651280|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
43715206|NCT02662855|Favipiravir|favipiravir|mesh-list
43651281|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651282|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651283|NCT03007927|Dexamethasone|dexamethasone|mesh-list
43651284|NCT03007927|Bupivacaine|bupivacaine|mesh-list
43651285|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651286|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
43651287|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
43651288|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651289|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651290|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651291|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
43651292|NCT03007927|Hormones|hormones|mesh-ancestor
43651293|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651294|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651295|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651296|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
43761389|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761391|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43761392|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
43761393|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761394|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761395|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553027|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761396|NCT02439034|Acetaminophen|acetaminophen|mesh-list
43761397|NCT02439034|Ketoprofen|ketoprofen|mesh-list
43761398|NCT02439034|Codeine|codeine|mesh-list
43761399|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761400|NCT02439034|Analgesics|analgesics|mesh-ancestor
43761401|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
43761402|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761434|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761436|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761437|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43761438|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651301|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651302|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43651303|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43651304|NCT03008109|Growth Substances|growth substances|mesh-ancestor
43651305|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651306|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
43651307|NCT03007992|Vinorelbine|vinorelbine|mesh-list
43651308|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43651309|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651310|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
43651311|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
43651312|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
43761475|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43832134|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
43777202|NCT02333188|Irinotecan|irinotecan|mesh-list
43777236|NCT02333123|Aspirin|aspirin|mesh-list
43761476|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
43761477|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
43761478|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
43761479|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43761481|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43837461|NCT04906382|Carboplatin|carboplatin|mesh-list
43837462|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43837463|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43837464|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837465|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
43837466|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
43837467|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
43837468|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837469|NCT04906213|Empagliflozin|empagliflozin|mesh-list
43553053|NCT03600493|Analgesics|analgesics|mesh-ancestor
43837470|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43837471|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837472|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837473|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837474|NCT04905654|Cromakalim|cromakalim|mesh-list
43837475|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43837476|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43837477|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
43761501|NCT02438397|Insulin|insulin|mesh-list
43761502|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43761503|NCT02438397|Metformin|metformin|mesh-list
43761504|NCT02438397|Acarbose|acarbose|mesh-list
43761505|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43761506|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761507|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43761508|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553104|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
43761509|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651313|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651315|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
43651316|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
43651317|NCT03008057|Vitamins|vitamins|mesh-list
43651318|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
43651319|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651320|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43553162|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553163|NCT03595085|Streptokinase|streptokinase|mesh-list
43553164|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43553165|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43651321|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651322|NCT03008083|Clopidogrel|clopidogrel|mesh-list
43651323|NCT03008083|Ticagrelor|ticagrelor|mesh-list
43651324|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651325|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43651326|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43651327|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43651328|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
43651329|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651330|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651331|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651333|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651334|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43651335|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43761510|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
43761511|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43761545|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43761546|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761547|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43761548|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43761549|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43761550|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43777283|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777284|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43777285|NCT02332473|Molgramostim|molgramostim|mesh-list
43777286|NCT02332473|Sargramostim|sargramostim|mesh-list
43777287|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
43777288|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553223|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553224|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553225|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
43761551|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
43761552|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43761553|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
43761554|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43761617|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
43761618|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
43761619|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
43761620|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761621|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761623|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43761624|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761690|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761691|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43761692|NCT02436538|Hormones|hormones|mesh-list
43761693|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761694|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761695|NCT02436798|Ondansetron|ondansetron|mesh-list
43761696|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
43651337|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651338|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
43651339|NCT03007446|Apatinib|apatinib|mesh-list
43651340|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651341|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777289|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
43706571|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
43706572|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
43706573|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706574|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706575|NCT02705872|Sufentanil|sufentanil|mesh-list
43706577|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
43706578|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651342|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651343|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651344|NCT03007381|Ketorolac|ketorolac|mesh-list
43553315|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553316|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651345|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43651346|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651347|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43651348|NCT03007381|Analgesics|analgesics|mesh-ancestor
43651349|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
43651350|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651351|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761697|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
43761698|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761699|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761700|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761701|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
43777290|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761702|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
43761703|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43761704|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
43761726|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43761728|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553360|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43553361|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43761729|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
43761730|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761731|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761732|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761733|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
43761735|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43761736|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761737|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43761738|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43761739|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761740|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761741|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43761742|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
43761743|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43761744|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43761745|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43761746|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43761747|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761748|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
43761764|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43761765|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
43761766|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
43761767|NCT02436512|Protective Agents|protective agents|mesh-ancestor
43837478|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837479|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837480|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43837481|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
43777291|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777292|NCT02332512|Apatinib|apatinib|mesh-list
43777293|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777294|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777295|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777296|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777297|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
43777298|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43837482|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
43651352|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651353|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651354|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43651355|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651356|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651357|NCT03007303|Olanzapine|olanzapine|mesh-list
43651358|NCT03007303|Risperidone|risperidone|mesh-list
43651359|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43651360|NCT03007303|Ziprasidone|ziprasidone|mesh-list
43651361|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
43651362|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43651363|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
43651364|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715452|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
43651365|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651366|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837483|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837484|NCT04905446|Niacinamide|niacinamide|mesh-list
43837486|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
43837487|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
43837488|NCT04905446|Vitamins|vitamins|mesh-ancestor
43837489|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
43837490|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837491|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43837492|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
43553492|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43553493|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553494|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553495|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
43553496|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553497|NCT03579979|Methylene Blue|methylene blue|mesh-list
43553498|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553500|NCT03579927|Cytarabine|cytarabine|mesh-list
43837494|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43837495|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
43837496|NCT04905277|Atenolol|atenolol|mesh-list
43837497|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43777299|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43777300|NCT02332603|Prednisolone|prednisolone|mesh-list
43837498|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43837499|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
43837500|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
43837501|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837502|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837503|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43837504|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43652866|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652867|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
43837505|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43837506|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
43652868|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652869|NCT02987920|Narcotics|narcotics|mesh-ancestor
43837507|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761768|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
43761769|NCT02436395|Povidone|povidone|mesh-list
43761770|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
43761771|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
43761772|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43761773|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652870|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761774|NCT02436226|Citric Acid|citric acid|mesh-list
43761775|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
43761776|NCT02436226|Clomiphene|clomiphene|mesh-list
43761777|NCT02436226|Enclomiphene|enclomiphene|mesh-list
43761778|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
43761811|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
43761812|NCT02436044|Vitamins|vitamins|mesh-ancestor
43715502|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43715503|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715504|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
43715505|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715506|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43715507|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43715508|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
43715509|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715510|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
43715511|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43761813|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
43761814|NCT02435927|Leucovorin|leucovorin|mesh-list
43761815|NCT02435927|Fluorouracil|fluorouracil|mesh-list
43761816|NCT02435927|Capecitabine|capecitabine|mesh-list
43761817|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
43761818|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
43761819|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651368|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651369|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43651370|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43651371|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
43651372|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
43651373|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
43651374|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553538|NCT03579888|Fludarabine|fludarabine|mesh-list
43651375|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651376|NCT03007303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43651377|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43651378|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43651379|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
43651380|NCT03007342|Amoxicillin|amoxicillin|mesh-list
43651381|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
43651382|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
43651383|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43651384|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43651385|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651386|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43651387|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651388|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553575|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
43651389|NCT03007563|Bilirubin|bilirubin|mesh-list
43651390|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
43651391|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651392|NCT03007563|Protective Agents|protective agents|mesh-ancestor
43651393|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651394|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
43651395|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43651396|NCT03007524|Calcium|calcium|mesh-list
43651397|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651398|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761860|NCT02435654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43761922|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761923|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761924|NCT02435303|Urological Agents|urological agents|mesh-ancestor
43761925|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
43761926|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761927|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761928|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761929|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43553630|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553636|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
43553652|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715596|NCT02659917|Methamphetamine|methamphetamine|mesh-list
43715597|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43715598|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715599|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
43715600|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
43715601|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715602|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
43715603|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715604|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715605|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
43715606|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43715607|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43715608|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715609|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43715610|NCT02659657|Interleukin-2|interleukin-2|mesh-list
43715624|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43715625|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43715626|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715627|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
43715680|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715682|NCT02659033|Cefotaxime|cefotaxime|mesh-list
43715683|NCT02659033|Cefoxitin|cefoxitin|mesh-list
43715684|NCT02659033|Cephalosporins|cephalosporins|mesh-list
43715685|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43715686|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715687|NCT02658864|Lafutidine|lafutidine|mesh-list
43715688|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43715689|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715690|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43651399|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43651401|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651402|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
43651403|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651404|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43651405|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43651406|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651407|NCT03007654|Chitosan|chitosan|mesh-list
43651408|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43651409|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651410|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
43651411|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651412|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43651413|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
43761965|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761966|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761967|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761968|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43761969|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761970|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43761988|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
43761989|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762054|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762055|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
43762056|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
43762057|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43762058|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43651416|NCT03007654|Coagulants|coagulants|mesh-ancestor
43651417|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
43651418|NCT03007160|Diuretics|diuretics|mesh-ancestor
43651419|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
43651421|NCT03007160|Expectorants|expectorants|mesh-ancestor
43651422|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
43651423|NCT03006874|Esomeprazole|esomeprazole|mesh-list
43651424|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43651425|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651426|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43651427|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651428|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651429|NCT03006965|Factor VIII|factor viii|mesh-list
43651430|NCT03006965|BAX 855|bax 855|mesh-list
43651431|NCT03006965|Coagulants|coagulants|mesh-ancestor
43651432|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
43651433|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
43651434|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43651435|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43651436|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43651437|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43651438|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651439|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
43651440|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651441|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651442|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43651443|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777385|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
43762180|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762181|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43762182|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
43762183|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43762185|NCT02433730|Androgens|androgens|mesh-ancestor
43762186|NCT02433730|Hormones|hormones|mesh-ancestor
43762187|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762188|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762189|NCT02433912|Acetaminophen|acetaminophen|mesh-list
43762190|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
43762191|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43762192|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43762193|NCT02433912|Analgesics|analgesics|mesh-ancestor
43762194|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
43762195|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762196|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651444|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43651446|NCT03007121|Morphine|morphine|mesh-list
43651453|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
43651454|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651455|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651456|NCT03007121|Narcotics|narcotics|mesh-ancestor
43715951|NCT02657512|Charcoal|charcoal|mesh-list
43651457|NCT03007121|Analgesics|analgesics|mesh-ancestor
43651458|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43651459|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43651460|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
43651461|NCT03006835|Clopidogrel|clopidogrel|mesh-list
43651462|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651463|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43651464|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43651465|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43651466|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
43651467|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651468|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651469|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651470|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43651471|NCT03006809|Metronidazole|metronidazole|mesh-list
43651472|NCT03006809|Vancomycin|vancomycin|mesh-list
43716067|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651473|NCT03006809|Neomycin|neomycin|mesh-list
43651474|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651475|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43651476|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43777417|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651477|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43651478|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651479|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651480|NCT03006952|Losartan|losartan|mesh-list
43651481|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
43762198|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43762199|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762200|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
43651483|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43651484|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43651485|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43651486|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651487|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43651488|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651489|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651490|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43651491|NCT03006952|Protective Agents|protective agents|mesh-ancestor
43651492|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651493|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
43651494|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43651495|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
43762201|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
43762202|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
43762203|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
43762204|NCT02433184|Etanercept|etanercept|mesh-list
43762205|NCT02433184|Methotrexate|methotrexate|mesh-list
43762206|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43762207|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
43762208|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43762209|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762210|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43762211|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
43762212|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762213|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716165|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43762216|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43762217|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762218|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
43762219|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762275|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43762276|NCT02432807|Vancomycin|vancomycin|mesh-list
43762277|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43762278|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837525|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
43837526|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762279|NCT02432976|Insulin|insulin|mesh-list
43762280|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43762281|NCT02432976|Exenatide|exenatide|mesh-list
43762282|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
43762283|NCT02432976|Incretins|incretins|mesh-list
43762284|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43553754|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762299|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
43762300|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762301|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762302|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
43762421|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762422|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762534|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762570|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
43762571|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762572|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762573|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43762609|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43762610|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
43762611|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762612|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43847923|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43847924|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43847925|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
43847926|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716385|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
43651499|NCT03006757|Protective Agents|protective agents|mesh-ancestor
43716387|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716490|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
43716566|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716567|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716568|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
43716569|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43716570|NCT02653014|Diuretics|diuretics|mesh-ancestor
43716571|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
43716573|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43716574|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43716576|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651500|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651501|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651502|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43651503|NCT03006679|Meropenem|meropenem|mesh-list
43651504|NCT03006679|Tazobactam|tazobactam|mesh-list
43651505|NCT03006679|Piperacillin|piperacillin|mesh-list
43651506|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43651507|NCT03006679|Vaborbactam|vaborbactam|mesh-list
43651508|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43651509|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651510|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43651511|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651512|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824633|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43824634|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43716755|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716756|NCT02652065|Acetylcholine|acetylcholine|mesh-list
43716757|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
43716758|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43716759|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
43716760|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43716761|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716766|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716767|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
43716768|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652871|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43652872|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652873|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652874|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43716773|NCT02651870|Candesartan|candesartan|mesh-list
43824636|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43762884|NCT02429505|Miltefosine|miltefosine|mesh-list
43762885|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
43762886|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762887|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762888|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43762889|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43762890|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
43762891|NCT02429388|Spironolactone|spironolactone|mesh-list
43762892|NCT02429388|Diuretics|diuretics|mesh-list
43824637|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824638|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824639|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824640|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824641|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43824642|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824643|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846458|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
43846459|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846460|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43846461|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43846462|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43846463|NCT04199468|Hormones|hormones|mesh-ancestor
43846464|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846465|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
43846466|NCT04199104|Lenvatinib|lenvatinib|mesh-list
43846467|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846468|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846469|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846470|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846471|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846472|NCT04198649|Azithromycin|azithromycin|mesh-list
43846473|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43846474|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846475|NCT04197089|Vitamin D|vitamin d|mesh-list
43716843|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846476|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
43762893|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
43567534|NCT00743795|Ribavirin|ribavirin|mesh-list
43762918|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762919|NCT02429440|Molgramostim|molgramostim|mesh-list
43762920|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43762921|NCT02429440|Sargramostim|sargramostim|mesh-list
43762922|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43762923|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
43762924|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762925|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762926|NCT02429453|Thrombin|thrombin|mesh-list
43762927|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
43762928|NCT02429453|Coagulants|coagulants|mesh-ancestor
43762929|NCT02429518|Miltefosine|miltefosine|mesh-list
43762930|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
43762931|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43762932|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762933|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43762934|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43837539|NCT04903509|Liraglutide|liraglutide|mesh-list
43837540|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43837541|NCT04903509|Analgesics|analgesics|mesh-ancestor
43837542|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
43716888|NCT02651441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837543|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837544|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846478|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
43846479|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846480|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43846481|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43846482|NCT04195945|Cytarabine|cytarabine|mesh-list
43846483|NCT04195945|Daunorubicin|daunorubicin|mesh-list
43846484|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
43846485|NCT04195945|Cladribine|cladribine|mesh-list
43846486|NCT04195945|Lenograstim|lenograstim|mesh-list
43846487|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43846488|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
43846489|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837545|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
43837568|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837570|NCT04902625|Bupropion|bupropion|mesh-list
43837571|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43837572|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43837573|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837574|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
43837575|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762936|NCT02428751|Rituximab|rituximab|mesh-list
43762937|NCT02428751|Doxorubicin|doxorubicin|mesh-list
43762938|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43762940|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43762941|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762942|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
43762943|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762944|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762945|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43762946|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43762947|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43762948|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762949|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762950|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762951|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
43762952|NCT02428751|Hormones|hormones|mesh-ancestor
43762953|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43762954|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762955|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43762956|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43554314|NCT03572829|Hormones|hormones|mesh-ancestor
43554315|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43554316|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43762957|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43762958|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43762959|NCT02428764|Gemcitabine|gemcitabine|mesh-list
43762960|NCT02428764|Carboplatin|carboplatin|mesh-list
43762961|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
43762989|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762990|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762991|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762992|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43762993|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43762994|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43762995|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762996|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43762998|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762999|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
43763000|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
43763001|NCT02429037|Cisplatin|cisplatin|mesh-list
43763002|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777458|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717057|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43554340|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
43763003|NCT02429076|Propofol|propofol|mesh-list
43763004|NCT02429076|Sevoflurane|sevoflurane|mesh-list
43763005|NCT02429076|Methylphenidate|methylphenidate|mesh-list
43846490|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846491|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
43846492|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846493|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846494|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
43846495|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846496|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43846497|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43846498|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43846499|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846501|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
43846502|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846503|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43763006|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43763007|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763022|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763023|NCT02429050|Narcotics|narcotics|mesh-ancestor
43763024|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763025|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763026|NCT02429050|Analgesics|analgesics|mesh-ancestor
43763027|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
43554428|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554429|NCT03571815|Listerine|listerine|mesh-list
43554430|NCT03571815|Fluorides|fluorides|mesh-list
43554431|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
43554432|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
43554433|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
43554434|NCT03571815|Protective Agents|protective agents|mesh-ancestor
43717253|NCT02648958|Analgesics|analgesics|mesh-ancestor
43717254|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
43717255|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717256|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43763028|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763030|NCT02428972|Sevoflurane|sevoflurane|mesh-list
43763031|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43763032|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763033|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763034|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43554510|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
43717325|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
43717326|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43717327|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43763035|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
43763036|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
43763037|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43763038|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43763039|NCT02428946|Bromocriptine|bromocriptine|mesh-list
43763040|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43763041|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43763042|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
43763043|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763044|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763045|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
43763046|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
43763047|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763048|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763049|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43763050|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43763051|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43763052|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554724|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
43717390|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43717445|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717446|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777506|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763053|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763054|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43763055|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43717520|NCT02647255|Hormones|hormones|mesh-ancestor
43763056|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763057|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
43763062|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763063|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
43763064|NCT02428868|Coagulants|coagulants|mesh-ancestor
43763065|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
43717616|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717617|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
43717618|NCT02646904|Hormones|hormones|mesh-ancestor
43717619|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717620|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717621|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43554934|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43554936|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846506|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43846507|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
43846508|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846509|NCT04195698|Upadacitinib|upadacitinib|mesh-list
43846510|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43846511|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846512|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651513|NCT03006614|Gemcitabine|gemcitabine|mesh-list
43651514|NCT03006614|Cisplatin|cisplatin|mesh-list
43651515|NCT03006614|Docetaxel|docetaxel|mesh-list
43651516|NCT03006614|Capecitabine|capecitabine|mesh-list
43651517|NCT03006614|Trastuzumab|trastuzumab|mesh-list
43651518|NCT03006614|Vinorelbine|vinorelbine|mesh-list
43651519|NCT03006614|Epirubicin|epirubicin|mesh-list
43651520|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651521|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43651522|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
43554982|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43554983|NCT03566316|Amlodipine|amlodipine|mesh-list
43651523|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651524|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
43651525|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651526|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763066|NCT02428686|Hematinics|hematinics|mesh-ancestor
43763101|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43763102|NCT02428374|Clopidogrel|clopidogrel|mesh-list
43763103|NCT02428374|Ticagrelor|ticagrelor|mesh-list
43717676|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717677|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717678|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
43717697|NCT02646540|Metolazone|metolazone|mesh-list
43717718|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43717719|NCT02646137|Estrogens|estrogens|mesh-ancestor
43717720|NCT02646137|Hormones|hormones|mesh-ancestor
43717721|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717725|NCT02646319|Sirolimus|sirolimus|mesh-list
43763244|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
43763245|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763246|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763247|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763249|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
43763250|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763251|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837584|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555087|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43555131|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
43555132|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43555133|NCT03564704|Cytarabine|cytarabine|mesh-list
43555134|NCT03564704|Dexamethasone|dexamethasone|mesh-list
43555135|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
43555136|NCT03564704|Methotrexate|methotrexate|mesh-list
43555137|NCT03564704|Etoposide|etoposide|mesh-list
43555138|NCT03564704|Vincristine|vincristine|mesh-list
43555139|NCT03564704|Doxorubicin|doxorubicin|mesh-list
43555140|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
43555141|NCT03564704|Idarubicin|idarubicin|mesh-list
43555142|NCT03564704|Pegaspargase|pegaspargase|mesh-list
43837585|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43837586|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43837587|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837588|NCT04902378|Insulin|insulin|mesh-list
43837589|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837590|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837591|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43837592|NCT04902131|Menotropins|menotropins|mesh-list
43651527|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651529|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651530|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
43651531|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
43651532|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
43651533|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43651534|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43651536|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43651537|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43651538|NCT03006380|Oxytocin|oxytocin|mesh-list
43651539|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
43651540|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43651541|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651542|NCT03006445|Dotinurad|dotinurad|mesh-list
43651543|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
43651544|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
43651545|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651546|NCT03006445|Renal Agents|renal agents|mesh-ancestor
43777556|NCT02330952|Hormones|hormones|mesh-ancestor
43651547|NCT03006627|Morphine|morphine|mesh-list
43651548|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651549|NCT03006627|Narcotics|narcotics|mesh-ancestor
43651550|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651551|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651552|NCT03006627|Analgesics|analgesics|mesh-ancestor
43651553|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
43832366|NCT05268497|Esketamine|esketamine|mesh-list
43651554|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651555|NCT03006250|Sevoflurane|sevoflurane|mesh-list
43651556|NCT03006250|Desflurane|desflurane|mesh-list
43651557|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43651558|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43651559|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
43651560|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
43651561|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718058|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718059|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43718060|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
43718061|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718062|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43718063|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
43718064|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718065|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43718066|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43718067|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
43651562|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837593|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43837594|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
43837595|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43763266|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43651563|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
43651564|NCT03006419|Basiliximab|basiliximab|mesh-list
43651565|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
43555481|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651566|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651567|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651569|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
43651570|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43651571|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
43651572|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
43651573|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718125|NCT02644408|Megestrol|megestrol|mesh-list
43651574|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651575|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43651576|NCT03006211|Analgesics|analgesics|mesh-ancestor
43651577|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
43651578|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651579|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43651580|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
43651581|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651582|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
43651583|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43651584|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
43651585|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651586|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651587|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43651588|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
43651589|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
43651590|NCT03006211|Protective Agents|protective agents|mesh-ancestor
43651591|NCT03006146|Molgramostim|molgramostim|mesh-list
43777582|NCT02331251|Docetaxel|docetaxel|mesh-list
43651592|NCT03006146|Sargramostim|sargramostim|mesh-list
43651593|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
43651594|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555600|NCT03561402|Teriflunomide|teriflunomide|mesh-list
43651595|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651596|NCT03006003|Alendronate|alendronate|mesh-list
43651597|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43555643|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555674|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43555675|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43555676|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
43777587|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43777588|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777589|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
43555677|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555678|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555680|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555681|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555729|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43651598|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43651599|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718418|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43718419|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
43763267|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
43718943|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824112|NCT05515315|Nedaplatin|nedaplatin|mesh-list
43824113|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43824114|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824115|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
43824116|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
43824117|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
43824118|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824119|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
43824120|NCT05515185|Fludarabine|fludarabine|mesh-list
43647259|NCT02126917|Hydrocodone|hydrocodone|mesh-list
43647260|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43647261|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647262|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647263|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647418|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43647419|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43647420|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
43647421|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556188|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
43719688|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43719689|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43647442|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647444|NCT01407263|Hemostatics|hemostatics|mesh-list
43647445|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43647446|NCT01407263|Coagulants|coagulants|mesh-ancestor
43647447|NCT01386710|Bevacizumab|bevacizumab|mesh-list
43647448|NCT01386710|Carboplatin|carboplatin|mesh-list
43647449|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43647450|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43647451|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43647452|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43647453|NCT01386710|Growth Substances|growth substances|mesh-ancestor
43647454|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647455|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647456|NCT01362998|Fentanyl|fentanyl|mesh-list
43647457|NCT01362998|Morphine|morphine|mesh-list
43647458|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43647474|NCT01269853|Growth Substances|growth substances|mesh-ancestor
43647475|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647476|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
43647477|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
43647478|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43647479|NCT01219075|Estrogens|estrogens|mesh-ancestor
43647480|NCT01219075|Hormones|hormones|mesh-ancestor
43556244|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43556245|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
43556246|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556247|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
43556248|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43556249|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43556250|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556251|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556252|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43647669|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
43647670|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
43647671|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
43647673|NCT05620641|Gabapentin|gabapentin|mesh-list
43647688|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
43647689|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
43647690|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
43647691|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43647692|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
43647731|NCT05619848|Etomidate|etomidate|mesh-list
43647732|NCT05619848|Rocuronium|rocuronium|mesh-list
43777608|NCT02330757|Clomiphene|clomiphene|mesh-list
43647733|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43647758|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
43647759|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43647760|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43647761|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647762|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43647763|NCT05619627|Analgesics|analgesics|mesh-ancestor
43647764|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
43647765|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647766|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43647767|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43647768|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43647769|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
43647770|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647772|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
43647773|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43647774|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43647775|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43647776|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43647777|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647778|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
43556862|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
43647893|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43647894|NCT05136690|Nicotine|nicotine|mesh-list
43647895|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43647896|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
43647897|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43647898|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647899|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43647900|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43647901|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
43647902|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43647903|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647954|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43647955|NCT05097976|Protective Agents|protective agents|mesh-ancestor
43647956|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43647957|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824196|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824197|NCT05514899|Hormones|hormones|mesh-ancestor
43824198|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824199|NCT05514847|Aspirin|aspirin|mesh-list
43824200|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824201|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824202|NCT05514847|Analgesics|analgesics|mesh-ancestor
43824203|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
43824204|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824205|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824206|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824207|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824208|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43824209|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824210|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824211|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43824212|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824213|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824214|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
43720006|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43720007|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557746|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557747|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43824235|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824237|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824238|NCT05514275|Growth Substances|growth substances|mesh-ancestor
43824239|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824240|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
43824241|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
43824242|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
43846393|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
43647958|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
43647959|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43647960|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43647961|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43647962|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43647963|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43557893|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
43720065|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
43648012|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
43648013|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648014|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648016|NCT04831320|Nivolumab|nivolumab|mesh-list
43648017|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43648018|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648019|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
43648020|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
43648021|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720163|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720164|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720165|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43720166|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720167|NCT02631499|Epirubicin|epirubicin|mesh-list
43720168|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
43720169|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720170|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720171|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720172|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720173|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720321|NCT02631109|Doxorubicin|doxorubicin|mesh-list
43720323|NCT02631109|Pegaspargase|pegaspargase|mesh-list
43720324|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720325|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720326|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43720327|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43720328|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720329|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720330|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43720331|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43720332|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
43720333|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
43720334|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720335|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720336|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43720337|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
43720338|NCT02631109|Hormones|hormones|mesh-ancestor
43720339|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43720340|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43720341|NCT02631109|Protective Agents|protective agents|mesh-ancestor
43720342|NCT02630823|Paclitaxel|paclitaxel|mesh-list
43720343|NCT02630823|Carboplatin|carboplatin|mesh-list
43720344|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
43648068|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648070|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
43648071|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43648072|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
43648073|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558562|NCT03532711|Leucovorin|leucovorin|mesh-list
43558563|NCT03532711|Fluorouracil|fluorouracil|mesh-list
43558564|NCT03532711|Capecitabine|capecitabine|mesh-list
43558565|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
43558566|NCT03532711|Irinotecan|irinotecan|mesh-list
43558567|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
43720398|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720399|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
43720400|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720401|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43720402|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43720403|NCT02630264|Growth Substances|growth substances|mesh-ancestor
43720404|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720405|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648077|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648078|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648079|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43648080|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
43648081|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648082|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720416|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43720417|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720418|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
43720419|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720420|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720421|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43720422|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
43720423|NCT02630160|Epinephrine|epinephrine|mesh-list
43720424|NCT02630160|Bupivacaine|bupivacaine|mesh-list
43720425|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
43720426|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
43720427|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720428|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558583|NCT03532698|Aspirin|aspirin|mesh-list
43720459|NCT02630095|Nadroparin|nadroparin|mesh-list
43720460|NCT02630095|Warfarin|warfarin|mesh-list
43720461|NCT02630095|Calcium|calcium|mesh-list
43720462|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43720463|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720464|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
43720465|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43720466|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43720467|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720468|NCT02630004|Melatonin|melatonin|mesh-list
43720469|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
43720470|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720471|NCT02630004|Protective Agents|protective agents|mesh-ancestor
43720472|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832764|NCT05251636|Aflibercept|aflibercept|mesh-list
43832765|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832766|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832767|NCT05251636|Growth Substances|growth substances|mesh-ancestor
43832768|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832769|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
43558604|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43558605|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
43558606|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43558607|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558608|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832771|NCT05251038|Leucovorin|leucovorin|mesh-list
43832772|NCT05251038|Gemcitabine|gemcitabine|mesh-list
43832773|NCT05251038|Paclitaxel|paclitaxel|mesh-list
43832774|NCT05251038|Fluorouracil|fluorouracil|mesh-list
43832775|NCT05251038|Irinotecan|irinotecan|mesh-list
43832776|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43832777|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832778|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
43832779|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
43832780|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832781|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832782|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558635|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43558685|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43558686|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43558687|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558688|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558702|NCT05195775|Tadalafil|tadalafil|mesh-list
43720530|NCT02629523|Afatinib|afatinib|mesh-list
43558744|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777671|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
43558745|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558747|NCT05175001|Hormones|hormones|mesh-ancestor
43558748|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558749|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43720647|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720648|NCT02628574|Gemcitabine|gemcitabine|mesh-list
43720649|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
43720650|NCT02628574|Nivolumab|nivolumab|mesh-list
43720651|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558788|NCT05079217|Vaccines|vaccines|mesh-list
43720690|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558818|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558819|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558821|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558822|NCT05042791|Capecitabine|capecitabine|mesh-list
43558823|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43558824|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
43558825|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558826|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832785|NCT05251038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43832786|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832787|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832788|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
43832789|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832790|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43832791|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43832792|NCT05251038|Antidotes|antidotes|mesh-ancestor
43832793|NCT05251038|Protective Agents|protective agents|mesh-ancestor
43832794|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
43832795|NCT05251038|Vitamins|vitamins|mesh-ancestor
43832796|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
43832797|NCT05250791|Lidocaine|lidocaine|mesh-list
43832798|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
43832799|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
43558896|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
43558897|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43558898|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43558899|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43558900|NCT04772248|Analgesics|analgesics|mesh-ancestor
43558901|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
43558902|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558903|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720791|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720792|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720916|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
43720917|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720918|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43720919|NCT02626364|Crenolanib|crenolanib|mesh-list
43720920|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777678|NCT02330783|Sorafenib|sorafenib|mesh-list
43720922|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
43720923|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
43720924|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43720925|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720926|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
43720927|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832828|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43832830|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
43832831|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43832832|NCT05249959|Rituximab|rituximab|mesh-list
43832833|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43832834|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43832835|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832836|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832837|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
43721080|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
43721081|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43721082|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721083|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721084|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43721085|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43721086|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43721087|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43721088|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
43721089|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
43721090|NCT02625376|Resveratrol|resveratrol|mesh-list
43721091|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
43721212|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721213|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43721214|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
43559134|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43559135|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43559136|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721453|NCT02623036|Lisinopril|lisinopril|mesh-list
43559198|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648177|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648178|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824243|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824244|NCT05514197|Protective Agents|protective agents|mesh-ancestor
43824245|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824247|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
43824248|NCT05514119|Fenofibrate|fenofibrate|mesh-list
43648179|NCT04345913|Halichondrin B|halichondrin b|mesh-list
43648180|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
43721518|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721519|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43721520|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43721521|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43721522|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
43721523|NCT02622555|Mirabegron|mirabegron|mesh-list
43721524|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43777795|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721525|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43721526|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43721527|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721535|NCT02622672|Vitamins|vitamins|mesh-ancestor
43721725|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43734439|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43721878|NCT02620215|Dinoprostone|dinoprostone|mesh-list
43721879|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
43721880|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43721881|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721882|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
43721883|NCT02620345|Progestins|progestins|mesh-ancestor
43832943|NCT05245968|Sunitinib|sunitinib|mesh-list
43832944|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
43559304|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777799|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
43559312|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43559313|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559314|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559315|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43559316|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
43559317|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559318|NCT03888378|Minocycline|minocycline|mesh-list
43721964|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721965|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43721966|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43721967|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43721968|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
43721969|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722020|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43722021|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
43722022|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43722023|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43722024|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43722025|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43722026|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43832945|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832946|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832947|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832948|NCT05245968|Growth Substances|growth substances|mesh-ancestor
43832949|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559334|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43559335|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43559336|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559338|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43832977|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832978|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
43832979|NCT05243563|Hormones|hormones|mesh-ancestor
43832980|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832981|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559346|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559347|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43559348|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43559368|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43559369|NCT03832179|Growth Substances|growth substances|mesh-ancestor
43559370|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559371|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
43559372|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559373|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
43559374|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
43559375|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559376|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559377|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
43559378|NCT03832179|Hormones|hormones|mesh-ancestor
43722056|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
43722057|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722058|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722059|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43722060|NCT02619266|Megestrol|megestrol|mesh-list
43722061|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
43722062|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43722063|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43722064|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43722065|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
43722066|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43722100|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43722101|NCT02619032|Fentanyl|fentanyl|mesh-list
43722104|NCT02619032|Narcotics|narcotics|mesh-ancestor
43722105|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722106|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722107|NCT02619032|Analgesics|analgesics|mesh-ancestor
43722108|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
43722109|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833002|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43833003|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43833004|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
43833005|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833006|NCT05240755|Cannabidiol|cannabidiol|mesh-list
43833016|NCT05239091|Lidocaine|lidocaine|mesh-list
43722301|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43559399|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43559400|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43559401|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559403|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559404|NCT03775421|Macitentan|macitentan|mesh-list
43559405|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43559406|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43648214|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648215|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648216|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
43648217|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
43648218|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43648219|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43648220|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43648221|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43648222|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43648223|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648224|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43559411|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
43559412|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559413|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559414|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
43559415|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559416|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722419|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722420|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722421|NCT02616770|Perflubron|perflubron|mesh-list
43722422|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43722423|NCT02616692|Sorafenib|sorafenib|mesh-list
43722424|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722425|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43722426|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722427|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722428|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
43722429|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43722430|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722431|NCT02616822|Resveratrol|resveratrol|mesh-list
43722432|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
43722454|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43559430|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43559431|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559432|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43559433|NCT03747575|Astegolimab|astegolimab|mesh-list
43559434|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43559435|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559436|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
43559440|NCT03740737|Hormones|hormones|mesh-ancestor
43559490|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
43559491|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
43559492|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559493|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43559494|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43559495|NCT03721965|Protective Agents|protective agents|mesh-ancestor
43722569|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43722570|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43722571|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
43722740|NCT02614937|Protective Agents|protective agents|mesh-ancestor
43722741|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43722742|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43722743|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43722744|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
43722745|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722746|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722747|NCT02614612|Prednisone|prednisone|mesh-list
43722748|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
43722751|NCT02614612|Prednisolone|prednisolone|mesh-list
43559506|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43559507|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43559508|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
43722825|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722826|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
43722827|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43722828|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722829|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722830|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43722831|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722859|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43722860|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
43722861|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43722862|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43722863|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43722864|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722865|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722866|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722868|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
43722869|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
43722870|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777847|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777848|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777849|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
43722915|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
43722983|NCT02612545|Artenimol|artenimol|mesh-list
43722984|NCT02612545|Mefloquine|mefloquine|mesh-list
43722985|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
43722986|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43722987|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43722988|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722989|NCT02612480|Aspirin|aspirin|mesh-list
43722990|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
43722991|NCT02612480|Clopidogrel|clopidogrel|mesh-list
43722992|NCT02612480|Ticagrelor|ticagrelor|mesh-list
43722993|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43722994|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723142|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43723144|NCT02611973|Analgesics|analgesics|mesh-ancestor
43723145|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
43723194|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723195|NCT02611635|Warfarin|warfarin|mesh-list
43723196|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
43723197|NCT02611635|Dabigatran|dabigatran|mesh-list
43723198|NCT02611635|Apixaban|apixaban|mesh-list
43723199|NCT02611635|Edoxaban|edoxaban|mesh-list
43723260|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723261|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43723262|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43723263|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
43723264|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723265|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43723266|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43723267|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43723268|NCT02611505|Esketamine|esketamine|mesh-list
43723269|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
43723270|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723271|NCT02611336|Tadalafil|tadalafil|mesh-list
43723272|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
43723322|NCT02610881|Trace Elements|trace elements|mesh-list
43723323|NCT02610881|Folic Acid|folic acid|mesh-list
43723324|NCT02610881|Micronutrients|micronutrients|mesh-list
43723325|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723326|NCT02610881|Hematinics|hematinics|mesh-ancestor
43723327|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
43723328|NCT02610881|Vitamins|vitamins|mesh-ancestor
43723329|NCT02610712|Ketamine|ketamine|mesh-list
43723362|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43723364|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43723365|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723366|NCT02610556|Cisplatin|cisplatin|mesh-list
43723367|NCT02610556|Docetaxel|docetaxel|mesh-list
43723368|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723369|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723370|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723371|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
43723372|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723373|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
43833099|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
43723469|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43723470|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723549|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43723550|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43723551|NCT02609230|TIC10 compound|tic10 compound|mesh-list
43723553|NCT02609087|Propofol|propofol|mesh-list
43723978|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724067|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43724173|NCT02605772|Saxagliptin|saxagliptin|mesh-list
43724174|NCT02605772|Acarbose|acarbose|mesh-list
43724283|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43724594|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43724595|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724596|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43559551|NCT03659929|Amphetamine|amphetamine|mesh-list
43559552|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43559553|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559554|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
43724597|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43724598|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43724601|NCT02603497|Peficitinib|peficitinib|mesh-list
43724646|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43724647|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43724648|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
43724649|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724650|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43724651|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43724652|NCT02602938|Aspirin|aspirin|mesh-list
43724653|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724655|NCT02602938|Analgesics|analgesics|mesh-ancestor
43724656|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
43724657|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724658|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724746|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43724747|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559585|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559586|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43839009|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43839010|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839011|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839012|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
43839013|NCT04802382|Coagulants|coagulants|mesh-ancestor
43839014|NCT04801953|Nimodipine|nimodipine|mesh-list
43839015|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839016|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43584203|NCT03431649|Beraprost|beraprost|mesh-list
43559587|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725119|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
43725749|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725815|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
43725816|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725817|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725818|NCT02595242|Prednisone|prednisone|mesh-list
43725988|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43726140|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43726628|NCT02589444|Vitamins|vitamins|mesh-ancestor
43726629|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
43726630|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726631|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43833499|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726941|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726942|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726943|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726944|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726945|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43726946|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43726947|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833537|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
43833538|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833539|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833540|NCT05204862|Antibodies|antibodies|mesh-list
43833541|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
43833542|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833543|NCT05204667|Acetaminophen|acetaminophen|mesh-list
43833544|NCT05204667|Aspirin|aspirin|mesh-list
43833545|NCT05204667|Methocarbamol|methocarbamol|mesh-list
43726993|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43726994|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726996|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
43726997|NCT02586402|Hematinics|hematinics|mesh-ancestor
43726998|NCT02586259|Budesonide|budesonide|mesh-list
43726999|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727000|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43727001|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
43727002|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559667|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43559682|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559684|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559685|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43559686|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43559687|NCT03541655|Analgesics|analgesics|mesh-ancestor
43559688|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43559689|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43727053|NCT02586181|Folic Acid|folic acid|mesh-list
43727054|NCT02586181|Calcium|calcium|mesh-list
43727055|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
43727056|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727057|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43727188|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43727189|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43727190|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43777926|NCT02328716|Cisplatin|cisplatin|mesh-list
43777927|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777928|NCT02328651|Ribavirin|ribavirin|mesh-list
43777966|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
43777967|NCT02328053|Clotrimazole|clotrimazole|mesh-list
43777968|NCT02328053|Miconazole|miconazole|mesh-list
43777969|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777970|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43777971|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43727191|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43727192|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727193|NCT02585258|Prednisolone|prednisolone|mesh-list
43727194|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727195|NCT02585258|Glucocorticoids|glucocorticoids|mesh-ancestor
43727196|NCT02585258|Hormones|hormones|mesh-ancestor
43727197|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727198|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727199|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727200|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727201|NCT02585401|Aflibercept|aflibercept|mesh-list
43727202|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43727203|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43727204|NCT02585401|Growth Substances|growth substances|mesh-ancestor
43727250|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
43727251|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
43727252|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
43727253|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43833604|NCT05201612|Olaparib|olaparib|mesh-list
43833605|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833606|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833607|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43833608|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833609|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833610|NCT05201547|Paclitaxel|paclitaxel|mesh-list
43727306|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
43727307|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727308|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43727309|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43727310|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43727311|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727312|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43559759|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
43727335|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727336|NCT02584465|Tamoxifen|tamoxifen|mesh-list
43727337|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43727338|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
43727339|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727340|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727341|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43727342|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727343|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43727344|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43727345|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43727346|NCT02584400|Imidazole|imidazole|mesh-list
43727347|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727349|NCT02584335|Lidocaine|lidocaine|mesh-list
43727379|NCT02584010|Silicon|silicon|mesh-list
43727380|NCT02584010|Trace Elements|trace elements|mesh-ancestor
43727381|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
43727382|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727383|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43727384|NCT02583958|Laxatives|laxatives|mesh-ancestor
43727385|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727386|NCT02583854|Hemostatics|hemostatics|mesh-list
43727387|NCT02583854|Coagulants|coagulants|mesh-ancestor
43727388|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
43727389|NCT02583828|Letrozole|letrozole|mesh-list
43727390|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43727432|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
43727433|NCT02583594|Hormones|hormones|mesh-ancestor
43727434|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43727436|NCT02583594|Protective Agents|protective agents|mesh-ancestor
43727437|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707976|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
43727438|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727439|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
43727440|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727441|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
43727460|NCT02583568|Bevacizumab|bevacizumab|mesh-list
43727461|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43727462|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727463|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43727464|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43727465|NCT02583568|Growth Substances|growth substances|mesh-ancestor
43727466|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727467|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
43727468|NCT02583451|Lemborexant|lemborexant|mesh-list
43727470|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43727471|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727472|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727473|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43727474|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43727683|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43727684|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
43727686|NCT02582437|Narcotics|narcotics|mesh-ancestor
43727687|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727688|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727689|NCT02582437|Analgesics|analgesics|mesh-ancestor
43727690|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
43727691|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727692|NCT02582307|Acetaminophen|acetaminophen|mesh-list
43727693|NCT02582307|Scopolamine|scopolamine|mesh-list
43559858|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43559859|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559860|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43559861|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
43559862|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559863|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43559864|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
43559865|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727694|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43727696|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43727697|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
43727698|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727699|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727700|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
43727701|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43727737|NCT02582177|BB 1101|bb 1101|mesh-list
43727738|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727739|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
43727740|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
43727741|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727742|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727743|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727745|NCT02582177|Hormones|hormones|mesh-ancestor
43652903|NCT02987751|Insulin|insulin|mesh-list
43727797|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43727798|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
43727799|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
43727800|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727801|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727802|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43727803|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43727804|NCT02581696|Protective Agents|protective agents|mesh-ancestor
43727805|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43727806|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
43727807|NCT02581683|Ropivacaine|ropivacaine|mesh-list
43559961|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43559962|NCT05472766|Anticoagulants|anticoagulants|mesh-list
43559963|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
43727814|NCT02581683|Analgesics|analgesics|mesh-ancestor
43727837|NCT02581566|Bupivacaine|bupivacaine|mesh-list
43727838|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
43727839|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
43559968|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559969|NCT05436535|Triamcinolone|triamcinolone|mesh-list
43559970|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43559971|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43727852|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727854|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43727855|NCT02581371|Protective Agents|protective agents|mesh-ancestor
43559999|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560000|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560001|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560003|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560004|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43727856|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727858|NCT02581501|Gemcitabine|gemcitabine|mesh-list
43833641|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833642|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833643|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43833644|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43833646|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833647|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
43833648|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43560005|NCT05358639|Olaparib|olaparib|mesh-list
43727977|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43727978|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43727979|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43727980|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
43727981|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727982|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727983|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727984|NCT02579642|Ketamine|ketamine|mesh-list
43727985|NCT02579642|Analgesics|analgesics|mesh-ancestor
43727986|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
43727987|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727988|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727989|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43727990|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43727991|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
43728029|NCT02579564|Endostatins|endostatins|mesh-list
43728030|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560023|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560024|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43560025|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43560027|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
43560028|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560029|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
43560030|NCT05327023|Sirolimus|sirolimus|mesh-list
43560031|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
43560032|NCT05327023|Busulfan|busulfan|mesh-list
43560033|NCT05327023|Fludarabine|fludarabine|mesh-list
43560034|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560035|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
43560036|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560037|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560038|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43560060|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43560068|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560069|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43560071|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560087|NCT05259527|Vitamin D|vitamin d|mesh-list
43728068|NCT02579434|Midazolam|midazolam|mesh-list
43728069|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43728070|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43728071|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728073|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43833664|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43833665|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43833666|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
43833667|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43833668|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
43833669|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560092|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560093|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43560094|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43560095|NCT05252988|Loperamide|loperamide|mesh-list
43560096|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
43560097|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
43560098|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43728114|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43728115|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43728116|NCT02578953|Dutasteride|dutasteride|mesh-list
43728117|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43728118|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43728119|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728120|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728121|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
43728153|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43728154|NCT02578550|Tenofovir|tenofovir|mesh-list
43728155|NCT02578550|Emtricitabine|emtricitabine|mesh-list
43560101|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
43560102|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560103|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43560104|NCT05215951|Osimertinib|osimertinib|mesh-list
43560105|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560106|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43728156|NCT02578550|Darunavir|darunavir|mesh-list
43728157|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43728158|NCT02578550|Cobicistat|cobicistat|mesh-list
43728159|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43728160|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43728161|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
43728162|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728163|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43728164|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43728165|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728166|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728167|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43728168|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43560107|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652918|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
43652920|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560108|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560109|NCT05209984|Topiramate|topiramate|mesh-list
43560110|NCT05209984|Sibutramine|sibutramine|mesh-list
43560111|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
43560112|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43728206|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43728208|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
43728209|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728210|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728211|NCT02578511|Ixazomib|ixazomib|mesh-list
43728212|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728213|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728214|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728215|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560150|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560151|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560152|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560153|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
43560155|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560156|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43560157|NCT05177939|Protective Agents|protective agents|mesh-ancestor
43560158|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43560174|NCT05139017|Rituximab|rituximab|mesh-list
43560193|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560194|NCT05127044|Protective Agents|protective agents|mesh-ancestor
43560195|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728309|NCT02577783|Hormones|hormones|mesh-ancestor
43728310|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728311|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728312|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728313|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728314|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728315|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728316|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43728317|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43728318|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43833715|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560230|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
43560231|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
43560232|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
43560234|NCT05081102|Oxycodone|oxycodone|mesh-list
43560235|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43560236|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43560237|NCT05081102|Analgesics|analgesics|mesh-ancestor
43560238|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
43560239|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728751|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43728752|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43728753|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43728755|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
43728782|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728783|NCT02575547|Cisplatin|cisplatin|mesh-list
43728784|NCT02575547|Docetaxel|docetaxel|mesh-list
43728785|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728786|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
43728787|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
43728788|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
43728789|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728791|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728792|NCT02575664|Narcotics|narcotics|mesh-ancestor
43728793|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728794|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728795|NCT02575664|Analgesics|analgesics|mesh-ancestor
43560290|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833737|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833738|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833741|NCT05190094|Palbociclib|palbociclib|mesh-list
43833742|NCT05190094|Anastrozole|anastrozole|mesh-list
43833743|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43560295|NCT04966546|Memantine|memantine|mesh-list
43833749|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
43833750|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833751|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833752|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43833753|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43833755|NCT05189977|Prazosin|prazosin|mesh-list
43833756|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43833757|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43833758|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833759|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833760|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833761|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833762|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43833763|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43833764|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
43560322|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560323|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560324|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560325|NCT04860141|Gabapentin|gabapentin|mesh-list
43560326|NCT04860141|Analgesics|analgesics|mesh-ancestor
43833765|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43833767|NCT05189535|Paclitaxel|paclitaxel|mesh-list
43560332|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43560333|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560334|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43560346|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560347|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560348|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560349|NCT04818086|Buprenorphine|buprenorphine|mesh-list
43560351|NCT04818086|Lemborexant|lemborexant|mesh-list
43728919|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43728920|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728921|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728922|NCT02574741|Aripiprazole|aripiprazole|mesh-list
43728923|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
43728924|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43728925|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43728926|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43728927|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728929|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
43728957|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43728958|NCT02574663|Growth Substances|growth substances|mesh-ancestor
43728959|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728960|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
43728961|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43728962|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
43728963|NCT02574663|Antiviral Agents|antiviral agents|mesh-ancestor
43728964|NCT02574663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43728965|NCT02574663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728966|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43728967|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
43728969|NCT02574663|Protective Agents|protective agents|mesh-ancestor
43728970|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
43728971|NCT02574663|Vitamins|vitamins|mesh-ancestor
43728972|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
43560409|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
43560410|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560411|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560412|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43560413|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
43560414|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
43560415|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43560416|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43560417|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43560418|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560419|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728989|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728990|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728991|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
43728992|NCT02574611|Neostigmine|neostigmine|mesh-list
43728993|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43728994|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728995|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778099|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778100|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43778126|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
43778127|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43778128|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43778129|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778130|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778131|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778155|NCT02327923|Atropine|atropine|mesh-list
43778156|NCT02327923|Ephedrine|ephedrine|mesh-list
43778157|NCT02327923|Fentanyl|fentanyl|mesh-list
43728996|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728997|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728998|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728999|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43729017|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729018|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
43729019|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729020|NCT02574221|Fluorides|fluorides|mesh-list
43729021|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
43560422|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560423|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778172|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778173|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43560424|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43560425|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560426|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560427|NCT04598321|Talazoparib|talazoparib|mesh-list
43560428|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43560429|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560430|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560432|NCT04596657|Vitamin D|vitamin d|mesh-list
43729108|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729109|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43729110|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43729111|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
43729112|NCT02573831|Oxycodone|oxycodone|mesh-list
43729113|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729114|NCT02573831|Narcotics|narcotics|mesh-ancestor
43729115|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729116|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729117|NCT02573831|Analgesics|analgesics|mesh-ancestor
43729118|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
43729239|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43729240|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43729241|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729242|NCT02573220|Antidotes|antidotes|mesh-ancestor
43729422|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43729423|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43778174|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43778175|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43778176|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778178|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729424|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
43560477|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
43560478|NCT04528329|BB 1101|bb 1101|mesh-list
43560479|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560480|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
43560481|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
43560482|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560483|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560484|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560485|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
43560486|NCT04528329|Hormones|hormones|mesh-ancestor
43560487|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43729686|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43729687|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
43729689|NCT02570243|Heparin|heparin|mesh-list
43560521|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43560522|NCT04446962|Growth Substances|growth substances|mesh-ancestor
43560523|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
43560524|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560525|NCT04402723|Cytarabine|cytarabine|mesh-list
43560526|NCT04402723|Daunorubicin|daunorubicin|mesh-list
43763352|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
43763353|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763354|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763355|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763356|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
43763357|NCT02426736|Hormones|hormones|mesh-ancestor
43763358|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778224|NCT02327715|Emtricitabine|emtricitabine|mesh-list
43778225|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
43778226|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778229|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763359|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763360|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763361|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
43763362|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
43763363|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763364|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
43729754|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43560615|NCT04046887|Paclitaxel|paclitaxel|mesh-list
43729803|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729805|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43729940|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729941|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43729942|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43729943|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43729974|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
43729975|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729976|NCT02567942|Propofol|propofol|mesh-list
43729977|NCT02567942|Sevoflurane|sevoflurane|mesh-list
43729978|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729979|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560634|NCT04002141|Letrozole|letrozole|mesh-list
43730016|NCT02567981|Trace Elements|trace elements|mesh-list
43730017|NCT02567981|Vitamins|vitamins|mesh-ancestor
43560655|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
43560656|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
43560657|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560658|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
43730056|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730057|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730058|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
43730059|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730060|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43730061|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43730062|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43730063|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43560876|NCT03117751|Vorinostat|vorinostat|mesh-list
43560877|NCT03117751|Idarubicin|idarubicin|mesh-list
43648265|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648266|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648267|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43648268|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43648269|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
43648270|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648271|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648272|NCT03941587|Aflibercept|aflibercept|mesh-list
43648273|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648274|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43648275|NCT03941587|Growth Substances|growth substances|mesh-ancestor
43730216|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43730217|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43730218|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
43730219|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43730221|NCT02566928|Mupirocin|mupirocin|mesh-list
43730222|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43730223|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730224|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
43730225|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
43560931|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
43730226|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43730227|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43730228|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730229|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730230|NCT02566707|Lamivudine|lamivudine|mesh-list
43730231|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43730232|NCT02566707|Dolutegravir|dolutegravir|mesh-list
43730246|NCT02566720|Amantadine|amantadine|mesh-list
43648276|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648277|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648278|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778353|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778354|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43648279|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
43648280|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648281|NCT03875144|Cisplatin|cisplatin|mesh-list
43648282|NCT03875144|Doxorubicin|doxorubicin|mesh-list
43648283|NCT03875144|Pemetrexed|pemetrexed|mesh-list
43833913|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43833914|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43833915|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43833916|NCT05176821|Antacids|antacids|mesh-ancestor
43833917|NCT05176821|Diuretics|diuretics|mesh-ancestor
43833918|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
43833919|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833920|NCT05176821|Expectorants|expectorants|mesh-ancestor
43833921|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
43833922|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43833923|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43560932|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560933|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560935|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
43648285|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648289|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730559|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
43730560|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730561|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
43730562|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
43730563|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
43730565|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560986|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560987|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560988|NCT02737826|Buprenorphine|buprenorphine|mesh-list
43560989|NCT02737826|Gabapentin|gabapentin|mesh-list
43730590|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
43730591|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43561000|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43730685|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730687|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
43730688|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43730689|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
43730690|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
43730691|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43730692|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43730693|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43730694|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43833954|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833955|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43833956|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43561075|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43561076|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43561077|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561078|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
43561079|NCT02238639|Coagulants|coagulants|mesh-ancestor
43561080|NCT02229136|Prednisolone|prednisolone|mesh-list
43561081|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
43561082|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43561083|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
43833957|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43833958|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
43833959|NCT05174585|Antibodies|antibodies|mesh-list
43833960|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
43833961|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43833962|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
43833963|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833964|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43833965|NCT05174039|Miglustat|miglustat|mesh-list
43731024|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43731025|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731026|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43731028|NCT02560376|Hormones|hormones|mesh-ancestor
43731030|NCT02560220|Mitomycins|mitomycins|mesh-list
43731099|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43731100|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731101|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731102|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731103|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731104|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731105|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
43731106|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
43731107|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731108|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
43731109|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43731110|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
43731111|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43731112|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
43731113|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43731170|NCT02559180|Aflibercept|aflibercept|mesh-list
43731171|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43731172|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731173|NCT02559180|Growth Substances|growth substances|mesh-ancestor
43731174|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731175|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
43561237|NCT02989597|Remifentanil|remifentanil|mesh-list
43561288|NCT02971891|Diuretics|diuretics|mesh-ancestor
43561289|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
43561290|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561291|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43731204|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43731205|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731206|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731207|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731208|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731209|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43731210|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43561335|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43561336|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561337|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561338|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561339|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43561340|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561342|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561343|NCT02820714|Laxatives|laxatives|mesh-list
43561344|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561345|NCT02814019|Idebenone|idebenone|mesh-list
43561346|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
43561347|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561348|NCT02814019|Protective Agents|protective agents|mesh-ancestor
43561349|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834001|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
43834002|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834009|NCT05170113|Caffeine|caffeine|mesh-list
43561418|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43561419|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561420|NCT02762929|Bupivacaine|bupivacaine|mesh-list
43561421|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
43561422|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
43561423|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561424|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731221|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43731222|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731223|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43731224|NCT02558959|Capecitabine|capecitabine|mesh-list
43731225|NCT02558959|Irinotecan|irinotecan|mesh-list
43561434|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43561436|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43561449|NCT02733432|Fluconazole|fluconazole|mesh-list
43561450|NCT02733432|Rezafungin|rezafungin|mesh-list
43561451|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
43561452|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561453|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43561454|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43561455|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561456|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731282|NCT02558387|Nintedanib|nintedanib|mesh-list
43561480|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561481|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561482|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
43561483|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43561484|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561485|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561486|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561487|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43561488|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43561490|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43561491|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
43561492|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561493|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561494|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731283|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731284|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43561506|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561525|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561526|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561527|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43561528|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
43561529|NCT02654990|Hormones|hormones|mesh-ancestor
43561530|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561531|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43561532|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561536|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
43648309|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648310|NCT03854032|Nivolumab|nivolumab|mesh-list
43648311|NCT03854032|Linrodostat|linrodostat|mesh-list
43778458|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778459|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
43778460|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
43778461|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
43778478|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
43778479|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778481|NCT02325986|Fluorouracil|fluorouracil|mesh-list
43778482|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778483|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
43778484|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778485|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43778486|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778487|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
43708608|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
43708609|NCT04430894|Hormones|hormones|mesh-ancestor
43708610|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43648312|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43648313|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648314|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43648315|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648316|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731351|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731352|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
43731353|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731354|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
43731355|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
43731356|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43731357|NCT02558023|Nicardipine|nicardipine|mesh-list
43731358|NCT02558023|Urapidil|urapidil|mesh-list
43731359|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43731360|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43731361|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731362|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561558|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43561559|NCT02636582|Molgramostim|molgramostim|mesh-list
43561560|NCT02636582|Vaccines|vaccines|mesh-list
43561561|NCT02636582|Sargramostim|sargramostim|mesh-list
43561562|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
43561563|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561564|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561565|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43561566|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43561567|NCT02626338|Cytarabine|cytarabine|mesh-list
43561568|NCT02626338|Fludarabine|fludarabine|mesh-list
43561569|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
43561570|NCT02626338|Etoposide|etoposide|mesh-list
43731363|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43731364|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731365|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
43731366|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43778488|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648317|NCT03834363|Fentanyl|fentanyl|mesh-list
43648318|NCT03834363|Morphine|morphine|mesh-list
43648319|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43648320|NCT03834363|Narcotics|narcotics|mesh-ancestor
43648321|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648322|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648323|NCT03834363|Analgesics|analgesics|mesh-ancestor
43648324|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
43648325|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561571|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
43561572|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
43561573|NCT02626338|Idarubicin|idarubicin|mesh-list
43561574|NCT02626338|Crenolanib|crenolanib|mesh-list
43561575|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561576|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561577|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
43561578|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561579|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561580|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
43561581|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561582|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
43561583|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561588|NCT02626338|Analgesics|analgesics|mesh-ancestor
43648326|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43648327|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43648328|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
43648329|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
43648330|NCT03798691|Vaccines|vaccines|mesh-list
43648331|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
43648332|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648333|NCT03733314|Quetmolimab|quetmolimab|mesh-list
43648334|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43648335|NCT03729245|Nivolumab|nivolumab|mesh-list
43731398|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731399|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731400|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
43731401|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731402|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731403|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43731404|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731405|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
43731406|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43731407|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731408|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731409|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43731410|NCT02557867|Analgesics|analgesics|mesh-ancestor
43731411|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
43731412|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43648338|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648339|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43648340|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648341|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43648342|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731437|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731438|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731439|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43731440|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
43731441|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
43731442|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
43731443|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43731444|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43731445|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43731446|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731447|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731448|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731449|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731450|NCT02557958|Azithromycin|azithromycin|mesh-list
43731451|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43731452|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731453|NCT02557854|Doxorubicin|doxorubicin|mesh-list
43731454|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43561613|NCT02607930|Triumeq|triumeq|mesh-list
43561614|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43561615|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731455|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43731456|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731457|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43731458|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43731459|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561617|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561618|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
43561619|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561620|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43561621|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43561622|NCT02606305|Bevacizumab|bevacizumab|mesh-list
43561623|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
43561624|NCT02606305|Carboplatin|carboplatin|mesh-list
43561625|NCT02606305|Doxorubicin|doxorubicin|mesh-list
43561626|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43648343|NCT03729245|Growth Substances|growth substances|mesh-ancestor
43648344|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648345|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
43648346|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43648347|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43648348|NCT03656536|Gemcitabine|gemcitabine|mesh-list
43648350|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43648351|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561658|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561659|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561660|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561661|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43561662|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561663|NCT02588677|Riluzole|riluzole|mesh-list
43561664|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
43561665|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43731508|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731510|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731511|NCT02557373|Protective Agents|protective agents|mesh-ancestor
43731512|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43731513|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834032|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834033|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43834035|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
43834036|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834037|NCT05168709|Vaccines|vaccines|mesh-list
43834038|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
43834039|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834040|NCT05168423|Cyclophosphamide|cyclophosphamide|mesh-list
43834041|NCT05168423|Fludarabine|fludarabine|mesh-list
43834042|NCT05168423|Isotretinoin|isotretinoin|mesh-list
43834043|NCT05168423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834044|NCT05168423|Immunologic Factors|immunologic factors|mesh-ancestor
43834045|NCT05168423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834046|NCT05168423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43834047|NCT05168423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834048|NCT05168423|Alkylating Agents|alkylating agents|mesh-ancestor
43652949|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
43834049|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834050|NCT05168423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834060|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834061|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43834063|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43834064|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834065|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834066|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834067|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43834069|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834070|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834071|NCT05166616|Osimertinib|osimertinib|mesh-list
43834072|NCT05166616|Triptolide|triptolide|mesh-list
43834073|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834074|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834075|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834076|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731613|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43561754|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
43561755|NCT02539537|Irinotecan|irinotecan|mesh-list
43561756|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
43561757|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561758|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
43561759|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561760|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561761|NCT02539537|Antiviral Agents|antiviral agents|mesh-ancestor
43731664|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731665|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43731666|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
43731667|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731668|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
43731669|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43731671|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
43731672|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731673|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
43731674|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43561837|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43561838|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43561839|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561840|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561841|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
43652958|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
43561842|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561843|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561844|NCT02502669|Urological Agents|urological agents|mesh-ancestor
43561845|NCT02490488|Gemcitabine|gemcitabine|mesh-list
43561846|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43561847|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
43561848|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561911|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
43561912|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561913|NCT01616303|Paclitaxel|paclitaxel|mesh-list
43561914|NCT01616303|Carboplatin|carboplatin|mesh-list
43561915|NCT01616303|Oregovomab|oregovomab|mesh-list
43561916|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561917|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834123|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834124|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834125|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43834128|NCT05162222|Diltiazem|diltiazem|mesh-list
43731916|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43731917|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
43731918|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43731919|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731922|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847609|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732388|NCT02550119|Hormones|hormones|mesh-ancestor
43732467|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562049|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
43562050|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562051|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562052|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562053|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43562055|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
43562056|NCT01554696|Methotrexate|methotrexate|mesh-list
43562057|NCT01554696|Peficitinib|peficitinib|mesh-list
43732515|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43732516|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
43732517|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732518|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834186|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834187|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778523|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778524|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778525|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43778526|NCT05076942|Cisplatin|cisplatin|mesh-list
43778527|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778528|NCT05076773|Morphine|morphine|mesh-list
43778557|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778558|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834188|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43834189|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
43834190|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834191|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834192|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43562102|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
43562103|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43648377|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
43648378|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43648379|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43648380|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43648381|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732650|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732652|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648391|NCT03528694|Durvalumab|durvalumab|mesh-list
43732714|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732806|NCT02548195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732807|NCT02548195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43732808|NCT02548195|Immunologic Factors|immunologic factors|mesh-ancestor
43732809|NCT02548195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732810|NCT02548286|Amlodipine|amlodipine|mesh-list
43732811|NCT02548286|Candesartan|candesartan|mesh-list
43732922|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43732923|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43732924|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732925|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732926|NCT02547480|Irinotecan|irinotecan|mesh-list
43732927|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43732928|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732933|NCT02547025|Amoxicillin|amoxicillin|mesh-list
43732939|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43732940|NCT02547025|Rabeprazole|rabeprazole|mesh-list
43732941|NCT02547025|Bismuth|bismuth|mesh-list
43732942|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732943|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
43732944|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43732945|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733133|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43733134|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43733135|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43733136|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733137|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733139|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43733140|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
43733141|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733142|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43562123|NCT01519804|Cisplatin|cisplatin|mesh-list
43733143|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43733181|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733183|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
43733184|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733185|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
43733186|NCT02545426|Calcium|calcium|mesh-list
43562154|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
43562155|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562156|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
43562157|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562158|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562159|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43562160|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
43562161|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562162|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562163|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43562165|NCT01516203|Isoniazid|isoniazid|mesh-list
43562166|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
43562203|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562204|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43562205|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
43652980|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43652981|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652982|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
43562206|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
43562207|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43733383|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733384|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733385|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848097|NCT04049851|Ivermectin|ivermectin|mesh-list
43733386|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
43848098|NCT04049851|Moxidectin|moxidectin|mesh-list
43848099|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43848100|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652988|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43652989|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652990|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43733388|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43733389|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652991|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
43652992|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
43733390|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834232|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834233|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
43834234|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43562281|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
43733480|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43733587|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733588|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43733589|NCT05139212|Analgesics|analgesics|mesh-ancestor
43733590|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
43733591|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43733592|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43733593|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43733594|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43733717|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43733718|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43733719|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43733720|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43733721|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43733722|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43733723|NCT04366115|Dexamethasone|dexamethasone|mesh-list
43733724|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
43733725|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43733756|NCT04209790|Temozolomide|temozolomide|mesh-list
43733757|NCT04209790|Benzolamide|benzolamide|mesh-list
43562295|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43562296|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652993|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
43652994|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
43652995|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652996|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562297|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562298|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
43562299|NCT01493505|Paclitaxel|paclitaxel|mesh-list
43562300|NCT01493505|Carboplatin|carboplatin|mesh-list
43562301|NCT01493505|Trebananib|trebananib|mesh-list
43562314|NCT01489046|Lamivudine|lamivudine|mesh-list
43834284|NCT05155124|Cetuximab|cetuximab|mesh-list
43834285|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834286|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834287|NCT05154487|Fulvestrant|fulvestrant|mesh-list
43834288|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43834289|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834290|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43648405|NCT03490864|Melatonin|melatonin|mesh-list
43648409|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43648410|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43648412|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
43648413|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43648414|NCT03490825|Protective Agents|protective agents|mesh-ancestor
43562616|NCT01421056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43562617|NCT01421056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562618|NCT01421056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562619|NCT01421056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43734085|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734086|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734087|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
43734088|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734089|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
43734090|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43734091|NCT02541643|Elotuzumab|elotuzumab|mesh-list
43734092|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734093|NCT02541708|Folic Acid|folic acid|mesh-list
43734094|NCT02541708|Hematinics|hematinics|mesh-ancestor
43734095|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
43734096|NCT02541708|Vitamins|vitamins|mesh-ancestor
43734127|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43848108|NCT04049331|Androgens|androgens|mesh-ancestor
43848109|NCT04049331|Hormones|hormones|mesh-ancestor
43848110|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848111|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848112|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43848113|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848114|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
43848115|NCT04048863|Imidacloprid|imidacloprid|mesh-list
43734128|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43734129|NCT02541396|Ketamine|ketamine|mesh-list
43734130|NCT02541396|Oxycodone|oxycodone|mesh-list
43734248|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
43734249|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734250|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734251|NCT02540876|Ilorasertib|ilorasertib|mesh-list
43734252|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43734253|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43734254|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734255|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562924|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43562929|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
43763505|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763506|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763507|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763508|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
43763509|NCT02425813|Hormones|hormones|mesh-ancestor
43763510|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763511|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43763512|NCT02425813|Protective Agents|protective agents|mesh-ancestor
43763513|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763514|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763515|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43763516|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43763517|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
43763518|NCT02425852|Prednisolone|prednisolone|mesh-list
43763519|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
43763520|NCT02425852|Azathioprine|azathioprine|mesh-list
43763521|NCT02425852|Infliximab|infliximab|mesh-list
43763522|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763523|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
43763524|NCT02425852|Hormones|hormones|mesh-ancestor
43763525|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763526|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763527|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763528|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562969|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43763576|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
43763577|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
43763579|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763580|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651670|NCT03005496|Carotenoids|carotenoids|mesh-list
43651671|NCT03005496|Picolinic acid|picolinic acid|mesh-list
43651672|NCT03005496|Vitamins|vitamins|mesh-ancestor
43651673|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
43651674|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651675|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763581|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763582|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837596|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837597|NCT04901715|Albuterol|albuterol|mesh-list
43837598|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43837599|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
43837600|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837601|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837602|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43563009|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43563010|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563011|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
43837606|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43837607|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43763649|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43563043|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
43563044|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563045|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43563047|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
43563048|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43563049|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43763705|NCT02424461|Ofloxacin|ofloxacin|mesh-list
43763706|NCT02424461|Levofloxacin|levofloxacin|mesh-list
43763765|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763766|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763767|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43763768|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43763769|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43763770|NCT02424071|Melatonin|melatonin|mesh-list
43763807|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
43763808|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763809|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763846|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
43763924|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563086|NCT01336465|Etrolizumab|etrolizumab|mesh-list
43734582|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
43734583|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
43734584|NCT02538718|Ritodrine|ritodrine|mesh-list
43734585|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
43734586|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
43734587|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734588|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763927|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763928|NCT02423395|Orphenadrine|orphenadrine|mesh-list
43763929|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763930|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43651676|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
43651677|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
43834401|NCT05139420|Topiramate|topiramate|mesh-list
43651678|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824787|NCT05508009|Melphalan|melphalan|mesh-list
43824788|NCT05508009|Rituximab|rituximab|mesh-list
43824789|NCT05508009|Fludarabine|fludarabine|mesh-list
43824790|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651679|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651681|NCT03005496|Hormones|hormones|mesh-ancestor
43651682|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651683|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43651684|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763931|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43763932|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43763933|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43763934|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763935|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
43763985|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763986|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43763987|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43763988|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
43763989|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43763990|NCT02422836|Protective Agents|protective agents|mesh-ancestor
43763991|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763992|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
43763993|NCT02422901|Ascorbic Acid|ascorbic acid|mesh-list
43764121|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43764126|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
43764127|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651703|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651704|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
43651705|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651706|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563243|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43563244|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563245|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
43563246|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
43563247|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43563249|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43563250|NCT01302249|Latanoprost|latanoprost|mesh-list
43563251|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43651707|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
43651708|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651709|NCT03005665|Acetazolamide|acetazolamide|mesh-list
43651710|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
43651711|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43764173|NCT02422199|Capecitabine|capecitabine|mesh-list
43764174|NCT02422199|Lapatinib|lapatinib|mesh-list
43764175|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43764176|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
43764177|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824791|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
43824792|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824793|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824794|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824795|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
43764178|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43764179|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43764180|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764181|NCT02422017|Timolol|timolol|mesh-list
43764182|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43764183|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43764198|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764199|NCT02422108|Denosumab|denosumab|mesh-list
43764200|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764201|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837669|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837670|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837671|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43837672|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43837673|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
43837674|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837675|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837676|NCT04895917|Daratumumab|daratumumab|mesh-list
43837677|NCT04895917|Pomalidomide|pomalidomide|mesh-list
43837678|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837679|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
43837680|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837681|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43837682|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43837683|NCT04895917|Growth Substances|growth substances|mesh-ancestor
43837684|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
43837685|NCT04895592|Dexamethasone|dexamethasone|mesh-list
43837686|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
43837687|NCT04895592|Ichthammol|ichthammol|mesh-list
43653019|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837688|NCT04895592|BB 1101|bb 1101|mesh-list
43837689|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837690|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
43837691|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
43837692|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837693|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837694|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837695|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
43837696|NCT04895592|Hormones|hormones|mesh-ancestor
43837697|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651712|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651713|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651714|NCT03005665|Diuretics|diuretics|mesh-ancestor
43651715|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
43734745|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734746|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43734747|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43734748|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43734749|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734750|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43563293|NCT01281462|Avibactam|avibactam|mesh-list
43563294|NCT01281462|Doripenem|doripenem|mesh-list
43563295|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43563296|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43563297|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43563298|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651716|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651718|NCT03005405|Fluorides|fluorides|mesh-list
43651719|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
43651720|NCT03005405|Protective Agents|protective agents|mesh-ancestor
43651721|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837698|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837699|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837700|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
43837701|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837702|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837703|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
43837704|NCT04893161|Belimumab|belimumab|mesh-list
43837705|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837706|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
43837707|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837708|NCT04892888|Vaccines|vaccines|mesh-list
43837709|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
43837710|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764230|NCT02421640|Cisplatin|cisplatin|mesh-list
43764231|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43563356|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563357|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563358|NCT01262261|Analgesics|analgesics|mesh-ancestor
43764232|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
43764233|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43764234|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
43764235|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43764236|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764237|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764238|NCT02422277|Urological Agents|urological agents|mesh-ancestor
43764239|NCT02422121|RNS60|rns60|mesh-list
43653039|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764240|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764241|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764242|NCT02422121|Analgesics|analgesics|mesh-ancestor
43764243|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
43764244|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764245|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764246|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764247|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764248|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43764249|NCT02421289|Efavirenz|efavirenz|mesh-list
43764250|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43764251|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43764252|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43764253|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764254|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
43764255|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764256|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43764257|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43764258|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43764259|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43651731|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43651732|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43764270|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43764271|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734830|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43734831|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43734832|NCT02537366|Analgesics|analgesics|mesh-ancestor
43764272|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764273|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43764274|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43764275|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764276|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
43764277|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764313|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43764314|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43764315|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43764316|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
43563477|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
43563478|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43563479|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43563480|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563481|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43563482|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43563483|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43563484|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43563485|NCT01234779|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43734844|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
43734845|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651733|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43651734|NCT03005704|Aspirin|aspirin|mesh-list
43651735|NCT03005704|Ticagrelor|ticagrelor|mesh-list
43764536|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764538|NCT02419118|Lenalidomide|lenalidomide|mesh-list
43764539|NCT02419118|Daratumumab|daratumumab|mesh-list
43764540|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764541|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
43764542|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
43764543|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764544|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764545|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43563494|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43764625|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43764626|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764627|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764628|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43764629|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
43764630|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43764631|NCT02418273|Denosumab|denosumab|mesh-list
43764632|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43764633|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764634|NCT02418130|Inositol|inositol|mesh-list
43764635|NCT02418130|Thiamine|thiamine|mesh-list
43764636|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43651743|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651744|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651745|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43651746|NCT03005704|Analgesics|analgesics|mesh-ancestor
43563594|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
43651747|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
43651748|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651749|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651750|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43651751|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43651752|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43563631|NCT01207115|Analgesics|analgesics|mesh-ancestor
43651753|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43651754|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651755|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
43651756|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43651757|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43651758|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
43651759|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764637|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
43764638|NCT02418130|Vitamins|vitamins|mesh-ancestor
43764639|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
43764640|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764641|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43764642|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837724|NCT04891484|Ondansetron|ondansetron|mesh-list
43837725|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
43764649|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764651|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43764652|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
43764653|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43764654|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764655|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43764656|NCT02417896|Diuretics|diuretics|mesh-ancestor
43764657|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
43734984|NCT02536209|Oxycodone|oxycodone|mesh-list
43764658|NCT02418065|Testosterone|testosterone|mesh-list
43764659|NCT02418065|Androgens|androgens|mesh-ancestor
43764690|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764691|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43764692|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43764693|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
43764694|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764695|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653098|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43764696|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
43764697|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
43764698|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
43764699|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43764700|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
43764701|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43764702|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
43764703|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735087|NCT02535156|Risperidone|risperidone|mesh-list
43764740|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764741|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
43764742|NCT02417116|Protective Agents|protective agents|mesh-ancestor
43764768|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
43651760|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651761|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651762|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
43651763|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43651764|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43651765|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43651766|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
43651767|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651768|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651770|NCT03005678|Alendronate|alendronate|mesh-list
43778719|NCT03978767|Ketorolac|ketorolac|mesh-list
43651771|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43651772|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764769|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43735334|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43735335|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
43735336|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735337|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735338|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735339|NCT04655157|Nivolumab|nivolumab|mesh-list
43735340|NCT04655157|Ipilimumab|ipilimumab|mesh-list
43735341|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43735342|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43735343|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43735344|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735345|NCT04585477|Durvalumab|durvalumab|mesh-list
43735346|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43764770|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
43778720|NCT03978767|Oxycodone|oxycodone|mesh-list
43764771|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764772|NCT02417337|Acetaminophen|acetaminophen|mesh-list
43764773|NCT02417337|Ibuprofen|ibuprofen|mesh-list
43764774|NCT02417337|Diclofenac|diclofenac|mesh-list
43764775|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
43764776|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43764777|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43764778|NCT02417337|Analgesics|analgesics|mesh-ancestor
43834476|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
43764779|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
43764780|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43764781|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43585131|NCT03423823|Ranibizumab|ranibizumab|mesh-list
43764782|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43764783|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764784|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43764785|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735395|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
43735404|NCT04397406|Narcotics|narcotics|mesh-ancestor
43764786|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764788|NCT02416817|Thrombin|thrombin|mesh-list
43764789|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
43764790|NCT02416817|Coagulants|coagulants|mesh-ancestor
43764791|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43764792|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
43764828|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
43764904|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43764905|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43764906|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
43764907|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43764908|NCT02416232|Trametinib|trametinib|mesh-list
43764909|NCT02416232|Dabrafenib|dabrafenib|mesh-list
43764910|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569768|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43764929|NCT02416258|Betamethasone|betamethasone|mesh-list
43564050|NCT01133990|Protective Agents|protective agents|mesh-ancestor
43564051|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
43564052|NCT01133990|Vitamins|vitamins|mesh-ancestor
43564053|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
43564054|NCT01130142|Gemcitabine|gemcitabine|mesh-list
43764964|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
43764965|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764967|NCT02416115|Morphine|morphine|mesh-list
43764968|NCT02416115|Ramosetron|ramosetron|mesh-list
43764969|NCT02416115|Naloxone|naloxone|mesh-list
43764970|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43764971|NCT02416115|Narcotics|narcotics|mesh-ancestor
43765007|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
43778771|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43778772|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709270|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709271|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709272|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709273|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709274|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43709275|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43709276|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
43709277|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43709278|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43709279|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
43709280|NCT01526603|Carboplatin|carboplatin|mesh-list
43765008|NCT02416128|Hormones|hormones|mesh-ancestor
43651773|NCT03005548|Morphine|morphine|mesh-list
43651774|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651775|NCT03005548|Narcotics|narcotics|mesh-ancestor
43564114|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564115|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564116|NCT01126970|Orlistat|orlistat|mesh-list
43564117|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564118|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564119|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43564120|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43564132|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
43564133|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43564134|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43564135|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43651776|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651777|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651778|NCT03005548|Analgesics|analgesics|mesh-ancestor
43651779|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
43651780|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564167|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
43651781|NCT03005483|Gabapentin|gabapentin|mesh-list
43651782|NCT03005483|Analgesics|analgesics|mesh-ancestor
43651783|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
43651784|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651785|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778786|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765009|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765042|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
43765043|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765044|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765045|NCT02415881|Panitumumab|panitumumab|mesh-list
43765046|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43765047|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765048|NCT02415803|Clopidogrel|clopidogrel|mesh-list
43765049|NCT02415803|Ticagrelor|ticagrelor|mesh-list
43765050|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43765051|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43765052|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43765082|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564271|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
43564272|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564278|NCT01106807|Adapalene|adapalene|mesh-list
43765094|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765095|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765096|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
43735815|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
43765114|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564352|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564354|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
43564355|NCT01076764|Heparin|heparin|mesh-list
43564356|NCT01076764|Calcium heparin|calcium heparin|mesh-list
43564357|NCT01076764|Otamixaban|otamixaban|mesh-list
43564358|NCT01076764|Eptifibatide|eptifibatide|mesh-list
43564359|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
43564360|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43735896|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43735897|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43735898|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43735900|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43735901|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
43735902|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
43735903|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
43735904|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43735905|NCT05208190|Clozapine|clozapine|mesh-list
43735906|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43735907|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
43735908|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653120|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653121|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653122|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
43653123|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
43653124|NCT02986321|Hormones|hormones|mesh-ancestor
43735909|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43735911|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43735946|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
43735947|NCT05178628|Antiviral Agents|antiviral agents|mesh-ancestor
43735948|NCT05178628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43735949|NCT05178628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43735950|NCT05178628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735951|NCT05178628|Immunologic Factors|immunologic factors|mesh-ancestor
43735952|NCT05178628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735953|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
43735954|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43735955|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43735956|NCT05147493|Dexamethasone|dexamethasone|mesh-list
43735957|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
43735958|NCT05147493|Lenalidomide|lenalidomide|mesh-list
43735959|NCT05147493|Bortezomib|bortezomib|mesh-list
43735960|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43735961|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
43735962|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43735963|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43735964|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43564400|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
43564401|NCT01071239|Busulfan|busulfan|mesh-list
43564402|NCT01071239|Fludarabine|fludarabine|mesh-list
43564403|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43564404|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
43564405|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564406|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43564407|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43778810|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778811|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43778812|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778817|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
43564408|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
43735975|NCT05147493|Hormones|hormones|mesh-ancestor
43765115|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765144|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765145|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765146|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43765147|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765148|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765149|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43765150|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43765151|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43765152|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43735984|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
43735990|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
43765153|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
43765154|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651786|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
43651787|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43651788|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43651789|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651790|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43651791|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43765155|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765156|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
43765157|NCT02415179|Hormones|hormones|mesh-ancestor
43736047|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736048|NCT05008354|Pyridoxine|pyridoxine|mesh-list
43736049|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
43736050|NCT05008354|Vitamins|vitamins|mesh-ancestor
43736051|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
43736052|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736053|NCT04988841|Nivolumab|nivolumab|mesh-list
43736054|NCT04988841|Ipilimumab|ipilimumab|mesh-list
43736055|NCT04988841|Laxatives|laxatives|mesh-list
43564412|NCT01057667|Ribavirin|ribavirin|mesh-list
43765158|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43765159|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
43765160|NCT02415114|Resveratrol|resveratrol|mesh-list
43765161|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
43765198|NCT02414984|Golimumab|golimumab|mesh-list
43765199|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43765200|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43765231|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43765232|NCT02414802|Tinzaparin|tinzaparin|mesh-list
43765233|NCT02414802|Dalteparin|dalteparin|mesh-list
43765234|NCT02414802|Calcium|calcium|mesh-list
43765235|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43765236|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765237|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43765238|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
43834499|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43834500|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43834501|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43834502|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
43834503|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43834504|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834505|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43564425|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43564426|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43564427|NCT01038739|Analgesics|analgesics|mesh-ancestor
43564428|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
43564429|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43564430|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564453|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564454|NCT01037062|Entecavir|entecavir|mesh-list
43564455|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
43564456|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564457|NCT01037036|Latanoprost|latanoprost|mesh-list
43564458|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43564459|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43564460|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43564461|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43564462|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564463|NCT01035879|Incretins|incretins|mesh-ancestor
43564464|NCT01035879|Hormones|hormones|mesh-ancestor
43564465|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43564470|NCT01035502|Idarubicin|idarubicin|mesh-list
43765239|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43765240|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43765241|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765242|NCT02414503|Oxytocin|oxytocin|mesh-list
43765243|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
43765244|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43736440|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736441|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
43736442|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
43564488|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43564489|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
43564490|NCT01030432|Asunaprevir|asunaprevir|mesh-list
43564491|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
43564492|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564493|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
43564494|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43564495|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
43564496|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736503|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
43736561|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736563|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
43736564|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43736565|NCT05360394|Paclitaxel|paclitaxel|mesh-list
43736566|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43736567|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43736573|NCT05360342|Vitamins|vitamins|mesh-list
43765286|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
43653133|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653134|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653135|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653136|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43653137|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43653138|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653139|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43653140|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653141|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653142|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
43653143|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
43765287|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
43765288|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43653144|NCT02986100|Rucaparib|rucaparib|mesh-list
43765324|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765325|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
43765326|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
43765327|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
43765328|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765329|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43837778|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43837779|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564497|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
43564498|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564499|NCT01029873|Cisplatin|cisplatin|mesh-list
43564500|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43564501|NCT01027013|Rebamipide|rebamipide|mesh-list
43564502|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43564503|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43564504|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43564505|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43564506|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
43564507|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43564508|NCT01027013|Protective Agents|protective agents|mesh-ancestor
43564509|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564510|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564511|NCT01025648|Epinephrine|epinephrine|mesh-list
43564512|NCT01025648|Racepinephrine|racepinephrine|mesh-list
43564513|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
43834624|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834625|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
43834626|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43834627|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834628|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
43834629|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834630|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43736622|NCT05359874|Growth Substances|growth substances|mesh-ancestor
43736623|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43736624|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
43736626|NCT05359627|Polymyxin B|polymyxin b|mesh-list
43736627|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736628|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736629|NCT05359497|Liver Extracts|liver extracts|mesh-list
43653152|NCT02985736|Hormones|hormones|mesh-ancestor
43736630|NCT05359497|Hematinics|hematinics|mesh-ancestor
43736631|NCT05359432|Empagliflozin|empagliflozin|mesh-list
43736632|NCT05359432|Vildagliptin|vildagliptin|mesh-list
43653153|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653154|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653155|NCT02985697|Midazolam|midazolam|mesh-list
43653156|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
43653157|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
43736633|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43736635|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43736803|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43736804|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43736805|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43736806|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
43736807|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43736808|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43736809|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43736810|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43736811|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43837780|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837781|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
43837782|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43736981|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43736982|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
43737047|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43737048|NCT05270863|Analgesics|analgesics|mesh-ancestor
43737049|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
43737050|NCT05270863|Protective Agents|protective agents|mesh-ancestor
43737051|NCT05265910|Loratadine|loratadine|mesh-list
43737052|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43778860|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43778861|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778862|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778863|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
43778864|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
43778865|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
43778867|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
43778877|NCT05079087|Midazolam|midazolam|mesh-list
43737053|NCT05265910|Dextrans|dextrans|mesh-list
43737054|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43737055|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43737056|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
43737057|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43837783|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43837784|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43837785|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837786|NCT04886323|Itraconazole|itraconazole|mesh-list
43837787|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
43837788|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837789|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43837790|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43837791|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837792|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837793|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43837794|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
43737109|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737110|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539113|NCT03783403|Rituximab|rituximab|mesh-list
43737111|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
43834696|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43834697|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837795|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651792|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43651793|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43651794|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651795|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
43651796|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43651797|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
43651798|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837796|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765346|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737208|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765347|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
43765348|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765349|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765350|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43765351|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765352|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
43765353|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43765354|NCT02414464|Calcium|calcium|mesh-list
43765355|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43737357|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43737358|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
43737359|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778908|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778912|NCT05078372|Midazolam|midazolam|mesh-list
43737360|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43737361|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
43834715|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
43834716|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43834717|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834718|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43834719|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
43765357|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43765358|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765359|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765361|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43765362|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765363|NCT02414256|Anesthetics|anesthetics|mesh-list
43765364|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778919|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778920|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778921|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778922|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778923|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778924|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778925|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778926|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
43778927|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
43778928|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
43778929|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778930|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778931|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
43778939|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778940|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
43778941|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778942|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778944|NCT05078138|Hematinics|hematinics|mesh-ancestor
43778945|NCT05077813|Vitamin D|vitamin d|mesh-list
43778946|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
43778947|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
43778948|NCT05077813|Vitamins|vitamins|mesh-list
43778949|NCT05077813|Minocycline|minocycline|mesh-list
43778950|NCT05077813|Tretinoin|tretinoin|mesh-list
43778951|NCT05077813|Alitretinoin|alitretinoin|mesh-list
43778952|NCT05077813|Isotretinoin|isotretinoin|mesh-list
43778953|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
43709471|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709472|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
43765365|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765366|NCT02414373|Bupivacaine|bupivacaine|mesh-list
43765367|NCT02414373|Ropivacaine|ropivacaine|mesh-list
43765368|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
43765436|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
43765437|NCT02413658|Phenytoin|phenytoin|mesh-list
43765438|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
43765439|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43765440|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43765441|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43765442|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765443|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43765470|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765471|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737714|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
43765472|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43737877|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43737970|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43737971|NCT04265105|Fluticasone|fluticasone|mesh-list
43737972|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43737973|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43834845|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43834846|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43834847|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43834849|NCT05096663|Antiviral Agents|antiviral agents|mesh-ancestor
43834850|NCT05096663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43834851|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43834852|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
43834853|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
43834854|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
43834855|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43834856|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43765473|NCT02413554|Protective Agents|protective agents|mesh-ancestor
43765474|NCT02413541|Polymyxins|polymyxins|mesh-list
43765475|NCT02413541|Polymyxin B|polymyxin b|mesh-list
43765476|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43765477|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765478|NCT02413086|Chitosan|chitosan|mesh-list
43765479|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43765480|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43765481|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
43778954|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778955|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43778956|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43778957|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778958|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778959|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778960|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
43778961|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
43778962|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
43778963|NCT05077592|Povidone|povidone|mesh-list
43709478|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709480|NCT05368675|Methadone|methadone|mesh-list
43709481|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43709482|NCT05368675|Naloxone|naloxone|mesh-list
43738230|NCT03840226|Antacids|antacids|mesh-ancestor
43738231|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738232|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43738233|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
43738234|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43738235|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738236|NCT03802058|Paclitaxel|paclitaxel|mesh-list
43738237|NCT03802058|Carboplatin|carboplatin|mesh-list
43738238|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738239|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738240|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43738241|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43738242|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43765482|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765483|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43765484|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
43765485|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
43738506|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738508|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738583|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43738584|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738585|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
43738586|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43738587|NCT02983045|Paclitaxel|paclitaxel|mesh-list
43738588|NCT02983045|Cisplatin|cisplatin|mesh-list
43738589|NCT02983045|Carboplatin|carboplatin|mesh-list
43738590|NCT02983045|Nivolumab|nivolumab|mesh-list
43738591|NCT02983045|Pemetrexed|pemetrexed|mesh-list
43738592|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43738593|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43738647|NCT02732288|Protective Agents|protective agents|mesh-ancestor
43738648|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43738649|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43738650|NCT02726581|Dexamethasone|dexamethasone|mesh-list
43738651|NCT02726581|Nivolumab|nivolumab|mesh-list
43738652|NCT02726581|Pomalidomide|pomalidomide|mesh-list
43738653|NCT02726581|Elotuzumab|elotuzumab|mesh-list
43738654|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43738655|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
43738656|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
43765486|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
43765487|NCT02413086|Coagulants|coagulants|mesh-ancestor
43765488|NCT02412930|Tramadol|tramadol|mesh-list
43765489|NCT02412930|Bupivacaine|bupivacaine|mesh-list
43765490|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
43765491|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
43765492|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765493|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765526|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651800|NCT03005353|Miconazole|miconazole|mesh-list
43651801|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43651802|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651803|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
43651804|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43651806|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43738748|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
43738749|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564581|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43564582|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43564583|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43738829|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43738830|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
43738831|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43738832|NCT02094625|Expectorants|expectorants|mesh-ancestor
43738833|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
43738835|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
43765529|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43765530|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43765531|NCT02412475|Cytarabine|cytarabine|mesh-list
43765532|NCT02412475|Fludarabine|fludarabine|mesh-list
43765533|NCT02412475|Sorafenib|sorafenib|mesh-list
43765534|NCT02412475|Decitabine|decitabine|mesh-list
43765535|NCT02412475|Vorinostat|vorinostat|mesh-list
43765536|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765537|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43765538|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
43564661|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564662|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43738883|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43564746|NCT01000922|Insulin|insulin|mesh-list
43738956|NCT01345175|Metronidazole|metronidazole|mesh-list
43765571|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765572|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43765573|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43765592|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43739040|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
43765593|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
43765594|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
43765595|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765596|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43765597|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43765632|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43765634|NCT02411942|Analgesics|analgesics|mesh-ancestor
43765635|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
43765636|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765637|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765666|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43765667|NCT02411994|Pyronaridine|pyronaridine|mesh-list
43765668|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
43765669|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43765670|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43765671|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765672|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765673|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
43778964|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
43778965|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
43778966|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43778967|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778968|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
43778969|NCT05077527|Fludarabine|fludarabine|mesh-list
43778970|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778971|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
43778972|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43564827|NCT00981357|Naproxen|naproxen|mesh-list
43765674|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
43765675|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43709483|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43709484|NCT05368675|Narcotics|narcotics|mesh-ancestor
43765676|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
43765677|NCT02411877|Clotrimazole|clotrimazole|mesh-list
43765678|NCT02411877|Miconazole|miconazole|mesh-list
43765679|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765680|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43765681|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
43765682|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43765683|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43739194|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43739199|NCT03617523|Vaccines|vaccines|mesh-list
43564925|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43651807|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651808|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43651809|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
43565006|NCT00955981|Renal Agents|renal agents|mesh-ancestor
43765685|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43565096|NCT00945763|Ibuprofen|ibuprofen|mesh-list
43739569|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43739705|NCT02534402|Hormones|hormones|mesh-ancestor
43765686|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43765687|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
43765712|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765713|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43765715|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43765717|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
43765718|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
43765719|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765720|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43739782|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43739854|NCT02532790|Prednisone|prednisone|mesh-list
43765721|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43739991|NCT02532062|Vitamins|vitamins|mesh-ancestor
43765723|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
43765724|NCT02411604|Tacrolimus|tacrolimus|mesh-list
43765725|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778973|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778974|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43778975|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
43778976|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778977|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778978|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43778993|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43765726|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
43765727|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765729|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765730|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765731|NCT02411149|Epinephrine|epinephrine|mesh-list
43765732|NCT02411149|Racepinephrine|racepinephrine|mesh-list
43570628|NCT00393952|Fluticasone|fluticasone|mesh-list
43765733|NCT02411149|Morphine|morphine|mesh-list
43765734|NCT02411149|Ropivacaine|ropivacaine|mesh-list
43765770|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43765771|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765772|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43765773|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765774|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765874|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43765875|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43765876|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
43740067|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43565376|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43837883|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837884|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837885|NCT04881799|Topiramate|topiramate|mesh-list
43837886|NCT04881799|Phentermine|phentermine|mesh-list
43837887|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
43837888|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837889|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43740161|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
43837890|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43837891|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
43765923|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43765924|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43765925|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765926|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43765927|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43765928|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43740244|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43565642|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765929|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43765930|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
43765961|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765962|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765963|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
43765964|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43778994|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778995|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778997|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778998|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778999|NCT05075863|Letrozole|letrozole|mesh-list
43779000|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709513|NCT05368181|Protective Agents|protective agents|mesh-ancestor
43709514|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43709521|NCT05368051|Antibodies|antibodies|mesh-list
43765965|NCT02410031|Cyproterone|cyproterone|mesh-list
43570925|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
43765966|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43740437|NCT02529774|Floxuridine|floxuridine|mesh-list
43740438|NCT02529774|Heparin|heparin|mesh-list
43740439|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
43565838|NCT00858702|Olmesartan|olmesartan|mesh-list
43765967|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43765968|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43765969|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43765970|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
43651810|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43740658|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
43740825|NCT02527772|Fluorouracil|fluorouracil|mesh-list
43565921|NCT00849862|Levetiracetam|levetiracetam|mesh-list
43651811|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651812|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43651813|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43651816|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43765972|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43741343|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
43835250|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43765973|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43765974|NCT02410031|Estrogens|estrogens|mesh-ancestor
43765975|NCT02410031|Hormones|hormones|mesh-ancestor
43766012|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43766013|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43766014|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
43766051|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
43741608|NCT05669768|Tamoxifen|tamoxifen|mesh-list
43766088|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43741844|NCT05634369|Antiviral Agents|antiviral agents|mesh-ancestor
43741845|NCT05634369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43741846|NCT05634369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43741847|NCT05634369|Immunologic Factors|immunologic factors|mesh-ancestor
43741848|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
43831559|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831560|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
43831561|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43831562|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831563|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43831564|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831565|NCT05305859|Azacitidine|azacitidine|mesh-list
43831566|NCT05305859|Venetoclax|venetoclax|mesh-list
43831567|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43831568|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
43831569|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831570|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831571|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831572|NCT05305404|Dexamethasone|dexamethasone|mesh-list
43709529|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
43709530|NCT05367765|HH-GV-678|hh-gv-678|mesh-list
43709531|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709532|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43742047|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742048|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43742049|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
43766106|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43766107|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
43766108|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43766109|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766110|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
43566404|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43742306|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
43766111|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43766112|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43742469|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43742470|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43742479|NCT05181735|Luspatercept|luspatercept|mesh-list
43742480|NCT05181735|Hematinics|hematinics|mesh-ancestor
43742481|NCT05179876|Selexipag|selexipag|mesh-list
43742482|NCT05179876|Tadalafil|tadalafil|mesh-list
43766113|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766114|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43766115|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43742785|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43742790|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
43766150|NCT02409186|Cisplatin|cisplatin|mesh-list
43766183|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766184|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
43766185|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43651817|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651818|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43651819|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43779011|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779012|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779013|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779014|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779015|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779016|NCT05053425|Cytarabine|cytarabine|mesh-list
43779017|NCT05053425|Azacitidine|azacitidine|mesh-list
43779018|NCT05053425|Venetoclax|venetoclax|mesh-list
43779019|NCT05053425|Idarubicin|idarubicin|mesh-list
43779020|NCT05053425|Cladribine|cladribine|mesh-list
43779021|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779022|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
43779023|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779024|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651820|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43566641|NCT00831051|Oxycodone|oxycodone|mesh-list
43651821|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651822|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651823|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
43766186|NCT02408705|Incretins|incretins|mesh-ancestor
43766187|NCT02408705|Hormones|hormones|mesh-ancestor
43766188|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766189|NCT02408744|Pirfenidone|pirfenidone|mesh-list
43766190|NCT02408744|Analgesics|analgesics|mesh-ancestor
43766191|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
43766192|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837917|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837919|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43837920|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837921|NCT04878198|Melatonin|melatonin|mesh-list
43837922|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
43837923|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837924|NCT04878198|Protective Agents|protective agents|mesh-ancestor
43837925|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837926|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837927|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
43837928|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
43837929|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766338|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766341|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43743221|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
43743222|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43743223|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43743224|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43743225|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
43743226|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43766342|NCT02408042|Carboplatin|carboplatin|mesh-list
43651824|NCT03005340|Vitamin D|vitamin d|mesh-list
43651825|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
43651826|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43651827|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651828|NCT03005340|Vitamins|vitamins|mesh-ancestor
43566835|NCT00820300|Latanoprost|latanoprost|mesh-list
43839065|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839066|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839067|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839068|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43839069|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839070|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839071|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
43839072|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839073|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839074|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
43839075|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839076|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839077|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
43709572|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709573|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
43651830|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43766376|NCT02407821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43766377|NCT02407821|Antidepressive Agents|antidepressive agents|mesh-ancestor
43766378|NCT02407821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43766380|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766381|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
43766382|NCT02407834|Eusol|eusol|mesh-list
43766383|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
43766419|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43766420|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
43766421|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43566990|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43566991|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
43743402|NCT04543383|Thrombin|thrombin|mesh-list
43743403|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
43743404|NCT04543383|Coagulants|coagulants|mesh-ancestor
43743405|NCT04543188|Midazolam|midazolam|mesh-list
43743406|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43743407|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43743408|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43743409|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43743410|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43743411|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43743439|NCT04498286|Antibodies|antibodies|mesh-list
43743440|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
43743472|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766422|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43766423|NCT02407392|Protective Agents|protective agents|mesh-ancestor
43766424|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766457|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766458|NCT02407314|Aspirin|aspirin|mesh-list
43766459|NCT02407314|Ticagrelor|ticagrelor|mesh-list
43567121|NCT00772785|Buprenorphine|buprenorphine|mesh-list
43766460|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766461|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766462|NCT02407314|Analgesics|analgesics|mesh-ancestor
43766463|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
43766464|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43743694|NCT04297150|Edoxaban|edoxaban|mesh-list
43766465|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766466|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766467|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43766468|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43766469|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43766495|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43744161|NCT03983824|Analgesics|analgesics|mesh-ancestor
43744162|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
43744163|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43567531|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43567532|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567533|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
43744164|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43744165|NCT03959592|Carotenoids|carotenoids|mesh-list
43744166|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
43744168|NCT03959592|Protective Agents|protective agents|mesh-ancestor
43744246|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766496|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
43766497|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43567662|NCT00724841|Temozolomide|temozolomide|mesh-list
43766498|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837936|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43567898|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43837938|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43837939|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837940|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837941|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43744590|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43744591|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43567996|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43744786|NCT03031730|Hormones|hormones|mesh-ancestor
43744788|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766499|NCT02406911|Ticagrelor|ticagrelor|mesh-list
43766500|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43766501|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43766502|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43766503|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43766504|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
43766505|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568131|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43568132|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568133|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568134|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
43568135|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43568136|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43568137|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43779077|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779078|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43779079|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779080|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43779081|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
43568138|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
43568151|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
43568157|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43568158|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
43568159|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43568160|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568161|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43568162|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43568163|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43568164|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
43568165|NCT00667953|Temozolomide|temozolomide|mesh-list
43568166|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
43779083|NCT04973826|Avibactam|avibactam|mesh-list
43779084|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779085|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779086|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43779087|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779088|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779089|NCT04940637|Niraparib|niraparib|mesh-list
43779090|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43779091|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779092|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779127|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43779128|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43779129|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43779130|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779131|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779155|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43779156|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43779157|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779158|NCT04734886|Vitamin D|vitamin d|mesh-list
43568167|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43568168|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
43568169|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568170|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568171|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43568172|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568173|NCT00666497|Azacitidine|azacitidine|mesh-list
43568174|NCT00666497|Mocetinostat|mocetinostat|mesh-list
43568175|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43568176|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
43568177|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43568178|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568179|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43568180|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43568181|NCT00663767|Celecoxib|celecoxib|mesh-list
43568182|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
43568183|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43568184|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43568185|NCT00663767|Analgesics|analgesics|mesh-ancestor
43568186|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
43568187|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43568188|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43568189|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43568190|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43745166|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766523|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43766524|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
43651832|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43766525|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766527|NCT02406508|Sorafenib|sorafenib|mesh-list
43766528|NCT02406508|Melphalan|melphalan|mesh-list
43766554|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43766555|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
43766556|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766557|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43745649|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43766559|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
43766560|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
43766561|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
43766562|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766563|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766564|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
43766565|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766566|NCT02406521|Sorafenib|sorafenib|mesh-list
43766567|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43568388|NCT00645177|Paclitaxel|paclitaxel|mesh-list
43766568|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766569|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43766570|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766571|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779172|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
43766572|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43766573|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43766574|NCT02406300|Bupivacaine|bupivacaine|mesh-list
43766575|NCT02406300|Ropivacaine|ropivacaine|mesh-list
43766576|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
43766577|NCT02406300|Sevoflurane|sevoflurane|mesh-list
43766578|NCT02406300|Desflurane|desflurane|mesh-list
43766601|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766602|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
43766603|NCT02406144|Hormones|hormones|mesh-ancestor
43766604|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43766605|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766606|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766607|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
43766608|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43568542|NCT00624351|Epratuzumab|epratuzumab|mesh-list
43766609|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43766610|NCT02406144|Growth Substances|growth substances|mesh-ancestor
43766611|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
43766612|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
43766613|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43766614|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766615|NCT02406170|Paclitaxel|paclitaxel|mesh-list
43766616|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43766617|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43568594|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
43568645|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43766618|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766619|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
43766620|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
43766621|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766623|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766624|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766625|NCT02406014|Analgesics|analgesics|mesh-ancestor
43766626|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
43766627|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766628|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766696|NCT02405988|Narcotics|narcotics|mesh-ancestor
43746310|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
43766697|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43766720|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43766722|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
43766723|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766724|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766725|NCT02405598|Albuterol|albuterol|mesh-list
43766726|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43766728|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651834|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651835|NCT03005171|Lidocaine|lidocaine|mesh-list
43651836|NCT03005171|Bupivacaine|bupivacaine|mesh-list
43651837|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
43779184|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
43779185|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779211|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
43651838|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
43651839|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651840|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651841|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
43766729|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766730|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43766731|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
43766732|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
43766733|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43766734|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43746619|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
43766735|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43766737|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
43766738|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43569477|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43569478|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
43766740|NCT02405793|Meloxicam|meloxicam|mesh-list
43569628|NCT00488839|Baclofen|baclofen|mesh-list
43746858|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
43766741|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43766742|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43766743|NCT02405793|Analgesics|analgesics|mesh-ancestor
43766744|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
43766745|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43569835|NCT00467402|S 20098|s 20098|mesh-list
43746890|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43569962|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
43569963|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
43746983|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43746990|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
43747056|NCT02520245|Cemiplimab|cemiplimab|mesh-list
43747057|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43747058|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747059|NCT02520180|Everolimus|everolimus|mesh-list
43747060|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747061|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747062|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
43779228|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779229|NCT04551911|Calcifediol|calcifediol|mesh-list
43747063|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766746|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766747|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43766781|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766782|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766783|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
43766785|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43747118|NCT02519608|Aspirin|aspirin|mesh-list
43570215|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43570216|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43570217|NCT00434811|Analgesics|analgesics|mesh-ancestor
43570218|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
43570219|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570220|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570221|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570222|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570223|NCT00434226|Paclitaxel|paclitaxel|mesh-list
43570224|NCT00434226|Bevacizumab|bevacizumab|mesh-list
43570225|NCT00434226|Carboplatin|carboplatin|mesh-list
43570226|NCT00434226|Sunitinib|sunitinib|mesh-list
43835843|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43835844|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
43835845|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
43835846|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43835849|NCT05019885|Ketamine|ketamine|mesh-list
43766786|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43766787|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779231|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
43779232|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766788|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
43747228|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
43779233|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43779234|NCT04536272|Heparin|heparin|mesh-list
43779235|NCT04536272|Calcium heparin|calcium heparin|mesh-list
43709679|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709680|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709681|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43709682|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43747303|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747304|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747305|NCT02518516|Atorvastatin|atorvastatin|mesh-list
43747306|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43747307|NCT02518516|Simvastatin|simvastatin|mesh-list
43747308|NCT02518516|Pravastatin|pravastatin|mesh-list
43747309|NCT02518516|Lovastatin|lovastatin|mesh-list
43747310|NCT02518516|L 647318|l 647318|mesh-list
43747311|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
43747312|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43747313|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43747314|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
43747315|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747319|NCT02518438|Tramadol|tramadol|mesh-list
43570251|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570252|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43570253|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43570254|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570255|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43570256|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43570257|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43570258|NCT00430508|Olmesartan|olmesartan|mesh-list
43570259|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43570260|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43766819|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43766820|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43766822|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766823|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43766824|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
43766825|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
43766826|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
43766827|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43837944|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837945|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43837946|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43747379|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570397|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570398|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570400|NCT00411892|Pioglitazone|pioglitazone|mesh-list
43570401|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43570402|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43570403|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570404|NCT00411528|Prednisone|prednisone|mesh-list
43570405|NCT00411528|Docetaxel|docetaxel|mesh-list
43570406|NCT00411528|Epothilone B|epothilone b|mesh-list
43570407|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570408|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
43570414|NCT00411528|Hormones|hormones|mesh-ancestor
43570445|NCT00406588|Levodopa|levodopa|mesh-list
43570446|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43570447|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43570448|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
43570449|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570450|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570451|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570452|NCT00405951|Docetaxel|docetaxel|mesh-list
43570453|NCT00405951|Obatoclax|obatoclax|mesh-list
43570454|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570460|NCT00405743|Cytarabine|cytarabine|mesh-list
43837975|NCT04877275|Doxorubicin|doxorubicin|mesh-list
43837976|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43837977|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43837978|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
43837980|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43837981|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43837982|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
43837983|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837984|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747501|NCT05583214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43747502|NCT05583006|Tenofovir|tenofovir|mesh-list
43839122|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
43839123|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839124|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43839125|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43839138|NCT04796012|Atezolizumab|atezolizumab|mesh-list
43839139|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43839140|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43839141|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839142|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839143|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709696|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709697|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
43747503|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
43747504|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43747505|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43747506|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43747507|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43747508|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43747509|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43747510|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43747511|NCT05578586|Meropenem|meropenem|mesh-list
43835925|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
43835926|NCT05011383|Testosterone|testosterone|mesh-list
43835927|NCT05011383|Androgens|androgens|mesh-list
43835928|NCT05011383|Hormones|hormones|mesh-ancestor
43835929|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43835930|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835931|NCT05011266|Buprenorphine|buprenorphine|mesh-list
43835932|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43835933|NCT05011266|Naloxone|naloxone|mesh-list
43835934|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43835935|NCT05011266|Narcotics|narcotics|mesh-ancestor
43835936|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43835937|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43835938|NCT05011266|Analgesics|analgesics|mesh-ancestor
43835939|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
43835940|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43835941|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43835942|NCT05010772|Decitabine|decitabine|mesh-list
43835943|NCT05010772|Venetoclax|venetoclax|mesh-list
43747562|NCT05553704|Metformin|metformin|mesh-list
43747563|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43747564|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747565|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
43747566|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747567|NCT05550714|Anesthetics|anesthetics|mesh-list
43747568|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43747569|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747570|NCT05513807|Niacinamide|niacinamide|mesh-list
43747571|NCT05513807|Niacin|niacin|mesh-list
43747572|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
43747610|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747612|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747613|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839144|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43839145|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
43839146|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
43839147|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653159|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653160|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653161|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653163|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
43653164|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653165|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43653166|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43653167|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43653168|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
43747615|NCT05493501|Osimertinib|osimertinib|mesh-list
43570481|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570482|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570483|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570484|NCT00403169|Growth Substances|growth substances|mesh-ancestor
43570485|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
43570486|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570487|NCT00402428|Interferons|interferons|mesh-list
43570488|NCT00402428|Ribavirin|ribavirin|mesh-list
43747672|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43747673|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43747674|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43747675|NCT05337137|Bevacizumab|bevacizumab|mesh-list
43570498|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570499|NCT00401570|Gemcitabine|gemcitabine|mesh-list
43570500|NCT00401570|Volociximab|volociximab|mesh-list
43570510|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570511|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570512|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570513|NCT00401570|Growth Substances|growth substances|mesh-ancestor
43570516|NCT00401388|Antiemetics|antiemetics|mesh-list
43570517|NCT00401388|Loperamide|loperamide|mesh-list
43570518|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
43570519|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
43570520|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570521|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570522|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
43570523|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43570525|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
43570538|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570539|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
43570540|NCT00401011|Hormones|hormones|mesh-ancestor
43570541|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43570542|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43570543|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570544|NCT00398879|Capecitabine|capecitabine|mesh-list
43570545|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570546|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
43570547|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570548|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570549|NCT00397293|Topotecan|topotecan|mesh-list
43570552|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570553|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570554|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570555|NCT00397254|Rizatriptan|rizatriptan|mesh-list
43570556|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43570557|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
43570558|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570561|NCT00396357|Metformin|metformin|mesh-list
43570584|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
43570585|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43570586|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43570587|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43570588|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570589|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570590|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570591|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570592|NCT00394121|Fluticasone|fluticasone|mesh-list
43570593|NCT00394121|Xhance|xhance|mesh-list
43570597|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
43570624|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43570625|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
43570626|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43570627|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570630|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
43570631|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43570632|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43747811|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43747812|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
43747813|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43747814|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43747815|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43570657|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43570658|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43570659|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43570660|NCT00393068|Growth Substances|growth substances|mesh-ancestor
43570661|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570662|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
43570663|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
43570664|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43570665|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43570666|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
43570667|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43570668|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570669|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
43570670|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43747848|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
43839162|NCT04795336|Melatonin|melatonin|mesh-list
43839163|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
43839164|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839165|NCT04795336|Protective Agents|protective agents|mesh-ancestor
43839166|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839167|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839168|NCT04794842|Phenol|phenol|mesh-list
43779258|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
43779259|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747883|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747885|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
43747886|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747887|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43747889|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747890|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
43747891|NCT04848454|Cisplatin|cisplatin|mesh-list
43747892|NCT04848454|Vinorelbine|vinorelbine|mesh-list
43747893|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43747924|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43747925|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43747926|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43747928|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
43747929|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747930|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43747931|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
43747932|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43747933|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
43747935|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
43747964|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43747966|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
43747967|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570741|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570742|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43570743|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43570744|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43570745|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43570746|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43570747|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43570748|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43570749|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
43748061|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748062|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748063|NCT04163419|Tanezumab|tanezumab|mesh-list
43748064|NCT04163419|Analgesics|analgesics|mesh-ancestor
43748065|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
43779260|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779261|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779262|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779263|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43779264|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779265|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779266|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
43779267|NCT04162756|Fludarabine|fludarabine|mesh-list
43779268|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779269|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
43709749|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
43709750|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43748066|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748067|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748068|NCT04153760|Aspirin|aspirin|mesh-list
43748069|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43837985|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43748168|NCT03834519|Hormones|hormones|mesh-ancestor
43748170|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837986|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43837987|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
43837988|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
43748379|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748380|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43748381|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
43748382|NCT02378298|Hormones|hormones|mesh-ancestor
43748383|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837989|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651842|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651843|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43748422|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570830|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43570831|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570833|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570834|NCT00374296|Mocetinostat|mocetinostat|mesh-list
43570835|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43570836|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43570837|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570838|NCT00374166|Paroxetine|paroxetine|mesh-list
43570839|NCT00374166|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43748526|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43748527|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570860|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
43570861|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570862|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43570863|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
43570864|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43570865|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651844|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43651845|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43651846|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43837990|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837991|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
43627419|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43766849|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
43766850|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43766851|NCT02405013|Ledipasvir|ledipasvir|mesh-list
43570875|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570876|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43570877|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
43570878|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570879|NCT00369070|Paclitaxel|paclitaxel|mesh-list
43570880|NCT00369070|Bevacizumab|bevacizumab|mesh-list
43570881|NCT00369070|Carboplatin|carboplatin|mesh-list
43766852|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
43766853|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766854|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
43766855|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43766856|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
43766857|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43748616|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748617|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
43748618|NCT02516475|Astringents|astringents|mesh-ancestor
43748619|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748620|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
43748621|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
43748622|NCT02516423|Dexamethasone|dexamethasone|mesh-list
43748623|NCT02516423|Lenalidomide|lenalidomide|mesh-list
43748624|NCT02516423|Ixazomib|ixazomib|mesh-list
43748625|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43748626|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
43779311|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
43779312|NCT03971474|Pemetrexed|pemetrexed|mesh-list
43779313|NCT03971474|Ramucirumab|ramucirumab|mesh-list
43779314|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43779315|NCT03971474|Antibodies|antibodies|mesh-list
43779316|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
43779317|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43779318|NCT03971474|Lexatumumab|lexatumumab|mesh-list
43779319|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
43748627|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
43748628|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748629|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43570971|NCT00361582|Analgesics|analgesics|mesh-ancestor
43570972|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
43570973|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43570974|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43570975|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43836073|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836074|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43748645|NCT02516436|Buprenorphine|buprenorphine|mesh-list
43748674|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748675|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748676|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43748677|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
43748678|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
43748679|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43748680|NCT02515955|Minocycline|minocycline|mesh-list
43748681|NCT02515955|Amphetamine|amphetamine|mesh-list
43748682|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
43570998|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43570999|NCT00358982|Mocetinostat|mocetinostat|mesh-list
43571000|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43571001|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571002|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571055|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571057|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43748683|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779352|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779353|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43748684|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748685|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43748686|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748688|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
43748689|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748690|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
43571102|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571104|NCT00337532|Cisplatin|cisplatin|mesh-list
43571105|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43571106|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571107|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571111|NCT00337454|Dasatinib|dasatinib|mesh-list
43766858|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
43766895|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766896|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
43766932|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43766933|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
43627420|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
43766985|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43766986|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43766988|NCT02404051|Fulvestrant|fulvestrant|mesh-list
43766989|NCT02404051|Exemestane|exemestane|mesh-list
43766990|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43766991|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43571181|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43571184|NCT00323037|Carvedilol|carvedilol|mesh-list
43748792|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43748793|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571285|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571286|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43571287|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43571288|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43571289|NCT00313768|Growth Substances|growth substances|mesh-ancestor
43571290|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571291|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
43748794|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43748795|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43748796|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43748797|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43748798|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
43779368|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43779369|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43767001|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767002|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43748879|NCT02515188|Analgesics|analgesics|mesh-ancestor
43748887|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
43748889|NCT02514941|Amoxicillin|amoxicillin|mesh-list
43748891|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43748892|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43748893|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43748894|NCT02514941|Analgesics|analgesics|mesh-ancestor
43748895|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
43748896|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43748897|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43748898|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
43836082|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836083|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836085|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43836086|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43836087|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43836088|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43836089|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
43836090|NCT05002816|Elotuzumab|elotuzumab|mesh-list
43836091|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43836092|NCT05001373|Vaccines|vaccines|mesh-list
43836093|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
43836094|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571339|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
43767003|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
43767004|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43767005|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43767006|NCT02403856|Prednisolone|prednisolone|mesh-list
43767007|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
43767008|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43653178|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
43653179|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
43653180|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43653181|NCT02985983|Brodalumab|brodalumab|mesh-list
43653182|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653183|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
43653184|NCT02985905|Astringents|astringents|mesh-ancestor
43653185|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653186|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653187|NCT02985658|Cisplatin|cisplatin|mesh-list
43653188|NCT02985658|Vinorelbine|vinorelbine|mesh-list
43653189|NCT02985658|Veliparib|veliparib|mesh-list
43653198|NCT02985671|Acetaminophen|acetaminophen|mesh-list
43767009|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
43767010|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767011|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
43767012|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
43767013|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767042|NCT02403687|Topiramate|topiramate|mesh-list
43767043|NCT02403687|Diclofenac|diclofenac|mesh-list
43767044|NCT02403687|Meloxicam|meloxicam|mesh-list
43767045|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
43767046|NCT02403687|Lidocaine|lidocaine|mesh-list
43767047|NCT02403687|Clonidine|clonidine|mesh-list
43767048|NCT02403687|Sumatriptan|sumatriptan|mesh-list
43767049|NCT02403687|Ketamine|ketamine|mesh-list
43767050|NCT02403687|Gabapentin|gabapentin|mesh-list
43767051|NCT02403687|Amitriptyline|amitriptyline|mesh-list
43767052|NCT02403687|Tizanidine|tizanidine|mesh-list
43748998|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43748999|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
43749000|NCT02514330|Vitamins|vitamins|mesh-ancestor
43749001|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
43749002|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749003|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43749004|NCT02514421|Gemcitabine|gemcitabine|mesh-list
43749005|NCT02514421|Paclitaxel|paclitaxel|mesh-list
43749006|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43749007|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749008|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749009|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749010|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749011|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749012|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43749013|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
43749072|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43749073|NCT02513654|Lamotrigine|lamotrigine|mesh-list
43749074|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
43749075|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43749076|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749077|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749078|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43653202|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653203|NCT02985671|Analgesics|analgesics|mesh-ancestor
43653204|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
43653205|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709888|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
43709923|NCT04697485|Bumetanide|bumetanide|mesh-list
43749079|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749080|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43651847|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651849|NCT03005184|Valsartan|valsartan|mesh-list
43651851|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43651852|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43571393|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
43571394|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
43571395|NCT00299507|Anecortave|anecortave|mesh-list
43571403|NCT00299325|Rimonabant|rimonabant|mesh-list
43749210|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43749211|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749212|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43767063|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
43767149|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43838004|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43838005|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43838006|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
43838007|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838008|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
43838009|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
43838010|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838011|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838012|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43838013|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
43836106|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43836108|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
43836109|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836110|NCT04995497|Lidocaine|lidocaine|mesh-list
43836111|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838015|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838016|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43838017|NCT04876534|Protective Agents|protective agents|mesh-ancestor
43838018|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767169|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43767170|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
43571515|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43571516|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43836130|NCT04993352|Growth Substances|growth substances|mesh-ancestor
43836132|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
43836133|NCT04992026|Hormones|hormones|mesh-list
43836134|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43749243|NCT02512380|Docetaxel|docetaxel|mesh-list
43749244|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
43749245|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749246|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
43749247|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
43749248|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
43749249|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749250|NCT02512315|Cisplatin|cisplatin|mesh-list
43749251|NCT02512315|Docetaxel|docetaxel|mesh-list
43749288|NCT02511795|Olaparib|olaparib|mesh-list
43749289|NCT02511795|Adavosertib|adavosertib|mesh-list
43749290|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43749291|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749292|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749293|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749294|NCT02511613|Squalamine|squalamine|mesh-list
43749295|NCT02511613|Ranibizumab|ranibizumab|mesh-list
43749297|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43709925|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
43749363|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749365|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43749366|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749367|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43749368|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43749369|NCT02511405|Growth Substances|growth substances|mesh-ancestor
43749370|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43749371|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
43749372|NCT02511353|Ivermectin|ivermectin|mesh-list
43749373|NCT02511353|Piperaquine|piperaquine|mesh-list
43749426|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43749427|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43571520|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571521|NCT00262990|Doxorubicin|doxorubicin|mesh-list
43571522|NCT00262990|Epothilone B|epothilone b|mesh-list
43571523|NCT00262990|Epothilones|epothilones|mesh-list
43571524|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43571525|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43571526|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43571527|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43571528|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43571529|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571530|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
43571531|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
43571532|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653206|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653207|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
43653208|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43653209|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43653210|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653211|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653212|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43653213|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43653214|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
43653215|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779386|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571533|NCT00260156|Vildagliptin|vildagliptin|mesh-list
43571534|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43571557|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43571558|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43571559|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43571560|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43571561|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43749443|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43749444|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43836182|NCT04990869|Niacinamide|niacinamide|mesh-list
43836183|NCT04990869|Niacin|niacin|mesh-list
43836184|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
43836185|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
43836186|NCT04990869|Vitamins|vitamins|mesh-ancestor
43836187|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
43836188|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43836189|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43836190|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
43836191|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571565|NCT00257205|Dacarbazine|dacarbazine|mesh-list
43571566|NCT00257205|Tremelimumab|tremelimumab|mesh-list
43571567|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43571568|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
43836192|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43836193|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
43836194|NCT04990258|Infliximab|infliximab|mesh-list
43552842|NCT03601624|Hormones|hormones|mesh-ancestor
43749485|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
43749486|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43749499|NCT02510963|Tenofovir|tenofovir|mesh-list
43749517|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43749518|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43749519|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43749520|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43749521|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43749522|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43749523|NCT02510287|Narcotics|narcotics|mesh-ancestor
43749524|NCT02510287|Analgesics|analgesics|mesh-ancestor
43749525|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43749526|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43749527|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
43749528|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
43749529|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749531|NCT02510469|Apatinib|apatinib|mesh-list
43767171|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43767172|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43767173|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43767174|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43767175|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767176|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
43767177|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767178|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767179|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43767180|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749570|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
43749579|NCT02509949|Analgesics|analgesics|mesh-ancestor
43767183|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767184|NCT02403284|Incretins|incretins|mesh-ancestor
43767219|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
43767220|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767221|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767222|NCT02402972|Leucovorin|leucovorin|mesh-list
43767223|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
43571590|NCT00254891|Paclitaxel|paclitaxel|mesh-list
43571647|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43571648|NCT00232141|Pregabalin|pregabalin|mesh-list
43749730|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43749731|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43749732|NCT02509091|Amikacin|amikacin|mesh-list
43767224|NCT02402972|Floxuridine|floxuridine|mesh-list
43767225|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
43767226|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767227|NCT02402972|Antidotes|antidotes|mesh-ancestor
43651856|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43651857|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
43651858|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651859|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43651860|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43749751|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43749758|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
43836198|NCT04989699|Aflibercept|aflibercept|mesh-list
43651861|NCT03005184|Analgesics|analgesics|mesh-ancestor
43571777|NCT00135395|Ritonavir|ritonavir|mesh-list
43749882|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
43767245|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767246|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43767248|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767249|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767250|NCT02402725|Dexamethasone|dexamethasone|mesh-list
43750004|NCT02506998|Histamine|histamine|mesh-list
43750005|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
43750006|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43750007|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
43750008|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
43750009|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
43750010|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43571916|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43750043|NCT02507128|Liraglutide|liraglutide|mesh-list
43767251|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
43767252|NCT02402725|BB 1101|bb 1101|mesh-list
43571925|NCT00116298|Lamivudine|lamivudine|mesh-list
43571981|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43571983|NCT00110422|Irbesartan|irbesartan|mesh-list
43750142|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
43750143|NCT02506894|Analgesics|analgesics|mesh-ancestor
43767253|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767254|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
43767255|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
43767256|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767257|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767258|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767259|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
43750272|NCT02505841|Ropivacaine|ropivacaine|mesh-list
43767261|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767262|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43572224|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43750762|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767263|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767264|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
43750862|NCT02502175|Opium|opium|mesh-list
43767265|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767266|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767267|NCT02402712|Docetaxel|docetaxel|mesh-list
43767268|NCT02402712|Trastuzumab|trastuzumab|mesh-list
43767269|NCT02402712|Pertuzumab|pertuzumab|mesh-list
43767270|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767271|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
43750962|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43750964|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43572402|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43751098|NCT02500563|Caseins|caseins|mesh-list
43767272|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
43767273|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
43767274|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767275|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43767277|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43767278|NCT02402621|Narcotics|narcotics|mesh-ancestor
43767279|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767280|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767281|NCT02402621|Analgesics|analgesics|mesh-ancestor
43751463|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767283|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767284|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43767316|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
43767317|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43767318|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43767319|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
43767320|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767321|NCT02402465|Fluticasone|fluticasone|mesh-list
43751899|NCT02495415|Fenretinide|fenretinide|mesh-list
43751900|NCT02495415|Retinamide|retinamide|mesh-list
43779413|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779414|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
43751905|NCT02495363|Bupivacaine|bupivacaine|mesh-list
43767322|NCT02402465|Xhance|xhance|mesh-list
43767323|NCT02402465|Azelastine|azelastine|mesh-list
43767349|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767351|NCT02402413|Hormones|hormones|mesh-ancestor
43767352|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43752412|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43767353|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767354|NCT02402283|Metronidazole|metronidazole|mesh-list
43767355|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43752644|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767356|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43752788|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
43752789|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43752790|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43767357|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43752834|NCT02488538|Fluoxetine|fluoxetine|mesh-list
43836578|NCT04965116|Hormones|hormones|mesh-ancestor
43752964|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767358|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43767359|NCT02402231|Omalizumab|omalizumab|mesh-list
43767360|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43767361|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43767362|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
43767363|NCT02402543|Acetaminophen|acetaminophen|mesh-list
43767364|NCT02402543|Dexamethasone|dexamethasone|mesh-list
43651862|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
43651863|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651864|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651865|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651866|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767366|NCT02402543|Gabapentin|gabapentin|mesh-list
43767367|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767368|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
43767369|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
43767370|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767371|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767372|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767400|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767402|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43767403|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
43767404|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43767405|NCT02401945|Aflibercept|aflibercept|mesh-list
43767406|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43767407|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767408|NCT02401945|Growth Substances|growth substances|mesh-ancestor
43767409|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767410|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
43767411|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767412|NCT02401971|Thalidomide|thalidomide|mesh-list
43753318|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753319|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43753320|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
43753321|NCT02485613|Hormones|hormones|mesh-ancestor
43753322|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753323|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43753324|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43753325|NCT02485431|Deflazacort|deflazacort|mesh-list
43753326|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43753327|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753328|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
43753397|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43753398|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
43753400|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43753401|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43753402|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
43753403|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43753404|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43753405|NCT02485041|Mirodenafil|mirodenafil|mesh-list
43753519|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
43753520|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753521|NCT02484209|Metformin|metformin|mesh-list
43753522|NCT02484209|Glimepiride|glimepiride|mesh-list
43753523|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43753524|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753525|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43753526|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43753555|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43753556|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753557|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43753616|NCT02483884|Bombesin|bombesin|mesh-list
43753618|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753620|NCT02483689|Bupivacaine|bupivacaine|mesh-list
43753621|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
43753622|NCT02483689|Anesthetics|anesthetics|mesh-list
43753623|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753624|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753625|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
43753635|NCT02483598|Buspirone|buspirone|mesh-list
43753740|NCT02483195|Minoxidil|minoxidil|mesh-list
43779435|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779436|NCT03618225|Analgesics|analgesics|mesh-ancestor
43779437|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
43779438|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779439|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
43653216|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710104|NCT04173962|Midazolam|midazolam|mesh-list
43767414|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43767416|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767417|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767418|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767419|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767420|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
43557646|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
43753818|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43753819|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43753820|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43753821|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43753822|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43753823|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43753824|NCT02482649|Methylphenidate|methylphenidate|mesh-list
43753825|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43753828|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43753869|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43753870|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43753871|NCT02482155|Analgesics|analgesics|mesh-ancestor
43753872|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
43753873|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43753874|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753876|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572987|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43572988|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43572989|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
43572990|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43572991|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43572992|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43572993|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
43572994|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43572999|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
43753968|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43753970|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43753971|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43753972|NCT02481323|Diuretics|diuretics|mesh-ancestor
43779444|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43779445|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779446|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779447|NCT03561831|Propofol|propofol|mesh-list
43779448|NCT03561831|Sevoflurane|sevoflurane|mesh-list
43753973|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
43753974|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43753975|NCT02481479|Saxagliptin|saxagliptin|mesh-list
43753976|NCT02481479|Incretins|incretins|mesh-ancestor
43753977|NCT02481479|Hormones|hormones|mesh-ancestor
43753978|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43753979|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753992|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43753993|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43753994|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
43753995|NCT02480946|Methotrexate|methotrexate|mesh-list
43753996|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43753997|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
43753998|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43753999|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754000|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43754001|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
43754002|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754003|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754004|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
43754005|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43754006|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43573066|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573067|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43573068|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43573069|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573070|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43573071|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754096|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754098|NCT02480400|Citalopram|citalopram|mesh-list
43754099|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43754100|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43754101|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43754102|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754123|NCT02480088|Ramosetron|ramosetron|mesh-list
43754155|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573102|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573104|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43573105|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573106|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573107|NCT03530007|Ondansetron|ondansetron|mesh-list
43573113|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
43573114|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
43754157|NCT02479854|Montelukast|montelukast|mesh-list
43573135|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573136|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573138|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43573139|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43573140|NCT03529929|Prednisolone|prednisolone|mesh-list
43779454|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
43573141|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
43573142|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43573143|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
43573144|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43573145|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
43573146|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
43573164|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573165|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43573166|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43573167|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43754176|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
43754177|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
43754178|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754179|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754180|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
43754181|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767421|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767422|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
43767423|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43767452|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767453|NCT02401477|Amoxicillin|amoxicillin|mesh-list
43767454|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43767455|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767456|NCT02401594|Enoxaparin|enoxaparin|mesh-list
43767457|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
43767458|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43767459|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
43767460|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43573220|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43573221|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43573222|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43573223|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43836719|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43836721|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43836722|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43836723|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43836724|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779473|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43779474|NCT03501979|Capecitabine|capecitabine|mesh-list
43779475|NCT03501979|Trastuzumab|trastuzumab|mesh-list
43779476|NCT03501979|Tucatinib|tucatinib|mesh-list
43779477|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779478|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
43779479|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779480|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779481|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779482|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43779483|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779484|NCT03473574|Gemcitabine|gemcitabine|mesh-list
43779485|NCT03473574|Cisplatin|cisplatin|mesh-list
43779486|NCT03473574|Durvalumab|durvalumab|mesh-list
43779487|NCT03473574|Tremelimumab|tremelimumab|mesh-list
43779488|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779489|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779490|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
43779491|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754293|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43754294|NCT02479256|Tamoxifen|tamoxifen|mesh-list
43573235|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
43754478|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754479|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754480|NCT02478125|Docetaxel|docetaxel|mesh-list
43754481|NCT02478125|Lenograstim|lenograstim|mesh-list
43754482|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43754483|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
43754484|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
43754485|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754486|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754487|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43754488|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
43754489|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754491|NCT02478047|Ramosetron|ramosetron|mesh-list
43754492|NCT02478047|Antiemetics|antiemetics|mesh-list
43754493|NCT02478047|Tropisetron|tropisetron|mesh-list
43754562|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754563|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43754564|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43754565|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43754566|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43754567|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43754568|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43754569|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43754570|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43754571|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
43754572|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43754573|NCT02477813|Temozolomide|temozolomide|mesh-list
43754574|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43754575|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
43754576|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573351|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43573352|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
43573353|NCT03528616|Propranolol|propranolol|mesh-list
43779492|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
43839192|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43839193|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839194|NCT04793919|Tretinoin|tretinoin|mesh-list
43839195|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
43573354|NCT03528616|Digoxin|digoxin|mesh-list
43573355|NCT03528616|Adenosine|adenosine|mesh-list
43573356|NCT03528616|Amiodarone|amiodarone|mesh-list
43573357|NCT03528616|Flecainide|flecainide|mesh-list
43573358|NCT03528616|Procainamide|procainamide|mesh-list
43573359|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43573360|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43573361|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
43573362|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754665|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43754666|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43754667|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
43754668|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43754669|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43754670|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
43573421|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43573422|NCT03528057|Hemostatics|hemostatics|mesh-list
43767461|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
43767462|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767463|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767464|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
43767465|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43767466|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43767467|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
43767468|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43573423|NCT03528057|Coagulants|coagulants|mesh-ancestor
43573425|NCT03527836|Bupivacaine|bupivacaine|mesh-list
43573426|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43573427|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
43573428|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43573429|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43573430|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
43573431|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43573432|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43573433|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43573437|NCT03527732|Ivermectin|ivermectin|mesh-list
43838019|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767496|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43767497|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767498|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43767499|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767500|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767501|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
43767502|NCT02401295|Itraconazole|itraconazole|mesh-list
43767503|NCT02401295|Celecoxib|celecoxib|mesh-list
43767504|NCT02401295|Tretinoin|tretinoin|mesh-list
43767505|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43767506|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767507|NCT02401295|Analgesics|analgesics|mesh-ancestor
43767508|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
43767509|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651867|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43651868|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43651869|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43754749|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43573474|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
43754784|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43779507|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
43754785|NCT02476981|Ephedrine|ephedrine|mesh-list
43754786|NCT02476981|Midazolam|midazolam|mesh-list
43754787|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
43754788|NCT02476981|Remifentanil|remifentanil|mesh-list
43754789|NCT02476981|Propofol|propofol|mesh-list
43754790|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43754791|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43754792|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754793|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43754794|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
43754795|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
43754819|NCT02476825|Xhance|xhance|mesh-list
43573512|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43573513|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43573514|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
43573515|NCT03526575|Zaleplon|zaleplon|mesh-list
43573516|NCT03526575|Zolpidem|zolpidem|mesh-list
43573517|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43754824|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754825|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43754826|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
43754889|NCT02476760|Carbutamide|carbutamide|mesh-list
43754891|NCT02476760|Glibornuride|glibornuride|mesh-list
43754892|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43754893|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
43754894|NCT02476760|Incretins|incretins|mesh-list
43754895|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43754896|NCT02476760|Hormones|hormones|mesh-ancestor
43754897|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43754905|NCT02476552|Niraparib|niraparib|mesh-list
43651870|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653224|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
43767510|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767511|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767512|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767513|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43767514|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767515|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627421|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43767539|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
43767540|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767541|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43572611|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
43767542|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43767543|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43767544|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767546|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43767547|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43755284|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43767548|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43836809|NCT04947254|Androgens|androgens|mesh-list
43767549|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767550|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767552|NCT02400879|Remifentanil|remifentanil|mesh-list
43779596|NCT02431767|Interleukin-12|interleukin-12|mesh-list
43767553|NCT02400879|Sevoflurane|sevoflurane|mesh-list
43767554|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43755506|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755507|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
43755508|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43755509|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43755526|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755527|NCT02473094|Metformin|metformin|mesh-list
43755528|NCT02473094|Capecitabine|capecitabine|mesh-list
43573546|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43573547|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
43573548|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573549|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43755572|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
43573588|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
43755724|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43755728|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43767556|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
43767557|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
43767558|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43755951|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43755954|NCT02469831|Rocuronium|rocuronium|mesh-list
43767559|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767560|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43767561|NCT02400879|Narcotics|narcotics|mesh-ancestor
43767562|NCT02400879|Analgesics|analgesics|mesh-ancestor
43767563|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
43779622|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43779623|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43767564|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767593|NCT02400866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43767594|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43755991|NCT02468999|Insulin|insulin|mesh-list
43756032|NCT02468531|Xenon|xenon|mesh-list
43767595|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43767596|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767597|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43756118|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
43573966|NCT03521492|Vitamins|vitamins|mesh-ancestor
43573986|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43573988|NCT03521167|Lidocaine|lidocaine|mesh-list
43573989|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
43574045|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43756630|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
43756755|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
43756758|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
43767600|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43767601|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43767602|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767604|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43756986|NCT02462525|Hormones|hormones|mesh-ancestor
43757078|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43574139|NCT03519776|Progesterone|progesterone|mesh-list
43847872|NCT04070833|Vitamin D|vitamin d|mesh-list
43767607|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767608|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43767609|NCT02400801|Dienogest|dienogest|mesh-list
43757657|NCT02458716|Bicalutamide|bicalutamide|mesh-list
43574286|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43757915|NCT02457208|Rifampin|rifampin|mesh-list
43757975|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43758041|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43758042|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43758066|NCT02456714|Folfirinox|folfirinox|mesh-list
43758179|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
43758180|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43767638|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43758230|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767639|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767640|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
43767642|NCT02400151|Vitamins|vitamins|mesh-ancestor
43767643|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
43767644|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767645|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43767646|NCT02400385|Nivolumab|nivolumab|mesh-list
43767647|NCT02400385|Sunitinib|sunitinib|mesh-list
43767648|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43767649|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767650|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43767651|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651871|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
43651873|NCT03005002|Ipilimumab|ipilimumab|mesh-list
43651874|NCT03005002|Tremelimumab|tremelimumab|mesh-list
43651875|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
43758419|NCT02454881|Analgesics|analgesics|mesh-ancestor
43574718|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43574785|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43574807|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
43574808|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
43574809|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
43651876|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43651877|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
43651878|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43651879|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651880|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
43758643|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43758685|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43758686|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
43574937|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43758942|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
43767683|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767684|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43575023|NCT03510871|Nivolumab|nivolumab|mesh-list
43767686|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43759322|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43759430|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43759431|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43759457|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43759458|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
43767688|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43767689|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767690|NCT02400021|Progesterone|progesterone|mesh-list
43767691|NCT02400021|Progestins|progestins|mesh-ancestor
43767693|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43759724|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43759725|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
43767694|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767695|NCT02400047|Dexamethasone|dexamethasone|mesh-list
43767696|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
43767697|NCT02400047|Ketoprofen|ketoprofen|mesh-list
43767698|NCT02400047|BB 1101|bb 1101|mesh-list
43575128|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
43653229|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43653231|NCT02985593|KHK4083|khk4083|mesh-list
43759841|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43767699|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767700|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
43759940|NCT02446431|Sirolimus|sirolimus|mesh-list
43575314|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43760103|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43575397|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43760132|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760134|NCT02445508|Sevelamer|sevelamer|mesh-list
43575476|NCT03507244|Dexamethasone|dexamethasone|mesh-list
43767752|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760260|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
43837320|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43575635|NCT03506178|Phenylephrine|phenylephrine|mesh-list
43767753|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
43760350|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43767755|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43767756|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
43767757|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
43767758|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767759|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767760|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43767761|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
43575828|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
43575871|NCT03504072|Tofacitinib|tofacitinib|mesh-list
43575873|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43760458|NCT01194622|Azelastine|azelastine|mesh-list
43760511|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
43760516|NCT00777127|Imiquimod|imiquimod|mesh-list
43767763|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767764|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43767765|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838020|NCT04876430|Meropenem|meropenem|mesh-list
43576044|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847982|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779769|NCT04455100|Itraconazole|itraconazole|mesh-list
43779770|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
43779771|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779772|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43779773|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779774|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779775|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779776|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43779777|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
43779778|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779779|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779780|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43779781|NCT04439578|Rifampin|rifampin|mesh-list
43779804|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
43847983|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43651882|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43576120|NCT03501433|Niacin|niacin|mesh-list
43760617|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
43760618|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760621|NCT00189241|Imiquimod|imiquimod|mesh-list
43576176|NCT03500874|Vitamins|vitamins|mesh-ancestor
43576234|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43576351|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43576354|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
43576519|NCT03498248|Lenograstim|lenograstim|mesh-list
43651883|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651884|NCT03004768|BMS-986165|bms-986165|mesh-list
43651885|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651886|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43651887|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651888|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651890|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43651891|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
43651892|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651893|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43847984|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
43670935|NCT05419583|Anticoagulants|anticoagulants|mesh-list
43576795|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43847986|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847987|NCT04062123|Analgesics|analgesics|mesh-ancestor
43847988|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
43576923|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43576959|NCT03493412|Verapamil|verapamil|mesh-list
43653235|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653236|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43653237|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824801|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43653238|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710422|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710423|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710424|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710426|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
43710427|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710428|NCT01524926|Crizotinib|crizotinib|mesh-list
43710429|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767766|NCT02399709|Simvastatin|simvastatin|mesh-list
43767767|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43767768|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43767769|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
43767770|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43671313|NCT04863638|Vaccines|vaccines|mesh-list
43671347|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767771|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43767772|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43767773|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43767774|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43767775|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43846846|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
43846851|NCT04169737|Venetoclax|venetoclax|mesh-list
43767808|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43586375|NCT03411941|Aflibercept|aflibercept|mesh-list
43779812|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43779813|NCT03971929|Diuretics|diuretics|mesh-ancestor
43779814|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
43779815|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779816|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43779817|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779818|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779819|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
43779820|NCT03971084|Caseins|caseins|mesh-list
43779821|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43779822|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
43779823|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779859|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779860|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779897|NCT03317223|Clarithromycin|clarithromycin|mesh-list
43767809|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43767810|NCT02399189|Methotrexate|methotrexate|mesh-list
43767811|NCT02399189|Temozolomide|temozolomide|mesh-list
43767812|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43767813|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
43767814|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767816|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43767817|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
43767818|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43767819|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43767820|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
43577022|NCT03492996|Delpazolid|delpazolid|mesh-list
43672034|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767821|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43767857|NCT02398994|Hormones|hormones|mesh-ancestor
43767858|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577194|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
43827301|NCT05489848|Carboplatin|carboplatin|mesh-list
43672176|NCT02572141|Leucovorin|leucovorin|mesh-list
43767859|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43767860|NCT02398994|Protective Agents|protective agents|mesh-ancestor
43672259|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43767861|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
43767897|NCT02398682|Protective Agents|protective agents|mesh-ancestor
43767934|NCT02398357|Nadroparin|nadroparin|mesh-list
43767935|NCT02398357|Warfarin|warfarin|mesh-list
43767936|NCT02398357|Calcium|calcium|mesh-list
43577423|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
43577512|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43577515|NCT03489239|Tenofovir|tenofovir|mesh-list
43577568|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43767965|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
43767966|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
43767967|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43767968|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767969|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
43767970|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651894|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43578038|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43578103|NCT03483636|Lemborexant|lemborexant|mesh-list
43578125|NCT03483415|Analgesics|analgesics|mesh-ancestor
43578126|NCT03483389|Ethanol|ethanol|mesh-list
43578133|NCT03483350|Midazolam|midazolam|mesh-list
43767973|NCT02398136|Analgesics|analgesics|mesh-ancestor
43767974|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
43767975|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43767976|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767977|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43767978|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43838038|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
43672917|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43578332|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43672986|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43673016|NCT02057172|Liraglutide|liraglutide|mesh-list
43838039|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838040|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43838041|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838042|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838043|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
43768012|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768013|NCT02397863|Cannabidiol|cannabidiol|mesh-list
43779958|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43779959|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779960|NCT05084196|Melatonin|melatonin|mesh-list
43779961|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
43779962|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779963|NCT05084196|Protective Agents|protective agents|mesh-ancestor
43779964|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653243|NCT02985229|Misoprostol|misoprostol|mesh-list
43653244|NCT02985229|Mifepristone|mifepristone|mesh-list
43653245|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43710517|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43710518|NCT02696915|Narcotics|narcotics|mesh-ancestor
43710519|NCT02696915|Analgesics|analgesics|mesh-ancestor
43710520|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43710521|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43710522|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
43710523|NCT02696590|Vitamin D|vitamin d|mesh-list
43710524|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
43710525|NCT02696590|Vitamins|vitamins|mesh-ancestor
43710526|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
43710527|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710528|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43578541|NCT03479918|Hormones|hormones|mesh-ancestor
43768014|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
43768016|NCT02398058|Trabectedin|trabectedin|mesh-list
43768017|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43768018|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768019|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768020|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768021|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43768022|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
43768023|NCT02397382|Midazolam|midazolam|mesh-list
43768024|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
43578599|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43768026|NCT02397382|Omeprazole|omeprazole|mesh-list
43768027|NCT02397382|Warfarin|warfarin|mesh-list
43768028|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43768029|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43768030|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768031|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768032|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43768033|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43768034|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43578773|NCT03477461|Terlipressin|terlipressin|mesh-list
43673149|NCT02014649|Laninamivir|laninamivir|mesh-list
43768035|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768036|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
43768045|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43768046|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673242|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768047|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43768048|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43768049|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43768080|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768081|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768083|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43768084|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
43579105|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43710529|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43710530|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
43710531|NCT02696512|Minocycline|minocycline|mesh-list
43710532|NCT02696512|Lamotrigine|lamotrigine|mesh-list
43710533|NCT02696512|Flumazenil|flumazenil|mesh-list
43710534|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43710535|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43710536|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
43710537|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43710538|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710539|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710540|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43710541|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710542|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43579215|NCT03473314|Protective Agents|protective agents|mesh-ancestor
43673380|NCT01917383|Timolol|timolol|mesh-list
43579320|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43579322|NCT03472378|Analgesics|analgesics|mesh-ancestor
43768085|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43768086|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768087|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768088|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579428|NCT03471325|Methamphetamine|methamphetamine|mesh-list
43768089|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43673616|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43673617|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43673618|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43673619|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43673620|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
43579605|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43579610|NCT03469310|Tramadol|tramadol|mesh-list
43768118|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43579734|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43579735|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
43768119|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768120|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43768121|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
43768122|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43768124|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43768125|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43768126|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
43768127|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43579861|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
43768128|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43768129|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43768131|NCT02397356|Ketamine|ketamine|mesh-list
43768132|NCT02397356|Analgesics|analgesics|mesh-ancestor
43768133|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
43768134|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768135|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579924|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43768137|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43779965|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779967|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43779968|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43779969|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779970|NCT05084001|Listerine|listerine|mesh-list
43839242|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839244|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839245|NCT04787744|Prednisone|prednisone|mesh-list
43839246|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
43839247|NCT04787744|Docetaxel|docetaxel|mesh-list
43839248|NCT04787744|Leuprolide|leuprolide|mesh-list
43839249|NCT04787744|Goserelin|goserelin|mesh-list
43768138|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
43768139|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
43580064|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
43768140|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768141|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43768177|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
43768217|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768218|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43673912|NCT01730027|Montelukast|montelukast|mesh-list
43580119|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
43580174|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43580221|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43580251|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768219|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43768222|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768223|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43580391|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43674116|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768225|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
43768226|NCT02396329|Povidone|povidone|mesh-list
43653252|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43768243|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768245|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
43580520|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43580521|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43580522|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43580523|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43580524|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
43580525|NCT02457221|Hormones|hormones|mesh-ancestor
43580530|NCT02186847|Metformin|metformin|mesh-list
43768247|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768248|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768249|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43768250|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
43580652|NCT03468231|Sorafenib|sorafenib|mesh-list
43674296|NCT00585507|Fulvestrant|fulvestrant|mesh-list
43768251|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43674401|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43674402|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768253|NCT02396108|Carboplatin|carboplatin|mesh-list
43768254|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43768255|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768256|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674558|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
43768258|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768259|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43581068|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43581071|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43674608|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43674609|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43674614|NCT02891967|Z 350|z 350|mesh-list
43674660|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43674661|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674662|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
43674663|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653281|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
43581267|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43838051|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838052|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838053|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43674712|NCT02890823|Vitamins|vitamins|mesh-ancestor
43674719|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838056|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838057|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43674879|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43674880|NCT02889367|Odalasvir|odalasvir|mesh-list
43581668|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838059|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43674942|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43838060|NCT04872608|Letrozole|letrozole|mesh-list
43838061|NCT04872608|Palbociclib|palbociclib|mesh-list
43581949|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
43581988|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
43582113|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582115|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
43582202|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
43675154|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
43675248|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43675249|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43675250|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675251|NCT02885441|Ketorolac|ketorolac|mesh-list
43675253|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653292|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
43838063|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838064|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43838065|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43838066|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43582309|NCT02194595|Hormones|hormones|mesh-ancestor
43582311|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
43675446|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43675447|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43675448|NCT02884115|Penicillins|penicillins|mesh-list
43675449|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43675450|NCT02884115|Penicillin G|penicillin g|mesh-list
43838067|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582523|NCT03448835|Capecitabine|capecitabine|mesh-list
43582586|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
43582589|NCT03447925|Analgesics|analgesics|mesh-ancestor
43582649|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43838068|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43838069|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
43582688|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43582694|NCT03446872|Antidotes|antidotes|mesh-ancestor
43582872|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
43582887|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
43675831|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43675833|NCT02881125|Paclitaxel|paclitaxel|mesh-list
43582953|NCT03443843|Xhance|xhance|mesh-list
43675964|NCT02879435|Bupivacaine|bupivacaine|mesh-list
43838070|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838071|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838072|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43583009|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43676219|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
43583144|NCT03441412|Epinephrine|epinephrine|mesh-list
43676253|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838073|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43583288|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
43768295|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
43768296|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43768297|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43780095|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
43780096|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780097|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780098|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
43780099|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780100|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43780101|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43780102|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780103|NCT05072054|Atorvastatin|atorvastatin|mesh-list
43676471|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43676472|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43768298|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
43768299|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768300|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43768301|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768333|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768334|NCT02395458|Amoxicillin|amoxicillin|mesh-list
43768335|NCT02395458|Metronidazole|metronidazole|mesh-list
43676588|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
43768338|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43768339|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768340|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43583571|NCT03436225|Dexamethasone|dexamethasone|mesh-list
43676604|NCT02874989|Quercetin|quercetin|mesh-list
43583935|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
43676815|NCT02872818|Hormones|hormones|mesh-ancestor
43676816|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43584033|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43676827|NCT02873026|Triamcinolone|triamcinolone|mesh-list
43584129|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43584130|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584131|NCT03431909|Aspirin|aspirin|mesh-list
43584132|NCT03431909|Kallikreins|kallikreins|mesh-list
43584133|NCT03431909|Clopidogrel|clopidogrel|mesh-list
43584134|NCT03431909|Atorvastatin|atorvastatin|mesh-list
43584135|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43584136|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43768353|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43651895|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824644|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43824645|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824646|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824648|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43584202|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
43584257|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43824649|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824650|NCT05509569|Analgesics|analgesics|mesh-ancestor
43768354|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43768355|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43584430|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43677111|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
43584540|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584597|NCT03427437|Bupivacaine|bupivacaine|mesh-list
43768356|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768357|NCT02395510|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43780154|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43768358|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43768359|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768360|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768361|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768362|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
43768363|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43768364|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43584830|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
43584831|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768365|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43768392|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768393|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768394|NCT02395016|Antiviral Agents|antiviral agents|mesh-ancestor
43768395|NCT02395016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768396|NCT02395016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768397|NCT02395016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768398|NCT02395016|Immunologic Factors|immunologic factors|mesh-ancestor
43768399|NCT02395016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43584910|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584912|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
43584913|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43584914|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43584915|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43584917|NCT03425162|Bupivacaine|bupivacaine|mesh-list
43584918|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
43584919|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
43768400|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43768401|NCT02394821|Metronidazole|metronidazole|mesh-list
43768402|NCT02394821|Polihexanide|polihexanide|mesh-list
43768403|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768404|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43768405|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43768406|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43768407|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
43768408|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43768409|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43780185|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43780186|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780187|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780188|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780189|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43780190|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780191|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43768410|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768411|NCT02394652|Metformin|metformin|mesh-list
43768412|NCT02394652|Cisplatin|cisplatin|mesh-list
43768413|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43768414|NCT02394652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43573579|NCT03526042|Losartan|losartan|mesh-list
43585016|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43677502|NCT02867800|Analgesics|analgesics|mesh-ancestor
43768415|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768446|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768447|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768448|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
43585203|NCT03422887|Narcotics|narcotics|mesh-ancestor
43677693|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
43768449|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
43768452|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
43768453|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768454|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43768455|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43768456|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43651896|NCT03004625|Ribavirin|ribavirin|mesh-list
43651897|NCT03004625|Asunaprevir|asunaprevir|mesh-list
43651899|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651900|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
43838075|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43838076|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
43838077|NCT04872595|Melphalan|melphalan|mesh-list
43838078|NCT04872595|Busulfan|busulfan|mesh-list
43838079|NCT04872595|Thiotepa|thiotepa|mesh-list
43838080|NCT04872595|Fludarabine|fludarabine|mesh-list
43838081|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838082|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
43838083|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838084|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838085|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838086|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
43838087|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780217|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780218|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780219|NCT04858711|Lidocaine|lidocaine|mesh-list
43780220|NCT04858711|Fentanyl|fentanyl|mesh-list
43780221|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
43780222|NCT04858711|Ketamine|ketamine|mesh-list
43780223|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
43780224|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
43780225|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780226|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780227|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
43780228|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780229|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43780230|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43780231|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43838088|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838089|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43838090|NCT04872582|Bevacizumab|bevacizumab|mesh-list
43838091|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43585629|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43585633|NCT03419858|Naloxone|naloxone|mesh-list
43838092|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838093|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838094|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43838095|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43838096|NCT04872582|Growth Substances|growth substances|mesh-ancestor
43838097|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838121|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838122|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43838123|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
43838124|NCT04869488|Prednisone|prednisone|mesh-list
43838125|NCT04869488|Apatinib|apatinib|mesh-list
43838126|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
43838127|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838128|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
43838129|NCT04869488|Hormones|hormones|mesh-ancestor
43838130|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838131|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43677990|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
43838133|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838134|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838135|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838136|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838137|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43838140|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43838141|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
43838142|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838143|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
43838144|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43838145|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
43838146|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838147|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
43838148|NCT04869306|Protective Agents|protective agents|mesh-ancestor
43768501|NCT02394106|Ofatumumab|ofatumumab|mesh-list
43768502|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768532|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768533|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768534|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43768535|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43768536|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43768537|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768538|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768539|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43768540|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768541|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
43768542|NCT02393898|Paclitaxel|paclitaxel|mesh-list
43768543|NCT02393898|Bevacizumab|bevacizumab|mesh-list
43768544|NCT02393898|Carboplatin|carboplatin|mesh-list
43768545|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43768546|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768576|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
43768577|NCT02393963|Coagulants|coagulants|mesh-ancestor
43768578|NCT02393664|Bupivacaine|bupivacaine|mesh-list
43768579|NCT02393664|Propofol|propofol|mesh-list
43768580|NCT02393664|Sevoflurane|sevoflurane|mesh-list
43768581|NCT02393664|Rocuronium|rocuronium|mesh-list
43768582|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
43768583|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
43768584|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678061|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43768587|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768589|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43768590|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
43780248|NCT04858711|Narcotics|narcotics|mesh-ancestor
43780249|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43780250|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43780251|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
43780252|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768591|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43768592|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43586021|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43651906|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43651907|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651908|NCT03004612|Incretins|incretins|mesh-ancestor
43651909|NCT03004612|Hormones|hormones|mesh-ancestor
43651910|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651911|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43768663|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768664|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
43768665|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43768666|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43768667|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768692|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43768693|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
43768694|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
43768695|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
43768696|NCT02393144|Meperidine|meperidine|mesh-list
43768697|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
43768698|NCT02393144|Analgesics|analgesics|mesh-list
43768699|NCT02393144|Oxytocin|oxytocin|mesh-list
43768700|NCT02393144|Dinoprostone|dinoprostone|mesh-list
43768701|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
43768702|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768703|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768705|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43768706|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
43768707|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43768708|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43768709|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43768710|NCT02392910|Hematinics|hematinics|mesh-ancestor
43768711|NCT02392845|Docetaxel|docetaxel|mesh-list
43768712|NCT02392845|Epirubicin|epirubicin|mesh-list
43768713|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768714|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768715|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
43768716|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
43768717|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768718|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43768719|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43768720|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43768758|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839307|NCT04786964|Hematinics|hematinics|mesh-ancestor
43768778|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
43768779|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43768780|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43768781|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43768782|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
43586114|NCT03414450|Dasatinib|dasatinib|mesh-list
43768783|NCT02392520|Cetrorelix|cetrorelix|mesh-list
43768784|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43768785|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
43768786|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43768787|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768788|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
43768789|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768790|NCT02392702|Ivacaftor|ivacaftor|mesh-list
43768791|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43678238|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43768792|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43768793|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768794|NCT02392468|BI 409306|bi 409306|mesh-list
43768795|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43651913|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651914|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768796|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768797|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848158|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
43848159|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768799|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43768800|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43768801|NCT02392364|Growth Substances|growth substances|mesh-ancestor
43768802|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768803|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
43586256|NCT03412721|Analgesics|analgesics|mesh-list
43678421|NCT02861690|Paclitaxel|paclitaxel|mesh-list
43768804|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768805|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43768806|NCT02392676|Olaparib|olaparib|mesh-list
43768807|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848160|NCT04046094|Protective Agents|protective agents|mesh-ancestor
43848161|NCT04044859|Nivolumab|nivolumab|mesh-list
43848162|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848163|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848164|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848165|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780275|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780277|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43780278|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780279|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43780280|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43780283|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768808|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768809|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768810|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768811|NCT02392117|Insulin|insulin|mesh-list
43768812|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43768814|NCT02392039|Loratadine|loratadine|mesh-list
43586330|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43586331|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768815|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
43768816|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
43768817|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43768818|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43768819|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43768820|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
43768821|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
43768822|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43768823|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768824|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768825|NCT02392130|Clobetasol|clobetasol|mesh-list
43768826|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43768827|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
43768828|NCT02392130|Hormones|hormones|mesh-ancestor
43768829|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43768857|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768858|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768860|NCT02391805|Entecavir|entecavir|mesh-list
43768861|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
43768862|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768863|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43768864|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43768865|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768866|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768867|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43768868|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43768869|NCT02391662|Gemcitabine|gemcitabine|mesh-list
43768870|NCT02391662|Paclitaxel|paclitaxel|mesh-list
43768871|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43768872|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43768873|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43768874|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
43768910|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43768911|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43768912|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43768913|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43768915|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
43768949|NCT02391181|Hematinics|hematinics|mesh-ancestor
43768950|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43768951|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
43768952|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
43768953|NCT02391077|Povidone|povidone|mesh-list
43768954|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768955|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43768986|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43768987|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
43768988|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651916|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
43780289|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
43780290|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780291|NCT05392374|TIC10 compound|tic10 compound|mesh-list
43780292|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780293|NCT05392257|Rituximab|rituximab|mesh-list
43780294|NCT05392257|Lenalidomide|lenalidomide|mesh-list
43780295|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
43780296|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780297|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780323|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43651917|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43651918|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43651919|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43651920|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651921|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651922|NCT03004105|Durvalumab|durvalumab|mesh-list
43651923|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43651924|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43651925|NCT03004339|Betamethasone|betamethasone|mesh-list
43651926|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
43651927|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43651928|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
43651929|NCT03004339|Calcipotriene|calcipotriene|mesh-list
43651930|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43651931|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43651932|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
43651933|NCT03004339|Hormones|hormones|mesh-ancestor
43768989|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
43768990|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43768991|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43678565|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43768992|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43768993|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
43768994|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
43780324|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780325|NCT05391789|Urinastatin|urinastatin|mesh-list
43780326|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43780338|NCT05386784|Vitamin D|vitamin d|mesh-list
43768995|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43768996|NCT02390674|Cyclosporine|cyclosporine|mesh-list
43768997|NCT02390674|Cyclosporins|cyclosporins|mesh-list
43769035|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769037|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43586787|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769038|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43769039|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43769040|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
43769041|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769042|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43651934|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43651935|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651936|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651937|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
43651938|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651939|NCT03004066|Daptomycin|daptomycin|mesh-list
43651940|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43651941|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651942|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43651943|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43651944|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43651945|NCT03004222|Bupivacaine|bupivacaine|mesh-list
43651946|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
43651947|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
43651948|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651949|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651950|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
43780389|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780390|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
43780391|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780392|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
43780393|NCT05338931|Gossypol|gossypol|mesh-list
43780394|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43780395|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780396|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43780397|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
43780398|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43780399|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780418|NCT05318157|Budesonide|budesonide|mesh-list
43780419|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43780420|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43780421|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780422|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43780423|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
43780424|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780425|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780426|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43651951|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651952|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
43587079|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43769044|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43769045|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43769046|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
43769047|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43769048|NCT02390544|Melphalan|melphalan|mesh-list
43769049|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769050|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
43769051|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769052|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769053|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43587180|NCT03396861|Aflibercept|aflibercept|mesh-list
43769054|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769055|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
43769087|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769088|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769089|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43769090|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769092|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43769120|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43587222|NCT03396393|Artenimol|artenimol|mesh-list
43769122|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769123|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43769124|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769125|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769128|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43769129|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43769130|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769131|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
43769132|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43769133|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43769134|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769135|NCT02389868|Lovastatin|lovastatin|mesh-list
43651953|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43651954|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651955|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
43651956|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
43651957|NCT03004209|Hematinics|hematinics|mesh-ancestor
43651958|NCT03004261|Ganciclovir|ganciclovir|mesh-list
43651959|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43651960|NCT03004261|Foscarnet|foscarnet|mesh-list
43651961|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
43780427|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
43780428|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
43651962|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43827944|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43769167|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769168|NCT02389400|Methotrexate|methotrexate|mesh-list
43769204|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
43769205|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43769206|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
43769209|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769239|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769240|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769241|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43769242|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
43769243|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769244|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769245|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43678834|NCT02857946|Hormones|hormones|mesh-ancestor
43769246|NCT02388581|Amoxicillin|amoxicillin|mesh-list
43769247|NCT02388581|Metronidazole|metronidazole|mesh-list
43769248|NCT02388581|Clarithromycin|clarithromycin|mesh-list
43769249|NCT02388581|Lansoprazole|lansoprazole|mesh-list
43651963|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43651965|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651966|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43651968|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43651969|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678866|NCT02857842|Hormones|hormones|mesh-ancestor
43651971|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43651972|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
43651973|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
43769250|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
43769251|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769252|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769253|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838180|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838182|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838183|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43678877|NCT02857582|Metronidazole|metronidazole|mesh-list
43838184|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
43838185|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838186|NCT04863716|Fentanyl|fentanyl|mesh-list
43838187|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43838188|NCT04863716|Narcotics|narcotics|mesh-ancestor
43838189|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43678975|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43587719|NCT03393507|Apatinib|apatinib|mesh-list
43838190|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838191|NCT04863716|Analgesics|analgesics|mesh-ancestor
43838192|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
43838193|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838194|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43838195|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43838196|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
43838197|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
43587774|NCT03393273|Elotuzumab|elotuzumab|mesh-list
43847989|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847990|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43847991|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43847993|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847994|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769287|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769288|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43769289|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
43769290|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769292|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43769293|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43769294|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769295|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
43769296|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769297|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769298|NCT02388048|Ofatumumab|ofatumumab|mesh-list
43769299|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769322|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780443|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780444|NCT05199753|Antibodies|antibodies|mesh-list
43780445|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
43780446|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780447|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
43780448|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43780450|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43769323|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43769324|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769325|NCT02387918|Dexamethasone|dexamethasone|mesh-list
43769326|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769327|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
43769328|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
43769329|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651976|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651977|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651978|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43769331|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769334|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769335|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769336|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769337|NCT02387619|Amlodipine|amlodipine|mesh-list
43769338|NCT02387619|Telmisartan|telmisartan|mesh-list
43769339|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
43769340|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43769341|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43769342|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43769343|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769345|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43769346|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769347|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
43769348|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43769363|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769364|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769365|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
43769366|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769367|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43769368|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43769369|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43769370|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769371|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769372|NCT02387242|Rifampin|rifampin|mesh-list
43769373|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43769374|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
43769375|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769402|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769403|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769405|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43769406|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780465|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
43780466|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
43769407|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769408|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43769409|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43651979|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
43651980|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
43651981|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
43651982|NCT03003832|Analgesics|analgesics|mesh-list
43651983|NCT03003832|Narcotics|narcotics|mesh-ancestor
43651984|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43651985|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43651986|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
43769410|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769411|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
43769412|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769413|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
43769414|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
43769415|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43588283|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
43769416|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769417|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43769418|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43769420|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
43769439|NCT02387060|Narcotics|narcotics|mesh-ancestor
43769440|NCT02387060|Analgesics|analgesics|mesh-ancestor
43769441|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43769442|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43769443|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
43769444|NCT02387021|Ropivacaine|ropivacaine|mesh-list
43769445|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
43769446|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
43769447|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769448|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769449|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
43769450|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780515|NCT04751994|Sorbitol|sorbitol|mesh-list
43769451|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43769452|NCT02386943|Saxagliptin|saxagliptin|mesh-list
43769453|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43588392|NCT03388346|Edetic Acid|edetic acid|mesh-list
43769454|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769455|NCT02386943|Incretins|incretins|mesh-ancestor
43769456|NCT02386943|Hormones|hormones|mesh-ancestor
43769457|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769458|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43769459|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
43769460|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769461|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769462|NCT02386735|Prednisone|prednisone|mesh-list
43769463|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769464|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
43769465|NCT02386735|Hormones|hormones|mesh-ancestor
43769466|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769467|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769468|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769469|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838198|NCT04860505|Doxycycline|doxycycline|mesh-list
43838199|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838200|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838201|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
43838202|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838203|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43838204|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
43838205|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43588465|NCT03387644|Pregabalin|pregabalin|mesh-list
43838206|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
43838207|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
43838208|NCT04859946|Busulfan|busulfan|mesh-list
43769471|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769472|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
43769473|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769474|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43769475|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43769476|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769477|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769478|NCT02386397|Gemcitabine|gemcitabine|mesh-list
43769479|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
43651987|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43651988|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
43651989|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43651990|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43651991|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43651992|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
43587267|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653335|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653336|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653337|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43653338|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653340|NCT02985242|Glimepiride|glimepiride|mesh-list
43653341|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43651993|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
43651995|NCT03003728|Elotuzumab|elotuzumab|mesh-list
43651996|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43651997|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
43651998|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43651999|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652000|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43769480|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43769481|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
43769482|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769483|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769485|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769486|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769487|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588714|NCT03385967|Analgesics|analgesics|mesh-ancestor
43588826|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43588853|NCT03384862|Folic Acid|folic acid|mesh-list
43769489|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769490|NCT02386488|Vortioxetine|vortioxetine|mesh-list
43769491|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
43769492|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43769493|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43769494|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43588903|NCT03384238|Panitumumab|panitumumab|mesh-list
43589029|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
43589032|NCT03383302|Nivolumab|nivolumab|mesh-list
43769495|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43769496|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769497|NCT02386488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43769498|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43769499|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769500|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769501|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703529|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
43769502|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
43769503|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43769504|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43769505|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43589097|NCT03382886|Bevacizumab|bevacizumab|mesh-list
43769507|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
43769508|NCT02386462|Propofol|propofol|mesh-list
43769513|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
43769514|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
43769515|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769516|NCT02386462|Analgesics|analgesics|mesh-ancestor
43769517|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
43769518|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769519|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43769520|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43769521|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769553|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43769554|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43679586|NCT02852382|Morphine|morphine|mesh-list
43769555|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769557|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769558|NCT02386475|Dexetimide|dexetimide|mesh-list
43769559|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43769560|NCT02386475|Citalopram|citalopram|mesh-list
43652001|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652002|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
43652003|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652004|NCT03003637|Nivolumab|nivolumab|mesh-list
43652005|NCT03003637|Ipilimumab|ipilimumab|mesh-list
43652006|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652007|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652008|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43652009|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652010|NCT03003611|Anesthetics|anesthetics|mesh-list
43652011|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780530|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43780531|NCT04655586|Heparin|heparin|mesh-list
43780532|NCT04655586|Protein C|protein c|mesh-list
43653342|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652012|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43679591|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653343|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653344|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653345|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652013|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43769561|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43769562|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43769563|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43769564|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769565|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769566|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
43769567|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769590|NCT02386111|Growth Substances|growth substances|mesh-ancestor
43769591|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769592|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
43769593|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43589567|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769595|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769596|NCT02386033|Atorvastatin|atorvastatin|mesh-list
43769597|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43769598|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43769599|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
43769600|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769601|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43769602|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43769603|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769604|NCT02386059|Dexamethasone|dexamethasone|mesh-list
43769605|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
43769606|NCT02386059|Ondansetron|ondansetron|mesh-list
43769607|NCT02386059|BB 1101|bb 1101|mesh-list
43769608|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769609|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
43769610|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
43769611|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769612|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769613|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43769614|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
43769615|NCT02386059|Hormones|hormones|mesh-ancestor
43769616|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769617|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43769618|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769619|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780557|NCT04551261|Ritonavir|ritonavir|mesh-list
43769620|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769647|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
43769648|NCT02385825|Vaccines|vaccines|mesh-list
43679743|NCT05382481|Dalteparin|dalteparin|mesh-list
43769649|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
43769650|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769652|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43769653|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769654|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43652014|NCT03003273|Amoxicillin|amoxicillin|mesh-list
43652015|NCT03003273|Levofloxacin|levofloxacin|mesh-list
43652017|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
43652018|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
43652019|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43589931|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652020|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43652021|NCT03003273|Renal Agents|renal agents|mesh-ancestor
43652022|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652023|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43652024|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43589996|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652025|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652026|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652027|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43652028|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43652029|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43652030|NCT03003416|Dexamethasone|dexamethasone|mesh-list
43652031|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769655|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43769656|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43769657|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769658|NCT02385617|Octreotide|octreotide|mesh-list
43769659|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43590317|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
43769660|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43590391|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
43769662|NCT02385734|Mitogens|mitogens|mesh-list
43769663|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780632|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780633|NCT04167111|Vitamin D|vitamin d|mesh-list
43780635|NCT04167111|Vitamins|vitamins|mesh-ancestor
43769664|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769665|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43780658|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43769666|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
43848006|NCT04061239|Daunorubicin|daunorubicin|mesh-list
43769667|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43680010|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769768|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769770|NCT02385058|Piperazine|piperazine|mesh-list
43769771|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
43769772|NCT02385058|DMP 777|dmp 777|mesh-list
43769773|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
43769774|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
43769775|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43769776|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769777|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
43769778|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
43769779|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
43769815|NCT02385188|Emollients|emollients|mesh-ancestor
43769816|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769817|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43652032|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
43652033|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
43652034|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652035|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652036|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652037|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
43769818|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43838241|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43780659|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838242|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43838243|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838245|NCT04858269|Carboplatin|carboplatin|mesh-list
43838246|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
43838247|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838248|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838249|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
43838250|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
43838251|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838252|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838253|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838255|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43838256|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43839444|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839445|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
43680351|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
43575178|NCT03509662|Vitamins|vitamins|mesh-ancestor
43769831|NCT02384915|Prilocaine|prilocaine|mesh-list
43769832|NCT02384915|Mepivacaine|mepivacaine|mesh-list
43769833|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
43769834|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43680394|NCT05052541|Hormones|hormones|mesh-ancestor
43769864|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
43591544|NCT03361319|Paclitaxel|paclitaxel|mesh-list
43769865|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43769866|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769867|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43769868|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43769869|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
43769871|NCT02384837|Sirolimus|sirolimus|mesh-list
43769872|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43769873|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43769874|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43769875|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43591900|NCT03358004|Vinorelbine|vinorelbine|mesh-list
43769876|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
43769877|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769878|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
43769879|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769880|NCT02384889|Eflornithine|eflornithine|mesh-list
43769881|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769914|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43769915|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
43592085|NCT03356444|Docetaxel|docetaxel|mesh-list
43592439|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43592654|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43652039|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652040|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652041|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43592861|NCT03349112|Lidocaine|lidocaine|mesh-list
43769946|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43769947|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
43769948|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43769949|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43769950|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43769951|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
43769952|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769953|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43769954|NCT02383823|Estradiol|estradiol|mesh-list
43769955|NCT02383823|Estrogens|estrogens|mesh-list
43769956|NCT02383823|Hormones|hormones|mesh-ancestor
43769976|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769977|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
43769979|NCT02383771|Ticagrelor|ticagrelor|mesh-list
43769980|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43769981|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43769982|NCT02383771|Analgesics|analgesics|mesh-ancestor
43780802|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43769983|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
43769984|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43769985|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769986|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43769987|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43769988|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43769989|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43769990|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769991|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43652049|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780803|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43780804|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780805|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
43780806|NCT03085771|Deferoxamine|deferoxamine|mesh-list
43780807|NCT03085771|Siderophores|siderophores|mesh-ancestor
43780808|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43780809|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
43780810|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
43780811|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780812|NCT03033446|Nivolumab|nivolumab|mesh-list
43780813|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780814|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824819|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
43824820|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
43824821|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824822|NCT05507697|Protective Agents|protective agents|mesh-ancestor
43824823|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824824|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
43824825|NCT05507697|Vitamins|vitamins|mesh-ancestor
43824826|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
43824827|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
43824828|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43652050|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
43652051|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652052|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652053|NCT03003039|Rituximab|rituximab|mesh-list
43769992|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43769994|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
43769995|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43769996|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43769997|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43769998|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
43769999|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770000|NCT02383563|Metformin|metformin|mesh-list
43770001|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770002|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770003|NCT02383121|Midodrine|midodrine|mesh-list
43770004|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
43770005|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
43770006|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770007|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770008|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43770009|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43770010|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43770011|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43770041|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770042|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770044|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770045|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770046|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43770047|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43770048|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770049|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770050|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838257|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
43838258|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43838259|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838260|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770069|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770070|NCT02382666|Rolapitant|rolapitant|mesh-list
43770071|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43770072|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770073|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770074|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770075|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43770076|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
43770077|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
43770078|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770079|NCT02382263|Gemcitabine|gemcitabine|mesh-list
43770080|NCT02382263|Paclitaxel|paclitaxel|mesh-list
43770081|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43770082|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43770083|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770084|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
43770085|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
43770086|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
43770143|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770145|NCT02382432|Narcotics|narcotics|mesh-ancestor
43770146|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43770148|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
43770149|NCT02382146|Ondansetron|ondansetron|mesh-list
43652055|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770166|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770167|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43770168|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
43770169|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43681028|NCT04260412|Psyllium|psyllium|mesh-list
43770170|NCT02382146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43593695|NCT03341429|Hormones|hormones|mesh-ancestor
43770171|NCT02382146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43770172|NCT02382146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770173|NCT02382146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43681109|NCT04166292|Lidocaine|lidocaine|mesh-list
43593795|NCT03340701|Progesterone|progesterone|mesh-list
43770174|NCT02382146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43770175|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
43770177|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
43593865|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
43593914|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770178|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770179|NCT02382068|Dexamethasone|dexamethasone|mesh-list
43770180|NCT02382068|Cisplatin|cisplatin|mesh-list
43770181|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770182|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
43594073|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43681210|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43770183|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
43770184|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770218|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770219|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43770222|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
43681300|NCT03741517|Edotreotide|edotreotide|mesh-list
43770224|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43594528|NCT03333018|Bromides|bromides|mesh-list
43838272|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838273|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838275|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43838276|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
43838277|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838279|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
43594878|NCT03329651|Metformin|metformin|mesh-list
43838280|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
43838281|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838282|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838283|NCT04854889|Decitabine|decitabine|mesh-list
43838284|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43595138|NCT03327506|Alprazolam|alprazolam|mesh-list
43838285|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
43838286|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838287|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838319|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43575666|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
43595354|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43595356|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43770253|NCT02381275|Tenofovir|tenofovir|mesh-list
43770254|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
43770255|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43595469|NCT03324776|Insulin|insulin|mesh-list
43681530|NCT03396926|Antibodies|antibodies|mesh-list
43770256|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43770257|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43770258|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770259|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780892|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780893|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770260|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43770261|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43770262|NCT02381184|Clomiphene|clomiphene|mesh-list
43770263|NCT02381184|Enclomiphene|enclomiphene|mesh-list
43770264|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
43770282|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43770283|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
43770285|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43770286|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770287|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770288|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43770289|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43770290|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43770291|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43770292|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43770293|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43770294|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43770296|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770297|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
43595766|NCT03322631|Tirzepatide|tirzepatide|mesh-list
43652056|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
43652058|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652060|NCT03002844|Carboplatin|carboplatin|mesh-list
43652061|NCT03002844|Pemetrexed|pemetrexed|mesh-list
43652062|NCT03002844|Gefitinib|gefitinib|mesh-list
43652063|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770299|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770300|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770302|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
43770303|NCT02381028|Emollients|emollients|mesh-list
43770304|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770305|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43770306|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
43770307|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770308|NCT02381145|Resveratrol|resveratrol|mesh-list
43770337|NCT02380898|Analgesics|analgesics|mesh-ancestor
43770338|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
43770339|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770340|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770341|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770342|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770343|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43770344|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770345|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770346|NCT02380755|Clomiphene|clomiphene|mesh-list
43770347|NCT02380755|Enclomiphene|enclomiphene|mesh-list
43770348|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
43770349|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43770350|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43770380|NCT02380625|Growth Substances|growth substances|mesh-ancestor
43596050|NCT03320447|Prilocaine|prilocaine|mesh-list
43596055|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
43770381|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770382|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
43770383|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43770384|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43770385|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43770387|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770388|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770389|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43770390|NCT02380521|Incretins|incretins|mesh-ancestor
43770391|NCT02380521|Hormones|hormones|mesh-ancestor
43770428|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770429|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770430|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43770432|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43770433|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43770434|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
43770435|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
43770436|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
43770437|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
43770438|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848026|NCT04060342|Gemcitabine|gemcitabine|mesh-list
43848028|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
43848029|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43848030|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848031|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848032|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
43848033|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
43848034|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770498|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770500|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
43770526|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770527|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770528|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770529|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770530|NCT02379676|Clopidogrel|clopidogrel|mesh-list
43770531|NCT02379676|Ticagrelor|ticagrelor|mesh-list
43770532|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43828430|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43770533|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43770534|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43770535|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43770536|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
43770537|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770538|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770539|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770541|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43770547|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43770548|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
43770549|NCT02379000|Hormones|hormones|mesh-ancestor
43780997|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
43780998|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43780999|NCT04631393|Narcotics|narcotics|mesh-ancestor
43781021|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43781022|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43781028|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770551|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770582|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
43770584|NCT02378740|Analgesics|analgesics|mesh-ancestor
43770585|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
43770586|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770587|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770588|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43770589|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43770590|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
43770591|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
43770592|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770594|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43770595|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770627|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43770628|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43770629|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
43770630|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770631|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43770632|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43770633|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770634|NCT02378532|Chloroquine|chloroquine|mesh-list
43770635|NCT02378532|Temozolomide|temozolomide|mesh-list
43770664|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43596406|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43596408|NCT03317847|Dexamethasone|dexamethasone|mesh-list
43770667|NCT02377856|Interferons|interferons|mesh-list
43770668|NCT02377856|Ribavirin|ribavirin|mesh-list
43770669|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
43770670|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
43770671|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43770672|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770673|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
43838359|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
43838360|NCT04844814|Prednisone|prednisone|mesh-list
43682005|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838365|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838366|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838367|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838368|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838369|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838370|NCT04844216|Lidocaine|lidocaine|mesh-list
43838371|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
43838372|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
43838373|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
43838374|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838375|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838376|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
43838377|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838378|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43824862|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
43781038|NCT04200534|Nicotine|nicotine|mesh-list
43781039|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43781040|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
43781041|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781042|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781043|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43781044|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43781045|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781046|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781047|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781048|NCT04028388|Docetaxel|docetaxel|mesh-list
43838379|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43838401|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43838403|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
43770679|NCT02377778|Thiopental|thiopental|mesh-list
43770680|NCT02377778|Propofol|propofol|mesh-list
43770681|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43770682|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770683|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770685|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
43770687|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
43770688|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
43770689|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
43770690|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43770691|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770692|NCT02377609|Tacrolimus|tacrolimus|mesh-list
43770693|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770694|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
43770695|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770696|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43770697|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770698|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770699|NCT02377648|Everolimus|everolimus|mesh-list
43770700|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770701|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770702|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
43770703|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770704|NCT02377635|Selenious Acid|selenious acid|mesh-list
43770705|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
43770706|NCT02377635|Trace Elements|trace elements|mesh-ancestor
43770707|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
43770708|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770709|NCT02377661|Amlodipine|amlodipine|mesh-list
43770710|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43770711|NCT02377661|Olmesartan|olmesartan|mesh-list
43770739|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770740|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770742|NCT02377193|Tacrolimus|tacrolimus|mesh-list
43770743|NCT02377193|Basiliximab|basiliximab|mesh-list
43770744|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770745|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
43770746|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770747|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43770748|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770749|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770750|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43770751|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770752|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43770792|NCT02376478|Infliximab|infliximab|mesh-list
43770793|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
43770794|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43770795|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
43770796|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43828460|NCT05476991|Aspirin|aspirin|mesh-list
43770797|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770819|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43770821|NCT02376595|Rocuronium|rocuronium|mesh-list
43770822|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
43770823|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43770824|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43770825|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43770826|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770827|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770828|NCT02376452|Leucovorin|leucovorin|mesh-list
43770829|NCT02376452|Fluorouracil|fluorouracil|mesh-list
43770830|NCT02376452|Raltitrexed|raltitrexed|mesh-list
43770831|NCT02376452|Irinotecan|irinotecan|mesh-list
43770832|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
43770833|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770834|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43770835|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770836|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43770837|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
43770838|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770839|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43770840|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43770841|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770842|NCT02376452|Antidotes|antidotes|mesh-ancestor
43770843|NCT02376452|Protective Agents|protective agents|mesh-ancestor
43770844|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
43770845|NCT02376452|Vitamins|vitamins|mesh-ancestor
43770846|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
43770847|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43770848|NCT02376413|Trastuzumab|trastuzumab|mesh-list
43770849|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43770850|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43770851|NCT02376309|Nandrolone|nandrolone|mesh-list
43770852|NCT02376309|Androgens|androgens|mesh-ancestor
43770853|NCT02376309|Hormones|hormones|mesh-ancestor
43770869|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
43770870|NCT02376192|Ephedrine|ephedrine|mesh-list
43770871|NCT02376192|Bupivacaine|bupivacaine|mesh-list
43770872|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
43770873|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
43770874|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43770875|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770911|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
43770912|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770913|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43770914|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
43770935|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
43781080|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770937|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770939|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43770940|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43770941|NCT02376335|Rituximab|rituximab|mesh-list
43770975|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43770977|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43770978|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652065|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
43652066|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652067|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
43652068|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652069|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652070|NCT03002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652071|NCT03002844|Immunologic Factors|immunologic factors|mesh-ancestor
43597032|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
43770979|NCT02375646|Heparin|heparin|mesh-list
43770980|NCT02375646|Enoxaparin|enoxaparin|mesh-list
43770981|NCT02375646|Warfarin|warfarin|mesh-list
43597094|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
43597241|NCT03310593|Cannabidiol|cannabidiol|mesh-list
43770982|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
43770983|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43771018|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771019|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43771048|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43771049|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43771050|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
43771051|NCT02375178|Biguanides|biguanides|mesh-list
43771052|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
43771053|NCT02375178|Polihexanide|polihexanide|mesh-list
43771054|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43771055|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771056|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
43682353|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
43771057|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771058|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771059|NCT02375100|Acetaminophen|acetaminophen|mesh-list
43771060|NCT02375100|Tramadol|tramadol|mesh-list
43771061|NCT02375100|Analgesics|analgesics|mesh-list
43771062|NCT02375100|Bupivacaine|bupivacaine|mesh-list
43771063|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771064|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
43771065|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771066|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771067|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
43771068|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771106|NCT02374320|Bupivacaine|bupivacaine|mesh-list
43771107|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771109|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43771170|NCT02374567|Flupenthixol|flupenthixol|mesh-list
43771171|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43771172|NCT02374567|Perphenazine|perphenazine|mesh-list
43771173|NCT02374567|Sertindole|sertindole|mesh-list
43771174|NCT02374567|Fluphenazine|fluphenazine|mesh-list
43781134|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43824863|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824864|NCT05507372|Pimozide|pimozide|mesh-list
43824865|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43771175|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
43771176|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
43771177|NCT02374567|Sulpiride|sulpiride|mesh-list
43771178|NCT02374567|Thioridazine|thioridazine|mesh-list
43771179|NCT02374567|Pipamperone|pipamperone|mesh-list
43682523|NCT02847442|Opicapone|opicapone|mesh-list
43597740|NCT03305978|Ivermectin|ivermectin|mesh-list
43682573|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43597876|NCT03303677|Vancomycin|vancomycin|mesh-list
43771180|NCT02374567|Clopenthixol|clopenthixol|mesh-list
43771181|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
43771182|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
43771183|NCT02374567|Fluspirilene|fluspirilene|mesh-list
43771185|NCT02374567|Bromperidol|bromperidol|mesh-list
43682681|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
43771186|NCT02374567|Benperidol|benperidol|mesh-list
43771187|NCT02374567|Rivastigmine|rivastigmine|mesh-list
43771188|NCT02374567|Piracetam|piracetam|mesh-list
43771189|NCT02374567|Donepezil|donepezil|mesh-list
43771190|NCT02374567|Galantamine|galantamine|mesh-list
43771191|NCT02374567|Citalopram|citalopram|mesh-list
43771192|NCT02374567|Bupropion|bupropion|mesh-list
43771193|NCT02374567|Sertraline|sertraline|mesh-list
43682809|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
43771194|NCT02374567|Fluoxetine|fluoxetine|mesh-list
43771195|NCT02374567|Paroxetine|paroxetine|mesh-list
43771196|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43771197|NCT02374567|Nortriptyline|nortriptyline|mesh-list
43771198|NCT02374567|Reboxetine|reboxetine|mesh-list
43771199|NCT02374567|Imipramine|imipramine|mesh-list
43683302|NCT04475848|Midazolam|midazolam|mesh-list
43771200|NCT02374567|Clomipramine|clomipramine|mesh-list
43627932|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
43771202|NCT02374567|Moclobemide|moclobemide|mesh-list
43628057|NCT03069339|Carvedilol|carvedilol|mesh-list
43628116|NCT03069248|Interferons|interferons|mesh-list
43628189|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43628344|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43628345|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
43683550|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
43683552|NCT02721342|Ramipril|ramipril|mesh-list
43652072|NCT03002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652073|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43652074|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43652075|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43683675|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
43771203|NCT02374567|Opipramol|opipramol|mesh-list
43771204|NCT02374567|Trimipramine|trimipramine|mesh-list
43771205|NCT02374567|Maprotiline|maprotiline|mesh-list
43771206|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
43771207|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43771238|NCT02374567|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43771239|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43771240|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43771241|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
43628930|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43628931|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43628950|NCT03063359|Fentanyl|fentanyl|mesh-list
43771242|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43771243|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43771244|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
43771245|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
43771246|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43771247|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43771248|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
43771250|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771275|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43781157|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781158|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43771276|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43771277|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43771278|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43771279|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
43771280|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43771281|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43771282|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43629288|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
43629360|NCT03059888|Abatacept|abatacept|mesh-list
43629539|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
43683938|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771283|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43629652|NCT03058536|Hormones|hormones|mesh-ancestor
43629709|NCT03058094|Cisplatin|cisplatin|mesh-list
43771284|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43771285|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43771286|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43771287|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43771288|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43771289|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43771290|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
43771291|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43684037|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771452|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771453|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43771454|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
43771455|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
43771457|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
43630018|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
43771458|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771459|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771460|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771494|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771495|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771498|NCT02373163|Telmisartan|telmisartan|mesh-list
43771499|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43771500|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43771501|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43771502|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771503|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43771504|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771505|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
43824654|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824656|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43824657|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43824658|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824659|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43824660|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824661|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
43824662|NCT05509478|Lenvatinib|lenvatinib|mesh-list
43824663|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43781174|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
43824664|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630064|NCT03055507|Ibuprofen|ibuprofen|mesh-list
43771520|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
43771521|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771522|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43771523|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43771524|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43771525|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771526|NCT02372903|Hormones|hormones|mesh-ancestor
43684191|NCT00132717|L 647318|l 647318|mesh-list
43771527|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771529|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43771530|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43684222|NCT00095017|Analgesics|analgesics|mesh-ancestor
43771531|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771532|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771533|NCT02372916|Ranibizumab|ranibizumab|mesh-list
43771534|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43771535|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43771536|NCT02372916|Growth Substances|growth substances|mesh-ancestor
43771537|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771538|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
43771539|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630309|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
43838439|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43838454|NCT04840823|Enoxacin|enoxacin|mesh-list
43838455|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838456|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838457|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43684273|NCT00092768|Celecoxib|celecoxib|mesh-list
43838459|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838460|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838461|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838462|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43838463|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43838464|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
43838465|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43838466|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
43684296|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652082|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43652083|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652085|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652086|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838467|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838468|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
43838469|NCT04839692|Protective Agents|protective agents|mesh-ancestor
43838470|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43838471|NCT04839185|Hematinics|hematinics|mesh-ancestor
43838472|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43838473|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43838474|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
43838475|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43838476|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838477|NCT04838288|Tacrolimus|tacrolimus|mesh-list
43838478|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838479|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
43838480|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838481|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43838482|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838483|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838484|NCT04837924|Acetaminophen|acetaminophen|mesh-list
43838485|NCT04837924|Tramadol|tramadol|mesh-list
43838486|NCT04837924|Analgesics|analgesics|mesh-list
43838487|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
43838489|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
43838490|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838491|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771540|NCT02372526|Orlistat|orlistat|mesh-list
43771541|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43630526|NCT03051503|Fentanyl|fentanyl|mesh-list
43771542|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771543|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43771544|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771545|NCT02372656|Metformin|metformin|mesh-list
43771546|NCT02372656|Simvastatin|simvastatin|mesh-list
43771547|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43771548|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771549|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43771581|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771582|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
43771583|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43771584|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43771585|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771586|NCT02372487|Urological Agents|urological agents|mesh-ancestor
43771588|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43771589|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43771590|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
43771591|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771704|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43771705|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
43771707|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
43771708|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43771709|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
43771710|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771711|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652088|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
43839481|NCT04770623|Irinotecan|irinotecan|mesh-list
43652089|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652091|NCT03002805|Doxorubicin|doxorubicin|mesh-list
43652092|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43652093|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43684529|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43684591|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
43652094|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652095|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43652096|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652097|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771712|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771713|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
43771714|NCT02371577|Lenalidomide|lenalidomide|mesh-list
43771715|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
43771716|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771803|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
43771804|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771805|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43630821|NCT03049345|Methylene Blue|methylene blue|mesh-list
43771806|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43771807|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
43771808|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630927|NCT03047772|Atorvastatin|atorvastatin|mesh-list
43771832|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43771833|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43771834|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771892|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771894|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43771895|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43630949|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631004|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43631006|NCT03047057|Lidocaine|lidocaine|mesh-list
43631100|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43631179|NCT03045471|Rituximab|rituximab|mesh-list
43771896|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43771897|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
43771898|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652099|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
43652100|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652101|NCT03002935|Vitamins|vitamins|mesh-ancestor
43652102|NCT03002792|Anesthetics|anesthetics|mesh-list
43652103|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652104|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652105|NCT03002675|Exenatide|exenatide|mesh-list
43631255|NCT03045133|Methadone|methadone|mesh-list
43652110|NCT03002675|Hormones|hormones|mesh-ancestor
43685204|NCT02837614|Hormones|hormones|mesh-ancestor
43771920|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43771921|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43771922|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
43771923|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771960|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43631406|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
43685459|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43771983|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43771985|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
43771986|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771987|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771988|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43771989|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781242|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781243|NCT05086848|Antidotes|antidotes|mesh-ancestor
43771991|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43771992|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
43771993|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771995|NCT02369081|Doxazosin|doxazosin|mesh-list
43771996|NCT02369081|Spironolactone|spironolactone|mesh-list
43771997|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43771998|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
43685666|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771999|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772000|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772001|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43772003|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
43772004|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772005|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
43772006|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
43772007|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772008|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43772009|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43772010|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43772011|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772012|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653361|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43652111|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772013|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772014|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43838536|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
43838537|NCT04836780|Hormones|hormones|mesh-ancestor
43838538|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43577668|NCT03487562|Amoxicillin|amoxicillin|mesh-list
43772016|NCT02368860|Capecitabine|capecitabine|mesh-list
43772017|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
43772018|NCT02368860|Irinotecan|irinotecan|mesh-list
43772019|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43772020|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
43772021|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772022|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772023|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43772057|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43772058|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772059|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772060|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43772062|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
43772063|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772064|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43772082|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772083|NCT02368665|Amlodipine|amlodipine|mesh-list
43772084|NCT02368665|Candesartan|candesartan|mesh-list
43772085|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
43772086|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772087|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43653362|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
43653363|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653364|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43653365|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43653366|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653367|NCT02984930|Esomeprazole|esomeprazole|mesh-list
43772088|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772089|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772090|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43772091|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772092|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772093|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43772094|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43772095|NCT02368652|Amlodipine|amlodipine|mesh-list
43772096|NCT02368652|Candesartan|candesartan|mesh-list
43828751|NCT05472259|Vitamins|vitamins|mesh-ancestor
43772097|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
43772098|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772099|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43772100|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772101|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772102|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43772103|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772104|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772105|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43772106|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43772107|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
43686154|NCT02830789|Calcium|calcium|mesh-list
43686165|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43686167|NCT02831023|Artenimol|artenimol|mesh-list
43686365|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43652117|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
43652118|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772144|NCT02368054|Bupivacaine|bupivacaine|mesh-list
43772145|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
43772147|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
43772148|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772149|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772150|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
43772151|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772152|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772153|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43772154|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772155|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772156|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772157|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43772158|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43772159|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
43772160|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43772161|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
43772162|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
43772163|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
43772164|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43772165|NCT02368379|Metyrapone|metyrapone|mesh-list
43772166|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
43772197|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
43772207|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772208|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43772210|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
43772211|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772212|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43652119|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652120|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652121|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43652122|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43772249|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
43772250|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772251|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772252|NCT02367664|Vaccines|vaccines|mesh-list
43588120|NCT03390387|Dexamethasone|dexamethasone|mesh-list
43781255|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43781256|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
43781257|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781258|NCT05086081|Ticagrelor|ticagrelor|mesh-list
43772278|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
43772280|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43772281|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772282|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
43772283|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772284|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838559|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43686582|NCT02826759|Insulin|insulin|mesh-list
43838560|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838561|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
43838562|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838563|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838564|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43772316|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772317|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43772343|NCT02367118|Hormones|hormones|mesh-ancestor
43772344|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632025|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772345|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772346|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43772348|NCT02366949|Paclitaxel|paclitaxel|mesh-list
43772349|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43772350|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772351|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772352|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772354|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772356|NCT02366546|Fludarabine|fludarabine|mesh-list
43772357|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772358|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
43772359|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772360|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772361|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43772362|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
43772363|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772364|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772398|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652131|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
43652132|NCT03002545|Cathartics|cathartics|mesh-ancestor
43652133|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652134|NCT03002649|Tofacitinib|tofacitinib|mesh-list
43652135|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652136|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652137|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652138|NCT03002636|Anesthetics|anesthetics|mesh-list
43652139|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772407|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43772408|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772409|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
43772410|NCT02366299|Propofol|propofol|mesh-list
43772463|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43772464|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772465|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43772466|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772467|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772530|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772531|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
43772532|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43772533|NCT02365805|Paclitaxel|paclitaxel|mesh-list
43772534|NCT02365805|Docetaxel|docetaxel|mesh-list
43772535|NCT02365805|Cisplatin|cisplatin|mesh-list
43772536|NCT02365805|Fluorouracil|fluorouracil|mesh-list
43772537|NCT02365805|Epirubicin|epirubicin|mesh-list
43772538|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
43652140|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652141|NCT03002376|Cemiplimab|cemiplimab|mesh-list
43652142|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652143|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652144|NCT03002064|Cisplatin|cisplatin|mesh-list
43652145|NCT03002064|Docetaxel|docetaxel|mesh-list
43772576|NCT02365415|Sirolimus|sirolimus|mesh-list
43772577|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772578|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838579|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838580|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43652162|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43652163|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43652164|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43652165|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43652166|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
43652167|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652168|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652169|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652173|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652174|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43652176|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43652177|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652178|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43652179|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
43632076|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
43772646|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772647|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43686791|NCT02825199|Caffeine|caffeine|mesh-list
43632202|NCT03038516|Vitamins|vitamins|mesh-ancestor
43772648|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43772649|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772686|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772700|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772701|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
43772702|NCT02364453|Growth Substances|growth substances|mesh-ancestor
43772703|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772704|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772705|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772706|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772707|NCT02364206|Temozolomide|temozolomide|mesh-list
43772708|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43772709|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
43772710|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772711|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772712|NCT02364258|Atorvastatin|atorvastatin|mesh-list
43772713|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43772714|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43772715|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43772716|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
43781269|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43652180|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43687128|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652181|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652182|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652183|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43652184|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43652185|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43652186|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
43652187|NCT03001609|Abivertinib|abivertinib|mesh-list
43652188|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652189|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652190|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652191|NCT03001661|Dinoprostone|dinoprostone|mesh-list
43652192|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
43652193|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652194|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652195|NCT03001635|Oxytocin|oxytocin|mesh-list
43652196|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
43652197|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652198|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652199|NCT03001570|Cetuximab|cetuximab|mesh-list
43652200|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652201|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652202|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43652203|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43652204|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43772717|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772718|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43772719|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43772720|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772721|NCT02364362|Docetaxel|docetaxel|mesh-list
43772722|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772723|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43772724|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43772725|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
43772726|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772727|NCT02364089|Epinephrine|epinephrine|mesh-list
43772728|NCT02364089|Racepinephrine|racepinephrine|mesh-list
43772729|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
43772730|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43772731|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43772732|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772733|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772734|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772735|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772736|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43772737|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43772738|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
43828949|NCT05459194|Hormones|hormones|mesh-ancestor
43772739|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652205|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43652206|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652207|NCT03001349|Octreotide|octreotide|mesh-list
43652208|NCT03001349|Edotreotide|edotreotide|mesh-list
43652209|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652211|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652212|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652213|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43652214|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
43652215|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824666|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824667|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43687502|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43632965|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
43632966|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
43632967|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43632968|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43632969|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
43824668|NCT05509374|Dexamethasone|dexamethasone|mesh-list
43824669|NCT05509374|Pomalidomide|pomalidomide|mesh-list
43824670|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824671|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
43824672|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
43824673|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43633049|NCT05613179|Ibuprofen|ibuprofen|mesh-list
43824674|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824675|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824676|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
43772740|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43772741|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
43772742|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
43772743|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
43772744|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43772745|NCT02363985|Vitamin A|vitamin a|mesh-list
43772746|NCT02363985|Vitamins|vitamins|mesh-ancestor
43772758|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
43772759|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772760|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772761|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43772762|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43772763|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
43633120|NCT05612984|Vitamins|vitamins|mesh-ancestor
43772764|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772765|NCT02363699|Lidocaine|lidocaine|mesh-list
43772766|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
43772767|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
43633171|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
43772768|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772769|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772770|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
43772771|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772772|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43772773|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43772774|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43772775|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772776|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772777|NCT02363751|Bevacizumab|bevacizumab|mesh-list
43772786|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43772788|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43772789|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772790|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43772791|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772792|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
43772794|NCT02363452|Zidovudine|zidovudine|mesh-list
43772795|NCT02363452|Abacavir|abacavir|mesh-list
43772796|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
43772797|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43772798|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772799|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772800|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
43772801|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772802|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43772803|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43772804|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
43838595|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838596|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838597|NCT04833582|Antiviral Agents|antiviral agents|mesh-ancestor
43838598|NCT04833582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838599|NCT04833582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43688427|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
43772821|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43772822|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43772823|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
43772824|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
43772825|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772826|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
43772827|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772828|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43772829|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772830|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772831|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
43772832|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43772833|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43688620|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43688621|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
43688622|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43688623|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688624|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43688625|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43688626|NCT02810548|Mitogens|mitogens|mesh-list
43688627|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
43688628|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43688629|NCT02810275|Leucovorin|leucovorin|mesh-list
43633577|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43633627|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
43772834|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43772835|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43772836|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43772837|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772838|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
43772839|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772840|NCT02362906|Azithromycin|azithromycin|mesh-list
43653379|NCT02985086|Misoprostol|misoprostol|mesh-list
43653380|NCT02985086|Oxytocin|oxytocin|mesh-list
43653381|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
43772841|NCT02362906|Erythromycin|erythromycin|mesh-list
43772842|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
43772843|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43772844|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
43772845|NCT02362906|Cephalosporins|cephalosporins|mesh-list
43772846|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43772847|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772848|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43633657|NCT05699473|Vitamins|vitamins|mesh-ancestor
43688851|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43633830|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
43772849|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43633888|NCT05697185|Evolocumab|evolocumab|mesh-list
43772851|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772852|NCT02362958|Capecitabine|capecitabine|mesh-list
43772853|NCT02362958|Vinorelbine|vinorelbine|mesh-list
43772866|NCT02363127|Progestins|progestins|mesh-ancestor
43772867|NCT02363127|Hormones|hormones|mesh-ancestor
43772868|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772869|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772871|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
43772872|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43772873|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772874|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
43772875|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43772876|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43772877|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
43772878|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43772879|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772880|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43772881|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43772882|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43772883|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43772884|NCT02362711|Estrogens|estrogens|mesh-ancestor
43772885|NCT02362711|Hormones|hormones|mesh-ancestor
43772886|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772887|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43772888|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
43772889|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43772890|NCT02362516|BI 425809|bi 425809|mesh-list
43772891|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
43772892|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
43772893|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772894|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
43772895|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43772896|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43772897|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43772898|NCT02362399|Urological Agents|urological agents|mesh-ancestor
43772899|NCT02362529|Minocycline|minocycline|mesh-list
43772900|NCT02362529|Celecoxib|celecoxib|mesh-list
43772902|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772903|NCT02362529|Analgesics|analgesics|mesh-ancestor
43772904|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
43772905|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772906|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772907|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772908|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772920|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
43772921|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
43772922|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772923|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43634342|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772926|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
43634445|NCT05645705|Listerine|listerine|mesh-list
43652220|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
43652221|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43652222|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
43652223|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43652224|NCT03001102|Povidone|povidone|mesh-list
43652225|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652226|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
43652227|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
43652228|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
43652229|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
43652230|NCT03000946|Octreotide|octreotide|mesh-list
43652231|NCT03000946|Somatostatin|somatostatin|mesh-list
43652232|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772927|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772928|NCT02362308|Hormones|hormones|mesh-ancestor
43772929|NCT02362256|Clonidine|clonidine|mesh-list
43772930|NCT02362256|Naltrexone|naltrexone|mesh-list
43772931|NCT02362256|Lorazepam|lorazepam|mesh-list
43772932|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43772933|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43772934|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772935|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
43772936|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772937|NCT02362256|Analgesics|analgesics|mesh-ancestor
43772938|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43772939|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
43829151|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
43848964|NCT03976323|Carboplatin|carboplatin|mesh-list
43772940|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
43772941|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43772942|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43652233|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43689436|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
43652235|NCT03000946|Hormones|hormones|mesh-ancestor
43652236|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652237|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652238|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43652239|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
43652240|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652241|NCT03000660|Dexamethasone|dexamethasone|mesh-list
43652242|NCT03000660|Venetoclax|venetoclax|mesh-list
43652243|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652244|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
43652245|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
43839565|NCT04763252|Coal Tar|coal tar|mesh-list
43839566|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
43839567|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
43839568|NCT04762875|Plerixafor|plerixafor|mesh-list
43839569|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43839570|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43839571|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
43839572|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839573|NCT04761822|Vaccines|vaccines|mesh-list
43652246|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43578649|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
43772944|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43772945|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43772946|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772947|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
43772948|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
43772949|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772950|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43772951|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772952|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43772953|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43772954|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772955|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
43772956|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
43772957|NCT02362152|Diclofenac|diclofenac|mesh-list
43772958|NCT02362152|Fluorouracil|fluorouracil|mesh-list
43772959|NCT02362152|Imiquimod|imiquimod|mesh-list
43772960|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
43772961|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43772962|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43772963|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43772964|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43772966|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43772967|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43772968|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772969|NCT02362152|Analgesics|analgesics|mesh-ancestor
43772970|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
43772971|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43772972|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43772973|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43772974|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43772995|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43772996|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
43772998|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43772999|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773000|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43773001|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43773002|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43773003|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773004|NCT02362022|Morphine|morphine|mesh-list
43773005|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773006|NCT02362022|Narcotics|narcotics|mesh-ancestor
43773007|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773008|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773009|NCT02362022|Analgesics|analgesics|mesh-ancestor
43773010|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
43773011|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652247|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652248|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652249|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
43652251|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652252|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652253|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652254|NCT03000413|Fentanyl|fentanyl|mesh-list
43781419|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43652255|NCT03000413|Ketamine|ketamine|mesh-list
43652256|NCT03000413|Analgesics|analgesics|mesh-ancestor
43652257|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
43652258|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773012|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
43773013|NCT02361931|Hematinics|hematinics|mesh-ancestor
43773014|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
43773015|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43773016|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
43634957|NCT05450432|Analgesics|analgesics|mesh-ancestor
43578725|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43773017|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773018|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773019|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43773020|NCT02361567|Acetaminophen|acetaminophen|mesh-list
43773022|NCT02361567|Tramadol|tramadol|mesh-list
43773023|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773024|NCT02361567|Narcotics|narcotics|mesh-ancestor
43773025|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773026|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773027|NCT02361567|Analgesics|analgesics|mesh-ancestor
43773028|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
43838617|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838619|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
43773064|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43773065|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43773066|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43773067|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
43773068|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773069|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773070|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773071|NCT02361502|Urological Agents|urological agents|mesh-ancestor
43773072|NCT02361905|Leuprolide|leuprolide|mesh-list
43773073|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
43773074|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43773075|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
43773076|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773077|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773078|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773079|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773080|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43773081|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
43773082|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43652259|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652261|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652262|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
43652263|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
43652264|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781420|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781421|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43781422|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781423|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
43653416|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
43653417|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653418|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43653419|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43653420|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653421|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652265|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43773083|NCT02361775|Ropivacaine|ropivacaine|mesh-list
43773084|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773085|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
43773086|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773087|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773088|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
43773089|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773090|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
43773091|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43773092|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773093|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773094|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
43773095|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773096|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773097|NCT02361619|Clarithromycin|clarithromycin|mesh-list
43773098|NCT02361619|Diclofenac|diclofenac|mesh-list
43781424|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773099|NCT02361619|Metoprolol|metoprolol|mesh-list
43773116|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773117|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773118|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43773119|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773120|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43773121|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773122|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43773123|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43773124|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43635039|NCT05411237|Paclitaxel|paclitaxel|mesh-list
43773125|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43773126|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
43773127|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773128|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773129|NCT02361619|Analgesics|analgesics|mesh-ancestor
43773130|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
43773131|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773132|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773133|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773134|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43773135|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773136|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773137|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43578850|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
43773138|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43773139|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773140|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
43773141|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43773142|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
43773143|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
43773144|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43773145|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43773146|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
43773147|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
43773148|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43773149|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43773150|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43773151|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781425|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
43781426|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781427|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
43781428|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43781429|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781430|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43773153|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
43773154|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43689957|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43689958|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43689959|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43689960|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
43689980|NCT02799797|Dsuvia|dsuvia|mesh-list
43773155|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
43652267|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652268|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652269|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652270|NCT03000413|Narcotics|narcotics|mesh-ancestor
43652271|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43652272|NCT03000777|Melatonin|melatonin|mesh-list
43652273|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
43652274|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773156|NCT02361190|Testosterone|testosterone|mesh-list
43773157|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
43773158|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
43773159|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43773160|NCT02361190|Androgens|androgens|mesh-ancestor
43773175|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773176|NCT02360956|Olmesartan|olmesartan|mesh-list
43773177|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43773178|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
43773179|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43773180|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43773181|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773182|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43773183|NCT02360800|Hemostatics|hemostatics|mesh-list
43773184|NCT02360800|Coagulants|coagulants|mesh-ancestor
43773185|NCT02360826|Simvastatin|simvastatin|mesh-list
43773186|NCT02360826|Pravastatin|pravastatin|mesh-list
43773187|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43773188|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43773189|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
43773190|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773191|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43773192|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43773193|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773194|NCT02361060|Atropine|atropine|mesh-list
43773195|NCT02361060|Neostigmine|neostigmine|mesh-list
43773196|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43773197|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43773198|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43773199|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
43773200|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773201|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773202|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773203|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773204|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
43773205|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
43773206|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43773207|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43773208|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781431|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781432|NCT04861558|Fluorouracil|fluorouracil|mesh-list
43781433|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
43773209|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773210|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773211|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43773212|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773213|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43773214|NCT02360982|Fentanyl|fentanyl|mesh-list
43773215|NCT02360982|Propofol|propofol|mesh-list
43773216|NCT02360982|Bupivacaine|bupivacaine|mesh-list
43773217|NCT02360982|Rocuronium|rocuronium|mesh-list
43773218|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43773219|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773220|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773221|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43773242|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773243|NCT02360644|Vitamin D|vitamin d|mesh-list
43773244|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
43773245|NCT02360644|Vitamins|vitamins|mesh-ancestor
43773246|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
43652275|NCT03000777|Protective Agents|protective agents|mesh-ancestor
43652276|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652277|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652278|NCT03000634|Dexamethasone|dexamethasone|mesh-list
43652279|NCT03000634|Lenalidomide|lenalidomide|mesh-list
43652280|NCT03000634|Bortezomib|bortezomib|mesh-list
43652281|NCT03000634|Elotuzumab|elotuzumab|mesh-list
43652282|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652283|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
43652284|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
43652285|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652286|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652287|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43690152|NCT02798055|Bosentan|bosentan|mesh-list
43652289|NCT03000634|Hormones|hormones|mesh-ancestor
43652290|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773247|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773248|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43773249|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773250|NCT02360501|Cisplatin|cisplatin|mesh-list
43781451|NCT04771962|Sevoflurane|sevoflurane|mesh-list
43773251|NCT02360501|Docetaxel|docetaxel|mesh-list
43773252|NCT02360501|Capecitabine|capecitabine|mesh-list
43773253|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773254|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773255|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773256|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
43773257|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773258|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43773259|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
43773260|NCT02360618|Metformin|metformin|mesh-list
43773261|NCT02360618|Simvastatin|simvastatin|mesh-list
43773262|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43773263|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773264|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43690261|NCT02797236|Vaccines|vaccines|mesh-list
43773265|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43773266|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
43773267|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773268|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43773269|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43773270|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773274|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43773275|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773276|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
43773277|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773278|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
43635518|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773279|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652291|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652292|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652293|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
43652294|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43652295|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43652296|NCT03000634|Growth Substances|growth substances|mesh-ancestor
43652297|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
43652298|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43652300|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43652301|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43652302|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
43773281|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
43773282|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
43773284|NCT02360592|Interleukin-2|interleukin-2|mesh-list
43773285|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773286|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
43773287|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773288|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
43773289|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773290|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773291|NCT02360592|Analgesics|analgesics|mesh-ancestor
43773292|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
43781507|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
43781534|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
43773293|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773294|NCT02360384|Linaclotide|linaclotide|mesh-list
43773295|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
43773296|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
43773297|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773298|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773299|NCT02360202|Clobetasol|clobetasol|mesh-list
43635584|NCT05253651|Tucatinib|tucatinib|mesh-list
43773300|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773302|NCT02360202|Hormones|hormones|mesh-ancestor
43773303|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773304|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773305|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
43773306|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773307|NCT02360254|Insulin|insulin|mesh-list
43773308|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43773309|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773310|NCT02360007|Buprenorphine|buprenorphine|mesh-list
43773311|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43773312|NCT02360007|Narcotics|narcotics|mesh-ancestor
43635646|NCT05211947|BI 425809|bi 425809|mesh-list
43773314|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773315|NCT02360007|Analgesics|analgesics|mesh-ancestor
43773316|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
43773317|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773318|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43838620|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43838621|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43838622|NCT04832269|Prednisolone|prednisolone|mesh-list
43838623|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
43838624|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43838625|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
43838626|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838627|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
43838628|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
43838629|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838648|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838649|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43838650|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43773319|NCT02359942|Citric Acid|citric acid|mesh-list
43652303|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652304|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
43652305|NCT03000556|Protective Agents|protective agents|mesh-ancestor
43652306|NCT03000127|Testosterone|testosterone|mesh-list
43652309|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652310|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652312|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43652313|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652314|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652315|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43635680|NCT05198830|Cisplatin|cisplatin|mesh-list
43635681|NCT05198830|Pemetrexed|pemetrexed|mesh-list
43652316|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652317|NCT03000205|Lidocaine|lidocaine|mesh-list
43652318|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
43652319|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
43652320|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652321|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781535|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781536|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43781537|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43781538|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781539|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652322|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
43652323|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652324|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652325|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652326|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43652327|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652328|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635762|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652329|NCT03000036|Doxorubicin|doxorubicin|mesh-list
43773320|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
43773321|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
43773322|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43773323|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
43773324|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
43773325|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773326|NCT02359604|Esomeprazole|esomeprazole|mesh-list
43773327|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43773328|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773329|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43773330|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773331|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773332|NCT02359695|Hormones|hormones|mesh-list
43773333|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773334|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773335|NCT02359643|Aspirin|aspirin|mesh-list
43773336|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773337|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652330|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43652331|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43652332|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773339|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
43773340|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773341|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773342|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773343|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773344|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43773345|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43773346|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773347|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43773348|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43773349|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773350|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
43773351|NCT02359721|Clarithromycin|clarithromycin|mesh-list
43773352|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773372|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773374|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
43773375|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773376|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
43773377|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773378|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773379|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
43773380|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773381|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43773382|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43773383|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43773384|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43636030|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43636031|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
43636032|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773385|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773388|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43773389|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773390|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
43773391|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43773392|NCT02359448|Melatonin|melatonin|mesh-list
43773393|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
43773394|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773395|NCT02359448|Protective Agents|protective agents|mesh-ancestor
43773396|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773397|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773398|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43636125|NCT05042128|Gemcitabine|gemcitabine|mesh-list
43690889|NCT02792140|Naltrexone|naltrexone|mesh-list
43773399|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773400|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
43773401|NCT02359526|Hormones|hormones|mesh-ancestor
43773402|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773403|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773404|NCT02359331|Amoxicillin|amoxicillin|mesh-list
43773405|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
43773406|NCT02359331|Metronidazole|metronidazole|mesh-list
43773427|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43773428|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773429|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
43773430|NCT02359149|Growth Substances|growth substances|mesh-ancestor
43773431|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773433|NCT02359500|Edotreotide|edotreotide|mesh-list
43773434|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773435|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43773436|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773437|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43773438|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773439|NCT02359474|Trabectedin|trabectedin|mesh-list
43773440|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43652333|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652334|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43652335|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652336|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652338|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
43652339|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
43652340|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43652342|NCT02999815|Antitoxins|antitoxins|mesh-list
43652343|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
43652344|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652345|NCT02999841|Vildagliptin|vildagliptin|mesh-list
43652346|NCT02999841|Acarbose|acarbose|mesh-list
43652347|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652348|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652349|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43652350|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
43652351|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652352|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652353|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43652354|NCT02999204|Vitamin D|vitamin d|mesh-list
43652355|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
43652356|NCT02999204|Vitamins|vitamins|mesh-ancestor
43652357|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
43652358|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781580|NCT04505670|Donepezil|donepezil|mesh-list
43652359|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43652360|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43652361|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43652362|NCT02999217|Hematinics|hematinics|mesh-ancestor
43652363|NCT02999126|Remifentanil|remifentanil|mesh-list
43652364|NCT02999126|Propofol|propofol|mesh-list
43773441|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
43773442|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773443|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773444|NCT02358824|Amlodipine|amlodipine|mesh-list
43773445|NCT02358824|Telmisartan|telmisartan|mesh-list
43773446|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43773447|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43773448|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773450|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43773451|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652365|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43652366|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652374|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
43652375|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773453|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43773454|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43773455|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
43773456|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
43773457|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
43773458|NCT02358993|Methenamine|methenamine|mesh-list
43773459|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43773460|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773461|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43773482|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773483|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
43773484|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
43773485|NCT02359136|Epinephrine|epinephrine|mesh-list
43773486|NCT02359136|Analgesics|analgesics|mesh-list
43773487|NCT02359136|Anesthetics|anesthetics|mesh-list
43691386|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652378|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652379|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652380|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43579286|NCT03472651|Flupenthixol|flupenthixol|mesh-list
43773495|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43773496|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
43773497|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773498|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773499|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43773500|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43773501|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
43773502|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43773523|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43773538|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773539|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773540|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
43773542|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773543|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773544|NCT02358707|Analgesics|analgesics|mesh-ancestor
43773545|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
43773546|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773547|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773548|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773549|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773550|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43773551|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829437|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43829439|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773552|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773553|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
43691715|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43691721|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
43773554|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43773555|NCT02358694|Antibodies|antibodies|mesh-list
43773556|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
43773557|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773558|NCT02358642|Lisinopril|lisinopril|mesh-list
43652382|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43652383|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652384|NCT02998918|Analgesics|analgesics|mesh-ancestor
43652385|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
43652386|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652387|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652388|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652389|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652390|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652391|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773559|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43773560|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43773561|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
43773562|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773563|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43773564|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43773565|NCT02358642|Protective Agents|protective agents|mesh-ancestor
43773566|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773567|NCT02358499|Posaconazole|posaconazole|mesh-list
43773568|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
43773569|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773570|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43773571|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43691903|NCT02784483|Atezolizumab|atezolizumab|mesh-list
43773572|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43773573|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43773574|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773575|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773576|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773577|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43773578|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
43773579|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43773580|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773582|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
43773597|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773599|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43773600|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
43773601|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43773602|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
43773603|NCT02358057|Alfentanil|alfentanil|mesh-list
43773604|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43781606|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781607|NCT04335084|Vitamin D|vitamin d|mesh-list
43781608|NCT04335084|Vitamins|vitamins|mesh-list
43781609|NCT04335084|Ascorbic Acid|ascorbic acid|mesh-list
43781610|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
43781611|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
43781612|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773605|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773606|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773607|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773608|NCT02358057|Analgesics|analgesics|mesh-ancestor
43773609|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
43773610|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773611|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43773612|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43773613|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43773614|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
43773615|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43691993|NCT02784080|Isoantibodies|isoantibodies|mesh-list
43773616|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773618|NCT02358057|Narcotics|narcotics|mesh-ancestor
43773619|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43773620|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
43773621|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
43773622|NCT02358161|Gemcitabine|gemcitabine|mesh-list
43773623|NCT02358161|Paclitaxel|paclitaxel|mesh-list
43773624|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43773625|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652392|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652394|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43692012|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
43692014|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652395|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652396|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
43652397|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652398|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
43652399|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652400|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
43692158|NCT02782624|Empagliflozin|empagliflozin|mesh-list
43652401|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
43652402|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
43652403|NCT02996318|Sirolimus|sirolimus|mesh-list
43652404|NCT02996318|Paclitaxel|paclitaxel|mesh-list
43652405|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43652406|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652407|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
43652408|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
43652409|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
43652410|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652411|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43652412|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652413|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43652414|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
43652415|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652416|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
43637821|NCT04428151|Lenvatinib|lenvatinib|mesh-list
43652417|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652418|NCT02995772|Tamoxifen|tamoxifen|mesh-list
43652419|NCT02995772|Fluorouracil|fluorouracil|mesh-list
43652420|NCT02995772|Letrozole|letrozole|mesh-list
43652421|NCT02995772|Anastrozole|anastrozole|mesh-list
43773626|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773627|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
43773628|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
43773629|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43637893|NCT04380636|Paclitaxel|paclitaxel|mesh-list
43773630|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43773631|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
43773632|NCT02358161|Antiviral Agents|antiviral agents|mesh-ancestor
43773633|NCT02358161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773634|NCT02358161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773635|NCT02358161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773636|NCT02358161|Immunologic Factors|immunologic factors|mesh-ancestor
43773637|NCT02358161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773638|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43773639|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773640|NCT02358200|Paclitaxel|paclitaxel|mesh-list
43773641|NCT02358200|Carboplatin|carboplatin|mesh-list
43773642|NCT02358200|Talazoparib|talazoparib|mesh-list
43652422|NCT02995772|Exemestane|exemestane|mesh-list
43652423|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43652424|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
43652425|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652426|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652427|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652428|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652429|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
43652430|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652431|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637958|NCT04363801|Vitamins|vitamins|mesh-ancestor
43652432|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43652433|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43652434|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
43652435|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652436|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652437|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43652438|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43652439|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43652440|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
43652441|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43652442|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43829486|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
43652448|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652450|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652451|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
43652452|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43652453|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43652454|NCT02995083|Prednisolone|prednisolone|mesh-list
43652455|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
43652457|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43652458|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
43652459|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
43652460|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
43652461|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43692606|NCT02779283|Antidotes|antidotes|mesh-ancestor
43692607|NCT02779283|Protective Agents|protective agents|mesh-ancestor
43692608|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
43692609|NCT02779283|Vitamins|vitamins|mesh-ancestor
43692610|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
43692611|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43692612|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
43692613|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
43692614|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
43692615|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43692616|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43692617|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43638266|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43638267|NCT04227704|Ketamine|ketamine|mesh-list
43638268|NCT04227704|Analgesics|analgesics|mesh-ancestor
43638269|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
43692626|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
43692627|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43692628|NCT02779270|Protective Agents|protective agents|mesh-ancestor
43692629|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692630|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
43692631|NCT02779465|Vitamin D|vitamin d|mesh-list
43692632|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
43692633|NCT02779465|Vitamins|vitamins|mesh-ancestor
43692634|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
43692635|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43692636|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43692637|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43692638|NCT02779530|Diclofenac|diclofenac|mesh-list
43692639|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653450|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
43653451|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653452|NCT02984397|Ketotifen|ketotifen|mesh-list
43692641|NCT02779530|Analgesics|analgesics|mesh-ancestor
43652462|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652463|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
43652464|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652465|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652466|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652467|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43652468|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652469|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43692677|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
43638351|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
43638352|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638353|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43638354|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638373|NCT04176705|Triamcinolone|triamcinolone|mesh-list
43638378|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
43638379|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
43638380|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43638381|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43638382|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
43638383|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43638384|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43638385|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652470|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652471|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
43652472|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
43652473|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652474|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
43652475|NCT02995083|Hormones|hormones|mesh-ancestor
43652476|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652480|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824682|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824683|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824684|NCT05509374|Growth Substances|growth substances|mesh-ancestor
43824685|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
43824687|NCT05509244|Ibuprofen|ibuprofen|mesh-list
43824688|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43824689|NCT05509244|Analgesics|analgesics|mesh-ancestor
43824690|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
43824691|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824692|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824693|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
43824694|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43824695|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824696|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824697|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43824698|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692907|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
43692936|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692938|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
43824699|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824701|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
43824702|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824703|NCT05509153|Expectorants|expectorants|mesh-ancestor
43824704|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
43824712|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
43824713|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43824714|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839581|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
43824715|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824716|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
43824717|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824718|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43638791|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
43824719|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
43824721|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43824722|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824723|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
43824724|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824725|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43824726|NCT05508737|Trifluridine|trifluridine|mesh-list
43824727|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
43652482|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
43652483|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652484|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43652485|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43652486|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652487|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43693752|NCT02771925|Gabapentin|gabapentin|mesh-list
43838654|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43838655|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
43838656|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43838657|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43838658|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
43838659|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848038|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848039|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848040|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43693907|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43693908|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43693909|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43693910|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
43693911|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
43693912|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43639011|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43693986|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43848041|NCT04060342|Immunologic Factors|immunologic factors|mesh-ancestor
43848042|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848043|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848044|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
43848045|NCT04060030|Leucovorin|leucovorin|mesh-list
43848046|NCT04060030|Calcium|calcium|mesh-list
43848047|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
43848048|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43848049|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848050|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43848051|NCT04060030|Antidotes|antidotes|mesh-ancestor
43652489|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43652490|NCT02994602|ST 1435|st 1435|mesh-list
43694061|NCT02770430|Infliximab|infliximab|mesh-list
43652491|NCT02994602|Testosterone|testosterone|mesh-list
43652492|NCT02994602|Androgens|androgens|mesh-ancestor
43652493|NCT02994602|Hormones|hormones|mesh-ancestor
43652494|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652495|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652496|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43652497|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
43652498|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652499|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43652500|NCT02993705|Trabectedin|trabectedin|mesh-list
43652501|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43652502|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
43652503|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652504|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652505|NCT02992808|Menotropins|menotropins|mesh-list
43848052|NCT04060030|Protective Agents|protective agents|mesh-ancestor
43848053|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
43848054|NCT04060030|Vitamins|vitamins|mesh-ancestor
43848055|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
43848056|NCT04058678|Danazol|danazol|mesh-list
43848057|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43848058|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639232|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
43734409|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848059|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848060|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848062|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848063|NCT04055428|Valsartan|valsartan|mesh-list
43848064|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43848065|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43848080|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848081|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
43848082|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43848083|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848986|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43639263|NCT03428958|Leucovorin|leucovorin|mesh-list
43848987|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848989|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
43848990|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848991|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43848992|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43848993|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
43848994|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
43848995|NCT03976063|Nifedipine|nifedipine|mesh-list
43848996|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43848997|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848998|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848999|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43849000|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849001|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
43849002|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
43773651|NCT02358018|Edotreotide|edotreotide|mesh-list
43773652|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43773653|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652506|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43652507|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
43652508|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652509|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43694436|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43652510|NCT02992886|Raltitrexed|raltitrexed|mesh-list
43652511|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652512|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
43652513|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652514|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652515|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43652516|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652517|NCT02992028|Vitamins|vitamins|mesh-list
43652518|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
43652519|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839591|NCT04761601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652520|NCT02991209|Testosterone|testosterone|mesh-list
43652521|NCT02991209|Androgens|androgens|mesh-ancestor
43652522|NCT02991209|Hormones|hormones|mesh-ancestor
43652523|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652524|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652525|NCT02990975|Ketamine|ketamine|mesh-list
43652526|NCT02990975|Analgesics|analgesics|mesh-ancestor
43639373|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
43652527|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
43652528|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652529|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652530|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43652531|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652532|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
43652533|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
43652552|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652553|NCT02990962|Triamcinolone|triamcinolone|mesh-list
43652554|NCT02990962|Lidocaine|lidocaine|mesh-list
43639387|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
43652555|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652556|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
43652558|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652559|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652560|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652561|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
43652562|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
43639446|NCT03252600|Elotuzumab|elotuzumab|mesh-list
43639455|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639456|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639525|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
43652563|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652564|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
43652565|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773654|NCT02357797|Vortioxetine|vortioxetine|mesh-list
43773655|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
43773656|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43773657|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43773658|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43773659|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773660|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773661|NCT02357797|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43773662|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43694795|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43773663|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43773664|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773665|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773666|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
43773667|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43773668|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43773669|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43773670|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43773671|NCT02357849|Aripiprazole|aripiprazole|mesh-list
43773672|NCT02357849|Fluoxetine|fluoxetine|mesh-list
43781659|NCT03898154|Hormones|hormones|mesh-ancestor
43773673|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
43773705|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773707|NCT02357732|Trametinib|trametinib|mesh-list
43773708|NCT02357732|Dabrafenib|dabrafenib|mesh-list
43694891|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
43639725|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43639726|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773709|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43773710|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773711|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43773740|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
43773741|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773742|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43773743|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43773744|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773745|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773746|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43773747|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43773748|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43773749|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43773750|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
43773751|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773752|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
43773753|NCT02357303|Simethicone|simethicone|mesh-list
43773754|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43773755|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
43773756|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43773757|NCT02357303|Expectorants|expectorants|mesh-ancestor
43652566|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652567|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43652568|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43652569|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652571|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652572|NCT02989870|Sorafenib|sorafenib|mesh-list
43652573|NCT02989870|Bavituximab|bavituximab|mesh-list
43652574|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652575|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652576|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652577|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652578|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652580|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
43652581|NCT02990013|Povidone|povidone|mesh-list
43652582|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43781677|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653454|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653455|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43653456|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
43653457|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
43653458|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653460|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652583|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652584|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
43652585|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
43652586|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
43652587|NCT02989701|Plerixafor|plerixafor|mesh-list
43652588|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43773789|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43773790|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43773791|NCT02357407|Renal Agents|renal agents|mesh-ancestor
43773792|NCT02357225|Bromides|bromides|mesh-list
43773793|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43773794|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
43773795|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43773796|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695135|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
43639922|NCT02941926|Letrozole|letrozole|mesh-list
43695368|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
43695412|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43640069|NCT02877303|Ofatumumab|ofatumumab|mesh-list
43695613|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43695614|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43640220|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43695909|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
43652591|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652592|NCT02989519|Progesterone|progesterone|mesh-list
43652593|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
43652594|NCT02989519|Progestins|progestins|mesh-ancestor
43652595|NCT02989519|Hormones|hormones|mesh-ancestor
43652596|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43640473|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652597|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652599|NCT02989623|Trace Elements|trace elements|mesh-ancestor
43773806|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43773807|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
43773808|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43773809|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
43773810|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
43773811|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773812|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773834|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43773835|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43773836|NCT02357069|Analgesics|analgesics|mesh-ancestor
43773837|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
43773838|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773839|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43773840|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43773841|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773842|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773843|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773844|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
43773846|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43773847|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
43773848|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773849|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696074|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
43696075|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781693|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43829911|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43696076|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696077|NCT02757508|Vitamins|vitamins|mesh-list
43696078|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
43696079|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696080|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
43696081|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43696082|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696083|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696084|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696085|NCT02757495|Analgesics|analgesics|mesh-ancestor
43696086|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
43696087|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696088|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43696117|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696118|NCT02757287|Desogestrel|desogestrel|mesh-list
43696119|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43696120|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43696121|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43696122|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
43696123|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43696124|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696125|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43696126|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43696127|NCT02757287|Progestins|progestins|mesh-ancestor
43696128|NCT02757287|Hormones|hormones|mesh-ancestor
43773850|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43773851|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43773852|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
43773853|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43773854|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773855|NCT02356965|Ketamine|ketamine|mesh-list
43773856|NCT02356965|Analgesics|analgesics|mesh-ancestor
43773857|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
43773858|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43773859|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43829924|NCT05399602|Anesthetics|anesthetics|mesh-list
43696209|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43696210|NCT02757196|Prednisolone|prednisolone|mesh-list
43696211|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
43696212|NCT02757196|Rituximab|rituximab|mesh-list
43696214|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
43696215|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696216|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696217|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
43696218|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696219|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696220|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696221|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
43696222|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
43781715|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696223|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696224|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696225|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
43696226|NCT02757196|Hormones|hormones|mesh-ancestor
43696227|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696228|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43696229|NCT02757196|Protective Agents|protective agents|mesh-ancestor
43696268|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43696269|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696270|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696271|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43696272|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
43696273|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
43696274|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43696275|NCT02756598|Narcotics|narcotics|mesh-ancestor
43696408|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696409|NCT02755545|Analgesics|analgesics|mesh-ancestor
43696410|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
43696411|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696412|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696413|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696414|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773860|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43773861|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43773864|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43773894|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773895|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
43773897|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43773898|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43773900|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43773901|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43773902|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43773904|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773905|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
43773906|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641130|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43641131|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43641132|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641133|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43641134|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641135|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641136|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43641137|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43641138|NCT01349881|Analgesics|analgesics|mesh-ancestor
43839614|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839621|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
43641139|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
43641140|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641141|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641142|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641143|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641195|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43641197|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641198|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641199|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641200|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641201|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641202|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641203|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43641204|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696646|NCT02753725|Fentanyl|fentanyl|mesh-list
43696672|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43696673|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43696674|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696675|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696676|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
43641358|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43641458|NCT00001521|Letrozole|letrozole|mesh-list
43773908|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
43652600|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
43652601|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652602|NCT02989558|Aspirin|aspirin|mesh-list
43652603|NCT02989558|Clopidogrel|clopidogrel|mesh-list
43652604|NCT02989558|Ticagrelor|ticagrelor|mesh-list
43652605|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43652606|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696775|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43696776|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696777|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696778|NCT02753218|Midazolam|midazolam|mesh-list
43696779|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43696780|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43696781|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696782|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696783|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43696784|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43696785|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43641497|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641498|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641499|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
43641500|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641501|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
43641502|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641503|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
43641504|NCT00001230|Filaricides|filaricides|mesh-ancestor
43641505|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
43641506|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
43641507|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43641508|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641510|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696805|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43696806|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696807|NCT02752971|Diclofenac|diclofenac|mesh-list
43696808|NCT02752971|Bupivacaine|bupivacaine|mesh-list
43696809|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
43696810|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
43696811|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696812|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696813|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
43696814|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696815|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43696816|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696817|NCT02752971|Analgesics|analgesics|mesh-ancestor
43696818|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696819|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696820|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43781791|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43781792|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43781793|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43696821|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696822|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696823|NCT02753166|Dexamethasone|dexamethasone|mesh-list
43696824|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696825|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
43696827|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696828|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696829|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43696861|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
43696862|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43696863|NCT02753088|Diuretics|diuretics|mesh-ancestor
43696864|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
43696865|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696866|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43696867|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
43696868|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43696870|NCT02752646|Ketorolac|ketorolac|mesh-list
43696872|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43696873|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43696875|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
43696876|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696877|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696878|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43696879|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781830|NCT05090137|Diuretics|diuretics|mesh-list
43652618|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652636|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
43652637|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43652638|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652639|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43652640|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652641|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
43652642|NCT02989259|Apatinib|apatinib|mesh-list
43696917|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696918|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696919|NCT02752113|Metformin|metformin|mesh-list
43696920|NCT02752113|Empagliflozin|empagliflozin|mesh-list
43696921|NCT02752113|Linagliptin|linagliptin|mesh-list
43696922|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43696923|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696924|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43696925|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696926|NCT02752113|Incretins|incretins|mesh-ancestor
43696927|NCT02752113|Hormones|hormones|mesh-ancestor
43696928|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43696929|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43696930|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
43696931|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696933|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43696934|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43696935|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
43696936|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696937|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43696938|NCT02752308|Atropine|atropine|mesh-list
43696939|NCT02752308|Epinephrine|epinephrine|mesh-list
43696940|NCT02752308|Fentanyl|fentanyl|mesh-list
43696941|NCT02752308|Bupivacaine|bupivacaine|mesh-list
43696942|NCT02752308|Neostigmine|neostigmine|mesh-list
43696943|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
43696944|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
43849498|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43696945|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696946|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696947|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
43696948|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43696949|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43696963|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43696964|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
43696965|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
43696966|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
43696967|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43696968|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43696969|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
43696970|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43696971|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43696972|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
43696993|NCT02751996|Tenofovir|tenofovir|mesh-list
43696994|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
43696995|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781883|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
43696996|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43696997|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43696998|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43696999|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697000|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43697001|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43697002|NCT02751918|Doxorubicin|doxorubicin|mesh-list
43697004|NCT02751918|Maytansine|maytansine|mesh-list
43652644|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43652645|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652646|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652647|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
43652648|NCT02989272|Analgesics|analgesics|mesh-ancestor
43652649|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
43652650|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652651|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652652|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
43652653|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652654|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43652655|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
43652656|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43830042|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697374|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697375|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697376|NCT04529135|Analgesics|analgesics|mesh-ancestor
43697377|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
43697378|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697379|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43697380|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43697381|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43697382|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
43652657|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652658|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652659|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43652661|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43838673|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838674|NCT04831450|Cemiplimab|cemiplimab|mesh-list
43838675|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697459|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43697460|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
43697461|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697462|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
43697463|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697464|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697465|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
43697466|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43697467|NCT03824535|Fluorides|fluorides|mesh-list
43697468|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43697469|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697470|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
43697471|NCT03824535|Protective Agents|protective agents|mesh-ancestor
43697472|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697563|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
43697564|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697565|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43697566|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43697567|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43697568|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697569|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697570|NCT02789345|Osimertinib|osimertinib|mesh-list
43697571|NCT02789345|Ramucirumab|ramucirumab|mesh-list
43697572|NCT02789345|Necitumumab|necitumumab|mesh-list
43697573|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697574|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43697575|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697580|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
43697581|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43697582|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697583|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697808|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43697809|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43697810|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697811|NCT02750917|Etoricoxib|etoricoxib|mesh-list
43697812|NCT02750917|Lornoxicam|lornoxicam|mesh-list
43773968|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43773969|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43773970|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43773971|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43773972|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43773974|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
43773975|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
43774004|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697813|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43697814|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43697815|NCT02750917|Analgesics|analgesics|mesh-ancestor
43697816|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
43697817|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697818|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697819|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697820|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43697821|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43697822|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43697823|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697824|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697826|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
43697827|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
43697828|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697829|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697830|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
43774006|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774007|NCT02355184|Leronlimab|leronlimab|mesh-list
43774008|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43774009|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43774010|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774011|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43774012|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43697859|NCT02750696|Narcotics|narcotics|mesh-ancestor
43697860|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43697861|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
43697862|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
43697863|NCT02750670|Gemcitabine|gemcitabine|mesh-list
43697864|NCT02750670|Dexamethasone|dexamethasone|mesh-list
43697866|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
43697867|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43697868|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
43697869|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
43697870|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43697871|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43697872|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43697873|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
43697874|NCT02750670|Hormones|hormones|mesh-ancestor
43697875|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43697876|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43697877|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43697878|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43697879|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
43697880|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43697881|NCT02750670|Antiviral Agents|antiviral agents|mesh-ancestor
43697882|NCT02750670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43697883|NCT02750670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43697884|NCT02750670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43697885|NCT02750670|Immunologic Factors|immunologic factors|mesh-ancestor
43697886|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43697887|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
43697888|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43774013|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
43774014|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774015|NCT02355236|Celecoxib|celecoxib|mesh-list
43774016|NCT02355236|Naproxen|naproxen|mesh-list
43774017|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43774018|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774019|NCT02355236|Analgesics|analgesics|mesh-ancestor
43774020|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
43774045|NCT02355119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43774046|NCT02355119|Immunologic Factors|immunologic factors|mesh-ancestor
43774047|NCT02355119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774048|NCT02355093|Ropivacaine|ropivacaine|mesh-list
43774049|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774050|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
43774051|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774052|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774059|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774060|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774061|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43774063|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
43774064|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43774065|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43774066|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774067|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
43774068|NCT02354885|Coagulants|coagulants|mesh-ancestor
43774070|NCT02354768|Loperamide|loperamide|mesh-list
43652666|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652667|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43652668|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43652669|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
43652670|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652671|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652672|NCT02989207|Mitomycins|mitomycins|mesh-list
43652673|NCT02989207|Mitomycin|mitomycin|mesh-list
43652674|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43698070|NCT02749032|Metformin|metformin|mesh-list
43652675|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652676|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
43652677|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652678|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43652679|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652680|NCT02989311|Iron|iron|mesh-list
43652681|NCT02989311|Trace Elements|trace elements|mesh-ancestor
43652682|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
43652683|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652684|NCT02989129|Quercetin|quercetin|mesh-list
43848200|NCT04041973|Lumefantrine|lumefantrine|mesh-list
43652685|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
43774071|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
43579945|NCT05255900|Metyrapone|metyrapone|mesh-list
43774105|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774106|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43774107|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43774108|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
43774109|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774110|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774111|NCT02354638|Nicotine|nicotine|mesh-list
43774112|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43774138|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43774139|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
43774140|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774141|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43774142|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43774143|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
43774144|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774145|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774152|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774153|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43774154|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43774155|NCT02354313|Growth Substances|growth substances|mesh-ancestor
43774156|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
43774157|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774158|NCT02354560|Erythromycin|erythromycin|mesh-list
43774161|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
43774182|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
43774183|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43774184|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652686|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652687|NCT02989129|Protective Agents|protective agents|mesh-ancestor
43652688|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652689|NCT02988999|Erythritol|erythritol|mesh-list
43652690|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652691|NCT02989012|Oseltamivir|oseltamivir|mesh-list
43652692|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
43774185|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43774186|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43774187|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43774188|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
43774189|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43774190|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43774191|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774192|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774193|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
43774194|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43774195|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43838681|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838682|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43838683|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838684|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838685|NCT04830462|Rifampin|rifampin|mesh-list
43838686|NCT04830462|Isoniazid|isoniazid|mesh-list
43838687|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43838688|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
43838689|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838723|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
43838725|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43782010|NCT04788550|Protective Agents|protective agents|mesh-ancestor
43838726|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43838727|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774219|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774220|NCT02353858|Fluorouracil|fluorouracil|mesh-list
43774221|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
43830187|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43830188|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
43774222|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774223|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774224|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774225|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43774228|NCT02353988|Bicalutamide|bicalutamide|mesh-list
43774229|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
43774230|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774258|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
43774259|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774261|NCT02353494|Artenimol|artenimol|mesh-list
43774262|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
43774263|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43774264|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774265|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43774266|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43774267|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
43774268|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774269|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
43774270|NCT02353325|Fesoterodine|fesoterodine|mesh-list
43774271|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
43774272|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782026|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
43782027|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782028|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782029|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782030|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
43782031|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43782032|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43782033|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43782034|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653502|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653503|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653504|NCT02983773|Hormones|hormones|mesh-ancestor
43653505|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653506|NCT02983734|Cycloserine|cycloserine|mesh-list
43653507|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43774273|NCT02353325|Protective Agents|protective agents|mesh-ancestor
43698517|NCT02744768|Dasatinib|dasatinib|mesh-list
43698536|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698537|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830212|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43830213|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
43830214|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
43830215|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830216|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43830217|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43830218|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830219|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830220|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43830221|NCT05379179|Narcotics|narcotics|mesh-ancestor
43830222|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43830223|NCT05378945|Varenicline|varenicline|mesh-list
43698742|NCT02743260|Adefovir|adefovir|mesh-list
43698743|NCT02743260|Digoxin|digoxin|mesh-list
43698744|NCT02743260|Pitavastatin|pitavastatin|mesh-list
43698745|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43698746|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698747|NCT02743260|Incretins|incretins|mesh-ancestor
43698748|NCT02743260|Hormones|hormones|mesh-ancestor
43698749|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43698780|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698781|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
43698782|NCT02743247|Tacrolimus|tacrolimus|mesh-list
43698783|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698784|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
43698785|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698786|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43698787|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838743|NCT04824092|Vincristine|vincristine|mesh-list
43838744|NCT04824092|Lenalidomide|lenalidomide|mesh-list
43838745|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43838746|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
43824729|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824730|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
43824731|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824733|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824734|NCT05508633|Mebeverine|mebeverine|mesh-list
43824735|NCT05508633|Alverine|alverine|mesh-list
43824736|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
43824737|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
43824738|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698794|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43698795|NCT02743390|Infliximab|infliximab|mesh-list
43698796|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
43782047|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782048|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
43698797|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43698798|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43698799|NCT02743104|Lidocaine|lidocaine|mesh-list
43698800|NCT02743104|Atropine|atropine|mesh-list
43698801|NCT02743104|Midazolam|midazolam|mesh-list
43698802|NCT02743104|Ketamine|ketamine|mesh-list
43698803|NCT02743104|Propofol|propofol|mesh-list
43698804|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
43698805|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
43698806|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43698807|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698808|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
43698809|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43698810|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43698811|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43698812|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43698813|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698814|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698815|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43698816|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43698818|NCT02743104|Analgesics|analgesics|mesh-ancestor
43698819|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43698820|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43698821|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43698822|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43698823|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43698833|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
43698834|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
43698835|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43698836|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43698837|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
43698838|NCT02743065|Doxorubicin|doxorubicin|mesh-list
43698839|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43698840|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43698841|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43698842|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43698843|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43698844|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698845|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
43698851|NCT02742675|Leuprolide|leuprolide|mesh-list
43824739|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824740|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
43824741|NCT05508620|Sirolimus|sirolimus|mesh-list
43824742|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43838747|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838748|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782075|NCT04254731|Analgesics|analgesics|mesh-ancestor
43838749|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838750|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
43698881|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
43830271|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
43830272|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
43830273|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830274|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830275|NCT05372939|Adalimumab|adalimumab|mesh-list
43830276|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43830277|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830278|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
43830279|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
43699037|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699038|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43699039|NCT02741414|Amoxicillin|amoxicillin|mesh-list
43699040|NCT02741414|Metronidazole|metronidazole|mesh-list
43699041|NCT02741414|Clarithromycin|clarithromycin|mesh-list
43699042|NCT02741414|Levofloxacin|levofloxacin|mesh-list
43699043|NCT02741414|Ofloxacin|ofloxacin|mesh-list
43699044|NCT02741414|Tetracycline|tetracycline|mesh-list
43699045|NCT02741414|Furazolidone|furazolidone|mesh-list
43699046|NCT02741414|Esomeprazole|esomeprazole|mesh-list
43699047|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699048|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699049|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43699050|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43699051|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43774472|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43774473|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43774474|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774475|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774476|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43774477|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43774478|NCT02352155|Epinephrine|epinephrine|mesh-list
43774479|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43774480|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43774481|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
43774482|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43774483|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774484|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699073|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43699074|NCT02741219|Analgesics|analgesics|mesh-ancestor
43699075|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
43699076|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699077|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43699078|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43699079|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43699080|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699081|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699082|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699083|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43699084|NCT02741219|Narcotics|narcotics|mesh-ancestor
43699085|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43782128|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
43699086|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43699087|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
43839690|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43699088|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
43699089|NCT02740933|Demeclocycline|demeclocycline|mesh-list
43699090|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699091|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699092|NCT02740894|Gefitinib|gefitinib|mesh-list
43699093|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774486|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43774487|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
43774488|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774489|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774520|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774522|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
43774523|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43774524|NCT02352025|Estrogens|estrogens|mesh-ancestor
43774525|NCT02352025|Hormones|hormones|mesh-ancestor
43774526|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774527|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774528|NCT02351908|Tenofovir|tenofovir|mesh-list
43774529|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
43699103|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
43699104|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43699105|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699106|NCT02741115|Udenafil|udenafil|mesh-list
43699107|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43699108|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43699109|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699110|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839691|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699111|NCT02741154|Letrozole|letrozole|mesh-list
43699112|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43699113|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699114|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43699170|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699171|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43699172|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43699173|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699174|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43699175|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43699176|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699177|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43699178|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
43699179|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
43699189|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43699190|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43699191|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43699196|NCT02740712|Protective Agents|protective agents|mesh-ancestor
43699197|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43699198|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699199|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
43699200|NCT02740712|Coagulants|coagulants|mesh-ancestor
43699201|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43699202|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699203|NCT02740426|Pirarubicin|pirarubicin|mesh-list
43699204|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699205|NCT02740270|Spartalizumab|spartalizumab|mesh-list
43699206|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43699207|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699209|NCT02740101|Oxytocin|oxytocin|mesh-list
43847291|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847292|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847293|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847294|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847295|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847296|NCT04122443|Acetaminophen|acetaminophen|mesh-list
43847297|NCT04122443|Oxycodone|oxycodone|mesh-list
43847298|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847299|NCT04122443|Analgesics|analgesics|mesh-ancestor
43847300|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
43847301|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847302|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847303|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
43847320|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43847321|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847322|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43847323|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847324|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
43847325|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
43847326|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847327|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
43847328|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847329|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43847330|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847331|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782157|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43847332|NCT04116073|Antibodies|antibodies|mesh-list
43847333|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
43699240|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
43699244|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
43699247|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43699248|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
43699249|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43699250|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699251|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43699252|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
43699253|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699254|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43699255|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699256|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699257|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
43699258|NCT02739815|Coagulants|coagulants|mesh-ancestor
43699310|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43699311|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43699312|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699313|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699314|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699315|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774533|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43774572|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774609|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
43699420|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699421|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43699422|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699423|NCT02738619|Vitamin D|vitamin d|mesh-list
43699424|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
43699425|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
43699426|NCT02738619|Vitamins|vitamins|mesh-list
43699427|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
43699428|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699429|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43699430|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43699432|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774668|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699437|NCT02738502|Darunavir|darunavir|mesh-list
43699438|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43699439|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43699440|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
43699442|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699443|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43699444|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43699445|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
43699446|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699447|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43699448|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699449|NCT02738346|Carboplatin|carboplatin|mesh-list
43699450|NCT02738346|Etoposide|etoposide|mesh-list
43699451|NCT02738346|Topotecan|topotecan|mesh-list
43699452|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699455|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699456|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782189|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
43699457|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699458|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43699460|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43699461|NCT02738632|Telmisartan|telmisartan|mesh-list
43699463|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43699464|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43699465|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699466|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699467|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43699468|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699469|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
43699470|NCT02738632|Diuretics|diuretics|mesh-ancestor
43699471|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
43699472|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43699473|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43699474|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43699476|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43699477|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43699478|NCT02738177|Misoprostol|misoprostol|mesh-list
43774670|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
43774671|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824754|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824755|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824756|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824758|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
43774672|NCT02350751|MEDI8852|medi8852|mesh-list
43774673|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
43774674|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699482|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699483|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43699484|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699485|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
43699486|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43699487|NCT02738177|Diuretics|diuretics|mesh-ancestor
43699488|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
43699489|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
43699490|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43699491|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830301|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
43830302|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
43830303|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830304|NCT05369793|Protective Agents|protective agents|mesh-ancestor
43774676|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43774677|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774679|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
43774680|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774681|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774709|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774710|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774711|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43830305|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830306|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
43782208|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782209|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
43782210|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653519|NCT02983214|Clopidogrel|clopidogrel|mesh-list
43830307|NCT05369793|Vitamins|vitamins|mesh-ancestor
43782243|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
43782244|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43830308|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
43830309|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43830310|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43830311|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
43830312|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830313|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43830314|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43830315|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
43830316|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
43830317|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830318|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830319|NCT05368415|Norepinephrine|norepinephrine|mesh-list
43830320|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43830321|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43830322|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830323|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830324|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830325|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774712|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43774713|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
43774714|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43774715|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43774716|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43774717|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43774718|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
43774719|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43774721|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
43830346|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
43830347|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43830348|NCT05367492|Varenicline|varenicline|mesh-list
43830349|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43830350|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43830351|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
43830352|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830353|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830354|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830355|NCT05367401|Azacitidine|azacitidine|mesh-list
43830357|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43830358|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
43830359|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830360|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774765|NCT02350361|Growth Substances|growth substances|mesh-ancestor
43774766|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699535|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43699536|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43699537|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699538|NCT02737774|Carboplatin|carboplatin|mesh-list
43699539|NCT02737774|Pemetrexed|pemetrexed|mesh-list
43699540|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699541|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699542|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699543|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43699544|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43699545|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
43699546|NCT02737696|Narcotics|narcotics|mesh-ancestor
43699547|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699548|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699549|NCT02737696|Analgesics|analgesics|mesh-ancestor
43699550|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
43699551|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699552|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
43699553|NCT02737605|Esketamine|esketamine|mesh-list
43699554|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699555|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699556|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43849505|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699557|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699558|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699559|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699560|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699561|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
43699562|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699564|NCT02737371|Clotrimazole|clotrimazole|mesh-list
43699565|NCT02737371|Miconazole|miconazole|mesh-list
43699566|NCT02737371|Olorofim|olorofim|mesh-list
43699572|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699573|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43699575|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699576|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699577|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43699578|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43699579|NCT02737423|Vitamin D|vitamin d|mesh-list
43774793|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
43774794|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774795|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43774796|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43774797|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
43774798|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43774799|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43774800|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774802|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43699582|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
43699583|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699584|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43699585|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43699586|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
43699587|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
43699588|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
43699589|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699590|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699591|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
43699592|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699593|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43699594|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43699595|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43699596|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
43699680|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699681|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43699682|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699683|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43699684|NCT02736682|Metronidazole|metronidazole|mesh-list
43699685|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43699686|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699687|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
43699688|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699689|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43774803|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43774805|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
43774806|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774807|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699748|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
43699749|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699750|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699751|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43699752|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43699753|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43699754|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43699755|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699756|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699757|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43699758|NCT02736019|Narcotics|narcotics|mesh-ancestor
43699759|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699760|NCT02735837|Doxycycline|doxycycline|mesh-list
43699761|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699762|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699763|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
43699764|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43699767|NCT02735928|Doxorubicin|doxorubicin|mesh-list
43699768|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699769|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43699770|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43699771|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699772|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699773|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699774|NCT02735876|Rituximab|rituximab|mesh-list
43699775|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
43699776|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43699777|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699778|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
43699779|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699811|NCT02735343|Ketamine|ketamine|mesh-list
43699812|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
43699813|NCT02735343|Analgesics|analgesics|mesh-ancestor
43699814|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
43699815|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699816|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699817|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43699818|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43699819|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
43699820|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
43699831|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699832|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43699833|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
43699834|NCT02735356|Itraconazole|itraconazole|mesh-list
43699835|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
43699836|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699837|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43699838|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43699839|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824767|NCT05508152|Amoxicillin|amoxicillin|mesh-list
43849506|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
43699852|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699853|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699854|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699855|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699856|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699857|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43699858|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43699859|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
43699860|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699861|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43839735|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
43839736|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839737|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839738|NCT04752631|Tenecteplase|tenecteplase|mesh-list
43839739|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43839740|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839741|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839742|NCT04752566|Eculizumab|eculizumab|mesh-list
43839743|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43839744|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839745|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
43839747|NCT04752267|Clevudine|clevudine|mesh-list
43699862|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
43699863|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43699864|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43699865|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43699866|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43699867|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
43699868|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699869|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43699870|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43782343|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43699871|NCT02735330|Ethanol|ethanol|mesh-list
43699872|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43699873|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699874|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699875|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699876|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
43699877|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
43699878|NCT02735317|Gentamicins|gentamicins|mesh-list
43699879|NCT02735317|Dexamethasone|dexamethasone|mesh-list
43699880|NCT02735317|Procaine|procaine|mesh-list
43699883|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699884|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43699885|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
43699886|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
43699887|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699888|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43699889|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
43699890|NCT02735317|Hormones|hormones|mesh-ancestor
43699891|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699892|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43699893|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699894|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
43699895|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699896|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699897|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43774876|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43774877|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
43774878|NCT02349802|Exenatide|exenatide|mesh-list
43774879|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43774880|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774881|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43774882|NCT02349802|Incretins|incretins|mesh-ancestor
43774883|NCT02349802|Hormones|hormones|mesh-ancestor
43699902|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
43699903|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43699904|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
43699905|NCT02735031|Exenatide|exenatide|mesh-list
43699906|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43782344|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699907|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699908|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43699909|NCT02735031|Incretins|incretins|mesh-ancestor
43699910|NCT02735031|Hormones|hormones|mesh-ancestor
43699911|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43699912|NCT02734875|Anticoagulants|anticoagulants|mesh-list
43699913|NCT02735018|Epinephrine|epinephrine|mesh-list
43699914|NCT02735018|Racepinephrine|racepinephrine|mesh-list
43699915|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
43699916|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43699917|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43699918|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
43699919|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43699920|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699921|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699922|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43699923|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43699925|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43699926|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43699927|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
43699928|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
43699929|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
43699930|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43699931|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
43699932|NCT02734732|Trimethoprim|trimethoprim|mesh-list
43699933|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
43699934|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43699935|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43699936|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43699937|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43699938|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699939|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699944|NCT02734732|Renal Agents|renal agents|mesh-ancestor
43699969|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699970|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
43699971|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699972|NCT02734173|Ritonavir|ritonavir|mesh-list
43699973|NCT02734173|Ribavirin|ribavirin|mesh-list
43699974|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43699975|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43699976|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
43699977|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43699978|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43699980|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43830434|NCT05363631|Trace Elements|trace elements|mesh-ancestor
43700051|NCT02733705|Propofol|propofol|mesh-list
43700052|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700053|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700054|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700055|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43700056|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
43700057|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
43700058|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43700097|NCT02733458|Dexamethasone|dexamethasone|mesh-list
43700098|NCT02733458|Etoposide|etoposide|mesh-list
43700099|NCT02733458|Pegaspargase|pegaspargase|mesh-list
43700100|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700101|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
43700102|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
43782372|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700103|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700104|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700105|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700106|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
43700107|NCT02733458|Hormones|hormones|mesh-ancestor
43700108|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700111|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43774884|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774885|NCT02349958|Doxorubicin|doxorubicin|mesh-list
43774886|NCT02349958|Cisplatin|cisplatin|mesh-list
43774921|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43774922|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43774924|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
43774953|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43774954|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774955|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43774956|NCT02349399|Estrogens|estrogens|mesh-ancestor
43774957|NCT02349399|Hormones|hormones|mesh-ancestor
43700156|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43700157|NCT02733393|Lidocaine|lidocaine|mesh-list
43700158|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
43700159|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
43700160|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700164|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700165|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43700166|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43700167|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700168|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700169|NCT02733380|Thalidomide|thalidomide|mesh-list
43700170|NCT02733380|Dexamethasone|dexamethasone|mesh-list
43700171|NCT02733380|Doxorubicin|doxorubicin|mesh-list
43700172|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43700173|NCT02733380|Vinorelbine|vinorelbine|mesh-list
43700174|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
43700175|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700176|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
43700177|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
43700199|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700200|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43700201|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43700202|NCT02733380|Growth Substances|growth substances|mesh-ancestor
43700203|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
43700204|NCT02733380|Analgesics|analgesics|mesh-ancestor
43700205|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
43700207|NCT02733341|Cangrelor|cangrelor|mesh-list
43700208|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43700209|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43700210|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43700211|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43700212|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
43782413|NCT03423680|Aripiprazole|aripiprazole|mesh-list
43774958|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43774959|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
43774960|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
43774961|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43774962|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43774963|NCT02349581|Bupivacaine|bupivacaine|mesh-list
43774964|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
43774965|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
43774966|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43774967|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43774968|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
43774969|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43774971|NCT02349607|Pregabalin|pregabalin|mesh-list
43775002|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43775003|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775004|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700263|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
43700264|NCT02732405|Grazoprevir|grazoprevir|mesh-list
43700265|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
43700266|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700267|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43700268|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
43700269|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
43700270|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700271|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700272|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43700273|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43700274|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43700275|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43700276|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700277|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43700278|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43700284|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700286|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
43700287|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
43700288|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
43700289|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
43700290|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700291|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700292|NCT02732067|Anesthetics|anesthetics|mesh-list
43700293|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700294|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700295|NCT02732262|Oxycodone|oxycodone|mesh-list
43700296|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43700297|NCT02732262|Narcotics|narcotics|mesh-ancestor
43700298|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700299|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700300|NCT02732262|Analgesics|analgesics|mesh-ancestor
43700301|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
43700302|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830454|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830455|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43830456|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43830457|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830458|NCT05361941|Tobramycin|tobramycin|mesh-list
43830459|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830460|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830461|NCT05361642|Lidocaine|lidocaine|mesh-list
43830462|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
43830463|NCT05361642|Bupivacaine|bupivacaine|mesh-list
43830464|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
43830465|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
43830466|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830467|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830468|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
43830469|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830470|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43830471|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43830472|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43700333|NCT02732249|Bismuth|bismuth|mesh-list
43700401|NCT02731664|Glucagon|glucagon|mesh-list
43700402|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43700403|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43700404|NCT02731664|Hormones|hormones|mesh-ancestor
43700405|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700406|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700407|NCT02731664|Incretins|incretins|mesh-ancestor
43700408|NCT02731846|Fluticasone|fluticasone|mesh-list
43700409|NCT02731846|Xhance|xhance|mesh-list
43700410|NCT02731846|Albuterol|albuterol|mesh-list
43700411|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700412|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43700413|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
43700414|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700415|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700426|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700427|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700429|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43700430|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700431|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
43700432|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700433|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700434|NCT02731378|Iron|iron|mesh-list
43700435|NCT02731378|Dextrans|dextrans|mesh-list
43700436|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
43700437|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
43700438|NCT02731378|Trace Elements|trace elements|mesh-ancestor
43700439|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
43700441|NCT02731378|Hematinics|hematinics|mesh-ancestor
43700458|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
43700459|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700460|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700461|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700462|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43700463|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43700464|NCT02731092|Lactoferrin|lactoferrin|mesh-list
43700465|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700466|NCT02731105|Clindamycin|clindamycin|mesh-list
43700467|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
43700468|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
43700469|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43700470|NCT02731105|Tretinoin|tretinoin|mesh-list
43700471|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43700472|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43700473|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43700474|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700475|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700476|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700477|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
43700478|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700479|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43700480|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43700481|NCT02731105|Analgesics|analgesics|mesh-ancestor
43838757|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43838758|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838759|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838760|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
43838761|NCT04824092|Hormones|hormones|mesh-ancestor
43838762|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838763|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43838764|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43838765|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
43838766|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
43838767|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
43838768|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43700492|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
43700493|NCT02730949|Vitamins|vitamins|mesh-ancestor
43700494|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
43700495|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700496|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
43700497|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
43700498|NCT02731040|Diphosphonates|diphosphonates|mesh-list
43700499|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
43700500|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43700501|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700502|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
43700503|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700504|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43700505|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700506|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700507|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700508|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700509|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700510|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43700512|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700513|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700514|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700526|NCT02730689|Ezetimibe|ezetimibe|mesh-list
43838769|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43700590|NCT02730364|Vitamins|vitamins|mesh-ancestor
43700591|NCT02730364|Micronutrients|micronutrients|mesh-ancestor
43700592|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700593|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43700594|NCT02730364|Analgesics|analgesics|mesh-ancestor
43700595|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
43700596|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700597|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
43700598|NCT02730364|Antioxidants|antioxidants|mesh-ancestor
43700617|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
43700618|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43700619|NCT02730117|Cephalosporins|cephalosporins|mesh-list
43700620|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43700621|NCT02730117|Dobutamine|dobutamine|mesh-list
43700622|NCT02730117|Dopamine|dopamine|mesh-list
43700643|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43700644|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782456|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846533|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846534|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43775044|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43775045|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775046|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
43775047|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775048|NCT02348528|Dexamethasone|dexamethasone|mesh-list
43775049|NCT02348528|Lenalidomide|lenalidomide|mesh-list
43775050|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775051|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
43775052|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
43775053|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849545|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
43700647|NCT02730091|Vinorelbine|vinorelbine|mesh-list
43700648|NCT02730091|Anastrozole|anastrozole|mesh-list
43700649|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700650|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43700651|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43700652|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700653|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700654|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43700655|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700656|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700698|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43700699|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700700|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43700702|NCT02729714|Suvorexant|suvorexant|mesh-list
43700703|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43700704|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43700705|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700706|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700707|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43700708|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700709|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700728|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43700729|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43700730|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700731|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700732|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43700733|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43700734|NCT02729935|Analgesics|analgesics|mesh-ancestor
43700735|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
43700736|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700737|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700738|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43700739|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700740|NCT02729285|Ketorolac|ketorolac|mesh-list
43700744|NCT02729285|Analgesics|analgesics|mesh-ancestor
43700782|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43700783|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43700784|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43700785|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43700786|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43700788|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
43700789|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700791|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43782498|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43700792|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43700793|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700794|NCT02728869|Vaccines|vaccines|mesh-list
43700795|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
43700796|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700797|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43700798|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
43700799|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43700800|NCT02728856|Protective Agents|protective agents|mesh-ancestor
43775085|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775086|NCT02348268|Analgesics|analgesics|mesh-list
43775087|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
43775088|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775089|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775090|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
43775091|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
43775092|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43775093|NCT02348346|Protective Agents|protective agents|mesh-ancestor
43700801|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700802|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700803|NCT02728947|Rotigotine|rotigotine|mesh-list
43700804|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
43700805|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
43700806|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43700807|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700808|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700809|NCT02728934|Golimumab|golimumab|mesh-list
43700810|NCT02728934|Infliximab|infliximab|mesh-list
43700811|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700876|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43700877|NCT02728687|Diuretics|diuretics|mesh-ancestor
43700878|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
43700879|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700880|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
43700881|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
43700882|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
43700883|NCT02728466|Procyanidin|procyanidin|mesh-list
43700894|NCT02728492|Carboplatin|carboplatin|mesh-list
43700895|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43700896|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700918|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700919|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700920|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
43700938|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43700940|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43700941|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700942|NCT02728037|Analgesics|analgesics|mesh-ancestor
43700943|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
43700944|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43700945|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43700946|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
43700947|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700948|NCT02728245|Dienogest|dienogest|mesh-list
43700949|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43700950|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
43700951|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43700952|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700953|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43700954|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43700962|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43700963|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700964|NCT02727647|Factor VIII|factor viii|mesh-list
43700965|NCT02727647|Coagulants|coagulants|mesh-ancestor
43775246|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838801|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
43838802|NCT04820452|Aflibercept|aflibercept|mesh-list
43838803|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43838804|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43838805|NCT04820452|Growth Substances|growth substances|mesh-ancestor
43838806|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838807|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
43838808|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838809|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43838810|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43838811|NCT04818944|Tirofiban|tirofiban|mesh-list
43700985|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43700986|NCT02727738|Trace Elements|trace elements|mesh-ancestor
43700987|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
43700988|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
43700989|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
43700990|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43700991|NCT02727907|Interferons|interferons|mesh-list
43700992|NCT02727907|Interferon-beta|interferon-beta|mesh-list
43700993|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
43700994|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701035|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701036|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701037|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43701038|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43701039|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701040|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701041|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701042|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701043|NCT02727504|Protective Agents|protective agents|mesh-ancestor
43701045|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701049|NCT02727296|Propofol|propofol|mesh-list
43838812|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43838813|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43848086|NCT04051320|Progesterone|progesterone|mesh-list
43775247|NCT02346682|Clonazepam|clonazepam|mesh-list
43775248|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43775249|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43775250|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43701058|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43701059|NCT02727348|Anesthetics|anesthetics|mesh-list
43701060|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701061|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701062|NCT02726919|Clobazam|clobazam|mesh-list
43701063|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
43701064|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43701065|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43701066|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701067|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701068|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43701069|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43701070|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
43701071|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
43701074|NCT02727205|Rotigotine|rotigotine|mesh-list
43701107|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43701109|NCT02726984|Fluorides|fluorides|mesh-list
43701110|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
43701111|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
43701112|NCT02726984|Protective Agents|protective agents|mesh-ancestor
43701113|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701114|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43701115|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701116|NCT02726854|Apatinib|apatinib|mesh-list
43701117|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701125|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701126|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701127|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43701128|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43701129|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
43701130|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
43701131|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830610|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
43830611|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43830612|NCT05353348|Hematinics|hematinics|mesh-ancestor
43830613|NCT05352828|Nivolumab|nivolumab|mesh-list
43830614|NCT05352828|Fludarabine|fludarabine|mesh-list
43839785|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43830615|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43830616|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830617|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830618|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43830619|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830620|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43830621|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
43830622|NCT05352685|Propofol|propofol|mesh-list
43830623|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43830624|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830625|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830634|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43830635|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43830636|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830637|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
43830638|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830639|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830640|NCT05351593|Lenalidomide|lenalidomide|mesh-list
43830641|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
43830642|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830643|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43701143|NCT02726555|Atorvastatin|atorvastatin|mesh-list
43775251|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775272|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
43775273|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775274|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775275|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775276|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775277|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701178|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701179|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701180|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701181|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
43701182|NCT02726308|Hormones|hormones|mesh-ancestor
43701183|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701184|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43701185|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701186|NCT02726269|Ofloxacin|ofloxacin|mesh-list
43701187|NCT02726269|Levofloxacin|levofloxacin|mesh-list
43701188|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43701189|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701190|NCT02726269|Renal Agents|renal agents|mesh-ancestor
43701191|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43701192|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43701193|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43701194|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701195|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701196|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701197|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43701198|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43701199|NCT02726126|Fentanyl|fentanyl|mesh-list
43701200|NCT02726126|Melatonin|melatonin|mesh-list
43701201|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43701202|NCT02726126|Narcotics|narcotics|mesh-ancestor
43701203|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701204|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701205|NCT02726126|Analgesics|analgesics|mesh-ancestor
43701206|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
43701210|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
43652710|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
43652711|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43652712|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
43652713|NCT02988921|Paclitaxel|paclitaxel|mesh-list
43652714|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43652715|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652716|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
43652717|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
43775280|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775281|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43775282|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43775284|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775286|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43775287|NCT02346357|Ropivacaine|ropivacaine|mesh-list
43775288|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
43775289|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
43701213|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701214|NCT02726126|Protective Agents|protective agents|mesh-ancestor
43701215|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43701216|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
43701217|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701219|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43701220|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43701221|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701222|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
43701223|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701224|NCT02725736|Nifedipine|nifedipine|mesh-list
43701225|NCT02725736|Atosiban|atosiban|mesh-list
43701226|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43701227|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701228|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701229|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43701230|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701231|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
43701232|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
43782600|NCT04770454|Serotonin Agents|serotonin agents|mesh-ancestor
43782601|NCT04770454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782603|NCT04691128|Anesthetics|anesthetics|mesh-list
43701233|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701234|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701235|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701236|NCT02725918|Cisplatin|cisplatin|mesh-list
43701237|NCT02725918|Pemetrexed|pemetrexed|mesh-list
43775290|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43775291|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775292|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
43775293|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775294|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43775295|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775296|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
43775297|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
43775298|NCT02346188|Trace Elements|trace elements|mesh-ancestor
43775299|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
43775300|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775301|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775302|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
43775303|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43775304|NCT02346188|Protective Agents|protective agents|mesh-ancestor
43701238|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701239|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701240|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701241|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43701242|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701243|NCT02725541|Trastuzumab|trastuzumab|mesh-list
43701244|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43701245|NCT02725541|Maytansine|maytansine|mesh-list
43701246|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43701247|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701248|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43701249|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
43701250|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
43701251|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
43701252|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701253|NCT02725502|Linagliptin|linagliptin|mesh-list
43701254|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43701255|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701256|NCT02725502|Incretins|incretins|mesh-ancestor
43701257|NCT02725502|Hormones|hormones|mesh-ancestor
43701258|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43701259|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43701282|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43701283|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824891|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
43824892|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43824893|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
43782638|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775340|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775342|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775343|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
43775344|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775380|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43775381|NCT02345993|Beclomethasone|beclomethasone|mesh-list
43775382|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
43775404|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775405|NCT02345980|Urological Agents|urological agents|mesh-ancestor
43775406|NCT02345746|Leucovorin|leucovorin|mesh-list
43701296|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701297|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701298|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
43701299|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701301|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
43701302|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43701303|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43701304|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
43701305|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
43701306|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43701307|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43701312|NCT02725489|Durvalumab|durvalumab|mesh-list
43701354|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43701355|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43701356|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43701358|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830644|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43701359|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703313|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43703314|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703315|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703316|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
43703318|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43703319|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703320|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703321|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
43703322|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703323|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701360|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701362|NCT02724904|Fludarabine|fludarabine|mesh-list
43701363|NCT02724904|Thiotepa|thiotepa|mesh-list
43701364|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43701365|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
43701366|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701367|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782640|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701368|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43701369|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
43701370|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701371|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701372|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
43701373|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701374|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43775534|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775535|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775565|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775566|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43775567|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
43775568|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43775569|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43701391|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43701392|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43701393|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43701394|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701395|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43701396|NCT02724761|Epinephrine|epinephrine|mesh-list
43701397|NCT02724761|Racepinephrine|racepinephrine|mesh-list
43701398|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
43701399|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43701400|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43701401|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
43701402|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701403|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701404|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701405|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43701406|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43701407|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
43701408|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701409|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43701410|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
43701411|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
43701417|NCT02724618|Analgesics|analgesics|mesh-ancestor
43701418|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
43701419|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701420|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701421|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701422|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701423|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701424|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701455|NCT02724150|Omeprazole|omeprazole|mesh-list
43701456|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43701457|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43701476|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43701477|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701478|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43701479|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43701480|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701481|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782666|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
43701482|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701483|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43701484|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43652721|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43652722|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838817|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43838818|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43838819|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838820|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
43838821|NCT04818866|Coagulants|coagulants|mesh-ancestor
43838822|NCT04818450|Gabapentin|gabapentin|mesh-list
43838823|NCT04818450|Analgesics|analgesics|mesh-ancestor
43838824|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
43701536|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43701537|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43701538|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43701539|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43701540|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
43701541|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701542|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701543|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43701544|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
43701545|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43701546|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
43701547|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701548|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43701549|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43701550|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
43701551|NCT02723981|Coagulants|coagulants|mesh-ancestor
43701552|NCT02723903|Fluoxetine|fluoxetine|mesh-list
43701553|NCT02723903|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43701569|NCT02723578|Pemetrexed|pemetrexed|mesh-list
43701670|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
43701671|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43701672|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701673|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
43701674|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
43701675|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701676|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43849549|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43701677|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43701678|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43775616|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701703|NCT02722759|Chrysarobin|chrysarobin|mesh-list
43701704|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43701705|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43701706|NCT02722759|Analgesics|analgesics|mesh-ancestor
43701707|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
43701708|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701709|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701710|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701711|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43701712|NCT02722746|Epinephrine|epinephrine|mesh-list
43701713|NCT02722746|Ropivacaine|ropivacaine|mesh-list
43701714|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
43701715|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
43701716|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701717|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701718|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
43701719|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775642|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775643|NCT02344589|Lidocaine|lidocaine|mesh-list
43775644|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
43775645|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
43775646|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43701732|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43701733|NCT02722772|Etanercept|etanercept|mesh-list
43775648|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
43838827|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
43775649|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43775650|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43775651|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43775652|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43775653|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775654|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775655|NCT02344641|Exenatide|exenatide|mesh-list
43701786|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43701787|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43701788|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701789|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701790|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
43701791|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43701792|NCT02722603|Narcotics|narcotics|mesh-ancestor
43701793|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
43701794|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43701795|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
43701797|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
43701798|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701799|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701800|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
43701801|NCT02722421|Efavirenz|efavirenz|mesh-list
43701802|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
43701803|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43701804|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701805|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701806|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701807|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
43701808|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43701809|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43775656|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775657|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775658|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43775659|NCT02344641|Incretins|incretins|mesh-ancestor
43775660|NCT02344641|Hormones|hormones|mesh-ancestor
43775661|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775662|NCT02344732|Polymyxins|polymyxins|mesh-list
43775663|NCT02344732|Neomycin|neomycin|mesh-list
43775664|NCT02344732|Polymyxin B|polymyxin b|mesh-list
43775665|NCT02344732|Dexamethasone|dexamethasone|mesh-list
43775666|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43775667|NCT02344732|Homatropine|homatropine|mesh-list
43775668|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775669|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
43701810|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43701811|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43701812|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43701813|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43701814|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43701815|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43701816|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
43701817|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701818|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701819|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43701820|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43701821|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43701822|NCT02722369|Gemcitabine|gemcitabine|mesh-list
43701823|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
43701824|NCT02722369|Carboplatin|carboplatin|mesh-list
43701825|NCT02722369|Etoposide|etoposide|mesh-list
43701826|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43701827|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43775693|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
43775694|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775695|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775696|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43652723|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652724|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
43652725|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652726|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701852|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43701853|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43701854|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43701855|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701856|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43701857|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43701858|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
43701859|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782708|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
43782709|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824898|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
43824899|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43782710|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782711|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782712|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43782713|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43701860|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
43701861|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
43701862|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43701863|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
43701864|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
43701865|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43701866|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701912|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701913|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43701914|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43701918|NCT02721329|Acetaminophen|acetaminophen|mesh-list
43701922|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43701923|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43701924|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
43701926|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
43701927|NCT02721433|Pamidronate|pamidronate|mesh-list
43701976|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43701977|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830665|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43830666|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43830667|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43830668|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830669|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43701979|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
43701982|NCT02720991|Misoprostol|misoprostol|mesh-list
43701998|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
43701999|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702000|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
43702001|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43702002|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43702003|NCT02720822|Morphine|morphine|mesh-list
43702027|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
43702028|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702030|NCT02720783|Benzydamine|benzydamine|mesh-list
43702031|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43702032|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
43702033|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702034|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43702035|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43702036|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782747|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782748|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43782749|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782750|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
43782751|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782752|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702037|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702038|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43702039|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702040|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702042|NCT02720692|Meloxicam|meloxicam|mesh-list
43775718|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
43775719|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775720|NCT02344017|Prednisone|prednisone|mesh-list
43775721|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43775722|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
43775723|NCT02344017|Hormones|hormones|mesh-ancestor
43775724|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775725|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775726|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43775727|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775728|NCT02343861|Emollients|emollients|mesh-list
43775729|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775730|NCT02343718|Sirolimus|sirolimus|mesh-list
43775731|NCT02343718|Vinblastine|vinblastine|mesh-list
43775732|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43702062|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702064|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43702077|NCT02720601|Camptothecin|camptothecin|mesh-list
43702078|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702079|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
43702080|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702081|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702082|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43702083|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43702084|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702085|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43702086|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43702089|NCT02720575|Vitamin D|vitamin d|mesh-list
43775733|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43775734|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43775735|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702129|NCT02719756|Metformin|metformin|mesh-list
43702183|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43702184|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
43830672|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43830673|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43830674|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43830675|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
43830676|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
43830677|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
43830678|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43830679|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43830680|NCT05351346|Growth Substances|growth substances|mesh-ancestor
43830681|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
43830682|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43830683|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
43702208|NCT02718950|Incretins|incretins|mesh-ancestor
43702209|NCT02718950|Hormones|hormones|mesh-ancestor
43702210|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702211|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
43702212|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43702213|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702214|NCT02718911|Durvalumab|durvalumab|mesh-list
43702215|NCT02718911|Tremelimumab|tremelimumab|mesh-list
43702217|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775749|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
43775750|NCT02343666|Lenograstim|lenograstim|mesh-list
43775751|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43652729|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
43652731|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652732|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652733|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
43652734|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652735|NCT02988362|Amlodipine|amlodipine|mesh-list
43652736|NCT02988362|Candesartan|candesartan|mesh-list
43652737|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43702247|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
43702248|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702249|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43702250|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43702251|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
43702252|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43702253|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
43702255|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
43703324|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
43703325|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703326|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43703327|NCT02711683|Protective Agents|protective agents|mesh-ancestor
43703328|NCT02711176|Amoxicillin|amoxicillin|mesh-list
43703339|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703340|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43703341|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43703342|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43703343|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
43849552|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703355|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703356|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
43703357|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703358|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43703359|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703360|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703361|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703362|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703363|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43782801|NCT03329378|Carboplatin|carboplatin|mesh-list
43703364|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703365|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
43703366|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703367|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703368|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703369|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43703370|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
43703372|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
43703373|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43703374|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43703375|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
43703376|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703377|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43703378|NCT02711215|Mirtazapine|mirtazapine|mesh-list
43703379|NCT02711215|Citalopram|citalopram|mesh-list
43703380|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43703381|NCT02711215|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43703382|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43702257|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
43702258|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
43702260|NCT02718677|Coagulants|coagulants|mesh-ancestor
43702261|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
43702262|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702263|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
43702264|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702265|NCT02718547|Timolol|timolol|mesh-list
43702266|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43652739|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775752|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
43775753|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775754|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43775755|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
43782829|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
43775756|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775757|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775758|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775759|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775788|NCT02343536|Vincristine|vincristine|mesh-list
43775789|NCT02343536|Azacitidine|azacitidine|mesh-list
43775790|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702297|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
43702298|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702299|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
43702300|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43702301|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702302|NCT02718482|Gemcitabine|gemcitabine|mesh-list
43702304|NCT02718482|Ifosfamide|ifosfamide|mesh-list
43702305|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
43702306|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702307|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
43702308|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702309|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702310|NCT02718482|Antiviral Agents|antiviral agents|mesh-ancestor
43702311|NCT02718482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702312|NCT02718482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702313|NCT02718482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702314|NCT02718482|Immunologic Factors|immunologic factors|mesh-ancestor
43702315|NCT02718482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702316|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
43702317|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
43702318|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
43702319|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43702320|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
43702321|NCT02718599|Terlipressin|terlipressin|mesh-list
43702322|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43702323|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43702324|NCT02718261|Pantoprazole|pantoprazole|mesh-list
43702325|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43775791|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
43775792|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775793|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775794|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43775795|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
43775796|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775797|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775798|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43775799|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43775802|NCT02343536|Hormones|hormones|mesh-ancestor
43702329|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702330|NCT02717884|Cytarabine|cytarabine|mesh-list
43702331|NCT02717884|Tretinoin|tretinoin|mesh-list
43702332|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
43702333|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702334|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
43702335|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702336|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702337|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
43702338|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702339|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702340|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
43702341|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702342|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
43702343|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702344|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
43702345|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43702346|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43702347|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702348|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43702349|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43702352|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
43702386|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
43702387|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
43702388|NCT02717871|Besifloxacin|besifloxacin|mesh-list
43702389|NCT02717871|Prednisolone|prednisolone|mesh-list
43702390|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43702391|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
43702392|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43702393|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
43702394|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43702427|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43702429|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702430|NCT02717858|Liraglutide|liraglutide|mesh-list
43702431|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43702432|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702433|NCT02717858|Incretins|incretins|mesh-ancestor
43702434|NCT02717858|Hormones|hormones|mesh-ancestor
43702435|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702436|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43702437|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43775839|NCT02343393|Isosorbide|isosorbide|mesh-list
43839866|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43839867|NCT04745949|Nivolumab|nivolumab|mesh-list
43775840|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
43775841|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
43775842|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43775843|NCT02343393|Diuretics|diuretics|mesh-ancestor
43775844|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
43775845|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775846|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
43775847|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43775848|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652740|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652741|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43652742|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652743|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652744|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43652745|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43775849|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43775850|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
43775851|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43775852|NCT02343211|Antibodies|antibodies|mesh-list
43775853|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
43775854|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775855|NCT02343289|Clarithromycin|clarithromycin|mesh-list
43775856|NCT02343289|Esketamine|esketamine|mesh-list
43830739|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830740|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830741|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43830742|NCT05347173|Narcotics|narcotics|mesh-ancestor
43830743|NCT05347069|Aspirin|aspirin|mesh-list
43830744|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702537|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43702539|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702541|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
43702542|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702543|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
43702544|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43702545|NCT02716285|Peppermint oil|peppermint oil|mesh-list
43702546|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
43702547|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
43702548|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839899|NCT04742491|Emtricitabine|emtricitabine|mesh-list
43839900|NCT04742491|Tenofovir|tenofovir|mesh-list
43839901|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43590175|NCT03373669|Vaccines|vaccines|mesh-list
43839902|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43782902|NCT05095714|Liver Extracts|liver extracts|mesh-list
43782903|NCT05095714|Hematinics|hematinics|mesh-ancestor
43782904|NCT05095636|Apatinib|apatinib|mesh-list
43782905|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782906|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43782907|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782908|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782909|NCT05095571|Niacinamide|niacinamide|mesh-list
43702549|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702550|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43775870|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775871|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775872|NCT02343250|Valsartan|valsartan|mesh-list
43775873|NCT02343250|Cilnidipine|cilnidipine|mesh-list
43775874|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43775875|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43775876|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43775877|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702576|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43702577|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
43702578|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43702579|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702580|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43702581|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43702582|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
43702583|NCT02716090|Adapalene|adapalene|mesh-list
43702584|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43702585|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775878|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43775879|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43775880|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43775881|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775882|NCT02342925|Metformin|metformin|mesh-list
43775883|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775884|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775885|NCT02342769|Dolutegravir|dolutegravir|mesh-list
43775886|NCT02342769|Abacavir|abacavir|mesh-list
43775887|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43775888|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43775889|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702628|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830790|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43830791|NCT05345990|Antibodies|antibodies|mesh-list
43830792|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
43830793|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830794|NCT05345782|Bupivacaine|bupivacaine|mesh-list
43830795|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43830796|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
43830797|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43830798|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830799|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
43830800|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830801|NCT05345509|Donepezil|donepezil|mesh-list
43830802|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43830803|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830804|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653553|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653554|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43653556|NCT02983344|Analgesics|analgesics|mesh-ancestor
43653557|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43653558|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43653559|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
43653560|NCT02983084|Copper|copper|mesh-list
43830805|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
43830806|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43830807|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830808|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
43830809|NCT05344404|Niacinamide|niacinamide|mesh-list
43830810|NCT05344404|Niacin|niacin|mesh-list
43830811|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
43775939|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775940|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43838829|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43775941|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775942|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43775943|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775944|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775945|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
43775946|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43775947|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43775963|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775964|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43775966|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775967|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43775968|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43775969|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43775970|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43702691|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43702692|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702693|NCT02714998|Methotrexate|methotrexate|mesh-list
43702694|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43702695|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
43702696|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43702697|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702698|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702699|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
43702700|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702701|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702702|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702703|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702704|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43702705|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43702706|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
43775971|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43775972|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
43775973|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43775974|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43775975|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
43775979|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43775980|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
43775981|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43775983|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43775984|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43775985|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43775986|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775987|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43590230|NCT03373149|Hormones|hormones|mesh-list
43782910|NCT05095571|Niacin|niacin|mesh-list
43782911|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
43782912|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
43782914|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
43782915|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782916|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782917|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
43703530|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775988|NCT02342093|Diuretics|diuretics|mesh-ancestor
43775989|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
43775990|NCT02342067|Pioglitazone|pioglitazone|mesh-list
43652755|NCT02988440|Sorafenib|sorafenib|mesh-list
43652756|NCT02988440|Spartalizumab|spartalizumab|mesh-list
43652757|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652758|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43702791|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702792|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43652759|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652760|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652761|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43652762|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43652763|NCT02988089|Amoxicillin|amoxicillin|mesh-list
43775991|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
43775992|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43775993|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775994|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43775995|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775996|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43775997|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43775998|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
43775999|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776000|NCT02341872|Calcium|calcium|mesh-list
43776001|NCT02341872|Fluorides|fluorides|mesh-list
43776002|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43776003|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776004|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
43776005|NCT02341872|Protective Agents|protective agents|mesh-ancestor
43776006|NCT02342002|Misoprostol|misoprostol|mesh-list
43702816|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43702817|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702818|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702865|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702866|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
43702868|NCT02714231|Scopolamine|scopolamine|mesh-list
43702869|NCT02714231|Bromides|bromides|mesh-list
43702870|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43702871|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43702872|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43702896|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
43702897|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43702898|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702899|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
43702900|NCT02714361|Vitamin D|vitamin d|mesh-list
43702901|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
43702902|NCT02714361|Vitamins|vitamins|mesh-ancestor
43702903|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
43702904|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702905|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43702906|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43702907|NCT02714036|Ibudilast|ibudilast|mesh-list
43702908|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43776024|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
43776025|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43776026|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43776027|NCT02341833|Sevoflurane|sevoflurane|mesh-list
43776028|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43776029|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43776030|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
43776031|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
43776032|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776033|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776035|NCT02341963|Analgesics|analgesics|mesh-ancestor
43776036|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
43776037|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776038|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702930|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43702931|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702932|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702933|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43702934|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702935|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702936|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702937|NCT02714010|Gefitinib|gefitinib|mesh-list
43702938|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43702939|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43702940|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43702941|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702942|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
43702943|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43702944|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702945|NCT02714075|Zinc|zinc|mesh-list
43702946|NCT02714075|Iron|iron|mesh-list
43702947|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
43702948|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
43702949|NCT02714075|Citric Acid|citric acid|mesh-list
43702950|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
43702951|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
43702952|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43702953|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
43702954|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
43776043|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776044|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43776045|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43776046|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776047|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776048|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43776049|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43776050|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43776051|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
43776052|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43702962|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43702963|NCT02714075|Protective Agents|protective agents|mesh-ancestor
43702964|NCT02713802|Propofol|propofol|mesh-list
43702965|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43702966|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43702967|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43702968|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43702969|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
43702970|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
43830815|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830816|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782933|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782953|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
43830817|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
43830818|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830819|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43830820|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
43830821|NCT05344209|Sargramostim|sargramostim|mesh-list
43830822|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
43830823|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830824|NCT05342519|Sirolimus|sirolimus|mesh-list
43830825|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43830826|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43830827|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43830828|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776053|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43776054|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43776055|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776057|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43776058|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43652765|NCT02988089|Clarithromycin|clarithromycin|mesh-list
43652766|NCT02988089|Levofloxacin|levofloxacin|mesh-list
43652767|NCT02988089|Ofloxacin|ofloxacin|mesh-list
43652768|NCT02988089|Tetracycline|tetracycline|mesh-list
43652769|NCT02988089|Tinidazole|tinidazole|mesh-list
43652770|NCT02988089|Furazolidone|furazolidone|mesh-list
43652771|NCT02988089|Bismuth|bismuth|mesh-list
43652772|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43652773|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652774|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43776081|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848088|NCT04051320|Hormones|hormones|mesh-ancestor
43776082|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776083|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
43776084|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43703020|NCT02713191|Fentanyl|fentanyl|mesh-list
43703021|NCT02713191|Midazolam|midazolam|mesh-list
43703022|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
43703023|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703024|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703025|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703047|NCT02713009|Vitamin D|vitamin d|mesh-list
43703048|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
43703049|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
43703050|NCT02713009|Vitamins|vitamins|mesh-list
43703051|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
43776087|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776088|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776090|NCT02341586|Trace Elements|trace elements|mesh-ancestor
43776091|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
43776092|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776093|NCT02341638|Aspirin|aspirin|mesh-list
43776094|NCT02341638|Itraconazole|itraconazole|mesh-list
43776095|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43776096|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776097|NCT02341638|Analgesics|analgesics|mesh-ancestor
43703072|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782963|NCT05095077|Tadalafil|tadalafil|mesh-list
43703073|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43776108|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776109|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
43776110|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
43776111|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43838843|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703132|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43703133|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
43703134|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703135|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703137|NCT02712528|Remifentanil|remifentanil|mesh-list
43703138|NCT02712528|Sevoflurane|sevoflurane|mesh-list
43703139|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703140|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43703141|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
43703142|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
43703143|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703144|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703145|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703146|NCT02712528|Narcotics|narcotics|mesh-ancestor
43703147|NCT02712528|Analgesics|analgesics|mesh-ancestor
43838844|NCT04816682|Protective Agents|protective agents|mesh-ancestor
43838845|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848089|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776164|NCT02341079|Bupivacaine|bupivacaine|mesh-list
43776165|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
43776166|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
43776190|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
43776191|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776192|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
43703148|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
43703149|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703150|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703151|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703152|NCT02712502|Amoxicillin|amoxicillin|mesh-list
43703153|NCT02712502|Levofloxacin|levofloxacin|mesh-list
43703154|NCT02712502|Ofloxacin|ofloxacin|mesh-list
43703155|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
43703156|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
43703157|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43703158|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703159|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703160|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43703161|NCT02712502|Renal Agents|renal agents|mesh-ancestor
43703162|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43703163|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43703164|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703211|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703213|NCT02711943|Ofloxacin|ofloxacin|mesh-list
43703214|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43703215|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703216|NCT02711943|Renal Agents|renal agents|mesh-ancestor
43703217|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703218|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43703219|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43703220|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703221|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703222|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703223|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43776193|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
43776194|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776195|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776196|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43776197|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43776198|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43776199|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43703337|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43703338|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703344|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43703345|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43703346|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43703347|NCT02711189|Oxytocin|oxytocin|mesh-list
43703348|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
43703349|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703350|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703351|NCT02711202|Sirolimus|sirolimus|mesh-list
43703352|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
43703353|NCT02711202|Infliximab|infliximab|mesh-list
43703354|NCT02711202|Tacrolimus|tacrolimus|mesh-list
43776207|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
43776208|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838846|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43776209|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776210|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
43703386|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
43703440|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703441|NCT02711241|Analgesics|analgesics|mesh-ancestor
43703442|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
43703443|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703444|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776255|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43776256|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776257|NCT02340247|Cathartics|cathartics|mesh-ancestor
43776258|NCT02340117|Gemcitabine|gemcitabine|mesh-list
43776284|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776285|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776286|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776287|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43776288|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43776289|NCT02340169|Desoximetasone|desoximetasone|mesh-list
43776290|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776291|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
43776292|NCT02340169|Hormones|hormones|mesh-ancestor
43776293|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776294|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776295|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43776296|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
43776297|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43776298|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43782998|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703467|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703468|NCT02710877|Analgesics|analgesics|mesh-ancestor
43703469|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
43703470|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703471|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703472|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703473|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
43703474|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
43703475|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703476|NCT02710656|Paclitaxel|paclitaxel|mesh-list
43703477|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43703478|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703479|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43703480|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43703481|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
43703482|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703483|NCT02710539|Amlodipine|amlodipine|mesh-list
43776300|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
43776301|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776302|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776303|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43776304|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43776305|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43776306|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43776307|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776308|NCT02339714|Loratadine|loratadine|mesh-list
43776309|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
43776335|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43703484|NCT02710539|Perindopril|perindopril|mesh-list
43703485|NCT02710539|Indapamide|indapamide|mesh-list
43703486|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43703487|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43703488|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703489|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703490|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43703491|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849553|NCT03916068|Vitamin E|vitamin e|mesh-list
43849554|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
43703492|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703493|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43703494|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
43703495|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703496|NCT02710539|Diuretics|diuretics|mesh-ancestor
43703497|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
43703498|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43703499|NCT02710604|Tenofovir|tenofovir|mesh-list
43703500|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
43703501|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
43783026|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703502|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703503|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43703504|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43703505|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703506|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703507|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43703508|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43703510|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
43703511|NCT02710552|Perindopril|perindopril|mesh-list
43703512|NCT02710552|Indapamide|indapamide|mesh-list
43703513|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43703514|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783027|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703515|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703516|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43703517|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703518|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703519|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43703520|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
43703574|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703575|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43703576|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
43703577|NCT02710110|Capsaicin|capsaicin|mesh-list
43703578|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
43703579|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703580|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
43703581|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703582|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703583|NCT02710162|Capsaicin|capsaicin|mesh-list
43703584|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
43703585|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703586|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
43703587|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703588|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830864|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830865|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43830866|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830867|NCT05340764|Infliximab|infliximab|mesh-list
43830868|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
43830870|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43830871|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43830872|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43783038|NCT04492891|Cyclosporine|cyclosporine|mesh-list
43830873|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830875|NCT05339529|Thymalfasin|thymalfasin|mesh-list
43830876|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
43776351|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653582|NCT02983422|Diuretics|diuretics|mesh-ancestor
43776352|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703589|NCT02709863|Propofol|propofol|mesh-list
43703590|NCT02709863|Sevoflurane|sevoflurane|mesh-list
43703591|NCT02709863|Desflurane|desflurane|mesh-list
43703592|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43703593|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703594|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703595|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43703596|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
43703597|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
43703598|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43703599|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43703600|NCT02709902|Adapalene|adapalene|mesh-list
43703601|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
43703602|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43703603|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703604|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43703605|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43703606|NCT02709902|Analgesics|analgesics|mesh-ancestor
43703607|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
43703608|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653583|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
43783099|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43783100|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783102|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43703609|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703613|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43830884|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
43703614|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43703615|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703616|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
43703617|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703619|NCT02709720|Vinorelbine|vinorelbine|mesh-list
43703620|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703657|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703658|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703659|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703660|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
43703661|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43703662|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
43703663|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703664|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703665|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43703666|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
43703667|NCT02709564|Misoprostol|misoprostol|mesh-list
43703668|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43703669|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
43776367|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
43776368|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776369|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776370|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43776371|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
43776372|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776373|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776374|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
43703670|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43703671|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703672|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43703673|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43703674|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
43703675|NCT02709265|Amikacin|amikacin|mesh-list
43703676|NCT02709265|Fosfomycin|fosfomycin|mesh-list
43703677|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703678|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703679|NCT02709304|Lidocaine|lidocaine|mesh-list
43703680|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703681|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
43703682|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703683|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776376|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43776377|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776378|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
43776414|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776415|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
43776416|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848237|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43848238|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43848239|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
43848240|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
43848241|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43848242|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43776417|NCT02339428|Diclofenac|diclofenac|mesh-list
43703822|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703823|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
43703824|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703825|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703826|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703827|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43703828|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703829|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703830|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703831|NCT02708459|Morphine|morphine|mesh-list
43703832|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43703833|NCT02708459|Narcotics|narcotics|mesh-ancestor
43703834|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703835|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703836|NCT02708459|Analgesics|analgesics|mesh-ancestor
43703837|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
43703838|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703839|NCT02708173|Vaccines|vaccines|mesh-list
43830894|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43830895|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776423|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703870|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43703871|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703872|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703873|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43703874|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703875|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
43703877|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
43703878|NCT02707666|Pemetrexed|pemetrexed|mesh-list
43703879|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703880|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43703885|NCT02707653|Misoprostol|misoprostol|mesh-list
43776459|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43776460|NCT02339116|Growth Substances|growth substances|mesh-ancestor
43776461|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776462|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
43776463|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43590468|NCT03371173|Ferric maltol|ferric maltol|mesh-list
43783145|NCT03806309|Leucovorin|leucovorin|mesh-list
43783146|NCT03806309|Fluorouracil|fluorouracil|mesh-list
43783147|NCT03806309|Irinotecan|irinotecan|mesh-list
43783148|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
43783149|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783150|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783151|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783152|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783153|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
43783154|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783155|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43783156|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43783157|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783158|NCT03806309|Antidotes|antidotes|mesh-ancestor
43783159|NCT03806309|Protective Agents|protective agents|mesh-ancestor
43783160|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
43776464|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776465|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776466|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776503|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776530|NCT02338570|Everolimus|everolimus|mesh-list
43776531|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776532|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776533|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
43703941|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43703942|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43703943|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
43703944|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849555|NCT03916068|Vitamins|vitamins|mesh-ancestor
43703945|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43703946|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
43703947|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43703948|NCT02707575|Ranibizumab|ranibizumab|mesh-list
43703949|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43703950|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43703977|NCT02707315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43703978|NCT02707315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703979|NCT02707315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43703980|NCT02707315|Immunologic Factors|immunologic factors|mesh-ancestor
43703981|NCT02707315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703982|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43703983|NCT02706977|Carbidopa|carbidopa|mesh-list
43703984|NCT02706977|Levodopa|levodopa|mesh-list
43703985|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43703986|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
43704010|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704012|NCT02707263|Calcium heparin|calcium heparin|mesh-list
43704013|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
43704014|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43704015|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43704016|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776541|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43776542|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43776543|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849556|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
43704027|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43704028|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43704029|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43704030|NCT02707159|Gemcitabine|gemcitabine|mesh-list
43704031|NCT02707159|Paclitaxel|paclitaxel|mesh-list
43704032|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43704033|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43704034|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704035|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
43704036|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
43704037|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
43704038|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704039|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704040|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
43704041|NCT02707159|Antiviral Agents|antiviral agents|mesh-ancestor
43704042|NCT02707159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704043|NCT02707159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704044|NCT02707159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704045|NCT02707159|Immunologic Factors|immunologic factors|mesh-ancestor
43704046|NCT02707159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704047|NCT02707211|Antibodies|antibodies|mesh-list
43704048|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
43704049|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
43652777|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652778|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704050|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704051|NCT02707250|Meperidine|meperidine|mesh-list
43704052|NCT02707250|Bupivacaine|bupivacaine|mesh-list
43704129|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43704131|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704132|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704133|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43704134|NCT02706509|Narcotics|narcotics|mesh-ancestor
43704135|NCT02706509|Analgesics|analgesics|mesh-ancestor
43704136|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
43704137|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652789|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43652790|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43652791|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43652792|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
43652793|NCT02988063|Polidocanol|polidocanol|mesh-list
43652794|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43652795|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43652796|NCT02987985|Acetaminophen|acetaminophen|mesh-list
43652797|NCT02987985|Dexamethasone|dexamethasone|mesh-list
43849557|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847357|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
43847358|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43847359|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43847360|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
43847361|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847362|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847363|NCT04113317|Lenograstim|lenograstim|mesh-list
43847364|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43847365|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
43847366|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847367|NCT04112823|Dexamethasone|dexamethasone|mesh-list
43847368|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
43847369|NCT04112823|BB 1101|bb 1101|mesh-list
43847370|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43847371|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
43847372|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
43847373|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847374|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847375|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43847376|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
43847377|NCT04112823|Hormones|hormones|mesh-ancestor
43847378|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847379|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847380|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847381|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
43847382|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652799|NCT02987985|Fentanyl|fentanyl|mesh-list
43652800|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
43652801|NCT02987985|Ketamine|ketamine|mesh-list
43652802|NCT02987985|Gabapentin|gabapentin|mesh-list
43652803|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
43652804|NCT02987985|Ondansetron|ondansetron|mesh-list
43652805|NCT02987985|Sevoflurane|sevoflurane|mesh-list
43776547|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776548|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
43776582|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776584|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43776586|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
43776587|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
43776614|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776615|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43776616|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43776617|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43776618|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776619|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838849|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43652806|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652807|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
43847383|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847384|NCT04112368|Estradiol|estradiol|mesh-list
43847385|NCT04112368|Progesterone|progesterone|mesh-list
43847386|NCT04112368|Estrogens|estrogens|mesh-ancestor
43847387|NCT04112368|Hormones|hormones|mesh-ancestor
43847388|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847389|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847390|NCT04112368|Progestins|progestins|mesh-ancestor
43704157|NCT05264883|Azacitidine|azacitidine|mesh-list
43704158|NCT05264883|Decitabine|decitabine|mesh-list
43704159|NCT05264883|Venetoclax|venetoclax|mesh-list
43704160|NCT05264883|Aclarubicin|aclarubicin|mesh-list
43704161|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43704162|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
43704163|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704164|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704165|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704166|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43704167|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43704168|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43704169|NCT05264805|Bupivacaine|bupivacaine|mesh-list
43704183|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704184|NCT05264077|Midazolam|midazolam|mesh-list
43704185|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
43704186|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43704187|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704193|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43704194|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43704195|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43704196|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
43704197|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43704198|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704199|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43704200|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43704201|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43704202|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43704203|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43704204|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
43838862|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43838863|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43838864|NCT04813991|Analgesics|analgesics|mesh-ancestor
43838865|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
43776626|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776627|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43776628|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
43776629|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704225|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43704226|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704227|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43704228|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704229|NCT05263700|FAPI-46|fapi-46|mesh-list
43704230|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43704231|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704232|NCT05260619|Lenalidomide|lenalidomide|mesh-list
43704233|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
43704234|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704235|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43704236|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43704237|NCT05260619|Growth Substances|growth substances|mesh-ancestor
43704238|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
43704239|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704240|NCT05260554|Fosfomycin|fosfomycin|mesh-list
43776631|NCT02337413|Laxatives|laxatives|mesh-ancestor
43776632|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776633|NCT02337283|BI 425809|bi 425809|mesh-list
43776634|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
43776663|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43776664|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43783314|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43776665|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776666|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
43776667|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
43830937|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830938|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43830939|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43830940|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
43830941|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43830942|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43830943|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43704273|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43776668|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43776669|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776670|NCT02337192|Analgesics|analgesics|mesh-ancestor
43776671|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
43776672|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776673|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776674|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776675|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776676|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704340|NCT05174598|Vitamins|vitamins|mesh-ancestor
43704341|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
43704342|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43704343|NCT05151848|Adalimumab|adalimumab|mesh-list
43704344|NCT05151848|Tofacitinib|tofacitinib|mesh-list
43704345|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43704346|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704347|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43704348|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704349|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704350|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
43704352|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
43704353|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704354|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704355|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
43704356|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704357|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43704358|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
43704359|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43704360|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704361|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704362|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43704363|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
43704364|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704365|NCT05087589|Tofacitinib|tofacitinib|mesh-list
43704366|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43704367|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704368|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704369|NCT05079061|Misoprostol|misoprostol|mesh-list
43704370|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43704371|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
43704372|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43704373|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704374|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43704375|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43704376|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
43704377|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
43704378|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43776722|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776724|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43776725|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776744|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704412|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43704413|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
43704414|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704415|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43704417|NCT04993027|Vancomycin|vancomycin|mesh-list
43704418|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704419|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704420|NCT04956146|Carboplatin|carboplatin|mesh-list
43704421|NCT04956146|Pemetrexed|pemetrexed|mesh-list
43704422|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704423|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704424|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776749|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776751|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
43776752|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
43652813|NCT02987985|Hormones|hormones|mesh-ancestor
43703383|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703384|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703385|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703387|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703388|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43703389|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
43830961|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43830962|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
43830963|NCT05334329|Fludarabine|fludarabine|mesh-list
43830964|NCT05334329|Atezolizumab|atezolizumab|mesh-list
43830965|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
43830966|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43830967|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652814|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703390|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43652815|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652816|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652817|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
43783382|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783383|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783384|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
43783385|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43652818|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
43776753|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776754|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776755|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
43776756|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776757|NCT02336516|Azithromycin|azithromycin|mesh-list
43776758|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43776759|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776760|NCT02336308|Ketamine|ketamine|mesh-list
43776761|NCT02336308|Analgesics|analgesics|mesh-ancestor
43776762|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
43776763|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776764|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776765|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43776766|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43704575|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43704576|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
43704577|NCT04663555|Hormones|hormones|mesh-ancestor
43704578|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776767|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
43776768|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
43776769|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43582889|NCT03444246|Iodine|iodine|mesh-list
43776770|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43776771|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43776772|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776773|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704627|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
43704628|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704629|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704630|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
43704631|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43704632|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704633|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704634|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43704635|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43704636|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43704637|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43704638|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43704639|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43704640|NCT04546113|Ropivacaine|ropivacaine|mesh-list
43653606|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43653607|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
43704641|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704642|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
43704643|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704644|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704645|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
43704646|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704647|NCT04527757|Anesthetics|anesthetics|mesh-list
43783426|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704648|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704649|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704650|NCT04519164|Eplerenone|eplerenone|mesh-list
43704651|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
43704652|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43704653|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
43704654|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704655|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704657|NCT04519164|Diuretics|diuretics|mesh-ancestor
43776774|NCT02336386|Dexamethasone|dexamethasone|mesh-list
43776775|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
43776776|NCT02336386|Doxorubicin|doxorubicin|mesh-list
43776778|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704801|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704802|NCT04175626|Sirolimus|sirolimus|mesh-list
43704803|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704804|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704805|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43704806|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704807|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
43704808|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704809|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
43704810|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704811|NCT04126473|Ivacaftor|ivacaftor|mesh-list
43776779|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
43776780|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776806|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776808|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783442|NCT04616274|Venetoclax|venetoclax|mesh-list
43776809|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776810|NCT02336347|Quinidine|quinidine|mesh-list
43776811|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
43776812|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
43776813|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
43776814|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43776815|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43776816|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43776817|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776818|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776819|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43776820|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43776821|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776822|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43776823|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
43704841|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704843|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
43704844|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704845|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43704846|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
43704847|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704848|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43704849|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704850|NCT03931408|Gentamicins|gentamicins|mesh-list
43704851|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704852|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704853|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43704854|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704855|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704856|NCT03896685|Linezolid|linezolid|mesh-list
43776825|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43776826|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43776846|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
43776847|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43776848|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
43776849|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
43776850|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43776851|NCT02335593|Hematinics|hematinics|mesh-ancestor
43776852|NCT02335593|Astringents|astringents|mesh-ancestor
43783469|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43783470|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43783471|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783472|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43783473|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43783474|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43783475|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43783476|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43783477|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43783478|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
43783479|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
43783480|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43783481|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
43783482|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43783483|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43783485|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776853|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776854|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
43704881|NCT03815019|Megestrol|megestrol|mesh-list
43652824|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652825|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704970|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43704971|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704972|NCT03765567|Vancomycin|vancomycin|mesh-list
43704973|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43704974|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43704975|NCT03762109|Dantrolene|dantrolene|mesh-list
43704976|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43704977|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704978|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43704979|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704980|NCT03746951|Ropivacaine|ropivacaine|mesh-list
43704981|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
43704982|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
43704983|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43704984|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704985|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
43704986|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43704988|NCT03746769|Hormones|hormones|mesh-ancestor
43704989|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43704990|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43704991|NCT03699631|Methotrexate|methotrexate|mesh-list
43704992|NCT03699631|Tacrolimus|tacrolimus|mesh-list
43704993|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43704994|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
43705000|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43705001|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
43705002|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43705003|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43705004|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43705005|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
43705006|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43705007|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43705143|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43705144|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705147|NCT05345236|Aflibercept|aflibercept|mesh-list
43705238|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43705239|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705240|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43705241|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
43705242|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43705243|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
43705244|NCT05343728|Hemostatics|hemostatics|mesh-list
43705245|NCT05343728|Coagulants|coagulants|mesh-ancestor
43705297|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43705298|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
43705299|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43705300|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705301|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43783489|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783490|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43783492|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
43705302|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705303|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
43705304|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43705305|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43705306|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43705307|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43705308|NCT05342870|Analgesics|analgesics|mesh-ancestor
43705309|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
43705330|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705331|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831100|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
43831101|NCT05331027|Sevoflurane|sevoflurane|mesh-list
43831102|NCT05331027|Desflurane|desflurane|mesh-list
43831103|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43831104|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43831105|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
43776857|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776859|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
43776860|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776861|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
43776862|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652831|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43652832|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
43652833|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652834|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43652835|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652836|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
43705375|NCT05244538|Propofol|propofol|mesh-list
43652837|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43652838|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43652839|NCT02987985|Narcotics|narcotics|mesh-ancestor
43652840|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43652841|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
43652842|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43652843|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43652844|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
43652845|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43705406|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776863|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776864|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
43776865|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43776866|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43776867|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43776868|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43776869|NCT02335372|Acetic Acid|acetic acid|mesh-list
43776870|NCT02335372|Proflavine|proflavine|mesh-list
43776871|NCT02335372|Retinol acetate|retinol acetate|mesh-list
43776890|NCT02335281|Mesalamine|mesalamine|mesh-list
43776891|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653624|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43653625|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
43653626|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653627|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43776892|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43776893|NCT02335281|Analgesics|analgesics|mesh-ancestor
43776894|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
43705443|NCT05042440|Coagulants|coagulants|mesh-ancestor
43705519|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776895|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776896|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776897|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43776898|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43776899|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
43776900|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43776901|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43776902|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776903|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
43776904|NCT02335359|Coagulants|coagulants|mesh-ancestor
43776905|NCT02335398|Methadone|methadone|mesh-list
43776906|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43776907|NCT02335398|Narcotics|narcotics|mesh-ancestor
43776908|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776909|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776910|NCT02335398|Analgesics|analgesics|mesh-ancestor
43776911|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
43776912|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776913|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
43776914|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
43776915|NCT02335190|Lidocaine|lidocaine|mesh-list
43776916|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
43705553|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43705559|NCT04416737|Insulin|insulin|mesh-list
43776918|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43776919|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43776920|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
43776921|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43776922|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43776923|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43776924|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43776925|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43652846|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43652847|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43652848|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
43652849|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
43652850|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
43776926|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776927|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
43653628|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43776928|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
43776929|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
43776960|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43703522|NCT02710552|Diuretics|diuretics|mesh-ancestor
43705745|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
43705746|NCT03794336|Incretins|incretins|mesh-ancestor
43705747|NCT03794336|Hormones|hormones|mesh-ancestor
43705748|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43705749|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43705750|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
43705751|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43705752|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
43776965|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43703523|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
43776966|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43776967|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43776968|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43776969|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43776970|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
43776971|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43776972|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43776973|NCT02334475|Prednisolone|prednisolone|mesh-list
43776974|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
43776975|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43776976|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
43777009|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43777010|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777011|NCT02334670|Fluconazole|fluconazole|mesh-list
43777012|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
43777013|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777014|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43777015|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43777016|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777017|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777018|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43777052|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777053|NCT02334163|Metronidazole|metronidazole|mesh-list
43783519|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783528|NCT04345887|Diuretics|diuretics|mesh-ancestor
43777054|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
43777055|NCT02334163|Lactulose|lactulose|mesh-list
43777056|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777057|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43706023|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43706024|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43706025|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43706026|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
43706027|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706028|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706029|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706030|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43706031|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706032|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43706033|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
43706034|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
43706035|NCT02415153|Pomalidomide|pomalidomide|mesh-list
43706036|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
43706037|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706038|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43706057|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706058|NCT02274285|Vaccines|vaccines|mesh-list
43706059|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
43706060|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706062|NCT02078427|BAX 855|bax 855|mesh-list
43777058|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43777085|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43777086|NCT02334150|Sufentanil|sufentanil|mesh-list
43777087|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43777088|NCT02334150|Narcotics|narcotics|mesh-ancestor
43777089|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777090|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777091|NCT02334150|Analgesics|analgesics|mesh-ancestor
43777092|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
43777093|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777094|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43777095|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43652851|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43652852|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
43706119|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706120|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43706121|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43706122|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706123|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43706124|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43706125|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706126|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
43831184|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831185|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783553|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831186|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831187|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
43831188|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
43831189|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
43831190|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43831191|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831192|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831199|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
43831218|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43706127|NCT03172780|Diclofenac|diclofenac|mesh-list
43706128|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43706129|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706130|NCT03172780|Analgesics|analgesics|mesh-ancestor
43706131|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
43706132|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706135|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652853|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43777096|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
43777098|NCT02334046|Remifentanil|remifentanil|mesh-list
43777099|NCT02334046|Sevoflurane|sevoflurane|mesh-list
43777101|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43777102|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
43777103|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
43777104|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777105|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777106|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43777107|NCT02334046|Narcotics|narcotics|mesh-ancestor
43777126|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
43777128|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777129|NCT02333838|Fludarabine|fludarabine|mesh-list
43777130|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
43777131|NCT02333838|Busulfan|busulfan|mesh-list
43777132|NCT02333838|Thiotepa|thiotepa|mesh-list
43777133|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777134|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777135|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
43777136|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777137|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777138|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
43777139|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706268|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43706269|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43706270|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706271|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777140|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
43777141|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777142|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43777143|NCT02334007|Dalteparin|dalteparin|mesh-list
43777144|NCT02334007|Tinzaparin|tinzaparin|mesh-list
43777145|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43777146|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
43777147|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43777148|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43783563|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43777149|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777150|NCT02333799|Linezolid|linezolid|mesh-list
43777151|NCT02333799|Bedaquiline|bedaquiline|mesh-list
43706306|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43706307|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706308|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43706309|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777153|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777154|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43777155|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777156|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777157|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
43777158|NCT02333682|Vitamin D|vitamin d|mesh-list
43777159|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
43777160|NCT02333682|Calcifediol|calcifediol|mesh-list
43777161|NCT02333682|Vitamins|vitamins|mesh-ancestor
43777162|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
43777163|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777198|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777199|NCT02333188|Leucovorin|leucovorin|mesh-list
43777200|NCT02333188|Paclitaxel|paclitaxel|mesh-list
43777201|NCT02333188|Fluorouracil|fluorouracil|mesh-list
43706364|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43706365|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706366|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43706367|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706368|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43706369|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43706370|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706371|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43706372|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43706373|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706374|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706375|NCT01542021|Androgens|androgens|mesh-list
43783678|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
43706407|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43706408|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
43706409|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
43706410|NCT01246310|Inositol|inositol|mesh-list
43706411|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
43706412|NCT01246310|Vitamins|vitamins|mesh-ancestor
43706413|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
43706414|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706415|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
43777203|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43777235|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777237|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43777238|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777239|NCT02333123|Analgesics|analgesics|mesh-ancestor
43777240|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
43777241|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777242|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777243|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777244|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777245|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43777246|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43777247|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777276|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43777278|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652855|NCT02987920|Celecoxib|celecoxib|mesh-list
43652856|NCT02987920|Ketorolac|ketorolac|mesh-list
43652857|NCT02987920|Oxycodone|oxycodone|mesh-list
43652858|NCT02987920|Gabapentin|gabapentin|mesh-list
43652859|NCT02987920|Hydromorphone|hydromorphone|mesh-list
43652860|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
43706487|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43706488|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43706489|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760762|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43706490|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706491|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43706492|NCT00193427|Gemcitabine|gemcitabine|mesh-list
43706493|NCT00193427|Carboplatin|carboplatin|mesh-list
43706494|NCT00193427|Docetaxel|docetaxel|mesh-list
43706495|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706496|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783679|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43783680|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
43783681|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43783682|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706497|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
43706498|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706499|NCT00193427|Antiviral Agents|antiviral agents|mesh-ancestor
43706500|NCT00193427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43706501|NCT00193427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706502|NCT00193427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43706503|NCT00193427|Immunologic Factors|immunologic factors|mesh-ancestor
43652861|NCT02987920|Pantoprazole|pantoprazole|mesh-list
43652862|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43652863|NCT02987920|Analgesics|analgesics|mesh-ancestor
43652864|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
43652865|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777279|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777280|NCT02332811|Sevelamer|sevelamer|mesh-list
43777281|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
43777282|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
43777301|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
43777302|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43777303|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
43706604|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
43706606|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43706607|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706608|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43706610|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777304|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777305|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
43777306|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
43777307|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777339|NCT02332629|Protective Agents|protective agents|mesh-ancestor
43777340|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777341|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777342|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
43777343|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43831252|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43831253|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831254|NCT05320887|Nicotine|nicotine|mesh-list
43831255|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43831256|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
43831257|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831258|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831259|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43831260|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43831261|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
43831262|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706635|NCT02706067|Orlistat|orlistat|mesh-list
43706636|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706637|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706638|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43706639|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43706640|NCT02705768|Carbamazepine|carbamazepine|mesh-list
43706641|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
43706642|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
43706643|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
43706644|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43706645|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706646|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706647|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43706648|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43706649|NCT02705768|Analgesics|analgesics|mesh-ancestor
43706650|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
43706651|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706652|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43706653|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43777344|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43777345|NCT02332616|Prednisolone|prednisolone|mesh-list
43777346|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
43777347|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43777348|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
43777349|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777350|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
43777351|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
43777381|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777382|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777383|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777384|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777386|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838895|NCT04809311|Hormones|hormones|mesh-ancestor
43838896|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43838897|NCT04809311|Incretins|incretins|mesh-ancestor
43838898|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
43838899|NCT04809038|Analgesics|analgesics|mesh-ancestor
43838901|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43838902|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838903|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
43838904|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43838905|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43706721|NCT02705378|Naloxegol|naloxegol|mesh-list
43706722|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43706723|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706724|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
43706725|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706727|NCT02705638|Lenalidomide|lenalidomide|mesh-list
43706728|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43706729|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43706730|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
43706731|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706732|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838940|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838941|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43838942|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43838943|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43777407|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
43777408|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43777410|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777411|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777412|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777413|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777414|NCT02331771|Donepezil|donepezil|mesh-list
43777415|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43777416|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706772|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43706773|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706774|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43706775|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43706776|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43706777|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706778|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43706779|NCT02704962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43706780|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43706781|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43706782|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706783|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43706784|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
43706785|NCT02704715|Anesthetics|anesthetics|mesh-list
43706786|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43706787|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706789|NCT02704624|Vitamins|vitamins|mesh-ancestor
43706790|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
43706791|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706792|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43706793|NCT02704754|Suvorexant|suvorexant|mesh-list
43706794|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43706795|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43777418|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
43777419|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43777420|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777421|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
43777422|NCT02331745|Lenograstim|lenograstim|mesh-list
43777423|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43777424|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
43777425|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777426|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
43777427|NCT02331823|Isoniazid|isoniazid|mesh-list
43706809|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43706810|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43706811|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43706819|NCT02704598|Warfarin|warfarin|mesh-list
43652875|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43652876|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831263|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831264|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43831265|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43831266|NCT05320068|Vancomycin|vancomycin|mesh-list
43831267|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653684|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
43653687|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43831268|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831269|NCT05319431|Lenvatinib|lenvatinib|mesh-list
43831274|NCT05318755|Testosterone|testosterone|mesh-list
43583615|NCT03436121|Ketamine|ketamine|mesh-list
43777451|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43777452|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
43777453|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777455|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
43777456|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777457|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777459|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
43777460|NCT02331862|Hormones|hormones|mesh-ancestor
43777461|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777462|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43777463|NCT02331862|Protective Agents|protective agents|mesh-ancestor
43777464|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777488|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777489|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
43777490|NCT02331602|Dabigatran|dabigatran|mesh-list
43777491|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43777492|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
43777493|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43777494|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
43777495|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777496|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777497|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
43777498|NCT02331576|Fentanyl|fentanyl|mesh-list
43777499|NCT02331576|Ropivacaine|ropivacaine|mesh-list
43777500|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
43777501|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
43707065|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43777502|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777503|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777504|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
43777505|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777507|NCT02331576|Narcotics|narcotics|mesh-ancestor
43777508|NCT02331576|Analgesics|analgesics|mesh-ancestor
43777509|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43777510|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43777511|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
43777512|NCT02331511|Aspirin|aspirin|mesh-list
43777513|NCT02331511|Clopidogrel|clopidogrel|mesh-list
43777514|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43777515|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777516|NCT02331511|Analgesics|analgesics|mesh-ancestor
43777517|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
43777518|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777519|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653692|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
43777552|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777553|NCT02330952|Prednisone|prednisone|mesh-list
43783863|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
43777554|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777555|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
43777557|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777558|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777559|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777575|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777576|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777577|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
43777578|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777579|NCT02331251|Gemcitabine|gemcitabine|mesh-list
43777581|NCT02331251|Vinorelbine|vinorelbine|mesh-list
43652877|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652878|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
43652879|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43652880|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43652881|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43707253|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707254|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43707255|NCT02701673|Antiviral Agents|antiviral agents|mesh-ancestor
43707256|NCT02701673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707257|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707258|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707259|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
43707260|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707261|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43707262|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
43707263|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43707264|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
43707266|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
43707267|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43707268|NCT02701595|Amoxicillin|amoxicillin|mesh-list
43707269|NCT02701595|Vancomycin|vancomycin|mesh-list
43707270|NCT02701595|Gentamicins|gentamicins|mesh-list
43707271|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
43707272|NCT02701595|Penicillins|penicillins|mesh-list
43707273|NCT02701595|Penicillin G|penicillin g|mesh-list
43707274|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43707275|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
43707276|NCT02701595|Netilmicin|netilmicin|mesh-list
43652882|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43652883|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43652884|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652885|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
43652886|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43652887|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43777583|NCT02331251|Doxorubicin|doxorubicin|mesh-list
43777584|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43777585|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
43777586|NCT02331251|Irinotecan|irinotecan|mesh-list
43707287|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707288|NCT02701608|Renal Agents|renal agents|mesh-ancestor
43707289|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43707290|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43707291|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43777590|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
43777591|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
43777592|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777593|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777594|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
43777595|NCT02331251|Antiviral Agents|antiviral agents|mesh-ancestor
43777596|NCT02331251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777597|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783864|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783865|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43777598|NCT02331251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777599|NCT02331251|Immunologic Factors|immunologic factors|mesh-ancestor
43777600|NCT02331251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777601|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43583764|NCT03434340|Hormones|hormones|mesh-ancestor
43777602|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43777603|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43707341|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43707342|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43707343|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
43707344|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707345|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43707346|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
43707347|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831313|NCT05316935|Letrozole|letrozole|mesh-list
43707348|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43707349|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43707351|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
43707352|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
43707353|NCT02701309|Trace Elements|trace elements|mesh-ancestor
43707354|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
43707355|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707356|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43707357|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
43707358|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707359|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707360|NCT02701179|Lidocaine|lidocaine|mesh-list
43707361|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43707362|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
43707363|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
43707364|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43707365|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777604|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43777605|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43777606|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43777607|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43777609|NCT02330757|Enclomiphene|enclomiphene|mesh-list
43777610|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
43777611|NCT02330757|Estradiol|estradiol|mesh-list
43777612|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43777613|NCT02330757|Estrogens|estrogens|mesh-ancestor
43777614|NCT02330757|Hormones|hormones|mesh-ancestor
43777615|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43777616|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777617|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43777618|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
43707366|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
43707367|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707368|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43653695|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653696|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43783872|NCT05087615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783873|NCT05087615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43783874|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43707369|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43777619|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43777655|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43777656|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43777657|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777658|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
43777669|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777670|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777672|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43777673|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
43777674|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777675|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
43777676|NCT02330822|Protective Agents|protective agents|mesh-ancestor
43777677|NCT02330783|Bevacizumab|bevacizumab|mesh-list
43652888|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43652889|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
43652890|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
43652891|NCT02987907|Dexamethasone|dexamethasone|mesh-list
43652892|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43652893|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
43652894|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
43777679|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43777680|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777681|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43777682|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43777683|NCT02330783|Growth Substances|growth substances|mesh-ancestor
43777684|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777685|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
43777686|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777687|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838980|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43838981|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43838982|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
43838983|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43838984|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43838985|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43838986|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43838987|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43838988|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43838989|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43838990|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43838991|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
43777712|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
43707749|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
43707750|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
43707751|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43783902|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
43783903|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783904|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
43783905|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783906|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783907|NCT04658277|Clarithromycin|clarithromycin|mesh-list
43783908|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783909|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777713|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777714|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777715|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
43777716|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777717|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43777718|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43777719|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
43777720|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43777721|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43777722|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777723|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43777724|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777725|NCT02330380|Analgesics|analgesics|mesh-ancestor
43777760|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
43777761|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
43777762|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43777763|NCT02330120|Analgesics|analgesics|mesh-ancestor
43777764|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
43777788|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777789|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43777790|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
43777791|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43777792|NCT02329860|Apatinib|apatinib|mesh-list
43777793|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777794|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43777796|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777798|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43777800|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777801|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777802|NCT02329561|Tramadol|tramadol|mesh-list
43777803|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43777804|NCT02329561|Narcotics|narcotics|mesh-ancestor
43652895|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652896|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652897|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43652898|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
43777805|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43777806|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777807|NCT02329561|Analgesics|analgesics|mesh-ancestor
43783910|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43783911|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783912|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783913|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43783914|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43783916|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43783917|NCT04602117|Trastuzumab|trastuzumab|mesh-list
43783918|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43783954|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783955|NCT04517357|Apatinib|apatinib|mesh-list
43784000|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
43777808|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
43707785|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43707786|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43707787|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43707788|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
43707789|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43707790|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707791|NCT02698995|Acetaminophen|acetaminophen|mesh-list
43707792|NCT02698995|Dexamethasone|dexamethasone|mesh-list
43707793|NCT02698995|Lidocaine|lidocaine|mesh-list
43707794|NCT02698995|Morphine|morphine|mesh-list
43707795|NCT02698995|Ropivacaine|ropivacaine|mesh-list
43707796|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707797|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
43707798|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
43707799|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707800|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707801|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707802|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
43707803|NCT02698995|Hormones|hormones|mesh-ancestor
43847420|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43707804|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707805|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707806|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777809|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43777810|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43777811|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43777834|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43777835|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43777836|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43777837|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43777838|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43777839|NCT02329288|Triamcinolone|triamcinolone|mesh-list
43777840|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43777841|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43777842|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43777843|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43777844|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
43777845|NCT02329288|Hormones|hormones|mesh-ancestor
43777846|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707815|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707816|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43707817|NCT02698995|Narcotics|narcotics|mesh-ancestor
43707818|NCT02698995|Analgesics|analgesics|mesh-ancestor
43707819|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43707820|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
43707821|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
43707822|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43707823|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
43784001|NCT04176718|Hormones|hormones|mesh-ancestor
43840049|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43840050|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840051|NCT04731103|Lamivudine|lamivudine|mesh-list
43840052|NCT04731103|Zidovudine|zidovudine|mesh-list
43840053|NCT04731103|Abacavir|abacavir|mesh-list
43840054|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
43840055|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43840056|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43840057|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840058|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840059|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
43707824|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707825|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
43707826|NCT02698813|Protective Agents|protective agents|mesh-ancestor
43707827|NCT02698553|Bupropion|bupropion|mesh-list
43707828|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43707829|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
43707858|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43707859|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43707860|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707861|NCT02698748|Chloroquine|chloroquine|mesh-list
43707862|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
43707863|NCT02698748|Amebicides|amebicides|mesh-ancestor
43707864|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43707865|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43707866|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707867|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
43707868|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43707871|NCT02698748|Analgesics|analgesics|mesh-ancestor
43777850|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43777851|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43777852|NCT02329054|Favipiravir|favipiravir|mesh-list
43777853|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
43777854|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43777855|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43777856|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43831357|NCT05314998|Irinotecan|irinotecan|mesh-list
43831358|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
43831359|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43831360|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
43831361|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831362|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831363|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
43831364|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831365|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831366|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831367|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
43831368|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831369|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43831370|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43831371|NCT05314998|Antidotes|antidotes|mesh-ancestor
43831372|NCT05314998|Protective Agents|protective agents|mesh-ancestor
43831373|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
43831374|NCT05314998|Vitamins|vitamins|mesh-ancestor
43831375|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
43831376|NCT05314998|Hematinics|hematinics|mesh-ancestor
43831377|NCT05314621|Fluticasone|fluticasone|mesh-list
43831378|NCT05314621|Xhance|xhance|mesh-list
43831379|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
43831380|NCT05314621|Dextrans|dextrans|mesh-list
43831381|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43777857|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777858|NCT02329171|Imiquimod|imiquimod|mesh-list
43777859|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43777860|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
43777861|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777898|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43777900|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839007|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840060|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43591445|NCT03362281|Amoxicillin|amoxicillin|mesh-list
43840062|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43784010|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
43784011|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43784012|NCT03809533|Velpatasvir|velpatasvir|mesh-list
43839008|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
43831382|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43831383|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831384|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43831385|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
43831386|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831387|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831388|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831389|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831390|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
43831391|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43831392|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43707880|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
43707881|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43707882|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43707883|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43707884|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43707885|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43707886|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43707887|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
43707888|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707889|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707890|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43707891|NCT02698280|Bevacizumab|bevacizumab|mesh-list
43707908|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43707909|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
43707910|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
43707911|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43707912|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707913|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43707914|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
43707915|NCT02698306|Hormones|hormones|mesh-ancestor
43707916|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43707917|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43707977|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43707978|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43707979|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43707980|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43784054|NCT02951130|Protective Agents|protective agents|mesh-ancestor
43784055|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784056|NCT02813655|Cosyntropin|cosyntropin|mesh-list
43784057|NCT02813655|Hormones|hormones|mesh-ancestor
43784058|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784059|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784060|NCT02747407|Vaccines|vaccines|mesh-list
43784061|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
43784062|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784063|NCT02718833|Dexamethasone|dexamethasone|mesh-list
43784064|NCT02718833|Bortezomib|bortezomib|mesh-list
43784065|NCT02718833|Pomalidomide|pomalidomide|mesh-list
43784066|NCT02718833|Elotuzumab|elotuzumab|mesh-list
43707981|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43707982|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43707983|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43707984|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
43707985|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652900|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652901|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652902|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652904|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
43652905|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652906|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652907|NCT02987699|Leucovorin|leucovorin|mesh-list
43652908|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
43652909|NCT02987699|Fluorouracil|fluorouracil|mesh-list
43652910|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
43652911|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652912|NCT02987699|Antidotes|antidotes|mesh-ancestor
43708039|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708040|NCT05324800|Turmeric extract|turmeric extract|mesh-list
43708041|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
43708042|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784077|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784078|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
43708043|NCT05324800|Protective Agents|protective agents|mesh-ancestor
43708044|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708045|NCT05324774|Aflibercept|aflibercept|mesh-list
43708046|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43708047|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43708048|NCT05324774|Growth Substances|growth substances|mesh-ancestor
43708050|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
43652913|NCT02987699|Protective Agents|protective agents|mesh-ancestor
43652914|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652915|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
43652916|NCT02987699|Vitamins|vitamins|mesh-ancestor
43652917|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
43652919|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652921|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43652922|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
43652923|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
43777995|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831396|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831397|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43831398|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43831399|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
43831400|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
43831401|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43831402|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831403|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
43831404|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
43831405|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
43777996|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784079|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43784098|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
43784099|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784100|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784101|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43777997|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43777999|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
43778000|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778001|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43778002|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43778003|NCT02328079|Protective Agents|protective agents|mesh-ancestor
43778004|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784114|NCT05102422|Sevoflurane|sevoflurane|mesh-list
43784115|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784116|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784117|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778005|NCT02328209|Ranibizumab|ranibizumab|mesh-list
43778006|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43778007|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43778008|NCT02328209|Growth Substances|growth substances|mesh-ancestor
43778009|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778010|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
43778011|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778012|NCT02328118|Triamcinolone|triamcinolone|mesh-list
43778013|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43778014|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43778015|NCT02328118|Ranibizumab|ranibizumab|mesh-list
43778016|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43778017|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43778018|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43778019|NCT02328118|Growth Substances|growth substances|mesh-ancestor
43778020|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652924|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43778055|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778056|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43778057|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43778058|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
43778059|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778060|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
43778094|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43778095|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778096|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778097|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
43778098|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708272|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784118|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43784119|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
43708273|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708274|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
43778158|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
43778159|NCT02327923|Morphine|morphine|mesh-list
43778160|NCT02327923|Tramadol|tramadol|mesh-list
43778161|NCT02327923|Ondansetron|ondansetron|mesh-list
43778162|NCT02327923|Bupivacaine|bupivacaine|mesh-list
43778163|NCT02327923|Propofol|propofol|mesh-list
43778164|NCT02327923|Neostigmine|neostigmine|mesh-list
43778165|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
43778166|NCT02327923|Esmolol|esmolol|mesh-list
43778167|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43778168|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
43778169|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778170|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778171|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
43831451|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43708334|NCT04965272|Cariprazine|cariprazine|mesh-list
43708335|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43708336|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708337|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708338|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778177|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778179|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778180|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
43778182|NCT02327923|Narcotics|narcotics|mesh-ancestor
43778183|NCT02327923|Analgesics|analgesics|mesh-ancestor
43778184|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778185|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778186|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
43778187|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
43778217|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43778218|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
43778219|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43778220|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43778221|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43778222|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43778223|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43708339|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708340|NCT04958772|Lenograstim|lenograstim|mesh-list
43708341|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43708342|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
43708343|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708344|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
43708345|NCT04954989|Hematinics|hematinics|mesh-ancestor
43708346|NCT04937738|Leucovorin|leucovorin|mesh-list
43708347|NCT04937738|Docetaxel|docetaxel|mesh-list
43708348|NCT04937738|Fluorouracil|fluorouracil|mesh-list
43708349|NCT04937738|Capecitabine|capecitabine|mesh-list
43708350|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
43778227|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778228|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43652925|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784156|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
43652926|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43778230|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784157|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784158|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784167|NCT05101811|Vitamin D|vitamin d|mesh-list
43778231|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43778232|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43778233|NCT02327702|Emtricitabine|emtricitabine|mesh-list
43778263|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43778264|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
43778265|NCT02327416|Adefovir|adefovir|mesh-list
43778266|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43778267|NCT02327416|Molgramostim|molgramostim|mesh-list
43778268|NCT02327416|Sargramostim|sargramostim|mesh-list
43778269|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
43778270|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778271|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
43778272|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778273|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43778274|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43778275|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778276|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778277|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778278|NCT02327234|Ibuprofen|ibuprofen|mesh-list
43839046|NCT04800471|Insulin|insulin|mesh-list
43839047|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43778319|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43708365|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
43708366|NCT04924621|Midazolam|midazolam|mesh-list
43708367|NCT04924621|Sufentanil|sufentanil|mesh-list
43708368|NCT04924621|Propofol|propofol|mesh-list
43708369|NCT04924621|Tetracaine|tetracaine|mesh-list
43708370|NCT04924621|Rocuronium|rocuronium|mesh-list
43708371|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43708372|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708373|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708374|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43708375|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
43708376|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
43708377|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43708378|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708379|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708380|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778320|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778321|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778322|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43778323|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778324|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778350|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43778351|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778352|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43784176|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43784177|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784178|NCT05101785|Lidocaine|lidocaine|mesh-list
43784179|NCT05101785|Epinephrine|epinephrine|mesh-list
43708381|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
43784180|NCT05101785|Racepinephrine|racepinephrine|mesh-list
43708383|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708384|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708385|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43708386|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43708387|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43708388|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708389|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43708390|NCT04924621|Narcotics|narcotics|mesh-ancestor
43708391|NCT04924621|Analgesics|analgesics|mesh-ancestor
43784219|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708392|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
43708393|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
43708395|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708396|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43708397|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708398|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708399|NCT04897919|Lumefantrine|lumefantrine|mesh-list
43708400|NCT04897919|Artemether|artemether|mesh-list
43708401|NCT04897919|Piperaquine|piperaquine|mesh-list
43708402|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43708403|NCT04897919|Artenimol|artenimol|mesh-list
43708404|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
43708405|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43708406|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43708407|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708409|NCT04865042|Analgesics|analgesics|mesh-ancestor
43708410|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
43708411|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708412|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708413|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
43778355|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
43778356|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43778357|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778358|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43778359|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778360|NCT02327078|Nivolumab|nivolumab|mesh-list
43778361|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778362|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778363|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43778364|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778365|NCT02326779|Aspirin|aspirin|mesh-list
43708414|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43708415|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43708416|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708417|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43708418|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708419|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708420|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708421|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708422|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
43708423|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43708424|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
43708425|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43708426|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43708427|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43708428|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43708429|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708430|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708431|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708432|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708433|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43708434|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708435|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
43708436|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
43708437|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708438|NCT04808531|Oxycodone|oxycodone|mesh-list
43708440|NCT04808531|Narcotics|narcotics|mesh-ancestor
43778366|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778367|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778368|NCT02326779|Analgesics|analgesics|mesh-ancestor
43778369|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
43778370|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778371|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778408|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778409|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
43778410|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840065|NCT04730999|Carboplatin|carboplatin|mesh-list
43840066|NCT04730999|Etoposide|etoposide|mesh-list
43840067|NCT04730999|Atezolizumab|atezolizumab|mesh-list
43840068|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840069|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840070|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840071|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43840072|NCT04730999|Growth Substances|growth substances|mesh-ancestor
43840073|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653719|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653720|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653721|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653722|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653723|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43653724|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653725|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653726|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653727|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43653728|NCT02982161|Narcotics|narcotics|mesh-ancestor
43840074|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840075|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840076|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43840077|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43840078|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840079|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840080|NCT04730856|Tinzaparin|tinzaparin|mesh-list
43840081|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43840082|NCT04730856|Dalteparin|dalteparin|mesh-list
43840083|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
43778411|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
43778412|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778435|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778437|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43840084|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43840085|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778438|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778439|NCT02326350|Aspirin|aspirin|mesh-list
43778440|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778441|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778442|NCT02326350|Analgesics|analgesics|mesh-ancestor
43778443|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
43708446|NCT04804644|Memantine|memantine|mesh-list
43708447|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43708448|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43708449|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
43708450|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708451|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708452|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708453|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43708454|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43708455|NCT04766008|Metformin|metformin|mesh-list
43708456|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43708457|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708458|NCT04760132|Vaccines|vaccines|mesh-list
43708459|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
43708460|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708461|NCT04734197|Cyclosporine|cyclosporine|mesh-list
43708462|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
43652927|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652929|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43652930|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652931|NCT02987465|Norepinephrine|norepinephrine|mesh-list
43652932|NCT02987465|Acetylcholine|acetylcholine|mesh-list
43652933|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
43652934|NCT02987465|Hematinics|hematinics|mesh-ancestor
43708484|NCT04734197|Hormones|hormones|mesh-ancestor
43652935|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43840086|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784232|NCT05036473|Levodopa|levodopa|mesh-list
43784233|NCT05036473|Carbidopa|carbidopa|mesh-list
43784234|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43784235|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43784236|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43784237|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
43784238|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784239|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784240|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784241|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43784242|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784243|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43652936|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708485|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708486|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43708487|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
43708488|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43708489|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708490|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43708491|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
43708492|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43708493|NCT04733144|Dexamethasone|dexamethasone|mesh-list
43708494|NCT04733144|Prednisolone|prednisolone|mesh-list
43708495|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708496|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
43708497|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
43708498|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708499|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708500|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708501|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
43708510|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
43708511|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
43652937|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778444|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778445|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778446|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778447|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778448|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43778449|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778450|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778451|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43778452|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778453|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778454|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
43778455|NCT02326285|Cisplatin|cisplatin|mesh-list
43778456|NCT02326285|Docetaxel|docetaxel|mesh-list
43778457|NCT02326285|Gefitinib|gefitinib|mesh-list
43734410|NCT02540369|Growth Substances|growth substances|mesh-ancestor
43708536|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708537|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43708538|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
43708539|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708540|NCT04648540|Acetaminophen|acetaminophen|mesh-list
43708542|NCT04648540|Ketorolac|ketorolac|mesh-list
43708543|NCT04648540|Lidocaine|lidocaine|mesh-list
43708544|NCT04648540|Pregabalin|pregabalin|mesh-list
43708545|NCT04648540|Fentanyl|fentanyl|mesh-list
43708547|NCT04648540|Morphine|morphine|mesh-list
43778462|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778463|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43778464|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778474|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778475|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43778476|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43708579|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43708580|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43708581|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43708582|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43708583|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43708584|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708586|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43708587|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708588|NCT04521647|Nicotine|nicotine|mesh-list
43708589|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43708590|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
43708591|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708592|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708593|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43784254|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
43708594|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43708595|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708596|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708597|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831452|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43831453|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43831454|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778489|NCT02326038|Methylphenidate|methylphenidate|mesh-list
43778490|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43778491|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778492|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43778493|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43778494|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43778495|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778496|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
43708611|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708612|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708613|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
43708614|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43708615|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43708616|NCT04430894|Growth Substances|growth substances|mesh-ancestor
43708617|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
43708618|NCT04409834|Heparin|heparin|mesh-list
43708619|NCT04409834|Calcium heparin|calcium heparin|mesh-list
43708620|NCT04409834|Enoxaparin|enoxaparin|mesh-list
43708621|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
43708622|NCT04409834|Clopidogrel|clopidogrel|mesh-list
43708623|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43708624|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43708625|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43708626|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43708627|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
43708628|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708629|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778497|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778498|NCT02326051|Enoxaparin|enoxaparin|mesh-list
43778499|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
43778500|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
43778501|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43778502|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43778503|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778504|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
43778505|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43778506|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
43652938|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43652939|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652940|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652941|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
43652942|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
43784259|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784260|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43784261|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784262|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784263|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784264|NCT04565574|Rifampin|rifampin|mesh-list
43784265|NCT04565574|Rabeprazole|rabeprazole|mesh-list
43784266|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43784267|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784268|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43784269|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43652943|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652944|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43652945|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
43652946|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43652947|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708647|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
43708648|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708649|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43708650|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43708651|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43708652|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
43708653|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708654|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708656|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43708657|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43708658|NCT04355832|Hormones|hormones|mesh-ancestor
43708659|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43708660|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708661|NCT04355832|Incretins|incretins|mesh-ancestor
43708662|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
43708663|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43708664|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708665|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708666|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
43708667|NCT04349982|Coagulants|coagulants|mesh-ancestor
43708668|NCT04340947|Nicotine|nicotine|mesh-list
43708669|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43708670|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
43708671|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652950|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43652951|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43652952|NCT02987218|Propofol|propofol|mesh-list
43708672|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652953|NCT02987218|Desflurane|desflurane|mesh-list
43652954|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43652955|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43652956|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652957|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43708673|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43708674|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43708675|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
43708676|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43708677|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708678|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
43708679|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
43708680|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43708681|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43708682|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708683|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708684|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708685|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43778507|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778508|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43784271|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43778509|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43778510|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778511|NCT05076955|Vancomycin|vancomycin|mesh-list
43778512|NCT05076955|Tobramycin|tobramycin|mesh-list
43778513|NCT05076955|Itraconazole|itraconazole|mesh-list
43778514|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778515|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778516|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
43778517|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43778518|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43778519|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778520|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778521|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43778522|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
43708725|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708726|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
43708727|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43708728|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43708729|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708730|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
43708731|NCT04304625|Coagulants|coagulants|mesh-ancestor
43708732|NCT04298541|Edotreotide|edotreotide|mesh-list
43708733|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43708734|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708735|NCT04288206|Cefazolin|cefazolin|mesh-list
43708736|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43708737|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708739|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43708740|NCT04278625|Analgesics|analgesics|mesh-ancestor
43778559|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43778560|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43778561|NCT05076461|Ondansetron|ondansetron|mesh-list
43778562|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
43778563|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
43652959|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
43652960|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43652961|NCT02987270|Piperaquine|piperaquine|mesh-list
43652962|NCT02987270|Artenimol|artenimol|mesh-list
43652963|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
43652964|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43652965|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43652966|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43652967|NCT02987244|Prednisone|prednisone|mesh-list
43652968|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
43652970|NCT02987244|Epirubicin|epirubicin|mesh-list
43652971|NCT02987244|Vindesine|vindesine|mesh-list
43652972|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708767|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
43652973|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
43652974|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43652975|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43652976|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43652977|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
43652978|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43652979|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708798|NCT04048278|Lidocaine|lidocaine|mesh-list
43708799|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
43708800|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
43708809|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708810|NCT03950037|Albendazole|albendazole|mesh-list
43708811|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
43708812|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43708813|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708814|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
43708815|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43708816|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43708817|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
43708818|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
43708819|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
43708820|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708821|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708822|NCT03936309|Lidocaine|lidocaine|mesh-list
43708823|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
43708824|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
43708825|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43708826|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708827|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
43708828|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43652983|NCT02987244|Hormones|hormones|mesh-ancestor
43652984|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43652985|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43652986|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43652987|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43778564|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778565|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778566|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43778567|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
43778568|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
43778569|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43778570|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
43778571|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778572|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778573|NCT05076461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43778574|NCT05076461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778575|NCT05076461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784327|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784328|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43784329|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43784330|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
43784331|NCT03522753|Hormones|hormones|mesh-ancestor
43784332|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784333|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784334|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840103|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839056|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839057|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
43839058|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848095|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43848096|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831463|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43831464|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
43831465|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
43831466|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
43831467|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43831468|NCT05311852|Palmidrol|palmidrol|mesh-list
43831469|NCT05311852|Antioxidants|antioxidants|mesh-list
43831470|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831471|NCT05311852|Protective Agents|protective agents|mesh-ancestor
43831472|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831473|NCT05311852|Analgesics|analgesics|mesh-ancestor
43831474|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
43831475|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831476|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43831477|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43831478|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831479|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831480|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
43831481|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831482|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43831483|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43652997|NCT02987348|Insulin|insulin|mesh-list
43652998|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43652999|NCT02987348|Exenatide|exenatide|mesh-list
43653000|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
43653001|NCT02987348|Glucagon|glucagon|mesh-list
43653002|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43653003|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653004|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653005|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43848101|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
43848102|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
43848103|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
43848104|NCT04049331|Testosterone|testosterone|mesh-list
43848105|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
43848106|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
43848107|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43848116|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
43848117|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848118|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848119|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848120|NCT04047836|Nicotine|nicotine|mesh-list
43848121|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43848122|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
43848123|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848124|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848125|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43848126|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43848127|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
43848128|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848129|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848130|NCT04046744|Lidocaine|lidocaine|mesh-list
43848131|NCT04046744|Analgesics|analgesics|mesh-list
43848132|NCT04046744|Ropivacaine|ropivacaine|mesh-list
43778635|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43778636|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778637|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778638|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708838|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43840115|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840116|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840117|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43708839|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778639|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778640|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
43778641|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
43778642|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778643|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43778644|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
43778645|NCT04501861|Coagulants|coagulants|mesh-ancestor
43653006|NCT02987348|Incretins|incretins|mesh-ancestor
43653007|NCT02987348|Hormones|hormones|mesh-ancestor
43653008|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653009|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824776|NCT05508035|Valsartan|valsartan|mesh-list
43824777|NCT05508035|Ramipril|ramipril|mesh-list
43824778|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43824779|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43824780|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43824781|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43824782|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824783|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43824784|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
43824785|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824786|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
43708903|NCT03563560|Daunorubicin|daunorubicin|mesh-list
43708904|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43708905|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
43708906|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43708907|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708908|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
43708909|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43708910|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43708911|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
43708912|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840118|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43840119|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
43840120|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43840121|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
43840122|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
43840123|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
43840124|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43840125|NCT04730193|Caffeine|caffeine|mesh-list
43840126|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43840127|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840128|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43840129|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840130|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840131|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43784337|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43708913|NCT03563560|Analgesics|analgesics|mesh-ancestor
43708914|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
43708915|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708916|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43708917|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43708918|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708919|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
43708920|NCT03563560|Growth Substances|growth substances|mesh-ancestor
43708921|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43708922|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43708923|NCT03551691|Omeprazole|omeprazole|mesh-list
43708929|NCT03548805|Mitomycins|mitomycins|mesh-list
43824796|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824797|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824798|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824799|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824800|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
43653010|NCT02986685|Rabeprazole|rabeprazole|mesh-list
43653011|NCT02986685|Trimebutine|trimebutine|mesh-list
43653012|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653013|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653014|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653015|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653016|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43784338|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43784339|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43653017|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
43653018|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
43709001|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43709002|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
43709003|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
43709004|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
43709005|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43653020|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653021|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43653022|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43653023|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
43653024|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43653025|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43653026|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43653027|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653028|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653029|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
43653030|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653031|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653032|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43653033|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653034|NCT02986906|Triamcinolone|triamcinolone|mesh-list
43653035|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653036|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
43653037|NCT02986906|Hormones|hormones|mesh-ancestor
43703524|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43709030|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709031|NCT02641873|Antidotes|antidotes|mesh-ancestor
43709032|NCT02641873|Protective Agents|protective agents|mesh-ancestor
43709033|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
43709034|NCT02641873|Vitamins|vitamins|mesh-ancestor
43709035|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
43709036|NCT02605993|Ravulizumab|ravulizumab|mesh-list
43709037|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43709038|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709039|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
43709040|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709041|NCT02471911|Dexamethasone|dexamethasone|mesh-list
43709042|NCT02471911|Rituximab|rituximab|mesh-list
43709043|NCT02471911|Carboplatin|carboplatin|mesh-list
43709044|NCT02471911|Etoposide|etoposide|mesh-list
43709045|NCT02471911|Ifosfamide|ifosfamide|mesh-list
43709046|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709092|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43709093|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43709095|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43709096|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
43709097|NCT02364713|Antibodies|antibodies|mesh-list
43709098|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
43709099|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43709100|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
43709101|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653038|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653040|NCT02986347|Epinephrine|epinephrine|mesh-list
43653041|NCT02986347|Racepinephrine|racepinephrine|mesh-list
43653042|NCT02986347|Anesthetics|anesthetics|mesh-list
43653043|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
43653046|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43653047|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43653048|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
43653049|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653050|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653051|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43653052|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43653053|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
43653054|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653055|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653056|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
43653058|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
43653059|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43653060|NCT02986503|Cisplatin|cisplatin|mesh-list
43653061|NCT02986503|Doxorubicin|doxorubicin|mesh-list
43653062|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43653063|NCT02986503|Methotrexate|methotrexate|mesh-list
43653064|NCT02986503|Ifosfamide|ifosfamide|mesh-list
43653065|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
43653066|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653067|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43653068|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43653069|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43653070|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653071|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653072|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653073|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
43653074|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653075|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653753|NCT02981836|Vaccines|vaccines|mesh-list
43653754|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
43653076|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43653088|NCT02986451|Lenalidomide|lenalidomide|mesh-list
43653089|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653090|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
43653091|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
43653092|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653093|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653094|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653095|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
43653097|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703525|NCT02710448|Metformin|metformin|mesh-list
43831520|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43831521|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43831522|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
43831523|NCT05306548|Hormones|hormones|mesh-ancestor
43831524|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831525|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831526|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831527|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
43831528|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831529|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831530|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
43831531|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43831532|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
43831533|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
43709161|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43709162|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43709163|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709164|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709205|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43709206|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
43709207|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
43709208|NCT01946711|Hormones|hormones|mesh-ancestor
43709209|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709210|NCT01864746|Palbociclib|palbociclib|mesh-list
43709211|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709212|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43709213|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709214|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709215|NCT01858896|Glucagon|glucagon|mesh-list
43709216|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43709217|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709218|NCT01858896|Hormones|hormones|mesh-ancestor
43709219|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653099|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653100|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
43778646|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43778647|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
43778648|NCT04498741|Midazolam|midazolam|mesh-list
43778649|NCT04498741|Dabigatran|dabigatran|mesh-list
43778650|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43778651|NCT04498741|Tacrolimus|tacrolimus|mesh-list
43778652|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778653|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
43778654|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778655|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43778656|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778657|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778658|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43778659|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778660|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778661|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43778662|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778663|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778664|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43778665|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
43778666|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
43778667|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
43778668|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
43778669|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778670|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43778671|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43778672|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
43778673|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43778674|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43778675|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
43778676|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43778677|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
43778678|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
43778680|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778681|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43778682|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43778683|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778684|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778685|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43778716|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778717|NCT03978767|Acetaminophen|acetaminophen|mesh-list
43778718|NCT03978767|Ibuprofen|ibuprofen|mesh-list
43778721|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778722|NCT03978767|Analgesics|analgesics|mesh-ancestor
43778723|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
43778724|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653101|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43653102|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43653103|NCT02986451|Growth Substances|growth substances|mesh-ancestor
43784415|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
43784416|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784417|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43784418|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43784419|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784420|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784421|NCT02683018|Hormones|hormones|mesh-ancestor
43840132|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43653104|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
43653105|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653106|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653107|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43653108|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653109|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653110|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43778725|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778726|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
43778727|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778728|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778763|NCT02913495|Hormones|hormones|mesh-ancestor
43778764|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778765|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778766|NCT02823990|Nivolumab|nivolumab|mesh-list
43778767|NCT02823990|Interleukin-2|interleukin-2|mesh-list
43778768|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778769|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43703526|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709267|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709268|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43709269|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43849561|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43709281|NCT01526603|Etoposide|etoposide|mesh-list
43709282|NCT01526603|Melphalan|melphalan|mesh-list
43709283|NCT01526603|Tretinoin|tretinoin|mesh-list
43709284|NCT01526603|Isotretinoin|isotretinoin|mesh-list
43778787|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778788|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
43778789|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43778790|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778791|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43778792|NCT02578069|Sirolimus|sirolimus|mesh-list
43778793|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43778794|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43778795|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43778796|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778797|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
43778798|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43778799|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
43778800|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778801|NCT02427126|Aspirin|aspirin|mesh-list
43778802|NCT02427126|Apixaban|apixaban|mesh-list
43778803|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43778804|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43778805|NCT02427126|Analgesics|analgesics|mesh-ancestor
43778806|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
43778807|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778808|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778809|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653111|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43653112|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
43653113|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43653114|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653116|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653117|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43653118|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
43653119|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709285|NCT01526603|Lenograstim|lenograstim|mesh-list
43709286|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709287|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43709288|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43709289|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43709290|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709291|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709292|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43709293|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
43709294|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43709295|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709296|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
43709297|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709298|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43709299|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
43849562|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653125|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653126|NCT02986594|Aspirin|aspirin|mesh-list
43653127|NCT02986594|Heparin|heparin|mesh-list
43653128|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653129|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653130|NCT02986594|Analgesics|analgesics|mesh-ancestor
43653131|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
43709300|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43709301|NCT01475123|Nicorandil|nicorandil|mesh-list
43709302|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43709303|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43709304|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
43709305|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
43709306|NCT01475123|Vitamins|vitamins|mesh-ancestor
43709307|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
43709308|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709309|NCT01207011|Docetaxel|docetaxel|mesh-list
43709310|NCT01207011|Amrubicin|amrubicin|mesh-list
43709311|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709312|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
43709313|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
43709314|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709315|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709316|NCT01165632|Fluorides|fluorides|mesh-list
43709317|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
43709318|NCT01165632|Protective Agents|protective agents|mesh-ancestor
43778813|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778814|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43778815|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43778816|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778818|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43778819|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
43778820|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43778821|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
43778822|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
43778823|NCT05080569|Progesterone|progesterone|mesh-list
43778824|NCT05080569|Progestins|progestins|mesh-ancestor
43778825|NCT05080569|Hormones|hormones|mesh-ancestor
43778826|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43778827|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778828|NCT05080543|Terlipressin|terlipressin|mesh-list
43778829|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43778830|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43778831|NCT05080478|Clopidogrel|clopidogrel|mesh-list
43778832|NCT05080478|Ticagrelor|ticagrelor|mesh-list
43778833|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43709319|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709320|NCT01003964|Gemcitabine|gemcitabine|mesh-list
43709321|NCT01003964|Cisplatin|cisplatin|mesh-list
43709322|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709323|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709324|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
43709325|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709326|NCT01003964|Antiviral Agents|antiviral agents|mesh-ancestor
43709327|NCT01003964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709328|NCT01003964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709329|NCT01003964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709330|NCT01003964|Immunologic Factors|immunologic factors|mesh-ancestor
43709331|NCT01003964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709332|NCT00890266|Riboflavin|riboflavin|mesh-list
43709333|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
43709334|NCT00890266|Vitamins|vitamins|mesh-ancestor
43709335|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
43709336|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709337|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43709338|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
43709339|NCT00711269|Risperidone|risperidone|mesh-list
43778834|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43778835|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43778836|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43778854|NCT05080010|Carboplatin|carboplatin|mesh-list
43778855|NCT05080010|Etoposide|etoposide|mesh-list
43778856|NCT05080010|Vincristine|vincristine|mesh-list
43778857|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778858|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653132|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709340|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43709341|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43709342|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
43653145|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43653146|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653147|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653148|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653149|NCT02985736|Desoximetasone|desoximetasone|mesh-list
43653150|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653151|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
43709392|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709393|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709394|NCT02697370|Factor VIII|factor viii|mesh-list
43709395|NCT02697370|Coagulants|coagulants|mesh-ancestor
43709396|NCT02697045|Aripiprazole|aripiprazole|mesh-list
43653158|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43778859|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43709416|NCT02697058|Fluorouracil|fluorouracil|mesh-list
43709417|NCT02697058|Calcium|calcium|mesh-list
43709418|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
43709419|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43709420|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709421|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43709422|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
43709423|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784422|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709424|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43709425|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709426|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709427|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
43709428|NCT02697058|Antidotes|antidotes|mesh-ancestor
43709429|NCT02697058|Protective Agents|protective agents|mesh-ancestor
43709430|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
43709431|NCT02697058|Vitamins|vitamins|mesh-ancestor
43709432|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
43709433|NCT02697318|Timolol|timolol|mesh-list
43709434|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43709435|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43709436|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43778868|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778869|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43778870|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778871|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43778872|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43778873|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43778874|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43778875|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
43778876|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43778878|NCT05079087|Ketamine|ketamine|mesh-list
43778879|NCT05079087|Analgesics|analgesics|mesh-ancestor
43778880|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
43778881|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43778906|NCT05078788|Hormones|hormones|mesh-ancestor
43778907|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709437|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709438|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709439|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709440|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709441|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709442|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43709443|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43709444|NCT02697032|Bicalutamide|bicalutamide|mesh-list
43709445|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
43709446|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
43709447|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709448|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709449|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709450|NCT02696837|Rocuronium|rocuronium|mesh-list
43709451|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43709452|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43709453|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43709454|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709455|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778909|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43778910|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
43784424|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
43778911|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778913|NCT05078372|Ropivacaine|ropivacaine|mesh-list
43778914|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
43778915|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
43709456|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
43778916|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43778917|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43778918|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
43709457|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709458|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
43709459|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709460|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709461|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709462|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43709463|NCT05368766|Diuretics|diuretics|mesh-list
43709464|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
43709465|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709466|NCT05368753|Lidocaine|lidocaine|mesh-list
43709467|NCT05368753|Ropivacaine|ropivacaine|mesh-list
43709468|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
43709469|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
43709470|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709473|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709474|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43709475|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43709476|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43709477|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709485|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709486|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709487|NCT05368675|Analgesics|analgesics|mesh-ancestor
43709488|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
43709489|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709490|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43709491|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
43709492|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
43709493|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
43709494|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709495|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709496|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
43709497|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43778979|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
43778980|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
43778981|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
43778982|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778983|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778984|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
43778985|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
43778986|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
43778987|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43778988|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43778989|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
43778990|NCT05077215|Lenvatinib|lenvatinib|mesh-list
43778991|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43778992|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709498|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43709499|NCT05368181|Prednisolone|prednisolone|mesh-list
43709500|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
43709501|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43709502|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
43709503|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709504|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
43709505|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
43709506|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709507|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709508|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709509|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
43784433|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784435|NCT02675842|Hormones|hormones|mesh-ancestor
43709511|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709512|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43709533|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709535|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43779025|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
43779026|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779027|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779028|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
43779029|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779030|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779031|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43779032|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43779033|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43709545|NCT05367284|Hormones|hormones|mesh-ancestor
43709546|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709547|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709548|NCT05367206|Paclitaxel|paclitaxel|mesh-list
43709549|NCT05367206|Carboplatin|carboplatin|mesh-list
43709550|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43709551|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43709552|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709562|NCT05367063|Hormones|hormones|mesh-ancestor
43709574|NCT05321576|Narcotics|narcotics|mesh-ancestor
43709575|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709576|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839078|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43839079|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779038|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779039|NCT04996199|Zileuton|zileuton|mesh-list
43779040|NCT04996199|Carbamazepine|carbamazepine|mesh-list
43779041|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
43779061|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43779062|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779063|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43779064|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
43779065|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779066|NCT04988971|Corticosterone|corticosterone|mesh-list
43779067|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
43779068|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779069|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43779070|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
43779071|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
43779072|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779073|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779074|NCT04984733|Nivolumab|nivolumab|mesh-list
43779075|NCT04984733|Temozolomide|temozolomide|mesh-list
43779076|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709577|NCT05321576|Analgesics|analgesics|mesh-ancestor
43709578|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
43709579|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709580|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
43709581|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43709582|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709583|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709584|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43709585|NCT05320705|Analgesics|analgesics|mesh-ancestor
43709586|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
43709587|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709588|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43709589|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43709590|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43779082|NCT04973826|Aztreonam|aztreonam|mesh-list
43709592|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709593|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709594|NCT05297682|Propofol|propofol|mesh-list
43709595|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
43709596|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709597|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709598|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43709599|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43709600|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
43709601|NCT05296629|Doxycycline|doxycycline|mesh-list
43709602|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709603|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709604|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
43709605|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43709608|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
43709609|NCT05271721|BB 1101|bb 1101|mesh-list
43779159|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
43779160|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
43779161|NCT04734886|Vitamins|vitamins|mesh-list
43779162|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
43779163|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779164|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43779165|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43779166|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
43779167|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43779168|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
43779169|NCT04662723|Empagliflozin|empagliflozin|mesh-list
43779170|NCT04662723|Canagliflozin|canagliflozin|mesh-list
43709610|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709611|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
43709612|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
43709613|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709614|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709615|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43709616|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
43709617|NCT05271721|Hormones|hormones|mesh-ancestor
43709618|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709619|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43709620|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709621|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
43779171|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43779173|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43779174|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43779175|NCT04662723|Prednisolone|prednisolone|mesh-list
43779176|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
43779177|NCT04662723|Losartan|losartan|mesh-list
43779178|NCT04662723|Ramipril|ramipril|mesh-list
43779179|NCT04662723|Lisinopril|lisinopril|mesh-list
43779180|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43779181|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
43779182|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779183|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
43709622|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709623|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709624|NCT05260593|Vitamins|vitamins|mesh-list
43709625|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
43709626|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
43709627|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
43709628|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
43709629|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709630|NCT05260593|Hematinics|hematinics|mesh-ancestor
43709631|NCT05240391|Midodrine|midodrine|mesh-list
43709632|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
43709633|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
43709634|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779212|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
43779213|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43779214|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
43779215|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779216|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779217|NCT04654429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43784461|NCT05104255|Anesthetics|anesthetics|mesh-list
43779218|NCT04654429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43779219|NCT04654429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779220|NCT04654429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779221|NCT04654429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43779222|NCT04593563|Psilocybin|psilocybin|mesh-list
43779223|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
43779224|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779225|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779226|NCT04554836|Cetuximab|cetuximab|mesh-list
43779227|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43709661|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43709662|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43709666|NCT05170672|Abatacept|abatacept|mesh-list
43779236|NCT04536272|Enoxaparin|enoxaparin|mesh-list
43779237|NCT04536272|Nadroparin|nadroparin|mesh-list
43779238|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
43779239|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43779240|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43779241|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779242|NCT04529460|Antibodies|antibodies|mesh-list
43779243|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
43779244|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779245|NCT04478721|Meropenem|meropenem|mesh-list
43779246|NCT04478721|Temocillin|temocillin|mesh-list
43779247|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779248|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779249|NCT04428203|Cannabidiol|cannabidiol|mesh-list
43779250|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
43839111|NCT04797325|Vedolizumab|vedolizumab|mesh-list
43839112|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839113|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
43839114|NCT04797325|Hormones|hormones|mesh-ancestor
43839115|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839116|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839117|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839118|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839119|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839120|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
43839121|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849563|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43709683|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
43709685|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709686|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43709687|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43709688|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709689|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709690|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
43709691|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43709692|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709693|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43709694|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43709695|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43709698|NCT05154734|Belimumab|belimumab|mesh-list
43709699|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709700|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
43709701|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709702|NCT05143164|Gentamicins|gentamicins|mesh-list
43709703|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43709704|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839148|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43839149|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
43839150|NCT04795752|Cyclosporine|cyclosporine|mesh-list
43839151|NCT04795752|Cyclosporins|cyclosporins|mesh-list
43839152|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839153|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839154|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43784470|NCT05104138|Diuretics|diuretics|mesh-ancestor
43839155|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
43839156|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839157|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
43839158|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839159|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
43839160|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839161|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43709705|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43709706|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709707|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709708|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
43709709|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43709710|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709711|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43709712|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709713|NCT05096468|Pregabalin|pregabalin|mesh-list
43709714|NCT05096468|Ketamine|ketamine|mesh-list
43709715|NCT05096468|Esketamine|esketamine|mesh-list
43709716|NCT05096468|Analgesics|analgesics|mesh-ancestor
43709717|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
43709718|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831574|NCT05305404|BB 1101|bb 1101|mesh-list
43839169|NCT04794842|Tetracaine|tetracaine|mesh-list
43779251|NCT04202263|Minocycline|minocycline|mesh-list
43779252|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779253|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779254|NCT04192955|Salicylates|salicylates|mesh-list
43779255|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43779256|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779257|NCT04192955|Analgesics|analgesics|mesh-ancestor
43831583|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831584|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43831586|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
43831587|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831588|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831589|NCT05305105|Psilocybin|psilocybin|mesh-list
43709742|NCT05025397|Propofol|propofol|mesh-list
43709743|NCT05025397|Sevoflurane|sevoflurane|mesh-list
43709744|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43709745|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709746|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709747|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43709748|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
43709751|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43709752|NCT05011617|Anesthetics|anesthetics|mesh-list
43709753|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709754|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709755|NCT05003102|Fentanyl|fentanyl|mesh-list
43709756|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
43709757|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43709758|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709759|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779270|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779290|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43779291|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
43779292|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779293|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779295|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43779296|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
43779297|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779298|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43779299|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779300|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43653169|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653170|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653171|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43779301|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43824934|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824936|NCT05506410|Cytarabine|cytarabine|mesh-list
43779302|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43779303|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43779304|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43779305|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43779306|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43779307|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43779308|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43779309|NCT03971474|Gemcitabine|gemcitabine|mesh-list
43779310|NCT03971474|Docetaxel|docetaxel|mesh-list
43709760|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43709761|NCT05003102|Analgesics|analgesics|mesh-ancestor
43709762|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
43709763|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709764|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43709765|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43709766|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43709767|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709768|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709769|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709770|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43709771|NCT05003102|Narcotics|narcotics|mesh-ancestor
43709772|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43709773|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43709774|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
43779320|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779321|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779322|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
43779323|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779324|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43585749|NCT03418532|Osimertinib|osimertinib|mesh-list
43779333|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43779335|NCT03968562|Petrolatum|petrolatum|mesh-list
43779336|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779337|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779338|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
43779339|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43779340|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43779341|NCT03968562|Emollients|emollients|mesh-ancestor
43779342|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
43779343|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
43779344|NCT03939026|Fludarabine|fludarabine|mesh-list
43779345|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779346|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
43779347|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779348|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779349|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43653789|NCT02981446|Latanoprost|latanoprost|mesh-list
43779350|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
43779351|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779354|NCT03915613|Insulin|insulin|mesh-list
43779355|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43779356|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43779357|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779358|NCT03868150|Amiodarone|amiodarone|mesh-list
43779359|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43779360|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
43779361|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43779362|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779363|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779364|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43779365|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43779366|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779367|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709775|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
43709776|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43709777|NCT05001750|Doxycycline|doxycycline|mesh-list
43709778|NCT05001750|Nafcillin|nafcillin|mesh-list
43709779|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43709780|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709781|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
43709782|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
43709783|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43709784|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43709785|NCT04992572|Lidocaine|lidocaine|mesh-list
43709786|NCT04992572|Propofol|propofol|mesh-list
43709787|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
43709788|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
43709789|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43709790|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709791|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
43709792|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709793|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43709794|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43709795|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43709796|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709797|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709798|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43709799|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43709800|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
43709801|NCT04988256|Cyclosporine|cyclosporine|mesh-list
43709802|NCT04988256|Prednisone|prednisone|mesh-list
43779370|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43779371|NCT03864276|Propofol|propofol|mesh-list
43779372|NCT03864276|Desflurane|desflurane|mesh-list
43779373|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
43779374|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653172|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43653173|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653174|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43653175|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43653176|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
43653177|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
43709803|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
43709804|NCT04988256|Cyclosporins|cyclosporins|mesh-list
43709805|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43709806|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
43709807|NCT04988256|Hormones|hormones|mesh-ancestor
43709808|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709809|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709810|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43709811|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709812|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709813|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709814|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709815|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
43709816|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
43709817|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709818|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
43709819|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43709820|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43709821|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
43653190|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653191|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653192|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653193|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653194|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653195|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653196|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43653197|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653199|NCT02985671|Diclofenac|diclofenac|mesh-list
43653200|NCT02985671|Orphenadrine|orphenadrine|mesh-list
43653201|NCT02985671|Caffeine|caffeine|mesh-list
43709867|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709868|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709869|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43709870|NCT04834206|Docetaxel|docetaxel|mesh-list
43709871|NCT04834206|Fluorouracil|fluorouracil|mesh-list
43709872|NCT04834206|Nedaplatin|nedaplatin|mesh-list
43709873|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43709874|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
43709875|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
43709876|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
43709883|NCT04829344|Carticaine|carticaine|mesh-list
43709889|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43709891|NCT04788641|Tacrolimus|tacrolimus|mesh-list
43709892|NCT04788641|Cyclosporins|cyclosporins|mesh-list
43709893|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709894|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
43709895|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709896|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43709897|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709898|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709899|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
43709900|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709901|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
43709902|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784567|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
43709903|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43709904|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43709905|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709906|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709907|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709908|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709909|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
43709910|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43709911|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
43784569|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709912|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709913|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43709914|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43709915|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
43709916|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43709917|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
43709924|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43709926|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709927|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43709928|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43709929|NCT04697485|Diuretics|diuretics|mesh-ancestor
43709930|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
43709931|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43709932|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43709933|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43709934|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709935|NCT04672525|Rifampin|rifampin|mesh-list
43709936|NCT04672525|Rifabutin|rifabutin|mesh-list
43779388|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43709942|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43709943|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709944|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709945|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43709946|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43709947|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43709948|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43709949|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43709950|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43849564|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43709951|NCT04650269|Emtricitabine|emtricitabine|mesh-list
43709952|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
43709953|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43709954|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43831590|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
43709955|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43709956|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43709957|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43709958|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43709959|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43709960|NCT04608448|Sirolimus|sirolimus|mesh-list
43709961|NCT04608448|Petrolatum|petrolatum|mesh-list
43709962|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779390|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779391|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779392|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43779393|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779394|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
43779395|NCT03811756|Vitamins|vitamins|mesh-ancestor
43779396|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
43779397|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779398|NCT03768414|Gemcitabine|gemcitabine|mesh-list
43779399|NCT03768414|Paclitaxel|paclitaxel|mesh-list
43779400|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43779401|NCT03768414|Cisplatin|cisplatin|mesh-list
43779402|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43779403|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779404|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779405|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779406|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779407|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779408|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43779409|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
43779410|NCT03768414|Antiviral Agents|antiviral agents|mesh-ancestor
43779411|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779412|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710034|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43710035|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710036|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710037|NCT04437329|Cisplatin|cisplatin|mesh-list
43710038|NCT04437329|Docetaxel|docetaxel|mesh-list
43710039|NCT04437329|Fluorouracil|fluorouracil|mesh-list
43710040|NCT04437329|Nedaplatin|nedaplatin|mesh-list
43710041|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710042|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
43710043|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
43710044|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
43710045|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710046|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
43710047|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43710048|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710049|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
43710050|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710051|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
43710052|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43710053|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710054|NCT04400929|Molgramostim|molgramostim|mesh-list
43710055|NCT04400929|Sargramostim|sargramostim|mesh-list
43710056|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
43710057|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710058|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710059|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
43710060|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43779415|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779416|NCT03757130|Liraglutide|liraglutide|mesh-list
43779417|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43779418|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779419|NCT03757130|Incretins|incretins|mesh-ancestor
43779420|NCT03757130|Hormones|hormones|mesh-ancestor
43779421|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710070|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
43710071|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710072|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710073|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43710074|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43710075|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
43710076|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
43710077|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710078|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43710079|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43710080|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710081|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710082|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43710083|NCT04309773|Bezafibrate|bezafibrate|mesh-list
43779422|NCT03733418|Vitamin D|vitamin d|mesh-list
43779423|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
43779429|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43779430|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43779431|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43779432|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43779433|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779434|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710084|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43710085|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43710086|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43710087|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
43710088|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710089|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43710090|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43710091|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710092|NCT04224701|Vaccines|vaccines|mesh-list
43710093|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
43710094|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784583|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
43710095|NCT04174196|Lenalidomide|lenalidomide|mesh-list
43710096|NCT04174196|Cc-486|cc-486|mesh-list
43710097|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
43710098|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710099|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43710100|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43710101|NCT04174196|Growth Substances|growth substances|mesh-ancestor
43710102|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
43779440|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779441|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
43779442|NCT03566199|Panobinostat|panobinostat|mesh-list
43779443|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710103|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710105|NCT04173962|Ketamine|ketamine|mesh-list
43710106|NCT04173962|Analgesics|analgesics|mesh-ancestor
43710107|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
43710108|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710109|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710110|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43710111|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43710112|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
43710113|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
43710114|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710115|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43710116|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43710117|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710118|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710119|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43710120|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43710121|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43779449|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779450|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779451|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710122|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43710123|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43710124|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
43710126|NCT04117074|Bupivacaine|bupivacaine|mesh-list
43710127|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710128|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
43710129|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710130|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710131|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
43710132|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710133|NCT04115189|Sunitinib|sunitinib|mesh-list
43710134|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710135|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43710136|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43710137|NCT04115189|Growth Substances|growth substances|mesh-ancestor
43710138|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784621|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
43784622|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784623|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710139|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
43710140|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784626|NCT04725032|Propofol|propofol|mesh-list
43710141|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710142|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710143|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
43710144|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710145|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710146|NCT03983031|Rituximab|rituximab|mesh-list
43779452|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43779453|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
43779455|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43779456|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43779457|NCT03551626|Trametinib|trametinib|mesh-list
43779458|NCT03551626|Dabrafenib|dabrafenib|mesh-list
43779459|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779460|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43779461|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779462|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779463|NCT03544736|Paclitaxel|paclitaxel|mesh-list
43779464|NCT03544736|Carboplatin|carboplatin|mesh-list
43779465|NCT03544736|Nivolumab|nivolumab|mesh-list
43779466|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43779468|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779469|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779470|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779471|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779472|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710147|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710148|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710149|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
43710150|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779499|NCT03351439|Celecoxib|celecoxib|mesh-list
43779500|NCT03351439|Naproxen|naproxen|mesh-list
43779501|NCT03351439|Gabapentin|gabapentin|mesh-list
43779502|NCT03351439|Zopiclone|zopiclone|mesh-list
43779503|NCT03351439|Analgesics|analgesics|mesh-ancestor
43779504|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
43779505|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779506|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710167|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43710168|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710169|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710170|NCT03944954|Dronabinol|dronabinol|mesh-list
43710171|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
43710172|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784643|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
43784683|NCT04482686|Vitamin D|vitamin d|mesh-list
43710173|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43710174|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710175|NCT03944954|Analgesics|analgesics|mesh-ancestor
43710176|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
43710177|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43710178|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43710179|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43710180|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710181|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710182|NCT03944954|Hormones|hormones|mesh-ancestor
43710183|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710184|NCT03913234|Trastuzumab|trastuzumab|mesh-list
43710185|NCT03913234|Letrozole|letrozole|mesh-list
43710186|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43710187|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710188|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43779508|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43779509|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43779510|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779511|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779512|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43779513|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43779535|NCT03245008|Fasinumab|fasinumab|mesh-list
43653217|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653218|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653219|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653220|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43653221|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43653222|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43653223|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43710189|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43710190|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653225|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
43779536|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779537|NCT03245008|Analgesics|analgesics|mesh-ancestor
43779538|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
43779539|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779540|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779541|NCT03199755|Lumefantrine|lumefantrine|mesh-list
43779543|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43779544|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
43779545|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43779546|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43779547|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779548|NCT03181126|Venetoclax|venetoclax|mesh-list
43779549|NCT03181126|Navitoclax|navitoclax|mesh-list
43779550|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779551|NCT03139747|Everolimus|everolimus|mesh-list
43779552|NCT03139747|Lenvatinib|lenvatinib|mesh-list
43779553|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779554|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779555|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
43779556|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779557|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43779558|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779559|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779560|NCT03059498|Bupivacaine|bupivacaine|mesh-list
43779561|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
43779562|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
43779563|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779564|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779565|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
43779566|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779567|NCT02951013|Chrysarobin|chrysarobin|mesh-list
43779589|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779590|NCT02486666|Enoxaparin|enoxaparin|mesh-list
43779591|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
43779592|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
43779593|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43779594|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43710191|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710192|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43710193|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
43710194|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43710195|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710196|NCT03889743|Dexamethasone|dexamethasone|mesh-list
43710197|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43710198|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
43710199|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
43710200|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779595|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779597|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43779598|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
43779599|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779600|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43779601|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43779602|NCT02431767|Growth Substances|growth substances|mesh-ancestor
43779603|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
43779604|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779605|NCT02389517|Dexamethasone|dexamethasone|mesh-list
43779606|NCT02389517|Lenalidomide|lenalidomide|mesh-list
43779607|NCT02389517|Ixazomib|ixazomib|mesh-list
43779608|NCT02389517|Glycine|glycine|mesh-list
43779609|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
43779610|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43779611|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
43779612|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
43779613|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779614|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779615|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43779616|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
43779617|NCT02389517|Hormones|hormones|mesh-ancestor
43653226|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43653227|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43653228|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
43779618|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779619|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43710218|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43710219|NCT03847506|Ezetimibe|ezetimibe|mesh-list
43710220|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43710221|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43710222|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710223|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710224|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43710225|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710226|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
43710227|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43710228|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43710229|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
43710230|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43710231|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43710232|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710233|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43710234|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43710235|NCT03683251|Ranibizumab|ranibizumab|mesh-list
43710236|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43710237|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43710238|NCT03683251|Growth Substances|growth substances|mesh-ancestor
43710239|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779624|NCT02389517|Growth Substances|growth substances|mesh-ancestor
43779625|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
43779626|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779627|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
43779628|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779629|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
43784715|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
43779630|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779631|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
43779632|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43779633|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43779634|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779635|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
43779670|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
43779671|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779672|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779673|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
43779674|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779675|NCT05080803|Bevacizumab|bevacizumab|mesh-list
43779676|NCT05080803|Ranibizumab|ranibizumab|mesh-list
43779708|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779709|NCT04976387|Acetaminophen|acetaminophen|mesh-list
43779710|NCT04976387|Ibuprofen|ibuprofen|mesh-list
43779711|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43779712|NCT04976387|Hydrocodone|hydrocodone|mesh-list
43779713|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779714|NCT04976387|Analgesics|analgesics|mesh-ancestor
43779715|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
43779716|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779717|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779718|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
43779719|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43839204|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839205|NCT04791969|Naltrexone|naltrexone|mesh-list
43839206|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43710240|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
43710241|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710242|NCT03577704|Gemcitabine|gemcitabine|mesh-list
43710243|NCT03577704|Paclitaxel|paclitaxel|mesh-list
43710244|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43710245|NCT03577704|Cisplatin|cisplatin|mesh-list
43710246|NCT03577704|Carboplatin|carboplatin|mesh-list
43710247|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
43710248|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43710249|NCT03577704|Antibodies|antibodies|mesh-list
43710250|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
43710251|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43839207|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43839208|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839209|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
43839210|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839211|NCT04791553|Cenobamate|cenobamate|mesh-list
43839212|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
43839213|NCT04791514|Treprostinil|treprostinil|mesh-list
43839214|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839215|NCT04790279|Amlodipine|amlodipine|mesh-list
43784727|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784728|NCT04125771|Diclofenac|diclofenac|mesh-list
43839216|NCT04790279|Nifedipine|nifedipine|mesh-list
43839217|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43839218|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43839219|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839220|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839221|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43839222|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839223|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839224|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
43839225|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784741|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
43784742|NCT04026438|Protective Agents|protective agents|mesh-ancestor
43784743|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784744|NCT03765359|Metformin|metformin|mesh-list
43784745|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784746|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784747|NCT03711604|Tenalisib|tenalisib|mesh-list
43784748|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
43784749|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784750|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784751|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
43653807|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653808|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43653809|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
43653810|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653811|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653812|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653813|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653814|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43592292|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43784752|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784753|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784754|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784755|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784756|NCT03645603|Analgesics|analgesics|mesh-ancestor
43784757|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
43784758|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382399|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382400|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382401|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44382402|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382403|NCT03600428|Vaccines|vaccines|mesh-list
44382404|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
44382405|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382406|NCT03600376|Dantrolene|dantrolene|mesh-list
44382407|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44382408|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382409|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44382410|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382411|NCT03599362|Nivolumab|nivolumab|mesh-list
43689543|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880648|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880650|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880651|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880652|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880653|NCT04653779|Metformin|metformin|mesh-list
44382412|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382414|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44382415|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382416|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
44382417|NCT03599193|Tazarotene|tazarotene|mesh-list
44382418|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
44382419|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
44382420|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
44382421|NCT03599193|Vitamins|vitamins|mesh-ancestor
44382422|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
44382423|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382425|NCT03599089|Ketorolac|ketorolac|mesh-list
44382426|NCT03599089|Oxycodone|oxycodone|mesh-list
44382427|NCT03599089|Bupivacaine|bupivacaine|mesh-list
44382428|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382429|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
44382430|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382431|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382432|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
44382433|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382434|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382435|NCT03599089|Analgesics|analgesics|mesh-ancestor
43880654|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880655|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880656|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
43880657|NCT04653493|Fludarabine|fludarabine|mesh-list
43880658|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43880659|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
43880660|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880661|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880662|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43880663|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
43880664|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880665|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880666|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43880667|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
43880668|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43880669|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43880670|NCT04653415|Prednisolone|prednisolone|mesh-list
43880671|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
43880672|NCT04653415|Gabapentin|gabapentin|mesh-list
43880673|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43880674|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
43880675|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880676|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
43880677|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
43880678|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880679|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880680|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880681|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
43880682|NCT04653415|Hormones|hormones|mesh-ancestor
43880683|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382436|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
44382437|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44382438|NCT03599089|Narcotics|narcotics|mesh-ancestor
44382439|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382440|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382441|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382442|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653816|NCT02981212|Hormones|hormones|mesh-ancestor
44382443|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382444|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382445|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
44382446|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382447|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
44382448|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44382449|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44382450|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382451|NCT03598140|Urological Agents|urological agents|mesh-ancestor
44382452|NCT03597529|Melatonin|melatonin|mesh-list
44382453|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
44382454|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382455|NCT03597529|Protective Agents|protective agents|mesh-ancestor
44382456|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382457|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382458|NCT03597139|Cyclosporine|cyclosporine|mesh-list
43829175|NCT05441930|Renal Agents|renal agents|mesh-ancestor
43880684|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43880685|NCT04653415|Protective Agents|protective agents|mesh-ancestor
43880686|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880687|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880688|NCT04653415|Analgesics|analgesics|mesh-ancestor
43880689|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
43880690|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
43880691|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880692|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880693|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880694|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880695|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43880696|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43880697|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880698|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880699|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
44155908|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
44155909|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
44155910|NCT00228839|Infliximab|infliximab|mesh-list
44155911|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
44155912|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44155913|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44155914|NCT00228852|Fludarabine|fludarabine|mesh-list
44155915|NCT00228852|Busulfan|busulfan|mesh-list
44155916|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155917|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382459|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44382460|NCT03597139|Cyclosporins|cyclosporins|mesh-list
44382461|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382462|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382463|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43784837|NCT05105412|Growth Substances|growth substances|mesh-ancestor
43784838|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
43784839|NCT05105347|Prednisone|prednisone|mesh-list
43784840|NCT05105347|Adalimumab|adalimumab|mesh-list
43784841|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784842|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
43784843|NCT05105347|Hormones|hormones|mesh-ancestor
43784844|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784845|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784846|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784847|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784848|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784849|NCT05105256|Prednisolone|prednisolone|mesh-list
44382464|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
44382465|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382466|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
44382467|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382468|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
44382469|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382470|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44382471|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44382472|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
44382473|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
44382474|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
44382475|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
44382476|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382477|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
44382478|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44382479|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44382480|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382481|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44382482|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
44382483|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382484|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44382485|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
44382486|NCT03594552|Baclofen|baclofen|mesh-list
44382487|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44382488|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382489|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44382490|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382491|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44382492|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
44382493|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
44155918|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44155919|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
44155920|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155921|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
43880700|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
44382494|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382495|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382496|NCT03593915|Azacitidine|azacitidine|mesh-list
44382497|NCT03593915|Decitabine|decitabine|mesh-list
44382498|NCT03593915|Alvocidib|alvocidib|mesh-list
44382499|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44382501|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382502|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382503|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382504|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
44382505|NCT03593915|Growth Substances|growth substances|mesh-ancestor
44382506|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382507|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382508|NCT03592277|Vitamins|vitamins|mesh-list
44382509|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
44382510|NCT03592277|Thiamine|thiamine|mesh-list
44382511|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
44382512|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382513|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
44382514|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382515|NCT03592277|Protective Agents|protective agents|mesh-ancestor
43784852|NCT05105256|Hormones|hormones|mesh-ancestor
44382516|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
44382517|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44382518|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44382519|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44382520|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44382544|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
44382545|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382546|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44382547|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382548|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382549|NCT03588910|Acetaminophen|acetaminophen|mesh-list
44382550|NCT03588910|Ibuprofen|ibuprofen|mesh-list
44382551|NCT03588910|Oxycodone|oxycodone|mesh-list
44382552|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382553|NCT03588910|Analgesics|analgesics|mesh-ancestor
44382554|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
44382555|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653833|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44382556|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382557|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
44382558|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382559|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382560|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382561|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44382562|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382563|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382564|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44382565|NCT03588910|Narcotics|narcotics|mesh-ancestor
44382566|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382567|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44382568|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44382569|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44382570|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382571|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44038926|NCT00002571|Etoposide|etoposide|mesh-list
44382572|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382585|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382587|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382588|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382589|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
44382590|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382591|NCT03586726|Rifampin|rifampin|mesh-list
44382592|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44382593|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
44382594|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44382595|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382596|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
44382597|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44382598|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382599|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653834|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784939|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840179|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
43840180|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
43840181|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840182|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840183|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43840184|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43840185|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43840186|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
43840187|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382600|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44382601|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44382602|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44382603|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44382604|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44382605|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44382606|NCT03586609|Cytarabine|cytarabine|mesh-list
44382607|NCT03586609|Azacitidine|azacitidine|mesh-list
44382608|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
44382609|NCT03586609|Venetoclax|venetoclax|mesh-list
44382610|NCT03586609|Cladribine|cladribine|mesh-list
44382611|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44382612|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
44382613|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382614|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382615|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
44382616|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382617|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44382618|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
44382619|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382620|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382622|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44382623|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
44382624|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382625|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382626|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44382627|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
44382628|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
44382629|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44382630|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44382631|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44382632|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44382633|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
44382634|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382635|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382636|NCT03585712|Norgestrel|norgestrel|mesh-list
44382637|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44382638|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44382639|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44382640|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
44382641|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44382642|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382643|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44382644|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44382645|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
43880701|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
43880702|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43880703|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43880704|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880705|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880706|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43703557|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703558|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703559|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
43703560|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43703561|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703562|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703563|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43703564|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703565|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880707|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880708|NCT04652739|Prednisolone|prednisolone|mesh-list
43880709|NCT04652739|Lycopene|lycopene|mesh-list
43880713|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880714|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880715|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43880716|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880717|NCT04652739|Protective Agents|protective agents|mesh-ancestor
43880718|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
43880719|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880720|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43880721|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43880722|NCT04652661|Midazolam|midazolam|mesh-list
43880723|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
43880724|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880725|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880726|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880727|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382647|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44382648|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382649|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44382650|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44382651|NCT03584009|Venetoclax|venetoclax|mesh-list
44382652|NCT03584009|Fulvestrant|fulvestrant|mesh-list
44382653|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382654|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44382655|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44382656|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44382657|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382658|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382659|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382660|NCT03583385|Metformin|metformin|mesh-list
44382661|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44382662|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382663|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44382664|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43880728|NCT04652661|Analgesics|analgesics|mesh-ancestor
43880729|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
43880730|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880731|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880732|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880733|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43880734|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880735|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880736|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880737|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43880738|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43880739|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43880740|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880741|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880742|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
43880743|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
43880744|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
43880745|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
43880746|NCT04652765|Bicalutamide|bicalutamide|mesh-list
43880747|NCT04652765|Camostat|camostat|mesh-list
43880748|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
43880749|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
43840188|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840189|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43840190|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840191|NCT04726592|Analgesics|analgesics|mesh-ancestor
43840192|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
43880750|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880751|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880752|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880753|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
43880754|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880755|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880756|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43880757|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43880758|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
43880759|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43880760|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880761|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880762|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880763|NCT04652427|Analgesics|analgesics|mesh-ancestor
43880764|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
43598257|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
44382665|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44382666|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
44382667|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382668|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382669|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382670|NCT03583372|Urological Agents|urological agents|mesh-ancestor
44382671|NCT03583359|Lidocaine|lidocaine|mesh-list
44382672|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382673|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
44382674|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382675|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382676|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
44382677|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382678|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44382679|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44382680|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44382681|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382682|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382683|NCT03582215|Salicylates|salicylates|mesh-list
44382684|NCT03582215|Avobenzone|avobenzone|mesh-list
44382685|NCT03582215|Homosalate|homosalate|mesh-list
44382686|NCT03582215|Oxybenzone|oxybenzone|mesh-list
44382687|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
44382688|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
44382689|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
44382690|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44382691|NCT03582215|Protective Agents|protective agents|mesh-ancestor
44382692|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382693|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
44382694|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382695|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382696|NCT03582215|Analgesics|analgesics|mesh-ancestor
44382697|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
44382698|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382699|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880765|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880766|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43880767|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43880768|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44382700|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382701|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44382702|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382703|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382705|NCT03580382|Antibodies|antibodies|mesh-list
44382706|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
44382707|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382708|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382709|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382710|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382711|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382712|NCT03579940|Lasmiditan|lasmiditan|mesh-list
44382713|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44382714|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
44382715|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382716|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382717|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382718|NCT03579719|Itraconazole|itraconazole|mesh-list
44382719|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
44382720|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382721|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44382722|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44382723|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382724|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382725|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44382726|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
44382727|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382728|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382729|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44382730|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
44382731|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44382732|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
44382737|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
44382738|NCT03577730|Caffeine|caffeine|mesh-list
44382739|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
44382740|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382741|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44382742|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382743|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44382744|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382745|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44382746|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44382747|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
44382748|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382749|NCT03576066|Tenofovir|tenofovir|mesh-list
44382750|NCT03576066|Entecavir|entecavir|mesh-list
44382751|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
44382752|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382753|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44382754|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44382755|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382756|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382757|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44382758|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44039149|NCT00002582|Tamoxifen|tamoxifen|mesh-list
44382759|NCT03575871|Abrocitinib|abrocitinib|mesh-list
44382760|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382761|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382762|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382763|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
44382764|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44382765|NCT03575806|Estrogens|estrogens|mesh-ancestor
44382766|NCT03575806|Hormones|hormones|mesh-ancestor
44382767|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382768|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382771|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44382776|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382778|NCT03575702|Urological Agents|urological agents|mesh-ancestor
44382779|NCT03573908|Linaclotide|linaclotide|mesh-list
44382780|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44382781|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
44382782|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382783|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382784|NCT03573323|Ixekizumab|ixekizumab|mesh-list
44382785|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
44382786|NCT03572933|Pregnanolone|pregnanolone|mesh-list
44382787|NCT03572933|Ganaxolone|ganaxolone|mesh-list
44382788|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
44382789|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382790|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382791|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382792|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
44382793|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
44382794|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
44382795|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382796|NCT03572582|Nivolumab|nivolumab|mesh-list
44382797|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44382798|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880769|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880770|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880771|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880772|NCT04652284|Amoxicillin|amoxicillin|mesh-list
43880773|NCT04652284|Clarithromycin|clarithromycin|mesh-list
43880774|NCT04652284|Rifabutin|rifabutin|mesh-list
43880775|NCT04652284|Tinidazole|tinidazole|mesh-list
43880776|NCT04652284|Esomeprazole|esomeprazole|mesh-list
43880777|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43880778|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880779|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43880780|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880781|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43880782|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880784|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43880785|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43880786|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43880787|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43880788|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
43880789|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
43880790|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43880791|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43880792|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43880794|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880795|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880796|NCT04651959|Favipiravir|favipiravir|mesh-list
43880797|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
43880798|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382799|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44382800|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382801|NCT03571516|Teduglutide|teduglutide|mesh-list
44382802|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382803|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44382804|NCT03571516|Protective Agents|protective agents|mesh-ancestor
44382805|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382806|NCT03570697|Evolocumab|evolocumab|mesh-list
44382807|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44382808|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44382809|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
44382810|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382811|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44382812|NCT03570554|Acetaminophen|acetaminophen|mesh-list
44382813|NCT03570554|Celecoxib|celecoxib|mesh-list
44382814|NCT03570554|Naproxen|naproxen|mesh-list
44382815|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382816|NCT03570554|Analgesics|analgesics|mesh-ancestor
44382817|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
44382818|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382819|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382820|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
44382821|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44382822|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382823|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382824|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44382825|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44382826|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382827|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382828|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
44382829|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43880799|NCT04652011|Analgesics|analgesics|mesh-list
43880800|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
43880801|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880802|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880803|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
43880804|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43880805|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880806|NCT04652115|Defibrotide|defibrotide|mesh-list
43880807|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43880808|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43880809|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880810|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43880811|NCT04651842|Insulin|insulin|mesh-list
44382830|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44382831|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
44382832|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44382833|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44382834|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
44382835|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44382836|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382837|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382838|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
44382839|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382840|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382841|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44382842|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382843|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
44382844|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
44382845|NCT03568500|Olanzapine|olanzapine|mesh-list
44382846|NCT03568500|Risperidone|risperidone|mesh-list
44382847|NCT03568500|Aripiprazole|aripiprazole|mesh-list
44382848|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44382849|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44382850|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
44382851|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382852|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382853|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880812|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880813|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880814|NCT04651556|Acetaminophen|acetaminophen|mesh-list
43880815|NCT04651556|Ketorolac|ketorolac|mesh-list
43880816|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
43880817|NCT04651556|Bupivacaine|bupivacaine|mesh-list
43880818|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
43880819|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
43880820|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880821|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880822|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
43880823|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880824|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43880825|NCT04651556|Analgesics|analgesics|mesh-ancestor
43880826|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
43880827|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43880828|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880829|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43880830|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43880831|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880832|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880833|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43880834|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
43880835|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43880836|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43880837|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43880838|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
44382855|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44382856|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382857|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44382858|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44382859|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
44382860|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
44382861|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
44382862|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382863|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382864|NCT03568500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44382865|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44382866|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382867|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
44382868|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
44382869|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44382870|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44382871|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44382872|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44382873|NCT03568318|Upadacitinib|upadacitinib|mesh-list
44382874|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44382875|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44382876|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382877|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880839|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43880840|NCT04651049|Propranolol|propranolol|mesh-list
43880841|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43880842|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43880843|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880844|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880845|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880846|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880847|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43880848|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43880849|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
43880850|NCT04651205|Thiamine|thiamine|mesh-list
43880851|NCT04651205|Vitamins|vitamins|mesh-ancestor
43880852|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
43880853|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880854|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
43880855|NCT04650828|Tenofovir|tenofovir|mesh-list
43880856|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
43880861|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880862|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43880863|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43880864|NCT04650555|Genistein|genistein|mesh-list
43880865|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43880866|NCT04650555|Protective Agents|protective agents|mesh-ancestor
43880867|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382878|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382879|NCT03567616|Dexamethasone|dexamethasone|mesh-list
44382881|NCT03567616|Pomalidomide|pomalidomide|mesh-list
44382882|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44382883|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
44382884|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
44382885|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382886|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382887|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44382888|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
44382889|NCT03567616|Hormones|hormones|mesh-ancestor
44382890|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382891|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44382892|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382893|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
44382894|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44382895|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44382896|NCT03567616|Growth Substances|growth substances|mesh-ancestor
44382897|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
44382898|NCT03567382|Tenofovir|tenofovir|mesh-list
44382899|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
44382900|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44382901|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44382902|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44382903|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44382904|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382905|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44382906|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44382924|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382925|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44382926|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
44382927|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382928|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44382929|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44382930|NCT03565211|Progesterone|progesterone|mesh-list
44382931|NCT03565211|Progestins|progestins|mesh-ancestor
44382932|NCT03565211|Hormones|hormones|mesh-ancestor
44382933|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44382934|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382935|NCT03563716|Atezolizumab|atezolizumab|mesh-list
44382936|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382937|NCT03562481|Lidocaine|lidocaine|mesh-list
44382938|NCT03562481|Epinephrine|epinephrine|mesh-list
44382939|NCT03562481|Racepinephrine|racepinephrine|mesh-list
44382940|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
44382941|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44382942|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
44382943|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44382944|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382945|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
44382946|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382947|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44382948|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44382949|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44382950|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382951|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382952|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44382953|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44382954|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
44382955|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44382961|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
44382966|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382967|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
44382968|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382969|NCT03560258|Vaccines|vaccines|mesh-list
44382970|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
44382971|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382972|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
44382973|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44382974|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
44382975|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382976|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44382977|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
44382978|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44382979|NCT03559062|Ivacaftor|ivacaftor|mesh-list
44382980|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44382981|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44382982|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44382983|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44382984|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
44039380|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44382985|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382986|NCT03558555|Acetaminophen|acetaminophen|mesh-list
44382987|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44382988|NCT03558555|Analgesics|analgesics|mesh-ancestor
44382989|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
44382990|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44382991|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44382992|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
44382993|NCT03558503|Mitomycins|mitomycins|mesh-list
44382994|NCT03558503|Mitomycin|mitomycin|mesh-list
44382995|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44383001|NCT03557931|Olanzapine|olanzapine|mesh-list
44383011|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383012|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383013|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383014|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44383015|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44383016|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383017|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44383018|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44383019|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
44383020|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
44383021|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
44383022|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383023|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383024|NCT03557931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44383025|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44383026|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44383027|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
44383028|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
44383029|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44383030|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44383031|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44383032|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44383033|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44383034|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44383035|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44383036|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44383037|NCT03557307|Benralizumab|benralizumab|mesh-list
44383038|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44383039|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
44383040|NCT03555890|Cetirizine|cetirizine|mesh-list
44383041|NCT03555890|Levocetirizine|levocetirizine|mesh-list
44383042|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44383043|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44383049|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44383050|NCT03555565|Metformin|metformin|mesh-list
44383051|NCT03555565|Alogliptin|alogliptin|mesh-list
44383052|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383053|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383054|NCT03555565|Incretins|incretins|mesh-ancestor
44383055|NCT03555565|Hormones|hormones|mesh-ancestor
44383056|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383057|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44383058|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
44383059|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44039458|NCT00002604|Carmustine|carmustine|mesh-list
44383060|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383061|NCT03555305|Insulin|insulin|mesh-list
44383062|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44383063|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
44383064|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383065|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383066|NCT03554772|Celecoxib|celecoxib|mesh-list
44383067|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44383068|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383069|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383070|NCT03554772|Analgesics|analgesics|mesh-ancestor
44383071|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
44383072|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383073|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383074|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383075|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383076|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44383077|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44383078|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412309|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880868|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880869|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43880870|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880871|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880872|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
43880873|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43880874|NCT04650555|Estrogens|estrogens|mesh-ancestor
43880875|NCT04650555|Hormones|hormones|mesh-ancestor
43880876|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155922|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44155923|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44383079|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383080|NCT03554486|Insulin|insulin|mesh-list
44383081|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44383082|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
44383083|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
44383084|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44383085|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383086|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383087|NCT03554018|Acetaminophen|acetaminophen|mesh-list
44383088|NCT03554018|Ibuprofen|ibuprofen|mesh-list
44383089|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383090|NCT03554018|Analgesics|analgesics|mesh-ancestor
44383091|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
44383092|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383093|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383094|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
44383095|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383096|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383097|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383098|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44383099|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383100|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383101|NCT03554005|Acetaminophen|acetaminophen|mesh-list
44383102|NCT03554005|Interferons|interferons|mesh-list
44383103|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
44383104|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
44383105|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44383106|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383107|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
44383108|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43690027|NCT02799446|Reslizumab|reslizumab|mesh-list
44155924|NCT00228865|Insulin|insulin|mesh-list
44155925|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44155926|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
44155927|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155928|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155929|NCT00228878|Insulin|insulin|mesh-list
44155930|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
44155931|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155932|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155933|NCT00228891|Insulin|insulin|mesh-list
44155934|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44155935|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155936|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155937|NCT00228904|Insulin|insulin|mesh-list
44155938|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
44155939|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
44383109|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383110|NCT03554005|Analgesics|analgesics|mesh-ancestor
44383111|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
44383112|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383113|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383114|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
44383115|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
44383116|NCT03553758|Ketamine|ketamine|mesh-list
44383117|NCT03553758|Analgesics|analgesics|mesh-ancestor
44383118|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
44383119|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383120|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383121|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44383122|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44383123|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
44383124|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
44383125|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383126|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44383127|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44383128|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383129|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383130|NCT03552549|Interferons|interferons|mesh-list
44155940|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44155941|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44155942|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155943|NCT00228930|Tamoxifen|tamoxifen|mesh-list
44155944|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44155945|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
44155946|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44155947|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155948|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44155949|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44155950|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44155951|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44155952|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44155953|NCT00228982|Vancomycin|vancomycin|mesh-list
44155954|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
44155955|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
44155956|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155957|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155958|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
44155959|NCT00228995|Hematinics|hematinics|mesh-ancestor
44155960|NCT00229060|Doripenem|doripenem|mesh-list
44155961|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155962|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155963|NCT00229112|Tazobactam|tazobactam|mesh-list
44155964|NCT00229112|Piperacillin|piperacillin|mesh-list
44155965|NCT00229112|Ertapenem|ertapenem|mesh-list
44155966|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44155967|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155968|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44155969|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44155970|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44383132|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
44383133|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44383134|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383135|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
44383136|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383137|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
44383138|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383139|NCT03552523|Pancrelipase|pancrelipase|mesh-list
44383140|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383142|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44383143|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
44383144|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44383145|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
44383146|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383147|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383148|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
44383149|NCT03551730|Enoxaparin|enoxaparin|mesh-list
44383150|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
44383151|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
44383152|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44383153|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44383154|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383155|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43690061|NCT02799277|Testosterone|testosterone|mesh-list
44155971|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44155972|NCT00229125|Gabapentin|gabapentin|mesh-list
43880877|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
43880878|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
43880884|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
43880885|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880886|NCT04649723|Rifampin|rifampin|mesh-list
43880887|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43880888|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
43880889|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43880890|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880891|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
43880892|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43880893|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880894|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880895|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43880896|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43880897|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43880898|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43880899|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43880900|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43880901|NCT04649645|Nicotine|nicotine|mesh-list
43880902|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43880903|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
43880904|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43598258|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44383157|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383158|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44383159|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
44383160|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383161|NCT03547154|Interferons|interferons|mesh-list
44383162|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
44383163|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
44383164|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44383165|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383166|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
44383167|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383168|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
44383169|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383170|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
44383171|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
44383172|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383173|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383174|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383175|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44383176|NCT03546816|Serlopitant|serlopitant|mesh-list
44383177|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44383178|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383179|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383180|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383181|NCT03546621|Tenofovir|tenofovir|mesh-list
44383182|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
44383183|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383184|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43880905|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880906|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43880907|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43880908|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
43880909|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880910|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880911|NCT04649697|Clobetasol|clobetasol|mesh-list
43880912|NCT04649697|Rebamipide|rebamipide|mesh-list
43880913|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880914|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
43880915|NCT04649697|Hormones|hormones|mesh-ancestor
43880916|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43880917|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880918|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43880919|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880920|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
44383185|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44383186|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383187|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383188|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44383189|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44383190|NCT03545503|Ketamine|ketamine|mesh-list
44383191|NCT03545503|Etomidate|etomidate|mesh-list
44383192|NCT03545503|Analgesics|analgesics|mesh-ancestor
44383193|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
44383194|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383195|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383196|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44383197|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44383198|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
44383199|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
44383200|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383201|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44383202|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44383203|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383204|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383205|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44383206|NCT03544229|Maleic acid|maleic acid|mesh-list
44383207|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383208|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383209|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
44383210|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
44383211|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880921|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880922|NCT04649697|Protective Agents|protective agents|mesh-ancestor
43880923|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43880924|NCT04649502|Metformin|metformin|mesh-list
43880925|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43880926|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880927|NCT04648813|Bromides|bromides|mesh-list
43880928|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
43880929|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43880930|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
43880931|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880932|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880933|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43880934|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
43880935|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
43880936|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43880937|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
43880938|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43702473|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44383213|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44383214|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
44383215|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383216|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383217|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44383218|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44383219|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383220|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383221|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383222|NCT03541252|Cisplatin|cisplatin|mesh-list
44383223|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383224|NCT03541044|Nicotine|nicotine|mesh-list
44383225|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44383226|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
44383227|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383228|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383229|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44383230|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44383231|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383232|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383233|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383234|NCT03540160|Serlopitant|serlopitant|mesh-list
44383235|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44383236|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383237|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383238|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383239|NCT03540030|Acetaminophen|acetaminophen|mesh-list
44383240|NCT03540030|Celecoxib|celecoxib|mesh-list
44383241|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44383242|NCT03540030|Lidocaine|lidocaine|mesh-list
44383257|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44383258|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44383259|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383260|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44383261|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44383263|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383264|NCT03540030|Analgesics|analgesics|mesh-ancestor
44383265|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
44383266|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44383267|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44383268|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383269|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383270|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383271|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44383272|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44383273|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383274|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
44383275|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44383276|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44383277|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44383278|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44383279|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44383280|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383281|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
44383282|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44383283|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44383284|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44383285|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43880939|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880940|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
43880941|NCT04648358|Dexamethasone|dexamethasone|mesh-list
43880942|NCT04648358|Bupivacaine|bupivacaine|mesh-list
43880943|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43880944|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
43880945|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
43880946|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880947|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880948|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43880959|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43880960|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43880961|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
43880962|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
43880963|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880964|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383286|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44383287|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383288|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
44383289|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383290|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383291|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
44383292|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44383293|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
44383294|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383295|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44383296|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44383297|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44383298|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383299|NCT03538431|Buspirone|buspirone|mesh-list
44383300|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44383301|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44383302|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44039768|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383303|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383304|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44383305|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44383306|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
44383307|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383308|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383309|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
44383310|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
44383311|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
44383312|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44383313|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44383314|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383327|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383328|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44383329|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383330|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44383332|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44383333|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44383334|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
44383335|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383336|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44383337|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383338|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383339|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383340|NCT03531840|Olaparib|olaparib|mesh-list
44383341|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44383342|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383343|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383344|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383345|NCT03528577|Albuterol|albuterol|mesh-list
44383346|NCT03528577|Procaterol|procaterol|mesh-list
44383347|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44383348|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
44383349|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383350|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880965|NCT04648917|Caffeic acid|caffeic acid|mesh-list
43880966|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
43880967|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880968|NCT04648917|Protective Agents|protective agents|mesh-ancestor
43880969|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880970|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43880971|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
43880972|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880973|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43880974|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
43880975|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43880976|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880977|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43880978|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43880979|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43880980|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
43880981|NCT04648332|Bupivacaine|bupivacaine|mesh-list
43880982|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
43880983|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
43880984|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43880985|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43880986|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
43880987|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43880988|NCT04648280|Fostemsavir|fostemsavir|mesh-list
43880989|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43880990|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43880991|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
44383351|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44383352|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
44383353|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
44383354|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44383355|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44383356|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44383357|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44383358|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
44383359|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383360|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383361|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
44383362|NCT03528369|Capsaicin|capsaicin|mesh-list
44383363|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
44383364|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
44383365|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
44383366|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383367|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383368|NCT03528174|Pancrelipase|pancrelipase|mesh-list
44383369|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383370|NCT03527745|Albendazole|albendazole|mesh-list
44383371|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
44383372|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44383373|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383374|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
44383375|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44383376|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44383377|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
44383378|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
44383379|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
44383380|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383381|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383382|NCT03527173|Vaccines|vaccines|mesh-list
44383383|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
44383384|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383385|NCT03526432|Bevacizumab|bevacizumab|mesh-list
43880992|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43880993|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43880994|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43880995|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155973|NCT00229125|Lorazepam|lorazepam|mesh-list
44155974|NCT00229125|Analgesics|analgesics|mesh-ancestor
44155975|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
44383386|NCT03526432|Atezolizumab|atezolizumab|mesh-list
44383387|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383388|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383389|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44383390|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44383391|NCT03526432|Growth Substances|growth substances|mesh-ancestor
44383392|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383393|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
44383394|NCT03525834|Everolimus|everolimus|mesh-list
44383395|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383396|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44383397|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
44383398|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383399|NCT03525444|Ivacaftor|ivacaftor|mesh-list
44383400|NCT03525444|Elexacaftor|elexacaftor|mesh-list
44383401|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44383402|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44383403|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383404|NCT03525119|Vaccines|vaccines|mesh-list
44383405|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
44383406|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383407|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44383408|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44155976|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44155977|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44155978|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
44155979|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44155980|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44155981|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44155982|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44155983|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44155984|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44155985|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44155986|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155987|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
44155988|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
44155989|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
44155999|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156000|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156001|NCT00229216|Tinidazole|tinidazole|mesh-list
44156002|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
44156003|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43880996|NCT04647669|Interferons|interferons|mesh-list
43880997|NCT04647669|Interferon-beta|interferon-beta|mesh-list
43880998|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
43880999|NCT04647669|Remdesivir|remdesivir|mesh-list
43881000|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
43881001|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881002|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
43881003|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881004|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
43881005|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383409|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
44383410|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44383411|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
44383412|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383413|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
44383414|NCT03524157|Protective Agents|protective agents|mesh-ancestor
44383415|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
44383416|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
44383417|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383418|NCT03523156|Azithromycin|azithromycin|mesh-list
44383419|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44383420|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383421|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44383422|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44383423|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44383424|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383425|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383426|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44383427|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44383428|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383429|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383430|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383432|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43690274|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881006|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43881007|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
43785016|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881008|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881009|NCT04647877|Phenytoin|phenytoin|mesh-list
43881010|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
43881011|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43881012|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43881013|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881014|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881015|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43881016|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43881017|NCT04647838|Tepotinib|tepotinib|mesh-list
43881018|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881019|NCT04647773|Pregabalin|pregabalin|mesh-list
43881020|NCT04647773|Analgesics|analgesics|mesh-ancestor
43881021|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
43881022|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881023|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881024|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
43881025|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43881026|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881027|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881028|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44383433|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383435|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44383436|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44383437|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383438|NCT03521817|Ethanol|ethanol|mesh-list
44383439|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44383440|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383441|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383442|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383443|NCT03521791|Bromfenac|bromfenac|mesh-list
44383444|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383445|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383446|NCT03521791|Analgesics|analgesics|mesh-ancestor
44383447|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
44383448|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383449|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383450|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383451|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383452|NCT03521635|Pramipexole|pramipexole|mesh-list
44383453|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
44383454|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383455|NCT03521635|Protective Agents|protective agents|mesh-ancestor
44383456|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383457|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44383458|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44383459|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
44383460|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
44383461|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383462|NCT03521193|Aspirin|aspirin|mesh-list
44383463|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383464|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383473|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383474|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44383476|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383477|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
44383478|NCT03521141|Nicotine|nicotine|mesh-list
44383479|NCT03521141|Varenicline|varenicline|mesh-list
44383480|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44383481|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
44383482|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383483|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383484|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44383485|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44383486|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383487|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383488|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383489|NCT03520920|Rituximab|rituximab|mesh-list
44383490|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
44383491|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383492|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383493|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
44383494|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383495|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383496|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44383497|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383498|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383499|NCT03520569|Octreotide|octreotide|mesh-list
44383500|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383501|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44383502|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44040000|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
44383503|NCT03519971|Paclitaxel|paclitaxel|mesh-list
44383504|NCT03519971|Etoposide|etoposide|mesh-list
44383505|NCT03519971|Cisplatin|cisplatin|mesh-list
44383506|NCT03519971|Carboplatin|carboplatin|mesh-list
43881029|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43881030|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43881031|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881032|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43881033|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43881034|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44383507|NCT03519971|Pemetrexed|pemetrexed|mesh-list
44383508|NCT03519971|Durvalumab|durvalumab|mesh-list
44383509|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44383510|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383511|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44383512|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44383513|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44383514|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383515|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44383516|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44383517|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383518|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44383519|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44383520|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383521|NCT03519867|Bromides|bromides|mesh-list
44383522|NCT03519867|Rocuronium|rocuronium|mesh-list
44383523|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
44383524|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44383525|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44383526|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44383527|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383528|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383529|NCT03519854|Bromides|bromides|mesh-list
44383530|NCT03519854|Rocuronium|rocuronium|mesh-list
44383531|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
44383532|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44383533|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44383534|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44383535|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690342|NCT02796794|Estrogens|estrogens|mesh-ancestor
43881035|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43881036|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881037|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43881038|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881039|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881040|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881041|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881042|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881043|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881044|NCT04647695|Interferons|interferons|mesh-list
43881045|NCT04647695|Interferon-beta|interferon-beta|mesh-list
43881046|NCT04647695|Remdesivir|remdesivir|mesh-list
43881047|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
43881048|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881056|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
44383536|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383538|NCT03519516|Levofloxacin|levofloxacin|mesh-list
44383539|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44383540|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44383541|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43839226|NCT04789837|Cilostazol|cilostazol|mesh-list
44383542|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383543|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44383544|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44383545|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383546|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383547|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383548|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44383549|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44383550|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44383551|NCT03519516|Renal Agents|renal agents|mesh-ancestor
44383552|NCT03519204|Lidocaine|lidocaine|mesh-list
44383553|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
44383554|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
44383555|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383556|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383557|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
44383558|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383559|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44383560|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44383561|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44383562|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44383563|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881057|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881058|NCT04647344|Paclitaxel|paclitaxel|mesh-list
43881059|NCT04647344|Carboplatin|carboplatin|mesh-list
43881060|NCT04647344|Pemetrexed|pemetrexed|mesh-list
43881061|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43881062|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881063|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
43881064|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
43881065|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
43881066|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881067|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881068|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43881069|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881070|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
43881071|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
44383565|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
44383566|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383567|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
44383568|NCT03518112|Leucovorin|leucovorin|mesh-list
44383569|NCT03518112|Folic Acid|folic acid|mesh-list
44383570|NCT03518112|Cytarabine|cytarabine|mesh-list
44383571|NCT03518112|Dexamethasone|dexamethasone|mesh-list
44383572|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
44383573|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
44383574|NCT03518112|Rituximab|rituximab|mesh-list
44383575|NCT03518112|Methotrexate|methotrexate|mesh-list
44383576|NCT03518112|Vincristine|vincristine|mesh-list
44383577|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
44383578|NCT03518112|Blinatumomab|blinatumomab|mesh-list
44383579|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44040037|NCT00002659|Cisplatin|cisplatin|mesh-list
44383580|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
44383582|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
44383583|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44383584|NCT03518112|Lenograstim|lenograstim|mesh-list
44383585|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44383586|NCT03518112|BB 1101|bb 1101|mesh-list
44383587|NCT03518112|Calcium|calcium|mesh-list
44383588|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
44383589|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44383590|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
44383591|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383592|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383593|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44383594|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
44383596|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383614|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44383615|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
44383616|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
44383617|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44383618|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44383619|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
44383620|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383621|NCT03518112|Antidotes|antidotes|mesh-ancestor
44383622|NCT03518112|Protective Agents|protective agents|mesh-ancestor
44383623|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
44383624|NCT03518112|Vitamins|vitamins|mesh-ancestor
44383625|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
44383626|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44383627|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44383628|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
44383629|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
44383630|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
44383631|NCT03518112|Hematinics|hematinics|mesh-ancestor
44383632|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
44383633|NCT03516812|Olaparib|olaparib|mesh-list
44383634|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44383635|NCT03516812|Testosterone|testosterone|mesh-list
44383636|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
44383637|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
44383638|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44383639|NCT03516812|Androgens|androgens|mesh-ancestor
44383640|NCT03516812|Hormones|hormones|mesh-ancestor
44383641|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383642|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383643|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44383644|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383645|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
44383646|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383648|NCT03515941|Leucovorin|leucovorin|mesh-list
44383657|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
44383658|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383659|NCT03515941|Antidotes|antidotes|mesh-ancestor
44383660|NCT03515941|Protective Agents|protective agents|mesh-ancestor
44383661|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
44383662|NCT03515941|Vitamins|vitamins|mesh-ancestor
44383663|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
44383664|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
44383665|NCT03515629|Cemiplimab|cemiplimab|mesh-list
44383666|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44383667|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383668|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
44383669|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383670|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383671|NCT03512353|Dexamethasone|dexamethasone|mesh-list
44383672|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383673|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
44383674|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
44383675|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383676|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383677|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383678|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
44383679|NCT03512353|Hormones|hormones|mesh-ancestor
44383680|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383681|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44383682|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383683|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44383684|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
44383685|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383686|NCT03512275|Antibodies|antibodies|mesh-list
44383687|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44383688|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
44383689|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383701|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383702|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383703|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
44383704|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
44383705|NCT03510715|Niacin|niacin|mesh-list
44383706|NCT03510715|Niacinamide|niacinamide|mesh-list
44383707|NCT03510715|Atorvastatin|atorvastatin|mesh-list
44383708|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44383709|NCT03510715|Simvastatin|simvastatin|mesh-list
44383710|NCT03510715|Ezetimibe|ezetimibe|mesh-list
44383711|NCT03510715|Pravastatin|pravastatin|mesh-list
44383712|NCT03510715|Lovastatin|lovastatin|mesh-list
44383713|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
44383714|NCT03510715|Fenofibrate|fenofibrate|mesh-list
44383715|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44383716|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44383717|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
44383718|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383719|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44383720|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44383721|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383722|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
44383723|NCT03510715|Vitamins|vitamins|mesh-ancestor
44383724|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
44383725|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383726|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
44383727|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
44383728|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44383729|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383730|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44383731|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44383732|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383733|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383734|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383735|NCT03510455|Infigratinib|infigratinib|mesh-list
44383736|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383737|NCT03509675|Ibuprofen|ibuprofen|mesh-list
44383738|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383740|NCT03509675|Analgesics|analgesics|mesh-ancestor
44383741|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
44383742|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840226|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383743|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383744|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383745|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383746|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44383747|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383748|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383749|NCT03509350|Vitamins|vitamins|mesh-list
44383750|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
44383751|NCT03509350|Thiamine|thiamine|mesh-list
44383752|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
44383753|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44383754|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44383755|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44383756|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
44383757|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383758|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383759|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
44383760|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383761|NCT03509350|Protective Agents|protective agents|mesh-ancestor
44383762|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
43881072|NCT04646876|Analgesics|analgesics|mesh-ancestor
43881073|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
43881074|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881075|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881076|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
43881077|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881078|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43881079|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
43881080|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43881081|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881082|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840259|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43881083|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43881084|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
43881085|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43881086|NCT04646824|Cisplatin|cisplatin|mesh-list
43881087|NCT04646824|Pemetrexed|pemetrexed|mesh-list
43881088|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881089|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881090|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881091|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43881092|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881093|NCT04646707|Lidocaine|lidocaine|mesh-list
43881094|NCT04646707|Bupivacaine|bupivacaine|mesh-list
43881095|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881096|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
43881097|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881098|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881099|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
43881100|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881101|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44383764|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383765|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44383766|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383767|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383768|NCT03508830|Bupivacaine|bupivacaine|mesh-list
44383769|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
44383770|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
44383771|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383772|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383773|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
44383774|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383775|NCT03505021|Simendan|simendan|mesh-list
44383776|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44383777|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
44383778|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44383779|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44383780|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881102|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43881103|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43881104|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881105|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881106|NCT04646759|Capecitabine|capecitabine|mesh-list
43881107|NCT04646759|Fulvestrant|fulvestrant|mesh-list
43881108|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43881109|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
43881110|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881111|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881112|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881113|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43881114|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43881117|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881119|NCT04646694|Analgesics|analgesics|mesh-ancestor
43881120|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
43881121|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881122|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881123|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43881124|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43881125|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
43881126|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
43881127|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881128|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43881129|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43881130|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881131|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881132|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
43881133|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43881134|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881135|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881136|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43881137|NCT04646317|Analgesics|analgesics|mesh-ancestor
43881138|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
43881139|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383782|NCT03505021|Protective Agents|protective agents|mesh-ancestor
44383783|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383784|NCT03503318|Risperidone|risperidone|mesh-list
44383785|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44383786|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
44383787|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383788|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383789|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383790|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44383791|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44383792|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383793|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44383794|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44383795|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
43840267|NCT04720105|Halobetasol|halobetasol|mesh-list
44383796|NCT03502616|Tofacitinib|tofacitinib|mesh-list
43881140|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43881141|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881142|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881143|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881144|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881145|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881146|NCT04646161|Misoprostol|misoprostol|mesh-list
43881147|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43881148|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
43881149|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43881150|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881151|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43881152|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881153|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
43881154|NCT04646135|Lorazepam|lorazepam|mesh-list
43881155|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
43881156|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
43881157|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
43881158|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881159|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881160|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881161|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43881162|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881163|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43881164|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43881165|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43881166|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
43881167|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
43881168|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881169|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881170|NCT04645914|Nicotine|nicotine|mesh-list
43881171|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43881172|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
43881173|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881174|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881175|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43881176|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43881177|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
43881178|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881179|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881180|NCT04645940|Rabeprazole|rabeprazole|mesh-list
44383799|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383800|NCT03502070|Tobramycin|tobramycin|mesh-list
44383801|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44383802|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383803|NCT03501277|Pioglitazone|pioglitazone|mesh-list
44383804|NCT03501277|Alogliptin|alogliptin|mesh-list
44383805|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383806|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383807|NCT03501277|Incretins|incretins|mesh-ancestor
44383808|NCT03501277|Hormones|hormones|mesh-ancestor
44383809|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383810|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44383811|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
44383812|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383813|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383814|NCT03500211|Lidocaine|lidocaine|mesh-list
44383815|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
44383816|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
44383817|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383818|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383819|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
44383820|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383821|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44383822|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44383823|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44383824|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881181|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43881182|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881183|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43881184|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881191|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
43881192|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156004|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156005|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156006|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44156007|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44156008|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44156009|NCT00229242|Diuretics|diuretics|mesh-list
44156010|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
44156011|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156012|NCT00229333|Citalopram|citalopram|mesh-list
44156013|NCT00229333|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44383825|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383826|NCT03499873|Nepafenac|nepafenac|mesh-list
44383827|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383828|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383829|NCT03499873|Analgesics|analgesics|mesh-ancestor
44383830|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
44383831|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383832|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383833|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383834|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383835|NCT03499353|Talazoparib|talazoparib|mesh-list
44383836|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44383837|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383838|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383839|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383840|NCT03498313|Estradiol|estradiol|mesh-list
44383841|NCT03498313|Progesterone|progesterone|mesh-list
44383842|NCT03498313|Estrogens|estrogens|mesh-ancestor
44383843|NCT03498313|Hormones|hormones|mesh-ancestor
44383844|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383845|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383846|NCT03498313|Progestins|progestins|mesh-ancestor
44383847|NCT03497429|Niraparib|niraparib|mesh-list
44383848|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44383849|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156014|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156015|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156016|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156017|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156018|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
44156019|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156020|NCT00229333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44156021|NCT00229333|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156022|NCT00229333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156023|NCT00229385|Ziprasidone|ziprasidone|mesh-list
44156024|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44156025|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
44156026|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156027|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156028|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881193|NCT04645303|Triamcinolone|triamcinolone|mesh-list
43881194|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43881195|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43881196|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
43881197|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43881198|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881199|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
43702474|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383850|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383851|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383852|NCT03497039|Diclofenac|diclofenac|mesh-list
44383853|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44383854|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44383855|NCT03497039|Analgesics|analgesics|mesh-ancestor
44383856|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
44383857|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383858|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383859|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383860|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383861|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44383862|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383863|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383864|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
44383865|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383866|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383867|NCT03495102|Dulaglutide|dulaglutide|mesh-list
44383868|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44383869|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383870|NCT03494985|Muramidase|muramidase|mesh-list
44383871|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383872|NCT03494816|Axitinib|axitinib|mesh-list
44383873|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383874|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44383875|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383876|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383877|NCT03493698|Midazolam|midazolam|mesh-list
44383878|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44383879|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44383880|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383881|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383882|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43829310|NCT05435547|Hormones|hormones|mesh-ancestor
44383890|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383891|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383892|NCT03493542|Vaccines|vaccines|mesh-list
44383893|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
44383894|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383895|NCT03493386|Glycine|glycine|mesh-list
44383896|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
44383897|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383898|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383899|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383900|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44383901|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44383902|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44383903|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
44383904|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383905|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383906|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383907|NCT03492281|Urological Agents|urological agents|mesh-ancestor
44383908|NCT03489863|Ticagrelor|ticagrelor|mesh-list
44383909|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44383910|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44383911|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44383912|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44383913|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44383914|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
44383915|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383916|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383917|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383918|NCT03489551|Haloperidol|haloperidol|mesh-list
44383932|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44383933|NCT03489304|Zaleplon|zaleplon|mesh-list
44383934|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
44383935|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44383936|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44383937|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383938|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
44383939|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
44383940|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44383941|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383942|NCT03488251|Gemcitabine|gemcitabine|mesh-list
44383943|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
44383944|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44383945|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
44383946|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383947|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383948|NCT03488251|Antiviral Agents|antiviral agents|mesh-ancestor
44383949|NCT03488251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44383950|NCT03488251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44383951|NCT03488251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44383952|NCT03488251|Immunologic Factors|immunologic factors|mesh-ancestor
44383953|NCT03488251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383954|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
44383955|NCT03488225|Leucovorin|leucovorin|mesh-list
44383956|NCT03488225|Folic Acid|folic acid|mesh-list
44383957|NCT03488225|Cytarabine|cytarabine|mesh-list
44383958|NCT03488225|Dexamethasone|dexamethasone|mesh-list
44383959|NCT03488225|Prednisone|prednisone|mesh-list
44383960|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
44383961|NCT03488225|Cortisone|cortisone|mesh-list
44383962|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
44383963|NCT03488225|Rituximab|rituximab|mesh-list
44383964|NCT03488225|Doxorubicin|doxorubicin|mesh-list
44383965|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44383966|NCT03488225|Methotrexate|methotrexate|mesh-list
44383967|NCT03488225|Vincristine|vincristine|mesh-list
44383968|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
44383969|NCT03488225|Ofatumumab|ofatumumab|mesh-list
44383976|NCT03488225|Calcium|calcium|mesh-list
44383977|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
44040500|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
44383978|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44383979|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
44383980|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383981|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44383982|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44383983|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
44383984|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44383985|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44383986|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44383987|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44383988|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
44383989|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
44383990|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44383991|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44383992|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
44383993|NCT03488225|Hormones|hormones|mesh-ancestor
43881201|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881202|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881203|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881204|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
43881205|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881206|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881207|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43881208|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
43881209|NCT04645303|Protective Agents|protective agents|mesh-ancestor
43881210|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
43881211|NCT04644484|Vaccines|vaccines|mesh-list
43881212|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
43881213|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
43881214|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881215|NCT04644354|Nifedipine|nifedipine|mesh-list
43881216|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43881217|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881218|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881219|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43881220|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881221|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
43881222|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
43881223|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43881224|NCT04644250|Paclitaxel|paclitaxel|mesh-list
43881225|NCT04644250|Carboplatin|carboplatin|mesh-list
43881226|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43881227|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881228|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
43881229|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
43881230|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
43881241|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881242|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881243|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881244|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
43881245|NCT04644185|Paraproteins|paraproteins|mesh-list
43881246|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
43881247|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44383994|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44383995|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44383996|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44383997|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44383999|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384000|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44384001|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44384002|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44384003|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
44384004|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43881248|NCT04644406|Trastuzumab|trastuzumab|mesh-list
43881249|NCT04644406|Pertuzumab|pertuzumab|mesh-list
43881250|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881251|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881252|NCT04643821|Calcitriol|calcitriol|mesh-list
43881253|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
43881254|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43881255|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
43881256|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881257|NCT04643821|Expectorants|expectorants|mesh-ancestor
43881258|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
43881259|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43881260|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
43881261|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881262|NCT04643821|Protective Agents|protective agents|mesh-ancestor
43881263|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881264|NCT04643821|Antidotes|antidotes|mesh-ancestor
43881265|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43881266|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43881267|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881268|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43881270|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
43881271|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43881272|NCT04643691|Losartan|losartan|mesh-list
43881273|NCT04643691|Spironolactone|spironolactone|mesh-list
43881274|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43881275|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881276|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43881277|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43881278|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826989|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881279|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43881280|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
43881281|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881282|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881283|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43881284|NCT04643691|Diuretics|diuretics|mesh-ancestor
43881285|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
43881287|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
43881288|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881289|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881290|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881291|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
43881292|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881293|NCT04643132|Ketamine|ketamine|mesh-list
43881294|NCT04643132|Esketamine|esketamine|mesh-list
43881295|NCT04643132|Analgesics|analgesics|mesh-ancestor
43881296|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
43881300|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43881301|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
44384005|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44384006|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
44384007|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384008|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44384009|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44384010|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
44384011|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384012|NCT03488225|Antidotes|antidotes|mesh-ancestor
44384013|NCT03488225|Protective Agents|protective agents|mesh-ancestor
44384014|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
44384015|NCT03488225|Vitamins|vitamins|mesh-ancestor
44384016|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
44384017|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44384018|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
44384019|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
44384020|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44384021|NCT03488225|Hematinics|hematinics|mesh-ancestor
44384022|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
44384023|NCT03488108|Minoxidil|minoxidil|mesh-list
44384024|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44384025|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
44384026|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
44384027|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
44384028|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384029|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44384030|NCT03487549|Cantharidin|cantharidin|mesh-list
43690636|NCT02794155|Insulin|insulin|mesh-list
43881302|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
43881303|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881304|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43881305|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43881306|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881307|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881308|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
43881309|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43881310|NCT04643301|Liraglutide|liraglutide|mesh-list
43881311|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43881312|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881313|NCT04643301|Incretins|incretins|mesh-ancestor
43881314|NCT04643301|Hormones|hormones|mesh-ancestor
43881315|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881316|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43881317|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881318|NCT04643106|Hemostatics|hemostatics|mesh-list
43881319|NCT04643106|Coagulants|coagulants|mesh-ancestor
43881320|NCT04642846|Fluorides|fluorides|mesh-list
43881321|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
43881322|NCT04642846|Protective Agents|protective agents|mesh-ancestor
43881323|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881324|NCT04642664|Apatinib|apatinib|mesh-list
43881325|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881326|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881327|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384031|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384032|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384034|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
44384035|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384036|NCT03486392|Liraglutide|liraglutide|mesh-list
44384037|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384038|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384039|NCT03486392|Incretins|incretins|mesh-ancestor
44384040|NCT03486392|Hormones|hormones|mesh-ancestor
44384041|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384042|NCT03486314|Rifampin|rifampin|mesh-list
44384043|NCT03486314|Paclitaxel|paclitaxel|mesh-list
44384044|NCT03486314|Docetaxel|docetaxel|mesh-list
44384045|NCT03486314|Carboplatin|carboplatin|mesh-list
44384046|NCT03486314|Pevonedistat|pevonedistat|mesh-list
44384047|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44384048|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384049|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
44384050|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
44384051|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
43690644|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
43881328|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881329|NCT04642547|Lenvatinib|lenvatinib|mesh-list
43881330|NCT04642547|Gefitinib|gefitinib|mesh-list
43881331|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881332|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881333|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881334|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156029|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156030|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156031|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156032|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156033|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44156034|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
44156035|NCT00229424|Famotidine|famotidine|mesh-list
44156036|NCT00229424|Lafutidine|lafutidine|mesh-list
44156037|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43881335|NCT04642391|Cosyntropin|cosyntropin|mesh-list
43881336|NCT04642391|Hormones|hormones|mesh-ancestor
43881337|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881338|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881339|NCT04642001|Listerine|listerine|mesh-list
43881340|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
43881341|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
43881342|NCT04642001|Protective Agents|protective agents|mesh-ancestor
43881343|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881344|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43881345|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881346|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
43881347|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
43881348|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881349|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881350|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881351|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
43881352|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
43881353|NCT04640870|Afatinib|afatinib|mesh-list
44384052|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384053|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44384054|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
44384055|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384056|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384057|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
44384058|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44384059|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384060|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44384061|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44384062|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44384063|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44384064|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44384065|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44384066|NCT03485950|Meropenem|meropenem|mesh-list
44384067|NCT03485950|Tazobactam|tazobactam|mesh-list
44384068|NCT03485950|Piperacillin|piperacillin|mesh-list
44384069|NCT03485950|Cefepime|cefepime|mesh-list
44384070|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44384071|NCT03485950|Ceftolozane|ceftolozane|mesh-list
44384072|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881354|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653855|NCT02980991|Cisplatin|cisplatin|mesh-list
43881355|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881356|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881357|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881358|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
43881359|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881364|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881365|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43881366|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43881367|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
43881368|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881369|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881370|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43881371|NCT04640181|Enoxaparin|enoxaparin|mesh-list
43881372|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
43881373|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43881374|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
43881375|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43881376|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
43881377|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881378|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881379|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
43881380|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43881381|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43881382|NCT04640129|Interferons|interferons|mesh-list
43881383|NCT04640129|Tenofovir|tenofovir|mesh-list
43881384|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
43881385|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881386|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
43881387|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881388|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44384074|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44384075|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384076|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384077|NCT03485222|Empagliflozin|empagliflozin|mesh-list
44384078|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44384079|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384080|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384081|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384082|NCT03482882|Pimavanserin|pimavanserin|mesh-list
44384083|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44384084|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44384085|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44384086|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384087|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384088|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384089|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384090|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44384091|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44384092|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
44384093|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384094|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384095|NCT03482011|Mirikizumab|mirikizumab|mesh-list
44384096|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43881389|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881390|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881391|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881392|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43881393|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43881394|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
43881395|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881396|NCT04640324|Vitamin D|vitamin d|mesh-list
43881397|NCT04640324|Vitamins|vitamins|mesh-list
43881398|NCT04640324|Vitamin E|vitamin e|mesh-list
43881399|NCT04640324|Silybin|silybin|mesh-list
43881400|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
43881401|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881402|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43881403|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
43881404|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881405|NCT04640324|Protective Agents|protective agents|mesh-ancestor
43881406|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43881407|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881408|NCT04640285|Menthol|menthol|mesh-list
43881409|NCT04640285|Nicotine|nicotine|mesh-list
43881410|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43881411|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
44384097|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384098|NCT03482011|Analgesics|analgesics|mesh-ancestor
44384099|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
44384100|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384101|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384102|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384103|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384104|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44384105|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384106|NCT03481816|Vaccines|vaccines|mesh-list
44384107|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
44384108|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384109|NCT03481725|Coal Tar|coal tar|mesh-list
44384110|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
44384111|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384112|NCT03480932|Interferons|interferons|mesh-list
44384113|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
44384114|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
44384115|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44384116|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
44384117|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384118|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
44384119|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384120|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
44384121|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881412|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881413|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881414|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43881415|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43881416|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
43881417|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881418|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881419|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
43881420|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
43881421|NCT04639817|Levofloxacin|levofloxacin|mesh-list
43881422|NCT04639817|Ofloxacin|ofloxacin|mesh-list
43881423|NCT04639817|Trimethoprim|trimethoprim|mesh-list
43881424|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43881425|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
43881426|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43881427|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881428|NCT04639817|Renal Agents|renal agents|mesh-ancestor
43881429|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881430|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43881431|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43881432|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881438|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43881439|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43881440|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43881441|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43881442|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43881443|NCT04639804|Celecoxib|celecoxib|mesh-list
43881444|NCT04639804|Naproxen|naproxen|mesh-list
43881445|NCT04639804|Aceclofenac|aceclofenac|mesh-list
44384122|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44384123|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
44384124|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384125|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44384126|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
44384127|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384128|NCT03480750|Carboplatin|carboplatin|mesh-list
44040658|NCT00002704|Vitamins|vitamins|mesh-ancestor
44384129|NCT03480750|Doxorubicin|doxorubicin|mesh-list
44384130|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44384131|NCT03480750|Trientine|trientine|mesh-list
44384132|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384133|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43785125|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44384134|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44384135|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44384136|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384137|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384138|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
44384139|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
44384140|NCT03480243|Erythromycin|erythromycin|mesh-list
44384141|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
44384142|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44384143|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
43690718|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
43881446|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43881447|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43881448|NCT04639804|Analgesics|analgesics|mesh-ancestor
43881449|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
43881450|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881451|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881452|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881453|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881454|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43881455|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43881456|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881457|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881458|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
44156038|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44156039|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44156040|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
44156041|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
44156042|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156043|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156044|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156045|NCT00229450|Estrogens|estrogens|mesh-list
44156046|NCT00229450|Hormones|hormones|mesh-ancestor
44156047|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156048|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156049|NCT00229476|Sertraline|sertraline|mesh-list
44156050|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
44384144|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384145|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384146|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384147|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44384148|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384149|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384150|NCT03480022|Liraglutide|liraglutide|mesh-list
44384151|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384152|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384153|NCT03480022|Incretins|incretins|mesh-ancestor
44384154|NCT03480022|Hormones|hormones|mesh-ancestor
44384155|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384156|NCT03480009|Oxycodone|oxycodone|mesh-list
44384157|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
44384158|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44384159|NCT03480009|Narcotics|narcotics|mesh-ancestor
44384160|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384161|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384162|NCT03480009|Analgesics|analgesics|mesh-ancestor
44384163|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
44384164|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384165|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
44384166|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384167|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44384168|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44384169|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384170|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384171|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
44384172|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
44384173|NCT03479216|Bupivacaine|bupivacaine|mesh-list
44384174|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
44384175|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
44384176|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384177|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384183|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44384184|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44384185|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44384186|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44384187|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384188|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384189|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44384190|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
44384191|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44384192|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384193|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44384194|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
44384195|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384196|NCT03478969|Insulin|insulin|mesh-list
44384197|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384198|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384199|NCT03478891|Ansuvimab|ansuvimab|mesh-list
44384200|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
44384201|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384202|NCT03478696|Budesonide|budesonide|mesh-list
44384203|NCT03478696|Albuterol|albuterol|mesh-list
44384204|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
44384206|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44384207|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384208|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44384209|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
44384210|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384211|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384212|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384213|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384214|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
44384215|NCT03478696|Hormones|hormones|mesh-ancestor
43690778|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
44156051|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156052|NCT00229476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156053|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156054|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156055|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156056|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156057|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
44156058|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384216|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384217|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44384218|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44384220|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
44384221|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384222|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384223|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
44384224|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44384225|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44384226|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
44384227|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384228|NCT03478683|Budesonide|budesonide|mesh-list
44384229|NCT03478683|Albuterol|albuterol|mesh-list
44384230|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
44384231|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
44384232|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44384233|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384234|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44384235|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
44384236|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384237|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384238|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384239|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384240|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
44384241|NCT03478683|Hormones|hormones|mesh-ancestor
43839227|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44384242|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156059|NCT00229515|Sirolimus|sirolimus|mesh-list
44156060|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
44156061|NCT00229515|Tirofiban|tirofiban|mesh-list
44156062|NCT00229515|Abciximab|abciximab|mesh-list
44156063|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881459|NCT04639362|Venetoclax|venetoclax|mesh-list
43881460|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
43881461|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881462|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881463|NCT04639232|Probenecid|probenecid|mesh-list
43881464|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
43881465|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
43881466|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881467|NCT04639232|Renal Agents|renal agents|mesh-ancestor
43881468|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
43881469|NCT04639284|Antibodies|antibodies|mesh-list
43881470|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
43881471|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881472|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43881473|NCT04639284|Growth Substances|growth substances|mesh-ancestor
43881474|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
44384243|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44384244|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44384245|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44384246|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
44384247|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384248|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384249|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
44384250|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44384251|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
44384252|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
44384253|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384254|NCT03477903|Metoclopramide|metoclopramide|mesh-list
44384255|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
44384256|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
44384257|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384258|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384259|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384260|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44384261|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44384262|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
44384263|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384264|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881475|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881479|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881480|NCT04639180|Apatinib|apatinib|mesh-list
43881481|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881482|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881483|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881484|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881485|NCT04638816|Lidocaine|lidocaine|mesh-list
43881486|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
43881487|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881488|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
43881489|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881490|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881491|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
43881492|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881493|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43881494|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43881495|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43881496|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881497|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881498|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43881499|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
43881500|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
43881501|NCT04638816|Protective Agents|protective agents|mesh-ancestor
43881502|NCT04639193|Acetazolamide|acetazolamide|mesh-list
43881503|NCT04639193|Eszopiclone|eszopiclone|mesh-list
43881504|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43881505|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43881506|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44384265|NCT03476239|Blinatumomab|blinatumomab|mesh-list
44384266|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384267|NCT03474081|Albuterol|albuterol|mesh-list
44384268|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
44384269|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44384270|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
44384271|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384272|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384273|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384274|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384275|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
44384276|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44384277|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44384278|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384279|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384280|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
44384281|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384282|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44384283|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44384284|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44384285|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44384286|NCT03473340|Pirfenidone|pirfenidone|mesh-list
44384287|NCT03473340|Analgesics|analgesics|mesh-ancestor
44384288|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
44384289|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43690853|NCT02792400|Incretins|incretins|mesh-ancestor
43881507|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881508|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881509|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881510|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881511|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43881512|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
43881513|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43881514|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
43881515|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43881516|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881517|NCT04639193|Diuretics|diuretics|mesh-ancestor
43881518|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
43881519|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43881520|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881521|NCT04638686|Lamivudine|lamivudine|mesh-list
43881522|NCT04638686|Dolutegravir|dolutegravir|mesh-list
43881523|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43881524|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881525|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881526|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881527|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
43881528|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881529|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43881530|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44384290|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384291|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384292|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384293|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384294|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384295|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384296|NCT03473197|Diacetylrhein|diacetylrhein|mesh-list
44384297|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384298|NCT03472885|Eculizumab|eculizumab|mesh-list
44384299|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44384300|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384301|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
44384302|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384303|NCT03472547|Diacetylrhein|diacetylrhein|mesh-list
43881531|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43881532|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43881533|NCT04638582|Paclitaxel|paclitaxel|mesh-list
43881534|NCT04638582|Carboplatin|carboplatin|mesh-list
43881535|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
43881536|NCT04638582|Pemetrexed|pemetrexed|mesh-list
43881537|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43881538|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881539|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
43881540|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
43881541|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
43881542|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881543|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881544|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881545|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43881546|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43881554|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881555|NCT04638036|Cetuximab|cetuximab|mesh-list
43881556|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881557|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881558|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
43881559|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43881560|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43881561|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43881562|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881563|NCT04637152|Valsartan|valsartan|mesh-list
43881564|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43881565|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881566|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43881567|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43881568|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156064|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156065|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156066|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156067|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
44156068|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156069|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
44156070|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156071|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
44156072|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44156073|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44156074|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44156075|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156076|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44156077|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
44156078|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
44384304|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384305|NCT03472534|Diacetylrhein|diacetylrhein|mesh-list
44384306|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384307|NCT03472521|Gabapentin|gabapentin|mesh-list
44384308|NCT03472521|Analgesics|analgesics|mesh-ancestor
44384309|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
44384310|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384311|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384312|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
44384313|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44384314|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384315|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384316|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384317|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44384318|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44384319|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384320|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384321|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
44384322|NCT03472326|GS-9131|gs-9131|mesh-list
44384323|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384324|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384325|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44384326|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44384327|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
44384328|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384329|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44384330|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44384331|NCT03471871|Lemborexant|lemborexant|mesh-list
44384332|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44384333|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384334|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384335|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43785165|NCT04977024|Vaccines|vaccines|mesh-list
44156079|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44156080|NCT00229515|Protective Agents|protective agents|mesh-ancestor
44156081|NCT00229528|Paroxetine|paroxetine|mesh-list
44156082|NCT00229528|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156083|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156084|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156085|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156086|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384336|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44384337|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384338|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384339|NCT03469349|Actovegin|actovegin|mesh-list
44384340|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44384341|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384342|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44384343|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384344|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
44384345|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384346|NCT03469349|Protective Agents|protective agents|mesh-ancestor
44384347|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44384348|NCT03469336|Betamethasone|betamethasone|mesh-list
44384349|NCT03469336|Calcipotriene|calcipotriene|mesh-list
44384350|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384351|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
44384352|NCT03469336|Hormones|hormones|mesh-ancestor
44040888|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
44384353|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384354|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384355|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384356|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384358|NCT03469258|Pancrelipase|pancrelipase|mesh-list
44156087|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
44156088|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156089|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44156090|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156091|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156092|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44156093|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44156094|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156095|NCT00229567|Lidocaine|lidocaine|mesh-list
44156096|NCT00229567|Ketamine|ketamine|mesh-list
44156097|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
44156098|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
44156099|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156100|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156101|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
44156102|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881570|NCT04636918|Cyclosporins|cyclosporins|mesh-list
43881571|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881572|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881573|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881574|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
43881584|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881585|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881586|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
43881587|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
43785171|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785172|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43785173|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
43785174|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
43785175|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785176|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785177|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881588|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43881589|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43702523|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384360|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384361|NCT03468543|Memantine|memantine|mesh-list
44384362|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44384363|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44384364|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
44384365|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384366|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384367|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384368|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44384369|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44384370|NCT03467971|Metformin|metformin|mesh-list
44384371|NCT03467971|Gliclazide|gliclazide|mesh-list
44384372|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384373|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384374|NCT03467945|Metformin|metformin|mesh-list
44384375|NCT03467945|Gliclazide|gliclazide|mesh-list
44384376|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384377|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384378|NCT03467763|Metformin|metformin|mesh-list
44384379|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384380|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384381|NCT03467217|Losartan|losartan|mesh-list
44384382|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44384383|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881590|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881591|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43881592|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43881593|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881594|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881595|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881596|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43881597|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43881598|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881599|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
43881600|NCT04636957|Hormones|hormones|mesh-ancestor
43881601|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881602|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881603|NCT04637360|Calcitriol|calcitriol|mesh-list
43881604|NCT04637360|Cinacalcet|cinacalcet|mesh-list
43881605|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43881606|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881607|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43881608|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881609|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881610|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43881611|NCT04637360|Vitamins|vitamins|mesh-ancestor
43881612|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
43881613|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44384384|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44384385|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44384386|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384387|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
44384388|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44384389|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44384390|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44384391|NCT03465891|Atezolizumab|atezolizumab|mesh-list
44384392|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384393|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
44384394|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384395|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384396|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
44384398|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384399|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384400|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44384401|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44384402|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384403|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384404|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384405|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384406|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44384407|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
44384408|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384409|NCT03464383|Citalopram|citalopram|mesh-list
44384410|NCT03464383|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44384411|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44384412|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384413|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384414|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384415|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
44384416|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384417|NCT03464383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44384418|NCT03464383|Antidepressive Agents|antidepressive agents|mesh-ancestor
43881614|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
43881615|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
43702524|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
44384419|NCT03464383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384420|NCT03464136|Adalimumab|adalimumab|mesh-list
44384421|NCT03464136|Ustekinumab|ustekinumab|mesh-list
44384422|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384423|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384424|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384425|NCT03464097|Ozanimod|ozanimod|mesh-list
44384426|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44384427|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384428|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384429|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
44384430|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384431|NCT03462680|Niacin|niacin|mesh-list
44384432|NCT03462680|Vitamins|vitamins|mesh-ancestor
44384433|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
44384434|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384435|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
44384436|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44384437|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
44384438|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384439|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44384440|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
44384441|NCT03462641|Flumazenil|flumazenil|mesh-list
44384442|NCT03462641|Antidotes|antidotes|mesh-ancestor
44384443|NCT03462641|Protective Agents|protective agents|mesh-ancestor
43881616|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881617|NCT04636125|Doxycycline|doxycycline|mesh-list
43881618|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881619|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881620|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
43881621|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43881622|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43881623|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43881624|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43881625|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
43881626|NCT04635852|Fentanyl|fentanyl|mesh-list
43881627|NCT04635852|Morphine|morphine|mesh-list
43881628|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43881629|NCT04635852|Narcotics|narcotics|mesh-ancestor
43881630|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881631|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881632|NCT04635852|Analgesics|analgesics|mesh-ancestor
43881633|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
43881634|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881635|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43881636|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43881637|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
43881638|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
43881639|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
43881640|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881641|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
43881649|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881650|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
43653859|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653860|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43653862|NCT02981030|Misoprostol|misoprostol|mesh-list
43881651|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
44384444|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384445|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
44384446|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
44384447|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384448|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384449|NCT03461003|Losartan|losartan|mesh-list
44384450|NCT03461003|Amlodipine|amlodipine|mesh-list
44384451|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44384452|NCT03461003|Lisinopril|lisinopril|mesh-list
44384453|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44384454|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44384455|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384456|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384457|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44384458|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384459|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
44384460|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44384461|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44384462|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44384463|NCT03461003|Diuretics|diuretics|mesh-ancestor
44384464|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
44384465|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43690993|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881652|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881653|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881654|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881655|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
43881656|NCT04635176|Hormones|hormones|mesh-ancestor
43881657|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881658|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881659|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881660|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881661|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
43881662|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881663|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
43881664|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881665|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881666|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881667|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881668|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881669|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43881670|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43881671|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43881672|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
43881673|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
43881674|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
43881675|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43881676|NCT04635566|Mebeverine|mebeverine|mesh-list
43881677|NCT04635566|Alverine|alverine|mesh-list
43881678|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
43881679|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
44384467|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44384468|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384469|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44384470|NCT03461003|Protective Agents|protective agents|mesh-ancestor
44384471|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44384472|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
44384473|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44384474|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44384475|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
44384476|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384477|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384478|NCT03457727|Omeprazole|omeprazole|mesh-list
44384479|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44384480|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384481|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44384482|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384483|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384484|NCT03457636|Doxycycline|doxycycline|mesh-list
44384485|NCT03457636|Adapalene|adapalene|mesh-list
44384486|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44384487|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44384488|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384489|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384490|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
44384491|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44384492|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44384493|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384494|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384495|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384496|NCT03457636|Analgesics|analgesics|mesh-ancestor
44384497|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
44384498|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384499|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384500|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881680|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
43881681|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384501|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384502|NCT03456960|Aspirin|aspirin|mesh-list
44384503|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384504|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384505|NCT03456960|Analgesics|analgesics|mesh-ancestor
44384506|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
44384507|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384508|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384509|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384510|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384511|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44384512|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44384513|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384514|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44384515|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44384516|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384517|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
44384518|NCT03453151|Anesthetics|anesthetics|mesh-list
44384519|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
44384520|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384521|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384522|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
44384523|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384524|NCT03452527|Aflibercept|aflibercept|mesh-list
44384525|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
44384526|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44384527|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44384528|NCT03452527|Growth Substances|growth substances|mesh-ancestor
44384529|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691055|NCT02790203|Celecoxib|celecoxib|mesh-list
43881682|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881683|NCT04635293|Simendan|simendan|mesh-list
43881684|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43881685|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
43881686|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43881687|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43670185|NCT02897206|Cilastatin|cilastatin|mesh-list
43881688|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881689|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881690|NCT04635293|Protective Agents|protective agents|mesh-ancestor
43881691|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881692|NCT04635553|Praziquantel|praziquantel|mesh-list
43881693|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
43881694|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43881695|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384530|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
44384531|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384532|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
44384533|NCT03452189|Vancomycin|vancomycin|mesh-list
44384534|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384535|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384536|NCT03451773|Gemcitabine|gemcitabine|mesh-list
44384537|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44384538|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
44384539|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384540|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384541|NCT03451773|Antiviral Agents|antiviral agents|mesh-ancestor
44384542|NCT03451773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653866|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384543|NCT03451773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384544|NCT03451773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384545|NCT03451773|Immunologic Factors|immunologic factors|mesh-ancestor
44041153|NCT00002755|Cobalt|cobalt|mesh-list
44384546|NCT03451773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384547|NCT03451006|Metformin|metformin|mesh-list
44384548|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384549|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384550|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
44384551|NCT03449758|Chloroquine|chloroquine|mesh-list
44384552|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
44384553|NCT03449758|Methotrexate|methotrexate|mesh-list
44384554|NCT03449758|Azathioprine|azathioprine|mesh-list
44384555|NCT03449758|Leflunomide|leflunomide|mesh-list
44384556|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44384557|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
44384558|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44384576|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384577|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384578|NCT03449758|Analgesics|analgesics|mesh-ancestor
44384579|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
44384580|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384581|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384582|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384583|NCT03449446|Firsocostat|firsocostat|mesh-list
44384584|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384585|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384586|NCT03448536|Acetaminophen|acetaminophen|mesh-list
44384587|NCT03448536|Naproxen|naproxen|mesh-list
44384588|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384589|NCT03448536|Analgesics|analgesics|mesh-ancestor
44384590|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
44384591|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384592|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384593|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
43691095|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
43881696|NCT04634981|Anesthetics|anesthetics|mesh-list
43881697|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881698|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881699|NCT04634656|Lidocaine|lidocaine|mesh-list
43881700|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881701|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
43881702|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881703|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881704|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
43881705|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881706|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43881707|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43881708|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43881709|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881710|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881717|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881718|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
43881719|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881720|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881722|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156103|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44156104|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44156105|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44156106|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156107|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156108|NCT00229567|Analgesics|analgesics|mesh-ancestor
44156109|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44156110|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44156111|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
44156112|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44156113|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44156114|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156115|NCT00229593|ST 1435|st 1435|mesh-list
44156116|NCT00229593|Testosterone|testosterone|mesh-list
44156117|NCT00229593|Androgens|androgens|mesh-ancestor
44156118|NCT00229593|Hormones|hormones|mesh-ancestor
44384594|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384595|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384596|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384597|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
44384598|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44384599|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384600|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384601|NCT03448419|Empagliflozin|empagliflozin|mesh-list
44384602|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44384603|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384604|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384605|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384606|NCT03448406|Empagliflozin|empagliflozin|mesh-list
44384607|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44384608|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384609|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384610|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384612|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
44384613|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384614|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384615|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384616|NCT03447353|Acetaminophen|acetaminophen|mesh-list
44384617|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44384618|NCT03447353|Hydrocodone|hydrocodone|mesh-list
44384619|NCT03447353|Alprazolam|alprazolam|mesh-list
44156119|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156120|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156121|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44156122|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
44156123|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44156124|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44156125|NCT00229632|Idebenone|idebenone|mesh-list
44156126|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
44156127|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156128|NCT00229632|Protective Agents|protective agents|mesh-ancestor
44156129|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156130|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44156131|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156132|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156133|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156134|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156135|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156136|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156137|NCT00229684|Pioglitazone|pioglitazone|mesh-list
44384620|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384621|NCT03447353|Analgesics|analgesics|mesh-ancestor
44384622|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
44384623|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384624|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384625|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
44384626|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44384627|NCT03447353|Narcotics|narcotics|mesh-ancestor
44384628|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384629|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
44384630|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384631|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44384632|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44384633|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384634|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384635|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
44384636|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
44384637|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384638|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156138|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653871|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43653872|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43653873|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44156139|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156141|NCT00229697|Gefitinib|gefitinib|mesh-list
44156142|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44156143|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
44156144|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156145|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156146|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44156147|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156148|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44156149|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44156150|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44156151|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44156152|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156153|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156154|NCT00229775|Chloroquine|chloroquine|mesh-list
44156155|NCT00229775|Artemether|artemether|mesh-list
44156156|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
44156157|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
44156158|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44156159|NCT00229775|Amebicides|amebicides|mesh-ancestor
44158284|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881723|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
43881724|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881725|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881726|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43881727|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881728|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43881729|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881730|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881731|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881732|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881733|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881734|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881736|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
43881737|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
44384639|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44384640|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384641|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384642|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
44384643|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384644|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384645|NCT03447249|Ivacaftor|ivacaftor|mesh-list
44384647|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44384648|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384649|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384650|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44384651|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44384652|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384653|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44384654|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44384655|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384656|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384657|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
44384658|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384659|NCT03444766|Nivolumab|nivolumab|mesh-list
44384660|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384661|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384662|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44384663|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384664|NCT03444584|Metformin|metformin|mesh-list
44384665|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44384666|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384667|NCT03444155|Folic Acid|folic acid|mesh-list
44384668|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
44384669|NCT03444155|Vitamins|vitamins|mesh-ancestor
44384670|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
44384671|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384672|NCT03444155|Hematinics|hematinics|mesh-ancestor
44384673|NCT03442569|Nivolumab|nivolumab|mesh-list
44384674|NCT03442569|Ipilimumab|ipilimumab|mesh-list
43839228|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
44384677|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384678|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44384679|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384680|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
44384681|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384682|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384683|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384684|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384685|NCT03441789|Betamethasone|betamethasone|mesh-list
44384686|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
44384687|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44384688|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
44384689|NCT03441789|Calcipotriene|calcipotriene|mesh-list
44384690|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44384691|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384692|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
44384693|NCT03441789|Hormones|hormones|mesh-ancestor
44384694|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384695|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44041277|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
44384696|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384697|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384698|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384699|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
44384700|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44384701|NCT03440411|Dexamethasone|dexamethasone|mesh-list
44384702|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
44384703|NCT03440411|Pomalidomide|pomalidomide|mesh-list
44384704|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384705|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
44384706|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384707|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44384708|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44384709|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
44384717|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384718|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
44384719|NCT03440411|Hormones|hormones|mesh-ancestor
44384720|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384721|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44384722|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44384723|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44384724|NCT03440411|Growth Substances|growth substances|mesh-ancestor
44384725|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
44384726|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
44384727|NCT03439137|Hematinics|hematinics|mesh-ancestor
44384728|NCT03439072|Glucagon|glucagon|mesh-list
44384729|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44384730|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384731|NCT03439072|Hormones|hormones|mesh-ancestor
44384732|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384733|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384734|NCT03439072|Incretins|incretins|mesh-ancestor
44384735|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
44384736|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384737|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384738|NCT03437577|Tacrolimus|tacrolimus|mesh-list
44384739|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44384740|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
44384741|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384742|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44384743|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384744|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384745|NCT03437447|Praziquantel|praziquantel|mesh-list
44384746|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
44384747|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44384748|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384749|NCT03436420|Calcium|calcium|mesh-list
44384750|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44384751|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43691203|NCT02789332|Paclitaxel|paclitaxel|mesh-list
44384752|NCT03435692|Acetaminophen|acetaminophen|mesh-list
43785189|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384753|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
44384754|NCT03435692|Promethazine|promethazine|mesh-list
44384755|NCT03435692|Fentanyl|fentanyl|mesh-list
44384756|NCT03435692|Morphine|morphine|mesh-list
44384757|NCT03435692|Oxycodone|oxycodone|mesh-list
44384758|NCT03435692|Lorazepam|lorazepam|mesh-list
44384759|NCT03435692|Ondansetron|ondansetron|mesh-list
44384760|NCT03435692|Ropivacaine|ropivacaine|mesh-list
44384761|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44384762|NCT03435692|Narcotics|narcotics|mesh-ancestor
44384763|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384764|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384765|NCT03435692|Analgesics|analgesics|mesh-ancestor
44384766|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
44384767|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384768|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
44384769|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
44384770|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44384771|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44384772|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
44384773|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384774|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
44384775|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
44384776|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
44384777|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384778|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
44384779|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44384780|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44384781|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
44384782|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384783|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384784|NCT03435692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44384785|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384786|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384787|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44384788|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43691238|NCT02789566|Primaquine|primaquine|mesh-list
43881738|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881739|NCT04633850|Dexamethasone|dexamethasone|mesh-list
43881740|NCT04633850|Bupivacaine|bupivacaine|mesh-list
43881741|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881742|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
43881743|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
44384789|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44384790|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44384791|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
44384792|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
44384793|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44384794|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
44384795|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
44384796|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
44384798|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44384799|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
44384800|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
44384801|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384802|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384803|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44384804|NCT03435055|Analgesics|analgesics|mesh-ancestor
44384805|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
44384806|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384807|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44384808|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44384809|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44384810|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384811|NCT03434119|Insulin|insulin|mesh-list
44384844|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384845|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384846|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
44384847|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384848|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44384849|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44384850|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44384851|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384852|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384854|NCT03430895|Tremelimumab|tremelimumab|mesh-list
44384855|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384856|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384857|NCT03430856|Insulin|insulin|mesh-list
44384858|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44384859|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
44384860|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43881744|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881745|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881746|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881747|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
43881748|NCT04633850|Hormones|hormones|mesh-ancestor
43881749|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881750|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881751|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881752|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
43881753|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
43881754|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881755|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
43881756|NCT04633746|Endostatins|endostatins|mesh-list
43881757|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881758|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43881759|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43881760|NCT04633746|Growth Substances|growth substances|mesh-ancestor
43881761|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881762|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
43881763|NCT04633733|Tacrolimus|tacrolimus|mesh-list
43881764|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881765|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
43881766|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881767|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43881768|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881769|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881770|NCT04633044|Betaine|betaine|mesh-list
43881771|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43881772|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
43881773|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43881774|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
43785195|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43881775|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881781|NCT04632693|Antioxidants|antioxidants|mesh-ancestor
43881782|NCT04632693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881783|NCT04632693|Protective Agents|protective agents|mesh-ancestor
43881785|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881786|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43881787|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881788|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384861|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384862|NCT03430063|Ipilimumab|ipilimumab|mesh-list
44384863|NCT03430063|Cemiplimab|cemiplimab|mesh-list
44384864|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384865|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384866|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44384867|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384868|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
44384869|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44384870|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384871|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384872|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
44384873|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44384874|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384876|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44384877|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
44384878|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
44384879|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
44384880|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384881|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384882|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384883|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44384884|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384885|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44384886|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44384887|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44384888|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44384889|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44384890|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44384891|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
44384905|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384907|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44384908|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384909|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
44384910|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44384911|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384912|NCT03425396|Renal Agents|renal agents|mesh-ancestor
44384913|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44384914|NCT03425253|Lidocaine|lidocaine|mesh-list
44384915|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
44384916|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
44384917|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44384918|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384919|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
44384920|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384921|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44384922|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44384923|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44384924|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44384925|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384926|NCT03424239|Vitamin D|vitamin d|mesh-list
44384927|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
44384928|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
44384929|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
44384930|NCT03424239|Vitamins|vitamins|mesh-list
44384931|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
43881789|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
43881790|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43881791|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
43881792|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881793|NCT04632238|Metronidazole|metronidazole|mesh-list
43881794|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881795|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881796|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43881797|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43881798|NCT04632121|Nicorandil|nicorandil|mesh-list
43881799|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43881800|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43881801|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
43881802|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
43881803|NCT04632121|Vitamins|vitamins|mesh-ancestor
43881804|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
43881805|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881806|NCT04631874|Varenicline|varenicline|mesh-list
43881807|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43881808|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43881809|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
43881810|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881811|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384932|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384933|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44384934|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44384935|NCT03424044|Glucagon|glucagon|mesh-list
44384936|NCT03424044|Pancrelipase|pancrelipase|mesh-list
44384937|NCT03424044|Pancreatin|pancreatin|mesh-list
44384938|NCT03424044|Hormones|hormones|mesh-list
43785207|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44384939|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384940|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384941|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384942|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
44384943|NCT03422159|Thiamine|thiamine|mesh-list
44384944|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
44384945|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44384946|NCT03422159|Vitamins|vitamins|mesh-ancestor
44384947|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
44384948|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384949|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384950|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
44384951|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384952|NCT03422159|Protective Agents|protective agents|mesh-ancestor
44384953|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
44384954|NCT03421730|Budesonide|budesonide|mesh-list
44384955|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44384956|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44384957|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
44384958|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44384959|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384960|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44384961|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
44384962|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
44384963|NCT03421730|Hormones|hormones|mesh-ancestor
44384964|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384965|NCT03421379|Glucagon|glucagon|mesh-list
43881812|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881813|NCT04631822|Dexamethasone|dexamethasone|mesh-list
43881814|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881815|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
43881816|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
43881817|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881818|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881819|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384966|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44384967|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44384969|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44384970|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384971|NCT03421379|Incretins|incretins|mesh-ancestor
44384972|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44384973|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
44384974|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44384975|NCT03419403|Temozolomide|temozolomide|mesh-list
44384976|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44384977|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44384978|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44384979|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
44384980|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384981|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384982|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43785243|NCT04316364|Paclitaxel|paclitaxel|mesh-list
44384983|NCT03419364|Niacinamide|niacinamide|mesh-list
44384984|NCT03419364|Niacin|niacin|mesh-list
44384985|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
44384986|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
44384987|NCT03419364|Vitamins|vitamins|mesh-ancestor
44384988|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
44384989|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384990|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44384991|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
44384992|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44384993|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44384994|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
44384995|NCT03418922|Nivolumab|nivolumab|mesh-list
44384996|NCT03418922|Lenvatinib|lenvatinib|mesh-list
43829426|NCT05426434|Artenimol|artenimol|mesh-list
43881820|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
43881821|NCT04631822|Hormones|hormones|mesh-ancestor
43881822|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43881823|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43881824|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881825|NCT04631627|Aspirin|aspirin|mesh-list
43881826|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43881827|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43881828|NCT04631627|Analgesics|analgesics|mesh-ancestor
43881829|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
43881830|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43881831|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44384997|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44384998|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44384999|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385000|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385001|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44385002|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385003|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44385004|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44385005|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44385006|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44385007|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44385008|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44385009|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44385010|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385011|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385012|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385013|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385014|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385015|NCT03418727|Laxatives|laxatives|mesh-ancestor
44385016|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385017|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
44385018|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
44385019|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385020|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385021|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385022|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
44041657|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
43691391|NCT02787746|Donepezil|donepezil|mesh-list
43881832|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881833|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43881834|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43881835|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43881836|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881837|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43881838|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43881839|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43881840|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
44156170|NCT00229918|Triamcinolone|triamcinolone|mesh-list
44156171|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44156172|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44156173|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44156174|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156175|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
43785255|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
44156176|NCT00229918|Hormones|hormones|mesh-ancestor
43881849|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44385023|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
44385024|NCT03418571|Gontivimab|gontivimab|mesh-list
44385025|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
44385026|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385027|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
44385028|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
44385029|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385030|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44385031|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385032|NCT03416374|Dexamethasone|dexamethasone|mesh-list
44385033|NCT03416374|Lenalidomide|lenalidomide|mesh-list
44385034|NCT03416374|Bortezomib|bortezomib|mesh-list
44385035|NCT03416374|Ixazomib|ixazomib|mesh-list
44385036|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385037|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
44385038|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
44385039|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385040|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385041|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385042|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
44385043|NCT03416374|Hormones|hormones|mesh-ancestor
44385044|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385045|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44385046|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385047|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
44385048|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385049|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385050|NCT03416374|Growth Substances|growth substances|mesh-ancestor
43881850|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
43881852|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43881853|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43881877|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881878|NCT04631341|Melatonin|melatonin|mesh-list
43881879|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
43881880|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881881|NCT04631341|Protective Agents|protective agents|mesh-ancestor
43881882|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881883|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881884|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43881885|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43881886|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
43881887|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
43881888|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43881889|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43881890|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881891|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
43881892|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385051|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385052|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
44385053|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385054|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385055|NCT03415178|Atorvastatin|atorvastatin|mesh-list
44385056|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44385057|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44385058|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44385059|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
44385060|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385061|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44385062|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44385063|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385064|NCT03414983|Leucovorin|leucovorin|mesh-list
44385065|NCT03414983|Bevacizumab|bevacizumab|mesh-list
44385066|NCT03414983|Nivolumab|nivolumab|mesh-list
44385067|NCT03414983|Fluorouracil|fluorouracil|mesh-list
44385068|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
44385069|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385070|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385071|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385072|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385073|NCT03414983|Growth Substances|growth substances|mesh-ancestor
44385074|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385075|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385076|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
44385077|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43691418|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881893|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881894|NCT04630522|Vitamin D|vitamin d|mesh-list
43881895|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
43881896|NCT04630522|Calcium|calcium|mesh-list
43881897|NCT04630522|Vitamins|vitamins|mesh-ancestor
43881898|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
43881899|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881900|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43881901|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43881902|NCT04630444|Riluzole|riluzole|mesh-list
43881903|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
43881904|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43881913|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
43881914|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881915|NCT04630288|Clopidogrel|clopidogrel|mesh-list
43881916|NCT04630288|Ticagrelor|ticagrelor|mesh-list
44156204|NCT00230035|Methotrexate|methotrexate|mesh-list
43881917|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43881918|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44385078|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44385079|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385080|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
44385081|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385082|NCT03414983|Antidotes|antidotes|mesh-ancestor
44385083|NCT03414983|Protective Agents|protective agents|mesh-ancestor
44385084|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
44385085|NCT03414983|Vitamins|vitamins|mesh-ancestor
44385086|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
44385087|NCT03414359|Lidocaine|lidocaine|mesh-list
44385088|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
44385089|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44385090|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
44385091|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385092|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385093|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
44385094|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385095|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44385096|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44041742|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
44385097|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44385098|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385099|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385101|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385102|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44385103|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
44385104|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44385105|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385106|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
44385107|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
44385108|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44385109|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385110|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385119|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44385120|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44385121|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44385122|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385123|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385124|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
44385125|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
44385126|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385127|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385128|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44385129|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44385130|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
44385131|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44385132|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44385133|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44385134|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44385135|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
44385136|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
44385137|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
44385138|NCT03408639|Vitamins|vitamins|mesh-ancestor
44385139|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
44385140|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385141|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
44385142|NCT03408639|Hematinics|hematinics|mesh-ancestor
44041788|NCT00002792|Busulfan|busulfan|mesh-list
44385170|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385171|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385172|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
44385173|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44385174|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385175|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385176|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44385177|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44385178|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44385179|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385180|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44385181|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
44385182|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385183|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385184|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
44385185|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385186|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385187|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
44385188|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44385189|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385190|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43691543|NCT02786667|Rotigotine|rotigotine|mesh-list
43881919|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43881920|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43881921|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
43881922|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43881923|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881924|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881926|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
43881927|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43881928|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881929|NCT04629846|Docetaxel|docetaxel|mesh-list
43881930|NCT04629846|Trastuzumab|trastuzumab|mesh-list
43881931|NCT04629846|Pertuzumab|pertuzumab|mesh-list
43881932|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881933|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
43881934|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
43881935|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
43881936|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881937|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43881938|NCT04629573|Anesthetics|anesthetics|mesh-list
43881939|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881940|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881941|NCT04629612|Anesthetics|anesthetics|mesh-list
43881942|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43670203|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
43881943|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881945|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881946|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
43881947|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881948|NCT04629209|TIC10 compound|tic10 compound|mesh-list
43881949|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385191|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
44385192|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385193|NCT03406260|Lasmiditan|lasmiditan|mesh-list
44385194|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44385195|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
44385196|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385197|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385198|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385199|NCT03406156|Venetoclax|venetoclax|mesh-list
44385200|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44385201|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
44385202|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385203|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44385204|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
44385205|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385206|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385207|NCT03405818|Tavaborole|tavaborole|mesh-list
44385208|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
44385209|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385210|NCT03404843|Fasudil|fasudil|mesh-list
44385211|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44385212|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385213|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385214|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44385215|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385216|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
44385217|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44385218|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385219|NCT03404518|Acetaminophen|acetaminophen|mesh-list
44385220|NCT03404518|Ibuprofen|ibuprofen|mesh-list
44385221|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44385222|NCT03404518|Hydrocodone|hydrocodone|mesh-list
44385223|NCT03404518|Narcotics|narcotics|mesh-list
44385224|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44385225|NCT03404518|Analgesics|analgesics|mesh-ancestor
44385226|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
43691560|NCT02786641|Cisplatin|cisplatin|mesh-list
44385227|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385228|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385230|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44385231|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385232|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44385233|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44385234|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385235|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385236|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44385237|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385238|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
44385239|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385240|NCT03404206|Ibuprofen|ibuprofen|mesh-list
44385241|NCT03404206|Naproxen|naproxen|mesh-list
44385242|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44385243|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44385244|NCT03404206|Analgesics|analgesics|mesh-ancestor
44385245|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
44385246|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385247|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385248|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385249|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44385250|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44385251|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385252|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385253|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
44385254|NCT03403634|Interferons|interferons|mesh-list
44385255|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
44385256|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
44385257|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
44385258|NCT03403634|Celecoxib|celecoxib|mesh-list
44385259|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
44385260|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881950|NCT04628884|Heparin|heparin|mesh-list
43881951|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
43881952|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43881953|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43881954|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881955|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44385261|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
44385262|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385263|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
43785266|NCT03982576|Nicotine|nicotine|mesh-list
44385264|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385265|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44385266|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44385267|NCT03403634|Analgesics|analgesics|mesh-ancestor
44385268|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
44385269|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385270|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385271|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44385272|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44385273|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44385274|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385275|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385276|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44385277|NCT03403374|Evolocumab|evolocumab|mesh-list
44385278|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43881956|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881957|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881958|NCT04629118|Sirolimus|sirolimus|mesh-list
43881959|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43881960|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43881961|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43881962|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881963|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
43881964|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43881965|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
43881966|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43881967|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
43881968|NCT04628559|Ketamine|ketamine|mesh-list
43881969|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43881970|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43881971|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156205|NCT00230035|Azathioprine|azathioprine|mesh-list
44156206|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
44156207|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43881988|NCT04628676|Epinephrine|epinephrine|mesh-list
43881989|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
43881990|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
43881991|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43881992|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43881993|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43881994|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
43881995|NCT04628676|Coagulants|coagulants|mesh-ancestor
43881996|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43881997|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43881998|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
43881999|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882000|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882001|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43882002|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43882003|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
43882004|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882005|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43882006|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
43882007|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
44385279|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44385280|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
44385281|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385282|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44385283|NCT03403036|Brodalumab|brodalumab|mesh-list
44385284|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385285|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
44385286|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44385287|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44385288|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385289|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
44385290|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385291|NCT03401450|Bupivacaine|bupivacaine|mesh-list
44385292|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
44385293|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
44385294|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385295|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385296|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
44385297|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385298|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
44385299|NCT03401229|Benralizumab|benralizumab|mesh-list
44385300|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385301|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385302|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44385303|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385304|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385305|NCT03400852|Cosyntropin|cosyntropin|mesh-list
44385306|NCT03400852|Hormones|hormones|mesh-ancestor
43691595|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882008|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
43670208|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
43882009|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43882010|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
43882011|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882012|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43882013|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882014|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882015|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882016|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882018|NCT04628325|Diuretics|diuretics|mesh-ancestor
43882019|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
43882020|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882021|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43882022|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43882023|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882024|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
43882025|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43882026|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385307|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385308|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385309|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
44385310|NCT03400033|Hematinics|hematinics|mesh-ancestor
44385311|NCT03398356|Metformin|metformin|mesh-list
44385312|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385313|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385314|NCT03395639|Heparin|heparin|mesh-list
44385315|NCT03395639|Enoxaparin|enoxaparin|mesh-list
44385316|NCT03395639|Warfarin|warfarin|mesh-list
44385317|NCT03395639|Edoxaban|edoxaban|mesh-list
44385318|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
44385319|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44385320|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44385321|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385322|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44385323|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
44385324|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44385325|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
44385326|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385327|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
44385328|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44385329|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385330|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44385331|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44385332|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44385333|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385334|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385335|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385336|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385337|NCT03395353|Analgesics|analgesics|mesh-ancestor
43882036|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
43882037|NCT04628624|Antioxidants|antioxidants|mesh-list
43882038|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882039|NCT04628624|Protective Agents|protective agents|mesh-ancestor
43882040|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882041|NCT04628000|Vitamin D|vitamin d|mesh-list
43882042|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
43882043|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
43882044|NCT04628000|Vitamins|vitamins|mesh-list
43882045|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
43882046|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882047|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43882048|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44385338|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
44385339|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385340|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
44385341|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44385342|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
44385343|NCT03394885|Paclitaxel|paclitaxel|mesh-list
44385344|NCT03394885|Bevacizumab|bevacizumab|mesh-list
44385345|NCT03394885|Carboplatin|carboplatin|mesh-list
44385346|NCT03394885|Atezolizumab|atezolizumab|mesh-list
44385347|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44385348|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385349|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
44385350|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
44385351|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
44385352|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385353|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385354|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385355|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385356|NCT03394885|Growth Substances|growth substances|mesh-ancestor
44385357|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385358|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385359|NCT03394027|TIC10 compound|tic10 compound|mesh-list
44385360|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385361|NCT03393000|Vitamin A|vitamin a|mesh-list
44385362|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
44385363|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
44385364|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385365|NCT03393000|Protective Agents|protective agents|mesh-ancestor
44385387|NCT03390166|Vaccines|vaccines|mesh-list
44385388|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
44385389|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385390|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44385391|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
44385392|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385393|NCT03389555|Vitamins|vitamins|mesh-list
44385394|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
44385395|NCT03389555|Thiamine|thiamine|mesh-list
44385396|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
44385397|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
44385398|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385399|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882049|NCT04628143|Nafamostat|nafamostat|mesh-list
43882050|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882051|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882052|NCT04628143|Analgesics|analgesics|mesh-ancestor
43882053|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
43882054|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882055|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882056|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882057|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882058|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
43882059|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
43882060|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882061|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882062|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43882063|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43882064|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43882065|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882066|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
43882068|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
43882069|NCT04627779|Analgesics|analgesics|mesh-ancestor
43882070|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
43882071|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882072|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882073|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882074|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882075|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882076|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882077|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43882078|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882079|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882080|NCT04627467|Chloroquine|chloroquine|mesh-list
43882081|NCT04627467|Amebicides|amebicides|mesh-ancestor
43882082|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43882083|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43882084|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882085|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
43882086|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882087|NCT04627623|Antibodies|antibodies|mesh-list
43882088|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
43882089|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
43882090|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882091|NCT04627363|Bevacizumab|bevacizumab|mesh-list
43882092|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882098|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
43882099|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
43882100|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
43882101|NCT04627181|Hematinics|hematinics|mesh-ancestor
43882102|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
43882103|NCT04627181|Vitamins|vitamins|mesh-ancestor
43882104|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
44385400|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
44385401|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385402|NCT03389555|Protective Agents|protective agents|mesh-ancestor
44385403|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
44385404|NCT03389308|Diacetylrhein|diacetylrhein|mesh-list
44385405|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385406|NCT03388164|Dexetimide|dexetimide|mesh-list
44385407|NCT03388164|Citalopram|citalopram|mesh-list
44385408|NCT03388164|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44385409|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44385410|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385411|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385412|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385413|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
44385414|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385415|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44385416|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
44385417|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44385418|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44385419|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44385420|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
44385421|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
44385422|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385423|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44385424|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44385425|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
44385426|NCT03388138|Ketotifen|ketotifen|mesh-list
44385427|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
44385428|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385429|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44385431|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
44385444|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385445|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44385446|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44385447|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385448|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385449|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44385450|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44385451|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
44385452|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44385453|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44385454|NCT03387046|Prednisolone|prednisolone|mesh-list
44385455|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
44385456|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44385457|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
44385458|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385459|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
44385460|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
44385461|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385462|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385463|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385464|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
44385466|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385467|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44385468|NCT03387046|Protective Agents|protective agents|mesh-ancestor
44385469|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44385470|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385471|NCT03387020|Everolimus|everolimus|mesh-list
44385472|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385473|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385474|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
44385476|NCT03386474|Aflibercept|aflibercept|mesh-list
44385487|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44385488|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385489|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
44385490|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385491|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44385492|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
44385493|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
44385494|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385495|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
44385496|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44385497|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
44385498|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385499|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385500|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44385501|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
44385502|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44385503|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44385504|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385505|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385506|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385507|NCT03386032|Desonide|desonide|mesh-list
44385508|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385509|NCT03384940|Trastuzumab|trastuzumab|mesh-list
44385510|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385511|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385512|NCT03384693|Defibrotide|defibrotide|mesh-list
44385513|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44385514|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44385516|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44385530|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44385531|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44385532|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
44385533|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385534|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385535|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44385536|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44385537|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
44385538|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385539|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44385540|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44385541|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
44385542|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44385543|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44385544|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
44385545|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385546|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385547|NCT03383614|Emodepside|emodepside|mesh-list
44385548|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44385549|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385550|NCT03382912|Nivolumab|nivolumab|mesh-list
44385551|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385552|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385553|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385554|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385555|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
44385556|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385557|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385558|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44385559|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44385560|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
44385561|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385562|NCT03382418|Antacids|antacids|mesh-ancestor
44385563|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385564|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385565|NCT03382262|Triamcinolone|triamcinolone|mesh-list
44385566|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44385567|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44385568|NCT03382262|FX006|fx006|mesh-list
44385569|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44385570|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385571|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
44385572|NCT03382262|Hormones|hormones|mesh-ancestor
44385573|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385574|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385575|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385576|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
44385577|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385578|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385579|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
44385580|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44385581|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385582|NCT03381274|Osimertinib|osimertinib|mesh-list
44385583|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385584|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44385585|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385586|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385587|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
44385588|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44385589|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
44385590|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385591|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
44385613|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385614|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385615|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385616|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
44385617|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
44385618|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385619|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
44385620|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44385621|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385622|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44385623|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
44385624|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44385625|NCT03380390|Protective Agents|protective agents|mesh-ancestor
44385626|NCT03380091|Vitamin D|vitamin d|mesh-list
44385627|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
44385628|NCT03380091|Metformin|metformin|mesh-list
44385629|NCT03380091|Vitamins|vitamins|mesh-ancestor
44385630|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
44385631|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385632|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385633|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44385634|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44042331|NCT00002826|Paclitaxel|paclitaxel|mesh-list
44385636|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385637|NCT03378635|Hormones|hormones|mesh-ancestor
44385638|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385639|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385640|NCT03377556|Talazoparib|talazoparib|mesh-list
44385641|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44385642|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385643|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385644|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385645|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
44385646|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385647|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385648|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
44385652|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385653|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44385654|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44385655|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385656|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385657|NCT03373760|Durvalumab|durvalumab|mesh-list
44385658|NCT03373760|Ipilimumab|ipilimumab|mesh-list
44385659|NCT03373760|Tremelimumab|tremelimumab|mesh-list
44385660|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
44385661|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44385662|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
44385663|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385664|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385665|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
44385666|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385667|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385668|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385669|NCT03372083|Deferasirox|deferasirox|mesh-list
44385670|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44385671|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
44385672|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
44385673|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385674|NCT03371459|Albuterol|albuterol|mesh-list
44385675|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43882105|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882106|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
43882107|NCT04626739|Fludarabine|fludarabine|mesh-list
43882108|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882109|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
43882110|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882111|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882112|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882113|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
43882114|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882115|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882116|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43882117|NCT04627129|Itraconazole|itraconazole|mesh-list
43882118|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
43882119|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882120|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43882121|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882122|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882123|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882124|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43882125|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
43840287|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882126|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882127|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385676|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
44385677|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385678|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385679|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385680|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385681|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
44385682|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44385683|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44385684|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44385685|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385686|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385687|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385688|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385689|NCT03371381|Nivolumab|nivolumab|mesh-list
44385690|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882128|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43882129|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43882130|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43882131|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882132|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
43882133|NCT04626765|Fludarabine|fludarabine|mesh-list
43882134|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882135|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
43882136|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882137|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882138|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882139|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
43882140|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882141|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882142|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43882143|NCT04626973|Ezetimibe|ezetimibe|mesh-list
43882144|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43882145|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43882146|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43882147|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
43882148|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882149|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43882150|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882151|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
43882153|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882154|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
43882155|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882156|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882157|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882158|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
43882159|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882160|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882161|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43882164|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882165|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
43882166|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882167|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882168|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882169|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
43882170|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882171|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882172|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44385691|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385692|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385693|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385694|NCT03370770|Osimertinib|osimertinib|mesh-list
44385695|NCT03370770|Afatinib|afatinib|mesh-list
44385696|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385697|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44385698|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385699|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385700|NCT03370510|Oxytocin|oxytocin|mesh-list
44385701|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
44385702|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44385703|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385704|NCT03370289|Vaccines|vaccines|mesh-list
44385705|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
44385706|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385707|NCT03370133|Ustekinumab|ustekinumab|mesh-list
44385708|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385709|NCT03369951|Minocycline|minocycline|mesh-list
44385710|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44385711|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385712|NCT03369704|Omalizumab|omalizumab|mesh-list
44385713|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44385714|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385715|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385716|NCT03368859|Leucovorin|leucovorin|mesh-list
44385717|NCT03368859|Bevacizumab|bevacizumab|mesh-list
43882173|NCT04626414|Ferric maltol|ferric maltol|mesh-list
43882174|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
43882175|NCT04626414|Hematinics|hematinics|mesh-ancestor
43882176|NCT04626089|Metformin|metformin|mesh-list
43882177|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882178|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882179|NCT04626193|Amoxicillin|amoxicillin|mesh-list
43882180|NCT04626193|Doxycycline|doxycycline|mesh-list
43882181|NCT04626193|Levofloxacin|levofloxacin|mesh-list
43882182|NCT04626193|Ofloxacin|ofloxacin|mesh-list
43882183|NCT04626193|Esomeprazole|esomeprazole|mesh-list
43882184|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882185|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882186|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43882187|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882188|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43882189|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882190|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882191|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
43882192|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43882193|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43882194|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43882195|NCT04626193|Renal Agents|renal agents|mesh-ancestor
43882196|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43882197|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44385718|NCT03368859|Fluorouracil|fluorouracil|mesh-list
44385719|NCT03368859|Irinotecan|irinotecan|mesh-list
44385720|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385721|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385722|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44385723|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44385724|NCT03368859|Growth Substances|growth substances|mesh-ancestor
44385725|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385726|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385727|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
44385728|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385729|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44385730|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385731|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
44385732|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44385733|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44385734|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385735|NCT03368859|Antidotes|antidotes|mesh-ancestor
44385736|NCT03368859|Protective Agents|protective agents|mesh-ancestor
44385737|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
44385738|NCT03368859|Vitamins|vitamins|mesh-ancestor
44385739|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
44385740|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
44385741|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882198|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882199|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43882200|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44156208|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44156209|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
44156210|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44156211|NCT00230035|Leflunomide|leflunomide|mesh-list
44156212|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
44156213|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44156214|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44156215|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156216|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
44156217|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156218|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156219|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44156220|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
43882201|NCT04626258|Fluconazole|fluconazole|mesh-list
43882202|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
43882203|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882204|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43882205|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882206|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882207|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882208|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43882209|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
43882210|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882211|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385742|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385744|NCT03368664|Acyclovir|acyclovir|mesh-list
44385745|NCT03368664|Interferon-beta|interferon-beta|mesh-list
44385746|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
44385747|NCT03368664|Prednisolone|prednisolone|mesh-list
44385748|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
44385749|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
44385750|NCT03368664|Ranitidine|ranitidine|mesh-list
44385751|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
44385752|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
44385753|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385754|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
44385755|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385756|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385757|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
44385758|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
44385759|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385760|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385761|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385762|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
44385763|NCT03368664|Hormones|hormones|mesh-ancestor
43691915|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882212|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43882213|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43882214|NCT04626063|Acetaminophen|acetaminophen|mesh-list
43882215|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43882216|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43882217|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882218|NCT04626063|Analgesics|analgesics|mesh-ancestor
43882219|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
43882220|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882221|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882222|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
43882227|NCT04625699|Durvalumab|durvalumab|mesh-list
43882228|NCT04625699|Tremelimumab|tremelimumab|mesh-list
43882229|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882230|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882231|NCT04625608|Acetaminophen|acetaminophen|mesh-list
43882232|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882233|NCT04625608|Analgesics|analgesics|mesh-ancestor
43882234|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
43882235|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840304|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840305|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882236|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882237|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
43882238|NCT04625595|Methyldopa|methyldopa|mesh-list
43882239|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43882240|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
43882241|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
43882242|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882243|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882244|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43882245|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43882246|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43882247|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882248|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882249|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385764|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385765|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44385766|NCT03368664|Protective Agents|protective agents|mesh-ancestor
44385767|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44385768|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385769|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44385770|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
44385771|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385772|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44385773|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44385774|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44385775|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
44385776|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
44385777|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385778|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385779|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44385780|NCT03367793|Metronidazole|metronidazole|mesh-list
44385781|NCT03367793|Methamphetamine|methamphetamine|mesh-list
44385782|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44385783|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385784|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
44385785|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
44385786|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385787|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
44042490|NCT00002833|Hormones|hormones|mesh-ancestor
44385788|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385789|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385790|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385791|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44385792|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44385793|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44385794|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44385795|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385796|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882250|NCT04625543|Paclitaxel|paclitaxel|mesh-list
43882251|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43882252|NCT04625543|Cisplatin|cisplatin|mesh-list
43882253|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44385799|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44385800|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385801|NCT03365791|Spartalizumab|spartalizumab|mesh-list
44385802|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44385803|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385804|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385805|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
44385806|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44385807|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
44385808|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
44385809|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385810|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385811|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44385812|NCT03365011|Analgesics|analgesics|mesh-ancestor
44385813|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
44385814|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840321|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385816|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
44385817|NCT03364686|Vitamins|vitamins|mesh-ancestor
44385818|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
43882254|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882255|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
43882256|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
43882257|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
43882258|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882259|NCT04625426|Protective Agents|protective agents|mesh-list
43882260|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882261|NCT04625179|Melatonin|melatonin|mesh-list
43882262|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
43882263|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
43882264|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882265|NCT04625179|Protective Agents|protective agents|mesh-ancestor
43882266|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882267|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882268|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43882269|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
43882270|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
43882271|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43882272|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
43882273|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
43882274|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882275|NCT04625114|Gabexate|gabexate|mesh-list
43882276|NCT04625114|Camostat|camostat|mesh-list
43882277|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
43882278|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882279|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882280|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43882281|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43882282|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
43882283|NCT04624750|Mexiletine|mexiletine|mesh-list
43882284|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44385819|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385820|NCT03364608|Albuterol|albuterol|mesh-list
44385821|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44385822|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
44385823|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385824|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385825|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385826|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385827|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
44385828|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44385829|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44385830|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44385831|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385832|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385833|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385834|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385835|NCT03364309|Ixekizumab|ixekizumab|mesh-list
44385836|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385837|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
44385838|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385839|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385840|NCT03364036|Cladribine|cladribine|mesh-list
44385841|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385842|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385843|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
44385844|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385845|NCT03363906|Dulaglutide|dulaglutide|mesh-list
44385846|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
44385847|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385848|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385849|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
44385850|NCT03363776|Nivolumab|nivolumab|mesh-list
44385851|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385859|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385860|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
44385861|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385862|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
44385863|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
44385864|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44385865|NCT03361605|Propofol|propofol|mesh-list
44385866|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44385867|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385868|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385869|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44385870|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
44385871|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
44385872|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
44385873|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43691974|NCT02784054|Melphalan|melphalan|mesh-list
43882285|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43882286|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43882287|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43882288|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882289|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
43882290|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
43882291|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43882292|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43882293|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882294|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882302|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882303|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882304|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
43882305|NCT04624360|Hormones|hormones|mesh-ancestor
43882306|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882307|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43882308|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882309|NCT04623879|Ivacaftor|ivacaftor|mesh-list
43882310|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43882311|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43882312|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882313|NCT04624217|Gemcitabine|gemcitabine|mesh-list
43882314|NCT04624217|Paclitaxel|paclitaxel|mesh-list
43882315|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43882316|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882317|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
43882318|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
43882319|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
43882320|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882321|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43882322|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
43882323|NCT04624217|Antiviral Agents|antiviral agents|mesh-ancestor
43882324|NCT04624217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882325|NCT04624217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882326|NCT04624217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882327|NCT04624217|Immunologic Factors|immunologic factors|mesh-ancestor
43882328|NCT04624217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882329|NCT04623866|Valsartan|valsartan|mesh-list
43882330|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43882331|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43882332|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43670233|NCT02897037|Heparin|heparin|mesh-list
43882333|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385874|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385875|NCT03361176|Triamcinolone|triamcinolone|mesh-list
44385876|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44385877|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44385878|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
44385879|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44385880|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44385881|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
44385882|NCT03361176|Hormones|hormones|mesh-ancestor
44385883|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385884|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385885|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385886|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
44385887|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385888|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385889|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44385890|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44385891|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
44385892|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385893|NCT03359850|Niraparib|niraparib|mesh-list
43840329|NCT04712903|Durvalumab|durvalumab|mesh-list
44156221|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44156222|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44156223|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
44156224|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156225|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156226|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156227|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44156228|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44156229|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156230|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44156231|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
44156232|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156233|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156234|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156235|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
43840330|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882334|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
43882335|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
43882336|NCT04623619|Vitamins|vitamins|mesh-ancestor
43882337|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
43882338|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882339|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
43882340|NCT04623840|Tadalafil|tadalafil|mesh-list
43882341|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
43882342|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43882343|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43882344|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882345|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882348|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43882349|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
43882350|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882351|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882353|NCT04623385|Isotretinoin|isotretinoin|mesh-list
43882354|NCT04623385|Testosterone|testosterone|mesh-list
43882355|NCT04623385|Androgens|androgens|mesh-ancestor
43882356|NCT04623385|Hormones|hormones|mesh-ancestor
44163840|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44385894|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44385895|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385896|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385897|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385898|NCT03359811|Bupivacaine|bupivacaine|mesh-list
44385899|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
44385900|NCT03359811|Anesthetics|anesthetics|mesh-list
44385901|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385902|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385903|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
44385904|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385905|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44385906|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44385907|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385908|NCT03359590|Incretins|incretins|mesh-ancestor
44385909|NCT03359590|Hormones|hormones|mesh-ancestor
44385910|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385911|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44385912|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44385913|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44385914|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385915|NCT03359473|GSK2881078|gsk2881078|mesh-list
44385916|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
44385917|NCT03359473|Hormones|hormones|mesh-ancestor
44385918|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44385919|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385920|NCT03359395|Alfentanil|alfentanil|mesh-list
44385921|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44385922|NCT03359395|Narcotics|narcotics|mesh-ancestor
44385923|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44385924|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385925|NCT03359395|Analgesics|analgesics|mesh-ancestor
44385926|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
44385934|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
44385936|NCT03358472|Carboplatin|carboplatin|mesh-list
44385937|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
44385938|NCT03358472|Fluorouracil|fluorouracil|mesh-list
44385939|NCT03358472|Cetuximab|cetuximab|mesh-list
44042648|NCT00002845|Aldesleukin|aldesleukin|mesh-list
44385940|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44385941|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44385942|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
44385943|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385944|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44385945|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44385946|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
44385947|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385948|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
44385949|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44385950|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
44385951|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385952|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385953|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43882357|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882358|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882359|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882360|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
43882361|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882362|NCT04623021|Nafamostat|nafamostat|mesh-list
43882363|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882364|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882365|NCT04623021|Analgesics|analgesics|mesh-ancestor
43882366|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
43882367|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882368|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882369|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882370|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882371|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
43882372|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
43882373|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882374|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882375|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43882376|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43882377|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43882378|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882379|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
43882380|NCT04622618|Gabapentin|gabapentin|mesh-list
43882381|NCT04622618|Analgesics|analgesics|mesh-ancestor
43882382|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
43882383|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882384|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882385|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
43882386|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882387|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43670245|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
43882388|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882389|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44385955|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
44385956|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44385957|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
44385958|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385959|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385960|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
44385961|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
44385962|NCT03357341|Albuterol|albuterol|mesh-list
44385963|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44385964|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
44385965|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44385966|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385967|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44385968|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
44385969|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
44385970|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44385971|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44385972|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43882390|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43882391|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43882392|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882393|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882394|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
43882395|NCT04622995|Diazepam|diazepam|mesh-list
43882396|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43882397|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
43882398|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
43882399|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
43882400|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882401|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882402|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882403|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882404|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882405|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43882406|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43882407|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882408|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882409|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882410|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882411|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
43882412|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
43882413|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
43882414|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
43882415|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882416|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882417|NCT04622956|Methotrexate|methotrexate|mesh-list
43882418|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43882434|NCT04622891|Clarithromycin|clarithromycin|mesh-list
43882435|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882436|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882437|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43882438|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882439|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385973|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44385974|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
44385975|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385976|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44385978|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44385979|NCT03355326|Protective Agents|protective agents|mesh-ancestor
44385980|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44385981|NCT03354429|Ticagrelor|ticagrelor|mesh-list
44385982|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44385983|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44385984|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44385985|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44385986|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
44385987|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44385988|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386030|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386031|NCT03351231|Nivolumab|nivolumab|mesh-list
44386032|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386033|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386034|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44386035|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386036|NCT03349710|Cisplatin|cisplatin|mesh-list
44386037|NCT03349710|Nivolumab|nivolumab|mesh-list
44386038|NCT03349710|Cetuximab|cetuximab|mesh-list
44386039|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386040|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386041|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44386042|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386043|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44386044|NCT03349333|Folic Acid|folic acid|mesh-list
44386045|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
44386046|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
44386047|NCT03349333|Vitamins|vitamins|mesh-ancestor
43882440|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43882441|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882442|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
43882443|NCT04622566|Lenvatinib|lenvatinib|mesh-list
43882444|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882445|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882446|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43882447|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882448|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882449|NCT04622579|Rituximab|rituximab|mesh-list
43882450|NCT04622579|Lenalidomide|lenalidomide|mesh-list
43882451|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882452|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882453|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
43882454|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882455|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882456|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43670249|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
43882457|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43882458|NCT04622579|Growth Substances|growth substances|mesh-ancestor
43882459|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
43882460|NCT04622982|Vitamin D|vitamin d|mesh-list
43882461|NCT04622982|Vitamins|vitamins|mesh-ancestor
43882462|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
43882463|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882464|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43882465|NCT04622488|Diclofenac|diclofenac|mesh-list
43882466|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882467|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882468|NCT04622488|Analgesics|analgesics|mesh-ancestor
43882469|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
43882470|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882471|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882472|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882473|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882474|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43882475|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882476|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386048|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
44386049|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386050|NCT03349333|Hematinics|hematinics|mesh-ancestor
44386051|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
44386052|NCT03349060|Abrocitinib|abrocitinib|mesh-list
44386053|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44386054|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386055|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386056|NCT03348930|Tolcapone|tolcapone|mesh-list
44386057|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44386058|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44386059|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44386060|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386061|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386062|NCT03348904|Gemcitabine|gemcitabine|mesh-list
44386063|NCT03348904|Paclitaxel|paclitaxel|mesh-list
44386064|NCT03348904|Cisplatin|cisplatin|mesh-list
44386065|NCT03348904|Carboplatin|carboplatin|mesh-list
44386066|NCT03348904|Nivolumab|nivolumab|mesh-list
44386067|NCT03348904|Pemetrexed|pemetrexed|mesh-list
44386068|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44386069|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386070|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
44386071|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
44386072|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
44386073|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44042796|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
44386074|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44386075|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
44386076|NCT03348904|Antiviral Agents|antiviral agents|mesh-ancestor
44386077|NCT03348904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386078|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386079|NCT03348904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386080|NCT03348904|Immunologic Factors|immunologic factors|mesh-ancestor
44386081|NCT03348904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386088|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386090|NCT03346070|Rocuronium|rocuronium|mesh-list
44386091|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
44386092|NCT03346070|Neostigmine|neostigmine|mesh-list
44386093|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44386094|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44386095|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44386096|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386097|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386098|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44386099|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386100|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386101|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
44386102|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386103|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44386104|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
44386105|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44386106|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44386107|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43692200|NCT02782260|Dipyridamole|dipyridamole|mesh-list
43882481|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882482|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
43882483|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43882484|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43882485|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882486|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43882487|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882488|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882489|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882490|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882491|NCT04622358|Rabeprazole|rabeprazole|mesh-list
43882492|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43882493|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882494|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43882495|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882496|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882497|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
43882498|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43882499|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43882500|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882501|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
43882502|NCT04622397|Coagulants|coagulants|mesh-ancestor
43882503|NCT04622111|Metformin|metformin|mesh-list
43882504|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882505|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882506|NCT04621929|Topiramate|topiramate|mesh-list
43882507|NCT04621929|Phentermine|phentermine|mesh-list
43882508|NCT04621929|Allopurinol|allopurinol|mesh-list
43882509|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882510|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
43882511|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882512|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882513|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
44386108|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44386109|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
44386111|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
44386112|NCT03346057|Neostigmine|neostigmine|mesh-list
44386113|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44386114|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44386115|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44386116|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386117|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386118|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44386119|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386120|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386121|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
44386122|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386123|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44386124|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
44386125|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44386126|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44386127|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44386128|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44386129|NCT03345979|Aripiprazole|aripiprazole|mesh-list
44386130|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44386131|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
44386132|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
44386133|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386134|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44386135|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386136|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386153|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386154|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386155|NCT03345407|Albuterol|albuterol|mesh-list
44386156|NCT03345407|Nemiralisib|nemiralisib|mesh-list
44386157|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44386158|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
44386159|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386160|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386161|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44386162|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44386163|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
44386164|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44386165|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44386166|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44386167|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43882514|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882515|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
43882516|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882517|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43882518|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
43882519|NCT04621929|Protective Agents|protective agents|mesh-ancestor
43882520|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43882521|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
43882522|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43882523|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
43882524|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
43882525|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882526|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882527|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882528|NCT04622033|Brodalumab|brodalumab|mesh-list
43882529|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882530|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43882531|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
43882532|NCT04621799|Coagulants|coagulants|mesh-ancestor
43882533|NCT04621370|Capecitabine|capecitabine|mesh-list
43882534|NCT04621370|Durvalumab|durvalumab|mesh-list
43882535|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43882536|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
43882537|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882538|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882539|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882540|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
43882541|NCT04621461|Astringents|astringents|mesh-ancestor
43882542|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882543|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882544|NCT04621487|Amoxicillin|amoxicillin|mesh-list
43882545|NCT04621487|Metronidazole|metronidazole|mesh-list
43882546|NCT04621487|Clarithromycin|clarithromycin|mesh-list
43882547|NCT04621487|Pantoprazole|pantoprazole|mesh-list
43882548|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882549|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882550|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43882551|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43882555|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43882556|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882558|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882559|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43882560|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
43882561|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43882563|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43882564|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882565|NCT04621617|Midodrine|midodrine|mesh-list
44386168|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44386169|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386170|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386171|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44386172|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386174|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
44386175|NCT03344172|Paclitaxel|paclitaxel|mesh-list
43882566|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
43882567|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
43882568|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882569|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882570|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43882571|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43882572|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43882573|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43882574|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882575|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882576|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882577|NCT04621669|Metformin|metformin|mesh-list
43882578|NCT04621669|Digoxin|digoxin|mesh-list
43882579|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43882580|NCT04621669|Calcium|calcium|mesh-list
43882581|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882582|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882583|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43882584|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43882585|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43882586|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
43882587|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882588|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43882589|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43882590|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882591|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43882592|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43882593|NCT04621669|Protective Agents|protective agents|mesh-ancestor
43882594|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
43882595|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43882596|NCT04621227|Midazolam|midazolam|mesh-list
43882597|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43882598|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43882599|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882600|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882601|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882602|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882603|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882604|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882605|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882606|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
43882608|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
43882609|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
43882610|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882611|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882612|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43882613|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43882614|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
43882615|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43882616|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43882617|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156236|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
44156237|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156238|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44156239|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
44156240|NCT00230035|Hormones|hormones|mesh-ancestor
44156241|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156249|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386178|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44386179|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386180|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44386181|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44386182|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44386183|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386184|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44386185|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
44386186|NCT03344172|Antiviral Agents|antiviral agents|mesh-ancestor
44386187|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386188|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386189|NCT03344172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386190|NCT03344172|Immunologic Factors|immunologic factors|mesh-ancestor
44386191|NCT03344172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156250|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
44156251|NCT00230321|Hematinics|hematinics|mesh-ancestor
44156252|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
44156253|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156254|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44156255|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882619|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43882620|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
43882621|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43882622|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
43882623|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882624|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882625|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43882626|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43882627|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882628|NCT04620954|Nivolumab|nivolumab|mesh-list
43882629|NCT04620954|Oregovomab|oregovomab|mesh-list
43882630|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882631|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882632|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43882633|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882634|NCT04621253|Dipyrone|dipyrone|mesh-list
43882635|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882636|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882637|NCT04621253|Analgesics|analgesics|mesh-ancestor
43882638|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
43882639|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882640|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882641|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882642|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882643|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
43882644|NCT04621110|Fentanyl|fentanyl|mesh-list
43882645|NCT04621110|Midazolam|midazolam|mesh-list
43882646|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
43882647|NCT04621110|Ketamine|ketamine|mesh-list
43882648|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882649|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882650|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882651|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882652|NCT04621110|Analgesics|analgesics|mesh-ancestor
43882653|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
44386193|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386194|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386195|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785436|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
44386196|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386197|NCT03343639|Serlopitant|serlopitant|mesh-list
44386198|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44386199|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386200|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386201|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386202|NCT03343067|Norethindrone|norethindrone|mesh-list
44386203|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
44386204|NCT03343067|Estradiol|estradiol|mesh-list
44386205|NCT03343067|Estrogens|estrogens|mesh-ancestor
44386206|NCT03343067|Hormones|hormones|mesh-ancestor
44386207|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386208|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386209|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44386210|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
44386211|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44386212|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44386213|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44386214|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44386215|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44386216|NCT03343054|Talazoparib|talazoparib|mesh-list
44386217|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44386218|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386219|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386220|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386221|NCT03342963|Aripiprazole|aripiprazole|mesh-list
44386222|NCT03342963|Sertraline|sertraline|mesh-list
44042952|NCT00002878|Dexamethasone|dexamethasone|mesh-list
44386223|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
44386224|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386225|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44386226|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386228|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386229|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
44386230|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
44386231|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386232|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386233|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44386234|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44386235|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
44386236|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44386237|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44386238|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44386239|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44386240|NCT03342963|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44386241|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44386242|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44386243|NCT03342690|Eplerenone|eplerenone|mesh-list
44386244|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44386245|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
44386246|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386247|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386248|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44386249|NCT03342690|Diuretics|diuretics|mesh-ancestor
44386250|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
44386251|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44386252|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
44386253|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44386254|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
44386255|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
44386256|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386257|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
44386258|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386268|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386269|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386270|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
44386271|NCT03342638|Hormones|hormones|mesh-ancestor
44386272|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386273|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44386274|NCT03342638|Protective Agents|protective agents|mesh-ancestor
44386275|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44386276|NCT03342001|Calcitonin|calcitonin|mesh-list
44386277|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
44386278|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44386279|NCT03342001|Katacalcin|katacalcin|mesh-list
44386280|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44386281|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386282|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44386283|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
44386284|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
44386285|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386286|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386287|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
44386288|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43829458|NCT05422066|Prednisone|prednisone|mesh-list
43882654|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882655|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43882656|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43882657|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43882658|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882659|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882660|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882661|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43882662|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882663|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
43882664|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
43882665|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43882666|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43882667|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43882668|NCT04621110|Narcotics|narcotics|mesh-ancestor
43882669|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43882670|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882671|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882672|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882673|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
43882682|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882683|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882684|NCT04620785|Methylene Blue|methylene blue|mesh-list
43882685|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882686|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882687|NCT04620720|Gabapentin|gabapentin|mesh-list
43882688|NCT04620720|Analgesics|analgesics|mesh-ancestor
43882689|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
43882690|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386289|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386290|NCT03341273|Azithromycin|azithromycin|mesh-list
44386291|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44386292|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386293|NCT03340961|Doxycycline|doxycycline|mesh-list
44386294|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44386295|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44043027|NCT00002882|Analgesics|analgesics|mesh-ancestor
44386296|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
44386297|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386298|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386300|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
44386301|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43785455|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386302|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
44386303|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
44386304|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386305|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386306|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
44386307|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44386308|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
44386309|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
44386310|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44386311|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43829480|NCT05422066|Hormones|hormones|mesh-ancestor
43882691|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882692|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
43882693|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882694|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882695|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882696|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43882697|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43882698|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43882699|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882700|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882701|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
43882702|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
43882703|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43882704|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882705|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882706|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882707|NCT04620616|Menthol|menthol|mesh-list
43882708|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
43882709|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882710|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
43882711|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882712|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
43882713|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882714|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882715|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882716|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
43882717|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882718|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386313|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
44386314|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386315|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386316|NCT03339726|Protective Agents|protective agents|mesh-ancestor
44386317|NCT03339583|Zopiclone|zopiclone|mesh-list
44386318|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44386319|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386320|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386321|NCT03339453|Glucagon|glucagon|mesh-list
44386322|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44386323|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386324|NCT03339453|Hormones|hormones|mesh-ancestor
44386325|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386326|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386327|NCT03339453|Incretins|incretins|mesh-ancestor
44386328|NCT03339401|Brincidofovir|brincidofovir|mesh-list
44386329|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
44386330|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386331|NCT03339297|Defibrotide|defibrotide|mesh-list
44386332|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44386333|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44386334|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386335|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44386336|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44386337|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44386338|NCT03338998|Siponimod|siponimod|mesh-list
43785462|NCT05109377|Tadalafil|tadalafil|mesh-list
44386339|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44386340|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386341|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386342|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
44386343|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386344|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
44386345|NCT03338972|Fludarabine|fludarabine|mesh-list
43882719|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43882720|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43882721|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882722|NCT04620018|Amoxicillin|amoxicillin|mesh-list
43882723|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44386346|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386347|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
44386348|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386349|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386350|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386351|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
44386352|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386353|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386354|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386355|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
44386356|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44386357|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386358|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386359|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386360|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
44386362|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
44386363|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386364|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
44386365|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386366|NCT03338569|Protective Agents|protective agents|mesh-ancestor
44386367|NCT03338400|Dexamethasone|dexamethasone|mesh-list
44386368|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386369|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
44386370|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
44386371|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386372|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386373|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386374|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
44386375|NCT03338400|Hormones|hormones|mesh-ancestor
44386376|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386377|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44386378|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386379|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
44386385|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386386|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
44386387|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386388|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386389|NCT03337490|Ivermectin|ivermectin|mesh-list
44386390|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386391|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386392|NCT03337477|Insulin|insulin|mesh-list
44386393|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44386394|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386395|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386396|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44386397|NCT03337308|Ezetimibe|ezetimibe|mesh-list
44386398|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44386399|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44386400|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
44386401|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386402|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44386403|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386404|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386405|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386406|NCT03337152|Chloroquine|chloroquine|mesh-list
44386407|NCT03337152|Primaquine|primaquine|mesh-list
44386408|NCT03337152|Amebicides|amebicides|mesh-ancestor
44386409|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386410|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386411|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882724|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882726|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882727|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882728|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882729|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882730|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
43882731|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
43882732|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43882733|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43882734|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43882735|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43882736|NCT04620213|Phentolamine|phentolamine|mesh-list
43882737|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43882738|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43882739|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43882740|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43882741|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882742|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882747|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882748|NCT04619914|Letrozole|letrozole|mesh-list
43882749|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882750|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43882751|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44386412|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
44386413|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386414|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
44386415|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386416|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386417|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
44386418|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
44386419|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386420|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386421|NCT03336502|Posaconazole|posaconazole|mesh-list
44386422|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
44386423|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386424|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44386425|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386426|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386427|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44386428|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44386429|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386435|NCT03335163|Topiramate|topiramate|mesh-list
44386471|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44386472|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44386473|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386474|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386475|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
44386477|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386478|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386479|NCT03334409|Vitamins|vitamins|mesh-list
44386480|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
44386481|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
44386482|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386483|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
44386484|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386485|NCT03334409|Protective Agents|protective agents|mesh-ancestor
44386486|NCT05683054|Adalimumab|adalimumab|mesh-list
44386487|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386488|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386489|NCT05682911|Simvastatin|simvastatin|mesh-list
44386490|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44386491|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44386492|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
44386493|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386494|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44386495|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44386496|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386497|NCT05682807|Caffeine|caffeine|mesh-list
43882752|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882753|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882754|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43882755|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
43882756|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882757|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882758|NCT04619875|Lactulose|lactulose|mesh-list
43882759|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882760|NCT04619862|Gabapentin|gabapentin|mesh-list
43882761|NCT04619862|Analgesics|analgesics|mesh-ancestor
43882762|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
43882763|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882764|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882765|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
43882766|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43882767|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43882768|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882769|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386498|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44386499|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386500|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44386501|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386502|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386503|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44386504|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44386505|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
44386506|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386508|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
44386509|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
44386510|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44386511|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44386512|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
44386513|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
44386514|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
44386515|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386516|NCT05682339|Quinine|quinine|mesh-list
44386517|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
44386518|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386519|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386520|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386521|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43882770|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43882771|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43882772|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882773|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882774|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
43882775|NCT04619290|Methylene Blue|methylene blue|mesh-list
43882776|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882777|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882778|NCT04619303|Dexamethasone|dexamethasone|mesh-list
43882779|NCT04619303|Bevacizumab|bevacizumab|mesh-list
43882780|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43882781|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882782|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43882783|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43882784|NCT04619303|Growth Substances|growth substances|mesh-ancestor
43882785|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882786|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
43882787|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882788|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
43882789|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
43882790|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882791|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882792|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
43882793|NCT04619303|Hormones|hormones|mesh-ancestor
44386522|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386523|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44386524|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386525|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386527|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
44386528|NCT05682209|Octreotide|octreotide|mesh-list
44386529|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386530|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44386531|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386532|NCT05682196|Rituximab|rituximab|mesh-list
44386533|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386534|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386535|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
44386536|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386537|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386538|NCT05681975|Antibodies|antibodies|mesh-list
44386539|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
44386540|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44386541|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
44386542|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
44386543|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386544|NCT05681897|Minoxidil|minoxidil|mesh-list
44386545|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44386546|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
44386547|NCT05681871|Folic Acid|folic acid|mesh-list
44386548|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
44386549|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
44386550|NCT05681871|Hematinics|hematinics|mesh-ancestor
44386551|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
44386552|NCT05681871|Vitamins|vitamins|mesh-ancestor
44386553|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
44386554|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386555|NCT05681871|Trace Elements|trace elements|mesh-ancestor
44386556|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
44386557|NCT05681780|Nivolumab|nivolumab|mesh-list
44386558|NCT05681780|Fludarabine|fludarabine|mesh-list
44386559|NCT05681780|Interleukin-2|interleukin-2|mesh-list
44386560|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882794|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882795|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44386561|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
44386562|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386563|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386564|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386565|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
44386566|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386567|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386568|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386569|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386570|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44386571|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386572|NCT05681780|Analgesics|analgesics|mesh-ancestor
44386573|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
44386574|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386575|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
44386576|NCT05681754|Calcium|calcium|mesh-list
44386577|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44386578|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386579|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44386580|NCT05681728|Paclitaxel|paclitaxel|mesh-list
44386581|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
44386614|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386615|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386616|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386617|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386618|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44386619|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44386620|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386621|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44386622|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44386623|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386624|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
44386625|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44386626|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44386627|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44386628|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
44386629|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386630|NCT05681611|Rocuronium|rocuronium|mesh-list
44386631|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44386632|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44386633|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44386634|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386635|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785473|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
44386636|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
44386637|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386638|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
44386639|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386640|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386641|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44386642|NCT05681572|Midazolam|midazolam|mesh-list
44386643|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
44386644|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44386648|NCT05681572|Analgesics|analgesics|mesh-ancestor
44386654|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
44386655|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386656|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386657|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44386658|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44386659|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386660|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386661|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44386662|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
44386663|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
44386664|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
44386665|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
44386666|NCT05681481|Prednisone|prednisone|mesh-list
44386667|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386668|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
44386669|NCT05681481|Hormones|hormones|mesh-ancestor
44386670|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386671|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386672|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43785495|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386673|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386674|NCT05681429|Acetaminophen|acetaminophen|mesh-list
44386675|NCT05681429|Parecoxib|parecoxib|mesh-list
44386676|NCT05681429|Lidocaine|lidocaine|mesh-list
44386677|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
44386678|NCT05681429|Sevoflurane|sevoflurane|mesh-list
44386679|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44386680|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386681|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386682|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386683|NCT05681429|Analgesics|analgesics|mesh-ancestor
44386684|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
44386685|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386686|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43692520|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
43882796|NCT04619537|Docetaxel|docetaxel|mesh-list
43882798|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
43882799|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
43882800|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
43882801|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882802|NCT04619563|Docetaxel|docetaxel|mesh-list
43882803|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882804|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
43882805|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
44386688|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44386689|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44386690|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386691|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386692|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
44386693|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44386694|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44386695|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
44386696|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
44386697|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
44386698|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44386699|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44386700|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44386701|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44386702|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44386703|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44386704|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386705|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44386706|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386707|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386709|NCT05681403|Carmustine|carmustine|mesh-list
44386710|NCT05681403|Melphalan|melphalan|mesh-list
44386711|NCT05681403|Etoposide|etoposide|mesh-list
44386712|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43882806|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
43882807|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882808|NCT04619251|Itraconazole|itraconazole|mesh-list
43882809|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
43882810|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882811|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43882812|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882813|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882817|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882818|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882819|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43882820|NCT04619381|Clopidogrel|clopidogrel|mesh-list
43882821|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43882822|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43882823|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43882824|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43882825|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
43882826|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882827|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386713|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
44386714|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386715|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386716|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44386717|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
44386718|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
44386719|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386720|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386721|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
44386722|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386723|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44386724|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44386725|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44386726|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386727|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386728|NCT05681312|Amoxicillin|amoxicillin|mesh-list
44386729|NCT05681312|Metronidazole|metronidazole|mesh-list
44386730|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44386731|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386732|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44386733|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44386734|NCT05681299|Liraglutide|liraglutide|mesh-list
44386735|NCT05681299|Hormones|hormones|mesh-list
44386736|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386737|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386738|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43882828|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882829|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
43882830|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882831|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882832|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882833|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882834|NCT04618965|Analgesics|analgesics|mesh-ancestor
43882835|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
43882836|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882837|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43882838|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43882839|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43882840|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
43882841|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882842|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156256|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156257|NCT00230373|Imiquimod|imiquimod|mesh-list
44156258|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44156259|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
44156260|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156261|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386739|NCT05681299|Incretins|incretins|mesh-ancestor
44386740|NCT05681273|Empagliflozin|empagliflozin|mesh-list
44386741|NCT05681273|Valsartan|valsartan|mesh-list
44386742|NCT05681273|Atorvastatin|atorvastatin|mesh-list
44386743|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44386744|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44386745|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
44386746|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386747|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44386748|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44386749|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386750|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44386751|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44386752|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44386753|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44386754|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44386755|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386756|NCT05681260|Cytarabine|cytarabine|mesh-list
44386757|NCT05681260|Dexamethasone|dexamethasone|mesh-list
44386758|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
44386759|NCT05681260|Prednisone|prednisone|mesh-list
44386760|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
44386761|NCT05681260|Ifosfamide|ifosfamide|mesh-list
44386762|NCT05681260|Doxorubicin|doxorubicin|mesh-list
44386763|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44386792|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
44386793|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386794|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44386795|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44386796|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44386797|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44386798|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
44386799|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44386800|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44386801|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
44386802|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
44386803|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44386804|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44386805|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44386806|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
44386807|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44386808|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
44386809|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
44386810|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156262|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
44156263|NCT00230399|Celecoxib|celecoxib|mesh-list
44156264|NCT00230399|Capecitabine|capecitabine|mesh-list
44156265|NCT00230399|Irinotecan|irinotecan|mesh-list
44156266|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44156267|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
44156268|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156269|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156270|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44156271|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44156272|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156273|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156274|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44156275|NCT00230399|Analgesics|analgesics|mesh-ancestor
44156276|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
44156277|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156278|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156279|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156280|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156281|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44156282|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44156283|NCT00230451|Paclitaxel|paclitaxel|mesh-list
44156284|NCT00230451|Cisplatin|cisplatin|mesh-list
44156285|NCT00230451|Fluorouracil|fluorouracil|mesh-list
44156286|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44156287|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156288|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
44156289|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
44156290|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156291|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156292|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
44156293|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44156294|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156295|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
44156301|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
44156302|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386811|NCT05681247|Ezetimibe|ezetimibe|mesh-list
44386812|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44386813|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44386814|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
44386815|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386816|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44386817|NCT05681221|Calcium|calcium|mesh-list
44386818|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44386819|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386820|NCT05681195|Pemetrexed|pemetrexed|mesh-list
44386821|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
44386822|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386823|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386824|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386825|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44386826|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44386827|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44386828|NCT05679765|Dexamethasone|dexamethasone|mesh-list
44386829|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
44386830|NCT05679765|Lidocaine|lidocaine|mesh-list
44386831|NCT05679765|BB 1101|bb 1101|mesh-list
44386832|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44386833|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
44386834|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
44386835|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386836|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386837|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386838|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
44386839|NCT05679765|Hormones|hormones|mesh-ancestor
44386840|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386841|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44386842|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386843|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
44386844|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156303|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156304|NCT00230477|Lamivudine|lamivudine|mesh-list
44156305|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44156306|NCT00230477|Adefovir|adefovir|mesh-list
44156307|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44156308|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44156309|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386873|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
44386874|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386875|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386876|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156310|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156311|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
44156312|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156313|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44156314|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44156315|NCT00230490|Adefovir|adefovir|mesh-list
44156316|NCT00230490|Pradefovir|pradefovir|mesh-list
44386878|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44386879|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
44386880|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386881|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386882|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
44386883|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44386884|NCT05628571|Fluorides|fluorides|mesh-list
44386885|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
44386886|NCT05628571|Protective Agents|protective agents|mesh-ancestor
44386887|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386888|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
44386889|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
44386890|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44386891|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386892|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386893|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
44386894|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44386895|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44386896|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386897|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44386898|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
44386899|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
44386900|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386901|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
44386902|NCT05603910|Lenvatinib|lenvatinib|mesh-list
44386903|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44386904|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386905|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44386906|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43692675|NCT02779569|Decitabine|decitabine|mesh-list
44156317|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
44156318|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156319|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44156320|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44156321|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156322|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156323|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44156324|NCT00230503|Adefovir|adefovir|mesh-list
44156325|NCT00230503|Pradefovir|pradefovir|mesh-list
44156326|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
44156327|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882843|NCT04618952|Calcium|calcium|mesh-list
43882844|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44386907|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386908|NCT05583721|Regadenoson|regadenoson|mesh-list
44386909|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44386910|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44386911|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
44386912|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
44386913|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386914|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386915|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386916|NCT05583617|Lenalidomide|lenalidomide|mesh-list
44386917|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
44386918|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386919|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44386920|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44386921|NCT05583617|Growth Substances|growth substances|mesh-ancestor
44386922|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
44386923|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386924|NCT05577988|Aspirin|aspirin|mesh-list
44386925|NCT05577988|Clopidogrel|clopidogrel|mesh-list
44386926|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44386927|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44386928|NCT05577988|Analgesics|analgesics|mesh-ancestor
43882845|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882846|NCT04619433|Carboplatin|carboplatin|mesh-list
43882847|NCT04619433|Pemetrexed|pemetrexed|mesh-list
43882848|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882849|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882850|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882851|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43882852|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43882853|NCT04619160|Propofol|propofol|mesh-list
43882854|NCT04619160|Sevoflurane|sevoflurane|mesh-list
43882855|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43882856|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882857|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882858|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43882859|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
43882860|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
43882861|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43882862|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43882863|NCT04619069|Hormones|hormones|mesh-list
43882864|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882865|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882866|NCT04618497|Ketorolac|ketorolac|mesh-list
43882867|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
43882868|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43882869|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43882870|NCT04618497|Analgesics|analgesics|mesh-ancestor
43882871|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
43882872|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882873|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386935|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44386936|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386937|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44386938|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44386939|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44386941|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44386942|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44386943|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44386944|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
44386945|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386946|NCT05571592|Cannabidiol|cannabidiol|mesh-list
44386947|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
44386955|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44386956|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
44386957|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386958|NCT05551949|Estradiol|estradiol|mesh-list
44386959|NCT05551949|Estrogens|estrogens|mesh-ancestor
43882874|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882875|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43882876|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43882877|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882878|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882879|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43882883|NCT04618367|Lenvatinib|lenvatinib|mesh-list
43882884|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882885|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43882886|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882887|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882888|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43882889|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43882890|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44386960|NCT05551949|Hormones|hormones|mesh-ancestor
44386961|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44386962|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386963|NCT05541497|Varenicline|varenicline|mesh-list
44386964|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44386965|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44386966|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
44386967|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44386968|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386969|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386970|NCT05540262|Edaravone|edaravone|mesh-list
44386971|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44386972|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
44386973|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386974|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44386975|NCT05540262|Protective Agents|protective agents|mesh-ancestor
44386976|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386977|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
44386978|NCT05535166|Cisplatin|cisplatin|mesh-list
44386979|NCT05535166|Carboplatin|carboplatin|mesh-list
44386980|NCT05535166|Methotrexate|methotrexate|mesh-list
44386981|NCT05535166|Etoposide|etoposide|mesh-list
44386982|NCT05535166|Vincristine|vincristine|mesh-list
44386983|NCT05535166|Topotecan|topotecan|mesh-list
44386984|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44386985|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
43829521|NCT05420337|Morphine|morphine|mesh-list
43882891|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
43882892|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43882893|NCT04618536|Protective Agents|protective agents|mesh-ancestor
43882894|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882895|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
43882896|NCT04618601|Spironolactone|spironolactone|mesh-list
43882897|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43882898|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
43882899|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882900|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882901|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43882902|NCT04618601|Diuretics|diuretics|mesh-ancestor
43882903|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
43882904|NCT04618107|Anesthetics|anesthetics|mesh-list
43882905|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882906|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882907|NCT04618146|Morphine|morphine|mesh-list
43882908|NCT04618146|Bupivacaine|bupivacaine|mesh-list
43882909|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
43882910|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
43882911|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882912|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882913|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
44386986|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44386987|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44386988|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44386989|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
44386990|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44386991|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44386992|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44386993|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44386994|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
44386995|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44386996|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44386997|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
44386998|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
44386999|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387000|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387001|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387002|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387003|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44387004|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44387005|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387006|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387007|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387008|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44387009|NCT05518903|FAPI-46|fapi-46|mesh-list
44387010|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44387011|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387012|NCT05502237|Paclitaxel|paclitaxel|mesh-list
44387013|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44387014|NCT05502237|Cisplatin|cisplatin|mesh-list
44387015|NCT05502237|Carboplatin|carboplatin|mesh-list
44387016|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
44387017|NCT05502237|Pemetrexed|pemetrexed|mesh-list
44387018|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43829544|NCT05417386|Leucovorin|leucovorin|mesh-list
43882914|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882915|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43882916|NCT04618146|Narcotics|narcotics|mesh-ancestor
43882917|NCT04618146|Analgesics|analgesics|mesh-ancestor
43882919|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882920|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
43882921|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387019|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387020|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387021|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387022|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387023|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387024|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387025|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387026|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387027|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387028|NCT05498480|Nivolumab|nivolumab|mesh-list
44387029|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387030|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387031|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387032|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387033|NCT05490511|Cannabidiol|cannabidiol|mesh-list
44387034|NCT05490511|Tacrolimus|tacrolimus|mesh-list
44387035|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387036|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
44387037|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387038|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44387039|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387040|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387041|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
44387042|NCT05482516|Bevacizumab|bevacizumab|mesh-list
44387043|NCT05482516|Atezolizumab|atezolizumab|mesh-list
44387044|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387045|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387046|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44387047|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44387048|NCT05482516|Growth Substances|growth substances|mesh-ancestor
44387049|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882922|NCT04617782|Donepezil|donepezil|mesh-list
43882923|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43882924|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43882925|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882926|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
43882927|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882928|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882929|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
43882930|NCT04617613|Amoxicillin|amoxicillin|mesh-list
43882931|NCT04617613|Metronidazole|metronidazole|mesh-list
43882932|NCT04617613|Clarithromycin|clarithromycin|mesh-list
44387050|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
44387051|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44387052|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
44387053|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387054|NCT05438303|Celecoxib|celecoxib|mesh-list
44387055|NCT05438303|Midazolam|midazolam|mesh-list
44387056|NCT05438303|Omeprazole|omeprazole|mesh-list
44387057|NCT05438303|Dabigatran|dabigatran|mesh-list
44387058|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44387059|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44387060|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387061|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387062|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44387063|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44387064|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44387065|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44387066|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
44387067|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
44387068|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
44387069|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
44387070|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387071|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387072|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44387073|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44387074|NCT05438303|Analgesics|analgesics|mesh-ancestor
44387075|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
44387076|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387077|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387078|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387079|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44387080|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44387081|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387095|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387096|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44043870|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387098|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
44387099|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387100|NCT05430230|Naproxen|naproxen|mesh-list
44387101|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44387102|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44387103|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44387104|NCT05430230|Analgesics|analgesics|mesh-ancestor
44387105|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
44387106|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387107|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387108|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387109|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
44387110|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44387111|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387112|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387113|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
44387114|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44387115|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44387116|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44387117|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44387118|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387119|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44387120|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44387121|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387122|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387123|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387124|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44387125|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
43882934|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882935|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882936|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43882937|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43882938|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43882939|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882940|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43882941|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387126|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44387127|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387128|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44387129|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44387130|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44387131|NCT05408429|Vaccines|vaccines|mesh-list
44387132|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44387133|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
44387134|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387135|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
44387136|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
44387137|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387138|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
44387139|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44387140|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44387141|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
44387142|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387143|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387144|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653901|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
43653902|NCT02980965|Docetaxel|docetaxel|mesh-list
43653903|NCT02980965|Fluorouracil|fluorouracil|mesh-list
43653904|NCT02980965|Letrozole|letrozole|mesh-list
43653905|NCT02980965|Epirubicin|epirubicin|mesh-list
43653906|NCT02980965|Leuprolide|leuprolide|mesh-list
43653907|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387145|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
44387146|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
43882942|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882943|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43882944|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43882945|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43882946|NCT04617626|Azithromycin|azithromycin|mesh-list
43882947|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43882948|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43882949|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
43882950|NCT04617652|Analgesics|analgesics|mesh-ancestor
43882951|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
43882952|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882953|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882954|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
43882966|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882967|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
43882968|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43882969|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43882970|NCT04617561|Prednisolone|prednisolone|mesh-list
43882971|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
43882972|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43882973|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43882974|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
43882975|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
43882976|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43882977|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
43882978|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
43882979|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43882980|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882981|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43882982|NCT04617561|Hormones|hormones|mesh-ancestor
43882983|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43882984|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44387148|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
44387149|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44387150|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44387151|NCT05386472|Ritonavir|ritonavir|mesh-list
44387152|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44387153|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44387154|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387155|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387156|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387157|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44387158|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44387159|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
44387160|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387161|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44387162|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44387163|NCT05381350|Vaccines|vaccines|mesh-list
44387164|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
44387165|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387166|NCT05363592|Metformin|metformin|mesh-list
44387167|NCT05363592|Alogliptin|alogliptin|mesh-list
44387168|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387169|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387170|NCT05363592|Incretins|incretins|mesh-ancestor
44387171|NCT05363592|Hormones|hormones|mesh-ancestor
44387172|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387173|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44387174|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387175|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387176|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882985|NCT04617561|Protective Agents|protective agents|mesh-ancestor
43882986|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43882987|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43882988|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43882989|NCT04617483|Vaccines|vaccines|mesh-list
43882990|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
43882991|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882992|NCT04617249|Anesthetics|anesthetics|mesh-list
43882993|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43882994|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43882996|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43882997|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
43882998|NCT04616872|Methotrexate|methotrexate|mesh-list
44387177|NCT05363384|Metformin|metformin|mesh-list
44387178|NCT05363384|Alogliptin|alogliptin|mesh-list
44387179|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387180|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387181|NCT05363384|Incretins|incretins|mesh-ancestor
44387182|NCT05363384|Hormones|hormones|mesh-ancestor
44387183|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387184|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44387185|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387186|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387187|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387188|NCT05358249|Cetuximab|cetuximab|mesh-list
44387189|NCT05358249|Trametinib|trametinib|mesh-list
44387190|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387191|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387192|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44387193|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387194|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387195|NCT05331183|Ivacaftor|ivacaftor|mesh-list
44387196|NCT05331183|Elexacaftor|elexacaftor|mesh-list
44387197|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44387198|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387199|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387200|NCT05330273|Efavirenz|efavirenz|mesh-list
44387201|NCT05330273|Lumefantrine|lumefantrine|mesh-list
44387202|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43692870|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
43882999|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43883000|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
43883001|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883002|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883003|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883004|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
43883005|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883006|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883007|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
43883008|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883009|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43883010|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883011|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
43883012|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883013|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43883014|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43883015|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
43883016|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43883018|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883019|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387203|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387204|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387205|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387206|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
44387207|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387208|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44387209|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44387210|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44387211|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44387212|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44387213|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44387214|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
44387215|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44387216|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44387217|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44387218|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
44387219|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387220|NCT05316116|Siltuximab|siltuximab|mesh-list
44387221|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387222|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
44387223|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44387224|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387225|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387226|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
44387227|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44387228|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44387229|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883020|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43883021|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43883023|NCT04616807|Mexiletine|mexiletine|mesh-list
43883024|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883025|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43883026|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43883027|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43883028|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883029|NCT04617015|Bromides|bromides|mesh-list
43883030|NCT04617015|Ipratropium|ipratropium|mesh-list
43883031|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
43883032|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43883033|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
43883034|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883035|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883036|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883037|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
44387230|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
44387231|NCT05302986|Coagulants|coagulants|mesh-ancestor
44387232|NCT05297851|Riboflavin|riboflavin|mesh-list
44387233|NCT05297851|Niacinamide|niacinamide|mesh-list
44387234|NCT05297851|Niacin|niacin|mesh-list
44387235|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
44387236|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
44387237|NCT05297851|Vitamins|vitamins|mesh-ancestor
44387238|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
44387239|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387240|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44387241|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387242|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44387243|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
44387244|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387245|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44387246|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
44387247|NCT05268562|Ketamine|ketamine|mesh-list
44387248|NCT05268562|Propofol|propofol|mesh-list
44387249|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44387250|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387251|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387252|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44387253|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
44387254|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
44387255|NCT05268562|Analgesics|analgesics|mesh-ancestor
44387256|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
44387257|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387258|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44387259|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44387260|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44387261|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387262|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387263|NCT05255601|Nivolumab|nivolumab|mesh-list
44387268|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
44387272|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387273|NCT05245552|Vaccines|vaccines|mesh-list
44387274|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
44387275|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387276|NCT05229653|Ketamine|ketamine|mesh-list
44387277|NCT05229653|Analgesics|analgesics|mesh-ancestor
44387278|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
44387279|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387280|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387281|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44387282|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44387283|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
44387284|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
44387285|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387286|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44387287|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44387288|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387289|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387290|NCT05199571|Ofatumumab|ofatumumab|mesh-list
44387291|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387292|NCT05182892|Dopamine|dopamine|mesh-list
43883038|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43883039|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
43883040|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883041|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883042|NCT04616859|Ethanol|ethanol|mesh-list
43883043|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43883044|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883045|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883046|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883047|NCT04616586|Siltuximab|siltuximab|mesh-list
43883048|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883049|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
43883050|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43883051|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
43883052|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883053|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785549|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883054|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883055|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883056|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43883057|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43883058|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43883059|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883060|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883061|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883062|NCT04616352|Cefuroxime|cefuroxime|mesh-list
43883063|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
43883064|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883065|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883066|NCT04616313|Xenon|xenon|mesh-list
43883067|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43883068|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
43883069|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
43883070|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387294|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44387295|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
44387296|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
44387297|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387298|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387299|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
44387300|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387301|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387302|NCT05182892|Protective Agents|protective agents|mesh-ancestor
44387303|NCT05156658|Etonogestrel|etonogestrel|mesh-list
44387304|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44387305|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
44387306|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43692959|NCT02777151|Atoltivimab|atoltivimab|mesh-list
43883071|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883072|NCT04616391|Insulin|insulin|mesh-list
43883073|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883074|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883075|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
43883076|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
43883077|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43883078|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43883079|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43883080|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883081|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
43883082|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43883083|NCT04615767|Inositol|inositol|mesh-list
43883084|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
43785554|NCT04595864|Vitamins|vitamins|mesh-ancestor
43883085|NCT04615767|Vitamins|vitamins|mesh-ancestor
43883086|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
43883087|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883088|NCT04615702|Acetaminophen|acetaminophen|mesh-list
43883090|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
43883091|NCT04615702|Imipenem|imipenem|mesh-list
43883092|NCT04615702|Diclofenac|diclofenac|mesh-list
43883100|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
43883101|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883102|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
43883103|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883104|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883105|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43883106|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43883107|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883108|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883109|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43883110|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883111|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883112|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43883113|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43883114|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883115|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43883116|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43883117|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43883118|NCT04615702|Narcotics|narcotics|mesh-ancestor
43883119|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883120|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883121|NCT04615702|Hormones|hormones|mesh-ancestor
43883122|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883123|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
43883124|NCT04615702|Protective Agents|protective agents|mesh-ancestor
43883125|NCT04615611|Albuterol|albuterol|mesh-list
44387307|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387308|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44387309|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44387310|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44387311|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
44387313|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387314|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387315|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387316|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387317|NCT05119075|Dopamine|dopamine|mesh-list
44387318|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
44387319|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44387320|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
44387321|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
44387322|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387323|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387324|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
44387325|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387326|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387327|NCT05119075|Protective Agents|protective agents|mesh-ancestor
44387328|NCT05111314|Edetic Acid|edetic acid|mesh-list
44387329|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44387330|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
44387331|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
44387332|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840345|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848283|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43848284|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43848285|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43848288|NCT04036188|Vitamin D|vitamin d|mesh-list
44387333|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
44387334|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44387335|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44387336|NCT05098938|Acyclovir|acyclovir|mesh-list
44387337|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
44387338|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387339|NCT05092386|Vaccines|vaccines|mesh-list
44387340|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
44387341|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387342|NCT05059522|Pemetrexed|pemetrexed|mesh-list
44387343|NCT05059522|Avelumab|avelumab|mesh-list
43883126|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43883127|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
44387345|NCT05059522|Talazoparib|talazoparib|mesh-list
44387346|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387347|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387348|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387349|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387350|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387351|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387352|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44387353|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44387354|NCT05054439|Paclitaxel|paclitaxel|mesh-list
44387355|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387356|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387357|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387358|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387359|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387360|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387361|NCT05053152|Relugolix|relugolix|mesh-list
44387362|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
44387363|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
44387364|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387365|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387366|NCT05050084|Leuprolide|leuprolide|mesh-list
44387367|NCT05050084|Goserelin|goserelin|mesh-list
44387368|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44387369|NCT05050084|Flutamide|flutamide|mesh-list
44387370|NCT05050084|Bicalutamide|bicalutamide|mesh-list
43692995|NCT02776891|Citric Acid|citric acid|mesh-list
43883128|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883129|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883130|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883131|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883132|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
43883133|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883134|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43883135|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43883136|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43883137|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883138|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883139|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883140|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43883141|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883142|NCT04615481|Metronidazole|metronidazole|mesh-list
43883143|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883144|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883145|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44044175|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44387372|NCT05050084|Buserelin|buserelin|mesh-list
44387373|NCT05050084|Hormones|hormones|mesh-list
44387374|NCT05050084|Relugolix|relugolix|mesh-list
44387375|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387376|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387377|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44387378|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
44387379|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44387380|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44387381|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387382|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
44387383|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
44387384|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
44387385|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44387386|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
44387387|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44387388|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44387389|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
44387390|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44387391|NCT05048264|Dexamethasone|dexamethasone|mesh-list
44387392|NCT05048264|Methylprednisolone|methylprednisolone|mesh-list
44387393|NCT05048264|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44387394|NCT05048264|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44387395|NCT05048264|Prednisolone|prednisolone|mesh-list
44387396|NCT05048264|Prednisolone acetate|prednisolone acetate|mesh-list
44387397|NCT05048264|Triamcinolone|triamcinolone|mesh-list
44387398|NCT05048264|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44387399|NCT05048264|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44387400|NCT05048264|Betamethasone|betamethasone|mesh-list
44387401|NCT05048264|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44387402|NCT05048264|Prednisolone phosphate|prednisolone phosphate|mesh-list
44387403|NCT05048264|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44387404|NCT05048264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387423|NCT05030441|Ivosidenib|ivosidenib|mesh-list
44387424|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387425|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387426|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883146|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43883147|NCT04615403|Travoprost|travoprost|mesh-list
43883148|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883149|NCT04615351|Metformin|metformin|mesh-list
43883150|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883151|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883152|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
43883153|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43883154|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
43883155|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883156|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
43883157|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883158|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43883159|NCT04614727|Calcium|calcium|mesh-list
43883160|NCT04614727|Fluorides|fluorides|mesh-list
43670330|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
43883161|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43883173|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883174|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883175|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43883176|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44387453|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44387454|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387455|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387457|NCT05020457|Docetaxel|docetaxel|mesh-list
44387458|NCT05020457|Cisplatin|cisplatin|mesh-list
44387459|NCT05020457|Pemetrexed|pemetrexed|mesh-list
44387460|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387461|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387462|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387463|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387464|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387465|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387466|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387467|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387468|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387469|NCT05018091|Dexamethasone|dexamethasone|mesh-list
44387470|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
44387471|NCT05018091|BB 1101|bb 1101|mesh-list
44387472|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387473|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
43883177|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883178|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43883179|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44387491|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883180|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43883181|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883182|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43883183|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43883184|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
44387523|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387524|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
44387525|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387526|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387527|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
44387528|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44387529|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387530|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387531|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387532|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
44387533|NCT04947501|Ifosfamide|ifosfamide|mesh-list
44387534|NCT04947501|Carboplatin|carboplatin|mesh-list
44387535|NCT04947501|Doxorubicin|doxorubicin|mesh-list
44387536|NCT04947501|Etoposide|etoposide|mesh-list
44387537|NCT04947501|Vincristine|vincristine|mesh-list
44387538|NCT04947501|Topotecan|topotecan|mesh-list
44387539|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387540|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
44387541|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387542|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387544|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
44387548|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44387549|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44387550|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44387551|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387552|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387553|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387554|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387555|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387556|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44387558|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44387559|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
44387560|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44387561|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
44387562|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387563|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387564|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
44387565|NCT04906889|Lidocaine|lidocaine|mesh-list
44387566|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
44387567|NCT04906889|Remifentanil|remifentanil|mesh-list
44387568|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44387569|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
44387570|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387571|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387572|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
43693135|NCT02776436|Hormones|hormones|mesh-ancestor
43883185|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43883186|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43883187|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
43883188|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
43883189|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883190|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
43883191|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43883192|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43883193|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43883194|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43883195|NCT04614298|Brodalumab|brodalumab|mesh-list
43883196|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
43883197|NCT04614259|Bupivacaine|bupivacaine|mesh-list
43883198|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
43883199|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
43883200|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883201|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883202|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
43883203|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883204|NCT04614194|Letrozole|letrozole|mesh-list
43883205|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883206|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43883207|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43883208|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387573|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387574|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44387575|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44387576|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44387577|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387578|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387579|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44387580|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44387581|NCT04906889|Analgesics|analgesics|mesh-ancestor
44387582|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44387583|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44387584|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44387585|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44387586|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387587|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44387588|NCT04906889|Narcotics|narcotics|mesh-ancestor
44387589|NCT04895098|Ezetimibe|ezetimibe|mesh-list
44387590|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44387591|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44044399|NCT00003037|Docetaxel|docetaxel|mesh-list
44387592|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44387594|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387595|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44387596|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387597|NCT04868747|Lidocaine|lidocaine|mesh-list
44387598|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
44387599|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
44387600|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387601|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387602|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
44387603|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387604|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44387605|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44387606|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43693158|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883209|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883210|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44387607|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387608|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387609|NCT04827576|Docetaxel|docetaxel|mesh-list
44387610|NCT04827576|Magrolimab|magrolimab|mesh-list
44387611|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387612|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387613|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387614|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387615|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387616|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387617|NCT04822350|Avelumab|avelumab|mesh-list
44387618|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387619|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387620|NCT04817345|Plerixafor|plerixafor|mesh-list
44387621|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44387622|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44387623|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
44387624|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387625|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
44387626|NCT04789408|Fludarabine|fludarabine|mesh-list
44387627|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387628|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
44387629|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387630|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387631|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44387632|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
44387633|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387634|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387635|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44387636|NCT04786210|Triamcinolone|triamcinolone|mesh-list
44387637|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44387638|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44387639|NCT04786210|Fluorouracil|fluorouracil|mesh-list
44387640|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44387647|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387648|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387649|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
44387650|NCT04786210|Hormones|hormones|mesh-ancestor
44387651|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387652|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387653|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
44387654|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44387655|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
44387656|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44387657|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387658|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44387659|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44387660|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44387661|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
44387662|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44387663|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387664|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44387665|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44387666|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387667|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387668|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387669|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
44387670|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387672|NCT04760288|Pralsetinib|pralsetinib|mesh-list
44387696|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44387697|NCT04731233|Mitogens|mitogens|mesh-list
44387698|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387699|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
44387700|NCT04731233|Hormones|hormones|mesh-ancestor
44387701|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44387702|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387703|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387704|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
44387705|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387706|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387707|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387708|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44387709|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
44387710|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387711|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44387712|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
44387713|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387714|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387715|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44387716|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44387717|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387718|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
44387719|NCT04705480|Pregabalin|pregabalin|mesh-list
44387720|NCT04705480|Gabapentin|gabapentin|mesh-list
44387721|NCT04705480|Analgesics|analgesics|mesh-ancestor
44387722|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
44387723|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387724|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387725|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
44387726|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44387727|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44387728|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387729|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44387732|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387733|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44387734|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44387735|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44387736|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387737|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
44387738|NCT04698187|Nivolumab|nivolumab|mesh-list
44387739|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387740|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387741|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387742|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387744|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387745|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387746|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387747|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387748|NCT04599972|Pilocarpine|pilocarpine|mesh-list
44387749|NCT04599972|Miotics|miotics|mesh-ancestor
44387750|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
44387751|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387752|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387753|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44387754|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44387755|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
44387756|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387757|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387758|NCT04599933|Pilocarpine|pilocarpine|mesh-list
44387759|NCT04599933|Miotics|miotics|mesh-ancestor
44387760|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
44387761|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387762|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387763|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44387764|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44387765|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
44387766|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387767|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387768|NCT04588246|Memantine|memantine|mesh-list
44387769|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44387770|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44387771|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
44387772|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387773|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387774|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387775|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44387776|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44387777|NCT04551430|Nivolumab|nivolumab|mesh-list
44387778|NCT04551430|Ipilimumab|ipilimumab|mesh-list
44387779|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387780|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387781|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387782|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387783|NCT04533737|Brodalumab|brodalumab|mesh-list
44387784|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387785|NCT04524910|Aflibercept|aflibercept|mesh-list
44387786|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44387787|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44387788|NCT04524910|Growth Substances|growth substances|mesh-ancestor
44387789|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387790|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
43848336|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
44387791|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387792|NCT04521231|Blinatumomab|blinatumomab|mesh-list
44387793|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387794|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
44387816|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
44387817|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
44387819|NCT04384692|Busulfan|busulfan|mesh-list
44387820|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
44387821|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44387822|NCT04384692|Methotrexate|methotrexate|mesh-list
44387823|NCT04384692|Fludarabine|fludarabine|mesh-list
44387824|NCT04384692|Tacrolimus|tacrolimus|mesh-list
44387825|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387826|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
44387827|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387828|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387829|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44387830|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
44387831|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387832|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387833|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44387834|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44387835|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
44387836|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44387837|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44387838|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
44387839|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387840|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387841|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387842|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387843|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44387844|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44387845|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44387846|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
44387847|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44387848|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387849|NCT04382898|Cemiplimab|cemiplimab|mesh-list
44387850|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387851|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387852|NCT04305249|Nivolumab|nivolumab|mesh-list
44387853|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387854|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387855|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44387856|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387857|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
44387858|NCT04303507|Chloroquine|chloroquine|mesh-list
44387859|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
44387860|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44387861|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44387862|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387863|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387864|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387865|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44387866|NCT04303507|Amebicides|amebicides|mesh-ancestor
44387867|NCT04301778|Durvalumab|durvalumab|mesh-list
44387868|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387869|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387870|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
44387871|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44387872|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387873|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387874|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
44387876|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44387877|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387878|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44387879|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44387880|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43693361|NCT02774382|Vancomycin|vancomycin|mesh-list
43883211|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
43883212|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883213|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883214|NCT04613609|Nicotine|nicotine|mesh-list
43883215|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43883216|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
43883217|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883218|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883219|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43883220|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43883221|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
43883222|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883223|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883224|NCT04613700|Secretin|secretin|mesh-list
43883229|NCT04613869|Hydromorphone|hydromorphone|mesh-list
43883230|NCT04613869|Esketamine|esketamine|mesh-list
43883231|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43883232|NCT04613869|Narcotics|narcotics|mesh-ancestor
43883233|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883234|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883235|NCT04613869|Analgesics|analgesics|mesh-ancestor
44387881|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44387882|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
44387883|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44387884|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387885|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387886|NCT04258631|Hydromorphone|hydromorphone|mesh-list
44387887|NCT04258631|Bupivacaine|bupivacaine|mesh-list
44387888|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
44387889|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
44387890|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387891|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387892|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
44387893|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387894|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44387895|NCT04258631|Narcotics|narcotics|mesh-ancestor
44387896|NCT04258631|Analgesics|analgesics|mesh-ancestor
44387897|NCT04252287|Canagliflozin|canagliflozin|mesh-list
44387898|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44387899|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387900|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387901|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387902|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
44387903|NCT04245423|Narcotics|narcotics|mesh-ancestor
44387904|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387905|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387906|NCT04245423|Analgesics|analgesics|mesh-ancestor
44387907|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
44387908|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387909|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
44387910|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387911|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883236|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
43883237|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883238|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
43883239|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883240|NCT04613726|Ondansetron|ondansetron|mesh-list
43883241|NCT04613726|Granisetron|granisetron|mesh-list
43883242|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
43883243|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
43883244|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883245|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883246|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883247|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
43883248|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
44387912|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
44387913|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44387914|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387915|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44387916|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387917|NCT04177108|Paclitaxel|paclitaxel|mesh-list
44387918|NCT04177108|Atezolizumab|atezolizumab|mesh-list
44387919|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44387920|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387921|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387922|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387923|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387924|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387925|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387926|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
44387927|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387928|NCT04158141|Cisplatin|cisplatin|mesh-list
44387929|NCT04158141|Carboplatin|carboplatin|mesh-list
44387930|NCT04158141|Pemetrexed|pemetrexed|mesh-list
44387931|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387932|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387933|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387934|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44387935|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44387936|NCT04138615|Morphine|morphine|mesh-list
44387937|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44387938|NCT04138615|Narcotics|narcotics|mesh-ancestor
44387939|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387940|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387941|NCT04138615|Analgesics|analgesics|mesh-ancestor
44387942|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
44387943|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387944|NCT04127786|Vaccines|vaccines|mesh-list
44387954|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
44387955|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387956|NCT04020848|Protective Agents|protective agents|mesh-ancestor
44387957|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387958|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44387959|NCT04003636|Gemcitabine|gemcitabine|mesh-list
44387960|NCT04003636|Cisplatin|cisplatin|mesh-list
44387961|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
44387962|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387963|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44387964|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
44387965|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387966|NCT04003636|Antiviral Agents|antiviral agents|mesh-ancestor
44387967|NCT04003636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44387968|NCT04003636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387969|NCT04003636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387970|NCT04003636|Immunologic Factors|immunologic factors|mesh-ancestor
44387971|NCT04003636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387972|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44387973|NCT03997123|Paclitaxel|paclitaxel|mesh-list
44387974|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44387975|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44387976|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
44387977|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
44387978|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
44387979|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387980|NCT03958474|Remifentanil|remifentanil|mesh-list
44387981|NCT03958474|Oxycodone|oxycodone|mesh-list
44387982|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44387983|NCT03958474|Narcotics|narcotics|mesh-ancestor
43693459|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43883249|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43883250|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
43883251|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883252|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883253|NCT04613726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43883254|NCT04613726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43883255|NCT04613726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883256|NCT04613726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883257|NCT04613726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43883258|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
43883259|NCT04613557|Fludarabine|fludarabine|mesh-list
43883260|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
43883261|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44387985|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44387986|NCT03958474|Analgesics|analgesics|mesh-ancestor
44387987|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
44387988|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44387989|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
44387990|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
44387991|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44387992|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44387993|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44387994|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44387995|NCT03945643|Urological Agents|urological agents|mesh-ancestor
44387996|NCT03942224|Dexamethasone|dexamethasone|mesh-list
44387997|NCT03942224|Bortezomib|bortezomib|mesh-list
44387998|NCT03942224|Daratumumab|daratumumab|mesh-list
44387999|NCT03942224|Ixazomib|ixazomib|mesh-list
44388000|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44388001|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
44388002|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
44388003|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388004|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388005|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44388006|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
44388007|NCT03942224|Hormones|hormones|mesh-ancestor
44388008|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388009|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44388010|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388011|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
44388012|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388013|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388014|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
44388015|NCT03914625|Leucovorin|leucovorin|mesh-list
44388016|NCT03914625|Folic Acid|folic acid|mesh-list
44388017|NCT03914625|Cytarabine|cytarabine|mesh-list
44388018|NCT03914625|Dexamethasone|dexamethasone|mesh-list
43883262|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
43883263|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883264|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883265|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883266|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
44163841|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388019|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
44388020|NCT03914625|Prednisone|prednisone|mesh-list
44388021|NCT03914625|Prednisolone|prednisolone|mesh-list
44044817|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388022|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44388023|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
44388024|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44388025|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
44388026|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
44388027|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44388028|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44388029|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44388030|NCT03914625|Cortisone|cortisone|mesh-list
44388031|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
44388032|NCT03914625|Doxorubicin|doxorubicin|mesh-list
44388033|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44388034|NCT03914625|Methotrexate|methotrexate|mesh-list
44388035|NCT03914625|Vincristine|vincristine|mesh-list
44388036|NCT03914625|Asparaginase|asparaginase|mesh-list
44388037|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
44388043|NCT03914625|Antibodies|antibodies|mesh-list
44388078|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44388079|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
44388080|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44388081|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388082|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
44388083|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44388084|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44388085|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44388086|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
44388087|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388088|NCT03914625|Antidotes|antidotes|mesh-ancestor
44388089|NCT03914625|Protective Agents|protective agents|mesh-ancestor
44388090|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
44388091|NCT03914625|Vitamins|vitamins|mesh-ancestor
44388092|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
44388093|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388094|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388095|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
44388096|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
44388097|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44388098|NCT03914625|Hematinics|hematinics|mesh-ancestor
44044904|NCT00003089|Paclitaxel|paclitaxel|mesh-list
44388099|NCT03904550|Rocuronium|rocuronium|mesh-list
44388100|NCT03904550|Cisatracurium|cisatracurium|mesh-list
44388104|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44388129|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388130|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
44388131|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388132|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388133|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
44388134|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388135|NCT03755804|Prednisone|prednisone|mesh-list
44388136|NCT03755804|Prednisolone|prednisolone|mesh-list
44388137|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
44388138|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44388139|NCT03755804|Dacarbazine|dacarbazine|mesh-list
44388140|NCT03755804|Doxorubicin|doxorubicin|mesh-list
44388141|NCT03755804|Etoposide|etoposide|mesh-list
44388142|NCT03755804|Vincristine|vincristine|mesh-list
44388143|NCT03755804|Bleomycin|bleomycin|mesh-list
44388144|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44388145|NCT03755804|Vinblastine|vinblastine|mesh-list
44388146|NCT03755804|Imidazole|imidazole|mesh-list
44388147|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388148|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
44388149|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388150|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388151|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44388152|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
44388153|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388154|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388155|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44388156|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44388157|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44388158|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388159|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388160|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44388161|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
44388162|NCT03755804|Hormones|hormones|mesh-ancestor
44388163|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388164|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43829602|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
43883267|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163842|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388165|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388166|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388167|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44388168|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44388169|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388170|NCT03682224|Epinephrine|epinephrine|mesh-list
44388171|NCT03682224|Bupivacaine|bupivacaine|mesh-list
44388172|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
44388173|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
44388174|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388175|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388176|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
44388177|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388178|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44388179|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44388180|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
44388181|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388182|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388183|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44388184|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44388185|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
44388186|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44388187|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
44388188|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
44388189|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
44045048|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
44388190|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44388192|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
44388193|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388194|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388199|NCT03618641|Nivolumab|nivolumab|mesh-list
44388227|NCT03525379|Protective Agents|protective agents|mesh-ancestor
44388228|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388229|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388230|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44388232|NCT03523000|Bupivacaine|bupivacaine|mesh-list
44388233|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
44388234|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
43883268|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883269|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43883270|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883271|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
43883272|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43883273|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883274|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883275|NCT04613102|Cannabidiol|cannabidiol|mesh-list
43883276|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
43883277|NCT04613219|Tofacitinib|tofacitinib|mesh-list
43883278|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43883279|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883280|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883281|NCT04613167|Evolocumab|evolocumab|mesh-list
43883282|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43883283|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883284|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
43883285|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883286|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43883287|NCT04613271|Azithromycin|azithromycin|mesh-list
43883288|NCT04613271|Favipiravir|favipiravir|mesh-list
43883289|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883290|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388235|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388236|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388237|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
44388238|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388239|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44388241|NCT03523000|Analgesics|analgesics|mesh-ancestor
44388242|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44388243|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44388244|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
44388245|NCT03504410|Cytarabine|cytarabine|mesh-list
44388246|NCT03504410|Fludarabine|fludarabine|mesh-list
44388247|NCT03504410|Etoposide|etoposide|mesh-list
44388248|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
44388249|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388250|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388251|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
44388252|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388253|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388254|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
44388255|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388256|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388257|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44388258|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388259|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388260|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
43883291|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
43883292|NCT04613284|Durvalumab|durvalumab|mesh-list
43883293|NCT04613284|Endostar protein|endostar protein|mesh-list
43883294|NCT04613284|Endostatins|endostatins|mesh-list
43883295|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44156328|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44156329|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44156331|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156332|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44156333|NCT00230516|Lansoprazole|lansoprazole|mesh-list
44156334|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43785657|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
44156335|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44156336|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44156337|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156338|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156339|NCT00230529|Infliximab|infliximab|mesh-list
44156340|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156341|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44156342|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156343|NCT00230542|Carboplatin|carboplatin|mesh-list
44156344|NCT00230542|Pemetrexed|pemetrexed|mesh-list
44156345|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156346|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156378|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44156379|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44156380|NCT00230776|Pregabalin|pregabalin|mesh-list
44156381|NCT00230776|Analgesics|analgesics|mesh-ancestor
44156382|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
44156383|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156384|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156385|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
44156386|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44156387|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156388|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883305|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44388321|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
44388322|NCT03202537|Lansoprazole|lansoprazole|mesh-list
44388323|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44388324|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44388325|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44388326|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388327|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388328|NCT03179761|Vaccines|vaccines|mesh-list
44388329|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
44388330|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388331|NCT03143153|Cisplatin|cisplatin|mesh-list
44388332|NCT03143153|Fluorouracil|fluorouracil|mesh-list
44388333|NCT03143153|Nivolumab|nivolumab|mesh-list
44388334|NCT03143153|Ipilimumab|ipilimumab|mesh-list
44388335|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388336|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
44388337|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388338|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388339|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388340|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
44388341|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388342|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388343|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44388345|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388346|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44388347|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44388348|NCT03140176|Growth Substances|growth substances|mesh-ancestor
43883306|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883307|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43883308|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
43883309|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883310|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883311|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883312|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883313|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
43883314|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
44388349|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388350|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
44388351|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44388352|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388353|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388354|NCT03129867|Ticagrelor|ticagrelor|mesh-list
44388355|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44388356|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44388357|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44388358|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44388359|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
44388360|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388361|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388362|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388363|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
44388364|NCT03110432|Niacin|niacin|mesh-list
44388365|NCT03110432|Ezetimibe|ezetimibe|mesh-list
44388366|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44388367|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44388368|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44388369|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
44388370|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388371|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44388372|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
44388373|NCT03110432|Vitamins|vitamins|mesh-ancestor
44388374|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
44388375|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388376|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
44388377|NCT03093155|Bevacizumab|bevacizumab|mesh-list
44388396|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388397|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
44388398|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
44388399|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388400|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388401|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
44388402|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
44388403|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388404|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388405|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388406|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
44388407|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388408|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388409|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44388410|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44388411|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44388412|NCT02913612|Timolol|timolol|mesh-list
44388413|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44388414|NCT02913612|Maleic acid|maleic acid|mesh-list
44388415|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44388416|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44388417|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
44388418|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388419|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388420|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388421|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44388422|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44388423|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388424|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
44388425|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388426|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388427|NCT02864147|Imiquimod|imiquimod|mesh-list
44388428|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43883315|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43883316|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43883317|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
43883318|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883319|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883320|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
43883321|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44388429|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
44388430|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388431|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388432|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
44388434|NCT02710331|Dronabinol|dronabinol|mesh-list
44388435|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44388436|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388437|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388438|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388439|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
44388440|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388441|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44388442|NCT02710331|Analgesics|analgesics|mesh-ancestor
44388443|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
44388444|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388445|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44388446|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44388447|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388448|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388449|NCT02710331|Hormones|hormones|mesh-ancestor
44388450|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388451|NCT02709954|Ethanol|ethanol|mesh-list
44388452|NCT02709954|Dronabinol|dronabinol|mesh-list
44388453|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44388454|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388455|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388456|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388457|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
44388458|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883322|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43883323|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43883324|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
43883325|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43883326|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
43883327|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43883328|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883329|NCT04613180|Montelukast|montelukast|mesh-list
43883330|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883331|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883332|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43883333|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
43883334|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388459|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44388460|NCT02709954|Analgesics|analgesics|mesh-ancestor
44388461|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
44388462|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388463|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44388464|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44388465|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388466|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388467|NCT02709954|Hormones|hormones|mesh-ancestor
44388468|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388469|NCT02404688|Ethanol|ethanol|mesh-list
44388470|NCT02404688|Dronabinol|dronabinol|mesh-list
44388471|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44388472|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388473|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388474|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388475|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
44388476|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388477|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44388478|NCT02404688|Analgesics|analgesics|mesh-ancestor
44388479|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
44388480|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388481|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44388482|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44388483|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388484|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883335|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883336|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43883337|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43883338|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883339|NCT04612894|Apatinib|apatinib|mesh-list
43883340|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883341|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43883342|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883343|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883344|NCT04612634|Vaccines|vaccines|mesh-list
43883345|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
43883346|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883347|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
43883348|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43883349|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
43785668|NCT03783351|Clopidogrel|clopidogrel|mesh-list
43883350|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883351|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883352|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883353|NCT04612556|Vaccines|vaccines|mesh-list
43883354|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
44388485|NCT02404688|Hormones|hormones|mesh-ancestor
44388486|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388487|NCT02388906|Nivolumab|nivolumab|mesh-list
44388488|NCT02388906|Ipilimumab|ipilimumab|mesh-list
44388489|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388490|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388491|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44388492|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44045357|NCT00003143|Amifostine|amifostine|mesh-list
44388494|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44388495|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44388496|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388497|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
44388498|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388499|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
44388500|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
44388501|NCT02251821|Melphalan|melphalan|mesh-list
44388502|NCT02251821|Busulfan|busulfan|mesh-list
44388503|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
44388504|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44388505|NCT02251821|Methotrexate|methotrexate|mesh-list
44388506|NCT02251821|Fludarabine|fludarabine|mesh-list
44388507|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
44388508|NCT02251821|Tacrolimus|tacrolimus|mesh-list
44388509|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388510|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
44388511|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388512|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388513|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44388514|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
44388515|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388516|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388517|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44388528|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44388529|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44388530|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
44388531|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44388532|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388533|NCT02227199|Carboplatin|carboplatin|mesh-list
44388534|NCT02227199|Etoposide|etoposide|mesh-list
44388535|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
44388536|NCT02227199|Ifosfamide|ifosfamide|mesh-list
44388537|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
44388538|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44388539|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
44388540|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44388541|NCT02227199|Antibodies|antibodies|mesh-list
44388542|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
44388543|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44388544|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
44388545|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
44388546|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388547|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388548|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44388549|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44388550|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388551|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388552|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388580|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388581|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388582|NCT01610700|Nabiximols|nabiximols|mesh-list
44388583|NCT01610700|Analgesics|analgesics|mesh-ancestor
44388584|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
44388585|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388586|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388587|NCT01268579|Ribavirin|ribavirin|mesh-list
44388588|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
44388589|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785673|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43785674|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
44388590|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
44388591|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388592|NCT01005745|Aldesleukin|aldesleukin|mesh-list
44388593|NCT01005745|Interleukin-2|interleukin-2|mesh-list
44388594|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388595|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44388596|NCT01005745|Analgesics|analgesics|mesh-ancestor
44388597|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
44388598|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388599|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388600|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44388601|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44388602|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
44388603|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388604|NCT00536172|Citalopram|citalopram|mesh-list
44388605|NCT00536172|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44388628|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388629|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
44388630|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44388631|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388632|NCT03332589|Dabrafenib|dabrafenib|mesh-list
44388633|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388634|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44388635|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388636|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388637|NCT03332212|Empagliflozin|empagliflozin|mesh-list
44388638|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44388639|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388640|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44388641|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388642|NCT03332095|Tenofovir|tenofovir|mesh-list
44388643|NCT03332095|Lamivudine|lamivudine|mesh-list
44388644|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44388645|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
44388646|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388647|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44388648|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44388649|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388650|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388651|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44388652|NCT03331666|Evolocumab|evolocumab|mesh-list
44388658|NCT03331315|Celecoxib|celecoxib|mesh-list
44388674|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44388675|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388676|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388677|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388678|NCT03330236|Anesthetics|anesthetics|mesh-list
44388679|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388680|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388681|NCT03329846|Nivolumab|nivolumab|mesh-list
44388682|NCT03329846|Linrodostat|linrodostat|mesh-list
44388683|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388684|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388685|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44388686|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388687|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388688|NCT03329573|Paroxetine|paroxetine|mesh-list
44388689|NCT03329573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44388690|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44388691|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388692|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388693|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388694|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
44388695|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388696|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44388697|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388698|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388699|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44388700|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44388701|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388702|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
44388703|NCT03329196|Hematinics|hematinics|mesh-ancestor
44388704|NCT03328897|Omalizumab|omalizumab|mesh-list
44388705|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44388706|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44388707|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
44388713|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44388714|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388715|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
44388716|NCT03328832|Coagulants|coagulants|mesh-ancestor
44388717|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44388718|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
44388719|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44388720|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44388721|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388722|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
44388723|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388724|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388725|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44388726|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44388727|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388728|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388729|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388730|NCT03328325|Vaccines|vaccines|mesh-list
44388731|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
44388732|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388733|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
44388734|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44388735|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44388736|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44388737|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388738|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388739|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
44388740|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388741|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388742|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44388743|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388744|NCT03325712|Midazolam|midazolam|mesh-list
44388745|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43693916|NCT02771158|Midodrine|midodrine|mesh-list
44388751|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388752|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44388753|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
44388755|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
44388756|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
44388757|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388758|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388759|NCT03325556|Pimavanserin|pimavanserin|mesh-list
44388760|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44388761|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44388762|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44388763|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388764|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388765|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388766|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388767|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44388768|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44388769|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
44388770|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388771|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388772|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
44388773|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44388774|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388775|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883355|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883356|NCT04612582|Thalidomide|thalidomide|mesh-list
43883357|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
43883358|NCT04612582|Bortezomib|bortezomib|mesh-list
43883359|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883364|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
43883365|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883366|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883367|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43883368|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
43883369|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883370|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883371|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43883372|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43883373|NCT04612582|Growth Substances|growth substances|mesh-ancestor
43883374|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
43883375|NCT04612504|Atezolizumab|atezolizumab|mesh-list
43883376|NCT04612504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883378|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883379|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883380|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43883381|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883382|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
43883383|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883384|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
43883385|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388776|NCT03325166|Hematinics|hematinics|mesh-ancestor
44388777|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44388778|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44388779|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44388780|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44388781|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44388782|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388783|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388784|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
44388785|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388786|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388787|NCT03323164|Timolol|timolol|mesh-list
44388788|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44388789|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43883386|NCT04612257|Insulin|insulin|mesh-list
43883387|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883388|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883389|NCT04611958|Bupivacaine|bupivacaine|mesh-list
43883390|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
43883391|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
43883392|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883393|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883394|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
43883395|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883396|NCT04611971|Belimumab|belimumab|mesh-list
43883397|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883398|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
43883399|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883400|NCT04611724|Folfirinox|folfirinox|mesh-list
43883401|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883402|NCT04611438|Cannabidiol|cannabidiol|mesh-list
43883403|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
43883404|NCT04611711|Decitabine|decitabine|mesh-list
43883405|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883406|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
43883407|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883408|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883409|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883410|NCT04611685|Parecoxib|parecoxib|mesh-list
43883411|NCT04611685|Loxoprofen|loxoprofen|mesh-list
43883412|NCT04611685|Tramadol|tramadol|mesh-list
43883413|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43883414|NCT04611685|Narcotics|narcotics|mesh-ancestor
43883415|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883416|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883417|NCT04611685|Analgesics|analgesics|mesh-ancestor
43883418|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
43883419|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883420|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43883421|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43883422|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883423|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883424|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883425|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883426|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883427|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883428|NCT04611373|Levamisole|levamisole|mesh-list
43883429|NCT04611373|Acetazolamide|acetazolamide|mesh-list
43883430|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
43883431|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43883432|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388790|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44388791|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
44045651|NCT00003178|Idarubicin|idarubicin|mesh-list
44388792|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388793|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388794|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388795|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44388796|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44388797|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44388798|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44388799|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44388800|NCT03323034|Irinotecan|irinotecan|mesh-list
44388801|NCT03323034|Temozolomide|temozolomide|mesh-list
44388802|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44388803|NCT03323034|Pevonedistat|pevonedistat|mesh-list
44388804|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44388805|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44388806|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388807|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388808|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44388809|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
44388810|NCT03321526|Norepinephrine|norepinephrine|mesh-list
44388811|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44388812|NCT03321526|Serotonin|serotonin|mesh-list
44388813|NCT03321526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44388814|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388815|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388816|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44388817|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388818|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883444|NCT04611464|Misoprostol|misoprostol|mesh-list
43883445|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43883446|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
43883447|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883448|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883449|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43883450|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883451|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
43883452|NCT04611776|Gemcitabine|gemcitabine|mesh-list
43883453|NCT04611776|Paclitaxel|paclitaxel|mesh-list
43883454|NCT04611776|Cisplatin|cisplatin|mesh-list
43883456|NCT04611776|Pemetrexed|pemetrexed|mesh-list
43883457|NCT04611776|Atezolizumab|atezolizumab|mesh-list
43883458|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43883459|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883460|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
44388819|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388820|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44388821|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44388822|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44388823|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388824|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388825|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
44388826|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
44388827|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388828|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44388829|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44388830|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
44388831|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43785678|NCT03579693|Niacinamide|niacinamide|mesh-list
43785680|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
43785681|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
43785682|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
43785683|NCT03579693|Vitamins|vitamins|mesh-ancestor
44388832|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388833|NCT03321396|Calcium|calcium|mesh-list
44388834|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44388835|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388836|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44388837|NCT03321006|Citalopram|citalopram|mesh-list
44388838|NCT03321006|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44388839|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44388840|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388841|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388842|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388843|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
44388844|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388845|NCT03321006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44388846|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
44388861|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44388862|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388863|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388864|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
44388865|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44388866|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388867|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44388868|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388869|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44388870|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44388871|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388872|NCT03320057|Mifepristone|mifepristone|mesh-list
44388873|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44388874|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
44388875|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44388876|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388877|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44388878|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44388879|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44388880|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
44388881|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44388882|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44388883|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
44388884|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44388885|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
43694052|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883461|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
43883462|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
43883463|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883464|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883465|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
43883466|NCT04611776|Antiviral Agents|antiviral agents|mesh-ancestor
43883467|NCT04611776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883468|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883469|NCT04611776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883470|NCT04611776|Immunologic Factors|immunologic factors|mesh-ancestor
43883471|NCT04611776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883472|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43883473|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43883474|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
43883475|NCT04611126|Nivolumab|nivolumab|mesh-list
43883476|NCT04611126|Fludarabine|fludarabine|mesh-list
43883477|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
43883478|NCT04611126|Ipilimumab|ipilimumab|mesh-list
43883479|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388886|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44388887|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44388889|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388890|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388891|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388892|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44045804|NCT00003194|Thiotepa|thiotepa|mesh-list
44388894|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
44388895|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
44388896|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
44388897|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388898|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388899|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
44388900|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44388901|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44388902|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44388903|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44388904|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44388905|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639107|NCT03587662|Ixazomib|ixazomib|mesh-list
43883480|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
43883481|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883482|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883483|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883484|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
43883485|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883486|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883487|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43883488|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43883489|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43883490|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883491|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
43883492|NCT04611165|Nivolumab|nivolumab|mesh-list
43883493|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43883494|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883495|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43883496|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883497|NCT04610879|Carbamazepine|carbamazepine|mesh-list
43883504|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883505|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883506|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883507|NCT04610879|Analgesics|analgesics|mesh-ancestor
43883508|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
43883509|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883510|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43883511|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43883512|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883513|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43883514|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44388906|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44388908|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
44388909|NCT03319719|Protective Agents|protective agents|mesh-ancestor
44388910|NCT03318315|Vaccines|vaccines|mesh-list
44388911|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
44388912|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388913|NCT03317496|Gemcitabine|gemcitabine|mesh-list
44388914|NCT03317496|Cisplatin|cisplatin|mesh-list
44388915|NCT03317496|Carboplatin|carboplatin|mesh-list
44388916|NCT03317496|Pemetrexed|pemetrexed|mesh-list
44388917|NCT03317496|Avelumab|avelumab|mesh-list
44388918|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44388919|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388920|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44388921|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
44388922|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44388923|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
44388924|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44388925|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44388926|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44388927|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
44388928|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388929|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44388930|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44388957|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388958|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44388959|NCT03313076|Vitamin D|vitamin d|mesh-list
44388960|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
44388961|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
44388962|NCT03313076|Vitamins|vitamins|mesh-list
44388963|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
44388964|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388965|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44388966|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44388967|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44388968|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
44388969|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388971|NCT03312907|Belimumab|belimumab|mesh-list
44388972|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44388973|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388974|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388975|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
44388976|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388977|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44388978|NCT03312114|Avelumab|avelumab|mesh-list
44388979|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44388980|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44388981|NCT03311841|Rifampin|rifampin|mesh-list
44388982|NCT03311841|Midazolam|midazolam|mesh-list
44388983|NCT03311841|Dabigatran|dabigatran|mesh-list
44388984|NCT03311841|Atorvastatin|atorvastatin|mesh-list
44388985|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44388986|NCT03311841|Pitavastatin|pitavastatin|mesh-list
43883515|NCT04610580|Choline|choline|mesh-list
43883516|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
43883517|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883518|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
43883519|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883520|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883521|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43883522|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
43883523|NCT04611243|Vaccines|vaccines|mesh-list
43883524|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
43883525|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156395|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44156396|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44156397|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156398|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883526|NCT04610567|Methotrexate|methotrexate|mesh-list
43883527|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43883528|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
43883529|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883530|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388987|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44388988|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43785684|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
43785685|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785686|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43785687|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
43785688|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785689|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43785690|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785691|NCT03540901|Acetazolamide|acetazolamide|mesh-list
43785692|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
44388989|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44388990|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44388991|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44388992|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44388993|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44388994|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44388995|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44388996|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
44388997|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
44388998|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
44388999|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
44389000|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389001|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389002|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44389003|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44389004|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
44389005|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44389006|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44389007|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389008|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
44389009|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44389010|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
44389011|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
44389012|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44389013|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
44389014|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389015|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389016|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
43883531|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43883532|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
43883533|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883534|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883535|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
43883536|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883537|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43883538|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883539|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
43883540|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883541|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43883542|NCT04610541|Remdesivir|remdesivir|mesh-list
43883543|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
43883544|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389017|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44389018|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44389019|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44389020|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44389021|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44389022|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44389023|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44389024|NCT03311724|Tirzepatide|tirzepatide|mesh-list
44389025|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389026|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389027|NCT03311724|Incretins|incretins|mesh-ancestor
44389028|NCT03311724|Hormones|hormones|mesh-ancestor
44389029|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389030|NCT03311646|Nicotine|nicotine|mesh-list
44389031|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44389032|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
44389033|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389034|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389035|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43883545|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
43883546|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883547|NCT04610320|Daratumumab|daratumumab|mesh-list
43883548|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883549|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
43883550|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43883551|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43883552|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883553|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
43883554|NCT04610164|Coagulants|coagulants|mesh-ancestor
43883555|NCT04610307|Anesthetics|anesthetics|mesh-list
43883556|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883557|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883558|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
43883559|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43883560|NCT04610502|Antibodies|antibodies|mesh-list
43883561|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
43883562|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883563|NCT04610398|Dexamethasone|dexamethasone|mesh-list
43883569|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883570|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883572|NCT04610398|Hormones|hormones|mesh-ancestor
43883573|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883574|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43883575|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883576|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
43883577|NCT04610125|Fludarabine|fludarabine|mesh-list
43883578|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883579|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
43883580|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883581|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883582|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883583|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
43670362|NCT02896023|Menotropins|menotropins|mesh-list
43883584|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389036|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44389037|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
44389038|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389039|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389041|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
44389042|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
44389043|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389044|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389045|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
44389046|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389047|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44389048|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44389049|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44389050|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653920|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43785696|NCT03540901|Diuretics|diuretics|mesh-ancestor
44389051|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389052|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44389053|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44389054|NCT03310411|Sumatriptan|sumatriptan|mesh-list
44389055|NCT03310411|Lasmiditan|lasmiditan|mesh-list
44389056|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44389057|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44389058|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44389059|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
44389060|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389061|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389062|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389063|NCT03310268|Listerine|listerine|mesh-list
44389064|NCT03310268|Fluorides|fluorides|mesh-list
44389065|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
44389066|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
44389067|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
44389068|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
44389069|NCT03310268|Protective Agents|protective agents|mesh-ancestor
44389070|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389071|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44389073|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
44389074|NCT03310021|Apixaban|apixaban|mesh-list
44389075|NCT03310021|Edoxaban|edoxaban|mesh-list
44389076|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44389077|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
44389078|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44389079|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
44389080|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389081|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389082|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
44389083|NCT03309943|Propranolol|propranolol|mesh-list
44389084|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44389085|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44389086|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
44389087|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389088|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389089|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389090|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44389091|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44389092|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
44389093|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
44389094|NCT03308942|Niraparib|niraparib|mesh-list
44389095|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389096|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883585|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883586|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43883588|NCT04609748|Cannabidiol|cannabidiol|mesh-list
43883589|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
43883590|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883591|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883592|NCT04609748|Analgesics|analgesics|mesh-ancestor
43883593|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
43883594|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883595|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883596|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883597|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883598|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43883599|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883600|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883601|NCT04609540|Trastuzumab|trastuzumab|mesh-list
43883602|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43883603|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883604|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43883605|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883606|NCT04609254|Acetaminophen|acetaminophen|mesh-list
43883607|NCT04609254|Ibuprofen|ibuprofen|mesh-list
43785757|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43883608|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43883609|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883610|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883611|NCT04609254|Analgesics|analgesics|mesh-ancestor
43883612|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
43883613|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389097|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44389098|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389099|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389101|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
44389102|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389103|NCT03308786|Aldesleukin|aldesleukin|mesh-list
44389104|NCT03308786|Interleukin-2|interleukin-2|mesh-list
44389105|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389106|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44389107|NCT03308786|Analgesics|analgesics|mesh-ancestor
44389108|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
44389109|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389110|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389111|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44389112|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44389113|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
44389114|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389115|NCT03307252|Metformin|metformin|mesh-list
44389116|NCT03307252|Rifampin|rifampin|mesh-list
44389117|NCT03307252|Probenecid|probenecid|mesh-list
44389118|NCT03307252|Digoxin|digoxin|mesh-list
44389119|NCT03307252|Verapamil|verapamil|mesh-list
44389120|NCT03307252|Furosemide|furosemide|mesh-list
44389121|NCT03307252|Cimetidine|cimetidine|mesh-list
44389122|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44389123|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389124|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389125|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44389126|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44389127|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
44389128|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389129|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44389130|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44389131|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389132|NCT03307252|Diuretics|diuretics|mesh-ancestor
43694209|NCT02769325|Propofol|propofol|mesh-list
43883614|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883615|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883616|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883617|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44389133|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
44389134|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44389135|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389136|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44389137|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
44389138|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389139|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389140|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
44389141|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44389142|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44389143|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44389144|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44389145|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44389146|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44389147|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44389148|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44389149|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44389150|NCT03307252|Protective Agents|protective agents|mesh-ancestor
44389151|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43840349|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389152|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44389153|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
44389154|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
44389155|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
44389156|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44389157|NCT03307252|Renal Agents|renal agents|mesh-ancestor
44389158|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44389159|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389160|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44389161|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
44389162|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
44389163|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43694226|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883618|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883619|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883620|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
43883621|NCT04609293|Apatinib|apatinib|mesh-list
43883622|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883623|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43883624|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883625|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883626|NCT04609189|Vitamin D|vitamin d|mesh-list
44389164|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44389165|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44389166|NCT03307174|Fentanyl|fentanyl|mesh-list
44389167|NCT03307174|Bupivacaine|bupivacaine|mesh-list
44389168|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
44389169|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
44389170|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389171|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389172|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
44389173|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389174|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44389175|NCT03307174|Narcotics|narcotics|mesh-ancestor
44389176|NCT03307174|Analgesics|analgesics|mesh-ancestor
44389177|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44389178|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44389179|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
44389180|NCT03305666|Bupivacaine|bupivacaine|mesh-list
44389181|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
44389182|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
44389183|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389184|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389185|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
44389186|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389187|NCT03305575|Bupivacaine|bupivacaine|mesh-list
44389188|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
44389189|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
44389190|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
44389191|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389192|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389193|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
44389194|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389195|NCT03305081|Copper|copper|mesh-list
44389196|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
44389197|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44389199|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44389200|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389205|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
44389206|NCT03305055|Fentanyl|fentanyl|mesh-list
44389207|NCT03305055|Ketamine|ketamine|mesh-list
44389208|NCT03305055|Analgesics|analgesics|mesh-ancestor
44389209|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
44389210|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389211|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389212|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44389213|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44389214|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
44389215|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
44389216|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389217|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44389218|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44389219|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389220|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389221|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44389222|NCT03305055|Narcotics|narcotics|mesh-ancestor
44389223|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44389224|NCT03304873|Retapamulin|retapamulin|mesh-list
44389225|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389226|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389227|NCT03304626|Prednisone|prednisone|mesh-list
43883627|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
43883628|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
43883629|NCT04609189|Calcium|calcium|mesh-list
43883630|NCT04609189|Vitamins|vitamins|mesh-ancestor
43883631|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
43883632|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883633|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43883649|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43883650|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883651|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43883652|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
43883653|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
43883654|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
43883655|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
43883656|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883657|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883658|NCT04609033|Ketamine|ketamine|mesh-list
43883659|NCT04609033|Morphine|morphine|mesh-list
43883660|NCT04609033|Bupivacaine|bupivacaine|mesh-list
43883661|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
43883662|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
43883663|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883664|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883665|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
43883666|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883667|NCT04609033|Analgesics|analgesics|mesh-ancestor
43883668|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43883669|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43883670|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
43883671|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43883672|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44389228|NCT03304626|Budesonide|budesonide|mesh-list
44389229|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44389230|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
44389231|NCT03304626|Hormones|hormones|mesh-ancestor
44389232|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840366|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389233|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389234|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44389235|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389236|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44389237|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
44389238|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389239|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44389240|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389241|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44389242|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
43694310|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
43883673|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883674|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883675|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43883676|NCT04609033|Narcotics|narcotics|mesh-ancestor
43883677|NCT04608981|Prednisolone|prednisolone|mesh-list
43883678|NCT04608981|Diclofenac|diclofenac|mesh-list
43883679|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883680|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
43883681|NCT04608981|Hormones|hormones|mesh-ancestor
43883682|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883683|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883684|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43883685|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883686|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883687|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883688|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883689|NCT04608981|Analgesics|analgesics|mesh-ancestor
43883690|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
43883701|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
43883702|NCT04608253|Choline|choline|mesh-list
43883703|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
43883704|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883705|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
43883706|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883707|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883708|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43883709|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
43883710|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43883711|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44156399|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156400|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156401|NCT00230789|Urological Agents|urological agents|mesh-ancestor
44156402|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44156403|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44156404|NCT00230815|Hormones|hormones|mesh-ancestor
44156405|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156406|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156407|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44156408|NCT00230867|Acyclovir|acyclovir|mesh-list
44156409|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
44156410|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156411|NCT00230958|Interferons|interferons|mesh-list
44156412|NCT00230958|Ribavirin|ribavirin|mesh-list
44156413|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
44389243|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389245|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
44389246|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389247|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44389248|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
44389249|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389250|NCT03302559|Vitamin A|vitamin a|mesh-list
44389251|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
44389252|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
44389253|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44389254|NCT03302559|Protective Agents|protective agents|mesh-ancestor
44389255|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389256|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389257|NCT03302559|Vitamins|vitamins|mesh-ancestor
44389258|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
44389259|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
44389260|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389261|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43785822|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44389262|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389263|NCT03302247|Gemcitabine|gemcitabine|mesh-list
44389264|NCT03302247|Nivolumab|nivolumab|mesh-list
44389265|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44389266|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
44389267|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389268|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389269|NCT03302247|Antiviral Agents|antiviral agents|mesh-ancestor
44389270|NCT03302247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44046181|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
44389271|NCT03302247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389272|NCT03302247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44389273|NCT03302247|Immunologic Factors|immunologic factors|mesh-ancestor
44389274|NCT03302247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389275|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389276|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44389277|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
44156414|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
44156415|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44156416|NCT00230958|Taribavirin|taribavirin|mesh-list
44156417|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389279|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389280|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389281|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44389282|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389283|NCT03301649|Ivermectin|ivermectin|mesh-list
44389284|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44389285|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389286|NCT03300570|Dolcanatide|dolcanatide|mesh-list
44389287|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44389288|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
44389289|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389290|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389291|NCT03299244|Cinacalcet|cinacalcet|mesh-list
44389292|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44389293|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389294|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44389295|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
44389296|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389297|NCT03298984|Cytarabine|cytarabine|mesh-list
44389298|NCT03298984|Daunorubicin|daunorubicin|mesh-list
44389299|NCT03298984|Alvocidib|alvocidib|mesh-list
44389300|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44389301|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
44389302|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389303|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389304|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
44389305|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389306|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44389307|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
44389308|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389309|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44389310|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44156418|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
44156419|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156420|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
44156421|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156422|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
44156423|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389312|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389313|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
44389314|NCT03298984|Growth Substances|growth substances|mesh-ancestor
44389315|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44389316|NCT03298412|Blinatumomab|blinatumomab|mesh-list
44389317|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389318|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
44389319|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
44389320|NCT03297398|Androgens|androgens|mesh-list
44389321|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44389322|NCT03297398|Hormones|hormones|mesh-ancestor
44389323|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389324|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389325|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
44389326|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389327|NCT03297398|Protective Agents|protective agents|mesh-ancestor
44389328|NCT03297398|Vitamins|vitamins|mesh-ancestor
44389329|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
44389330|NCT03297398|Estrogens|estrogens|mesh-ancestor
44389331|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44389332|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389333|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
44389334|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44389335|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44389336|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44389337|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
44389338|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389339|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389340|NCT03297216|Progestins|progestins|mesh-ancestor
44389341|NCT03297216|Hormones|hormones|mesh-ancestor
44389342|NCT03297021|Ondansetron|ondansetron|mesh-list
44389343|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
44389344|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
44389345|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389352|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389353|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389354|NCT03297021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44389355|NCT03297021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44389356|NCT03297021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389357|NCT03297021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389358|NCT03297021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44389359|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44389360|NCT03296527|Hormones|hormones|mesh-ancestor
44389361|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389362|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389363|NCT03295721|Bupivacaine|bupivacaine|mesh-list
44389364|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
44389365|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
44389366|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389367|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389368|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
44389369|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389370|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44389371|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44389372|NCT03294538|Estradiol|estradiol|mesh-list
44389373|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44389374|NCT03294538|Estrogens|estrogens|mesh-ancestor
44389375|NCT03294538|Hormones|hormones|mesh-ancestor
44389376|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389377|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389378|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44389379|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
44389380|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44389381|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44389382|NCT03293654|Bevacizumab|bevacizumab|mesh-list
44389383|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389384|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389385|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44389386|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44389389|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
44389390|NCT03293485|Imipenem|imipenem|mesh-list
44389391|NCT03293485|Relebactam|relebactam|mesh-list
44389392|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44389393|NCT03293485|Cilastatin|cilastatin|mesh-list
44389394|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389395|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389396|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
44389397|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389398|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389399|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44389400|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44389401|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43785856|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389402|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389403|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389404|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389405|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
44389406|NCT03292640|Tazarotene|tazarotene|mesh-list
44389407|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389408|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
44389409|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
44389410|NCT03292640|Vitamins|vitamins|mesh-ancestor
44389411|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
44389412|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389413|NCT03292016|Apomorphine|apomorphine|mesh-list
44389414|NCT03292016|Emetics|emetics|mesh-ancestor
44389415|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389416|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
44389417|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156424|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
44156425|NCT00230984|Testosterone|testosterone|mesh-list
44156426|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
44156427|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
44156428|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44156429|NCT00230984|Androgens|androgens|mesh-ancestor
44156430|NCT00230984|Hormones|hormones|mesh-ancestor
44156431|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156432|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156433|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44156434|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389418|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389419|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
44389420|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
44389421|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389422|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389424|NCT03291288|Midazolam|midazolam|mesh-list
44389425|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44389426|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44389427|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389428|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389429|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44389430|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44389431|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389432|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44389433|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
44389434|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
44389435|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
44389436|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
44389437|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389439|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389473|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389474|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44389475|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
44389476|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389477|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44389478|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44389479|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
44389480|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44389481|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44389482|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389483|NCT03288987|Antidotes|antidotes|mesh-ancestor
44389484|NCT03288987|Protective Agents|protective agents|mesh-ancestor
44389485|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
44389487|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
44389488|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
44389489|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
44389490|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389491|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389492|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389493|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
43785863|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
44389494|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
44389495|NCT03287791|Azelaic acid|azelaic acid|mesh-list
44389496|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
44389497|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44389498|NCT03287791|Protective Agents|protective agents|mesh-ancestor
44389499|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389500|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389501|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389502|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44389503|NCT03287635|Hormones|hormones|mesh-ancestor
44389504|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389505|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389506|NCT03287219|Methylene Blue|methylene blue|mesh-list
44389507|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389508|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389511|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389512|NCT03287089|Renal Agents|renal agents|mesh-ancestor
44389513|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389514|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
44389515|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389516|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389517|NCT03286218|Alprazolam|alprazolam|mesh-list
44389518|NCT03286218|Lasmiditan|lasmiditan|mesh-list
44389519|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44389520|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389521|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389522|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44389523|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44389524|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389525|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
44389526|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
44389527|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389528|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389529|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44389530|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
44389531|NCT03285646|Fasinumab|fasinumab|mesh-list
44389532|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44389533|NCT03285646|Analgesics|analgesics|mesh-ancestor
44389534|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
44389535|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389536|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389537|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
44389538|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44389539|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389540|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389541|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43839229|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785872|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785873|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785874|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43785875|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
43785876|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785877|NCT05094323|Bupivacaine|bupivacaine|mesh-list
43785878|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785879|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
43785907|NCT04910230|Vitamins|vitamins|mesh-ancestor
43785908|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
44389542|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389543|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
44389544|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43829738|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44156435|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
44156436|NCT00230997|Galantamine|galantamine|mesh-list
44156437|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44389545|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389546|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
44389547|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389548|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389549|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
44389550|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
44389551|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389552|NCT03283696|Doxorubicin|doxorubicin|mesh-list
44389553|NCT03283696|Ifosfamide|ifosfamide|mesh-list
44389554|NCT03283696|Olaratumab|olaratumab|mesh-list
44389555|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44389556|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389557|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44389558|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44389559|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389560|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389561|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44389562|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
44156438|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156439|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883712|NCT04608006|Fentanyl|fentanyl|mesh-list
43883713|NCT04608006|Bupivacaine|bupivacaine|mesh-list
43883714|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
43883715|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
43883725|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
43883727|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883728|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883729|NCT04607733|Analgesics|analgesics|mesh-ancestor
43883730|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
43883731|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883732|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883733|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883734|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883735|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43883736|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883737|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
43883738|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43883739|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43883740|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883741|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
43883742|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
43883743|NCT04607629|Omalizumab|omalizumab|mesh-list
43883744|NCT04607629|Budesonide|budesonide|mesh-list
43883745|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
43883746|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43883747|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43883748|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883749|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43883750|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
43883751|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883752|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883753|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43883754|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
43883756|NCT04607629|Hormones|hormones|mesh-ancestor
43785918|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
43883757|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883758|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44389563|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
44389564|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
44389565|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44389566|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44389567|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389568|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389569|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389570|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44389571|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
44389572|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389573|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44389574|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
44389575|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
44389576|NCT03282357|Protective Agents|protective agents|mesh-ancestor
44389577|NCT03282240|Vaccines|vaccines|mesh-list
44389578|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
44389579|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389580|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
44389581|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
44389582|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44389583|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44389584|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
44389585|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389586|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389587|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883759|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43883760|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43883761|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883762|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883763|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883764|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43883765|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
43883766|NCT04607447|Dexamethasone|dexamethasone|mesh-list
43883767|NCT04607447|Atorvastatin|atorvastatin|mesh-list
43883768|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883769|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
43883770|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
43883771|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883772|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883773|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883774|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
43883775|NCT04607447|Hormones|hormones|mesh-ancestor
43883776|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883777|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43883778|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883779|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43883780|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883781|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
43883790|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883791|NCT04607525|Analgesics|analgesics|mesh-ancestor
44389588|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389589|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44389590|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389591|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44389592|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
44389593|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389594|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389595|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
43785925|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
44389596|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389597|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389598|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44389599|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44389600|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389601|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
44389602|NCT03281304|Tofacitinib|tofacitinib|mesh-list
44389603|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44389604|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389605|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44046564|NCT00003269|Cisplatin|cisplatin|mesh-list
44389606|NCT03280550|Omalizumab|omalizumab|mesh-list
44389607|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44389608|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44389609|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389610|NCT03280537|Omalizumab|omalizumab|mesh-list
44389611|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44389636|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389637|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44389638|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44389639|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44389640|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
44389641|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389642|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389644|NCT03276026|Neostigmine|neostigmine|mesh-list
44389645|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44389646|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389647|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389648|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
44389649|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389650|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389651|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44389652|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
44389653|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389654|NCT03275350|Naltrexone|naltrexone|mesh-list
44389655|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44389656|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44389657|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389658|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
44389659|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389660|NCT03274687|Androgens|androgens|mesh-list
44389661|NCT03274687|Hormones|hormones|mesh-ancestor
44389662|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389663|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883792|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
43883793|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883794|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43883795|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43883796|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43883797|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883798|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883799|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883800|NCT04607642|Manganese|manganese|mesh-list
43883801|NCT04607642|Cisplatin|cisplatin|mesh-list
43883802|NCT04607642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883803|NCT04607642|Trace Elements|trace elements|mesh-ancestor
43883804|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
43883805|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883806|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
43883807|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43883808|NCT04606836|Bupivacaine|bupivacaine|mesh-list
43883809|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785986|NCT04315311|Pancrelipase|pancrelipase|mesh-list
44389664|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44389666|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389667|NCT03274453|Ketamine|ketamine|mesh-list
44389668|NCT03274453|Analgesics|analgesics|mesh-ancestor
44389669|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
44389670|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389671|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389672|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44389673|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44389674|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
44389675|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
44389676|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389677|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44389678|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44389679|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389680|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389681|NCT03274076|Tofacitinib|tofacitinib|mesh-list
44389682|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44389683|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43694633|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43883810|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
43883811|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43883812|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883813|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
43883814|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883815|NCT04606563|Losartan|losartan|mesh-list
43883816|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883817|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883818|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43883819|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43883820|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883821|NCT04606537|Itraconazole|itraconazole|mesh-list
43883822|NCT04606537|Rifampin|rifampin|mesh-list
43883823|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
43883824|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43883825|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43883826|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43883827|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883828|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883829|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43883830|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
43883831|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883832|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883833|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43883834|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43883835|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
43883836|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43883837|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
43883838|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43883839|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44389684|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389685|NCT03273946|Fluticasone|fluticasone|mesh-list
44389686|NCT03273946|Xhance|xhance|mesh-list
44389687|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44389688|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44389689|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
44389690|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389691|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389692|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44389693|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389694|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389695|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44389696|NCT03273387|Trimetazidine|trimetazidine|mesh-list
44389697|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
44389698|NCT03273257|Riociguat|riociguat|mesh-list
44389699|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
44389700|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43639509|NCT03214510|Fentanyl|fentanyl|mesh-list
43883840|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43883841|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43785998|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883842|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43883843|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43883853|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883854|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43883855|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43883856|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883857|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43883858|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883859|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883860|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43883861|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883862|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883863|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
43883864|NCT04606017|Antacids|antacids|mesh-ancestor
43883865|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883866|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43883867|NCT04605770|Cisplatin|cisplatin|mesh-list
43883868|NCT04605770|Pemetrexed|pemetrexed|mesh-list
43883869|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883870|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883871|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883872|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43883873|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43883874|NCT04605705|Chrysarobin|chrysarobin|mesh-list
43883875|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43883876|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43883877|NCT04605705|Analgesics|analgesics|mesh-ancestor
43883878|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
43883879|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883880|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883881|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43883882|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883883|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43883884|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883885|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
43883886|NCT04605952|Antibodies|antibodies|mesh-list
44389701|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
44389702|NCT03273153|Atezolizumab|atezolizumab|mesh-list
44389703|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44389704|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389705|NCT03272347|Tenofovir|tenofovir|mesh-list
44389706|NCT03272347|Lamivudine|lamivudine|mesh-list
44389707|NCT03272347|Islatravir|islatravir|mesh-list
44389708|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
44389709|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389710|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44389711|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44389712|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389713|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389714|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44389715|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44389716|NCT03271528|Lacosamide|lacosamide|mesh-list
44389717|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
44389718|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44389719|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44389720|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389722|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44389755|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44389756|NCT03269552|Antibodies|antibodies|mesh-list
44389757|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
44389758|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44389759|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
44389760|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389761|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389762|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44389763|NCT03268941|Metoclopramide|metoclopramide|mesh-list
44389764|NCT03268941|Maleic acid|maleic acid|mesh-list
44389765|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389766|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389767|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
44389768|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
44389769|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389770|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389771|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389772|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44389773|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44389774|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
44389775|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389776|NCT03267940|Atezolizumab|atezolizumab|mesh-list
44389777|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389778|NCT03267576|Metformin|metformin|mesh-list
44389779|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44389780|NCT03267576|Canagliflozin|canagliflozin|mesh-list
44389781|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389782|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389783|NCT03267576|Incretins|incretins|mesh-ancestor
44389784|NCT03267576|Hormones|hormones|mesh-ancestor
44389785|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389786|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44389787|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
44389788|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883887|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
43883888|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
43883889|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883890|NCT04605562|Palbociclib|palbociclib|mesh-list
43883891|NCT04605562|Antibodies|antibodies|mesh-list
43883892|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
43883893|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
44163843|NCT00254033|Methylphenidate|methylphenidate|mesh-list
44389789|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389790|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44389791|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44389792|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44389793|NCT03264066|Atezolizumab|atezolizumab|mesh-list
44389794|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44389795|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389796|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
44389797|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389798|NCT03263442|Thiamine|thiamine|mesh-list
44389799|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
44389800|NCT03263442|Vitamins|vitamins|mesh-ancestor
44389801|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
44389802|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389803|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
44389804|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44389805|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389806|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44389807|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
44389808|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389809|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389810|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389811|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389812|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44389813|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43694731|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43883894|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883895|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883896|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43883897|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883898|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883899|NCT04605419|Calcium|calcium|mesh-list
43883900|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43883901|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883902|NCT04605575|Vinorelbine|vinorelbine|mesh-list
43883903|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43883904|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883905|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
43883906|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
43850056|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
44156447|NCT00231023|Triamcinolone|triamcinolone|mesh-list
44156448|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44156449|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44156450|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44156451|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156452|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
44156453|NCT00231023|Hormones|hormones|mesh-ancestor
44156454|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389814|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389815|NCT03262233|Nicotine|nicotine|mesh-list
44389816|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44389817|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
44389818|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389819|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389820|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44389821|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44389822|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44389823|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389824|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389825|NCT03262038|Ondansetron|ondansetron|mesh-list
44389826|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
44389827|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
44389828|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389829|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389830|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44389831|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
44389832|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
44389833|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44389834|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
44389835|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389836|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389837|NCT03262038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44389838|NCT03262038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44389839|NCT03262038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44389840|NCT03262038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44389841|NCT03262038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43694755|NCT02767024|Diuretics|diuretics|mesh-ancestor
44156455|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156456|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156457|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
44156458|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156459|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156460|NCT00231075|Paclitaxel|paclitaxel|mesh-list
44156461|NCT00231075|Carboplatin|carboplatin|mesh-list
44156462|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44156463|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156464|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
43883909|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43883910|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43883911|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883912|NCT04604938|Losartan|losartan|mesh-list
43883913|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883914|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883915|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44389842|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44389843|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44389844|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
44389846|NCT03261336|Calcitriol|calcitriol|mesh-list
44389847|NCT03261336|Ketoconazole|ketoconazole|mesh-list
44389848|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
44389849|NCT03261336|Vitamins|vitamins|mesh-ancestor
44389850|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
44389851|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389852|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44389853|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44389854|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44389855|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
44389856|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389857|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44389858|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44389859|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389860|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389861|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44389862|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
44389863|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43883916|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43883917|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883918|NCT04604756|Losartan|losartan|mesh-list
43883919|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43883920|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43883921|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43883922|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43883923|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883924|NCT04604886|Dobutamine|dobutamine|mesh-list
43883925|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43883926|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
43883927|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
43883928|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883929|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883930|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43883931|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43883932|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43883933|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883934|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883935|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883936|NCT04604886|Protective Agents|protective agents|mesh-ancestor
43883937|NCT04604678|Metformin|metformin|mesh-list
43883938|NCT04604678|Naltrexone|naltrexone|mesh-list
43883939|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883940|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883941|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43883942|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43883943|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
44163844|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
44389864|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44389865|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44389866|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389867|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44389868|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
44389869|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44389870|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44389871|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44389872|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389873|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389874|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44389875|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389876|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389877|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44389878|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44389880|NCT03260894|Sunitinib|sunitinib|mesh-list
44389881|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786026|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786027|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389882|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389883|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44389884|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44389885|NCT03260894|Growth Substances|growth substances|mesh-ancestor
44389886|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389887|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
44389888|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44389889|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389890|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389891|NCT03260868|Insulin|insulin|mesh-list
44389892|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44389893|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
44389894|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
44389895|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
44389896|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389897|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389898|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
43883944|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883945|NCT04604795|Itraconazole|itraconazole|mesh-list
43883946|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
44389899|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44389900|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389901|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44389902|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44389903|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44389904|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389906|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389907|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
44389908|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389909|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389910|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
44389911|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
44389912|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389913|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389914|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389915|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
44389916|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
44389917|NCT03259490|Metformin|metformin|mesh-list
44389918|NCT03259490|Empagliflozin|empagliflozin|mesh-list
44389919|NCT03259490|Linagliptin|linagliptin|mesh-list
44389920|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44389921|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389922|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44389923|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389924|NCT03259490|Incretins|incretins|mesh-ancestor
44389925|NCT03259490|Hormones|hormones|mesh-ancestor
44389926|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44389930|NCT03258762|Leucovorin|leucovorin|mesh-list
44389945|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44389946|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389947|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389948|NCT03258710|Tenofovir|tenofovir|mesh-list
44389949|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
44389950|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389951|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44389952|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44389953|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389954|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389955|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44389956|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44389957|NCT03257995|Maleic acid|maleic acid|mesh-list
44389958|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389959|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389960|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
44389961|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
44389962|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44389963|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389964|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389965|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
44389966|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
44389967|NCT03257813|Timolol|timolol|mesh-list
44389968|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44389969|NCT03257813|Dorzolamide|dorzolamide|mesh-list
44389970|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44389971|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44389972|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
43883956|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43883958|NCT04604509|Nicotine|nicotine|mesh-list
43883959|NCT04604509|Varenicline|varenicline|mesh-list
43883960|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43883961|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
43883962|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43883963|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883964|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43883965|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43883966|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
43883967|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43883968|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883969|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43883970|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
43883971|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43883972|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44389974|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44389975|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389976|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44389977|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44389978|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44389979|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44389980|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44389981|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44389982|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44389983|NCT03257631|Thalidomide|thalidomide|mesh-list
44389984|NCT03257631|Pomalidomide|pomalidomide|mesh-list
44389985|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
44389986|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44389987|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44389988|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44389989|NCT03257631|Growth Substances|growth substances|mesh-ancestor
44389990|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
44389991|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44389992|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44389993|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
44389994|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44389995|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44389996|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44046998|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
44389997|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43883973|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43883974|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43883975|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
43883976|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43883977|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43883978|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43883979|NCT04604327|Bemiparin|bemiparin|mesh-list
43883980|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
43883981|NCT04604223|Pioglitazone|pioglitazone|mesh-list
43883982|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43883983|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883984|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
43883985|NCT04604028|Lenalidomide|lenalidomide|mesh-list
43883986|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43883987|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
43883988|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43883989|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43883990|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43883991|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
43883992|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786030|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786031|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786032|NCT04196075|Analgesics|analgesics|mesh-ancestor
43786033|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
44389998|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390000|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
44390001|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390003|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390004|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390005|NCT03256695|Albuterol|albuterol|mesh-list
44390006|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44390007|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
44390008|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390009|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390010|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44390011|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
44390012|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
44390013|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390014|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44390015|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44390016|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44390017|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
44390018|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390019|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390020|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
44390021|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390022|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44390023|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44390024|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390025|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390028|NCT03255824|Fentanyl|fentanyl|mesh-list
44390045|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
44390046|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390047|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390048|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44390050|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390051|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44390052|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44390053|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44390054|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
44390055|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
44390056|NCT03255629|Glucagon|glucagon|mesh-list
44390057|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44390058|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390059|NCT03255629|Hormones|hormones|mesh-ancestor
44390060|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390061|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390062|NCT03255629|Incretins|incretins|mesh-ancestor
44390063|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44390064|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
44390065|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390066|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
44390067|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390068|NCT03254485|Praliciguat|praliciguat|mesh-list
44390069|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44390070|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
44047073|NCT00003337|Epratuzumab|epratuzumab|mesh-list
44390071|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883993|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43883994|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43883995|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43883996|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43883997|NCT04604028|Growth Substances|growth substances|mesh-ancestor
43883998|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
43883999|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43884000|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43884001|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884002|NCT04603729|Dexamethasone|dexamethasone|mesh-list
43884003|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
43884004|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43884005|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43884007|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
43884008|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43884019|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884020|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884021|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43884022|NCT04603729|Protective Agents|protective agents|mesh-ancestor
43884023|NCT04603976|Erenumab|erenumab|mesh-list
44390074|NCT03254459|Oxycodone|oxycodone|mesh-list
44390075|NCT03254459|Buprenorphine|buprenorphine|mesh-list
44390076|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44390077|NCT03254459|Narcotics|narcotics|mesh-ancestor
44390078|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390079|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390080|NCT03254459|Analgesics|analgesics|mesh-ancestor
44390081|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
44390082|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390083|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44390084|NCT03254134|Warfarin|warfarin|mesh-list
44390085|NCT03254134|Dabigatran|dabigatran|mesh-list
44390086|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
44390087|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
44390088|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44390089|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
44390090|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390091|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390092|NCT03254108|Tolvaptan|tolvaptan|mesh-list
44390093|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44390094|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390095|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
44390096|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390097|NCT03253796|Golimumab|golimumab|mesh-list
44390098|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43884024|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43884025|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884026|NCT04603976|Analgesics|analgesics|mesh-ancestor
43884027|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
43884028|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884029|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884030|NCT04603833|Docetaxel|docetaxel|mesh-list
43884031|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884032|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43884033|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
43884034|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
43884035|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884036|NCT04603872|Dasatinib|dasatinib|mesh-list
43884037|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884038|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43884039|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884040|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884041|NCT04603924|Niclosamide|niclosamide|mesh-list
43884042|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
43884043|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43884044|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
43884045|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43884046|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390099|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390100|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390101|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
44390102|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390104|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
44390105|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
44390106|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390107|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44390108|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44390109|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390110|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390111|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44390112|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44390113|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390114|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390115|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44390116|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44390117|NCT03252522|Micronutrients|micronutrients|mesh-list
44390118|NCT03252522|Trace Elements|trace elements|mesh-list
44390119|NCT03252522|Antioxidants|antioxidants|mesh-list
44390120|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390121|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390122|NCT03252522|Protective Agents|protective agents|mesh-ancestor
44390123|NCT03252015|Lasmiditan|lasmiditan|mesh-list
44390124|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44390125|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
44390126|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390127|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390128|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390129|NCT03251963|Enoxaparin|enoxaparin|mesh-list
43884047|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
43884048|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
43884049|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43884050|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
43884051|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43884052|NCT04603794|Povidone|povidone|mesh-list
43884053|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43884054|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884055|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
43884056|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884057|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
44390130|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
44390131|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
44390132|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44390133|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44390134|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390135|NCT03251482|Apixaban|apixaban|mesh-list
44390136|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44390137|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
44390138|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44390139|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
44390140|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390141|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390142|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
44390143|NCT03250273|Nivolumab|nivolumab|mesh-list
44390144|NCT03250273|Entinostat|entinostat|mesh-list
44047152|NCT00003345|Cisplatin|cisplatin|mesh-list
44390145|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390146|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390147|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390148|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390149|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44390150|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390151|NCT03250182|Budesonide|budesonide|mesh-list
44390152|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
44390153|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
44390154|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390155|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44390156|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
43786055|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
44390157|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390158|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390159|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44390160|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44390161|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
44390162|NCT03250182|Hormones|hormones|mesh-ancestor
44390163|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390168|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390169|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390170|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390171|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44390172|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44390173|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390174|NCT03249935|Azithromycin|azithromycin|mesh-list
44390175|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390176|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390177|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44390178|NCT03249909|Laxatives|laxatives|mesh-ancestor
44390179|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44047227|NCT00003353|Melphalan|melphalan|mesh-list
44390180|NCT03247673|Bevacizumab|bevacizumab|mesh-list
44390181|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390182|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390183|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44390184|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44390185|NCT03247673|Growth Substances|growth substances|mesh-ancestor
44390186|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390187|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884058|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
43884059|NCT04603664|Cystatins|cystatins|mesh-list
43884060|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43884061|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884062|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884063|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884064|NCT04603573|Listerine|listerine|mesh-list
43884065|NCT04603573|Fluorides|fluorides|mesh-list
43884066|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
43884067|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
43884068|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
43884069|NCT04603573|Protective Agents|protective agents|mesh-ancestor
43884070|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884071|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43884072|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884073|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
43884074|NCT04603456|Antacids|antacids|mesh-ancestor
43884085|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884086|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
43884087|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884088|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43884089|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
43884090|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884091|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884092|NCT04603066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43884093|NCT04603066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43884094|NCT04603066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884095|NCT04603066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43884096|NCT04603066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43884097|NCT04602767|Phenylephrine|phenylephrine|mesh-list
43884098|NCT04602767|Vasopressins|vasopressins|mesh-list
43884099|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
43884100|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
43884101|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43884102|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
44390188|NCT03246724|Midazolam|midazolam|mesh-list
44390189|NCT03246724|Triazolam|triazolam|mesh-list
44390190|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390191|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43786075|NCT04169828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44390192|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390193|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390194|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44390195|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44390196|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44390197|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44390198|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
44390199|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
44390200|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
44390201|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
44390202|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390203|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390204|NCT03246152|Bevacizumab|bevacizumab|mesh-list
44390205|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390206|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390207|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44390208|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44390209|NCT03246152|Growth Substances|growth substances|mesh-ancestor
44390210|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390211|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44390212|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
44390213|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390214|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390215|NCT03245450|Irinotecan|irinotecan|mesh-list
44390216|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44390217|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44390218|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390219|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390220|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884103|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
43884104|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884105|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884106|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
43884107|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43884108|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
43884109|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
43884110|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44390223|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
44390224|NCT03245398|DMP 777|dmp 777|mesh-list
44390225|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
44390226|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
44390227|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44390228|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390229|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
44390230|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390231|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
44390232|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390233|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390234|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390235|NCT03244618|Fluorides|fluorides|mesh-list
44390236|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
44390237|NCT03244618|Protective Agents|protective agents|mesh-ancestor
44390238|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390239|NCT03243630|Menthol|menthol|mesh-list
44390240|NCT03243630|Nicotine|nicotine|mesh-list
44390241|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44390242|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
44390243|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390244|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390245|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44390246|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44390247|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390248|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390249|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884111|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43884112|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43884113|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
43884114|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884115|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884116|NCT04602767|Protective Agents|protective agents|mesh-ancestor
43884117|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
43884118|NCT04602767|Coagulants|coagulants|mesh-ancestor
43884119|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43884120|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
44156465|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
44156466|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156467|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156468|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44156469|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156470|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156471|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156472|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156473|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390252|NCT03242759|Pirfenidone|pirfenidone|mesh-list
44390253|NCT03242759|Nintedanib|nintedanib|mesh-list
44390254|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390255|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44047314|NCT00003367|Vitamin E|vitamin e|mesh-list
44390256|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390257|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390258|NCT03242759|Analgesics|analgesics|mesh-ancestor
44390259|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
44390260|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390261|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390262|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44390263|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44390264|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390265|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390266|NCT03242434|Mannitol|mannitol|mesh-list
44390267|NCT03242434|Lactulose|lactulose|mesh-list
44390268|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44390269|NCT03242434|Diuretics|diuretics|mesh-ancestor
44390270|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
44390271|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390272|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390273|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44390274|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44390275|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390276|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390277|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412310|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695044|NCT02764749|Phenol|phenol|mesh-list
44156474|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156475|NCT00231140|Thalidomide|thalidomide|mesh-list
44156476|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156477|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
43884121|NCT04602273|Azacitidine|azacitidine|mesh-list
43884122|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43884123|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
43884124|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884125|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390278|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44390279|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44390280|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390281|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390282|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390283|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
44390284|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390285|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390286|NCT03241173|Nivolumab|nivolumab|mesh-list
44390287|NCT03241173|Ipilimumab|ipilimumab|mesh-list
44390288|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390289|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390290|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390291|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390292|NCT03240575|Fluticasone|fluticasone|mesh-list
44390293|NCT03240575|Xhance|xhance|mesh-list
44390294|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
44390295|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44390296|NCT03240575|Olodaterol|olodaterol|mesh-list
44390297|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390298|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44390299|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
44390300|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390301|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390302|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44390303|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
44390304|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
44390305|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43884139|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884140|NCT04601961|Propofol|propofol|mesh-list
43884141|NCT04601961|Sevoflurane|sevoflurane|mesh-list
43884142|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43884143|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884144|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884145|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43884146|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
43884147|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
43884148|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43884149|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43884150|NCT04602013|Paclitaxel|paclitaxel|mesh-list
43884151|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43884152|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43884153|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884154|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
43884155|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390306|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
44390307|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44390308|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390309|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390310|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390311|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44390312|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44390313|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44390314|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
44390315|NCT03240133|Berotralstat|berotralstat|mesh-list
44390316|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390317|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390318|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44390319|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44390320|NCT03240081|Estradiol|estradiol|mesh-list
44390321|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44390322|NCT03240081|Estrogens|estrogens|mesh-ancestor
44390323|NCT03240081|Hormones|hormones|mesh-ancestor
44390324|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390325|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390326|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44047381|NCT00003378|Gemcitabine|gemcitabine|mesh-list
44390327|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
44390328|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43884156|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
43884157|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884158|NCT04601688|Dexamethasone|dexamethasone|mesh-list
43884159|NCT04601688|Bevacizumab|bevacizumab|mesh-list
43884160|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884161|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884162|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43884163|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43884164|NCT04601688|Growth Substances|growth substances|mesh-ancestor
43884165|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884166|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884167|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884168|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
43884169|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
43884170|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884171|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884172|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
43884173|NCT04601688|Hormones|hormones|mesh-ancestor
43884174|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884175|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884176|NCT04601701|Dexamethasone|dexamethasone|mesh-list
43884177|NCT04601701|Bevacizumab|bevacizumab|mesh-list
43884178|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884179|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884180|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44390329|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44390331|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44390332|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44390333|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
44390334|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390335|NCT03238924|Oxytocin|oxytocin|mesh-list
44390336|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
44390337|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390338|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390339|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44390340|NCT03238911|Hematinics|hematinics|mesh-ancestor
44390341|NCT03238352|Listerine|listerine|mesh-list
44390342|NCT03238352|Fluorides|fluorides|mesh-list
44390343|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
44390344|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
44390345|NCT03238352|Protective Agents|protective agents|mesh-ancestor
44390346|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390347|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44390348|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390349|NCT03237481|Bupivacaine|bupivacaine|mesh-list
44390350|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44390351|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
44390352|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390353|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390354|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
44390383|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44390384|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44390385|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
44390386|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390387|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44390388|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44390389|NCT03233438|Dalbavancin|dalbavancin|mesh-list
44390390|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390391|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390392|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44390393|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44390394|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
44390395|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390396|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390397|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44390398|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
44390399|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44390400|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
44390401|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44047464|NCT00003387|Paclitaxel|paclitaxel|mesh-list
44390402|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390403|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44390404|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44390405|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390406|NCT03231709|Alogliptin|alogliptin|mesh-list
44390407|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390408|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390409|NCT03231709|Incretins|incretins|mesh-ancestor
44390410|NCT03231709|Hormones|hormones|mesh-ancestor
44390411|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390427|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390429|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390430|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390431|NCT03230864|Olanzapine|olanzapine|mesh-list
44390432|NCT03230864|Risperidone|risperidone|mesh-list
44390433|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44390434|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
44390435|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390436|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390437|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390438|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44390439|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44390440|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390441|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44390442|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44390443|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
44390444|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
44390445|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
44390446|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390447|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390448|NCT03230864|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44390449|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44390450|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44390451|NCT03230838|Meropenem|meropenem|mesh-list
44390452|NCT03230838|Tazobactam|tazobactam|mesh-list
44390453|NCT03230838|Ceftolozane|ceftolozane|mesh-list
43884181|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43884182|NCT04601701|Growth Substances|growth substances|mesh-ancestor
43884183|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884184|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884185|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884186|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
43884187|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
43884188|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884193|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884195|NCT04601675|Ranibizumab|ranibizumab|mesh-list
43884196|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884197|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
43884198|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
43884199|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884200|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884201|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884202|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
43884204|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884205|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884206|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884207|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43884208|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44390454|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44390455|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390456|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390457|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44390458|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390459|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390460|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44390461|NCT03230838|Renal Agents|renal agents|mesh-ancestor
44390462|NCT03229759|Octenidine|octenidine|mesh-list
44390463|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390464|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44390465|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
44390466|NCT03229486|Neostigmine|neostigmine|mesh-list
44390467|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44390468|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390469|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390470|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390471|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390472|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390473|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44390474|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
44390475|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390476|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390477|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44390479|NCT03226275|Amlodipine|amlodipine|mesh-list
44390503|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44390504|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44390505|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390506|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44390507|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44390508|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390509|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390510|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390511|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44390512|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
44390513|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44390514|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44390515|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
44390516|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390517|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
44390518|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
44390519|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
44390520|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390522|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390523|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
44390524|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43786093|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390525|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
44390526|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390527|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
44390528|NCT03223909|Protective Agents|protective agents|mesh-ancestor
44390529|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
44390530|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44390531|NCT03222531|Velpatasvir|velpatasvir|mesh-list
44390532|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
43695231|NCT02763007|Pioglitazone|pioglitazone|mesh-list
43884209|NCT04601675|Growth Substances|growth substances|mesh-ancestor
43884210|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884211|NCT04601324|Fluticasone|fluticasone|mesh-list
43884212|NCT04601324|Xhance|xhance|mesh-list
43884213|NCT04601324|Azelastine|azelastine|mesh-list
43884214|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884215|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43884216|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
43884217|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884218|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884219|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884220|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
43884221|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884222|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43884223|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44390533|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390535|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44390536|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
44390537|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
44390538|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
44390539|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390540|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390541|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390542|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44390543|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390544|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44390545|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44390546|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44390547|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44390548|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44390549|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44390550|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
44390551|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
44390552|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
44390553|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
44390554|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390555|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390556|NCT03221842|Complement C1s|complement c1s|mesh-list
44390557|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44390558|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44390559|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
44390560|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390561|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44390562|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390563|NCT03219723|Amoxicillin|amoxicillin|mesh-list
44390564|NCT03219723|Metronidazole|metronidazole|mesh-list
44390565|NCT03219723|Clarithromycin|clarithromycin|mesh-list
44390574|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44390576|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44390577|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44390578|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
44390579|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390580|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44390581|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44390582|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390583|NCT03217591|Praliciguat|praliciguat|mesh-list
44390584|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44390585|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
44390586|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390587|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390588|NCT03217175|Glucagon|glucagon|mesh-list
44390589|NCT03217175|Pancrelipase|pancrelipase|mesh-list
44390590|NCT03217175|Pancreatin|pancreatin|mesh-list
44390591|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390592|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390593|NCT03217175|Hormones|hormones|mesh-ancestor
43653935|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390594|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390595|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
44390596|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44390597|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
44390598|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390599|NCT03216954|Expectorants|expectorants|mesh-ancestor
44390600|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
44390601|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44390602|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
44390603|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390604|NCT03216954|Protective Agents|protective agents|mesh-ancestor
44390605|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390606|NCT03216954|Antidotes|antidotes|mesh-ancestor
43884224|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884225|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884226|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43884227|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43884228|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
43884229|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
43884230|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884231|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
43884232|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44390607|NCT03216226|Glucagon|glucagon|mesh-list
44390608|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390609|NCT03216226|Hormones|hormones|mesh-ancestor
44390610|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390611|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390612|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
44390613|NCT03215810|Nivolumab|nivolumab|mesh-list
44390614|NCT03215810|Fludarabine|fludarabine|mesh-list
44390615|NCT03215810|Interleukin-2|interleukin-2|mesh-list
44390616|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390617|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
44390618|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390619|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390620|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44390621|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
44390622|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390623|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390624|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44390625|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390626|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390627|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44390628|NCT03215810|Analgesics|analgesics|mesh-ancestor
44390629|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
44390630|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390631|NCT03215706|Paclitaxel|paclitaxel|mesh-list
44390632|NCT03215706|Cisplatin|cisplatin|mesh-list
44390633|NCT03215706|Carboplatin|carboplatin|mesh-list
44390634|NCT03215706|Nivolumab|nivolumab|mesh-list
44390635|NCT03215706|Pemetrexed|pemetrexed|mesh-list
44390636|NCT03215706|Ipilimumab|ipilimumab|mesh-list
44390637|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43884233|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43884234|NCT04601142|Prednisolone|prednisolone|mesh-list
43884235|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
43884236|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43884237|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
43884238|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884239|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
43884240|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
43884241|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884242|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884243|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884244|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
43884245|NCT04601142|Hormones|hormones|mesh-ancestor
43884246|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884247|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43884248|NCT04601142|Protective Agents|protective agents|mesh-ancestor
44390638|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390639|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
44390640|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
44390641|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
44390642|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390643|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390644|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390645|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390646|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44390647|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44390648|NCT03214380|Insulin|insulin|mesh-list
44390649|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44390650|NCT03214380|Metformin|metformin|mesh-list
44390651|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
44390652|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
44390653|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44390654|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390655|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390656|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390657|NCT03214367|Insulin|insulin|mesh-list
44390658|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44390659|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
44390660|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
44390661|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390662|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390663|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44390664|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390665|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44390666|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390668|NCT03213457|Norethindrone|norethindrone|mesh-list
44390683|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44390684|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
44390686|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
44390687|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44390688|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390689|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390690|NCT03211156|Amoxicillin|amoxicillin|mesh-list
44390691|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390692|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390693|NCT03210259|Adalimumab|adalimumab|mesh-list
44390694|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390695|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390696|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
44390697|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
44390698|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
44390699|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44390700|NCT03209570|Protective Agents|protective agents|mesh-ancestor
44390701|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390702|NCT03209518|Leuprolide|leuprolide|mesh-list
44390703|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44390704|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
44390705|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390706|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390707|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44390708|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390709|NCT03209492|Leuprolide|leuprolide|mesh-list
44390710|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44390711|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
44390712|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44390713|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390714|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44390715|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390716|NCT03208933|Pirfenidone|pirfenidone|mesh-list
44390717|NCT03208933|Analgesics|analgesics|mesh-ancestor
44390718|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
44390719|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884249|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884250|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884251|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
44390720|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390721|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44390722|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44390723|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390725|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390726|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
44390727|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390728|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
44390729|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390730|NCT03207750|Vaccines|vaccines|mesh-list
44390731|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44390732|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
44390733|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390734|NCT03207451|Aspirin|aspirin|mesh-list
44390735|NCT03207451|Clopidogrel|clopidogrel|mesh-list
44390736|NCT03207451|Vorapaxar|vorapaxar|mesh-list
44390737|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44390738|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44390739|NCT03207451|Analgesics|analgesics|mesh-ancestor
44390740|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
44390741|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390742|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390743|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884252|NCT04601259|Salicylates|salicylates|mesh-list
43884253|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884254|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
43884255|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
43884256|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884257|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43884258|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884259|NCT04601259|Analgesics|analgesics|mesh-ancestor
43884260|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
43884268|NCT04601389|Omalizumab|omalizumab|mesh-list
43884269|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43884270|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43884271|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884272|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
43884273|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
43827037|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
43884274|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884275|NCT04601116|Atorvastatin|atorvastatin|mesh-list
43884276|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43884277|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43884278|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
43884279|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884280|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43884281|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43884282|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884284|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43884285|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390744|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390745|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44390746|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44390747|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390748|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44390749|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44390750|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390751|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
44390752|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44390753|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44390754|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44390755|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
44390756|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390757|NCT03207243|Fluticasone|fluticasone|mesh-list
44390759|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44390760|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390761|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44390762|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
44390763|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390764|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390765|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44390766|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44390767|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
44390768|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44390769|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44390770|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44390771|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44390772|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44390773|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390789|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44390790|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390791|NCT03205566|Lamivudine|lamivudine|mesh-list
44390792|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
44390793|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44390794|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44390795|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390796|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390797|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
44047890|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
44390798|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390799|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44390800|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44390801|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44390802|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44390803|NCT03205163|Factor VIII|factor viii|mesh-list
44390804|NCT03205163|Coagulants|coagulants|mesh-ancestor
44390805|NCT03205150|Licogliflozin|licogliflozin|mesh-list
44390806|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44390807|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43695439|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
43884286|NCT04600167|Isoniazid|isoniazid|mesh-list
43884287|NCT04600167|Rifapentine|rifapentine|mesh-list
43884288|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
43884289|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43884290|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884291|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43884292|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43884293|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
43884294|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884295|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43884296|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43884297|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
43884298|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43884299|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43884300|NCT04600271|Norepinephrine|norepinephrine|mesh-list
43884301|NCT04600271|Analgesics|analgesics|mesh-list
43884302|NCT04600271|Diuretics|diuretics|mesh-list
43884303|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
43884304|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884305|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884306|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
43884307|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43884308|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43884309|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
43884310|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884311|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884312|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
43884313|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
43884314|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44390809|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390810|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
44390811|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390812|NCT03204812|Durvalumab|durvalumab|mesh-list
44390813|NCT03204812|Ipilimumab|ipilimumab|mesh-list
44390814|NCT03204812|Tremelimumab|tremelimumab|mesh-list
44390815|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
44390816|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44390817|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
44390818|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390819|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390820|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
44390821|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390822|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390823|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390824|NCT03204279|Palonosetron|palonosetron|mesh-list
44390825|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
44390826|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
44390827|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390828|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390829|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390830|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44390831|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44390832|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
44390833|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884315|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884316|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884317|NCT04600089|Ketamine|ketamine|mesh-list
43884318|NCT04600089|Analgesics|analgesics|mesh-ancestor
43884319|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
43884320|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884321|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884322|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43884323|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43884324|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
43884325|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
43884326|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884340|NCT04600115|Adenosine|adenosine|mesh-list
43884341|NCT04600115|Regadenoson|regadenoson|mesh-list
43884342|NCT04600115|Analgesics|analgesics|mesh-ancestor
43884343|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
43884344|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884345|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884346|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43884347|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
43884348|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43884349|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
43884350|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
44390834|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390835|NCT03203473|Nivolumab|nivolumab|mesh-list
44390836|NCT03203473|Ipilimumab|ipilimumab|mesh-list
44390837|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390838|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390839|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44390840|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390841|NCT03203447|Triamcinolone|triamcinolone|mesh-list
44390842|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44390843|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44390844|NCT03203447|Bevacizumab|bevacizumab|mesh-list
44390845|NCT03203447|Ranibizumab|ranibizumab|mesh-list
44390846|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44390847|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44390848|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390849|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44390850|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44390851|NCT03203447|Growth Substances|growth substances|mesh-ancestor
44390852|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390853|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
44390854|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44390855|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
44390856|NCT03203447|Hormones|hormones|mesh-ancestor
44390857|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390858|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390859|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
44390860|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390861|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884351|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884352|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884353|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43884355|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
43884356|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884357|NCT04600037|Pregabalin|pregabalin|mesh-list
43884358|NCT04600037|Analgesics|analgesics|mesh-ancestor
43884359|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
43884360|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884361|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884362|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
43884363|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43884364|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43884365|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884366|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44390862|NCT03202511|Tenofovir|tenofovir|mesh-list
44390863|NCT03202511|Emtricitabine|emtricitabine|mesh-list
44390864|NCT03202511|Probenecid|probenecid|mesh-list
44390865|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
44390866|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390867|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44390868|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44390869|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390870|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390871|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44390872|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44390873|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
44390874|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
44390875|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390876|NCT03202511|Renal Agents|renal agents|mesh-ancestor
44390877|NCT03201562|Tropicamide|tropicamide|mesh-list
44390878|NCT03201562|Aceclidine|aceclidine|mesh-list
44390879|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
44390880|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
44390881|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390882|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390883|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44390884|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44390885|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
44390886|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44390887|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390888|NCT03201562|Miotics|miotics|mesh-ancestor
44390889|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44390890|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44390891|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
44390892|NCT03201419|Coagulants|coagulants|mesh-ancestor
44390893|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43884367|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43884368|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43884369|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884370|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156478|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156479|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
44156480|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156481|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156482|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44156483|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44156484|NCT00231140|Growth Substances|growth substances|mesh-ancestor
44156485|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
44156486|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156487|NCT00231192|Repaglinide|repaglinide|mesh-list
44390894|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
44390895|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390896|NCT03201211|Vaccines|vaccines|mesh-list
44390897|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
44390898|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390899|NCT03200860|Empagliflozin|empagliflozin|mesh-list
44390900|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44390901|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390902|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43786115|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44390903|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390904|NCT03199963|Tamoxifen|tamoxifen|mesh-list
44390905|NCT03199963|Afimoxifene|afimoxifene|mesh-list
44390906|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44390907|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
44390908|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44390909|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390910|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44390911|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44390912|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44390913|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44390914|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44390915|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44156488|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156489|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156490|NCT00231218|Ascorbic Acid|ascorbic acid|mesh-list
44156491|NCT00231218|Propolis|propolis|mesh-list
44156492|NCT00231218|Vitamins|vitamins|mesh-ancestor
44156493|NCT00231218|Micronutrients|micronutrients|mesh-ancestor
44156494|NCT00231218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156495|NCT00231218|Antioxidants|antioxidants|mesh-ancestor
44156504|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
44156505|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156506|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
44156507|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156508|NCT00231322|Praziquantel|praziquantel|mesh-list
44156509|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
44156510|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44156511|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156512|NCT00231335|Citalopram|citalopram|mesh-list
44156513|NCT00231335|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156514|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156515|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156516|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156517|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156518|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
44156519|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156520|NCT00231335|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44156521|NCT00231335|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156522|NCT00231335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156523|NCT00231348|Nefazodone|nefazodone|mesh-list
44156524|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44390916|NCT03199911|Erythromycin|erythromycin|mesh-list
44390918|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390919|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390920|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44390921|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390922|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390923|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44390924|NCT03198767|Licogliflozin|licogliflozin|mesh-list
44390925|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
44390926|NCT03198767|Psyllium|psyllium|mesh-list
44390927|NCT03198767|Calcium|calcium|mesh-list
44390928|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44390929|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390930|NCT03198767|Antacids|antacids|mesh-ancestor
44390931|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390932|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390933|NCT03198767|Cathartics|cathartics|mesh-ancestor
44390934|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44390935|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390936|NCT03198507|Amoxicillin|amoxicillin|mesh-list
44390937|NCT03198507|Rifabutin|rifabutin|mesh-list
44390938|NCT03198507|Omeprazole|omeprazole|mesh-list
44390939|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44390940|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390941|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44390942|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44390943|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44390944|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390945|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390946|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44390947|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
44390948|NCT03197935|Paclitaxel|paclitaxel|mesh-list
44390949|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
44390950|NCT03197935|Doxorubicin|doxorubicin|mesh-list
44390951|NCT03197935|Atezolizumab|atezolizumab|mesh-list
44390952|NCT03197935|Antibodies|antibodies|mesh-list
44390957|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
44390958|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390959|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44390960|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
44390961|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390962|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44390963|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44390964|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
44390965|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44390966|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44390967|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44390968|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44390969|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390970|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
44390971|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44390972|NCT03197883|Protective Agents|protective agents|mesh-ancestor
44390973|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390974|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156525|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156526|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156527|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884371|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
43884372|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884373|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884375|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
43884376|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884377|NCT04599621|Protective Agents|protective agents|mesh-ancestor
43884378|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884379|NCT04599699|Androgens|androgens|mesh-list
43884380|NCT04599699|Hormones|hormones|mesh-ancestor
43884381|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884382|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884383|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
43884384|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43884385|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43884386|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884387|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
43884388|NCT04599205|Coagulants|coagulants|mesh-ancestor
43884389|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
43884390|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
43884391|NCT04598880|Cathartics|cathartics|mesh-ancestor
43884392|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884393|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
43884394|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
43884395|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43884396|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884397|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884398|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
43884399|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43884400|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884401|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884402|NCT04598542|Triamcinolone|triamcinolone|mesh-list
43884403|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44390975|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44390976|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
44390977|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390978|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
44390979|NCT03197324|Digoxin|digoxin|mesh-list
44390980|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44390981|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44390982|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44390983|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44390984|NCT03197324|Protective Agents|protective agents|mesh-ancestor
44390985|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390986|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44390987|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44390988|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44390989|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44390990|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
44390991|NCT03196505|Bupivacaine|bupivacaine|mesh-list
44390992|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
44390993|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
44390994|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44390995|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44390996|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
44390997|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44390998|NCT03196349|Warfarin|warfarin|mesh-list
44391026|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391028|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44391029|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391030|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391031|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391032|NCT03191396|Liraglutide|liraglutide|mesh-list
44391033|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391034|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391035|NCT03191396|Incretins|incretins|mesh-ancestor
44391036|NCT03191396|Hormones|hormones|mesh-ancestor
44391037|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391038|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
44391039|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391040|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44391041|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391042|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391043|NCT03189446|Paclitaxel|paclitaxel|mesh-list
44391044|NCT03189446|Carboplatin|carboplatin|mesh-list
43884404|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43884405|NCT04598542|Lorecivivint|lorecivivint|mesh-list
43884414|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884415|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884416|NCT04598594|Nicotine|nicotine|mesh-list
43884417|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43884418|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
43884419|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43827059|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
43884420|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884421|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43884422|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43884423|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
43884424|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884425|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884426|NCT04598191|Iloprost|iloprost|mesh-list
43884427|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43884428|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
43884429|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
43884430|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43884431|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884432|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884433|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884434|NCT04598061|Analgesics|analgesics|mesh-ancestor
43884435|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
43884436|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884437|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43884438|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43884439|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43884440|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43884441|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884442|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884443|NCT04597762|Cyclosporine|cyclosporine|mesh-list
43884444|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
43884445|NCT04597762|Cyclosporins|cyclosporins|mesh-list
43884446|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391045|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44391046|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391047|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
44391048|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
44391049|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
44391050|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391051|NCT03188185|Naltrexone|naltrexone|mesh-list
44391052|NCT03188185|Buprenorphine|buprenorphine|mesh-list
44391053|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44391054|NCT03188185|Narcotics|narcotics|mesh-ancestor
44391055|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391056|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391057|NCT03188185|Analgesics|analgesics|mesh-ancestor
44391058|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
44391059|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391060|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44391061|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44391062|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
43695624|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
43884447|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884448|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884449|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
43884450|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884451|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
43884452|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884453|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884454|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884455|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43884456|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884457|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
43884458|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43884459|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884460|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
43884461|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
43884462|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43884463|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43884464|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884465|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884466|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884467|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884468|NCT04597424|Doxycycline|doxycycline|mesh-list
43884469|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43884473|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43884475|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
43884476|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884477|NCT04597203|Protective Agents|protective agents|mesh-ancestor
43884478|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884479|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44156528|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156529|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156530|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44156531|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156532|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156533|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44156534|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44156535|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
44391063|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391064|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
44391065|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391066|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391067|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44391068|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391069|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
44391070|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391071|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391072|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391073|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391074|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
44391075|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391076|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
44391077|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391078|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391079|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44391080|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
44391081|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391082|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156536|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
44156537|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156538|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156539|NCT00231452|Artesunate|artesunate|mesh-list
44156540|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
44156541|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
44156542|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44156543|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
44156544|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44156545|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44156546|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156547|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156548|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
44156549|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
44156550|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44156551|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
44156552|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44156553|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156554|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156555|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44156556|NCT00231452|Renal Agents|renal agents|mesh-ancestor
44156557|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
44156558|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44156559|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44156560|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44156561|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156562|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156563|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156564|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156565|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156566|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44156567|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156568|NCT00231517|Morphine|morphine|mesh-list
44156569|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44391083|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44391084|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
44391085|NCT03187301|Apomorphine|apomorphine|mesh-list
44391086|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44391087|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391088|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44391089|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44391090|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391091|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391092|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391093|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391094|NCT03187301|Emetics|emetics|mesh-ancestor
44391095|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
44391096|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391097|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391098|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
44391099|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
44391100|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391101|NCT03187197|Dabigatran|dabigatran|mesh-list
44391102|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
44391103|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44391104|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
44391105|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391106|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391107|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
44391108|NCT03184987|Albuterol|albuterol|mesh-list
44391109|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391110|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
44391111|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391112|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391113|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44391114|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391115|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
43884480|NCT04596839|Remdesivir|remdesivir|mesh-list
43884481|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
43884482|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884483|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
43884484|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884485|NCT04596488|Efavirenz|efavirenz|mesh-list
43884486|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43884487|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43884488|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163845|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44391116|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44391117|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44391118|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44391119|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44391120|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
44391121|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391122|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391123|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
44391124|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391125|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391126|NCT03183908|Vaccines|vaccines|mesh-list
44391127|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
44391128|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391129|NCT03181789|Interleukin-12|interleukin-12|mesh-list
44391130|NCT03181789|Vaccines|vaccines|mesh-list
44391131|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
44391132|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391133|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44391134|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44391135|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44391136|NCT03181789|Growth Substances|growth substances|mesh-ancestor
44391137|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
44391138|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391139|NCT03181451|Ferric maltol|ferric maltol|mesh-list
44391140|NCT03181451|Hematinics|hematinics|mesh-ancestor
44391141|NCT03180736|Dexamethasone|dexamethasone|mesh-list
44391142|NCT03180736|Daratumumab|daratumumab|mesh-list
44391143|NCT03180736|Pomalidomide|pomalidomide|mesh-list
44391144|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391145|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
44391146|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
44391147|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391148|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391149|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391150|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
43884489|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884490|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
43884491|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884492|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43884493|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43884494|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44391151|NCT03180736|Hormones|hormones|mesh-ancestor
44391152|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391153|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391154|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391155|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
44391156|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44391157|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44391158|NCT03180736|Growth Substances|growth substances|mesh-ancestor
44391159|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
44391160|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
44391161|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
44391162|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391163|NCT03179891|Diazepam|diazepam|mesh-list
44391164|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44048278|NCT00003461|Antibodies|antibodies|mesh-list
44391165|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
44391166|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
44391168|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391169|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391170|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391171|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44391172|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391173|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44391174|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43786173|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786175|NCT05115578|Midazolam|midazolam|mesh-list
44391175|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44391176|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44391177|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44391178|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44391179|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
44391180|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
44391181|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
44391182|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
44391183|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391184|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391185|NCT03179787|Aripiprazole|aripiprazole|mesh-list
44391191|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391192|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
44391193|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
44391194|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391195|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391196|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44391197|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44391198|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
44391199|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44391200|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44391201|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44391202|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44391204|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391205|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391206|NCT03178851|Atezolizumab|atezolizumab|mesh-list
44391207|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44391208|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391209|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
44391210|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391211|NCT03176966|Vitamin E|vitamin e|mesh-list
44391212|NCT03176966|Ropinirole|ropinirole|mesh-list
44391213|NCT03176966|Vitamins|vitamins|mesh-ancestor
44391214|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
44391215|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391216|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
44391217|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391218|NCT03176966|Protective Agents|protective agents|mesh-ancestor
44391219|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44391220|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44391221|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
44391222|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
44391223|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391224|NCT03176459|Bupivacaine|bupivacaine|mesh-list
44391233|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391234|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391235|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
44391236|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391237|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44391238|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44391239|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391240|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391241|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44391242|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
44391243|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391244|NCT03175549|Apremilast|apremilast|mesh-list
44391245|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44391246|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44391247|NCT03175549|Analgesics|analgesics|mesh-ancestor
44391248|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
44391249|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391250|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391251|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391252|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391253|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44391254|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43786183|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786184|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43653937|NCT02980653|Megestrol|megestrol|mesh-list
44391255|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391256|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391257|NCT03175198|Dabigatran|dabigatran|mesh-list
44391258|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
44391259|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44391260|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
44391261|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391262|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391263|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
44391264|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
44391265|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391266|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391271|NCT03175120|Xultophy|xultophy|mesh-list
44391272|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391273|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391274|NCT03175120|Incretins|incretins|mesh-ancestor
44391275|NCT03175120|Hormones|hormones|mesh-ancestor
44391276|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391277|NCT03172325|Folic Acid|folic acid|mesh-list
44391278|NCT03172325|Prednisolone|prednisolone|mesh-list
44391279|NCT03172325|Adalimumab|adalimumab|mesh-list
44391280|NCT03172325|Methotrexate|methotrexate|mesh-list
44391281|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44391282|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
44391283|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44391284|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391285|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44391286|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
44391287|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391288|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391289|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391290|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391291|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44391292|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391293|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
44391294|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391295|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44391296|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391297|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
44391298|NCT03172325|Hormones|hormones|mesh-ancestor
44391299|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391300|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391301|NCT03172325|Hematinics|hematinics|mesh-ancestor
44391302|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
43884495|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43884496|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43884497|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43884498|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
43884500|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
43884501|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
43884509|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884510|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884511|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884512|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
44391303|NCT03172325|Vitamins|vitamins|mesh-ancestor
44391304|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
44391305|NCT03172026|Maraviroc|maraviroc|mesh-list
44391306|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44391307|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44391308|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391309|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44391310|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44391311|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
44391312|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391313|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44391314|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
44391315|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391316|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391317|NCT03170271|Benralizumab|benralizumab|mesh-list
44391318|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44391319|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391320|NCT03169530|Ethanol|ethanol|mesh-list
44391321|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44391322|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391323|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391324|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391325|NCT03169244|Bupropion|bupropion|mesh-list
44391326|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44391327|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
44391328|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44391329|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44391330|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44391331|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43884513|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43884514|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
43884515|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884516|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43884517|NCT04595929|Leucovorin|leucovorin|mesh-list
43884518|NCT04595929|Docetaxel|docetaxel|mesh-list
43884519|NCT04595929|Fluorouracil|fluorouracil|mesh-list
43884520|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
43884521|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884522|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
43884523|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
43884524|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
43884525|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884526|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
43884527|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43884528|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884529|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
44391333|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
44391334|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391335|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391336|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44391337|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44391338|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391339|NCT03168919|Temozolomide|temozolomide|mesh-list
44391340|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44391341|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
44391342|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391343|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391344|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
44391345|NCT03168555|Cathartics|cathartics|mesh-ancestor
44391346|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391347|NCT03167619|Durvalumab|durvalumab|mesh-list
44391348|NCT03167619|Olaparib|olaparib|mesh-list
44391349|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391350|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391351|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44391352|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391353|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391354|NCT03167411|Exenatide|exenatide|mesh-list
44391355|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
44391356|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391357|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884530|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884531|NCT04595929|Antidotes|antidotes|mesh-ancestor
43884532|NCT04595929|Protective Agents|protective agents|mesh-ancestor
43884533|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
43884534|NCT04595929|Vitamins|vitamins|mesh-ancestor
43884535|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
43884536|NCT04595812|Misoprostol|misoprostol|mesh-list
43884537|NCT04595812|Hemostatics|hemostatics|mesh-list
43884538|NCT04595812|Oxytocin|oxytocin|mesh-list
43884539|NCT04595812|Carbetocin|carbetocin|mesh-list
43884540|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
43884541|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43884542|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884543|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43884544|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
43884545|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43884546|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884547|NCT04595812|Coagulants|coagulants|mesh-ancestor
43884548|NCT04595877|Dipyrone|dipyrone|mesh-list
43884549|NCT04595877|Endorphins|endorphins|mesh-list
43884550|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
43884551|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44391358|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44391359|NCT03167411|Incretins|incretins|mesh-ancestor
44391360|NCT03167411|Hormones|hormones|mesh-ancestor
44391361|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391362|NCT03167242|Lumefantrine|lumefantrine|mesh-list
44391363|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44391365|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44391366|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44391367|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391368|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
44391369|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391370|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391371|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
44391372|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391373|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391374|NCT03165955|Paclitaxel|paclitaxel|mesh-list
44391375|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44391376|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391377|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
44391378|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
44391379|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
44391380|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391381|NCT03165721|Guadecitabine|guadecitabine|mesh-list
44391382|NCT03165721|Azacitidine|azacitidine|mesh-list
44391383|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391384|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44391385|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
44391386|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391387|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391388|NCT03164772|Durvalumab|durvalumab|mesh-list
43884552|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884553|NCT04595877|Analgesics|analgesics|mesh-ancestor
43884554|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
43884555|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884556|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884557|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884558|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884559|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
43884560|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884561|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884562|NCT04595318|Varenicline|varenicline|mesh-list
43884563|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43884564|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43884565|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
43884566|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884567|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391389|NCT03164772|Tremelimumab|tremelimumab|mesh-list
44391390|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391391|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391392|NCT03163667|Everolimus|everolimus|mesh-list
44391393|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391394|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391395|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
44391396|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391397|NCT03162224|Durvalumab|durvalumab|mesh-list
44391398|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391399|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391400|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
44391401|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
44391402|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391403|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
44391404|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391405|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391406|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884568|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884569|NCT04595409|Ustekinumab|ustekinumab|mesh-list
43884570|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156572|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156574|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
44156575|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156576|NCT00231530|Topiramate|topiramate|mesh-list
44156577|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
44156578|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156579|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156580|NCT00231556|Topiramate|topiramate|mesh-list
44156581|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
44156582|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156583|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158285|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158286|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
44158287|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158288|NCT00236483|Narcotics|narcotics|mesh-ancestor
44158289|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158290|NCT00236496|Topiramate|topiramate|mesh-list
44158291|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
44158292|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158293|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158294|NCT00236509|Topiramate|topiramate|mesh-list
44158295|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
44158296|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158297|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158298|NCT00236522|Levofloxacin|levofloxacin|mesh-list
44158299|NCT00236522|Ofloxacin|ofloxacin|mesh-list
44158300|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44158301|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158302|NCT00236522|Renal Agents|renal agents|mesh-ancestor
44158303|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158304|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158305|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158306|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158307|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158308|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158309|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158310|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158311|NCT00236535|Acetaminophen|acetaminophen|mesh-list
44391407|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391408|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44391409|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44391410|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44391411|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
44391412|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391413|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391414|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44391415|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44391416|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391417|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391418|NCT03161405|Itraconazole|itraconazole|mesh-list
44391419|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391420|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391421|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
44391422|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391423|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44391424|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44391425|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44391426|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
44391427|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391428|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391429|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44391430|NCT03161093|Naproxen|naproxen|mesh-list
44391431|NCT03161093|Fasinumab|fasinumab|mesh-list
44391432|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43695973|NCT02758444|Micronutrients|micronutrients|mesh-list
44158312|NCT00236535|Tramadol|tramadol|mesh-list
44158313|NCT00236535|Hydrocodone|hydrocodone|mesh-list
44158314|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44158315|NCT00236535|Analgesics|analgesics|mesh-ancestor
44158316|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
44158317|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158318|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158319|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
44158320|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158321|NCT00236535|Narcotics|narcotics|mesh-ancestor
44158322|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158323|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
44158324|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
44158325|NCT00236548|Risperidone|risperidone|mesh-list
44158326|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158327|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
44158328|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158329|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391433|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44391434|NCT03161093|Analgesics|analgesics|mesh-ancestor
44391435|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
44391436|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391437|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391438|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391439|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391440|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
44391441|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44391442|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391443|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391444|NCT03160716|Lidocaine|lidocaine|mesh-list
44391445|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
44391446|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
44391447|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391448|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391449|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
44391450|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391451|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44391452|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44391453|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44391454|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391455|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391456|NCT03160703|Fluorides|fluorides|mesh-list
44391457|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
44391458|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
44391459|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
44391460|NCT03160703|Protective Agents|protective agents|mesh-ancestor
44391461|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391462|NCT03158688|Dexamethasone|dexamethasone|mesh-list
44391463|NCT03158688|Daratumumab|daratumumab|mesh-list
44391464|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391465|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
43695983|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
44158330|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158331|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158332|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43884574|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43884575|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43884576|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884577|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391466|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
44391467|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391468|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391469|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391470|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
44391471|NCT03158688|Hormones|hormones|mesh-ancestor
44391472|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391473|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391474|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391475|NCT03158311|Fluticasone|fluticasone|mesh-list
44391476|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
44391477|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44391478|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391479|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391480|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
44391481|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391482|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391483|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44391484|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391485|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391486|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44391487|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
44391488|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391489|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391490|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391491|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391492|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44391493|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44391494|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44391495|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
44391496|NCT03158272|Nivolumab|nivolumab|mesh-list
43884578|NCT04593706|Dexamethasone|dexamethasone|mesh-list
43884579|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
43884580|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43884581|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43884582|NCT04593706|Prednisolone|prednisolone|mesh-list
43884592|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
43884593|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43884594|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
43884595|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43884596|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43884597|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43884598|NCT04593706|BB 1101|bb 1101|mesh-list
43884599|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884600|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
44391497|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391498|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391499|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44391500|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391501|NCT03158220|Vaccines|vaccines|mesh-list
44391502|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
44391503|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391504|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
44391505|NCT03157583|Glycerol|glycerol|mesh-list
44391506|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44391507|NCT03157583|Protective Agents|protective agents|mesh-ancestor
44391508|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391509|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391510|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44391511|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
44391513|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391514|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391515|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44391516|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391517|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391518|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
44391519|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
44391520|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
44391521|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391522|NCT03156504|Ketamine|ketamine|mesh-list
44391523|NCT03156504|Analgesics|analgesics|mesh-ancestor
44391524|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
44391525|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391526|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391527|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43884601|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
43884602|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884603|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884604|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884605|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
43884606|NCT04593706|Hormones|hormones|mesh-ancestor
43884607|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884608|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884609|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884610|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43884611|NCT04593706|Protective Agents|protective agents|mesh-ancestor
43884612|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884613|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
44391528|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44391529|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
44391530|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
44391531|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391532|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44391533|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44391534|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391535|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391536|NCT03155178|Ethanol|ethanol|mesh-list
44391537|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
44391538|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44391539|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44391540|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391541|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391542|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391543|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
44391544|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391545|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
44391546|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
44391547|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44391548|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44391549|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391550|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391551|NCT03154476|Urological Agents|urological agents|mesh-ancestor
44391552|NCT03153137|Macitentan|macitentan|mesh-list
44391553|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44391554|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44391555|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391556|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43884614|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884615|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884616|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884617|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
43884618|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884619|NCT04593836|Peppermint oil|peppermint oil|mesh-list
43884620|NCT04593836|Menthol|menthol|mesh-list
43884621|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
43884622|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
43884623|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
43884624|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
43884625|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884626|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884627|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391558|NCT03152552|Licogliflozin|licogliflozin|mesh-list
44391559|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44391560|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391561|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391562|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391563|NCT03152019|Tacrolimus|tacrolimus|mesh-list
44391564|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391565|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
44391566|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391567|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44391568|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391569|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391570|NCT03151551|Adalimumab|adalimumab|mesh-list
43884628|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
43884629|NCT04593654|Dalteparin|dalteparin|mesh-list
43884630|NCT04593654|Tinzaparin|tinzaparin|mesh-list
43884631|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43884632|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
43884633|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43884634|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43884635|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884636|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43884637|NCT04593238|Calcium|calcium|mesh-list
43884638|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43884639|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884640|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884641|NCT04593524|Vitamin D|vitamin d|mesh-list
43884642|NCT04593524|Vitamins|vitamins|mesh-ancestor
43786190|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786192|NCT05115578|Narcotics|narcotics|mesh-ancestor
43786193|NCT05115578|Analgesics|analgesics|mesh-ancestor
43786194|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
43786195|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884643|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
43884644|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884645|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43884646|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
43884647|NCT04593446|Cathartics|cathartics|mesh-ancestor
43884648|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884649|NCT04593160|Acetaminophen|acetaminophen|mesh-list
43884650|NCT04593160|Diclofenac|diclofenac|mesh-list
43884651|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884652|NCT04593160|Analgesics|analgesics|mesh-ancestor
43884657|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43884658|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884659|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884660|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43884661|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884662|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884663|NCT04593108|Letrozole|letrozole|mesh-list
43884664|NCT04593108|Misoprostol|misoprostol|mesh-list
43884665|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884666|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43884667|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43884668|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884669|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884670|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43884671|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
43884672|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884673|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884674|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43884675|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
43884676|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43884677|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43884678|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391572|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391573|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391574|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391575|NCT03151408|Azacitidine|azacitidine|mesh-list
44391576|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44391577|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
44391578|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391579|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391580|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391581|NCT03151304|Azacitidine|azacitidine|mesh-list
44391582|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44391583|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
44391584|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391585|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391586|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391587|NCT03150719|Ivacaftor|ivacaftor|mesh-list
44391588|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44391589|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391590|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391591|NCT03150589|Ranibizumab|ranibizumab|mesh-list
44391592|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44391593|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44391594|NCT03150589|Growth Substances|growth substances|mesh-ancestor
44391595|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391596|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
44391597|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391598|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
44391599|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44391600|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391601|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44391602|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44391603|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391604|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391605|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884679|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
43884680|NCT04593030|Warfarin|warfarin|mesh-list
43884681|NCT04593030|Apixaban|apixaban|mesh-list
43884682|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
43884683|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43884684|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
44391606|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44391607|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44391608|NCT03150056|Prednisone|prednisone|mesh-list
44391609|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391610|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
44391611|NCT03150056|Hormones|hormones|mesh-ancestor
44391612|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391613|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391614|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391615|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391616|NCT03149848|Rifabutin|rifabutin|mesh-list
44391617|NCT03149848|Cabotegravir|cabotegravir|mesh-list
44391618|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44391619|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391620|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44391621|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
44391622|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44391623|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44391624|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391625|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391626|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44391627|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44391628|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
44391629|NCT03149055|Isavuconazole|isavuconazole|mesh-list
44391630|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
44391631|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391632|NCT03148756|Dalbavancin|dalbavancin|mesh-list
44391633|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44391634|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884685|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43884686|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884687|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884688|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884689|NCT04592822|Dabigatran|dabigatran|mesh-list
43884690|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
43884691|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43884692|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884693|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884694|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884695|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
43884696|NCT04592666|Carboplatin|carboplatin|mesh-list
43884697|NCT04592666|Pemetrexed|pemetrexed|mesh-list
43884698|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884699|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884700|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884701|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44391636|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391637|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391638|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44391639|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44391640|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
44391641|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391642|NCT03146403|Vaccines|vaccines|mesh-list
44391643|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
44391644|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391645|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
44391646|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44391647|NCT03145766|Antibodies|antibodies|mesh-list
44391648|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
44391649|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391650|NCT03145207|Lidocaine|lidocaine|mesh-list
44391651|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
44391652|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
44391653|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391654|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391655|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
44391656|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391657|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44391658|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44391659|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44391660|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391661|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391662|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
44391663|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391664|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44391665|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391666|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391667|NCT03144804|Lamivudine|lamivudine|mesh-list
43884702|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43884703|NCT04593056|Warfarin|warfarin|mesh-list
43884704|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
43884705|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
43884706|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43884707|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
43884708|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43884709|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884710|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391668|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44391669|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44391670|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391671|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391672|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
44391673|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391674|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44391675|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44391676|NCT03143166|Telmisartan|telmisartan|mesh-list
44391677|NCT03143166|Dabigatran|dabigatran|mesh-list
44391678|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44391679|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44391680|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44391681|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391682|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
44391683|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44391684|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
44391685|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391686|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
44391687|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
44391688|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
44391689|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391690|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
44391691|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391692|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391693|NCT03142451|Minocycline|minocycline|mesh-list
44391694|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44391695|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391696|NCT03139604|Prednisone|prednisone|mesh-list
44391697|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
44391698|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44391699|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44391700|NCT03139604|Prednisolone|prednisolone|mesh-list
44391701|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
44391706|NCT03139604|Hormones|hormones|mesh-ancestor
44391708|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391709|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391710|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391711|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
44391712|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
44048832|NCT00003580|Protective Agents|protective agents|mesh-ancestor
44391713|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391714|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391715|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44391716|NCT03139604|Protective Agents|protective agents|mesh-ancestor
44391717|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
44391718|NCT03139279|Propofol|propofol|mesh-list
44391719|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44391720|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391721|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391722|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44391723|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
44391724|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
44391725|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44391726|NCT03139279|Analgesics|analgesics|mesh-ancestor
44391727|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
44391728|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391729|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44391730|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44391731|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44391732|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44391733|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391734|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391735|NCT03139240|Oxycodone|oxycodone|mesh-list
44391736|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44391737|NCT03139240|Narcotics|narcotics|mesh-ancestor
44391738|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391739|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391740|NCT03139240|Analgesics|analgesics|mesh-ancestor
44391741|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
43884711|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884712|NCT04593043|Warfarin|warfarin|mesh-list
43884713|NCT04593043|Dabigatran|dabigatran|mesh-list
43884714|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
43884715|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
43884716|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44391742|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391744|NCT03138967|Bromides|bromides|mesh-list
44391745|NCT03138967|Rocuronium|rocuronium|mesh-list
44391746|NCT03138967|Neostigmine|neostigmine|mesh-list
44391747|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
44391748|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44391749|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44391750|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44391751|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391752|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391753|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44391754|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391755|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391756|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391757|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391758|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44391759|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
44391760|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44391761|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44391762|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391763|NCT03138655|Vedolizumab|vedolizumab|mesh-list
44391764|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391765|NCT03137992|Bromides|bromides|mesh-list
44391766|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
44391767|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391768|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
44391769|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391770|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391771|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884717|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884718|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884719|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884720|NCT04592211|Paclitaxel|paclitaxel|mesh-list
43884721|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
43884722|NCT04592211|Olaparib|olaparib|mesh-list
43884723|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43884724|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884727|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
43884728|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884729|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884730|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43884731|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884732|NCT04592380|Clevidipine|clevidipine|mesh-list
43884733|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44391772|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391773|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
44391774|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391775|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391776|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391777|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391778|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
44391779|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
44391780|NCT03137784|Bromides|bromides|mesh-list
44391781|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
44391782|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44391783|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44391784|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44391785|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
44391786|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391787|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391788|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391790|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44391791|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
44391792|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391793|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391794|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44391795|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
44391796|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
44391797|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44391798|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44391799|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44391800|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44391801|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
44391802|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391803|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391804|NCT03137121|Olanzapine|olanzapine|mesh-list
44391805|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
44391806|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
43696213|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43884734|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43884735|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43884736|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44391807|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391808|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391810|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44391811|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44391812|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391813|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44391814|NCT03137121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44391815|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44391816|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391817|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391818|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391819|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
44391820|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44391821|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
44391822|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391823|NCT03136484|Canagliflozin|canagliflozin|mesh-list
44391824|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44391825|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391826|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391827|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391828|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
44391829|NCT03136198|Diuretics|diuretics|mesh-list
44391830|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
44391831|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
44391832|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391833|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391834|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391835|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
44391836|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44391837|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
44391838|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44391839|NCT03136107|Protective Agents|protective agents|mesh-ancestor
44391840|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884737|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43884738|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391841|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
44391843|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44391844|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44391845|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391846|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391847|NCT03136068|Protective Agents|protective agents|mesh-ancestor
44391848|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391849|NCT03135028|Cytarabine|cytarabine|mesh-list
44391850|NCT03135028|Daunorubicin|daunorubicin|mesh-list
44391851|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44391852|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
44391853|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391854|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391855|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
44391856|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44391857|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391858|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
44391859|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391860|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44391861|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44391862|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44391863|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391864|NCT03134183|Misoprostol|misoprostol|mesh-list
44391865|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44391866|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
44391867|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44391868|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391869|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43696289|NCT02756663|Dexamethasone|dexamethasone|mesh-list
43884739|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884740|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43884741|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884742|NCT04592198|Palonosetron|palonosetron|mesh-list
43884743|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
43884744|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
43884745|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884746|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884747|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884748|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43884749|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43884750|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
43884751|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44391870|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391871|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
44391872|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
44391874|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
44391875|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391876|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44391877|NCT03133481|Ropivacaine|ropivacaine|mesh-list
44391878|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
44391879|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
44391880|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44391881|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391882|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
44391883|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391884|NCT03132636|Cemiplimab|cemiplimab|mesh-list
44391885|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391886|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391887|NCT03132467|Durvalumab|durvalumab|mesh-list
44391888|NCT03132467|Ipilimumab|ipilimumab|mesh-list
44391889|NCT03132467|Tremelimumab|tremelimumab|mesh-list
44391890|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
44391891|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44391892|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
44391893|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884752|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884753|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
43884754|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43884755|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43884756|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43884757|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884758|NCT04592081|Dexamethasone|dexamethasone|mesh-list
43884759|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
43884760|NCT04592081|BB 1101|bb 1101|mesh-list
43884761|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884762|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
43884763|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
43884764|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884765|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884766|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884767|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
43884768|NCT04592081|Hormones|hormones|mesh-ancestor
43884769|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884770|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884771|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884772|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
43884773|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884774|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884775|NCT04591795|Diclofenac|diclofenac|mesh-list
43884776|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43884777|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884778|NCT04591795|Analgesics|analgesics|mesh-ancestor
43884779|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
43884780|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884781|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884782|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391894|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391895|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
44391896|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391897|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44391898|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391899|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
44391900|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391901|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44391902|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391903|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391904|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
44391905|NCT03131895|Lansoprazole|lansoprazole|mesh-list
44391906|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44391907|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391908|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44391909|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391910|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391911|NCT03131713|Acetaminophen|acetaminophen|mesh-list
44391912|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44391913|NCT03131713|Analgesics|analgesics|mesh-ancestor
44391914|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
44391915|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391916|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391917|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
44391918|NCT03131687|Dulaglutide|dulaglutide|mesh-list
44391919|NCT03131687|Tirzepatide|tirzepatide|mesh-list
44391920|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44391921|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391922|NCT03131687|Incretins|incretins|mesh-ancestor
44391923|NCT03131687|Hormones|hormones|mesh-ancestor
44391924|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391925|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44391926|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
44391927|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43696342|NCT02756104|Vitamin D|vitamin d|mesh-list
44391932|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391934|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391935|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391936|NCT03131219|Ravulizumab|ravulizumab|mesh-list
44391937|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44391938|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391939|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
44391940|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391941|NCT03130959|Nivolumab|nivolumab|mesh-list
44391942|NCT03130959|Ipilimumab|ipilimumab|mesh-list
44391943|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44391944|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391945|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44391946|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391947|NCT03129360|Levetiracetam|levetiracetam|mesh-list
44391948|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
44391949|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
44391950|NCT03127384|Lidocaine|lidocaine|mesh-list
44391951|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
44391952|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
44391953|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43696379|NCT02756000|Dobutamine|dobutamine|mesh-list
43884783|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884784|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43884785|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884786|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884787|NCT04591743|Nicotine|nicotine|mesh-list
43884788|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43884789|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
43884790|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884791|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884792|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43884793|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43884794|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
43884795|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884798|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43884799|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884800|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43884801|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884803|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43884804|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884805|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43884806|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43884807|NCT04592029|Growth Substances|growth substances|mesh-ancestor
43884808|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884809|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884810|NCT04591847|Vitamin D|vitamin d|mesh-list
43884811|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
43884812|NCT04591847|Vitamins|vitamins|mesh-ancestor
43884813|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
43884814|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884815|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44391954|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391955|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
44391956|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391957|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44391958|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44391959|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44391960|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391961|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391962|NCT03126786|Triamcinolone|triamcinolone|mesh-list
44391963|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44391964|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44391965|NCT03126786|Aflibercept|aflibercept|mesh-list
44391966|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44391967|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391968|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
44391969|NCT03126786|Hormones|hormones|mesh-ancestor
44391970|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391971|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391972|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44391973|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
44391974|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44391975|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391976|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44391977|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44391978|NCT03126786|Growth Substances|growth substances|mesh-ancestor
44391979|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44391980|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391981|NCT03125941|Dexamethasone|dexamethasone|mesh-list
44391982|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44391983|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
44391984|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
43884816|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44156585|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43786204|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44156586|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44156587|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
44156588|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156589|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44156590|NCT00231582|Paclitaxel|paclitaxel|mesh-list
44156591|NCT00231582|Etoposide|etoposide|mesh-list
44156592|NCT00231582|Carboplatin|carboplatin|mesh-list
44156593|NCT00231582|Epirubicin|epirubicin|mesh-list
44156594|NCT00231582|Ifosfamide|ifosfamide|mesh-list
44156595|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44391985|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44391986|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44391987|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44391988|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
44391989|NCT03125941|Hormones|hormones|mesh-ancestor
44391990|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44391991|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44391992|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44391993|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44391994|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44391995|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44391996|NCT03125395|Ivacaftor|ivacaftor|mesh-list
44391997|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44391998|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44391999|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392000|NCT03124407|Capsaicin|capsaicin|mesh-list
44392001|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
44392002|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156596|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156597|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
44156598|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
44156599|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156600|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156601|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44156602|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44156603|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156604|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156605|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44156606|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
44156607|NCT00231595|Topiramate|topiramate|mesh-list
44156608|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
44156609|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156610|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156611|NCT00231608|Topiramate|topiramate|mesh-list
44156612|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
44156613|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156614|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156615|NCT00231621|Topiramate|topiramate|mesh-list
44156616|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
44156617|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156618|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156619|NCT00231634|Topiramate|topiramate|mesh-list
44156620|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
44156621|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156622|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156623|NCT00231647|Topiramate|topiramate|mesh-list
44156624|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
44156625|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156626|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156627|NCT00231660|Topiramate|topiramate|mesh-list
44156628|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
44156629|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156630|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156631|NCT00231673|Topiramate|topiramate|mesh-list
44156632|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
44156633|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156634|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156635|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
44392003|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
44392004|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392005|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392006|NCT03124199|Rifaximin|rifaximin|mesh-list
44392007|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44392008|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392009|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392010|NCT03123861|Gabapentin|gabapentin|mesh-list
44392011|NCT03123861|Analgesics|analgesics|mesh-ancestor
44392012|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
44392013|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392014|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392015|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
44392016|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44392017|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44392018|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392019|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392020|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44392021|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44392022|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392023|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392024|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
44392026|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44392027|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44392028|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392030|NCT03123471|Apremilast|apremilast|mesh-list
44392050|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392051|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392052|NCT03122457|C 1027|c 1027|mesh-list
44392053|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44392054|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392055|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44392056|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392057|NCT03122145|Capsaicin|capsaicin|mesh-list
44392058|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
44392059|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392060|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
44392061|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392062|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392063|NCT03121261|Clonidine|clonidine|mesh-list
44392064|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
44392065|NCT03121261|Analgesics|analgesics|mesh-ancestor
44392066|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
44392067|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392068|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392069|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44392070|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
44392071|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
44392072|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44392073|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44392074|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44392075|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
44392076|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392077|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392078|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392079|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
44392080|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392081|NCT03120676|Atezolizumab|atezolizumab|mesh-list
44392083|NCT03120520|Plecanatide|plecanatide|mesh-list
44392094|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392095|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44392096|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44392097|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44049294|NCT00003624|Paclitaxel|paclitaxel|mesh-list
44392098|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392099|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392100|NCT03119701|Interferons|interferons|mesh-list
44392101|NCT03119701|Interferon-beta|interferon-beta|mesh-list
44392102|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
44392103|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392104|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
44392105|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392106|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
44392107|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392108|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44392109|NCT03119610|Oxytocin|oxytocin|mesh-list
44392110|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
44392111|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44392112|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392113|NCT03118947|Pimavanserin|pimavanserin|mesh-list
44392114|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44392115|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44392116|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44392117|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44392118|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392142|NCT03118739|Verinurad|verinurad|mesh-list
44392143|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
44392144|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392145|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44392146|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
44392147|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44392148|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
44392149|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44392150|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392151|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44392152|NCT03117361|Dexamethasone|dexamethasone|mesh-list
44392153|NCT03117361|Bortezomib|bortezomib|mesh-list
44392154|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392155|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
44392156|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
44392157|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392158|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392159|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392160|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
44392161|NCT03117361|Hormones|hormones|mesh-ancestor
44392162|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392163|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44392164|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392165|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44392166|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
44392167|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44392168|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44392169|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392170|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392171|NCT03116152|Paclitaxel|paclitaxel|mesh-list
44392172|NCT03116152|Irinotecan|irinotecan|mesh-list
44392173|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43696472|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44156643|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
43884818|NCT04591535|Carbidopa|carbidopa|mesh-list
43884819|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43884820|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43884821|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43884822|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
43884823|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884824|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392174|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392175|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392176|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392177|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392178|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392179|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44392180|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44392181|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392182|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44392183|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
44392184|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44392185|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392186|NCT03115112|Incretins|incretins|mesh-ancestor
44392187|NCT03115112|Hormones|hormones|mesh-ancestor
44392188|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392189|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44392190|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44392191|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392192|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392193|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44392194|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
44392195|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44392196|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392197|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392198|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392199|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
43696505|NCT02754765|Renal Agents|renal agents|mesh-ancestor
43884825|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884826|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43884827|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884828|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43884829|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
43884830|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
43884831|NCT04591444|Fluorides|fluorides|mesh-list
43884832|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
43884833|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
43884834|NCT04591444|Protective Agents|protective agents|mesh-ancestor
43884835|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884836|NCT04591457|Insulin|insulin|mesh-list
43884837|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43884838|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
43884839|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43884840|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884841|NCT04591327|Anesthetics|anesthetics|mesh-list
43884842|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884843|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392200|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392201|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392202|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
44392203|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44392204|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392205|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392206|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392207|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
44392208|NCT03114969|Hormones|hormones|mesh-ancestor
44392209|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392210|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
44392211|NCT03113409|Naltrexone|naltrexone|mesh-list
44392212|NCT03113409|Buprenorphine|buprenorphine|mesh-list
43884844|NCT04591600|Ivermectin|ivermectin|mesh-list
43884845|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43884846|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43884847|NCT04591405|Vaccines|vaccines|mesh-list
43884848|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
43884849|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884850|NCT04590742|Melatonin|melatonin|mesh-list
43884851|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
43884852|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884853|NCT04590742|Protective Agents|protective agents|mesh-ancestor
43884854|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884855|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884856|NCT04590638|Epinephrine|epinephrine|mesh-list
43884857|NCT04590638|Racepinephrine|racepinephrine|mesh-list
43884858|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
43884859|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43884860|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43884861|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
43884862|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884863|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884864|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884865|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43884866|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43884867|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
43884868|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884869|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43884870|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
43884871|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
43884872|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
43884873|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43884874|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43884875|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43884876|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43884877|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
43884878|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884886|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43884887|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43884888|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43884889|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
43884890|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43884891|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43670468|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
43884892|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884893|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43884895|NCT04590612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43884896|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43884897|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43884898|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
44392213|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44392214|NCT03113409|Narcotics|narcotics|mesh-ancestor
44392215|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392216|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392217|NCT03113409|Analgesics|analgesics|mesh-ancestor
44392218|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
44392219|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392220|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44392221|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44392222|NCT03113071|Decitabine|decitabine|mesh-list
44392223|NCT03113071|Digoxin|digoxin|mesh-list
44392224|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44392225|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
44392226|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392227|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392228|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392229|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44392230|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44392231|NCT03113071|Protective Agents|protective agents|mesh-ancestor
43884899|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43884900|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
43884901|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43884902|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43884903|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
43884904|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
43884905|NCT04590625|Carboplatin|carboplatin|mesh-list
43884906|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43884907|NCT04590625|Apatinib|apatinib|mesh-list
43884908|NCT04590625|Cisplatin|cisplatin|mesh-list
43884909|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884910|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884911|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43884912|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884913|NCT04590183|Prednisolone|prednisolone|mesh-list
43884914|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43884915|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
43884916|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43884917|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
43884918|NCT04590183|Tacrolimus|tacrolimus|mesh-list
43884919|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43884920|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
43884921|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43884922|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
43884923|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884924|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43884925|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884926|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884927|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884928|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
43884929|NCT04590183|Hormones|hormones|mesh-ancestor
43884930|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884931|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43884932|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884933|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
43884934|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
43884935|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884936|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392235|NCT03112590|Paclitaxel|paclitaxel|mesh-list
44392236|NCT03112590|Trastuzumab|trastuzumab|mesh-list
44392237|NCT03112590|Pertuzumab|pertuzumab|mesh-list
44392238|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392239|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392240|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392241|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392242|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392243|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884937|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43884938|NCT04590183|Protective Agents|protective agents|mesh-ancestor
43884939|NCT04590508|Xanthohumol|xanthohumol|mesh-list
43884940|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884941|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43884942|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43884943|NCT04590508|Growth Substances|growth substances|mesh-ancestor
43884944|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884945|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
43884946|NCT04590482|Letrozole|letrozole|mesh-list
43884947|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884948|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43884949|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43884950|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884951|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884952|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43884953|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
43670469|NCT02895074|Tropicamide|tropicamide|mesh-list
43884954|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43884955|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884956|NCT04590196|Curcumin|curcumin|mesh-list
43884957|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43884958|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43884959|NCT04590196|Analgesics|analgesics|mesh-ancestor
43884960|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
43884961|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884962|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884963|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43884964|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43884965|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43884966|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884967|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884968|NCT04589429|Morphine|morphine|mesh-list
43884969|NCT04589429|Nalbuphine|nalbuphine|mesh-list
43884970|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43884971|NCT04589429|Narcotics|narcotics|mesh-ancestor
43884972|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884973|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884974|NCT04589429|Analgesics|analgesics|mesh-ancestor
43884975|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
43884976|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884977|NCT04589390|Selexipag|selexipag|mesh-list
43884978|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43884979|NCT04589494|Morphine|morphine|mesh-list
43884980|NCT04589494|Tramadol|tramadol|mesh-list
43884981|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43884982|NCT04589494|Narcotics|narcotics|mesh-ancestor
43884983|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884984|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884985|NCT04589494|Analgesics|analgesics|mesh-ancestor
43884986|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
44392244|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392245|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
44392246|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392247|NCT03111108|Grazoprevir|grazoprevir|mesh-list
44049445|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392248|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
44392249|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392250|NCT03110900|Lorazepam|lorazepam|mesh-list
44392251|NCT03110900|Haloperidol|haloperidol|mesh-list
44392252|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
44392253|NCT03110900|Loxapine|loxapine|mesh-list
44392254|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
44392255|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
44392256|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392257|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392258|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43884987|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43884988|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
43884989|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43884990|NCT04589299|Antibodies|antibodies|mesh-list
43884991|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
43884992|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884993|NCT04589143|S 20098|s 20098|mesh-list
43653942|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
43840427|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43884994|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43884995|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43884996|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43884997|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
43884998|NCT04589130|Naltrexone|naltrexone|mesh-list
43884999|NCT04589130|Bupropion|bupropion|mesh-list
43885000|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43885001|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43885002|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885003|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
43885004|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885005|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43885006|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885007|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885008|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43885009|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43885010|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885011|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885012|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
43885013|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885014|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43885015|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885016|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885017|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43885018|NCT04589234|Gemcitabine|gemcitabine|mesh-list
43885019|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43885022|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
43885023|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885024|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885025|NCT04589234|Antiviral Agents|antiviral agents|mesh-ancestor
43885026|NCT04589234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885027|NCT04589234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885028|NCT04589234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885029|NCT04589234|Immunologic Factors|immunologic factors|mesh-ancestor
43885030|NCT04589234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885031|NCT04588935|Bisoprolol|bisoprolol|mesh-list
43885032|NCT04588935|Perindopril|perindopril|mesh-list
44392259|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44392260|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44392261|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392262|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392263|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44392264|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
44392265|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392266|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392267|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44392268|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
44392269|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44392270|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44392271|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
44392272|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
44392273|NCT03110029|Efinaconazole|efinaconazole|mesh-list
44392274|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
44392275|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392276|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44392277|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43885033|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885034|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
43885035|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
43885036|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885037|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885038|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43885039|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43885040|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43885041|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885042|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885043|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885044|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43885045|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
43885046|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885048|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885049|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43885050|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885051|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156644|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156645|NCT00231829|Celecoxib|celecoxib|mesh-list
44156646|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156647|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44156648|NCT00231829|Analgesics|analgesics|mesh-ancestor
44156649|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
44156650|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156651|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156652|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156653|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156654|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44156655|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44156656|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156657|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156658|NCT00231855|Docetaxel|docetaxel|mesh-list
44156659|NCT00231855|Topotecan|topotecan|mesh-list
44156660|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156661|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44156662|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392279|NCT03108521|Incretins|incretins|mesh-ancestor
44392280|NCT03108521|Hormones|hormones|mesh-ancestor
44392281|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392282|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44392283|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
44392284|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392285|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392286|NCT03107091|Terlipressin|terlipressin|mesh-list
44392287|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44392288|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44392289|NCT03106753|Bupivacaine|bupivacaine|mesh-list
44156663|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156664|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156665|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44156666|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44156667|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156668|NCT00231959|Pramipexole|pramipexole|mesh-list
44156669|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
44156670|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156671|NCT00231959|Protective Agents|protective agents|mesh-ancestor
44156672|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156673|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44156674|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44156675|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
44156676|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
44156677|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156678|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
44156679|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156680|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44156681|NCT00231998|Analgesics|analgesics|mesh-ancestor
44156682|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
44156683|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156684|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156693|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
44156694|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156695|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44156696|NCT00232011|Analgesics|analgesics|mesh-ancestor
44156697|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
44156698|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156699|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156700|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156701|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156702|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156703|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156704|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
44156705|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44156706|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885052|NCT04588532|Doxepin|doxepin|mesh-list
43885053|NCT04588532|Histamine|histamine|mesh-list
43885054|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
43885055|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
43885056|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885057|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885058|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885059|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43885060|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43885061|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885062|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43885063|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885064|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392290|NCT03106753|Terbutaline|terbutaline|mesh-list
44392291|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392292|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
44392293|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392294|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392295|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
44392296|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392297|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392298|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
44392299|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392300|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392301|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
44392302|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
44392303|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44392304|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44392305|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44392306|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44392307|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
44392308|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392309|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392310|NCT03106077|Maytansine|maytansine|mesh-list
44392311|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392312|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392313|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392314|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392315|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392316|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392317|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44392318|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
44392319|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392320|NCT03104816|Acetaminophen|acetaminophen|mesh-list
44392321|NCT03104816|Hydromorphone|hydromorphone|mesh-list
44392322|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392323|NCT03104816|Analgesics|analgesics|mesh-ancestor
44392324|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
44392325|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392328|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44392329|NCT03104816|Narcotics|narcotics|mesh-ancestor
44392330|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392331|NCT03103919|Rotigotine|rotigotine|mesh-list
44392332|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
44392333|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
44392334|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392335|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392336|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392337|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
44392338|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44392339|NCT03103906|Protective Agents|protective agents|mesh-ancestor
44392340|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392341|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392342|NCT03103763|Warfarin|warfarin|mesh-list
44392343|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
44392344|NCT03103100|Lidocaine|lidocaine|mesh-list
44392345|NCT03103100|Bupivacaine|bupivacaine|mesh-list
44392346|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392347|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
44392348|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392349|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392350|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
44392351|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392352|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44392353|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44392354|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44392355|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392356|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392357|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44392358|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44392359|NCT03103087|Norethindrone|norethindrone|mesh-list
44392361|NCT03103087|Estradiol|estradiol|mesh-list
44392371|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44392372|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44392373|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44392374|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44392375|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
44392376|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
44392377|NCT03102918|Cannabidiol|cannabidiol|mesh-list
44392378|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
44392379|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
44392380|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44392381|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44392382|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44392383|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392384|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392385|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392386|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392387|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392388|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44392389|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392390|NCT03102710|Lidocaine|lidocaine|mesh-list
44392391|NCT03102710|Capsaicin|capsaicin|mesh-list
44392392|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392393|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
43885065|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
43885066|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
43885067|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885068|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
43885069|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
43885070|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885071|NCT04588441|Adenosine|adenosine|mesh-list
43885072|NCT04588441|Analgesics|analgesics|mesh-ancestor
43885073|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
43885074|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885075|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885076|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43885077|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
43885078|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43885079|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
43885080|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
43885081|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885082|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885083|NCT04588389|Lidocaine|lidocaine|mesh-list
43885084|NCT04588389|Ropivacaine|ropivacaine|mesh-list
43885085|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
43885086|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
43885087|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885088|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885089|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
43885090|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392394|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392395|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392396|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
44392397|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392398|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44392399|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44392400|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44392401|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392402|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392403|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
44392404|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392405|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43840438|NCT04698226|Temazepam|temazepam|mesh-list
44392406|NCT03101930|Liraglutide|liraglutide|mesh-list
44392407|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44392408|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885091|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43885092|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43885093|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43885094|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885096|NCT04588220|Plasminogen|plasminogen|mesh-list
43885097|NCT04588220|Melatonin|melatonin|mesh-list
43885098|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
43885099|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885100|NCT04588220|Protective Agents|protective agents|mesh-ancestor
43885101|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885102|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885103|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43885104|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43885105|NCT04588194|Dexamethasone|dexamethasone|mesh-list
43885106|NCT04588194|Rituximab|rituximab|mesh-list
43885107|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43885108|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885109|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
43885110|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885111|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885112|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885113|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
43885114|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
43885115|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885116|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885117|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
43885118|NCT04588194|Hormones|hormones|mesh-ancestor
43885119|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885120|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43885121|NCT04588090|Cisplatin|cisplatin|mesh-list
43885122|NCT04588090|Paclitaxel|paclitaxel|mesh-list
43885123|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885124|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43885125|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885126|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885127|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885128|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885129|NCT04588285|Ambroxol|ambroxol|mesh-list
43885130|NCT04588285|Expectorants|expectorants|mesh-ancestor
43885131|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
43885132|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
43885133|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
43885134|NCT04587843|Naltrexone|naltrexone|mesh-list
44392409|NCT03101930|Incretins|incretins|mesh-ancestor
44392410|NCT03101930|Hormones|hormones|mesh-ancestor
44392411|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392412|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44392413|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
44392414|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392415|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392416|NCT03101462|Vaccines|vaccines|mesh-list
44392417|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
44392418|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392419|NCT03101371|Iodine|iodine|mesh-list
44392420|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
44392421|NCT03101371|Povidone|povidone|mesh-list
44392422|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44392423|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392424|NCT03101371|Trace Elements|trace elements|mesh-ancestor
44392425|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
44392426|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392427|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
44392428|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
44392429|NCT03101358|Paclitaxel|paclitaxel|mesh-list
44392430|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44392431|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392432|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392433|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392434|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392435|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392436|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392438|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
44392439|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
44392440|NCT03101150|Vitamins|vitamins|mesh-list
44392441|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
44392442|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392443|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44392444|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44392445|NCT03100838|Nifedipine|nifedipine|mesh-list
44392446|NCT03100838|Omeprazole|omeprazole|mesh-list
43885135|NCT04587843|Bupropion|bupropion|mesh-list
44392448|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44392449|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392450|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44392451|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392452|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392453|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44392454|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392455|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44392456|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392457|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
44392458|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
44392459|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44392460|NCT03100058|Licogliflozin|licogliflozin|mesh-list
44392461|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44392462|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392463|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44392464|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392465|NCT03099538|Ixekizumab|ixekizumab|mesh-list
44392466|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392467|NCT03099187|Pirfenidone|pirfenidone|mesh-list
44392468|NCT03099187|Analgesics|analgesics|mesh-ancestor
44392469|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
44392470|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392471|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392496|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44392497|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392499|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
44392500|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
44392501|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392502|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392503|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392504|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44392505|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44392506|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
44392507|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392508|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392510|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44392511|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44392512|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44392513|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392514|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
44392515|NCT03097315|Hormones|hormones|mesh-ancestor
44392516|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392517|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392518|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44392519|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
44392520|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392521|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392522|NCT03097133|Esketamine|esketamine|mesh-list
44392523|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885136|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43885137|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43885138|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885139|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
43885140|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885141|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43885142|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885143|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885144|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43885145|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43885146|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885147|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885148|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
43885149|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885150|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43885151|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44392524|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392525|NCT03096847|Letrozole|letrozole|mesh-list
44392526|NCT03096847|Goserelin|goserelin|mesh-list
44392527|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392528|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44392529|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44392530|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392531|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392532|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44392533|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
44392534|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392535|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392536|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44392537|NCT03096314|Vitamin D|vitamin d|mesh-list
44392538|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
44392539|NCT03096314|Vitamins|vitamins|mesh-ancestor
44392540|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
44392541|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392542|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44392543|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44392544|NCT03096288|Evolocumab|evolocumab|mesh-list
44392545|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44392546|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44392547|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
44392548|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43696708|NCT02753647|Prednisone|prednisone|mesh-list
43885152|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885153|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43885154|NCT04587778|Ketamine|ketamine|mesh-list
43885155|NCT04587778|Esketamine|esketamine|mesh-list
43885156|NCT04587778|Analgesics|analgesics|mesh-ancestor
43885157|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
43885158|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885159|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885160|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43885161|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43885162|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
43885163|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
43885164|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885165|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43885166|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43885167|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885172|NCT04587505|Tramadol|tramadol|mesh-list
43885173|NCT04587505|Anesthetics|anesthetics|mesh-list
43885174|NCT04587505|Ropivacaine|ropivacaine|mesh-list
43885175|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885176|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885177|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43885178|NCT04587505|Narcotics|narcotics|mesh-ancestor
43885179|NCT04587505|Analgesics|analgesics|mesh-ancestor
43885180|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
44392549|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44392550|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
44392551|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44392552|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392553|NCT03095521|Menthol|menthol|mesh-list
44392554|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
44392555|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392556|NCT03095508|Menthol|menthol|mesh-list
44392557|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
44392558|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392559|NCT03095287|Factor VIII|factor viii|mesh-list
44392560|NCT03095287|Coagulants|coagulants|mesh-ancestor
44392561|NCT03095118|Daratumumab|daratumumab|mesh-list
44392562|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392563|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43696729|NCT02753647|Hormones|hormones|mesh-ancestor
43885181|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885182|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
43885183|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
43885184|NCT04587141|Hematinics|hematinics|mesh-ancestor
43885185|NCT04587115|Oxycodone|oxycodone|mesh-list
43885186|NCT04587115|Risperidone|risperidone|mesh-list
43885187|NCT04587115|Ziprasidone|ziprasidone|mesh-list
43885188|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43885189|NCT04587115|Narcotics|narcotics|mesh-ancestor
43885190|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885191|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885192|NCT04587115|Analgesics|analgesics|mesh-ancestor
43885193|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
43885194|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885195|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43885196|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
43885197|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885198|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885199|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43885200|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43644790|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
43885201|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885202|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43885203|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
43885204|NCT04586543|Docetaxel|docetaxel|mesh-list
43885205|NCT04586543|Selegiline|selegiline|mesh-list
43885206|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885207|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885208|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885209|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885210|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885211|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885212|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885213|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43885214|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43885215|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43885216|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885217|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43885218|NCT04586543|Protective Agents|protective agents|mesh-ancestor
43885219|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885220|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43885221|NCT04586790|Epinephrine|epinephrine|mesh-list
43885222|NCT04586790|Racepinephrine|racepinephrine|mesh-list
43885223|NCT04586790|Midodrine|midodrine|mesh-list
43885224|NCT04586790|Norepinephrine|norepinephrine|mesh-list
43885225|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
43885226|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43885227|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43885228|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885229|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392565|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392566|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44392567|NCT03093870|Capecitabine|capecitabine|mesh-list
44392568|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44392569|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
44392570|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392571|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885230|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885231|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885232|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43885233|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43885234|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
43885235|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885236|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43885237|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
43885238|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
43885239|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
43885240|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43885243|NCT04586790|Coagulants|coagulants|mesh-ancestor
43885244|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43885245|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
43885246|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43885247|NCT04586465|Gemcitabine|gemcitabine|mesh-list
43885249|NCT04586465|Carboplatin|carboplatin|mesh-list
43885250|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
43885252|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885253|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43885254|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
43885255|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885256|NCT04586465|Antiviral Agents|antiviral agents|mesh-ancestor
43885257|NCT04586465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885258|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885259|NCT04586465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885260|NCT04586465|Immunologic Factors|immunologic factors|mesh-ancestor
43885261|NCT04586465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885262|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43885263|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43885264|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43885265|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43885266|NCT04586088|Apatinib|apatinib|mesh-list
43885267|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885268|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43885269|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885270|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885271|NCT04586348|Iodine|iodine|mesh-list
43885272|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
43885273|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43885274|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885275|NCT04586348|Trace Elements|trace elements|mesh-ancestor
43885276|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
43885277|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885278|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
43885279|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43885280|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
43885281|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885282|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
43885283|NCT04586361|Protective Agents|protective agents|mesh-ancestor
43885284|NCT04585997|Omalizumab|omalizumab|mesh-list
43885285|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43885286|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43885287|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
43885288|NCT04585867|Bupivacaine|bupivacaine|mesh-list
43885289|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
43885290|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
43885291|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392572|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
44392573|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392574|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392575|NCT03093415|Grazoprevir|grazoprevir|mesh-list
44392576|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44392577|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
44392578|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392579|NCT03093402|Dronabinol|dronabinol|mesh-list
44392580|NCT03093402|Lenabasum|lenabasum|mesh-list
44392581|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44392582|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44392583|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392584|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392585|NCT03093402|Hormones|hormones|mesh-ancestor
44392586|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392587|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392588|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
44392589|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392590|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392591|NCT03093402|Analgesics|analgesics|mesh-ancestor
44392592|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
44392593|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392594|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44392595|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392596|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44392597|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
44392598|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392599|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44392600|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885292|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885293|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
43885294|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156707|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156708|NCT00232024|Tegaserod|tegaserod|mesh-list
44156709|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44156710|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
44156711|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156712|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156713|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156714|NCT00232037|Tegaserod|tegaserod|mesh-list
44156715|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44156716|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
44156717|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156718|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392602|NCT03092726|Analgesics|analgesics|mesh-ancestor
44392603|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
44392604|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392605|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392606|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
44392607|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
44392608|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392609|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392610|NCT03092375|Ribavirin|ribavirin|mesh-list
44392611|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
44392612|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392613|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
44392614|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156719|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156720|NCT00232050|Omalizumab|omalizumab|mesh-list
44156721|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44156722|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44156723|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
44156724|NCT00232063|Cyclosporine|cyclosporine|mesh-list
44156725|NCT00232063|Cyclosporins|cyclosporins|mesh-list
44156727|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156737|NCT00232076|Cyclosporins|cyclosporins|mesh-list
44156738|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156739|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156740|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156741|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
44156742|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156743|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
44156744|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156745|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156746|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44156747|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44156748|NCT00232089|Tegaserod|tegaserod|mesh-list
44156749|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44156750|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
44156751|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156752|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156753|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156754|NCT00232102|Tegaserod|tegaserod|mesh-list
44156755|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44156756|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
44156757|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156758|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156759|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156760|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
44156761|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44156762|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44156763|NCT00232115|Analgesics|analgesics|mesh-ancestor
44156764|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
44156765|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885295|NCT04585932|Leuprolide|leuprolide|mesh-list
43885296|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43885297|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
43885298|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43885299|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885300|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43885301|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885302|NCT04585334|Diclofenac|diclofenac|mesh-list
43885303|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885304|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392615|NCT03091920|Praliciguat|praliciguat|mesh-list
44392616|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44392617|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
44392618|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392619|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392620|NCT03091777|Metronidazole|metronidazole|mesh-list
44392621|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392622|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44392623|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44392624|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44392625|NCT03091439|Dalbavancin|dalbavancin|mesh-list
44392626|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44392627|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392628|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44392629|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44392630|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44392631|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885305|NCT04585334|Analgesics|analgesics|mesh-ancestor
43885306|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
43885307|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885308|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885309|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885310|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885311|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43885312|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885313|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885314|NCT04585412|Palonosetron|palonosetron|mesh-list
43885315|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
43885316|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
43885317|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885318|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885319|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885320|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43885321|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43885322|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
43885327|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885328|NCT04585438|Analgesics|analgesics|mesh-ancestor
43885329|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
43885330|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885331|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885332|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885333|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885334|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43885335|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885336|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885337|NCT04585321|Diclofenac|diclofenac|mesh-list
43885338|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
43885339|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885340|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885341|NCT04585321|Analgesics|analgesics|mesh-ancestor
43885342|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
43885343|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885344|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885345|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885346|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885347|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44392632|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392633|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
44392634|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392635|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392636|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
44392637|NCT03091348|Testosterone|testosterone|mesh-list
44392638|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
44392639|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
44392640|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44392641|NCT03091348|Androgens|androgens|mesh-ancestor
44392643|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392644|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392645|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44392646|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392647|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
44392648|NCT03090152|Bupivacaine|bupivacaine|mesh-list
44392649|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392650|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
44392651|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392652|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392653|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
44392654|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392655|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
44392656|NCT03089216|Calcium|calcium|mesh-list
44392657|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44392658|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392659|NCT03089216|Antacids|antacids|mesh-ancestor
44392660|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392661|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392662|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
44392665|NCT03087786|Nicotine|nicotine|mesh-list
44392674|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392675|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
44392676|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392677|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
44392678|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392679|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392680|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392681|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392682|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44392683|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44392684|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44392685|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
44392686|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392687|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392688|NCT03086369|Gemcitabine|gemcitabine|mesh-list
44392689|NCT03086369|Paclitaxel|paclitaxel|mesh-list
44392690|NCT03086369|Olaratumab|olaratumab|mesh-list
44392691|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392692|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392693|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392694|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392695|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392696|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392697|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44392698|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
44392699|NCT03086369|Antiviral Agents|antiviral agents|mesh-ancestor
44392700|NCT03086369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392701|NCT03086369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392702|NCT03086369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44392703|NCT03086369|Immunologic Factors|immunologic factors|mesh-ancestor
44392704|NCT03086369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392705|NCT03085914|Leucovorin|leucovorin|mesh-list
44392706|NCT03085914|Gemcitabine|gemcitabine|mesh-list
44392707|NCT03085914|Paclitaxel|paclitaxel|mesh-list
44392708|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43885348|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885349|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885350|NCT04585230|Mineral Oil|mineral oil|mesh-list
43885351|NCT04585230|Emollients|emollients|mesh-ancestor
44392709|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
44392710|NCT03085914|Carboplatin|carboplatin|mesh-list
44392711|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
44392712|NCT03085914|Fluorouracil|fluorouracil|mesh-list
44392713|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
44392714|NCT03085914|Pemetrexed|pemetrexed|mesh-list
44392715|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392716|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392717|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392718|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392719|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392720|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392721|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44392722|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
43885352|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885353|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43885354|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43885355|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43885356|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43885357|NCT04585022|Cimetidine|cimetidine|mesh-list
43885358|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43885359|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885360|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43885361|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
43885362|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
43885363|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885364|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885365|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885366|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43885367|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885368|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885369|NCT04584515|Itraconazole|itraconazole|mesh-list
43885370|NCT04584515|Rifampin|rifampin|mesh-list
43885371|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
43885372|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885373|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43885374|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885375|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885376|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885377|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43885378|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
43885379|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885380|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885381|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43885382|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43885383|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
43885384|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885385|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
43885386|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43885387|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43885388|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43885389|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43885408|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885409|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885411|NCT04584736|Pitavastatin|pitavastatin|mesh-list
43885412|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43885413|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43885414|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
43885415|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392724|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392725|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44392726|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
44392727|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44392728|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44392729|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
44392730|NCT03085914|Antiviral Agents|antiviral agents|mesh-ancestor
44392731|NCT03085914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392732|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392733|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392734|NCT03085914|Antidotes|antidotes|mesh-ancestor
44392735|NCT03085914|Protective Agents|protective agents|mesh-ancestor
43885416|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43885417|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43885418|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885419|NCT04584307|Pomalidomide|pomalidomide|mesh-list
43885420|NCT04584307|Elotuzumab|elotuzumab|mesh-list
43885421|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
43885422|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885423|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43885424|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43885425|NCT04584307|Growth Substances|growth substances|mesh-ancestor
43885426|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
43885427|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885428|NCT04584034|Albuterol|albuterol|mesh-list
43885429|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
43885430|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
43885431|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885432|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885433|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43885434|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
43885435|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
43885436|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43885437|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43885438|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43885439|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43885440|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885441|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156766|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885442|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885443|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43885444|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885445|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885446|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885447|NCT04583813|Empagliflozin|empagliflozin|mesh-list
43885448|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43885455|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885456|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885458|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43885459|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
43885460|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885461|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885463|NCT04583267|Emtricitabine|emtricitabine|mesh-list
43885464|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
43885465|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885466|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43885467|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43885468|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392736|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
44392737|NCT03085914|Vitamins|vitamins|mesh-ancestor
44392738|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
44392739|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44392740|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44392741|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
44392742|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392743|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
44392744|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44392745|NCT03084796|Bromides|bromides|mesh-list
44392746|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
44392747|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44392748|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
44392749|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392750|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392751|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44392752|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
44392753|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
44392754|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44392755|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392756|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392757|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392758|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
44392759|NCT03084536|Acetaminophen|acetaminophen|mesh-list
44392760|NCT03084536|Celecoxib|celecoxib|mesh-list
44392761|NCT03084536|Fentanyl|fentanyl|mesh-list
44392762|NCT03084536|Midazolam|midazolam|mesh-list
44392763|NCT03084536|Gabapentin|gabapentin|mesh-list
44392764|NCT03084536|Bupivacaine|bupivacaine|mesh-list
44392765|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392766|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
44392767|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392768|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392769|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
44392770|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392771|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43885469|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885470|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43885471|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43885472|NCT04583111|Domperidone|domperidone|mesh-list
43885473|NCT04583111|Sulpiride|sulpiride|mesh-list
43885474|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
43885475|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
44392772|NCT03084536|Narcotics|narcotics|mesh-ancestor
44392773|NCT03084536|Analgesics|analgesics|mesh-ancestor
44392774|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44392775|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44392776|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
44392777|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44392778|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44392779|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44392780|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392781|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
44392782|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
44392783|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392784|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392785|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392786|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
44392787|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44392788|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392789|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392790|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44392791|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44392792|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392793|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
44392794|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44392795|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44392796|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
44392797|NCT03084315|Nicotine|nicotine|mesh-list
44392798|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44392799|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
44392800|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392801|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885476|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885477|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885478|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885479|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43885480|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
43885481|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885482|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885483|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43885484|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43885485|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885486|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885487|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43885488|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156767|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156768|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392802|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44392803|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44392804|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
44392805|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392806|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392807|NCT03083990|Bevacizumab|bevacizumab|mesh-list
44392808|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44392809|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392810|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44392811|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44392812|NCT03083990|Growth Substances|growth substances|mesh-ancestor
44392813|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392814|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44392815|NCT03083847|Chloroquine|chloroquine|mesh-list
43696932|NCT02752204|Rituximab|rituximab|mesh-list
44156769|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
44156770|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156771|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
44156772|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44156773|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156774|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156775|NCT00232154|Azithromycin|azithromycin|mesh-list
44156776|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156777|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156778|NCT00232167|Indiplon|indiplon|mesh-list
44156779|NCT00232167|Sertraline|sertraline|mesh-list
44156780|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156781|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156782|NCT00232167|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156783|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156784|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156785|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156786|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156787|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
44156788|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156789|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44156790|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156791|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
44156792|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
44156793|NCT00232206|Cisplatin|cisplatin|mesh-list
43885489|NCT04583046|Iloprost|iloprost|mesh-list
43885490|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43885499|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43885500|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43885501|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43885502|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885503|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885505|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43885506|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
43885507|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885508|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885509|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43885510|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43885511|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885512|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885513|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43885514|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885515|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392817|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
44392818|NCT03083847|Amebicides|amebicides|mesh-ancestor
44392819|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44392820|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44392821|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392822|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
44392823|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392824|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44392825|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392826|NCT03083847|Analgesics|analgesics|mesh-ancestor
44392827|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
44392828|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392829|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392830|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392831|NCT03083847|Filaricides|filaricides|mesh-ancestor
44392832|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
44392833|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
44392834|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44392835|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392836|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885516|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
43885517|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885518|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43885519|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885520|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885521|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885522|NCT04582604|Decitabine|decitabine|mesh-list
43885523|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43885524|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
43885525|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885526|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885527|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885528|NCT04582786|Morphine|morphine|mesh-list
43885529|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43885530|NCT04582786|Narcotics|narcotics|mesh-ancestor
43885531|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885532|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885533|NCT04582786|Analgesics|analgesics|mesh-ancestor
43885534|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
43885535|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885536|NCT04582084|Etanercept|etanercept|mesh-list
43885537|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885538|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885539|NCT04582084|Analgesics|analgesics|mesh-ancestor
43885540|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
43885541|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885542|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885543|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885544|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885545|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885546|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885547|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
43885548|NCT04582136|Sirolimus|sirolimus|mesh-list
44392838|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44392839|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44392840|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44392841|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392842|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392844|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44392845|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392846|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392847|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
44392848|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
44392849|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392850|NCT03083132|Modafinil|modafinil|mesh-list
44392851|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44392852|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392853|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44392854|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44392855|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44392856|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392857|NCT03082729|Apremilast|apremilast|mesh-list
44392858|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885549|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885550|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885551|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43885552|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885553|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
43885554|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885555|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
43885556|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885559|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885560|NCT04582032|Analgesics|analgesics|mesh-ancestor
43885561|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
43885562|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885563|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885564|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43885566|NCT04582097|Ramipril|ramipril|mesh-list
43885567|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43885568|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
43885569|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885570|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885571|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885573|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43885574|NCT04581876|Raltitrexed|raltitrexed|mesh-list
43885575|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43885576|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885577|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44392860|NCT03082729|Analgesics|analgesics|mesh-ancestor
44392861|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
44392862|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392863|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392864|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392865|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392866|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44392867|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44392868|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392869|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392870|NCT03082677|Ixazomib|ixazomib|mesh-list
44392871|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44392872|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
44392873|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392874|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392875|NCT03080493|Acetaminophen|acetaminophen|mesh-list
44392876|NCT03080493|Ibuprofen|ibuprofen|mesh-list
44392877|NCT03080493|Gabapentin|gabapentin|mesh-list
44392878|NCT03080493|Codeine|codeine|mesh-list
44392879|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43885578|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885579|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885580|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885581|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43885582|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
43885583|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43885584|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885585|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
43885586|NCT04581967|Doxorubicin|doxorubicin|mesh-list
43885587|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885588|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
43885589|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885590|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885591|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43885592|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
43885593|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885594|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885595|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43885596|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43885597|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43885598|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43885599|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885600|NCT04581213|Anesthetics|anesthetics|mesh-list
43885601|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885602|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885603|NCT04581408|Ivacaftor|ivacaftor|mesh-list
43885604|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43885605|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885606|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885607|NCT04581265|Paclitaxel|paclitaxel|mesh-list
43885608|NCT04581265|Cisplatin|cisplatin|mesh-list
43885609|NCT04581265|Ifosfamide|ifosfamide|mesh-list
44392880|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44392881|NCT03080493|Analgesics|analgesics|mesh-ancestor
44392882|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
44392883|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392884|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392885|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
44392886|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44392887|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44392888|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44392889|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44392890|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44392891|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392892|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
44392893|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44392894|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44392895|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44050206|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
44392896|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44392897|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44392898|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44392899|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44392900|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
44392931|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392932|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44392933|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44392934|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44392935|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44392936|NCT03077919|Ropivacaine|ropivacaine|mesh-list
44392937|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
44392938|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
44392939|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44392940|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392941|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
44392942|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44392943|NCT03077711|Trimethoprim|trimethoprim|mesh-list
44392944|NCT03077711|Methenamine|methenamine|mesh-list
44392945|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
44392946|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
44392947|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44392948|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392949|NCT03077711|Renal Agents|renal agents|mesh-ancestor
44392950|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
44392951|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44392986|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392987|NCT03077607|Itraconazole|itraconazole|mesh-list
44392988|NCT03077607|Rifampin|rifampin|mesh-list
44392989|NCT03077607|Talazoparib|talazoparib|mesh-list
44392990|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
44392991|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44392992|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44392993|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44392994|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839230|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44392995|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44392996|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44392997|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
44392998|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44392999|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393000|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44393001|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44393002|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
44393003|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44393004|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
44393005|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44393006|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44393007|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44393008|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44393009|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44393010|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44393011|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44393012|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44393013|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393014|NCT03077438|Vaccines|vaccines|mesh-list
44393015|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
44393017|NCT03076970|Sumatriptan|sumatriptan|mesh-list
44393024|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393025|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393026|NCT03075891|Doxycycline|doxycycline|mesh-list
44393027|NCT03075891|Ivermectin|ivermectin|mesh-list
44393028|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44393029|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393030|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
44393031|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44393032|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44393033|NCT03075826|Guadecitabine|guadecitabine|mesh-list
44393034|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393035|NCT03075527|Durvalumab|durvalumab|mesh-list
44393036|NCT03075527|Tremelimumab|tremelimumab|mesh-list
44393037|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393038|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393039|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44393040|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393041|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393042|NCT03075410|GSK656|gsk656|mesh-list
44393043|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44393044|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393045|NCT03075267|Budesonide|budesonide|mesh-list
44393046|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
44393047|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
44393048|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393049|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44393050|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
44393051|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393052|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393053|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44393054|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
44393055|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
44393056|NCT03075267|Hormones|hormones|mesh-ancestor
44393057|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393065|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44393066|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44393067|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393068|NCT03075163|Ondansetron|ondansetron|mesh-list
44393069|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
44393070|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
44393071|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393072|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393073|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393074|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
44393075|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393076|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44393077|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
44393078|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393079|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393080|NCT03075163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44393081|NCT03075163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44393082|NCT03075163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393083|NCT03075163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393084|NCT03075163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44393085|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
44393086|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44393087|NCT03074331|Velpatasvir|velpatasvir|mesh-list
44393088|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
44393089|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393090|NCT03074162|Diclofenac|diclofenac|mesh-list
44393091|NCT03074162|Capsaicin|capsaicin|mesh-list
44393092|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44393114|NCT03073200|Etanercept|etanercept|mesh-list
44393115|NCT03073200|Ixekizumab|ixekizumab|mesh-list
44393116|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44393117|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393118|NCT03073200|Analgesics|analgesics|mesh-ancestor
44393119|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
44393120|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393121|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44050453|NCT00003741|Antibodies|antibodies|mesh-list
44393122|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393123|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44393124|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393125|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393126|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
44393127|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393129|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
44393130|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
44393131|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
44393132|NCT03072719|Protective Agents|protective agents|mesh-ancestor
44393133|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393134|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
44393135|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393136|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393137|NCT03071276|Cytarabine|cytarabine|mesh-list
44393138|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
44393139|NCT03071276|Methotrexate|methotrexate|mesh-list
44393140|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
44393141|NCT03071276|Fludarabine|fludarabine|mesh-list
44393142|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44393143|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
44393144|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44393145|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393146|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44393147|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
44393148|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393149|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393150|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393151|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393152|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44393153|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393154|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
44393155|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44393156|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44393157|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
44393158|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393159|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393160|NCT03071263|Spironolactone|spironolactone|mesh-list
44393161|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44393162|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
44393163|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393164|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393165|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44393166|NCT03071263|Diuretics|diuretics|mesh-ancestor
44393167|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
44393168|NCT03071094|Nivolumab|nivolumab|mesh-list
44393169|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393170|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786255|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43786258|NCT05105919|Aspirin|aspirin|mesh-list
44393171|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393172|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393173|NCT03070483|Vitamin D|vitamin d|mesh-list
44393174|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
44393175|NCT03070483|Vitamins|vitamins|mesh-ancestor
44393202|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44393203|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
44393204|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393205|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393206|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
44393207|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393208|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393209|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
44393210|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393211|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
44393212|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
44393213|NCT03069313|Vitamins|vitamins|mesh-ancestor
44393214|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
44393215|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393216|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
44393217|NCT03069313|Hematinics|hematinics|mesh-ancestor
44393218|NCT03068767|Vitamin D|vitamin d|mesh-list
44393219|NCT03068767|Vitamins|vitamins|mesh-ancestor
44393220|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
44393221|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393222|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44393223|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44393224|NCT03068754|Hormones|hormones|mesh-ancestor
44393227|NCT03068455|Nivolumab|nivolumab|mesh-list
44393251|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393252|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44393253|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44393254|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393255|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44393256|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44393257|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393258|NCT03066778|Cisplatin|cisplatin|mesh-list
44393259|NCT03066778|Carboplatin|carboplatin|mesh-list
44393260|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
44393261|NCT03066778|Etoposide|etoposide|mesh-list
44393262|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393263|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393264|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44393265|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44393266|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44393267|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393268|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393269|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44393270|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
44393271|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393272|NCT03066193|Palmidrol|palmidrol|mesh-list
44393273|NCT03066193|Dronabinol|dronabinol|mesh-list
44393274|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
44393275|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393276|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393277|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393297|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393298|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
44393299|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
44393300|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44393301|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44393302|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393303|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393304|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393305|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393306|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
44393307|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44393308|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393309|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393310|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393311|NCT03065530|Analgesics|analgesics|mesh-ancestor
44393312|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
44393313|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393314|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44393315|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44393316|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393317|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393318|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393319|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393320|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
44393321|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393345|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393346|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393348|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44393349|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44393350|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393351|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44393352|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393353|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393354|NCT03061214|Incretins|incretins|mesh-ancestor
44393355|NCT03061214|Hormones|hormones|mesh-ancestor
44393356|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393357|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44393358|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
44393359|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393360|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393361|NCT03061188|Nivolumab|nivolumab|mesh-list
44393362|NCT03061188|Veliparib|veliparib|mesh-list
44393363|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393364|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393365|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393366|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393367|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44393368|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393369|NCT03060512|Naloxegol|naloxegol|mesh-list
44393391|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393392|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393393|NCT03057600|Paclitaxel|paclitaxel|mesh-list
44393394|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44393395|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393396|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
44393397|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
44393398|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
44393399|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393400|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
44393401|NCT03056352|Promethazine|promethazine|mesh-list
44393402|NCT03056352|Metoclopramide|metoclopramide|mesh-list
44393403|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44393404|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44393405|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393406|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393407|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
44393408|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
44393409|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
44393410|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393411|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
44393412|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
44393413|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885610|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43885611|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43885612|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885613|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885614|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885615|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885616|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885617|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43885618|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
43885619|NCT04580797|PF-06700841|pf-06700841|mesh-list
43885620|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43885621|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885622|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156794|NCT00232206|Docetaxel|docetaxel|mesh-list
44156795|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156796|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
44156797|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
44156798|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
44156799|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156800|NCT00232271|Enoxaparin|enoxaparin|mesh-list
43885625|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885626|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885627|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43885628|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43885629|NCT04580342|Propranolol|propranolol|mesh-list
43885630|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43885631|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43885632|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885633|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885634|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393418|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393419|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44393420|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
44393421|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393422|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44393423|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44393424|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
44393425|NCT03056040|Eculizumab|eculizumab|mesh-list
44393426|NCT03056040|Ravulizumab|ravulizumab|mesh-list
44393427|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44393428|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393429|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
44393430|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393431|NCT03055988|Fluticasone|fluticasone|mesh-list
44393433|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
44393434|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44393435|NCT03055988|Olodaterol|olodaterol|mesh-list
44393436|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393437|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44393438|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
44393439|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393440|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393441|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44393442|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
44393443|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393444|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44393445|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
44393446|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44393447|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393448|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885635|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885636|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43885637|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885638|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
44393449|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393450|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44393451|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44393452|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393453|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393454|NCT03055936|Levodopa|levodopa|mesh-list
44393455|NCT03055936|Carbidopa|carbidopa|mesh-list
44393456|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44393457|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44393458|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
44393459|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393460|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393461|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393462|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44393463|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393464|NCT03055338|Risperidone|risperidone|mesh-list
44393465|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44393466|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
44393467|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393468|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393514|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393515|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
44393516|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44393517|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44393518|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44393519|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44393520|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393521|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393522|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393523|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885655|NCT04580199|Ethanol|ethanol|mesh-list
43885656|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43885657|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885658|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885659|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885660|NCT04580498|Paclitaxel|paclitaxel|mesh-list
43885661|NCT04580498|Carboplatin|carboplatin|mesh-list
43885662|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43885663|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885664|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885665|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885666|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885667|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885668|NCT04579731|Lactitol|lactitol|mesh-list
43885669|NCT04579731|Cathartics|cathartics|mesh-ancestor
43885670|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885671|NCT04579302|Bupivacaine|bupivacaine|mesh-list
44393524|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44393525|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393526|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
44393527|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44393528|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
44393529|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393530|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
44393531|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44393532|NCT03052517|Growth Substances|growth substances|mesh-ancestor
44393533|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393534|NCT03052400|Mifepristone|mifepristone|mesh-list
44393535|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44393536|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
44393537|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44393538|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393539|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44393540|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44393541|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44393542|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
44393543|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44393544|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44393545|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
44050837|NCT00003796|Irofulven|irofulven|mesh-list
44393546|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393547|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
44393548|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44393549|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44393550|NCT03052322|Adalimumab|adalimumab|mesh-list
44393551|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44393552|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44393553|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
44393554|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393555|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393556|NCT03051620|Alendronate|alendronate|mesh-list
44393562|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44393563|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44393564|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
44393565|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393566|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44393567|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44393568|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393569|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393570|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393571|NCT03050450|Lenalidomide|lenalidomide|mesh-list
44393572|NCT03050450|Vorinostat|vorinostat|mesh-list
44393573|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
44393574|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393575|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44393576|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44393577|NCT03050450|Growth Substances|growth substances|mesh-ancestor
44393578|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
44393579|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393580|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44393581|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393582|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393583|NCT03050398|Letrozole|letrozole|mesh-list
44393584|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393585|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44393586|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44393587|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393588|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393589|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44393590|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
43885672|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
43885673|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
43885674|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885675|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885676|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
43885677|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885678|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43885679|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43885680|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43885681|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885682|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885683|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43885684|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163846|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393591|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393592|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393594|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
44393595|NCT03050359|Bismuth|bismuth|mesh-list
44393596|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44393597|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393598|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44393599|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393600|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393601|NCT03050359|Antacids|antacids|mesh-ancestor
44393602|NCT03050307|Lansoprazole|lansoprazole|mesh-list
44393603|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
44393604|NCT03050307|Bismuth|bismuth|mesh-list
44393605|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44393606|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393607|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44393608|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393609|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393610|NCT03050307|Antacids|antacids|mesh-ancestor
44393611|NCT03050060|Nelfinavir|nelfinavir|mesh-list
44393612|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
44393613|NCT03050060|Nivolumab|nivolumab|mesh-list
44393614|NCT03050060|Atezolizumab|atezolizumab|mesh-list
44393615|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44393616|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393617|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393618|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393619|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393620|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
44393621|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393622|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44393623|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44393624|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
44393625|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393626|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44393627|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44393630|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44393631|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44393632|NCT03049735|Norethindrone|norethindrone|mesh-list
44393633|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
44393634|NCT03049735|Estradiol|estradiol|mesh-list
44393635|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44393636|NCT03049735|Relugolix|relugolix|mesh-list
44393637|NCT03049735|Estrogens|estrogens|mesh-ancestor
44393638|NCT03049735|Hormones|hormones|mesh-ancestor
44393639|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393640|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393641|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44393642|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
44393643|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44393644|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44393645|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44393646|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44393647|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44393648|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
44393649|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
44393650|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
44393651|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393652|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393653|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44393654|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44393655|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
44393657|NCT03049488|Antacids|antacids|mesh-ancestor
44393678|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44393679|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44393680|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
44393681|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393682|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44393683|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44393684|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393685|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393686|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44393687|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44393688|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44393694|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44393738|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393739|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393740|NCT03043651|Treprostinil|treprostinil|mesh-list
44393741|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393742|NCT03043560|Ezogabine|ezogabine|mesh-list
44393743|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
44393744|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44393745|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44051067|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
44393747|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44393748|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393749|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393750|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393751|NCT03042611|Apatinib|apatinib|mesh-list
44393752|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393753|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44393754|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393755|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393756|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
44393757|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44393792|NCT03041181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393793|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
44393794|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
44393795|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
44393796|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44393797|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44393798|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44393799|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44393800|NCT03040024|Ketamine|ketamine|mesh-list
44393801|NCT03040024|Analgesics|analgesics|mesh-ancestor
44393802|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
44393803|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393804|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393805|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44393806|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44393807|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
44393808|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
44393809|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393810|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44393811|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44393812|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393813|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393814|NCT03039192|Esketamine|esketamine|mesh-list
44393815|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
44393816|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393817|NCT03039023|Choline|choline|mesh-list
44393818|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
44393819|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44393820|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
44393821|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393822|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393823|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44393824|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
44393833|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393834|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393835|NCT03038620|Incretins|incretins|mesh-ancestor
44393836|NCT03038620|Hormones|hormones|mesh-ancestor
44393837|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393838|NCT03037580|Treprostinil|treprostinil|mesh-list
44393839|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393840|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
44393841|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44393842|NCT03036852|Velpatasvir|velpatasvir|mesh-list
44393843|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
44393844|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393845|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
44393846|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44393847|NCT03036839|Ledipasvir|ledipasvir|mesh-list
44393848|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
44393849|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393850|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
44393851|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44393852|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393853|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44393854|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393855|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
44393856|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43885685|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885698|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43885699|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885700|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885702|NCT04578470|Vitamins|vitamins|mesh-ancestor
43885703|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
43885704|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885705|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43885706|NCT04578496|Afamelanotide|afamelanotide|mesh-list
43885707|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885708|NCT04578236|Tretinoin|tretinoin|mesh-list
43885709|NCT04578236|Captopril|captopril|mesh-list
43885710|NCT04578236|Isotretinoin|isotretinoin|mesh-list
43885711|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885712|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
43885713|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885714|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43885715|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
43885716|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885717|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885718|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885719|NCT04578158|Quercetin|quercetin|mesh-list
43885720|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
43885721|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885722|NCT04578158|Protective Agents|protective agents|mesh-ancestor
43885723|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885724|NCT04577846|Cephalexin|cephalexin|mesh-list
44393857|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393859|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393860|NCT03035942|Dexamethasone|dexamethasone|mesh-list
44393861|NCT03035942|Ondansetron|ondansetron|mesh-list
44393862|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786306|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
44393863|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
44393864|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
44393865|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393866|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393867|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44393868|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
44393869|NCT03035942|Hormones|hormones|mesh-ancestor
44393870|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44393871|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44393872|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393873|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
44393874|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393875|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43885725|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885726|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885727|NCT04577885|Rifampin|rifampin|mesh-list
43885728|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43885729|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
43885730|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885731|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885732|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
43885733|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43885734|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885735|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885736|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43885737|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43885738|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43885739|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43885740|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43885741|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44156806|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156807|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156808|NCT00232284|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156809|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44156810|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156811|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156812|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156824|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156825|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156826|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156827|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156828|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156829|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44156830|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
44156831|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156832|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
44156833|NCT00232362|Pioglitazone|pioglitazone|mesh-list
44393877|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393878|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393879|NCT03035942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44393880|NCT03035942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44393881|NCT03035942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393882|NCT03035942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44393883|NCT03035942|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44393884|NCT03035916|Anesthetics|anesthetics|mesh-list
44393885|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44393886|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393887|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
44393888|NCT03035032|Leuprolide|leuprolide|mesh-list
44393889|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44393890|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
44393891|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44393892|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393893|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44393894|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393895|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44393896|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44393897|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
44393898|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393899|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393900|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44393901|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
44393902|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44393903|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44393904|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44393905|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393906|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393907|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393908|NCT03034772|Timolol|timolol|mesh-list
44393909|NCT03034772|Dorzolamide|dorzolamide|mesh-list
44393910|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
43697825|NCT02751034|Lidocaine|lidocaine|mesh-list
44156834|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
43885742|NCT04577378|Itraconazole|itraconazole|mesh-list
44393911|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44393912|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44393913|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
44393914|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393915|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393916|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393917|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44393918|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393919|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44393920|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44393921|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44393922|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393923|NCT03034577|Neostigmine|neostigmine|mesh-list
43697850|NCT02750696|Tramadol|tramadol|mesh-list
43885743|NCT04577378|Tretinoin|tretinoin|mesh-list
43885744|NCT04577378|Isotretinoin|isotretinoin|mesh-list
43885745|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
43885746|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885747|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43885748|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885749|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885750|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885751|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43885752|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
43885753|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885754|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885755|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43885756|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885757|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
43885758|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885759|NCT04577027|Travoprost|travoprost|mesh-list
43885760|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885761|NCT04577040|Tadalafil|tadalafil|mesh-list
43885762|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
43885763|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43885764|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43885765|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885766|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885767|NCT04577040|Urological Agents|urological agents|mesh-ancestor
43885768|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
43885769|NCT04576975|Ketamine|ketamine|mesh-list
43885770|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43885771|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885772|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885773|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885774|NCT04576975|Analgesics|analgesics|mesh-ancestor
43885775|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
43885776|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885777|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43885778|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43885779|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43885780|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885781|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165313|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43885789|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
43885790|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43885791|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786309|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885792|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885793|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44393924|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44393925|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393926|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393927|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393928|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44393929|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393930|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44393931|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
44393932|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393933|NCT03034135|Copper|copper|mesh-list
44393934|NCT03034135|Temozolomide|temozolomide|mesh-list
44393935|NCT03034135|Disulfiram|disulfiram|mesh-list
44393936|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44393937|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
44393938|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393939|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393940|NCT03034135|Trace Elements|trace elements|mesh-ancestor
44393941|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
44393942|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393943|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44393944|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44393945|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44393946|NCT03033784|Oxytocin|oxytocin|mesh-list
44393947|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
44393948|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44393949|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393950|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44393951|NCT03033394|Penicillins|penicillins|mesh-list
44393952|NCT03033394|Lactams|lactams|mesh-list
44393953|NCT03033394|beta-Lactams|beta-lactams|mesh-list
44393954|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393955|NCT03032380|Meropenem|meropenem|mesh-list
44393956|NCT03032380|Linezolid|linezolid|mesh-list
44393957|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44393958|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393959|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43697865|NCT02750670|Cisplatin|cisplatin|mesh-list
44393964|NCT03031899|Coagulants|coagulants|mesh-ancestor
44393965|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
44393966|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393967|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44393969|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
44393970|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44393971|NCT03031496|Diuretics|diuretics|mesh-ancestor
44393972|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
44393973|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393974|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44393975|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44393976|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44393977|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44393978|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44393979|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44393980|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44393981|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
44393982|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44393983|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44393984|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44393985|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
44393986|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
44393987|NCT03029832|Atezolizumab|atezolizumab|mesh-list
44393988|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44393989|NCT03029819|Nicotine|nicotine|mesh-list
44393990|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44393991|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
44393992|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44393993|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44393994|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44393995|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44393996|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
44393997|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394003|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
44394004|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394005|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394006|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394007|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
44394008|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44394009|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
44394010|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394011|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394012|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44394013|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
44394014|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
44394015|NCT03029247|Hematinics|hematinics|mesh-ancestor
44394016|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
44394017|NCT03029208|Hematinics|hematinics|mesh-ancestor
44394018|NCT03029143|Vedolizumab|vedolizumab|mesh-list
44394019|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394020|NCT03028870|Naproxen|naproxen|mesh-list
44394021|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44394022|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394023|NCT03028870|Analgesics|analgesics|mesh-ancestor
44394024|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
44394025|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394026|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394027|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394028|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394029|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
44394030|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44394031|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394032|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394033|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
44394034|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394035|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
44394036|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394037|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394038|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44394039|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394042|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44394043|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394044|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394045|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44051372|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394046|NCT03028129|Isoniazid|isoniazid|mesh-list
44394047|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394048|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
44394049|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44394050|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44394051|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
44394052|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394053|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44394054|NCT03028012|Dexamethasone|dexamethasone|mesh-list
44394055|NCT03028012|Ketorolac|ketorolac|mesh-list
44394056|NCT03028012|Lidocaine|lidocaine|mesh-list
44394057|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394058|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
44394059|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
44394064|NCT03028012|Hormones|hormones|mesh-ancestor
44394097|NCT03026166|Nivolumab|nivolumab|mesh-list
44394098|NCT03026166|Ipilimumab|ipilimumab|mesh-list
44394099|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394100|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394101|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44394102|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394103|NCT03026088|Bisoprolol|bisoprolol|mesh-list
44394104|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44394105|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
44394106|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
44394107|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394108|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394109|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44394110|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44394111|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44394112|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394113|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394114|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394115|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44394116|NCT03025828|Hormones|hormones|mesh-ancestor
44394153|NCT03023046|Dasatinib|dasatinib|mesh-list
44394154|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
44394155|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44394156|NCT03023046|Antibodies|antibodies|mesh-list
44394157|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
44394158|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44394159|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394160|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
44394161|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394162|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394163|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44394164|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
44394165|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394216|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
44394217|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
44394218|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394219|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394220|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394221|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44394222|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394223|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44394224|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394225|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394226|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
44394227|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
44394228|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394229|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394230|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
44394231|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394232|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
44394233|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394234|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394235|NCT03020966|Acetaminophen|acetaminophen|mesh-list
44394236|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394237|NCT03020966|Analgesics|analgesics|mesh-ancestor
44394238|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
44394239|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394240|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394241|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
43698010|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698011|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
43698012|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43698013|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43698014|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43698015|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43698017|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
44394243|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44394244|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394245|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
44394246|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
44394247|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394248|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
44394249|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394250|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394251|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394252|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44394253|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44394254|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44394255|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44394256|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
44394257|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394258|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
44394259|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394260|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394261|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44394262|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44394263|NCT03020407|Dopamine|dopamine|mesh-list
44394264|NCT03020407|Epinephrine|epinephrine|mesh-list
44394265|NCT03020407|Norepinephrine|norepinephrine|mesh-list
44394266|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44394267|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394268|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44394269|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44394270|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394271|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394272|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394273|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43698021|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885794|NCT04577430|Analgesics|analgesics|mesh-ancestor
43885795|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
43670562|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
43885796|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885797|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43885798|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43885799|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44394274|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44394275|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394276|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
44394277|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394278|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44394279|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394280|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
44394281|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
44394282|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44394283|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
44394284|NCT03020407|Protective Agents|protective agents|mesh-ancestor
44394285|NCT03019965|Meropenem|meropenem|mesh-list
44394286|NCT03019965|Tazobactam|tazobactam|mesh-list
44394287|NCT03019965|Piperacillin|piperacillin|mesh-list
44394288|NCT03019965|Imipenem|imipenem|mesh-list
44394289|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44394290|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44394291|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394292|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44394293|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394294|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394295|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44394296|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44394297|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44394298|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
44394299|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394300|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44394301|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44394302|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394303|NCT03018938|Insulin|insulin|mesh-list
44394304|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44394305|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394318|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394319|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394320|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44394322|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
44394323|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44394324|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44394325|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44394326|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44394327|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
44394328|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44394329|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394330|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44394331|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44394332|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44394333|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394334|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394335|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394336|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394337|NCT03018106|Estrogens|estrogens|mesh-list
44394338|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43885800|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885801|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885802|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885803|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
43885804|NCT04576364|Analgesics|analgesics|mesh-ancestor
43885805|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
43885806|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885807|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885808|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
43885809|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885810|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43885811|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
43885812|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43885813|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885814|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885815|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43885816|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
43885817|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43885818|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
43885819|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885820|NCT04576143|Paclitaxel|paclitaxel|mesh-list
43885821|NCT04576143|Docetaxel|docetaxel|mesh-list
43885822|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
43885823|NCT04576143|Epirubicin|epirubicin|mesh-list
43885824|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43885825|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885826|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
43885827|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
43885828|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
43885829|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885830|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394339|NCT03018106|Hormones|hormones|mesh-ancestor
44394340|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394341|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394342|NCT03018028|Liraglutide|liraglutide|mesh-list
44394343|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394344|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394345|NCT03018028|Incretins|incretins|mesh-ancestor
44394346|NCT03018028|Hormones|hormones|mesh-ancestor
44394347|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394348|NCT03017846|Cantharidin|cantharidin|mesh-list
44394349|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394350|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394351|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
44394352|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
44394353|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
44394354|NCT03017235|Citric Acid|citric acid|mesh-list
44394355|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
44394356|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44394357|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
44394358|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
44394359|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394360|NCT03017235|Cathartics|cathartics|mesh-ancestor
44394393|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394394|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
44394395|NCT03012334|Alprazolam|alprazolam|mesh-list
44394396|NCT03012334|Lasmiditan|lasmiditan|mesh-list
44394397|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44394398|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394399|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394400|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44394401|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394402|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394403|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
44394404|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
44394405|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394406|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394407|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44394408|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
44394409|NCT03012061|Fluticasone|fluticasone|mesh-list
44394411|NCT03012061|Albuterol|albuterol|mesh-list
44394412|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394413|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394414|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
44394415|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394416|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394417|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44394418|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394419|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885831|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
43885832|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885833|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653954|NCT02980562|Laxatives|laxatives|mesh-ancestor
43885834|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43885835|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
43885836|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43885837|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43885838|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43885839|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43885840|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885841|NCT04576390|Ondansetron|ondansetron|mesh-list
43885842|NCT04576390|Palonosetron|palonosetron|mesh-list
43885843|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
43885844|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
43885845|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885846|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885847|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43885848|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
43885849|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885850|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43885851|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
43885852|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885853|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394420|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44394421|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
44394422|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44394423|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44394424|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44394425|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44394426|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394427|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394428|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394429|NCT03011892|Triamcinolone|triamcinolone|mesh-list
44394430|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394431|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
44394432|NCT03011892|Hormones|hormones|mesh-ancestor
44394433|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394434|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394435|NCT03011333|Epinephrine|epinephrine|mesh-list
44051802|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
44394436|NCT03011333|Bupivacaine|bupivacaine|mesh-list
44394438|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
44394439|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394440|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394441|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
44394442|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394443|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44394444|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44394445|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394446|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394447|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394448|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44394449|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394450|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
44394451|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44394452|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394453|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
44394454|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
44394455|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43885854|NCT04576390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43885855|NCT04576390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394457|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44394458|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44394459|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
44394460|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
44394461|NCT03010423|Vitamins|vitamins|mesh-ancestor
44394462|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
44394463|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394464|NCT03008915|Aspirin|aspirin|mesh-list
44394465|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43653958|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
44394466|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
44394467|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44394468|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394469|NCT03008915|Analgesics|analgesics|mesh-ancestor
44394470|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
44394471|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394472|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394473|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394474|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394475|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44394476|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44394477|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394478|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44394479|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44394480|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394481|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
44394482|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44394483|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44394484|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
44394485|NCT03008005|Dronabinol|dronabinol|mesh-list
43885856|NCT04576390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43885857|NCT04576390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885858|NCT04576390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43885859|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43885861|NCT04575779|Cyclosporins|cyclosporins|mesh-list
43885862|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885863|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885864|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43885865|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
43885866|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885867|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
43885868|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885869|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
43885870|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885871|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43885872|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
43885873|NCT04575675|Valsartan|valsartan|mesh-list
44394486|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
44394487|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394488|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394489|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394490|NCT03008005|Analgesics|analgesics|mesh-ancestor
44394491|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
44394492|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394493|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44394494|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44394495|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394496|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394498|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394499|NCT03007979|Letrozole|letrozole|mesh-list
44394500|NCT03007979|Fulvestrant|fulvestrant|mesh-list
44394501|NCT03007979|Palbociclib|palbociclib|mesh-list
44394502|NCT03007979|Goserelin|goserelin|mesh-list
44394503|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394504|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44394505|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44394506|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394507|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394508|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44394509|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
44394510|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885874|NCT04575675|Carvedilol|carvedilol|mesh-list
43885875|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43885876|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43885877|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
43885878|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43885879|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43885880|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43885881|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43786314|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
43885882|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885883|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43885884|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43885885|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885886|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43885887|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
43885888|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885889|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
43885890|NCT04575675|Protective Agents|protective agents|mesh-ancestor
43885891|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43885892|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885893|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43885894|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
43885895|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44051882|NCT00003945|Cisplatin|cisplatin|mesh-list
44394511|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394512|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394513|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44394514|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44394516|NCT03007966|Epinephrine|epinephrine|mesh-list
44394517|NCT03007966|Bupivacaine|bupivacaine|mesh-list
44394518|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
44394519|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
44394520|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394521|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394522|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
44394523|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394524|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44394525|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44394526|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
44394527|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394528|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394529|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44394530|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394531|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
44394532|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43698102|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
43885896|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43885897|NCT04575675|Hormones|hormones|mesh-ancestor
43885898|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885899|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
43885900|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43885901|NCT04575675|Diuretics|diuretics|mesh-ancestor
43885902|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
43885903|NCT04575558|Azithromycin|azithromycin|mesh-list
43885904|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
43885905|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885906|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885907|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
43885908|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43885909|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43885910|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885911|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885912|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43885913|NCT04575519|Aspirin|aspirin|mesh-list
43885914|NCT04575519|Ibuprofen|ibuprofen|mesh-list
43885915|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43885916|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43885917|NCT04575519|Analgesics|analgesics|mesh-ancestor
43885918|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
43885919|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885920|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885929|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
43885930|NCT04575194|Liraglutide|liraglutide|mesh-list
43885931|NCT04575194|Naltrexone|naltrexone|mesh-list
43885932|NCT04575194|Bupropion|bupropion|mesh-list
43885933|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44394533|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394534|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
44394535|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
44394536|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44394537|NCT03007966|Analgesics|analgesics|mesh-ancestor
43786318|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
44394538|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44394539|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
44394540|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44394541|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44394542|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44394543|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
44394544|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394545|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44394546|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44394547|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
44394548|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
44394549|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394550|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394551|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
44394552|NCT03006887|Lenvatinib|lenvatinib|mesh-list
44394553|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394554|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394555|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44394556|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394557|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394558|NCT03006848|Avelumab|avelumab|mesh-list
43885934|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43885935|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885936|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
43885937|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43885938|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43885939|NCT04575194|Incretins|incretins|mesh-ancestor
43885940|NCT04575194|Hormones|hormones|mesh-ancestor
43885941|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43885942|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43885943|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
43885944|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43885945|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43885946|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43885947|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43885948|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885949|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
43885950|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43885951|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43885952|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43885953|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885954|NCT04575415|Bevacizumab|bevacizumab|mesh-list
44394559|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394561|NCT03006562|Heparin|heparin|mesh-list
44394562|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
44394563|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44394564|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44394565|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394566|NCT03006393|Infliximab|infliximab|mesh-list
44394567|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44394568|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394569|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394570|NCT03006341|Telmisartan|telmisartan|mesh-list
44394571|NCT03006341|Warfarin|warfarin|mesh-list
44394572|NCT03006341|Dabigatran|dabigatran|mesh-list
44394573|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
44394574|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44394575|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44394576|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44394577|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394578|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
44394579|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44394580|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
44394581|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394583|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44394584|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44394585|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394586|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394587|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
44394588|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394589|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394590|NCT03004469|Urological Agents|urological agents|mesh-ancestor
44394591|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
44394592|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
44394593|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43698149|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43885955|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43885956|NCT04575415|Gefitinib|gefitinib|mesh-list
43885957|NCT04575415|Osimertinib|osimertinib|mesh-list
43885958|NCT04575415|Afatinib|afatinib|mesh-list
44394595|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394596|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394597|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44394598|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
44394599|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394600|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394601|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44394602|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394603|NCT03003520|Prednisone|prednisone|mesh-list
44394604|NCT03003520|Prednisolone|prednisolone|mesh-list
44394605|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
44394606|NCT03003520|Rituximab|rituximab|mesh-list
44394607|NCT03003520|Doxorubicin|doxorubicin|mesh-list
44394608|NCT03003520|Vincristine|vincristine|mesh-list
44394609|NCT03003520|Lenalidomide|lenalidomide|mesh-list
44394610|NCT03003520|Durvalumab|durvalumab|mesh-list
44394611|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394612|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
44394613|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394614|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394615|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44394616|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
44394617|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394618|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394619|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44394620|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43698184|NCT02748304|Aspirin|aspirin|mesh-list
43885959|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43885960|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885961|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43885962|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43885963|NCT04575415|Growth Substances|growth substances|mesh-ancestor
43885964|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885965|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
43885966|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43885967|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885968|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885969|NCT04575389|Uric Acid|uric acid|mesh-list
43885970|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
43885971|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885972|NCT04575389|Protective Agents|protective agents|mesh-ancestor
43885973|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43885974|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
43885975|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43885976|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394621|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44394622|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44394623|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44394624|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394625|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394626|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
44394627|NCT03003520|Hormones|hormones|mesh-ancestor
44394628|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394629|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394630|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44394631|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394632|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394633|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394634|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44394635|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44394636|NCT03003520|Growth Substances|growth substances|mesh-ancestor
44394637|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
44394638|NCT03003390|Enoxaparin|enoxaparin|mesh-list
44394639|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
44394640|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44394641|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44394642|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394643|NCT03003000|Ibuprofen|ibuprofen|mesh-list
44394644|NCT03003000|Caffeine|caffeine|mesh-list
44394645|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44394646|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394647|NCT03003000|Analgesics|analgesics|mesh-ancestor
44394648|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
44394649|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394650|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394651|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394652|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394653|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44394654|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394655|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394656|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44394657|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44394658|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44394660|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
44394661|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394662|NCT03002038|Rituximab|rituximab|mesh-list
44394663|NCT03002038|Azathioprine|azathioprine|mesh-list
44394664|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394665|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394666|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
44394667|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394668|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394669|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
44394670|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394671|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44394672|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394673|NCT03001557|Lemborexant|lemborexant|mesh-list
44394674|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44394675|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394676|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394677|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44394678|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44394679|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394680|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394681|NCT03001219|Methotrexate|methotrexate|mesh-list
44394682|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44394683|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
44394684|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698246|NCT02747953|Afatinib|afatinib|mesh-list
43885977|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43885978|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43885979|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885980|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885981|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43885982|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43885993|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43885994|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
43885995|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43885996|NCT04574960|Antiviral Agents|antiviral agents|mesh-ancestor
43885997|NCT04574960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43885998|NCT04574960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43885999|NCT04574960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886000|NCT04574960|Immunologic Factors|immunologic factors|mesh-ancestor
43886001|NCT04574960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156835|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44394685|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394686|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44394687|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
44394688|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394689|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394690|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
44394691|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394692|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44394693|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394694|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
44394695|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44394696|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44394697|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44394698|NCT03001076|Ezetimibe|ezetimibe|mesh-list
44394699|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44394700|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44394701|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
44156836|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156837|NCT00232375|Insulin|insulin|mesh-list
44156838|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44156839|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156840|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44156841|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156842|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156843|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156844|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156845|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156846|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156847|NCT00232492|Ketamine|ketamine|mesh-list
44156848|NCT00232492|Analgesics|analgesics|mesh-ancestor
44156849|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
44156850|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156851|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156852|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44156853|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44156854|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
44156855|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
44156856|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156857|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44156858|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44156859|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156860|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156861|NCT00232531|Niacin|niacin|mesh-list
44156862|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
44156863|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44156864|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
44156865|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156866|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44156867|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
44156868|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
44156869|NCT00232531|Vitamins|vitamins|mesh-ancestor
44156870|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
44156871|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886002|NCT04574778|Acetaminophen|acetaminophen|mesh-list
43886003|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43886004|NCT04574778|Analgesics|analgesics|mesh-ancestor
43886005|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
43886006|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394702|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394703|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44394704|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394705|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44394706|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394707|NCT03000673|Heparin|heparin|mesh-list
44394708|NCT03000673|Enoxaparin|enoxaparin|mesh-list
44394709|NCT03000673|Calcium heparin|calcium heparin|mesh-list
44394710|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
44394711|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44394712|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44394713|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394714|NCT03000452|Durvalumab|durvalumab|mesh-list
44394715|NCT03000452|Daratumumab|daratumumab|mesh-list
44394716|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394717|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394718|NCT03000348|Cysteamine|cysteamine|mesh-list
44394719|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44394720|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394721|NCT03000179|Avelumab|avelumab|mesh-list
44394722|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394723|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394724|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44394725|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
44394726|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394727|NCT02999984|Busulfan|busulfan|mesh-list
44394728|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
44052107|NCT00003960|Protective Agents|protective agents|mesh-ancestor
44394729|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394730|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394731|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
44394732|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394733|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44394734|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394735|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44394736|NCT02999672|Trastuzumab|trastuzumab|mesh-list
43886007|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886008|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
43886009|NCT04574791|Tizanidine|tizanidine|mesh-list
43886010|NCT04574791|Analgesics|analgesics|mesh-ancestor
44394737|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44394738|NCT02999672|Maytansine|maytansine|mesh-list
44394739|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44394740|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394741|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44394742|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394743|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394744|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394745|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394746|NCT02999178|Nintedanib|nintedanib|mesh-list
44394747|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394748|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44394749|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394750|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394751|NCT02999100|Oxytocin|oxytocin|mesh-list
44394752|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
44394753|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43886011|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
43886019|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43886020|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43886021|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43886022|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
43886023|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886024|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886025|NCT04575064|Remdesivir|remdesivir|mesh-list
43886026|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
43886027|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886028|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
43886029|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886030|NCT04574141|Melatonin|melatonin|mesh-list
43886031|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
43886032|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886033|NCT04574141|Protective Agents|protective agents|mesh-ancestor
43886034|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886035|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886036|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
43886037|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43886038|NCT04573855|Antibodies|antibodies|mesh-list
43886039|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
43886040|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886041|NCT04573803|Phenytoin|phenytoin|mesh-list
43886042|NCT04573803|Levetiracetam|levetiracetam|mesh-list
43886043|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
43886044|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
43886045|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43886046|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43886047|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886048|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886049|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43886050|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43886051|NCT04573426|Acetaminophen|acetaminophen|mesh-list
43886052|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43886053|NCT04573426|Analgesics|analgesics|mesh-ancestor
43886054|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
43886055|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886056|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886057|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
44394754|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394755|NCT02998996|Endocine|endocine|mesh-list
44394756|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44394757|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
44394758|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394759|NCT02998151|Minocycline|minocycline|mesh-list
44394760|NCT02998151|Acamprosate|acamprosate|mesh-list
44394761|NCT02998151|Baclofen|baclofen|mesh-list
44394762|NCT02998151|Lovastatin|lovastatin|mesh-list
44394763|NCT02998151|L 647318|l 647318|mesh-list
44394764|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
44394765|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44394766|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394767|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44394768|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394769|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44394770|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394771|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44394772|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
44394773|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
44394774|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394775|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394776|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44394777|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44394778|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
44394779|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44394780|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44394781|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394782|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44394783|NCT02997176|Talazoparib|talazoparib|mesh-list
44394785|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394798|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394799|NCT02996500|Tofacitinib|tofacitinib|mesh-list
44394800|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44394801|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394802|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394803|NCT02996097|Triamcinolone|triamcinolone|mesh-list
44394804|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44394805|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44394806|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44394807|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394808|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
44394810|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394811|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394812|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394813|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
44394814|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394815|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394816|NCT02994940|Acetaminophen|acetaminophen|mesh-list
44394817|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44394818|NCT02994940|Analgesics|analgesics|mesh-ancestor
44394819|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
44394820|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394821|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394822|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
44394823|NCT02994394|Tolvaptan|tolvaptan|mesh-list
44394824|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44394825|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394826|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
43886058|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
43886059|NCT04573686|Hematinics|hematinics|mesh-ancestor
43886060|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
43886061|NCT04573153|Sorbitol|sorbitol|mesh-list
43886062|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
43886063|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43886064|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886065|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886066|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886067|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886068|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886069|NCT04573153|Cathartics|cathartics|mesh-ancestor
43886070|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886071|NCT04573192|Lomustine|lomustine|mesh-list
43886072|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43886073|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
44394827|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394828|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
44394829|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44394830|NCT02994056|Velpatasvir|velpatasvir|mesh-list
44394831|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
44394832|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394833|NCT02993926|Leuprolide|leuprolide|mesh-list
44394834|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44394835|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
44394836|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44394837|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394838|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44394839|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394840|NCT02993822|Maleic acid|maleic acid|mesh-list
44394841|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394842|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394843|NCT02993783|Vedolizumab|vedolizumab|mesh-list
44394844|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394845|NCT02993731|Gemcitabine|gemcitabine|mesh-list
44394846|NCT02993731|Paclitaxel|paclitaxel|mesh-list
44394847|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44394848|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394849|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394850|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
44394851|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
44394852|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394853|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44394854|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
44394855|NCT02993731|Antiviral Agents|antiviral agents|mesh-ancestor
44394856|NCT02993731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394857|NCT02993731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394858|NCT02993731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394859|NCT02993731|Immunologic Factors|immunologic factors|mesh-ancestor
43698385|NCT02745912|Metformin|metformin|mesh-list
43886074|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886075|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886076|NCT04573049|Simendan|simendan|mesh-list
43886077|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43886078|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
43886079|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44165314|NCT00259779|Prednisolone|prednisolone|mesh-list
43886091|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43886092|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43886093|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394860|NCT02993731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394861|NCT02993471|Vitamin K|vitamin k|mesh-list
44394862|NCT02993471|Midazolam|midazolam|mesh-list
44394863|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
44394864|NCT02993471|Caffeine|caffeine|mesh-list
44394865|NCT02993471|Ixekizumab|ixekizumab|mesh-list
44394866|NCT02993471|Omeprazole|omeprazole|mesh-list
44394867|NCT02993471|Warfarin|warfarin|mesh-list
44394868|NCT02993471|Vitamins|vitamins|mesh-ancestor
44394869|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
44394870|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394871|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44394872|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44394873|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394874|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44394875|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394876|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394877|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44394878|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
44394879|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
44394880|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
44394881|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
44394882|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394883|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394884|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
44394885|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44394886|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394887|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44394888|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394889|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44394890|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44394891|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44394892|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44394893|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
44394894|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44394895|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44394896|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
43886094|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886095|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886096|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43886097|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44394897|NCT02993471|Coagulants|coagulants|mesh-ancestor
44394898|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
44394899|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394900|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44394901|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44394902|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
44394903|NCT02993250|Simeprevir|simeprevir|mesh-list
44394904|NCT02993250|Odalasvir|odalasvir|mesh-list
44394905|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
44394906|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394907|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
44394908|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394909|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394910|NCT02993224|Deferasirox|deferasirox|mesh-list
44394911|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44394912|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
44394913|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
44394914|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394915|NCT02992132|Pimavanserin|pimavanserin|mesh-list
44394916|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44394917|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44394918|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44394919|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44394920|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394921|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394922|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44394923|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44394924|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44394925|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
44394926|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44394927|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394928|NCT02991859|Fluticasone|fluticasone|mesh-list
44394930|NCT02991859|Budesonide|budesonide|mesh-list
44394931|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394932|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44394933|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
43830175|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394934|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394935|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394936|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44394937|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
44394938|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
44394939|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44394940|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
44394941|NCT02991859|Hormones|hormones|mesh-ancestor
44394942|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394943|NCT02991482|Gemcitabine|gemcitabine|mesh-list
44394944|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
44394945|NCT02991482|Vinorelbine|vinorelbine|mesh-list
44394946|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44394947|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
44394948|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394949|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394950|NCT02991482|Antiviral Agents|antiviral agents|mesh-ancestor
44394951|NCT02991482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44394952|NCT02991482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44394953|NCT02991482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44394954|NCT02991482|Immunologic Factors|immunologic factors|mesh-ancestor
44394955|NCT02991482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394956|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44052339|NCT00004002|Bortezomib|bortezomib|mesh-list
44394957|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43734413|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44394958|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
44394980|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44394982|NCT02990910|Narcotics|narcotics|mesh-ancestor
44394983|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44394984|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394985|NCT02990910|Analgesics|analgesics|mesh-ancestor
44394986|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
44394987|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394988|NCT02990338|Dexamethasone|dexamethasone|mesh-list
44394989|NCT02990338|Pomalidomide|pomalidomide|mesh-list
44394990|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44394991|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
44394992|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
44394993|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44394994|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44394995|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44394996|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
44394997|NCT02990338|Hormones|hormones|mesh-ancestor
44394998|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44394999|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44395000|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395001|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
44395002|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44395003|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44395004|NCT02990338|Growth Substances|growth substances|mesh-ancestor
44395005|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
44395006|NCT02989649|Metformin|metformin|mesh-list
44395007|NCT02989649|Pioglitazone|pioglitazone|mesh-list
44395008|NCT02989649|Alogliptin|alogliptin|mesh-list
44395009|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395010|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395011|NCT02989649|Incretins|incretins|mesh-ancestor
44395012|NCT02989649|Hormones|hormones|mesh-ancestor
43886098|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43886099|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
43886100|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886101|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886102|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43886103|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43886104|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
44163847|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44395013|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395014|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44395015|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
44395016|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395017|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395019|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
44395020|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395021|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44395022|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44395023|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395024|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395025|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44395026|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
44395027|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395028|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395029|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44395030|NCT02988219|Epinephrine|epinephrine|mesh-list
44395031|NCT02988219|Fentanyl|fentanyl|mesh-list
44395032|NCT02988219|Bupivacaine|bupivacaine|mesh-list
43886106|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43886107|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43886108|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43886109|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43886110|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886111|NCT04572620|Rituximab|rituximab|mesh-list
43886112|NCT04572620|Abatacept|abatacept|mesh-list
43886113|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43886114|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886115|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
43886116|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886117|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886118|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43886119|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886120|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886121|NCT04572542|Paclitaxel|paclitaxel|mesh-list
43886122|NCT04572542|Apatinib|apatinib|mesh-list
43886123|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43886124|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886125|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
43886126|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
43886127|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
43886128|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886129|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43886130|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886131|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43886132|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43886133|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43886134|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395033|NCT02988219|Anesthetics|anesthetics|mesh-list
44395034|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
44395035|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395036|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395037|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
44395038|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395039|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44395040|NCT02988219|Narcotics|narcotics|mesh-ancestor
44395041|NCT02988219|Analgesics|analgesics|mesh-ancestor
44395042|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44395043|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44395044|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
44395045|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44395046|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44395047|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395048|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395049|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395050|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44395051|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44395052|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
44395053|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44395054|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
44395055|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
44395056|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
44395057|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44395082|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44395083|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44395084|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44395085|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395086|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395088|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395089|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44395090|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44395091|NCT02985879|Tilavonemab|tilavonemab|mesh-list
44395092|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
44395093|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
44395094|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44395095|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
44395096|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44395097|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395098|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44395099|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44395100|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44395101|NCT02985021|Carboplatin|carboplatin|mesh-list
44395102|NCT02985021|Docetaxel|docetaxel|mesh-list
44052486|NCT00004024|Aldesleukin|aldesleukin|mesh-list
44395103|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395104|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
44395105|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
44395106|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
44395107|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395108|NCT02984982|Anticoagulants|anticoagulants|mesh-list
44395109|NCT02984982|Atorvastatin|atorvastatin|mesh-list
44395110|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44395111|NCT02984982|Ezetimibe|ezetimibe|mesh-list
44395112|NCT02984982|Fenofibrate|fenofibrate|mesh-list
43886135|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886136|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43886137|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886138|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886139|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
43886140|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886141|NCT04572373|SMOFlipid|smoflipid|mesh-list
44156872|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44156873|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156874|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395113|NCT02984982|Bezafibrate|bezafibrate|mesh-list
44395114|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44395115|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44395116|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
44395117|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395118|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44395119|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44395120|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395121|NCT02983799|Olaparib|olaparib|mesh-list
44395122|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44395123|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395124|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43698523|NCT02744872|Felodipine|felodipine|mesh-list
44156875|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156876|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156877|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886145|NCT04571879|Lidocaine|lidocaine|mesh-list
43886146|NCT04571879|Midazolam|midazolam|mesh-list
43886147|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
43886148|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
43670610|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
43886149|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886150|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886151|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
43886152|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886153|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43886154|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43886155|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43886156|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886157|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886158|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43886159|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43886160|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43886161|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43886162|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43886163|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43886164|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
43886165|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
43886166|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
43886167|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886168|NCT04571437|Capecitabine|capecitabine|mesh-list
43886170|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43886171|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
43886172|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886173|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886174|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43886175|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43886176|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886177|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43886178|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
43886179|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886180|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886181|NCT04571489|Gemcitabine|gemcitabine|mesh-list
43886182|NCT04571489|Tegafur|tegafur|mesh-list
43886183|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43886184|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
43886185|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886186|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886187|NCT04571489|Antiviral Agents|antiviral agents|mesh-ancestor
43886188|NCT04571489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886189|NCT04571489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395125|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395126|NCT02983604|Fulvestrant|fulvestrant|mesh-list
44395127|NCT02983604|Exemestane|exemestane|mesh-list
44395128|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44395129|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395130|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44395131|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44395132|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
44395133|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395134|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395135|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44395136|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44395137|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395138|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395139|NCT02982772|Nicotine|nicotine|mesh-list
44395140|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44395141|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
44395142|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395143|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395144|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44395145|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44395146|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
44395147|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395148|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395149|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44395150|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
44395151|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395152|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395153|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
43886190|NCT04571489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886191|NCT04571489|Immunologic Factors|immunologic factors|mesh-ancestor
43886192|NCT04571489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886193|NCT04571996|Acetaminophen|acetaminophen|mesh-list
43886194|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43886195|NCT04571996|Analgesics|analgesics|mesh-ancestor
43886196|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
43886197|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886198|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886199|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
43886200|NCT04571606|Bupivacaine|bupivacaine|mesh-list
43886201|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
43886202|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
43886203|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886204|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395154|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395155|NCT02982590|Warfarin|warfarin|mesh-list
44395156|NCT02982590|Apixaban|apixaban|mesh-list
44395157|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
44395158|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44395159|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
44395160|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44395161|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
44395162|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395163|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395164|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
44395165|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
44395166|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
44395167|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395168|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886205|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
43886206|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886207|NCT04571164|Rotigotine|rotigotine|mesh-list
43886215|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886216|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43886217|NCT04571229|Mifamurtide|mifamurtide|mesh-list
43886218|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43886219|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
43886220|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886221|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
43886222|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43886223|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886224|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43886225|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886226|NCT04570592|Dexamethasone|dexamethasone|mesh-list
43886227|NCT04570592|Granisetron|granisetron|mesh-list
43886228|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43886229|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886230|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
43886231|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
43886232|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886233|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886234|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886235|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
43886237|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886238|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886239|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886240|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43886241|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
43886242|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886243|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886244|NCT04570683|Nivolumab|nivolumab|mesh-list
43886245|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43886246|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886247|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43886248|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886249|NCT04570449|Fluoxetine|fluoxetine|mesh-list
43886250|NCT04570449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43886251|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43886252|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886253|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886254|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886255|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
43886256|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886257|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44395169|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395170|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44395171|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
44395172|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395173|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395174|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44395175|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395176|NCT02981472|Vitamin K|vitamin k|mesh-list
44395177|NCT02981472|Heparin|heparin|mesh-list
44395178|NCT02981472|Enoxaparin|enoxaparin|mesh-list
44395179|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44395180|NCT02981472|Tinzaparin|tinzaparin|mesh-list
44395181|NCT02981472|Dalteparin|dalteparin|mesh-list
44395182|NCT02981472|Warfarin|warfarin|mesh-list
44395183|NCT02981472|Apixaban|apixaban|mesh-list
44395184|NCT02981472|Vitamins|vitamins|mesh-ancestor
44395185|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
44395186|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395187|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
44395188|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44395189|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44395190|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395191|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44395192|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
44395193|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44395194|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
44395195|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395196|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44395197|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
43786333|NCT04954339|Bevacizumab|bevacizumab|mesh-list
43786334|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786335|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786336|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43653963|NCT02980497|Protective Agents|protective agents|mesh-ancestor
43653964|NCT02980458|Deferiprone|deferiprone|mesh-list
44395198|NCT02981472|Coagulants|coagulants|mesh-ancestor
44395199|NCT02981342|Gemcitabine|gemcitabine|mesh-list
44395200|NCT02981342|Capecitabine|capecitabine|mesh-list
44395201|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44395202|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
44395203|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395204|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395205|NCT02981342|Antiviral Agents|antiviral agents|mesh-ancestor
43698585|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
43886258|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
43886259|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43886260|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44395207|NCT02981342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395208|NCT02981342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395209|NCT02981342|Immunologic Factors|immunologic factors|mesh-ancestor
44395210|NCT02981342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395211|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44395212|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395213|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395214|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
44395215|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395216|NCT02980874|Triamcinolone|triamcinolone|mesh-list
44395217|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44395218|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44395219|NCT02980874|Aflibercept|aflibercept|mesh-list
44395220|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44395221|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395222|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
43886261|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43886262|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886263|NCT04570345|Aspirin|aspirin|mesh-list
43886264|NCT04570345|Ticagrelor|ticagrelor|mesh-list
43886265|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43886266|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43886267|NCT04570345|Analgesics|analgesics|mesh-ancestor
43886268|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
43886269|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886270|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886271|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886272|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886273|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43886274|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43886281|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43886282|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43886283|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
43886284|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886285|NCT04570293|Lidocaine|lidocaine|mesh-list
43886286|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
43886287|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
43886288|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886289|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886290|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
43886291|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886292|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43886293|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43886295|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886296|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886297|NCT04570254|Vitamins|vitamins|mesh-list
43886298|NCT04570254|Vitamin E|vitamin e|mesh-list
43886299|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
43886300|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
43886301|NCT04570254|Melatonin|melatonin|mesh-list
43886302|NCT04570254|Antioxidants|antioxidants|mesh-list
43886303|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43886304|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
43886305|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886306|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886307|NCT04570254|Protective Agents|protective agents|mesh-ancestor
43886308|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886309|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44395224|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395225|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395226|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395227|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
44395228|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395229|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395230|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44395231|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44395232|NCT02980874|Growth Substances|growth substances|mesh-ancestor
44395233|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
44395234|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886310|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886311|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43886312|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43886313|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
43886314|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43886315|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
43886316|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886317|NCT04570254|Expectorants|expectorants|mesh-ancestor
43886318|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886320|NCT04570150|Neostigmine|neostigmine|mesh-list
43886321|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43886322|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886323|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886324|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
43886325|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886326|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886327|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43886328|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
43886329|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886330|NCT04570306|Belimumab|belimumab|mesh-list
43886331|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886332|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
43886333|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886334|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
43886335|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43886336|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886337|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43886338|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43886339|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
43886340|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886341|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886342|NCT04569916|Irinotecan|irinotecan|mesh-list
43886343|NCT04569916|Apatinib|apatinib|mesh-list
43886352|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43886353|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
43886354|NCT04569890|Prednisone|prednisone|mesh-list
43886355|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
43886356|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886357|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
43886358|NCT04569890|Hormones|hormones|mesh-ancestor
43886359|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886360|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886361|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886362|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886363|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
43886364|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43886365|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886366|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886367|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395235|NCT02980783|Lidocaine|lidocaine|mesh-list
44395236|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
44395237|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
44395238|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395239|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395240|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
44395241|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395242|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44395243|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44395244|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44395245|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395246|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395247|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
44395248|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
44395249|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
44395250|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44395251|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
44395252|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44395253|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395254|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395255|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44395256|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44395257|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395258|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395259|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395260|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395283|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395286|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395287|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395288|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
44395289|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395290|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395291|NCT02979431|Gontivimab|gontivimab|mesh-list
44395292|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
44395293|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395294|NCT02979197|Celecoxib|celecoxib|mesh-list
44395295|NCT02979197|Amlodipine|amlodipine|mesh-list
44395296|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44395297|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44395298|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395299|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395300|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44395301|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395302|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
44395303|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44395304|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44395305|NCT02979197|Analgesics|analgesics|mesh-ancestor
44395306|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
44395307|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395308|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395309|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395310|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43698664|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
43886368|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886369|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886370|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886371|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
43886372|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
43886373|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43886374|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886375|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43886376|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156878|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156879|NCT00232622|Streptokinase|streptokinase|mesh-list
44156880|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44156881|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44156882|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156884|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44156885|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44156886|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
44395312|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395314|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44395315|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44395316|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395317|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
44395318|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395319|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
44395320|NCT02977507|Hydroquinone|hydroquinone|mesh-list
44395321|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44395322|NCT02977507|Protective Agents|protective agents|mesh-ancestor
44395323|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395324|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395325|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
44395326|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395327|NCT02976103|Analgesics|analgesics|mesh-list
44395328|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
44156887|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156888|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156889|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44156890|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
44156891|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
44156892|NCT00232648|Hormones|hormones|mesh-ancestor
44156893|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156894|NCT00232661|Tamoxifen|tamoxifen|mesh-list
44156895|NCT00232661|Anastrozole|anastrozole|mesh-list
44156896|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44156897|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
44156898|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156899|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156900|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44156901|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156902|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44156903|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44156904|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44156905|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44156906|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44156907|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44156908|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156909|NCT00232674|Budesonide|budesonide|mesh-list
44156919|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44156921|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156922|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156923|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44156924|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44156925|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44156926|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156927|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
44156928|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
44156929|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156930|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156931|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44156932|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44395329|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395330|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395331|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44395332|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395333|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395334|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
44395335|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395336|NCT02975206|Serlopitant|serlopitant|mesh-list
44395337|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44395338|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395339|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395340|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395341|NCT02974868|PF-06700841|pf-06700841|mesh-list
44395342|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44395343|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395344|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395345|NCT02974114|Acetaminophen|acetaminophen|mesh-list
44395346|NCT02974114|Caffeine|caffeine|mesh-list
44395347|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44395348|NCT02974114|Analgesics|analgesics|mesh-ancestor
44395349|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
44395350|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395351|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395352|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
44052725|NCT00004062|Azacitidine|azacitidine|mesh-list
44395353|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44395354|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44395355|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395356|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395357|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44395358|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44395359|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
44395360|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395361|NCT02974010|Cycloserine|cycloserine|mesh-list
44395367|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395368|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44395369|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44395371|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
44395372|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395373|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44395374|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44395375|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395376|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395377|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44395378|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395379|NCT02974010|Renal Agents|renal agents|mesh-ancestor
44395380|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44395381|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
44156933|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
44156934|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44156935|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44156936|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44156937|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44156939|NCT00232700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44156940|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43886377|NCT04569214|PAZ320|paz320|mesh-list
43886378|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43886379|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886380|NCT04569279|Warfarin|warfarin|mesh-list
43886381|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
43886382|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
43886383|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43886384|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
43886385|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43886386|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
43886387|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886388|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886389|NCT04568863|Melatonin|melatonin|mesh-list
43886390|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
43886391|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886392|NCT04568863|Protective Agents|protective agents|mesh-ancestor
43886393|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886394|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886395|NCT04568772|Atovaquone|atovaquone|mesh-list
43886396|NCT04568772|Proguanil|proguanil|mesh-list
43886397|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
43886398|NCT04568772|Esomeprazole|esomeprazole|mesh-list
43886399|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43886400|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886401|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43886402|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886403|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886404|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886405|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
43886406|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43886407|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886408|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
43886409|NCT04568603|Islatravir|islatravir|mesh-list
43886410|NCT04568603|Methadone|methadone|mesh-list
43886411|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43886412|NCT04568603|Narcotics|narcotics|mesh-ancestor
43886413|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886414|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395384|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44395385|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44395386|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395387|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44395388|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44395389|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44395390|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395391|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44395392|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44395393|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
44395394|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44395395|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44395396|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
44395397|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
44395398|NCT02973477|Glimepiride|glimepiride|mesh-list
43886415|NCT04568603|Analgesics|analgesics|mesh-ancestor
43886416|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
43886417|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886418|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
43886419|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886420|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
43886421|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886422|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886423|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886424|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43886425|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43886426|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43886427|NCT04568876|Palmidrol|palmidrol|mesh-list
43886428|NCT04568876|Analgesics|analgesics|mesh-ancestor
43886429|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
43886430|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886431|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886432|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43886433|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43886434|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886435|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886436|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
43886437|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886438|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43886439|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43886440|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886441|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886442|NCT04568876|Hormones|hormones|mesh-ancestor
43886443|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886444|NCT04568837|Dexamethasone|dexamethasone|mesh-list
43886445|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
43886446|NCT04568837|Prednisone|prednisone|mesh-list
43886447|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43886448|NCT04568837|BB 1101|bb 1101|mesh-list
43886449|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886450|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
43886451|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
43886452|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886453|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886454|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395399|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44395400|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395402|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395403|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44395404|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395405|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
44395406|NCT02973100|Dulaglutide|dulaglutide|mesh-list
44395407|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395408|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395409|NCT02973087|Factor VIII|factor viii|mesh-list
44395410|NCT02973087|Coagulants|coagulants|mesh-ancestor
44395411|NCT02973048|Bupivacaine|bupivacaine|mesh-list
44395412|NCT02973048|Prilocaine|prilocaine|mesh-list
44395413|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
43886455|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
43886456|NCT04568837|Hormones|hormones|mesh-ancestor
43886457|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886458|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886459|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886460|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
43886461|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886462|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886463|NCT04568265|Entecavir|entecavir|mesh-list
43886464|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
43886465|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886466|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43886467|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
43886468|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886469|NCT04568304|Gemcitabine|gemcitabine|mesh-list
43886470|NCT04568304|Cisplatin|cisplatin|mesh-list
43886471|NCT04568304|Carboplatin|carboplatin|mesh-list
43886472|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886473|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43886474|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
43886475|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886476|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
43886477|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886478|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886479|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886480|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
43886481|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886482|NCT04568096|Tamoxifen|tamoxifen|mesh-list
43886483|NCT04568096|Tretinoin|tretinoin|mesh-list
43886484|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43886485|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
44165315|NCT00259779|Budesonide|budesonide|mesh-list
43886494|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886496|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886497|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
43886498|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886499|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886500|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43886501|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
43886502|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886503|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886504|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43886505|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43886506|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886507|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
43886508|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
44395415|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395416|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395417|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
44395418|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395419|NCT02972632|Vortioxetine|vortioxetine|mesh-list
44395420|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44395421|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395422|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44395423|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44395424|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395425|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395426|NCT02972632|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44395427|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44395428|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395429|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395430|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395431|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
44395432|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44395433|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44395434|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43698741|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43886509|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886510|NCT04567290|Ticagrelor|ticagrelor|mesh-list
43886511|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43886512|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43886513|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43886514|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43886515|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
43886516|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886517|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886518|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886519|NCT04566952|Olaparib|olaparib|mesh-list
43886520|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43886521|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886522|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886523|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886524|NCT04567069|Vaccines|vaccines|mesh-list
43886525|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
43886526|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886527|NCT04566796|Neostigmine|neostigmine|mesh-list
43886528|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43886529|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886530|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886531|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
43886532|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886533|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886534|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44395435|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44395437|NCT02972502|Promethazine|promethazine|mesh-list
44395438|NCT02972502|Haloperidol|haloperidol|mesh-list
44395439|NCT02972502|Metoclopramide|metoclopramide|mesh-list
44395440|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
44395441|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44395442|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44395443|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395444|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395445|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
44395446|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
44395447|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
44395448|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886535|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
43886536|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156941|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44156942|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156943|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156944|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
44156945|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156946|NCT00232700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44156947|NCT00232700|Antidepressive Agents|antidepressive agents|mesh-ancestor
44156948|NCT00232700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44156949|NCT00232765|Sirolimus|sirolimus|mesh-list
44156950|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156961|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156962|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156964|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44156965|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
44156966|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156967|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156968|NCT00232856|Sirolimus|sirolimus|mesh-list
44156969|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44156970|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44156971|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44156972|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44156973|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
44156974|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44156975|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
44156976|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156977|NCT00232882|Atenolol|atenolol|mesh-list
44156978|NCT00232882|Candesartan|candesartan|mesh-list
44156979|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
44156980|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44156981|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44156982|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44156983|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44156984|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44156985|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44156986|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
44156987|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
44156988|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44156989|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44156990|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44156991|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44156992|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44156993|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
44156994|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44156995|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395449|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
44395450|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
44395451|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395452|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44395453|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
44395454|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
44395455|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395456|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395457|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44395458|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
44395459|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
44395460|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44395461|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44395462|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395463|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44395464|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
44395465|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44395466|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44395467|NCT02971683|Abatacept|abatacept|mesh-list
44395468|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44395469|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395470|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395471|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395472|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
44395473|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395474|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395475|NCT02971605|Psilocybin|psilocybin|mesh-list
44395476|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
44395477|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395478|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395479|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
44395480|NCT02971228|Glucagon|glucagon|mesh-list
44395481|NCT02971228|Pancrelipase|pancrelipase|mesh-list
44395482|NCT02971228|Pancreatin|pancreatin|mesh-list
44395483|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43698777|NCT02743234|Vancomycin|vancomycin|mesh-list
44156996|NCT00232882|Diuretics|diuretics|mesh-ancestor
44156997|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
44156998|NCT00232895|Propofol|propofol|mesh-list
44156999|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44157000|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157001|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157002|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44395485|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395486|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395487|NCT02971228|Hormones|hormones|mesh-ancestor
44395488|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395489|NCT02971228|Incretins|incretins|mesh-ancestor
44395490|NCT02971007|Fluconazole|fluconazole|mesh-list
44395491|NCT02971007|Amphotericin B|amphotericin b|mesh-list
44395492|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44395493|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
44395494|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395495|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44395496|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44395497|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395498|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395499|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44395500|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
44395501|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395502|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395503|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44395504|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44395505|NCT02971007|Amebicides|amebicides|mesh-ancestor
44395506|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44395507|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44157003|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
43886537|NCT04566718|Metformin|metformin|mesh-list
43886539|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886540|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
43886541|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
43886542|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886543|NCT04566211|Amoxicillin|amoxicillin|mesh-list
43886544|NCT04566211|Metronidazole|metronidazole|mesh-list
43886545|NCT04566211|Clarithromycin|clarithromycin|mesh-list
43886546|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43886547|NCT04566211|Pantoprazole|pantoprazole|mesh-list
43886548|NCT04566211|Bismuth|bismuth|mesh-list
43886549|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43886550|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886551|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43886552|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886553|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43886554|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886555|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886556|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43886557|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43886558|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43886559|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886560|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44395508|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395509|NCT02970669|Valsartan|valsartan|mesh-list
44395510|NCT02970669|Enalapril|enalapril|mesh-list
44395511|NCT02970669|Enalaprilat|enalaprilat|mesh-list
44395512|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44395513|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44395514|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44395515|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44395516|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395517|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44395518|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
44395519|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395520|NCT02970305|Pimavanserin|pimavanserin|mesh-list
44395521|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44395522|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44395523|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44395524|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44395525|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395526|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395527|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395528|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44395529|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44395530|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
44395531|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395532|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395533|NCT02970292|Pimavanserin|pimavanserin|mesh-list
44395534|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44395535|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44395536|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44395537|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44395538|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395539|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395540|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395541|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43886561|NCT04566211|Antacids|antacids|mesh-ancestor
43886562|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
43886563|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43886564|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395542|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43786411|NCT04557215|Antidotes|antidotes|mesh-ancestor
44395543|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
44395544|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395545|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395546|NCT02969863|Pancrelipase|pancrelipase|mesh-list
44395547|NCT02969863|Pancreatin|pancreatin|mesh-list
44395548|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395549|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
44395550|NCT02969655|Glycine|glycine|mesh-list
44395551|NCT02969655|Hematinics|hematinics|mesh-ancestor
43886565|NCT04565184|Artesunate|artesunate|mesh-list
43886566|NCT04565184|Lumefantrine|lumefantrine|mesh-list
43886567|NCT04565184|Artemether|artemether|mesh-list
43886568|NCT04565184|Amodiaquine|amodiaquine|mesh-list
43886569|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43886570|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
43886571|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
43886572|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43886573|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886574|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886575|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886576|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
43886577|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
43886578|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43886579|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
43886580|NCT04564638|Cyclosporine|cyclosporine|mesh-list
43886581|NCT04564638|Cyclosporins|cyclosporins|mesh-list
43886582|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886583|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886584|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43886585|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
43886586|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886587|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
43886588|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886589|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886590|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886591|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43886592|NCT04564326|Fentanyl|fentanyl|mesh-list
43886593|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43886594|NCT04564326|Narcotics|narcotics|mesh-ancestor
43886595|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886596|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886597|NCT04564326|Analgesics|analgesics|mesh-ancestor
43886598|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
43886599|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886600|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43886601|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43886602|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
43886603|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
43886604|NCT04564690|Vitamin E|vitamin e|mesh-list
43886605|NCT04564690|Selenium|selenium|mesh-list
43886606|NCT04564690|Vitamins|vitamins|mesh-ancestor
43886607|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
43886608|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886609|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
43670648|NCT05427500|Bupivacaine|bupivacaine|mesh-list
43886610|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886611|NCT04564690|Protective Agents|protective agents|mesh-ancestor
43886612|NCT04564690|Trace Elements|trace elements|mesh-ancestor
43886613|NCT04564469|Furosemide|furosemide|mesh-list
43886614|NCT04564469|Diuretics|diuretics|mesh-ancestor
43886615|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
43886616|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886617|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43886618|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886619|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886620|NCT04564456|Fluticasone|fluticasone|mesh-list
43886621|NCT04564456|Xhance|xhance|mesh-list
43886622|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43886623|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44395552|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
44395553|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395554|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395555|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395556|NCT02969590|Leuprolide|leuprolide|mesh-list
44395557|NCT02969590|Norethindrone|norethindrone|mesh-list
44395558|NCT02969590|Estradiol|estradiol|mesh-list
44395559|NCT02969590|Estrogens|estrogens|mesh-list
44395560|NCT02969590|Progesterone|progesterone|mesh-list
44395561|NCT02969590|Progestins|progestins|mesh-list
44395562|NCT02969590|Hormones|hormones|mesh-ancestor
44395563|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395564|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395565|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44395566|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
44395567|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43698817|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
43886624|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886625|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43886626|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
43886628|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886629|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43886630|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886631|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886632|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43886633|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43886634|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43886635|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43886636|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
43886637|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886638|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886639|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
43886640|NCT04564456|Hormones|hormones|mesh-ancestor
43886641|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886642|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
43886643|NCT04564430|Clonidine|clonidine|mesh-list
43886644|NCT04564430|Analgesics|analgesics|mesh-ancestor
43886645|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
43886646|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886647|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886648|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43886649|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
43886650|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
43886651|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43886652|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43886653|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43886654|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
43886655|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886656|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886657|NCT04564144|Meclizine|meclizine|mesh-list
43886658|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
43886659|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
43886660|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886661|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886662|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886663|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43886664|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
43886665|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
43886666|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395569|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44395570|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
44395571|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44395572|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395573|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44395574|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44395575|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44395576|NCT02969408|Albuterol|albuterol|mesh-list
44395577|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44395578|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
44395579|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395580|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395581|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44395582|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44395583|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
44395584|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44395585|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44395586|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44395587|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44395588|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395589|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886667|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886668|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43886669|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
43886670|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886671|NCT04564222|Micronutrients|micronutrients|mesh-list
43886672|NCT04564222|Trace Elements|trace elements|mesh-list
43886673|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886674|NCT04563936|Goserelin|goserelin|mesh-list
43886675|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886676|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886677|NCT04563975|Paclitaxel|paclitaxel|mesh-list
43886678|NCT04563975|Docetaxel|docetaxel|mesh-list
43886679|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43886680|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886681|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
43886682|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
43886683|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
43886684|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886685|NCT04563962|Methamphetamine|methamphetamine|mesh-list
43886686|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43886687|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886688|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
43886689|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
43886690|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886691|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
43886692|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886693|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886694|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
43886695|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44395590|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395591|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
44395592|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44395593|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44395594|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44395595|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395596|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395597|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
44395598|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395599|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395600|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44395601|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395602|NCT02969187|Bupivacaine|bupivacaine|mesh-list
44395603|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
44395604|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
44395605|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44395606|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395607|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
44395608|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395609|NCT02969018|PF-06700841|pf-06700841|mesh-list
44395610|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44395611|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395612|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395613|NCT02968576|Tenofovir|tenofovir|mesh-list
44395614|NCT02968576|Emtricitabine|emtricitabine|mesh-list
44395615|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44395616|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
44395617|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395618|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44395619|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44395620|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395621|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395622|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44395628|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
44395629|NCT02967679|Vitamins|vitamins|mesh-ancestor
44395630|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
44395631|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395633|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44395634|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44395635|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44395636|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44395637|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395638|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395639|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395640|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395641|NCT02966002|Aspirin|aspirin|mesh-list
44395642|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44395643|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44395644|NCT02966002|Analgesics|analgesics|mesh-ancestor
44395645|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
44395646|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395647|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395648|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395649|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395650|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44395651|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44395652|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395653|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44395678|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395679|NCT02963935|Liraglutide|liraglutide|mesh-list
44395680|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395681|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395682|NCT02963935|Incretins|incretins|mesh-ancestor
44395683|NCT02963935|Hormones|hormones|mesh-ancestor
44395684|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395685|NCT02963922|Liraglutide|liraglutide|mesh-list
44395686|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395687|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395688|NCT02963922|Incretins|incretins|mesh-ancestor
44395689|NCT02963922|Hormones|hormones|mesh-ancestor
44395690|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395691|NCT02963701|Ibuprofen|ibuprofen|mesh-list
44395692|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
44395693|NCT02963701|Ephedrine|ephedrine|mesh-list
44395694|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44395695|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44395696|NCT02963701|Analgesics|analgesics|mesh-ancestor
44395697|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
44395698|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395699|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395700|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395701|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395702|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44395703|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395704|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395725|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395726|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44395727|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395728|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44395730|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395731|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44395732|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395733|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
44395734|NCT02962739|Tenofovir|tenofovir|mesh-list
44395735|NCT02962739|Emtricitabine|emtricitabine|mesh-list
44395736|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
44395737|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395738|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43886696|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43886697|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886698|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43886699|NCT04563871|Osimertinib|osimertinib|mesh-list
43886703|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886704|NCT04564001|Infliximab|infliximab|mesh-list
43886705|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
43886706|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886707|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43886708|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
43886709|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43886710|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157004|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
44157005|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
44157006|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44157007|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44157008|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157009|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157010|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157011|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
44157012|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157013|NCT00232934|Thalidomide|thalidomide|mesh-list
44157014|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157015|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
44157016|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157017|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
44157018|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157019|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157020|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44157021|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44157022|NCT00232934|Growth Substances|growth substances|mesh-ancestor
44157023|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
44157024|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157025|NCT00232947|Vaccines|vaccines|mesh-list
44157026|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
44157027|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157028|NCT00233012|Topiramate|topiramate|mesh-list
44157029|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
44157030|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44157031|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157032|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44157033|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44157034|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44157035|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395739|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44395740|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395741|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395742|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44395743|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44395744|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44395745|NCT02962648|Hematinics|hematinics|mesh-ancestor
44395746|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
44395747|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44395748|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44395749|NCT02962284|Prednisolone|prednisolone|mesh-list
44395750|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
44395751|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
44395752|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44395753|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
44395754|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44395755|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
44395756|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
43786442|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
43786443|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395757|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786444|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786445|NCT04424225|Niacin|niacin|mesh-list
44395758|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395759|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395760|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
44395761|NCT02962284|Hormones|hormones|mesh-ancestor
44395762|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44395763|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44395764|NCT02962284|Protective Agents|protective agents|mesh-ancestor
44395765|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44395766|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395767|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44395768|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395769|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395770|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
44395771|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44395772|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
44157036|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157037|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157038|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157039|NCT00233025|Analgesics|analgesics|mesh-ancestor
44157040|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
44395774|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
44395775|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
44395776|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395777|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395778|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44395779|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44395780|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
44395781|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395782|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395783|NCT02961790|Urological Agents|urological agents|mesh-ancestor
44395784|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44395785|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395787|NCT02961764|Dalbavancin|dalbavancin|mesh-list
44395788|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395789|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395790|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
44395791|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395792|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395793|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44395794|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44395795|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395796|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395797|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395798|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44395799|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44395821|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44395822|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395823|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395824|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
44395825|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44395826|NCT02959892|Amphetamine|amphetamine|mesh-list
44395828|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43699029|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
44157041|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157042|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
44157043|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44157044|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
44157045|NCT00233038|Ethanol|ethanol|mesh-list
44157046|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44157047|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157048|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44157049|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157050|NCT00233051|Fluticasone|fluticasone|mesh-list
44157051|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44157052|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157053|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44157054|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
44157055|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157056|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157057|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43886711|NCT04563299|Prednisolone|prednisolone|mesh-list
43886712|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43886713|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
43886714|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43886715|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
43886716|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43886717|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
43886720|NCT04563299|Hormones|hormones|mesh-ancestor
43886721|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886722|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886723|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886724|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886725|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
43886726|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
43886727|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886728|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886729|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43886730|NCT04563299|Protective Agents|protective agents|mesh-ancestor
43886731|NCT04563260|Palonosetron|palonosetron|mesh-list
43886732|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
43886733|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
43886734|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886735|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886736|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886737|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43886738|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43886739|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
43886740|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886741|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886742|NCT04563351|Anesthetics|anesthetics|mesh-list
43886743|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
43886744|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886745|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886746|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
43886747|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886748|NCT04563429|Vitamin A|vitamin a|mesh-list
43886749|NCT04563429|Vitamins|vitamins|mesh-ancestor
43886750|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
43886751|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886752|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
43886753|NCT04563000|Vitamins|vitamins|mesh-ancestor
44395831|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
44395832|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395833|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
44395834|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395835|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395836|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395837|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44395838|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44395839|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395840|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44395841|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
44395842|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
44395843|NCT02959437|Azacitidine|azacitidine|mesh-list
44395844|NCT02959437|INCB057643|incb057643|mesh-list
44395845|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395846|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395847|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44395848|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
44395849|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886754|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
43886755|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886756|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
43886757|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886758|NCT04563000|Protective Agents|protective agents|mesh-ancestor
43886759|NCT04561934|Fluorides|fluorides|mesh-list
43886760|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
43886761|NCT04561934|Protective Agents|protective agents|mesh-ancestor
43886762|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886763|NCT04561960|Fluorides|fluorides|mesh-list
43886764|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
43886765|NCT04561960|Protective Agents|protective agents|mesh-ancestor
43886766|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886767|NCT04562103|Epinephrine|epinephrine|mesh-list
43886768|NCT04562103|Ropivacaine|ropivacaine|mesh-list
43886769|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
43886770|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
43886771|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886772|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886773|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
43886774|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886775|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43886776|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43886777|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
43886778|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886779|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886780|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43886781|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43886782|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
43886783|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44395850|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395851|NCT02958865|PF-06700841|pf-06700841|mesh-list
44395852|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44395853|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395854|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44053261|NCT00004128|Etoposide|etoposide|mesh-list
44395855|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44395856|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44395857|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44395858|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44395859|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395860|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395861|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395862|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43699069|NCT02741219|Dsuvia|dsuvia|mesh-list
43886784|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886785|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
43886786|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
43886788|NCT04561635|Micronutrients|micronutrients|mesh-list
43886789|NCT04561635|Trace Elements|trace elements|mesh-list
43886790|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886791|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
43886792|NCT04561921|Nordefrin|nordefrin|mesh-list
43886793|NCT04561921|Mepivacaine|mepivacaine|mesh-list
43886795|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
43886796|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886797|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886798|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
43886799|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886800|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43886801|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
43886802|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43886803|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886804|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886805|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43886806|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
43886807|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43886808|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
43670691|NCT05427084|Canagliflozin|canagliflozin|mesh-list
43886809|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43886810|NCT04561687|Azelastine|azelastine|mesh-list
43886811|NCT04561687|Budesonide|budesonide|mesh-list
43886812|NCT04561687|Montelukast|montelukast|mesh-list
43886813|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886814|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43886815|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
43886816|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886817|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886818|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43886819|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
43886820|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
43886821|NCT04561687|Hormones|hormones|mesh-ancestor
43886822|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886823|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43886824|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
43886825|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43886826|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43886827|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395863|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
44395864|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44395865|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
44395866|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44395867|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
44395868|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395869|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
44395870|NCT02958267|Protective Agents|protective agents|mesh-ancestor
44395871|NCT02957331|Propranolol|propranolol|mesh-list
44395872|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44395873|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44395874|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
44395875|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44395876|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395877|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395878|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44395879|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44395880|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44395881|NCT02956837|Vaccines|vaccines|mesh-list
44395882|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
44395883|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395884|NCT02956629|Ribavirin|ribavirin|mesh-list
44395885|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
44395886|NCT02956629|Ruzasvir|ruzasvir|mesh-list
44395887|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
44395888|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395889|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
44395890|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395891|NCT02956278|Allopurinol|allopurinol|mesh-list
44395892|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
44395893|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395894|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886828|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43886829|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886830|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43886831|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43886832|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43886833|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
43886834|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
43886835|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886836|NCT04561947|Mitogens|mitogens|mesh-list
43886837|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
43886838|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886839|NCT04561466|Bezafibrate|bezafibrate|mesh-list
44395895|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
44395896|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395897|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44395899|NCT02956278|Protective Agents|protective agents|mesh-ancestor
44395900|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395901|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
44395902|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
44395903|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
44395904|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395905|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
44395906|NCT02956057|Protective Agents|protective agents|mesh-ancestor
44395907|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395908|NCT02956057|Vitamins|vitamins|mesh-ancestor
44395909|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
44395910|NCT02956057|Cathartics|cathartics|mesh-ancestor
44395911|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44395912|NCT02956005|Tacrolimus|tacrolimus|mesh-list
44395913|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395914|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
44395915|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395916|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44395917|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395918|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395919|NCT02955797|Vaccines|vaccines|mesh-list
44395920|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
44395921|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395922|NCT02955602|Seladelpar|seladelpar|mesh-list
44395923|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44395924|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
44395925|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395926|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44395927|NCT02955212|Upadacitinib|upadacitinib|mesh-list
44395928|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43886840|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43886841|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
43886842|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886843|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43886844|NCT04561856|Dexamethasone|dexamethasone|mesh-list
43886845|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
43886846|NCT04561856|BB 1101|bb 1101|mesh-list
43886847|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886848|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
43886849|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
43886850|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44395929|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44395930|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395931|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395932|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395934|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395935|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395936|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395938|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44395939|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395940|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395941|NCT02954887|Cannabidiol|cannabidiol|mesh-list
44395942|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
44395943|NCT02954653|Cytarabine|cytarabine|mesh-list
44395944|NCT02954653|Azacitidine|azacitidine|mesh-list
44395945|NCT02954653|Decitabine|decitabine|mesh-list
44395946|NCT02954653|Daunorubicin|daunorubicin|mesh-list
44395947|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44395948|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
44395949|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395950|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395951|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
44395952|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395953|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395954|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
44395955|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886851|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886852|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886853|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
43886854|NCT04561856|Hormones|hormones|mesh-ancestor
43886855|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886856|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886857|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886858|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
43886859|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886860|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886861|NCT04561817|Paclitaxel|paclitaxel|mesh-list
43886862|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43886863|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886864|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
43886865|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
43886866|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
43886869|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43886870|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886871|NCT04561336|Cetuximab|cetuximab|mesh-list
43886872|NCT04561336|Avelumab|avelumab|mesh-list
43886873|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43886874|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886875|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
43886876|NCT04561076|Paraproteins|paraproteins|mesh-list
44395957|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44395958|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44395959|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44395960|NCT02954601|Insulin|insulin|mesh-list
44395961|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44395962|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44395963|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44395964|NCT02954575|Factor VIII|factor viii|mesh-list
44395965|NCT02954575|Coagulants|coagulants|mesh-ancestor
44395966|NCT02954406|Gemcitabine|gemcitabine|mesh-list
44395967|NCT02954406|Rituximab|rituximab|mesh-list
44395968|NCT02954406|Lenalidomide|lenalidomide|mesh-list
44395969|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44395970|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44395971|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44395972|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
43886877|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
43886878|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157058|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
43670696|NCT05426824|Pegaspargase|pegaspargase|mesh-list
44157059|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157060|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44157061|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44157062|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44157063|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44157064|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44157065|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157066|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158333|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158334|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158335|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158336|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
44158337|NCT00236561|Topiramate|topiramate|mesh-list
44158338|NCT00236561|Propranolol|propranolol|mesh-list
44158339|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44158340|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44158341|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
44158342|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158343|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158344|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158345|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44158346|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44158347|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
44158348|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
44158349|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158350|NCT00236574|Galantamine|galantamine|mesh-list
44158351|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44158352|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158353|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158354|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
44158355|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158356|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158357|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44158358|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
44158359|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158360|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
44158361|NCT00236587|Risperidone|risperidone|mesh-list
44158362|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158363|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
44395974|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44395975|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44395976|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
44395977|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395978|NCT02954406|Antiviral Agents|antiviral agents|mesh-ancestor
44395979|NCT02954406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395980|NCT02954406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395981|NCT02954406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44395982|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44395983|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44395984|NCT02954406|Growth Substances|growth substances|mesh-ancestor
44395985|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
44395986|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44395987|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
44395988|NCT02954354|Oseltamivir|oseltamivir|mesh-list
44395989|NCT02954354|Baloxavir|baloxavir|mesh-list
44395990|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
44395991|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44395992|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44395993|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44395994|NCT02954172|Paclitaxel|paclitaxel|mesh-list
44395995|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44395996|NCT02954172|Bevacizumab|bevacizumab|mesh-list
44395997|NCT02954172|Carboplatin|carboplatin|mesh-list
44395998|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44395999|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396000|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
44396001|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
44396002|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
44158364|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158365|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158366|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158367|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158368|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158369|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158370|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158371|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158372|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
44158373|NCT00236600|Topiramate|topiramate|mesh-list
44158374|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
44158375|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158376|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158377|NCT00236613|Topiramate|topiramate|mesh-list
44396003|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396004|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396005|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44396006|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396007|NCT02954172|Growth Substances|growth substances|mesh-ancestor
44396008|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396009|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
44396011|NCT02954159|Tacrolimus|tacrolimus|mesh-list
44396012|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396013|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
44396014|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396015|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44396016|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396017|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396018|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396019|NCT02953938|Ranibizumab|ranibizumab|mesh-list
44396020|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44396021|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396022|NCT02953938|Growth Substances|growth substances|mesh-ancestor
44396023|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396024|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
44396025|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396026|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44396027|NCT02953821|Hormones|hormones|mesh-ancestor
44396028|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396029|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396030|NCT02953782|Cetuximab|cetuximab|mesh-list
44158378|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
44158379|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158380|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158381|NCT00236626|Topiramate|topiramate|mesh-list
44158382|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
44158383|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43886879|NCT04560894|Sorafenib|sorafenib|mesh-list
43886880|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886883|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886884|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
43886885|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43886886|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43886887|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886888|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
43886889|NCT04560465|Coagulants|coagulants|mesh-ancestor
43886890|NCT04560322|Venetoclax|venetoclax|mesh-list
43886891|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
43886892|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
43886893|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396032|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396033|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396034|NCT02953678|Prednisone|prednisone|mesh-list
44396035|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
44396036|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44396037|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44396038|NCT02953678|Prednisolone|prednisolone|mesh-list
44396039|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
44396040|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44396041|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
44396042|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396043|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
44396044|NCT02953678|Hormones|hormones|mesh-ancestor
43886894|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43886895|NCT04560751|Lenvatinib|lenvatinib|mesh-list
43886896|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886897|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43886898|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886899|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886900|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
43886901|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43886902|NCT04560816|Choline|choline|mesh-list
43886903|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43886904|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886905|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43886906|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43886907|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886908|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886909|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886910|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886911|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
43886912|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43886913|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
43886914|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886915|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43886916|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
43886917|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
43886918|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
43886919|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43886920|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43886921|NCT04560816|Growth Substances|growth substances|mesh-ancestor
43886922|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
43886923|NCT04560569|Antibodies|antibodies|mesh-list
43886924|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
43886925|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886926|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
43886927|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43886928|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886929|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
43886930|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43886931|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43886932|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886933|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
43886934|NCT04559880|Coagulants|coagulants|mesh-ancestor
43886935|NCT04560231|Remdesivir|remdesivir|mesh-list
43886936|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
43886937|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886938|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
43886939|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886940|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
43886941|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43886942|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43886943|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44396045|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396046|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396047|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396048|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396050|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
44396051|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396052|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396053|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44396054|NCT02953678|Protective Agents|protective agents|mesh-ancestor
44396055|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
44396056|NCT02953340|Docetaxel|docetaxel|mesh-list
44396057|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396058|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
44396059|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396060|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396061|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396062|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
44396063|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396064|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396065|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44396066|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
44396067|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
44396068|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
44396069|NCT02953314|Ivacaftor|ivacaftor|mesh-list
44396070|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44396071|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44396072|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396073|NCT02952898|Diclofenac|diclofenac|mesh-list
43886944|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43886945|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886946|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
43886947|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43886948|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886949|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43886950|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886951|NCT04560218|Misoprostol|misoprostol|mesh-list
43886952|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43786506|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43886953|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
43886955|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43670706|NCT05426499|Fluconazole|fluconazole|mesh-list
43886956|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43886957|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396074|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396075|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396076|NCT02952898|Analgesics|analgesics|mesh-ancestor
44396077|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
44396078|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396079|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396080|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396081|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396082|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44396083|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396084|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396085|NCT02952820|Lemborexant|lemborexant|mesh-list
44396086|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44396087|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396088|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396089|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44396090|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44396091|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396092|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396093|NCT02952586|Avelumab|avelumab|mesh-list
44396094|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396095|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786507|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44396096|NCT02952001|Triamcinolone|triamcinolone|mesh-list
44396097|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44396098|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44396099|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44396100|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396101|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
44396102|NCT02952001|Hormones|hormones|mesh-ancestor
44396103|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396104|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886958|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
43886960|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
43886961|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43886962|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43886963|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
43886964|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43886965|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43886966|NCT04559841|Simvastatin|simvastatin|mesh-list
43886967|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43886968|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44396105|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396106|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
44396107|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396108|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396109|NCT02951819|Dexamethasone|dexamethasone|mesh-list
44396110|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
44396111|NCT02951819|Bortezomib|bortezomib|mesh-list
44396112|NCT02951819|Daratumumab|daratumumab|mesh-list
44396113|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396114|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
44396115|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396116|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396117|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396118|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
44396119|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396120|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396121|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44396122|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396123|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
44396124|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
44396125|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396126|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396127|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
44396128|NCT02951819|Hormones|hormones|mesh-ancestor
44396129|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886969|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
43886970|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886971|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43886972|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43886973|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886974|NCT04559425|Dexamethasone|dexamethasone|mesh-list
43886975|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
43886976|NCT04559425|BB 1101|bb 1101|mesh-list
43886977|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43886978|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
43886979|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
43886980|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43886981|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886982|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43886983|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
43886984|NCT04559425|Hormones|hormones|mesh-ancestor
43886985|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43886986|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43886987|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43886988|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
43886989|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43886990|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886991|NCT04559568|Midazolam|midazolam|mesh-list
43886992|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44396130|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396131|NCT02951429|Pirfenidone|pirfenidone|mesh-list
44396132|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
43786515|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44396133|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
44396134|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44396135|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44396136|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396137|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43886993|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43886994|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43886995|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43886996|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43886997|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43886998|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43886999|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43887000|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
43887001|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
43887002|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
43887003|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
43887004|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887005|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887007|NCT04559308|Paclitaxel|paclitaxel|mesh-list
43887008|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
43887009|NCT04559308|Doxorubicin|doxorubicin|mesh-list
43887010|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43887011|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887012|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887013|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887014|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887015|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887016|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887017|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
43887018|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887019|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887020|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43887021|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
43887022|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43887023|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887024|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43887025|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43887026|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43887027|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887028|NCT04559165|Chitosan|chitosan|mesh-list
43887040|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43887041|NCT04559113|Prednisolone|prednisolone|mesh-list
43887042|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
43887043|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43887044|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
43887045|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887046|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
43887047|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
43887048|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887049|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887050|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887051|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
43887052|NCT04559113|Hormones|hormones|mesh-ancestor
43887053|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887054|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43887055|NCT04559113|Protective Agents|protective agents|mesh-ancestor
43887056|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887057|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887058|NCT04559074|Amlodipine|amlodipine|mesh-list
43887059|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43887060|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43887061|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43887062|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396139|NCT02951429|Analgesics|analgesics|mesh-ancestor
44396140|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
44396141|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396142|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396143|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396144|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396145|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396146|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396147|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396148|NCT02951156|Gemcitabine|gemcitabine|mesh-list
44396149|NCT02951156|Rituximab|rituximab|mesh-list
44396150|NCT02951156|Avelumab|avelumab|mesh-list
44396151|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
44396152|NCT02951156|Azacitidine|azacitidine|mesh-list
44396153|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44396154|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887063|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887064|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887065|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
43887066|NCT04559048|Tacrolimus|tacrolimus|mesh-list
43887067|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887068|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
43887069|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887070|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43887071|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887072|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887078|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
43887079|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43887080|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887081|NCT04558580|Rufinamide|rufinamide|mesh-list
43887082|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
43887083|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43887084|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43887085|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43887086|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887087|NCT04558463|Oseltamivir|oseltamivir|mesh-list
43887088|NCT04558463|Favipiravir|favipiravir|mesh-list
43887089|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
43887090|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887091|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887096|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887097|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
43887098|NCT04558268|Hormones|hormones|mesh-ancestor
43887099|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887100|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887101|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887102|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887103|NCT04558268|Progestins|progestins|mesh-ancestor
43887104|NCT04558268|Hematinics|hematinics|mesh-ancestor
43887105|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
43887107|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
43887108|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
43887109|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
43887110|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887111|NCT04558424|Protective Agents|protective agents|mesh-ancestor
43887112|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887113|NCT04558424|Vitamins|vitamins|mesh-ancestor
43887114|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
44396156|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
44396157|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396158|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44053644|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
44396159|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44396160|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
44396161|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396162|NCT02951156|Antiviral Agents|antiviral agents|mesh-ancestor
44396163|NCT02951156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396164|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396165|NCT02951156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396166|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396167|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
43653971|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
43653972|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653973|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396168|NCT02950558|Ropivacaine|ropivacaine|mesh-list
44396169|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
44396170|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
44396171|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396172|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396173|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
44396174|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396175|NCT02950480|Zafirlukast|zafirlukast|mesh-list
44396176|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44396177|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
44396178|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44396179|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
44157067|NCT00233155|Capsaicin|capsaicin|mesh-list
44157068|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
44157069|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157070|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
44157071|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157072|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157073|NCT00233337|Artemether|artemether|mesh-list
44157074|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44157075|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
44157076|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44157077|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44157078|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157079|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44157080|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44157081|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157082|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
44157083|NCT00233532|Verapamil|verapamil|mesh-list
44157084|NCT00233532|Trandolapril|trandolapril|mesh-list
44157085|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44157086|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44157087|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157088|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396180|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396181|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396182|NCT02949934|Tolcapone|tolcapone|mesh-list
44396183|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44396184|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44396185|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44396186|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396187|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396188|NCT02949700|Metformin|metformin|mesh-list
44396189|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396190|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396191|NCT02949362|Teduglutide|teduglutide|mesh-list
44396192|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396193|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44396194|NCT02949362|Protective Agents|protective agents|mesh-ancestor
44396195|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396196|NCT02949271|Fentanyl|fentanyl|mesh-list
43594478|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
43840466|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786519|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
43786520|NCT04198961|Narcotics|narcotics|mesh-ancestor
43786521|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396197|NCT02949271|Ropivacaine|ropivacaine|mesh-list
44396198|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
44396199|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
44157089|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44157090|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157091|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44157092|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44157093|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157094|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157095|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44157096|NCT00233545|Miltefosine|miltefosine|mesh-list
44157097|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
44157098|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157099|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157100|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44157101|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44157102|NCT00233558|Adalimumab|adalimumab|mesh-list
44157103|NCT00233558|Methotrexate|methotrexate|mesh-list
44157104|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44157105|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
44157106|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44157107|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157108|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44157109|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
44157110|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157111|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157112|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157113|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157114|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44157115|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157116|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
44157117|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157118|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157119|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157120|NCT00233571|Adalimumab|adalimumab|mesh-list
44157121|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157122|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157123|NCT00233584|Budesonide|budesonide|mesh-list
44396200|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396201|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396202|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
44396203|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396204|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44396206|NCT02949271|Analgesics|analgesics|mesh-ancestor
44396207|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44396208|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43847317|NCT04117087|Nivolumab|nivolumab|mesh-list
44157124|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157125|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44157126|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
44157127|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44157128|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157129|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44157130|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44157131|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
44157132|NCT00233584|Hormones|hormones|mesh-ancestor
44158384|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887115|NCT04558021|Niclosamide|niclosamide|mesh-list
43887116|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
43887117|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43887118|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
43887119|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43887120|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887121|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
43887122|NCT04557878|Mitogens|mitogens|mesh-list
43887123|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887124|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887125|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
43887126|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43887127|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
43887128|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887129|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
43887130|NCT04557943|Protective Agents|protective agents|mesh-ancestor
43887131|NCT04557475|Aspirin|aspirin|mesh-list
43887132|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43887133|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43887134|NCT04557475|Analgesics|analgesics|mesh-ancestor
43887135|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
43887136|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887137|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887138|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887139|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887140|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43887141|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43887142|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887143|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43887144|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43887145|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887146|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
43887147|NCT04557397|Itraconazole|itraconazole|mesh-list
43887148|NCT04557397|Rifampin|rifampin|mesh-list
43887149|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
43887150|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887151|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43887152|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43887153|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887154|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887155|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43887156|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
43887157|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887158|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887159|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44396209|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
44396210|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
44396211|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396212|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396213|NCT02949128|Ravulizumab|ravulizumab|mesh-list
44396214|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44396215|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396216|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
44396217|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396218|NCT02949024|Triamcinolone|triamcinolone|mesh-list
44396219|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44396220|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44396221|NCT02949024|Aflibercept|aflibercept|mesh-list
44396222|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44396223|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396224|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
44396225|NCT02949024|Hormones|hormones|mesh-ancestor
44396226|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396227|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396228|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396229|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
44396230|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396231|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396232|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44053722|NCT00004197|Prednisone|prednisone|mesh-list
44396233|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396235|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
44396236|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396237|NCT02949011|Oseltamivir|oseltamivir|mesh-list
44396238|NCT02949011|Baloxavir|baloxavir|mesh-list
44396239|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
43887160|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43887161|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
43887162|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887163|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
43887164|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43887165|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43887166|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43887167|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43887168|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43887169|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43887170|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43887171|NCT04557384|Ramucirumab|ramucirumab|mesh-list
43887180|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44396240|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396241|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396242|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396244|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44396245|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44396246|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
44396247|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396248|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44396249|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
44396250|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44396251|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44396252|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44396253|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44396254|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
44396255|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396256|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396257|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396258|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
44396259|NCT02947022|Zinc|zinc|mesh-list
44396260|NCT02947022|Edetic Acid|edetic acid|mesh-list
44396261|NCT02947022|Calcium|calcium|mesh-list
44396262|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
44396263|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44396264|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396265|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44396266|NCT02947022|Trace Elements|trace elements|mesh-ancestor
44396267|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
44396268|NCT02947022|Antidotes|antidotes|mesh-ancestor
44396269|NCT02947022|Protective Agents|protective agents|mesh-ancestor
44396270|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
44396271|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
44396272|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396273|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44396274|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
44396276|NCT02946580|Naloxegol|naloxegol|mesh-list
44396281|NCT02946463|Eculizumab|eculizumab|mesh-list
44396282|NCT02946463|Ravulizumab|ravulizumab|mesh-list
44396283|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44396284|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396285|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
44396286|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396287|NCT02946385|Vaccines|vaccines|mesh-list
44396288|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
44396289|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396290|NCT02945410|Vitamin D|vitamin d|mesh-list
44396291|NCT02945410|Calcium|calcium|mesh-list
44396292|NCT02945410|Vitamins|vitamins|mesh-ancestor
43887181|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
43887182|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887183|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887184|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887185|NCT04557202|Urological Agents|urological agents|mesh-ancestor
43887186|NCT04557020|Gemcitabine|gemcitabine|mesh-list
43887187|NCT04557020|Cisplatin|cisplatin|mesh-list
43887188|NCT04557020|Antibodies|antibodies|mesh-list
43887189|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
43887190|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887191|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43887192|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
43887193|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887194|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887195|NCT04557020|Antiviral Agents|antiviral agents|mesh-ancestor
43887196|NCT04557020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887197|NCT04557020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887198|NCT04557020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887199|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43887200|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43887201|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887202|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
43887203|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887204|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887205|NCT04556760|Prednisolone|prednisolone|mesh-list
43887206|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887207|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
43887208|NCT04556760|Hormones|hormones|mesh-ancestor
43887209|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887210|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887211|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887212|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887213|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
43887214|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43887215|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887216|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
43887217|NCT04556110|Perindopril|perindopril|mesh-list
43887218|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43887219|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
43887220|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887221|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887222|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43887223|NCT04556136|Vitamin D|vitamin d|mesh-list
43887224|NCT04556136|Vitamins|vitamins|mesh-ancestor
43887225|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
43887226|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887227|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43887228|NCT04556058|Perindopril|perindopril|mesh-list
43887229|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43887230|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396293|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
44396294|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396295|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44396296|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44396297|NCT02944656|Gabapentin|gabapentin|mesh-list
44396298|NCT02944656|Analgesics|analgesics|mesh-ancestor
44396299|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
44396300|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396301|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396302|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
44396303|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44396304|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44396305|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396306|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44396307|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44396308|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44396309|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396310|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396311|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
44396312|NCT02943993|Edoxaban|edoxaban|mesh-list
44396313|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44396314|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
44396315|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44396316|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396317|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396318|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396319|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
44396320|NCT02943668|Deferasirox|deferasirox|mesh-list
44396321|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44396322|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
44396338|NCT02942485|Tinidazole|tinidazole|mesh-list
44396339|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396340|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44396341|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44396342|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44396343|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
44396344|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396345|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44396346|NCT02942407|Warfarin|warfarin|mesh-list
44396347|NCT02942407|Apixaban|apixaban|mesh-list
44396348|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
44396349|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44396350|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
44396351|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43786537|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396352|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
44396353|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396354|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396355|NCT02942264|Temozolomide|temozolomide|mesh-list
44396356|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396357|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
44396358|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396359|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396360|NCT02941523|Carboplatin|carboplatin|mesh-list
44396361|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396362|NCT02940886|Iron|iron|mesh-list
44396363|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44396364|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44396365|NCT02940886|Trace Elements|trace elements|mesh-ancestor
44396366|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
44396367|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396368|NCT02940886|Hematinics|hematinics|mesh-ancestor
44396369|NCT02940860|Iron|iron|mesh-list
44396370|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44396371|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
44396372|NCT02940860|Trace Elements|trace elements|mesh-ancestor
44396381|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44396382|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
44396383|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396384|NCT02940574|Oxytocin|oxytocin|mesh-list
44396385|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
44396386|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44396387|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396388|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44396389|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44396390|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44396391|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
44396392|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396393|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396394|NCT02940522|Progestins|progestins|mesh-ancestor
44396395|NCT02940522|Hormones|hormones|mesh-ancestor
44396396|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44396397|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44396398|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44396399|NCT02939937|Phenytoin|phenytoin|mesh-list
44396400|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
44396401|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44396402|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44396403|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44396404|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396405|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44396406|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44396407|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44396408|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44396409|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396410|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396411|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
44396412|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887231|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887232|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887233|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43887234|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
43887235|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
43887236|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396414|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396415|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396416|NCT02938585|Factor VIII|factor viii|mesh-list
44396417|NCT02938585|Coagulants|coagulants|mesh-ancestor
44396418|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
44396419|NCT02937740|Testosterone|testosterone|mesh-list
44396420|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
44396421|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
44396422|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44396423|NCT02937740|Androgens|androgens|mesh-ancestor
44396424|NCT02937740|Hormones|hormones|mesh-ancestor
44396425|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396426|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396427|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396428|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396429|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
44396430|NCT02937701|Infliximab|infliximab|mesh-list
44396431|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
44396432|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396433|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396434|NCT02937636|Fluorides|fluorides|mesh-list
44396435|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
44396436|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
44396437|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
44396438|NCT02937636|Protective Agents|protective agents|mesh-ancestor
44396439|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396440|NCT02937571|Dexamethasone|dexamethasone|mesh-list
44396441|NCT02937571|Lenalidomide|lenalidomide|mesh-list
44396442|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396443|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
44396444|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
44396445|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396449|NCT02937571|Hormones|hormones|mesh-ancestor
44396458|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44396459|NCT02937350|Calcifediol|calcifediol|mesh-list
44396460|NCT02937350|Vitamins|vitamins|mesh-ancestor
44396461|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
44396462|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396463|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44396464|NCT02936037|Biotin|biotin|mesh-list
44396465|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
44396466|NCT02936037|Vitamins|vitamins|mesh-ancestor
44396467|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
44396468|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396469|NCT02935894|Ibuprofen|ibuprofen|mesh-list
44396470|NCT02935894|Pilocarpine|pilocarpine|mesh-list
44396471|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396472|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396473|NCT02935894|Analgesics|analgesics|mesh-ancestor
44396474|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
44396475|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396476|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396477|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396478|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396479|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44396480|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396481|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396482|NCT02935894|Miotics|miotics|mesh-ancestor
44396483|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
44396484|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44396485|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44396486|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
44396487|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396489|NCT02934503|Carboplatin|carboplatin|mesh-list
44396490|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
44396491|NCT02934503|Etoposide|etoposide|mesh-list
44396492|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887238|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43887240|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
43887241|NCT04556032|Ergothioneine|ergothioneine|mesh-list
43887242|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
43887243|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887244|NCT04556032|Protective Agents|protective agents|mesh-ancestor
43887245|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887246|NCT04556071|Bevacizumab|bevacizumab|mesh-list
43887247|NCT04556071|Niraparib|niraparib|mesh-list
43887248|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887249|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396493|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396494|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44396495|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44396496|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44396497|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396498|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396499|NCT02932904|Vortioxetine|vortioxetine|mesh-list
44396500|NCT02932904|Paroxetine|paroxetine|mesh-list
44396501|NCT02932904|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44396502|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43887250|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43887251|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43887252|NCT04556071|Growth Substances|growth substances|mesh-ancestor
43887253|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887254|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
43887255|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43887256|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887257|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887258|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43887259|NCT04555694|Cyclosporine|cyclosporine|mesh-list
43887260|NCT04555694|Dexamethasone|dexamethasone|mesh-list
43887261|NCT04555694|Cyclosporins|cyclosporins|mesh-list
43887262|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887263|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
43887264|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
43887265|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887266|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887267|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887268|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
43887269|NCT04555694|Hormones|hormones|mesh-ancestor
43887270|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887271|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887272|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887273|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887274|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887275|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887276|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
43887277|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
43887278|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887279|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887280|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887281|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43887282|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43887283|NCT04555733|Lemborexant|lemborexant|mesh-list
43887284|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43887285|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887286|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887287|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43887288|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43887289|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887290|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887291|NCT04555707|Betamethasone|betamethasone|mesh-list
43887292|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
43887293|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43887294|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
43887295|NCT04555707|Apremilast|apremilast|mesh-list
43887296|NCT04555707|Calcipotriene|calcipotriene|mesh-list
43887297|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43887298|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887299|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
43887300|NCT04555707|Hormones|hormones|mesh-ancestor
43887301|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887302|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396503|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44396504|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396505|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396506|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
44396507|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396508|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44396509|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
44396510|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44396511|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44396512|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44396513|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396514|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44396515|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44396516|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396517|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44396518|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44396519|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44396520|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44396521|NCT02932579|Acetaminophen|acetaminophen|mesh-list
44396522|NCT02932579|Ibuprofen|ibuprofen|mesh-list
44396523|NCT02932579|Oxycodone|oxycodone|mesh-list
43699431|NCT02738658|Everolimus|everolimus|mesh-list
43887303|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43887304|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
43887305|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43887306|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43887307|NCT04555707|Analgesics|analgesics|mesh-ancestor
43887308|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
44165316|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
43887311|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43887312|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43887314|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887315|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887316|NCT04555525|Sarecycline|sarecycline|mesh-list
43887317|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887318|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887319|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157133|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157134|NCT00233610|Tamoxifen|tamoxifen|mesh-list
44157135|NCT00233610|Bicalutamide|bicalutamide|mesh-list
44157136|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44157137|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
44157138|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44157139|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157140|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44157141|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157142|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44157143|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44157144|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44396524|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396525|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396527|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
44396528|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396529|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396530|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396531|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396532|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44396533|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396534|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396535|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44396536|NCT02932579|Narcotics|narcotics|mesh-ancestor
43699441|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157145|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
44157146|NCT00233623|Leucovorin|leucovorin|mesh-list
44157147|NCT00233623|Fluorouracil|fluorouracil|mesh-list
44157148|NCT00233623|Irinotecan|irinotecan|mesh-list
43887320|NCT04555304|Paclitaxel|paclitaxel|mesh-list
43887321|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43887322|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43887323|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887324|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887325|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887326|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887327|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887328|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43887329|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
43887330|NCT04554979|Anticoagulants|anticoagulants|mesh-list
43887331|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887332|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
43887333|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43887334|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43887335|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887336|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887337|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887338|NCT04554654|Progesterone|progesterone|mesh-list
43887339|NCT04554654|Progestins|progestins|mesh-ancestor
43887340|NCT04554654|Hormones|hormones|mesh-ancestor
43887341|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887342|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887343|NCT04554680|Trametinib|trametinib|mesh-list
43887344|NCT04554680|Dabrafenib|dabrafenib|mesh-list
43887345|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887346|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887347|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887348|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887349|NCT04554615|Insulin|insulin|mesh-list
43887350|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887351|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887352|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
43887353|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43887354|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43887355|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43887356|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
43887357|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887358|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887359|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887360|NCT04554433|Ethanol|ethanol|mesh-list
43887361|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43887362|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396537|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396538|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
44396539|NCT02932267|Adapalene|adapalene|mesh-list
44396540|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396541|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396542|NCT02932267|Analgesics|analgesics|mesh-ancestor
44396543|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
44396544|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396545|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396546|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396547|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396548|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
44396549|NCT02931838|BMS-986165|bms-986165|mesh-list
43699459|NCT02738632|Amlodipine|amlodipine|mesh-list
43887363|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887364|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887365|NCT04554524|Paclitaxel|paclitaxel|mesh-list
43887366|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
43887379|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887380|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887381|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
43887382|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43887383|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43887384|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887385|NCT04553380|Insulin|insulin|mesh-list
43887386|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
43887387|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887388|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887389|NCT04553393|Decitabine|decitabine|mesh-list
43887390|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43887391|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
43887392|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887393|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887394|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887395|NCT04553510|Bevacizumab|bevacizumab|mesh-list
43887396|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887397|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887398|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43887399|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43887400|NCT04553510|Growth Substances|growth substances|mesh-ancestor
43887401|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887402|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
43887403|NCT04553458|Ethanol|ethanol|mesh-list
43887404|NCT04553458|Sorafenib|sorafenib|mesh-list
43887405|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887406|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887407|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887408|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887409|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43887410|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887411|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887412|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887413|NCT04553328|Bupivacaine|bupivacaine|mesh-list
43887414|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
43887415|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
43887416|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887417|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887418|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
43887419|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887420|NCT04552977|Temozolomide|temozolomide|mesh-list
43887421|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396550|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
44396551|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44396552|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396553|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396554|NCT02931539|Valganciclovir|valganciclovir|mesh-list
44396555|NCT02931539|Ganciclovir|ganciclovir|mesh-list
44396556|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44396557|NCT02931539|Cidofovir|cidofovir|mesh-list
44396558|NCT02931539|Foscarnet|foscarnet|mesh-list
44396559|NCT02931539|Maribavir|maribavir|mesh-list
44396560|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
44396561|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396562|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44396563|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396564|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396565|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44396566|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
44396567|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43699475|NCT02738177|Isosorbide|isosorbide|mesh-list
43887422|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
43887423|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887424|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157149|NCT00233623|Gefitinib|gefitinib|mesh-list
44157150|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
44157153|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157154|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157155|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
44157156|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157157|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44157158|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44157159|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157160|NCT00233623|Antidotes|antidotes|mesh-ancestor
44157161|NCT00233623|Protective Agents|protective agents|mesh-ancestor
44157162|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
44157163|NCT00233623|Vitamins|vitamins|mesh-ancestor
44157164|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
44157165|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157166|NCT00233636|Gefitinib|gefitinib|mesh-list
44157167|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157168|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44157169|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157170|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157171|NCT00233662|Alefacept|alefacept|mesh-list
44157172|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44157173|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
44157174|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157175|NCT00233675|Tiagabine|tiagabine|mesh-list
44157176|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
44157177|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
44157178|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44157179|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157180|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157181|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
44157182|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157183|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157184|NCT00233714|Sirolimus|sirolimus|mesh-list
44157185|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157186|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396568|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44396569|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396571|NCT02930941|Coagulants|coagulants|mesh-ancestor
44396572|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44396573|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44396574|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43786565|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43786566|NCT03727139|Protective Agents|protective agents|mesh-ancestor
44396575|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396576|NCT02930343|Folic Acid|folic acid|mesh-list
44396577|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
44396578|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
44396579|NCT02930343|Prednisolone|prednisolone|mesh-list
44396580|NCT02930343|Methotrexate|methotrexate|mesh-list
44157187|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157188|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157189|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
44157190|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157191|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
44157192|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158457|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44158458|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
44158459|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44158460|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44158461|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44158462|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44158463|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44158464|NCT00236782|Norelgestromin|norelgestromin|mesh-list
44158466|NCT00236782|Estrogens|estrogens|mesh-ancestor
44158467|NCT00236782|Hormones|hormones|mesh-ancestor
43670751|NCT05425654|Busulfan|busulfan|mesh-list
44158468|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158469|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158470|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44158471|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
44158472|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44158473|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44158474|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44158475|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44158476|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44158477|NCT00236795|Norelgestromin|norelgestromin|mesh-list
44158478|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44158479|NCT00236795|Estradiol|estradiol|mesh-list
44158480|NCT00236795|Estrogens|estrogens|mesh-ancestor
44158481|NCT00236795|Hormones|hormones|mesh-ancestor
44158482|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158483|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158484|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44158485|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
44158486|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44158490|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44158491|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44158492|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
44158493|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44158494|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44158495|NCT00236808|Levofloxacin|levofloxacin|mesh-list
44158496|NCT00236808|Ofloxacin|ofloxacin|mesh-list
44158497|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44158498|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158499|NCT00236808|Renal Agents|renal agents|mesh-ancestor
44158500|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158501|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158502|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44396581|NCT02930343|Leflunomide|leflunomide|mesh-list
44396582|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
44396583|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44396584|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
44396585|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44396586|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396587|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44396588|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
44396589|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396590|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396591|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
44396592|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396593|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44396594|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396595|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
44396596|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786572|NCT03625986|Nicotine|nicotine|mesh-list
44396597|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44396598|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396599|NCT02930343|Hormones|hormones|mesh-ancestor
44396600|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396601|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396602|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396603|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396604|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
44396605|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44158503|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158504|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158505|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158506|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158507|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158508|NCT00236821|Levofloxacin|levofloxacin|mesh-list
44158509|NCT00236821|Ofloxacin|ofloxacin|mesh-list
44158510|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44158511|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158512|NCT00236821|Renal Agents|renal agents|mesh-ancestor
44158513|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158514|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158515|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158516|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158517|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158518|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158519|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158520|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158521|NCT00236834|Levofloxacin|levofloxacin|mesh-list
44158522|NCT00236834|Ofloxacin|ofloxacin|mesh-list
44158523|NCT00236834|Imipenem|imipenem|mesh-list
44158524|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44396606|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44396607|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396608|NCT02930343|Hematinics|hematinics|mesh-ancestor
44396609|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
44396610|NCT02930343|Vitamins|vitamins|mesh-ancestor
44396611|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
44396612|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396613|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396614|NCT02930343|Analgesics|analgesics|mesh-ancestor
44396615|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
44396616|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44396617|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396618|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
44396619|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
44396620|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
44396621|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44396622|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44396623|NCT02930005|Analgesics|analgesics|mesh-ancestor
44396624|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
44396625|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396626|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396627|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43830326|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
44158525|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158526|NCT00236834|Renal Agents|renal agents|mesh-ancestor
44158527|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158528|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158529|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158530|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158531|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158532|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158533|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158534|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158535|NCT00236847|Topiramate|topiramate|mesh-list
44158536|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
44158537|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158538|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158539|NCT00236860|Topiramate|topiramate|mesh-list
44158540|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
44158541|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158542|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158543|NCT00236873|Topiramate|topiramate|mesh-list
44158544|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
44158545|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158546|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158547|NCT00236886|Topiramate|topiramate|mesh-list
44158548|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
44158549|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158550|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158551|NCT00236912|Metronidazole|metronidazole|mesh-list
44158552|NCT00236912|Levofloxacin|levofloxacin|mesh-list
44158553|NCT00236912|Ofloxacin|ofloxacin|mesh-list
44158554|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158555|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44396679|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396680|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
44396681|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396682|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396683|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
44396684|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396685|NCT02927925|Daratumumab|daratumumab|mesh-list
44396686|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396687|NCT02927873|Vaccines|vaccines|mesh-list
44396688|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
44396689|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396690|NCT02927847|Nicotine|nicotine|mesh-list
44396691|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44396692|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
44396693|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396694|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396695|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44396696|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44396697|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
44396698|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396730|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
44396731|NCT02926833|Fludarabine|fludarabine|mesh-list
44396732|NCT02926833|Atezolizumab|atezolizumab|mesh-list
44396733|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44396734|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
44396735|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396736|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44396737|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44396738|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
44396739|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396740|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396741|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44396742|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44396743|NCT02926638|Rilotumumab|rilotumumab|mesh-list
44396744|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44396745|NCT02926638|Antibodies|antibodies|mesh-list
44396746|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
44396747|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44396748|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
44396749|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396750|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43699527|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158556|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44158557|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44158558|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44158559|NCT00236912|Renal Agents|renal agents|mesh-ancestor
44158564|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158565|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44158566|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44158568|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158569|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
44158570|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44158571|NCT00236964|Hematinics|hematinics|mesh-ancestor
44158572|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
44158573|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
44158574|NCT00237016|Doxycycline|doxycycline|mesh-list
44158575|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158576|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158577|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
44158578|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44158579|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44158580|NCT00237068|Lansoprazole|lansoprazole|mesh-list
44158581|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
44158582|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44158583|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158584|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44158585|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158586|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158587|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
44158588|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158589|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44158590|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158591|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158592|NCT00237133|Letrozole|letrozole|mesh-list
44396751|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44396752|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396753|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396754|NCT02926573|Gabapentin|gabapentin|mesh-list
44396755|NCT02926573|Analgesics|analgesics|mesh-ancestor
44396756|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
44396757|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396758|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396759|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
44396760|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44396761|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44396762|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396763|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44396764|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44396765|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44396766|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396767|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158593|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158594|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44158595|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44158596|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158597|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158598|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44158599|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
44158600|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158601|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158602|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
44158603|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44158604|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158606|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44158607|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158608|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
44158609|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158610|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44158611|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158612|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158613|NCT00237198|Letrozole|letrozole|mesh-list
44158614|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158615|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44158616|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44158617|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158618|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158619|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44158620|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
44158621|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158622|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158623|NCT00237211|Letrozole|letrozole|mesh-list
44158624|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158625|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44158626|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44158627|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786573|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43786574|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
44158628|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158641|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396768|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
44396769|NCT02925923|Clopidogrel|clopidogrel|mesh-list
44396770|NCT02925923|Ticagrelor|ticagrelor|mesh-list
44396771|NCT02925923|Eptifibatide|eptifibatide|mesh-list
44396772|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44396773|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44396774|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44396775|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44396776|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
44396777|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396778|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396779|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396780|NCT02925494|Norethindrone|norethindrone|mesh-list
44396781|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
44396782|NCT02925494|Estradiol|estradiol|mesh-list
44396783|NCT02925494|Estrogens|estrogens|mesh-ancestor
44396784|NCT02925494|Hormones|hormones|mesh-ancestor
44158642|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158643|NCT00237237|Vildagliptin|vildagliptin|mesh-list
44158644|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158645|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158646|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44158647|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
44158648|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158649|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158650|NCT00237250|Vildagliptin|vildagliptin|mesh-list
44158651|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158652|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158653|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44158654|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
44158655|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158656|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158657|NCT00237263|Entacapone|entacapone|mesh-list
44158658|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44158659|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44158660|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44158661|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158662|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158663|NCT00237289|Topiramate|topiramate|mesh-list
44158664|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
44158665|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158666|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158667|NCT00237302|Topiramate|topiramate|mesh-list
44158668|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
44158669|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158670|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158671|NCT00237328|Heparin|heparin|mesh-list
44158672|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
44158673|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44158674|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44158675|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158676|NCT00237341|Fentanyl|fentanyl|mesh-list
44158677|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158678|NCT00237341|Narcotics|narcotics|mesh-ancestor
44158679|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158680|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158681|NCT00237341|Analgesics|analgesics|mesh-ancestor
44158682|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
44158683|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396785|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396786|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396787|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44396788|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
44396789|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44396790|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44396791|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44396792|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44396793|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44396794|NCT02925117|Upadacitinib|upadacitinib|mesh-list
44396795|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44396796|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44396797|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158684|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44158685|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44158686|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
44158687|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
44158688|NCT00237367|Rabeprazole|rabeprazole|mesh-list
44158689|NCT00237367|Pantoprazole|pantoprazole|mesh-list
44158690|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44158691|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158692|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44158693|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158694|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158695|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44158696|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158697|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158698|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158699|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158700|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158701|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158702|NCT00237419|Infliximab|infliximab|mesh-list
44158703|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
44158704|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158705|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158706|NCT00237445|Azithromycin|azithromycin|mesh-list
44158707|NCT00237445|Telithromycin|telithromycin|mesh-list
44158708|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44158709|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158710|NCT00237471|Insulin|insulin|mesh-list
44158711|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44158712|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158713|NCT00237484|Interferons|interferons|mesh-list
44158714|NCT00237484|Ribavirin|ribavirin|mesh-list
44158715|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
44158716|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
44158717|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44158718|NCT00237484|Infliximab|infliximab|mesh-list
44158719|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158720|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
44158721|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158722|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
44158723|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158724|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
44158725|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158726|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44158727|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158728|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158729|NCT00237497|Zopiclone|zopiclone|mesh-list
44158730|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44158731|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158732|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158733|NCT00237510|Terazosin|terazosin|mesh-list
44396798|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396800|NCT02924883|Trastuzumab|trastuzumab|mesh-list
44396801|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44396802|NCT02924883|Atezolizumab|atezolizumab|mesh-list
44396803|NCT02924883|Maytansine|maytansine|mesh-list
44396804|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44396805|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396806|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44396807|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44396808|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44396809|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44396810|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396811|NCT02924688|Fluticasone|fluticasone|mesh-list
44396812|NCT02924688|Albuterol|albuterol|mesh-list
44158734|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43786582|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44158735|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43786586|NCT03416855|Insulin|insulin|mesh-list
44158736|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44158737|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44158738|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158739|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158740|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158741|NCT00237510|Urological Agents|urological agents|mesh-ancestor
44158742|NCT00237523|Iodine|iodine|mesh-list
44158743|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
44158744|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44158745|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158746|NCT00237523|Trace Elements|trace elements|mesh-ancestor
44158747|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
44158748|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158749|NCT00237536|Lonidamine|lonidamine|mesh-list
44158750|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158751|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44158752|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158753|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44158754|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
44158755|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44158756|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44158757|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44158758|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44158759|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158760|NCT00237575|Gemcitabine|gemcitabine|mesh-list
44158761|NCT00237575|Cisplatin|cisplatin|mesh-list
44158762|NCT00237575|Sargramostim|sargramostim|mesh-list
44158763|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158764|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44158765|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
44158766|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158767|NCT00237575|Antiviral Agents|antiviral agents|mesh-ancestor
44158776|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44158777|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158778|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158779|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44158780|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158781|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
44158782|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44158783|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44158784|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44158786|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44158787|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
44396813|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44396814|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44396815|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396816|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44396817|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
44396818|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396819|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396820|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44396821|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
44396822|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
44396823|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44396824|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44396825|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44396826|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44396827|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
44396828|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396829|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396830|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
44396831|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44396832|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
44396833|NCT02924688|Hormones|hormones|mesh-ancestor
44396835|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
44396864|NCT02920528|Analgesics|analgesics|mesh-ancestor
44396865|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
44396866|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396867|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396868|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43786590|NCT03342417|Nivolumab|nivolumab|mesh-list
44396869|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44396870|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
44396871|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
44396872|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396873|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44396874|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44396875|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396876|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396877|NCT02920450|Paclitaxel|paclitaxel|mesh-list
44396878|NCT02920450|Carboplatin|carboplatin|mesh-list
44396879|NCT02920450|Gedatolisib|gedatolisib|mesh-list
44396880|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44396881|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396882|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
44396883|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
44396884|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
44396885|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396886|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44396887|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396888|NCT02920242|Rifaximin|rifaximin|mesh-list
44396889|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44396890|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44396891|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396892|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44396893|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396894|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
44396895|NCT02920177|Hormones|hormones|mesh-ancestor
44396896|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396903|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396905|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44396906|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44396907|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44396908|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44396909|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396910|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396911|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396912|NCT02919436|Urological Agents|urological agents|mesh-ancestor
44396913|NCT02918968|Flutamide|flutamide|mesh-list
44396914|NCT02918968|Androgens|androgens|mesh-list
44396915|NCT02918968|Hormones|hormones|mesh-ancestor
44396916|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396917|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396918|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
44396919|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
44396920|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44158788|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158789|NCT00237614|Expectorants|expectorants|mesh-ancestor
44158790|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
44158791|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44158792|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
44158793|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158794|NCT00237614|Protective Agents|protective agents|mesh-ancestor
44158795|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158796|NCT00237614|Antidotes|antidotes|mesh-ancestor
44158797|NCT00237627|Doxorubicin|doxorubicin|mesh-list
44158798|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44158799|NCT00237627|Bortezomib|bortezomib|mesh-list
44158800|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44158801|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158802|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44158803|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44158804|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158805|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158806|NCT00237653|Valganciclovir|valganciclovir|mesh-list
44158807|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
44158808|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158809|NCT00237705|Metoclopramide|metoclopramide|mesh-list
44158810|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
44158811|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
44158812|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158813|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158814|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158815|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43786594|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44158816|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158817|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
44158818|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158819|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158821|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44158822|NCT00237731|Narcotics|narcotics|mesh-ancestor
44158823|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158824|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158825|NCT00237731|Analgesics|analgesics|mesh-ancestor
44158826|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
44396921|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396922|NCT02918877|Propofol|propofol|mesh-list
44396923|NCT02918877|Sevoflurane|sevoflurane|mesh-list
44396924|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44396925|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44396926|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396927|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44396928|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
44396929|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
44396930|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44396931|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44396932|NCT02918318|Esketamine|esketamine|mesh-list
44396933|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
44396934|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44396935|NCT02918279|Liraglutide|liraglutide|mesh-list
44396936|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44396937|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396938|NCT02918279|Incretins|incretins|mesh-ancestor
44396939|NCT02918279|Hormones|hormones|mesh-ancestor
44396940|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396941|NCT02918266|Scopolamine|scopolamine|mesh-list
44396942|NCT02918266|Donepezil|donepezil|mesh-list
44396943|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44396944|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44396945|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44396946|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44396947|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
44396948|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44396949|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43699698|NCT02736240|Vaccines|vaccines|mesh-list
44158827|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158828|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
44158829|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44158830|NCT00237861|Olanzapine|olanzapine|mesh-list
44158831|NCT00237861|Risperidone|risperidone|mesh-list
44158832|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44158833|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158834|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
44158835|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165317|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158845|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
44158846|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158847|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158848|NCT00237861|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44158849|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44158850|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44396950|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
44396951|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44396952|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
44396953|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
44396954|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396955|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396956|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
44396957|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44396958|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44396959|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
44396960|NCT02918071|Benralizumab|benralizumab|mesh-list
44396961|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44396962|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
44396963|NCT02917941|Dexamethasone|dexamethasone|mesh-list
44396964|NCT02917941|Lenalidomide|lenalidomide|mesh-list
44396965|NCT02917941|Ixazomib|ixazomib|mesh-list
44396966|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44396967|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
44396968|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
44396969|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44396970|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44396971|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44396972|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
44396973|NCT02917941|Hormones|hormones|mesh-ancestor
44396974|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44396975|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44396976|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44396977|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
44396978|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44396979|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44396996|NCT02916927|Ketamine|ketamine|mesh-list
44396997|NCT02916927|Analgesics|analgesics|mesh-ancestor
44396998|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
44396999|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397000|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397001|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44397002|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44397003|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
44397004|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
44397005|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397006|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44397007|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44397008|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397009|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397010|NCT02916693|Mirabegron|mirabegron|mesh-list
44397011|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44397012|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44397013|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44397014|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
44397015|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397016|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397017|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397018|NCT02916693|Urological Agents|urological agents|mesh-ancestor
44397019|NCT02916433|Octreotide|octreotide|mesh-list
44397020|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397021|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44397022|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397023|NCT02915978|Fentanyl|fentanyl|mesh-list
44397024|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44397025|NCT02915978|Narcotics|narcotics|mesh-ancestor
44397042|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397043|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397044|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397045|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397046|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
44397047|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397048|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397049|NCT02914275|Vaccines|vaccines|mesh-list
44397050|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
44397051|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397052|NCT02913326|Warfarin|warfarin|mesh-list
44397053|NCT02913326|Dabigatran|dabigatran|mesh-list
44397054|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
44397055|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
44158851|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158852|NCT00237874|Aripiprazole|aripiprazole|mesh-list
44158853|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158854|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158855|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158856|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158857|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158858|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158859|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
44158860|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
44158861|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158862|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158863|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44158864|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44158865|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
44158866|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44158867|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158868|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44158869|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158870|NCT00237887|Adalimumab|adalimumab|mesh-list
44158871|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44158872|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158873|NCT00237900|Leucovorin|leucovorin|mesh-list
44158874|NCT00237900|Fluorouracil|fluorouracil|mesh-list
44158875|NCT00237900|Gefitinib|gefitinib|mesh-list
44158876|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
44158877|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158878|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44158879|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158880|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44158881|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
44158882|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158884|NCT00237900|Protective Agents|protective agents|mesh-ancestor
44158885|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
44158886|NCT00237900|Vitamins|vitamins|mesh-ancestor
44158887|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
44158888|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44158889|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44158890|NCT00237913|Olanzapine|olanzapine|mesh-list
44158891|NCT00237913|Risperidone|risperidone|mesh-list
44158892|NCT00237913|Aripiprazole|aripiprazole|mesh-list
44158893|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44158894|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158895|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
44158896|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158897|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158898|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397057|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397058|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397059|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397060|NCT02912650|Acetaminophen|acetaminophen|mesh-list
44397061|NCT02912650|Ibuprofen|ibuprofen|mesh-list
44397062|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397063|NCT02912650|Analgesics|analgesics|mesh-ancestor
44397064|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
44397065|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397066|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397067|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
44397068|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44397069|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397070|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44158899|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158900|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158901|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158902|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158911|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44158913|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
44158914|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44158915|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44158916|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44158917|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44158918|NCT00237939|Aripiprazole|aripiprazole|mesh-list
44158919|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
44158920|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44158921|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44158922|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44158923|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158924|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158925|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
44158926|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
44158927|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44158928|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158929|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44158930|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44158931|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
44158932|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44158933|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44158934|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44158935|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158936|NCT00237952|Chelating Agents|chelating agents|mesh-list
44158937|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
44158938|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158939|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
44158941|NCT00238004|Niacinamide|niacinamide|mesh-list
44158942|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
44158943|NCT00238004|Vitamins|vitamins|mesh-ancestor
44158944|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
44158945|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158946|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44158947|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
44158948|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158949|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44158950|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
44158951|NCT00238017|Artesunate|artesunate|mesh-list
44397071|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44397072|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397073|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397074|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
44397075|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397076|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397077|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44397078|NCT02912455|Canagliflozin|canagliflozin|mesh-list
44397079|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44397080|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397081|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397082|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397083|NCT02911948|Insulin|insulin|mesh-list
44397084|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44397085|NCT02911948|Liraglutide|liraglutide|mesh-list
44397086|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
44397087|NCT02911948|Xultophy|xultophy|mesh-list
44397088|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397089|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397090|NCT02911948|Incretins|incretins|mesh-ancestor
44397091|NCT02911948|Hormones|hormones|mesh-ancestor
44397092|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397093|NCT02911935|Azithromycin|azithromycin|mesh-list
44397094|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397095|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397096|NCT02911688|Vitamin E|vitamin e|mesh-list
44397097|NCT02911688|Tocopherols|tocopherols|mesh-list
44397098|NCT02911688|Tocotrienols|tocotrienols|mesh-list
44397099|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
44397100|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
44397101|NCT02911688|Vitamins|vitamins|mesh-ancestor
44397102|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
44397103|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158952|NCT00238017|Amodiaquine|amodiaquine|mesh-list
44158953|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
44158954|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44158955|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44158956|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44158957|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158958|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
44158959|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
44158960|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44158961|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
44158962|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
44158963|NCT00238043|Hematinics|hematinics|mesh-ancestor
44158964|NCT00238056|Domperidone|domperidone|mesh-list
44397104|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
44397105|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397106|NCT02911688|Protective Agents|protective agents|mesh-ancestor
44397107|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
44397108|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44397109|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
44397110|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397111|NCT02911285|Expectorants|expectorants|mesh-ancestor
44397112|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
44397113|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44397114|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
44397115|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397116|NCT02911285|Protective Agents|protective agents|mesh-ancestor
44397117|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397118|NCT02911285|Antidotes|antidotes|mesh-ancestor
44397119|NCT02911116|Ustekinumab|ustekinumab|mesh-list
44397120|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397122|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397123|NCT02910167|Acetaminophen|acetaminophen|mesh-list
44397124|NCT02910167|Scopolamine|scopolamine|mesh-list
44397125|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44397126|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397127|NCT02910167|Analgesics|analgesics|mesh-ancestor
44397128|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
44397129|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397130|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397131|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
44397132|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44397133|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
44397134|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
43699766|NCT02735928|Cisplatin|cisplatin|mesh-list
44158965|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
44158966|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
44158967|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158968|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158969|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44158970|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44158971|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
44158979|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44158980|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158981|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44158982|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
44158984|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44158985|NCT00238147|Carboplatin|carboplatin|mesh-list
44158986|NCT00238147|Docetaxel|docetaxel|mesh-list
44397135|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397136|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
44397137|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44397138|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397139|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397140|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397141|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44397142|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
44397143|NCT02910063|Blinatumomab|blinatumomab|mesh-list
44397144|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397145|NCT02910011|Doxycycline|doxycycline|mesh-list
44397146|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397147|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397148|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
44397149|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44397150|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44397151|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
44397152|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44397153|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397154|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397155|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397156|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397157|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397158|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
44397159|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
44397160|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397161|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397162|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397163|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
44397164|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44397165|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397166|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397167|NCT02908529|Oxybutynin|oxybutynin|mesh-list
44397168|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44397169|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43699781|NCT02735798|Trastuzumab|trastuzumab|mesh-list
44158987|NCT00238147|Capecitabine|capecitabine|mesh-list
44158988|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397171|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397172|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397173|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
44397174|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397175|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397176|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
44397177|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
44397178|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397179|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44397180|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44158989|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
44158990|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
44158991|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
44158992|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44158993|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44158994|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
44158995|NCT00238160|Cisplatin|cisplatin|mesh-list
44158996|NCT00238160|Fluorouracil|fluorouracil|mesh-list
44158997|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44158998|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
44158999|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159000|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44159001|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159002|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
44159003|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159004|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
44159005|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
44159006|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
44159007|NCT00238173|Carboplatin|carboplatin|mesh-list
44159008|NCT00238173|Etoposide|etoposide|mesh-list
44159009|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
44159010|NCT00238173|Mannitol|mannitol|mesh-list
44159011|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44159012|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159013|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
44159014|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159015|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159016|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44159017|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
44159018|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159019|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159020|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44159021|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44159022|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44159023|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44159024|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159025|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
44159026|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159027|NCT00238173|Expectorants|expectorants|mesh-ancestor
44159028|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159029|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44159030|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
44159031|NCT00238173|Protective Agents|protective agents|mesh-ancestor
44159032|NCT00238173|Antidotes|antidotes|mesh-ancestor
44159033|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44159034|NCT00238173|Diuretics|diuretics|mesh-ancestor
44159035|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
44159036|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159037|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159038|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
44159039|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
44159040|NCT00238199|Calcitriol|calcitriol|mesh-list
44159041|NCT00238199|Docetaxel|docetaxel|mesh-list
44397181|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397182|NCT02908529|Urological Agents|urological agents|mesh-ancestor
44397183|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
44397184|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44397185|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44397186|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397188|NCT02908516|Coagulants|coagulants|mesh-ancestor
44397189|NCT02907177|Ponesimod|ponesimod|mesh-list
44397190|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44397191|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397192|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397193|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
44397194|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397195|NCT02906917|Insulin|insulin|mesh-list
44159049|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44159050|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159051|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44159052|NCT00238199|Vitamins|vitamins|mesh-ancestor
44159053|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
43786633|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44159054|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159055|NCT00238212|Sorafenib|sorafenib|mesh-list
44159056|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159057|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159058|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159059|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159061|NCT00238225|Ketoconazole|ketoconazole|mesh-list
44159062|NCT00238225|Dexamethasone|dexamethasone|mesh-list
44159063|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159064|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
44159065|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
44159066|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159067|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159068|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159069|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
44159070|NCT00238225|Hormones|hormones|mesh-ancestor
44159071|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159072|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44159073|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159074|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
44159075|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159076|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44159077|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44159078|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159079|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159080|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44159081|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
44159082|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44159083|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44159084|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44159085|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159086|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44159087|NCT00238225|Vitamins|vitamins|mesh-ancestor
44159088|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
44159089|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159090|NCT00238251|Temozolomide|temozolomide|mesh-list
44159091|NCT00238251|Gefitinib|gefitinib|mesh-list
44159092|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44159093|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
44397196|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44397197|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
44397198|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
44397199|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
44397200|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44397201|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397202|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397203|NCT02906709|Insulin|insulin|mesh-list
44397204|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397205|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397206|NCT02906644|Nicotine|nicotine|mesh-list
44397207|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44397208|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
44397209|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397210|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397211|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43699846|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
44159094|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159095|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159096|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159097|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159098|NCT00238277|Temozolomide|temozolomide|mesh-list
44159099|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44159100|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
44159101|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159102|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159103|NCT00238290|Trastuzumab|trastuzumab|mesh-list
44159104|NCT00238290|Letrozole|letrozole|mesh-list
44159105|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44159106|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159107|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44159108|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44159115|NCT00238316|Letrozole|letrozole|mesh-list
44159116|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159117|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44159118|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44159119|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159120|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159121|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44159122|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
44159123|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159124|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159125|NCT00238329|Interferons|interferons|mesh-list
44159126|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
44159127|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
44159128|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44159129|NCT00238329|Thalidomide|thalidomide|mesh-list
44159130|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43598868|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159131|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
44159132|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159133|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
44159134|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159135|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159136|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
44159137|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159138|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44159139|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44159140|NCT00238329|Growth Substances|growth substances|mesh-ancestor
44397212|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44397213|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397214|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397215|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397216|NCT02906579|Praliciguat|praliciguat|mesh-list
44397217|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44397218|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
44397219|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397220|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397221|NCT02905266|Nivolumab|nivolumab|mesh-list
44397222|NCT02905266|Ipilimumab|ipilimumab|mesh-list
44397223|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397224|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397225|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397226|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397227|NCT02904902|Adalimumab|adalimumab|mesh-list
44397228|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397229|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397230|NCT02904265|Acetazolamide|acetazolamide|mesh-list
44397231|NCT02904265|Diazepam|diazepam|mesh-list
44397232|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
44397233|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44397234|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397235|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397236|NCT02904265|Diuretics|diuretics|mesh-ancestor
44397237|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
44397238|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397239|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44397240|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
44397241|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
44159141|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
44159142|NCT00238368|Cytarabine|cytarabine|mesh-list
44159143|NCT00238368|Prednisone|prednisone|mesh-list
44159144|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
44159145|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
44159146|NCT00238368|Busulfan|busulfan|mesh-list
44159147|NCT00238368|Rituximab|rituximab|mesh-list
44159148|NCT00238368|Doxorubicin|doxorubicin|mesh-list
44159149|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44159150|NCT00238368|Etoposide|etoposide|mesh-list
44159151|NCT00238368|Vincristine|vincristine|mesh-list
44159152|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44159153|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159154|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
44159155|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159156|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159157|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44159158|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
44397242|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397243|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397244|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44397245|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397246|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44397247|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44397248|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44397249|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44397250|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397251|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44397252|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
44397253|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
44397254|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
44397255|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
44397256|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397257|NCT02904200|Silicon|silicon|mesh-list
44397258|NCT02904200|Trace Elements|trace elements|mesh-ancestor
44397259|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
44397260|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397261|NCT02904096|Lidocaine|lidocaine|mesh-list
44397262|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
44397263|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
44397264|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397265|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397266|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
44397267|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159159|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159160|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159161|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44159162|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44159163|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159164|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44159165|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44159166|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159167|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159168|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
44159170|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159171|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44159172|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44159173|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44159174|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
44159175|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
44159176|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159187|NCT00238394|Cediranib|cediranib|mesh-list
44159188|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159189|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159190|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159191|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159192|NCT00238407|Cisplatin|cisplatin|mesh-list
44397268|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44397269|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44397270|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44397271|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397272|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397273|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
44397274|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397275|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397276|NCT02903511|Metformin|metformin|mesh-list
44397277|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397278|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397279|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44397280|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43699900|NCT02735317|Hematinics|hematinics|mesh-ancestor
44159193|NCT00238407|Docetaxel|docetaxel|mesh-list
44159194|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159195|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44159196|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44159197|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44159198|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159199|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44159200|NCT00238459|Vaccines|vaccines|mesh-list
44159201|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
43786642|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
44159202|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159203|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
44159204|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159205|NCT00238472|Nateglinide|nateglinide|mesh-list
44159206|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44159207|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159208|NCT00238498|Vildagliptin|vildagliptin|mesh-list
44159209|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44159210|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159211|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44159212|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
44159213|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159214|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159215|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44159216|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44159217|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44159218|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159219|NCT00238563|Triamcinolone|triamcinolone|mesh-list
44159220|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159221|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
44159223|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159224|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159225|NCT00238628|Bexarotene|bexarotene|mesh-list
44159226|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159227|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
44159228|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
44159229|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44159230|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44159231|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44159232|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159233|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159234|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159235|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159236|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159237|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44397281|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44397282|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397283|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397284|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397285|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397287|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
44397288|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397289|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
44397290|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397291|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
44397292|NCT02903030|Silicon|silicon|mesh-list
44397293|NCT02903030|Trace Elements|trace elements|mesh-ancestor
44397294|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
44397295|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397296|NCT02902965|Dexamethasone|dexamethasone|mesh-list
44397297|NCT02902965|Bortezomib|bortezomib|mesh-list
44397298|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159238|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159239|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44159240|NCT00238667|Aspirin|aspirin|mesh-list
44159241|NCT00238667|Heparin|heparin|mesh-list
44159242|NCT00238667|Calcium heparin|calcium heparin|mesh-list
44159243|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44159254|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159255|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159257|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44159258|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44159259|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159260|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44159261|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44159262|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159263|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
44159264|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44159265|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44159266|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44159267|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
44159268|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159269|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44159270|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
44159271|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44159272|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44159273|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44159274|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159275|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159276|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159277|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159278|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44159279|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
44159280|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43599007|NCT03294525|Analgesics|analgesics|mesh-ancestor
44159281|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
44159282|NCT00238732|Estrogens|estrogens|mesh-list
44159283|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44159284|NCT00238732|Hormones|hormones|mesh-ancestor
44163848|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44397299|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
44397300|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
44397301|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397302|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397303|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397304|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
44397305|NCT02902965|Hormones|hormones|mesh-ancestor
44397306|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397307|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44397308|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397309|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44397310|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
44397311|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397312|NCT02902120|Grazoprevir|grazoprevir|mesh-list
44397313|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
44397314|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397315|NCT02901548|Durvalumab|durvalumab|mesh-list
44397316|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397317|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397318|NCT02901054|Ondansetron|ondansetron|mesh-list
44397319|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
44397320|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
44397321|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397322|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397323|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397324|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
44397325|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397347|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
44397348|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397349|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397350|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397351|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
44397352|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
44397353|NCT02899988|Mirikizumab|mirikizumab|mesh-list
44397354|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44397355|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397356|NCT02899988|Analgesics|analgesics|mesh-ancestor
44397357|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
44397358|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397359|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397360|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397361|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397362|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397363|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397364|NCT02899728|Cisplatin|cisplatin|mesh-list
44397365|NCT02899728|Carboplatin|carboplatin|mesh-list
44397366|NCT02899728|Etoposide|etoposide|mesh-list
44397367|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
44397368|NCT02899728|Olaparib|olaparib|mesh-list
44397369|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
44397370|NCT02899728|Cediranib|cediranib|mesh-list
43786662|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44397371|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44397372|NCT02899728|Maleic acid|maleic acid|mesh-list
44397373|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397374|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44397375|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44397376|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44397377|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397378|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397379|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
44159285|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159286|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159287|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44159288|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44159290|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159291|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
44159292|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44159293|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44159294|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
44397380|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397381|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
44397382|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
44397383|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
44397384|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44397385|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44397386|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397387|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
44397388|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
44397389|NCT02899195|Durvalumab|durvalumab|mesh-list
44397390|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397391|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397392|NCT02899156|Flumazenil|flumazenil|mesh-list
44397393|NCT02899156|Antidotes|antidotes|mesh-ancestor
44397394|NCT02899156|Protective Agents|protective agents|mesh-ancestor
44397395|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397396|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
44397397|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
44397398|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397399|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397400|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
44397401|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397402|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397403|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44054919|NCT00004419|Mitogens|mitogens|mesh-list
44397404|NCT02898259|Rituximab|rituximab|mesh-list
44397405|NCT02898259|Lenalidomide|lenalidomide|mesh-list
44397406|NCT02898259|Ixazomib|ixazomib|mesh-list
44397407|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397408|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397409|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
44397410|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397411|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397412|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44397413|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44397414|NCT02898259|Growth Substances|growth substances|mesh-ancestor
44397415|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
44159295|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397416|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397417|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397418|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397419|NCT02898116|Durvalumab|durvalumab|mesh-list
44397420|NCT02898116|Ensartinib|ensartinib|mesh-list
44397421|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397422|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397423|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44397424|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397425|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397426|NCT02897349|Linagliptin|linagliptin|mesh-list
44397427|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397428|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397429|NCT02897349|Incretins|incretins|mesh-ancestor
44397430|NCT02897349|Hormones|hormones|mesh-ancestor
44397431|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397432|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44397433|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397434|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397435|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397436|NCT02897115|Adalimumab|adalimumab|mesh-list
44397437|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44397438|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44397439|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397440|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397441|NCT02897115|Analgesics|analgesics|mesh-ancestor
44397442|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
44397443|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397444|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397445|NCT02896400|Nicotine|nicotine|mesh-list
44397446|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44397447|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
44397448|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397449|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397450|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44397451|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44397453|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397454|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397455|NCT02896296|Buprenorphine|buprenorphine|mesh-list
44397456|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44397457|NCT02896296|Narcotics|narcotics|mesh-ancestor
44397458|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397459|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397460|NCT02896296|Analgesics|analgesics|mesh-ancestor
44397461|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
44397462|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397463|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44397464|NCT02895945|Factor VIII|factor viii|mesh-list
44397465|NCT02895945|Coagulants|coagulants|mesh-ancestor
44397467|NCT02892734|Ipilimumab|ipilimumab|mesh-list
44397468|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397469|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397470|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397471|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397472|NCT02892409|Amoxicillin|amoxicillin|mesh-list
44397473|NCT02892409|Clarithromycin|clarithromycin|mesh-list
44397474|NCT02892409|Lansoprazole|lansoprazole|mesh-list
44397475|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
44397476|NCT02892409|Bismuth|bismuth|mesh-list
44397477|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397478|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44054981|NCT00004430|Prednisolone|prednisolone|mesh-list
44397479|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44397480|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397481|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397482|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44397483|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44397484|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397485|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397486|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44397487|NCT02892409|Antacids|antacids|mesh-ancestor
44397488|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
44397489|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397490|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397491|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44397492|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
44397493|NCT02892149|Hematinics|hematinics|mesh-ancestor
44397494|NCT02891915|Amoxicillin|amoxicillin|mesh-list
44397495|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
44397496|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
44397497|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44397498|NCT02891915|Cefdinir|cefdinir|mesh-list
44397499|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397500|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397501|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44397502|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397503|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397504|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
44397505|NCT02891850|Tadalafil|tadalafil|mesh-list
44397506|NCT02891850|Riociguat|riociguat|mesh-list
44397507|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
44397508|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44397509|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44397510|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397511|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397512|NCT02891850|Urological Agents|urological agents|mesh-ancestor
44397513|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
44397514|NCT02891408|Fenofibrate|fenofibrate|mesh-list
44159296|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159297|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159298|NCT00238784|Budesonide|budesonide|mesh-list
44159299|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
44159300|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159301|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159302|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
44159303|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159304|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159305|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159306|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159307|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
44159308|NCT00238784|Hormones|hormones|mesh-ancestor
44159309|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159310|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44159311|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44159312|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159313|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159314|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159315|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159316|NCT00238797|Gefitinib|gefitinib|mesh-list
44159317|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159318|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159319|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159320|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159321|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
44159322|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397515|NCT02891408|Firsocostat|firsocostat|mesh-list
44397516|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44397517|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
44397518|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397519|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44397520|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397521|NCT02891226|Mirikizumab|mirikizumab|mesh-list
44397522|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44397523|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397524|NCT02891226|Analgesics|analgesics|mesh-ancestor
44397525|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
44397526|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397527|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397528|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397529|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397530|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397531|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397532|NCT02891174|Acetaminophen|acetaminophen|mesh-list
44397533|NCT02891174|Ibuprofen|ibuprofen|mesh-list
44397534|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44397535|NCT02891174|Analgesics|analgesics|mesh-ancestor
44397536|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
44397537|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397538|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397539|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
44397540|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44397541|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397542|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43700072|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
44159323|NCT00238901|Basiliximab|basiliximab|mesh-list
44159324|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159325|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
44159326|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159327|NCT00238914|Naltrexone|naltrexone|mesh-list
44159328|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44159329|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44159330|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159331|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
44159332|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159333|NCT00238927|Fluticasone|fluticasone|mesh-list
44159334|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159335|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159336|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
44159337|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159338|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159339|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159340|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159341|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397543|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44397544|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397545|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397546|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44397548|NCT02891070|Coagulants|coagulants|mesh-ancestor
44397549|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
44397550|NCT02890992|Niacin|niacin|mesh-list
44397551|NCT02890992|Niacinamide|niacinamide|mesh-list
44397552|NCT02890992|Ezetimibe|ezetimibe|mesh-list
44397553|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
44397554|NCT02890992|Fenofibrate|fenofibrate|mesh-list
44397555|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44397556|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44397557|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
44397558|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397559|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44397560|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
44397561|NCT02890992|Vitamins|vitamins|mesh-ancestor
44397562|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
44397563|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397564|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44397565|NCT02889796|Adalimumab|adalimumab|mesh-list
44397566|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397567|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397568|NCT02889562|Warfarin|warfarin|mesh-list
44397569|NCT02889562|Apixaban|apixaban|mesh-list
44397570|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
44397571|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44397572|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
44397573|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44397574|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397577|NCT02888106|Tenofovir|tenofovir|mesh-list
44397590|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44397591|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44397592|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44397593|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44397594|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397595|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
44397597|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397598|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
44397599|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
44397600|NCT02886715|Vitamins|vitamins|mesh-ancestor
44397601|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
44397602|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397603|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
44397604|NCT02886702|Tazarotene|tazarotene|mesh-list
44397605|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397606|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
44397607|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
44397608|NCT02886702|Vitamins|vitamins|mesh-ancestor
44397609|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
44397610|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397611|NCT02886624|Grazoprevir|grazoprevir|mesh-list
44397612|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44397613|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
44397614|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397615|NCT02885181|Methotrexate|methotrexate|mesh-list
44397616|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44397617|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
44397618|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44397619|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397620|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44397621|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
44397622|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397623|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397624|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397629|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397630|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44397632|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397633|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397634|NCT02883452|Infliximab|infliximab|mesh-list
44397635|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397636|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397637|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397638|NCT02882854|Guanfacine|guanfacine|mesh-list
44397639|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44397640|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44397641|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44397642|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44397643|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
44397644|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397645|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397646|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397647|NCT02882152|Morphine|morphine|mesh-list
44397648|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44397649|NCT02882152|Narcotics|narcotics|mesh-ancestor
44397650|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397651|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397652|NCT02882152|Analgesics|analgesics|mesh-ancestor
44397653|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
44397654|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397655|NCT02881567|Daclizumab|daclizumab|mesh-list
44397656|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159342|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44159343|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
44159344|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159345|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159346|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159347|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159348|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159349|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159350|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159351|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159352|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
44159353|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159354|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159355|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159356|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159357|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159358|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159359|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159360|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397657|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
44397658|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397659|NCT02880956|Tilavonemab|tilavonemab|mesh-list
44397660|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
44397661|NCT02880865|Vaccines|vaccines|mesh-list
44397662|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
44397663|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397664|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
43653983|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
44397665|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397666|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397667|NCT02877927|Linezolid|linezolid|mesh-list
44397668|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397669|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397670|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44397671|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397672|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397673|NCT02877134|Ustekinumab|ustekinumab|mesh-list
44397674|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
44397675|NCT02877082|Bortezomib|bortezomib|mesh-list
44397676|NCT02877082|Tacrolimus|tacrolimus|mesh-list
44397677|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
44397678|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44397679|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397680|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
44397681|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397682|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44397683|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397684|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397685|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397686|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
44397687|NCT02876835|Hematinics|hematinics|mesh-ancestor
44397688|NCT02876601|Defibrotide|defibrotide|mesh-list
44397689|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44397690|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44397693|NCT02875613|Avelumab|avelumab|mesh-list
44397700|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397701|NCT02875366|Ivacaftor|ivacaftor|mesh-list
44397702|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44397703|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397704|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397705|NCT02875340|Risperidone|risperidone|mesh-list
44397706|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44397707|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
44397708|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397709|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397710|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397711|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44397712|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44397713|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397714|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397715|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44397716|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
44397717|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
44397718|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
44397719|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397720|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397721|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397722|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
44397723|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
44397724|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
44397725|NCT02875067|Lenalidomide|lenalidomide|mesh-list
44397726|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397727|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397728|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
44397729|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397730|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44397731|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44397732|NCT02875067|Growth Substances|growth substances|mesh-ancestor
44397733|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44397734|NCT02875028|Vorapaxar|vorapaxar|mesh-list
44397735|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44397736|NCT02874924|Sirolimus|sirolimus|mesh-list
44397739|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44397740|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397741|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
44397742|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397743|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
44397744|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397745|NCT02874794|Valsartan|valsartan|mesh-list
44397746|NCT02874794|Enalapril|enalapril|mesh-list
44397747|NCT02874794|Enalaprilat|enalaprilat|mesh-list
44397748|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44397749|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44397750|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44397751|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44397752|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397753|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44397754|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397755|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397756|NCT02874742|Dexamethasone|dexamethasone|mesh-list
44397757|NCT02874742|Lenalidomide|lenalidomide|mesh-list
44397758|NCT02874742|Bortezomib|bortezomib|mesh-list
44397759|NCT02874742|Daratumumab|daratumumab|mesh-list
44397760|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397761|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
44397762|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
44397763|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397764|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397765|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397766|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
44397767|NCT02874742|Hormones|hormones|mesh-ancestor
44397768|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397769|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44397770|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397776|NCT02873754|Bupropion|bupropion|mesh-list
44397782|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44397783|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44397784|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397785|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397786|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397787|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44397788|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
44397789|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44397790|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44397791|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44397792|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397793|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
44397794|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44397795|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44397796|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397798|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
44159361|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
44159362|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159363|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159364|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159365|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159366|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159367|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159368|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159369|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159370|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
44159371|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159372|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159373|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159374|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159375|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159376|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159377|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159378|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159379|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
44159380|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159384|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159385|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159386|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159387|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159388|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
44159389|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159390|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159391|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159392|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159393|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159394|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159395|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839231|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159396|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159397|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
44159398|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159399|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159400|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44397799|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397800|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397801|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44397802|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397803|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397804|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
44397805|NCT02873689|Lansoprazole|lansoprazole|mesh-list
44397806|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44397807|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397808|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44397809|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397810|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397811|NCT02873377|Nicotine|nicotine|mesh-list
44397812|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44397813|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
44397814|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397815|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397816|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44397817|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44397818|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397819|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397820|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159401|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159402|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159403|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159404|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159405|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159406|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
44159407|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159408|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159409|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159410|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159411|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159412|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159413|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159414|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159415|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
44159416|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159417|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159418|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159419|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159420|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159421|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159422|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159423|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159424|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
44159425|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159426|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159427|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159428|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
44159429|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44397822|NCT02873338|Idarubicin|idarubicin|mesh-list
44397823|NCT02873338|Heparin|heparin|mesh-list
44397824|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44397825|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
44397826|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397827|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397828|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
44397829|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397830|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397831|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
44397832|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397833|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
44397834|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44397835|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44397836|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44397837|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44397838|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44397839|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397840|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
44397841|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44397842|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44397843|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44397844|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397845|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397846|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397847|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397848|NCT02872311|Vaccines|vaccines|mesh-list
44397849|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
44397850|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397852|NCT02872116|Fluorouracil|fluorouracil|mesh-list
44397853|NCT02872116|Capecitabine|capecitabine|mesh-list
44397854|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
44397855|NCT02872116|Nivolumab|nivolumab|mesh-list
44397856|NCT02872116|Ipilimumab|ipilimumab|mesh-list
44159430|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159431|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159432|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159433|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
44159434|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159435|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159436|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44159437|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
44397857|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
44397858|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397859|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44397860|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397861|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397862|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
44397863|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397864|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397865|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397866|NCT02872116|Antidotes|antidotes|mesh-ancestor
44397867|NCT02872116|Protective Agents|protective agents|mesh-ancestor
44397868|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
44397869|NCT02872116|Vitamins|vitamins|mesh-ancestor
44397870|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
44397871|NCT02872012|Lidocaine|lidocaine|mesh-list
44397872|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
44397873|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
44397874|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44397875|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397876|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
44397877|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397878|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44159438|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159439|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159440|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159441|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159443|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44159444|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44159445|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44159446|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44159447|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159448|NCT00239109|Olanzapine|olanzapine|mesh-list
44159449|NCT00239109|Ziprasidone|ziprasidone|mesh-list
44159450|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
44159460|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44159461|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159462|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159463|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159464|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
44159465|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44159466|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44159467|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
44159468|NCT00239161|Levofloxacin|levofloxacin|mesh-list
44159469|NCT00239161|Ofloxacin|ofloxacin|mesh-list
44159470|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44159471|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159472|NCT00239161|Renal Agents|renal agents|mesh-ancestor
44159473|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159474|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44159475|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44159476|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159477|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397879|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44397880|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44397881|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44397882|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397883|NCT02871791|Everolimus|everolimus|mesh-list
44397884|NCT02871791|Palbociclib|palbociclib|mesh-list
44397885|NCT02871791|Exemestane|exemestane|mesh-list
44397886|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397887|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44397888|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
44397889|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397890|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44397891|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397892|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397893|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44397894|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44397895|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44397896|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
44397897|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397898|NCT02871635|Adalimumab|adalimumab|mesh-list
44397899|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44397900|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44397901|NCT02871492|Acyclovir|acyclovir|mesh-list
44397902|NCT02871492|Pritelivir|pritelivir|mesh-list
44397903|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
44397904|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44397905|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397906|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397907|NCT02870972|Berotralstat|berotralstat|mesh-list
44397908|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397909|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397910|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44397911|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44397912|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44397913|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
44159478|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159479|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44159480|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44397915|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397916|NCT02869893|Secretin|secretin|mesh-list
44397917|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44397918|NCT02869893|Hormones|hormones|mesh-ancestor
44397919|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44397920|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397921|NCT02869438|Benralizumab|benralizumab|mesh-list
44397922|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44397923|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
44397924|NCT02868892|Pemetrexed|pemetrexed|mesh-list
44397925|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397926|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397927|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397928|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44397929|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44397930|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44397931|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44397932|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
44397933|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44397934|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44159481|NCT00239174|Surinabant|surinabant|mesh-list
44159482|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44159483|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44159484|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159485|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159486|NCT00239174|Hormones|hormones|mesh-ancestor
44159487|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159488|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159489|NCT00239200|Lapatinib|lapatinib|mesh-list
44159490|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159491|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159492|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159493|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159494|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
44159495|NCT00239239|Hematinics|hematinics|mesh-ancestor
44159496|NCT00239252|Interferons|interferons|mesh-list
44159497|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
43599224|NCT03292744|Vitamins|vitamins|mesh-ancestor
44159498|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159499|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
44159500|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159501|NCT00239278|Prednisolone|prednisolone|mesh-list
44159502|NCT00239278|Budesonide|budesonide|mesh-list
44159503|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
44159504|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159505|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
44159506|NCT00239278|Hormones|hormones|mesh-ancestor
44159507|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159508|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159509|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44159510|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397936|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397937|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397938|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397939|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397941|NCT02866175|Edoxaban|edoxaban|mesh-list
44397942|NCT02866175|Clopidogrel|clopidogrel|mesh-list
44397943|NCT02866175|Ticagrelor|ticagrelor|mesh-list
44397944|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44397945|NCT02866175|Vitamins|vitamins|mesh-ancestor
44397946|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
44397947|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397948|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44397949|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44397950|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44397951|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44397952|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
44397953|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397954|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397955|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44397956|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44397957|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
44397958|NCT02866175|Coagulants|coagulants|mesh-ancestor
44397959|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44397960|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
44397961|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44159511|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
44159512|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159513|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159527|NCT00239304|Cisplatin|cisplatin|mesh-list
44159528|NCT00239304|Gefitinib|gefitinib|mesh-list
44159529|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159530|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44159531|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159532|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159533|NCT00239330|Atorvastatin|atorvastatin|mesh-list
44159534|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159535|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159536|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159537|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
44159538|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159539|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44159540|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44159542|NCT00239343|Gefitinib|gefitinib|mesh-list
44159543|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159544|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44397962|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
44397963|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397964|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
44397965|NCT02865499|Acarbose|acarbose|mesh-list
44397966|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44397967|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44397968|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397969|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44397970|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397971|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
44397972|NCT02864407|Olodaterol|olodaterol|mesh-list
44397973|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44397974|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
44397975|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44397976|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44397977|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44397978|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44397979|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
44397980|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44397981|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
44397982|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44397983|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44397984|NCT02864381|Nivolumab|nivolumab|mesh-list
44397985|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44397986|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44397987|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44397988|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398006|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398007|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44398008|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44398009|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44398010|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44398011|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
44398012|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398013|NCT02863419|Liraglutide|liraglutide|mesh-list
44398014|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398015|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398016|NCT02863419|Incretins|incretins|mesh-ancestor
44398018|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398019|NCT02863354|Aflibercept|aflibercept|mesh-list
44398020|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44398021|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44398022|NCT02863354|Growth Substances|growth substances|mesh-ancestor
44398023|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398024|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
44398025|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398026|NCT02863328|Empagliflozin|empagliflozin|mesh-list
44398027|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44398028|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398029|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398031|NCT02862730|Pancrelipase|pancrelipase|mesh-list
44398052|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398053|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398054|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
44398055|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398056|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44398057|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398058|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
44398059|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398060|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398061|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398063|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
44398064|NCT02862535|Nivolumab|nivolumab|mesh-list
44398065|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398066|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398067|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398068|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398069|NCT02862457|Paclitaxel|paclitaxel|mesh-list
44398070|NCT02862457|Cisplatin|cisplatin|mesh-list
44398071|NCT02862457|Carboplatin|carboplatin|mesh-list
44398072|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
44398073|NCT02862457|Pemetrexed|pemetrexed|mesh-list
44398074|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398075|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398076|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398077|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398078|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398079|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398080|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398081|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398082|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44398083|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398084|NCT02862171|Dapivirine|dapivirine|mesh-list
44398085|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44398094|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
44398095|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
44398096|NCT02861664|Protective Agents|protective agents|mesh-ancestor
44398097|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398098|NCT02861586|Vaccines|vaccines|mesh-list
44398099|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
44398100|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398101|NCT02860546|Nivolumab|nivolumab|mesh-list
44398102|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398103|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398104|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398105|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398106|NCT02859558|Tenofovir|tenofovir|mesh-list
44398107|NCT02859558|Emtricitabine|emtricitabine|mesh-list
44159545|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159546|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159547|NCT00239369|Telmisartan|telmisartan|mesh-list
44159548|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44159549|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44159550|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44159551|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44159552|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159553|NCT00239369|Diuretics|diuretics|mesh-ancestor
44159554|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
44159555|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159556|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44159557|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159558|NCT00239382|Meloxicam|meloxicam|mesh-list
44159559|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44159560|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44159561|NCT00239382|Analgesics|analgesics|mesh-ancestor
44159562|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
44159563|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159564|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159565|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159566|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159567|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44159568|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44159569|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159570|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159571|NCT00239395|Meloxicam|meloxicam|mesh-list
44159572|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44159583|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159584|NCT00239408|Bromides|bromides|mesh-list
44159585|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
44159586|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159587|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
44159588|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159589|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159590|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159591|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159592|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
44159593|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159594|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159595|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159596|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159597|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
44159598|NCT00239421|Fluticasone|fluticasone|mesh-list
44159599|NCT00239421|Xhance|xhance|mesh-list
44159600|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
43654001|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44398108|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44398110|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44398112|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44398113|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
44398114|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398115|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44398116|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398117|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398118|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398119|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44398120|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44398121|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44398122|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44398123|NCT02859454|Avelumab|avelumab|mesh-list
44398124|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398125|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398126|NCT02859415|Plicamycin|plicamycin|mesh-list
43700428|NCT02731560|Rituximab|rituximab|mesh-list
44159601|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
44159602|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44159603|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159604|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159605|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
44159606|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159607|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159608|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159609|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159610|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
44159611|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44159612|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44159613|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44159614|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159615|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159616|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159617|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159618|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
44159619|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159620|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159621|NCT00239434|Bromides|bromides|mesh-list
44159622|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
44159623|NCT00239434|Ipratropium|ipratropium|mesh-list
44159624|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159625|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
44159626|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159627|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159628|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159629|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159630|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
44159631|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159632|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159633|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398128|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398129|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44398130|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398131|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44398132|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654008|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654009|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43786685|NCT02437604|Xhance|xhance|mesh-list
44398133|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398134|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398135|NCT02859324|Nivolumab|nivolumab|mesh-list
44398136|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398137|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398138|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398139|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398140|NCT02859246|Guaifenesin|guaifenesin|mesh-list
44398141|NCT02859246|Expectorants|expectorants|mesh-ancestor
44398142|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
44398143|NCT02859142|Nicotine|nicotine|mesh-list
44398144|NCT02859142|Varenicline|varenicline|mesh-list
44398145|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44398146|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
44398147|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44055599|NCT00004686|Prednisone|prednisone|mesh-list
44398148|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398149|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44398150|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44398151|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44398152|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398153|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398155|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44398156|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
44398157|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398158|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398159|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398160|NCT02858401|Vesatolimod|vesatolimod|mesh-list
44159634|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159635|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
44159636|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
44159638|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
44398162|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398163|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
44398164|NCT02858180|Ledipasvir|ledipasvir|mesh-list
44398165|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
44398166|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398167|NCT02858076|Aflibercept|aflibercept|mesh-list
44398168|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
44398169|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44398170|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44398171|NCT02858076|Growth Substances|growth substances|mesh-ancestor
44398172|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398173|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
44398174|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159639|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159640|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159641|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159642|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159643|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
44159644|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159645|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159646|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159647|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159648|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
44159649|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159650|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
44159651|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159652|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159653|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159654|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159655|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
44159656|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159657|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159658|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159659|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159660|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44159661|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
44159662|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159663|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
44159664|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159665|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159666|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159667|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159668|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
44159669|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159670|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159671|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159672|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159674|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
44159675|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159676|NCT00239486|Protective Agents|protective agents|mesh-ancestor
44159677|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159678|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44159679|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44159680|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
44159681|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
44159682|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159683|NCT00239499|Fluticasone|fluticasone|mesh-list
44159684|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
44159685|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44159686|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398175|NCT02858037|Dapivirine|dapivirine|mesh-list
44398176|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44398177|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44398178|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
44398179|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398180|NCT02857270|Gemcitabine|gemcitabine|mesh-list
44398181|NCT02857270|Paclitaxel|paclitaxel|mesh-list
44398182|NCT02857270|Cetuximab|cetuximab|mesh-list
44398183|NCT02857270|Midazolam|midazolam|mesh-list
44398184|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398185|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398186|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398187|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398188|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398189|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398190|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398191|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
44398192|NCT02857270|Antiviral Agents|antiviral agents|mesh-ancestor
44398193|NCT02857270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398194|NCT02857270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159687|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44159688|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
44159689|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159690|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159691|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44159692|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159693|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
44159694|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44159695|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
44159696|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44159697|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44159698|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159699|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159700|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44159701|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44159702|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159703|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159705|NCT00239512|Indomethacin|indomethacin|mesh-list
44159706|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44159707|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44159708|NCT00239512|Analgesics|analgesics|mesh-ancestor
44159709|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
44159717|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
44159718|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
44159719|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44159720|NCT00239538|Valsartan|valsartan|mesh-list
44159721|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44159722|NCT00239538|Telmisartan|telmisartan|mesh-list
44159723|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44159724|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44159725|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44159726|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159727|NCT00239538|Diuretics|diuretics|mesh-ancestor
44159728|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
44159729|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159730|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44159731|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398195|NCT02857270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398196|NCT02857270|Immunologic Factors|immunologic factors|mesh-ancestor
44398197|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398198|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44398199|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44398200|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398201|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44398202|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44398203|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44398204|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44398205|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
44398206|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
44398207|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
44398208|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
44398209|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398210|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398211|NCT02856880|Zinc|zinc|mesh-list
44398212|NCT02856880|Trace Elements|trace elements|mesh-ancestor
44398213|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
44398214|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398215|NCT02856802|Sumatriptan|sumatriptan|mesh-list
44398216|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44398217|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44398218|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44398219|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
44398220|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398221|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43700511|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
44159732|NCT00239551|Lansoprazole|lansoprazole|mesh-list
44159733|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44159734|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159735|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44159736|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159737|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159738|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44159739|NCT00239616|Hematinics|hematinics|mesh-ancestor
44159740|NCT00239629|Teriparatide|teriparatide|mesh-list
44159741|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
44159742|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44159743|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159744|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159745|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
44159746|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159747|NCT00239707|Incretins|incretins|mesh-ancestor
44159748|NCT00239707|Hormones|hormones|mesh-ancestor
44159749|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159750|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159751|NCT00239746|Ibuprofen|ibuprofen|mesh-list
44398222|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398223|NCT02856555|Firsocostat|firsocostat|mesh-list
44398224|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398225|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398226|NCT02856113|Alogliptin|alogliptin|mesh-list
44398227|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398228|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398229|NCT02856113|Incretins|incretins|mesh-ancestor
44398230|NCT02856113|Hormones|hormones|mesh-ancestor
44398231|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398232|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44398233|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398234|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398235|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398236|NCT02855944|Gemcitabine|gemcitabine|mesh-list
44398237|NCT02855944|Paclitaxel|paclitaxel|mesh-list
44398238|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44398239|NCT02855944|Cisplatin|cisplatin|mesh-list
44398240|NCT02855944|Carboplatin|carboplatin|mesh-list
44398241|NCT02855944|Rucaparib|rucaparib|mesh-list
44398242|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398243|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398244|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398245|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398246|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398247|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398248|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398249|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
44398250|NCT02855944|Antiviral Agents|antiviral agents|mesh-ancestor
44398251|NCT02855944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398252|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398253|NCT02855944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398254|NCT02855944|Immunologic Factors|immunologic factors|mesh-ancestor
44398255|NCT02855944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398256|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44398257|NCT02855359|Prednisone|prednisone|mesh-list
44398258|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
44398260|NCT02855359|Doxorubicin|doxorubicin|mesh-list
44398261|NCT02855359|Vincristine|vincristine|mesh-list
44398262|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398263|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
44398264|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398265|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398266|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44398267|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
44398268|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398269|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398270|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44398271|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398272|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44398273|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44398274|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44398275|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398276|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398277|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
44398278|NCT02855359|Hormones|hormones|mesh-ancestor
44398279|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398280|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44398281|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398282|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398283|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398284|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398285|NCT02854800|Varenicline|varenicline|mesh-list
44398286|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44398287|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44398288|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
44398289|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398290|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398291|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398292|NCT02854631|Prednisolone|prednisolone|mesh-list
44398293|NCT02854631|Selonsertib|selonsertib|mesh-list
44398299|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44398300|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398301|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398302|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398303|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398305|NCT02854527|Digoxin|digoxin|mesh-list
44398306|NCT02854527|Furosemide|furosemide|mesh-list
44398307|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44398308|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398309|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398310|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44398311|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44398312|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
44398313|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398314|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44398315|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44398316|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398317|NCT02854527|Diuretics|diuretics|mesh-ancestor
44398318|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
44398319|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44398320|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398321|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44398322|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44398323|NCT02854527|Protective Agents|protective agents|mesh-ancestor
44398324|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
44398325|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398326|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398327|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
44398328|NCT02853331|Sunitinib|sunitinib|mesh-list
44398329|NCT02853331|Axitinib|axitinib|mesh-list
44398330|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398331|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398332|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44398333|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44398334|NCT02853331|Growth Substances|growth substances|mesh-ancestor
44398335|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398338|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398339|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398340|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
44398341|NCT02853318|Bevacizumab|bevacizumab|mesh-list
44398342|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
44398343|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44398344|NCT02853318|Antibodies|antibodies|mesh-list
44398345|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
44398346|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44398347|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
44398348|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
44159752|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44159753|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44159754|NCT00239746|Analgesics|analgesics|mesh-ancestor
44159755|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
44159756|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159757|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159758|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44159759|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159760|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44159761|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159762|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159763|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159764|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44159765|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159766|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159767|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
44159768|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159769|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159770|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44159771|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159772|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159782|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43839232|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159783|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159784|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159785|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
44159786|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159787|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159788|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44159789|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159790|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159791|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
44159792|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159793|NCT00239889|Calcitonin|calcitonin|mesh-list
44159794|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
44159795|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44159796|NCT00239889|Katacalcin|katacalcin|mesh-list
44159797|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44159798|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159799|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44159800|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
44159801|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44159802|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44159803|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398350|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
44398351|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398352|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398353|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44398354|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
44398355|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398356|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398357|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44398358|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44398359|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44398360|NCT02853318|Growth Substances|growth substances|mesh-ancestor
44398361|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
44398362|NCT02853305|Gemcitabine|gemcitabine|mesh-list
44398363|NCT02853305|Cisplatin|cisplatin|mesh-list
44398364|NCT02853305|Carboplatin|carboplatin|mesh-list
44398365|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
44398366|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398367|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398368|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
44398369|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398370|NCT02853305|Antiviral Agents|antiviral agents|mesh-ancestor
44398371|NCT02853305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398372|NCT02853305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398373|NCT02853305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398374|NCT02853305|Immunologic Factors|immunologic factors|mesh-ancestor
44398375|NCT02853305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398376|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44055813|NCT00004740|Isoniazid|isoniazid|mesh-list
44398377|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
44398378|NCT02853123|Olodaterol|olodaterol|mesh-list
44398379|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44398380|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
44159804|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159805|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
44159806|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159807|NCT00239954|Citalopram|citalopram|mesh-list
44159808|NCT00239954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44159809|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44159810|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159811|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159812|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398381|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398382|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398383|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44398384|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
44398386|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44398387|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
44398388|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398389|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398390|NCT02852967|Belumosudil|belumosudil|mesh-list
44398391|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398392|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398393|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398394|NCT02852434|Lidocaine|lidocaine|mesh-list
44398395|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
44398396|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
44398397|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398398|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398399|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
44398400|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398401|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44398402|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44398403|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44398404|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398405|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398427|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398428|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398429|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
44398430|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398431|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398432|NCT02850016|Romidepsin|romidepsin|mesh-list
44398433|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44398434|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44398435|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398436|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398437|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398438|NCT02849743|Oxytocin|oxytocin|mesh-list
44398439|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
44398440|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398441|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398442|NCT02849704|Pancrelipase|pancrelipase|mesh-list
44398443|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44398444|NCT02849678|Lidocaine|lidocaine|mesh-list
44398445|NCT02849678|Ropivacaine|ropivacaine|mesh-list
44398446|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
44398447|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
44398448|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398449|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398480|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398481|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398482|NCT02848833|Empagliflozin|empagliflozin|mesh-list
44398483|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44398484|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398485|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398486|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398487|NCT02848729|Acetaminophen|acetaminophen|mesh-list
44398488|NCT02848729|Morphine|morphine|mesh-list
44398489|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44398490|NCT02848729|Narcotics|narcotics|mesh-ancestor
44398491|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398492|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398493|NCT02848729|Analgesics|analgesics|mesh-ancestor
44398494|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
44398495|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398496|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398497|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
44159813|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
44159814|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159815|NCT00239954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44159816|NCT00239954|Antidepressive Agents|antidepressive agents|mesh-ancestor
44159817|NCT00239954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44159818|NCT00239967|Rimonabant|rimonabant|mesh-list
44159819|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44159820|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44159821|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44159822|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159823|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159824|NCT00239967|Hormones|hormones|mesh-ancestor
44159825|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44159826|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159827|NCT00239980|Dalteparin|dalteparin|mesh-list
44159828|NCT00239980|Tinzaparin|tinzaparin|mesh-list
44159829|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44159830|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
44159831|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44159841|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44159842|NCT00240019|Furosemide|furosemide|mesh-list
44159843|NCT00240019|Diuretics|diuretics|mesh-ancestor
44159844|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
44159845|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159846|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44159847|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44159848|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159849|NCT00240032|Cetirizine|cetirizine|mesh-list
44159850|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
44159851|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
44159852|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44159853|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44159854|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44159855|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
44159856|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
44159857|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398498|NCT02848651|Atezolizumab|atezolizumab|mesh-list
44398499|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398500|NCT02848599|Morphine|morphine|mesh-list
44398501|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
44398502|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44398503|NCT02848599|Narcotics|narcotics|mesh-ancestor
44398504|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398505|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398506|NCT02848599|Analgesics|analgesics|mesh-ancestor
44398507|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
44398508|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398509|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
44398510|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
44398511|NCT02847494|Dexamethasone|dexamethasone|mesh-list
44398512|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
44398513|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44398514|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44398515|NCT02847494|Prednisolone|prednisolone|mesh-list
44398516|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
44398517|NCT02847494|Metoclopramide|metoclopramide|mesh-list
44398518|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44398519|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
44398520|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398521|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
44398522|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
44398523|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398524|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398525|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44398526|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
44398527|NCT02847494|Hormones|hormones|mesh-ancestor
44398528|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398529|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44398530|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398531|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44398532|NCT02847494|Protective Agents|protective agents|mesh-ancestor
43840483|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398533|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44398534|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44398535|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
44398537|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398539|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44398540|NCT02846532|Aspirin|aspirin|mesh-list
44398541|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
44398542|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44398543|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
44398544|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44398545|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398546|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398547|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398548|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
44398549|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398550|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398551|NCT02846532|Analgesics|analgesics|mesh-ancestor
44398552|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
44398553|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398554|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398555|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398556|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398557|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44159858|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159859|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786736|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159860|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44159861|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
44159862|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159863|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44159864|NCT00240045|Octreotide|octreotide|mesh-list
44159865|NCT00240045|Midodrine|midodrine|mesh-list
44159866|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159867|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44159868|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159869|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
44159870|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
44159871|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159872|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159873|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44159874|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44159875|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43786737|NCT02092571|Progesterone|progesterone|mesh-list
43786738|NCT02092571|Progestins|progestins|mesh-ancestor
43786739|NCT02092571|Hormones|hormones|mesh-ancestor
43786740|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786741|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786742|NCT02030457|Beclomethasone|beclomethasone|mesh-list
43786743|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786744|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
44159876|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159877|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159878|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159879|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159880|NCT00240058|Phenylephrine|phenylephrine|mesh-list
44159881|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
44159882|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
44159883|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44159884|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
44159885|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
44159886|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159887|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159888|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
44159889|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44398558|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44398559|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44398560|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44398561|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
44398562|NCT02845375|Neostigmine|neostigmine|mesh-list
44398563|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44398564|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398565|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398566|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
44398567|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398568|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398569|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44398570|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
44398571|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398572|NCT02845336|Celecoxib|celecoxib|mesh-list
44398573|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
44398574|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398575|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398576|NCT02845336|Analgesics|analgesics|mesh-ancestor
44398577|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
44398578|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398579|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398580|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398581|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398582|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44398583|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44398584|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43700701|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159890|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
44159891|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
44159892|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44159893|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44159894|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44159895|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44159896|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159903|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44159905|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
44159906|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44159907|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
44159908|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159909|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
44159910|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44159911|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44159912|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44159913|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398585|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398586|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44398587|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44398588|NCT02844439|XL647|xl647|mesh-list
44398589|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398590|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398591|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398592|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398593|NCT02842866|Vaccines|vaccines|mesh-list
44398594|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
44398595|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398596|NCT02842853|Vaccines|vaccines|mesh-list
44398597|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
44398598|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398599|NCT02842073|Naltrexone|naltrexone|mesh-list
44398600|NCT02842073|Bupropion|bupropion|mesh-list
44398601|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44398602|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44398603|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398604|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
44398605|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398606|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44398607|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
44398608|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44398609|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44398610|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44398611|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398612|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398613|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
44398614|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398615|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44398616|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44398617|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159914|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
44159915|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
44159916|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
44159917|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159918|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
44159919|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
44159920|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44159921|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44398619|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44398620|NCT02841280|Diuretics|diuretics|mesh-ancestor
44398621|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
44398622|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398623|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44398624|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398625|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398626|NCT02840461|Ivermectin|ivermectin|mesh-list
44398627|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44398628|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398629|NCT02839876|Acetaminophen|acetaminophen|mesh-list
44398630|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398631|NCT02839876|Analgesics|analgesics|mesh-ancestor
44398632|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
44398633|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398634|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398635|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
44398636|NCT02839681|Maytansine|maytansine|mesh-list
44398637|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398638|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398639|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398640|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398641|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398642|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398643|NCT02839200|Zolpidem|zolpidem|mesh-list
44159922|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
44159923|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
44159924|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44159925|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159926|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44159927|NCT00240149|Insulin|insulin|mesh-list
44159928|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44159929|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44159930|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159932|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44159933|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44159934|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44159935|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44159936|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
44159937|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44159938|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
44159939|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159940|NCT00240253|Pramlintide|pramlintide|mesh-list
44159941|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44159942|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159943|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159944|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159945|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159946|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
44398644|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44398645|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44398646|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398647|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398648|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44398650|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
44398651|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398652|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398653|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
44398654|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398655|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398656|NCT02838420|Crizotinib|crizotinib|mesh-list
44398657|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398658|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398659|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398660|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398661|NCT02838134|Rocuronium|rocuronium|mesh-list
44398662|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44398663|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43700790|NCT02729064|Insulin|insulin|mesh-list
44159947|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159948|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44159949|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44159950|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159951|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159952|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159953|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159954|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
44159955|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159956|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44159957|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44159958|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159959|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159960|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159961|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159962|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
44159963|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159964|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44159973|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44159974|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159975|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44159976|NCT00240318|Calcium|calcium|mesh-list
44159977|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44159978|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159979|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44159980|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159981|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
44159982|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159983|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44398664|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44398665|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398666|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398667|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
44398668|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398669|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398670|NCT02836652|Aspirin|aspirin|mesh-list
44398671|NCT02836652|Warfarin|warfarin|mesh-list
44398672|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398673|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398674|NCT02836652|Analgesics|analgesics|mesh-ancestor
44398675|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
44398676|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398677|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398678|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398679|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398680|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44398681|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44398682|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398683|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44398684|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44398685|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398686|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
44398687|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
44398688|NCT02836496|Prednisone|prednisone|mesh-list
44398689|NCT02836496|Prednisolone|prednisolone|mesh-list
44398690|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398691|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
44398692|NCT02836496|Hormones|hormones|mesh-ancestor
44398693|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398694|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398695|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44398696|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398697|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
44398698|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398699|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398703|NCT02835339|Analgesics|analgesics|mesh-ancestor
44398704|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
44398705|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398706|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398707|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
44398708|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398709|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44398710|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
44398711|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44398712|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398713|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398714|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44398715|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
44398716|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398717|NCT02834390|Cytarabine|cytarabine|mesh-list
44398718|NCT02834390|Daunorubicin|daunorubicin|mesh-list
44398719|NCT02834390|Idarubicin|idarubicin|mesh-list
44398720|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398721|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
44398722|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398723|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398724|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
44398725|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398726|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44398727|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
44398728|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398729|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43700821|NCT02728843|Deferiprone|deferiprone|mesh-list
44159984|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43599748|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44159985|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44159986|NCT00240396|Narcotics|narcotics|mesh-list
44159987|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44159988|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159989|NCT00240396|Analgesics|analgesics|mesh-ancestor
44159990|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
44159991|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44159992|NCT00240409|Pramipexole|pramipexole|mesh-list
44159993|NCT00240409|Bromocriptine|bromocriptine|mesh-list
44159994|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
44159995|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44159996|NCT00240409|Protective Agents|protective agents|mesh-ancestor
44159997|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44159998|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44159999|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44160000|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
44398731|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44398732|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398733|NCT02834247|Nivolumab|nivolumab|mesh-list
44398734|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398735|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398736|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398737|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398738|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44398739|NCT02833948|Aspirin|aspirin|mesh-list
44398740|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
44398741|NCT02833948|Clopidogrel|clopidogrel|mesh-list
44398742|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44398743|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44398744|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43700830|NCT02728700|Sirolimus|sirolimus|mesh-list
44160001|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
44160002|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160003|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160004|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160005|NCT00240422|Telmisartan|telmisartan|mesh-list
44160006|NCT00240422|Ramipril|ramipril|mesh-list
44160007|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160008|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160009|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160010|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160011|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44160012|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
44160013|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160014|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44160015|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
44160016|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44160017|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
44160018|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160019|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160020|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160021|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160022|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
44160023|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44160024|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
44160025|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160026|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160027|NCT00240448|Valsartan|valsartan|mesh-list
44160043|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44160044|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160045|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160046|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44160047|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160048|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
44160050|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
44160051|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44160052|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160054|NCT00240513|Minocycline|minocycline|mesh-list
44160055|NCT00240513|Tretinoin|tretinoin|mesh-list
44160056|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160057|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398745|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44398746|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
44398747|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44398748|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398749|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398750|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44398751|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
44398752|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44398753|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398754|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398755|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
44398756|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398757|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398759|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
44398760|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398761|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398762|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398763|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44398764|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44398765|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43599831|NCT03286673|Antacids|antacids|mesh-ancestor
44160058|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160059|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
44160060|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160061|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
44160062|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44160063|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44160064|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
44160065|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160066|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160067|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44160068|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44160069|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
44160070|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160071|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
44160072|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160073|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160074|NCT00240617|Naproxen|naproxen|mesh-list
44160075|NCT00240617|Sumatriptan|sumatriptan|mesh-list
44160076|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160077|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160078|NCT00240617|Analgesics|analgesics|mesh-ancestor
44160079|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
44160080|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160081|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160082|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160083|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160084|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
44160085|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44160096|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160097|NCT00240630|Analgesics|analgesics|mesh-ancestor
44160098|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
44160099|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160100|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398766|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
44398767|NCT02833844|Evolocumab|evolocumab|mesh-list
44398768|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44398769|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44398770|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
44398771|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398772|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44398773|NCT02833350|Folic Acid|folic acid|mesh-list
44398774|NCT02833350|Adalimumab|adalimumab|mesh-list
44398775|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398776|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398777|NCT02833350|Hematinics|hematinics|mesh-ancestor
44398778|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
44398779|NCT02833350|Vitamins|vitamins|mesh-ancestor
44398780|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
44398781|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398782|NCT02832375|Fluorides|fluorides|mesh-list
44398783|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
44398784|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
44398785|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
44398786|NCT02832375|Protective Agents|protective agents|mesh-ancestor
44398787|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398788|NCT02832037|BI 425809|bi 425809|mesh-list
44056257|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44398789|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
44398790|NCT02831855|Methotrexate|methotrexate|mesh-list
44398791|NCT02831855|Tofacitinib|tofacitinib|mesh-list
44398792|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44398793|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
44398794|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44398795|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398796|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398797|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
44398798|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398799|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398810|NCT02831764|Emtricitabine|emtricitabine|mesh-list
44398811|NCT02831764|Dolutegravir|dolutegravir|mesh-list
44398812|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
44398813|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398814|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44398815|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398816|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398817|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398818|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44398819|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44398820|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44398821|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44398822|NCT02831673|Tenofovir|tenofovir|mesh-list
44398823|NCT02831673|Lamivudine|lamivudine|mesh-list
44398824|NCT02831673|Emtricitabine|emtricitabine|mesh-list
44398825|NCT02831673|Dolutegravir|dolutegravir|mesh-list
44398826|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
44398827|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398828|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44398829|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44398830|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398831|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398832|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44398833|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44398834|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44160101|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160102|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160103|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
44160104|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44160105|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160106|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160107|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44160108|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44160109|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44160110|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
44160111|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160112|NCT00240656|Carvedilol|carvedilol|mesh-list
44160113|NCT00240656|Captopril|captopril|mesh-list
44160114|NCT00240656|Spironolactone|spironolactone|mesh-list
44160115|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44160116|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160117|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160118|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160119|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44160121|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
44160122|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44160123|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44160124|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
44398835|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44398836|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44398837|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44398838|NCT02830776|Bimatoprost|bimatoprost|mesh-list
44398839|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44398840|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44398841|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44398842|NCT02829996|Latanoprost|latanoprost|mesh-list
44398843|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44398844|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44398845|NCT02829944|Ketorolac|ketorolac|mesh-list
44398846|NCT02829944|Ropivacaine|ropivacaine|mesh-list
44398847|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
44398848|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
44398849|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44398850|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398851|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
44398852|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44398853|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398854|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44398855|NCT02829944|Analgesics|analgesics|mesh-ancestor
44398856|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44398857|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398858|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44398859|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398860|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398861|NCT02829918|Nivolumab|nivolumab|mesh-list
44398862|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398863|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43594747|NCT03331302|Xenon|xenon|mesh-list
44398864|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44160125|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160126|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160127|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160128|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
44160129|NCT00240656|Protective Agents|protective agents|mesh-ancestor
44160130|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44160131|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43599897|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160132|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44160133|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
44160134|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44160135|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44160136|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44160137|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398865|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398866|NCT02829775|Interferons|interferons|mesh-list
44398867|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
44398868|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
44398869|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44398871|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
44398872|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398873|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
44398874|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398875|NCT02828124|Nivolumab|nivolumab|mesh-list
44398876|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398877|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160138|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160139|NCT00240682|Cetuximab|cetuximab|mesh-list
44160140|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44160141|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160142|NCT00240695|Galantamine|galantamine|mesh-list
44160143|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44160144|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160145|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160146|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786745|NCT02030457|Hormones|hormones|mesh-ancestor
43786746|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786747|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160147|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160154|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44160155|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
44160156|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160157|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160158|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160159|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44160160|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44160161|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44160162|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44160163|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44160164|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
44160165|NCT00240721|Topiramate|topiramate|mesh-list
44160166|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
44160167|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160168|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160169|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
44160170|NCT00240734|Hematinics|hematinics|mesh-ancestor
44160171|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
44160172|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160173|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160174|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44160175|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160176|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160177|NCT00240760|Memantine|memantine|mesh-list
44160178|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44160179|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44160180|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
44160181|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160182|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160183|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160184|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44160185|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44160186|NCT00240773|Acetaminophen|acetaminophen|mesh-list
44160187|NCT00240773|Naproxen|naproxen|mesh-list
44160188|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160189|NCT00240773|Analgesics|analgesics|mesh-ancestor
44160190|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
44160191|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160192|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160193|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
44160194|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44398879|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398880|NCT02826603|Ustekinumab|ustekinumab|mesh-list
44398881|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44398882|NCT02825420|Trabectedin|trabectedin|mesh-list
44398883|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44398884|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
44398885|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398886|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398887|NCT02825251|Insulin|insulin|mesh-list
44398888|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44398889|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
44398890|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
44398891|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44398892|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398893|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398894|NCT02824627|Oxytocin|oxytocin|mesh-list
44398895|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
44160195|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160196|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160197|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
44160198|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44160199|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160200|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160201|NCT00240786|Acetaminophen|acetaminophen|mesh-list
44160202|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160203|NCT00240786|Analgesics|analgesics|mesh-ancestor
44160204|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
44160205|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160206|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160207|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
44160208|NCT00240799|Acetaminophen|acetaminophen|mesh-list
44160209|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160210|NCT00240799|Analgesics|analgesics|mesh-ancestor
44160211|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
44160212|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160213|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160214|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
44160215|NCT00240812|Ibuprofen|ibuprofen|mesh-list
44160216|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
44160217|NCT00240812|Ephedrine|ephedrine|mesh-list
44160218|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160224|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160225|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160226|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44160227|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160228|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160229|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44160230|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
44160231|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160232|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160233|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
44160234|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44160235|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44160236|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
44160237|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
44160238|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160239|NCT00240825|Acetaminophen|acetaminophen|mesh-list
44398897|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398899|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44398900|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
44398901|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398902|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398903|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44398904|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398905|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44398906|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44160241|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160242|NCT00240825|Analgesics|analgesics|mesh-ancestor
44160243|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
44160244|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160245|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160246|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
44160247|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160248|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160249|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160250|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44160251|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160252|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160253|NCT00240838|Acetaminophen|acetaminophen|mesh-list
44160254|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160255|NCT00240838|Analgesics|analgesics|mesh-ancestor
44160256|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
44160257|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160258|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160260|NCT00240851|Acetaminophen|acetaminophen|mesh-list
44160261|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160262|NCT00240851|Analgesics|analgesics|mesh-ancestor
44160263|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
44160264|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160265|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160266|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
44160267|NCT00240864|Acetaminophen|acetaminophen|mesh-list
44160268|NCT00240864|Ibuprofen|ibuprofen|mesh-list
44160269|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44160270|NCT00240864|Analgesics|analgesics|mesh-ancestor
44160271|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
44160272|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160273|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160274|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
44160275|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44160276|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160277|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160278|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43600048|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160279|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160280|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160281|NCT00240929|Palivizumab|palivizumab|mesh-list
44160282|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
44160283|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160284|NCT00240942|Letrozole|letrozole|mesh-list
44160285|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160286|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44160287|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44160288|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160292|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160294|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
44398907|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44398908|NCT02823574|Nivolumab|nivolumab|mesh-list
44398909|NCT02823574|Ipilimumab|ipilimumab|mesh-list
44398910|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398911|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398912|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398913|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398914|NCT02823470|Ivacaftor|ivacaftor|mesh-list
44398915|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44398916|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398917|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398918|NCT02822794|Ribavirin|ribavirin|mesh-list
44398919|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
44398920|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44398921|NCT02822794|Velpatasvir|velpatasvir|mesh-list
44160295|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44160296|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160297|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44160298|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
44160299|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160300|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160301|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160302|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160303|NCT00241007|Valsartan|valsartan|mesh-list
44160304|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44160305|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160306|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160307|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160308|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160309|NCT00241007|Diuretics|diuretics|mesh-ancestor
44160310|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
44160311|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160312|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44160313|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160314|NCT00241020|Octreotide|octreotide|mesh-list
44160315|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160316|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160317|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160318|NCT00241046|Letrozole|letrozole|mesh-list
44160319|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786803|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
43786804|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44160320|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44160321|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44160322|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160323|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160324|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44160325|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160326|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160327|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160328|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
44160329|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44160330|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160331|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44160332|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
44160333|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160334|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160335|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160336|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160337|NCT00241072|Valsartan|valsartan|mesh-list
44398922|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
44398923|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398924|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
44398925|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398926|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
44398927|NCT02822222|Cathartics|cathartics|mesh-ancestor
44398928|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44398929|NCT02821910|Metformin|metformin|mesh-list
44398930|NCT02821910|Empagliflozin|empagliflozin|mesh-list
44398931|NCT02821910|Linagliptin|linagliptin|mesh-list
44398932|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398933|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398934|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44398935|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398936|NCT02821910|Incretins|incretins|mesh-ancestor
44398937|NCT02821910|Hormones|hormones|mesh-ancestor
44398938|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398939|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44398940|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
44398941|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398942|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44398943|NCT02821819|Hormones|hormones|mesh-ancestor
43700936|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160338|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160339|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160340|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160341|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160342|NCT00241085|Valsartan|valsartan|mesh-list
44160343|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160344|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160345|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160346|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160347|NCT00241098|Valsartan|valsartan|mesh-list
44160348|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160349|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160350|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160351|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160352|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
44160353|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43786818|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44160354|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160362|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
44160363|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160364|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43786838|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
44160365|NCT00241124|Protective Agents|protective agents|mesh-ancestor
44160366|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160367|NCT00241137|Valsartan|valsartan|mesh-list
44160368|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160369|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160370|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44398944|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44398945|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398947|NCT02821715|Modafinil|modafinil|mesh-list
44056484|NCT00004875|Enoxaparin|enoxaparin|mesh-list
44398948|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43786847|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
44398949|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398950|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44398951|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44398952|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44398953|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398954|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44398955|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44398956|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44398957|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398958|NCT02821416|Benralizumab|benralizumab|mesh-list
44398959|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44398960|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
44398961|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44398962|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398963|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
44398964|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44398965|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398966|NCT02819804|Nivolumab|nivolumab|mesh-list
44398967|NCT02819804|Dasatinib|dasatinib|mesh-list
44398968|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398969|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43700961|NCT02727712|Anesthetics|anesthetics|mesh-list
44160371|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160372|NCT00241150|Valsartan|valsartan|mesh-list
44160373|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44160374|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160375|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44160376|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160377|NCT00241163|Thrombin|thrombin|mesh-list
44160378|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
44160379|NCT00241163|Coagulants|coagulants|mesh-ancestor
44160380|NCT00241189|Sirolimus|sirolimus|mesh-list
44160381|NCT00241189|Methotrexate|methotrexate|mesh-list
44160382|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44160383|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
44160384|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44160385|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160386|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160387|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
44163849|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44398970|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44398971|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398972|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44398973|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398974|NCT02819726|Rituximab|rituximab|mesh-list
43849565|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
44398975|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44398976|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398977|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
44398978|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44398979|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44398980|NCT02819518|Gemcitabine|gemcitabine|mesh-list
44398981|NCT02819518|Paclitaxel|paclitaxel|mesh-list
44398982|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44398983|NCT02819518|Carboplatin|carboplatin|mesh-list
44398984|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
44398985|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44398986|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44398987|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
44398988|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
44398989|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
44398990|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44398991|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44398992|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
44398993|NCT02819518|Antiviral Agents|antiviral agents|mesh-ancestor
44398994|NCT02819518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44398995|NCT02819518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44398996|NCT02819518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160388|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160389|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160390|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160391|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160392|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44160393|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160394|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
44160395|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160396|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44160397|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160398|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160399|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44160400|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
44160402|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44160403|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160404|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160405|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
44160406|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160407|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160408|NCT00241241|Interferons|interferons|mesh-list
44160409|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
44398999|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399000|NCT02819440|Tadalafil|tadalafil|mesh-list
44399001|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
44399002|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44399003|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44399004|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399005|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399006|NCT02819440|Urological Agents|urological agents|mesh-ancestor
44399007|NCT02819310|Laxatives|laxatives|mesh-list
44399008|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399009|NCT02819297|Laxatives|laxatives|mesh-list
44399010|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399011|NCT02818998|Aflibercept|aflibercept|mesh-list
44399012|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44399013|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44399014|NCT02818998|Growth Substances|growth substances|mesh-ancestor
44399015|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399016|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44399017|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399018|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
44399019|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399020|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399021|NCT02818777|Cannabidiol|cannabidiol|mesh-list
43786860|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43786861|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43786862|NCT05116345|Dexamethasone|dexamethasone|mesh-list
43786863|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
43786864|NCT05116345|BB 1101|bb 1101|mesh-list
44056566|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
44399022|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
44399023|NCT02818036|Naltrexone|naltrexone|mesh-list
44399024|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44399025|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44399026|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399027|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
44399028|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399029|NCT02817841|Drospirenone|drospirenone|mesh-list
44160410|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
44160411|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44160412|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160413|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
44160414|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160415|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
44399030|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44399031|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399032|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399033|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399034|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44399035|NCT02817841|Diuretics|diuretics|mesh-ancestor
44399036|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
44399037|NCT02817828|Drospirenone|drospirenone|mesh-list
44399038|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44399039|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399040|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399041|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399042|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44399043|NCT02817828|Diuretics|diuretics|mesh-ancestor
44399044|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
44399045|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
44399046|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
44399047|NCT02817555|Hematinics|hematinics|mesh-ancestor
44399048|NCT02816138|Nicotine|nicotine|mesh-list
44399049|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44399050|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
44399051|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399052|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399053|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44399054|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44399055|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44399056|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399057|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399058|NCT02815540|Cannabidiol|cannabidiol|mesh-list
44399059|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
44399060|NCT02815397|Metformin|metformin|mesh-list
44399061|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44399062|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399063|NCT02814643|Benralizumab|benralizumab|mesh-list
44160416|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160417|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
44160418|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44160419|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44160420|NCT00241254|Prednisolone|prednisolone|mesh-list
44160421|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
44399066|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
44399067|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44399068|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
44399069|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44399070|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44399071|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399072|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44399073|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399074|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44399075|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399076|NCT02814175|Adalimumab|adalimumab|mesh-list
44399077|NCT02814175|Methotrexate|methotrexate|mesh-list
44399078|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44160431|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160432|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160433|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44160434|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160435|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
44160436|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
44160437|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160438|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160439|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
44160440|NCT00241254|Hormones|hormones|mesh-ancestor
44160441|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160442|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44160443|NCT00241254|Protective Agents|protective agents|mesh-ancestor
44160444|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160445|NCT00241332|Fentanyl|fentanyl|mesh-list
44160446|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44160447|NCT00241332|Narcotics|narcotics|mesh-ancestor
44160448|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44160449|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160450|NCT00241332|Analgesics|analgesics|mesh-ancestor
44160451|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
44160452|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160453|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44160454|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44160455|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
44160456|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
44160457|NCT00241345|Valganciclovir|valganciclovir|mesh-list
44160458|NCT00241345|Ganciclovir|ganciclovir|mesh-list
44160459|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44160460|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
44160461|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600280|NCT03280095|Acetaminophen|acetaminophen|mesh-list
44160462|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44160463|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160464|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160466|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160467|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
44160468|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160469|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160471|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160472|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160473|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44160474|NCT00241423|Incretins|incretins|mesh-ancestor
44160475|NCT00241423|Hormones|hormones|mesh-ancestor
44399079|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
44399080|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44399081|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399082|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44399083|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
44399084|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399085|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399086|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399087|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399088|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44399089|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399090|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
44399091|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399092|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44399093|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399094|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
44399095|NCT02813694|Lefamulin|lefamulin|mesh-list
44399096|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399097|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399098|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44399099|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44399100|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399101|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701044|NCT02727309|Apatinib|apatinib|mesh-list
44160476|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160477|NCT00241436|Anastrozole|anastrozole|mesh-list
44160478|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160479|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160480|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44160481|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44160482|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160483|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160484|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44160485|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160486|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160494|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160495|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160496|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44160497|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44160498|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44160499|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44160500|NCT00241475|Gefitinib|gefitinib|mesh-list
44160501|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160502|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160503|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160504|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160505|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44160506|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44160507|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44399102|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399104|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44399105|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44399106|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44399107|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399108|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399109|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
44399110|NCT02811861|Everolimus|everolimus|mesh-list
44399111|NCT02811861|Sunitinib|sunitinib|mesh-list
44399112|NCT02811861|Lenvatinib|lenvatinib|mesh-list
44399113|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399114|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399115|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399116|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
44399117|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399118|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44399119|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44399120|NCT02811861|Growth Substances|growth substances|mesh-ancestor
44399121|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
44399122|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399123|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399124|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399125|NCT02810964|Sulforaphane|sulforaphane|mesh-list
44399126|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44399127|NCT02810964|Protective Agents|protective agents|mesh-ancestor
44399128|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399129|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399130|NCT02810418|Paclitaxel|paclitaxel|mesh-list
44399131|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44399132|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399133|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44399134|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44399135|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160508|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
44160509|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160510|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44160511|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44160512|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160513|NCT00241501|Esomeprazole|esomeprazole|mesh-list
44160514|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44399136|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399137|NCT02810392|Insulin|insulin|mesh-list
44399138|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44399139|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44399140|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399141|NCT02809053|Rituximab|rituximab|mesh-list
44399142|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399143|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399144|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
44399145|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399146|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399147|NCT02808975|Adalimumab|adalimumab|mesh-list
44399148|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399149|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399150|NCT02808819|Benralizumab|benralizumab|mesh-list
44399151|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399152|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399153|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
44399154|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44399155|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
43701090|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
44160515|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160516|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160517|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160518|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160519|NCT00241514|Esomeprazole|esomeprazole|mesh-list
44160520|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160521|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160522|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160523|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160524|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160525|NCT00241527|Esomeprazole|esomeprazole|mesh-list
44160526|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160527|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160528|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160529|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160530|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160531|NCT00241540|Esomeprazole|esomeprazole|mesh-list
44160532|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160533|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160534|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160535|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160536|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160537|NCT00241553|Esomeprazole|esomeprazole|mesh-list
44160538|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160539|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160540|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160541|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160542|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160543|NCT00241605|Metformin|metformin|mesh-list
44160544|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
44160545|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160546|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160547|NCT00241618|Interferons|interferons|mesh-list
44160548|NCT00241618|Ribavirin|ribavirin|mesh-list
44160549|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
44399156|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399157|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399158|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44399159|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
44399160|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399161|NCT02807844|Spartalizumab|spartalizumab|mesh-list
44399162|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44399163|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399164|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399165|NCT02807623|Ibuprofen|ibuprofen|mesh-list
44399166|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399167|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399168|NCT02807623|Analgesics|analgesics|mesh-ancestor
44399169|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
44399170|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399171|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399172|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399173|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399174|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44399175|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399176|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399177|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
44399178|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399179|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
44399180|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
44399181|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399182|NCT02807363|Leuprolide|leuprolide|mesh-list
44399183|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44399184|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
44399185|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43701108|NCT02726984|Listerine|listerine|mesh-list
44160550|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
44160551|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160552|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
44160553|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160564|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160565|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
44160566|NCT00241982|Hormones|hormones|mesh-ancestor
44160567|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160568|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160569|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160570|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160571|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
44399186|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399187|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44399188|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399189|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
44399190|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
44399191|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44399192|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44399193|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
44399194|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399195|NCT02806973|Glucagon|glucagon|mesh-list
44399196|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399197|NCT02806973|Hormones|hormones|mesh-ancestor
44399198|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399199|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399200|NCT02806960|Glucagon|glucagon|mesh-list
44399201|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399202|NCT02806960|Hormones|hormones|mesh-ancestor
44160572|NCT00242008|Rotigotine|rotigotine|mesh-list
44160573|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
44160574|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
44160575|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160576|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160577|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160578|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
44160579|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44160580|NCT00242177|Pioglitazone|pioglitazone|mesh-list
44160581|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160582|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160583|NCT00242190|Gemcitabine|gemcitabine|mesh-list
44160584|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
44160585|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160586|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
44160587|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160588|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160589|NCT00242190|Antiviral Agents|antiviral agents|mesh-ancestor
44160590|NCT00242190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160591|NCT00242190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160592|NCT00242190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160593|NCT00242190|Immunologic Factors|immunologic factors|mesh-ancestor
44160594|NCT00242190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160595|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
44160596|NCT00242203|Docetaxel|docetaxel|mesh-list
44160598|NCT00242203|Epirubicin|epirubicin|mesh-list
44160599|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160600|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
44160601|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
44160602|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160603|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160604|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44160605|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44160606|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44160607|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44160608|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160609|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44160610|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160611|NCT00242268|Simvastatin|simvastatin|mesh-list
44160612|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43600501|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44160613|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44399203|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399204|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399205|NCT02806947|Sirolimus|sirolimus|mesh-list
44399206|NCT02806947|Prednisone|prednisone|mesh-list
44399207|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399208|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
44399209|NCT02806947|Hormones|hormones|mesh-ancestor
44399210|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399211|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399212|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44399213|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399214|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399215|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399216|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44399217|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
44399218|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399219|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
44399220|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44399221|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
44399222|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399223|NCT02806414|Ivermectin|ivermectin|mesh-list
44399224|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44399225|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399226|NCT02806232|Praziquantel|praziquantel|mesh-list
44399227|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
44160614|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
44160615|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160616|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44160617|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44160618|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160622|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44160624|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160625|NCT00242359|Omalizumab|omalizumab|mesh-list
44160626|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44160627|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160628|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160629|NCT00242372|Insulin|insulin|mesh-list
44160630|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160631|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160632|NCT00242411|Budesonide|budesonide|mesh-list
44160633|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
44160634|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160635|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44160636|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
44160637|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160638|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160639|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160640|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160641|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
44160642|NCT00242411|Hormones|hormones|mesh-ancestor
44399228|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44399229|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399230|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
44399231|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44399232|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44399233|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399234|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
44399235|NCT02806024|Coagulants|coagulants|mesh-ancestor
44399237|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44399238|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399239|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
44399240|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399241|NCT02805907|Calcifediol|calcifediol|mesh-list
44399242|NCT02805907|Vitamins|vitamins|mesh-ancestor
44399243|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
44399244|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399245|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44399246|NCT02805660|Durvalumab|durvalumab|mesh-list
44399247|NCT02805660|Mocetinostat|mocetinostat|mesh-list
44399248|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399249|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399250|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44399251|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399252|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399253|NCT02804399|Rifampin|rifampin|mesh-list
44399254|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44399255|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
44399256|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399257|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399258|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
44399259|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44160643|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160644|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44160645|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44160646|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44160647|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
44160648|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160649|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160650|NCT00242437|Thrombin|thrombin|mesh-list
44160651|NCT00242437|Hemostatics|hemostatics|mesh-list
44160652|NCT00242437|Coagulants|coagulants|mesh-ancestor
44160653|NCT00242450|Metoclopramide|metoclopramide|mesh-list
44399260|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399261|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399262|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44399263|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44399264|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44399265|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44399266|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44399267|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44399269|NCT02803138|Ribavirin|ribavirin|mesh-list
44399270|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44399271|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44399272|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
44399273|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399274|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399275|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44399276|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44399277|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
44399278|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399279|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44056847|NCT00004922|Irinotecan|irinotecan|mesh-list
44399280|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44399281|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
44399282|NCT02802865|Letrozole|letrozole|mesh-list
44399283|NCT02802865|Clomiphene|clomiphene|mesh-list
44399284|NCT02802865|Enclomiphene|enclomiphene|mesh-list
44399285|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
44399286|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399287|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399288|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44160654|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
44160655|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
44160656|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160657|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160658|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160659|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44160660|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44160661|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
44160662|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160663|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160664|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
44160665|NCT00242463|Nandrolone|nandrolone|mesh-list
44160666|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
44160667|NCT00242463|Testosterone Congeners|testosterone congeners|mesh-list
44399289|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44399290|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399291|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44399292|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399293|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399294|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399295|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44399296|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
44399297|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44399298|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44399299|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44399300|NCT02802735|Apremilast|apremilast|mesh-list
44399301|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399302|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399303|NCT02802735|Analgesics|analgesics|mesh-ancestor
44399304|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
44399305|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399306|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399307|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399308|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160668|NCT00242463|Androgens|androgens|mesh-ancestor
44160669|NCT00242463|Hormones|hormones|mesh-ancestor
44160670|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160671|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160672|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
44160673|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43600502|NCT05074589|Leucovorin|leucovorin|mesh-list
43600503|NCT05074589|Fluorouracil|fluorouracil|mesh-list
44160675|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44160676|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160677|NCT00242541|Octreotide|octreotide|mesh-list
44160678|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160679|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44160680|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160681|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
44160682|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44160683|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160684|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
44160685|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44160686|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160687|NCT00242606|Lamotrigine|lamotrigine|mesh-list
44160688|NCT00242606|Levetiracetam|levetiracetam|mesh-list
44160689|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
44160690|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
44160694|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44160696|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44160697|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44160698|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44160699|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44160700|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44160701|NCT00242697|Anesthetics|anesthetics|mesh-list
44160702|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44160703|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160704|NCT00242736|Esomeprazole|esomeprazole|mesh-list
44399310|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44399311|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399312|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399313|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
44399314|NCT02802592|Hematinics|hematinics|mesh-ancestor
44399315|NCT02802345|Nintedanib|nintedanib|mesh-list
44399316|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
44399317|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
44399318|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44399319|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44399320|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399321|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399322|NCT02802345|Urological Agents|urological agents|mesh-ancestor
44399323|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399324|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399325|NCT02801669|Edoxaban|edoxaban|mesh-list
44399326|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44399327|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
44399328|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44399329|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
44399330|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399331|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399332|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
44399333|NCT02801617|Latanoprost|latanoprost|mesh-list
44399334|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44399335|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44399336|NCT02800928|Aticaprant|aticaprant|mesh-list
44399337|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44399338|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399339|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
44399340|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399341|NCT02800642|Aflibercept|aflibercept|mesh-list
44399342|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44399343|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44399344|NCT02800642|Growth Substances|growth substances|mesh-ancestor
44160705|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44160706|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160707|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44160708|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399345|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399346|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
44399347|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399348|NCT02799784|Albuterol|albuterol|mesh-list
44399349|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44399350|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
44399351|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399352|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399353|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399354|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399355|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
44399356|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44399357|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44399358|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44399359|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399360|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399361|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399362|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399363|NCT02799381|Levodopa|levodopa|mesh-list
44399364|NCT02799381|Carbidopa|carbidopa|mesh-list
44399365|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43701218|NCT02726035|Naltrexone|naltrexone|mesh-list
44160709|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160710|NCT00242749|Cisplatin|cisplatin|mesh-list
44160711|NCT00242749|Gefitinib|gefitinib|mesh-list
44160712|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160713|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160714|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160715|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160716|NCT00242762|Cisplatin|cisplatin|mesh-list
44160717|NCT00242762|Docetaxel|docetaxel|mesh-list
44160718|NCT00242762|Gefitinib|gefitinib|mesh-list
44160719|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160720|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44160721|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44160722|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160723|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160724|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160725|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160727|NCT00242775|Budesonide|budesonide|mesh-list
44160728|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
44160729|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44160730|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160731|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44160732|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
44160733|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160734|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160735|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160736|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160737|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160738|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44160739|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
44160740|NCT00242775|Hormones|hormones|mesh-ancestor
44160741|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399366|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
44399367|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44399368|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
44399369|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399370|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399371|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399372|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44399373|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399374|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44399375|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
44399376|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
44399377|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44399378|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44399379|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399380|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44399381|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44399382|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399383|NCT02798835|Dexamethasone|dexamethasone|mesh-list
44399384|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
44399386|NCT02798835|Bupivacaine|bupivacaine|mesh-list
44399387|NCT02798835|Ropivacaine|ropivacaine|mesh-list
44399388|NCT02798835|BB 1101|bb 1101|mesh-list
44399389|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399390|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
44399391|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
44399392|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399393|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399394|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44160742|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44160743|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44160744|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43849182|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43600580|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43600581|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43600583|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
44160745|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44160746|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160747|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160748|NCT00242788|Capecitabine|capecitabine|mesh-list
44160749|NCT00242788|Gefitinib|gefitinib|mesh-list
44160750|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160751|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
44160752|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160753|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160754|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160755|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399395|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
44399396|NCT02798835|Hormones|hormones|mesh-ancestor
44399397|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399398|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44399399|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399400|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
44399401|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399402|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399403|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
44399404|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
44399405|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399406|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
44399407|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44399408|NCT02798835|Narcotics|narcotics|mesh-ancestor
44399409|NCT02798835|Analgesics|analgesics|mesh-ancestor
44160756|NCT00242801|Gefitinib|gefitinib|mesh-list
44160757|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160773|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44160774|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
44160775|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44160776|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160777|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160778|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160779|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44160780|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
44160781|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160782|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160783|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44160784|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
44160785|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
44160786|NCT00242853|Protective Agents|protective agents|mesh-ancestor
44160787|NCT00242879|Ritonavir|ritonavir|mesh-list
44160788|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44160789|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44160790|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
44160791|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160792|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160793|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44160794|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44160795|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
44160796|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160797|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44160798|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44160799|NCT00242918|Docetaxel|docetaxel|mesh-list
44160800|NCT00242918|Gefitinib|gefitinib|mesh-list
44160801|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160802|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
44160803|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
44160804|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160805|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160806|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44160807|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160808|NCT00242944|Atorvastatin|atorvastatin|mesh-list
44160809|NCT00242944|Pitavastatin|pitavastatin|mesh-list
44160810|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44160811|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44160812|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
44160813|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160814|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44160825|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399410|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44399411|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44399412|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
44399413|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44399414|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
44399415|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399416|NCT02797808|Sertraline|sertraline|mesh-list
44399417|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
44399418|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44399419|NCT02797808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44399420|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44399421|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44399422|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399423|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399424|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
44399425|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399426|NCT02797522|Acetaminophen|acetaminophen|mesh-list
44399427|NCT02797522|Tenofovir|tenofovir|mesh-list
44399428|NCT02797522|Entecavir|entecavir|mesh-list
44399429|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
44399430|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44399431|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399432|NCT02797522|Analgesics|analgesics|mesh-ancestor
44399433|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
44399434|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399435|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399436|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
44399437|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
44399438|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399439|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44399440|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44160826|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44160827|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
44160828|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160829|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160830|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44160831|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44160832|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44160833|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44160834|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44160835|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160836|NCT00243009|Cyclosporine|cyclosporine|mesh-list
44160837|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
44399441|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399442|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399444|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44399445|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
44399446|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399447|NCT02797080|Interferons|interferons|mesh-list
44399448|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
44399449|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399450|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
44399451|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399452|NCT02796755|Riluzole|riluzole|mesh-list
44399453|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
44399454|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44399455|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44399456|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399457|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399458|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399459|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44399460|NCT02796755|Protective Agents|protective agents|mesh-ancestor
44399461|NCT02796677|Bromides|bromides|mesh-list
44399462|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
44399463|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
44399464|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44399465|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
44399466|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399467|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399468|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399469|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399470|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44399471|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44399472|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399473|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399474|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399475|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701300|NCT02725359|Analgesics|analgesics|mesh-ancestor
44160838|NCT00243009|Fludarabine|fludarabine|mesh-list
44160839|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
44160840|NCT00243009|Cyclosporins|cyclosporins|mesh-list
44160841|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399476|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
44399477|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44399478|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
44399479|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
44399480|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44399481|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
44399482|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44399483|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
44399484|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399485|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399486|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43848351|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
44399487|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399488|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44399489|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44399490|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399491|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399492|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399493|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399494|NCT02796560|Travoprost|travoprost|mesh-list
44399495|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44399496|NCT02796391|Nicotine|nicotine|mesh-list
44399497|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44160842|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160843|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
44160844|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160845|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160846|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
44160847|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160848|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160849|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
44160850|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160851|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160852|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160853|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44160854|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44160855|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44160856|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
44160857|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44160859|NCT00243035|Tipifarnib|tipifarnib|mesh-list
44160860|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160861|NCT00243100|Gemcitabine|gemcitabine|mesh-list
44160862|NCT00243100|Vorinostat|vorinostat|mesh-list
44160863|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160864|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
44160865|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160866|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160867|NCT00243100|Antiviral Agents|antiviral agents|mesh-ancestor
44160868|NCT00243100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160869|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160870|NCT00243100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160871|NCT00243100|Immunologic Factors|immunologic factors|mesh-ancestor
44160872|NCT00243100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160873|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44399499|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399500|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399501|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44399502|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44399503|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
44399504|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399505|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399506|NCT02794974|Anesthetics|anesthetics|mesh-list
44057070|NCT00004999|Capravirine|capravirine|mesh-list
44399507|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399508|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399509|NCT02794883|Durvalumab|durvalumab|mesh-list
44399510|NCT02794883|Ipilimumab|ipilimumab|mesh-list
44399511|NCT02794883|Tremelimumab|tremelimumab|mesh-list
44399512|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
44399513|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44399514|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
44399515|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399516|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399517|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
44399518|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399519|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44399520|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399521|NCT02793947|Epinephrine|epinephrine|mesh-list
43848352|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848353|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44399522|NCT02793947|Morphine|morphine|mesh-list
44160874|NCT00243113|Docetaxel|docetaxel|mesh-list
44160875|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160876|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
44160877|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
44160878|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160879|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160881|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44160882|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44160883|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44160884|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44160885|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
44160886|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160887|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160888|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160889|NCT00243204|Docetaxel|docetaxel|mesh-list
44160890|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160891|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44160892|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44160893|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44160894|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160895|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
44160896|NCT00243256|Vitamin D|vitamin d|mesh-list
44160897|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44399523|NCT02793947|Ropivacaine|ropivacaine|mesh-list
44399524|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44399525|NCT02793947|Narcotics|narcotics|mesh-ancestor
44399526|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399527|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399528|NCT02793947|Analgesics|analgesics|mesh-ancestor
44399529|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
44399530|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399531|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
44399532|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
44399533|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44399534|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399535|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399536|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399537|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399538|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44399539|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44399540|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
44399541|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399542|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399543|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
44160898|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160899|NCT00243256|Vitamins|vitamins|mesh-ancestor
44160900|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
44160901|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44160902|NCT00243399|Oxandrolone|oxandrolone|mesh-list
44160903|NCT00243399|Androgens|androgens|mesh-ancestor
44160904|NCT00243399|Hormones|hormones|mesh-ancestor
44160905|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160906|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160907|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
44160908|NCT00243464|Betamethasone|betamethasone|mesh-list
44160909|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
44160910|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44160911|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
44160912|NCT00243464|Calcipotriene|calcipotriene|mesh-list
44160913|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44160914|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44160915|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
44160916|NCT00243464|Hormones|hormones|mesh-ancestor
44160917|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160918|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160919|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44160920|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
44160921|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160922|NCT00243477|Citalopram|citalopram|mesh-list
44160923|NCT00243477|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44160924|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44160925|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160926|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160927|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44160928|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
44160929|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160930|NCT00243477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44160931|NCT00243477|Antidepressive Agents|antidepressive agents|mesh-ancestor
44399545|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44399546|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
44399547|NCT02793622|Piperaquine|piperaquine|mesh-list
44399548|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
44399549|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44399550|NCT02793622|Artenimol|artenimol|mesh-list
44399551|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
44399552|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44399553|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44399554|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399555|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44399556|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399557|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399558|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44399559|NCT02793622|Renal Agents|renal agents|mesh-ancestor
44399560|NCT02793128|Mitomycins|mitomycins|mesh-list
44399561|NCT02793128|Mitomycin|mitomycin|mesh-list
44399562|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44399563|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399564|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
44399565|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399566|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44399567|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399568|NCT02792829|Lenvatinib|lenvatinib|mesh-list
44399569|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399570|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399571|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399572|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399573|NCT02792699|Rituximab|rituximab|mesh-list
44399574|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399575|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399576|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
44399577|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399578|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399579|NCT02792517|Erenumab|erenumab|mesh-list
44160932|NCT00243477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44160933|NCT00243646|Bicalutamide|bicalutamide|mesh-list
44160934|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160935|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399580|NCT02792517|Norgestimate|norgestimate|mesh-list
44399581|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
44399582|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
44399583|NCT02792517|Estradiol|estradiol|mesh-list
44399584|NCT02792517|Estrogens|estrogens|mesh-ancestor
44399585|NCT02792517|Hormones|hormones|mesh-ancestor
44399586|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399587|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399588|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44399589|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44399590|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44399591|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44399592|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399593|NCT02792517|Analgesics|analgesics|mesh-ancestor
44399594|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
44399595|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399596|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44399597|NCT02792231|Teriflunomide|teriflunomide|mesh-list
44399598|NCT02792231|Ofatumumab|ofatumumab|mesh-list
44399599|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44399600|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160936|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
44160937|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
44160938|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44160939|NCT00243672|Atorvastatin|atorvastatin|mesh-list
44160940|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
44160941|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44160942|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44160943|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
44160944|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160945|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44160946|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44160947|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160948|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44160949|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44160950|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44160952|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44160962|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160964|NCT00243737|Mefloquine|mefloquine|mesh-list
44160965|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
44160966|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44160967|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44160968|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44160969|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160970|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
44160971|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
44160972|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44160973|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
44160974|NCT00243750|Methotrexate|methotrexate|mesh-list
44160975|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44160976|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
44160977|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44160978|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399602|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399603|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399604|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399605|NCT02792231|Analgesics|analgesics|mesh-ancestor
44399606|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
44399607|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399608|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399609|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399610|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399611|NCT02792218|Teriflunomide|teriflunomide|mesh-list
44399612|NCT02792218|Ofatumumab|ofatumumab|mesh-list
44399613|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44399614|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399615|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
44399616|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399617|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399618|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399619|NCT02792218|Analgesics|analgesics|mesh-ancestor
44399620|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
44399621|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399622|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399623|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399624|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399625|NCT02792192|Atezolizumab|atezolizumab|mesh-list
44399626|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399627|NCT02792062|Relugolix|relugolix|mesh-list
44399628|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
44399629|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399647|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399648|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44399649|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44399650|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44399651|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399652|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44399653|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
44399654|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399656|NCT02789657|Carboplatin|carboplatin|mesh-list
44399657|NCT02789657|Trastuzumab|trastuzumab|mesh-list
44399658|NCT02789657|Pertuzumab|pertuzumab|mesh-list
44399659|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44399660|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399661|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44399662|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44399663|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44399664|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399665|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399666|NCT02789111|Alvimopan|alvimopan|mesh-list
44399667|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399668|NCT02788656|Valsartan|valsartan|mesh-list
44399669|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
44399670|NCT02788656|Giapreza|giapreza|mesh-list
44399671|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
44399672|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44399675|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44399693|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399694|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399695|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399696|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399697|NCT02788279|Atezolizumab|atezolizumab|mesh-list
44399698|NCT02788279|Antibodies|antibodies|mesh-list
44399699|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
44399700|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399701|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399702|NCT02788175|Vedolizumab|vedolizumab|mesh-list
44399703|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399704|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44399705|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
44399706|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44057295|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
44399707|NCT02787304|Volixibat|volixibat|mesh-list
44399708|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44399709|NCT02787083|Mirabegron|mirabegron|mesh-list
44399710|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44399711|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44399712|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399713|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399714|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399715|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399716|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399717|NCT02787083|Urological Agents|urological agents|mesh-ancestor
44399718|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44399719|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44399720|NCT02785939|Docetaxel|docetaxel|mesh-list
44399721|NCT02785939|Palbociclib|palbociclib|mesh-list
44399722|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399723|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
44399724|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
44399725|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
44399726|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399727|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399728|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399730|NCT02785900|Decitabine|decitabine|mesh-list
44399731|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44399732|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
44399733|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399734|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399735|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399736|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
44399737|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399738|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399739|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44399740|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44399741|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399742|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399743|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399744|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44399745|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399746|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848370|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43848371|NCT04024696|Abexinostat|abexinostat|mesh-list
44399747|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
44399748|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399749|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44399750|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44399751|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44399752|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44160979|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44160980|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
44160981|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160982|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44160983|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44160984|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160985|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44160986|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44160987|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
44160988|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44160989|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44160990|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
44160991|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44160992|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44160993|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44160994|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44160995|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44160996|NCT00243789|Protective Agents|protective agents|mesh-ancestor
44160997|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44160998|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
44160999|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44161000|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
44161002|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161003|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161004|NCT00243815|Analgesics|analgesics|mesh-ancestor
44161005|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
44399754|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399755|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399756|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399757|NCT02783729|Zolpidem|zolpidem|mesh-list
44399758|NCT02783729|Lemborexant|lemborexant|mesh-list
44399759|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44399760|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44399761|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399762|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399763|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44399764|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
44399765|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
44399766|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399767|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399768|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44399769|NCT02783599|Doxorubicin|doxorubicin|mesh-list
44399770|NCT02783599|Olaratumab|olaratumab|mesh-list
44399771|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44399772|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399773|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44399774|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44399775|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399776|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399777|NCT02783170|Vaccines|vaccines|mesh-list
44399778|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
44399779|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399780|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
43786904|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
43786905|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
44399781|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44399782|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
44399783|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399785|NCT02782676|Protective Agents|protective agents|mesh-ancestor
44399786|NCT02782169|Pregabalin|pregabalin|mesh-list
44161006|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161007|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161008|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161009|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161010|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44161011|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161012|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399788|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
44399789|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399790|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399791|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
44399792|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44399793|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44399794|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399795|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44399796|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44399797|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44399798|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399799|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44399800|NCT02781818|Triamcinolone|triamcinolone|mesh-list
44399801|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44399802|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44399803|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44399804|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399805|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
44399806|NCT02781818|Hormones|hormones|mesh-ancestor
44399807|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399808|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399809|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399810|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
44399811|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399812|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399813|NCT02781584|Firsocostat|firsocostat|mesh-list
44399814|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399815|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399816|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
44399818|NCT02781558|Velpatasvir|velpatasvir|mesh-list
44399828|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44399829|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399830|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399831|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399832|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399833|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399834|NCT02781311|Urological Agents|urological agents|mesh-ancestor
44399836|NCT02780700|Nintedanib|nintedanib|mesh-list
44399837|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44399838|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
44399839|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399840|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399841|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399842|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399843|NCT02780687|Afatinib|afatinib|mesh-list
44399844|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399845|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399846|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399847|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399848|NCT02780167|Abrocitinib|abrocitinib|mesh-list
44399849|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399850|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399851|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399852|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44399853|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44399854|NCT02779855|Paclitaxel|paclitaxel|mesh-list
44399855|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44399856|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44399857|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399858|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44399859|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44399860|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44399861|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701613|NCT02723461|Oxytocin|oxytocin|mesh-list
44399865|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399866|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44399867|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
44399868|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399869|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399870|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44399871|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399872|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
44399873|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44399874|NCT02778399|OBE2109|obe2109|mesh-list
44399875|NCT02778399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44399876|NCT02778399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399877|NCT02778399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399878|NCT02778100|Phenylephrine|phenylephrine|mesh-list
44399879|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
44399880|NCT02778100|Glucagon|glucagon|mesh-list
44399881|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44399882|NCT02778100|Hormones|hormones|mesh-ancestor
44399883|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44399884|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399885|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44399886|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44399887|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
44399888|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399889|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399890|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
44399891|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
44399892|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161013|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44161014|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161015|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161016|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161017|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161018|NCT00243880|Lovastatin|lovastatin|mesh-list
44161019|NCT00243880|L 647318|l 647318|mesh-list
44161021|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44161022|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44161023|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
44161024|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161025|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44161026|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44161027|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161028|NCT00243893|Doxycycline|doxycycline|mesh-list
44161029|NCT00243893|Minocycline|minocycline|mesh-list
44161030|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399893|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
44399894|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44399895|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
44399896|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44399897|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
44399898|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44399899|NCT02778100|Protective Agents|protective agents|mesh-ancestor
44399900|NCT02777970|Acetaminophen|acetaminophen|mesh-list
44399901|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44399902|NCT02777970|Tramadol|tramadol|mesh-list
44399903|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399904|NCT02777970|Analgesics|analgesics|mesh-ancestor
44399905|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
44399906|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399907|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399908|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
44399909|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44399910|NCT02777970|Narcotics|narcotics|mesh-ancestor
44399911|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399912|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399913|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399914|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399915|NCT02777554|Thalidomide|thalidomide|mesh-list
44399916|NCT02777554|Apremilast|apremilast|mesh-list
44399917|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44399918|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44399919|NCT02777554|Analgesics|analgesics|mesh-ancestor
44399920|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
44399921|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44399922|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399923|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44399924|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44399925|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44399926|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44161031|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161032|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
44161033|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44161034|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44161035|NCT00243945|Rotigotine|rotigotine|mesh-list
44161036|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
44161037|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
44161038|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44399927|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399928|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44057472|NCT00005054|Temozolomide|temozolomide|mesh-list
44399929|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44399930|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
44399931|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
44399932|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44399933|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44399934|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44399935|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44399936|NCT02777554|Growth Substances|growth substances|mesh-ancestor
44399937|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
44399938|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399939|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
44399941|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
44399942|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
44399943|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44399944|NCT02777242|Androgens|androgens|mesh-ancestor
44399946|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161039|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161040|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161041|NCT00243984|Topiramate|topiramate|mesh-list
44161042|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
44161043|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44161044|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161045|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
44161046|NCT00244023|Testosterone|testosterone|mesh-list
44161047|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
43786937|NCT04690504|Melatonin|melatonin|mesh-list
43786938|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
43786939|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786940|NCT04690504|Protective Agents|protective agents|mesh-ancestor
43786941|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786943|NCT04675333|Cisplatin|cisplatin|mesh-list
44161048|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
44161049|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44161050|NCT00244023|Androgens|androgens|mesh-ancestor
44161051|NCT00244023|Hormones|hormones|mesh-ancestor
44161052|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161053|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161054|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161055|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161056|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
44161057|NCT00244075|Hormones|hormones|mesh-list
44161058|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161059|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161060|NCT00244127|Prednisone|prednisone|mesh-list
44161061|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
44161062|NCT00244127|Rituximab|rituximab|mesh-list
44161063|NCT00244127|Vincristine|vincristine|mesh-list
44161064|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161065|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
44161066|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161067|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161068|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161069|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
44161070|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161071|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161072|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44399947|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399948|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44399949|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399950|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
44399951|NCT02776683|Bevacizumab|bevacizumab|mesh-list
44399952|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399953|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399954|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44399955|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44399956|NCT02776683|Growth Substances|growth substances|mesh-ancestor
44399957|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399958|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
44399959|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44399960|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
44399961|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44399962|NCT02775903|Azacitidine|azacitidine|mesh-list
44399963|NCT02775903|Durvalumab|durvalumab|mesh-list
44399964|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44399965|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
44399966|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399967|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399968|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399969|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44399970|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
44399971|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
44399972|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786945|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
44399973|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44399974|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44399975|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399976|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44399977|NCT02774681|Trastuzumab|trastuzumab|mesh-list
44399978|NCT02774681|Palbociclib|palbociclib|mesh-list
44399979|NCT02774681|Antibodies|antibodies|mesh-list
44399980|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
44399981|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44161073|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44161074|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161075|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
44161076|NCT00244127|Hormones|hormones|mesh-ancestor
44163850|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399982|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
44399983|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44399984|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399985|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399986|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399987|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399988|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44399989|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44399990|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44399991|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44399992|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44399994|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44399995|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
44399996|NCT02773368|Liraglutide|liraglutide|mesh-list
44399997|NCT02773368|Xultophy|xultophy|mesh-list
44399998|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44399999|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400000|NCT02773368|Incretins|incretins|mesh-ancestor
44400001|NCT02773368|Hormones|hormones|mesh-ancestor
44400002|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400003|NCT02772978|Tolcapone|tolcapone|mesh-list
44400004|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44400005|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44400006|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44400007|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400008|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400009|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44400010|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
44400011|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400012|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44400013|NCT02770820|Aldesleukin|aldesleukin|mesh-list
44400014|NCT02770820|Interleukin-2|interleukin-2|mesh-list
44400023|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
44400024|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400025|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
44400026|NCT02770612|Narcotics|narcotics|mesh-ancestor
44400027|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400028|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400029|NCT02770612|Analgesics|analgesics|mesh-ancestor
44400030|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
44400031|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400032|NCT02770391|Leuprolide|leuprolide|mesh-list
44400033|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44400034|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
44400035|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44400036|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400037|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400038|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400039|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44400040|NCT02770248|Brinzolamide|brinzolamide|mesh-list
44400041|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400042|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44400043|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43786977|NCT04450498|Vaccines|vaccines|mesh-list
44400044|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400045|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400046|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400047|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400048|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400049|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44400050|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400051|NCT02769624|Treprostinil|treprostinil|mesh-list
44400052|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400053|NCT02769481|Glimepiride|glimepiride|mesh-list
44400054|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
44400055|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400056|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44161077|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161078|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161079|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161080|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161081|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161082|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
44400057|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400058|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400060|NCT02769247|Naproxen|naproxen|mesh-list
44400061|NCT02769247|Lidocaine|lidocaine|mesh-list
44400062|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
44400063|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
44400064|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400065|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400066|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
44400067|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400068|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400069|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44400070|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44400071|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43701796|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44161083|NCT00244153|Dexamethasone|dexamethasone|mesh-list
44161084|NCT00244153|Morphine|morphine|mesh-list
44161085|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161086|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
44161087|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
44161088|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161089|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161090|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161091|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
44161092|NCT00244153|Hormones|hormones|mesh-ancestor
44161093|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161094|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161106|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161107|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161108|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161109|NCT00244179|Interferons|interferons|mesh-list
44161110|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
44161111|NCT00244179|Infliximab|infliximab|mesh-list
44161112|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161113|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
44161114|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161115|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
44161116|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161117|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161118|NCT00244192|Infliximab|infliximab|mesh-list
44161119|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
43600967|NCT03268733|Folic Acid|folic acid|mesh-list
44161120|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161121|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161123|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44161124|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44161125|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
44161126|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
44161127|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161128|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161129|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44161130|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44161131|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44161132|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161133|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161134|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161135|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161136|NCT00244296|Analgesics|analgesics|mesh-ancestor
44400072|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400073|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44400074|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400075|NCT02769247|Analgesics|analgesics|mesh-ancestor
44400076|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400077|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400078|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
44400079|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44400080|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400081|NCT02769065|Donepezil|donepezil|mesh-list
44400082|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44400083|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400084|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400085|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
44400086|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400087|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400088|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
44400089|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
44400090|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400091|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400092|NCT02768298|Enalapril|enalapril|mesh-list
44400093|NCT02768298|Enalaprilat|enalaprilat|mesh-list
44400094|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43786981|NCT04425174|Anesthetics|anesthetics|mesh-list
43786982|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786983|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786984|NCT04418479|Aspirin|aspirin|mesh-list
43786985|NCT04418479|Clopidogrel|clopidogrel|mesh-list
44400095|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44400096|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
44400097|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161137|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
44161138|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161139|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
44161140|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161141|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
44161142|NCT00244309|Tamsulosin|tamsulosin|mesh-list
44161143|NCT00244309|Dutasteride|dutasteride|mesh-list
44161144|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44161145|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44161146|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44161147|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
44161148|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161149|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161150|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161151|NCT00244309|Urological Agents|urological agents|mesh-ancestor
44161152|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44161153|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44161154|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161155|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
44161156|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161157|NCT00244348|Fluorouracil|fluorouracil|mesh-list
44400098|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400099|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400100|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44400101|NCT02768194|Fluorides|fluorides|mesh-list
44400102|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
44400103|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
44400104|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
44400105|NCT02768194|Protective Agents|protective agents|mesh-ancestor
44400106|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400107|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
44400108|NCT02767765|Hematinics|hematinics|mesh-ancestor
44400109|NCT02766777|Lubiprostone|lubiprostone|mesh-list
44400110|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44400111|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400112|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400113|NCT02766608|Budesonide|budesonide|mesh-list
44400114|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
44400115|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44400116|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400117|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44400118|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
44400119|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400120|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400121|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44400122|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44161158|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
44161159|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
44161160|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161161|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44161162|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161163|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161164|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
44161165|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161166|NCT00244361|Rituximab|rituximab|mesh-list
44161167|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44161168|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161169|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
44161170|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161171|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161172|NCT00244426|Aspirin|aspirin|mesh-list
44161173|NCT00244426|Indobufen|indobufen|mesh-list
43787031|NCT04014803|Analgesics|analgesics|mesh-ancestor
44161174|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161175|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161176|NCT00244426|Analgesics|analgesics|mesh-ancestor
44161177|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
44161178|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161179|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161180|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161181|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400124|NCT02766608|Hormones|hormones|mesh-ancestor
44400125|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400126|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44400127|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44400128|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400129|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400130|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400131|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400132|NCT02766478|Genistein|genistein|mesh-list
44400133|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44400134|NCT02766478|Protective Agents|protective agents|mesh-ancestor
44400135|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400136|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400137|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44400138|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400139|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400140|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
44400141|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44400142|NCT02766478|Estrogens|estrogens|mesh-ancestor
44400143|NCT02766478|Hormones|hormones|mesh-ancestor
44400144|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400145|NCT02766023|Metronidazole|metronidazole|mesh-list
44400146|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400147|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400148|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44400149|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44400150|NCT02765490|Simeprevir|simeprevir|mesh-list
44400151|NCT02765490|Odalasvir|odalasvir|mesh-list
44400152|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
44400153|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400154|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
44400155|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400156|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400157|NCT02765399|Liraglutide|liraglutide|mesh-list
44400158|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44161182|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44161183|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44161184|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400159|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400160|NCT02765399|Incretins|incretins|mesh-ancestor
44400161|NCT02765399|Hormones|hormones|mesh-ancestor
44400162|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400163|NCT02765165|Lomustine|lomustine|mesh-list
44400164|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44400165|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
44400166|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400167|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400168|NCT02765100|Minocycline|minocycline|mesh-list
44400169|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400170|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400171|NCT02764762|Adalimumab|adalimumab|mesh-list
44400172|NCT02764762|Methotrexate|methotrexate|mesh-list
44400173|NCT02764762|Vedolizumab|vedolizumab|mesh-list
44400174|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44400175|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
44400176|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44400177|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400178|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44400179|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
44400180|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400181|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400182|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
44400183|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400184|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44400185|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400186|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
44400187|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400188|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44400189|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400190|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400191|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44400192|NCT02764697|Hormones|hormones|mesh-ancestor
44400193|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400196|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400197|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400198|NCT02763566|Letrozole|letrozole|mesh-list
44400199|NCT02763566|Fulvestrant|fulvestrant|mesh-list
44400200|NCT02763566|Anastrozole|anastrozole|mesh-list
44400201|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400202|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44400203|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44400204|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400205|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400206|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44400207|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
44400208|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400209|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400210|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400211|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44400212|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44400213|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
44400214|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400215|NCT02762578|Insulin|insulin|mesh-list
44400216|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44400217|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
44400218|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
44400219|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44400220|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
44400221|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44400222|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400223|NCT02762370|Triamcinolone|triamcinolone|mesh-list
44400224|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44400225|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44400226|NCT02762370|FX006|fx006|mesh-list
44400227|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44400228|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400229|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
44400230|NCT02762370|Hormones|hormones|mesh-ancestor
44400236|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400237|NCT02761980|Acetaminophen|acetaminophen|mesh-list
44400238|NCT02761980|Ibuprofen|ibuprofen|mesh-list
44400239|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400240|NCT02761980|Analgesics|analgesics|mesh-ancestor
44400241|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
44400242|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400243|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400244|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
44400245|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44400246|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400247|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400248|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44400249|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400250|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400251|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
44400252|NCT02761915|Fludarabine|fludarabine|mesh-list
44400253|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400254|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
44400255|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400256|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400257|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44400258|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
44400259|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43701925|NCT02721433|Denosumab|denosumab|mesh-list
44161185|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44161186|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44161187|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161188|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
44161189|NCT00244439|Permethrin|permethrin|mesh-list
44161190|NCT00244439|Malathion|malathion|mesh-list
44161191|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161192|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161193|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43601100|NCT03267316|Gemcitabine|gemcitabine|mesh-list
44161194|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
44161195|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161196|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161198|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44161199|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
44161200|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161201|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161202|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
44161203|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161204|NCT00244504|Moxonidine|moxonidine|mesh-list
44161205|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44161206|NCT00244517|Remifentanil|remifentanil|mesh-list
44161207|NCT00244517|Sevoflurane|sevoflurane|mesh-list
44161208|NCT00244517|Desflurane|desflurane|mesh-list
44400260|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400261|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44400262|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
44400263|NCT02761642|Hematinics|hematinics|mesh-ancestor
44400264|NCT02761629|Interferons|interferons|mesh-list
44400265|NCT02761629|Ribavirin|ribavirin|mesh-list
44400266|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
44400267|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
44400268|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44400269|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400270|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
44400271|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400272|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
44400273|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400274|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
44400275|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400276|NCT02761330|Ketamine|ketamine|mesh-list
44400277|NCT02761330|Analgesics|analgesics|mesh-ancestor
44400278|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
44400279|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400280|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400281|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44400282|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44400283|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
44400284|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
44400285|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400286|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44400287|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44400288|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400290|NCT02761057|Sunitinib|sunitinib|mesh-list
44400307|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400308|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400309|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400310|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
44400311|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
44400312|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44400313|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
44400314|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400315|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400316|NCT02760069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44400317|NCT02760069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44400318|NCT02760069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400319|NCT02760069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44400320|NCT02760069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44400321|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
44400322|NCT02759315|Ruzasvir|ruzasvir|mesh-list
44400323|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
44400324|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400325|NCT02759185|Dronabinol|dronabinol|mesh-list
44400326|NCT02759185|Cannabidiol|cannabidiol|mesh-list
44400327|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
44400328|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
44400329|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400330|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161209|NCT00244517|Isoflurane|isoflurane|mesh-list
44161210|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
44161211|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161212|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161213|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44161214|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44161215|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
44161216|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44161217|NCT00244517|Narcotics|narcotics|mesh-ancestor
44161218|NCT00244517|Analgesics|analgesics|mesh-ancestor
44161219|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
44161220|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161221|NCT00244530|Nifedipine|nifedipine|mesh-list
44161222|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44161223|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161224|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161225|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44161226|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161227|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
44161228|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
44161229|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161230|NCT00244556|Etanercept|etanercept|mesh-list
44161231|NCT00244556|Methotrexate|methotrexate|mesh-list
44161232|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44161233|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
44161238|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161239|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161240|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44400332|NCT02759185|Analgesics|analgesics|mesh-ancestor
44400333|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
44400334|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400335|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44400336|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44400337|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400338|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400339|NCT02759185|Hormones|hormones|mesh-ancestor
44400340|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400341|NCT02759120|Doxycycline|doxycycline|mesh-list
44400342|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44400343|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44400344|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
44400345|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
44400346|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44161241|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161242|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44161243|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161244|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
44161245|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787069|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44161246|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44161247|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161248|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161250|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
44161251|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161252|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161253|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161254|NCT00244608|Budesonide|budesonide|mesh-list
44161255|NCT00244608|Terbutaline|terbutaline|mesh-list
44161256|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
44161257|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161258|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44161259|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
44161260|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161261|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161262|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44161263|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44161264|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
44161265|NCT00244608|Hormones|hormones|mesh-ancestor
44161266|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161267|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44161268|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44161269|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44161270|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
44161271|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161272|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161273|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
44161274|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
44161275|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161276|NCT00244738|Castor Oil|castor oil|mesh-list
44161277|NCT00244738|Cathartics|cathartics|mesh-ancestor
44161278|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161279|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
44161280|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161281|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161282|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400347|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44400348|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44400349|NCT02759120|Renal Agents|renal agents|mesh-ancestor
44400350|NCT02759016|BI 836826|bi 836826|mesh-list
44400351|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400352|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400353|NCT02758171|Empagliflozin|empagliflozin|mesh-list
44400354|NCT02758171|Linagliptin|linagliptin|mesh-list
44400355|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44400356|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400357|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44400358|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400359|NCT02758171|Incretins|incretins|mesh-ancestor
44400360|NCT02758171|Hormones|hormones|mesh-ancestor
44400361|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400362|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44400363|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
44400364|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400365|NCT02757768|Tamsulosin|tamsulosin|mesh-list
44400366|NCT02757768|Mirabegron|mirabegron|mesh-list
44400367|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44400368|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44400369|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44400370|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400371|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400372|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161283|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161284|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
44161285|NCT00244907|Genistein|genistein|mesh-list
44161286|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44161288|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161289|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44161290|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161291|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44161292|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44161293|NCT00244907|Protective Agents|protective agents|mesh-ancestor
44161294|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161295|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161296|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161297|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
44161298|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44161299|NCT00244907|Estrogens|estrogens|mesh-ancestor
44161300|NCT00244907|Hormones|hormones|mesh-ancestor
44161301|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161302|NCT00244920|Squalamine|squalamine|mesh-list
44161303|NCT00244920|Leuprolide|leuprolide|mesh-list
44161304|NCT00244920|Bicalutamide|bicalutamide|mesh-list
44163851|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
44400373|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400374|NCT02757768|Urological Agents|urological agents|mesh-ancestor
44400375|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44400376|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44400377|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400378|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
44400379|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44400380|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400381|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400382|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400383|NCT02757625|Analgesics|analgesics|mesh-ancestor
44400384|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
44400385|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400386|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44400387|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44400388|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400389|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400390|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400391|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400392|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
44400393|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44400394|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
44400395|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
44400396|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400399|NCT02757521|Analgesics|analgesics|mesh-ancestor
44400421|NCT02756403|Metronidazole|metronidazole|mesh-list
44400422|NCT02756403|Doxycycline|doxycycline|mesh-list
44400423|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400424|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400425|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44400426|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44400427|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
44400428|NCT02756364|Fulvestrant|fulvestrant|mesh-list
44400429|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400430|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400431|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44400432|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44400433|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
44400434|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400435|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400436|NCT02755818|Heparin|heparin|mesh-list
44400437|NCT02755818|Calcium heparin|calcium heparin|mesh-list
44400438|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
44400439|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44400440|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44400441|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400442|NCT02755116|Olanzapine|olanzapine|mesh-list
44400443|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
44400444|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
44400445|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400446|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400447|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400448|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44400449|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44400450|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400451|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787071|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787072|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
44400452|NCT02755116|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44400464|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400465|NCT02755090|Analgesics|analgesics|mesh-ancestor
44400466|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
44400467|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400468|NCT02753946|Tazobactam|tazobactam|mesh-list
44400469|NCT02753946|Piperacillin|piperacillin|mesh-list
44400470|NCT02753946|Fosfomycin|fosfomycin|mesh-list
44400471|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44400472|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400473|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400474|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44400475|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400476|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400477|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
44400478|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44400479|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44400480|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400481|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
44400482|NCT02753816|Coagulants|coagulants|mesh-ancestor
44400483|NCT02753127|Leucovorin|leucovorin|mesh-list
44400484|NCT02753127|Bevacizumab|bevacizumab|mesh-list
44400485|NCT02753127|Fluorouracil|fluorouracil|mesh-list
44400486|NCT02753127|Irinotecan|irinotecan|mesh-list
44400487|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400488|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400489|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44400490|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44400491|NCT02753127|Growth Substances|growth substances|mesh-ancestor
44400492|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400493|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
44400494|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
43702076|NCT02720601|Irinotecan|irinotecan|mesh-list
44161307|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161308|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161309|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44161310|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
44161311|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161312|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161313|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161314|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
44161315|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161316|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161317|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44161318|NCT00244920|Protective Agents|protective agents|mesh-ancestor
44400495|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400496|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44400497|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400498|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
44400499|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44400500|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44400501|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400502|NCT02753127|Antidotes|antidotes|mesh-ancestor
44400503|NCT02753127|Protective Agents|protective agents|mesh-ancestor
44400504|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
44400505|NCT02753127|Vitamins|vitamins|mesh-ancestor
44400506|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
44400507|NCT02753075|Fluorides|fluorides|mesh-list
44400508|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
44400509|NCT02753075|Protective Agents|protective agents|mesh-ancestor
44400510|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400511|NCT02752958|Fluorides|fluorides|mesh-list
44400512|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
44400513|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
44400514|NCT02752958|Protective Agents|protective agents|mesh-ancestor
44400515|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400516|NCT02752906|Vaccines|vaccines|mesh-list
44400517|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
44400518|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400519|NCT02752633|Allopurinol|allopurinol|mesh-list
44400520|NCT02752633|Febuxostat|febuxostat|mesh-list
44400521|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
44400522|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400523|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400524|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
44400525|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400526|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44400527|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
44400528|NCT02752633|Protective Agents|protective agents|mesh-ancestor
44400529|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400530|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
44400531|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400536|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400537|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400538|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400539|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400540|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400541|NCT02751931|Urological Agents|urological agents|mesh-ancestor
44400542|NCT02751450|Fluorides|fluorides|mesh-list
44400543|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
44400544|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
44400545|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
44400546|NCT02751450|Protective Agents|protective agents|mesh-ancestor
44400547|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400548|NCT02751359|Cannabidiol|cannabidiol|mesh-list
44400549|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
44400550|NCT02751320|Citric Acid|citric acid|mesh-list
44400551|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
44400552|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
44400553|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44400554|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
44400555|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
44400556|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400557|NCT02750943|Fluorides|fluorides|mesh-list
44400558|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
44400559|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
44400560|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
44400561|NCT02750943|Protective Agents|protective agents|mesh-ancestor
44400562|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400563|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
44400564|NCT02750930|Incretins|incretins|mesh-ancestor
44400565|NCT02750930|Hormones|hormones|mesh-ancestor
44400566|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400567|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400568|NCT02750800|Adalimumab|adalimumab|mesh-list
44400569|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400570|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400572|NCT02750761|Tedizolid|tedizolid|mesh-list
44400580|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400581|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400582|NCT02750514|Nivolumab|nivolumab|mesh-list
44400583|NCT02750514|Ipilimumab|ipilimumab|mesh-list
44400584|NCT02750514|Dasatinib|dasatinib|mesh-list
44400585|NCT02750514|Linrodostat|linrodostat|mesh-list
44400586|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400587|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400588|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44400589|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400590|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44400591|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400592|NCT02750410|Dulaglutide|dulaglutide|mesh-list
44400593|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44400594|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400595|NCT02750345|Nitisinone|nitisinone|mesh-list
44400596|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400597|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400598|NCT02750332|Nitisinone|nitisinone|mesh-list
44400599|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400600|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400601|NCT02750306|Suvorexant|suvorexant|mesh-list
44400602|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44161319|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44161320|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44161321|NCT00244920|Growth Substances|growth substances|mesh-ancestor
44161322|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44161323|NCT00244946|Cytarabine|cytarabine|mesh-list
44161324|NCT00244946|Etoposide|etoposide|mesh-list
44161325|NCT00244946|Melphalan|melphalan|mesh-list
44161326|NCT00244946|Carmustine|carmustine|mesh-list
44161327|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161328|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161329|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44161330|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44161331|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161332|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161333|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44161334|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
44161335|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
44161336|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161337|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161338|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
44161339|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161340|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161341|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
44161342|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44161343|NCT00244959|Anastrozole|anastrozole|mesh-list
44161344|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161345|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161346|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44400603|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44400604|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400605|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400606|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44400607|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400608|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400610|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
44400611|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44400612|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
44400613|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44400614|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400615|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
44400616|NCT02749799|Hormones|hormones|mesh-ancestor
44400617|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43702181|NCT02719431|Warfarin|warfarin|mesh-list
44161347|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44161348|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161349|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161350|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44161351|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
44161352|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161353|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161356|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161357|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161358|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161359|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161360|NCT00244998|Fulvestrant|fulvestrant|mesh-list
44161361|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161362|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161363|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44161364|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44161365|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
44161366|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161367|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161368|NCT00245024|Sulindac|sulindac|mesh-list
44161369|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161370|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161371|NCT00245024|Analgesics|analgesics|mesh-ancestor
44161372|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
44161373|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161374|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161375|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161376|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161377|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161378|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44161401|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161402|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44161403|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
44161405|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161406|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
44161407|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161408|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161409|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161410|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
44400618|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400619|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44400620|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44400621|NCT02749721|Vortioxetine|vortioxetine|mesh-list
44400622|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
44400623|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44400624|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44400625|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44400626|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400627|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400628|NCT02749721|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44400629|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44400630|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400631|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400632|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400633|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
44400634|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44400635|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44400636|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44400637|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44400638|NCT02749370|Etanercept|etanercept|mesh-list
44400639|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44400640|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44400641|NCT02749370|Analgesics|analgesics|mesh-ancestor
44400642|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
44400643|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400644|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400665|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
44400666|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400667|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44400668|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
44400669|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400670|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44400672|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44400673|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44400674|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
44400675|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400676|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44400677|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44400678|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400679|NCT02747875|Fentanyl|fentanyl|mesh-list
44400680|NCT02747875|Methadone|methadone|mesh-list
44400681|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44400682|NCT02747875|Narcotics|narcotics|mesh-ancestor
44400683|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400684|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400685|NCT02747875|Analgesics|analgesics|mesh-ancestor
44400686|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
44400687|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400688|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44400689|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44400690|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
44400691|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
44400692|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
44400693|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44161411|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161412|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161413|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44161414|NCT00245141|Dactinomycin|dactinomycin|mesh-list
44161415|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
44161416|NCT00245141|Vincristine|vincristine|mesh-list
44161417|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161418|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
44161419|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161420|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400695|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400696|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400697|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
44400698|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400699|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400700|NCT02747004|Tamoxifen|tamoxifen|mesh-list
44400701|NCT02747004|Loperamide|loperamide|mesh-list
44400702|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
44400703|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44400704|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44400705|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400706|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400707|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400708|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400709|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44400710|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44400711|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44400712|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400713|NCT02746575|Metoprolol|metoprolol|mesh-list
44400714|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400715|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400716|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
44400717|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
44400718|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400719|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161421|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161422|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
44161423|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161424|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161425|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44161426|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161427|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161428|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161439|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161440|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161441|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161442|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161443|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
44161444|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161445|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161446|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161447|NCT00245206|Olanzapine|olanzapine|mesh-list
44161448|NCT00245206|Risperidone|risperidone|mesh-list
44161449|NCT00245206|Aripiprazole|aripiprazole|mesh-list
44161450|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44161451|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
44161452|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161453|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400720|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44400721|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44400722|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44400724|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400725|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400726|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
44400727|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44400728|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44400729|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
43602427|NCT03254511|Enoxaparin|enoxaparin|mesh-list
44400730|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400731|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400732|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400733|NCT02745080|Adalimumab|adalimumab|mesh-list
44400734|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400735|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400736|NCT02744898|Paclitaxel|paclitaxel|mesh-list
44400737|NCT02744898|Carboplatin|carboplatin|mesh-list
44400738|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44400739|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44400740|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400741|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
44400742|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
44400743|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
44400744|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400745|NCT02744755|Adalimumab|adalimumab|mesh-list
44400746|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400747|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44400748|NCT02744391|Levodopa|levodopa|mesh-list
44400749|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44400750|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44400751|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
44400752|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161454|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161455|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161456|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161457|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161458|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161459|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161460|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
44161461|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
44400753|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400754|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400755|NCT02743949|Esomeprazole|esomeprazole|mesh-list
44400756|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44400757|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44058362|NCT00005607|Vitamins|vitamins|mesh-ancestor
44400758|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44400759|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400760|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400761|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
44400762|NCT02743819|Ipilimumab|ipilimumab|mesh-list
44400763|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400764|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400765|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44400766|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400767|NCT02743780|MGV354|mgv354|mesh-list
44400768|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
44400769|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400770|NCT02743221|Trifluridine|trifluridine|mesh-list
44161462|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
44161463|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161464|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161465|NCT00245206|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44161466|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44161467|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161468|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
44161469|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
44161470|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44161471|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44161472|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44161473|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44161474|NCT00245245|Factor VIII|factor viii|mesh-list
44161475|NCT00245245|Coagulants|coagulants|mesh-ancestor
43840529|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
44161476|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
44161477|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161478|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
44161479|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44161480|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44161481|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161482|NCT00245258|Urological Agents|urological agents|mesh-ancestor
44161483|NCT00245297|Factor VIII|factor viii|mesh-list
44161484|NCT00245297|Coagulants|coagulants|mesh-ancestor
44161485|NCT00245336|Thrombin|thrombin|mesh-list
44161486|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
44161487|NCT00245336|Coagulants|coagulants|mesh-ancestor
44161488|NCT00245375|Acetaminophen|acetaminophen|mesh-list
44161489|NCT00245375|Ibuprofen|ibuprofen|mesh-list
44161490|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161491|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161492|NCT00245375|Analgesics|analgesics|mesh-ancestor
44161493|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
44161494|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165318|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
44161496|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161497|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161498|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44400771|NCT02743221|Bevacizumab|bevacizumab|mesh-list
44400772|NCT02743221|Capecitabine|capecitabine|mesh-list
44400773|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400774|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400775|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44400776|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44400777|NCT02743221|Growth Substances|growth substances|mesh-ancestor
44400778|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400779|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
44400780|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43702254|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
44161499|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161500|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161501|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
44161502|NCT00245401|Sirolimus|sirolimus|mesh-list
44161503|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161504|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161505|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44161506|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161507|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
44161508|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161509|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
44161510|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161511|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44161512|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
44161513|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
44161514|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161515|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
44161516|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161517|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44161518|NCT00245427|Lactams|lactams|mesh-list
44161519|NCT00245427|beta-Lactams|beta-lactams|mesh-list
44161520|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44161521|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161522|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
44161523|NCT00245440|Azithromycin|azithromycin|mesh-list
44161524|NCT00245440|Telithromycin|telithromycin|mesh-list
44161525|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161526|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161527|NCT00245453|Azithromycin|azithromycin|mesh-list
44161528|NCT00245453|Clarithromycin|clarithromycin|mesh-list
44161529|NCT00245453|Telithromycin|telithromycin|mesh-list
44161530|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161531|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161532|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44161533|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161534|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161535|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44161536|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44161537|NCT00245505|Mesalamine|mesalamine|mesh-list
44161538|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161539|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43602637|NCT03251690|Efavirenz|efavirenz|mesh-list
44161540|NCT00245505|Analgesics|analgesics|mesh-ancestor
44161541|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
44161542|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161543|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161544|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161545|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161546|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
44161547|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
44161548|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44161549|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44161550|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161551|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161552|NCT00245596|Urological Agents|urological agents|mesh-ancestor
44400781|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
44400782|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400783|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
44400784|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400785|NCT02742649|Timolol|timolol|mesh-list
44400786|NCT02742649|Bimatoprost|bimatoprost|mesh-list
44400787|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44400788|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44400789|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400790|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400791|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400792|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400793|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400794|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400795|NCT02742519|Ivacaftor|ivacaftor|mesh-list
44400796|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44400797|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400798|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400799|NCT02742181|Alvimopan|alvimopan|mesh-list
44400800|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44400801|NCT02741713|Lidocaine|lidocaine|mesh-list
44400802|NCT02741713|Clonidine|clonidine|mesh-list
44400803|NCT02741713|Epinephrine|epinephrine|mesh-list
44400804|NCT02741713|Racepinephrine|racepinephrine|mesh-list
44400805|NCT02741713|Bupivacaine|bupivacaine|mesh-list
44400806|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43702259|NCT02718677|Factor VIII|factor viii|mesh-list
44161553|NCT00245609|Pregabalin|pregabalin|mesh-list
44161554|NCT00245609|Alprazolam|alprazolam|mesh-list
44161555|NCT00245609|Analgesics|analgesics|mesh-ancestor
44161556|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
44161557|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161558|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161559|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
44161560|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44161561|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161562|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161563|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44161564|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44161565|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161566|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161567|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161568|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44161569|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
44161578|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161579|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
44161580|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
44161581|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161582|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161583|NCT00245674|Amisulpride|amisulpride|mesh-list
44400807|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
44400808|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
44400809|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
44400810|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400811|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400812|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
44400813|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400814|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400815|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44400816|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44400817|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400818|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400819|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44400820|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400821|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
44400822|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400823|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44400824|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44400825|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
44400826|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44400827|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
44400828|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
44400829|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
44161584|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161585|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161586|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161587|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161588|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161589|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161590|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
44161591|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161592|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161593|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44161594|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
44161595|NCT00245713|Levetiracetam|levetiracetam|mesh-list
44161596|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
44161597|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
44161598|NCT00245739|Darunavir|darunavir|mesh-list
44161599|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44161600|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44161601|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
44161602|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161603|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161604|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44161605|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44161606|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
44161607|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161608|NCT00245791|Levofloxacin|levofloxacin|mesh-list
44161609|NCT00245791|Ofloxacin|ofloxacin|mesh-list
44161610|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44161611|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400831|NCT02741713|Analgesics|analgesics|mesh-ancestor
44400832|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44400833|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
44400834|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44400835|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44400836|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
44400837|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400838|NCT02741570|Cisplatin|cisplatin|mesh-list
44400839|NCT02741570|Carboplatin|carboplatin|mesh-list
44400840|NCT02741570|Fluorouracil|fluorouracil|mesh-list
44400841|NCT02741570|Nivolumab|nivolumab|mesh-list
44400842|NCT02741570|Cetuximab|cetuximab|mesh-list
44400843|NCT02741570|Ipilimumab|ipilimumab|mesh-list
44400844|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400845|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
44400846|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400847|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44400848|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44400849|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
44400850|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400851|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44400852|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44400853|NCT02741310|Sumatriptan|sumatriptan|mesh-list
44400854|NCT02741310|Erenumab|erenumab|mesh-list
44161612|NCT00245791|Renal Agents|renal agents|mesh-ancestor
44161613|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161614|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44161615|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44161616|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161617|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161618|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161619|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44161620|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44161621|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
44161622|NCT00245895|Hematinics|hematinics|mesh-ancestor
44161623|NCT00245908|Azithromycin|azithromycin|mesh-list
44161624|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161625|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161626|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
44161627|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44161628|NCT00245921|Estradiol|estradiol|mesh-list
44161629|NCT00245921|Estrogens|estrogens|mesh-ancestor
44161630|NCT00245921|Hormones|hormones|mesh-ancestor
44161631|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161632|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161633|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44161634|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
44161635|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44161636|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44161637|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44161640|NCT00245934|Etanercept|etanercept|mesh-list
44400856|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44400857|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44400858|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
44400859|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400860|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400861|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400862|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44400863|NCT02741310|Analgesics|analgesics|mesh-ancestor
44400864|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
44400865|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400866|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
44400867|NCT02741271|Prednisone|prednisone|mesh-list
44400868|NCT02741271|Prednisolone|prednisolone|mesh-list
44400869|NCT02741271|Albuterol|albuterol|mesh-list
44400870|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44400871|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
44400872|NCT02741271|Hormones|hormones|mesh-ancestor
44400873|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400874|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400875|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44400876|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400877|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
44400878|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400879|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44400880|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44400881|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
44400882|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
44400883|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44400884|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44400886|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44400897|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400898|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44400899|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44400900|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400901|NCT02741076|Oxymorphone|oxymorphone|mesh-list
44400903|NCT02741076|Oxycodone|oxycodone|mesh-list
44400904|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
44400905|NCT02741076|Narcotics|narcotics|mesh-ancestor
44400906|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400907|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400908|NCT02741076|Analgesics|analgesics|mesh-ancestor
44400909|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
44400910|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43734414|NCT02540070|Ketorolac|ketorolac|mesh-list
43787107|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44400911|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44400912|NCT02739997|Metronidazole|metronidazole|mesh-list
44400913|NCT02739997|Tazobactam|tazobactam|mesh-list
44400914|NCT02739997|Ceftolozane|ceftolozane|mesh-list
44400915|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400916|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44400917|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44400918|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44400919|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44400920|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400921|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400922|NCT02739984|Evolocumab|evolocumab|mesh-list
44400923|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44400924|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44400925|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44400926|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
44400927|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400928|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44400929|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
44400930|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400931|NCT02739828|Adalimumab|adalimumab|mesh-list
44400938|NCT02739360|Idelalisib|idelalisib|mesh-list
44400939|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44400940|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400941|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400942|NCT02738879|Metformin|metformin|mesh-list
44400943|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
44400944|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44400945|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44400946|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400947|NCT02738879|Incretins|incretins|mesh-ancestor
44400948|NCT02738879|Hormones|hormones|mesh-ancestor
44400949|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400950|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44400951|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
44400952|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400953|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400954|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44400955|NCT02738580|Hormones|hormones|mesh-ancestor
44400956|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44400957|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400958|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
44400959|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
44400960|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400961|NCT02738203|Lidocaine|lidocaine|mesh-list
44400962|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
44400963|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
44400964|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44400965|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161641|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161642|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161643|NCT00245934|Analgesics|analgesics|mesh-ancestor
44161644|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
44161645|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161646|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161647|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161648|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161649|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161650|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161651|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
44161653|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
44161654|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161655|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161656|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
44161657|NCT00246103|Fluorouracil|fluorouracil|mesh-list
43654016|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654017|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161658|NCT00246103|Epirubicin|epirubicin|mesh-list
44161659|NCT00246103|Valproic Acid|valproic acid|mesh-list
44161660|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44161661|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
44400966|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
44400967|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44400968|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44400969|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44400970|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44400971|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44400972|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400973|NCT02738151|Insulin|insulin|mesh-list
44400974|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44400975|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
44400976|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44400977|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44058589|NCT00005642|Semaxinib|semaxinib|mesh-list
44400978|NCT02738008|Tenofovir|tenofovir|mesh-list
44400979|NCT02738008|Entecavir|entecavir|mesh-list
44400980|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
44400981|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44400982|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
44400983|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44400984|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44400985|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44400986|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44400987|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44400988|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44400989|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44400990|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
44400991|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44400992|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44400993|NCT02737930|Fluoxetine|fluoxetine|mesh-list
44400994|NCT02737930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44400995|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44400996|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161662|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161663|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161664|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44161665|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
44161666|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161667|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161668|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44161669|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
44161670|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44400999|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
44401000|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401001|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44401002|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401003|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401004|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44401005|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401006|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401007|NCT02737501|Crizotinib|crizotinib|mesh-list
44401008|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401009|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44401010|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161671|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44161672|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44161673|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44161674|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161675|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
44161676|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
44161677|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161678|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
44161679|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161680|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161681|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161682|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
44161683|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44161684|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44161685|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44161686|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161687|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161688|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
44161689|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161690|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161691|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43601622|NCT03262740|Estradiol|estradiol|mesh-list
44161692|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161693|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
44161694|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44161695|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44161696|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44161697|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161698|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161699|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44161700|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161701|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161702|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44161703|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161704|NCT00246168|Acetaminophen|acetaminophen|mesh-list
44161705|NCT00246168|Tramadol|tramadol|mesh-list
44161706|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161707|NCT00246168|Analgesics|analgesics|mesh-ancestor
44161708|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
44161709|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161710|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161711|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
44161718|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401011|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401012|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
44401013|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44401014|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
44401015|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401016|NCT02737358|Expectorants|expectorants|mesh-ancestor
44401017|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401018|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44401019|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
44401020|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401021|NCT02737358|Protective Agents|protective agents|mesh-ancestor
44401022|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401023|NCT02737358|Antidotes|antidotes|mesh-ancestor
44401024|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
44401025|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44401026|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44161719|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161720|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161721|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161722|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161723|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161724|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161725|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161726|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
44161727|NCT00246207|Methylphenidate|methylphenidate|mesh-list
44161728|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44161729|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161730|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44161731|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44161732|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161733|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161734|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
44161735|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161736|NCT00246220|Methylphenidate|methylphenidate|mesh-list
44161737|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44161738|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787114|NCT03463408|Nivolumab|nivolumab|mesh-list
44161739|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44161740|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44161741|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161742|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161743|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
44161744|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161745|NCT00246233|Methylphenidate|methylphenidate|mesh-list
44161746|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44161747|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161748|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44161749|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44161750|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44161751|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161752|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
44161753|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161754|NCT00246246|Risperidone|risperidone|mesh-list
44161755|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44161756|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
44161757|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161758|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401027|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44401028|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401029|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401030|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
44401031|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401032|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401033|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44401034|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401035|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44401036|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
44401037|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401039|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401040|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401041|NCT02736474|Naltrexone|naltrexone|mesh-list
44401042|NCT02736474|Bupropion|bupropion|mesh-list
44401043|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44401044|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44401045|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401046|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
44401047|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401048|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44401049|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401050|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161759|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161760|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161761|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161762|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161763|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161764|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161765|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
44161766|NCT00246272|Risperidone|risperidone|mesh-list
44161767|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44161768|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
44161769|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161770|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161771|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161772|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44161773|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161774|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161775|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161776|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161777|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
44161778|NCT00246285|Risperidone|risperidone|mesh-list
44161787|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161788|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44161789|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
43603496|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
44161790|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
44161791|NCT00246298|Hematinics|hematinics|mesh-ancestor
44161792|NCT00246363|Silymarin|silymarin|mesh-list
44161793|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
44058667|NCT00005652|Rituximab|rituximab|mesh-list
44401052|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401053|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401054|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401055|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
44401056|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401057|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44401058|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401059|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401060|NCT02736409|Budesonide|budesonide|mesh-list
44401061|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401062|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44401063|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
44401064|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401065|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401066|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44401067|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401068|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
44401069|NCT02736409|Hormones|hormones|mesh-ancestor
44401070|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401071|NCT02735577|Disulfiram|disulfiram|mesh-list
44401072|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44401073|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44401074|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401075|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401076|NCT02735200|Vitamin D|vitamin d|mesh-list
44401077|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
44401078|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
44401079|NCT02735200|Vitamins|vitamins|mesh-list
44401080|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
44401084|NCT02734862|Fluconazole|fluconazole|mesh-list
44401092|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401093|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44401094|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
44401095|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401096|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401097|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44401098|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44401100|NCT02732938|Paclitaxel|paclitaxel|mesh-list
44401101|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401102|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401103|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401104|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44401105|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401106|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401107|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401108|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
44401109|NCT02732938|Antiviral Agents|antiviral agents|mesh-ancestor
44401110|NCT02732938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401111|NCT02732938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401112|NCT02732938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401113|NCT02732938|Immunologic Factors|immunologic factors|mesh-ancestor
44401114|NCT02732938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401115|NCT02732912|Zopiclone|zopiclone|mesh-list
44401116|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44401117|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401118|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401119|NCT02732639|Interferons|interferons|mesh-list
44401120|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401121|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
44401122|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401123|NCT02732327|Vancomycin|vancomycin|mesh-list
44401124|NCT02732327|Meropenem|meropenem|mesh-list
44401125|NCT02732327|Tazobactam|tazobactam|mesh-list
44401126|NCT02732327|Linezolid|linezolid|mesh-list
44401127|NCT02732327|Piperacillin|piperacillin|mesh-list
44401128|NCT02732327|Cefepime|cefepime|mesh-list
44161794|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401129|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43603639|NCT03244462|Methotrexate|methotrexate|mesh-list
44401130|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401131|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401132|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44401133|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401134|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401135|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44401136|NCT02732119|Everolimus|everolimus|mesh-list
44401137|NCT02732119|Exemestane|exemestane|mesh-list
44401138|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401139|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401140|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
44401141|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401142|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44401143|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44401144|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401145|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401146|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44401147|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
44401148|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401149|NCT02732015|Dexamethasone|dexamethasone|mesh-list
44401150|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
44401151|NCT02732015|Doxorubicin|doxorubicin|mesh-list
44401152|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44401153|NCT02732015|Vincristine|vincristine|mesh-list
44401154|NCT02732015|Daunorubicin|daunorubicin|mesh-list
44401155|NCT02732015|Ifosfamide|ifosfamide|mesh-list
44401156|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
44401157|NCT02732015|Ondansetron|ondansetron|mesh-list
44401158|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
44401159|NCT02732015|Aprepitant|aprepitant|mesh-list
44161795|NCT00246363|Protective Agents|protective agents|mesh-ancestor
44161796|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161797|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
44161798|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44161799|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44161800|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44161801|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44161802|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161803|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44161804|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161805|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44161806|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161807|NCT00246402|Acipimox|acipimox|mesh-list
44161808|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44401160|NCT02732015|BB 1101|bb 1101|mesh-list
44401161|NCT02732015|Rolapitant|rolapitant|mesh-list
44401162|NCT02732015|Mesna|mesna|mesh-list
44401163|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401164|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
44401165|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
44401166|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401167|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401168|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401169|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
44401170|NCT02732015|Hormones|hormones|mesh-ancestor
44401171|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401172|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44401173|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401174|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
44401175|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401176|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401177|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44401178|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44401179|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44401180|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401181|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401182|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161809|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
43603757|NCT03242993|Folic Acid|folic acid|mesh-list
44161810|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161811|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44161812|NCT00246415|Memantine|memantine|mesh-list
44161813|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44161814|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44161815|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
44161816|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44161817|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161818|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161819|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44161820|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44161821|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44161822|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44161823|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
44161824|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161825|NCT00246467|Antacids|antacids|mesh-ancestor
44161826|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161827|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161828|NCT00246532|Morphine|morphine|mesh-list
44161829|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44161830|NCT00246532|Narcotics|narcotics|mesh-ancestor
44161831|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44161832|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161833|NCT00246532|Analgesics|analgesics|mesh-ancestor
44161834|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
44161835|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161836|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
44161837|NCT00246597|Hematinics|hematinics|mesh-ancestor
44401183|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401184|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
44401185|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
44401186|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401187|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
44401188|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401189|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44401190|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401191|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401192|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401193|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44401194|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44401195|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
44401196|NCT02732015|Protective Agents|protective agents|mesh-ancestor
44401197|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44401198|NCT02731638|Voriconazole|voriconazole|mesh-list
44401199|NCT02731638|Natamycin|natamycin|mesh-list
44401200|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
44401201|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401202|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44058805|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44401203|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401204|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401205|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401231|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44401232|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44401233|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44401234|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44401235|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401236|NCT02730793|Aztreonam|aztreonam|mesh-list
44401237|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401238|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401239|NCT02730455|Natalizumab|natalizumab|mesh-list
44401240|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
44401241|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401242|NCT02730377|Liraglutide|liraglutide|mesh-list
44401243|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44401244|NCT02730377|Meglitinide|meglitinide|mesh-list
44401245|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44401246|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43603902|NCT03242096|Sirolimus|sirolimus|mesh-list
44401247|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44401248|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44401249|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401250|NCT02730377|Incretins|incretins|mesh-ancestor
44401251|NCT02730377|Hormones|hormones|mesh-ancestor
44401252|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401253|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401254|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
44401255|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401256|NCT02730351|Fluticasone|fluticasone|mesh-list
44401257|NCT02730351|Xhance|xhance|mesh-list
44401258|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401259|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44161838|NCT00246610|Nelfinavir|nelfinavir|mesh-list
44161839|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44161840|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44161841|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
43601766|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161842|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161843|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161844|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44161861|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161862|NCT00246688|Sagopilone|sagopilone|mesh-list
44161863|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161864|NCT00246701|Simvastatin|simvastatin|mesh-list
44161865|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44161866|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44161867|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
44161868|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161869|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44401260|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
44401261|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401262|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401263|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44401264|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401265|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
44401266|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44401267|NCT02730208|Ivacaftor|ivacaftor|mesh-list
44401268|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44401269|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401270|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401271|NCT02730195|Pioglitazone|pioglitazone|mesh-list
44401272|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44401273|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401274|NCT02729909|Lubiprostone|lubiprostone|mesh-list
44401275|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44401276|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401277|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401278|NCT02729896|Rituximab|rituximab|mesh-list
44401279|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
44401280|NCT02729896|Atezolizumab|atezolizumab|mesh-list
44401281|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401282|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401283|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
44401284|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401285|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44401286|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
44161870|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44161871|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161872|NCT00246909|Pantoprazole|pantoprazole|mesh-list
44161873|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44161874|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161875|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44161876|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787119|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824945|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43824946|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
44161877|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161878|NCT00246974|Gemcitabine|gemcitabine|mesh-list
44161879|NCT00246974|Cisplatin|cisplatin|mesh-list
44161880|NCT00246974|Gefitinib|gefitinib|mesh-list
44161881|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161882|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44161883|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
44161884|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161885|NCT00246974|Antiviral Agents|antiviral agents|mesh-ancestor
44161886|NCT00246974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161887|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161888|NCT00246974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401288|NCT02729545|Cyproterone|cyproterone|mesh-list
44401289|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44401290|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44401291|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44401292|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
44401293|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44401294|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401295|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44401296|NCT02729545|Estrogens|estrogens|mesh-ancestor
44401297|NCT02729545|Hormones|hormones|mesh-ancestor
44401298|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401299|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
44401300|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
44401301|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401302|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44401303|NCT02729051|Albuterol|albuterol|mesh-list
44401304|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44401305|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
44401306|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401307|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401308|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44401309|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401310|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
44401311|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44401312|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44401313|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44401314|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44401315|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401316|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401317|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401318|NCT02729025|Evolocumab|evolocumab|mesh-list
44401319|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44401320|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44161889|NCT00246974|Immunologic Factors|immunologic factors|mesh-ancestor
44161890|NCT00246974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161891|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161892|NCT00247026|Ubiquinone|ubiquinone|mesh-list
44161893|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
44161894|NCT00247026|Curcumin|curcumin|mesh-list
44401321|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
44401322|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401323|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44401324|NCT02728895|Vedolizumab|vedolizumab|mesh-list
44401325|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401326|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
44401327|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401328|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401330|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44401331|NCT02728206|Velpatasvir|velpatasvir|mesh-list
44401332|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
44401333|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401334|NCT02728089|Tazobactam|tazobactam|mesh-list
44401335|NCT02728089|Ceftolozane|ceftolozane|mesh-list
44401336|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401337|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401338|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43824947|NCT05506410|Hormones|hormones|mesh-ancestor
43787120|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44401339|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401340|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401341|NCT02727660|Budesonide|budesonide|mesh-list
44401342|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
44401343|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401344|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44401345|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
44401346|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401347|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401348|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44401369|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401370|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
44401371|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401372|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401373|NCT02726113|Vitamin D|vitamin d|mesh-list
44401374|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
44401375|NCT02726113|Vitamins|vitamins|mesh-ancestor
44401376|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
44401377|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401378|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44401379|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44401380|NCT02726022|Ribavirin|ribavirin|mesh-list
44401381|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44401382|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
44401383|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401384|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
44401385|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401386|NCT02725866|Ritonavir|ritonavir|mesh-list
44401387|NCT02725866|Ribavirin|ribavirin|mesh-list
44401388|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44401389|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44401390|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
44401391|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401392|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401393|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44401394|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44401395|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
44401396|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401397|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44401398|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401399|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
44401400|NCT02725710|Gabapentin|gabapentin|mesh-list
44401401|NCT02725710|Analgesics|analgesics|mesh-ancestor
44401402|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
44401403|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401404|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401405|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
44401406|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44401407|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401408|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401409|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401410|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44401411|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44401412|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401413|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401414|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
44401415|NCT02725411|Celecoxib|celecoxib|mesh-list
44401416|NCT02725411|Tanezumab|tanezumab|mesh-list
44401417|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44401418|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44401419|NCT02725411|Analgesics|analgesics|mesh-ancestor
44401420|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
44401421|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401422|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401423|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401424|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161895|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161896|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161897|NCT00247026|Analgesics|analgesics|mesh-ancestor
44161898|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
44161899|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161900|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161901|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161902|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161903|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161906|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
44161907|NCT00247026|Vitamins|vitamins|mesh-ancestor
44161908|NCT00247052|Diclofenac|diclofenac|mesh-list
44161909|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44161910|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44161911|NCT00247052|Analgesics|analgesics|mesh-ancestor
44161912|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
44161913|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44161914|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161915|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44161916|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44161917|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44161918|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161919|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161920|NCT00247078|Antivenins|antivenins|mesh-list
44161921|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
44161922|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161923|NCT00247117|Metformin|metformin|mesh-list
44161924|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44161925|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161926|NCT00247130|Omeprazole|omeprazole|mesh-list
44161927|NCT00247130|Ranitidine|ranitidine|mesh-list
44161928|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44161929|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44161930|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44161931|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44161932|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161933|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401425|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44401426|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44401427|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401428|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401429|NCT02725268|Paclitaxel|paclitaxel|mesh-list
44401430|NCT02725268|Serabelisib|serabelisib|mesh-list
44401431|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401432|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401433|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401434|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
44401435|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401436|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401437|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401438|NCT02725008|Dexamethasone|dexamethasone|mesh-list
44401439|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401440|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
44401441|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
44401442|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401443|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401444|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401445|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
44401446|NCT02725008|Hormones|hormones|mesh-ancestor
44401447|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401448|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44161934|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44161935|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
44161936|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
44161937|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43604323|NCT03238092|Estradiol|estradiol|mesh-list
44161938|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161939|NCT00247169|Progesterone|progesterone|mesh-list
44161940|NCT00247169|Progestins|progestins|mesh-ancestor
44161941|NCT00247169|Hormones|hormones|mesh-ancestor
44161942|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44161943|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161944|NCT00247208|Paclitaxel|paclitaxel|mesh-list
44161945|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44161946|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161947|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161948|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161949|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44161950|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161951|NCT00247247|Entacapone|entacapone|mesh-list
44161952|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44161953|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44161954|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44161955|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161956|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161957|NCT00247364|Levetiracetam|levetiracetam|mesh-list
44161958|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
44161959|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
44401450|NCT02724878|Bevacizumab|bevacizumab|mesh-list
44401451|NCT02724878|Atezolizumab|atezolizumab|mesh-list
44401452|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401453|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401454|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44401455|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44401456|NCT02724878|Growth Substances|growth substances|mesh-ancestor
44401457|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401458|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44401459|NCT02724592|Fluorides|fluorides|mesh-list
44401460|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
44401461|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
44401462|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
44401463|NCT02724592|Protective Agents|protective agents|mesh-ancestor
44401464|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401465|NCT02724111|Rocuronium|rocuronium|mesh-list
44401466|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44401467|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44401468|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44401469|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401470|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401471|NCT02724020|Everolimus|everolimus|mesh-list
44161960|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
44161961|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
44161962|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161963|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
44161964|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161965|NCT00247481|Docetaxel|docetaxel|mesh-list
44161966|NCT00247481|Gefitinib|gefitinib|mesh-list
44161967|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161968|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
44161969|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
44161970|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
44161971|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161972|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44161973|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161974|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
44161975|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44161976|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44161977|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44161978|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
44161979|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44161980|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161981|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161982|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161984|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44161985|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
44161986|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44161987|NCT00247507|Expectorants|expectorants|mesh-ancestor
44161988|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44161989|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44401473|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401474|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401475|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
44401476|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401477|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401478|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401479|NCT02723864|Cisplatin|cisplatin|mesh-list
44401480|NCT02723864|Veliparib|veliparib|mesh-list
44401481|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401482|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44401483|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401484|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401485|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
44401486|NCT02723786|Azathioprine|azathioprine|mesh-list
44401487|NCT02723786|Tacrolimus|tacrolimus|mesh-list
44401488|NCT02723786|Basiliximab|basiliximab|mesh-list
44401489|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401490|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
44401491|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401492|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44401493|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44161990|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
44161991|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44161992|NCT00247507|Protective Agents|protective agents|mesh-ancestor
44161993|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44161994|NCT00247507|Antidotes|antidotes|mesh-ancestor
44161995|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
44161996|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44161997|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44161998|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44161999|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162000|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162001|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162002|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162003|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162004|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44162005|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162006|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44162007|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44162008|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162009|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44162010|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162011|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162012|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162013|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
44162014|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162015|NCT00247585|Ethanol|ethanol|mesh-list
44162016|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44162017|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162018|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401495|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44401496|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401497|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44401498|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
44401499|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44401500|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401501|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
43787164|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
44401502|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401503|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44401504|NCT02723630|Lenvatinib|lenvatinib|mesh-list
44401505|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401506|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44401507|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401508|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401509|NCT02723591|Tacrolimus|tacrolimus|mesh-list
44401510|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401511|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
44162019|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162020|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
44162021|NCT00247650|Letrozole|letrozole|mesh-list
44162022|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162023|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44162024|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44162025|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162026|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162027|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44162028|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
44162029|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162030|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162031|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44162032|NCT00247663|Letrozole|letrozole|mesh-list
44162033|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162034|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44162035|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44162036|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162037|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162038|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44162039|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44162040|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162041|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162042|NCT00247702|Warfarin|warfarin|mesh-list
44162043|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
44162044|NCT00247715|Pantoprazole|pantoprazole|mesh-list
44162045|NCT00247715|Ranitidine|ranitidine|mesh-list
44162046|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44162047|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
44162048|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44162049|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44162050|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162057|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162058|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162059|NCT00247715|Antacids|antacids|mesh-ancestor
44162060|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44401512|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401513|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44401514|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401515|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401516|NCT02723084|Ribavirin|ribavirin|mesh-list
44401517|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
44401518|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
44401519|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401520|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
44401521|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401522|NCT02723006|Nivolumab|nivolumab|mesh-list
44401523|NCT02723006|Ipilimumab|ipilimumab|mesh-list
44401524|NCT02723006|Vedolizumab|vedolizumab|mesh-list
44401525|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401526|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401527|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44401528|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401529|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401530|NCT02722967|Aripiprazole|aripiprazole|mesh-list
44401531|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401532|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401533|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44401534|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401535|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401536|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401537|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
44401538|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
44401539|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401540|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401541|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44401555|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44401556|NCT02722278|Testosterone|testosterone|mesh-list
44401557|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
44401558|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
44401559|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44401560|NCT02722278|Androgens|androgens|mesh-ancestor
44401561|NCT02722278|Hormones|hormones|mesh-ancestor
44401562|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401563|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401564|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44401565|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401566|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
44401567|NCT02722044|Adalimumab|adalimumab|mesh-list
44401568|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401569|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44401570|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44401571|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
44401572|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401573|NCT02721875|Azacitidine|azacitidine|mesh-list
44401574|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401575|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
44401576|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401577|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401578|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401579|NCT02720536|Deferasirox|deferasirox|mesh-list
44401580|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44401581|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
44401582|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
44401583|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401584|NCT02720523|Upadacitinib|upadacitinib|mesh-list
44401585|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44401586|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44401587|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401588|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401589|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44401590|NCT02720510|Dexamethasone|dexamethasone|mesh-list
44401591|NCT02720510|Lenalidomide|lenalidomide|mesh-list
44162061|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
44401592|NCT02720510|Bortezomib|bortezomib|mesh-list
44401593|NCT02720510|Panobinostat|panobinostat|mesh-list
44401594|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401595|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
44401596|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
44401597|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401598|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401599|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401600|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
44401601|NCT02720510|Hormones|hormones|mesh-ancestor
44401602|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401603|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44401604|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401605|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
44401606|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44401607|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44401608|NCT02720510|Growth Substances|growth substances|mesh-ancestor
44401609|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
44401610|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44401611|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401612|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401613|NCT02720484|Nivolumab|nivolumab|mesh-list
44401614|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401615|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401616|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44401617|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401618|NCT02720198|Milnacipran|milnacipran|mesh-list
44401619|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44401620|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
44401621|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401634|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
44401635|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401636|NCT02720081|Albuterol|albuterol|mesh-list
44401637|NCT02720081|Montelukast|montelukast|mesh-list
44401638|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44401639|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44401640|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44401641|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
44401642|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401643|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401644|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44401645|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44401646|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401647|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44401648|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
44401649|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401650|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
44401651|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44401652|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44401653|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44401654|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44401655|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401656|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401657|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44401658|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
44401659|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401660|NCT02718898|Ixekizumab|ixekizumab|mesh-list
44401661|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
44401662|NCT02718417|Paclitaxel|paclitaxel|mesh-list
44401663|NCT02718417|Carboplatin|carboplatin|mesh-list
44401664|NCT02718417|Avelumab|avelumab|mesh-list
44401665|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44401666|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401667|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162062|NCT00247741|Lidocaine|lidocaine|mesh-list
44162063|NCT00247741|Carticaine|carticaine|mesh-list
44162064|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
44162065|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
44162066|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162067|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401668|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401669|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44401670|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401671|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401672|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401673|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
44401674|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401675|NCT02718326|Aflibercept|aflibercept|mesh-list
44401676|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43787186|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
43787188|NCT05084534|Midodrine|midodrine|mesh-list
44401677|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44401678|NCT02718326|Growth Substances|growth substances|mesh-ancestor
44401679|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401680|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
44401681|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401682|NCT02717754|Oseltamivir|oseltamivir|mesh-list
44401683|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
44401684|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401685|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401686|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401688|NCT02717195|Risperidone|risperidone|mesh-list
44401689|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401690|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
44401691|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401692|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401693|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401694|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162068|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
44162069|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162070|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44162071|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44162072|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44162073|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162074|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162076|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44162077|NCT00247910|Diuretics|diuretics|mesh-ancestor
44162078|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
44162079|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162080|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44162081|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162082|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162083|NCT00247988|Carboplatin|carboplatin|mesh-list
44162084|NCT00247988|Docetaxel|docetaxel|mesh-list
44162085|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162086|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401695|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401696|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401697|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401698|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44401699|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
44401700|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
44401701|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
44401702|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401703|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401704|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44401705|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401706|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401707|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
44401708|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401709|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401710|NCT02717130|Aripiprazole|aripiprazole|mesh-list
44401711|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401712|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401713|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44401714|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401715|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401716|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401717|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
44401718|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
44401719|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401720|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162087|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162088|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162089|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162090|NCT00248053|Curcumin|curcumin|mesh-list
44162091|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44162092|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44162093|NCT00248053|Analgesics|analgesics|mesh-ancestor
44162094|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
44162095|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162096|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162097|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44162098|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162099|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162100|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162101|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162102|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44162103|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44162104|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162105|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44162106|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162107|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401721|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44401722|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44401723|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
44401724|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44401725|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401726|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44401727|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44401728|NCT02716779|Interferons|interferons|mesh-list
44401729|NCT02716779|Ribavirin|ribavirin|mesh-list
44401730|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401731|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
44401732|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401733|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
44401734|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401735|NCT02716194|Factor VIII|factor viii|mesh-list
44401736|NCT02716194|Coagulants|coagulants|mesh-ancestor
44401737|NCT02715804|Gemcitabine|gemcitabine|mesh-list
44401738|NCT02715804|Paclitaxel|paclitaxel|mesh-list
44401739|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401740|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401741|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
44401742|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
44401743|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
44401744|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401745|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401746|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
44401747|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
44401748|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401749|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401750|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401751|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
44401752|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401753|NCT02715726|Atorvastatin|atorvastatin|mesh-list
44401754|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44401755|NCT02715726|Simvastatin|simvastatin|mesh-list
44401756|NCT02715726|Ezetimibe|ezetimibe|mesh-list
44401757|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44401758|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44163852|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401759|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44401761|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401762|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44401763|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44401764|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401765|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
44401766|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401767|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
44401768|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44401769|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401770|NCT02714569|Atorvastatin|atorvastatin|mesh-list
44401771|NCT02714569|Simvastatin|simvastatin|mesh-list
44401772|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44401773|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44401774|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
43787206|NCT05025163|Protective Agents|protective agents|mesh-ancestor
44401775|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401776|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44401777|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44401778|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401779|NCT02714218|Nivolumab|nivolumab|mesh-list
44401780|NCT02714218|Ipilimumab|ipilimumab|mesh-list
44401781|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401782|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401783|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44401784|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401785|NCT02714062|Topiramate|topiramate|mesh-list
44401786|NCT02714062|Phentermine|phentermine|mesh-list
44401787|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
44401788|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44401789|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401790|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44401791|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
44162108|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162109|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
44162110|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162111|NCT00248118|Bupropion|bupropion|mesh-list
44162112|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162113|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162114|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162115|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44401792|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44401793|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
44401794|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
44401795|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401796|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401797|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401798|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401799|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
44401800|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44401801|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44401802|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401803|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
44401804|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401805|NCT02713490|Bupivacaine|bupivacaine|mesh-list
44401806|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
44401807|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
43702915|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162116|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162117|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162131|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162132|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44162133|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162134|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162136|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162137|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44162138|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162139|NCT00248183|Naluzotan|naluzotan|mesh-list
44162140|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44162141|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44162142|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
44162143|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162144|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162145|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162146|NCT00248209|Bupropion|bupropion|mesh-list
44162147|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162148|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162149|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162150|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44162151|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162152|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162153|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162154|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
44162155|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162156|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162157|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44162158|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162159|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162160|NCT00248248|Doxorubicin|doxorubicin|mesh-list
44162161|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44162162|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44162163|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162164|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44162165|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162166|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162167|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401808|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401809|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401810|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
44401811|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401812|NCT02713204|Aflibercept|aflibercept|mesh-list
44401813|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44401814|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44401815|NCT02713204|Growth Substances|growth substances|mesh-ancestor
44401816|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401817|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
44401818|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401819|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44401820|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44401821|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401822|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44401823|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401824|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401825|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401826|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
44162168|NCT00248261|Ziprasidone|ziprasidone|mesh-list
44162169|NCT00248261|Sertraline|sertraline|mesh-list
44162170|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162171|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162172|NCT00248261|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44162173|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162174|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162175|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162188|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
44162190|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162191|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162192|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44162193|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162194|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
44162195|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162196|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
44162197|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162198|NCT00248339|Ribavirin|ribavirin|mesh-list
44162199|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44162200|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
44162201|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
44162202|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162203|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
44162204|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162205|NCT00248339|Hematinics|hematinics|mesh-ancestor
44162206|NCT00248430|Aldesleukin|aldesleukin|mesh-list
44162207|NCT00248430|Melphalan|melphalan|mesh-list
44162208|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44162209|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
43710252|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162210|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162211|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162212|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44162213|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162214|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
44401827|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401829|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44401830|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44401831|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
44401832|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44401833|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44401834|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401835|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401836|NCT02712788|Protective Agents|protective agents|mesh-ancestor
44401837|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401838|NCT02712008|Aflibercept|aflibercept|mesh-list
44401839|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44401840|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44401841|NCT02712008|Growth Substances|growth substances|mesh-ancestor
44162215|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162216|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44162217|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44162218|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
44162219|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162220|NCT00248443|Dimercaprol|dimercaprol|mesh-list
44162221|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
44162222|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
44162223|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162224|NCT00248456|Betamethasone|betamethasone|mesh-list
44162225|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
44162226|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44162227|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
44162228|NCT00248456|Calcipotriene|calcipotriene|mesh-list
44162229|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44162231|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
44162232|NCT00248456|Hormones|hormones|mesh-ancestor
44162233|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162234|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162235|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44162236|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
44162237|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
44162238|NCT00248482|Cisplatin|cisplatin|mesh-list
44162239|NCT00248482|Irinotecan|irinotecan|mesh-list
44162240|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
44162241|NCT00248482|Camptothecin|camptothecin|mesh-list
44162242|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162252|NCT00248729|Etomidate|etomidate|mesh-list
44162253|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44162254|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44162255|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162256|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162257|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44162258|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162259|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162260|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44162261|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
44162262|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
44162263|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
44162264|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
44162265|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162266|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162267|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
44162268|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44162269|NCT00248963|Estradiol|estradiol|mesh-list
44162270|NCT00248963|Estrogens|estrogens|mesh-ancestor
44401842|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401843|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
44401844|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401845|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44401846|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
44401847|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44401848|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401849|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401850|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
44401851|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401852|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401853|NCT02711995|Laxatives|laxatives|mesh-ancestor
44401854|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401855|NCT02711553|Gemcitabine|gemcitabine|mesh-list
44401856|NCT02711553|Cisplatin|cisplatin|mesh-list
44401857|NCT02711553|Ramucirumab|ramucirumab|mesh-list
44401858|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401859|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401860|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
44401861|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401862|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
44401863|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401864|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401865|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401866|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
44401867|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401868|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44401869|NCT02711306|Cathartics|cathartics|mesh-ancestor
44401870|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44401871|NCT02711137|Gemcitabine|gemcitabine|mesh-list
44401872|NCT02711137|Paclitaxel|paclitaxel|mesh-list
44401873|NCT02711137|Azacitidine|azacitidine|mesh-list
44401874|NCT02711137|Rucaparib|rucaparib|mesh-list
44401875|NCT02711137|INCB057643|incb057643|mesh-list
44401876|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44401877|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401882|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44401884|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
44401885|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44401886|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401887|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44401888|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
44401889|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401890|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44401891|NCT02710214|Estrogens|estrogens|mesh-list
44401892|NCT02710214|Hormones|hormones|mesh-ancestor
44401893|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401894|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401895|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44401896|NCT02710071|Nebivolol|nebivolol|mesh-list
44401897|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44401898|NCT02710071|Diuretics|diuretics|mesh-ancestor
44401899|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
44401900|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401901|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44401902|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401903|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401904|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
44401905|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44401906|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44401907|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44401908|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
44401909|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401910|NCT02710045|Vaccines|vaccines|mesh-list
44401911|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
44401912|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401913|NCT02709889|Dexamethasone|dexamethasone|mesh-list
44401914|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44401915|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
44401916|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
44401917|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43830833|NCT05342194|Gemcitabine|gemcitabine|mesh-list
44162271|NCT00248963|Hormones|hormones|mesh-ancestor
43701623|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401918|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401920|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
44401921|NCT02709889|Hormones|hormones|mesh-ancestor
44401922|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44401923|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44401924|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401925|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
44401926|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44401927|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44059528|NCT00005861|Doxorubicin|doxorubicin|mesh-list
44401928|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
44401929|NCT02709746|Vortioxetine|vortioxetine|mesh-list
44401930|NCT02709746|Fluoxetine|fluoxetine|mesh-list
44401931|NCT02709746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44401932|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44401933|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401934|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401935|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44401936|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
44401937|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401938|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44401939|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
44401940|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401941|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44401943|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401962|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44401963|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44401964|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44401965|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401966|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44401967|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44401968|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44401969|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44401970|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44401971|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44401972|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44401974|NCT02709486|Analgesics|analgesics|mesh-ancestor
44401975|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
44401976|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44401977|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401978|NCT02709109|Ivacaftor|ivacaftor|mesh-list
44401979|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44401980|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44401981|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401982|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
44401983|NCT02709083|Dasatinib|dasatinib|mesh-list
44401984|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44401985|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44401986|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401987|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401988|NCT02709005|Monolaurin|monolaurin|mesh-list
44401989|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
44401990|NCT02709005|Protective Agents|protective agents|mesh-ancestor
44401991|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44401992|NCT02708355|Esomeprazole|esomeprazole|mesh-list
44401993|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44401994|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162272|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162273|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162274|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44162275|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
44162276|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44162277|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44162278|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44401995|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44401996|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44401997|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44401998|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
44401999|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402000|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402001|NCT02707965|Topiramate|topiramate|mesh-list
44402002|NCT02707965|Lamotrigine|lamotrigine|mesh-list
44402003|NCT02707965|Zonisamide|zonisamide|mesh-list
44402004|NCT02707965|Carbamazepine|carbamazepine|mesh-list
44402005|NCT02707965|Phenytoin|phenytoin|mesh-list
44402006|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
44402007|NCT02707965|Levetiracetam|levetiracetam|mesh-list
44402008|NCT02707965|Valproic Acid|valproic acid|mesh-list
44402009|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
44402010|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402011|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402012|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
44402013|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44402014|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402015|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402016|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44402017|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44402018|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402019|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402020|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402021|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44402022|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
44402023|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402024|NCT02707965|Analgesics|analgesics|mesh-ancestor
44402025|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
43703069|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
44162279|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44162280|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44162281|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44162282|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44162283|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
44162284|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162285|NCT00249041|Etanercept|etanercept|mesh-list
44162286|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44162287|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44162288|NCT00249041|Analgesics|analgesics|mesh-ancestor
44162289|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
44162290|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162291|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162292|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402026|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402027|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44402028|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44402029|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402030|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
44402031|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402032|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44402033|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44402034|NCT02707952|Ritonavir|ritonavir|mesh-list
44402035|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44402036|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44402037|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
44402038|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402039|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402040|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44402041|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44402042|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
44402043|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402044|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44402045|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44402046|NCT02707861|Ibalizumab|ibalizumab|mesh-list
44402047|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44402048|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
44402049|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402050|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44402075|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44402076|NCT02707601|Ledipasvir|ledipasvir|mesh-list
44402077|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44402078|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
44402079|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402080|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44402081|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44402082|NCT02706951|Methotrexate|methotrexate|mesh-list
44402083|NCT02706951|Upadacitinib|upadacitinib|mesh-list
44402084|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44402085|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
44402086|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402087|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402088|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44402089|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
44402090|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402091|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402092|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402093|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402094|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44402095|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44402096|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
44402097|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162293|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162294|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162295|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162296|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
44162297|NCT00249106|Vaccines|vaccines|mesh-list
44162298|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
44162299|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162300|NCT00249119|Risperidone|risperidone|mesh-list
44162301|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162302|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
44162303|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162304|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162305|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162306|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162307|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162308|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162321|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162322|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162323|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
44162324|NCT00249145|Risperidone|risperidone|mesh-list
44162325|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162326|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
44162327|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162328|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162329|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162330|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162331|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402098|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44402099|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44402100|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402101|NCT02706899|Azacitidine|azacitidine|mesh-list
44402102|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44402103|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
44402104|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402105|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402106|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402107|NCT02706886|Lumasiran|lumasiran|mesh-list
44402108|NCT02706886|Renal Agents|renal agents|mesh-ancestor
44402109|NCT02706847|Upadacitinib|upadacitinib|mesh-list
44402110|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44402111|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402112|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402113|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402114|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402115|NCT02706691|Infigratinib|infigratinib|mesh-list
44402116|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402117|NCT02706483|Plecanatide|plecanatide|mesh-list
44402118|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44402119|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
44402120|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402121|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44402122|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
44402123|NCT02706405|Fludarabine|fludarabine|mesh-list
44402124|NCT02706405|Durvalumab|durvalumab|mesh-list
44402125|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
44162332|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162333|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162334|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162335|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
44162336|NCT00249158|Risperidone|risperidone|mesh-list
44162337|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162338|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
44162339|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162340|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162341|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162342|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162343|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162344|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162345|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162346|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162347|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
44162348|NCT00249171|Risperidone|risperidone|mesh-list
44162349|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162350|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
44162351|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402126|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402127|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
44402128|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44402129|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
44402130|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402131|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402132|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44402133|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
44402134|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402135|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402136|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44402137|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402139|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
44402140|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
44402141|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
44402142|NCT02705716|Protective Agents|protective agents|mesh-ancestor
44402143|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402144|NCT02705105|Nivolumab|nivolumab|mesh-list
44162352|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162353|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162354|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162355|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162356|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162357|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162358|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162359|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
44162360|NCT00249197|Levofloxacin|levofloxacin|mesh-list
44162361|NCT00249197|Ofloxacin|ofloxacin|mesh-list
44162362|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44162363|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162364|NCT00249197|Renal Agents|renal agents|mesh-ancestor
44162365|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162366|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44162367|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162368|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162369|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162370|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162371|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44162379|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44162380|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162381|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162382|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162383|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162384|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44162385|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162386|NCT00249223|Risperidone|risperidone|mesh-list
44162387|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162388|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
44162389|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162390|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162391|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162392|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162393|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162394|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162395|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402145|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
44402146|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402147|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402148|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44402149|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402150|NCT02703636|Rivastigmine|rivastigmine|mesh-list
44402151|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44402152|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402153|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402154|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
44402155|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402156|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402157|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44402158|NCT02703636|Protective Agents|protective agents|mesh-ancestor
44402159|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
44402160|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402161|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402162|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
44402163|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402164|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402165|NCT02703259|Acetaminophen|acetaminophen|mesh-list
44402166|NCT02703259|Celecoxib|celecoxib|mesh-list
44402167|NCT02703259|Gabapentin|gabapentin|mesh-list
44402168|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402169|NCT02703259|Analgesics|analgesics|mesh-ancestor
44402170|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
44402171|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402172|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402173|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
44402174|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402189|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
44402190|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
44402191|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402192|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402193|NCT02702388|Lenvatinib|lenvatinib|mesh-list
44402194|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402195|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402196|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402197|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402198|NCT02702011|Empagliflozin|empagliflozin|mesh-list
44402199|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44402200|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402201|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402202|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402203|NCT02701985|Petesicatib|petesicatib|mesh-list
44402204|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402205|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402206|NCT02701764|Pregabalin|pregabalin|mesh-list
44402207|NCT02701764|Analgesics|analgesics|mesh-ancestor
44162396|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162397|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
44162398|NCT00249236|Risperidone|risperidone|mesh-list
44162399|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162400|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
44162401|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162402|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162403|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162404|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162405|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162406|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162407|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162408|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162409|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
44162410|NCT00249353|Methylphenidate|methylphenidate|mesh-list
44162411|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44162412|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162413|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44162414|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162415|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162416|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162417|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
44162418|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162419|NCT00249366|Lorazepam|lorazepam|mesh-list
44162420|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
44162421|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
44162422|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
44162423|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162424|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162425|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162426|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44162427|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162428|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44162429|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162430|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162431|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
44402208|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
44402209|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402210|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402211|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
44402212|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44402213|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402214|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402215|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44402216|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44402217|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402218|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402219|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402220|NCT02701296|Epinephrine|epinephrine|mesh-list
44402221|NCT02701296|Ropivacaine|ropivacaine|mesh-list
44402222|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44402223|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
44402224|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402225|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402226|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
44402227|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402228|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44402229|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44402230|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
44402231|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402232|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402233|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44402234|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44402235|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
44402236|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44402237|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402249|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
44402250|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402251|NCT02700815|Diclofenac|diclofenac|mesh-list
44402252|NCT02700815|Capsaicin|capsaicin|mesh-list
44402253|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402254|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402255|NCT02700815|Analgesics|analgesics|mesh-ancestor
44402256|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
44402257|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402258|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402259|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402260|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402261|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402262|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402263|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402264|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
44402265|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402266|NCT02700412|Cannabidiol|cannabidiol|mesh-list
44402267|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
44402268|NCT02699892|Rituximab|rituximab|mesh-list
44402269|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402270|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402271|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
44402272|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402273|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402274|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44402275|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44402276|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44402296|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44402297|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44402298|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402299|NCT02699099|Vitamin A|vitamin a|mesh-list
44402300|NCT02699099|Vaccines|vaccines|mesh-list
44402301|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
44402302|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402303|NCT02699099|Vitamins|vitamins|mesh-ancestor
44402304|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
44402305|NCT02698891|Paclitaxel|paclitaxel|mesh-list
44402306|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44402307|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402308|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
44402309|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
44402310|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
44402311|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402312|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
44402313|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44402314|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
44402315|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402316|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
44402317|NCT02698865|Protective Agents|protective agents|mesh-ancestor
44402318|NCT02698475|Ustekinumab|ustekinumab|mesh-list
44402319|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402320|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44402321|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402323|NCT02698410|Lanreotide|lanreotide|mesh-list
44402347|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402348|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44402349|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402350|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402351|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
44402352|NCT02697773|Tanezumab|tanezumab|mesh-list
44402353|NCT02697773|Analgesics|analgesics|mesh-ancestor
44402354|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
44402355|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402356|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44060012|NCT00005942|Daunorubicin|daunorubicin|mesh-list
44402358|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402359|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402360|NCT02696850|Budesonide|budesonide|mesh-list
44402361|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402362|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44402363|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
44402364|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402365|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402366|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44402367|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402368|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
44402369|NCT02696850|Hormones|hormones|mesh-ancestor
44402370|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402371|NCT02696798|Ixekizumab|ixekizumab|mesh-list
44402372|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402373|NCT02696785|Adalimumab|adalimumab|mesh-list
44402374|NCT02696785|Ixekizumab|ixekizumab|mesh-list
43787271|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44402375|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402376|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402395|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
44402396|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402397|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402398|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402399|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402400|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44402401|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44402402|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402403|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44402404|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402405|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402406|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
44402407|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44402408|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44402409|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44402410|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
44402411|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402412|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
44402413|NCT02696096|Buprenorphine|buprenorphine|mesh-list
44402414|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44402415|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44402416|NCT02696096|Narcotics|narcotics|mesh-ancestor
44402417|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402418|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402419|NCT02696096|Analgesics|analgesics|mesh-ancestor
43703317|NCT02711683|Donepezil|donepezil|mesh-list
44162432|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
44162433|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162434|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162435|NCT00249405|Citalopram|citalopram|mesh-list
44162436|NCT00249405|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44162437|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162438|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162439|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162449|NCT00249431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44162450|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162451|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162452|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162453|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162454|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
44162455|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162456|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44162457|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44162458|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162459|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402420|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
44402421|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402422|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44402424|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44402425|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402426|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402427|NCT02695628|Misonidazole|misonidazole|mesh-list
44402428|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402429|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44402430|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44402431|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402432|NCT02695537|Cannabidiol|cannabidiol|mesh-list
44402433|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
44402434|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44402435|NCT02694978|Hematinics|hematinics|mesh-ancestor
44162460|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162461|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162462|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162463|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162464|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162465|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162466|NCT00249509|Bupropion|bupropion|mesh-list
44162467|NCT00249509|Nefazodone|nefazodone|mesh-list
44162468|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162469|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162470|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162471|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44162472|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162473|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162474|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162475|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
44162476|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162477|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162478|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44162479|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162480|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43602522|NCT03253250|Tenofovir|tenofovir|mesh-list
44162481|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44162482|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44162483|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162484|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
44162485|NCT00249574|Buprenorphine|buprenorphine|mesh-list
44162486|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44162487|NCT00249574|Naloxone|naloxone|mesh-list
44162488|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44162489|NCT00249574|Narcotics|narcotics|mesh-ancestor
44162490|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162491|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162492|NCT00249574|Analgesics|analgesics|mesh-ancestor
44162493|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
44162494|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162495|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44162496|NCT00249587|Methadone|methadone|mesh-list
44162497|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44162498|NCT00249587|Narcotics|narcotics|mesh-ancestor
44162499|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162500|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402436|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44402437|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44402438|NCT02694718|Capecitabine|capecitabine|mesh-list
44402439|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
44402440|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44402441|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
44402442|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402443|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402444|NCT02694536|Gemcitabine|gemcitabine|mesh-list
44402445|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44402446|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44402447|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
44402448|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402449|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402450|NCT02694536|Antiviral Agents|antiviral agents|mesh-ancestor
44402451|NCT02694536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402452|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402453|NCT02694536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44402454|NCT02694536|Immunologic Factors|immunologic factors|mesh-ancestor
44402455|NCT02694536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402456|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402458|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402459|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44162501|NCT00249587|Analgesics|analgesics|mesh-ancestor
44165319|NCT00259779|Hormones|hormones|mesh-ancestor
44162504|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
44162505|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
44162506|NCT00249691|Topiramate|topiramate|mesh-list
44162507|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
44162508|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44162509|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162510|NCT00249704|Vitamin D|vitamin d|mesh-list
44162511|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
44162512|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
44162513|NCT00249704|Vitamins|vitamins|mesh-list
44162514|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
44162515|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162516|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44162517|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44162518|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
44162519|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
44162520|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44162521|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44162522|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162523|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162524|NCT00249730|Urological Agents|urological agents|mesh-ancestor
44162525|NCT00249782|Metronidazole|metronidazole|mesh-list
44162526|NCT00249782|Dapsone|dapsone|mesh-list
44162527|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162528|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162529|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44402460|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402461|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
44402462|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402463|NCT02694328|Olanzapine|olanzapine|mesh-list
44402464|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
44402465|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
44402466|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402467|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402468|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44402469|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44402470|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402471|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402472|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402473|NCT02694328|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44402474|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44402475|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402476|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402477|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402478|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
44402479|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
44402480|NCT02693535|Nivolumab|nivolumab|mesh-list
44402481|NCT02693535|Trastuzumab|trastuzumab|mesh-list
44402482|NCT02693535|Ipilimumab|ipilimumab|mesh-list
44402483|NCT02693535|Pertuzumab|pertuzumab|mesh-list
44402484|NCT02693535|Atezolizumab|atezolizumab|mesh-list
44402485|NCT02693535|Sunitinib|sunitinib|mesh-list
44402486|NCT02693535|Olaparib|olaparib|mesh-list
44402487|NCT02693535|Palbociclib|palbociclib|mesh-list
44402488|NCT02693535|Afatinib|afatinib|mesh-list
44402489|NCT02693535|Vemurafenib|vemurafenib|mesh-list
44402490|NCT02693535|Crizotinib|crizotinib|mesh-list
44402491|NCT02693535|Talazoparib|talazoparib|mesh-list
44402492|NCT02693535|Tucatinib|tucatinib|mesh-list
44402493|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402494|NCT02693535|Entrectinib|entrectinib|mesh-list
44402495|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402496|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402497|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43703371|NCT02711228|Antibodies|antibodies|mesh-list
44402501|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44402502|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44402503|NCT02693535|Growth Substances|growth substances|mesh-ancestor
44402504|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
44402505|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402506|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402507|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44402508|NCT02693171|Dinutuximab|dinutuximab|mesh-list
44402509|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402510|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44402511|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44402512|NCT02693002|Norethindrone|norethindrone|mesh-list
44402513|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
44402514|NCT02693002|Estradiol|estradiol|mesh-list
44402515|NCT02693002|Estrogens|estrogens|mesh-ancestor
44402516|NCT02693002|Hormones|hormones|mesh-ancestor
44402517|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402518|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402519|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44402520|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
44402521|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402522|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44402523|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44402524|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44402525|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44402526|NCT02691936|Estrogens|estrogens|mesh-list
44402527|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44402528|NCT02691936|Hormones|hormones|mesh-ancestor
44402529|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402530|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402531|NCT02691702|Melatonin|melatonin|mesh-list
44402532|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
44402533|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402534|NCT02691702|Protective Agents|protective agents|mesh-ancestor
44402541|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
44402542|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
44402543|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402544|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402545|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
44402546|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402547|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44402548|NCT02691572|Narcotics|narcotics|mesh-ancestor
44402549|NCT02691572|Analgesics|analgesics|mesh-ancestor
44402550|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44402551|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44402552|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
44402553|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402554|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
44402555|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402556|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402557|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402558|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402559|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402560|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402561|NCT02691507|Decanoic acid|decanoic acid|mesh-list
44402562|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
44402563|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402564|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44402565|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44402566|NCT02691494|Norethindrone|norethindrone|mesh-list
44402567|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
44402568|NCT02691494|Estradiol|estradiol|mesh-list
44402569|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44162530|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44162531|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
44162532|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44162533|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162534|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162535|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
44162536|NCT00249847|Paroxetine|paroxetine|mesh-list
44162537|NCT00249847|Estrogens|estrogens|mesh-list
44162538|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44162539|NCT00249847|Hormones|hormones|mesh-ancestor
44162540|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162541|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162542|NCT00249847|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44162543|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162544|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162545|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162546|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402570|NCT02691494|Estrogens|estrogens|mesh-ancestor
44402571|NCT02691494|Hormones|hormones|mesh-ancestor
44402572|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402573|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402574|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44402575|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
44402576|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402577|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44402578|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44402579|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44402580|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44402581|NCT02691468|Silicon|silicon|mesh-list
44402582|NCT02691468|Trace Elements|trace elements|mesh-ancestor
44402583|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
44402584|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402585|NCT02690974|Valsartan|valsartan|mesh-list
44402586|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44402587|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44402588|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44402589|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43703456|NCT02711007|Apatinib|apatinib|mesh-list
44162547|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
44162548|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162549|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162550|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162551|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44162552|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44162553|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162554|NCT00249860|Interferons|interferons|mesh-list
44162555|NCT00249860|Ribavirin|ribavirin|mesh-list
44162556|NCT00249860|Interferon-beta|interferon-beta|mesh-list
44162557|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
44162558|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162559|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
44162560|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162561|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
44162562|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162563|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
44162564|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162565|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44162567|NCT00249886|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44162568|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44162569|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162570|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162571|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162572|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
44162573|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162574|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44162623|NCT00250029|Capecitabine|capecitabine|mesh-list
44162624|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
44162625|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44402590|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402592|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
44402593|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402594|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402595|NCT02690714|Plasminogen|plasminogen|mesh-list
44402596|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44402597|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44402598|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402599|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
44402600|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
44402601|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
44402602|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
44402603|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402604|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402605|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44402606|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44402607|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44402608|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44402609|NCT02689518|Aflibercept|aflibercept|mesh-list
44402610|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44402611|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44402612|NCT02689518|Growth Substances|growth substances|mesh-ancestor
44402613|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402614|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
44162626|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
44162627|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162628|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162629|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
44162630|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
44162631|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162632|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44162633|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162634|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162636|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162637|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44162638|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162639|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162640|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162641|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
44162642|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44162643|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162644|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162645|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162646|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162647|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162648|NCT00250094|Topotecan|topotecan|mesh-list
44402615|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402616|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
44402617|NCT02689284|Margetuximab|margetuximab|mesh-list
44402618|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402619|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402620|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402621|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
44402622|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402623|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44402624|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402625|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402626|NCT02689206|Glycine|glycine|mesh-list
44402627|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
44402628|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402629|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402630|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402631|NCT02688933|Insulin|insulin|mesh-list
44162649|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44162650|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162651|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162652|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162653|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162654|NCT00250120|Camptothecin|camptothecin|mesh-list
44162655|NCT00250120|Rubitecan|rubitecan|mesh-list
44162656|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162657|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162658|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44162659|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44162660|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162661|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162662|NCT00250172|Rolipram|rolipram|mesh-list
44162663|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
44162664|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162665|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44162666|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44162667|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162668|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162693|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44162694|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
44162695|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
44162696|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162697|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162698|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44162699|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44162700|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44162701|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
44162702|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162703|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162704|NCT00250315|Protective Agents|protective agents|mesh-ancestor
44162706|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162707|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
44162708|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787295|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162709|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162710|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162711|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162712|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162713|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402632|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44402633|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
44402634|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402635|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402636|NCT02688764|Calcium|calcium|mesh-list
44402637|NCT02688764|Calcium acetate|calcium acetate|mesh-list
44402638|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44402639|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402640|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
44402641|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
44402642|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402643|NCT02688647|Belumosudil|belumosudil|mesh-list
44402644|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402645|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402646|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402647|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
44402648|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402649|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402650|NCT02688530|Dexamethasone|dexamethasone|mesh-list
44402651|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
44402652|NCT02688530|BB 1101|bb 1101|mesh-list
44402653|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402654|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
44402655|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
44402656|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402657|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402682|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402683|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402685|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402686|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402687|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44402688|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
44402689|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
44402690|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
44402691|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
44402692|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402693|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402694|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
44402695|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44402696|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44402697|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703566|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
44162714|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162715|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44162716|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
44162717|NCT00250367|Risperidone|risperidone|mesh-list
44162718|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162719|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
44162742|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162743|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162744|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
44162745|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44162746|NCT00250562|Valsartan|valsartan|mesh-list
44162747|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44162748|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44162749|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44162750|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44162751|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162752|NCT00250562|Diuretics|diuretics|mesh-ancestor
44162753|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
44162754|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162755|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44162756|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44162757|NCT00250575|Clozapine|clozapine|mesh-list
44162758|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44162759|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
44162760|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162761|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162762|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162763|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44162764|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162765|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162766|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162767|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
44162768|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
44162769|NCT00250640|Iloprost|iloprost|mesh-list
44162770|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44162782|NCT00250744|Gabapentin|gabapentin|mesh-list
44162783|NCT00250744|Aprepitant|aprepitant|mesh-list
44162784|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
44162785|NCT00250744|Analgesics|analgesics|mesh-ancestor
44162786|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
44162787|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402698|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44402699|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44402700|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
44402701|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
44402702|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402703|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44402704|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44402706|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
44402707|NCT02687815|Vitamins|vitamins|mesh-ancestor
44402708|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
44402709|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402710|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44402711|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44402712|NCT02687451|Oxymorphone|oxymorphone|mesh-list
44402713|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44402714|NCT02687451|Narcotics|narcotics|mesh-ancestor
44402715|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402716|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402717|NCT02687451|Analgesics|analgesics|mesh-ancestor
44402718|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
44402719|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402720|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44402721|NCT02686164|Lenvatinib|lenvatinib|mesh-list
44402722|NCT02686164|Midazolam|midazolam|mesh-list
44402723|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44402724|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44162788|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162789|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
44162790|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44162791|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44162792|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44162793|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162794|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44162795|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44162796|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162797|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162798|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
44162799|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
44162800|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
44162801|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162802|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44162803|NCT00250796|Interferons|interferons|mesh-list
44162804|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
44162805|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44162806|NCT00250796|Thalidomide|thalidomide|mesh-list
44162807|NCT00250796|Octreotide|octreotide|mesh-list
44162808|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162809|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
44402725|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402726|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402727|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44402728|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402729|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44402730|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44402731|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
44402732|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
44402733|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
44402734|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
44402735|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402736|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402737|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402738|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402739|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402740|NCT02685072|Progesterone|progesterone|mesh-list
44402741|NCT02685072|Progestins|progestins|mesh-ancestor
44402742|NCT02685072|Hormones|hormones|mesh-ancestor
44402743|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402744|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402745|NCT02685033|Dalbavancin|dalbavancin|mesh-list
44402746|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44402747|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402748|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
44402749|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402750|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402751|NCT02684370|Ustekinumab|ustekinumab|mesh-list
44402752|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402753|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402754|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
44402755|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402756|NCT02684357|Ustekinumab|ustekinumab|mesh-list
44402757|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44402758|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
44402759|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
43830882|NCT05339386|Xenon|xenon|mesh-list
44162810|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162811|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162812|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
44162813|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162814|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
44402760|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402761|NCT02684344|Tamsulosin|tamsulosin|mesh-list
44402762|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44402763|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44402764|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44402765|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
44402766|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402767|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402768|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402769|NCT02684344|Urological Agents|urological agents|mesh-ancestor
44402770|NCT02683941|Lanreotide|lanreotide|mesh-list
44402771|NCT02683941|Somatostatin|somatostatin|mesh-list
44402772|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402773|NCT02683941|Hormones|hormones|mesh-ancestor
44402774|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402775|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402776|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
44402777|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44402778|NCT02683746|Incretins|incretins|mesh-ancestor
44402779|NCT02683746|Hormones|hormones|mesh-ancestor
44402780|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402781|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402782|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
44402783|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44402784|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
44402785|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402786|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402787|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44402788|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402789|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
44402790|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44402791|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162815|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162816|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44162817|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44162818|NCT00250796|Growth Substances|growth substances|mesh-ancestor
44162819|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
44162820|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44162821|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44162822|NCT00250861|Aldesleukin|aldesleukin|mesh-list
44162824|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44402792|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402793|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402795|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402796|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402797|NCT02683525|Incretins|incretins|mesh-ancestor
44402798|NCT02683525|Hormones|hormones|mesh-ancestor
44402799|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402800|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44402801|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
44402802|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402803|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402804|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44402805|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402806|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402807|NCT02683187|Incretins|incretins|mesh-ancestor
44402808|NCT02683187|Hormones|hormones|mesh-ancestor
44402809|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402810|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44402811|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
44402812|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402813|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402814|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
44402815|NCT02683109|Olodaterol|olodaterol|mesh-list
44402816|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44162825|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840548|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44162826|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
44162827|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162828|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162829|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44162830|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44162831|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
44162832|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162833|NCT00250874|Docetaxel|docetaxel|mesh-list
44162834|NCT00250874|Doxorubicin|doxorubicin|mesh-list
44162835|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44162836|NCT00250874|Trastuzumab|trastuzumab|mesh-list
44162837|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162838|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
44162845|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162846|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162847|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44162848|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44162849|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44162850|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44162851|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162852|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44162853|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402818|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402819|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402820|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44402821|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
44402822|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
44402823|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44402824|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
44402825|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402826|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402827|NCT02682927|Fenfluramine|fenfluramine|mesh-list
44402828|NCT02682927|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44402829|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44402830|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44402831|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402832|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402833|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
44402834|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402835|NCT02682784|Oxytocin|oxytocin|mesh-list
44402836|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
44402837|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44402838|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402839|NCT02682602|Tacrine|tacrine|mesh-list
44402840|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44402841|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162854|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162855|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162856|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44162857|NCT00250978|Bevacizumab|bevacizumab|mesh-list
44162858|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162859|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162860|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44162861|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44162862|NCT00250978|Growth Substances|growth substances|mesh-ancestor
44162863|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162864|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
44162865|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44162866|NCT00250991|Eptifibatide|eptifibatide|mesh-list
44162867|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44162868|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44162869|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162870|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44162872|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44162873|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162874|NCT00251030|Nelfinavir|nelfinavir|mesh-list
44162875|NCT00251030|Omeprazole|omeprazole|mesh-list
44162876|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44162877|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44402842|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402843|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
44402844|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402845|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402846|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44402847|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
44402848|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402849|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
44402850|NCT02681510|Nicotine|nicotine|mesh-list
44402851|NCT02681510|Varenicline|varenicline|mesh-list
44402852|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44402853|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
44402854|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402855|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402856|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44402857|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44402858|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
44162878|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44162879|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162880|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654030|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654031|NCT02979704|Atorvastatin|atorvastatin|mesh-list
44162881|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44162882|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44162883|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
44162884|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44162885|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44162886|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
44162887|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162888|NCT00251056|Mannitol|mannitol|mesh-list
44162889|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44162890|NCT00251056|Diuretics|diuretics|mesh-ancestor
44162891|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
44162892|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162893|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44162894|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44162895|NCT00251082|Estradiol|estradiol|mesh-list
44162896|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44162897|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
44162898|NCT00251082|Estrogens|estrogens|mesh-ancestor
44162899|NCT00251082|Hormones|hormones|mesh-ancestor
44162900|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44162901|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162902|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44162903|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
44162904|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44162905|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44162906|NCT00251082|Progestins|progestins|mesh-ancestor
44162931|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162933|NCT00251355|Antiviral Agents|antiviral agents|mesh-ancestor
44162934|NCT00251355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44162935|NCT00251355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162936|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162937|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
44162938|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162939|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
44162940|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162941|NCT00251381|Cetuximab|cetuximab|mesh-list
44162942|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162943|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162944|NCT00251394|Rituximab|rituximab|mesh-list
43701624|NCT02723448|Aclarubicin|aclarubicin|mesh-list
44402859|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44402860|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402861|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
44402862|NCT02681094|Saxagliptin|saxagliptin|mesh-list
44402863|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44402864|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402865|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44402866|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402867|NCT02681094|Incretins|incretins|mesh-ancestor
44402868|NCT02681094|Hormones|hormones|mesh-ancestor
44402869|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402870|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44402871|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44402872|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402873|NCT02680847|Naltrexone|naltrexone|mesh-list
44402874|NCT02680847|Oxycodone|oxycodone|mesh-list
44402875|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43787322|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44402876|NCT02680847|Narcotics|narcotics|mesh-ancestor
44402877|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44402878|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402879|NCT02680847|Analgesics|analgesics|mesh-ancestor
44402880|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
44402881|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402882|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44402883|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44402884|NCT02680756|Ferric maltol|ferric maltol|mesh-list
44402885|NCT02680756|Hematinics|hematinics|mesh-ancestor
44402886|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
44402887|NCT02680574|Hematinics|hematinics|mesh-ancestor
44402888|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
44402889|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44162945|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162946|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162947|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
44162948|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162949|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44162950|NCT00251407|Cisplatin|cisplatin|mesh-list
44162951|NCT00251407|Docetaxel|docetaxel|mesh-list
44162952|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162953|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44162954|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162955|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162956|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162958|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43701625|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
44402890|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
44402891|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402892|NCT02679755|Letrozole|letrozole|mesh-list
44402893|NCT02679755|Palbociclib|palbociclib|mesh-list
44402894|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402895|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44402896|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44402897|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402898|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402899|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44402900|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44402901|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44402902|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402903|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44402904|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
44402905|NCT02679573|Linezolid|linezolid|mesh-list
44402906|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44402907|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44402908|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44402909|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44402910|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402911|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402912|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402913|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44402914|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
44402915|NCT02679274|Testosterone|testosterone|mesh-list
44402916|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
44402917|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
44402918|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44402935|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402937|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44402938|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44402939|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402940|NCT02678286|Meloxicam|meloxicam|mesh-list
44402941|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402942|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402943|NCT02678286|Analgesics|analgesics|mesh-ancestor
44402944|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
44402945|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402946|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402947|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402948|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402949|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44402950|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402951|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402952|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402953|NCT02677844|Loperamide|loperamide|mesh-list
44402954|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
44402955|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44402956|NCT02677324|Venetoclax|venetoclax|mesh-list
44402957|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402958|NCT02677116|Doxorubicin|doxorubicin|mesh-list
44402959|NCT02677116|Irinotecan|irinotecan|mesh-list
44402960|NCT02677116|Vincristine|vincristine|mesh-list
44402961|NCT02677116|Ifosfamide|ifosfamide|mesh-list
44402962|NCT02677116|Olaratumab|olaratumab|mesh-list
44402963|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44402964|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44402965|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44402966|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44402967|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402969|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44402978|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402980|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44402981|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44402982|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44402983|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44402984|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402985|NCT02675907|Meloxicam|meloxicam|mesh-list
44402986|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44402987|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44402988|NCT02675907|Analgesics|analgesics|mesh-ancestor
44402989|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
44402990|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44402991|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44402992|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44402993|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44402994|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44402995|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44402996|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44402997|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44402998|NCT02675426|Upadacitinib|upadacitinib|mesh-list
44402999|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44403000|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44403001|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403002|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403003|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403004|NCT02675231|Trastuzumab|trastuzumab|mesh-list
44403005|NCT02675231|Fulvestrant|fulvestrant|mesh-list
44403006|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403007|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403008|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44403009|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44403010|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44403011|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
44162959|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44162960|NCT00251459|Growth Substances|growth substances|mesh-ancestor
44162961|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403012|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403013|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403014|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44403015|NCT02674854|Latanoprost|latanoprost|mesh-list
44403016|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44403017|NCT02674399|Hylan|hylan|mesh-list
44403018|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
44403019|NCT02674399|Protective Agents|protective agents|mesh-ancestor
44403020|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403021|NCT02674204|Atorvastatin|atorvastatin|mesh-list
44403022|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44403023|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44403024|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
44403025|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403026|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44403027|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44403028|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403029|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
44403030|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44403031|NCT02671500|Velpatasvir|velpatasvir|mesh-list
44403032|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
44403033|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403034|NCT02671461|Aspirin|aspirin|mesh-list
44403035|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403036|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403037|NCT02671461|Analgesics|analgesics|mesh-ancestor
44403038|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
44403039|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403040|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403041|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403042|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403043|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44162962|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
44162963|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162965|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44162966|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162967|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44162968|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44162969|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44162970|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162971|NCT00251485|Cetuximab|cetuximab|mesh-list
44162972|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403044|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44403045|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403046|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44403047|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403048|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403050|NCT02671266|Oxytocin|oxytocin|mesh-list
44403051|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
44403052|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403053|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403054|NCT02670915|Insulin|insulin|mesh-list
44403055|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44403056|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
44403057|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
44403058|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44403059|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403060|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403061|NCT02670551|Cariprazine|cariprazine|mesh-list
44403062|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44403063|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403064|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403065|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403066|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403067|NCT02670538|Cariprazine|cariprazine|mesh-list
44403068|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44403069|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403070|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403071|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403072|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44162973|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162974|NCT00251498|Cetuximab|cetuximab|mesh-list
44162975|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162976|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162977|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
44162978|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162979|NCT00251524|Bevacizumab|bevacizumab|mesh-list
44162980|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
44162981|NCT00251524|Pemetrexed|pemetrexed|mesh-list
44162982|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44162983|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162984|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44162985|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44162986|NCT00251524|Growth Substances|growth substances|mesh-ancestor
44162987|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44162988|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44162989|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403073|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44403074|NCT02669407|Lidocaine|lidocaine|mesh-list
44403075|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
44403076|NCT02669407|Anesthetics|anesthetics|mesh-list
43787346|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
44403077|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403078|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403079|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
44403080|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403081|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44403082|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44403083|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44403084|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403085|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403086|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44403087|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403088|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403089|NCT02669043|Ketamine|ketamine|mesh-list
44403090|NCT02669043|Analgesics|analgesics|mesh-ancestor
44403091|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
44403092|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403093|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403094|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44403095|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403096|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
44403097|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
44403098|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403099|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403100|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44403101|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403102|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403103|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44403104|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403105|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403106|NCT02668640|Adalimumab|adalimumab|mesh-list
44403111|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403112|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403113|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403114|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403115|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403116|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44403117|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403118|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44403119|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44403120|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
44403121|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44403122|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
44403123|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403124|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44403125|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403126|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403127|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403128|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
44403129|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403130|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403131|NCT02665689|Ranibizumab|ranibizumab|mesh-list
44403132|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44403133|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44162990|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162991|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44162992|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44162993|NCT00251550|Cisplatin|cisplatin|mesh-list
44162994|NCT00251550|Pemetrexed|pemetrexed|mesh-list
44162995|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44162996|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44162997|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44162998|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44162999|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44163000|NCT00251602|Propranolol|propranolol|mesh-list
44163001|NCT00251602|Atropine|atropine|mesh-list
44163002|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44163003|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44163004|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163005|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163006|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163007|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163008|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44163009|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44163010|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163011|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44163012|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44163013|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
44163014|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163015|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44403135|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403136|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
44403137|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403138|NCT02665286|Naproxen|naproxen|mesh-list
44403139|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44403140|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44403141|NCT02665286|Orphenadrine|orphenadrine|mesh-list
44403142|NCT02665286|Methocarbamol|methocarbamol|mesh-list
44403143|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44403144|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44163016|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
44163017|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
44163018|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
44163019|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44163020|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44163021|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163022|NCT00251654|Anesthetics|anesthetics|mesh-list
44163023|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163024|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163025|NCT00251680|Atorvastatin|atorvastatin|mesh-list
44163026|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44163027|NCT00251680|Simvastatin|simvastatin|mesh-list
44163028|NCT00251680|Fenofibrate|fenofibrate|mesh-list
44163029|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44163030|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44163031|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
44163040|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163041|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163042|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44163043|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44163044|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44163045|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163046|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44163047|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44163048|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44163049|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
44163051|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
44163052|NCT00251732|Rabeprazole|rabeprazole|mesh-list
44163053|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44163054|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163055|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44163056|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710253|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163057|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163058|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163059|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44163060|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44163061|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163062|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163063|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163064|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163065|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
44163066|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163067|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44163068|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44163069|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43603087|NCT03248544|Vitamin D|vitamin d|mesh-list
44163070|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163071|NCT00251784|Urological Agents|urological agents|mesh-ancestor
44163072|NCT00251797|Thalidomide|thalidomide|mesh-list
44163073|NCT00251797|Irinotecan|irinotecan|mesh-list
44163074|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44163075|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163076|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403146|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
44403147|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403148|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403149|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403150|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
44403151|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403152|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403153|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403154|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
44403155|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403156|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44403157|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44403158|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44403159|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44403160|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
44403161|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
44403162|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44403163|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
44403164|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44403165|NCT02664441|Exenatide|exenatide|mesh-list
44403166|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403167|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403168|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44403169|NCT02664441|Incretins|incretins|mesh-ancestor
44403170|NCT02664441|Hormones|hormones|mesh-ancestor
44403171|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403190|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403191|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403192|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44403193|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44403194|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44403195|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44403196|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44403197|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44403198|NCT02663271|Bevacizumab|bevacizumab|mesh-list
44403199|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403200|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403201|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44403202|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44403203|NCT02663271|Growth Substances|growth substances|mesh-ancestor
44403204|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403205|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
44403206|NCT02662764|Sufentanil|sufentanil|mesh-list
44403207|NCT02662764|Dsuvia|dsuvia|mesh-list
44403208|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403209|NCT02662764|Narcotics|narcotics|mesh-ancestor
44403210|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403211|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403212|NCT02662764|Analgesics|analgesics|mesh-ancestor
43710254|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403213|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
44403214|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403215|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44403216|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403217|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
44403218|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
44403219|NCT02662569|Atorvastatin|atorvastatin|mesh-list
44403220|NCT02662569|Evolocumab|evolocumab|mesh-list
44163077|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163078|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163079|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163080|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
44163081|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163082|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
44163083|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44163084|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163085|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44163086|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44163087|NCT00251797|Growth Substances|growth substances|mesh-ancestor
44403221|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44403222|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44403223|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
44403224|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403225|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44403226|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44403227|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403228|NCT02662556|Sufentanil|sufentanil|mesh-list
44403229|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403230|NCT02662556|Narcotics|narcotics|mesh-ancestor
44403231|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403232|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403233|NCT02662556|Analgesics|analgesics|mesh-ancestor
44403234|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
44403235|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403236|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44403237|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403238|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
44403239|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
44403240|NCT02661815|Paclitaxel|paclitaxel|mesh-list
44403241|NCT02661815|Bevacizumab|bevacizumab|mesh-list
44403242|NCT02661815|Ricolinostat|ricolinostat|mesh-list
44403243|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403244|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403245|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403246|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403247|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403248|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403249|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403250|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44403251|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44403252|NCT02661815|Growth Substances|growth substances|mesh-ancestor
44403253|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403254|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
44403255|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44403256|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703956|NCT02707328|Paclitaxel|paclitaxel|mesh-list
44403257|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
44403258|NCT02661594|Amisulpride|amisulpride|mesh-list
44403259|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44403260|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403261|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44403262|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44403263|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403264|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403265|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403266|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403267|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44403268|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403269|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403270|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403271|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44403272|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
44403273|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403274|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44403275|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
44403276|NCT02661490|Vaccines|vaccines|mesh-list
44403277|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
44403278|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403279|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44403280|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44403281|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403282|NCT02661178|Emodepside|emodepside|mesh-list
44403283|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44403284|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403285|NCT02661061|Midazolam|midazolam|mesh-list
44403286|NCT02661061|Ketamine|ketamine|mesh-list
44403287|NCT02661061|Analgesics|analgesics|mesh-ancestor
44403288|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
44403289|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403297|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44403298|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403299|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403300|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44403301|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44403302|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44403303|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403304|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403305|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
44403306|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
44403307|NCT02660983|Donepezil|donepezil|mesh-list
44403308|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44403309|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403310|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787428|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
44403311|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
44403312|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403313|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403314|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
44403315|NCT02660580|Adalimumab|adalimumab|mesh-list
44403316|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403317|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403318|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
44403319|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44403320|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44403321|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
44403322|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44403323|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163088|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44163089|NCT00251823|Eptifibatide|eptifibatide|mesh-list
44163090|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44163091|NCT00251849|KRM 1648|krm 1648|mesh-list
44163092|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44163093|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
44163105|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44163106|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163107|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44163108|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163109|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163110|NCT00251914|Esomeprazole|esomeprazole|mesh-list
44163111|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44163112|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163113|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44163114|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163115|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163116|NCT00251940|Glyburide|glyburide|mesh-list
44163117|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44163118|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163119|NCT00251953|Metformin|metformin|mesh-list
44163120|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403325|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
44403326|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403327|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403328|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44403329|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403331|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
44403332|NCT02660242|Glucagon|glucagon|mesh-list
44403333|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44403334|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403335|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44403336|NCT02660242|Hormones|hormones|mesh-ancestor
44403337|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403338|NCT02660242|Incretins|incretins|mesh-ancestor
44403339|NCT02660229|Morphine|morphine|mesh-list
44403340|NCT02660229|Oxycodone|oxycodone|mesh-list
44403341|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403342|NCT02660229|Narcotics|narcotics|mesh-ancestor
44403343|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403344|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403345|NCT02660229|Analgesics|analgesics|mesh-ancestor
44163121|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163122|NCT00251966|Esomeprazole|esomeprazole|mesh-list
44163123|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44163124|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163125|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44163126|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163127|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163128|NCT00251992|Esomeprazole|esomeprazole|mesh-list
44163129|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44163130|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163131|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44163132|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163133|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163134|NCT00252044|Pergolide|pergolide|mesh-list
44163135|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
44163136|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
44163137|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163138|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163139|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163140|NCT00252122|Ketamine|ketamine|mesh-list
44163141|NCT00252122|Analgesics|analgesics|mesh-ancestor
44163142|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
44163143|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163144|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603127|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
44163145|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44163146|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44163147|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
44163149|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163150|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403346|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
44403347|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403348|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
44403349|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44403350|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44403351|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
44403352|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44403353|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403354|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403355|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
44403356|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403357|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403358|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44403359|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403360|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
44403361|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
44163151|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44163152|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163153|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163154|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44163155|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
44163156|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163180|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44163181|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44163182|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163183|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163184|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163185|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
44163186|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163187|NCT00252304|Astringents|astringents|mesh-ancestor
44163188|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163189|NCT00252317|Captopril|captopril|mesh-list
44163190|NCT00252317|Trandolapril|trandolapril|mesh-list
44163191|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44163192|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
44163193|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163194|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163195|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44163196|NCT00252330|Amibegron|amibegron|mesh-list
44163197|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163198|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163199|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163200|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163201|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163202|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163203|NCT00252343|Amibegron|amibegron|mesh-list
44163204|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163205|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163216|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163217|NCT00252369|Infliximab|infliximab|mesh-list
44163218|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44163219|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163220|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163221|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44163222|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
44163223|NCT00252369|Coagulants|coagulants|mesh-ancestor
44163224|NCT00252408|Hormones|hormones|mesh-list
44163225|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163226|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403362|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
44403363|NCT02659943|Fludarabine|fludarabine|mesh-list
44403364|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44403365|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
44403366|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403367|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403368|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44403369|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
44403370|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403371|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403372|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44403373|NCT02659059|Paclitaxel|paclitaxel|mesh-list
44403374|NCT02659059|Cisplatin|cisplatin|mesh-list
44403375|NCT02659059|Carboplatin|carboplatin|mesh-list
44403376|NCT02659059|Nivolumab|nivolumab|mesh-list
44403377|NCT02659059|Pemetrexed|pemetrexed|mesh-list
44403378|NCT02659059|Ipilimumab|ipilimumab|mesh-list
44403379|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403380|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403381|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403382|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403383|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403384|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403385|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403386|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44403387|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403388|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44061139|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
44403389|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44403390|NCT02658734|Trastuzumab|trastuzumab|mesh-list
44403391|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44403392|NCT02658734|Maytansine|maytansine|mesh-list
44403393|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403400|NCT02658149|Ketorolac|ketorolac|mesh-list
44403405|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403406|NCT02658149|Narcotics|narcotics|mesh-ancestor
44403407|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403408|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403409|NCT02658149|Analgesics|analgesics|mesh-ancestor
44403410|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
43787534|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43787535|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44403411|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403412|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
44403413|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
44403414|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44403415|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44403416|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
44403417|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403418|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403419|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44403420|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44403421|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
44403422|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44403423|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
44403424|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
44403425|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
44403426|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44403427|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403428|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403429|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403430|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403431|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403432|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403433|NCT02658084|Trastuzumab|trastuzumab|mesh-list
44403434|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44403435|NCT02658084|Vinorelbine|vinorelbine|mesh-list
44403436|NCT02658084|Maytansine|maytansine|mesh-list
44403437|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403438|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840569|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
43840570|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
43840571|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787559|NCT04752527|Sorafenib|sorafenib|mesh-list
43787560|NCT04752527|Decitabine|decitabine|mesh-list
43787575|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654050|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43654051|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
43654052|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654053|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787576|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43787577|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43787578|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
43787579|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787580|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43787581|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43787582|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787583|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
43787584|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43609921|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
44403444|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
44403445|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403446|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403447|NCT02657369|Lenvatinib|lenvatinib|mesh-list
44403448|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403449|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44403450|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403451|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403452|NCT02657343|Trastuzumab|trastuzumab|mesh-list
44403453|NCT02657343|Fulvestrant|fulvestrant|mesh-list
44403454|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403455|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403456|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44403457|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44403458|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44403459|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
44403460|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403461|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403462|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
44403463|NCT02657031|Promethazine|promethazine|mesh-list
44061220|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403464|NCT02657031|Ketamine|ketamine|mesh-list
44403465|NCT02657031|Ondansetron|ondansetron|mesh-list
44403466|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
44403467|NCT02657031|Analgesics|analgesics|mesh-ancestor
44403468|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
44403469|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403470|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403471|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44163227|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
44163228|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163229|NCT00252434|Methamphetamine|methamphetamine|mesh-list
44163230|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44163231|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163232|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
44163233|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
44163234|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163235|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
44163236|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163237|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163238|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163239|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44163240|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44163241|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163242|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44163243|NCT00252603|Galantamine|galantamine|mesh-list
44403472|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403473|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
44403474|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
44403475|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403476|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403477|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44403478|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403479|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403480|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
44403481|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
44403482|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44403483|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
44403484|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403485|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44403486|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
44403487|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44403488|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403489|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403490|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44403491|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44403492|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44403493|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
44403494|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44403495|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
44403496|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
44403497|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44403498|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44403499|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
43704130|NCT02706509|Tramadol|tramadol|mesh-list
44163244|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44163245|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163246|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163247|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163248|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163249|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163250|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163251|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
44163252|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163253|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
43603287|NCT03247400|Calcium|calcium|mesh-list
44163254|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44163255|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
44163256|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163257|NCT00252655|Sirolimus|sirolimus|mesh-list
44163258|NCT00252655|Tacrolimus|tacrolimus|mesh-list
44163259|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163260|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
44163261|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403501|NCT02656329|Lugol's solution|lugol's solution|mesh-list
44403502|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403503|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403504|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403505|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44403506|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
44403507|NCT02656329|Coagulants|coagulants|mesh-ancestor
44403508|NCT02656173|Tamsulosin|tamsulosin|mesh-list
44403509|NCT02656173|Mirabegron|mirabegron|mesh-list
44403510|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44403511|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44403512|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44163262|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44163263|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163264|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163265|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44163266|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163267|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44163268|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163297|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44163298|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44163299|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163300|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163301|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163302|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163303|NCT00252785|Budesonide|budesonide|mesh-list
44163304|NCT00252785|Theophylline|theophylline|mesh-list
44163305|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
44163306|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163307|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44163308|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
44163309|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163310|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163311|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44163312|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
44163313|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
44163314|NCT00252785|Hormones|hormones|mesh-ancestor
44163316|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44163318|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163319|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163320|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163321|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163322|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44163323|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163324|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163325|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44163326|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44163327|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
44163328|NCT00252798|Paclitaxel|paclitaxel|mesh-list
44163329|NCT00252798|Carboplatin|carboplatin|mesh-list
44163330|NCT00252798|Gefitinib|gefitinib|mesh-list
44163331|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44163332|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163333|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
44163334|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
44163335|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163336|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163337|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163338|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163339|NCT00252811|Gefitinib|gefitinib|mesh-list
44163340|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403513|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
44403514|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403515|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403516|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403517|NCT02656173|Urological Agents|urological agents|mesh-ancestor
44403518|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44403519|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44403520|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44403521|NCT02656017|Metformin|metformin|mesh-list
44403522|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403523|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403524|NCT02655679|Ether|ether|mesh-list
44403525|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44403526|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
44403527|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
44403528|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403529|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43830929|NCT05337566|Cefuroxime|cefuroxime|mesh-list
44163341|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163342|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163343|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163344|NCT00252824|Budesonide|budesonide|mesh-list
44163345|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
44163346|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163347|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44163348|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
44163349|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163350|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163351|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44163352|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
44163353|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
44163354|NCT00252824|Hormones|hormones|mesh-ancestor
43787774|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787775|NCT02333149|Melatonin|melatonin|mesh-list
43787776|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
43787777|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787778|NCT02333149|Protective Agents|protective agents|mesh-ancestor
43787779|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787780|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787781|NCT02144857|Cyclosporine|cyclosporine|mesh-list
43787782|NCT02144857|Etanercept|etanercept|mesh-list
43787783|NCT02144857|Apremilast|apremilast|mesh-list
43787784|NCT02144857|Ustekinumab|ustekinumab|mesh-list
43787785|NCT02144857|Cyclosporins|cyclosporins|mesh-list
43787786|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787787|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787788|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787789|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
43787790|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163355|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163356|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44163357|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44163358|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163359|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
44163360|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163361|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163362|NCT00252863|Fluticasone|fluticasone|mesh-list
44163363|NCT00252863|Xhance|xhance|mesh-list
44163364|NCT00252863|Budesonide|budesonide|mesh-list
44163365|NCT00252863|Theophylline|theophylline|mesh-list
44163366|NCT00252863|Albuterol|albuterol|mesh-list
44163367|NCT00252863|Terbutaline|terbutaline|mesh-list
44163368|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
44163369|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44163370|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44163371|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44163372|NCT00252863|Montelukast|montelukast|mesh-list
44163373|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163374|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44163375|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
44163376|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163377|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163378|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44163379|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
44403530|NCT02655419|Metronidazole|metronidazole|mesh-list
44403531|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403532|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44403533|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44403534|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43787792|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787793|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787794|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787795|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43787808|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787809|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787810|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403535|NCT02655237|Leuprolide|leuprolide|mesh-list
44403536|NCT02655237|Relugolix|relugolix|mesh-list
44403537|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44403538|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
44403539|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403540|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403541|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44403542|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403543|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
44403544|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
44403545|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403546|NCT02655224|Relugolix|relugolix|mesh-list
44403547|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
44403548|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
44403549|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403550|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403551|NCT02654145|Omalizumab|omalizumab|mesh-list
44403552|NCT02654145|Albuterol|albuterol|mesh-list
44403553|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44403554|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
44403555|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163380|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163381|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44163382|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
44163383|NCT00252863|Hormones|hormones|mesh-ancestor
44163384|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163385|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44163416|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
44163417|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
44163418|NCT00252954|Levetiracetam|levetiracetam|mesh-list
44163419|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
44163420|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
44163421|NCT00253058|Cetirizine|cetirizine|mesh-list
44163422|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44163423|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44163424|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44163425|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
44163426|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
44163427|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163428|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163429|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163435|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163436|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163437|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403556|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403557|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44403558|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
44403559|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
44403560|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403561|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44403562|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44403563|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44403564|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44403565|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403566|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403567|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44403568|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44403569|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44403570|NCT02654054|Norethindrone|norethindrone|mesh-list
44403571|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
44403572|NCT02654054|Estradiol|estradiol|mesh-list
44403573|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44403574|NCT02654054|Estrogens|estrogens|mesh-ancestor
44403575|NCT02654054|Hormones|hormones|mesh-ancestor
44403576|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403577|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403578|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44403579|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
44403580|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403581|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44403582|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44403583|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44403584|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44403585|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
44403586|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44163438|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163439|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163440|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163441|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163442|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163443|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
44163444|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
44163445|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
44163446|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163447|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163448|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44163449|NCT00253123|Risperidone|risperidone|mesh-list
44163450|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44403587|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403588|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44403589|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44403590|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
44403591|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403592|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
44403593|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44403594|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403595|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403596|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403597|NCT02653300|Insulin|insulin|mesh-list
44403598|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403599|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403600|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44403601|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
44403602|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403603|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44403604|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43787965|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
44403605|NCT02652260|Tenofovir|tenofovir|mesh-list
44403606|NCT02652260|Lamivudine|lamivudine|mesh-list
44403607|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44403608|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
44403609|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163451|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
44163452|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163453|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163454|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163455|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163456|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163457|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163458|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163459|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163460|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
44163461|NCT00253136|Risperidone|risperidone|mesh-list
44163462|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163463|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
44163464|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163465|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163466|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163467|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163468|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163469|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163470|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163471|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163472|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
44163473|NCT00253149|Risperidone|risperidone|mesh-list
44163474|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163475|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
44403610|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44403611|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44403612|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403613|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788009|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788010|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
43788011|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43788012|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43654079|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43654080|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
43654081|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
43654082|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43610578|NCT03178643|Renal Agents|renal agents|mesh-ancestor
44403614|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44403615|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44403616|NCT02652156|Bupivacaine|bupivacaine|mesh-list
44403617|NCT02652156|Ropivacaine|ropivacaine|mesh-list
44403618|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
44403619|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
44403620|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403621|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403622|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
44403623|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403624|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
44403625|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403626|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
44403627|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403628|NCT02651987|Lanreotide|lanreotide|mesh-list
44403629|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163476|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163477|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163478|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603511|NCT03245528|Giapreza|giapreza|mesh-list
44163479|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163480|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163481|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163482|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163483|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163484|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
44163485|NCT00253162|Risperidone|risperidone|mesh-list
44163486|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163487|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
44163488|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163489|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163490|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163491|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163492|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163493|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44163494|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163495|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44163496|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
44163497|NCT00253175|Topiramate|topiramate|mesh-list
44163498|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
44163499|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43788013|NCT05228418|Naltrexone|naltrexone|mesh-list
43788014|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43788015|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43788016|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788017|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
43788018|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788019|NCT05222256|Simendan|simendan|mesh-list
43788020|NCT05222256|Epinephrine|epinephrine|mesh-list
43788021|NCT05222256|Racepinephrine|racepinephrine|mesh-list
43788022|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
43788023|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43788024|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44163500|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163521|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163522|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
44163523|NCT00253214|Galantamine|galantamine|mesh-list
44163524|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44163525|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163526|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163527|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163528|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163529|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403631|NCT02651688|Clomiphene|clomiphene|mesh-list
44403632|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
44403633|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44403634|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
44403635|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403636|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403637|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44403638|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
44403639|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403640|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44403641|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44403642|NCT02651220|Adapalene|adapalene|mesh-list
44403643|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44403644|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44403645|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403646|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403647|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403648|NCT02651220|Analgesics|analgesics|mesh-ancestor
44403649|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
44403650|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403651|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403652|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403653|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403654|NCT02651155|Lubiprostone|lubiprostone|mesh-list
44403655|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44403656|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403657|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403658|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
44403673|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44403674|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44403675|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44403676|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43710255|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403677|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403678|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
44403679|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44403680|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403681|NCT02649231|Ketamine|ketamine|mesh-list
44403682|NCT02649231|Analgesics|analgesics|mesh-ancestor
44403683|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
44403684|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403685|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403686|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44403687|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403688|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
44403689|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
44403690|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403691|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44403692|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44403693|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403694|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403695|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44403696|NCT02648698|Levofloxacin|levofloxacin|mesh-list
44403697|NCT02648698|Tinidazole|tinidazole|mesh-list
44403698|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403699|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44403700|NCT02648698|Renal Agents|renal agents|mesh-ancestor
44403701|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44403702|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44403703|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403712|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
44403715|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44403716|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
43788063|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
44403717|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
44403718|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44403719|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
44403720|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403721|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403722|NCT02648204|Dulaglutide|dulaglutide|mesh-list
44403723|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403724|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403725|NCT02647944|Liraglutide|liraglutide|mesh-list
44403726|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403727|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403728|NCT02647944|Incretins|incretins|mesh-ancestor
44403729|NCT02647944|Hormones|hormones|mesh-ancestor
44403730|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403731|NCT02647866|KHK4083|khk4083|mesh-list
44403732|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403733|NCT02647788|Acetaminophen|acetaminophen|mesh-list
44403734|NCT02647788|Ibuprofen|ibuprofen|mesh-list
44403735|NCT02647788|Codeine|codeine|mesh-list
44403736|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403737|NCT02647788|Analgesics|analgesics|mesh-ancestor
44403738|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
44403739|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403740|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403741|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
44403742|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403743|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403744|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403745|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403746|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403747|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403748|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44403749|NCT02647788|Narcotics|narcotics|mesh-ancestor
43704267|NCT05244031|Analgesics|analgesics|mesh-ancestor
44163530|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163531|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
44163532|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163533|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
44403750|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403751|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
44403752|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
44403753|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44403755|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403756|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403757|NCT02647320|Incretins|incretins|mesh-ancestor
44403758|NCT02647320|Hormones|hormones|mesh-ancestor
44403759|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403760|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44403761|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
44403762|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403763|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403764|NCT02646332|Amoxicillin|amoxicillin|mesh-list
43788107|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44403765|NCT02646332|Metronidazole|metronidazole|mesh-list
44403766|NCT02646332|Clarithromycin|clarithromycin|mesh-list
44403767|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
44403768|NCT02646332|Lansoprazole|lansoprazole|mesh-list
44403769|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44403770|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403771|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44403772|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44403773|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44403774|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403775|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403776|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44403777|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44403796|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
44403797|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
44403798|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
44403799|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44403800|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44403801|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403802|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44403803|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44403804|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44403805|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403806|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403807|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44403808|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
44403809|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
44403810|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
44403811|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
44403812|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403813|NCT02644967|Ipilimumab|ipilimumab|mesh-list
44403814|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44403815|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403816|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44403817|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403818|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
44403819|NCT02643420|Docetaxel|docetaxel|mesh-list
44403820|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44403821|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
44403822|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403823|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403824|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44163534|NCT00253227|Galantamine|galantamine|mesh-list
44163535|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44163536|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163537|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163538|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
44163539|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163540|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163541|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44163542|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
44163543|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163544|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
44163545|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44163546|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44163547|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
44163548|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44163549|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44163550|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163551|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403825|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
44403826|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403827|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403828|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44403829|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
44061516|NCT05597163|Atropine|atropine|mesh-list
44403830|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403831|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403832|NCT02643394|Acetaminophen|acetaminophen|mesh-list
44403833|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403834|NCT02643394|Analgesics|analgesics|mesh-ancestor
44403835|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
44403836|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403837|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403838|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
44403840|NCT02643355|Olanzapine|olanzapine|mesh-list
44403841|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
44403842|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
44403843|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403844|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163552|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163553|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43603584|NCT03244930|Plerixafor|plerixafor|mesh-list
44163568|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44163570|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
44163571|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163572|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163573|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44163574|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
44163575|NCT00253318|Hormones|hormones|mesh-ancestor
44163576|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163577|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44163578|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163579|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44163580|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44163581|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163582|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163583|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163584|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
44163585|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
44163586|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
44163587|NCT00253344|Docetaxel|docetaxel|mesh-list
44163588|NCT00253344|Lenalidomide|lenalidomide|mesh-list
44163589|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163590|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
44163591|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
44163592|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
44163593|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163594|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
44163595|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163596|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44163597|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44163598|NCT00253344|Growth Substances|growth substances|mesh-ancestor
44163599|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44163601|NCT00253396|Enoxaparin|enoxaparin|mesh-list
44163602|NCT00253396|Calcium heparin|calcium heparin|mesh-list
44403845|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44403846|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44403847|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44403848|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44403849|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44403850|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44403851|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44403852|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44403853|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403854|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403855|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
44403856|NCT02643355|Analgesics|analgesics|mesh-ancestor
44403857|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
44403858|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44403859|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
44403860|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44403861|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44403862|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44403863|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
44403864|NCT02643251|Clonidine|clonidine|mesh-list
44403865|NCT02643251|Analgesics|analgesics|mesh-ancestor
44403866|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
44403867|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403868|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163603|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
44163604|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44163605|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44163606|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163607|NCT00253422|Fulvestrant|fulvestrant|mesh-list
44163608|NCT00253422|Anastrozole|anastrozole|mesh-list
44163609|NCT00253422|Exemestane|exemestane|mesh-list
44163610|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44163611|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163612|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44163613|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44163614|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44163615|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44163626|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163627|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163628|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44163629|NCT00253474|Interferons|interferons|mesh-list
44163630|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
44163631|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
44163632|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44163633|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163634|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
44163635|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163636|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
44163637|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163638|NCT00253487|Temozolomide|temozolomide|mesh-list
44403869|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44403870|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
44403871|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
44403872|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44403873|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44403874|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44403875|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
44403876|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44403877|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403879|NCT02642653|L 647318|l 647318|mesh-list
44403880|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
44403881|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44403882|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44403883|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
44403884|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403885|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44403886|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44403887|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403888|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
44403889|NCT02642159|Niacin|niacin|mesh-list
44403890|NCT02642159|Niacinamide|niacinamide|mesh-list
44403891|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44403892|NCT02642159|Ezetimibe|ezetimibe|mesh-list
44403893|NCT02642159|Fenofibrate|fenofibrate|mesh-list
44403894|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44403895|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44403896|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
44403897|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403898|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44403899|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
44163639|NCT00253487|Busulfan|busulfan|mesh-list
44163640|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44163641|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44163642|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
44163643|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163644|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163645|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163646|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
44163647|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163648|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44163649|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163650|NCT00253500|Epirubicin|epirubicin|mesh-list
44163651|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44163652|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403901|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
44403902|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403903|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
44403904|NCT02641379|Ribavirin|ribavirin|mesh-list
44403905|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44061596|NCT05550129|Metformin|metformin|mesh-list
44403906|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
44403907|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403908|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
44403909|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403910|NCT02641080|Aspirin|aspirin|mesh-list
44403911|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44403912|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44403913|NCT02641080|Analgesics|analgesics|mesh-ancestor
44403914|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
44403915|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44403916|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403917|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44403918|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403919|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44403920|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44403921|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403922|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43704416|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
44163653|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44163654|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163655|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163656|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163658|NCT00253526|Bevacizumab|bevacizumab|mesh-list
44163659|NCT00253526|Antibodies|antibodies|mesh-list
44163660|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
44163661|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44163662|NCT00253526|Mitogens|mitogens|mesh-list
44163663|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44163664|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163665|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44163666|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44163667|NCT00253526|Growth Substances|growth substances|mesh-ancestor
44163668|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163669|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
44163670|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
44163671|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44163672|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
44163673|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163674|NCT00253526|Antiviral Agents|antiviral agents|mesh-ancestor
44163675|NCT00253526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163676|NCT00253526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163677|NCT00253526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163678|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403923|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44403924|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403925|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
44403926|NCT02640755|Paclitaxel|paclitaxel|mesh-list
44403927|NCT02640755|Fulvestrant|fulvestrant|mesh-list
44403928|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403929|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403930|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403931|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403932|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403933|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403934|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44403935|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44403936|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44403937|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
44403938|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44403939|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403940|NCT02640404|Vaccines|vaccines|mesh-list
44403941|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
44403942|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403943|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
44403944|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
44403945|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44403946|NCT02640053|Paclitaxel|paclitaxel|mesh-list
44403947|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44403948|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44403949|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403950|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44403951|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44403952|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44403953|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403954|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
44403966|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403968|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44403969|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
44403970|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44403971|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654096|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
44403972|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44403973|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
44403974|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44403975|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44403976|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403977|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44403978|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44403979|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44403980|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
44061667|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
44403981|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44403982|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44403983|NCT02638259|GP2015|gp2015|mesh-list
44403984|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
44403985|NCT02638129|Naltrexone|naltrexone|mesh-list
44403986|NCT02638129|Bupropion|bupropion|mesh-list
44403987|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44403988|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44403989|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44403990|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
44403991|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404011|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404012|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404014|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44404015|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44404016|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404017|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404018|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
44404019|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44404020|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44404021|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44404022|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44404023|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
44404024|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
44404025|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404026|NCT02637323|Triamcinolone|triamcinolone|mesh-list
44404027|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44404028|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44404029|NCT02637323|FX006|fx006|mesh-list
44404030|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44404031|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404032|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
44404033|NCT02637323|Hormones|hormones|mesh-ancestor
44404034|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404035|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404036|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404037|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
44404038|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404039|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404040|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44163679|NCT00253539|Tamoxifen|tamoxifen|mesh-list
44163680|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44163681|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
43603726|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43603727|NCT03243331|Gedatolisib|gedatolisib|mesh-list
43603728|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43603729|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163698|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44163699|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44163700|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
44163701|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404041|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44404042|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44404043|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44404044|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44404045|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
44404046|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404047|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404048|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404049|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
44404050|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44404051|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44404052|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
44404053|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
44061749|NCT05431543|Aceclidine|aceclidine|mesh-list
44404054|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404055|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404056|NCT02637037|Metformin|metformin|mesh-list
44404057|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
44404058|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404059|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404060|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44404061|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404062|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
44404063|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404064|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404065|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44404066|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44404067|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404068|NCT02635984|Olanzapine|olanzapine|mesh-list
44404081|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404082|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404083|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
44404085|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
44404086|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404087|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404088|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404089|NCT02635386|Metformin|metformin|mesh-list
44404090|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
44404091|NCT02635386|Exenatide|exenatide|mesh-list
44404092|NCT02635386|Topiramate|topiramate|mesh-list
44404093|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44404094|NCT02635386|Phentermine|phentermine|mesh-list
44404095|NCT02635386|Glucagon|glucagon|mesh-list
44404096|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44404097|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404098|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404099|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404100|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44404101|NCT02635386|Incretins|incretins|mesh-ancestor
44404102|NCT02635386|Hormones|hormones|mesh-ancestor
44404103|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404104|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
44404105|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404106|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44404107|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
44404108|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
44404109|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
44404110|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404111|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
44404125|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44404126|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
44404127|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404128|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404129|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404130|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404131|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43611585|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404132|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404133|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
44404134|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404135|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44061825|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
44404136|NCT02634788|Buprenorphine|buprenorphine|mesh-list
44404137|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44404138|NCT02634788|Narcotics|narcotics|mesh-ancestor
44404139|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404140|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404141|NCT02634788|Analgesics|analgesics|mesh-ancestor
44404142|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
44404143|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404144|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44404145|NCT02634606|Tocotrienols|tocotrienols|mesh-list
44404147|NCT02634606|Tocopherols|tocopherols|mesh-list
44404148|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
44404149|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404150|NCT02634606|Protective Agents|protective agents|mesh-ancestor
44404151|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404152|NCT02634606|Vitamins|vitamins|mesh-ancestor
44404173|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44404174|NCT02634346|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44404175|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44404176|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44404177|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404178|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404179|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
44404181|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
44404182|NCT02634333|Mitogens|mitogens|mesh-list
44404183|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404184|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404185|NCT02634333|Growth Substances|growth substances|mesh-ancestor
44404186|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404187|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404188|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404189|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404190|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404191|NCT02634320|Aripiprazole|aripiprazole|mesh-list
44404192|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
44404193|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
44404194|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44404195|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44404196|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44404197|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404198|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404199|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
44404200|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
44404201|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163702|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163703|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44163704|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44163705|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
44163706|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44163707|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44163709|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163710|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163711|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43710256|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
43611675|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43611676|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849366|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
43611682|NCT03170284|Bevacizumab|bevacizumab|mesh-list
44163712|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44404202|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404203|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44404204|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44404205|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
44404206|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44404207|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44404208|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44404209|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44404210|NCT02633800|Cisplatin|cisplatin|mesh-list
44061914|NCT05160597|Edetic Acid|edetic acid|mesh-list
44404211|NCT02633800|Carboplatin|carboplatin|mesh-list
44404212|NCT02633800|Cetuximab|cetuximab|mesh-list
44404213|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404214|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404215|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44404216|NCT02633046|Hormones|hormones|mesh-ancestor
44404217|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404218|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404219|NCT02632747|Empagliflozin|empagliflozin|mesh-list
44404220|NCT02632747|Ramipril|ramipril|mesh-list
44404221|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44404222|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404223|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404224|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404225|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44404226|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
44404227|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404228|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44404229|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44404230|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44404231|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163713|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44163714|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44163715|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163716|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
44163717|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163718|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44163719|NCT00253565|Capecitabine|capecitabine|mesh-list
44163720|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
44163721|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44163722|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
44163723|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404232|NCT02631876|Paclitaxel|paclitaxel|mesh-list
44404233|NCT02631876|Maytansine|maytansine|mesh-list
44404234|NCT02631876|Doxorubicin|doxorubicin|mesh-list
44404235|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44404236|NCT02631876|Topotecan|topotecan|mesh-list
44404237|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404238|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404239|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404240|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
43788320|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
43788321|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43611749|NCT03169764|Avelumab|avelumab|mesh-list
44404241|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404242|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404243|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44404244|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44404245|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44404246|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404247|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44404248|NCT02631746|Nivolumab|nivolumab|mesh-list
44404249|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404250|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43704625|NCT04558216|Rifampin|rifampin|mesh-list
44163724|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163725|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44163726|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163727|NCT00253578|Sorafenib|sorafenib|mesh-list
44163728|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163740|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44163741|NCT00253617|Trioxsalen|trioxsalen|mesh-list
44163742|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163743|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
44163744|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44163745|NCT00253721|Melphalan|melphalan|mesh-list
44163746|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44163747|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
44163748|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163749|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163750|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44163751|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44163752|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
44163753|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163754|NCT00253773|Acetaminophen|acetaminophen|mesh-list
44163755|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44163756|NCT00253773|Analgesics|analgesics|mesh-ancestor
44163757|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
44163758|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163759|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163760|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
44163761|NCT00253799|Hylan|hylan|mesh-list
44163762|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
44163763|NCT00253799|Protective Agents|protective agents|mesh-ancestor
44163764|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163765|NCT00253851|Heparin|heparin|mesh-list
44163766|NCT00253851|Calcium heparin|calcium heparin|mesh-list
44163767|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
44163768|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44163769|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44163770|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163771|NCT00253903|SR 46349B|sr 46349b|mesh-list
44163772|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44404251|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44404252|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404253|NCT02631577|Lenalidomide|lenalidomide|mesh-list
44404254|NCT02631577|Atezolizumab|atezolizumab|mesh-list
44404255|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
44404256|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
44404257|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404258|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43788322|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404259|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404260|NCT02631577|Growth Substances|growth substances|mesh-ancestor
44404261|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404262|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404263|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404264|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
44404265|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44404266|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404267|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404268|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44404269|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44404270|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44404271|NCT02631551|Analgesics|analgesics|mesh-ancestor
44404272|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
44404273|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404274|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404275|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404276|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44404277|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44404278|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
44404279|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
44404280|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404281|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404282|NCT02631538|Rituximab|rituximab|mesh-list
44404283|NCT02631538|Belimumab|belimumab|mesh-list
44404284|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404290|NCT02631148|Melatonin|melatonin|mesh-list
44404291|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
44404292|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404293|NCT02631148|Protective Agents|protective agents|mesh-ancestor
44404294|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404295|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404296|NCT02630966|Vedolizumab|vedolizumab|mesh-list
44404297|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404298|NCT02630706|Metformin|metformin|mesh-list
44404299|NCT02630706|Glimepiride|glimepiride|mesh-list
44404300|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
44404301|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404302|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404303|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44404304|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404305|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
44404306|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44404307|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404308|NCT02630693|Tamoxifen|tamoxifen|mesh-list
44404309|NCT02630693|Fulvestrant|fulvestrant|mesh-list
44404310|NCT02630693|Palbociclib|palbociclib|mesh-list
44404311|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
44404312|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44404313|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
44404314|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404315|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404316|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44404317|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404318|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44404319|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44404320|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44404321|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44404322|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404323|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404324|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404325|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44163773|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44404327|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
44404328|NCT02630563|Cyclosporins|cyclosporins|mesh-list
44404329|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404330|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404331|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404332|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
44404333|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404334|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
44404335|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404336|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404337|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404338|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44404339|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44404340|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404341|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44404342|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
44404343|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404344|NCT02630472|Quinine|quinine|mesh-list
44404345|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
44404346|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44404347|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44404348|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404349|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44404350|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404351|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44404352|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404353|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44404354|NCT02630472|Analgesics|analgesics|mesh-ancestor
44404355|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
44404356|NCT02630186|Atezolizumab|atezolizumab|mesh-list
44404357|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404358|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
44404359|NCT02629965|Olodaterol|olodaterol|mesh-list
44404360|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44062052|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44404366|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
44404367|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44404368|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
44404369|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404370|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404372|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44404373|NCT02629861|Katacalcin|katacalcin|mesh-list
44404374|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44404375|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404376|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44404377|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
44404378|NCT02629822|Tenofovir|tenofovir|mesh-list
44404379|NCT02629822|Lamivudine|lamivudine|mesh-list
44404380|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
44404381|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404382|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44404383|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44404384|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404385|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404386|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44404387|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44404388|NCT02629159|Adalimumab|adalimumab|mesh-list
44404389|NCT02629159|Upadacitinib|upadacitinib|mesh-list
44404390|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404391|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404392|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44404393|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404394|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404395|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404396|NCT02628769|Solithromycin|solithromycin|mesh-list
44404409|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654107|NCT02978976|Betamethasone|betamethasone|mesh-list
44404410|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404411|NCT02627144|Interferons|interferons|mesh-list
44404412|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
44404413|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
44404414|NCT02627144|Bevacizumab|bevacizumab|mesh-list
44404415|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404416|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404417|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404418|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404419|NCT02627144|Growth Substances|growth substances|mesh-ancestor
44404420|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404421|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404422|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
44404423|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404424|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
44404425|NCT02626520|Gemcitabine|gemcitabine|mesh-list
44404426|NCT02626520|Paclitaxel|paclitaxel|mesh-list
44404427|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44404428|NCT02626520|Fluorouracil|fluorouracil|mesh-list
44404429|NCT02626520|Irinotecan|irinotecan|mesh-list
44404430|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404431|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404432|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404433|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
44404434|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404435|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062094|NCT04910568|Dexamethasone|dexamethasone|mesh-list
44404436|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44404437|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
44404439|NCT02626520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404440|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404441|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404442|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
44404443|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404444|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44404449|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44404450|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404451|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404452|NCT02626182|Urological Agents|urological agents|mesh-ancestor
44404453|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
44404454|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44404455|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404456|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404457|NCT02625974|Nifurtimox|nifurtimox|mesh-list
44404458|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44404459|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44404460|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44404461|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404462|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
44404463|NCT02625909|Velpatasvir|velpatasvir|mesh-list
44404464|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
44404465|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404466|NCT02625623|Paclitaxel|paclitaxel|mesh-list
44404467|NCT02625623|Irinotecan|irinotecan|mesh-list
44404468|NCT02625623|Avelumab|avelumab|mesh-list
44404469|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404470|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404471|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404472|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
44404473|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404474|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404475|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44404476|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44404477|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404478|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404479|NCT02625259|Lansoprazole|lansoprazole|mesh-list
44404480|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
44404481|NCT02625259|Serabelisib|serabelisib|mesh-list
44404482|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44404487|NCT02624986|Rituximab|rituximab|mesh-list
44404492|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404493|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404494|NCT02624492|Rituximab|rituximab|mesh-list
44404495|NCT02624492|BI 836826|bi 836826|mesh-list
44404496|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404497|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404498|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
44404499|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404500|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404501|NCT02624050|Propofol|propofol|mesh-list
44404502|NCT02624050|Methohexital|methohexital|mesh-list
44404503|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44404504|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404505|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404506|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44404507|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
44404508|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
44404509|NCT02623959|Doxycycline|doxycycline|mesh-list
44404510|NCT02623959|Fentanyl|fentanyl|mesh-list
44404511|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44404512|NCT02623959|Narcotics|narcotics|mesh-ancestor
44404513|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404514|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404515|NCT02623959|Analgesics|analgesics|mesh-ancestor
44404516|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
44404517|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404518|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44404519|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44404520|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
44404521|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
44404522|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404523|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404524|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
44404525|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44404526|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44404527|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
44404528|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44404532|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
44404533|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404534|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404535|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44404536|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404537|NCT02622724|Interferons|interferons|mesh-list
44404538|NCT02622724|Interferon-beta|interferon-beta|mesh-list
44404539|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
44404540|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404541|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
44404542|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404543|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
44404544|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404545|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44404546|NCT02622386|Riboflavin|riboflavin|mesh-list
44404547|NCT02622386|Vitamins|vitamins|mesh-ancestor
44404548|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
44404549|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404550|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
44404551|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44404552|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404553|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
44404554|NCT02622321|Coagulants|coagulants|mesh-ancestor
44404555|NCT02622113|Canagliflozin|canagliflozin|mesh-list
44404556|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404557|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404558|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44404559|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404561|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44404562|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
44404563|NCT02622074|Carboplatin|carboplatin|mesh-list
44404564|NCT02622074|Doxorubicin|doxorubicin|mesh-list
44404565|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
44404566|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404567|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404568|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404569|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
44404570|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
43701626|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44404571|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404572|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404573|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
44404574|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404575|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404576|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44404577|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
44404578|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44404579|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44404580|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44404581|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44404582|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404583|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404584|NCT02621931|Calcitonin|calcitonin|mesh-list
44404585|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44404586|NCT02621931|Katacalcin|katacalcin|mesh-list
44404587|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44404588|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404589|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44404590|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
44404591|NCT02620787|Tedizolid|tedizolid|mesh-list
44404592|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404593|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404594|NCT02620384|Metolazone|metolazone|mesh-list
44404595|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43788471|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163774|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163775|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44163776|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44163777|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
44163778|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163779|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163781|NCT00253929|Nitroprusside|nitroprusside|mesh-list
44163783|NCT00253929|Caffeine|caffeine|mesh-list
44163784|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44163785|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163786|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44163787|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163788|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163789|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44163790|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44163791|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
44163792|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44163793|NCT00253929|Analgesics|analgesics|mesh-ancestor
44163794|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
44163810|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44163811|NCT00253955|Renal Agents|renal agents|mesh-ancestor
44163812|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44163813|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44404596|NCT02620384|Diuretics|diuretics|mesh-ancestor
44404597|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
44404598|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404599|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44404600|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44404601|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404602|NCT02620020|Fasinumab|fasinumab|mesh-list
44404603|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44404604|NCT02620020|Analgesics|analgesics|mesh-ancestor
44404605|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
44404606|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404607|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404608|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44404609|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
44404610|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44404611|NCT02619812|Antibodies|antibodies|mesh-list
44404612|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
44404613|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404614|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44404615|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44404616|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
44404617|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404618|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44404619|NCT02619682|Lenalidomide|lenalidomide|mesh-list
44404620|NCT02619682|Ixazomib|ixazomib|mesh-list
44404621|NCT02619682|Glycine|glycine|mesh-list
44404622|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
44404623|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404624|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43704842|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163814|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44163815|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163816|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163817|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44163818|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44163819|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44163820|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44163821|NCT00254007|Citalopram|citalopram|mesh-list
44163822|NCT00254007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44163823|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44163824|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44163825|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163826|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788500|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
44404625|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404626|NCT02619682|Growth Substances|growth substances|mesh-ancestor
44404627|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404628|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404629|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404630|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
44404631|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404633|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404634|NCT02619617|Pasireotide|pasireotide|mesh-list
44404635|NCT02619617|Hormones|hormones|mesh-ancestor
44404636|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404637|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404638|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
44404639|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44404640|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44404641|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404642|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
44404643|NCT02618382|Coagulants|coagulants|mesh-ancestor
44404644|NCT02617628|Naltrexone|naltrexone|mesh-list
44404645|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44404646|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44404647|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404648|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
44404649|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404650|NCT02617589|Nivolumab|nivolumab|mesh-list
44404651|NCT02617589|Temozolomide|temozolomide|mesh-list
44404652|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404653|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404654|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44404656|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44404670|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44404671|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404672|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404673|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44404674|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404675|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404676|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404677|NCT02616601|Fluorouracil|fluorouracil|mesh-list
44404678|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
44404679|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404680|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44404681|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404682|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404683|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
44404684|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404685|NCT02616393|XL647|xl647|mesh-list
44404686|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404687|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404688|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404689|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404690|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44404691|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44404692|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44404693|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
44404694|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404695|NCT02614898|Eculizumab|eculizumab|mesh-list
44404696|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44404697|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404698|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
44404699|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404700|NCT02614859|Metformin|metformin|mesh-list
44106654|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44106655|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
44106656|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106657|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44106658|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44106659|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106660|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106661|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44106662|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44106663|NCT00076856|Temozolomide|temozolomide|mesh-list
44404702|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404703|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404704|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
44404705|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
44404706|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404707|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404709|NCT02614794|Trastuzumab|trastuzumab|mesh-list
44404710|NCT02614794|Tucatinib|tucatinib|mesh-list
44404711|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43788526|NCT02812433|Urological Agents|urological agents|mesh-ancestor
43788527|NCT02673996|Phenylephrine|phenylephrine|mesh-list
43788528|NCT02673996|Isoproterenol|isoproterenol|mesh-list
43788529|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
43788530|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43788531|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
43788532|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
43788533|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788534|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654113|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43654114|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
43734418|NCT02540070|Ropivacaine|ropivacaine|mesh-list
43612750|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404712|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
44404713|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404714|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404715|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404716|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404717|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404718|NCT02614703|Acetic Acid|acetic acid|mesh-list
44404719|NCT02614703|Retinol acetate|retinol acetate|mesh-list
44404720|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404721|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404722|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44404723|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
44404724|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404725|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44404726|NCT02614703|Protective Agents|protective agents|mesh-ancestor
44404727|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404728|NCT02614560|Fludarabine|fludarabine|mesh-list
44404729|NCT02614560|Melphalan|melphalan|mesh-list
44404730|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404731|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404732|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404733|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
44404734|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404735|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44404736|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
44106664|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44404737|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44404738|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
44404739|NCT02614066|Fludarabine|fludarabine|mesh-list
44404740|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44404741|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
44404742|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404743|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44404744|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44404745|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
44404746|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404747|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404748|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44404749|NCT02613910|Acetaminophen|acetaminophen|mesh-list
44404750|NCT02613910|Cetirizine|cetirizine|mesh-list
44404751|NCT02613910|Prednisone|prednisone|mesh-list
44404752|NCT02613910|Prednisolone|prednisolone|mesh-list
44404753|NCT02613910|Ofatumumab|ofatumumab|mesh-list
44404754|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
44404755|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44404756|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404757|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
44404758|NCT02613910|Hormones|hormones|mesh-ancestor
44404759|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404760|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404761|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44404762|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404763|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44404764|NCT02613910|Analgesics|analgesics|mesh-ancestor
44404765|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
44404766|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404767|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
44404768|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44404769|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44404770|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
44404779|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
44062461|NCT04360473|Ketamine|ketamine|mesh-list
44404780|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404781|NCT02613572|Protective Agents|protective agents|mesh-ancestor
44404782|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404783|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
44404785|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
44404786|NCT02613507|Docetaxel|docetaxel|mesh-list
44404787|NCT02613507|Nivolumab|nivolumab|mesh-list
44404788|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404789|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404790|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
44404791|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404792|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404793|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404794|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44404795|NCT02613403|Ribavirin|ribavirin|mesh-list
44404796|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
44404797|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
44404798|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404799|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
44404800|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404801|NCT02613221|Panitumumab|panitumumab|mesh-list
44404802|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404803|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404804|NCT02613208|Paclitaxel|paclitaxel|mesh-list
44404805|NCT02613208|Bevacizumab|bevacizumab|mesh-list
44404806|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404807|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404808|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404809|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106665|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
44106666|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106667|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106668|NCT00076869|Amphotericin B|amphotericin b|mesh-list
44106669|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44106670|NCT00076869|Caspofungin|caspofungin|mesh-list
44106671|NCT00076869|Amebicides|amebicides|mesh-ancestor
44106672|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44106673|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44106674|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106675|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44106676|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
44106677|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106678|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163827|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
44404810|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404811|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404812|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404813|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404814|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404815|NCT02613208|Growth Substances|growth substances|mesh-ancestor
44404816|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404817|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404818|NCT02613169|Isoniazid|isoniazid|mesh-list
44404819|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
44404820|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44404821|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788556|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404822|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44404823|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44404824|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
44404825|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404826|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44404827|NCT02612779|Dexamethasone|dexamethasone|mesh-list
44404828|NCT02612779|Nivolumab|nivolumab|mesh-list
44404829|NCT02612779|Pomalidomide|pomalidomide|mesh-list
44404830|NCT02612779|Elotuzumab|elotuzumab|mesh-list
44404831|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404832|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
44404833|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
43704987|NCT03746769|Gastrins|gastrins|mesh-list
44153480|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44153481|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44153482|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44153483|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820420|NCT05613842|Copper|copper|mesh-list
44153484|NCT00220480|Citalopram|citalopram|mesh-list
44106679|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
44106680|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106681|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106682|NCT00076986|Carmustine|carmustine|mesh-list
44106683|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106687|NCT00077025|Gefitinib|gefitinib|mesh-list
44106688|NCT00077025|Anastrozole|anastrozole|mesh-list
44106689|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106690|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44106691|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106692|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106693|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106694|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44106695|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44106696|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43549756|NCT03629717|Vitamin D|vitamin d|mesh-list
44106698|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106699|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106700|NCT00077051|Cisplatin|cisplatin|mesh-list
44106701|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
44404834|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404835|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404836|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404837|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
44404838|NCT02612779|Hormones|hormones|mesh-ancestor
44404839|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404840|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44404841|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404842|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404843|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44404844|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404845|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
44404846|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404847|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404848|NCT02612779|Growth Substances|growth substances|mesh-ancestor
44404849|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404850|NCT02612194|Crizotinib|crizotinib|mesh-list
44404851|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654115|NCT02979132|Iron|iron|mesh-list
44404852|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404853|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404854|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404855|NCT02612077|Bevacizumab|bevacizumab|mesh-list
44404856|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44404857|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404858|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404859|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404860|NCT02612077|Growth Substances|growth substances|mesh-ancestor
44404861|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404862|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404863|NCT02612064|Fluorides|fluorides|mesh-list
44404864|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
44404865|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
44404866|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
44404867|NCT02612064|Protective Agents|protective agents|mesh-ancestor
44404872|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
44404873|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
44404874|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404875|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
44404876|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44404877|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44404878|NCT02611778|Ranibizumab|ranibizumab|mesh-list
44404879|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44404880|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44404881|NCT02611778|Growth Substances|growth substances|mesh-ancestor
44404882|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404883|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
44404884|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404885|NCT02611752|Buprenorphine|buprenorphine|mesh-list
44404886|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44404887|NCT02611752|Narcotics|narcotics|mesh-ancestor
44404888|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44404889|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404890|NCT02611752|Analgesics|analgesics|mesh-ancestor
44404891|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
44404892|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404893|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44404894|NCT02610816|Fluticasone|fluticasone|mesh-list
44404896|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44404897|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44404898|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
44404899|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44404900|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404901|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44404902|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
44404903|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
44404904|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44404905|NCT02610777|Azacitidine|azacitidine|mesh-list
44404906|NCT02610777|Pevonedistat|pevonedistat|mesh-list
44404907|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44404908|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
44404912|NCT02610231|Istradefylline|istradefylline|mesh-list
44404913|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44404914|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44404915|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44404916|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
44404917|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44404918|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404919|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404920|NCT02610140|Vinorelbine|vinorelbine|mesh-list
44404921|NCT02610140|Maytansine|maytansine|mesh-list
44404922|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44404923|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404924|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
44404925|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
44404926|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
44404927|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404928|NCT02609984|Atezolizumab|atezolizumab|mesh-list
44404929|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404930|NCT02609659|Ritonavir|ritonavir|mesh-list
44404931|NCT02609659|Ribavirin|ribavirin|mesh-list
44404932|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44404933|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44404934|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
44404935|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404936|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404937|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44404938|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44404939|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
44404940|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404941|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44404942|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44404943|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
44404944|NCT02609607|Bisacodyl|bisacodyl|mesh-list
44404945|NCT02609607|Cathartics|cathartics|mesh-ancestor
44404946|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44404947|NCT02609607|Laxatives|laxatives|mesh-ancestor
44404952|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404953|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404954|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
44404955|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44404956|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404957|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
44404958|NCT02608099|Apixaban|apixaban|mesh-list
44404959|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44404960|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
44404961|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44404962|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
44404963|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404964|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404965|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
44404966|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44404967|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404968|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404969|NCT02607865|Incretins|incretins|mesh-ancestor
44404970|NCT02607865|Hormones|hormones|mesh-ancestor
44404971|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44404972|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44404973|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
44404974|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404975|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44404976|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
44404977|NCT02607800|Velpatasvir|velpatasvir|mesh-list
44404978|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
44404979|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404980|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
44404981|NCT02607735|Velpatasvir|velpatasvir|mesh-list
44404982|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
44404983|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44404984|NCT02607306|Insulin|insulin|mesh-list
44404985|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44106702|NCT00077051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106703|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
44106704|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106705|NCT00077077|Capecitabine|capecitabine|mesh-list
44106706|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106707|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
44106708|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106709|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404986|NCT02607306|Liraglutide|liraglutide|mesh-list
44404987|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
44404988|NCT02607306|Xultophy|xultophy|mesh-list
44404989|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44404990|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44404991|NCT02607306|Incretins|incretins|mesh-ancestor
44404992|NCT02607306|Hormones|hormones|mesh-ancestor
44404993|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44062693|NCT04078568|Hormones|hormones|mesh-ancestor
44404994|NCT02606877|Pirfenidone|pirfenidone|mesh-list
44404995|NCT02606877|Nintedanib|nintedanib|mesh-list
44404996|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44404997|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44404998|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44404999|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405000|NCT02606877|Analgesics|analgesics|mesh-ancestor
44405001|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
44405002|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405003|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405004|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44405005|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405006|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405007|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405008|NCT02606279|Valsartan|valsartan|mesh-list
44405009|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44405010|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44405011|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44405012|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405013|NCT02606253|Metolazone|metolazone|mesh-list
44106710|NCT00077103|Cisplatin|cisplatin|mesh-list
44106711|NCT00077103|Doxorubicin|doxorubicin|mesh-list
44106712|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44106713|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
44106714|NCT00077103|Combretastatin|combretastatin|mesh-list
44106715|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106716|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106717|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106718|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106719|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106720|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106721|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106722|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106723|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106724|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106725|NCT00077116|Cytarabine|cytarabine|mesh-list
44106726|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
44106727|NCT00077116|Busulfan|busulfan|mesh-list
44106728|NCT00077116|Idarubicin|idarubicin|mesh-list
44405014|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
44405015|NCT02606253|Tolvaptan|tolvaptan|mesh-list
44405016|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44405017|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405018|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
44405019|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405020|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44405021|NCT02606253|Diuretics|diuretics|mesh-ancestor
44405022|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44405023|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44405024|NCT02605967|Spartalizumab|spartalizumab|mesh-list
44405025|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44405026|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405027|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405028|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44405029|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
44405030|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405031|NCT02605837|Budesonide|budesonide|mesh-list
44405032|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405033|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44405034|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
44405035|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405036|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405037|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44405038|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
44405039|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
44405040|NCT02605837|Hormones|hormones|mesh-ancestor
44405042|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
44405061|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405062|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405063|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405064|NCT02605122|Amoxicillin|amoxicillin|mesh-list
44405065|NCT02605122|Azithromycin|azithromycin|mesh-list
44405066|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
44405067|NCT02605122|Erythromycin|erythromycin|mesh-list
44405068|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
44405069|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44405070|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
44405071|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
44405072|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
44405073|NCT02605122|Ampicillin|ampicillin|mesh-list
44405074|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44405075|NCT02605122|Solithromycin|solithromycin|mesh-list
44405076|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
44405077|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44405078|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405079|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405080|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44405081|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405082|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405083|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44405084|NCT02604589|Hydromorphone|hydromorphone|mesh-list
44405085|NCT02604589|Bupivacaine|bupivacaine|mesh-list
44405086|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
44405087|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
44405088|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405089|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405090|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
44405091|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44106729|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
44106730|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106731|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
44106732|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106733|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106734|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106735|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
44106736|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106737|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106738|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44106739|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106740|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
44106741|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
44405093|NCT02604589|Narcotics|narcotics|mesh-ancestor
44405094|NCT02604589|Analgesics|analgesics|mesh-ancestor
44405095|NCT02604550|Naproxen|naproxen|mesh-list
44405096|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44405097|NCT02604550|Ropivacaine|ropivacaine|mesh-list
44405098|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
44405099|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
44405100|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405101|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405102|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
44405103|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405104|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44405105|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405106|NCT02604550|Analgesics|analgesics|mesh-ancestor
44405107|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405108|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405109|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
44405110|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44405111|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405112|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405113|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44405114|NCT02604550|Narcotics|narcotics|mesh-ancestor
44405115|NCT02604342|Docetaxel|docetaxel|mesh-list
44405116|NCT02604342|Pemetrexed|pemetrexed|mesh-list
44405117|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405118|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405119|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405120|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405121|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106742|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106743|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106744|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44106745|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106746|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106747|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106748|NCT00077129|Paclitaxel|paclitaxel|mesh-list
44106749|NCT00077129|Carboplatin|carboplatin|mesh-list
44106750|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106751|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106752|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106753|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106754|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106755|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106759|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44106760|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
44405122|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405123|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44405124|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405125|NCT02604212|Tenofovir|tenofovir|mesh-list
44405126|NCT02604212|Entecavir|entecavir|mesh-list
44405127|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
44405128|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44405129|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
44405130|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405131|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44405132|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405133|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405134|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405135|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405136|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405137|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
44405138|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405139|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405140|NCT02604199|Tenofovir|tenofovir|mesh-list
44405141|NCT02604199|Entecavir|entecavir|mesh-list
44405142|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
44405143|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44405144|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
44405145|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405146|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44405147|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405148|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405149|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405150|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405151|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405152|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
44405153|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405154|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106761|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44106762|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106763|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44106764|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106765|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44106766|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44106767|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44405155|NCT02603952|Oseltamivir|oseltamivir|mesh-list
44405156|NCT02603952|MEDI8852|medi8852|mesh-list
44405157|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
44405158|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405159|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788734|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
43788735|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788736|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788737|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
43788738|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788739|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43788740|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
43788741|NCT04746989|Protective Agents|protective agents|mesh-ancestor
43788742|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788744|NCT04746989|Renal Agents|renal agents|mesh-ancestor
44405160|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405161|NCT02603432|Avelumab|avelumab|mesh-list
44405162|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44405163|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405164|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405165|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
44405166|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405167|NCT02603419|Avelumab|avelumab|mesh-list
44405168|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44405169|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405170|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405171|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
44405172|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405173|NCT02603393|Fluticasone|fluticasone|mesh-list
44405174|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
44405175|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44405176|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405177|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44405178|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
44405179|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405180|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405181|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44405182|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
44405183|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405184|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44106768|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44106769|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44106770|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106771|NCT00077181|Cytarabine|cytarabine|mesh-list
44106772|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106773|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
44106774|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106775|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106776|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
44106777|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106778|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106779|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
44106780|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106781|NCT00077194|Romidepsin|romidepsin|mesh-list
44106782|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106783|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405185|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
44405186|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44405187|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
44405188|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405189|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405190|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44405191|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44405192|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44405193|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
44405194|NCT02603120|Tenofovir|tenofovir|mesh-list
44405195|NCT02603120|Emtricitabine|emtricitabine|mesh-list
44405196|NCT02603120|Lamivudine|lamivudine|mesh-list
44405197|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44405198|NCT02603120|Triumeq|triumeq|mesh-list
44405199|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
44405200|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405201|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44405202|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405203|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405204|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405205|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405206|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405207|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44405208|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405209|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405210|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
44405211|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405212|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405213|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405214|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44106784|NCT00077220|Paclitaxel|paclitaxel|mesh-list
44106785|NCT00077220|Carboplatin|carboplatin|mesh-list
44106786|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106787|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106788|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106789|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106790|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106791|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106792|NCT00077233|Leucovorin|leucovorin|mesh-list
44106793|NCT00077233|Fluorouracil|fluorouracil|mesh-list
44106794|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
44106795|NCT00077233|Irinotecan|irinotecan|mesh-list
44106796|NCT00077233|Cetuximab|cetuximab|mesh-list
44106797|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106798|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
44163828|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405215|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405216|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405217|NCT02602288|Nicotine|nicotine|mesh-list
44405218|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44405219|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
44405220|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405221|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405222|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44405223|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44405224|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
44405225|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405226|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405227|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44405228|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
44405229|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405230|NCT02601573|Ribavirin|ribavirin|mesh-list
44405231|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
44405232|NCT02601573|Grazoprevir|grazoprevir|mesh-list
44405233|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
44405234|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405235|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
44405236|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405237|NCT02601027|Acetaminophen|acetaminophen|mesh-list
44405238|NCT02601027|Oxycodone|oxycodone|mesh-list
44405239|NCT02601027|Hydromorphone|hydromorphone|mesh-list
44405240|NCT02601027|Ondansetron|ondansetron|mesh-list
44405241|NCT02601027|Bupivacaine|bupivacaine|mesh-list
44405242|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
44405243|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
44405244|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405245|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106799|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106800|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106801|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106802|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106803|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
44106804|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44106805|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106806|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106807|NCT00077233|Antidotes|antidotes|mesh-ancestor
44106808|NCT00077233|Protective Agents|protective agents|mesh-ancestor
44106809|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
43654146|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654150|NCT02978040|Tirofiban|tirofiban|mesh-list
44106810|NCT00077233|Vitamins|vitamins|mesh-ancestor
44106811|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
44106812|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106813|NCT00077246|Paclitaxel|paclitaxel|mesh-list
44106814|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44405246|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
44405247|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405248|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44405249|NCT02601027|Narcotics|narcotics|mesh-ancestor
44405250|NCT02601027|Analgesics|analgesics|mesh-ancestor
44405251|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
44405252|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
44405253|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405254|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
44405255|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405256|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44405257|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
44405258|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405259|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405260|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44405261|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44405262|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44405263|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44405264|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405265|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
44405266|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
44405268|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
44405269|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
44405270|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44405271|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405272|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44405273|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405274|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405275|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
44405276|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405277|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
44405278|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44405279|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405280|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44405281|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44405282|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405285|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44405286|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405287|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
44405288|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44405289|NCT02600351|Ledipasvir|ledipasvir|mesh-list
44405290|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
44405291|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405292|NCT02599402|Nivolumab|nivolumab|mesh-list
44405293|NCT02599402|Ipilimumab|ipilimumab|mesh-list
44405294|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405295|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405296|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44405297|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44062938|NCT03600883|Midazolam|midazolam|mesh-list
44405298|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
44405299|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44405300|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405301|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
44405302|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
44405303|NCT02598622|Vitamins|vitamins|mesh-ancestor
44405304|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
44405305|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405306|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
44405307|NCT02598193|Pirfenidone|pirfenidone|mesh-list
44405308|NCT02598193|Nintedanib|nintedanib|mesh-list
44405309|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405310|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405311|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654154|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43654155|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43613858|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405312|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405313|NCT02598193|Analgesics|analgesics|mesh-ancestor
44405314|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
44405315|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405316|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405317|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44405318|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405319|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405320|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44106815|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44405322|NCT02597946|Afatinib|afatinib|mesh-list
44405323|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44405324|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405325|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405326|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405327|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405328|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405329|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405330|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405331|NCT02597933|Nintedanib|nintedanib|mesh-list
44405332|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405333|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405334|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405335|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405336|NCT02597855|Aflibercept|aflibercept|mesh-list
44405337|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405338|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44405339|NCT02597855|Growth Substances|growth substances|mesh-ancestor
44405340|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405341|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
44405342|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405343|NCT02597478|Fentanyl|fentanyl|mesh-list
44405344|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44405345|NCT02597478|Narcotics|narcotics|mesh-ancestor
44405346|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405347|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405348|NCT02597478|Analgesics|analgesics|mesh-ancestor
44405349|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
44405350|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405351|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44405352|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44405353|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
44405354|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
44405355|NCT02597062|Dexamethasone|dexamethasone|mesh-list
44405356|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
44405357|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405360|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405361|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44405362|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
44405363|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405364|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405365|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44405366|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405367|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
44405368|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
44405369|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405370|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405371|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
44405373|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44405374|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44405375|NCT02597049|Metformin|metformin|mesh-list
44405376|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
44405377|NCT02597049|Empagliflozin|empagliflozin|mesh-list
44405378|NCT02597049|Canagliflozin|canagliflozin|mesh-list
44405379|NCT02597049|Dulaglutide|dulaglutide|mesh-list
44405380|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
44405381|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405382|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405383|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405384|NCT02596971|Prednisone|prednisone|mesh-list
44405385|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
44405386|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44405387|NCT02596971|Rituximab|rituximab|mesh-list
43596956|NCT03313557|Adavosertib|adavosertib|mesh-list
43788760|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43788761|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
43788762|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43788764|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
44405388|NCT02596971|Doxorubicin|doxorubicin|mesh-list
44405406|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405407|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
44405408|NCT02596971|Hormones|hormones|mesh-ancestor
44405409|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44405410|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44405411|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44405412|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405413|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405414|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405415|NCT02596958|Bevacizumab|bevacizumab|mesh-list
44405416|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405417|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405418|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405419|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44405420|NCT02596958|Growth Substances|growth substances|mesh-ancestor
44405421|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405422|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
44405423|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
44405424|NCT02596945|Hematinics|hematinics|mesh-ancestor
44405425|NCT02596711|Nicotine|nicotine|mesh-list
44405426|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
44405427|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44405428|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
44405429|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405430|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405431|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44405432|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44405433|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
44405434|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405435|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405436|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
44405437|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
44405438|NCT02596620|Amoxicillin|amoxicillin|mesh-list
44405439|NCT02596620|Metronidazole|metronidazole|mesh-list
44405440|NCT02596620|Levofloxacin|levofloxacin|mesh-list
44405441|NCT02596620|Esomeprazole|esomeprazole|mesh-list
44405442|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44405443|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405444|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44405445|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44405446|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44405447|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405448|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44405449|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44063092|NCT03003325|Aspirin|aspirin|mesh-list
44405450|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405451|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44405452|NCT02596620|Renal Agents|renal agents|mesh-ancestor
44405453|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44405454|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44405455|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405456|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44405457|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405458|NCT02595749|Oxytocin|oxytocin|mesh-list
44405459|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
44405460|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44405461|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405462|NCT02595723|Megestrol|megestrol|mesh-list
44405463|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
44405464|NCT02595723|Phenytoin|phenytoin|mesh-list
44405465|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44405466|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44405467|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44405468|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
44405469|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44405470|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405471|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44405472|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44405486|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44405487|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405488|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405489|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405490|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405492|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44405493|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44405494|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44405495|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405496|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
44405497|NCT02595398|Hormones|hormones|mesh-ancestor
44405498|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44405499|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405500|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405501|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
44405502|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405503|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405504|NCT02594735|Abatacept|abatacept|mesh-list
44405505|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44405506|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405507|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405508|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405509|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
44405510|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405511|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405512|NCT02594163|Rituximab|rituximab|mesh-list
44405513|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44405514|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44405515|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405516|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405517|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
44405518|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405519|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405524|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405526|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44405527|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405528|NCT02593773|Interferons|interferons|mesh-list
44405529|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
44405530|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405531|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
44405532|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405533|NCT02593539|Nemiralisib|nemiralisib|mesh-list
44405534|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405535|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405536|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405537|NCT02593305|Methamphetamine|methamphetamine|mesh-list
44405538|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44405539|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405540|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
44405541|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
44405542|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405543|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
44405544|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405545|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405546|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
44405547|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44405548|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43788821|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44405549|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44405550|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44405551|NCT02593097|Metformin|metformin|mesh-list
44405552|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405553|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405554|NCT02592876|Rituximab|rituximab|mesh-list
44405555|NCT02592876|Carboplatin|carboplatin|mesh-list
44405556|NCT02592876|Etoposide|etoposide|mesh-list
44405557|NCT02592876|Ifosfamide|ifosfamide|mesh-list
44405558|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405564|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44405565|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44405566|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405567|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405568|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44405569|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
44405571|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44405572|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405573|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405574|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405575|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
44405576|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405577|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405578|NCT02592551|Durvalumab|durvalumab|mesh-list
44405579|NCT02592551|Tremelimumab|tremelimumab|mesh-list
44405580|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405581|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405582|NCT02592434|Tofacitinib|tofacitinib|mesh-list
44405583|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405584|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405585|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405586|NCT02591238|Melatonin|melatonin|mesh-list
44405587|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
44405588|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405589|NCT02591238|Protective Agents|protective agents|mesh-ancestor
44405590|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405591|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405592|NCT02590588|Idelalisib|idelalisib|mesh-list
44405593|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405594|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405595|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405596|NCT02590432|Linaclotide|linaclotide|mesh-list
44405597|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44405598|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
44405603|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44405604|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405605|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405606|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405607|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405608|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405609|NCT02589665|Mirikizumab|mirikizumab|mesh-list
44405610|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44405611|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405612|NCT02589665|Analgesics|analgesics|mesh-ancestor
44405613|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
44405614|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405615|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405616|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405617|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405618|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44405619|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405620|NCT02589639|Empagliflozin|empagliflozin|mesh-list
44405621|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43788833|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405622|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405623|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405624|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405625|NCT02589626|Empagliflozin|empagliflozin|mesh-list
44405626|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44405627|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405628|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405629|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405630|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44405631|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405632|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
44405633|NCT02588612|Fludarabine|fludarabine|mesh-list
44405634|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405635|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
44405641|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405642|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44405643|NCT02588339|Sirolimus|sirolimus|mesh-list
44405644|NCT02588339|Panobinostat|panobinostat|mesh-list
44405645|NCT02588339|Tacrolimus|tacrolimus|mesh-list
44405646|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405647|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
44405648|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405649|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44405650|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405651|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405652|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44405653|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405654|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44405655|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405656|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
44405657|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44405658|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44405659|NCT02588261|Gefitinib|gefitinib|mesh-list
44405660|NCT02588261|Naquotinib|naquotinib|mesh-list
44405661|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405662|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44405663|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405664|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405665|NCT02588248|Peppermint oil|peppermint oil|mesh-list
44405666|NCT02588248|Menthol|menthol|mesh-list
44405691|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
44405692|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405693|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44405694|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44405695|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
44405696|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405697|NCT02586727|Aflibercept|aflibercept|mesh-list
44405698|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405699|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44405700|NCT02586727|Growth Substances|growth substances|mesh-ancestor
44405701|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405702|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
43788842|NCT04393103|Atropine|atropine|mesh-list
44405703|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405704|NCT02586207|Cisplatin|cisplatin|mesh-list
44405705|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
44405706|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405707|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405708|NCT02586155|Atorvastatin|atorvastatin|mesh-list
44405709|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44405710|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44405711|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44405712|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
44405713|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405714|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44405715|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44405716|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405717|NCT02586025|Docetaxel|docetaxel|mesh-list
44405718|NCT02586025|Trastuzumab|trastuzumab|mesh-list
44405719|NCT02586025|Pertuzumab|pertuzumab|mesh-list
44405720|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405721|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405722|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405735|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405737|NCT02585713|Tinzaparin|tinzaparin|mesh-list
44405738|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44405739|NCT02585713|Apixaban|apixaban|mesh-list
44405740|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44405741|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
44405742|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44405743|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405744|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405745|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405746|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
44405747|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44405748|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44405749|NCT02584959|Complement C1s|complement c1s|mesh-list
44405750|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44405751|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44405752|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
44405753|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405754|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44405755|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405756|NCT02584855|Ixekizumab|ixekizumab|mesh-list
44405757|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
44405758|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
44405759|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44405760|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
44405761|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44405762|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405763|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405764|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405765|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
44405766|NCT02584634|Avelumab|avelumab|mesh-list
44405767|NCT02584634|Crizotinib|crizotinib|mesh-list
44405779|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44405780|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405782|NCT02584452|Fentanyl|fentanyl|mesh-list
44405783|NCT02584452|Bupivacaine|bupivacaine|mesh-list
44405784|NCT02584452|Ropivacaine|ropivacaine|mesh-list
44405785|NCT02584452|Mepivacaine|mepivacaine|mesh-list
44405786|NCT02584452|Propofol|propofol|mesh-list
44405787|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405788|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
44405789|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
44405790|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405791|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405792|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44405793|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
44405794|NCT02584452|Hormones|hormones|mesh-ancestor
44405795|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44063404|NCT00006044|Hormones|hormones|mesh-ancestor
44405796|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44405797|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405798|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
44405799|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
44405800|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44405801|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
44405802|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44405803|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44405804|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
44405805|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44405806|NCT02584452|Narcotics|narcotics|mesh-ancestor
44405807|NCT02584452|Analgesics|analgesics|mesh-ancestor
44405808|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44405809|NCT02584257|Albuterol|albuterol|mesh-list
44106816|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106817|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106818|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106819|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106820|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106821|NCT00077259|Epothilones|epothilones|mesh-list
44106822|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
44106823|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106824|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106825|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106826|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106827|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106828|NCT00077298|Bevacizumab|bevacizumab|mesh-list
44106829|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44106830|NCT00077298|Cetuximab|cetuximab|mesh-list
44405810|NCT02584257|Procaterol|procaterol|mesh-list
44405811|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
44405812|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44405813|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
44405814|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405815|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405816|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44405817|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
44405818|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
44405819|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44405820|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44405821|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44405822|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44405823|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
44405824|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44405825|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405826|NCT02584257|Miotics|miotics|mesh-ancestor
44405827|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44405828|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44405829|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44405830|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44405831|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
44405832|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
44405833|NCT02583477|Gemcitabine|gemcitabine|mesh-list
44405834|NCT02583477|Paclitaxel|paclitaxel|mesh-list
44405835|NCT02583477|Durvalumab|durvalumab|mesh-list
44405836|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44405837|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44405838|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405839|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44405840|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44405841|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44405842|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43705770|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
44106831|NCT00077298|Irinotecan|irinotecan|mesh-list
44106832|NCT00077298|Antibodies|antibodies|mesh-list
44106833|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
44106834|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44106835|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106836|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44106837|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44106838|NCT00077298|Growth Substances|growth substances|mesh-ancestor
44106839|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106840|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
44405843|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44405844|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
44405845|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
44405846|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405847|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405848|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44405849|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
44405850|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405851|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44405852|NCT02583399|Ibuprofen|ibuprofen|mesh-list
44405853|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44405854|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44405855|NCT02583399|Analgesics|analgesics|mesh-ancestor
44405856|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
44405857|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44405858|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405859|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405860|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405861|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44405862|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405863|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405864|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
44405865|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44405866|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44405867|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405868|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405869|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405870|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
44405871|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405872|NCT02582866|Lacosamide|lacosamide|mesh-list
44063475|NCT00006050|Antidotes|antidotes|mesh-ancestor
44405873|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
44405874|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44405875|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43788905|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788906|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
43788907|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
43788908|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43788909|NCT03738696|Bupivacaine|bupivacaine|mesh-list
43788910|NCT03738696|Ropivacaine|ropivacaine|mesh-list
43788911|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788912|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
44405876|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44106841|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
44106842|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44106843|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44405877|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405878|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
44405879|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44405880|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405881|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405882|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405883|NCT02582749|Bicalutamide|bicalutamide|mesh-list
44405884|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44405885|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
44405886|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
44405887|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44405888|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405889|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405890|NCT02582684|Lamivudine|lamivudine|mesh-list
44405891|NCT02582684|Dolutegravir|dolutegravir|mesh-list
44405892|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44405893|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405894|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405895|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405896|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
44405897|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405898|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405899|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405900|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44405901|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44405902|NCT02582671|Ritonavir|ritonavir|mesh-list
44405903|NCT02582671|Ribavirin|ribavirin|mesh-list
44405904|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44405921|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405922|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405923|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405924|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
44405925|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405926|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44405927|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405929|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44405930|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405931|NCT02582515|Renal Agents|renal agents|mesh-ancestor
44405932|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44405933|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
44405934|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44405935|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
44405936|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405937|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
43788955|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788956|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43788957|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43614884|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
44405938|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
44405939|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44405940|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44405941|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405942|NCT02581995|Aflibercept|aflibercept|mesh-list
44405943|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405944|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44063559|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
44405945|NCT02581995|Growth Substances|growth substances|mesh-ancestor
44405946|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405947|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
44106844|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106845|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106846|NCT00077311|Cisplatin|cisplatin|mesh-list
44106847|NCT00077311|Docetaxel|docetaxel|mesh-list
44106848|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
44106849|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
44106850|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106851|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
44106852|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106853|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106854|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106855|NCT00077311|Hematinics|hematinics|mesh-ancestor
44106856|NCT00077311|Protective Agents|protective agents|mesh-ancestor
44106857|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106858|NCT00077337|Romidepsin|romidepsin|mesh-list
44106859|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44106860|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106861|NCT00077350|Gemcitabine|gemcitabine|mesh-list
44405948|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405949|NCT02581891|Aflibercept|aflibercept|mesh-list
44405950|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44405951|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44405952|NCT02581891|Growth Substances|growth substances|mesh-ancestor
44405953|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44405954|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
44405955|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44405957|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44405958|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44405959|NCT02581202|Ritonavir|ritonavir|mesh-list
44405960|NCT02581202|Lopinavir|lopinavir|mesh-list
44405961|NCT02581202|Lamivudine|lamivudine|mesh-list
44405962|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44405963|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44405964|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405965|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405966|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405967|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405968|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405969|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
44405970|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44405971|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44405972|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44405973|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44405974|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44405975|NCT02581189|Ritonavir|ritonavir|mesh-list
44405976|NCT02581189|Ribavirin|ribavirin|mesh-list
44405977|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44405978|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44405979|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405989|NCT02581163|Ritonavir|ritonavir|mesh-list
44405992|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44405993|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
44405994|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44405995|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44405996|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44405997|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44405998|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
44405999|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406000|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44406001|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44406002|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
44406003|NCT02580877|Insulin|insulin|mesh-list
44406004|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44406005|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
44406006|NCT02580877|Methamphetamine|methamphetamine|mesh-list
44406007|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406008|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406009|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44406010|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
44406011|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
44406012|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406013|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
44406014|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406015|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406016|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406017|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44406018|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44406019|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44063628|NCT00006072|Rituximab|rituximab|mesh-list
44406020|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44406021|NCT02580591|Empagliflozin|empagliflozin|mesh-list
44406024|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406032|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44406033|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44406034|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406035|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406036|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406038|NCT02579928|Ketamine|ketamine|mesh-list
44406039|NCT02579928|Analgesics|analgesics|mesh-ancestor
44406040|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
44406041|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406042|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406043|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44406044|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44406045|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
44406046|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
44406047|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406048|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44406049|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44406050|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406051|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406052|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44406053|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44406054|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44406055|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44406056|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44406057|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
44406058|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
44406059|NCT02579863|Dexamethasone|dexamethasone|mesh-list
44406060|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
44406061|NCT02579863|Lenalidomide|lenalidomide|mesh-list
44406062|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406063|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
44406064|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
44406065|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406066|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406067|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406070|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406071|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44406072|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406073|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406074|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
44406075|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406076|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44406077|NCT02579863|Growth Substances|growth substances|mesh-ancestor
44406078|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
44406079|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
44406080|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44406081|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
44406082|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406083|NCT02579772|Expectorants|expectorants|mesh-ancestor
44406084|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406085|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44406086|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
44406087|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406088|NCT02579772|Protective Agents|protective agents|mesh-ancestor
44406089|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406090|NCT02579772|Antidotes|antidotes|mesh-ancestor
44406091|NCT02579629|Ropivacaine|ropivacaine|mesh-list
44406092|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
44406093|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
44406094|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406095|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406096|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
44406097|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406099|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406100|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406101|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406102|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406103|NCT02579603|Pirfenidone|pirfenidone|mesh-list
44406104|NCT02579603|Nintedanib|nintedanib|mesh-list
44406105|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406106|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406107|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406108|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406109|NCT02579603|Analgesics|analgesics|mesh-ancestor
44406110|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
44406111|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406112|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406113|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44406114|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44406115|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406116|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406117|NCT02579382|Vesatolimod|vesatolimod|mesh-list
44406118|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
44406119|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406120|NCT02579096|Allopurinol|allopurinol|mesh-list
44406121|NCT02579096|Febuxostat|febuxostat|mesh-list
44406122|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
44406123|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406124|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406125|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
44406126|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406127|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44406128|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
44406129|NCT02579096|Protective Agents|protective agents|mesh-ancestor
44406130|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406131|NCT02578862|Propofol|propofol|mesh-list
44406132|NCT02578862|Sevoflurane|sevoflurane|mesh-list
44406133|NCT02578862|Isoflurane|isoflurane|mesh-list
44406134|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44406135|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406136|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406137|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44406138|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
44406139|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
44406140|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44106862|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106863|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
44106864|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106865|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106866|NCT00077350|Antiviral Agents|antiviral agents|mesh-ancestor
44106867|NCT00077350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106868|NCT00077350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106869|NCT00077350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106870|NCT00077350|Immunologic Factors|immunologic factors|mesh-ancestor
44406141|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44406143|NCT02578706|Clopidogrel|clopidogrel|mesh-list
44406144|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44406145|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44406146|NCT02578706|Analgesics|analgesics|mesh-ancestor
44406147|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
44406148|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406149|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406150|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406151|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406152|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44406153|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44406154|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406155|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44406156|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44406157|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406158|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
44406159|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44406160|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44406161|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44406162|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
44406163|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406164|NCT02578316|Lenvatinib|lenvatinib|mesh-list
44406165|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406166|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406167|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406168|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406169|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
44406170|NCT02578186|Promethazine|promethazine|mesh-list
44406171|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44106871|NCT00077350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106872|NCT00077363|Capecitabine|capecitabine|mesh-list
44106873|NCT00077363|Tipifarnib|tipifarnib|mesh-list
44106874|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106875|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
44106876|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106877|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106878|NCT00077389|Cisplatin|cisplatin|mesh-list
44106879|NCT00077389|Carboplatin|carboplatin|mesh-list
44106880|NCT00077389|Doxorubicin|doxorubicin|mesh-list
44106881|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44106882|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106883|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44406172|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44406173|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406174|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406175|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
44406176|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
44406177|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
44406178|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406179|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
44406180|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
44406181|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406182|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44406183|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
44406184|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
44406185|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788977|NCT03066739|Narcotics|narcotics|mesh-ancestor
43788978|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406186|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406187|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44406188|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
44406189|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406190|NCT02577718|Ethanol|ethanol|mesh-list
44406191|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
44406192|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44406193|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406194|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406195|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406196|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
44406197|NCT02577523|Levodopa|levodopa|mesh-list
44406198|NCT02577523|Carbidopa|carbidopa|mesh-list
44406199|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44406200|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44406201|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44406202|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
44406203|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406204|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406205|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406206|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44406207|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406208|NCT02577315|Metformin|metformin|mesh-list
44406209|NCT02577315|Empagliflozin|empagliflozin|mesh-list
44106884|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44406210|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406211|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406212|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44406213|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406215|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406216|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44406217|NCT02577107|Growth Substances|growth substances|mesh-ancestor
44406218|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406219|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
44406220|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406221|NCT02577029|Interferons|interferons|mesh-list
44406222|NCT02577029|Tenofovir|tenofovir|mesh-list
44406223|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
44406224|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
44406225|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44406226|NCT02577029|Entecavir|entecavir|mesh-list
44406227|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
44406228|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44406229|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406230|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
44406231|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406232|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44406233|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44406234|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406235|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406236|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44406237|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44406238|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
44406239|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406240|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
44406241|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406242|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44406243|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
44406244|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406245|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106885|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106886|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734419|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44406246|NCT02577016|Incretins|incretins|mesh-ancestor
44406247|NCT02577016|Hormones|hormones|mesh-ancestor
44406248|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406249|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44406250|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406251|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406252|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406253|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44406254|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44406255|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
44406256|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406257|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406258|NCT02577003|Incretins|incretins|mesh-ancestor
44406259|NCT02577003|Hormones|hormones|mesh-ancestor
44406260|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406261|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44406262|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406263|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406264|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406265|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44406266|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
44406267|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106887|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106888|NCT00077402|Fenretinide|fenretinide|mesh-list
44106889|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106890|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44106891|NCT00077402|Protective Agents|protective agents|mesh-ancestor
44106892|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106893|NCT00077415|Gemcitabine|gemcitabine|mesh-list
44106894|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106895|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
44106896|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106897|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106898|NCT00077415|Antiviral Agents|antiviral agents|mesh-ancestor
44106899|NCT00077415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44106900|NCT00077415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106901|NCT00077415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106902|NCT00077415|Immunologic Factors|immunologic factors|mesh-ancestor
44106903|NCT00077415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106904|NCT00077428|Doxorubicin|doxorubicin|mesh-list
44106905|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44106912|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106915|NCT00077454|Temozolomide|temozolomide|mesh-list
44106916|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44106917|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44106918|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
44106919|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106920|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406268|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406269|NCT02576977|Dexamethasone|dexamethasone|mesh-list
44406270|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
44406271|NCT02576977|Pomalidomide|pomalidomide|mesh-list
44406272|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406273|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
44406274|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
44406275|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406276|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406277|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406278|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
43789019|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789020|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789023|NCT02604446|Oxycodone|oxycodone|mesh-list
44406279|NCT02576977|Hormones|hormones|mesh-ancestor
44406280|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406281|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44406282|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406283|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406284|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
44406285|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406286|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44406287|NCT02576977|Growth Substances|growth substances|mesh-ancestor
44406288|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
44406289|NCT02576938|Triamcinolone|triamcinolone|mesh-list
44406290|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406291|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
44406292|NCT02576938|Hormones|hormones|mesh-ancestor
44406293|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406294|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406295|NCT02576678|Apremilast|apremilast|mesh-list
44406296|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44406297|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44406298|NCT02576678|Analgesics|analgesics|mesh-ancestor
44406299|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
44106921|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44106922|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106923|NCT00077467|Bortezomib|bortezomib|mesh-list
44106924|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106925|NCT00077493|Antibodies|antibodies|mesh-list
44106926|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
44106927|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44106928|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
44106929|NCT00077493|Immunotoxins|immunotoxins|mesh-list
44106930|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
44106931|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106932|NCT00077519|Tipifarnib|tipifarnib|mesh-list
44406300|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406301|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406302|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406303|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406304|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44406305|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44406306|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406307|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406308|NCT02576652|Tetracycline|tetracycline|mesh-list
44406309|NCT02576652|Demeclocycline|demeclocycline|mesh-list
44406310|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44406311|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406312|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44406313|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406314|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406316|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406317|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44063936|NCT00006117|Antiviral Agents|antiviral agents|mesh-ancestor
44406318|NCT02576145|Daclizumab|daclizumab|mesh-list
44406319|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406320|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
44406321|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406322|NCT02576067|Methotrexate|methotrexate|mesh-list
44406323|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44406324|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
44406325|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44406326|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406327|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406328|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
44406329|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406330|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406331|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406332|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106933|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106934|NCT00077532|Ipilimumab|ipilimumab|mesh-list
44106935|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
44106936|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44106937|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106938|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43701627|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406333|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44406334|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406335|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
44406336|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406337|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44406339|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44406340|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406341|NCT02575833|Analgesics|analgesics|mesh-ancestor
44406342|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
44406343|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406344|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406345|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
44406346|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406347|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406348|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44406349|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44406350|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406351|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406352|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
44406353|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406354|NCT02575339|Sorafenib|sorafenib|mesh-list
44406355|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406356|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406357|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406358|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406359|NCT02574845|Metformin|metformin|mesh-list
44406360|NCT02574845|Furosemide|furosemide|mesh-list
44406361|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44406362|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406363|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406373|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44406374|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44406375|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44406376|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
44406377|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406378|NCT02574520|Bupivacaine|bupivacaine|mesh-list
44406379|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44406380|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
44406381|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
43840654|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840655|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848379|NCT04023071|Rituximab|rituximab|mesh-list
44406382|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406383|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406384|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
44406385|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406386|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44406387|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406388|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406389|NCT02574078|Gemcitabine|gemcitabine|mesh-list
44406390|NCT02574078|Paclitaxel|paclitaxel|mesh-list
44406391|NCT02574078|Docetaxel|docetaxel|mesh-list
44406392|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44406393|NCT02574078|Bevacizumab|bevacizumab|mesh-list
44406394|NCT02574078|Carboplatin|carboplatin|mesh-list
44406395|NCT02574078|Nivolumab|nivolumab|mesh-list
44406396|NCT02574078|Pemetrexed|pemetrexed|mesh-list
44406397|NCT02574078|Crizotinib|crizotinib|mesh-list
44406398|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406399|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406400|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406401|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406402|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406403|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406404|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406405|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406406|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44406407|NCT02574078|Growth Substances|growth substances|mesh-ancestor
44406408|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406409|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
43701628|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44406410|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406411|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
44406412|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
44406413|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406414|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406415|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406416|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
44406417|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44406418|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44406419|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44406420|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406421|NCT02573883|Clobetasol|clobetasol|mesh-list
44406422|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406423|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
44406424|NCT02573883|Hormones|hormones|mesh-ancestor
44406425|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406426|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406427|NCT02573870|Fluticasone|fluticasone|mesh-list
44406428|NCT02573870|Xhance|xhance|mesh-list
44406429|NCT02573870|Albuterol|albuterol|mesh-list
44406430|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406431|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43848394|NCT04022239|Melphalan|melphalan|mesh-list
43848395|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43848396|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
43848397|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43848398|NCT04022239|Rituximab|rituximab|mesh-list
43848399|NCT04022239|Fludarabine|fludarabine|mesh-list
43848400|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43848401|NCT04022239|Tacrolimus|tacrolimus|mesh-list
43848402|NCT04022239|Antibodies|antibodies|mesh-list
44406432|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
44406433|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406434|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406435|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44406436|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406437|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406438|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44406439|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
44406440|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44406455|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406456|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406457|NCT02573311|Tamsulosin|tamsulosin|mesh-list
44406458|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44406459|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44406460|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44406461|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406462|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406463|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406464|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406465|NCT02573311|Urological Agents|urological agents|mesh-ancestor
44406466|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
44406467|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44406468|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
44406469|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406470|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406471|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44406472|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406473|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
44406474|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44406475|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
44406476|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406477|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406479|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406480|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
44406481|NCT02573012|Hormones|hormones|mesh-ancestor
44406482|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406483|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406484|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44406485|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406486|NCT02571972|Timolol|timolol|mesh-list
44406487|NCT02571972|Dorzolamide|dorzolamide|mesh-list
44406488|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44106939|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106940|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44106941|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
44106942|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406490|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406491|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406492|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406493|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406494|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44406495|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44406496|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44406497|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406498|NCT02571777|Fluticasone|fluticasone|mesh-list
44406499|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44406500|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406501|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44406502|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
44406503|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406504|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406505|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44406506|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
43789056|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
44406507|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406508|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44406509|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44406510|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44406511|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44406512|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406513|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406514|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406515|NCT02571049|Sumatriptan|sumatriptan|mesh-list
44406516|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44406517|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44406518|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44106944|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106945|NCT00077558|Fludarabine|fludarabine|mesh-list
44106946|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
44106947|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106948|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44106949|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
44106950|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106951|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44106952|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
44106953|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106954|NCT00077584|Bosentan|bosentan|mesh-list
44106955|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44406519|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
44406520|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406521|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406522|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406524|NCT02570711|Paclitaxel|paclitaxel|mesh-list
44406525|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
44406526|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406527|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406528|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406529|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406530|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406531|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406532|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406533|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
44406534|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
44406535|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406536|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406537|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406538|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
44406539|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406540|NCT02570074|Fosfomycin|fosfomycin|mesh-list
44406542|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406543|NCT02569996|Rituximab|rituximab|mesh-list
44406544|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406545|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406546|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
44406547|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406548|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406549|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
44406550|NCT02569957|Topotecan|topotecan|mesh-list
44406551|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44406552|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44406553|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44106956|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44106957|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106958|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
44106959|NCT00077597|Hematinics|hematinics|mesh-ancestor
44106960|NCT00077688|Paclitaxel|paclitaxel|mesh-list
44106961|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44106962|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44106963|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406554|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406555|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406556|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406558|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406559|NCT02569957|Expectorants|expectorants|mesh-ancestor
44406560|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406561|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44406562|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
44406563|NCT02569957|Protective Agents|protective agents|mesh-ancestor
44406564|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406565|NCT02569957|Antidotes|antidotes|mesh-ancestor
44406566|NCT02569801|Fulvestrant|fulvestrant|mesh-list
44406567|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44406568|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406569|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44406570|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44406571|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
44406572|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406573|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406574|NCT02569710|Simeprevir|simeprevir|mesh-list
44406575|NCT02569710|Odalasvir|odalasvir|mesh-list
44406576|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
44406577|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406578|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406579|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406580|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406581|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
44406582|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
44406583|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406584|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406585|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406586|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412312|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
44106964|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
44106965|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106966|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106967|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44106968|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44106969|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44106970|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406587|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406589|NCT02569437|Doxycycline|doxycycline|mesh-list
44406590|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
44406591|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44406592|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44406593|NCT02569437|Prednisolone|prednisolone|mesh-list
44406594|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
44406595|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44406596|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
44406597|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406598|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
44406599|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
44406600|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406601|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406602|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406603|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
44406604|NCT02569437|Hormones|hormones|mesh-ancestor
44406605|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406606|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44406607|NCT02569437|Protective Agents|protective agents|mesh-ancestor
44406608|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44406609|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406610|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44406611|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406612|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
44406613|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44406614|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44406615|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44406616|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44406633|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406634|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406635|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406636|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406637|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406638|NCT02568397|Dabigatran|dabigatran|mesh-list
44406639|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
44406640|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44406641|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406642|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406643|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406644|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
44406645|NCT02568046|Leucovorin|leucovorin|mesh-list
44406646|NCT02568046|Fluorouracil|fluorouracil|mesh-list
44406647|NCT02568046|Irinotecan|irinotecan|mesh-list
44406648|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
44406649|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406650|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406651|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406652|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406653|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
44406654|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406655|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44406656|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44406657|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406658|NCT02568046|Antidotes|antidotes|mesh-ancestor
44406659|NCT02568046|Protective Agents|protective agents|mesh-ancestor
44406660|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
44406661|NCT02568046|Vitamins|vitamins|mesh-ancestor
44406662|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
44406663|NCT02567708|Nemiralisib|nemiralisib|mesh-list
44406664|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406665|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412313|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106971|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106972|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44106973|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44106974|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44106975|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
44106978|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44106979|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44106980|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
44106981|NCT00077727|Galantamine|galantamine|mesh-list
44106982|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44406666|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406667|NCT02567656|Tenalisib|tenalisib|mesh-list
44406668|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
44406669|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406670|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406671|NCT02567552|Progesterone|progesterone|mesh-list
44406672|NCT02567552|Progestins|progestins|mesh-ancestor
44406673|NCT02567552|Hormones|hormones|mesh-ancestor
44406674|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406675|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406676|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
44406677|NCT02566993|Doxorubicin|doxorubicin|mesh-list
44406678|NCT02566993|Vincristine|vincristine|mesh-list
44406679|NCT02566993|Topotecan|topotecan|mesh-list
44406680|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406681|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
44406682|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406683|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406684|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44406685|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
44106983|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106984|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106985|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
44106986|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44106987|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44106988|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44106989|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
44106990|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44106991|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
44106992|NCT00077753|Enoxaparin|enoxaparin|mesh-list
44106993|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
44106994|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
44106995|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44106996|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44106997|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44106999|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107000|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107001|NCT00077792|Enoxaparin|enoxaparin|mesh-list
44107002|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
44107003|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
44107004|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44107005|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44107006|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107007|NCT00077805|Enoxaparin|enoxaparin|mesh-list
44107008|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
44107009|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
44107010|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44107011|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44107012|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107013|NCT00077818|Enoxaparin|enoxaparin|mesh-list
44107014|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
44107015|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
44107016|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44107017|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44107018|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107019|NCT00077844|Enoxaparin|enoxaparin|mesh-list
44406686|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406688|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44406689|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44406690|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44064283|NCT00006196|Vitamin D|vitamin d|mesh-list
44406691|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44406692|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406693|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406694|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406695|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44406696|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406697|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44406698|NCT02566902|Albuterol|albuterol|mesh-list
44406699|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44406700|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
44406701|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406702|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406703|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44406704|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406705|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
44406706|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44406707|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44406708|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44406709|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44406710|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
44406711|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406712|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406713|NCT02566889|Infliximab|infliximab|mesh-list
44406714|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406715|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406716|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406717|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
44406718|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
44406719|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44107020|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
43789093|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43789094|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43616394|NCT03070301|Everolimus|everolimus|mesh-list
44107021|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
44107022|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44107023|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44406721|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406722|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406724|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
44406725|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
44406726|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44406727|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
44406728|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406729|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406730|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44406731|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44406732|NCT02566005|Misoprostol|misoprostol|mesh-list
44406733|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44406734|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
44406735|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44406736|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406737|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44406738|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406739|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
44406740|NCT02565810|Adalimumab|adalimumab|mesh-list
44406741|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406742|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406743|NCT02565511|CNP520|cnp520|mesh-list
44406744|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406745|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406746|NCT02565381|Nicotine|nicotine|mesh-list
44406747|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44406748|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
44406749|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406750|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406751|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44406752|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44406753|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
44406754|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406755|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406756|NCT02565186|Lasmiditan|lasmiditan|mesh-list
44406758|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
44406759|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406760|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406761|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406763|NCT02565147|Bivalirudin|bivalirudin|mesh-list
44406764|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
44406765|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44406766|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44406767|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406768|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
44406769|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44406770|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406771|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406772|NCT02565108|Cannabidiol|cannabidiol|mesh-list
44406773|NCT02565108|Clobazam|clobazam|mesh-list
44406774|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
44406775|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44406776|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44406777|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406778|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406779|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44406780|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44406781|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
44406782|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
44406783|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406784|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406785|NCT02564952|Cannabidiol|cannabidiol|mesh-list
44406786|NCT02564952|Clobazam|clobazam|mesh-list
43789095|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789101|NCT00584025|Levetiracetam|levetiracetam|mesh-list
44406787|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
44406788|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44406789|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107024|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107025|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
44107026|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
44107027|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107028|NCT00077883|Cisplatin|cisplatin|mesh-list
44107029|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107030|NCT00077948|Metoprolol|metoprolol|mesh-list
44107031|NCT00077948|Enoximone|enoximone|mesh-list
44107032|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44107033|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44107034|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
44107035|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
44107036|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107037|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406790|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44406791|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406792|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44406793|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44406794|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
44406795|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
44406796|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406797|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406798|NCT02564796|Iron|iron|mesh-list
44406799|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
44406800|NCT02564796|Trace Elements|trace elements|mesh-ancestor
44406801|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
44406802|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406803|NCT02564796|Hematinics|hematinics|mesh-ancestor
44406804|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
44406805|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44406806|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
44406807|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44406808|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406809|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406810|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406811|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
44406812|NCT02564471|Doxycycline|doxycycline|mesh-list
44406813|NCT02564471|Chloroquine|chloroquine|mesh-list
44406814|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44406815|NCT02564471|Atovaquone|atovaquone|mesh-list
44406816|NCT02564471|Proguanil|proguanil|mesh-list
44406817|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44064428|NCT00006215|Docetaxel|docetaxel|mesh-list
44406818|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406819|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
44406820|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44406821|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44406822|NCT02564471|Amebicides|amebicides|mesh-ancestor
44406823|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406824|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44107038|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44107039|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44107040|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44107041|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
44107042|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107043|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406826|NCT02564471|Analgesics|analgesics|mesh-ancestor
44406827|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
44406828|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406829|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406830|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44406831|NCT02564471|Filaricides|filaricides|mesh-ancestor
44406832|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
44406833|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
44406834|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406835|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406836|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
44406837|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44406838|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
44406839|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406840|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406841|NCT02564211|Incretins|incretins|mesh-ancestor
44406842|NCT02564211|Hormones|hormones|mesh-ancestor
44406843|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44406844|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44406845|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
44406846|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406847|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406848|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44406849|NCT02564198|Ramucirumab|ramucirumab|mesh-list
44406850|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406851|NCT02564146|Gemcitabine|gemcitabine|mesh-list
44406852|NCT02564146|Paclitaxel|paclitaxel|mesh-list
44406853|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44406854|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44406855|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406856|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44406857|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107044|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44107045|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
44107046|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44107047|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44107048|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107049|NCT00077948|Protective Agents|protective agents|mesh-ancestor
44107050|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
44107055|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406858|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44406859|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406860|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406861|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
44406862|NCT02564146|Antiviral Agents|antiviral agents|mesh-ancestor
44406863|NCT02564146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406864|NCT02564146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406865|NCT02564146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406866|NCT02564146|Immunologic Factors|immunologic factors|mesh-ancestor
44406867|NCT02564146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406868|NCT02563925|Durvalumab|durvalumab|mesh-list
44406869|NCT02563925|Tremelimumab|tremelimumab|mesh-list
44406870|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406871|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406872|NCT02563561|Apaziquone|apaziquone|mesh-list
44406873|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406874|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
44406875|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406876|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406877|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
44406878|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44406879|NCT02563067|Growth Substances|growth substances|mesh-ancestor
44406880|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406881|NCT02562716|Gemcitabine|gemcitabine|mesh-list
44406882|NCT02562716|Paclitaxel|paclitaxel|mesh-list
44406883|NCT02562716|Camptothecin|camptothecin|mesh-list
44406884|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44406885|NCT02562716|Fluorouracil|fluorouracil|mesh-list
44406886|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
44406887|NCT02562716|Irinotecan|irinotecan|mesh-list
44406889|NCT02562716|Pancreatin|pancreatin|mesh-list
43789141|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44406905|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44406906|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406907|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
44406908|NCT02561832|Carboplatin|carboplatin|mesh-list
44406909|NCT02561832|Olaparib|olaparib|mesh-list
44406910|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406911|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
44406912|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406913|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406914|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44406915|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
44406916|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406917|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406918|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44406919|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44406920|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406921|NCT02561806|Ustekinumab|ustekinumab|mesh-list
44406922|NCT02561806|Ixekizumab|ixekizumab|mesh-list
44107056|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44107057|NCT00077987|Growth Substances|growth substances|mesh-ancestor
44107058|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107059|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
44107060|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107061|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107062|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107063|NCT00078000|Sunitinib|sunitinib|mesh-list
44107064|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107065|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44107066|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44107067|NCT00078000|Growth Substances|growth substances|mesh-ancestor
44107068|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107069|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
44107070|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107071|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107072|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107073|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44107074|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107075|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107076|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107077|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107078|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107079|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44107080|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107081|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
44107082|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107083|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107084|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44107085|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44107086|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
44107087|NCT00078117|Buprenorphine|buprenorphine|mesh-list
44107088|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44107089|NCT00078117|Narcotics|narcotics|mesh-ancestor
44107090|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107091|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107092|NCT00078117|Analgesics|analgesics|mesh-ancestor
44107093|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
44107094|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44406923|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
44406924|NCT02561078|Insulin|insulin|mesh-list
44406925|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44406926|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44406927|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406928|NCT02560558|Abatacept|abatacept|mesh-list
44406929|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44406930|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406931|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406932|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406933|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
44406934|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406935|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44406936|NCT02560389|Levodopa|levodopa|mesh-list
44406937|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44406938|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44406939|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
44406940|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44406941|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406942|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406943|NCT02560025|Cytarabine|cytarabine|mesh-list
44406944|NCT02560025|Daunorubicin|daunorubicin|mesh-list
44406945|NCT02560025|Idarubicin|idarubicin|mesh-list
44406946|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44406947|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
44406948|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406949|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406950|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
44406951|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406952|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406953|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
44406954|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406955|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44406956|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44406957|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44406958|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406959|NCT02560012|Sirolimus|sirolimus|mesh-list
44107095|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44107096|NCT00078130|Buprenorphine|buprenorphine|mesh-list
44406960|NCT02560012|Everolimus|everolimus|mesh-list
44406961|NCT02560012|Sorafenib|sorafenib|mesh-list
44406962|NCT02560012|Sunitinib|sunitinib|mesh-list
44406963|NCT02560012|Axitinib|axitinib|mesh-list
44406964|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406965|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44406966|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
44406967|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406968|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44406969|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44406970|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406971|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44406972|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44406973|NCT02560012|Growth Substances|growth substances|mesh-ancestor
44406974|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
44406975|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44406976|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44406977|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44406978|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
44406979|NCT02559817|Linaclotide|linaclotide|mesh-list
44406980|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44406981|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
44406982|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406983|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406984|NCT02559713|Vedolizumab|vedolizumab|mesh-list
44406985|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406986|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
44406987|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44406988|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44406989|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44406990|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
44406991|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44406992|NCT02559570|Linaclotide|linaclotide|mesh-list
44406993|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44107097|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44107098|NCT00078130|Naloxone|naloxone|mesh-list
44107099|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44107100|NCT00078130|Narcotics|narcotics|mesh-ancestor
44107101|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107102|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107103|NCT00078130|Analgesics|analgesics|mesh-ancestor
44107104|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
44406995|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44406996|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44406998|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
44406999|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407000|NCT02559414|Aspirin|aspirin|mesh-list
44407001|NCT02559414|Clopidogrel|clopidogrel|mesh-list
44407002|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407003|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407004|NCT02559414|Analgesics|analgesics|mesh-ancestor
44407005|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
44407006|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407007|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407008|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407009|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407010|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44407011|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44407012|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407013|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44407014|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407015|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407016|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
44407017|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44407018|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44407019|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44407020|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
44407021|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407022|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
44407023|NCT02559310|Linezolid|linezolid|mesh-list
44407024|NCT02559310|Lefamulin|lefamulin|mesh-list
44407025|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44407026|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407027|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44407028|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107105|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107106|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44107107|NCT00078182|Tenofovir|tenofovir|mesh-list
44107108|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
43789190|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43789191|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789192|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43789193|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407029|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407030|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407031|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407032|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44407033|NCT02559206|Linaclotide|linaclotide|mesh-list
44407034|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44407035|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
44407036|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407037|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407038|NCT02558894|Durvalumab|durvalumab|mesh-list
44407039|NCT02558894|Tremelimumab|tremelimumab|mesh-list
44407040|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44407041|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407042|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407043|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
44407044|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407045|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44407046|NCT02558400|Latanoprost|latanoprost|mesh-list
44407047|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44407048|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
44407049|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407050|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407051|NCT02558231|Selexipag|selexipag|mesh-list
44407052|NCT02558231|Tadalafil|tadalafil|mesh-list
44407053|NCT02558231|Macitentan|macitentan|mesh-list
44407054|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
44407055|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44407056|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44407057|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43706726|NCT02705638|Rituximab|rituximab|mesh-list
44107109|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107110|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44107111|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44107112|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107113|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107114|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44107115|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44107116|NCT00078195|Omalizumab|omalizumab|mesh-list
44107117|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
44107118|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
44107119|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44107120|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107121|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44107124|NCT00078234|Rituximab|rituximab|mesh-list
44107125|NCT00078234|Fludarabine|fludarabine|mesh-list
44107126|NCT00078234|Oblimersen|oblimersen|mesh-list
44107127|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407058|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407059|NCT02558231|Urological Agents|urological agents|mesh-ancestor
44407060|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44407061|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44407062|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44407063|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44407064|NCT02557672|Thrombin|thrombin|mesh-list
44407065|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
44407066|NCT02557672|Coagulants|coagulants|mesh-ancestor
44407067|NCT02557646|Ribavirin|ribavirin|mesh-list
44407068|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43789221|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
43789223|NCT04827030|Ropivacaine|ropivacaine|mesh-list
44407069|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
44407070|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407071|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
44407072|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407073|NCT02557100|Adalimumab|adalimumab|mesh-list
44407074|NCT02557100|Methotrexate|methotrexate|mesh-list
44407075|NCT02557100|Abatacept|abatacept|mesh-list
44407076|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44407077|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
44407078|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44407079|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407080|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44407081|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
44407082|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43706754|NCT02705053|Insulin|insulin|mesh-list
44107128|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107129|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
44107130|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107131|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107132|NCT00078247|Lamivudine|lamivudine|mesh-list
44107133|NCT00078247|Zidovudine|zidovudine|mesh-list
44107134|NCT00078247|Abacavir|abacavir|mesh-list
44107135|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44107136|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44107137|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107138|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107139|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
44107140|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107141|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44107142|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44107143|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
44107144|NCT00078260|Pemetrexed|pemetrexed|mesh-list
44107145|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107146|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107147|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107148|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44107149|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44107150|NCT00078351|Hylan|hylan|mesh-list
44107151|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
44407083|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407084|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407085|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407086|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44407087|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407088|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
44407089|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407090|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44407091|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407092|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44407094|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44407095|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
44407096|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44407097|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
44407098|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
44407099|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407100|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407101|NCT02556918|Incretins|incretins|mesh-ancestor
44407102|NCT02556918|Hormones|hormones|mesh-ancestor
44407103|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407104|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44407105|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407106|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407107|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407108|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
43617219|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
44407109|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44407110|NCT02556775|Antibodies|antibodies|mesh-list
44407111|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
44407112|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44407113|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
44407114|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407115|NCT02556632|Curcumin|curcumin|mesh-list
44407116|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407117|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407118|NCT02556632|Analgesics|analgesics|mesh-ancestor
44407119|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
44107152|NCT00078351|Protective Agents|protective agents|mesh-ancestor
44107153|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407120|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407121|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407122|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407123|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407124|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407125|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44064731|NCT00006258|Etoposide|etoposide|mesh-list
44407126|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407127|NCT02556307|Ribavirin|ribavirin|mesh-list
44407128|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44407129|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
44407130|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407131|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
44407132|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407133|NCT02556203|Aspirin|aspirin|mesh-list
44407134|NCT02556203|Vitamin K|vitamin k|mesh-list
44407135|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
44407136|NCT02556203|Clopidogrel|clopidogrel|mesh-list
44407137|NCT02556203|Vitamins|vitamins|mesh-ancestor
44407138|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
44407144|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
44407176|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44407177|NCT02555683|Growth Substances|growth substances|mesh-ancestor
44407178|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407179|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44407180|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407181|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407182|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
44407183|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407184|NCT02554981|Cyclosporine|cyclosporine|mesh-list
44407185|NCT02554981|Cyclosporins|cyclosporins|mesh-list
44407186|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407187|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407188|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407189|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
44407190|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407191|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
44407192|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407193|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407194|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407195|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44407196|NCT02554903|Macitentan|macitentan|mesh-list
44407197|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44407198|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44407199|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407200|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44407201|NCT02554890|Valsartan|valsartan|mesh-list
44407202|NCT02554890|Enalapril|enalapril|mesh-list
44407203|NCT02554890|Enalaprilat|enalaprilat|mesh-list
44407204|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44407205|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44407206|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44407207|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44407208|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412314|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44107155|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
44107156|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107157|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407209|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44407210|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407211|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407212|NCT02554786|Fluticasone|fluticasone|mesh-list
44407213|NCT02554786|Xhance|xhance|mesh-list
44407214|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
44407215|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44407216|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407217|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44407218|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
44407219|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407220|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407221|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44407222|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
44407223|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407224|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44407225|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44407226|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44407227|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44407228|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407229|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407230|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407231|NCT02554721|Aspirin|aspirin|mesh-list
44407232|NCT02554721|Cilostazol|cilostazol|mesh-list
44407233|NCT02554721|Clopidogrel|clopidogrel|mesh-list
44407234|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44407235|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44407236|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44407237|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44407238|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
44407239|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407240|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407241|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407242|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44107158|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107159|NCT00078442|Interferons|interferons|mesh-list
44107160|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
44107161|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
44107162|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44407243|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407244|NCT02554721|Analgesics|analgesics|mesh-ancestor
44407245|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
44407246|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407247|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407248|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407249|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44407250|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44407251|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407252|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407253|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
44407254|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44407255|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
44407256|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44407257|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44407258|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
44407259|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44407260|NCT02554721|Protective Agents|protective agents|mesh-ancestor
44407261|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44407262|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44407264|NCT02554318|Isoniazid|isoniazid|mesh-list
44407265|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
44407266|NCT02554318|Ethambutol|ethambutol|mesh-list
44407267|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44407268|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
44407293|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
44407294|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407295|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407296|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407297|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44407298|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44407299|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44407300|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44407301|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44407302|NCT02553772|Laxatives|laxatives|mesh-ancestor
44407303|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407304|NCT02553629|Rocuronium|rocuronium|mesh-list
44407305|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44407306|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44407307|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44407308|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407309|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407310|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
44407311|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407312|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407313|NCT02553265|Carbidopa|carbidopa|mesh-list
44407314|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44407315|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44407316|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
44407317|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407318|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407319|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407320|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44407321|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407322|NCT02552355|Metformin|metformin|mesh-list
44407323|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407324|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407325|NCT02552303|Modafinil|modafinil|mesh-list
44407326|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44407327|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407330|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44407331|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407332|NCT02552225|Amitriptyline|amitriptyline|mesh-list
44407333|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44407334|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
44407335|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44407336|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407337|NCT02552225|Analgesics|analgesics|mesh-ancestor
44407338|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
44407339|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407340|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407341|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44407342|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44407343|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44407345|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407388|NCT02551874|Incretins|incretins|mesh-ancestor
44407389|NCT02551874|Hormones|hormones|mesh-ancestor
44407390|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407391|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44407392|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407393|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407394|NCT02551731|Cannabidiol|cannabidiol|mesh-list
44407395|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
44407396|NCT02551692|Nicotine|nicotine|mesh-list
44407397|NCT02551692|Varenicline|varenicline|mesh-list
44407398|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44407399|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
43789238|NCT04737603|Buprenorphine|buprenorphine|mesh-list
43789239|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44407400|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407401|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407402|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44407403|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44407404|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
44407405|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407406|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407446|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44407447|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407448|NCT02550795|Analgesics|analgesics|mesh-ancestor
44407449|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
44407450|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44407451|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44407452|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44407453|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407454|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407455|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407456|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
44407457|NCT02550652|Prednisone|prednisone|mesh-list
44407458|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
44407459|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
44407460|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407461|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
44407462|NCT02550652|Hormones|hormones|mesh-ancestor
44407463|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407464|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407465|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44407466|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407467|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44407468|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44407469|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
44407470|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44407471|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407472|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407473|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407474|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
44407490|NCT02550106|Omalizumab|omalizumab|mesh-list
44407491|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44407492|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44407493|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
44407494|NCT02549573|Apomorphine|apomorphine|mesh-list
44407495|NCT02549573|Emetics|emetics|mesh-ancestor
44407496|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407497|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
44407498|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407499|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407500|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
44407501|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
44407502|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407503|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407504|NCT02549196|Donepezil|donepezil|mesh-list
44407505|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
44407506|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44407507|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407508|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407509|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
44407510|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407511|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407512|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
44407513|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44407514|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44407515|NCT02549196|Urological Agents|urological agents|mesh-ancestor
44407516|NCT02549092|Levodopa|levodopa|mesh-list
44407517|NCT02549092|Carbidopa|carbidopa|mesh-list
44407518|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44407537|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407538|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
44407539|NCT02548962|Hormones|hormones|mesh-ancestor
44407540|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407541|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44407542|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407543|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
44407544|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44407545|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44407546|NCT02548962|Growth Substances|growth substances|mesh-ancestor
44407547|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
44407549|NCT02548650|Clopidogrel|clopidogrel|mesh-list
44407550|NCT02548650|Vorapaxar|vorapaxar|mesh-list
44407551|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407552|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407553|NCT02548650|Analgesics|analgesics|mesh-ancestor
44407554|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
44407555|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407556|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407557|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407558|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407559|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44407560|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44407561|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407562|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44407563|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407564|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407565|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
44407566|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44407567|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44407568|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44407569|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
44407570|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407571|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44107163|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107164|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
44107165|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107166|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
44407572|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44407573|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
44407574|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44407575|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407576|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44407577|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44407578|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44407580|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
44407581|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407582|NCT02547987|Carboplatin|carboplatin|mesh-list
44407583|NCT02547987|Docetaxel|docetaxel|mesh-list
44407584|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407585|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
44407586|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
44407587|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
44407588|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407589|NCT02547974|Vaccines|vaccines|mesh-list
44407590|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
44407591|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407592|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
44407593|NCT02547935|Saxagliptin|saxagliptin|mesh-list
44407594|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44407595|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407596|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407597|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407598|NCT02547935|Incretins|incretins|mesh-ancestor
44407599|NCT02547935|Hormones|hormones|mesh-ancestor
44407600|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407601|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44407602|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
44407613|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407614|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
44407615|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407616|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44407617|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44407618|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407619|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
44407620|NCT02547038|Amoxicillin|amoxicillin|mesh-list
44407621|NCT02547038|Metronidazole|metronidazole|mesh-list
44407622|NCT02547038|Clarithromycin|clarithromycin|mesh-list
44407623|NCT02547038|Tetracycline|tetracycline|mesh-list
44407624|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
44407625|NCT02547038|Pantoprazole|pantoprazole|mesh-list
44407627|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44407628|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407629|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44407630|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44407631|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44407632|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407633|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407634|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44407635|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44407636|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44407637|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407638|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44407639|NCT02547038|Antacids|antacids|mesh-ancestor
44407640|NCT02546765|Acetaminophen|acetaminophen|mesh-list
44407641|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
44407642|NCT02546765|Propofol|propofol|mesh-list
44407643|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44407644|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44407657|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407658|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407659|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
44407660|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44407661|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44407662|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44407663|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
44407664|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407665|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44407666|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44407667|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407668|NCT02546193|Misoprostol|misoprostol|mesh-list
44407669|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44407670|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
44407671|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44407672|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407673|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44407674|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44407675|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
44407676|NCT02545933|Aspirin|aspirin|mesh-list
44407677|NCT02545933|Ticagrelor|ticagrelor|mesh-list
44407678|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44407679|NCT02545933|Vorapaxar|vorapaxar|mesh-list
44407680|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407681|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407682|NCT02545933|Analgesics|analgesics|mesh-ancestor
44407683|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
44407684|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107167|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107168|NCT00078481|Idebenone|idebenone|mesh-list
44107169|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
44107170|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107171|NCT00078481|Protective Agents|protective agents|mesh-ancestor
44107172|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107173|NCT00078546|Antibodies|antibodies|mesh-list
44107174|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44107175|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
44107176|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107177|NCT00078572|Capecitabine|capecitabine|mesh-list
44107178|NCT00078572|Lapatinib|lapatinib|mesh-list
44107179|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107180|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
44107181|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107182|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107183|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107184|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107185|NCT00078598|Rituximab|rituximab|mesh-list
44407685|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407686|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407687|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407688|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44407689|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44407690|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407691|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44407692|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407693|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407694|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
44407695|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44407696|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44407697|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44407698|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
44407699|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407700|NCT02545868|Vaccines|vaccines|mesh-list
44407701|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
44407702|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407703|NCT02545504|Leucovorin|leucovorin|mesh-list
44407704|NCT02545504|Fluorouracil|fluorouracil|mesh-list
44407705|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
44407706|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
44407707|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407708|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44407709|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407710|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407711|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
43707265|NCT02701673|Vitamins|vitamins|mesh-ancestor
44107186|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
44107187|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107188|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107189|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
44107190|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107191|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107192|NCT00078611|Natalizumab|natalizumab|mesh-list
44107193|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
44107194|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153485|NCT00220480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44153486|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44153487|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153489|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153490|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
44153491|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153492|NCT00220480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44153493|NCT00220480|Antidepressive Agents|antidepressive agents|mesh-ancestor
44153494|NCT00220480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44407712|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407713|NCT02545504|Antidotes|antidotes|mesh-ancestor
44407714|NCT02545504|Protective Agents|protective agents|mesh-ancestor
44407715|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
44407717|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
44407718|NCT02545075|Ipilimumab|ipilimumab|mesh-list
44407719|NCT02545075|Dacarbazine|dacarbazine|mesh-list
44407720|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407721|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407722|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44407723|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407724|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44407725|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
44407726|NCT02544763|Cannabidiol|cannabidiol|mesh-list
44407727|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
44407728|NCT02544750|Cannabidiol|cannabidiol|mesh-list
44407729|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
44407730|NCT02544451|Ivacaftor|ivacaftor|mesh-list
44407731|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44407732|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44407733|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407734|NCT02544321|Bromocriptine|bromocriptine|mesh-list
44407735|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44407736|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44407737|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
44407738|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407739|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407740|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
44407741|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
44407742|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407743|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407744|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
44407745|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
44407751|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44407752|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407754|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44407755|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
44407756|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407757|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44407758|NCT02543918|Ixekizumab|ixekizumab|mesh-list
44407759|NCT02543918|Vaccines|vaccines|mesh-list
44407760|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44407761|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
44407762|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44065376|NCT00006381|Celecoxib|celecoxib|mesh-list
43789304|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789305|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789306|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43789307|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44407763|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407765|NCT02543801|Clonidine|clonidine|mesh-list
44407766|NCT02543801|Epinephrine|epinephrine|mesh-list
44407767|NCT02543801|Bupivacaine|bupivacaine|mesh-list
44407768|NCT02543801|Ropivacaine|ropivacaine|mesh-list
44407769|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
44407770|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
44407771|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44407772|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407773|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
44407774|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407775|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44407776|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44407777|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407778|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407779|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407780|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44153495|NCT00220493|Methylphenidate|methylphenidate|mesh-list
44153496|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44153497|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153498|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44153499|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43820841|NCT05197621|Vaccines|vaccines|mesh-list
44107195|NCT00078689|Daclizumab|daclizumab|mesh-list
44107196|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107197|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
44107198|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107199|NCT00078793|Etanercept|etanercept|mesh-list
44107200|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44107201|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44107202|NCT00078793|Analgesics|analgesics|mesh-ancestor
44107203|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
44407781|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44407782|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
44407783|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44407784|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
44407785|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
44407786|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
44407787|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44407788|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407789|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407790|NCT02543801|Analgesics|analgesics|mesh-ancestor
44407791|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44407792|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44407793|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44407794|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407795|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44407796|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
44407797|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44407798|NCT02543658|Neostigmine|neostigmine|mesh-list
44407799|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44407800|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407801|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407802|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
44407803|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407804|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407805|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44407806|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
44407807|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407808|NCT02543346|Cetirizine|cetirizine|mesh-list
44407809|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44107204|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107205|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107206|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107207|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107208|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44107209|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107211|NCT00078832|Anastrozole|anastrozole|mesh-list
44107212|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44107213|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107214|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44107215|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44107216|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107217|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107218|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44107219|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
44107220|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44407810|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44407811|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44407812|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
44407813|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
44407814|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407815|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407816|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407817|NCT02542943|Fluorides|fluorides|mesh-list
44407818|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
44407819|NCT02542943|Protective Agents|protective agents|mesh-ancestor
44407820|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407821|NCT02542631|Insulin|insulin|mesh-list
44407822|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44407823|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44407824|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407825|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44407826|NCT02542605|Erenumab|erenumab|mesh-list
44407827|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44407828|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407829|NCT02542605|Analgesics|analgesics|mesh-ancestor
44407830|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
44407831|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407832|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407833|NCT02542605|Growth Substances|growth substances|mesh-ancestor
44407834|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
44407835|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407836|NCT02541903|Afatinib|afatinib|mesh-list
44407837|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407838|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107221|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107222|NCT00078845|Amifostine|amifostine|mesh-list
44107223|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44107224|NCT00078845|Protective Agents|protective agents|mesh-ancestor
44107225|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107226|NCT00078858|Cyclosporine|cyclosporine|mesh-list
44107227|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
44107228|NCT00078858|Fludarabine|fludarabine|mesh-list
44107229|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
44107230|NCT00078858|Cyclosporins|cyclosporins|mesh-list
44107231|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107232|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107233|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
44107234|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107235|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107236|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
44407839|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44407840|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407841|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44407842|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44407843|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44407844|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407845|NCT02541604|Atezolizumab|atezolizumab|mesh-list
44407846|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407847|NCT02540954|Aflibercept|aflibercept|mesh-list
44407848|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44407849|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44407850|NCT02540954|Growth Substances|growth substances|mesh-ancestor
44407851|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407852|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
44407853|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44407854|NCT02540668|Warfarin|warfarin|mesh-list
44407855|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
44407856|NCT02540356|Antibodies|antibodies|mesh-list
44407857|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
44407858|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
44407859|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407860|NCT02540265|Meloxicam|meloxicam|mesh-list
44407861|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44407862|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44407863|NCT02540265|Analgesics|analgesics|mesh-ancestor
44407889|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407890|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44407891|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
44407892|NCT02538107|Hematinics|hematinics|mesh-ancestor
44407893|NCT02537015|Bimatoprost|bimatoprost|mesh-list
44407894|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44407895|NCT02536976|Mirabegron|mirabegron|mesh-list
44407896|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44407897|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44407898|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44407899|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
44407900|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407954|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789403|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44407955|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44407956|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
44407957|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
44407958|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44407959|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44407960|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44407961|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44407962|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44407963|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44407964|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44407965|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44407966|NCT02535000|Analgesics|analgesics|mesh-ancestor
44407967|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
44407968|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44407969|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
44407970|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44407971|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
44407973|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
44408006|NCT02533453|Hormones|hormones|mesh-ancestor
44408007|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408008|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
44408009|NCT02533401|Rituximab|rituximab|mesh-list
44408010|NCT02533401|Fludarabine|fludarabine|mesh-list
44408011|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408012|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
44408013|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408014|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408015|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44408016|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
44408017|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408018|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408019|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44408020|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408021|NCT02533375|Adalimumab|adalimumab|mesh-list
44408022|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408023|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408024|NCT02532855|Metformin|metformin|mesh-list
44408025|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44408026|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
44408027|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408028|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408029|NCT02532855|Incretins|incretins|mesh-ancestor
44408030|NCT02532855|Hormones|hormones|mesh-ancestor
44408031|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408032|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44408033|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44408034|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408035|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408036|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44408037|NCT02532647|Midazolam|midazolam|mesh-list
44408038|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44408039|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44408041|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408046|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
44408047|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
44408048|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
44408049|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
44408050|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408051|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789414|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43789415|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43789416|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789417|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
44408052|NCT02532374|Nicotine|nicotine|mesh-list
44408053|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44408054|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
44408055|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408056|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408057|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44408058|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44408059|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408060|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408061|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408062|NCT02532283|Oseltamivir|oseltamivir|mesh-list
44408063|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
44408064|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408065|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408066|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408067|NCT02531698|Vaccines|vaccines|mesh-list
44408068|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
44408069|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408071|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44408072|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408095|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
44408096|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408097|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44408098|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44408099|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408100|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408101|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408102|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
44408103|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
44408104|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408105|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
44408106|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408107|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408108|NCT02530125|Pidilizumab|pidilizumab|mesh-list
44408109|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408110|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408111|NCT02529995|Osimertinib|osimertinib|mesh-list
44408112|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408113|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408114|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408115|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408116|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
44408117|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408118|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408119|NCT02528253|Tramadol|tramadol|mesh-list
44408120|NCT02528253|Tanezumab|tanezumab|mesh-list
44408121|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44408122|NCT02528253|Narcotics|narcotics|mesh-ancestor
44408123|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408124|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408125|NCT02528253|Analgesics|analgesics|mesh-ancestor
44408126|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
44408127|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408128|NCT02528214|Prednisone|prednisone|mesh-list
44107237|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107238|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789429|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
43789430|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789431|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
44408130|NCT02528214|Albuterol|albuterol|mesh-list
44408131|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408132|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
44408133|NCT02528214|Hormones|hormones|mesh-ancestor
44408134|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408135|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408136|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408137|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408138|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
44408139|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44065760|NCT00006465|Irinotecan|irinotecan|mesh-list
44408140|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44408141|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44408142|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408143|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
44408144|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44408145|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44408146|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44408147|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44408148|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44408149|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408150|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408152|NCT02528188|Analgesics|analgesics|mesh-ancestor
44408153|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
44408154|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408155|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408156|NCT02527421|Betamethasone|betamethasone|mesh-list
44408157|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408158|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
44408159|NCT02527421|Hormones|hormones|mesh-ancestor
44408160|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408161|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408162|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44412315|NCT02422186|Citalopram|citalopram|mesh-list
44107239|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
44107240|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107241|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107242|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408163|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408165|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408166|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408167|NCT02527200|Incretins|incretins|mesh-ancestor
44408168|NCT02527200|Hormones|hormones|mesh-ancestor
44408169|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408170|NCT02526550|Vaccines|vaccines|mesh-list
44408171|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
44408172|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789442|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789443|NCT02256800|Leucovorin|leucovorin|mesh-list
43789444|NCT02256800|Bevacizumab|bevacizumab|mesh-list
43789445|NCT02256800|Irinotecan|irinotecan|mesh-list
43789446|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789447|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789448|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43789449|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43789450|NCT02256800|Growth Substances|growth substances|mesh-ancestor
43789451|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789452|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43789453|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43789454|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44408173|NCT02526212|Buprenorphine|buprenorphine|mesh-list
44408174|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44408175|NCT02526212|Narcotics|narcotics|mesh-ancestor
44408176|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408177|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408178|NCT02526212|Analgesics|analgesics|mesh-ancestor
44408179|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
44408180|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408181|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44408182|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44408183|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408184|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408185|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
44408186|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408187|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
44408188|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44408189|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408190|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408191|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44408192|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44408193|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
44408194|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408195|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408196|NCT02525471|RNS60|rns60|mesh-list
44408197|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44107243|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44107244|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107245|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44107246|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
44107247|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107248|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
44408198|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408199|NCT02525471|Analgesics|analgesics|mesh-ancestor
44408200|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
44408201|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408202|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408203|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408204|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408205|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44408206|NCT02525133|Bupivacaine|bupivacaine|mesh-list
44408207|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
44408208|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
44408209|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408210|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408211|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
44408212|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408213|NCT02524847|Methoxsalen|methoxsalen|mesh-list
44408214|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44408215|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408216|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
44408217|NCT02524665|Salicylates|salicylates|mesh-list
44408218|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44408219|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408220|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
44408221|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
44408222|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408223|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408224|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408225|NCT02524665|Analgesics|analgesics|mesh-ancestor
43789455|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789457|NCT02256800|Antidotes|antidotes|mesh-ancestor
44408226|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
44408227|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408228|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408229|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408230|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408231|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44408232|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408233|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107249|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107250|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44107251|NCT00078910|Protective Agents|protective agents|mesh-ancestor
44408234|NCT02524379|Glyburide|glyburide|mesh-list
44408235|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408236|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408237|NCT02524275|Docetaxel|docetaxel|mesh-list
44408238|NCT02524275|Capecitabine|capecitabine|mesh-list
44408239|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408240|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44408241|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44408242|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44408243|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44065910|NCT00006485|Irinotecan|irinotecan|mesh-list
44408244|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44408245|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
44408246|NCT02524145|Isoproterenol|isoproterenol|mesh-list
44408247|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
44408248|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
44408249|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44408250|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408251|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408252|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408253|NCT02524145|Analgesics|analgesics|mesh-ancestor
44408254|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
44408255|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408256|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44408257|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44408258|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44408259|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44408260|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408261|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408262|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44408279|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
44408280|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408281|NCT02522780|Mesalamine|mesalamine|mesh-list
44408282|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408283|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408284|NCT02522780|Analgesics|analgesics|mesh-ancestor
44408285|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
44408286|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408287|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408288|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408289|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408290|NCT02522767|Mesalamine|mesalamine|mesh-list
44408291|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408292|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408293|NCT02522767|Analgesics|analgesics|mesh-ancestor
44408294|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
44408295|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408296|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408297|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408298|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408299|NCT02522377|Midazolam|midazolam|mesh-list
44408300|NCT02522377|Ketamine|ketamine|mesh-list
44408301|NCT02522377|Analgesics|analgesics|mesh-ancestor
44408302|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
44408303|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408304|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408305|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44408306|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44408307|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
44408308|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
44408309|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408310|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44408322|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
44408323|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44408324|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
44408325|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408326|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408327|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
44408328|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408329|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44408330|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44408331|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44408332|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408333|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408334|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
44408335|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408336|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44408337|NCT02522299|Nemiralisib|nemiralisib|mesh-list
44408338|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408339|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408340|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408341|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
44408342|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408343|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408344|NCT02520726|Sertraline|sertraline|mesh-list
44408345|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
44107252|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107253|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44107254|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43633309|NCT05611086|Antidotes|antidotes|mesh-ancestor
44107256|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44107258|NCT00078910|Analgesics|analgesics|mesh-ancestor
44107259|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
44107260|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107261|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107262|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107263|NCT00078962|Gemcitabine|gemcitabine|mesh-list
44107264|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107265|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
44107266|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107267|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107268|NCT00078962|Antiviral Agents|antiviral agents|mesh-ancestor
44107269|NCT00078962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107270|NCT00078962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107271|NCT00078962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107272|NCT00078962|Immunologic Factors|immunologic factors|mesh-ancestor
44107273|NCT00078962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107274|NCT00078975|Gemcitabine|gemcitabine|mesh-list
44107275|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107276|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
44107277|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408346|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44408347|NCT02520726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44408348|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44408349|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408350|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408351|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408352|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
44408353|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408354|NCT02520388|Methylphenidate|methylphenidate|mesh-list
44408355|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44408356|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408357|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44408358|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44408359|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408360|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408361|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
44408362|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408363|NCT02520011|Cytarabine|cytarabine|mesh-list
44408364|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
44408365|NCT02520011|Alvocidib|alvocidib|mesh-list
44408366|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44408367|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
44408368|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408369|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408370|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
44408371|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408372|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408373|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
44408374|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408375|NCT02520011|Analgesics|analgesics|mesh-ancestor
44408376|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
43840734|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
44408377|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408378|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44408379|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107278|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107279|NCT00078975|Antiviral Agents|antiviral agents|mesh-ancestor
44107280|NCT00078975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408381|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
44408382|NCT02520011|Growth Substances|growth substances|mesh-ancestor
44408383|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408384|NCT02519842|Dexamethasone|dexamethasone|mesh-list
44408385|NCT02519842|Ondansetron|ondansetron|mesh-list
44408386|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
44408387|NCT02519842|Aprepitant|aprepitant|mesh-list
44408388|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
44408389|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408390|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
44408391|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
44408392|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408393|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408394|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44066024|NCT00006669|Prednisone|prednisone|mesh-list
44408395|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
44408397|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408398|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408399|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408400|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
44408401|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408402|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44408403|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
44408404|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408405|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408406|NCT02519842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107281|NCT00078975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107282|NCT00078975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107283|NCT00078975|Immunologic Factors|immunologic factors|mesh-ancestor
44107284|NCT00078975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107285|NCT00078988|Carboplatin|carboplatin|mesh-list
44107286|NCT00078988|Etoposide|etoposide|mesh-list
44107287|NCT00078988|Thiotepa|thiotepa|mesh-list
44107288|NCT00078988|Isotretinoin|isotretinoin|mesh-list
44107289|NCT00078988|Lenograstim|lenograstim|mesh-list
44107290|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107291|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107292|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44107293|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107294|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107295|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107296|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44107297|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
44107298|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107299|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44107300|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
44107301|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44107302|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408407|NCT02519842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44408408|NCT02519842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408409|NCT02519842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44408410|NCT02519842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44408411|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44408412|NCT02519777|Maraviroc|maraviroc|mesh-list
44408413|NCT02519777|Dolutegravir|dolutegravir|mesh-list
44408414|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44408415|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44408416|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408417|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44408418|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44408419|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
44408420|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408421|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44408422|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44408423|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44408424|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408425|NCT02519595|Ketamine|ketamine|mesh-list
44408426|NCT02519595|Analgesics|analgesics|mesh-ancestor
44408427|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
44408428|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408429|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408430|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44408431|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44408432|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
44408433|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
44408434|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408435|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44408436|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44408437|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107303|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107304|NCT00079014|Doxorubicin|doxorubicin|mesh-list
44107305|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44107306|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107307|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107308|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44107309|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107310|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107311|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107312|NCT00079027|Doxorubicin|doxorubicin|mesh-list
44107313|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44107314|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107315|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408438|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408439|NCT02519231|Naproxen|naproxen|mesh-list
44408440|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408441|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408442|NCT02519231|Analgesics|analgesics|mesh-ancestor
44408443|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
44408444|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408445|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408446|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408447|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408448|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
44408449|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44408450|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408451|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408452|NCT02518971|Tamsulosin|tamsulosin|mesh-list
44408453|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44408454|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44408455|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44408456|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
44408457|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789526|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789527|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789528|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408458|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408459|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408460|NCT02518971|Urological Agents|urological agents|mesh-ancestor
44408461|NCT02518464|Ticagrelor|ticagrelor|mesh-list
44408462|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44408463|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44408464|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44408465|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44408466|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
44408467|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408468|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107316|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44107317|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107318|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107319|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107320|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44107321|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107322|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408469|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408470|NCT02518113|Dexamethasone|dexamethasone|mesh-list
44408471|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408472|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
44408473|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
44408474|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408475|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408476|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44408477|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
44408478|NCT02518113|Hormones|hormones|mesh-ancestor
44408479|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408480|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408481|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408482|NCT02517905|Bupivacaine|bupivacaine|mesh-list
44408483|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
44408484|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
44408485|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408486|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408487|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
44408488|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408489|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44107323|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107324|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107325|NCT00079066|Cetuximab|cetuximab|mesh-list
44107326|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107334|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107335|NCT00079079|Antiviral Agents|antiviral agents|mesh-ancestor
44107336|NCT00079079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107337|NCT00079079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107338|NCT00079079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107339|NCT00079079|Immunologic Factors|immunologic factors|mesh-ancestor
44107340|NCT00079079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107341|NCT00079092|Thalidomide|thalidomide|mesh-list
44107342|NCT00079092|Procarbazine|procarbazine|mesh-list
44107343|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107344|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
44107345|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107346|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
44107347|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107348|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43619581|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43619582|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
43619583|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43619585|NCT03121417|Nivolumab|nivolumab|mesh-list
44107349|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44107350|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44107351|NCT00079092|Growth Substances|growth substances|mesh-ancestor
44107352|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44107353|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107354|NCT00079105|Prednisolone|prednisolone|mesh-list
44107355|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
44107357|NCT00079105|Vincristine|vincristine|mesh-list
44107358|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
44107359|NCT00079105|Bleomycin|bleomycin|mesh-list
43550440|NCT03623087|Cisplatin|cisplatin|mesh-list
44107360|NCT00079105|Vinblastine|vinblastine|mesh-list
44107361|NCT00079105|Procarbazine|procarbazine|mesh-list
44107362|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
44107363|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408490|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44408491|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44408492|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408493|NCT02517528|Ritonavir|ritonavir|mesh-list
44408494|NCT02517528|Ribavirin|ribavirin|mesh-list
44408495|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44408496|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44408497|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44408498|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408499|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408500|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44408501|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44408502|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
44408503|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408504|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44408505|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44408506|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
44408507|NCT02517515|Ritonavir|ritonavir|mesh-list
44408508|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44408509|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44408510|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107364|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
44107365|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107366|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107367|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44107368|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
44107369|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107370|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107371|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44107372|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107373|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44107374|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107375|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107376|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107377|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107378|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107379|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107380|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
44107381|NCT00079105|Hormones|hormones|mesh-ancestor
44107382|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107383|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43789529|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789530|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789531|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
43789532|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
43789534|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789535|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789536|NCT05127707|Analgesics|analgesics|mesh-ancestor
43789556|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43789557|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44107384|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107385|NCT00079105|Analgesics|analgesics|mesh-ancestor
44107386|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
44107387|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107388|NCT00079118|Docetaxel|docetaxel|mesh-list
44107389|NCT00079118|Irinotecan|irinotecan|mesh-list
44107390|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107391|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107392|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107393|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107394|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107395|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44408511|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408512|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408513|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44408514|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44408515|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
44408516|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408517|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44408518|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44408519|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
44408520|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44408521|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
44408522|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44408523|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408524|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44408526|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44408527|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408528|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44408529|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
44408530|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408531|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408532|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44408533|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408534|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408535|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44408536|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44107396|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107406|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
44107407|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107408|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107409|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44107410|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
44107411|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107412|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107413|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44107414|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107415|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
44107416|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44107417|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44107418|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44107419|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
44107420|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107421|NCT00079157|Sargramostim|sargramostim|mesh-list
44107422|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
44107423|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
44107424|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107425|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44408537|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44408538|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44408539|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
44408540|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44066174|NCT00006786|Fluorouracil|fluorouracil|mesh-list
44408541|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408543|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44408544|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408545|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408546|NCT02516332|Citalopram|citalopram|mesh-list
44408547|NCT02516332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44408548|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44408549|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408550|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408551|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408552|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
44408553|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408554|NCT02516332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44408555|NCT02516332|Antidepressive Agents|antidepressive agents|mesh-ancestor
44408556|NCT02516332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44408557|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44408558|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44408559|NCT02516241|Gemcitabine|gemcitabine|mesh-list
44408560|NCT02516241|Cisplatin|cisplatin|mesh-list
44408561|NCT02516241|Carboplatin|carboplatin|mesh-list
44408562|NCT02516241|Durvalumab|durvalumab|mesh-list
44408563|NCT02516241|Tremelimumab|tremelimumab|mesh-list
44408564|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408565|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44408566|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
44408580|NCT02516098|Scopolamine|scopolamine|mesh-list
44408581|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44408582|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44408583|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
44408584|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
44408585|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408586|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408587|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44408588|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
44408589|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44408590|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408591|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408592|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408593|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44408594|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
43789591|NCT05125640|Hormones|hormones|mesh-ancestor
44408595|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
44408596|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408597|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408598|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408599|NCT02515279|Ribavirin|ribavirin|mesh-list
44408600|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44408601|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
44408602|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408603|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
44408604|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408605|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
44408606|NCT02515045|Prednisolone|prednisolone|mesh-list
44408607|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44408608|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
44408609|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44408610|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
44107426|NCT00079170|Docetaxel|docetaxel|mesh-list
44107427|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107428|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107429|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107430|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107431|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107432|NCT00079222|Itraconazole|itraconazole|mesh-list
44107433|NCT00079222|Voriconazole|voriconazole|mesh-list
44107434|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
44107435|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107436|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44107437|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44408612|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44408613|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
44408614|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408615|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
44408616|NCT02515045|Hormones|hormones|mesh-ancestor
44408617|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408618|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408619|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44408620|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408621|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
44408622|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
44408623|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408624|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44408625|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44408626|NCT02515045|Protective Agents|protective agents|mesh-ancestor
44408627|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44408628|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408629|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44408630|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44408631|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408632|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408633|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408634|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408635|NCT02515045|Analgesics|analgesics|mesh-ancestor
44408636|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
44408637|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408638|NCT02514772|Rituximab|rituximab|mesh-list
44408639|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408640|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408641|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
44408642|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408643|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408644|NCT02514551|Paclitaxel|paclitaxel|mesh-list
44408645|NCT02514551|Ramucirumab|ramucirumab|mesh-list
44107438|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107439|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107440|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44107441|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
44408646|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44408647|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408648|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44408649|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44408650|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44408651|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408652|NCT02514473|Ivacaftor|ivacaftor|mesh-list
44408653|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44408654|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408655|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408656|NCT02514174|Afatinib|afatinib|mesh-list
44408657|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408658|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408659|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408660|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408661|NCT02514122|Ketamine|ketamine|mesh-list
44408662|NCT02514122|Analgesics|analgesics|mesh-ancestor
44408663|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
44408664|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408665|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408666|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44408667|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44408668|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
44408669|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
44408670|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408671|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44408672|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44408673|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408674|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408675|NCT02513823|Vitamin D|vitamin d|mesh-list
44408676|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
44408677|NCT02513823|Vitamins|vitamins|mesh-ancestor
44408678|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
44408679|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107442|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107443|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107444|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44107446|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107447|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408680|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44408681|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44408682|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44408683|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408684|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408685|NCT02513771|Incretins|incretins|mesh-ancestor
44408686|NCT02513771|Hormones|hormones|mesh-ancestor
44408687|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408688|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44408689|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
44408690|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408691|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408692|NCT02513667|Ceritinib|ceritinib|mesh-list
44408693|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408694|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408695|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408696|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408697|NCT02513550|Ixekizumab|ixekizumab|mesh-list
44408698|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
44408699|NCT02513485|Levodopa|levodopa|mesh-list
44408700|NCT02513485|Carbidopa|carbidopa|mesh-list
44408701|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44408702|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44408703|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
44408704|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408705|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408706|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408707|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44408708|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408709|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
44408710|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408711|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43708009|NCT02697929|Neostigmine|neostigmine|mesh-list
44107448|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107449|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107450|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
44107451|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107452|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
44107453|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107454|NCT00079248|Progesterone|progesterone|mesh-list
44107455|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44408712|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44408713|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
44408714|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408716|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408717|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408718|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408719|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408720|NCT02513160|Beclomethasone|beclomethasone|mesh-list
44408721|NCT02513160|Albuterol|albuterol|mesh-list
44408722|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43789711|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44408723|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
44408724|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408725|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408726|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44408727|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
44408728|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
44408729|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44408730|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44408731|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44408732|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44408733|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
44408734|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408735|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408736|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408737|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
44408738|NCT02513160|Hormones|hormones|mesh-ancestor
44408739|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408740|NCT02512861|Bupivacaine|bupivacaine|mesh-list
44408741|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
44408742|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
44408743|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408744|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107456|NCT00079248|Estrogens|estrogens|mesh-list
44107457|NCT00079248|Progestins|progestins|mesh-ancestor
44107458|NCT00079248|Hormones|hormones|mesh-ancestor
44107459|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107460|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107461|NCT00079261|Gemcitabine|gemcitabine|mesh-list
44107462|NCT00079261|Prednisone|prednisone|mesh-list
44107463|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
44408745|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
44408746|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408747|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
44408748|NCT02512302|Bromides|bromides|mesh-list
44408749|NCT02512302|Charcoal|charcoal|mesh-list
44408750|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
44408751|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44408752|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44408753|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44408754|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408755|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408756|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408757|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408758|NCT02512302|Antidotes|antidotes|mesh-ancestor
44408759|NCT02512302|Protective Agents|protective agents|mesh-ancestor
44408760|NCT02512042|Brinzolamide|brinzolamide|mesh-list
44408761|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44408762|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408763|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408764|NCT02511431|Ritonavir|ritonavir|mesh-list
44408765|NCT02511431|Lonafarnib|lonafarnib|mesh-list
44408766|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44408767|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44408768|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
44408769|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408770|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408771|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44408772|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44408773|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
44408774|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44408775|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43789734|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44408776|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44408777|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
44408779|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408780|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408781|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408782|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107464|NCT00079261|Doxorubicin|doxorubicin|mesh-list
44408783|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408785|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44408786|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44408787|NCT02510794|Growth Substances|growth substances|mesh-ancestor
44408788|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408789|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
44408790|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408791|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
44408792|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44408793|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408794|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408795|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
44408796|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44408797|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408798|NCT02510014|Buprenorphine|buprenorphine|mesh-list
44408799|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44408800|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44408801|NCT02510014|Narcotics|narcotics|mesh-ancestor
44408802|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408803|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408804|NCT02510014|Analgesics|analgesics|mesh-ancestor
44408805|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
44408806|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408807|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44408808|NCT02510001|Crizotinib|crizotinib|mesh-list
44408809|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408810|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408826|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44408828|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408829|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408830|NCT02509026|Etanercept|etanercept|mesh-list
44408831|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408832|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408833|NCT02509026|Analgesics|analgesics|mesh-ancestor
44408834|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
44408835|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408836|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408837|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408838|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408839|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44408840|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408841|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
44408842|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44408843|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44408844|NCT02508935|Narcotics|narcotics|mesh-ancestor
44408845|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44408846|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408847|NCT02508935|Analgesics|analgesics|mesh-ancestor
44408848|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
44408849|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408850|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408851|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408852|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408853|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408854|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
44408855|NCT02508428|Diuretics|diuretics|mesh-ancestor
44408856|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
44107465|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44107466|NCT00079261|Vincristine|vincristine|mesh-list
44107470|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107471|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44107472|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
44107473|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107474|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107475|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44107476|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44408857|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408858|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44408859|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408860|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408861|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44408862|NCT02507375|Pertuzumab|pertuzumab|mesh-list
44408863|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408864|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44408865|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408866|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408867|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44408868|NCT02507219|Ibuprofen|ibuprofen|mesh-list
44408869|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44408870|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44408871|NCT02507219|Analgesics|analgesics|mesh-ancestor
44408872|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
44408873|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44408874|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408875|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44408876|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408877|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44408878|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408879|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408880|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
44408881|NCT02506881|Hematinics|hematinics|mesh-ancestor
44408882|NCT02506816|Olaparib|olaparib|mesh-list
44408883|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44408884|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408885|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408886|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408887|NCT02506257|Biguanides|biguanides|mesh-list
44408888|NCT02506257|Polihexanide|polihexanide|mesh-list
44408898|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408899|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
44408900|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408901|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
44408902|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408903|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408904|NCT02505334|Liraglutide|liraglutide|mesh-list
44408905|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44408906|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44408907|NCT02505334|Incretins|incretins|mesh-ancestor
44408908|NCT02505334|Hormones|hormones|mesh-ancestor
44408909|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44408910|NCT02504892|Everolimus|everolimus|mesh-list
44408911|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44408912|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408959|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44408960|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
44408961|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44408962|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44408963|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44408964|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
44408965|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44408966|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
44408967|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44408968|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44408969|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408970|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408971|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
44408972|NCT02504151|Cannabidiol|cannabidiol|mesh-list
44408973|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
44408974|NCT02503865|Orlistat|orlistat|mesh-list
44408975|NCT02503865|Diltiazem|diltiazem|mesh-list
44408976|NCT02503865|Atorvastatin|atorvastatin|mesh-list
44408977|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44408978|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44408979|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
44408980|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44408981|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44408982|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44408983|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44408984|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44408985|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44408986|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44408987|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44409005|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
44409006|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409007|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409008|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409009|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409010|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44409011|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789770|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
43789771|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
43789772|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789773|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789774|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43789775|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43789776|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
43789777|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789779|NCT04909853|Ritonavir|ritonavir|mesh-list
44409012|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409013|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
44409014|NCT02502864|Docetaxel|docetaxel|mesh-list
44409015|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409016|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
44409017|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409018|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409019|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44409020|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
44409021|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409022|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409023|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44409024|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409025|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409026|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409027|NCT02502734|Fluticasone|fluticasone|mesh-list
44409028|NCT02502734|Xhance|xhance|mesh-list
44409029|NCT02502734|Albuterol|albuterol|mesh-list
44409030|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409031|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44409032|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
44409033|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409034|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409035|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409036|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409037|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
44409038|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44409039|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
44409040|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44409042|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44409044|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409045|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409046|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409047|NCT02502149|Factor VIII|factor viii|mesh-list
44409048|NCT02502149|Coagulants|coagulants|mesh-ancestor
44409049|NCT02501928|Fesoterodine|fesoterodine|mesh-list
44409050|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44409051|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44409052|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409053|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409054|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409055|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409056|NCT02501928|Urological Agents|urological agents|mesh-ancestor
44409057|NCT02501902|Paclitaxel|paclitaxel|mesh-list
44409058|NCT02501902|Palbociclib|palbociclib|mesh-list
44409105|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409106|NCT02500797|Nivolumab|nivolumab|mesh-list
44409107|NCT02500797|Ipilimumab|ipilimumab|mesh-list
44409108|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409109|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409110|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44409111|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409112|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
44409113|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44409114|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409115|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
44409116|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
44409117|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44409118|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
44409119|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44409120|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44409121|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44409122|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409123|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409124|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409125|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409126|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409127|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409128|NCT02500706|Insulin|insulin|mesh-list
44409129|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44409130|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
44409131|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
44409132|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44409133|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409134|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409135|NCT02500641|Naproxen|naproxen|mesh-list
44409136|NCT02500641|Colchicine|colchicine|mesh-list
44409137|NCT02500641|Allopurinol|allopurinol|mesh-list
44409138|NCT02500641|Febuxostat|febuxostat|mesh-list
44409139|NCT02500641|Omeprazole|omeprazole|mesh-list
44409140|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43831424|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107478|NCT00079261|Antiviral Agents|antiviral agents|mesh-ancestor
44107479|NCT00079261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409141|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409142|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44409143|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409144|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409145|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44409146|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409147|NCT02500641|Analgesics|analgesics|mesh-ancestor
44409148|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
44409149|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409150|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409151|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409152|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409153|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
44409154|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44409155|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409156|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409157|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409158|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409159|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
44409160|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44409161|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
44409162|NCT02500641|Protective Agents|protective agents|mesh-ancestor
44409163|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
44409164|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409165|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409166|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
44409167|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409168|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409169|NCT02499783|Adalimumab|adalimumab|mesh-list
44409170|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409171|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107480|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107481|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107482|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44107483|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107484|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107485|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
44107486|NCT00079261|Hormones|hormones|mesh-ancestor
44107487|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107488|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44107489|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107490|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409172|NCT02499770|Carboplatin|carboplatin|mesh-list
44409173|NCT02499770|Etoposide|etoposide|mesh-list
44409174|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409175|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44409176|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43789894|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789895|NCT04635644|Morphine|morphine|mesh-list
44409177|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44409178|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409179|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409180|NCT02499575|Bupivacaine|bupivacaine|mesh-list
44409181|NCT02499575|Ropivacaine|ropivacaine|mesh-list
44409182|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
44409183|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
44409184|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409185|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409186|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
44409187|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409188|NCT02499159|Bupivacaine|bupivacaine|mesh-list
44409189|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
44409190|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
44409191|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409192|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409193|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
44409194|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409195|NCT02499146|Letrozole|letrozole|mesh-list
44409196|NCT02499146|Palbociclib|palbociclib|mesh-list
44409197|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409198|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44409199|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44409200|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409201|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409202|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44409203|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
44107491|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107492|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107493|NCT00079287|Gemcitabine|gemcitabine|mesh-list
44107494|NCT00079287|Paclitaxel|paclitaxel|mesh-list
44107495|NCT00079287|Vinorelbine|vinorelbine|mesh-list
44107496|NCT00079287|Docetaxel|docetaxel|mesh-list
44107497|NCT00079287|Carboplatin|carboplatin|mesh-list
44107498|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107499|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107500|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107501|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107502|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107503|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409204|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409205|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409206|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44409207|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
44409208|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44409209|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
44409210|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409211|NCT02499029|Expectorants|expectorants|mesh-ancestor
44409212|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409213|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44409214|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
44409215|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409216|NCT02499029|Protective Agents|protective agents|mesh-ancestor
44409217|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409218|NCT02499029|Antidotes|antidotes|mesh-ancestor
44409219|NCT02498652|Allopurinol|allopurinol|mesh-list
44409220|NCT02498652|Verinurad|verinurad|mesh-list
43789964|NCT04422743|Tramiprosate|tramiprosate|mesh-list
44409221|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
44409222|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107504|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107505|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
44107506|NCT00079287|Antiviral Agents|antiviral agents|mesh-ancestor
44107507|NCT00079287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107508|NCT00079287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107509|NCT00079287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107510|NCT00079287|Immunologic Factors|immunologic factors|mesh-ancestor
44107511|NCT00079287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107513|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44107514|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
44107515|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107516|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107517|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
44107518|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
44107519|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107520|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107521|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107522|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107523|NCT00079352|Gemcitabine|gemcitabine|mesh-list
44107524|NCT00079352|Irinotecan|irinotecan|mesh-list
44107525|NCT00079352|Alvocidib|alvocidib|mesh-list
44107526|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107527|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
44107528|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107529|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107530|NCT00079352|Antiviral Agents|antiviral agents|mesh-ancestor
44107531|NCT00079352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107532|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107533|NCT00079352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107534|NCT00079352|Immunologic Factors|immunologic factors|mesh-ancestor
44107535|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107536|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44107537|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44107538|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
44107539|NCT00079352|Growth Substances|growth substances|mesh-ancestor
44107545|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409223|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409224|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
44409225|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409226|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44409227|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
44409228|NCT02498652|Protective Agents|protective agents|mesh-ancestor
44409229|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409230|NCT02498444|Treprostinil|treprostinil|mesh-list
44409231|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44409232|NCT02498418|Rifaximin|rifaximin|mesh-list
44409233|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44409234|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409235|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409236|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
44409237|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409238|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409239|NCT02498236|Oxytocin|oxytocin|mesh-list
44409240|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
44409241|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44409242|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409243|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
44409244|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409245|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
44409246|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43708382|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
44107547|NCT00079365|Antiviral Agents|antiviral agents|mesh-ancestor
44107548|NCT00079365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107549|NCT00079365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107550|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107551|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
44107552|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107553|NCT00079378|Decitabine|decitabine|mesh-list
44107554|NCT00079378|Azacitidine|azacitidine|mesh-list
44107555|NCT00079378|Valproic Acid|valproic acid|mesh-list
44107556|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107557|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
44107558|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107559|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107560|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107561|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
44107562|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
44107563|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107564|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107565|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
44107566|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107567|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107568|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107569|NCT00079430|Paclitaxel|paclitaxel|mesh-list
44107570|NCT00079430|Bevacizumab|bevacizumab|mesh-list
44107571|NCT00079430|Carboplatin|carboplatin|mesh-list
44107572|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44107573|NCT00079430|Antibodies|antibodies|mesh-list
44107574|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
44107575|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44409248|NCT02497781|Ceftazidime|ceftazidime|mesh-list
44409249|NCT02497781|Cefepime|cefepime|mesh-list
44409250|NCT02497781|Avibactam|avibactam|mesh-list
44409251|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44409252|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44409253|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409254|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44409255|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409256|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409257|NCT02497469|Adalimumab|adalimumab|mesh-list
44409258|NCT02497469|Vedolizumab|vedolizumab|mesh-list
44409259|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409260|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790023|NCT04122287|Levofloxacin|levofloxacin|mesh-list
44409261|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409262|NCT02497404|Fludarabine|fludarabine|mesh-list
44409263|NCT02497404|Azacitidine|azacitidine|mesh-list
44409264|NCT02497404|Melphalan|melphalan|mesh-list
44409265|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
44409266|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409267|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44409268|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
44409269|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409270|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409271|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
44409272|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409273|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43708408|NCT04865042|Gabapentin|gabapentin|mesh-list
44107576|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107577|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107578|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107579|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107580|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107581|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107582|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44107583|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44107584|NCT00079430|Growth Substances|growth substances|mesh-ancestor
44107585|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107586|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
44107587|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
44107589|NCT00079443|Fludarabine|fludarabine|mesh-list
44107590|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
44107592|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44107593|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107594|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
44107595|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107596|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44107597|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44107598|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
44409274|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44409275|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
44409276|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44409277|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409279|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44409280|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44409281|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
44409282|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409283|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44409284|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44409285|NCT02497287|Citalopram|citalopram|mesh-list
44409286|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44409287|NCT02497287|Sertraline|sertraline|mesh-list
44409288|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
44409289|NCT02497287|Esketamine|esketamine|mesh-list
44409290|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44409291|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409292|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409293|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409294|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409295|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
44409296|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409297|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44409298|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44409299|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409300|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44409301|NCT02497287|Analgesics|analgesics|mesh-ancestor
44409302|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
44409303|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
43790060|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43790061|NCT03828045|Apremilast|apremilast|mesh-list
44409304|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44409305|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409306|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409307|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
44409308|NCT02496676|Analgesics|analgesics|mesh-ancestor
44409309|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
44409311|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409312|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
44409313|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409314|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44409315|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
44409316|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44409317|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409318|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409319|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44409320|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
44409321|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44409322|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
44409323|NCT02496221|Incretins|incretins|mesh-ancestor
44409324|NCT02496221|Hormones|hormones|mesh-ancestor
44409325|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409326|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409327|NCT02496039|Quinidine|quinidine|mesh-list
44409328|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
44409329|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
44409330|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409331|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44409332|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44409333|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409334|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409335|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409336|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44409337|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44409338|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409339|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44409340|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
44409341|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44409342|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44409351|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44409352|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409353|NCT02496000|Insulin|insulin|mesh-list
44409354|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409355|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409356|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44409357|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43654220|NCT02977169|Carboplatin|carboplatin|mesh-list
43654221|NCT02977169|Pemetrexed|pemetrexed|mesh-list
43654222|NCT02977169|Vinorelbine|vinorelbine|mesh-list
43654223|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654224|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654225|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654226|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43654227|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654228|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43654229|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654230|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
43654231|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
43654232|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
43654239|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
44409358|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44409359|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409360|NCT02495883|Ethanol|ethanol|mesh-list
44409361|NCT02495883|Propranolol|propranolol|mesh-list
44409362|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44409363|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44409364|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409365|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409366|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409367|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409368|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44409369|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44409370|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
44409371|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44409372|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409373|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409374|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
44107599|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107600|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107601|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107602|NCT00079456|Sirolimus|sirolimus|mesh-list
44107603|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107604|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107605|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44107606|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107607|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
44107608|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107609|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
44107610|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107611|NCT00079469|Bupropion|bupropion|mesh-list
43633649|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107618|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107620|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654240|NCT02977286|Naloxegol|naloxegol|mesh-list
43654241|NCT02977286|Bisacodyl|bisacodyl|mesh-list
43654242|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
43654243|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
43654244|NCT02977286|Cathartics|cathartics|mesh-ancestor
43654245|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654246|NCT02977286|Laxatives|laxatives|mesh-ancestor
43654247|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43790066|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790067|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790069|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790070|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43790071|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43790072|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790074|NCT03805841|Bromides|bromides|mesh-list
44107621|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107622|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44107623|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44107624|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107625|NCT00079508|Bivalirudin|bivalirudin|mesh-list
44107626|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
44107627|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44107628|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107629|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409375|NCT02495857|Viscosupplements|viscosupplements|mesh-list
44409376|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44409377|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
44409378|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409379|NCT02495857|Protective Agents|protective agents|mesh-ancestor
44409380|NCT02495389|Mirabegron|mirabegron|mesh-list
44409381|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44409382|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44409383|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44409384|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409385|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409386|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409387|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409388|NCT02495389|Urological Agents|urological agents|mesh-ancestor
44409389|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44409390|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409391|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44409392|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409393|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409394|NCT02495168|Budesonide|budesonide|mesh-list
44409395|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
44409396|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44409397|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409398|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44409399|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
44409400|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409401|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409402|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409403|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409404|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
44409405|NCT02495168|Hormones|hormones|mesh-ancestor
44409406|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409407|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44409408|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44409409|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44409412|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409413|NCT02495077|Acetaminophen|acetaminophen|mesh-list
44409414|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
44409415|NCT02495077|Promethazine|promethazine|mesh-list
44409416|NCT02495077|Loratadine|loratadine|mesh-list
44409417|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
44409418|NCT02495077|Prednisone|prednisone|mesh-list
44409419|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
44409420|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44409421|NCT02495077|Infliximab|infliximab|mesh-list
44409422|NCT02495077|Tacrolimus|tacrolimus|mesh-list
44409423|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
44409424|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44409425|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409426|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
44409427|NCT02495077|Hormones|hormones|mesh-ancestor
44409428|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409429|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409430|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44409431|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409432|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409433|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
44409434|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44409435|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409436|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409437|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409438|NCT02495077|Analgesics|analgesics|mesh-ancestor
44409439|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
44409440|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409441|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
44409442|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43708585|NCT04555798|Meropenem|meropenem|mesh-list
44107630|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107631|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
44107632|NCT00079560|Dronabinol|dronabinol|mesh-list
44107633|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
44107634|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107635|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107636|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44107637|NCT00079560|Analgesics|analgesics|mesh-ancestor
44107638|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
44107639|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107640|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44107641|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43790118|NCT03277924|Growth Substances|growth substances|mesh-ancestor
44107642|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409443|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44409445|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44409446|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409447|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
44409448|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
44409449|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409450|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44409451|NCT02495077|Protective Agents|protective agents|mesh-ancestor
44409452|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
44409453|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409454|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44409455|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44409456|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409457|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
44409458|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
44409459|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44409460|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
44409461|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
44409462|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409463|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44409464|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
44409465|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44409466|NCT02494921|Prednisone|prednisone|mesh-list
44409467|NCT02494921|Docetaxel|docetaxel|mesh-list
44409468|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409469|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409470|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409471|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409472|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409473|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409474|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
44409475|NCT02494921|Hormones|hormones|mesh-ancestor
44409476|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409477|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409478|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44107643|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107644|NCT00079560|Hormones|hormones|mesh-ancestor
44409479|NCT02494596|Capecitabine|capecitabine|mesh-list
44409480|NCT02494596|Pertuzumab|pertuzumab|mesh-list
44409481|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44409482|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
44409483|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409484|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067187|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
44409485|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409486|NCT02494583|Cisplatin|cisplatin|mesh-list
44409487|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
44409488|NCT02494583|Capecitabine|capecitabine|mesh-list
44409490|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409491|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44409492|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
44409493|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409494|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
44409495|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44409496|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44409497|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44409498|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409499|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409500|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409501|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409502|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409503|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44409504|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409505|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44107645|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107646|NCT00079586|Heparin|heparin|mesh-list
44107647|NCT00079586|Bivalirudin|bivalirudin|mesh-list
44107648|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
44107649|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44107650|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44107651|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107652|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
44107653|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44107654|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107655|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107656|NCT00079612|Sorafenib|sorafenib|mesh-list
44107657|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107658|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107659|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107660|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107661|NCT00079638|Niacin|niacin|mesh-list
44107662|NCT00079638|Atorvastatin|atorvastatin|mesh-list
44107663|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44107664|NCT00079638|Simvastatin|simvastatin|mesh-list
44107665|NCT00079638|Ezetimibe|ezetimibe|mesh-list
44409507|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44409508|NCT02493868|Sertraline|sertraline|mesh-list
44409509|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
44409510|NCT02493868|Esketamine|esketamine|mesh-list
44409511|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44409512|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409513|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409514|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409515|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409516|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
44409517|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409518|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44409519|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44409520|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409521|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44409522|NCT02493868|Analgesics|analgesics|mesh-ancestor
44409523|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
44409524|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
44409525|NCT02493855|Ritonavir|ritonavir|mesh-list
44409526|NCT02493855|Ribavirin|ribavirin|mesh-list
44409527|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44409528|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44409529|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409530|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409531|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409532|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44107666|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44107667|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44107668|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
44107669|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107670|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44107671|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44107672|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107673|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
44107674|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
44107675|NCT00079638|Vitamins|vitamins|mesh-ancestor
44107676|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
44107677|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107678|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
44107685|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790176|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107686|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107687|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
44107688|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
44107689|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107690|NCT00079807|Protective Agents|protective agents|mesh-ancestor
44107691|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107692|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
44409534|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
44409535|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409536|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44409537|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409538|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
44409539|NCT02493777|Methylphenidate|methylphenidate|mesh-list
44409540|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44409541|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409542|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44409543|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409544|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409545|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409546|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
44409547|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409548|NCT02493764|Tazobactam|tazobactam|mesh-list
44409549|NCT02493764|Linezolid|linezolid|mesh-list
44409550|NCT02493764|Piperacillin|piperacillin|mesh-list
44409551|NCT02493764|Imipenem|imipenem|mesh-list
44409552|NCT02493764|Relebactam|relebactam|mesh-list
44409553|NCT02493764|Cilastatin|cilastatin|mesh-list
44409554|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43708655|NCT04355832|Glucagon|glucagon|mesh-list
44107693|NCT00079807|Vitamins|vitamins|mesh-ancestor
44107694|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
44107695|NCT00079820|Vaccines|vaccines|mesh-list
44107696|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
44107697|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107698|NCT00079833|Esomeprazole|esomeprazole|mesh-list
44107699|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44107700|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44107701|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44107702|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107703|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107704|NCT00079872|Pemetrexed|pemetrexed|mesh-list
44107705|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107706|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107707|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107708|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44107709|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44107710|NCT00079885|Tigecycline|tigecycline|mesh-list
44107711|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107712|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107713|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44107714|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107715|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107716|NCT00079911|Valacyclovir|valacyclovir|mesh-list
44107717|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
44107718|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790216|NCT01899989|Cisplatin|cisplatin|mesh-list
44107719|NCT00079924|Teriparatide|teriparatide|mesh-list
44107720|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44107721|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44107722|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409555|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409556|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44409557|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409558|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409559|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44409560|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409561|NCT02493751|Avelumab|avelumab|mesh-list
44409562|NCT02493751|Axitinib|axitinib|mesh-list
44409563|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409564|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409565|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44409566|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409567|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409568|NCT02493712|Mesalamine|mesalamine|mesh-list
44409569|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44409570|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409571|NCT02493712|Analgesics|analgesics|mesh-ancestor
44409572|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
44409573|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409574|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409575|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409576|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44409577|NCT02493517|Lanreotide|lanreotide|mesh-list
44409578|NCT02493517|Somatostatin|somatostatin|mesh-list
44409579|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409580|NCT02493517|Hormones|hormones|mesh-ancestor
44409581|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409582|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409583|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
44409584|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409585|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409586|NCT02492997|Glycerol|glycerol|mesh-list
44409587|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44409588|NCT02492997|Protective Agents|protective agents|mesh-ancestor
44409590|NCT02492984|Factor VIII|factor viii|mesh-list
44409594|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44409595|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409596|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44409598|NCT02492763|Liraglutide|liraglutide|mesh-list
44409599|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409600|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409601|NCT02492763|Incretins|incretins|mesh-ancestor
44409602|NCT02492763|Hormones|hormones|mesh-ancestor
44409603|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409604|NCT02492165|Vaccines|vaccines|mesh-list
44409605|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
44409606|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409607|NCT02491892|Pertuzumab|pertuzumab|mesh-list
44409608|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409609|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409610|NCT02491684|Interferons|interferons|mesh-list
44409611|NCT02491684|Interferon-beta|interferon-beta|mesh-list
44409612|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
44409613|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409614|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
44409615|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409616|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
44409617|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409618|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44409619|NCT02491463|Vaccines|vaccines|mesh-list
44409620|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
44409621|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409622|NCT02491411|Dexamethasone|dexamethasone|mesh-list
44409623|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
44409624|NCT02491411|Ichthammol|ichthammol|mesh-list
44409625|NCT02491411|BB 1101|bb 1101|mesh-list
44409626|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107723|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44107724|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44107725|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
44153500|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44107726|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107727|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44107728|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44107729|NCT00079963|Vitamins|vitamins|mesh-list
44107730|NCT00079963|Ascorbic Acid|ascorbic acid|mesh-list
44107731|NCT00079963|Vitamin E|vitamin e|mesh-list
44107732|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
44409627|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
44409628|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
44409629|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409630|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409631|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409632|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
44409634|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409635|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44409636|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409637|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409638|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409639|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409640|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
44409641|NCT02490878|Bevacizumab|bevacizumab|mesh-list
44409642|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409643|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409644|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44409645|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44409646|NCT02490878|Growth Substances|growth substances|mesh-ancestor
44409647|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409648|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
44409649|NCT02490475|Docetaxel|docetaxel|mesh-list
44409650|NCT02490475|Pertuzumab|pertuzumab|mesh-list
44409651|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409652|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409653|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409654|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409655|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409656|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409657|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
44409658|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44409659|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
44409660|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43708738|NCT04278625|Acetaminophen|acetaminophen|mesh-list
44107733|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107734|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
44107735|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409661|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409662|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409663|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409664|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
44409665|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44409666|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409667|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409668|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409670|NCT02489968|Linagliptin|linagliptin|mesh-list
44409671|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44409672|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409673|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44409674|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409675|NCT02489968|Incretins|incretins|mesh-ancestor
44409676|NCT02489968|Hormones|hormones|mesh-ancestor
44409677|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409678|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44409679|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409680|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409681|NCT02489630|Ketamine|ketamine|mesh-list
44409682|NCT02489630|Analgesics|analgesics|mesh-list
44409683|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
44409684|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409685|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409686|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44409687|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44409688|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
44409689|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
44409690|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409691|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44409701|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409702|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44409703|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409704|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
44409705|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409706|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44409707|NCT02489448|Durvalumab|durvalumab|mesh-list
44409708|NCT02489448|Tremelimumab|tremelimumab|mesh-list
44409709|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409710|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409711|NCT02488980|Mefloquine|mefloquine|mesh-list
44409712|NCT02488980|Tafenoquine|tafenoquine|mesh-list
44409713|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
44409714|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44409715|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44409716|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409717|NCT02488330|Bevacizumab|bevacizumab|mesh-list
44409718|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44409719|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44409720|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409721|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44409722|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44409723|NCT02488330|Growth Substances|growth substances|mesh-ancestor
44409724|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409725|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44409726|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43790284|NCT05129033|Prednisone|prednisone|mesh-list
43790287|NCT05129033|Hormones|hormones|mesh-ancestor
44107736|NCT00079963|Protective Agents|protective agents|mesh-ancestor
44107737|NCT00079976|Tigecycline|tigecycline|mesh-list
44107738|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107739|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107740|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44107741|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107742|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107743|NCT00079989|Tigecycline|tigecycline|mesh-list
44107744|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107745|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107756|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107757|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
44107758|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107759|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44107760|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107761|NCT00080080|Docetaxel|docetaxel|mesh-list
44107762|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107763|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107764|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107765|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107766|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107767|NCT00080145|Risperidone|risperidone|mesh-list
44107768|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107769|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
44409727|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409728|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409729|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
44409730|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44409731|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44409732|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44409733|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409734|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409735|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409736|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409737|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
44409739|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
44409740|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409741|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44409742|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44409743|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44409744|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
44409745|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409746|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409747|NCT02487199|Ritonavir|ritonavir|mesh-list
44409748|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44409749|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44409750|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
44409751|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107770|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107771|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107772|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107773|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107774|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107775|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790295|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44107776|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107777|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44107778|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
44107779|NCT00080158|Mirtazapine|mirtazapine|mesh-list
44107780|NCT00080158|Citalopram|citalopram|mesh-list
44107781|NCT00080158|Bupropion|bupropion|mesh-list
44107782|NCT00080158|Fluoxetine|fluoxetine|mesh-list
44107783|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44107784|NCT00080158|Sertraline|sertraline|mesh-list
44107785|NCT00080158|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44107786|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44107787|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44107788|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107789|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107790|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
44107791|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107792|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44107793|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
44409752|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409753|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44409754|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44409755|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
44409756|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409757|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44409758|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409759|NCT02487108|Acetaminophen|acetaminophen|mesh-list
44409760|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44409761|NCT02487108|Hydrocodone|hydrocodone|mesh-list
44409762|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409763|NCT02487108|Analgesics|analgesics|mesh-ancestor
44409764|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
44409765|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409766|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409767|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
44409768|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44409769|NCT02487108|Narcotics|narcotics|mesh-ancestor
44409770|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409771|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
44409772|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409773|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44409776|NCT02487095|Topotecan|topotecan|mesh-list
44409803|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409804|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
44409805|NCT02486952|Hormones|hormones|mesh-ancestor
44409806|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409807|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44409808|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44409809|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
44409810|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
44409811|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
44409812|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44409813|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44409814|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44409815|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409816|NCT02486796|Ubiquinone|ubiquinone|mesh-list
44409817|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
44409818|NCT02486796|Melatonin|melatonin|mesh-list
44409819|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
44409820|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409821|NCT02486796|Protective Agents|protective agents|mesh-ancestor
44409822|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409823|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409824|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
44409825|NCT02486796|Vitamins|vitamins|mesh-ancestor
44409826|NCT02486757|Estradiol|estradiol|mesh-list
44409827|NCT02486757|Progesterone|progesterone|mesh-list
44409828|NCT02486757|Estrogens|estrogens|mesh-ancestor
44409829|NCT02486757|Hormones|hormones|mesh-ancestor
44409830|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409831|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409832|NCT02486757|Progestins|progestins|mesh-ancestor
44409833|NCT02486653|Tamsulosin|tamsulosin|mesh-list
44409834|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44409835|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44107794|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107795|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44107796|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
44107797|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44107798|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44107799|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107800|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107801|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107802|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44409836|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44409837|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409838|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409839|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409840|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409841|NCT02486653|Urological Agents|urological agents|mesh-ancestor
44409843|NCT02486627|Ofloxacin|ofloxacin|mesh-list
44409844|NCT02486627|Meropenem|meropenem|mesh-list
44409845|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44409846|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409847|NCT02486627|Renal Agents|renal agents|mesh-ancestor
44409848|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44409849|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44409850|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44409851|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409852|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409853|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44067437|NCT05638763|Ketoconazole|ketoconazole|mesh-list
44409890|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409891|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44409892|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409893|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409894|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
44409895|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44409896|NCT02485353|Cytarabine|cytarabine|mesh-list
44409897|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44409898|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
44409899|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409900|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409901|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
44409902|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44409903|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44409904|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
44409905|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409906|NCT02485158|Dronabinol|dronabinol|mesh-list
44409907|NCT02485158|Amphetamine|amphetamine|mesh-list
44409908|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
44409909|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44409910|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409911|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
44409912|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
44409913|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409914|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
44409915|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409916|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409917|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409918|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44409919|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409920|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409921|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44409922|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
44107803|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44107804|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
44107805|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
44107806|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44107807|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44107808|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44409923|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44409924|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44409926|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
44409927|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44409928|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44409929|NCT02485158|Hormones|hormones|mesh-ancestor
44409930|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409931|NCT02484911|Dexamethasone|dexamethasone|mesh-list
44409932|NCT02484911|Olanzapine|olanzapine|mesh-list
44409933|NCT02484911|Aprepitant|aprepitant|mesh-list
44409934|NCT02484911|Palonosetron|palonosetron|mesh-list
44409935|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44409936|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
44409937|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
44409938|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409939|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409940|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44409941|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
44409942|NCT02484911|Hormones|hormones|mesh-ancestor
44409943|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409944|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44409945|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409946|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44409947|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44409948|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44409949|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44409950|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44409951|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44409952|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44409953|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409954|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409955|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
44409963|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44409964|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44409965|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409966|NCT02484690|Ranibizumab|ranibizumab|mesh-list
44409967|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44409968|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44409969|NCT02484690|Growth Substances|growth substances|mesh-ancestor
44409970|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409971|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
44409972|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44409973|NCT02483975|Albuterol|albuterol|mesh-list
44409974|NCT02483975|Montelukast|montelukast|mesh-list
44409975|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44409976|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
44409977|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44409978|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
44409979|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44409980|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44409981|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44409982|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44409983|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44409984|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44409985|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
44409986|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44409987|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
44409988|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44409989|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44409990|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44409991|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44409992|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44409993|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44409994|NCT02483611|Lidocaine|lidocaine|mesh-list
44409995|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
44409996|NCT02483611|Cisatracurium|cisatracurium|mesh-list
43708970|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
44107809|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44107826|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44409997|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
44409998|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
44409999|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410000|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410001|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
44410002|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410003|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44410004|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44410005|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44410006|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410007|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410009|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
44410010|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44410011|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44410012|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
44410013|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43840835|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840836|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840837|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840838|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43654259|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43654260|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654261|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43654262|NCT02977013|Dalteparin|dalteparin|mesh-list
43654263|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
43654264|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43654265|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44410014|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44410015|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44410016|NCT02483585|Erenumab|erenumab|mesh-list
44410017|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44412318|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
44107827|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107828|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
44107829|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
44107830|NCT00080275|Vitamins|vitamins|mesh-ancestor
44107831|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
44107832|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107833|NCT00080314|Aripiprazole|aripiprazole|mesh-list
44107834|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
44107835|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107836|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107837|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107838|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107839|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107840|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
44107841|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
44107842|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107843|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107844|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44107845|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44107846|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
44107847|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44107848|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107849|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44107850|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44107851|NCT00080327|Aripiprazole|aripiprazole|mesh-list
44107852|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
44107853|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107854|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107855|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107856|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410018|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410019|NCT02483585|Analgesics|analgesics|mesh-ancestor
44410020|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
44410021|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410022|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410023|NCT02483078|Leronlimab|leronlimab|mesh-list
44410024|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44410025|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44410026|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410027|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410028|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410029|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
44410030|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410031|NCT02482428|Imiquimod|imiquimod|mesh-list
44410032|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44410077|NCT02481830|Amrubicin|amrubicin|mesh-list
44410078|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790377|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790378|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43790379|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43790380|NCT04405674|Growth Substances|growth substances|mesh-ancestor
43790381|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790382|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
43790383|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790384|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44410079|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410080|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44410081|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410082|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44410083|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44410084|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410085|NCT02481310|Cytarabine|cytarabine|mesh-list
44410086|NCT02481310|Prednisone|prednisone|mesh-list
44410087|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
44410088|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44410089|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44410090|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44410091|NCT02481310|Cortisone|cortisone|mesh-list
44410092|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
44410093|NCT02481310|Rituximab|rituximab|mesh-list
44410094|NCT02481310|Doxorubicin|doxorubicin|mesh-list
44410095|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44410096|NCT02481310|Methotrexate|methotrexate|mesh-list
44410097|NCT02481310|Etoposide|etoposide|mesh-list
44410098|NCT02481310|Vincristine|vincristine|mesh-list
44410099|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
44410100|NCT02481310|Ixazomib|ixazomib|mesh-list
44410101|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
44410103|NCT02481310|Antibodies|antibodies|mesh-list
44410129|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
44410130|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44410131|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44410132|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44410133|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44410134|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
44410135|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410136|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
44410137|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
44410138|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
44410139|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44410140|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
44410141|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
44410142|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410143|NCT02480764|Valsartan|valsartan|mesh-list
44410144|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44410145|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44410146|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44410147|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44410148|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410149|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
44410150|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44410151|NCT02480712|Velpatasvir|velpatasvir|mesh-list
44410152|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
44410153|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790385|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44410154|NCT02480621|Bupivacaine|bupivacaine|mesh-list
44410155|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
44410156|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
44410157|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410158|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410159|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
44410175|NCT02480114|Analgesics|analgesics|mesh-ancestor
44410176|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
44410177|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410178|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44410179|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44410180|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
44410181|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
44410182|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410183|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
44410184|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44410185|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410186|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410187|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44410188|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410189|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410190|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
44410191|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44410192|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44410193|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410194|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44410195|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44410196|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410197|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
44410198|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
44410199|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
44410200|NCT02480010|Pertuzumab|pertuzumab|mesh-list
44410201|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410202|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410203|NCT02479880|Tenofovir|tenofovir|mesh-list
44410204|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
44410205|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410206|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44410207|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44107857|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107858|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
44107859|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
44107860|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44107861|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107862|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44107863|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44107864|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
44107865|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44410208|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410209|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410211|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410212|NCT02479412|Albuterol|albuterol|mesh-list
44410213|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44410214|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
44410215|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410216|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410217|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44410218|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
44410219|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
44410220|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44410221|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44410222|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44410223|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44410224|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
44410266|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
44410267|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44410268|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
44410269|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44410270|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44410271|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410272|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
44410273|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44410274|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
44410275|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44410276|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44410277|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
44410278|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
44410279|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44410280|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410281|NCT02478398|Analgesics|analgesics|mesh-ancestor
44410282|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
44410283|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410284|NCT02478372|Bupivacaine|bupivacaine|mesh-list
44410285|NCT02478372|Ropivacaine|ropivacaine|mesh-list
44410286|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
44410287|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
44410320|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410321|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410322|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
44410323|NCT02477215|Hormones|hormones|mesh-ancestor
44410324|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410325|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44410326|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410327|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790528|NCT04038489|Analgesics|analgesics|mesh-ancestor
44410328|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
44410329|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410330|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
44410331|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410332|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44410333|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44410334|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44410335|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44410336|NCT02476968|Olaparib|olaparib|mesh-list
44410337|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44410338|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410339|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410340|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410341|NCT02476617|Ritonavir|ritonavir|mesh-list
44410342|NCT02476617|Ribavirin|ribavirin|mesh-list
44410343|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44410344|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44410345|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
44410346|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410347|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410348|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410349|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410362|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410363|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410364|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410365|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44410366|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410367|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410368|NCT02476175|Mirabegron|mirabegron|mesh-list
44410369|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44410370|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44410371|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44410372|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
44410373|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709258|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
44107866|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107876|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
44107877|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153501|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153502|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
44153503|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153504|NCT00220506|Modafinil|modafinil|mesh-list
44153505|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43550952|NCT03618589|Pregabalin|pregabalin|mesh-list
44153506|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153507|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44153508|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44153509|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44153510|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153511|NCT00220532|Folic Acid|folic acid|mesh-list
44153512|NCT00220532|Riboflavin|riboflavin|mesh-list
44153513|NCT00220532|Hematinics|hematinics|mesh-ancestor
44153514|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
44153515|NCT00220532|Vitamins|vitamins|mesh-ancestor
44153516|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
44153517|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153518|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44153519|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153520|NCT00220584|Donepezil|donepezil|mesh-list
44153521|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44153522|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153523|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153524|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
44153525|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153526|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153527|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
44153528|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
44153529|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44153530|NCT00220649|Leucovorin|leucovorin|mesh-list
44153531|NCT00220649|Gemcitabine|gemcitabine|mesh-list
44153532|NCT00220649|Fluorouracil|fluorouracil|mesh-list
44153533|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
44153534|NCT00220649|Irinotecan|irinotecan|mesh-list
44153535|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44153536|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
44153537|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153538|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153539|NCT00220649|Antiviral Agents|antiviral agents|mesh-ancestor
44153540|NCT00220649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153541|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153542|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44153543|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
44410374|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410375|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410376|NCT02476175|Urological Agents|urological agents|mesh-ancestor
44410378|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44410379|NCT02476006|Simvastatin|simvastatin|mesh-list
44410380|NCT02476006|Ezetimibe|ezetimibe|mesh-list
44410381|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44410382|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44410383|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
44410384|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410385|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44410386|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44410387|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410388|NCT02475733|Metronidazole|metronidazole|mesh-list
44153544|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153545|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44153546|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44153547|NCT00220649|Antidotes|antidotes|mesh-ancestor
44153548|NCT00220649|Protective Agents|protective agents|mesh-ancestor
44153549|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
44153550|NCT00220649|Vitamins|vitamins|mesh-ancestor
44153551|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
44153552|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
44153553|NCT00220675|Hematinics|hematinics|mesh-ancestor
44153554|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
44153555|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44153561|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
44153562|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44153563|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44153564|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
44153565|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
44153566|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153567|NCT00220818|Lansoprazole|lansoprazole|mesh-list
44153568|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
44153569|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44153570|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153571|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44153572|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153573|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107878|NCT00080405|Bortezomib|bortezomib|mesh-list
44107879|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107880|NCT00080418|Paclitaxel|paclitaxel|mesh-list
44107881|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44107882|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107883|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107884|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107885|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107886|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107887|NCT00080431|Daclizumab|daclizumab|mesh-list
44107888|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44107889|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
44107890|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107892|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
44107893|NCT00080444|Ondansetron|ondansetron|mesh-list
44107894|NCT00080444|Aprepitant|aprepitant|mesh-list
44107895|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
44107896|NCT00080444|BB 1101|bb 1101|mesh-list
44107897|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44107898|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
44107899|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
44107900|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44107901|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410389|NCT02475733|Meropenem|meropenem|mesh-list
44410390|NCT02475733|Ceftazidime|ceftazidime|mesh-list
44410391|NCT02475733|Avibactam|avibactam|mesh-list
44410392|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
44410393|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410394|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44410395|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44410396|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44410397|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44410398|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410399|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410400|NCT02475629|Ibalizumab|ibalizumab|mesh-list
44410401|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410402|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410403|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
44410404|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107902|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44107903|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
44107904|NCT00080444|Hormones|hormones|mesh-ancestor
44107905|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107906|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44107907|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107908|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107909|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107910|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107911|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
44107912|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
44107913|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44107914|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
44107915|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790579|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
44107916|NCT00080444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44107917|NCT00080444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44107918|NCT00080444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44107919|NCT00080444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44107920|NCT00080444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44107921|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44107922|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
44107923|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44107924|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107925|NCT00080496|Imipenem|imipenem|mesh-list
44107926|NCT00080496|Tigecycline|tigecycline|mesh-list
44107927|NCT00080496|Cilastatin|cilastatin|mesh-list
44107928|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44107929|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107930|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44107931|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107932|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107949|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
44107950|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107951|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821597|NCT03908437|Naloxone|naloxone|mesh-list
44107952|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44107953|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44107954|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
44107955|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44107956|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44107957|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44107958|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44107959|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44410405|NCT02475564|Resveratrol|resveratrol|mesh-list
44410406|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
44410407|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410408|NCT02475564|Protective Agents|protective agents|mesh-ancestor
44410409|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410410|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410411|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44410412|NCT02475369|Pancrelipase|pancrelipase|mesh-list
44410413|NCT02475369|Pancreatin|pancreatin|mesh-list
44410414|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410415|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
44410416|NCT02475265|Estradiol|estradiol|mesh-list
44410417|NCT02475265|Estrogens|estrogens|mesh-ancestor
44410418|NCT02475265|Hormones|hormones|mesh-ancestor
44410419|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410420|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410421|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44410422|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
44410423|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44410424|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44410425|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44410426|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44410427|NCT02474355|Osimertinib|osimertinib|mesh-list
44410428|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107960|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
44107961|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44107962|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44107963|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44107964|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44107965|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44107966|NCT00080613|Exemestane|exemestane|mesh-list
44107967|NCT00080613|Hormones|hormones|mesh-list
44107968|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44107969|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44107970|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107971|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44107972|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44107973|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790586|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
44107974|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107975|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44107976|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
44107977|NCT00080626|Docetaxel|docetaxel|mesh-list
44107978|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107979|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
44107980|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107981|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107982|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107983|NCT00080665|Docetaxel|docetaxel|mesh-list
44107984|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
44107985|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44107986|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
44410429|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410430|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410431|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410433|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
44410434|NCT02474199|Promethazine|promethazine|mesh-list
44410435|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410436|NCT02474199|Analgesics|analgesics|mesh-ancestor
44410437|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
44410438|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410439|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410440|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
44410441|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44410442|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44410443|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410444|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
44410445|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
44410446|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
44410447|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
44410448|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410449|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44410450|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
44410451|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
44410452|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410453|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410454|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44410455|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
44410456|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
44410457|NCT02473913|Silymarin|silymarin|mesh-list
44410458|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
44410459|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410460|NCT02473913|Protective Agents|protective agents|mesh-ancestor
44410461|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410462|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
44410463|NCT02473640|Esomeprazole|esomeprazole|mesh-list
44410464|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44410465|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410466|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44410467|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410468|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410469|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44410470|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790593|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43790594|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43790595|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
43790596|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
43790597|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790598|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43790602|NCT03319459|Trastuzumab|trastuzumab|mesh-list
44410472|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44410473|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410474|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
44410475|NCT02473367|Antacids|antacids|mesh-list
44410476|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410477|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410478|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
44410479|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410480|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44410481|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44410482|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410483|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410484|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410485|NCT02473250|Fluoxetine|fluoxetine|mesh-list
44410486|NCT02473250|Citalopram|citalopram|mesh-list
44410487|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44410488|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44410489|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410490|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410491|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410492|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
44410493|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410494|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44410495|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
44410496|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410497|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44410500|NCT02472977|Nivolumab|nivolumab|mesh-list
44410510|NCT02472847|Dronabinol|dronabinol|mesh-list
44410511|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
44410512|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410513|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410514|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410515|NCT02472847|Analgesics|analgesics|mesh-ancestor
44410516|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
44410517|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410518|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44410519|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44410520|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410521|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410522|NCT02472847|Hormones|hormones|mesh-ancestor
44410523|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410524|NCT02472756|Rituximab|rituximab|mesh-list
44410525|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410526|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410527|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
44410528|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410529|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410530|NCT02472652|Aripiprazole|aripiprazole|mesh-list
44410531|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
43790668|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790669|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
43790670|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
43790671|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790672|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790673|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790674|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
43790677|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44410532|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410533|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44410534|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44410535|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410536|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410537|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
44410538|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
44410539|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412319|NCT02422186|Esketamine|esketamine|mesh-list
44107987|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
44107988|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
44107989|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44107990|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44107991|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44107992|NCT00080678|Docetaxel|docetaxel|mesh-list
43634206|NCT05694897|Bupivacaine|bupivacaine|mesh-list
44108006|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108007|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410540|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410541|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44410542|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44410544|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44410545|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44410546|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44410547|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44410548|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44410549|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410550|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
44410551|NCT02472366|Hormones|hormones|mesh-ancestor
44410552|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410553|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410554|NCT02472353|Metformin|metformin|mesh-list
44410555|NCT02472353|Doxorubicin|doxorubicin|mesh-list
44410556|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410557|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108008|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108009|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108010|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44108011|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43840844|NCT04667572|Riboflavin|riboflavin|mesh-list
44108012|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44108013|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108014|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108015|NCT00080782|Celecoxib|celecoxib|mesh-list
44108016|NCT00080782|Doxorubicin|doxorubicin|mesh-list
44108017|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108018|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108019|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108020|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108021|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108022|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108023|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108024|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44108025|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44108026|NCT00080782|Analgesics|analgesics|mesh-ancestor
44108027|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
44153574|NCT00220831|Vitamin E|vitamin e|mesh-list
44108028|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108029|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108030|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108031|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108032|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44108033|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44108034|NCT00080795|Gemcitabine|gemcitabine|mesh-list
44108036|NCT00080795|Doxorubicin|doxorubicin|mesh-list
44108037|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108039|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108040|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108041|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
44108042|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108043|NCT00080795|Antiviral Agents|antiviral agents|mesh-ancestor
44108044|NCT00080795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108045|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410559|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410560|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44410561|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44410562|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410563|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410564|NCT02472145|Decitabine|decitabine|mesh-list
44410565|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44410566|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
44410567|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410568|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410569|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410570|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
44410571|NCT02471404|Glimepiride|glimepiride|mesh-list
44410572|NCT02471404|Saxagliptin|saxagliptin|mesh-list
44410573|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44410574|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410575|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410576|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410577|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44410578|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43709414|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
44108046|NCT00080795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108047|NCT00080795|Immunologic Factors|immunologic factors|mesh-ancestor
44108048|NCT00080795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108049|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108050|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108051|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108052|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108053|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
44108054|NCT00080808|Phentolamine|phentolamine|mesh-list
44108067|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108068|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108069|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44108070|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44108071|NCT00080847|Prednisone|prednisone|mesh-list
44108072|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
44108073|NCT00080847|Rituximab|rituximab|mesh-list
44108074|NCT00080847|Doxorubicin|doxorubicin|mesh-list
44108075|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108076|NCT00080847|Vincristine|vincristine|mesh-list
44108077|NCT00080847|Oblimersen|oblimersen|mesh-list
44108078|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108079|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
44108080|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108081|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108082|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108083|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
44108084|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108085|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108086|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44410579|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
44410580|NCT02471404|Incretins|incretins|mesh-ancestor
44410581|NCT02471404|Hormones|hormones|mesh-ancestor
44410582|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410583|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44410584|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
44410585|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410586|NCT02471183|Selexipag|selexipag|mesh-list
44410587|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44410588|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44410589|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
44410590|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410591|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44410592|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
44410593|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44410594|NCT02470403|Licogliflozin|licogliflozin|mesh-list
44410595|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44410596|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410597|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410598|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108087|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108088|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108089|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108090|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108091|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108092|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108093|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
44108094|NCT00080847|Hormones|hormones|mesh-ancestor
44108095|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108096|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108097|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108098|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108099|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108100|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108101|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44108102|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44153575|NCT00220831|Vitamins|vitamins|mesh-ancestor
44108103|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108104|NCT00080886|Cytarabine|cytarabine|mesh-list
44108105|NCT00080886|Rituximab|rituximab|mesh-list
44108106|NCT00080886|Etoposide|etoposide|mesh-list
44108107|NCT00080886|Melphalan|melphalan|mesh-list
44108108|NCT00080886|Carmustine|carmustine|mesh-list
44108109|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108111|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
44108112|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108113|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108114|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790730|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
44108115|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108116|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108117|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43634326|NCT05671900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108125|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
44108126|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44410599|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
44410601|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44410602|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410603|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410604|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44410605|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
44410606|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
44410607|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44410608|NCT02469961|Analgesics|analgesics|mesh-ancestor
44410609|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
44410610|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410611|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44410612|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44410613|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44410614|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
44108128|NCT00080925|Cyclosporine|cyclosporine|mesh-list
44108129|NCT00080925|Prednisone|prednisone|mesh-list
44108130|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
44108131|NCT00080925|Rituximab|rituximab|mesh-list
44108132|NCT00080925|Doxorubicin|doxorubicin|mesh-list
44108133|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108134|NCT00080925|Fludarabine|fludarabine|mesh-list
44108135|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
44108136|NCT00080925|Etoposide|etoposide|mesh-list
44108137|NCT00080925|Vincristine|vincristine|mesh-list
44108138|NCT00080925|Cyclosporins|cyclosporins|mesh-list
44108139|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108140|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
44108141|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108142|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108143|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108144|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
44108145|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108146|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108147|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44108148|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790735|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43790809|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
43790810|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
43790811|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43790812|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790813|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790814|NCT05008536|Fludarabine|fludarabine|mesh-list
43790815|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
43790816|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790818|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108149|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108150|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108151|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108152|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108153|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108154|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
44108155|NCT00080925|Hormones|hormones|mesh-ancestor
44108156|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108157|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108158|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108159|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
44108160|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108161|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
44108162|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108163|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108164|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108165|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108166|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
44108167|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44108168|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44108169|NCT00080951|Leucovorin|leucovorin|mesh-list
44108170|NCT00080951|Fluorouracil|fluorouracil|mesh-list
44108171|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
44108172|NCT00080951|Irinotecan|irinotecan|mesh-list
44108173|NCT00080951|Calcium|calcium|mesh-list
44410615|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410616|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410617|NCT02469610|Bupivacaine|bupivacaine|mesh-list
44410618|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
44410619|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
44410620|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410621|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410622|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
44410623|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410624|NCT02469415|Azacitidine|azacitidine|mesh-list
44410625|NCT02469415|Decitabine|decitabine|mesh-list
44410626|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44410627|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
44410628|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410629|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410630|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410631|NCT02469298|Oseltamivir|oseltamivir|mesh-list
44410632|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
44410633|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410634|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410635|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410636|NCT02469246|Lamivudine|lamivudine|mesh-list
44410637|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44410638|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44410639|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410640|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108174|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
43790966|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43790967|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
43790968|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790969|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108175|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44108176|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108177|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
44108178|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108179|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108180|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108181|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108182|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
44108183|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44108184|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108185|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108187|NCT00080951|Protective Agents|protective agents|mesh-ancestor
44108198|NCT00080990|Fluorouracil|fluorouracil|mesh-list
44108199|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
44108200|NCT00080990|Alvocidib|alvocidib|mesh-list
44108201|NCT00080990|Calcium|calcium|mesh-list
44108202|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
44108203|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44108204|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108205|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
43701629|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44410641|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
44410642|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410643|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410644|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410645|NCT02469090|Apomorphine|apomorphine|mesh-list
44410646|NCT02469090|Emetics|emetics|mesh-ancestor
44410647|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410648|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
44410649|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410650|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44410651|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
44410652|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
44410653|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410654|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410655|NCT02469077|Morphine|morphine|mesh-list
44410656|NCT02469077|Naloxone|naloxone|mesh-list
44410657|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44410658|NCT02469077|Narcotics|narcotics|mesh-ancestor
44410659|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410660|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410661|NCT02469077|Analgesics|analgesics|mesh-ancestor
44410662|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
44410663|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410664|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44410665|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
44410666|NCT02468648|Velpatasvir|velpatasvir|mesh-list
44410667|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
44410668|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410669|NCT02468557|Paclitaxel|paclitaxel|mesh-list
44410670|NCT02468557|Idelalisib|idelalisib|mesh-list
43709479|NCT05368675|Buprenorphine|buprenorphine|mesh-list
44108206|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108207|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108208|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108209|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108210|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
44108211|NCT00080990|Antidotes|antidotes|mesh-ancestor
44108212|NCT00080990|Protective Agents|protective agents|mesh-ancestor
44108213|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
44108214|NCT00080990|Vitamins|vitamins|mesh-ancestor
44108215|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
44108216|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108217|NCT00080990|Growth Substances|growth substances|mesh-ancestor
44108218|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108219|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108220|NCT00081042|Paclitaxel|paclitaxel|mesh-list
44108221|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44108222|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108223|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410671|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44410673|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
44410674|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
44410675|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
44410676|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410677|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410678|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44410679|NCT02466399|Latanoprost|latanoprost|mesh-list
44410680|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44410681|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44410682|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44410683|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410684|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44410685|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44410686|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410687|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410688|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
44410689|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410690|NCT02465866|Promethazine|promethazine|mesh-list
44410691|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
44410692|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44410693|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44410694|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
44410695|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
44410696|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410697|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410698|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410699|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44410700|NCT02465528|Ceritinib|ceritinib|mesh-list
44410701|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410702|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410703|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410704|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108224|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108225|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108226|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
44410706|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44410707|NCT02465515|Incretins|incretins|mesh-ancestor
44410708|NCT02465515|Hormones|hormones|mesh-ancestor
44410709|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410710|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410711|NCT02465489|Deferiprone|deferiprone|mesh-list
44410712|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44410713|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
44410714|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
44410715|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410716|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
44410717|NCT02464410|Narcotics|narcotics|mesh-ancestor
44410718|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410719|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410720|NCT02464410|Analgesics|analgesics|mesh-ancestor
44108227|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108228|NCT00081055|Cyclosporine|cyclosporine|mesh-list
44108229|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
44108230|NCT00081055|Busulfan|busulfan|mesh-list
44108231|NCT00081055|Methotrexate|methotrexate|mesh-list
44108232|NCT00081055|Cyclosporins|cyclosporins|mesh-list
44108233|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108234|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
44108235|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108236|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108237|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108238|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
44108239|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108240|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108241|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44108242|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44108243|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
44108244|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44108245|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108246|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
44108247|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
44108248|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108249|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44108250|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108251|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
44108252|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108253|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44108254|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
44108255|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108256|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108259|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108260|NCT00081107|Epothilones|epothilones|mesh-list
44108261|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
44108262|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108264|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108265|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108266|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108267|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
44108268|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
44108269|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108270|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410721|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
44410722|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410723|NCT02464059|Vitamin D|vitamin d|mesh-list
44410724|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
44410725|NCT02464059|Vitamins|vitamins|mesh-ancestor
44410726|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
44410727|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410728|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44410729|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44410730|NCT02463409|Theophylline|theophylline|mesh-list
44410731|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44410732|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
44410733|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410734|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410735|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44410736|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
44410737|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44410738|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410739|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410740|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
44410741|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44108271|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108272|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108274|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44108275|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
44108276|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108277|NCT00081224|Celecoxib|celecoxib|mesh-list
44108278|NCT00081224|Capecitabine|capecitabine|mesh-list
44108279|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108280|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
44108281|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108282|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108283|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44108284|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44108285|NCT00081224|Analgesics|analgesics|mesh-ancestor
44108286|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
44108287|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108288|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108289|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108290|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108291|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44108292|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44108293|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108294|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
44108295|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108296|NCT00081276|Cisplatin|cisplatin|mesh-list
44108297|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108298|NCT00081302|Paclitaxel|paclitaxel|mesh-list
44108299|NCT00081302|Carboplatin|carboplatin|mesh-list
44108300|NCT00081302|Cetuximab|cetuximab|mesh-list
44108301|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108302|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108303|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44410742|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44410743|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
44410744|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410746|NCT02463357|Nifedipine|nifedipine|mesh-list
44410747|NCT02463357|Methazolamide|methazolamide|mesh-list
44410748|NCT02463357|Quercetin|quercetin|mesh-list
44410749|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410750|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410751|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44410752|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410753|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410754|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44410755|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
44410756|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
44410757|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44410758|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
44410759|NCT02463357|Protective Agents|protective agents|mesh-ancestor
44410760|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44410761|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410762|NCT02463357|Diuretics|diuretics|mesh-ancestor
44410763|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
44410764|NCT02463331|Chloroquine|chloroquine|mesh-list
43840867|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43625294|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
44410765|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44410766|NCT02463331|Prednisone|prednisone|mesh-list
44410767|NCT02463331|Azathioprine|azathioprine|mesh-list
44410768|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44410769|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
44410770|NCT02463331|Hormones|hormones|mesh-ancestor
44410771|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410772|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410773|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44410787|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
44410788|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
44410789|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
44410790|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410791|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44410792|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44410793|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
44410794|NCT02463097|Insulin|insulin|mesh-list
44410795|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410796|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410797|NCT02462928|Ranibizumab|ranibizumab|mesh-list
44410798|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44410799|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44410800|NCT02462928|Growth Substances|growth substances|mesh-ancestor
44410801|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410802|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
44410803|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410804|NCT02462720|Polidocanol|polidocanol|mesh-list
44410805|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44410806|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44410807|NCT02462486|Ranibizumab|ranibizumab|mesh-list
43791195|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43791196|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43791197|NCT05132270|Thalidomide|thalidomide|mesh-list
43791198|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
43791199|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791200|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
43791201|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791222|NCT05129176|Renal Agents|renal agents|mesh-ancestor
44410808|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44410809|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44410810|NCT02462486|Growth Substances|growth substances|mesh-ancestor
44410811|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410812|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
44410813|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410814|NCT02462473|Olanzapine|olanzapine|mesh-list
44410815|NCT02462473|Risperidone|risperidone|mesh-list
44410835|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44410836|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410837|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
44410838|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
44410839|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44410840|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44410841|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44410842|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44410844|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
44068442|NCT00000504|Flecainide|flecainide|mesh-list
44410845|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410847|NCT02461745|Ritonavir|ritonavir|mesh-list
44410848|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
44410849|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410850|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
44410851|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410852|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44410853|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44410854|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
44410855|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410856|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44410857|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44410858|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44108304|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108305|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108306|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108307|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108308|NCT00081315|Amifostine|amifostine|mesh-list
44108309|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44108310|NCT00081315|Protective Agents|protective agents|mesh-ancestor
44108311|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108312|NCT00081380|Valproic Acid|valproic acid|mesh-list
44108313|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44108314|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
44108315|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
44108316|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44108317|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44108318|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44108319|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108320|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108321|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108322|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
44108323|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
44108324|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
44108325|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108326|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
44108327|NCT00081471|Hematinics|hematinics|mesh-ancestor
44108328|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
44108329|NCT00081484|Hematinics|hematinics|mesh-ancestor
44108330|NCT00081536|Capecitabine|capecitabine|mesh-list
44410859|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44410860|NCT02461589|Liraglutide|liraglutide|mesh-list
44410861|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410862|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410863|NCT02461589|Incretins|incretins|mesh-ancestor
44410864|NCT02461589|Hormones|hormones|mesh-ancestor
44410865|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44410866|NCT02461290|Rituximab|rituximab|mesh-list
44410867|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410868|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410869|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
44410870|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410871|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44410872|NCT02461160|Midazolam|midazolam|mesh-list
44410873|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44410874|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44410875|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410876|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410877|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44410878|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44410879|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410880|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44410881|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
44410882|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
44410883|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
44410884|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
44410885|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44410886|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410887|NCT02461134|Ponesimod|ponesimod|mesh-list
44410888|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44410889|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410890|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108340|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44108341|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108343|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108344|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108345|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108346|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108347|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108348|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108349|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44410891|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
44410892|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410894|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410895|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410896|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410897|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410898|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
44410899|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43625521|NCT03101085|Equol|equol|mesh-list
44410900|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410901|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410902|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410903|NCT02460380|Vitamin D|vitamin d|mesh-list
44410904|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
44410905|NCT02460380|Vitamins|vitamins|mesh-ancestor
44410906|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
44410907|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108350|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44108351|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44108352|NCT00081588|Darunavir|darunavir|mesh-list
44108353|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44108354|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44108355|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
44108356|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108357|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108358|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44108359|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44108360|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
44108361|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108362|NCT00081614|Bevacizumab|bevacizumab|mesh-list
44108363|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44108364|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108365|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108366|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108367|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108368|NCT00081614|Growth Substances|growth substances|mesh-ancestor
44108369|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108370|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108371|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108372|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108373|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108374|NCT00081744|Tigecycline|tigecycline|mesh-list
44108375|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108376|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108377|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44108378|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108379|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108380|NCT00081757|Thalidomide|thalidomide|mesh-list
44108381|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108382|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
44108383|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108384|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108385|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108386|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108387|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108388|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108389|NCT00081757|Growth Substances|growth substances|mesh-ancestor
44410908|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44410909|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44410910|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
44410911|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44410912|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410913|NCT02459964|Fentanyl|fentanyl|mesh-list
44410914|NCT02459964|Hydromorphone|hydromorphone|mesh-list
44410915|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44410916|NCT02459964|Narcotics|narcotics|mesh-ancestor
44410917|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410918|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410919|NCT02459964|Analgesics|analgesics|mesh-ancestor
44410920|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
44410921|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44410922|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44410923|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44410924|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
44108390|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108391|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108392|NCT00081796|Capecitabine|capecitabine|mesh-list
44108393|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108394|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
44108395|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108403|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
44108404|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108405|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108406|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
44108407|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822011|NCT03006276|Celecoxib|celecoxib|mesh-list
44108408|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
44108409|NCT00081835|Antibodies|antibodies|mesh-list
44108410|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
44108411|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44108413|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
44108414|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108415|NCT00081848|Metronidazole|metronidazole|mesh-list
44108416|NCT00081848|Celecoxib|celecoxib|mesh-list
44108417|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44108418|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44108419|NCT00081848|Analgesics|analgesics|mesh-ancestor
44108420|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
44108421|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108422|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108423|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108424|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108425|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44108426|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44108427|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108428|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108429|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108430|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654335|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108431|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44108432|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108433|NCT00081874|Everolimus|everolimus|mesh-list
44108434|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108435|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108436|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
44108437|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108438|NCT00081887|Clofarabine|clofarabine|mesh-list
44410925|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
44410926|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44410927|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44410928|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410929|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44410930|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410931|NCT02459665|Metronidazole|metronidazole|mesh-list
44410932|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410933|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44410934|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44410935|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44410936|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44410937|NCT02459418|Hormones|hormones|mesh-ancestor
44410938|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43709591|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
44108439|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108440|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
44108441|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108442|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108443|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
44108444|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44108445|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108446|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
44108447|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108448|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108449|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108450|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108451|NCT00081978|Etravirine|etravirine|mesh-list
44108452|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44108453|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108454|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108455|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108456|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
44108457|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108458|NCT00082043|Dutasteride|dutasteride|mesh-list
44108459|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44108460|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44108461|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108462|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108463|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
44108473|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108474|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108475|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108476|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108477|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108478|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108479|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108480|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
43822068|NCT02813785|Docetaxel|docetaxel|mesh-list
44108481|NCT00082186|Bosentan|bosentan|mesh-list
44108482|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44108483|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44108484|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108486|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
44410939|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410940|NCT02458638|Atezolizumab|atezolizumab|mesh-list
44410941|NCT02458638|Antibodies|antibodies|mesh-list
44410942|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
44410943|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410944|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410945|NCT02458469|Buspirone|buspirone|mesh-list
44410946|NCT02458469|Trazodone|trazodone|mesh-list
44410947|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44410948|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44410949|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44410950|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44410951|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44410952|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44410953|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
44410954|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43709606|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108487|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44108488|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44108489|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44108490|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44108491|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108492|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
44108493|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
44108494|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108495|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108496|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44108497|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44108498|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
44108499|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44108500|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44108501|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44108502|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44108503|NCT00082212|Cetuximab|cetuximab|mesh-list
44108504|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108505|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108506|NCT00082225|Antibodies|antibodies|mesh-list
44108507|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
44108508|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108510|NCT00082251|Simvastatin|simvastatin|mesh-list
44108511|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44108512|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44108513|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
44108514|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108515|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44108516|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44108517|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108518|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
44108519|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
44108520|NCT00082251|Vitamins|vitamins|mesh-ancestor
44108521|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
44108522|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153577|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153578|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
44153579|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153580|NCT00220831|Protective Agents|protective agents|mesh-ancestor
44153581|NCT00220844|Amitriptyline|amitriptyline|mesh-list
44153582|NCT00220844|Desipramine|desipramine|mesh-list
44153592|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44410955|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410956|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44410957|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44410958|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44410959|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44410960|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
44410961|NCT02458287|Bococizumab|bococizumab|mesh-list
44410962|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43791259|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44410963|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44410964|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
44410965|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410966|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44410967|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
44410968|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44410969|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44410970|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44410971|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44410972|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
44410973|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44410974|NCT02457611|Ledipasvir|ledipasvir|mesh-list
44410975|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
44410976|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44410977|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44410978|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
44410979|NCT02457546|Coagulants|coagulants|mesh-ancestor
44410980|NCT02457520|Isotretinoin|isotretinoin|mesh-list
44410981|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
44410982|NCT02457325|Carticaine|carticaine|mesh-list
44410983|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
44410984|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
44411000|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
44411001|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411002|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411003|NCT02456909|Morphine|morphine|mesh-list
44411004|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44411005|NCT02456909|Narcotics|narcotics|mesh-ancestor
44411006|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411007|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411008|NCT02456909|Analgesics|analgesics|mesh-ancestor
44411009|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
44411010|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411011|NCT02456740|Erenumab|erenumab|mesh-list
44411012|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44411013|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411014|NCT02456740|Analgesics|analgesics|mesh-ancestor
44411015|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
44411016|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411017|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411018|NCT02456662|Ondansetron|ondansetron|mesh-list
44411019|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
44411020|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
43654348|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44411021|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411022|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411023|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44411024|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
44411025|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44411026|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44411027|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
44411028|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411029|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411030|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44411031|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44411032|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411033|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44411034|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44411035|NCT02455557|Temozolomide|temozolomide|mesh-list
43709645|NCT05212311|Chitosan|chitosan|mesh-list
44411037|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44411038|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44411039|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
44411040|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411041|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411042|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
44411043|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411044|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44411045|NCT02455518|Acetaminophen|acetaminophen|mesh-list
44411046|NCT02455518|Ibuprofen|ibuprofen|mesh-list
44411047|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44411048|NCT02455518|Oxycodone|oxycodone|mesh-list
44411049|NCT02455518|Hydrocodone|hydrocodone|mesh-list
44411050|NCT02455518|Codeine|codeine|mesh-list
44411051|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44411052|NCT02455518|Analgesics|analgesics|mesh-ancestor
44411053|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
44411054|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411055|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411056|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
44411057|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44411058|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411059|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44411060|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44411088|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44411089|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411090|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411091|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44411092|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411093|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
44411095|NCT02454478|Lenvatinib|lenvatinib|mesh-list
44411096|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411097|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411098|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
44411099|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411100|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411101|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411102|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411103|NCT02453841|Phenylephrine|phenylephrine|mesh-list
44411104|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
44411105|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44153593|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44153594|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153595|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
44153596|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153597|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153598|NCT00220857|Rabeprazole|rabeprazole|mesh-list
44153599|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44153600|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153601|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44153602|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153603|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153604|NCT00220896|Donepezil|donepezil|mesh-list
44153605|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44153606|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153607|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153608|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
43822142|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44108524|NCT00082277|Anastrozole|anastrozole|mesh-list
44108525|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108526|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108527|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44108528|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44108529|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108530|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108531|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44108532|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
44108533|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108534|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108535|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44108536|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44108537|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44108538|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44108539|NCT00082316|Capsaicin|capsaicin|mesh-list
44108540|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
44108541|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
44108542|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
44411107|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411108|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411109|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411110|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411111|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
44411112|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
44411113|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411114|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
44411115|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44411116|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411117|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44411118|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
44411119|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44411120|NCT02453841|Protective Agents|protective agents|mesh-ancestor
44411121|NCT02453711|Liraglutide|liraglutide|mesh-list
44411122|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411123|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411124|NCT02453711|Incretins|incretins|mesh-ancestor
44411125|NCT02453711|Hormones|hormones|mesh-ancestor
44411126|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411127|NCT02453685|Insulin|insulin|mesh-list
44411128|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44108543|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108544|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108545|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44108546|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44108547|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44108548|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44108549|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44108550|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108551|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108552|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44108553|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44108554|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
44108555|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108556|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44108557|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108558|NCT00082446|Vaccines|vaccines|mesh-list
44108566|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108567|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108568|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108569|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108570|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108571|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108572|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108573|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108574|NCT00082485|Baclofen|baclofen|mesh-list
44108575|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44108576|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411129|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
44411130|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
44411131|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
44411132|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44411133|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
44411134|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
44411135|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411136|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411137|NCT02453555|Empagliflozin|empagliflozin|mesh-list
44411138|NCT02453555|Linagliptin|linagliptin|mesh-list
44411139|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44411140|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411141|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411142|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411143|NCT02453555|Incretins|incretins|mesh-ancestor
44411144|NCT02453555|Hormones|hormones|mesh-ancestor
44411145|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411146|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44411147|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411148|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411149|NCT02453321|Bupivacaine|bupivacaine|mesh-list
44411150|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
44411151|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
44411152|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411153|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108577|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44108578|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108579|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44108580|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
44108581|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
44108582|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108583|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108584|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44108585|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44108586|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
44108587|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108588|NCT00082524|Caspofungin|caspofungin|mesh-list
44108589|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
43791421|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791423|NCT02795520|OTS167|ots167|mesh-list
44108590|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108591|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108592|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108593|NCT00082537|Caspofungin|caspofungin|mesh-list
44108594|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44108595|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
44108596|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108597|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108598|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108600|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44411154|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
44411155|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411156|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44411157|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411158|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411159|NCT02452762|Vitamin D|vitamin d|mesh-list
44411160|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
44411161|NCT02452762|Vitamins|vitamins|mesh-ancestor
44411162|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
44411163|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411164|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44411165|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44411166|NCT02452476|Poractant alfa|poractant alfa|mesh-list
44411167|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43709684|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
44108601|NCT00082563|Azithromycin|azithromycin|mesh-list
44108602|NCT00082563|Chloroquine|chloroquine|mesh-list
44108603|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
44108604|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108605|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108606|NCT00082563|Amebicides|amebicides|mesh-ancestor
44108607|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44108608|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108609|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
44108610|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108611|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44108612|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44108613|NCT00082563|Analgesics|analgesics|mesh-ancestor
44108614|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
44108615|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108616|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108617|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108618|NCT00082563|Filaricides|filaricides|mesh-ancestor
44108619|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
44108620|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
44108621|NCT00082576|Azithromycin|azithromycin|mesh-list
44108622|NCT00082576|Chloroquine|chloroquine|mesh-list
44108623|NCT00082576|Mefloquine|mefloquine|mesh-list
44108624|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108625|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108626|NCT00082576|Amebicides|amebicides|mesh-ancestor
44108627|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44108628|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108629|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
44108630|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108631|NCT00082589|Eplerenone|eplerenone|mesh-list
44108644|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
44108645|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108646|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108647|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44108648|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
44108649|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108650|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
44108651|NCT00082667|Gefitinib|gefitinib|mesh-list
43791427|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
44108652|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108653|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108654|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108655|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108656|NCT00082719|Interferons|interferons|mesh-list
44108657|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
44108658|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
44108659|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108660|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
44108661|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411168|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411169|NCT02452463|Durvalumab|durvalumab|mesh-list
44411170|NCT02452463|Nintedanib|nintedanib|mesh-list
44411171|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
44411172|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44411173|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
44411174|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411175|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411176|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
44411177|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411178|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108662|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
44108663|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108664|NCT00082784|Bortezomib|bortezomib|mesh-list
44108665|NCT00082784|Alvocidib|alvocidib|mesh-list
44108666|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108667|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108668|NCT00082784|Growth Substances|growth substances|mesh-ancestor
44108669|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108670|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108671|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108672|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108673|NCT00082797|Leucovorin|leucovorin|mesh-list
44108674|NCT00082797|Methotrexate|methotrexate|mesh-list
44108675|NCT00082797|Calcium|calcium|mesh-list
44108676|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
44108677|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44108678|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108679|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44108681|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44108682|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108683|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
44108684|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108685|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108686|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
44108687|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108688|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44108689|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108690|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
44108691|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108692|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108693|NCT00082797|Antidotes|antidotes|mesh-ancestor
44108694|NCT00082797|Protective Agents|protective agents|mesh-ancestor
44108706|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108707|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108708|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
44108709|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108710|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108711|NCT00082862|Gemcitabine|gemcitabine|mesh-list
44108712|NCT00082862|Interferons|interferons|mesh-list
44108713|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
44108714|NCT00082862|Cisplatin|cisplatin|mesh-list
44108715|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108716|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108717|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
44108718|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108719|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
43626210|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108720|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108721|NCT00082862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108722|NCT00082862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108723|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
44108724|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108725|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
44108726|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108727|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
43701630|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411180|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411181|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
44411182|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411183|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411184|NCT02452320|Acetaminophen|acetaminophen|mesh-list
44411185|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44411186|NCT02452320|Analgesics|analgesics|mesh-ancestor
44411187|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
44411188|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411189|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411190|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
44411191|NCT02452190|Reslizumab|reslizumab|mesh-list
44411192|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411193|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411194|NCT02452047|Imipenem|imipenem|mesh-list
44411195|NCT02452047|Relebactam|relebactam|mesh-list
44411196|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
44411197|NCT02452047|Cilastatin|cilastatin|mesh-list
44411198|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44411199|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411200|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411201|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411202|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411203|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44411204|NCT02452034|Posaconazole|posaconazole|mesh-list
44411205|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
44411206|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411207|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44411208|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44411209|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44411210|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44411211|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44411212|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411213|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411214|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44411217|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411218|NCT02451943|Doxorubicin|doxorubicin|mesh-list
44411220|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44411221|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411222|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44411223|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44411224|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411225|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411226|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
44411227|NCT02451930|Necitumumab|necitumumab|mesh-list
44411228|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411229|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411230|NCT02451917|Insulin|insulin|mesh-list
44411231|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44411232|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
44411233|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
44411234|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
44108728|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44108729|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108730|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
44108731|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108732|NCT00082966|Bortezomib|bortezomib|mesh-list
44108733|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108734|NCT00083005|Thalidomide|thalidomide|mesh-list
44108735|NCT00083005|Docetaxel|docetaxel|mesh-list
44108736|NCT00083005|Estramustine|estramustine|mesh-list
44108737|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108738|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108739|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108740|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108741|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108742|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108743|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
44108744|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108745|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108746|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108747|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822368|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
44108748|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108749|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43840935|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43840936|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840937|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108750|NCT00083005|Growth Substances|growth substances|mesh-ancestor
44108751|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108752|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108753|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
44108754|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108755|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
44108756|NCT00083031|Bevacizumab|bevacizumab|mesh-list
44108757|NCT00083031|Methotrexate|methotrexate|mesh-list
44108758|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108759|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
44108760|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108765|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108766|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44108767|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108768|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108769|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108770|NCT00083031|Growth Substances|growth substances|mesh-ancestor
44108771|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44411235|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
44411236|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411237|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411239|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411240|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411241|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
44411242|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411243|NCT02451358|Vaccines|vaccines|mesh-list
44411244|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
44411245|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411246|NCT02451137|Insulin|insulin|mesh-list
44411247|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44411248|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
44411249|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
44411250|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411251|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411252|NCT02450903|Ceritinib|ceritinib|mesh-list
44411253|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411254|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411255|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411256|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411257|NCT02450578|Atovaquone|atovaquone|mesh-list
44411258|NCT02450578|Proguanil|proguanil|mesh-list
44411259|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44411260|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411261|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
44411262|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44411263|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44411264|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411265|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411280|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44411281|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411282|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411283|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
44411284|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411285|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411286|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44411287|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411288|NCT02450487|Piroxicam|piroxicam|mesh-list
44411289|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44411290|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44108772|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44108773|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
44108774|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43791520|NCT05135286|Miotics|miotics|mesh-ancestor
43791521|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
43791522|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791523|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43791524|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
43626356|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
44108775|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108776|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
44108777|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
44108778|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108779|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44108780|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108781|NCT00083057|Paclitaxel|paclitaxel|mesh-list
44108782|NCT00083057|Gefitinib|gefitinib|mesh-list
44108783|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108784|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108785|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108786|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108787|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108788|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108789|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44108790|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108791|NCT00083070|Temozolomide|temozolomide|mesh-list
44108792|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108793|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
44108794|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108795|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108796|NCT00083083|Paclitaxel|paclitaxel|mesh-list
44108797|NCT00083083|Etoposide|etoposide|mesh-list
44108798|NCT00083083|Vinorelbine|vinorelbine|mesh-list
44108799|NCT00083083|Vinblastine|vinblastine|mesh-list
44108800|NCT00083083|Docetaxel|docetaxel|mesh-list
44108801|NCT00083083|Cisplatin|cisplatin|mesh-list
44108802|NCT00083083|Carboplatin|carboplatin|mesh-list
44108803|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44108804|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108805|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108806|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
44108807|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
44108808|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
44108809|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108810|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108811|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108812|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108813|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44108814|NCT00083096|Temozolomide|temozolomide|mesh-list
44108815|NCT00083096|Lonafarnib|lonafarnib|mesh-list
44108816|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108817|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
44108818|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108819|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108820|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108821|NCT00083109|Suramin|suramin|mesh-list
44108822|NCT00083109|Fluorouracil|fluorouracil|mesh-list
44108823|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
44108824|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411291|NCT02450487|Analgesics|analgesics|mesh-ancestor
44411292|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
44411293|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411294|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411295|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411296|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791529|NCT05135013|Drospirenone|drospirenone|mesh-list
43791533|NCT05135013|Norethindrone|norethindrone|mesh-list
44411297|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44411298|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411299|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411300|NCT02450331|Atezolizumab|atezolizumab|mesh-list
44411301|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411302|NCT02449915|Bupivacaine|bupivacaine|mesh-list
44411303|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44411304|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
44411305|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411306|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108825|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108826|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108828|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
44108829|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108830|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
44108831|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
44108832|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44108838|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108839|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108840|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44108841|NCT00083148|Capecitabine|capecitabine|mesh-list
44108843|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108844|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
44108845|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108846|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108847|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44108848|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108849|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108850|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
44108851|NCT00083161|Cisplatin|cisplatin|mesh-list
44108852|NCT00083161|Etoposide|etoposide|mesh-list
44108853|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108854|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
44108855|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108856|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108857|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108858|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
44108859|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108860|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108861|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44108862|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108863|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108864|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108865|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108866|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
44108867|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108868|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
44108869|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108870|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108871|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44108872|NCT00083213|Aflibercept|aflibercept|mesh-list
44411307|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
44411308|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411309|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44411310|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44411311|NCT02449902|Estradiol|estradiol|mesh-list
44411312|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44411313|NCT02449902|Estrogens|estrogens|mesh-ancestor
44411314|NCT02449902|Hormones|hormones|mesh-ancestor
44411315|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411316|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411317|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44411318|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
44411319|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44411320|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44411321|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44411322|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44411323|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411324|NCT02449044|Tolvaptan|tolvaptan|mesh-list
44411325|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44411326|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411327|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
44411328|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108873|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108874|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108875|NCT00083213|Growth Substances|growth substances|mesh-ancestor
44108876|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108877|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108878|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108879|NCT00083252|Cisplatin|cisplatin|mesh-list
44108880|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108881|NCT00083278|Ipilimumab|ipilimumab|mesh-list
44108882|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44108883|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108884|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44108885|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108886|NCT00083304|Efaproxiral|efaproxiral|mesh-list
44108887|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
44108888|NCT00083343|Caspofungin|caspofungin|mesh-list
44108889|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
44108890|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108891|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108892|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108893|NCT00083408|Pamidronate|pamidronate|mesh-list
44108894|NCT00083408|Thalidomide|thalidomide|mesh-list
44108895|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108896|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
44108897|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108898|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108899|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108900|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108901|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44411330|NCT02448810|Panitumumab|panitumumab|mesh-list
44411331|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
44411332|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411333|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44411334|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411335|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411336|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
44411337|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411338|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411339|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
44411340|NCT02448771|Palbociclib|palbociclib|mesh-list
44411341|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411342|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411343|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411344|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411345|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44411346|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44411347|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44411348|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411349|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411350|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44411351|NCT02448537|Gemcitabine|gemcitabine|mesh-list
44411352|NCT02448537|Doxorubicin|doxorubicin|mesh-list
44411377|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411378|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
44411379|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411380|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411381|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411382|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411383|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
44411384|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411385|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
44411386|NCT02448225|Fluorides|fluorides|mesh-list
44411387|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44411388|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
44411389|NCT02448225|Protective Agents|protective agents|mesh-ancestor
44411390|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411391|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44411392|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411393|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
44411394|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
44411395|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411396|NCT02448043|Bimatoprost|bimatoprost|mesh-list
44411397|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44108902|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108907|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
44108908|NCT00083434|Hematinics|hematinics|mesh-ancestor
44108909|NCT00083460|Thalidomide|thalidomide|mesh-list
44108910|NCT00083460|Dexamethasone|dexamethasone|mesh-list
44108911|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108912|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
44108913|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
44108914|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108915|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108916|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44108917|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
44108918|NCT00083460|Hormones|hormones|mesh-ancestor
44108919|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108920|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108921|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108922|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108923|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
44108924|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108925|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108926|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108927|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108928|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108929|NCT00083460|Growth Substances|growth substances|mesh-ancestor
44108930|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108931|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
44108932|NCT00083486|Hematinics|hematinics|mesh-ancestor
44108933|NCT00083525|Capecitabine|capecitabine|mesh-list
44108934|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44108935|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
43791606|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43626646|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
44108936|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108937|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108938|NCT00083538|Thalidomide|thalidomide|mesh-list
44108939|NCT00083538|Dexamethasone|dexamethasone|mesh-list
44108940|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
44108941|NCT00083538|Etoposide|etoposide|mesh-list
44411398|NCT02447991|Rizatriptan|rizatriptan|mesh-list
44411399|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44411400|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
44411401|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411402|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411403|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411404|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
44411405|NCT02447887|Ixazomib|ixazomib|mesh-list
44411406|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411407|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411408|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411409|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411410|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
44411411|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411412|NCT02447848|Sufentanil|sufentanil|mesh-list
44411413|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44411414|NCT02447848|Narcotics|narcotics|mesh-ancestor
44411415|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411416|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411417|NCT02447848|Analgesics|analgesics|mesh-ancestor
44411418|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
44411419|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411420|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44411421|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44411422|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
44411423|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
44411425|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44411426|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
44411427|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411428|NCT02447432|Vaccines|vaccines|mesh-list
44411429|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44411430|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
44108942|NCT00083538|Doxorubicin|doxorubicin|mesh-list
44108943|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44108944|NCT00083538|Cisplatin|cisplatin|mesh-list
44108945|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108946|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
44108947|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108948|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44108949|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44108950|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
44108951|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108952|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411432|NCT02447328|Fulvestrant|fulvestrant|mesh-list
44411433|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44411434|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791608|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411435|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44411436|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44411437|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
44411438|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411439|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411440|NCT02447250|Albuterol|albuterol|mesh-list
44411441|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44411442|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
44411443|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411444|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411445|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411446|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411447|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
44411448|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44411449|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44411450|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44411451|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411452|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
43709890|NCT04788641|Cyclosporine|cyclosporine|mesh-list
44108953|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44108954|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44108955|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
44108956|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
44108957|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44108958|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44108959|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
44108960|NCT00083538|Hormones|hormones|mesh-ancestor
44108961|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44108962|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44108963|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44108964|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44108965|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44108966|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108967|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44108968|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
44108969|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44108970|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44108971|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44108972|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44108973|NCT00083538|Growth Substances|growth substances|mesh-ancestor
44108974|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
44108975|NCT00083577|Thalidomide|thalidomide|mesh-list
44108976|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44108977|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
43791838|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791839|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791840|NCT03976934|Tamsulosin|tamsulosin|mesh-list
43791841|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43626799|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626800|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43626801|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
43626802|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43626803|NCT03081676|Hormones|hormones|mesh-ancestor
44108986|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44108987|NCT00083590|Huperzine A|huperzine a|mesh-list
44411453|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411454|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411455|NCT02447172|Gentamicins|gentamicins|mesh-list
44411456|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44411457|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411458|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44411459|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411460|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411461|NCT02447029|Lidocaine|lidocaine|mesh-list
44411462|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
44411463|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
44411464|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411465|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411466|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
44411467|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411468|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44411469|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44411470|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44411471|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44108988|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44108989|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44108990|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44108991|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
44108992|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44108993|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44108994|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44108995|NCT00083590|Protective Agents|protective agents|mesh-ancestor
44108996|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44108997|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44108998|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44108999|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109000|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109001|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44109002|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44109003|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44109004|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
44109005|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109006|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109007|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44109008|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44109009|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
44109010|NCT00083681|Thalidomide|thalidomide|mesh-list
44109011|NCT00083681|Dexamethasone|dexamethasone|mesh-list
44109012|NCT00083681|Cisplatin|cisplatin|mesh-list
44109013|NCT00083681|Etoposide|etoposide|mesh-list
44109014|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
44109015|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109016|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
44109017|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
44109018|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109019|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109020|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109021|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
44109022|NCT00083681|Hormones|hormones|mesh-ancestor
44411472|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411473|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
44411474|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411475|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411476|NCT02446886|Hormones|hormones|mesh-list
44411477|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44411478|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44411479|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
44411480|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411481|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411482|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411483|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411484|NCT02446717|Ribavirin|ribavirin|mesh-list
44411485|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
44411486|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411487|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
44411488|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411489|NCT02446418|Fluticasone|fluticasone|mesh-list
44411490|NCT02446418|Xhance|xhance|mesh-list
44411491|NCT02446418|Budesonide|budesonide|mesh-list
44411492|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
44411493|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44411494|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411495|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44109023|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109024|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109025|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109026|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109027|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44109028|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109029|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109030|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109031|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109032|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
44109033|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109034|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44109035|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
44109036|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44109037|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
44109038|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44109039|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109040|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44109041|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44109042|NCT00083681|Growth Substances|growth substances|mesh-ancestor
44109043|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109044|NCT00083694|Thalidomide|thalidomide|mesh-list
44109066|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
44109067|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109068|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44109069|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
44411496|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
44411497|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411498|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411499|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411500|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411501|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
44411502|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44411503|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
44411504|NCT02446418|Hormones|hormones|mesh-ancestor
44411505|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411506|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44411507|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44411508|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411509|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791877|NCT03763643|Rituximab|rituximab|mesh-list
44411510|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411511|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411512|NCT02446171|Naloxegol|naloxegol|mesh-list
44411513|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44411514|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411515|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
44411516|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411517|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44411518|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
44411519|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44411520|NCT02445586|Docetaxel|docetaxel|mesh-list
44411521|NCT02445586|Trastuzumab|trastuzumab|mesh-list
44411522|NCT02445586|Pertuzumab|pertuzumab|mesh-list
44411523|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411524|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
44411525|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
44411526|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
44411527|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411538|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
44411539|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
44411540|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411541|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411542|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
44411543|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411544|NCT02443883|Ramucirumab|ramucirumab|mesh-list
44411545|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411546|NCT02443402|Insulin|insulin|mesh-list
44411547|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44411548|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
44411549|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44411550|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
44411551|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
44411552|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411553|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411554|NCT02443402|Incretins|incretins|mesh-ancestor
44411555|NCT02443402|Hormones|hormones|mesh-ancestor
44411556|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411557|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44411558|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411559|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411560|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411561|NCT02443337|Necitumumab|necitumumab|mesh-list
44411590|NCT02442284|Ribavirin|ribavirin|mesh-list
44411591|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44411592|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44411593|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411594|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411595|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411596|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44411597|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44411598|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
44411599|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411600|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44411601|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44411602|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
44411603|NCT02442271|Ritonavir|ritonavir|mesh-list
44411604|NCT02442271|Ribavirin|ribavirin|mesh-list
44411605|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44411606|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44411607|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
44411608|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411609|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411610|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44411611|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44411612|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
44411613|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411614|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44411615|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44411616|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
44411617|NCT02441946|Anastrozole|anastrozole|mesh-list
44109070|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109071|NCT00083785|Talaporfin|talaporfin|mesh-list
44109072|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109073|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44109074|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44109075|NCT05568602|Dexamethasone|dexamethasone|mesh-list
44109076|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109077|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
44109078|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
44109079|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109080|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109081|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44109082|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
44109083|NCT05568602|Hormones|hormones|mesh-ancestor
44109084|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109085|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109086|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109087|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
44109088|NCT05568550|Olaparib|olaparib|mesh-list
44109089|NCT05568550|Androgens|androgens|mesh-list
44109090|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411618|NCT02441946|Loperamide|loperamide|mesh-list
44411619|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
44411620|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44411621|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411622|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44411623|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44411624|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411625|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411626|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44411627|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
44411628|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411629|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411630|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44411631|NCT02441309|Ifosfamide|ifosfamide|mesh-list
44411632|NCT02441309|Mifamurtide|mifamurtide|mesh-list
44411633|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44411634|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
43791953|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792141|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792142|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792143|NCT05137184|Analgesics|analgesics|mesh-ancestor
44411635|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411636|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411637|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44411638|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
44411639|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411640|NCT02441114|Fluticasone|fluticasone|mesh-list
44411641|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
44411642|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44411643|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44411644|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411645|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44411646|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
44109091|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109092|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44109093|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109094|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109095|NCT05568550|Hormones|hormones|mesh-ancestor
44109096|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109097|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153609|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153610|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153618|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153620|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44153621|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153622|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411647|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411648|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411649|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411650|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411651|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
44411652|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44411653|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
44411654|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44411655|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
44411656|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411657|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411658|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44411659|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44411660|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411661|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411663|NCT02441114|Hormones|hormones|mesh-ancestor
44153623|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153624|NCT00220987|Insulin|insulin|mesh-list
44153625|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44153626|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44153627|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153628|NCT00221000|Methoxsalen|methoxsalen|mesh-list
44153629|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44153630|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153631|NCT00221026|Methoxsalen|methoxsalen|mesh-list
44153632|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44153633|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153634|NCT00221039|Methoxsalen|methoxsalen|mesh-list
44153635|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44153636|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
44153637|NCT00221052|Diclofenac|diclofenac|mesh-list
44153638|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44153639|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44153640|NCT00221052|Analgesics|analgesics|mesh-ancestor
44153641|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
44109098|NCT05568212|Durvalumab|durvalumab|mesh-list
44109099|NCT05568212|Olaparib|olaparib|mesh-list
44109100|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109101|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109102|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44109103|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109104|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109105|NCT05568147|Aspirin|aspirin|mesh-list
44109106|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44109107|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44109108|NCT05568147|Analgesics|analgesics|mesh-ancestor
44109109|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
44109110|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109111|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109112|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109113|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109114|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44109115|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44109116|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109117|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44109118|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44109119|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109120|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
44109121|NCT05568082|Itraconazole|itraconazole|mesh-list
44411664|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411665|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
44411666|NCT02440854|Afatinib|afatinib|mesh-list
44411667|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411668|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44411669|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411670|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411671|NCT02440789|Sirolimus|sirolimus|mesh-list
44411672|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44411673|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411674|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44411675|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411676|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
44411677|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411678|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
44411679|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411680|NCT02440568|Cytarabine|cytarabine|mesh-list
44411681|NCT02440568|Idarubicin|idarubicin|mesh-list
44411682|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
44109122|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
44109123|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109124|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44109125|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109126|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109127|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109128|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44109129|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
44109130|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109131|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109132|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44109133|NCT05568017|Edotreotide|edotreotide|mesh-list
44109134|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43792152|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44109137|NCT05567770|Hormones|hormones|mesh-ancestor
44109138|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109139|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109140|NCT05567731|Hormones|hormones|mesh-list
44109141|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109142|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109143|NCT05567718|Anesthetics|anesthetics|mesh-list
44109144|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109145|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109146|NCT05567653|Sulfalene|sulfalene|mesh-list
44109147|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109148|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44109149|NCT05567653|Renal Agents|renal agents|mesh-ancestor
44109150|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
44109151|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44109152|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44109153|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
44109154|NCT05567484|Itraconazole|itraconazole|mesh-list
44109155|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
44109156|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109157|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44109158|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109159|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411683|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44411684|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
44411685|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411686|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411687|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
44411688|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411689|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792317|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43792318|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792319|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44411690|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
44411691|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411692|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44411693|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44411694|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44411695|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411696|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44411697|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44411698|NCT02439970|Valganciclovir|valganciclovir|mesh-list
44411699|NCT02439970|Brincidofovir|brincidofovir|mesh-list
44411700|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
44411701|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411702|NCT02439957|Valganciclovir|valganciclovir|mesh-list
44109160|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109161|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44109162|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
44109163|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109164|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109165|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44109166|NCT05567471|Vaccines|vaccines|mesh-list
44109167|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
44109168|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109169|NCT05567315|Anesthetics|anesthetics|mesh-list
44109170|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
44109172|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109173|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
44109174|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109175|NCT05567081|Triamcinolone|triamcinolone|mesh-list
44109176|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44109177|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44109178|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44109179|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109180|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
44109181|NCT05567081|Hormones|hormones|mesh-ancestor
44109182|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109183|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109184|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109185|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
44109186|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109187|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109188|NCT05567016|Lumefantrine|lumefantrine|mesh-list
44109189|NCT05567016|Artemether|artemether|mesh-list
44109190|NCT05567016|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44109191|NCT05567016|Antimalarials|antimalarials|mesh-ancestor
44109192|NCT05567016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44109193|NCT05567016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44109194|NCT05567016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411703|NCT02439957|Brincidofovir|brincidofovir|mesh-list
44411704|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
44411705|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411706|NCT02439320|Lasmiditan|lasmiditan|mesh-list
44411707|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44411708|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
44411709|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411710|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411711|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411712|NCT02439138|Idelalisib|idelalisib|mesh-list
44411713|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411714|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411715|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411716|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
44411717|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44411718|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44411719|NCT02438787|Golimumab|golimumab|mesh-list
44411720|NCT02438787|Ustekinumab|ustekinumab|mesh-list
44411721|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44069371|NCT00000681|Zidovudine|zidovudine|mesh-list
44411722|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44411723|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411724|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710125|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
44109195|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
44109196|NCT05566054|Azacitidine|azacitidine|mesh-list
44109197|NCT05566054|Venetoclax|venetoclax|mesh-list
44109198|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44109199|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
44109200|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109201|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109202|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109203|NCT05566041|Cisplatin|cisplatin|mesh-list
44109204|NCT05566041|Carboplatin|carboplatin|mesh-list
44109205|NCT05566041|Etoposide|etoposide|mesh-list
44109206|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109207|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109211|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109212|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
44109213|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
44109214|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109215|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109216|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109217|NCT05549180|Emtricitabine|emtricitabine|mesh-list
44109218|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
44109219|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109220|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44109221|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44109222|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109223|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109224|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44109225|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44411725|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
44411726|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411729|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44411730|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411731|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411732|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44411733|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411734|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
44411735|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
44411736|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44411737|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44411738|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44411739|NCT02438371|Analgesics|analgesics|mesh-ancestor
44411740|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
44411741|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411742|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411743|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44411744|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
44411745|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44411746|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411747|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44411748|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
44411749|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411750|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
44411751|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411752|NCT02437318|Fulvestrant|fulvestrant|mesh-list
44411753|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44411754|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411755|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44411756|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44411757|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
44411758|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411759|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411760|NCT02437162|Golimumab|golimumab|mesh-list
44411761|NCT02437162|Ustekinumab|ustekinumab|mesh-list
44109226|NCT05502900|Melatonin|melatonin|mesh-list
44411763|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44411764|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44411765|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411766|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
44411767|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411768|NCT02437084|Atorvastatin|atorvastatin|mesh-list
44411769|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44411770|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44411771|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
44411772|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411773|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44411774|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44411775|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411776|NCT02436889|Mirabegron|mirabegron|mesh-list
43792404|NCT05302921|Nivolumab|nivolumab|mesh-list
43792405|NCT05302921|Ipilimumab|ipilimumab|mesh-list
43792406|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792407|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792408|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43792409|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792410|NCT05302817|Xenon|xenon|mesh-list
43792411|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43841046|NCT04654689|Resveratrol|resveratrol|mesh-list
43627398|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43627399|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43627400|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627401|NCT03073889|Ropivacaine|ropivacaine|mesh-list
43627402|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
43627403|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
43627404|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627405|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411777|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44411778|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44411779|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44411780|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411781|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411782|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411783|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411784|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411785|NCT02436889|Urological Agents|urological agents|mesh-ancestor
44411786|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44411787|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44411788|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
44411789|NCT02436759|Phenylephrine|phenylephrine|mesh-list
44411790|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
44411791|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44411792|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44411793|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44411794|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411795|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411796|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109227|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
44109228|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109229|NCT05502900|Protective Agents|protective agents|mesh-ancestor
44411797|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411798|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411799|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
44411800|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
44411801|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411802|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
44411803|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44411804|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411805|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44411806|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
44411807|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44411808|NCT02436759|Protective Agents|protective agents|mesh-ancestor
44411809|NCT02436577|Ticagrelor|ticagrelor|mesh-list
44411810|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43841047|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841048|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841049|NCT04654689|Analgesics|analgesics|mesh-ancestor
43841050|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
43841051|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841052|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841053|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841054|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841055|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411811|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44411812|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44411813|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44411814|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
44411815|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411816|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411817|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411818|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44411819|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
44411820|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44411821|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44411822|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44411823|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44411824|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411825|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411826|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
44109230|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109231|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109232|NCT05438888|Warfarin|warfarin|mesh-list
44109233|NCT05438888|Apixaban|apixaban|mesh-list
44109234|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
44109235|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44109236|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
44109237|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44109238|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
44109239|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109240|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109241|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44411827|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411828|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44411829|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44411831|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411832|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411833|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411834|NCT02435992|Ozanimod|ozanimod|mesh-list
44411835|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44411836|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411837|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411838|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
44411839|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411840|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44411841|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44411842|NCT02435836|Aripiprazole|aripiprazole|mesh-list
44411843|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
43760830|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760831|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43760832|NCT02442791|Exenatide|exenatide|mesh-list
43760833|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43760834|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760836|NCT02442791|Incretins|incretins|mesh-ancestor
43760837|NCT02442791|Hormones|hormones|mesh-ancestor
43760838|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760839|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
44411844|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44411845|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44109242|NCT05424757|Laxatives|laxatives|mesh-ancestor
44109243|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44153642|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109245|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109246|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109247|NCT05319353|Maribavir|maribavir|mesh-list
44109248|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
44109249|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109250|NCT05262556|Nivolumab|nivolumab|mesh-list
44109251|NCT05262556|Ipilimumab|ipilimumab|mesh-list
44109252|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109253|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109254|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44109255|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109256|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
44109257|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109258|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109259|NCT05047718|Vaccines|vaccines|mesh-list
44109260|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
44109261|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109262|NCT04984070|Metformin|metformin|mesh-list
44109263|NCT04984070|Drospirenone|drospirenone|mesh-list
44109264|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
44109265|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44109266|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
44109267|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
44109268|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44109269|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44109270|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109271|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44109272|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44109273|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44109274|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44109275|NCT04984070|Estrogens|estrogens|mesh-ancestor
44109276|NCT04984070|Hormones|hormones|mesh-ancestor
44109277|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44411846|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44411847|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411848|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411849|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
44411850|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
44109278|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44109290|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109292|NCT04943627|Antiviral Agents|antiviral agents|mesh-ancestor
44109293|NCT04943627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44109294|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109295|NCT04943627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109296|NCT04943627|Immunologic Factors|immunologic factors|mesh-ancestor
44109297|NCT04943627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109298|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44109299|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44109300|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44109301|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44109302|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109303|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109304|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109305|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109306|NCT04928339|Bupivacaine|bupivacaine|mesh-list
44109307|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
44109308|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
44109309|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109310|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109311|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
44109312|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109313|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
44109314|NCT04924374|Atezolizumab|atezolizumab|mesh-list
44109315|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44109316|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109317|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109318|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
44109319|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109321|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109322|NCT04856176|Paclitaxel|paclitaxel|mesh-list
44109323|NCT04856176|Carboplatin|carboplatin|mesh-list
44109324|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
44109325|NCT04856176|Pemetrexed|pemetrexed|mesh-list
44109326|NCT04856176|Molgramostim|molgramostim|mesh-list
44109327|NCT04856176|Sargramostim|sargramostim|mesh-list
44109328|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44109329|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109330|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
44109331|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
44109332|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
44109333|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109334|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44109335|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109336|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44109337|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44109338|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
44109339|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109340|NCT04786574|Tolvaptan|tolvaptan|mesh-list
44109341|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44109342|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109343|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
44109344|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109345|NCT04764162|Choline|choline|mesh-list
44109353|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
44109354|NCT04732845|Fludarabine|fludarabine|mesh-list
44109355|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44109356|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
44109357|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109358|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109359|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44109360|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
44109361|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411851|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411852|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411853|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44411854|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44411855|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
44411856|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44411857|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44411858|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44411859|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44411860|NCT02435680|Gemcitabine|gemcitabine|mesh-list
44411861|NCT02435680|Carboplatin|carboplatin|mesh-list
44411862|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411863|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44411864|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
44411865|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411866|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
44411867|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411868|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411869|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411870|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
44411871|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411873|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411874|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411875|NCT02435147|Denosumab|denosumab|mesh-list
44411876|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44411877|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411878|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44411879|NCT02435069|Glycerol|glycerol|mesh-list
44109362|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109363|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44109364|NCT04732507|Lidocaine|lidocaine|mesh-list
44109365|NCT04732507|Bupivacaine|bupivacaine|mesh-list
44109366|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
44109367|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
44109368|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109369|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109370|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
44109371|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109372|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44109373|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44109374|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44109375|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109376|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411880|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44411881|NCT02435069|Protective Agents|protective agents|mesh-ancestor
44411882|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411883|NCT02434939|Ketamine|ketamine|mesh-list
44411884|NCT02434939|Morphine|morphine|mesh-list
44411885|NCT02434939|Analgesics|analgesics|mesh-ancestor
44411886|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
44411887|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411888|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411889|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44411890|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44411891|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
44411892|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
44411893|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44411894|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44411895|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44411896|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411897|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411898|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44411899|NCT02434939|Narcotics|narcotics|mesh-ancestor
44411900|NCT02434770|Vaccines|vaccines|mesh-list
44411901|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
44411902|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411903|NCT02434328|Aflibercept|aflibercept|mesh-list
44109377|NCT04631484|Riboflavin|riboflavin|mesh-list
44109378|NCT04631484|Niacinamide|niacinamide|mesh-list
44109379|NCT04631484|Niacin|niacin|mesh-list
44109380|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
44109381|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
44109382|NCT04631484|Vitamins|vitamins|mesh-ancestor
44109383|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
44109384|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109385|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44109386|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
44109387|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44109388|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
44109389|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109390|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44109391|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
44109392|NCT04607603|Cannabidiol|cannabidiol|mesh-list
44109393|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
44109394|NCT04605081|Naltrexone|naltrexone|mesh-list
43822930|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
44109396|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44109397|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44109398|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109399|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
44109400|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109401|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44109402|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
44109403|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44109404|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44109405|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44411904|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44411905|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44411906|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44411907|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44411908|NCT02434328|Growth Substances|growth substances|mesh-ancestor
44411909|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411910|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
44411911|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44411912|NCT02434081|Nivolumab|nivolumab|mesh-list
44411913|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44411914|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109406|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109407|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109408|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
44109409|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109410|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44109411|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109412|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109413|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44109421|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44153643|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153644|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44153645|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153646|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44153647|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153648|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153650|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44153651|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153652|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153653|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44153654|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153655|NCT00221260|Anesthetics|anesthetics|mesh-list
44153656|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44153657|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153658|NCT00221286|Interferons|interferons|mesh-list
44153659|NCT00221286|Tenofovir|tenofovir|mesh-list
44153660|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
43792473|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
43792474|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792475|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
43792523|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
43792524|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153661|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
44153662|NCT00221286|Emtricitabine|emtricitabine|mesh-list
44153663|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44153664|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153665|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
44153666|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44153667|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44153668|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44153669|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44153670|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44153671|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44153672|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44153673|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
44153674|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153675|NCT00221312|Alendronate|alendronate|mesh-list
44153676|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44153677|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153678|NCT00221325|Rituximab|rituximab|mesh-list
44153679|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44153680|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44153681|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
44153682|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44153683|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44153684|NCT00221364|Azithromycin|azithromycin|mesh-list
44153685|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44153686|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44411915|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44411916|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411918|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44411919|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44411920|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44411921|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44411922|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
44411923|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44411924|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411925|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411926|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44411927|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
44411928|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44411929|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44411930|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
44411931|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44411932|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44411933|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44411934|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44411935|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
44411936|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44411937|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411938|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44411939|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411940|NCT02433483|Cytarabine|cytarabine|mesh-list
44411941|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
44411942|NCT02433483|Methotrexate|methotrexate|mesh-list
44411943|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44411944|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
44411945|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44411946|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44411947|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44411948|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
44411949|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44411951|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
44411952|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44411953|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44411954|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44411955|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
44411956|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44411957|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44411958|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
44412017|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44412018|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412019|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
44412020|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44412021|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
44412022|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412023|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412024|NCT02431260|INCB054329|incb054329|mesh-list
44412025|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412026|NCT02431247|Tenofovir|tenofovir|mesh-list
44412027|NCT02431247|Emtricitabine|emtricitabine|mesh-list
44412028|NCT02431247|Darunavir|darunavir|mesh-list
44412029|NCT02431247|Cobicistat|cobicistat|mesh-list
44412030|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44412031|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
44412032|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
44412033|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412034|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44412035|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44412036|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412037|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412038|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44412068|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
44412069|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412070|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412072|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44412073|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44412074|NCT02429427|Analgesics|analgesics|mesh-ancestor
44412075|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
44412076|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412134|NCT02427841|Fluorouracil|fluorouracil|mesh-list
44412135|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412136|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412137|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412138|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412139|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412140|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412141|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412142|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
44412143|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
44412144|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412145|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412146|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412147|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
44412148|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412150|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412151|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412152|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44412153|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412154|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412155|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44412156|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44412157|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
44412158|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43710425|NCT01706692|Analgesics|analgesics|mesh-ancestor
44153687|NCT00221390|Ropinirole|ropinirole|mesh-list
44153688|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44153689|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44153690|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
44109422|NCT04599478|Naltrexone|naltrexone|mesh-list
44109423|NCT04599478|Bupropion|bupropion|mesh-list
44109424|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44109425|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44109426|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109427|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
44109428|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109429|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44109430|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
44109431|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44109432|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44109434|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109435|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109436|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
44109437|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44109438|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44109439|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109440|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109442|NCT04556617|Olaparib|olaparib|mesh-list
44109443|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
44109444|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412159|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44412160|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412161|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412162|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44412163|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412164|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412165|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
44412166|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412167|NCT02426918|Vancomycin|vancomycin|mesh-list
44412168|NCT02426918|Linezolid|linezolid|mesh-list
44412169|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412170|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412171|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44412172|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412173|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412174|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
44412175|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44412176|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412177|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412178|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412179|NCT02426125|Docetaxel|docetaxel|mesh-list
44412180|NCT02426125|Ramucirumab|ramucirumab|mesh-list
44412181|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412182|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412183|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412184|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412185|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412186|NCT02426086|Niacinamide|niacinamide|mesh-list
44412187|NCT02426086|Imetelstat|imetelstat|mesh-list
44412188|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
44412189|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412190|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412191|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44109445|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
44109446|NCT04556617|Hormones|hormones|mesh-ancestor
44109447|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44109448|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109449|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44109450|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44109451|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44412192|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
44412193|NCT02426086|Vitamins|vitamins|mesh-ancestor
44412194|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
44412195|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412196|NCT02425904|Clofarabine|clofarabine|mesh-list
44412197|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412198|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
44412199|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412200|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412201|NCT02425826|Thalidomide|thalidomide|mesh-list
44412202|NCT02425826|Apremilast|apremilast|mesh-list
44412203|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44412204|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44412205|NCT02425826|Analgesics|analgesics|mesh-ancestor
44412206|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
44412207|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412208|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412209|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412210|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412211|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44412212|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44412213|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412214|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412215|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412216|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
44412217|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
44412218|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44412219|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412240|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412241|NCT02424591|Ketamine|ketamine|mesh-list
44412242|NCT02424591|Analgesics|analgesics|mesh-ancestor
44412243|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
44412244|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412245|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412246|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44412247|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44412248|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
44412249|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
44412250|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412251|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44412252|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44412253|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412254|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412255|NCT02424578|Diclofenac|diclofenac|mesh-list
43710511|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
44109452|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109453|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109454|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44109455|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
44109456|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44109457|NCT04554862|Ketorolac|ketorolac|mesh-list
44109458|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44109459|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
44109460|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44109461|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44109462|NCT04554862|Analgesics|analgesics|mesh-ancestor
44109463|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
44109464|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109465|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109466|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109467|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44109468|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44109469|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44109470|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109471|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
44109472|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44109473|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44109474|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
44109475|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44109476|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44109477|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44109478|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
44109479|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44109480|NCT04551170|Theophylline|theophylline|mesh-list
44109481|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44109482|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
44109483|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44109484|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44109485|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44109486|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
44109487|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44109488|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43761308|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43761309|NCT02439866|Prednisolone|prednisolone|mesh-list
43761310|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
43761311|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43761312|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
43761313|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761314|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
43761315|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
44412256|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44412258|NCT02424578|Analgesics|analgesics|mesh-ancestor
44412259|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
44412260|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412261|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412262|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412263|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412264|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44412265|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412266|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412267|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
44412268|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44412269|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
44412270|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412271|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412272|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44412273|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
44412274|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44412275|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44412276|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44412277|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
44412278|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412279|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412280|NCT02424097|Listerine|listerine|mesh-list
44412281|NCT02424097|Fluorides|fluorides|mesh-list
44412282|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
44412283|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
44412284|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
44412285|NCT02424097|Protective Agents|protective agents|mesh-ancestor
44412286|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412287|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44412288|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412289|NCT02423343|Nivolumab|nivolumab|mesh-list
44109489|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44109490|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
44109491|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44109492|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43823080|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
44412323|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412324|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412325|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
44412326|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412327|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44412328|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44412329|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792530|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792531|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792532|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792533|NCT05285800|Bupivacaine|bupivacaine|mesh-list
43792534|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
43792535|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
43792536|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761385|NCT02439411|Trametinib|trametinib|mesh-list
44412330|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44412331|NCT02422186|Analgesics|analgesics|mesh-ancestor
44412340|NCT02421588|Topotecan|topotecan|mesh-list
44412385|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44412386|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412387|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412388|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44412389|NCT02421120|Renal Agents|renal agents|mesh-ancestor
44412390|NCT02420717|Leucovorin|leucovorin|mesh-list
44412391|NCT02420717|Cytarabine|cytarabine|mesh-list
44412392|NCT02420717|Dexamethasone|dexamethasone|mesh-list
44412393|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
44412394|NCT02420717|Prednisone|prednisone|mesh-list
44412395|NCT02420717|Cortisone|cortisone|mesh-list
44412396|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
44412397|NCT02420717|Rituximab|rituximab|mesh-list
44412398|NCT02420717|Doxorubicin|doxorubicin|mesh-list
44412399|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44412400|NCT02420717|Methotrexate|methotrexate|mesh-list
44412401|NCT02420717|Vincristine|vincristine|mesh-list
44412402|NCT02420717|Daunorubicin|daunorubicin|mesh-list
44412403|NCT02420717|Dasatinib|dasatinib|mesh-list
44412404|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
44412405|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44412406|NCT02420717|Antibodies|antibodies|mesh-list
44412407|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
44412408|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44412409|NCT02420717|BB 1101|bb 1101|mesh-list
44412410|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412411|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
44412412|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412413|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412414|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44412415|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
44412417|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412433|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44412434|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
44412435|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412436|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44412437|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
44412438|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
44412439|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44412440|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44412441|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
44412442|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412443|NCT02420717|Antidotes|antidotes|mesh-ancestor
44412444|NCT02420717|Protective Agents|protective agents|mesh-ancestor
44412445|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
44412446|NCT02420717|Vitamins|vitamins|mesh-ancestor
44412447|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
44412448|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44412449|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44412450|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44412451|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44412452|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44412453|NCT02420327|Galantamine|galantamine|mesh-list
44412454|NCT02420327|Nicotine|nicotine|mesh-list
44412455|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44412456|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
44412457|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412458|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412459|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44412468|NCT02420262|Insulin|insulin|mesh-list
44412481|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44412483|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792537|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792538|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
43792539|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792540|NCT05284656|Folic Acid|folic acid|mesh-list
43792581|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
43792582|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412484|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412485|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412486|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44412487|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44412488|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
44412489|NCT02419755|Cytarabine|cytarabine|mesh-list
44412490|NCT02419755|Dexamethasone|dexamethasone|mesh-list
44412491|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
44412492|NCT02419755|Doxorubicin|doxorubicin|mesh-list
44412493|NCT02419755|Methotrexate|methotrexate|mesh-list
44412494|NCT02419755|Bortezomib|bortezomib|mesh-list
44412495|NCT02419755|Asparaginase|asparaginase|mesh-list
44412496|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
44412497|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
44412498|NCT02419755|Vorinostat|vorinostat|mesh-list
44412499|NCT02419755|Pegaspargase|pegaspargase|mesh-list
44412507|NCT02419755|Hormones|hormones|mesh-ancestor
44412539|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44412540|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44412541|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
44412543|NCT02419612|Hormones|hormones|mesh-ancestor
44412544|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44412545|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44412546|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
44412547|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412548|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44412549|NCT02419508|Bimatoprost|bimatoprost|mesh-list
44412550|NCT02419508|Travoprost|travoprost|mesh-list
44412551|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44412552|NCT02419508|Latanoprost|latanoprost|mesh-list
44412553|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44412554|NCT02419508|Brinzolamide|brinzolamide|mesh-list
44412555|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44412556|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44412557|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44412558|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44412559|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
44412560|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412561|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412562|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412563|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43792588|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
44412564|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412565|NCT02419469|Cytarabine|cytarabine|mesh-list
44412566|NCT02419469|Dexamethasone|dexamethasone|mesh-list
44412567|NCT02419469|Prednisone|prednisone|mesh-list
44412568|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
44412569|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
44412570|NCT02419469|Rituximab|rituximab|mesh-list
44412571|NCT02419469|Doxorubicin|doxorubicin|mesh-list
44412572|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44412573|NCT02419469|Methotrexate|methotrexate|mesh-list
44412574|NCT02419469|Vincristine|vincristine|mesh-list
44412578|NCT02419469|Ofatumumab|ofatumumab|mesh-list
44412583|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
44412584|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412585|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412586|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44412587|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
44412588|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412589|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412590|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44412591|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44412592|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412645|NCT02418754|Growth Substances|growth substances|mesh-ancestor
44412646|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412647|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
44412648|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44412649|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44412650|NCT02418585|Citalopram|citalopram|mesh-list
44412651|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44412713|NCT02417064|Citalopram|citalopram|mesh-list
44412714|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44412715|NCT02417064|Sertraline|sertraline|mesh-list
44412716|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
44412717|NCT02417064|Esketamine|esketamine|mesh-list
44412718|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44412719|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44412720|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44412721|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412722|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412723|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
44412724|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412725|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44412775|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44412776|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
44412777|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44412779|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44412780|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44412781|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412782|NCT02415400|Aspirin|aspirin|mesh-list
44412783|NCT02415400|Vitamin K|vitamin k|mesh-list
44412784|NCT02415400|Apixaban|apixaban|mesh-list
44412785|NCT02415400|Vitamins|vitamins|mesh-ancestor
44412786|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
44412787|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412788|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841106|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841107|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43841108|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841110|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841111|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
43841112|NCT04652414|Hormones|hormones|mesh-ancestor
43841113|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43792684|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412789|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44412790|NCT02415400|Analgesics|analgesics|mesh-ancestor
44412791|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
44412792|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44412793|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44412794|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44412795|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44412796|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44412797|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412798|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44412799|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44412800|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44412801|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
44412802|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44412825|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412826|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44412827|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44412828|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
44412829|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
44412830|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44412831|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44412894|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
44412895|NCT02412761|Diuretics|diuretics|mesh-list
44412896|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44412897|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44412898|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44412899|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44412900|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412961|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44412962|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
44412963|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44412964|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44412965|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412966|NCT02412618|Misoprostol|misoprostol|mesh-list
44412967|NCT02412618|Mifepristone|mifepristone|mesh-list
44412968|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44412969|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
44412970|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44412971|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44412972|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44412973|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44412974|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
44412975|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44412976|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44412977|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44412978|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44412979|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
44413014|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413015|NCT02411591|Necitumumab|necitumumab|mesh-list
44413016|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413017|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413018|NCT02411578|Glucagon|glucagon|mesh-list
44413019|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44413020|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413021|NCT02411578|Hormones|hormones|mesh-ancestor
44413022|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413023|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413024|NCT02411578|Incretins|incretins|mesh-ancestor
44413025|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44413075|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413076|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44413078|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413079|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413080|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
44413081|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413082|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
44413083|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44413084|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44413085|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44413086|NCT02410278|Montelukast|montelukast|mesh-list
44413087|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413088|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413089|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44413090|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
44413132|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413133|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44413134|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
44413135|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413136|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
44413137|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413138|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413139|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44413140|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
44413141|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413142|NCT02408523|Lacosamide|lacosamide|mesh-list
44413143|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44413144|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
43792856|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
43792857|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43792858|NCT04943679|Interferons|interferons|mesh-list
43792859|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
43792860|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792861|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
43792862|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792863|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
43792864|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792865|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
43792875|NCT04892459|Vaccines|vaccines|mesh-list
44413145|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44413146|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44413147|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413190|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44413191|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
44413192|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413193|NCT02407704|Lorazepam|lorazepam|mesh-list
44413194|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44413195|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44413196|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44413197|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413198|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413199|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413200|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413201|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44413202|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
44413203|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413204|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
44413205|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
44413206|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
44413207|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413208|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413209|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44413210|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413211|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413212|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413213|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
44413214|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
44413215|NCT02407223|Ustekinumab|ustekinumab|mesh-list
44413237|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44413238|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44413239|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44413240|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44413241|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44413242|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413243|NCT02406586|Analgesics|analgesics|mesh-ancestor
44413244|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
44413245|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413246|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413247|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413249|NCT02406261|Donepezil|donepezil|mesh-list
44413250|NCT02406261|Simvastatin|simvastatin|mesh-list
44413251|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413252|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44413253|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413254|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413255|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413256|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413257|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413258|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44413259|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
44413260|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
44413261|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
44413262|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
44413263|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413264|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413265|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44413266|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44413283|NCT02405780|Adalimumab|adalimumab|mesh-list
44413284|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413285|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413286|NCT02404805|Dolutegravir|dolutegravir|mesh-list
44413287|NCT02404805|Simeprevir|simeprevir|mesh-list
44413288|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44413289|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44413290|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413291|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413348|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413349|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413350|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413351|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413352|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413353|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44413354|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
44413355|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
44413356|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
44413357|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
44413358|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413359|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413361|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413362|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413363|NCT02402933|Glucagon|glucagon|mesh-list
44413408|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44413409|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44413410|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44413411|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
44413412|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413413|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413414|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44413415|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44413416|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44413417|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44413418|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44413419|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
44413420|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413421|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44413422|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44413423|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44413424|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44413426|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413427|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44413428|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44413429|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44413430|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44413431|NCT02401230|Tenofovir|tenofovir|mesh-list
44413432|NCT02401230|Emtricitabine|emtricitabine|mesh-list
44413434|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
44413452|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44413453|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413454|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413455|NCT02400580|Acetaminophen|acetaminophen|mesh-list
44413456|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44413522|NCT02397889|Midazolam|midazolam|mesh-list
44413523|NCT02397889|Ketamine|ketamine|mesh-list
44413524|NCT02397889|Analgesics|analgesics|mesh-ancestor
44413525|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
44413526|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413527|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413528|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44413529|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44413530|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
44413531|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
44413532|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413533|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44413534|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44413535|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413536|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413537|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413538|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44413539|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413540|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413541|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413542|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
44413543|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
44413544|NCT02397837|Pramipexole|pramipexole|mesh-list
44413545|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
44413546|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413547|NCT02397837|Protective Agents|protective agents|mesh-ancestor
44413548|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413549|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44413550|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44413551|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
44413552|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
44413553|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413554|NCT02397694|Dolutegravir|dolutegravir|mesh-list
44413555|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44413556|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44413557|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413559|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44413562|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413563|NCT02397408|Choline|choline|mesh-list
44413564|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
44413565|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44413566|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
44413567|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413568|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44413569|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44413571|NCT02397096|Ritonavir|ritonavir|mesh-list
44413572|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44413573|NCT02397096|Tenofovir|tenofovir|mesh-list
44413574|NCT02397096|Lamivudine|lamivudine|mesh-list
44413626|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44413627|NCT02396316|Growth Substances|growth substances|mesh-ancestor
44413628|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413629|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
43792905|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
43792906|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792907|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43792908|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43841153|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
44413630|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413631|NCT02395653|Fentanyl|fentanyl|mesh-list
44413632|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44413633|NCT02395653|Narcotics|narcotics|mesh-ancestor
44413634|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413635|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413636|NCT02395653|Analgesics|analgesics|mesh-ancestor
44413637|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
44413638|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44413639|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44413640|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44413641|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
44413642|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
44413643|NCT02395627|Tamoxifen|tamoxifen|mesh-list
44413644|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
44413645|NCT02395627|Vorinostat|vorinostat|mesh-list
44413646|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413647|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413648|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44413649|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
44413650|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413676|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44413677|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44413678|NCT02394730|Vorapaxar|vorapaxar|mesh-list
44413679|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44413680|NCT02394665|Temozolomide|temozolomide|mesh-list
44413681|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44413682|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
44413683|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413684|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413686|NCT02394340|Omeprazole|omeprazole|mesh-list
44413742|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413743|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413744|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413745|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413746|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413747|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413748|NCT02392377|Leucovorin|leucovorin|mesh-list
44413749|NCT02392377|Paclitaxel|paclitaxel|mesh-list
44413750|NCT02392377|Carboplatin|carboplatin|mesh-list
44413751|NCT02392377|Fluorouracil|fluorouracil|mesh-list
44413752|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
44413753|NCT02392377|Calcium|calcium|mesh-list
44413754|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
44413755|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44413767|NCT02392377|Antidotes|antidotes|mesh-ancestor
44413804|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
44413805|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44413806|NCT02390531|Bevacizumab|bevacizumab|mesh-list
44413807|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413808|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413809|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44413810|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44413811|NCT02390531|Growth Substances|growth substances|mesh-ancestor
44413812|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413813|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
44413814|NCT02390362|Rituximab|rituximab|mesh-list
44413815|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44413816|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413817|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
44413866|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44413867|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413868|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413869|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44413870|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
44413871|NCT02389816|Vortioxetine|vortioxetine|mesh-list
44413872|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
44413873|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44413874|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44413875|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44413876|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44413877|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413888|NCT02389764|Nintedanib|nintedanib|mesh-list
44413929|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
44413930|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413931|NCT02387983|Posaconazole|posaconazole|mesh-list
44413932|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
44413933|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44413934|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44413935|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44413936|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44413937|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44413938|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44413939|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413940|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413941|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44413942|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
44413943|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44413944|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44413945|NCT02387957|Bevacizumab|bevacizumab|mesh-list
44413946|NCT02387957|Ranibizumab|ranibizumab|mesh-list
44413985|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44413986|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413987|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44413988|NCT02387372|Renal Agents|renal agents|mesh-ancestor
44413990|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44413991|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44413992|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44413993|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44413994|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44413995|NCT02387164|Vitamin D|vitamin d|mesh-list
44413996|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
44413997|NCT02387164|Vitamins|vitamins|mesh-ancestor
44413998|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
44413999|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414000|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44414001|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44414002|NCT02386839|Mecasermin|mecasermin|mesh-list
44414003|NCT02386839|Growth Substances|growth substances|mesh-ancestor
44414004|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414005|NCT02386098|Ritonavir|ritonavir|mesh-list
44414006|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44414007|NCT02386098|Tenofovir|tenofovir|mesh-list
44414008|NCT02386098|Dolutegravir|dolutegravir|mesh-list
44414009|NCT02386098|BMS-955176|bms-955176|mesh-list
44414010|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44414011|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44414012|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
44414013|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414015|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44414032|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414033|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
44414034|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414035|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
44414036|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44414037|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44414038|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414039|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
44414040|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414041|NCT02385669|Ipilimumab|ipilimumab|mesh-list
44414042|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414043|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414044|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44414045|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414046|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
44414047|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44414048|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414049|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414050|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414051|NCT02384850|Leucovorin|leucovorin|mesh-list
44414052|NCT02384850|Folic Acid|folic acid|mesh-list
44414053|NCT02384850|Fluorouracil|fluorouracil|mesh-list
44414054|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
44071714|NCT00001495|Irinotecan|irinotecan|mesh-list
44414055|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
44414056|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
44414057|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414058|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414063|NCT02384850|Antidotes|antidotes|mesh-ancestor
44414075|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414076|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
44414077|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414078|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44414079|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44414080|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44414081|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44414082|NCT02383966|Cisplatin|cisplatin|mesh-list
43841195|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841196|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841199|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44414083|NCT02383966|Carboplatin|carboplatin|mesh-list
44414084|NCT02383966|Fluorouracil|fluorouracil|mesh-list
44414085|NCT02383966|Cetuximab|cetuximab|mesh-list
44414086|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414087|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
44414088|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414089|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414090|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414091|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
44414092|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414097|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414130|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
44414131|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414132|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
44414133|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44414134|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44414135|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
44414136|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414137|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44414138|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44414139|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414140|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414141|NCT02382640|Febuxostat|febuxostat|mesh-list
44414142|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
44414143|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414144|NCT02382276|Nalmefene|nalmefene|mesh-list
44414145|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44414189|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44414190|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
44414191|NCT02379390|Hormones|hormones|mesh-ancestor
44414192|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44414193|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414194|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44414195|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414196|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44414197|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414198|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414199|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
44414200|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44414201|NCT02379221|Lidocaine|lidocaine|mesh-list
44414202|NCT02379221|Epinephrine|epinephrine|mesh-list
44414203|NCT02379221|Benzocaine|benzocaine|mesh-list
44414204|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
44414205|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
44414206|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414207|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414208|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
44414209|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414210|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44414211|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44414212|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44414213|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44071945|NCT00001696|Genistein|genistein|mesh-list
44414214|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414215|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44414224|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
44414233|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414234|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414235|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414236|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
44414237|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414238|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414239|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414240|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414241|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44414242|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414243|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
44414244|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414245|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414247|NCT02379091|Protective Agents|protective agents|mesh-ancestor
44414248|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
44414249|NCT02379091|Vitamins|vitamins|mesh-ancestor
44414250|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
44414251|NCT02379091|Hematinics|hematinics|mesh-ancestor
44414252|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
44414253|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44414254|NCT02378961|Velpatasvir|velpatasvir|mesh-list
44414255|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
44414256|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414257|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
44414258|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44414259|NCT02378935|Velpatasvir|velpatasvir|mesh-list
44414260|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
44414261|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414262|NCT02378506|Etanercept|etanercept|mesh-list
44414263|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44414264|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44414265|NCT02378506|Analgesics|analgesics|mesh-ancestor
44414266|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
44414267|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414268|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414269|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44414272|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414273|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
44414274|NCT02378480|Linezolid|linezolid|mesh-list
44414275|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414276|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414277|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44414278|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414279|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414280|NCT02376790|Etanercept|etanercept|mesh-list
44414281|NCT02376790|Methotrexate|methotrexate|mesh-list
44414282|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44414283|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
44414284|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414285|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414286|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414287|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
44414289|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414330|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
44414331|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44414332|NCT02374957|Protective Agents|protective agents|mesh-ancestor
44414333|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44414334|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44414335|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414336|NCT02374853|Vancomycin|vancomycin|mesh-list
44414337|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414338|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414339|NCT02374099|Azacitidine|azacitidine|mesh-list
44414340|NCT02374099|Fulvestrant|fulvestrant|mesh-list
44414341|NCT02374099|Cc-486|cc-486|mesh-list
44414342|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44414343|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
44414344|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414345|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414346|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414347|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44414348|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44414349|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44414350|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
44414351|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44414352|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414353|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
44414354|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
44414355|NCT02374021|Adalimumab|adalimumab|mesh-list
44414356|NCT02374021|Etanercept|etanercept|mesh-list
43762120|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43762121|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44414357|NCT02374021|Methotrexate|methotrexate|mesh-list
44414358|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44414359|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
44414372|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414373|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44414375|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44414376|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44414377|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414378|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44414379|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44414380|NCT02374021|Analgesics|analgesics|mesh-ancestor
44414381|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
44414382|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414383|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414384|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
44414385|NCT02373202|Mizoribine|mizoribine|mesh-list
44414386|NCT02373202|Bucillamine|bucillamine|mesh-list
44414387|NCT02373202|Tacrolimus|tacrolimus|mesh-list
44414388|NCT02373202|Leflunomide|leflunomide|mesh-list
44414389|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414390|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
44414391|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414392|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44414393|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414394|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414395|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414396|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44414397|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44414398|NCT02373202|Analgesics|analgesics|mesh-ancestor
44414399|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
44414400|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414401|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44414402|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414403|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414404|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
44414405|NCT02373202|Protective Agents|protective agents|mesh-ancestor
44414406|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44414407|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44414408|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414409|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
44414410|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44414412|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44414413|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44414414|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414415|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414416|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
44414417|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414418|NCT02372799|Fluoxetine|fluoxetine|mesh-list
44414419|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
43601846|NCT03260439|Tramadol|tramadol|mesh-list
43793051|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
43793052|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793053|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793054|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43793055|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414420|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44414421|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44414422|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414423|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414424|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414425|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
44414426|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414427|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44414428|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
44414429|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414430|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44414431|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44414432|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414458|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414459|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414460|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44414461|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414462|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44414463|NCT02372006|Afatinib|afatinib|mesh-list
44414464|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414465|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44414466|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414467|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414468|NCT02371980|Vortioxetine|vortioxetine|mesh-list
44414469|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
44414470|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414471|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44414472|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44414473|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414474|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414475|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44414476|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44414477|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44414478|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414479|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414480|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
44414481|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44414482|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44414483|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44414484|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44414485|NCT02371759|Anesthetics|anesthetics|mesh-list
44414486|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414487|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414488|NCT02371746|Travoprost|travoprost|mesh-list
44414489|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44414496|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414497|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414498|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44414499|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
44414500|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
44414501|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414502|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44414503|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44414504|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44414505|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44414506|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414507|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414508|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44414509|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44414510|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44414511|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
44414512|NCT02371616|Listerine|listerine|mesh-list
44414513|NCT02371616|Calcium|calcium|mesh-list
44414514|NCT02371616|Fluorides|fluorides|mesh-list
44414515|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
44414516|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
44414517|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44414518|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414519|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
44414520|NCT02371616|Protective Agents|protective agents|mesh-ancestor
43824973|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44414521|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44414522|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414524|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
44414525|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414526|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44414527|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44414528|NCT02370888|Growth Substances|growth substances|mesh-ancestor
44414529|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
44414537|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44414538|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414539|NCT02370615|Itraconazole|itraconazole|mesh-list
44414540|NCT02370615|Digoxin|digoxin|mesh-list
44414541|NCT02370615|Midazolam|midazolam|mesh-list
44414542|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
44414543|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44414544|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44414545|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44414546|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414547|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44414548|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44414549|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44414550|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44414551|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
44414552|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
44414553|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
44414554|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
44414555|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414556|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414557|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
44414558|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414559|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44414560|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44414561|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414562|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44414563|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
44414564|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44414565|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44414566|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44414567|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44414568|NCT02370615|Protective Agents|protective agents|mesh-ancestor
44414569|NCT02370498|Paclitaxel|paclitaxel|mesh-list
44414570|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
44414577|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414579|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414580|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414581|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414582|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414583|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414584|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414585|NCT02370095|Treprostinil|treprostinil|mesh-list
44414586|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44414587|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44414588|NCT02369874|Durvalumab|durvalumab|mesh-list
44414589|NCT02369874|Tremelimumab|tremelimumab|mesh-list
44414590|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44414591|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414592|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414593|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
44414594|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414596|NCT02369510|Racepinephrine|racepinephrine|mesh-list
44414597|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
44414598|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44414599|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44414600|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44414601|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44414602|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414603|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414604|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44414605|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44414626|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44414627|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414628|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
44414630|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
44414631|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44414632|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44414633|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414634|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44414635|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44414636|NCT02367781|Paclitaxel|paclitaxel|mesh-list
44414637|NCT02367781|Carboplatin|carboplatin|mesh-list
44414638|NCT02367781|Pemetrexed|pemetrexed|mesh-list
44414639|NCT02367781|Atezolizumab|atezolizumab|mesh-list
44414640|NCT02367781|Antibodies|antibodies|mesh-list
44414641|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44414642|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414643|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414644|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414645|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414646|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414647|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414648|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
44414653|NCT02367352|Paclitaxel|paclitaxel|mesh-list
44414678|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44414679|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
44414680|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414681|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44414682|NCT02366468|Ranibizumab|ranibizumab|mesh-list
44414683|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44414684|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44414685|NCT02366468|Growth Substances|growth substances|mesh-ancestor
44414686|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414687|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
44414688|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414689|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44414690|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414691|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414692|NCT02366143|Paclitaxel|paclitaxel|mesh-list
44414693|NCT02366143|Bevacizumab|bevacizumab|mesh-list
44414694|NCT02366143|Carboplatin|carboplatin|mesh-list
44414695|NCT02366143|Atezolizumab|atezolizumab|mesh-list
44414696|NCT02366143|Antibodies|antibodies|mesh-list
44414697|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44414698|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44414699|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414700|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414701|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414702|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414704|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414726|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414727|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414728|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414729|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414730|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44414731|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44414732|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
44414733|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414734|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44414735|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
44414736|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
44414737|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
44414738|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
44414739|NCT02365584|Lanreotide|lanreotide|mesh-list
44414740|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414741|NCT02365558|Omeprazole|omeprazole|mesh-list
44414742|NCT02365558|Evacetrapib|evacetrapib|mesh-list
44414743|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44414744|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414745|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44414746|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414747|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414748|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44414749|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44414750|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
44414751|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44414752|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44414753|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44414754|NCT02365285|Heparin|heparin|mesh-list
44414755|NCT02365285|Galantamine|galantamine|mesh-list
44414756|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44414757|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
44414758|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44414759|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44414769|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44414770|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
44414771|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44414772|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
44414773|NCT02365233|Insulin|insulin|mesh-list
44414774|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44414775|NCT02365233|Pioglitazone|pioglitazone|mesh-list
44414776|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44414777|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
44414778|NCT02365233|Saxagliptin|saxagliptin|mesh-list
44414779|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44414780|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44414781|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414831|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414832|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44414833|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
44414834|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414835|NCT02363738|Infliximab|infliximab|mesh-list
44414836|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
44414837|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44414838|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44414839|NCT02363478|Buspirone|buspirone|mesh-list
44414840|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44414841|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44414897|NCT02360995|Protective Agents|protective agents|mesh-ancestor
44414898|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414899|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44414900|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414901|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44414902|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44414903|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
44414904|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414905|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44414906|NCT02360475|Vaccines|vaccines|mesh-list
44414907|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
44414908|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414909|NCT02360397|Ranolazine|ranolazine|mesh-list
44414910|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44414913|NCT02360280|Midazolam|midazolam|mesh-list
44414958|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
44414959|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44414960|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
44414961|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44414962|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44414963|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
44414964|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44414965|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44414966|NCT02359552|Rasagiline|rasagiline|mesh-list
44414967|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44414968|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44414969|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44414970|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44414971|NCT02359552|Protective Agents|protective agents|mesh-ancestor
44414972|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415020|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415021|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415022|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
44415023|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
44415024|NCT02358473|Docetaxel|docetaxel|mesh-list
44415025|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
44415026|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415027|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
44415028|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
44415029|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
44415030|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415031|NCT02358369|Timolol|timolol|mesh-list
44415032|NCT02358369|Bimatoprost|bimatoprost|mesh-list
44415033|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44415034|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44415035|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44415036|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44415037|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415038|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415039|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415040|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415041|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44415042|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44415043|NCT02358343|Sertraline|sertraline|mesh-list
44415044|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
44415045|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44415046|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44415047|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44415067|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44415068|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44415069|NCT02357901|Narcotics|narcotics|mesh-ancestor
44415070|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415071|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415072|NCT02357901|Analgesics|analgesics|mesh-ancestor
44415073|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
44415074|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415075|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44415076|NCT02357810|Topotecan|topotecan|mesh-list
44415077|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44415078|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44415079|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415080|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415081|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415082|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44415083|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44415084|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44415085|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44415086|NCT02357459|Triamcinolone|triamcinolone|mesh-list
44415087|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44415088|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44415089|NCT02357459|FX006|fx006|mesh-list
44415090|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44415092|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
44415115|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44415116|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44415117|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415118|NCT02357342|Sirolimus|sirolimus|mesh-list
44415119|NCT02357342|Aflibercept|aflibercept|mesh-list
44415120|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415121|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415122|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415123|NCT02357342|Growth Substances|growth substances|mesh-ancestor
44415124|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415125|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415126|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415127|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415128|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44415129|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
44415130|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415131|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
44415132|NCT02357147|Cisplatin|cisplatin|mesh-list
44415133|NCT02357147|Pemetrexed|pemetrexed|mesh-list
44415173|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415174|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415175|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415177|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44415178|NCT02355028|Acrizanib|acrizanib|mesh-list
44415179|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44415180|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415181|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415182|NCT02355028|Growth Substances|growth substances|mesh-ancestor
44415183|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415184|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415185|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415186|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44415187|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415188|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415189|NCT02354976|Fenofibrate|fenofibrate|mesh-list
44415190|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44415191|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
44415192|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415193|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44415194|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
44415195|NCT02354690|Fludarabine|fludarabine|mesh-list
44415196|NCT02354690|Interleukin-2|interleukin-2|mesh-list
44415197|NCT02354690|Vemurafenib|vemurafenib|mesh-list
44415199|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
43762561|NCT02431208|Hormones|hormones|mesh-ancestor
44415223|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415224|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415225|NCT02354235|Canagliflozin|canagliflozin|mesh-list
44415226|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44415227|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415228|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415229|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415230|NCT02354222|Canagliflozin|canagliflozin|mesh-list
44415231|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44415232|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415233|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415234|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415235|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
44415236|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44415237|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44415238|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44415239|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44415276|NCT02353468|Hormones|hormones|mesh-ancestor
44415277|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415278|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44415279|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415280|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
44415281|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415282|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415283|NCT02353468|Growth Substances|growth substances|mesh-ancestor
44415284|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415285|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
44415286|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44415287|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44415288|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415289|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44415290|NCT02353169|Analgesics|analgesics|mesh-ancestor
44415291|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
44415292|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415293|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44415294|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44415295|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415296|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415297|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415298|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415299|NCT02352090|Dienogest|dienogest|mesh-list
44415300|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43824989|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793143|NCT04288687|Niraparib|niraparib|mesh-list
44415324|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44415325|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415326|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44415327|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415328|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415329|NCT02351934|Celecoxib|celecoxib|mesh-list
44415330|NCT02351934|Furosemide|furosemide|mesh-list
44415331|NCT02351934|Gabapentin|gabapentin|mesh-list
44415332|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44415333|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44415334|NCT02351934|Analgesics|analgesics|mesh-ancestor
44415335|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
44415336|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415337|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415385|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415386|NCT02350309|Lemborexant|lemborexant|mesh-list
44415387|NCT02350309|Flurazepam|flurazepam|mesh-list
44415388|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44415389|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415390|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415391|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44415392|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44415453|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
44415454|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415455|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415456|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44415457|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
44415458|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415459|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415460|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44415461|NCT02348008|Bevacizumab|bevacizumab|mesh-list
44415462|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
44415463|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44415464|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415465|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415466|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415467|NCT02348008|Growth Substances|growth substances|mesh-ancestor
44415468|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415469|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415470|NCT02347813|Pioglitazone|pioglitazone|mesh-list
44415471|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44415472|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415473|NCT02347657|Ivacaftor|ivacaftor|mesh-list
44415474|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44415475|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44415476|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415477|NCT02347631|Dipivefrin|dipivefrin|mesh-list
44415478|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415479|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415480|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415498|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44415499|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44415500|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
44415501|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415502|NCT02347098|Atorvastatin|atorvastatin|mesh-list
44415503|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44415504|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44415505|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44415506|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
44415507|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415508|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44415509|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415510|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
44415560|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415561|NCT02346240|Etanercept|etanercept|mesh-list
44415562|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
44415563|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44415564|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44415565|NCT02346240|Analgesics|analgesics|mesh-ancestor
44415566|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
44415567|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415568|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415569|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44415570|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44415571|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44415572|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415573|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
44415574|NCT02345330|Interleukin-12|interleukin-12|mesh-list
44415575|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44415576|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
44415577|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415578|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44415579|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44415580|NCT02345330|Growth Substances|growth substances|mesh-ancestor
44415581|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
44415582|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415583|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
44415584|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
44415588|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415606|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44415607|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
44415608|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415609|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415610|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44415611|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415612|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
44415613|NCT02345161|Hormones|hormones|mesh-ancestor
44415614|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44415615|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44415616|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44415617|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415668|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
44415669|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44415670|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44415671|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44415672|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415673|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415674|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415675|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44415676|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44415677|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44415678|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
44415679|NCT02343406|Temozolomide|temozolomide|mesh-list
44415680|NCT02343406|Lomustine|lomustine|mesh-list
44415730|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44415731|NCT02342704|Natalizumab|natalizumab|mesh-list
44415732|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44415733|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
44415734|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415735|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44415736|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415737|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44415738|NCT02342639|Rifaximin|rifaximin|mesh-list
44415793|NCT02340962|Ribavirin|ribavirin|mesh-list
44415794|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
44415795|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
44415796|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44415797|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
44415798|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415799|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
44415800|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415801|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
44415802|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44073491|NCT04817254|Nivolumab|nivolumab|mesh-list
44415804|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
44415805|NCT02340949|Aflibercept|aflibercept|mesh-list
44415806|NCT02340949|Fluorouracil|fluorouracil|mesh-list
44415855|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44415856|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44415857|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44415858|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415859|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415860|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44415861|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44415862|NCT02339584|Brinzolamide|brinzolamide|mesh-list
44415863|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44415864|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44415865|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44415874|NCT02339506|Cosyntropin|cosyntropin|mesh-list
44415918|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415919|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44415920|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415921|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
44415922|NCT02337946|Leucovorin|leucovorin|mesh-list
44415923|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
44415924|NCT02337946|Fluorouracil|fluorouracil|mesh-list
44415925|NCT02337946|Panitumumab|panitumumab|mesh-list
44415926|NCT02337946|Calcium|calcium|mesh-list
44415927|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
44415928|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44415929|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44415982|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44415983|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44415984|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
44415985|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
44415986|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44415987|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44415988|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44415989|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44415990|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
44415991|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44415992|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44415993|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
44415994|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44415995|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44415996|NCT02336607|Protective Agents|protective agents|mesh-ancestor
44415997|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44415998|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44415999|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
44416001|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416035|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44416036|NCT02335983|Dexamethasone|dexamethasone|mesh-list
44416037|NCT02335983|Lenalidomide|lenalidomide|mesh-list
44416038|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416039|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
44416040|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
44416041|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416042|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416043|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416044|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
44416046|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416047|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44416048|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416049|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
44416050|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416051|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416052|NCT02335983|Growth Substances|growth substances|mesh-ancestor
44416053|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416054|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
44416055|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416056|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416057|NCT02335411|Cisplatin|cisplatin|mesh-list
44416058|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
44416059|NCT02335411|Capecitabine|capecitabine|mesh-list
44416060|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416061|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416062|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416063|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
44416082|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416083|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416084|NCT02335242|Urological Agents|urological agents|mesh-ancestor
44416085|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
44416086|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44416087|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44416088|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44416089|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416090|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416091|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416092|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416093|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416094|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44416095|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416096|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
44416097|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44416141|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
44416142|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416143|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
44416144|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416145|NCT02332655|Cannabidiol|cannabidiol|mesh-list
44416146|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
44416147|NCT02332590|Adalimumab|adalimumab|mesh-list
44416148|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416149|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416150|NCT02332291|Citalopram|citalopram|mesh-list
44416151|NCT02332291|Bupropion|bupropion|mesh-list
44416152|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44416153|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44416154|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416155|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793226|NCT04140968|Progesterone|progesterone|mesh-list
44416156|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416157|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
44416158|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416159|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44416160|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
44416161|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44416162|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44416163|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
44416164|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44416165|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44416166|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416167|NCT02331680|Tolvaptan|tolvaptan|mesh-list
44416168|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44416187|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416188|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
44416189|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44416190|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416191|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44416192|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44416193|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
44416194|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416195|NCT02329223|Omalizumab|omalizumab|mesh-list
44416196|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44416197|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44416198|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
44416199|NCT02328105|Paclitaxel|paclitaxel|mesh-list
44416200|NCT02328105|Carboplatin|carboplatin|mesh-list
44416201|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44416202|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44416203|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416204|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416205|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
44416206|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
44416243|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416244|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416245|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416246|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
44416247|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44416248|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44416249|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44416250|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44073858|NCT04321954|Lenvatinib|lenvatinib|mesh-list
44416308|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44416309|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
44416310|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416311|NCT02324842|Liraglutide|liraglutide|mesh-list
44416312|NCT02324842|Canagliflozin|canagliflozin|mesh-list
44416313|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416314|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416315|NCT02324842|Incretins|incretins|mesh-ancestor
44416316|NCT02324842|Hormones|hormones|mesh-ancestor
44416317|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416318|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44416319|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416320|NCT02324699|Prednisone|prednisone|mesh-list
44416321|NCT02324699|Vedolizumab|vedolizumab|mesh-list
44416322|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416323|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
44416324|NCT02324699|Hormones|hormones|mesh-ancestor
44416325|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416326|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416327|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44416328|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416329|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44416330|NCT02324270|Diclofenac|diclofenac|mesh-list
44416331|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44416332|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44416333|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44416334|NCT02324270|Analgesics|analgesics|mesh-ancestor
44416335|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
44416336|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416339|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416352|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416353|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44416354|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44416355|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416356|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416357|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44416358|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
44416359|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416360|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416361|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44416362|NCT02322892|Thiamine|thiamine|mesh-list
44416363|NCT02322892|Vitamins|vitamins|mesh-ancestor
44416364|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
44416365|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416366|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
44416367|NCT02322866|Sarecycline|sarecycline|mesh-list
44416368|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416369|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416370|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416371|NCT02322814|Paclitaxel|paclitaxel|mesh-list
44416372|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44416373|NCT02322814|Atezolizumab|atezolizumab|mesh-list
44416374|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44416375|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416376|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416377|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
44416378|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
44416380|NCT02322775|Benralizumab|benralizumab|mesh-list
44416399|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
44416400|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416401|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44416402|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416403|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44416404|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44416405|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44416406|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44416407|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44416408|NCT02322216|Analgesics|analgesics|mesh-ancestor
44416409|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
44416410|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416411|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416412|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416413|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416414|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44416415|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44416416|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44416417|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
44416418|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
44416419|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416420|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416421|NCT02322190|Methoxsalen|methoxsalen|mesh-list
44416422|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44416423|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416447|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416448|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416449|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
44416450|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44416451|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44416452|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44416453|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416454|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416455|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416456|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416457|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416458|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44416459|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416460|NCT02321319|Hydromorphone|hydromorphone|mesh-list
44416461|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44416462|NCT02321319|Narcotics|narcotics|mesh-ancestor
44416463|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44416464|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416465|NCT02321319|Analgesics|analgesics|mesh-ancestor
44416466|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
44416467|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416468|NCT02320721|Insulin|insulin|mesh-list
44416469|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44416470|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
44416471|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416472|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416494|NCT02320058|Nivolumab|nivolumab|mesh-list
44416495|NCT02320058|Ipilimumab|ipilimumab|mesh-list
44416496|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44416497|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416498|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44416499|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416500|NCT02319759|Ustekinumab|ustekinumab|mesh-list
44416501|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416502|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
44416503|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44416504|NCT02319668|Listerine|listerine|mesh-list
44416505|NCT02319668|Fluorides|fluorides|mesh-list
44416506|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
44416507|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
44416508|NCT02319668|Protective Agents|protective agents|mesh-ancestor
44416509|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416510|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44416511|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416554|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44416555|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416556|NCT02318693|Incretins|incretins|mesh-ancestor
44416557|NCT02318693|Hormones|hormones|mesh-ancestor
43841267|NCT04641195|Zinc|zinc|mesh-list
43841268|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
43841269|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841270|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43763100|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763107|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43763108|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43763109|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43763110|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
43763120|NCT02428322|Vitamin D|vitamin d|mesh-list
44416558|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44416559|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44416560|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416561|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416562|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416563|NCT02318667|Golimumab|golimumab|mesh-list
44416564|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44416565|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44416566|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416567|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
44416568|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416569|NCT02318602|Cannabidiol|cannabidiol|mesh-list
44416570|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
44416571|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44416572|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416573|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416574|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416575|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416576|NCT02318095|Gemcitabine|gemcitabine|mesh-list
44416577|NCT02318095|Paclitaxel|paclitaxel|mesh-list
44416578|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44416579|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416580|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
44416581|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
44416582|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
44416583|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416584|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416585|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
44416586|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
44416587|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416588|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416591|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416592|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44416593|NCT02317809|Hormones|hormones|mesh-ancestor
44416617|NCT02316847|Diazepam|diazepam|mesh-list
44416662|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416663|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416664|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
43846557|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
43846558|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
43846559|NCT04192136|Vitamins|vitamins|mesh-ancestor
43846560|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
43793366|NCT05430217|Buspirone|buspirone|mesh-list
43763162|NCT02428062|Phenylephrine|phenylephrine|mesh-list
44416665|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416666|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44416667|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44416668|NCT02315625|Growth Substances|growth substances|mesh-ancestor
44416669|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
44416670|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44416671|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416672|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416673|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44416675|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
44416676|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416677|NCT02314728|Misoprostol|misoprostol|mesh-list
44416678|NCT02314728|Oxytocin|oxytocin|mesh-list
44416679|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
44416719|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
44416720|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44416721|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
44416722|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44416723|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
44416724|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
44416726|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44416727|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
44416728|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416730|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44416786|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416787|NCT02310789|Ivacaftor|ivacaftor|mesh-list
44416788|NCT02310789|Pilocarpine|pilocarpine|mesh-list
44416789|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
44416790|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44416791|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44416792|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416793|NCT02310789|Miotics|miotics|mesh-ancestor
44416794|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
44416795|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44416850|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416851|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416852|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416853|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44416854|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44416855|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
44416856|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44416857|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44416858|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
44416917|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44416918|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44416919|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
44416920|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44416921|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416922|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44416923|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44416924|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
44416925|NCT02308046|Terconazole|terconazole|mesh-list
44416926|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
44416927|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416928|NCT02308033|Metronidazole|metronidazole|mesh-list
44416929|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416930|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416931|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44416932|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44416933|NCT02308007|Metronidazole|metronidazole|mesh-list
44416934|NCT02308007|Terconazole|terconazole|mesh-list
44416935|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44416936|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44416937|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44416938|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44416939|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
44416940|NCT02307682|Aflibercept|aflibercept|mesh-list
44416941|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44416942|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44416968|NCT02305849|Peficitinib|peficitinib|mesh-list
44416969|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44416970|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
44416971|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44416972|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44416973|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44416974|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
44416975|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44416976|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44416977|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
44416978|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417029|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44417030|NCT02305238|Growth Substances|growth substances|mesh-ancestor
44417031|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417032|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
44417033|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417034|NCT02304926|Simvastatin|simvastatin|mesh-list
44417035|NCT02304926|Ezetimibe|ezetimibe|mesh-list
44417036|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
44417037|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44417038|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44417039|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
44417040|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417091|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417092|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
44417093|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417094|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417096|NCT02302807|Docetaxel|docetaxel|mesh-list
44417097|NCT02302807|Atezolizumab|atezolizumab|mesh-list
44417098|NCT02302807|Antibodies|antibodies|mesh-list
44074808|NCT03079440|Capecitabine|capecitabine|mesh-list
44417099|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417100|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417101|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417102|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417103|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417104|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417105|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
44417106|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417107|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44417108|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417110|NCT02302339|Nivolumab|nivolumab|mesh-list
44417127|NCT02301975|Xhance|xhance|mesh-list
44417147|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
44417148|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417149|NCT02301624|Eculizumab|eculizumab|mesh-list
44417150|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44417151|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417152|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
44417153|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417154|NCT02301403|Nicotine|nicotine|mesh-list
44417155|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44417156|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
43793417|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417157|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417158|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417159|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44417160|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44417161|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
44417162|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417163|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417164|NCT02301390|Amiodarone|amiodarone|mesh-list
44417165|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44417166|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
44417167|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44417168|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417169|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417170|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44417171|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44417194|NCT02300610|Gemcitabine|gemcitabine|mesh-list
44417195|NCT02300610|Cisplatin|cisplatin|mesh-list
44417196|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417197|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417198|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
44417199|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417200|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
44417201|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417202|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417203|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417204|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
44417205|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417206|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
44417207|NCT02300311|Capsaicin|capsaicin|mesh-list
44417208|NCT02300311|Nonivamide|nonivamide|mesh-list
44417209|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
44417210|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417211|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417212|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
44417213|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417214|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
44417215|NCT02300311|Vitamins|vitamins|mesh-ancestor
44417216|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
44417217|NCT02300298|Docetaxel|docetaxel|mesh-list
44417218|NCT02300298|Nintedanib|nintedanib|mesh-list
44417219|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417220|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417245|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44417246|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
43795613|NCT03136809|Copper|copper|mesh-list
44417247|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44417248|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44417249|NCT02300259|Urological Agents|urological agents|mesh-ancestor
44417250|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44417251|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44417252|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417253|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44417254|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
44417255|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44417256|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417257|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44417258|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44417259|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417260|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417261|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417262|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44417263|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44417264|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
44417266|NCT02300103|Velpatasvir|velpatasvir|mesh-list
44417295|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44417296|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417297|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
44417298|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417299|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
44417300|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44417301|NCT02299206|Protective Agents|protective agents|mesh-ancestor
44417302|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417303|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
44417304|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417305|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
44417306|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417307|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417308|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44417309|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
44417310|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417311|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417312|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44417313|NCT02298868|Baclofen|baclofen|mesh-list
44417314|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44417315|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417316|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44417317|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417318|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44417319|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
44417320|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
44417321|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417324|NCT02298192|Xultophy|xultophy|mesh-list
44075052|NCT02706873|Methotrexate|methotrexate|mesh-list
44417343|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417344|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
44417345|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
44417346|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44417347|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
44417348|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44417349|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417350|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417351|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
44417352|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417353|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417354|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44417403|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417404|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43793459|NCT05339113|FAPI-46|fapi-46|mesh-list
43793460|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43793560|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43793561|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
43793562|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
43793563|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763401|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763402|NCT02426450|Antidotes|antidotes|mesh-ancestor
43763403|NCT02426450|Protective Agents|protective agents|mesh-ancestor
43763404|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
43763405|NCT02426450|Vitamins|vitamins|mesh-ancestor
43763406|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
43763407|NCT02426229|Dabigatran|dabigatran|mesh-list
43763408|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
43763409|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43763410|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
43763411|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417405|NCT02296840|Narcotics|narcotics|mesh-ancestor
44417406|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417407|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
44417408|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
44417409|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44417410|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
44417411|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417413|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44417414|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44417415|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417416|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44417417|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417418|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
44417419|NCT02296138|Olodaterol|olodaterol|mesh-list
44417420|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44417421|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
44417422|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417423|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417424|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44417425|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
44417453|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44417454|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44417455|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
44417456|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
44417457|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417458|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417459|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44417460|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
44417461|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417462|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44417463|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44417519|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44417520|NCT02294396|Propiverine|propiverine|mesh-list
44417521|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44417522|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44417523|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
44417524|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417525|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417526|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417527|NCT02294396|Urological Agents|urological agents|mesh-ancestor
44417528|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44417529|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44417530|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44417531|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44417532|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
44417533|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
44417534|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846567|NCT04191447|Budesonide|budesonide|mesh-list
43846568|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
43846569|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43846570|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417535|NCT02294058|Interferons|interferons|mesh-list
44417536|NCT02294058|Interferon-beta|interferon-beta|mesh-list
44417537|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
44417538|NCT02294058|Ozanimod|ozanimod|mesh-list
44417539|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417540|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
44417571|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417572|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
44417573|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417574|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44417575|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417576|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
44417577|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417578|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44417579|NCT02293902|Hematinics|hematinics|mesh-ancestor
44417580|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
44417581|NCT02293902|Vitamins|vitamins|mesh-ancestor
44417582|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
44417583|NCT02293863|Oseltamivir|oseltamivir|mesh-list
44417584|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
44417585|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417586|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417587|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417588|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44417589|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44417590|NCT02293395|Aspirin|aspirin|mesh-list
44417591|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
44417592|NCT02293395|Clopidogrel|clopidogrel|mesh-list
44417593|NCT02293395|Ticagrelor|ticagrelor|mesh-list
44417594|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417595|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417596|NCT02293395|Analgesics|analgesics|mesh-ancestor
44417608|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
44417622|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417623|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
44417624|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417625|NCT02292771|Vasotocin|vasotocin|mesh-list
44417626|NCT02292771|Atosiban|atosiban|mesh-list
44417627|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417628|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417629|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417630|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
44417631|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44417632|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
44417633|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44417634|NCT02292719|Ritonavir|ritonavir|mesh-list
44417635|NCT02292719|Ribavirin|ribavirin|mesh-list
44417636|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
44417637|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44417638|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44417639|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44417640|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417641|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417642|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44417643|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44417644|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
44417645|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44417646|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44417647|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44417648|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
44417649|NCT02292238|Benphothiamine|benphothiamine|mesh-list
44417650|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44417651|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
44417652|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417653|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
44417654|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
44417657|NCT02291913|Everolimus|everolimus|mesh-list
44417667|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44417668|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417669|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417670|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44417671|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
44417672|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417673|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44417674|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44417675|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44417676|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44417677|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44417678|NCT02291679|Linaclotide|linaclotide|mesh-list
44417679|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44417680|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
44417681|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417722|NCT02291289|Vemurafenib|vemurafenib|mesh-list
44417723|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417724|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417725|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44417726|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44417727|NCT02291289|Growth Substances|growth substances|mesh-ancestor
44417728|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417729|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
44417730|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417731|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
44417732|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417733|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417734|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
44417735|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44417736|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417737|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44417738|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
44417739|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417740|NCT02290873|Midazolam|midazolam|mesh-list
44417741|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44417745|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44417776|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417777|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417778|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417779|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417780|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417781|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417782|NCT02289690|Carboplatin|carboplatin|mesh-list
44417783|NCT02289690|Etoposide|etoposide|mesh-list
44417784|NCT02289690|Veliparib|veliparib|mesh-list
44417785|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793857|NCT03136029|Antioxidants|antioxidants|mesh-list
44417786|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417787|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44417788|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44417789|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417790|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417791|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44417792|NCT02289456|Paclitaxel|paclitaxel|mesh-list
44417793|NCT02289456|Carboplatin|carboplatin|mesh-list
44417794|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44417795|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44075504|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417796|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
44417797|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
44417798|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44417799|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417800|NCT02289417|Apremilast|apremilast|mesh-list
44417801|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44417802|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44417803|NCT02289417|Analgesics|analgesics|mesh-ancestor
44417804|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
44417805|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44417806|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417815|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44417816|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44417817|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44417818|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
44417819|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44417820|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417821|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417822|NCT02289079|Bupivacaine|bupivacaine|mesh-list
44417823|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
44417824|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
44417825|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44417876|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417878|NCT02287233|Venetoclax|venetoclax|mesh-list
44417879|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44417880|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
44417881|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417882|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417944|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44417945|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
44417946|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44417947|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44417948|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44417949|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
44417950|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44417951|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44417952|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44417953|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44417954|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44417955|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44417956|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44417957|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417958|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44417959|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
44417960|NCT02285062|Hormones|hormones|mesh-ancestor
44417961|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44417998|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44417999|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418000|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44418001|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
44418002|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44418003|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418004|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418005|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418007|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
44418008|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418009|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44418010|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44418011|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44418012|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44418013|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418014|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418015|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
44418016|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418017|NCT02284009|Incretins|incretins|mesh-ancestor
44418018|NCT02284009|Hormones|hormones|mesh-ancestor
44418019|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418020|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
44418021|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44418022|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44418023|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418024|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44418025|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44418026|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418027|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418033|NCT02283762|Riociguat|riociguat|mesh-list
44418040|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
44418041|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418042|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44418043|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44418044|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418045|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418046|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44418047|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
44418106|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418107|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418108|NCT02281773|BI 409306|bi 409306|mesh-list
44418109|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44418110|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418111|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418112|NCT02281760|Trametinib|trametinib|mesh-list
44418113|NCT02281760|Dabrafenib|dabrafenib|mesh-list
44418171|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418173|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44418174|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418175|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418176|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418177|NCT02278614|Timolol|timolol|mesh-list
44418178|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44418179|NCT02278614|Latanoprost|latanoprost|mesh-list
44418180|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44418181|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44418234|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
44418235|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418236|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44418237|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44418238|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43846580|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43654379|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
44418239|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418240|NCT02276872|Treprostinil|treprostinil|mesh-list
44418241|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44418242|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44418243|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44418244|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44418297|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44418299|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
44418300|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
44418301|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44418305|NCT02276027|Ceritinib|ceritinib|mesh-list
44418366|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418368|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418369|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418370|NCT02274792|Analgesics|analgesics|mesh-ancestor
44418371|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
44418372|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418373|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418374|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418375|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418376|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418377|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418378|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
44418379|NCT02274766|Amantadine|amantadine|mesh-list
44418380|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44418381|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44418382|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
44418383|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44076148|NCT00010686|Hormones|hormones|mesh-ancestor
44418384|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
44418419|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418421|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418422|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418423|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
44418424|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418425|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
44418426|NCT02273726|Hematinics|hematinics|mesh-ancestor
44418427|NCT02273180|Insulin|insulin|mesh-list
44418428|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44418429|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
44418430|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
44418431|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418432|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418433|NCT02273050|Metformin|metformin|mesh-list
44418434|NCT02273050|Saxagliptin|saxagliptin|mesh-list
44418435|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44418436|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418437|NCT02273050|Incretins|incretins|mesh-ancestor
44418438|NCT02273050|Hormones|hormones|mesh-ancestor
44418478|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418479|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44418480|NCT02272725|Analgesics|analgesics|mesh-ancestor
44418481|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
44418482|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418483|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418484|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418485|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418486|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44418542|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418543|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418544|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418545|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418546|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44418547|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44418548|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763731|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
44418549|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44418550|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44418551|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418552|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
44418553|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44418554|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44418555|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44418556|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
44418557|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418558|NCT02269943|Azacitidine|azacitidine|mesh-list
44418559|NCT02269943|Cc-486|cc-486|mesh-list
44418560|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44418561|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
44418562|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418563|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418564|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418565|NCT02269670|Tamoxifen|tamoxifen|mesh-list
44418566|NCT02269670|Everolimus|everolimus|mesh-list
44418567|NCT02269670|Letrozole|letrozole|mesh-list
44418568|NCT02269670|Fulvestrant|fulvestrant|mesh-list
44418569|NCT02269670|Anastrozole|anastrozole|mesh-list
44418570|NCT02269670|Megestrol|megestrol|mesh-list
44418587|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44418588|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44418589|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44418590|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44418591|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
44418592|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44418593|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44418594|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44418595|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
44418596|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44418597|NCT02269241|Drospirenone|drospirenone|mesh-list
44418598|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44418599|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
44418603|NCT02269241|Diuretics|diuretics|mesh-ancestor
44418647|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418648|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418649|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
44418650|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44418651|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418652|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418653|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44418654|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418656|NCT02268045|Rituximab|rituximab|mesh-list
44418711|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418713|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44418714|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418715|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418716|NCT02265744|Antibodies|antibodies|mesh-list
44418717|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
44418718|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418719|NCT02265510|Gemcitabine|gemcitabine|mesh-list
44418720|NCT02265510|Dexamethasone|dexamethasone|mesh-list
44418721|NCT02265510|Paclitaxel|paclitaxel|mesh-list
44418722|NCT02265510|Lenalidomide|lenalidomide|mesh-list
44418723|NCT02265510|Azacitidine|azacitidine|mesh-list
44418724|NCT02265510|Bortezomib|bortezomib|mesh-list
44418725|NCT02265510|Pomalidomide|pomalidomide|mesh-list
44418726|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44418727|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418728|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
44418729|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
44418730|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
44418731|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418732|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418733|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
43654385|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418734|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
44418735|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418736|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418737|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418738|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
44418739|NCT02265510|Hormones|hormones|mesh-ancestor
44418740|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44418758|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44076483|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
44418759|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418760|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44418761|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44418762|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
44418763|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418764|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44418765|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44418766|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
44418767|NCT02264990|Paclitaxel|paclitaxel|mesh-list
44418768|NCT02264990|Cisplatin|cisplatin|mesh-list
44418769|NCT02264990|Carboplatin|carboplatin|mesh-list
44418770|NCT02264990|Pemetrexed|pemetrexed|mesh-list
44418771|NCT02264990|Veliparib|veliparib|mesh-list
44418772|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44418773|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418774|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
44418775|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
44418776|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
44418777|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418778|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418782|NCT02264821|Morphine|morphine|mesh-list
44418810|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418811|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
44418812|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44418813|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
44418814|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418815|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418816|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
44418817|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
44418818|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44418819|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418820|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44076559|NCT00012350|Tipifarnib|tipifarnib|mesh-list
44418821|NCT02263365|Loperamide|loperamide|mesh-list
44418822|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
44418823|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418824|NCT02263326|Lamivudine|lamivudine|mesh-list
44418825|NCT02263326|Dolutegravir|dolutegravir|mesh-list
44418826|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44418827|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44418828|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44418829|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418830|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418831|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
44418832|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418833|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44418834|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44418858|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
44418859|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418860|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418861|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418862|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418863|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
44418864|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654386|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
44418865|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418866|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418867|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
44418868|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
44418869|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418870|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
44418871|NCT02262728|Simeprevir|simeprevir|mesh-list
44418872|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
44418873|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44418874|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
44418875|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44418876|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418877|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
44418878|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44418879|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44418880|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44418881|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44418882|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418883|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
44418884|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44418885|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418886|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44418887|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44418888|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
44418889|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44418899|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44418900|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
44418901|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418902|NCT02260934|Acetaminophen|acetaminophen|mesh-list
44418903|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
44418904|NCT02260934|Promethazine|promethazine|mesh-list
44418905|NCT02260934|Prednisone|prednisone|mesh-list
44418906|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
44418907|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44418908|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44418909|NCT02260934|Prednisolone|prednisolone|mesh-list
44418910|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
44418911|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
44418912|NCT02260934|Rituximab|rituximab|mesh-list
44418913|NCT02260934|Belimumab|belimumab|mesh-list
44418914|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44418915|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
44418916|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44418917|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
44418918|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418919|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418921|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
44418955|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418956|NCT02260817|Choline|choline|mesh-list
44418957|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
44418958|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44418959|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
44418960|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44418961|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44418962|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44418963|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
44418964|NCT02260804|Rituximab|rituximab|mesh-list
44418965|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44418966|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44418967|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
44418968|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44418969|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418970|NCT02260791|Adalimumab|adalimumab|mesh-list
44418971|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44418972|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44418973|NCT02260648|Atorvastatin|atorvastatin|mesh-list
44418974|NCT02260648|Ezetimibe|ezetimibe|mesh-list
44418975|NCT02260648|Evacetrapib|evacetrapib|mesh-list
44418976|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44418977|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44418978|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
44419007|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419008|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
44419009|NCT02260492|Hormones|hormones|mesh-ancestor
44419010|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419011|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
44419012|NCT02260388|Mexiletine|mexiletine|mesh-list
44419013|NCT02260388|Pregabalin|pregabalin|mesh-list
44419014|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44419015|NCT02260388|Nortriptyline|nortriptyline|mesh-list
44419016|NCT02260388|Analgesics|analgesics|mesh-ancestor
44419017|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
44419018|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419019|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419020|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
44419021|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44419022|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44419023|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419024|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44419025|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44419026|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44419027|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419028|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44419029|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44419030|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44419031|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419032|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
44419033|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
44419034|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44419035|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44419036|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419037|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44419038|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44419045|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419047|NCT02260154|Alverine|alverine|mesh-list
44419048|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
44419049|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
44419050|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
44419051|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419052|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419053|NCT02259582|Carboplatin|carboplatin|mesh-list
44419055|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419056|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419057|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419058|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44419059|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44419060|NCT02259348|Aldesleukin|aldesleukin|mesh-list
44419108|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419109|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44419110|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
44419111|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419112|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419113|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44419115|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44419116|NCT02258659|Cisplatin|cisplatin|mesh-list
44419117|NCT02258659|Carboplatin|carboplatin|mesh-list
44419118|NCT02258659|Fluorouracil|fluorouracil|mesh-list
44419119|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
44419120|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44419121|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419122|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419123|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419124|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419125|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419126|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
44419127|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419128|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419129|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
44419130|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419131|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
44419132|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419133|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44419134|NCT02258529|Rituximab|rituximab|mesh-list
44419135|NCT02258529|Idelalisib|idelalisib|mesh-list
44419136|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419137|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419138|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
44419139|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419140|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419147|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419148|NCT02258074|Niacinamide|niacinamide|mesh-list
44419150|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
44419151|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
44419152|NCT02258074|Vitamins|vitamins|mesh-ancestor
44419153|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
44419154|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419155|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44419156|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
44419157|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419158|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44419159|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
44419160|NCT02257632|Ranibizumab|ranibizumab|mesh-list
44419161|NCT02257632|Aflibercept|aflibercept|mesh-list
44419162|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44419208|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419209|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419210|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44419211|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
44419212|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
44419213|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44419214|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44419215|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44419216|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44419217|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
44419218|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419219|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419220|NCT02256982|Gemcitabine|gemcitabine|mesh-list
44419221|NCT02256982|Cisplatin|cisplatin|mesh-list
44419269|NCT02256540|Protective Agents|protective agents|mesh-ancestor
43794119|NCT03864094|Ephedrine|ephedrine|mesh-list
44419270|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419271|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44419272|NCT02256436|Paclitaxel|paclitaxel|mesh-list
44419273|NCT02256436|Docetaxel|docetaxel|mesh-list
44419274|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
44419275|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44419276|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419277|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419278|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419279|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419280|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419281|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419282|NCT02256267|Rifampin|rifampin|mesh-list
44419283|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44419284|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
44419285|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44419286|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419287|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
44419288|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44419289|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419290|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419291|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44419292|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44419293|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44419294|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44419295|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44419296|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44419297|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44419298|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
44419300|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
44419309|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419310|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
44419311|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44419312|NCT02255500|Bupivacaine|bupivacaine|mesh-list
44419313|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
44419314|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
44419315|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419316|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419317|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
44419318|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419319|NCT02255461|Palbociclib|palbociclib|mesh-list
44419320|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419321|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44419322|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419323|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419324|NCT02255279|Vaccines|vaccines|mesh-list
44419325|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
44419326|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419327|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
44419328|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44419330|NCT02254772|Ipilimumab|ipilimumab|mesh-list
44419429|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44419430|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419431|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419432|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419433|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419434|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419435|NCT05650151|Vitamin D|vitamin d|mesh-list
44419436|NCT05650151|Vitamins|vitamins|mesh-ancestor
44419437|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
44419438|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419439|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44419440|NCT05650099|Cimetidine|cimetidine|mesh-list
44419441|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44419442|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44419443|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44419487|NCT05649605|Androgens|androgens|mesh-ancestor
44419488|NCT05649605|Hormones|hormones|mesh-ancestor
44419489|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419490|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419491|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419492|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419493|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
44419494|NCT05649540|Amoxicillin|amoxicillin|mesh-list
44419495|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44419496|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419497|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
44419498|NCT05649293|Pyridoxal|pyridoxal|mesh-list
44419499|NCT05649293|Pyridoxine|pyridoxine|mesh-list
44419500|NCT05649293|Vitamins|vitamins|mesh-ancestor
44419501|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
44419502|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419503|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
44419504|NCT05649241|Nicotine|nicotine|mesh-list
44419505|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44419506|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
44419507|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794157|NCT03843970|Bupivacaine|bupivacaine|mesh-list
44419545|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44419546|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419547|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419548|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419549|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419550|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419551|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419552|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
44419553|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419554|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419555|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419556|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
44419557|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44419558|NCT05648734|Pirfenidone|pirfenidone|mesh-list
44419559|NCT05648734|Colchicine|colchicine|mesh-list
44419560|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
44419561|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419562|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
44419563|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
44419564|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
44419565|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419566|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794158|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
43794159|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43794160|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
43794161|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
44419567|NCT05648734|Analgesics|analgesics|mesh-ancestor
44419568|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
44419572|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44419593|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419594|NCT05648448|Oseltamivir|oseltamivir|mesh-list
44419595|NCT05648448|Favipiravir|favipiravir|mesh-list
44419596|NCT05648448|Zanamivir|zanamivir|mesh-list
44419597|NCT05648448|Peramivir|peramivir|mesh-list
44419598|NCT05648448|Baloxavir|baloxavir|mesh-list
44419599|NCT05648448|Laninamivir|laninamivir|mesh-list
44419600|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
44419601|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419660|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419661|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419662|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44419664|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44419665|NCT05647681|Analgesics|analgesics|mesh-ancestor
44419666|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
44419667|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419668|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419669|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
44419670|NCT05647642|Midazolam|midazolam|mesh-list
44419671|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
44419672|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44419673|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419674|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419675|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44419676|NCT05647642|Analgesics|analgesics|mesh-ancestor
44419677|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
44419681|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44419717|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419718|NCT05647356|Bicalutamide|bicalutamide|mesh-list
44419719|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
44419720|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
44419721|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44419722|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419723|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419724|NCT05647343|Ciclopirox|ciclopirox|mesh-list
44419725|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
44419726|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419727|NCT05647330|Gemcitabine|gemcitabine|mesh-list
44419728|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
44419729|NCT05647330|Chloroquine|chloroquine|mesh-list
44419730|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44419731|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
44419732|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44419733|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419734|NCT05647330|Antiviral Agents|antiviral agents|mesh-ancestor
44419735|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419736|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44419737|NCT05647330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419744|NCT05647330|Amebicides|amebicides|mesh-ancestor
44419770|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44419771|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419772|NCT05646810|Lidocaine|lidocaine|mesh-list
44419773|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
44419774|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
44419775|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419776|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419777|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
44419778|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419779|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44419780|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44419781|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44419834|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44419835|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44419836|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419837|NCT05646199|Metformin|metformin|mesh-list
44419838|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44419839|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419840|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44419841|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
44419842|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44419843|NCT05645913|Anticoagulants|anticoagulants|mesh-list
44419844|NCT05645861|Benzocaine|benzocaine|mesh-list
44419846|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
44419901|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44419902|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44419903|NCT05641818|Vitamin D|vitamin d|mesh-list
44419904|NCT05641818|Vitamins|vitamins|mesh-ancestor
44419905|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
44419906|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419907|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44419908|NCT05641480|Donepezil|donepezil|mesh-list
44419909|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44419967|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44419968|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419969|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
44419970|NCT05625594|Fludarabine|fludarabine|mesh-list
44419971|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44419972|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
44419973|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44419974|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44419975|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44419976|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
44419977|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420029|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420030|NCT05598905|Pregabalin|pregabalin|mesh-list
44420031|NCT05598905|Lacosamide|lacosamide|mesh-list
44420032|NCT05598905|Oxycodone|oxycodone|mesh-list
44420033|NCT05598905|Analgesics|analgesics|mesh-ancestor
44420034|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
44420035|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420036|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420037|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
44420038|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44420039|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420040|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420041|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44420042|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44420043|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44420044|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420045|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420046|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44420047|NCT05598905|Narcotics|narcotics|mesh-ancestor
44420048|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44420049|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44420050|NCT05597878|Acetaminophen|acetaminophen|mesh-list
44420083|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44420084|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420085|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420086|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
44420087|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44420088|NCT05595603|Protective Agents|protective agents|mesh-ancestor
44420152|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420153|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44420154|NCT05565235|Narcotics|narcotics|mesh-ancestor
44420155|NCT05565235|Analgesics|analgesics|mesh-ancestor
44420156|NCT05561361|Spironolactone|spironolactone|mesh-list
44420157|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44420158|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
44420159|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44420160|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420161|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44420162|NCT05561361|Diuretics|diuretics|mesh-ancestor
43654402|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44420214|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44420216|NCT05544734|Ibuprofen|ibuprofen|mesh-list
44420217|NCT05544734|Hydrocodone|hydrocodone|mesh-list
44420218|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420219|NCT05544734|Analgesics|analgesics|mesh-ancestor
44420220|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
44420221|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420222|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420223|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
44420224|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44420225|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420226|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44420227|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44420228|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420229|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420230|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44420231|NCT05544734|Narcotics|narcotics|mesh-ancestor
44420232|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420233|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
44420234|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44420235|NCT05544071|Sertraline|sertraline|mesh-list
44420268|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44420269|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44420270|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44420271|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
44420272|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420273|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44420274|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44420275|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420276|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
44420277|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420278|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420279|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44420280|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44420281|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44420282|NCT05468489|Carboplatin|carboplatin|mesh-list
44420283|NCT05468489|Etoposide|etoposide|mesh-list
44420284|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
44420285|NCT05468489|Atezolizumab|atezolizumab|mesh-list
44420286|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420287|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44420288|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44420289|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44420290|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420291|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420299|NCT05438264|Donepezil|donepezil|mesh-list
44420318|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420319|NCT05422703|Analgesics|analgesics|mesh-list
44420320|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
44420321|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420322|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420323|NCT05392972|Anesthetics|anesthetics|mesh-list
44420324|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420325|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420326|NCT05382299|Gemcitabine|gemcitabine|mesh-list
44420327|NCT05382299|Paclitaxel|paclitaxel|mesh-list
44420328|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44420329|NCT05382299|Carboplatin|carboplatin|mesh-list
44420330|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44420331|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420332|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
44420333|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
44420334|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
44420335|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420336|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44420337|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
44420338|NCT05382299|Antiviral Agents|antiviral agents|mesh-ancestor
44420339|NCT05382299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420340|NCT05382299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420341|NCT05382299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44420342|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
44420343|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420344|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
44420364|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
44420365|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420366|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420367|NCT05346393|Terlipressin|terlipressin|mesh-list
44420368|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420369|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44420370|NCT05345678|Durvalumab|durvalumab|mesh-list
44420371|NCT05345678|Tremelimumab|tremelimumab|mesh-list
44420372|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420373|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420374|NCT05341843|Sertraline|sertraline|mesh-list
44420375|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
44420376|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420377|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44420378|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44420379|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420380|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420381|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420382|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
44420383|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420384|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
44420385|NCT05341349|Nivolumab|nivolumab|mesh-list
44420386|NCT05341349|Ipilimumab|ipilimumab|mesh-list
44420387|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420388|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420389|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44420390|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420391|NCT05334108|Ecopipam|ecopipam|mesh-list
44420392|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44420393|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44420394|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420395|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420396|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420397|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44420398|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
44420399|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420403|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420404|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
44420405|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420406|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
44420407|NCT05311475|Azelastine|azelastine|mesh-list
44420408|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420409|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44420410|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44420411|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44420412|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
44420413|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420414|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420415|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44420416|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
44420417|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44420418|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420419|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420420|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44420421|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44420422|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
44420423|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
44420424|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420425|NCT05302297|Cemiplimab|cemiplimab|mesh-list
44420426|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420427|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420428|NCT05299944|Cannabidiol|cannabidiol|mesh-list
44420429|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
44420430|NCT05289050|Ketamine|ketamine|mesh-list
44420431|NCT05289050|Esketamine|esketamine|mesh-list
43794315|NCT03493646|Cc-486|cc-486|mesh-list
44078380|NCT00017069|Dexamethasone|dexamethasone|mesh-list
44420432|NCT05289050|Analgesics|analgesics|mesh-ancestor
44420433|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
44420434|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420435|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420444|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420445|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
44420446|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420447|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
44420448|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44420449|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44420450|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420451|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420452|NCT05287906|Protective Agents|protective agents|mesh-ancestor
44420453|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420454|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44420455|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44420456|NCT05285358|Gemcitabine|gemcitabine|mesh-list
44420457|NCT05285358|Paclitaxel|paclitaxel|mesh-list
44420458|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44420459|NCT05285358|Cisplatin|cisplatin|mesh-list
44420460|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44420461|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420462|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
44420463|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
44420464|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
44420465|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420466|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44420467|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
44420468|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
44420469|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420470|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420495|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420502|NCT05247697|Mirtazapine|mirtazapine|mesh-list
44420503|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
44420504|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44420505|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44420506|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
44420507|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
44420508|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420509|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420510|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420511|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44420512|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44420513|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420514|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44420515|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44420516|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44420517|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
44420518|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44420519|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44420520|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
44420521|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44420522|NCT05244057|Interferons|interferons|mesh-list
44420523|NCT05244057|Tenofovir|tenofovir|mesh-list
44420524|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
44420525|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
44420526|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44420529|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420530|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44420531|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44420532|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420533|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420534|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420535|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420536|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
44420537|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420538|NCT05243797|Lenalidomide|lenalidomide|mesh-list
44420539|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
44420540|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420541|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43764554|NCT02419118|Growth Substances|growth substances|mesh-ancestor
44420542|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44420543|NCT05243797|Growth Substances|growth substances|mesh-ancestor
44420544|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
44420545|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420546|NCT05219669|Nalmefene|nalmefene|mesh-list
44420547|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44420548|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420549|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
44420550|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420551|NCT05214664|Anesthetics|anesthetics|mesh-list
44420552|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420576|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420577|NCT05194735|Aldesleukin|aldesleukin|mesh-list
44420578|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420579|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420580|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420581|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
44420582|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420583|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44420584|NCT05184712|Carboplatin|carboplatin|mesh-list
44420585|NCT05184712|Pemetrexed|pemetrexed|mesh-list
44420586|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420587|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420588|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420589|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44420590|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44420591|NCT05171673|Diclofenac|diclofenac|mesh-list
44420592|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44420593|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44420594|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44420595|NCT05171673|Analgesics|analgesics|mesh-ancestor
44420596|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
44420599|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44420628|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44420629|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420630|NCT05142228|Analgesics|analgesics|mesh-ancestor
44420631|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
44420632|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420633|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420634|NCT05128344|Vigabatrin|vigabatrin|mesh-list
44420635|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
44420636|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420637|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420638|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
44420639|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420640|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420641|NCT05122767|Dolutegravir|dolutegravir|mesh-list
44420642|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44420643|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44420644|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420645|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420646|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44420647|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44420648|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
44420649|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420650|NCT05122026|Isoniazid|isoniazid|mesh-list
44420651|NCT05122026|Rifapentine|rifapentine|mesh-list
44420652|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
44420653|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44420654|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420655|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44420656|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44420657|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
44420658|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420659|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44420660|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44420668|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420669|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420670|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44420671|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420672|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44420673|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44420674|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44420675|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420676|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420677|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44420678|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420679|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420680|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
44420681|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44420682|NCT05096884|Metoprolol|metoprolol|mesh-list
44420683|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44420684|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420685|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
44420686|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
44420687|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420688|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420689|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44420716|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420717|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
44420718|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420720|NCT05059626|Simvastatin|simvastatin|mesh-list
44420721|NCT05059626|Estrogens|estrogens|mesh-list
44420722|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44420723|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44420724|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
44420725|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420726|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44420727|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44420728|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420729|NCT05059626|Hormones|hormones|mesh-ancestor
44420730|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44420731|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420732|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44420733|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44420734|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
44420735|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44420736|NCT05050942|Octreotide|octreotide|mesh-list
44420737|NCT05050942|Lanreotide|lanreotide|mesh-list
44420738|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44420739|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44420740|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420741|NCT05039944|Irinotecan|irinotecan|mesh-list
44420742|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44420743|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44420744|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420745|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420746|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420747|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
44420748|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420749|NCT05031494|Gemcitabine|gemcitabine|mesh-list
44420756|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420757|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44420758|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
44420759|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
44420760|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420761|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420828|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420829|NCT04968522|Methylphenidate|methylphenidate|mesh-list
44420830|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
44420831|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44420832|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420833|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44420834|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44420835|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420839|NCT04957368|Midazolam|midazolam|mesh-list
44420893|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420895|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44420896|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420897|NCT04890106|Bimatoprost|bimatoprost|mesh-list
44420898|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44420899|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44420900|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44420901|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44420902|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
44420903|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420904|NCT04884360|Olaparib|olaparib|mesh-list
44420905|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44420906|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420907|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44420908|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420909|NCT04880707|Anesthetics|anesthetics|mesh-list
44420910|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
44420911|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420912|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420913|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
44420914|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420915|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
44420916|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44420917|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420918|NCT04824794|Daratumumab|daratumumab|mesh-list
44420919|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420920|NCT04824131|Tenofovir|tenofovir|mesh-list
44420921|NCT04824131|Emtricitabine|emtricitabine|mesh-list
44420922|NCT04824131|Cabotegravir|cabotegravir|mesh-list
44420923|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
44420924|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44420925|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44420926|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44420927|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44420932|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44420933|NCT04810494|Lidocaine|lidocaine|mesh-list
44420934|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
44420935|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
44420936|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44420937|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44420938|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
44420939|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44420940|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44420941|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44420942|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44420943|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44420945|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
44420991|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44420992|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44420993|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44420994|NCT04791059|Sufentanil|sufentanil|mesh-list
44420995|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
44420996|NCT04791059|Ketamine|ketamine|mesh-list
44420997|NCT04791059|Esketamine|esketamine|mesh-list
44420998|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44420999|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421000|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421001|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421002|NCT04791059|Analgesics|analgesics|mesh-ancestor
44421003|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
44421004|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421005|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44421006|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44421050|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421051|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421052|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421053|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
44421054|NCT04756726|Hormones|hormones|mesh-ancestor
44421055|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421056|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43794316|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794317|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
44421057|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421058|NCT04745299|Riluzole|riluzole|mesh-list
44421059|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
44421060|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44421061|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44421062|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421111|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421112|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421113|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421114|NCT04718961|Volixibat|volixibat|mesh-list
44421115|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44421116|NCT04691960|Metformin|metformin|mesh-list
44421117|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44421118|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421120|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44421121|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44421122|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44421123|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
44421124|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421125|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421126|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421127|NCT04666636|Urological Agents|urological agents|mesh-ancestor
44421128|NCT04665843|Atezolizumab|atezolizumab|mesh-list
44421129|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421130|NCT04662073|Camostat|camostat|mesh-list
44421131|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
44421132|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421133|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421134|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44421135|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44421136|NCT04660643|Tirzepatide|tirzepatide|mesh-list
44421137|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44421138|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421139|NCT04660643|Incretins|incretins|mesh-ancestor
44421140|NCT04660643|Hormones|hormones|mesh-ancestor
44421142|NCT04659317|Oxycodone|oxycodone|mesh-list
44421156|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421157|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421158|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44421159|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421160|NCT04641273|Pregabalin|pregabalin|mesh-list
44421161|NCT04641273|Analgesics|analgesics|mesh-ancestor
44421162|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
44421163|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421164|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421165|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
44421166|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44421170|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44421216|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44421217|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
44421218|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421219|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421220|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44421221|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44421222|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44421224|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
44421225|NCT04612751|Carboplatin|carboplatin|mesh-list
44421282|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
44421283|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44421284|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421285|NCT04577417|Methylphenidate|methylphenidate|mesh-list
44421286|NCT04577417|Amphetamine|amphetamine|mesh-list
44421287|NCT04577417|Adderall|adderall|mesh-list
44421288|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
44421289|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44421290|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44421291|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421292|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44421293|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44421294|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44421296|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
44421342|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421343|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44421345|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421346|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421348|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
44421349|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421350|NCT04562246|Antibodies|antibodies|mesh-list
44421351|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
44421352|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421353|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
44421354|NCT04561557|Fludarabine|fludarabine|mesh-list
44421364|NCT04557735|Ravulizumab|ravulizumab|mesh-list
44421403|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421404|NCT04530149|Acetaminophen|acetaminophen|mesh-list
44421405|NCT04530149|Bupivacaine|bupivacaine|mesh-list
44421406|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
44421407|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
44421408|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421409|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421410|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
44421411|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421413|NCT04530149|Analgesics|analgesics|mesh-ancestor
44421468|NCT04481009|Paclitaxel|paclitaxel|mesh-list
44421469|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421470|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421471|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
44421472|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
44421473|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
44421474|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421475|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44421476|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
44421477|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
44421478|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421479|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421480|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44421486|NCT04474470|Cetuximab|cetuximab|mesh-list
44421532|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421534|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421535|NCT04454229|Penicillins|penicillins|mesh-list
44421536|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44421537|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421538|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
44421539|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44079578|NCT05485558|Protective Agents|protective agents|mesh-ancestor
44421540|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44421541|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421542|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
44421543|NCT04448184|Coagulants|coagulants|mesh-ancestor
44421544|NCT04431635|Rituximab|rituximab|mesh-list
44421545|NCT04431635|Nivolumab|nivolumab|mesh-list
44421546|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421547|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421589|NCT04373369|Atezolizumab|atezolizumab|mesh-list
44421590|NCT04373369|Vorolanib|vorolanib|mesh-list
44421591|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421592|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44421593|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421594|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421595|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
44421596|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421597|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421598|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
44421599|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
44421656|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421657|NCT04307576|Dexamethasone|dexamethasone|mesh-list
44421658|NCT04307576|Doxorubicin|doxorubicin|mesh-list
44421659|NCT04307576|Vincristine|vincristine|mesh-list
44421660|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
44421661|NCT04307576|Blinatumomab|blinatumomab|mesh-list
44421662|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
44421663|NCT04307576|Thioguanine|thioguanine|mesh-list
44421664|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421665|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
44421666|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
44421667|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421668|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421669|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421717|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44421718|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421719|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
44421720|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421721|NCT04254549|Rifaximin|rifaximin|mesh-list
44421722|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44421723|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421724|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421725|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44421726|NCT04253626|Hematinics|hematinics|mesh-ancestor
44421727|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44421728|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44421729|NCT04246047|Dexamethasone|dexamethasone|mesh-list
44421730|NCT04246047|Bortezomib|bortezomib|mesh-list
44421731|NCT04246047|Daratumumab|daratumumab|mesh-list
44421732|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421733|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
44421734|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
44421735|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421736|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421737|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44421738|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
44421739|NCT04246047|Hormones|hormones|mesh-ancestor
44421740|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44421741|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44421742|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421743|NCT04245215|Ustekinumab|ustekinumab|mesh-list
44421744|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
44421745|NCT04232358|Anesthetics|anesthetics|mesh-list
44421746|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44421747|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421748|NCT04227847|Azacitidine|azacitidine|mesh-list
44421749|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44421750|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
44421751|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421752|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421753|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421755|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44421756|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421757|NCT04224493|Rituximab|rituximab|mesh-list
44421758|NCT04224493|Lenalidomide|lenalidomide|mesh-list
44421759|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44421760|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421761|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
44421762|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421763|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421764|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44421765|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44421768|NCT04222504|Tenofovir|tenofovir|mesh-list
44421818|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44421819|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421820|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44421821|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44421822|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421823|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421824|NCT04166487|Paclitaxel|paclitaxel|mesh-list
44421825|NCT04166487|Carboplatin|carboplatin|mesh-list
44421826|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
44421827|NCT04166487|Pemetrexed|pemetrexed|mesh-list
44421828|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44421829|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421883|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44421884|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
44421885|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44421886|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
44421887|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44421888|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
44421889|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421890|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44421891|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44421892|NCT04093323|Analgesics|analgesics|mesh-ancestor
44421893|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
44421894|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44421895|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44421896|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44421897|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44421898|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44421902|NCT04091867|Cetuximab|cetuximab|mesh-list
44421940|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44421941|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44421943|NCT04016090|Hematinics|hematinics|mesh-ancestor
44421944|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
44421945|NCT04016090|Vitamins|vitamins|mesh-ancestor
44421946|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
44421947|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44421948|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
44421949|NCT04013555|Tryptophan|tryptophan|mesh-list
44422009|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422010|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44422011|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44422012|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44422013|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422014|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422015|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
44422016|NCT03943901|Hormones|hormones|mesh-ancestor
44422017|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422018|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422019|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422020|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422021|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422022|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422023|NCT03943875|Vaccines|vaccines|mesh-list
44422024|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
44422025|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422026|NCT03940352|Venetoclax|venetoclax|mesh-list
44422027|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422028|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
44422029|NCT03939637|Antibodies|antibodies|mesh-list
44422030|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
44422031|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44422032|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44422061|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44422063|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422064|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44422065|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44422066|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422067|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422068|NCT03895099|Desogestrel|desogestrel|mesh-list
44422069|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44422070|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44422071|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44422072|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
44422073|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44422074|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422075|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44422076|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44422077|NCT03895099|Progestins|progestins|mesh-ancestor
44422078|NCT03895099|Hormones|hormones|mesh-ancestor
44422079|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422080|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44422081|NCT03877289|Oxybutynin|oxybutynin|mesh-list
44422082|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422083|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
44422084|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
44422085|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422086|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422087|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44422088|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44422089|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
44422090|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44422092|NCT03877289|Urological Agents|urological agents|mesh-ancestor
44422102|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422103|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422104|NCT03846765|Phenylephrine|phenylephrine|mesh-list
44422105|NCT03846765|Dobutamine|dobutamine|mesh-list
44422106|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
44422107|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44422108|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
44422109|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
44422110|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422111|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422112|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
44422113|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44422114|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
44422115|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
44422116|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44422117|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44422118|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44422119|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
44422120|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44422121|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422158|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422159|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44422160|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
44422161|NCT03781960|Nivolumab|nivolumab|mesh-list
44422162|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422163|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422164|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44422165|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422225|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422226|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422227|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422228|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44422229|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44422230|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422231|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422232|NCT03774641|Lamotrigine|lamotrigine|mesh-list
44422233|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
44422234|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44422235|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44422236|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422237|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44422238|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422239|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44422240|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44422241|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44422242|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44422243|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44422244|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
44422245|NCT03774472|Letrozole|letrozole|mesh-list
44422246|NCT03774472|Palbociclib|palbociclib|mesh-list
44422247|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422248|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44422249|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44422250|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422251|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422252|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44422253|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
44422255|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422267|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422268|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
44422269|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44422270|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422271|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44422272|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44422273|NCT03740204|Estradiol|estradiol|mesh-list
44422274|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44422275|NCT03740204|Progesterone|progesterone|mesh-list
44422276|NCT03740204|Estrogens|estrogens|mesh-ancestor
44422277|NCT03740204|Hormones|hormones|mesh-ancestor
44422278|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422279|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422280|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44422281|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
44422282|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44422283|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44422284|NCT03740204|Progestins|progestins|mesh-ancestor
44422285|NCT03734237|Vaccines|vaccines|mesh-list
44422286|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
44422323|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44422324|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44422325|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422326|NCT03623243|Siponimod|siponimod|mesh-list
44422327|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44422328|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422329|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422330|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
44422331|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422332|NCT03593473|Oxytocin|oxytocin|mesh-list
44422333|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
44422334|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44422335|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422336|NCT03591861|Carmustine|carmustine|mesh-list
44422337|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422338|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
44422339|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422340|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422341|NCT03582176|Ketotifen|ketotifen|mesh-list
44422342|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
44422343|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
44422344|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44422345|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
44422346|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
44422347|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44422348|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422349|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422350|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44422351|NCT03574779|Paclitaxel|paclitaxel|mesh-list
44422352|NCT03574779|Bevacizumab|bevacizumab|mesh-list
44422353|NCT03574779|Carboplatin|carboplatin|mesh-list
44422354|NCT03574779|Niraparib|niraparib|mesh-list
44422364|NCT03574779|Growth Substances|growth substances|mesh-ancestor
44422365|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422366|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
44422367|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44422368|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422369|NCT03573297|Cariprazine|cariprazine|mesh-list
44422370|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44422371|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44422372|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44422373|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422374|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44422375|NCT03569241|Androgens|androgens|mesh-list
44422376|NCT03569241|Hormones|hormones|mesh-ancestor
44422377|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422378|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422380|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
44422421|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44422422|NCT03541902|Growth Substances|growth substances|mesh-ancestor
44422423|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422424|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
44422425|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44422426|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422427|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422428|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44422429|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44422430|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422431|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422437|NCT03508895|Caseins|caseins|mesh-list
44422484|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422485|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422486|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422487|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422488|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422489|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422490|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422491|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
44422492|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422493|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422494|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422495|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
44422496|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422497|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44422498|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44422499|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44422500|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422501|NCT03496662|Gemcitabine|gemcitabine|mesh-list
44422502|NCT03496662|Paclitaxel|paclitaxel|mesh-list
44422503|NCT03496662|Nivolumab|nivolumab|mesh-list
44422504|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422505|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422506|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422507|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422508|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422509|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422510|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422511|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
44422512|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
44422513|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422514|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422515|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422516|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
44422524|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422525|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44422527|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44422528|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422529|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44422530|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
44422531|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422532|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
44422533|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44422534|NCT03401073|Antibodies|antibodies|mesh-list
44422535|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
44422587|NCT03257163|Capecitabine|capecitabine|mesh-list
44422588|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422589|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422590|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422591|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
44422592|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422593|NCT03256149|Dexamethasone|dexamethasone|mesh-list
44422594|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422595|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
44422596|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
44422597|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422598|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422599|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422600|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
44422601|NCT03256149|Hormones|hormones|mesh-ancestor
44422602|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422603|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422643|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422644|NCT03167437|Vorinostat|vorinostat|mesh-list
44422645|NCT03167437|Ustekinumab|ustekinumab|mesh-list
44422646|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422647|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44422648|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422649|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422650|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
44422651|NCT03164473|Rituximab|rituximab|mesh-list
44422652|NCT03164473|Azathioprine|azathioprine|mesh-list
44422653|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422654|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422655|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
44422656|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422657|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422658|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
44422659|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422660|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422661|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422662|NCT03140670|Rucaparib|rucaparib|mesh-list
44422663|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44422664|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422667|NCT03119064|Irinotecan|irinotecan|mesh-list
44422707|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44422708|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
44422723|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
44422724|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
44422725|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44422726|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422727|NCT03033225|Verteporfin|verteporfin|mesh-list
44422728|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44422729|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
44422732|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
44422733|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422734|NCT03003962|Gemcitabine|gemcitabine|mesh-list
44422736|NCT03003962|Cisplatin|cisplatin|mesh-list
44422737|NCT03003962|Carboplatin|carboplatin|mesh-list
44422738|NCT03003962|Pemetrexed|pemetrexed|mesh-list
44422739|NCT03003962|Durvalumab|durvalumab|mesh-list
44422740|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422741|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422742|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422743|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422744|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422745|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422746|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44422747|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
44422748|NCT03003962|Antiviral Agents|antiviral agents|mesh-ancestor
44422749|NCT03003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422750|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422751|NCT03003962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422752|NCT03003962|Immunologic Factors|immunologic factors|mesh-ancestor
44422753|NCT03003962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422754|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44422755|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44422756|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422757|NCT02999477|Paclitaxel|paclitaxel|mesh-list
44422758|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
44422759|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422760|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422761|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
44422762|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
44422763|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
44422764|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422765|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44422766|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
44422769|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
44422772|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422773|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
44422774|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422775|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422776|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422777|NCT02991456|Ondansetron|ondansetron|mesh-list
44422778|NCT02991456|Rolapitant|rolapitant|mesh-list
44422779|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
44422780|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
44422781|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422782|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422783|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422784|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
44422837|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44422838|NCT02960022|Prednisone|prednisone|mesh-list
44422839|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
44422840|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422841|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
44422842|NCT02960022|Hormones|hormones|mesh-ancestor
44422843|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422844|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422845|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422846|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422847|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44422848|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422849|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422850|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
44422851|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44422853|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44422854|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44422855|NCT02944578|Analgesics|analgesics|mesh-ancestor
44422856|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
44422857|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422858|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422859|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422860|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44422861|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422862|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422863|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422864|NCT02917096|Vidarabine|vidarabine|mesh-list
44422865|NCT02917096|Sirolimus|sirolimus|mesh-list
44422866|NCT02917096|Fludarabine|fludarabine|mesh-list
44422867|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
44422868|NCT02917096|Melphalan|melphalan|mesh-list
44422869|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
44422870|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44422871|NCT02917096|Tacrolimus|tacrolimus|mesh-list
44422872|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422877|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
44422878|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422879|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
44422880|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422881|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44422882|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422883|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44422884|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44422885|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
44422886|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44422887|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
44422888|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44422889|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
44422890|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
44422891|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422892|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
44422893|NCT02909335|Prednisone|prednisone|mesh-list
44422894|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
44422895|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44422896|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44422897|NCT02909335|Prednisolone|prednisolone|mesh-list
44422898|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
44422899|NCT02909335|Everolimus|everolimus|mesh-list
44422900|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44422901|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
44422902|NCT02909335|Tacrolimus|tacrolimus|mesh-list
44422903|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44422904|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
44422905|NCT02909335|Hormones|hormones|mesh-ancestor
44422906|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44422907|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422908|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44422909|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422910|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44422911|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
44422912|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44422916|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44422917|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
44422918|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44422919|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44422920|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
44422921|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
44422922|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44422923|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44422924|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44422925|NCT02909335|Protective Agents|protective agents|mesh-ancestor
44422926|NCT02849496|Atezolizumab|atezolizumab|mesh-list
44422927|NCT02849496|Olaparib|olaparib|mesh-list
44080955|NCT03152149|Xhance|xhance|mesh-list
44422928|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44422929|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44422930|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422931|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422932|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422933|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
44422934|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44422935|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44422936|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422937|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422938|NCT02817633|Cisplatin|cisplatin|mesh-list
44422939|NCT02817633|Carboplatin|carboplatin|mesh-list
44422940|NCT02817633|Docetaxel|docetaxel|mesh-list
44422941|NCT02817633|Nivolumab|nivolumab|mesh-list
44422942|NCT02817633|Pemetrexed|pemetrexed|mesh-list
44422943|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422953|NCT02797548|Aspirin|aspirin|mesh-list
44422962|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44422963|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44422964|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44422965|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44422966|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44422967|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44422968|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
44422970|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44422971|NCT02775435|Carboplatin|carboplatin|mesh-list
44422972|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
44422973|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44422974|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44422975|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44423024|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423025|NCT02698254|Growth Substances|growth substances|mesh-ancestor
44423026|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423027|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423028|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
44423029|NCT02696993|Nivolumab|nivolumab|mesh-list
44423030|NCT02696993|Ipilimumab|ipilimumab|mesh-list
44423031|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423032|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423033|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44423034|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423035|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
44423036|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
44423037|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
44423038|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
44423039|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423040|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
44423041|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423042|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423043|NCT02667418|Vancomycin|vancomycin|mesh-list
44423044|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
44423045|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423046|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423047|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
44423048|NCT02619253|Vorinostat|vorinostat|mesh-list
44423049|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423054|NCT02611024|Irinotecan|irinotecan|mesh-list
44423072|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423073|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44423074|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
44423075|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423076|NCT02527707|Ritonavir|ritonavir|mesh-list
44423077|NCT02527707|Lonafarnib|lonafarnib|mesh-list
44423078|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44423079|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44423080|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
44423081|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423082|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423083|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44423084|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44423085|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
44423086|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423087|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44423088|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44423089|NCT02488759|Nivolumab|nivolumab|mesh-list
44423090|NCT02488759|Ipilimumab|ipilimumab|mesh-list
44423091|NCT02488759|Daratumumab|daratumumab|mesh-list
44423092|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423093|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423094|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44423095|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423096|NCT02456974|Amoxicillin|amoxicillin|mesh-list
44423097|NCT02456974|Vancomycin|vancomycin|mesh-list
44423098|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
44423099|NCT02456974|Meropenem|meropenem|mesh-list
44423100|NCT02456974|Tazobactam|tazobactam|mesh-list
44423101|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
44423119|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423120|NCT02334865|Lenalidomide|lenalidomide|mesh-list
44423121|NCT02334865|Sargramostim|sargramostim|mesh-list
44423122|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44423123|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
44423124|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
44423125|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423126|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423127|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423128|NCT02334865|Growth Substances|growth substances|mesh-ancestor
44423129|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423130|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423131|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44423132|NCT02321501|Everolimus|everolimus|mesh-list
44423133|NCT02321501|Ceritinib|ceritinib|mesh-list
44423141|NCT02311179|Cimetidine|cimetidine|mesh-list
44423178|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44423179|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423180|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423181|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44423182|NCT02158052|Tacrolimus|tacrolimus|mesh-list
44423183|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44423184|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423185|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
44423186|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423187|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44423188|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423189|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423190|NCT02106988|Dexamethasone|dexamethasone|mesh-list
44423191|NCT02106988|Carboplatin|carboplatin|mesh-list
44423192|NCT02106988|Etoposide|etoposide|mesh-list
44423193|NCT02106988|Ifosfamide|ifosfamide|mesh-list
44423194|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
44423195|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423196|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
44423197|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
44423201|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
44423232|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423233|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44423235|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44423236|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423237|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
44423238|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
44423239|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423240|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423241|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423295|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44423296|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44423298|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423299|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423300|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
44423301|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423302|NCT01575834|Denosumab|denosumab|mesh-list
44423303|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44423304|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423305|NCT01469156|Ranibizumab|ranibizumab|mesh-list
44423306|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44423307|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44423308|NCT01469156|Growth Substances|growth substances|mesh-ancestor
44423309|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423310|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423311|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423312|NCT01287091|Rabeprazole|rabeprazole|mesh-list
44423313|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44423314|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423315|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44423316|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423327|NCT01258933|Ofatumumab|ofatumumab|mesh-list
44423347|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44423348|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423349|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44423350|NCT01038778|Analgesics|analgesics|mesh-ancestor
44423351|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
44423352|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423353|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423354|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44423355|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44423356|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
44423357|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423358|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44423359|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423360|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423361|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
44423362|NCT01035099|Letrozole|letrozole|mesh-list
44423363|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423364|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44423365|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44423366|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423367|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423372|NCT00942331|Gemcitabine|gemcitabine|mesh-list
44423400|NCT00851136|Growth Substances|growth substances|mesh-ancestor
44423401|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423402|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423403|NCT00679120|Cimetidine|cimetidine|mesh-list
44423404|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44423405|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423406|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44423407|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
44423408|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
44423409|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423410|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423411|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423412|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44423413|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44423414|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423415|NCT00664898|Bortezomib|bortezomib|mesh-list
44423416|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423417|NCT00646204|Memantine|memantine|mesh-list
44423418|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44423419|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44423420|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
44423421|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423422|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423423|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423424|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44423425|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44423426|NCT00630565|Dexamethasone|dexamethasone|mesh-list
44423427|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
44423428|NCT00630565|Busulfan|busulfan|mesh-list
44423429|NCT00630565|Etoposide|etoposide|mesh-list
44423430|NCT00630565|Sargramostim|sargramostim|mesh-list
44423431|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423432|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
44423433|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423441|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
44423442|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
44423443|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423444|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44423445|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
44423446|NCT00630565|Hormones|hormones|mesh-ancestor
44423447|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423448|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423449|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44423450|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44423451|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423453|NCT00434434|Omalizumab|omalizumab|mesh-list
44423575|NCT00098475|Growth Substances|growth substances|mesh-ancestor
44423576|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
44423577|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423578|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
44423579|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44423580|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423581|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
44423583|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44423584|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
44423585|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423586|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423587|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44423588|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
44423589|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
44423590|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44423591|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44423592|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44423593|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44423594|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
44423595|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423596|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423597|NCT05652751|Mitogens|mitogens|mesh-list
44423598|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
44423599|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44081603|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
44423600|NCT05652673|Nivolumab|nivolumab|mesh-list
44423601|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44423605|NCT05652517|Ethanol|ethanol|mesh-list
44423620|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44423621|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423622|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423623|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44423624|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44423625|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
44423626|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
44423627|NCT05651789|Protective Agents|protective agents|mesh-ancestor
44423628|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44423629|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44423632|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44423683|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423684|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423685|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
44423686|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44423687|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44423688|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423689|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423690|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423691|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44423692|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44423694|NCT05651347|Melatonin|melatonin|mesh-list
44423748|NCT05647889|Lidocaine|lidocaine|mesh-list
44081753|NCT01807455|Lidocaine|lidocaine|mesh-list
44423749|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
44423750|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
44423751|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44423752|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423753|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
44423754|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44423755|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44423756|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44423757|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44423758|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44423759|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423760|NCT05639712|Fentanyl|fentanyl|mesh-list
44423807|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423808|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423809|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423810|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
44423811|NCT05605899|Hormones|hormones|mesh-ancestor
44423812|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44423813|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44423814|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44423815|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
44423816|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
44423817|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
44423818|NCT05599984|Cisplatin|cisplatin|mesh-list
44423819|NCT05599984|Carboplatin|carboplatin|mesh-list
44423820|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423868|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44423869|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44423870|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44423871|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44423872|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423873|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
44423874|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44423875|NCT05494619|Antibodies|antibodies|mesh-list
44423876|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
44423877|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44423878|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
44423879|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423880|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44423881|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44423882|NCT05477953|Nifurtimox|nifurtimox|mesh-list
44423929|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44423930|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44423931|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44423933|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44423934|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44423935|NCT05231629|Dexamethasone|dexamethasone|mesh-list
44423936|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
44423937|NCT05231629|Melphalan|melphalan|mesh-list
44423938|NCT05231629|Lenalidomide|lenalidomide|mesh-list
44423939|NCT05231629|Bortezomib|bortezomib|mesh-list
44423940|NCT05231629|Daratumumab|daratumumab|mesh-list
44423941|NCT05231629|BB 1101|bb 1101|mesh-list
44423942|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44423943|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44423944|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
44423992|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44423994|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44423995|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
44423996|NCT05062174|Mifepristone|mifepristone|mesh-list
44423997|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44423998|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
44423999|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44424000|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424001|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44424002|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44424003|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44424053|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
44424054|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
44424055|NCT05020444|Fludarabine|fludarabine|mesh-list
44424056|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424057|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
44424058|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424059|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424060|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424065|NCT04963283|Nivolumab|nivolumab|mesh-list
44424124|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424125|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424126|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
44424127|NCT04827992|Narcotics|narcotics|mesh-ancestor
44424128|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44424129|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424130|NCT04827992|Analgesics|analgesics|mesh-ancestor
44424131|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
44424132|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424133|NCT04825678|Erenumab|erenumab|mesh-list
44424143|NCT04781088|Paclitaxel|paclitaxel|mesh-list
44424186|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424187|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44424188|NCT04746495|Diuretics|diuretics|mesh-ancestor
44424189|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
44424190|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44424191|NCT04745689|Cisplatin|cisplatin|mesh-list
44424192|NCT04745689|Carboplatin|carboplatin|mesh-list
44424193|NCT04745689|Etoposide|etoposide|mesh-list
44424194|NCT04745689|Durvalumab|durvalumab|mesh-list
44424195|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424196|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424197|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424198|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424199|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424200|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424201|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424202|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
44424203|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
44424204|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44424205|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424206|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
44424207|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424208|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424209|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
44082162|NCT01723839|Rituximab|rituximab|mesh-list
44424210|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44424211|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44424212|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424214|NCT04691362|Coagulants|coagulants|mesh-ancestor
44424215|NCT04684212|Warfarin|warfarin|mesh-list
44424216|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
44424217|NCT04684212|Dabigatran|dabigatran|mesh-list
44424218|NCT04684212|Edoxaban|edoxaban|mesh-list
44424219|NCT04684212|Apixaban|apixaban|mesh-list
44424220|NCT04684212|Betrixaban|betrixaban|mesh-list
44424221|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
44424222|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44424223|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
44424224|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44424225|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424226|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424227|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424228|NCT04639219|Trastuzumab|trastuzumab|mesh-list
44424229|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424230|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424231|NCT04626791|Cytarabine|cytarabine|mesh-list
44424232|NCT04626791|Prednisone|prednisone|mesh-list
44424233|NCT04626791|Cortisone|cortisone|mesh-list
44424234|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
44424235|NCT04626791|Rituximab|rituximab|mesh-list
44424236|NCT04626791|Doxorubicin|doxorubicin|mesh-list
44424237|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44424238|NCT04626791|Bortezomib|bortezomib|mesh-list
44424239|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
44424240|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44424241|NCT04626791|Antibodies|antibodies|mesh-list
44424242|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
44424243|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44424244|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424245|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
44424246|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424247|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424248|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44424249|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
44424250|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424251|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424252|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424253|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44424254|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424274|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44424275|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44424276|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424277|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424278|NCT04596826|Hormones|hormones|mesh-ancestor
44424279|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424280|NCT04566653|Calcium|calcium|mesh-list
44424281|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
44424282|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44424283|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424284|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
44424285|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
44424286|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424287|NCT04544293|Molgramostim|molgramostim|mesh-list
44424288|NCT04544293|Sargramostim|sargramostim|mesh-list
44424289|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
44424290|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424291|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424292|NCT04522804|Psilocybin|psilocybin|mesh-list
44424293|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
44424294|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424295|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44424296|NCT04521569|Regadenoson|regadenoson|mesh-list
44424297|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44424298|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44424299|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
44424300|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
44424301|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424302|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424303|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424304|NCT04516447|Gemcitabine|gemcitabine|mesh-list
44082315|NCT01466127|Oxytocin|oxytocin|mesh-list
44424305|NCT04516447|Paclitaxel|paclitaxel|mesh-list
44424306|NCT04516447|Carboplatin|carboplatin|mesh-list
44424307|NCT04516447|Doxorubicin|doxorubicin|mesh-list
44424308|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44424309|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424310|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424311|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424312|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424313|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424314|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424315|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424316|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
44424317|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
44424318|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424319|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424320|NCT04516447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424321|NCT04516447|Immunologic Factors|immunologic factors|mesh-ancestor
44424322|NCT04516447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424323|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44424324|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424325|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424326|NCT04511078|Panitumumab|panitumumab|mesh-list
44424327|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424328|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424329|NCT04501978|Remdesivir|remdesivir|mesh-list
44424330|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
44424331|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
44424332|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424333|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
44424335|NCT04499677|Ritonavir|ritonavir|mesh-list
44424360|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424361|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424362|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
44424363|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424364|NCT04334070|Clofazimine|clofazimine|mesh-list
44424365|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424366|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
44424367|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44424368|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424369|NCT04274894|Testosterone|testosterone|mesh-list
44424370|NCT04274894|Androgens|androgens|mesh-ancestor
44424371|NCT04274894|Hormones|hormones|mesh-ancestor
44424372|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424373|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424374|NCT04274361|Ketamine|ketamine|mesh-list
44424375|NCT04274361|Analgesics|analgesics|mesh-ancestor
44424376|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
44424377|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424378|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424379|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44424380|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44424381|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
44424382|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
44424383|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44424384|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44424409|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44424410|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
44424411|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
44424412|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424413|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424414|NCT04240756|Amphetamine|amphetamine|mesh-list
44424415|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44424416|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424417|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
44424418|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
44424419|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424420|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
44424421|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424422|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424423|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
44424424|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44424425|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44424426|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44424427|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44424428|NCT04234360|Prednisone|prednisone|mesh-list
44424429|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424430|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
44424431|NCT04234360|Hormones|hormones|mesh-ancestor
44424432|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794754|NCT01799629|Glycerol|glycerol|mesh-list
44424433|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424434|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424435|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424436|NCT04227288|Betamethasone|betamethasone|mesh-list
44424437|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
44424453|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44424454|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424456|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
44424457|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424458|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44424460|NCT04216784|Diuretics|diuretics|mesh-ancestor
44424461|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
44424462|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424463|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44424464|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44424465|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424466|NCT04195399|Imidazole|imidazole|mesh-list
44424467|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424468|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424469|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
44424470|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44424471|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
44424472|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424473|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
44424474|NCT04192630|Protective Agents|protective agents|mesh-ancestor
44424475|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
44424476|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44424477|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
44424478|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424479|NCT04152200|Lumasiran|lumasiran|mesh-list
44424480|NCT04152200|Renal Agents|renal agents|mesh-ancestor
44424482|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424499|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
44424500|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424501|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424502|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44424503|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424504|NCT04070573|Aspirin|aspirin|mesh-list
44424505|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44424506|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44424507|NCT04070573|Analgesics|analgesics|mesh-ancestor
44424508|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
44424509|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424510|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424511|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424512|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44424513|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44424556|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
44424557|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424558|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424559|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424560|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
44424561|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424562|NCT03967288|Bupivacaine|bupivacaine|mesh-list
44424563|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
44424564|NCT03967288|Procaine|procaine|mesh-list
44424565|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
44424566|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
44424567|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794906|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43794907|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43794908|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794910|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
43794911|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654411|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
44424568|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424569|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
44424570|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424571|NCT03965468|Paclitaxel|paclitaxel|mesh-list
44424572|NCT03965468|Carboplatin|carboplatin|mesh-list
44424573|NCT03965468|Durvalumab|durvalumab|mesh-list
44424574|NCT03965468|Tremelimumab|tremelimumab|mesh-list
44424575|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424576|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424577|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424578|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424579|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424580|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424581|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424582|NCT03962062|Moxidectin|moxidectin|mesh-list
44424583|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
44424584|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44424585|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424586|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
44424588|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44424589|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
44424590|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424591|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424592|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44424593|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44424598|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424599|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424600|NCT03835676|Treprostinil|treprostinil|mesh-list
44424601|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44424602|NCT03777436|Apremilast|apremilast|mesh-list
44424603|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44424604|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44424605|NCT03777436|Analgesics|analgesics|mesh-ancestor
44424606|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
44424607|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424608|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424660|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
44082654|NCT01057069|Paclitaxel|paclitaxel|mesh-list
44424661|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424663|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
44424664|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
44424665|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424666|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424667|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44424668|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
44424669|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424670|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424671|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44424672|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424673|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44424674|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424675|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424676|NCT03710772|Cytarabine|cytarabine|mesh-list
44424719|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
44424720|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43841484|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841485|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841486|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
43841487|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43841488|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841489|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841490|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841493|NCT04613830|Tramadol|tramadol|mesh-list
44424721|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44424722|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
44424723|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424724|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424725|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424726|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424727|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424728|NCT03659136|Everolimus|everolimus|mesh-list
44424729|NCT03659136|Exemestane|exemestane|mesh-list
44424785|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424786|NCT03583710|Cisplatin|cisplatin|mesh-list
44424787|NCT03583710|Etoposide|etoposide|mesh-list
44424788|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
44424789|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
44424790|NCT03583710|Mitotane|mitotane|mesh-list
44424791|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424792|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424793|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424794|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424795|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424796|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424797|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
44424798|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
44424799|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424800|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424801|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424802|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424803|NCT03542695|Alendronate|alendronate|mesh-list
44424804|NCT03542695|Copper|copper|mesh-list
44424805|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44424806|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424807|NCT03542695|Trace Elements|trace elements|mesh-ancestor
44424808|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
44424809|NCT03525873|Methylphenidate|methylphenidate|mesh-list
44424810|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44424811|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44082802|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424812|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44424813|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44424814|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44424815|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424816|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
44424817|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44424818|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
44424819|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44424820|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
44424822|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424823|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424824|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424825|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
44424826|NCT03518034|Testosterone|testosterone|mesh-list
44424827|NCT03518034|Androgens|androgens|mesh-ancestor
43794995|NCT04498273|Aspirin|aspirin|mesh-list
44424829|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424830|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424831|NCT03471260|Azacitidine|azacitidine|mesh-list
44424832|NCT03471260|Venetoclax|venetoclax|mesh-list
44424833|NCT03471260|Ivosidenib|ivosidenib|mesh-list
44424834|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44424835|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
44424836|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424837|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424838|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424839|NCT03455270|Palbociclib|palbociclib|mesh-list
44424840|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424841|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44424842|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424843|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424844|NCT03418649|Eplerenone|eplerenone|mesh-list
44424846|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
44424875|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44424876|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424877|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44424878|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
44424880|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424881|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424882|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424883|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
44424884|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424885|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424886|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
44424887|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44424888|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44424889|NCT03224507|Growth Substances|growth substances|mesh-ancestor
44424891|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
44424934|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44424935|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
44424936|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424937|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424938|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44424939|NCT02901184|Diuretics|diuretics|mesh-ancestor
44424940|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
44424942|NCT02874430|Doxycycline|doxycycline|mesh-list
44424943|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44424944|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44424945|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44424946|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44424947|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
44424948|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44424949|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44424950|NCT02759419|Riociguat|riociguat|mesh-list
44424951|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
44424952|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44424953|NCT02740699|Atorvastatin|atorvastatin|mesh-list
44424954|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44424955|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44424956|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44424957|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
44424958|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795104|NCT05243290|Niacinamide|niacinamide|mesh-list
44424959|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44424960|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44424961|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44082897|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44424962|NCT02626455|Prednisone|prednisone|mesh-list
44424963|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
44424964|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44424965|NCT02626455|Rituximab|rituximab|mesh-list
44424975|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44424976|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44424977|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44424978|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44424979|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44424980|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44424981|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44424982|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44424983|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
44424984|NCT02626455|Hormones|hormones|mesh-ancestor
44424985|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44424986|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44424987|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44424988|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
44424989|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
44424990|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
44424991|NCT02623205|Citalopram|citalopram|mesh-list
44424992|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44425030|NCT02476786|Anastrozole|anastrozole|mesh-list
44425031|NCT02476786|Goserelin|goserelin|mesh-list
44425032|NCT02476786|Exemestane|exemestane|mesh-list
44425033|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44425034|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425035|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425036|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425037|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44425038|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425039|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44425040|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44425041|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44425042|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44425043|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44425044|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44425045|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425046|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425047|NCT02469519|Dexamethasone|dexamethasone|mesh-list
44425048|NCT02469519|Betamethasone|betamethasone|mesh-list
44425084|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44425085|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44425086|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425087|NCT02375204|Paclitaxel|paclitaxel|mesh-list
44425088|NCT02375204|Etoposide|etoposide|mesh-list
44425089|NCT02375204|Cisplatin|cisplatin|mesh-list
44425090|NCT02375204|Carboplatin|carboplatin|mesh-list
44425091|NCT02375204|Ifosfamide|ifosfamide|mesh-list
44425092|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
44425093|NCT02375204|Lenograstim|lenograstim|mesh-list
44425094|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44425095|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425096|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
44425097|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
44425098|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425099|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425100|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44425108|NCT02263729|Losartan|losartan|mesh-list
44425142|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425143|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425144|NCT01545271|Xenon|xenon|mesh-list
44425145|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44425146|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
44425147|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
44425148|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425149|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425150|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44425151|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
44425152|NCT01439997|Coagulants|coagulants|mesh-ancestor
44425153|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44425154|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425155|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425156|NCT01420250|Bicalutamide|bicalutamide|mesh-list
44425157|NCT01420250|Hormones|hormones|mesh-list
44425158|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44425159|NCT01420250|Androgens|androgens|mesh-list
44425160|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
44425161|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425162|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425163|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
44425164|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425165|NCT01356628|Palbociclib|palbociclib|mesh-list
44425166|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425167|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44425168|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425169|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425170|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44425171|NCT00846430|Interferons|interferons|mesh-list
44425172|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
44425173|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
44425186|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44425187|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
44425188|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
44425189|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425190|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44425191|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425192|NCT00846430|Analgesics|analgesics|mesh-ancestor
44425193|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
44425194|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425252|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425253|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
44425254|NCT02252536|Gabapentin|gabapentin|mesh-list
44425255|NCT02252536|Analgesics|analgesics|mesh-ancestor
44425256|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
44425257|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425258|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425259|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
44425260|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44425261|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44425262|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425263|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44425264|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44425265|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44425266|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425267|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425268|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
44425269|NCT02252406|Ranolazine|ranolazine|mesh-list
44425270|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44425271|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425272|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425273|NCT02252081|Metformin|metformin|mesh-list
44425274|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425275|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425276|NCT02252042|Docetaxel|docetaxel|mesh-list
44425277|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
44425278|NCT02252042|Methotrexate|methotrexate|mesh-list
44425279|NCT02252042|Cetuximab|cetuximab|mesh-list
44425280|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795118|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795243|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795244|NCT04552847|Octreotide|octreotide|mesh-list
43795245|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
43795251|NCT04509401|Vitamins|vitamins|mesh-list
44425298|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44425300|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
44425301|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425302|NCT02251990|Grazoprevir|grazoprevir|mesh-list
44425303|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44425304|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
44425305|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425306|NCT02251912|Oxytocin|oxytocin|mesh-list
44425307|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
44425308|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44425309|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425310|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
44425311|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44425312|NCT02251717|Ledipasvir|ledipasvir|mesh-list
44425313|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
44425314|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425315|NCT02251275|Tolvaptan|tolvaptan|mesh-list
44425316|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44425317|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425318|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425354|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425355|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44425356|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44425357|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44425359|NCT02248961|Losartan|losartan|mesh-list
44425360|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425361|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425362|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44425363|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44425365|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44425414|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44425415|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44425416|NCT02246764|Timolol|timolol|mesh-list
44425417|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44425418|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44425419|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44425420|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425421|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425422|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425423|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425424|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425425|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425426|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44425427|NCT02246673|Febuxostat|febuxostat|mesh-list
44425428|NCT02246673|Verinurad|verinurad|mesh-list
44425429|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
44425430|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425431|NCT02246660|Resveratrol|resveratrol|mesh-list
44425472|NCT02244619|Analgesics|analgesics|mesh-ancestor
44425473|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
44425474|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425475|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425476|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
44425477|NCT02243631|Probenecid|probenecid|mesh-list
44425478|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
44425479|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
44425480|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425481|NCT02243631|Renal Agents|renal agents|mesh-ancestor
44425482|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
44425483|NCT02243371|Nivolumab|nivolumab|mesh-list
44425484|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
44425495|NCT02243293|Ribavirin|ribavirin|mesh-list
44083484|NCT00276757|Vitamins|vitamins|mesh-ancestor
44425535|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44425536|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
44425537|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
44425538|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425539|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425540|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425541|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
44425542|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44425543|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
44425544|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425545|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425546|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44425547|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
44425548|NCT02242201|Ketorolac|ketorolac|mesh-list
44425549|NCT02242201|Epinephrine|epinephrine|mesh-list
44425550|NCT02242201|Bupivacaine|bupivacaine|mesh-list
44425551|NCT02242201|Ropivacaine|ropivacaine|mesh-list
44425552|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
44425553|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
44425554|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425555|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425556|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
44425557|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425558|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44425559|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44425560|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425561|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425562|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425563|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44425564|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44425565|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
44425579|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425580|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425581|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425582|NCT02241889|Pancrelipase|pancrelipase|mesh-list
44425583|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44425584|NCT02241785|Natalizumab|natalizumab|mesh-list
44425585|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
44425586|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425587|NCT02241551|Gemcitabine|gemcitabine|mesh-list
44425588|NCT02241551|Paclitaxel|paclitaxel|mesh-list
44425589|NCT02241551|Fluorouracil|fluorouracil|mesh-list
44425590|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
44425591|NCT02241551|Irinotecan|irinotecan|mesh-list
44425592|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44425593|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425594|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
44425595|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
44425596|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425597|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425598|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44425599|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
44425600|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
44425601|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425602|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425603|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425604|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
44425605|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425606|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44425607|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44425624|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44425625|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425626|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425627|NCT02240680|Linagliptin|linagliptin|mesh-list
44425628|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44425629|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425630|NCT02240680|Incretins|incretins|mesh-ancestor
44425631|NCT02240680|Hormones|hormones|mesh-ancestor
44425632|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425633|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44425634|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
44425635|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425636|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425637|NCT02240628|Lidocaine|lidocaine|mesh-list
44425638|NCT02240628|Tetracaine|tetracaine|mesh-list
44425639|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
44425640|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
44425641|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425642|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425643|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
44425644|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425645|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44425676|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
44425677|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44425678|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
44425679|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425680|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425681|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
44425682|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44425683|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44425684|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44083622|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
44425685|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425686|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425687|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44425688|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44425689|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44425690|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425691|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425692|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425693|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425694|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44425695|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44425696|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
44425697|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44425698|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44425699|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
44425700|NCT02238626|Ibudilast|ibudilast|mesh-list
44425701|NCT02238626|Riluzole|riluzole|mesh-list
44425702|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
44425703|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44425704|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44425705|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425716|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425717|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44425718|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
44425719|NCT02238483|AZD7624|azd7624|mesh-list
44425720|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44425721|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425722|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425723|NCT02238379|Oxytocin|oxytocin|mesh-list
44425724|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
44425725|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44425726|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425727|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
44425728|NCT02238080|Hematinics|hematinics|mesh-ancestor
44425729|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
44425730|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425731|NCT02237157|Gemcitabine|gemcitabine|mesh-list
44425732|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44425733|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
44425734|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425735|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425736|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
44425737|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425738|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425739|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425740|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
44425741|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425742|NCT02236988|Thalidomide|thalidomide|mesh-list
44425743|NCT02236988|Apremilast|apremilast|mesh-list
44425744|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44425745|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44425746|NCT02236988|Analgesics|analgesics|mesh-ancestor
44425747|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
44425748|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44425749|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425750|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44425751|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425752|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44425753|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44425754|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425755|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425756|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425757|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
44425758|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
44425759|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44425760|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44425761|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44425819|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44425820|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425821|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44425822|NCT02235077|Diuretics|diuretics|mesh-ancestor
44425823|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425824|NCT02234596|Nintedanib|nintedanib|mesh-list
44425825|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425826|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44425882|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425883|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
44425884|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425885|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
44425886|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44425887|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44425888|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44425889|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
44425890|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425891|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425892|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425893|NCT02233309|Anesthetics|anesthetics|mesh-list
44425894|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44425895|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425896|NCT02232880|Abatacept|abatacept|mesh-list
44425897|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44425898|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425899|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425900|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425901|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
44425902|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425903|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44425904|NCT02232802|Enoxaparin|enoxaparin|mesh-list
44425905|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
44425906|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
44425927|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425928|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44425930|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425931|NCT02231918|Pramipexole|pramipexole|mesh-list
44425932|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
44425933|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425934|NCT02231918|Protective Agents|protective agents|mesh-ancestor
44425935|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425936|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44425937|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44425938|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
44425939|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
44425940|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425941|NCT02231164|Docetaxel|docetaxel|mesh-list
44425942|NCT02231164|Nintedanib|nintedanib|mesh-list
44425943|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44425944|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
44425945|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
44425946|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44425947|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425948|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44425949|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44425950|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
44425951|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44425952|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44425953|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44425954|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44425961|NCT02230904|Rotigotine|rotigotine|mesh-list
44425972|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44425973|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44425974|NCT02230891|Diuretics|diuretics|mesh-ancestor
44425975|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
44425976|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44425977|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44425978|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44425979|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44425980|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44425991|NCT02230527|Ticagrelor|ticagrelor|mesh-list
44426036|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426037|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44426038|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44426039|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
44426040|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
44426041|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426042|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44426043|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
44426044|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
44426045|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426046|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44426047|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
44426048|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426049|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44426050|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
44426051|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426052|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
44426053|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44426054|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426055|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426056|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426057|NCT02229383|Exenatide|exenatide|mesh-list
44426058|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426059|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426060|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44426061|NCT02229383|Incretins|incretins|mesh-ancestor
44426062|NCT02229383|Hormones|hormones|mesh-ancestor
44426064|NCT02229227|Insulin|insulin|mesh-list
44426071|NCT02229227|Hormones|hormones|mesh-ancestor
44426084|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44426085|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426086|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426087|NCT02228980|Vaccines|vaccines|mesh-list
44426088|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
44426089|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426090|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
44426091|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426092|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426093|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44426094|NCT02228590|Apomorphine|apomorphine|mesh-list
44426095|NCT02228590|Emetics|emetics|mesh-ancestor
44426096|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426097|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
44426098|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426099|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426100|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
44426101|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
44426102|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426103|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426104|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
44426105|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426106|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426107|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
44426108|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426109|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426110|NCT02227849|Canagliflozin|canagliflozin|mesh-list
44426111|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44426112|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426113|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426114|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426115|NCT02227784|Atorvastatin|atorvastatin|mesh-list
44426116|NCT02227784|Ezetimibe|ezetimibe|mesh-list
44426117|NCT02227784|Evacetrapib|evacetrapib|mesh-list
44426118|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44426119|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44426123|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44426124|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426125|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44426127|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426128|NCT02227368|Ticagrelor|ticagrelor|mesh-list
44426129|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426130|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426131|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426132|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44426133|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44426134|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44426135|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
44426136|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426137|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
44426138|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426139|NCT02226653|Evacetrapib|evacetrapib|mesh-list
44426140|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44426141|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44426142|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
44426143|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426144|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44426145|NCT02226562|Listerine|listerine|mesh-list
44426146|NCT02226562|Fluorides|fluorides|mesh-list
44426147|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
44426148|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
44426170|NCT02226003|Glimepiride|glimepiride|mesh-list
44426171|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
44426172|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426173|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426174|NCT02226003|Incretins|incretins|mesh-ancestor
44426175|NCT02226003|Hormones|hormones|mesh-ancestor
44426176|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426177|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44426178|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426179|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426180|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426181|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44426182|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426183|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
44426184|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44426185|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
44426200|NCT02225353|Hormones|hormones|mesh-ancestor
44426228|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426229|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426230|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44426231|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44426232|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
44426233|NCT02224560|Cannabidiol|cannabidiol|mesh-list
44426234|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
44426235|NCT02224391|Nicotine|nicotine|mesh-list
44426236|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44426237|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
44426238|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426239|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426240|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44426241|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44426242|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426243|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426244|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426245|NCT02224274|Clopidogrel|clopidogrel|mesh-list
44426246|NCT02224274|Ticagrelor|ticagrelor|mesh-list
44426247|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426248|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44426249|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44426250|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44426251|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
44426252|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426253|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426254|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426255|NCT02224157|Budesonide|budesonide|mesh-list
44426256|NCT02224157|Terbutaline|terbutaline|mesh-list
44426257|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
44426258|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426259|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44426260|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
44426261|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426262|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426267|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426268|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44426269|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44426270|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44426271|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44426272|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426273|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426274|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
44426275|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
44426276|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44426277|NCT02224053|Osimertinib|osimertinib|mesh-list
44426279|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44426280|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426281|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44426282|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426283|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426284|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426285|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44426286|NCT02223364|Bupivacaine|bupivacaine|mesh-list
44426287|NCT02223364|Ropivacaine|ropivacaine|mesh-list
44426288|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
44426289|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
44426290|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426315|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426317|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
44426318|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44426319|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44426320|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426321|NCT02222558|Testosterone|testosterone|mesh-list
44426322|NCT02222558|Androgens|androgens|mesh-ancestor
44426323|NCT02222558|Hormones|hormones|mesh-ancestor
44426324|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44426325|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426326|NCT02222493|Infliximab|infliximab|mesh-list
44426327|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426377|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
44426378|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426379|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426380|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
44426381|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
44426382|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426383|NCT02220920|Canagliflozin|canagliflozin|mesh-list
44426384|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426385|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426386|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43766979|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44426387|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426388|NCT02220907|Canagliflozin|canagliflozin|mesh-list
44426389|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44426390|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426391|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44426392|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426393|NCT02220894|Paclitaxel|paclitaxel|mesh-list
44426394|NCT02220894|Carboplatin|carboplatin|mesh-list
44426395|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
44426396|NCT02220894|Pemetrexed|pemetrexed|mesh-list
44426397|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44426398|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426399|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
44426400|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
44426401|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
44426402|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426403|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426404|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426405|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44426406|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44426407|NCT02220712|Aripiprazole|aripiprazole|mesh-list
44426408|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
44426409|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44426410|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44426416|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426417|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426418|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44426419|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44426420|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
44426421|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44426422|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44426423|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44426424|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44426425|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
44426479|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44426480|NCT02218372|Vancomycin|vancomycin|mesh-list
44426481|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
44426482|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426483|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426484|NCT02217982|Simethicone|simethicone|mesh-list
44426485|NCT02217982|Loperamide|loperamide|mesh-list
44426486|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
44426487|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44426488|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
44426489|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426490|NCT02217982|Emollients|emollients|mesh-ancestor
44426491|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44426492|NCT02217878|Morphine|morphine|mesh-list
44426493|NCT02217878|Ticagrelor|ticagrelor|mesh-list
44426494|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44426495|NCT02217878|Narcotics|narcotics|mesh-ancestor
44426496|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426497|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426498|NCT02217878|Analgesics|analgesics|mesh-ancestor
44426499|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
44426500|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426501|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426502|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44426503|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44426504|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44426505|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
44426506|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426507|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426508|NCT02217566|Prednisone|prednisone|mesh-list
44426510|NCT02217566|Androgens|androgens|mesh-list
44426525|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44426526|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44426527|NCT02217501|Analgesics|analgesics|mesh-ancestor
44426528|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
44426529|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426530|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426531|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44426532|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426533|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44426534|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44426535|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426536|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426537|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44426538|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426539|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
44426540|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44426541|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44426542|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44426543|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
44426544|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426545|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
44426546|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44426548|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44426574|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44426575|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44426576|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
44426577|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
44426578|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426579|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
44426580|NCT02216812|Vitamins|vitamins|mesh-ancestor
44426581|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
44426582|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426583|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
44426584|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426585|NCT02216812|Protective Agents|protective agents|mesh-ancestor
44426586|NCT02216357|Ifetroban|ifetroban|mesh-list
44426587|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44426588|NCT02216214|Mirabegron|mirabegron|mesh-list
44426589|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44426590|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44426591|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44426592|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
44426593|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426594|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426595|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426596|NCT02216214|Urological Agents|urological agents|mesh-ancestor
44426597|NCT02216123|Chloroquine|chloroquine|mesh-list
44426598|NCT02216123|Primaquine|primaquine|mesh-list
44426600|NCT02216123|Amebicides|amebicides|mesh-ancestor
44426601|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44426602|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44426603|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426604|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
44426623|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426624|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426625|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426626|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44426627|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44426628|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43795403|NCT03882905|Ezetimibe|ezetimibe|mesh-list
44426629|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426630|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
44426631|NCT02215967|Fludarabine|fludarabine|mesh-list
44426632|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44426678|NCT02213094|Niacin|niacin|mesh-list
44426685|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426686|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44426687|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
44426689|NCT02213055|Malathion|malathion|mesh-list
44426690|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426691|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426692|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44426693|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426694|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426695|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426696|NCT02213042|Trastuzumab|trastuzumab|mesh-list
44426697|NCT02213042|Lapatinib|lapatinib|mesh-list
44426746|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44426747|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44426748|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426749|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
44426750|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426751|NCT02210689|Clindamycin|clindamycin|mesh-list
44426752|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
44426753|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
44426754|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426755|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426756|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44426810|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426812|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44426813|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44426814|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44426815|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44426816|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426817|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426818|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426819|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426820|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426821|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44426822|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426823|NCT02207907|Listerine|listerine|mesh-list
44426824|NCT02207907|Fluorides|fluorides|mesh-list
44426825|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
44426869|NCT02207556|Doxycycline|doxycycline|mesh-list
44426870|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44426871|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44426872|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
44426873|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44426874|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44426875|NCT02207530|Durvalumab|durvalumab|mesh-list
44426876|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426877|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426878|NCT02207491|Timolol|timolol|mesh-list
44426879|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44426880|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44426881|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44426882|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44426883|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
44426884|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426885|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426929|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44426930|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44426931|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
44426932|NCT02206685|Methadone|methadone|mesh-list
44426933|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44426934|NCT02206685|Narcotics|narcotics|mesh-ancestor
44426935|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44426936|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426937|NCT02206685|Analgesics|analgesics|mesh-ancestor
44426938|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
44426939|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44426940|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
44426941|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
44426942|NCT02206620|Donepezil|donepezil|mesh-list
44426943|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44426944|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44426945|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426946|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
44426947|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426948|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426981|NCT02204982|Rituximab|rituximab|mesh-list
44426982|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44426983|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44426984|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
44426985|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426986|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44426987|NCT02204410|Methylphenidate|methylphenidate|mesh-list
44426988|NCT02204410|Amphetamine|amphetamine|mesh-list
44426989|NCT02204410|Adderall|adderall|mesh-list
44426990|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
44426991|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44426992|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44426993|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44426994|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44426995|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44426996|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44426997|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
44426998|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44426999|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
44427000|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
44427001|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427002|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
44427003|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44427004|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44427005|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44427006|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44427007|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427008|NCT02203838|Risperidone|risperidone|mesh-list
44427009|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44427010|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
44427011|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427012|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427013|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427014|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44427015|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44427018|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44427019|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
44427020|NCT02203591|Ethanol|ethanol|mesh-list
44427021|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
44427022|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44427023|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44427024|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427025|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427026|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427027|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
44427028|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427029|NCT02203331|Anastrozole|anastrozole|mesh-list
44427030|NCT02203331|Leuprolide|leuprolide|mesh-list
44427031|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
44427032|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44427033|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427034|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44427079|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427080|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427081|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427082|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44427083|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427084|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
44427085|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
44427086|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427087|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44427088|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44427089|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44427090|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427091|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427092|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427093|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
44427094|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
44427095|NCT02202577|Povidone|povidone|mesh-list
44427096|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44427097|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427098|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
44427099|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
44427100|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
44427101|NCT02202551|Amantadine|amantadine|mesh-list
44427102|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44427103|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44427104|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
44427121|NCT02202161|Metformin|metformin|mesh-list
44427128|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44427129|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
44427130|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427131|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427132|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
44427133|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
44427134|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427135|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
44427136|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44427137|NCT02201940|Velpatasvir|velpatasvir|mesh-list
44427138|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
44427139|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427140|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
44427141|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
44427142|NCT02201901|Velpatasvir|velpatasvir|mesh-list
44427143|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
44427144|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427145|NCT02201784|Ropivacaine|ropivacaine|mesh-list
44427146|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
44427147|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
44427148|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
44427149|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427150|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427151|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
44427152|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427153|NCT02201771|Aspirin|aspirin|mesh-list
44427154|NCT02201771|Ticagrelor|ticagrelor|mesh-list
44427155|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44427156|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427174|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427175|NCT02201524|Abrocitinib|abrocitinib|mesh-list
44427176|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427177|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427178|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427179|NCT02201329|Azacitidine|azacitidine|mesh-list
44427180|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44427181|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
44427182|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427183|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427184|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427185|NCT02201251|Topiramate|topiramate|mesh-list
44427186|NCT02201251|Levetiracetam|levetiracetam|mesh-list
44427187|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
44427188|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427189|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427190|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
44427191|NCT02200445|Aldesleukin|aldesleukin|mesh-list
44427192|NCT02200445|Interleukin-2|interleukin-2|mesh-list
44427193|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427194|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44427195|NCT02200445|Analgesics|analgesics|mesh-ancestor
44427196|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
44427197|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427198|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44085225|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
44427199|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44427200|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44427201|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
44427202|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427203|NCT02199509|Levetiracetam|levetiracetam|mesh-list
44427204|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
44427205|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
44427206|NCT02199314|Desflurane|desflurane|mesh-list
44427207|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44427208|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
44427215|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427216|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
44427217|NCT02199080|Coagulants|coagulants|mesh-ancestor
44427218|NCT02198651|Adalimumab|adalimumab|mesh-list
44427219|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427220|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427221|NCT02198235|Dexamethasone|dexamethasone|mesh-list
44427222|NCT02198235|Buprenorphine|buprenorphine|mesh-list
44427223|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427224|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
44427225|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
44427226|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427227|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427228|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44427229|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
44427230|NCT02198235|Hormones|hormones|mesh-ancestor
44427231|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427275|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427276|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427277|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44427278|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44427279|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44427280|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44427281|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44427282|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44427283|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427284|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427285|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
44427286|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
44427287|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44427288|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
44427289|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427290|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427291|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44427292|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
44427293|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44427294|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44427295|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44427296|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
44427297|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427323|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
44427324|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
44427325|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427326|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427327|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427328|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
44427329|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
44427330|NCT02196324|Serlopitant|serlopitant|mesh-list
44427331|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44427332|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427333|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427334|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427335|NCT02196259|Ketamine|ketamine|mesh-list
44427336|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
44427337|NCT02196259|Anesthetics|anesthetics|mesh-list
44427338|NCT02196259|Analgesics|analgesics|mesh-ancestor
44427339|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
44427340|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427341|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427342|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44427343|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
44427344|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427345|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44427346|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44427347|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427372|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
44427373|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427374|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44427375|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44427376|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427377|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427378|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44427379|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44427380|NCT02194998|Ritonavir|ritonavir|mesh-list
44427381|NCT02194998|Ribavirin|ribavirin|mesh-list
44427382|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44427383|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44427384|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
44427385|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427386|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427387|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44427388|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44427389|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
44427390|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44427391|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44427392|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44427393|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
44427394|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
44427395|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
44427396|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427397|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427398|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427399|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
44427417|NCT02194465|Hormones|hormones|mesh-ancestor
44427418|NCT02194062|Fluticasone|fluticasone|mesh-list
44427420|NCT02194062|Budesonide|budesonide|mesh-list
44427421|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427422|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44427423|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
44427424|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427425|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427426|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44427427|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
44427428|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427429|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44427430|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
44427431|NCT02194062|Hormones|hormones|mesh-ancestor
44427432|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427433|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
44427434|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427435|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
44427436|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427437|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427438|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44427439|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
44427440|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427441|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427442|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44427443|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
44427444|NCT02193776|Rifampin|rifampin|mesh-list
44427445|NCT02193776|Isoniazid|isoniazid|mesh-list
44427446|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
44427447|NCT02193776|Ethambutol|ethambutol|mesh-list
44427448|NCT02193776|Bedaquiline|bedaquiline|mesh-list
44427462|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44427463|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44427464|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44427465|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44427466|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44427467|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44427468|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
44427469|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44427470|NCT02193165|Triclosan|triclosan|mesh-list
44427471|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
44427525|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427526|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427527|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
44427528|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427529|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44427530|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
44427531|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427532|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44427533|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44427534|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
44427535|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
44427536|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427537|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44427538|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44427539|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
44427540|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44427541|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
44427542|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44427543|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44427544|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427545|NCT02191137|Riociguat|riociguat|mesh-list
44427546|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
44427547|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427548|NCT02189941|Deferiprone|deferiprone|mesh-list
44427549|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44427550|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
44427551|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
44427573|NCT02188719|Valganciclovir|valganciclovir|mesh-list
44427574|NCT02188719|Ganciclovir|ganciclovir|mesh-list
44427575|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
44427576|NCT02188719|Prednisone|prednisone|mesh-list
44427577|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44427578|NCT02188719|Everolimus|everolimus|mesh-list
44427579|NCT02188719|Liver Extracts|liver extracts|mesh-list
44427580|NCT02188719|Tacrolimus|tacrolimus|mesh-list
44427581|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
44427582|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44427583|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427584|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
44427585|NCT02188719|Hormones|hormones|mesh-ancestor
44427586|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427587|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427588|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44427589|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427590|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427633|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427634|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44427635|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44427636|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427637|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44427638|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44427652|NCT02187861|Rituximab|rituximab|mesh-list
44427653|NCT02187861|Venetoclax|venetoclax|mesh-list
44427654|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44427655|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44427656|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427657|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
44427658|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427659|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44427660|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44427661|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
44427663|NCT02187809|Clobazam|clobazam|mesh-list
44427690|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44427691|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427692|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427693|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44427694|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44427695|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44427696|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427697|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44427698|NCT02187172|Ustekinumab|ustekinumab|mesh-list
44427699|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427700|NCT02187159|Pregabalin|pregabalin|mesh-list
44427701|NCT02187159|Analgesics|analgesics|mesh-ancestor
44427702|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
44427703|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427704|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427705|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
44427715|NCT02187055|Methotrexate|methotrexate|mesh-list
44427746|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44427747|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44427748|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44427749|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427750|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427751|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44427752|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427753|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44427754|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427755|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427756|NCT02186015|Vitamin D|vitamin d|mesh-list
44427757|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
44427758|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
44427759|NCT02186015|Vitamins|vitamins|mesh-list
44427760|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
44427761|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427762|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44427763|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44427764|NCT02185534|Clopidogrel|clopidogrel|mesh-list
44427765|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44427766|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44427767|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44427768|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44427769|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
44427770|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44427792|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44427793|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44427794|NCT02183675|Diuretics|diuretics|mesh-ancestor
44427795|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
44427796|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44427797|NCT02183519|Capsaicin|capsaicin|mesh-list
44427798|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
44427799|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427800|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
44427801|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427802|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427803|NCT02182999|Ropivacaine|ropivacaine|mesh-list
44427804|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
44427805|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
44427806|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427807|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427808|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
44427809|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427810|NCT02182895|Saxagliptin|saxagliptin|mesh-list
44427811|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44427812|NCT02182895|Incretins|incretins|mesh-ancestor
44427813|NCT02182895|Hormones|hormones|mesh-ancestor
44427814|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44427815|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427816|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
44427817|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44427818|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427819|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427820|NCT02182830|Empagliflozin|empagliflozin|mesh-list
44427821|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44427822|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427823|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44427828|NCT02181816|Amlodipine|amlodipine|mesh-list
44427832|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44427833|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427834|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44427835|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427836|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
44427837|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44427838|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44427839|NCT02181790|Acitretin|acitretin|mesh-list
44427840|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
44427841|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
44427842|NCT02181673|Golimumab|golimumab|mesh-list
44427843|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44427844|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427845|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44427846|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
44427847|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427848|NCT02181634|Gemcitabine|gemcitabine|mesh-list
44427849|NCT02181634|Paclitaxel|paclitaxel|mesh-list
44427850|NCT02181634|Antimetabolites|antimetabolites|mesh-list
44427851|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44427852|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427853|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
44427854|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
44427855|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
44427856|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44427857|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44427858|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
44427878|NCT02181296|Ropivacaine|ropivacaine|mesh-list
44427879|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
44427880|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
44427881|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44427882|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44427883|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
44427884|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427885|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
44427886|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427887|NCT02180672|Fluticasone|fluticasone|mesh-list
44427888|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44427889|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44427890|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
44427891|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44427939|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44427940|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427941|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
44427942|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44427943|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44427944|NCT02179177|Apixaban|apixaban|mesh-list
44427945|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44427946|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
44427947|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44427948|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
44427949|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428003|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
43795594|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44428004|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
44428005|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
44428006|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44428007|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44428008|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44428009|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44428010|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428011|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428012|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428013|NCT02177942|Micronutrients|micronutrients|mesh-list
44428014|NCT02177942|Trace Elements|trace elements|mesh-list
44428015|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428016|NCT02177838|Cisplatin|cisplatin|mesh-list
44428017|NCT02177838|Cetuximab|cetuximab|mesh-list
44428018|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44428063|NCT02176655|Analgesics|analgesics|mesh-ancestor
44428064|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
44428065|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428066|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428067|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428068|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428069|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44428070|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44428128|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428129|NCT02176291|Analgesics|analgesics|mesh-ancestor
44428130|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
44428131|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428132|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44428133|NCT02176018|Quinidine|quinidine|mesh-list
44428134|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
44428135|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
44428136|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428137|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44428138|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44428139|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428140|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086173|NCT00020878|Celecoxib|celecoxib|mesh-list
44428141|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428142|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44428186|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44428187|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
44428188|NCT02175771|Hormones|hormones|mesh-ancestor
44428189|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428190|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
44428191|NCT02175758|Ribavirin|ribavirin|mesh-list
44428192|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
44428193|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
44428194|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428195|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
44428196|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428203|NCT02175277|Hematinics|hematinics|mesh-ancestor
44428250|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44428251|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428252|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
44428253|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44428254|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428255|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428256|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428257|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44428258|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428259|NCT02173054|Adapalene|adapalene|mesh-list
44428260|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428312|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
44428313|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44428314|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428315|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44428316|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428317|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428318|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44428319|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
44428320|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44428321|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44428322|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428323|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428324|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44428325|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
44428326|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44428327|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44428328|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428329|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428331|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
44428332|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428333|NCT02169830|Topiramate|topiramate|mesh-list
44428334|NCT02169830|Nortriptyline|nortriptyline|mesh-list
44428335|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
44428336|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44428337|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428338|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44428339|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
44428340|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428341|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44428353|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44428354|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428356|NCT02169414|Carbidopa|carbidopa|mesh-list
44428357|NCT02169414|Opicapone|opicapone|mesh-list
44428358|NCT02169414|Benserazide|benserazide|mesh-list
44428359|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44428360|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44428361|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
44428362|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428363|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428364|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428365|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44428366|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428367|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44428368|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
44428369|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44428370|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428371|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428372|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428373|NCT02169336|Analgesics|analgesics|mesh-ancestor
44428374|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
44428375|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428376|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44428377|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44428378|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44428379|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428380|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428381|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428382|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44428383|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428384|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44428385|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44163993|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44163994|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43654426|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43654427|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44163995|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44163996|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
44163997|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44163998|NCT00254709|Sirolimus|sirolimus|mesh-list
44428386|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428388|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428389|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428390|NCT02169271|Analgesics|analgesics|mesh-ancestor
44428391|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
44428392|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428393|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428394|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428395|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428396|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44428397|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44428398|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428399|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44428400|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44428401|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428402|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
44428403|NCT02169219|Prednisone|prednisone|mesh-list
44428404|NCT02169219|Rituximab|rituximab|mesh-list
44428405|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
44428406|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44428407|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428408|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
44428409|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428410|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428411|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428412|NCT02169219|Hormones|hormones|mesh-ancestor
44428413|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428414|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428415|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44428416|NCT02168946|Meropenem|meropenem|mesh-list
44428417|NCT02168946|Vaborbactam|vaborbactam|mesh-list
44428418|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
44428419|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
44428420|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428425|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44428426|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44428427|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428428|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428429|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44428430|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428431|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
44428432|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
44428433|NCT02168816|Metronidazole|metronidazole|mesh-list
44428434|NCT02168816|Vancomycin|vancomycin|mesh-list
44428435|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
44428436|NCT02168816|Clindamycin|clindamycin|mesh-list
44428437|NCT02168816|Meropenem|meropenem|mesh-list
44428438|NCT02168816|Tazobactam|tazobactam|mesh-list
44428439|NCT02168816|Linezolid|linezolid|mesh-list
44428440|NCT02168816|Piperacillin|piperacillin|mesh-list
44428441|NCT02168816|Daptomycin|daptomycin|mesh-list
44428442|NCT02168816|Cefepime|cefepime|mesh-list
44428443|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44428444|NCT02168816|Aztreonam|aztreonam|mesh-list
44428445|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44428446|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44428447|NCT02168816|Trimethoprim|trimethoprim|mesh-list
44428448|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
44428449|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841665|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841666|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
43841667|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43841668|NCT04599465|Ivacaftor|ivacaftor|mesh-list
43841669|NCT04599465|Elexacaftor|elexacaftor|mesh-list
44428450|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44428451|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44428452|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428453|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428454|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428471|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428472|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44428474|NCT02168491|Lixisenatide|lixisenatide|mesh-list
44428475|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44428476|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428477|NCT02168478|Neomycin|neomycin|mesh-list
44428478|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44428479|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428480|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44428481|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428482|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428483|NCT02168439|Midazolam|midazolam|mesh-list
44428484|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
44428485|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44428486|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428487|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428488|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428489|NCT02168439|Analgesics|analgesics|mesh-ancestor
44428490|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
44428491|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428492|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44428493|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44428494|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44428495|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44428496|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428497|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44086486|NCT00021398|Leucovorin|leucovorin|mesh-list
44428517|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428518|NCT02168387|Antidotes|antidotes|mesh-ancestor
44428519|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
44428520|NCT02168270|Temozolomide|temozolomide|mesh-list
44428521|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44428522|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
44428586|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44428587|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44428588|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428589|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428590|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428591|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44428592|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44428594|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
44428595|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
44428596|NCT02166333|Vitamins|vitamins|mesh-list
44428597|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
44428598|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428599|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44428600|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44428601|NCT02166047|Vesatolimod|vesatolimod|mesh-list
44428602|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
44428603|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428604|NCT02165397|Rituximab|rituximab|mesh-list
44428605|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44428606|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428607|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
44428608|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428609|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428610|NCT02165202|Rilpivirine|rilpivirine|mesh-list
44428611|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44428637|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428638|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428639|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
44428641|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44428642|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428643|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428644|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
44428645|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
44428646|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428647|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
44428648|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44428649|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44428650|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44428651|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428652|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428653|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44428654|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44428655|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
44428656|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44428657|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44428658|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44428659|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428660|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
44428661|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
44428662|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428663|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428664|NCT02164929|Analgesics|analgesics|mesh-ancestor
44428665|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
44428683|NCT02164916|Camptothecin|camptothecin|mesh-list
44428684|NCT02164916|Vemurafenib|vemurafenib|mesh-list
44428685|NCT02164916|Antibodies|antibodies|mesh-list
44428686|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
44428687|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44428688|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
44428689|NCT02164916|Mitogens|mitogens|mesh-list
44428690|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
44428691|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428692|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428693|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44428694|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44428695|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428696|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428697|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
44428698|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44428699|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44428700|NCT02164864|Aspirin|aspirin|mesh-list
44428701|NCT02164864|Warfarin|warfarin|mesh-list
44086710|NCT00022087|Vitamin D|vitamin d|mesh-list
44428702|NCT02164864|Dabigatran|dabigatran|mesh-list
44428703|NCT02164864|Clopidogrel|clopidogrel|mesh-list
44428704|NCT02164864|Ticagrelor|ticagrelor|mesh-list
44428705|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44428706|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44428707|NCT02164864|Analgesics|analgesics|mesh-ancestor
44428708|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
44428709|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428710|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428711|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428712|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428713|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44428714|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44428715|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428716|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44428717|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44428718|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44428722|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44428723|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
44428724|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428725|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
43795704|NCT00867191|Desloratadine|desloratadine|mesh-list
44428726|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
44428727|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44428728|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
44428729|NCT02164513|Fluticasone|fluticasone|mesh-list
44428730|NCT02164513|Xhance|xhance|mesh-list
44428731|NCT02164513|Bromides|bromides|mesh-list
44428732|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428733|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44428734|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
44428735|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428736|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428737|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44428738|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
44428739|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
44428740|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44428741|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
44428742|NCT02164383|Nicotine|nicotine|mesh-list
44428743|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44428744|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
44428745|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428746|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428747|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44428748|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44428749|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428750|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428751|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428752|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
44428753|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
44428754|NCT02163759|Adalimumab|adalimumab|mesh-list
44428755|NCT02163759|Etrolizumab|etrolizumab|mesh-list
44428756|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44428757|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44428758|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428759|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
44428760|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428762|NCT02163447|Piperaquine|piperaquine|mesh-list
44428763|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
44428764|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44428765|NCT02163447|Artenimol|artenimol|mesh-list
44428766|NCT02163447|Artemisinins|artemisinins|mesh-list
44428767|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
44428768|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44428769|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44428829|NCT02161731|Evacetrapib|evacetrapib|mesh-list
44428830|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
44428831|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44428832|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44428833|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
44428834|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428835|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44428836|NCT02161718|Olanzapine|olanzapine|mesh-list
44428837|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
44428838|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
44428839|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428840|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428841|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44428842|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44428843|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44428844|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428845|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428846|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44428847|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44428848|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44428849|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428850|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44428851|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
44428852|NCT02161575|Ranibizumab|ranibizumab|mesh-list
44428855|NCT02161575|Growth Substances|growth substances|mesh-ancestor
44428876|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
44428877|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44428878|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44428879|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44428880|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
44428882|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428883|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44428884|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44428885|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
44428886|NCT02161406|Abatacept|abatacept|mesh-list
44428887|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44428894|NCT02161185|Midazolam|midazolam|mesh-list
44428939|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
44428940|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44428941|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428942|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
44428943|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44428944|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44428945|NCT02159807|Narcotics|narcotics|mesh-ancestor
44428946|NCT02159807|Analgesics|analgesics|mesh-ancestor
44428947|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44428948|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44428949|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
44428950|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44428951|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44428952|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44428953|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44428954|NCT02159482|Interferons|interferons|mesh-list
44428955|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
44428956|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
44428957|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428958|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
44428959|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44428960|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
44428961|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44428962|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
44428963|NCT02159469|Testosterone|testosterone|mesh-list
44428964|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
44428965|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
44428966|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44428967|NCT02159469|Androgens|androgens|mesh-ancestor
44428968|NCT02159469|Hormones|hormones|mesh-ancestor
44428986|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44428987|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44428988|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
44428989|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44428990|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44428991|NCT02159365|Growth Substances|growth substances|mesh-ancestor
44428992|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
44428994|NCT02159352|Lopinavir|lopinavir|mesh-list
44428995|NCT02159352|Darunavir|darunavir|mesh-list
44428996|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44429052|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429053|NCT02158533|Analgesics|analgesics|mesh-ancestor
44429054|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
44429055|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429056|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44429057|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44429058|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
44429059|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
44429060|NCT02158442|Ticarcillin|ticarcillin|mesh-list
44429061|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44429062|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429063|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429064|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429065|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429066|NCT02158364|Vaccines|vaccines|mesh-list
44429067|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
44429068|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429069|NCT02158039|Ethanol|ethanol|mesh-list
44429070|NCT02158039|Lidocaine|lidocaine|mesh-list
44429071|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
44429072|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
44429074|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429104|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429105|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44429106|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429107|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429110|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
44429172|NCT02155829|Protective Agents|protective agents|mesh-ancestor
44429173|NCT02155738|Acetaminophen|acetaminophen|mesh-list
44429174|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429175|NCT02155738|Analgesics|analgesics|mesh-ancestor
44429176|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
44429177|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429178|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429179|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
44429180|NCT02155660|Benralizumab|benralizumab|mesh-list
44429181|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429182|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429183|NCT02155647|Avelumab|avelumab|mesh-list
44429186|NCT02155322|Interferons|interferons|mesh-list
44429238|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44429239|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44429240|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429241|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429242|NCT02153918|Metronidazole|metronidazole|mesh-list
44429243|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429244|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429245|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44429246|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44429247|NCT02153905|Aldesleukin|aldesleukin|mesh-list
44429248|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
44429249|NCT02153905|Fludarabine|fludarabine|mesh-list
44429250|NCT02153905|Interleukin-2|interleukin-2|mesh-list
44429251|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429252|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
44429253|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429254|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429255|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44429256|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
44429257|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795732|NCT00795522|Desloratadine|desloratadine|mesh-list
43795733|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44429258|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429259|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44429260|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429261|NCT02153905|Analgesics|analgesics|mesh-ancestor
44429262|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
44429263|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429264|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44429265|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44429266|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
44429267|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429268|NCT02153788|Temazepam|temazepam|mesh-list
44429269|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44429270|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429271|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429272|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44429273|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44163999|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164000|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164001|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44429274|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44429276|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
44429277|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429278|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429279|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44429280|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429281|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44429282|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429283|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429284|NCT02152384|Insulin|insulin|mesh-list
44429285|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44429286|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
44429287|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
44429288|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429290|NCT02152371|Metformin|metformin|mesh-list
44429335|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429336|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
44429337|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429338|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429339|NCT02152007|Sirolimus|sirolimus|mesh-list
44429340|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429341|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429342|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44429343|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429344|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
44429345|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429346|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
44429347|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429348|NCT02151851|Methotrexate|methotrexate|mesh-list
44429349|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
44429350|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44429351|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
44429352|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429353|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429354|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429355|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
44429388|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429389|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429391|NCT02151643|Trace Elements|trace elements|mesh-ancestor
44429392|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
44429393|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429394|NCT02151591|Varenicline|varenicline|mesh-list
44429395|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44429396|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44429397|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429398|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429399|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429400|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429401|NCT02151461|Metformin|metformin|mesh-list
44429402|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429403|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429404|NCT02151149|Paclitaxel|paclitaxel|mesh-list
44429405|NCT02151149|Carboplatin|carboplatin|mesh-list
44429406|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44429407|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429408|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
44429409|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
43838113|NCT04870866|Niacin|niacin|mesh-list
44429410|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429411|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429412|NCT02151058|Listerine|listerine|mesh-list
44429441|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44429442|NCT02149836|Ezogabine|ezogabine|mesh-list
44429443|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
44429444|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429445|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429446|NCT02149264|Testosterone|testosterone|mesh-list
44429447|NCT02149264|Androgens|androgens|mesh-ancestor
44429448|NCT02149264|Hormones|hormones|mesh-ancestor
44429449|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429450|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429451|NCT02149199|Budesonide|budesonide|mesh-list
44429452|NCT02149199|Terbutaline|terbutaline|mesh-list
44429453|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
44429454|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429455|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44429456|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
44429457|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429458|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429459|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429460|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429461|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
44429462|NCT02149199|Hormones|hormones|mesh-ancestor
44429463|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429464|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44429490|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429491|NCT02148250|Insulin|insulin|mesh-list
44429492|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44429493|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429494|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429495|NCT02147691|Azelaic acid|azelaic acid|mesh-list
44429496|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44429497|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44429498|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44429499|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44429500|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44429501|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429502|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429503|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429504|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429505|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429506|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429507|NCT02147587|Tofacitinib|tofacitinib|mesh-list
44429508|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44429509|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429510|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429511|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
44429512|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44429513|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44429514|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44429515|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164002|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164003|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
44164004|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44164005|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
44164006|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164007|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164008|NCT00254735|Clomipramine|clomipramine|mesh-list
43795870|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795871|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
43768563|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
44164009|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164010|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164011|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164012|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164013|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164014|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164015|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44164016|NCT00254735|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44164017|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43631832|NCT03041948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44429516|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429518|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429519|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429520|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44429521|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429522|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
44429523|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44429524|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
44429525|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429526|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429527|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44429528|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
44429529|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44429530|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
44429531|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429532|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429533|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44429534|NCT02147132|Nicotine|nicotine|mesh-list
44429535|NCT02147132|Varenicline|varenicline|mesh-list
44429536|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44429545|NCT02147067|Ranolazine|ranolazine|mesh-list
44429566|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
44429567|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44429568|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429569|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429570|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44429571|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44429572|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44429573|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44429574|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44429575|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44429576|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429577|NCT02145182|Eculizumab|eculizumab|mesh-list
44429578|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44429579|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429580|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
44429581|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429583|NCT02145078|Docetaxel|docetaxel|mesh-list
44429584|NCT02145078|Pemetrexed|pemetrexed|mesh-list
44429585|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44429586|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
44429587|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429588|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429589|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
44429590|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429617|NCT02143843|Bimatoprost|bimatoprost|mesh-list
44429618|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44429619|NCT02143141|Morphine|morphine|mesh-list
44429620|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44429621|NCT02143141|Narcotics|narcotics|mesh-ancestor
44429622|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795885|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429623|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429624|NCT02143141|Analgesics|analgesics|mesh-ancestor
44429625|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
44429626|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429627|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
44429628|NCT02142712|Promethazine|promethazine|mesh-list
44429629|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
44429630|NCT02142712|Pantoprazole|pantoprazole|mesh-list
44429631|NCT02142712|Famotidine|famotidine|mesh-list
44429632|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44429633|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429634|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44429635|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429636|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429637|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44429638|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44429639|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429640|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429641|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
44429642|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
44429643|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
44429644|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429645|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
44429646|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
44429647|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44429649|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
44429662|NCT02141854|Fluticasone|fluticasone|mesh-list
44429663|NCT02141854|Xhance|xhance|mesh-list
44429664|NCT02141854|Albuterol|albuterol|mesh-list
44429665|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44429666|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
44429667|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429668|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44429669|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
44429670|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429671|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429672|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429673|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429674|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429675|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429676|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44429677|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429678|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429679|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429680|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429681|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
44429682|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429683|NCT02141672|Cyclosporine|cyclosporine|mesh-list
44429684|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
44429685|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429686|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429687|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429694|NCT02141659|Relugolix|relugolix|mesh-list
44429712|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429713|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44429714|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429715|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44429716|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429717|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429718|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429719|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
44429720|NCT02141620|Cocaine|cocaine|mesh-list
44429721|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44429722|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
44429723|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429724|NCT02141620|Expectorants|expectorants|mesh-ancestor
44429725|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429726|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44429727|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
44429728|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429729|NCT02141620|Protective Agents|protective agents|mesh-ancestor
44429730|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429731|NCT02141620|Antidotes|antidotes|mesh-ancestor
44429732|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
44429733|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
44429734|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429735|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
44429736|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429737|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44429738|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44429739|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44429740|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429741|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
44429742|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429743|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44429755|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44429756|NCT02141295|Growth Substances|growth substances|mesh-ancestor
44429757|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429758|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
44429760|NCT02141295|Protective Agents|protective agents|mesh-ancestor
44429761|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
44429762|NCT02141295|Vitamins|vitamins|mesh-ancestor
44429763|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
44429764|NCT02141295|Hematinics|hematinics|mesh-ancestor
44429765|NCT02141217|Amoxicillin|amoxicillin|mesh-list
44429766|NCT02141217|Clindamycin|clindamycin|mesh-list
44429767|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
44429768|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
44429769|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
44429770|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
44429771|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44429772|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429773|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429774|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44429775|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429776|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429777|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44429778|NCT02140970|Ibuprofen|ibuprofen|mesh-list
44429779|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44429806|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429807|NCT02140164|Minocycline|minocycline|mesh-list
44429808|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44429809|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429810|NCT02140060|Travoprost|travoprost|mesh-list
44429811|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44429812|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44429813|NCT02140060|Brinzolamide|brinzolamide|mesh-list
44429814|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44429815|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44429816|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429817|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429818|NCT02139982|Ropivacaine|ropivacaine|mesh-list
44429819|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
44429820|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
44429821|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44429822|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429823|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
44429824|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429825|NCT02139943|Canagliflozin|canagliflozin|mesh-list
44429826|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44429827|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429828|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44429829|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429830|NCT02139644|Fluticasone|fluticasone|mesh-list
44429831|NCT02139644|Xhance|xhance|mesh-list
44429832|NCT02139644|Beclomethasone|beclomethasone|mesh-list
44429833|NCT02139644|Albuterol|albuterol|mesh-list
44429834|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44429835|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
44429836|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429837|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44429838|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
44429839|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429840|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429841|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429843|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429844|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44429845|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44429846|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429847|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429848|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429849|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429850|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
44429851|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44429852|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
44429853|NCT02139644|Hormones|hormones|mesh-ancestor
44429854|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429855|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44429856|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44429857|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429858|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
44429859|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44429860|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
44429861|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429862|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429863|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44429864|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
44429865|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429866|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429867|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44429868|NCT02139046|Naproxen|naproxen|mesh-list
44429869|NCT02139046|Colchicine|colchicine|mesh-list
44429870|NCT02139046|Febuxostat|febuxostat|mesh-list
44429871|NCT02139046|Lansoprazole|lansoprazole|mesh-list
44429872|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
44429874|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429886|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
44429887|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
44429888|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429889|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44429890|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44429891|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44429893|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44429894|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
44429895|NCT02138838|Cinacalcet|cinacalcet|mesh-list
44429896|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44429897|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429899|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
44429900|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429901|NCT02138825|Riociguat|riociguat|mesh-list
44429902|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
44429903|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429904|NCT02138747|Mirabegron|mirabegron|mesh-list
44429905|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44429906|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44429907|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44429908|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44429909|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
44429910|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429911|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429912|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429913|NCT02138747|Urological Agents|urological agents|mesh-ancestor
44429914|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44429915|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44429916|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429917|NCT02138136|Lubiprostone|lubiprostone|mesh-list
44429918|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44429919|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429920|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429921|NCT02137837|Everolimus|everolimus|mesh-list
44429926|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
43795909|NCT00651404|Ezetimibe|ezetimibe|mesh-list
44429927|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429928|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44429929|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44429930|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44429931|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
44429932|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44429933|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44429934|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44429935|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429936|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429937|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44429938|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44429939|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
44429940|NCT02137772|Letermovir|letermovir|mesh-list
44429941|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44429942|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44429943|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429944|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44429945|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
44429946|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429947|NCT02137369|Dexetimide|dexetimide|mesh-list
44429948|NCT02137369|Citalopram|citalopram|mesh-list
44429949|NCT02137369|Sertraline|sertraline|mesh-list
44429950|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
44429951|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44429952|NCT02137369|Serotonin|serotonin|mesh-list
44429953|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44429954|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44429955|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429956|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429964|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
44429965|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429966|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44429967|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44429968|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
44429969|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44429970|NCT02137252|Naltrexone|naltrexone|mesh-list
44429971|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44429972|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44429973|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429974|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
44429975|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44429976|NCT02137226|Adalimumab|adalimumab|mesh-list
44429977|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44429978|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44429979|NCT02136914|Amantadine|amantadine|mesh-list
44429980|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44429981|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44429982|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
44429983|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44429984|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
44429985|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44429986|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44429987|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44429988|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44429989|NCT02136914|Analgesics|analgesics|mesh-ancestor
44429990|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
44430013|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44430014|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430015|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430016|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430017|NCT02134925|Poly ICLC|poly iclc|mesh-list
44430018|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
44430019|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
44430020|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430021|NCT02134353|Mannitol|mannitol|mesh-list
44430022|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44430023|NCT02134353|Diuretics|diuretics|mesh-ancestor
44430024|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
44430025|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430026|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44430027|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430028|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430029|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430030|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430031|NCT02133924|Prednisone|prednisone|mesh-list
44430032|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
44430033|NCT02133924|Natalizumab|natalizumab|mesh-list
44430034|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430035|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
44430036|NCT02133924|Hormones|hormones|mesh-ancestor
44430037|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430038|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430039|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430060|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
44430061|NCT02133664|Vitamins|vitamins|mesh-ancestor
44430062|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
44430063|NCT02133352|Ranolazine|ranolazine|mesh-list
44430064|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44430065|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430066|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430067|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
44430068|NCT02133131|Grazoprevir|grazoprevir|mesh-list
44430069|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
44430070|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
44430071|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430124|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430125|NCT02132637|Insulin|insulin|mesh-list
44430126|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44430127|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
44430128|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430129|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430130|NCT02132312|Phenylephrine|phenylephrine|mesh-list
44430131|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
44430132|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44430133|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
44430134|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
44430135|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430136|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430137|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
44430138|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44430139|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
44430140|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430141|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44430142|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44430143|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44430144|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44430145|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430146|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430147|NCT02132312|Protective Agents|protective agents|mesh-ancestor
44430148|NCT02132247|Diclofenac|diclofenac|mesh-list
44430149|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44430150|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44430151|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796330|NCT05070195|Midazolam|midazolam|mesh-list
43654456|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44430152|NCT02132247|Analgesics|analgesics|mesh-ancestor
44430153|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
44430154|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430155|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430156|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430157|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430158|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44430163|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
44430164|NCT02132195|Hormones|hormones|mesh-ancestor
44430165|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430166|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430167|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430168|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430169|NCT02132117|Phenylephrine|phenylephrine|mesh-list
44430170|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
44430171|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44430172|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44430173|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
44430174|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430175|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430176|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430177|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
44430178|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
44430179|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430180|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
44430181|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44430182|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430183|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44430184|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
44430185|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44430186|NCT02132117|Protective Agents|protective agents|mesh-ancestor
44430187|NCT02131324|Clobetasol|clobetasol|mesh-list
44430188|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430189|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
44430190|NCT02131324|Hormones|hormones|mesh-ancestor
44430191|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430192|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430207|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44430208|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44430209|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44430210|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
44430211|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430212|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44430213|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44430214|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430215|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430216|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44430217|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44430218|NCT02131155|Afatinib|afatinib|mesh-list
44430219|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430220|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430221|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430222|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430223|NCT02131064|Carboplatin|carboplatin|mesh-list
44430224|NCT02131064|Docetaxel|docetaxel|mesh-list
44430225|NCT02131064|Trastuzumab|trastuzumab|mesh-list
44430226|NCT02131064|Pertuzumab|pertuzumab|mesh-list
44430227|NCT02131064|Maytansine|maytansine|mesh-list
44430228|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44430229|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430230|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430231|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430232|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430256|NCT02130024|Ranibizumab|ranibizumab|mesh-list
44430257|NCT02130024|Aflibercept|aflibercept|mesh-list
44430258|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44430259|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44430260|NCT02130024|Growth Substances|growth substances|mesh-ancestor
44430261|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430262|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
44430263|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430264|NCT02129647|Axitinib|axitinib|mesh-list
44430265|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430266|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430267|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430268|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430269|NCT02129192|Amlodipine|amlodipine|mesh-list
44088326|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
44430270|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44430271|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44430272|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430273|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430274|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44430275|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430276|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
44430277|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
44430278|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430279|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430303|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430304|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44430305|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430306|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44430308|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
44430309|NCT02128217|Ledipasvir|ledipasvir|mesh-list
44430310|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44430311|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
44430312|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430313|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
44430314|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430315|NCT02127970|Dalbavancin|dalbavancin|mesh-list
44430316|NCT02127970|Teicoplanin|teicoplanin|mesh-list
44430317|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430318|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430319|NCT02127372|Cisplatin|cisplatin|mesh-list
44430320|NCT02127372|Docetaxel|docetaxel|mesh-list
44430321|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
44430322|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430323|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430324|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430325|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430326|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430327|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430328|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430329|NCT02127125|Sevelamer|sevelamer|mesh-list
44430330|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
44430353|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430354|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430355|NCT02125877|Deferasirox|deferasirox|mesh-list
44088479|NCT00025454|Tipifarnib|tipifarnib|mesh-list
44430356|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44430357|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
44430358|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
44430359|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430360|NCT02125734|Bromides|bromides|mesh-list
44430361|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
44430362|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44430363|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
44430364|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430413|NCT02124707|Paclitaxel|paclitaxel|mesh-list
44430414|NCT02124707|Carboplatin|carboplatin|mesh-list
44430415|NCT02124707|Cetuximab|cetuximab|mesh-list
44430416|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44430417|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430418|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430419|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430420|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430421|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430422|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430423|NCT02124564|Lacosamide|lacosamide|mesh-list
44430424|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
44430425|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44430426|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43654477|NCT02975570|Renal Agents|renal agents|mesh-ancestor
44430427|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430428|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430429|NCT02124161|Vaccines|vaccines|mesh-list
44430430|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44430431|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
44430432|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430434|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430435|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430436|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44430437|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430438|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
44430439|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430440|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
44430441|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430442|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
44430459|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44430460|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
44430461|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430462|NCT02123511|Protective Agents|protective agents|mesh-ancestor
44430463|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430464|NCT02123511|Antidotes|antidotes|mesh-ancestor
44430465|NCT02123472|Cephalexin|cephalexin|mesh-list
44430466|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430467|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430468|NCT02123459|Cephalexin|cephalexin|mesh-list
44430469|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430470|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430471|NCT02123446|Cephalexin|cephalexin|mesh-list
44430472|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430473|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430474|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
44430475|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44430476|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430477|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
44430478|NCT02123108|Tacrolimus|tacrolimus|mesh-list
44430479|NCT02123108|Basiliximab|basiliximab|mesh-list
44430480|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430481|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
44430482|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430483|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44430484|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430485|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430486|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44430487|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430488|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44430489|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
44430506|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44430507|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44430508|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430509|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44430510|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
44430511|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430512|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430513|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44430514|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44430515|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44430516|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44430517|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430518|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430519|NCT02122380|Incretins|incretins|mesh-ancestor
44430520|NCT02122380|Hormones|hormones|mesh-ancestor
44430521|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430522|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44430523|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
44430524|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430525|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430526|NCT02121847|Cyclosporine|cyclosporine|mesh-list
44430527|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44430528|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44430529|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
44430530|NCT02121847|Cyclosporins|cyclosporins|mesh-list
44430531|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430532|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430548|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44430550|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430551|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44430552|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
44430553|NCT02121509|Metformin|metformin|mesh-list
44430554|NCT02121509|Linagliptin|linagliptin|mesh-list
44430555|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44430556|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430557|NCT02121509|Incretins|incretins|mesh-ancestor
44430558|NCT02121509|Hormones|hormones|mesh-ancestor
44430559|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430560|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44430561|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
44430562|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430563|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430564|NCT02121392|Bupivacaine|bupivacaine|mesh-list
44430565|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
44430566|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
44430567|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44430568|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430569|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
44430570|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430571|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44430572|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44430573|NCT02121262|Dexamethasone|dexamethasone|mesh-list
44430574|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430575|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
44430576|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
44430577|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430578|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430579|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430580|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
44430581|NCT02121262|Hormones|hormones|mesh-ancestor
44164018|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164019|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430582|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430583|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44430586|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44430587|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44430588|NCT02121002|Analgesics|analgesics|mesh-ancestor
44430589|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
44430590|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430591|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654488|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
43654489|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
43654490|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43654491|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
43654492|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654493|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654494|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44430592|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430593|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430594|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44430595|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430596|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430597|NCT02120950|Aflibercept|aflibercept|mesh-list
44430598|NCT02120950|Verteporfin|verteporfin|mesh-list
44430599|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44430600|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44430601|NCT02120950|Growth Substances|growth substances|mesh-ancestor
44430602|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430603|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
44430604|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430605|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44430606|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430607|NCT02120924|Azelaic acid|azelaic acid|mesh-list
44430608|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430610|NCT02120898|Imiquimod|imiquimod|mesh-list
44430631|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
44430632|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430633|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430634|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
44430635|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
44430636|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430637|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
44430638|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
44430639|NCT02120157|Busulfan|busulfan|mesh-list
44430640|NCT02120157|Tacrolimus|tacrolimus|mesh-list
44430641|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430642|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
44430643|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430644|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430645|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44430646|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
44430647|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430657|NCT02119819|Metformin|metformin|mesh-list
44430689|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430690|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
44430691|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430692|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44430693|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
44430694|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430695|NCT02119026|Bevacizumab|bevacizumab|mesh-list
44430696|NCT02119026|Capecitabine|capecitabine|mesh-list
44430697|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
44430699|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44430700|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430701|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44430702|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44430703|NCT02119026|Growth Substances|growth substances|mesh-ancestor
44430704|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430705|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
44430706|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44430707|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
44430708|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430709|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44430710|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44430711|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430741|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44430742|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430743|NCT02118012|Ribavirin|ribavirin|mesh-list
44430744|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
44430745|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430746|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
44430747|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430748|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44430749|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
44430750|NCT02117687|Glycerol|glycerol|mesh-list
44430751|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43654495|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430752|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
44430753|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430754|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
44430755|NCT02117687|Protective Agents|protective agents|mesh-ancestor
44430756|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44430757|NCT02117687|Laxatives|laxatives|mesh-ancestor
44430758|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44430759|NCT02117648|Clarithromycin|clarithromycin|mesh-list
44430760|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44430761|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430762|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44430763|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430764|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430765|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44430766|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44430767|NCT02117570|Vaccines|vaccines|mesh-list
44430768|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
44430769|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430784|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430785|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
44430786|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430787|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44430789|NCT02117024|Paclitaxel|paclitaxel|mesh-list
44430790|NCT02117024|Vinorelbine|vinorelbine|mesh-list
44430791|NCT02117024|Docetaxel|docetaxel|mesh-list
44430792|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
44430793|NCT02117024|Pemetrexed|pemetrexed|mesh-list
44430794|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44430795|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44430796|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430797|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
44430798|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
44430799|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
44430800|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430801|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430802|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
44430803|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430804|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430805|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44430806|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
44430807|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44430808|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44430809|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
44430810|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
44430811|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430812|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430813|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44430814|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44430815|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44430827|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44430828|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44430829|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
44430830|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44430831|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430832|NCT02116777|Temozolomide|temozolomide|mesh-list
44430833|NCT02116777|Talazoparib|talazoparib|mesh-list
44430834|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44430835|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
44430836|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430837|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430838|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44430839|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430840|NCT02116660|Ritonavir|ritonavir|mesh-list
44430841|NCT02116660|Lopinavir|lopinavir|mesh-list
44430842|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44430843|NCT02116660|Darunavir|darunavir|mesh-list
44430844|NCT02116660|Tenofovir|tenofovir|mesh-list
44430845|NCT02116660|Lamivudine|lamivudine|mesh-list
44430846|NCT02116660|Emtricitabine|emtricitabine|mesh-list
44430847|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
44430849|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44430850|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44430851|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
44430852|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430853|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769543|NCT02386449|Antacids|antacids|mesh-ancestor
44430854|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44430855|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44430856|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
44430857|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430858|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44430859|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44430860|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44164020|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164021|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
44164022|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164023|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164024|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164025|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164026|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164027|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44430861|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44430862|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44430863|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44430864|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44430865|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44430866|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
44430867|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
44430868|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
44430869|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
44430870|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430871|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44430872|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430873|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
44430874|NCT02116530|Dexamethasone|dexamethasone|mesh-list
44430875|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
44430876|NCT02116530|Doxorubicin|doxorubicin|mesh-list
44430877|NCT02116530|Ondansetron|ondansetron|mesh-list
44430878|NCT02116530|Olanzapine|olanzapine|mesh-list
44430879|NCT02116530|Aprepitant|aprepitant|mesh-list
44430880|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
44430881|NCT02116530|Palonosetron|palonosetron|mesh-list
44430882|NCT02116530|Granisetron|granisetron|mesh-list
44430883|NCT02116530|Antiemetics|antiemetics|mesh-list
44430884|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44430885|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
44430886|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430887|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430888|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44430889|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
43654496|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43654498|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796913|NCT05055544|Fosfomycin|fosfomycin|mesh-list
44430894|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
44430910|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44430911|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44430912|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44430913|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44430914|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44430915|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44430916|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44430917|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430918|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44430919|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44430920|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
44089096|NCT00026585|Tamoxifen|tamoxifen|mesh-list
44430921|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44430922|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44430923|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44430924|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44430925|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430926|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
44430927|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430928|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430929|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44430930|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430931|NCT02116309|Indomethacin|indomethacin|mesh-list
44430932|NCT02116309|Epinephrine|epinephrine|mesh-list
44430933|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44430934|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44430935|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
44430936|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430937|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430938|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430939|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44430940|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44430941|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
44430942|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430947|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44430948|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44430949|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44430950|NCT02116309|Analgesics|analgesics|mesh-ancestor
44430951|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
44430952|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44430953|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44430954|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
44430955|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
44430956|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44430957|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44430958|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430960|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
44430961|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430962|NCT02115321|Grazoprevir|grazoprevir|mesh-list
44430963|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
43796918|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430964|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44430965|NCT02115308|Regadenoson|regadenoson|mesh-list
44430966|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44430967|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44430968|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
44430969|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
44430970|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44430971|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430972|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430973|NCT02115282|Exemestane|exemestane|mesh-list
44430974|NCT02115282|Goserelin|goserelin|mesh-list
44430975|NCT02115282|Entinostat|entinostat|mesh-list
44430976|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44430977|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44430978|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44430979|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44430980|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44430981|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44430982|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44430987|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
44430988|NCT02115256|Terbutaline|terbutaline|mesh-list
44430989|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
44430990|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44430991|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
44430992|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44430993|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44430994|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44430995|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44430996|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
44430997|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
44430998|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44430999|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44431000|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44431001|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44431002|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431003|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431004|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431006|NCT02115113|Tacrolimus|tacrolimus|mesh-list
44431007|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431008|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
44431009|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431010|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44431011|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431012|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431013|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431014|NCT02114931|Adalimumab|adalimumab|mesh-list
44431015|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431016|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431017|NCT02114892|Resveratrol|resveratrol|mesh-list
44431018|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
44431019|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431020|NCT02114892|Protective Agents|protective agents|mesh-ancestor
44431021|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164028|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164029|NCT00254774|Valproic Acid|valproic acid|mesh-list
44431022|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431023|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44431024|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
44431025|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44431026|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431027|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44431028|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44431029|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431030|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431031|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431032|NCT02114385|Vaccines|vaccines|mesh-list
44431033|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
44431034|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431035|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
44431036|NCT02114177|Simeprevir|simeprevir|mesh-list
44431037|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
44431038|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431039|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431040|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431041|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431042|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
44431043|NCT02114151|Simeprevir|simeprevir|mesh-list
44431044|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
44431045|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431046|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431047|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431048|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431049|NCT02113579|Fluorides|fluorides|mesh-list
44431050|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
44431051|NCT02113579|Protective Agents|protective agents|mesh-ancestor
44431070|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431071|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
44431072|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44431073|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431074|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431075|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44431076|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431077|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431078|NCT02112045|Melphalan|melphalan|mesh-list
44431079|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44431080|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
44431081|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431082|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431083|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44431084|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431085|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
44431086|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431087|NCT02111850|Aldesleukin|aldesleukin|mesh-list
44431088|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
44431089|NCT02111850|Fludarabine|fludarabine|mesh-list
44431090|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431091|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
44431092|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431093|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431094|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44431095|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
44431096|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431097|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164030|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164031|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164032|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164033|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164034|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164035|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164036|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164037|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
44164038|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164039|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164040|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
44164041|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431098|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44431099|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44431100|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44431101|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
44431102|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431103|NCT02111785|Dexamethasone|dexamethasone|mesh-list
44431104|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431105|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
44431106|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
44431107|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431108|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431109|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431110|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
44431111|NCT02111785|Hormones|hormones|mesh-ancestor
44431112|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431113|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44431114|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431115|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44431116|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44431117|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44431118|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
44431119|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431120|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44431121|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
44431122|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44431123|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
44431129|NCT02111369|Propranolol|propranolol|mesh-list
44431146|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431147|NCT02111096|Incretins|incretins|mesh-ancestor
44431148|NCT02111096|Hormones|hormones|mesh-ancestor
44431149|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431150|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44431151|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431152|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431153|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431154|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
44431155|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431156|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431157|NCT02110706|Rituximab|rituximab|mesh-list
44431158|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797152|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
43797158|NCT05049473|Vincristine|vincristine|mesh-list
43797159|NCT05049473|Vindesine|vindesine|mesh-list
43797160|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797161|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
43797162|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797163|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431159|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431160|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
44431161|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431162|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431163|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
44431164|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44431165|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
44431166|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431167|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
44431168|NCT02110238|Protective Agents|protective agents|mesh-ancestor
44431169|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44431170|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44431171|NCT02110225|Mitogens|mitogens|mesh-list
44431172|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431173|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431174|NCT02109744|Decitabine|decitabine|mesh-list
44431175|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431176|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
44431177|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431178|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431179|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431180|NCT02109562|Risperidone|risperidone|mesh-list
44431181|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164042|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
44164043|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44431183|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431184|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431185|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431186|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44431187|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44431191|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
44431250|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44431251|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44431252|NCT02107131|Growth Substances|growth substances|mesh-ancestor
44431253|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431254|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
44431255|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431256|NCT02107014|Naltrexone|naltrexone|mesh-list
44431257|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44431258|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44431259|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431260|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
44431261|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431262|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
44431263|NCT02106975|Vitamins|vitamins|mesh-ancestor
44431264|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
44431265|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431266|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
44431267|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431268|NCT02106975|Protective Agents|protective agents|mesh-ancestor
44431269|NCT02106923|Metformin|metformin|mesh-list
44431270|NCT02106923|Empagliflozin|empagliflozin|mesh-list
44431271|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431272|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431273|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44431274|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431275|NCT02106884|Gemcitabine|gemcitabine|mesh-list
44431276|NCT02106884|Paclitaxel|paclitaxel|mesh-list
44431277|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44431278|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431279|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
44431280|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
44431281|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431282|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431283|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431284|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
44164044|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164045|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164054|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44164055|NCT00254800|Estradiol|estradiol|mesh-list
44164056|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44431285|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
44431286|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431287|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431288|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431289|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
44431290|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431291|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
44431292|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44431293|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431294|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44431295|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44431296|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431297|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431298|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431299|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44431300|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44431302|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44431303|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431304|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431305|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44431306|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431307|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44431308|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
44431309|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44431310|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431311|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431312|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44431313|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431314|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44431315|NCT02106403|Disinfectants|disinfectants|mesh-list
44431316|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431318|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
44431322|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44431323|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44431324|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431325|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431326|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
44431327|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431328|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431329|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44431330|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431331|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
44431332|NCT02106325|Promethazine|promethazine|mesh-list
44431333|NCT02106325|Ketamine|ketamine|mesh-list
44431334|NCT02106325|Analgesics|analgesics|mesh-ancestor
44431335|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
44431336|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431337|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431338|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44431380|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431381|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44431382|NCT02105701|Ribavirin|ribavirin|mesh-list
44431383|NCT02105701|Grazoprevir|grazoprevir|mesh-list
44431384|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
44431385|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431386|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
44431387|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431388|NCT02105688|Grazoprevir|grazoprevir|mesh-list
44431389|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
44431390|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431391|NCT02105662|Grazoprevir|grazoprevir|mesh-list
44431392|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
44431393|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431394|NCT02105636|Docetaxel|docetaxel|mesh-list
44431395|NCT02105636|Methotrexate|methotrexate|mesh-list
44431396|NCT02105636|Nivolumab|nivolumab|mesh-list
44431397|NCT02105636|Cetuximab|cetuximab|mesh-list
44431398|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431399|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
44431400|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
44431401|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431402|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431403|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44431435|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431436|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431437|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44431438|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44431439|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
44431440|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
44431441|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431442|NCT02105272|Carteolol|carteolol|mesh-list
44431443|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44431444|NCT02105272|Latanoprost|latanoprost|mesh-list
44431445|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44431446|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44431447|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44431448|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431449|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431450|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431451|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431452|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44431453|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44431454|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
44431455|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
44431456|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431457|NCT02105116|Cytarabine|cytarabine|mesh-list
44431458|NCT02105116|Fludarabine|fludarabine|mesh-list
44431459|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
44431460|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431461|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431462|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
44431463|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431464|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431465|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
44431466|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431467|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
44431468|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164057|NCT00254800|Estrogens|estrogens|mesh-ancestor
44164058|NCT00254800|Hormones|hormones|mesh-ancestor
44164059|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164060|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164061|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44431470|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44431471|NCT02104804|Metformin|metformin|mesh-list
44431472|NCT02104804|Saxagliptin|saxagliptin|mesh-list
44431473|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
44431474|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431475|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431476|NCT02104804|Incretins|incretins|mesh-ancestor
44431477|NCT02104804|Hormones|hormones|mesh-ancestor
44431478|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431479|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44431480|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431481|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797357|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
44431482|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431483|NCT02104752|Curcumin|curcumin|mesh-list
44431484|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44431485|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44431486|NCT02104752|Analgesics|analgesics|mesh-ancestor
44431487|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
44431488|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431489|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431490|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431491|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431492|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431493|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431520|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431521|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431522|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
44431523|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431524|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431525|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
44431526|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431527|NCT02101359|Tetracaine|tetracaine|mesh-list
44431528|NCT02101359|Tropicamide|tropicamide|mesh-list
44431529|NCT02101359|Mydriatics|mydriatics|mesh-list
44431530|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
44431531|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
44431532|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431533|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431534|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
44431535|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431536|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
44431537|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44431538|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44431539|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
44431540|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431541|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431542|NCT02101112|Apixaban|apixaban|mesh-list
44431543|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44431544|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
44431546|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431569|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
44431570|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44431571|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44431572|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
44431573|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431574|NCT02100696|Etrolizumab|etrolizumab|mesh-list
44431575|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431576|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
44431577|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431578|NCT02100670|Diclofenac|diclofenac|mesh-list
44431579|NCT02100670|Menthol|menthol|mesh-list
44431580|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44431581|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44431582|NCT02100670|Analgesics|analgesics|mesh-ancestor
44431583|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
44431584|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431585|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431586|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431587|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431588|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44431589|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431590|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431591|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
44431621|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
44431622|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431623|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44431624|NCT02100475|Insulin|insulin|mesh-list
44431625|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44431626|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
44431627|NCT02100475|Liraglutide|liraglutide|mesh-list
44431628|NCT02100475|Xultophy|xultophy|mesh-list
44431629|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431630|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431631|NCT02100475|Incretins|incretins|mesh-ancestor
44431632|NCT02100475|Hormones|hormones|mesh-ancestor
44431633|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431634|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44431635|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44431636|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44431637|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431638|NCT02100228|Vitamin K|vitamin k|mesh-list
44431639|NCT02100228|Heparin|heparin|mesh-list
44431640|NCT02100228|Apixaban|apixaban|mesh-list
44431641|NCT02100228|Vitamins|vitamins|mesh-ancestor
44431642|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
44431643|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431644|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
44431645|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44431646|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44431647|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431648|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44431649|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
44431650|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44164062|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
44164063|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164064|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44164065|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44164066|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44164067|NCT00254800|Incretins|incretins|mesh-ancestor
44164068|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44164069|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44164070|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44164071|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164072|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164073|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164074|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164075|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43631833|NCT03041948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44431651|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431652|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431653|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44431654|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
44431655|NCT02100228|Coagulants|coagulants|mesh-ancestor
44431656|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
44431657|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44431658|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431659|NCT02099838|Metformin|metformin|mesh-list
44431660|NCT02099838|Pioglitazone|pioglitazone|mesh-list
44431661|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431662|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431663|NCT02099708|Lansoprazole|lansoprazole|mesh-list
44431664|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
44431665|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44431666|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431667|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44431668|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431669|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431670|NCT02099682|Lansoprazole|lansoprazole|mesh-list
44431671|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
44431672|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44431673|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431674|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44431675|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431676|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431677|NCT02099110|Metformin|metformin|mesh-list
44431678|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
44431679|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44431680|NCT02099110|Glimepiride|glimepiride|mesh-list
44431681|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
44431682|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431683|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431684|NCT02099110|Incretins|incretins|mesh-ancestor
44431685|NCT02099110|Hormones|hormones|mesh-ancestor
44431686|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431687|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44431688|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
44431690|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431692|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431693|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
44431694|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44431695|NCT02098876|Everolimus|everolimus|mesh-list
44431696|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431697|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431698|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
44431699|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431700|NCT02098746|Pioglitazone|pioglitazone|mesh-list
44431701|NCT02098746|Glimepiride|glimepiride|mesh-list
44431702|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431703|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431704|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44431705|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431706|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
44431707|NCT02098733|Pioglitazone|pioglitazone|mesh-list
44431708|NCT02098733|Glimepiride|glimepiride|mesh-list
44431709|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431710|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431711|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44431712|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431713|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
44431714|NCT02098395|Liraglutide|liraglutide|mesh-list
44431742|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44431743|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431744|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431745|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
44431746|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44431747|NCT02097745|Rituximab|rituximab|mesh-list
44431748|NCT02097745|Methotrexate|methotrexate|mesh-list
44431749|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44431750|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431751|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
44431752|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431753|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44431754|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44431755|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
44431756|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44431757|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431758|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
44431759|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431760|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
44431761|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431762|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44431763|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431764|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44431765|NCT02097719|Timolol|timolol|mesh-list
44431766|NCT02097719|Bimatoprost|bimatoprost|mesh-list
44431767|NCT02097719|Travoprost|travoprost|mesh-list
44431768|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44431769|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44431770|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431771|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431772|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431773|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431774|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43797382|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44431775|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44431776|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44164076|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431777|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
44431778|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431779|NCT02097238|Halichondrin B|halichondrin b|mesh-list
44431781|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
44431782|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
44431783|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431784|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431785|NCT02097134|Melphalan|melphalan|mesh-list
44431786|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
44431787|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
44431788|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44431789|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
44431790|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431791|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431792|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44431793|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44431794|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
44431795|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431796|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
44431797|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44431798|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44431799|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
44431800|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431801|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44431802|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44431803|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431804|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431805|NCT02097056|Donepezil|donepezil|mesh-list
44431806|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44431807|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431820|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
44431821|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431823|NCT02096900|Zolpidem|zolpidem|mesh-list
44431824|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44431825|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44431826|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431827|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431828|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44431829|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44431830|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44431831|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44431832|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
44431833|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
44431834|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
44431835|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
44431836|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431837|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431838|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44431839|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44431840|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
44431841|NCT02096835|Dexamethasone|dexamethasone|mesh-list
43654525|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43654526|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654528|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
43654529|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43654530|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43654531|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43654532|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
44431842|NCT02096835|Tropisetron|tropisetron|mesh-list
44431843|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44431844|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
44431845|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
44431846|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431847|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431848|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44431849|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
44431850|NCT02096835|Hormones|hormones|mesh-ancestor
44431851|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44431852|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164077|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164078|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44164079|NCT00254865|Norelgestromin|norelgestromin|mesh-list
44164080|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
44164081|NCT00254865|Estradiol|estradiol|mesh-list
44164082|NCT00254865|Estrogens|estrogens|mesh-ancestor
44164083|NCT00254865|Hormones|hormones|mesh-ancestor
44164084|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164085|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164086|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43631834|NCT03041948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44431853|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431854|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44431855|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44431857|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431858|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431860|NCT02096744|Analgesics|analgesics|mesh-ancestor
44431861|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
44431862|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431863|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431864|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44431865|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
44431866|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
44431867|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44431868|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44431869|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44431870|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431871|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431872|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431873|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
44431874|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44431875|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431876|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44431877|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431901|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431902|NCT02096042|Azacitidine|azacitidine|mesh-list
44431903|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44431904|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44431905|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
44431906|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431907|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431908|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654533|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654534|NCT02975219|Bevacizumab|bevacizumab|mesh-list
43654535|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44431909|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44431910|NCT02096003|Morphine|morphine|mesh-list
44431911|NCT02096003|Hydromorphone|hydromorphone|mesh-list
44431912|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44431913|NCT02096003|Narcotics|narcotics|mesh-ancestor
44431914|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431915|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431916|NCT02096003|Analgesics|analgesics|mesh-ancestor
44431917|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
44431918|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431919|NCT02095951|Ethanol|ethanol|mesh-list
44431920|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44431921|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44431922|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44431923|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431924|NCT02095873|Resveratrol|resveratrol|mesh-list
44431925|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
44431926|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431927|NCT02095873|Protective Agents|protective agents|mesh-ancestor
44431928|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431929|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431931|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
44431946|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44431947|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44431948|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431949|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431950|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44431951|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
44431952|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
44431953|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44431954|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
44431955|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44431956|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
44431957|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44431958|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
44431959|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44431960|NCT02095158|Protective Agents|protective agents|mesh-ancestor
44431961|NCT02095132|Irinotecan|irinotecan|mesh-list
44431962|NCT02095132|Camptothecin|camptothecin|mesh-list
44431963|NCT02095132|Adavosertib|adavosertib|mesh-list
44431964|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44431965|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44431966|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44431967|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44431968|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44431969|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44431996|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44431997|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44431998|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44431999|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432000|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44432001|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
44432002|NCT02094885|Coagulants|coagulants|mesh-ancestor
44432003|NCT02093897|Factor VIII|factor viii|mesh-list
44432004|NCT02093897|Coagulants|coagulants|mesh-ancestor
44432005|NCT02093663|Mesalamine|mesalamine|mesh-list
44432006|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432007|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432008|NCT02093663|Analgesics|analgesics|mesh-ancestor
44432009|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
44432010|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432011|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432012|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432013|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432014|NCT02093390|Fluconazole|fluconazole|mesh-list
44432015|NCT02093390|Atorvastatin|atorvastatin|mesh-list
44432016|NCT02093390|Relugolix|relugolix|mesh-list
44432017|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44432018|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44432019|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
44432020|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432021|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44432022|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44432023|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432043|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432044|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44432045|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432046|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432047|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432048|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432049|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44432050|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44432051|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44432052|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44432053|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
44432054|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44432055|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
44432056|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432057|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432058|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44432059|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44432060|NCT02093026|Folic Acid|folic acid|mesh-list
44432061|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
44432062|NCT02093026|Rituximab|rituximab|mesh-list
44164087|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164088|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44164089|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44164090|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44164091|NCT00254878|Methylphenidate|methylphenidate|mesh-list
44164092|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44164093|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164094|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44164095|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44164096|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164097|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164098|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
44164099|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164100|NCT00254917|Vaccines|vaccines|mesh-list
44164101|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
44164102|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164103|NCT00254930|Risperidone|risperidone|mesh-list
44164104|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164105|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
44164106|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164107|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164108|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164109|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164110|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164111|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164112|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164129|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164130|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164131|NCT00255242|Simvastatin|simvastatin|mesh-list
44164132|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44432064|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432065|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432066|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
44432067|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432068|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432069|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44432070|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
43797577|NCT05041985|Diazepam|diazepam|mesh-list
44432071|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44432072|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44432073|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
44432074|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432075|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432076|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432077|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44432078|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432079|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44432080|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432081|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
44432082|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
44432083|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432084|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432085|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
44432087|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432088|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44432089|NCT02093026|Protective Agents|protective agents|mesh-ancestor
44432090|NCT02093026|Hematinics|hematinics|mesh-ancestor
44432091|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
44432092|NCT02093026|Vitamins|vitamins|mesh-ancestor
44432093|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
44432094|NCT02092961|Adalimumab|adalimumab|mesh-list
44432095|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432096|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432097|NCT02092467|Adalimumab|adalimumab|mesh-list
44432098|NCT02092467|Etanercept|etanercept|mesh-list
44432105|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
44432106|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432107|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432108|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432109|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432110|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
44432111|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44432112|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432113|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432114|NCT02092350|Grazoprevir|grazoprevir|mesh-list
44432115|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
44432116|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432117|NCT02092285|Golimumab|golimumab|mesh-list
44432118|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44432119|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432120|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432121|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
44432122|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432123|NCT02092220|Pancrelipase|pancrelipase|mesh-list
44432124|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432125|NCT02092116|Romidepsin|romidepsin|mesh-list
44432126|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44432127|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432128|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44432129|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44432130|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44432131|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432151|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432152|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432154|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44432155|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44432156|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44432157|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44432158|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797588|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44432159|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432160|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
44432161|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432162|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432163|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44432164|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432165|NCT02091414|Cyclosporine|cyclosporine|mesh-list
44432166|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
44432167|NCT02091414|Cyclosporins|cyclosporins|mesh-list
44432168|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432169|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432170|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432171|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
44432172|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432173|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
44432174|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432175|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432176|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432177|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44432178|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44432179|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432180|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44432181|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
44432182|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432183|NCT02091375|Cannabidiol|cannabidiol|mesh-list
44432191|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44432192|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432193|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432194|NCT02090413|Analgesics|analgesics|mesh-ancestor
44432195|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
44432196|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432197|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432198|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432199|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432200|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44432201|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44432202|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432203|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44432204|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44432205|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432206|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
44432207|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432208|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432209|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
44432210|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
44432211|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
44432212|NCT02090114|Testosterone|testosterone|mesh-list
44432213|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
44432214|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
44432215|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44432216|NCT02090114|Androgens|androgens|mesh-ancestor
44432217|NCT02090114|Hormones|hormones|mesh-ancestor
44432218|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432219|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432220|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432221|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432222|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
44432223|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44432230|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432231|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432232|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44432233|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432234|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44432236|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432237|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432238|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
44432239|NCT02089685|Ipilimumab|ipilimumab|mesh-list
44432240|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432241|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432242|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44432243|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432244|NCT02089347|Vaccines|vaccines|mesh-list
44432245|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
44432246|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432247|NCT02088957|Phenytoin|phenytoin|mesh-list
44432248|NCT02088957|Brivaracetam|brivaracetam|mesh-list
44432249|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44432250|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
44432251|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44432252|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44432253|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432255|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44432277|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44432278|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432279|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432280|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432281|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
44432282|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
44432283|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432284|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432285|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44432286|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44432287|NCT02087943|Growth Substances|growth substances|mesh-ancestor
44432288|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
44432289|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432290|NCT02087241|Carboplatin|carboplatin|mesh-list
44432291|NCT02087241|Pemetrexed|pemetrexed|mesh-list
44432292|NCT02087241|Adavosertib|adavosertib|mesh-list
44432293|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432294|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432295|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432296|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44432297|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44432298|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
44432299|NCT02087176|Adavosertib|adavosertib|mesh-list
44432300|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432301|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432302|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
44432303|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432304|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44432305|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44432306|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44432307|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44432308|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44432309|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
44432310|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432311|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432312|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432314|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432315|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432316|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
44432317|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44432318|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44432319|NCT02085460|Rebamipide|rebamipide|mesh-list
44432320|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44432321|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432322|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
44432323|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432324|NCT02085460|Protective Agents|protective agents|mesh-ancestor
44432325|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432326|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432327|NCT02085252|Bicalutamide|bicalutamide|mesh-list
44432376|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432377|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432378|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432381|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432382|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432383|NCT02084082|Incretins|incretins|mesh-ancestor
44432384|NCT02084082|Hormones|hormones|mesh-ancestor
44432385|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432386|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44432387|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432388|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432389|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432390|NCT02084056|Metformin|metformin|mesh-list
44432391|NCT02084056|Linagliptin|linagliptin|mesh-list
44432392|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432393|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432394|NCT02084056|Incretins|incretins|mesh-ancestor
44432395|NCT02084056|Hormones|hormones|mesh-ancestor
44432396|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432397|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44432398|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432399|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432400|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432401|NCT02083965|Factor VIII|factor viii|mesh-list
44432402|NCT02083965|Coagulants|coagulants|mesh-ancestor
44432403|NCT02083926|Ketamine|ketamine|mesh-list
44432404|NCT02083926|Analgesics|analgesics|mesh-ancestor
44432405|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
44432406|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432419|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432420|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
44432421|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
44432422|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432423|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
44432424|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432425|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432426|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
44432427|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44432428|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44432429|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432430|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44432431|NCT02083653|Fluorouracil|fluorouracil|mesh-list
44432432|NCT02083653|Capecitabine|capecitabine|mesh-list
44432433|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44432434|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
44432435|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432436|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44432437|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432438|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432439|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
44432440|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432441|NCT02083380|Piperaquine|piperaquine|mesh-list
44432442|NCT02083380|Artefenomel|artefenomel|mesh-list
44432443|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
44432444|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44432445|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44432446|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432447|NCT02083185|Leuprolide|leuprolide|mesh-list
44432448|NCT02083185|Relugolix|relugolix|mesh-list
44090648|NCT00030511|Fluorouracil|fluorouracil|mesh-list
44164133|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44164134|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
44164135|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164136|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44164137|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44164138|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164139|NCT00255255|Budesonide|budesonide|mesh-list
44164140|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
44164141|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164142|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44164143|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
44164144|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164145|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164146|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44432449|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44432450|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
44432451|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44432452|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432453|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432454|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432455|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
44432456|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432457|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432458|NCT02082912|Cycloserine|cycloserine|mesh-list
44432459|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44432460|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432461|NCT02082912|Renal Agents|renal agents|mesh-ancestor
44432462|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44432463|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
44432464|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432465|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
44432466|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432467|NCT02082522|Gemcitabine|gemcitabine|mesh-list
44432468|NCT02082522|Cisplatin|cisplatin|mesh-list
44432469|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44432470|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44432471|NCT02082522|Trioxsalen|trioxsalen|mesh-list
44432472|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432473|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44432474|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
44432497|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432498|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
44432499|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432500|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432501|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44432502|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
44432503|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432504|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432505|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44432506|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432507|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
44432508|NCT02081183|Hormones|hormones|mesh-ancestor
44432509|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432510|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432511|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44432512|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44432513|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
44432514|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432515|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432516|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432517|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
44432518|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44432519|NCT02081079|Ledipasvir|ledipasvir|mesh-list
44432520|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
44432521|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432522|NCT02081001|Glucagon|glucagon|mesh-list
44432523|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432524|NCT02081001|Hormones|hormones|mesh-ancestor
44432525|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432526|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432527|NCT02080832|Dexetimide|dexetimide|mesh-list
44432528|NCT02080832|Citalopram|citalopram|mesh-list
44432529|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44432531|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432536|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44432537|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
44432538|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44432539|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44432540|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44432541|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
44432542|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
44432543|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432544|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44432545|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44432546|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
44432547|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
44432548|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44432549|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44432550|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432551|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
44432552|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432553|NCT02080221|Leucovorin|leucovorin|mesh-list
44432554|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
44432555|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432556|NCT02080221|Antidotes|antidotes|mesh-ancestor
44432557|NCT02080221|Protective Agents|protective agents|mesh-ancestor
44432558|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432559|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
44432560|NCT02080221|Vitamins|vitamins|mesh-ancestor
44090751|NCT00030693|Vaccines|vaccines|mesh-list
44432561|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
44432562|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
44432563|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44432564|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432565|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432566|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44432567|NCT02079805|Telmisartan|telmisartan|mesh-list
44432568|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44432579|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432580|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432581|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44432583|NCT02079649|Hormones|hormones|mesh-ancestor
44432584|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432585|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44432586|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432587|NCT02079636|Gemcitabine|gemcitabine|mesh-list
44432588|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
44432589|NCT02079636|Pemetrexed|pemetrexed|mesh-list
44432590|NCT02079636|Ramucirumab|ramucirumab|mesh-list
44432591|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44432592|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
44432593|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432594|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432595|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
44432596|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432597|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432598|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432599|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
44432600|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432601|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432602|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44432603|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44432604|NCT02079532|Rituximab|rituximab|mesh-list
44432605|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44432606|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432607|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
44432610|NCT02079519|Bevacizumab|bevacizumab|mesh-list
44432623|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432624|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432625|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432626|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432627|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432628|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432629|NCT02079077|Analgesics|analgesics|mesh-ancestor
44432630|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
44432631|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432632|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432633|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432634|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44432635|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44432636|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44432637|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44432638|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
44432639|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
44432640|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44432641|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432642|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44432643|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654557|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43654558|NCT02975141|Gemcitabine|gemcitabine|mesh-list
44432644|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432645|NCT02078817|Ketamine|ketamine|mesh-list
44432646|NCT02078817|Analgesics|analgesics|mesh-ancestor
44432647|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
44432648|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432649|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432667|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
44432668|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432669|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44432670|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
44432671|NCT02078219|Protective Agents|protective agents|mesh-ancestor
44432672|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432673|NCT02078102|Meloxicam|meloxicam|mesh-list
44432674|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432675|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44432676|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44432677|NCT02078102|Analgesics|analgesics|mesh-ancestor
44432678|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
44432679|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432680|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432681|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432682|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44432683|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44432684|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432685|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432686|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44432687|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
44432688|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432689|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
44432690|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44432691|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
44432692|NCT02075632|Hormones|hormones|mesh-ancestor
44432693|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432694|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432695|NCT02075606|Lanreotide|lanreotide|mesh-list
44432696|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798142|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798143|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
43798144|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798145|NCT05029453|Apatinib|apatinib|mesh-list
43798146|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798147|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44432697|NCT02075515|Vaccines|vaccines|mesh-list
44432698|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
44432700|NCT02075255|Benralizumab|benralizumab|mesh-list
44432709|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432710|NCT02075047|Ziprasidone|ziprasidone|mesh-list
44432711|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44432712|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
44432713|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44432714|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432715|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432716|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44432717|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44432718|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432719|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44432720|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44432721|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
44432722|NCT02074982|Ustekinumab|ustekinumab|mesh-list
44432723|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44432724|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
44432725|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432726|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44432727|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
44432728|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
44432729|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432730|NCT02073929|Liraglutide|liraglutide|mesh-list
44432731|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432732|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432733|NCT02073929|Incretins|incretins|mesh-ancestor
44432734|NCT02073929|Hormones|hormones|mesh-ancestor
44432735|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432736|NCT02073682|Heparin|heparin|mesh-list
44432737|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44432738|NCT02073682|Tinzaparin|tinzaparin|mesh-list
44432739|NCT02073682|Dalteparin|dalteparin|mesh-list
44432740|NCT02073682|Edoxaban|edoxaban|mesh-list
44432741|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
44432755|NCT02073565|Everolimus|everolimus|mesh-list
44432756|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44432757|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432758|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
44432759|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432760|NCT02072824|Pregabalin|pregabalin|mesh-list
44432761|NCT02072824|Analgesics|analgesics|mesh-ancestor
44432762|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
44432763|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432764|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432765|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
44432766|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44432767|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44432768|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432769|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44432770|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44432771|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44432772|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44432773|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44432774|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
44432775|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43798280|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43798281|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798282|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798283|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43771118|NCT02374567|Lacosamide|lacosamide|mesh-list
43771119|NCT02374567|Carbamazepine|carbamazepine|mesh-list
43771120|NCT02374567|Phenytoin|phenytoin|mesh-list
43771121|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
43771122|NCT02374567|Nicergoline|nicergoline|mesh-list
43771123|NCT02374567|Midazolam|midazolam|mesh-list
44432776|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
44432777|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44432778|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432779|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432805|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44432806|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432807|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44432808|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44432809|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432810|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
44432811|NCT02072096|Metformin|metformin|mesh-list
44432812|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
44432813|NCT02072096|Pioglitazone|pioglitazone|mesh-list
44432814|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44432815|NCT02072096|Liraglutide|liraglutide|mesh-list
44432816|NCT02072096|Exenatide|exenatide|mesh-list
44432817|NCT02072096|Glimepiride|glimepiride|mesh-list
44432818|NCT02072096|Linagliptin|linagliptin|mesh-list
44432819|NCT02072096|Acarbose|acarbose|mesh-list
44432820|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432821|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432822|NCT02072096|Incretins|incretins|mesh-ancestor
44432823|NCT02072096|Hormones|hormones|mesh-ancestor
44432824|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44432825|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44432826|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432827|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432828|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432829|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44432830|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44432831|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44432832|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
44432833|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44432834|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44432835|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
44432836|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44432837|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
44432838|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432845|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432846|NCT02070991|Macitentan|macitentan|mesh-list
44432847|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44432848|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44432849|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432850|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44432851|NCT02070757|Meropenem|meropenem|mesh-list
44432852|NCT02070757|Tazobactam|tazobactam|mesh-list
44432912|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432913|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44432914|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
44432915|NCT02068508|Pioglitazone|pioglitazone|mesh-list
44432916|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44432917|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44432918|NCT02068495|Amlodipine|amlodipine|mesh-list
44432919|NCT02068495|Candesartan|candesartan|mesh-list
44432920|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
44432921|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44432922|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44432930|NCT02068443|Metformin|metformin|mesh-list
44432973|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44432974|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432975|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44432976|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432977|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432978|NCT02066389|Upadacitinib|upadacitinib|mesh-list
44432979|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44432980|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44432981|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432982|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432983|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44432984|NCT02066311|Nelfinavir|nelfinavir|mesh-list
44432985|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44432986|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44432987|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
44432988|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44432989|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44432990|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44432991|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44432992|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
44432993|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44432994|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
44432995|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
44432996|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44432997|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
44432998|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44432999|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433000|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44433001|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
44433002|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
44433003|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44433004|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433005|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433006|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164147|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
44164148|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
44164149|NCT00255255|Hormones|hormones|mesh-ancestor
44164150|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43634137|NCT05695508|Hormones|hormones|mesh-ancestor
44433007|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433008|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433009|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433016|NCT02066129|Xhance|xhance|mesh-list
44433017|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433018|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44433019|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
44433020|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433021|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433022|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44433023|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798298|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43798299|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798300|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43798301|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
43798304|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
44433024|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433025|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433026|NCT02065791|Canagliflozin|canagliflozin|mesh-list
44433027|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44433028|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433029|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433030|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433031|NCT02065713|Golimumab|golimumab|mesh-list
44433032|NCT02065713|Methotrexate|methotrexate|mesh-list
44433033|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44433034|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
44433035|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433036|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433037|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433038|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
44433039|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433040|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433041|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433042|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433043|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44433044|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433045|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
44164151|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44433046|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433047|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44433048|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44433049|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433050|NCT02065622|Adalimumab|adalimumab|mesh-list
44433051|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433052|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433053|NCT02065570|Adalimumab|adalimumab|mesh-list
44433054|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433055|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433056|NCT02065557|Adalimumab|adalimumab|mesh-list
44433057|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433058|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433059|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
44433060|NCT02065336|Entecavir|entecavir|mesh-list
44433061|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
44433062|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433063|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
44433064|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433065|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44433066|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
44433067|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
44433068|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433069|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433100|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44433101|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433102|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433103|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
44433104|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44433105|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
44433106|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433107|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433108|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
44433109|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433110|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
44433111|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44433112|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
44433113|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44433114|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
44433115|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433116|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433117|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
44433118|NCT02064166|Insulin|insulin|mesh-list
44433119|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43798310|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
43798311|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433120|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433121|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
44433122|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
44433123|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44433152|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433153|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44433154|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44433155|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
44433157|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433158|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44433159|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44433160|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433161|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433162|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44433163|NCT02062879|Narcotics|narcotics|mesh-ancestor
44433164|NCT02062658|Ketamine|ketamine|mesh-list
44433165|NCT02062658|Analgesics|analgesics|mesh-ancestor
44433166|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
44433167|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433168|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433169|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44433207|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44433208|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
44433209|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433210|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433211|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44433212|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
44433213|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433214|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433215|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44433216|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44433217|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44433218|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433219|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433220|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433221|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
44433222|NCT02061280|Hormones|hormones|mesh-ancestor
43798334|NCT05025098|Venetoclax|venetoclax|mesh-list
44433223|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433224|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
44433225|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
44433226|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433227|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433228|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44433229|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
44433230|NCT02060487|Citric Acid|citric acid|mesh-list
44433231|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
44433232|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
44433233|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44433234|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
44433235|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
44433252|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44433253|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
44433254|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433255|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433257|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433258|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44433259|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44433260|NCT02060370|Growth Substances|growth substances|mesh-ancestor
44433261|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433262|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44433263|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44433264|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433265|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433266|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
44433267|NCT02059434|LAS190792|las190792|mesh-list
44433268|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44433269|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
44433270|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433271|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433272|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44433273|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44433274|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
44433275|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44433276|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433277|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433278|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433279|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44433280|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44433281|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44433282|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44433283|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433284|NCT02059278|Latanoprost|latanoprost|mesh-list
44433285|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44433292|NCT02059239|Cytarabine|cytarabine|mesh-list
44433293|NCT02059239|Rituximab|rituximab|mesh-list
44433294|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
44433295|NCT02059239|Etoposide|etoposide|mesh-list
44433296|NCT02059239|Melphalan|melphalan|mesh-list
44433297|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44433298|NCT02059239|Carmustine|carmustine|mesh-list
44433299|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44433300|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433301|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
44433302|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433303|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433304|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44433305|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44433306|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44433307|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798350|NCT05024799|Narcotics|narcotics|mesh-ancestor
44433308|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433309|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433310|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
44433311|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
44433312|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433313|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433314|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44433315|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
44433316|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44433317|NCT02059187|Insulin|insulin|mesh-list
44433318|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44433319|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
44433320|NCT02059187|MK-1293|mk-1293|mesh-list
44433321|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433322|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433323|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44433324|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
44433325|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433332|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
44433333|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433334|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44433335|NCT02059161|Insulin|insulin|mesh-list
44433336|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44433337|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
44433338|NCT02059161|MK-1293|mk-1293|mesh-list
44433339|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433340|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433341|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44433342|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
44433343|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433344|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44433345|NCT02059135|Antithrombins|antithrombins|mesh-list
44433346|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
44433347|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44433348|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
44433349|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433350|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433351|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
44433352|NCT02058966|Entacapone|entacapone|mesh-list
44433353|NCT02058966|Methamphetamine|methamphetamine|mesh-list
44433354|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44433355|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44433356|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44433357|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433358|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433359|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44433360|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433361|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
44433362|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
44433363|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433364|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
44433365|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433366|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433367|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44433368|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44433369|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433370|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44433372|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433373|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433374|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43798392|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43798393|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798395|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798396|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
43798397|NCT05024448|Hormones|hormones|mesh-ancestor
43798399|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433375|NCT02058940|Incretins|incretins|mesh-ancestor
44433377|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433378|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
44433379|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44433380|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44433381|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433382|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433383|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
44433384|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433385|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433386|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44433387|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433388|NCT02058628|Clindamycin|clindamycin|mesh-list
44433389|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
44433390|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
44433391|NCT02058628|Azelaic acid|azelaic acid|mesh-list
44433392|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433393|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433394|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44433395|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433396|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433397|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433398|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433399|NCT02058537|Bethanechol|bethanechol|mesh-list
44433400|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44433401|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
44433402|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433404|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44433409|NCT02058368|Tamsulosin|tamsulosin|mesh-list
44433410|NCT02058368|Dutasteride|dutasteride|mesh-list
44433411|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44433412|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44433413|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44433414|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433415|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433416|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433417|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433418|NCT02058368|Urological Agents|urological agents|mesh-ancestor
43798459|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433419|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44433420|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44433421|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433422|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
44433423|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433424|NCT02058290|Morphine|morphine|mesh-list
44433425|NCT02058290|Bupivacaine|bupivacaine|mesh-list
44433426|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
44433427|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
44433428|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433429|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433430|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
44433431|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433432|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44433433|NCT02058290|Narcotics|narcotics|mesh-ancestor
44433434|NCT02058290|Analgesics|analgesics|mesh-ancestor
44433435|NCT02058160|Insulin|insulin|mesh-list
44433436|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44433437|NCT02058160|Metformin|metformin|mesh-list
44433438|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
44433439|NCT02058160|Lixisenatide|lixisenatide|mesh-list
44433440|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44433441|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433442|NCT02058147|Insulin|insulin|mesh-list
44433443|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43798525|NCT05023122|Vitamin D|vitamin d|mesh-list
44433451|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433452|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44433453|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433454|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433455|NCT02058095|Tadalafil|tadalafil|mesh-list
44433456|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433457|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44433458|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44433459|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433460|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433461|NCT02058095|Urological Agents|urological agents|mesh-ancestor
44091710|NCT00033046|Modafinil|modafinil|mesh-list
44433462|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
44433463|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44433464|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433465|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44433466|NCT02057575|Latanoprost|latanoprost|mesh-list
44433467|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44433468|NCT02057549|Haloperidol|haloperidol|mesh-list
44433469|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
44433470|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
44433471|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
44433472|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433473|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433474|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44433475|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44433476|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44433477|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433478|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44433479|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44433480|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
44433481|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433482|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433483|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44433484|NCT02057523|Hormones|hormones|mesh-list
44433485|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44433488|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433489|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433490|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433491|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798657|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
43798658|NCT05018923|Rabeprazole|rabeprazole|mesh-list
43798659|NCT05018923|Bismuth|bismuth|mesh-list
43798671|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43798672|NCT05018923|Diuretics|diuretics|mesh-ancestor
43654569|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
44433492|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
44433493|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433494|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44433495|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44433496|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433497|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433498|NCT02057458|Urological Agents|urological agents|mesh-ancestor
44433499|NCT02057393|Methylene Blue|methylene blue|mesh-list
44433500|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433547|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44433548|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
44433549|NCT02056626|Protective Agents|protective agents|mesh-ancestor
44433550|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44433551|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433552|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44433553|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433554|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44433555|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44433556|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
44433557|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433558|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433559|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44433560|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44433561|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433564|NCT02056340|Atorvastatin|atorvastatin|mesh-list
44433607|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433608|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433609|NCT02055820|Prednisone|prednisone|mesh-list
44433610|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
44433611|NCT02055820|Rituximab|rituximab|mesh-list
44433612|NCT02055820|Doxorubicin|doxorubicin|mesh-list
44433613|NCT02055820|Vincristine|vincristine|mesh-list
44433615|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
44433616|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433617|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
44433618|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433619|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433620|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44433621|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
44433622|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433623|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433624|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44433625|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44433626|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44433627|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44433628|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44433629|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433630|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433631|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
44433632|NCT02055820|Hormones|hormones|mesh-ancestor
44433633|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433634|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44433635|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44433636|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
44433637|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
44433653|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433654|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44433655|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44433656|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44433657|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433658|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433659|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433660|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
44433661|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
44433662|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433663|NCT02054702|Aripiprazole|aripiprazole|mesh-list
44433664|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
44433665|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
44433672|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
44433712|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44433713|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44433714|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44433715|NCT02053493|Diuretics|diuretics|mesh-ancestor
44433716|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
44433717|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433718|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433719|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44433720|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433721|NCT02053246|Nebivolol|nebivolol|mesh-list
44433722|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44433723|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
44433724|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44433725|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44433726|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44433727|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433728|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433729|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842082|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842083|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
43842084|NCT04553666|Vitamins|vitamins|mesh-list
43842085|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
43842086|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43842087|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
43842088|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842089|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
43842090|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842091|NCT04553666|Protective Agents|protective agents|mesh-ancestor
43842092|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43842093|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43798778|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43798779|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
43798780|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433730|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433731|NCT02052960|Cisplatin|cisplatin|mesh-list
44433732|NCT02052960|Fluorouracil|fluorouracil|mesh-list
44433733|NCT02052960|Cetuximab|cetuximab|mesh-list
44433734|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433735|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
44433736|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433737|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433738|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433739|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
44433740|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433741|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44433742|NCT02052739|Brexanolone|brexanolone|mesh-list
44433743|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
44433744|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433745|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433746|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433747|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
44433748|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
44433749|NCT02052440|Baclofen|baclofen|mesh-list
44433750|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44433751|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433752|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44433753|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433754|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44433755|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
44433756|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
44433757|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433758|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433759|NCT02052414|Gabapentin|gabapentin|mesh-list
44433760|NCT02052414|Analgesics|analgesics|mesh-ancestor
44433761|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
44433762|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433763|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433764|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
44433765|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44433766|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44433767|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44433768|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44433769|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44433770|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44433771|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433772|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433773|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
44433775|NCT02052310|Hematinics|hematinics|mesh-ancestor
44433776|NCT02052011|Ranolazine|ranolazine|mesh-list
44433777|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44433778|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44433779|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433791|NCT02051296|Minocycline|minocycline|mesh-list
44433792|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44433793|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433794|NCT02050321|Vemurafenib|vemurafenib|mesh-list
44433795|NCT02050321|Acitretin|acitretin|mesh-list
44433796|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433797|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44433798|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433799|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433800|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
44433801|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433802|NCT02049957|Fulvestrant|fulvestrant|mesh-list
44433803|NCT02049957|Exemestane|exemestane|mesh-list
44433804|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44433805|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433806|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44433807|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44433808|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
44433809|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433810|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433846|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44433847|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
44433848|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433849|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433850|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433851|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44433852|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44433853|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433854|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433855|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
44433856|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433857|NCT02047903|Afatinib|afatinib|mesh-list
44433858|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433859|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44433860|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433861|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433862|NCT02047734|Interferons|interferons|mesh-list
44433863|NCT02047734|Interferon-beta|interferon-beta|mesh-list
44433864|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
44433865|NCT02047734|Ozanimod|ozanimod|mesh-list
44433866|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433867|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
44433868|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433869|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
44433870|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433871|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44433872|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44433873|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433874|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433875|NCT02047513|Gemcitabine|gemcitabine|mesh-list
44433876|NCT02047513|Paclitaxel|paclitaxel|mesh-list
44433877|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44433878|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44433879|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433880|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
44433881|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
44433882|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
44433883|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433884|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433885|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
44433886|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
44433887|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433888|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433889|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433890|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
44433891|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433892|NCT02047253|Acyclovir|acyclovir|mesh-list
44433893|NCT02047253|Dexamethasone|dexamethasone|mesh-list
44433894|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44433895|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
44433896|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
44433897|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44433898|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433899|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44433900|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
44433901|NCT02047253|Hormones|hormones|mesh-ancestor
44433902|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433903|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44433904|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433905|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
44433906|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433907|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44433908|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44433909|NCT02047227|Hormones|hormones|mesh-ancestor
44433910|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44433911|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433926|NCT02046616|Methotrexate|methotrexate|mesh-list
44433927|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44433928|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
44433929|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433930|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433931|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433932|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
44433933|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433934|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433935|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433936|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433937|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44433938|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433939|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
44433940|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433941|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44433942|NCT02046603|Methotrexate|methotrexate|mesh-list
44433943|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44433944|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
44433945|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44433946|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433947|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433948|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
44433949|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433950|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433951|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
44433952|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433953|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44433954|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433955|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
44433968|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44433969|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433970|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44433971|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44433972|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
44433973|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44433974|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44433975|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
44433976|NCT02046122|Cytarabine|cytarabine|mesh-list
44433977|NCT02046122|Idarubicin|idarubicin|mesh-list
44433978|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44433979|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
44433980|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44433981|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44433982|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
44433983|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44433984|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433985|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
44433986|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433987|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44433988|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44433989|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44433990|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44433992|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
44433993|NCT02046070|Ixazomib|ixazomib|mesh-list
44433994|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44433995|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
44433996|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44433997|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44433998|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44433999|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
44434000|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434001|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434004|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
44434009|NCT02046070|Hormones|hormones|mesh-ancestor
44434010|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434011|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44434012|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434013|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434014|NCT02045979|Adalimumab|adalimumab|mesh-list
44434015|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434016|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434017|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
44434018|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
44434019|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44434020|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
44434021|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434022|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434023|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434024|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434025|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44434026|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434027|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434028|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434029|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434030|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434031|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434032|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
44434033|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44434034|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
44434035|NCT02045862|Mirabegron|mirabegron|mesh-list
44434036|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44434037|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44434038|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
44434039|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434040|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434041|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434042|NCT02045862|Urological Agents|urological agents|mesh-ancestor
44434048|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44434049|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
44434050|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434051|NCT02044822|Rituximab|rituximab|mesh-list
44434052|NCT02044822|Idelalisib|idelalisib|mesh-list
44434053|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44434054|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434055|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
44434056|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434057|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434058|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434059|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434060|NCT02044510|Mirabegron|mirabegron|mesh-list
44434061|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44434062|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434063|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434064|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434065|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434066|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434067|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434068|NCT02044510|Urological Agents|urological agents|mesh-ancestor
44434069|NCT02044302|Morphine|morphine|mesh-list
44434070|NCT02044302|Narcotics|narcotics|mesh-list
44434071|NCT02044302|Analgesics|analgesics|mesh-list
44434072|NCT02044302|Bupivacaine|bupivacaine|mesh-list
44434073|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
44434074|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
44434075|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
44434076|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434077|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434078|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
44434079|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434080|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434081|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44434082|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434083|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434085|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434086|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
44434087|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44434088|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434089|NCT02044094|Buprenorphine|buprenorphine|mesh-list
44434090|NCT02044094|Hydromorphone|hydromorphone|mesh-list
44434091|NCT02044094|Naloxone|naloxone|mesh-list
44434092|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434093|NCT02044094|Narcotics|narcotics|mesh-ancestor
44434094|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434095|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434096|NCT02044094|Analgesics|analgesics|mesh-ancestor
44434097|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
44434098|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434099|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44434100|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44434101|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434102|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434103|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434104|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44434105|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
44434106|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
44434107|NCT02043366|Sufentanil|sufentanil|mesh-list
44434108|NCT02043366|Remifentanil|remifentanil|mesh-list
44434109|NCT02043366|Butorphanol|butorphanol|mesh-list
44434110|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434111|NCT02043366|Narcotics|narcotics|mesh-ancestor
43798921|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798922|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798923|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798924|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798925|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
43798926|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44434112|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434113|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434114|NCT02043366|Analgesics|analgesics|mesh-ancestor
44434115|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
44434116|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434120|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
44434129|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434130|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44434131|NCT02043301|Bococizumab|bococizumab|mesh-list
44434132|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44434133|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44434134|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
44434135|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434136|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44434137|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
44434138|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
44434139|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44434144|NCT02042443|Leucovorin|leucovorin|mesh-list
44434197|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434198|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434199|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434200|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434201|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434202|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434203|NCT02041299|Deferiprone|deferiprone|mesh-list
44434204|NCT02041299|Deferoxamine|deferoxamine|mesh-list
44434205|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44434206|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
44434207|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
44434208|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434209|NCT02041299|Siderophores|siderophores|mesh-ancestor
44434210|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44434211|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
44434212|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434213|NCT02040870|Ceritinib|ceritinib|mesh-list
44434214|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434215|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164152|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44164153|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44164154|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
44164155|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164156|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164157|NCT00255268|Goserelin|goserelin|mesh-list
44164158|NCT00255268|Bicalutamide|bicalutamide|mesh-list
44164159|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164160|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164161|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
44164162|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
44164163|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164164|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164165|NCT00255372|Lactulose|lactulose|mesh-list
44164166|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164167|NCT00255385|Micronutrients|micronutrients|mesh-list
44164168|NCT00255385|Trace Elements|trace elements|mesh-list
44164169|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164170|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44164171|NCT00255424|Hematinics|hematinics|mesh-ancestor
44164183|NCT00255463|Anastrozole|anastrozole|mesh-list
44164184|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164185|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164186|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164187|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164188|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164189|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44164190|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44164191|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44164192|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
44164193|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164194|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164196|NCT00255476|Gefitinib|gefitinib|mesh-list
44164197|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164198|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44434216|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434217|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434218|NCT02040779|Beclomethasone|beclomethasone|mesh-list
44434219|NCT02040779|Albuterol|albuterol|mesh-list
44092496|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44434220|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
44434221|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
44434222|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434223|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434224|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434225|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434226|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
44434227|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44434228|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44434229|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44434230|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44434231|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44434232|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434233|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434234|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434235|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
44434236|NCT02040779|Hormones|hormones|mesh-ancestor
44434237|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434238|NCT02040766|Beclomethasone|beclomethasone|mesh-list
44434239|NCT02040766|Albuterol|albuterol|mesh-list
44434240|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
44434241|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
44434242|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434243|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434244|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434245|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434246|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
44434247|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44434255|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
44434256|NCT02040766|Hormones|hormones|mesh-ancestor
44434257|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434258|NCT02040532|Gabapentin|gabapentin|mesh-list
44434259|NCT02040532|Analgesics|analgesics|mesh-ancestor
44434260|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
44434261|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434262|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434263|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
44434264|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44434265|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44434266|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772131|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434267|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44434268|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44434269|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44434270|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434271|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434272|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
44434273|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44434274|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
44434275|NCT02040428|Coagulants|coagulants|mesh-ancestor
44434276|NCT02039908|Methylphenidate|methylphenidate|mesh-list
44434277|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44434278|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434279|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44434303|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44434304|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434305|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44434306|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434307|NCT02039427|Analgesics|analgesics|mesh-ancestor
44434308|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
44434309|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434310|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44434311|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434312|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434313|NCT02038933|Nivolumab|nivolumab|mesh-list
44434314|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44434315|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434316|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44434317|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434318|NCT02038920|Vedolizumab|vedolizumab|mesh-list
44434319|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434320|NCT02038907|Vaccines|vaccines|mesh-list
44434321|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
44434322|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434323|NCT02038881|Vaccines|vaccines|mesh-list
44434324|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
44434325|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434326|NCT02038790|Buprenorphine|buprenorphine|mesh-list
44434327|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44434328|NCT02038790|Naloxone|naloxone|mesh-list
44434329|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434330|NCT02038790|Narcotics|narcotics|mesh-ancestor
44434331|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434332|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434333|NCT02038790|Analgesics|analgesics|mesh-ancestor
44434334|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
44434335|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434336|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44434337|NCT02038777|Cytarabine|cytarabine|mesh-list
44434338|NCT02038777|Azacitidine|azacitidine|mesh-list
44164199|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164200|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164201|NCT00255489|Gefitinib|gefitinib|mesh-list
44434339|NCT02038777|Daunorubicin|daunorubicin|mesh-list
44434340|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44434341|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
44434342|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434343|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434344|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
44434345|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434346|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434347|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
44434348|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434349|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434350|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44434351|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44434352|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43654574|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
43654575|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798957|NCT05015322|Prednisolone|prednisolone|mesh-list
43798958|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
43772232|NCT02367755|Lorazepam|lorazepam|mesh-list
44434353|NCT02038647|Paclitaxel|paclitaxel|mesh-list
44434354|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434355|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434356|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434357|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434358|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434359|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434360|NCT02038153|Lenalidomide|lenalidomide|mesh-list
44434361|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
44434362|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434363|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44434364|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44434365|NCT02038153|Growth Substances|growth substances|mesh-ancestor
44434366|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
44434384|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
44434385|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434386|NCT02037477|Esomeprazole|esomeprazole|mesh-list
44434387|NCT02037477|Rabeprazole|rabeprazole|mesh-list
44434388|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44434389|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434390|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44434391|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434392|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434393|NCT02037295|Vancomycin|vancomycin|mesh-list
44434394|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44434395|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434396|NCT02037256|Bortezomib|bortezomib|mesh-list
44434397|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434398|NCT02037165|Celecoxib|celecoxib|mesh-list
44434399|NCT02037165|Pregabalin|pregabalin|mesh-list
44434400|NCT02037165|Analgesics|analgesics|mesh-ancestor
44434401|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
44434402|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434403|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434404|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
44434405|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44434406|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434407|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434408|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434409|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44434410|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44434411|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434412|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44434413|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44434414|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434415|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434416|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43798959|NCT05015322|Bupivacaine|bupivacaine|mesh-list
43798960|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43798961|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
43799055|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799057|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
43799058|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434427|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44434428|NCT02036515|Glimepiride|glimepiride|mesh-list
44434429|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
44434430|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434431|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434432|NCT02036515|Incretins|incretins|mesh-ancestor
44434433|NCT02036515|Hormones|hormones|mesh-ancestor
44434434|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434435|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44434436|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434437|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434438|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434439|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44434440|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434441|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
44434442|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44434443|NCT02036502|Dexamethasone|dexamethasone|mesh-list
44434444|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
44434445|NCT02036502|Lenalidomide|lenalidomide|mesh-list
44434446|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434447|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
44434448|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
44434449|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434450|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434451|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434452|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
44434453|NCT02036502|Hormones|hormones|mesh-ancestor
44434454|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434456|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434471|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434472|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434473|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44434474|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44434475|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44434476|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
44434477|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434478|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434479|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
44434480|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44434481|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434482|NCT02034916|Talazoparib|talazoparib|mesh-list
44434483|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44434484|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434485|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434486|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434487|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44434488|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
44434489|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434490|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44434491|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
44434492|NCT02034799|Coagulants|coagulants|mesh-ancestor
44434493|NCT02034591|Apixaban|apixaban|mesh-list
44434494|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44434495|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
44434496|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44434497|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434498|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434500|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
44434515|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434516|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434517|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44434518|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434519|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44434520|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434521|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434522|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
44434523|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44434525|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44434526|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
44434527|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
44434528|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434529|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434530|NCT02034435|Amlodipine|amlodipine|mesh-list
44434531|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44434532|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44434533|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44434534|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434535|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434536|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434537|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
44434538|NCT02034162|Mebendazole|mebendazole|mesh-list
44434539|NCT02034162|Piperazine|piperazine|mesh-list
44434540|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
44434541|NCT02034162|DMP 777|dmp 777|mesh-list
44434542|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
44434543|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
44434544|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44434545|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434546|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434547|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
44434548|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
44434549|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164202|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164203|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164204|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434550|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434551|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434552|NCT02034006|Ranibizumab|ranibizumab|mesh-list
44434553|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44434554|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44434555|NCT02034006|Growth Substances|growth substances|mesh-ancestor
44434556|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434557|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
44434558|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434559|NCT02033889|Insulin|insulin|mesh-list
44434560|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44434561|NCT02033889|Metformin|metformin|mesh-list
44434562|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
44434563|NCT02033889|Glimepiride|glimepiride|mesh-list
44434564|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
44434565|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
44434566|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434567|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434568|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799214|NCT05009953|Vitamins|vitamins|mesh-ancestor
44434569|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434570|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
44434571|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44434572|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434573|NCT02033369|Pramipexole|pramipexole|mesh-list
44434574|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
44434575|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434576|NCT02033369|Protective Agents|protective agents|mesh-ancestor
44434577|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434578|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44434579|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44434580|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
44434581|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
44434582|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434583|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
44434584|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
44434585|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434586|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
44434587|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
44164205|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164206|NCT00255502|Metoprolol|metoprolol|mesh-list
44434588|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434590|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
44434591|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
44434592|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434593|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
44434594|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434595|NCT02032407|Dapsone|dapsone|mesh-list
44434596|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434597|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
44434598|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44434599|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44434600|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44434601|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434602|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434603|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
44434604|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44434605|NCT02032173|Ranibizumab|ranibizumab|mesh-list
44434606|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44434607|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44434608|NCT02032173|Growth Substances|growth substances|mesh-ancestor
44434609|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434610|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
44434611|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434612|NCT02031640|Beclomethasone|beclomethasone|mesh-list
44434613|NCT02031640|Albuterol|albuterol|mesh-list
44434614|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
44434615|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
44434616|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434617|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434618|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434619|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434620|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
44434621|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44434631|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434632|NCT02031536|Everolimus|everolimus|mesh-list
44434633|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434634|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434635|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
44434636|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434637|NCT02031458|Atezolizumab|atezolizumab|mesh-list
44434638|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434639|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44434640|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
44434641|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434642|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
44434643|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
44434644|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44434645|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44434646|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434647|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
44434648|NCT02030821|Coagulants|coagulants|mesh-ancestor
44434649|NCT02030600|Insulin|insulin|mesh-list
44434650|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44434651|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
44434652|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434653|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434654|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
44434655|NCT02030535|Olodaterol|olodaterol|mesh-list
44434656|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44434657|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
44434658|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434659|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434660|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434678|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434679|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44434680|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434681|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44434682|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44434683|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
44434684|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434685|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44434686|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44434687|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434688|NCT02030015|Miglustat|miglustat|mesh-list
44434689|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434690|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434691|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44434692|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44434693|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
44434694|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434695|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44434696|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434697|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434698|NCT02029989|Chrysarobin|chrysarobin|mesh-list
44434699|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43799232|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43799233|NCT05009017|Growth Substances|growth substances|mesh-ancestor
43799234|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799235|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
43799236|NCT05008939|Sevoflurane|sevoflurane|mesh-list
43799237|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43799238|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43799239|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
43799240|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
43799241|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799242|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799243|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
43799244|NCT05008861|Nivolumab|nivolumab|mesh-list
43799245|NCT05008861|Durvalumab|durvalumab|mesh-list
43772529|NCT02365727|Analgesics|analgesics|mesh-ancestor
43772563|NCT02365532|Dofetilide|dofetilide|mesh-list
44434700|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434701|NCT02029989|Analgesics|analgesics|mesh-ancestor
44434702|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
44434703|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434704|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434705|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434706|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434707|NCT02029846|Metformin|metformin|mesh-list
44434708|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44434709|NCT02029846|Incretins|incretins|mesh-list
44434710|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434715|NCT02029846|Hormones|hormones|mesh-ancestor
44434716|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434718|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
44434719|NCT02029638|Promethazine|promethazine|mesh-list
44434720|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
44434721|NCT02029638|Prednisone|prednisone|mesh-list
44434722|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
44434723|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
44434724|NCT02029638|Fludarabine|fludarabine|mesh-list
44434725|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
44434726|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44434727|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434728|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
44434729|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434730|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44434731|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44434732|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
44434733|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434734|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434735|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44434736|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44434737|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
44434738|NCT02029638|Hormones|hormones|mesh-ancestor
44434739|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44434740|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44434741|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434742|NCT02029638|Analgesics|analgesics|mesh-ancestor
44434743|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
44434744|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434745|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
44434746|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44434760|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
44434761|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
44434762|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44434763|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
44434764|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
44434765|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434766|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44434767|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
44434768|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
44434769|NCT02029417|Cytarabine|cytarabine|mesh-list
44434770|NCT02029417|Decitabine|decitabine|mesh-list
44434771|NCT02029417|Azacitidine|azacitidine|mesh-list
44434772|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
44434773|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44434774|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
44434775|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434776|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434777|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
44434778|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434779|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434780|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
44434781|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434782|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434783|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44434784|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44434785|NCT02029274|Siponimod|siponimod|mesh-list
44434786|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44434787|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434788|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44434789|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
44434805|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434806|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434807|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434808|NCT02029235|Narcotics|narcotics|mesh-ancestor
44434809|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434810|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
44434811|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434812|NCT02028871|Insulin|insulin|mesh-list
44434813|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434814|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434815|NCT02028767|Metformin|metformin|mesh-list
44434816|NCT02028767|Empagliflozin|empagliflozin|mesh-list
44434817|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434818|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434819|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44434820|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434821|NCT02028715|Acetaminophen|acetaminophen|mesh-list
44434822|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44434823|NCT02028715|Analgesics|analgesics|mesh-ancestor
44434824|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
44434825|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434826|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434827|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
44434828|NCT02028338|Dapivirine|dapivirine|mesh-list
44434829|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44434830|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44434831|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
44434832|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44434833|NCT02027428|Paclitaxel|paclitaxel|mesh-list
44434834|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44434835|NCT02027428|Carboplatin|carboplatin|mesh-list
44434838|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
44434851|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44434852|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44434853|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44434854|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434855|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44434856|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44434857|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44434858|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44434859|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
44434860|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
44434861|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
44434862|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
44434863|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434864|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434865|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44434866|NCT02027311|Narcotics|narcotics|mesh-ancestor
44434867|NCT02027311|Analgesics|analgesics|mesh-ancestor
44434868|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
44434869|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799246|NCT05008861|Antibodies|antibodies|mesh-list
43799247|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43799248|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
43799273|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
43799274|NCT05008458|Coagulants|coagulants|mesh-ancestor
44434870|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
44434871|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44434902|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44434903|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
44434904|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434905|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434906|NCT02025725|Metoclopramide|metoclopramide|mesh-list
44434907|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
44434908|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
44434909|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44434910|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434911|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44434912|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44434913|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44434914|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
44434915|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434916|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434917|NCT02025621|Simendan|simendan|mesh-list
44434918|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44434919|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
44434920|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44434921|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44434922|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434923|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434924|NCT02025621|Protective Agents|protective agents|mesh-ancestor
44434925|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434926|NCT02025179|Teriparatide|teriparatide|mesh-list
44434927|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44434928|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434929|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44434930|NCT02024971|Metformin|metformin|mesh-list
44434931|NCT02024971|Pioglitazone|pioglitazone|mesh-list
44434932|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44434933|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434934|NCT02024867|Trimethoprim|trimethoprim|mesh-list
44434935|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44434936|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
44434940|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
44434941|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44434942|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44434943|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44434944|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434945|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434946|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44434947|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44434948|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44434949|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44434950|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44434951|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
44434952|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434954|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
44434955|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434956|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44434957|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44434958|NCT02023151|Omalizumab|omalizumab|mesh-list
44434959|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44434960|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44434961|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
44434962|NCT02023112|Ritonavir|ritonavir|mesh-list
44434963|NCT02023112|Ribavirin|ribavirin|mesh-list
44434964|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44434965|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44434966|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
44434967|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44434968|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434986|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44434987|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44434988|NCT02022748|Ticagrelor|ticagrelor|mesh-list
44434989|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44434990|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44434991|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44434992|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44434993|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
44434994|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44434995|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44434996|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44434997|NCT02022657|Tenofovir|tenofovir|mesh-list
44434998|NCT02022657|Emtricitabine|emtricitabine|mesh-list
44434999|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44435000|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
44435001|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435002|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44435003|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44435004|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435005|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435006|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44435007|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44435008|NCT02022007|Metformin|metformin|mesh-list
44435009|NCT02022007|Saxagliptin|saxagliptin|mesh-list
44435010|NCT02022007|Biguanides|biguanides|mesh-list
44435011|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44435012|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435013|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435014|NCT02022007|Incretins|incretins|mesh-ancestor
44435015|NCT02022007|Hormones|hormones|mesh-ancestor
44435016|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435017|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44435018|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435020|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
44435025|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
44435026|NCT02021643|Ribavirin|ribavirin|mesh-list
44435027|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
44435028|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435029|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
44435030|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435031|NCT02021331|Cimetidine|cimetidine|mesh-list
44435032|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44435033|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435034|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44435035|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
44435036|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
44435037|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435038|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435039|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435040|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44435041|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44435042|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435043|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
44435044|NCT02021318|Hematinics|hematinics|mesh-ancestor
44435045|NCT02021292|Macitentan|macitentan|mesh-list
44435046|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44435047|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44435048|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435049|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44435050|NCT02020941|Dexamethasone|dexamethasone|mesh-list
44435051|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435052|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
44435053|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
43799394|NCT05006911|Miotics|miotics|mesh-ancestor
44435054|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435055|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435058|NCT02020941|Hormones|hormones|mesh-ancestor
44435066|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44435067|NCT02020616|Incretins|incretins|mesh-ancestor
44435069|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435070|NCT02020577|Cetuximab|cetuximab|mesh-list
44435071|NCT02020577|Afatinib|afatinib|mesh-list
44435072|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435073|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435074|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44435075|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435076|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435077|NCT02020512|Bimatoprost|bimatoprost|mesh-list
44435078|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44435079|NCT02020031|Vancomycin|vancomycin|mesh-list
44435080|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435081|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435082|NCT02019979|Metformin|metformin|mesh-list
44435083|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435084|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435085|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
44435086|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44435087|NCT02019667|Protective Agents|protective agents|mesh-ancestor
44435088|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435089|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
44435090|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
44435091|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435092|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435093|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
44435094|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435095|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
44435096|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435097|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435109|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44435110|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435111|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435112|NCT02019277|Paclitaxel|paclitaxel|mesh-list
44435113|NCT02019277|Docetaxel|docetaxel|mesh-list
44435114|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44435115|NCT02019277|Trastuzumab|trastuzumab|mesh-list
44435116|NCT02019277|Pertuzumab|pertuzumab|mesh-list
44435117|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435118|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435119|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435120|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435121|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435122|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435123|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435124|NCT02018861|Rituximab|rituximab|mesh-list
44435125|NCT02018861|Carboplatin|carboplatin|mesh-list
44435126|NCT02018861|Etoposide|etoposide|mesh-list
44435127|NCT02018861|Ifosfamide|ifosfamide|mesh-list
44435128|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435129|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435130|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
44435140|NCT02018822|Urethane|urethane|mesh-list
44435163|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435164|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435165|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
44435166|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44435167|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435168|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44435169|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44435170|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435171|NCT02018042|Abatacept|abatacept|mesh-list
44435172|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44435173|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435174|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435175|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435176|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
44435177|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435178|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435179|NCT02017899|Vaccines|vaccines|mesh-list
43799396|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44435180|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
44435181|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435182|NCT02017860|Everolimus|everolimus|mesh-list
44435183|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435184|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435185|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
44435186|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435187|NCT02017535|Fluoxetine|fluoxetine|mesh-list
44435188|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44435189|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44435210|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435211|NCT02017015|Gemcitabine|gemcitabine|mesh-list
44435212|NCT02017015|Paclitaxel|paclitaxel|mesh-list
44435213|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44435214|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435215|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435216|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435217|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435218|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435219|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435220|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
44435221|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
44435222|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435223|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435224|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435225|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
44435227|NCT02016898|Mitomycins|mitomycins|mesh-list
44435267|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44435268|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44435269|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44435270|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44435271|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44435272|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
44435273|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435274|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435275|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435277|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435278|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435279|NCT02015819|Leucovorin|leucovorin|mesh-list
44435280|NCT02015819|Flucytosine|flucytosine|mesh-list
44435281|NCT02015819|Calcium|calcium|mesh-list
44435282|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
44435283|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44435284|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435285|NCT02015819|Antidotes|antidotes|mesh-ancestor
44435286|NCT02015819|Protective Agents|protective agents|mesh-ancestor
44435287|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
44435288|NCT02015819|Vitamins|vitamins|mesh-ancestor
44435289|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
44435290|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
44435318|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435319|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435320|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
44435321|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435322|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44435323|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44435324|NCT02015195|Ethanol|ethanol|mesh-list
44435325|NCT02015195|Acetic Acid|acetic acid|mesh-list
44435326|NCT02015195|Retinol acetate|retinol acetate|mesh-list
44435327|NCT02015195|Lidocaine|lidocaine|mesh-list
44435328|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
44435329|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
44435330|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435331|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435332|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
44435333|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435334|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44435335|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44435336|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44435337|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435338|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435339|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44435340|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435341|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435342|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44435343|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
44435344|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44435364|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435365|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435366|NCT02014467|Vitamin D|vitamin d|mesh-list
44435367|NCT02014467|Denosumab|denosumab|mesh-list
44435368|NCT02014467|Calcium|calcium|mesh-list
44435369|NCT02014467|Vitamins|vitamins|mesh-ancestor
44435370|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
44435371|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435372|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44435373|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44435374|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44435375|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435376|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435377|NCT02014402|Thrombin|thrombin|mesh-list
44435378|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
44435379|NCT02014402|Coagulants|coagulants|mesh-ancestor
44435380|NCT02013830|Bevacizumab|bevacizumab|mesh-list
44435381|NCT02013830|Capecitabine|capecitabine|mesh-list
44435382|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435383|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435384|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44435385|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44435386|NCT02013830|Growth Substances|growth substances|mesh-ancestor
44435387|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44093655|NCT00038168|Paclitaxel|paclitaxel|mesh-list
44435388|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44435389|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435390|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
44435391|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435392|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
44435393|NCT02013817|Rituximab|rituximab|mesh-list
44435394|NCT02013817|Fludarabine|fludarabine|mesh-list
44435395|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435396|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
44435397|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435398|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435400|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
44435402|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435403|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44435404|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435405|NCT02013791|Cyclosporine|cyclosporine|mesh-list
44435406|NCT02013791|Cyclosporins|cyclosporins|mesh-list
44435407|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435408|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435409|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435410|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
44435411|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435412|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
44435413|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435414|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
44435415|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435416|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44435417|NCT02013765|Trastuzumab|trastuzumab|mesh-list
44435418|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435419|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435420|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
44435421|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
44435422|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435423|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435454|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435455|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435456|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44435457|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435458|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435459|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435460|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
44435461|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435462|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44435463|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435464|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44435467|NCT02013037|Eculizumab|eculizumab|mesh-list
44435512|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
44435513|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
44435514|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44435515|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44435516|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
44435517|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
44435518|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435519|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435520|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435521|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
44435522|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
44435523|NCT02011945|Nivolumab|nivolumab|mesh-list
44435524|NCT02011945|Dasatinib|dasatinib|mesh-list
44435525|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435526|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435527|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44435528|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435529|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44435530|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435531|NCT02011386|Golimumab|golimumab|mesh-list
44435532|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44435533|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435534|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435563|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435564|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44435565|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435567|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44435568|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44435569|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44435570|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44435571|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
44435572|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435573|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435574|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435575|NCT02010593|Dapivirine|dapivirine|mesh-list
44435576|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44435577|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44435578|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
44435579|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435580|NCT02010567|Capecitabine|capecitabine|mesh-list
44435581|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435582|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
44435583|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435584|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435585|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
44435586|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44435587|NCT02010255|Ledipasvir|ledipasvir|mesh-list
44435611|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435612|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44435613|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435614|NCT02009332|Gemcitabine|gemcitabine|mesh-list
44435615|NCT02009332|Sirolimus|sirolimus|mesh-list
44435616|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435617|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
44435618|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435619|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435620|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
44435621|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435622|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435623|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435624|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
44435625|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435626|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435627|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44435628|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
44435629|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44435630|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44435631|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435663|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
44435664|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435665|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435666|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44435667|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44435668|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44435669|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
44435670|NCT02008370|Bupivacaine|bupivacaine|mesh-list
44435671|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
44435672|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
44435673|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435674|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435675|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
44435676|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435677|NCT02008227|Docetaxel|docetaxel|mesh-list
44435678|NCT02008227|Atezolizumab|atezolizumab|mesh-list
44435679|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435680|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
44435681|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435682|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
44435683|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435684|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
44435685|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44435686|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44435687|NCT02007577|Analgesics|analgesics|mesh-ancestor
44435688|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
44435689|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435690|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435691|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435692|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435693|NCT02007512|Exemestane|exemestane|mesh-list
44435694|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435695|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44435696|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43962658|NCT01516268|Sufentanil|sufentanil|mesh-list
44435701|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435702|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435705|NCT02007434|Lidocaine|lidocaine|mesh-list
44435706|NCT02007434|Epinephrine|epinephrine|mesh-list
44435707|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
44435708|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
44435709|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
44435710|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435711|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435712|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
44435713|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435714|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44435715|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44435716|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44435720|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44435761|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
44435762|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44435763|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435764|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
44435765|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435766|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
44435767|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435768|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435769|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
44435770|NCT02006732|Olodaterol|olodaterol|mesh-list
44435771|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44435772|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
44435773|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435774|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435775|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44435776|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
44435777|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
44435778|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44435780|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435781|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435782|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
43799503|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44435783|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44435784|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44435785|NCT02006706|Prednisolone|prednisolone|mesh-list
44435786|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
44435787|NCT02006706|Rituximab|rituximab|mesh-list
44435788|NCT02006706|Methotrexate|methotrexate|mesh-list
44435789|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44435790|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
44435791|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435792|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435793|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
44435794|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435803|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435804|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44435805|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435806|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44435807|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44435808|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
44435809|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
44435810|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44435811|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435812|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
44435813|NCT02006706|Hormones|hormones|mesh-ancestor
44435814|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435815|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44435816|NCT02006706|Protective Agents|protective agents|mesh-ancestor
44435817|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44435862|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435863|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44435864|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
44435865|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44435866|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435867|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
44435868|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44435869|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
44435870|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44435871|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44435872|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44435873|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
44435874|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435875|NCT02005562|Cyclosporine|cyclosporine|mesh-list
44435876|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
44435877|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
44435878|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44435879|NCT02005562|Cyclosporins|cyclosporins|mesh-list
44435880|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435915|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435916|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435917|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435918|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
44435919|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435920|NCT02005029|Erythromycin|erythromycin|mesh-list
44435921|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
44435922|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44435923|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
44435924|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44435925|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44435926|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435927|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44435928|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435929|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435931|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435932|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435933|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
44435934|NCT02004262|Pancrelipase|pancrelipase|mesh-list
44435935|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435936|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
44435937|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435938|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44435939|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44435940|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
44435941|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435942|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435943|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44435944|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44435945|NCT02004093|Gemcitabine|gemcitabine|mesh-list
44435959|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435960|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44435961|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
44435962|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435963|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44435964|NCT02003898|Insulin|insulin|mesh-list
44435965|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44435966|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435967|NCT02003638|Niacin|niacin|mesh-list
44435968|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44435969|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
44435970|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435971|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44435972|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
44435973|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
44435974|NCT02003638|Vitamins|vitamins|mesh-ancestor
44435975|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
44435976|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44435977|NCT02003573|Decitabine|decitabine|mesh-list
44435978|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44435979|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
44435980|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44435981|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44435982|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44435983|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44435984|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44435985|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44435986|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44435987|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44435988|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
44435989|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44435990|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436001|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436002|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44436003|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44436004|NCT02003365|Triamcinolone|triamcinolone|mesh-list
44436005|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44436006|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44436007|NCT02003365|FX006|fx006|mesh-list
44436008|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44436009|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436010|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
44436011|NCT02003365|Hormones|hormones|mesh-ancestor
44436012|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436013|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436014|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436015|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
44436016|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436017|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436018|NCT02003144|Eculizumab|eculizumab|mesh-list
44436019|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44436020|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436053|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436054|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799504|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
44436055|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
44436056|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436057|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436058|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436059|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436060|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44436061|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436062|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
44436063|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436064|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44436065|NCT02001181|Tofacitinib|tofacitinib|mesh-list
44436066|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436067|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436068|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436069|NCT02000921|Nicotine|nicotine|mesh-list
44436070|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44436071|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
44436072|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436073|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436074|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44436103|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436104|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436105|NCT02000427|Blinatumomab|blinatumomab|mesh-list
44436106|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436107|NCT01999972|Axitinib|axitinib|mesh-list
44436108|NCT01999972|Crizotinib|crizotinib|mesh-list
44436109|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436110|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436111|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436112|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436113|NCT01999946|Naltrexone|naltrexone|mesh-list
44436114|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44436115|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44436116|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436117|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
44436118|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436119|NCT01999894|Memantine|memantine|mesh-list
44436120|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44436121|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44436122|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
44436123|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436124|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436125|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436126|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44436127|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44436128|NCT01999868|Abatacept|abatacept|mesh-list
44436129|NCT01999868|Ustekinumab|ustekinumab|mesh-list
44436130|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
44436131|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
44436132|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436133|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44436134|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436146|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436147|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
44436148|NCT01999335|Hormones|hormones|mesh-ancestor
44436149|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436150|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44436151|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436152|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
44436153|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436154|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436155|NCT01999335|Growth Substances|growth substances|mesh-ancestor
44436156|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436157|NCT01999322|Insulin|insulin|mesh-list
44436158|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44436159|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
44436160|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
44436161|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44436162|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436163|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436164|NCT01999218|Metformin|metformin|mesh-list
44436165|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44436166|NCT01999218|Glimepiride|glimepiride|mesh-list
44436167|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
44436168|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436169|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436170|NCT01999218|Incretins|incretins|mesh-ancestor
44436171|NCT01999218|Hormones|hormones|mesh-ancestor
44436172|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436173|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44436174|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436175|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436176|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436191|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44436192|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44436193|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436194|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44436195|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
44436196|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44436197|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436198|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436199|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
44436200|NCT01999114|Naltrexone|naltrexone|mesh-list
44436201|NCT01999114|Buprenorphine|buprenorphine|mesh-list
44436202|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44436203|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44436204|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436205|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44436206|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44436207|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436208|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436209|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436210|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44436211|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
44436212|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44436213|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436214|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44436215|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44436216|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44436217|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44436218|NCT01999114|Narcotics|narcotics|mesh-ancestor
44436219|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436220|NCT01999114|Analgesics|analgesics|mesh-ancestor
44436221|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
44436222|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436223|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44436224|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44436225|NCT01998958|Esketamine|esketamine|mesh-list
44436226|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
44436227|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44436228|NCT01998919|Gemcitabine|gemcitabine|mesh-list
44152567|NCT00217412|Vorinostat|vorinostat|mesh-list
44436229|NCT01998919|Cisplatin|cisplatin|mesh-list
44436230|NCT01998919|Carboplatin|carboplatin|mesh-list
44436231|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44436232|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436233|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436234|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
44436235|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436236|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
44436237|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436238|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436239|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436240|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
44436241|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436242|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436244|NCT01998906|Doxorubicin|doxorubicin|mesh-list
44436245|NCT01998906|Trastuzumab|trastuzumab|mesh-list
44436246|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44436247|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436248|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
44436249|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
44436250|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
44436251|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436252|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44436253|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44436254|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44436255|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436256|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436257|NCT01998893|Rituximab|rituximab|mesh-list
44436259|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436273|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436274|NCT01998399|Ticagrelor|ticagrelor|mesh-list
44436275|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44436276|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44436277|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44436278|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44436279|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
44436280|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436281|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436282|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436283|NCT01997333|Capecitabine|capecitabine|mesh-list
44436284|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436285|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
44436286|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436287|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436288|NCT01996826|Bevacizumab|bevacizumab|mesh-list
44436289|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44436290|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436291|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436292|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436293|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436294|NCT01996826|Growth Substances|growth substances|mesh-ancestor
44436295|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436296|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436297|NCT01996826|Laxatives|laxatives|mesh-ancestor
44436298|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436299|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
44436300|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
44436301|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44436302|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44436303|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436304|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
44436305|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44436311|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
44436312|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44436313|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44436314|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436315|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44436316|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436317|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44436318|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44436319|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436320|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44436321|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44436322|NCT01995526|Insulin|insulin|mesh-list
44436323|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436324|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436325|NCT01995266|Asunaprevir|asunaprevir|mesh-list
44436326|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436327|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436328|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436329|NCT01995201|Methotrexate|methotrexate|mesh-list
44436330|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44436331|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
44436332|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44436333|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436334|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436335|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
44436337|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436358|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436359|NCT01994720|Aspirin|aspirin|mesh-list
44436360|NCT01994720|Ticagrelor|ticagrelor|mesh-list
44436361|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44436362|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44436363|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44436364|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44436365|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
44436366|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436367|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436368|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436369|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44436370|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44436371|NCT01994720|Analgesics|analgesics|mesh-ancestor
44436372|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
44436373|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436374|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436375|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436376|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44436377|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44436378|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44436379|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436380|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
44436381|NCT01994590|Prednisone|prednisone|mesh-list
44436382|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
44436383|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436384|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
44436385|NCT01994590|Hormones|hormones|mesh-ancestor
44436386|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436387|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436388|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44436389|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436390|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44436391|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436397|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436398|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
44436399|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436400|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436401|NCT01994291|Ranibizumab|ranibizumab|mesh-list
44436402|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436403|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436404|NCT01994291|Growth Substances|growth substances|mesh-ancestor
44436405|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436406|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436407|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436408|NCT01994226|Naproxen|naproxen|mesh-list
44436409|NCT01994226|Colchicine|colchicine|mesh-list
44436410|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44436411|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44436412|NCT01994226|Analgesics|analgesics|mesh-ancestor
44436413|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
44436414|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436415|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436416|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436417|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436418|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
44436419|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44436420|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436421|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436422|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
44436423|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
44436424|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
44436425|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436426|NCT01993927|Voglibose|voglibose|mesh-list
44436427|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436441|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44436442|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
44436443|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44436444|NCT01993823|Clotrimazole|clotrimazole|mesh-list
44436445|NCT01993823|Miconazole|miconazole|mesh-list
44436446|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44436447|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436448|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
44436449|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44436450|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44436451|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436452|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436453|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44436454|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
44436455|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436456|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436457|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44436458|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44436459|NCT01993667|Acetazolamide|acetazolamide|mesh-list
44436460|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
44436461|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44436462|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436463|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436464|NCT01993667|Diuretics|diuretics|mesh-ancestor
44436490|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44436491|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44436492|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436493|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
44436494|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436495|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436496|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44436497|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44436498|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436499|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44436500|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
44436502|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44436503|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44436504|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44436505|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44436506|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
44436507|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436508|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436509|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436510|NCT01991743|Bupivacaine|bupivacaine|mesh-list
44436511|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
44436512|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
44436513|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436514|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436515|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
44436516|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436517|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44436518|NCT01991197|Gliclazide|gliclazide|mesh-list
44436519|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436520|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436521|NCT01991197|Incretins|incretins|mesh-ancestor
44436522|NCT01991197|Hormones|hormones|mesh-ancestor
44436523|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436526|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436527|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436528|NCT01990859|Ipilimumab|ipilimumab|mesh-list
44436529|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436530|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436531|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44436532|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436533|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
44436534|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44436535|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44436536|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44094765|NCT00039208|Leucovorin|leucovorin|mesh-list
44436537|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
44436538|NCT01990768|Coagulants|coagulants|mesh-ancestor
44436539|NCT01990573|Methadone|methadone|mesh-list
44436540|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44436541|NCT01990573|Narcotics|narcotics|mesh-ancestor
44436542|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436543|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436544|NCT01990573|Analgesics|analgesics|mesh-ancestor
44436545|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
44436546|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436547|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
44436548|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
44436549|NCT01990560|Mifepristone|mifepristone|mesh-list
44436550|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44436551|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
44436568|NCT01990339|Lansoprazole|lansoprazole|mesh-list
44436571|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436572|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44436573|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436574|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799692|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799693|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799694|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
43799751|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
43799752|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
43799753|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799831|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43799833|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44436575|NCT01990300|Pioglitazone|pioglitazone|mesh-list
44436576|NCT01990300|Alogliptin|alogliptin|mesh-list
44436577|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436578|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436579|NCT01990300|Incretins|incretins|mesh-ancestor
44436580|NCT01990300|Hormones|hormones|mesh-ancestor
44436581|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436582|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44436583|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436584|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436585|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436586|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44436587|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436588|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436589|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436590|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436591|NCT01989754|Canagliflozin|canagliflozin|mesh-list
44436592|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44436593|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436594|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436595|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436596|NCT01989689|Etanercept|etanercept|mesh-list
44436597|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44436598|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44436599|NCT01989689|Analgesics|analgesics|mesh-ancestor
44436600|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
44436601|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436602|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436603|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436609|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
44436610|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436611|NCT01989546|Talazoparib|talazoparib|mesh-list
44436612|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44436613|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436614|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436615|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436616|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44436617|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
44436618|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436619|NCT01989455|Deferiprone|deferiprone|mesh-list
44436620|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44436621|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
44436622|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
44436623|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436624|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
44436625|NCT01989208|Cathartics|cathartics|mesh-ancestor
44436626|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436627|NCT01989169|Midazolam|midazolam|mesh-list
44436628|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44436629|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44436630|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436631|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436632|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44436633|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44436634|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44436635|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44436636|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
44436637|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
44436638|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
44436639|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
44436640|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436641|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436652|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44436653|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436654|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436655|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436656|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44436657|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44436658|NCT01988662|Ranibizumab|ranibizumab|mesh-list
44436659|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436660|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436661|NCT01988662|Growth Substances|growth substances|mesh-ancestor
44436662|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436663|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436664|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436665|NCT01988493|Sorafenib|sorafenib|mesh-list
44436666|NCT01988493|Tepotinib|tepotinib|mesh-list
44436667|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436668|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436669|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436670|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436671|NCT01988402|Allopurinol|allopurinol|mesh-list
44436672|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
44436673|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436674|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436675|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
44436676|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436677|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44436678|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
44436679|NCT01988402|Protective Agents|protective agents|mesh-ancestor
44436680|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436681|NCT01988103|Thalidomide|thalidomide|mesh-list
44436682|NCT01988103|Apremilast|apremilast|mesh-list
44436683|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44436684|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44436685|NCT01988103|Analgesics|analgesics|mesh-ancestor
44436686|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
44436690|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436691|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44436692|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44436693|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436694|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436695|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44436696|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
44436697|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
44436698|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44436699|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436700|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436701|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436702|NCT01988103|Growth Substances|growth substances|mesh-ancestor
44436703|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436704|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436705|NCT01988090|Vitamin D|vitamin d|mesh-list
44436706|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
44436707|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
44436708|NCT01988090|Vitamins|vitamins|mesh-list
44436709|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
44436710|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436711|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44436712|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44436713|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
44436714|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
44436715|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436716|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436717|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436718|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
44436719|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
44436720|NCT01987895|Vancomycin|vancomycin|mesh-list
44436721|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
44436722|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44436723|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436724|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44436729|NCT01987596|Lenograstim|lenograstim|mesh-list
44436730|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44436731|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
44436732|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436733|NCT01987505|Rituximab|rituximab|mesh-list
44436734|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44436735|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436736|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
44436737|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436738|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44436739|NCT01987479|Methotrexate|methotrexate|mesh-list
44436740|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44436741|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
44436742|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44436743|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436744|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44436745|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
44436746|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436786|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
44436787|NCT01987102|Vitamins|vitamins|mesh-ancestor
44436788|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
44436789|NCT01986907|Ranibizumab|ranibizumab|mesh-list
44436790|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436791|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436792|NCT01986907|Growth Substances|growth substances|mesh-ancestor
44436793|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436794|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436795|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436796|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
44436797|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44436798|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436799|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436800|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436801|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
44436802|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44436803|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436804|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44436805|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436806|NCT01986751|Clonidine|clonidine|mesh-list
44436807|NCT01986751|Ropivacaine|ropivacaine|mesh-list
44436808|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
44436809|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
44436810|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436835|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44436836|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44436837|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44436838|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
44436839|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436840|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436841|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44436842|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44436843|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
44436844|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44436845|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44436846|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
44436848|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44436849|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436850|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
44436851|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
44436852|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436853|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
44436854|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436855|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436856|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
44436857|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44436858|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44436859|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44436860|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44436861|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
44436862|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44436863|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
44436864|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436866|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436867|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436868|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
44436874|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44436875|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
44436876|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436877|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436879|NCT01985321|Glycolic acid|glycolic acid|mesh-list
44436880|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44436881|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436882|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44436883|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436884|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
44436885|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436886|NCT01985126|Acetaminophen|acetaminophen|mesh-list
44436887|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
44436888|NCT01985126|Promethazine|promethazine|mesh-list
44436889|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
44436890|NCT01985126|Daratumumab|daratumumab|mesh-list
44436891|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44436892|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44436893|NCT01985126|Analgesics|analgesics|mesh-ancestor
44436894|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
44436895|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44436896|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436897|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
44436898|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44436899|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
44436900|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
44436901|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44436902|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
44436903|NCT01985126|Hormones|hormones|mesh-ancestor
44436904|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44095143|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
44436905|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44436906|NCT01985126|Protective Agents|protective agents|mesh-ancestor
44436907|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44436916|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
44436917|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44436918|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436919|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44436920|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
44436921|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
44436922|NCT01984892|Poly ICLC|poly iclc|mesh-list
44436923|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
44436924|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
44436925|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436926|NCT01984684|Vancomycin|vancomycin|mesh-list
44436927|NCT01984684|Aztreonam|aztreonam|mesh-list
44436928|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44436929|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436930|NCT01984424|Atorvastatin|atorvastatin|mesh-list
44436931|NCT01984424|Ezetimibe|ezetimibe|mesh-list
44436932|NCT01984424|Evolocumab|evolocumab|mesh-list
44436933|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44436934|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44436935|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44436936|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
44436937|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436938|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44436939|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44436940|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436941|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
44436942|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436943|NCT01984294|Ribavirin|ribavirin|mesh-list
44436944|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
44436945|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436946|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
44436947|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436948|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44436949|NCT01984268|Hormones|hormones|mesh-ancestor
44436959|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44436960|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44436961|NCT01984242|Growth Substances|growth substances|mesh-ancestor
44436962|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436963|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
44436964|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
44436965|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44436966|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436967|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436968|NCT01984229|Posaconazole|posaconazole|mesh-list
44436969|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
44436970|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44436971|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44436972|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44436973|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44436974|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44436975|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44436976|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436977|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436978|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44436979|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44436980|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436981|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44436982|NCT01984164|Candesartan|candesartan|mesh-list
44436984|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44436985|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44436986|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44436987|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44436988|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44436989|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
44436990|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44436991|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44436997|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44436998|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437000|NCT01983969|Gemcitabine|gemcitabine|mesh-list
44437001|NCT01983969|Dexamethasone|dexamethasone|mesh-list
44437002|NCT01983969|Rituximab|rituximab|mesh-list
44437003|NCT01983969|Azacitidine|azacitidine|mesh-list
44437004|NCT01983969|Melphalan|melphalan|mesh-list
44437005|NCT01983969|Busulfan|busulfan|mesh-list
44437006|NCT01983969|Vorinostat|vorinostat|mesh-list
44437007|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437008|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437009|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
44437010|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437011|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437012|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437013|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
44437014|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
44437015|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437016|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437017|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
44437018|NCT01983969|Hormones|hormones|mesh-ancestor
44437019|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437020|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44437021|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44437022|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
44437023|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437024|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
44437025|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437026|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437027|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44437028|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437033|NCT01983969|Vitamins|vitamins|mesh-ancestor
44437040|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437041|NCT01983683|Vancomycin|vancomycin|mesh-list
44437042|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
44437043|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437044|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437045|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44437046|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799930|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
44437047|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437048|NCT01983111|Acetaminophen|acetaminophen|mesh-list
44437049|NCT01983111|Buprenorphine|buprenorphine|mesh-list
44437050|NCT01983111|Tramadol|tramadol|mesh-list
44437051|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437052|NCT01983111|Analgesics|analgesics|mesh-ancestor
44437053|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
44437054|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437055|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437099|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437101|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
44437102|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437103|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
44437104|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44437105|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44437106|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
44437107|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437108|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437109|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437110|NCT01981954|Urological Agents|urological agents|mesh-ancestor
44437111|NCT01981616|Vedolizumab|vedolizumab|mesh-list
44437112|NCT01981616|Vaccines|vaccines|mesh-list
44437113|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
44437114|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437115|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437116|NCT01981473|Infliximab|infliximab|mesh-list
44437117|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437118|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437119|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437120|NCT01980940|Etoricoxib|etoricoxib|mesh-list
44437121|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
44437122|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44437123|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437124|NCT01980940|Analgesics|analgesics|mesh-ancestor
44437125|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
44437126|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437147|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
44437148|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437149|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437151|NCT01980875|Idelalisib|idelalisib|mesh-list
44437152|NCT01980875|Chlorambucil|chlorambucil|mesh-list
44437153|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437154|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437155|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437156|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437157|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437158|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
44437159|NCT01980706|Baclofen|baclofen|mesh-list
44437160|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44437161|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437162|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44437163|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437164|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44437165|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
44437166|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
44437167|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437168|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437169|NCT01979952|Nintedanib|nintedanib|mesh-list
44437170|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437171|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437172|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437173|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437174|NCT01979523|Trametinib|trametinib|mesh-list
44437193|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437194|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437195|NCT01978184|Gemcitabine|gemcitabine|mesh-list
44437196|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
44437197|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44437198|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44437199|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
44437200|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437201|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437202|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
44437203|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437204|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437205|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44437254|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437256|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
44437257|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437258|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44437259|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44437260|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437261|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437262|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437263|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
44437264|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437265|NCT01977677|Plerixafor|plerixafor|mesh-list
44437266|NCT01977677|Temozolomide|temozolomide|mesh-list
44437267|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44437268|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
44437269|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437270|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437271|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44437272|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44437273|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
44437274|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437275|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44437276|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44437277|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437278|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44437279|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44437280|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437281|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437282|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
44437297|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437298|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44437299|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
44437300|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
44437301|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44437302|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44437303|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44437304|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437305|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
44437306|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
44437307|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437308|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437309|NCT01976806|Aspirin|aspirin|mesh-list
44437310|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44437311|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437312|NCT01976806|Analgesics|analgesics|mesh-ancestor
44437313|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
44437314|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437315|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437316|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437317|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437318|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44437319|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44437320|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437323|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437344|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437345|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
44437346|NCT01976364|Methotrexate|methotrexate|mesh-list
44437347|NCT01976364|Tofacitinib|tofacitinib|mesh-list
44437348|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44437349|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
44437350|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44437351|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437352|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44437353|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
44437354|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437355|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437356|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437357|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437358|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44437359|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799959|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799960|NCT04999176|Enoxaparin|enoxaparin|mesh-list
43799961|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
43799962|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43799963|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
43799964|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43799965|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
43799966|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799967|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799968|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
43800029|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654608|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654609|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43609906|NCT03184805|Aspirin|aspirin|mesh-list
43800040|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43800041|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800042|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800043|NCT04997980|Amiodarone|amiodarone|mesh-list
44437360|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
44437361|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437362|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44437363|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437364|NCT01976338|Ranibizumab|ranibizumab|mesh-list
44437365|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44437366|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44437367|NCT01976338|Growth Substances|growth substances|mesh-ancestor
44437368|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437369|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
44437370|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437371|NCT01976312|Ranibizumab|ranibizumab|mesh-list
44437372|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44437373|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44437374|NCT01976312|Growth Substances|growth substances|mesh-ancestor
44437385|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437386|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
44437387|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437388|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437389|NCT01975376|Bococizumab|bococizumab|mesh-list
44437390|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437391|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437392|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
44437451|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437452|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
44437453|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437455|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437456|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
44437457|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44437458|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44437459|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44437460|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437461|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437462|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
44437463|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437464|NCT01973569|Denosumab|denosumab|mesh-list
44437465|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44437466|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437467|NCT01973439|Abacavir|abacavir|mesh-list
44437468|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
44437469|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44437473|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
44437506|NCT01973231|Hormones|hormones|mesh-ancestor
44437507|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437508|NCT01973218|Vaccines|vaccines|mesh-list
44437509|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
43800133|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437510|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437511|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
44437512|NCT01972841|Mirabegron|mirabegron|mesh-list
44437513|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44437514|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43800134|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800135|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44437572|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
44437573|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
44437574|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437575|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437576|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437577|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
44437578|NCT01971645|Hormones|hormones|mesh-ancestor
44437579|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437580|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44437581|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437582|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
44437583|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
44437586|NCT01971346|Etanercept|etanercept|mesh-list
44437635|NCT01970501|Bucindolol|bucindolol|mesh-list
44437636|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44437637|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44437638|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
44437639|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
44437640|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437641|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437642|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44437643|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44437644|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44437645|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
44437646|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44095798|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
44437647|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437648|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
44437649|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
44437650|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44437651|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44437652|NCT01970488|Adalimumab|adalimumab|mesh-list
44437653|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437654|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437655|NCT01970475|Adalimumab|adalimumab|mesh-list
44437656|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437685|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437686|NCT01969851|Lacosamide|lacosamide|mesh-list
44437687|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
44437688|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44437689|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44437690|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44437691|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437692|NCT01969799|Amikacin|amikacin|mesh-list
44437693|NCT01969799|Fosfomycin|fosfomycin|mesh-list
44437694|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437695|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437696|NCT01969721|Fluticasone|fluticasone|mesh-list
44437697|NCT01969721|Xhance|xhance|mesh-list
44437747|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437748|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437750|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437751|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437752|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
44437753|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437754|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437755|NCT01968954|Bococizumab|bococizumab|mesh-list
44437756|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437757|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437758|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
44437759|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437760|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44437761|NCT01968707|Ethanol|ethanol|mesh-list
44437762|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
44437763|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44437764|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44437765|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437766|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437767|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437768|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
44437769|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437770|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
44437771|NCT01968694|Promethazine|promethazine|mesh-list
44437772|NCT01968694|Lidocaine|lidocaine|mesh-list
44437773|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
44437774|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
44437775|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437777|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
44437792|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437793|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44437794|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
44437795|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437796|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44437797|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44437798|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44437799|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
44437800|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437802|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44437803|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437804|NCT01968434|Expectorants|expectorants|mesh-ancestor
44437805|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
44437807|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44437808|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437809|NCT01968070|Analgesics|analgesics|mesh-ancestor
44437810|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
44437811|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437812|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437813|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437814|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437815|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44437816|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44437817|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437818|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437819|NCT01968031|Istradefylline|istradefylline|mesh-list
44437820|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44437821|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44437822|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44437823|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
44437824|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437825|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437829|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44437830|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44437831|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
44437832|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437833|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437834|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44437835|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44437836|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
44437837|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437838|NCT01967628|Vitamin D|vitamin d|mesh-list
44437839|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
44437840|NCT01967628|Vitamins|vitamins|mesh-ancestor
44437841|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
44437842|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437843|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44437844|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44437845|NCT01967576|Axitinib|axitinib|mesh-list
44437846|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437847|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437848|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437849|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437850|NCT01967550|Diclofenac|diclofenac|mesh-list
44437851|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44437852|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44437853|NCT01967550|Analgesics|analgesics|mesh-ancestor
44437854|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
44437855|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437856|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437857|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437858|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44437859|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44437860|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437861|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437869|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437870|NCT01967173|Fluticasone|fluticasone|mesh-list
44437872|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44437873|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44437874|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
44437875|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437876|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437877|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44437878|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
44437879|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
44437880|NCT01967173|Hormones|hormones|mesh-ancestor
44437881|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437882|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
44437883|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44437884|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437885|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44437886|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44437887|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44437888|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44437889|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44437890|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437891|NCT01966107|Bromides|bromides|mesh-list
44437892|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
44437893|NCT01966003|Paclitaxel|paclitaxel|mesh-list
44437894|NCT01966003|Bevacizumab|bevacizumab|mesh-list
44437895|NCT01966003|Carboplatin|carboplatin|mesh-list
44437896|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44437897|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437898|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
44437899|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
44437900|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
44437901|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437902|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437903|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44437905|NCT01966003|Growth Substances|growth substances|mesh-ancestor
44437910|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44437911|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
44437912|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44096098|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
44437914|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44437915|NCT01965704|Ondansetron|ondansetron|mesh-list
44437916|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
44437917|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
44437918|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437919|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437920|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44437921|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
44437922|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
44437923|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44437924|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
44437925|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437926|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437927|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44437928|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44437929|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44437930|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44437931|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44437932|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
44437933|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44437934|NCT01965535|Ledipasvir|ledipasvir|mesh-list
44437935|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
44437936|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437937|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
44437938|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44437939|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44437940|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44437941|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44437942|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437954|NCT01964963|Hormones|hormones|mesh-ancestor
44437955|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44437956|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44437957|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
44437958|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437959|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437960|NCT01964924|Trametinib|trametinib|mesh-list
44437961|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44437962|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44437963|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44437964|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437965|NCT01964898|Nicotine|nicotine|mesh-list
44437966|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44437967|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
44437968|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44437969|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44437970|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44437971|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44437972|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
44437973|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44437974|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44437975|NCT01964755|Leucovorin|leucovorin|mesh-list
43800348|NCT04991896|Metoprolol|metoprolol|mesh-list
44437976|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
44437977|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
44437978|NCT01964755|Zidovudine|zidovudine|mesh-list
44437979|NCT01964755|Rituximab|rituximab|mesh-list
44437980|NCT01964755|Doxorubicin|doxorubicin|mesh-list
44437981|NCT01964755|Methotrexate|methotrexate|mesh-list
44437982|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
44437983|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
44437984|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44437986|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
44437994|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44437995|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
44437996|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44437997|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44437999|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438000|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44438001|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438002|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44438003|NCT01964755|Antidotes|antidotes|mesh-ancestor
44438004|NCT01964755|Protective Agents|protective agents|mesh-ancestor
44438005|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
44438006|NCT01964755|Vitamins|vitamins|mesh-ancestor
44438007|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
44438008|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44438009|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
44438010|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438011|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44438012|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44438013|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
44438014|NCT01964716|Vaccines|vaccines|mesh-list
44438015|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44438016|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
44438017|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438018|NCT01964560|Lacosamide|lacosamide|mesh-list
44438019|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
44438020|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44438024|NCT01964378|Morphine|morphine|mesh-list
44438044|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438045|NCT01964326|Atorvastatin|atorvastatin|mesh-list
44438046|NCT01964326|Calcium|calcium|mesh-list
44438047|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44438048|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438049|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44438050|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44438051|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
44438052|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438053|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44438054|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44438055|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438056|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44438057|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
44438058|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438059|NCT01963728|Insulin|insulin|mesh-list
44438060|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44438061|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
44438100|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
44438101|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438102|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44438103|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438104|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438105|NCT01962896|Sirolimus|sirolimus|mesh-list
44438106|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44438107|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438108|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44438109|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438110|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438111|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44438112|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438113|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44438114|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
44438115|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438116|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
44438117|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438118|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
44438119|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44438120|NCT01962493|Listerine|listerine|mesh-list
44438121|NCT01962493|Fluorides|fluorides|mesh-list
44438122|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
44438123|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
44438124|NCT01962493|Protective Agents|protective agents|mesh-ancestor
44438125|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438126|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44438127|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438128|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
44438129|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438130|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
44438131|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
44438132|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438133|NCT01962298|Rocuronium|rocuronium|mesh-list
44438134|NCT01962298|Neostigmine|neostigmine|mesh-list
44438135|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
44438136|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
44438137|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44438138|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438139|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438141|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438142|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438143|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
44438144|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438145|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44438146|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
44438147|NCT01962103|Paclitaxel|paclitaxel|mesh-list
44438148|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44438149|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44438150|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438151|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
44438152|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
44438153|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
44438154|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438155|NCT01961349|Propofol|propofol|mesh-list
44438156|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44438157|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44438158|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438159|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438160|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44438161|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
44438162|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
44438163|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44438164|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44438165|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44438166|NCT01961323|Nebivolol|nebivolol|mesh-list
44438167|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44438168|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
44438169|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44438170|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44438171|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44438172|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
44438173|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43635699|NCT05192889|Methotrexate|methotrexate|mesh-list
44438176|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
44438177|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44438178|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44438179|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
44438180|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
44438181|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438182|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438183|NCT01960855|Upadacitinib|upadacitinib|mesh-list
44438184|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
44438185|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44438186|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438187|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438188|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438189|NCT01960842|Levodopa|levodopa|mesh-list
44438190|NCT01960842|Carbidopa|carbidopa|mesh-list
44438191|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44438192|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44438193|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44438194|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
44438195|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438196|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438197|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438198|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44438199|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438200|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44438201|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
44438202|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
44438203|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
44438204|NCT01960413|Montelukast|montelukast|mesh-list
44438205|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438206|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438207|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44438208|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
44438210|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438215|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
44438216|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438217|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44438219|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44438220|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44438221|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44438222|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44438223|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
44438224|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438225|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438226|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438227|NCT01960140|Simvastatin|simvastatin|mesh-list
44438228|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43800413|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44438229|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44438230|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
44438231|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438232|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44438233|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44438234|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438235|NCT01960114|Acetaminophen|acetaminophen|mesh-list
44438236|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438237|NCT01960114|Analgesics|analgesics|mesh-ancestor
43800416|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
44438238|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
44438239|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438240|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438241|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
44438242|NCT01959919|Factor VIII|factor viii|mesh-list
44438243|NCT01959919|Coagulants|coagulants|mesh-ancestor
44438244|NCT01959841|Valacyclovir|valacyclovir|mesh-list
44438262|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44438263|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44438264|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44438265|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438266|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438267|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44438268|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
44438269|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
44438270|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438271|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
44438272|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
44438273|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
44438274|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
44438275|NCT01959672|Leucovorin|leucovorin|mesh-list
44438276|NCT01959672|Folic Acid|folic acid|mesh-list
44438277|NCT01959672|Gemcitabine|gemcitabine|mesh-list
44438278|NCT01959672|Nelfinavir|nelfinavir|mesh-list
44438279|NCT01959672|Fluorouracil|fluorouracil|mesh-list
44438280|NCT01959672|Oregovomab|oregovomab|mesh-list
44438281|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44438282|NCT01959672|Antibodies|antibodies|mesh-list
44438283|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
44438284|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44438285|NCT01959672|Calcium|calcium|mesh-list
44438286|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
44438287|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
44438288|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438289|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438290|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
44438291|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438292|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438294|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438309|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44438310|NCT01959529|Insulin|insulin|mesh-list
44438311|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44438312|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
44438313|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44438314|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438315|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
44438316|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
44438317|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44438318|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
44438319|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438320|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438321|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438322|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438323|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
44438324|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44438325|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44438326|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438327|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438328|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44438329|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44438330|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44438331|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
44438332|NCT01959503|Coagulants|coagulants|mesh-ancestor
44438333|NCT01959334|Glucagon|glucagon|mesh-list
44438334|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44438335|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438336|NCT01959334|Hormones|hormones|mesh-ancestor
44438337|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438338|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438353|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44438354|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44438355|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44438356|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44438357|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44438358|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
44438359|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438360|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438361|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438363|NCT01959139|Fluorouracil|fluorouracil|mesh-list
44438364|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
44438365|NCT01959139|Irinotecan|irinotecan|mesh-list
44438366|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
44438367|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438368|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
44438369|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438370|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438371|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438372|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438373|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
44438374|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44438375|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44438376|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438377|NCT01959139|Antidotes|antidotes|mesh-ancestor
44438378|NCT01959139|Protective Agents|protective agents|mesh-ancestor
44438379|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
44438380|NCT01959139|Vitamins|vitamins|mesh-ancestor
44438381|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
44438402|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438403|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438404|NCT01958918|Growth Substances|growth substances|mesh-ancestor
44438405|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438406|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438407|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438408|NCT01958827|Adalimumab|adalimumab|mesh-list
44438409|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438410|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438411|NCT01958671|Metformin|metformin|mesh-list
44438412|NCT01958671|Glimepiride|glimepiride|mesh-list
44438413|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
44438414|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44438415|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438416|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44438417|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438418|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
44438419|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44438420|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438421|NCT01958619|Artefenomel|artefenomel|mesh-list
44438422|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
44438423|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44438424|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44438425|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438426|NCT01958489|Pravastatin|pravastatin|mesh-list
44438427|NCT01958489|Evacetrapib|evacetrapib|mesh-list
44438428|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44438429|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44438430|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
44438435|NCT01958476|Morphine|morphine|mesh-list
44438448|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
44438449|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44438450|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44438451|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44438452|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438453|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438454|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
44438455|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
44438456|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44438457|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44438458|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44438459|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
44438460|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44438461|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
44438462|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800477|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438463|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44438464|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44438465|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44438466|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438467|NCT01957709|Interferons|interferons|mesh-list
44438468|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
44438469|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438470|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
44438471|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438472|NCT01957644|Azacitidine|azacitidine|mesh-list
44438473|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438496|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
44438498|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438499|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438500|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438501|NCT01957150|Fluticasone|fluticasone|mesh-list
44438502|NCT01957150|Xhance|xhance|mesh-list
44438503|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438504|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44438505|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
44438506|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438507|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438508|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44438509|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
44438510|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438511|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44438512|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44438513|NCT01956123|Hormones|hormones|mesh-ancestor
44438514|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438515|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438516|NCT01955707|Natalizumab|natalizumab|mesh-list
44438517|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
44438518|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438519|NCT01954927|Gabapentin|gabapentin|mesh-list
44438520|NCT01954927|Analgesics|analgesics|mesh-ancestor
44438521|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
44438545|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44438546|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438547|NCT01954121|Analgesics|analgesics|mesh-ancestor
44438548|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
44438549|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438550|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44438551|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44438552|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438553|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44438554|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44438555|NCT01954082|Inositol|inositol|mesh-list
44438556|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
44438557|NCT01954082|Vitamins|vitamins|mesh-ancestor
44438558|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
44438559|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438560|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
44438561|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438562|NCT01953913|Afatinib|afatinib|mesh-list
44438563|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438564|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44438565|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438566|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438568|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438569|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
44438583|NCT01953328|Evolocumab|evolocumab|mesh-list
44438596|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
44438597|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438598|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438599|NCT01952834|Vancomycin|vancomycin|mesh-list
44438600|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44438601|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438602|NCT01952145|Insulin|insulin|mesh-list
44438603|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44438604|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
44438605|NCT01952145|Liraglutide|liraglutide|mesh-list
44438606|NCT01952145|Xultophy|xultophy|mesh-list
44438607|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44438608|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438609|NCT01952145|Incretins|incretins|mesh-ancestor
44438610|NCT01952145|Hormones|hormones|mesh-ancestor
44438611|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438612|NCT01952080|Teduglutide|teduglutide|mesh-list
44438613|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438614|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44438615|NCT01952080|Protective Agents|protective agents|mesh-ancestor
44438616|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438617|NCT01952054|Denosumab|denosumab|mesh-list
44438618|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44438619|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438620|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
44438621|NCT01951586|Denosumab|denosumab|mesh-list
44438622|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44438623|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438645|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44438646|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44438647|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
44438648|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438649|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438650|NCT01951157|Gemcitabine|gemcitabine|mesh-list
44438651|NCT01951157|Docetaxel|docetaxel|mesh-list
44438652|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438653|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
44438654|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438655|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438656|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
44438657|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438658|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438659|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438660|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
44438661|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438662|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
44438663|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
44438664|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
44438665|NCT01951105|Naproxen|naproxen|mesh-list
44438666|NCT01951105|Levodopa|levodopa|mesh-list
44438667|NCT01951105|Carbidopa|carbidopa|mesh-list
44438668|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44438669|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438670|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438671|NCT01951105|Analgesics|analgesics|mesh-ancestor
44438695|NCT01950819|Basiliximab|basiliximab|mesh-list
44438696|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438697|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
44438698|NCT01950819|Hormones|hormones|mesh-ancestor
44438699|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438700|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438701|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44438702|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438703|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
44438704|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
44438705|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438706|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438707|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44438708|NCT01950819|Protective Agents|protective agents|mesh-ancestor
44438709|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438710|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
44438711|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44438712|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800494|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44438713|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438714|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438715|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
44438716|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438717|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438718|NCT01950741|Aflibercept|aflibercept|mesh-list
44438719|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438720|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438721|NCT01950741|Growth Substances|growth substances|mesh-ancestor
44438722|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438723|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438724|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438725|NCT01950364|Rifampin|rifampin|mesh-list
44438739|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438740|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44438741|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44438742|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44438743|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44438744|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44438745|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44438746|NCT01950273|Rituximab|rituximab|mesh-list
44438747|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44438748|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438749|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
44438750|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438751|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438752|NCT01950169|Vitamin D|vitamin d|mesh-list
44438753|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
44438754|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
44438755|NCT01950169|Diphosphonates|diphosphonates|mesh-list
44438756|NCT01950169|Calcium|calcium|mesh-list
44438757|NCT01950169|Vitamins|vitamins|mesh-ancestor
44438758|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
44438759|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438762|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44438790|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
44438791|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438792|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438793|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44438794|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
44438795|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44438796|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44438797|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
44438798|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
44438800|NCT01949116|Methotrexate|methotrexate|mesh-list
44438801|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44438802|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
44438803|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44438804|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438805|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44438806|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
44438807|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438808|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438809|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438810|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438811|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44438812|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438813|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
44438814|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800516|NCT04989140|Hormones|hormones|mesh-ancestor
44438815|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44438816|NCT01949116|Hematinics|hematinics|mesh-ancestor
44438817|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
44438818|NCT01949116|Vitamins|vitamins|mesh-ancestor
44438819|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
44438820|NCT01949051|Levocabastine|levocabastine|mesh-list
44438821|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44438822|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44438823|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
44438824|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
44438825|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438828|NCT01948908|Midazolam|midazolam|mesh-list
44438829|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44438830|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44438831|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44438832|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438833|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44438834|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44438835|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44438836|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44438837|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
44438838|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
44438839|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
44438840|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
44438841|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438842|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438843|NCT01948830|Ranibizumab|ranibizumab|mesh-list
44438844|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438845|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438846|NCT01948830|Growth Substances|growth substances|mesh-ancestor
44438847|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438848|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438849|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438850|NCT01948791|Rivastigmine|rivastigmine|mesh-list
44438851|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44438852|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438853|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438854|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
44438855|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44438856|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438857|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44438874|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44438875|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438876|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44438877|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44438878|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
44438879|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44438880|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438881|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800525|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
43800526|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800527|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800528|NCT04988945|Durvalumab|durvalumab|mesh-list
43654634|NCT02974660|Coagulants|coagulants|mesh-ancestor
43800663|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43800664|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
43800665|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43800666|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44438882|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438883|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
44438884|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44438885|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44438886|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438887|NCT01946880|Amebicides|amebicides|mesh-ancestor
44438888|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44438889|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44438890|NCT01946880|Analgesics|analgesics|mesh-ancestor
44438891|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
44438892|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438893|NCT01946880|Filaricides|filaricides|mesh-ancestor
44438894|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
44438895|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
44438896|NCT01946529|Sirolimus|sirolimus|mesh-list
44438897|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
44438898|NCT01946529|Temozolomide|temozolomide|mesh-list
44438899|NCT01946529|Ifosfamide|ifosfamide|mesh-list
44438900|NCT01946529|Bevacizumab|bevacizumab|mesh-list
44438901|NCT01946529|Doxorubicin|doxorubicin|mesh-list
44438902|NCT01946529|Etoposide|etoposide|mesh-list
44438903|NCT01946529|Vincristine|vincristine|mesh-list
44438904|NCT01946529|Sorafenib|sorafenib|mesh-list
44438905|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44438906|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
44438907|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438908|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44438909|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44438916|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438917|NCT01946529|Growth Substances|growth substances|mesh-ancestor
44438918|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438919|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44438920|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44438921|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44438922|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438923|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44438924|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
44438925|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
44438926|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
44438927|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44438928|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44438929|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44438930|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
44438931|NCT01946438|Vaccines|vaccines|mesh-list
44438932|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
44438933|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438934|NCT01946425|Vaccines|vaccines|mesh-list
44438935|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
44438936|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438937|NCT01946412|Ivacaftor|ivacaftor|mesh-list
44438970|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44438971|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438972|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44438973|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
43800667|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800668|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
43800669|NCT04986813|Coagulants|coagulants|mesh-ancestor
43800676|NCT04986735|Empagliflozin|empagliflozin|mesh-list
44438974|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44438975|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44438976|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44438977|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438978|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438979|NCT01946152|Growth Substances|growth substances|mesh-ancestor
44438980|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438981|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44438982|NCT01945866|Dexamethasone|dexamethasone|mesh-list
44438983|NCT01945866|Ranibizumab|ranibizumab|mesh-list
44438984|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44438985|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
44438986|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
44438987|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44438988|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44438989|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44438990|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
44438992|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44438993|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44438994|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44438995|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44438996|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44438997|NCT01945866|Growth Substances|growth substances|mesh-ancestor
44438998|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44438999|NCT01945593|Factor VIII|factor viii|mesh-list
44439000|NCT01945593|BAX 855|bax 855|mesh-list
44439014|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44439016|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44439017|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
44439018|NCT01945281|Amebicides|amebicides|mesh-ancestor
44439019|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44439020|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44439021|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439022|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439023|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
44439024|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439025|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439026|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44439027|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439029|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439030|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439031|NCT01945242|Incretins|incretins|mesh-ancestor
44439032|NCT01945242|Hormones|hormones|mesh-ancestor
44439033|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439034|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44439035|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439036|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439037|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439038|NCT01945216|Alogliptin|alogliptin|mesh-list
44439039|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439040|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439041|NCT01945216|Incretins|incretins|mesh-ancestor
44439042|NCT01945216|Hormones|hormones|mesh-ancestor
44439043|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43776275|NCT02340182|Metronidazole|metronidazole|mesh-list
44439044|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44439045|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439046|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439047|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439048|NCT01945086|Ustekinumab|ustekinumab|mesh-list
44439049|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
44439050|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
44164207|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44439052|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439053|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439054|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439055|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439056|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
44439057|NCT01944839|Ranibizumab|ranibizumab|mesh-list
44439058|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439059|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439060|NCT01944839|Growth Substances|growth substances|mesh-ancestor
44439061|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439062|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439063|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439064|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
44439065|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439066|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439067|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44439068|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44439069|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439070|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439071|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439072|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44439073|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
44439074|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439075|NCT01944098|Lidocaine|lidocaine|mesh-list
44097189|NCT00045682|Paclitaxel|paclitaxel|mesh-list
44439076|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
44439077|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
44439078|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439079|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439080|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
44439081|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439082|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44439087|NCT01944046|Oxytocin|oxytocin|mesh-list
44439090|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439091|NCT01943552|Bromides|bromides|mesh-list
44439092|NCT01943552|Ipratropium|ipratropium|mesh-list
44439093|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
44439094|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44439095|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
44439096|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439097|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439098|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44439099|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
44439100|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44439101|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439102|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439103|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439104|NCT01943435|Acetaminophen|acetaminophen|mesh-list
44439151|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44439152|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
44439153|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44439154|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
44439156|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44439157|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44439158|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44439159|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
44439161|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44439215|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44439216|NCT01942148|Aripiprazole|aripiprazole|mesh-list
44439217|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
44439218|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439219|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44439220|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439221|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439222|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439223|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439224|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
44439225|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439226|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439227|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44439228|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44439229|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
44439230|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44439231|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44439232|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44439233|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44439234|NCT01941537|Fezakinumab|fezakinumab|mesh-list
44439235|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
44439236|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
44439237|NCT01941095|Chloroquine|chloroquine|mesh-list
44439238|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
44439239|NCT01941095|Methotrexate|methotrexate|mesh-list
44439240|NCT01941095|Azathioprine|azathioprine|mesh-list
44439241|NCT01941095|Leflunomide|leflunomide|mesh-list
44439242|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44439263|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439264|NCT01941095|Analgesics|analgesics|mesh-ancestor
44439265|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
44439266|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439267|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44439268|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439269|NCT01940900|Ranibizumab|ranibizumab|mesh-list
44439270|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439271|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439272|NCT01940900|Growth Substances|growth substances|mesh-ancestor
44439273|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439274|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439275|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439276|NCT01940887|Bevacizumab|bevacizumab|mesh-list
44439277|NCT01940887|Aflibercept|aflibercept|mesh-list
44439278|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44439279|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439280|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439281|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439282|NCT01940887|Growth Substances|growth substances|mesh-ancestor
44439283|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439284|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439286|NCT01940497|Docetaxel|docetaxel|mesh-list
44439287|NCT01940497|Doxorubicin|doxorubicin|mesh-list
44439288|NCT01940497|Trastuzumab|trastuzumab|mesh-list
44439314|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439315|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439316|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439317|NCT01939366|Pregabalin|pregabalin|mesh-list
44439318|NCT01939366|Analgesics|analgesics|mesh-ancestor
44439319|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
44439320|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439321|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439322|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
44439323|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44439324|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439325|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439326|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44439327|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44439328|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439329|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439330|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439331|NCT01939314|Bupivacaine|bupivacaine|mesh-list
44439332|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
44439333|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
44439334|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439335|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439336|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
44439337|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439338|NCT01939197|Ritonavir|ritonavir|mesh-list
44439339|NCT01939197|Ribavirin|ribavirin|mesh-list
44439340|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44439341|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44439342|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439343|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439344|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439345|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44439346|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44439347|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
44439348|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439351|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
44439352|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44439353|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
44439354|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439355|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44439356|NCT01939002|Interferons|interferons|mesh-list
44439357|NCT01939002|Interferon-beta|interferon-beta|mesh-list
44439358|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
44439359|NCT01939002|Naproxen|naproxen|mesh-list
44439360|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44439361|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
44439362|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439363|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
44439364|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439365|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439366|NCT01939002|Analgesics|analgesics|mesh-ancestor
44439367|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
44439368|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439369|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439370|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439371|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
44439372|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44439373|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439374|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439375|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
44439376|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44439377|NCT01938846|Paclitaxel|paclitaxel|mesh-list
44439378|NCT01938846|Exemestane|exemestane|mesh-list
44439379|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44439396|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439397|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
44439398|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439399|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439400|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439401|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
44439402|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439403|NCT01938625|Cyclosporine|cyclosporine|mesh-list
44439404|NCT01938625|Ribavirin|ribavirin|mesh-list
44439405|NCT01938625|Simeprevir|simeprevir|mesh-list
44439406|NCT01938625|Tacrolimus|tacrolimus|mesh-list
44439407|NCT01938625|Cyclosporins|cyclosporins|mesh-list
44439408|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439409|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
44439410|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439411|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44439412|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439413|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439414|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
44439415|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439416|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44439417|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439418|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
44439419|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
44439420|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439421|NCT01938573|Gemcitabine|gemcitabine|mesh-list
44439422|NCT01938573|Sirolimus|sirolimus|mesh-list
44439423|NCT01938573|Cisplatin|cisplatin|mesh-list
44439424|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439425|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44439426|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
44439427|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439428|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
44439429|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439430|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439431|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439438|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44439439|NCT01938430|Ledipasvir|ledipasvir|mesh-list
44439440|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
44439441|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439442|NCT01937871|Tadalafil|tadalafil|mesh-list
44439443|NCT01937871|Tamsulosin|tamsulosin|mesh-list
44439444|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
44439445|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44439446|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44439447|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439448|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439449|NCT01937871|Urological Agents|urological agents|mesh-ancestor
44439450|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44439451|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44097514|NCT00046787|Lurtotecan|lurtotecan|mesh-list
44439452|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44439454|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439455|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439456|NCT01937715|Bevacizumab|bevacizumab|mesh-list
44439457|NCT01937715|Gedatolisib|gedatolisib|mesh-list
44439458|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842344|NCT04536805|Metformin|metformin|mesh-list
44439459|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439460|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439461|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439462|NCT01937715|Growth Substances|growth substances|mesh-ancestor
44439463|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439464|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439465|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44439466|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439467|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44097593|NCT00046943|Atrasentan|atrasentan|mesh-list
44439468|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
44439469|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44439470|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44439472|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
44439476|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44439477|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
44439478|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439479|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439480|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44439481|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44439482|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
44439483|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44439484|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439485|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439486|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439487|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
44439488|NCT01937364|Baclofen|baclofen|mesh-list
44439489|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44439490|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439491|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44439492|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439493|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44439494|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
44439495|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
44439496|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439497|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439498|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44439499|NCT01937312|Travoprost|travoprost|mesh-list
44439500|NCT01937312|Brinzolamide|brinzolamide|mesh-list
44439501|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44439502|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44439503|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44439504|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44439505|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44439506|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439507|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439508|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439509|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44439510|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439515|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44439516|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44439517|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44439518|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44439519|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44439520|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
44439521|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439522|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439523|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439524|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44439525|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439526|NCT01936974|Gemcitabine|gemcitabine|mesh-list
44439527|NCT01936974|Bevacizumab|bevacizumab|mesh-list
44439528|NCT01936974|Cisplatin|cisplatin|mesh-list
44439529|NCT01936974|Carboplatin|carboplatin|mesh-list
44439530|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
44439531|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44439532|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439533|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44439534|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44439535|NCT01936974|Growth Substances|growth substances|mesh-ancestor
44439536|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439537|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
44439538|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44439539|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
44439540|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439541|NCT01936974|Antiviral Agents|antiviral agents|mesh-ancestor
44439542|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439543|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439544|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439545|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
44439546|NCT01936870|Fesoterodine|fesoterodine|mesh-list
44439547|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44439553|NCT01936870|Urological Agents|urological agents|mesh-ancestor
44439554|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44439555|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439556|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439557|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439558|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44439559|NCT01936181|Infliximab|infliximab|mesh-list
44439560|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
44439561|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439562|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439563|NCT01935947|Gemcitabine|gemcitabine|mesh-list
44439564|NCT01935947|Azacitidine|azacitidine|mesh-list
44439565|NCT01935947|Docetaxel|docetaxel|mesh-list
44439566|NCT01935947|Irinotecan|irinotecan|mesh-list
44439567|NCT01935947|Pemetrexed|pemetrexed|mesh-list
44439568|NCT01935947|Camptothecin|camptothecin|mesh-list
44439569|NCT01935947|Entinostat|entinostat|mesh-list
44439570|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44439571|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44439572|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
44439573|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439574|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439575|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
44439576|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439577|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439578|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439579|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
43842389|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
44439580|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439581|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
44439582|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
44439583|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
44439584|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44439585|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44439586|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44439587|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44439588|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44439589|NCT01935700|Colchicine|colchicine|mesh-list
44439590|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
44439591|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439592|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
44439593|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
44439594|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
44439595|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439596|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439597|NCT01935336|Ponatinib|ponatinib|mesh-list
44439598|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439599|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44439600|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439601|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439602|NCT01935128|Everolimus|everolimus|mesh-list
44439603|NCT01935128|Tacrolimus|tacrolimus|mesh-list
44439604|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44439605|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
44439606|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439607|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44439608|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439609|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439610|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439611|NCT01934972|Cycloserine|cycloserine|mesh-list
44439612|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44439613|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439614|NCT01934972|Renal Agents|renal agents|mesh-ancestor
44439615|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44439616|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
44439617|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44439618|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
44097742|NCT00047216|Tipifarnib|tipifarnib|mesh-list
44439619|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439620|NCT01934894|Lapatinib|lapatinib|mesh-list
44439621|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439622|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44439633|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439634|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
44439635|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44439636|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
44439637|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439638|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
44439639|NCT01934218|Protective Agents|protective agents|mesh-ancestor
44439640|NCT01934192|Metoclopramide|metoclopramide|mesh-list
44439641|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
44439642|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
43801261|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44439643|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439644|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439645|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439646|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44439647|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44439648|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
44439649|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439650|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439651|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
44439652|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439653|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439654|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44439655|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439656|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439657|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439658|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439659|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44439661|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439677|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439678|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44439679|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439680|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439681|NCT01933672|Incretins|incretins|mesh-ancestor
44439682|NCT01933672|Hormones|hormones|mesh-ancestor
44439683|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439684|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44439685|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
44439686|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439687|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439688|NCT01933594|Romidepsin|romidepsin|mesh-list
44439689|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44439690|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439691|NCT01933334|Pirfenidone|pirfenidone|mesh-list
44439692|NCT01933334|Analgesics|analgesics|mesh-ancestor
44439693|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
44439694|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439695|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439696|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44439697|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439698|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44439699|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439700|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439701|NCT01933217|Methylphenidate|methylphenidate|mesh-list
44439702|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44439708|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
44439723|NCT01932788|Vitamin D|vitamin d|mesh-list
44439724|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
44439725|NCT01932788|Vitamins|vitamins|mesh-list
44439726|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
44439727|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439728|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44439729|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44439730|NCT01932762|Ribavirin|ribavirin|mesh-list
44439731|NCT01932762|Grazoprevir|grazoprevir|mesh-list
44439732|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
44439733|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439734|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
44439735|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439736|NCT01932697|Docetaxel|docetaxel|mesh-list
44439737|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439738|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
44439739|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
44439740|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
44439741|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439742|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44439743|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44439744|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439745|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439774|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439775|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439776|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439777|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
44439778|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439779|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44439780|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
44439781|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44439782|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44439783|NCT01931150|Dapsone|dapsone|mesh-list
44439784|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439785|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
44439786|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44439787|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44439788|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44439789|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439790|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439791|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
44439792|NCT01931059|Risperidone|risperidone|mesh-list
44439793|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44439794|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
44439795|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439796|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439797|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439798|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44439799|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44439821|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439822|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439823|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
44439824|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
44439825|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44439826|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44439827|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
44439828|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439829|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44439830|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44439831|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439832|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439833|NCT01930045|Antacids|antacids|mesh-ancestor
44439834|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44439835|NCT01929980|Bortezomib|bortezomib|mesh-list
44439836|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44439837|NCT01929876|Itraconazole|itraconazole|mesh-list
44439838|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
44439839|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44439840|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44439841|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44439842|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439843|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439844|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44439845|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
44439846|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439847|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439848|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44439850|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44439851|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439852|NCT01929343|Lidocaine|lidocaine|mesh-list
44439853|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
44439854|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
44439855|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44439859|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44439860|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44439861|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44439862|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44439863|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439865|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44439866|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44439867|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
44439868|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
44439869|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439870|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439871|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439872|NCT01929135|Atorvastatin|atorvastatin|mesh-list
44439873|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44439874|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44439875|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
44439876|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439877|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44439878|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44439879|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439880|NCT01929083|Ibutilide|ibutilide|mesh-list
44439881|NCT01929083|Progesterone|progesterone|mesh-list
44439882|NCT01929083|Progestins|progestins|mesh-ancestor
44439883|NCT01929083|Hormones|hormones|mesh-ancestor
44439884|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44439885|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439886|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44439887|NCT01929044|Anisodamine|anisodamine|mesh-list
44439903|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44439904|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44439905|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
44439906|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44439907|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44439908|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439909|NCT01929044|Analgesics|analgesics|mesh-ancestor
44439910|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
44098040|NCT00048152|Cyclosporins|cyclosporins|mesh-list
44439912|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439913|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44439914|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
44439915|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44439916|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
44439917|NCT01929044|Protective Agents|protective agents|mesh-ancestor
44439918|NCT01929031|Ibuprofen|ibuprofen|mesh-list
44439919|NCT01929031|Caffeine|caffeine|mesh-list
44439920|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44439921|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44439922|NCT01929031|Analgesics|analgesics|mesh-ancestor
44439923|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
44439924|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439925|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439926|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44439927|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44439928|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44439929|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44439930|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439931|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44439948|NCT01928771|Benralizumab|benralizumab|mesh-list
44439949|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44439950|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
44439951|NCT01928758|Nicotine|nicotine|mesh-list
44439952|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44439953|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
44439954|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439955|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439956|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44439957|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44439958|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439959|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439960|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439961|NCT01928719|Nicotine|nicotine|mesh-list
44439962|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44439963|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
44439964|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44439965|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44439966|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44439967|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44439968|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
44439969|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44439970|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439971|NCT01928615|Trastuzumab|trastuzumab|mesh-list
44439972|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44439973|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44439990|NCT01928394|Nivolumab|nivolumab|mesh-list
44439995|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44439996|NCT01928381|Pregabalin|pregabalin|mesh-list
44439997|NCT01928381|Analgesics|analgesics|mesh-ancestor
44439998|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
44439999|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440000|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440001|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
44440002|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44440003|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440004|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440005|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44440006|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44440007|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440008|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440009|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440010|NCT01928329|Exenatide|exenatide|mesh-list
44440011|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440012|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440013|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44440014|NCT01928329|Incretins|incretins|mesh-ancestor
44440015|NCT01928329|Hormones|hormones|mesh-ancestor
44440016|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440017|NCT01928225|Vaccines|vaccines|mesh-list
44440044|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44440045|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440046|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
44440047|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44440048|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44440049|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44440050|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44440051|NCT01927757|Analgesics|analgesics|mesh-ancestor
44440052|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
44440053|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440054|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44098126|NCT00048555|Galiximab|galiximab|mesh-list
44440055|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44440056|NCT01927419|Nivolumab|nivolumab|mesh-list
44440057|NCT01927419|Ipilimumab|ipilimumab|mesh-list
44440058|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440059|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440060|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44440061|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440062|NCT01927341|Panitumumab|panitumumab|mesh-list
44440063|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440064|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440065|NCT01927068|Paclitaxel|paclitaxel|mesh-list
44440066|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44440067|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440068|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
44440069|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
44440070|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
44440071|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440072|NCT01927055|Mannitol|mannitol|mesh-list
44440073|NCT01927055|Droxidopa|droxidopa|mesh-list
44440087|NCT01926626|Nicotine|nicotine|mesh-list
44440088|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44440089|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
44440090|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440091|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440092|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44440093|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44440094|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440095|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440096|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440097|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
44440098|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440099|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44440100|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440101|NCT01926444|Trimebutine|trimebutine|mesh-list
44440102|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44440103|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
44440104|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
44440105|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440106|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440107|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
44440108|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440109|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440110|NCT01925950|Beclomethasone|beclomethasone|mesh-list
44440111|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440112|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
44440113|NCT01925950|Hormones|hormones|mesh-ancestor
44440114|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440115|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440116|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440117|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440118|NCT01925768|Apremilast|apremilast|mesh-list
44440129|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440130|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440133|NCT01925612|Prednisone|prednisone|mesh-list
44440134|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
44440135|NCT01925612|Rituximab|rituximab|mesh-list
44440136|NCT01925612|Doxorubicin|doxorubicin|mesh-list
44440137|NCT01925612|Vincristine|vincristine|mesh-list
44440138|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44440139|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44440140|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440141|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
44440142|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440143|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44440144|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44440145|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
44440146|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440147|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440148|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44440149|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440150|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44440151|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44440152|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44440153|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440154|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440155|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
44440156|NCT01925612|Hormones|hormones|mesh-ancestor
44440180|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440181|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
43801532|NCT04794790|Buprenorphine|buprenorphine|mesh-list
44440182|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440183|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
44440184|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440185|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
44440186|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44440187|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440188|NCT01924767|Empagliflozin|empagliflozin|mesh-list
44440189|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44440190|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440191|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440192|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440193|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44440194|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44440195|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440196|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44440197|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44440198|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440199|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440200|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
44440201|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440202|NCT01924299|Fluconazole|fluconazole|mesh-list
44440203|NCT01924299|Ketoconazole|ketoconazole|mesh-list
44440204|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
44440205|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440206|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44440207|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44440208|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440209|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440210|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44440211|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
44440213|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440214|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44440215|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44440216|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44440217|NCT01924182|Morphine|morphine|mesh-list
44440218|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44440219|NCT01924182|Narcotics|narcotics|mesh-ancestor
44440220|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440221|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440222|NCT01924182|Analgesics|analgesics|mesh-ancestor
44440223|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
44440224|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440225|NCT01923896|Cycloserine|cycloserine|mesh-list
44440226|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44440227|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440228|NCT01923896|Renal Agents|renal agents|mesh-ancestor
44440229|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44440230|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
44440231|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44440232|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
44440233|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440234|NCT01923467|Nicotine|nicotine|mesh-list
44440235|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44440236|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
44440237|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440238|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440260|NCT01922934|Topiramate|topiramate|mesh-list
44440261|NCT01922934|Phentermine|phentermine|mesh-list
44440262|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
44440263|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440264|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440265|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44440266|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
44440267|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44440268|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
44440269|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
44440270|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440271|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440272|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440273|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440274|NCT01922739|Hydrocodone|hydrocodone|mesh-list
44440275|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44440276|NCT01922739|Narcotics|narcotics|mesh-ancestor
44440277|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440278|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098360|NCT00049166|Cisplatin|cisplatin|mesh-list
44440279|NCT01922739|Analgesics|analgesics|mesh-ancestor
44440280|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
44440281|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440282|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
44440283|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440284|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
44440285|NCT01922271|Albuterol|albuterol|mesh-list
44440286|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
44440287|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44440307|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
44440308|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440309|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440310|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440311|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
44440312|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
44440313|NCT01922102|Ranibizumab|ranibizumab|mesh-list
44440314|NCT01922102|Verteporfin|verteporfin|mesh-list
44440315|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44440316|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44440317|NCT01922102|Growth Substances|growth substances|mesh-ancestor
44440318|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440319|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
44440320|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440321|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44440322|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440323|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44440324|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44440325|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440326|NCT01922037|Omalizumab|omalizumab|mesh-list
44440327|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44440328|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440329|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440330|NCT01922011|Vancomycin|vancomycin|mesh-list
44440331|NCT01922011|Daptomycin|daptomycin|mesh-list
44440332|NCT01922011|Nafcillin|nafcillin|mesh-list
44440333|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44440334|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440335|NCT01921829|Diuretics|diuretics|mesh-list
44440336|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
44440337|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440338|NCT01921387|Cytarabine|cytarabine|mesh-list
44440339|NCT01921387|Etoposide|etoposide|mesh-list
44440342|NCT01921387|Melphalan|melphalan|mesh-list
44440350|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44440351|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440352|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44440353|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44098423|NCT00049335|Capecitabine|capecitabine|mesh-list
44440354|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440355|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440356|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44440357|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
44440358|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
44440359|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440360|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440361|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44440362|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
44440363|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44440364|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
44440365|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440366|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
44440367|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
44440368|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
44440369|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44440370|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44440371|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44440372|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440373|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440374|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440375|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440376|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440377|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44440379|NCT01921205|Lacosamide|lacosamide|mesh-list
44440392|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
44440393|NCT01920932|Dacarbazine|dacarbazine|mesh-list
44440394|NCT01920932|Doxorubicin|doxorubicin|mesh-list
44440395|NCT01920932|Etoposide|etoposide|mesh-list
44440396|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44440397|NCT01920932|Imidazole|imidazole|mesh-list
44440398|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440399|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
44440400|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440401|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44440402|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44440403|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
44440404|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440405|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440406|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44440407|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44440408|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44440409|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44440410|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440411|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440412|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
44440413|NCT01920932|Hormones|hormones|mesh-ancestor
44440414|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440415|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44440416|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44440417|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440418|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
44440419|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44440420|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440421|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440422|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44440423|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
44440424|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440432|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
43801750|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
44440433|NCT01920568|Denosumab|denosumab|mesh-list
44440434|NCT01920568|Calcium|calcium|mesh-list
44440435|NCT01920568|Vitamins|vitamins|mesh-ancestor
44440436|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
44440437|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440438|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44440439|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44440440|NCT01920555|Midazolam|midazolam|mesh-list
44440441|NCT01920555|Ketamine|ketamine|mesh-list
44440442|NCT01920555|Analgesics|analgesics|mesh-ancestor
44440443|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
44440444|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440445|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440446|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44440447|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44440448|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
44440449|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
44440450|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440451|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44440452|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44440453|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440454|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440455|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44440456|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44440457|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44440458|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440459|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440460|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
44440461|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
44440462|NCT01920477|Ofatumumab|ofatumumab|mesh-list
44440464|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
44440478|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44440479|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440480|NCT01919801|Icatibant|icatibant|mesh-list
44440481|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44440482|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44440483|NCT01919801|Analgesics|analgesics|mesh-ancestor
44440484|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
44440485|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440486|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440487|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440488|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44440489|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44440490|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44440491|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440492|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44440493|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440494|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
44440495|NCT01919723|Ticagrelor|ticagrelor|mesh-list
44440496|NCT01919723|Eptifibatide|eptifibatide|mesh-list
44440497|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44440498|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44440499|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44440500|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44440501|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
44440502|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440503|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440504|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440505|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
44440506|NCT01919489|Liraglutide|liraglutide|mesh-list
44440520|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440522|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440523|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44440524|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44440525|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440526|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440527|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44440528|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44440529|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440530|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440531|NCT01919190|Bupivacaine|bupivacaine|mesh-list
44440532|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
44440533|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
44440534|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440535|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440536|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
44440537|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440538|NCT01919164|Mitogens|mitogens|mesh-list
44440539|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
44440540|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440541|NCT01918371|Ranibizumab|ranibizumab|mesh-list
44440542|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44440543|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44440544|NCT01918371|Growth Substances|growth substances|mesh-ancestor
44440545|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440546|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
44440547|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440548|NCT01918332|Valsartan|valsartan|mesh-list
44440549|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44440550|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44440561|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440562|NCT01918033|Desloratadine|desloratadine|mesh-list
44440563|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44440564|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440565|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440566|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440567|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440568|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44440569|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44440570|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
44440571|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
44440573|NCT01917656|Liraglutide|liraglutide|mesh-list
44440574|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440575|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44098657|NCT00049790|Paclitaxel|paclitaxel|mesh-list
44440576|NCT01917656|Incretins|incretins|mesh-ancestor
44440577|NCT01917656|Hormones|hormones|mesh-ancestor
44440578|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440579|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
44440580|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44440581|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44440582|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44440583|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440584|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440585|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
44440586|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440587|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440588|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44440589|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440603|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440604|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440605|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440606|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43801916|NCT03914742|Temozolomide|temozolomide|mesh-list
44440607|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44440608|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
44440609|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
44440610|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44440611|NCT01916824|Mirtazapine|mirtazapine|mesh-list
44440612|NCT01916824|Citalopram|citalopram|mesh-list
44440613|NCT01916824|Bupropion|bupropion|mesh-list
44440614|NCT01916824|Fluoxetine|fluoxetine|mesh-list
44440615|NCT01916824|Paroxetine|paroxetine|mesh-list
44440616|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44440617|NCT01916824|Sertraline|sertraline|mesh-list
44440618|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
44440619|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44440620|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44440621|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44440622|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440623|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440624|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440625|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
44440626|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440627|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44440628|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440629|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440630|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44440631|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
44440632|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44440633|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44440634|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440644|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44440645|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44440646|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440647|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440648|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44440649|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440650|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44440651|NCT01916226|Cetirizine|cetirizine|mesh-list
44440652|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44440653|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44440654|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44440655|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
44440656|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
44440657|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440658|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440659|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440660|NCT01916109|Gemcitabine|gemcitabine|mesh-list
44440661|NCT01916109|Carboplatin|carboplatin|mesh-list
44440662|NCT01916109|Panitumumab|panitumumab|mesh-list
44440663|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440698|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44440699|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440701|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440702|NCT01915732|Clindamycin|clindamycin|mesh-list
44440703|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
44440704|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
44440705|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44440706|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44440707|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44440708|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440709|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440710|NCT01915303|Cabergoline|cabergoline|mesh-list
44440711|NCT01915303|Pasireotide|pasireotide|mesh-list
44440712|NCT01915303|Hormones|hormones|mesh-ancestor
44440713|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44440714|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440715|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44440716|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44440717|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
44440718|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
44440719|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440720|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440721|NCT01914926|Metoprolol|metoprolol|mesh-list
44440722|NCT01914926|Diltiazem|diltiazem|mesh-list
44440723|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44440724|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44440725|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
44440726|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
44440727|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440728|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440739|NCT01914757|Benralizumab|benralizumab|mesh-list
44440740|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44440741|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
44440742|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44440743|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44440744|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44440745|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440746|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440747|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440748|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440749|NCT01914666|Analgesics|analgesics|mesh-ancestor
44440750|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
44440751|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440752|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
44440753|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440754|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
44440755|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44440756|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44440757|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43825009|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801934|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440758|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440759|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440760|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440761|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44440762|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44440763|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440764|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440765|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440766|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440767|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44440768|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440769|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
44440770|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44440771|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44440777|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440778|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44440779|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440780|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440781|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
44440782|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440783|NCT01913639|Antidotes|antidotes|mesh-ancestor
44440784|NCT01913639|Protective Agents|protective agents|mesh-ancestor
44440785|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
44440786|NCT01913639|Vitamins|vitamins|mesh-ancestor
44440787|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
44440788|NCT01913483|Heparin|heparin|mesh-list
44440789|NCT01913483|Calcium heparin|calcium heparin|mesh-list
44440790|NCT01913483|Bivalirudin|bivalirudin|mesh-list
44440791|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
44440792|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44440793|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44440794|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440795|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
44440796|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44440797|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
44440798|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440799|NCT01913470|Losartan|losartan|mesh-list
44098922|NCT00050713|Sirolimus|sirolimus|mesh-list
44440800|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44440801|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44440802|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44440803|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43802049|NCT03424525|Trimethoprim|trimethoprim|mesh-list
43802133|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43802195|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802200|NCT02633059|Dexamethasone|dexamethasone|mesh-list
44440804|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440805|NCT01913405|Factor VIII|factor viii|mesh-list
44440807|NCT01913405|Coagulants|coagulants|mesh-ancestor
44440808|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
44440809|NCT01913340|Hematinics|hematinics|mesh-ancestor
44440810|NCT01913327|Risperidone|risperidone|mesh-list
44440811|NCT01913327|Aripiprazole|aripiprazole|mesh-list
44440812|NCT01913327|Modafinil|modafinil|mesh-list
44440813|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440814|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
44440817|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440819|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440820|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440821|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440822|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44440823|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
44440824|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
44440825|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
44440826|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44440827|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44440828|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44440829|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44440830|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44440831|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44440832|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44440833|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44440834|NCT01912963|Trastuzumab|trastuzumab|mesh-list
44440835|NCT01912963|Pertuzumab|pertuzumab|mesh-list
44440836|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44440837|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440838|NCT01912872|Omalizumab|omalizumab|mesh-list
44440839|NCT01912872|Budesonide|budesonide|mesh-list
44440840|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
44440841|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44440842|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44440849|NCT01912872|Hormones|hormones|mesh-ancestor
44440864|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
44440865|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
44440866|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440867|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
44440868|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440869|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440870|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44440871|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440872|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440873|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440874|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44440875|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44440876|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44440877|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44440878|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44440879|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44440880|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440881|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440882|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440883|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440884|NCT01912612|Analgesics|analgesics|mesh-ancestor
44440885|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
44440886|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44440887|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
44440888|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440889|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
44440890|NCT01912456|Complement C1s|complement c1s|mesh-list
44440910|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44440911|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44440912|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44440913|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440914|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44440915|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440916|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
44440917|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44440918|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44440919|NCT01911780|Diuretics|diuretics|mesh-ancestor
44440920|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
44440921|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44440922|NCT01911546|Everolimus|everolimus|mesh-list
44440923|NCT01911546|Tacrolimus|tacrolimus|mesh-list
44440924|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440925|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
44440926|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440927|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44440928|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440929|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440930|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44440931|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44440932|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44440933|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440934|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440935|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440936|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440937|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44440938|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44440939|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440940|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440949|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
44440950|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44440951|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44440952|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44440953|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440954|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44440955|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44440956|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44440957|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44440958|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
44440959|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44440960|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440961|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44440962|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44440963|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
44440964|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44440965|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44440966|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
44440967|NCT01911260|Chelating Agents|chelating agents|mesh-list
44440968|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
44440969|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440971|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
44440972|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440973|NCT01910441|Metformin|metformin|mesh-list
44440974|NCT01910441|Glimepiride|glimepiride|mesh-list
44440975|NCT01910441|Vildagliptin|vildagliptin|mesh-list
44440976|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44440977|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44440978|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44440979|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44440980|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
44440981|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44440982|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
44440989|NCT01910402|Emtricitabine|emtricitabine|mesh-list
44440990|NCT01910402|Dolutegravir|dolutegravir|mesh-list
44440991|NCT01910402|Abacavir|abacavir|mesh-list
44440992|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44440993|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44440994|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
44440995|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44440996|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44440997|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44440998|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44440999|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
44441000|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441001|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44441002|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44441003|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44441004|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44441005|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44441006|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44441007|NCT01910389|Tadalafil|tadalafil|mesh-list
44441008|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
44441009|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44441010|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44441011|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441012|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441013|NCT01910389|Urological Agents|urological agents|mesh-ancestor
44441014|NCT01910181|Vemurafenib|vemurafenib|mesh-list
44441037|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44441038|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44441039|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441040|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441041|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
44441042|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
44441043|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441044|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441045|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44441046|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44441047|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
44441048|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44441049|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44441050|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44441051|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44441052|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44441053|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
44441054|NCT01908829|Mirabegron|mirabegron|mesh-list
44441055|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44441056|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44441057|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441058|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441059|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441060|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441061|NCT01908829|Urological Agents|urological agents|mesh-ancestor
44441062|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44441063|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44441064|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44441065|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
44441066|NCT01908816|Ranibizumab|ranibizumab|mesh-list
44441067|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44441068|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44441078|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441079|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441080|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441081|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
44441082|NCT01908803|Hormones|hormones|mesh-ancestor
44441083|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441084|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441085|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441086|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44441087|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441088|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44441089|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44441090|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441091|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441092|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44441093|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44441094|NCT01908699|Beraprost|beraprost|mesh-list
44441095|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44441096|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
44441097|NCT01908582|Rifampin|rifampin|mesh-list
44441098|NCT01908582|Evacetrapib|evacetrapib|mesh-list
44441099|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44441100|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
44441101|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44441102|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441103|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
44441104|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44441124|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44441125|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441126|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44441127|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
44441128|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441129|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441130|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44441131|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
44441132|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
44441133|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44441134|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44441135|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44441136|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44441137|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
44441138|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441139|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441140|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
44441141|NCT01908101|Halichondrin B|halichondrin b|mesh-list
44441142|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
44441143|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441144|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
44441145|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441146|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441147|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44441170|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44441171|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
44441172|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
44441173|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441174|NCT01907100|Cisplatin|cisplatin|mesh-list
44441175|NCT01907100|Pemetrexed|pemetrexed|mesh-list
44441176|NCT01907100|Nintedanib|nintedanib|mesh-list
44441177|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441178|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441179|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441180|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44441181|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44441182|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44441183|NCT01906372|Hormones|hormones|mesh-list
44441184|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44441185|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
44441186|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
43802406|NCT00694655|Vaccines|vaccines|mesh-list
44441187|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441188|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441189|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441190|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441191|NCT01906346|Cocaine|cocaine|mesh-list
44441192|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
44441193|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
44441194|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441195|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441203|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
44441217|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44441218|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
44441219|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441220|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441221|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44441222|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44441223|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
44441224|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44441225|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44441226|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44441227|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44441228|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441229|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441230|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441231|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441232|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441233|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44441234|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441235|NCT01905657|Docetaxel|docetaxel|mesh-list
44441236|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
44441237|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441238|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
44441239|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441240|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44441241|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441242|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44441243|NCT01905592|Niraparib|niraparib|mesh-list
44441248|NCT01904903|Trastuzumab|trastuzumab|mesh-list
44441260|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44441261|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441262|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441263|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441264|NCT01904760|Analgesics|analgesics|mesh-ancestor
44441265|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
44441266|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441267|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44441268|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44441269|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44441270|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
44441271|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441272|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441273|NCT01904721|Bimatoprost|bimatoprost|mesh-list
44441274|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44441275|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44441276|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
44441277|NCT01904149|Tramadol|tramadol|mesh-list
44441278|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44441279|NCT01904149|Narcotics|narcotics|mesh-ancestor
44441280|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441281|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441282|NCT01904149|Analgesics|analgesics|mesh-ancestor
44441283|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
44441284|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441285|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441286|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441287|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441288|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441289|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
44441290|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44441302|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441303|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
44441304|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441305|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
44441306|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441307|NCT01903837|Naltrexone|naltrexone|mesh-list
44441308|NCT01903837|Olanzapine|olanzapine|mesh-list
44441309|NCT01903837|ALKS-33|alks-33|mesh-list
44441310|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
44441311|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
44441312|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441313|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441314|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441315|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44441316|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44441317|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441318|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441319|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44441320|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44441321|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441322|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441323|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441324|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
44441325|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44441326|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44441328|NCT01903811|Dexamethasone|dexamethasone|mesh-list
44441352|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441353|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441354|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
44441355|NCT01903720|Hormones|hormones|mesh-ancestor
44441356|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441357|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441358|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441359|NCT01903434|Evacetrapib|evacetrapib|mesh-list
44441360|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44441361|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44441362|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
44441363|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441364|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44441365|NCT01903356|Linagliptin|linagliptin|mesh-list
44441366|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44441367|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441368|NCT01903356|Incretins|incretins|mesh-ancestor
44441369|NCT01903356|Hormones|hormones|mesh-ancestor
44441370|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441371|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44441372|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441373|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441374|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441375|NCT01903252|Mesalamine|mesalamine|mesh-list
44441376|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441377|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441378|NCT01903252|Analgesics|analgesics|mesh-ancestor
44441379|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
44441380|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441381|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441382|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441383|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441384|NCT01903031|Ritonavir|ritonavir|mesh-list
44441394|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44441395|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
44441396|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441397|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441398|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44441399|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44441400|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
44441401|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441402|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44441403|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44441404|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44441405|NCT01903031|Estrogens|estrogens|mesh-ancestor
44441406|NCT01903031|Hormones|hormones|mesh-ancestor
44441407|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441408|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441409|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44441410|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
44441411|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44441412|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44441413|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44441414|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44441415|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44441416|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44441419|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44441440|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441441|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441442|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441443|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441444|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441445|NCT01901848|Bupropion|bupropion|mesh-list
44441446|NCT01901848|Nicotine|nicotine|mesh-list
44441447|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44441448|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
44441449|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441450|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441451|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44441452|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44441453|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441454|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441455|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441456|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44441457|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
44441458|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441459|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44441460|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44441461|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441462|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
44441463|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44441464|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44441465|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441466|NCT01901614|Anesthetics|anesthetics|mesh-list
44441467|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441468|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441483|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441484|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441485|NCT01901224|Metformin|metformin|mesh-list
44441486|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44441487|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441488|NCT01901185|Etanercept|etanercept|mesh-list
44441489|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441490|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441491|NCT01901185|Analgesics|analgesics|mesh-ancestor
44441492|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
44441493|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441494|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441495|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441496|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441497|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441498|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441499|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
44441500|NCT01901146|Paclitaxel|paclitaxel|mesh-list
44441501|NCT01901146|Trastuzumab|trastuzumab|mesh-list
44441502|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44441503|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441504|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
44441505|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
44441506|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
44441507|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441508|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825021|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44441509|NCT01900730|Valproic Acid|valproic acid|mesh-list
44441510|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
44441513|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
44441530|NCT01900431|Prednisone|prednisone|mesh-list
44441531|NCT01900431|Methotrexate|methotrexate|mesh-list
44441532|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
44441533|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441534|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
44441535|NCT01900431|Hormones|hormones|mesh-ancestor
44441536|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441537|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441538|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441539|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441540|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44441541|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
44441542|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44441543|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44441544|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
44441545|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441546|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
44441547|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441548|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44441549|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441550|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
44441551|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441552|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44441553|NCT01900431|Antidotes|antidotes|mesh-ancestor
44441554|NCT01900431|Protective Agents|protective agents|mesh-ancestor
44441555|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
44441556|NCT01900431|Vitamins|vitamins|mesh-ancestor
44441557|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
44441558|NCT01900431|Hematinics|hematinics|mesh-ancestor
44441559|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
44099735|NCT00053027|Rituximab|rituximab|mesh-list
44441573|NCT01899053|Serabelisib|serabelisib|mesh-list
44441574|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441575|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441576|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44441577|NCT01898923|Laxatives|laxatives|mesh-ancestor
44441578|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441579|NCT01898806|Triamcinolone|triamcinolone|mesh-list
44441580|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44441581|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44441582|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44441583|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441584|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
44441585|NCT01898806|Hormones|hormones|mesh-ancestor
44441586|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441587|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441588|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441589|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
44441590|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441591|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825026|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
43802603|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
43802604|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43802605|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43802607|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
43802608|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43802609|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
43802610|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
43802611|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802612|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
44441592|NCT01898442|Ticagrelor|ticagrelor|mesh-list
44441593|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44441594|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44441595|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44441596|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44441597|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
44441598|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441599|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441600|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441601|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
44441602|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44441603|NCT01898195|Varenicline|varenicline|mesh-list
44441604|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44441605|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44441606|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
44441607|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441610|NCT01898130|Bevacizumab|bevacizumab|mesh-list
44441611|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44441612|NCT01898130|Antibodies|antibodies|mesh-list
44441613|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
44441614|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44441615|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441616|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44441617|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44441618|NCT01898130|Growth Substances|growth substances|mesh-ancestor
44441619|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441620|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
44441621|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
44441622|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
44441623|NCT01898091|Glycerol|glycerol|mesh-list
44441624|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
44441625|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441626|NCT01898091|Protective Agents|protective agents|mesh-ancestor
44441627|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441628|NCT01898091|Vitamins|vitamins|mesh-ancestor
44441629|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
44441630|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44441631|NCT01897727|Spironolactone|spironolactone|mesh-list
44441632|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44441633|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
44441634|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441635|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802838|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441636|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44441637|NCT01897727|Diuretics|diuretics|mesh-ancestor
44441638|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
44441656|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441657|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44441659|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441660|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441661|NCT01897493|Digoxin|digoxin|mesh-list
44441662|NCT01897493|Evacetrapib|evacetrapib|mesh-list
44441663|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44441664|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44441665|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441666|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441667|NCT01897493|Protective Agents|protective agents|mesh-ancestor
44441668|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441669|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44441670|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44441671|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
44441672|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44441673|NCT01897233|Ivacaftor|ivacaftor|mesh-list
44441674|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44441675|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441676|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441677|NCT01896934|Sertraline|sertraline|mesh-list
44441678|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
44441679|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441680|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44441681|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43802898|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
43802899|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802900|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802901|NCT04976088|Diclofenac|diclofenac|mesh-list
43802911|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43802912|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802974|NCT04974827|Carboplatin|carboplatin|mesh-list
43802975|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441682|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441683|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441684|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441698|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441699|NCT01896869|Ipilimumab|ipilimumab|mesh-list
44441700|NCT01896869|Folfirinox|folfirinox|mesh-list
44441701|NCT01896869|Vaccines|vaccines|mesh-list
44441702|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
44441703|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441704|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44441705|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441706|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44441707|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44099889|NCT00053287|Topotecan|topotecan|mesh-list
44441708|NCT01896856|Trifluridine|trifluridine|mesh-list
44441710|NCT01896856|Guadecitabine|guadecitabine|mesh-list
44441711|NCT01896856|Azacitidine|azacitidine|mesh-list
44441712|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44441713|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44441714|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441715|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441716|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441717|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
44441718|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
44441719|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441720|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44441721|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
44441722|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
44441723|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44441724|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
44441725|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44441726|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441727|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44441728|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44441729|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44441736|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44441737|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441738|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44441739|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44441740|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44441741|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441742|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
44441743|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441744|NCT01896557|Omeprazole|omeprazole|mesh-list
44441745|NCT01896557|Ranitidine|ranitidine|mesh-list
44441746|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44441747|NCT01896557|Clopidogrel|clopidogrel|mesh-list
44441748|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
44441749|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44441750|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44441751|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44441752|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
44441753|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441754|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441755|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441756|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44441757|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441758|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44441787|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441788|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44441789|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
44441790|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441792|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
44441793|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441794|NCT01896128|Modafinil|modafinil|mesh-list
44441795|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44441796|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441797|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44441798|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44441799|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44441800|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441801|NCT01896050|Tamoxifen|tamoxifen|mesh-list
44441802|NCT01896050|Letrozole|letrozole|mesh-list
44441803|NCT01896050|Anastrozole|anastrozole|mesh-list
44441804|NCT01896050|Exemestane|exemestane|mesh-list
44441805|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441806|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44441807|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44441808|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441809|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441810|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44441811|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
44441812|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441813|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441814|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44441815|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44441816|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44441817|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44441827|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441828|NCT01895335|Analgesics|analgesics|mesh-ancestor
44441829|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
44441830|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441831|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441832|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441833|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441834|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441835|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
44441836|NCT01895322|Tolvaptan|tolvaptan|mesh-list
44441837|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44441838|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441839|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
44441840|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441841|NCT01895309|Etanercept|etanercept|mesh-list
44441842|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44441843|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44441844|NCT01895309|Analgesics|analgesics|mesh-ancestor
44441845|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
44441846|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441847|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441848|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441849|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44441852|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
44441876|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44441877|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44441878|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
44441879|NCT01894919|Vaccines|vaccines|mesh-list
44441880|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
44441881|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441882|NCT01894776|Maraviroc|maraviroc|mesh-list
44441883|NCT01894776|Rifabutin|rifabutin|mesh-list
44441884|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44441885|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44441886|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441887|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44441888|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44441889|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
44441890|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44441891|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
44441892|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44441893|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44441894|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
44441895|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44441896|NCT01894581|Hormones|hormones|mesh-ancestor
44441897|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44441898|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441899|NCT01894568|Insulin|insulin|mesh-list
44441900|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44441901|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
44441902|NCT01894568|Pioglitazone|pioglitazone|mesh-list
44441903|NCT01894568|Biguanides|biguanides|mesh-list
44441904|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44441905|NCT01894568|Meglitinide|meglitinide|mesh-list
44441906|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441907|NCT01894477|Fludarabine|fludarabine|mesh-list
44441922|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44441923|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441924|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441925|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441926|NCT01894243|Olaparib|olaparib|mesh-list
44441927|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44441928|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44441929|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441930|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441931|NCT01894152|Everolimus|everolimus|mesh-list
44441932|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44441933|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441934|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
44441935|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441936|NCT01894022|Ambrisentan|ambrisentan|mesh-list
44441937|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44441938|NCT01893827|Naltrexone|naltrexone|mesh-list
44441939|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44441940|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44441941|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441942|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
44441943|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441944|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
44441945|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44441946|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44441947|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44441970|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44441971|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
44441972|NCT01892345|Eculizumab|eculizumab|mesh-list
44441973|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44441974|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44441975|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
44441976|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441977|NCT01892189|Ketamine|ketamine|mesh-list
44441978|NCT01892189|Analgesics|analgesics|mesh-ancestor
44441979|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
44441980|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441981|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441982|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44441983|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44441984|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
44441985|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
44441986|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44441987|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44441988|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44441989|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44441990|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44441991|NCT01892163|Dexamethasone|dexamethasone|mesh-list
44441992|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44441993|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
44441994|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
44441995|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44441996|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44441997|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44441998|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
44442014|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44442015|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442016|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442017|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44442018|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442019|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44442020|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442021|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442022|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442023|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44442024|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44442025|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44442026|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44442028|NCT01891864|GP2015|gp2015|mesh-list
44442029|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442030|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442032|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
44442033|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442034|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442035|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442036|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442037|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442041|NCT01891669|PF-06263507|pf-06263507|mesh-list
44442063|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442064|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442065|NCT01890967|Atorvastatin|atorvastatin|mesh-list
44442066|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44442067|NCT01890967|Simvastatin|simvastatin|mesh-list
44442068|NCT01890967|Ezetimibe|ezetimibe|mesh-list
43842698|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44442069|NCT01890967|Pravastatin|pravastatin|mesh-list
44442070|NCT01890967|Pitavastatin|pitavastatin|mesh-list
44442071|NCT01890967|Lovastatin|lovastatin|mesh-list
44442072|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44442073|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44442074|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
44442075|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442076|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44442077|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44442078|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442079|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44442080|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44442081|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442082|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44442083|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44442084|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442085|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442086|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
44442087|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442088|NCT01890746|Cytarabine|cytarabine|mesh-list
44442089|NCT01890746|Daunorubicin|daunorubicin|mesh-list
44442090|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442091|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
44442092|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442107|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44442108|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442110|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442111|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
44442112|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442113|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442114|NCT01890265|Pirfenidone|pirfenidone|mesh-list
44442115|NCT01890265|Nintedanib|nintedanib|mesh-list
44442116|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
44442117|NCT01890265|Antibodies|antibodies|mesh-list
44442118|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
44442119|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44442120|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
44442121|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442122|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442123|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442124|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442125|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442126|NCT01890265|Analgesics|analgesics|mesh-ancestor
44442127|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
44442128|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442129|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442130|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442131|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442132|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442133|NCT01890122|Metformin|metformin|mesh-list
44442134|NCT01890122|Alogliptin|alogliptin|mesh-list
44442135|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442136|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442137|NCT01890122|Incretins|incretins|mesh-ancestor
44442138|NCT01890122|Hormones|hormones|mesh-ancestor
44442149|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442150|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442151|NCT01889862|Dextrans|dextrans|mesh-list
44442152|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
44442153|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
44442154|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
44442155|NCT01889602|Topiramate|topiramate|mesh-list
44442156|NCT01889602|Lorazepam|lorazepam|mesh-list
44442157|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
44442158|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442159|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442160|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
44442161|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
44442162|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442163|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442164|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44442165|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442166|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44442167|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442168|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442169|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
44442170|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
44442171|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442172|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442173|NCT01889069|Prednisone|prednisone|mesh-list
44442174|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
44442175|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44442198|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44442199|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442200|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442201|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442202|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
44442203|NCT01888497|Promethazine|promethazine|mesh-list
44442204|NCT01888497|Triazolam|triazolam|mesh-list
44442205|NCT01888497|Gabapentin|gabapentin|mesh-list
44442206|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442207|NCT01888497|Analgesics|analgesics|mesh-ancestor
44442208|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
44442209|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442210|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442211|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
44442212|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44442213|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442214|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442215|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442216|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44442217|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44442218|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442219|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
44442220|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44442221|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44442222|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
44442223|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
44442224|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
44442225|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
44442226|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442227|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44442228|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
44442229|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
44442230|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44442231|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
44442232|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
44442233|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44442234|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
44442239|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
44442240|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442241|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44442242|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442243|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442244|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442245|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44442246|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442247|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
44442248|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44442249|NCT01888003|Hematinics|hematinics|mesh-ancestor
44442250|NCT01887717|Sorafenib|sorafenib|mesh-list
44442251|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442252|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442253|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442254|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442255|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
44442256|NCT01887418|Testosterone|testosterone|mesh-list
44442257|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
44442258|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
44442259|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44442260|NCT01887418|Androgens|androgens|mesh-ancestor
44442261|NCT01887418|Hormones|hormones|mesh-ancestor
44442262|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442263|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442264|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442265|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442266|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
44442267|NCT01887353|Ranolazine|ranolazine|mesh-list
44442268|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44442271|NCT01887288|Capecitabine|capecitabine|mesh-list
44442282|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44442283|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44442284|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44442285|NCT01886690|Laxatives|laxatives|mesh-ancestor
44442286|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442287|NCT01886287|Octreotide|octreotide|mesh-list
44442288|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442289|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442290|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442291|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44442292|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442293|NCT01886105|Analgesics|analgesics|mesh-ancestor
44442294|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
44442295|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442296|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442297|NCT01885936|Albuterol|albuterol|mesh-list
44442298|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44442299|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
44442300|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442301|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442302|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44442303|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
44442304|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
44442305|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44442306|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44442307|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44442308|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44442309|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
44442310|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442311|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442312|NCT01885559|Telmisartan|telmisartan|mesh-list
44442313|NCT01885559|Lisinopril|lisinopril|mesh-list
44442314|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44442315|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442316|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44442317|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43635700|NCT05192889|Etoposide|etoposide|mesh-list
44442318|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442320|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442321|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44442322|NCT01885559|Protective Agents|protective agents|mesh-ancestor
44442323|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442324|NCT01885208|Exenatide|exenatide|mesh-list
44442325|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442326|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442327|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44442328|NCT01885208|Incretins|incretins|mesh-ancestor
44442329|NCT01885208|Hormones|hormones|mesh-ancestor
44442330|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442331|NCT01885182|Oxycodone|oxycodone|mesh-list
44442332|NCT01885182|Naloxone|naloxone|mesh-list
44442333|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44442335|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442336|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442337|NCT01885182|Analgesics|analgesics|mesh-ancestor
44442338|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
44442339|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442340|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44442341|NCT01885104|Bisacodyl|bisacodyl|mesh-list
44442342|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44442343|NCT01885104|Laxatives|laxatives|mesh-list
44442344|NCT01885104|Cathartics|cathartics|mesh-ancestor
44442345|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442346|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44442347|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442348|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44442349|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44442350|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44442362|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
44442363|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442364|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
44442365|NCT01884571|Prednisone|prednisone|mesh-list
44442366|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
44442367|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44442368|NCT01884571|Tacrolimus|tacrolimus|mesh-list
44442369|NCT01884571|Basiliximab|basiliximab|mesh-list
44442370|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442371|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
44442372|NCT01884571|Hormones|hormones|mesh-ancestor
44442373|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442374|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442375|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442376|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442377|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442378|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
44442379|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44442380|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442381|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442382|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44442383|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44442384|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
44442385|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44442386|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442387|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
44442388|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
44442389|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442390|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442391|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44442392|NCT01884571|Protective Agents|protective agents|mesh-ancestor
44442393|NCT01884350|Apixaban|apixaban|mesh-list
44442406|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44100599|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442407|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442408|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
44442409|NCT01883362|Midostaurin|midostaurin|mesh-list
44442410|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442411|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442412|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442413|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442415|NCT01882985|Docetaxel|docetaxel|mesh-list
44442416|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442417|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442418|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442419|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442422|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
44442464|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442465|NCT01882088|Psyllium|psyllium|mesh-list
44442466|NCT01882088|Cathartics|cathartics|mesh-ancestor
44442467|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442468|NCT01881789|Dexamethasone|dexamethasone|mesh-list
44442469|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
44442470|NCT01881789|Lenalidomide|lenalidomide|mesh-list
44442471|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442472|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
44442473|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442474|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442475|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44442476|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
44442477|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442478|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442479|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44442480|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442481|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
44442482|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
44100640|NCT00055484|Zonisamide|zonisamide|mesh-list
44442483|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442484|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442485|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
44442486|NCT01881789|Hormones|hormones|mesh-ancestor
44442487|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442488|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442513|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44442514|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44442515|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
44442516|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442517|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442518|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442519|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44442520|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442521|NCT01880957|Lamotrigine|lamotrigine|mesh-list
44442522|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
44442523|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
44442524|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442525|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442526|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442527|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
44442528|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442529|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442530|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442531|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
44442532|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44442533|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442534|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44442535|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44442536|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44442537|NCT01880736|Insulin|insulin|mesh-list
44442538|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44442539|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
44442540|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442541|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442542|NCT01880593|Ketamine|ketamine|mesh-list
44442543|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
44442544|NCT01880593|Analgesics|analgesics|mesh-ancestor
44442545|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
44442553|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44442554|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44442555|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442556|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442557|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44442558|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442559|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442561|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442563|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44442564|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442565|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442566|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442614|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44442615|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442616|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442618|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442619|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44442620|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44442621|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44442622|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44442623|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44442624|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44442625|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44442626|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
44442627|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442628|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44442629|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44100796|NCT00055770|Docetaxel|docetaxel|mesh-list
44442630|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442631|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442632|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442633|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
44442634|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442635|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44442636|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44442637|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
44442638|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44442639|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
44442640|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44442641|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
44442642|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442643|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442644|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
44442645|NCT01877668|Adalimumab|adalimumab|mesh-list
44442646|NCT01877668|Tofacitinib|tofacitinib|mesh-list
44442647|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442649|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442650|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442651|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442652|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
44442653|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
44442654|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442655|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44442656|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442657|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
44442658|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442659|NCT01877083|Lenvatinib|lenvatinib|mesh-list
44442660|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442661|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442662|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442663|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442664|NCT01876823|Memantine|memantine|mesh-list
44442665|NCT01876823|Citalopram|citalopram|mesh-list
44442666|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44442667|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44442668|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
44442669|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442670|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442671|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442672|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44442673|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44442674|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44442675|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44442676|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44442677|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
44442678|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44442680|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442692|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
44442693|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442694|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
44442695|NCT01876732|Hematinics|hematinics|mesh-ancestor
44442696|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
44442697|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442698|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442699|NCT01876446|Irinotecan|irinotecan|mesh-list
44442700|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44442701|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44442702|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442703|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44100877|NCT00055874|Interferons|interferons|mesh-list
44442704|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442705|NCT01876381|Tolvaptan|tolvaptan|mesh-list
44442706|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44442707|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442708|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
44442709|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442710|NCT01876368|Olmesartan|olmesartan|mesh-list
44442711|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44442712|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44442713|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44442714|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44442715|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44442716|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442717|NCT01876251|Docetaxel|docetaxel|mesh-list
44442718|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442719|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442732|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442733|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
44442734|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442735|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44442736|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442737|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
44442738|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442739|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44442740|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44442741|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
44442742|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
44442743|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
44442744|NCT01875991|Etanercept|etanercept|mesh-list
44442745|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442746|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442747|NCT01875991|Analgesics|analgesics|mesh-ancestor
44442748|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
44442749|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442750|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442751|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442752|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442753|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442754|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442755|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
44442756|NCT01875848|Buprenorphine|buprenorphine|mesh-list
44442757|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
44442758|NCT01875848|Naloxone|naloxone|mesh-list
44442759|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44442760|NCT01875848|Narcotics|narcotics|mesh-ancestor
44442761|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442762|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442763|NCT01875848|Analgesics|analgesics|mesh-ancestor
44442764|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
44442765|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442766|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44442772|NCT01875367|Trastuzumab|trastuzumab|mesh-list
44442773|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442774|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442775|NCT01875250|Metronidazole|metronidazole|mesh-list
44442776|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44442777|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44442778|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44442779|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44442780|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
44442781|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44442782|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44442783|NCT01875237|Prednisolone|prednisolone|mesh-list
44442784|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
44442785|NCT01875237|Methotrexate|methotrexate|mesh-list
44442786|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
44442787|NCT01875237|Fludarabine|fludarabine|mesh-list
44442788|NCT01875237|Melphalan|melphalan|mesh-list
44442789|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
44442790|NCT01875237|Tacrolimus|tacrolimus|mesh-list
44442791|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44442792|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
44442793|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44442794|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
44442795|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44442796|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442797|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44442798|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
44442799|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442800|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803382|NCT04967326|Analgesics|analgesics|mesh-ancestor
44442801|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
44442802|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442803|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44442804|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44442805|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
44442806|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442807|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44442808|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44442812|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442813|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442814|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
44442815|NCT01875237|Hormones|hormones|mesh-ancestor
44442816|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442817|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44442818|NCT01875237|Protective Agents|protective agents|mesh-ancestor
44442819|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442820|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44442821|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
44442822|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44442823|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44442824|NCT01874665|Ponatinib|ponatinib|mesh-list
44442825|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442826|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44442829|NCT01874535|Esomeprazole|esomeprazole|mesh-list
44442870|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44442871|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44442872|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44442873|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
44442874|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44442875|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44442876|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44442877|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44442879|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44442880|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442881|NCT01873729|Naltrexone|naltrexone|mesh-list
44442882|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44442883|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44442884|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442885|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
44442886|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442887|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
44442926|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442927|NCT01872611|Prednisolone|prednisolone|mesh-list
44442928|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44442929|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
44442930|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44442931|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
44442932|NCT01872611|Nepafenac|nepafenac|mesh-list
44442933|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44442934|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
44442935|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44442936|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
44442937|NCT01872611|Hormones|hormones|mesh-ancestor
44442938|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44442939|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442940|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44442941|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44442942|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
44442943|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
44442944|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442945|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44442946|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44442947|NCT01872611|Protective Agents|protective agents|mesh-ancestor
44442948|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44442949|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44442950|NCT01872611|Analgesics|analgesics|mesh-ancestor
44442951|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
44442952|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44442953|NCT01871870|Pancrelipase|pancrelipase|mesh-list
44442974|NCT01871285|Analgesics|analgesics|mesh-ancestor
44442975|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
44442976|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44442977|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44442978|NCT01870999|Aripiprazole|aripiprazole|mesh-list
44442979|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
44442980|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44442981|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44442982|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44442983|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44442984|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44442985|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
44442986|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
44442987|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44442988|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44442989|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44443031|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44443032|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44443033|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44443034|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443035|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44443036|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443037|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
44443038|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44443039|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44443041|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
44443042|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44443043|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
44443044|NCT01870583|Povidone|povidone|mesh-list
44443045|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44443046|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443047|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
44443048|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443049|NCT01870583|Trace Elements|trace elements|mesh-ancestor
44443050|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
44443051|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443052|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
44443053|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
44443054|NCT01870297|Liraglutide|liraglutide|mesh-list
44443055|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443056|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443057|NCT01870297|Incretins|incretins|mesh-ancestor
44443058|NCT01870297|Hormones|hormones|mesh-ancestor
44443059|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443060|NCT01869725|Octreotide|octreotide|mesh-list
44443061|NCT01869725|Edotreotide|edotreotide|mesh-list
44443062|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
44443063|NCT01869725|Somatostatin|somatostatin|mesh-list
44443064|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443066|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443071|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443073|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44443074|NCT01869699|Analgesics|analgesics|mesh-ancestor
44443075|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
44443076|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443077|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443078|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
44443079|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
44443080|NCT01869192|Docetaxel|docetaxel|mesh-list
44443081|NCT01869192|Capecitabine|capecitabine|mesh-list
44443082|NCT01869192|Epirubicin|epirubicin|mesh-list
44443083|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443084|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
44443085|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443086|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443087|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44443088|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
44443129|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443130|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443131|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
44443132|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443133|NCT01868022|Paclitaxel|paclitaxel|mesh-list
44443134|NCT01868022|Docetaxel|docetaxel|mesh-list
44443135|NCT01868022|Cisplatin|cisplatin|mesh-list
44443136|NCT01868022|Carboplatin|carboplatin|mesh-list
44443137|NCT01868022|Pemetrexed|pemetrexed|mesh-list
44443138|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44443139|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443140|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443141|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443142|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443144|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443191|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44443192|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
44443193|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443194|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443195|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44443197|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
44443198|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44443199|NCT01867294|Protective Agents|protective agents|mesh-ancestor
44443200|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443201|NCT01867086|Carboplatin|carboplatin|mesh-list
44443202|NCT01867086|Vaccines|vaccines|mesh-list
44443203|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
44443204|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443205|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443206|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44443207|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443208|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443209|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443210|NCT01867021|Vaccines|vaccines|mesh-list
44443211|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
44443212|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443213|NCT01866917|Ropivacaine|ropivacaine|mesh-list
44443214|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
44443242|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44443243|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
44443244|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
44443245|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443246|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
44443247|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
44443248|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443249|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44443250|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44443251|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443252|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443253|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443254|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443255|NCT01866657|Protective Agents|protective agents|mesh-ancestor
44443256|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44443257|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
44443259|NCT01866319|Ipilimumab|ipilimumab|mesh-list
44443260|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44443300|NCT01864148|Interferons|interferons|mesh-list
44443301|NCT01864148|Interferon-beta|interferon-beta|mesh-list
44443302|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
44443303|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825055|NCT05505006|Hematinics|hematinics|mesh-ancestor
44443304|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
44443305|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443306|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
44443307|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443308|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44443309|NCT01864018|Dexamethasone|dexamethasone|mesh-list
44443310|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
44443311|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
44443312|NCT01864018|Ixazomib|ixazomib|mesh-list
44443313|NCT01864018|Ichthammol|ichthammol|mesh-list
44443314|NCT01864018|BB 1101|bb 1101|mesh-list
44443315|NCT01864018|Glycine|glycine|mesh-list
44443316|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443317|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
44443318|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443319|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443320|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44443321|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
44443322|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443355|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44443356|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443357|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443358|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443359|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443360|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443362|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44443363|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443364|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443365|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
44443366|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443367|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44443368|NCT01863680|Hormones|hormones|mesh-list
44443369|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44443370|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443371|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443372|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44443373|NCT01863667|Glimepiride|glimepiride|mesh-list
44443374|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44443375|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443376|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443377|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443378|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
44443404|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
44443405|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443406|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
44443407|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44443408|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44443409|NCT01862874|Vaccines|vaccines|mesh-list
44443410|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
44443411|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443412|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
44443413|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
44443414|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443415|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443416|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443417|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
44443418|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
44443419|NCT01862328|Gemcitabine|gemcitabine|mesh-list
44443420|NCT01862328|Paclitaxel|paclitaxel|mesh-list
44443421|NCT01862328|Docetaxel|docetaxel|mesh-list
44443422|NCT01862328|Carboplatin|carboplatin|mesh-list
44443423|NCT01862328|Pevonedistat|pevonedistat|mesh-list
44443424|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44443425|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443426|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443457|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44443458|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443459|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443460|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443461|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
44443462|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443463|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443464|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
44443465|NCT01860703|Deferiprone|deferiprone|mesh-list
44443466|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443467|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443468|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44443469|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443470|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443471|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443472|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443473|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44443474|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
44443475|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
44443476|NCT01860040|Gemcitabine|gemcitabine|mesh-list
44443477|NCT01860040|Cisplatin|cisplatin|mesh-list
44443478|NCT01860040|Pemetrexed|pemetrexed|mesh-list
44443479|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443480|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443481|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
44443507|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44443508|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443509|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443510|NCT01859715|Oxycodone|oxycodone|mesh-list
44443511|NCT01859715|Hydrocodone|hydrocodone|mesh-list
44443512|NCT01859715|Ondansetron|ondansetron|mesh-list
44443513|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44443514|NCT01859715|Narcotics|narcotics|mesh-ancestor
44443515|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443516|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443517|NCT01859715|Analgesics|analgesics|mesh-ancestor
44443518|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
44443519|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443520|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
44443521|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
44443522|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443523|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
44443524|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443525|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44443526|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
44443564|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443565|NCT01858532|Atrasentan|atrasentan|mesh-list
44443566|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443567|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44443568|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44443569|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443570|NCT01858363|Paclitaxel|paclitaxel|mesh-list
44443571|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44443572|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443573|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443574|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443575|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443576|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443577|NCT01857622|Edoxaban|edoxaban|mesh-list
44443578|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44443579|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
44443580|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44443581|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
44443582|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443619|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44443620|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44443621|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44443622|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443623|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443624|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443625|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443626|NCT01857310|Folic Acid|folic acid|mesh-list
44443627|NCT01857310|Hematinics|hematinics|mesh-ancestor
44443628|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
44443629|NCT01857310|Vitamins|vitamins|mesh-ancestor
44443630|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
44443631|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443680|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443681|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44443682|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443683|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443684|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44443685|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
44443686|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443687|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
44443688|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
44443690|NCT01856257|Tacrolimus|tacrolimus|mesh-list
44443692|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44443693|NCT01856257|Basiliximab|basiliximab|mesh-list
44443694|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443695|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
44443696|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443697|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44443698|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443699|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443700|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44443701|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443702|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44443703|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
44443704|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44443705|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443706|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443707|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
44443712|NCT01856257|Hormones|hormones|mesh-ancestor
44443730|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44443731|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44443732|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44443733|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44443734|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443735|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443736|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443737|NCT01855919|Analgesics|analgesics|mesh-ancestor
44443738|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
44443739|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443740|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
44443741|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44443742|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
44443743|NCT01855828|Paclitaxel|paclitaxel|mesh-list
44443744|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
44443745|NCT01855828|Fluorouracil|fluorouracil|mesh-list
44443746|NCT01855828|Trastuzumab|trastuzumab|mesh-list
44443747|NCT01855828|Epirubicin|epirubicin|mesh-list
44443748|NCT01855828|Pertuzumab|pertuzumab|mesh-list
44443749|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44443750|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443751|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
44443752|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
44443753|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443754|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443755|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443756|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
44443757|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443758|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443759|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44443760|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
44443761|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44443762|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
44443770|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44443772|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44443773|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443774|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443775|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
44443776|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443777|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443778|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44443779|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44443780|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44443781|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443782|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
44443783|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443784|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44443785|NCT01855750|Prednisone|prednisone|mesh-list
44443786|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
44443787|NCT01855750|Rituximab|rituximab|mesh-list
44443788|NCT01855750|Doxorubicin|doxorubicin|mesh-list
44443789|NCT01855750|Vincristine|vincristine|mesh-list
44443790|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443791|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
44443792|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443793|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44443794|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44443795|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
44443796|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443797|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443798|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44443799|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44443800|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44443812|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44443813|NCT01855243|Insulin|insulin|mesh-list
44443814|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44443815|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44443816|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443817|NCT01855074|Risperidone|risperidone|mesh-list
44443818|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44443819|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
44443820|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443821|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443822|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443823|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44443824|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44443825|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443826|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44443827|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44443828|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
44443829|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
44443830|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
44443831|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443832|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443833|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443834|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
44443835|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
44443836|NCT01854918|Evolocumab|evolocumab|mesh-list
44443837|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44443838|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44443839|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
44102010|NCT00060294|Rituximab|rituximab|mesh-list
44443840|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443859|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44443860|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44443861|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44443862|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44443863|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44443864|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
44443865|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443866|NCT01854697|Interferons|interferons|mesh-list
44443867|NCT01854697|Ribavirin|ribavirin|mesh-list
44443868|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
44443869|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
44443870|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44443871|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443872|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
43842791|NCT04513639|Hormones|hormones|mesh-ancestor
44443873|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443874|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
44443875|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443876|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
44443877|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443878|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
44443879|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
44443880|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44443881|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
44443882|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443883|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443884|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44443885|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443886|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44443887|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44443888|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443889|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
44443890|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443891|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443898|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44443899|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
44443900|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443901|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443902|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44443903|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443904|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
44443905|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44443906|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
44443907|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443908|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443909|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
44443910|NCT01854528|Interferons|interferons|mesh-list
44443911|NCT01854528|Ribavirin|ribavirin|mesh-list
44443912|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443913|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
44443914|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443915|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
44443916|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443918|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44443919|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
44443920|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443921|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443922|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44443923|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
44443924|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
44443925|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44443926|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43842801|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443927|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44443928|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44443932|NCT01853982|Tazobactam|tazobactam|mesh-list
44443941|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443942|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44443943|NCT01853982|Renal Agents|renal agents|mesh-ancestor
44443944|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44443945|NCT01853696|Prednisolone|prednisolone|mesh-list
44443946|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44443947|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
44443948|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44443949|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
44443950|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44443951|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
44443952|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44443953|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
44443954|NCT01853696|Hormones|hormones|mesh-ancestor
44443955|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44443956|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443957|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44443958|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443959|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
44443960|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
44443961|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44443962|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44443963|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44443964|NCT01853696|Protective Agents|protective agents|mesh-ancestor
44443965|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44443966|NCT01853618|Tremelimumab|tremelimumab|mesh-list
44443967|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443968|NCT01853475|Artefenomel|artefenomel|mesh-list
44443969|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
44443970|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44443971|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44443972|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443973|NCT01853280|Methylphenidate|methylphenidate|mesh-list
44443974|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44443975|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443976|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44443977|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44443978|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44443979|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443980|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
44443981|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44443982|NCT01853254|Ribavirin|ribavirin|mesh-list
44443983|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44443984|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
44443985|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443986|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
44443987|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443988|NCT01853228|Cytarabine|cytarabine|mesh-list
44443989|NCT01853228|Decitabine|decitabine|mesh-list
44102167|NCT00060554|PENTA|penta|mesh-list
44443990|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44443991|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
44443992|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44443993|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44443994|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
44443995|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44443996|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44443997|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
44443998|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44443999|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444000|NCT01853176|Bupivacaine|bupivacaine|mesh-list
44444001|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
44444002|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
44444003|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444004|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444025|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444026|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44444027|NCT01853072|Protective Agents|protective agents|mesh-ancestor
44444028|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44444029|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44444030|NCT01853072|Analgesics|analgesics|mesh-ancestor
44444031|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
44444032|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444033|NCT01852942|Losartan|losartan|mesh-list
44444034|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44444035|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44444036|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44444037|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44444038|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444039|NCT01852812|Montelukast|montelukast|mesh-list
44444040|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44444041|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44444042|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44444043|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
44444044|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444045|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444046|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44444047|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44444048|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444049|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44444050|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
44444051|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444052|NCT01852292|Paclitaxel|paclitaxel|mesh-list
44444053|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44444054|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444055|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
44444056|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
44444062|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44444063|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44444064|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44444065|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
44444066|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444067|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444068|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444069|NCT01852162|Dabigatran|dabigatran|mesh-list
44444070|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
44444071|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44444072|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444073|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444074|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444075|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
44102237|NCT00060866|Propranolol|propranolol|mesh-list
44444076|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
44444077|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44444078|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44444079|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44444080|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444081|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444082|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
44444083|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444084|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444085|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44444086|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444087|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
44444088|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44444089|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44444104|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444105|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444106|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44444107|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44444108|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444109|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444110|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44444111|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44444112|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
44444113|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444114|NCT01851720|Fentanyl|fentanyl|mesh-list
44444115|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44444116|NCT01851720|Narcotics|narcotics|mesh-ancestor
44444117|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444118|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444119|NCT01851720|Analgesics|analgesics|mesh-ancestor
44444120|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
44444121|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444122|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44444123|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44444124|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
44444125|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
44444126|NCT01851590|Terbinafine|terbinafine|mesh-list
44444127|NCT01851590|Amorolfine|amorolfine|mesh-list
44444128|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
44444129|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444130|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444156|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444157|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444158|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444159|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
44444160|NCT01850524|Hormones|hormones|mesh-ancestor
44444161|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444162|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44444163|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444164|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
44444165|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44444166|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44444167|NCT01850524|Growth Substances|growth substances|mesh-ancestor
44444168|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
44444169|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444170|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444171|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444172|NCT01850446|Oseltamivir|oseltamivir|mesh-list
44444173|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
44444174|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444175|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444176|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444177|NCT01850030|Progesterone|progesterone|mesh-list
44444178|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
44444179|NCT01850030|Progestins|progestins|mesh-ancestor
44444180|NCT01850030|Hormones|hormones|mesh-ancestor
44444181|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444182|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444183|NCT01850004|Dasatinib|dasatinib|mesh-list
44444184|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444185|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44444186|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444187|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444188|NCT01849783|Thalidomide|thalidomide|mesh-list
44444189|NCT01849783|Dexamethasone|dexamethasone|mesh-list
44444190|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
44444191|NCT01849783|Melphalan|melphalan|mesh-list
44164208|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44444192|NCT01849783|Doxorubicin|doxorubicin|mesh-list
44444193|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44444194|NCT01849783|Etoposide|etoposide|mesh-list
44444195|NCT01849783|Bortezomib|bortezomib|mesh-list
44444196|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
44444197|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444198|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
44444199|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444200|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444201|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44444202|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
44444203|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848625|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444204|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444205|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44444206|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444207|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
44444208|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
44444209|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444210|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444211|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
44444212|NCT01849783|Hormones|hormones|mesh-ancestor
44444213|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444214|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44444215|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44444243|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444244|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44444245|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
44444246|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444248|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44444249|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
44444250|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444251|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444252|NCT01849276|Metformin|metformin|mesh-list
44444253|NCT01849276|Cytarabine|cytarabine|mesh-list
44444254|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444255|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444256|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444257|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
44444258|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444259|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444260|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
44444261|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444262|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444263|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
44444264|NCT01849055|Celecoxib|celecoxib|mesh-list
44444265|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44444266|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44444267|NCT01849055|Analgesics|analgesics|mesh-ancestor
44444268|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
44444269|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444270|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444271|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444272|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444273|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44444287|NCT01848457|Methotrexate|methotrexate|mesh-list
44444288|NCT01848457|Pantoprazole|pantoprazole|mesh-list
44444289|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44444290|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
44444291|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44444292|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444293|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444294|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
44444295|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444296|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444297|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444298|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444299|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44444300|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444301|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
44444302|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444303|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44444304|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44444305|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444306|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44444307|NCT01848210|Troxerutin|troxerutin|mesh-list
44444308|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
44444309|NCT01848145|Ofatumumab|ofatumumab|mesh-list
44444310|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444311|NCT01847443|Nicotine|nicotine|mesh-list
44444312|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44444313|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
44444314|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444315|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444316|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44444317|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44444318|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
44444319|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444320|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444321|NCT01847313|Liraglutide|liraglutide|mesh-list
44444322|NCT01847313|Glucagon|glucagon|mesh-list
44444323|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44444324|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444325|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444326|NCT01847313|Incretins|incretins|mesh-ancestor
44444327|NCT01847313|Hormones|hormones|mesh-ancestor
44444328|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444329|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444330|NCT01846624|Decitabine|decitabine|mesh-list
44444331|NCT01846624|Azacitidine|azacitidine|mesh-list
44444332|NCT01846624|Midostaurin|midostaurin|mesh-list
44444333|NCT01846624|Staurosporine|staurosporine|mesh-list
44444334|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444335|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
44444336|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444337|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444338|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444339|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44444340|NCT01846611|Dexamethasone|dexamethasone|mesh-list
44444341|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44444342|NCT01846611|Doxorubicin|doxorubicin|mesh-list
44444343|NCT01846611|Trabectedin|trabectedin|mesh-list
44444344|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444345|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
44444346|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
44444347|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444348|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444349|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444350|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
44444351|NCT01846611|Hormones|hormones|mesh-ancestor
44444352|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444373|NCT01846416|Antibodies|antibodies|mesh-list
44444374|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
44444375|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444376|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444377|NCT01846299|Ranibizumab|ranibizumab|mesh-list
44444378|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44444379|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44444380|NCT01846299|Growth Substances|growth substances|mesh-ancestor
44444381|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444382|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
44444383|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444385|NCT01846221|Fentanyl|fentanyl|mesh-list
44444386|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44444387|NCT01846221|Narcotics|narcotics|mesh-ancestor
44444388|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444389|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444390|NCT01846221|Analgesics|analgesics|mesh-ancestor
44444391|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
44444392|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444393|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44444394|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44444395|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
44444396|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
44444397|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44444398|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
43803588|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43803589|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43803590|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43803591|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44444399|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
44444400|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44444401|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44444402|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44444403|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444404|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444405|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444418|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444419|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444421|NCT01845831|Hormones|hormones|mesh-ancestor
44444422|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444423|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44444424|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444425|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444426|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444427|NCT01845805|Azacitidine|azacitidine|mesh-list
44444428|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444429|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
44444430|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444431|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444432|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444433|NCT01845077|Metformin|metformin|mesh-list
44444434|NCT01845077|Linagliptin|linagliptin|mesh-list
44444435|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444436|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444437|NCT01845077|Incretins|incretins|mesh-ancestor
44444438|NCT01845077|Hormones|hormones|mesh-ancestor
44444439|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444440|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44444441|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444442|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444443|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444444|NCT01845025|Fluticasone|fluticasone|mesh-list
44444445|NCT01845025|Xhance|xhance|mesh-list
44444446|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
44444447|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444448|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44444460|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444461|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444462|NCT01844986|Olaparib|olaparib|mesh-list
44444463|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44444464|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444465|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444466|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444467|NCT01844895|Abatacept|abatacept|mesh-list
44444468|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44444469|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444470|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444471|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444472|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
44444473|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444474|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444475|NCT01844830|Phenylephrine|phenylephrine|mesh-list
44444476|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
44444477|NCT01844830|Tetracaine|tetracaine|mesh-list
44444478|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
44444479|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
44444480|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444481|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444482|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
44444483|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444484|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44444509|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444510|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44444511|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44444512|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444513|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44444514|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44444515|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
44444516|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
44444517|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
44444518|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44444519|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44444520|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44444521|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44444522|NCT01844687|Cannabidiol|cannabidiol|mesh-list
44444523|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
44444524|NCT01844583|Rifampin|rifampin|mesh-list
44444525|NCT01844583|Esomeprazole|esomeprazole|mesh-list
44444526|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44444527|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444528|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44444529|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444530|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444531|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44444543|NCT01844531|Metformin|metformin|mesh-list
44444559|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44444560|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444561|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44444562|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444563|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
44444564|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
44444565|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44444566|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44444567|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44444568|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444569|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444570|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444571|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
44444572|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444573|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44444574|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44444575|NCT01844076|Quinacrine|quinacrine|mesh-list
44444576|NCT01844076|Capecitabine|capecitabine|mesh-list
44444577|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44444578|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
44444579|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444580|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444581|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
44444582|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44444583|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
44444584|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44444585|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444586|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
44444587|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44444588|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
44444589|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444600|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444601|NCT01843348|Cyclosporine|cyclosporine|mesh-list
44444602|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
44444603|NCT01843348|Everolimus|everolimus|mesh-list
44444604|NCT01843348|Tacrolimus|tacrolimus|mesh-list
44444605|NCT01843348|Cyclosporins|cyclosporins|mesh-list
44444606|NCT01843348|Basiliximab|basiliximab|mesh-list
44444607|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444608|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
43654685|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
43654686|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654687|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842867|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
43842868|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842869|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842870|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
43842871|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43842872|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
44444609|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444610|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44444611|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444612|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444613|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
44444614|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444615|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444616|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444617|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444618|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44444619|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44444620|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
44444621|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444622|NCT01843205|Methamphetamine|methamphetamine|mesh-list
44444654|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444655|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444656|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444657|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44444658|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44444659|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444660|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444661|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
44444662|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44444663|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44444664|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44444665|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44444666|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
44444667|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444668|NCT01842620|Metformin|metformin|mesh-list
44444669|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444670|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444671|NCT01842581|Rifaximin|rifaximin|mesh-list
44444672|NCT01842581|Lactulose|lactulose|mesh-list
44444673|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444674|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444675|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444676|NCT01842334|Nicotine|nicotine|mesh-list
44444677|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44444678|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
44444679|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444680|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444681|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44444682|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44444683|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
44444684|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444686|NCT01842308|Melphalan|melphalan|mesh-list
44444696|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444697|NCT01841762|Macitentan|macitentan|mesh-list
44444698|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44444699|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44444700|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444701|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44444702|NCT01841697|Metformin|metformin|mesh-list
44444703|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44444704|NCT01841697|Glimepiride|glimepiride|mesh-list
44444705|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444706|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444707|NCT01841697|Incretins|incretins|mesh-ancestor
44444708|NCT01841697|Hormones|hormones|mesh-ancestor
44444709|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444710|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44444711|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444712|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444713|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444714|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44444715|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44444716|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
44444717|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
44444718|NCT01841593|Amlodipine|amlodipine|mesh-list
44444719|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44444720|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44444721|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444722|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444723|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44444724|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444725|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
44444726|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44444727|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44444737|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44444738|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44444739|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444740|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444741|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444742|NCT01840605|Ketotifen|ketotifen|mesh-list
44444743|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
44444744|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
44444745|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
44444746|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44444747|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
44444748|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
44444749|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444750|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444751|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444752|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44444753|NCT01840579|Paclitaxel|paclitaxel|mesh-list
44444754|NCT01840579|Etoposide|etoposide|mesh-list
44444755|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44444756|NCT01840579|Cisplatin|cisplatin|mesh-list
44444757|NCT01840579|Carboplatin|carboplatin|mesh-list
44444758|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
44444759|NCT01840579|Pemetrexed|pemetrexed|mesh-list
44444760|NCT01840579|Ipilimumab|ipilimumab|mesh-list
44444761|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44444762|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444763|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
44444764|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
44444765|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
44444766|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444767|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44444768|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44444769|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44444770|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444778|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444779|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
44444780|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444782|NCT01840228|Progestins|progestins|mesh-ancestor
44444783|NCT01840228|Hormones|hormones|mesh-ancestor
44444784|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444785|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444786|NCT01839487|Gemcitabine|gemcitabine|mesh-list
44444787|NCT01839487|Dexamethasone|dexamethasone|mesh-list
44444788|NCT01839487|Paclitaxel|paclitaxel|mesh-list
44444789|NCT01839487|Enoxaparin|enoxaparin|mesh-list
44444790|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44444791|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444792|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
44444793|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
44444794|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
44444795|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444796|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44444835|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44444836|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44444837|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444838|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444839|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44444840|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
44444841|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444842|NCT01838941|Betaine|betaine|mesh-list
44444843|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44444844|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
44444845|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44444846|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
44444847|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444848|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44444849|NCT01838876|Cariprazine|cariprazine|mesh-list
44444850|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
44444851|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44444852|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44444853|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44444854|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44444855|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444856|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
44444857|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
44444858|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444859|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444860|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444861|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
44444862|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
44444863|NCT01838642|Ponatinib|ponatinib|mesh-list
44444864|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44444865|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44444866|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444867|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444868|NCT01838616|Oxycodone|oxycodone|mesh-list
44444876|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
44444877|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444878|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44444879|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44444880|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44444881|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444882|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444883|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
44444884|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444885|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
44444886|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
44444887|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444888|NCT01838447|Vitamin D|vitamin d|mesh-list
44444889|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
44444890|NCT01838447|Vitamins|vitamins|mesh-ancestor
44444891|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
44444892|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444893|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44444894|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44444895|NCT01838044|Celecoxib|celecoxib|mesh-list
44444896|NCT01838044|Pregabalin|pregabalin|mesh-list
44444897|NCT01838044|Analgesics|analgesics|mesh-ancestor
44444898|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
43654688|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654689|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842889|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43842890|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43782164|NCT05091606|Anesthetics|anesthetics|mesh-list
44444899|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44444900|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444901|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
44444902|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44444903|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44444922|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44444923|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44444924|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444925|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
44444926|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
44444927|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444928|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444929|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444930|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
44444931|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
44444932|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44444933|NCT01837719|Cobicistat|cobicistat|mesh-list
44444934|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44444935|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44444936|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44444937|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444938|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444939|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44444940|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44444941|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
44444942|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444943|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44444944|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44444945|NCT01837680|Insulin|insulin|mesh-list
44444946|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44444947|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44444971|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44444972|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44444973|NCT01836471|Growth Substances|growth substances|mesh-ancestor
44444974|NCT01836276|Varenicline|varenicline|mesh-list
44444975|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44444976|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44444977|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
44444978|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44444979|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444980|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44444981|NCT01836198|Clarithromycin|clarithromycin|mesh-list
44444982|NCT01836198|Ketoconazole|ketoconazole|mesh-list
44444983|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
44444984|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44444985|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44444986|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44444987|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44444988|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44444989|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44444990|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44444991|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
44444992|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44444993|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44444994|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
44444995|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44444996|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445018|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445019|NCT01835158|Sunitinib|sunitinib|mesh-list
44445020|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445021|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44445022|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44445023|NCT01835158|Growth Substances|growth substances|mesh-ancestor
44445024|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445025|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
44445026|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445027|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445029|NCT01835145|Temozolomide|temozolomide|mesh-list
44445080|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44445081|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44445082|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44445083|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44445084|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44445085|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44445086|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445087|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
44445088|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
44445089|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44445090|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44445091|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44445092|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445093|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44445094|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445095|NCT01833897|Renal Agents|renal agents|mesh-ancestor
44445096|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44445097|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
44445098|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445099|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
44445100|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
44445101|NCT01833832|Cisplatin|cisplatin|mesh-list
44445102|NCT01833832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445103|NCT01833832|Antidotes|antidotes|mesh-ancestor
44445131|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445132|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44445133|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445134|NCT01832766|Analgesics|analgesics|mesh-ancestor
44445135|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
44445136|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445137|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44445138|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44445139|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445140|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445141|NCT01832766|Hormones|hormones|mesh-ancestor
44445142|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445143|NCT01832727|Dexamethasone|dexamethasone|mesh-list
44445144|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445145|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
44445146|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
44445187|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445188|NCT01831765|Insulin|insulin|mesh-list
44445189|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44445190|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
44445191|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
44445192|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44445193|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
44445194|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445195|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445196|NCT01831466|Tofacitinib|tofacitinib|mesh-list
43842902|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842903|NCT04501406|Pioglitazone|pioglitazone|mesh-list
43842904|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842905|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842906|NCT04500860|Tadalafil|tadalafil|mesh-list
43842907|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43842908|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842909|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43842910|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43842911|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445197|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445198|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445199|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445200|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44445201|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
44445202|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445203|NCT01831089|Paclitaxel|paclitaxel|mesh-list
44445204|NCT01831089|Bevacizumab|bevacizumab|mesh-list
44445205|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445206|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445207|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445208|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445209|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445210|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445237|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
44445238|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
44445239|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
44445240|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445241|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44445242|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445243|NCT01830881|Analgesics|analgesics|mesh-ancestor
44445244|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445245|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445246|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44445247|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445248|NCT01830816|Ixazomib|ixazomib|mesh-list
44445249|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445250|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
44445251|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445252|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445253|NCT01830595|Lactoferrin|lactoferrin|mesh-list
44445254|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445255|NCT01830543|Aspirin|aspirin|mesh-list
44445256|NCT01830543|Vitamin K|vitamin k|mesh-list
44445257|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
44445258|NCT01830543|Clopidogrel|clopidogrel|mesh-list
44445259|NCT01830543|Ticagrelor|ticagrelor|mesh-list
44445260|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44445261|NCT01830543|Vitamins|vitamins|mesh-ancestor
44445262|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
44445263|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445264|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44445265|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445266|NCT01830543|Analgesics|analgesics|mesh-ancestor
44445267|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
44445268|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445269|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445270|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445271|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44445272|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44445277|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
44445278|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44445279|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44445280|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44445281|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
44445282|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445283|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44445284|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
44445285|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44445286|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44445287|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
44445288|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44445289|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
43803837|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
43842951|NCT04500548|Ipilimumab|ipilimumab|mesh-list
43842952|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803894|NCT04953117|Paclitaxel|paclitaxel|mesh-list
43803920|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43803921|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44445290|NCT01830543|Coagulants|coagulants|mesh-ancestor
44445291|NCT01830127|Ribavirin|ribavirin|mesh-list
44445292|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
44445293|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445294|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
44445295|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445296|NCT01829477|Glimepiride|glimepiride|mesh-list
44445333|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445334|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
44445335|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44103438|NCT00065143|Clofarabine|clofarabine|mesh-list
44445336|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44445337|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44445338|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44445339|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
44445340|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445341|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445342|NCT01829243|Milnacipran|milnacipran|mesh-list
44445343|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
44445344|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44445345|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44445346|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445347|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445348|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445349|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445350|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445351|NCT01829243|Analgesics|analgesics|mesh-ancestor
44445352|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
44445353|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445354|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
44445355|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44103510|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
44445357|NCT01828099|Carboplatin|carboplatin|mesh-list
44445358|NCT01828099|Pemetrexed|pemetrexed|mesh-list
44445359|NCT01828099|Ceritinib|ceritinib|mesh-list
44445360|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445361|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445362|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445363|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44445364|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44445372|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44445373|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445374|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445375|NCT01828034|Gemcitabine|gemcitabine|mesh-list
44445376|NCT01828034|Cisplatin|cisplatin|mesh-list
44445377|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445378|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445379|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
44445380|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445381|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
44445382|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445383|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445384|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445385|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
44445386|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445387|NCT01828021|Margetuximab|margetuximab|mesh-list
44445388|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445389|NCT01827943|Sirolimus|sirolimus|mesh-list
44445390|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445391|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445392|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44445393|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445394|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
44445395|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445396|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
44445397|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445422|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44445423|NCT01827332|Oxytocin|oxytocin|mesh-list
44445424|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
44445425|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44445426|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445427|NCT01827267|Sirolimus|sirolimus|mesh-list
44445428|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445429|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445430|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44445431|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445432|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
44445433|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445434|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
44445435|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445436|NCT01827254|Sunitinib|sunitinib|mesh-list
44445437|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445438|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44445439|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44445440|NCT01827254|Growth Substances|growth substances|mesh-ancestor
44445441|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445442|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
44445443|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445444|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445445|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445446|NCT01827163|Paclitaxel|paclitaxel|mesh-list
44445447|NCT01827163|Trastuzumab|trastuzumab|mesh-list
44445448|NCT01827163|Lapatinib|lapatinib|mesh-list
44445449|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445450|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445468|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44445469|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44445470|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44445471|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44445472|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445474|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
44445475|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445476|NCT01826448|Vemurafenib|vemurafenib|mesh-list
44445477|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445478|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445479|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445480|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445481|NCT01826370|Linagliptin|linagliptin|mesh-list
44445482|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445483|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445484|NCT01826370|Incretins|incretins|mesh-ancestor
44445485|NCT01826370|Hormones|hormones|mesh-ancestor
44445486|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445487|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44445488|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
44445489|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445490|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445491|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
44445492|NCT01825941|Promethazine|promethazine|mesh-list
44445493|NCT01825941|Metoclopramide|metoclopramide|mesh-list
44445515|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
44445517|NCT01825876|Evacetrapib|evacetrapib|mesh-list
44445518|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
44445519|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44445520|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44445521|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
44445522|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445523|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44445524|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
43803925|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803926|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43803927|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445525|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
44445526|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445527|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445528|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445529|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445530|NCT01825798|Metformin|metformin|mesh-list
44445531|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44445532|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445533|NCT01825577|Methylphenidate|methylphenidate|mesh-list
44445534|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44445535|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445536|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44445540|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
44445567|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445568|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44445569|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
44445570|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445571|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445572|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44445573|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445574|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
44445575|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44445576|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445577|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44445578|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44445579|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
44445580|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445581|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44103727|NCT00066391|Cisplatin|cisplatin|mesh-list
44445582|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44445583|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
44445584|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445585|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445586|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445587|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445588|NCT01824342|Denosumab|denosumab|mesh-list
44445589|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44445591|NCT01824290|Tadalafil|tadalafil|mesh-list
44445614|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44445615|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44445616|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
44445617|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
44445618|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445619|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44445620|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44445621|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445622|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445623|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44445624|NCT01823289|Itraconazole|itraconazole|mesh-list
44445625|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
44445626|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445627|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44445628|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44445629|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445630|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445631|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44445632|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
44445633|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445634|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445635|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44445636|NCT01823224|Acetaminophen|acetaminophen|mesh-list
44445637|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445638|NCT01823224|Analgesics|analgesics|mesh-ancestor
44445639|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
44445640|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445641|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445642|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
44445643|NCT01823146|Oxytocin|oxytocin|mesh-list
44445644|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
44445645|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44445648|NCT01822899|Xhance|xhance|mesh-list
44445654|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445655|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445656|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44445657|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
44445658|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445659|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44445660|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44445661|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44445662|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44445663|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
44445664|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445665|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445667|NCT01822821|Acetaminophen|acetaminophen|mesh-list
44445668|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445669|NCT01822821|Analgesics|analgesics|mesh-ancestor
44445670|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
44445671|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445672|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445673|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
44445674|NCT01822756|Gemcitabine|gemcitabine|mesh-list
44445676|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445677|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445678|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445679|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445680|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445681|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445682|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445683|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
44445684|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
44445685|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445686|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445687|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445694|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445695|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445696|NCT01822665|Acetaminophen|acetaminophen|mesh-list
44445697|NCT01822665|Ibuprofen|ibuprofen|mesh-list
44445698|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44445699|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44445700|NCT01822665|Analgesics|analgesics|mesh-ancestor
44445701|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
44445702|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445703|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445704|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445705|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445706|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44445707|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445708|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445709|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
44445710|NCT01822587|Propranolol|propranolol|mesh-list
44445711|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44445712|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44445713|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
44445714|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445715|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445716|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445717|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44445718|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44445719|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
44445720|NCT01822561|Eplerenone|eplerenone|mesh-list
44445721|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44445738|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
44445739|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445740|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445741|NCT01822496|Paclitaxel|paclitaxel|mesh-list
44445742|NCT01822496|Etoposide|etoposide|mesh-list
44445743|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
44445744|NCT01822496|Cisplatin|cisplatin|mesh-list
44445745|NCT01822496|Carboplatin|carboplatin|mesh-list
44445746|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44445747|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
44445748|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44445749|NCT01822496|Crizotinib|crizotinib|mesh-list
44445750|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445751|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445752|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445753|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445754|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445755|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445756|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44445757|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44445758|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445759|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44445760|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
44445761|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445762|NCT01822132|Naltrexone|naltrexone|mesh-list
44445763|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44445764|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44445765|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445766|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
44445767|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445768|NCT01821963|Interferons|interferons|mesh-list
44445769|NCT01821963|Ribavirin|ribavirin|mesh-list
44445770|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
44445771|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
44445772|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44445779|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445780|NCT01821898|Budesonide|budesonide|mesh-list
44445781|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445782|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44445783|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
44445784|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445785|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445786|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44445787|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44445788|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
44445789|NCT01821898|Hormones|hormones|mesh-ancestor
44445790|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44445791|NCT01821729|Leucovorin|leucovorin|mesh-list
44445792|NCT01821729|Fluorouracil|fluorouracil|mesh-list
44445793|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
44445794|NCT01821729|Folfirinox|folfirinox|mesh-list
44445795|NCT01821729|Losartan|losartan|mesh-list
44445796|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
43803993|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44445797|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445798|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44445799|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445800|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445801|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
44445802|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445803|NCT01821729|Antidotes|antidotes|mesh-ancestor
44445804|NCT01821729|Protective Agents|protective agents|mesh-ancestor
44445805|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
44445806|NCT01821729|Vitamins|vitamins|mesh-ancestor
44445807|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
44445827|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44445828|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44445829|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445830|NCT01820637|Paclitaxel|paclitaxel|mesh-list
44445831|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44445832|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445833|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
44445834|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
44445835|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
44445836|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445837|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44445838|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
44445839|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44445840|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44445841|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44445842|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445843|NCT01820572|Cyclosporine|cyclosporine|mesh-list
44445844|NCT01820572|Abatacept|abatacept|mesh-list
44445845|NCT01820572|Tacrolimus|tacrolimus|mesh-list
44445846|NCT01820572|Cyclosporins|cyclosporins|mesh-list
44445847|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445848|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
44445849|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445850|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44445879|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44104024|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445880|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445881|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44445882|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44445883|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44445884|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
44445885|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445886|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44445887|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445888|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
44445889|NCT01818726|Deferasirox|deferasirox|mesh-list
44445890|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44445891|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
44445892|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
44445893|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445895|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44445896|NCT01818700|Narcotics|narcotics|mesh-ancestor
44445897|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44445898|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445899|NCT01818700|Analgesics|analgesics|mesh-ancestor
44445900|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
44445901|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445902|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44445903|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44445904|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44445905|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44445906|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
44445907|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445908|NCT01818336|Amoxicillin|amoxicillin|mesh-list
44445909|NCT01818336|Penicillins|penicillins|mesh-list
44445910|NCT01818336|Penicillin G|penicillin g|mesh-list
44445911|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445912|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445914|NCT01818284|Lenograstim|lenograstim|mesh-list
44445915|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44445916|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
44445917|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445918|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44445919|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44445920|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
44445921|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445922|NCT01818258|Ritonavir|ritonavir|mesh-list
44445923|NCT01818258|Lopinavir|lopinavir|mesh-list
44445924|NCT01818258|Lamivudine|lamivudine|mesh-list
44445925|NCT01818258|Zidovudine|zidovudine|mesh-list
44445926|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44445927|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44445928|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
44445929|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445930|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445931|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44445932|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44445933|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
44445934|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445935|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44445936|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44445937|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44445938|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44445939|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
44445940|NCT01818141|Vancomycin|vancomycin|mesh-list
44445941|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
44445942|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44445943|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445944|NCT01817790|Fluticasone|fluticasone|mesh-list
44445945|NCT01817790|Xhance|xhance|mesh-list
44445960|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44445961|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44445962|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44445963|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
44445964|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44445965|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445966|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44104131|NCT00067600|Calcium|calcium|mesh-list
44445967|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
44445968|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445969|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44445970|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44445971|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44445972|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44445973|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
44445974|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44445975|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445976|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44445978|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44445979|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
44445980|NCT01817582|Cyclosporins|cyclosporins|mesh-list
44445981|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44445982|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44445983|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44445984|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
44445985|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44445986|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
44445987|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44445988|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
44445989|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44445990|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44445995|NCT01817530|Norethindrone|norethindrone|mesh-list
44446003|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43804006|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
43842954|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43804065|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44446004|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
44446005|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44446006|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44446007|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44446008|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44446009|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44446010|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
44446011|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44446012|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44446013|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446014|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
44446015|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446016|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44446017|NCT01816984|Cetuximab|cetuximab|mesh-list
44446018|NCT01816984|Antibodies|antibodies|mesh-list
44446019|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
44446020|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44446021|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
44446022|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446023|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446024|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44446025|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446026|NCT01816594|Paclitaxel|paclitaxel|mesh-list
44446027|NCT01816594|Trastuzumab|trastuzumab|mesh-list
44446028|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44446029|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446051|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446052|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44446053|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446054|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
44446055|NCT01816243|Fentanyl|fentanyl|mesh-list
44446056|NCT01816243|Morphine|morphine|mesh-list
44446057|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446058|NCT01816243|Narcotics|narcotics|mesh-ancestor
44446059|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446060|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446061|NCT01816243|Analgesics|analgesics|mesh-ancestor
44446062|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
44446063|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446064|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44446065|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44446066|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
44446067|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
44446068|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44446069|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44446070|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446071|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44446072|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446073|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446074|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446097|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446098|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
44446099|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446100|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44446101|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44446102|NCT01815424|Tofacitinib|tofacitinib|mesh-list
44446103|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446104|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804367|NCT04946669|Abatacept|abatacept|mesh-list
43804368|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43804369|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804370|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804371|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43615145|NCT03160651|Hormones|hormones|mesh-ancestor
43804372|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
43783694|NCT02806687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446105|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446106|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44446107|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44446108|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446109|NCT01814878|Acetaminophen|acetaminophen|mesh-list
44446110|NCT01814878|Tramadol|tramadol|mesh-list
44446111|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446112|NCT01814878|Analgesics|analgesics|mesh-ancestor
44446113|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
44446114|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446115|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446116|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
44446117|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446118|NCT01814878|Narcotics|narcotics|mesh-ancestor
44446119|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446120|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
44446121|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
44446122|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446123|NCT01814761|Bimatoprost|bimatoprost|mesh-list
44446124|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446125|NCT01814748|Metformin|metformin|mesh-list
44446126|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446143|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446144|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446145|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446146|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44446147|NCT01814397|Letrozole|letrozole|mesh-list
44446148|NCT01814397|Anastrozole|anastrozole|mesh-list
44446149|NCT01814397|Exemestane|exemestane|mesh-list
44446150|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446151|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44446152|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44446153|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446154|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446155|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44446156|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
44446157|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446158|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446159|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44446160|NCT01814371|Mupirocin|mupirocin|mesh-list
44446161|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446162|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446163|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44446164|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446165|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446166|NCT01814137|Insulin|insulin|mesh-list
44446167|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44446168|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
44446169|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
44446170|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44446171|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446172|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446173|NCT01814046|Aldesleukin|aldesleukin|mesh-list
44446174|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
44446184|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446185|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44446186|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446188|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
44446189|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446190|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44446191|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44446192|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
44446193|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446194|NCT01813890|Tapentadol|tapentadol|mesh-list
44446195|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446196|NCT01813890|Narcotics|narcotics|mesh-ancestor
44446197|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446245|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
44446246|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446247|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44446248|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44446249|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446250|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
44446251|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44446252|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44446253|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446254|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
44446255|NCT01813058|Coagulants|coagulants|mesh-ancestor
44446256|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44446257|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44446258|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446259|NCT01812759|Fentanyl|fentanyl|mesh-list
44446260|NCT01812759|Hydromorphone|hydromorphone|mesh-list
44446261|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446262|NCT01812759|Narcotics|narcotics|mesh-ancestor
44446263|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446264|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446265|NCT01812759|Analgesics|analgesics|mesh-ancestor
44446266|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
44446267|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446268|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44446269|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44446270|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
44446294|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446295|NCT01811953|Metformin|metformin|mesh-list
44446296|NCT01811953|Empagliflozin|empagliflozin|mesh-list
44446297|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446298|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446299|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44446300|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446301|NCT01811732|Vancomycin|vancomycin|mesh-list
44446302|NCT01811732|Aztreonam|aztreonam|mesh-list
44446303|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446304|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446305|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
44446306|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44446307|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446308|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446309|NCT01811238|Oxycodone|oxycodone|mesh-list
44446310|NCT01811238|Naloxone|naloxone|mesh-list
44446311|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446312|NCT01811238|Narcotics|narcotics|mesh-ancestor
44446313|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446314|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446315|NCT01811238|Analgesics|analgesics|mesh-ancestor
44446316|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
44446317|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446318|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44446319|NCT01811225|Progesterone|progesterone|mesh-list
44446320|NCT01811225|Progestins|progestins|mesh-ancestor
44446321|NCT01811225|Hormones|hormones|mesh-ancestor
44446322|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446324|NCT01811186|Oxycodone|oxycodone|mesh-list
44446340|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
44446342|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44446343|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44446344|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
44446345|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446346|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44446347|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44446348|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
44446349|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446350|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446351|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44446352|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44446353|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446354|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446355|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
44446356|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446357|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446358|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
44446359|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
44446360|NCT01810302|Nicardipine|nicardipine|mesh-list
44446361|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446362|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44446363|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446364|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446365|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44446366|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446367|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44446368|NCT01810042|Ranibizumab|ranibizumab|mesh-list
44446386|NCT01809210|Pemetrexed|pemetrexed|mesh-list
44446387|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446388|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44446389|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
44446390|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446391|NCT01809210|Antiviral Agents|antiviral agents|mesh-ancestor
44446392|NCT01809210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446393|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446394|NCT01809210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446395|NCT01809210|Immunologic Factors|immunologic factors|mesh-ancestor
44446396|NCT01809210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446397|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44446398|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44446399|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44446400|NCT01809132|Zinc|zinc|mesh-list
44446401|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
44446402|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44446403|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44446404|NCT01809132|Prednisolone|prednisolone|mesh-list
44446405|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
44446406|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44446407|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
44446408|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
44446409|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44446410|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
44446411|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446412|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
44446413|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
44446414|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446430|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44446431|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44446432|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
44446433|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44446434|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
44446435|NCT01809132|Astringents|astringents|mesh-ancestor
44446436|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446437|NCT01808690|Metformin|metformin|mesh-list
44446438|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446439|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446440|NCT01808651|Fluoxetine|fluoxetine|mesh-list
44446441|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44446442|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446443|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446444|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446445|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446446|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
44446447|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446448|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44446449|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446450|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446451|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44446452|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446453|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446454|NCT01808612|Fluoxetine|fluoxetine|mesh-list
44446455|NCT01808612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44446456|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446457|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446459|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446472|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446473|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446474|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446475|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446476|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
44446477|NCT01808534|Ifosfamide|ifosfamide|mesh-list
44446478|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44446479|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
44446480|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446481|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446482|NCT01808339|Fluticasone|fluticasone|mesh-list
44446483|NCT01808339|Xhance|xhance|mesh-list
44446484|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446485|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44446486|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
44446487|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446488|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446489|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44446490|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
44446491|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446492|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44446493|NCT01808313|Ambrisentan|ambrisentan|mesh-list
44446527|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446528|NCT01807923|Ivacaftor|ivacaftor|mesh-list
44446529|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44446530|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446531|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446532|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44446533|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
44446534|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44446535|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446536|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
44446537|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446538|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44446539|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
44446540|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446541|NCT01807234|Ketorolac|ketorolac|mesh-list
44446542|NCT01807234|Sumatriptan|sumatriptan|mesh-list
44446543|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44446544|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446545|NCT01807234|Analgesics|analgesics|mesh-ancestor
44446546|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
44446547|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446548|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446549|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446550|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446551|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44446552|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804406|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
44446553|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446554|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44446555|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44446556|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44446557|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
44446558|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446559|NCT01807221|Eplerenone|eplerenone|mesh-list
44446560|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44446563|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446564|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44446565|NCT01807221|Diuretics|diuretics|mesh-ancestor
44446566|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
44446567|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44446568|NCT01807182|Aldesleukin|aldesleukin|mesh-list
44446569|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
44446570|NCT01807182|Fludarabine|fludarabine|mesh-list
44446571|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
44446572|NCT01807182|Interleukin-2|interleukin-2|mesh-list
44446573|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446574|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
44446575|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446576|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446577|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44446578|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
44446579|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446580|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446581|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44446582|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44446583|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
44446584|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446585|NCT01807182|Analgesics|analgesics|mesh-ancestor
44446586|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
44446587|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446588|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44446589|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44446590|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
44446591|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446592|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44446593|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44446594|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446595|NCT01806779|Bupropion|bupropion|mesh-list
44446606|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446607|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44446608|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446609|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446610|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44446611|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446612|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446613|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
44446614|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44446615|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446616|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446617|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
44446618|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
44446619|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
44446620|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446621|NCT01806662|Ustekinumab|ustekinumab|mesh-list
44446622|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
44446623|NCT01806623|Fluconazole|fluconazole|mesh-list
44446624|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
44446625|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446626|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44446627|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446628|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446629|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446630|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44446631|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
44446632|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446633|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446634|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44446635|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44446636|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44446637|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
43962668|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
44446639|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44446640|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
44446641|NCT01806584|Coagulants|coagulants|mesh-ancestor
44446642|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
44446643|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
44446644|NCT01806545|Coagulants|coagulants|mesh-ancestor
44446645|NCT01806298|Hormones|hormones|mesh-list
44446646|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446647|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446648|NCT01806064|Axitinib|axitinib|mesh-list
44446649|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446650|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446651|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446652|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446653|NCT01805037|Rituximab|rituximab|mesh-list
44446654|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44446655|NCT01805037|Antibodies|antibodies|mesh-list
44446656|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
44446657|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44446658|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
44446659|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
44446660|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446661|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44446662|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446663|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446664|NCT01804946|Oseltamivir|oseltamivir|mesh-list
44446665|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
44446666|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446667|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446668|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446669|NCT01804673|Fentanyl|fentanyl|mesh-list
44446670|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44446671|NCT01804673|Narcotics|narcotics|mesh-ancestor
44446672|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44446673|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446681|NCT01804049|Metformin|metformin|mesh-list
44446682|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446683|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446684|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44446685|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44446686|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446687|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446688|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446689|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446690|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446691|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
44446692|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44446693|NCT01803282|Leucovorin|leucovorin|mesh-list
44446694|NCT01803282|Gemcitabine|gemcitabine|mesh-list
44446695|NCT01803282|Paclitaxel|paclitaxel|mesh-list
44446696|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44446697|NCT01803282|Bevacizumab|bevacizumab|mesh-list
44446698|NCT01803282|Carboplatin|carboplatin|mesh-list
44446699|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
44446700|NCT01803282|Irinotecan|irinotecan|mesh-list
44446701|NCT01803282|Pemetrexed|pemetrexed|mesh-list
44446702|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44446703|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446704|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
44446705|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
44446706|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
44446707|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446708|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44446709|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44446728|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44446729|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44446730|NCT01803269|Topotecan|topotecan|mesh-list
44446731|NCT01803269|Camptothecin|camptothecin|mesh-list
44446732|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44446733|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44446734|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446735|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446736|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446737|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44446738|NCT01802879|Panobinostat|panobinostat|mesh-list
44446739|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446740|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44446741|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446742|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446743|NCT01802775|Aspirin|aspirin|mesh-list
44446744|NCT01802775|Edoxaban|edoxaban|mesh-list
44446745|NCT01802775|Clopidogrel|clopidogrel|mesh-list
44446746|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44446747|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446748|NCT01802775|Analgesics|analgesics|mesh-ancestor
44446749|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
44446750|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446751|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446752|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446753|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446754|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44446755|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44446757|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44446773|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44446774|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446775|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446776|NCT01802580|Fluocinonide|fluocinonide|mesh-list
44446777|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446778|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
44446779|NCT01802580|Hormones|hormones|mesh-ancestor
44446780|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44446781|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446782|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44446783|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44446784|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44446785|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446786|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446787|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446788|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
44446789|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446790|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446791|NCT01802437|Fluoxetine|fluoxetine|mesh-list
44446792|NCT01802437|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44446793|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44446794|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446795|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446796|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446797|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
44446798|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446799|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44446814|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446815|NCT01802333|Cytarabine|cytarabine|mesh-list
44446816|NCT01802333|Daunorubicin|daunorubicin|mesh-list
44446817|NCT01802333|Vorinostat|vorinostat|mesh-list
44446818|NCT01802333|Idarubicin|idarubicin|mesh-list
44446819|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44446820|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
44446821|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446822|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446823|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
44446824|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446825|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446826|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
43804461|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804462|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43804463|NCT04945226|Finasteride|finasteride|mesh-list
43804464|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44446827|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446828|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44446829|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44446830|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44446831|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446832|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44446833|NCT01802216|Minocycline|minocycline|mesh-list
44446834|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446835|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446836|NCT01802073|Vancomycin|vancomycin|mesh-list
44446837|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44446838|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446839|NCT01801917|Siponimod|siponimod|mesh-list
44446840|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44446841|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446842|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44446843|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
44446844|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446845|NCT01801735|Meloxicam|meloxicam|mesh-list
44446846|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44446847|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44446848|NCT01801735|Analgesics|analgesics|mesh-ancestor
44446849|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
44446850|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446851|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446852|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44446853|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44446854|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44446855|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44446856|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446857|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446858|NCT01801475|Ondansetron|ondansetron|mesh-list
44446859|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
44446860|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
44446861|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44446862|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446912|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446913|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44446914|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44446915|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
44446916|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44446917|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
44446918|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44446919|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44446920|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446921|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44446922|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44446923|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44446924|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
44446925|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44446926|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44446927|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446928|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44446929|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44446931|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
44446932|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44446933|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446934|NCT01799226|Triclosan|triclosan|mesh-list
44446935|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44446936|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44446937|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44446938|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44446939|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
44446940|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446941|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44446942|NCT01798992|Metoprolol|metoprolol|mesh-list
44446955|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44446956|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446958|NCT01798992|Protective Agents|protective agents|mesh-ancestor
44446959|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44446960|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44446961|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44446962|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
44446963|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44446964|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44446965|NCT01798706|Lixisenatide|lixisenatide|mesh-list
44446966|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44446967|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44446968|NCT01798485|Docetaxel|docetaxel|mesh-list
44446969|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44446970|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
44446971|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
44446972|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
44446973|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44446974|NCT01798056|Vaccines|vaccines|mesh-list
44446975|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
44447009|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447010|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
44447011|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447012|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447013|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44447014|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44447015|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447016|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447017|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
44447018|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44447019|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44447020|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44447021|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447022|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447023|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
44447024|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447025|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447026|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44447027|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447028|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
44447029|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44447030|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44447031|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44447032|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447034|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
44447056|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447057|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
44447058|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
44447059|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
44447060|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447061|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447062|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
44447063|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447064|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447065|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44447066|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
44447067|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44447068|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44447069|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44447070|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44447071|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447072|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44447073|NCT01795937|Itraconazole|itraconazole|mesh-list
44447074|NCT01795937|Atorvastatin|atorvastatin|mesh-list
44447075|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44447076|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44447077|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44447078|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
44447079|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447080|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44447081|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44447082|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447083|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
44447084|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447085|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44447086|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447087|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447092|NCT01795898|Fentanyl|fentanyl|mesh-list
44447095|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447096|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447097|NCT01795898|Analgesics|analgesics|mesh-ancestor
44447098|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
44447099|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447100|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44447101|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44447102|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
44447103|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
44447104|NCT01795547|Aripiprazole|aripiprazole|mesh-list
44447105|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44447106|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
44447107|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44447108|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44447109|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44447110|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447111|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447112|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
44447113|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
44447114|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447115|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447116|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44447117|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44447118|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
44447119|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44447120|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44447121|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44447122|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44447123|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
44447124|NCT01795495|Remifentanil|remifentanil|mesh-list
44447125|NCT01795495|Methadone|methadone|mesh-list
44447126|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44447127|NCT01795495|Narcotics|narcotics|mesh-ancestor
44447128|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447135|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
44447136|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43804487|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43804488|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804489|NCT04945096|Cytarabine|cytarabine|mesh-list
43804490|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
43804491|NCT04945096|Cyclosporine|cyclosporine|mesh-list
43804492|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
43804493|NCT04945096|Busulfan|busulfan|mesh-list
43804494|NCT04945096|Semustine|semustine|mesh-list
43804495|NCT04945096|Decitabine|decitabine|mesh-list
43804496|NCT04945096|Cyclosporins|cyclosporins|mesh-list
43804497|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
44447137|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447138|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447139|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44447140|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
44447141|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447142|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
44447143|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447144|NCT01794845|Docetaxel|docetaxel|mesh-list
44447145|NCT01794845|Cetuximab|cetuximab|mesh-list
44447146|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447147|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
44447148|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
44447149|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
44447152|NCT01794780|Fluticasone|fluticasone|mesh-list
44447194|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447195|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44447196|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44447197|NCT01793883|Laninamivir|laninamivir|mesh-list
44447198|NCT01793883|Zanamivir|zanamivir|mesh-list
44447199|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
44447200|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447201|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447202|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447203|NCT01793688|Ampicillin|ampicillin|mesh-list
44447204|NCT01793688|Sulbactam|sulbactam|mesh-list
44447205|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44447206|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447207|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44105448|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44447208|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447209|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447210|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
44447211|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
44447212|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447213|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44447214|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
44447215|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447216|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447217|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44447220|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
44447242|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447243|NCT01792115|Vitamins|vitamins|mesh-list
44447244|NCT01792115|Vitamin E|vitamin e|mesh-list
44447245|NCT01792115|Tocopherols|tocopherols|mesh-list
44447246|NCT01792115|Tocotrienols|tocotrienols|mesh-list
44447247|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
44447248|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
44447249|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447250|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
44447251|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447252|NCT01792115|Protective Agents|protective agents|mesh-ancestor
44447253|NCT01791985|Letrozole|letrozole|mesh-list
44447254|NCT01791985|Anastrozole|anastrozole|mesh-list
44447255|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447256|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44447257|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447258|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447260|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44447300|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44447301|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
43804591|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804592|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
43804593|NCT04943536|Bicalutamide|bicalutamide|mesh-list
43804594|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
43804595|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
43804729|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43804730|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43804731|NCT04942301|Growth Substances|growth substances|mesh-ancestor
44447302|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447303|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447304|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
44447305|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447306|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
44447307|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447308|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44447309|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447310|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
44447311|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447312|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44447313|NCT01790828|Factor VIII|factor viii|mesh-list
44447314|NCT01790828|Coagulants|coagulants|mesh-ancestor
44447315|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
44447316|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
44447317|NCT01790594|Abatacept|abatacept|mesh-list
44447318|NCT01790594|Tacrolimus|tacrolimus|mesh-list
44447319|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
44447320|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44447321|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447322|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
44447323|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447324|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44447325|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447326|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447327|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44447328|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447329|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44447330|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
44447331|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44447332|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447333|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447334|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
44447335|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
44447340|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447341|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44447342|NCT01790594|Protective Agents|protective agents|mesh-ancestor
44447343|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44447344|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447345|NCT01790568|Methotrexate|methotrexate|mesh-list
44447346|NCT01790568|Vorinostat|vorinostat|mesh-list
44447347|NCT01790568|Tacrolimus|tacrolimus|mesh-list
44447348|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44447349|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
44447350|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447351|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447352|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447353|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
44447354|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447355|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447356|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
44447357|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44105600|NCT00072930|Prednisone|prednisone|mesh-list
44447358|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44447359|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447360|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
44447361|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447362|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44447363|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44447364|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44447365|NCT01790516|Cisplatin|cisplatin|mesh-list
44447366|NCT01790516|Cetuximab|cetuximab|mesh-list
44447367|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447368|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44447383|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447384|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44447385|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447386|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
44447387|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44447388|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
44447389|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44447390|NCT01789970|Hydrocodone|hydrocodone|mesh-list
44447391|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44447392|NCT01789970|Narcotics|narcotics|mesh-ancestor
44447393|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447394|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447395|NCT01789970|Analgesics|analgesics|mesh-ancestor
44447396|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
44447397|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447398|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
44447399|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447400|NCT01789606|Ibuprofen|ibuprofen|mesh-list
44447401|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44447402|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447403|NCT01789606|Analgesics|analgesics|mesh-ancestor
44447404|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
44447405|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447406|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447407|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447408|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447409|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44447410|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447411|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447412|NCT01789320|Triamcinolone|triamcinolone|mesh-list
44447413|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44447426|NCT01789281|Octreotide|octreotide|mesh-list
44447427|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447428|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447429|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
44447430|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447431|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44447432|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44447434|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44447435|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447436|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44447437|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44447438|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447439|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447440|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447441|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44447442|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447443|NCT01789047|Topiramate|topiramate|mesh-list
44447444|NCT01789047|Amantadine|amantadine|mesh-list
44447445|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
44447446|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447447|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447448|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44447449|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44447450|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
44447451|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447452|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
44447453|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447454|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447471|NCT01788566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447472|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43615608|NCT03147677|Vitamins|vitamins|mesh-ancestor
43843006|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
43804752|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804753|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43804754|NCT04942002|Protective Agents|protective agents|mesh-ancestor
43804755|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804756|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804758|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44447473|NCT01788358|Candesartan|candesartan|mesh-list
44447474|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
44447475|NCT01788358|Nifedipine|nifedipine|mesh-list
44447476|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44447477|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44447478|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44447479|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447480|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44447481|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447482|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44447483|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447528|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447529|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447530|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44447531|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447532|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44447533|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44447534|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44447535|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
44447536|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447537|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447538|NCT01787032|Ketoconazole|ketoconazole|mesh-list
44447539|NCT01787032|Voriconazole|voriconazole|mesh-list
44447540|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
44447541|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447542|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44447543|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447544|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447545|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447546|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447547|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447548|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447549|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447550|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44447551|NCT01786707|Metformin|metformin|mesh-list
44447552|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447554|NCT01786668|Tofacitinib|tofacitinib|mesh-list
44447572|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
44447573|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44447574|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44447575|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44447576|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447577|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447578|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
44447579|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447580|NCT01786109|Dronabinol|dronabinol|mesh-list
44447581|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
44447582|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447583|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44447584|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447585|NCT01786109|Analgesics|analgesics|mesh-ancestor
44447586|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
44447587|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447588|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44447589|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44447590|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447591|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447592|NCT01786109|Hormones|hormones|mesh-ancestor
43804760|NCT04941911|Octreotide|octreotide|mesh-list
44447593|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447594|NCT01785615|Atorvastatin|atorvastatin|mesh-list
44447595|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44447596|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44447597|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
44447598|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447599|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44447600|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44447601|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447602|NCT01785472|Olmesartan|olmesartan|mesh-list
44447611|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44447612|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
44447613|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447614|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44447615|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44447616|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447617|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447618|NCT01784965|Liraglutide|liraglutide|mesh-list
44447619|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447620|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447621|NCT01784965|Incretins|incretins|mesh-ancestor
44447622|NCT01784965|Hormones|hormones|mesh-ancestor
44447623|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447624|NCT01784861|Everolimus|everolimus|mesh-list
44447625|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447626|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447629|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
44447670|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447671|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44447672|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447673|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
44447674|NCT01783821|Hormones|hormones|mesh-ancestor
44447675|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447676|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44447677|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44447678|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44447679|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
44447680|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804768|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804770|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
44447681|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447682|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
44447683|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
44447684|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447685|NCT01783548|Beclomethasone|beclomethasone|mesh-list
44447686|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447687|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
44447688|NCT01783548|Hormones|hormones|mesh-ancestor
44447689|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447690|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447691|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44447692|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
44447693|NCT01783444|Capecitabine|capecitabine|mesh-list
44447694|NCT01783444|Everolimus|everolimus|mesh-list
44447695|NCT01783444|Exemestane|exemestane|mesh-list
44447696|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447697|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
44447698|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447699|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447700|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447701|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
44447702|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447709|NCT01783015|Etanercept|etanercept|mesh-list
44447710|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44447711|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447713|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
44447714|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447715|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447716|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447717|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447718|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44447719|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447720|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
44447721|NCT01782885|Acetaminophen|acetaminophen|mesh-list
44447722|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447723|NCT01782885|Analgesics|analgesics|mesh-ancestor
44447724|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
44447725|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447769|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44447770|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44447771|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
44447772|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447773|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44447774|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447775|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
44447776|NCT01782222|Rotigotine|rotigotine|mesh-list
44447777|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
44447778|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
44447779|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447780|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447781|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447782|NCT01782131|Voriconazole|voriconazole|mesh-list
44447783|NCT01782131|Posaconazole|posaconazole|mesh-list
44447784|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
44447785|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447786|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44447787|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447788|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447789|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447790|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447791|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447792|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447793|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447794|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44447795|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44447796|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44447797|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44447798|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
44447799|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447800|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44447801|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44106079|NCT00074607|Immunologic Factors|immunologic factors|mesh-ancestor
44447802|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447805|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44447806|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447807|NCT01781611|Analgesics|analgesics|mesh-ancestor
44447808|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
44447809|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447810|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447811|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44447812|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44447813|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44447814|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44447815|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447816|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44447817|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44447818|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447819|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
44447820|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44447821|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
44447822|NCT01781234|Insulin|insulin|mesh-list
44447823|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44447824|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447825|NCT01781026|Vemurafenib|vemurafenib|mesh-list
44447826|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447827|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44447858|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
44447859|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44447860|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44447861|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
44447862|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447863|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44447864|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44447865|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447866|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447867|NCT01780662|Gemcitabine|gemcitabine|mesh-list
44447868|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44447869|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44447870|NCT01780662|Antibodies|antibodies|mesh-list
44447871|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
44447872|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44447873|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
44447874|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
44447875|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447876|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44447877|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
44447878|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447879|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447880|NCT01780662|Antiviral Agents|antiviral agents|mesh-ancestor
44447881|NCT01780662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447882|NCT01780662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447883|NCT01780662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447885|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44447886|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
44447887|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
44447888|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
44447891|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44447900|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447901|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447902|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447903|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44447904|NCT01780389|Analgesics|analgesics|mesh-ancestor
44447905|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
44447906|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447907|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
44447908|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44447909|NCT01779869|Regadenoson|regadenoson|mesh-list
44447910|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44447911|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44447912|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
44447913|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
44447914|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447915|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447916|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447917|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44447918|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44447919|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447920|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44447921|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
44447922|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447923|NCT01778985|Estrogens|estrogens|mesh-list
44447924|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44447925|NCT01778985|Hormones|hormones|mesh-ancestor
44447926|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447927|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447928|NCT01778049|Empagliflozin|empagliflozin|mesh-list
44447929|NCT01778049|Linagliptin|linagliptin|mesh-list
44447930|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44447931|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447937|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44447938|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
44447939|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447941|NCT01778010|Modafinil|modafinil|mesh-list
44447942|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44447943|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447944|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44447945|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44447946|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44447947|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447948|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
44447949|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
44447950|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44447951|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
44447952|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44447953|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44447954|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44447955|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44447956|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447958|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447959|NCT01777997|Tenofovir|tenofovir|mesh-list
44447960|NCT01777997|Emtricitabine|emtricitabine|mesh-list
44447961|NCT01777997|Rilpivirine|rilpivirine|mesh-list
44447962|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
44447963|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447964|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44447965|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44447966|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447967|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447968|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44447969|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44447970|NCT01777854|Omeprazole|omeprazole|mesh-list
44447971|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44164209|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
44447976|NCT01777763|Posaconazole|posaconazole|mesh-list
44447977|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
44447978|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44447979|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44447980|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44447981|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44447982|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43804976|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804977|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
43804978|NCT04938037|Hormones|hormones|mesh-ancestor
43805008|NCT04937907|Benazepril|benazepril|mesh-list
44447983|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44447984|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44447985|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447986|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44447987|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
44447988|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44447989|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447990|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
44447991|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44447992|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44447993|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44447994|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44447995|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44447996|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
44447997|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44447998|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44447999|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44448000|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448001|NCT01777581|Milnacipran|milnacipran|mesh-list
44448002|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
44448003|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44448004|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44448005|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448006|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448013|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
44448014|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448016|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44448017|NCT01777542|Mitogens|mitogens|mesh-list
44448018|NCT01777542|Mecasermin|mecasermin|mesh-list
44448019|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448020|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448021|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
44106230|NCT00075374|Docetaxel|docetaxel|mesh-list
44448022|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448023|NCT01777542|Growth Substances|growth substances|mesh-ancestor
44448024|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
44448025|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448026|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
44448027|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448028|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448029|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448030|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448031|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
44448032|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44448033|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
44448034|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448035|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448036|NCT01777282|Biguanides|biguanides|mesh-list
44448037|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44448038|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
44448039|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
44448040|NCT01777282|Incretins|incretins|mesh-ancestor
44448041|NCT01777282|Hormones|hormones|mesh-ancestor
44448057|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44448058|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44448059|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448060|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
44448061|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448062|NCT01777191|Ixekizumab|ixekizumab|mesh-list
44448063|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448064|NCT01777152|Prednisone|prednisone|mesh-list
44448065|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
44448066|NCT01777152|Doxorubicin|doxorubicin|mesh-list
44448067|NCT01777152|Vincristine|vincristine|mesh-list
44448068|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44448069|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448070|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
44448071|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448072|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448073|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44448074|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
44448075|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448076|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448077|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44448078|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44448079|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44448080|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448081|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448082|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448083|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
44448084|NCT01777152|Hormones|hormones|mesh-ancestor
44448085|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448086|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44448087|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44448088|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
44448089|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
44448090|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
44448096|NCT01776307|Capecitabine|capecitabine|mesh-list
44448097|NCT01776307|Cetuximab|cetuximab|mesh-list
44448098|NCT01776307|Panitumumab|panitumumab|mesh-list
44448099|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448100|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
44448101|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448102|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448103|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448104|NCT01776008|Anastrozole|anastrozole|mesh-list
44448105|NCT01776008|Goserelin|goserelin|mesh-list
44448106|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44448107|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448108|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44448109|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44448110|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448111|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448112|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44448113|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
44448114|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448115|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448116|NCT01775787|Menthol|menthol|mesh-list
44448117|NCT01775787|Nicotine|nicotine|mesh-list
44448118|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44448119|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
44448120|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448121|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448122|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44448123|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44448124|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
44448125|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164210|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
44164211|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164212|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164213|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44164214|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44164215|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44164216|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
44164217|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164218|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164219|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164220|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164221|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164222|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164223|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44448126|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448127|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
44448128|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448129|NCT01775501|Leucovorin|leucovorin|mesh-list
44448130|NCT01775501|Fluorouracil|fluorouracil|mesh-list
44448131|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
44448132|NCT01775501|Sorafenib|sorafenib|mesh-list
44448133|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
44448134|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448135|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448136|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448137|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448138|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
44448139|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448140|NCT01775501|Antidotes|antidotes|mesh-ancestor
44448141|NCT01775501|Protective Agents|protective agents|mesh-ancestor
44448142|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
44448143|NCT01775501|Vitamins|vitamins|mesh-ancestor
44448144|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
44448145|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448146|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448147|NCT01775475|Prednisone|prednisone|mesh-list
44448148|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
44448149|NCT01775475|Lomustine|lomustine|mesh-list
44448150|NCT01775475|Doxorubicin|doxorubicin|mesh-list
44448151|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44448152|NCT01775475|Etoposide|etoposide|mesh-list
44448153|NCT01775475|Vincristine|vincristine|mesh-list
44448154|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
44448155|NCT01775475|Procarbazine|procarbazine|mesh-list
44448156|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448157|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
44448158|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448159|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448160|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44448161|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
44448162|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448163|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448166|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44448167|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448169|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448170|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
44448171|NCT01775475|Hormones|hormones|mesh-ancestor
44448172|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448173|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44448174|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44448175|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
44448176|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
44448177|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
44448178|NCT01775189|Naltrexone|naltrexone|mesh-list
44448179|NCT01775189|Oxycodone|oxycodone|mesh-list
44448180|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44448181|NCT01775189|Narcotics|narcotics|mesh-ancestor
44448182|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448183|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448184|NCT01775189|Analgesics|analgesics|mesh-ancestor
44448185|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
44448186|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448187|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44106462|NCT00075855|Testosterone|testosterone|mesh-list
44448220|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44448221|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
44448222|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
44448224|NCT01774786|Fluorouracil|fluorouracil|mesh-list
44448225|NCT01774786|Capecitabine|capecitabine|mesh-list
44448226|NCT01774786|Trastuzumab|trastuzumab|mesh-list
44448227|NCT01774786|Pertuzumab|pertuzumab|mesh-list
44448228|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448229|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
44448230|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448231|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448232|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448233|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
44448234|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448235|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448236|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44448237|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44448238|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44448239|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448240|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
44448241|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44448242|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448243|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448244|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44448245|NCT01774305|Analgesics|analgesics|mesh-ancestor
44448246|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
44448247|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448248|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44448249|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44448250|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44448251|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448252|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448254|NCT01773993|Pregabalin|pregabalin|mesh-list
44448259|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
44448260|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44448261|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448262|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448263|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44448264|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44448265|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44448266|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448267|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448268|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
44448269|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
44448270|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448271|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
44448272|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448274|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44448275|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
44448276|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448277|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448278|NCT01773122|Dapsone|dapsone|mesh-list
44448279|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448280|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
44448281|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44448282|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44448283|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44448284|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448285|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448286|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
44448287|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44448288|NCT01773109|Irinotecan|irinotecan|mesh-list
44448289|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
44448290|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
44448291|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448292|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448293|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448299|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
44448300|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448301|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448302|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44448303|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44448304|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
44448305|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448306|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44448307|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44448308|NCT01772823|Tenofovir|tenofovir|mesh-list
44448309|NCT01772823|Emtricitabine|emtricitabine|mesh-list
44448310|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44448311|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
44448312|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448313|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44448314|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448315|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448316|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448317|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44448318|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44448319|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
44448320|NCT01772719|Simvastatin|simvastatin|mesh-list
44448321|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44448322|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44448323|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
44448324|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448325|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44448326|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44448327|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448328|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44448329|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448341|NCT01772368|Albuterol|albuterol|mesh-list
44448342|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44448343|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44448344|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
44448345|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448346|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448347|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
44448348|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448349|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448350|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448351|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448352|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448353|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44448354|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44448355|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44448356|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448357|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448358|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448359|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
44448360|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44448361|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
44448362|NCT01772368|Hormones|hormones|mesh-ancestor
44448363|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448364|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
44448365|NCT01772147|Fluticasone|fluticasone|mesh-list
44448366|NCT01772147|Xhance|xhance|mesh-list
44448367|NCT01772147|Bromides|bromides|mesh-list
44448368|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44448369|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448370|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448371|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
44448372|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448376|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448382|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448383|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448384|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
44448385|NCT01772134|Fluticasone|fluticasone|mesh-list
44448386|NCT01772134|Xhance|xhance|mesh-list
44448387|NCT01772134|Bromides|bromides|mesh-list
44448388|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44448389|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43805388|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805389|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43805390|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
43805391|NCT04931121|Viscosupplements|viscosupplements|mesh-list
43805408|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448390|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448391|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
44448392|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448393|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448394|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448395|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448396|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448397|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44448398|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44448399|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44448400|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44448401|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448402|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448403|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448404|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
44448405|NCT01771250|Insulin|insulin|mesh-list
44448406|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44448407|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
44448408|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448409|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448410|NCT01770912|Triamcinolone|triamcinolone|mesh-list
44448411|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44448412|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44448413|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44448414|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448415|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
44448416|NCT01770912|Hormones|hormones|mesh-ancestor
44448418|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448421|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448422|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448424|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
44448425|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448426|NCT01770392|Rifampin|rifampin|mesh-list
44448427|NCT01770392|Nintedanib|nintedanib|mesh-list
44448428|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44448429|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
44448430|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44448431|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448432|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
44448433|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448434|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448435|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448436|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44448437|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44448438|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44448439|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44448440|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44448441|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44448442|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448443|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448444|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44448445|NCT01770353|Hematinics|hematinics|mesh-ancestor
44448446|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44448447|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44448448|NCT01770145|Levodopa|levodopa|mesh-list
44448449|NCT01770145|Carbidopa|carbidopa|mesh-list
44448450|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44448451|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
44448452|NCT01770145|Apomorphine|apomorphine|mesh-list
44448453|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44448460|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448461|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44448462|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
44448463|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
44448464|NCT01770145|Emetics|emetics|mesh-ancestor
44448465|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
44448466|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448467|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44448468|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
44448469|NCT01769508|Fluorouracil|fluorouracil|mesh-list
44448470|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
44448471|NCT01769508|Lapatinib|lapatinib|mesh-list
44448472|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
44448473|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448474|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448475|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448520|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448521|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448522|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
44448523|NCT01769339|Miconazole|miconazole|mesh-list
44448524|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
44448525|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448526|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
44448527|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448528|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44448529|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44448530|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448531|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448538|NCT01768858|Adalimumab|adalimumab|mesh-list
44448581|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448582|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
44448583|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44448584|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44448585|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448586|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44448587|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44448588|NCT01768572|Analgesics|analgesics|mesh-ancestor
44448589|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
44448590|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448591|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448592|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44448593|NCT01768559|Insulin|insulin|mesh-list
44448594|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44448595|NCT01768559|Metformin|metformin|mesh-list
44448596|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
44448597|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
44448598|NCT01768559|Lixisenatide|lixisenatide|mesh-list
44448599|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448600|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448601|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44448602|NCT01768286|Ledipasvir|ledipasvir|mesh-list
44448603|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
44448604|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448605|NCT01767987|Ranolazine|ranolazine|mesh-list
44448606|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44448607|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44448608|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448609|NCT01767909|Insulin|insulin|mesh-list
44448610|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44448611|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448612|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448613|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
44448614|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
44448615|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44448622|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448623|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44448624|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448625|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44448626|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43843156|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
44448627|NCT01767519|Urological Agents|urological agents|mesh-ancestor
44448628|NCT01767194|Sirolimus|sirolimus|mesh-list
44448629|NCT01767194|Irinotecan|irinotecan|mesh-list
44448630|NCT01767194|Camptothecin|camptothecin|mesh-list
44448631|NCT01767194|Temozolomide|temozolomide|mesh-list
44448632|NCT01767194|Dinutuximab|dinutuximab|mesh-list
44448633|NCT01767194|Sargramostim|sargramostim|mesh-list
44448634|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44448635|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448636|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448637|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448638|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448639|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44448640|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
44448641|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44448642|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448643|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44448644|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
44106913|NCT00077441|Bortezomib|bortezomib|mesh-list
44448645|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448646|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
44448647|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448648|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44448671|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
44448672|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448673|NCT01766050|Abatacept|abatacept|mesh-list
44448674|NCT01766050|Losartan|losartan|mesh-list
44448675|NCT01766050|Midazolam|midazolam|mesh-list
44448676|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
44448677|NCT01766050|Caffeine|caffeine|mesh-list
44448678|NCT01766050|Omeprazole|omeprazole|mesh-list
44448679|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44448680|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44448681|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448682|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448683|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44448684|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44448685|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448686|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44448687|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
44448688|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
44448689|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
44448690|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
44448691|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448692|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448693|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44448694|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44448695|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44448696|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44448697|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44448698|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44448699|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44448720|NCT01765582|Bevacizumab|bevacizumab|mesh-list
44448721|NCT01765582|Fluorouracil|fluorouracil|mesh-list
44448722|NCT01765582|Capecitabine|capecitabine|mesh-list
44448723|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
44448724|NCT01765582|Irinotecan|irinotecan|mesh-list
44448725|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
44448726|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448727|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448728|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44448729|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44448730|NCT01765582|Growth Substances|growth substances|mesh-ancestor
44448731|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448732|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
44448733|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
44448734|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448735|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448736|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448737|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
44448738|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44448739|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44448740|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448741|NCT01765582|Antidotes|antidotes|mesh-ancestor
44448742|NCT01765582|Protective Agents|protective agents|mesh-ancestor
44448743|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
44448744|NCT01765582|Vitamins|vitamins|mesh-ancestor
44448745|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
44448746|NCT01765582|Hematinics|hematinics|mesh-ancestor
44448747|NCT01765569|Vemurafenib|vemurafenib|mesh-list
44448748|NCT01765569|Digoxin|digoxin|mesh-list
44448758|NCT01765543|Vemurafenib|vemurafenib|mesh-list
44448768|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44448769|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44448770|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44448771|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44448772|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44448773|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448774|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448775|NCT01765270|Saxagliptin|saxagliptin|mesh-list
44448776|NCT01765270|Incretins|incretins|mesh-ancestor
44448777|NCT01765270|Hormones|hormones|mesh-ancestor
44448778|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448779|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448780|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44448781|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
44448782|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448783|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448784|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448785|NCT01765192|Montelukast|montelukast|mesh-list
44448786|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448787|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448788|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44448789|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
44448790|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448791|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448792|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44448793|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44448794|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448810|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44448811|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
44448812|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44448813|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448814|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44448815|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
44448816|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448817|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448818|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448819|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448820|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44448821|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44448822|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
44448823|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448824|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44448825|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448826|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44448827|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44448828|NCT01764997|Analgesics|analgesics|mesh-ancestor
44448829|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
44448830|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448831|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44448832|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
44448833|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44448834|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44448835|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44448842|NCT01764633|Evolocumab|evolocumab|mesh-list
44448856|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448857|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448858|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44448859|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44448860|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448861|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448863|NCT01764022|Paclitaxel|paclitaxel|mesh-list
44448864|NCT01764022|Trastuzumab|trastuzumab|mesh-list
44448865|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44448866|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448867|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
44448868|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
44448869|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
44448870|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448871|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44448872|NCT01763996|Febuxostat|febuxostat|mesh-list
44448873|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
44448874|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44448875|NCT01763918|Evolocumab|evolocumab|mesh-list
44448876|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44448877|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44448878|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
44448879|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448880|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44448881|NCT01763905|Ezetimibe|ezetimibe|mesh-list
44448882|NCT01763905|Evolocumab|evolocumab|mesh-list
44448883|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44448884|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44448885|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44448886|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
44448887|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448888|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44448889|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
44448890|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448895|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448896|NCT01762943|Leuprolide|leuprolide|mesh-list
44448897|NCT01762943|Estradiol|estradiol|mesh-list
44448898|NCT01762943|Progesterone|progesterone|mesh-list
44448899|NCT01762943|Estrogens|estrogens|mesh-ancestor
44448900|NCT01762943|Hormones|hormones|mesh-ancestor
44448901|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448902|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448903|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44448904|NCT01762943|Progestins|progestins|mesh-ancestor
44448905|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44448906|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
44448907|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44448908|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448909|NCT01762800|Fluticasone|fluticasone|mesh-list
44448910|NCT01762800|Xhance|xhance|mesh-list
44448911|NCT01762800|Bromides|bromides|mesh-list
44448912|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
44448913|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44448914|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44448915|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44448916|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448917|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
44448918|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448919|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448920|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448921|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448922|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448923|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44448924|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
44448925|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44448926|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
44448927|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448928|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448929|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44448936|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448938|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44448939|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44448940|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448941|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448942|NCT01761266|Sorafenib|sorafenib|mesh-list
44448943|NCT01761266|Lenvatinib|lenvatinib|mesh-list
44448944|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44448945|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44448946|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448947|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448948|NCT01760447|Metformin|metformin|mesh-list
44448949|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44448950|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44448951|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448952|NCT01760447|Incretins|incretins|mesh-ancestor
44448953|NCT01760447|Hormones|hormones|mesh-ancestor
44448954|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44448955|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44448956|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
44448957|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44448958|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448959|NCT01759862|Aminophylline|aminophylline|mesh-list
44448960|NCT01759862|Theophylline|theophylline|mesh-list
44448961|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44448962|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
44448963|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448964|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448965|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44448966|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
44448967|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44448976|NCT01759862|Protective Agents|protective agents|mesh-ancestor
44448977|NCT01759420|Ondansetron|ondansetron|mesh-list
44448978|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
44448979|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
44448980|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44448981|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44448983|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
44448984|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
44448985|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44448986|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
44448987|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448988|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44448989|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44448990|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44448991|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44448992|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44448993|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44448994|NCT01759407|Epinephrine|epinephrine|mesh-list
44448995|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44448996|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44448997|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
44448998|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44448999|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449000|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449001|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44449002|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44449003|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
44449004|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449005|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44449006|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449007|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
44449008|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
44449009|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44449010|NCT01758731|Cetuximab|cetuximab|mesh-list
44449011|NCT01758731|Olaparib|olaparib|mesh-list
44449012|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44449013|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449015|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449016|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449017|NCT01758523|Dutasteride|dutasteride|mesh-list
44449018|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44449019|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44449020|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449021|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449022|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
44449023|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654716|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
44449024|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449025|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44449026|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44449027|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449028|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449029|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
44449030|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449031|NCT01757288|Paclitaxel|paclitaxel|mesh-list
44449032|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44449033|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44449034|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449035|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
44449036|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
44449037|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449038|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449039|NCT01757275|Esomeprazole|esomeprazole|mesh-list
44449040|NCT01757275|Cimetidine|cimetidine|mesh-list
44449041|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44449042|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449043|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44449056|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
44449057|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44449058|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44449059|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44449060|NCT01756456|Mitogens|mitogens|mesh-list
44449061|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449062|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449063|NCT01756157|Complement C1s|complement c1s|mesh-list
44449064|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
44449065|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
44449066|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
44449067|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449068|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44449069|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449070|NCT01756079|Ribavirin|ribavirin|mesh-list
44449071|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44449072|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
44449073|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449074|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
44449075|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449076|NCT01755702|Acetaminophen|acetaminophen|mesh-list
44449077|NCT01755702|Ibuprofen|ibuprofen|mesh-list
44449078|NCT01755702|Caffeine|caffeine|mesh-list
44449079|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44449080|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449081|NCT01755702|Analgesics|analgesics|mesh-ancestor
44449082|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
44449083|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449084|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449099|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44449100|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449101|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
44449102|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44449103|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44449104|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
44449105|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
44449106|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
44449107|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449108|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449109|NCT01755546|Buprenorphine|buprenorphine|mesh-list
44449110|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449111|NCT01755546|Narcotics|narcotics|mesh-ancestor
44449112|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449113|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449114|NCT01755546|Analgesics|analgesics|mesh-ancestor
44449115|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
44449116|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449117|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44449118|NCT01755416|Insulin|insulin|mesh-list
44449119|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44449120|NCT01755416|Liraglutide|liraglutide|mesh-list
44449121|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44449122|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449123|NCT01755416|Incretins|incretins|mesh-ancestor
44449124|NCT01755416|Hormones|hormones|mesh-ancestor
44449125|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449126|NCT01755234|Propofol|propofol|mesh-list
44449127|NCT01755234|Sevoflurane|sevoflurane|mesh-list
44449128|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44449129|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449130|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449131|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44164224|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164225|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164226|NCT00255528|Metoprolol|metoprolol|mesh-list
44164227|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44164228|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44164229|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
44164230|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
44164231|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164232|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635701|NCT05192889|Vincristine|vincristine|mesh-list
44449132|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
44449133|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
44449134|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44449135|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44449136|NCT01755156|Metformin|metformin|mesh-list
44449137|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
44449138|NCT01755156|Glimepiride|glimepiride|mesh-list
44449139|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44449140|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449141|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44449142|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449143|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
44449144|NCT01755091|Dronabinol|dronabinol|mesh-list
44449145|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
44449146|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449147|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44449148|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449149|NCT01755091|Analgesics|analgesics|mesh-ancestor
44449150|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
44449151|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449152|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44449153|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44449154|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449155|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449156|NCT01755091|Hormones|hormones|mesh-ancestor
44449157|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449158|NCT01755026|Cefazolin|cefazolin|mesh-list
44449159|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449160|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449161|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44449162|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44449175|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44449176|NCT01754402|Pomalidomide|pomalidomide|mesh-list
44449177|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449178|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
44449179|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
44449180|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449181|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449182|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449183|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
44449184|NCT01754402|Hormones|hormones|mesh-ancestor
44449185|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449186|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449187|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449188|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44449189|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
44449190|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449191|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
44449192|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44449193|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44449194|NCT01754402|Growth Substances|growth substances|mesh-ancestor
44449195|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
44449196|NCT01754376|Aldesleukin|aldesleukin|mesh-list
44449197|NCT01754376|Interleukin-2|interleukin-2|mesh-list
44449198|NCT01754376|Vemurafenib|vemurafenib|mesh-list
44449199|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449200|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449201|NCT01754376|Analgesics|analgesics|mesh-ancestor
44449202|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
44107512|NCT00079300|Imiquimod|imiquimod|mesh-list
44449203|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449204|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449219|NCT01753856|Tetracycline|tetracycline|mesh-list
44449220|NCT01753856|Demeclocycline|demeclocycline|mesh-list
44449221|NCT01753856|Calcium|calcium|mesh-list
44449222|NCT01753856|Vitamins|vitamins|mesh-ancestor
44449223|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
44449224|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449225|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44449226|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44449227|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449228|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449229|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44449230|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449231|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449232|NCT01753570|Interferon-beta|interferon-beta|mesh-list
44449233|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449234|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
44449235|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449236|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
44449237|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449238|NCT01753401|Prednisone|prednisone|mesh-list
44449239|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44449240|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449241|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
44449242|NCT01753401|Hormones|hormones|mesh-ancestor
44449243|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449268|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449269|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44449270|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
44449271|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44449272|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
44449273|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449274|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449275|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44107588|NCT00079443|Rituximab|rituximab|mesh-list
44449276|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449277|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449278|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
44449279|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449280|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449281|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44449282|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44449283|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449284|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449285|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449286|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44449287|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44449288|NCT01752933|Guadecitabine|guadecitabine|mesh-list
44449289|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449290|NCT01752855|Adalimumab|adalimumab|mesh-list
44449291|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449317|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449318|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44449319|NCT01751867|Decitabine|decitabine|mesh-list
44449320|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44449321|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
44449322|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449323|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449324|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449325|NCT01751802|Ecopipam|ecopipam|mesh-list
44449326|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44449327|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44449328|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449329|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449330|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44449331|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44449332|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
44449333|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449334|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449335|NCT01751724|Caffeine|caffeine|mesh-list
44449336|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
44449337|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449338|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44449339|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449340|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44449341|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449342|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44449343|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44449344|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
44449345|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449346|NCT01751646|Vitamin D|vitamin d|mesh-list
44449347|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
44449348|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
44449355|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44449356|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44449357|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
44449358|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449359|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44449360|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44449361|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449362|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449363|NCT01751178|Ethanol|ethanol|mesh-list
44449364|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
44449365|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44449366|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44449367|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449368|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449369|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449370|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
43805705|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
43805706|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
43805707|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
43805708|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805709|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
44449371|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44449372|NCT01751113|Fluticasone|fluticasone|mesh-list
44449373|NCT01751113|Xhance|xhance|mesh-list
44449374|NCT01751113|Bromides|bromides|mesh-list
44449375|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
44449376|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44449377|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44449378|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449379|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44449380|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
44449381|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449382|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449405|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
44449406|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449407|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44449408|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
44449409|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449410|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44449411|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449412|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
44449413|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
44449414|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44449415|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44449416|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44449417|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44449418|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
44449419|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44449420|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44449421|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
44449422|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449423|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
44449424|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44449425|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44449426|NCT01750918|Fluorouracil|fluorouracil|mesh-list
44449427|NCT01750918|Panitumumab|panitumumab|mesh-list
44449428|NCT01750918|Trametinib|trametinib|mesh-list
44449429|NCT01750918|Dabrafenib|dabrafenib|mesh-list
44449431|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449450|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44449451|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449452|NCT01750697|Rituximab|rituximab|mesh-list
44449453|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44449454|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449455|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
44449456|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449457|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449458|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
44449459|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44449460|NCT01750294|Diuretics|diuretics|mesh-ancestor
44449461|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
44449462|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449463|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44449464|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449465|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449466|NCT01750268|Topiramate|topiramate|mesh-list
44449467|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
43805807|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805808|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44449468|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44449469|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449470|NCT01749982|Choline|choline|mesh-list
44449471|NCT01749982|Betaine|betaine|mesh-list
44449472|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
44449473|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44449474|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
44449475|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449476|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44449477|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44449478|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
44449479|NCT01749826|Morphine|morphine|mesh-list
44449480|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449481|NCT01749826|Narcotics|narcotics|mesh-ancestor
44449482|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449483|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449484|NCT01749826|Analgesics|analgesics|mesh-ancestor
44449485|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
44449489|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449490|NCT01748825|Adavosertib|adavosertib|mesh-list
44449491|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449492|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449493|NCT01748292|Ranibizumab|ranibizumab|mesh-list
44449494|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44449495|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44449496|NCT01748292|Growth Substances|growth substances|mesh-ancestor
44449497|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449498|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
44449499|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449500|NCT01748162|Fluticasone|fluticasone|mesh-list
44449501|NCT01748162|Prednisolone|prednisolone|mesh-list
44449502|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449503|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44449504|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
44449505|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449506|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449507|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44449508|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449509|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
44449510|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44449511|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
44449512|NCT01748162|Hormones|hormones|mesh-ancestor
44449513|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449514|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44449515|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449516|NCT01747915|Pregabalin|pregabalin|mesh-list
44449517|NCT01747915|Analgesics|analgesics|mesh-ancestor
44449518|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
44449519|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449520|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449531|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44449533|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449534|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449535|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44449536|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449537|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
44449538|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449539|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44449540|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44449541|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44449542|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449543|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449544|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449545|NCT01747551|Leucovorin|leucovorin|mesh-list
44449546|NCT01747551|Fluorouracil|fluorouracil|mesh-list
44449547|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
44449548|NCT01747551|Aflibercept|aflibercept|mesh-list
44449549|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
44449550|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449551|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44449552|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449553|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449554|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
44449555|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449556|NCT01747551|Antidotes|antidotes|mesh-ancestor
44449557|NCT01747551|Protective Agents|protective agents|mesh-ancestor
44449558|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
44449559|NCT01747551|Vitamins|vitamins|mesh-ancestor
44449560|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
44449561|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44449576|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449577|NCT01746901|Analgesics|analgesics|mesh-ancestor
44449578|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
44449579|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449580|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44449581|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44449582|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
44449583|NCT01746732|Evacetrapib|evacetrapib|mesh-list
44449584|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44449585|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44449586|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44449587|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
44449588|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449589|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44449590|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44449591|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44449592|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44449593|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44449594|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449595|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449596|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44449597|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
44449598|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449599|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449600|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44449601|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44449623|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449624|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
44449625|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
44449626|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
44449627|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44449628|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
44449629|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44449630|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
44449631|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44449632|NCT01745380|Protective Agents|protective agents|mesh-ancestor
44449633|NCT01745367|Paclitaxel|paclitaxel|mesh-list
44449634|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44449635|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449636|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
44449637|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
44449683|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449684|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44449685|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
44449686|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449687|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44449688|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44449689|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449690|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449691|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44449692|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
44449693|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449694|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44449695|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44449696|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44449697|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44449698|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449699|NCT01743027|Analgesics|analgesics|mesh-ancestor
44449700|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
44449701|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449702|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449703|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449704|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449705|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44449706|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44449707|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44449708|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
44449709|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
44449710|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449711|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449712|NCT01743001|Macitentan|macitentan|mesh-list
44449713|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44449717|NCT01742897|Fentanyl|fentanyl|mesh-list
44449721|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449722|NCT01742897|Analgesics|analgesics|mesh-ancestor
44449723|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
44449724|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449725|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44449726|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44449727|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
44449728|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
44449729|NCT01742286|Ceritinib|ceritinib|mesh-list
44449730|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449731|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44449732|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449733|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449734|NCT01741792|Blinatumomab|blinatumomab|mesh-list
44449735|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449736|NCT01741545|Interferons|interferons|mesh-list
44449737|NCT01741545|Ribavirin|ribavirin|mesh-list
44449780|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449781|NCT01740323|Curcumin|curcumin|mesh-list
44449782|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44449783|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44449784|NCT01740323|Analgesics|analgesics|mesh-ancestor
44449785|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
44449786|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449787|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449788|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44449789|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44449790|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449791|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44449843|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449844|NCT01739595|Enclomiphene|enclomiphene|mesh-list
44449845|NCT01739595|Clomiphene|clomiphene|mesh-list
44449846|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
44449847|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44449848|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
44449849|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44449850|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449851|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44449852|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
43805899|NCT04919460|Coagulants|coagulants|mesh-ancestor
44449853|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44449854|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44449855|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44449856|NCT01739400|Macitentan|macitentan|mesh-list
44449857|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
44449858|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44449859|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44449860|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44449861|NCT01739335|Mifepristone|mifepristone|mesh-list
44449862|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44449893|NCT01738594|Romidepsin|romidepsin|mesh-list
44449894|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44449895|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44449896|NCT01738503|Buprenorphine|buprenorphine|mesh-list
44449897|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44449898|NCT01738503|Narcotics|narcotics|mesh-ancestor
44449899|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449900|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449901|NCT01738503|Analgesics|analgesics|mesh-ancestor
44449902|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
44449903|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44449904|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44449905|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44449906|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44449907|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44449908|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44449910|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
44449951|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44449952|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
44449953|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
44449954|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44449955|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449956|NCT01737710|Vaccines|vaccines|mesh-list
44449957|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
44449958|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44449959|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44449960|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44449961|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44449962|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44449963|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44449964|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44449965|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450012|NCT01736176|Levodopa|levodopa|mesh-list
44450013|NCT01736176|Carbidopa|carbidopa|mesh-list
44450014|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43805935|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
44450015|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44450016|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44450017|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
44450018|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450019|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450020|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450021|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44450022|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450023|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44450024|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
44450025|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
44450026|NCT01735630|Inositol|inositol|mesh-list
44450027|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
44450028|NCT01735630|Vitamins|vitamins|mesh-ancestor
44450029|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
44450030|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450031|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
44450032|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450033|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44450034|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450035|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450036|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
44450037|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450038|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450039|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44450040|NCT01735279|Mineral Oil|mineral oil|mesh-list
44450041|NCT01735279|Emollients|emollients|mesh-ancestor
44450055|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450056|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44450057|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
44450058|NCT01734850|Busulfan|busulfan|mesh-list
44450059|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
44450060|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450061|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450062|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
44450063|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450064|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450065|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450066|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44450067|NCT01734785|Empagliflozin|empagliflozin|mesh-list
44450068|NCT01734785|Linagliptin|linagliptin|mesh-list
44450069|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44450070|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450071|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450072|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450073|NCT01734785|Incretins|incretins|mesh-ancestor
44450074|NCT01734785|Hormones|hormones|mesh-ancestor
44450075|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450076|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44450077|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450078|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450079|NCT01734772|Dabigatran|dabigatran|mesh-list
44450080|NCT01734772|Ticagrelor|ticagrelor|mesh-list
44450081|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44450082|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44450083|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44450084|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44450089|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
44450096|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450097|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450098|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
44450099|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450100|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450101|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44450102|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
44450103|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450104|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
44450105|NCT01733758|Liraglutide|liraglutide|mesh-list
44450106|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
44450107|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44450108|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450158|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450159|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
44450160|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450161|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450162|NCT01732913|Rituximab|rituximab|mesh-list
44450163|NCT01732913|Idelalisib|idelalisib|mesh-list
44450164|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450165|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450166|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
44450167|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450168|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450169|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450170|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450171|NCT01732822|Clopidogrel|clopidogrel|mesh-list
44450172|NCT01732822|Ticagrelor|ticagrelor|mesh-list
44450173|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44450174|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44450181|NCT01732796|Ribavirin|ribavirin|mesh-list
44450214|NCT01732640|Afatinib|afatinib|mesh-list
44450215|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44450216|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450217|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450218|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450219|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450220|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450221|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44450222|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450223|NCT01732588|Artefenomel|artefenomel|mesh-list
44450224|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
44450225|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44450226|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44450227|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450228|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
44450229|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450230|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44450231|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44450232|NCT01732458|Ondansetron|ondansetron|mesh-list
44450233|NCT01732458|Aprepitant|aprepitant|mesh-list
44450234|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
44450235|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
44450236|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
44450237|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450238|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450239|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450240|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
44450241|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
44450242|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44450243|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
44450244|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450245|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450246|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450247|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450248|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450249|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450250|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44450252|NCT01731951|Imetelstat|imetelstat|mesh-list
44450253|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
44450254|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450255|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450256|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44450257|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44450258|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
44450259|NCT01731938|Coagulants|coagulants|mesh-ancestor
44450260|NCT01731886|Dexamethasone|dexamethasone|mesh-list
44450261|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
44450262|NCT01731886|Melphalan|melphalan|mesh-list
44450263|NCT01731886|Lenalidomide|lenalidomide|mesh-list
44450264|NCT01731886|Lenograstim|lenograstim|mesh-list
44450265|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450266|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
44450267|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450268|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450269|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450270|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
44450271|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450272|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450273|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44450274|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450275|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
44450276|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
44450277|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450278|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450279|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
44450280|NCT01731886|Hormones|hormones|mesh-ancestor
44450281|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450282|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44450283|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44450284|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44450285|NCT01731886|Growth Substances|growth substances|mesh-ancestor
44450286|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
44450287|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44450288|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44450289|NCT01731002|Latanoprost|latanoprost|mesh-list
44450292|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44450293|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44450294|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
44450295|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
44450296|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450297|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450298|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450299|NCT01730586|Paclitaxel|paclitaxel|mesh-list
44450300|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44450301|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44450302|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450303|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450304|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450305|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450306|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450307|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
44450308|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44450309|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450310|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450311|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450312|NCT01730378|Vaccines|vaccines|mesh-list
44450313|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
44450314|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450315|NCT01730118|Mitogens|mitogens|mesh-list
44450316|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450317|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450318|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44450319|NCT01730053|Ezetimibe|ezetimibe|mesh-list
44450320|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44450321|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44450322|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
44450323|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450333|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806033|NCT04918264|Capecitabine|capecitabine|mesh-list
44450334|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44450335|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44450336|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450337|NCT01729871|Vitamin K|vitamin k|mesh-list
44450338|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
44450339|NCT01729871|Vitamins|vitamins|mesh-ancestor
44450340|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
44450341|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450342|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44450343|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
44450344|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44450345|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450346|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450347|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450348|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
44450349|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44450350|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44450351|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
44450352|NCT01729871|Coagulants|coagulants|mesh-ancestor
44450353|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44450354|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44450387|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450389|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44450390|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450391|NCT01728779|Nelfinavir|nelfinavir|mesh-list
44450392|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44450393|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44450394|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450395|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450396|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450397|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44450398|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44450399|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
44450401|NCT01728623|Lenvatinib|lenvatinib|mesh-list
44450448|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450449|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450450|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450451|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450452|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450453|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
44450454|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
44450455|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450456|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450457|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44450458|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44450459|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
44450460|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44450461|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44450462|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44450463|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44450464|NCT01727700|Aripiprazole|aripiprazole|mesh-list
44450465|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450466|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450467|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450468|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450469|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806045|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806047|NCT04917692|Empagliflozin|empagliflozin|mesh-list
44450470|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450471|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
44450472|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
44450473|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450474|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450475|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44450476|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44450477|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
44450490|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
44450491|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450492|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450493|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450494|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
44450495|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44450496|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
44450497|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450498|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450499|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44450500|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
44450501|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
44450502|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44450503|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
44450504|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450505|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450506|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44450507|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
44450544|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44450545|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44450546|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44450547|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450548|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450549|NCT01725529|Ribavirin|ribavirin|mesh-list
44450550|NCT01725529|Simeprevir|simeprevir|mesh-list
44450551|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
44450552|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450553|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
44450554|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450555|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450556|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450557|NCT01725451|Testosterone|testosterone|mesh-list
44450558|NCT01725451|Androgens|androgens|mesh-ancestor
44450559|NCT01725451|Hormones|hormones|mesh-ancestor
43806058|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
43806061|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44450560|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450561|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450562|NCT01725386|Capecitabine|capecitabine|mesh-list
44450563|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44450564|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
44450565|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450566|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450567|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44450568|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
44450569|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44450570|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450581|NCT01725126|Metformin|metformin|mesh-list
44450592|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450593|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450594|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450595|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
44450596|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450597|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450598|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44450599|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450600|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450601|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450602|NCT01724528|Allopurinol|allopurinol|mesh-list
44450603|NCT01724528|Febuxostat|febuxostat|mesh-list
44450604|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
44450605|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450606|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450607|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
44450608|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44450609|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44450610|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
44450611|NCT01724528|Protective Agents|protective agents|mesh-ancestor
44450612|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450613|NCT01724489|Hormones|hormones|mesh-list
44450614|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450615|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450616|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44450617|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44450618|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44450619|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450620|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450635|NCT01724177|Growth Substances|growth substances|mesh-ancestor
44450636|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
44450637|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450638|NCT01724021|Prednisone|prednisone|mesh-list
44450639|NCT01724021|Prednisolone|prednisolone|mesh-list
44450640|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44450641|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
44450642|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44450643|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
44450644|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
44450645|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44450646|NCT01724021|Rituximab|rituximab|mesh-list
44450647|NCT01724021|Vincristine|vincristine|mesh-list
44450648|NCT01724021|Doxorubicin|doxorubicin|mesh-list
44450649|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44450650|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44450651|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
44450652|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450694|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44450695|NCT01723228|Protective Agents|protective agents|mesh-ancestor
44450696|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450698|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44450699|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44450700|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44450701|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
44450702|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
44450703|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806236|NCT04915963|Vitamin D|vitamin d|mesh-list
43806237|NCT04915963|Vitamins|vitamins|mesh-ancestor
43806238|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
43806239|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450704|NCT01722669|Quercetin|quercetin|mesh-list
44450705|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
44450706|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450707|NCT01722669|Protective Agents|protective agents|mesh-ancestor
44450708|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450709|NCT01722162|Bevacizumab|bevacizumab|mesh-list
44450710|NCT01722162|Capecitabine|capecitabine|mesh-list
44450711|NCT01722162|Levocetirizine|levocetirizine|mesh-list
44450712|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450713|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450714|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44450715|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44450716|NCT01722162|Growth Substances|growth substances|mesh-ancestor
44450717|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450718|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
44450719|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44450720|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
44450721|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450722|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44450723|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44450724|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
44450725|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
44450726|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450735|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44450736|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450737|NCT01722045|Aflibercept|aflibercept|mesh-list
44450738|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44450739|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44450740|NCT01722045|Growth Substances|growth substances|mesh-ancestor
44450741|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450742|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
44450743|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450744|NCT01721876|Cytarabine|cytarabine|mesh-list
44450745|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44450746|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
44450747|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450748|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450749|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
44450750|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450751|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44450752|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
44450753|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450754|NCT01721772|Nivolumab|nivolumab|mesh-list
44450755|NCT01721772|Dacarbazine|dacarbazine|mesh-list
44450756|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450757|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450758|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44450759|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450760|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450761|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
44450762|NCT01721759|Nivolumab|nivolumab|mesh-list
44450763|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450764|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450765|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44450766|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450767|NCT01721746|Paclitaxel|paclitaxel|mesh-list
44450768|NCT01721746|Carboplatin|carboplatin|mesh-list
44450769|NCT01721746|Nivolumab|nivolumab|mesh-list
44450770|NCT01721746|Dacarbazine|dacarbazine|mesh-list
44164233|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44450771|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44450772|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450773|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450774|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450775|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450776|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450777|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44450778|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44450779|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44450780|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
44450781|NCT01721486|Acetaminophen|acetaminophen|mesh-list
44450782|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44450783|NCT01721486|Analgesics|analgesics|mesh-ancestor
44450784|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
44450785|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450786|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450787|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
44450788|NCT01721408|Imipenem|imipenem|mesh-list
44450789|NCT01721408|Tigecycline|tigecycline|mesh-list
44450790|NCT01721408|Cilastatin|cilastatin|mesh-list
44450791|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44450792|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450793|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44450794|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450795|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450796|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
44450797|NCT01721330|Naltrexone|naltrexone|mesh-list
44450798|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44450799|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44450800|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450801|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
44450803|NCT01721317|Ezogabine|ezogabine|mesh-list
44450813|NCT01721070|Sufentanil|sufentanil|mesh-list
44450814|NCT01721070|Dsuvia|dsuvia|mesh-list
44450815|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44450816|NCT01721070|Narcotics|narcotics|mesh-ancestor
44450817|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450818|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450819|NCT01721070|Analgesics|analgesics|mesh-ancestor
44450820|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
44450821|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450822|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44450823|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44450824|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
44450825|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
44450826|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
44450827|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450828|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44450829|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44450830|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44450831|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450832|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44450833|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
44450834|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450835|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44450836|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
44450837|NCT01720797|Anesthetics|anesthetics|mesh-list
44450838|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
44450839|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44450840|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44450841|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
44450842|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450843|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450844|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
44450845|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44450846|NCT01720667|Levetiracetam|levetiracetam|mesh-list
44450847|NCT01720667|Phenobarbital|phenobarbital|mesh-list
44450848|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
44450851|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450852|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450853|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44450854|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44450855|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450856|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450857|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
44450858|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
44450859|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44450860|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44450861|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44450862|NCT01720602|Letrozole|letrozole|mesh-list
44450863|NCT01720602|Anastrozole|anastrozole|mesh-list
44450910|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450911|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44450912|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44450913|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44450914|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
44450915|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44450916|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450918|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
44450919|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450920|NCT01719757|Oxycodone|oxycodone|mesh-list
44450921|NCT01719757|Naloxone|naloxone|mesh-list
44450922|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44450923|NCT01719757|Narcotics|narcotics|mesh-ancestor
44450924|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44450925|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450926|NCT01719757|Analgesics|analgesics|mesh-ancestor
44450967|NCT01718353|Prednisone|prednisone|mesh-list
44450968|NCT01718353|Docetaxel|docetaxel|mesh-list
44450969|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44450970|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
44450971|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
44450972|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
44450973|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44450974|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44450975|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
44450976|NCT01718353|Hormones|hormones|mesh-ancestor
44450977|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450978|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450979|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44450980|NCT01717768|Testosterone|testosterone|mesh-list
44450981|NCT01717768|Androgens|androgens|mesh-ancestor
44450982|NCT01717768|Hormones|hormones|mesh-ancestor
44450983|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44450984|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44450985|NCT01717638|Vaccines|vaccines|mesh-list
44450986|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
44450987|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451022|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44451023|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43806273|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
44451024|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451025|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451026|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451027|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451028|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451029|NCT01716585|Ribavirin|ribavirin|mesh-list
44451030|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
44451031|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451032|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
44451033|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451034|NCT01716234|Posaconazole|posaconazole|mesh-list
44451035|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
44451036|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451037|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44451038|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44451039|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44451040|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44451041|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44451042|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451043|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451044|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44451045|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
44451046|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451047|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451048|NCT01716156|Ribavirin|ribavirin|mesh-list
44451049|NCT01716156|Grazoprevir|grazoprevir|mesh-list
44451050|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
44451051|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451052|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
44451053|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451063|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44451064|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451065|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451066|NCT01715896|Golimumab|golimumab|mesh-list
44451067|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
44451068|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44451069|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451070|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451071|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
44451072|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451073|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451074|NCT01715805|Cariprazine|cariprazine|mesh-list
44451075|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
44451076|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44451077|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44451120|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
44451121|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451122|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44451123|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
44451124|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44451125|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44451126|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44451127|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451128|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44451129|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44451130|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
44451131|NCT01713946|Everolimus|everolimus|mesh-list
44451132|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
44451133|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451134|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451177|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44451178|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451179|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451180|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451181|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451182|NCT01712490|Doxorubicin|doxorubicin|mesh-list
44451183|NCT01712490|Bleomycin|bleomycin|mesh-list
44451184|NCT01712490|Dacarbazine|dacarbazine|mesh-list
44451185|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
44451186|NCT01712490|Vinblastine|vinblastine|mesh-list
44451187|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44451202|NCT01712204|Febuxostat|febuxostat|mesh-list
44451242|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451243|NCT01711853|Dabigatran|dabigatran|mesh-list
44451244|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
44451245|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44451246|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451247|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451248|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451249|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
44451250|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
44451251|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44451252|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
44451253|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451254|NCT01711645|Antacids|antacids|mesh-ancestor
44451255|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451256|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451257|NCT01711359|Folic Acid|folic acid|mesh-list
44451258|NCT01711359|Methotrexate|methotrexate|mesh-list
44451259|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44451260|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
44451298|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44451299|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44451300|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44451301|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44451302|NCT01710657|Lacosamide|lacosamide|mesh-list
44451303|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
44451304|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44451305|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44451306|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451307|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451308|NCT01710527|Metformin|metformin|mesh-list
44451309|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451310|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451311|NCT01710501|Interferons|interferons|mesh-list
44451312|NCT01710501|Ribavirin|ribavirin|mesh-list
44451313|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
44451314|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
44451315|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44451316|NCT01710501|Grazoprevir|grazoprevir|mesh-list
44451317|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451318|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
44451319|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451320|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
44451321|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451322|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
44451323|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451324|NCT01710358|Adalimumab|adalimumab|mesh-list
44451343|NCT01710345|Dsuvia|dsuvia|mesh-list
44451346|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44451347|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451348|NCT01710345|Analgesics|analgesics|mesh-ancestor
44451349|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
44451350|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451351|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44451352|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44451353|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
44451354|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
44451355|NCT01710046|Tofacitinib|tofacitinib|mesh-list
44451356|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44451357|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451358|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451359|NCT01710033|Tofacitinib|tofacitinib|mesh-list
44451360|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44451361|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451362|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451363|NCT01710020|Tofacitinib|tofacitinib|mesh-list
44451364|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44451365|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451366|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451367|NCT01709903|Fluticasone|fluticasone|mesh-list
44451368|NCT01709903|Xhance|xhance|mesh-list
44451369|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
44451370|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43790553|NCT03933007|Colchicine|colchicine|mesh-list
44451371|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44451372|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451373|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451374|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
44451375|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451376|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451377|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451378|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451386|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451388|NCT01709903|Hormones|hormones|mesh-ancestor
44451389|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451390|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
44451391|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44451392|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44451393|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44451394|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451395|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
44451396|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44451397|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44451398|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44451399|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
44451400|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451401|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451443|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451444|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451445|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451446|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44451447|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451448|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
44451449|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451450|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44451451|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
44451452|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44451453|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44451454|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451455|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44451456|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44451457|NCT01709578|Analgesics|analgesics|mesh-ancestor
44451458|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
44451459|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806279|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43806280|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806281|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806282|NCT04914910|Insulin|insulin|mesh-list
43806285|NCT04914936|Rifampin|rifampin|mesh-list
44451460|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44109799|NCT03495232|Cimetidine|cimetidine|mesh-list
44451461|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451462|NCT01709513|Atorvastatin|atorvastatin|mesh-list
44451463|NCT01709513|Ezetimibe|ezetimibe|mesh-list
44451464|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44451465|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44451494|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44451495|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
44451496|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451497|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44451498|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44451499|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44451500|NCT01709305|Metformin|metformin|mesh-list
44451501|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44451502|NCT01709305|Glimepiride|glimepiride|mesh-list
44451503|NCT01709305|Acarbose|acarbose|mesh-list
44451504|NCT01709305|Repaglinide|repaglinide|mesh-list
44451505|NCT01709305|Gliclazide|gliclazide|mesh-list
44451506|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451507|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451508|NCT01709305|Incretins|incretins|mesh-ancestor
44451509|NCT01709305|Hormones|hormones|mesh-ancestor
44451510|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451519|NCT01709227|Furosemide|furosemide|mesh-list
44451551|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451552|NCT01709084|Tenofovir|tenofovir|mesh-list
44451553|NCT01709084|Emtricitabine|emtricitabine|mesh-list
44451554|NCT01709084|Efavirenz|efavirenz|mesh-list
44451555|NCT01709084|Rilpivirine|rilpivirine|mesh-list
44451556|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
44451557|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451558|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44451559|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44451560|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451561|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451562|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44451563|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44451564|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44451565|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43806329|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43806330|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
43806331|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
43806332|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806333|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790630|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451566|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44451567|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44451568|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44451569|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44451570|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44451571|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451572|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44451573|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451574|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451575|NCT01708941|Interferons|interferons|mesh-list
44451576|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
44451577|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
44451578|NCT01708941|Ipilimumab|ipilimumab|mesh-list
44451579|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451580|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
44451593|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
44451594|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451595|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
44451596|NCT01708915|Vitamins|vitamins|mesh-ancestor
44451597|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
44451598|NCT01708902|Metformin|metformin|mesh-list
44451599|NCT01708902|Linagliptin|linagliptin|mesh-list
44451600|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451601|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451602|NCT01708902|Incretins|incretins|mesh-ancestor
44451603|NCT01708902|Hormones|hormones|mesh-ancestor
44451604|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451605|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451606|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451607|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451608|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451609|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
44451610|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451611|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
44451616|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
44451649|NCT01707004|Fludarabine|fludarabine|mesh-list
44451650|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
44451651|NCT01707004|Azacitidine|azacitidine|mesh-list
44451652|NCT01707004|Decitabine|decitabine|mesh-list
44451653|NCT01707004|Tacrolimus|tacrolimus|mesh-list
44451654|NCT01707004|Lenograstim|lenograstim|mesh-list
44451655|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451656|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
44451657|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451658|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451659|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44451660|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
44451661|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451662|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654751|NCT02973958|Bupivacaine|bupivacaine|mesh-list
44451663|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44451664|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451665|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
44451666|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
44451667|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451668|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44451669|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451670|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44451671|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44451672|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44451673|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
44451675|NCT01706939|Carboplatin|carboplatin|mesh-list
44451701|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44451702|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
44451703|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451704|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451705|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
44451706|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44451707|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
44451708|NCT01706250|Salicylates|salicylates|mesh-list
44451709|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451710|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
44451711|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
44451712|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451713|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44451714|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44451715|NCT01706250|Analgesics|analgesics|mesh-ancestor
44451716|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
44451717|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451718|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451719|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451720|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451721|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44451722|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451723|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451724|NCT01706198|Fluticasone|fluticasone|mesh-list
44451725|NCT01706198|Xhance|xhance|mesh-list
44451726|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451727|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451728|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
43806337|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806338|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
43806339|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43806340|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806341|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451729|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451730|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451731|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451732|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451733|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
44451734|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44451735|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
44451741|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44451742|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451743|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451744|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451745|NCT01705691|Paclitaxel|paclitaxel|mesh-list
44451746|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
44451747|NCT01705691|Doxorubicin|doxorubicin|mesh-list
44451748|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451749|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451750|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451751|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451752|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451753|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451754|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451755|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
44451756|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451757|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451758|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44451759|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
44451760|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44451761|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44451762|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44451763|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44451764|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451765|NCT01705587|Teriparatide|teriparatide|mesh-list
44451766|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44451767|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451768|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44451769|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44451774|NCT01705509|Ranolazine|ranolazine|mesh-list
44451781|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451782|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
44451783|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451784|NCT01705145|Ivacaftor|ivacaftor|mesh-list
44451785|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44451786|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44451787|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451788|NCT01704755|Ribavirin|ribavirin|mesh-list
44451789|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
44451790|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451791|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
43806345|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806346|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
43806347|NCT04913480|Durvalumab|durvalumab|mesh-list
43806348|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806349|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806350|NCT04913389|Acetazolamide|acetazolamide|mesh-list
43806351|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
43806352|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43806353|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790803|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43790804|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
43790805|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451792|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451793|NCT01704651|Alvimopan|alvimopan|mesh-list
44451794|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451795|NCT01704599|Vitamins|vitamins|mesh-list
44451796|NCT01704599|Folic Acid|folic acid|mesh-list
44451797|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
44451798|NCT01704599|Pyridoxine|pyridoxine|mesh-list
44451799|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
44451800|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
44451801|NCT01704599|Adalimumab|adalimumab|mesh-list
44451802|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
44451803|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451804|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44451805|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451806|NCT01704599|Hematinics|hematinics|mesh-ancestor
44451807|NCT01704287|Paclitaxel|paclitaxel|mesh-list
44451808|NCT01704287|Carboplatin|carboplatin|mesh-list
44451809|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
44451810|NCT01704287|Temozolomide|temozolomide|mesh-list
44451811|NCT01704287|Dacarbazine|dacarbazine|mesh-list
44451812|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451813|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451814|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451815|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451816|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451820|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
44451824|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451825|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44451826|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451827|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
44451828|NCT01704079|Calcifediol|calcifediol|mesh-list
44451830|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
44451831|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451832|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44451833|NCT01703858|Pantoprazole|pantoprazole|mesh-list
44451834|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44451835|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44451836|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44451837|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451838|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451839|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
44451840|NCT01703845|Olodaterol|olodaterol|mesh-list
44451841|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44451842|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
44451843|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44451844|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451845|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44451846|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
44451854|NCT01703741|Hormones|hormones|mesh-ancestor
44451875|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451876|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451877|NCT01703221|Incretins|incretins|mesh-ancestor
44451878|NCT01703221|Hormones|hormones|mesh-ancestor
44451879|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451880|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451881|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
44451882|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451883|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451884|NCT01703117|Riluzole|riluzole|mesh-list
44451885|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
44451886|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44451887|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44451888|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44451889|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451890|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451891|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44451892|NCT01703117|Protective Agents|protective agents|mesh-ancestor
44451893|NCT01703091|Docetaxel|docetaxel|mesh-list
44451894|NCT01703091|Ramucirumab|ramucirumab|mesh-list
44451895|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451896|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451897|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451898|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451899|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451900|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
44451923|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451924|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451925|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44451926|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
44451927|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
44451928|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44451929|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44451930|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
44451931|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451932|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44451933|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44451934|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44451935|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
44451936|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44451937|NCT01702844|Paclitaxel|paclitaxel|mesh-list
44451938|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44451939|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44451940|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
44451941|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
44451942|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
44451976|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451977|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44451978|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
44451979|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451980|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
44451981|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451982|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451984|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44451985|NCT01702298|Simvastatin|simvastatin|mesh-list
43840858|NCT04666714|Pregabalin|pregabalin|mesh-list
44451986|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44451987|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44451988|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44451989|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44451990|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
44451991|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44451992|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44451993|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44451994|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44451995|NCT01702298|Incretins|incretins|mesh-ancestor
44451996|NCT01702298|Hormones|hormones|mesh-ancestor
44451997|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44451998|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44451999|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452000|NCT01702246|Simvastatin|simvastatin|mesh-list
44452001|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44452002|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44452003|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
44452004|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452019|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452020|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
44452021|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44452022|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44452023|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
44452024|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452025|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44452026|NCT01702025|Protective Agents|protective agents|mesh-ancestor
44452027|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44452028|NCT01702025|Diuretics|diuretics|mesh-ancestor
44452029|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
44452030|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44452031|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452032|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452033|NCT01701973|Incretins|incretins|mesh-ancestor
44452035|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452036|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44452037|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452038|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806366|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843310|NCT04465318|Nicotine|nicotine|mesh-list
44452039|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452040|NCT01701674|Aldesleukin|aldesleukin|mesh-list
44452041|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
44452042|NCT01701674|Fludarabine|fludarabine|mesh-list
44452043|NCT01701674|Ipilimumab|ipilimumab|mesh-list
44452044|NCT01701674|Interleukin-2|interleukin-2|mesh-list
44452045|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452046|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
44452047|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452048|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452049|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452061|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452062|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
44452063|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452064|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
44452065|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
44452066|NCT01701401|Ledipasvir|ledipasvir|mesh-list
44452067|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
44452068|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452069|NCT01701362|Pregabalin|pregabalin|mesh-list
44452070|NCT01701362|Analgesics|analgesics|mesh-ancestor
44452071|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
44452072|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452073|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452074|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
44452075|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44452076|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44452077|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452078|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44452079|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44452080|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44452081|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452115|NCT01700946|Rituximab|rituximab|mesh-list
44452116|NCT01700946|Methotrexate|methotrexate|mesh-list
44452117|NCT01700946|Etoposide|etoposide|mesh-list
44452118|NCT01700946|Vincristine|vincristine|mesh-list
44452119|NCT01700946|Interleukin-2|interleukin-2|mesh-list
44452120|NCT01700946|Asparaginase|asparaginase|mesh-list
44452121|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
44452122|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
44452123|NCT01700946|Clofarabine|clofarabine|mesh-list
44452124|NCT01700946|Vinblastine|vinblastine|mesh-list
44452125|NCT01700946|Pegaspargase|pegaspargase|mesh-list
44452126|NCT01700946|Teniposide|teniposide|mesh-list
44452127|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452128|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
44452129|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452130|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452131|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452132|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
44452133|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452134|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452135|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44452136|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44452137|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452138|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
44452139|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
44452140|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452141|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452142|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
44452143|NCT01700946|Hormones|hormones|mesh-ancestor
44452144|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44452145|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452146|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44452147|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
43790928|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44452148|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44452158|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
44452159|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452160|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
44452161|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
44452162|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
44452163|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452164|NCT01700946|Analgesics|analgesics|mesh-ancestor
44452165|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
44452166|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44452167|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452169|NCT01700829|Ketamine|ketamine|mesh-list
44452170|NCT01700829|Analgesics|analgesics|mesh-ancestor
44452171|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
44452172|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452173|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452174|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44452175|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44452176|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
44452177|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
44452178|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452179|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44452180|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44452181|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452182|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452183|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44452184|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44452185|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44452186|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44452187|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44452188|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
44452189|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
44452190|NCT01700621|Vaccines|vaccines|mesh-list
44452191|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
44452192|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452193|NCT01700530|Simvastatin|simvastatin|mesh-list
44452194|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
44452195|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44452198|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452199|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44452200|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452201|NCT01700387|Topiramate|topiramate|mesh-list
44452202|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
44452203|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44452204|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44452205|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44452206|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44452207|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452208|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452209|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452210|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452211|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44452212|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452213|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
44452214|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452215|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
44452216|NCT01700192|Loratadine|loratadine|mesh-list
44452217|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44452218|NCT01700192|Epinephrine|epinephrine|mesh-list
44452219|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44452220|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44452221|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44452222|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
44452223|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452224|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452225|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452226|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44452227|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452228|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
44452229|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452230|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452239|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44452240|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44452241|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
44452242|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
44452243|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44452244|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452245|NCT01700192|Analgesics|analgesics|mesh-ancestor
44452246|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
44452247|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452248|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44452249|NCT01700179|Ribavirin|ribavirin|mesh-list
44452250|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
44452251|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452252|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
44452253|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452254|NCT01699815|Acetaminophen|acetaminophen|mesh-list
44452255|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44452256|NCT01699815|Analgesics|analgesics|mesh-ancestor
44452257|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
44452258|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452259|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452260|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
44452261|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
44452262|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44452263|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44452264|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452265|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452269|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
44452286|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44452287|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452288|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44452289|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44452290|NCT01698918|Dexamethasone|dexamethasone|mesh-list
44452291|NCT01698918|Everolimus|everolimus|mesh-list
44452292|NCT01698918|Letrozole|letrozole|mesh-list
44452293|NCT01698918|Exemestane|exemestane|mesh-list
44452294|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452295|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
44452296|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
44452297|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452298|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452299|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452300|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
44452301|NCT01698918|Hormones|hormones|mesh-ancestor
44452347|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
44452348|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44452349|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44452350|NCT01698801|Growth Substances|growth substances|mesh-ancestor
44452351|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
44452352|NCT01698775|Glipizide|glipizide|mesh-list
44452353|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44452354|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452355|NCT01698554|Bimatoprost|bimatoprost|mesh-list
44452356|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44452357|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44452358|NCT01698320|Albuterol|albuterol|mesh-list
44452359|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452360|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
44452363|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452404|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452406|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
44452407|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44452408|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44452409|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452410|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452411|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452412|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452413|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452414|NCT01697579|Ondansetron|ondansetron|mesh-list
44452415|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
44452416|NCT01697579|Aprepitant|aprepitant|mesh-list
44452417|NCT01697579|Serotonin|serotonin|mesh-list
44452418|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
44452419|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
44452420|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452421|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452422|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452460|NCT01696942|Analgesics|analgesics|mesh-ancestor
44452461|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
44452462|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452463|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452464|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
44452465|NCT01696877|Molgramostim|molgramostim|mesh-list
44452466|NCT01696877|Sargramostim|sargramostim|mesh-list
44452467|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452528|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
44452529|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452530|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452531|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452532|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452533|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
44452534|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452535|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452536|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452537|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452538|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
44452539|NCT01696058|Olodaterol|olodaterol|mesh-list
44452540|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452541|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
44452542|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452588|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452590|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44452661|NCT01694433|Calcitriol|calcitriol|mesh-list
44452662|NCT01694433|Calcipotriene|calcipotriene|mesh-list
44452663|NCT01694433|Vitamins|vitamins|mesh-ancestor
44452664|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
44452665|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452666|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44452667|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452668|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44452669|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44452670|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44452671|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452672|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44452673|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44452674|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44452675|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452676|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
44452718|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452719|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452720|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452721|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452722|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452723|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452724|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
44452725|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44452726|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452727|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452728|NCT01692301|Amlodipine|amlodipine|mesh-list
44452729|NCT01692301|Valsartan|valsartan|mesh-list
44452777|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452778|NCT01691885|Fluticasone|fluticasone|mesh-list
44452780|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452781|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452782|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
44452783|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452784|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452785|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452786|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452787|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452788|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44452789|NCT01691794|Ritonavir|ritonavir|mesh-list
44452790|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44452791|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44452792|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44452793|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452794|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452795|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452796|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44452797|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44452798|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
44452799|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452800|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44452801|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44452802|NCT01691781|Lisinopril|lisinopril|mesh-list
44452804|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452827|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44452828|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452830|NCT01691482|Ipratropium|ipratropium|mesh-list
44452831|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44452832|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
44452833|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452834|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452835|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44452836|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
44452837|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
44452838|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44452839|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44452840|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44452841|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44452842|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
44452843|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452844|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452845|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44452846|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
44452847|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
44452848|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44452849|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452850|NCT01691092|Ketamine|ketamine|mesh-list
44452851|NCT01691092|Analgesics|analgesics|mesh-ancestor
44452852|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
44452853|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44452854|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452855|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44452872|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
44452873|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44452874|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44452875|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44452876|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44452877|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452878|NCT01690520|Cyclosporine|cyclosporine|mesh-list
44452879|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
44452880|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
44452881|NCT01690520|Thiotepa|thiotepa|mesh-list
44452882|NCT01690520|Fludarabine|fludarabine|mesh-list
44452883|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
44452884|NCT01690520|Cyclosporins|cyclosporins|mesh-list
44452885|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452886|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
44452887|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452888|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452889|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452890|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
44452891|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452892|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452893|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44452894|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44452895|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
44452896|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452897|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
44452898|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452899|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
44452900|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44452901|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44452902|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44452903|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
44452904|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44452905|NCT01690299|Etanercept|etanercept|mesh-list
44452906|NCT01690299|Apremilast|apremilast|mesh-list
44452913|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44452914|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44452915|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44452916|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452917|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
44452918|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44452919|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44452920|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452921|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452922|NCT01690143|Melphalan|melphalan|mesh-list
44452923|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44452924|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
44452925|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452926|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452927|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44452928|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44452929|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
44452930|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452931|NCT01690052|Pilocarpine|pilocarpine|mesh-list
44452932|NCT01690052|Cevimeline|cevimeline|mesh-list
44452933|NCT01690052|Miotics|miotics|mesh-ancestor
44452934|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
44452963|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806652|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
44452964|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452965|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452967|NCT01689207|Avibactam|avibactam|mesh-list
44452968|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44452969|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44452970|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44452971|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452972|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452973|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44452974|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44452975|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44452976|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452977|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452978|NCT01688921|Vaccines|vaccines|mesh-list
44452979|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
44452980|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44452981|NCT01688830|Dabigatran|dabigatran|mesh-list
44452982|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
44452983|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44452984|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
44452985|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44452986|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44452987|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
44452988|NCT01688739|Erenumab|erenumab|mesh-list
44452989|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
44452991|NCT01688739|Analgesics|analgesics|mesh-ancestor
44453008|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
44453009|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44453010|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44453011|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453012|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44111410|NCT00088049|Aripiprazole|aripiprazole|mesh-list
44453013|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453014|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453015|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453016|NCT01687998|Evacetrapib|evacetrapib|mesh-list
44453017|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44453018|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44453019|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
44453020|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453021|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44453022|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
44453024|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453025|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453026|NCT01687673|Sirolimus|sirolimus|mesh-list
44453027|NCT01687673|Sorafenib|sorafenib|mesh-list
44453028|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453029|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453030|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453031|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453032|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44453033|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453034|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44453035|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
43654769|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43654770|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
43654772|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654773|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654774|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654775|NCT02973724|Remifentanil|remifentanil|mesh-list
43654776|NCT02973724|Propofol|propofol|mesh-list
43654777|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
44453036|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453037|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
44453038|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453039|NCT01687478|Olanzapine|olanzapine|mesh-list
44453040|NCT01687478|Fluoxetine|fluoxetine|mesh-list
44453041|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
44453042|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
44164241|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164243|NCT00255554|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44453043|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453044|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453045|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453046|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44453047|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453048|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453049|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453050|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44453051|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44453052|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453053|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453054|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453055|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
44453056|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44453057|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
44453058|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44453099|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453100|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453101|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44453102|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
44453103|NCT01687283|Hormones|hormones|mesh-ancestor
44453104|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453105|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
44453106|NCT01687270|Ribavirin|ribavirin|mesh-list
44453107|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
44453108|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453109|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
44453110|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453111|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
44453112|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
44453113|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453114|NCT01687218|Tenofovir|tenofovir|mesh-list
44453115|NCT01687218|Emtricitabine|emtricitabine|mesh-list
44453116|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44453117|NCT01687218|Glycerol|glycerol|mesh-list
44453118|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
44453119|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453120|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44453121|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44453122|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453123|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453124|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44453125|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44453126|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44453127|NCT01687218|Protective Agents|protective agents|mesh-ancestor
43806852|NCT04906161|Vitamin D|vitamin d|mesh-list
44453128|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453129|NCT01687166|Acifluorfen|acifluorfen|mesh-list
44453130|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453131|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453132|NCT01687101|Menthol|menthol|mesh-list
44453133|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
44453134|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453138|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453139|NCT01686932|Incretins|incretins|mesh-ancestor
44453140|NCT01686932|Hormones|hormones|mesh-ancestor
44453141|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453142|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44453143|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
44453144|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453145|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453146|NCT01686828|Letrozole|letrozole|mesh-list
44453147|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
44453148|NCT01686828|Acyline|acyline|mesh-list
44453149|NCT01686828|Testosterone|testosterone|mesh-list
44453150|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
44453151|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
44453152|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44453154|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44453197|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
44453198|NCT01685983|Hormones|hormones|mesh-ancestor
44453199|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453200|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453201|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453202|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453203|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453204|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453205|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453206|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453207|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453208|NCT01685801|Ivacaftor|ivacaftor|mesh-list
44453209|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
44453210|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453211|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453212|NCT01685372|Vaccines|vaccines|mesh-list
44453213|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
44453214|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453215|NCT01685203|Ribavirin|ribavirin|mesh-list
44453216|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
44453217|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453218|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
44453219|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453220|NCT01685138|Ceritinib|ceritinib|mesh-list
44453221|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453222|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453223|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453224|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453225|NCT01685073|Zolpidem|zolpidem|mesh-list
44453226|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44453227|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44453228|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453229|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453231|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
44453234|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453235|NCT01685060|Ceritinib|ceritinib|mesh-list
44111631|NCT00088959|Analgesics|analgesics|mesh-ancestor
44453236|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453237|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453238|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453239|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453240|NCT01684943|Insulin|insulin|mesh-list
43791297|NCT04818320|Favipiravir|favipiravir|mesh-list
44453241|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453242|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453243|NCT01684878|Gemcitabine|gemcitabine|mesh-list
44453244|NCT01684878|Paclitaxel|paclitaxel|mesh-list
44453245|NCT01684878|Topotecan|topotecan|mesh-list
44453246|NCT01684878|Pertuzumab|pertuzumab|mesh-list
44453247|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44453248|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453293|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44453294|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453295|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
44453296|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453297|NCT01683994|Prednisone|prednisone|mesh-list
44453298|NCT01683994|Docetaxel|docetaxel|mesh-list
44453299|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453300|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
44453301|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
44453302|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
44453303|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453304|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453305|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
44453306|NCT01683994|Hormones|hormones|mesh-ancestor
44453307|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453308|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44111690|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44453309|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453310|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
44453311|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44453312|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453313|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453314|NCT01683266|Insulin|insulin|mesh-list
44453315|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44453316|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
44453317|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453318|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453319|NCT01683071|Bupivacaine|bupivacaine|mesh-list
44453320|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
44453321|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
44453334|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
44453335|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453336|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453337|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44453338|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44453339|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
43806897|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43806898|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
43806899|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806900|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654779|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654780|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654781|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44453340|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44453341|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44453342|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44453343|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44453344|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
44453345|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44453346|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44453347|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44453348|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
44453349|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453350|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453351|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453352|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
44453353|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
44453354|NCT01682837|Citric Acid|citric acid|mesh-list
44453355|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
44453356|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
44453357|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44453386|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
44453387|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44453388|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44453389|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44453390|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453391|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453392|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
44453393|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453394|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453395|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44453396|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453397|NCT01682512|Rituximab|rituximab|mesh-list
44453398|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453399|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453400|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
44453401|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453402|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44453403|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44453404|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
44453405|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44453406|NCT01682213|Dabrafenib|dabrafenib|mesh-list
44453407|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453408|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453409|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453410|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453411|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
44453412|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44453413|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44453414|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44453415|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453416|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453417|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
44453426|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453427|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44453428|NCT01682031|Selenium|selenium|mesh-list
44453429|NCT01682031|Cisplatin|cisplatin|mesh-list
44453430|NCT01682031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453431|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
44453432|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453433|NCT01682031|Protective Agents|protective agents|mesh-ancestor
44453434|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453435|NCT01682031|Trace Elements|trace elements|mesh-ancestor
44453436|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
44453437|NCT01681992|Vaccines|vaccines|mesh-list
44453438|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
44453439|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453440|NCT01681849|Paroxetine|paroxetine|mesh-list
44453441|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44453442|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44453484|NCT01681212|Dacarbazine|dacarbazine|mesh-list
44453485|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453486|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453487|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44453488|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453489|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44453490|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
44453491|NCT01681186|Lansoprazole|lansoprazole|mesh-list
44453492|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
44453493|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44453494|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453495|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44453496|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453497|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453498|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
44453499|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453500|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453501|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
44453502|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
44453503|NCT01680861|Everolimus|everolimus|mesh-list
44453504|NCT01680861|Tacrolimus|tacrolimus|mesh-list
44453505|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453506|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
44453507|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453508|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44453509|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453510|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453511|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453512|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44453513|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44453514|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
44453515|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44453516|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453517|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453518|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
44453519|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
44453522|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
44453523|NCT01680861|Hormones|hormones|mesh-ancestor
44453524|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453525|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44453526|NCT01680861|Protective Agents|protective agents|mesh-ancestor
44453527|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
44453528|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44453530|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453531|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
44453532|NCT01680497|Protective Agents|protective agents|mesh-ancestor
44453533|NCT01680458|Fluconazole|fluconazole|mesh-list
44453534|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
44453535|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453536|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44453537|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44453538|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453539|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453540|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44453541|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453542|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453543|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453544|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44453545|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44453546|NCT01680341|Insulin|insulin|mesh-list
44453547|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44453548|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
44453549|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
44453550|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44453551|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453553|NCT01679613|Ketoconazole|ketoconazole|mesh-list
44453564|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453565|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44453566|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453567|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453568|NCT01679405|Gemcitabine|gemcitabine|mesh-list
44453569|NCT01679405|Cisplatin|cisplatin|mesh-list
44453570|NCT01679405|Afatinib|afatinib|mesh-list
44453571|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453572|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44453573|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
44453574|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453575|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
44453576|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453577|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453578|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453579|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
44453580|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453581|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453582|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
44453583|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
44453584|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
44453585|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44453586|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44453587|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453588|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453589|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44453590|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44453591|NCT01678911|Gabapentin|gabapentin|mesh-list
44453592|NCT01678911|Analgesics|analgesics|mesh-ancestor
44453608|NCT01678820|Glimepiride|glimepiride|mesh-list
44453609|NCT01678820|Simvastatin|simvastatin|mesh-list
44453610|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453611|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453612|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44453613|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44453614|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
44453615|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453616|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44453617|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44453618|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453619|NCT01678820|Incretins|incretins|mesh-ancestor
44453620|NCT01678820|Hormones|hormones|mesh-ancestor
44453621|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453622|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44453623|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
44453624|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44453625|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44453626|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
44453627|NCT01678313|Celecoxib|celecoxib|mesh-list
44453628|NCT01678313|Doxazosin|doxazosin|mesh-list
44453629|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44453630|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44453631|NCT01678313|Analgesics|analgesics|mesh-ancestor
44453632|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
43806942|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44453655|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
44453656|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453657|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44453658|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
44453660|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44453661|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
44453662|NCT01678131|Liver Extracts|liver extracts|mesh-list
44453663|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
44453664|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453665|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
44453666|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453667|NCT01678131|Hematinics|hematinics|mesh-ancestor
44453668|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453669|NCT01677988|Folfirinox|folfirinox|mesh-list
44453670|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453671|NCT01677858|Dexamethasone|dexamethasone|mesh-list
44453672|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44453673|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
44453674|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
44112010|NCT00090155|Aprepitant|aprepitant|mesh-list
44453675|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453676|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453677|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453678|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
44453707|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453708|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453709|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453710|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44453711|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
44453712|NCT01677299|Metformin|metformin|mesh-list
44453713|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453714|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453715|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
44453716|NCT01677195|Antacids|antacids|mesh-ancestor
44453717|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807066|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807067|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807068|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
43807069|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807070|NCT04902222|Morphine|morphine|mesh-list
43807071|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43807072|NCT04902222|Narcotics|narcotics|mesh-ancestor
43807073|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791585|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
43791586|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
43791587|NCT05121571|Sorafenib|sorafenib|mesh-list
43791588|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791589|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44453718|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453719|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44453720|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
44453721|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453722|NCT01676220|Insulin|insulin|mesh-list
44453723|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44453724|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
44453725|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453726|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453727|NCT01676116|Liraglutide|liraglutide|mesh-list
44453728|NCT01676116|Exenatide|exenatide|mesh-list
44453729|NCT01676116|Xultophy|xultophy|mesh-list
44453730|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44453731|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453732|NCT01676116|Incretins|incretins|mesh-ancestor
44453733|NCT01676116|Hormones|hormones|mesh-ancestor
44453734|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453735|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44453736|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
44453737|NCT01675765|Cisplatin|cisplatin|mesh-list
44453738|NCT01675765|Pemetrexed|pemetrexed|mesh-list
44453739|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
44453752|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44453753|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
44453754|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453755|NCT01675661|Expectorants|expectorants|mesh-ancestor
44453756|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453757|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44453758|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
44453759|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453760|NCT01675661|Protective Agents|protective agents|mesh-ancestor
44453761|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453762|NCT01675661|Antidotes|antidotes|mesh-ancestor
44453763|NCT01675622|Morphine|morphine|mesh-list
44453764|NCT01675622|Oxycodone|oxycodone|mesh-list
44453765|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44453766|NCT01675622|Narcotics|narcotics|mesh-ancestor
44453767|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453768|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453769|NCT01675622|Analgesics|analgesics|mesh-ancestor
43807074|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807075|NCT04902222|Analgesics|analgesics|mesh-ancestor
43807076|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
43807077|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807078|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
43807079|NCT04902027|Analgesics|analgesics|mesh-ancestor
43807080|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
43807081|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807082|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807083|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807084|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44453770|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
44453771|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453772|NCT01675531|Oxycodone|oxycodone|mesh-list
44453773|NCT01675531|Naloxone|naloxone|mesh-list
43807085|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44453774|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44453775|NCT01675531|Narcotics|narcotics|mesh-ancestor
44453776|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453777|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453778|NCT01675531|Analgesics|analgesics|mesh-ancestor
44453779|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
44453780|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453801|NCT01675141|Growth Substances|growth substances|mesh-ancestor
44453802|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
44453803|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453804|NCT01675128|Irinotecan|irinotecan|mesh-list
44453805|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44453806|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44453807|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453808|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453809|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453810|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
44453811|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
44453812|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453813|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44453814|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44453815|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
44453816|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
44453817|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453818|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453819|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453820|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44453821|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
44453822|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44453823|NCT01674725|Ribavirin|ribavirin|mesh-list
44453824|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
44453825|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453826|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
44453827|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44453828|NCT01674712|Simvastatin|simvastatin|mesh-list
44453829|NCT01674712|Fenofibrate|fenofibrate|mesh-list
44453830|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44453831|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44453832|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
44453833|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453834|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44453835|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44453836|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453840|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
44453841|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453842|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44453843|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
44453844|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44453845|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
44453846|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453847|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453848|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
44453849|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44453850|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43807095|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807096|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807097|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
43807098|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43807099|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807100|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43807101|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43807102|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44453851|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
44453852|NCT01674647|Coagulants|coagulants|mesh-ancestor
44453853|NCT01674621|Abaloparatide|abaloparatide|mesh-list
44453854|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
44453855|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44453856|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453857|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44453858|NCT01674569|Ranibizumab|ranibizumab|mesh-list
44453859|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44453860|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44453861|NCT01674569|Growth Substances|growth substances|mesh-ancestor
44453862|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453863|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
44453864|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453865|NCT01674062|Trastuzumab|trastuzumab|mesh-list
44453866|NCT01674062|Pertuzumab|pertuzumab|mesh-list
44453867|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453868|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453869|NCT01674010|Inositol|inositol|mesh-list
44453870|NCT01674010|Lamotrigine|lamotrigine|mesh-list
44453871|NCT01674010|Valproic Acid|valproic acid|mesh-list
44453872|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
44453873|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44453874|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44453875|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453878|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44453879|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453880|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44453881|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453882|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44453883|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453884|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
44453885|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453886|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
44453887|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
44453888|NCT01674010|Vitamins|vitamins|mesh-ancestor
44453889|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
44453890|NCT01673984|Goserelin|goserelin|mesh-list
44453891|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44453892|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44453893|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453894|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
44453895|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44453896|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
44453897|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44453898|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453899|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44453900|NCT01673854|Ipilimumab|ipilimumab|mesh-list
44453901|NCT01673854|Vemurafenib|vemurafenib|mesh-list
44112240|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
44453902|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44453903|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453904|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44175768|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
44175769|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
44175770|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44175786|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44175787|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
44175788|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175789|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44175790|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44175791|NCT00301106|Growth Substances|growth substances|mesh-ancestor
44175792|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
44175793|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175794|NCT00301145|Varenicline|varenicline|mesh-list
44175795|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44175796|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43600127|NCT03282513|Ivosidenib|ivosidenib|mesh-list
44175797|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
44175798|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175799|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175800|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175801|NCT00301171|Fluticasone|fluticasone|mesh-list
44175802|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44175803|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44175804|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
44175805|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175806|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175807|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44175808|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
44175809|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
44175810|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44175811|NCT00301210|Tramadol|tramadol|mesh-list
44175812|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44175813|NCT00301210|Narcotics|narcotics|mesh-ancestor
44175814|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175816|NCT00301210|Analgesics|analgesics|mesh-ancestor
44175829|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44175830|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44175831|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175832|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44175833|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
44175834|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44175835|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175836|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44175837|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175838|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175839|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175840|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
44175841|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175842|NCT00301301|Gemcitabine|gemcitabine|mesh-list
44175845|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44175846|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175847|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
44175848|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175849|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175850|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44175851|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
44175852|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175853|NCT00301301|Antiviral Agents|antiviral agents|mesh-ancestor
44175854|NCT00301301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175877|NCT00301457|Anastrozole|anastrozole|mesh-list
44175878|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44175879|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175880|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44175881|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44175882|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175883|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175884|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44175885|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
44175886|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175887|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175888|NCT00301483|Chrysarobin|chrysarobin|mesh-list
44175889|NCT00301483|HBOC 201|hboc 201|mesh-list
44175890|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44175891|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44175892|NCT00301483|Analgesics|analgesics|mesh-ancestor
44175893|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
44175894|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175895|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175896|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843461|NCT04452747|Dinoprostone|dinoprostone|mesh-list
44175897|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175898|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
44175899|NCT00301509|Ribavirin|ribavirin|mesh-list
44175900|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
44175901|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175902|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
44175903|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175904|NCT00301522|Paclitaxel|paclitaxel|mesh-list
44175905|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44175906|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175920|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44175921|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
44175922|NCT00301574|Galantamine|galantamine|mesh-list
44175923|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44175924|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175925|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175926|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
44175927|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175928|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175929|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44175930|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
44175931|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44175932|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
44175933|NCT00301587|Folic Acid|folic acid|mesh-list
44175934|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
44175935|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44175936|NCT00301587|Norgestimate|norgestimate|mesh-list
44175937|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44175938|NCT00301587|Estradiol|estradiol|mesh-list
44175939|NCT00301587|Estrogens|estrogens|mesh-ancestor
44175940|NCT00301587|Hormones|hormones|mesh-ancestor
44175941|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44175942|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175943|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44175944|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
44175945|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44175946|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44175947|NCT00301587|Hematinics|hematinics|mesh-ancestor
44175948|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
44175949|NCT00301587|Vitamins|vitamins|mesh-ancestor
44175950|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
44175951|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44175963|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175964|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175965|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175966|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175967|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175968|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44175969|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175970|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175971|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
44175972|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175973|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175974|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175975|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175976|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175977|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807180|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
43807181|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
44175978|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807182|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
44175979|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175980|NCT00301639|Methylphenidate|methylphenidate|mesh-list
44175981|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44175982|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44175983|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44175984|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44175985|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44175986|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44175987|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
44175988|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44175989|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
44175990|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44175991|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44175992|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44175993|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
44175994|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44175995|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176000|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44176001|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44176002|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176003|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176004|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
44176005|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176006|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176007|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44176008|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176009|NCT00301730|Aldesleukin|aldesleukin|mesh-list
44176010|NCT00301730|Paclitaxel|paclitaxel|mesh-list
44176011|NCT00301730|Trastuzumab|trastuzumab|mesh-list
44176012|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44176013|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176014|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
44176015|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
44176016|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
44176017|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176018|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176019|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176020|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176021|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
44176022|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176023|NCT00301782|Cisplatin|cisplatin|mesh-list
44176024|NCT00301782|Carboplatin|carboplatin|mesh-list
44176025|NCT00301782|Etoposide|etoposide|mesh-list
44176026|NCT00301782|Vincristine|vincristine|mesh-list
44176027|NCT00301782|Bleomycin|bleomycin|mesh-list
44176028|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
44176029|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176030|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44176031|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44176032|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176033|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176042|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176043|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
44176044|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176045|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176046|NCT00301847|Sorafenib|sorafenib|mesh-list
44176047|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176048|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44176049|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176050|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176051|NCT00301860|Cyclosporine|cyclosporine|mesh-list
44176052|NCT00301860|Methotrexate|methotrexate|mesh-list
44176053|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
44176054|NCT00301860|Fludarabine|fludarabine|mesh-list
44176055|NCT00301860|Melphalan|melphalan|mesh-list
44176056|NCT00301860|Cyclosporins|cyclosporins|mesh-list
44176057|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43791733|NCT04576663|Phenylephrine|phenylephrine|mesh-list
44176058|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44176059|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
44176060|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44176061|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176062|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176063|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
44176064|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176065|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176066|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176067|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176068|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176069|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176070|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
44176071|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176072|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176073|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
44176074|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176075|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176076|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176077|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
44176078|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176080|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
44176081|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44176082|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176084|NCT00301899|Pertuzumab|pertuzumab|mesh-list
44176085|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176086|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176087|NCT00301912|Methotrexate|methotrexate|mesh-list
44176088|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
44176089|NCT00301912|Fludarabine|fludarabine|mesh-list
44176090|NCT00301912|Busulfan|busulfan|mesh-list
44176091|NCT00301912|Tacrolimus|tacrolimus|mesh-list
44176092|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44176093|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
44176094|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44176095|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176096|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176097|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
44176098|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176099|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176100|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176101|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176102|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176103|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176104|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
44176105|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176106|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176107|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176108|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
44176109|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176110|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176111|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
44176112|NCT00301925|Fluorouracil|fluorouracil|mesh-list
44176113|NCT00301925|Capecitabine|capecitabine|mesh-list
44176114|NCT00301925|Methotrexate|methotrexate|mesh-list
44176115|NCT00301925|Epirubicin|epirubicin|mesh-list
44176116|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176117|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
44176120|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176121|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
44176122|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176123|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176124|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176125|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
44176126|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176127|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44176128|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
44176129|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44176130|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176131|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176132|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176133|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176134|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44176135|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44176136|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176137|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
44176138|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176139|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44176140|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176141|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176142|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
44176143|NCT00301951|Fludarabine|fludarabine|mesh-list
44176144|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
44176145|NCT00301951|Busulfan|busulfan|mesh-list
44176146|NCT00301951|Tacrolimus|tacrolimus|mesh-list
44176147|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44176148|NCT00301951|Sargramostim|sargramostim|mesh-list
44176149|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176150|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176151|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
44176152|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176153|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176154|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
44164244|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44164245|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164246|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176155|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176156|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176157|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176158|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44176159|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44176160|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
44176161|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44176162|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176163|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
44176164|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176165|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176166|NCT00301990|Aldesleukin|aldesleukin|mesh-list
44176167|NCT00301990|Bevacizumab|bevacizumab|mesh-list
44176168|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176169|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176170|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44176171|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44176172|NCT00301990|Growth Substances|growth substances|mesh-ancestor
44176173|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176174|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
44176175|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176176|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176177|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
44176178|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176179|NCT00302224|Ketoconazole|ketoconazole|mesh-list
44176180|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
44176202|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44176203|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
44176204|NCT00302341|Pafuramidine|pafuramidine|mesh-list
44176205|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176206|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176207|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44176208|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176209|NCT00302341|Renal Agents|renal agents|mesh-ancestor
44176210|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
44176211|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44176212|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44176213|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176214|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44176215|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44176216|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44176217|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791855|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176219|NCT00302354|Methylphenidate|methylphenidate|mesh-list
44176220|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176221|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176222|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44176223|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176224|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176225|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176226|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
44176227|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176228|NCT00302367|Methylphenidate|methylphenidate|mesh-list
44176229|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176230|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176231|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44176232|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176235|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
44176241|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176242|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176243|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176244|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
44176245|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176246|NCT00302406|Methylphenidate|methylphenidate|mesh-list
44176247|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176248|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176249|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44176250|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176251|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176252|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176253|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
44176254|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176255|NCT00302419|Streptokinase|streptokinase|mesh-list
44176256|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44176257|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44176258|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176259|NCT00302432|Menthol|menthol|mesh-list
44176260|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
44176261|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176262|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
44176263|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44176264|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176265|NCT00302497|Basiliximab|basiliximab|mesh-list
44176266|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176267|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
44176268|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176269|NCT00302523|Tacrolimus|tacrolimus|mesh-list
44176270|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176271|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
44176272|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176274|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176280|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176281|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176282|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176283|NCT00302549|Tacrolimus|tacrolimus|mesh-list
44176284|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176285|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
44176286|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176287|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176288|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176289|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176290|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
44176291|NCT00302627|Vitamin D|vitamin d|mesh-list
44176292|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
44176293|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
44176294|NCT00302627|Pamidronate|pamidronate|mesh-list
44176295|NCT00302627|Vitamins|vitamins|mesh-list
44176296|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
44176297|NCT00302627|Calcium|calcium|mesh-list
44176298|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
44176299|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176300|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44176301|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44176302|NCT00302627|Antacids|antacids|mesh-ancestor
44176303|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176304|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44176305|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
44176306|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44176330|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44176331|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44176332|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
44176333|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
44176334|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176335|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176336|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44176337|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44176338|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44176339|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
44176340|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176341|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176342|NCT00302705|Valsartan|valsartan|mesh-list
44176343|NCT00302705|Enalapril|enalapril|mesh-list
44176344|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44176345|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44176346|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44176347|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176348|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44176349|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
44176350|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176351|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44176352|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
44176353|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44176354|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44176355|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44176372|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44176373|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44176374|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44176375|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44176376|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44176377|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44176378|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44176379|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
44176380|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44176381|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44176382|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44176383|NCT00302835|Analgesics|analgesics|mesh-list
44176384|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
44176385|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807282|NCT04900129|Expectorants|expectorants|mesh-ancestor
44176386|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176387|NCT00302913|Clopidogrel|clopidogrel|mesh-list
44176388|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44176389|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44176390|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44176391|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44176392|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
44176393|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176394|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176395|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176396|NCT00303004|Bosentan|bosentan|mesh-list
44176397|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
44176398|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
44176399|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44176400|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44176401|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176402|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176403|NCT00303004|Urological Agents|urological agents|mesh-ancestor
44176406|NCT00303017|Naproxen|naproxen|mesh-list
44176408|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44176409|NCT00303017|Analgesics|analgesics|mesh-ancestor
44176410|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
44176411|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176412|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176413|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44176414|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176415|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
44176416|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44176417|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176418|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176419|NCT00303056|Icatibant|icatibant|mesh-list
44176420|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44176421|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44176422|NCT00303056|Analgesics|analgesics|mesh-ancestor
44176423|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
44176424|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176425|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176426|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44176427|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176428|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
44176429|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
44112874|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
43807292|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43807293|NCT04899570|Prednisone|prednisone|mesh-list
43807294|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
43807295|NCT04899570|Rituximab|rituximab|mesh-list
43654793|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654794|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654795|NCT02973646|Tenofovir|tenofovir|mesh-list
43654796|NCT02973646|Entecavir|entecavir|mesh-list
43654797|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43654798|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
43654799|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792040|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
43792041|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
43792042|NCT01503489|Serotonin|serotonin|mesh-list
43792043|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43792044|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44176430|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176431|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44176432|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176433|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
44176434|NCT00303160|Ascorbic Acid|ascorbic acid|mesh-list
44176435|NCT00303160|Vitamins|vitamins|mesh-ancestor
44176436|NCT00303160|Micronutrients|micronutrients|mesh-ancestor
44176437|NCT00303160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176450|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44176451|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
44176452|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176453|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44176454|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44176455|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176456|NCT00303290|Interferons|interferons|mesh-list
44176457|NCT00303290|Cytarabine|cytarabine|mesh-list
44176458|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
44176459|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
44176460|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44176461|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176462|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
44176463|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176464|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176465|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
44176466|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176467|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176468|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
44176469|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176470|NCT00303381|Interferons|interferons|mesh-list
44176471|NCT00303381|Interferon-beta|interferon-beta|mesh-list
44176472|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
44176473|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176474|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
44176475|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176476|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
44176477|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176478|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44176479|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44176480|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176481|NCT00303407|Nadroparin|nadroparin|mesh-list
44176482|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
44176483|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44176489|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176490|NCT00303433|Memantine|memantine|mesh-list
44176491|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43654800|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43654801|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654802|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654803|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654804|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43654805|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43654806|NCT02973659|Oxybutynin|oxybutynin|mesh-list
43654807|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
43807296|NCT04899570|Epirubicin|epirubicin|mesh-list
43792069|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43792070|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43792071|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792076|NCT05137964|Vitamin D|vitamin d|mesh-list
44176492|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44176493|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
44176494|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176495|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176496|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176497|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44176498|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44176499|NCT00303524|Goserelin|goserelin|mesh-list
44176500|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44176501|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176502|NCT00303537|Metformin|metformin|mesh-list
44176503|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44176504|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176505|NCT00303550|Linezolid|linezolid|mesh-list
44176506|NCT00303550|Iclaprim|iclaprim|mesh-list
44176507|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44176508|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176509|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44176510|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176511|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176540|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
44176541|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176542|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44176543|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176544|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176545|NCT00303745|Capecitabine|capecitabine|mesh-list
44176546|NCT00303745|Irinotecan|irinotecan|mesh-list
44176547|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176548|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
44176549|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176550|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176551|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44176552|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176553|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176554|NCT00303758|Leucovorin|leucovorin|mesh-list
44176555|NCT00303758|Gemcitabine|gemcitabine|mesh-list
44176556|NCT00303758|Cisplatin|cisplatin|mesh-list
44176557|NCT00303758|Fluorouracil|fluorouracil|mesh-list
44176558|NCT00303758|Calcium|calcium|mesh-list
44176559|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
44176560|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176561|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176562|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
44176563|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176564|NCT00303758|Antiviral Agents|antiviral agents|mesh-ancestor
44176565|NCT00303758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176566|NCT00303758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176567|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176568|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
44176569|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176571|NCT00303758|Antidotes|antidotes|mesh-ancestor
44176584|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176586|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176587|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176588|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
44176589|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44176590|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176591|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176593|NCT00303771|Protective Agents|protective agents|mesh-ancestor
44176594|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
44176595|NCT00303771|Vitamins|vitamins|mesh-ancestor
44176596|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
44176597|NCT00303784|Goserelin|goserelin|mesh-list
44176598|NCT00303784|Estradiol|estradiol|mesh-list
44176599|NCT00303784|Estrogens|estrogens|mesh-ancestor
44176600|NCT00303784|Hormones|hormones|mesh-ancestor
44176601|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176602|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176603|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44176604|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176605|NCT00303797|Bortezomib|bortezomib|mesh-list
44176606|NCT00303797|Sorafenib|sorafenib|mesh-list
44176607|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176608|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44176609|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176610|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176611|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
44176612|NCT00303810|Thiotepa|thiotepa|mesh-list
44176613|NCT00303810|Lomustine|lomustine|mesh-list
44176614|NCT00303810|Cisplatin|cisplatin|mesh-list
44176615|NCT00303810|Carboplatin|carboplatin|mesh-list
44176616|NCT00303810|Methotrexate|methotrexate|mesh-list
44176617|NCT00303810|Etoposide|etoposide|mesh-list
44176618|NCT00303810|Vincristine|vincristine|mesh-list
44176629|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44176631|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44176632|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176633|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
44176634|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176635|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176636|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44176637|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44176638|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44176639|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44176640|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176641|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44176642|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44176643|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44176644|NCT00303836|Aldesleukin|aldesleukin|mesh-list
44176645|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
44176646|NCT00303836|Fludarabine|fludarabine|mesh-list
44176647|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
44176648|NCT00303836|Interleukin-2|interleukin-2|mesh-list
44176649|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
44176650|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176651|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
44176652|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176653|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176654|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176655|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
44176656|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176657|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176658|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44176659|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176660|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
44176661|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44176662|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44176663|NCT00303836|Analgesics|analgesics|mesh-ancestor
44176664|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
44176665|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164247|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164248|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
44176666|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176667|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176668|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
44176669|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176671|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176672|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
44176673|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
44176674|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
44176675|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176676|NCT00303927|Capecitabine|capecitabine|mesh-list
44176677|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176678|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
44176679|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176680|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176681|NCT00303940|Carboplatin|carboplatin|mesh-list
44176682|NCT00303940|Temozolomide|temozolomide|mesh-list
44176683|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176724|NCT00304135|Cisplatin|cisplatin|mesh-list
44176725|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
44176726|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176727|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44176728|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
44176729|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176730|NCT00304135|Antiviral Agents|antiviral agents|mesh-ancestor
44176731|NCT00304135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176732|NCT00304135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176733|NCT00304135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807368|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176734|NCT00304135|Immunologic Factors|immunologic factors|mesh-ancestor
44176735|NCT00304135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176736|NCT00304200|Temozolomide|temozolomide|mesh-list
44176737|NCT00304200|Sunitinib|sunitinib|mesh-list
44176738|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44176739|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
44176740|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176741|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176742|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44176743|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44176744|NCT00304200|Growth Substances|growth substances|mesh-ancestor
44176745|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176746|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
44176747|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44176748|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176749|NCT00304213|Testosterone|testosterone|mesh-list
44176750|NCT00304213|Androgens|androgens|mesh-ancestor
44176752|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176753|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176754|NCT00304226|Amlodipine|amlodipine|mesh-list
44176755|NCT00304226|Valsartan|valsartan|mesh-list
44176756|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44176757|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44176758|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176764|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44176765|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44176766|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44176767|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44176768|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
44176769|NCT00304252|Interferons|interferons|mesh-list
44176770|NCT00304252|Interferon-beta|interferon-beta|mesh-list
44176771|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
44176772|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176773|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
44176774|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176775|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
44176776|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176777|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44176778|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
44176779|NCT00304291|Analgesics|analgesics|mesh-ancestor
44176780|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
44176781|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176782|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176783|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176784|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44176785|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44176786|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176787|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176788|NCT00304317|Celecoxib|celecoxib|mesh-list
44176789|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43807369|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43807370|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807371|NCT04899414|Dexamethasone|dexamethasone|mesh-list
43807372|NCT04899414|Azacitidine|azacitidine|mesh-list
43807373|NCT04899414|Pegaspargase|pegaspargase|mesh-list
43807374|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807375|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
43807376|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
43807377|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176790|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44176791|NCT00304317|Analgesics|analgesics|mesh-ancestor
44176792|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
44176793|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176794|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176795|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44176796|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176797|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44176801|NCT00304369|Metronidazole|metronidazole|mesh-list
44176803|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44176804|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44176805|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44176806|NCT00304382|Vaccines|vaccines|mesh-list
44176807|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44176808|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
44176809|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176810|NCT00304421|Rabeprazole|rabeprazole|mesh-list
44176811|NCT00304421|Pantoprazole|pantoprazole|mesh-list
44176812|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44176813|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44176814|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44176815|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176816|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176817|NCT00304434|Oseltamivir|oseltamivir|mesh-list
44176818|NCT00304434|Probenecid|probenecid|mesh-list
44176819|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
44176820|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176821|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176822|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176823|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
44176824|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
44176825|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44176826|NCT00304434|Renal Agents|renal agents|mesh-ancestor
44176827|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
44176828|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44176829|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176830|NCT00304460|Aldesleukin|aldesleukin|mesh-list
44176831|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44176832|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176833|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176834|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
44176835|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176836|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44176837|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
44176838|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44176843|NCT00304499|Oxybutynin|oxybutynin|mesh-list
44176844|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
44176845|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
44176846|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176847|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176848|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44176849|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44176850|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
44176851|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176852|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176853|NCT00304499|Urological Agents|urological agents|mesh-ancestor
44176854|NCT00304538|Glucagon|glucagon|mesh-list
44176855|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44176856|NCT00304538|Hormones|hormones|mesh-ancestor
44176857|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176858|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176859|NCT00304551|Ribavirin|ribavirin|mesh-list
43807381|NCT04899414|Hormones|hormones|mesh-ancestor
44176860|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44176861|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
44176862|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
44176863|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176864|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
44176865|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176866|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
44176867|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176868|NCT00304616|Olanzapine|olanzapine|mesh-list
44176869|NCT00304616|Risperidone|risperidone|mesh-list
44176870|NCT00304616|Aripiprazole|aripiprazole|mesh-list
44176871|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44176872|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44176889|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176890|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
44176891|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
44176892|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44176893|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44176894|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44176895|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44176896|NCT00304629|Galantamine|galantamine|mesh-list
44176897|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44176898|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176899|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176900|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
44176901|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176902|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176903|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44176904|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
44176905|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176906|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
44176907|NCT00304642|Dapivirine|dapivirine|mesh-list
44176908|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44176909|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44176910|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
44176911|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176912|NCT00304655|Aripiprazole|aripiprazole|mesh-list
44176913|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
44176914|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44176915|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44176916|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44453910|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453912|NCT01673620|Loratadine|loratadine|mesh-list
44453913|NCT01673620|Montelukast|montelukast|mesh-list
44453914|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44453915|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
44453916|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44453917|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
44453918|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44453919|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44453920|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44453921|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44453922|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453923|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
44453924|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
44453925|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44453926|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44453927|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44453928|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
44453929|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
44453930|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44453931|NCT01673594|Naltrexone|naltrexone|mesh-list
44453932|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44453933|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44453934|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44113347|NCT00095355|Valproic Acid|valproic acid|mesh-list
44176935|NCT00304681|Methylphenidate|methylphenidate|mesh-list
44176936|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44176937|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176938|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44176939|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44176940|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44176941|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176942|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
44164249|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176943|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176945|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44176946|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
44176947|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176948|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44176949|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176950|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176951|NCT00304772|Fluconazole|fluconazole|mesh-list
44176952|NCT00304772|Micafungin|micafungin|mesh-list
44176953|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
44176954|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176955|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44176956|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44176957|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44176958|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44176959|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44176960|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
44176961|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44176962|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176963|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44176964|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44176965|NCT00304785|Latanoprost|latanoprost|mesh-list
44176966|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44176967|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44176968|NCT00304811|Vancomycin|vancomycin|mesh-list
44176969|NCT00304811|Rifampin|rifampin|mesh-list
44176970|NCT00304811|Gentamicins|gentamicins|mesh-list
44176971|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44176972|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44176973|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44176974|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
44176975|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
44176981|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44176982|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44176983|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44176984|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44176985|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44176987|NCT00304850|Analgesics|analgesics|mesh-ancestor
44176988|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
43792304|NCT05304520|Natalizumab|natalizumab|mesh-list
44176989|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44176990|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44176991|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44176992|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44176993|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
44176994|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
44176995|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44176996|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44176997|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44176998|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44176999|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177000|NCT00304980|Lumefantrine|lumefantrine|mesh-list
44177001|NCT00304980|Artemether|artemether|mesh-list
44177002|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
44177003|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
44177004|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44177005|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44113417|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
44177006|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
44177007|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44177008|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44177009|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177010|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44177011|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177012|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177013|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44177015|NCT00304993|Niacin|niacin|mesh-list
44177018|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177019|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177020|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44177021|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
44177022|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177023|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44177024|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
44177025|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
44177026|NCT00304993|Vitamins|vitamins|mesh-ancestor
44177027|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
44177028|NCT00305019|Clevudine|clevudine|mesh-list
44177029|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
44177030|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177031|NCT00305201|Pravastatin|pravastatin|mesh-list
44177032|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44177033|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44177034|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
44177035|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177036|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44177037|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44177038|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177039|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
44177040|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
44177041|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177042|NCT00305292|Modafinil|modafinil|mesh-list
44177043|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44177066|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
44177067|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
44177068|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177069|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177070|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44177071|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44177072|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
44177073|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44177074|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177075|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44177076|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177077|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44177078|NCT00305383|Taribavirin|taribavirin|mesh-list
44177079|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
44177080|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177081|NCT00305396|Sirolimus|sirolimus|mesh-list
44177082|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177083|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177084|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44177085|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177086|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
44177087|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177088|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
44177089|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177090|NCT00305409|Sulfalene|sulfalene|mesh-list
44177091|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177092|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44177093|NCT00305409|Renal Agents|renal agents|mesh-ancestor
44177094|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
44177095|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44177096|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44177097|NCT00305422|Risperidone|risperidone|mesh-list
44177098|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44177099|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177100|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
44177101|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177106|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177107|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177108|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177109|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
44177110|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
44177111|NCT00305461|Ciclesonide|ciclesonide|mesh-list
44177112|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
44177113|NCT00305461|Hormones|hormones|mesh-ancestor
44177114|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177115|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177116|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44177117|NCT00305474|Risperidone|risperidone|mesh-list
44177118|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177119|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
44177120|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177121|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177122|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177123|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44177124|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177125|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177126|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177127|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177128|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
44177129|NCT00305487|Ciclesonide|ciclesonide|mesh-list
44177130|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
44177131|NCT00305487|Hormones|hormones|mesh-ancestor
44177132|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177133|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177134|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44177135|NCT00305500|Citalopram|citalopram|mesh-list
44177136|NCT00305500|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44177137|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44177138|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44177147|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44177148|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177149|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44177150|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177151|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177152|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44177153|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44177154|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
44177155|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177157|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177158|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44177159|NCT00305552|Thalidomide|thalidomide|mesh-list
44177160|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177161|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
44177162|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177163|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
44177164|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177165|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177166|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177167|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177168|NCT00305552|Growth Substances|growth substances|mesh-ancestor
44177169|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177170|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177171|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
44177172|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44177173|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44177174|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177175|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177176|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177177|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
44177178|NCT00305630|Triamcinolone|triamcinolone|mesh-list
44177179|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44177180|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44177181|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44177184|NCT00305630|Hormones|hormones|mesh-ancestor
44177185|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177187|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177188|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
44177189|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177190|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177191|NCT00305669|Sargramostim|sargramostim|mesh-list
44177192|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
44177193|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177194|NCT00305708|Fludarabine|fludarabine|mesh-list
44177195|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
44177196|NCT00305708|Busulfan|busulfan|mesh-list
44177197|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44177198|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177199|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177200|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
44177201|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177202|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177203|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
44177204|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177205|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
44177206|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44177207|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44177208|NCT00305734|Gemcitabine|gemcitabine|mesh-list
44177209|NCT00305734|Bortezomib|bortezomib|mesh-list
44177210|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177211|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
44177212|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177213|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177214|NCT00305734|Antiviral Agents|antiviral agents|mesh-ancestor
44177227|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177228|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
44177229|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177230|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177231|NCT00305786|Antiviral Agents|antiviral agents|mesh-ancestor
44177232|NCT00305786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177233|NCT00305786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177234|NCT00305786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177235|NCT00305786|Immunologic Factors|immunologic factors|mesh-ancestor
44177236|NCT00305786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177238|NCT00305812|Lenalidomide|lenalidomide|mesh-list
44177239|NCT00305812|Melphalan|melphalan|mesh-list
44177240|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177241|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
44177242|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
44177243|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177244|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177245|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177246|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
44177247|NCT00305812|Hormones|hormones|mesh-ancestor
44177248|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177249|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177250|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177251|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
44177252|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177253|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177254|NCT00305812|Growth Substances|growth substances|mesh-ancestor
44177255|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177256|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44177257|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
44177272|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177273|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177274|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44177275|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
44177276|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177277|NCT00305838|Tamoxifen|tamoxifen|mesh-list
44177278|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44177279|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
44177280|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177281|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177282|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177283|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177284|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44177285|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44177286|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44177287|NCT00305903|Memantine|memantine|mesh-list
44177288|NCT00305903|Rivastigmine|rivastigmine|mesh-list
44177289|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44177290|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44177291|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
44177292|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177293|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177294|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177295|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44177296|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44177297|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44177298|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177299|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
44177300|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44177301|NCT00305903|Protective Agents|protective agents|mesh-ancestor
44177313|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
44177314|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
43843538|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44177315|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177316|NCT00306046|Diphosphonates|diphosphonates|mesh-list
44177317|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44177318|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177319|NCT00306124|Levodopa|levodopa|mesh-list
44177320|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44177321|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44177322|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
44177323|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177324|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177325|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177326|NCT00306137|Aprotinin|aprotinin|mesh-list
44177327|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
44177328|NCT00306137|Coagulants|coagulants|mesh-ancestor
44177329|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44177330|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44177331|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
44177332|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177368|NCT00306358|Vitamins|vitamins|mesh-ancestor
44177369|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
44177370|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177371|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
44177372|NCT00306358|Hematinics|hematinics|mesh-ancestor
44177373|NCT00306397|Sirolimus|sirolimus|mesh-list
44177374|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177375|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177376|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44177377|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177378|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
44177379|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177380|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
44177381|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177382|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
44177383|NCT00306410|Vitamin D|vitamin d|mesh-list
44177384|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44177385|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177386|NCT00306410|Vitamins|vitamins|mesh-ancestor
44177387|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
44177388|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44177389|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
44177390|NCT00306462|Nifedipine|nifedipine|mesh-list
44177391|NCT00306462|Analgesics|analgesics|mesh-ancestor
44177392|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
44177393|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177394|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177395|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
44177396|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177397|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44177398|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
44177399|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44177400|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44177401|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177402|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44177403|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
44177404|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44177405|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
44177407|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
44177408|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177409|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177410|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
44177411|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177412|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177413|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
44177414|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177415|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177416|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44453935|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
44453936|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44453937|NCT01673490|Tamsulosin|tamsulosin|mesh-list
44453938|NCT01673490|Dutasteride|dutasteride|mesh-list
44453939|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44453940|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44177421|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177422|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177423|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177425|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177426|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44177427|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
44177428|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
44177429|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177430|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
44177431|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177432|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177433|NCT00306683|Diazoxide|diazoxide|mesh-list
44177434|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44177435|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
44177436|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
44177437|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44177438|NCT00306696|Spironolactone|spironolactone|mesh-list
44177439|NCT00306696|Furosemide|furosemide|mesh-list
44177440|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44177441|NCT00306696|Diuretics|diuretics|mesh-ancestor
43807433|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44177442|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
44177443|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177444|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44177445|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44177446|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177447|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44177448|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
44177449|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807434|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807435|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807436|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43807437|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43807438|NCT04898725|Vitamin D|vitamin d|mesh-list
43807439|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
43807440|NCT04898725|Vitamins|vitamins|mesh-ancestor
43807441|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
43807442|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807443|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43807445|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
44177450|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44177451|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177452|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44177453|NCT00306722|Fospropofol|fospropofol|mesh-list
44177454|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44177455|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177460|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177461|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177462|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177463|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44177464|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177465|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
44177466|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177467|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177468|NCT00306748|Linaclotide|linaclotide|mesh-list
44177469|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44177470|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
44177471|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177472|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177473|NCT00306774|Vitamin D|vitamin d|mesh-list
44177474|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
44177475|NCT00306774|Vitamins|vitamins|mesh-ancestor
44177476|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
44177477|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177478|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44177479|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44177480|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44177513|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44177514|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
44177515|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177516|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44177517|NCT00307099|Meropenem|meropenem|mesh-list
44177518|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177519|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44177520|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
44177521|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
44177522|NCT00307177|Vaccines|vaccines|mesh-list
44177523|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
44177524|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177525|NCT00307203|Bupropion|bupropion|mesh-list
44177526|NCT00307203|Nicotine|nicotine|mesh-list
44177527|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44177528|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
43807557|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807558|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43807559|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
43807560|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807561|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
43843562|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843563|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843564|NCT04442412|Vitamin D|vitamin d|mesh-list
43843565|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
43843566|NCT04442412|Vitamins|vitamins|mesh-ancestor
43843567|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
43843568|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843571|NCT04441138|Durvalumab|durvalumab|mesh-list
44177529|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177530|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177531|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44177532|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44177533|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
44177534|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177535|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177536|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44177537|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
44177538|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177539|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44177540|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44177541|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44177542|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
44177543|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44177544|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44177545|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177546|NCT00307255|Gemcitabine|gemcitabine|mesh-list
44177547|NCT00307255|Paclitaxel|paclitaxel|mesh-list
44177551|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
44177552|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
44177553|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
44177554|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177555|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44177556|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
44177557|NCT00307255|Antiviral Agents|antiviral agents|mesh-ancestor
44177558|NCT00307255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44177559|NCT00307255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177560|NCT00307255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177561|NCT00307255|Immunologic Factors|immunologic factors|mesh-ancestor
44177562|NCT00307255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177563|NCT00307307|Niacin|niacin|mesh-list
44177564|NCT00307307|Simvastatin|simvastatin|mesh-list
44177565|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44177566|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44177567|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
44177568|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177569|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44177570|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44177571|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177572|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
44177573|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
44177606|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44177607|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44177608|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44177609|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44177610|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44177611|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44177612|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44177613|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44177614|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44177615|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
44177616|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44177617|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44177618|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
44177619|NCT00307515|Coagulants|coagulants|mesh-ancestor
44177620|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44177621|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
44177622|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177623|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43654820|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43654821|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44177624|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44177625|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44177626|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177655|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177656|NCT00307619|Topiramate|topiramate|mesh-list
44177657|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
44177658|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177659|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177660|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44177661|NCT00307632|Estradiol|estradiol|mesh-list
44177662|NCT00307632|Estrogens|estrogens|mesh-ancestor
44177663|NCT00307632|Hormones|hormones|mesh-ancestor
44177664|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177665|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177666|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44177667|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
44177668|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44177669|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44177716|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44177717|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44177719|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
44177720|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
44177721|NCT00307671|Methotrexate|methotrexate|mesh-list
44177722|NCT00307671|Azathioprine|azathioprine|mesh-list
44177723|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44177724|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
44177725|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44177726|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
44177727|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177728|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44177730|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
44177778|NCT00307775|Estradiol|estradiol|mesh-list
44177779|NCT00307775|Estrogens|estrogens|mesh-ancestor
44177780|NCT00307775|Hormones|hormones|mesh-ancestor
44177781|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177782|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177783|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
44177784|NCT00307814|Hematinics|hematinics|mesh-ancestor
44177785|NCT00307827|Visilizumab|visilizumab|mesh-list
44177786|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
44177787|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177788|NCT00307944|Pantoprazole|pantoprazole|mesh-list
44177789|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44177790|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177791|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44177842|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
44177843|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
44453972|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44453973|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
44453974|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
44453975|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44453976|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44453977|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44453978|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
44453979|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44453980|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807624|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43807625|NCT04895059|Ezetimibe|ezetimibe|mesh-list
43807626|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43807627|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43807628|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
43792798|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44453981|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44453982|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177878|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
44177879|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177880|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177881|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177882|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177883|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
44177884|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177885|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177886|NCT00308360|Valproic Acid|valproic acid|mesh-list
44177887|NCT00308360|Risperidone|risperidone|mesh-list
44177888|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44177889|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
44177890|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44177891|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177892|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177893|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44177894|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44177895|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44177896|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44177897|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44177898|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
44177899|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
44177900|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177901|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
44177902|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
44177903|NCT00308373|Metformin|metformin|mesh-list
44177904|NCT00308373|Pioglitazone|pioglitazone|mesh-list
44177905|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44177906|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44177907|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177908|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
44177909|NCT00308425|Valsartan|valsartan|mesh-list
44177922|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177923|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44177924|NCT00308438|Protective Agents|protective agents|mesh-ancestor
44177925|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177927|NCT00308451|Biotin|biotin|mesh-list
44177928|NCT00308451|Picolinic acid|picolinic acid|mesh-list
44177929|NCT00308451|Trace Elements|trace elements|mesh-ancestor
44177930|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
44177931|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177932|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
44177933|NCT00308451|Vitamins|vitamins|mesh-ancestor
44177934|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44177935|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
44177936|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
44177937|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807633|NCT04895007|Vaccines|vaccines|mesh-list
44177938|NCT00308477|Dexamethasone|dexamethasone|mesh-list
44177939|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177940|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
44177941|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
44177942|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177943|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177944|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177945|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
44177946|NCT00308477|Hormones|hormones|mesh-ancestor
44177947|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177948|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177949|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177950|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44177951|NCT00308490|Hematinics|hematinics|mesh-ancestor
44177952|NCT00308503|SR 46349B|sr 46349b|mesh-list
44177953|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44177954|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44177966|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44177967|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44177968|NCT00308529|Growth Substances|growth substances|mesh-ancestor
44177969|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177970|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
44177971|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44177972|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44177973|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44177974|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44177975|NCT00308542|Dexamethasone|dexamethasone|mesh-list
44177976|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177977|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
44177978|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
44177979|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177980|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177981|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177982|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
44177983|NCT00308542|Hormones|hormones|mesh-ancestor
44177984|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177985|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177986|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177987|NCT00308594|Dexamethasone|dexamethasone|mesh-list
44177988|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44177989|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
44177990|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
44177991|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44177992|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44177993|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44177994|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
44114360|NCT00099008|Genistein|genistein|mesh-list
44177995|NCT00308594|Hormones|hormones|mesh-ancestor
44177996|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44177997|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44177998|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44177999|NCT00308607|Interferons|interferons|mesh-list
44178000|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
44178001|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
44178003|NCT00308607|Dacarbazine|dacarbazine|mesh-list
44178004|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178005|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178006|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44178007|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44178008|NCT00308607|Growth Substances|growth substances|mesh-ancestor
44178009|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807662|NCT04893993|Thiamine|thiamine|mesh-list
44178010|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
44178011|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
44178012|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178013|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
44178014|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178015|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
44178016|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178017|NCT00308763|Bupropion|bupropion|mesh-list
44178059|NCT00308945|Travoprost|travoprost|mesh-list
44178060|NCT00308945|Latanoprost|latanoprost|mesh-list
44178061|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44178062|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44178063|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178064|NCT00308971|Vitamin E|vitamin e|mesh-list
44178065|NCT00308971|Tocopherols|tocopherols|mesh-list
44178066|NCT00308971|Tocotrienols|tocotrienols|mesh-list
44178067|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
44178068|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
44178069|NCT00308971|Vitamins|vitamins|mesh-ancestor
44178070|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
44178071|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178072|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
44178073|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178074|NCT00308971|Protective Agents|protective agents|mesh-ancestor
44178075|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
44178076|NCT00309049|Epothilones|epothilones|mesh-list
44178077|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178078|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178079|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178080|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178081|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178082|NCT00309088|Tacrolimus|tacrolimus|mesh-list
44178083|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178084|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
44178085|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178086|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44178087|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178088|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178089|NCT00309101|Tacrolimus|tacrolimus|mesh-list
44178090|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178091|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
44178092|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178093|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44178094|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178096|NCT00309192|Triamcinolone|triamcinolone|mesh-list
44178100|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178101|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
44178102|NCT00309192|Hormones|hormones|mesh-ancestor
44178103|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178104|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178105|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178106|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
44178107|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178108|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178109|NCT00309205|Dapivirine|dapivirine|mesh-list
44178110|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44178111|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44178112|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
44178161|NCT00309335|Phentolamine|phentolamine|mesh-list
44178162|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44178163|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178164|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178165|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178166|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178167|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178168|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178169|NCT00309361|Phentolamine|phentolamine|mesh-list
44178170|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44178171|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178172|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178173|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178174|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178175|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178176|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178177|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44178178|NCT00309374|Simvastatin|simvastatin|mesh-list
44178179|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44178180|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44178181|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
44178182|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178183|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44178184|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44178185|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178186|NCT00309413|Cannabidiol|cannabidiol|mesh-list
44178187|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
44178189|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
44178190|NCT00309478|Fluorouracil|fluorouracil|mesh-list
44178191|NCT00309478|Methotrexate|methotrexate|mesh-list
44178192|NCT00309478|Goserelin|goserelin|mesh-list
44178193|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178194|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
44178195|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178196|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178201|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178202|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
44178203|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178204|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44178205|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
44178206|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44178207|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
44178208|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178209|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44178210|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44178211|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44178212|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178213|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178214|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178215|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44178216|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44178217|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44178219|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
44178220|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44178221|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178222|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178223|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178224|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178225|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178226|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44178233|NCT00309517|Leucovorin|leucovorin|mesh-list
44178246|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178247|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178248|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178249|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178250|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
44178251|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178252|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
44178253|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178254|NCT00309543|Leucovorin|leucovorin|mesh-list
44178255|NCT00309543|Fluorouracil|fluorouracil|mesh-list
44178256|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
44178257|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178258|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178259|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178260|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178261|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
44178262|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178263|NCT00309543|Antidotes|antidotes|mesh-ancestor
44178264|NCT00309543|Protective Agents|protective agents|mesh-ancestor
44178265|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
44178266|NCT00309543|Vitamins|vitamins|mesh-ancestor
44178267|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
44178268|NCT00309556|Docetaxel|docetaxel|mesh-list
44178269|NCT00309556|Capecitabine|capecitabine|mesh-list
44178270|NCT00309556|Trastuzumab|trastuzumab|mesh-list
44178271|NCT00309556|Epirubicin|epirubicin|mesh-list
44178272|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178273|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178274|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178275|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178276|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178277|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178278|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
44178279|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178289|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
44178290|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178291|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178292|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178293|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
44178294|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178295|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178296|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178297|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
44178298|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178299|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44178300|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
44178301|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44178302|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44178303|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178304|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44178305|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44178345|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44178346|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
44178347|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44178348|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44178349|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
44178350|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44178351|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44178352|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44178353|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178354|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178355|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44178356|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44178357|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
44178358|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178359|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178403|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178404|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178405|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178406|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44178407|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44178408|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178409|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178410|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178411|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44178412|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44178413|NCT00309881|Prednisone|prednisone|mesh-list
44178414|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
44178415|NCT00309881|Rituximab|rituximab|mesh-list
44178416|NCT00309881|Doxorubicin|doxorubicin|mesh-list
44178417|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44178418|NCT00309881|Vincristine|vincristine|mesh-list
44178419|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178420|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
44178421|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178422|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178423|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178424|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
44178435|NCT00309881|Hormones|hormones|mesh-ancestor
44178452|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178453|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44178454|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44178455|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178456|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178457|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44178458|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178459|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178460|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44178461|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
44178462|NCT00309920|Docetaxel|docetaxel|mesh-list
44178463|NCT00309920|Doxorubicin|doxorubicin|mesh-list
44178464|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44178513|NCT00310011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178514|NCT00310011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178515|NCT00310011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178516|NCT00310011|Immunologic Factors|immunologic factors|mesh-ancestor
44454000|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
44178517|NCT00310011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178519|NCT00310024|Vorinostat|vorinostat|mesh-list
44178520|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178521|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44178522|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178523|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178524|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
44178525|NCT00310089|Docetaxel|docetaxel|mesh-list
44178526|NCT00310089|Doxorubicin|doxorubicin|mesh-list
44178527|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44178528|NCT00310089|Cediranib|cediranib|mesh-list
44178529|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178530|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
44178531|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178532|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178533|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178534|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
44178535|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178536|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178537|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44178538|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178539|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178540|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178541|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44178542|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178543|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178544|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178545|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44178546|NCT00310128|Cytarabine|cytarabine|mesh-list
44178547|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
44178548|NCT00310128|Rituximab|rituximab|mesh-list
44178549|NCT00310128|Etoposide|etoposide|mesh-list
44178550|NCT00310128|Antibodies|antibodies|mesh-list
44178552|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44178553|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
44178554|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178555|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178556|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178557|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44178558|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44178559|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44178560|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44178561|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178562|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178563|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178564|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
44178565|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
44178566|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178567|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178568|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44178569|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
44178574|NCT00310128|Hormones|hormones|mesh-ancestor
44178609|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44178610|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178611|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178612|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44178613|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44178614|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
44178615|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178616|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
43807711|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44178617|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
44178618|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44178619|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44178620|NCT00310336|Interferons|interferons|mesh-list
44178621|NCT00310336|Ribavirin|ribavirin|mesh-list
44178622|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
44178623|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
44178624|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44178625|NCT00310336|Betaine|betaine|mesh-list
44178626|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178627|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
44178628|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178629|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
44178630|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178631|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
44178632|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178633|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178634|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
44178635|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44178636|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44178637|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44178638|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
44178639|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178652|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
44178653|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178654|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44178655|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44178656|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178657|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178658|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
44178659|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44178660|NCT00310531|Estradiol|estradiol|mesh-list
44178661|NCT00310531|Estrogens|estrogens|mesh-ancestor
44178662|NCT00310531|Hormones|hormones|mesh-ancestor
44178663|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178664|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178665|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44178666|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44178667|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44178668|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44178707|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44178708|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178709|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178710|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44178711|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44178712|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44178713|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178714|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44178715|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44178716|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44178717|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178718|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
44178719|NCT00310778|Atenolol|atenolol|mesh-list
44178720|NCT00310778|Valsartan|valsartan|mesh-list
44178721|NCT00310778|Candesartan|candesartan|mesh-list
44178722|NCT00310778|Ramipril|ramipril|mesh-list
44178723|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178724|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44178725|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44178726|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178740|NCT00310843|Nevirapine|nevirapine|mesh-list
44178759|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43619168|NCT03125616|Vaccines|vaccines|mesh-list
44178760|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178761|NCT00310908|Analgesics|analgesics|mesh-ancestor
44178762|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
44178763|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178764|NCT00310921|Misoprostol|misoprostol|mesh-list
44178765|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44178766|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
44178767|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44178768|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178769|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44178770|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178771|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
44178772|NCT00310934|Buprenorphine|buprenorphine|mesh-list
44178773|NCT00310934|Methadone|methadone|mesh-list
44178774|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44178775|NCT00310934|Narcotics|narcotics|mesh-ancestor
44178776|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44178777|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178778|NCT00310934|Analgesics|analgesics|mesh-ancestor
44178779|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
44178780|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178781|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44178782|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
44178783|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
44178784|NCT00311038|Landiolol|landiolol|mesh-list
44178785|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44178786|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44178787|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
44178788|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44178789|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178790|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178791|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44178800|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44178801|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44178802|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178803|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44178804|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
44178805|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44178806|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178807|NCT00311116|Vitamin E|vitamin e|mesh-list
44178808|NCT00311116|Vitamins|vitamins|mesh-ancestor
44178809|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
44178810|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178811|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
44178812|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178813|NCT00311116|Protective Agents|protective agents|mesh-ancestor
44178861|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
44178862|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44178863|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178864|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
44178865|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44178866|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
44178867|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178868|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44178869|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44178870|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
44178871|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44178872|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
44178873|NCT00311636|Paclitaxel|paclitaxel|mesh-list
44178874|NCT00311636|Docetaxel|docetaxel|mesh-list
44178875|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
44178876|NCT00311636|Doxorubicin|doxorubicin|mesh-list
44178877|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44178878|NCT00311636|Fluorouracil|fluorouracil|mesh-list
44178879|NCT00311636|Methotrexate|methotrexate|mesh-list
44178880|NCT00311636|Epirubicin|epirubicin|mesh-list
44178881|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44178882|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44178883|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178884|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
44178885|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
44178886|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
44178887|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178888|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44178889|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
44178908|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44178909|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
44178910|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44178911|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44454002|NCT01672736|BB 1101|bb 1101|mesh-list
44454003|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454004|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
44454005|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
44454006|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454007|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454008|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44454009|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
44454010|NCT01672736|Hormones|hormones|mesh-ancestor
44454012|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178935|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178936|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
44178937|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44178938|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178939|NCT00311857|Cetuximab|cetuximab|mesh-list
44178940|NCT00311857|Temozolomide|temozolomide|mesh-list
44178941|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44178942|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178943|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44178944|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
44178945|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178946|NCT00311870|Lisinopril|lisinopril|mesh-list
44178947|NCT00311870|Nisoldipine|nisoldipine|mesh-list
44178948|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44178949|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
44178950|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44178951|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44178952|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178953|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44178954|NCT00311870|Protective Agents|protective agents|mesh-ancestor
44178955|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178956|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44178957|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44178958|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44178959|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44178960|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
44178981|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178982|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44178983|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44178984|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
44178985|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
44178986|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44178987|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44178988|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44178989|NCT00311961|Protective Agents|protective agents|mesh-ancestor
44178990|NCT00311974|Dihydralazine|dihydralazine|mesh-list
44178991|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44178992|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
44178994|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44178995|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44178996|NCT00312000|Capecitabine|capecitabine|mesh-list
44178997|NCT00312000|Irinotecan|irinotecan|mesh-list
44178998|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44178999|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
44179000|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179001|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179002|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44179003|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179004|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179005|NCT00312013|Nadroparin|nadroparin|mesh-list
44179006|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
44179007|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44179008|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44179009|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179026|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179027|NCT00312130|Vildagliptin|vildagliptin|mesh-list
44179028|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179029|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179030|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44179031|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
44179032|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179033|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179034|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
44179035|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44179036|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179037|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44179038|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
44179039|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179040|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179041|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179042|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179043|NCT00312156|Insulin|insulin|mesh-list
44179044|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44179045|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
44179046|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
44179047|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
44179048|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
44179049|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
44179050|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179051|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179052|NCT00312182|Nelfinavir|nelfinavir|mesh-list
44179053|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44179054|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44179055|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
44179056|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179071|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179072|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179073|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44179074|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44179075|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179076|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179077|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
44179078|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44179079|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
44179080|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44179081|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44179082|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44179083|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44179084|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179085|NCT00312273|Aminophylline|aminophylline|mesh-list
44179086|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44179087|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
44179088|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179089|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179090|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44179092|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44179121|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179122|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179123|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
44179124|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
44179125|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
44179126|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44179127|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179128|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
44179129|NCT00312481|Protective Agents|protective agents|mesh-ancestor
44179130|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179131|NCT00312481|Vitamins|vitamins|mesh-ancestor
44179132|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
44179133|NCT00312481|Cathartics|cathartics|mesh-ancestor
44179134|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44179135|NCT00312481|Laxatives|laxatives|mesh-ancestor
44179136|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44115457|NCT00102609|Hormones|hormones|mesh-ancestor
44179137|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
44179138|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
44179139|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44179140|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44179141|NCT00312520|Prednisolone|prednisolone|mesh-list
44179142|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
44179143|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44179152|NCT00312520|Hormones|hormones|mesh-ancestor
44179173|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179174|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44179175|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44179176|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44179177|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44179178|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
44179179|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179180|NCT00312598|Aripiprazole|aripiprazole|mesh-list
44179181|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
44179182|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179183|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44179184|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179185|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179186|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179233|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179234|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179235|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
44179236|NCT00312871|Hematinics|hematinics|mesh-ancestor
44179237|NCT00312988|Gemcitabine|gemcitabine|mesh-list
44179238|NCT00312988|Topotecan|topotecan|mesh-list
44179239|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44179240|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
44179241|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179242|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179243|NCT00312988|Antiviral Agents|antiviral agents|mesh-ancestor
44179244|NCT00312988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179245|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179246|NCT00312988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179247|NCT00312988|Immunologic Factors|immunologic factors|mesh-ancestor
44179249|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44179294|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
44179295|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44179296|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44179297|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179298|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179299|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44179300|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
44179301|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179302|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179303|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44179304|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44179305|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44179306|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44179307|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
44179308|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44179309|NCT00313157|Metoprolol|metoprolol|mesh-list
44179310|NCT00313157|Verapamil|verapamil|mesh-list
44179311|NCT00313157|Carvedilol|carvedilol|mesh-list
44179312|NCT00313157|Diltiazem|diltiazem|mesh-list
44179313|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44179314|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179315|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
44179316|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
44179317|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179318|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179319|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44179320|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44179321|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44179322|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179323|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179335|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179336|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
44179338|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
44179339|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179340|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179341|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44179342|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44179343|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
44179344|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179345|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179346|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44179347|NCT00313261|Clevudine|clevudine|mesh-list
44179348|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
44179349|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179350|NCT00313274|Clevudine|clevudine|mesh-list
44179351|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
43807900|NCT04890626|BB 1101|bb 1101|mesh-list
44179352|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179353|NCT00313287|Clevudine|clevudine|mesh-list
44179354|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
44179355|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454033|NCT01671488|Mitomycins|mitomycins|mesh-list
44454034|NCT01671488|Mitomycin|mitomycin|mesh-list
44454035|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44454036|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454037|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
44454038|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454039|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44179376|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179377|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179378|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807936|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179379|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
44179380|NCT00313482|Hormones|hormones|mesh-ancestor
44179381|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179382|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179383|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44179384|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
44179385|NCT00313508|Vidarabine|vidarabine|mesh-list
44179386|NCT00313508|Fludarabine|fludarabine|mesh-list
44179387|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
44179388|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179389|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44179390|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
44179391|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179392|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179393|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
44179394|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179397|NCT00313521|Thiotepa|thiotepa|mesh-list
44179429|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179430|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44179431|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44179432|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179433|NCT00313599|Paclitaxel|paclitaxel|mesh-list
44179434|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44179435|NCT00313599|Lapatinib|lapatinib|mesh-list
44179436|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44179437|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179438|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807937|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654840|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654841|NCT02973295|Silymarin|silymarin|mesh-list
43654842|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
43654843|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654844|NCT02973295|Protective Agents|protective agents|mesh-ancestor
43807938|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43807939|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43807940|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807941|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807942|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43807943|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807944|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807945|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
43807946|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179439|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179440|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179441|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179442|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44179443|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179444|NCT00313625|Methotrexate|methotrexate|mesh-list
44179445|NCT00313625|Melphalan|melphalan|mesh-list
44179446|NCT00313625|Busulfan|busulfan|mesh-list
44179447|NCT00313625|Tacrolimus|tacrolimus|mesh-list
44179448|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44179449|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
44179450|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44179451|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179452|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44179453|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
44179454|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179455|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179456|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
44179457|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179476|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44179477|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
44179478|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
44179479|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
44179480|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
44179481|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
44179482|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44179483|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179484|NCT00313833|Buprenorphine|buprenorphine|mesh-list
44179485|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44179486|NCT00313833|Narcotics|narcotics|mesh-ancestor
44179487|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179488|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179489|NCT00313833|Analgesics|analgesics|mesh-ancestor
44179490|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
44179491|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179492|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44179493|NCT00313859|Simvastatin|simvastatin|mesh-list
44179494|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44179495|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44179530|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179531|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
44179532|NCT00313963|Analgesics|analgesics|mesh-ancestor
44179533|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
44179534|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179535|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179536|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
44179537|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179538|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44179539|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
44179540|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44179541|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44179542|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179543|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44179544|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
44179545|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44179546|NCT00313976|Interferons|interferons|mesh-list
44179547|NCT00313976|Interferon-beta|interferon-beta|mesh-list
44179548|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
44179549|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179550|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
44179551|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807947|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44179552|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
44179553|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179554|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44179555|NCT00314080|Antitoxins|antitoxins|mesh-list
44179556|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
44179557|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
44179558|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179559|NCT00314158|Timolol|timolol|mesh-list
44179560|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44179561|NCT00314158|Brinzolamide|brinzolamide|mesh-list
44179562|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44179563|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44179564|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44179565|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179566|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179567|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179568|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179569|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44179570|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179571|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44179572|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179573|NCT00314171|Timolol|timolol|mesh-list
44179574|NCT00314171|Dorzolamide|dorzolamide|mesh-list
44179575|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44179576|NCT00314171|Brinzolamide|brinzolamide|mesh-list
44179577|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44179578|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44179579|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44179580|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
44115821|NCT00103727|Risperidone|risperidone|mesh-list
44179581|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179582|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179583|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179584|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44179585|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179586|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44179587|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179588|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44179589|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
44179590|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179591|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44179592|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179593|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179594|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179595|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44179596|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
44179597|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179602|NCT00314314|Insulin|insulin|mesh-list
44179610|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179611|NCT00314379|Protective Agents|protective agents|mesh-ancestor
44179612|NCT00314405|Methylene Blue|methylene blue|mesh-list
44179613|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179614|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179615|NCT00314457|Bupivacaine|bupivacaine|mesh-list
44179616|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
43807955|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807956|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179617|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
43807957|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44179618|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179619|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179620|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
44179621|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179622|NCT00314509|Ciclesonide|ciclesonide|mesh-list
44179623|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
44179624|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44179625|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
44179626|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179627|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179628|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44179629|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
44179630|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44179631|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44179632|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44179633|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44179634|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179635|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179636|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
44179637|NCT00314509|Hormones|hormones|mesh-ancestor
44179638|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179639|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44179640|NCT00314548|Epoprostenol|epoprostenol|mesh-list
44179641|NCT00314548|Alprostadil|alprostadil|mesh-list
44179642|NCT00314548|Tezosentan|tezosentan|mesh-list
44179643|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44179644|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
44179650|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179651|NCT00314613|Risperidone|risperidone|mesh-list
44179652|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
44179653|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44179654|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
44179655|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179656|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454042|NCT01671332|Docetaxel|docetaxel|mesh-list
44179657|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179658|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44179659|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179660|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44179661|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44179662|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
44179663|NCT00314626|Lamivudine|lamivudine|mesh-list
44179664|NCT00314626|Efavirenz|efavirenz|mesh-list
44179665|NCT00314626|Abacavir|abacavir|mesh-list
44179666|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44179667|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44179668|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179669|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179670|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
44179671|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179672|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44179673|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44179674|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44179675|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44179676|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44179680|NCT00314639|Modafinil|modafinil|mesh-list
44179691|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179692|NCT00314652|Analgesics|analgesics|mesh-ancestor
44179693|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
44179694|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179695|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44179696|NCT00314665|Thalidomide|thalidomide|mesh-list
44179697|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179698|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
44179699|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179700|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
44179701|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179702|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179703|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44179704|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44179705|NCT00314665|Growth Substances|growth substances|mesh-ancestor
44179706|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
44179707|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179708|NCT00314678|Paclitaxel|paclitaxel|mesh-list
44179709|NCT00314678|Cisplatin|cisplatin|mesh-list
44179710|NCT00314678|Topotecan|topotecan|mesh-list
44179711|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44179712|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179713|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179714|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179715|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179716|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179717|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44179718|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179719|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179720|NCT00314704|Dopamine|dopamine|mesh-list
44179721|NCT00314704|Norepinephrine|norepinephrine|mesh-list
44179722|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44179723|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44179734|NCT00314704|Protective Agents|protective agents|mesh-ancestor
44179735|NCT00314743|Dexamethasone|dexamethasone|mesh-list
44179736|NCT00314743|Ondansetron|ondansetron|mesh-list
44179737|NCT00314743|Aprepitant|aprepitant|mesh-list
44179738|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44179739|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
44179740|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
44179741|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179742|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179743|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44179744|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
44179745|NCT00314743|Hormones|hormones|mesh-ancestor
44179746|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179747|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44179748|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179749|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
44179750|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
44179793|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179795|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
44179796|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
44179797|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
44179798|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179799|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179800|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179801|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
44179802|NCT00314977|Docetaxel|docetaxel|mesh-list
44179803|NCT00314977|Doxorubicin|doxorubicin|mesh-list
44179804|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44179805|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44179806|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
44179807|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179808|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44179809|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44179810|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
44179811|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179812|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179813|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44179814|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
44179815|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
44179816|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
44179817|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44179818|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44179819|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44179820|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179821|NCT00314990|Folic Acid|folic acid|mesh-list
44179822|NCT00314990|Pyridoxine|pyridoxine|mesh-list
44179823|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
44179824|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
44179825|NCT00314990|Hematinics|hematinics|mesh-ancestor
44179827|NCT00314990|Vitamins|vitamins|mesh-ancestor
44179837|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
44179838|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44179839|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179840|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44179841|NCT00315016|Diuretics|diuretics|mesh-ancestor
44179842|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
44179843|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44179844|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44179845|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
44179846|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179847|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179848|NCT00315042|Penicillins|penicillins|mesh-list
44179849|NCT00315042|Telithromycin|telithromycin|mesh-list
44179852|NCT00315081|Bromocriptine|bromocriptine|mesh-list
44179875|NCT00315276|Modafinil|modafinil|mesh-list
44179876|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44179877|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179878|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44179879|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44179880|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44179881|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179882|NCT00315367|Donepezil|donepezil|mesh-list
44179883|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44179884|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44179885|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179886|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
44179887|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179888|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179889|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
44179890|NCT00315432|Interferons|interferons|mesh-list
44179891|NCT00315432|Ribavirin|ribavirin|mesh-list
44179892|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44179893|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
44179894|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179895|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
44179896|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179897|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
44179924|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807961|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807962|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43807963|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43654846|NCT02973581|Acetaminophen|acetaminophen|mesh-list
44179925|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44179926|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44179927|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44179928|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
44179929|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44179930|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44179931|NCT00315549|Penicillins|penicillins|mesh-list
44179932|NCT00315549|Telithromycin|telithromycin|mesh-list
44179933|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44179934|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44179964|NCT00315744|Xhance|xhance|mesh-list
44179988|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179990|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
44179991|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44179992|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44179993|NCT00315848|Buprenorphine|buprenorphine|mesh-list
44179994|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44179995|NCT00315848|Narcotics|narcotics|mesh-ancestor
44179996|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44179997|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44179998|NCT00315848|Analgesics|analgesics|mesh-ancestor
44179999|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
44180000|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180001|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44180002|NCT00315861|Pemetrexed|pemetrexed|mesh-list
44180003|NCT00315861|Topotecan|topotecan|mesh-list
44180004|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180005|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180006|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180007|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44180008|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44180009|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44180010|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180011|NCT00315874|Buprenorphine|buprenorphine|mesh-list
44180012|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44180013|NCT00315874|Narcotics|narcotics|mesh-ancestor
44180014|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180015|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180016|NCT00315874|Analgesics|analgesics|mesh-ancestor
44180017|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
44180018|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180019|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44180020|NCT00315887|Buprenorphine|buprenorphine|mesh-list
44180030|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44180031|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180032|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180033|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44180034|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44180035|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180036|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180037|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
44180038|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180039|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180040|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
44180041|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180042|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
44180043|NCT00315913|Propranolol|propranolol|mesh-list
44180044|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44180045|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44180046|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
44180047|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180048|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180049|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180050|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44180051|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180052|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180053|NCT00315926|Melatonin|melatonin|mesh-list
44180054|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
44180055|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180056|NCT00315926|Protective Agents|protective agents|mesh-ancestor
44180057|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180058|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180059|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
44180060|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
44180061|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44180062|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
44180063|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180069|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180070|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180071|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44180072|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180073|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
44180074|NCT00315965|Protective Agents|protective agents|mesh-ancestor
44180075|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
44180076|NCT00316030|Bexarotene|bexarotene|mesh-list
44180077|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180078|NCT00316095|Telmisartan|telmisartan|mesh-list
44180079|NCT00316095|Simvastatin|simvastatin|mesh-list
44180080|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44180081|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44180082|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
44180083|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180084|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44180085|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44180086|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180087|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180088|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44180089|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44180090|NCT00316160|Bupropion|bupropion|mesh-list
44180091|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44180092|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44180093|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180116|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180117|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180118|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180119|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44180120|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44180121|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44180122|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180123|NCT00316238|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44180124|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44180125|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44180126|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180127|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180128|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
44180129|NCT00316329|Artesunate|artesunate|mesh-list
44180130|NCT00316329|Amodiaquine|amodiaquine|mesh-list
44180131|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
44180132|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44180133|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44180134|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180135|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180136|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
44180137|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
44180138|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44180139|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
44180140|NCT00316407|Paclitaxel|paclitaxel|mesh-list
44180141|NCT00316407|Carboplatin|carboplatin|mesh-list
44180142|NCT00316407|Lapatinib|lapatinib|mesh-list
44180143|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44180144|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180145|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180146|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180147|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
44180150|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180159|NCT00316420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180160|NCT00316420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180161|NCT00316420|Immunologic Factors|immunologic factors|mesh-ancestor
44454065|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
44116365|NCT00106301|Romidepsin|romidepsin|mesh-list
44180162|NCT00316420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180163|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
44180164|NCT00316433|Irinotecan|irinotecan|mesh-list
44180165|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180166|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44180167|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180168|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180169|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180170|NCT00316472|Niacinamide|niacinamide|mesh-list
44180171|NCT00316472|Niacin|niacin|mesh-list
44180172|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
44180173|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
44180174|NCT00316472|Vitamins|vitamins|mesh-ancestor
44180175|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
44180176|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180177|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44180178|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
44180179|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180180|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44180181|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
44180182|NCT00316498|Miglustat|miglustat|mesh-list
44180183|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180184|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180185|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44180186|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44180187|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
44180188|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180190|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180201|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44180202|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180203|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180204|NCT00316563|Hormones|hormones|mesh-ancestor
44180205|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180206|NCT00316680|Vaccines|vaccines|mesh-list
44180207|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
43843641|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180208|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180209|NCT00316745|Leucovorin|leucovorin|mesh-list
44180210|NCT00316745|Fluorouracil|fluorouracil|mesh-list
44180211|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
44180212|NCT00316745|Irinotecan|irinotecan|mesh-list
44180213|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
44180214|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180215|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180216|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180217|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180218|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
44180219|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180220|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44180221|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180222|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180223|NCT00316745|Antidotes|antidotes|mesh-ancestor
44180224|NCT00316745|Protective Agents|protective agents|mesh-ancestor
44180225|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
44180226|NCT00316745|Vitamins|vitamins|mesh-ancestor
44180227|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
44180228|NCT00316758|Metformin|metformin|mesh-list
44180229|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44180230|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180231|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
44180232|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
44180233|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44180234|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44116441|NCT00106561|Irbesartan|irbesartan|mesh-list
44180235|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
44180241|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
44180242|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180243|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180244|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44180245|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180246|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44180247|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
44180248|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180249|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
44180250|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180251|NCT00316875|Doxorubicin|doxorubicin|mesh-list
44180252|NCT00316875|Lapatinib|lapatinib|mesh-list
44180253|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43843655|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843656|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843657|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843658|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43843659|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43843660|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843661|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43807997|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
43654855|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
43793670|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180254|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180255|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44180256|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44180257|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180258|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180259|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44180260|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44180261|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44180262|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180263|NCT00316927|Aspirin|aspirin|mesh-list
44180264|NCT00316927|Dexamethasone|dexamethasone|mesh-list
44180265|NCT00316927|Fosfestrol|fosfestrol|mesh-list
44180266|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
44180289|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
44180290|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44180291|NCT00316927|Estrogens|estrogens|mesh-ancestor
44180292|NCT00316940|Bortezomib|bortezomib|mesh-list
44180293|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44180294|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180295|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44180296|NCT00316940|Analgesics|analgesics|mesh-ancestor
44180297|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
44180298|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180299|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180300|NCT00316953|Dasatinib|dasatinib|mesh-list
44180301|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180302|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44180303|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180304|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454066|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
44454067|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
44454068|NCT01671280|Azithromycin|azithromycin|mesh-list
44454069|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44454070|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454071|NCT01670877|Trastuzumab|trastuzumab|mesh-list
44454072|NCT01670877|Fulvestrant|fulvestrant|mesh-list
44454073|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454074|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454075|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44180305|NCT00317031|Naltrexone|naltrexone|mesh-list
44180329|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
44180330|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180332|NCT00317200|Bevacizumab|bevacizumab|mesh-list
44180333|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44180334|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180335|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
44180336|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180337|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
44180338|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180339|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44180340|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44180341|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44180342|NCT00317200|Growth Substances|growth substances|mesh-ancestor
44180343|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180390|NCT00317408|Ifosfamide|ifosfamide|mesh-list
44180391|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
44180392|NCT00317408|Idarubicin|idarubicin|mesh-list
44180393|NCT00317408|Thiotepa|thiotepa|mesh-list
44180394|NCT00317408|Carmustine|carmustine|mesh-list
44180395|NCT00317408|Vinblastine|vinblastine|mesh-list
44180396|NCT00317408|Lomustine|lomustine|mesh-list
44180397|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
44180398|NCT00317408|Vindesine|vindesine|mesh-list
44180399|NCT00317408|Cyclosporins|cyclosporins|mesh-list
44180400|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44180401|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
44180402|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180403|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
44180404|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
44180405|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180406|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180407|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44180451|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44180452|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180453|NCT00317421|Urological Agents|urological agents|mesh-ancestor
44180454|NCT00317434|Lapatinib|lapatinib|mesh-list
44180455|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44180456|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44180457|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180458|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180459|NCT00317447|Prednisone|prednisone|mesh-list
44180460|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44180461|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
44180462|NCT00317447|Hormones|hormones|mesh-ancestor
44180463|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180464|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180512|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44180513|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44180514|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44180515|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44180516|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44180517|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44180518|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
44180519|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44180520|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
44180521|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44180522|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180523|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44180524|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
44180525|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44180571|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180573|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
44180574|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180575|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44180576|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
44180577|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44180578|NCT00317759|Fludarabine|fludarabine|mesh-list
44180636|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44180637|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44180638|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
44180639|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180640|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
44180641|NCT00317811|Protective Agents|protective agents|mesh-ancestor
44180642|NCT00317811|Vitamins|vitamins|mesh-ancestor
44180643|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
44180704|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44180705|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
44180706|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180707|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44180708|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44180709|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180710|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44180711|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44180712|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43793722|NCT04132791|Aspirin|aspirin|mesh-list
44180713|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44180714|NCT00317993|Simvastatin|simvastatin|mesh-list
44180715|NCT00317993|Ezetimibe|ezetimibe|mesh-list
44180716|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44180717|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44180718|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
44180719|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180720|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44180721|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44180722|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180723|NCT00318084|Esomeprazole|esomeprazole|mesh-list
44180724|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44180729|NCT00318162|Naltrexone|naltrexone|mesh-list
44180756|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44180757|NCT00318318|Estrogens|estrogens|mesh-ancestor
44180758|NCT00318318|Hormones|hormones|mesh-ancestor
44180759|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180760|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180761|NCT00318383|Vaccines|vaccines|mesh-list
44180762|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
44180763|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180764|NCT00318422|Liraglutide|liraglutide|mesh-list
44180765|NCT00318422|Glimepiride|glimepiride|mesh-list
44180766|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
44454076|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44454077|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44454078|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
44454079|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454080|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454082|NCT01670721|Fluorouracil|fluorouracil|mesh-list
44454083|NCT01670721|Irinotecan|irinotecan|mesh-list
44454084|NCT01670721|Aflibercept|aflibercept|mesh-list
44454085|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
44454086|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454087|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44180870|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44180871|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44180872|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180873|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44180874|NCT00318890|Protective Agents|protective agents|mesh-ancestor
44180875|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180876|NCT00318903|Docetaxel|docetaxel|mesh-list
44180937|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44180938|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180939|NCT00319059|Annexin A5|annexin a5|mesh-list
44180940|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44180941|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180942|NCT00319072|Hormones|hormones|mesh-list
44180943|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44180944|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44180945|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
44180946|NCT00319150|Hematinics|hematinics|mesh-ancestor
44180947|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
44180948|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44180996|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
44180997|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44180998|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44180999|NCT00319319|Mecamylamine|mecamylamine|mesh-list
44181000|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44181001|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44181002|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
44181003|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181004|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181005|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
44181006|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44181007|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181057|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44181058|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
44181059|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43654859|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43654860|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654861|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654862|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807998|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807999|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43808000|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808001|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808002|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
43808008|NCT04889196|Protective Agents|protective agents|mesh-ancestor
44181060|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181061|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44181062|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44181063|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44181064|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44181065|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181066|NCT00319566|Estrogens|estrogens|mesh-ancestor
44181067|NCT00319566|Hormones|hormones|mesh-ancestor
44181068|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181069|NCT00319605|Levetiracetam|levetiracetam|mesh-list
44181070|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
44181071|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
44181072|NCT00319618|Docetaxel|docetaxel|mesh-list
44181073|NCT00319618|Gefitinib|gefitinib|mesh-list
44181074|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181075|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181113|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181114|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181115|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181116|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181117|NCT00319852|Vaccines|vaccines|mesh-list
44181118|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
44181119|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181120|NCT00319865|Thalidomide|thalidomide|mesh-list
44181121|NCT00319865|Dexamethasone|dexamethasone|mesh-list
44181122|NCT00319865|Doxorubicin|doxorubicin|mesh-list
44181123|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44181124|NCT00319865|Bortezomib|bortezomib|mesh-list
44181125|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181126|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
44181127|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
44181128|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181129|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181130|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181131|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
44181132|NCT00319865|Hormones|hormones|mesh-ancestor
44181133|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181134|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44181135|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181136|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44181137|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44181138|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181139|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181140|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181141|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181142|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
44181143|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
44181144|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181145|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181146|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181147|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44164250|NCT00255554|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44164251|NCT00255554|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181149|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181150|NCT00319878|Cyclosporine|cyclosporine|mesh-list
44181151|NCT00319878|Sirolimus|sirolimus|mesh-list
44181152|NCT00319878|Cyclosporins|cyclosporins|mesh-list
44181153|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181154|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181155|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181156|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
43808013|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808014|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181157|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181158|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
43808020|NCT04888728|Nebivolol|nebivolol|mesh-list
44181159|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181160|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
44181161|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181162|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181163|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181164|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44181165|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181166|NCT00319917|Tacrolimus|tacrolimus|mesh-list
44181206|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
44181207|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181208|NCT00320073|Pemetrexed|pemetrexed|mesh-list
44181209|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44181210|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181211|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181212|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181213|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44181214|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44181215|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181216|NCT00320099|Insulin|insulin|mesh-list
44181217|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44181218|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
44181219|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44181220|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44181221|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44181222|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
44181223|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44181224|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181225|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181226|NCT00320125|Calcium|calcium|mesh-list
44181227|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44181228|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181229|NCT00320229|Abciximab|abciximab|mesh-list
44181230|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
44181231|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44181232|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44181233|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181234|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181235|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44181236|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44181237|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181238|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181239|NCT00320294|Cisplatin|cisplatin|mesh-list
44181240|NCT00320294|Irinotecan|irinotecan|mesh-list
44181245|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808023|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43808024|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808025|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808026|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808027|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
43808028|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181246|NCT00320307|Abacavir|abacavir|mesh-list
44181247|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44181248|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44181249|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181250|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181251|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
44181252|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181253|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44181254|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44181255|NCT00320320|Irinotecan|irinotecan|mesh-list
44181256|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181257|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181258|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181259|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181260|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181261|NCT00320359|Cisplatin|cisplatin|mesh-list
44181262|NCT00320359|Etoposide|etoposide|mesh-list
44181263|NCT00320359|Topotecan|topotecan|mesh-list
44181264|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181265|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181266|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44181267|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181268|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454112|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454113|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454114|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454115|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454116|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454117|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44454118|NCT01670526|Protective Agents|protective agents|mesh-ancestor
44454119|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
44454120|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
44454121|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454122|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454123|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454124|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
44454125|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
44454126|NCT01670097|Dexamethasone|dexamethasone|mesh-list
44454127|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454128|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
44454129|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
44454130|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454131|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454132|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44454133|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
44454134|NCT01670097|Hormones|hormones|mesh-ancestor
44454135|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808039|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43808040|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
43808041|NCT04888741|Cyclosporine|cyclosporine|mesh-list
43808042|NCT04888741|Sirolimus|sirolimus|mesh-list
43808043|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
43808044|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
43808045|NCT04888741|Cyclosporins|cyclosporins|mesh-list
43808046|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
43808047|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808048|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
44454136|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43808049|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454137|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454138|NCT01670019|Asenapine|asenapine|mesh-list
44454139|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44454140|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454141|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454142|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454143|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454144|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
44454151|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454152|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454153|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454154|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44454155|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454156|NCT01669811|Esomeprazole|esomeprazole|mesh-list
44454157|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44454158|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181273|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44181274|NCT00320567|Norgestimate|norgestimate|mesh-list
44181275|NCT00320567|Estradiol|estradiol|mesh-list
44181276|NCT00320567|Estrogens|estrogens|mesh-ancestor
44181277|NCT00320567|Hormones|hormones|mesh-ancestor
44181278|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181279|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181280|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44181281|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
44181282|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44181283|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44181284|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44181285|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44181286|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44181287|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44181288|NCT00320580|Norelgestromin|norelgestromin|mesh-list
44181289|NCT00320580|Estradiol|estradiol|mesh-list
44181290|NCT00320580|Estrogens|estrogens|mesh-ancestor
44181291|NCT00320580|Hormones|hormones|mesh-ancestor
44181292|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181293|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181294|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44181295|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
44181296|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44181297|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44181298|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44181299|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44181304|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
44181305|NCT00320619|Coagulants|coagulants|mesh-ancestor
44181306|NCT00320632|Desipramine|desipramine|mesh-list
43808057|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
43808058|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181307|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44181308|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181309|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181310|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181311|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181312|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44181313|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44181314|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181315|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
44181316|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181317|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181318|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44181319|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44181320|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
44181321|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181322|NCT00320658|Antacids|antacids|mesh-ancestor
44181323|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181324|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181325|NCT00320697|Bupropion|bupropion|mesh-list
44181326|NCT00320697|Nicotine|nicotine|mesh-list
44181327|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44181328|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
44181329|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181330|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181331|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44181332|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44181333|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181334|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181335|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181336|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44181337|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181338|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164252|NCT00255554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164253|NCT00255567|Paromomycin|paromomycin|mesh-list
44164254|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44181339|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44181340|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44181341|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181342|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
44181343|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44181344|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44181345|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181346|NCT00320723|Bupropion|bupropion|mesh-list
44181347|NCT00320723|Nicotine|nicotine|mesh-list
44181348|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44181349|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
44181350|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181351|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181352|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44181353|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44181354|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181355|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181356|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181357|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44181358|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181359|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181360|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44181361|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44181362|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181363|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
44181364|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44181365|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44181366|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181367|NCT00320736|Galantamine|galantamine|mesh-list
44181368|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44181369|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181370|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181371|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
44181372|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164255|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164256|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164257|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44164258|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44181373|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181374|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44181375|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
44181376|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181377|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
44181378|NCT00320775|Aflibercept|aflibercept|mesh-list
44181379|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181380|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44181381|NCT00320775|Growth Substances|growth substances|mesh-ancestor
44181382|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181383|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181384|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181385|NCT00320814|Aflibercept|aflibercept|mesh-list
44181386|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181387|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44181388|NCT00320814|Growth Substances|growth substances|mesh-ancestor
44181389|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181390|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181391|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181392|NCT00320827|Antibodies|antibodies|mesh-list
44181393|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
44181394|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181395|NCT00320853|Vitamin D|vitamin d|mesh-list
44181396|NCT00320853|Vitamins|vitamins|mesh-ancestor
44181397|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
44181398|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181399|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44181400|NCT00320879|Irbesartan|irbesartan|mesh-list
44181421|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808114|NCT04887649|Narcotics|narcotics|mesh-ancestor
43808115|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808116|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808119|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808120|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
43808121|NCT04887844|Lidocaine|lidocaine|mesh-list
43808122|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808123|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
43793877|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
43841335|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181422|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44181424|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44181425|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44181426|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44181427|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181429|NCT00320983|Topotecan|topotecan|mesh-list
44181430|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181431|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181432|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181433|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181434|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181435|NCT00321074|Tacrolimus|tacrolimus|mesh-list
44181436|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181437|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
44181438|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181439|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181440|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181441|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181442|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
44181443|NCT00321113|Tacrolimus|tacrolimus|mesh-list
44181444|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181445|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
44181446|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181447|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181448|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181449|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181450|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44181451|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181452|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44181453|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
44181454|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181455|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181456|NCT00321126|Zinc|zinc|mesh-list
44181457|NCT00321126|Trace Elements|trace elements|mesh-ancestor
44164259|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
44181458|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
44181459|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181460|NCT00321165|Taurolidine|taurolidine|mesh-list
44181461|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181462|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44181463|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181464|NCT00321178|Clarithromycin|clarithromycin|mesh-list
44181465|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181466|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181467|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44181468|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181469|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181470|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44181471|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44181472|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
44181473|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44181474|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
44181475|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
44181476|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181477|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181478|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181479|NCT00321191|Analgesics|analgesics|mesh-ancestor
44181480|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
44181481|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181482|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
44181483|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
44181484|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
44181485|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181486|NCT00321230|Protective Agents|protective agents|mesh-ancestor
44181487|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181488|NCT00321230|Vitamins|vitamins|mesh-ancestor
44181489|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
44181490|NCT00321230|Laxatives|laxatives|mesh-ancestor
44181500|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44181502|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181503|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181504|NCT00321360|Propofol|propofol|mesh-list
44181505|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44181506|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181507|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181508|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44181509|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
44181510|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
44181511|NCT00321477|Casopitant|casopitant|mesh-list
44181512|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
44181513|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
44181514|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181515|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181516|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181517|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44181518|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808147|NCT04887493|Alprostadil|alprostadil|mesh-list
43808148|NCT04887493|Misoprostol|misoprostol|mesh-list
43808149|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43808150|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
43808151|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793896|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793897|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793898|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793899|NCT02579811|Axitinib|axitinib|mesh-list
43793900|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793901|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181519|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181520|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44181521|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44181522|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181523|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181524|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44181525|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44181526|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181527|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181528|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44181529|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44181533|NCT00321490|Analgesics|analgesics|mesh-ancestor
44181540|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44181541|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44181542|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181543|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181544|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
44181546|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181547|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181548|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44181549|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44181550|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
44181551|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44181552|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44181553|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44181554|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44181555|NCT00321581|Cediranib|cediranib|mesh-list
44181556|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181557|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181558|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181559|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181560|NCT00321633|Carboplatin|carboplatin|mesh-list
44181561|NCT00321633|Docetaxel|docetaxel|mesh-list
44181562|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181563|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181564|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181565|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181566|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181567|NCT00321724|Cediranib|cediranib|mesh-list
44181568|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454159|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44181570|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181581|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
44181582|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181583|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
44181584|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181585|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181586|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181587|NCT00321802|Simvastatin|simvastatin|mesh-list
44181588|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44181589|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44181590|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
44181591|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181592|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44181593|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44181594|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181595|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44181596|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44181597|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
44181598|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181599|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181600|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
44181601|NCT00322036|Analgesics|analgesics|mesh-ancestor
44181602|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
44181603|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181604|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181605|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44181606|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181607|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181608|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181609|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44181610|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181611|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181620|NCT00322062|Laxatives|laxatives|mesh-ancestor
44181621|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44181622|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
44181623|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44181624|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181625|NCT00322114|Lycopene|lycopene|mesh-list
44181626|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181627|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
44181628|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181629|NCT00322114|Protective Agents|protective agents|mesh-ancestor
44181630|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181631|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44181632|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44181633|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181634|NCT00322127|Plerixafor|plerixafor|mesh-list
44181635|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44181681|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181682|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44181683|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181684|NCT00322569|Analgesics|analgesics|mesh-ancestor
44181685|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
44181686|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181687|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181688|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181689|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181690|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44181691|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181692|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
44181693|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44181694|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181695|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44181697|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
44181698|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181699|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44181700|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44181701|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181702|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181703|NCT00322595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44181704|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44181705|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44181706|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181707|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44181708|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
44181709|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44181723|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44181724|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
44181725|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181726|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44181727|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
44181729|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
44181730|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44454160|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454161|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454162|NCT01669798|Nintedanib|nintedanib|mesh-list
44454163|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454164|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454165|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454166|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454167|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
44454168|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44454169|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
44454170|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454171|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454172|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44454173|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44454174|NCT01669343|Letrozole|letrozole|mesh-list
44454175|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454176|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44454177|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44454198|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454200|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
44454201|NCT01668784|Nivolumab|nivolumab|mesh-list
44454202|NCT01668784|Everolimus|everolimus|mesh-list
44454203|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454204|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454205|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44454206|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454207|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454208|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
44454209|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454210|NCT01668667|Gabapentin|gabapentin|mesh-list
44454211|NCT01668667|Analgesics|analgesics|mesh-ancestor
44454212|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
44454213|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454214|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454215|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
44454216|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44454217|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454218|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454219|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44181731|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44181732|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
44181733|NCT00322699|Trioxsalen|trioxsalen|mesh-list
44181737|NCT00322751|Topotecan|topotecan|mesh-list
44181758|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44181759|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44181760|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181761|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44181762|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181763|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44181764|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181765|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44181766|NCT00322907|Analgesics|analgesics|mesh-ancestor
44181767|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
43808152|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808153|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43808154|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808155|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
43808156|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44181768|NCT00322920|Cisplatin|cisplatin|mesh-list
44181769|NCT00322920|Topotecan|topotecan|mesh-list
44181770|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181771|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181772|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181773|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181774|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181775|NCT00321009|Enoxaparin|enoxaparin|mesh-list
44181776|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
44181777|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44181778|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44181779|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181780|NCT00322972|Azithromycin|azithromycin|mesh-list
44181781|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44181782|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181783|NCT00322985|Lenalidomide|lenalidomide|mesh-list
44181809|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
44181810|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44181811|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181812|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181813|NCT00323011|Antidotes|antidotes|mesh-ancestor
44181814|NCT00323011|Protective Agents|protective agents|mesh-ancestor
44181815|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
44181816|NCT00323011|Vitamins|vitamins|mesh-ancestor
44181817|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
44181818|NCT00323011|Hematinics|hematinics|mesh-ancestor
44181819|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
44181820|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44181821|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44181822|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44181823|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44181824|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181825|NCT00323154|Nalbuphine|nalbuphine|mesh-list
44181826|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44181827|NCT00323154|Narcotics|narcotics|mesh-ancestor
44181828|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44181829|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181830|NCT00323154|Analgesics|analgesics|mesh-ancestor
44181831|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
44181832|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181833|NCT00323206|Interleukin-12|interleukin-12|mesh-list
44181834|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44181835|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
44181836|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181837|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44181838|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44181839|NCT00323206|Growth Substances|growth substances|mesh-ancestor
44181840|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
44181841|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181842|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
44181843|NCT00323219|Cefazolin|cefazolin|mesh-list
44181849|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181850|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181851|NCT00323323|Prednisone|prednisone|mesh-list
44181852|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
44181853|NCT00323323|Doxorubicin|doxorubicin|mesh-list
44181854|NCT00323323|Vincristine|vincristine|mesh-list
44181855|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
44181856|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181857|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
44181858|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181859|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44181860|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44181861|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
44181862|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181863|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181864|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44181865|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44181866|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44181867|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44181868|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181869|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44181870|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
44181871|NCT00323323|Hormones|hormones|mesh-ancestor
44181872|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44181873|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44181874|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181875|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181898|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44181899|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
44181900|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181901|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44181902|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44181903|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181904|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181905|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44181906|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44181907|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
44181908|NCT00323583|Leucovorin|leucovorin|mesh-list
44181909|NCT00323583|Paclitaxel|paclitaxel|mesh-list
44181910|NCT00323583|Fluorouracil|fluorouracil|mesh-list
44181911|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
44181912|NCT00323583|Calcium|calcium|mesh-list
44181913|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44181914|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181915|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44181916|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44181917|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44181918|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181919|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44181920|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181921|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
44181922|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44181923|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181924|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
44181925|NCT00323583|Antidotes|antidotes|mesh-ancestor
44181926|NCT00323583|Protective Agents|protective agents|mesh-ancestor
44181927|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
44181928|NCT00323583|Vitamins|vitamins|mesh-ancestor
44181929|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
44181930|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44181931|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181932|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44181933|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44164260|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44181935|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181936|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181937|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
44181938|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181939|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44181940|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44181941|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
44181942|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44181943|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
44181944|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181945|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
44181946|NCT00323778|Protective Agents|protective agents|mesh-ancestor
44181947|NCT00323791|Gemcitabine|gemcitabine|mesh-list
44181948|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
44181949|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44181950|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
44181951|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181952|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44181953|NCT00323791|Antiviral Agents|antiviral agents|mesh-ancestor
44181954|NCT00323791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44181955|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181956|NCT00323791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44181957|NCT00323791|Immunologic Factors|immunologic factors|mesh-ancestor
44181958|NCT00323791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181959|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44181985|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44181986|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44181987|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44181988|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
44181989|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44181990|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44181991|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
44181992|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44181993|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
44181994|NCT00323843|Protective Agents|protective agents|mesh-ancestor
44181995|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
44181996|NCT00323934|Mocetinostat|mocetinostat|mesh-list
44181997|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44181998|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44181999|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182000|NCT00323947|Methylphenidate|methylphenidate|mesh-list
44182001|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44182002|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182003|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44182004|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44182005|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182006|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182007|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
44182008|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182009|NCT00323973|Bisoprolol|bisoprolol|mesh-list
44182010|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182011|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
44182012|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
44182013|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843665|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843666|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843667|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
43843668|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43843669|NCT04436913|Fluorides|fluorides|mesh-list
43843670|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
43843671|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
43843692|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
43843693|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
43843694|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841386|NCT04624178|Nivolumab|nivolumab|mesh-list
44182014|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182015|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44182016|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44182017|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44182022|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182023|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182024|NCT00324012|Cisplatin|cisplatin|mesh-list
44182025|NCT00324012|Docetaxel|docetaxel|mesh-list
44182026|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182027|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
44182028|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182029|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182030|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182031|NCT00324025|Efungumab|efungumab|mesh-list
44182032|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
44182033|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182034|NCT00324051|Olanzapine|olanzapine|mesh-list
44182035|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
44182036|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
44182037|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182038|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182039|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182040|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44182041|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182042|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182043|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182044|NCT00324051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44182045|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44182046|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182047|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182048|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182070|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182071|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182072|NCT00324298|Cisplatin|cisplatin|mesh-list
44182073|NCT00324298|Etoposide|etoposide|mesh-list
44182074|NCT00324298|Bleomycin|bleomycin|mesh-list
44182075|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182076|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44182077|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182078|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182079|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182080|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182081|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182082|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
44182083|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44182084|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182085|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182086|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182087|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182088|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182089|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182090|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182091|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44182092|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
44182093|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44182094|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182095|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44182096|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44182097|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44182098|NCT00324363|Exenatide|exenatide|mesh-list
44182113|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182114|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
43843697|NCT04436107|Growth Substances|growth substances|mesh-ancestor
44182115|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182116|NCT00324454|Levetiracetam|levetiracetam|mesh-list
44182117|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
44182118|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
44182119|NCT00324467|Acetaminophen|acetaminophen|mesh-list
44182120|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
44182121|NCT00324467|Promethazine|promethazine|mesh-list
44182122|NCT00324467|Dexamethasone|dexamethasone|mesh-list
44182123|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
44182124|NCT00324467|Prednisone|prednisone|mesh-list
44182125|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
44182126|NCT00324467|Ifosfamide|ifosfamide|mesh-list
44182127|NCT00324467|Rituximab|rituximab|mesh-list
44182128|NCT00324467|Carboplatin|carboplatin|mesh-list
44182129|NCT00324467|Doxorubicin|doxorubicin|mesh-list
44182130|NCT00324467|Etoposide|etoposide|mesh-list
44182131|NCT00324467|Vincristine|vincristine|mesh-list
44182132|NCT00324467|Ondansetron|ondansetron|mesh-list
44182133|NCT00324467|BB 1101|bb 1101|mesh-list
44182134|NCT00324467|Mesna|mesna|mesh-list
44182135|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182136|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
44182137|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182138|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182139|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44182140|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
44182141|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182142|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182143|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44182144|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44182145|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182146|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
44182147|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
44182159|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44182161|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182162|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182163|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44182164|NCT00324467|Analgesics|analgesics|mesh-ancestor
44182165|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
44182166|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
44182167|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
44182168|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
44182169|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44182170|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
44182171|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182172|NCT00324467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44182173|NCT00324467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182174|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182175|NCT00324467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182176|NCT00324467|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44182177|NCT00324467|Protective Agents|protective agents|mesh-ancestor
44182178|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43808186|NCT04886362|Ivermectin|ivermectin|mesh-list
43808187|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43808188|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808189|NCT04886193|Leucovorin|leucovorin|mesh-list
43808190|NCT04886193|Docetaxel|docetaxel|mesh-list
43808191|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
43841414|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841415|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43841416|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841418|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
43841419|NCT04621500|Vitamins|vitamins|mesh-ancestor
44182179|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44182180|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
44182181|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
44182182|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44182183|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
44182184|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
44182210|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182211|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182212|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
44182213|NCT00324558|Bemiparin|bemiparin|mesh-list
44182214|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
44454220|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44454221|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44454222|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454223|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454224|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
44454225|NCT01668654|Ezogabine|ezogabine|mesh-list
44454226|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
44454227|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454228|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454229|NCT01668147|Ritonavir|ritonavir|mesh-list
44454230|NCT01668147|Efavirenz|efavirenz|mesh-list
44454231|NCT01668147|Loperamide|loperamide|mesh-list
44454232|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
44454233|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44454234|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44454235|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454236|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454237|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454238|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44454239|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44454240|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
44454241|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454242|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44454243|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44454244|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44454245|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44454246|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44454247|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44454248|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44454249|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44454250|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44454252|NCT01668004|Golimumab|golimumab|mesh-list
44454253|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44454254|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454255|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454256|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
44454257|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454258|NCT01667926|Ketamine|ketamine|mesh-list
44454259|NCT01667926|Analgesics|analgesics|mesh-ancestor
44454260|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
44454261|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454262|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454263|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44454264|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44454265|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
44454266|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
44454267|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454268|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43808192|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808193|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808194|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808195|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808197|NCT04886193|Antidotes|antidotes|mesh-ancestor
44182216|NCT00324571|Sevelamer|sevelamer|mesh-list
44182217|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182218|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182219|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
44182220|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
44182221|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182222|NCT00324597|Gemcitabine|gemcitabine|mesh-list
44182223|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
44182224|NCT00324597|Imetelstat|imetelstat|mesh-list
44182225|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44182226|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
44182227|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182228|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182229|NCT00324597|Antiviral Agents|antiviral agents|mesh-ancestor
44182230|NCT00324597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182231|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182232|NCT00324597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182239|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182240|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182241|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
44182242|NCT00324623|Fludarabine|fludarabine|mesh-list
44182243|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
44182244|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182245|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
44182246|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182247|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182248|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44182249|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
44182250|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182251|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182252|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44182253|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44182254|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
44182255|NCT00324688|Tenofovir|tenofovir|mesh-list
44182256|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
44182257|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182258|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44182259|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44182260|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182261|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182262|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44182263|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44182264|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
44182265|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44182266|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182267|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182269|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182280|NCT00324766|Simendan|simendan|mesh-list
44182281|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44182282|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182283|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44182284|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44182285|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182286|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182287|NCT00324766|Protective Agents|protective agents|mesh-ancestor
44182288|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182289|NCT00324779|Rituximab|rituximab|mesh-list
44182290|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808204|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
43808222|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808223|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43808224|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43808225|NCT04885660|Protective Agents|protective agents|mesh-ancestor
43808227|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
44182291|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182292|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
44182293|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182294|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182295|NCT00324792|Insulin|insulin|mesh-list
44182296|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44182297|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182304|NCT00324831|Prednisone|prednisone|mesh-list
44182337|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182338|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182340|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44182341|NCT00324922|Trimethoprim|trimethoprim|mesh-list
44182342|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
44182343|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182344|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182345|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44182346|NCT00324922|Renal Agents|renal agents|mesh-ancestor
44182347|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
44182348|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44182349|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44182350|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44182351|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182352|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182353|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44182354|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44182355|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44182356|NCT00324948|Alprostadil|alprostadil|mesh-list
44182357|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44182358|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182359|NCT00324948|Urological Agents|urological agents|mesh-ancestor
44182360|NCT00324974|Lansoprazole|lansoprazole|mesh-list
44182361|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
44182362|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182363|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182364|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44182365|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182366|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182367|NCT00325000|Amitriptyline|amitriptyline|mesh-list
44182368|NCT00325000|Sertraline|sertraline|mesh-list
44182369|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
44182370|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182371|NCT00325000|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44182372|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44182373|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164261|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
44182374|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182375|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182376|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
44182377|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182378|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44182379|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44182380|NCT00325000|Analgesics|analgesics|mesh-ancestor
44182381|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
44182382|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182383|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44182384|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182385|NCT00325026|Misoprostol|misoprostol|mesh-list
44182386|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44182387|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
44182388|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43808231|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43808232|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808233|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
43808235|NCT04885751|Protective Agents|protective agents|mesh-ancestor
44182389|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182390|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182391|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182392|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
44182393|NCT00325104|Calcium|calcium|mesh-list
44182394|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
44182395|NCT00325104|Hormones|hormones|mesh-list
44182396|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182397|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182398|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182399|NCT00325117|Vildagliptin|vildagliptin|mesh-list
44182400|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44182401|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182402|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44182403|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
44182404|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182406|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
44182414|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
44182415|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44182416|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44182417|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182418|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182419|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
44182420|NCT00325169|Hormones|hormones|mesh-ancestor
44182421|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182422|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
44182423|NCT00325182|Levetiracetam|levetiracetam|mesh-list
44182424|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
44182425|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
44182426|NCT00325286|Carbamazepine|carbamazepine|mesh-list
44182427|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182428|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182429|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
44182430|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182431|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182432|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182433|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
44182434|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44182435|NCT00325286|Analgesics|analgesics|mesh-ancestor
44182436|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
44182437|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182438|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44182439|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182440|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44182441|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44182443|NCT00325325|Tacrolimus|tacrolimus|mesh-list
44182444|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182445|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
44182446|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182456|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44182457|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44182458|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44182459|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
44182460|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182461|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182462|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182463|NCT00325429|Vildagliptin|vildagliptin|mesh-list
44182464|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44182465|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182466|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44182467|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
44182468|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182469|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182476|NCT00325546|Rimonabant|rimonabant|mesh-list
44182512|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182513|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182514|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44182515|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
44182516|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
44182517|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
44182518|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44182519|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44182520|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44182521|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44182522|NCT00325715|Esomeprazole|esomeprazole|mesh-list
44182523|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44182524|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182525|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44182526|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182571|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182572|NCT00325936|Cilnidipine|cilnidipine|mesh-list
44182573|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44182574|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182575|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182576|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182577|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182578|NCT00325949|Acetaminophen|acetaminophen|mesh-list
44182579|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44182580|NCT00325949|Hydrocodone|hydrocodone|mesh-list
44182581|NCT00325949|Oxycodone|oxycodone|mesh-list
44182582|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44182583|NCT00325949|Analgesics|analgesics|mesh-ancestor
44118840|NCT00115492|Xhance|xhance|mesh-list
44182584|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
44182585|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182586|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182587|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
44182588|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44182589|NCT00325949|Narcotics|narcotics|mesh-ancestor
44182590|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182591|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
44182592|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
44182593|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44182594|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182595|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182596|NCT00325962|Verapamil|verapamil|mesh-list
44182616|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182617|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44182618|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
44182619|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
44182620|NCT00326053|Hormones|hormones|mesh-ancestor
44182621|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182622|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44182623|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43808280|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43808281|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808282|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808283|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43808284|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43808285|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43808321|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808323|NCT04884516|Vitamin A|vitamin a|mesh-list
44182624|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44182625|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182626|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182627|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182628|NCT00326092|Timolol|timolol|mesh-list
44182629|NCT00326092|Brinzolamide|brinzolamide|mesh-list
44182630|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44182631|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44182632|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
44182633|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182634|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182635|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182636|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44182637|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44182638|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44182639|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182640|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44182641|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
44182642|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182643|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44182662|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44182663|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44182664|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182665|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182666|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44182667|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44182668|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
44182669|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182670|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182671|NCT00326248|Casopitant|casopitant|mesh-list
44182672|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
44182673|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
44182674|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182675|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182676|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44182677|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44182678|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182679|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182680|NCT00326300|Methylphenidate|methylphenidate|mesh-list
44182681|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44182682|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182683|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44182684|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44182685|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182686|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182687|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
44182707|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182708|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182709|NCT00326391|Methylphenidate|methylphenidate|mesh-list
43808324|NCT04884516|Vitamins|vitamins|mesh-ancestor
43808325|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
43808326|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808327|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43808367|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808369|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
43808370|NCT04883164|Antibodies|antibodies|mesh-list
43808371|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
43808372|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808373|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43808387|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44182710|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44182711|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182712|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44182713|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44182714|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182715|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182716|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
44182717|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182718|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44182719|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44182720|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44182721|NCT00326404|Desogestrel|desogestrel|mesh-list
44182722|NCT00326404|Estradiol|estradiol|mesh-list
44182723|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44182724|NCT00326404|Estrogens|estrogens|mesh-ancestor
44182725|NCT00326404|Hormones|hormones|mesh-ancestor
44182726|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182727|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182728|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44182729|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
44182730|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44182731|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44182732|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44182734|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44454285|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454286|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44454287|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454288|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454289|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454290|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454291|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44454292|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
44454293|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454294|NCT01667419|Vemurafenib|vemurafenib|mesh-list
44454295|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454296|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454297|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182745|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182746|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182747|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182748|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182749|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182750|NCT00326469|Lanreotide|lanreotide|mesh-list
44182751|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182752|NCT00326508|Daclizumab|daclizumab|mesh-list
44182753|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44182754|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
44182755|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182756|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
44182757|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
44182758|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
44182759|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182760|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182761|NCT00326664|Cediranib|cediranib|mesh-list
44182762|NCT00326664|Maleic acid|maleic acid|mesh-list
44182763|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182764|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182765|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182766|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43808390|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182767|NCT00326768|Telmisartan|telmisartan|mesh-list
44182796|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44182797|NCT00326859|Narcotics|narcotics|mesh-ancestor
44182798|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44182799|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182800|NCT00326859|Analgesics|analgesics|mesh-ancestor
44182801|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
44182802|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182803|NCT00327080|Acetylcholine|acetylcholine|mesh-list
44182804|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182805|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44182806|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
44182807|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44182808|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182809|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182810|NCT00327093|Bevacizumab|bevacizumab|mesh-list
44182811|NCT00327093|Cetuximab|cetuximab|mesh-list
44182812|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44182813|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182814|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44182815|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44182816|NCT00327093|Growth Substances|growth substances|mesh-ancestor
44182817|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182818|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
44182819|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
44182820|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44182846|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44182847|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182848|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44182849|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182850|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
44182851|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44182852|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44182853|NCT00327145|Diuretics|diuretics|mesh-ancestor
44182854|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
44182855|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44182856|NCT00327184|PENTA|penta|mesh-list
44182857|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
44182858|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44182861|NCT00327197|Prednisolone|prednisolone|mesh-list
44182906|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
44182907|NCT00327379|Coagulants|coagulants|mesh-ancestor
44182908|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44182909|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44182910|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808402|NCT04882540|Brivaracetam|brivaracetam|mesh-list
43808403|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
43808404|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
43808405|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808406|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808407|NCT04882683|Prednisone|prednisone|mesh-list
43808408|NCT04882683|Adalimumab|adalimumab|mesh-list
43808409|NCT04882683|Azathioprine|azathioprine|mesh-list
43808410|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808411|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
43808412|NCT04882683|Hormones|hormones|mesh-ancestor
43794263|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794264|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43794265|NCT03646617|Nivolumab|nivolumab|mesh-list
44182911|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182912|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182913|NCT00327418|Atorvastatin|atorvastatin|mesh-list
44182914|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44182915|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44182916|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
44182917|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182918|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44182919|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44182920|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182921|NCT05458765|Tenofovir|tenofovir|mesh-list
44182922|NCT05458765|Emtricitabine|emtricitabine|mesh-list
44182923|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44182924|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
44182925|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
44182926|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44182927|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44182928|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44182929|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182930|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182931|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44182932|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44182933|NCT05458492|Sirolimus|sirolimus|mesh-list
44182934|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44182949|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182950|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44182951|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44182952|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
44182953|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182954|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44182955|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44182956|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44182957|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
44182958|NCT05458180|Hormones|hormones|mesh-ancestor
44182959|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44182960|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44182961|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44182962|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44182963|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44182964|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44182965|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
44182966|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
44182967|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
44182968|NCT05458180|Analgesics|analgesics|mesh-ancestor
44182969|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
44182970|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44182971|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44182972|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44182973|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44182974|NCT05458076|Ritonavir|ritonavir|mesh-list
44182975|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44182976|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44182977|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454346|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44454347|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
44454348|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44454349|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
44454350|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454352|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454353|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44454354|NCT01666444|Doxorubicin|doxorubicin|mesh-list
44454355|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44454356|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44454357|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454358|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44454359|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454360|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454361|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454362|NCT01666314|Prednisone|prednisone|mesh-list
44454363|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454364|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
44454365|NCT01666314|Hormones|hormones|mesh-ancestor
44454366|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454367|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454368|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44454369|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454370|NCT01666119|Buprenorphine|buprenorphine|mesh-list
44454371|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44454372|NCT01666119|Narcotics|narcotics|mesh-ancestor
44454373|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454374|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454375|NCT01666119|Analgesics|analgesics|mesh-ancestor
44454376|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
44454377|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454378|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44454379|NCT01665911|Listerine|listerine|mesh-list
44454380|NCT01665911|Fluorides|fluorides|mesh-list
44164262|NCT00255593|Rituximab|rituximab|mesh-list
44164263|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44164264|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164265|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
44164266|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454381|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
44454382|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
44454383|NCT01665911|Protective Agents|protective agents|mesh-ancestor
44454384|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454385|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43808420|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43808421|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808422|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
43808423|NCT04882163|Gemcitabine|gemcitabine|mesh-list
43808424|NCT04882163|Dexamethasone|dexamethasone|mesh-list
43808425|NCT04882163|Rituximab|rituximab|mesh-list
43808426|NCT04882163|Cisplatin|cisplatin|mesh-list
43808427|NCT04882163|Lenalidomide|lenalidomide|mesh-list
43808428|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44454386|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454387|NCT01665768|Rituximab|rituximab|mesh-list
44454388|NCT01665768|Everolimus|everolimus|mesh-list
44119289|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
44182986|NCT05457946|Vaccines|vaccines|mesh-list
44182987|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
44182988|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182989|NCT05457894|Vaccines|vaccines|mesh-list
44182990|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
44182991|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44182992|NCT05457829|Doxorubicin|doxorubicin|mesh-list
44182993|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44182994|NCT05457829|Irinotecan|irinotecan|mesh-list
44182995|NCT05457829|Vincristine|vincristine|mesh-list
44182996|NCT05457829|Temozolomide|temozolomide|mesh-list
44182997|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44182998|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183032|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183033|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183034|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183035|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44183036|NCT05456113|Cannabidiol|cannabidiol|mesh-list
44183037|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
44183038|NCT05455944|Pregabalin|pregabalin|mesh-list
44183039|NCT05455944|Analgesics|analgesics|mesh-ancestor
44183040|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
44183041|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183042|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183043|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
44183044|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44183045|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183046|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183047|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44183048|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44183049|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44183050|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183051|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183087|NCT05354258|Amodiaquine|amodiaquine|mesh-list
44183088|NCT05354258|Albendazole|albendazole|mesh-list
44183089|NCT05354258|Praziquantel|praziquantel|mesh-list
44183090|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
44183091|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44183092|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43808429|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808430|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808431|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
43808432|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808433|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808434|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808435|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
43808436|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
43841472|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183093|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183094|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44183095|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841473|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841475|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
44183096|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183097|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44183098|NCT05354258|Renal Agents|renal agents|mesh-ancestor
44183099|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
44183100|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
44183101|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44183102|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183103|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183104|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183105|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183106|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
44183107|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183108|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183109|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
44183110|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183111|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183112|NCT05238831|Paclitaxel|paclitaxel|mesh-list
44183113|NCT05238831|Vinorelbine|vinorelbine|mesh-list
44183114|NCT05238831|Maytansine|maytansine|mesh-list
44183115|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
44183140|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
44183141|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183142|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183143|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183144|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183145|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183146|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183147|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44183148|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44183149|NCT05238831|Growth Substances|growth substances|mesh-ancestor
44183150|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183151|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
44183152|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
44183153|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183154|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
44183155|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44183156|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183157|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183158|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44183159|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44183160|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44183161|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
44183162|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183163|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44183164|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183165|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44183166|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183167|NCT05222932|Avelumab|avelumab|mesh-list
44183168|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183169|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183170|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
44183180|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183181|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183182|NCT05198960|Analgesics|analgesics|mesh-ancestor
44183183|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
44183184|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183185|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183186|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183187|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183188|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44183189|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44183190|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183191|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44183192|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44183193|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183194|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
44183195|NCT05181007|Valproic Acid|valproic acid|mesh-list
44183196|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
44183197|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183198|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183199|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
44183200|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183201|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183202|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
44183203|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44183204|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183205|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183206|NCT05126836|Cilostazol|cilostazol|mesh-list
44183207|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44183208|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
44183209|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183210|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183211|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44183212|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
44183213|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44183219|NCT05126836|Protective Agents|protective agents|mesh-ancestor
44183220|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44183221|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44183222|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454389|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454390|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454391|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
44454392|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454393|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454394|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454395|NCT01665599|Testosterone|testosterone|mesh-list
44454396|NCT01665599|Androgens|androgens|mesh-ancestor
44454397|NCT01665599|Hormones|hormones|mesh-ancestor
44454398|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454399|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454400|NCT01665144|Siponimod|siponimod|mesh-list
44454401|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44454402|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454403|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454404|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
44454405|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454406|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44454407|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44454408|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
44454409|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44454410|NCT01664949|Laxatives|laxatives|mesh-ancestor
44454411|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44454412|NCT01664923|Bicalutamide|bicalutamide|mesh-list
44454413|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
44454414|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
44454415|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454416|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454417|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454418|NCT01664624|Exenatide|exenatide|mesh-list
44454425|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454426|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44454427|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
44454428|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454429|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454430|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44454431|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454432|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454433|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454434|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454435|NCT01664494|Capecitabine|capecitabine|mesh-list
44454436|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454437|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
44454438|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454439|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454440|NCT01664247|Liraglutide|liraglutide|mesh-list
44454441|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454442|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454443|NCT01664247|Incretins|incretins|mesh-ancestor
44454444|NCT01664247|Hormones|hormones|mesh-ancestor
44454445|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454446|NCT01664039|Bimatoprost|bimatoprost|mesh-list
44454447|NCT01664039|Travoprost|travoprost|mesh-list
44454448|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44454449|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44454450|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44454451|NCT01663987|Bromides|bromides|mesh-list
44454452|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
44454453|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44454454|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
44454455|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454457|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44183231|NCT05008224|Bleomycin|bleomycin|mesh-list
44183232|NCT05008224|Vinblastine|vinblastine|mesh-list
44183233|NCT05008224|Procarbazine|procarbazine|mesh-list
44183234|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183235|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
44183236|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183237|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183238|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183239|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
44183240|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183241|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183242|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183243|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44183244|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44183245|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183246|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183247|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183248|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183250|NCT05008224|Hormones|hormones|mesh-ancestor
44183287|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44183288|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44183289|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183290|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44183291|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44183292|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
44183293|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44183294|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44183295|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43808482|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808483|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808484|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808485|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808489|NCT04881851|Folic Acid|folic acid|mesh-list
44183296|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44183297|NCT04803422|Amoxicillin|amoxicillin|mesh-list
44183298|NCT04803422|Metronidazole|metronidazole|mesh-list
44183299|NCT04803422|Tazobactam|tazobactam|mesh-list
44183300|NCT04803422|Piperacillin|piperacillin|mesh-list
44183301|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
44183302|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
44183303|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44183304|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183305|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44183306|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44183307|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44183308|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183309|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183310|NCT04790513|Evolocumab|evolocumab|mesh-list
44183311|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44183312|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44183313|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
44183314|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183315|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44183333|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44183334|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44183335|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44183336|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183337|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183338|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
44183339|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183340|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183341|NCT04507412|Dexamethasone|dexamethasone|mesh-list
44183342|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183343|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
44183344|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
44183345|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183346|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183347|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183348|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
44183349|NCT04507412|Hormones|hormones|mesh-ancestor
44183350|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183351|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183352|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183353|NCT04485195|Procainamide|procainamide|mesh-list
44183354|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44183355|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44183356|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44183357|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183380|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
44183381|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183382|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183383|NCT04392531|Cyclosporine|cyclosporine|mesh-list
44183384|NCT04392531|Cyclosporins|cyclosporins|mesh-list
43808491|NCT04881851|Inositol|inositol|mesh-list
43808492|NCT04881851|Hematinics|hematinics|mesh-ancestor
43808493|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
43808494|NCT04881851|Vitamins|vitamins|mesh-ancestor
43808495|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
43808496|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808497|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
43808498|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808499|NCT04881851|Protective Agents|protective agents|mesh-ancestor
43843721|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
43843722|NCT04432662|Hematinics|hematinics|mesh-ancestor
43843723|NCT04431895|Tofacitinib|tofacitinib|mesh-list
43843724|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183385|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183386|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183387|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183388|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
44183389|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183390|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
44183391|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183392|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
44183393|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183394|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44183395|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44183396|NCT04326257|Nivolumab|nivolumab|mesh-list
44183397|NCT04326257|Ipilimumab|ipilimumab|mesh-list
44183398|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183399|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183400|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44183401|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183402|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
44183403|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44183404|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
44183405|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183406|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183407|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44183408|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
44183409|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44183410|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
44183411|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183412|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44183420|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
44183421|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183422|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183423|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183424|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
44183425|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183426|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183427|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183428|NCT04034485|Evolocumab|evolocumab|mesh-list
44183429|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44183430|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44183431|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
44183432|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183433|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44183434|NCT03975439|Chrysarobin|chrysarobin|mesh-list
44183435|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183475|NCT03878524|Bortezomib|bortezomib|mesh-list
44183476|NCT03878524|Ipilimumab|ipilimumab|mesh-list
44183477|NCT03878524|Sorafenib|sorafenib|mesh-list
44183478|NCT03878524|Durvalumab|durvalumab|mesh-list
44183479|NCT03878524|Sunitinib|sunitinib|mesh-list
44183480|NCT03878524|Daunorubicin|daunorubicin|mesh-list
44183481|NCT03878524|Venetoclax|venetoclax|mesh-list
44183482|NCT03878524|Dasatinib|dasatinib|mesh-list
44183483|NCT03878524|Olaparib|olaparib|mesh-list
44183484|NCT03878524|Lenvatinib|lenvatinib|mesh-list
44183485|NCT03878524|Palbociclib|palbociclib|mesh-list
44183486|NCT03878524|Vorinostat|vorinostat|mesh-list
44183487|NCT03878524|Pertuzumab|pertuzumab|mesh-list
44183488|NCT03878524|Trametinib|trametinib|mesh-list
44183489|NCT03878524|Tretinoin|tretinoin|mesh-list
44183490|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
44183491|NCT03878524|Bicalutamide|bicalutamide|mesh-list
44183492|NCT03878524|Afatinib|afatinib|mesh-list
44183493|NCT03878524|Vemurafenib|vemurafenib|mesh-list
44183494|NCT03878524|Panobinostat|panobinostat|mesh-list
44183495|NCT03878524|Dabrafenib|dabrafenib|mesh-list
44183496|NCT03878524|Ponatinib|ponatinib|mesh-list
44183540|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
44183541|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183542|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183543|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183544|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44183545|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44183546|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44183547|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44183548|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44183549|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44183550|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44183551|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43843725|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183552|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
44183553|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
44183554|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
44183555|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44183556|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
44183557|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
44183558|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183559|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44183602|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183603|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
44183604|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44183605|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183606|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183607|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44183608|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44183609|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44183610|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44183611|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44183612|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44183613|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44183614|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44183615|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
44183616|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44183618|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44183619|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44183620|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183621|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183622|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
44183630|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44183631|NCT03031483|Growth Substances|growth substances|mesh-ancestor
44183632|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
44183633|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183634|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183635|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183636|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44183637|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183638|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183639|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44183640|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44183641|NCT03011268|Adalimumab|adalimumab|mesh-list
44183642|NCT03011268|Golimumab|golimumab|mesh-list
44183643|NCT03011268|Infliximab|infliximab|mesh-list
44183644|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44183645|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183646|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183647|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
44183648|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183649|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
44183650|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183651|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
44183652|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183653|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
44183654|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183655|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843726|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183656|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
44183657|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
44183658|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
44183659|NCT02676791|Povidone|povidone|mesh-list
44183660|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
44183682|NCT02329080|Cytarabine|cytarabine|mesh-list
44183683|NCT02329080|Rituximab|rituximab|mesh-list
44183684|NCT02329080|Methotrexate|methotrexate|mesh-list
44183685|NCT02329080|Etoposide|etoposide|mesh-list
44183686|NCT02329080|Ifosfamide|ifosfamide|mesh-list
44183687|NCT02329080|Thiotepa|thiotepa|mesh-list
44183688|NCT02329080|Carmustine|carmustine|mesh-list
44183689|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183690|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183691|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
44183692|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183693|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183694|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44183695|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
44183696|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44183697|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183698|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
44183699|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183700|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
44183701|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183702|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44183703|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183704|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44183705|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183706|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44183707|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183708|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
44183709|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183710|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183711|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
44183712|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183713|NCT02244125|Dexamethasone|dexamethasone|mesh-list
44164267|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164268|NCT00255606|Prednisone|prednisone|mesh-list
43808507|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808508|NCT04881110|Incretins|incretins|mesh-ancestor
43808509|NCT04881110|Hormones|hormones|mesh-ancestor
43808510|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808511|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
43808546|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
43808547|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43808548|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
43808549|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43794467|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794468|NCT03104270|Growth Substances|growth substances|mesh-ancestor
44164269|NCT00255606|Docetaxel|docetaxel|mesh-list
44164270|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183714|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
44183715|NCT02244125|Pomalidomide|pomalidomide|mesh-list
44183716|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183717|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
44183718|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183719|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183720|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183721|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
44183722|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183723|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183724|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183779|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183780|NCT01539447|Naproxen|naproxen|mesh-list
44183781|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183782|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44183783|NCT01539447|Analgesics|analgesics|mesh-ancestor
44183784|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
44183785|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183786|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183787|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183788|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183789|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
44183790|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44183791|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183792|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183793|NCT01370486|Melatonin|melatonin|mesh-list
44183794|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
44183795|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183796|NCT01370486|Protective Agents|protective agents|mesh-ancestor
44183797|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183798|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44183799|NCT00945724|Cytarabine|cytarabine|mesh-list
44183800|NCT00945724|Prednisolone|prednisolone|mesh-list
44183801|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
44183802|NCT00945724|Rituximab|rituximab|mesh-list
44183803|NCT00945724|Doxorubicin|doxorubicin|mesh-list
44183804|NCT00945724|Methotrexate|methotrexate|mesh-list
44183805|NCT00945724|Vincristine|vincristine|mesh-list
44183806|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183807|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
44183808|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183809|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183810|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183811|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
44183812|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183813|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183814|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183815|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183817|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44183818|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44183819|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183820|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44183821|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
44183822|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44183823|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44183824|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
44183825|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794493|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
43794494|NCT03020875|Acetaminophen|acetaminophen|mesh-list
43794495|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794496|NCT03020875|Analgesics|analgesics|mesh-ancestor
43794497|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
43794498|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794499|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183826|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44183827|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44183828|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
44183829|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183830|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44183831|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183832|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
44183833|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
44183834|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183835|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
44183837|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183838|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183839|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44183840|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
44183841|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183842|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
44183843|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
44183844|NCT00327535|Hematinics|hematinics|mesh-ancestor
44183845|NCT00327587|Amlodipine|amlodipine|mesh-list
44183846|NCT00327587|Valsartan|valsartan|mesh-list
44183847|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44183848|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44183849|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44183850|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44183851|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183855|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44183856|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44183857|NCT00327587|Diuretics|diuretics|mesh-ancestor
44183858|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
44183859|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44183860|NCT00327665|Vaccines|vaccines|mesh-list
44183861|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44183862|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
44183863|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183864|NCT00327678|Rituximab|rituximab|mesh-list
44183865|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
44183866|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44183867|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183868|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
44183869|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183870|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44183871|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44183872|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183873|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183874|NCT00327691|Atorvastatin|atorvastatin|mesh-list
44183875|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44183876|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44183877|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
44183878|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183879|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44183880|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44183881|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183882|NCT00327730|Eperisone|eperisone|mesh-list
44183883|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
44183884|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44183898|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183899|NCT00327756|Vitamins|vitamins|mesh-ancestor
44183900|NCT00327769|Fulvestrant|fulvestrant|mesh-list
44183901|NCT00327769|Anastrozole|anastrozole|mesh-list
44183902|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44183903|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44120178|NCT00120367|Tenofovir|tenofovir|mesh-list
44183904|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44183905|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44183906|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
44183907|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183908|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183909|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44183910|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44183911|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44183912|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183913|NCT00327808|Budesonide|budesonide|mesh-list
44183914|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44183915|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44183916|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
44183917|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44183918|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183919|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44183920|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
44183921|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
44183922|NCT00327808|Hormones|hormones|mesh-ancestor
44183923|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44183924|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44454469|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
44454470|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454471|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
44454472|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454473|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454474|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454475|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
44454476|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454477|NCT01663740|Valganciclovir|valganciclovir|mesh-list
44454478|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
44454479|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454480|NCT01663727|Paclitaxel|paclitaxel|mesh-list
44454481|NCT01663727|Bevacizumab|bevacizumab|mesh-list
44454482|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44454483|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454484|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
44454485|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
44454486|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
44454487|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454488|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454489|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44454490|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44454491|NCT01663727|Growth Substances|growth substances|mesh-ancestor
44454492|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454493|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
44454494|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
44454495|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454496|NCT01663623|Azathioprine|azathioprine|mesh-list
44454497|NCT01663623|Belimumab|belimumab|mesh-list
44454498|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
44454499|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454500|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454501|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454502|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454503|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
44454504|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808593|NCT04879030|Cefixime|cefixime|mesh-list
43808594|NCT04879030|beta-Lactams|beta-lactams|mesh-list
43808595|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
43808596|NCT04879030|Ticarcillin|ticarcillin|mesh-list
43808597|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183937|NCT00327925|Antibodies|antibodies|mesh-list
44164271|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
44183938|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
44183939|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183940|NCT00327990|Alendronate|alendronate|mesh-list
44183941|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
44183942|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44183943|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183944|NCT00328029|Busulfan|busulfan|mesh-list
44183945|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
44183946|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44183947|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44183948|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
44183949|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183950|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44183951|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44183952|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44183953|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
44183954|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
44183955|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
44183956|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183957|NCT00328120|Fulvestrant|fulvestrant|mesh-list
44183990|NCT00328380|Rifaximin|rifaximin|mesh-list
44183991|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44183992|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44183993|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44183994|NCT00328393|Pioglitazone|pioglitazone|mesh-list
44183995|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44183996|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44183997|NCT00328432|Celecoxib|celecoxib|mesh-list
44183998|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44183999|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184000|NCT00328432|Analgesics|analgesics|mesh-ancestor
44184001|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
44184002|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184003|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184004|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184005|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184006|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44184007|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184008|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184009|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44120324|NCT00120744|Ondansetron|ondansetron|mesh-list
44184010|NCT00328458|Epothilones|epothilones|mesh-list
44184011|NCT00328458|Epothilone B|epothilone b|mesh-list
44184012|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
44184013|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
44184014|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
44184015|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184016|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184017|NCT00328497|Bevacizumab|bevacizumab|mesh-list
44184018|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44184019|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808615|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
43808616|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808617|NCT04878770|Cyclosporine|cyclosporine|mesh-list
43808618|NCT04878770|Cyclosporins|cyclosporins|mesh-list
43808619|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808620|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808621|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808622|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
43808624|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
44184020|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184021|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44184022|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44184023|NCT00328497|Growth Substances|growth substances|mesh-ancestor
44184024|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184025|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
44184026|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
44164272|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
44164273|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44184028|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
44184029|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184030|NCT00328549|Interferons|interferons|mesh-list
44184031|NCT00328549|Ribavirin|ribavirin|mesh-list
44184032|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184033|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
44184034|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184035|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
44184036|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184037|NCT00328692|Rolofylline|rolofylline|mesh-list
44184038|NCT00328692|Diuretics|diuretics|mesh-ancestor
44184039|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
44184040|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184041|NCT00328718|Fluticasone|fluticasone|mesh-list
44184042|NCT00328718|Xhance|xhance|mesh-list
44184043|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44184044|NCT00328718|Montelukast|montelukast|mesh-list
44184045|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184046|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44184047|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
44184048|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184049|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184050|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44184051|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
44184052|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
44184053|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44184054|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44184055|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44184056|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44184057|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
44184058|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184059|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808626|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
43808627|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808628|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43808629|NCT04878718|Vancomycin|vancomycin|mesh-list
43843774|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43843776|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843777|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843778|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
43843779|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43843780|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43843781|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
43843782|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
43843783|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43843784|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43843785|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43843786|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
43843787|NCT04428307|Artemisinins|artemisinins|mesh-list
44184060|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44184061|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184062|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184065|NCT00328796|Lidocaine|lidocaine|mesh-list
44184066|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
44184067|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
44184068|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184069|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184070|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
44184071|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184072|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184073|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44184074|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44184075|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184076|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184077|NCT00328809|Spironolactone|spironolactone|mesh-list
44184078|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44184079|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184080|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184081|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184082|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44184083|NCT00328809|Diuretics|diuretics|mesh-ancestor
44184084|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
44184085|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44184086|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184087|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184088|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184089|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184090|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184091|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184092|NCT00328874|Ubiquinone|ubiquinone|mesh-list
44184093|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
44184094|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
44184095|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184096|NCT00328874|Vitamins|vitamins|mesh-ancestor
44184097|NCT00328900|Atropine|atropine|mesh-list
44184105|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
44184106|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
44184107|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
44184108|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44184109|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44184110|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
44184111|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184112|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184113|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
44184114|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44184115|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184116|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184117|NCT00328939|Enoxaparin|enoxaparin|mesh-list
44184118|NCT00328939|PENTA|penta|mesh-list
44184119|NCT00328939|Fondaparinux|fondaparinux|mesh-list
44184120|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
44184121|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44184122|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44184123|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184124|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44184125|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
44184126|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44184127|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
43843788|NCT04428307|Artemisinin|artemisinin|mesh-list
43843789|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
44184128|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184129|NCT00328965|Lacidipine|lacidipine|mesh-list
44184130|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44184131|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43808681|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44184132|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184133|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184134|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44184135|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184136|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44184137|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184138|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184139|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184143|NCT00329069|Atorvastatin|atorvastatin|mesh-list
44184144|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44184145|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184146|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
44184147|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184148|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184149|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44184150|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184151|NCT00329095|Bimatoprost|bimatoprost|mesh-list
44184152|NCT00329095|Travoprost|travoprost|mesh-list
44184153|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
44184154|NCT00329095|Latanoprost|latanoprost|mesh-list
44184155|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44184156|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44184157|NCT00329134|Quinine|quinine|mesh-list
44184158|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
44184159|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44184160|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184161|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184162|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44184163|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184164|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44184165|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184166|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184167|NCT00329134|Analgesics|analgesics|mesh-ancestor
44184168|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
44184169|NCT00329147|Paroxetine|paroxetine|mesh-list
44184170|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44184171|NCT00329147|Desipramine|desipramine|mesh-list
44184172|NCT00329147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44184173|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184187|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43808682|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808683|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808684|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43808685|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
43808686|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808687|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808688|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43808689|NCT05257291|Melatonin|melatonin|mesh-list
43808702|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43808703|NCT05256719|Abatacept|abatacept|mesh-list
43808704|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43808705|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184188|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
44184189|NCT00329173|Atorvastatin|atorvastatin|mesh-list
44184190|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44184191|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44184192|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184193|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
44184194|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184195|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184196|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44184197|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184198|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
44184199|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44184200|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44184201|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184202|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184203|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184204|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184205|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184206|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44184207|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184208|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184209|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
44184210|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44184211|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184212|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44184213|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184214|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184215|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184216|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184217|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184218|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184219|NCT00329316|Progesterone|progesterone|mesh-list
44184220|NCT00329316|Progestins|progestins|mesh-ancestor
44184221|NCT00329316|Hormones|hormones|mesh-ancestor
44164274|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164275|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164276|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
44184222|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184223|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184225|NCT00329329|Satraplatin|satraplatin|mesh-list
44184226|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44184227|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
44184228|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184229|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184230|NCT00329355|Naproxen|naproxen|mesh-list
44184231|NCT00329355|Sumatriptan|sumatriptan|mesh-list
44184232|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184233|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184234|NCT00329355|Analgesics|analgesics|mesh-ancestor
44184235|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
44184236|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184237|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184238|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184239|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184240|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
44184241|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184242|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184243|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184244|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44184245|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44184246|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44184247|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
44184248|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184249|NCT00329368|Folic Acid|folic acid|mesh-list
44184250|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
44184251|NCT00329368|Interferons|interferons|mesh-list
44184252|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
44184253|NCT00329368|Interleukin-2|interleukin-2|mesh-list
44184254|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
44184255|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184261|NCT00329368|Analgesics|analgesics|mesh-ancestor
44184262|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
44184263|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184264|NCT00329368|Hematinics|hematinics|mesh-ancestor
44184265|NCT00329368|Vitamins|vitamins|mesh-ancestor
44184266|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
44184267|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44184268|NCT00329381|Omalizumab|omalizumab|mesh-list
44184269|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44184270|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44184271|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44184272|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
44184273|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
44184274|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184275|NCT00329394|Ketamine|ketamine|mesh-list
44184276|NCT00329394|Analgesics|analgesics|mesh-ancestor
44184277|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
44184278|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184279|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184280|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44184281|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44184282|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
44184283|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
44184284|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184285|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44184286|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44184287|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184288|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184289|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44184310|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184311|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184312|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184313|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184314|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
44184315|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184316|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184317|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184318|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44184319|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44184320|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44184321|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
44184322|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184323|NCT00329472|Gemcitabine|gemcitabine|mesh-list
44184324|NCT00329472|Cisplatin|cisplatin|mesh-list
44184325|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184326|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44184327|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
44184328|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184329|NCT00329472|Antiviral Agents|antiviral agents|mesh-ancestor
44184330|NCT00329472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184331|NCT00329472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184332|NCT00329472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184333|NCT00329472|Immunologic Factors|immunologic factors|mesh-ancestor
43808706|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184334|NCT00329472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184340|NCT00329498|Vitamins|vitamins|mesh-ancestor
44184358|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
44184359|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454505|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454506|NCT01663532|Aripiprazole|aripiprazole|mesh-list
44454507|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
44454508|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454509|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44454510|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454511|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454512|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454513|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
44454514|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
44454515|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454516|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454517|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44454518|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44454519|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
44454520|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44454521|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44454522|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44454523|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44454524|NCT01663233|Amlodipine|amlodipine|mesh-list
44454525|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44454526|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44454527|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44184360|NCT00329589|Bortezomib|bortezomib|mesh-list
44184361|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184362|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
44184363|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
44184364|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
44184365|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44184366|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184367|NCT00329628|Enoxaparin|enoxaparin|mesh-list
44184368|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
44184369|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44184370|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
44164277|NCT00255606|Hormones|hormones|mesh-ancestor
44164278|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184371|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44184372|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
44184373|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184374|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184375|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
44184376|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44184377|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44184378|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
44184379|NCT00329680|Antioxidants|antioxidants|mesh-list
44184380|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184381|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184382|NCT00329680|Protective Agents|protective agents|mesh-ancestor
44184383|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184384|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184385|NCT00329680|Analgesics|analgesics|mesh-ancestor
44184386|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
43808717|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808718|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808719|NCT05256342|Etoricoxib|etoricoxib|mesh-list
43808720|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44184387|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184388|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184389|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184390|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184391|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
44184392|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184393|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
44184394|NCT00329693|Quinagolide|quinagolide|mesh-list
44184395|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
44184396|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
44184397|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184398|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184399|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184400|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44184401|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44184402|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184403|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
44184411|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44184412|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44184413|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184414|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184415|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
44184416|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
44184417|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184418|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184419|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44184420|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44184421|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
44184422|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44184423|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44184424|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44184425|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44184426|NCT00329823|Etanercept|etanercept|mesh-list
44184427|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184428|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184429|NCT00329823|Analgesics|analgesics|mesh-ancestor
44184430|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
44184431|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184432|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184433|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184434|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184435|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184436|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184437|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
44184438|NCT00329914|Progesterone|progesterone|mesh-list
44184439|NCT00329914|Progestins|progestins|mesh-ancestor
44184440|NCT00329914|Hormones|hormones|mesh-ancestor
44184441|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184452|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184453|NCT00330018|Acyclovir|acyclovir|mesh-list
44184454|NCT00330018|Valganciclovir|valganciclovir|mesh-list
44184455|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
44184456|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184457|NCT00330044|Carboplatin|carboplatin|mesh-list
44184458|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184459|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
44184460|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44184461|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
44184462|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184463|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
44184464|NCT00330135|Protective Agents|protective agents|mesh-ancestor
43794792|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43794793|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794794|NCT01347970|Carvedilol|carvedilol|mesh-list
43794795|NCT01347970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43794796|NCT01347970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43794797|NCT01347970|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794798|NCT01347970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184465|NCT00330148|Eflornithine|eflornithine|mesh-list
44184466|NCT00330148|Nifurtimox|nifurtimox|mesh-list
44184467|NCT00330148|Melarsoprol|melarsoprol|mesh-list
44184468|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184469|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44184470|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44184471|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184472|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184473|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44184474|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184475|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184476|NCT00330239|Paroxetine|paroxetine|mesh-list
44184477|NCT00330239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44184478|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184479|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184480|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184481|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184482|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
44184498|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44184499|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184500|NCT00330304|Isoniazid|isoniazid|mesh-list
44184501|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44184502|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
44184503|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44184504|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184505|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44184506|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184507|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
44184508|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184509|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184510|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44184512|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
44184513|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44184514|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184515|NCT00330317|Letrozole|letrozole|mesh-list
44184516|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184517|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44184518|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44184519|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184520|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184549|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44184550|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44184551|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44184552|NCT00330655|Memantine|memantine|mesh-list
44184553|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44184554|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44184555|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
44184556|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184557|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184558|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184559|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44184560|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44184561|NCT00330707|Interferons|interferons|mesh-list
44184562|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
44184563|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
44184564|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184565|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
44184566|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184567|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
44184568|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184569|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44184570|NCT00330746|Gemcitabine|gemcitabine|mesh-list
44184571|NCT00330746|Cetuximab|cetuximab|mesh-list
44184572|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44184573|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
44184574|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184575|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184576|NCT00330746|Antiviral Agents|antiviral agents|mesh-ancestor
44184577|NCT00330746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184578|NCT00330746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184594|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44184595|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184596|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44184597|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184598|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184599|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
44184600|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44184601|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44184602|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44184603|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
44184604|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184605|NCT00330785|Amlodipine|amlodipine|mesh-list
44184606|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
44184607|NCT00330785|Atorvastatin|atorvastatin|mesh-list
44184608|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44184609|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184610|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
44184611|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184612|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184613|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44184614|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184615|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44184616|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44184617|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184620|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
44184641|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
44184642|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
44184643|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184644|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184645|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184646|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
44184648|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184649|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44184650|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184651|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
44184652|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184653|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184654|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184655|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44184656|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44184657|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44120931|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44184658|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
44184659|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44184660|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44184661|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44184662|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44184663|NCT00330902|Artesunate|artesunate|mesh-list
44184664|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
44184665|NCT00330902|Primaquine|primaquine|mesh-list
44184666|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
44184667|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44184668|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
44184669|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44184685|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44184686|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184687|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
44184688|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184689|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184690|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44184691|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44184692|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184693|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184694|NCT00330980|Simvastatin|simvastatin|mesh-list
44184695|NCT00330980|Pravastatin|pravastatin|mesh-list
44184696|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44184697|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44184698|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
44184699|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184700|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44184701|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44184702|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184703|NCT00330993|Misoprostol|misoprostol|mesh-list
44184704|NCT00330993|Mifepristone|mifepristone|mesh-list
44184705|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44184706|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
44184707|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44184708|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184709|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44184710|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184711|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
44184712|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44184713|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44184714|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44184715|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44184716|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
44184723|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44184724|NCT00331045|Alvimopan|alvimopan|mesh-list
44184725|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44184726|NCT00331058|Prednisolone|prednisolone|mesh-list
44184727|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184728|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
44184729|NCT00331058|Hormones|hormones|mesh-ancestor
44184730|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184731|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44120978|NCT00122616|Ribavirin|ribavirin|mesh-list
44184732|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44184733|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184735|NCT00331071|Ortho Evra|ortho evra|mesh-list
44184736|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
44184737|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44184738|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184739|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44184740|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44184741|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44184742|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
44184743|NCT00331084|Dexamethasone|dexamethasone|mesh-list
44184744|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
44184745|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44184746|NCT00331084|BB 1101|bb 1101|mesh-list
44184747|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44184774|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184775|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
44184776|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184777|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184778|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44184779|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
44184780|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184781|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184782|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44184783|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44184784|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44184785|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44184786|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
44184787|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44184788|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44184789|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
44184790|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44184791|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
44184792|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184793|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43808727|NCT05256342|Analgesics|analgesics|mesh-ancestor
44184794|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44184795|NCT00331123|Testosterone|testosterone|mesh-list
44184796|NCT00331123|Androgens|androgens|mesh-ancestor
44184797|NCT00331123|Hormones|hormones|mesh-ancestor
44184798|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184799|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184800|NCT00331149|Ropinirole|ropinirole|mesh-list
44184801|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44121055|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
44184802|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44184817|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184818|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184819|NCT00331240|Timolol|timolol|mesh-list
44184820|NCT00331240|Travoprost|travoprost|mesh-list
44184821|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
44184822|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44184823|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44184824|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
44184825|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184826|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184827|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184828|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184829|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44184830|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44184831|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44184832|NCT00331305|Sertraline|sertraline|mesh-list
44184833|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
44184834|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44184835|NCT00331305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44184836|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44184837|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44184838|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184839|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184840|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
44184841|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184842|NCT00331435|Verteporfin|verteporfin|mesh-list
44184843|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44184844|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
44184845|NCT00331487|Pioglitazone|pioglitazone|mesh-list
44184846|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
44184859|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184860|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44184861|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44184862|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44184863|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
44184864|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
44184865|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44184866|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184867|NCT00331513|Vorinostat|vorinostat|mesh-list
44184868|NCT00331513|Idarubicin|idarubicin|mesh-list
44184869|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184870|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44184871|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184872|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184873|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44184874|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44184875|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454528|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454529|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454530|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44184876|NCT00331526|Aldesleukin|aldesleukin|mesh-list
44184877|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184878|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44184879|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44184880|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
44184881|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184882|NCT00331604|Insulin|insulin|mesh-list
44184883|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44184884|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
44184885|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
44184886|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44184887|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
44184888|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44184889|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184890|NCT00331643|Epothilones|epothilones|mesh-list
44184895|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184896|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184897|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
44184898|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
44184899|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44184900|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
44184901|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184902|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184903|NCT00331695|Progestins|progestins|mesh-ancestor
44184904|NCT00331695|Hormones|hormones|mesh-ancestor
44184905|NCT00331708|Artesunate|artesunate|mesh-list
44184906|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
44184907|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
44184908|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44184909|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
44184910|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44184911|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44184912|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44184913|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44184914|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
44184915|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
44184916|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44184917|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
44184918|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44184919|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184920|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184921|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44184922|NCT00331708|Renal Agents|renal agents|mesh-ancestor
44184923|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
44184924|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
44184925|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44184926|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
44184927|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184928|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44184929|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184930|NCT00331786|Aspirin|aspirin|mesh-list
44184931|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
44184932|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
44184933|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44184934|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44184936|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
44184937|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44184938|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184939|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808744|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808745|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808746|NCT05256147|Ibuprofen|ibuprofen|mesh-list
43808747|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43808748|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808749|NCT05256147|Analgesics|analgesics|mesh-ancestor
43794826|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
43794827|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794833|NCT00540995|Etoposide|etoposide|mesh-list
44184940|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44184941|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44184942|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44184943|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44184944|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44184945|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44184946|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44184947|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
44184948|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44184994|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44184995|NCT00331851|Incretins|incretins|mesh-ancestor
44184996|NCT00331851|Hormones|hormones|mesh-ancestor
44184997|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44184998|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44184999|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185000|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
44185001|NCT00331890|Choline|choline|mesh-list
44185002|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
44185003|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
44185004|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44185005|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
44185006|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185007|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185008|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44185009|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
44185010|NCT00331955|Doxorubicin|doxorubicin|mesh-list
44185011|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44185012|NCT00331955|Vorinostat|vorinostat|mesh-list
44185013|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44185014|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185015|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44185016|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44185017|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185018|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185019|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44185020|NCT00331981|Amisulpride|amisulpride|mesh-list
44185021|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44185022|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185023|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185024|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185035|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44185036|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44185037|NCT00332020|Enoxaparin|enoxaparin|mesh-list
44185038|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
44185039|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44185040|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
44185041|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44185042|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
44185043|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185044|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185045|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
44185046|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44185047|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44185048|NCT00332033|Pirfenidone|pirfenidone|mesh-list
44185049|NCT00332033|Analgesics|analgesics|mesh-ancestor
44185050|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
44185051|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185052|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185053|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185054|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185055|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185056|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185057|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185058|NCT00332046|Casopitant|casopitant|mesh-list
44185059|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
44185060|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
44185061|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185062|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185063|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808812|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43808813|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185064|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44185065|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185066|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185067|NCT00332059|Timolol|timolol|mesh-list
44185068|NCT00332059|Bimatoprost|bimatoprost|mesh-list
44185069|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44164279|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164280|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164281|NCT00255658|Sirolimus|sirolimus|mesh-list
44164282|NCT00255658|Sorafenib|sorafenib|mesh-list
44185070|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185071|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185072|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185073|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185074|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185075|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185076|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185078|NCT00332072|Bimatoprost|bimatoprost|mesh-list
44185079|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185080|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185081|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185082|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185083|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185084|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185085|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185086|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185087|NCT00332085|Chromium|chromium|mesh-list
44185088|NCT00332085|Picolinic acid|picolinic acid|mesh-list
44185089|NCT00332085|Trace Elements|trace elements|mesh-ancestor
44185090|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
44185091|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185092|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44185093|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
44185094|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
44185095|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185096|NCT00332124|Choline|choline|mesh-list
44185097|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
44185098|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44185099|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
44185100|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185101|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185102|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44185103|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
44185104|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44164283|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164284|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164285|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164286|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185105|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44185106|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44185108|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185109|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185110|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185111|NCT00332137|Urological Agents|urological agents|mesh-ancestor
44185112|NCT00332176|Ribavirin|ribavirin|mesh-list
44185113|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44185114|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
44185115|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185116|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
44185117|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185118|NCT00332228|Naltrexone|naltrexone|mesh-list
44185119|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44185120|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44185121|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185122|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
44185123|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185124|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44185125|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185126|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
44185127|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44185128|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44185129|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44185130|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44185131|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185132|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44185133|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44185134|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185135|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185136|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185137|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44185138|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
44185145|NCT00332306|Efavirenz|efavirenz|mesh-list
44185146|NCT00332306|Nevirapine|nevirapine|mesh-list
44185147|NCT00332306|Didanosine|didanosine|mesh-list
44185148|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44185149|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44185150|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185151|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185152|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
44185153|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185154|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44185163|NCT00332319|Casopitant|casopitant|mesh-list
44185207|NCT00332436|Timolol|timolol|mesh-list
44185208|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44185209|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185210|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185211|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185212|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185213|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185214|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185215|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185216|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185217|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44185218|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44185219|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185220|NCT00332540|Timolol|timolol|mesh-list
44185221|NCT00332540|Bimatoprost|bimatoprost|mesh-list
44185222|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185223|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185224|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185225|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185226|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843821|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43843822|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44185227|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185228|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185229|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185230|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44185231|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44185232|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44185233|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44185234|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
44185235|NCT00332553|Estradiol|estradiol|mesh-list
44185236|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44185237|NCT00332553|Estrogens|estrogens|mesh-list
44185238|NCT00332553|Hormones|hormones|mesh-ancestor
44185239|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185240|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185242|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
44185243|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44185244|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44185245|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44185246|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44185247|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44185248|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44185249|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44185250|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185251|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44185252|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185253|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44185254|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44185255|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44185256|NCT00332618|Glycerol|glycerol|mesh-list
44185257|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44185258|NCT00332618|Protective Agents|protective agents|mesh-ancestor
44185259|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185260|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
44185261|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44185262|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
44185263|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185264|NCT00332631|Expectorants|expectorants|mesh-ancestor
44185265|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
44185266|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44185267|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
44185268|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185269|NCT00332631|Protective Agents|protective agents|mesh-ancestor
44185288|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44185289|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44185290|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185291|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44185292|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185293|NCT00332774|Ketorolac|ketorolac|mesh-list
44185294|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44185295|NCT00332774|Nepafenac|nepafenac|mesh-list
44185296|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44185297|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44185298|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185299|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185300|NCT00332774|Analgesics|analgesics|mesh-ancestor
44185301|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
44185302|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185345|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185346|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185347|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185348|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185349|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185350|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185351|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185352|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43843830|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
43808820|NCT05189730|Carboplatin|carboplatin|mesh-list
43808822|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185353|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
44185354|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44185355|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
44185356|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185357|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44185359|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
44185360|NCT00332930|Interferons|interferons|mesh-list
44185361|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
44185362|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185363|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
44185364|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185365|NCT00332969|Octreotide|octreotide|mesh-list
44185366|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185367|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44185368|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185369|NCT00332995|Dapivirine|dapivirine|mesh-list
44185370|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44185371|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44185372|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
44185373|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185374|NCT00333008|Prednisone|prednisone|mesh-list
44185375|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
44185376|NCT00333008|Rituximab|rituximab|mesh-list
44185377|NCT00333008|Vincristine|vincristine|mesh-list
44185378|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185387|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44185388|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185389|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
44185390|NCT00333008|Hormones|hormones|mesh-ancestor
44185391|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185392|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44185393|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44185394|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44185395|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44185396|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44185449|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185450|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185451|NCT00333112|Urological Agents|urological agents|mesh-ancestor
44185452|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44185453|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44185454|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
44185456|NCT00333125|Travoprost|travoprost|mesh-list
44185457|NCT00333125|Dorzolamide|dorzolamide|mesh-list
44185458|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44185459|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44185460|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44185461|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44185462|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185463|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185464|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185465|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185466|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44185467|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185468|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44185469|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185470|NCT00333151|Metformin|metformin|mesh-list
44185471|NCT00333151|Liraglutide|liraglutide|mesh-list
44185472|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
44185473|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185474|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185475|NCT00333151|Incretins|incretins|mesh-ancestor
44185476|NCT00333151|Hormones|hormones|mesh-ancestor
44185478|NCT00333164|Cilostazol|cilostazol|mesh-list
44185480|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
44185495|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
44185496|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
44185497|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
44185498|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44185499|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43808826|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185500|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185501|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185502|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185503|NCT00333255|Nepafenac|nepafenac|mesh-list
44185504|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185505|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185506|NCT00333255|Analgesics|analgesics|mesh-ancestor
44185507|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
44185508|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185509|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185510|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185511|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185512|NCT00333281|Tadalafil|tadalafil|mesh-list
44185513|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
44185514|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44185515|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44185516|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185517|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185518|NCT00333281|Urological Agents|urological agents|mesh-ancestor
44185519|NCT00333294|Cisplatin|cisplatin|mesh-list
44185520|NCT00333294|Vinorelbine|vinorelbine|mesh-list
44185521|NCT00333294|Gefitinib|gefitinib|mesh-list
44185522|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185523|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44185524|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
44185525|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
44185526|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
44185527|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185528|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44185529|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185533|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44185534|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454531|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454532|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
44454533|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44454534|NCT01663103|Rilonacept|rilonacept|mesh-list
44454535|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44454536|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
44454537|NCT01662999|Saxagliptin|saxagliptin|mesh-list
44454538|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44454539|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454540|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454541|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454542|NCT01662999|Incretins|incretins|mesh-ancestor
44454543|NCT01662999|Hormones|hormones|mesh-ancestor
44185535|NCT00333346|Tramadol|tramadol|mesh-list
44185536|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44185537|NCT00333346|Narcotics|narcotics|mesh-ancestor
44185538|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185539|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185540|NCT00333346|Analgesics|analgesics|mesh-ancestor
44185575|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185576|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44185577|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44185578|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185579|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
44185580|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44185581|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44185582|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185583|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185584|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185585|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185586|NCT00333567|Analgesics|analgesics|mesh-ancestor
44185587|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
44185588|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185589|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185590|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185591|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185592|NCT00333632|Fentanyl|fentanyl|mesh-list
44185593|NCT00333632|Midazolam|midazolam|mesh-list
44185594|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
44185595|NCT00333632|Propofol|propofol|mesh-list
44185596|NCT00333632|Isoflurane|isoflurane|mesh-list
44185597|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44185598|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185599|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185600|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44185601|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
44185602|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
44185603|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185604|NCT00333632|Analgesics|analgesics|mesh-ancestor
44185605|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
44185606|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185607|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44185608|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44185609|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185614|NCT00333632|Narcotics|narcotics|mesh-ancestor
44185615|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44185616|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44185617|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185618|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185619|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
44185620|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
44185621|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44185622|NCT00333645|Caspofungin|caspofungin|mesh-list
44185623|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
44185624|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185625|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185626|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185627|NCT00333671|Glycerol|glycerol|mesh-list
44185628|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
44185629|NCT00333671|Protective Agents|protective agents|mesh-ancestor
44185630|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185631|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
44185632|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185633|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185634|NCT00333918|Bromfenac|bromfenac|mesh-list
44185635|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44185636|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44185637|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44185638|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185639|NCT00333918|Analgesics|analgesics|mesh-ancestor
44185640|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
44185641|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185642|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185643|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185644|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185645|NCT00333931|Phenytoin|phenytoin|mesh-list
44185646|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
44185656|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185657|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
44185658|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
44185659|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185660|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
44185661|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185662|NCT00333996|Dexamethasone|dexamethasone|mesh-list
44185663|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44185664|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
44185665|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
44185666|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185667|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185668|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185669|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
44185670|NCT00333996|Hormones|hormones|mesh-ancestor
44185671|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44185672|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44185673|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185674|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
44185675|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44185676|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44185677|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185678|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44185679|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44185680|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
44185681|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185682|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44185683|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
44121917|NCT00125736|Rabeprazole|rabeprazole|mesh-list
44185684|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185685|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44185698|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44185699|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
44185700|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185701|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44185702|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185703|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185704|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185705|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44185706|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44185707|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
44185708|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185709|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185710|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44185711|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44185712|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
44185713|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
44185714|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44185715|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185716|NCT00334152|Casopitant|casopitant|mesh-list
44185717|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
44185718|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
44185719|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185720|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185721|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185722|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44185725|NCT00334256|Tenofovir|tenofovir|mesh-list
44185746|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185747|NCT00334347|Valproic Acid|valproic acid|mesh-list
44185748|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
44185749|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185750|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185751|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
44185752|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185753|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185754|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
44185755|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185756|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185757|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185758|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
44185759|NCT00334360|Buspirone|buspirone|mesh-list
44121983|NCT00125918|Tadalafil|tadalafil|mesh-list
44185760|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44185761|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185762|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185763|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44185765|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
44185766|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185767|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44185768|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44185769|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44185770|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
44185771|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185772|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185773|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44185774|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44185775|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44185776|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44185788|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185789|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185790|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185791|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44185792|NCT00334412|Caspofungin|caspofungin|mesh-list
44185793|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44185794|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
44185795|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185796|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185797|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185798|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44185799|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44185800|NCT00334425|Menotropins|menotropins|mesh-list
44185801|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44185802|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
44185803|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44185804|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185805|NCT00334438|Rituximab|rituximab|mesh-list
44185806|NCT00334438|Bortezomib|bortezomib|mesh-list
44185807|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44185808|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44185809|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185810|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
44185811|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185812|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44185813|NCT00334464|Warfarin|warfarin|mesh-list
44185814|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
44185815|NCT00334477|Tadalafil|tadalafil|mesh-list
44185816|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
44185817|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44185818|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44185819|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185820|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185821|NCT00334477|Urological Agents|urological agents|mesh-ancestor
44185822|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
44185823|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
44185824|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44185826|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185827|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185828|NCT00334490|Urological Agents|urological agents|mesh-ancestor
44185830|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185831|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185832|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185833|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185834|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44185836|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
44185837|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185838|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44185839|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185840|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
44185841|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44185842|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185843|NCT00334581|Irbesartan|irbesartan|mesh-list
44185844|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44185845|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44185846|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44185847|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185848|NCT00334594|Cisplatin|cisplatin|mesh-list
44185849|NCT00334594|Pemetrexed|pemetrexed|mesh-list
44185850|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185851|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808859|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43808860|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43808861|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43808862|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43808863|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43808869|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
44185852|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185853|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44185854|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44185855|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
44185856|NCT00334646|Casopitant|casopitant|mesh-list
44185857|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185858|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
44185859|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185860|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164287|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164288|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164289|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44164290|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
44185861|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44185862|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
44185863|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185864|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185865|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44185867|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
44185868|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44185869|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44185870|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44185871|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44185872|NCT00334672|Cyclosporine|cyclosporine|mesh-list
44185873|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
44185874|NCT00334672|Dexamethasone|dexamethasone|mesh-list
44185875|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
44185876|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44185877|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44185878|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44185879|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
44185880|NCT00334672|Busulfan|busulfan|mesh-list
44185881|NCT00334672|Methotrexate|methotrexate|mesh-list
44185882|NCT00334672|Etoposide|etoposide|mesh-list
44185883|NCT00334672|Cyclosporins|cyclosporins|mesh-list
44185884|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44185885|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44185886|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
44185911|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44185912|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44185913|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44185914|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44185915|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
44185916|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44185917|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44185918|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44185919|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44185920|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
44185921|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44185922|NCT00334685|Pregabalin|pregabalin|mesh-list
44185923|NCT00334685|Reboxetine|reboxetine|mesh-list
44185924|NCT00334685|Analgesics|analgesics|mesh-ancestor
44185925|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
44185970|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
44185971|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185972|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44185973|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44185974|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44185975|NCT00334763|Growth Substances|growth substances|mesh-ancestor
44185976|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808873|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
43808874|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44185977|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
44185978|NCT00334789|Vitamin A|vitamin a|mesh-list
44185979|NCT00334789|Tretinoin|tretinoin|mesh-list
44185980|NCT00334789|Belinostat|belinostat|mesh-list
44185981|NCT00334789|Isotretinoin|isotretinoin|mesh-list
44185982|NCT00334789|Vitamins|vitamins|mesh-ancestor
44185983|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
44185984|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44185985|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44185986|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
44185987|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
44185988|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44185989|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44186026|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
44186027|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
44186028|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44186029|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44186030|NCT00334867|Protective Agents|protective agents|mesh-ancestor
44186031|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44186032|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44186033|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186034|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44186035|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44186036|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44186037|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186038|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
44186039|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186040|NCT00334906|Memantine|memantine|mesh-list
44186041|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44186042|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44186043|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
44186044|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186045|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186052|NCT00334932|Bortezomib|bortezomib|mesh-list
44454554|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44454555|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
44454557|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44454558|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454559|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454560|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454561|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
44454562|NCT01662895|Deferoxamine|deferoxamine|mesh-list
44454563|NCT01662895|Siderophores|siderophores|mesh-ancestor
44454564|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44454565|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
44454566|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
44454567|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454568|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44454569|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44454570|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454571|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454572|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454573|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454574|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44454575|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44454576|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
44186081|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186082|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186083|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186084|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186085|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186086|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44186087|NCT00335088|Trace Elements|trace elements|mesh-ancestor
44186088|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
43808885|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186089|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
44186090|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
44186091|NCT00335114|Cyclosporine|cyclosporine|mesh-list
44186092|NCT00335114|Cyclosporins|cyclosporins|mesh-list
44186093|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186094|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186095|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186096|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
44186097|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186098|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
44186099|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186100|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
44186101|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186102|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44186103|NCT00335166|Pramipexole|pramipexole|mesh-list
44186104|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
44186105|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186106|NCT00335166|Protective Agents|protective agents|mesh-ancestor
44186107|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186108|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44186109|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44186110|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
44186111|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
44186112|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186113|NCT00335179|Imiquimod|imiquimod|mesh-list
44186114|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44186115|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
44186116|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186118|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
44186119|NCT00335192|Tenofovir|tenofovir|mesh-list
44186120|NCT00335192|Lamivudine|lamivudine|mesh-list
44186121|NCT00335192|Abacavir|abacavir|mesh-list
44186122|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
44186123|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186124|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186125|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186126|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186127|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186182|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186183|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
44186184|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
44186185|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186186|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186187|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44186188|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
44186189|NCT00335348|Hormones|hormones|mesh-ancestor
44186190|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186191|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44186192|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186244|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186245|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186246|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
44186247|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44186248|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
44186249|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186250|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186251|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44186252|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
44186253|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
44186254|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44186255|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795185|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44186256|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186257|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186259|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
44186260|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
44186261|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44186262|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44186263|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186264|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186265|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186266|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44186267|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
44186268|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186269|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186270|NCT00335673|Irbesartan|irbesartan|mesh-list
44186271|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44186272|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44186273|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44186274|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186285|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186286|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44186287|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44186288|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186289|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186290|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44186291|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44186292|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44186293|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44186294|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44186295|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
44186296|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186297|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44186298|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44186299|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186300|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44186301|NCT00335920|Dexamethasone|dexamethasone|mesh-list
44186302|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186303|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
44186304|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
44186305|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186306|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186307|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44186308|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
44186309|NCT00335920|Hormones|hormones|mesh-ancestor
44186311|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44186332|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
44186333|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186334|NCT00335998|Cisplatin|cisplatin|mesh-list
44186335|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186336|NCT00336141|Vorinostat|vorinostat|mesh-list
44186337|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186338|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44186339|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186340|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186341|NCT00336154|Tetracycline|tetracycline|mesh-list
44186342|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186343|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186344|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44186345|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186347|NCT00336167|Bezafibrate|bezafibrate|mesh-list
44186388|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186389|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
44186390|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186391|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
44186392|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186393|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186394|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186395|NCT00336375|Lumefantrine|lumefantrine|mesh-list
44186396|NCT00336375|Artemether|artemether|mesh-list
44186397|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44186398|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
44186399|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44186400|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44186401|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186402|NCT00336401|Propofol|propofol|mesh-list
44186403|NCT00336401|Sevoflurane|sevoflurane|mesh-list
44186404|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44186405|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186406|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186407|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44186408|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
44186409|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
44186410|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44186411|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44186412|NCT00336414|Prednisone|prednisone|mesh-list
44186413|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
44186414|NCT00336414|Azathioprine|azathioprine|mesh-list
44186415|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186416|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
44186417|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186418|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186419|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186420|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
44186421|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186429|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
44186430|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186431|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
44186432|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
44186433|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
44186434|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186435|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
44186436|NCT00336466|Hematinics|hematinics|mesh-ancestor
44186437|NCT00336518|Ribavirin|ribavirin|mesh-list
44186438|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44186439|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
44186440|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186441|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
44186442|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186443|NCT00336531|Itraconazole|itraconazole|mesh-list
44186444|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
44186445|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186446|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44186447|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44186448|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808934|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808935|NCT04481048|Antidotes|antidotes|mesh-ancestor
43808936|NCT04469530|Sirolimus|sirolimus|mesh-list
43808937|NCT04469530|Celecoxib|celecoxib|mesh-list
43808963|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44186449|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186450|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44186451|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
44186452|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186453|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186454|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44186455|NCT00336648|Gemcitabine|gemcitabine|mesh-list
44186456|NCT00336648|Bevacizumab|bevacizumab|mesh-list
44186457|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186474|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186476|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44186477|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186478|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44186479|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
44186480|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186482|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186483|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44186484|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186485|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186486|NCT00336791|Paclitaxel|paclitaxel|mesh-list
44186487|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
44186488|NCT00336791|Doxorubicin|doxorubicin|mesh-list
44186489|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44186490|NCT00336791|Fluorouracil|fluorouracil|mesh-list
44186491|NCT00336791|Epirubicin|epirubicin|mesh-list
44186494|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
44186527|NCT00336921|Alfuzosin|alfuzosin|mesh-list
44186528|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44186529|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44186530|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44186531|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
44186532|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186533|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186534|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186535|NCT00336921|Urological Agents|urological agents|mesh-ancestor
44186536|NCT00336947|Tegafur|tegafur|mesh-list
44186537|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186538|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
44186539|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186540|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186541|NCT00336960|Celecoxib|celecoxib|mesh-list
44186542|NCT00336960|Fluorouracil|fluorouracil|mesh-list
44186543|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
44186544|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186545|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186546|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186547|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186548|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
44186549|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186550|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44186551|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44186575|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186576|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186577|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186578|NCT00337090|Urological Agents|urological agents|mesh-ancestor
44186579|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
44186580|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186582|NCT00337246|Rituximab|rituximab|mesh-list
44186583|NCT00337246|Fludarabine|fludarabine|mesh-list
44186584|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
44186585|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
44122869|NCT05519917|Afatinib|afatinib|mesh-list
44186586|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808964|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43808966|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
43620654|NCT03798080|Insulin|insulin|mesh-list
44186587|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
44186588|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186589|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186590|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186591|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
44186592|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186593|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186594|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44186595|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186596|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186597|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
44186598|NCT00337246|Analgesics|analgesics|mesh-ancestor
44186599|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
44186600|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186601|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44186602|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44186603|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186604|NCT00337259|Gemcitabine|gemcitabine|mesh-list
44186605|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186606|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
44186607|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186608|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186609|NCT00337259|Antiviral Agents|antiviral agents|mesh-ancestor
44186610|NCT00337259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186612|NCT00337259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186613|NCT00337259|Immunologic Factors|immunologic factors|mesh-ancestor
44186614|NCT00337259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186615|NCT00337298|Amlodipine|amlodipine|mesh-list
44186616|NCT00337298|Lisinopril|lisinopril|mesh-list
44186617|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44186618|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44186619|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44186620|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186621|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44186622|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186623|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
44186624|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44186625|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
44186626|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186627|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44186628|NCT00337298|Protective Agents|protective agents|mesh-ancestor
44186629|NCT00337376|Sirolimus|sirolimus|mesh-list
44186630|NCT00337376|Paclitaxel|paclitaxel|mesh-list
44186631|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44186632|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44186633|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186634|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
44186635|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
44186636|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
44186637|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186638|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186639|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186640|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44186641|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
44186642|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186655|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
44186656|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186657|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186658|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186659|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
44186660|NCT00337389|Antidotes|antidotes|mesh-ancestor
44186661|NCT00337389|Protective Agents|protective agents|mesh-ancestor
44186662|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
44186663|NCT00337389|Vitamins|vitamins|mesh-ancestor
44186664|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
44186665|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
44186666|NCT00337441|Hematinics|hematinics|mesh-ancestor
44186667|NCT00337493|Cyclosporine|cyclosporine|mesh-list
44186668|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
44186669|NCT00337493|Tacrolimus|tacrolimus|mesh-list
44186670|NCT00337493|Cyclosporins|cyclosporins|mesh-list
44186671|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186672|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
44186673|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186674|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44186675|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186676|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186677|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
44186678|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186679|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
44186680|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186681|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44186682|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186683|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44186684|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
44186685|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44186686|NCT00337506|Dexamethasone|dexamethasone|mesh-list
44186687|NCT00337506|Bortezomib|bortezomib|mesh-list
44186688|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186689|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
44186690|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
44186691|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186692|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186693|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44186694|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
44186695|NCT00337506|Hormones|hormones|mesh-ancestor
44186696|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186697|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44186698|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186699|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
44186700|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44186701|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186702|NCT00337545|Everolimus|everolimus|mesh-list
44186703|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186704|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44186705|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
44186706|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186707|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
44186708|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44186709|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44186710|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
44186711|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186712|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186713|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186714|NCT00337558|Urological Agents|urological agents|mesh-ancestor
44186715|NCT00337623|Prednisolone|prednisolone|mesh-list
44186716|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186717|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
44186718|NCT00337623|Hormones|hormones|mesh-ancestor
44186719|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186720|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186721|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44186722|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186723|NCT00337649|Trastuzumab|trastuzumab|mesh-list
44186724|NCT00337649|Epothilones|epothilones|mesh-list
44186725|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
44186732|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
44186735|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186736|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186737|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44186738|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
44186739|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186740|NCT00337740|Propranolol|propranolol|mesh-list
44186741|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44186742|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44186743|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
44186744|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186745|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186746|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186747|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44186748|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44186749|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
44186750|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
44186751|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
44186752|NCT00337766|Coagulants|coagulants|mesh-ancestor
44186753|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44186754|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
44186755|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186756|NCT00337792|Fentanyl|fentanyl|mesh-list
44186790|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186791|NCT00337922|Lamivudine|lamivudine|mesh-list
44186792|NCT00337922|Abacavir|abacavir|mesh-list
44186793|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44186794|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44186795|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186796|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186797|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
44186798|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44186799|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44186800|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44186801|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
44186802|NCT00337948|Hematinics|hematinics|mesh-ancestor
44186803|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
44186804|NCT00338000|Hematinics|hematinics|mesh-ancestor
44186805|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44186806|NCT00338052|Norethindrone|norethindrone|mesh-list
44186807|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
44186808|NCT00338052|Estradiol|estradiol|mesh-list
44186809|NCT00338052|Estrogens|estrogens|mesh-ancestor
44186810|NCT00338052|Hormones|hormones|mesh-ancestor
44186811|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186812|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186813|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44186814|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
44186815|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44186816|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44186817|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44186818|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44186819|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44186820|NCT00338091|Losartan|losartan|mesh-list
44186821|NCT00338091|Benazepril|benazepril|mesh-list
44186833|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186834|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
44186835|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186836|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186837|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44186838|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
44186839|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186840|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
44186841|NCT00338130|Temozolomide|temozolomide|mesh-list
44186842|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44186843|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
44186844|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186845|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186846|NCT00338195|Caffeine|caffeine|mesh-list
44186847|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44186848|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186849|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44186850|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44186851|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186852|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44186853|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44186854|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
44186855|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186856|NCT00338221|Glycine|glycine|mesh-list
44186857|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
44186858|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186859|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186860|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186861|NCT00338247|Capecitabine|capecitabine|mesh-list
44186862|NCT00338247|Lapatinib|lapatinib|mesh-list
44186863|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186864|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
44186865|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186866|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44186867|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44186869|NCT00338273|Aripiprazole|aripiprazole|mesh-list
44186870|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
44186871|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44186872|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44186873|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44186874|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186875|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186876|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
44186877|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
44186878|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44186879|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186880|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44186881|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44186882|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
44186883|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44186884|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44186885|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44186886|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44186887|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
44186888|NCT00338299|Hematinics|hematinics|mesh-ancestor
44186889|NCT00338312|Testosterone|testosterone|mesh-list
44186890|NCT00338312|Androgens|androgens|mesh-ancestor
44186892|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44186893|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186894|NCT00338338|Amlodipine|amlodipine|mesh-list
44186895|NCT00338338|Lacidipine|lacidipine|mesh-list
44186896|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44186915|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
44186916|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
44186917|NCT00338416|Hematinics|hematinics|mesh-ancestor
44186918|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
44186919|NCT00338468|Hematinics|hematinics|mesh-ancestor
44186920|NCT00338481|Morphine|morphine|mesh-list
44186921|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44186922|NCT00338481|Narcotics|narcotics|mesh-ancestor
44186923|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44186924|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186925|NCT00338481|Analgesics|analgesics|mesh-ancestor
44186926|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
44186927|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44186928|NCT00338494|Clofarabine|clofarabine|mesh-list
44186929|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44186930|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
44186931|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44186932|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454601|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44454602|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
44454603|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454604|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44454605|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44454606|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44454607|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44454608|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454609|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454610|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454611|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454612|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44454613|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44454614|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
44454615|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454616|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454617|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44454618|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44454619|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
44454620|NCT01662102|Rituximab|rituximab|mesh-list
44454621|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44454622|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454623|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
44454624|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454626|NCT01661972|Capecitabine|capecitabine|mesh-list
44454649|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44454650|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44454651|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454652|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454653|NCT01661595|Urological Agents|urological agents|mesh-ancestor
44454654|NCT01661140|Methotrexate|methotrexate|mesh-list
44454655|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44454656|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
44454657|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44454658|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454659|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44454660|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
44454661|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454662|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454663|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
44454664|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454665|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44186973|NCT00338754|Antibodies|antibodies|mesh-list
44186974|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44186975|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
44186976|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44186977|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44186978|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44186979|NCT00338767|Fluoxetine|fluoxetine|mesh-list
44186980|NCT00338767|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44186993|NCT00338780|Lamivudine|lamivudine|mesh-list
44187003|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187004|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
44187005|NCT00338793|Hormones|hormones|mesh-ancestor
44187006|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187007|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187008|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44187009|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187010|NCT00338910|Metronidazole|metronidazole|mesh-list
44187011|NCT00338910|Budesonide|budesonide|mesh-list
44187012|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187013|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44187014|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
44187015|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187016|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187017|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44187018|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
44187019|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
44187020|NCT00338910|Hormones|hormones|mesh-ancestor
44187022|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187056|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44187058|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
44187059|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187060|NCT00339066|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44187061|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44187062|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187063|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187064|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187065|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
44187066|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187067|NCT00339118|Doxorubicin|doxorubicin|mesh-list
44187068|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
44187069|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44187070|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187071|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44187072|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44187073|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187074|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187075|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187076|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
44187077|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187078|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187079|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44187080|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
44187081|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44187082|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44187083|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187084|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187100|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
44187101|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187102|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187103|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
44187104|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44187105|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187106|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187107|NCT00339417|Ivermectin|ivermectin|mesh-list
44187108|NCT00339417|Albendazole|albendazole|mesh-list
44187109|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187110|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187111|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
44187112|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
44187113|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44187114|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187115|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
44187116|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
44187117|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187118|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187119|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187120|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44187121|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454667|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
44454668|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454669|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44454670|NCT01660906|Dasatinib|dasatinib|mesh-list
44454671|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454672|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44454673|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454674|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454675|NCT01660763|Sufentanil|sufentanil|mesh-list
44454677|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44454678|NCT01660763|Narcotics|narcotics|mesh-ancestor
44454679|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454680|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454681|NCT01660763|Analgesics|analgesics|mesh-ancestor
44454682|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
44454683|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454684|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44454685|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44454686|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
44454687|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
44454688|NCT01660711|Leucovorin|leucovorin|mesh-list
44454689|NCT01660711|Fluorouracil|fluorouracil|mesh-list
44454690|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
44454691|NCT01660711|Irinotecan|irinotecan|mesh-list
44187161|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187162|NCT00340691|Doxycycline|doxycycline|mesh-list
44187163|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187164|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187165|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
44187166|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187167|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187168|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
44187169|NCT00341055|Hematinics|hematinics|mesh-ancestor
44187170|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44187171|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44187172|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
44187173|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187174|NCT00341250|Antacids|antacids|mesh-ancestor
44187175|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187176|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187177|NCT00341432|Nicotine|nicotine|mesh-list
44187178|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44187179|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
44187180|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187181|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187182|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44187183|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44454737|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44454738|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44454739|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
44454740|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454741|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454742|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454743|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454744|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
44454745|NCT01659567|Interferons|interferons|mesh-list
44454746|NCT01659567|Ribavirin|ribavirin|mesh-list
44454747|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
44454748|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
44454749|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44454750|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454751|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
44187188|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44187189|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187190|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187191|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44187192|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187193|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187194|NCT00342849|Succimer|succimer|mesh-list
44187195|NCT00342849|Antidotes|antidotes|mesh-ancestor
44187196|NCT00342849|Protective Agents|protective agents|mesh-ancestor
44187197|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187198|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
44187199|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
44187200|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187201|NCT00342862|Alefacept|alefacept|mesh-list
44187202|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
44187203|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
44187205|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44187215|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187216|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187217|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187218|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
44187219|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187220|NCT00343070|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44187221|NCT00343070|Antidepressive Agents|antidepressive agents|mesh-ancestor
44187222|NCT00343070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187224|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
44187225|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
44187226|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
44187227|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187228|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187229|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187230|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44187231|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187232|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44187233|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44187234|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44187235|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
44187236|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
44187237|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187238|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187239|NCT00343135|Amoxicillin|amoxicillin|mesh-list
44187240|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
44187241|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
44187242|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44187243|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44123628|NCT01803594|Niacin|niacin|mesh-list
44187262|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44187263|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44187264|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187265|NCT00343187|Dapsone|dapsone|mesh-list
44187266|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187267|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
44187268|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187269|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187270|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44187271|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187272|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187273|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
44187274|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187275|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
44187277|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
44187324|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187325|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
44187326|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187327|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187328|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44187329|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
44187330|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187331|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187332|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44187333|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187334|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
44187335|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
44187336|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187337|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187338|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
44187340|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187341|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44187342|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44187343|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44187344|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44187345|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187346|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44187347|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
44187348|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44187349|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187350|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
44187351|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
44187352|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44187354|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
44187367|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
44187368|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187369|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44187370|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
44187371|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187372|NCT00343408|Antiviral Agents|antiviral agents|mesh-ancestor
44187373|NCT00343408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187374|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187375|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187376|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
44187377|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187378|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44187379|NCT00343408|Antidotes|antidotes|mesh-ancestor
44187380|NCT00343408|Protective Agents|protective agents|mesh-ancestor
44187381|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
43808984|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
43809006|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
43809007|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809008|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
43809009|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
43809010|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809011|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809012|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809013|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
43809014|NCT04371445|Hormones|hormones|mesh-ancestor
44187382|NCT00343408|Vitamins|vitamins|mesh-ancestor
44187383|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
44187384|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44187385|NCT00343421|Vaccines|vaccines|mesh-list
44187386|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44187387|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
44187388|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187389|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
44187390|NCT00343447|Rituximab|rituximab|mesh-list
44187391|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187392|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
44187393|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187394|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187395|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44187396|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
44187398|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187411|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44187412|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44187413|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187415|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187416|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187417|NCT00343629|Sulindac|sulindac|mesh-list
44187418|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44187419|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44187420|NCT00343629|Analgesics|analgesics|mesh-ancestor
44187421|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
44187422|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187423|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187424|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187425|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187426|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187427|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44187438|NCT00343668|Irinotecan|irinotecan|mesh-list
44187465|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187466|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187468|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
44187469|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187470|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44187471|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44187472|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
44187473|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
44187474|NCT00343759|Lapatinib|lapatinib|mesh-list
44187475|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187476|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44187477|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187478|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454752|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454753|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
44454754|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454755|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
44454756|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454757|NCT01659554|Cisplatin|cisplatin|mesh-list
44454758|NCT01659554|Doxorubicin|doxorubicin|mesh-list
44454759|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44187508|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44187509|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44187510|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43795531|NCT03415854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795532|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
43795533|NCT03375645|Narcotics|narcotics|mesh-ancestor
43795534|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43795535|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795536|NCT03375645|Analgesics|analgesics|mesh-ancestor
43795537|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
43795538|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187511|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187512|NCT00343850|Mesalamine|mesalamine|mesh-list
44187513|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44187514|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44187515|NCT00343850|Analgesics|analgesics|mesh-ancestor
44187516|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
44187517|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187518|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187519|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187520|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187521|NCT00343876|Aspirin|aspirin|mesh-list
44187522|NCT00343876|Clopidogrel|clopidogrel|mesh-list
44187523|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44187524|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44187525|NCT00343876|Analgesics|analgesics|mesh-ancestor
44187526|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
44187527|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187528|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187529|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187530|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187531|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44187532|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44187533|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187534|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44187535|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44187536|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187552|NCT00344006|Artesunate|artesunate|mesh-list
44187553|NCT00344006|Lumefantrine|lumefantrine|mesh-list
44187554|NCT00344006|Artemether|artemether|mesh-list
44187555|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44187557|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
44187558|NCT00344006|Proguanil|proguanil|mesh-list
44187559|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
44187560|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44187561|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187562|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187563|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187564|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
44187565|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
44187566|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44187567|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
44187568|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44187569|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187570|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187571|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
44187572|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44187573|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
44187574|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
44187575|NCT00344058|Analgesics|analgesics|mesh-ancestor
44187576|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
44187577|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187578|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187602|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44187603|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187604|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43809027|NCT04311606|Aflibercept|aflibercept|mesh-list
43809028|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43809029|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43809030|NCT04311606|Growth Substances|growth substances|mesh-ancestor
43809031|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809032|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
43809033|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187605|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
44187606|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44187607|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44187608|NCT00344149|Rituximab|rituximab|mesh-list
44187609|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187610|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187611|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
44187612|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187613|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44187614|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44187615|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
44187616|NCT00344201|Coagulants|coagulants|mesh-ancestor
44187617|NCT00344227|Ranibizumab|ranibizumab|mesh-list
44187618|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187619|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44187620|NCT00344227|Growth Substances|growth substances|mesh-ancestor
44187621|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187622|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
44187623|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187624|NCT00344253|Interferons|interferons|mesh-list
44187625|NCT00344253|Interferon-beta|interferon-beta|mesh-list
44187626|NCT00344253|Methotrexate|methotrexate|mesh-list
44187653|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44187654|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44187655|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44187656|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44187657|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44187658|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
44187659|NCT00344409|Hematinics|hematinics|mesh-ancestor
44187660|NCT00344422|Dexamethasone|dexamethasone|mesh-list
44187661|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
44187662|NCT00344422|Doxorubicin|doxorubicin|mesh-list
44187663|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44187664|NCT00344422|Vincristine|vincristine|mesh-list
44187665|NCT00344422|BB 1101|bb 1101|mesh-list
44187666|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187667|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
44187668|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
44187669|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187670|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187671|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187672|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
44187673|NCT00344422|Hormones|hormones|mesh-ancestor
44187674|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187675|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44187676|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187677|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
44187678|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187679|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187680|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44187687|NCT00344513|Carvedilol|carvedilol|mesh-list
44187698|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44187699|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187700|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44187701|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
44187702|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44187703|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44187704|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
44187705|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187707|NCT00344526|Melphalan|melphalan|mesh-list
43809035|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43809036|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43809037|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43809038|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795560|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795561|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187708|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44187709|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
44187710|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
44187711|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187712|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187713|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44187714|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
44187715|NCT00344526|Hormones|hormones|mesh-ancestor
44187716|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44187717|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44187718|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187719|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44187720|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
44187721|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187722|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44187723|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44187724|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
44187725|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44187726|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44187727|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
44187728|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187741|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187742|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44187743|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44187744|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44187745|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187746|NCT00344617|Bevacizumab|bevacizumab|mesh-list
44187747|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187748|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187749|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187750|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44187751|NCT00344617|Growth Substances|growth substances|mesh-ancestor
44187752|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187753|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
44187754|NCT00344669|Albendazole|albendazole|mesh-list
44187755|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
44187756|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44187797|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44187798|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44187799|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44187800|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44187801|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44187802|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44187803|NCT00344812|Buprenorphine|buprenorphine|mesh-list
44187804|NCT00344812|Methadone|methadone|mesh-list
44187805|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44187806|NCT00344812|Narcotics|narcotics|mesh-ancestor
44187807|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44187808|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187809|NCT00344812|Analgesics|analgesics|mesh-ancestor
44187810|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
44187811|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44187812|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44187813|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
44187814|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
44187852|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44187853|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
44187854|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187855|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44187856|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44187857|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187858|NCT00344981|Tenofovir|tenofovir|mesh-list
44187859|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
44187860|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
44187861|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44187862|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44187863|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44187864|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187865|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187866|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44187867|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44187868|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187869|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
44187870|NCT00344994|Pramipexole|pramipexole|mesh-list
44187871|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
44187872|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187873|NCT00344994|Protective Agents|protective agents|mesh-ancestor
44187874|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187875|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44187876|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44187877|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
44187878|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
44187879|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187880|NCT00345059|Gemcitabine|gemcitabine|mesh-list
44187881|NCT00345059|Capecitabine|capecitabine|mesh-list
44187882|NCT00345059|Docetaxel|docetaxel|mesh-list
44187896|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
44187897|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44187898|NCT00345098|Amibegron|amibegron|mesh-list
44187899|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44187900|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44187901|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44187902|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44187903|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187904|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187905|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44187906|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187907|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187908|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44187909|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187910|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187911|NCT00345163|Bevacizumab|bevacizumab|mesh-list
44187912|NCT00345163|Irinotecan|irinotecan|mesh-list
44187913|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187914|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187915|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187916|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44187917|NCT00345163|Growth Substances|growth substances|mesh-ancestor
44187918|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187919|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
44187920|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44187921|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44187922|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44187923|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187924|NCT00345202|Atorvastatin|atorvastatin|mesh-list
43809048|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43809049|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
43809050|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43809051|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809052|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43809053|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43809054|NCT04050553|Tirzepatide|tirzepatide|mesh-list
44124228|NCT00132236|Nicotine|nicotine|mesh-list
44187925|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44187926|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44187936|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187937|NCT00345501|Iloprost|iloprost|mesh-list
44187938|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44187939|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
44454762|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44454763|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454764|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454765|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454766|NCT01659320|Minocycline|minocycline|mesh-list
44454767|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44454768|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454769|NCT01659151|Aldesleukin|aldesleukin|mesh-list
44454770|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
44454771|NCT01659151|Fludarabine|fludarabine|mesh-list
44454772|NCT01659151|Interleukin-2|interleukin-2|mesh-list
44454773|NCT01659151|Vemurafenib|vemurafenib|mesh-list
44454774|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44454775|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454776|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
43809058|NCT04050553|Hormones|hormones|mesh-ancestor
44454777|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809059|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454815|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454816|NCT01658813|Interferons|interferons|mesh-list
44454817|NCT01658813|Fluorouracil|fluorouracil|mesh-list
44454818|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
44454819|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454820|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44124307|NCT00132548|Renal Agents|renal agents|mesh-ancestor
44187941|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
44187942|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44187943|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44187944|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44187945|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44187946|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187947|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44187948|NCT00345657|Niacin|niacin|mesh-list
44187949|NCT00345657|Lovastatin|lovastatin|mesh-list
44187950|NCT00345657|L 647318|l 647318|mesh-list
44187951|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
44187952|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44187958|NCT00345657|Vitamins|vitamins|mesh-ancestor
44187988|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
44187989|NCT00345761|Bevacizumab|bevacizumab|mesh-list
44187990|NCT00345761|Capecitabine|capecitabine|mesh-list
44187991|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
44187992|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44187993|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44187994|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44187995|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44187996|NCT00345761|Growth Substances|growth substances|mesh-ancestor
44187997|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44187998|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
44187999|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188000|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
44188001|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188002|NCT00345787|Buprenorphine|buprenorphine|mesh-list
44188003|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188004|NCT00345787|Narcotics|narcotics|mesh-ancestor
44188005|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188006|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188007|NCT00345787|Analgesics|analgesics|mesh-ancestor
44188008|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
44188009|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188010|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44188011|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
44188012|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44188013|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44188014|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
44188015|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
44188036|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188037|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44188038|NCT00346099|Capecitabine|capecitabine|mesh-list
44188039|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
44188040|NCT00346099|Panitumumab|panitumumab|mesh-list
44188041|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188042|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
44188043|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188044|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188045|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188046|NCT00346190|Alendronate|alendronate|mesh-list
44188047|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44188048|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188049|NCT00346229|Doxorubicin|doxorubicin|mesh-list
44188050|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44188051|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44188052|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188053|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44188054|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44188055|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188056|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188057|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
44188058|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44188059|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188060|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
44188061|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188062|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188063|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44188064|NCT00346294|Etanercept|etanercept|mesh-list
44188065|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188066|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188067|NCT00346294|Analgesics|analgesics|mesh-ancestor
44188068|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
44188075|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
44188077|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
44188078|NCT00346359|Fludarabine|fludarabine|mesh-list
44188079|NCT00346359|Busulfan|busulfan|mesh-list
44188080|NCT00346359|Tacrolimus|tacrolimus|mesh-list
44188081|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44188082|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44188083|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
44188084|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44188085|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188086|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188087|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
44188088|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188089|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188090|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188091|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188092|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44188093|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188094|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
44188095|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188096|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44188097|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44188098|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
44188100|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44188125|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44188126|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
44188127|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44188128|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188129|NCT00346502|Betulinic acid|betulinic acid|mesh-list
44188130|NCT00346502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188131|NCT00346502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188132|NCT00346502|Analgesics|analgesics|mesh-ancestor
44188133|NCT00346502|Sensory System Agents|sensory system agents|mesh-ancestor
44188134|NCT00346502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188135|NCT00346502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188136|NCT00346502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188137|NCT00346502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188138|NCT00346502|Antimalarials|antimalarials|mesh-ancestor
44188186|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188187|NCT00346684|Rituximab|rituximab|mesh-list
44188188|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44188189|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188190|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
44188191|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188192|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188193|NCT00346749|Fluticasone|fluticasone|mesh-list
44188195|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44188196|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188197|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44188198|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
44188199|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188200|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188201|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44188202|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
44188203|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188204|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44188205|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44188206|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44188207|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44188208|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188209|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188211|NCT00346801|Celecoxib|celecoxib|mesh-list
44188236|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
44188237|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188238|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188239|NCT00346840|Misoprostol|misoprostol|mesh-list
44188240|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44188241|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
44188242|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44188243|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188244|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44188245|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188246|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
44188247|NCT00346853|Fomepizole|fomepizole|mesh-list
44188248|NCT00346853|Antidotes|antidotes|mesh-ancestor
44188249|NCT00346853|Protective Agents|protective agents|mesh-ancestor
44188250|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188251|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188252|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188253|NCT00346866|Anecortave|anecortave|mesh-list
44188254|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44188255|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44188256|NCT00346866|Growth Substances|growth substances|mesh-ancestor
44188257|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188258|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188289|NCT00346970|Niacin|niacin|mesh-list
44188290|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44188291|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
44188292|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188293|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44188294|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
44188295|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
44188296|NCT00346970|Vitamins|vitamins|mesh-ancestor
44188297|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
44188298|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188299|NCT00346996|Insulin|insulin|mesh-list
44188300|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44188301|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
44188302|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
44188303|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
44188304|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
44188305|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188306|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188307|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44188308|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188309|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44188310|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44188311|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44188312|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188313|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188341|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44188342|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44188343|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
44188344|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
44188345|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
44188346|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188347|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188348|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44188349|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44188350|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
44188351|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188352|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188353|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44188354|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
44188355|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44188356|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44188357|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44188358|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188359|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188360|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188361|NCT00347152|Valproic Acid|valproic acid|mesh-list
44188362|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
44188363|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188364|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188365|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
44188366|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188367|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188368|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
44188369|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44188370|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188385|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
44188386|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188387|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188388|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188389|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188390|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188391|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188392|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188393|NCT00347256|Cisplatin|cisplatin|mesh-list
44188394|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188395|NCT00347295|Estazolam|estazolam|mesh-list
44188396|NCT00347295|Brotizolam|brotizolam|mesh-list
44188397|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
44188398|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44188399|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44188400|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188401|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188402|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44188403|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
44188404|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
44188405|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188406|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188407|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44454821|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454822|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44454823|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
44454824|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454825|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
44454826|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454827|NCT01658579|Insulin|insulin|mesh-list
44454828|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44454829|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
43795656|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454830|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44454831|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454832|NCT01658436|Dactolisib|dactolisib|mesh-list
44454833|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454837|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454838|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454839|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44454840|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454842|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
44454843|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44454844|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454845|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44454846|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454847|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44454848|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454849|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454850|NCT01657903|Listerine|listerine|mesh-list
44454851|NCT01657903|Fluorides|fluorides|mesh-list
44454852|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
44188420|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
44188421|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44188422|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188423|NCT00347425|Olanzapine|olanzapine|mesh-list
44188424|NCT00347425|Risperidone|risperidone|mesh-list
44188425|NCT00347425|Aripiprazole|aripiprazole|mesh-list
44188426|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44188427|NCT00347425|Ziprasidone|ziprasidone|mesh-list
44188428|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44188429|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
44188430|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188431|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188432|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188433|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44188434|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44188481|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188482|NCT00347581|Methamphetamine|methamphetamine|mesh-list
44188483|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44188484|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188486|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
44188487|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188488|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
44188489|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188490|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188491|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188492|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44188493|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44188494|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44188495|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44188541|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188542|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188543|NCT00347802|Bimatoprost|bimatoprost|mesh-list
44188544|NCT00347802|Travoprost|travoprost|mesh-list
44188545|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188546|NCT00347815|Buprenorphine|buprenorphine|mesh-list
44188547|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188548|NCT00347815|Narcotics|narcotics|mesh-ancestor
44188549|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188550|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188551|NCT00347815|Analgesics|analgesics|mesh-ancestor
44188552|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
44188553|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809105|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
43809106|NCT03769844|Molgramostim|molgramostim|mesh-list
43809107|NCT03769844|Sargramostim|sargramostim|mesh-list
43809108|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
43809109|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188554|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44188555|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
44188556|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
44188557|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44188558|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44188559|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44188560|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188561|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44188562|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44188563|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188564|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188565|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188566|NCT00347841|Bimatoprost|bimatoprost|mesh-list
44188567|NCT00347841|Latanoprost|latanoprost|mesh-list
44188568|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44188569|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188570|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188571|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44188588|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188589|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188590|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44188591|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
44188592|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188593|NCT00348010|Tramadol|tramadol|mesh-list
44188594|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44188595|NCT00348010|Narcotics|narcotics|mesh-ancestor
44188596|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188597|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188598|NCT00348010|Analgesics|analgesics|mesh-ancestor
44188599|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
44188600|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188601|NCT00348023|Timolol|timolol|mesh-list
44188602|NCT00348023|Bimatoprost|bimatoprost|mesh-list
44188603|NCT00348023|Travoprost|travoprost|mesh-list
44188604|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44188605|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44188606|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188607|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188608|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188609|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188610|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44188611|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188637|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
44188638|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44188639|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44188640|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
44188641|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188642|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188644|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44188645|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188646|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188647|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
44188648|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188649|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188650|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
44188651|NCT00348231|Insulin|insulin|mesh-list
44188652|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188653|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188654|NCT00348244|Prednisolone|prednisolone|mesh-list
44188655|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44188656|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
44188657|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44188658|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
44188659|NCT00348244|Ketorolac|ketorolac|mesh-list
44188660|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44188661|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
44188662|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188663|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
44188664|NCT00348244|Hormones|hormones|mesh-ancestor
43843870|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188665|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44188666|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188667|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44188668|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188669|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
44188670|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
44188671|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188672|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188676|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188677|NCT00348244|Analgesics|analgesics|mesh-ancestor
44188678|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
44188679|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188680|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188681|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188682|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188683|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
44188684|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44188685|NCT00348296|Antibodies|antibodies|mesh-list
44188686|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
44188687|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44188688|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
44188689|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188690|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44188691|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
44188692|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188693|NCT00348335|Cyclosporine|cyclosporine|mesh-list
44188694|NCT00348335|Cyclosporins|cyclosporins|mesh-list
44188695|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188696|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188697|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188698|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
44188699|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188700|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
44188701|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188702|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188703|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188704|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44188705|NCT00348361|Fluticasone|fluticasone|mesh-list
44188706|NCT00348361|Xhance|xhance|mesh-list
44188707|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188708|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44188709|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
44188710|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188711|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188717|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
44188718|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188719|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44188721|NCT00348400|Latanoprost|latanoprost|mesh-list
44188722|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44188723|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44188724|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44188725|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44188726|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44188727|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43795747|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795748|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795749|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795750|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795751|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
44188728|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188729|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188730|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188731|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188732|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44188733|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188734|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
44188735|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44188736|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44188737|NCT00348413|Prednisolone|prednisolone|mesh-list
44188738|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
44188739|NCT00348413|Methotrexate|methotrexate|mesh-list
44188740|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44188741|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
44188742|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44188743|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
44188744|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44188745|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188746|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188747|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
44188748|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188749|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188750|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
44188751|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188752|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44188754|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
44188755|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188756|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44188757|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188758|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
44188759|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
44188760|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188761|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44188762|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
44188763|NCT00348413|Hormones|hormones|mesh-ancestor
44188764|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44188765|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44188766|NCT00348413|Protective Agents|protective agents|mesh-ancestor
44188767|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44188768|NCT00348426|Antitoxins|antitoxins|mesh-list
44188769|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
44188770|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
44188771|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188772|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
44188773|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44188774|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44188775|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188776|NCT00348452|Celecoxib|celecoxib|mesh-list
44188777|NCT00348452|Tramadol|tramadol|mesh-list
44188778|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188779|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188780|NCT00348452|Analgesics|analgesics|mesh-ancestor
44188781|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
44188782|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188783|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188784|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188785|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188786|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44188787|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188794|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44188795|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188796|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188797|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188798|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188799|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809123|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43809124|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43809125|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
43809126|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
44188800|NCT00348491|Analgesics|analgesics|mesh-ancestor
44188801|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
44188802|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188803|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188804|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188805|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188806|NCT00348504|Simendan|simendan|mesh-list
44188807|NCT00348504|Dobutamine|dobutamine|mesh-list
44188808|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44188809|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
44188810|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44188811|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44188812|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188813|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188814|NCT00348504|Protective Agents|protective agents|mesh-ancestor
44188815|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188816|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
44188817|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
44188818|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188819|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44188839|NCT00348582|Nepafenac|nepafenac|mesh-list
44188840|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44188841|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44188842|NCT00348582|Analgesics|analgesics|mesh-ancestor
44188843|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
44188844|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44188845|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188846|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44188847|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44188848|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44188849|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188850|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188851|NCT00348634|Tegaserod|tegaserod|mesh-list
44188852|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44188853|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
44188854|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188855|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188856|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188857|NCT00348712|Insulin|insulin|mesh-list
44188858|NCT00348712|Metformin|metformin|mesh-list
44188859|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
44188860|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44188861|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188862|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188863|NCT00348725|Metformin|metformin|mesh-list
44188864|NCT00348725|Fenofibrate|fenofibrate|mesh-list
44188865|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44188866|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188867|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44454892|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454893|NCT01657292|Octenidine|octenidine|mesh-list
44454894|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44454895|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44454896|NCT01657266|Nepafenac|nepafenac|mesh-list
44454897|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44454898|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44454899|NCT01657266|Analgesics|analgesics|mesh-ancestor
44454900|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
44454901|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454902|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454903|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654867|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43654868|NCT02973113|Nivolumab|nivolumab|mesh-list
43654869|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654873|NCT02973204|Everolimus|everolimus|mesh-list
44454904|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44454905|NCT01657162|Alendronate|alendronate|mesh-list
44454906|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44454907|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454908|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
44454909|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44454910|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454911|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44454912|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44454913|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454914|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454915|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
44454916|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454917|NCT01656733|Nicotine|nicotine|mesh-list
44454918|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44454919|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
44454920|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454921|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454922|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44454932|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44454933|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454934|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44454935|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44454936|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454937|NCT01656304|Bevacizumab|bevacizumab|mesh-list
44454938|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44454939|NCT01656304|Antibodies|antibodies|mesh-list
44188876|NCT00348894|Reboxetine|reboxetine|mesh-list
44188877|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
44188878|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44188879|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44188880|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44188881|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44188882|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188883|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
44188884|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44188885|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188886|NCT00348920|Bupivacaine|bupivacaine|mesh-list
44188887|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
44188888|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
44188889|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44188890|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188917|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
44188918|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44188919|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
44188920|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188921|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
44188922|NCT00349024|Protective Agents|protective agents|mesh-ancestor
44188923|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
44188924|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
44188925|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
44188926|NCT00349076|Fluorouracil|fluorouracil|mesh-list
44188927|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188928|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
44188929|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188930|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188979|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188980|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44188981|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
44188982|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188983|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
44188984|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188985|NCT00349219|Gemcitabine|gemcitabine|mesh-list
44188986|NCT00349219|Cisplatin|cisplatin|mesh-list
44188987|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44188988|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44188989|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44188990|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
44188991|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44188992|NCT00349219|Antiviral Agents|antiviral agents|mesh-ancestor
44188993|NCT00349219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44188994|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44188995|NCT00349219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44188996|NCT00349219|Immunologic Factors|immunologic factors|mesh-ancestor
44188997|NCT00349219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44188998|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44188999|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
44189000|NCT00349245|Remifentanil|remifentanil|mesh-list
44189001|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44189002|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189003|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189004|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189005|NCT00349245|Analgesics|analgesics|mesh-ancestor
44189006|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
44189007|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189008|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44189009|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44189010|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44189011|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
44189020|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189021|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44189022|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189023|NCT00349284|Ezetimibe|ezetimibe|mesh-list
44189024|NCT00349284|Fenofibrate|fenofibrate|mesh-list
44189025|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44189026|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189027|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
44189028|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189029|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189030|NCT00349310|Pramipexole|pramipexole|mesh-list
44189031|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
44189032|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189033|NCT00349310|Protective Agents|protective agents|mesh-ancestor
44189034|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189035|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44189036|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44189037|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
44189038|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
44189039|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189040|NCT00349362|Testosterone|testosterone|mesh-list
44189041|NCT00349362|Androgens|androgens|mesh-ancestor
44189042|NCT00349362|Hormones|hormones|mesh-ancestor
44189043|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189071|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189072|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189073|NCT00349440|Cyclosporine|cyclosporine|mesh-list
44189074|NCT00349440|Cyclosporins|cyclosporins|mesh-list
44189075|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189076|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189077|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189078|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
44189079|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189080|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
44189081|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189082|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189083|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189084|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44189085|NCT00349453|Deferiprone|deferiprone|mesh-list
44189086|NCT00349453|Deferoxamine|deferoxamine|mesh-list
44189087|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44189130|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189131|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189132|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189133|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
44189134|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189135|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
44189136|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189137|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189138|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189139|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44189141|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189142|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
44189143|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189144|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189145|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189146|NCT00349635|Metformin|metformin|mesh-list
44189147|NCT00349635|Fenofibrate|fenofibrate|mesh-list
44189148|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189149|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189150|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189151|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
44189152|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189182|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189183|NCT00349791|Testosterone|testosterone|mesh-list
44189184|NCT00349791|Androgens|androgens|mesh-ancestor
44189185|NCT00349791|Hormones|hormones|mesh-ancestor
44189186|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44189187|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189188|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
44189189|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189190|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189191|NCT00350038|Irbesartan|irbesartan|mesh-list
44189192|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
44189193|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44189194|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44189195|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44189196|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189197|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44189198|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
44189199|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189200|NCT00350051|Prednisone|prednisone|mesh-list
44189201|NCT00350051|Sagopilone|sagopilone|mesh-list
44189202|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189203|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
44189204|NCT00350051|Hormones|hormones|mesh-ancestor
44189237|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189238|NCT00350168|Amlodipine|amlodipine|mesh-list
44189239|NCT00350168|Valsartan|valsartan|mesh-list
44189240|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44189241|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44189242|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189243|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189244|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44189245|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189246|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
44189247|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44189248|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44189249|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
44189250|NCT00350181|Sirolimus|sirolimus|mesh-list
44189251|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
44189252|NCT00350181|Busulfan|busulfan|mesh-list
44189253|NCT00350181|Carmustine|carmustine|mesh-list
44189254|NCT00350181|Etoposide|etoposide|mesh-list
44189255|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189256|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
44189257|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189258|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189259|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44189260|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
44189261|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189284|NCT00350415|Mesalamine|mesalamine|mesh-list
44189285|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189286|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189287|NCT00350415|Analgesics|analgesics|mesh-ancestor
44189288|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
44189289|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189290|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189291|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189292|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189293|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
44189294|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189295|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
44189296|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44189297|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44189298|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189299|NCT00350441|Urological Agents|urological agents|mesh-ancestor
44189341|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454940|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
44454941|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44454942|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454943|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43809224|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809225|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809226|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43809227|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809229|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
43809230|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43809231|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43809232|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809233|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809234|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
43809235|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
43809236|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43809237|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
43809238|NCT04877509|Vitamin D|vitamin d|mesh-list
44454944|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44454945|NCT01656304|Growth Substances|growth substances|mesh-ancestor
44454946|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454947|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
44454948|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
44454949|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44454950|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
44454951|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44454952|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
44454953|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44454954|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454955|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44454956|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44454957|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454958|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
44454959|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
44454960|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
44454961|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454962|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454963|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
44454964|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44454965|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44454966|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44454967|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454968|NCT01655693|Doxorubicin|doxorubicin|mesh-list
44454969|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44454970|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44454971|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44454973|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44454977|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44454978|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44454979|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
44454980|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454981|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454982|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454983|NCT01655069|Urological Agents|urological agents|mesh-ancestor
44454984|NCT01654601|Clozapine|clozapine|mesh-list
44454985|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44454986|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
44454987|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44454988|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44454989|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44454990|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44454991|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44454992|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44454993|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44454994|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
44454995|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
44454998|NCT01654536|Hormones|hormones|mesh-ancestor
44189374|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
44189375|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189376|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189377|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809239|NCT04877509|Vitamin A|vitamin a|mesh-list
43809240|NCT04877509|Selenium|selenium|mesh-list
43809241|NCT04877509|Copper|copper|mesh-list
43809242|NCT04877509|Vitamins|vitamins|mesh-ancestor
44189378|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809243|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
44189379|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189380|NCT00350857|Analgesics|analgesics|mesh-ancestor
44189381|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
44189382|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189383|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44189384|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189385|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189386|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44189387|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44189388|NCT00350948|Doxorubicin|doxorubicin|mesh-list
44189389|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44189390|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44189391|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189392|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44189427|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189428|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
44189429|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189430|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
44189431|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44189432|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189433|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189434|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
44189435|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44189436|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189437|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189438|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44189439|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189440|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44189441|NCT00351104|Ketoprofen|ketoprofen|mesh-list
44189442|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189443|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189444|NCT00351104|Analgesics|analgesics|mesh-ancestor
44189445|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
44189446|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189447|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189477|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44189478|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44189479|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
44189480|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189481|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189482|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44189483|NCT00351169|Citalopram|citalopram|mesh-list
44189484|NCT00351169|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44189485|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44189486|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189487|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44125948|NCT00137033|Celecoxib|celecoxib|mesh-list
44189488|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189489|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
44189490|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189491|NCT00351169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44189493|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189532|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189533|NCT00351403|Ribavirin|ribavirin|mesh-list
44189534|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44189535|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
44189536|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189537|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
44189538|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189539|NCT00351507|Vildagliptin|vildagliptin|mesh-list
44189540|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654880|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654881|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43809266|NCT04876716|Posaconazole|posaconazole|mesh-list
44189541|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189542|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44189543|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
44189544|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189545|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189546|NCT00351546|Vildagliptin|vildagliptin|mesh-list
44189547|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189548|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189549|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44189588|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189589|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189590|NCT00351715|Analgesics|analgesics|mesh-ancestor
44189591|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
44189592|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189593|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
44189594|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
44189595|NCT00351832|Vildagliptin|vildagliptin|mesh-list
44189596|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189597|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189598|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44189599|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
44189600|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189601|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189603|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44189604|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
44189605|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189606|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
44189607|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44189608|NCT00351884|Vildagliptin|vildagliptin|mesh-list
44189609|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44189639|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189640|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189641|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189642|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189643|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44189644|NCT00351910|Analgesics|analgesics|mesh-ancestor
44189645|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
44189646|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44189647|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189648|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44189649|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
44189650|NCT00351975|Azacitidine|azacitidine|mesh-list
44189652|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44189653|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
44189654|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189655|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809270|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809271|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43809272|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43809273|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809274|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809275|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44189656|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189657|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44189658|NCT00352079|Gefitinib|gefitinib|mesh-list
44189659|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
44189660|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189661|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189662|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189663|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189664|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44189665|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
44189688|NCT00352170|Vitamin D|vitamin d|mesh-list
44189689|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
44189690|NCT00352170|Calcium|calcium|mesh-list
44189691|NCT00352170|Vitamins|vitamins|mesh-ancestor
44189692|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
44189693|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189694|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44189695|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44189696|NCT00352183|Simvastatin|simvastatin|mesh-list
44189697|NCT00352183|Fenofibrate|fenofibrate|mesh-list
44189698|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44189717|NCT00352235|KRN 7000|krn 7000|mesh-list
44455009|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455010|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455011|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
44455012|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455013|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44455014|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44455015|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44455016|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44455017|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455019|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
44455020|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455021|NCT01654224|Vaccines|vaccines|mesh-list
44455022|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
44455023|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455024|NCT01653912|Paclitaxel|paclitaxel|mesh-list
44455025|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44455026|NCT01653912|Carboplatin|carboplatin|mesh-list
44455027|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44455028|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455029|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455030|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455031|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
44189759|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44189760|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44189761|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44189762|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44189763|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
44189764|NCT00352378|Docetaxel|docetaxel|mesh-list
44189765|NCT00352378|Doxorubicin|doxorubicin|mesh-list
44189766|NCT00352378|Capecitabine|capecitabine|mesh-list
44189767|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44189768|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
43668074|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668075|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43796006|NCT00370890|Immunologic Factors|immunologic factors|mesh-ancestor
43796007|NCT00370890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796008|NCT04231565|Tenofovir|tenofovir|mesh-list
43796009|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
43796010|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796011|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43796012|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44189769|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189770|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44189771|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44189772|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
44189773|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189774|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189775|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44189776|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
44189777|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
44189778|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
44189779|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44189780|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44189781|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189782|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189810|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189811|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189812|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44189813|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189814|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189815|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189816|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
44189817|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
44189818|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44189819|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44189820|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189821|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189822|NCT00352482|Urological Agents|urological agents|mesh-ancestor
44189823|NCT00352495|Carboplatin|carboplatin|mesh-list
44189824|NCT00352495|Vinblastine|vinblastine|mesh-list
44189825|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189826|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44189827|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
44189828|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
44189829|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
44189830|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189831|NCT00352521|Bevacizumab|bevacizumab|mesh-list
44189832|NCT00352521|Irinotecan|irinotecan|mesh-list
44189833|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44189834|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189835|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44189836|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44189837|NCT00352521|Growth Substances|growth substances|mesh-ancestor
44189838|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189839|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
44189840|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44189841|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44189842|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189843|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189849|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
44189850|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189851|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44189852|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44189853|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189854|NCT00352625|Ketoprofen|ketoprofen|mesh-list
44189855|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189856|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189857|NCT00352625|Analgesics|analgesics|mesh-ancestor
44189858|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
44189859|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189860|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189861|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44189862|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796042|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
44189863|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44189864|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189865|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189866|NCT00352651|Pregabalin|pregabalin|mesh-list
44189867|NCT00352651|Analgesics|analgesics|mesh-ancestor
44189868|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
44189869|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189870|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189871|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
44189872|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44189873|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189874|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189875|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44189876|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44189877|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189891|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44189892|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44189893|NCT00352742|Growth Substances|growth substances|mesh-ancestor
44189894|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189895|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
44189896|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
44189897|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44189898|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189899|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44189900|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44189901|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189902|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189903|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44189904|NCT00352768|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44189905|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44189906|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189907|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44189908|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
44189909|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44189910|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
44189911|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44189912|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44189913|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44189914|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44189915|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44189936|NCT00352859|Immunologic Factors|immunologic factors|mesh-ancestor
44189937|NCT00352859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189938|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44189939|NCT00352950|Panitumumab|panitumumab|mesh-list
44189940|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44189941|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44189942|NCT00353002|Lidocaine|lidocaine|mesh-list
44189943|NCT00353002|Tetracaine|tetracaine|mesh-list
44189944|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
44189945|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
44189946|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44189947|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44189948|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
44189949|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44189950|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44189951|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44189952|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43809277|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809280|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44189953|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189955|NCT00353015|Cisplatin|cisplatin|mesh-list
44189989|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44189990|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44189991|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189992|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
44189993|NCT00353054|Antacids|antacids|mesh-ancestor
44189994|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44189995|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44189996|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
44189997|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44189998|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44189999|NCT00353067|Analgesics|analgesics|mesh-ancestor
44190000|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
44190001|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190002|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190003|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190004|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190005|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44190006|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190007|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190008|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
44190036|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190037|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
44190038|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44190039|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
44190040|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190041|NCT00353340|Expectorants|expectorants|mesh-ancestor
44190042|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190043|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44190044|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
44190045|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190046|NCT00353340|Protective Agents|protective agents|mesh-ancestor
44190047|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190048|NCT00353340|Antidotes|antidotes|mesh-ancestor
44190050|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190051|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44190052|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44190053|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44190054|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190055|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190056|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190057|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190058|NCT00353561|Fluconazole|fluconazole|mesh-list
44190059|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
44190060|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843915|NCT04418999|Dexamethasone|dexamethasone|mesh-list
43841699|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841700|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
43841701|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43841702|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43841703|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43841704|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841705|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841706|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841707|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841708|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190061|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44190062|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190063|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190064|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190065|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44190066|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
44190067|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190068|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190069|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44190074|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44190075|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
44190076|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190077|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190078|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190079|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44190080|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44190081|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
44190082|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44190083|NCT00353665|Protective Agents|protective agents|mesh-ancestor
44190084|NCT00353678|Darexaban|darexaban|mesh-list
44190085|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44190086|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
44190087|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44190088|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190089|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190090|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190091|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
44190092|NCT00353691|Metformin|metformin|mesh-list
44190093|NCT00353691|Glimepiride|glimepiride|mesh-list
44190094|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44190095|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190096|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44190097|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190098|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
44190099|NCT00353717|Paclitaxel|paclitaxel|mesh-list
44190100|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44190101|NCT00353717|Cetuximab|cetuximab|mesh-list
44190102|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44190121|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190122|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190123|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190124|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190125|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190126|NCT00353912|Amlodipine|amlodipine|mesh-list
44190127|NCT00353912|Valsartan|valsartan|mesh-list
44190128|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190129|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44190130|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843916|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843917|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
43843918|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
43809380|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43809381|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809383|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43809420|NCT04874675|Ibuprofen|ibuprofen|mesh-list
44190131|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190132|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44190133|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190134|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
44190135|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44190136|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44190137|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
44190138|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44190139|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190140|NCT00354068|Temozolomide|temozolomide|mesh-list
44190141|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
44190142|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44190143|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
44190144|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190145|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190146|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44190147|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190148|NCT00354081|Vitamins|vitamins|mesh-list
44190149|NCT00354081|Folic Acid|folic acid|mesh-list
44190150|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
44190151|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
44190152|NCT00354081|Pyridoxine|pyridoxine|mesh-list
44190153|NCT00354081|Pyridoxal|pyridoxal|mesh-list
44190154|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
44190155|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
44190156|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
44190160|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
44190161|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44190162|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44190163|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44190164|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190165|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190166|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190167|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190168|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190169|NCT00354146|Tipifarnib|tipifarnib|mesh-list
44190170|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190171|NCT00354185|Belinostat|belinostat|mesh-list
44190172|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455067|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455068|NCT01653262|Brivaracetam|brivaracetam|mesh-list
44455069|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
44455070|NCT01653158|Docetaxel|docetaxel|mesh-list
44455071|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455072|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455073|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455074|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455075|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455076|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
44455077|NCT01652872|Hematinics|hematinics|mesh-ancestor
44455078|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44455079|NCT01652729|Exenatide|exenatide|mesh-list
44455080|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455081|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455082|NCT01652729|Incretins|incretins|mesh-ancestor
44455083|NCT01652729|Hormones|hormones|mesh-ancestor
44455084|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455085|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44455086|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
44455087|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455089|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44190210|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
44190211|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
44190212|NCT00354302|Calcium|calcium|mesh-list
44190213|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43809450|NCT04874246|Coagulants|coagulants|mesh-ancestor
44190214|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190215|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44190216|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190217|NCT00354302|Vitamins|vitamins|mesh-ancestor
44190218|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
44190219|NCT00354302|Antacids|antacids|mesh-ancestor
44190220|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190221|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44190222|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190223|NCT00354354|Ipratropium|ipratropium|mesh-list
44190224|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44190225|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
44190226|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190227|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190228|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44190229|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190230|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190231|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190232|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44190233|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
44190234|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
44190235|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190236|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
44190237|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190238|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190239|NCT00354380|Artesunate|artesunate|mesh-list
44190256|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190257|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44190258|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
44190259|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44190260|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190261|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190262|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
44190263|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190264|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
44190265|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190266|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44190267|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190268|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
44190269|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190270|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190271|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44190272|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
44190273|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
44190274|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190276|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
44190277|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44190278|NCT00354419|Cyclosporine|cyclosporine|mesh-list
44190279|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
44190280|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
44190281|NCT00354419|Cyclosporins|cyclosporins|mesh-list
44190282|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
44190283|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44190284|NCT00354419|Lenograstim|lenograstim|mesh-list
44190285|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
44190286|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190287|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
44190301|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44190302|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44190303|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
44190304|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190306|NCT00354458|Diuretics|diuretics|mesh-ancestor
44190307|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
44190308|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190309|NCT00354523|Capecitabine|capecitabine|mesh-list
44190310|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
44190311|NCT00354523|Dacarbazine|dacarbazine|mesh-list
44190312|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190313|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
44190314|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190315|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190316|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44190317|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190318|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44190319|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
44190320|NCT00354549|Gemcitabine|gemcitabine|mesh-list
44190321|NCT00354549|Bevacizumab|bevacizumab|mesh-list
44190322|NCT00354549|Cisplatin|cisplatin|mesh-list
44190323|NCT00354549|Carboplatin|carboplatin|mesh-list
44190324|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44190325|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44190326|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190327|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44190328|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44190329|NCT00354549|Growth Substances|growth substances|mesh-ancestor
44190330|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190331|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
44190332|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190333|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
44190334|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190341|NCT00354562|Docetaxel|docetaxel|mesh-list
44190342|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190343|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
44190344|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
44190345|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190346|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190347|NCT00354627|Etravirine|etravirine|mesh-list
44190348|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44190349|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190350|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190351|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190352|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
44190353|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190354|NCT00354653|Lamivudine|lamivudine|mesh-list
44190355|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44190356|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190357|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190358|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190359|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
44190360|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190361|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190362|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44190363|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44190364|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
44190365|NCT00354692|Hematinics|hematinics|mesh-ancestor
44190366|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
44190367|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44190368|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190369|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190370|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44190371|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44190372|NCT00354731|Protective Agents|protective agents|mesh-ancestor
44190373|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190374|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
44190375|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44190376|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
44190380|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44190381|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190382|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654884|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190383|NCT00354809|Casopitant|casopitant|mesh-list
44190384|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
44190385|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
44190386|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190387|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190388|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190389|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44190390|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190391|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190392|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
44190393|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44190394|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
44190395|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190396|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44190397|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44190398|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
44190399|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190400|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190401|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44190402|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190403|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44190404|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44190405|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44190406|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190407|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190408|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190409|NCT00354900|Aprotinin|aprotinin|mesh-list
44190410|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
44190411|NCT00354900|Coagulants|coagulants|mesh-ancestor
44190412|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44190421|NCT00354952|Clarithromycin|clarithromycin|mesh-list
44190422|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190423|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190424|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44190425|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190426|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190427|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44190428|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190429|NCT00354965|Amoxicillin|amoxicillin|mesh-list
44190430|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
44190431|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
44190432|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44190433|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190434|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190435|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44190436|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190438|NCT00354991|Losartan|losartan|mesh-list
44190476|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
44190477|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190478|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190479|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44190480|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44190481|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190482|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190483|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190484|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190485|NCT00355290|Vitamin K|vitamin k|mesh-list
44190486|NCT00355290|Vitamins|vitamins|mesh-ancestor
44190487|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
44190488|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190489|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44190490|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44190491|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190492|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
44190493|NCT00355290|Coagulants|coagulants|mesh-ancestor
44190494|NCT00355303|Misoprostol|misoprostol|mesh-list
44190495|NCT00355303|Dinoprostone|dinoprostone|mesh-list
44190496|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44190497|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
44190498|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44190499|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190500|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44190501|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190502|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
44190503|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
44190504|NCT00355407|Hematinics|hematinics|mesh-ancestor
44190505|NCT00355446|Bimatoprost|bimatoprost|mesh-list
44190506|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190507|NCT00355459|Doxycycline|doxycycline|mesh-list
44190508|NCT00355459|Tetracycline|tetracycline|mesh-list
44190509|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190510|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190511|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
44190512|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44190513|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190514|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44190515|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190516|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190517|NCT00355524|Ritonavir|ritonavir|mesh-list
44190518|NCT00355524|Darunavir|darunavir|mesh-list
44190519|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44190520|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44190521|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190522|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190523|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190524|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190525|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44190526|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
44190527|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190528|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44190529|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190530|NCT00355537|Testosterone|testosterone|mesh-list
44190531|NCT00355537|Androgens|androgens|mesh-ancestor
44190532|NCT00355537|Hormones|hormones|mesh-ancestor
44190533|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190536|NCT00355576|Celecoxib|celecoxib|mesh-list
44190568|NCT00355602|Rifaximin|rifaximin|mesh-list
44190569|NCT00355602|Cefuroxime|cefuroxime|mesh-list
44190570|NCT00355602|Neomycin|neomycin|mesh-list
44190571|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44127042|NCT00140452|Thalidomide|thalidomide|mesh-list
44190572|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44190573|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190574|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190575|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44190576|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44190577|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44190578|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190579|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190580|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44190628|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44190629|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841714|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
43841715|NCT04594772|Irinotecan|irinotecan|mesh-list
43841716|NCT04594772|Folfirinox|folfirinox|mesh-list
44190630|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43841717|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44190631|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
44190632|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
44190633|NCT00355719|Ritonavir|ritonavir|mesh-list
44190634|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44190635|NCT00355719|Nevirapine|nevirapine|mesh-list
44190636|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44190637|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44190638|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190639|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190640|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190641|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190642|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44190643|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
44190644|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190645|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44190646|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190647|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44190648|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44127117|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190649|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44190650|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44190651|NCT00355771|Levocetirizine|levocetirizine|mesh-list
44190652|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44190675|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44190676|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44190677|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190678|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190679|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
44190680|NCT00355862|Hormones|hormones|mesh-ancestor
44190681|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44190682|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44190683|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
44190684|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190685|NCT00355901|Visilizumab|visilizumab|mesh-list
44190686|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
44190687|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190688|NCT00355927|Propofol|propofol|mesh-list
44190689|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44190690|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44190691|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190692|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44190693|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
44190694|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
44190695|NCT00355953|Genistein|genistein|mesh-list
44190696|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44190697|NCT00355953|Protective Agents|protective agents|mesh-ancestor
44190698|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190699|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190700|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44190706|NCT00355953|Hormones|hormones|mesh-ancestor
44190723|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190724|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
44190725|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
44190726|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44190727|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
44455109|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44455110|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44455111|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44455112|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
44455113|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455114|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455115|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455116|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44455117|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190728|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44190729|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44190730|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44190731|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44190732|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190733|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190734|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190735|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190736|NCT00356083|Methadone|methadone|mesh-list
44190738|NCT00356083|Narcotics|narcotics|mesh-ancestor
44190763|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
44190764|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44190765|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44190766|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44190767|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
44190768|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190769|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190770|NCT00356252|Carotenoids|carotenoids|mesh-list
44190771|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
44190772|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190773|NCT00356252|Protective Agents|protective agents|mesh-ancestor
44190774|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190775|NCT00356356|Etanercept|etanercept|mesh-list
44190776|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44190777|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44190778|NCT00356356|Analgesics|analgesics|mesh-ancestor
44190779|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
44190780|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190781|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190782|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44190783|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44190784|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44190785|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190786|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
44190787|NCT00356395|Candesartan|candesartan|mesh-list
44190788|NCT00356395|Ramipril|ramipril|mesh-list
44190789|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44190790|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44190791|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44190808|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190809|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190810|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190811|NCT00356473|Atorvastatin|atorvastatin|mesh-list
44190812|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44190813|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44190814|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
44190815|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190816|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44190817|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44190818|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190820|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44190821|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
43809536|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809537|NCT04873011|Analgesics|analgesics|mesh-ancestor
43809538|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
43809539|NCT04872985|Paclitaxel|paclitaxel|mesh-list
43809540|NCT04872985|Docetaxel|docetaxel|mesh-list
43809541|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
43809542|NCT04872985|Doxorubicin|doxorubicin|mesh-list
43809543|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43809544|NCT04872985|Epirubicin|epirubicin|mesh-list
43809545|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44190822|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
43848518|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43848519|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44190823|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190824|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
44190867|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190868|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190869|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44190871|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
44190872|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44190873|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
44127387|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44190874|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
44190875|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
44190876|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190877|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
44190878|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
44190879|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190880|NCT00356954|Protective Agents|protective agents|mesh-ancestor
44190881|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190882|NCT00356954|Vitamins|vitamins|mesh-ancestor
44190883|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
44190884|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
44190885|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44190886|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
44190887|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44190888|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190889|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44190890|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
44190891|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44190892|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
44190893|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
44190894|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44190895|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190896|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44190897|NCT00357019|Protective Agents|protective agents|mesh-ancestor
44190898|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44190899|NCT00357045|Paroxetine|paroxetine|mesh-list
44190900|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44190906|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190907|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44190908|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
44190909|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44190910|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44190911|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190912|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190913|NCT00357084|Prednisone|prednisone|mesh-list
44190914|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
43809546|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843936|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843937|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
43843938|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43843939|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43843940|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43843941|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43843942|NCT04418531|Antibodies|antibodies|mesh-list
43843943|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
44190915|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44190916|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44190917|NCT00357084|Prednisolone|prednisolone|mesh-list
44190918|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
44190919|NCT00357084|Methotrexate|methotrexate|mesh-list
44190921|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
44190964|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
44190965|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44190966|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44190967|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
44190968|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44190969|NCT00357188|Ritonavir|ritonavir|mesh-list
44190970|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44190971|NCT00357188|Efavirenz|efavirenz|mesh-list
44190972|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44190973|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44190974|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
44190975|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44190976|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44190977|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44190978|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44190979|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
44190980|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44190981|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44190982|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44190983|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44190984|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44190985|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44190986|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44190987|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44190990|NCT00357240|Ritonavir|ritonavir|mesh-list
44191011|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191012|NCT00357292|Azithromycin|azithromycin|mesh-list
44191013|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191014|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191016|NCT00357305|Etoposide|etoposide|mesh-list
43843946|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809562|NCT04872907|Fluorides|fluorides|mesh-list
43809563|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
43809564|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
43809565|NCT04872907|Protective Agents|protective agents|mesh-ancestor
43809566|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809567|NCT04872881|Fentanyl|fentanyl|mesh-list
43796405|NCT05069454|Vaccines|vaccines|mesh-list
43796406|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
43796407|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796408|NCT05069688|Rifampin|rifampin|mesh-list
43796409|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43796410|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
43796411|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796412|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796413|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
44191017|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
44191018|NCT00357305|Vorinostat|vorinostat|mesh-list
43796414|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43796415|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191019|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44191020|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191021|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44191022|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191023|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191024|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191025|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191026|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
44191027|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
44191028|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191029|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191070|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
44191071|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191072|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44191073|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191074|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44191075|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191076|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44191077|NCT00357474|Ethanol|ethanol|mesh-list
44191078|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44191079|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191080|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191081|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191082|NCT00357539|Azithromycin|azithromycin|mesh-list
44191083|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191084|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191085|NCT00357604|Ritonavir|ritonavir|mesh-list
44191086|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44191087|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
44191088|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44191089|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44191090|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44191091|NCT00357604|Norgestimate|norgestimate|mesh-list
44191092|NCT00357604|Norgestrel|norgestrel|mesh-list
44191093|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44191094|NCT00357604|Estradiol|estradiol|mesh-list
44191095|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44191096|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44191097|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44191098|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
44191099|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191100|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44127608|NCT00141700|Rituximab|rituximab|mesh-list
44191101|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44191102|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44191110|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191111|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44191112|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
44191113|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191114|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44191115|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44191116|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44191117|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44191118|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44191119|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191120|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44191121|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191122|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191124|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44191125|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191126|NCT00357617|Analgesics|analgesics|mesh-ancestor
44191127|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
44191136|NCT00357630|Gemcitabine|gemcitabine|mesh-list
44191165|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191166|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44191167|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44191168|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191169|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44191170|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44191171|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191173|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44191174|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191175|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44191176|NCT00357708|Decitabine|decitabine|mesh-list
44191177|NCT00357708|Azacitidine|azacitidine|mesh-list
44191178|NCT00357708|Vorinostat|vorinostat|mesh-list
44191179|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191180|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
44191181|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191182|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191222|NCT00357864|Carbachol|carbachol|mesh-list
44191223|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44191224|NCT00357864|Miotics|miotics|mesh-ancestor
44191225|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
44191226|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191227|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191228|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44191229|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
44191230|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191231|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191232|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191233|NCT00357864|Analgesics|analgesics|mesh-ancestor
44191234|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
44191235|NCT00357864|Protective Agents|protective agents|mesh-ancestor
44191239|NCT00357942|Morphine|morphine|mesh-list
44191282|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44191283|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43809576|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43809577|NCT04872881|Narcotics|narcotics|mesh-ancestor
43809578|NCT04872881|Analgesics|analgesics|mesh-ancestor
44191284|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44191285|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191286|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191288|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191289|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191290|NCT00358280|Bupivacaine|bupivacaine|mesh-list
44191291|NCT00358280|Ropivacaine|ropivacaine|mesh-list
44191292|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
44191293|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
44191294|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191295|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191296|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
44191297|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191298|NCT00358293|Tizanidine|tizanidine|mesh-list
44191299|NCT00358293|Analgesics|analgesics|mesh-ancestor
44191337|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44191338|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44191339|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44191340|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44191341|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191342|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191343|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191344|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
44191346|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191347|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
44191348|NCT00358371|Floxacillin|floxacillin|mesh-list
44191349|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191350|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191351|NCT00358384|Betamethasone|betamethasone|mesh-list
44191352|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
44191353|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44191354|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
44191392|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191393|NCT00358566|Gemcitabine|gemcitabine|mesh-list
44191394|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44191395|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
44191396|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809581|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43809582|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43809613|NCT04872283|Aspirin|aspirin|mesh-list
43809614|NCT04872283|Acetaminophen|acetaminophen|mesh-list
43809615|NCT04872283|Ketorolac|ketorolac|mesh-list
43809616|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44191397|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191398|NCT00358566|Antiviral Agents|antiviral agents|mesh-ancestor
44191399|NCT00358566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191400|NCT00358566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191401|NCT00358566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191402|NCT00358566|Immunologic Factors|immunologic factors|mesh-ancestor
44191403|NCT00358566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191405|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44191406|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191407|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191408|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44191409|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
44191410|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
44191411|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
43809620|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809621|NCT04872283|Analgesics|analgesics|mesh-ancestor
44191412|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191413|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
44191414|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191415|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191416|NCT00358696|Tenofovir|tenofovir|mesh-list
44191417|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
44191418|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191419|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44191420|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44191421|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191423|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44191436|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
44191437|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191438|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44191439|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44191440|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191441|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191442|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
44191443|NCT00358969|Guanfacine|guanfacine|mesh-list
44191444|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44191445|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44191446|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43809622|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
43809623|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809624|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809625|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809626|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809658|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
43809659|NCT04871724|Fluconazole|fluconazole|mesh-list
43809660|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
43841748|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
44191447|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44191448|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191449|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191450|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191451|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191452|NCT00359112|Metformin|metformin|mesh-list
44191453|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191454|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191455|NCT00359125|Mifepristone|mifepristone|mesh-list
44191456|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44191457|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
44191458|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191459|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191460|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44191461|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44191462|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44191463|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
44191464|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44191465|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44191466|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
44191467|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191468|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
44191469|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44191470|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44191472|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44191473|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191475|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
44191476|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191477|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191478|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191479|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191480|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44191481|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44191482|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191483|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191485|NCT00359164|Verteporfin|verteporfin|mesh-list
44191486|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44191487|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191488|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44191489|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44191490|NCT00359164|Growth Substances|growth substances|mesh-ancestor
44191491|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191492|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
44191493|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44191494|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191495|NCT00359177|Casopitant|casopitant|mesh-list
44191523|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191524|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191525|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
44191526|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191527|NCT00359333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191528|NCT00359333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191529|NCT00359333|Immunologic Factors|immunologic factors|mesh-ancestor
44191530|NCT00359333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809665|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191531|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
44191532|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
44191533|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
44191534|NCT00359359|Cisplatin|cisplatin|mesh-list
44191535|NCT00359359|Sagopilone|sagopilone|mesh-list
44191536|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191537|NCT00359385|Alendronate|alendronate|mesh-list
44191538|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44191539|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191540|NCT00359567|Palonosetron|palonosetron|mesh-list
44191541|NCT00359567|Granisetron|granisetron|mesh-list
44191542|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
44191543|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
44191544|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191545|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191546|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191547|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44191548|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44191549|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
44191550|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191551|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191552|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
44191553|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
44191554|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191566|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191567|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44191568|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191569|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
44191570|NCT00359658|Hormones|hormones|mesh-ancestor
44191571|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191572|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44191573|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191574|NCT00359671|Docetaxel|docetaxel|mesh-list
44191575|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191576|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
44191577|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
44191578|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
44191579|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191580|NCT00359697|Mannitol|mannitol|mesh-list
44191581|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44191582|NCT00359697|Diuretics|diuretics|mesh-ancestor
44191583|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
44191584|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191585|NCT00359723|Methylphenidate|methylphenidate|mesh-list
44191586|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44191587|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191588|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44191589|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44191590|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44191591|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191592|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
44191593|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191610|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191611|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44191612|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191613|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191614|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191615|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191616|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44191617|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44191618|NCT00359879|Exenatide|exenatide|mesh-list
44191619|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191620|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668076|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668077|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
43796577|NCT05063422|Trimethoprim|trimethoprim|mesh-list
44191621|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44191622|NCT00359879|Incretins|incretins|mesh-ancestor
44191623|NCT00359879|Hormones|hormones|mesh-ancestor
44191624|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191625|NCT00359892|Obatoclax|obatoclax|mesh-list
44191626|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191627|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455121|NCT01652573|Katacalcin|katacalcin|mesh-list
44455122|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44455123|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455124|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44455125|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
44455126|NCT01652469|Docetaxel|docetaxel|mesh-list
44455127|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44455128|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455129|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455130|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455131|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455132|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455145|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455146|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44455147|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455148|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
44455149|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455150|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455151|NCT01651780|Heparin|heparin|mesh-list
44455152|NCT01651780|Calcium heparin|calcium heparin|mesh-list
44455153|NCT01651780|Bivalirudin|bivalirudin|mesh-list
43809694|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455154|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
44455155|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44455156|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44455157|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455158|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
44455159|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44455160|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
44455161|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455162|NCT01651403|Tenofovir|tenofovir|mesh-list
44455163|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
44455164|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455165|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44455166|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455167|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455168|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455169|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44191630|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44191631|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44191632|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44191633|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191634|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191635|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191636|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191637|NCT00359905|Urological Agents|urological agents|mesh-ancestor
44191638|NCT00359970|Azithromycin|azithromycin|mesh-list
44191639|NCT00359970|Loperamide|loperamide|mesh-list
44191640|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
43809695|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43809696|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809697|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809698|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43809699|NCT04871633|Protective Agents|protective agents|mesh-ancestor
43809700|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191641|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191642|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191643|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191644|NCT00360048|Oxytocin|oxytocin|mesh-list
44191645|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
44191646|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191647|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191648|NCT00360087|Bosentan|bosentan|mesh-list
44191649|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44191650|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44191651|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191652|NCT00360178|Amlodipine|amlodipine|mesh-list
44191653|NCT00360178|Valsartan|valsartan|mesh-list
44191655|NCT00360178|Candesartan|candesartan|mesh-list
44191679|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191680|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191681|NCT00360386|Clopidogrel|clopidogrel|mesh-list
44191682|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44191683|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44191684|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44191685|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44191686|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
44191687|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191688|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191689|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191690|NCT00360438|Rasburicase|rasburicase|mesh-list
44191691|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
44191692|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191693|NCT00360464|Azithromycin|azithromycin|mesh-list
44191694|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191695|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191696|NCT00360594|Acamprosate|acamprosate|mesh-list
44191697|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44191698|NCT00360607|Metronidazole|metronidazole|mesh-list
44191699|NCT00360607|Amikacin|amikacin|mesh-list
44191700|NCT00360607|Ceftazidime|ceftazidime|mesh-list
44191734|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
44191735|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44191736|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44191737|NCT00360763|Candesartan|candesartan|mesh-list
44191738|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
44191739|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44191740|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44191741|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44191742|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191743|NCT00360776|Tipifarnib|tipifarnib|mesh-list
44191744|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191745|NCT00360815|Insulin|insulin|mesh-list
44191746|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44191747|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191748|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44191749|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191750|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44191751|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191752|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191753|NCT00360945|Cisplatin|cisplatin|mesh-list
44191754|NCT00360945|Temozolomide|temozolomide|mesh-list
44191757|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
44191788|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
44191789|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44191790|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44191791|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191792|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44191793|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191794|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191795|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44191796|NCT00361114|Renal Agents|renal agents|mesh-ancestor
44191797|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
44191798|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191799|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44191800|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44191801|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44191802|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
44191803|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191804|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44191805|NCT00361166|Pimavanserin|pimavanserin|mesh-list
44191806|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44191807|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44191842|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191843|NCT00361322|Clindamycin|clindamycin|mesh-list
44191844|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
44191845|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
44191846|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
44191847|NCT00361322|Salicylates|salicylates|mesh-list
44191848|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191849|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191850|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44191851|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191852|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191853|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
44191854|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
44191855|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
44191856|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44191857|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44191859|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
44191860|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191861|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191862|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191863|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191864|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44191865|NCT00361348|Heparin|heparin|mesh-list
43809713|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809714|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654899|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
43654900|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43654901|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43809715|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809716|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809717|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
43796708|NCT05061641|Progestins|progestins|mesh-ancestor
44191866|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
44191867|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44191868|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44191869|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191870|NCT00361387|Methylphenidate|methylphenidate|mesh-list
44191871|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44191886|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44191887|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
44191888|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44191889|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191890|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191891|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44191892|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44191894|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44191895|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44191896|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44191897|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
44191898|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
44191899|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44191900|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
44191901|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44191902|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44191903|NCT00361517|Amphotericin B|amphotericin b|mesh-list
44191904|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44191905|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44191906|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
44191907|NCT00361517|Amebicides|amebicides|mesh-ancestor
44191908|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44191909|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44191910|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44191911|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44191912|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
44191913|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44191914|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44191915|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44191916|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44191917|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
44191918|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191919|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191920|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44191921|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44191923|NCT00361621|Prednisone|prednisone|mesh-list
44191924|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
44191925|NCT00361621|Rituximab|rituximab|mesh-list
44191926|NCT00361621|Doxorubicin|doxorubicin|mesh-list
44191927|NCT00361621|Vincristine|vincristine|mesh-list
44191928|NCT00361621|Bortezomib|bortezomib|mesh-list
44191929|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44191930|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
44191931|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191932|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44191933|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44191934|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
44191935|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44191936|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44191937|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44191938|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44191939|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44191940|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44191941|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191942|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191943|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44191944|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
44191945|NCT00361621|Hormones|hormones|mesh-ancestor
44191946|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44191947|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44191973|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
44191974|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44191975|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44191976|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
44191977|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44191978|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44191979|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44191980|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44191981|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
44191982|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
44191983|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44191984|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44191985|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44191986|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44191987|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44191988|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44191989|NCT00361803|Topotecan|topotecan|mesh-list
44191990|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44191991|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44191992|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44191993|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192016|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192017|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
44192018|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44192019|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44192020|NCT00361907|Insulin|insulin|mesh-list
44192021|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44192022|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192023|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192024|NCT00361920|Prednisone|prednisone|mesh-list
44192025|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192026|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
44192027|NCT00361920|Hormones|hormones|mesh-ancestor
44192028|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192029|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192030|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44192031|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192036|NCT00361959|Xhance|xhance|mesh-list
44192075|NCT00362063|Hormones|hormones|mesh-list
44192076|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192077|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192078|NCT00362089|Dronabinol|dronabinol|mesh-list
44192079|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
44192080|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192081|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192082|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192083|NCT00362089|Analgesics|analgesics|mesh-ancestor
44192084|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
44192085|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192086|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44192087|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44192088|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192089|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192133|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44192134|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44192135|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43809753|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43809754|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43809755|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44192136|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192137|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44192138|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44192140|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44192141|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44192142|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192143|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192144|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192145|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44192146|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44192147|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
44192148|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192149|NCT00362323|Metformin|metformin|mesh-list
44192150|NCT00362323|Fenofibrate|fenofibrate|mesh-list
44192151|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192152|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192153|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192154|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
44192155|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192156|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192157|NCT00362505|Clevudine|clevudine|mesh-list
44192158|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
44192159|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192160|NCT00362531|Prednisone|prednisone|mesh-list
44192179|NCT00362570|Temozolomide|temozolomide|mesh-list
44192180|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44192181|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
44192182|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192183|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192184|NCT00362583|Fentanyl|fentanyl|mesh-list
44192185|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44192186|NCT00362583|Narcotics|narcotics|mesh-ancestor
44192187|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192188|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192189|NCT00362583|Analgesics|analgesics|mesh-ancestor
44192190|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
44192191|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192192|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44192193|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43809765|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43809766|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627428|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809805|NCT04870203|Adalimumab|adalimumab|mesh-list
44192194|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
44192195|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
44192196|NCT00362596|Acyclovir|acyclovir|mesh-list
44192197|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
44192198|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192199|NCT00362635|Clevudine|clevudine|mesh-list
44192200|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
44192201|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192202|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
44192203|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44192204|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44192205|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44192206|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192207|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44192208|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44192209|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192210|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192212|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
44192220|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44192221|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192222|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44192223|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192224|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
44192225|NCT00362726|Ritonavir|ritonavir|mesh-list
44192226|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44192227|NCT00362726|Maleic acid|maleic acid|mesh-list
44192228|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44192229|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44192230|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192231|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192232|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192233|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44192234|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44192235|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
44192236|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192237|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44192238|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44192239|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192240|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192241|NCT00362752|Norfloxacin|norfloxacin|mesh-list
44192242|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192243|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192244|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192268|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192269|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192270|NCT00362869|Levofloxacin|levofloxacin|mesh-list
44192271|NCT00362869|Ofloxacin|ofloxacin|mesh-list
44192272|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44192273|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843953|NCT04416451|Venetoclax|venetoclax|mesh-list
43843954|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843955|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843956|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
43843957|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843958|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43843959|NCT04415853|Irinotecan|irinotecan|mesh-list
43843960|NCT04415853|Tegafur|tegafur|mesh-list
43796830|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43796831|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
44192274|NCT00362869|Renal Agents|renal agents|mesh-ancestor
44192275|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44192276|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192277|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44192278|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192279|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192280|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192281|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44192328|NCT00362960|Losartan|losartan|mesh-list
44192329|NCT00362960|Olmesartan|olmesartan|mesh-list
44192330|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44192331|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44192332|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44192333|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44192334|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44192335|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192336|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44192337|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44192338|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192339|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
44192340|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44192341|NCT00362986|Protective Agents|protective agents|mesh-ancestor
44192342|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192343|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192344|NCT00363025|Daunorubicin|daunorubicin|mesh-list
44192386|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44192387|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
44192388|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192389|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192390|NCT00363259|Ribavirin|ribavirin|mesh-list
44192391|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44192392|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
44192393|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192394|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
44192395|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192396|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
44192397|NCT00363285|Hormones|hormones|mesh-list
44192398|NCT00363285|Cyproterone|cyproterone|mesh-list
44192399|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192400|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192401|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
44192402|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
44192403|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192404|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44192405|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
44192406|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44192407|NCT00363337|Aripiprazole|aripiprazole|mesh-list
44192408|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
44192409|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192410|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192411|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192412|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192413|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192414|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
44192415|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
44192416|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192417|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192418|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44192419|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44192420|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
44192423|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44192424|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44192425|NCT00363350|Rituximab|rituximab|mesh-list
43627429|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
44192426|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44192427|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192428|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
44192429|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192430|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192431|NCT00363376|Zonisamide|zonisamide|mesh-list
44192432|NCT00363376|Olanzapine|olanzapine|mesh-list
44192433|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
44192434|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
44192435|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192436|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192437|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192438|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192439|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192440|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192441|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192442|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44192443|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192444|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44192445|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192446|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192447|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
44192448|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
44192449|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44192450|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44192451|NCT00363389|Misoprostol|misoprostol|mesh-list
44192452|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44192453|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
44192454|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44192456|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192464|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192465|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44192466|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192467|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192468|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192469|NCT00363532|Calcitonin|calcitonin|mesh-list
44192470|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
44192471|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44192472|NCT00363532|Katacalcin|katacalcin|mesh-list
44192473|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44192474|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192475|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44192476|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
44192477|NCT00363571|Acetazolamide|acetazolamide|mesh-list
44192478|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
44192479|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44192480|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192481|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192482|NCT00363571|Diuretics|diuretics|mesh-ancestor
44192483|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
44192484|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192485|NCT00363584|Capecitabine|capecitabine|mesh-list
44192486|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44192487|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
44192488|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192490|NCT00363610|Pegaspargase|pegaspargase|mesh-list
44455214|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455215|NCT01650519|Ibuprofen|ibuprofen|mesh-list
44455216|NCT01650519|Ketorolac|ketorolac|mesh-list
44455217|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44455218|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44455219|NCT01650519|Analgesics|analgesics|mesh-ancestor
44455220|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
44455221|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455222|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455223|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192501|NCT00363727|Ropinirole|ropinirole|mesh-list
44192502|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44192503|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44192504|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
44192505|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
44192506|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192507|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192508|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192509|NCT00363753|Aspirin|aspirin|mesh-list
44192510|NCT00363753|Clopidogrel|clopidogrel|mesh-list
44192511|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44192512|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192513|NCT00363753|Analgesics|analgesics|mesh-ancestor
44192514|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
44192515|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192516|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192517|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192518|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192519|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44192520|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44192521|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192525|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
44192534|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192535|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44192536|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192537|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192538|NCT00363844|Incretins|incretins|mesh-ancestor
44192539|NCT00363844|Hormones|hormones|mesh-ancestor
44192540|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192541|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44192542|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192543|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192544|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192545|NCT00363857|Ropinirole|ropinirole|mesh-list
44192546|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44192547|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44192548|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
44192549|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
44192550|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192551|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192552|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192553|NCT00363909|Dexetimide|dexetimide|mesh-list
44192586|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192587|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44192588|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44192589|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192590|NCT00363948|Incretins|incretins|mesh-ancestor
44192591|NCT00363948|Hormones|hormones|mesh-ancestor
44192592|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44192593|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44192594|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192595|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192596|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192597|NCT00364000|Calcium|calcium|mesh-list
44192598|NCT00364000|Sevelamer|sevelamer|mesh-list
44192599|NCT00364000|Calcium acetate|calcium acetate|mesh-list
44192600|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44192601|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192602|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
44192603|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
44192604|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192605|NCT00364026|Darusentan|darusentan|mesh-list
44192608|NCT00364052|Valganciclovir|valganciclovir|mesh-list
44192638|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
44192639|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192640|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192641|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44192642|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
44192643|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44192644|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44192645|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44192646|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
44192647|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192648|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192650|NCT00364429|Risperidone|risperidone|mesh-list
44192651|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44192652|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
44192653|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192654|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192655|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192656|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192657|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44192658|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192659|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44192660|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44192661|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
44192662|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
44192663|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
44192664|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
44192687|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192688|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192689|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
44192690|NCT00364455|Hematinics|hematinics|mesh-ancestor
44192691|NCT00364481|Omeprazole|omeprazole|mesh-list
44192692|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192693|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192694|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44192695|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192696|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192697|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44192698|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44192699|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192700|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
44192701|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192702|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192703|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192704|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192705|NCT00364572|Etanercept|etanercept|mesh-list
43809865|NCT04869046|Acetaminophen|acetaminophen|mesh-list
44192706|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44192707|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192708|NCT00364572|Analgesics|analgesics|mesh-ancestor
44192709|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
44192710|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192711|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192712|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192713|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192714|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192715|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192716|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
44192717|NCT00364702|Methylphenidate|methylphenidate|mesh-list
44192718|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44192719|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192720|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44192721|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44192723|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192724|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
44192725|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192726|NCT00364754|Tesmilifene|tesmilifene|mesh-list
44192727|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
44192728|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
44192729|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192730|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192731|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192732|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44192733|NCT00364806|Metoclopramide|metoclopramide|mesh-list
44192734|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
44192735|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
44192736|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
44192737|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192738|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192739|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192740|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44192741|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44192742|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
44192743|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192745|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44192774|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44192775|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44192776|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192777|NCT00365001|Methotrexate|methotrexate|mesh-list
44192778|NCT00365001|Simvastatin|simvastatin|mesh-list
44192779|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44192780|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
44192781|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44192782|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192783|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44192784|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
43809905|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43809907|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
43809908|NCT04868513|Protective Agents|protective agents|mesh-ancestor
43809909|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809910|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43809911|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809912|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
43809913|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
43809914|NCT04868175|Timolol|timolol|mesh-list
44192785|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192786|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192787|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192788|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192789|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44192790|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192791|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
44192792|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192793|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192794|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44129243|NCT05058612|Midodrine|midodrine|mesh-list
44192795|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44192796|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44192797|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44192819|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192820|NCT00365222|Temozolomide|temozolomide|mesh-list
44192821|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44192822|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
44192823|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192824|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192825|NCT00365287|Cyclosporine|cyclosporine|mesh-list
44192826|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
44192827|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
44192828|NCT00365287|Fludarabine|fludarabine|mesh-list
44192829|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
44192830|NCT00365287|Cyclosporins|cyclosporins|mesh-list
44192831|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44192832|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44192833|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
44192834|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192835|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192836|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44192837|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
43809956|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
43809957|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
43809959|NCT04867993|Amikacin|amikacin|mesh-list
44192838|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192839|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44192840|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44192841|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44192842|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
44192843|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192844|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
44192845|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192846|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
44192847|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44192848|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44192849|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44192863|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44192864|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192865|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192866|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44192867|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44192868|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44192869|NCT00365339|Ritonavir|ritonavir|mesh-list
44192870|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44192871|NCT00365339|Tenofovir|tenofovir|mesh-list
44192872|NCT00365339|Aripiprazole|aripiprazole|mesh-list
44192873|NCT00365339|Famotidine|famotidine|mesh-list
44192874|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44192875|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44192876|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
44192877|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192878|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192879|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44192880|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44192881|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
44192882|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192918|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192919|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192920|NCT00365586|Ketoprofen|ketoprofen|mesh-list
44192921|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44192922|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44192923|NCT00365586|Analgesics|analgesics|mesh-ancestor
44192924|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
44192925|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44192926|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192927|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44192928|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44192929|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44192930|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192931|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192932|NCT00365612|Tenofovir|tenofovir|mesh-list
44192933|NCT00365612|Emtricitabine|emtricitabine|mesh-list
44192934|NCT00365612|Efavirenz|efavirenz|mesh-list
44192935|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
44192936|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44192937|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44192938|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44192939|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192940|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192941|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44192942|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44192943|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44192944|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44192945|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44192946|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44192947|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44192948|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44455233|NCT01650194|Prednisone|prednisone|mesh-list
44455235|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455236|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
44455237|NCT01650194|Hormones|hormones|mesh-ancestor
44455238|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455239|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455240|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44455241|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455242|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44455243|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455244|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455245|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
44455246|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44455247|NCT01649869|Valganciclovir|valganciclovir|mesh-list
44455248|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
44455249|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455250|NCT01649856|Rituximab|rituximab|mesh-list
44455251|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455252|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455253|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
44455254|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455255|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455256|NCT01649791|Lenalidomide|lenalidomide|mesh-list
44455257|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
44455258|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455259|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44455260|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44455261|NCT01649791|Growth Substances|growth substances|mesh-ancestor
44455262|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
44455263|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455264|NCT01649765|Belimumab|belimumab|mesh-list
44455265|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455266|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
44455267|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455268|NCT01649427|Tacrolimus|tacrolimus|mesh-list
44455272|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44455273|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455274|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455275|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455276|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
44455277|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455278|NCT01649297|Empagliflozin|empagliflozin|mesh-list
44455279|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44455280|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455281|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455282|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455283|NCT01649271|Trastuzumab|trastuzumab|mesh-list
44455284|NCT01649271|Afatinib|afatinib|mesh-list
44455285|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455286|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455287|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44455288|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455289|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192981|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44192982|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44192983|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44192984|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44192985|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
44192986|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
44192987|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
44192988|NCT00365820|Tegaserod|tegaserod|mesh-list
44192989|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44192990|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
44192991|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44192992|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44192993|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192994|NCT00365898|Hydromorphone|hydromorphone|mesh-list
44192995|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44192996|NCT00365898|Narcotics|narcotics|mesh-ancestor
44192997|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44192998|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44192999|NCT00365898|Analgesics|analgesics|mesh-ancestor
44193000|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
44193001|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193002|NCT00365924|Teriparatide|teriparatide|mesh-list
44193003|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193004|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193005|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44193006|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44193007|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
44193008|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
44193026|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44193027|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44193028|NCT00366093|Eszopiclone|eszopiclone|mesh-list
44193030|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44193031|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193032|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193033|NCT00366119|Ramipril|ramipril|mesh-list
44193034|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44193035|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193036|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193037|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193038|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193039|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
44193040|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44193041|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193042|NCT00366262|Naproxen|naproxen|mesh-list
44193043|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193044|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193045|NCT00366262|Analgesics|analgesics|mesh-ancestor
44193046|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
44193047|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193048|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193077|NCT00366652|Analgesics|analgesics|mesh-ancestor
44193078|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
44193079|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193080|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
44193081|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193082|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
44193083|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44193084|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193085|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44193086|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
44193087|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44193088|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44193089|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
44193090|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44193091|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193092|NCT00366834|Dexamethasone|dexamethasone|mesh-list
44193093|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
44193094|NCT00366834|Ondansetron|ondansetron|mesh-list
44193095|NCT00366834|Casopitant|casopitant|mesh-list
44193096|NCT00366834|BB 1101|bb 1101|mesh-list
44193097|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193098|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
44193100|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193101|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193102|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193103|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
44193104|NCT00366834|Hormones|hormones|mesh-ancestor
44193105|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193106|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44193107|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193108|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193124|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193125|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
44193126|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44193127|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44193128|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193129|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193130|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193131|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193132|NCT00366938|Analgesics|analgesics|mesh-ancestor
44193133|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
44193134|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193135|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193136|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193137|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193138|NCT00367068|Baclofen|baclofen|mesh-list
44193139|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44193140|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193141|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44193142|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193143|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44193144|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
44193145|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
44193146|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193147|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193148|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
44193149|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44193150|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
44193151|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
44193152|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44193153|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44193154|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193155|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44193156|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193158|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44193162|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44193163|NCT00367094|Benazepril|benazepril|mesh-list
43810210|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
44193164|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193165|NCT00367094|Diuretics|diuretics|mesh-ancestor
44193166|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
44193167|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193168|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44193169|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193170|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193171|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44193172|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193173|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193174|NCT00367120|Amoxicillin|amoxicillin|mesh-list
44193175|NCT00367120|Azithromycin|azithromycin|mesh-list
44193176|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
44193177|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
44193178|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44193179|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193180|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193181|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44193182|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193183|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193184|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44193185|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
44193186|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193187|NCT00367185|Thalidomide|thalidomide|mesh-list
44193188|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193189|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
44193190|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193191|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
44193192|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193193|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193199|NCT00367211|Naproxen|naproxen|mesh-list
44193204|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193205|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193206|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193207|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193208|NCT00367211|Analgesics|analgesics|mesh-ancestor
44193209|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
44193210|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193211|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193212|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193213|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193214|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
44193215|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44193216|NCT00367250|Trastuzumab|trastuzumab|mesh-list
44193217|NCT00367250|Cetuximab|cetuximab|mesh-list
44193218|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193219|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193220|NCT00367263|Ciclesonide|ciclesonide|mesh-list
44193221|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
44193222|NCT00367263|Hormones|hormones|mesh-ancestor
44193223|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193224|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193225|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44193226|NCT00367276|Drospirenone|drospirenone|mesh-list
44193227|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44193228|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
44193229|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193230|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810221|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797295|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
44193231|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44193232|NCT00367276|Diuretics|diuretics|mesh-ancestor
44193233|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
44193247|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44193248|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44193249|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193250|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193251|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193252|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193253|NCT00367315|Analgesics|analgesics|mesh-ancestor
44193254|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
44193255|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193256|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193257|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193258|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193259|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
44193260|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193261|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193262|NCT00367393|Analgesics|analgesics|mesh-ancestor
44193263|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
44193264|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455322|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455323|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455324|NCT01648283|Analgesics|analgesics|mesh-ancestor
44455325|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
44455326|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455327|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
44455328|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455329|NCT01648270|Buprenorphine|buprenorphine|mesh-list
44455330|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44455331|NCT01648270|Narcotics|narcotics|mesh-ancestor
44455332|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455333|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455334|NCT01648270|Analgesics|analgesics|mesh-ancestor
44455335|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
44455336|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455337|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44455338|NCT01648205|Ranolazine|ranolazine|mesh-list
44455339|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44455340|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44455341|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455342|NCT01648140|Interferons|interferons|mesh-list
44129711|NCT03770767|Insulin|insulin|mesh-list
44193274|NCT00367419|Erythromycin|erythromycin|mesh-list
44193275|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
44193276|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
44193277|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
43841898|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43841899|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43841900|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841901|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841902|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841903|NCT04575922|Nivolumab|nivolumab|mesh-list
43841904|NCT04575922|Ipilimumab|ipilimumab|mesh-list
43841905|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841906|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193278|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193279|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193280|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193281|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44193282|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193284|NCT00367445|Insulin|insulin|mesh-list
44193289|NCT00367471|Paclitaxel|paclitaxel|mesh-list
44193296|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44193297|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44193298|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193299|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193300|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44193301|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193302|NCT00367497|Cytarabine|cytarabine|mesh-list
44193303|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
44193304|NCT00367497|Rituximab|rituximab|mesh-list
44193305|NCT00367497|Etoposide|etoposide|mesh-list
44193306|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193307|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193308|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
43654911|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654912|NCT02972905|Nemiralisib|nemiralisib|mesh-list
43654913|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654914|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193309|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193310|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193311|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44193312|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44129795|NCT03632369|Xenon|xenon|mesh-list
44193352|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193353|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44193354|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193355|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193356|NCT00367627|Albendazole|albendazole|mesh-list
44193357|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
44193358|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44193359|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193360|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
44193361|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44193362|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44193363|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
44193364|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
44193365|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
44193366|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193367|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193368|NCT00367653|Azithromycin|azithromycin|mesh-list
44193369|NCT00367653|Chloroquine|chloroquine|mesh-list
44193370|NCT00367653|Mefloquine|mefloquine|mesh-list
44193371|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193372|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44193373|NCT00367653|Amebicides|amebicides|mesh-ancestor
44193407|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193408|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44193409|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
44193410|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193411|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193412|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
44193413|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193414|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
44193415|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193416|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193417|NCT00367913|Clarithromycin|clarithromycin|mesh-list
44193418|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
44193419|NCT00367913|Rifampin|rifampin|mesh-list
44193420|NCT00367913|Ethambutol|ethambutol|mesh-list
44193421|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44193422|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654915|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654917|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654918|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43797385|NCT05045508|Varenicline|varenicline|mesh-list
43797386|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43797387|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43797388|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43797389|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797391|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193423|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44193424|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193425|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193426|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44455343|NCT01648140|Ribavirin|ribavirin|mesh-list
44193427|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44193428|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44193429|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44193430|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193431|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44193453|NCT00367965|Eszopiclone|eszopiclone|mesh-list
44193454|NCT00367965|Zopiclone|zopiclone|mesh-list
44193455|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44193456|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193457|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193458|NCT00367978|Amlodipine|amlodipine|mesh-list
44193459|NCT00367978|Benazepril|benazepril|mesh-list
44193460|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193461|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44193462|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193463|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193464|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193465|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193466|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
44193467|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44193468|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
44193469|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193470|NCT00368017|Pioglitazone|pioglitazone|mesh-list
44193471|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193472|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193473|NCT00368030|Eszopiclone|eszopiclone|mesh-list
44193474|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44193505|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43622188|NCT03110198|Mesalamine|mesalamine|mesh-list
43810226|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
43810227|NCT04863183|Triamcinolone|triamcinolone|mesh-list
43810228|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43810229|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43810230|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43810231|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810232|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
43810233|NCT04863183|Hormones|hormones|mesh-ancestor
43734421|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797424|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43797425|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193506|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193507|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193509|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
44193510|NCT00368238|Clopidogrel|clopidogrel|mesh-list
44193511|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44193512|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193513|NCT00368238|Analgesics|analgesics|mesh-ancestor
44193514|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
44193515|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193516|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193517|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193518|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193519|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44193520|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44193521|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193522|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44193523|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44193524|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193525|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
44193526|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44193527|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44193528|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44193529|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
44193530|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193531|NCT00368238|Hematinics|hematinics|mesh-ancestor
44193532|NCT00368264|Infliximab|infliximab|mesh-list
44193533|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193534|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44193535|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193536|NCT00368303|Paroxetine|paroxetine|mesh-list
44193547|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44193548|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44193549|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193550|NCT00368329|Carboplatin|carboplatin|mesh-list
44193551|NCT00368329|Fluorouracil|fluorouracil|mesh-list
44193552|NCT00368329|Capecitabine|capecitabine|mesh-list
44193553|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44193554|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193555|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
44193556|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193557|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44193558|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193559|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
44193560|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193561|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44193562|NCT00368342|Azithromycin|azithromycin|mesh-list
44193563|NCT00368342|Clarithromycin|clarithromycin|mesh-list
44193564|NCT00368342|Erythromycin|erythromycin|mesh-list
44193604|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44193605|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
44193606|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193607|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193608|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193609|NCT00368706|Urological Agents|urological agents|mesh-ancestor
44193610|NCT00368719|Tacrolimus|tacrolimus|mesh-list
44193611|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193612|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
44193613|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193614|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44193615|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193616|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193617|NCT00368862|Memantine|memantine|mesh-list
43810308|NCT04862377|Hormones|hormones|mesh-ancestor
44193618|NCT00368862|Citalopram|citalopram|mesh-list
44193619|NCT00368862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44193620|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44193636|NCT00368914|Sirolimus|sirolimus|mesh-list
44193661|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193662|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
44193663|NCT00369044|Hormones|hormones|mesh-ancestor
44193664|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193665|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193666|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44193667|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193668|NCT00369096|Bemiparin|bemiparin|mesh-list
44193669|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
44193670|NCT00369148|Nateglinide|nateglinide|mesh-list
44193671|NCT00369148|Mitiglinide|mitiglinide|mesh-list
44193672|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193673|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193674|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
44193675|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193676|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193677|NCT00369239|Risperidone|risperidone|mesh-list
44193678|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44193679|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
44193680|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193681|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193682|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193683|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44193684|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193685|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193686|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193687|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44193688|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
44193689|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
44193691|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455356|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44455357|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455358|NCT01647516|Ozanimod|ozanimod|mesh-list
44455359|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44455360|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455361|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455362|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
44455363|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455364|NCT01647282|Minocycline|minocycline|mesh-list
44455365|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455366|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455367|NCT01646827|Aripiprazole|aripiprazole|mesh-list
44455368|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
44455369|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44455370|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44455371|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193735|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193737|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
44193738|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193739|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44193740|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193741|NCT00369551|Paclitaxel|paclitaxel|mesh-list
44193742|NCT00369551|Bevacizumab|bevacizumab|mesh-list
43810314|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810315|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810316|NCT04861922|Heparin|heparin|mesh-list
43810317|NCT04861922|Calcium heparin|calcium heparin|mesh-list
43810318|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
43810319|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844099|NCT04407390|Niacin|niacin|mesh-list
44193743|NCT00369551|Carboplatin|carboplatin|mesh-list
44193744|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44193745|NCT00369551|Antibodies|antibodies|mesh-list
44193746|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
44193747|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44193749|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193797|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
44193799|NCT00369837|Clevidipine|clevidipine|mesh-list
44193800|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44193801|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44193802|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193803|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44193804|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193805|NCT00369863|Triamcinolone|triamcinolone|mesh-list
44193806|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44193807|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44193808|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44193809|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844100|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
44193810|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
44193811|NCT00369863|Hormones|hormones|mesh-ancestor
44193812|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193813|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193814|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193815|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
44193816|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193817|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193818|NCT00369889|Bevacizumab|bevacizumab|mesh-list
44193819|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44193820|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193821|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193822|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193823|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193824|NCT00369889|Growth Substances|growth substances|mesh-ancestor
44193825|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193826|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193828|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193838|NCT00369954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193839|NCT00369954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193840|NCT00369954|Immunologic Factors|immunologic factors|mesh-ancestor
44193841|NCT00369954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193843|NCT00369993|Xhance|xhance|mesh-list
44193844|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44193845|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193846|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44193847|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
43810377|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810378|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810379|NCT04860167|Diclofenac|diclofenac|mesh-list
44193848|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193849|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193850|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44193851|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
44193852|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193853|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44193854|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44193855|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44193856|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44193857|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
44193858|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44193859|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193891|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193892|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193893|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44193894|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
44193895|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
44193896|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44193897|NCT00370188|Topiramate|topiramate|mesh-list
44193898|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
44193899|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44193900|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193901|NCT00370201|Colchicine|colchicine|mesh-list
44193902|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
44193903|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44193904|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
44193905|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
44193906|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
44193907|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44193908|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193909|NCT00370240|Ropivacaine|ropivacaine|mesh-list
44193910|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
44193911|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
44193912|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193913|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193914|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
44193915|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193916|NCT00370253|Terlipressin|terlipressin|mesh-list
44193917|NCT00370253|Norepinephrine|norepinephrine|mesh-list
44193918|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44193919|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44193920|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44193929|NCT00370266|Triamcinolone|triamcinolone|mesh-list
44193937|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193938|NCT00370318|Acetaminophen|acetaminophen|mesh-list
44193939|NCT00370318|Vaccines|vaccines|mesh-list
44193940|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44193941|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
44193942|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193943|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44193944|NCT00370318|Analgesics|analgesics|mesh-ancestor
44193945|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
44193946|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44193947|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
44193948|NCT00370370|Triamcinolone|triamcinolone|mesh-list
44193949|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44193950|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44193951|NCT00370370|Bevacizumab|bevacizumab|mesh-list
44193952|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44193953|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193954|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193955|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193956|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44193957|NCT00370370|Growth Substances|growth substances|mesh-ancestor
44193958|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193959|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44193960|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44193961|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
44193962|NCT00370370|Hormones|hormones|mesh-ancestor
44193963|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44193964|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44193965|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
44193966|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44193968|NCT00370422|Triamcinolone|triamcinolone|mesh-list
44193981|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44193982|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
44193983|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44193984|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44193985|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44193986|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44193987|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44193988|NCT00370539|Triamcinolone|triamcinolone|mesh-list
44193989|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44193990|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44193991|NCT00370539|Bevacizumab|bevacizumab|mesh-list
44193992|NCT00370539|Verteporfin|verteporfin|mesh-list
44193993|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44193994|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44193995|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44193996|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44193998|NCT00370539|Growth Substances|growth substances|mesh-ancestor
44194041|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194042|NCT00370630|Growth Substances|growth substances|mesh-ancestor
44194043|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194044|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194045|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194046|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
44194047|NCT00370630|Hormones|hormones|mesh-ancestor
44194048|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194049|NCT00370643|Insulin|insulin|mesh-list
44194050|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44194051|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194052|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194053|NCT00370656|Pregabalin|pregabalin|mesh-list
44194054|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44194055|NCT00370656|Amitriptyline|amitriptyline|mesh-list
44194056|NCT00370656|Analgesics|analgesics|mesh-ancestor
44194057|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
44194058|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194059|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194060|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
44194061|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44194062|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194063|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194064|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44194065|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44194066|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44194067|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844160|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194068|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194069|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44194070|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44194080|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44194081|NCT00370669|Bevacizumab|bevacizumab|mesh-list
44194082|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44194083|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194084|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194085|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194086|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194087|NCT00370669|Growth Substances|growth substances|mesh-ancestor
44194088|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194089|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194090|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194091|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
44194092|NCT00370669|Hormones|hormones|mesh-ancestor
44194093|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194094|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194095|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
44194096|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194097|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194098|NCT00370721|Bevacizumab|bevacizumab|mesh-list
44194099|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194135|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
44194136|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
44194137|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194138|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194139|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194140|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
44194141|NCT00370760|Hormones|hormones|mesh-ancestor
44194142|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194143|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44194144|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130572|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
44194145|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
44194146|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44194147|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44194148|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194149|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
44194150|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194151|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
44194152|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
44194153|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
44194154|NCT00370786|Bevacizumab|bevacizumab|mesh-list
44194155|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194156|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194157|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194158|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194183|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194184|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654933|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194185|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194186|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194187|NCT00370851|Growth Substances|growth substances|mesh-ancestor
44194188|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194189|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194190|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
44194191|NCT00370968|Astringents|astringents|mesh-ancestor
44194192|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194193|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194194|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44194195|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194196|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194197|NCT00371007|Incretins|incretins|mesh-ancestor
44194198|NCT00371007|Hormones|hormones|mesh-ancestor
44194199|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194200|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44194201|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44194202|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194203|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194204|NCT00371020|Heparin|heparin|mesh-list
44194205|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44194206|NCT00371020|Tinzaparin|tinzaparin|mesh-list
44194207|NCT00371020|Dalteparin|dalteparin|mesh-list
44194208|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
44194209|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44194210|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44194211|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194212|NCT00371033|Pregabalin|pregabalin|mesh-list
44194213|NCT00371033|Analgesics|analgesics|mesh-ancestor
44194214|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
44194224|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194225|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194226|NCT00371072|Mitomycins|mitomycins|mesh-list
44194227|NCT00371072|Mitomycin|mitomycin|mesh-list
44194228|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44194229|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194230|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
44194231|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194232|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44194233|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194234|NCT00371111|Triamcinolone|triamcinolone|mesh-list
44194235|NCT00371111|Bevacizumab|bevacizumab|mesh-list
44194236|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194237|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194238|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194239|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194240|NCT00371111|Growth Substances|growth substances|mesh-ancestor
44194241|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194242|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194243|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194244|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
44194245|NCT00371111|Hormones|hormones|mesh-ancestor
44194246|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194247|NCT00371124|Atropine|atropine|mesh-list
44194248|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44194249|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44194250|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44194251|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44194252|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44194253|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
44194254|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810569|NCT04857450|Ketamine|ketamine|mesh-list
43810570|NCT04857450|Etomidate|etomidate|mesh-list
43810571|NCT04857450|Analgesics|analgesics|mesh-ancestor
43810572|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
43810603|NCT04856878|Vancomycin|vancomycin|mesh-list
44194255|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194256|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44194257|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194264|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455373|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455374|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
44455375|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
44455376|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455377|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455378|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44455379|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44455380|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
44455381|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44455382|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44455383|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44455384|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44455386|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44455387|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
44455388|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455389|NCT01646385|Etanercept|etanercept|mesh-list
44455390|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
44455391|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44455392|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44455393|NCT01646385|Analgesics|analgesics|mesh-ancestor
44455394|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
44455395|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455396|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455397|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455398|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455399|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455400|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
44455401|NCT01646320|Metformin|metformin|mesh-list
44455402|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
44194275|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194276|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194277|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44194278|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194279|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44194280|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
44194281|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194282|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194283|NCT00371332|Minocycline|minocycline|mesh-list
44194284|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194285|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194286|NCT00371410|Triamcinolone|triamcinolone|mesh-list
44194287|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44194288|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43810604|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43810605|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194289|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44194290|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194291|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
44194292|NCT00371410|Hormones|hormones|mesh-ancestor
44194293|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194294|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194295|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194296|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
44194297|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194298|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194299|NCT00371488|Lapatinib|lapatinib|mesh-list
44194300|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194301|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194321|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44194322|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44194323|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
44194324|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44194325|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44194326|NCT00371527|Ipratropium|ipratropium|mesh-list
44194327|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44194328|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
44194329|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194330|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194331|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44194332|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194333|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44194334|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194335|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194336|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194337|NCT00371553|Sunitinib|sunitinib|mesh-list
44194338|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44130809|NCT00146601|Fulvestrant|fulvestrant|mesh-list
44194339|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194340|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194341|NCT00371553|Growth Substances|growth substances|mesh-ancestor
44194342|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194343|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194344|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194345|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194346|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194347|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44194348|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44194349|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44194350|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
44194351|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194352|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44194360|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194361|NCT00371696|Analgesics|analgesics|mesh-ancestor
44194362|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
44194363|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194364|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194365|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
44194366|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44194367|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194368|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194369|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44194370|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194371|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194372|NCT00371735|Artesunate|artesunate|mesh-list
44194373|NCT00371735|Dapsone|dapsone|mesh-list
44194374|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
44194375|NCT00371735|Proguanil|proguanil|mesh-list
44194376|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
44194377|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194378|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194379|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194380|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194381|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
44194382|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
44194383|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44194384|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
44194385|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44194386|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194387|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194388|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
44194389|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194390|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
44194391|NCT00371813|Varenicline|varenicline|mesh-list
44194392|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44194393|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44194394|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194402|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194403|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194404|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
44194405|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194406|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194407|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44194408|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44194409|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
44194410|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194411|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194412|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44130871|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
44194413|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44194414|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44194415|NCT00371995|Amphotericin B|amphotericin b|mesh-list
44194416|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44194417|NCT00371995|Miltefosine|miltefosine|mesh-list
44194418|NCT00371995|Amebicides|amebicides|mesh-ancestor
44194419|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194420|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194421|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194422|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194423|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
44194424|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194425|NCT00372008|Testosterone|testosterone|mesh-list
44194426|NCT00372008|Androgens|androgens|mesh-ancestor
44194427|NCT00372008|Hormones|hormones|mesh-ancestor
44194428|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194429|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194430|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
44194431|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44194432|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194433|NCT00372099|Calcitonin|calcitonin|mesh-list
44194434|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
44194435|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44194436|NCT00372099|Katacalcin|katacalcin|mesh-list
44164291|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194437|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44194438|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194439|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44194440|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
44194441|NCT00372138|Thrombin|thrombin|mesh-list
44194442|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
44194443|NCT00372138|Coagulants|coagulants|mesh-ancestor
44194444|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
44194445|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
44194446|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194447|NCT00372216|Clopidogrel|clopidogrel|mesh-list
44194448|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44194449|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44194450|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44194451|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44194452|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
44194453|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194454|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194455|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194456|NCT00372294|Clindamycin|clindamycin|mesh-list
44194457|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
44194458|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
44194459|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
44194460|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
44194461|NCT00372294|Dexamethasone|dexamethasone|mesh-list
44194462|NCT00372294|Prednisolone|prednisolone|mesh-list
44194463|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194464|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
44194465|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
44194466|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194467|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194468|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194469|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
44194470|NCT00372294|Hormones|hormones|mesh-ancestor
44194471|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194476|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44194477|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194478|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194479|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
44194480|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194481|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194482|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44194483|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
44194484|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
44194485|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44194486|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194487|NCT00372307|Analgesics|analgesics|mesh-ancestor
44194488|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
44194489|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194490|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194491|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194492|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194493|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194494|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194495|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
44194496|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44194497|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194498|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194499|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
44194500|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44194501|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194502|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194503|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44194504|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194505|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44194506|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
44194507|NCT00372476|Vinorelbine|vinorelbine|mesh-list
44194515|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
44194516|NCT00372515|Gefitinib|gefitinib|mesh-list
44194517|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194518|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194519|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194520|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194521|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
44194522|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194523|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194524|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
44194525|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
44194526|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44194527|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
44194528|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194529|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194530|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194531|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44194532|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194533|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194534|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44194535|NCT00372632|Renal Agents|renal agents|mesh-ancestor
44194536|NCT00372645|Folic Acid|folic acid|mesh-list
44194537|NCT00372645|Hematinics|hematinics|mesh-ancestor
44194538|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
44194539|NCT00372645|Vitamins|vitamins|mesh-ancestor
44194540|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
44194541|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194542|NCT00372658|Lidocaine|lidocaine|mesh-list
44194543|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
44194544|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
44194545|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194546|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194547|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
44194548|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194549|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43797958|NCT05035147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797959|NCT05035147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797960|NCT05035147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797961|NCT05035147|Immunologic Factors|immunologic factors|mesh-ancestor
43797962|NCT05035147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797963|NCT05034887|Trastuzumab|trastuzumab|mesh-list
43797964|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797965|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797966|NCT05034406|Lidocaine|lidocaine|mesh-list
43797967|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
43797968|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
43797969|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
44194550|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44194551|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44194553|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194554|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
44194555|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44194556|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194557|NCT00372723|Infliximab|infliximab|mesh-list
44194558|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194559|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194560|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194561|NCT00372736|Docetaxel|docetaxel|mesh-list
44194562|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194563|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
44194564|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
44194565|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
44194566|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194567|NCT00372762|Furosemide|furosemide|mesh-list
44194568|NCT00372762|Bumetanide|bumetanide|mesh-list
44194569|NCT00372762|Diuretics|diuretics|mesh-ancestor
44194570|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
44194571|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194572|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44194573|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194574|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194575|NCT00372788|Pemetrexed|pemetrexed|mesh-list
44194576|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194577|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194578|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194579|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44194580|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44194598|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194599|NCT00372853|Tremelimumab|tremelimumab|mesh-list
44194601|NCT00372853|Sunitinib|sunitinib|mesh-list
44194602|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194603|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44194604|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44194605|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194606|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194607|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43810620|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43810621|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43810622|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43810623|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
44194608|NCT00372853|Growth Substances|growth substances|mesh-ancestor
44194609|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194610|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194611|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44194613|NCT00372879|Vitamin E|vitamin e|mesh-list
44194650|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194651|NCT00373165|Ganciclovir|ganciclovir|mesh-list
44194652|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44194653|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
44194654|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194655|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44194656|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194657|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194658|NCT00373178|Metformin|metformin|mesh-list
44194659|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
44194660|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
44194661|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194662|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
44194663|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194664|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44194665|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
44194666|NCT00373282|Triamcinolone|triamcinolone|mesh-list
44194667|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44194668|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44194669|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44194670|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194671|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
44194672|NCT00373282|Hormones|hormones|mesh-ancestor
44194673|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194674|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194699|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44194700|NCT00373464|Etoricoxib|etoricoxib|mesh-list
44194701|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44194702|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194703|NCT00373464|Analgesics|analgesics|mesh-ancestor
44194704|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
44194705|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194706|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194707|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44194708|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44194709|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44194710|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44194711|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194712|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194713|NCT00373503|Lofexidine|lofexidine|mesh-list
44194714|NCT00373503|Dronabinol|dronabinol|mesh-list
44194715|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
44194716|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194717|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194718|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44194719|NCT00373503|Analgesics|analgesics|mesh-ancestor
44194720|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
44194721|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194722|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44194723|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44194724|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194725|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194726|NCT00373503|Hormones|hormones|mesh-ancestor
44194727|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44194728|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44194741|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194742|NCT00373568|Miltefosine|miltefosine|mesh-list
44194743|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
44194744|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194745|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194746|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194747|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194748|NCT00373581|Cocaine|cocaine|mesh-list
44194749|NCT00373581|Vigabatrin|vigabatrin|mesh-list
44194750|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
44194751|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
44194752|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194753|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194754|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
44194755|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194756|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44194757|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44194758|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44194759|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194760|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194765|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
44194797|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44194798|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194799|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194800|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194801|NCT00373646|Growth Substances|growth substances|mesh-ancestor
44194802|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194803|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194804|NCT00373659|Ranibizumab|ranibizumab|mesh-list
44194805|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44194806|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44194807|NCT00373659|Growth Substances|growth substances|mesh-ancestor
44194808|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194809|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
44194810|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194811|NCT00373672|Modafinil|modafinil|mesh-list
44194812|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44194813|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194814|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44194815|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44194816|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44194817|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194818|NCT00373776|Miltefosine|miltefosine|mesh-list
44194819|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
44194820|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194821|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194822|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194823|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194824|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
44194825|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44194826|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44194827|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44194828|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194829|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194830|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194831|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194832|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194834|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194835|NCT00373802|Phenylephrine|phenylephrine|mesh-list
44194836|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
44194837|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44194838|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
44194839|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
44194840|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194841|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194842|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
44194843|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44194844|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
44194845|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
44194846|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44194847|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44194848|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44194849|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
44194850|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194851|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194852|NCT00373802|Protective Agents|protective agents|mesh-ancestor
44194853|NCT00373815|Everolimus|everolimus|mesh-list
44194854|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194855|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44194889|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194890|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
44194891|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194892|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194893|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
44194894|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44194895|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194896|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194897|NCT00374101|Omeprazole|omeprazole|mesh-list
44194898|NCT00374101|Pantoprazole|pantoprazole|mesh-list
44194899|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44194900|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194901|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44194902|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44194903|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194904|NCT00374192|Eszopiclone|eszopiclone|mesh-list
44194905|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44194906|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44194907|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194908|NCT00374205|Artesunate|artesunate|mesh-list
44194909|NCT00374205|Lumefantrine|lumefantrine|mesh-list
44194910|NCT00374205|Artemether|artemether|mesh-list
44194911|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44194912|NCT00374205|Amodiaquine|amodiaquine|mesh-list
44194913|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
44194914|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44194915|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44194916|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44194917|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44194918|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
44194922|NCT00374348|Aripiprazole|aripiprazole|mesh-list
44194933|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44194934|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44194935|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
44194936|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44194937|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44194938|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44194939|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44194941|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44194942|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
44194943|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44194944|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842005|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842006|NCT04563533|Vaccines|vaccines|mesh-list
43842007|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
43842008|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842009|NCT04563273|Vaccines|vaccines|mesh-list
43842010|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
43842011|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
43842012|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194945|NCT00374426|Sertraline|sertraline|mesh-list
44194946|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
44194947|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44194948|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44194949|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44194950|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44194951|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194952|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194953|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
44194954|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194955|NCT00374465|Verapamil|verapamil|mesh-list
44194956|NCT00374465|Carvedilol|carvedilol|mesh-list
44194957|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44194958|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44194959|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
44194960|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194961|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194962|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194963|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44194964|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
44194973|NCT00374478|Scopolamine|scopolamine|mesh-list
44194974|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
44194975|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44194976|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
44194977|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
44194978|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44194979|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194980|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44194981|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
44194982|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44194983|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
44194984|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44194985|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44194986|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44194987|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
44194988|NCT00374621|Isosorbide|isosorbide|mesh-list
44194989|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
44194990|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
44194991|NCT00374621|Misoprostol|misoprostol|mesh-list
44194992|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44194993|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
44194994|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44194995|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44194996|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44195026|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
44195027|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195028|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195029|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195030|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44195031|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44195032|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195033|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195034|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44195035|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
44195036|NCT00374777|Nitrazepam|nitrazepam|mesh-list
44195037|NCT00374777|Zolpidem|zolpidem|mesh-list
44195038|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44195039|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44195040|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195041|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810680|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
43810681|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810682|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810683|NCT04856098|Antidotes|antidotes|mesh-ancestor
43810684|NCT04856098|Protective Agents|protective agents|mesh-ancestor
43810686|NCT04856111|Nintedanib|nintedanib|mesh-list
44195042|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44195043|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
44195044|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
44195045|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195046|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195047|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
44195048|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44195049|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44455414|NCT01646268|Rotigotine|rotigotine|mesh-list
44455436|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455437|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455438|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455439|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455440|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455441|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
44455442|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
44455443|NCT01646125|Docetaxel|docetaxel|mesh-list
44195052|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44195053|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44195054|NCT00374855|Diuretics|diuretics|mesh-ancestor
44195055|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
44195056|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195057|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44195058|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44195059|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195060|NCT00374881|Phenylephrine|phenylephrine|mesh-list
44195061|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
44195062|NCT00374881|Morphine|morphine|mesh-list
44195063|NCT00374881|Sorbitol|sorbitol|mesh-list
44195064|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44195065|NCT00374881|Narcotics|narcotics|mesh-ancestor
44195066|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195067|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195068|NCT00374881|Analgesics|analgesics|mesh-ancestor
44195069|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
44195070|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195071|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44195072|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
44195073|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
44195074|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
44195087|NCT00374894|Succimer|succimer|mesh-list
44195090|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195091|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
44195092|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
44195093|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195094|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
43810687|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195095|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195096|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195097|NCT00374985|Docetaxel|docetaxel|mesh-list
44195098|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
44195099|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195100|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195101|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195102|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195103|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195104|NCT00375050|Riluzole|riluzole|mesh-list
44195105|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
44195106|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44195107|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44195108|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195109|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195110|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195111|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44195112|NCT00375050|Protective Agents|protective agents|mesh-ancestor
44195113|NCT00375076|Enoxaparin|enoxaparin|mesh-list
44195114|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
44195115|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44195116|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195117|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195118|NCT00375232|Montelukast|montelukast|mesh-list
44195119|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44195120|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
44195121|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44195122|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
44195124|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195128|NCT00375245|Sirolimus|sirolimus|mesh-list
44195129|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195130|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195131|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195132|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195133|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
44195134|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195135|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
43810781|NCT04854044|TIC10 compound|tic10 compound|mesh-list
43810782|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810783|NCT04854252|Fentanyl|fentanyl|mesh-list
43810784|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43810785|NCT04854252|Narcotics|narcotics|mesh-ancestor
43810786|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810787|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810788|NCT04854252|Analgesics|analgesics|mesh-ancestor
43810789|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
43810790|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810791|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43810868|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
43810869|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44195136|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195137|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
44195138|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44195139|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195140|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195141|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
44195142|NCT00375258|Coagulants|coagulants|mesh-ancestor
44195143|NCT00375284|Pramipexole|pramipexole|mesh-list
44195144|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
44195145|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195146|NCT00375284|Protective Agents|protective agents|mesh-ancestor
44195147|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195148|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44195149|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44195150|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
44195181|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44195182|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195183|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195184|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
44195185|NCT00375440|Coagulants|coagulants|mesh-ancestor
44195186|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
44195187|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44195188|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44195189|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195190|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
44195191|NCT00375466|Coagulants|coagulants|mesh-ancestor
44195192|NCT00375557|Valproic Acid|valproic acid|mesh-list
44195193|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44195194|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
44195195|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195196|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44195197|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44195198|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195199|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195200|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
44195234|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44195235|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195236|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44195237|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44195238|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44195239|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
44195240|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44195241|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195242|NCT00375661|Interferons|interferons|mesh-list
44195243|NCT00375661|Ribavirin|ribavirin|mesh-list
44195244|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
44195245|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
44195246|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195247|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
44195248|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195249|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
44195250|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195251|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
44195252|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195253|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44195270|NCT00375778|Memantine|memantine|mesh-list
44195285|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195286|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
44195287|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195288|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44195289|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
44195290|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195291|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
44195293|NCT00375895|Cyclosporine|cyclosporine|mesh-list
44195294|NCT00375895|Cyclosporins|cyclosporins|mesh-list
44195295|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195296|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195297|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195298|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
44195299|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195300|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
44195301|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195302|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195303|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44195304|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44195305|NCT00376012|Rifampin|rifampin|mesh-list
44195306|NCT00376012|Isoniazid|isoniazid|mesh-list
44195307|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
44195308|NCT00376012|Ethambutol|ethambutol|mesh-list
44195309|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44195310|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
44195311|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195312|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195332|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44195333|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195334|NCT00376051|Citalopram|citalopram|mesh-list
44195335|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44195336|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44195337|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44195338|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195339|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195340|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
44195341|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195342|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44195343|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
44195344|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195345|NCT00376064|Octreotide|octreotide|mesh-list
44195346|NCT00376064|Cabergoline|cabergoline|mesh-list
44195347|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195348|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44131739|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
44195349|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195350|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44195351|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44195352|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
44195383|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
44195384|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195386|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
44195387|NCT00376155|Amodiaquine|amodiaquine|mesh-list
44195388|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
44195389|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44195390|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44195391|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195392|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44195393|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195394|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195395|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44195396|NCT00376155|Renal Agents|renal agents|mesh-ancestor
44195397|NCT00376181|Pioglitazone|pioglitazone|mesh-list
44195398|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
44195399|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44195400|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195401|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44195402|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44195403|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195404|NCT00376272|Valsartan|valsartan|mesh-list
44195405|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44195406|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44195414|NCT00376311|Calcitonin|calcitonin|mesh-list
44195433|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44195434|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44195435|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44195436|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195437|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195438|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44195439|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
44195440|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195441|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195442|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44195443|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44195444|NCT00376376|Levofloxacin|levofloxacin|mesh-list
44195445|NCT00376376|Ofloxacin|ofloxacin|mesh-list
44195446|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44195447|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195448|NCT00376376|Renal Agents|renal agents|mesh-ancestor
44195449|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195450|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44195451|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44195452|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195453|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195454|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195455|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44195456|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44195457|NCT00376428|Gentamicins|gentamicins|mesh-list
44195458|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195459|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195460|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44195461|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195462|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195463|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
44195464|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195465|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44195466|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195469|NCT00376480|Fludarabine|fludarabine|mesh-list
44195470|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
44195471|NCT00376480|Thiotepa|thiotepa|mesh-list
44195472|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44195473|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195474|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195475|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
44195476|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195477|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195478|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
44195479|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195480|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44195481|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
44195482|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
44195483|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195484|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44195485|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
44195486|NCT00376480|Hormones|hormones|mesh-ancestor
44195487|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195488|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44195489|NCT00376480|Protective Agents|protective agents|mesh-ancestor
44195490|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44195491|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
44195492|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44195493|NCT00376493|Metronidazole|metronidazole|mesh-list
44195494|NCT00376493|Doxycycline|doxycycline|mesh-list
44131895|NCT00150046|Everolimus|everolimus|mesh-list
44455463|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
44455464|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455465|NCT01645930|Dexamethasone|dexamethasone|mesh-list
44455466|NCT01645930|Lenalidomide|lenalidomide|mesh-list
44455467|NCT01645930|Ixazomib|ixazomib|mesh-list
44455468|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44455469|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
44455470|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
44455471|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455472|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455473|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455474|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
44455475|NCT01645930|Hormones|hormones|mesh-ancestor
44195508|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195509|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44195510|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44195511|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
44195512|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195513|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195514|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44195515|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195516|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
44195517|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195518|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
44195519|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195520|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195521|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44195522|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195523|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44195524|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
44195525|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44195526|NCT00376584|Niacin|niacin|mesh-list
44195527|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44195528|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
44195529|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195530|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44195531|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
44195532|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
44195533|NCT00376584|Vitamins|vitamins|mesh-ancestor
44195534|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
44195554|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195555|NCT00376766|Levetiracetam|levetiracetam|mesh-list
44195556|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
44195557|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
44195559|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195560|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195561|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195562|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195563|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195564|NCT00376818|Hormones|hormones|mesh-list
44195565|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195566|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195567|NCT00376831|Fentanyl|fentanyl|mesh-list
44195568|NCT00376831|Midazolam|midazolam|mesh-list
44195569|NCT00376831|Ketamine|ketamine|mesh-list
44195570|NCT00376831|Analgesics|analgesics|mesh-ancestor
44195571|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
44195614|NCT00377052|Gemcitabine|gemcitabine|mesh-list
44195615|NCT00377052|Bortezomib|bortezomib|mesh-list
44195616|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195617|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
44195618|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195619|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195620|NCT00377052|Antiviral Agents|antiviral agents|mesh-ancestor
44195621|NCT00377052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195622|NCT00377052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195623|NCT00377052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195624|NCT00377052|Immunologic Factors|immunologic factors|mesh-ancestor
44195625|NCT00377052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195626|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
44195627|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44195628|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44195635|NCT00377078|Lactoferrin|lactoferrin|mesh-list
44195675|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
44195676|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44195677|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44195678|NCT00377390|Omalizumab|omalizumab|mesh-list
44195679|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44195680|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44195681|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
44195682|NCT00377442|Simvastatin|simvastatin|mesh-list
44195683|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44195684|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44195685|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
44195686|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195687|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44195688|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44195689|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195690|NCT00377468|Dronabinol|dronabinol|mesh-list
44195691|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
44195692|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195693|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195694|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44195695|NCT00377468|Analgesics|analgesics|mesh-ancestor
44195696|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
44195697|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195698|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44195699|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44195700|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195701|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195702|NCT00377468|Hormones|hormones|mesh-ancestor
44195703|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44195720|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44195721|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195722|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195723|NCT00377559|Docetaxel|docetaxel|mesh-list
44195724|NCT00377559|Doxorubicin|doxorubicin|mesh-list
44195725|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44195726|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195727|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195728|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
44195729|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195730|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195731|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195732|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44195733|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44195734|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195735|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
44195736|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44195737|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
44195738|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195739|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
44195740|NCT00377624|Protective Agents|protective agents|mesh-ancestor
44195741|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44195742|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44195743|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44195767|NCT00377806|Diclofenac|diclofenac|mesh-list
44195768|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811073|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
44195769|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44195770|NCT00377806|Analgesics|analgesics|mesh-ancestor
44195771|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
44195772|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195773|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195774|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44195775|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44195776|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44195777|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195778|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195779|NCT00377910|Lidocaine|lidocaine|mesh-list
44195780|NCT00377910|Polidocanol|polidocanol|mesh-list
44195781|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
44195782|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
44195783|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195784|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195785|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
44195786|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195787|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44195788|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44195789|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44195790|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44195792|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44195814|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44195815|NCT00377975|Pioglitazone|pioglitazone|mesh-list
44195816|NCT00377975|Ephedrine|ephedrine|mesh-list
44195817|NCT00377975|Caffeine|caffeine|mesh-list
44195818|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44195819|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195820|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44195821|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44195822|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195823|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44195824|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44195825|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44195826|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
44195827|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44195828|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
44195829|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
44195830|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195831|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44195832|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
44195833|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
44195870|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195871|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44195872|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44195873|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44195874|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44195875|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44195876|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
44195877|NCT00378118|Antibodies|antibodies|mesh-list
44195878|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
44195879|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
43811110|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43811111|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43811112|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
44195880|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
44195881|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195882|NCT00378144|Acetaminophen|acetaminophen|mesh-list
44195883|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
44195884|NCT00378144|Ephedrine|ephedrine|mesh-list
44195885|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44195886|NCT00378144|Analgesics|analgesics|mesh-ancestor
44195887|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
44195888|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44195889|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195890|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
44195891|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44195892|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
44195893|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44195894|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455520|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44455521|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455522|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455523|NCT01645111|Clevidipine|clevidipine|mesh-list
44455524|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44455525|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44455526|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455527|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44455528|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455529|NCT01644890|Paclitaxel|paclitaxel|mesh-list
44455530|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44455531|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455532|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455533|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455534|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455535|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455536|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
44455537|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44455538|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
44455539|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455540|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455541|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44455542|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455543|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
44455544|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44455545|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
44195936|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44195938|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
44195939|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195940|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44195941|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44195942|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
44195943|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44195944|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44195945|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44195946|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44195947|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
44195948|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195949|NCT00378404|Docetaxel|docetaxel|mesh-list
44195950|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195951|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
44195955|NCT00378417|Vaccines|vaccines|mesh-list
44195997|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44195998|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44195999|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43654958|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654959|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43654960|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
43654961|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
43654962|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43654963|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
43654964|NCT02972476|Hormones|hormones|mesh-ancestor
44196000|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44196001|NCT00378547|Acetaminophen|acetaminophen|mesh-list
44196002|NCT00378547|Dexamethasone|dexamethasone|mesh-list
44196003|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
44196004|NCT00378547|Pregabalin|pregabalin|mesh-list
44196005|NCT00378547|BB 1101|bb 1101|mesh-list
44196006|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196007|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
44196008|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
44196009|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196010|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196011|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196012|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
44196013|NCT00378547|Hormones|hormones|mesh-ancestor
44196014|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196015|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196016|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196017|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
44196018|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196019|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196020|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196021|NCT00378547|Analgesics|analgesics|mesh-ancestor
44196049|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44196050|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
44196051|NCT00378638|Bevacizumab|bevacizumab|mesh-list
44196052|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44196053|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196054|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44196055|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44196056|NCT00378638|Growth Substances|growth substances|mesh-ancestor
44196057|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196058|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
44196059|NCT00378677|Cyclosporine|cyclosporine|mesh-list
44196060|NCT00378677|Cyclosporins|cyclosporins|mesh-list
44196061|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196062|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196063|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196064|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
44196065|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196066|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
44196067|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196068|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
44196069|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196070|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44132515|NCT00151450|Pregabalin|pregabalin|mesh-list
44196072|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44196073|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
44196098|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196099|NCT00378755|Bortezomib|bortezomib|mesh-list
44196100|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196101|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44196102|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
44196103|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196104|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196105|NCT00378781|Minocycline|minocycline|mesh-list
44196106|NCT00378781|Heparin|heparin|mesh-list
44196107|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
44196108|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44196109|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44196110|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196111|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196112|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196113|NCT00378820|Caseins|caseins|mesh-list
44196114|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
44196158|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196159|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
44196160|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
44196161|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196162|NCT00378976|Valacyclovir|valacyclovir|mesh-list
44196163|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
44196164|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196165|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
44196166|NCT00379015|Docetaxel|docetaxel|mesh-list
44196167|NCT00379015|Trastuzumab|trastuzumab|mesh-list
44196168|NCT00379015|Epirubicin|epirubicin|mesh-list
44196169|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196170|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
44196171|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196172|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196173|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44196174|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
44196175|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196219|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44196220|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196221|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196222|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196223|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
44196224|NCT00379041|Hormones|hormones|mesh-ancestor
44196225|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196226|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196227|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196228|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44196229|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
44196230|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
44196231|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
44196232|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
44196233|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44196235|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44196236|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44196237|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44196238|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196239|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196240|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196241|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196242|NCT00379067|Urological Agents|urological agents|mesh-ancestor
44196243|NCT00379158|Micronutrients|micronutrients|mesh-list
44196244|NCT00379158|Trace Elements|trace elements|mesh-list
44196245|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196246|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44196247|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44196248|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44196260|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196261|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
44196262|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196263|NCT00379405|Ritonavir|ritonavir|mesh-list
44196264|NCT00379405|Saquinavir|saquinavir|mesh-list
44196265|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44196266|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44196267|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
44196268|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196269|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196270|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44196271|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43811136|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43811137|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
43811138|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811141|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44196272|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
44196273|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196274|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44196275|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44196276|NCT00379418|Abciximab|abciximab|mesh-list
44196277|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
44196278|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44196279|NCT00379457|Dactinomycin|dactinomycin|mesh-list
44196280|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
44196281|NCT00379457|Ifosfamide|ifosfamide|mesh-list
44196282|NCT00379457|Carboplatin|carboplatin|mesh-list
44196283|NCT00379457|Doxorubicin|doxorubicin|mesh-list
44196284|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44196285|NCT00379457|Etoposide|etoposide|mesh-list
44196286|NCT00379457|Vincristine|vincristine|mesh-list
44196287|NCT00379457|Topotecan|topotecan|mesh-list
44196288|NCT00379457|Vinorelbine|vinorelbine|mesh-list
44196289|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44196290|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
44196291|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196292|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196293|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44196294|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
43599308|NCT03291314|Axitinib|axitinib|mesh-list
44196300|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44196301|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196302|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44132700|NCT00151944|Mesalamine|mesalamine|mesh-list
44196303|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
44196304|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
44196305|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
44196306|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44196307|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196308|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196309|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44196310|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44196311|NCT00379483|Deferasirox|deferasirox|mesh-list
44196312|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44196313|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
44196314|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
44196315|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196316|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
44196317|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196318|NCT00379509|Lapatinib|lapatinib|mesh-list
44196319|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196320|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44196321|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196322|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196323|NCT00379522|Vasopressins|vasopressins|mesh-list
44196324|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
44196325|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
44196326|NCT00379522|Coagulants|coagulants|mesh-ancestor
44196327|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44196328|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44196329|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
44196344|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196345|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196347|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44196348|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
44196349|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196350|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44196351|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44196352|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44196353|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
44196354|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196355|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196356|NCT00379691|Protective Agents|protective agents|mesh-ancestor
44196357|NCT00379717|Docetaxel|docetaxel|mesh-list
44196358|NCT00379717|Cisplatin|cisplatin|mesh-list
44196359|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196360|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
44196361|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
44196362|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
44196363|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196364|NCT00379730|Prednisolone|prednisolone|mesh-list
44196365|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196366|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
44196367|NCT00379730|Hormones|hormones|mesh-ancestor
44196368|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196369|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196370|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196371|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196372|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44196373|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196374|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44196375|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44196376|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196383|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196384|NCT00379886|Thiopental|thiopental|mesh-list
44196385|NCT00379886|Propofol|propofol|mesh-list
44196386|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44196387|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196388|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196389|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44196390|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
44196391|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
44196392|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
44196393|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
44196394|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
44196395|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196396|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196397|NCT00379951|Ertapenem|ertapenem|mesh-list
44196398|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196399|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196400|NCT00379964|Caspofungin|caspofungin|mesh-list
44196401|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
44196402|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196403|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196404|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196405|NCT00379977|Vaccines|vaccines|mesh-list
44196406|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
44196407|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455550|NCT01644643|Avibactam|avibactam|mesh-list
44455551|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455552|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455553|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44455573|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455575|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455576|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44455577|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44455578|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
44455579|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455580|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44455581|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
44455582|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455583|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44455584|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
44455585|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455586|NCT01643928|Rituximab|rituximab|mesh-list
44455587|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44455588|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455589|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
44455590|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455591|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455592|NCT01643772|Oxycodone|oxycodone|mesh-list
44455593|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44455594|NCT01643772|Narcotics|narcotics|mesh-ancestor
44455595|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455596|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455597|NCT01643772|Analgesics|analgesics|mesh-ancestor
44455598|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
44455599|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455600|NCT01643668|Busulfan|busulfan|mesh-list
44455601|NCT01643668|Clofarabine|clofarabine|mesh-list
44196408|NCT00380120|Warfarin|warfarin|mesh-list
44196409|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
44196425|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44196426|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196427|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196428|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44196429|NCT00380146|Renal Agents|renal agents|mesh-ancestor
44196430|NCT00380224|Olanzapine|olanzapine|mesh-list
44196431|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
44196432|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
44196433|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196434|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196435|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196436|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44196437|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196438|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196439|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196440|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43811212|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
43811213|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196441|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44196442|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196443|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196444|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196445|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
44196446|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
44196447|NCT00380263|Growth Substances|growth substances|mesh-ancestor
44196449|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196470|NCT00380406|Leuprolide|leuprolide|mesh-list
44196471|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44196472|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
44196473|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44196474|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196475|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44196476|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196477|NCT00380445|Vildagliptin|vildagliptin|mesh-list
44196478|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44455602|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
44196479|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196480|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44196481|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
44196482|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196483|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196484|NCT00380484|Budesonide|budesonide|mesh-list
44196485|NCT00380484|Montelukast|montelukast|mesh-list
44196486|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196487|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44196488|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
44196489|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196490|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196491|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44196492|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
44196493|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
44196494|NCT00380484|Hormones|hormones|mesh-ancestor
44196495|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196514|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44196515|NCT00380640|Trimethoprim|trimethoprim|mesh-list
44196516|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44196517|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196518|NCT00380640|Renal Agents|renal agents|mesh-ancestor
44196519|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
44196520|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44196521|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44196522|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44196523|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196524|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196525|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44196526|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44196527|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44196528|NCT00380770|Lamivudine|lamivudine|mesh-list
44196529|NCT00380770|Stavudine|stavudine|mesh-list
44196530|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
44196531|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44196532|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44196533|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196534|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196535|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
44196536|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196537|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44196538|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44196539|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
44196540|NCT00380822|Miglitol|miglitol|mesh-list
44196541|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196542|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196543|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44196546|NCT00380835|Amrubicin|amrubicin|mesh-list
44196557|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196558|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196559|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196560|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196561|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196562|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196564|NCT00380939|Pravastatin|pravastatin|mesh-list
44196565|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44196566|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44196567|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
44196568|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196569|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44196570|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44196571|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196572|NCT00380965|Nabilone|nabilone|mesh-list
44196573|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
44196574|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
44196575|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196576|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196577|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196578|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196579|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196580|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196581|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196591|NCT00381030|Carvedilol|carvedilol|mesh-list
44196606|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44196607|NCT00381134|Losartan|losartan|mesh-list
44196608|NCT00381134|Spironolactone|spironolactone|mesh-list
44196609|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44196610|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44196611|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44196612|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44196613|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196614|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44196615|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
44196616|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196617|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196618|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44196619|NCT00381134|Diuretics|diuretics|mesh-ancestor
44196620|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
44196621|NCT00381147|Clarithromycin|clarithromycin|mesh-list
44196622|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196623|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196624|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44196625|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196626|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196655|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
44196656|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
44196657|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196658|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196659|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196660|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196661|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44196662|NCT00381251|Estrogens|estrogens|mesh-ancestor
44196663|NCT00381251|Hormones|hormones|mesh-ancestor
44196664|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196665|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196666|NCT00381264|Nabilone|nabilone|mesh-list
44196667|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
44196668|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
44196669|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196670|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196671|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44196672|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196673|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196674|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196675|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196676|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
44196709|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196710|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196711|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196712|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196713|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196714|NCT00381537|Analgesics|analgesics|mesh-ancestor
44196715|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
44196716|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196717|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44196718|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196719|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196720|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44196721|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44196722|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44196723|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44196724|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44196725|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196726|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
44196727|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
44196728|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44196730|NCT00381589|Ipratropium|ipratropium|mesh-list
44196731|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
43811232|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811233|NCT04847622|Remdesivir|remdesivir|mesh-list
43811234|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
43811235|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811236|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
43811237|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811238|NCT04847661|Mefloquine|mefloquine|mesh-list
43811266|NCT04847024|Parecoxib|parecoxib|mesh-list
44196732|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44196733|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
44196734|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196735|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196754|NCT00381758|Methylphenidate|methylphenidate|mesh-list
44196755|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44196756|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196757|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44196758|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44196759|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196760|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196761|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
44196762|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196763|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
44196764|NCT00381836|Hematinics|hematinics|mesh-ancestor
44196765|NCT00381875|Sargramostim|sargramostim|mesh-list
44196766|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
44196767|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
44196768|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196769|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44196770|NCT00381901|Trastuzumab|trastuzumab|mesh-list
44196771|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44196772|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196774|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
44196775|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
44196777|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
44196778|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196779|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44196780|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44455603|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455604|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455605|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
44455606|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455607|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44455608|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455609|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44455610|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44455611|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
44455612|NCT01643408|Asparaginase|asparaginase|mesh-list
44455613|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455614|NCT01642914|Linaclotide|linaclotide|mesh-list
44455615|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
44455616|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
44455617|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455618|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455619|NCT01642732|Everolimus|everolimus|mesh-list
44455620|NCT01642732|Leuprolide|leuprolide|mesh-list
44455621|NCT01642732|Bicalutamide|bicalutamide|mesh-list
44455622|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455623|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455624|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
44455625|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455626|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44455627|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
44455628|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811280|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43811281|NCT04847245|Esketamine|esketamine|mesh-list
43811282|NCT04847245|Analgesics|analgesics|mesh-ancestor
43811283|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
43811284|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811285|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811286|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
44455629|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44455630|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
44455631|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
44455632|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455633|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
44455634|NCT01642615|Lansoprazole|lansoprazole|mesh-list
44455635|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44455636|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455637|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44455638|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455639|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455640|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
44455641|NCT01642602|Lansoprazole|lansoprazole|mesh-list
44455642|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44455643|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455657|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
44455658|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44455659|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44455660|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
44455661|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455662|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455663|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455664|NCT01642277|Urological Agents|urological agents|mesh-ancestor
44455665|NCT01642251|Cisplatin|cisplatin|mesh-list
44455666|NCT01642251|Etoposide|etoposide|mesh-list
44455667|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
44455668|NCT01642251|Veliparib|veliparib|mesh-list
44455669|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
44455670|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455671|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44196781|NCT00381953|Interferons|interferons|mesh-list
44196782|NCT00381953|Ribavirin|ribavirin|mesh-list
44196783|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
44196784|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
44196785|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44196786|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196787|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
44196788|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196789|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
44196790|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196791|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
44196792|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196793|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
44196794|NCT00382044|Hematinics|hematinics|mesh-ancestor
44196795|NCT00382057|Anastrozole|anastrozole|mesh-list
44196796|NCT00382057|Goserelin|goserelin|mesh-list
44196814|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
44196815|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196816|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196817|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
44196818|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44196819|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44196820|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44196821|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44196822|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44196823|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196824|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196825|NCT00382083|Analgesics|analgesics|mesh-ancestor
44196826|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
44196827|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44196828|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196829|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196830|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44196831|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196832|NCT00382135|Tadalafil|tadalafil|mesh-list
44196833|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
44196834|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44196835|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44196836|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196837|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196838|NCT00382135|Urological Agents|urological agents|mesh-ancestor
44196839|NCT00382213|Olmesartan|olmesartan|mesh-list
44196840|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44196841|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44196842|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44196843|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44196844|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196845|NCT00382239|Exenatide|exenatide|mesh-list
44196846|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44196850|NCT00382239|Hormones|hormones|mesh-ancestor
44196851|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196853|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
44196854|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196855|NCT00382343|Trimethoprim|trimethoprim|mesh-list
44196856|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44196857|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
44196858|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44196859|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44196860|NCT00382343|Renal Agents|renal agents|mesh-ancestor
44196861|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
44196862|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44196863|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44196864|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44196865|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196866|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196867|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44196868|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44196869|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44196870|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44196871|NCT00382356|Dutasteride|dutasteride|mesh-list
44196872|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44196873|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44196874|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196875|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196876|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
44196877|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44196878|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44196879|NCT00382421|Aspirin|aspirin|mesh-list
44196880|NCT00382421|Amlodipine|amlodipine|mesh-list
44196881|NCT00382421|Bisoprolol|bisoprolol|mesh-list
44196882|NCT00382421|Molsidomine|molsidomine|mesh-list
44196890|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44196891|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44196893|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
44196894|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654970|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654971|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654972|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
43654973|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
43654974|NCT02972320|Temozolomide|temozolomide|mesh-list
43654975|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43811341|NCT04846634|Antiviral Agents|antiviral agents|mesh-ancestor
44196895|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44196896|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44196897|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44196898|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44196899|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44196953|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
44196954|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44196955|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196956|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44196957|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44196958|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44196959|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44196960|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44196961|NCT00382668|Dasatinib|dasatinib|mesh-list
44196962|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196963|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44196964|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44196965|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44196966|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44196967|NCT00382694|Fludarabine|fludarabine|mesh-list
44196968|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196969|NCT00382837|Epratuzumab|epratuzumab|mesh-list
44196970|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44196971|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44196972|NCT00382889|Beclomethasone|beclomethasone|mesh-list
44196973|NCT00382889|Albuterol|albuterol|mesh-list
44196974|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44196975|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
44196978|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44197004|NCT00382980|Antacids|antacids|mesh-ancestor
44197005|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197006|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197007|NCT00383032|Mifepristone|mifepristone|mesh-list
44197008|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44197009|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
44197010|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44197011|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197012|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44197013|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44197014|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44197015|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
44197016|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44197017|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44197018|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197019|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197020|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
44197021|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44197022|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44197023|NCT00383045|Naltrexone|naltrexone|mesh-list
44197024|NCT00383045|Buprenorphine|buprenorphine|mesh-list
44197025|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44197026|NCT00383045|Narcotics|narcotics|mesh-ancestor
44197027|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197028|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197029|NCT00383045|Analgesics|analgesics|mesh-ancestor
44197030|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
44197031|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197032|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44197033|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44197034|NCT00383136|Tirofiban|tirofiban|mesh-list
44197035|NCT00383136|Abciximab|abciximab|mesh-list
44197036|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
44197038|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44197045|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44197046|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44197047|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197048|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197049|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44197050|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
44197051|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
44197052|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811367|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811368|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
44197053|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197054|NCT00383370|Aflibercept|aflibercept|mesh-list
44197055|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197056|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44197057|NCT00383370|Growth Substances|growth substances|mesh-ancestor
44197058|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197059|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197060|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197061|NCT00383396|Cyclosporine|cyclosporine|mesh-list
44197062|NCT00383396|Cyclosporins|cyclosporins|mesh-list
44197063|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197064|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197065|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197066|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
44197067|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197068|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
44197069|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197070|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
44197071|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197072|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44197073|NCT00383474|Bortezomib|bortezomib|mesh-list
44197074|NCT00383474|Tipifarnib|tipifarnib|mesh-list
44197075|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197076|NCT00383487|Calcitriol|calcitriol|mesh-list
44197077|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
44197078|NCT00383487|Naproxen|naproxen|mesh-list
44197079|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44197084|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197085|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197086|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44197087|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197088|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
44197089|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44197090|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197091|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197092|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44197093|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44197094|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197095|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44197096|NCT00383487|Vitamins|vitamins|mesh-ancestor
44197097|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
44197098|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44197099|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44197100|NCT00383526|Vaccines|vaccines|mesh-list
44197101|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
44197102|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197103|NCT00383539|Vaccines|vaccines|mesh-list
44197104|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
44197105|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197106|NCT00383591|Vaccines|vaccines|mesh-list
44197107|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
44197133|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197134|NCT00383799|Amiodarone|amiodarone|mesh-list
44197135|NCT00383799|Procainamide|procainamide|mesh-list
44197136|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44197137|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
44197138|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44197139|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197140|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197141|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44197142|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44197143|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197144|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197145|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44197146|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44197147|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44197148|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44197149|NCT00383812|Bevacizumab|bevacizumab|mesh-list
44197150|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197151|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43852507|NCT03833440|Docetaxel|docetaxel|mesh-list
44197152|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44197154|NCT00383812|Growth Substances|growth substances|mesh-ancestor
44197183|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
44197184|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44197185|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197186|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
44197187|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44197188|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197189|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197190|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44197191|NCT00383890|Analgesics|analgesics|mesh-ancestor
44197192|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
44197193|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197194|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44197195|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44197196|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44197197|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197214|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197215|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197216|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44197217|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44197218|NCT00383994|Rituximab|rituximab|mesh-list
44197219|NCT00383994|Sargramostim|sargramostim|mesh-list
44197220|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197221|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197222|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
44197223|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197224|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197225|NCT00384020|Citalopram|citalopram|mesh-list
44197226|NCT00384020|Paroxetine|paroxetine|mesh-list
44197227|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44197228|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44197229|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197230|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197231|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197232|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
44197233|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197234|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44197235|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
44197236|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44197237|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44197238|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197239|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197240|NCT00384046|Testosterone|testosterone|mesh-list
44197241|NCT00384046|Androgens|androgens|mesh-ancestor
44197242|NCT00384046|Hormones|hormones|mesh-ancestor
44197243|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197244|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197245|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
44197251|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44197252|NCT00384124|Imiquimod|imiquimod|mesh-list
44197253|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44197254|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
44197255|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197256|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197257|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
44197258|NCT00384137|Tacrolimus|tacrolimus|mesh-list
44197259|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197260|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
44197261|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197262|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44197263|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197264|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197265|NCT00384202|Tacrolimus|tacrolimus|mesh-list
44197266|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197267|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
44197268|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197269|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44197270|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197304|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
44197305|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197306|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197307|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44197308|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197309|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
44197310|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811586|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197311|NCT00384410|Nabilone|nabilone|mesh-list
44197312|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
44197313|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
44197314|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197315|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197316|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197317|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44197318|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44197319|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197320|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44197321|NCT00384436|Citalopram|citalopram|mesh-list
44197322|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44197323|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44197324|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197325|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197326|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197327|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
44197328|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197329|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44197330|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
44197331|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44197332|NCT00384475|Ciclesonide|ciclesonide|mesh-list
44197333|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
44197334|NCT00384475|Hormones|hormones|mesh-ancestor
44197335|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197346|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
44197347|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197348|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197349|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44197350|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44197351|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44197352|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197353|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197354|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197355|NCT00384540|Protective Agents|protective agents|mesh-ancestor
44197356|NCT00384553|Rituximab|rituximab|mesh-list
44197357|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197358|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197359|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
44197360|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197361|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197362|NCT00384566|Metoprolol|metoprolol|mesh-list
44197363|NCT00384566|Carvedilol|carvedilol|mesh-list
44197364|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44197365|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44197366|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
44197367|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
44197368|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197369|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197370|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44197371|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44197372|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44197373|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197374|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197375|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197376|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
44197377|NCT00384566|Protective Agents|protective agents|mesh-ancestor
44197378|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44197379|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44197384|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
44197385|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44197386|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654980|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197387|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197388|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
44197389|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197390|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197391|NCT00384592|Esomeprazole|esomeprazole|mesh-list
44197392|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44197393|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197394|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44197395|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197396|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197397|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
44197398|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44197399|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44197400|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197401|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197402|NCT00384605|Hormones|hormones|mesh-ancestor
44197403|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197404|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197405|NCT00384618|Vitamin E|vitamin e|mesh-list
44197406|NCT00384618|Pravastatin|pravastatin|mesh-list
44197407|NCT00384618|Vitamins|vitamins|mesh-ancestor
44197408|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
44197409|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197410|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
44197411|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197424|NCT00384631|Growth Substances|growth substances|mesh-ancestor
44197425|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197426|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
44197427|NCT00384657|Iron|iron|mesh-list
44197428|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
44197429|NCT00384657|Trace Elements|trace elements|mesh-ancestor
44197430|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
44197431|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197432|NCT00384657|Hematinics|hematinics|mesh-ancestor
44197433|NCT00384696|Nicotine|nicotine|mesh-list
44197434|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44197435|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
44197436|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197437|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197438|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44197439|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44197440|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
44197441|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197442|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197443|NCT00384800|Thalidomide|thalidomide|mesh-list
44197444|NCT00384800|Tegafur|tegafur|mesh-list
44197480|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197481|NCT00384878|Antidotes|antidotes|mesh-ancestor
44197482|NCT00384878|Protective Agents|protective agents|mesh-ancestor
44197483|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
44197484|NCT00384878|Vitamins|vitamins|mesh-ancestor
44197485|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
44197486|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44197487|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
44197488|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44197489|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
44197490|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197491|NCT00384917|Ketoconazole|ketoconazole|mesh-list
44197492|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
44197493|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197496|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197541|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197542|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44197543|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
44197544|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197545|NCT00385307|Amibegron|amibegron|mesh-list
44197546|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44197547|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44197548|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197549|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197550|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197551|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197552|NCT00385359|Albuterol|albuterol|mesh-list
44197553|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44197554|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
44197555|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197556|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197557|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44197558|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
44197559|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
44197595|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44197596|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
44197597|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
44197598|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197599|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197600|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197601|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44197602|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44197603|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197604|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
44197605|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44197606|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44197607|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
44197608|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44197609|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44197610|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
44197611|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44197612|NCT00385450|Nelfinavir|nelfinavir|mesh-list
44197613|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44197614|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44197615|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
44197616|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197617|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197618|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44197619|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197620|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
44197621|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197622|NCT00385463|Montelukast|montelukast|mesh-list
44197623|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44197624|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44197625|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
44197626|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44197627|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197632|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197633|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44197634|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
44197635|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197636|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
44197638|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
44197639|NCT00385502|Econazole|econazole|mesh-list
44197640|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
44197641|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43853010|NCT03794037|Montelukast|montelukast|mesh-list
44197642|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44197643|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197644|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197645|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197646|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44197647|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197648|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197649|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197651|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197652|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
44197653|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197654|NCT00385606|Gemcitabine|gemcitabine|mesh-list
44197655|NCT00385606|Rofecoxib|rofecoxib|mesh-list
44197656|NCT00385606|Cisplatin|cisplatin|mesh-list
44197657|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197671|NCT00385606|Analgesics|analgesics|mesh-ancestor
44197680|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44197681|NCT00385645|Zidovudine|zidovudine|mesh-list
44197682|NCT00385645|Lamivudine|lamivudine|mesh-list
44197683|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44197684|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44197685|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
44197686|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197687|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197688|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44197689|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197690|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
44197691|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197692|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44197693|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197694|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
44197695|NCT00385658|Simvastatin|simvastatin|mesh-list
44197696|NCT00385658|Ezetimibe|ezetimibe|mesh-list
44197697|NCT00385658|Fenofibrate|fenofibrate|mesh-list
44197698|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44197699|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44197700|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
44197701|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197702|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44197703|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44197704|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197705|NCT00385710|Valproic Acid|valproic acid|mesh-list
44197706|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
44197707|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197726|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44197727|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44197728|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
44197729|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197730|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44197731|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44197732|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197733|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44197734|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44197735|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44197736|NCT00385957|Lamivudine|lamivudine|mesh-list
44197737|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44197738|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197787|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
44197788|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
44197789|NCT00386178|Vitamins|vitamins|mesh-ancestor
44197790|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
44197791|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197792|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
44197793|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197794|NCT00386178|Protective Agents|protective agents|mesh-ancestor
44197795|NCT00386191|Clopidogrel|clopidogrel|mesh-list
44197796|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44197797|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44197798|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44197799|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44197800|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
44197801|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197802|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197803|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811642|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
43811643|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811709|NCT04839536|Sevoflurane|sevoflurane|mesh-list
43811710|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43811711|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43811712|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
43811713|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
43811714|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811715|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811720|NCT04839549|Hormones|hormones|mesh-ancestor
43811727|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197805|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
44197806|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197807|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44197808|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197809|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197810|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
44197811|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197812|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44197813|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197814|NCT00386269|Codeine|codeine|mesh-list
44197815|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44197816|NCT00386269|Narcotics|narcotics|mesh-ancestor
44197817|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44197818|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197819|NCT00386269|Analgesics|analgesics|mesh-ancestor
44197820|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
44197821|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197822|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
44197824|NCT00386282|Misoprostol|misoprostol|mesh-list
44197827|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
44197828|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44197829|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197830|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44197831|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197832|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
44197833|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44197834|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44197835|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44197836|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44197837|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
43811761|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
43811762|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44197838|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44197839|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43811763|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811765|NCT04839237|Liraglutide|liraglutide|mesh-list
43811766|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44197840|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197841|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44197842|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
44197843|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44197844|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44197845|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
44197846|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197847|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44197848|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197849|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197850|NCT00386399|Mitomycins|mitomycins|mesh-list
44197851|NCT00386399|Mitomycin|mitomycin|mesh-list
44197852|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44197853|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197854|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
44197855|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197870|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44197871|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
44197872|NCT00386516|Fluorouracil|fluorouracil|mesh-list
44197873|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
44197874|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197875|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44197876|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197877|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44197878|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
44197879|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197880|NCT00386529|Aspirin|aspirin|mesh-list
44197881|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44197882|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44197883|NCT00386529|Analgesics|analgesics|mesh-ancestor
44197884|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
44197885|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44197886|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197887|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44197888|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44197889|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44197890|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44197891|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197892|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44197893|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44197894|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197895|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
44197896|NCT00386555|Docetaxel|docetaxel|mesh-list
44197897|NCT00386555|Axitinib|axitinib|mesh-list
44197898|NCT00386555|Crenolanib|crenolanib|mesh-list
43811880|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44197899|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44197900|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
44197913|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44197914|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
44197915|NCT00386646|Laxatives|laxatives|mesh-ancestor
44197916|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44197917|NCT00386659|Ritonavir|ritonavir|mesh-list
44197918|NCT00386659|Lopinavir|lopinavir|mesh-list
44197919|NCT00386659|Tenofovir|tenofovir|mesh-list
44197920|NCT00386659|Abacavir|abacavir|mesh-list
44197921|NCT00386659|Efavirenz|efavirenz|mesh-list
44197922|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
44197923|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44197924|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44197925|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
44197926|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197927|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197928|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44197929|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44197930|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
44197931|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197932|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44197933|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197934|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44197935|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44197936|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44197937|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44197938|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44197939|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44197940|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44197941|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
44197942|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
44197958|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
44197959|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44197960|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44197961|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197962|NCT00386763|Lumefantrine|lumefantrine|mesh-list
44197964|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44197965|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
44197966|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44197967|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44197968|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197969|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
44197970|NCT00386802|Clotrimazole|clotrimazole|mesh-list
44197971|NCT00386802|Miconazole|miconazole|mesh-list
44197972|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44197973|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44197974|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44197975|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44197976|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44197977|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44197978|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44197979|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
44197984|NCT00386815|Cisplatin|cisplatin|mesh-list
43842175|NCT04548518|Vaccines|vaccines|mesh-list
44198008|NCT00386841|Antidepressive Agents|antidepressive agents|mesh-ancestor
44198009|NCT00386841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44198010|NCT00386867|Misoprostol|misoprostol|mesh-list
44198011|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44198012|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
44198013|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44198014|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198015|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44198016|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198017|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
44198018|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
44198019|NCT00386958|Povidone|povidone|mesh-list
44198020|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
44198021|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
44198022|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44198023|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198024|NCT00386984|Octreotide|octreotide|mesh-list
44198025|NCT00386984|Somatostatin|somatostatin|mesh-list
44198026|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198027|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198028|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198029|NCT00386984|Hormones|hormones|mesh-ancestor
44198030|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198031|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198032|NCT00386997|Amphotericin B|amphotericin b|mesh-list
44198033|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44198059|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44198060|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198061|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198062|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198063|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44198064|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198065|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198066|NCT00387374|Paclitaxel|paclitaxel|mesh-list
44198067|NCT00387374|Bevacizumab|bevacizumab|mesh-list
44198068|NCT00387374|Carboplatin|carboplatin|mesh-list
44198069|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44198070|NCT00387374|Antibodies|antibodies|mesh-list
44198071|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
44198072|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44198073|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198074|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198075|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
44198076|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
44198077|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
44198078|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198079|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198080|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198081|NCT00387374|Growth Substances|growth substances|mesh-ancestor
43655008|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844381|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43844382|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
43844383|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
43844384|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
44198082|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198083|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198085|NCT00387400|Everolimus|everolimus|mesh-list
44198107|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
44198108|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
44198109|NCT00387413|Vitamins|vitamins|mesh-ancestor
44198110|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
44198111|NCT00387504|Fenretinide|fenretinide|mesh-list
44198112|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198113|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44198114|NCT00387504|Protective Agents|protective agents|mesh-ancestor
44198115|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198116|NCT00387530|Valganciclovir|valganciclovir|mesh-list
44198117|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
44198118|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
44198119|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198120|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198121|NCT00387556|Ondansetron|ondansetron|mesh-list
44198122|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
44198123|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
44198124|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198125|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198126|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198127|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
44198128|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
44198129|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44198130|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
44198131|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198132|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455719|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455720|NCT01641900|Eszopiclone|eszopiclone|mesh-list
44455721|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44455722|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455723|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198141|NCT00387582|Ranibizumab|ranibizumab|mesh-list
44198142|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198143|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198144|NCT00387582|Growth Substances|growth substances|mesh-ancestor
44198145|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198146|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198147|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198148|NCT00387608|Veliparib|veliparib|mesh-list
44198149|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44198150|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198151|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198152|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198153|NCT00387699|Bevacizumab|bevacizumab|mesh-list
44198154|NCT00387699|Cisplatin|cisplatin|mesh-list
44198155|NCT00387699|Etoposide|etoposide|mesh-list
44198156|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198157|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198158|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198159|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198160|NCT00387699|Growth Substances|growth substances|mesh-ancestor
44198161|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198162|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198168|NCT00387738|Histamine|histamine|mesh-list
44198182|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44198183|NCT00387868|Cisplatin|cisplatin|mesh-list
44198184|NCT00387868|Etoposide|etoposide|mesh-list
44198185|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198186|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198187|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44198188|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198189|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198190|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198191|NCT00387920|Sunitinib|sunitinib|mesh-list
44198192|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198193|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198194|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198195|NCT00387920|Growth Substances|growth substances|mesh-ancestor
44198196|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198197|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198198|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198199|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198200|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198201|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
44198202|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
44198203|NCT00387933|Vatalanib|vatalanib|mesh-list
43655009|NCT02972268|Urological Agents|urological agents|mesh-ancestor
43655010|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43655011|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43655012|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
43655013|NCT02972216|Cisplatin|cisplatin|mesh-list
43655014|NCT02972216|Docetaxel|docetaxel|mesh-list
43655015|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655016|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
43655017|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
43800223|NCT04994626|Rituximab|rituximab|mesh-list
44198204|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198205|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198206|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198207|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198208|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
44198209|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198210|NCT00388011|Morphine|morphine|mesh-list
44198211|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198212|NCT00388011|Narcotics|narcotics|mesh-ancestor
44198213|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43853544|NCT03747432|Propofol|propofol|mesh-list
44198214|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198215|NCT00388011|Analgesics|analgesics|mesh-ancestor
44198221|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44198222|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198223|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
44198224|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
44198225|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
44198226|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198227|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198228|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198230|NCT00388089|Topotecan|topotecan|mesh-list
44198231|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198232|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44198233|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198234|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198235|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198236|NCT00388128|Caffeine|caffeine|mesh-list
44198237|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44198238|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198239|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44198240|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198241|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198242|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44198243|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44198244|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
44198245|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198246|NCT00388167|Caspofungin|caspofungin|mesh-list
44198247|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
44198248|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198249|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198250|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198263|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
44198264|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198265|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44198266|NCT00388258|Alvimopan|alvimopan|mesh-list
44198267|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198268|NCT00388271|Alfuzosin|alfuzosin|mesh-list
44198269|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44198270|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44198271|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44198272|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
44198273|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198274|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198275|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198276|NCT00388271|Urological Agents|urological agents|mesh-ancestor
44198277|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
44198278|NCT00388336|Hematinics|hematinics|mesh-ancestor
44198279|NCT00388388|Losartan|losartan|mesh-list
44198280|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44198281|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44198282|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44198283|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44198284|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43811929|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198285|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198286|NCT00388388|Diuretics|diuretics|mesh-ancestor
44198287|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
44198288|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198289|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44198291|NCT00388401|Alvimopan|alvimopan|mesh-list
44198308|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198309|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44198310|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
44198311|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198312|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198313|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44198314|NCT00388635|Prednisone|prednisone|mesh-list
44198315|NCT00388635|Melphalan|melphalan|mesh-list
44198316|NCT00388635|Bortezomib|bortezomib|mesh-list
44198317|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198318|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
44198319|NCT00388635|Hormones|hormones|mesh-ancestor
44198320|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198321|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198322|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198323|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198324|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198325|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
44198326|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198327|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44198328|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198329|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
44198330|NCT00388661|Melatonin|melatonin|mesh-list
44198331|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
44198332|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198333|NCT00388661|Protective Agents|protective agents|mesh-ancestor
44198334|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198335|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198336|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
44198337|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44198338|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198339|NCT00388700|Leucovorin|leucovorin|mesh-list
44198340|NCT00388700|Bevacizumab|bevacizumab|mesh-list
44198341|NCT00388700|Fluorouracil|fluorouracil|mesh-list
44198342|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198344|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198345|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198346|NCT00388700|Growth Substances|growth substances|mesh-ancestor
44198347|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198348|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198349|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
44198350|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198351|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44198352|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198353|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
44198354|NCT00388700|Antidotes|antidotes|mesh-ancestor
44198355|NCT00388700|Protective Agents|protective agents|mesh-ancestor
44198356|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
44198357|NCT00388700|Vitamins|vitamins|mesh-ancestor
44198358|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
44198359|NCT00388739|Prednisolone|prednisolone|mesh-list
44198360|NCT00388739|Budesonide|budesonide|mesh-list
44198361|NCT00388739|Albuterol|albuterol|mesh-list
44198362|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198363|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
44198364|NCT00388739|Hormones|hormones|mesh-ancestor
44455724|NCT01641822|Tobramycin|tobramycin|mesh-list
44198365|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198366|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198369|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
44198397|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
44198398|NCT00388882|Ipratropium|ipratropium|mesh-list
44198399|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44198400|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
44198401|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198402|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198403|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44198404|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198405|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
44198406|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44198407|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
44198408|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198409|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198410|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
44198411|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
44198412|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44198413|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44198417|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
44198454|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198455|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44198456|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44198457|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44198458|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198459|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
44198460|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198461|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44198462|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198463|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
44198464|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198465|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198466|NCT00389090|Temozolomide|temozolomide|mesh-list
44198467|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
44198468|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198469|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
44198470|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198471|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198472|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198473|NCT00389129|Aspirin|aspirin|mesh-list
44198474|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44198475|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198476|NCT00389129|Analgesics|analgesics|mesh-ancestor
44198477|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
44198478|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198479|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198480|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198498|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198499|NCT00389272|Acetaminophen|acetaminophen|mesh-list
44198500|NCT00389272|Ibuprofen|ibuprofen|mesh-list
44198501|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198502|NCT00389272|Analgesics|analgesics|mesh-ancestor
44198503|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
44198504|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198505|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198506|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
44198507|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44198508|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198509|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198510|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44198511|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198512|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198513|NCT00389285|Sorafenib|sorafenib|mesh-list
44198514|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198515|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198516|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198517|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198518|NCT00389311|Nonoxynol|nonoxynol|mesh-list
44198519|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44198520|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44198521|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198522|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44198523|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
44198524|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44198525|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44198526|NCT00389376|Silymarin|silymarin|mesh-list
44198527|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
44198528|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198529|NCT00389376|Protective Agents|protective agents|mesh-ancestor
44198530|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198531|NCT00389402|Ritonavir|ritonavir|mesh-list
44198532|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44198538|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198539|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44198540|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44198541|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
44198542|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198543|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44198544|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44198545|NCT00389415|Vildagliptin|vildagliptin|mesh-list
44198546|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198547|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198548|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44198549|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
44198550|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198551|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198552|NCT00389428|Cytarabine|cytarabine|mesh-list
44198553|NCT00389428|Daunorubicin|daunorubicin|mesh-list
44198554|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44198555|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
44198556|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198557|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198558|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
44198559|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198567|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
44198568|NCT00389506|Fludarabine|fludarabine|mesh-list
44198569|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
44198570|NCT00389506|Immunotoxins|immunotoxins|mesh-list
44198571|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198572|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
44198573|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198574|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198575|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198576|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
44198577|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198578|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198579|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44198580|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44198581|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
44198582|NCT00389558|Amikacin|amikacin|mesh-list
44198583|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44198584|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44198585|NCT00389584|Irinotecan|irinotecan|mesh-list
44198586|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44198587|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198588|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198589|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198590|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198591|NCT00389636|Becaplermin|becaplermin|mesh-list
44198592|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
44198593|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44198594|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198595|NCT00389636|Growth Substances|growth substances|mesh-ancestor
44198596|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198597|NCT00389688|Cisplatin|cisplatin|mesh-list
44198598|NCT00389688|Pemetrexed|pemetrexed|mesh-list
44198599|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198600|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198609|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198610|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198611|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198612|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
44198614|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198615|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198616|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198617|NCT00389766|Topotecan|topotecan|mesh-list
44198618|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44198619|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44198620|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44198621|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198622|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198623|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198624|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44198625|NCT00389883|Anesthetics|anesthetics|mesh-list
44198626|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198627|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198663|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198664|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198665|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198666|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44198667|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198668|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198669|NCT00390026|Bevacizumab|bevacizumab|mesh-list
44198670|NCT00390026|Verteporfin|verteporfin|mesh-list
44198671|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198672|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198673|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198674|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198675|NCT00390026|Growth Substances|growth substances|mesh-ancestor
44198676|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198677|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198678|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44198679|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
44198680|NCT00390039|Morphine|morphine|mesh-list
44198681|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198682|NCT00390039|Narcotics|narcotics|mesh-ancestor
44198685|NCT00390039|Analgesics|analgesics|mesh-ancestor
44198716|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198717|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198718|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
44198719|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198720|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198721|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44198722|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198723|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198724|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198725|NCT00390156|Growth Substances|growth substances|mesh-ancestor
44198726|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198727|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44198728|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198729|NCT00390195|Everolimus|everolimus|mesh-list
44198730|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198731|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44198732|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
44198733|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198734|NCT00390208|Dexamethasone|dexamethasone|mesh-list
44198735|NCT00390208|Ranibizumab|ranibizumab|mesh-list
44198736|NCT00390208|Verteporfin|verteporfin|mesh-list
44198737|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198738|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
44198739|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
44198740|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198741|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198742|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198743|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
44198744|NCT00390208|Hormones|hormones|mesh-ancestor
44198746|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44198762|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198763|NCT00390247|Growth Substances|growth substances|mesh-ancestor
44198764|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198765|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198766|NCT00390260|Acetaminophen|acetaminophen|mesh-list
44198767|NCT00390260|Rofecoxib|rofecoxib|mesh-list
44198768|NCT00390260|Hydrocodone|hydrocodone|mesh-list
44198769|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198770|NCT00390260|Analgesics|analgesics|mesh-ancestor
44198771|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
44198772|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198773|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198774|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
44198775|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198776|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
44198777|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198778|NCT00390260|Narcotics|narcotics|mesh-ancestor
44198779|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198780|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
44198781|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44198782|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44198783|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198784|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44198785|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198786|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44198787|NCT00390273|Metformin|metformin|mesh-list
44198788|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44198789|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198790|NCT00390312|Morphine|morphine|mesh-list
44198791|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198792|NCT00390312|Narcotics|narcotics|mesh-ancestor
44198793|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198794|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198795|NCT00390312|Analgesics|analgesics|mesh-ancestor
44198796|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
44198801|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44198802|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43812054|NCT04834986|Lenvatinib|lenvatinib|mesh-list
44198803|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44198804|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198805|NCT00390403|Acetic Acid|acetic acid|mesh-list
44198806|NCT00390403|Temozolomide|temozolomide|mesh-list
44198807|NCT00390403|Retinol acetate|retinol acetate|mesh-list
44198808|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
44198809|NCT00390403|Gossypol|gossypol|mesh-list
44198810|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44198811|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
44198868|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44198869|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198870|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198871|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44198872|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
44198874|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44198876|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
44198877|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198878|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44198879|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44198880|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44198881|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
44198882|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44198883|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198884|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198885|NCT00390871|Narcotics|narcotics|mesh-ancestor
44198886|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44198887|NCT00390897|Interferons|interferons|mesh-list
44198925|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44198926|NCT00391105|Narcotics|narcotics|mesh-ancestor
44198927|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44198928|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655028|NCT02971982|Rituximab|rituximab|mesh-list
44198929|NCT00391105|Analgesics|analgesics|mesh-ancestor
44198930|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
44198931|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198932|NCT00391144|Triamcinolone|triamcinolone|mesh-list
44198933|NCT00391144|Bevacizumab|bevacizumab|mesh-list
44198934|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44198935|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44198936|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44198937|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44198938|NCT00391144|Growth Substances|growth substances|mesh-ancestor
44198939|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198940|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
44198941|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198942|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
44198943|NCT00391144|Hormones|hormones|mesh-ancestor
44198944|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198945|NCT00391157|Dexamethasone|dexamethasone|mesh-list
44198946|NCT00391157|Bortezomib|bortezomib|mesh-list
44198947|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44198948|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
44198949|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
44198950|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44198951|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198974|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44198975|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198977|NCT00391417|Estrogens|estrogens|mesh-ancestor
44198978|NCT00391417|Hormones|hormones|mesh-ancestor
44198979|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44198980|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44198981|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
44198982|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
44198983|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44198984|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44198985|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44198986|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44198987|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44455748|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44198997|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44198998|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44198999|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199000|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199001|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44199002|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44199003|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
44199004|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44199005|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199006|NCT00391651|Renal Agents|renal agents|mesh-ancestor
44199060|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199061|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199063|NCT00392106|Flecainide|flecainide|mesh-list
44199064|NCT00392106|Propafenone|propafenone|mesh-list
44199065|NCT00392106|Dofetilide|dofetilide|mesh-list
44199066|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44199067|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
44199068|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44199069|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199070|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199071|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44199072|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44199073|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199119|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44199120|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199121|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199122|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44199123|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199124|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199125|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199126|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44199127|NCT00392418|Micronutrients|micronutrients|mesh-list
44199128|NCT00392418|Trace Elements|trace elements|mesh-list
44199129|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199130|NCT00392431|Amiodarone|amiodarone|mesh-list
44199131|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44199132|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
44199133|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44199134|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199135|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199136|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44199137|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43812114|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43812115|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812116|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812117|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43812118|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
43812119|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812120|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812121|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43812122|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812123|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812124|NCT04834440|Ropivacaine|ropivacaine|mesh-list
43812125|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
44199138|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199139|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199140|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44199141|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44199142|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44199143|NCT00392457|Ketoconazole|ketoconazole|mesh-list
44199144|NCT00392457|Hormones|hormones|mesh-list
44199145|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199146|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199147|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
44199148|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199149|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44199154|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
44199155|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44199156|NCT00392470|Irinotecan|irinotecan|mesh-list
44199157|NCT00392470|Cetuximab|cetuximab|mesh-list
44199158|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44199159|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44199160|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199161|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199162|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199163|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199164|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
44199165|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44199166|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
44199167|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
44199168|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199169|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199170|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44199171|NCT00392522|Analgesics|analgesics|mesh-ancestor
44199172|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
44199173|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199174|NCT00392561|Vitamin E|vitamin e|mesh-list
44199175|NCT00392561|Selenium|selenium|mesh-list
44199176|NCT00392561|Vitamins|vitamins|mesh-ancestor
44199177|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
44199178|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199179|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
44199180|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199181|NCT00392561|Protective Agents|protective agents|mesh-ancestor
44199182|NCT00392561|Trace Elements|trace elements|mesh-ancestor
44199200|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199201|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44199202|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199203|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199204|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199206|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44199207|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44199208|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
44199209|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199210|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44199211|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44199212|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199213|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
44199214|NCT00392886|Temozolomide|temozolomide|mesh-list
44199215|NCT00392886|Thiotepa|thiotepa|mesh-list
44199216|NCT00392886|Cisplatin|cisplatin|mesh-list
44199217|NCT00392886|Carboplatin|carboplatin|mesh-list
44199218|NCT00392886|Methotrexate|methotrexate|mesh-list
43800627|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
43800628|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800629|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
43800630|NCT04987450|Hormones|hormones|mesh-ancestor
43800631|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800632|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800633|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44199219|NCT00392886|Etoposide|etoposide|mesh-list
44199220|NCT00392886|Vincristine|vincristine|mesh-list
44199221|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199222|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
44199223|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199224|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199225|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44199250|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
44199251|NCT00392912|Testosterone|testosterone|mesh-list
44199252|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
44199253|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
44199254|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44199255|NCT00392912|Androgens|androgens|mesh-ancestor
44199256|NCT00392912|Hormones|hormones|mesh-ancestor
44199257|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199258|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199259|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44199260|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199261|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
44199262|NCT00392938|Docetaxel|docetaxel|mesh-list
44199263|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
44199264|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199265|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199266|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199267|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199268|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199269|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
44199270|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199271|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199272|NCT00393003|Anesthetics|anesthetics|mesh-list
44199273|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199274|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199275|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
44199276|NCT00393107|Rituximab|rituximab|mesh-list
44199277|NCT00393107|Fludarabine|fludarabine|mesh-list
44199278|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199279|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
44199280|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199289|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
43655032|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
43655033|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655034|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655035|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43655036|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
43800710|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800711|NCT04985656|Decitabine|decitabine|mesh-list
43800712|NCT04985656|Pevonedistat|pevonedistat|mesh-list
43800713|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43800714|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
43800715|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800716|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800717|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800718|NCT04985435|Adalimumab|adalimumab|mesh-list
43800719|NCT04985435|Etanercept|etanercept|mesh-list
43800720|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800721|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199293|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199294|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44199295|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44199296|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44199297|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44199298|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
44199299|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44199300|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44199301|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
44199302|NCT00393263|Clobetasol|clobetasol|mesh-list
44199303|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
44199304|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199305|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
44199306|NCT00393263|Hormones|hormones|mesh-ancestor
44199307|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199308|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199309|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44199310|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44199311|NCT00393263|Analgesics|analgesics|mesh-ancestor
44199312|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
44199313|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199314|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199315|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
44199316|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199317|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
44199318|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44199319|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199320|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199321|NCT00393289|Calcium|calcium|mesh-list
44199324|NCT00393315|Paclitaxel|paclitaxel|mesh-list
43812128|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812129|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
43812130|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812132|NCT04834752|Omeprazole|omeprazole|mesh-list
43812133|NCT04834752|Rabeprazole|rabeprazole|mesh-list
43812134|NCT04834752|Pantoprazole|pantoprazole|mesh-list
43842307|NCT04539808|Folic Acid|folic acid|mesh-list
43842308|NCT04539808|Fluorouracil|fluorouracil|mesh-list
43842309|NCT04539808|Capecitabine|capecitabine|mesh-list
43842310|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
43842311|NCT04539808|Irinotecan|irinotecan|mesh-list
43842312|NCT04539808|Camptothecin|camptothecin|mesh-list
43842313|NCT04539808|Losartan|losartan|mesh-list
43842314|NCT04539808|Calcium|calcium|mesh-list
43842315|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
43842316|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842317|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842318|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43842319|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
43842320|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842322|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199338|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199339|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44199340|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44199341|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
44199342|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199343|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44199344|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199345|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
44199346|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199347|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44199348|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199349|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199350|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199351|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
44199352|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
44199353|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199354|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44199355|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44199356|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
44199357|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44199358|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44199359|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44199360|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44199362|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
44199363|NCT00393393|Protective Agents|protective agents|mesh-ancestor
44199364|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199365|NCT00393445|Glucagon|glucagon|mesh-list
44199366|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44199367|NCT00393445|Incretins|incretins|mesh-ancestor
44199368|NCT00393445|Hormones|hormones|mesh-ancestor
44199369|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199370|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199371|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44199372|NCT00393471|Etanercept|etanercept|mesh-list
44199373|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44199374|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44199375|NCT00393471|Analgesics|analgesics|mesh-ancestor
44199376|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
44199377|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199378|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199379|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199380|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44199381|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44199382|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199383|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
44199384|NCT00393497|Bevacizumab|bevacizumab|mesh-list
44199385|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199386|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199387|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44199388|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199389|NCT00393497|Growth Substances|growth substances|mesh-ancestor
44199390|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199391|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
44199392|NCT00393562|Methylphenidate|methylphenidate|mesh-list
44199393|NCT00393562|Modafinil|modafinil|mesh-list
43812135|NCT04834752|Lansoprazole|lansoprazole|mesh-list
44199394|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44199395|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199396|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44199397|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44199398|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199399|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455799|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44455800|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44455801|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44455802|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455803|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44455804|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44455805|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
44455806|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455807|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455808|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44455809|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
44199408|NCT00393679|Artesunate|artesunate|mesh-list
44199409|NCT00393679|Lumefantrine|lumefantrine|mesh-list
44199410|NCT00393679|Artemether|artemether|mesh-list
44199411|NCT00393679|Piperaquine|piperaquine|mesh-list
44199412|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44199413|NCT00393679|Amodiaquine|amodiaquine|mesh-list
44199414|NCT00393679|Artenimol|artenimol|mesh-list
44199415|NCT00393679|Dapsone|dapsone|mesh-list
44199416|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
44199417|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
44199418|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44199419|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44199420|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199421|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199422|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
44199423|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
44199424|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44199425|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
44199426|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44199427|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812146|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44199428|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199429|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
44199440|NCT00393744|Amoxicillin|amoxicillin|mesh-list
44199441|NCT00393744|Pristinamycin|pristinamycin|mesh-list
44199442|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199443|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199444|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
44199445|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
44199446|NCT00393770|Vitamins|vitamins|mesh-ancestor
44199447|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
44199448|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199449|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
44199450|NCT00393835|Azithromycin|azithromycin|mesh-list
44199451|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199452|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199453|NCT00394056|Paroxetine|paroxetine|mesh-list
44199454|NCT00394056|Vestipitant|vestipitant|mesh-list
44199455|NCT00394056|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44199456|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44199457|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199458|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199459|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199460|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
44199461|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199462|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44199463|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
44199464|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199465|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44199466|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44199467|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199468|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44199469|NCT00394186|Solabegron|solabegron|mesh-list
44199470|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44199471|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44199472|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44199482|NCT00394368|Beclomethasone|beclomethasone|mesh-list
44199483|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
44199484|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44199485|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199486|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44199487|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
44199488|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199489|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199490|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44199491|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
44199492|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
44199493|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44199494|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44199495|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44199496|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44199497|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199498|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199499|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199500|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
44199501|NCT00394368|Hormones|hormones|mesh-ancestor
43844457|NCT04380545|Nivolumab|nivolumab|mesh-list
44199502|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44199503|NCT00394394|Enalapril|enalapril|mesh-list
44199504|NCT00394394|Amiloride|amiloride|mesh-list
44199505|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44199506|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
44199507|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199508|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199509|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44199510|NCT00394394|Diuretics|diuretics|mesh-ancestor
44199511|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
44199512|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199524|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199525|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
44199526|NCT00394485|Procaterol|procaterol|mesh-list
44199527|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44199528|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
44199529|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199530|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199531|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44199532|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
44199533|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
44199534|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44199535|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
44199536|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199537|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199538|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
44199539|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44199540|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44199541|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44199542|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199543|NCT00394498|Lenograstim|lenograstim|mesh-list
44199544|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44199545|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
44199546|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199547|NCT00394537|Labetalol|labetalol|mesh-list
44199548|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44199555|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
44199572|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44199573|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44199574|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199575|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44199576|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199577|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44199578|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44199579|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44199580|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199582|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44199583|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199584|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199585|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199586|NCT00394992|Bevacizumab|bevacizumab|mesh-list
44199587|NCT00394992|Capecitabine|capecitabine|mesh-list
44199588|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
44199589|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199590|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199591|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44199592|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199593|NCT00394992|Growth Substances|growth substances|mesh-ancestor
44199594|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199595|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
43844458|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
44199596|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44199597|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
44199598|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199599|NCT00395031|Ziprasidone|ziprasidone|mesh-list
44199600|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44199601|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
44199602|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199613|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44199614|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
44199615|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199616|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199618|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
44199619|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
44199620|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199621|NCT00395213|Norepinephrine|norepinephrine|mesh-list
44199622|NCT00395213|Serotonin|serotonin|mesh-list
44199623|NCT00395213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
44199624|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44199625|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44199626|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
44199627|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199628|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199629|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199630|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
44199631|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
44199632|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44199633|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44199634|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44199635|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
44199636|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44199637|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199647|NCT00395239|Hormones|hormones|mesh-ancestor
44199661|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199662|NCT00395369|Aprotinin|aprotinin|mesh-list
44199663|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
44199664|NCT00395369|Coagulants|coagulants|mesh-ancestor
44199665|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44199666|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44199667|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
44199668|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199669|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199670|NCT00395382|Alendronate|alendronate|mesh-list
44199671|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44199672|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199673|NCT00395395|Calcitonin|calcitonin|mesh-list
44199674|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
44199675|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44199676|NCT00395395|Katacalcin|katacalcin|mesh-list
44199677|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44199678|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199679|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44199680|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
44199681|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44199682|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
44199683|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199684|NCT00395434|Bevacizumab|bevacizumab|mesh-list
44199685|NCT00395434|Combretastatin|combretastatin|mesh-list
44199686|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
44199687|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44199688|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199689|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44199690|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199691|NCT00395434|Growth Substances|growth substances|mesh-ancestor
44199692|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199693|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
44199694|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44199702|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199703|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199704|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199705|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44199706|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199707|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199708|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199709|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44199710|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
44199711|NCT00395551|Ranibizumab|ranibizumab|mesh-list
44199712|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44199713|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44199766|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199767|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44199768|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
44199769|NCT00395772|Coagulants|coagulants|mesh-ancestor
44199770|NCT00395902|Cinacalcet|cinacalcet|mesh-list
44199771|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44199772|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199773|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44199774|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
44199775|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812218|NCT04833777|Lidocaine|lidocaine|mesh-list
44455810|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455811|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
44455812|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44455813|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
44455814|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455815|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455816|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44455817|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
44455819|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44199810|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199811|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44199812|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44199813|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44199814|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199815|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
44199816|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44199817|NCT00396071|Vildagliptin|vildagliptin|mesh-list
44199818|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199819|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199820|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44199821|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
44199822|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199823|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199824|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44199825|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
44199826|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44199827|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44199828|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44199829|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44199830|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199831|NCT00396227|Pioglitazone|pioglitazone|mesh-list
44199832|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
44199833|NCT00396227|Vildagliptin|vildagliptin|mesh-list
44199834|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
44199835|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199836|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199837|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44199838|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
44199839|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199840|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199850|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44199852|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44199853|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44199854|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
44199855|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44199856|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
44199857|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199858|NCT00396396|Expectorants|expectorants|mesh-ancestor
44199859|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
44199860|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44199861|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
44199862|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199863|NCT00396396|Protective Agents|protective agents|mesh-ancestor
44199864|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199865|NCT00396396|Antidotes|antidotes|mesh-ancestor
44199866|NCT00396487|Fluorouracil|fluorouracil|mesh-list
44199867|NCT00396487|Capecitabine|capecitabine|mesh-list
44199868|NCT00396487|Irinotecan|irinotecan|mesh-list
44199869|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
44199870|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199879|NCT00396500|Vitamin A|vitamin a|mesh-list
44199905|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199907|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44199908|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199909|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199910|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44199911|NCT00396526|Renal Agents|renal agents|mesh-ancestor
44199912|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
44199913|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44199914|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44199915|NCT00396578|Vancomycin|vancomycin|mesh-list
44199916|NCT00396578|Gentamicins|gentamicins|mesh-list
44199917|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44199918|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44199919|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44199920|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199921|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199922|NCT00396604|Maleic acid|maleic acid|mesh-list
44199923|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199924|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199925|NCT00396669|Bupropion|bupropion|mesh-list
44199955|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44199956|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
44199957|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44199958|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
44199959|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199960|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44199961|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44199962|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
44199963|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199964|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44199965|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44199966|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
44199967|NCT00396734|Topiramate|topiramate|mesh-list
44199968|NCT00396734|Modafinil|modafinil|mesh-list
44199969|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
44199970|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44199971|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44199972|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44199973|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44199974|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44199975|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44199976|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44199977|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
44199978|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44199979|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44199980|NCT00396747|Prednisolone|prednisolone|mesh-list
44200004|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200005|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44200006|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
44200008|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200009|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44200010|NCT00396747|Protective Agents|protective agents|mesh-ancestor
44200011|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200012|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
44200013|NCT00396760|Aprotinin|aprotinin|mesh-list
44200014|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44200015|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200016|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200017|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
44200018|NCT00396760|Coagulants|coagulants|mesh-ancestor
44200019|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44200020|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44200021|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
44200022|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200023|NCT00396786|Enoxaparin|enoxaparin|mesh-list
44200024|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
44200025|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44200026|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
44200027|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44200028|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
44200029|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200030|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200035|NCT00396799|Estrogens|estrogens|mesh-list
44200053|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200054|NCT00396968|Plerixafor|plerixafor|mesh-list
44200055|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44200056|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44200057|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
44200058|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200059|NCT00397059|Citalopram|citalopram|mesh-list
44200060|NCT00397059|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44200061|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44200062|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44200063|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200064|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200065|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
44200066|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200067|NCT00397059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44200068|NCT00397059|Antidepressive Agents|antidepressive agents|mesh-ancestor
44200069|NCT00397059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200070|NCT00397072|Sagopilone|sagopilone|mesh-list
44200071|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200072|NCT00397098|Amibegron|amibegron|mesh-list
44200073|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44200074|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44200075|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
44200076|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200077|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200078|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200088|NCT00397241|Timolol|timolol|mesh-list
44200097|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200098|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44200099|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44200100|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44200101|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44200102|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44200103|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200104|NCT00397319|Hormones|hormones|mesh-list
44200105|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200106|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200107|NCT00397332|Alefacept|alefacept|mesh-list
44200108|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
44200109|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
44200110|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200111|NCT00397358|Icodextrin|icodextrin|mesh-list
44200112|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
44200156|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200158|NCT00397501|Protective Agents|protective agents|mesh-ancestor
44200159|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
44200160|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
44200161|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200162|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200163|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
44200164|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
44200165|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
44200166|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200167|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200168|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
44200169|NCT00397566|BMS-707035|bms-707035|mesh-list
44200170|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
44200171|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200172|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200173|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44200174|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44200175|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
44200176|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200177|NCT00397592|Hormones|hormones|mesh-list
44200178|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200179|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200180|NCT00397657|Niacin|niacin|mesh-list
44200207|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44200208|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44200209|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44200210|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
44200211|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44200212|NCT00397722|Paroxetine|paroxetine|mesh-list
44200213|NCT00397722|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44200214|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44200215|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44200216|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200217|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200218|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
44200219|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200220|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44200221|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
44200222|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200223|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44200224|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44200225|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200226|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
44200227|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44200228|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
44200229|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200230|NCT00397735|Expectorants|expectorants|mesh-ancestor
44200231|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
44200255|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
44200256|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200257|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200258|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200259|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
44200260|NCT00397800|Rituximab|rituximab|mesh-list
44200261|NCT00397800|Fludarabine|fludarabine|mesh-list
44200262|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
44200263|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200264|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
44200265|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200266|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200267|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44200268|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
44200269|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200270|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200271|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44200272|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200273|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200274|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
44200275|NCT00397826|Simvastatin|simvastatin|mesh-list
44200276|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44200277|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44200278|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
43812318|NCT04832776|Bevacizumab|bevacizumab|mesh-list
43812319|NCT04832776|Cetuximab|cetuximab|mesh-list
43844479|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
43844480|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844481|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844482|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43844483|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43844484|NCT04377087|Olaparib|olaparib|mesh-list
44200279|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200280|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44200282|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200292|NCT00398008|Naltrexone|naltrexone|mesh-list
44200293|NCT00398008|Buprenorphine|buprenorphine|mesh-list
44200294|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44200295|NCT00398008|Narcotics|narcotics|mesh-ancestor
44200296|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200297|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200298|NCT00398008|Analgesics|analgesics|mesh-ancestor
44200299|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
44200300|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200301|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44200302|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44200303|NCT00398034|Testosterone|testosterone|mesh-list
44200304|NCT00398034|Androgens|androgens|mesh-ancestor
44200305|NCT00398034|Hormones|hormones|mesh-ancestor
44200306|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200307|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200308|NCT00398099|Ertapenem|ertapenem|mesh-list
44200309|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200310|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200311|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44200312|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44200313|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200314|NCT00398281|Dutasteride|dutasteride|mesh-list
44200315|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44200316|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44200317|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200318|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200319|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200320|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200321|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200336|NCT00398385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200337|NCT00398385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200338|NCT00398385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200339|NCT00398385|Immunologic Factors|immunologic factors|mesh-ancestor
44200340|NCT00398385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200342|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200343|NCT00398437|Trastuzumab|trastuzumab|mesh-list
44200344|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200345|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812344|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812345|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812346|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43812347|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43812348|NCT04831528|Growth Substances|growth substances|mesh-ancestor
43812349|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812350|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
43812351|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812352|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812389|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200346|NCT00398450|Interferons|interferons|mesh-list
44200347|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
44200348|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
44200349|NCT00398450|Azacitidine|azacitidine|mesh-list
44200350|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200351|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
44200352|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200353|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200354|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
44200355|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200356|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200357|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
44200358|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200359|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
44200360|NCT00398463|Tirofiban|tirofiban|mesh-list
44200361|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44200362|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200363|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200370|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
44200386|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44200387|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
44200388|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200389|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200390|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44200391|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200392|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200393|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200394|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44200395|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44200396|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44200397|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44200398|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200399|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44200400|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
44200401|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200402|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200403|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44200404|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43812416|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43812417|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43812419|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43812420|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43812421|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812422|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655043|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
43655044|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655045|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655046|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
43655047|NCT02971982|Hormones|hormones|mesh-ancestor
43655048|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655049|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43655050|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655051|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655052|NCT02972125|Lacosamide|lacosamide|mesh-list
44200405|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44200406|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44200407|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44200408|NCT00398515|Sirolimus|sirolimus|mesh-list
44200409|NCT00398515|Lenalidomide|lenalidomide|mesh-list
44200410|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
44200414|NCT00398515|Growth Substances|growth substances|mesh-ancestor
44200430|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
44200431|NCT00398554|Doxorubicin|doxorubicin|mesh-list
44200432|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44200433|NCT00398554|Etoposide|etoposide|mesh-list
44200434|NCT00398554|Vincristine|vincristine|mesh-list
44200435|NCT00398554|Vinblastine|vinblastine|mesh-list
44200436|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200437|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
43855603|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
44200438|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200439|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200440|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44200441|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
44200442|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200443|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200444|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44200445|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44200446|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44200447|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44200448|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200449|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44200450|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
44200451|NCT00398554|Hormones|hormones|mesh-ancestor
44200452|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200453|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200465|NCT00398580|Hormones|hormones|mesh-ancestor
44200480|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44200481|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200482|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44200483|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200484|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200485|NCT00398684|Nevirapine|nevirapine|mesh-list
44200486|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44200487|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200488|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200489|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200490|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
44200491|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200492|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44200493|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44200494|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44200495|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44200496|NCT00398697|Gemcitabine|gemcitabine|mesh-list
44200498|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
44200533|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44200534|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44200535|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
44200536|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200537|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200539|NCT00398853|Picolinic acid|picolinic acid|mesh-list
44200540|NCT00398853|Trace Elements|trace elements|mesh-ancestor
44200541|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
44200542|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200543|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44200544|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
44200545|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
44200546|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200547|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
44200548|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
44200549|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200553|NCT00398892|Vitamins|vitamins|mesh-ancestor
43812428|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
44200592|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44200594|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200595|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200596|NCT00399048|Analgesics|analgesics|mesh-ancestor
44200597|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
44200598|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200599|NCT00399061|Cyclosporine|cyclosporine|mesh-list
44200600|NCT00399061|Cyclosporins|cyclosporins|mesh-list
44200601|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200602|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200603|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200604|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
44200605|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200606|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
44200607|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200608|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
44200609|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200610|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44200611|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
44200612|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
44200613|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44200614|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
44200615|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44200616|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44200617|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200618|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44200619|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200620|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200621|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44200622|NCT00399074|Renal Agents|renal agents|mesh-ancestor
44200623|NCT00399087|Prednisone|prednisone|mesh-list
44200624|NCT00399087|Docetaxel|docetaxel|mesh-list
44200625|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200626|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200633|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200634|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200635|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44200636|NCT00399126|Paclitaxel|paclitaxel|mesh-list
44200637|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44200638|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200639|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
44200640|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
44200641|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
44200642|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200643|NCT00399152|Sunitinib|sunitinib|mesh-list
44200644|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200645|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44200646|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44200647|NCT00399152|Growth Substances|growth substances|mesh-ancestor
44200648|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200649|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
44200650|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200651|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200653|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
43812432|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812433|NCT04829695|Artesunate|artesunate|mesh-list
43812434|NCT04829695|Lumefantrine|lumefantrine|mesh-list
43812435|NCT04829695|Artemether|artemether|mesh-list
43812436|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43812437|NCT04829695|Amodiaquine|amodiaquine|mesh-list
43812438|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
43801315|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43801316|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801317|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
44200684|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44200685|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
44200686|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200687|NCT00399256|Expectorants|expectorants|mesh-ancestor
44200688|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
44200689|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44200690|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
44200691|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200692|NCT00399256|Protective Agents|protective agents|mesh-ancestor
44200693|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200694|NCT00399256|Antidotes|antidotes|mesh-ancestor
44200695|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
44200696|NCT00399269|Hematinics|hematinics|mesh-ancestor
44200697|NCT00399282|Vitamin E|vitamin e|mesh-list
44200698|NCT00399282|Vitamins|vitamins|mesh-ancestor
44200699|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
44200700|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200701|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
44200702|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200703|NCT00399282|Protective Agents|protective agents|mesh-ancestor
44200704|NCT00399295|Naltrexone|naltrexone|mesh-list
44200705|NCT00399295|Hydromorphone|hydromorphone|mesh-list
44200706|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
44200707|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44200708|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200709|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
44200710|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200711|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44200712|NCT00399295|Narcotics|narcotics|mesh-ancestor
44200714|NCT00399295|Analgesics|analgesics|mesh-ancestor
44200732|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200733|NCT00399425|Heparin|heparin|mesh-list
44200734|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44200735|NCT00399425|Tinzaparin|tinzaparin|mesh-list
43812453|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
43812454|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812455|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43812456|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43812463|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812464|NCT04829097|Temozolomide|temozolomide|mesh-list
43812465|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43812466|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
43812467|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200736|NCT00399425|Dalteparin|dalteparin|mesh-list
44200737|NCT00399425|Bemiparin|bemiparin|mesh-list
44200738|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
44200739|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44200740|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44200741|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200742|NCT00399451|Polidocanol|polidocanol|mesh-list
44200743|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
44200744|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44200745|NCT00399464|Alfuzosin|alfuzosin|mesh-list
44200746|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44200747|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44200748|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44200749|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
44200750|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200751|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200752|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200753|NCT00399464|Urological Agents|urological agents|mesh-ancestor
44200754|NCT00399477|Levodopa|levodopa|mesh-list
44200755|NCT00399477|Pramipexole|pramipexole|mesh-list
44200756|NCT00399477|Rasagiline|rasagiline|mesh-list
44200757|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44200758|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44200759|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
44200760|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200761|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200762|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200763|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44200764|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200765|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44200766|NCT00399477|Protective Agents|protective agents|mesh-ancestor
44200767|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
44200768|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
44200769|NCT00399633|Sumatriptan|sumatriptan|mesh-list
44200771|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44200772|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44200773|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
44200774|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200775|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200776|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200778|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44200779|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
44200780|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200781|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200782|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200783|NCT00399672|Interferons|interferons|mesh-list
44200784|NCT00399672|Ribavirin|ribavirin|mesh-list
44200785|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200786|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
44200787|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200788|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
44200789|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200790|NCT00399685|Efavirenz|efavirenz|mesh-list
44200791|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
44200792|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44200793|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44200794|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44200795|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200796|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200797|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
44200798|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200799|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44200800|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44200801|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44200802|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44200809|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44200810|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
44200811|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44200812|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200813|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44200814|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44200815|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44200816|NCT00399698|Risperidone|risperidone|mesh-list
44200817|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44200818|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
44200819|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200820|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200821|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200822|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44200823|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44200824|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200825|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200826|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44200827|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
44200828|NCT00399711|Metformin|metformin|mesh-list
44200829|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
44200830|NCT00399711|Repaglinide|repaglinide|mesh-list
44200831|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200832|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200833|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
44200834|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200837|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
44455841|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455842|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
44455843|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455844|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44455845|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44455846|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
44455847|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801352|NCT05268744|Micronutrients|micronutrients|mesh-list
44455848|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455849|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44455850|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44455851|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
44455852|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44455853|NCT01640301|Analgesics|analgesics|mesh-ancestor
44455854|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
44455855|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44455856|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44455857|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44455858|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
44455859|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455860|NCT01640184|Vitamin D|vitamin d|mesh-list
44455861|NCT01640184|Vitamins|vitamins|mesh-ancestor
44455862|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
44455863|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455864|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44455865|NCT01639833|Hemostatics|hemostatics|mesh-list
44455866|NCT01639833|Coagulants|coagulants|mesh-ancestor
44455867|NCT01639729|Sufentanil|sufentanil|mesh-list
44200860|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
44200861|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200862|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
44200863|NCT00400075|Azathioprine|azathioprine|mesh-list
44200864|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44200865|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
44200866|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200867|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200868|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44200869|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
44200870|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200871|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44200872|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44200873|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
44200874|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44200875|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
44200876|NCT00400088|Paroxetine|paroxetine|mesh-list
44200877|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
44200878|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44200879|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44200880|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200881|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
44200882|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44200883|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44200884|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200885|NCT00400088|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44200886|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44200887|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44200888|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44200893|NCT00400114|Cisplatin|cisplatin|mesh-list
44200903|NCT00400114|Growth Substances|growth substances|mesh-ancestor
44200904|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200905|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
44200906|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44200908|NCT00400231|Fenofibrate|fenofibrate|mesh-list
44200909|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44200910|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200911|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44200912|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
44200913|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44200914|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44200915|NCT00400322|Valganciclovir|valganciclovir|mesh-list
44200916|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
44200917|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44200918|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
44200919|NCT00400335|Testosterone|testosterone|mesh-list
44200920|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
44200921|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
44200922|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43856051|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
44200923|NCT00400335|Dutasteride|dutasteride|mesh-list
44200924|NCT00400335|Androgens|androgens|mesh-ancestor
44200925|NCT00400335|Hormones|hormones|mesh-ancestor
44200926|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44200927|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200952|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44200953|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44200954|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44200955|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44200956|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44200957|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44200958|NCT00400387|Riboflavin|riboflavin|mesh-list
44200959|NCT00400387|Thiamine|thiamine|mesh-list
44200960|NCT00400387|Pyridoxine|pyridoxine|mesh-list
44200961|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
44200962|NCT00400387|Folic Acid|folic acid|mesh-list
44200963|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
44200964|NCT00400387|Tocopherols|tocopherols|mesh-list
44200965|NCT00400387|Vitamin E|vitamin e|mesh-list
44200966|NCT00400387|Tocotrienols|tocotrienols|mesh-list
44200967|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
44200968|NCT00400387|Heparin|heparin|mesh-list
44200969|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44200970|NCT00400387|Tinzaparin|tinzaparin|mesh-list
44200971|NCT00400387|Dalteparin|dalteparin|mesh-list
44200977|NCT00400387|Vitamins|vitamins|mesh-ancestor
44201013|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44201014|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201015|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201016|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44201017|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44201018|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
44201019|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201020|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201021|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201022|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201023|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
44201024|NCT00400608|Hormones|hormones|mesh-ancestor
44201025|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201026|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
44201027|NCT00400621|Acetaminophen|acetaminophen|mesh-list
44201028|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201029|NCT00400621|Analgesics|analgesics|mesh-ancestor
44201030|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
44201031|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201032|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201033|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
44201034|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
44201065|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44201066|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44201067|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44201068|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201069|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201070|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44201071|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201072|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
44201073|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44201074|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44201076|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
43655058|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
44201077|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44201078|NCT00400790|Propofol|propofol|mesh-list
44201079|NCT00400790|Desflurane|desflurane|mesh-list
44201080|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44201081|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201082|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201083|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44201084|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
44201085|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
44201086|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44201087|NCT00400816|Temozolomide|temozolomide|mesh-list
44201088|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44201089|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
44201090|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201092|NCT00400855|Fluticasone|fluticasone|mesh-list
44201113|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44201114|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
44201115|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201116|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44201117|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201118|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201119|NCT00401115|Sirolimus|sirolimus|mesh-list
44201120|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201121|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201122|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201123|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201124|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
44201125|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201126|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
44201127|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201128|NCT00401128|Gemcitabine|gemcitabine|mesh-list
44201129|NCT00401128|Irinotecan|irinotecan|mesh-list
44201130|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201131|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
43812578|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201132|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201133|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201134|NCT00401128|Antiviral Agents|antiviral agents|mesh-ancestor
44201135|NCT00401128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201136|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201137|NCT00401128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201160|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
44201161|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44201162|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201163|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201164|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201165|NCT00401206|Analgesics|analgesics|mesh-ancestor
44201166|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
44201167|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201168|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44201169|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44201170|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44201171|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201172|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201173|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201174|NCT00401219|Estrogens|estrogens|mesh-list
44201175|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44201176|NCT00401219|Progestins|progestins|mesh-list
44201177|NCT00401219|Hormones|hormones|mesh-ancestor
44201178|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201179|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201180|NCT00401323|Cisplatin|cisplatin|mesh-list
44201181|NCT00401323|Docetaxel|docetaxel|mesh-list
44201182|NCT00401323|Fluorouracil|fluorouracil|mesh-list
44201183|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201184|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201185|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201186|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201187|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201188|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
44201189|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201190|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201191|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
44201192|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201202|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44201203|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201204|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44201205|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201206|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201207|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201208|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201209|NCT00401440|Misoprostol|misoprostol|mesh-list
44201210|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44201211|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
44201212|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44201213|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201214|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44201215|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201216|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
44201217|NCT00401479|Solabegron|solabegron|mesh-list
44201218|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44201219|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44201220|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44201221|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201222|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201223|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201224|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201225|NCT00401492|Gemcitabine|gemcitabine|mesh-list
44201226|NCT00401492|Cisplatin|cisplatin|mesh-list
44201227|NCT00401492|Vinorelbine|vinorelbine|mesh-list
44201228|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201229|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201230|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
44201231|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201232|NCT00401492|Antiviral Agents|antiviral agents|mesh-ancestor
43604597|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
44201241|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455880|NCT01639560|Varenicline|varenicline|mesh-list
44455881|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44455882|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44455883|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
44455884|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44455885|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455886|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455887|NCT01639339|Belimumab|belimumab|mesh-list
44455888|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812813|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844572|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844574|NCT04361162|Nivolumab|nivolumab|mesh-list
44455889|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
44455890|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455891|NCT01639131|Gemcitabine|gemcitabine|mesh-list
44455892|NCT01639131|Docetaxel|docetaxel|mesh-list
44455893|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44455894|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
44455895|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455896|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44455897|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
44455898|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455899|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455900|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455901|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
44455902|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455903|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
44455904|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
44455905|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
44455928|NCT01638429|Neomycin|neomycin|mesh-list
44455929|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44455930|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44455931|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455932|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44455933|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455934|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455935|NCT01638013|Peficitinib|peficitinib|mesh-list
44455936|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455937|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44455938|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44455939|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
43856382|NCT03455829|Osimertinib|osimertinib|mesh-list
44201243|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44201244|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44201245|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201246|NCT00401609|Gemcitabine|gemcitabine|mesh-list
44201247|NCT00401609|Cisplatin|cisplatin|mesh-list
44201248|NCT00401609|Carboplatin|carboplatin|mesh-list
44201249|NCT00401609|Etoposide|etoposide|mesh-list
44201250|NCT00401609|Vinorelbine|vinorelbine|mesh-list
44201251|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201252|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201284|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201285|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201286|NCT00401661|Urological Agents|urological agents|mesh-ancestor
44201287|NCT00401674|Paclitaxel|paclitaxel|mesh-list
44201288|NCT00401674|Carboplatin|carboplatin|mesh-list
44201289|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44201290|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201291|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201292|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201293|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201294|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201295|NCT00401765|Docetaxel|docetaxel|mesh-list
44201296|NCT00401765|Siltuximab|siltuximab|mesh-list
44201297|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201298|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
44201299|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
44201300|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
44201301|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201302|NCT00401804|Dexamethasone|dexamethasone|mesh-list
44201303|NCT00401804|Doxorubicin|doxorubicin|mesh-list
44201304|NCT00401804|Bortezomib|bortezomib|mesh-list
44201337|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201339|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44201340|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201341|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
44201342|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201343|NCT00402077|Pramlintide|pramlintide|mesh-list
44201344|NCT00402077|Phentermine|phentermine|mesh-list
44201345|NCT00402077|Sibutramine|sibutramine|mesh-list
44201346|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44201347|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201348|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44201349|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
44201350|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44201351|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
44201352|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
44201353|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201354|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201355|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201356|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201357|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
44201358|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44201359|NCT00402142|Vaccines|vaccines|mesh-list
44201360|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
44201361|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201362|NCT00402181|Dexamethasone|dexamethasone|mesh-list
44201363|NCT00402181|Siltuximab|siltuximab|mesh-list
44201364|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201365|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
44201384|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201385|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44201386|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
44201387|NCT00402207|Hormones|hormones|mesh-ancestor
44201388|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201389|NCT00402259|Esomeprazole|esomeprazole|mesh-list
44201390|NCT00402259|Omeprazole|omeprazole|mesh-list
44201391|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44201392|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201393|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44201394|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201395|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201396|NCT00402272|Everolimus|everolimus|mesh-list
44201397|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201398|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201399|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
44201400|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201401|NCT00402350|Fentanyl|fentanyl|mesh-list
44201402|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44201403|NCT00402350|Narcotics|narcotics|mesh-ancestor
44201404|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201405|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201406|NCT00402350|Analgesics|analgesics|mesh-ancestor
44201407|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
44201408|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201409|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44201410|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44201411|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
44201412|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
44201413|NCT00402376|Carvedilol|carvedilol|mesh-list
44201414|NCT00402376|Perindopril|perindopril|mesh-list
44201415|NCT00402376|Pravastatin|pravastatin|mesh-list
44201416|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44201417|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44201418|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201419|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201425|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44201426|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201427|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44201428|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
44201429|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44201430|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44201431|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44201432|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44201434|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44201435|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44201436|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201437|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44201438|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
44201481|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44201482|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
44201483|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44201484|NCT00402467|Enoxaparin|enoxaparin|mesh-list
44201485|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
44201486|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
44201487|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44201488|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
44201489|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44201490|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44201491|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201492|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201493|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
44201494|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44201495|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44201496|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
44201497|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201498|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
44201499|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201500|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201501|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44201502|NCT00402493|Ibuprofen|ibuprofen|mesh-list
44201503|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44201504|NCT00402493|Latanoprost|latanoprost|mesh-list
44201505|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44201506|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201507|NCT00402493|Analgesics|analgesics|mesh-ancestor
44201508|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
44201509|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201510|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201511|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201512|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201513|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44201514|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201515|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201522|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
44201523|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201524|NCT00402506|Pyridoxal|pyridoxal|mesh-list
44201525|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44201526|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
44201527|NCT00402506|Vitamins|vitamins|mesh-ancestor
44201528|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
44201529|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201530|NCT00402532|Everolimus|everolimus|mesh-list
44201531|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201532|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201533|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
44201534|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201535|NCT00402545|Cisplatin|cisplatin|mesh-list
44201587|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201588|NCT00402571|Analgesics|analgesics|mesh-ancestor
44201589|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
44201590|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201591|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201592|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
44201593|NCT00402584|Sibutramine|sibutramine|mesh-list
44201594|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
44201595|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44201596|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
44201597|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44201598|NCT00402610|Rifampin|rifampin|mesh-list
44201599|NCT00402610|Isoniazid|isoniazid|mesh-list
44201600|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
44201601|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44201602|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
44201603|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201604|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201605|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
44201606|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44201607|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201608|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201609|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44201610|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44201639|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44201640|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201641|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201643|NCT00402766|Cisplatin|cisplatin|mesh-list
44201644|NCT00402766|Pemetrexed|pemetrexed|mesh-list
44201645|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
44201646|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201647|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
44201648|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
44201649|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201650|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201651|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201652|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
44201653|NCT00402766|Hormones|hormones|mesh-ancestor
44201654|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201655|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44201656|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201657|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201658|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201659|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44201660|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44201661|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44201662|NCT00402792|Acetaminophen|acetaminophen|mesh-list
44201663|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
44201664|NCT00402792|Hydrocodone|hydrocodone|mesh-list
44201665|NCT00402792|Oxycodone|oxycodone|mesh-list
44201666|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201667|NCT00402792|Analgesics|analgesics|mesh-ancestor
44201668|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
44201669|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201670|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201671|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
44201672|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44201673|NCT00402792|Narcotics|narcotics|mesh-ancestor
44201674|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201677|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44201678|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44201679|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44201680|NCT00402909|Nateglinide|nateglinide|mesh-list
44201681|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44201682|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201683|NCT00403000|Dutasteride|dutasteride|mesh-list
44201684|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44201685|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44201686|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201687|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201688|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
44201689|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201690|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201691|NCT00403013|Anesthetics|anesthetics|mesh-list
44201692|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44201694|NCT00403026|Bevacizumab|bevacizumab|mesh-list
44201733|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44201734|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201735|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201736|NCT00403182|Letrozole|letrozole|mesh-list
44201737|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201738|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44201739|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44201740|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201741|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201742|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44201743|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
44201744|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44201745|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201746|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
44201747|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
44201748|NCT00403247|Pyridoxine|pyridoxine|mesh-list
44201749|NCT00403247|Vitamins|vitamins|mesh-ancestor
44201750|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
44201751|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201752|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
44201753|NCT00403247|Hematinics|hematinics|mesh-ancestor
44201754|NCT00403286|Fluticasone|fluticasone|mesh-list
44201755|NCT00403286|Xhance|xhance|mesh-list
44201756|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
44201784|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201785|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201786|NCT00403325|Growth Substances|growth substances|mesh-ancestor
44201787|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201788|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201789|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201790|NCT00403338|Sirolimus|sirolimus|mesh-list
44201791|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201792|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201793|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44201794|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201795|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
44201796|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44201797|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
44201798|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201799|NCT00403364|Amoxicillin|amoxicillin|mesh-list
44201800|NCT00403364|Clarithromycin|clarithromycin|mesh-list
44201801|NCT00403364|Tinidazole|tinidazole|mesh-list
44201802|NCT00403364|Pantoprazole|pantoprazole|mesh-list
44201803|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44201804|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44201805|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44201806|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201807|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201808|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43844647|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201809|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44201810|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44201811|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44201812|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44201813|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
44201814|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44201815|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44201816|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44201817|NCT00403429|Capecitabine|capecitabine|mesh-list
43844648|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43844649|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43844650|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813092|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43655081|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
43655082|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813093|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813094|NCT04819217|Charcoal|charcoal|mesh-list
43813095|NCT04819217|Antidotes|antidotes|mesh-ancestor
43813096|NCT04819217|Protective Agents|protective agents|mesh-ancestor
44201818|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44201824|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44201825|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44201826|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44201827|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44201828|NCT00403442|Growth Substances|growth substances|mesh-ancestor
44201829|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201830|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
44201831|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44201832|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
44201834|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44201835|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44201836|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
44201837|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201838|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44201839|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44201840|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44455940|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455941|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
44455942|NCT01638000|Mirabegron|mirabegron|mesh-list
44455943|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44201841|NCT00403611|Praziquantel|praziquantel|mesh-list
44201874|NCT00403663|Narcotics|narcotics|mesh-ancestor
44201875|NCT00403663|Analgesics|analgesics|mesh-ancestor
44201876|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44201877|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44201878|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
44201879|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44201880|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44201881|NCT00403728|Cyclosporine|cyclosporine|mesh-list
44201882|NCT00403728|Cyclosporins|cyclosporins|mesh-list
44201883|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44201884|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201938|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201939|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44201940|NCT00403910|Diuretics|diuretics|mesh-ancestor
44201941|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
44201942|NCT00403962|Paroxetine|paroxetine|mesh-list
44201943|NCT00403962|Vestipitant|vestipitant|mesh-list
44201944|NCT00403962|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43813097|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813098|NCT04819243|Atezolizumab|atezolizumab|mesh-list
43813099|NCT04819243|Talazoparib|talazoparib|mesh-list
43813100|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813101|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43813102|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813103|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813104|NCT04818723|Montelukast|montelukast|mesh-list
43813105|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813106|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
44201945|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44201946|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44201947|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44201948|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44201949|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
44201950|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201951|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44201952|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
44201953|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44201954|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44201955|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44201993|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44201994|NCT00404183|Analgesics|analgesics|mesh-ancestor
44201995|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
44201996|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44201997|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44201998|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
44201999|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44202000|NCT00404183|Narcotics|narcotics|mesh-ancestor
44202001|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202002|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
44202003|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202004|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202005|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202006|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202007|NCT00404196|Calcipotriene|calcipotriene|mesh-list
44202008|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202053|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
44202054|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202055|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202056|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202057|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44202058|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813127|NCT04817982|Dexamethasone|dexamethasone|mesh-list
44202059|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202060|NCT00404326|Hydralazine|hydralazine|mesh-list
44202061|NCT00404326|Valproic Acid|valproic acid|mesh-list
44202062|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
44202063|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202064|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202065|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
44202066|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202067|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202068|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
44202070|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202071|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202072|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44202073|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
44202074|NCT00404378|Ketoconazole|ketoconazole|mesh-list
44202075|NCT00404378|Casopitant|casopitant|mesh-list
44202076|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
44202087|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
44202104|NCT00404391|Narcotics|narcotics|mesh-ancestor
44202105|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202106|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
44202107|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202108|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202109|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202110|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202111|NCT00404404|Paclitaxel|paclitaxel|mesh-list
44202112|NCT00404404|Bevacizumab|bevacizumab|mesh-list
44202113|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44202114|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43813150|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44202115|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202116|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
44202117|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202118|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
44202119|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202120|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202121|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202122|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202123|NCT00404404|Growth Substances|growth substances|mesh-ancestor
44202124|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202125|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202155|NCT00404508|Hydralazine|hydralazine|mesh-list
43813230|NCT04816344|Anesthetics|anesthetics|mesh-list
43813232|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813234|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
43655092|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43655093|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655094|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655095|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655096|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655097|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43813235|NCT04816461|Amodiaquine|amodiaquine|mesh-list
43813319|NCT04815187|Montelukast|montelukast|mesh-list
43813320|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813321|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
43813322|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43813323|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
43802055|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43802056|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43802057|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802058|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802059|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43802060|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43802061|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43802062|NCT03337698|Linagliptin|linagliptin|mesh-list
43802063|NCT03337698|Gemcitabine|gemcitabine|mesh-list
43802064|NCT03337698|Bevacizumab|bevacizumab|mesh-list
44202156|NCT00404508|Valproic Acid|valproic acid|mesh-list
44202157|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
44202158|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202159|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202160|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
44202161|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202162|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202163|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
44202164|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44202165|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202166|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202167|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44202168|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
44202169|NCT00404534|Amoxicillin|amoxicillin|mesh-list
44202170|NCT00404534|Clarithromycin|clarithromycin|mesh-list
44202171|NCT00404534|Omeprazole|omeprazole|mesh-list
44202172|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202173|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202174|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44202175|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202176|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44202177|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202178|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202179|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44202180|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44202181|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44202182|NCT00404573|Cariprazine|cariprazine|mesh-list
44202183|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44202184|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44202185|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202186|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202187|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202188|NCT00404586|Fluticasone|fluticasone|mesh-list
44202196|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202197|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202198|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44202199|NCT00404599|Simvastatin|simvastatin|mesh-list
44202200|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44202201|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44202202|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
44202203|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202204|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44202205|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44202206|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202207|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44202208|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
44202209|NCT00404703|Bevacizumab|bevacizumab|mesh-list
43813329|NCT04815200|Copper|copper|mesh-list
44202210|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202211|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202212|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202213|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202214|NCT00404703|Growth Substances|growth substances|mesh-ancestor
44202215|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202217|NCT00404716|Cilostazol|cilostazol|mesh-list
44202249|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202250|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44202251|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44202252|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202253|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
44202254|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44202255|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44202256|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44202257|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
44202258|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202259|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44202260|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
44202261|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202262|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202263|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
44202264|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44202265|NCT00404781|Protective Agents|protective agents|mesh-ancestor
44202266|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44202267|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44202268|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
44202269|NCT00404794|Prednisolone|prednisolone|mesh-list
44202270|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44202274|NCT00404794|Tacrolimus|tacrolimus|mesh-list
44202299|NCT00404794|Protective Agents|protective agents|mesh-ancestor
44202300|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
44202301|NCT00404833|Prednisolone|prednisolone|mesh-list
44202302|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44202303|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
44202304|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44202305|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
44202306|NCT00404833|Chlorambucil|chlorambucil|mesh-list
44202307|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44202308|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
44202309|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44202310|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202311|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44202312|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
44202313|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202314|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202315|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813332|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
43813333|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813334|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
43813386|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202316|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202317|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202318|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
44202319|NCT00404833|Hormones|hormones|mesh-ancestor
44202336|NCT00404937|Hormones|hormones|mesh-ancestor
44202353|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202354|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44202355|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44202356|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44202357|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44202358|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44202359|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44202360|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
44202361|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
44202362|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202363|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202364|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44455945|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
44202365|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44202366|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202367|NCT00405119|Esomeprazole|esomeprazole|mesh-list
44202368|NCT00405119|Ranitidine|ranitidine|mesh-list
44202369|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
44202370|NCT00405119|Loxtidine|loxtidine|mesh-list
44202371|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44202372|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202373|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44202374|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202375|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202376|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44202377|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
44202378|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
44202379|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202380|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202381|NCT00405158|Acetaminophen|acetaminophen|mesh-list
44202382|NCT00405158|Antipyretics|antipyretics|mesh-list
44202383|NCT00405158|Penicillins|penicillins|mesh-list
44202395|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202397|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44202398|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44202399|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202400|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202401|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
44202402|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202403|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44202404|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44202405|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44202406|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44202407|NCT00405210|Docetaxel|docetaxel|mesh-list
44202408|NCT00405210|Sorafenib|sorafenib|mesh-list
44202409|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202410|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
44202411|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202412|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
44202446|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44202447|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202448|NCT00405262|Analgesics|analgesics|mesh-ancestor
44202449|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202450|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202451|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44202452|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202453|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202454|NCT00403949|Azelaic acid|azelaic acid|mesh-list
44202455|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202456|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
44202457|NCT00405301|Rifampin|rifampin|mesh-list
44202458|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
44202459|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44202460|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
44202461|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202462|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202463|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
44202464|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44202473|NCT00405340|Rituximab|rituximab|mesh-list
44202500|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202501|NCT00405418|Insulin|insulin|mesh-list
44202502|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44202503|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
44202504|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
44202505|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44202506|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202507|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
44202508|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44202509|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44202510|NCT00405444|Fentanyl|fentanyl|mesh-list
44202511|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44202512|NCT00405444|Narcotics|narcotics|mesh-ancestor
44202513|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202514|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202515|NCT00405444|Analgesics|analgesics|mesh-ancestor
44202516|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
44202517|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202559|NCT00405730|Analgesics|analgesics|mesh-ancestor
44202560|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
44202561|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202562|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202563|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202564|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202565|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44202566|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202567|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202568|NCT00405769|Red yeast rice|red yeast rice|mesh-list
44202569|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44202570|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44202571|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44202572|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
44202573|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202574|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202575|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44202576|NCT00405808|Rimonabant|rimonabant|mesh-list
44202612|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44202613|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202614|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202615|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
44202616|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202617|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44202618|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44202619|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
44202620|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
44202621|NCT00405977|Analgesics|analgesics|mesh-ancestor
44202622|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
44202623|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202624|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202625|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
44202626|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202627|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44202628|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
44202629|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44202630|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44202631|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202632|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44202633|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
44202661|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44202662|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202664|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
44202665|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202666|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44202667|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44202668|NCT00406042|Protective Agents|protective agents|mesh-ancestor
44202669|NCT00406094|Montelukast|montelukast|mesh-list
44202670|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44202671|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
44202672|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44202673|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
44202674|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202722|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
44202723|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
44202724|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
44202725|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202726|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44202727|NCT00406341|Difluprednate|difluprednate|mesh-list
44202728|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
44202729|NCT00406341|Hormones|hormones|mesh-ancestor
44202730|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202731|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202732|NCT00406380|Bevacizumab|bevacizumab|mesh-list
44202733|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43857752|NCT03289949|Ketanserin|ketanserin|mesh-list
44202734|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202735|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44202736|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44202737|NCT00406380|Growth Substances|growth substances|mesh-ancestor
44202738|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202739|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
44202740|NCT00406432|Paroxetine|paroxetine|mesh-list
44202741|NCT00406432|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44202742|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44202743|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44202744|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202745|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202746|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
44202747|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202764|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202765|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202767|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44202768|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202769|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44202770|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202771|NCT00406601|Sorafenib|sorafenib|mesh-list
44202772|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202773|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44202774|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202775|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202776|NCT00406679|Acetaminophen|acetaminophen|mesh-list
44202777|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44202778|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44202779|NCT00406679|Analgesics|analgesics|mesh-ancestor
44202780|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
44202781|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202817|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202818|NCT00406887|Difluprednate|difluprednate|mesh-list
44202819|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
44202820|NCT00406887|Hormones|hormones|mesh-ancestor
44202821|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202822|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202823|NCT00406913|Mupirocin|mupirocin|mesh-list
44202824|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202825|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202826|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44202827|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202828|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202829|NCT00406952|Sertraline|sertraline|mesh-list
44202830|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
44202831|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202832|NCT00406952|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44202833|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44202834|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44202835|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202871|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
44202872|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44202873|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202874|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202875|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44202876|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44202877|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44202878|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202879|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44202880|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43813428|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813429|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813430|NCT04813471|Folic Acid|folic acid|mesh-list
43813431|NCT04813471|Nicorandil|nicorandil|mesh-list
43813432|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
44202881|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202882|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
44202883|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44202884|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44202885|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44202886|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
44202887|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44202888|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
44202889|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
44202890|NCT00407017|Ketorolac|ketorolac|mesh-list
44202891|NCT00407017|Nepafenac|nepafenac|mesh-list
44202892|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
44202893|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44202894|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44202895|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44202896|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44202897|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202898|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202916|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202917|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202918|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
44202919|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44202920|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
44202921|NCT00407082|Hormones|hormones|mesh-ancestor
44202922|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202923|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202924|NCT00407121|Bevacizumab|bevacizumab|mesh-list
44202957|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44202958|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44202959|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44202960|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44202961|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202962|NCT00407212|Maleic acid|maleic acid|mesh-list
44202963|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44202964|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44202965|NCT00407225|Difluprednate|difluprednate|mesh-list
44202966|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
44202967|NCT00407225|Hormones|hormones|mesh-ancestor
44202968|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44202969|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44202970|NCT00407251|Epothilone B|epothilone b|mesh-list
44202971|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44202977|NCT00407264|Xhance|xhance|mesh-list
44203017|NCT00407433|Gemcitabine|gemcitabine|mesh-list
44203018|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
44203019|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203020|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
44203021|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203022|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203023|NCT00407433|Antiviral Agents|antiviral agents|mesh-ancestor
44203024|NCT00407433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203025|NCT00407433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203026|NCT00407433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203027|NCT00407433|Immunologic Factors|immunologic factors|mesh-ancestor
44203028|NCT00407433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203029|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
44203030|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203031|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44203032|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44203033|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203034|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203035|NCT00407446|Urological Agents|urological agents|mesh-ancestor
44203036|NCT00407459|Bevacizumab|bevacizumab|mesh-list
44203037|NCT00407459|Carboplatin|carboplatin|mesh-list
44203070|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203071|NCT00407719|Bevacizumab|bevacizumab|mesh-list
44203072|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203073|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203074|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44203075|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44203076|NCT00407719|Growth Substances|growth substances|mesh-ancestor
44203077|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203078|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
44203079|NCT00407771|Tirofiban|tirofiban|mesh-list
44203080|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44203081|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44203082|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203084|NCT00407784|Eplerenone|eplerenone|mesh-list
44203128|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203130|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203131|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203132|NCT00408148|Rimonabant|rimonabant|mesh-list
44203133|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44203134|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44203135|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44203136|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203137|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203138|NCT00408148|Hormones|hormones|mesh-ancestor
44203139|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203140|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203188|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203189|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
44203190|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44203191|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203192|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203193|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
44203194|NCT00408278|Analgesics|analgesics|mesh-ancestor
44203195|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
44203196|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203197|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203198|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203251|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
44203253|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
44203254|NCT00408655|Sirolimus|sirolimus|mesh-list
44203255|NCT00408655|Paclitaxel|paclitaxel|mesh-list
44203256|NCT00408655|Carboplatin|carboplatin|mesh-list
44203257|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44203258|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203259|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
44203260|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
44203261|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
44203262|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203263|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203264|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203265|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44203266|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
44203268|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
44203310|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44203311|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44203312|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
44203313|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203314|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203315|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203316|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
44203317|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
44203318|NCT00408941|Propofol|propofol|mesh-list
44203319|NCT00408941|Prilocaine|prilocaine|mesh-list
44203320|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44203321|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203322|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203323|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44203324|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
44203325|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
44203326|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
44203327|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
43813590|NCT04810507|Incretins|incretins|mesh-ancestor
44203328|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203329|NCT00409019|Tenofovir|tenofovir|mesh-list
44203330|NCT00409019|Adefovir|adefovir|mesh-list
44203331|NCT00409019|Telbivudine|telbivudine|mesh-list
44203332|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
44203333|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203334|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44203335|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44455978|NCT01637402|Prednisone|prednisone|mesh-list
44455992|NCT01637272|Pasireotide|pasireotide|mesh-list
44455993|NCT01637272|Hormones|hormones|mesh-ancestor
44455994|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44455995|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44455996|NCT01637077|Pregabalin|pregabalin|mesh-list
44455997|NCT01637077|Analgesics|analgesics|mesh-ancestor
44455998|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
44455999|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456000|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456001|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
44456002|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44456003|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456004|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456005|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44456006|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44456007|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44456008|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456009|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456010|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44456011|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
44456012|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456013|NCT01636947|Dexamethasone|dexamethasone|mesh-list
44456014|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
44456015|NCT01636947|Ondansetron|ondansetron|mesh-list
44203340|NCT00409071|Sinomenine|sinomenine|mesh-list
44203341|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203342|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
44203343|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44203344|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203362|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44203363|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203364|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813614|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203365|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203366|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203367|NCT00409227|Urological Agents|urological agents|mesh-ancestor
44203368|NCT00409253|Nicardipine|nicardipine|mesh-list
43813615|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813616|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43813617|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43813618|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813619|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44203369|NCT00409253|Urapidil|urapidil|mesh-list
44203370|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203371|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43813620|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44203372|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203373|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203374|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203422|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44203423|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
44203424|NCT00409461|Sirolimus|sirolimus|mesh-list
44203425|NCT00409461|Tacrolimus|tacrolimus|mesh-list
44203426|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203427|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
44203428|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203429|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44203430|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203431|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203432|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203433|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203434|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44203435|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203436|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
44203437|NCT00409526|Iloprost|iloprost|mesh-list
44203438|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44203439|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203440|NCT00409591|Ritonavir|ritonavir|mesh-list
44203441|NCT00409591|Lopinavir|lopinavir|mesh-list
44203442|NCT00409591|Zidovudine|zidovudine|mesh-list
44203443|NCT00409591|Nevirapine|nevirapine|mesh-list
44203476|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203477|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203478|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203479|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44203480|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44203481|NCT00409656|Basiliximab|basiliximab|mesh-list
44203482|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203483|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
44203484|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203485|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
43813623|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43813624|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43813625|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43813626|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
43813627|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734422|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802476|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43802477|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43802478|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802479|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802480|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
43802481|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
44203486|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44203490|NCT00409721|Memantine|memantine|mesh-list
44203537|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
44203538|NCT00409903|Eprosartan|eprosartan|mesh-list
44203539|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203540|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44203541|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44203542|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203543|NCT00409942|Torsemide|torsemide|mesh-list
44203544|NCT00409942|Furosemide|furosemide|mesh-list
44203545|NCT00409942|Diuretics|diuretics|mesh-ancestor
44203546|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
44203547|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203548|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44203549|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44203550|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203551|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44203552|NCT00409981|Paclitaxel|paclitaxel|mesh-list
44203553|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44203554|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203555|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
44203556|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
44203557|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
44203558|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203559|NCT00409994|Sirolimus|sirolimus|mesh-list
44203560|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203568|NCT00410033|Insulin|insulin|mesh-list
44203587|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44203588|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44203589|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
44203590|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
44203591|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
44203592|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
44203593|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203594|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203595|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
44203596|NCT00410306|Testosterone|testosterone|mesh-list
44203597|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
44203598|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
44203599|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44203600|NCT00410306|Androgens|androgens|mesh-ancestor
44203602|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203603|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203604|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44203605|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203606|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
44203607|NCT00410345|Mifepristone|mifepristone|mesh-list
43813628|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
43813629|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43813630|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813631|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
43813632|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43813633|NCT04809935|Ethanol|ethanol|mesh-list
43813634|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43813635|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802496|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43802497|NCT04982055|Nadroparin|nadroparin|mesh-list
43802498|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
43802499|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43802502|NCT04981743|Vitamin D|vitamin d|mesh-list
44203608|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44203609|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
44203610|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44203611|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203612|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44203613|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44203614|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44203615|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
44203631|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44203632|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203633|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44203634|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44203635|NCT00410449|Tocopherols|tocopherols|mesh-list
44203636|NCT00410449|Vitamin E|vitamin e|mesh-list
44203637|NCT00410449|Tocotrienols|tocotrienols|mesh-list
44203638|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
44203639|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
44203640|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203641|NCT00410449|Protective Agents|protective agents|mesh-ancestor
44203642|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203643|NCT00410449|Vitamins|vitamins|mesh-ancestor
44203644|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
44203645|NCT00410462|Doxorubicin|doxorubicin|mesh-list
44203646|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44203647|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44203648|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203649|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44203650|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44203651|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203652|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203653|NCT00410527|Meropenem|meropenem|mesh-list
44203654|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44203655|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203656|NCT00410540|Morphine|morphine|mesh-list
44203657|NCT00410540|Hydromorphone|hydromorphone|mesh-list
44203658|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203659|NCT00410540|Narcotics|narcotics|mesh-ancestor
44203660|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203661|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203662|NCT00410540|Analgesics|analgesics|mesh-ancestor
44203663|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
44203676|NCT00410553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203677|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
44203678|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
44203679|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
44203680|NCT00410592|Esomeprazole|esomeprazole|mesh-list
44203681|NCT00410592|Pantoprazole|pantoprazole|mesh-list
44203682|NCT00410592|Lansoprazole|lansoprazole|mesh-list
44203683|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
44203684|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44203685|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203686|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44203687|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203688|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203689|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
44203690|NCT00410631|Melphalan|melphalan|mesh-list
44203691|NCT00410631|Ifosfamide|ifosfamide|mesh-list
44203692|NCT00410631|Dacarbazine|dacarbazine|mesh-list
44203693|NCT00410631|Carboplatin|carboplatin|mesh-list
44203694|NCT00410631|Doxorubicin|doxorubicin|mesh-list
44203695|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44203696|NCT00410631|Etoposide|etoposide|mesh-list
44203697|NCT00410631|Vincristine|vincristine|mesh-list
44203698|NCT00410631|Topotecan|topotecan|mesh-list
44203699|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
44203700|NCT00410631|Vindesine|vindesine|mesh-list
44203701|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44203702|NCT00410631|Isotretinoin|isotretinoin|mesh-list
44203703|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203704|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
44203705|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203724|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203726|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203727|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203728|NCT00410644|Analgesics|analgesics|mesh-ancestor
44203729|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
44203730|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203731|NCT00410657|Prednisone|prednisone|mesh-list
44203732|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
44203733|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44203734|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44203735|NCT00410657|Prednisolone|prednisolone|mesh-list
44203736|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
44203737|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
44203738|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44203739|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
44203740|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203741|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
44203742|NCT00410657|Hormones|hormones|mesh-ancestor
44203743|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203779|NCT00410774|Growth Substances|growth substances|mesh-ancestor
44203780|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203781|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
44203782|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203783|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
44203784|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203785|NCT00410774|Antiviral Agents|antiviral agents|mesh-ancestor
44203786|NCT00410774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203787|NCT00410774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203788|NCT00410774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203789|NCT00410774|Immunologic Factors|immunologic factors|mesh-ancestor
44203790|NCT00410787|Hydromorphone|hydromorphone|mesh-list
44203791|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203792|NCT00410787|Narcotics|narcotics|mesh-ancestor
44456016|NCT01636947|Aprepitant|aprepitant|mesh-list
44203793|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203794|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203795|NCT00410787|Analgesics|analgesics|mesh-ancestor
44203796|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
44203797|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203798|NCT00410852|Insulin|insulin|mesh-list
44203799|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44203800|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44203801|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203802|NCT00410878|Hydromorphone|hydromorphone|mesh-list
44203803|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203804|NCT00410878|Narcotics|narcotics|mesh-ancestor
44456036|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456037|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456038|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456039|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
44456040|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456041|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44456042|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
44456043|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655127|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
44456044|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44456045|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44456046|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456047|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456048|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44456049|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44456050|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44456051|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44456052|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
44456053|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44456054|NCT01636934|Minocycline|minocycline|mesh-list
44456055|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456056|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456057|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44456058|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
44456059|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456060|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43655134|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456061|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456062|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
44456063|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456064|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456065|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456066|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456067|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44456068|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43858887|NCT03141424|Hormones|hormones|mesh-ancestor
44203810|NCT00410943|Hydromorphone|hydromorphone|mesh-list
44203811|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203812|NCT00410943|Narcotics|narcotics|mesh-ancestor
44203813|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203814|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203815|NCT00410943|Analgesics|analgesics|mesh-ancestor
44203816|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
44203817|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203818|NCT00410982|Gemcitabine|gemcitabine|mesh-list
44203819|NCT00410982|Rituximab|rituximab|mesh-list
44203820|NCT00410982|Melphalan|melphalan|mesh-list
44203821|NCT00410982|Busulfan|busulfan|mesh-list
44203822|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44203823|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203824|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
44203825|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203826|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203827|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203828|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
44203829|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203830|NCT00410982|Antiviral Agents|antiviral agents|mesh-ancestor
44203831|NCT00410982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203832|NCT00410982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203833|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203834|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44203835|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
44203836|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44203837|NCT00410995|Naproxen|naproxen|mesh-list
44203838|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44203839|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44203840|NCT00410995|Analgesics|analgesics|mesh-ancestor
44203841|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
44203842|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203843|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203844|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203848|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203849|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203850|NCT00411034|Hydromorphone|hydromorphone|mesh-list
44203851|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203852|NCT00411034|Narcotics|narcotics|mesh-ancestor
44203853|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203854|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203855|NCT00411034|Analgesics|analgesics|mesh-ancestor
44203856|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
44203857|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203858|NCT00411047|Gefitinib|gefitinib|mesh-list
44203859|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203860|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44203861|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203862|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203863|NCT00411073|Darapladib|darapladib|mesh-list
44203864|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44203865|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203866|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203867|NCT00411125|Calcitonin|calcitonin|mesh-list
44203868|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
44203869|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44203870|NCT00411125|Katacalcin|katacalcin|mesh-list
44203871|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44203872|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203873|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44203874|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
44203875|NCT00411164|Hydromorphone|hydromorphone|mesh-list
44203894|NCT00411190|Analgesics|analgesics|mesh-ancestor
44203895|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
44203896|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203897|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813731|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43813732|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43813733|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43844744|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
43655141|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
43655142|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655143|NCT02971306|Expectorants|expectorants|mesh-ancestor
43848794|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44203898|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
44203899|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44203900|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203901|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44203902|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44203903|NCT00411203|Tamoxifen|tamoxifen|mesh-list
44203904|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44203905|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
44203906|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203907|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203908|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44203909|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203910|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44203911|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44203912|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44203913|NCT00411229|Capecitabine|capecitabine|mesh-list
44203914|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
44203915|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44203916|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
44203917|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203918|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203919|NCT00411268|Hydromorphone|hydromorphone|mesh-list
44203920|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203921|NCT00411268|Narcotics|narcotics|mesh-ancestor
44203922|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203923|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203924|NCT00411268|Analgesics|analgesics|mesh-ancestor
44203925|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
44203932|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
44203933|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44203934|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44203935|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
44203936|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203937|NCT00411307|Hydromorphone|hydromorphone|mesh-list
44203938|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44203939|NCT00411307|Narcotics|narcotics|mesh-ancestor
44203940|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44203941|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203942|NCT00411307|Analgesics|analgesics|mesh-ancestor
44203943|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
44203944|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203945|NCT00411320|Dexamethasone|dexamethasone|mesh-list
44203946|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44203947|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
44203948|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
44203949|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44203950|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44203951|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44203952|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
44203953|NCT00411320|Hormones|hormones|mesh-ancestor
44203954|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203955|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44203956|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44203957|NCT00411333|Triamcinolone|triamcinolone|mesh-list
44203958|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44203980|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
44203981|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
44203982|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44203983|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44203984|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44203985|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44203986|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
44203987|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203988|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44203989|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
44203990|NCT00411372|Hormones|hormones|mesh-ancestor
44203991|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44203992|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
44203993|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44203994|NCT00411437|Oxybutynin|oxybutynin|mesh-list
44203995|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44203996|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44203997|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
44203998|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44203999|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204000|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204001|NCT00411437|Urological Agents|urological agents|mesh-ancestor
44204002|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
44204003|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
44204004|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204028|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204029|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204030|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204031|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204033|NCT00411593|Bortezomib|bortezomib|mesh-list
44204034|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44204035|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204036|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204037|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204038|NCT00411593|Growth Substances|growth substances|mesh-ancestor
44204039|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204040|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
44204041|NCT00411736|Azithromycin|azithromycin|mesh-list
44204042|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44204043|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204044|NCT00411866|Ketoconazole|ketoconazole|mesh-list
44204045|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
44204046|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204047|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44204048|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44204082|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44204083|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44204084|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44204085|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
44204086|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204087|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204088|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44204089|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44204090|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
44204091|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204093|NCT00411996|Indinavir|indinavir|mesh-list
44204094|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44204095|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44204096|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
44204097|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204098|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204099|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44204100|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44204101|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
44204102|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204103|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44204104|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44204105|NCT00412022|Tamoxifen|tamoxifen|mesh-list
44204106|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
44204107|NCT00412022|Letrozole|letrozole|mesh-list
44204130|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44204131|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204132|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204133|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
44204134|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204135|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204136|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44204137|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204138|NCT00412100|Oxycodone|oxycodone|mesh-list
44204139|NCT00412100|Naloxone|naloxone|mesh-list
44204140|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44204141|NCT00412100|Narcotics|narcotics|mesh-ancestor
44204142|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204143|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204144|NCT00412100|Analgesics|analgesics|mesh-ancestor
44204145|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
44204146|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204147|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44204148|NCT00412126|Insulin|insulin|mesh-list
44204149|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44204150|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204151|NCT00412152|Oxycodone|oxycodone|mesh-list
44204152|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44204153|NCT00412152|Narcotics|narcotics|mesh-ancestor
44204154|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204155|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204156|NCT00412152|Analgesics|analgesics|mesh-ancestor
44204157|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
44204158|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204159|NCT00412191|Lamotrigine|lamotrigine|mesh-list
44204160|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
44204175|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204176|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204177|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44204178|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
44204179|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
44204180|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44204181|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
44204182|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43859219|NCT03105518|Acetaminophen|acetaminophen|mesh-list
44204183|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204184|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
44204185|NCT00412321|Siltuximab|siltuximab|mesh-list
44204186|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204187|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44204188|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
44204189|NCT00412334|Ribavirin|ribavirin|mesh-list
44204190|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
44204191|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204192|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
44204193|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204194|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
44204195|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204196|NCT00412347|Insulin|insulin|mesh-list
44204197|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44204198|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204199|NCT00412412|Trastuzumab|trastuzumab|mesh-list
44204200|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44204201|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204202|NCT00412503|Temozolomide|temozolomide|mesh-list
44204203|NCT00412503|Topotecan|topotecan|mesh-list
44204204|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44204205|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
44204206|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204215|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204216|NCT00412581|Lenalidomide|lenalidomide|mesh-list
44204217|NCT00412581|Dacarbazine|dacarbazine|mesh-list
44204218|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
44204219|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204220|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204221|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204222|NCT00412581|Growth Substances|growth substances|mesh-ancestor
44204223|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
44204224|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204225|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44204226|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
44204227|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204228|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
44204229|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204271|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44204272|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204273|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204274|NCT00413023|Casopitant|casopitant|mesh-list
44204275|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
44204276|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
44204277|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204278|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204279|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204280|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44204281|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204282|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204283|NCT00413075|Belinostat|belinostat|mesh-list
44204284|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204285|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44204286|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204287|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204288|NCT00413088|Bemiparin|bemiparin|mesh-list
44204289|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
44456113|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
44456114|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456115|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44456116|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44456117|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456119|NCT01634555|Protective Agents|protective agents|mesh-ancestor
44204290|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
44204291|NCT00413101|Hematinics|hematinics|mesh-ancestor
44204292|NCT00413127|Lidocaine|lidocaine|mesh-list
44204293|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
44204294|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
44204295|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204296|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204297|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
44204298|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204299|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44204300|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44204301|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44204302|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204303|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204304|NCT00413179|Metformin|metformin|mesh-list
44204305|NCT00413179|Clomiphene|clomiphene|mesh-list
44204306|NCT00413179|Enclomiphene|enclomiphene|mesh-list
44204307|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
44204308|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44204309|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204310|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44204311|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
44204312|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204313|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44204314|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
44204315|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204317|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44204324|NCT00413296|Levetiracetam|levetiracetam|mesh-list
44204325|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
44204326|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
44204327|NCT00413322|Fluorouracil|fluorouracil|mesh-list
44204328|NCT00413322|Belinostat|belinostat|mesh-list
44204329|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
44204330|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204331|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204332|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204333|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204334|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
44204335|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204336|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44204337|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204338|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
44204339|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
44204340|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44204341|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44204342|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204343|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204344|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204345|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44204346|NCT00413387|Budesonide|budesonide|mesh-list
44204347|NCT00413387|Beclomethasone|beclomethasone|mesh-list
44204348|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
44204349|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204350|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44204351|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
44204354|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44204371|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204372|NCT00413426|Urological Agents|urological agents|mesh-ancestor
44204373|NCT00413439|Isavuconazole|isavuconazole|mesh-list
44204374|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
44204375|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204376|NCT00413452|Etanercept|etanercept|mesh-list
44204377|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813873|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
43813874|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
43813875|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
43813876|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813907|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204378|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44204379|NCT00413452|Analgesics|analgesics|mesh-ancestor
44204380|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
44204381|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204382|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204383|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204384|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44204385|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204386|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204387|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
44204388|NCT00413504|PENTA|penta|mesh-list
44204389|NCT00413504|Fondaparinux|fondaparinux|mesh-list
44204390|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44204391|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
44204392|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44204393|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
44204394|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204395|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204396|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
44204397|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44204398|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44204399|NCT00413608|Clopidogrel|clopidogrel|mesh-list
44204400|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44204401|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44204402|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44204414|NCT00413686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204415|NCT00413686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204416|NCT00413686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204417|NCT00413686|Immunologic Factors|immunologic factors|mesh-ancestor
44204418|NCT00413686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204419|NCT00413712|Adenosine|adenosine|mesh-list
44204420|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
44204421|NCT00413712|Calcium|calcium|mesh-list
44204422|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44204423|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204424|NCT00413712|Analgesics|analgesics|mesh-ancestor
44204425|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
44204426|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204427|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44204428|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
44204429|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44204430|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
44204431|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
44204432|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204433|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204434|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204435|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44204436|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204437|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44204438|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44204439|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43842602|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842603|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842604|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842605|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842606|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842607|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43842608|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43842609|NCT04518306|Diuretics|diuretics|mesh-ancestor
43842610|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
43842611|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44204440|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44204441|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44204442|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44204455|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204456|NCT00413790|Urological Agents|urological agents|mesh-ancestor
44204457|NCT00413829|Ranibizumab|ranibizumab|mesh-list
44204458|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204459|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204460|NCT00413829|Growth Substances|growth substances|mesh-ancestor
44204461|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204462|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
44204463|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204464|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
44204518|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204519|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204520|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
44204521|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204522|NCT00414323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44204523|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
44204524|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44204525|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204526|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44204527|NCT00414323|Analgesics|analgesics|mesh-ancestor
44204528|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
44204529|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
44204530|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44204531|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44204532|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
44204533|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204534|NCT00414336|Antacids|antacids|mesh-ancestor
44204535|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204536|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204537|NCT00414349|Analgesics|analgesics|mesh-list
44204538|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
44204539|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204540|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204541|NCT00414414|Prednisone|prednisone|mesh-list
44204542|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842650|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842651|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842652|NCT04516993|Aspirin|aspirin|mesh-list
43842653|NCT04516993|Plasminogen|plasminogen|mesh-list
43842654|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43842655|NCT04516993|Tenecteplase|tenecteplase|mesh-list
43849036|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
43803006|NCT04974060|Remifentanil|remifentanil|mesh-list
43803007|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43803008|NCT04974060|Narcotics|narcotics|mesh-ancestor
43803009|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803010|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803011|NCT04974060|Analgesics|analgesics|mesh-ancestor
43803021|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43803022|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204543|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
44204544|NCT00414414|Hormones|hormones|mesh-ancestor
44204545|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204546|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204547|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204548|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204549|NCT00414531|Atorvastatin|atorvastatin|mesh-list
44204550|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44204551|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44204555|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44204557|NCT00414648|Sirolimus|sirolimus|mesh-list
44204558|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44204559|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204560|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204561|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204562|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
44204563|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44204564|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
44204565|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204566|NCT00414687|Iloprost|iloprost|mesh-list
44204567|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44204568|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
44204569|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
44204570|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44204571|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204572|NCT00414921|Clonidine|clonidine|mesh-list
44204573|NCT00414921|Methylphenidate|methylphenidate|mesh-list
44204574|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44204575|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204576|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44204577|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44204578|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44204579|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655150|NCT02971306|Antidotes|antidotes|mesh-ancestor
44204604|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204605|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204606|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44204607|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
44204608|NCT00415064|Hormones|hormones|mesh-ancestor
44204609|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204610|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204611|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204612|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
44204613|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204614|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204615|NCT00415064|Growth Substances|growth substances|mesh-ancestor
44204616|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
44204617|NCT00415090|Nevirapine|nevirapine|mesh-list
44204618|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44204619|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44204620|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204621|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204622|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
44204623|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204624|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44204625|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44204626|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44204627|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44204653|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204654|NCT00415116|Growth Substances|growth substances|mesh-ancestor
44204655|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456120|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
44456121|NCT01634555|Vitamins|vitamins|mesh-ancestor
44456122|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
44456123|NCT01634555|Hematinics|hematinics|mesh-ancestor
44456124|NCT01634243|Rotigotine|rotigotine|mesh-list
44456125|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
43859706|NCT03047928|Nivolumab|nivolumab|mesh-list
44456126|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
44456127|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204656|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44204657|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
44204658|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44204659|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
44204660|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204661|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204662|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44204663|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204664|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204666|NCT00415285|Capecitabine|capecitabine|mesh-list
44204667|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204668|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204669|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204670|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204671|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204672|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204673|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
44204674|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
44204675|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204676|NCT00415311|Lectins|lectins|mesh-list
44204677|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
44204692|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
44204693|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204694|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44204695|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44204696|NCT00415584|Cinacalcet|cinacalcet|mesh-list
44204697|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44204698|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204699|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44204700|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
44204701|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204702|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
44204703|NCT00415701|Propofol|propofol|mesh-list
44204704|NCT00415701|Etomidate|etomidate|mesh-list
44204705|NCT00415701|Cosyntropin|cosyntropin|mesh-list
44204706|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44204707|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44204708|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204709|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44204710|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
44204711|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
44204712|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204713|NCT00415701|Hormones|hormones|mesh-ancestor
44204714|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204715|NCT00415740|Levodopa|levodopa|mesh-list
44204716|NCT00415740|Carbidopa|carbidopa|mesh-list
43814036|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
43814037|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814038|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814039|NCT04804423|Listerine|listerine|mesh-list
43814040|NCT04804423|Fluorides|fluorides|mesh-list
43814041|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
43814042|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
43814043|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
43814044|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
43814045|NCT04804423|Protective Agents|protective agents|mesh-ancestor
43814046|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814047|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43655154|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44204717|NCT00415740|Entacapone|entacapone|mesh-list
43655155|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
43655156|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
43814097|NCT04803240|Protective Agents|protective agents|mesh-ancestor
44204718|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44204719|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44204720|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44204721|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
44204737|NCT00415779|Docetaxel|docetaxel|mesh-list
44204738|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204739|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204740|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204741|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204742|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204743|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44204744|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204745|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
44204746|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204747|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204748|NCT00415831|Levodopa|levodopa|mesh-list
44204749|NCT00415831|Carbidopa|carbidopa|mesh-list
44204750|NCT00415831|Entacapone|entacapone|mesh-list
44204751|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44204752|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44204753|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44204754|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
44204755|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204756|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204757|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204758|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44204759|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204760|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44204764|NCT00415844|Levodopa|levodopa|mesh-list
44204786|NCT00415922|Carbidopa|carbidopa|mesh-list
44204787|NCT00415922|Entacapone|entacapone|mesh-list
44204788|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44204789|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44204790|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44204791|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
44204792|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204793|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204794|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204795|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44204796|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204797|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44204798|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44204799|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
44204800|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
44204801|NCT00415935|Methotrexate|methotrexate|mesh-list
44204802|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44204803|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
44204804|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204805|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204806|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44204807|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
44204836|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
44204837|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204838|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204839|NCT00416130|Vorinostat|vorinostat|mesh-list
44204840|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204841|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44204842|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204843|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204844|NCT00416143|Prednisone|prednisone|mesh-list
44204845|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204846|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
44204847|NCT00416143|Hormones|hormones|mesh-ancestor
44204848|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204849|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204850|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204851|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204852|NCT00416169|Galantamine|galantamine|mesh-list
44204853|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44204854|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204855|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204856|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
44204857|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44204858|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204859|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44204860|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
44204861|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44204862|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
44204863|NCT00416208|Bortezomib|bortezomib|mesh-list
44204881|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204883|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204884|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44204885|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44204886|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204887|NCT00416377|Prednisolone|prednisolone|mesh-list
44204888|NCT00416377|Doxorubicin|doxorubicin|mesh-list
44204889|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44204890|NCT00416377|Bleomycin|bleomycin|mesh-list
43814130|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814131|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44204891|NCT00416377|Vincristine|vincristine|mesh-list
44204892|NCT00416377|Dacarbazine|dacarbazine|mesh-list
44204893|NCT00416377|Vinblastine|vinblastine|mesh-list
44204894|NCT00416377|Procarbazine|procarbazine|mesh-list
44204895|NCT00416377|Chlorambucil|chlorambucil|mesh-list
44204896|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204897|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204898|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44204899|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44204900|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204901|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204902|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44204903|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
44204904|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
44204905|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204906|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204907|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
44204908|NCT00416377|Hormones|hormones|mesh-ancestor
44204909|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204910|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204911|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204912|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44204913|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
44204914|NCT00416390|Lycopene|lycopene|mesh-list
44204915|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204922|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204923|NCT00416429|Interferons|interferons|mesh-list
44204924|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
44204925|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
44204926|NCT00416429|Aldesleukin|aldesleukin|mesh-list
44204927|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44204928|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
44204929|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204930|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
44204931|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44204932|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
44204933|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204934|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44204935|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43814168|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814169|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43814170|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
43814171|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814172|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
43814173|NCT04802785|Emollients|emollients|mesh-ancestor
44204936|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44204937|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43814174|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814175|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
43814176|NCT04802785|Antacids|antacids|mesh-ancestor
44204938|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44204939|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
44204940|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44204941|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44204942|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44204943|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44204944|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204945|NCT00416468|Valsartan|valsartan|mesh-list
44204946|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44204947|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44204948|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44204949|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204970|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44204971|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44204972|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44204973|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44204974|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44204975|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44204976|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44204977|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
44204979|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44204980|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204981|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44204982|NCT00416585|Isotretinoin|isotretinoin|mesh-list
44204983|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
44204984|NCT00416637|Bevacizumab|bevacizumab|mesh-list
44204985|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44204986|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44204987|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44204988|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44204989|NCT00416637|Growth Substances|growth substances|mesh-ancestor
44204990|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44204991|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
44204992|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44205020|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44205021|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44205022|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205023|NCT00416767|Leucovorin|leucovorin|mesh-list
44205024|NCT00416767|Fluorouracil|fluorouracil|mesh-list
44205025|NCT00416767|Irinotecan|irinotecan|mesh-list
44205026|NCT00416767|Calcium|calcium|mesh-list
44205027|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
44205028|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43655157|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655158|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655160|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
43655161|NCT02971345|Epirubicin|epirubicin|mesh-list
43655162|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
43655163|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43655164|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655165|NCT02971345|Trace Elements|trace elements|mesh-ancestor
43803254|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803257|NCT04970342|Alprazolam|alprazolam|mesh-list
44205029|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205030|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
44205031|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205032|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44205033|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205034|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205035|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
44205036|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44205037|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205038|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205039|NCT00416767|Antidotes|antidotes|mesh-ancestor
44205040|NCT00416767|Protective Agents|protective agents|mesh-ancestor
44205041|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
44205042|NCT00416767|Vitamins|vitamins|mesh-ancestor
44205043|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
44205044|NCT00416819|Leucovorin|leucovorin|mesh-list
44205045|NCT00416819|Cytarabine|cytarabine|mesh-list
44205070|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205071|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
44205072|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205073|NCT00416819|Antidotes|antidotes|mesh-ancestor
44205074|NCT00416819|Protective Agents|protective agents|mesh-ancestor
44205075|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
44205076|NCT00416819|Vitamins|vitamins|mesh-ancestor
44205077|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
44205078|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205079|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
44205080|NCT00416832|Prednisone|prednisone|mesh-list
44205081|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
44205082|NCT00416832|Dacarbazine|dacarbazine|mesh-list
44205083|NCT00416832|Doxorubicin|doxorubicin|mesh-list
44205084|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44205085|NCT00416832|Etoposide|etoposide|mesh-list
44205086|NCT00416832|Vincristine|vincristine|mesh-list
44205087|NCT00416832|Procarbazine|procarbazine|mesh-list
44205088|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205089|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
44205090|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205091|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205092|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44205093|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
44205094|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205095|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205096|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44205097|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44205098|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44205099|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205100|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205101|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205102|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
44205103|NCT00416832|Hormones|hormones|mesh-ancestor
44205104|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205105|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205106|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205107|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205108|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205109|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
44456128|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456129|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456131|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44456132|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456133|NCT01634178|Analgesics|analgesics|mesh-ancestor
44456134|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
44456135|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456136|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456137|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456138|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456139|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44456140|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44456141|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456142|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456143|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
44456144|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456145|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456146|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
44456147|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456148|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
44456149|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456150|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456151|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456152|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456153|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
44456171|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
44456172|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456173|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
44456174|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456175|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814221|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43814222|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43814223|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814224|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43814225|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
43814226|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43814227|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814228|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
43814229|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
43814230|NCT04801511|Vitamins|vitamins|mesh-ancestor
43814231|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
43814232|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814233|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
44456176|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456177|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456178|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
44456179|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44456180|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456181|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456182|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456183|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
44456185|NCT01634100|Rifampin|rifampin|mesh-list
44456186|NCT01634100|Probenecid|probenecid|mesh-list
44456187|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44456188|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456189|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456190|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456191|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44456192|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
44456193|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44456194|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456195|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
44456196|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44456197|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456198|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44205110|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
44205111|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44205112|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205122|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205123|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
44205124|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205125|NCT00416871|Interferons|interferons|mesh-list
44205126|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
44205127|NCT00416871|Aldesleukin|aldesleukin|mesh-list
44205128|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205129|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
44205130|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205131|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
44205132|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814246|NCT04801485|Inositol|inositol|mesh-list
44205133|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44205134|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44205135|NCT00416897|Dexamethasone|dexamethasone|mesh-list
44205136|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205137|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
44205138|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
44205139|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205140|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205141|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205142|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
44205143|NCT00416897|Hormones|hormones|mesh-ancestor
44205144|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205145|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205146|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205147|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
44205148|NCT00416910|Fludarabine|fludarabine|mesh-list
44205149|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
44205150|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205151|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
44205169|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205170|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205171|NCT00416962|Oseltamivir|oseltamivir|mesh-list
44205172|NCT00416962|Amantadine|amantadine|mesh-list
44205173|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
44205174|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205175|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205176|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205177|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44205178|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44205179|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
44205180|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205181|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205182|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205183|NCT00416962|Analgesics|analgesics|mesh-ancestor
44205184|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
44205185|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205186|NCT00417014|Prednisolone|prednisolone|mesh-list
44205187|NCT00417014|Vinblastine|vinblastine|mesh-list
44205188|NCT00417014|Procarbazine|procarbazine|mesh-list
44205189|NCT00417014|Chlorambucil|chlorambucil|mesh-list
44205190|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205191|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
44205192|NCT00417014|Hormones|hormones|mesh-ancestor
44205196|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205222|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44205223|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44205224|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205225|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205226|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205227|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205228|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
44205229|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
44205230|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44205232|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
44205233|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44205234|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
44205235|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44205236|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205237|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44205238|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205239|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205240|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205241|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205242|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44205243|NCT00417144|Ganirelix|ganirelix|mesh-list
44205244|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
44205255|NCT00417157|Ganirelix|ganirelix|mesh-list
44205271|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205272|NCT00417222|Olmesartan|olmesartan|mesh-list
44205273|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
44205274|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44205275|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44205276|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44205277|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205278|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
44205279|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44205280|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205281|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
44205282|NCT00417326|Sivelestat|sivelestat|mesh-list
44205283|NCT00417326|Glycine|glycine|mesh-list
44205284|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44205285|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205286|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205329|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44205330|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205331|NCT00417677|Growth Substances|growth substances|mesh-ancestor
44205332|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205333|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205334|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205335|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205336|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205337|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205338|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205339|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44205340|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
44205341|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205342|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
44205343|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
44205344|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
44205345|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205346|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205347|NCT00417716|Bevacizumab|bevacizumab|mesh-list
44205348|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44205349|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205350|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44205351|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205352|NCT00417716|Growth Substances|growth substances|mesh-ancestor
44205353|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205354|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205355|NCT00417729|Acarbose|acarbose|mesh-list
44205356|NCT00417729|Glyburide|glyburide|mesh-list
44205357|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44205358|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205359|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205370|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44205371|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205372|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
44205373|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205374|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205375|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
44205376|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205377|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43814280|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814281|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43814282|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814283|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814284|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205378|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205379|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205380|NCT00417833|Bevacizumab|bevacizumab|mesh-list
44205381|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44205382|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205383|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44205384|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205385|NCT00417833|Growth Substances|growth substances|mesh-ancestor
44205386|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205387|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205388|NCT00417872|Metronidazole|metronidazole|mesh-list
44205389|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
44205390|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205391|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205392|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44205393|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44205394|NCT00417898|Aspirin|aspirin|mesh-list
44205395|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205396|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205397|NCT00417898|Analgesics|analgesics|mesh-ancestor
44205398|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
44205399|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205400|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205401|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205402|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205403|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44205404|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44205405|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814446|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44205407|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44205408|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205409|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
44205411|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205412|NCT00417937|Azelaic acid|azelaic acid|mesh-list
44205413|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205414|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
44205415|NCT00417950|Acarbose|acarbose|mesh-list
44205416|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44205417|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205418|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205419|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205420|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205421|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44205422|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
44205423|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
44205424|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
44205425|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205426|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
44205427|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205428|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44205429|NCT00418067|Sirolimus|sirolimus|mesh-list
44205430|NCT00418067|Paclitaxel|paclitaxel|mesh-list
44205431|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44205432|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205433|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
44205459|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44205460|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205462|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205463|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205464|NCT00418171|Olanzapine|olanzapine|mesh-list
44205465|NCT00418171|Ziprasidone|ziprasidone|mesh-list
44205466|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
44205467|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
44205468|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205469|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205470|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205471|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44205472|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44205473|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44205474|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205475|NCT00418171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44205476|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205477|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44205514|NCT00418353|Betamethasone|betamethasone|mesh-list
44205515|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
44205516|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
44205517|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
44205518|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
44205519|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
44205520|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205521|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
44205522|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
44205523|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205524|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205525|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205526|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
44205527|NCT00418353|Hormones|hormones|mesh-ancestor
44205528|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205529|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205534|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44205571|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
44205572|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205573|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
44205574|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
44205575|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44205576|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
44205577|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205578|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205579|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43814529|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
44205580|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
44205581|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44205582|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44205583|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44205584|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
44205585|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205586|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205587|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205588|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456222|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456223|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
44456224|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456225|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44456226|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456227|NCT01633060|Fulvestrant|fulvestrant|mesh-list
44205604|NCT00418587|Vitamin D|vitamin d|mesh-list
44205605|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
44205606|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
44205607|NCT00418587|Vitamins|vitamins|mesh-list
44205608|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
44205609|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205610|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44205611|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44205612|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44205613|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
44205614|NCT00418600|Vitamins|vitamins|mesh-ancestor
44205615|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
43814530|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
43814531|NCT04794413|Pimavanserin|pimavanserin|mesh-list
43814532|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43814533|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43814534|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43814535|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43814536|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814537|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814538|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43814539|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43814540|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43814541|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
44205616|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205617|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44205619|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
44205654|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
44205655|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44205656|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205657|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205658|NCT00418847|Miglustat|miglustat|mesh-list
44205659|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205660|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205661|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44205662|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44205663|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
44205664|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205717|NCT00419042|Gemcitabine|gemcitabine|mesh-list
44205718|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44205719|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44205720|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
44205721|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205722|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205723|NCT00419042|Antiviral Agents|antiviral agents|mesh-ancestor
44205724|NCT00419042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205725|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205726|NCT00419042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205727|NCT00419042|Immunologic Factors|immunologic factors|mesh-ancestor
44205728|NCT00419042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205729|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205730|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
44205731|NCT00419068|Vitamin D|vitamin d|mesh-list
44205732|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44205733|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205734|NCT00419068|Vitamins|vitamins|mesh-ancestor
44205735|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
44205736|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44205737|NCT00419146|Vitamins|vitamins|mesh-list
44205738|NCT00419146|Vitamin E|vitamin e|mesh-list
44205739|NCT00419146|Tocopherols|tocopherols|mesh-list
44205740|NCT00419146|Tocotrienols|tocotrienols|mesh-list
44205741|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
44205742|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
44205743|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
44205744|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205745|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
44205746|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205747|NCT00419146|Protective Agents|protective agents|mesh-ancestor
43814613|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
43814616|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814617|NCT04792710|Metronidazole|metronidazole|mesh-list
43814618|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814619|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43814620|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43814621|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43814622|NCT04792840|Letrozole|letrozole|mesh-list
43814623|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655198|NCT02970630|Everolimus|everolimus|mesh-list
44205748|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44205749|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44205750|NCT00419172|Rifampin|rifampin|mesh-list
44205751|NCT00419172|Deferasirox|deferasirox|mesh-list
44205753|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
44205758|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205759|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205760|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44205761|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44205762|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44205763|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44205764|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44205765|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44205766|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44205767|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
44205768|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
44205770|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
44205771|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205772|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44205773|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44205774|NCT00419250|Growth Substances|growth substances|mesh-ancestor
44205775|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
44205776|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205777|NCT00419302|Insulin|insulin|mesh-list
44205778|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205779|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205780|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
44205781|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
44205782|NCT00419471|Citalopram|citalopram|mesh-list
44205783|NCT00419471|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44205784|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205785|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44205786|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205801|NCT00419549|Valdecoxib|valdecoxib|mesh-list
44205802|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44205803|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44205804|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205805|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205806|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44205807|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44205808|NCT00419549|Analgesics|analgesics|mesh-ancestor
44205809|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
44205810|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205811|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205812|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44205813|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44205814|NCT00419601|Fentanyl|fentanyl|mesh-list
44205815|NCT00419601|Remifentanil|remifentanil|mesh-list
44205816|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44205817|NCT00419601|Narcotics|narcotics|mesh-ancestor
44205818|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44205819|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205820|NCT00419601|Analgesics|analgesics|mesh-ancestor
44205821|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
44205822|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205823|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44205824|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44205825|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
44205826|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
44205827|NCT00419653|Haloperidol|haloperidol|mesh-list
44205829|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
44205830|NCT00419653|Amisulpride|amisulpride|mesh-list
44205831|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
44205832|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
44205833|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44205834|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655201|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
43814709|NCT04791332|Aticaprant|aticaprant|mesh-list
44205835|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205836|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164292|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
44164293|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164294|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
44164295|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
44164296|NCT00255710|Fludarabine|fludarabine|mesh-list
44164297|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
44164298|NCT00255710|Tacrolimus|tacrolimus|mesh-list
44164299|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44205837|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44205838|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44205839|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44205840|NCT00419653|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44205841|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44205842|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44205843|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205844|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205845|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
44205846|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44205847|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
44205848|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44205849|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44205850|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
44205851|NCT00419692|Ropinirole|ropinirole|mesh-list
44205852|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44205853|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44205854|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
44205855|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
44205856|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205857|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205858|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205859|NCT00419718|Insulin|insulin|mesh-list
44205860|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44205861|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205862|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205863|NCT00419731|Naltrexone|naltrexone|mesh-list
44205864|NCT00419731|Bupropion|bupropion|mesh-list
44205865|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44205866|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44205867|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205868|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
44205869|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814714|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
43814717|NCT04791202|Prednisolone|prednisolone|mesh-list
44205876|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205878|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44205879|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44205880|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44205881|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205882|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
44205883|NCT00419783|Ketoconazole|ketoconazole|mesh-list
44205884|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205885|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205886|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44205887|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44205888|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205889|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205890|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205891|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205892|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
44205893|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44205894|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44205895|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44205896|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
44205897|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44205924|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205925|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205926|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
44205927|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44205928|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44205929|NCT00419887|Vildagliptin|vildagliptin|mesh-list
44205930|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44205931|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205932|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44205933|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205934|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814726|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44205935|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205936|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44205937|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44205938|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
44205939|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205940|NCT00419991|Tigecycline|tigecycline|mesh-list
44205941|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205942|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205943|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44205944|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205945|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205947|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
44205948|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44205949|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
44205950|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205951|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44205952|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44205953|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205954|NCT00420082|Cetirizine|cetirizine|mesh-list
44205955|NCT00420082|Fexofenadine|fexofenadine|mesh-list
44205956|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44205957|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44205958|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44205959|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
44205962|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205963|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44205964|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44205965|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44205966|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
44205967|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
44205968|NCT00420355|Ritonavir|ritonavir|mesh-list
44205969|NCT00420355|Lopinavir|lopinavir|mesh-list
44205970|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44205971|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44205972|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44205973|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
44205974|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456228|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44205975|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44205976|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44205977|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44205978|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
44205979|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205980|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44205981|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44205982|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
44205983|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44205984|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44205985|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44205986|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
44205987|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44205988|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44205989|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456233|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456234|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456235|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
44456236|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814791|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814792|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43814793|NCT04790448|Irinotecan|irinotecan|mesh-list
43814794|NCT04790448|Camptothecin|camptothecin|mesh-list
43814830|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814832|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44456237|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
44456238|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456239|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456240|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44456242|NCT01632891|Lopinavir|lopinavir|mesh-list
44456243|NCT01632891|Tenofovir|tenofovir|mesh-list
44456244|NCT01632891|Emtricitabine|emtricitabine|mesh-list
44456245|NCT01632891|Nevirapine|nevirapine|mesh-list
44456246|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44456247|NCT01632891|Efavirenz|efavirenz|mesh-list
44456248|NCT01632891|Trimethoprim|trimethoprim|mesh-list
44456249|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
44456250|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44456251|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44456252|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456253|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456254|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456255|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44456269|NCT01632891|Renal Agents|renal agents|mesh-ancestor
44206008|NCT00420537|Cyclosporins|cyclosporins|mesh-list
44206009|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206010|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206011|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206012|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
44206013|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206014|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
44206015|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206016|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
44206017|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206018|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44206019|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206020|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43814908|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844940|NCT04320914|Ibuprofen|ibuprofen|mesh-list
43814924|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43814925|NCT04787510|Tinzaparin|tinzaparin|mesh-list
43814926|NCT04787510|Dalteparin|dalteparin|mesh-list
43814927|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
43814928|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43814929|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44206021|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44206022|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
44206023|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44206024|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
44206025|NCT00420563|Megestrol|megestrol|mesh-list
44206026|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206027|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
44206028|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206029|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206058|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206059|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206060|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206061|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
44206062|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206064|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206065|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206066|NCT00420693|Sevoflurane|sevoflurane|mesh-list
44206067|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44206068|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44206069|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
44206070|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
44206072|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206073|NCT00420797|Phenylephrine|phenylephrine|mesh-list
44206074|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
44206075|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44206076|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
44206077|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
44206078|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206079|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206080|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
44206081|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44206082|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
44206083|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206084|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44206085|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44206086|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44206087|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206088|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206089|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206090|NCT00420797|Protective Agents|protective agents|mesh-ancestor
44206091|NCT00420836|Tobramycin|tobramycin|mesh-list
44206101|NCT00420953|Amiodarone|amiodarone|mesh-list
44206102|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44206103|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206104|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44206105|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44206106|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206107|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44206108|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44206109|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44206110|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206111|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44206112|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44206113|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44206114|NCT00421018|Montelukast|montelukast|mesh-list
44206115|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44206116|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206117|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44206118|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206119|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206120|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206121|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44206122|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44206123|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206124|NCT00421044|Epothilone B|epothilone b|mesh-list
44206125|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206126|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206127|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
44206128|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206141|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
43861220|NCT02856893|Gefitinib|gefitinib|mesh-list
44206142|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206143|NCT00421096|Antiviral Agents|antiviral agents|mesh-ancestor
44206144|NCT00421096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206145|NCT00421096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206146|NCT00421096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206147|NCT00421096|Immunologic Factors|immunologic factors|mesh-ancestor
44206148|NCT00421096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206149|NCT00421109|Levocetirizine|levocetirizine|mesh-list
44206150|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44206151|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44206152|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
44206153|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
44206154|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206155|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206156|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206157|NCT00421122|Budesonide|budesonide|mesh-list
44206158|NCT00421122|Terbutaline|terbutaline|mesh-list
44206159|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
44206160|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
44206161|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206192|NCT00421252|Clopidogrel|clopidogrel|mesh-list
44206193|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44206194|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44206195|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44206196|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44206197|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
44206198|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206199|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206200|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206201|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
44206202|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206203|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206204|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206205|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206206|NCT00421369|Sertraline|sertraline|mesh-list
44206207|NCT00421369|Reboxetine|reboxetine|mesh-list
44206208|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
44206209|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206210|NCT00421369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44206211|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44206212|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44206213|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206214|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206216|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206217|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44206218|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206238|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
44206239|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206240|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44206241|NCT00421447|Anastrozole|anastrozole|mesh-list
44206242|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44206243|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206244|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44206245|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44206246|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206247|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206248|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44206249|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206250|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206251|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206252|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
44206253|NCT00421460|Testosterone|testosterone|mesh-list
44206254|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
44206255|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
44206256|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44206257|NCT00421460|Androgens|androgens|mesh-ancestor
44206258|NCT00421460|Hormones|hormones|mesh-ancestor
44206259|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206260|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206261|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44206262|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206263|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
44206264|NCT00421473|Atovaquone|atovaquone|mesh-list
44206265|NCT00421473|Proguanil|proguanil|mesh-list
44206266|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44206282|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206283|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206284|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206285|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206287|NCT00421538|Calcium|calcium|mesh-list
44206288|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44206289|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206290|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
44206291|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44206292|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44206293|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206294|NCT00421551|Ritonavir|ritonavir|mesh-list
44206295|NCT00421551|Darunavir|darunavir|mesh-list
44206296|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44206297|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44206298|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
44206299|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206300|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206301|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44206302|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44206303|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
44206307|NCT00421642|Adalimumab|adalimumab|mesh-list
44206335|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44206336|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
44206337|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206338|NCT00421785|Protective Agents|protective agents|mesh-ancestor
44206339|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206340|NCT00421785|Antidotes|antidotes|mesh-ancestor
44206341|NCT00421811|Melphalan|melphalan|mesh-list
44206342|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44206343|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
44206344|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206345|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206346|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44206398|NCT00421967|Ropivacaine|ropivacaine|mesh-list
44206399|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
44206400|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
44206401|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
44206402|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206403|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206404|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
44206405|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206406|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44206407|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44206408|NCT00421967|Analgesics|analgesics|mesh-ancestor
43814940|NCT04787276|Lactulose|lactulose|mesh-list
44206409|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206410|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206411|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44206412|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206413|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206414|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44206415|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44206416|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
44206417|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206418|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44206419|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44206420|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
44206421|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44206422|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206423|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
44206424|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
44206425|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44206426|NCT00421980|Etanercept|etanercept|mesh-list
44206427|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44206428|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44206429|NCT00421980|Analgesics|analgesics|mesh-ancestor
44206430|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
44206439|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
44206440|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206441|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44206442|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44206443|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44206444|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206445|NCT00422175|Siponimod|siponimod|mesh-list
44206446|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
44206447|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206448|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206449|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
44206450|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206451|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
44206452|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
44206453|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44206454|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44206455|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
44206456|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44206457|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44456297|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44456298|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456299|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44456300|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44456301|NCT01632566|Analgesics|analgesics|mesh-ancestor
44456302|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
44456303|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456304|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456305|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456306|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456307|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44456308|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44456309|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
44456310|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
44456311|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456312|NCT01632345|Efavirenz|efavirenz|mesh-list
44456313|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
44456314|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44456315|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44206473|NCT00422318|Benzbromarone|benzbromarone|mesh-list
44206505|NCT00422435|Paclitaxel|paclitaxel|mesh-list
44206506|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44206507|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206508|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206509|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
44206510|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206511|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206512|NCT00422526|Progesterone|progesterone|mesh-list
44206513|NCT00422526|Progestins|progestins|mesh-ancestor
44206514|NCT00422526|Hormones|hormones|mesh-ancestor
43814950|NCT04786158|Emetics|emetics|mesh-ancestor
44206515|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206516|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206517|NCT00422578|Tadalafil|tadalafil|mesh-list
44206518|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206519|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44206520|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44206521|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206522|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206523|NCT00422578|Urological Agents|urological agents|mesh-ancestor
44206524|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
44206525|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44206526|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44206527|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
44206528|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206529|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206530|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44206531|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
44206532|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
44206533|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44206534|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
44206535|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206536|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206544|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206545|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
44206546|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44206547|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
44456316|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206548|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206550|NCT00422643|Protective Agents|protective agents|mesh-ancestor
44206551|NCT00422682|Gemcitabine|gemcitabine|mesh-list
44206552|NCT00422682|Paclitaxel|paclitaxel|mesh-list
44206553|NCT00422682|Carboplatin|carboplatin|mesh-list
44206554|NCT00422682|Temozolomide|temozolomide|mesh-list
44206555|NCT00422682|Topotecan|topotecan|mesh-list
44206556|NCT00422682|Iniparib|iniparib|mesh-list
44206557|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44206558|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206607|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44206608|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
44206609|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
44206610|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206611|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206612|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206613|NCT00423007|Bromfenac|bromfenac|mesh-list
44206614|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44206615|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44206616|NCT00423007|Analgesics|analgesics|mesh-ancestor
44206617|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
44206618|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206619|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206620|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44206621|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206622|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
44206623|NCT00423020|Hematinics|hematinics|mesh-ancestor
44206624|NCT00423059|Bevacizumab|bevacizumab|mesh-list
44206625|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206626|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206627|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206628|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206629|NCT00423059|Growth Substances|growth substances|mesh-ancestor
44206630|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206631|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206632|NCT00423163|Voriconazole|voriconazole|mesh-list
44206634|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
44206654|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804115|NCT04949347|Glycerol|glycerol|mesh-list
44206655|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206656|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206657|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
44206658|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
44206659|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44206660|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
44206661|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206662|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
44206663|NCT00423371|Protective Agents|protective agents|mesh-ancestor
44206664|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
44206665|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44206666|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206667|NCT00423397|Interferons|interferons|mesh-list
44206668|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
44206669|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
44206670|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44206671|NCT00423397|Gefitinib|gefitinib|mesh-list
44206672|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206673|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
44206674|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206675|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
44206676|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206677|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206678|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206679|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206680|NCT00423475|Goserelin|goserelin|mesh-list
44206681|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44206685|NCT00423501|Hormones|hormones|mesh-ancestor
44206702|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206703|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44206705|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44206707|NCT00423696|Bevacizumab|bevacizumab|mesh-list
44206708|NCT00423696|Fluorouracil|fluorouracil|mesh-list
44206709|NCT00423696|Capecitabine|capecitabine|mesh-list
44206710|NCT00423696|Irinotecan|irinotecan|mesh-list
44206711|NCT00423696|Calcium|calcium|mesh-list
44206712|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
44206713|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44206714|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206715|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206716|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206717|NCT00423696|Growth Substances|growth substances|mesh-ancestor
44206718|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206719|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206720|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44206760|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206762|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
44206763|NCT00423826|Fludarabine|fludarabine|mesh-list
44206764|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
44206765|NCT00423826|Busulfan|busulfan|mesh-list
44206766|NCT00423826|Tacrolimus|tacrolimus|mesh-list
44206767|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206768|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44206769|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
44206770|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206771|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206772|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
44206773|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206774|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
44206775|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44206776|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44206778|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44206779|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44206780|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
44206781|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44206782|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
44206783|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43804159|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
44206784|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44206785|NCT00423865|Cisplatin|cisplatin|mesh-list
44206786|NCT00423865|Everolimus|everolimus|mesh-list
44206787|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206788|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206789|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
44206790|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206791|NCT00423969|Galantamine|galantamine|mesh-list
44206792|NCT00423969|Citalopram|citalopram|mesh-list
44206804|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44206805|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
44206806|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44206807|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206808|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44206809|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
44206810|NCT00423982|Vancomycin|vancomycin|mesh-list
44206811|NCT00423982|Rifampin|rifampin|mesh-list
44206812|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44206813|NCT00423982|Cloxacillin|cloxacillin|mesh-list
44206814|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
44206815|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44206816|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
44206817|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
44206818|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44206819|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206820|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206821|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44206822|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44206823|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44206824|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44206825|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44206826|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44206827|NCT00424034|Ambrisentan|ambrisentan|mesh-list
44206828|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44206829|NCT00424060|Sagopilone|sagopilone|mesh-list
44206830|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206831|NCT00424086|Vaccines|vaccines|mesh-list
44206832|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
44206833|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814952|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
43814953|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814954|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814955|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
43814956|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
43814957|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814958|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814959|NCT04786327|Edetic Acid|edetic acid|mesh-list
43804203|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206834|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44206835|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44206836|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206837|NCT00424151|Rituximab|rituximab|mesh-list
44206840|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
44206844|NCT00424164|Lapatinib|lapatinib|mesh-list
44206845|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206846|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44206847|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
44206848|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44206849|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206850|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44206851|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206852|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44206853|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44206854|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44206855|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44206856|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206857|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
44206858|NCT00424203|Doxorubicin|doxorubicin|mesh-list
44206859|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44206860|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44206861|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
44206862|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206863|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44206864|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44206865|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
44206866|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206893|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206894|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206895|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
44206896|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44206897|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44206898|NCT00424333|Insulin|insulin|mesh-list
44206899|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44206900|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206901|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206902|NCT00424411|Insulin|insulin|mesh-list
44206903|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44206904|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44206905|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456317|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456318|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
44456319|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814960|NCT04786327|Mitogens|mitogens|mesh-list
43814961|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
43814962|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
43814963|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814964|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
43814965|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43814966|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
43814967|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
43814968|NCT04786327|Antidotes|antidotes|mesh-ancestor
43804223|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804224|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804225|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804226|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43804227|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456320|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44456321|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44456322|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44456323|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44456324|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44456325|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44206923|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206924|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44206925|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44206926|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
44206927|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
44206928|NCT00424606|Docetaxel|docetaxel|mesh-list
44206929|NCT00424606|Epirubicin|epirubicin|mesh-list
44206930|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206931|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
44206932|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
44206933|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
44206934|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206935|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44206936|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44206937|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44206938|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206939|NCT00424710|Ranibizumab|ranibizumab|mesh-list
44206940|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44206941|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44206942|NCT00424710|Growth Substances|growth substances|mesh-ancestor
44206943|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206944|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
44206945|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206946|NCT00424723|Pemetrexed|pemetrexed|mesh-list
44206947|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44206948|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44206949|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44206950|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44206951|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44206952|NCT00424788|Natalizumab|natalizumab|mesh-list
44206953|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
44206955|NCT00424801|Nicorandil|nicorandil|mesh-list
44206967|NCT00424801|Diuretics|diuretics|mesh-ancestor
44206968|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
44206969|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44206970|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44206971|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44206972|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44206973|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44206974|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44206975|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
43844949|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43804259|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43804260|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
43804261|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
43804262|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804263|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
44206976|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44206977|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
44206978|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44206979|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
44206980|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44206981|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44206982|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
44206983|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
44206985|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
44206986|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44206987|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44206988|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44207019|NCT00424853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207020|NCT00424853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207021|NCT00424853|Immunologic Factors|immunologic factors|mesh-ancestor
44207022|NCT00424853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207023|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207024|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207025|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207026|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44207027|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44207028|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44207029|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207030|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207080|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44207081|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44207082|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44207083|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
44207084|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
44207085|NCT00425126|Hematinics|hematinics|mesh-ancestor
44207086|NCT00425152|Leucovorin|leucovorin|mesh-list
44207087|NCT00425152|Levamisole|levamisole|mesh-list
44207088|NCT00425152|Fluorouracil|fluorouracil|mesh-list
44207089|NCT00425152|Calcium|calcium|mesh-list
44207090|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
44207091|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44207092|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207093|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
44207094|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207095|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207096|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207097|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207098|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
44207099|NCT00425152|Antidotes|antidotes|mesh-ancestor
44207100|NCT00425152|Protective Agents|protective agents|mesh-ancestor
44207101|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
44207102|NCT00425152|Vitamins|vitamins|mesh-ancestor
44207103|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
44207104|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44207105|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
44207106|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
44207107|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44207108|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207131|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207132|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
44207133|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207134|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207135|NCT00425243|Zolpidem|zolpidem|mesh-list
44207136|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44207137|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44207138|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207139|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207140|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44207141|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
44207142|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
44207143|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207144|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207145|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44207146|NCT00425347|Elotuzumab|elotuzumab|mesh-list
44207147|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207148|NCT00425360|Gemcitabine|gemcitabine|mesh-list
44207149|NCT00425360|Capecitabine|capecitabine|mesh-list
44207150|NCT00425360|Sargramostim|sargramostim|mesh-list
44207151|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207152|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
44207153|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207154|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207183|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207184|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207185|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207186|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207187|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207188|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207189|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207190|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44207191|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44207192|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207193|NCT00425490|Incretins|incretins|mesh-ancestor
44207194|NCT00425490|Hormones|hormones|mesh-ancestor
44207195|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207196|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44207197|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
44207198|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207199|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207200|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
44207201|NCT00425516|Docetaxel|docetaxel|mesh-list
44207202|NCT00425516|Fluorouracil|fluorouracil|mesh-list
44207203|NCT00425516|Epirubicin|epirubicin|mesh-list
44207204|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207205|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
43862300|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
44207206|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207207|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207209|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
44207229|NCT00425594|Cathartics|cathartics|mesh-ancestor
44207230|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207231|NCT00425594|Laxatives|laxatives|mesh-ancestor
44207232|NCT00425620|Amphotericin B|amphotericin b|mesh-list
44207233|NCT00425620|Amebicides|amebicides|mesh-ancestor
44207234|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43815128|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44207235|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44207236|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207237|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207238|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
44207239|NCT00425646|Bevacizumab|bevacizumab|mesh-list
44207240|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
44207241|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207242|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207243|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44207244|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44207245|NCT00425646|Growth Substances|growth substances|mesh-ancestor
44207246|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207247|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
44207248|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44207249|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207250|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207251|NCT00425711|Acamprosate|acamprosate|mesh-list
44207252|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44207253|NCT00425724|Cyclosporine|cyclosporine|mesh-list
44207254|NCT00425724|Prednisone|prednisone|mesh-list
44207255|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
44207256|NCT00425724|Cyclosporins|cyclosporins|mesh-list
44207257|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207258|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
44207259|NCT00425724|Hormones|hormones|mesh-ancestor
44207260|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207261|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207262|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44207263|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207264|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207270|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207271|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815189|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815190|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43815191|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43815192|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43815193|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43815194|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
43655205|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655206|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207272|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44207273|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
44207274|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
44207275|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207276|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207277|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44207278|NCT00425724|Protective Agents|protective agents|mesh-ancestor
44207279|NCT00425841|Gemcitabine|gemcitabine|mesh-list
44207280|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
44207281|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207282|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
44207283|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207284|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207285|NCT00425841|Antiviral Agents|antiviral agents|mesh-ancestor
44207286|NCT00425841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207287|NCT00425841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207288|NCT00425841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207289|NCT00425841|Immunologic Factors|immunologic factors|mesh-ancestor
44207290|NCT00425841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207291|NCT00425906|Nicotine|nicotine|mesh-list
44207292|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44207293|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
44207294|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207295|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207296|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44207297|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44207298|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
44207299|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207300|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207301|NCT00425932|Rituximab|rituximab|mesh-list
44207302|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207303|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207304|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
44207305|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207310|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44207311|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44207312|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207313|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207314|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44207315|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207316|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
44207317|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44207318|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44207319|NCT00425997|Diuretics|diuretics|mesh-ancestor
44207320|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
44207321|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44207322|NCT00426010|Caffeine|caffeine|mesh-list
44207323|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44207324|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207325|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44207326|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207327|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207328|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44207329|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44207330|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
44207331|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207332|NCT00426023|Ketotifen|ketotifen|mesh-list
43815268|NCT05035862|Interferons|interferons|mesh-list
44207333|NCT00426023|Cyclosporine|cyclosporine|mesh-list
44207358|NCT00426101|Cyclosporine|cyclosporine|mesh-list
44207359|NCT00426101|Dexamethasone|dexamethasone|mesh-list
44207360|NCT00426101|Etoposide|etoposide|mesh-list
44207361|NCT00426101|Cyclosporins|cyclosporins|mesh-list
44207362|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207363|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
44207364|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
44207365|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207366|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207367|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207368|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
44207369|NCT00426101|Hormones|hormones|mesh-ancestor
44207370|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207371|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44207420|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44207421|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44207423|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44207424|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
44207425|NCT00426348|Protective Agents|protective agents|mesh-ancestor
44207426|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456338|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456339|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44456340|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
44456341|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
44456342|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456343|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456344|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456345|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
44456346|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207427|NCT00426413|Pioglitazone|pioglitazone|mesh-list
44207428|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44207429|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207430|NCT00426439|Chloroquine|chloroquine|mesh-list
44207431|NCT00426439|Lumefantrine|lumefantrine|mesh-list
44207432|NCT00426439|Artemether|artemether|mesh-list
44207433|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44207434|NCT00426439|Amebicides|amebicides|mesh-ancestor
44207435|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44207436|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44207437|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207438|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
44207439|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207440|NCT00426452|Vatalanib|vatalanib|mesh-list
44207441|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44207442|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207444|NCT00426478|Amlodipine|amlodipine|mesh-list
44207454|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44207455|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44207457|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
44207458|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44207459|NCT00426491|Misoprostol|misoprostol|mesh-list
44207460|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44207461|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
44207462|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44207463|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207464|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44207518|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44207519|NCT00426647|Narcotics|narcotics|mesh-ancestor
44207520|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207521|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207522|NCT00426647|Analgesics|analgesics|mesh-ancestor
44207523|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
44207524|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207525|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44207526|NCT00426673|Brivaracetam|brivaracetam|mesh-list
44207527|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
44207528|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
44207529|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44207530|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
44207531|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207532|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
44207533|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
44207534|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44207535|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207536|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207537|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44207538|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207548|NCT00426920|Insulin|insulin|mesh-list
44207571|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207573|NCT00426985|Analgesics|analgesics|mesh-ancestor
44207574|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
44207575|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207576|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207577|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207578|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207579|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207580|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207581|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207582|NCT00426998|Bevacizumab|bevacizumab|mesh-list
44207583|NCT00426998|Verteporfin|verteporfin|mesh-list
44207584|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207585|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207586|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44207587|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44207588|NCT00426998|Growth Substances|growth substances|mesh-ancestor
44207589|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207590|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
44207591|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44207592|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207593|NCT00427076|Vancomycin|vancomycin|mesh-list
44207594|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44207595|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207596|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207597|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44207617|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44207618|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207619|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207620|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
44207621|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207622|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44207623|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
44207624|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44207625|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44207626|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44207627|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207628|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44207629|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44207630|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
44207631|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207632|NCT00427167|Antacids|antacids|mesh-ancestor
44207633|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207634|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207635|NCT00427206|Acetaminophen|acetaminophen|mesh-list
44207636|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207637|NCT00427206|Analgesics|analgesics|mesh-ancestor
44207638|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
44207639|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207640|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207641|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
44207642|NCT00427232|BQ 788|bq 788|mesh-list
44207643|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44207644|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
44207645|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207646|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
44207647|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
44207648|NCT00427245|Goserelin|goserelin|mesh-list
44207649|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207656|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207657|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44207658|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44207660|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207661|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207662|NCT00427271|Analgesics|analgesics|mesh-ancestor
44207663|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
44207664|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207665|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207666|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207667|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207668|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44207669|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44207670|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207671|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44207672|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207673|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207674|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
44207675|NCT00427310|Fluorouracil|fluorouracil|mesh-list
44207676|NCT00427310|Heparin|heparin|mesh-list
44207677|NCT00427310|Calcium heparin|calcium heparin|mesh-list
44207678|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
44207679|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207680|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207681|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207682|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207704|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
44207706|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207707|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44207708|NCT00427388|Protective Agents|protective agents|mesh-ancestor
44207709|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44207710|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207711|NCT00427414|Daunorubicin|daunorubicin|mesh-list
44207712|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207713|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44207714|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207715|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44207716|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44207717|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207718|NCT00427427|Trastuzumab|trastuzumab|mesh-list
44207719|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207720|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207721|NCT00427466|Pemetrexed|pemetrexed|mesh-list
44207722|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207723|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207724|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207725|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44207726|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44207727|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
44134038|NCT00156650|Acyline|acyline|mesh-list
44207728|NCT00427492|Antacids|antacids|mesh-ancestor
44207729|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207730|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207748|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207749|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207750|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207751|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44207752|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44207753|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
44207754|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
44207755|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207756|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44207757|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207758|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207759|NCT00427596|Solabegron|solabegron|mesh-list
44207760|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44207761|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44207762|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44207763|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
44207764|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207765|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207766|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815380|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207767|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
44207768|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207769|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207770|NCT00427713|Capecitabine|capecitabine|mesh-list
44207771|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
44207772|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207773|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
44207774|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207775|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207776|NCT00427882|Alfuzosin|alfuzosin|mesh-list
44207777|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44207785|NCT00427947|Ropivacaine|ropivacaine|mesh-list
44207790|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
44207791|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207792|NCT00428025|Diclofenac|diclofenac|mesh-list
44207793|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44207794|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44207795|NCT00428025|Analgesics|analgesics|mesh-ancestor
44207796|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
44207797|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207798|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207799|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207800|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207801|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44207802|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207803|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207805|NCT00428064|Sirolimus|sirolimus|mesh-list
44207806|NCT00428064|Cyclosporins|cyclosporins|mesh-list
44207807|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207808|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207809|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207810|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
44207811|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207812|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
44207813|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207814|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
44207815|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44207816|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44207817|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207818|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44207819|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207820|NCT00428129|Plasminogen|plasminogen|mesh-list
44207821|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44207822|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44207823|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207824|NCT00428142|Prednisone|prednisone|mesh-list
44207825|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
44207830|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
44207831|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207832|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43815524|NCT03901001|Sirolimus|sirolimus|mesh-list
44207833|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44207834|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
44207835|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207836|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207837|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44207838|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44207839|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44207840|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
44207841|NCT00428142|Hormones|hormones|mesh-ancestor
44207842|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44207843|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44207844|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44207845|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
44207846|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
44207847|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
44207848|NCT00428168|Betahistine|betahistine|mesh-list
44207849|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
44207850|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
44207851|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
44207852|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207853|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207854|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207855|NCT00428181|Ethanol|ethanol|mesh-list
44207856|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44207857|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655231|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
43815526|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815527|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815528|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43815529|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815602|NCT03596918|Bleomycin|bleomycin|mesh-list
44207858|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44207859|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207860|NCT00428194|Cisplatin|cisplatin|mesh-list
44207861|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44207862|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207863|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44207864|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456347|NCT01632306|Antidotes|antidotes|mesh-ancestor
44456348|NCT01632306|Protective Agents|protective agents|mesh-ancestor
44456349|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
44456350|NCT01632306|Vitamins|vitamins|mesh-ancestor
44456351|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
44456352|NCT01632241|Belimumab|belimumab|mesh-list
44456353|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456354|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
44456355|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456356|NCT01632150|Thalidomide|thalidomide|mesh-list
43862859|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456357|NCT01632150|Dexamethasone|dexamethasone|mesh-list
44207866|NCT00428272|Interferons|interferons|mesh-list
44207867|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
44207868|NCT00428272|Lexatumumab|lexatumumab|mesh-list
44207869|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44207870|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207871|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
44207872|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207873|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
44207874|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207875|NCT00428311|Metformin|metformin|mesh-list
44207876|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
44207877|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44207878|NCT00428311|Estradiol|estradiol|mesh-list
44207879|NCT00428311|Cyproterone|cyproterone|mesh-list
43815774|NCT03358706|Vitamins|vitamins|mesh-ancestor
44207880|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44207881|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207882|NCT00428311|Estrogens|estrogens|mesh-ancestor
44207883|NCT00428311|Hormones|hormones|mesh-ancestor
44207905|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
44207906|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207907|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207908|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207909|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44207910|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
44207911|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207912|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44207913|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
44207914|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44207915|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
44207916|NCT00428428|Protective Agents|protective agents|mesh-ancestor
44207917|NCT00428454|Sirolimus|sirolimus|mesh-list
44207918|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44207919|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207920|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44207921|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207922|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
44207923|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207924|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
44207925|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815776|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815777|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43815778|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43815779|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815780|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815781|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44207926|NCT00428480|Methamphetamine|methamphetamine|mesh-list
44207927|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44207928|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207929|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
44207930|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
44207931|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207932|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
44207933|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207934|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207935|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
44207936|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44207946|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207947|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44207948|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207949|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207950|NCT00428545|Bevacizumab|bevacizumab|mesh-list
44207951|NCT00428545|Bortezomib|bortezomib|mesh-list
44207952|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815822|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815823|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
44207953|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207954|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44207955|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44207956|NCT00428545|Growth Substances|growth substances|mesh-ancestor
44207957|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207958|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
44207959|NCT00428558|Cytarabine|cytarabine|mesh-list
44207960|NCT00428558|Daunorubicin|daunorubicin|mesh-list
44207961|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44207962|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
44207963|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207964|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44207965|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
44207966|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44207967|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44207968|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
44207969|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207970|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44207971|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44207972|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44207973|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207974|NCT00428649|Selenium|selenium|mesh-list
44207975|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
44207976|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207977|NCT00428649|Protective Agents|protective agents|mesh-ancestor
44207978|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207979|NCT00428649|Trace Elements|trace elements|mesh-ancestor
44207980|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
44164300|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
44164309|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
44164310|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44164311|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845140|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845141|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845142|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
43815856|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
44207981|NCT00428701|Esomeprazole|esomeprazole|mesh-list
44207982|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44207983|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44207984|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44207985|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44207986|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207987|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
44207988|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44207989|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
44207990|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44207991|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44207992|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44207993|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
44207994|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44207995|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
44207996|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44207997|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44207998|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44207999|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208000|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
44208001|NCT00428727|Protective Agents|protective agents|mesh-ancestor
44208002|NCT00428766|Farletuzumab|farletuzumab|mesh-list
44208003|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208004|NCT00428818|Doxycycline|doxycycline|mesh-list
44208005|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44208006|NCT00428818|Trimethoprim|trimethoprim|mesh-list
44208007|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
44208010|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
44208028|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
44208029|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208030|NCT00428883|Protective Agents|protective agents|mesh-ancestor
44208031|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208032|NCT00428883|Antidotes|antidotes|mesh-ancestor
44208033|NCT00428896|Gefitinib|gefitinib|mesh-list
44208034|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208035|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44208036|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804909|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208037|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208038|NCT00428909|Acetaminophen|acetaminophen|mesh-list
44208039|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
44208040|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44208041|NCT00428909|Analgesics|analgesics|mesh-ancestor
44208042|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
44208043|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208044|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208045|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
44208046|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208047|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44208048|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208049|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208050|NCT00429065|Rituximab|rituximab|mesh-list
44208051|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208052|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208053|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
44208075|NCT00429234|Dasatinib|dasatinib|mesh-list
44208076|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208077|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
44208078|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208079|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208080|NCT00429234|Antiviral Agents|antiviral agents|mesh-ancestor
44208081|NCT00429234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208082|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208083|NCT00429234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208084|NCT00429234|Immunologic Factors|immunologic factors|mesh-ancestor
44208085|NCT00429234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208086|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44208087|NCT00429247|Trastuzumab|trastuzumab|mesh-list
44208088|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208089|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208090|NCT00429377|Tacrolimus|tacrolimus|mesh-list
44208091|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43863086|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208092|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
44208093|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208094|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44208095|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208096|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208097|NCT00429442|Simvastatin|simvastatin|mesh-list
44208098|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44208099|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44208100|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
44208101|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208119|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44208120|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208121|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208122|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
44208123|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208124|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
44208125|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208126|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
44208127|NCT00429520|Protective Agents|protective agents|mesh-ancestor
44208128|NCT00429533|Dapsone|dapsone|mesh-list
44208129|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208130|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
44208131|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43843019|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843020|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848655|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
43848656|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848657|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848659|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208132|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44208133|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44208134|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208135|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208136|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
44208137|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44208138|NCT00429559|Gemcitabine|gemcitabine|mesh-list
44208139|NCT00429559|Topotecan|topotecan|mesh-list
44208140|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208141|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
44208142|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208143|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208144|NCT00429559|Antiviral Agents|antiviral agents|mesh-ancestor
44208145|NCT00429559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208146|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208167|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208168|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208169|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208170|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44208171|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
44208172|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208173|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208174|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44208175|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
44208176|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208177|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
44208178|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208180|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
44208181|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
44208182|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208183|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208184|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208185|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44208186|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208222|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
44208223|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
44208224|NCT00429871|Docetaxel|docetaxel|mesh-list
44208225|NCT00429871|Capecitabine|capecitabine|mesh-list
44208226|NCT00429871|Epirubicin|epirubicin|mesh-list
44208227|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208228|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208229|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208230|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815979|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
43815980|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815981|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815983|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815984|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
43815985|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815986|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848664|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848665|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208231|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208232|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208233|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
44208234|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208235|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208236|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208237|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208238|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
44208239|NCT00429897|Amiloride|amiloride|mesh-list
44208240|NCT00429897|Spironolactone|spironolactone|mesh-list
44208241|NCT00429897|Furosemide|furosemide|mesh-list
44208242|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44208243|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
44456358|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
44208244|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208245|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208246|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44208271|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
44208272|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44208273|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208274|NCT00429975|Renal Agents|renal agents|mesh-ancestor
44208275|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44208276|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208277|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208278|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208279|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208280|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208281|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44208282|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44208283|NCT00430001|Docetaxel|docetaxel|mesh-list
44208284|NCT00430001|Trastuzumab|trastuzumab|mesh-list
44208285|NCT00430001|Vinorelbine|vinorelbine|mesh-list
44208286|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208287|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208288|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208289|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208290|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208291|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44208292|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208293|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
44208294|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208295|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43815987|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
43815988|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816028|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816029|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816030|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43816031|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
43816032|NCT02227940|Antiviral Agents|antiviral agents|mesh-ancestor
43825084|NCT05504694|Ofatumumab|ofatumumab|mesh-list
44208296|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208297|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208298|NCT00430079|Etanidazole|etanidazole|mesh-list
44208299|NCT00430079|Imidazole|imidazole|mesh-list
44208300|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208302|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208312|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44456359|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
44456360|NCT01632150|Elotuzumab|elotuzumab|mesh-list
44456361|NCT01632150|BB 1101|bb 1101|mesh-list
44456362|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208313|NCT00430118|Cytarabine|cytarabine|mesh-list
44208314|NCT00430118|Dexamethasone|dexamethasone|mesh-list
44208315|NCT00430118|Prednisone|prednisone|mesh-list
44208316|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
44208317|NCT00430118|Ifosfamide|ifosfamide|mesh-list
44208318|NCT00430118|Doxorubicin|doxorubicin|mesh-list
44208319|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44208320|NCT00430118|Methotrexate|methotrexate|mesh-list
44208321|NCT00430118|Etoposide|etoposide|mesh-list
44208322|NCT00430118|Vincristine|vincristine|mesh-list
44208323|NCT00430118|Daunorubicin|daunorubicin|mesh-list
44208324|NCT00430118|Asparaginase|asparaginase|mesh-list
44208325|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
44208326|NCT00430118|Thioguanine|thioguanine|mesh-list
44208327|NCT00430118|Vindesine|vindesine|mesh-list
44208328|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208329|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
44208330|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208331|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208332|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44208333|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
44208364|NCT00430144|Belotecan|belotecan|mesh-list
44208365|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44208366|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208367|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208368|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208369|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208370|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44208371|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44208372|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44208373|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208374|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208375|NCT00430170|Dipyridamole|dipyridamole|mesh-list
44208376|NCT00430170|Caffeine|caffeine|mesh-list
44208377|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44208378|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208379|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44208380|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208381|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208382|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44208383|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44208384|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
44208385|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208386|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44208387|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208408|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208409|NCT00430261|Sunitinib|sunitinib|mesh-list
44208410|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208411|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44208412|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44208413|NCT00430261|Growth Substances|growth substances|mesh-ancestor
44208414|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208415|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
44208416|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44208417|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208418|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208419|NCT00430365|Lenalidomide|lenalidomide|mesh-list
44208420|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
44208421|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208422|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44208423|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44208424|NCT00430365|Growth Substances|growth substances|mesh-ancestor
44208425|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
44208426|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208460|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44208461|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44208462|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208463|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208464|NCT00430742|Hormones|hormones|mesh-ancestor
44208465|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208466|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208467|NCT00430794|Spironolactone|spironolactone|mesh-list
44208468|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44208469|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
44208470|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208471|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208472|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44208473|NCT00430794|Diuretics|diuretics|mesh-ancestor
44208474|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
44208475|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
44208476|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
44208477|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44208478|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44208479|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208480|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208481|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208482|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208483|NCT00430833|Candesartan|candesartan|mesh-list
44208484|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44208501|NCT00430924|Eplerenone|eplerenone|mesh-list
44208505|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208506|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44208507|NCT00430924|Diuretics|diuretics|mesh-ancestor
44208508|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
44208509|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44208510|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44208511|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44208512|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208513|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208514|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44208515|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44208516|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208517|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
44208518|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208519|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
44208520|NCT00431028|Triamcinolone|triamcinolone|mesh-list
44208521|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208522|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
44208523|NCT00431028|Hormones|hormones|mesh-ancestor
44208524|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208525|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208526|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208527|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208528|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44208529|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208530|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208531|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43863477|NCT02495896|Gemcitabine|gemcitabine|mesh-list
44208532|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208533|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44208534|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44208546|NCT00431080|Lenograstim|lenograstim|mesh-list
44208548|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44208549|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208550|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
44208551|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
44208552|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
44208553|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208554|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208555|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
44208556|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208557|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208558|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44208559|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
44208560|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44208561|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208562|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208563|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208564|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208565|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
44208566|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208567|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208568|NCT00431106|Gemcitabine|gemcitabine|mesh-list
44208569|NCT00431106|Capecitabine|capecitabine|mesh-list
44208570|NCT00431106|Vinorelbine|vinorelbine|mesh-list
44208572|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
44208595|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
44208596|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44208597|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208598|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
44208599|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208600|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208601|NCT00431145|Niacin|niacin|mesh-list
44208602|NCT00431145|Niacinamide|niacinamide|mesh-list
44208603|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
44208604|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44208605|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
44208606|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208607|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44208608|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
44208609|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
44208610|NCT00431145|Vitamins|vitamins|mesh-ancestor
44208611|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
44208612|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208613|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
44208614|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
44208615|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208616|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208617|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208618|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
44208619|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208620|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208621|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208622|NCT00431197|Ketoconazole|ketoconazole|mesh-list
44208623|NCT00431197|Testosterone|testosterone|mesh-list
44208624|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
44208625|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208626|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44208627|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44208628|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208630|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44208634|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44208636|NCT00431197|Hormones|hormones|mesh-ancestor
44208637|NCT00431236|Dexamethasone|dexamethasone|mesh-list
43816034|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816035|NCT02227940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816036|NCT02227940|Immunologic Factors|immunologic factors|mesh-ancestor
43816037|NCT02227940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816038|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816039|NCT02072486|Sorafenib|sorafenib|mesh-list
44208638|NCT00431236|Ondansetron|ondansetron|mesh-list
44208639|NCT00431236|Casopitant|casopitant|mesh-list
44208640|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44208641|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
44208642|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
44208643|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208644|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208645|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208646|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
44208647|NCT00431236|Hormones|hormones|mesh-ancestor
44208649|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44208695|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208696|NCT00431353|Valganciclovir|valganciclovir|mesh-list
44208697|NCT00431353|Ganciclovir|ganciclovir|mesh-list
44208698|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
44208699|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
44208700|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208701|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44208702|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208703|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208704|NCT00431379|Tenecteplase|tenecteplase|mesh-list
44208705|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44208706|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44208707|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208708|NCT00431392|Atropine|atropine|mesh-list
44208709|NCT00431392|Propranolol|propranolol|mesh-list
44208710|NCT00431392|Phenylephrine|phenylephrine|mesh-list
44208711|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
44208712|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
44208713|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44208714|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
44208715|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
44208716|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208717|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208718|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
44208719|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44208720|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
44208744|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44208745|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44208746|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208747|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208748|NCT00431418|Urological Agents|urological agents|mesh-ancestor
44208749|NCT00431522|Valproic Acid|valproic acid|mesh-list
44208750|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
44208751|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208752|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208753|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
44208754|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43863699|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
44208755|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208756|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
44208757|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44208758|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208759|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44208760|NCT00431561|Temozolomide|temozolomide|mesh-list
44208761|NCT00431561|Lomustine|lomustine|mesh-list
44208762|NCT00431561|Trabedersen|trabedersen|mesh-list
44208763|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44208764|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
43816120|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43816121|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816122|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43816158|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208765|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208766|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208767|NCT00431613|Gemcitabine|gemcitabine|mesh-list
44208768|NCT00431613|Carboplatin|carboplatin|mesh-list
44208769|NCT00431613|Docetaxel|docetaxel|mesh-list
44208792|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44208793|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44208794|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44208796|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208797|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208798|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
44208799|NCT00431678|Levofloxacin|levofloxacin|mesh-list
44208800|NCT00431678|Ofloxacin|ofloxacin|mesh-list
44208801|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
44208802|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44208803|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44208804|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208805|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208806|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208807|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208808|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208809|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208810|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44208811|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
43816191|NCT05473858|Phentolamine|phentolamine|mesh-list
44208812|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44208813|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208814|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44208815|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44208816|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44208818|NCT00431678|Renal Agents|renal agents|mesh-ancestor
44208839|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208840|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44208841|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44208842|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208843|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456364|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456365|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44456366|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44456367|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
44456368|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456369|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456370|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44456371|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456372|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
44456373|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
44456374|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456375|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44456376|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
44456377|NCT01632150|Hormones|hormones|mesh-ancestor
44456378|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456379|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44456380|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456381|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456382|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
44208848|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
44208849|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
44208850|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44208851|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208852|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208853|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
44208854|NCT00431990|Hormones|hormones|mesh-ancestor
44208855|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44208856|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44208857|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208858|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44208859|NCT00432016|Zidovudine|zidovudine|mesh-list
44208860|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
44208861|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208862|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44208863|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43805191|NCT04935073|Cetrorelix|cetrorelix|mesh-list
44208864|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208865|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
44208866|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44208867|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44208868|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44208869|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
44208900|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44208901|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44208902|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44208903|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44208904|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
44208905|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208906|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208907|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208908|NCT00432146|Lugol's solution|lugol's solution|mesh-list
44208909|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
44208910|NCT00432146|Coagulants|coagulants|mesh-ancestor
44208911|NCT00432198|Zolpidem|zolpidem|mesh-list
44208912|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44208913|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44208914|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44208915|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208916|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44208917|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
44208918|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
44208919|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208920|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208921|NCT00432302|Sagopilone|sagopilone|mesh-list
44208922|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44208923|NCT00432315|Docetaxel|docetaxel|mesh-list
44208949|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
44208950|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44208951|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
44208952|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44208953|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816279|NCT05347459|Hormones|hormones|mesh-ancestor
44208954|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208955|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44208956|NCT00432367|Renal Agents|renal agents|mesh-ancestor
44208957|NCT00432393|Levodopa|levodopa|mesh-list
44208958|NCT00432393|Carbidopa|carbidopa|mesh-list
44208959|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
44208960|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44208961|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44208962|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
44208963|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44208964|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44208965|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44208966|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44208967|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44208968|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44208969|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
44208970|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
44208971|NCT00432406|Etanercept|etanercept|mesh-list
44208972|NCT00432406|Infliximab|infliximab|mesh-list
44208973|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
44208974|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44208975|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44208978|NCT00432406|Analgesics|analgesics|mesh-ancestor
44208995|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44208996|NCT00432549|Topiramate|topiramate|mesh-list
44208997|NCT00432549|Almotriptan|almotriptan|mesh-list
44208998|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
44208999|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44209000|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209001|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44209002|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
44209003|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209004|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209005|NCT00432575|Surinabant|surinabant|mesh-list
44209006|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44209007|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44209008|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209009|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209010|NCT00432575|Hormones|hormones|mesh-ancestor
44209011|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209012|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209013|NCT00432588|Misoprostol|misoprostol|mesh-list
44209014|NCT00432588|Dinoprostone|dinoprostone|mesh-list
44209015|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43816288|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43816330|NCT05225363|Fludarabine|fludarabine|mesh-list
44209016|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
44209017|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44209018|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209019|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44209020|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209021|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
44209022|NCT00432614|Citalopram|citalopram|mesh-list
44209023|NCT00432614|Amibegron|amibegron|mesh-list
44209039|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
44209040|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
44209041|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209042|NCT00432653|Rituximab|rituximab|mesh-list
44209043|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209044|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209045|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
44209046|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209047|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209048|NCT00432757|Ketotifen|ketotifen|mesh-list
44209049|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
44209050|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
44209051|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44209052|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
44209053|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
44209054|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209055|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209056|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209057|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44209058|NCT00432796|Dalteparin|dalteparin|mesh-list
44209059|NCT00432796|Tinzaparin|tinzaparin|mesh-list
44209060|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44209061|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
44209062|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44209066|NCT00432861|Pancreatin|pancreatin|mesh-list
44209090|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209091|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44209092|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44209093|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
44209094|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209095|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209096|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
44209097|NCT00433043|Protective Agents|protective agents|mesh-ancestor
44209098|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44209099|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209100|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44209101|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
44209102|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44209103|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44209104|NCT00433069|Pioglitazone|pioglitazone|mesh-list
44209105|NCT00433069|Interferons|interferons|mesh-list
44209106|NCT00433069|Ribavirin|ribavirin|mesh-list
44209107|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
44209108|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
44209109|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209110|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
44209111|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209112|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
44209113|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209114|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
44209115|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209116|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44209117|NCT00433095|Trastuzumab|trastuzumab|mesh-list
44209118|NCT00433095|Vinorelbine|vinorelbine|mesh-list
44209119|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209120|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209121|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209131|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209132|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209133|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209134|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44209135|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44209136|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44209137|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209138|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44209139|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
44209140|NCT00433121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44209141|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44209142|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43864100|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44209143|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44209144|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209145|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
44209146|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209148|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209149|NCT00433173|Anastrozole|anastrozole|mesh-list
44209150|NCT00433173|Goserelin|goserelin|mesh-list
44209151|NCT00433173|Testosterone|testosterone|mesh-list
44209152|NCT00433173|Androgens|androgens|mesh-ancestor
44209153|NCT00433173|Hormones|hormones|mesh-ancestor
44209154|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209155|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848832|NCT03986970|Tenofovir|tenofovir|mesh-list
43816405|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816406|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816407|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209156|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209157|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209158|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44209159|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44209160|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209161|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209162|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44209171|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209172|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209173|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
44209174|NCT00433225|Prednisolone|prednisolone|mesh-list
44209175|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44209176|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
44209177|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44209178|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
44209179|NCT00433225|Ketorolac|ketorolac|mesh-list
44209180|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44209181|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
44209182|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209183|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
44209184|NCT00433225|Hormones|hormones|mesh-ancestor
44209185|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209186|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209187|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209188|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209189|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
44209190|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
43816550|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816551|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816552|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43816553|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43816554|NCT04733963|Growth Substances|growth substances|mesh-ancestor
44209191|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209192|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209193|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44209194|NCT00433225|Protective Agents|protective agents|mesh-ancestor
44209195|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209196|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209197|NCT00433225|Analgesics|analgesics|mesh-ancestor
44209198|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
44209199|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209200|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44209201|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209202|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209203|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209204|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209205|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44209206|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44209209|NCT00433277|Cyclosporine|cyclosporine|mesh-list
44209210|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44209211|NCT00433277|Cyclosporins|cyclosporins|mesh-list
44209212|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209213|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209214|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209215|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
44209216|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209217|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
44209218|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209219|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
44209220|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209221|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44209222|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44209223|NCT00433316|Ropivacaine|ropivacaine|mesh-list
44209224|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
44209225|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
44209226|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44209227|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209228|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
44209229|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209230|NCT00433342|Floxacillin|floxacillin|mesh-list
44209231|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209232|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209233|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
44209234|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44209235|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44209236|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209237|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209238|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825098|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
43825099|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825100|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825101|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43825102|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816568|NCT04589611|Amobarbital|amobarbital|mesh-list
43816569|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
43816570|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44209239|NCT00433407|Trastuzumab|trastuzumab|mesh-list
44209240|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209241|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209251|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44209252|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209253|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
44209254|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209255|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209256|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44209257|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
44209258|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209259|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209260|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44209261|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209262|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
44209264|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209265|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209266|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209267|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209268|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209269|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209270|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44209271|NCT00433485|Sirolimus|sirolimus|mesh-list
44209272|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209273|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209274|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44209280|NCT00433498|Cisplatin|cisplatin|mesh-list
44209300|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209301|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209302|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44209303|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
44209304|NCT00433615|Hematinics|hematinics|mesh-ancestor
44209305|NCT00433641|Sibutramine|sibutramine|mesh-list
44209306|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
44209307|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209308|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
44209309|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44209310|NCT00433719|Efavirenz|efavirenz|mesh-list
44209311|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
44209312|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44209313|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44209314|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209315|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209316|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
44209317|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209318|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44209319|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44209320|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44209321|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44209322|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44209323|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44209324|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44209325|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44209326|NCT00433732|Naproxen|naproxen|mesh-list
44209327|NCT00433732|Sumatriptan|sumatriptan|mesh-list
44209328|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209343|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
44209344|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456403|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
44456404|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
43816643|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
44456405|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456406|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456407|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456408|NCT01631227|Eprosartan|eprosartan|mesh-list
44456409|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44456410|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
44456411|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44456412|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456413|NCT01630811|Quinidine|quinidine|mesh-list
44456414|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
44456415|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
44456416|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456417|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44456418|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44456419|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456420|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456421|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456422|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44209345|NCT00433784|Clopidogrel|clopidogrel|mesh-list
44209346|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44209347|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44209348|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44209367|NCT00433927|Irinotecan|irinotecan|mesh-list
44209368|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
44209369|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209370|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209371|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44209372|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44209373|NCT00433927|Growth Substances|growth substances|mesh-ancestor
44209374|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209375|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
44209376|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44209377|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209378|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209379|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209380|NCT00433927|Antidotes|antidotes|mesh-ancestor
44209381|NCT00433927|Protective Agents|protective agents|mesh-ancestor
44209382|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
44209383|NCT00433927|Vitamins|vitamins|mesh-ancestor
44209384|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
44209385|NCT00433927|Hematinics|hematinics|mesh-ancestor
44209386|NCT00433940|Prednisolone|prednisolone|mesh-list
44209387|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209388|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
44209389|NCT00433940|Hormones|hormones|mesh-ancestor
44209390|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209391|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209392|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209393|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209394|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
44209414|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209415|NCT00434005|Protective Agents|protective agents|mesh-ancestor
44209416|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209418|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
44209419|NCT00434031|Docetaxel|docetaxel|mesh-list
44209420|NCT00434031|Doxorubicin|doxorubicin|mesh-list
44209421|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44209423|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209424|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
44209425|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209426|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209427|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44209428|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
44209429|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209430|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209431|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44209432|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209433|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
43816695|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43816696|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43816697|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816698|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
43816699|NCT04331002|Hormones|hormones|mesh-ancestor
43816700|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816701|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816702|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805518|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209434|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209435|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44209436|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44209437|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209438|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209439|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209440|NCT00434044|Etanercept|etanercept|mesh-list
44209441|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209442|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209443|NCT00434044|Analgesics|analgesics|mesh-ancestor
44209444|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
44209445|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209446|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209447|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209448|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209449|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209450|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209453|NCT00434083|Sumatriptan|sumatriptan|mesh-list
44209454|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209455|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209456|NCT00434083|Analgesics|analgesics|mesh-ancestor
44209457|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
44209458|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209459|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209460|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209461|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209462|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
44209463|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44209464|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209465|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209466|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44209467|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44209468|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44209469|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
44209470|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209471|NCT00434096|Rimonabant|rimonabant|mesh-list
44209472|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44209473|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44209474|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44209475|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816706|NCT04313634|Dasatinib|dasatinib|mesh-list
44209476|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209477|NCT00434096|Hormones|hormones|mesh-ancestor
44209478|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209479|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209480|NCT00434135|Gemcitabine|gemcitabine|mesh-list
44209481|NCT00434135|Paclitaxel|paclitaxel|mesh-list
44209482|NCT00434135|Pemetrexed|pemetrexed|mesh-list
44209483|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209485|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209493|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209494|NCT00434135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43864476|NCT02285140|Vancomycin|vancomycin|mesh-list
44209495|NCT00434135|Immunologic Factors|immunologic factors|mesh-ancestor
44209496|NCT00434135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209497|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44209498|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44209500|NCT00434174|Everolimus|everolimus|mesh-list
44209501|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209502|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209503|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209504|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44209505|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44209506|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209507|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
44209508|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209509|NCT00434239|Lenalidomide|lenalidomide|mesh-list
44209510|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
44209511|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209512|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44209513|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44209514|NCT00434239|Growth Substances|growth substances|mesh-ancestor
44209515|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
44209516|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209517|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
44209518|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44209520|NCT00434382|Fentanyl|fentanyl|mesh-list
44209543|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44209544|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209546|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209547|NCT00434668|Cisplatin|cisplatin|mesh-list
44209548|NCT00434668|Docetaxel|docetaxel|mesh-list
44209549|NCT00434668|Vinorelbine|vinorelbine|mesh-list
44209550|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209551|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209552|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209553|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
43816805|NCT04053140|Penicillin G|penicillin g|mesh-list
44209554|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209555|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209556|NCT00434681|Acetaminophen|acetaminophen|mesh-list
44209557|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209558|NCT00434681|Analgesics|analgesics|mesh-ancestor
44209559|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
44209560|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209561|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209562|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
44209563|NCT00434746|Fezakinumab|fezakinumab|mesh-list
44209564|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
44209565|NCT00434772|Glucagon|glucagon|mesh-list
44209566|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209567|NCT00434772|Hormones|hormones|mesh-ancestor
44209568|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209569|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209570|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
44209571|NCT00434824|Testosterone|testosterone|mesh-list
44209572|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
44209573|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
44209574|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44209575|NCT00434824|Androgens|androgens|mesh-ancestor
44209576|NCT00434824|Hormones|hormones|mesh-ancestor
44209577|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209584|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44209585|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44209586|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209587|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209588|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
44209589|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209590|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209591|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44209592|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209593|NCT00434941|Capecitabine|capecitabine|mesh-list
44209594|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209595|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
43825132|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825133|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816837|NCT03971643|Vilobelimab|vilobelimab|mesh-list
43816838|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
44209596|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209597|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209598|NCT00435058|Timolol|timolol|mesh-list
44209599|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44209600|NCT00435058|Travoprost|travoprost|mesh-list
44209601|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44209602|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44209603|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
44209604|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209605|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209606|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209607|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44209608|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44209630|NCT00435292|Naproxen|naproxen|mesh-list
44209631|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209632|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209633|NCT00435292|Analgesics|analgesics|mesh-ancestor
44209634|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
44209635|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209636|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209637|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209638|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209639|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
44209640|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44209641|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209642|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209643|NCT00435305|Vancomycin|vancomycin|mesh-list
44209644|NCT00435305|Meropenem|meropenem|mesh-list
44209645|NCT00435305|Tazobactam|tazobactam|mesh-list
44209647|NCT00435305|Piperacillin|piperacillin|mesh-list
44209648|NCT00435305|Ceftazidime|ceftazidime|mesh-list
44209649|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44209650|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44209651|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209652|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44209653|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209654|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209655|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43816846|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816847|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
43816848|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
43816849|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816850|NCT03880396|Cisplatin|cisplatin|mesh-list
43816852|NCT03863288|Oxytocin|oxytocin|mesh-list
44209656|NCT00435331|Verapamil|verapamil|mesh-list
44209657|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44209658|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44209659|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209660|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209674|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44209675|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
44209676|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44209677|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44209678|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44209679|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44209680|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209682|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
44209683|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
44209684|NCT00435500|Protective Agents|protective agents|mesh-ancestor
44209685|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456423|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43816862|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816863|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
43816864|NCT03785925|Nivolumab|nivolumab|mesh-list
43816865|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816902|NCT03544606|Vitamins|vitamins|mesh-ancestor
44456424|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
44456425|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44456426|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
44456427|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44456428|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44456429|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456430|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456431|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44456432|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44456433|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
44456434|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44456435|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44456436|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456437|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44456438|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44456439|NCT01630135|Fluticasone|fluticasone|mesh-list
44456440|NCT01630135|Xhance|xhance|mesh-list
44456456|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209686|NCT00435747|Parecoxib|parecoxib|mesh-list
44209687|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44209688|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44209689|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209690|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209691|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44209692|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209693|NCT00435747|Analgesics|analgesics|mesh-ancestor
44209694|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
44209695|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209696|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209697|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209698|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209699|NCT00435760|Bromides|bromides|mesh-list
44209700|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
44209701|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44209702|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
43816920|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209703|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209704|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209705|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44209706|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
44209707|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
44209708|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44209709|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
44209710|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209711|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209712|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
44209713|NCT00435799|Riboflavin|riboflavin|mesh-list
44209714|NCT00435799|Dextrans|dextrans|mesh-list
44209715|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44209716|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
44209727|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209728|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209729|NCT00435955|Rituximab|rituximab|mesh-list
44209730|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209731|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209732|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
44209733|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209734|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209735|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44209736|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44209737|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
44209738|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209739|NCT00435981|Antacids|antacids|mesh-ancestor
44209740|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209741|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209742|NCT00436033|Milnacipran|milnacipran|mesh-list
44209743|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
44209744|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44209745|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43816936|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
44209746|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44209747|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209748|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209750|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44209775|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209776|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209777|NCT00436267|Fluorouracil|fluorouracil|mesh-list
44209778|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
44209779|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209780|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44209781|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209782|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209783|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
44209784|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209785|NCT00436293|Cisplatin|cisplatin|mesh-list
44209786|NCT00436293|Docetaxel|docetaxel|mesh-list
44209787|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209788|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209789|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209790|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209791|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209792|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
44209793|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44209794|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209795|NCT00436371|Amisulpride|amisulpride|mesh-list
44209796|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44209797|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44209798|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44209799|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209800|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44209822|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209824|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209825|NCT00436709|Paclitaxel|paclitaxel|mesh-list
44209826|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
44209827|NCT00436709|Bevacizumab|bevacizumab|mesh-list
44209828|NCT00436709|Doxorubicin|doxorubicin|mesh-list
44209829|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43816965|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209830|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44209831|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44209832|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209833|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209834|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209835|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209836|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209837|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209838|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
44209839|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209840|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209841|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44209842|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
44209843|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44209844|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44209845|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44209846|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44209847|NCT00436709|Growth Substances|growth substances|mesh-ancestor
44209848|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
44209849|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44209850|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44209851|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209852|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209866|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209867|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44209868|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
44209869|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209870|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
44209871|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44209872|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
44209873|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44209874|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44209875|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209876|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
44209877|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
44209878|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209879|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209880|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
44209881|NCT00436761|Hormones|hormones|mesh-ancestor
44209882|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209883|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44209884|NCT00436761|Protective Agents|protective agents|mesh-ancestor
44209885|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209886|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44209887|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
44209888|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44209889|NCT00436787|PENTA|penta|mesh-list
44209890|NCT00436787|Fondaparinux|fondaparinux|mesh-list
44209891|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44209892|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
44209893|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44209894|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
44209895|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209897|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
44209910|NCT00436800|Immunologic Factors|immunologic factors|mesh-ancestor
44209911|NCT00436800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209912|NCT00436839|Prednisone|prednisone|mesh-list
44209913|NCT00436839|Docetaxel|docetaxel|mesh-list
44209914|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
44209915|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209916|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
44209917|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
44209918|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
44209919|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209920|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209921|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
44209923|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44209924|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209925|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44209926|NCT00436839|Analgesics|analgesics|mesh-ancestor
44209927|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
44209928|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209929|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44209930|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44209931|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44209932|NCT00436930|Sargramostim|sargramostim|mesh-list
44209933|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
44209934|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209935|NCT00436943|Bupropion|bupropion|mesh-list
44209936|NCT00436943|Nicotine|nicotine|mesh-list
44209959|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44209960|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
44209961|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209962|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
44209963|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
44209964|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209966|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44209967|NCT00437164|Insulin|insulin|mesh-list
44209968|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44209969|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44209970|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209971|NCT00437177|Apomorphine|apomorphine|mesh-list
44209972|NCT00437177|Emetics|emetics|mesh-ancestor
44209973|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209974|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
44209975|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209976|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209977|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
44209978|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
44209979|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44209980|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44209981|NCT00437229|Dexamethasone|dexamethasone|mesh-list
44209982|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
44209983|NCT00437229|Ondansetron|ondansetron|mesh-list
43816992|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816993|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
43816994|NCT02521415|Acetaminophen|acetaminophen|mesh-list
43816995|NCT02521415|Ibuprofen|ibuprofen|mesh-list
43816996|NCT02521415|Fentanyl|fentanyl|mesh-list
43816997|NCT02521415|Ketamine|ketamine|mesh-list
43816998|NCT02521415|Analgesics|analgesics|mesh-list
43816999|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
43817000|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209984|NCT00437229|Casopitant|casopitant|mesh-list
44209985|NCT00437229|BB 1101|bb 1101|mesh-list
44209986|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44209987|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
44209988|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
44209989|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44209990|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44209991|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44209993|NCT00437229|Hormones|hormones|mesh-ancestor
44210003|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
44210004|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210005|NCT00437229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44210006|NCT00437229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210007|NCT00437229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210008|NCT00437229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210009|NCT00437229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44210010|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44210011|NCT00437307|Topotecan|topotecan|mesh-list
44210012|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44210013|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44210014|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210015|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210016|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210017|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44210018|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44210019|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210020|NCT00437333|Metformin|metformin|mesh-list
44210021|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210022|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210023|NCT00437359|Toremifene|toremifene|mesh-list
44210024|NCT00437359|Anastrozole|anastrozole|mesh-list
44210025|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210026|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210027|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210038|NCT00437372|Sunitinib|sunitinib|mesh-list
44210051|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210052|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210054|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210055|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210056|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210057|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
44210058|NCT00437450|Hematinics|hematinics|mesh-ancestor
44210059|NCT00437463|Ramipril|ramipril|mesh-list
44210060|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44210061|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
44210062|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210063|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210064|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44210065|NCT00437476|Ribavirin|ribavirin|mesh-list
44210066|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44210067|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44210068|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
44210069|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210070|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
44210071|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210072|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44210073|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210074|NCT00437502|Vaccines|vaccines|mesh-list
44210075|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
44456457|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456458|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
44456459|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456460|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44456461|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44456462|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44456463|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
44456464|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456465|NCT01629589|Vaccines|vaccines|mesh-list
44456466|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
44456467|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456468|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
44456469|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44456470|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
44456471|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44456472|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456473|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44456474|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
44456475|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44456476|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
44456477|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44456478|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
44456479|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210112|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210113|NCT00437697|Dalteparin|dalteparin|mesh-list
44210114|NCT00437697|Tinzaparin|tinzaparin|mesh-list
44210115|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44210116|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
44210117|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44210118|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44210119|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210120|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
44210121|NCT00437723|Hematinics|hematinics|mesh-ancestor
44210122|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
44210123|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44210124|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44210125|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44210126|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210127|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210128|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
44210129|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210130|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210131|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44210132|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210133|NCT00437814|Ketamine|ketamine|mesh-list
44210134|NCT00437814|Analgesics|analgesics|mesh-ancestor
44210135|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
44210136|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210137|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210138|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44210139|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44210140|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
44210141|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
44210156|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817004|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
43817005|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
43817006|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817007|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43817008|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43817009|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817049|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817050|NCT02197039|Coagulants|coagulants|mesh-ancestor
43817051|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
43805996|NCT04918862|Granisetron|granisetron|mesh-list
43805997|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
43805998|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
43805999|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806000|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806001|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806002|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43806003|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
44210157|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210158|NCT00437892|Atorvastatin|atorvastatin|mesh-list
44210159|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44210160|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44210161|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
44210162|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210163|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44210164|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44210165|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210220|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210221|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44210222|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44210223|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
44210224|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210225|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210226|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
44210227|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44210228|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44210229|NCT00438087|Prednisolone|prednisolone|mesh-list
44210230|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
44210231|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44210232|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
44210233|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210234|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
44210235|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
44210236|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210237|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210238|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210239|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
44210241|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210242|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43817052|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817053|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817054|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43817055|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
43817056|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
44210243|NCT00438087|Protective Agents|protective agents|mesh-ancestor
44210244|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210245|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210266|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44210268|NCT00438139|Dronabinol|dronabinol|mesh-list
44210269|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
44210270|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210271|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210272|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210273|NCT00438139|Analgesics|analgesics|mesh-ancestor
44210274|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
44210275|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210276|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44210277|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44210278|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210279|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210280|NCT00438139|Hormones|hormones|mesh-ancestor
44210281|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210282|NCT00438152|Ritonavir|ritonavir|mesh-list
44210283|NCT00438152|Lopinavir|lopinavir|mesh-list
44210284|NCT00438152|Saquinavir|saquinavir|mesh-list
44210285|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44210286|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44210287|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
44210288|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817071|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
43817072|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817073|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43817074|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210289|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210290|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44210291|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44210292|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
44210293|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210296|NCT00438178|Obatoclax|obatoclax|mesh-list
44210311|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44210312|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
44210313|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44210314|NCT00438230|Warfarin|warfarin|mesh-list
44210315|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
44210316|NCT00438243|Bromfenac|bromfenac|mesh-list
44210317|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44210318|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210319|NCT00438243|Analgesics|analgesics|mesh-ancestor
44210320|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
44210321|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210322|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210323|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210324|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210325|NCT00438269|Metronidazole|metronidazole|mesh-list
44210326|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
44210327|NCT00438269|Meropenem|meropenem|mesh-list
44210328|NCT00438269|Cefazolin|cefazolin|mesh-list
44210329|NCT00438269|Tazobactam|tazobactam|mesh-list
44210330|NCT00438269|Piperacillin|piperacillin|mesh-list
44210331|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44210367|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
44210368|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210369|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210370|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44210371|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44210372|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
44210373|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44210374|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44210375|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44210376|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44210377|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
44210378|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44210379|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210380|NCT00438568|Insulin|insulin|mesh-list
44210381|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44210382|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210383|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210384|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44210385|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
44210386|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817127|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44210387|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44210388|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44210389|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44210390|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44210391|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
44210392|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210393|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210394|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210395|NCT00438737|Leucovorin|leucovorin|mesh-list
44210396|NCT00438737|Bevacizumab|bevacizumab|mesh-list
44210397|NCT00438737|Cetuximab|cetuximab|mesh-list
44210398|NCT00438737|Fluorouracil|fluorouracil|mesh-list
43865355|NCT02073994|Ivosidenib|ivosidenib|mesh-list
44210404|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44210405|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44210406|NCT00438737|Growth Substances|growth substances|mesh-ancestor
44210407|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210408|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
44210409|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44210410|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
44210411|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210412|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44210413|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210414|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
44210415|NCT00438737|Antidotes|antidotes|mesh-ancestor
44210416|NCT00438737|Protective Agents|protective agents|mesh-ancestor
44210417|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
44210418|NCT00438737|Vitamins|vitamins|mesh-ancestor
44210419|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
44210420|NCT00438776|Olanzapine|olanzapine|mesh-list
43817153|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44210421|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
44210422|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
44210423|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210424|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210425|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210426|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44210427|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210428|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210429|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210430|NCT00438776|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44210431|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44210432|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210433|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210435|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
44210447|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210448|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
44210449|NCT00438828|Hormones|hormones|mesh-ancestor
44210450|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210451|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44210452|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210453|NCT00438841|Thalidomide|thalidomide|mesh-list
44210454|NCT00438841|Dexamethasone|dexamethasone|mesh-list
44210455|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
44210456|NCT00438841|Bortezomib|bortezomib|mesh-list
44210457|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210458|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
44210459|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210460|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845226|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845227|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
44210461|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44210462|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
44210463|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210464|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210465|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44210466|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210467|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
44210468|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
44210469|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210470|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44210471|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
44210496|NCT00438984|Aldesleukin|aldesleukin|mesh-list
44210497|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
44210498|NCT00438984|Interleukin-2|interleukin-2|mesh-list
44210499|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44210500|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
44210501|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210502|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210503|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44210504|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
44210505|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210506|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210507|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44210508|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210509|NCT00438984|Analgesics|analgesics|mesh-ancestor
44210510|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
44210511|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210512|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44210513|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44210514|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
44210515|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210516|NCT00439049|Naltrexone|naltrexone|mesh-list
44210517|NCT00439049|Modafinil|modafinil|mesh-list
44210518|NCT00439049|Amphetamine|amphetamine|mesh-list
44210519|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
44210520|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44210548|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44210549|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44210550|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
44210551|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
44210552|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44210553|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210554|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210555|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44210556|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44210557|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44210558|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44210559|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43845247|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630333|NCT03053414|Vitamin D|vitamin d|mesh-list
44210560|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44210561|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44210562|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44210563|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44210564|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
44210565|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210566|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210567|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210568|NCT00439192|Urological Agents|urological agents|mesh-ancestor
44210570|NCT00439283|Infliximab|infliximab|mesh-list
44210571|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44210572|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
44210573|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44210574|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210576|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
44210592|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44210593|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44210594|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44210595|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210596|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210597|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44210598|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
44210599|NCT00439400|Doxycycline|doxycycline|mesh-list
44210600|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44210601|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210602|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
44210603|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44210604|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44210605|NCT00439426|Capecitabine|capecitabine|mesh-list
44210606|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
44210607|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44210608|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
44210609|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210610|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456497|NCT01628913|Dactolisib|dactolisib|mesh-list
44456498|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456499|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456500|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
44456501|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456502|NCT01628874|Lidocaine|lidocaine|mesh-list
44456503|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
44210626|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210627|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210628|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
44210629|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
44210630|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210631|NCT00439530|Renal Agents|renal agents|mesh-ancestor
44210632|NCT00439543|Iloprost|iloprost|mesh-list
44210633|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44210634|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
44210635|NCT00439699|Memantine|memantine|mesh-list
44210636|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44210637|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44210638|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
44210639|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210640|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210641|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210642|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44210643|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44210644|NCT00439712|Levocetirizine|levocetirizine|mesh-list
44210645|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44210646|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44210647|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
44210678|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44210679|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44210680|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210681|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210682|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210683|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44210684|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44210685|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44210686|NCT00440024|Tazarotene|tazarotene|mesh-list
44210687|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210688|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
44210689|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
44210690|NCT00440063|Hematinics|hematinics|mesh-ancestor
44210691|NCT00440076|Bortezomib|bortezomib|mesh-list
44210692|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210693|NCT00440102|Ketamine|ketamine|mesh-list
44210694|NCT00440102|Etomidate|etomidate|mesh-list
44210695|NCT00440102|Analgesics|analgesics|mesh-ancestor
44210696|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
44210697|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210698|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210699|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44210700|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44210701|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
44210702|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
44210703|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210706|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210728|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44210729|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44210730|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44210732|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
44210733|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210734|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210735|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210736|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44210737|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210738|NCT00440154|Ezetimibe|ezetimibe|mesh-list
44210739|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44210740|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44210741|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
44210742|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210743|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44210744|NCT00440167|Gemcitabine|gemcitabine|mesh-list
44210745|NCT00440167|Capecitabine|capecitabine|mesh-list
44210746|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44210747|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44210748|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
44210751|NCT00440167|Antiviral Agents|antiviral agents|mesh-ancestor
44210779|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210780|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210781|NCT00440258|Cabergoline|cabergoline|mesh-list
44210782|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44210783|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44210784|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
44210785|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
44210786|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210787|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210788|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210789|NCT00440284|Insulin|insulin|mesh-list
44210790|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44210791|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817181|NCT00476190|Cytarabine|cytarabine|mesh-list
44210792|NCT00440323|Zolpidem|zolpidem|mesh-list
44210793|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44210794|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44210795|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210796|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210797|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44210798|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
44210799|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
44210800|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210801|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210802|NCT00440336|Latanoprost|latanoprost|mesh-list
44210803|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44210828|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44210829|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44210830|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44210831|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44210832|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44210833|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44210834|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210835|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210836|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210837|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
44210838|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210839|NCT00440440|Testosterone|testosterone|mesh-list
44210840|NCT00440440|Androgens|androgens|mesh-ancestor
44210841|NCT00440440|Hormones|hormones|mesh-ancestor
44210842|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44210843|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210844|NCT00440479|Bortezomib|bortezomib|mesh-list
44210845|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210846|NCT00440609|Ranibizumab|ranibizumab|mesh-list
44210847|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44210848|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44210849|NCT00440609|Growth Substances|growth substances|mesh-ancestor
44210850|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210851|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
44210852|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210853|NCT00440622|Gemcitabine|gemcitabine|mesh-list
44210854|NCT00440622|Capecitabine|capecitabine|mesh-list
44210855|NCT00440622|Trastuzumab|trastuzumab|mesh-list
44210856|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44210857|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
44210859|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210870|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
44210871|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
44210872|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210873|NCT00440661|Diacetylrhein|diacetylrhein|mesh-list
44210874|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210875|NCT00440674|Paclitaxel|paclitaxel|mesh-list
44210876|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44210877|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210878|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
44210879|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
44210880|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
44210881|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806414|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806415|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
43806416|NCT04912271|Hormones|hormones|mesh-ancestor
43806417|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806418|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806419|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806420|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44210882|NCT00440687|Fluticasone|fluticasone|mesh-list
44210883|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210884|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44210885|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
44210886|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210887|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210888|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44210889|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
44210890|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
44210891|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44210892|NCT00440713|Aripiprazole|aripiprazole|mesh-list
44210893|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
44210894|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44210895|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44210896|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44210897|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210898|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210899|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
44210900|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
44210901|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44210902|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210903|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44210908|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44210909|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44210910|NCT00440739|Etoricoxib|etoricoxib|mesh-list
44210911|NCT00440739|Flavoxate|flavoxate|mesh-list
44210912|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44210913|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44210914|NCT00440739|Analgesics|analgesics|mesh-ancestor
44210915|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
44210916|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210917|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210918|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44210919|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44210920|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44210921|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44210922|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44210923|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210924|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
44210925|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
44210926|NCT00440739|Urological Agents|urological agents|mesh-ancestor
44210927|NCT00440765|Bortezomib|bortezomib|mesh-list
44210928|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44210929|NCT00440778|Abciximab|abciximab|mesh-list
44210930|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
44210931|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44210959|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
44210960|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
44210961|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44210962|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
44210963|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44210964|NCT00440869|Expectorants|expectorants|mesh-ancestor
44210965|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
44210966|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44210967|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
44210968|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210969|NCT00440869|Protective Agents|protective agents|mesh-ancestor
44210970|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210971|NCT00440869|Antidotes|antidotes|mesh-ancestor
44210972|NCT00440895|Abciximab|abciximab|mesh-list
44210973|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
44210974|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44210975|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44210976|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
43849632|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
43806451|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806452|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44210977|NCT00440921|Coagulants|coagulants|mesh-ancestor
44210978|NCT00440960|Lidocaine|lidocaine|mesh-list
44210979|NCT00440960|Midazolam|midazolam|mesh-list
44210980|NCT00440960|Alfentanil|alfentanil|mesh-list
44210981|NCT00440960|Propofol|propofol|mesh-list
44210982|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
44210983|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
44210984|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44210985|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44210986|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
44210987|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44210988|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44210989|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44210990|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44210991|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211001|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
44211004|NCT00440960|Narcotics|narcotics|mesh-ancestor
44211005|NCT00440960|Analgesics|analgesics|mesh-ancestor
44211006|NCT00440973|Bevacizumab|bevacizumab|mesh-list
44211007|NCT00440973|Interleukin-2|interleukin-2|mesh-list
44211008|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211009|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211010|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211011|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211012|NCT00440973|Growth Substances|growth substances|mesh-ancestor
44211013|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211014|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
44211015|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211016|NCT00440973|Analgesics|analgesics|mesh-ancestor
44211017|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
44211018|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211019|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
44211020|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211021|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211023|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211024|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211025|NCT00441051|Analgesics|analgesics|mesh-ancestor
44211026|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
44211027|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211028|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211029|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211030|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211031|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211032|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211033|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211034|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
44211035|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211036|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44211047|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
44211048|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
44211049|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
44211050|NCT00441246|Ephedrine|ephedrine|mesh-list
44211051|NCT00441246|Guaifenesin|guaifenesin|mesh-list
44211052|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
44211053|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44211054|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
43817184|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44211055|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211056|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211057|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44211058|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
44211059|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
44211060|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44211061|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44211062|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
44211063|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211064|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211065|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211066|NCT00441246|Expectorants|expectorants|mesh-ancestor
44211067|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44456531|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456532|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
44456533|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456534|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
44456535|NCT01628120|Hematinics|hematinics|mesh-ancestor
44456536|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
44456537|NCT01628107|Hematinics|hematinics|mesh-ancestor
44456538|NCT01627860|Topiramate|topiramate|mesh-list
44456539|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
44456540|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456541|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456542|NCT01627782|Ketamine|ketamine|mesh-list
44456543|NCT01627782|Analgesics|analgesics|mesh-ancestor
44456544|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
44456545|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456546|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456547|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44456548|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44456549|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
44456550|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
44456551|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456552|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44456553|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44456554|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456555|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456556|NCT01627327|Fluticasone|fluticasone|mesh-list
44211093|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
44211094|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806532|NCT04909931|Vitamins|vitamins|mesh-ancestor
44211095|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211096|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211097|NCT00441428|Urological Agents|urological agents|mesh-ancestor
44211098|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
44211099|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211100|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211101|NCT00441519|Aspirin|aspirin|mesh-list
44211102|NCT00441519|Omeprazole|omeprazole|mesh-list
44211103|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211104|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211105|NCT00441519|Analgesics|analgesics|mesh-ancestor
44211106|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
44211107|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211108|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211109|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211110|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211111|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44211112|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211113|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211114|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44211115|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211141|NCT00441649|Methylphenidate|methylphenidate|mesh-list
44211142|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44211143|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211144|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44211145|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44211146|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211147|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211148|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
44211149|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211150|NCT00441662|Triamcinolone|triamcinolone|mesh-list
44211151|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211152|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
44211153|NCT00441662|Hormones|hormones|mesh-ancestor
44211154|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211155|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211156|NCT00441740|Gemcitabine|gemcitabine|mesh-list
44211157|NCT00441740|Docetaxel|docetaxel|mesh-list
44211158|NCT00441740|Vinorelbine|vinorelbine|mesh-list
44211159|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44211160|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
44211161|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211162|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211163|NCT00441740|Antiviral Agents|antiviral agents|mesh-ancestor
44211164|NCT00441740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211165|NCT00441740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211166|NCT00441740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211167|NCT00441740|Immunologic Factors|immunologic factors|mesh-ancestor
44211168|NCT00441740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211169|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211170|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211171|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
44211172|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44211173|NCT00441844|Simvastatin|simvastatin|mesh-list
44211182|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
44211183|NCT00441870|Hematinics|hematinics|mesh-ancestor
44211184|NCT00441870|Vitamins|vitamins|mesh-ancestor
44211185|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
44211186|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211188|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44211189|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
44211190|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211191|NCT00441922|Docetaxel|docetaxel|mesh-list
44211192|NCT00441922|Vinorelbine|vinorelbine|mesh-list
44211193|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211194|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211195|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211196|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
44211197|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211198|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44211199|NCT00441961|Methotrexate|methotrexate|mesh-list
44211200|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44211201|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
44211202|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44211203|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211204|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44211205|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
44211206|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211207|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211208|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
44211209|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211210|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44211211|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211212|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
44211213|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211214|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44211215|NCT00442026|Gemcitabine|gemcitabine|mesh-list
44211225|NCT00442026|Immunologic Factors|immunologic factors|mesh-ancestor
44211226|NCT00442026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211227|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211228|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211229|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
44211230|NCT00442052|Aspirin|aspirin|mesh-list
44211231|NCT00442052|Omeprazole|omeprazole|mesh-list
44211232|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211233|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211234|NCT00442052|Analgesics|analgesics|mesh-ancestor
44211235|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
44211236|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211237|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211238|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211239|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211240|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44211241|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211242|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211243|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44211244|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211245|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211246|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
44211247|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44211248|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211249|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211250|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
44211251|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44211252|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211268|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44211269|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44211270|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44211272|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211273|NCT00442234|Monteplase|monteplase|mesh-list
44211274|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44211275|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211276|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211277|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44211278|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44211279|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
44211280|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44211281|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44211282|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211283|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211284|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211285|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211286|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44211287|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44211288|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44211289|NCT00442325|Atorvastatin|atorvastatin|mesh-list
44211290|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44211291|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44211292|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
44211294|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44211315|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211316|NCT00442481|Citalopram|citalopram|mesh-list
44211317|NCT00442481|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44211318|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44211319|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211320|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211321|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211322|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
43817248|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817249|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817250|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
43817251|NCT05558319|Hormones|hormones|mesh-ancestor
43817252|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655267|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655268|NCT02970409|Heparin|heparin|mesh-list
43655269|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
43655270|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43655271|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43655272|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655273|NCT02970383|Narcotics|narcotics|mesh-list
43655276|NCT02970383|Analgesics|analgesics|mesh-ancestor
44211323|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211324|NCT00442481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44211325|NCT00442481|Antidepressive Agents|antidepressive agents|mesh-ancestor
44211326|NCT00442481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211327|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
44211328|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211329|NCT00442585|Ibuprofen|ibuprofen|mesh-list
44211330|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211331|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211332|NCT00442585|Analgesics|analgesics|mesh-ancestor
44211333|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
44211334|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211335|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211341|NCT00442637|Bevacizumab|bevacizumab|mesh-list
44211363|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44211364|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211365|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211366|NCT00442741|Epothilone B|epothilone b|mesh-list
44211367|NCT00442741|Epothilones|epothilones|mesh-list
44211368|NCT00442741|Omeprazole|omeprazole|mesh-list
44211369|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44211370|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211371|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211372|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211373|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211374|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211375|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
44211376|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
44211377|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
44211378|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44211379|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44211380|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44211381|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44211416|NCT00443170|Midazolam|midazolam|mesh-list
44211417|NCT00443170|Caffeine|caffeine|mesh-list
44211418|NCT00443170|Omeprazole|omeprazole|mesh-list
44211419|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44211420|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43843380|NCT04460872|Hormones|hormones|mesh-ancestor
44211421|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211422|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211423|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44211424|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44211425|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211426|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44211427|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
44211428|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
44211429|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
44211430|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
44211431|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211432|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211433|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44211434|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211435|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211436|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211437|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44211438|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44211439|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44211440|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44211441|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
44211442|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44211443|NCT00443170|Analgesics|analgesics|mesh-ancestor
44211444|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
44211464|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44211465|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211466|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44211467|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
44211468|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211469|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44211470|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211471|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
44211472|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
44211473|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44211474|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211475|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211476|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43817260|NCT05558280|Dinutuximab|dinutuximab|mesh-list
44211477|NCT00443235|Growth Substances|growth substances|mesh-ancestor
44211478|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
44456569|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
44456570|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44456574|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
44456609|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456610|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44456611|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
44456612|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44456613|NCT01626352|Ofatumumab|ofatumumab|mesh-list
44456614|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44456615|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
44456616|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211479|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
44211480|NCT00443339|Hematinics|hematinics|mesh-ancestor
44211481|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
44211482|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44211483|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
44211484|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211485|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211486|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44211487|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
44211488|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44211489|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44211490|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44211526|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211527|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44211528|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211529|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211530|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44211531|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44211532|NCT00443690|Rolofylline|rolofylline|mesh-list
44211533|NCT00443690|Diuretics|diuretics|mesh-ancestor
44211534|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
44211535|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211536|NCT00443716|Estrogens|estrogens|mesh-list
44211537|NCT00443716|Hormones|hormones|mesh-ancestor
44211538|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211539|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211540|NCT00443794|Aspirin|aspirin|mesh-list
44211541|NCT00443794|Atenolol|atenolol|mesh-list
44211542|NCT00443794|Ramipril|ramipril|mesh-list
44211543|NCT00443794|Simvastatin|simvastatin|mesh-list
44211544|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
44211545|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211579|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44211580|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44211581|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
44211582|NCT00443937|Everolimus|everolimus|mesh-list
44211583|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806708|NCT04907747|Furazolidone|furazolidone|mesh-list
44211584|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211585|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
44211586|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211587|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44211588|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44211589|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
44211590|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44211591|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211592|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211593|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211594|NCT00443950|Etanercept|etanercept|mesh-list
44211595|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211596|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211597|NCT00443950|Analgesics|analgesics|mesh-ancestor
44211598|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
44211599|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211600|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211601|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211602|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211603|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211604|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44211605|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
44211606|NCT00443963|Esomeprazole|esomeprazole|mesh-list
44211607|NCT00443963|Ranitidine|ranitidine|mesh-list
44211608|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44211609|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211610|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44211611|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211612|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211613|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44211614|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
44164312|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44164313|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44211615|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
44211616|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211617|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211618|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44211619|NCT00444015|Dasatinib|dasatinib|mesh-list
44211620|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211621|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44211622|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211623|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211624|NCT00444041|Bevacizumab|bevacizumab|mesh-list
44211625|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211626|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211627|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211628|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211630|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211631|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
44211632|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
44211633|NCT00444093|Loperamide|loperamide|mesh-list
44211634|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44211635|NCT00444132|Clopidogrel|clopidogrel|mesh-list
44211636|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44211637|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44211644|NCT00444171|Insulin|insulin|mesh-list
44211667|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211668|NCT00444249|Dipivefrin|dipivefrin|mesh-list
44211669|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44211670|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211671|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211672|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211673|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211674|NCT00444314|Sunitinib|sunitinib|mesh-list
44211675|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211676|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211677|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211678|NCT00444314|Growth Substances|growth substances|mesh-ancestor
44211679|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211680|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
44211681|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44211682|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44211683|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211684|NCT00444340|Etanercept|etanercept|mesh-list
44211685|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44211686|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44211687|NCT00444340|Analgesics|analgesics|mesh-ancestor
44211688|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
44211689|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211716|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44211717|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44211718|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44211719|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44211722|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44211723|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44211724|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211725|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
44211726|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44211727|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
44211728|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44211729|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211730|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211731|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
44211732|NCT00444470|Coagulants|coagulants|mesh-ancestor
44211733|NCT00444522|Alprazolam|alprazolam|mesh-list
44211734|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44211735|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211736|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211737|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44211738|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44211739|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211740|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
44211741|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
44211742|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211743|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211744|NCT00444548|Reboxetine|reboxetine|mesh-list
44211762|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211763|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211764|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
44211765|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211766|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
44211767|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
44211768|NCT00444613|Vitamins|vitamins|mesh-ancestor
44211769|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
44211770|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211771|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44211772|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
44211773|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44211774|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
44211775|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44211776|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211777|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44211778|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44211779|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211780|NCT00444652|Enoxaparin|enoxaparin|mesh-list
44211781|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
44211782|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44211783|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44211784|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211785|NCT00444665|Travoprost|travoprost|mesh-list
44211812|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211813|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44211814|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44211815|NCT00444834|Carvedilol|carvedilol|mesh-list
44211816|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44211817|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44211818|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
44211819|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211820|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211821|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211822|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211823|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
44211824|NCT00444834|Protective Agents|protective agents|mesh-ancestor
44211825|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44211826|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211827|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44211828|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
44211829|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44211830|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44211831|NCT00444873|Lanreotide|lanreotide|mesh-list
44211832|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211833|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
44211834|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44211835|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44211836|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44211859|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44211860|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44211861|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211862|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44211863|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44211864|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44211866|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44211867|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211868|NCT00445081|Cyclosporine|cyclosporine|mesh-list
44211869|NCT00445081|Prednisolone|prednisolone|mesh-list
44211870|NCT00445081|Cyclosporins|cyclosporins|mesh-list
44211871|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211872|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
44211873|NCT00445081|Hormones|hormones|mesh-ancestor
44211874|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211875|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211876|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44211877|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211878|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655300|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
43655301|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
43655302|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655303|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655304|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
43655305|NCT02970084|Vitamin K|vitamin k|mesh-list
43655306|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
43655307|NCT02970084|Vitamins|vitamins|mesh-ancestor
43655308|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
43655309|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655310|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43655311|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43618137|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806805|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43806806|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44211879|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456630|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44456631|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456632|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456633|NCT01625897|Risperidone|risperidone|mesh-list
44456634|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44456635|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
44456636|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456637|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456638|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456639|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43866891|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
44456640|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44211899|NCT00445159|Treprostinil|treprostinil|mesh-list
44211900|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44211902|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
44211903|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211904|NCT00445250|Calcipotriene|calcipotriene|mesh-list
44211905|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44211906|NCT00445276|Diacetylrhein|diacetylrhein|mesh-list
44211907|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211908|NCT00445406|Bevacizumab|bevacizumab|mesh-list
44211909|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44211910|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211911|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44211912|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44211935|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211936|NCT00445523|Interferons|interferons|mesh-list
44211937|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
44211938|NCT00445523|Vaccines|vaccines|mesh-list
44211939|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211940|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
44211941|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211942|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
44211943|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211944|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
44211945|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
44211946|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44211947|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44211948|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211949|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44211950|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44211951|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44211952|NCT00445796|Artesunate|artesunate|mesh-list
43817366|NCT05556720|Vaccines|vaccines|mesh-list
44211953|NCT00445796|Amodiaquine|amodiaquine|mesh-list
44211954|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
44211955|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44211956|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44211957|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44211958|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211963|NCT00445861|Cisplatin|cisplatin|mesh-list
44211988|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44211989|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44211990|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
44211991|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44211992|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44211993|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44211994|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44211995|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
44211996|NCT00445900|Hormones|hormones|mesh-ancestor
44211997|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44211998|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44211999|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
44212000|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212001|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212002|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212003|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212004|NCT00445900|Growth Substances|growth substances|mesh-ancestor
44212005|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
44212006|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
44212007|NCT00446004|Omeprazole|omeprazole|mesh-list
44212008|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44212009|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212010|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212011|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212012|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212013|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44212014|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44212015|NCT00446017|Milrinone|milrinone|mesh-list
44212016|NCT00446017|Epinephrine|epinephrine|mesh-list
44212017|NCT00446017|Racepinephrine|racepinephrine|mesh-list
44212018|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
44212019|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44212020|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44212021|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
44212022|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212023|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212025|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44212026|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44212027|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
44212028|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212029|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44212030|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
44212032|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
44212033|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44212034|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44212035|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44212036|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
44212037|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44212038|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44212039|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655318|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655319|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655320|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43817413|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817414|NCT05556083|Urological Agents|urological agents|mesh-ancestor
43817415|NCT05556005|Trimetazidine|trimetazidine|mesh-list
43817416|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
43817417|NCT05555823|Repaglinide|repaglinide|mesh-list
44212040|NCT00446017|Protective Agents|protective agents|mesh-ancestor
44212041|NCT00446043|Adapalene|adapalene|mesh-list
44212042|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
44212043|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
44212044|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
44212045|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212046|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212079|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44212080|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212081|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212082|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44212083|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
44212084|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
44212085|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44212086|NCT00446303|Azacitidine|azacitidine|mesh-list
44212087|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212088|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
44212089|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212090|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212091|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212092|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
44212094|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655321|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
43655322|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655323|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655324|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44212095|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212096|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212097|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212098|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44212099|NCT00446329|Cinacalcet|cinacalcet|mesh-list
44212100|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212101|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212102|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44212103|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
44212104|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212105|NCT00446368|Everolimus|everolimus|mesh-list
44212106|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212107|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212108|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
44212109|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212110|NCT00446420|Fentanyl|fentanyl|mesh-list
44212111|NCT00446420|Midazolam|midazolam|mesh-list
43817480|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817482|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817483|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
43817484|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817485|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817486|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
43817487|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817488|NCT05555069|Menthol|menthol|mesh-list
43817489|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
43817490|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817491|NCT05554978|Landiolol|landiolol|mesh-list
43817492|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43817493|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43817494|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817495|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817496|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212112|NCT00446420|Propofol|propofol|mesh-list
44212119|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44212121|NCT00446420|Analgesics|analgesics|mesh-ancestor
44212122|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
44212123|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212124|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44212125|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44212126|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44212127|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212128|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
44212129|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
44212130|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212131|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212132|NCT00446433|Lenalidomide|lenalidomide|mesh-list
44212133|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
44212134|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212135|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212136|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212137|NCT00446433|Growth Substances|growth substances|mesh-ancestor
44212138|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
44212139|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212140|NCT00446472|Becaplermin|becaplermin|mesh-list
44212141|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
44212142|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44212143|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212144|NCT00446472|Growth Substances|growth substances|mesh-ancestor
44212145|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212146|NCT00446524|Amlodipine|amlodipine|mesh-list
44212147|NCT00446524|Valsartan|valsartan|mesh-list
44212164|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
44212165|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212166|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
44212167|NCT00446576|Hematinics|hematinics|mesh-ancestor
44212168|NCT00446589|Teriparatide|teriparatide|mesh-list
44212169|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
44212170|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212171|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212172|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44212173|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
44212174|NCT00446602|Hematinics|hematinics|mesh-ancestor
44212175|NCT00446667|Mannitol|mannitol|mesh-list
44212176|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44212177|NCT00446667|Diuretics|diuretics|mesh-ancestor
44212178|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
44212179|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212180|NCT00446680|Mannitol|mannitol|mesh-list
44212181|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44212182|NCT00446680|Diuretics|diuretics|mesh-ancestor
44212183|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
44212184|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212185|NCT00446771|Mannitol|mannitol|mesh-list
44212186|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44212187|NCT00446771|Diuretics|diuretics|mesh-ancestor
44212188|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
44212189|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212190|NCT00446784|Methotrexate|methotrexate|mesh-list
44212191|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44212192|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
44212193|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44212194|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212195|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212210|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
44212211|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
44212212|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212213|NCT00446836|Paclitaxel|paclitaxel|mesh-list
44212214|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
44212215|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44212216|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212217|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212218|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212219|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212220|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212221|NCT00446862|Losartan|losartan|mesh-list
44212222|NCT00446862|Enalapril|enalapril|mesh-list
44212223|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
44212224|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
44212225|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44212226|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44212227|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44212228|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44212229|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212230|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
44212231|NCT00446901|Selenium|selenium|mesh-list
44212232|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
44212233|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212234|NCT00446901|Protective Agents|protective agents|mesh-ancestor
44212235|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212236|NCT00446901|Trace Elements|trace elements|mesh-ancestor
44212237|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
44212238|NCT00446940|Atorvastatin|atorvastatin|mesh-list
44212239|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44212240|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44212241|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44212242|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
44212243|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212244|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44212248|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212249|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
44212250|NCT00446953|Hormones|hormones|mesh-ancestor
44212251|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212252|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212253|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44212254|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
44212255|NCT00446979|UC-781|uc-781|mesh-list
44212256|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44212257|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
44212258|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212259|NCT00447018|Mannitol|mannitol|mesh-list
44212260|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44212261|NCT00447018|Diuretics|diuretics|mesh-ancestor
44212262|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
44212263|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212264|NCT00447031|Triamcinolone|triamcinolone|mesh-list
44212265|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44212266|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44212267|NCT00447031|Bevacizumab|bevacizumab|mesh-list
44212268|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44212269|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44212270|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212271|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212272|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212273|NCT00447031|Growth Substances|growth substances|mesh-ancestor
44212274|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212275|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
44212276|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212277|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
44212278|NCT00447031|Hormones|hormones|mesh-ancestor
44212279|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212280|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212281|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
44212282|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212284|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44212288|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212289|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212290|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44212291|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44212292|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
44212293|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456641|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456642|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456643|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44456644|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
44456645|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
44456646|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44456647|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456648|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456649|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44456650|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44456651|NCT01625845|Protective Agents|protective agents|mesh-ancestor
44456652|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456653|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44456654|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44456655|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
44456657|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44456658|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44456659|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456660|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
44456683|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456684|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456685|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
44456686|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456687|NCT01625091|Naltrexone|naltrexone|mesh-list
44456688|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44456689|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44456690|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456691|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
44456692|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456693|NCT01625000|Risperidone|risperidone|mesh-list
44456694|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44456695|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
44456696|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456697|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456698|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212294|NCT00447213|Insulin|insulin|mesh-list
44212295|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44212296|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
44212297|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845276|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845305|NCT04292054|Cefazolin|cefazolin|mesh-list
44212298|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212299|NCT00447239|Insulin|insulin|mesh-list
44212300|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44212301|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212302|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
44212303|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212304|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212305|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44212306|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212307|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212308|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212309|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212310|NCT00447356|Interferons|interferons|mesh-list
44212311|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
44212312|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212313|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
44212314|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212316|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212317|NCT00447369|Pregabalin|pregabalin|mesh-list
44212318|NCT00447369|Valproic Acid|valproic acid|mesh-list
44212319|NCT00447369|Analgesics|analgesics|mesh-ancestor
44212320|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
44212321|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212322|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212323|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
44212324|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44212325|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44212326|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212327|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212328|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44212329|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44212330|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212331|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212332|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212333|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
44212334|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212335|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
44212369|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212370|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212371|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44212373|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
44212374|NCT00447759|Ibuprofen|ibuprofen|mesh-list
44212375|NCT00447759|Celecoxib|celecoxib|mesh-list
44212376|NCT00447759|Diclofenac|diclofenac|mesh-list
44212377|NCT00447759|Naproxen|naproxen|mesh-list
44212378|NCT00447759|Meloxicam|meloxicam|mesh-list
44212379|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212380|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212381|NCT00447759|Analgesics|analgesics|mesh-ancestor
44212382|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
44212383|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212384|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212385|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212386|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212387|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44212388|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212389|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212390|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44212391|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
44212392|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
44212393|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44212394|NCT00447863|Estradiol|estradiol|mesh-list
44212395|NCT00447863|Estrogens|estrogens|mesh-ancestor
44212396|NCT00447863|Hormones|hormones|mesh-ancestor
44212406|NCT00447915|Vitamin D|vitamin d|mesh-list
44212422|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212423|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212424|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212425|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212426|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
44212427|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212428|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44212429|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212430|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212431|NCT00447967|Antidotes|antidotes|mesh-ancestor
44212432|NCT00447967|Protective Agents|protective agents|mesh-ancestor
44212433|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
44212434|NCT00447967|Vitamins|vitamins|mesh-ancestor
44212435|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
44212436|NCT00448097|Docetaxel|docetaxel|mesh-list
44212437|NCT00448097|Cetuximab|cetuximab|mesh-list
44212438|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212439|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212440|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212441|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212442|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212443|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43867458|NCT01364051|Cediranib|cediranib|mesh-list
44212444|NCT00448110|Diclofenac|diclofenac|mesh-list
44212445|NCT00448110|Ketorolac|ketorolac|mesh-list
44212446|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212447|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212449|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
44212450|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212451|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212452|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212453|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212454|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44212457|NCT00448149|Everolimus|everolimus|mesh-list
44212465|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212466|NCT00448214|Warfarin|warfarin|mesh-list
44212467|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
44212468|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44212469|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212470|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212471|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212472|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212473|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
44212474|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
44212475|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212476|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
44212477|NCT00448266|Thiotepa|thiotepa|mesh-list
44212478|NCT00448266|Carboplatin|carboplatin|mesh-list
44212479|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845321|NCT04291508|Analgesics|analgesics|mesh-ancestor
43845322|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
43845323|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845324|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
43845325|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
43845326|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212480|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
44212481|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212482|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212483|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44212484|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
44212485|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212486|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212487|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44212488|NCT00448292|Naluzotan|naluzotan|mesh-list
44212489|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44212490|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44212491|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
44212492|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212493|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212494|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212495|NCT00448305|Paclitaxel|paclitaxel|mesh-list
44212496|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44212497|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44212502|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212503|NCT00448383|Adalimumab|adalimumab|mesh-list
44212504|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212505|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212506|NCT00448396|Epothilone B|epothilone b|mesh-list
43817570|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
43817571|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43817572|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43817575|NCT05554211|Coagulants|coagulants|mesh-ancestor
44212507|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212508|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212509|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212510|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212511|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212512|NCT00448409|Sargramostim|sargramostim|mesh-list
44212513|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
44212514|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212515|NCT00448461|Heparin|heparin|mesh-list
44212516|NCT00448461|Bivalirudin|bivalirudin|mesh-list
44212517|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
44212518|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44212519|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44212520|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212561|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
44212562|NCT00448838|Cetuximab|cetuximab|mesh-list
44212563|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212564|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
44212565|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212566|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212567|NCT00448838|Antiviral Agents|antiviral agents|mesh-ancestor
44212568|NCT00448838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212569|NCT00448838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212570|NCT00448838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212571|NCT00448838|Immunologic Factors|immunologic factors|mesh-ancestor
44212572|NCT00448838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212573|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44212574|NCT00448903|Bemiparin|bemiparin|mesh-list
44212575|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
44212576|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
44212577|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44212578|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212579|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
44212580|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
44212581|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44212582|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817633|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817634|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
43817635|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817636|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817637|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
43817638|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817639|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43817640|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43817641|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43817642|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655349|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655350|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655351|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
43655352|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43655353|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43807157|NCT04901117|Antacids|antacids|mesh-ancestor
44212583|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
44212584|NCT00449020|Carboplatin|carboplatin|mesh-list
44212585|NCT00449020|Docetaxel|docetaxel|mesh-list
44212586|NCT00449020|Irinotecan|irinotecan|mesh-list
44212587|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212588|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212589|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212590|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212591|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212592|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44212593|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212595|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
44212603|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212604|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
44212605|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212606|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212607|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212608|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212609|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
44212610|NCT00449137|Antidotes|antidotes|mesh-ancestor
44212611|NCT00449137|Protective Agents|protective agents|mesh-ancestor
44212612|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
44212613|NCT00449137|Vitamins|vitamins|mesh-ancestor
44212614|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
44212615|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
44212616|NCT00449202|Estrone|estrone|mesh-list
44212617|NCT00449202|Estrogens|estrogens|mesh-ancestor
44212618|NCT00449202|Hormones|hormones|mesh-ancestor
44212619|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655354|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43817662|NCT05553496|Rituximab|rituximab|mesh-list
44212620|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212621|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44212622|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
44212623|NCT00449254|Estrone|estrone|mesh-list
44212624|NCT00449254|Estrogens|estrogens|mesh-ancestor
44212625|NCT00449254|Hormones|hormones|mesh-ancestor
44212626|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212627|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212628|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44212629|NCT00449280|Sirolimus|sirolimus|mesh-list
44212630|NCT00449280|Sorafenib|sorafenib|mesh-list
44212631|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212632|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44212633|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212635|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212648|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212649|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44212650|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
44212651|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212652|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44212653|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44212654|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212655|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212656|NCT00449410|Atorvastatin|atorvastatin|mesh-list
44212658|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44212659|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44212660|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
44212661|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212662|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44212663|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44212664|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212665|NCT00449423|Acipimox|acipimox|mesh-list
44212666|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44212667|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
44212668|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212669|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44212670|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
44212671|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
44212672|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
44456702|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212673|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44212674|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212675|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212676|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
44212677|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212678|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44212687|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212688|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44212689|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44212690|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44212691|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44212692|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212693|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
44212694|NCT00449488|Hematinics|hematinics|mesh-ancestor
44212695|NCT00449501|Budesonide|budesonide|mesh-list
44212696|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
44212697|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212698|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44212699|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
44212700|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212701|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212702|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44212703|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
44212704|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
44212705|NCT00449501|Hormones|hormones|mesh-ancestor
44212706|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212707|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44212708|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44212709|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44212713|NCT00449514|Tamoxifen|tamoxifen|mesh-list
44212736|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44212737|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
44212738|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
44212739|NCT00449527|Hormones|hormones|mesh-ancestor
43817731|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212740|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44212741|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44212742|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44212743|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44212744|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
44212745|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456703|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44212746|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212747|NCT00449553|Metformin|metformin|mesh-list
44212748|NCT00449553|Pioglitazone|pioglitazone|mesh-list
44212749|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44212750|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212751|NCT00449618|Aspirin|aspirin|mesh-list
44212752|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212753|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212754|NCT00449618|Analgesics|analgesics|mesh-ancestor
44212766|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
44212790|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212791|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212792|NCT00449683|Urological Agents|urological agents|mesh-ancestor
44212793|NCT00449722|Mesalamine|mesalamine|mesh-list
44212794|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44212795|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44212796|NCT00449722|Analgesics|analgesics|mesh-ancestor
44212797|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
44212798|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212799|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212800|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212801|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212802|NCT00449774|Lamotrigine|lamotrigine|mesh-list
44212803|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
44212804|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44212805|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44212806|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212807|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44212808|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212809|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44212810|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44212811|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44212812|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44212813|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44212814|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
44212815|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212816|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212817|NCT00449813|Pantoprazole|pantoprazole|mesh-list
44212818|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44212832|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212833|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
44212834|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
44212835|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
44212836|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212837|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212838|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
44212839|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212840|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
44212841|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212842|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212843|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212844|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212845|NCT00450008|Growth Substances|growth substances|mesh-ancestor
44212846|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
44212847|NCT00450086|Budesonide|budesonide|mesh-list
44212848|NCT00450086|Mesalamine|mesalamine|mesh-list
44212849|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212850|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44212851|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
44212852|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212853|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212854|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44212855|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
44212856|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
44212883|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44212884|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212885|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44212886|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44212887|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44212888|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44212889|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
44212890|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44212891|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44212892|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44212893|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
44212894|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
44212895|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44212896|NCT00450203|Bevacizumab|bevacizumab|mesh-list
44212897|NCT00450203|Cisplatin|cisplatin|mesh-list
44212898|NCT00450203|Capecitabine|capecitabine|mesh-list
44212900|NCT00450203|Lapatinib|lapatinib|mesh-list
44212901|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44212902|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212903|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44212904|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44212905|NCT00450203|Growth Substances|growth substances|mesh-ancestor
44212906|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212907|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
44212908|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212909|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
44212910|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212911|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44212912|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44212913|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44212914|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212915|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43817792|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817795|NCT05551910|Remifentanil|remifentanil|mesh-list
44212916|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44212924|NCT00450307|Antibodies|antibodies|mesh-list
44212925|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44212926|NCT00450307|Sargramostim|sargramostim|mesh-list
44212927|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
44212928|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212929|NCT00450320|Sirolimus|sirolimus|mesh-list
44212930|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44212931|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212932|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44212933|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212934|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
44212935|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212936|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
44212937|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212938|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
44212939|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44212940|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
44212941|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212942|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44212943|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212944|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
44212945|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212946|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
44212947|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44212948|NCT00450398|Protective Agents|protective agents|mesh-ancestor
44212949|NCT00450515|Capecitabine|capecitabine|mesh-list
44212950|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212951|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
44212972|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44212973|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44212974|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44212975|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44212976|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212977|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212978|NCT00450762|Gemcitabine|gemcitabine|mesh-list
44212979|NCT00450762|Carboplatin|carboplatin|mesh-list
44212980|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44212981|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44212982|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
44212983|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44212984|NCT00450762|Antiviral Agents|antiviral agents|mesh-ancestor
44212985|NCT00450762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44212986|NCT00450762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44212987|NCT00450762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44212988|NCT00450762|Immunologic Factors|immunologic factors|mesh-ancestor
44212989|NCT00450762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44212990|NCT00450827|Bevacizumab|bevacizumab|mesh-list
44213027|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44213028|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213030|NCT00450944|Immunotoxins|immunotoxins|mesh-list
44213031|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
44213032|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213033|NCT00450957|Lycopene|lycopene|mesh-list
44213034|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213035|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
44213036|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213037|NCT00450957|Protective Agents|protective agents|mesh-ancestor
44213038|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213039|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44213040|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44213041|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456704|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
44456705|NCT01624974|Montelukast|montelukast|mesh-list
44456706|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456707|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456708|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44456709|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
43817863|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43817864|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43817865|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817866|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43868010|NCT00936832|Leucovorin|leucovorin|mesh-list
44213042|NCT00451061|Tamsulosin|tamsulosin|mesh-list
44213043|NCT00451061|Alfuzosin|alfuzosin|mesh-list
44213044|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44213045|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44213046|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44213047|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
44213048|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213049|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213050|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213051|NCT00451061|Urological Agents|urological agents|mesh-ancestor
44213062|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213064|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213065|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213066|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44213067|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
44213068|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213069|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44213070|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44213071|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44213072|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44213073|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
44213074|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213075|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213076|NCT00451113|Incretins|incretins|mesh-ancestor
44213077|NCT00451113|Hormones|hormones|mesh-ancestor
43817900|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213078|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213079|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
44213080|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213081|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213082|NCT00451139|Lumefantrine|lumefantrine|mesh-list
44213083|NCT00451139|Artemether|artemether|mesh-list
44213084|NCT00451139|Quinine|quinine|mesh-list
44213085|NCT00451139|Atovaquone|atovaquone|mesh-list
44213086|NCT00451139|Proguanil|proguanil|mesh-list
44213087|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44213088|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
44213089|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
44213090|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44213091|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44213092|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213093|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44213094|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213095|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44213096|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213101|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213102|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
44213103|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
44213104|NCT00451230|Cocaine|cocaine|mesh-list
44213105|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213106|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
44213107|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
44213108|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213109|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213110|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
44213111|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213112|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44213113|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44213114|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44213115|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43868085|NCT00878254|Leucovorin|leucovorin|mesh-list
44213116|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213117|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
44213118|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213119|NCT00451360|Diacetylrhein|diacetylrhein|mesh-list
44213120|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845382|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213121|NCT00451373|Vancomycin|vancomycin|mesh-list
44213122|NCT00451373|Daptomycin|daptomycin|mesh-list
44213123|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213124|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213153|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
44213154|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213155|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213156|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213157|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
44213158|NCT00451594|Hormones|hormones|mesh-ancestor
44213159|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213160|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44213161|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213162|NCT00451620|Glyburide|glyburide|mesh-list
44213163|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213164|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213165|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44213166|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44213167|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44213168|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44213169|NCT00451672|Bromocriptine|bromocriptine|mesh-list
44213170|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44213171|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44213172|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
44213173|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213174|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213175|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
44213176|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
43845383|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845384|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43845385|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
43845386|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845387|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845388|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43845389|NCT04282109|Paclitaxel|paclitaxel|mesh-list
43845390|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43845391|NCT04282109|Nivolumab|nivolumab|mesh-list
43845392|NCT04282109|Cetuximab|cetuximab|mesh-list
44213202|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213203|NCT00451763|Bevacizumab|bevacizumab|mesh-list
44213204|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44213205|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213206|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44213207|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44213208|NCT00451763|Growth Substances|growth substances|mesh-ancestor
44213209|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213210|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
44213211|NCT00451776|Propofol|propofol|mesh-list
44213212|NCT00451776|Etomidate|etomidate|mesh-list
44213213|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44213214|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213215|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213216|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44213217|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
44213218|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
44213219|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44213220|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44213221|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44213222|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44213223|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
44213224|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213225|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213250|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213251|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213252|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213253|NCT00451971|Leflunomide|leflunomide|mesh-list
44213254|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213255|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213256|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213257|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
44213258|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213259|NCT00451984|Interleukin-2|interleukin-2|mesh-list
44213260|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213261|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44213262|NCT00451984|Analgesics|analgesics|mesh-ancestor
43807605|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807606|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43807607|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
43807608|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807609|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43807610|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43807611|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43807612|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
44213263|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
44213264|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213265|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213266|NCT00451997|Cytarabine|cytarabine|mesh-list
44213267|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
44213268|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213269|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
44213270|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213271|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213272|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
44213273|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213297|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213298|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213300|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44213301|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44213302|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44213303|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213304|NCT00452218|Sorafenib|sorafenib|mesh-list
44213305|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213306|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213307|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213308|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213309|NCT00452231|Cycloserine|cycloserine|mesh-list
44213310|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44213311|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213312|NCT00452231|Renal Agents|renal agents|mesh-ancestor
44213313|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44213314|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
44213315|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213316|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
44213318|NCT00452244|Gefitinib|gefitinib|mesh-list
44213351|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213352|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213353|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213354|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213355|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213356|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44213357|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
44213358|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43655401|NCT02969265|Amlodipine|amlodipine|mesh-list
43655402|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
43655403|NCT02969265|Candesartan|candesartan|mesh-list
43655404|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43631374|NCT03044522|Analgesics|analgesics|mesh-ancestor
43817998|NCT05549752|Flecainide|flecainide|mesh-list
43849634|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
44213359|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213360|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44213362|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213363|NCT00452569|Thalidomide|thalidomide|mesh-list
44213364|NCT00452569|Dexamethasone|dexamethasone|mesh-list
44213365|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213366|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
44213367|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
44213368|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213369|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213370|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213371|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
44213372|NCT00452569|Hormones|hormones|mesh-ancestor
44213373|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213400|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44213401|NCT00452608|Atorvastatin|atorvastatin|mesh-list
44213402|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213403|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213404|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
44213405|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213406|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213407|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213408|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213409|NCT00452634|Cisplatin|cisplatin|mesh-list
44213410|NCT00452634|Irinotecan|irinotecan|mesh-list
44213411|NCT00452634|Simvastatin|simvastatin|mesh-list
44213412|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213413|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44213414|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44213415|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213416|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213417|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213418|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213419|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
44213420|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213421|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44213422|NCT00452660|Deferasirox|deferasirox|mesh-list
44213423|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44213424|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
44213425|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
44213426|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213427|NCT00452725|Hormones|hormones|mesh-list
44213428|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213429|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456710|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456715|NCT01624662|Fluticasone|fluticasone|mesh-list
44456720|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456721|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456722|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456723|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456724|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817999|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43818000|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43818001|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
43818002|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43818003|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456725|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44456726|NCT01624467|Necitumumab|necitumumab|mesh-list
44456727|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44456728|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456729|NCT01624259|Metformin|metformin|mesh-list
44456730|NCT01624259|Liraglutide|liraglutide|mesh-list
44456731|NCT01624259|Dulaglutide|dulaglutide|mesh-list
44456732|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44456733|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456734|NCT01624259|Incretins|incretins|mesh-ancestor
44456735|NCT01624259|Hormones|hormones|mesh-ancestor
44456736|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456737|NCT01624233|Ixekizumab|ixekizumab|mesh-list
44456738|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456739|NCT01624194|Oxytocin|oxytocin|mesh-list
44456740|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
44456741|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44456742|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213436|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213437|NCT00452855|Remifentanil|remifentanil|mesh-list
44213438|NCT00452855|Sevoflurane|sevoflurane|mesh-list
44213439|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
44213440|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818014|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44213441|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213442|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44213443|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44213444|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
44213445|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44213446|NCT00452855|Narcotics|narcotics|mesh-ancestor
44213447|NCT00452855|Analgesics|analgesics|mesh-ancestor
44213448|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
44213449|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213450|NCT00452881|Gemcitabine|gemcitabine|mesh-list
44213451|NCT00452881|Cisplatin|cisplatin|mesh-list
44213452|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
44213453|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213454|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213455|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
44213456|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213457|NCT00452881|Antiviral Agents|antiviral agents|mesh-ancestor
44213458|NCT00452881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213459|NCT00452881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655406|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655407|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213460|NCT00452881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213461|NCT00452881|Immunologic Factors|immunologic factors|mesh-ancestor
44213462|NCT00452881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213463|NCT00452894|Varenicline|varenicline|mesh-list
44213464|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44213465|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44213466|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
44213467|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213468|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213469|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213470|NCT00452907|Artesunate|artesunate|mesh-list
44213471|NCT00452907|Lumefantrine|lumefantrine|mesh-list
44213476|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44213477|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44213478|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213479|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213480|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
44213481|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
44213482|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44213483|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
44213484|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44213485|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213486|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213487|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44213488|NCT00452907|Renal Agents|renal agents|mesh-ancestor
44213489|NCT00452920|Docetaxel|docetaxel|mesh-list
44213490|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213491|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213492|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213493|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213494|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213495|NCT00452972|Anesthetics|anesthetics|mesh-list
44213496|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213497|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213498|NCT00452985|Carboplatin|carboplatin|mesh-list
44213499|NCT00452985|Docetaxel|docetaxel|mesh-list
44213500|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818140|NCT05548465|Analgesics|analgesics|mesh-ancestor
44213501|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213502|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213503|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213504|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213505|NCT00453050|Imiquimod|imiquimod|mesh-list
44213521|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
44213522|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213523|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213524|NCT00453115|Antiviral Agents|antiviral agents|mesh-ancestor
44213525|NCT00453115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213526|NCT00453115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213527|NCT00453115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213528|NCT00453115|Immunologic Factors|immunologic factors|mesh-ancestor
44213529|NCT00453115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213530|NCT00453141|Betamethasone|betamethasone|mesh-list
44213531|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213532|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
44213533|NCT00453141|Hormones|hormones|mesh-ancestor
44213534|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213535|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213536|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44213537|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
44213538|NCT00453167|Gemcitabine|gemcitabine|mesh-list
44213539|NCT00453167|Paclitaxel|paclitaxel|mesh-list
44213540|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44213541|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213542|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213543|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213544|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213545|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213546|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213547|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
44213548|NCT00453167|Antiviral Agents|antiviral agents|mesh-ancestor
44213549|NCT00453167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213566|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44213567|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213568|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213569|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213570|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213571|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213572|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213573|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
44213574|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
44213575|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
44213576|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213577|NCT00453375|Protective Agents|protective agents|mesh-ancestor
44213578|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213579|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
44213580|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
44213581|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213582|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213583|NCT00453414|Iloprost|iloprost|mesh-list
44213584|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44213585|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
44213586|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
44213587|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44213588|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213589|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44213590|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
44213591|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213592|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
44213593|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44213594|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44213595|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213596|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44213597|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213598|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44164314|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
44164315|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164316|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164318|NCT00255749|Hematinics|hematinics|mesh-ancestor
44213599|NCT00453609|Naltrexone|naltrexone|mesh-list
44213600|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44213601|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44213602|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213603|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
44213604|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213605|NCT00453635|Carboplatin|carboplatin|mesh-list
44213606|NCT00453635|Docetaxel|docetaxel|mesh-list
44213607|NCT00453635|Trastuzumab|trastuzumab|mesh-list
44213608|NCT00453635|Vinorelbine|vinorelbine|mesh-list
44213609|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213610|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
44213611|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
44213612|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
44213613|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213614|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44213615|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44213616|NCT00453648|Vitamin A|vitamin a|mesh-list
44213617|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
44213618|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
44213619|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213620|NCT00453648|Protective Agents|protective agents|mesh-ancestor
44213621|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213622|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44213623|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213624|NCT00453648|Vitamins|vitamins|mesh-ancestor
44213625|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
44213626|NCT00453765|Montelukast|montelukast|mesh-list
44213647|NCT00453804|Naltrexone|naltrexone|mesh-list
44213648|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44213649|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44213650|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213651|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
44213652|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213653|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
44213654|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
44213655|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44213656|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
44213657|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44213658|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44213659|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213660|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44213661|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213662|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213663|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44213664|NCT00453856|Renal Agents|renal agents|mesh-ancestor
44213666|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44213667|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44213668|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44213669|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
44213670|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213671|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213672|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655424|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
43655425|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655426|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655427|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
43655428|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
43655429|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
44213673|NCT00453908|Urological Agents|urological agents|mesh-ancestor
44213674|NCT00453960|Norethindrone|norethindrone|mesh-list
44213675|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
44213676|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44213693|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213694|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213695|NCT00454259|Analgesics|analgesics|mesh-ancestor
44213696|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
44213697|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213698|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44213699|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44213700|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
44213701|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
44213702|NCT00454272|Vancomycin|vancomycin|mesh-list
44213703|NCT00454272|Teicoplanin|teicoplanin|mesh-list
44213704|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44213705|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213706|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44213707|NCT00454350|Vitamins|vitamins|mesh-ancestor
44213708|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
44213709|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213710|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44213711|NCT00454389|Ranibizumab|ranibizumab|mesh-list
44213712|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44213713|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44213714|NCT00454389|Growth Substances|growth substances|mesh-ancestor
44213715|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213716|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
44213717|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213718|NCT00454402|Alfuzosin|alfuzosin|mesh-list
44213719|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44213720|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43818172|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818173|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43818174|NCT05548075|Psilocybin|psilocybin|mesh-list
43818175|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43818176|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
43818177|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818178|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818179|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43818180|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
43818181|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818182|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818183|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44213721|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44213722|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
44213723|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213724|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213725|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213726|NCT00454402|Urological Agents|urological agents|mesh-ancestor
44213727|NCT00454480|Cytarabine|cytarabine|mesh-list
44213734|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
44213735|NCT00454480|Clofarabine|clofarabine|mesh-list
44213736|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
44213737|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
44213738|NCT00454480|Tipifarnib|tipifarnib|mesh-list
44213739|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213740|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213741|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
44213742|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213743|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213744|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
44213745|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213746|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
44213747|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213748|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213749|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44213750|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
44213751|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44213752|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44213753|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44213754|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44213755|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44213756|NCT00454519|Cisplatin|cisplatin|mesh-list
44213757|NCT00454519|Mitomycins|mitomycins|mesh-list
44213758|NCT00454519|Mitomycin|mitomycin|mesh-list
44213765|NCT00454545|Atorvastatin|atorvastatin|mesh-list
44456776|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456777|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44456778|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
44456779|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456780|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44456781|NCT01623271|Gabapentin|gabapentin|mesh-list
44456782|NCT01623271|Analgesics|analgesics|mesh-ancestor
44456783|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
44456784|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456785|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456786|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
44456787|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44456788|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44456789|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456790|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456791|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44456792|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44456793|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44456794|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456795|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
44456796|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44456797|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
44456798|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456799|NCT01622868|Lapatinib|lapatinib|mesh-list
44456800|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213777|NCT00454662|Olmesartan|olmesartan|mesh-list
44213798|NCT00454714|Urological Agents|urological agents|mesh-ancestor
44213799|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
44213800|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44213801|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44213802|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
44213803|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213804|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213805|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213806|NCT00454740|Urological Agents|urological agents|mesh-ancestor
44213808|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44213809|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213810|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
44213811|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213812|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213813|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
44213814|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
44213815|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
44213816|NCT00454831|Coagulants|coagulants|mesh-ancestor
44213817|NCT00454883|Ziprasidone|ziprasidone|mesh-list
44213818|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44213819|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
44213851|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213852|NCT00455039|Lapatinib|lapatinib|mesh-list
44213853|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818284|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818285|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818286|NCT05546411|Leucovorin|leucovorin|mesh-list
43818287|NCT05546411|Fluorouracil|fluorouracil|mesh-list
43655430|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43808206|NCT04885777|Lidocaine|lidocaine|mesh-list
44213854|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44213855|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213856|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213857|NCT00455091|Lamivudine|lamivudine|mesh-list
44213858|NCT00455091|Adefovir|adefovir|mesh-list
44213859|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
44213860|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44213861|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44213862|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213863|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213864|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
44213865|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213866|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44213867|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44213868|NCT00455117|Parecoxib|parecoxib|mesh-list
44213869|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44213870|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44213871|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213872|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213873|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44213874|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44213875|NCT00455117|Analgesics|analgesics|mesh-ancestor
44213876|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
44213877|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213878|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213879|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213880|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44213881|NCT00455130|Mannitol|mannitol|mesh-list
44213882|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44213883|NCT00455130|Diuretics|diuretics|mesh-ancestor
44213884|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
44213892|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213893|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213895|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44213896|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44213897|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44213898|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44213899|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44213900|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
44213901|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44213902|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213903|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44213904|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
44213905|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
44213906|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44213907|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
44213908|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
44213909|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44213910|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44213911|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44213912|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
44213913|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
44213914|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
44213915|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
44213916|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44213917|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44213918|NCT00455286|Prednisolone|prednisolone|mesh-list
44213919|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
44213920|NCT00455286|Methotrexate|methotrexate|mesh-list
44213921|NCT00455286|Temozolomide|temozolomide|mesh-list
44213922|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44213923|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
44213924|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44213925|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
44213926|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44213927|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213928|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44213930|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44213931|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213932|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
44213933|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213934|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44213935|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44213936|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
44213937|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44213938|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44213939|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44213940|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
44213941|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44213942|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
44213943|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
44213944|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44213945|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44213946|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
44213947|NCT00455286|Hormones|hormones|mesh-ancestor
44213948|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44213949|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44213950|NCT00455286|Protective Agents|protective agents|mesh-ancestor
44213951|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44213952|NCT00455351|Vorinostat|vorinostat|mesh-list
44213953|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44213954|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44213955|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213957|NCT00455364|Voriconazole|voriconazole|mesh-list
44213976|NCT00455416|Protective Agents|protective agents|mesh-ancestor
44213977|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818288|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
43818289|NCT05546411|Irinotecan|irinotecan|mesh-list
43818290|NCT05546411|Camptothecin|camptothecin|mesh-list
43818291|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
43818292|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818293|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
43818294|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818295|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818296|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818297|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818298|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
43818299|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43818300|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43818301|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213978|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44213979|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44213980|NCT00455416|Trace Elements|trace elements|mesh-ancestor
44213981|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
44213982|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44213983|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44213984|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
44213985|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44213986|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44213987|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44213988|NCT00455442|Mifepristone|mifepristone|mesh-list
44213989|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44213990|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
44213991|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44213992|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44213993|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44213994|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44213995|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44213996|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
44213997|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44213998|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44213999|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
44214000|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214001|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
44214002|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44214003|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44214004|NCT00455507|Istradefylline|istradefylline|mesh-list
44214005|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44214006|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44214018|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
44214019|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214020|NCT00455585|Lamivudine|lamivudine|mesh-list
44214021|NCT00455585|Nevirapine|nevirapine|mesh-list
44214022|NCT00455585|Stavudine|stavudine|mesh-list
44214023|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44214024|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44214025|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214026|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214027|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
44214028|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214029|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44214030|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44214031|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44214032|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44214033|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
44214034|NCT00455624|Androgens|androgens|mesh-list
44214035|NCT00455624|Hormones|hormones|mesh-ancestor
44214038|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
44214071|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214072|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44214073|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214074|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44214075|NCT00455832|Ribavirin|ribavirin|mesh-list
44214076|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
44214077|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214078|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
44214079|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214080|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
44214081|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44214082|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
43818321|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214083|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44214084|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214085|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44214086|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44214087|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44214088|NCT00455871|Ranibizumab|ranibizumab|mesh-list
44214089|NCT00455871|Verteporfin|verteporfin|mesh-list
44214090|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214091|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214092|NCT00455871|Growth Substances|growth substances|mesh-ancestor
44214093|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214094|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214095|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214096|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44214097|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214118|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44214119|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214120|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214121|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44214122|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44214123|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
44214124|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214126|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214127|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214128|NCT00456144|Hormones|hormones|mesh-list
44214129|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818334|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
44214130|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214131|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
44214132|NCT00456235|Cyclosporine|cyclosporine|mesh-list
44214133|NCT00456235|Tacrolimus|tacrolimus|mesh-list
44214134|NCT00456235|Cyclosporins|cyclosporins|mesh-list
44214135|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214136|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
44214137|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214138|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44214139|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214140|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214141|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44214142|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214143|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44214144|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
44214145|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214146|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214147|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
44214148|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214149|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44214150|NCT00456248|Ribavirin|ribavirin|mesh-list
44214152|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
44214153|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214154|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
44164319|NCT00255762|Paclitaxel|paclitaxel|mesh-list
44214155|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214156|NCT00456313|Fluticasone|fluticasone|mesh-list
44214157|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
44214158|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44214159|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
44214160|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214161|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214162|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44214163|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
44214164|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
44214165|NCT00456313|Hormones|hormones|mesh-ancestor
44214166|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214167|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
44214168|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214169|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214170|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44214171|NCT00456339|Amoxicillin|amoxicillin|mesh-list
44214172|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
44214173|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
44214174|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44214175|NCT00456339|Prednisolone|prednisolone|mesh-list
44214176|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214177|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214178|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214179|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
44214180|NCT00456339|Hormones|hormones|mesh-ancestor
44214181|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44456803|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456804|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
44456805|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
44456806|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
44456807|NCT01622673|Antacids|antacids|mesh-list
44456808|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
44456809|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
44456810|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
44456812|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456813|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44456814|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44456815|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
44456816|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456817|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44456818|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44456819|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456820|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456821|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214227|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44214228|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44214229|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
44214230|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214231|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214232|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214233|NCT00456677|Minocycline|minocycline|mesh-list
44214234|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214235|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214236|NCT00456716|Sorafenib|sorafenib|mesh-list
44214237|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214238|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44214239|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214240|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214241|NCT00456729|Metronidazole|metronidazole|mesh-list
44214242|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214243|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214244|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44214245|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44214246|NCT00456794|Istradefylline|istradefylline|mesh-list
44214247|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44214248|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44214249|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44214250|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
44214251|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214252|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214253|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214254|NCT00456820|Bupropion|bupropion|mesh-list
44214255|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214256|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214268|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44214269|NCT00456833|Everolimus|everolimus|mesh-list
43869236|NCT04782388|Alprazolam|alprazolam|mesh-list
44214270|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214271|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44214272|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214273|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214274|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214275|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
44214276|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214277|NCT00456872|Lidocaine|lidocaine|mesh-list
44214278|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
44214279|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
44214280|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214281|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214282|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
44214283|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214284|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44214285|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44214286|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44214287|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214288|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214289|NCT00456898|Codeine|codeine|mesh-list
44214290|NCT00456898|Paroxetine|paroxetine|mesh-list
44214291|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
44214292|NCT00456898|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44214293|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214294|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214295|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214296|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214297|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
44214298|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214299|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214305|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44214306|NCT00456898|Narcotics|narcotics|mesh-ancestor
44214307|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214308|NCT00456898|Analgesics|analgesics|mesh-ancestor
44214309|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
44214310|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214311|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
44214312|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
44214313|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44214314|NCT00456937|Citalopram|citalopram|mesh-list
44214315|NCT00456937|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44214316|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44214317|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214318|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214319|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214320|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
44214321|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214322|NCT00456937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44214323|NCT00456937|Antidepressive Agents|antidepressive agents|mesh-ancestor
44214324|NCT00456937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214325|NCT00456963|Losartan|losartan|mesh-list
44214326|NCT00456963|Enalapril|enalapril|mesh-list
44214327|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44214328|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44214329|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44214330|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44214331|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214348|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214349|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214350|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214351|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
44214352|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214353|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214354|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214355|NCT00457067|Ranibizumab|ranibizumab|mesh-list
44214356|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214357|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214358|NCT00457067|Growth Substances|growth substances|mesh-ancestor
44214359|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214360|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214361|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214362|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
44214363|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44214364|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214365|NCT00457106|Risperidone|risperidone|mesh-list
44214366|NCT00457106|Paroxetine|paroxetine|mesh-list
44214367|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44214368|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
44214372|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44214401|NCT00457340|Atorvastatin|atorvastatin|mesh-list
44214402|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44214403|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44214404|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
44214405|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214406|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44214407|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44214408|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214409|NCT00457405|Dipyridamole|dipyridamole|mesh-list
44214410|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44214411|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214412|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214413|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44214414|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
44214416|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44214417|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214418|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214419|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214420|NCT00457483|Valsartan|valsartan|mesh-list
44214421|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44214422|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43818480|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818481|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
44214423|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44214424|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44214425|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214448|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214449|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214450|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44214451|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
44214453|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214454|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44214455|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214456|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214457|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214458|NCT00457678|Growth Substances|growth substances|mesh-ancestor
44214459|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214460|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44214461|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214462|NCT00457717|Atropine|atropine|mesh-list
44214463|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44214464|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44214466|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
44214505|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214506|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214508|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214509|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214510|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
44214511|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214512|NCT00458042|Treprostinil|treprostinil|mesh-list
44214513|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44214514|NCT00458055|Niacin|niacin|mesh-list
44214515|NCT00458055|Atorvastatin|atorvastatin|mesh-list
44214516|NCT00458055|Fenofibrate|fenofibrate|mesh-list
44214517|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44214518|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44214519|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
44214520|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214521|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44214522|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44214523|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214524|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
44214525|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
44214526|NCT00458055|Vitamins|vitamins|mesh-ancestor
44214527|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
44214528|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456832|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44456833|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456834|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44456835|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
44456836|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456837|NCT01622569|Fluticasone|fluticasone|mesh-list
44456839|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44456840|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44456841|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
44214550|NCT00458250|Cyclosporine|cyclosporine|mesh-list
44214551|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
44214552|NCT00458250|Busulfan|busulfan|mesh-list
44214553|NCT00458250|Methotrexate|methotrexate|mesh-list
44214554|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
44214555|NCT00458250|Cyclosporins|cyclosporins|mesh-list
44214556|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214557|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
44214558|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214559|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44214560|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44214561|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
44214562|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214563|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214564|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44214565|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44214566|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
44214567|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44214568|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44214569|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
44214570|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214571|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214572|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44214573|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44214574|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
44214575|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164320|NCT00255762|Bevacizumab|bevacizumab|mesh-list
44164321|NCT00255762|Carboplatin|carboplatin|mesh-list
44164322|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44164323|NCT00255762|Antibodies|antibodies|mesh-list
44164324|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
44214576|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44214577|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214578|NCT00458263|Hormones|hormones|mesh-list
44214579|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214580|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214581|NCT00458315|Gemcitabine|gemcitabine|mesh-list
44214582|NCT00458315|Paclitaxel|paclitaxel|mesh-list
44214583|NCT00458315|Bevacizumab|bevacizumab|mesh-list
44214584|NCT00458315|Cisplatin|cisplatin|mesh-list
44214585|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44214586|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214587|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
44214588|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
44214589|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
44214590|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214591|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44214592|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214593|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214594|NCT00458315|Growth Substances|growth substances|mesh-ancestor
44214595|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214596|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214597|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44214598|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
44214599|NCT00458315|Antiviral Agents|antiviral agents|mesh-ancestor
44214600|NCT00458315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214601|NCT00458315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214602|NCT00458315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214603|NCT00458315|Immunologic Factors|immunologic factors|mesh-ancestor
44214604|NCT00458328|Z 338|z 338|mesh-list
44214605|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44214606|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214607|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214608|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
44214616|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214617|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214618|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43818588|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43818589|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43818590|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43818601|NCT05542615|Pirfenidone|pirfenidone|mesh-list
44214619|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214620|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214621|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44214622|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44214623|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
44214625|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44214626|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214627|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
44214628|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214630|NCT00458458|Norethindrone|norethindrone|mesh-list
44214631|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
44214632|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44214633|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
44214634|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44214635|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214636|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44214637|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214638|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44214639|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44214640|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44214641|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
44214642|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44214643|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44214664|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214665|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214666|NCT00458718|Rimonabant|rimonabant|mesh-list
44214667|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44214668|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44214669|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44214670|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214671|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214672|NCT00458718|Hormones|hormones|mesh-ancestor
44214673|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44214674|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214675|NCT00458731|Bevacizumab|bevacizumab|mesh-list
43845601|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
44214676|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44214677|NCT00458731|Cediranib|cediranib|mesh-list
44214678|NCT00458731|Antibodies|antibodies|mesh-list
44214679|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
44214680|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44214681|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214682|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44214683|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44214684|NCT00458731|Growth Substances|growth substances|mesh-ancestor
44214685|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214686|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214687|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
44214688|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214689|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214690|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44214691|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
44214692|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214693|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
44214694|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44214695|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43618976|NCT03126578|Midazolam|midazolam|mesh-list
44164325|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44164326|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44164327|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164328|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
44164329|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
44164330|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
44164331|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214696|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44214697|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44214698|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214699|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43869638|NCT04777045|Diltiazem|diltiazem|mesh-list
44214700|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214701|NCT00458913|Cisplatin|cisplatin|mesh-list
44214702|NCT00458913|Bortezomib|bortezomib|mesh-list
44214703|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214704|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
44214705|NCT00458991|Caffeine|caffeine|mesh-list
44214706|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44214707|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214708|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44214709|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214711|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44214753|NCT00459420|Caffeine|caffeine|mesh-list
44214754|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44214755|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214756|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44214757|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214758|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214759|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44214760|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44214761|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
44214762|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214763|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
44214764|NCT00459485|Astringents|astringents|mesh-ancestor
44214765|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214766|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
44214767|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
44214768|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44214769|NCT00459563|Vitamin D|vitamin d|mesh-list
44214770|NCT00459563|Calcitriol|calcitriol|mesh-list
44214771|NCT00459563|Vitamins|vitamins|mesh-ancestor
44214772|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
44214808|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214809|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44214810|NCT00459836|Antiviral Agents|antiviral agents|mesh-ancestor
44214811|NCT00459836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214812|NCT00459836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214813|NCT00459836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214814|NCT00459836|Immunologic Factors|immunologic factors|mesh-ancestor
44214815|NCT00459836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214816|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
44214817|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
44214818|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
44214819|NCT00459901|Capecitabine|capecitabine|mesh-list
44214871|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214872|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
44214873|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44214874|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
44214875|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214876|NCT00460174|Antiviral Agents|antiviral agents|mesh-ancestor
44214877|NCT00460174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214878|NCT00460174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44214879|NCT00460174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44214880|NCT00460174|Immunologic Factors|immunologic factors|mesh-ancestor
44214881|NCT00460213|Valsartan|valsartan|mesh-list
44214882|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44214883|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44214884|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44214885|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214886|NCT00460226|Lamotrigine|lamotrigine|mesh-list
44214887|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
44214888|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44214889|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44214890|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214891|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44214892|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214893|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44214894|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44214895|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44214896|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44456846|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
44456860|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
44456861|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456862|NCT01622088|Protective Agents|protective agents|mesh-ancestor
44456863|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456864|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44456865|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44456866|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
44214899|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44214900|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44214901|NCT00460304|Pramlintide|pramlintide|mesh-list
44214902|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44214904|NCT00460369|Artesunate|artesunate|mesh-list
44214955|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44214956|NCT00460473|Analgesics|analgesics|mesh-ancestor
44214957|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
44214958|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44214959|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44214960|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44214961|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44214962|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
44214963|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44214964|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44214965|NCT00460486|Formaldehyde|formaldehyde|mesh-list
44214966|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
44214967|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44214968|NCT00460499|Insulin|insulin|mesh-list
44215014|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215015|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215016|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44215017|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
44215018|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
44215019|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215020|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215021|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44215022|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215023|NCT00460733|Vitamin D|vitamin d|mesh-list
44215024|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
44215025|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
44215026|NCT00460733|Calcium|calcium|mesh-list
44215027|NCT00460733|Vitamins|vitamins|mesh-ancestor
44215028|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
44215029|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215072|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215073|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215074|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44215075|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215076|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
44215077|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
44215078|NCT00460928|Antibodies|antibodies|mesh-list
44215079|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
44215084|NCT00460954|Levodopa|levodopa|mesh-list
44215137|NCT00461422|Ganirelix|ganirelix|mesh-list
44215138|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
44215139|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215140|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215141|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
44215142|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44215143|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
44215144|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44215145|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44215146|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215147|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215148|NCT00461565|Urological Agents|urological agents|mesh-ancestor
44215149|NCT00461578|Artesunate|artesunate|mesh-list
44215150|NCT00461578|Dapsone|dapsone|mesh-list
44215151|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
44215152|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
44215153|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44215154|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44215155|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215156|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215157|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
44215158|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
44215192|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
44215193|NCT00461747|Bortezomib|bortezomib|mesh-list
44215194|NCT00461747|BB 1101|bb 1101|mesh-list
44215195|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215196|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
44215197|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
44215198|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215199|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215200|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215201|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
44215259|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44215260|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
44215261|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44215262|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215263|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44215264|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44215265|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215266|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44215267|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
44215268|NCT00461968|Simvastatin|simvastatin|mesh-list
44215269|NCT00461968|Ezetimibe|ezetimibe|mesh-list
44215270|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44215271|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44215272|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
44456895|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44456896|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456897|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456898|NCT01621490|Nivolumab|nivolumab|mesh-list
44456899|NCT01621490|Ipilimumab|ipilimumab|mesh-list
44456900|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44456901|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44456902|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44456903|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456904|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44456905|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44456906|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44456907|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456908|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456917|NCT01621178|Insulin|insulin|mesh-list
44215322|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215323|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215324|NCT00462540|Bromides|bromides|mesh-list
44215325|NCT00462540|Albuterol|albuterol|mesh-list
44215326|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
44215327|NCT00462540|Ipratropium|ipratropium|mesh-list
44215328|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44215329|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
44215330|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215331|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215332|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44215333|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
44215334|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44215335|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44215336|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44215381|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44215382|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44215383|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44215384|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215385|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215386|NCT00462631|Paclitaxel|paclitaxel|mesh-list
44215387|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44215388|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44215389|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215390|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
44215391|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
44215392|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
44215393|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215394|NCT00462657|Dimercaprol|dimercaprol|mesh-list
44215395|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
44215396|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
44215440|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
44215441|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44215442|NCT00462813|Protective Agents|protective agents|mesh-ancestor
44215443|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215444|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215446|NCT00462852|Dalteparin|dalteparin|mesh-list
44215447|NCT00462852|Tinzaparin|tinzaparin|mesh-list
44215448|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
44215449|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215450|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
44215451|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215452|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215453|NCT00462852|Antiviral Agents|antiviral agents|mesh-ancestor
44215454|NCT00462852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215455|NCT00462852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215456|NCT00462852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44215457|NCT00462852|Immunologic Factors|immunologic factors|mesh-ancestor
44215459|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
44215497|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44215499|NCT00463073|Cetuximab|cetuximab|mesh-list
44215500|NCT00463073|Irinotecan|irinotecan|mesh-list
44215501|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44215502|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215503|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44215504|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44215505|NCT00463073|Growth Substances|growth substances|mesh-ancestor
44215506|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215507|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
44215508|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44215509|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44215510|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215511|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215512|NCT00463086|Isoniazid|isoniazid|mesh-list
44215513|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
44215514|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44215515|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215516|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44215517|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44215518|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
44215519|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215520|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44215522|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
44215523|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809258|NCT04877106|Incretins|incretins|mesh-ancestor
44215524|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
44215525|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44215526|NCT00463203|Bevacizumab|bevacizumab|mesh-list
44215544|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215545|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44215546|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44215548|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44215549|NCT00463359|Imiquimod|imiquimod|mesh-list
44215550|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44215551|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
44215552|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215553|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215554|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
44215555|NCT00463502|Metformin|metformin|mesh-list
44215556|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44215557|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215558|NCT00463515|Gemcitabine|gemcitabine|mesh-list
44215559|NCT00463515|Cisplatin|cisplatin|mesh-list
44215560|NCT00463515|Carboplatin|carboplatin|mesh-list
44215561|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215562|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44215563|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
44215564|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215565|NCT00463515|Antiviral Agents|antiviral agents|mesh-ancestor
44215598|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44215599|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44215600|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
44215601|NCT00463736|Analgesics|analgesics|mesh-ancestor
44215602|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
44215603|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215604|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215605|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
44215606|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215607|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44215608|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
44215661|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215662|NCT00463957|Urological Agents|urological agents|mesh-ancestor
44215663|NCT00463983|Octreotide|octreotide|mesh-list
44215664|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215665|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44215666|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215667|NCT00464035|Calcium|calcium|mesh-list
44215670|NCT00464165|Rimonabant|rimonabant|mesh-list
44456972|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44456973|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456974|NCT01619852|Lidocaine|lidocaine|mesh-list
44456975|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
44456976|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
44456977|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44456978|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456979|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
44456980|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44456981|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44456982|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44456983|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44456984|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44456985|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456986|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
44456987|NCT01619423|Edetic Acid|edetic acid|mesh-list
44215716|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44215717|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44215718|NCT00464347|Bevacizumab|bevacizumab|mesh-list
44215719|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44215720|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44215721|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44215722|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44215723|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44215724|NCT00464347|Growth Substances|growth substances|mesh-ancestor
44215725|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215726|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
44215779|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215780|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44215781|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215782|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215783|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
44215784|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44215785|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215786|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215787|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44215789|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
44215790|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215791|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44215792|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44215793|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44215794|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215795|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215796|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215833|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215834|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
44215835|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44215836|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44215837|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
44215838|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
44215839|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44215840|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44215841|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44215842|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215843|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215844|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215845|NCT00464971|Estradiol|estradiol|mesh-list
44215846|NCT00464971|Estrogens|estrogens|mesh-ancestor
44215847|NCT00464971|Hormones|hormones|mesh-ancestor
44215848|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215849|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215850|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
44215851|NCT00465036|Cathartics|cathartics|mesh-ancestor
44215852|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44215853|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
44215854|NCT00465075|Estrogens|estrogens|mesh-list
44215855|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44215856|NCT00465075|Hormones|hormones|mesh-ancestor
44215857|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44215858|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215859|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44215860|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44215861|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
44215862|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44215876|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
44215877|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44215878|NCT00465231|Fentanyl|fentanyl|mesh-list
44215879|NCT00465231|Bupivacaine|bupivacaine|mesh-list
44215880|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
44215881|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
44215882|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215883|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215884|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
44215885|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215886|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44215887|NCT00465231|Narcotics|narcotics|mesh-ancestor
44215888|NCT00465231|Analgesics|analgesics|mesh-ancestor
44215889|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44215890|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44215891|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
44215892|NCT00465244|Levetiracetam|levetiracetam|mesh-list
44215893|NCT00465244|Lorazepam|lorazepam|mesh-list
44215894|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
44215895|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
44215896|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
44215897|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
44215898|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215899|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215903|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44215931|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215933|NCT00465439|Epinephrine|epinephrine|mesh-list
44215934|NCT00465439|Racepinephrine|racepinephrine|mesh-list
44215935|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
44215936|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
44215937|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
44215938|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44215939|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215940|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
44215941|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215942|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44215943|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44215944|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44215945|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44215946|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215947|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44215948|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43845612|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
44215949|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215950|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215951|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44215952|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44215953|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
44215954|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44215955|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
44215956|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
44215957|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
44215958|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44215959|NCT00465452|Dopamine|dopamine|mesh-list
44215960|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
44215962|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
44215975|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44215976|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215977|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44215978|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44215979|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
44215980|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215981|NCT00465543|Protective Agents|protective agents|mesh-ancestor
44215982|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44215983|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44215984|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
44215985|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44215986|NCT00465608|Propranolol|propranolol|mesh-list
44215987|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44215988|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44215989|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
44215990|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44215991|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44215992|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44215993|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44215994|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44215995|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
44215996|NCT00465621|Latanoprost|latanoprost|mesh-list
44215997|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44215998|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44215999|NCT00465673|Doxorubicin|doxorubicin|mesh-list
44216000|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44216001|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44216002|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216003|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44216020|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216021|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44456990|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
44456991|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
44456992|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44456993|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
44456994|NCT01619423|Vitamins|vitamins|mesh-ancestor
44456995|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
44456996|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44456997|NCT01619410|Clindamycin|clindamycin|mesh-list
44456998|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
44456999|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
44457000|NCT01619410|Linezolid|linezolid|mesh-list
44457001|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44457002|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457003|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44457004|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457005|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457006|NCT01619059|Metformin|metformin|mesh-list
44457007|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
44457008|NCT01619059|Saxagliptin|saxagliptin|mesh-list
44457009|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457010|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457011|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43818842|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457012|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457013|NCT01619059|Incretins|incretins|mesh-ancestor
44457014|NCT01619059|Hormones|hormones|mesh-ancestor
44457015|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457016|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44457017|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457018|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457019|NCT01618708|Hylan|hylan|mesh-list
44457020|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
44216029|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44216030|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
44216031|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216032|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216033|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216034|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44216035|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216036|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44216037|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216038|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216039|NCT00466102|Everolimus|everolimus|mesh-list
44216040|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216041|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216042|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
44216089|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
44216090|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44216091|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216092|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
44216093|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216094|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
44216095|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216096|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
44216097|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216098|NCT00466232|Sorafenib|sorafenib|mesh-list
44216099|NCT00466232|Topotecan|topotecan|mesh-list
44216100|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216101|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44216102|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216103|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216104|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44216105|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216106|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
44216107|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
44216108|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216109|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44216143|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
44216144|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216145|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216146|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216147|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44216148|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216149|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216150|NCT00466518|Incretins|incretins|mesh-ancestor
44216151|NCT00466518|Hormones|hormones|mesh-ancestor
44216152|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216153|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44216154|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
44216155|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216156|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216157|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
44216158|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
44216159|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216160|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216161|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44216162|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216163|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216164|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216165|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216166|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44216167|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44216168|NCT00466596|Vitamins|vitamins|mesh-list
44216169|NCT00466596|Vitamin E|vitamin e|mesh-list
44216170|NCT00466596|Tocopherols|tocopherols|mesh-list
43871054|NCT02918864|Oxytocin|oxytocin|mesh-list
44216171|NCT00466596|Tocotrienols|tocotrienols|mesh-list
44216172|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
44216173|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
44216174|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
44216175|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216176|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
44216177|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216178|NCT00466596|Protective Agents|protective agents|mesh-ancestor
44164332|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216179|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44216180|NCT00466609|Fluoxetine|fluoxetine|mesh-list
44216181|NCT00466609|Clomipramine|clomipramine|mesh-list
44216182|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
44216183|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44216184|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44216185|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44216186|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44216187|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216188|NCT00466609|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44216189|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44216190|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44216191|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216192|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216193|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
44216194|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44216195|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44216196|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44216197|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216198|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44216199|NCT00466622|Metformin|metformin|mesh-list
44216200|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216201|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216202|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
44216203|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216204|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216225|NCT00466856|Octreotide|octreotide|mesh-list
44216226|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44216227|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44216228|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216229|NCT00466869|Betahistine|betahistine|mesh-list
44216230|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
44216231|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
44216232|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
44216233|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216234|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216235|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216236|NCT00466895|Lenalidomide|lenalidomide|mesh-list
44216237|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
44216238|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216239|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216240|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216241|NCT00466895|Growth Substances|growth substances|mesh-ancestor
44216242|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216243|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216254|NCT00467012|Paclitaxel|paclitaxel|mesh-list
44216280|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216282|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216283|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
44216284|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
44216285|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
44216286|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216287|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216288|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216289|NCT00467194|Sirolimus|sirolimus|mesh-list
44216290|NCT00467194|Bevacizumab|bevacizumab|mesh-list
44216291|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216292|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216293|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216294|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216295|NCT00467194|Growth Substances|growth substances|mesh-ancestor
44216296|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216297|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216298|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216335|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216336|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216337|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216338|NCT00467467|Urological Agents|urological agents|mesh-ancestor
44216339|NCT00467493|Anastrozole|anastrozole|mesh-list
44216340|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44216341|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216342|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44216343|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44216344|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216345|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216346|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44216347|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
44216348|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216349|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216350|NCT00467506|Antibodies|antibodies|mesh-list
44216351|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
44216352|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
44216353|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216354|NCT00467545|Telbivudine|telbivudine|mesh-list
44216355|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
44216356|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216357|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44216358|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216360|NCT00467571|Amoxicillin|amoxicillin|mesh-list
44216383|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216384|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216385|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216386|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216387|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216388|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
44216390|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44216391|NCT00467883|Amebicides|amebicides|mesh-ancestor
44216392|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44216393|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44216394|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216395|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216396|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
44216397|NCT00467909|Micronutrients|micronutrients|mesh-list
44216398|NCT00467909|Trace Elements|trace elements|mesh-list
44216399|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216400|NCT00467935|Ranibizumab|ranibizumab|mesh-list
44216401|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216402|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216403|NCT00467935|Growth Substances|growth substances|mesh-ancestor
44216404|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216405|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216406|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216407|NCT00467948|Cefazolin|cefazolin|mesh-list
44216408|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44216409|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457024|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
44457025|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
44457026|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
44457027|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
44457028|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457029|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818916|NCT05537584|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44457039|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457040|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
44457041|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457042|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44457043|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44457044|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
44457045|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44457046|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44457047|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44457048|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44457049|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44457050|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44457051|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44457052|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44457053|NCT01618266|Dexamethasone|dexamethasone|mesh-list
44457054|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457055|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
44457056|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
44457057|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457058|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457059|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457061|NCT01618266|Hormones|hormones|mesh-ancestor
44216416|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216417|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44216418|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
44216419|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
44216420|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
44216421|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44216422|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44216423|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216424|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216425|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216426|NCT00468182|Interferons|interferons|mesh-list
44216427|NCT00468182|Interferon-beta|interferon-beta|mesh-list
44216428|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
44216429|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216430|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
44216431|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216432|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
44216433|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216434|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44216472|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44216473|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
44216474|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
44216475|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
44216476|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
44216477|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44216478|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216479|NCT00468429|Bevacizumab|bevacizumab|mesh-list
44216480|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216481|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216482|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216483|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216484|NCT00468429|Growth Substances|growth substances|mesh-ancestor
44216485|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216486|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216488|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
44216489|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44216529|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44216530|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216531|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
44216532|NCT00468923|Candesartan|candesartan|mesh-list
44216533|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44216534|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44216535|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44216536|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
44216537|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216538|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44216539|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44216540|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216541|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44216542|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44216543|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44216544|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
44216545|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44216553|NCT00468988|Travoprost|travoprost|mesh-list
44216584|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
44216585|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44216586|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44216588|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
44216589|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216590|NCT00469326|Atorvastatin|atorvastatin|mesh-list
44216591|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44216592|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44216593|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
44216594|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216595|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44216596|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44216597|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845674|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44216598|NCT00469352|Ranibizumab|ranibizumab|mesh-list
44216599|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216600|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216601|NCT00469352|Growth Substances|growth substances|mesh-ancestor
44216602|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216603|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216641|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44216642|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44216643|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216644|NCT00469443|Antidotes|antidotes|mesh-ancestor
44216645|NCT00469443|Protective Agents|protective agents|mesh-ancestor
44216646|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
44216647|NCT00469443|Vitamins|vitamins|mesh-ancestor
44216648|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
44216649|NCT00469469|Bevacizumab|bevacizumab|mesh-list
44216650|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44216651|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216652|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216653|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216654|NCT00469469|Growth Substances|growth substances|mesh-ancestor
44216655|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216656|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216657|NCT00469495|Anthelmintics|anthelmintics|mesh-list
44216658|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44216701|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216702|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216703|NCT00469690|Analgesics|analgesics|mesh-ancestor
44216704|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
44216705|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216706|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216707|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216708|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216709|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44216710|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216711|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216712|NCT00469703|Thalidomide|thalidomide|mesh-list
44216727|NCT00469768|Dapivirine|dapivirine|mesh-list
44216763|NCT00469846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216765|NCT00469885|Nicotine|nicotine|mesh-list
44216766|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44216767|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
44216768|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216769|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216770|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44216771|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44216772|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
44216773|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216774|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216775|NCT00469924|Caffeine|caffeine|mesh-list
44216776|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44216777|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216778|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44216815|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216816|NCT00470015|Analgesics|analgesics|mesh-ancestor
44216817|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
44216818|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216819|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216820|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44216821|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44216822|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
44216823|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216824|NCT00470041|Lamivudine|lamivudine|mesh-list
44216825|NCT00470041|Zidovudine|zidovudine|mesh-list
44216826|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
44216827|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44216828|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44216829|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818929|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
44216830|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216831|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44216835|NCT00470197|Cytarabine|cytarabine|mesh-list
44216874|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
44216875|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
44216876|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44216877|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44216878|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216879|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216880|NCT00470340|Gemcitabine|gemcitabine|mesh-list
44216881|NCT00470340|Cisplatin|cisplatin|mesh-list
44216882|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
44216883|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
44216884|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216885|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216886|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
44216887|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216888|NCT00470340|Antiviral Agents|antiviral agents|mesh-ancestor
44216934|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44216935|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216936|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44216937|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
44216938|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216939|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216940|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
44216941|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216942|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44216943|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44216944|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
44216945|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216946|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44216947|NCT00470522|Hematinics|hematinics|mesh-ancestor
44216948|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
44216949|NCT00470522|Vitamins|vitamins|mesh-ancestor
44216950|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
44216951|NCT00470561|Aspirin|aspirin|mesh-list
44216952|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216953|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216954|NCT00470561|Analgesics|analgesics|mesh-ancestor
44216955|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
44216956|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216957|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216958|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216959|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216960|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44216961|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44216962|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216963|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44216964|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44216965|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216976|NCT00470678|Ranibizumab|ranibizumab|mesh-list
44216977|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44216978|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44216979|NCT00470678|Growth Substances|growth substances|mesh-ancestor
44216980|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216981|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
44216982|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44216983|NCT00470743|Ibuprofen|ibuprofen|mesh-list
44216984|NCT00470743|Indomethacin|indomethacin|mesh-list
44216985|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44216986|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44216987|NCT00470743|Analgesics|analgesics|mesh-ancestor
44216988|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
44216989|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44216990|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44216991|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44216992|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44216993|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44216994|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44216995|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44216996|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
44216997|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
44216998|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44216999|NCT00470821|Melatonin|melatonin|mesh-list
44217000|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
44217001|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217002|NCT00470821|Protective Agents|protective agents|mesh-ancestor
44217003|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217004|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217005|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44217006|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
44217007|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44217008|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44217009|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43621503|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
44164333|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44164334|NCT00255762|Growth Substances|growth substances|mesh-ancestor
44164335|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164336|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
44164337|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
44217010|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217011|NCT00470873|Urological Agents|urological agents|mesh-ancestor
44217012|NCT00470886|Telmisartan|telmisartan|mesh-list
44217013|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217014|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44217015|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44217016|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217017|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
44217018|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44217019|NCT00470912|Protective Agents|protective agents|mesh-ancestor
44217020|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217021|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217022|NCT00470977|Ranibizumab|ranibizumab|mesh-list
44217023|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44217025|NCT00470977|Growth Substances|growth substances|mesh-ancestor
44217069|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
43818954|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43818955|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
43818956|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818957|NCT05537220|Protective Agents|protective agents|mesh-ancestor
43818958|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818959|NCT05537220|Antidotes|antidotes|mesh-ancestor
44217070|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217071|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217072|NCT00471185|Acyline|acyline|mesh-list
44217073|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217074|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217075|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217076|NCT00471289|Paclitaxel|paclitaxel|mesh-list
44217077|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44217078|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217079|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
44217080|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
44217081|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217082|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217083|NCT00471341|Celecoxib|celecoxib|mesh-list
44217084|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217085|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217086|NCT00471341|Analgesics|analgesics|mesh-ancestor
44217087|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
44217088|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217089|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217090|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217091|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217094|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217116|NCT00471419|Rimexolone|rimexolone|mesh-list
44217117|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
44217118|NCT00471419|Hormones|hormones|mesh-ancestor
44217119|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217120|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217121|NCT00471432|Docetaxel|docetaxel|mesh-list
44217122|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217123|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
44217124|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
44217125|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
44217126|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217127|NCT00471471|Sargramostim|sargramostim|mesh-list
44217128|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
44217129|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217130|NCT00471484|Interferons|interferons|mesh-list
44217131|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
44217132|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
44217133|NCT00471484|Doxorubicin|doxorubicin|mesh-list
44217134|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44217135|NCT00471484|Fluorouracil|fluorouracil|mesh-list
44217136|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
44217137|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44217138|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217139|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44217140|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44217166|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44217167|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44217168|NCT00471549|Simvastatin|simvastatin|mesh-list
44217169|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44217170|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44217171|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
44217172|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217173|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44217174|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44217175|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217176|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
44217177|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217178|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
44217179|NCT00471588|Pramipexole|pramipexole|mesh-list
44217180|NCT00471588|Amisulpride|amisulpride|mesh-list
44217181|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
44217182|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217183|NCT00471588|Protective Agents|protective agents|mesh-ancestor
44217184|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217185|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44217186|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44217187|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
44217188|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
44217189|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217190|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44217191|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44217192|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217193|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217194|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44217195|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44217196|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
44217208|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217209|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44217211|NCT00471653|Temozolomide|temozolomide|mesh-list
44217212|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44217213|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
44217214|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217215|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217216|NCT00471679|Ethanol|ethanol|mesh-list
44217217|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44217218|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217219|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217220|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217221|NCT00471744|Levetiracetam|levetiracetam|mesh-list
44217222|NCT00471744|Sulthiame|sulthiame|mesh-list
44217223|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
44217224|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
44217225|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
44217226|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44217227|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217228|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
44217229|NCT00471809|Azithromycin|azithromycin|mesh-list
44217230|NCT00471809|Budesonide|budesonide|mesh-list
44217231|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44217232|NCT00471809|Montelukast|montelukast|mesh-list
44217233|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457093|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
44457094|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457095|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44457096|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457097|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457098|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457099|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
44457100|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
44457101|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457102|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457103|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44457104|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44457105|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
44457106|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44457107|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44457108|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44457109|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44457110|NCT01617447|Aripiprazole|aripiprazole|mesh-list
44457111|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
44457112|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457113|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44457114|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457115|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457116|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457117|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
44457118|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
44457119|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457139|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457140|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457141|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44457142|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457143|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457144|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457145|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44217255|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44217256|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44217257|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
44217258|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217259|NCT00471952|Caffeine|caffeine|mesh-list
44217260|NCT00471952|Rizatriptan|rizatriptan|mesh-list
44217261|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44217262|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217263|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44217264|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217265|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217266|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44217267|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44217268|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
44217269|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217270|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44217271|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
44217272|NCT00471965|Leucovorin|leucovorin|mesh-list
44217273|NCT00471965|Doxorubicin|doxorubicin|mesh-list
44217274|NCT00471965|Fluorouracil|fluorouracil|mesh-list
44217275|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
44217276|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44217282|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
44217293|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44217294|NCT00471991|Estradiol|estradiol|mesh-list
44217295|NCT00471991|Estrogens|estrogens|mesh-ancestor
44217296|NCT00471991|Hormones|hormones|mesh-ancestor
44217297|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217298|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819094|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
43819095|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44217299|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43819096|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819097|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43632721|NCT05617690|Propofol|propofol|mesh-list
43819098|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43819099|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655471|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43655472|NCT02968693|Vancomycin|vancomycin|mesh-list
43655473|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43655474|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
43655475|NCT02968693|Calcium|calcium|mesh-list
43844049|NCT04411654|Protective Agents|protective agents|mesh-ancestor
44217300|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
44217301|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217302|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44217303|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44217304|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44217305|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44217306|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217307|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44217308|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217309|NCT00472004|Tibolone|tibolone|mesh-list
44217310|NCT00472004|Estradiol|estradiol|mesh-list
44217311|NCT00472004|Estrogens|estrogens|mesh-ancestor
44217312|NCT00472004|Hormones|hormones|mesh-ancestor
44217313|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217314|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217315|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
44217316|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
44217317|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217318|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44217319|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217321|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
44217340|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217341|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
44217342|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217343|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217344|NCT00472329|Fludarabine|fludarabine|mesh-list
44217345|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217346|NCT00472355|Apomorphine|apomorphine|mesh-list
44217347|NCT00472355|Emetics|emetics|mesh-ancestor
44217348|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217349|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
44217350|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217351|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217352|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
44217353|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
44217354|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217355|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217356|NCT00472368|Panobinostat|panobinostat|mesh-list
44217357|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217358|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44217359|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217360|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217394|NCT00472823|Vitamin D|vitamin d|mesh-list
44217395|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
44217396|NCT00472823|Calcium|calcium|mesh-list
44217397|NCT00472823|Vitamins|vitamins|mesh-ancestor
44217398|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
44217399|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217400|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44217401|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44217402|NCT00472875|Glyburide|glyburide|mesh-list
44217403|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44217404|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217405|NCT00472901|Afamelanotide|afamelanotide|mesh-list
44217406|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217407|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44217408|NCT00472927|Estrogens|estrogens|mesh-ancestor
44217409|NCT00472927|Hormones|hormones|mesh-ancestor
44217410|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849635|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43810280|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44217411|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217412|NCT00472953|Insulin|insulin|mesh-list
44217413|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44217414|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
44217415|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44217416|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217417|NCT00473005|Capecitabine|capecitabine|mesh-list
44217418|NCT00473005|Everolimus|everolimus|mesh-list
44217419|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44217420|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
44217444|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217445|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
44217446|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217447|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
44217448|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217449|NCT00473239|Vitamin D|vitamin d|mesh-list
44217450|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
44217451|NCT00473239|Vitamins|vitamins|mesh-ancestor
44217452|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
44217453|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217454|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44217455|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44217456|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
44217457|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43819104|NCT05536011|Methylphenidate|methylphenidate|mesh-list
44217458|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44217459|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217460|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44217461|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44217462|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217463|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217464|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217465|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44217466|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
44217467|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217468|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217469|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44217470|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44217471|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44217472|NCT00473486|Carboplatin|carboplatin|mesh-list
44217473|NCT00473486|Pemetrexed|pemetrexed|mesh-list
44217489|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217490|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44217491|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
44217492|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217493|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217494|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44217495|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44217496|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44217497|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
44217498|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217499|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44217500|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43819105|NCT05536011|Modafinil|modafinil|mesh-list
43819106|NCT05536011|Amphetamine|amphetamine|mesh-list
43819107|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44217501|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
43819108|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819109|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43819110|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44217502|NCT00473603|Heparin|heparin|mesh-list
44217503|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
44217504|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44217505|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44457167|NCT01616173|BB 1101|bb 1101|mesh-list
44457168|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457169|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
44457170|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
44457171|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457172|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457173|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457174|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
44457175|NCT01616173|Hormones|hormones|mesh-ancestor
44457176|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457177|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457178|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217526|NCT00473915|Fluticasone|fluticasone|mesh-list
44217528|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217529|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217530|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
44217531|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217532|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217533|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44217534|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217535|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217536|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44217537|NCT00473980|Celecoxib|celecoxib|mesh-list
44217538|NCT00473980|Indomethacin|indomethacin|mesh-list
44217539|NCT00473980|Esomeprazole|esomeprazole|mesh-list
44217566|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217567|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217568|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44217569|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217570|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217571|NCT00474071|Remifentanil|remifentanil|mesh-list
44217572|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44217573|NCT00474071|Narcotics|narcotics|mesh-ancestor
44217574|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217575|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217576|NCT00474071|Analgesics|analgesics|mesh-ancestor
44217577|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
44217578|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217580|NCT00474110|Hydromorphone|hydromorphone|mesh-list
44217581|NCT00474110|Analgesics|analgesics|mesh-ancestor
44217582|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
44217583|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217584|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217585|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44217586|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44217587|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
44217588|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
44217589|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217590|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44217591|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44217592|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217593|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217594|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44217595|NCT00474110|Narcotics|narcotics|mesh-ancestor
44217596|NCT00474136|Diclofenac|diclofenac|mesh-list
44217597|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217598|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217606|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217607|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217608|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
44217609|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
44217610|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
44217612|NCT00474279|Secretagogues|secretagogues|mesh-list
44217613|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217614|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217615|NCT00474435|Tenofovir|tenofovir|mesh-list
44217616|NCT00474435|Emtricitabine|emtricitabine|mesh-list
44217617|NCT00474435|Efavirenz|efavirenz|mesh-list
44217618|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
44217619|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217620|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44217621|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44217622|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217623|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217624|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44217625|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44217626|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44217627|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44217628|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44217629|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44217630|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44217631|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44217653|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217654|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
44217655|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217657|NCT00474721|Ibuprofen|ibuprofen|mesh-list
44217658|NCT00474721|Codeine|codeine|mesh-list
44217659|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217660|NCT00474721|Analgesics|analgesics|mesh-ancestor
44217661|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
44217662|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217663|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217664|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
44217665|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217666|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217667|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217668|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217669|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217670|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217671|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44217672|NCT00474721|Narcotics|narcotics|mesh-ancestor
44217673|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217674|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
44217675|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217677|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217678|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217679|NCT00474773|Analgesics|analgesics|mesh-ancestor
44217680|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
44217681|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217682|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217683|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217684|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217685|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44217686|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217694|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44217695|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
44217696|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
44217697|NCT00474890|Ephedrine|ephedrine|mesh-list
44217698|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217699|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
44217700|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217701|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217702|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44217703|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217704|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
44217705|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44217706|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44217707|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
44217708|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
44217709|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217710|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217711|NCT00474916|KRN 5500|krn 5500|mesh-list
44217712|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217713|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44217714|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217715|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217716|NCT00475059|Cimetidine|cimetidine|mesh-list
44217717|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44217718|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217719|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44217720|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
44217721|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
44217722|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217740|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217741|NCT00475137|Lamotrigine|lamotrigine|mesh-list
44217742|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
44217743|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44217744|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44217745|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217746|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44217747|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217748|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44217749|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44217750|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44217751|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217752|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44217753|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44217754|NCT00475189|Norinyl|norinyl|mesh-list
44217755|NCT00475189|Mestranol|mestranol|mesh-list
44217756|NCT00475189|Norethindrone|norethindrone|mesh-list
44217757|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44217758|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44217759|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44217760|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
44217761|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217762|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217763|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44217764|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44217767|NCT00475189|Estrogens|estrogens|mesh-ancestor
44217783|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
44217784|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217785|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
44217786|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44217787|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44217788|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44217789|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44217790|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217791|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217792|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217793|NCT00475397|Analgesics|analgesics|mesh-ancestor
44217794|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
44217795|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217796|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
44217797|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217798|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
44217799|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44217800|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
44217801|NCT00475410|Coagulants|coagulants|mesh-ancestor
44217802|NCT00475462|Metoprolol|metoprolol|mesh-list
44217803|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44217804|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44217805|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
44217806|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
44217807|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217808|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217811|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44217830|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44217831|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44217832|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217833|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217834|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44217835|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44217836|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44217837|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44217838|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44217839|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44217840|NCT00475553|Etonogestrel|etonogestrel|mesh-list
44217841|NCT00475553|Desogestrel|desogestrel|mesh-list
44217842|NCT00475553|NuvaRing|nuvaring|mesh-list
44217843|NCT00475553|Estradiol|estradiol|mesh-list
44217844|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44217845|NCT00475553|Estrogens|estrogens|mesh-ancestor
44217846|NCT00475553|Hormones|hormones|mesh-ancestor
44217847|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44217848|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217849|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44217850|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
44217851|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44217852|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44217853|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44217854|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44217855|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44217856|NCT00475553|Progestins|progestins|mesh-ancestor
44217857|NCT00475566|Everolimus|everolimus|mesh-list
44217858|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217862|NCT00475618|Fluorides|fluorides|mesh-list
44217874|NCT00475696|Analgesics|analgesics|mesh-ancestor
44217875|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
44217876|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217877|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
44217878|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44217879|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
44217880|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
44217881|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44217882|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44217883|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217884|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217885|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44217886|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44217887|NCT00475800|Analgesics|analgesics|mesh-ancestor
44217888|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
44217889|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217890|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217891|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44217892|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44217893|NCT00475813|Fluticasone|fluticasone|mesh-list
44217894|NCT00475813|Xhance|xhance|mesh-list
44217895|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
44217897|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44217927|NCT00475917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217928|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
44217929|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44217930|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44217931|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44217932|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
44217933|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217934|NCT00475956|Cediranib|cediranib|mesh-list
44217935|NCT00475956|Saracatinib|saracatinib|mesh-list
44217936|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44217937|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44217938|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44217939|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217972|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44217973|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44217974|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44217975|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
44217976|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44217977|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44217978|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44217979|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44217980|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44217981|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
44217982|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44217983|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44217984|NCT00476099|Budesonide|budesonide|mesh-list
44218032|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44218033|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
44218034|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44218035|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44218036|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44218037|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218038|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218039|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218040|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218041|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
44218042|NCT00476268|Hormones|hormones|mesh-ancestor
44218044|NCT00476346|Vitamin D|vitamin d|mesh-list
44218094|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218095|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
44218096|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218097|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218098|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
44218099|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218100|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218101|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
44218102|NCT00476619|Hematinics|hematinics|mesh-ancestor
44218103|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
44218104|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44218105|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44218106|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
44218107|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218108|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44218109|NCT00476853|Nevirapine|nevirapine|mesh-list
44218110|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44218111|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44218112|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819143|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43819144|NCT05535738|Betamethasone|betamethasone|mesh-list
43819145|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
43845715|NCT04257682|Mepivacaine|mepivacaine|mesh-list
44218113|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218114|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
44218115|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218116|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218117|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218118|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44218119|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44218120|NCT00476918|Triamcinolone|triamcinolone|mesh-list
44218121|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44218122|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44218123|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44218124|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218125|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
44218136|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44218137|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44218138|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
44218139|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218140|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218141|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218142|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218143|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
44218144|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218145|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44218146|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218147|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44218197|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
44218198|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218200|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44218201|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44218202|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
44218203|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218204|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218205|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44218206|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44218207|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
44218208|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218209|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44218210|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218211|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
44218256|NCT00477581|Hormones|hormones|mesh-ancestor
44218257|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218258|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44218259|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
44218260|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218261|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218262|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44218263|NCT00477711|Cisplatin|cisplatin|mesh-list
44218264|NCT00477711|Capecitabine|capecitabine|mesh-list
44218265|NCT00477711|Cetuximab|cetuximab|mesh-list
44218266|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218267|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218268|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
44218269|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218270|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218271|NCT00477737|Propofol|propofol|mesh-list
44218272|NCT00477737|Sevoflurane|sevoflurane|mesh-list
44218273|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44218274|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218275|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218276|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44218277|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
44218278|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
44218279|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44218280|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43819204|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
43819205|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819206|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43819207|NCT05592418|Poly I-C|poly i-c|mesh-list
43819208|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
43819209|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819210|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
43819211|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
43819212|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819213|NCT05592327|Citric Acid|citric acid|mesh-list
43819214|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
43819215|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
43819216|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43825143|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43825144|NCT05504330|Analgesics|analgesics|mesh-ancestor
43819227|NCT05592171|Estrogens|estrogens|mesh-ancestor
43632963|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
43819228|NCT05592171|Hormones|hormones|mesh-ancestor
43819229|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819230|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218281|NCT00477763|Cyclosporine|cyclosporine|mesh-list
44218282|NCT00477763|Cyclosporins|cyclosporins|mesh-list
44218283|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218284|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218285|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218286|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
44218299|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44218300|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44218301|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
44218302|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218303|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218304|NCT00477789|Allopurinol|allopurinol|mesh-list
44218305|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
44218306|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218307|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218308|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
44218309|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218310|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44218311|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
44218312|NCT00477789|Protective Agents|protective agents|mesh-ancestor
44218313|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218314|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
44457199|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44457200|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457201|NCT01614886|Rivastigmine|rivastigmine|mesh-list
44457202|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44457203|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457204|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457205|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457206|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457207|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457208|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44457209|NCT01614886|Protective Agents|protective agents|mesh-ancestor
44457210|NCT01614795|Sirolimus|sirolimus|mesh-list
44218371|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
44218372|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
44218373|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218374|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218375|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218376|NCT00478075|Bortezomib|bortezomib|mesh-list
44218377|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
44218378|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218379|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44218380|NCT00478075|Analgesics|analgesics|mesh-ancestor
44218381|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
44218382|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218383|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218384|NCT00478101|Fentanyl|fentanyl|mesh-list
44218385|NCT00478101|Oxycodone|oxycodone|mesh-list
44218386|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44218387|NCT00478101|Narcotics|narcotics|mesh-ancestor
44218430|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44218431|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44218432|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218433|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44218434|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
44218435|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218436|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218498|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44218499|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218500|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218501|NCT00478907|Ketamine|ketamine|mesh-list
44218502|NCT00478907|Thiopental|thiopental|mesh-list
44218503|NCT00478907|Propofol|propofol|mesh-list
44218504|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44218505|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218506|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218507|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44218509|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
44218510|NCT00478907|Analgesics|analgesics|mesh-ancestor
44218511|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
44218512|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218513|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44218514|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44218515|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44218516|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218517|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218518|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
44218519|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
44218520|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
44218521|NCT00478946|Leucovorin|leucovorin|mesh-list
44218522|NCT00478946|Antidotes|antidotes|mesh-ancestor
44218523|NCT00478946|Protective Agents|protective agents|mesh-ancestor
44218524|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218526|NCT00478946|Vitamins|vitamins|mesh-ancestor
44218548|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218549|NCT00478998|Urological Agents|urological agents|mesh-ancestor
44218550|NCT00479076|Aflibercept|aflibercept|mesh-list
44218551|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44218552|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44218553|NCT00479076|Growth Substances|growth substances|mesh-ancestor
43819254|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819255|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
43819256|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
43819257|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819258|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819259|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218554|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218555|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
44218556|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218557|NCT00479193|Bacitracin|bacitracin|mesh-list
44218558|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44218559|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218560|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44218561|NCT00479206|Artesunate|artesunate|mesh-list
44218562|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
44218563|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44218564|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44218565|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218566|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218567|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
44218568|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
44218569|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44218570|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
44218571|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44218572|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
44218573|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218574|NCT00479362|Aspirin|aspirin|mesh-list
44218575|NCT00479362|Warfarin|warfarin|mesh-list
44218576|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44218577|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44218578|NCT00479362|Analgesics|analgesics|mesh-ancestor
44218579|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
44218580|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218581|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218583|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218584|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44218589|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218590|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
44218591|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
44218592|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
44218593|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
44218594|NCT00479479|Vitamins|vitamins|mesh-ancestor
44218595|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
44218596|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218597|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
44218598|NCT00479479|Hematinics|hematinics|mesh-ancestor
44218599|NCT00479609|Testosterone|testosterone|mesh-list
44218600|NCT00479609|Androgens|androgens|mesh-ancestor
44218601|NCT00479609|Hormones|hormones|mesh-ancestor
44218602|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218603|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218604|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
43819283|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44218605|NCT00479661|Propofol|propofol|mesh-list
44218606|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44218607|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218608|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218609|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44218610|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
44218611|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
44218612|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44218613|NCT00479661|Analgesics|analgesics|mesh-ancestor
44218614|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
44218615|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218616|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44218617|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44218618|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44218619|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218620|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218621|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218631|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218632|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
44218633|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218634|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
44218635|NCT00479739|Fluticasone|fluticasone|mesh-list
44218636|NCT00479739|Xhance|xhance|mesh-list
44218637|NCT00479739|Budesonide|budesonide|mesh-list
44218638|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
44218639|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44218640|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218641|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44218642|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
44218643|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218644|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218645|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44218646|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
44218647|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
44218648|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44218649|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
44218650|NCT00479739|Hormones|hormones|mesh-ancestor
44218651|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845741|NCT04252768|Paclitaxel|paclitaxel|mesh-list
44218652|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44218653|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44218654|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44218655|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218656|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218657|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218658|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
44218659|NCT00479752|Cetuximab|cetuximab|mesh-list
44218660|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218661|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44218662|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
44218663|NCT00479778|Estrogens|estrogens|mesh-list
44218664|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44218665|NCT00479778|Hormones|hormones|mesh-ancestor
44218667|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218671|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44218672|NCT00479895|Chrysarobin|chrysarobin|mesh-list
44218673|NCT00479895|HBOC 201|hboc 201|mesh-list
44218674|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44218675|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44218676|NCT00479895|Analgesics|analgesics|mesh-ancestor
44218677|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
44218678|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218679|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218680|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218681|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218682|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
44218683|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
44218684|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
44218685|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218686|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
44218687|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44218688|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44218689|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218690|NCT00479908|Urological Agents|urological agents|mesh-ancestor
44218691|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
44218692|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218693|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218694|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218695|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218696|NCT00479986|Pioglitazone|pioglitazone|mesh-list
44218697|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44218698|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457243|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457244|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
44457245|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
44457246|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457247|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457248|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457249|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
44457252|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457253|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457255|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457256|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457257|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
44457258|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457259|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457260|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
44457261|NCT01613326|Albuterol|albuterol|mesh-list
44457262|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
44457263|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44457264|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
44457265|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457266|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457267|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44457268|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
44457269|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
44457270|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44457271|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845775|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457272|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218730|NCT00480142|Narcotics|narcotics|mesh-ancestor
44218731|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218732|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218733|NCT00480142|Analgesics|analgesics|mesh-ancestor
44218734|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
44218735|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218736|NCT00480181|Nabilone|nabilone|mesh-list
44218737|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
44218738|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
44218739|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218740|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218741|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218742|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44218743|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44218744|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218745|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218746|NCT00480194|Xylometazoline|xylometazoline|mesh-list
44218747|NCT00480194|Bromides|bromides|mesh-list
44218748|NCT00480194|Ipratropium|ipratropium|mesh-list
44218749|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
44218750|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44218751|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
44218752|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218753|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218754|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44218755|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
44218756|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44218757|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
44218758|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218759|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218760|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
44218761|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44218762|NCT00480207|Folic Acid|folic acid|mesh-list
44218774|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44218775|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
44218776|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218777|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218779|NCT00480272|Adalimumab|adalimumab|mesh-list
44218780|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218781|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
44218782|NCT00480272|Hormones|hormones|mesh-ancestor
44218783|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218784|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218785|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44218786|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218787|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218788|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
44218789|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44218790|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44218791|NCT00480298|Prednisolone|prednisolone|mesh-list
44218792|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
44218793|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44218794|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
44218795|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218796|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
44218797|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
44218798|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218827|NCT00480376|Ofloxacin|ofloxacin|mesh-list
44218828|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44218829|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218830|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44218831|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218832|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811013|NCT04850417|Aspirin|aspirin|mesh-list
44218833|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44218834|NCT00480376|Renal Agents|renal agents|mesh-ancestor
44218835|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44218836|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44218837|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218838|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44218839|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44218840|NCT00480389|Sorafenib|sorafenib|mesh-list
44218841|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218842|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218843|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218844|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218845|NCT00480402|Progesterone|progesterone|mesh-list
44218846|NCT00480402|Progestins|progestins|mesh-ancestor
44218847|NCT00480402|Hormones|hormones|mesh-ancestor
44218848|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44218849|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218850|NCT00480454|Vaccines|vaccines|mesh-list
44218851|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
44218852|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218853|NCT00480558|Vaccines|vaccines|mesh-list
44218854|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
44218855|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218856|NCT00480571|Perphenazine|perphenazine|mesh-list
44218857|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
44218858|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
44218859|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43623584|NCT04219449|Protein C|protein c|mesh-list
44218865|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218866|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44218867|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
44218868|NCT00480584|Gemcitabine|gemcitabine|mesh-list
44218869|NCT00480584|Capecitabine|capecitabine|mesh-list
44218870|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44218871|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218872|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
44218873|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218874|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218875|NCT00480584|Antiviral Agents|antiviral agents|mesh-ancestor
44218876|NCT00480584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218877|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218878|NCT00480584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218879|NCT00480584|Immunologic Factors|immunologic factors|mesh-ancestor
44218880|NCT00480584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218881|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44218882|NCT00480597|Gemcitabine|gemcitabine|mesh-list
44218883|NCT00480597|Cisplatin|cisplatin|mesh-list
44218884|NCT00480597|Capecitabine|capecitabine|mesh-list
44218885|NCT00480597|Vinorelbine|vinorelbine|mesh-list
44218886|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218887|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44218888|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
44218889|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218890|NCT00480597|Antiviral Agents|antiviral agents|mesh-ancestor
44218891|NCT00480597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44218892|NCT00480597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218893|NCT00480597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44218894|NCT00480597|Immunologic Factors|immunologic factors|mesh-ancestor
44218912|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218913|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44218914|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
44218915|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218916|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218917|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44218918|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
44218919|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
44218920|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44218921|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44218922|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44218923|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44218924|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
44218925|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218926|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218927|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44218928|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
44218929|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44218930|NCT00480675|Prednisolone|prednisolone|mesh-list
44218931|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
44218932|NCT00480675|Bupivacaine|bupivacaine|mesh-list
44218933|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44218934|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
44218935|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
44218936|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
44218937|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218938|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218939|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
44218940|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44218941|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44218942|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
44218943|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
44218944|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44218953|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
44218954|NCT00480844|Risperidone|risperidone|mesh-list
44218955|NCT00480844|Sertindole|sertindole|mesh-list
44218956|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44218957|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
44218958|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218959|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218960|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218961|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44218962|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44218963|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44218964|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44218965|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44218966|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
44218967|NCT00480870|Donepezil|donepezil|mesh-list
44218968|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44218969|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218970|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218971|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
44218972|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44218973|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44218974|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
44218975|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44218976|NCT00480883|Allopurinol|allopurinol|mesh-list
44218977|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
44218978|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44218979|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44218980|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
44218981|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44218982|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44218983|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
44218984|NCT00480883|Protective Agents|protective agents|mesh-ancestor
44218989|NCT00480896|Tacrolimus|tacrolimus|mesh-list
44218997|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44218998|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44218999|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219000|NCT00480935|Growth Substances|growth substances|mesh-ancestor
44219001|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219002|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
43825149|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825150|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844252|NCT04393207|BB 1101|bb 1101|mesh-list
44219003|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44219004|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219005|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219006|NCT00481013|Valproic Acid|valproic acid|mesh-list
44219007|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
44219008|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219009|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219010|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
44219011|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219012|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219013|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
44219014|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44219015|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219016|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44219017|NCT00481143|Deferasirox|deferasirox|mesh-list
44219018|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44219019|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
44219020|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
44219021|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219022|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
44219023|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44219024|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44219025|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
44219026|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219029|NCT00481182|Ritonavir|ritonavir|mesh-list
44219037|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44219038|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44219039|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
44219040|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219041|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44219042|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219043|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44219044|NCT00481182|Narcotics|narcotics|mesh-ancestor
44219045|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219046|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219047|NCT00481182|Analgesics|analgesics|mesh-ancestor
44219048|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
44219052|NCT00481273|Azacitidine|azacitidine|mesh-list
44219099|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219100|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
44219101|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44219102|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
44219103|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
43819325|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
43819326|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819327|NCT05576272|Gemcitabine|gemcitabine|mesh-list
43819328|NCT05576272|Cisplatin|cisplatin|mesh-list
43819329|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819330|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819331|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
43819332|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819333|NCT05576272|Antiviral Agents|antiviral agents|mesh-ancestor
43819334|NCT05576272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819335|NCT05576272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819350|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
43819351|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219104|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44219105|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44219106|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44219107|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
44219108|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219109|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219110|NCT00481442|Protective Agents|protective agents|mesh-ancestor
44219111|NCT00481455|Temozolomide|temozolomide|mesh-list
44219112|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
44219113|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44219114|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
44219115|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219116|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219117|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
44219118|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
44219119|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
44219120|NCT00481481|Tacrolimus|tacrolimus|mesh-list
44219121|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219122|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
44219123|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219124|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44219125|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219126|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219127|NCT00481533|Oxytocin|oxytocin|mesh-list
44219128|NCT00481533|Ergonovine|ergonovine|mesh-list
44219129|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
44219130|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44219132|NCT00481572|Terlipressin|terlipressin|mesh-list
44219141|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219142|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
44219143|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
44219144|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219145|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44219146|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
44219147|NCT00481572|Coagulants|coagulants|mesh-ancestor
44219148|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
44219149|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
44219150|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44219151|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
44219152|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
44219153|NCT00481624|Hematinics|hematinics|mesh-ancestor
44219154|NCT00481663|Metformin|metformin|mesh-list
44219155|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44219156|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219157|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219158|NCT00481663|Incretins|incretins|mesh-ancestor
44219159|NCT00481663|Hormones|hormones|mesh-ancestor
44219160|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219161|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44219162|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
44219163|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219164|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219165|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
44219166|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219167|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219168|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44219169|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219170|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219186|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219187|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219188|NCT00481728|Urological Agents|urological agents|mesh-ancestor
44219190|NCT00481741|Coagulants|coagulants|mesh-ancestor
44457276|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44457277|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44457278|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44457279|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
44457280|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44457281|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44457282|NCT01613131|Estradiol|estradiol|mesh-list
44457283|NCT01613131|Estrogens|estrogens|mesh-ancestor
44457284|NCT01613131|Hormones|hormones|mesh-ancestor
44457285|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457286|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457287|NCT01613027|Rituximab|rituximab|mesh-list
44457288|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457289|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457290|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
44457291|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457292|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457293|NCT01612858|Metformin|metformin|mesh-list
44457294|NCT01612858|Pioglitazone|pioglitazone|mesh-list
44457295|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457296|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457297|NCT01612702|Dexamethasone|dexamethasone|mesh-list
44457298|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457299|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
44457300|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
44457301|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457315|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457316|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44219191|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
44219192|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
44219193|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44219194|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44219195|NCT00481819|Prednisolone|prednisolone|mesh-list
44219196|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
44219197|NCT00481819|Tacrolimus|tacrolimus|mesh-list
44219198|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44219199|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
44219200|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219201|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
44219202|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219203|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44219204|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219205|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219206|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219207|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219208|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44219209|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
44219210|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219211|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219212|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219213|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
44219214|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
44219215|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219216|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219217|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
44219218|NCT00481819|Hormones|hormones|mesh-ancestor
44219233|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819370|NCT05497778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819371|NCT05497778|Immunologic Factors|immunologic factors|mesh-ancestor
43819372|NCT05497778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819373|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
43819374|NCT05485012|Narcotics|narcotics|mesh-ancestor
43819377|NCT05485012|Analgesics|analgesics|mesh-ancestor
44219234|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219235|NCT00481962|Tigecycline|tigecycline|mesh-list
44219236|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219237|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219238|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44219239|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219240|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219241|NCT00481975|Rimonabant|rimonabant|mesh-list
44219242|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44219243|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44219244|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44219245|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219246|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219247|NCT00481975|Hormones|hormones|mesh-ancestor
44219248|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219249|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219250|NCT00482027|Vaccines|vaccines|mesh-list
44219251|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
44219252|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219253|NCT00482066|Abatacept|abatacept|mesh-list
44219283|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
44219284|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44219285|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43819389|NCT05461261|Docetaxel|docetaxel|mesh-list
44219286|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44219287|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
44219288|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
44219289|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
44219290|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
44219291|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219292|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
44219293|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44219294|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
44219295|NCT00482222|Leucovorin|leucovorin|mesh-list
44219296|NCT00482222|Fluorouracil|fluorouracil|mesh-list
44219297|NCT00482222|Capecitabine|capecitabine|mesh-list
44219298|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
44219299|NCT00482222|Cetuximab|cetuximab|mesh-list
44219300|NCT00482222|Calcium|calcium|mesh-list
44219301|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
44219302|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44219303|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219304|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
44219305|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219306|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44219307|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219308|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219309|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
44219310|NCT00482222|Antidotes|antidotes|mesh-ancestor
44219331|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219332|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44219333|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219334|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219335|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219336|NCT00482261|Analgesics|analgesics|mesh-ancestor
44219337|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
44219338|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219339|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44219340|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44219341|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219342|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44219343|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44219344|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219345|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
44219346|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
44219347|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219348|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219349|NCT00482261|Growth Substances|growth substances|mesh-ancestor
44219384|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44219385|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219386|NCT00482521|Pomalidomide|pomalidomide|mesh-list
44219387|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
44219388|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219389|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219390|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219391|NCT00482521|Growth Substances|growth substances|mesh-ancestor
44219392|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
44219393|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219394|NCT00482573|Epinephrine|epinephrine|mesh-list
44219395|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
44219396|NCT00482573|Anesthetics|anesthetics|mesh-list
44219397|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819509|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43819510|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219398|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219399|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44219400|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44219401|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
44219402|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219441|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44219443|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219444|NCT00482807|Docetaxel|docetaxel|mesh-list
44219445|NCT00482807|Goserelin|goserelin|mesh-list
44219446|NCT00482807|Bicalutamide|bicalutamide|mesh-list
44219447|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219448|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
44219449|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
44219450|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
44219451|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219452|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44219453|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
44219454|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
44219455|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219456|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219457|NCT00482846|Melphalan|melphalan|mesh-list
44219458|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44219459|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
44219460|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219461|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219462|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44219463|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219464|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
44219489|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219491|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
44219492|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219493|NCT00483028|Donepezil|donepezil|mesh-list
44219494|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44219495|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219496|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219497|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
44219498|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219499|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219500|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
44219501|NCT00483054|Efavirenz|efavirenz|mesh-list
44219502|NCT00483054|Nevirapine|nevirapine|mesh-list
44219503|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44219504|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44219505|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219506|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219507|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
44219508|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825153|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43825154|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43825155|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825156|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
43825157|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43825158|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43825159|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
43825160|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43825161|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44219509|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44219510|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44219511|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44219512|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44219513|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44219514|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44219515|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44219516|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44219517|NCT00483067|Cytarabine|cytarabine|mesh-list
44219518|NCT00483067|Cladribine|cladribine|mesh-list
44219519|NCT00483067|Lenograstim|lenograstim|mesh-list
44219520|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44219521|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
44219524|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
44219527|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
44219528|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219529|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44219530|NCT00483093|Cisplatin|cisplatin|mesh-list
44219531|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219532|NCT00483106|Methylphenidate|methylphenidate|mesh-list
44219533|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44219534|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219535|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44219536|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44219537|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219538|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219539|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
44219540|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219541|NCT00483132|Interferons|interferons|mesh-list
44219542|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
44219543|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
44219544|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219545|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
44219546|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219547|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
44219548|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219549|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44219550|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44219551|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44219552|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
44219553|NCT00483158|Finafloxacin|finafloxacin|mesh-list
44219554|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44219555|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219556|NCT00483158|Renal Agents|renal agents|mesh-ancestor
44219557|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219558|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44219559|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219560|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219561|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43874129|NCT03912818|Gemcitabine|gemcitabine|mesh-list
44164338|NCT00255788|Everolimus|everolimus|mesh-list
44219564|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44219565|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
44219566|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219567|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44219568|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
44219569|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44219570|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44219571|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219572|NCT00483275|Vitamins|vitamins|mesh-ancestor
44219573|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
44219574|NCT00483301|Sorafenib|sorafenib|mesh-list
44219575|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44219576|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219577|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44219578|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219579|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562871|NCT01366131|Growth Substances|growth substances|mesh-ancestor
43819522|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219580|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
44219581|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44219582|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
44219583|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219584|NCT00483314|Expectorants|expectorants|mesh-ancestor
44219585|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219586|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44219587|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
44219588|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219589|NCT00483314|Protective Agents|protective agents|mesh-ancestor
44219590|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219591|NCT00483314|Antidotes|antidotes|mesh-ancestor
44219592|NCT00483366|Gemcitabine|gemcitabine|mesh-list
44219593|NCT00483366|Capecitabine|capecitabine|mesh-list
44219594|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
44219595|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44219596|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
44219597|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219598|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219604|NCT00483366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219605|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44219606|NCT00483392|Metformin|metformin|mesh-list
44219607|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
44219608|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219609|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219610|NCT00483431|Vitamin MK 7|vitamin mk 7|mesh-list
44219611|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
44219612|NCT00483431|Coagulants|coagulants|mesh-ancestor
44219613|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44219614|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219615|NCT00483470|Vaccines|vaccines|mesh-list
44219616|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
44219617|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219618|NCT00483600|PENTA|penta|mesh-list
44219619|NCT00483600|Fondaparinux|fondaparinux|mesh-list
44219620|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44219621|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
44219622|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44219623|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
44219624|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219625|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219626|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
44219627|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44219646|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219647|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44219649|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219650|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219651|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44219652|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
44219653|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
44219654|NCT00483743|Hormones|hormones|mesh-ancestor
44219655|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44219656|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
44219657|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219658|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219659|NCT00483782|Paclitaxel|paclitaxel|mesh-list
44219660|NCT00483782|Bevacizumab|bevacizumab|mesh-list
44219661|NCT00483782|Carboplatin|carboplatin|mesh-list
44219662|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44219663|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219664|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
44219665|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
44219666|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
44219667|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219668|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44219669|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219670|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219671|NCT00483782|Growth Substances|growth substances|mesh-ancestor
44219672|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219673|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
44219674|NCT00483795|Citric Acid|citric acid|mesh-list
44219675|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
44219676|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
44219677|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44219678|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
44219679|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
44219680|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164339|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164340|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44164341|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
44164342|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164343|NCT00255879|Olanzapine|olanzapine|mesh-list
44164344|NCT00255879|Risperidone|risperidone|mesh-list
44219681|NCT00483834|Bevacizumab|bevacizumab|mesh-list
44219682|NCT00483834|Capecitabine|capecitabine|mesh-list
44219683|NCT00483834|Irinotecan|irinotecan|mesh-list
44219684|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44219685|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219686|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44219687|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44219688|NCT00483834|Growth Substances|growth substances|mesh-ancestor
44219689|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219690|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
44219691|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44219692|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
44219693|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219694|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44219695|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219696|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219697|NCT00483860|Topotecan|topotecan|mesh-list
44219698|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44219699|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219700|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219701|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219702|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43874257|NCT03606213|Vaccines|vaccines|mesh-list
44219703|NCT00483886|Prucalopride|prucalopride|mesh-list
44219704|NCT00483886|Laxatives|laxatives|mesh-ancestor
44219705|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219706|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44219707|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44219708|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
44219709|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219710|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219711|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219712|NCT00483964|Olanzapine|olanzapine|mesh-list
44219713|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
44219714|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
44219715|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219718|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44219719|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44219720|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44219721|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44219722|NCT00483964|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44219723|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44219724|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219725|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219726|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219782|NCT00484133|Enoximone|enoximone|mesh-list
44219783|NCT00484133|Norepinephrine|norepinephrine|mesh-list
44219784|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
44219785|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
44219786|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44219787|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
44219788|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
44219789|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219790|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219791|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44219792|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44219793|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44219794|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
44219795|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44219796|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219797|NCT00484133|Protective Agents|protective agents|mesh-ancestor
44219798|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
44219799|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44219800|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44219801|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44219802|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44219803|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219804|NCT00484237|Etanercept|etanercept|mesh-list
44219805|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219806|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219807|NCT00484237|Analgesics|analgesics|mesh-ancestor
44219808|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
44219809|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219810|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219811|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219812|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219813|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219814|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219823|NCT00484328|Ribavirin|ribavirin|mesh-list
44219824|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
44219825|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219826|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
44219827|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219828|NCT00484341|Doxorubicin|doxorubicin|mesh-list
44219829|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219830|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219831|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44219832|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219833|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219834|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219835|NCT00484432|Doxorubicin|doxorubicin|mesh-list
44219836|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219837|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219838|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44219839|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219840|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219841|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219842|NCT00484484|Ketamine|ketamine|mesh-list
44219843|NCT00484484|Analgesics|analgesics|mesh-ancestor
44219844|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
44219876|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219877|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44219878|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44219879|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219880|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219881|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44219882|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
44219883|NCT00484640|Warfarin|warfarin|mesh-list
44219884|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
44219885|NCT00484692|Bupropion|bupropion|mesh-list
44219886|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44219887|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
44219888|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44219889|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44219890|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44219891|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44219893|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
44219932|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44219933|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219934|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
44219935|NCT00484822|Heparin|heparin|mesh-list
43704142|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
44219936|NCT00484822|Calcium heparin|calcium heparin|mesh-list
44219937|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
44219938|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44219939|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44219940|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219941|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44219942|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
44219943|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44219944|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44219945|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219946|NCT00484926|Aspirin|aspirin|mesh-list
44219947|NCT00484926|Clopidogrel|clopidogrel|mesh-list
44219948|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44219949|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44219950|NCT00484926|Analgesics|analgesics|mesh-ancestor
44219951|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
44219952|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44219953|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219954|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44219955|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44219956|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44219957|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44219958|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44219959|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44219960|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44219961|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44219962|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
44219963|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44219973|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44219974|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219975|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
44219976|NCT00485004|Sirolimus|sirolimus|mesh-list
44219977|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219978|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219979|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219980|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219981|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
44219982|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219983|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
44219984|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219985|NCT00485030|Sirolimus|sirolimus|mesh-list
44219986|NCT00485030|Everolimus|everolimus|mesh-list
44219987|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44219988|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44219989|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
44219990|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219991|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44219992|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44219993|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44219994|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
44219995|NCT00485056|Pioglitazone|pioglitazone|mesh-list
44219996|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44219997|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44219998|NCT00485108|Prednisolone|prednisolone|mesh-list
44219999|NCT00485108|Ketorolac|ketorolac|mesh-list
44220000|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
44220001|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220002|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
44220003|NCT00485108|Hormones|hormones|mesh-ancestor
44220004|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220011|NCT00485108|Analgesics|analgesics|mesh-ancestor
44220016|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220018|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44220019|NCT00485121|Ezetimibe|ezetimibe|mesh-list
44220020|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44220021|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44220022|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
44220023|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220024|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44220025|NCT00485160|Ibuprofen|ibuprofen|mesh-list
44220026|NCT00485160|Indomethacin|indomethacin|mesh-list
44220027|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44220028|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220029|NCT00485160|Analgesics|analgesics|mesh-ancestor
44220030|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
44220031|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220032|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220033|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220034|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457351|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
44457352|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43874613|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
44457353|NCT01611857|Antidotes|antidotes|mesh-ancestor
44457354|NCT01611857|Protective Agents|protective agents|mesh-ancestor
44457355|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
44220049|NCT00485342|Interferons|interferons|mesh-list
44220050|NCT00485342|Ribavirin|ribavirin|mesh-list
44220051|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
44220052|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
44220053|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44220054|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220055|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
44220056|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220057|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
44220058|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220059|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
44220060|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220061|NCT00485368|Perindopril|perindopril|mesh-list
44220062|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44220063|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
44220064|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220065|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220066|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44220067|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220068|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220069|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220090|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220091|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220092|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220093|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220094|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44220096|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
44220097|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
44220098|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220099|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220100|NCT00485498|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220101|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220102|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220103|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
44220104|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220105|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
43819643|NCT04448873|Sirolimus|sirolimus|mesh-list
44220106|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220107|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220108|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44220109|NCT00485550|Methylphenidate|methylphenidate|mesh-list
44220110|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220111|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44220112|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220113|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44220137|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44220138|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44220139|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220140|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220141|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220142|NCT00485680|Olanzapine|olanzapine|mesh-list
44220143|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
44220144|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
44220145|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
44220146|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220147|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220148|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220149|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220150|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220151|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220152|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220153|NCT00485680|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220154|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220155|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220156|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220157|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220188|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44220189|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220190|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
44220191|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44220192|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44457356|NCT01611857|Vitamins|vitamins|mesh-ancestor
44220193|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44220194|NCT00485797|Methylphenidate|methylphenidate|mesh-list
44220195|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44220196|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220197|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44220198|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220199|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220200|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220201|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
44220202|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220203|NCT00485810|Olanzapine|olanzapine|mesh-list
44220204|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
44220205|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
44220206|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220207|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220208|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220209|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220210|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220211|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220212|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220213|NCT00485810|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220214|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220215|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220216|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220218|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
44220228|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220229|NCT00485823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220230|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220231|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220232|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220233|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220234|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
44220235|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220236|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220237|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220238|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220239|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220240|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220241|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220242|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220243|NCT00485862|Sertraline|sertraline|mesh-list
44220244|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220280|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220281|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220282|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220283|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220284|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220285|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220286|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220287|NCT00485901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44220288|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220289|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220290|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220291|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220292|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
44220293|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44220294|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
44220295|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44220296|NCT00485940|Prucalopride|prucalopride|mesh-list
44220297|NCT00485940|Laxatives|laxatives|mesh-ancestor
44220298|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220299|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44220333|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
44220334|NCT00486083|Methylphenidate|methylphenidate|mesh-list
44220335|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220336|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44220337|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220338|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44220339|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220340|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220341|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220342|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
44220343|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220344|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220345|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220346|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220347|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220348|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220349|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220350|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220351|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220352|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220353|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220354|NCT00486174|Methylene Blue|methylene blue|mesh-list
44220355|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220356|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220357|NCT00486187|Metformin|metformin|mesh-list
44220358|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
44220359|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44220360|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220361|NCT00486213|Pyridoxine|pyridoxine|mesh-list
44220362|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
44220363|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
44220364|NCT00486213|Vitamins|vitamins|mesh-ancestor
44220374|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
44220375|NCT00486343|Zileuton|zileuton|mesh-list
44220376|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44220377|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220378|NCT00486343|Analgesics|analgesics|mesh-ancestor
44220379|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
44220380|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220381|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220382|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220383|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220384|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
44220385|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220386|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220387|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44220388|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
44220389|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220390|NCT00486356|Carboplatin|carboplatin|mesh-list
44220391|NCT00486356|Capecitabine|capecitabine|mesh-list
44220392|NCT00486356|Epirubicin|epirubicin|mesh-list
44220393|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220394|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44220395|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
44220396|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220397|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44220398|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44220399|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44220400|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220401|NCT00486369|Calcitonin|calcitonin|mesh-list
44220402|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
44220403|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
44220404|NCT00486369|Katacalcin|katacalcin|mesh-list
44220405|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220406|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220407|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44220412|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220413|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
44220414|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220415|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220416|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220417|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
44220418|NCT00486421|Hormones|hormones|mesh-ancestor
44220419|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220420|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44220421|NCT00486460|Gemcitabine|gemcitabine|mesh-list
44220422|NCT00486460|Curcumin|curcumin|mesh-list
44220423|NCT00486460|Celecoxib|celecoxib|mesh-list
44220424|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44220425|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
44220426|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220427|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220428|NCT00486460|Antiviral Agents|antiviral agents|mesh-ancestor
44220429|NCT00486460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220430|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220431|NCT00486460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220432|NCT00486460|Immunologic Factors|immunologic factors|mesh-ancestor
44220433|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220434|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44220435|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220436|NCT00486460|Analgesics|analgesics|mesh-ancestor
44220437|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
44220438|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220439|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220440|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220441|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44220442|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44220443|NCT00486486|Timolol|timolol|mesh-list
44220444|NCT00486486|Bimatoprost|bimatoprost|mesh-list
44220445|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44220446|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44220451|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44220452|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44220453|NCT00486564|Nifurtimox|nifurtimox|mesh-list
44220454|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44220455|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44220456|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44220457|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220458|NCT00486668|Paclitaxel|paclitaxel|mesh-list
44220459|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
44220460|NCT00486668|Doxorubicin|doxorubicin|mesh-list
44220461|NCT00486668|Trastuzumab|trastuzumab|mesh-list
44220462|NCT00486668|Lapatinib|lapatinib|mesh-list
44220463|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44220464|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220465|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
44220466|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
44220467|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
44220468|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220469|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220470|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
44220471|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220472|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220473|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44220474|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
44220504|NCT00486772|Sevelamer|sevelamer|mesh-list
44220505|NCT00486772|Calcium acetate|calcium acetate|mesh-list
44220506|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44220507|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220508|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
44220509|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
44220510|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220511|NCT00486785|Alfuzosin|alfuzosin|mesh-list
44220512|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44220513|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44220514|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44220515|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220516|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220517|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220518|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220519|NCT00486785|Urological Agents|urological agents|mesh-ancestor
44220520|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44220521|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220522|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220523|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44220524|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220525|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220526|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220527|NCT00486876|Tofisopam|tofisopam|mesh-list
44220528|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220536|NCT00487032|Xhance|xhance|mesh-list
44220554|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220555|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220556|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44220557|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44220558|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
44220559|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
44220560|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44220561|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44220563|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44220564|NCT00487032|Protective Agents|protective agents|mesh-ancestor
44457359|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457360|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457361|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44457362|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457363|NCT01611298|Vaccines|vaccines|mesh-list
44457364|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
44457365|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457366|NCT01611259|Rituximab|rituximab|mesh-list
44457367|NCT01611259|Lenalidomide|lenalidomide|mesh-list
44457368|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457369|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457370|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
44457371|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457372|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457373|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44457374|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44457375|NCT01611259|Growth Substances|growth substances|mesh-ancestor
44457376|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
44457392|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457393|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457394|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44457395|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
44457396|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457397|NCT01610596|Halobetasol|halobetasol|mesh-list
44457398|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44457399|NCT01610492|Belimumab|belimumab|mesh-list
44457400|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457401|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
44457402|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457403|NCT01610336|Gefitinib|gefitinib|mesh-list
44457404|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457405|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44457406|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457407|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457408|NCT01610297|Deferasirox|deferasirox|mesh-list
44457409|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44457410|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
44457411|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
44457412|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457413|NCT01610284|Fulvestrant|fulvestrant|mesh-list
44457414|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457415|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457416|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44164345|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44164346|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164347|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
44164348|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164349|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164350|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164351|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164352|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164353|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164354|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164355|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44164356|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
44164357|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
44164358|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
44164359|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164360|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164361|NCT00255879|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44164362|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44164363|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164364|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
44164365|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
44164366|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44457417|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44457418|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
44457419|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457420|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457421|NCT01610206|Gemcitabine|gemcitabine|mesh-list
44457422|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44457423|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
44457424|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457425|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457426|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
44457427|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220565|NCT00487110|Acetaminophen|acetaminophen|mesh-list
44220566|NCT00487110|Tropisetron|tropisetron|mesh-list
44220567|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44220568|NCT00487110|Analgesics|analgesics|mesh-ancestor
44220569|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
44220570|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220571|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220572|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
44220573|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
44220574|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
44220575|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220576|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44220577|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44220578|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
44220579|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220580|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220581|NCT00487123|Valsartan|valsartan|mesh-list
44220592|NCT00487136|Warfarin|warfarin|mesh-list
44220599|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220601|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44220602|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220603|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
44220604|NCT00487175|Tramadol|tramadol|mesh-list
44220605|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44220606|NCT00487175|Narcotics|narcotics|mesh-ancestor
44220607|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220608|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220609|NCT00487175|Analgesics|analgesics|mesh-ancestor
44220610|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
44220611|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220612|NCT00487227|Caffeine|caffeine|mesh-list
44220613|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44220614|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220615|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44220616|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220617|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220618|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44220619|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44220620|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
44220621|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220622|NCT00487253|Miltefosine|miltefosine|mesh-list
44220623|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44220624|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
44220625|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220626|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220627|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44220628|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44164377|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164379|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44164380|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
44164381|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164382|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164383|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44164384|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164385|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
44164386|NCT00256100|PENTA|penta|mesh-list
44164387|NCT00256100|Fondaparinux|fondaparinux|mesh-list
44164388|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44164389|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
44164390|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44164391|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
44220629|NCT00487422|Prucalopride|prucalopride|mesh-list
44220630|NCT00487422|Laxatives|laxatives|mesh-ancestor
44220631|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220632|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44220633|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44220634|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
44220635|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220636|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220637|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220638|NCT00487448|Cytarabine|cytarabine|mesh-list
44220639|NCT00487448|Fludarabine|fludarabine|mesh-list
44220640|NCT00487448|Idarubicin|idarubicin|mesh-list
44220641|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220642|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44220643|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
44220644|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220645|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220646|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
44220647|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220648|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
44220649|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220650|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44220651|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44220652|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44220653|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220655|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44220656|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44220657|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
44220658|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220659|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44220660|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44220661|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220662|NCT00487682|Valacyclovir|valacyclovir|mesh-list
44164392|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164393|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164394|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
44164395|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44164396|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44164397|NCT00256178|Simvastatin|simvastatin|mesh-list
44164398|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44164399|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44164400|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
44220663|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
44220664|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220665|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
44220666|NCT00487734|Testosterone|testosterone|mesh-list
44220667|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
44220668|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
44220669|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44220670|NCT00487734|Androgens|androgens|mesh-ancestor
44220671|NCT00487734|Hormones|hormones|mesh-ancestor
44220672|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220673|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220674|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44220675|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220676|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
44220677|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
44220678|NCT00487773|Budesonide|budesonide|mesh-list
44220679|NCT00487773|Albuterol|albuterol|mesh-list
44220680|NCT00487773|Montelukast|montelukast|mesh-list
44220681|NCT00487773|Vitamins|vitamins|mesh-ancestor
44220682|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
44220683|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220684|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220685|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44220716|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220717|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220718|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44220719|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
44220720|NCT00487799|Diuretics|diuretics|mesh-ancestor
44220721|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
44220722|NCT00487812|Dobutamine|dobutamine|mesh-list
44220723|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44220724|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
44220725|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
44220726|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220727|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220728|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44220729|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44220730|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44220731|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220732|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220733|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220734|NCT00487812|Protective Agents|protective agents|mesh-ancestor
44220735|NCT00487994|Atorvastatin|atorvastatin|mesh-list
44220736|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44220737|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44220738|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
44220739|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220740|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44220741|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44220742|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220743|NCT00488137|Prucalopride|prucalopride|mesh-list
44220744|NCT00488137|Laxatives|laxatives|mesh-ancestor
44220745|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44220746|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
44220747|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43819935|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44164401|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164402|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44164403|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44164404|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164405|NCT00256230|Disulfiram|disulfiram|mesh-list
44164406|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44164407|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
44164408|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43635702|NCT05192889|Venetoclax|venetoclax|mesh-list
44220748|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
44220749|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220750|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220751|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220752|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44220753|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44220754|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220755|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220756|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220757|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
44220758|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220759|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220760|NCT00488176|Cetirizine|cetirizine|mesh-list
44220761|NCT00488176|Montelukast|montelukast|mesh-list
44220762|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44220763|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
44220764|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44220765|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
44220766|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220767|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220768|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44220769|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44220770|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220771|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44220772|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44220773|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44220774|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
44220775|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
44220789|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44220790|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
44220791|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220792|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220793|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220794|NCT00488306|Tigecycline|tigecycline|mesh-list
44220795|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220796|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220797|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44220798|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220799|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220800|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44220801|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
44220802|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220803|NCT00488384|Acitretin|acitretin|mesh-list
44220804|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
44220805|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
44220806|NCT00488436|Cyclosporine|cyclosporine|mesh-list
44220807|NCT00488436|Cyclosporins|cyclosporins|mesh-list
44220808|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44220809|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220811|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220841|NCT00488605|Leucovorin|leucovorin|mesh-list
44220842|NCT00488605|Prednisone|prednisone|mesh-list
44220843|NCT00488605|Methotrexate|methotrexate|mesh-list
44220844|NCT00488605|Vinblastine|vinblastine|mesh-list
44220845|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
44220846|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44220847|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
44220848|NCT00488605|Hormones|hormones|mesh-ancestor
44220849|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44220850|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220851|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44220852|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220853|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44220854|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
44220855|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44220856|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44220857|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
44220858|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220859|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
44220860|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220861|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44220862|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220864|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44220865|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44220866|NCT00488605|Antidotes|antidotes|mesh-ancestor
44220867|NCT00488605|Protective Agents|protective agents|mesh-ancestor
44220868|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
44220869|NCT00488605|Vitamins|vitamins|mesh-ancestor
44220870|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
44220871|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44220872|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
44220873|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
44220874|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
44220875|NCT00488670|Citalopram|citalopram|mesh-list
44220876|NCT00488670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43625713|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44164409|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164410|NCT00256256|Glucagon|glucagon|mesh-list
44164411|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
44164412|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164413|NCT00256256|Hormones|hormones|mesh-ancestor
44220877|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220878|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220879|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220880|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220881|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
44220882|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220883|NCT00488670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44220884|NCT00488670|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220885|NCT00488670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220886|NCT00488709|Cytarabine|cytarabine|mesh-list
44220887|NCT00488709|Fludarabine|fludarabine|mesh-list
44220888|NCT00488709|Topotecan|topotecan|mesh-list
44220889|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845892|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220890|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44220891|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
44220892|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220893|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220894|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
44220895|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220896|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
44220897|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220898|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44220899|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44220900|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220901|NCT00488722|Goserelin|goserelin|mesh-list
44220902|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44220903|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220904|NCT00488761|Tigecycline|tigecycline|mesh-list
44220905|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220906|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220907|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44220908|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44220909|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220910|NCT00488787|Ketamine|ketamine|mesh-list
44220911|NCT00488787|Analgesics|analgesics|mesh-ancestor
44220915|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44220916|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44220917|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
44220918|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
44220919|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220920|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44220921|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44220922|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220923|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220924|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44220925|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
44220926|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220927|NCT00488813|Cephalosporins|cephalosporins|mesh-list
44220928|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220929|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220930|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44220931|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
44220932|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44220933|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220934|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220935|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220936|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44220937|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44220938|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
44220939|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220940|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220941|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44220942|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44220943|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
44220944|NCT00488969|Morphine|morphine|mesh-list
44220945|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44220946|NCT00488969|Narcotics|narcotics|mesh-ancestor
44220947|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44220948|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220949|NCT00488969|Analgesics|analgesics|mesh-ancestor
44220950|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
44220951|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457429|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457430|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
44457431|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457432|NCT01610167|Listerine|listerine|mesh-list
44457433|NCT01610167|Fluorides|fluorides|mesh-list
44457434|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
44457435|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
44457436|NCT01610167|Protective Agents|protective agents|mesh-ancestor
44457437|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457438|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44457439|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220952|NCT00488995|Tremelimumab|tremelimumab|mesh-list
44220953|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220954|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44220955|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44220956|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44220957|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44220958|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44220959|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44220960|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220961|NCT00489073|Analgesics|analgesics|mesh-ancestor
44220962|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
44220963|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44220964|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
44220965|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44220966|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
44220967|NCT00489099|Vaccines|vaccines|mesh-list
44220968|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
44220970|NCT00489138|Ertapenem|ertapenem|mesh-list
44220985|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44220986|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44220987|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44220988|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44220989|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
44220990|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44220991|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
44220992|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220993|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
44220994|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44220995|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44220997|NCT00489229|Ramipril|ramipril|mesh-list
44220998|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44220999|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221000|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44221001|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
44221002|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221003|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221004|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44221005|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
44221006|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44221007|NCT00489372|Protective Agents|protective agents|mesh-ancestor
44164414|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164415|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164416|NCT00256256|Incretins|incretins|mesh-ancestor
44164417|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
44164418|NCT00256269|Irinotecan|irinotecan|mesh-list
44164419|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164420|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44164421|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164422|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164423|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164424|NCT00256321|Celecoxib|celecoxib|mesh-list
44164425|NCT00256321|Capecitabine|capecitabine|mesh-list
44164426|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
44164427|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44164428|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
44164429|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164430|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164448|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44164449|NCT00256347|Morphine|morphine|mesh-list
44164450|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44164451|NCT00256347|Narcotics|narcotics|mesh-ancestor
44164452|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164453|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164454|NCT00256347|Analgesics|analgesics|mesh-ancestor
44164455|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
44164456|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164457|NCT00256542|Lidocaine|lidocaine|mesh-list
44164458|NCT00256542|Heparin|heparin|mesh-list
44164459|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
44164460|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
44221008|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221009|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221010|NCT00489385|Ribavirin|ribavirin|mesh-list
44221011|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
44221012|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221013|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
44221014|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221015|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
44221016|NCT00489398|Epinastine|epinastine|mesh-list
44221017|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44221018|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44221019|NCT00489398|Analgesics|analgesics|mesh-ancestor
44221020|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
44221021|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221022|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221023|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221024|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44221025|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43820290|NCT05677126|Trace Elements|trace elements|mesh-list
44221026|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44221027|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44221028|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
44221029|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
44221030|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221031|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221032|NCT00489437|Heparin|heparin|mesh-list
44221033|NCT00489437|Antibodies|antibodies|mesh-list
44221034|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
44221035|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221036|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
44221037|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44164461|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164462|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164463|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
44164464|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164465|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44164466|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44164467|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44164468|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164469|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164470|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
44164471|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44164472|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44164473|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
44164474|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43635703|NCT05192889|Asparaginase|asparaginase|mesh-list
44221038|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44221039|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221041|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221042|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221043|NCT00489593|Olanzapine|olanzapine|mesh-list
44221044|NCT00489593|Fluoxetine|fluoxetine|mesh-list
44221045|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
44221046|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
44221047|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221048|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221049|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221050|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44221051|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44221052|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44221053|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221054|NCT00489593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44221055|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221056|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221057|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221058|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221059|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
44221060|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44221061|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44221062|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44221063|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44221064|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221065|NCT00489645|Pramlintide|pramlintide|mesh-list
44164475|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164476|NCT00256711|Vinorelbine|vinorelbine|mesh-list
44164477|NCT00256711|Gefitinib|gefitinib|mesh-list
44164478|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44164479|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164480|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44164481|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44164482|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44164483|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812845|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43812846|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44164484|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164485|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164486|NCT00256737|Omeprazole|omeprazole|mesh-list
44164487|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44164488|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164489|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44164502|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44221066|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44221067|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221068|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221069|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
44221070|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44221071|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44221072|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221073|NCT00489658|Eflornithine|eflornithine|mesh-list
44221074|NCT00489658|Nifurtimox|nifurtimox|mesh-list
44221075|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221076|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
44221077|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44221078|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44221079|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221080|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
44221081|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221082|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221083|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
44221084|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221085|NCT00489723|Tamsulosin|tamsulosin|mesh-list
44221086|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44221087|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44221088|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44221089|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
44221090|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221091|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221092|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221093|NCT00489723|Urological Agents|urological agents|mesh-ancestor
44221094|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44221095|NCT00489775|Paroxetine|paroxetine|mesh-list
44221106|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221107|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
44221108|NCT00489775|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44221109|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
44221110|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44221111|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44221112|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44221113|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221114|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
44221116|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44221117|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44221118|NCT00489840|Growth Substances|growth substances|mesh-ancestor
44221119|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221120|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
44221121|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221122|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221123|NCT00489892|Modafinil|modafinil|mesh-list
44221124|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44221125|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221126|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44221127|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44221128|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44221129|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221130|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
44221131|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221132|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221133|NCT00489944|Tamoxifen|tamoxifen|mesh-list
44221134|NCT00489944|Cisplatin|cisplatin|mesh-list
44221135|NCT00489944|Sunitinib|sunitinib|mesh-list
44221136|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625934|NCT03097211|Benserazide|benserazide|mesh-list
44221147|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221148|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44221149|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44221150|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44221151|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221152|NCT00489983|Gemcitabine|gemcitabine|mesh-list
44221153|NCT00489983|Pemetrexed|pemetrexed|mesh-list
44221154|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221155|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
44221156|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221157|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221158|NCT00489983|Antiviral Agents|antiviral agents|mesh-ancestor
44221159|NCT00489983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221160|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221161|NCT00489983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221162|NCT00489983|Immunologic Factors|immunologic factors|mesh-ancestor
44221163|NCT00489983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221164|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43820535|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
44221165|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44221166|NCT00489996|Gemcitabine|gemcitabine|mesh-list
44221167|NCT00489996|Cisplatin|cisplatin|mesh-list
44221168|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221169|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221170|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
44221171|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221172|NCT00489996|Antiviral Agents|antiviral agents|mesh-ancestor
44221174|NCT00489996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221195|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44221196|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
44221197|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221198|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44221199|NCT00490204|Cetirizine|cetirizine|mesh-list
44221200|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44221201|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44221202|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44221203|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
43820564|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221204|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
44221205|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221206|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221207|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221208|NCT00490243|Budesonide|budesonide|mesh-list
44221209|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
44221210|NCT00490243|Montelukast|montelukast|mesh-list
44221211|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221212|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44221213|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
44221214|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221215|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221216|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44221217|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
44221218|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
44221219|NCT00490243|Hormones|hormones|mesh-ancestor
44221220|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221221|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44221222|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44221223|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44164503|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44164504|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164505|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44164506|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44164507|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44164508|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44164509|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
44164510|NCT00256893|Ropinirole|ropinirole|mesh-list
44164511|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44164512|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44164513|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
44164514|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
44164515|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164516|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221224|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
44221225|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221226|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221227|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44221228|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
44221229|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44221230|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44221231|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
44221232|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
44221233|NCT00490308|Estradiol|estradiol|mesh-list
44221234|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
44221235|NCT00490308|Estrogens|estrogens|mesh-ancestor
44221236|NCT00490308|Hormones|hormones|mesh-ancestor
44221237|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221238|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221239|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44221240|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
43820695|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
44221241|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44221242|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44221243|NCT00490360|Gemcitabine|gemcitabine|mesh-list
44221244|NCT00490360|Cisplatin|cisplatin|mesh-list
44221245|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221246|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221247|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
44221248|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221249|NCT00490360|Antiviral Agents|antiviral agents|mesh-ancestor
44221250|NCT00490360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221270|NCT00490399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221271|NCT00490399|Immunologic Factors|immunologic factors|mesh-ancestor
44221272|NCT00490399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221273|NCT00490412|Vitamin D|vitamin d|mesh-list
44221274|NCT00490412|Vitamins|vitamins|mesh-ancestor
44221275|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
44221276|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221277|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221278|NCT00490464|Nicardipine|nicardipine|mesh-list
44221279|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44221280|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44221281|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221282|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221283|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44221284|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221285|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221286|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
44221287|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221288|NCT00490633|Ethanol|ethanol|mesh-list
44221289|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
44221290|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44221291|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221292|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44221293|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221294|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
44221295|NCT00490659|Gemcitabine|gemcitabine|mesh-list
44221296|NCT00490659|Cisplatin|cisplatin|mesh-list
44221297|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221298|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221299|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
44221300|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221301|NCT00490659|Antiviral Agents|antiviral agents|mesh-ancestor
44221302|NCT00490659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221303|NCT00490659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221304|NCT00490659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221305|NCT00490659|Immunologic Factors|immunologic factors|mesh-ancestor
44221309|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221310|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221311|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221313|NCT00490711|Paclitaxel|paclitaxel|mesh-list
44221314|NCT00490711|Carboplatin|carboplatin|mesh-list
44221315|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44221316|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221317|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
44221318|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
44221319|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
44221320|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221321|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221322|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
44221323|NCT00490711|Antiviral Agents|antiviral agents|mesh-ancestor
44221324|NCT00490711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221325|NCT00490711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221326|NCT00490711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221327|NCT00490711|Immunologic Factors|immunologic factors|mesh-ancestor
44221328|NCT00490711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221329|NCT00490737|Daptomycin|daptomycin|mesh-list
44221330|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221331|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221332|NCT00490789|Sirolimus|sirolimus|mesh-list
44221333|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221334|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221335|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44221336|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221337|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
44221338|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221339|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
44221340|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221341|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
44221342|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44221343|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44221344|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44221345|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221346|NCT00490854|Insulin|insulin|mesh-list
43635704|NCT05192889|Dasatinib|dasatinib|mesh-list
44221347|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44221348|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
44221349|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
44221350|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
44221351|NCT00490854|Protamines|protamines|mesh-list
44221352|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221353|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221354|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
44221355|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221356|NCT00490854|Coagulants|coagulants|mesh-ancestor
44221357|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
44221358|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
44221359|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221360|NCT00490867|Protective Agents|protective agents|mesh-ancestor
44221361|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221362|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
44221363|NCT00490867|Vitamins|vitamins|mesh-ancestor
44221364|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
44221365|NCT00490880|Gemcitabine|gemcitabine|mesh-list
44221366|NCT00490880|Cisplatin|cisplatin|mesh-list
44221367|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221368|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221369|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
44221370|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221371|NCT00490880|Antiviral Agents|antiviral agents|mesh-ancestor
44221372|NCT00490880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457452|NCT01609933|Interferons|interferons|mesh-list
44457458|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457460|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221380|NCT00490906|Interferons|interferons|mesh-list
44221381|NCT00490906|Interferon-beta|interferon-beta|mesh-list
44221382|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
44221383|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
44221384|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
44221385|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
44221386|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221387|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
44221388|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221389|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
44221390|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221391|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44221392|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221393|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44221394|NCT00490958|Telmisartan|telmisartan|mesh-list
44221395|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44221396|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44221397|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44221398|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221399|NCT00490997|Ketamine|ketamine|mesh-list
44221400|NCT00490997|Propofol|propofol|mesh-list
44221401|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44221402|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44221404|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44221426|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221427|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221428|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44221429|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44221430|NCT00491114|Gemcitabine|gemcitabine|mesh-list
44221431|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221432|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
44221433|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221434|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221435|NCT00491114|Antiviral Agents|antiviral agents|mesh-ancestor
44221436|NCT00491114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221437|NCT00491114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221438|NCT00491114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221439|NCT00491114|Immunologic Factors|immunologic factors|mesh-ancestor
44221440|NCT00491114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221441|NCT00491127|Gemcitabine|gemcitabine|mesh-list
44221442|NCT00491127|Dexamethasone|dexamethasone|mesh-list
44221443|NCT00491127|Cisplatin|cisplatin|mesh-list
44221444|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221445|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
44221446|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
44221447|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221448|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221449|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221450|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
44221451|NCT00491127|Hormones|hormones|mesh-ancestor
44221452|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221453|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44221454|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221455|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44221456|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
43844676|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
43844678|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
44221469|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
44221470|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221471|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221472|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221473|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44221474|NCT00491192|Diclofenac|diclofenac|mesh-list
44221475|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44221476|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44221477|NCT00491192|Analgesics|analgesics|mesh-ancestor
44221478|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
44221479|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221480|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221481|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221482|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44221483|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44221484|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221485|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221486|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44221487|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44221488|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221489|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221490|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221491|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221492|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221493|NCT00491348|Analgesics|analgesics|mesh-ancestor
44221494|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
44221495|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221496|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
44221497|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221498|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
44164517|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164518|NCT00256932|Alvimopan|alvimopan|mesh-list
44164519|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820817|NCT05267613|Esomeprazole|esomeprazole|mesh-list
44164520|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44164521|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164522|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164523|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164524|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164525|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221499|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
44221500|NCT00491413|Hematinics|hematinics|mesh-ancestor
44221501|NCT00491426|Metronidazole|metronidazole|mesh-list
44221502|NCT00491426|Tazobactam|tazobactam|mesh-list
44221503|NCT00491426|Piperacillin|piperacillin|mesh-list
44221504|NCT00491426|Amphotericin B|amphotericin b|mesh-list
44221505|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44221506|NCT00491426|Acyclovir|acyclovir|mesh-list
44221507|NCT00491426|Ampicillin|ampicillin|mesh-list
44221508|NCT00491426|Caspofungin|caspofungin|mesh-list
44221509|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44221510|NCT00491426|Anidulafungin|anidulafungin|mesh-list
44221511|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221512|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221513|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44221514|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44221515|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44221516|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221517|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221518|NCT00491426|Amebicides|amebicides|mesh-ancestor
44221519|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
44221520|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
44221521|NCT00491478|Sertraline|sertraline|mesh-list
44221522|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
44221523|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221524|NCT00491478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44221525|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221526|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221527|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221528|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221529|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
44221530|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221531|NCT00491517|Sirolimus|sirolimus|mesh-list
44221532|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221533|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221534|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44221535|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164526|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44164527|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164528|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
44164529|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221537|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221538|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
44221539|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221540|NCT00491582|Hormones|hormones|mesh-list
44221541|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221542|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221543|NCT00491634|Treosulfan|treosulfan|mesh-list
44221544|NCT00491634|Busulfan|busulfan|mesh-list
44221545|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44221546|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
44221547|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221548|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221549|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221550|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
44221551|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221552|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44221553|NCT00491712|Triamcinolone|triamcinolone|mesh-list
44221554|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221555|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
44221556|NCT00491712|Hormones|hormones|mesh-ancestor
44221557|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221558|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221559|NCT00491725|Metformin|metformin|mesh-list
44221560|NCT00491725|Repaglinide|repaglinide|mesh-list
44221561|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221562|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221563|NCT00491790|Montelukast|montelukast|mesh-list
44221564|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44221565|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
44221566|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44221578|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221579|NCT00491803|Urological Agents|urological agents|mesh-ancestor
44221580|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44221581|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221582|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221583|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221584|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221585|NCT00491855|Paclitaxel|paclitaxel|mesh-list
44221586|NCT00491855|Bevacizumab|bevacizumab|mesh-list
44221587|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
44221588|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44221589|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221590|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
44221591|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
44221592|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
44221593|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221594|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44221595|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43634764|NCT05529069|Venetoclax|venetoclax|mesh-list
44221596|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44221597|NCT00491855|Growth Substances|growth substances|mesh-ancestor
44221598|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221599|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
44221600|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
44221601|NCT00491868|Hematinics|hematinics|mesh-ancestor
44221602|NCT00491907|Folic Acid|folic acid|mesh-list
44221603|NCT00491907|Hematinics|hematinics|mesh-ancestor
44221604|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
44221605|NCT00491907|Vitamins|vitamins|mesh-ancestor
44221606|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
44221607|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221608|NCT00491920|Vitamin D|vitamin d|mesh-list
44221609|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
44221622|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221623|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44221624|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221625|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44221626|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44221627|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221628|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44221629|NCT00491985|Vaccines|vaccines|mesh-list
44221630|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
44221631|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221632|NCT00491998|Entacapone|entacapone|mesh-list
44221633|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44221634|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44221635|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
44221636|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221637|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221638|NCT00492037|Conivaptan|conivaptan|mesh-list
44221639|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44221640|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221641|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
44221642|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221643|NCT00492102|Montelukast|montelukast|mesh-list
44221644|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44221645|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
44221646|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44221647|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
44221648|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221664|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44221665|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44221666|NCT00492128|Diuretics|diuretics|mesh-ancestor
44221667|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
44221668|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44221669|NCT00492141|Temozolomide|temozolomide|mesh-list
44221670|NCT00492141|Camptothecin|camptothecin|mesh-list
44221671|NCT00492141|Rubitecan|rubitecan|mesh-list
44221672|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44221673|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
44221674|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221675|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221676|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44221677|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43876158|NCT04715152|BB 1101|bb 1101|mesh-list
44221678|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44221679|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221681|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44221682|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221683|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
44221684|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
43820909|NCT05110001|Natamycin|natamycin|mesh-list
44221685|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
44221686|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221687|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221688|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221689|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44221690|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44221691|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221692|NCT00492245|Mitomycins|mitomycins|mesh-list
44221693|NCT00492245|Mitomycin|mitomycin|mesh-list
44221694|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44221695|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221696|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
44221704|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221706|NCT00492388|Analgesics|analgesics|mesh-ancestor
44221707|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
44221708|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221709|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221710|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44221711|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44221712|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
44221713|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
44221714|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44221715|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44221716|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44221717|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221718|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221719|NCT00492414|Paroxetine|paroxetine|mesh-list
44221720|NCT00492414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44221721|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221722|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221723|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221724|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221725|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
44221726|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221727|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44221728|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
44221729|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221730|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43820910|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
43820911|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43820912|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820913|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
43820914|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
44221731|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44221732|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221733|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
44221734|NCT00492427|Hematinics|hematinics|mesh-ancestor
44221735|NCT00492466|Interferons|interferons|mesh-list
44221736|NCT00492466|Interferon-beta|interferon-beta|mesh-list
44164530|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164531|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44164532|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44164533|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
44164534|NCT00257036|Levofloxacin|levofloxacin|mesh-list
44221737|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
44221738|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
44221739|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221740|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
44221741|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221742|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221743|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
44221744|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
44221745|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221746|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221747|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221748|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
44221749|NCT00492466|Hormones|hormones|mesh-ancestor
44221750|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43876224|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
44221751|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44221752|NCT00492466|Protective Agents|protective agents|mesh-ancestor
44221753|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
44221754|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44221755|NCT00492479|Kinetin|kinetin|mesh-list
44221756|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
44221757|NCT00492479|Growth Substances|growth substances|mesh-ancestor
44221758|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221759|NCT00492505|Tamoxifen|tamoxifen|mesh-list
44221760|NCT00492505|Cisplatin|cisplatin|mesh-list
44221761|NCT00492505|Sorafenib|sorafenib|mesh-list
44221762|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221763|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221764|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221765|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221766|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44221767|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
43820946|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
44221768|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221780|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
44221781|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44221782|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
44221783|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221784|NCT00492518|Protective Agents|protective agents|mesh-ancestor
44221785|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221786|NCT00492518|Antidotes|antidotes|mesh-ancestor
44221787|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44221788|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
44221789|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221790|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44221791|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44221792|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221793|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221794|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44221795|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44221796|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
44221797|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221798|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44221799|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221800|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44221801|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44221802|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221803|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221804|NCT00492635|Urological Agents|urological agents|mesh-ancestor
44221805|NCT00492661|Tacrolimus|tacrolimus|mesh-list
44221806|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44221807|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
44221808|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221809|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44221810|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221811|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221812|NCT00492687|Tamoxifen|tamoxifen|mesh-list
44221813|NCT00492687|Carboplatin|carboplatin|mesh-list
44221814|NCT00492687|Temozolomide|temozolomide|mesh-list
44221815|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221817|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44221818|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
44221819|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44221820|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
44221821|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221822|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221823|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44221824|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44221825|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44221826|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44221828|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44221829|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221830|NCT00492765|Interferons|interferons|mesh-list
44221831|NCT00492765|Interferon-beta|interferon-beta|mesh-list
44221832|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
44221833|NCT00492765|Simvastatin|simvastatin|mesh-list
44221834|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221835|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
43844736|NCT04341350|Analgesics|analgesics|mesh-list
44221836|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221837|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44221838|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44221839|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
44221840|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221841|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44221842|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44221843|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221844|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
44221845|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221846|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44221847|NCT00492778|Cisplatin|cisplatin|mesh-list
44221848|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221849|NCT00492830|Antibodies|antibodies|mesh-list
44221853|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
44457463|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457464|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457465|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457466|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44457467|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44457468|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44457469|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44457470|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
44457471|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
44457472|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457473|NCT01609790|Bevacizumab|bevacizumab|mesh-list
44457474|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
44457475|NCT01609790|Trebananib|trebananib|mesh-list
44457476|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
44457477|NCT01609790|Antibodies|antibodies|mesh-list
44457478|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
44457479|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44457480|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
44457481|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457482|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44457483|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44457484|NCT01609790|Growth Substances|growth substances|mesh-ancestor
44457485|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457486|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
44457487|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
44457488|NCT01609556|Maytansine|maytansine|mesh-list
44457489|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44457500|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
44221863|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44221864|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221865|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221866|NCT00493077|Interferons|interferons|mesh-list
44221867|NCT00493077|Interferon-beta|interferon-beta|mesh-list
44221868|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
44221869|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221870|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
44221871|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221872|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
44221873|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221874|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43820956|NCT05041907|Ivermectin|ivermectin|mesh-list
43820957|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
43820958|NCT05041907|Favipiravir|favipiravir|mesh-list
43820959|NCT05041907|Remdesivir|remdesivir|mesh-list
44221875|NCT00493116|Interferons|interferons|mesh-list
44221876|NCT00493116|Interferon-beta|interferon-beta|mesh-list
44221877|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
44221878|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
44221879|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221880|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
44221881|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44221882|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44221883|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
44221920|NCT00493233|Olanzapine|olanzapine|mesh-list
44221921|NCT00493233|Risperidone|risperidone|mesh-list
44221922|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44221923|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
44221924|NCT00493233|Clozapine|clozapine|mesh-list
44221925|NCT00493233|Perphenazine|perphenazine|mesh-list
44221926|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44221927|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
44221928|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44221929|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44221930|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221931|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44221932|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44221933|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44221934|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44221935|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
44221936|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
43821025|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821026|NCT04956640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821027|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44221937|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
44221938|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221939|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44221940|NCT00493233|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44221941|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44221942|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44221943|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
44221944|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
44221945|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
44221946|NCT00493324|Alefacept|alefacept|mesh-list
44221947|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44221948|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
44221949|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221950|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
44221951|NCT00493363|Artesunate|artesunate|mesh-list
44221952|NCT00493363|Mefloquine|mefloquine|mesh-list
44221953|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
44221954|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44221955|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44221956|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164535|NCT00257036|Ofloxacin|ofloxacin|mesh-list
44164536|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164537|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164538|NCT00257036|Renal Agents|renal agents|mesh-ancestor
44221957|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221958|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
44221959|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
44221960|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44221961|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
44221962|NCT00493389|Hormones|hormones|mesh-list
44221963|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
44221964|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221965|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221966|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
44221967|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44221968|NCT00493402|Estrogens|estrogens|mesh-ancestor
44221969|NCT00493402|Hormones|hormones|mesh-ancestor
44221970|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44221971|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221972|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44221973|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44221974|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
44221975|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
44221976|NCT00493428|Baclofen|baclofen|mesh-list
44221977|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44221978|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44221979|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44221980|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44221981|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44221982|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
44221983|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
44222004|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
44222005|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44222006|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222007|NCT00493545|Poly ICLC|poly iclc|mesh-list
43876463|NCT04712929|Fluconazole|fluconazole|mesh-list
44222008|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
44222009|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
44222010|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222011|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
44222012|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44222013|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
44222014|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222015|NCT00493610|Expectorants|expectorants|mesh-ancestor
44222016|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
43845965|NCT04227028|Bevacizumab|bevacizumab|mesh-list
44222017|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44222018|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
44222019|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222020|NCT00493610|Protective Agents|protective agents|mesh-ancestor
44222021|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222022|NCT00493610|Antidotes|antidotes|mesh-ancestor
44222023|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
44222024|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44222025|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222026|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
44222055|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44222056|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
44222057|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222058|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222059|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
44222060|NCT00493857|Antibodies|antibodies|mesh-list
44222061|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44222062|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
44222063|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222064|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222065|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222066|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
44222067|NCT00493870|Docetaxel|docetaxel|mesh-list
44222068|NCT00493870|Doxorubicin|doxorubicin|mesh-list
44222069|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222070|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
44222071|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222072|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222073|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44222074|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
44222075|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222076|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222077|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44222078|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222079|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
44222080|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222081|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44222082|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44222083|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44222084|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222085|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
44222086|NCT00493987|Testosterone|testosterone|mesh-list
43626738|NCT03086473|Caffeine|caffeine|mesh-list
44164539|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164540|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164541|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164542|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164543|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164544|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164545|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164546|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164547|NCT00257049|Levofloxacin|levofloxacin|mesh-list
44222088|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
44222089|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
44222090|NCT00493987|Dutasteride|dutasteride|mesh-list
44222091|NCT00493987|Androgens|androgens|mesh-ancestor
44222092|NCT00493987|Hormones|hormones|mesh-ancestor
44222093|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222094|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222095|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44222096|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222097|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
44222098|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44222099|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44222100|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222101|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222102|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
44222103|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
44222104|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
44222105|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
44222106|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222107|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222108|NCT00494104|Vitamin D|vitamin d|mesh-list
44222109|NCT00494104|Vitamins|vitamins|mesh-ancestor
44222110|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
44222111|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222112|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44222113|NCT00494156|Aspirin|aspirin|mesh-list
44222114|NCT00494156|Heparin|heparin|mesh-list
44222115|NCT00494156|Clopidogrel|clopidogrel|mesh-list
44222116|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44222117|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44222118|NCT00494156|Analgesics|analgesics|mesh-ancestor
44222130|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
44222131|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44222132|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
44222133|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44222134|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
43846003|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846004|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43813791|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813792|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813793|NCT04807569|Urological Agents|urological agents|mesh-ancestor
43813794|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43813795|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
43813796|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43813797|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43813798|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
43813799|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43813800|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
44222135|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222136|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
44222137|NCT00494208|Testosterone|testosterone|mesh-list
44222138|NCT00494208|Androgens|androgens|mesh-ancestor
44222139|NCT00494208|Hormones|hormones|mesh-ancestor
44222140|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222141|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222142|NCT00494247|Antibodies|antibodies|mesh-list
44222143|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
44222144|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222145|NCT00494312|Pioglitazone|pioglitazone|mesh-list
44222146|NCT00494312|Glyburide|glyburide|mesh-list
44222147|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222148|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222149|NCT00494338|Docetaxel|docetaxel|mesh-list
44222150|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222151|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222152|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
44222153|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222154|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222155|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44222156|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44222157|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44222158|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222159|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222160|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222161|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222162|NCT00494377|Analgesics|analgesics|mesh-ancestor
44222163|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
44222164|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164548|NCT00257049|Ofloxacin|ofloxacin|mesh-list
44222166|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222167|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
44222168|NCT00494429|Morphine|morphine|mesh-list
44222169|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44222170|NCT00494429|Narcotics|narcotics|mesh-ancestor
44222171|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222172|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222173|NCT00494429|Analgesics|analgesics|mesh-ancestor
44222174|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
44222175|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222176|NCT00494468|Zolpidem|zolpidem|mesh-list
44222177|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44222178|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44222179|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222180|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222181|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44222182|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
44222183|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
44222184|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222185|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222186|NCT00494533|Treprostinil|treprostinil|mesh-list
44222187|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44222188|NCT00494559|Pioglitazone|pioglitazone|mesh-list
44222189|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222190|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222191|NCT00494572|Montelukast|montelukast|mesh-list
44222192|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44222212|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
44222213|NCT00494611|Cetuximab|cetuximab|mesh-list
44222214|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222215|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222216|NCT00494624|Prednisolone|prednisolone|mesh-list
44222217|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222218|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
44222219|NCT00494624|Hormones|hormones|mesh-ancestor
43846005|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43846008|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222220|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222221|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222222|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44222223|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222224|NCT00494663|Ketoconazole|ketoconazole|mesh-list
44222225|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
44222226|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222227|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
44222228|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44222229|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222230|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222231|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44222232|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
44222233|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222234|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222235|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44222236|NCT00494715|Valsartan|valsartan|mesh-list
44222237|NCT00494715|Benazepril|benazepril|mesh-list
44222238|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44222239|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44222240|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44222241|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222242|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44222243|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
44222250|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
44222251|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222252|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222253|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222254|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222255|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
44222256|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222257|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222258|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
44222259|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222260|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457506|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44457507|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44457508|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457509|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457510|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457511|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457512|NCT01609218|Charcoal|charcoal|mesh-list
44457513|NCT01609218|Antidotes|antidotes|mesh-ancestor
44457514|NCT01609218|Protective Agents|protective agents|mesh-ancestor
44457515|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457516|NCT01609023|Rituximab|rituximab|mesh-list
44457517|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457518|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457519|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
44457520|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457521|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457522|NCT01609010|Interferons|interferons|mesh-list
44457523|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
44457524|NCT01609010|Rituximab|rituximab|mesh-list
44457525|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457526|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457527|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
44457528|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457535|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457536|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457537|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44457538|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457539|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457540|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457541|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457542|NCT01608308|Acetaminophen|acetaminophen|mesh-list
44457543|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44457544|NCT01608308|Analgesics|analgesics|mesh-ancestor
44457545|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
44457546|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457547|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457548|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
44457549|NCT01608087|Bevacizumab|bevacizumab|mesh-list
44457550|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457551|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457552|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43876685|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222261|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
44222262|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44222263|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222264|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222265|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44222266|NCT00494832|Analgesics|analgesics|mesh-ancestor
44222267|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
44222268|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222269|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44222270|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44222271|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44222272|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222281|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222283|NCT00494897|Prednisone|prednisone|mesh-list
44222284|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
44222285|NCT00494897|Methotrexate|methotrexate|mesh-list
44222286|NCT00494897|Vincristine|vincristine|mesh-list
44222287|NCT00494897|Daunorubicin|daunorubicin|mesh-list
44222288|NCT00494897|Asparaginase|asparaginase|mesh-list
44222289|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
44222290|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222291|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
44222292|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222293|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222294|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44222295|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
44222296|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222297|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222298|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44222299|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222300|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
44222301|NCT00494897|Hormones|hormones|mesh-ancestor
44222302|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222303|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44222304|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44222305|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
44222306|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44222307|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222308|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
44222309|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
44222310|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222311|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44222312|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44222313|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
44222314|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222316|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222320|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44222321|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44222322|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44222324|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44222325|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
44222326|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
44222327|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
44222328|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
44222329|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44222330|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222331|NCT00495066|Ipilimumab|ipilimumab|mesh-list
44222332|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222333|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222334|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44222335|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222336|NCT00495092|Biperiden|biperiden|mesh-list
44222337|NCT00495092|Caffeine|caffeine|mesh-list
44222338|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44222339|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222340|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44222341|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222342|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222343|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44222344|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44222345|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
44222346|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222347|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44222348|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44222349|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
44222350|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
44222351|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222352|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44222353|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44222354|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
44222355|NCT00495118|Risperidone|risperidone|mesh-list
44164549|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164550|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164551|NCT00257049|Renal Agents|renal agents|mesh-ancestor
44222356|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44222357|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
44222358|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222359|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222360|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222361|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44222362|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44222363|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222364|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222365|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44222366|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
44222367|NCT00495183|Biperiden|biperiden|mesh-list
44222368|NCT00495183|Caffeine|caffeine|mesh-list
44222369|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44222370|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222371|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44222372|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222373|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222374|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44222375|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44222376|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
44222377|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222378|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43846027|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43846028|NCT04223518|Antibodies|antibodies|mesh-list
44222379|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44222380|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
44222381|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
44222382|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222383|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44222384|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44222385|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
44222386|NCT00495287|Cytarabine|cytarabine|mesh-list
44222387|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222388|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
44222398|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222399|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222400|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44222401|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44222402|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
44222403|NCT00495326|Efavirenz|efavirenz|mesh-list
44222404|NCT00495326|Nevirapine|nevirapine|mesh-list
44222405|NCT00495326|Rifampin|rifampin|mesh-list
44222406|NCT00495326|Isoniazid|isoniazid|mesh-list
44222407|NCT00495326|Ethambutol|ethambutol|mesh-list
44222408|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44222409|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44222410|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43876829|NCT04709029|BB 1101|bb 1101|mesh-list
44222411|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222412|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
44222413|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222414|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44222415|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44222416|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44222417|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44222418|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44222419|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44222420|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44222421|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
44222422|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222423|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
44222424|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
44222425|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
44222426|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
44222427|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44222428|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44222429|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44222436|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222437|NCT00495339|Renal Agents|renal agents|mesh-ancestor
44222438|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222439|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44222440|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44222441|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222442|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222443|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222444|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44222445|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44222446|NCT00495352|Bupropion|bupropion|mesh-list
44222447|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44222448|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
44222449|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222450|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44222451|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44222452|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222453|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222454|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
44222455|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222456|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222457|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44222459|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222488|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44222489|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44222490|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
44222491|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222492|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44222493|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
44222494|NCT00495729|Simvastatin|simvastatin|mesh-list
44222495|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44222496|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44222497|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
44222498|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222499|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44222500|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44222501|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222502|NCT00495781|Iron|iron|mesh-list
44222503|NCT00495781|Trace Elements|trace elements|mesh-ancestor
44222504|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
44164559|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164560|NCT00257062|Levofloxacin|levofloxacin|mesh-list
44164561|NCT00257062|Ofloxacin|ofloxacin|mesh-list
44164562|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164563|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164564|NCT00257062|Renal Agents|renal agents|mesh-ancestor
44164565|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164566|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164567|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164568|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164569|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164570|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164571|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164572|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164573|NCT00257075|Risperidone|risperidone|mesh-list
44164574|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44164575|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
44164576|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164577|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164578|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821113|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
43821114|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821115|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821116|NCT04795245|Afatinib|afatinib|mesh-list
43821135|NCT04756557|Fluorides|fluorides|mesh-list
44164579|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164580|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164581|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164582|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164583|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44164584|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
44164585|NCT00257114|Bortezomib|bortezomib|mesh-list
44164586|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164587|NCT00257127|Vaccines|vaccines|mesh-list
44164588|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44164589|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
44164590|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164591|NCT00257140|Levofloxacin|levofloxacin|mesh-list
44164592|NCT00257140|Ofloxacin|ofloxacin|mesh-list
44164593|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164594|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164595|NCT00257140|Renal Agents|renal agents|mesh-ancestor
44164596|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222505|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222507|NCT00495846|Lanreotide|lanreotide|mesh-list
44222508|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44222509|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44222510|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222511|NCT00495872|Lenalidomide|lenalidomide|mesh-list
44222512|NCT00495872|Sunitinib|sunitinib|mesh-list
44222513|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44222514|NCT00495872|Sorafenib|sorafenib|mesh-list
44222515|NCT00495872|Dasatinib|dasatinib|mesh-list
44222516|NCT00495872|Lapatinib|lapatinib|mesh-list
44222517|NCT00495872|Valproic Acid|valproic acid|mesh-list
44222518|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
44222519|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222520|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43821145|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
43821146|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821147|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821148|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821149|NCT04717414|Luspatercept|luspatercept|mesh-list
43821150|NCT04717414|Hematinics|hematinics|mesh-ancestor
43821151|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
43821152|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821153|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821154|NCT04671667|Cisplatin|cisplatin|mesh-list
43821155|NCT04671667|Carboplatin|carboplatin|mesh-list
43821156|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
43821161|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821162|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821163|NCT04609046|Rituximab|rituximab|mesh-list
43821164|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43821165|NCT04609046|Nivolumab|nivolumab|mesh-list
43821166|NCT04609046|Methotrexate|methotrexate|mesh-list
43821167|NCT04609046|Lenalidomide|lenalidomide|mesh-list
43821168|NCT04609046|Antibodies|antibodies|mesh-list
43821169|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
43821170|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43821171|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
43821228|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
44222521|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44222522|NCT00495872|Growth Substances|growth substances|mesh-ancestor
44222523|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
44222524|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222525|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44222526|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222527|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222528|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
44222529|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
44222530|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222531|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
44222532|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44222533|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222534|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222535|NCT00495898|Sirolimus|sirolimus|mesh-list
44222536|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222551|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222553|NCT00496028|Carboplatin|carboplatin|mesh-list
44222554|NCT00496028|Saracatinib|saracatinib|mesh-list
44222555|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44222556|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222557|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222558|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
44222559|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222560|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222561|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222562|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
44222563|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
44222564|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222565|NCT00496158|Adefovir|adefovir|mesh-list
44222566|NCT00496158|Clevudine|clevudine|mesh-list
44222567|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
44222568|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222569|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44222570|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44222571|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222572|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222573|NCT00496184|Nifedipine|nifedipine|mesh-list
44222574|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44222575|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222576|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222577|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44222578|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821314|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43846043|NCT04221438|Alovudine|alovudine|mesh-list
43846044|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
43846045|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846046|NCT04220021|Metformin|metformin|mesh-list
43846047|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43846048|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821365|NCT04394624|Ramucirumab|ramucirumab|mesh-list
43821366|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222579|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
44222580|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
43627176|NCT03076684|Allopurinol|allopurinol|mesh-list
44164597|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164598|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164599|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164600|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164601|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164602|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164603|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164604|NCT00257257|Rimonabant|rimonabant|mesh-list
44164605|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44164606|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
44222581|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44222582|NCT00496223|Sunitinib|sunitinib|mesh-list
44222583|NCT00496223|Dacarbazine|dacarbazine|mesh-list
44222584|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222585|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44222586|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44222587|NCT00496223|Growth Substances|growth substances|mesh-ancestor
44222588|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222589|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
44222590|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44222591|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222592|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222593|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44222594|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
44222595|NCT00496275|Gemcitabine|gemcitabine|mesh-list
44222596|NCT00496275|Cisplatin|cisplatin|mesh-list
44222597|NCT00496275|Vinorelbine|vinorelbine|mesh-list
44222598|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222599|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222600|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
44222601|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222602|NCT00496275|Antiviral Agents|antiviral agents|mesh-ancestor
44222603|NCT00496275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222604|NCT00496275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222605|NCT00496275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222606|NCT00496275|Immunologic Factors|immunologic factors|mesh-ancestor
44222607|NCT00496275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222608|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44222609|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222610|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
44222611|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222612|NCT00496301|Gemcitabine|gemcitabine|mesh-list
44222613|NCT00496301|Capecitabine|capecitabine|mesh-list
44222614|NCT00496301|Sorafenib|sorafenib|mesh-list
44222622|NCT00496301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222624|NCT00496301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821381|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
43821383|NCT04342572|Melphalan|melphalan|mesh-list
44222625|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44222626|NCT00496392|Fentanyl|fentanyl|mesh-list
44222627|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44222628|NCT00496392|Narcotics|narcotics|mesh-ancestor
44222629|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222630|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222631|NCT00496392|Analgesics|analgesics|mesh-ancestor
44222632|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
44222633|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222634|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44222635|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44222636|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
43876998|NCT04706910|Furosemide|furosemide|mesh-list
44222637|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
44222638|NCT00496405|Bevacizumab|bevacizumab|mesh-list
44222639|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222640|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222641|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44222642|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44222643|NCT00496405|Growth Substances|growth substances|mesh-ancestor
44222644|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222645|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
44222647|NCT00496444|Valproic Acid|valproic acid|mesh-list
44222648|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222649|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
44222650|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222651|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222652|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222653|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
44222666|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222667|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
44222668|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222669|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
44222670|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821420|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821425|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
44222671|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
44222672|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222673|NCT00496652|Zalutumumab|zalutumumab|mesh-list
44222674|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222675|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222676|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
44222677|NCT00496665|Methotrexate|methotrexate|mesh-list
44222678|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222679|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
44222680|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222681|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222682|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44222683|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
44222684|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222685|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222686|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44222687|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44222688|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
44222689|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44222690|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222691|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
44222692|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
44222693|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222694|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44222695|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44457553|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44457554|NCT01608087|Growth Substances|growth substances|mesh-ancestor
44457555|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457556|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
44457557|NCT01607593|Sertraline|sertraline|mesh-list
44222710|NCT00497003|Carvedilol|carvedilol|mesh-list
44222711|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43821510|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821511|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821512|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43821513|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43821514|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
43821515|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
43821516|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222712|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44222713|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
44222714|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
44222715|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222716|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222717|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44222718|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44222719|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44222720|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222721|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222722|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222723|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
44222760|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222761|NCT00497120|Diuretics|diuretics|mesh-ancestor
44222762|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
44222763|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222764|NCT00497172|Sirolimus|sirolimus|mesh-list
44222765|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222766|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222767|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44222768|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222769|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
44222770|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44222771|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
44222772|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222773|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44222774|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222775|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44222776|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222777|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222778|NCT00497237|Fluticasone|fluticasone|mesh-list
44222779|NCT00497237|Beclomethasone|beclomethasone|mesh-list
44222813|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44222814|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
44222815|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222817|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
44222818|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44222819|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
44222820|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222821|NCT00497328|Protective Agents|protective agents|mesh-ancestor
44222822|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222823|NCT00497328|Antidotes|antidotes|mesh-ancestor
44222824|NCT00497341|Cefuroxime|cefuroxime|mesh-list
44222825|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
44222826|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222827|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222828|NCT00497354|Anesthetics|anesthetics|mesh-list
44222829|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
44222830|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222831|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222832|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
44222833|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222834|NCT00497458|Testosterone|testosterone|mesh-list
44222835|NCT00497458|Androgens|androgens|mesh-ancestor
44222836|NCT00497458|Hormones|hormones|mesh-ancestor
44222837|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222838|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222839|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
44222840|NCT00497471|Dapsone|dapsone|mesh-list
44222841|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
44222842|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44222843|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44222844|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222845|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44222846|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222847|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222848|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
44222849|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44222853|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44222854|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222855|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44222856|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44222857|NCT00497497|Growth Substances|growth substances|mesh-ancestor
44222858|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222859|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
44222860|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44222861|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44222862|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222863|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222864|NCT00497523|Beclomethasone|beclomethasone|mesh-list
44222865|NCT00497523|Albuterol|albuterol|mesh-list
44222866|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44222867|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
44222868|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222869|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222870|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44222871|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
44222872|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
44222873|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44222874|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44222875|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44222876|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44222877|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222878|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222879|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222880|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222881|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
44222882|NCT00497523|Hormones|hormones|mesh-ancestor
44222884|NCT00497536|Insulin|insulin|mesh-list
44222895|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44222896|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222897|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44222898|NCT00497562|Narcotics|narcotics|mesh-ancestor
44222899|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222900|NCT00497562|Analgesics|analgesics|mesh-ancestor
44222901|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
44222902|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222903|NCT00497562|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44222904|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44222905|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222906|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222907|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222908|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
44222909|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44222910|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
44222911|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44222912|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44222913|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44222914|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222915|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44222916|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43821561|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821562|NCT04067648|Sufentanil|sufentanil|mesh-list
43821563|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43821564|NCT04067648|Narcotics|narcotics|mesh-ancestor
44222917|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44222918|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
44222919|NCT00497601|Amphotericin B|amphotericin b|mesh-list
44222920|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44222921|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44222922|NCT00497601|Amebicides|amebicides|mesh-ancestor
44222923|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44222938|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44222939|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
44222940|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222941|NCT00497900|Vitamin D|vitamin d|mesh-list
44222942|NCT00497900|Vitamins|vitamins|mesh-ancestor
44222943|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
44222944|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222945|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44222946|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
44222947|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44222948|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44222949|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44222950|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44222951|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222952|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
44222953|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222954|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222955|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44222956|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222957|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
44222958|NCT00497939|Urological Agents|urological agents|mesh-ancestor
44222959|NCT00498004|Risperidone|risperidone|mesh-list
44222960|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44222961|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44222962|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
44222963|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44222964|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222965|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222966|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44222967|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44222968|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44222969|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43821585|NCT03932409|Paclitaxel|paclitaxel|mesh-list
44222980|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44222981|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222982|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222983|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44222984|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44222985|NCT00498134|Analgesics|analgesics|mesh-ancestor
44222986|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
44222987|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44222988|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44222989|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44222990|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44222991|NCT00498225|Gemcitabine|gemcitabine|mesh-list
44222992|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44222993|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
44222994|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44222995|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44222996|NCT00498225|Antiviral Agents|antiviral agents|mesh-ancestor
44222997|NCT00498225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44222998|NCT00498225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44222999|NCT00498225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223000|NCT00498225|Immunologic Factors|immunologic factors|mesh-ancestor
44223001|NCT00498225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223002|NCT00498251|Albuterol|albuterol|mesh-list
44223003|NCT00498251|Ipratropium|ipratropium|mesh-list
44223004|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44223005|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
44223006|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223007|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223008|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43846077|NCT04218539|Psilocybin|psilocybin|mesh-list
44223009|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
44223010|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
44223011|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223012|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44223013|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44223014|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44223017|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223018|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44223019|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
44223020|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
44223021|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
44223022|NCT00498316|Melphalan|melphalan|mesh-list
44223023|NCT00498316|Busulfan|busulfan|mesh-list
44223024|NCT00498316|Rituximab|rituximab|mesh-list
44223025|NCT00498316|Fludarabine|fludarabine|mesh-list
44223026|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
44223027|NCT00498316|Clofarabine|clofarabine|mesh-list
44223028|NCT00498316|Tacrolimus|tacrolimus|mesh-list
44223029|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
44223030|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
44223031|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223032|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
44223033|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223034|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223035|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223036|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
44223037|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223038|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223039|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44223040|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223041|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223042|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
44223043|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223044|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44223045|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223046|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44223047|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44223048|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
44223049|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821675|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821676|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821687|NCT03569085|Sevoflurane|sevoflurane|mesh-list
43821688|NCT03569085|Isoflurane|isoflurane|mesh-list
43821689|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43821692|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
44223050|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
44223051|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44223052|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
44223053|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223057|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
44223058|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223059|NCT00498342|Protective Agents|protective agents|mesh-ancestor
44223060|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223061|NCT00498342|Antidotes|antidotes|mesh-ancestor
44457558|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
44457559|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457560|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44457561|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44457562|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457563|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457564|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457565|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
44457566|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457567|NCT01607554|Irinotecan|irinotecan|mesh-list
44457568|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44457569|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44457570|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457571|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457572|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457573|NCT01607476|Corticosterone|corticosterone|mesh-list
44457574|NCT01607476|Flutemetamol|flutemetamol|mesh-list
44457575|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457576|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44457577|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457578|NCT01607346|Ezogabine|ezogabine|mesh-list
44457579|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
44457580|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457581|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457582|NCT01607073|Verapamil|verapamil|mesh-list
44223062|NCT00498537|Spironolactone|spironolactone|mesh-list
44223063|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44223064|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223065|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223070|NCT00498589|Methotrexate|methotrexate|mesh-list
44223071|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44223072|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
44223073|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223074|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223075|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223076|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
44223077|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223078|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223079|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
44223080|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223081|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44223082|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223083|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
44223084|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223085|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44223086|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
44223087|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
44223088|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
44223089|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44223090|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44223091|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223092|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223093|NCT00498680|Urological Agents|urological agents|mesh-ancestor
44223094|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
44223095|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44223096|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
44223097|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223098|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223099|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44223100|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44223101|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44223102|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44223103|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44223107|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223108|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223109|NCT00498888|Urological Agents|urological agents|mesh-ancestor
44223110|NCT00498901|Letrozole|letrozole|mesh-list
44223111|NCT00498901|Leuprolide|leuprolide|mesh-list
44223112|NCT00498901|Goserelin|goserelin|mesh-list
44223113|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223114|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44223115|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44223116|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223117|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223118|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44223119|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223120|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223121|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223122|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44223123|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
44223124|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223125|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44223126|NCT00498953|Cisplatin|cisplatin|mesh-list
44223127|NCT00498953|Carboplatin|carboplatin|mesh-list
44223128|NCT00498953|Docetaxel|docetaxel|mesh-list
44223129|NCT00498953|Fluorouracil|fluorouracil|mesh-list
44223130|NCT00498953|Lapatinib|lapatinib|mesh-list
44223131|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
44223132|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223133|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223134|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223153|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
44223154|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223155|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
44223156|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223157|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223158|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
44223159|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223160|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44223161|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223162|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223163|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
44223164|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44223165|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44223166|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
44223167|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44223168|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
44223169|NCT00498992|Vitamin E|vitamin e|mesh-list
44223170|NCT00498992|Lidocaine|lidocaine|mesh-list
44223171|NCT00498992|Vitamins|vitamins|mesh-ancestor
44223172|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
44223173|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223174|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
44223175|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
44223176|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44223177|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
44223178|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223179|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44223180|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44223181|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44223182|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44223200|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223201|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223202|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
44223203|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223204|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223205|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223206|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
44223207|NCT00499018|Hormones|hormones|mesh-ancestor
44223208|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223209|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44223210|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223211|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
44223212|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223213|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
44223214|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223215|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223216|NCT00499018|Analgesics|analgesics|mesh-ancestor
44223217|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
44223218|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223219|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44223220|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223221|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223222|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223223|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
44223224|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44223225|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44223226|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44223227|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223228|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223229|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
44223230|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44223231|NCT00499135|Alovudine|alovudine|mesh-list
44223232|NCT00499135|Sunitinib|sunitinib|mesh-list
44223240|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223241|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223242|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
44223243|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223244|NCT00499265|Gemcitabine|gemcitabine|mesh-list
44223245|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
44223246|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
44223247|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223248|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
44223249|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223250|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223251|NCT00499265|Antiviral Agents|antiviral agents|mesh-ancestor
44223252|NCT00499265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223253|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223254|NCT00499265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223255|NCT00499265|Immunologic Factors|immunologic factors|mesh-ancestor
44223256|NCT00499265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223257|NCT00499291|Paclitaxel|paclitaxel|mesh-list
44223258|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44223259|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44223260|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223261|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223262|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223263|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
44223264|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223265|NCT00499525|Paclitaxel|paclitaxel|mesh-list
44223266|NCT00499525|Sorafenib|sorafenib|mesh-list
44223267|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44223268|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223269|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223270|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821771|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
43821772|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821773|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
44223282|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44223283|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223284|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223285|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223286|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223287|NCT00499668|Ondansetron|ondansetron|mesh-list
43877613|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
44223288|NCT00499668|Aprepitant|aprepitant|mesh-list
44223289|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
44223290|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
44223291|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223292|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223293|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44223294|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
44223295|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
44223296|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44223297|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
44223298|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223299|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223300|NCT00499668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44223301|NCT00499668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44223302|NCT00499668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44223303|NCT00499668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44223304|NCT00499668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44223305|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44223306|NCT00499707|Metformin|metformin|mesh-list
44223307|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
44223308|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223309|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223310|NCT00499720|Aztreonam|aztreonam|mesh-list
44223311|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44223312|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821819|NCT03440112|Antidotes|antidotes|mesh-ancestor
43821820|NCT03440112|Protective Agents|protective agents|mesh-ancestor
43821821|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821822|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
43821823|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
43821824|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821825|NCT03398655|Paclitaxel|paclitaxel|mesh-list
43821826|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43821827|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821828|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821829|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821830|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821833|NCT03391479|Avelumab|avelumab|mesh-list
44223313|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
44223314|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223315|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
44223321|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223322|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44223323|NCT00499811|Vorinostat|vorinostat|mesh-list
44223324|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223325|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44223326|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223327|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223328|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
44223329|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
44223330|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44223331|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44223332|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
44223333|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223334|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223335|NCT00499850|Leucovorin|leucovorin|mesh-list
44223336|NCT00499850|Fluorouracil|fluorouracil|mesh-list
44223337|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
44223338|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
44223339|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223340|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223341|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223342|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223343|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
44223344|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223345|NCT00499850|Antidotes|antidotes|mesh-ancestor
44223346|NCT00499850|Protective Agents|protective agents|mesh-ancestor
44223347|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
44223370|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44223371|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44223372|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
44223373|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223374|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223375|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
44223376|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223377|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223378|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223379|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223380|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
44223381|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
44223382|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44223383|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
44223384|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223385|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223386|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44223387|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
44223388|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44223389|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
44223390|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223391|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223392|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44223393|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
44223394|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
44223395|NCT00500253|Protective Agents|protective agents|mesh-ancestor
44223396|NCT00500253|Miotics|miotics|mesh-ancestor
44223397|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44223398|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44223399|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44223400|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44223401|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
44223402|NCT00500279|Celecoxib|celecoxib|mesh-list
44223403|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44223405|NCT00500279|Analgesics|analgesics|mesh-ancestor
44223409|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223410|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223411|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44223412|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44223413|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223414|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223415|NCT00500344|Ranibizumab|ranibizumab|mesh-list
44223416|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44223417|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44223418|NCT00500344|Growth Substances|growth substances|mesh-ancestor
44223419|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223420|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
44223421|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223422|NCT00500409|Vitamin D|vitamin d|mesh-list
44223423|NCT00500409|Vitamins|vitamins|mesh-ancestor
44223424|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
44223425|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223426|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44223427|NCT00500422|Gemcitabine|gemcitabine|mesh-list
44223428|NCT00500422|Doxorubicin|doxorubicin|mesh-list
44223429|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44223430|NCT00500422|Bortezomib|bortezomib|mesh-list
44223431|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223432|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
44223433|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223434|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223435|NCT00500422|Antiviral Agents|antiviral agents|mesh-ancestor
44223436|NCT00500422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223437|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223438|NCT00500422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223439|NCT00500422|Immunologic Factors|immunologic factors|mesh-ancestor
43877738|NCT04697745|Hormones|hormones|mesh-ancestor
44223440|NCT00500422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457588|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457589|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
44457590|NCT01606800|Ribavirin|ribavirin|mesh-list
44457591|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
44457592|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44457593|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
44457594|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457595|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
44457596|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457597|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457598|NCT01606787|Mannitol|mannitol|mesh-list
44457599|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
44457600|NCT01606787|Diuretics|diuretics|mesh-ancestor
44457601|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
44457602|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457603|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44457604|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
44457605|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457606|NCT01606748|Gemcitabine|gemcitabine|mesh-list
44457607|NCT01606748|Cisplatin|cisplatin|mesh-list
44457608|NCT01606748|Necitumumab|necitumumab|mesh-list
44457609|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457610|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44457611|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
44457612|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457613|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
44457614|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457615|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457616|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457617|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
44457618|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457619|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457620|NCT01606319|Acetaminophen|acetaminophen|mesh-list
43822022|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822023|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822024|NCT02910843|Capecitabine|capecitabine|mesh-list
43822025|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822026|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
43822027|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822029|NCT02889523|Prednisolone|prednisolone|mesh-list
43822030|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
43822031|NCT02889523|Rituximab|rituximab|mesh-list
43822041|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457621|NCT01606319|Ibuprofen|ibuprofen|mesh-list
44457622|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44457630|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457631|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44457632|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457633|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457634|NCT01606306|Fluticasone|fluticasone|mesh-list
44457636|NCT01606306|Montelukast|montelukast|mesh-list
44457637|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457638|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44457639|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
44457640|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457641|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457642|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44457643|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
44457644|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
44457645|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43822057|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
43822058|NCT02869217|Fludarabine|fludarabine|mesh-list
43822059|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822060|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
43822062|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457646|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44457647|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
44457648|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457649|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44457650|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44457651|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457652|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
44457653|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44223444|NCT00500552|Perhexiline|perhexiline|mesh-list
44223445|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44223446|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44223447|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223448|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44223449|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822168|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822169|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822170|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43822171|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44223450|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
44223451|NCT00500565|Bupivacaine|bupivacaine|mesh-list
44223452|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
44223453|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
44223454|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43635705|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
44223456|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
44223457|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223458|NCT00500604|Valsartan|valsartan|mesh-list
44223459|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44223460|NCT00500604|Irbesartan|irbesartan|mesh-list
44223461|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44223462|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44223463|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44223464|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223465|NCT00500604|Diuretics|diuretics|mesh-ancestor
44223466|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
44223467|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223468|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44223469|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44223470|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
44223471|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44223472|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223473|NCT00500721|Desipramine|desipramine|mesh-list
44223474|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44223475|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
44223476|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44223477|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223478|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223479|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44223480|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44223481|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44223482|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
44223483|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223484|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223497|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44223498|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
44223499|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223500|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
44223501|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223502|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223503|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
44223504|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223505|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223506|NCT00501098|Caspofungin|caspofungin|mesh-list
44223507|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
44223508|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223509|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223510|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223511|NCT00501111|Donepezil|donepezil|mesh-list
44223512|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44223513|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223514|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223515|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
44223516|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223517|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223518|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
44223519|NCT00501124|Clevudine|clevudine|mesh-list
44223520|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
44223521|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223522|NCT00501137|Vaccines|vaccines|mesh-list
44223523|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
44223524|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223525|NCT00501150|Linezolid|linezolid|mesh-list
44223526|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44223527|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223528|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44223529|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223539|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223540|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223541|NCT00501254|Aspirin|aspirin|mesh-list
44223542|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
44223543|NCT00501254|Salicylates|salicylates|mesh-list
44223544|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223545|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
44223546|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
43655557|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
43822357|NCT00587067|Floxuridine|floxuridine|mesh-list
43822359|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
44223547|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
44223548|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44223549|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223550|NCT00501254|Analgesics|analgesics|mesh-ancestor
44223551|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
44223552|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223553|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223554|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223555|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223556|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44223557|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223558|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223559|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44223560|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44223561|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44223562|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
44223563|NCT00501267|Oxybutynin|oxybutynin|mesh-list
44223564|NCT00501267|Solabegron|solabegron|mesh-list
44223565|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
44223566|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
44223567|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223568|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223569|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44223570|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44223571|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
44223572|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223573|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223574|NCT00501267|Urological Agents|urological agents|mesh-ancestor
44223575|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44223576|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44223577|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44223578|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
44223579|NCT00501384|Satavaptan|satavaptan|mesh-list
44223580|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44223581|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223582|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
44223583|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223584|NCT00501397|Ketoconazole|ketoconazole|mesh-list
44223585|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
44223586|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223587|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43877959|NCT04694105|Hormones|hormones|mesh-ancestor
44223588|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44223589|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223590|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223591|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44223592|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223593|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223594|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223595|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44223597|NCT00501410|Fluorouracil|fluorouracil|mesh-list
44223598|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
44223599|NCT00501410|Cetuximab|cetuximab|mesh-list
44223600|NCT00501410|Dasatinib|dasatinib|mesh-list
44223601|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
44223602|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223603|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223604|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223605|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223606|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
44223607|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223608|NCT00501410|Antidotes|antidotes|mesh-ancestor
44223609|NCT00501410|Protective Agents|protective agents|mesh-ancestor
44223610|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
44223611|NCT00501410|Vitamins|vitamins|mesh-ancestor
44223613|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223614|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223615|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223617|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223618|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223619|NCT00501514|Hormones|hormones|mesh-list
44223620|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223621|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223622|NCT00501566|Satavaptan|satavaptan|mesh-list
44223623|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44223624|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223625|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
44223626|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223627|NCT00501579|Prednisolone|prednisolone|mesh-list
44223628|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44223629|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
44223630|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44223631|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
44223632|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44223633|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
44223634|NCT00501579|Difluprednate|difluprednate|mesh-list
44223635|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223636|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
44223637|NCT00501579|Hormones|hormones|mesh-ancestor
44223638|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223639|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223640|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44223641|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223642|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
44223656|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223657|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223658|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223659|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44223660|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44223661|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44223662|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44223663|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
44223664|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
44223665|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
44223666|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223667|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223668|NCT00501657|Incretins|incretins|mesh-ancestor
44223669|NCT00501657|Hormones|hormones|mesh-ancestor
44223670|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223671|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44223672|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
44223673|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223674|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223675|NCT00501696|Naltrexone|naltrexone|mesh-list
44223676|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44223677|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44223678|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223679|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
44223680|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223681|NCT00501722|Satavaptan|satavaptan|mesh-list
44223682|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
44223683|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223684|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
44223685|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223686|NCT00501748|Rituximab|rituximab|mesh-list
44223687|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223696|NCT00501839|Enclomiphene|enclomiphene|mesh-list
44223697|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
44223698|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44223699|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223700|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223701|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223702|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44223703|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
44223704|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223705|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44223706|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44223707|NCT00501878|Phenylephrine|phenylephrine|mesh-list
44223708|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
44223709|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44223710|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
44223711|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
44223712|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223713|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223714|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
44223715|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44223716|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
44223717|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
44223718|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
44223719|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44223720|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44223721|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
44223722|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44223723|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223724|NCT00501878|Protective Agents|protective agents|mesh-ancestor
44223725|NCT00501904|Metformin|metformin|mesh-list
44223726|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223727|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223728|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
44223729|NCT00501917|Hematinics|hematinics|mesh-ancestor
44223738|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
44223739|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223740|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
44223741|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223742|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223743|NCT00502034|Analgesics|analgesics|mesh-ancestor
44223744|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
44223745|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223747|NCT00502060|Gefitinib|gefitinib|mesh-list
44223748|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223749|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223750|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223751|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223752|NCT00502073|Cyclosporine|cyclosporine|mesh-list
44223753|NCT00502073|Cyclosporins|cyclosporins|mesh-list
44223754|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223755|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223756|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223757|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
44223758|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223759|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
44223760|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223761|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
44223762|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223763|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44223764|NCT00502099|Interferons|interferons|mesh-list
44223765|NCT00502099|Ribavirin|ribavirin|mesh-list
44223766|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
44223767|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
44223768|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44223769|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44223783|NCT00502112|Growth Substances|growth substances|mesh-ancestor
44223784|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
44223785|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223786|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223787|NCT00502138|Pramlintide|pramlintide|mesh-list
44223788|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
44223789|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223790|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223791|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
44223792|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44223793|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
44223794|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223795|NCT00502164|Cediranib|cediranib|mesh-list
44223796|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223797|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223798|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223799|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223800|NCT00502190|Silicon|silicon|mesh-list
44223801|NCT00502190|Trace Elements|trace elements|mesh-ancestor
44223802|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
44223803|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223804|NCT00502229|Metformin|metformin|mesh-list
44223805|NCT00502229|Clomiphene|clomiphene|mesh-list
44223806|NCT00502229|Enclomiphene|enclomiphene|mesh-list
44223807|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
44223808|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44223809|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223810|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44223811|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
44223812|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44223813|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43878163|NCT04690608|Hormones|hormones|mesh-ancestor
44223814|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
44223815|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44223816|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44164607|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44164608|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164609|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164610|NCT00257257|Hormones|hormones|mesh-ancestor
44173266|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44223817|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43846183|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
43846184|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
43822577|NCT05533125|Rituximab|rituximab|mesh-list
43822578|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822579|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822580|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
43822581|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822582|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822583|NCT05533073|Etoricoxib|etoricoxib|mesh-list
43822584|NCT05533073|Tramadol|tramadol|mesh-list
43822585|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43822586|NCT05533073|Narcotics|narcotics|mesh-ancestor
43822617|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43822618|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655560|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655561|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
43655562|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43655563|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
43655564|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822651|NCT05532332|Fluoxetine|fluoxetine|mesh-list
43822652|NCT05532332|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43822653|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43822654|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43822655|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223818|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
44223820|NCT00502268|Vitamins|vitamins|mesh-ancestor
44223821|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
44223822|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223823|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44223824|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44223825|NCT00502294|Visilizumab|visilizumab|mesh-list
44223826|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
44223827|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223828|NCT00502385|Cediranib|cediranib|mesh-list
44223829|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223830|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223831|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223832|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223833|NCT00502411|Doxorubicin|doxorubicin|mesh-list
44223834|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44223835|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44223836|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223837|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44223838|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223839|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223862|NCT00502541|Hormones|hormones|mesh-ancestor
44223868|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
44223869|NCT00502567|Irinotecan|irinotecan|mesh-list
44223870|NCT00502567|Pemetrexed|pemetrexed|mesh-list
44223871|NCT00502567|Cetuximab|cetuximab|mesh-list
44223872|NCT00502567|Cediranib|cediranib|mesh-list
44223873|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223874|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
44223875|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223876|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
44223877|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223878|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
44223879|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44223880|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223881|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
44223882|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223883|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44223884|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223885|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223886|NCT00502567|Antidotes|antidotes|mesh-ancestor
44223887|NCT00502567|Protective Agents|protective agents|mesh-ancestor
44223888|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
44223889|NCT00502567|Vitamins|vitamins|mesh-ancestor
44223890|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
44223891|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44223892|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44223893|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44223894|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44223895|NCT00502658|Vitamins|vitamins|mesh-list
44223896|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
44223897|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223898|NCT00502684|Etodolac|etodolac|mesh-list
44223899|NCT00502684|Propranolol|propranolol|mesh-list
44223900|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44223901|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44223912|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
44223913|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223914|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223915|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223916|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44223917|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44223918|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223919|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
44223920|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44223921|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223922|NCT00502762|Topotecan|topotecan|mesh-list
44223923|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44223924|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223925|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223926|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223927|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223928|NCT00502788|Ribavirin|ribavirin|mesh-list
44223929|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44223930|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
44223931|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223932|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
44223933|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223934|NCT00502879|Etanercept|etanercept|mesh-list
44223935|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44223936|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223937|NCT00502879|Analgesics|analgesics|mesh-ancestor
44223938|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
44223939|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223940|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223941|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223942|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223943|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164611|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164612|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164613|NCT00257270|Gabapentin|gabapentin|mesh-list
44164614|NCT00257270|Analgesics|analgesics|mesh-ancestor
44164615|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
44164616|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164629|NCT00257348|Capecitabine|capecitabine|mesh-list
44164630|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164631|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
44164632|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
44223944|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44223945|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
44223946|NCT00502892|Carboplatin|carboplatin|mesh-list
44223947|NCT00502892|Topotecan|topotecan|mesh-list
44223948|NCT00502892|Ifosfamide|ifosfamide|mesh-list
44223949|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223950|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44223951|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44223952|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223953|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223954|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223955|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
44223956|NCT00502970|Interferons|interferons|mesh-list
44223957|NCT00502970|Ribavirin|ribavirin|mesh-list
44223958|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
44223959|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44223960|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
44223961|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44223962|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
44223963|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223964|NCT00502970|Hematinics|hematinics|mesh-ancestor
44223965|NCT00503126|Bivalirudin|bivalirudin|mesh-list
44223966|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
44223967|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43815407|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
44223968|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
44223969|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44223970|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223971|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
44223972|NCT00503152|Valsartan|valsartan|mesh-list
44223973|NCT00503152|Benazepril|benazepril|mesh-list
44223974|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44223975|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44223976|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44223977|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223986|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44223987|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44223988|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
44223989|NCT00503243|Mesalamine|mesalamine|mesh-list
44223990|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44223991|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44223992|NCT00503243|Analgesics|analgesics|mesh-ancestor
44223993|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
44223994|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44223995|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44223996|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44223997|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44223998|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
44223999|NCT00503321|Tegafur|tegafur|mesh-list
44224000|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224001|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
44224002|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224003|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224004|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44224005|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
44224006|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224007|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44224008|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
44224009|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224010|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
44224011|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44224012|NCT00503321|Protective Agents|protective agents|mesh-ancestor
44224013|NCT00503347|Bavituximab|bavituximab|mesh-list
44224014|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44224015|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224016|NCT00503386|Palonosetron|palonosetron|mesh-list
44224017|NCT00503386|Granisetron|granisetron|mesh-list
44224018|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
44224019|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
44224020|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224021|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164633|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
44164634|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164635|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224022|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224023|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44224024|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44224025|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
44224026|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224027|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224028|NCT00503412|Cediranib|cediranib|mesh-list
44224029|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224030|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44224031|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224032|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224033|NCT00503451|Panobinostat|panobinostat|mesh-list
44224034|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224035|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44224036|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845029|NCT04314375|Hormones|hormones|mesh-ancestor
44224037|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224038|NCT00503477|Cediranib|cediranib|mesh-list
44224039|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224040|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44224041|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224042|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224043|NCT00503490|Levofloxacin|levofloxacin|mesh-list
44224044|NCT00503490|Ofloxacin|ofloxacin|mesh-list
44224045|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44224046|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224047|NCT00503490|Renal Agents|renal agents|mesh-ancestor
44224048|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224049|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44224066|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224067|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
44224069|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
44224070|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44224071|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44224072|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44224073|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
44224074|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224075|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224076|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44224077|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44224078|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44224079|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224080|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
44224081|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44224082|NCT00503542|Metronidazole|metronidazole|mesh-list
44224083|NCT00503542|Clindamycin|clindamycin|mesh-list
44224084|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
44224085|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
44224086|NCT00503542|Fluconazole|fluconazole|mesh-list
44224087|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224088|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224089|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44224090|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44224091|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44224092|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224114|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224115|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224116|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
44224117|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224118|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224119|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224120|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224121|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44224122|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224123|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
44224124|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224125|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44224126|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
44224127|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224128|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44224171|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224172|NCT00503828|Naproxen|naproxen|mesh-list
44224173|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224174|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224175|NCT00503828|Analgesics|analgesics|mesh-ancestor
44224176|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
44224177|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224178|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224179|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224180|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224181|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
44224182|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44224183|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224184|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224185|NCT00503932|Capecitabine|capecitabine|mesh-list
44224186|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224187|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
44224188|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224189|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224190|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44224191|NCT00503971|Vorinostat|vorinostat|mesh-list
44224192|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224193|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44224194|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224195|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224196|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44457654|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457655|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457656|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457657|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457660|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
44457669|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457670|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457671|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457672|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44457673|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44457674|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
44457675|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457676|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457677|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44457678|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44457679|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
44457680|NCT01606137|Nabiximols|nabiximols|mesh-list
44457681|NCT01606137|Analgesics|analgesics|mesh-ancestor
44457682|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
44457683|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457684|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457685|NCT01606007|Metformin|metformin|mesh-list
44457686|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
44457687|NCT01606007|Saxagliptin|saxagliptin|mesh-list
44457688|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457689|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457690|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
44457691|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457692|NCT01606007|Incretins|incretins|mesh-ancestor
44457693|NCT01606007|Hormones|hormones|mesh-ancestor
44457694|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457695|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
44457696|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457697|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822721|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
44457698|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
44457699|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44457700|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457701|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457702|NCT01605617|Fesoterodine|fesoterodine|mesh-list
44457703|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44164636|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
44457706|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457707|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457708|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457709|NCT01605617|Urological Agents|urological agents|mesh-ancestor
44457710|NCT01605396|Exemestane|exemestane|mesh-list
44457711|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457712|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44457713|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44457714|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457715|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457716|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44457717|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
44457718|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457719|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457720|NCT01605370|Metoprolol|metoprolol|mesh-list
44457721|NCT01605370|Nebivolol|nebivolol|mesh-list
44457722|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44457723|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44224198|NCT00504062|Budesonide|budesonide|mesh-list
44224199|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224200|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44224201|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
44224202|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224203|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224204|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44224205|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224206|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224207|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44224208|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
44164637|NCT00257361|Cycloserine|cycloserine|mesh-list
44164638|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164639|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164640|NCT00257361|Renal Agents|renal agents|mesh-ancestor
44164641|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44164642|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
44164643|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164644|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
44164645|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164646|NCT00257387|Cyclosporine|cyclosporine|mesh-list
44164647|NCT00257387|Cyclosporins|cyclosporins|mesh-list
44164648|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164649|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164650|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44164651|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
44224209|NCT00504062|Hormones|hormones|mesh-ancestor
44224210|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224211|NCT00504101|Bortezomib|bortezomib|mesh-list
44224212|NCT00504101|Melphalan|melphalan|mesh-list
44224213|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
44224214|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224215|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44224216|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
44224217|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224218|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44224219|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224220|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
44224221|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224222|NCT00504127|Naproxen|naproxen|mesh-list
44224223|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44224224|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224225|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224226|NCT00504127|Analgesics|analgesics|mesh-ancestor
44224227|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
44224228|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224229|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815626|NCT03535298|Siponimod|siponimod|mesh-list
44224230|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224231|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224232|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
44224233|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44224234|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224235|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224236|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44224237|NCT00504140|Interferons|interferons|mesh-list
44224238|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
44224239|NCT00504140|Etoposide|etoposide|mesh-list
44224240|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44224244|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224250|NCT00504192|Gemcitabine|gemcitabine|mesh-list
44224251|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
44224252|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224253|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
44224254|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224255|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224256|NCT00504192|Antiviral Agents|antiviral agents|mesh-ancestor
44224257|NCT00504192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224258|NCT00504192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224259|NCT00504192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224260|NCT00504192|Immunologic Factors|immunologic factors|mesh-ancestor
44224261|NCT00504192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224262|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
44224263|NCT00504244|Azathioprine|azathioprine|mesh-list
44224264|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
44224265|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224266|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224267|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224268|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224269|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
44224270|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224271|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224272|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44224273|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44224274|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
44224275|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224276|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224277|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224278|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
44224280|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44224281|NCT00504283|Narcotics|narcotics|mesh-ancestor
44224282|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224283|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224284|NCT00504283|Analgesics|analgesics|mesh-ancestor
44224291|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44224292|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224293|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224294|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
44224295|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224296|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224297|NCT00504400|Ranibizumab|ranibizumab|mesh-list
44224298|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44224299|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44224300|NCT00504400|Growth Substances|growth substances|mesh-ancestor
44224301|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224302|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
44224303|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224304|NCT00504413|Digoxin|digoxin|mesh-list
44224305|NCT00504413|Midazolam|midazolam|mesh-list
44224306|NCT00504413|Methadone|methadone|mesh-list
44224307|NCT00504413|Bupropion|bupropion|mesh-list
44224308|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44224309|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44224310|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224311|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224312|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44224313|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44224314|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44224315|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44224316|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
44224317|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
44224318|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
44224319|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
44224320|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224321|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224322|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44224323|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
44224324|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44224325|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44224327|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
44224329|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44224330|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224331|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44224332|NCT00504413|Narcotics|narcotics|mesh-ancestor
44224333|NCT00504413|Analgesics|analgesics|mesh-ancestor
44224334|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
44224335|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224336|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
44224337|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224338|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44224339|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44224340|NCT00504413|Protective Agents|protective agents|mesh-ancestor
44224341|NCT00504439|Simvastatin|simvastatin|mesh-list
44224342|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44224343|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224344|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
44224345|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224346|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224347|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44224348|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224349|NCT00504465|Dinoprostone|dinoprostone|mesh-list
44224350|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
44224351|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224352|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224353|NCT00504491|Rituximab|rituximab|mesh-list
44224354|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
44224355|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44224356|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224357|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
44224358|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224359|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224360|NCT00504543|Everolimus|everolimus|mesh-list
44224361|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224362|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
44224363|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224364|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224365|NCT00504634|Bortezomib|bortezomib|mesh-list
44224368|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44224369|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
44224370|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
44224371|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
44224372|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
44224373|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
44224374|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44224375|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224376|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
44224377|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224378|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
44224379|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44224380|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44224381|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44224382|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
44224383|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224384|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224385|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44224386|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44224387|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
44224388|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44224389|NCT00504855|Calpastatin|calpastatin|mesh-list
44224390|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
44224391|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
43703110|NCT02712697|Hormones|hormones|mesh-list
44224392|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224393|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224394|NCT00504933|Cetirizine|cetirizine|mesh-list
44224395|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44224396|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44224397|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44224398|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
44224399|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
44224408|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224409|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
44224410|NCT00504946|Hormones|hormones|mesh-ancestor
44224411|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224412|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224413|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44224414|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224415|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44224416|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224417|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44224418|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
44224419|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44224420|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43878657|NCT04682782|Esketamine|esketamine|mesh-list
44224421|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224422|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44224423|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
44224424|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224425|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44224426|NCT00504946|Vitamins|vitamins|mesh-ancestor
44224427|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
44224428|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44224429|NCT00504959|Ranibizumab|ranibizumab|mesh-list
44224430|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44224431|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44224432|NCT00504959|Growth Substances|growth substances|mesh-ancestor
44224433|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224434|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
44224435|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224436|NCT00505037|Sevelamer|sevelamer|mesh-list
44224437|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
44224438|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
44224439|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224440|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44224441|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
44224442|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224444|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224445|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224446|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
44224447|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224448|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44224449|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44224450|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224451|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
44224452|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224453|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224454|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44224455|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224456|NCT00505167|Memantine|memantine|mesh-list
44224457|NCT00505167|Donepezil|donepezil|mesh-list
44224458|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44224459|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224460|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224461|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
44224462|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224463|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224464|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
44224465|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44224466|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44224467|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
44224468|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44224469|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44224470|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44224471|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
44224472|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815928|NCT02715609|Copper|copper|mesh-list
44224473|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
44224477|NCT00505336|Eplerenone|eplerenone|mesh-list
44224488|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224489|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224490|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44224491|NCT00505336|Diuretics|diuretics|mesh-ancestor
44224492|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
44224493|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44224494|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
43878741|NCT04682210|Bevacizumab|bevacizumab|mesh-list
44224495|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
44224496|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224497|NCT00505427|Protective Agents|protective agents|mesh-ancestor
44224498|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224499|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
44224500|NCT00505427|Vitamins|vitamins|mesh-ancestor
44224501|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
44224502|NCT00505492|Paclitaxel|paclitaxel|mesh-list
44224503|NCT00505492|Cisplatin|cisplatin|mesh-list
44224504|NCT00505492|Carboplatin|carboplatin|mesh-list
44224505|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44224506|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224507|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
44224508|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
44224509|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
44224510|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224511|NCT00505505|Insulin|insulin|mesh-list
44224512|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44224513|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44224514|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224515|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
44224516|NCT00505531|Tramadol|tramadol|mesh-list
44224517|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44224518|NCT00505531|Narcotics|narcotics|mesh-ancestor
44224519|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224520|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224521|NCT00505531|Analgesics|analgesics|mesh-ancestor
44224527|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
44224528|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
44224529|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
44224530|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224531|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44224532|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
44224533|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
44224534|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224535|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224536|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44224537|NCT00505700|Cytarabine|cytarabine|mesh-list
44224538|NCT00505700|Bortezomib|bortezomib|mesh-list
44224539|NCT00505700|Idarubicin|idarubicin|mesh-list
44224540|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224541|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
44224542|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224586|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224587|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224588|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
44224589|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
44224590|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224591|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44224592|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44224593|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44224594|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44224595|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
44224596|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44224598|NCT00505817|Cetrorelix|cetrorelix|mesh-list
44224599|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44224600|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
44224601|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44224602|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224603|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44224604|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224605|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
44224606|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44224607|NCT00505843|Levodopa|levodopa|mesh-list
44224608|NCT00505843|Carbidopa|carbidopa|mesh-list
44224609|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44224610|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44224611|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
44224612|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224613|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224614|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224615|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
44224616|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224617|NCT00505882|Pramlintide|pramlintide|mesh-list
44224618|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44457728|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44457729|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44457730|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44457731|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
44457732|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457733|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457734|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
44457735|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44457736|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44457737|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44457738|NCT01605227|Prednisone|prednisone|mesh-list
44457739|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457740|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
44457741|NCT01605227|Hormones|hormones|mesh-ancestor
44457742|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457743|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457744|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44457745|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224624|NCT00506051|Pemetrexed|pemetrexed|mesh-list
44224625|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224659|NCT00506259|Protective Agents|protective agents|mesh-ancestor
44224660|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224661|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224662|NCT00506272|Insulin|insulin|mesh-list
44224663|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44224664|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224665|NCT00506298|Diflunisal|diflunisal|mesh-list
44224666|NCT00506298|Bezafibrate|bezafibrate|mesh-list
44224667|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224668|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
44224669|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224670|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224671|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224672|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224673|NCT00506298|Analgesics|analgesics|mesh-ancestor
44224674|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
44224675|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224676|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224677|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224678|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224679|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44224680|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224681|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
44224682|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
44224683|NCT00506311|Coagulants|coagulants|mesh-ancestor
44224684|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
44224685|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44224686|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
44224687|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224688|NCT00506506|Expectorants|expectorants|mesh-ancestor
44224689|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224690|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44224691|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
44224692|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224693|NCT00506506|Protective Agents|protective agents|mesh-ancestor
44224694|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224695|NCT00506506|Antidotes|antidotes|mesh-ancestor
44224696|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
44224698|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224699|NCT00506545|Rolapitant|rolapitant|mesh-list
44224700|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44224701|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224702|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224703|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224704|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
44224705|NCT00506571|Irinotecan|irinotecan|mesh-list
44224706|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224707|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224708|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224709|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224710|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224711|NCT00506623|Capecitabine|capecitabine|mesh-list
44224712|NCT00506623|Irinotecan|irinotecan|mesh-list
44224713|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224714|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
44224715|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224716|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224717|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224718|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224719|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224720|NCT00506701|Tadalafil|tadalafil|mesh-list
44224721|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
44224722|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44224723|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44224724|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224725|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224726|NCT00506701|Urological Agents|urological agents|mesh-ancestor
44224727|NCT00506727|Amphetamine|amphetamine|mesh-list
44224728|NCT00506727|Adderall|adderall|mesh-list
44224729|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44224730|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44224731|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44224732|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224735|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224736|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224737|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44224738|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
44224739|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
44224740|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224741|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
44224742|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44224743|NCT00506844|Capecitabine|capecitabine|mesh-list
44224744|NCT00506844|Irinotecan|irinotecan|mesh-list
44224745|NCT00506844|Cetuximab|cetuximab|mesh-list
44224746|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224747|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
44224748|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224749|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224750|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224751|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224752|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224753|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44224754|NCT00506935|Vigabatrin|vigabatrin|mesh-list
44224755|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
44224756|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224757|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224758|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
44224759|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224760|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224761|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
44224762|NCT00506961|Simvastatin|simvastatin|mesh-list
44224763|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44224764|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44224765|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
44224766|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822743|NCT05532111|Hormones|hormones|mesh-ancestor
44224767|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44224768|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44224769|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224770|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
44224771|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44224772|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44224773|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
44224774|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
44457746|NCT01605136|Afamelanotide|afamelanotide|mesh-list
44224775|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224776|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224778|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
44224779|NCT00507000|Vitamins|vitamins|mesh-ancestor
44224780|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
44224781|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224782|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44224783|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44224784|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
44224785|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44224786|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
44224787|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224788|NCT00507052|Expectorants|expectorants|mesh-ancestor
44224789|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43822812|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822813|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
43822814|NCT05531708|Fludarabine|fludarabine|mesh-list
43822815|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822816|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
43822817|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822818|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224790|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44224791|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
44224792|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224793|NCT00507052|Protective Agents|protective agents|mesh-ancestor
44224794|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224795|NCT00507052|Antidotes|antidotes|mesh-ancestor
44224796|NCT00507065|Amphetamine|amphetamine|mesh-list
44224797|NCT00507065|Adderall|adderall|mesh-list
44224798|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44224799|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224800|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
44224801|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
44224802|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164652|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164653|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
44164654|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164655|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44164656|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164657|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44164658|NCT00257426|Octreotide|octreotide|mesh-list
44164659|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164660|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44164661|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164662|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
44164663|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
44164664|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224803|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
44224804|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224805|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224806|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
44224807|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44224808|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44224809|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224810|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44224811|NCT00507091|Leucovorin|leucovorin|mesh-list
44224812|NCT00507091|Fluorouracil|fluorouracil|mesh-list
44224813|NCT00507091|Irinotecan|irinotecan|mesh-list
44224814|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
44224815|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224816|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224817|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224818|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224819|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
44224820|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224821|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224822|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44224823|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822967|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822968|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43823005|NCT05529355|Tegafur|tegafur|mesh-list
43823055|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823056|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43823057|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224824|NCT00507091|Antidotes|antidotes|mesh-ancestor
44224825|NCT00507091|Protective Agents|protective agents|mesh-ancestor
44224826|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
44224827|NCT00507091|Vitamins|vitamins|mesh-ancestor
44224828|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
44224829|NCT00507117|Eszopiclone|eszopiclone|mesh-list
44224830|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44224831|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224832|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224833|NCT00507143|Irinotecan|irinotecan|mesh-list
44224834|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44224835|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43823069|NCT05528887|Fludarabine|fludarabine|mesh-list
43823070|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224836|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224837|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224844|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44224845|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224846|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44224847|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
43879065|NCT04677335|Lovastatin|lovastatin|mesh-list
44224848|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
44224849|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44224850|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44224851|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44224852|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44224853|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
44224854|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
44224855|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224856|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224857|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44224858|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44224859|NCT00507221|Albendazole|albendazole|mesh-list
44224860|NCT00507221|Praziquantel|praziquantel|mesh-list
44224861|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
44224862|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44224863|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224864|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
44224865|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44224866|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44224867|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
44224868|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
44224869|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
44224870|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823071|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
44224871|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224872|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
44224873|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44224874|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
44224875|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224876|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224877|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44224878|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
44224880|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44224881|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44224882|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
44224883|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224884|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224885|NCT00507247|Daptomycin|daptomycin|mesh-list
44224886|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224887|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224888|NCT00507286|Alprostadil|alprostadil|mesh-list
44224889|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44224890|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
44224891|NCT00507286|Urological Agents|urological agents|mesh-ancestor
44224892|NCT00507403|Infliximab|infliximab|mesh-list
44224893|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224894|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44224895|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224896|NCT00507494|Pioglitazone|pioglitazone|mesh-list
44224897|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44224898|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224899|NCT00507585|Leucovorin|leucovorin|mesh-list
44224900|NCT00507585|Bevacizumab|bevacizumab|mesh-list
44224901|NCT00507585|Fluorouracil|fluorouracil|mesh-list
44224902|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
44224903|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44224904|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44224905|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44224906|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44224907|NCT00507585|Growth Substances|growth substances|mesh-ancestor
44224908|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224909|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
44224910|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
44224911|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224912|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44224913|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224914|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
44224915|NCT00507585|Antidotes|antidotes|mesh-ancestor
44224916|NCT00507585|Protective Agents|protective agents|mesh-ancestor
44224923|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44224924|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44224925|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224926|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224927|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
44224928|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224929|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224930|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44224931|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224933|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44224934|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44224935|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
44224936|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
43823108|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43823109|NCT05528588|Furosemide|furosemide|mesh-list
43823110|NCT05528588|Diuretics|diuretics|mesh-ancestor
44224937|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224938|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224939|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44224940|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44224941|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44224942|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
44224943|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44224944|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224945|NCT00507793|Cyclosporine|cyclosporine|mesh-list
44224946|NCT00507793|Sirolimus|sirolimus|mesh-list
44224947|NCT00507793|Cyclosporins|cyclosporins|mesh-list
44224948|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224949|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224950|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224951|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
44224952|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224953|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
44224954|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44224955|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224956|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224957|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44224958|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44224961|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
44224962|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44224963|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44224964|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44224965|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
44224966|NCT00507832|Tacrolimus|tacrolimus|mesh-list
44224967|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224968|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44224969|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44224970|NCT00507832|Analgesics|analgesics|mesh-ancestor
44224971|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
44224972|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44224973|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224974|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44224975|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
44224976|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44224977|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
44224978|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44224979|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224980|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457747|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
44457748|NCT01605071|Estradiol|estradiol|mesh-list
44457749|NCT01605071|Estrogens|estrogens|mesh-ancestor
44457750|NCT01605071|Hormones|hormones|mesh-ancestor
44457751|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457752|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457753|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
44457754|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
44457755|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457756|NCT01604785|Dopamine|dopamine|mesh-list
44457757|NCT01604785|Propofol|propofol|mesh-list
44457758|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
44457759|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44457760|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457761|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457767|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
44457768|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457769|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
44224982|NCT00507845|Ramipril|ramipril|mesh-list
44224983|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44224984|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
44224985|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44224986|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44224987|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44224988|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44224989|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44224990|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44224991|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44224992|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44224993|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
44224994|NCT00507858|Dexamethasone|dexamethasone|mesh-list
44224995|NCT00507858|Pemetrexed|pemetrexed|mesh-list
44224996|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44224997|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
44224998|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
44224999|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225000|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225001|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846230|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225002|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
44225003|NCT00507858|Hormones|hormones|mesh-ancestor
44225004|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225005|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225006|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225007|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225008|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225009|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44225010|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44225011|NCT00507949|Megestrol|megestrol|mesh-list
44225012|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
44225017|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44225018|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225019|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44225020|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44225021|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225022|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225023|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
44225024|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44225025|NCT00507962|Cisplatin|cisplatin|mesh-list
44225026|NCT00507962|Doxorubicin|doxorubicin|mesh-list
44225027|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44225028|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225029|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225030|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44225031|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225032|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225033|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225034|NCT00507975|Nicotine|nicotine|mesh-list
44225035|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44225036|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
44225037|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225038|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225039|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44225040|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44225041|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
44225042|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225043|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225044|NCT00508040|Interferons|interferons|mesh-list
44225045|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
44225046|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
44225047|NCT00508040|Prednisone|prednisone|mesh-list
44225048|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225049|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
44225050|NCT00508040|Hormones|hormones|mesh-ancestor
44225055|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
44225056|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225057|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
44225058|NCT00508092|Anesthetics|anesthetics|mesh-list
44225059|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
44225060|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225061|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225062|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
44225063|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225064|NCT00508209|Bortezomib|bortezomib|mesh-list
44225065|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225066|NCT00508287|Exenatide|exenatide|mesh-list
44225067|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225068|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225069|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44225070|NCT00508287|Incretins|incretins|mesh-ancestor
44225071|NCT00508287|Hormones|hormones|mesh-ancestor
44225072|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225073|NCT00508326|Paclitaxel|paclitaxel|mesh-list
44225074|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225075|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225076|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225077|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225078|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225079|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225080|NCT00508365|Carvedilol|carvedilol|mesh-list
44225081|NCT00508365|Lisinopril|lisinopril|mesh-list
44225082|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44225083|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44225084|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
44225085|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225086|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225087|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225088|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44225089|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
44225090|NCT00508365|Protective Agents|protective agents|mesh-ancestor
44164665|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164666|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164667|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164668|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164669|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225091|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44225092|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225093|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44225094|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225095|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44225096|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44225097|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44225098|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
44225099|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225100|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44225101|NCT00508456|Temozolomide|temozolomide|mesh-list
44225102|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44225103|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
44225104|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225105|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225106|NCT00508495|Acetaminophen|acetaminophen|mesh-list
44225107|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
44225108|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44225109|NCT00508495|Analgesics|analgesics|mesh-ancestor
44225110|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
44225111|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225112|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225113|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
44225114|NCT00508664|Cisplatin|cisplatin|mesh-list
44225115|NCT00508664|Docetaxel|docetaxel|mesh-list
44225116|NCT00508664|Fluorouracil|fluorouracil|mesh-list
44225117|NCT00508664|Cetuximab|cetuximab|mesh-list
44225118|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225119|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225120|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225137|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225138|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225139|NCT00508859|Sertraline|sertraline|mesh-list
44225140|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
44225141|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225142|NCT00508859|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44225143|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44225144|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225145|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225146|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225147|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
44225148|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225149|NCT00508885|Niacinamide|niacinamide|mesh-list
44225150|NCT00508885|Niacin|niacin|mesh-list
44225151|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
44225152|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
44225153|NCT00508885|Vitamins|vitamins|mesh-ancestor
44225154|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
44225155|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225156|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44225157|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
44225158|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225159|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44225160|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225161|NCT00508898|Calcitriol|calcitriol|mesh-list
44225162|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44225163|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225164|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44225165|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225166|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225167|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44225168|NCT00508898|Vitamins|vitamins|mesh-ancestor
44225169|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
44225170|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43762653|NCT02430298|Melatonin|melatonin|mesh-list
44225175|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44225176|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
44225177|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225178|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225179|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225180|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
44225181|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44225182|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
44225183|NCT00508976|Lidocaine|lidocaine|mesh-list
44225184|NCT00508976|Bupivacaine|bupivacaine|mesh-list
44225185|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
44225186|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
44225187|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225188|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225189|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
44225190|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225191|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44225192|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44225193|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44225194|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225195|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225196|NCT00509015|Artesunate|artesunate|mesh-list
44225197|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
44225198|NCT00509015|Primaquine|primaquine|mesh-list
44225199|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
44225200|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44225201|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
44225202|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44225203|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44225204|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823250|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44225205|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225206|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
44225207|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
44225218|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
44225219|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225220|NCT00509158|Antacids|antacids|mesh-ancestor
44225221|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225222|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225223|NCT00509184|Rituximab|rituximab|mesh-list
44225224|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44225225|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225226|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
44225227|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225228|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225229|NCT00509327|Bisacodyl|bisacodyl|mesh-list
44225230|NCT00509327|Cathartics|cathartics|mesh-ancestor
44225231|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225232|NCT00509327|Laxatives|laxatives|mesh-ancestor
44225233|NCT00509353|Irinotecan|irinotecan|mesh-list
44225234|NCT00509353|Vincristine|vincristine|mesh-list
44225235|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44225236|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44225237|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225238|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225239|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225240|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225271|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225272|NCT00509470|Amlodipine|amlodipine|mesh-list
44225273|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44225274|NCT00509470|Telmisartan|telmisartan|mesh-list
44225275|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44225276|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44225277|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225278|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225279|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43879492|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225280|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225281|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225282|NCT00509470|Diuretics|diuretics|mesh-ancestor
44225283|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
44225284|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44225285|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44225286|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44225287|NCT00509561|Cisplatin|cisplatin|mesh-list
44225288|NCT00509561|Capecitabine|capecitabine|mesh-list
44225289|NCT00509561|Cetuximab|cetuximab|mesh-list
44225290|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225291|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44225292|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
44225293|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225294|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44225295|NCT00509613|Sirolimus|sirolimus|mesh-list
44225296|NCT00509613|Sorafenib|sorafenib|mesh-list
44225297|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225298|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225299|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225315|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225316|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
44225317|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225318|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225319|NCT00509743|Diclofenac|diclofenac|mesh-list
44225320|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44225321|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44225322|NCT00509743|Analgesics|analgesics|mesh-ancestor
44225323|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
44225324|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225325|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225326|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225327|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225328|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44225329|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225330|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225331|NCT00509834|Lactoferrin|lactoferrin|mesh-list
44225332|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225333|NCT00509847|Lactoferrin|lactoferrin|mesh-list
44225334|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457770|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457771|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457772|NCT01604785|Protective Agents|protective agents|mesh-ancestor
44457773|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44457774|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
44457775|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457776|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
44457777|NCT01604278|Bromides|bromides|mesh-list
44457778|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
44457779|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44457780|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44457781|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44457782|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457783|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457784|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457785|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457786|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
44457787|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44457788|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44457789|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44457790|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457791|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457792|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
44225336|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44225337|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225338|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225339|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225340|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225341|NCT00509938|Lactoferrin|lactoferrin|mesh-list
44225342|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225343|NCT00509964|Irinotecan|irinotecan|mesh-list
44225344|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44225345|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225346|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225347|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225348|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225349|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
44225350|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44225351|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44225352|NCT00509990|Analgesics|analgesics|mesh-ancestor
44225353|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
44225354|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225355|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823260|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
44225356|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225357|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225358|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
44225359|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225360|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
44225361|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44225362|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225363|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225364|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
44164670|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164671|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164672|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44225365|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44225366|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44225367|NCT00510003|Analgesics|analgesics|mesh-ancestor
44225368|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
44225369|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225370|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225371|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225372|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225373|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
44225374|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225375|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
44225376|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44225377|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225378|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225380|NCT00510016|Analgesics|analgesics|mesh-ancestor
44225381|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
44225382|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225383|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225384|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44225385|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
44225386|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
44225387|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44225388|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44225389|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44225390|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
44225391|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225392|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225393|NCT00510081|Calcium|calcium|mesh-list
44225394|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44225395|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225396|NCT00510107|Cisplatin|cisplatin|mesh-list
44225409|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44225410|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
44225411|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44225412|NCT00510159|Renal Agents|renal agents|mesh-ancestor
44225413|NCT00510172|Epoprostenol|epoprostenol|mesh-list
44225414|NCT00510172|Tezosentan|tezosentan|mesh-list
44225415|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44225416|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44225417|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225418|NCT00510211|Olanzapine|olanzapine|mesh-list
44225419|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
44225420|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
44225421|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225422|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225423|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225424|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44225425|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225426|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225427|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225428|NCT00510211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44225429|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44225430|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225431|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225432|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225433|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
44225458|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225459|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44225460|NCT00510263|Protective Agents|protective agents|mesh-ancestor
44225461|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
44225462|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225463|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
44225464|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225465|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225466|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225467|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225468|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
44225470|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44225471|NCT00510367|Fluorouracil|fluorouracil|mesh-list
44225472|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225473|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
44225474|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225475|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225476|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44225477|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
44225479|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225511|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225512|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225513|NCT00510445|Imetelstat|imetelstat|mesh-list
44225514|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
44225515|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225516|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225517|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225518|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
44225519|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44225520|NCT00510471|Antibodies|antibodies|mesh-list
44225521|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
44225522|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
44225523|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225524|NCT00510536|Acetaminophen|acetaminophen|mesh-list
44225525|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44225526|NCT00510536|Analgesics|analgesics|mesh-ancestor
44225527|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
44225528|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225529|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225530|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
44225531|NCT00510588|Metformin|metformin|mesh-list
44225532|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225533|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225534|NCT00510614|Tinidazole|tinidazole|mesh-list
44225535|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
44225536|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225537|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225538|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225557|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225558|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225559|NCT00510666|Tramadol|tramadol|mesh-list
44225560|NCT00510666|Butorphanol|butorphanol|mesh-list
44225561|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44225562|NCT00510666|Narcotics|narcotics|mesh-ancestor
44225563|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225564|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225565|NCT00510666|Analgesics|analgesics|mesh-ancestor
44225566|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
44225567|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225568|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
44225569|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
44225570|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44225620|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44225621|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225622|NCT00511225|Vitamins|vitamins|mesh-ancestor
44225623|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
44225624|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44225625|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44225626|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
44225627|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225628|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44225629|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225630|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225631|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225632|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
44225633|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225634|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225635|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225636|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225637|NCT00511316|Montelukast|montelukast|mesh-list
44225638|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43879765|NCT04665895|Xhance|xhance|mesh-list
44225639|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
44225640|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44225641|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
44225642|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225643|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225644|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44225645|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44225646|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225647|NCT00511446|Docetaxel|docetaxel|mesh-list
44225648|NCT00511446|Capecitabine|capecitabine|mesh-list
44225649|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
44225650|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225651|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225652|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225658|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
44225659|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44225660|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44225661|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225662|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225663|NCT00511498|Urological Agents|urological agents|mesh-ancestor
44225664|NCT00511576|Docetaxel|docetaxel|mesh-list
44225665|NCT00511576|Mocetinostat|mocetinostat|mesh-list
44225666|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225667|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225668|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225669|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225670|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225671|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44225672|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225673|NCT00511602|Insulin|insulin|mesh-list
44225674|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225675|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225676|NCT00511628|Risperidone|risperidone|mesh-list
44225677|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44225678|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
44225679|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225680|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225681|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225682|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44225683|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225684|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225685|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225686|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44225687|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
44225688|NCT00511654|Midazolam|midazolam|mesh-list
44225689|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44225690|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44225691|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164673|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
44164674|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164675|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44164676|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
44164677|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
44164678|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44164696|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44225692|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225693|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44225694|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225695|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225696|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44225697|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
44225698|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
44225699|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
44225700|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
44225701|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225702|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225703|NCT00511719|Insulin|insulin|mesh-list
44225704|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44225705|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225706|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225707|NCT00511732|Insulin|insulin|mesh-list
44225708|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225709|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457793|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457794|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457795|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44457796|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225711|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44225712|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
44225713|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225714|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225715|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225716|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
44225717|NCT00511823|Granisetron|granisetron|mesh-list
44225718|NCT00511823|Casopitant|casopitant|mesh-list
44225719|NCT00511823|Dolasetron|dolasetron|mesh-list
44225720|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225721|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225722|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
44225723|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
44225724|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225725|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44164697|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44164698|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44225726|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44225727|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
44225728|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225729|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225730|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44225731|NCT00511849|Paclitaxel|paclitaxel|mesh-list
44225732|NCT00511849|Carboplatin|carboplatin|mesh-list
44225733|NCT00511849|Sunitinib|sunitinib|mesh-list
44225734|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225735|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225736|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225737|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225738|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225739|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225740|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44225741|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44225742|NCT00511849|Growth Substances|growth substances|mesh-ancestor
44225743|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225744|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
44225745|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44225746|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225747|NCT00511940|Acamprosate|acamprosate|mesh-list
44225748|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44225749|NCT00511953|Gabapentin|gabapentin|mesh-list
44225750|NCT00511953|Analgesics|analgesics|mesh-ancestor
44225751|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
44225752|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225753|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225754|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
44225755|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44225756|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225757|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225758|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225759|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44225760|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44225761|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164699|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
44164700|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
44225762|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225763|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
44225764|NCT00511966|Rabeprazole|rabeprazole|mesh-list
44225765|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44225766|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225767|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44225768|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225769|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225770|NCT00511979|Insulin|insulin|mesh-list
44225771|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44225772|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44225773|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225774|NCT00512044|Anesthetics|anesthetics|mesh-list
44225775|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225776|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225777|NCT00512057|Allopurinol|allopurinol|mesh-list
44225778|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
44225779|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225780|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225781|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
44225782|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225783|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44225784|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
44225785|NCT00512057|Protective Agents|protective agents|mesh-ancestor
44225786|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225787|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
44225788|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44225789|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
44225790|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225791|NCT00512265|Expectorants|expectorants|mesh-ancestor
44225792|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
44225793|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44225794|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
44225795|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225796|NCT00512265|Protective Agents|protective agents|mesh-ancestor
44225803|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225804|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225805|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44225806|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44225807|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225808|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225809|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225810|NCT00512291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44225811|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44225812|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44225813|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225814|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225815|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
44225816|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44225817|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
44225818|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44225819|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44225820|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225821|NCT00512395|Fentanyl|fentanyl|mesh-list
44225822|NCT00512395|Ropivacaine|ropivacaine|mesh-list
44225823|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44225824|NCT00512395|Narcotics|narcotics|mesh-ancestor
44225825|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225826|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225827|NCT00512395|Analgesics|analgesics|mesh-ancestor
44225828|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
44225829|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44225830|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44225831|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44225832|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
44225833|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
44225844|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44225845|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
44225846|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
44225847|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225848|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225849|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
44225850|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
44225851|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
44225852|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44225853|NCT00512668|Sirolimus|sirolimus|mesh-list
44225854|NCT00512668|Leuprolide|leuprolide|mesh-list
44225855|NCT00512668|Goserelin|goserelin|mesh-list
44225856|NCT00512668|Flutamide|flutamide|mesh-list
44225857|NCT00512668|Bicalutamide|bicalutamide|mesh-list
44225858|NCT00512668|Nilutamide|nilutamide|mesh-list
44225859|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44225860|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
44225861|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44225862|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225863|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225864|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225865|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44225897|NCT00512850|Folic Acid|folic acid|mesh-list
44225898|NCT00512850|Hematinics|hematinics|mesh-ancestor
44225899|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
44225900|NCT00512850|Vitamins|vitamins|mesh-ancestor
44225901|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
44225902|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225903|NCT00512863|Adalimumab|adalimumab|mesh-list
44225904|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225905|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44225906|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
44225907|NCT00512928|Vitamin K|vitamin k|mesh-list
44225908|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
44225909|NCT00512928|Vitamin MK 7|vitamin mk 7|mesh-list
44225910|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44225911|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44225912|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225913|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
44225914|NCT00512928|Coagulants|coagulants|mesh-ancestor
44225915|NCT00512928|Vitamins|vitamins|mesh-ancestor
44225916|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
44225917|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225918|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
44225919|NCT00512980|Gemcitabine|gemcitabine|mesh-list
44225920|NCT00512980|Prednisone|prednisone|mesh-list
44225921|NCT00512980|Doxorubicin|doxorubicin|mesh-list
44225922|NCT00512980|Vinblastine|vinblastine|mesh-list
44225923|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44225924|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
44225925|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225926|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225927|NCT00512980|Antiviral Agents|antiviral agents|mesh-ancestor
44225928|NCT00512980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44225929|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225930|NCT00512980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44225931|NCT00512980|Immunologic Factors|immunologic factors|mesh-ancestor
44225932|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763284|NCT02426840|Vitamin D|vitamin d|mesh-list
44164701|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164702|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164703|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164705|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44164706|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44164707|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44173267|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
44225933|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44225934|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44225935|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225936|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44225937|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
44225938|NCT00512980|Hormones|hormones|mesh-ancestor
43880011|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
44457797|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
44225939|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44225940|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44225941|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225942|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225943|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225944|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
44225945|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
44225946|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44225947|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225948|NCT00513032|Methylene Blue|methylene blue|mesh-list
44225949|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225950|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225951|NCT00513058|Vinorelbine|vinorelbine|mesh-list
44225953|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225954|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225955|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
44225956|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
44225979|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225980|NCT00513162|Etoposide|etoposide|mesh-list
44225981|NCT00513162|Valproic Acid|valproic acid|mesh-list
44225982|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44225983|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44225984|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44225985|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44225986|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44225987|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44225988|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
44225989|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
44225990|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44225991|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44225992|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
44225993|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44225994|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44225995|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44225996|NCT00513188|Leucovorin|leucovorin|mesh-list
44225997|NCT00513188|Cytarabine|cytarabine|mesh-list
44225998|NCT00513188|Prednisone|prednisone|mesh-list
44225999|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
44226000|NCT00513188|Doxorubicin|doxorubicin|mesh-list
44226001|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44226002|NCT00513188|Methotrexate|methotrexate|mesh-list
44226003|NCT00513188|Vincristine|vincristine|mesh-list
44226004|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
44226005|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
44226006|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226007|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
44226008|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226009|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226010|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226011|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
44226012|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164708|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
44164709|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
44164710|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164711|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164712|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164713|NCT00257595|Cetirizine|cetirizine|mesh-list
44164714|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44164715|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44164716|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44226013|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226014|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44226015|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44226016|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226017|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226018|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226019|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226021|NCT00513188|Hormones|hormones|mesh-ancestor
44226022|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226023|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44226024|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44226025|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
44226026|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226027|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226028|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
44226029|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226030|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44226031|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226032|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
44226033|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226034|NCT00513188|Antidotes|antidotes|mesh-ancestor
44226035|NCT00513188|Protective Agents|protective agents|mesh-ancestor
44226036|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
44226037|NCT00513188|Vitamins|vitamins|mesh-ancestor
44226038|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
44226039|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226040|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226041|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226042|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226043|NCT00513201|Insulin|insulin|mesh-list
44226044|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44226058|NCT00513266|Calcium|calcium|mesh-list
44226059|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
44226060|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44226061|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226062|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226063|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226064|NCT00513266|Growth Substances|growth substances|mesh-ancestor
44226065|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226066|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226067|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44226068|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
44226069|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226070|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226071|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226072|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
44226073|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44226074|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226075|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226076|NCT00513266|Antidotes|antidotes|mesh-ancestor
44226077|NCT00513266|Protective Agents|protective agents|mesh-ancestor
44226078|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
44226079|NCT00513266|Vitamins|vitamins|mesh-ancestor
44226080|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
44226081|NCT00513383|Paclitaxel|paclitaxel|mesh-list
44226082|NCT00513383|Docetaxel|docetaxel|mesh-list
44226083|NCT00513383|Cisplatin|cisplatin|mesh-list
44226084|NCT00513383|Carboplatin|carboplatin|mesh-list
44226085|NCT00513383|Fluorouracil|fluorouracil|mesh-list
44226086|NCT00513383|Panitumumab|panitumumab|mesh-list
44226087|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226088|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43880142|NCT04660773|Pregabalin|pregabalin|mesh-list
44226089|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226090|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226091|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226092|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226093|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
44226094|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226096|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
44226097|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226098|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44226099|NCT00513396|Isoniazid|isoniazid|mesh-list
44226100|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
44226101|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226102|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226103|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
44226104|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44226105|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
44226106|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226107|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44226108|NCT00513487|Fluticasone|fluticasone|mesh-list
44226109|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
44226110|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226111|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44226112|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
44226113|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226114|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226115|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44226116|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
44226117|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226118|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44226119|NCT00513487|Miotics|miotics|mesh-ancestor
44226120|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44226121|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
44226122|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44226123|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44226124|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
44226125|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226126|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226127|NCT00513513|Ritonavir|ritonavir|mesh-list
44164717|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
44164718|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
44164719|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164720|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164721|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164722|NCT00257621|Ritonavir|ritonavir|mesh-list
44164723|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44164724|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44164725|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
44164726|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164727|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226128|NCT00513513|Darunavir|darunavir|mesh-list
44226129|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44226130|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44226131|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
44226132|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226133|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226134|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44226135|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44226136|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
44226137|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226138|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44226139|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44226140|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
44226141|NCT00513539|Trioxsalen|trioxsalen|mesh-list
44226142|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226143|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226144|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44457798|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44457799|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44457800|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44226162|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226163|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44226164|NCT00513630|Metformin|metformin|mesh-list
44226165|NCT00513630|Glipizide|glipizide|mesh-list
44226166|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226167|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226168|NCT00513643|Insulin|insulin|mesh-list
44226169|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44226170|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
44226171|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226172|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226173|NCT00513656|Oxycodone|oxycodone|mesh-list
44226174|NCT00513656|Naloxone|naloxone|mesh-list
44226175|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44226176|NCT00513656|Narcotics|narcotics|mesh-ancestor
44226177|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226178|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226179|NCT00513656|Analgesics|analgesics|mesh-ancestor
44226180|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
44226181|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226182|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44226183|NCT00513786|Paclitaxel|paclitaxel|mesh-list
44226184|NCT00513786|Bevacizumab|bevacizumab|mesh-list
44226185|NCT00513786|Carboplatin|carboplatin|mesh-list
44226186|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226187|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226188|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226189|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226190|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226191|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226192|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44226193|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226194|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226195|NCT00513786|Growth Substances|growth substances|mesh-ancestor
44226196|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226197|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226198|NCT00513864|Morphine|morphine|mesh-list
44226199|NCT00513864|Codeine|codeine|mesh-list
44164728|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44164729|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44226201|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44226202|NCT00513864|Narcotics|narcotics|mesh-ancestor
44226203|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226204|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226205|NCT00513864|Analgesics|analgesics|mesh-ancestor
44226206|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
44226207|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226208|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
44226209|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
44226210|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44226211|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44226212|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226213|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226214|NCT00513877|Bortezomib|bortezomib|mesh-list
44226215|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226216|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
44226217|NCT00513929|Astringents|astringents|mesh-ancestor
44226218|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226219|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226220|NCT00513955|Prednisolone|prednisolone|mesh-list
44226221|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
44226222|NCT00513955|Doxorubicin|doxorubicin|mesh-list
44226223|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44226224|NCT00513955|Vincristine|vincristine|mesh-list
44226225|NCT00513955|Bortezomib|bortezomib|mesh-list
44226250|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226251|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44226252|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226253|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226254|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226255|NCT00513981|Leucovorin|leucovorin|mesh-list
44226256|NCT00513981|Methotrexate|methotrexate|mesh-list
44226257|NCT00513981|Calcium|calcium|mesh-list
44226258|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
44226259|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44226260|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226261|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44226262|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
44226263|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226264|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226265|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
44226266|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226267|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226268|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226269|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226270|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44226271|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226272|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
44226273|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226274|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226275|NCT00513981|Antidotes|antidotes|mesh-ancestor
44226276|NCT00513981|Protective Agents|protective agents|mesh-ancestor
44226277|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
44226278|NCT00513981|Vitamins|vitamins|mesh-ancestor
44226279|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
44226280|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
44226281|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
44226282|NCT00514072|Vaccines|vaccines|mesh-list
44226283|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
44226284|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
44226285|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226286|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44226287|NCT00514111|Interferons|interferons|mesh-list
44226288|NCT00514111|Ribavirin|ribavirin|mesh-list
44226289|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226290|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
44226291|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226292|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
44226293|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226294|NCT00514163|Gemcitabine|gemcitabine|mesh-list
44226295|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226296|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
44226297|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226298|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226299|NCT00514163|Antiviral Agents|antiviral agents|mesh-ancestor
44226300|NCT00514163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226301|NCT00514163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226302|NCT00514163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226303|NCT00514163|Immunologic Factors|immunologic factors|mesh-ancestor
44226304|NCT00514163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226305|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
44226306|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44226307|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226308|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44226309|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44226310|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226311|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226312|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
44226313|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226314|NCT00514228|Sunitinib|sunitinib|mesh-list
44226315|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226316|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226317|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226318|NCT00514228|Growth Substances|growth substances|mesh-ancestor
44226319|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226320|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226321|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44226322|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43837650|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44226323|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226325|NCT00514293|Carboplatin|carboplatin|mesh-list
44226326|NCT00514293|Docetaxel|docetaxel|mesh-list
44226327|NCT00514293|Capecitabine|capecitabine|mesh-list
44226328|NCT00514293|Tretinoin|tretinoin|mesh-list
44226329|NCT00514293|Bexarotene|bexarotene|mesh-list
44226330|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226331|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
44226332|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226333|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226334|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226335|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226336|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
44226337|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
44226338|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226339|NCT00514397|Temozolomide|temozolomide|mesh-list
44226340|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
44226341|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226342|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
44226343|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226344|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226345|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44226346|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226347|NCT00514410|Folic Acid|folic acid|mesh-list
44226348|NCT00514410|Hematinics|hematinics|mesh-ancestor
43641592|NCT05602311|Anesthetics|anesthetics|mesh-list
44226349|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
44226350|NCT00514410|Vitamins|vitamins|mesh-ancestor
44226351|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
44226352|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226353|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44226354|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
44226355|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226356|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
44226357|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226358|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44226365|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
44226366|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
44226367|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226368|NCT00514618|Misoprostol|misoprostol|mesh-list
44226369|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44226370|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
44226371|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226372|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226373|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44226374|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226375|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
44226376|NCT00514657|Mitogens|mitogens|mesh-list
44226377|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226378|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226379|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
44226380|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44226381|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226382|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
44226383|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
44226384|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44226385|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44226386|NCT00514748|Analgesics|analgesics|mesh-ancestor
44226387|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
44226388|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226389|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226390|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226391|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226392|NCT00514761|Capecitabine|capecitabine|mesh-list
44226393|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226394|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
44226395|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226408|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226410|NCT00514982|Mesalamine|mesalamine|mesh-list
44226411|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
44226412|NCT00514982|Infliximab|infliximab|mesh-list
44226413|NCT00514982|Tacrolimus|tacrolimus|mesh-list
44226414|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226415|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
44226416|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226417|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44226418|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226419|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226420|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226421|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226422|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226423|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226424|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
44226425|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226426|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226427|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226428|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44226429|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44226430|NCT00514982|Analgesics|analgesics|mesh-ancestor
44226431|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
44226432|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226433|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
44226434|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44226435|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44226436|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
44226437|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
44226438|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226439|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226440|NCT00515138|Rituximab|rituximab|mesh-list
44226441|NCT00515138|Carboplatin|carboplatin|mesh-list
44226442|NCT00515138|Etoposide|etoposide|mesh-list
44226443|NCT00515138|Bortezomib|bortezomib|mesh-list
44226444|NCT00515138|Ifosfamide|ifosfamide|mesh-list
44226445|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44226447|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
43641701|NCT05575999|Ketorolac|ketorolac|mesh-list
44226448|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226449|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226450|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44226451|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226452|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226453|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226454|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226455|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226456|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
44226457|NCT00515151|Ethanol|ethanol|mesh-list
44226458|NCT00515151|Octenidine|octenidine|mesh-list
44226459|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44226460|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226461|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226462|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226463|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
44226464|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226465|NCT00515229|Amitriptyline|amitriptyline|mesh-list
44226466|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44226467|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
44226468|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44226469|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44226470|NCT00515229|Analgesics|analgesics|mesh-ancestor
44226471|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
44226472|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226473|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226474|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44226475|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44226476|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226477|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226478|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
44226479|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226480|NCT00515255|Minocycline|minocycline|mesh-list
44226481|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226482|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226483|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
44226484|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
44226485|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44226486|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226487|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226488|NCT00515320|Fluoxetine|fluoxetine|mesh-list
44226489|NCT00515320|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44226490|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44226491|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226492|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226493|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226494|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
44226495|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226496|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44226497|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
44226498|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44226499|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44226500|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44226501|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226502|NCT00515359|Propofol|propofol|mesh-list
44226503|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44226504|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226505|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226506|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44226507|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
44226508|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
44226509|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
44226510|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44226511|NCT00515450|Antibodies|antibodies|mesh-list
44226512|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
44226513|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44226521|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226522|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44226523|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44226524|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226526|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44226527|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
44457818|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641892|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641893|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641894|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641895|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43641896|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43641897|NCT05554406|Cytarabine|cytarabine|mesh-list
44457819|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
44457820|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44457821|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44457822|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44457823|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457824|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457825|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457826|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457827|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457828|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44457829|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457830|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44457831|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44457832|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457833|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457834|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44457835|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457836|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457837|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
44457838|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44457839|NCT01603407|Prednisone|prednisone|mesh-list
44457840|NCT01603407|Deflazacort|deflazacort|mesh-list
44457841|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457842|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
44457843|NCT01603407|Hormones|hormones|mesh-ancestor
44457844|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44457845|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457849|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
44457850|NCT01603394|Pregabalin|pregabalin|mesh-list
44457851|NCT01603394|Analgesics|analgesics|mesh-ancestor
44457852|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
44457853|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457854|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457855|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
44457856|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44457857|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457858|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457859|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44457860|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44457861|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457862|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457863|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457864|NCT01603277|Antibodies|antibodies|mesh-list
44457865|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44457866|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
44457867|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457868|NCT01603121|Lisofylline|lisofylline|mesh-list
44457869|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44457870|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
44457871|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457872|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44457873|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44457874|NCT01603121|Analgesics|analgesics|mesh-ancestor
44457875|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
44457876|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457877|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457878|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44457879|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457880|NCT01603082|Clopidogrel|clopidogrel|mesh-list
44457881|NCT01603082|Ticagrelor|ticagrelor|mesh-list
44457882|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44457883|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
44457885|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44457887|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226529|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642101|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
44226530|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226531|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
44226532|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226533|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226534|NCT00515593|Hormones|hormones|mesh-list
44226535|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
44226536|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226537|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226538|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44226539|NCT00515684|Bevacizumab|bevacizumab|mesh-list
44226540|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44226541|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226542|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226543|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226544|NCT00515684|Growth Substances|growth substances|mesh-ancestor
44226545|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226546|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226547|NCT00515736|Vitamins|vitamins|mesh-list
44226548|NCT00515736|Vitamin E|vitamin e|mesh-list
44226549|NCT00515736|Thiamine|thiamine|mesh-list
44226550|NCT00515736|Zinc|zinc|mesh-list
44226551|NCT00515736|Selenium|selenium|mesh-list
44226552|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
44226553|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226554|NCT00515736|Trace Elements|trace elements|mesh-ancestor
44226555|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
44226556|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226557|NCT00515736|Protective Agents|protective agents|mesh-ancestor
44226558|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
44226559|NCT00515788|Cytarabine|cytarabine|mesh-list
44226560|NCT00515788|Temozolomide|temozolomide|mesh-list
44226570|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226571|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
44226572|NCT00515801|Glyburide|glyburide|mesh-list
44226573|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226574|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226575|NCT00515866|Gemcitabine|gemcitabine|mesh-list
44226576|NCT00515866|Olaparib|olaparib|mesh-list
44226577|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44226578|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226579|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
44226580|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226581|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226582|NCT00515866|Antiviral Agents|antiviral agents|mesh-ancestor
44226583|NCT00515866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226584|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226585|NCT00515866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226586|NCT00515866|Immunologic Factors|immunologic factors|mesh-ancestor
44226587|NCT00515866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226588|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
44226589|NCT00515892|Antibodies|antibodies|mesh-list
44226590|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
44226591|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
44226592|NCT00515892|Immunotoxins|immunotoxins|mesh-list
44226593|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
44226594|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226595|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226596|NCT00515905|Propofol|propofol|mesh-list
44226597|NCT00515905|Sevoflurane|sevoflurane|mesh-list
44226598|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44226599|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226600|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642199|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
44226601|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44226602|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
44226613|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226614|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226615|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44226616|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226617|NCT00515957|Antibodies|antibodies|mesh-list
44226618|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
44226619|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226620|NCT00516009|Dexamethasone|dexamethasone|mesh-list
44226621|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44226622|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
44226623|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
44226624|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226625|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226626|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226627|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
44226628|NCT00516009|Hormones|hormones|mesh-ancestor
44226629|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226630|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44226631|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226632|NCT00516100|Pemetrexed|pemetrexed|mesh-list
44226633|NCT00516100|Bortezomib|bortezomib|mesh-list
44226634|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226635|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226636|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226637|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44226638|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226639|NCT00516113|Paroxetine|paroxetine|mesh-list
44226640|NCT00516113|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44226641|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44226642|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226657|NCT00516152|Tacrolimus|tacrolimus|mesh-list
44226658|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44226659|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
44226660|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226661|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226662|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226663|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
44226664|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226665|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226666|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44226667|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226668|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44226669|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226670|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
44226671|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44226672|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226673|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44226674|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
44226675|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226676|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44226677|NCT00516191|Doxorubicin|doxorubicin|mesh-list
44226678|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44226679|NCT00516191|Bortezomib|bortezomib|mesh-list
44226680|NCT00516191|Melphalan|melphalan|mesh-list
44226681|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44226682|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226683|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226684|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226685|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226686|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226687|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226688|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
44226689|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44226690|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226691|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
44226694|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
44226695|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226696|NCT00516243|Protective Agents|protective agents|mesh-ancestor
44226697|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226698|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44226699|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44226700|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226701|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44226702|NCT00516282|Temozolomide|temozolomide|mesh-list
44226703|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226704|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
44226705|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226706|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226707|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
44226708|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44226709|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226710|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
44226711|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
44226712|NCT00516399|Natamycin|natamycin|mesh-list
44226713|NCT00516399|Povidone|povidone|mesh-list
44226714|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
44226715|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44226716|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
43823640|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44226717|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
44226718|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44226719|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226720|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226721|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
44226722|NCT00516412|Everolimus|everolimus|mesh-list
44226723|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226740|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44226741|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226742|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226743|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226744|NCT00516438|Topotecan|topotecan|mesh-list
44226745|NCT00516438|Olaparib|olaparib|mesh-list
44226746|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44226747|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44226748|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226749|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226750|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226751|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226752|NCT00516464|Ranibizumab|ranibizumab|mesh-list
44226753|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226754|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226755|NCT00516464|Growth Substances|growth substances|mesh-ancestor
44226756|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226757|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226758|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226759|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44226760|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
44226761|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44226762|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
44226763|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44226764|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226765|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44226766|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44226767|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226768|NCT00516542|Letrozole|letrozole|mesh-list
44226769|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226770|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44226771|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44226772|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226773|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226774|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44226778|NCT00516607|Temozolomide|temozolomide|mesh-list
44226779|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226780|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
44226781|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226782|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226783|NCT00516672|Lapatinib|lapatinib|mesh-list
44226784|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226785|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44226786|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226787|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226788|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
44226789|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44226790|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
44226791|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226792|NCT00516711|Sevoflurane|sevoflurane|mesh-list
44226793|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44226794|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44226795|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
44226796|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
44226797|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226798|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226799|NCT00516750|Cisplatin|cisplatin|mesh-list
44226800|NCT00516750|Doxorubicin|doxorubicin|mesh-list
44226801|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44226802|NCT00516750|Methotrexate|methotrexate|mesh-list
44226803|NCT00516750|Vinblastine|vinblastine|mesh-list
44226804|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226805|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44226824|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
44226825|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
44226826|NCT00516802|Olaparib|olaparib|mesh-list
44226827|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
44226828|NCT00516802|Dacarbazine|dacarbazine|mesh-list
44226829|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226830|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226831|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226832|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44226833|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
44226834|NCT00516828|Cytarabine|cytarabine|mesh-list
44226835|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44226836|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
44226837|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226838|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226839|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
44226840|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226841|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44226842|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
44226843|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226844|NCT00516841|Volociximab|volociximab|mesh-list
44226845|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44226846|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44226847|NCT00516841|Growth Substances|growth substances|mesh-ancestor
44226848|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226849|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
44226850|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226871|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44226872|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44226873|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226874|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226875|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
44226876|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226877|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44226878|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44226879|NCT00516958|Levofloxacin|levofloxacin|mesh-list
44226880|NCT00516958|Ofloxacin|ofloxacin|mesh-list
44226881|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
44226882|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44226883|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44226884|NCT00516958|Renal Agents|renal agents|mesh-ancestor
44226885|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44226886|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44226887|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44226888|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226889|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226890|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226891|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44226892|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44226893|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
44226894|NCT00516971|Esomeprazole|esomeprazole|mesh-list
44226895|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44226896|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226897|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44226898|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226915|NCT00517179|Urological Agents|urological agents|mesh-ancestor
44226917|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44226918|NCT00517257|Atorvastatin|atorvastatin|mesh-list
44226919|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44226920|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44226921|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
44226922|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226923|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44226924|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44226925|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226926|NCT00517270|Rabeprazole|rabeprazole|mesh-list
44226927|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43642294|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
44226928|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44226929|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44226930|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226931|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226932|NCT00517283|Exenatide|exenatide|mesh-list
44226933|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44226934|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226935|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44226936|NCT00517283|Incretins|incretins|mesh-ancestor
44226937|NCT00517283|Hormones|hormones|mesh-ancestor
44226938|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44226939|NCT00517309|Vaccines|vaccines|mesh-list
44226940|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
44226941|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226942|NCT00517322|Ramipril|ramipril|mesh-list
44226943|NCT00517322|Irbesartan|irbesartan|mesh-list
44226944|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44226945|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
44226946|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44226947|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226948|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44226949|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44457890|NCT01602562|Valacyclovir|valacyclovir|mesh-list
44457891|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
44457892|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457893|NCT01602510|Lamotrigine|lamotrigine|mesh-list
44457894|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
44457895|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44457896|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44457897|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457898|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44457899|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457900|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44457901|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44457902|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44457903|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44457904|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44457905|NCT01602315|Cetuximab|cetuximab|mesh-list
44457906|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44457907|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457908|NCT01602224|Dexamethasone|dexamethasone|mesh-list
44457909|NCT01602224|Bortezomib|bortezomib|mesh-list
44457910|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44457911|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
44457912|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
44457913|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44457914|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226951|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44226952|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
44226953|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44226954|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44226955|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44226956|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44226957|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226958|NCT00517426|Acetazolamide|acetazolamide|mesh-list
44226969|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44226970|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226971|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44226972|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44226973|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44226974|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44226975|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
44226976|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44226977|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
44226978|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
44226979|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
44226980|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226981|NCT00517582|Icatibant|icatibant|mesh-list
44226982|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44226983|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44226984|NCT00517582|Analgesics|analgesics|mesh-ancestor
44226985|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
44226986|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44226987|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44226988|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227021|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44227022|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44227023|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
44227024|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44227025|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44227027|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
44227028|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227029|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44227031|NCT00517764|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44227032|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227033|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227034|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227080|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
44227081|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44227082|NCT00518102|Growth Substances|growth substances|mesh-ancestor
44227083|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227084|NCT00518141|Aspirin|aspirin|mesh-list
44227085|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
44227086|NCT00518141|Salicylates|salicylates|mesh-list
44227087|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227088|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
44227089|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
44227090|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
44227091|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227092|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227093|NCT00518141|Analgesics|analgesics|mesh-ancestor
44227094|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
44227095|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227096|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227097|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227098|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227099|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44227100|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227101|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227102|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44227103|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44227104|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44227105|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
44227106|NCT00518193|Cetuximab|cetuximab|mesh-list
44227107|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44227108|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227109|NCT00518232|Methylphenidate|methylphenidate|mesh-list
44227110|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44227111|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227112|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44227116|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
44227120|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44227121|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44227122|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227124|NCT00518271|Tacrolimus|tacrolimus|mesh-list
44227125|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227126|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
44227127|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227128|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44227129|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227130|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227131|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227183|NCT00518479|Valsartan|valsartan|mesh-list
44227184|NCT00518479|Moxonidine|moxonidine|mesh-list
44227185|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
44227186|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44227187|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44227188|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227189|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227190|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227191|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227192|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
43642680|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
43642681|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
44227193|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44227194|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44227195|NCT00518479|Diuretics|diuretics|mesh-ancestor
44227196|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
44227197|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44227198|NCT00518570|Levetiracetam|levetiracetam|mesh-list
44227199|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
44227200|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
44227201|NCT00518583|Paclitaxel|paclitaxel|mesh-list
44227202|NCT00518583|Doxorubicin|doxorubicin|mesh-list
44227203|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44227204|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44227205|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227206|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
44227207|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
44227208|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
44227209|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227210|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44227211|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44227212|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44227213|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227214|NCT00518635|Insulin|insulin|mesh-list
44227215|NCT00518635|Hormones|hormones|mesh-list
44227216|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227219|NCT00518895|Dacarbazine|dacarbazine|mesh-list
44227223|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227224|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227225|NCT00518908|Sevoflurane|sevoflurane|mesh-list
44227226|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44227227|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44227228|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
44227229|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
44227230|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227231|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227232|NCT00518947|Verapamil|verapamil|mesh-list
44227233|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
44227234|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227235|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227236|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227237|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227238|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
44227239|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44227240|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227241|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227242|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227243|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44227244|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227245|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227246|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
44227247|NCT00519012|Sertraline|sertraline|mesh-list
44227248|NCT00519012|Paroxetine|paroxetine|mesh-list
43881269|NCT04643821|Vitamins|vitamins|mesh-ancestor
44227249|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
44227250|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227251|NCT00519012|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44227252|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227253|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227254|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227255|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227256|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
44227259|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44227260|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44227261|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227262|NCT00519051|Fluoxetine|fluoxetine|mesh-list
44227263|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
44227264|NCT00519051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44227265|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227266|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227267|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227268|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227269|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
44227270|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227271|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44227272|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227273|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44227274|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44227275|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227276|NCT00519116|Sirolimus|sirolimus|mesh-list
44227277|NCT00519116|Tacrolimus|tacrolimus|mesh-list
44227278|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227279|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
44227280|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227281|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44227282|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227283|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227284|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227285|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227286|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44227287|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227288|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
43642710|NCT05341154|Analgesics|analgesics|mesh-ancestor
44457915|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44457916|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
44457917|NCT01602224|Hormones|hormones|mesh-ancestor
44457923|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44457924|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44457925|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457927|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
44457928|NCT01601847|Vitamins|vitamins|mesh-ancestor
44457929|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
44457930|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457931|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44457932|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44457933|NCT01601821|Sirolimus|sirolimus|mesh-list
44457934|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44457935|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457936|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44457937|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44457938|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
44457939|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44457940|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
44457941|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457942|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
44457943|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44457944|NCT01601626|Pyridoxine|pyridoxine|mesh-list
44457945|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
44457946|NCT01601626|Ritonavir|ritonavir|mesh-list
44457947|NCT01601626|Lopinavir|lopinavir|mesh-list
44457948|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
44227289|NCT00519181|Valproic Acid|valproic acid|mesh-list
44227290|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
44227291|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227292|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227293|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
44227294|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227295|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227296|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
44227297|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44227298|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227299|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227302|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
44227303|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227304|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227305|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
44227306|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227307|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227308|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44227309|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44227310|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227311|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227312|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
44227313|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
44227314|NCT00519246|Narcotics|narcotics|mesh-ancestor
44227315|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227316|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227317|NCT00519246|Analgesics|analgesics|mesh-ancestor
44227318|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
44227319|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227320|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227321|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227322|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227323|NCT00519259|Lobeline|lobeline|mesh-list
44227324|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44227325|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
44227326|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227327|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227328|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44227346|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227347|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
44227348|NCT00519337|Vitamins|vitamins|mesh-ancestor
44227349|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
44227350|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227351|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
44227352|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227353|NCT00519337|Protective Agents|protective agents|mesh-ancestor
44227354|NCT00519363|Atorvastatin|atorvastatin|mesh-list
44227355|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44227356|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44227357|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
44227358|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227359|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44227360|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44227361|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227362|NCT00519467|Artesunate|artesunate|mesh-list
44227363|NCT00519467|Dapsone|dapsone|mesh-list
44227364|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
44227365|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
44227366|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44227367|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44227368|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227369|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227370|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
44227371|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
44227372|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44227373|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
44227374|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44227375|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227376|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227377|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
44227378|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227379|NCT00519480|Metformin|metformin|mesh-list
44227380|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227381|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227382|NCT00519519|Omeprazole|omeprazole|mesh-list
44227383|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44227384|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227385|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44227387|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227388|NCT00519675|Alitretinoin|alitretinoin|mesh-list
44227389|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227390|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
44227391|NCT00519688|Thalidomide|thalidomide|mesh-list
44227392|NCT00519688|Tegafur|tegafur|mesh-list
44227393|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227394|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
44227395|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227396|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
44227397|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227398|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227399|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44227400|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44227401|NCT00519688|Growth Substances|growth substances|mesh-ancestor
44227402|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
44227403|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227404|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44227405|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
44227406|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227407|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
44227408|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227409|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
44227435|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44227436|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44227437|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44227438|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227439|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44227440|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227441|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227442|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227443|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
44227444|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
44227445|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44227446|NCT00519909|Calcium|calcium|mesh-list
44227447|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227448|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227449|NCT00519987|Ketamine|ketamine|mesh-list
44227450|NCT00519987|Analgesics|analgesics|mesh-ancestor
44227451|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
44227452|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227453|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227454|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44227455|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44227456|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
44227457|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
44227482|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44227483|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227484|NCT00520091|Celecoxib|celecoxib|mesh-list
44227485|NCT00520091|Cisplatin|cisplatin|mesh-list
44227486|NCT00520091|Irinotecan|irinotecan|mesh-list
44227487|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227488|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44227489|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44227490|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227491|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227492|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227493|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227494|NCT00520091|Analgesics|analgesics|mesh-ancestor
44227495|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
44227496|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227497|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227498|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227499|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227500|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44227501|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44227502|NCT00520104|Ketamine|ketamine|mesh-list
44227503|NCT00520104|Analgesics|analgesics|mesh-ancestor
44227504|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
44227505|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227506|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227507|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44227508|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44227509|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
44227510|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
44227511|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227512|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44227513|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44227514|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642852|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227515|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227516|NCT00520169|Ketamine|ketamine|mesh-list
44227517|NCT00520169|Analgesics|analgesics|mesh-ancestor
43764547|NCT02419118|Hormones|hormones|mesh-ancestor
44227518|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
44227519|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227520|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227521|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44227522|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44227523|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
44227524|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
44227525|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227526|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44227527|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44227528|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227529|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227530|NCT00520247|Folic Acid|folic acid|mesh-list
44227531|NCT00520247|Enalapril|enalapril|mesh-list
44227532|NCT00520247|Hematinics|hematinics|mesh-ancestor
44227533|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
44227534|NCT00520247|Vitamins|vitamins|mesh-ancestor
44227535|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
44227536|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227537|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44227538|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
44227539|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227540|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227541|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44227542|NCT00520260|Ketorolac|ketorolac|mesh-list
44227543|NCT00520260|Bromfenac|bromfenac|mesh-list
44227544|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227545|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227546|NCT00520260|Analgesics|analgesics|mesh-ancestor
44227547|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
44227548|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227549|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227550|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227551|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227552|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44227555|NCT00520325|Lectins|lectins|mesh-list
44227557|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
44227558|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227559|NCT00520325|Coagulants|coagulants|mesh-ancestor
44227560|NCT00520338|Celecoxib|celecoxib|mesh-list
44227561|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227562|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227563|NCT00520338|Analgesics|analgesics|mesh-ancestor
44227564|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
44227565|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227566|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227567|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227568|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227569|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44227570|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44227571|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227572|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227573|NCT00520442|Ibuprofen|ibuprofen|mesh-list
44227574|NCT00520442|Codeine|codeine|mesh-list
44227575|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44227576|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44227577|NCT00520442|Analgesics|analgesics|mesh-ancestor
44227578|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
44227579|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227580|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227581|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227582|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227583|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44227584|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227585|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227586|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44227587|NCT00520442|Narcotics|narcotics|mesh-ancestor
43881569|NCT04636918|Cyclosporine|cyclosporine|mesh-list
44227588|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227589|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
44227590|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
44164730|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
44164731|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227591|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
44227592|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44227593|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
44227594|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44227595|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227596|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44227597|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44227598|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44227599|NCT00520507|Olanzapine|olanzapine|mesh-list
44227600|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
44227601|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
44227602|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227603|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227604|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227605|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44227606|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44227607|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227608|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44227609|NCT00520507|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44227610|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44227611|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44227612|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227613|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227614|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
44227639|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44227640|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44227641|NCT00520754|Levocetirizine|levocetirizine|mesh-list
44227642|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44227643|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44227644|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
44227645|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
44227646|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227647|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642880|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
44227648|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227649|NCT00520806|Methocarbamol|methocarbamol|mesh-list
44227650|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44227651|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227652|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44227653|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227654|NCT00520819|Antioxidants|antioxidants|mesh-list
44227655|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227656|NCT00520819|Protective Agents|protective agents|mesh-ancestor
44227657|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227658|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
44227659|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43881646|NCT04635176|Dexamethasone|dexamethasone|mesh-list
44227660|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44227661|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
44227662|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227663|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44227664|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44227665|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227666|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227667|NCT00520949|Amoxicillin|amoxicillin|mesh-list
44227668|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
44227681|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44227682|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44227683|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44227684|NCT00520949|Renal Agents|renal agents|mesh-ancestor
44227685|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
44227686|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44227687|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44227688|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44457949|NCT01601626|Rifampin|rifampin|mesh-list
44457950|NCT01601626|Isoniazid|isoniazid|mesh-list
44457951|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
44457952|NCT01601626|Ethambutol|ethambutol|mesh-list
44457953|NCT01601626|Rifabutin|rifabutin|mesh-list
44457954|NCT01601626|Vitamins|vitamins|mesh-ancestor
44457955|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
44457956|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457957|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44457958|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44457959|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
44457960|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457961|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457962|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44457963|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44457964|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
44457965|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44457966|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44457967|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44457968|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
44457969|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44457970|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44457974|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
44457985|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44457986|NCT01601535|Irinotecan|irinotecan|mesh-list
44457987|NCT01601535|Temozolomide|temozolomide|mesh-list
44457988|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44457989|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44457990|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44457991|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44457992|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43881721|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
44457993|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44457994|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
44227689|NCT00521040|Levocetirizine|levocetirizine|mesh-list
44227690|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44227691|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44227692|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
44227693|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
44227694|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227695|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227696|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227697|NCT00521092|Sunitinib|sunitinib|mesh-list
44227698|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227699|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44227700|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44227701|NCT00521092|Growth Substances|growth substances|mesh-ancestor
44227702|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227703|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
44227704|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44227705|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227706|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227707|NCT00521131|Levocetirizine|levocetirizine|mesh-list
44227708|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44227709|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44227710|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
44227711|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
44227714|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227715|NCT00521157|Naltrexone|naltrexone|mesh-list
44227716|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44227717|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44227718|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227719|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
44227720|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227721|NCT00521170|Levocetirizine|levocetirizine|mesh-list
44227722|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44227723|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44227724|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
44227725|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
44227726|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227727|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227728|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227729|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
44227730|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
44227731|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227732|NCT00521248|Morphine|morphine|mesh-list
44227733|NCT00521248|Buprenorphine|buprenorphine|mesh-list
44227734|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44227735|NCT00521248|Narcotics|narcotics|mesh-ancestor
44227736|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227737|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227738|NCT00521248|Analgesics|analgesics|mesh-ancestor
44227764|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44227765|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
44227766|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44227767|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227768|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44227769|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
44227770|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227771|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227772|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
44227773|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227774|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44227775|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227776|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
44227777|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227778|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44227779|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
44227780|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227781|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44227782|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227783|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
44227784|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
44227785|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227786|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227787|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
44227788|NCT00521430|Hormones|hormones|mesh-ancestor
44227789|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44227790|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44227791|NCT00521430|Protective Agents|protective agents|mesh-ancestor
44227792|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
44227793|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44227794|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44227795|NCT00521482|Thalidomide|thalidomide|mesh-list
44227796|NCT00521482|Temozolomide|temozolomide|mesh-list
44227803|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227804|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
44227805|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44227806|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227807|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44227808|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44227809|NCT00521482|Growth Substances|growth substances|mesh-ancestor
44227810|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
44227812|NCT00521521|Docetaxel|docetaxel|mesh-list
44227813|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227814|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
44227815|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
44227816|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
44227817|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227818|NCT00521612|Sevoflurane|sevoflurane|mesh-list
44227819|NCT00521612|Isoflurane|isoflurane|mesh-list
44227820|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44227821|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44227822|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
44227823|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
44227824|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227825|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227826|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
44227827|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227828|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227829|NCT00521703|Lidocaine|lidocaine|mesh-list
44227830|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
44227831|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
44227832|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227833|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227834|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
44227835|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227836|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44227837|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44227838|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44227840|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227841|NCT00521742|Pioglitazone|pioglitazone|mesh-list
44227842|NCT00521742|Glyburide|glyburide|mesh-list
44227843|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227844|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227845|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44227846|NCT00521781|Leuprolide|leuprolide|mesh-list
44227847|NCT00521781|Bicalutamide|bicalutamide|mesh-list
44227848|NCT00521781|Androgens|androgens|mesh-list
44227849|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
44227850|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227851|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44227852|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
44227853|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44227854|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227855|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44227856|NCT00521781|Hormones|hormones|mesh-ancestor
44227857|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44227858|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
44227859|NCT00521820|Pioglitazone|pioglitazone|mesh-list
44227860|NCT00521820|Glyburide|glyburide|mesh-list
44227861|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227862|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227863|NCT00521859|Fludarabine|fludarabine|mesh-list
44227864|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
44227865|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227866|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44227867|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
44227868|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227869|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227870|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
44227871|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227872|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
43655650|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43655651|NCT02967276|Metformin|metformin|mesh-list
43655652|NCT02967276|Dexamethasone|dexamethasone|mesh-list
44227873|NCT00521950|Azathioprine|azathioprine|mesh-list
44227874|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
44227876|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44227880|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227881|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44227882|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227883|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227885|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
44227886|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227887|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227888|NCT00522015|Rivastigmine|rivastigmine|mesh-list
44227889|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44227890|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227891|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227892|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
44227893|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44227894|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227895|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44227896|NCT00522015|Protective Agents|protective agents|mesh-ancestor
44227897|NCT00522132|Artesunate|artesunate|mesh-list
44227898|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
44227899|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44227900|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44227901|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227902|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227903|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
44227904|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
44227905|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44227906|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
44227907|NCT00522158|Atorvastatin|atorvastatin|mesh-list
44227908|NCT00522158|Simvastatin|simvastatin|mesh-list
44227909|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44227910|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44227911|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
44227912|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227913|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44227914|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44227915|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227920|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
44227921|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227922|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227923|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44227924|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44227925|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44227926|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44227927|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
44227929|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
44227930|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227931|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643098|NCT05195918|Analgesics|analgesics|mesh-ancestor
44227932|NCT00522249|Interferons|interferons|mesh-list
44227933|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
44227934|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
44227935|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
44227936|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44227937|NCT00522249|Sunitinib|sunitinib|mesh-list
44227938|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227939|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
44227940|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227941|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44227942|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227943|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227944|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44227945|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44227946|NCT00522249|Growth Substances|growth substances|mesh-ancestor
44227947|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227948|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
44227949|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
44227950|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
44227951|NCT00522444|Analgesics|analgesics|mesh-ancestor
44227952|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
44227953|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227955|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
44227961|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227962|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44227963|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
44227964|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44227965|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
44227966|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44227967|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227968|NCT00522509|Floxuridine|floxuridine|mesh-list
44227969|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44227970|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
44227971|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227972|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44227973|NCT00522587|Remifentanil|remifentanil|mesh-list
44227974|NCT00522587|Sevoflurane|sevoflurane|mesh-list
44227975|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44227976|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44227977|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
44227978|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
44227979|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44227980|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44227981|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44227982|NCT00522587|Narcotics|narcotics|mesh-ancestor
44227983|NCT00522587|Analgesics|analgesics|mesh-ancestor
44227984|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
44227985|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44227986|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
44227987|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
44227988|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44227989|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
43881925|NCT04629885|Oxytocin|oxytocin|mesh-list
44227990|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44227991|NCT00522665|Irinotecan|irinotecan|mesh-list
44227992|NCT00522665|Cetuximab|cetuximab|mesh-list
44227993|NCT00522665|Everolimus|everolimus|mesh-list
44227994|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44227995|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44227996|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44227999|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228000|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228001|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
44228002|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44457995|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
44457996|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44457997|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
44457998|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44457999|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44458000|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458001|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458002|NCT01601470|Urological Agents|urological agents|mesh-ancestor
44458003|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44458004|NCT01601132|Colchicine|colchicine|mesh-list
44458005|NCT01601132|Theophylline|theophylline|mesh-list
44458006|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
44458007|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458008|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
44458009|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
44458010|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
44458011|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458012|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458013|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44458014|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
44458015|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458016|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458017|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44458018|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
44458019|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44458020|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458033|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458034|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458035|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
44458036|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44458037|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44458038|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44458039|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44458040|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458041|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
44458042|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458043|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458044|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44458045|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458046|NCT01600053|Lenalidomide|lenalidomide|mesh-list
44458047|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
44458048|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458049|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458050|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44458051|NCT01600053|Growth Substances|growth substances|mesh-ancestor
44458052|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
44458053|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458054|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
44458055|NCT01599806|Ceftazidime|ceftazidime|mesh-list
43882017|NCT04628325|Furosemide|furosemide|mesh-list
44228003|NCT00522743|Hormones|hormones|mesh-list
44228004|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228024|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
44228025|NCT00522782|Protective Agents|protective agents|mesh-ancestor
44228026|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
44228027|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
44228028|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44228029|NCT00522821|Antibodies|antibodies|mesh-list
44228030|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
44228031|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
44228032|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228033|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
44228034|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228035|NCT00522886|Cetuximab|cetuximab|mesh-list
44228036|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228037|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228038|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44228039|NCT00522938|Tosedostat|tosedostat|mesh-list
44228040|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228041|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44228042|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228043|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228044|NCT00523055|Lidocaine|lidocaine|mesh-list
44228045|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
44228046|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
44228047|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228048|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228049|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
44228050|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228051|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44228052|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44228053|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44228054|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44228055|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228056|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
44228057|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44228058|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44228059|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
44228061|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228062|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643180|NCT05180097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228063|NCT00523068|Urological Agents|urological agents|mesh-ancestor
44228064|NCT00523120|Diclofenac|diclofenac|mesh-list
44228065|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228066|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228067|NCT00523120|Analgesics|analgesics|mesh-ancestor
44228068|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
44228069|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228070|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228071|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228072|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228073|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44228074|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228075|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43882067|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
44228077|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
44228078|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
44228079|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228080|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
44228081|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228082|NCT00523159|Sargramostim|sargramostim|mesh-list
44228083|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
44228084|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228085|NCT00523185|Diazepam|diazepam|mesh-list
44228086|NCT00523185|Lorazepam|lorazepam|mesh-list
44228087|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
44228088|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
44228089|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
44228090|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228091|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228092|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228093|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44228094|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228095|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44228100|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228101|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228102|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44228103|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44228104|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44228105|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44228106|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
44228107|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
44228108|NCT00523263|Heparin|heparin|mesh-list
44228109|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
44228110|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44228111|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44228112|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228113|NCT00523289|Bupivacaine|bupivacaine|mesh-list
44228114|NCT00523289|Ropivacaine|ropivacaine|mesh-list
44228115|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
44228116|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
44228117|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228118|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228119|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
44228120|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228121|NCT00523354|Infliximab|infliximab|mesh-list
44228122|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228123|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228124|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228125|NCT00523380|Doxorubicin|doxorubicin|mesh-list
44228126|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44228127|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228133|NCT00523393|Insulin|insulin|mesh-list
44228147|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228148|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228149|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228150|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228151|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228152|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228153|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
44228154|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228155|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
44228156|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228157|NCT00523445|Varenicline|varenicline|mesh-list
44228158|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44228159|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44228160|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
44228161|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228162|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228163|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228164|NCT00523458|Efavirenz|efavirenz|mesh-list
44228165|NCT00523458|Nevirapine|nevirapine|mesh-list
44228166|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44228167|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228168|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228169|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228170|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
44228171|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228172|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44228173|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44228174|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44228175|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44228176|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44228177|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44228178|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44228179|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44228180|NCT00523666|Galantamine|galantamine|mesh-list
44228182|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228183|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228184|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
44228185|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228186|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228187|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
44228188|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
44228189|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228190|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
44228191|NCT00523692|Etanercept|etanercept|mesh-list
44228192|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44228193|NCT00523692|Methotrexate|methotrexate|mesh-list
44228194|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44228195|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
44228196|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44228197|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228198|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228199|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
44228200|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228201|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228202|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228203|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228204|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44228205|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228206|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
44228207|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228208|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228209|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228210|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228211|NCT00523692|Analgesics|analgesics|mesh-ancestor
44228227|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228228|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228229|NCT00523887|Analgesics|analgesics|mesh-ancestor
44228230|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
44228231|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228232|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44228233|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44228234|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
44228235|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
44228236|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
44228237|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44228238|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228239|NCT00523926|Bedaquiline|bedaquiline|mesh-list
44228240|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
44228241|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228242|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228243|NCT00523952|Tacrolimus|tacrolimus|mesh-list
44228244|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228245|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
44228246|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228247|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44228248|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643467|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228249|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228250|NCT00523965|Amphotericin B|amphotericin b|mesh-list
44228251|NCT00523965|Paromomycin|paromomycin|mesh-list
44228252|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
44228253|NCT00523965|Miltefosine|miltefosine|mesh-list
44228254|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
44228255|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
44228256|NCT00523965|Amebicides|amebicides|mesh-ancestor
44228257|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44228258|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44228259|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228271|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228272|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228273|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44228274|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44228275|NCT00524069|Growth Substances|growth substances|mesh-ancestor
44228276|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228277|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
44228278|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228279|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
44228280|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228281|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
44228282|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228283|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228284|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228285|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
44228286|NCT00524095|Fluticasone|fluticasone|mesh-list
44228287|NCT00524095|Xhance|xhance|mesh-list
44228288|NCT00524095|Azithromycin|azithromycin|mesh-list
44228289|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228290|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44228291|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
44228292|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228293|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228294|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44228295|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
44228296|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228297|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44228298|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228299|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228300|NCT00524160|Fentanyl|fentanyl|mesh-list
44228301|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44228302|NCT00524160|Narcotics|narcotics|mesh-ancestor
44228303|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458057|NCT01599806|Doripenem|doripenem|mesh-list
44228305|NCT00524160|Analgesics|analgesics|mesh-ancestor
44228311|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
44228313|NCT00524186|Fluorouracil|fluorouracil|mesh-list
44228314|NCT00524186|Irinotecan|irinotecan|mesh-list
44228315|NCT00524186|Sunitinib|sunitinib|mesh-list
44228316|NCT00524186|Calcium|calcium|mesh-list
44228317|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
44228318|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44228319|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228320|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
44228321|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228322|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228323|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228324|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228325|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
44228326|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44228327|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228328|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228329|NCT00524186|Antidotes|antidotes|mesh-ancestor
44228330|NCT00524186|Protective Agents|protective agents|mesh-ancestor
44228331|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
44228332|NCT00524186|Vitamins|vitamins|mesh-ancestor
44228333|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
44228334|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44228335|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44228336|NCT00524186|Growth Substances|growth substances|mesh-ancestor
44228337|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
44228338|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44228339|NCT00524199|Mesna|mesna|mesh-list
44228340|NCT00524199|Protective Agents|protective agents|mesh-ancestor
44228360|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
44228361|NCT00524407|Hematinics|hematinics|mesh-ancestor
44228363|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
44228364|NCT00524498|Cisplatin|cisplatin|mesh-list
44228365|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228366|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
44228367|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228368|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44228369|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228370|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228371|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228372|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
44228373|NCT00524615|Spironolactone|spironolactone|mesh-list
44228374|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44228375|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
44228376|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228377|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228378|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44228379|NCT00524615|Diuretics|diuretics|mesh-ancestor
44228380|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
44228381|NCT00524667|Fludarabine|fludarabine|mesh-list
44228382|NCT00524667|Valproic Acid|valproic acid|mesh-list
44228383|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228384|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228388|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
44458072|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
44458073|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458074|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458075|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458076|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458077|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44458078|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44228394|NCT00524693|Montelukast|montelukast|mesh-list
44228395|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44228396|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
44228397|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44228398|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
44228399|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228400|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228401|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44228402|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44228403|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228404|NCT00524706|Leucovorin|leucovorin|mesh-list
44228405|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
44228406|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228407|NCT00524706|Antidotes|antidotes|mesh-ancestor
44228408|NCT00524706|Protective Agents|protective agents|mesh-ancestor
44228409|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228410|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
44228411|NCT00524706|Vitamins|vitamins|mesh-ancestor
44228412|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
44228413|NCT00524810|Docetaxel|docetaxel|mesh-list
44228414|NCT00524810|Doxorubicin|doxorubicin|mesh-list
44228415|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44228416|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228417|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228418|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228419|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228420|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164732|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44164733|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164734|NCT00257634|Dexamethasone|dexamethasone|mesh-list
44164745|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164747|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
44164748|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228422|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228423|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228424|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228425|NCT00524836|Levocetirizine|levocetirizine|mesh-list
44228426|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44228427|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44228428|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
44228429|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
44228430|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228431|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228432|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228433|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
44228434|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44228435|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228436|NCT00524875|Bevacizumab|bevacizumab|mesh-list
44228437|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228438|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228439|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44228440|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44228441|NCT00524875|Growth Substances|growth substances|mesh-ancestor
44228442|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228443|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
44228444|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
44228445|NCT00524901|Hematinics|hematinics|mesh-ancestor
44228446|NCT00524914|Apomorphine|apomorphine|mesh-list
44228447|NCT00524914|Emetics|emetics|mesh-ancestor
44228448|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228449|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
44228450|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228451|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228452|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
44228463|NCT00524966|Coagulants|coagulants|mesh-ancestor
44228464|NCT00525005|Docetaxel|docetaxel|mesh-list
44228465|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
44228466|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228467|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228468|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228469|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
44458079|NCT01599754|Axitinib|axitinib|mesh-list
43643740|NCT04918186|Durvalumab|durvalumab|mesh-list
44228470|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228471|NCT00525096|Celecoxib|celecoxib|mesh-list
44228472|NCT00525096|Exemestane|exemestane|mesh-list
44228473|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228474|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228475|NCT00525096|Analgesics|analgesics|mesh-ancestor
44228476|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
44228477|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228478|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228479|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228480|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228481|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44228482|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44228483|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228484|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228485|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228486|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44228487|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44228488|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44228512|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228514|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44228515|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
44228516|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228517|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44228518|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44228519|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44228520|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228521|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44228522|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44228523|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44228524|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44228525|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44228526|NCT00525252|Baclofen|baclofen|mesh-list
44228527|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44228528|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228529|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44228530|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228531|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
44228532|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
44228533|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
44228534|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228535|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228536|NCT00525278|Levocetirizine|levocetirizine|mesh-list
44228537|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44228538|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44228539|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
44228552|NCT00525408|Docetaxel|docetaxel|mesh-list
44228553|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228554|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228555|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228556|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228557|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228558|NCT00525447|Dexamethasone|dexamethasone|mesh-list
44228559|NCT00525447|Lenalidomide|lenalidomide|mesh-list
44228560|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
44228561|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228562|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
44228563|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
44228564|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228565|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228566|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228567|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
44228568|NCT00525447|Hormones|hormones|mesh-ancestor
44228569|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228570|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44228571|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228572|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
44228573|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44228574|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44228575|NCT00525447|Growth Substances|growth substances|mesh-ancestor
44228576|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
44228577|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44228578|NCT00525473|Azathioprine|azathioprine|mesh-list
44228579|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
44228580|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228581|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228582|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228592|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228593|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
44228594|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
44228595|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44228597|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44228598|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
44228599|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228600|NCT00525551|Expectorants|expectorants|mesh-ancestor
44228601|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
44228602|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44228603|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
44228604|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228605|NCT00525551|Protective Agents|protective agents|mesh-ancestor
44228606|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228607|NCT00525551|Antidotes|antidotes|mesh-ancestor
44228608|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
44228609|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44228610|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
44228611|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228612|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228613|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44228614|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
43882618|NCT04621513|Montelukast|montelukast|mesh-list
44228615|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44228616|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44228618|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
44228619|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228620|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228621|NCT00525577|Probucol|probucol|mesh-list
44228622|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44228623|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44228634|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228636|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
44228637|NCT00525642|Docetaxel|docetaxel|mesh-list
44228638|NCT00525642|Doxorubicin|doxorubicin|mesh-list
44228639|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44228640|NCT00525642|Epirubicin|epirubicin|mesh-list
44228641|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228642|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
44228643|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228644|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228645|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228646|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
44228647|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228648|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228649|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228650|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228651|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228652|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228653|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228654|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228655|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228656|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228657|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
44228658|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
44228659|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228660|NCT00525668|Protective Agents|protective agents|mesh-ancestor
44228661|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228662|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
44228663|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44228664|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228665|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44228666|NCT00525681|Cyclosporine|cyclosporine|mesh-list
44228667|NCT00525681|Tacrolimus|tacrolimus|mesh-list
44228668|NCT00525681|Cyclosporins|cyclosporins|mesh-list
44228675|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
44228676|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228677|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228678|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228679|NCT00525694|Cocaine|cocaine|mesh-list
44228680|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
44228681|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
44228682|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228683|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228684|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
44228685|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228686|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44228687|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44228688|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44228689|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44228690|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228692|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228693|NCT00525707|Tezosentan|tezosentan|mesh-list
44228694|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
44228695|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
44228696|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
44228697|NCT00525759|Docetaxel|docetaxel|mesh-list
44228698|NCT00525759|Fluorouracil|fluorouracil|mesh-list
44228699|NCT00525759|Epirubicin|epirubicin|mesh-list
44228700|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228701|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
44228702|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228703|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228704|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228705|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
44228706|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228707|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228708|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228709|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228710|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228716|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228717|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228718|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44228719|NCT00525772|Ciclesonide|ciclesonide|mesh-list
44228720|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
44228721|NCT00525772|Hormones|hormones|mesh-ancestor
44228722|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228723|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228724|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44228725|NCT00525889|Sirolimus|sirolimus|mesh-list
44228726|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228727|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228728|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228729|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228730|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
44228731|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228732|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
44228733|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228734|NCT00525928|Varenicline|varenicline|mesh-list
44228735|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44228736|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44228737|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
44228738|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44228739|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228740|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228741|NCT00525967|Acetaminophen|acetaminophen|mesh-list
44228765|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228766|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228768|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44228769|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44228770|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44228771|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228772|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228773|NCT00526175|Cytarabine|cytarabine|mesh-list
44228774|NCT00526175|Prednisone|prednisone|mesh-list
44228775|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
44228776|NCT00526175|Methotrexate|methotrexate|mesh-list
44228777|NCT00526175|Vincristine|vincristine|mesh-list
44228778|NCT00526175|Daunorubicin|daunorubicin|mesh-list
44228779|NCT00526175|Asparaginase|asparaginase|mesh-list
44228780|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
44228781|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228782|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
44228783|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228784|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228785|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228786|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
44228787|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228788|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228789|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228790|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228791|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
44228814|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44228815|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44228816|NCT00526214|Analgesics|analgesics|mesh-ancestor
44228817|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
44228818|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44228819|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228820|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228821|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821899|NCT03172975|Antacids|antacids|mesh-ancestor
44228822|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44228823|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44228824|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228825|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228826|NCT00526305|Cytarabine|cytarabine|mesh-list
44228827|NCT00526305|Dexamethasone|dexamethasone|mesh-list
44228828|NCT00526305|Prednisone|prednisone|mesh-list
44228829|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
44228830|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
44228831|NCT00526305|Vincristine|vincristine|mesh-list
44228832|NCT00526305|Daunorubicin|daunorubicin|mesh-list
44228833|NCT00526305|Asparaginase|asparaginase|mesh-list
44228834|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
44228835|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
44228836|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228837|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
44228838|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228839|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228840|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228841|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
44458081|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44228842|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228843|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228844|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228845|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228846|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
44228847|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
44228854|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44228855|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228856|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228857|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228858|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228859|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
44228860|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
44228861|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228862|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228863|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228864|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228865|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228866|NCT00526305|Analgesics|analgesics|mesh-ancestor
44228867|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
44228868|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228869|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
44228870|NCT00526318|Melphalan|melphalan|mesh-list
44228871|NCT00526318|Ifosfamide|ifosfamide|mesh-list
44228872|NCT00526318|Dacarbazine|dacarbazine|mesh-list
44228873|NCT00526318|Carboplatin|carboplatin|mesh-list
44228874|NCT00526318|Doxorubicin|doxorubicin|mesh-list
44228875|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44228876|NCT00526318|Etoposide|etoposide|mesh-list
44228877|NCT00526318|Vincristine|vincristine|mesh-list
44228878|NCT00526318|Topotecan|topotecan|mesh-list
44228879|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
44228880|NCT00526318|Vindesine|vindesine|mesh-list
44228881|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
44228882|NCT00526318|Isotretinoin|isotretinoin|mesh-list
44228883|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228884|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
44228885|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228886|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228887|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228888|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
44228889|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228890|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228891|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44164749|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44228894|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228895|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228896|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44228897|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228898|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228899|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228900|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44228901|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228902|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
44228903|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
44228904|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
44228905|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44228906|NCT00526396|Cisplatin|cisplatin|mesh-list
44228907|NCT00526396|Etoposide|etoposide|mesh-list
44228908|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
44228909|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228910|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44228911|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228912|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228913|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228914|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228915|NCT00526409|Cytarabine|cytarabine|mesh-list
44228916|NCT00526409|Prednisolone|prednisolone|mesh-list
44228917|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
44228918|NCT00526409|Methotrexate|methotrexate|mesh-list
44228919|NCT00526409|Vincristine|vincristine|mesh-list
44228920|NCT00526409|Daunorubicin|daunorubicin|mesh-list
44228921|NCT00526409|Asparaginase|asparaginase|mesh-list
44228922|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228923|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
44228924|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228925|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44228926|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228927|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
44228929|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228936|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
44228937|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228938|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44228939|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44228940|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44228941|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
44228942|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
44228943|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
44228944|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44228945|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
44228946|NCT00526409|Hormones|hormones|mesh-ancestor
44228947|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44228948|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44228949|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
44228950|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228951|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44228952|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44228953|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44228954|NCT00526448|Ribavirin|ribavirin|mesh-list
44228955|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44228956|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
44228957|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228958|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
44228959|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228960|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
44228961|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44228962|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458082|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458083|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458084|NCT01599650|Ranibizumab|ranibizumab|mesh-list
44458085|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44458086|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44458087|NCT01599650|Growth Substances|growth substances|mesh-ancestor
44458088|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458089|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
44458094|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458095|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458096|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458097|NCT01599234|Nabiximols|nabiximols|mesh-list
44458098|NCT01599234|Analgesics|analgesics|mesh-ancestor
44458099|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
44458100|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458101|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458102|NCT01599104|Olmesartan|olmesartan|mesh-list
44458103|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44458104|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44458105|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44458106|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44458107|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458108|NCT01598987|Cyclosporine|cyclosporine|mesh-list
44458109|NCT01598987|Everolimus|everolimus|mesh-list
44458110|NCT01598987|Tacrolimus|tacrolimus|mesh-list
44458111|NCT01598987|Cyclosporins|cyclosporins|mesh-list
44458112|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43882918|NCT04618328|Tretinoin|tretinoin|mesh-list
44228963|NCT00526617|Temozolomide|temozolomide|mesh-list
44228964|NCT00526617|Veliparib|veliparib|mesh-list
44228965|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228966|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
44228967|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228968|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228969|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44228970|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228971|NCT00526643|Gemcitabine|gemcitabine|mesh-list
44228972|NCT00526643|Cisplatin|cisplatin|mesh-list
44228973|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228974|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44228975|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
44228976|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228977|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
44164750|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44164751|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44228978|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44228979|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44228980|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228981|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
44228982|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228983|NCT00526695|Sevoflurane|sevoflurane|mesh-list
44228984|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44228985|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44228986|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
44228987|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
44228988|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44228989|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228990|NCT00526734|Melphalan|melphalan|mesh-list
44228991|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
44228992|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44228993|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44228994|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
44228995|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44228996|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44228997|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44228998|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44228999|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
44229000|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44229001|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229002|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229003|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229004|NCT00526760|Analgesics|analgesics|mesh-ancestor
44229005|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
44229006|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229007|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44229008|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44229018|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229019|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44229020|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44229021|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229022|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229023|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44229024|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
44229025|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
44229026|NCT00526929|Hematinics|hematinics|mesh-ancestor
44229027|NCT00527020|Nicotine|nicotine|mesh-list
44229028|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44229029|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
44229030|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229031|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229032|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44229033|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44229034|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
44229035|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43882995|NCT04617171|Benralizumab|benralizumab|mesh-list
44458113|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
44229036|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229037|NCT00527033|Mirabegron|mirabegron|mesh-list
44229038|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
44229039|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44229040|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44229041|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
44229042|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229043|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229044|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229045|NCT00527033|Urological Agents|urological agents|mesh-ancestor
44229046|NCT00527059|Simendan|simendan|mesh-list
44229047|NCT00527059|Spironolactone|spironolactone|mesh-list
44229048|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
44229050|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
44229057|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
44229058|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229059|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229060|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44229061|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
44229062|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
44229063|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44229064|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229065|NCT00527059|Protective Agents|protective agents|mesh-ancestor
44229066|NCT00527085|Cinacalcet|cinacalcet|mesh-list
44229067|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44229068|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229069|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44229070|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
44229071|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229072|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
44229073|NCT00527137|Hematinics|hematinics|mesh-ancestor
44229074|NCT00527150|Varenicline|varenicline|mesh-list
44229075|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44229076|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44229077|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
44229078|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229079|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229080|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229081|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
44229082|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44229083|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44229084|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44229102|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
44229103|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
44229104|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229105|NCT00527449|Carboplatin|carboplatin|mesh-list
44229106|NCT00527449|Docetaxel|docetaxel|mesh-list
44229107|NCT00527449|Epirubicin|epirubicin|mesh-list
44229108|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229109|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
44229110|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
44229111|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
44229112|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229113|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44229114|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44229115|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44229116|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229117|NCT00527501|Travoprost|travoprost|mesh-list
44229118|NCT00527501|Brinzolamide|brinzolamide|mesh-list
44229119|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44229120|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44229121|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229122|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229123|NCT00527540|Interferons|interferons|mesh-list
44229124|NCT00527540|Ribavirin|ribavirin|mesh-list
44229125|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
44229126|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
44229127|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44229128|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229129|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
44229130|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229131|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
44229132|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229133|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
44229134|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229135|NCT00527657|Thalidomide|thalidomide|mesh-list
44229136|NCT00527657|Temozolomide|temozolomide|mesh-list
44229137|NCT00527657|Lomustine|lomustine|mesh-list
44229141|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229142|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823893|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
44229143|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
44229144|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229145|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
44229146|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229147|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229148|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229149|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229150|NCT00527657|Growth Substances|growth substances|mesh-ancestor
44229151|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229153|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
44229154|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229155|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229156|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
44229157|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229158|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229159|NCT00527761|Cisplatin|cisplatin|mesh-list
44229160|NCT00527761|Docetaxel|docetaxel|mesh-list
44229161|NCT00527761|Temozolomide|temozolomide|mesh-list
44229162|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229163|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
44229164|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
44229165|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
44229166|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229167|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44229168|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
44229169|NCT00527800|Lumefantrine|lumefantrine|mesh-list
44229170|NCT00527800|Artemether|artemether|mesh-list
44229171|NCT00527800|Piperaquine|piperaquine|mesh-list
44229172|NCT00527800|Trimethoprim|trimethoprim|mesh-list
44229173|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44229174|NCT00527800|Artenimol|artenimol|mesh-list
44229175|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44229176|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
44229177|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
44229178|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44229180|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229181|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44229182|NCT00527800|Renal Agents|renal agents|mesh-ancestor
44229183|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44229184|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229185|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229186|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44229187|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44229188|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44229189|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229191|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229192|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
44229193|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
44229194|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44229195|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44229196|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229197|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229198|NCT00527995|Urological Agents|urological agents|mesh-ancestor
44229199|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
44229200|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44229201|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
44229202|NCT00528008|Povidone|povidone|mesh-list
44229203|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44229204|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229205|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
44229206|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
44229207|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
44229209|NCT00528060|Ritonavir|ritonavir|mesh-list
44229227|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229228|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229229|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44229230|NCT00528151|Curcumin|curcumin|mesh-list
44229231|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229232|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229233|NCT00528151|Analgesics|analgesics|mesh-ancestor
44229234|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
43644020|NCT04785287|Antibodies|antibodies|mesh-list
44229235|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229236|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229237|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229238|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229239|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229240|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229241|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229242|NCT00528177|Morphine|morphine|mesh-list
44229243|NCT00528177|Oxycodone|oxycodone|mesh-list
44229244|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44229245|NCT00528177|Narcotics|narcotics|mesh-ancestor
44229246|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229247|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229248|NCT00528177|Analgesics|analgesics|mesh-ancestor
44229249|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
44229250|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229251|NCT00528216|Capsaicin|capsaicin|mesh-list
44229252|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
44229253|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
44229254|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
44229255|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229275|NCT00528359|Aripiprazole|aripiprazole|mesh-list
44229276|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44229277|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44229278|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
44229279|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229280|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229281|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229282|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44229283|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44229284|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229285|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229286|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44229287|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
44229288|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
44229289|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
44229290|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229291|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44229292|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44229293|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44229294|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229295|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
44229296|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
44229297|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44229298|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44229299|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44229300|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44229301|NCT00528385|Spironolactone|spironolactone|mesh-list
44229302|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44229303|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
44229304|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229305|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229306|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
44458120|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458121|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458122|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458123|NCT01598896|Clonidine|clonidine|mesh-list
44458124|NCT01598896|Dronabinol|dronabinol|mesh-list
44458125|NCT01598896|Analgesics|analgesics|mesh-ancestor
44458126|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
44458127|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458128|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458129|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44458130|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
44458131|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
44458132|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44458133|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44458134|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44458135|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
44458136|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458137|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458138|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
44458139|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458140|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44458141|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44229309|NCT00528502|Lidocaine|lidocaine|mesh-list
44229310|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
44229311|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
44229312|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229313|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229314|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
44229315|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229316|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44229317|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44229328|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
44229329|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44229330|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
44229331|NCT00528593|Hematinics|hematinics|mesh-ancestor
44229333|NCT00528619|Carboplatin|carboplatin|mesh-list
44229334|NCT00528619|Pemetrexed|pemetrexed|mesh-list
44229335|NCT00528619|Sunitinib|sunitinib|mesh-list
44229336|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229337|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229338|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229339|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44229340|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44229341|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229342|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229343|NCT00528619|Growth Substances|growth substances|mesh-ancestor
44229344|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229345|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229346|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44229347|NCT00528658|Acetaminophen|acetaminophen|mesh-list
44229348|NCT00528658|Ibuprofen|ibuprofen|mesh-list
44229349|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229350|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229351|NCT00528658|Analgesics|analgesics|mesh-ancestor
44229352|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
44229353|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229354|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229355|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229356|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229357|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44229374|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44229375|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
44229376|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229377|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229378|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
44229379|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44229380|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229381|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
44229382|NCT00528827|Nicardipine|nicardipine|mesh-list
44229383|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44229384|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44229385|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229386|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229387|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44229388|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229389|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
44229390|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
44229391|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229392|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229393|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
44229394|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229395|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
44229396|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44229424|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229425|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
44229426|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44229427|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229428|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44229429|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
44229430|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229431|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229432|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229433|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229434|NCT00529295|Misoprostol|misoprostol|mesh-list
44229435|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44229436|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
44229437|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44229438|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229439|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44229440|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44229441|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
44229442|NCT00529360|Clofarabine|clofarabine|mesh-list
44229443|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229444|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
44229445|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229446|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229447|NCT00529425|Ropivacaine|ropivacaine|mesh-list
44229448|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
44229449|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
44229450|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229451|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229452|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
44229453|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229454|NCT00529594|Etoricoxib|etoricoxib|mesh-list
44229455|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229456|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229457|NCT00529594|Analgesics|analgesics|mesh-ancestor
44229458|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
44229462|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229463|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44229464|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44229465|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229466|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229467|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
44229468|NCT00529620|Piperaquine|piperaquine|mesh-list
44229469|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
44229470|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44229471|NCT00529620|Amodiaquine|amodiaquine|mesh-list
44229472|NCT00529620|Artenimol|artenimol|mesh-list
44229473|NCT00529620|Sulfalene|sulfalene|mesh-list
44229474|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
44229475|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44229476|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44229477|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229478|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44229479|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229480|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229481|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44229482|NCT00529620|Renal Agents|renal agents|mesh-ancestor
44229483|NCT00529646|APD791|apd791|mesh-list
44229484|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44229485|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44229486|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
44229487|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229488|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229489|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229490|NCT00529750|Atenolol|atenolol|mesh-list
44229491|NCT00529750|Irbesartan|irbesartan|mesh-list
44229492|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44229493|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43640844|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44229494|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44229495|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229502|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44229503|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44229504|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
44229505|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229507|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44229508|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229509|NCT00529867|Lumefantrine|lumefantrine|mesh-list
44229510|NCT00529867|Artemether|artemether|mesh-list
44229511|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
44229512|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
44229513|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44229514|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44229515|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229516|NCT00529880|Cytarabine|cytarabine|mesh-list
44229517|NCT00529880|Fludarabine|fludarabine|mesh-list
44229518|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229519|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229520|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
44229521|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229522|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229523|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
44229524|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229525|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
44229526|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229527|NCT00530101|Doxorubicin|doxorubicin|mesh-list
44229528|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44229529|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229530|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44229531|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44229532|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229533|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43883455|NCT04611776|Carboplatin|carboplatin|mesh-list
44229534|NCT00530127|Deferiprone|deferiprone|mesh-list
44229535|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44229536|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
44229540|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
44229541|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229542|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44229543|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
44229544|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229545|NCT00530387|Ibuprofen|ibuprofen|mesh-list
44229546|NCT00530387|Diclofenac|diclofenac|mesh-list
44229547|NCT00530387|Ketoprofen|ketoprofen|mesh-list
44229548|NCT00530387|Piroxicam|piroxicam|mesh-list
44229549|NCT00530387|Salicylates|salicylates|mesh-list
44229550|NCT00530387|Etofenamate|etofenamate|mesh-list
44229551|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
44229552|NCT00530387|Homosalate|homosalate|mesh-list
44229553|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
44229554|NCT00530387|Benzophenone|benzophenone|mesh-list
44229555|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229556|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229557|NCT00530387|Analgesics|analgesics|mesh-ancestor
44229558|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
44229559|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229560|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229561|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229562|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229563|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44229564|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229565|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229566|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
44229567|NCT00530387|Protective Agents|protective agents|mesh-ancestor
44229568|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
44229569|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44229570|NCT00530400|Cefuroxime|cefuroxime|mesh-list
44229571|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
44229572|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229573|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229574|NCT00530413|Phenobarbital|phenobarbital|mesh-list
44229575|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
44229582|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229583|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
44229584|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
44229585|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44229586|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44229587|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44229589|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44229590|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229591|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229592|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
44229593|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229594|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229595|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
44229596|NCT00530556|Zolpidem|zolpidem|mesh-list
44229597|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44229598|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44229599|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229600|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229601|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
44229602|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
44229603|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
44229604|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229605|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229606|NCT00530582|Progesterone|progesterone|mesh-list
44229607|NCT00530582|Progestins|progestins|mesh-ancestor
44229608|NCT00530582|Hormones|hormones|mesh-ancestor
44229609|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229610|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229612|NCT00530595|Valsartan|valsartan|mesh-list
44229613|NCT00530595|Candesartan|candesartan|mesh-list
44229614|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44229615|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44458144|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458145|NCT01598753|Tramadol|tramadol|mesh-list
44458146|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44458147|NCT01598753|Narcotics|narcotics|mesh-ancestor
44458148|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458149|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458150|NCT01598753|Analgesics|analgesics|mesh-ancestor
44458151|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
44458152|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458153|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
44458154|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44458155|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
44458156|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44458157|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458158|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44458159|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44458160|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44458161|NCT01598506|Hydromorphone|hydromorphone|mesh-list
44458162|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44458163|NCT01598506|Narcotics|narcotics|mesh-ancestor
44458164|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43644101|NCT04745988|Lenvatinib|lenvatinib|mesh-list
44458165|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458166|NCT01598506|Analgesics|analgesics|mesh-ancestor
44458167|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
44458168|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458169|NCT01598311|Vancomycin|vancomycin|mesh-list
44458170|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458171|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458172|NCT01598090|Ribavirin|ribavirin|mesh-list
44458173|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44458174|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
44458189|NCT01597622|Belimumab|belimumab|mesh-list
44458190|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458191|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
44458192|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458193|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
44458194|NCT01597557|Analgesics|analgesics|mesh-ancestor
44458195|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
44458196|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458197|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458198|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
44458199|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458200|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44458201|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
44458202|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44458203|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44458204|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458205|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44458206|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
44458207|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44458208|NCT01597505|Vancomycin|vancomycin|mesh-list
44458209|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229619|NCT00530868|Bevacizumab|bevacizumab|mesh-list
44229620|NCT00530868|Letrozole|letrozole|mesh-list
44229621|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229622|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229623|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229646|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229647|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
44229648|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229649|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
44229650|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44229651|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229652|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229653|NCT00530972|Ribavirin|ribavirin|mesh-list
43644109|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
43644110|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644111|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644112|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
43644113|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644114|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43644116|NCT04745988|Antidotes|antidotes|mesh-ancestor
44229654|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44229655|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
44229656|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229657|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
44229658|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229659|NCT00531024|Bevacizumab|bevacizumab|mesh-list
44229660|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229661|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229662|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229663|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229664|NCT00531024|Growth Substances|growth substances|mesh-ancestor
44229665|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229666|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229667|NCT00531063|Everolimus|everolimus|mesh-list
44229668|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229669|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229670|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
44229671|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229672|NCT00531076|Bevacizumab|bevacizumab|mesh-list
44229673|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229674|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229675|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229676|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229677|NCT00531076|Growth Substances|growth substances|mesh-ancestor
44229678|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229680|NCT00531089|Rituximab|rituximab|mesh-list
44229687|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229688|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229689|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
44229690|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44229691|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
44229692|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229693|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44229695|NCT00531167|Adefovir|adefovir|mesh-list
44229696|NCT00531167|Entecavir|entecavir|mesh-list
44229697|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44229698|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44229699|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229700|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229701|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
44229702|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229703|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229704|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229705|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
44229706|NCT00531193|SCH 442416|sch 442416|mesh-list
44229707|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
44229708|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
44229709|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
44229710|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
44229711|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229712|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229713|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229714|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
44229715|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229716|NCT00531271|Docetaxel|docetaxel|mesh-list
44229717|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229718|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
44229726|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229728|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229729|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
44229730|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44229731|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44229732|NCT00531323|Etravirine|etravirine|mesh-list
44229733|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44229734|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823137|NCT05528146|Psyllium|psyllium|mesh-list
44229735|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229736|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229737|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
44229738|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229739|NCT00531336|Bevacizumab|bevacizumab|mesh-list
44229740|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44229741|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229742|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229743|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229744|NCT00531336|Growth Substances|growth substances|mesh-ancestor
44229745|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229746|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229747|NCT00531349|Propofol|propofol|mesh-list
44229748|NCT00531349|Sevoflurane|sevoflurane|mesh-list
44229749|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
44229750|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44229757|NCT00531362|Aspirin|aspirin|mesh-list
44229774|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229775|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229776|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229778|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229779|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229780|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
44229781|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229782|NCT00531466|Tolperisone|tolperisone|mesh-list
44229783|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44229784|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229785|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44229786|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229787|NCT00531544|Sunitinib|sunitinib|mesh-list
44229788|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229789|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229790|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229791|NCT00531544|Growth Substances|growth substances|mesh-ancestor
44229792|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229793|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229794|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44229795|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229797|NCT00531557|Ritonavir|ritonavir|mesh-list
44229825|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
44229826|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44229827|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229829|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229830|NCT00531674|Tocopherols|tocopherols|mesh-list
44229831|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
44229832|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229833|NCT00531674|Protective Agents|protective agents|mesh-ancestor
44229834|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229835|NCT00531674|Vitamins|vitamins|mesh-ancestor
44229836|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
44229837|NCT00531687|Gemcitabine|gemcitabine|mesh-list
44229838|NCT00531687|Paclitaxel|paclitaxel|mesh-list
44229839|NCT00531687|Cisplatin|cisplatin|mesh-list
44229840|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44229841|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229842|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
44229844|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
44229845|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229846|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44229847|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
44229848|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
44229849|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229850|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229851|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44229852|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
44229853|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229854|NCT00531791|Prednisone|prednisone|mesh-list
44229855|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229856|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
44229857|NCT00531791|Hormones|hormones|mesh-ancestor
44229858|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44229859|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229860|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44229861|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229862|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
44229864|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229865|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
44229866|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229867|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229868|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44229869|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44229870|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44229871|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229872|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229873|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44229874|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229875|NCT00531895|Analgesics|analgesics|mesh-ancestor
44229876|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
44229877|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229878|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
44229879|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229880|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
44229882|NCT00531908|Diuretics|diuretics|mesh-ancestor
44229883|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
44229884|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229885|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
44229886|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44229887|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229888|NCT00531973|Doxorubicin|doxorubicin|mesh-list
44229889|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44229890|NCT00531973|Epirubicin|epirubicin|mesh-list
44229891|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44229892|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229893|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44229894|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44229895|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229896|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229897|NCT00531986|Lopinavir|lopinavir|mesh-list
44229900|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
44229901|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229902|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229903|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229904|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229905|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
44229906|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229907|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44229908|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44229909|NCT00531999|Ritonavir|ritonavir|mesh-list
44229910|NCT00531999|Lopinavir|lopinavir|mesh-list
44229911|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
44229912|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44229913|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44229914|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
44229915|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229916|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229917|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44229918|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44229919|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
44229920|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44229921|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44229925|NCT05319912|Molybdenum|molybdenum|mesh-list
44229955|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229956|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229957|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
44229958|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44229959|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
44229960|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44229961|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
44229962|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
44229963|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
44229964|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44229965|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44229966|NCT05319899|Growth Substances|growth substances|mesh-ancestor
44229967|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229968|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
44229969|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44229970|NCT05319834|Aspirin|aspirin|mesh-list
44229971|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44229972|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44229973|NCT05319834|Analgesics|analgesics|mesh-ancestor
44229974|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
44229975|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44229976|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44229977|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44229978|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44229979|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44229980|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44229981|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44229982|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44229983|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44229984|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44229985|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
44229986|NCT05319756|Oxycodone|oxycodone|mesh-list
44229987|NCT05319756|Gabapentin|gabapentin|mesh-list
44229995|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
44229996|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44229997|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44229998|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44229999|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44230000|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44230001|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230002|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230003|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
44230004|NCT05319340|Anticoagulants|anticoagulants|mesh-list
44230005|NCT05319301|Melatonin|melatonin|mesh-list
44230006|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
44230007|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655720|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655721|NCT02967029|Analgesics|analgesics|mesh-ancestor
43655722|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
44230008|NCT05319301|Protective Agents|protective agents|mesh-ancestor
44230009|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230010|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458210|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458211|NCT01597492|Belimumab|belimumab|mesh-list
44458212|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458213|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
44458214|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458215|NCT01597479|Anesthetics|anesthetics|mesh-list
44458216|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
44458217|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
44458218|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458219|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458220|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
44458221|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458222|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
44458223|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44458224|NCT01597258|Crizotinib|crizotinib|mesh-list
44458237|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44458238|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458239|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44458240|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458241|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
44458242|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458243|NCT01597193|Fulvestrant|fulvestrant|mesh-list
44458244|NCT01597193|Anastrozole|anastrozole|mesh-list
44458245|NCT01597193|Exemestane|exemestane|mesh-list
44458246|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44458247|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458248|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44458249|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44458250|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
44458251|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458252|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458253|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44458254|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44458255|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458256|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458257|NCT01596504|Metformin|metformin|mesh-list
44458258|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
44458259|NCT01596504|Liraglutide|liraglutide|mesh-list
44458260|NCT01596504|Lixisenatide|lixisenatide|mesh-list
44458261|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458262|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458263|NCT01596504|Incretins|incretins|mesh-ancestor
44458264|NCT01596504|Hormones|hormones|mesh-ancestor
44230029|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44230030|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
44230031|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230032|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230033|NCT05317767|Vaccines|vaccines|mesh-list
44230034|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
44230035|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230036|NCT05317676|Palmidrol|palmidrol|mesh-list
44230037|NCT05317676|Analgesics|analgesics|mesh-ancestor
44230038|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
44230039|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230040|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230041|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44230042|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230043|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230044|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230045|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
44230046|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230047|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
44230048|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
44230049|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230050|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230051|NCT05317676|Hormones|hormones|mesh-ancestor
44230052|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230053|NCT05317611|Ondansetron|ondansetron|mesh-list
44230054|NCT05317611|Bupivacaine|bupivacaine|mesh-list
44230055|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
44230056|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
44230057|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230058|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230070|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44230071|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44230072|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230073|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44230074|NCT05317572|Morphine|morphine|mesh-list
44230075|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44230076|NCT05317572|Narcotics|narcotics|mesh-ancestor
44230077|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230078|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230079|NCT05317572|Analgesics|analgesics|mesh-ancestor
44230080|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
44230081|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230082|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
44230083|NCT05302388|Promethazine|promethazine|mesh-list
44230084|NCT05302388|Dexamethasone|dexamethasone|mesh-list
44230085|NCT05302388|Prednisolone|prednisolone|mesh-list
44230086|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
44230087|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
44230088|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
44230089|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
44230090|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
44230091|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
44230092|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230093|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
44230094|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
44230095|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230096|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230097|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230098|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
44230100|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230101|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230102|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230103|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44230104|NCT05302388|Protective Agents|protective agents|mesh-ancestor
44230105|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
44230106|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44230111|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44230112|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
44230113|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
44230114|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230115|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230116|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44230117|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
44230118|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
44230119|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
44230120|NCT05273671|Nalbuphine|nalbuphine|mesh-list
44230121|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44230122|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230123|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230124|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230125|NCT05273671|Analgesics|analgesics|mesh-ancestor
44230126|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
44230127|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230128|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44230129|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44230130|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44230131|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
44230132|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230133|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230134|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44230135|NCT05273671|Narcotics|narcotics|mesh-ancestor
44230136|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
44230137|NCT05238233|Pilocarpine|pilocarpine|mesh-list
44230138|NCT05238233|Tropicamide|tropicamide|mesh-list
44230139|NCT05238233|Miotics|miotics|mesh-ancestor
44230140|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
44230141|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230142|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230143|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
44230144|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44230145|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
44230146|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230148|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
44230150|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44230151|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
44230152|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
44230153|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655832|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655833|NCT02966704|Caseins|caseins|mesh-list
43655834|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
43655835|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
44230154|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
44230155|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
44230156|NCT05220722|Nivolumab|nivolumab|mesh-list
44230157|NCT05220722|Ipilimumab|ipilimumab|mesh-list
44230158|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230159|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230160|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44230161|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43884137|NCT04602143|Hormones|hormones|mesh-ancestor
44230162|NCT05165212|Amoxicillin|amoxicillin|mesh-list
44230163|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230164|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230165|NCT05108454|Micronutrients|micronutrients|mesh-list
44230166|NCT05108454|Trace Elements|trace elements|mesh-list
44230167|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230168|NCT05096702|Primaquine|primaquine|mesh-list
44230169|NCT05096702|Tafenoquine|tafenoquine|mesh-list
44230170|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
44230171|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44230172|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44230173|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230174|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44230175|NCT05085808|Trazodone|trazodone|mesh-list
44230176|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
44230177|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230178|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44230179|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44230180|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230181|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230182|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44230183|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43766934|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164752|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164753|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164754|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164755|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164757|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44230184|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44230185|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44230186|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230187|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230188|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
44230189|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44230190|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
44230191|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44230192|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
44230193|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230194|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
44230195|NCT05085067|Protective Agents|protective agents|mesh-ancestor
44230197|NCT05061654|Ceftolozane|ceftolozane|mesh-list
44230198|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
44230199|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230200|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230201|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44230202|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230203|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230204|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43850130|NCT05701917|Calcium heparin|calcium heparin|mesh-list
43850131|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
43850132|NCT05701917|Apixaban|apixaban|mesh-list
43850133|NCT05701917|Warfarin|warfarin|mesh-list
43850134|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
43850135|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43850147|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641573|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641579|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
44230205|NCT05061654|Renal Agents|renal agents|mesh-ancestor
44458300|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44458301|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230206|NCT05035316|Aspirin|aspirin|mesh-list
44230207|NCT05035316|Calcium|calcium|mesh-list
44230208|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230209|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230210|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44230211|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230212|NCT05035316|Analgesics|analgesics|mesh-ancestor
44230213|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
44230214|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230215|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230216|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230217|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44230218|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44230219|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230220|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44230221|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44230222|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230223|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
44230224|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
44230225|NCT05034536|Infliximab|infliximab|mesh-list
44230226|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230227|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230228|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
44230229|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230230|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230251|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230252|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230253|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230254|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44230255|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
44230256|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230257|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
44230258|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230259|NCT04974684|Apixaban|apixaban|mesh-list
44230260|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44230261|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
44230262|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44230263|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
44230264|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230265|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230266|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
44230267|NCT04836910|Metformin|metformin|mesh-list
44230268|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
44230269|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
44230270|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
44230271|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44230272|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230273|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44230274|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44230275|NCT04817033|Midazolam|midazolam|mesh-list
44230276|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
44230277|NCT04817033|Anesthetics|anesthetics|mesh-list
44230278|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230279|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230280|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44230281|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230283|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
44230284|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230290|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230291|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44230293|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44230294|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230295|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44230296|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
44230297|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
44230298|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
44230299|NCT04748172|Antibodies|antibodies|mesh-list
44230300|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
44230301|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230302|NCT04684420|Metformin|metformin|mesh-list
44230303|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44230304|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230305|NCT04642378|Insulin|insulin|mesh-list
44230306|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44230307|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44230308|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230309|NCT04630886|Lidocaine|lidocaine|mesh-list
44230310|NCT04630886|Epinephrine|epinephrine|mesh-list
44230311|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
44230312|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
44230313|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
44230314|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230315|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230316|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
44230317|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230318|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44230319|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44230320|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44230321|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44230322|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230323|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44230324|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44230331|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44230332|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44230333|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
44230334|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44230335|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
44230336|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
44230337|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
44230338|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44230339|NCT04502667|Vitamin D|vitamin d|mesh-list
44230340|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
44230341|NCT04502667|Vitamins|vitamins|mesh-ancestor
44230342|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
44230343|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230344|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230345|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230346|NCT04497168|Citalopram|citalopram|mesh-list
44230347|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43850149|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
43850150|NCT05701813|Vitamins|vitamins|mesh-ancestor
43641766|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43641767|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
43641768|NCT05564416|Atezolizumab|atezolizumab|mesh-list
43641769|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43641770|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641771|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
43641772|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641773|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
43641774|NCT05564403|Leucovorin|leucovorin|mesh-list
43641775|NCT05564403|Folic Acid|folic acid|mesh-list
43641776|NCT05564403|Fluorouracil|fluorouracil|mesh-list
43641777|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
43641778|NCT05564403|Calcium|calcium|mesh-list
44230348|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44230349|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44230350|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230351|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230352|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
44230353|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230354|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44230355|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
44230356|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230357|NCT04480502|Ipilimumab|ipilimumab|mesh-list
44230358|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230359|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230360|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44230361|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230363|NCT04447040|Naproxen|naproxen|mesh-list
44230364|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230365|NCT04447040|Analgesics|analgesics|mesh-ancestor
44230366|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
44230367|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230369|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
44230370|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44230371|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230372|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230373|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
44230374|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44230375|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230376|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230377|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
44230378|NCT04416984|Fludarabine|fludarabine|mesh-list
44230379|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230380|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
44230381|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230382|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230383|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230384|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
43641807|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
43641808|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641809|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641810|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
43641811|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641812|NCT05560282|Fenfluramine|fenfluramine|mesh-list
43641813|NCT05560282|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43641814|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43641815|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43641816|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641817|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641818|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
43641819|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641820|NCT05559008|Azacitidine|azacitidine|mesh-list
43641821|NCT05559008|Apatinib|apatinib|mesh-list
43641822|NCT05559008|Dasatinib|dasatinib|mesh-list
43641823|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641824|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
44230385|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230386|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230387|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44458302|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
44458303|NCT01595581|Testosterone|testosterone|mesh-list
44458338|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44458339|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458340|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44458341|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44458342|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458343|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458344|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458345|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43884374|NCT04599621|Uric Acid|uric acid|mesh-list
44230388|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
44230389|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230390|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
44230391|NCT04288323|Edetic Acid|edetic acid|mesh-list
44230392|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
44230393|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44230394|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230395|NCT04288323|Antidotes|antidotes|mesh-ancestor
44230396|NCT04288323|Protective Agents|protective agents|mesh-ancestor
44230397|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230398|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
44230399|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
44230400|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
44230401|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
44230402|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
44230404|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
44230405|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44230406|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230407|NCT04231968|Ziresovir|ziresovir|mesh-list
44230408|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
44230409|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230410|NCT04167163|Abaloparatide|abaloparatide|mesh-list
44230411|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230412|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230420|NCT04137770|Ketorolac|ketorolac|mesh-list
44230421|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44230422|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44230423|NCT04137770|Analgesics|analgesics|mesh-ancestor
44230424|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
44230425|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230426|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230427|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230428|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230429|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43850154|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43850155|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850156|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43850157|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850158|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850159|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
44230430|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230431|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230432|NCT04107675|Cyclosporine|cyclosporine|mesh-list
44230433|NCT04107675|Cyclosporins|cyclosporins|mesh-list
44230434|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230435|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230436|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230447|NCT04067726|Vitamin D|vitamin d|mesh-list
44230477|NCT04000854|Calcium|calcium|mesh-list
44230478|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230479|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230480|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
44230481|NCT03981341|Estrogens|estrogens|mesh-list
44230482|NCT03981341|Hormones|hormones|mesh-ancestor
44230483|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230484|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230485|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44230486|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44230487|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230488|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230489|NCT03950817|Ketamine|ketamine|mesh-list
44230490|NCT03950817|Analgesics|analgesics|mesh-ancestor
44230491|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
44230492|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230493|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230494|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44230495|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44230496|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
44230497|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
44230498|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230499|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44230500|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44230501|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230502|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230503|NCT03924440|Nonoxynol|nonoxynol|mesh-list
44230504|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44230505|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44230506|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230507|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44230508|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
44230518|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44230519|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
44230520|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850160|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850161|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850179|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850180|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43850181|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43850182|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43655899|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
43655900|NCT02965443|Saxagliptin|saxagliptin|mesh-list
43655901|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43655902|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655914|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655917|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
43655918|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
43655919|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230521|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44230522|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44230523|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230525|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44230526|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44230527|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44230528|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44230529|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
44230530|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230531|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230532|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230533|NCT03532022|Dexamethasone|dexamethasone|mesh-list
44230534|NCT03532022|Prednisone|prednisone|mesh-list
44230535|NCT03532022|Prednisolone|prednisolone|mesh-list
44230536|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
44230537|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
44230538|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
44230539|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
44230540|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230541|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
44230542|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
44230546|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
44458346|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44458347|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44458349|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
44458350|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458351|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458352|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44458353|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458354|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
44458355|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44458356|NCT01594970|Bimatoprost|bimatoprost|mesh-list
44458357|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44458358|NCT01594931|Artesunate|artesunate|mesh-list
44458359|NCT01594931|Pyronaridine|pyronaridine|mesh-list
44458360|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
44458361|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44458362|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44458363|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458364|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458365|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
44458366|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
44458367|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44458368|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
44458369|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
44458370|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
44458371|NCT01594827|Vancomycin|vancomycin|mesh-list
44458372|NCT01594827|Doxycycline|doxycycline|mesh-list
44230566|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230568|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230569|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230570|NCT03153150|Warfarin|warfarin|mesh-list
44230571|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
44230572|NCT03153150|Dabigatran|dabigatran|mesh-list
44230573|NCT03153150|Apixaban|apixaban|mesh-list
44230574|NCT03153150|Edoxaban|edoxaban|mesh-list
44230575|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
44230576|NCT03153150|Phenindione|phenindione|mesh-list
44230577|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
44230578|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
44230579|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
44230580|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44230581|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
44230582|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230583|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230584|NCT03077685|Paclitaxel|paclitaxel|mesh-list
44230585|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44230586|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230587|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
44230588|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
44230589|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
44230590|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230591|NCT03074539|Riociguat|riociguat|mesh-list
44230592|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
44230593|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230594|NCT02978391|Epinephrine|epinephrine|mesh-list
44230595|NCT02978391|Hemostatics|hemostatics|mesh-list
44230596|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44230615|NCT02843230|Bevacizumab|bevacizumab|mesh-list
44230616|NCT02843230|Temozolomide|temozolomide|mesh-list
44230617|NCT02843230|Lomustine|lomustine|mesh-list
44230618|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230619|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230620|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44230621|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44230622|NCT02843230|Growth Substances|growth substances|mesh-ancestor
44230623|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230624|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
44230625|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230626|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
44230627|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230628|NCT02712814|Estrogens|estrogens|mesh-list
44230629|NCT02712814|Hormones|hormones|mesh-ancestor
44230630|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230631|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230632|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
44230633|NCT02670252|Busulfan|busulfan|mesh-list
44230634|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230635|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
44230636|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230637|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230638|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230639|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
44230640|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230662|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230663|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230664|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44230665|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44230666|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230667|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230668|NCT02274779|Leuprolide|leuprolide|mesh-list
44230669|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44230670|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
44230671|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44230672|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230673|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230674|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230675|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
43655920|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655921|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655922|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
43655923|NCT02965196|Hormones|hormones|mesh-ancestor
43655930|NCT02965248|Raltitrexed|raltitrexed|mesh-list
43655935|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655936|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230676|NCT02143830|Busulfan|busulfan|mesh-list
44230677|NCT02143830|Fludarabine|fludarabine|mesh-list
44230678|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
44230679|NCT02143830|Lenograstim|lenograstim|mesh-list
44230680|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230681|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
44230682|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230683|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44230684|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44230685|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
44230687|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230713|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
44230714|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44230715|NCT01824537|Vaccines|vaccines|mesh-list
44230716|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
44230717|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230718|NCT01655225|Cisplatin|cisplatin|mesh-list
44230719|NCT01655225|Pemetrexed|pemetrexed|mesh-list
44230720|NCT01655225|Letrozole|letrozole|mesh-list
44230721|NCT01655225|Fulvestrant|fulvestrant|mesh-list
44230722|NCT01655225|Midazolam|midazolam|mesh-list
44230723|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230724|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44230725|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44230726|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44230727|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230728|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44230729|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44230730|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230731|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44230732|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
44230733|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
44230734|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
44230735|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
44230736|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230737|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230738|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230739|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44230740|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44230741|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44230742|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44230759|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230760|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44230762|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230763|NCT00532025|Sorafenib|sorafenib|mesh-list
44230764|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230765|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44230766|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230767|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230768|NCT00532090|R04929097|r04929097|mesh-list
44230769|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230770|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230771|NCT00532116|Selegiline|selegiline|mesh-list
44230772|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
44230773|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230774|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44230775|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44230776|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
44230777|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230778|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230779|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44230780|NCT00532116|Protective Agents|protective agents|mesh-ancestor
43655937|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43655938|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
43655939|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655940|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850195|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44230781|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230782|NCT00532142|Triamcinolone|triamcinolone|mesh-list
44230783|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230784|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
44230785|NCT00532142|Hormones|hormones|mesh-ancestor
44230786|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230787|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230804|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44230805|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44230806|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44230807|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44230808|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44230809|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
44230810|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44230811|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44230812|NCT00532194|Cediranib|cediranib|mesh-list
44230813|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230814|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44230815|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230816|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230817|NCT00532207|Teriparatide|teriparatide|mesh-list
44230818|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44230819|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230820|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230821|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
44230822|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230823|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230824|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44230825|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44230826|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230827|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230828|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230846|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44230847|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44230848|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230849|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
44230850|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
44230851|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
44230852|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230853|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44230854|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
44230855|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
44230856|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230857|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230858|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230859|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
44230860|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230861|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
44230862|NCT00532324|Mupirocin|mupirocin|mesh-list
44230863|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44230864|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230865|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
44230866|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44230867|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44230868|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230869|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230870|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
43655961|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230871|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44230872|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
44230873|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230874|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230875|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44230876|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
44230877|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
44230878|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44230879|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
44230880|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230881|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230883|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230884|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44230885|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230886|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230887|NCT00532415|Triamcinolone|triamcinolone|mesh-list
44230888|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
44230889|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
44230890|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
44230891|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44230892|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
44230893|NCT00532415|Hormones|hormones|mesh-ancestor
44230894|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230895|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230896|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230897|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
44230898|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230899|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230900|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44230901|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44230902|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230903|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230904|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230905|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44230906|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44230907|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230908|NCT00532454|Tamoxifen|tamoxifen|mesh-list
44230909|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44230910|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
44230911|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44230912|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230913|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44230914|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230916|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44230919|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44230920|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44230921|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44230922|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230923|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44230924|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
44230925|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230926|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43655962|NCT02965261|Fluoxetine|fluoxetine|mesh-list
44230927|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
44230928|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44230929|NCT00532532|Tolperisone|tolperisone|mesh-list
44230930|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44230931|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230932|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44230933|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230934|NCT00532545|Teriparatide|teriparatide|mesh-list
44230935|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43884817|NCT04591535|Levodopa|levodopa|mesh-list
44230936|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230937|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44230938|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
44230939|NCT00532571|Vitamins|vitamins|mesh-ancestor
44458424|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
44458425|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458426|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458427|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
44458428|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
44458429|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44458430|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
44458431|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458432|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44458433|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44458434|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44458435|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458436|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44458437|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
44458438|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
44458439|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44458440|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
44458441|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44458442|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458443|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44458444|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
44458445|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44458446|NCT01594333|Methotrexate|methotrexate|mesh-list
44458447|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44458448|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
44458449|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44458450|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230946|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850221|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850222|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850223|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850224|NCT05701241|Hormones|hormones|mesh-ancestor
43850225|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850226|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850227|NCT05701215|Venetoclax|venetoclax|mesh-list
43850228|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850229|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
43850230|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43850231|NCT05701189|Antibodies|antibodies|mesh-list
43825193|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
44230947|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230948|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44230949|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
44230951|NCT00532623|Vinorelbine|vinorelbine|mesh-list
44230952|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44230953|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
44230954|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44230955|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44230956|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
44230957|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230958|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230959|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44230960|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
44230961|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230962|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44230963|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
44230964|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
44230965|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
44230966|NCT00532662|Ketamine|ketamine|mesh-list
44230967|NCT00532662|Analgesics|analgesics|mesh-ancestor
44230968|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
44230969|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44230970|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44230971|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44230972|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44230973|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
44230974|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
43767782|NCT02399397|Fentanyl|fentanyl|mesh-list
44230989|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44230990|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44230991|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825194|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43825195|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825201|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825202|NCT05504083|Renal Agents|renal agents|mesh-ancestor
43825203|NCT05504057|Amantadine|amantadine|mesh-list
43825204|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
43656000|NCT02964689|Cisplatin|cisplatin|mesh-list
43656001|NCT02964689|Pemetrexed|pemetrexed|mesh-list
43850245|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43850246|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44230993|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
44230994|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
44230995|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44230996|NCT00532688|Expectorants|expectorants|mesh-ancestor
44230997|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
44230998|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44230999|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
44231000|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231001|NCT00532688|Protective Agents|protective agents|mesh-ancestor
44231002|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231003|NCT00532688|Antidotes|antidotes|mesh-ancestor
44231004|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44231005|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
44231006|NCT00532701|Ribavirin|ribavirin|mesh-list
44231007|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
44231008|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231009|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
44231010|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231011|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
44231012|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231013|NCT00532714|Capecitabine|capecitabine|mesh-list
44231014|NCT00532714|Irinotecan|irinotecan|mesh-list
44231015|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231016|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
44458466|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231017|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231018|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231019|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44231020|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231021|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231029|NCT00532818|Hydralazine|hydralazine|mesh-list
44231030|NCT00532818|Valproic Acid|valproic acid|mesh-list
44231031|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
44231032|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231033|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231034|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
44231035|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231036|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231037|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
44231038|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231039|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231040|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231041|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231042|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231043|NCT00532857|Gemcitabine|gemcitabine|mesh-list
44231044|NCT00532857|Paclitaxel|paclitaxel|mesh-list
44231045|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44231046|NCT00532857|Trastuzumab|trastuzumab|mesh-list
44231047|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231048|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231049|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231050|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
43656017|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656019|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656020|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44231051|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231052|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231053|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231054|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
44231055|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
44231056|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231057|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231058|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231059|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
44231060|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231061|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231062|NCT00532909|Bevacizumab|bevacizumab|mesh-list
44231063|NCT00532909|Capecitabine|capecitabine|mesh-list
44231064|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
44231065|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231068|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231069|NCT00532909|Growth Substances|growth substances|mesh-ancestor
44231070|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231071|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231072|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231074|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231075|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
44231076|NCT00532961|Tobramycin|tobramycin|mesh-list
44231077|NCT00532961|Dexamethasone|dexamethasone|mesh-list
44231078|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44231079|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
44231080|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
44231081|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231082|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231083|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44231084|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
44231085|NCT00532961|Hormones|hormones|mesh-ancestor
44231086|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231087|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44231088|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231089|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231090|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231091|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43885047|NCT04588987|Apatinib|apatinib|mesh-list
44231092|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
44231093|NCT00533026|Warfarin|warfarin|mesh-list
44231094|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
44231095|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44231096|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43656026|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656027|NCT02964104|Insulin|insulin|mesh-list
43656028|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43656029|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43656030|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656031|NCT02964403|Indomethacin|indomethacin|mesh-list
43656032|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656033|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44231097|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44231098|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231099|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231100|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231101|NCT00533026|Analgesics|analgesics|mesh-ancestor
44231102|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
44231103|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231104|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
44231105|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231106|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
44231107|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
44231108|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
44231109|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231110|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231111|NCT00533065|Donepezil|donepezil|mesh-list
44231112|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44231113|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231114|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231115|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
44231116|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231117|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231118|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
44231119|NCT00533091|Sifalimumab|sifalimumab|mesh-list
44231120|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
44231121|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231122|NCT00533169|Tretinoin|tretinoin|mesh-list
44231123|NCT00533169|Isotretinoin|isotretinoin|mesh-list
44231124|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231125|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
44231126|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
44231127|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
44231128|NCT00533195|Methoxsalen|methoxsalen|mesh-list
44231129|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44231130|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
44231131|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44231132|NCT00533247|Celecoxib|celecoxib|mesh-list
44231133|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44231134|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44231135|NCT00533247|Analgesics|analgesics|mesh-ancestor
44231136|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
43850256|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43850257|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656060|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43656061|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656062|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656063|NCT02963896|Gentamicins|gentamicins|mesh-list
44231137|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231138|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231139|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44231141|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44231142|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44231143|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231144|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231145|NCT00533299|Hydralazine|hydralazine|mesh-list
44231146|NCT00533299|Valproic Acid|valproic acid|mesh-list
44231147|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
44231148|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231149|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231150|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
44231151|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231152|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231153|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
44231154|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231155|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231156|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231157|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231158|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231159|NCT00533312|Niacin|niacin|mesh-list
44231160|NCT00533312|Niacinamide|niacinamide|mesh-list
44231161|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
44231162|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44231163|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
44231164|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231165|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44231166|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231167|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
44231168|NCT00533312|Vitamins|vitamins|mesh-ancestor
44231169|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
44231170|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231185|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231186|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231187|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231188|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231190|NCT00533455|Analgesics|analgesics|mesh-ancestor
44231191|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
44231192|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231193|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231194|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
44231195|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44231196|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231197|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231198|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231199|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44231200|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44231201|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231202|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231203|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
44231204|NCT00533520|Ranibizumab|ranibizumab|mesh-list
44231205|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231206|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231207|NCT00533520|Growth Substances|growth substances|mesh-ancestor
44231208|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231209|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231210|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231211|NCT00533533|Docetaxel|docetaxel|mesh-list
44231212|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
44231213|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231214|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231215|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231216|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231217|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231226|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231227|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231228|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231229|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231230|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231231|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231232|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231233|NCT00533585|Growth Substances|growth substances|mesh-ancestor
44231234|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231235|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231236|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231237|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231239|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231240|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231241|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44231243|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44231246|NCT00533611|Vitamins|vitamins|mesh-ancestor
44231282|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231283|NCT00533741|Antacids|antacids|mesh-ancestor
44231284|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231285|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44231286|NCT00533858|Losartan|losartan|mesh-list
44231287|NCT00533858|Lacidipine|lacidipine|mesh-list
44231288|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44231289|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231290|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44231291|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44231292|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231293|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44231294|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44231295|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231296|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231297|NCT00533923|Cyclosporine|cyclosporine|mesh-list
44231298|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
44231299|NCT00533923|Fludarabine|fludarabine|mesh-list
44231300|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
44231301|NCT00533923|Cyclosporins|cyclosporins|mesh-list
44231302|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231303|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
44231304|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231305|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231306|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44231307|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
44231308|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231309|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231310|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44231311|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231319|NCT00533936|Doxorubicin|doxorubicin|mesh-list
44231325|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
44231326|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231327|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231328|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231329|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231330|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
44231331|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231332|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231333|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44231334|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
44231335|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44231336|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44231337|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44231338|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231339|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231340|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
44231341|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231342|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643045|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
44231343|NCT00533962|Anecortave|anecortave|mesh-list
44231344|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231345|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231346|NCT00533962|Growth Substances|growth substances|mesh-ancestor
44231347|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231348|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231377|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
44231378|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
44231379|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231380|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44231381|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44231382|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44231383|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44231384|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44231385|NCT00534261|Interferons|interferons|mesh-list
44231386|NCT00534261|Interferon-beta|interferon-beta|mesh-list
44231387|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
44231388|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231389|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
44231390|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231391|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
44231392|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231393|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44231394|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
44231395|NCT00534287|Meropenem|meropenem|mesh-list
44231396|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
44231397|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231398|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231399|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44231400|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231401|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231402|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231403|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231404|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44231405|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
44231406|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44231407|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231408|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
44231409|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44458468|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458471|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44458472|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458473|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458474|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
44458475|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44458476|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458477|NCT01593020|Paclitaxel|paclitaxel|mesh-list
44458478|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
44458479|NCT01593020|Doxorubicin|doxorubicin|mesh-list
44458480|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44458481|NCT01593020|Fluorouracil|fluorouracil|mesh-list
44458482|NCT01593020|Epirubicin|epirubicin|mesh-list
44458483|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44458484|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458485|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
44458486|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
44458487|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
44458488|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458489|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44458490|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
43656111|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43656112|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
43656113|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656114|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43656115|NCT02963168|Docetaxel|docetaxel|mesh-list
43656120|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458491|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458492|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44458493|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44458494|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
44458495|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44458496|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44458497|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44458498|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44458499|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458500|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
44458501|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44458502|NCT01592864|Fluorides|fluorides|mesh-list
44458512|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458513|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458514|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458515|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44458516|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44458517|NCT01592773|Memantine|memantine|mesh-list
44458518|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44458519|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458520|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
44458521|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458522|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231411|NCT00534378|Midazolam|midazolam|mesh-list
44231412|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44231413|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44231414|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231415|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231416|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44231417|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231418|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231419|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43656140|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
43656141|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656142|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656143|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
43656144|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656145|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43656162|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656164|NCT02962999|Analgesics|analgesics|mesh-ancestor
43656165|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
43850278|NCT05698147|Methotrexate|methotrexate|mesh-list
43656166|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656167|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656168|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43656169|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43656170|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
43656171|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
43656172|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231420|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
44231421|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
44231422|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
44231423|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
44231424|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231425|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231426|NCT00534391|Polymyxins|polymyxins|mesh-list
44231427|NCT00534391|Neomycin|neomycin|mesh-list
44231428|NCT00534391|Polymyxin B|polymyxin b|mesh-list
44231429|NCT00534391|Gramicidin|gramicidin|mesh-list
44231430|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
44231431|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44231432|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44231433|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231442|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231443|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
44231444|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231445|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44231446|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231447|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231449|NCT00534573|Moclobemide|moclobemide|mesh-list
44231450|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44231451|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44231452|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231453|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231454|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231455|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44231456|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
44231457|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231458|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231500|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231501|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44231502|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231503|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231504|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231505|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
44231506|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44231508|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44231509|NCT00534651|Analgesics|analgesics|mesh-ancestor
44231510|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
44231511|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231512|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231513|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
44231514|NCT00534677|Octreotide|octreotide|mesh-list
44231515|NCT00534677|Terlipressin|terlipressin|mesh-list
44231516|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44231517|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44231518|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231519|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231520|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44231521|NCT00534729|Carboplatin|carboplatin|mesh-list
44231522|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656181|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
43656182|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
43656183|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656184|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656193|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825224|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
43825225|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825226|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825227|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825228|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703120|NCT02712658|Terbutaline|terbutaline|mesh-list
44231523|NCT00534807|Rifampin|rifampin|mesh-list
44231524|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44231525|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
44231526|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231527|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231528|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
44231529|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44231530|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231531|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231538|NCT00534846|Toremifene|toremifene|mesh-list
44231539|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44231540|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231541|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44231542|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44231543|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231544|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231545|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231546|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231547|NCT00534898|Fenretinide|fenretinide|mesh-list
44231549|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231550|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44231551|NCT00534898|Protective Agents|protective agents|mesh-ancestor
44231552|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231553|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
44231554|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
44231555|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
44231556|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
44231557|NCT00535119|Paclitaxel|paclitaxel|mesh-list
44231558|NCT00535119|Carboplatin|carboplatin|mesh-list
44231559|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44231560|NCT00535119|Veliparib|veliparib|mesh-list
44231561|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44231562|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231564|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
44231565|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
44231566|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231567|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44231568|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231584|NCT00535353|Olaparib|olaparib|mesh-list
44231585|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44231586|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231587|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231588|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231589|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231590|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
44231591|NCT00535379|Sunitinib|sunitinib|mesh-list
44231592|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231593|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231594|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231595|NCT00535379|Growth Substances|growth substances|mesh-ancestor
44231596|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231597|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231598|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231599|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231600|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231601|NCT00535418|Letrozole|letrozole|mesh-list
44231602|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231603|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44231604|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44231605|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231606|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231607|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44231608|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231610|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231631|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850282|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656222|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43643342|NCT05093387|Carboplatin|carboplatin|mesh-list
44231632|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
44231633|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231634|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44231635|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231636|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231637|NCT00535808|Nitroprusside|nitroprusside|mesh-list
44231638|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
44231639|NCT00535808|Sevoflurane|sevoflurane|mesh-list
44231640|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44231641|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44231642|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
44231643|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
44231644|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231645|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231646|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
44231647|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231648|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44231649|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231650|NCT00535860|Teriparatide|teriparatide|mesh-list
44231651|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231652|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231653|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231654|NCT00535951|Panobinostat|panobinostat|mesh-list
44231655|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231656|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
44231657|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231659|NCT00536003|Progesterone|progesterone|mesh-list
44231677|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44231678|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44231679|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231680|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44231681|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231682|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231683|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
44231684|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44231685|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44231686|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44231687|NCT00536211|Metformin|metformin|mesh-list
44231688|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44231689|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458523|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458524|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44458525|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44458526|NCT01592747|Memantine|memantine|mesh-list
44458527|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44458528|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44458529|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
44458530|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458531|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458532|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458533|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
44231706|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
44231707|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231708|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231709|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231710|NCT00536393|Doxorubicin|doxorubicin|mesh-list
44231711|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44231712|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44231713|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656223|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43656252|NCT02962258|Diuretics|diuretics|mesh-ancestor
43656253|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
43656254|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43656256|NCT02962492|Exenatide|exenatide|mesh-list
44231714|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44231715|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44231716|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231717|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231718|NCT00536419|Methylphenidate|methylphenidate|mesh-list
44231719|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44231720|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231721|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44231722|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44231723|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44231724|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231725|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
44231726|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231727|NCT00536614|Cetuximab|cetuximab|mesh-list
44231728|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231729|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231730|NCT00536640|Gemcitabine|gemcitabine|mesh-list
44231731|NCT00536640|Bevacizumab|bevacizumab|mesh-list
44231732|NCT00536640|Cisplatin|cisplatin|mesh-list
44231733|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44231734|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231735|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231747|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231748|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
44231749|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231751|NCT00536653|Vitamin D|vitamin d|mesh-list
44231752|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
44231753|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
44231754|NCT00536653|Vitamins|vitamins|mesh-list
44231755|NCT00536653|Goserelin|goserelin|mesh-list
44231756|NCT00536653|Bicalutamide|bicalutamide|mesh-list
44231757|NCT00536653|Calcium|calcium|mesh-list
44231758|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
44231759|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
44231760|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231761|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231762|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231763|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44231764|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231765|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
44231766|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231767|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231768|NCT00536653|Hormones|hormones|mesh-ancestor
44231769|NCT00536692|Mecamylamine|mecamylamine|mesh-list
44231770|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44231771|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
44231772|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
44231773|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231774|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231775|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43656288|NCT02962310|Calcium|calcium|mesh-list
43656289|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43656290|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656302|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43656317|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43703122|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
44231776|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44231777|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
44231778|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44231779|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231780|NCT00536705|Montelukast|montelukast|mesh-list
44231781|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44231782|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
44231783|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44231784|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
44231785|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231786|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231787|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44231788|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44231789|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231790|NCT00536770|Calcitriol|calcitriol|mesh-list
44231791|NCT00536770|Gemcitabine|gemcitabine|mesh-list
44231792|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44231793|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231794|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
44231795|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231796|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231797|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
44231798|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231799|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231800|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231801|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
44231802|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231803|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44231804|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231805|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
44231806|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44231807|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44231808|NCT00536770|Vitamins|vitamins|mesh-ancestor
44231809|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
44231810|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44231811|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
44231812|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
44231813|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231814|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44231827|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231828|NCT00536887|Atorvastatin|atorvastatin|mesh-list
44231829|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44231830|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44231831|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
44231832|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231833|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44231834|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44231835|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231836|NCT00537121|Leucovorin|leucovorin|mesh-list
44231837|NCT00537121|Fluorouracil|fluorouracil|mesh-list
44231838|NCT00537121|Irinotecan|irinotecan|mesh-list
44231839|NCT00537121|Vorinostat|vorinostat|mesh-list
44231840|NCT00537121|Calcium|calcium|mesh-list
43885701|NCT04578470|Vitamin D|vitamin d|mesh-list
43656345|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
43656346|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656347|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656361|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43825257|NCT05503706|Protective Agents|protective agents|mesh-ancestor
43656363|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44231841|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
44231842|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44231843|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231844|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
44231845|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231846|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44231847|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231848|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44231880|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231881|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231882|NCT00537420|Sibutramine|sibutramine|mesh-list
44231883|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
44231884|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44231885|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
44231886|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44231887|NCT00537472|Bupivacaine|bupivacaine|mesh-list
44231888|NCT00537472|Anesthetics|anesthetics|mesh-list
44231889|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
44231890|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44231891|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231892|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
44231893|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44231894|NCT00537524|Vaccines|vaccines|mesh-list
44231895|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
44231896|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231897|NCT00537537|Telbivudine|telbivudine|mesh-list
44231898|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
44231899|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231900|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44231931|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231933|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231934|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231935|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44231936|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44231937|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
44231938|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231939|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
44231940|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44231941|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231942|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
44231943|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44231944|NCT00537732|Omeprazole|omeprazole|mesh-list
44231945|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44231946|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44231947|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44231948|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44231949|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44231950|NCT00537836|Estradiol|estradiol|mesh-list
44231951|NCT00537836|Estrogens|estrogens|mesh-ancestor
44231952|NCT00537836|Hormones|hormones|mesh-ancestor
44231953|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44231954|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44231955|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
44231956|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44231957|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231958|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44231959|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
44231960|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44231975|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44231976|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
44231977|NCT00537901|Bevacizumab|bevacizumab|mesh-list
44231978|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44231979|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231980|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44231981|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44231982|NCT00537901|Growth Substances|growth substances|mesh-ancestor
44231983|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656372|NCT02961829|Vitamins|vitamins|mesh-ancestor
44231984|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
44231985|NCT00537953|Miltefosine|miltefosine|mesh-list
44231986|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
44231987|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
44231988|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44231989|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44231990|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44231991|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44231992|NCT00537966|Ritonavir|ritonavir|mesh-list
44231993|NCT00537966|Darunavir|darunavir|mesh-list
44231994|NCT00537966|Tenofovir|tenofovir|mesh-list
44231995|NCT00537966|Lamivudine|lamivudine|mesh-list
44231996|NCT00537966|Emtricitabine|emtricitabine|mesh-list
44231997|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
44231998|NCT00537966|Dolutegravir|dolutegravir|mesh-list
44231999|NCT00537966|Abacavir|abacavir|mesh-list
44232000|NCT00537966|Cobicistat|cobicistat|mesh-list
44232001|NCT00537966|Rilpivirine|rilpivirine|mesh-list
44232002|NCT00537966|Elvitegravir|elvitegravir|mesh-list
44232003|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44232004|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44232005|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
44232023|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44232024|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44232025|NCT00538005|Growth Substances|growth substances|mesh-ancestor
44232026|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232027|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
44232028|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232029|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232030|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232031|NCT00538018|Telithromycin|telithromycin|mesh-list
44232032|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232033|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232034|NCT00538044|Simvastatin|simvastatin|mesh-list
44232035|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44232036|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44232037|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
44232038|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232039|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44232040|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44232041|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232042|NCT00538070|Glycine|glycine|mesh-list
44232043|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
44232044|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232045|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232047|NCT00538096|Blinatumomab|blinatumomab|mesh-list
44232072|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
44232073|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232074|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
44232075|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232076|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
44232077|NCT00538265|Tacrolimus|tacrolimus|mesh-list
44232078|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
44232079|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232080|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
44232081|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232082|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44232083|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232084|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232085|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44232086|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232087|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44232088|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
44232089|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232090|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232091|NCT00538317|Tirofiban|tirofiban|mesh-list
44232092|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44232093|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44232094|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232095|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44232096|NCT00538330|Tamoxifen|tamoxifen|mesh-list
44232097|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43656398|NCT02962024|Bupivacaine|bupivacaine|mesh-list
44232098|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
44232099|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232100|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232101|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232106|NCT00538382|Artesunate|artesunate|mesh-list
44232115|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
44232116|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
44232117|NCT00538395|Doxorubicin|doxorubicin|mesh-list
44232118|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44232119|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232120|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
44232121|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232122|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44232123|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44232124|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
44232125|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232126|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232127|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44232128|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44232129|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44232130|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232131|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232132|NCT00538421|Propofol|propofol|mesh-list
44232133|NCT00538421|Sevoflurane|sevoflurane|mesh-list
44232134|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44232135|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232136|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232137|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44232138|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
44232139|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
44232140|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44232141|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44232142|NCT00538486|Metformin|metformin|mesh-list
44232143|NCT00538486|Amlodipine|amlodipine|mesh-list
44232144|NCT00538486|Telmisartan|telmisartan|mesh-list
44232145|NCT00538486|Candesartan|candesartan|mesh-list
44232146|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
44232156|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44232157|NCT00538499|Fentanyl|fentanyl|mesh-list
44232158|NCT00538499|Bupivacaine|bupivacaine|mesh-list
44232159|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
44232160|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
44232161|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232162|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232163|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
44232164|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232165|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44232166|NCT00538499|Narcotics|narcotics|mesh-ancestor
44232167|NCT00538499|Analgesics|analgesics|mesh-ancestor
44232168|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44232169|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44232170|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
44232171|NCT00538525|Cisplatin|cisplatin|mesh-list
44232172|NCT00538525|Docetaxel|docetaxel|mesh-list
44232173|NCT00538525|Doxorubicin|doxorubicin|mesh-list
44232174|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232175|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232176|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232177|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232178|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232179|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44232183|NCT00538538|Ranibizumab|ranibizumab|mesh-list
44232208|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44232209|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232210|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232211|NCT00538655|Modafinil|modafinil|mesh-list
44232212|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44232213|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232214|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44232215|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44232216|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44232217|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232218|NCT00538694|Daptomycin|daptomycin|mesh-list
44232219|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232220|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232221|NCT00538720|Vitamin D|vitamin d|mesh-list
44232222|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
44232223|NCT00538720|Vitamins|vitamins|mesh-ancestor
44232224|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
44232225|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232226|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44232227|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232228|NCT00538811|Interferons|interferons|mesh-list
44232229|NCT00538811|Ribavirin|ribavirin|mesh-list
44232230|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
44232231|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
44232232|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
44232233|NCT00538811|Amantadine|amantadine|mesh-list
44232234|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232235|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
44232236|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232237|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
44232238|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232239|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
44232240|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232241|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
44232242|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44232243|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
44232244|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232247|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
44232248|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232249|NCT00538876|Decitabine|decitabine|mesh-list
44232250|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232251|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
44232252|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232253|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232254|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232255|NCT00538889|Citalopram|citalopram|mesh-list
44232256|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44232257|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44232258|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656405|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
44232259|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232260|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232261|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
44232262|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232263|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44232264|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
44232303|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44232304|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232305|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232306|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232307|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232308|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232309|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232310|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232311|NCT00539396|Insulin|insulin|mesh-list
44232312|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232313|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232314|NCT00539409|Insulin|insulin|mesh-list
44232315|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
44232316|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44232317|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232318|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232319|NCT00539435|Insulin|insulin|mesh-list
44232320|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
44232321|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232322|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232323|NCT00539448|Insulin|insulin|mesh-list
44232324|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44232325|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
44232326|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
44232327|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232328|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232329|NCT00539565|Prednisolone|prednisolone|mesh-list
44232330|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44232331|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
44232332|NCT00539565|Hormones|hormones|mesh-ancestor
44232334|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232350|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232351|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
44232352|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232353|NCT00539786|Rabeprazole|rabeprazole|mesh-list
44232354|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
44232355|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44232356|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44232357|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232358|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656422|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656423|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
43656432|NCT02961816|Hormones|hormones|mesh-ancestor
43656433|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43656434|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43656435|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232359|NCT00539799|Prednisolone|prednisolone|mesh-list
44232360|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44232361|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
44232362|NCT00539799|Hormones|hormones|mesh-ancestor
43656436|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
43656438|NCT02961816|Antiviral Agents|antiviral agents|mesh-ancestor
44232363|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232364|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232365|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232366|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232367|NCT00539877|Irinotecan|irinotecan|mesh-list
44232368|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44232369|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232370|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232371|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232372|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232373|NCT00539890|Insulin|insulin|mesh-list
44232374|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232375|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232376|NCT00539968|Docetaxel|docetaxel|mesh-list
44232377|NCT00539968|Lonafarnib|lonafarnib|mesh-list
44232379|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232397|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232398|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232399|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
44232400|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232401|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44232402|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
44232403|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44232404|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44232405|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44232406|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232407|NCT00540137|Ritonavir|ritonavir|mesh-list
44232408|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44232409|NCT00540137|Nevirapine|nevirapine|mesh-list
44232410|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44232411|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44232412|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
44232413|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232414|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232415|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44232416|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44232417|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
44232418|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232419|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44232420|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44232421|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44232422|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44232423|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44232424|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44232425|NCT00540202|Lumefantrine|lumefantrine|mesh-list
44232426|NCT00540202|Artemether|artemether|mesh-list
44232428|NCT00540202|Quinine|quinine|mesh-list
44232436|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232437|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44232438|NCT00540202|Analgesics|analgesics|mesh-ancestor
44232439|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
44232440|NCT00540241|Pemetrexed|pemetrexed|mesh-list
44232441|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232442|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232443|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232444|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44232445|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44458545|NCT01592708|Antiemetics|antiemetics|mesh-list
44232446|NCT00540280|Gemcitabine|gemcitabine|mesh-list
44232447|NCT00540280|Cisplatin|cisplatin|mesh-list
44232448|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232449|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232450|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
44232451|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232452|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
44232453|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232454|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232455|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232456|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
44232457|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232458|NCT00540345|Interferons|interferons|mesh-list
44232459|NCT00540345|Ribavirin|ribavirin|mesh-list
44232460|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
44232461|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
44232462|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
44232463|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232464|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
44232465|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232466|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
44232467|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232468|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
44232469|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232477|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44232478|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44232479|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232480|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232481|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
44232482|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
44232483|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44232484|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
44232485|NCT00540501|Oseltamivir|oseltamivir|mesh-list
44232486|NCT00540501|Zanamivir|zanamivir|mesh-list
44232487|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
44232488|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232489|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232490|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232491|NCT00540527|Plasminogen|plasminogen|mesh-list
44232492|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
44232493|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44232494|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44232495|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232496|NCT00540605|Tenofovir|tenofovir|mesh-list
44232497|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
44232498|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232499|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44232500|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44232501|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232502|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232503|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44232504|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44232505|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
44232506|NCT00540696|Hematinics|hematinics|mesh-ancestor
44232507|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
44232510|NCT00540748|Oxytocin|oxytocin|mesh-list
44232523|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232524|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232525|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
44232526|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44232527|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232528|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656472|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
44232529|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44232530|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44232531|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44232532|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232533|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44232534|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44232535|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44232536|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44232537|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44232538|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
44232539|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232540|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
44232541|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
44232542|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232543|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
44232544|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44232545|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
44232546|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44232547|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44232548|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232549|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44232550|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44232551|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
44232554|NCT00540800|Epirubicin|epirubicin|mesh-list
44232564|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232565|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232566|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
44232567|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44232568|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44232569|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232570|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232571|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
44232572|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232573|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232574|NCT00540891|Alfuzosin|alfuzosin|mesh-list
44232575|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44232576|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44232577|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44232578|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
44232579|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232580|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232581|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232582|NCT00540891|Urological Agents|urological agents|mesh-ancestor
44232583|NCT00540930|Ranibizumab|ranibizumab|mesh-list
44232584|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44232613|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232614|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
44232615|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232616|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232617|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232618|NCT00541021|Gemcitabine|gemcitabine|mesh-list
44232620|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232621|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
44232622|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232623|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232624|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
44232625|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232626|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232627|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232628|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
44232629|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232630|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232631|NCT00541047|Leuprolide|leuprolide|mesh-list
44232632|NCT00541047|Goserelin|goserelin|mesh-list
44232633|NCT00541047|Bicalutamide|bicalutamide|mesh-list
44232634|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44232635|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
44232636|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44232637|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232638|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232639|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232640|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
44232641|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
44232642|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232643|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
44232644|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
44232645|NCT00541073|Cisplatin|cisplatin|mesh-list
44232646|NCT00541073|Pemetrexed|pemetrexed|mesh-list
44232647|NCT00541073|Vitamins|vitamins|mesh-ancestor
44232654|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44232655|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
44232657|NCT00541086|Tamoxifen|tamoxifen|mesh-list
44232658|NCT00541086|Letrozole|letrozole|mesh-list
44232659|NCT00541086|Anastrozole|anastrozole|mesh-list
44232660|NCT00541086|Exemestane|exemestane|mesh-list
44232661|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232662|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232663|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44232664|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44232665|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232666|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44232667|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
44232668|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232669|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232670|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232671|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44458546|NCT01592708|Propofol|propofol|mesh-list
44232672|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
44232673|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44232675|NCT00541112|Fluorouracil|fluorouracil|mesh-list
44232676|NCT00541112|Capecitabine|capecitabine|mesh-list
44232677|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
44232678|NCT00541112|Cetuximab|cetuximab|mesh-list
43656488|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656489|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43656490|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43656505|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656507|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850184|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850185|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
43850186|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43850187|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850188|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
43850189|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850190|NCT05701436|Antidotes|antidotes|mesh-ancestor
43850191|NCT05701436|Protective Agents|protective agents|mesh-ancestor
44232679|NCT00541112|Calcium|calcium|mesh-list
44232680|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
44232681|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232682|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232683|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
44232702|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232703|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44232704|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44232705|NCT00541125|Growth Substances|growth substances|mesh-ancestor
44232706|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232707|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
44232708|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232709|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
44232710|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232711|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44232712|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232713|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
44232714|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44232715|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232716|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232717|NCT00541125|Antidotes|antidotes|mesh-ancestor
44232718|NCT00541125|Protective Agents|protective agents|mesh-ancestor
44232719|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
44232720|NCT00541125|Vitamins|vitamins|mesh-ancestor
44232721|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
44232722|NCT00541138|Tamoxifen|tamoxifen|mesh-list
44232723|NCT00541138|Carboplatin|carboplatin|mesh-list
44232724|NCT00541138|Topotecan|topotecan|mesh-list
44232725|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232729|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232754|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
44232755|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44232756|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44232757|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
44232758|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232759|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232760|NCT00541216|Ephedrine|ephedrine|mesh-list
44232761|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44232762|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232763|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
44232764|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
44232765|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232766|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44232767|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
44232768|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232769|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232770|NCT00541281|Prednisone|prednisone|mesh-list
44232771|NCT00541281|Docetaxel|docetaxel|mesh-list
44232772|NCT00541281|Estramustine|estramustine|mesh-list
44232773|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232774|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232775|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232776|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232777|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232778|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44232779|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
44232780|NCT00541281|Hormones|hormones|mesh-ancestor
44232781|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232782|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656508|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825258|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825259|NCT05503706|Trace Elements|trace elements|mesh-ancestor
43825260|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
43825261|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825262|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
43825263|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
43850206|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
43850207|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43850208|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
44232783|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232794|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
44232795|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44232796|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
44232797|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232798|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44232799|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44232800|NCT00541359|Bortezomib|bortezomib|mesh-list
44232801|NCT00541359|Topotecan|topotecan|mesh-list
44232802|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232803|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44232804|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44232805|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232806|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232807|NCT00541372|Insulin|insulin|mesh-list
44232808|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232809|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232810|NCT00541411|Dactinomycin|dactinomycin|mesh-list
44232811|NCT00541411|Vincristine|vincristine|mesh-list
44232812|NCT00541411|Ifosfamide|ifosfamide|mesh-list
44232813|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44232814|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232815|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
44232816|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
44232817|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
44232818|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232819|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44232820|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
44232821|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232822|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232823|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44232824|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44232825|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232826|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44232827|NCT00541463|Nelfinavir|nelfinavir|mesh-list
44232828|NCT00541463|Indinavir|indinavir|mesh-list
44232833|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232834|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44232835|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44232836|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
44232837|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44232838|NCT00541489|Naproxen|naproxen|mesh-list
44232839|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44232840|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44232841|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44232842|NCT00541489|Analgesics|analgesics|mesh-ancestor
43825264|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
44232843|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
44232844|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656589|NCT02959957|Temocillin|temocillin|mesh-list
43656590|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44232845|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232846|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44232847|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44232848|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
44232849|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44232850|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232851|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232852|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44232853|NCT00541515|Insulin|insulin|mesh-list
44232854|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44232855|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232856|NCT00541554|Aripiprazole|aripiprazole|mesh-list
44232857|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
44232858|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44232859|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44232860|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44232861|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232862|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232877|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232878|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232879|NCT00541567|Hormones|hormones|mesh-ancestor
44232880|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232881|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232882|NCT00541710|Genistein|genistein|mesh-list
44232883|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44232884|NCT00541710|Protective Agents|protective agents|mesh-ancestor
44232885|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232886|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44232887|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44232888|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44232889|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232890|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
44232891|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44232892|NCT00541710|Estrogens|estrogens|mesh-ancestor
44232893|NCT00541710|Hormones|hormones|mesh-ancestor
44232894|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232895|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44232896|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44232897|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232898|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232899|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44232902|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
44232925|NCT00541853|Cilnidipine|cilnidipine|mesh-list
44232926|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44232927|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44232928|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43656634|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656637|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44232929|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232930|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44232931|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232932|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44232933|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232934|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
44232935|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44232936|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44232937|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232938|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44232939|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44232940|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44232941|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
44232942|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44232943|NCT00541918|Propofol|propofol|mesh-list
44232944|NCT00541918|Sevoflurane|sevoflurane|mesh-list
44232945|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44232946|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232947|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232948|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
44232949|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
44232950|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
44232951|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44232952|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
44232953|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
44232967|NCT00542074|Emollients|emollients|mesh-list
44232968|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
44232969|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44232970|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458547|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
44232971|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232972|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232973|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
44232974|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
44232975|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44232976|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
44232977|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44232978|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232979|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44232980|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44232981|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458548|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656709|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43656710|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
43656711|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656712|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43656713|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
43656714|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
43656715|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
43656716|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
44458549|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458550|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44458587|NCT01592708|Hormones|hormones|mesh-ancestor
44458588|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44458589|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44458590|NCT01592708|Protective Agents|protective agents|mesh-ancestor
44458591|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44458592|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44458593|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44458594|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44458595|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
44458596|NCT01592695|Ethanol|ethanol|mesh-list
44458597|NCT01592695|Bupropion|bupropion|mesh-list
44458598|NCT01592695|Nicotine|nicotine|mesh-list
44458599|NCT01592695|Varenicline|varenicline|mesh-list
44458600|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
44458601|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
43656739|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43656740|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43656741|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43656879|NCT02958059|Cefoxitin|cefoxitin|mesh-list
44458602|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44458603|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458604|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
44458605|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44458606|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
44458607|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44458608|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458609|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44458610|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44458611|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44232982|NCT00542139|Betamethasone|betamethasone|mesh-list
44232983|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44232984|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
44232985|NCT00542139|Hormones|hormones|mesh-ancestor
44232986|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44232987|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44232990|NCT00542152|Cyclosporine|cyclosporine|mesh-list
44233000|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
44233001|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233002|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44233003|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44233004|NCT00542165|Alfuzosin|alfuzosin|mesh-list
44233005|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44233006|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44233007|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44233008|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
44233009|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233010|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233011|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233012|NCT00542165|Urological Agents|urological agents|mesh-ancestor
44233013|NCT00542243|Finasteride|finasteride|mesh-list
44233014|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
44233015|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44233016|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233017|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233018|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
44233019|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233020|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233021|NCT00542243|Urological Agents|urological agents|mesh-ancestor
44233022|NCT00542295|Mebeverine|mebeverine|mesh-list
44233023|NCT00542295|Alverine|alverine|mesh-list
44233024|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
44233025|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
44233029|NCT00542347|Esomeprazole|esomeprazole|mesh-list
44233046|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44233047|NCT00542412|Protective Agents|protective agents|mesh-ancestor
44233048|NCT00542555|Naproxen|naproxen|mesh-list
44233049|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
44233050|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44233051|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233052|NCT00542555|Analgesics|analgesics|mesh-ancestor
44233053|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
44233054|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233055|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233056|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233057|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233058|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
43656895|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656896|NCT02957994|Tenofovir|tenofovir|mesh-list
43656897|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
43656898|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233059|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44233060|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233061|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233062|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44233063|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
44233064|NCT00542568|Hematinics|hematinics|mesh-ancestor
44233065|NCT00542607|Levocetirizine|levocetirizine|mesh-list
44233066|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44233067|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44233068|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
44233069|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
44233070|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233071|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233072|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233073|NCT00542711|Curcumin|curcumin|mesh-list
44233091|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233092|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233093|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233094|NCT00542802|Carbamazepine|carbamazepine|mesh-list
44233095|NCT00542802|Levetiracetam|levetiracetam|mesh-list
44233096|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
44233097|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
44233098|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
44233099|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44233100|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233101|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233102|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233103|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233104|NCT00542802|Analgesics|analgesics|mesh-ancestor
44233105|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
44233106|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233107|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44233148|NCT00543075|Oblimersen|oblimersen|mesh-list
44233149|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233150|NCT00543114|Rituximab|rituximab|mesh-list
44233151|NCT00543114|Fludarabine|fludarabine|mesh-list
44233152|NCT00543114|Lenalidomide|lenalidomide|mesh-list
44233153|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233154|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233155|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
44233156|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233157|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656903|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43656904|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43656905|NCT02958111|Capecitabine|capecitabine|mesh-list
43656906|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43656907|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
43656908|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656909|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656910|NCT02958163|Doxorubicin|doxorubicin|mesh-list
44233158|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233159|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233160|NCT00543114|Growth Substances|growth substances|mesh-ancestor
44233161|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233162|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
44233163|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44233164|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
44233165|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233166|NCT00543179|Lanreotide|lanreotide|mesh-list
44233207|NCT00543504|Trastuzumab|trastuzumab|mesh-list
44233208|NCT00543504|Cetuximab|cetuximab|mesh-list
44233209|NCT00543504|Sunitinib|sunitinib|mesh-list
44233210|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
44233211|NCT00543504|Sorafenib|sorafenib|mesh-list
44233212|NCT00543504|Lapatinib|lapatinib|mesh-list
44233213|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233214|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657019|NCT02957656|Vaccines|vaccines|mesh-list
44233215|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233216|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233217|NCT00543504|Growth Substances|growth substances|mesh-ancestor
44233218|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233219|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233220|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233221|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233222|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233223|NCT00543608|Vancomycin|vancomycin|mesh-list
44233224|NCT00543608|Iclaprim|iclaprim|mesh-list
44233225|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44233226|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233227|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44233228|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233229|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233230|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44233231|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44233232|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44233233|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
44233234|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44233235|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233236|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44233237|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44233238|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44233250|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233251|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44233252|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
44233253|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233254|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233255|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44233256|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
44233257|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
44233258|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
44233259|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
44233260|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
44233261|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233262|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
44233263|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44233264|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233265|NCT00543829|Tamoxifen|tamoxifen|mesh-list
44233266|NCT00543829|Docetaxel|docetaxel|mesh-list
44233267|NCT00543829|Doxorubicin|doxorubicin|mesh-list
44233268|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44233269|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233270|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
44233271|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
44233272|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
44233273|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233274|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233275|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233276|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233277|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233294|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233295|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233296|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233297|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
44233298|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233299|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233300|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233301|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
44233302|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44233303|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
44233304|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233305|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233306|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44233307|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
44233308|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44233309|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
44233310|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233311|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233312|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44233313|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
44233347|NCT00544050|Levetiracetam|levetiracetam|mesh-list
44233348|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
44233349|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
44233350|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
44233351|NCT00544063|Irinotecan|irinotecan|mesh-list
44233352|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233353|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44233354|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233355|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233356|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44458612|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44233357|NCT00544128|Ritonavir|ritonavir|mesh-list
44233358|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
44233359|NCT00544128|Tenofovir|tenofovir|mesh-list
44233360|NCT00544128|Lamivudine|lamivudine|mesh-list
44233361|NCT00544128|Emtricitabine|emtricitabine|mesh-list
44233362|NCT00544128|Abacavir|abacavir|mesh-list
44233363|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44233364|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44233365|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
44233366|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233367|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657059|NCT02957162|Atorvastatin|atorvastatin|mesh-list
43657060|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43657061|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43657062|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
43657064|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44233368|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44233369|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44233370|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
44233371|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233372|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44233394|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233395|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233396|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233397|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
44233398|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233399|NCT00544219|Prednisone|prednisone|mesh-list
44233400|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
44233401|NCT00544219|Rituximab|rituximab|mesh-list
44233402|NCT00544219|Doxorubicin|doxorubicin|mesh-list
44233403|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
44233404|NCT00544219|Vincristine|vincristine|mesh-list
44233405|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233406|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
44233407|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233408|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233409|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233410|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
44233411|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233412|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233413|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44233414|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233415|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233416|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233417|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233418|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233419|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233420|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
44233421|NCT00544219|Hormones|hormones|mesh-ancestor
44233422|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233423|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44233424|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44164758|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164759|NCT00257712|Hormones|hormones|mesh-list
44164760|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
44164761|NCT00257712|Tesamorelin|tesamorelin|mesh-list
44164762|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164763|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164764|NCT00257712|Growth Substances|growth substances|mesh-ancestor
44164765|NCT00257751|Aprotinin|aprotinin|mesh-list
44164766|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
44164767|NCT00257751|Coagulants|coagulants|mesh-ancestor
44164768|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
44164769|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44233426|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
44233427|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
44233428|NCT00544232|Paclitaxel|paclitaxel|mesh-list
44233429|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44233430|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
44233431|NCT00544232|Methotrexate|methotrexate|mesh-list
44233432|NCT00544232|Epirubicin|epirubicin|mesh-list
44233433|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
44233434|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44233435|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233436|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
44233437|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
44233438|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
44233439|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233440|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233441|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
44233442|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233443|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43825277|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43657076|NCT02956655|Insulin|insulin|mesh-list
44233444|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233445|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
44233446|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44233447|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44233448|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
44233449|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44233450|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233451|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
44233452|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
44233453|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233454|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44233455|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44233456|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233457|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233458|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233466|NCT00544349|Leucovorin|leucovorin|mesh-list
44233467|NCT00544349|Fluorouracil|fluorouracil|mesh-list
44233468|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
44233469|NCT00544349|Cetuximab|cetuximab|mesh-list
44233470|NCT00544349|Calcium|calcium|mesh-list
44233471|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
44233472|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44233473|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233474|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
44233475|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233476|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233477|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233478|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233479|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
44233480|NCT00544349|Antidotes|antidotes|mesh-ancestor
44233481|NCT00544349|Protective Agents|protective agents|mesh-ancestor
44233482|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
44233483|NCT00544349|Vitamins|vitamins|mesh-ancestor
44233484|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
44233485|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233486|NCT00544362|Cisplatin|cisplatin|mesh-list
44233487|NCT00544362|Fluorouracil|fluorouracil|mesh-list
44233488|NCT00544362|Cetuximab|cetuximab|mesh-list
44233489|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233490|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
44233491|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233492|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233493|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233494|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
44233495|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233496|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233497|NCT00544388|Levocetirizine|levocetirizine|mesh-list
44233498|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
44233499|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
44233500|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
44233501|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
44233502|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233506|NCT00544505|Fluorouracil|fluorouracil|mesh-list
44233507|NCT00544505|Epirubicin|epirubicin|mesh-list
44233508|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233509|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
44233510|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657079|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657080|NCT02956538|Thalidomide|thalidomide|mesh-list
43657081|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657082|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
43657083|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657084|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
43657085|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44233511|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233512|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44233513|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
44233514|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233515|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233516|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44233517|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
44233518|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44233519|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233520|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233521|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233522|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233523|NCT00544518|Metformin|metformin|mesh-list
44233524|NCT00544518|Benfluorex|benfluorex|mesh-list
44233525|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233526|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233527|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44233528|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
44233529|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233530|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44233531|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
44233532|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44233533|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
44233534|NCT00544570|Melphalan|melphalan|mesh-list
44233535|NCT00544570|Carmustine|carmustine|mesh-list
44233536|NCT00544570|Etoposide|etoposide|mesh-list
44233537|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233538|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
44233549|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233550|NCT00544596|Acetic Acid|acetic acid|mesh-list
44233551|NCT00544596|Cisplatin|cisplatin|mesh-list
44233552|NCT00544596|Etoposide|etoposide|mesh-list
44233553|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
44233554|NCT00544596|Retinol acetate|retinol acetate|mesh-list
44233555|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
44233556|NCT00544596|Gossypol|gossypol|mesh-list
44233557|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233558|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44233559|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233560|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233561|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233562|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233563|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44233564|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233565|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44233566|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
44233567|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233568|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44233569|NCT00544596|Protective Agents|protective agents|mesh-ancestor
44233570|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
44233571|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
44233572|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44233573|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44233574|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
44233575|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
44233576|NCT00544609|Sorafenib|sorafenib|mesh-list
44233577|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233578|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233579|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657089|NCT02956538|Growth Substances|growth substances|mesh-ancestor
43657092|NCT02957409|Valsartan|valsartan|mesh-list
44233580|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233581|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
44233582|NCT00544687|Nortriptyline|nortriptyline|mesh-list
44233583|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233584|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
44233589|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44233590|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44233591|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44233592|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233593|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
44233594|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233595|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233596|NCT00544700|Bevacizumab|bevacizumab|mesh-list
44233597|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233598|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233599|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233600|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233601|NCT00544700|Growth Substances|growth substances|mesh-ancestor
44233602|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233603|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233604|NCT00544791|Melatonin|melatonin|mesh-list
44233605|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
44233606|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233607|NCT00544791|Protective Agents|protective agents|mesh-ancestor
44233608|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233609|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233610|NCT00544804|Lapatinib|lapatinib|mesh-list
44233611|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233612|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233613|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233615|NCT00544986|Anastrozole|anastrozole|mesh-list
44233634|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233635|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233636|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
44233637|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233638|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44233639|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44233640|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44233641|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233642|NCT00545012|Levetiracetam|levetiracetam|mesh-list
44233643|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
44233644|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
44233645|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
44233646|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233647|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233648|NCT00545142|Valproic Acid|valproic acid|mesh-list
44233649|NCT00545142|Aripiprazole|aripiprazole|mesh-list
44233650|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
44233651|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233652|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44233653|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44233654|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233655|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233656|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
44233657|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
44233658|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233659|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233660|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44233678|NCT00545246|Docetaxel|docetaxel|mesh-list
44233682|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
44233683|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
44233684|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233685|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233686|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233687|NCT00545246|Growth Substances|growth substances|mesh-ancestor
44233688|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233689|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233690|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
44233691|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44233692|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44233693|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44233694|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
44233695|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44233696|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233697|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233698|NCT00545389|Mesalamine|mesalamine|mesh-list
44233699|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44233700|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44233701|NCT00545389|Analgesics|analgesics|mesh-ancestor
44233702|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
44233703|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44233704|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233705|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44233706|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44233707|NCT00545467|Aripiprazole|aripiprazole|mesh-list
44233708|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
44233709|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44233710|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44233711|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44233712|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44233713|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233714|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
44233715|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
44233720|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
44233721|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44233722|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44233723|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44233724|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44233725|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
44233726|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233727|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233728|NCT00545493|Tacrolimus|tacrolimus|mesh-list
44233729|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
44233730|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44233731|NCT00545493|Antibodies|antibodies|mesh-list
44233732|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44233733|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
44233734|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233735|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44233736|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233737|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233738|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
44233775|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44233776|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44233777|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
44233778|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44233779|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
44233780|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233781|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
44233782|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
44233783|NCT00545831|Taurolidine|taurolidine|mesh-list
44233784|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44233785|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44233786|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233787|NCT00545857|Pioglitazone|pioglitazone|mesh-list
44233788|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44233789|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233790|NCT00545870|Bevacizumab|bevacizumab|mesh-list
43657107|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43657108|NCT02956421|Vaccines|vaccines|mesh-list
43657109|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
43657110|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657117|NCT02955810|Dexamethasone|dexamethasone|mesh-list
44233791|NCT00545870|Ranibizumab|ranibizumab|mesh-list
44233792|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44233793|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233794|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44233795|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44233796|NCT00545870|Growth Substances|growth substances|mesh-ancestor
44233797|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233798|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
44233799|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
44233800|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44233801|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233802|NCT00545935|Artesunate|artesunate|mesh-list
44233803|NCT00545935|Amodiaquine|amodiaquine|mesh-list
43657122|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
44233804|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
44233820|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233821|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233823|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
44233824|NCT00546039|Protective Agents|protective agents|mesh-ancestor
44233825|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44233826|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44233827|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44233828|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44233829|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44233830|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
44233831|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
44233832|NCT00546039|Estrogens|estrogens|mesh-ancestor
44233833|NCT00546039|Hormones|hormones|mesh-ancestor
44233834|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44233835|NCT00546065|Esomeprazole|esomeprazole|mesh-list
44233836|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44233837|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44233838|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44233839|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458621|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44458622|NCT01592409|Dronabinol|dronabinol|mesh-list
44458623|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
44458624|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44458625|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44458626|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44458627|NCT01592409|Analgesics|analgesics|mesh-ancestor
44458628|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
44458629|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44158465|NCT00236782|Estradiol|estradiol|mesh-list
43598347|NCT03300765|Apatinib|apatinib|mesh-list
44134807|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134808|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44134809|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44134810|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
44134811|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44158905|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
44159060|NCT00238225|Calcitriol|calcitriol|mesh-list
44159222|NCT00238563|Hormones|hormones|mesh-ancestor
44134812|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
43657123|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657124|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44134813|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870070|NCT05605314|Cyclosporine|cyclosporine|mesh-list
43870071|NCT05605314|Cyclosporins|cyclosporins|mesh-list
43870072|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870073|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870074|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870075|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
43870076|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870077|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
43870078|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870079|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
43870080|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43870108|NCT05574985|Vaccines|vaccines|mesh-list
43870109|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
43870110|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870142|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870144|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
44161001|NCT00243815|Ibuprofen|ibuprofen|mesh-list
43870145|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43870146|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43870147|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43870148|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43870149|NCT05411380|Capecitabine|capecitabine|mesh-list
43870150|NCT05411380|Letrozole|letrozole|mesh-list
43870151|NCT05411380|Fulvestrant|fulvestrant|mesh-list
43870152|NCT05411380|Anastrozole|anastrozole|mesh-list
43870153|NCT05411380|Exemestane|exemestane|mesh-list
43870154|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870155|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
43870156|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870157|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870158|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43870159|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43870160|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870161|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43870162|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
43870163|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870164|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870165|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43870166|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43870167|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
43870168|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43870169|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870170|NCT05390476|Capecitabine|capecitabine|mesh-list
43870171|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870172|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
43870173|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870174|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870175|NCT05358704|Leucovorin|leucovorin|mesh-list
43870176|NCT05358704|Fluorouracil|fluorouracil|mesh-list
43870179|NCT05358704|Irinotecan|irinotecan|mesh-list
43870180|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
43870181|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870182|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657142|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43870183|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870184|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870185|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
43870186|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870187|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43870188|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43870189|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870190|NCT05358704|Antidotes|antidotes|mesh-ancestor
43870191|NCT05358704|Protective Agents|protective agents|mesh-ancestor
43870192|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
43870193|NCT05358704|Vitamins|vitamins|mesh-ancestor
43870194|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
43870195|NCT05358691|Durvalumab|durvalumab|mesh-list
43870196|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870197|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870198|NCT05331131|Ketamine|ketamine|mesh-list
43870199|NCT05331131|Analgesics|analgesics|mesh-ancestor
43870200|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
43870201|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870202|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870203|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43870204|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43870205|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
43870206|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
43870207|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870208|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43870209|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43870210|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870211|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870212|NCT05327010|Talazoparib|talazoparib|mesh-list
43870218|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43870219|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870221|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
43870222|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43870223|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43870224|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134814|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134815|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44134816|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134817|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44134818|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
44134819|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134820|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134821|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44134822|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134823|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
44134824|NCT00159302|Protective Agents|protective agents|mesh-ancestor
44134825|NCT00159380|Pimagedine|pimagedine|mesh-list
44134826|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134827|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134828|NCT00159445|Gemcitabine|gemcitabine|mesh-list
43657210|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
43657211|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657212|NCT02955927|Atropine|atropine|mesh-list
43850296|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43657227|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
43657228|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43827088|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850334|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
43850335|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134829|NCT00159445|Capecitabine|capecitabine|mesh-list
44134830|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44134831|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
44162075|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44134832|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134833|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134835|NCT00159445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134836|NCT00159445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134837|NCT00159445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44134838|NCT00159445|Immunologic Factors|immunologic factors|mesh-ancestor
44134839|NCT00159445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134840|NCT00159458|Gemcitabine|gemcitabine|mesh-list
44134841|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
44134842|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44134845|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134846|NCT00159458|Antiviral Agents|antiviral agents|mesh-ancestor
44134847|NCT00159458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134848|NCT00159458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134849|NCT00159458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44134850|NCT00159458|Immunologic Factors|immunologic factors|mesh-ancestor
44134851|NCT00159458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134852|NCT00159471|Gemcitabine|gemcitabine|mesh-list
44134853|NCT00159471|Capecitabine|capecitabine|mesh-list
44134854|NCT00159471|Docetaxel|docetaxel|mesh-list
44134855|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44134856|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
44134857|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134858|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44134859|NCT00159471|Antiviral Agents|antiviral agents|mesh-ancestor
44134860|NCT00159471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44134861|NCT00159471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134862|NCT00159471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44162373|NCT00249210|Levofloxacin|levofloxacin|mesh-list
44162566|NCT00249886|Citalopram|citalopram|mesh-list
44134863|NCT00159471|Immunologic Factors|immunologic factors|mesh-ancestor
44134864|NCT00159471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134865|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
44134866|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
44134867|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
44134868|NCT00159484|Celecoxib|celecoxib|mesh-list
44134869|NCT00159484|Epothilone B|epothilone b|mesh-list
44134870|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44134871|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43870232|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870233|NCT05286619|Antiviral Agents|antiviral agents|mesh-ancestor
43870234|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870235|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870236|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870237|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
43870238|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870239|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870241|NCT05257629|Varenicline|varenicline|mesh-list
43870242|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43870243|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
43870244|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870245|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870246|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43870247|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43870248|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
43870249|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870250|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44163708|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
44163780|NCT00253929|Adenosine|adenosine|mesh-list
43870252|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
43870253|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870254|NCT05152888|Evolocumab|evolocumab|mesh-list
43870255|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43870256|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43870257|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
43870258|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870259|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43870260|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
43870261|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870262|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870263|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
43870264|NCT05087381|Niclosamide|niclosamide|mesh-list
43870272|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870273|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870274|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43870275|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870276|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870277|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870279|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43870280|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870281|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43870282|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870283|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43870284|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
43870285|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43870286|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
43870287|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43870288|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870289|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
43870290|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
43870291|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
43870292|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870293|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43870294|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
43870295|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
43870296|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43870297|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43870298|NCT05087381|Expectorants|expectorants|mesh-ancestor
43870299|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134886|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
43870317|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43870318|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43870319|NCT04880850|Insulin|insulin|mesh-list
43870320|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43870321|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
43870322|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
43870323|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870324|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870325|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
43870326|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
43850376|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850377|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43850378|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870327|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
43870328|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
43870329|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43870330|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43870331|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870332|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43870333|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870334|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870335|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43870336|NCT04783051|Renal Agents|renal agents|mesh-ancestor
43870337|NCT04748991|Amiodarone|amiodarone|mesh-list
43870338|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43870339|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
43870340|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43870341|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870342|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870343|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43870344|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43870345|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870350|NCT04733937|Caseins|caseins|mesh-list
43870359|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43870360|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43870361|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
43870362|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
43870363|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870364|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43870365|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43870366|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870367|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870368|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
43870369|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43870370|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43870371|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870372|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
43870373|NCT04696224|Coagulants|coagulants|mesh-ancestor
43870374|NCT04679480|Cemiplimab|cemiplimab|mesh-list
44134887|NCT00159510|Methylene Blue|methylene blue|mesh-list
44164756|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870413|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
43870414|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870415|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134888|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44134889|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
44134890|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134891|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134892|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44134893|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
44134894|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
44134895|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
44134896|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134897|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44134898|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
44134899|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
44134900|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
44134901|NCT00159510|Protective Agents|protective agents|mesh-ancestor
44134902|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44134904|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134905|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134906|NCT00159575|Metformin|metformin|mesh-list
44134907|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44134908|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134909|NCT00159614|Rolofylline|rolofylline|mesh-list
44134910|NCT00159614|Diuretics|diuretics|mesh-ancestor
44134911|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
44134912|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134913|NCT00159627|Rolofylline|rolofylline|mesh-list
43870424|NCT04531176|Topiramate|topiramate|mesh-list
43870425|NCT04531176|Orlistat|orlistat|mesh-list
43870426|NCT04531176|Phentermine|phentermine|mesh-list
43870427|NCT04531176|Naltrexone|naltrexone|mesh-list
43870428|NCT04531176|Bupropion|bupropion|mesh-list
43870429|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43870430|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43870431|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870432|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
43870433|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870434|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870435|NCT04531176|Incretins|incretins|mesh-ancestor
43870436|NCT04531176|Hormones|hormones|mesh-ancestor
43870437|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870438|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43870439|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870440|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870441|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43870442|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870443|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870444|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870445|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
43870446|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870447|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44165860|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44165948|NCT00262210|Hormones|hormones|mesh-ancestor
43870448|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870449|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870450|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
43870451|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43870458|NCT04526730|Nivolumab|nivolumab|mesh-list
43870466|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870467|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870468|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870469|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43870470|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870471|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870472|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870473|NCT04518319|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43870474|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870475|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870476|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870477|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870479|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
43870480|NCT04499950|Naltrexone|naltrexone|mesh-list
43870481|NCT04499950|Bupropion|bupropion|mesh-list
43870482|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43870483|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43870484|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870485|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
43870486|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870487|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43870488|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
43870489|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870490|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43870491|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870492|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870504|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870505|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870506|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
43870507|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870508|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43870509|NCT04446871|Methylene Blue|methylene blue|mesh-list
43870510|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870511|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870512|NCT04429503|Aflibercept|aflibercept|mesh-list
43870513|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43870514|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43870515|NCT04429503|Growth Substances|growth substances|mesh-ancestor
43870516|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870517|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
43870518|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870519|NCT04348474|Azithromycin|azithromycin|mesh-list
43870520|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
43870521|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870522|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870523|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
43870524|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43870525|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43870526|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870527|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870528|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43870529|NCT04284839|Warfarin|warfarin|mesh-list
43870530|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
43870531|NCT04284839|Dabigatran|dabigatran|mesh-list
43870532|NCT04284839|Apixaban|apixaban|mesh-list
43870533|NCT04284839|Edoxaban|edoxaban|mesh-list
43870534|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
43870535|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43870536|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
43870537|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43870538|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
43870539|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44166927|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870540|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770467|NCT02380053|Celiprolol|celiprolol|mesh-list
43870542|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43870544|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43870545|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870546|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
43870547|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
43870548|NCT04273139|Venetoclax|venetoclax|mesh-list
43870549|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870550|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
43870551|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
43870552|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
43870553|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43870554|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43870555|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870556|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870557|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870558|NCT04216472|Paclitaxel|paclitaxel|mesh-list
43870559|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43870560|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
43870561|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43870562|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870563|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870564|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870565|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
43870589|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44167740|NCT00269412|Rifaximin|rifaximin|mesh-list
43870590|NCT04117581|Vitamin D|vitamin d|mesh-list
43870591|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
44168051|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
43870592|NCT04117581|Vitamins|vitamins|mesh-ancestor
43870593|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
43870594|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870595|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43870596|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43870597|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
43870598|NCT04110340|Gentamicins|gentamicins|mesh-list
43870599|NCT04110340|Streptomycin|streptomycin|mesh-list
43870600|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43870601|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870602|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43870603|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43870604|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870605|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870606|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870607|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43870608|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43870609|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43870610|NCT04087460|Vaccines|vaccines|mesh-list
43870611|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43870615|NCT04085419|Denosumab|denosumab|mesh-list
43657233|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43870637|NCT04062656|Leucovorin|leucovorin|mesh-list
43870638|NCT04062656|Folic Acid|folic acid|mesh-list
43870639|NCT04062656|Docetaxel|docetaxel|mesh-list
43870640|NCT04062656|Fluorouracil|fluorouracil|mesh-list
43870641|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
43870642|NCT04062656|Nivolumab|nivolumab|mesh-list
43870643|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870644|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870645|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870646|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
43870647|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870648|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
43870649|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870650|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870651|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
43870652|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870653|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870654|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43870655|NCT04062656|Antidotes|antidotes|mesh-ancestor
43870656|NCT04062656|Protective Agents|protective agents|mesh-ancestor
43870657|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
43870658|NCT04062656|Vitamins|vitamins|mesh-ancestor
43870659|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
43657235|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657236|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
43657237|NCT02954939|Hormones|hormones|mesh-ancestor
43870686|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870687|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43657238|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850588|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870688|NCT04051203|Protective Agents|protective agents|mesh-ancestor
43870689|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43870690|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870691|NCT04042142|Glucagon|glucagon|mesh-list
43870692|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870693|NCT04042142|Hormones|hormones|mesh-ancestor
43870694|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870695|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870696|NCT04026451|Propofol|propofol|mesh-list
43870697|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43870698|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870699|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870700|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43870701|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
43870702|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
44169505|NCT00274872|Leucovorin|leucovorin|mesh-list
43870714|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
43870715|NCT04005599|Remifentanil|remifentanil|mesh-list
43870716|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43870717|NCT04005599|Narcotics|narcotics|mesh-ancestor
43870718|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870719|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870720|NCT04005599|Analgesics|analgesics|mesh-ancestor
43870721|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
43870722|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870723|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
44169858|NCT00278330|Vorinostat|vorinostat|mesh-list
44169941|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
43870724|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43870728|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870729|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44170245|NCT00280033|Antacids|antacids|mesh-ancestor
43870730|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
44170458|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870731|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43870732|NCT03980561|Varenicline|varenicline|mesh-list
43870733|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43870734|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43870735|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
43870736|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43870737|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870738|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870739|NCT03972397|Bupivacaine|bupivacaine|mesh-list
43870740|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
43870741|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
43870742|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870743|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44170540|NCT00281281|Vancomycin|vancomycin|mesh-list
44170828|NCT00282178|Candesartan|candesartan|mesh-list
44171273|NCT00284531|Daclizumab|daclizumab|mesh-list
44171348|NCT00284947|Prednisone|prednisone|mesh-list
43870744|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
43870745|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134923|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134924|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134925|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44134926|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43657294|NCT02954484|Ropivacaine|ropivacaine|mesh-list
44134927|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
44134928|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
44134930|NCT00159666|Analgesics|analgesics|mesh-ancestor
44134931|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
44134940|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134941|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134942|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134943|NCT00159679|Pregabalin|pregabalin|mesh-list
44134944|NCT00159679|Analgesics|analgesics|mesh-ancestor
43657295|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43657296|NCT02954484|Narcotics|narcotics|mesh-ancestor
43657305|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
43657306|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
43657307|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43657335|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657336|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43657337|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43657338|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43657339|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43657340|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43657341|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43657342|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43657343|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43657344|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
43657345|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43657346|NCT02953743|Lenvatinib|lenvatinib|mesh-list
43657347|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657348|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43657361|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44134945|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
44134946|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44134947|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44134948|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
44134949|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134950|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134951|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44134952|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44134953|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44134954|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44134955|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44134956|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44134957|NCT00159692|Amlodipine|amlodipine|mesh-list
44134958|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44134959|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44134960|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44134961|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44155720|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870748|NCT03855371|Decitabine|decitabine|mesh-list
43870749|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
43870750|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43870751|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
43870767|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870769|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
43870770|NCT03808610|Dexamethasone|dexamethasone|mesh-list
43870771|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
43870772|NCT03808610|Prednisone|prednisone|mesh-list
43870773|NCT03808610|Cortisone|cortisone|mesh-list
43870774|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
43870775|NCT03808610|Rituximab|rituximab|mesh-list
43870776|NCT03808610|Methotrexate|methotrexate|mesh-list
43870777|NCT03808610|Vincristine|vincristine|mesh-list
43870778|NCT03808610|Venetoclax|venetoclax|mesh-list
43870779|NCT03808610|Asparaginase|asparaginase|mesh-list
43870780|NCT03808610|Pegaspargase|pegaspargase|mesh-list
43870781|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43870782|NCT03808610|Antibodies|antibodies|mesh-list
43870783|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
43870784|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43870785|NCT03808610|BB 1101|bb 1101|mesh-list
43870786|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43870787|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
43870788|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870789|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43870790|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43870791|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
43870792|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870793|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870794|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43870795|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43870796|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
43870797|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
43870798|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870799|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870800|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
43870801|NCT03808610|Hormones|hormones|mesh-ancestor
43870802|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870810|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
43870811|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43870812|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43870813|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43870814|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
43870815|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43870816|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43870817|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43870818|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
43870819|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
43870820|NCT03793114|Cosyntropin|cosyntropin|mesh-list
43870821|NCT03793114|Hormones|hormones|mesh-ancestor
43870822|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43870823|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870824|NCT03786237|ON 01910|on 01910|mesh-list
43870825|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870826|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43870827|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870828|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870829|NCT03652870|Dexetimide|dexetimide|mesh-list
43870830|NCT03652870|Citalopram|citalopram|mesh-list
43870831|NCT03652870|Nortriptyline|nortriptyline|mesh-list
43870832|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44172111|NCT00287911|Cisplatin|cisplatin|mesh-list
43870854|NCT03583528|Edotreotide|edotreotide|mesh-list
43870855|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43870856|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870857|NCT03570632|Metformin|metformin|mesh-list
43870858|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870859|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870860|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
43870861|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
43870862|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870863|NCT03549000|Spartalizumab|spartalizumab|mesh-list
43870864|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43870865|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44172753|NCT00290628|Melphalan|melphalan|mesh-list
43657362|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43657363|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43657365|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
43657366|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657368|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613571|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44172968|NCT00291122|Analgesics|analgesics|mesh-ancestor
44173046|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
43870866|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870868|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
43870869|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
43870870|NCT03531918|Cladribine|cladribine|mesh-list
43870871|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
43870872|NCT03531918|Calicheamicins|calicheamicins|mesh-list
43870907|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43870908|NCT03509584|Nivolumab|nivolumab|mesh-list
43870909|NCT03509584|Ipilimumab|ipilimumab|mesh-list
43870910|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870911|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870912|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43870913|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870914|NCT03491631|Apatinib|apatinib|mesh-list
43870915|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870916|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43870917|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870918|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870919|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
43870920|NCT03463460|Sunitinib|sunitinib|mesh-list
43870921|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870922|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870923|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43870924|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43870925|NCT03463460|Growth Substances|growth substances|mesh-ancestor
43870926|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870927|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
43870928|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43870929|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43870930|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870931|NCT03448159|Fluoxetine|fluoxetine|mesh-list
43870932|NCT03448159|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43870933|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44173270|NCT00292526|Enalapril|enalapril|mesh-list
43870937|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
43870950|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43870951|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
43870952|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870953|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657384|NCT02953275|Protective Agents|protective agents|mesh-ancestor
43657385|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657386|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
43657387|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43657389|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657390|NCT02953210|Dexamethasone|dexamethasone|mesh-list
43657391|NCT02953210|Ketorolac|ketorolac|mesh-list
43657392|NCT02953210|Lidocaine|lidocaine|mesh-list
43657393|NCT02953210|Clonidine|clonidine|mesh-list
43657394|NCT02953210|Fentanyl|fentanyl|mesh-list
43657395|NCT02953210|Midazolam|midazolam|mesh-list
43657396|NCT02953210|Ketamine|ketamine|mesh-list
43657397|NCT02953210|Ondansetron|ondansetron|mesh-list
43657398|NCT02953210|Bupivacaine|bupivacaine|mesh-list
43657399|NCT02953210|Propofol|propofol|mesh-list
43870954|NCT03326180|Bupivacaine|bupivacaine|mesh-list
43870955|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
43870956|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
43870957|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870958|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870959|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
43870960|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870961|NCT03298295|Insulin|insulin|mesh-list
43870962|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43870963|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870964|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
43870965|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43870966|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43870967|NCT03246620|Diazepam|diazepam|mesh-list
43870968|NCT03246620|Haloperidol|haloperidol|mesh-list
43870969|NCT03246620|Olanzapine|olanzapine|mesh-list
43870970|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
43870971|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
43870972|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
44173836|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43870973|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43870974|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43870975|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43870976|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43870977|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43870978|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43870979|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43870980|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43870981|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43870982|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43870989|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43870990|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
43870991|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43870992|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43870993|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43870994|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43870995|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43870996|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
43870997|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
43657410|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657411|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
43870998|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
43870999|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
43871000|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
43871001|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871002|NCT03158376|Gabapentin|gabapentin|mesh-list
43871003|NCT03158376|Analgesics|analgesics|mesh-ancestor
43871004|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
43871005|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871006|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657412|NCT02953210|Hormones|hormones|mesh-ancestor
43657413|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657414|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657415|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657416|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
43657417|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
43657418|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657419|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
43657420|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43657421|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43657422|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43871007|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
43871008|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43871009|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43871010|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871046|NCT02954991|Nivolumab|nivolumab|mesh-list
43871047|NCT02954991|Mocetinostat|mocetinostat|mesh-list
43871048|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43871049|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871050|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43871051|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871052|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43871053|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871055|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
43871056|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43871057|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871058|NCT02892591|Oxycodone|oxycodone|mesh-list
43871059|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43871060|NCT02892591|Narcotics|narcotics|mesh-ancestor
43871061|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44175021|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44175091|NCT00298545|Vitamins|vitamins|mesh-ancestor
43871062|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871063|NCT02892591|Analgesics|analgesics|mesh-ancestor
43871064|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
43871065|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871066|NCT02850081|Atorvastatin|atorvastatin|mesh-list
43871067|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43871068|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43871069|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43871070|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
43871071|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871072|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43871073|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871074|NCT02783430|Ketamine|ketamine|mesh-list
43871075|NCT02783430|Milnacipran|milnacipran|mesh-list
43871076|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
43871077|NCT02783430|Analgesics|analgesics|mesh-ancestor
43871078|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
43871079|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871080|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871081|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44164770|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
44164771|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43871082|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43871083|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
43871084|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
43871085|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43871086|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43871087|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43871088|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657424|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871089|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43871090|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43871091|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43871092|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43871093|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43871094|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
43871095|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43871096|NCT02780609|Dexamethasone|dexamethasone|mesh-list
43871097|NCT02780609|Melphalan|melphalan|mesh-list
43871098|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
43871099|NCT02780609|Aprepitant|aprepitant|mesh-list
43871100|NCT02780609|Antiemetics|antiemetics|mesh-list
44175350|NCT00299351|Romidepsin|romidepsin|mesh-list
44175500|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43871101|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43871102|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
43871103|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871104|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871105|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43871106|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
43871107|NCT02780609|Hormones|hormones|mesh-ancestor
43871108|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871109|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43871110|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43871111|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43871120|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43871121|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
43871122|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43871123|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871124|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43871125|NCT02740179|Diuretics|diuretics|mesh-ancestor
43871126|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
43871127|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43871128|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
43871129|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
43871130|NCT02661035|Fludarabine|fludarabine|mesh-list
43887425|NCT04552951|Vitamin D|vitamin d|mesh-list
43887426|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
43887427|NCT04552951|Vitamins|vitamins|mesh-ancestor
43887428|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
43887429|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887430|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43887431|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887432|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
43887433|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43887434|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887435|NCT04552444|Biapenem|biapenem|mesh-list
43887436|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887437|NCT04552613|Carboplatin|carboplatin|mesh-list
43887438|NCT04552613|Pemetrexed|pemetrexed|mesh-list
43887439|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887440|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887441|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887442|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43887443|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43887444|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43887445|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
43887446|NCT04552431|Tamsulosin|tamsulosin|mesh-list
43887447|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887448|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887449|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43887454|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43887455|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43887456|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43887457|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43887458|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43887459|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
43887460|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887461|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887462|NCT04552431|Urological Agents|urological agents|mesh-ancestor
43887463|NCT04552093|Floxuridine|floxuridine|mesh-list
43887464|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43887465|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
43887466|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887467|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887468|NCT04551924|Ropivacaine|ropivacaine|mesh-list
43887469|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
43887470|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
43887471|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887472|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887473|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
43887474|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887476|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
43887477|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43887478|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43887479|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887480|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
43887481|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
43887482|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
43887483|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887484|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887496|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
43887497|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43887498|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43887499|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
43887500|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887501|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887502|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887503|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43887504|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43887506|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887507|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43887508|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
43887509|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
43887510|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
43887511|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43887512|NCT04551768|Ribavirin|ribavirin|mesh-list
43887513|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
43887514|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887515|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
43887516|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887517|NCT04551781|Prednisone|prednisone|mesh-list
43887518|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887519|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
43887520|NCT04551781|Hormones|hormones|mesh-ancestor
43887521|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887522|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887523|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887524|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887525|NCT04551573|Rifapentine|rifapentine|mesh-list
43887526|NCT04551573|Rifampin|rifampin|mesh-list
43887527|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43887528|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
43887529|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887536|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43887537|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43657442|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657443|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43657444|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
43848924|NCT03978442|Bupropion|bupropion|mesh-list
43887538|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43887539|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43887540|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43887541|NCT04551248|Vaccines|vaccines|mesh-list
43887542|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43887543|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
43887544|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887545|NCT04550936|Isavuconazole|isavuconazole|mesh-list
43887546|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
43887547|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848928|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43887548|NCT04550949|Denosumab|denosumab|mesh-list
43887549|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43887550|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887551|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
43887552|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43887553|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43887554|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887555|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
43887556|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887557|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887558|NCT04550858|Rebamipide|rebamipide|mesh-list
43887559|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43887560|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887561|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
43887562|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887563|NCT04550858|Protective Agents|protective agents|mesh-ancestor
43887564|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887565|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887566|NCT04550702|Mirabegron|mirabegron|mesh-list
43887567|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43887568|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43848929|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43850362|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
43850363|NCT05632627|Cannabidiol|cannabidiol|mesh-list
43850364|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
43657549|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
43657550|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657551|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657552|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657578|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43657579|NCT02952235|Protective Agents|protective agents|mesh-ancestor
43657580|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657581|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887569|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43887573|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887574|NCT04550702|Urological Agents|urological agents|mesh-ancestor
43887576|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
43887577|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887578|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
43887579|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43887580|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43887581|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887582|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
43887583|NCT04550338|Coagulants|coagulants|mesh-ancestor
43887584|NCT04550234|Allopurinol|allopurinol|mesh-list
43887586|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
43887587|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887588|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887589|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
43887590|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887591|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43887592|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
43887593|NCT04550234|Protective Agents|protective agents|mesh-ancestor
43887594|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887595|NCT04550585|Insulin|insulin|mesh-list
43887596|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43887597|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887598|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887599|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
43887600|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43887601|NCT04550611|Antibodies|antibodies|mesh-list
43887602|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
43887622|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887623|NCT04549844|Bupivacaine|bupivacaine|mesh-list
43851030|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851039|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851040|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43851041|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
43851042|NCT04759586|Hormones|hormones|mesh-ancestor
43851043|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851047|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43887624|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
43851048|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851049|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851050|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851051|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
43851052|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
43851053|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851054|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43851055|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43851056|NCT04759586|Protective Agents|protective agents|mesh-ancestor
43851057|NCT04729959|Atezolizumab|atezolizumab|mesh-list
43851058|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
43851059|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43851060|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
43851077|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
43851078|NCT04675710|Trametinib|trametinib|mesh-list
43851079|NCT04675710|Dabrafenib|dabrafenib|mesh-list
43887625|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
43887626|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887627|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887628|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
43887629|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136404|NCT00164710|Lumefantrine|lumefantrine|mesh-list
44136405|NCT00164710|Artemether|artemether|mesh-list
44136406|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
44136407|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
44136408|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
44136409|NCT00164710|Amodiaquine|amodiaquine|mesh-list
44136410|NCT00164710|Dapsone|dapsone|mesh-list
44136411|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
44136412|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
44136413|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44136414|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136415|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136416|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136417|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
44136418|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
44136419|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
44136420|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
44136421|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44136422|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136423|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136424|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43887630|NCT04549415|Metformin|metformin|mesh-list
43887631|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43887632|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887633|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
43887634|NCT04549012|Oxytocin|oxytocin|mesh-list
43887635|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
43887636|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43887637|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887643|NCT04548700|Prednisone|prednisone|mesh-list
43887644|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
43887645|NCT04548700|Vincristine|vincristine|mesh-list
43851082|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43851083|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851084|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851085|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
43851086|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851087|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851088|NCT04657692|Anesthetics|anesthetics|mesh-list
43851089|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851090|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851117|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851118|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43851119|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
43851120|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43851121|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
43851122|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43851123|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887646|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
43887647|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887648|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
43887649|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887650|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887651|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43887652|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
43887653|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887654|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887655|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43887656|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887657|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
43887658|NCT04548700|Hormones|hormones|mesh-ancestor
43887659|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887660|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887661|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43887662|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887663|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887664|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887665|NCT04548700|Analgesics|analgesics|mesh-ancestor
43887666|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
43887667|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887668|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43887669|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43887670|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887671|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
43887672|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43887673|NCT04548557|Antibodies|antibodies|mesh-list
43887674|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
43887675|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43887676|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
43887677|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887678|NCT04548440|Paclitaxel|paclitaxel|mesh-list
43887680|NCT04548440|Cisplatin|cisplatin|mesh-list
43887681|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43657629|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657630|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887682|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887683|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887684|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887685|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887686|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887687|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43887688|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
43887690|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887691|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887692|NCT04548271|Apatinib|apatinib|mesh-list
43887693|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887694|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887695|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887696|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887697|NCT04548219|Mirikizumab|mirikizumab|mesh-list
43887698|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43887699|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43887700|NCT04548219|Analgesics|analgesics|mesh-ancestor
43887701|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
43887702|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887703|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616963|NCT03143023|Fluorides|fluorides|mesh-list
43887704|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887705|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887706|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43887707|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43887708|NCT04547894|TMC-310911|tmc-310911|mesh-list
43887709|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
43887710|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887711|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887712|NCT04547829|Lenograstim|lenograstim|mesh-list
43887713|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44164772|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164773|NCT00257790|Tobramycin|tobramycin|mesh-list
44164774|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164775|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887715|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887716|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43887717|NCT04547764|Calcium|calcium|mesh-list
43887718|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887719|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887720|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887721|NCT04547855|Temozolomide|temozolomide|mesh-list
43887722|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43887723|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
43657631|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43657632|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
43657633|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
43657634|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
43562878|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657648|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657649|NCT02951806|Fentanyl|fentanyl|mesh-list
43850452|NCT05520567|Azacitidine|azacitidine|mesh-list
43850453|NCT05520567|Venetoclax|venetoclax|mesh-list
43850454|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43850455|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
43562879|NCT01366014|Analgesics|analgesics|mesh-ancestor
43657655|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
43657656|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657657|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43851207|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43887724|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887725|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887726|NCT04547621|Temozolomide|temozolomide|mesh-list
43887727|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43887728|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
43887729|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887730|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887731|NCT04547608|Propofol|propofol|mesh-list
43887732|NCT04547608|Rocuronium|rocuronium|mesh-list
43887733|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43887734|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887765|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887767|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
43887768|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887769|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887770|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43887771|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43887772|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
43887773|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43887774|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887775|NCT04546802|Grazoprevir|grazoprevir|mesh-list
43887776|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
43887777|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
43887778|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887779|NCT04546815|Daptomycin|daptomycin|mesh-list
43887780|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887781|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136426|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136427|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136428|NCT00164736|Ritonavir|ritonavir|mesh-list
44136429|NCT00164736|Lopinavir|lopinavir|mesh-list
44136430|NCT00164736|Lamivudine|lamivudine|mesh-list
44136431|NCT00164736|Zidovudine|zidovudine|mesh-list
44136432|NCT00164736|Nevirapine|nevirapine|mesh-list
44136433|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44136434|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44136435|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
44136436|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136437|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136438|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44136439|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44136452|NCT00164749|Analgesics|analgesics|mesh-ancestor
44136453|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
44136454|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136455|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136456|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44136457|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136458|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136459|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136460|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136461|NCT00164775|Imipramine|imipramine|mesh-list
44136462|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
44136463|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
44136464|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44136465|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44136466|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44136467|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44136468|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136469|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
44136470|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136471|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136472|NCT00164788|Esomeprazole|esomeprazole|mesh-list
44136473|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44136474|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136475|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43887784|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887785|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887786|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887788|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43887789|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887790|NCT04547179|Analgesics|analgesics|mesh-ancestor
43887791|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
43887792|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887793|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887794|NCT04547049|Cytarabine|cytarabine|mesh-list
43887795|NCT04547049|Cyclosporine|cyclosporine|mesh-list
43887796|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
43887797|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
43887798|NCT04547049|Busulfan|busulfan|mesh-list
43887799|NCT04547049|Cyclosporins|cyclosporins|mesh-list
43887800|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43887801|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
43887802|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43887841|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43887842|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
43887843|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43887844|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43887845|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887846|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43887847|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
43887848|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43887849|NCT04546256|Fluticasone|fluticasone|mesh-list
43887850|NCT04546256|Xhance|xhance|mesh-list
43887851|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43871131|NCT02661035|Allopurinol|allopurinol|mesh-list
43887852|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43887853|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43887854|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43887855|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
43887856|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887857|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887858|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43887859|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
43887860|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887861|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43887862|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43887863|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43887864|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43887865|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43887866|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887867|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164776|NCT00257803|Oxytocin|oxytocin|mesh-list
44164777|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
44164778|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164779|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164780|NCT00257816|Cisplatin|cisplatin|mesh-list
44164781|NCT00257816|Topotecan|topotecan|mesh-list
44164782|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164783|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44164784|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164785|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164786|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164787|NCT00257829|Cisplatin|cisplatin|mesh-list
44164788|NCT00257829|Methazolamide|methazolamide|mesh-list
44164789|NCT00257829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43635706|NCT05192889|Pegaspargase|pegaspargase|mesh-list
43887868|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
43887869|NCT04546256|Hormones|hormones|mesh-ancestor
43887870|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887871|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
43887872|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43887873|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
43887874|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43887875|NCT04545970|Protective Agents|protective agents|mesh-ancestor
43887876|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887877|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887878|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43887879|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
43887880|NCT04545931|Coagulants|coagulants|mesh-ancestor
43887881|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43887882|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
43887883|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887884|NCT04545944|Midazolam|midazolam|mesh-list
43887885|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43887886|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43887887|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887888|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887889|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43887890|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43887891|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43887892|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43887893|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
43887894|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
43887895|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
43887896|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
43887897|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887898|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887899|NCT04545879|Allicin|allicin|mesh-list
43887900|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887901|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43887910|NCT04545892|Capsaicin|capsaicin|mesh-list
43887911|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
43887912|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
43887913|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
43887914|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887915|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887916|NCT04545801|Ketamine|ketamine|mesh-list
43887917|NCT04545801|Analgesics|analgesics|mesh-ancestor
43887918|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
43887919|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887920|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887921|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43887922|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43887923|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
43887924|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
43887925|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43887926|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43887928|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887929|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887930|NCT04545788|Linezolid|linezolid|mesh-list
43887931|NCT04545788|Cycloserine|cycloserine|mesh-list
43887932|NCT04545788|Bedaquiline|bedaquiline|mesh-list
43887933|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43887934|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43887935|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43887936|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887937|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887938|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43887939|NCT04545788|Renal Agents|renal agents|mesh-ancestor
43887940|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43887941|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
43887942|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
43887954|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43887955|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887956|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43887957|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887958|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
43887959|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43887960|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43887961|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887962|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887963|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
43887964|NCT04545710|Osimertinib|osimertinib|mesh-list
43887965|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887966|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43887967|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887968|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887969|NCT04545099|Neostigmine|neostigmine|mesh-list
43887970|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43887971|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43887972|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887973|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
43887974|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43887975|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657672|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43887976|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43887977|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
43657673|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43887978|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43887979|NCT04544969|Gemcitabine|gemcitabine|mesh-list
43887980|NCT04544969|Cisplatin|cisplatin|mesh-list
43887981|NCT04544969|Docetaxel|docetaxel|mesh-list
43887982|NCT04544969|Fluorouracil|fluorouracil|mesh-list
43887983|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43887984|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43887985|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
43887986|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43887987|NCT04544969|Antiviral Agents|antiviral agents|mesh-ancestor
43887991|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
43887992|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43887993|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
43887994|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
43887995|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
43887996|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43887997|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43887998|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
43887999|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43888001|NCT04544228|Bupivacaine|bupivacaine|mesh-list
43888002|NCT04544228|Neostigmine|neostigmine|mesh-list
43888004|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
43888005|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888006|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888007|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
43888008|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888009|NCT04544228|Analgesics|analgesics|mesh-ancestor
43888010|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43888011|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888012|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
43888013|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43888014|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43888015|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888016|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888017|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43888018|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888019|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
43888020|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43888021|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
44136498|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136499|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136500|NCT00164866|Omeprazole|omeprazole|mesh-list
44136501|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44136502|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136506|NCT00164892|Rofecoxib|rofecoxib|mesh-list
44136507|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44136508|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44136509|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136510|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136511|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44136512|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44136513|NCT00164892|Analgesics|analgesics|mesh-ancestor
44136514|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
44136515|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136516|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136517|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44136518|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136519|NCT00164931|Omeprazole|omeprazole|mesh-list
44136520|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44136521|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44136522|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44136523|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136524|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657742|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657743|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
43657744|NCT02951117|Dexamethasone|dexamethasone|mesh-list
43657745|NCT02951117|Venetoclax|venetoclax|mesh-list
43657746|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657747|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
43657748|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
43657749|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657750|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657751|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657752|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
43657753|NCT02951117|Hormones|hormones|mesh-ancestor
43657754|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657755|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657756|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657757|NCT02950935|Progesterone|progesterone|mesh-list
43657758|NCT02950935|Progestins|progestins|mesh-ancestor
43657759|NCT02950935|Hormones|hormones|mesh-ancestor
43657760|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657761|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657762|NCT02950870|Ritonavir|ritonavir|mesh-list
43657763|NCT02950870|Ribavirin|ribavirin|mesh-list
43657764|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43657765|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43657766|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
43657767|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136525|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
44136526|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
44136527|NCT00164970|Vitamins|vitamins|mesh-ancestor
44136528|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
44136529|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136530|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
44136531|NCT00164970|Hematinics|hematinics|mesh-ancestor
44136532|NCT00164996|Anesthetics|anesthetics|mesh-list
44136533|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44136534|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136535|NCT00165035|Paclitaxel|paclitaxel|mesh-list
44136536|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
44136550|NCT00165048|Analgesics|analgesics|mesh-ancestor
44136551|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
43657768|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657769|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43657770|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43657771|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
43657772|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136552|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136553|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136554|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44136555|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136556|NCT00165074|Calfactant|calfactant|mesh-list
44136557|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
44136558|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
44136559|NCT00165087|Doxorubicin|doxorubicin|mesh-list
43888022|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
43888023|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43888024|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888025|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43888026|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888027|NCT04544059|Lenalidomide|lenalidomide|mesh-list
43888028|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
43888029|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888030|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43888031|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43888032|NCT04544059|Growth Substances|growth substances|mesh-ancestor
43888033|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
43888034|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888035|NCT04544163|Lidocaine|lidocaine|mesh-list
43888036|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
43888037|NCT04544163|Fentanyl|fentanyl|mesh-list
43888039|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
43888058|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
43888059|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43888060|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
43888061|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43888062|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888063|NCT04543916|Irinotecan|irinotecan|mesh-list
43888064|NCT04543916|Venetoclax|venetoclax|mesh-list
43888065|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43888066|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888067|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888068|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888069|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888070|NCT04543890|Cisplatin|cisplatin|mesh-list
43888071|NCT04543890|Etoposide|etoposide|mesh-list
43888072|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888073|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43888074|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888075|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888076|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888077|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888078|NCT04543565|Tenofovir|tenofovir|mesh-list
43888079|NCT04543565|Pradefovir|pradefovir|mesh-list
43888080|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
43888081|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888082|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43888083|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43888084|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888085|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888086|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43888087|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43888089|NCT04543370|Midazolam|midazolam|mesh-list
43888104|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888105|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888106|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
43888107|NCT04543110|Durvalumab|durvalumab|mesh-list
43888108|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43888109|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888110|NCT04543123|Citalopram|citalopram|mesh-list
43888111|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
43888112|NCT04543123|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43888113|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43657788|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657789|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43657792|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
43657793|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
43657794|NCT02950441|Vitamins|vitamins|mesh-ancestor
43888114|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888115|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888116|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888117|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
43888118|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888119|NCT04543123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43888120|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888121|NCT04542629|Trace Elements|trace elements|mesh-list
43888122|NCT04542629|Rituximab|rituximab|mesh-list
43888123|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43888124|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888128|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
43888157|NCT04542369|Etoposide|etoposide|mesh-list
43888158|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888159|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43888160|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888161|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888162|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888163|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888164|NCT04542252|Cyclosporine|cyclosporine|mesh-list
43888165|NCT04542252|Cyclosporins|cyclosporins|mesh-list
43888166|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888167|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888168|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888169|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
43888176|NCT04541719|Remifentanil|remifentanil|mesh-list
43888219|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
43888220|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888221|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888222|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888223|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
43888224|NCT04541147|Hormones|hormones|mesh-ancestor
43888225|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888226|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888227|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888228|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
43888229|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
43888230|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43888231|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888232|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888233|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
43888234|NCT04541303|Coagulants|coagulants|mesh-ancestor
44136560|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
44136561|NCT00165087|Asparaginase|asparaginase|mesh-list
44136562|NCT00165087|Razoxane|razoxane|mesh-list
44136563|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136564|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136565|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136567|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136568|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136569|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
44136570|NCT00165087|Protective Agents|protective agents|mesh-ancestor
44136571|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888235|NCT04541277|Cytarabine|cytarabine|mesh-list
43888236|NCT04541277|Azacitidine|azacitidine|mesh-list
43888237|NCT04541277|Decitabine|decitabine|mesh-list
43657824|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657825|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657826|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
43657827|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657828|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888238|NCT04541277|Idarubicin|idarubicin|mesh-list
43888239|NCT04541277|Lenograstim|lenograstim|mesh-list
43888250|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43888251|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43888252|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888253|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888254|NCT04540926|Cyclosporine|cyclosporine|mesh-list
43888255|NCT04540926|Cyclosporins|cyclosporins|mesh-list
43888256|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888257|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888258|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888259|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
43888260|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888261|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
43888262|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888263|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888264|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888265|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43888266|NCT04541251|Paclitaxel|paclitaxel|mesh-list
43888267|NCT04541251|Carboplatin|carboplatin|mesh-list
43888268|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43888269|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888270|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
43888271|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
43888272|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
43888273|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888274|NCT04540965|Famotidine|famotidine|mesh-list
43888275|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43888276|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888277|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43888278|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
43888279|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
43888280|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164790|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
44164791|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164792|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164793|NCT00257829|Diuretics|diuretics|mesh-ancestor
44164794|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
44164795|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164796|NCT00257855|Lamotrigine|lamotrigine|mesh-list
44164797|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
44164798|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44164815|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44164816|NCT00257868|Protective Agents|protective agents|mesh-ancestor
44164817|NCT00257959|Amiodarone|amiodarone|mesh-list
44164818|NCT00257959|Sotalol|sotalol|mesh-list
44164819|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43888281|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888282|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888284|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888285|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888286|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888287|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888288|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
43888289|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
43888290|NCT04540627|Palivizumab|palivizumab|mesh-list
43888291|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
43888292|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888293|NCT04539977|Cisplatin|cisplatin|mesh-list
43888294|NCT04539977|Etoposide|etoposide|mesh-list
43888295|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
43888296|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888297|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43888298|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888299|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43888300|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888301|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888302|NCT04540055|Anesthetics|anesthetics|mesh-list
43888303|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888304|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888305|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
43888306|NCT04540185|Vaccines|vaccines|mesh-list
43888307|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
43657878|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
43657880|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657881|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657882|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43657883|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657884|NCT02949778|Ropivacaine|ropivacaine|mesh-list
43657885|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
43657886|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
43657887|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657888|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657889|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
43657890|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825419|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825420|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888308|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888309|NCT04540185|Protective Agents|protective agents|mesh-ancestor
43888310|NCT04539301|Anticoagulants|anticoagulants|mesh-list
43888311|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
43888312|NCT04539314|Bupivacaine|bupivacaine|mesh-list
43888313|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888314|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
43888315|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888316|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888317|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
43888320|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43888322|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43888323|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43888324|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43888325|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888326|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888327|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888328|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
43888329|NCT04539249|Pentazocine|pentazocine|mesh-list
43888330|NCT04539249|Analgesics|analgesics|mesh-ancestor
43888331|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
43888332|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888333|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888334|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
43888335|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888336|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43888337|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
43888338|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43888339|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888340|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888341|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43825429|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43825430|NCT05501080|Diuretics|diuretics|mesh-ancestor
43825431|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
43825432|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43825433|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43825434|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825435|NCT05500742|Selenium|selenium|mesh-list
43825436|NCT05500742|Ubiquinone|ubiquinone|mesh-list
43825437|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
43825438|NCT05500742|Resveratrol|resveratrol|mesh-list
43825439|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
43825440|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825441|NCT05500742|Protective Agents|protective agents|mesh-ancestor
43825442|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825443|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825444|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43825445|NCT05500742|Trace Elements|trace elements|mesh-ancestor
43825446|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
43825447|NCT05500742|Vitamins|vitamins|mesh-ancestor
43888342|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
43888343|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43888344|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43888345|NCT04539249|Narcotics|narcotics|mesh-ancestor
43888346|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43888347|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43888348|NCT04539119|Tenofovir|tenofovir|mesh-list
43888349|NCT04539119|Entecavir|entecavir|mesh-list
43888350|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
43888364|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888365|NCT04538820|Dexamethasone|dexamethasone|mesh-list
43888366|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
43888367|NCT04538820|BB 1101|bb 1101|mesh-list
43888368|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888369|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
43888370|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
43888371|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888372|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888373|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888374|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
43888375|NCT04538820|Hormones|hormones|mesh-ancestor
43888376|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888377|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888378|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888379|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
43888380|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888381|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888382|NCT04539054|Caffeine|caffeine|mesh-list
43888383|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43888384|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888385|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43888386|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888387|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888388|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43888389|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43888390|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
44157193|NCT00233766|Sirolimus|sirolimus|mesh-list
44157194|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157195|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157196|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157197|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157198|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
44157199|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157200|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
44157201|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157202|NCT00233779|Sirolimus|sirolimus|mesh-list
44157203|NCT00233779|Heparin|heparin|mesh-list
44157204|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157205|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157206|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157207|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157208|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
44157209|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157210|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
44157211|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157212|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
44157213|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44157214|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44157215|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157216|NCT00233792|Sirolimus|sirolimus|mesh-list
44157217|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43825461|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
44157218|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157219|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157220|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157221|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
44157222|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157223|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
44157224|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157225|NCT00233805|Sirolimus|sirolimus|mesh-list
44157226|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157234|NCT00233818|Sirolimus|sirolimus|mesh-list
44157235|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44157236|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44157237|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44157238|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44157239|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
44157240|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44157241|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
44157242|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157243|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
44157244|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
44157245|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
44157246|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157247|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157248|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43888405|NCT04538521|Niacin|niacin|mesh-list
43888406|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
43888407|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43888408|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
43888409|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888410|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43888411|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
43888412|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
43888413|NCT04538521|Vitamins|vitamins|mesh-ancestor
43888414|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
43888415|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888416|NCT04538391|Bupivacaine|bupivacaine|mesh-list
43888417|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888418|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
43888419|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888420|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888421|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
43888422|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888423|NCT04538365|Triclosan|triclosan|mesh-list
43888424|NCT04538365|Propranolol|propranolol|mesh-list
43888425|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43888426|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43888427|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888429|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43888430|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
43888431|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888432|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43888433|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43888434|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43888435|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888436|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888437|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888438|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43888439|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43888440|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
43888441|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
43888442|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
43888443|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43888444|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43888445|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888446|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888447|NCT04538976|Urological Agents|urological agents|mesh-ancestor
43888448|NCT04537780|Montelukast|montelukast|mesh-list
43888449|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43888450|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
43888451|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43888452|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
43888453|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888454|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888455|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43888456|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43888457|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888458|NCT04537767|Esmolol|esmolol|mesh-list
43888468|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888469|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888470|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
43888471|NCT04537533|Coagulants|coagulants|mesh-ancestor
43888472|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43888473|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
43888474|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
43888475|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888476|NCT04537065|Mydriatics|mydriatics|mesh-list
43888477|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
44136574|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
43888478|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888479|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888480|NCT04536922|Aldesleukin|aldesleukin|mesh-list
43888481|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
43888482|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
43888483|NCT04536922|Fludarabine|fludarabine|mesh-list
43888484|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888485|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
43888486|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888487|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888488|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43888489|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
43888490|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888491|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888492|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43888493|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43888494|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43888495|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43888496|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
43888497|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888498|NCT04536961|BMS-986165|bms-986165|mesh-list
43888499|NCT04536961|Famotidine|famotidine|mesh-list
43888500|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43888504|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
43888506|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888507|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888508|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888509|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43888510|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888511|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
43888512|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888514|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
43888515|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
43888516|NCT04536831|Vitamins|vitamins|mesh-list
43888517|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
43888518|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888519|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43888520|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43888521|NCT04536558|Olanzapine|olanzapine|mesh-list
43888522|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
43888523|NCT04536558|Aprepitant|aprepitant|mesh-list
43888524|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
43888525|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
43888526|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888527|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888528|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888529|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43888530|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43888531|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888557|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43888558|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
43888559|NCT04536363|Urological Agents|urological agents|mesh-ancestor
44136576|NCT00165139|Ifosfamide|ifosfamide|mesh-list
44136577|NCT00165139|Carboplatin|carboplatin|mesh-list
44136578|NCT00165139|Etoposide|etoposide|mesh-list
44136579|NCT00165139|Vincristine|vincristine|mesh-list
44136580|NCT00165139|Doxorubicin|doxorubicin|mesh-list
44136581|NCT00165139|Lenograstim|lenograstim|mesh-list
44136582|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136583|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
44136584|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136585|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136586|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44136587|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
44136588|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136589|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136590|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44136591|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136592|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136593|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136594|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136595|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136596|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
44136597|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
44136598|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136599|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44136600|NCT00165178|Leucovorin|leucovorin|mesh-list
44136601|NCT00165178|Cytarabine|cytarabine|mesh-list
44136602|NCT00165178|Dexamethasone|dexamethasone|mesh-list
44136603|NCT00165178|Prednisone|prednisone|mesh-list
44136604|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
44136605|NCT00165178|Doxorubicin|doxorubicin|mesh-list
44136606|NCT00165178|Methotrexate|methotrexate|mesh-list
44136607|NCT00165178|Vincristine|vincristine|mesh-list
44136608|NCT00165178|Asparaginase|asparaginase|mesh-list
44136616|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
44136617|NCT00165178|Hormones|hormones|mesh-ancestor
44136618|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136619|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44136620|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136621|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136622|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136623|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136624|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136625|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136626|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
44136627|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
44136628|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44136629|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44136630|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
44136631|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
44136632|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44136633|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136634|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
44136635|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136636|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43618081|NCT03133845|Fentanyl|fentanyl|mesh-list
44136637|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
44136638|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136639|NCT00165178|Antidotes|antidotes|mesh-ancestor
43825473|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
43846612|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
43846613|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846614|NCT04188392|Pimavanserin|pimavanserin|mesh-list
43846615|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43846616|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43846617|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43846618|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43846619|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846620|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136640|NCT00165178|Protective Agents|protective agents|mesh-ancestor
44136641|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
44136642|NCT00165178|Vitamins|vitamins|mesh-ancestor
44136643|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
44136644|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136645|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
44136646|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
43888571|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888572|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888573|NCT04536051|Acetaminophen|acetaminophen|mesh-list
43888574|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43888575|NCT04536051|Analgesics|analgesics|mesh-ancestor
43888576|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
43888577|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888578|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888579|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
43888580|NCT04536493|Lidocaine|lidocaine|mesh-list
43888581|NCT04536493|Epinephrine|epinephrine|mesh-list
43888582|NCT04536493|Racepinephrine|racepinephrine|mesh-list
43888583|NCT04536493|Tetracaine|tetracaine|mesh-list
43888584|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
43888585|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
43888586|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
43888587|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888588|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888589|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
43888590|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888591|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43888592|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43888593|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43888594|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888595|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888596|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43888597|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43888598|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888599|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888600|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43888601|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43888614|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888615|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43888616|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888618|NCT04536181|Prednisolone|prednisolone|mesh-list
43888619|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888620|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
43888621|NCT04536181|Hormones|hormones|mesh-ancestor
43888622|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888623|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888624|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888625|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888626|NCT04536428|Hemostatics|hemostatics|mesh-list
43888627|NCT04536428|Coagulants|coagulants|mesh-ancestor
43888628|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
43888629|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
43888630|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888631|NCT04535817|Omalizumab|omalizumab|mesh-list
43888632|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43888633|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43888634|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
43888635|NCT04535804|Aspirin|aspirin|mesh-list
44136648|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43888636|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43888637|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43888638|NCT04535804|Analgesics|analgesics|mesh-ancestor
43888639|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
43888640|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888641|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888642|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888643|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888644|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43888645|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888646|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888648|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43888649|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888650|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
43888651|NCT04535518|Aspirin|aspirin|mesh-list
43888652|NCT04535518|Infliximab|infliximab|mesh-list
43888653|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
43888654|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43888655|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
43888656|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43888657|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43888658|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43888659|NCT04535518|Analgesics|analgesics|mesh-ancestor
43888660|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
43888661|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888662|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888663|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888664|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888665|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43888666|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888667|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888668|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43888705|NCT04534231|Nicotine|nicotine|mesh-list
43888706|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43888707|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
43888708|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888709|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888710|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43888711|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43888712|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
43888713|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888714|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888715|NCT04534452|Phenylephrine|phenylephrine|mesh-list
43888716|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
43888717|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43888718|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
43888719|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
43888720|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888721|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888722|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
43888723|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43888724|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
43888725|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
43888726|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43888727|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43888728|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43850484|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43850486|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850487|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850488|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43888729|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
43888730|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888731|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888732|NCT04534452|Protective Agents|protective agents|mesh-ancestor
43888733|NCT04534322|Dexamethasone|dexamethasone|mesh-list
43888734|NCT04534322|Melphalan|melphalan|mesh-list
43888735|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888747|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
43888748|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888749|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43888750|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888751|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
43888753|NCT04533984|Calcium|calcium|mesh-list
43888754|NCT04533984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43888755|NCT04533984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888756|NCT04533984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43888757|NCT04533724|Amisulpride|amisulpride|mesh-list
43888758|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43888759|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43888760|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888761|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888762|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43888763|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43888764|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
43888765|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888766|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888767|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43888768|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
43888769|NCT04533867|Ondansetron|ondansetron|mesh-list
43888770|NCT04533867|Palonosetron|palonosetron|mesh-list
43888771|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
43888772|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
43888773|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888774|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43871133|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43888775|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888776|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
43888777|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888778|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44136649|NCT00165191|Cisplatin|cisplatin|mesh-list
43888787|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
44136650|NCT00165191|Doxorubicin|doxorubicin|mesh-list
44136651|NCT00165191|Fluorouracil|fluorouracil|mesh-list
44136652|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136653|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44136654|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44136655|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136656|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136657|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136658|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
44136659|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657941|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657942|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657943|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
43657944|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657945|NCT02949206|Thrombin|thrombin|mesh-list
44136660|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136661|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
44136662|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136663|NCT00165204|Tibolone|tibolone|mesh-list
44136664|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
44136706|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
44136707|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136708|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
44136709|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
44136710|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
44136711|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136712|NCT00165295|Urological Agents|urological agents|mesh-ancestor
44136714|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44136715|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
44136716|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136717|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136718|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44136719|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136720|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
44136721|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43888788|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
43888789|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43888790|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888792|NCT04533243|Morphine|morphine|mesh-list
43888793|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43888794|NCT04533243|Narcotics|narcotics|mesh-ancestor
43888795|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888796|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888823|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888824|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
43888825|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43888826|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43888827|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888828|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
43888829|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43888830|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
43888831|NCT04532918|Cyclosporine|cyclosporine|mesh-list
43888832|NCT04532918|Rifampin|rifampin|mesh-list
43888833|NCT04532918|Allopurinol|allopurinol|mesh-list
43888834|NCT04532918|Verinurad|verinurad|mesh-list
43888835|NCT04532918|Cyclosporins|cyclosporins|mesh-list
43888836|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888837|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888838|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888839|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
43888840|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888841|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
43888842|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888843|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888844|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888845|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43888846|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43888847|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
43888848|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43888874|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888876|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888877|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888878|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
43888879|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
43888880|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657946|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
43657947|NCT02949206|Coagulants|coagulants|mesh-ancestor
43657948|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
43657949|NCT02949258|Etoposide|etoposide|mesh-list
43657950|NCT02949258|Epirubicin|epirubicin|mesh-list
43657951|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657952|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851613|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888881|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
43888882|NCT04532775|Hormones|hormones|mesh-ancestor
43888883|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888884|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43888885|NCT04532775|Protective Agents|protective agents|mesh-ancestor
43888886|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43888887|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888888|NCT04532775|Analgesics|analgesics|mesh-ancestor
43888889|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43888890|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
43888891|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43888892|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888893|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888894|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43888895|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
43888896|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43888897|NCT04532671|Ether|ether|mesh-list
43888898|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43888899|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
43888900|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
43657953|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43888901|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43888918|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43888919|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43657954|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43657955|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657956|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657957|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43657958|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43657959|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657965|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
43657966|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657967|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657968|NCT02948985|Cetuximab|cetuximab|mesh-list
43657969|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657970|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657971|NCT02948998|Spironolactone|spironolactone|mesh-list
43657992|NCT02948348|Capecitabine|capecitabine|mesh-list
43888920|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43888921|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
43888922|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
43888923|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
43888924|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
43888925|NCT04532736|Methotrexate|methotrexate|mesh-list
43888926|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43888927|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
43888928|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43888929|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888930|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43888931|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
43888932|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888933|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888934|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
43888935|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888936|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43888937|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43888938|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
43888939|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43888940|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43888941|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43888942|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
43888943|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
43888944|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43888945|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43888946|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
43888947|NCT04532736|Hormones|hormones|mesh-ancestor
43888948|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888949|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43888950|NCT04532736|Protective Agents|protective agents|mesh-ancestor
43888951|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43888956|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43888957|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43888958|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
43888959|NCT04532554|Hormones|hormones|mesh-list
43888960|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43888961|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43888962|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
43888963|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43888964|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888965|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
43888966|NCT04532060|Nystatin|nystatin|mesh-list
43888967|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43888968|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
43888969|NCT04532060|Ionophores|ionophores|mesh-ancestor
43888970|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43888971|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888972|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
43888973|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43888974|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43888975|NCT04532333|Heparin|heparin|mesh-list
43888976|NCT04532333|Bivalirudin|bivalirudin|mesh-list
43888977|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
43888978|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43888979|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43888980|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43888981|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
43888982|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43888983|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
43888984|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43888985|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
43888986|NCT04531865|Rituximab|rituximab|mesh-list
43888987|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43888988|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43888989|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
43888998|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889000|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
43889001|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889002|NCT04531748|Toremifene|toremifene|mesh-list
43889003|NCT04531748|Melatonin|melatonin|mesh-list
43889004|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
43889005|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889006|NCT04531748|Protective Agents|protective agents|mesh-ancestor
43889007|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889008|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889009|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889010|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889011|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43889012|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43889013|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
43889014|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889015|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43889016|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
43889017|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43889018|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889019|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889020|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889021|NCT04531371|Analgesics|analgesics|mesh-ancestor
43889022|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
43889023|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889024|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43889025|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43889026|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43889027|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
43889034|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
43889035|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889036|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
43889037|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43889038|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43889039|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889040|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43889041|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889042|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
43889043|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889044|NCT04531267|Calcium|calcium|mesh-list
43889045|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43889046|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889047|NCT04531475|Lansoprazole|lansoprazole|mesh-list
43889048|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
43889049|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43889050|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889051|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43889052|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889053|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889054|NCT04531228|Lenvatinib|lenvatinib|mesh-list
43889055|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889056|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43889057|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889058|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136722|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44136723|NCT00165334|Cetuximab|cetuximab|mesh-list
44136724|NCT00165334|Vinorelbine|vinorelbine|mesh-list
44136740|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136741|NCT00165373|Endostatins|endostatins|mesh-list
44136742|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136743|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44136744|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44136745|NCT00165373|Growth Substances|growth substances|mesh-ancestor
44136746|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136747|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
43889059|NCT04531332|Linezolid|linezolid|mesh-list
43889060|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889061|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889062|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43889063|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889064|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889065|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
43889066|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43889067|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
43889068|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889069|NCT04531163|Expectorants|expectorants|mesh-ancestor
43889070|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
43889071|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43889072|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
43889073|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889074|NCT04531163|Protective Agents|protective agents|mesh-ancestor
43889075|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889076|NCT04531163|Antidotes|antidotes|mesh-ancestor
43889077|NCT04531072|Ritonavir|ritonavir|mesh-list
43889101|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
43889102|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889103|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889104|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889105|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
43889106|NCT04530864|Hormones|hormones|mesh-ancestor
43889107|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889108|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889109|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889110|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
43889111|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889112|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825476|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889113|NCT04530903|Clonidine|clonidine|mesh-list
43889114|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
43825477|NCT05499689|Bupivacaine|bupivacaine|mesh-list
43825478|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
43825479|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
43825480|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889115|NCT04530903|Analgesics|analgesics|mesh-ancestor
43889116|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
43889117|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889118|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889119|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43889120|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
43889121|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
43889122|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43889123|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43889124|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43889125|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
43889126|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889127|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889128|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
43889129|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
43889130|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889145|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43889146|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43889147|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889148|NCT04530422|Azithromycin|azithromycin|mesh-list
43889149|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
43889150|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
43889151|NCT04530422|Oseltamivir|oseltamivir|mesh-list
43889152|NCT04530422|Ledipasvir|ledipasvir|mesh-list
43889153|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889154|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889155|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
43889156|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889157|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889158|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889159|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889160|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889161|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
43889162|NCT04530617|Camostat|camostat|mesh-list
43889163|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
43889164|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889165|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889166|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43889167|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43889168|NCT04529954|Valproic Acid|valproic acid|mesh-list
43889169|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
43889170|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889171|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889172|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
43889173|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889174|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889175|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
43889176|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43889177|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889189|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
43889190|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43889191|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43889192|NCT04530227|Paclitaxel|paclitaxel|mesh-list
43889193|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43889194|NCT04530227|Pemetrexed|pemetrexed|mesh-list
43889195|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43889196|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889197|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43889198|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43889199|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43889200|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889201|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825482|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
43889202|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43825483|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825484|NCT05499598|Vitamin A|vitamin a|mesh-list
43825485|NCT05499598|Vitamins|vitamins|mesh-ancestor
43825486|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
43825488|NCT05499572|Minocycline|minocycline|mesh-list
43889203|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43889205|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889206|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889207|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889208|NCT04529668|Vitamin D|vitamin d|mesh-list
43889209|NCT04529668|Vitamins|vitamins|mesh-ancestor
43889210|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
43889211|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889212|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43889213|NCT04529525|Ivermectin|ivermectin|mesh-list
43889214|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889215|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889216|NCT04529512|Dexamethasone|dexamethasone|mesh-list
43889217|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889218|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
43889219|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
43889220|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889221|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889235|NCT04529187|Midazolam|midazolam|mesh-list
43889236|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
43889237|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43889238|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889239|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889240|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43889241|NCT04529187|Analgesics|analgesics|mesh-ancestor
43889242|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
43889243|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889244|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43889245|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43889246|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43889247|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
43889248|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889249|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889250|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43889251|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43889252|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43889253|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889254|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43889255|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
43889256|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
43889257|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
43889258|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
43889259|NCT04529226|Haloperidol|haloperidol|mesh-list
43889260|NCT04529226|Pimozide|pimozide|mesh-list
43889261|NCT04529226|Olanzapine|olanzapine|mesh-list
43889262|NCT04529226|Risperidone|risperidone|mesh-list
43889263|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
43889264|NCT04529226|Clozapine|clozapine|mesh-list
43889265|NCT04529226|Amisulpride|amisulpride|mesh-list
43889266|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43658124|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43658125|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43658126|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658127|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
43658128|NCT02947529|Coagulants|coagulants|mesh-ancestor
43658129|NCT02947672|Dexamethasone|dexamethasone|mesh-list
43658130|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658131|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
43658132|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
43658133|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658134|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889267|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
43889268|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889269|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889270|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889271|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43889272|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43889274|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889275|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43889276|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
43889277|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
43889278|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
43889279|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889280|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889281|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43889282|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43889283|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43889284|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43889286|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
43889287|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43889288|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
43889289|NCT04528628|Norepinephrine|norepinephrine|mesh-list
43889290|NCT04528628|Serotonin|serotonin|mesh-list
43889291|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43889292|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
43889293|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43889294|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43889295|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
43889296|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889297|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889298|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889299|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
43889300|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
43889301|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889322|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889323|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43889324|NCT04528797|Protective Agents|protective agents|mesh-ancestor
43889325|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889326|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889327|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
43889328|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43889329|NCT04528888|Heparin|heparin|mesh-list
43889330|NCT04528888|Enoxaparin|enoxaparin|mesh-list
43889331|NCT04528888|Calcium heparin|calcium heparin|mesh-list
43889332|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889333|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
43889334|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
43889335|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889336|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889337|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889338|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
43889339|NCT04528888|Hormones|hormones|mesh-ancestor
43889340|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889341|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43889342|NCT04528888|Protective Agents|protective agents|mesh-ancestor
43889343|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889344|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658135|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43658136|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
43658138|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851739|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43889345|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
43889346|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43889347|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43889348|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889349|NCT04528927|Azithromycin|azithromycin|mesh-list
43889350|NCT04528927|Doxycycline|doxycycline|mesh-list
43889351|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889352|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889353|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
43889354|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889355|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44136756|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136757|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44136758|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
43889357|NCT04528277|Rifapentine|rifapentine|mesh-list
43889358|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
43889359|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889360|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889361|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43889362|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43889363|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
43889364|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889365|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43889366|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43889367|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
43889368|NCT04528290|Ozanimod|ozanimod|mesh-list
43889369|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43889370|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850532|NCT05403385|Pemetrexed|pemetrexed|mesh-list
43850533|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850534|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850535|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850536|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43850537|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43850538|NCT05391061|Abrocitinib|abrocitinib|mesh-list
43850539|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43850540|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850541|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658163|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658164|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658166|NCT02947269|Laxatives|laxatives|mesh-ancestor
43658181|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658182|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
43658183|NCT02946944|Apixaban|apixaban|mesh-list
43658184|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658185|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43658186|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43658187|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658188|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889371|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889372|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
43889373|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889374|NCT04528095|Clozapine|clozapine|mesh-list
43889375|NCT04528095|Amisulpride|amisulpride|mesh-list
43889376|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43889377|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
43889400|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43889401|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889402|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889403|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43889404|NCT04527562|Colchicine|colchicine|mesh-list
43889405|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
43889406|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889407|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
43889408|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
43889409|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
43889410|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889411|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889412|NCT04527679|Lenvatinib|lenvatinib|mesh-list
43889413|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889414|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43889415|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889416|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889417|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
43889418|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43889419|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889420|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
43889421|NCT04527666|Anticoagulants|anticoagulants|mesh-list
43889422|NCT04527211|Ivermectin|ivermectin|mesh-list
43889423|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889424|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889425|NCT05140811|Azacitidine|azacitidine|mesh-list
43889426|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43889427|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
43889428|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889429|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889430|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889431|NCT05140655|Fulvestrant|fulvestrant|mesh-list
43889432|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43889439|NCT05140512|Goserelin|goserelin|mesh-list
43889442|NCT05140096|Fluconazole|fluconazole|mesh-list
43889443|NCT05140096|Isavuconazole|isavuconazole|mesh-list
43889444|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
43889445|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
43889446|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889447|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43889448|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43889449|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889450|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889451|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43889452|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
43889453|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43889454|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889455|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43889456|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43889457|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889458|NCT05139966|Fluorides|fluorides|mesh-list
43889459|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
43889460|NCT05139966|Protective Agents|protective agents|mesh-ancestor
43889461|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889462|NCT05139667|Tacrolimus|tacrolimus|mesh-list
43889463|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889464|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
43889465|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889466|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43889467|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889468|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889469|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
43889470|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
43851798|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851799|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889471|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889472|NCT05138978|Listerine|listerine|mesh-list
43889473|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
43889474|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
43889475|NCT05138978|Protective Agents|protective agents|mesh-ancestor
43889476|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889477|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
44164820|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43889479|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43889480|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43889481|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43889482|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43889483|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136759|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
44136760|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44136761|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136762|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44136763|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
44136764|NCT00165451|Thalidomide|thalidomide|mesh-list
44136765|NCT00165451|Celecoxib|celecoxib|mesh-list
44136766|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
44136767|NCT00165451|Etoposide|etoposide|mesh-list
44136768|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44136769|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
44136771|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44136772|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44136773|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
44136774|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136775|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136776|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44136777|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44136778|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43889484|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
43889485|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43889486|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43889487|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889488|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
43889489|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889490|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43889501|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43889502|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658190|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43658191|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
43658192|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43658193|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
43658194|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
43658195|NCT02946970|Quinine|quinine|mesh-list
43658196|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
43658203|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658204|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658206|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
43658207|NCT02947061|Docetaxel|docetaxel|mesh-list
43658208|NCT02947061|Capecitabine|capecitabine|mesh-list
43658209|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658210|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
43658211|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
43658212|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851871|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43889503|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889504|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43889505|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43889506|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43889507|NCT05126121|Renal Agents|renal agents|mesh-ancestor
43889508|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43889509|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43889510|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889511|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43889512|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43889513|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43889514|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43889515|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43889516|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43889517|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
43889518|NCT05108688|Sumatriptan|sumatriptan|mesh-list
43889519|NCT05108688|Mirtazapine|mirtazapine|mesh-list
43889520|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43889521|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43889522|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43889523|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
43889524|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889525|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889526|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889527|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
43889528|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43889529|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43889530|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
43889531|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
43889532|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43889533|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43889534|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889535|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43889537|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43889538|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
43889539|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43889540|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43889541|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43889542|NCT04918017|Esomeprazole|esomeprazole|mesh-list
43889543|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43889544|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43889545|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43889546|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889547|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889549|NCT04455139|Topotecan|topotecan|mesh-list
43658213|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658214|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658215|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
43658241|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851876|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889550|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43889600|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889601|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43889602|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43889603|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889605|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
43889606|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43889607|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889608|NCT03366272|Gemcitabine|gemcitabine|mesh-list
43889609|NCT03366272|Rituximab|rituximab|mesh-list
43889666|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889667|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44136779|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44136780|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136781|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44136782|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44136784|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
44136785|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136786|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44136787|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44136788|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44136789|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
44136790|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136791|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136792|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43889703|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43889704|NCT04446793|Growth Substances|growth substances|mesh-ancestor
43889705|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889706|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
43889707|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43889708|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658242|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658243|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43658244|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43658245|NCT02946359|Growth Substances|growth substances|mesh-ancestor
43658246|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658247|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
43658248|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43658249|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658250|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658262|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43658263|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43658264|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
43658265|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
43658266|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851892|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
43889709|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889710|NCT04445415|Antibodies|antibodies|mesh-list
43889678|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43889679|NCT04488237|Vitamin D|vitamin d|mesh-list
43889680|NCT04488237|Vitamins|vitamins|mesh-ancestor
43889681|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
43889682|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889683|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43889684|NCT04482361|Antibodies|antibodies|mesh-list
43889685|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
43889686|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889727|NCT04397302|Valsartan|valsartan|mesh-list
43889728|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43889733|NCT04396587|Sufentanil|sufentanil|mesh-list
43889822|NCT04310631|Growth Substances|growth substances|mesh-ancestor
43889823|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889824|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
43889825|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889826|NCT04302012|Mydriatics|mydriatics|mesh-list
43889687|NCT04477382|Tretinoin|tretinoin|mesh-list
43889688|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889689|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
43889690|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
43889827|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
43889828|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889829|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889830|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43889831|NCT04296253|Mitogens|mitogens|mesh-list
43889832|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
43889833|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136822|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136823|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44136824|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
44136825|NCT00165516|Cisplatin|cisplatin|mesh-list
44136861|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136862|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136863|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
44136864|NCT00165633|Menatetrenone|menatetrenone|mesh-list
44136865|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
44136866|NCT00165633|Coagulants|coagulants|mesh-ancestor
44136867|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
44136868|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44136869|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136870|NCT00165633|Vitamins|vitamins|mesh-ancestor
44136871|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
44136872|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136873|NCT00165659|Donepezil|donepezil|mesh-list
44136874|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44136875|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136876|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136877|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
44136878|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136879|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136880|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
44136881|NCT00165685|Sibutramine|sibutramine|mesh-list
44136882|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
44136883|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44136884|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
44136885|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
44136886|NCT00165737|Donepezil|donepezil|mesh-list
43889835|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43889836|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43889837|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
43889838|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889839|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43889841|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136897|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136898|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
44136899|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136900|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136901|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
44136902|NCT00165763|Donepezil|donepezil|mesh-list
44136903|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44136904|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136905|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136906|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
44136907|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44136908|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136909|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
44136910|NCT00165815|Donepezil|donepezil|mesh-list
44136911|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44136912|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136913|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136914|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
43889844|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43889845|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
43889846|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889847|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889848|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43889849|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889850|NCT04264884|Daratumumab|daratumumab|mesh-list
43889851|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889852|NCT04261231|Anesthetics|anesthetics|mesh-list
43889853|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43889854|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889855|NCT04260139|Metronidazole|metronidazole|mesh-list
43889856|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850597|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850598|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43850599|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850600|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
43850601|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
43658275|NCT02946814|Protective Agents|protective agents|mesh-ancestor
43658276|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658277|NCT02946632|Metformin|metformin|mesh-list
43658278|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43658279|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
43658280|NCT02946632|Glimepiride|glimepiride|mesh-list
43658281|NCT02946632|Saxagliptin|saxagliptin|mesh-list
43658282|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658283|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658284|NCT02946632|Incretins|incretins|mesh-ancestor
43658285|NCT02946632|Hormones|hormones|mesh-ancestor
43850606|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658288|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
43658289|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658290|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658291|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43889857|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43889906|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43889907|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889908|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43889909|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43889910|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43889926|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43889928|NCT04179266|Analgesics|analgesics|mesh-ancestor
43889929|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
43889930|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43889931|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43889932|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43889911|NCT04216303|Chrysarobin|chrysarobin|mesh-list
44136964|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44136965|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
44136966|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44136967|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44136968|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44136969|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44136970|NCT00166400|Metoprolol|metoprolol|mesh-list
44136971|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44136972|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44136973|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
44136974|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
44136975|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44136976|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44136977|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44136978|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44136979|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44136980|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
44136981|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43889948|NCT04152941|Olaparib|olaparib|mesh-list
43889975|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43889976|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43889977|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43889978|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
43889979|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43889980|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
43889981|NCT04132882|Antidotes|antidotes|mesh-ancestor
43889982|NCT04132882|Protective Agents|protective agents|mesh-ancestor
43890044|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890045|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43890046|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43890047|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43890048|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
43890049|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658293|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658294|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
43658295|NCT02946294|Epinephrine|epinephrine|mesh-list
43658296|NCT02946294|Racepinephrine|racepinephrine|mesh-list
43658297|NCT02946294|Bupivacaine|bupivacaine|mesh-list
43658298|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
43658299|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658300|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
43658301|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658311|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43658312|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
43658313|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43658314|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
43658315|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
43890050|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890051|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43890052|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43890053|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
43890054|NCT04045171|Tacrolimus|tacrolimus|mesh-list
43890055|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890056|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
43890057|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890058|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43890059|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890060|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890062|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43890063|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890064|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890065|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43890066|NCT03994419|Anesthetics|anesthetics|mesh-list
43890067|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890068|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890069|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
43890070|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890071|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890072|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
43890073|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890074|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890075|NCT03979625|Heparin|heparin|mesh-list
43890076|NCT03979625|Antibodies|antibodies|mesh-list
43658316|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
43658317|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43658318|NCT02946268|Ropivacaine|ropivacaine|mesh-list
43658319|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
43658320|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
43658321|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658322|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658323|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
43658337|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658338|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658339|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658340|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43658342|NCT02945982|Protective Agents|protective agents|mesh-ancestor
43658343|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43658344|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658345|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43658346|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658370|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43658371|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658372|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658373|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658374|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
43658375|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43658376|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
43658377|NCT02945527|Dexamethasone|dexamethasone|mesh-list
43658378|NCT02945527|Acetazolamide|acetazolamide|mesh-list
43890077|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
43890078|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890079|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
43890080|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43890118|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890119|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890120|NCT03947632|Analgesics|analgesics|mesh-ancestor
43890121|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
43890122|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890123|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890124|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890125|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890126|NCT03947099|Ketamine|ketamine|mesh-list
43890127|NCT03947099|Analgesics|analgesics|mesh-ancestor
43890128|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
43890129|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890130|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890131|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43890132|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43890133|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
43890134|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
44157249|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
44137057|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137058|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137059|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137060|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137061|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137062|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137063|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137064|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44137065|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
44137066|NCT00166621|Buspirone|buspirone|mesh-list
44137067|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44137068|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137069|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137070|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137071|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137072|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44137073|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
44137074|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137076|NCT00166686|Clonidine|clonidine|mesh-list
43890159|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
43890160|NCT03907605|Hormones|hormones|mesh-list
43890161|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890162|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890163|NCT03903406|Dexamethasone|dexamethasone|mesh-list
43890164|NCT03903406|Lenalidomide|lenalidomide|mesh-list
43890165|NCT03903406|Ixazomib|ixazomib|mesh-list
43890166|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890167|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
43890168|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
43890169|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890170|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890171|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890172|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
43890173|NCT03903406|Hormones|hormones|mesh-ancestor
43658379|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658380|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
43658381|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
43658382|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658383|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851961|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851963|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851964|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
43890174|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890175|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890176|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890177|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
43890178|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43890179|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43890180|NCT03903406|Growth Substances|growth substances|mesh-ancestor
43890181|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
43890281|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890282|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43890283|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
43890284|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
43890285|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43890286|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43890287|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43890288|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890206|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43890207|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890208|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
43890209|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43890210|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
43890211|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890219|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
43890259|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890260|NCT05277701|Lazertinib|lazertinib|mesh-list
43890261|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43890262|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890263|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890264|NCT05277675|Bevacizumab|bevacizumab|mesh-list
43890265|NCT05277675|Lenvatinib|lenvatinib|mesh-list
43890266|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890268|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43890269|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43890270|NCT05277675|Growth Substances|growth substances|mesh-ancestor
43890271|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890272|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
43890273|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43890274|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890331|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43890332|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43890333|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43890334|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43890336|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43890337|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890338|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
43890339|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890340|NCT05326555|Imidacloprid|imidacloprid|mesh-list
43890341|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
43890342|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890343|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890392|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
43890393|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44137094|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
44137095|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44137096|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137097|NCT00166816|Cyclosporine|cyclosporine|mesh-list
44137098|NCT00166816|Sirolimus|sirolimus|mesh-list
44137099|NCT00166816|Tacrolimus|tacrolimus|mesh-list
44137100|NCT00166816|Cyclosporins|cyclosporins|mesh-list
44137101|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137102|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
44137103|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137104|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44137105|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137106|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137107|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
44137108|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137109|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
44137110|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137111|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137112|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43890399|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890400|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43890401|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
43890402|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890403|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890404|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
43890405|NCT05325073|Hematinics|hematinics|mesh-ancestor
43890406|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
43890407|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43890409|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
43890410|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43890411|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
43890412|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890414|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890463|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43890464|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890465|NCT05311579|Niraparib|niraparib|mesh-list
43890466|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43890467|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890468|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890469|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890470|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
43890471|NCT05263492|Lenvatinib|lenvatinib|mesh-list
43890472|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890473|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890474|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43890475|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890476|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890477|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
43890478|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890479|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890480|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
43890481|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43890482|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43890483|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
43890484|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890485|NCT05146804|Sulforaphane|sulforaphane|mesh-list
43890486|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43890487|NCT05146804|Protective Agents|protective agents|mesh-ancestor
43890488|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890489|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890490|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
43890491|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
43890492|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43890493|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
43890494|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890495|NCT05036980|Protective Agents|protective agents|mesh-ancestor
43890504|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
43890505|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890506|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43890507|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43890508|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
43890509|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43890510|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43890511|NCT04931615|Thrombin|thrombin|mesh-list
43890512|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
43890513|NCT04931615|Coagulants|coagulants|mesh-ancestor
43890514|NCT04754334|Insulin|insulin|mesh-list
43890515|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43890516|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851982|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890517|NCT04722575|Atezolizumab|atezolizumab|mesh-list
43890518|NCT04722575|Vemurafenib|vemurafenib|mesh-list
43890519|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890520|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43890521|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890522|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890523|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
43890524|NCT04717375|Cetuximab|cetuximab|mesh-list
43890525|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890526|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890527|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43890528|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43890529|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890530|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890531|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
43890532|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890551|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43890552|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43890553|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890554|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890555|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890556|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43890557|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43890558|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43890559|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43890560|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
43890561|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
43890562|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43890563|NCT04469556|Leucovorin|leucovorin|mesh-list
43890564|NCT04469556|Gemcitabine|gemcitabine|mesh-list
43890565|NCT04469556|Paclitaxel|paclitaxel|mesh-list
43890566|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
43890567|NCT04469556|Irinotecan|irinotecan|mesh-list
43890568|NCT04469556|Folfirinox|folfirinox|mesh-list
43890569|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43890570|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890571|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
43890572|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
43890573|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
43890574|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890575|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43890576|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
43890577|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
43890578|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890579|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890580|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43658498|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43890581|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
43658499|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43658500|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658501|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
43658502|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
43658503|NCT02944825|Trimethoprim|trimethoprim|mesh-list
43658504|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
43658505|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658506|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658507|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43851988|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851989|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851990|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890582|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890596|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890597|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890598|NCT04410965|Teriflunomide|teriflunomide|mesh-list
43890599|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890600|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890601|NCT04410965|Analgesics|analgesics|mesh-ancestor
43890602|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
43890603|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890604|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890605|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890606|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890607|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890608|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
43890609|NCT04405999|Bromhexine|bromhexine|mesh-list
43890610|NCT04405999|Expectorants|expectorants|mesh-ancestor
43890611|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
43890612|NCT04364555|Clobetasol|clobetasol|mesh-list
43890613|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890614|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
43890615|NCT04364555|Hormones|hormones|mesh-ancestor
43890616|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890617|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890618|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43890619|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43890620|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658514|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43658515|NCT02944825|Renal Agents|renal agents|mesh-ancestor
43658516|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
43658517|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43658518|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43658519|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43658520|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43658537|NCT02944227|Growth Substances|growth substances|mesh-ancestor
43890621|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890622|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
43890623|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890625|NCT04280536|Trifluridine|trifluridine|mesh-list
43890641|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
43890642|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
43890643|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137143|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137144|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137145|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44137146|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137147|NCT00166868|Neomycin|neomycin|mesh-list
44137148|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137149|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137150|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44137151|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137152|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137153|NCT00166881|Docetaxel|docetaxel|mesh-list
44137154|NCT00166881|Irinotecan|irinotecan|mesh-list
44137155|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137156|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137157|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
44137158|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137159|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137160|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44137161|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44137162|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137163|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
44137164|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
44137165|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44137166|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137167|NCT00167154|Risperidone|risperidone|mesh-list
44137168|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137169|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
44137170|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137171|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137182|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137183|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
44137184|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137186|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
44137187|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44137188|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137189|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137190|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137191|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137192|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137193|NCT00167375|Eszopiclone|eszopiclone|mesh-list
44137194|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44137195|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137196|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137197|NCT00167401|Cisplatin|cisplatin|mesh-list
44137198|NCT00167401|Docetaxel|docetaxel|mesh-list
44137199|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890644|NCT04184622|Tirzepatide|tirzepatide|mesh-list
43890645|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43890646|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890647|NCT04184622|Incretins|incretins|mesh-ancestor
43890680|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
43890681|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890682|NCT04082910|Etanercept|etanercept|mesh-list
43890683|NCT04082910|Infliximab|infliximab|mesh-list
43890684|NCT04082910|Metoprolol|metoprolol|mesh-list
43890685|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43890686|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890687|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890688|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43890689|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43890690|NCT04082910|Analgesics|analgesics|mesh-ancestor
43890691|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
43890692|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890693|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890694|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890695|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890696|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
43890697|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43658538|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658539|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
43851992|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890698|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43890699|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
43890700|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
43890701|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43890702|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43890703|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43890704|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
43890705|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890706|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890708|NCT04035382|Oxytocin|oxytocin|mesh-list
43890709|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
43890710|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43890726|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890727|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890728|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890729|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890730|NCT03702270|Penicillins|penicillins|mesh-list
43890731|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43890732|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890733|NCT03667443|Inositol|inositol|mesh-list
43890734|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
43890735|NCT03667443|Vitamins|vitamins|mesh-ancestor
43890736|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
43890737|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890738|NCT03622515|Anesthetics|anesthetics|mesh-list
43890739|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890740|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890741|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
43890742|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890743|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890744|NCT03519074|Cisplatin|cisplatin|mesh-list
43890745|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890746|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
43890747|NCT03345576|Testosterone|testosterone|mesh-list
43890748|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
43890749|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
43890750|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43890751|NCT03345576|Androgens|androgens|mesh-ancestor
43890752|NCT03345576|Hormones|hormones|mesh-ancestor
43658540|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658542|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43658543|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658544|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658579|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43658580|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658581|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43890753|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890754|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890755|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890756|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890757|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
43890761|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43890767|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890768|NCT03150004|Cytarabine|cytarabine|mesh-list
43890769|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
43890770|NCT03150004|Cladribine|cladribine|mesh-list
43890771|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43890772|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
43890773|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890774|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890775|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
43620849|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
43890776|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890777|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43890778|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
43890779|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890780|NCT03150004|Analgesics|analgesics|mesh-ancestor
43890781|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
43890782|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890783|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43890784|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890785|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890786|NCT03125811|Ethanol|ethanol|mesh-list
43890787|NCT03125811|Ondansetron|ondansetron|mesh-list
43890788|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43890789|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43890790|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890792|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
43890817|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890818|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
43890819|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
43890821|NCT02842359|Atorvastatin|atorvastatin|mesh-list
43890822|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43890823|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43890824|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
43890825|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890826|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43890827|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43890828|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890829|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43890830|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43890831|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43890832|NCT02679508|Lansoprazole|lansoprazole|mesh-list
43890833|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
43890834|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43890835|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890836|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43890837|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890838|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890839|NCT02678312|Enalapril|enalapril|mesh-list
43890840|NCT02678312|Enalaprilat|enalaprilat|mesh-list
43890841|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43890842|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43890843|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
43890844|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890845|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890846|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43890847|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43658585|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43658586|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
43658587|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658588|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658589|NCT02944526|Ropivacaine|ropivacaine|mesh-list
43890848|NCT02408315|Misoprostol|misoprostol|mesh-list
43890857|NCT02022592|Lormetazepam|lormetazepam|mesh-list
43890858|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43890859|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43890860|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43890861|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890862|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43890863|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43890864|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43890865|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43890866|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
43890867|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
43890868|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
43890869|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
43890870|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43890871|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890872|NCT01837862|Mebendazole|mebendazole|mesh-list
43890874|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
43890875|NCT01837862|Bevacizumab|bevacizumab|mesh-list
43890876|NCT01837862|Carboplatin|carboplatin|mesh-list
43890877|NCT01837862|Irinotecan|irinotecan|mesh-list
43890878|NCT01837862|Vincristine|vincristine|mesh-list
43890879|NCT01837862|Temozolomide|temozolomide|mesh-list
43890880|NCT01837862|DMP 777|dmp 777|mesh-list
43890881|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890882|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890883|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43890884|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43890885|NCT01837862|Growth Substances|growth substances|mesh-ancestor
43890886|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890887|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
43890905|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890906|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
43890907|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890908|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890909|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890910|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
43890911|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
43890912|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43890913|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43890914|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
43890915|NCT01813227|Hormones|hormones|mesh-ancestor
43890916|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43890917|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43890918|NCT01505569|Etoposide|etoposide|mesh-list
43890919|NCT01505569|Carboplatin|carboplatin|mesh-list
43890920|NCT01505569|Melphalan|melphalan|mesh-list
43890921|NCT01505569|Busulfan|busulfan|mesh-list
43890922|NCT01505569|Ifosfamide|ifosfamide|mesh-list
43890923|NCT01505569|Thiotepa|thiotepa|mesh-list
43890924|NCT01505569|Lenograstim|lenograstim|mesh-list
43890925|NCT01505569|Mesna|mesna|mesh-list
43890926|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43890927|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890928|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890929|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43890930|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890949|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43890950|NCT01004874|Bevacizumab|bevacizumab|mesh-list
43890951|NCT01004874|Temozolomide|temozolomide|mesh-list
43890952|NCT01004874|Topotecan|topotecan|mesh-list
43890953|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43890954|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890955|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43890956|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43890957|NCT01004874|Growth Substances|growth substances|mesh-ancestor
43890958|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890959|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
43890960|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43890961|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
43890962|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890963|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43890964|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43890965|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890966|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
43890967|NCT00268476|Metformin|metformin|mesh-list
43890968|NCT00268476|Prednisone|prednisone|mesh-list
43890969|NCT00268476|Prednisolone|prednisolone|mesh-list
43890970|NCT00268476|Celecoxib|celecoxib|mesh-list
43890971|NCT00268476|Docetaxel|docetaxel|mesh-list
43890972|NCT00268476|Estradiol|estradiol|mesh-list
43890973|NCT00268476|Androgens|androgens|mesh-list
43890974|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43890975|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43890976|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43890977|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
43890978|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
43890979|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
43890980|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43890981|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43890982|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
43890992|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43890993|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43890994|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43890995|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43890996|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43890997|NCT05127304|Bromides|bromides|mesh-list
43890998|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
43890999|NCT05127304|Olodaterol|olodaterol|mesh-list
43891000|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43891001|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
43891002|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891003|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891004|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43891005|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
43891006|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
43891007|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43891008|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
43891009|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891010|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891011|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
43891012|NCT05102162|Meropenem|meropenem|mesh-list
43891013|NCT05102162|Tazobactam|tazobactam|mesh-list
43891014|NCT05102162|Piperacillin|piperacillin|mesh-list
43891015|NCT05102162|Cefepime|cefepime|mesh-list
43891016|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43891017|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891041|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
43891042|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891043|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891044|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891045|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
43891047|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825504|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43891048|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891049|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849640|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
43891050|NCT04903353|Risperidone|risperidone|mesh-list
43891051|NCT04903353|Aripiprazole|aripiprazole|mesh-list
43891052|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43891053|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
43891054|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891055|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891056|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891057|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43891058|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43891059|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891060|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43891061|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43891062|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
43891063|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
43891064|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
43891065|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43891091|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891092|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891093|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43891094|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43891095|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43891097|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43891098|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43891099|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891100|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43891101|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891102|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891103|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891104|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
43891105|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
43891106|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891107|NCT04715022|Protective Agents|protective agents|mesh-ancestor
43891108|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891109|NCT04715022|Vitamins|vitamins|mesh-ancestor
43891110|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
43891111|NCT04683575|Selenium|selenium|mesh-list
43891112|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
43891113|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891114|NCT04683575|Protective Agents|protective agents|mesh-ancestor
43891115|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891116|NCT04683575|Trace Elements|trace elements|mesh-ancestor
43891117|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
43891118|NCT04566380|Capecitabine|capecitabine|mesh-list
43891119|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
43891120|NCT04566380|Nivolumab|nivolumab|mesh-list
43891121|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43891122|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
43891123|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891124|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891127|NCT04483206|Melphalan|melphalan|mesh-list
43891130|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891131|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891132|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43891133|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891134|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
43825505|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
43825506|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
43825507|NCT05564546|Protective Agents|protective agents|mesh-ancestor
43825509|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
43825510|NCT05564286|Aprepitant|aprepitant|mesh-list
43825511|NCT05564286|Tropisetron|tropisetron|mesh-list
43825512|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825513|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
43825514|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
43825515|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891135|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891136|NCT04474483|Melatonin|melatonin|mesh-list
43891137|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
43891138|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891139|NCT04474483|Protective Agents|protective agents|mesh-ancestor
43891140|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891141|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891142|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43891143|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43891144|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891145|NCT04424966|Infigratinib|infigratinib|mesh-list
43891146|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891147|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43891148|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137207|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137208|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137209|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137210|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137211|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137212|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137213|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137214|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44137215|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
44137216|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
43891159|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
43891160|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
43891161|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891162|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891163|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891164|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
43891165|NCT04116398|Hormones|hormones|mesh-ancestor
43891166|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891167|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891168|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891169|NCT04112589|Cytarabine|cytarabine|mesh-list
43891170|NCT04112589|Fludarabine|fludarabine|mesh-list
43891171|NCT04112589|Idarubicin|idarubicin|mesh-list
43891172|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891173|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43891174|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
43891175|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891176|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891177|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
43891178|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891179|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
43891180|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891181|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43891182|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43891183|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891184|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891185|NCT04080427|Dronabinol|dronabinol|mesh-list
43891186|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
43891187|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891188|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43891204|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
43891205|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891206|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43891207|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43891208|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43891209|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
43658664|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
43658665|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43658666|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43658667|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43850686|NCT05350501|Nivolumab|nivolumab|mesh-list
43850687|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658668|NCT02944110|Glucagon|glucagon|mesh-list
43658669|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43658670|NCT02944110|Hormones|hormones|mesh-ancestor
43658671|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43658672|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891210|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891211|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891212|NCT04070157|Analgesics|analgesics|mesh-ancestor
43891213|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
43891214|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
43891215|NCT03973333|Atezolizumab|atezolizumab|mesh-list
43891216|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891217|NCT03971877|Polymyxins|polymyxins|mesh-list
43891218|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891219|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891220|NCT03963414|Carboplatin|carboplatin|mesh-list
43891221|NCT03963414|Etoposide|etoposide|mesh-list
43891222|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
43891223|NCT03963414|Durvalumab|durvalumab|mesh-list
43891224|NCT03963414|Tremelimumab|tremelimumab|mesh-list
43891225|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43891226|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891227|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43891228|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43891229|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891230|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891231|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891232|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891233|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
43891234|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891235|NCT03955211|Acetaminophen|acetaminophen|mesh-list
43891236|NCT03955211|Ibuprofen|ibuprofen|mesh-list
43891237|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891245|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891246|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43891247|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891248|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891249|NCT03943927|Metoprolol|metoprolol|mesh-list
43891250|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43891251|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43891252|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
43891253|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
43891254|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891255|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891256|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43658685|NCT02943902|Vaccines|vaccines|mesh-list
43658686|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43658687|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
43658688|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658689|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
43658690|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43658691|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
43658692|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
43658693|NCT02943655|Progesterone|progesterone|mesh-list
43658694|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43658695|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658696|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43658697|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43658698|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43891257|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43891258|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43891259|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891260|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891261|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891262|NCT03900884|Letrozole|letrozole|mesh-list
43891263|NCT03900884|Venetoclax|venetoclax|mesh-list
43891264|NCT03900884|Palbociclib|palbociclib|mesh-list
43891265|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891266|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43891267|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43891268|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891296|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891297|NCT03805100|Ranibizumab|ranibizumab|mesh-list
43891298|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44158385|NCT00236639|Topiramate|topiramate|mesh-list
43891299|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43891300|NCT03805100|Growth Substances|growth substances|mesh-ancestor
43891301|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891302|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43658705|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43658706|NCT02943655|Analgesics|analgesics|mesh-ancestor
43658707|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
43658708|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658709|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43658710|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43658711|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43658712|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658713|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658726|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
43658727|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658728|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658729|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658731|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658732|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658733|NCT02943642|Vorinostat|vorinostat|mesh-list
43658734|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658735|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43850708|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891303|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891304|NCT03661645|Dexamethasone|dexamethasone|mesh-list
43891305|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
43891306|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
43891307|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43891308|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43891309|NCT03661645|BB 1101|bb 1101|mesh-list
43891310|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891311|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
43891312|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
43891313|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891314|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891315|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891316|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
43891317|NCT03661645|Hormones|hormones|mesh-ancestor
43891318|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891319|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891320|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891321|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
43891322|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891323|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891324|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43891325|NCT03661645|Protective Agents|protective agents|mesh-ancestor
43891326|NCT03647566|Listerine|listerine|mesh-list
43891327|NCT03647566|Fluorides|fluorides|mesh-list
43891337|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43891338|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891339|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
43891340|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43891341|NCT03533010|Vitamin D|vitamin d|mesh-list
43891342|NCT03533010|Vitamins|vitamins|mesh-ancestor
43891343|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
43850709|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43850710|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850711|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891344|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891345|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43891346|NCT03435003|Dexamethasone|dexamethasone|mesh-list
43891347|NCT03435003|Fentanyl|fentanyl|mesh-list
43891348|NCT03435003|Scopolamine|scopolamine|mesh-list
43891349|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
43891350|NCT03435003|Ondansetron|ondansetron|mesh-list
43891351|NCT03435003|Aprepitant|aprepitant|mesh-list
43891352|NCT03435003|Metoclopramide|metoclopramide|mesh-list
43891353|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
43891354|NCT03435003|Propofol|propofol|mesh-list
43891355|NCT03435003|Sevoflurane|sevoflurane|mesh-list
43891356|NCT03435003|Desflurane|desflurane|mesh-list
43891357|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43891358|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891359|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
43891360|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
43891361|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850712|NCT05312645|Emollients|emollients|mesh-ancestor
43891362|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891363|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891364|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
43891365|NCT03435003|Hormones|hormones|mesh-ancestor
43891388|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
43891389|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
43891390|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43891391|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
43891392|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43891393|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43891394|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43891395|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43891396|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43891397|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43891398|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43891399|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
43891400|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
43891401|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43891402|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
43891403|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43891404|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
43891406|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43891407|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
43891408|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
43891409|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891410|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891411|NCT03321656|Tacrolimus|tacrolimus|mesh-list
43891412|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891413|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
43891414|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891415|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43891416|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891418|NCT03182166|Golimumab|golimumab|mesh-list
43891438|NCT03088826|Narcotics|narcotics|mesh-ancestor
43891439|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891440|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891441|NCT03088826|Analgesics|analgesics|mesh-ancestor
43891442|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
43850713|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43891443|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891444|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891445|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
43891447|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43891448|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43891449|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891450|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891451|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43891452|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891453|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137222|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137223|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891454|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
43891455|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891456|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891457|NCT02639702|Clozapine|clozapine|mesh-list
43891458|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43891459|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
43891460|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891461|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891485|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43891486|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
43891487|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
43891488|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
43891489|NCT02444728|Azathioprine|azathioprine|mesh-list
43891490|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891491|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
43891492|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891493|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891494|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43891495|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
43891496|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891497|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891498|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43891499|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891500|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
43891501|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
43891502|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891503|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43658800|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658801|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43658802|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658818|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891504|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
43891506|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891507|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43891508|NCT02444728|Protective Agents|protective agents|mesh-ancestor
43891509|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
43891510|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43891511|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43891512|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891513|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891531|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891533|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
43891534|NCT01426529|Giapreza|giapreza|mesh-list
43891535|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
43891536|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43891537|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43891538|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891539|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891540|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891541|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891542|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
43891543|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
43891544|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891545|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43891546|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43891547|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
43891548|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891549|NCT00458835|Ciclesonide|ciclesonide|mesh-list
43891550|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
43891551|NCT00458835|Hormones|hormones|mesh-ancestor
43891552|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891553|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891554|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43891555|NCT05283278|Lactoferrin|lactoferrin|mesh-list
43891556|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658819|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658820|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891557|NCT05283057|Empagliflozin|empagliflozin|mesh-list
43891558|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43891559|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891560|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43891561|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891562|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
43891563|NCT05282771|Clobetasol|clobetasol|mesh-list
43891564|NCT05282771|Halobetasol|halobetasol|mesh-list
43891565|NCT05282771|Tazarotene|tazarotene|mesh-list
43891566|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
43891567|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
43891568|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
43891569|NCT05282771|Vitamins|vitamins|mesh-ancestor
43891570|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
44164821|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891571|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891572|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43891573|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891575|NCT05282771|Hormones|hormones|mesh-ancestor
43891576|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891577|NCT05282719|Azacitidine|azacitidine|mesh-list
43891578|NCT05282719|Venetoclax|venetoclax|mesh-list
43658821|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
43658822|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
43658823|NCT02942563|Capecitabine|capecitabine|mesh-list
43658824|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
43658825|NCT02942563|Irinotecan|irinotecan|mesh-list
43658826|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43658827|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
43850728|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891579|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43891580|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
43891581|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891582|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891583|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891584|NCT05282420|Ranibizumab|ranibizumab|mesh-list
43891585|NCT05282420|Aflibercept|aflibercept|mesh-list
43891586|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43891587|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43891588|NCT05282420|Growth Substances|growth substances|mesh-ancestor
43891589|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891590|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
43891591|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891592|NCT05282407|Tenofovir|tenofovir|mesh-list
43891593|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
43891594|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891595|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43891596|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43891597|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891598|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891599|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43891600|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43891601|NCT05282251|Bupivacaine|bupivacaine|mesh-list
43891602|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
43891603|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
43891604|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891605|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43635707|NCT05192889|Blinatumomab|blinatumomab|mesh-list
43891609|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891610|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
43891611|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
43891612|NCT05281926|Nivolumab|nivolumab|mesh-list
43891613|NCT05281926|Poly ICLC|poly iclc|mesh-list
43891614|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891615|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891616|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43891617|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891618|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
43891619|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
43891620|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891621|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
43891622|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
43891623|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43891624|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891625|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891626|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
43891627|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43891628|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891629|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891630|NCT05281419|Triamcinolone|triamcinolone|mesh-list
43891631|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43891632|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43891633|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43891656|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
43891657|NCT05281107|Vitamin D|vitamin d|mesh-list
43891658|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
43891659|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
43891660|NCT05281107|Vitamins|vitamins|mesh-list
43891661|NCT05281107|Calcium|calcium|mesh-list
43891662|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
43891663|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891664|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43891665|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43891667|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
43891668|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43850747|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43891669|NCT05281081|Narcotics|narcotics|mesh-ancestor
43891670|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891671|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891672|NCT05281081|Analgesics|analgesics|mesh-ancestor
43891673|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
43891674|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891675|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
43891676|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
44137224|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137225|NCT00167518|Triamcinolone|triamcinolone|mesh-list
44137226|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137227|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
43891706|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891707|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891708|NCT05280873|Analgesics|analgesics|mesh-ancestor
43891709|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
43891710|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43891711|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43891712|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891713|NCT05280626|Prednisolone|prednisolone|mesh-list
43891714|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43891715|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
43891716|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43891717|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
43891718|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
43891719|NCT05280626|Rituximab|rituximab|mesh-list
43891720|NCT05280626|Doxorubicin|doxorubicin|mesh-list
43891721|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43891722|NCT05280626|Vincristine|vincristine|mesh-list
43891723|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43850748|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850749|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43850750|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43850751|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891724|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
43891725|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43891726|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
43891727|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891728|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891729|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43891730|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
43891731|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891732|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891733|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43891734|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891752|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
43891753|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
43891754|NCT05280275|Dexamethasone|dexamethasone|mesh-list
43891755|NCT05280275|Lenalidomide|lenalidomide|mesh-list
43891756|NCT05280275|Daratumumab|daratumumab|mesh-list
43891757|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891758|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
43891759|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
43891760|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891761|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891762|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891763|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
43891764|NCT05280275|Hormones|hormones|mesh-ancestor
43891765|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891766|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891767|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891768|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
43891769|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43891770|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43891771|NCT05280275|Growth Substances|growth substances|mesh-ancestor
43891772|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
43891773|NCT05280236|Propofol|propofol|mesh-list
43891774|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43891775|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891776|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891777|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43891778|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
43891779|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
43891780|NCT05280197|Bupivacaine|bupivacaine|mesh-list
43891781|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
43891782|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
43891783|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43891784|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891785|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
43891844|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
43891845|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891846|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
43891847|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
43891848|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891849|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891850|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43891851|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
43850752|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850753|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43850754|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
43850755|NCT05283720|Hormones|hormones|mesh-ancestor
43850756|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850757|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850758|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43850759|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43850760|NCT05283720|Growth Substances|growth substances|mesh-ancestor
43850761|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
43850762|NCT05261386|Betadex|betadex|mesh-list
43891852|NCT05279482|Hormones|hormones|mesh-ancestor
43891853|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43891854|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43891855|NCT05279482|Protective Agents|protective agents|mesh-ancestor
43891856|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891857|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891858|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
43891859|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43891860|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43891861|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891862|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
43891863|NCT05279469|Coagulants|coagulants|mesh-ancestor
43891864|NCT05279391|Dexamethasone|dexamethasone|mesh-list
43891865|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43891866|NCT05279391|Heparin|heparin|mesh-list
43891867|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43891868|NCT05279391|Tinzaparin|tinzaparin|mesh-list
43891893|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891895|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
43891896|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43891897|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891898|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43891899|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891900|NCT05260671|Cetuximab|cetuximab|mesh-list
43891901|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891902|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891903|NCT05254808|Fosfomycin|fosfomycin|mesh-list
43891904|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
43891905|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891906|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891907|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43891908|NCT05254808|Renal Agents|renal agents|mesh-ancestor
43891909|NCT05250596|Colchicine|colchicine|mesh-list
43891910|NCT05250596|Atorvastatin|atorvastatin|mesh-list
43891911|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43891912|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43891913|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
43891914|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891915|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43658910|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43658911|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
43658912|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658913|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658914|NCT02941575|Methamphetamine|methamphetamine|mesh-list
43658915|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43658916|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658917|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
43658918|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
43658919|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658920|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
43658921|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658948|NCT02941744|Nivolumab|nivolumab|mesh-list
43658949|NCT02941744|Ipilimumab|ipilimumab|mesh-list
43658950|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43891916|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43891917|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891918|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
43891919|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43891920|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
43891940|NCT05232357|Protective Agents|protective agents|mesh-ancestor
43891941|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891942|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
43891943|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
43891944|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43891945|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43891946|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
43891947|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
43891948|NCT05229003|Irinotecan|irinotecan|mesh-list
43891949|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43891950|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43891951|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891952|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891953|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891954|NCT05215405|Venetoclax|venetoclax|mesh-list
43891955|NCT05215405|Navitoclax|navitoclax|mesh-list
43891956|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891957|NCT05213221|Lenvatinib|lenvatinib|mesh-list
43891958|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891959|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43891960|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891961|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891962|NCT05212857|Leuprolide|leuprolide|mesh-list
43891963|NCT05212857|Goserelin|goserelin|mesh-list
43891964|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43891965|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
43891966|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43891968|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43891969|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891970|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43891971|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43891972|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43891973|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43891974|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891975|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43891978|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
43891979|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43891980|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
43891981|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44157252|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43891982|NCT05193968|Nitroprusside|nitroprusside|mesh-list
43891983|NCT05193968|Norepinephrine|norepinephrine|mesh-list
43891984|NCT05193968|Acetylcholine|acetylcholine|mesh-list
43891985|NCT05193968|Terbutaline|terbutaline|mesh-list
43891986|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43851994|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
43851995|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851996|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
43851997|NCT00097474|Melatonin|melatonin|mesh-list
43851998|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43851999|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
43852000|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891987|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43891988|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
43891989|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43891990|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43891991|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43891992|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
43891993|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
43891994|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43891995|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43891996|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43891997|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
43891998|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43891999|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43892000|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
43892001|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43892002|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892003|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892004|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
43892005|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892008|NCT05193851|Ricolinostat|ricolinostat|mesh-list
43892026|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
43892027|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892028|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658963|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892029|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
43892030|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892031|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892032|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
43892033|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892034|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892035|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43892036|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43892037|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43892038|NCT05158309|Capsaicin|capsaicin|mesh-list
43892039|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
43892040|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892041|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
43892042|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892043|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892045|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892046|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892047|NCT05147376|Analgesics|analgesics|mesh-ancestor
43892048|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
43892049|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892050|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892051|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892052|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892053|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892054|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892055|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892056|NCT05137587|Ketamine|ketamine|mesh-list
43892070|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892071|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892073|NCT05137574|Propofol|propofol|mesh-list
43892074|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892075|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892076|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892077|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892078|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
43892079|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
43892080|NCT05137574|Analgesics|analgesics|mesh-ancestor
43892081|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
43892082|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892083|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43892084|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43892085|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43892086|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892087|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892088|NCT05132829|Azithromycin|azithromycin|mesh-list
43892089|NCT05132829|Cefazolin|cefazolin|mesh-list
43892090|NCT05132829|Indomethacin|indomethacin|mesh-list
43892091|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43892092|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892093|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892094|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892095|NCT05132829|Analgesics|analgesics|mesh-ancestor
43892096|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
43892097|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892098|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892099|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892100|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43659080|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43659081|NCT02940912|Apomorphine|apomorphine|mesh-list
43659083|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659084|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
43659085|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659086|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659087|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
43659088|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
43659089|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892101|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
43892111|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43892112|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892113|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43892114|NCT05125224|Diuretics|diuretics|mesh-ancestor
43892115|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
43892116|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43892117|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43892118|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892119|NCT05122819|Anesthetics|anesthetics|mesh-list
43892120|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892121|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892122|NCT05116917|Nivolumab|nivolumab|mesh-list
43892123|NCT05116917|Ipilimumab|ipilimumab|mesh-list
43892124|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892125|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892126|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43892127|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892128|NCT05102591|Ketorolac|ketorolac|mesh-list
43892129|NCT05102591|Metoclopramide|metoclopramide|mesh-list
43892130|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892131|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892132|NCT05102591|Analgesics|analgesics|mesh-ancestor
43892133|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
43892134|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892159|NCT05036317|Empagliflozin|empagliflozin|mesh-list
43892160|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43892161|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892162|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43892163|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892164|NCT05034367|Mannitol|mannitol|mesh-list
43892165|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43892166|NCT05034367|Diuretics|diuretics|mesh-ancestor
43892167|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
43892168|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892169|NCT05019638|Ketorolac|ketorolac|mesh-list
43892170|NCT05019638|Epinephrine|epinephrine|mesh-list
43892171|NCT05019638|Racepinephrine|racepinephrine|mesh-list
43892172|NCT05019638|Morphine|morphine|mesh-list
43852001|NCT00097474|Protective Agents|protective agents|mesh-ancestor
43892173|NCT05019638|Bupivacaine|bupivacaine|mesh-list
43892174|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
43892175|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
43892176|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
43659100|NCT02940808|Caffeine|caffeine|mesh-list
43659101|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43659102|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659103|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43659104|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892177|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892178|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892179|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
43892180|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892181|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43892182|NCT05019638|Narcotics|narcotics|mesh-ancestor
43892183|NCT05019638|Analgesics|analgesics|mesh-ancestor
43892184|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892185|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892186|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892187|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892188|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892189|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43892190|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43892205|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892206|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892207|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892208|NCT04994444|Nicotine|nicotine|mesh-list
43892209|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43892210|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
43892211|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892212|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892213|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43892214|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43892215|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
43892216|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892217|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892219|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
43892220|NCT04979338|Anesthetics|anesthetics|mesh-list
43892221|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892222|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892223|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
43892224|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892230|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
43892231|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892232|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892233|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892234|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892235|NCT04973124|Analgesics|analgesics|mesh-ancestor
43892236|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
43892237|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892238|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892239|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892240|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892248|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
43892249|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892251|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892252|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892253|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892254|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137229|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137230|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137231|NCT00167557|Interferons|interferons|mesh-list
44137232|NCT00167557|Ribavirin|ribavirin|mesh-list
44137233|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137234|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
44137235|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137236|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
44137237|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137238|NCT00167583|Interferons|interferons|mesh-list
44137239|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
44137240|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
44137241|NCT00167583|Cyclosporine|cyclosporine|mesh-list
44137242|NCT00167583|Cyclosporins|cyclosporins|mesh-list
44137243|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137244|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
44137245|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137246|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137247|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137248|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137249|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
44137250|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137251|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
44137252|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
44137253|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892262|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
43892263|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
43892264|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43892265|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
43892266|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892267|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892268|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43892269|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43892270|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43892271|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43892272|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43892273|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892274|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892275|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43892276|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43892277|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
43892278|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892279|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43892280|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43659118|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659119|NCT02940756|Artesunate|artesunate|mesh-list
43659120|NCT02940756|Lumefantrine|lumefantrine|mesh-list
43659129|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659130|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659132|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
43659133|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43850778|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
43850779|NCT05220319|Hormones|hormones|mesh-ancestor
43892281|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43892282|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892283|NCT04905810|Azacitidine|azacitidine|mesh-list
43892284|NCT04905810|Decitabine|decitabine|mesh-list
43892285|NCT04905810|Venetoclax|venetoclax|mesh-list
43892286|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892287|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
43892288|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892289|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892290|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892291|NCT04880980|Itraconazole|itraconazole|mesh-list
43892292|NCT04880980|Terbinafine|terbinafine|mesh-list
43892293|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
43892294|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850780|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850781|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43850782|NCT05220319|Protective Agents|protective agents|mesh-ancestor
43850783|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43659134|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
43659135|NCT02941068|Fluconazole|fluconazole|mesh-list
43659136|NCT02941068|Caspofungin|caspofungin|mesh-list
43659137|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
43659138|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659139|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43659140|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43659141|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43852002|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892303|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43892304|NCT04872257|Vitamin D|vitamin d|mesh-list
43892305|NCT04872257|Vitamins|vitamins|mesh-ancestor
43892306|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
43892307|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892308|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43892309|NCT04867928|Azacitidine|azacitidine|mesh-list
43892310|NCT04867928|Venetoclax|venetoclax|mesh-list
43892311|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892312|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
43892313|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892314|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892315|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892316|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
43892317|NCT04846348|Promethazine|promethazine|mesh-list
43892318|NCT04846348|Salicylates|salicylates|mesh-list
43892319|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
43892320|NCT04846348|Emollients|emollients|mesh-list
43892321|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43892322|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892323|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892324|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892325|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
43892326|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
43892327|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
43892328|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892329|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
43892330|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
43892331|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892332|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43892333|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
43892334|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
43892345|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43892346|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892347|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43892348|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
43892349|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892350|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892351|NCT04840472|Panitumumab|panitumumab|mesh-list
43892352|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892353|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892354|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
43892355|NCT04823091|Fludarabine|fludarabine|mesh-list
43892356|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892357|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
43892358|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892359|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892360|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43892361|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
43892362|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892363|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892364|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43892365|NCT04814602|Proglumide|proglumide|mesh-list
43659142|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659143|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43892366|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43659144|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659145|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659146|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825548|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
43659147|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43849642|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849643|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892367|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892368|NCT04798755|Adalimumab|adalimumab|mesh-list
43892369|NCT04798755|Methotrexate|methotrexate|mesh-list
43892370|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43892393|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
43892394|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
43892395|NCT04788108|Progestins|progestins|mesh-ancestor
43892397|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892398|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892399|NCT04774120|Propofol|propofol|mesh-list
43892400|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892401|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892402|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892403|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892404|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
43892405|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
43892406|NCT04773002|Anesthetics|anesthetics|mesh-list
43892407|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892408|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892409|NCT04762472|Montelukast|montelukast|mesh-list
43892410|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892411|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892412|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43892413|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
43892447|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
43892448|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43892449|NCT04749459|Protective Agents|protective agents|mesh-ancestor
43892450|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892451|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
43892452|NCT04734652|Tenofovir|tenofovir|mesh-list
43892453|NCT04734652|Lamivudine|lamivudine|mesh-list
43892454|NCT04734652|Dolutegravir|dolutegravir|mesh-list
43892455|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
43892456|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892457|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43892458|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43892459|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892460|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892461|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43892462|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43892463|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43892464|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43892465|NCT04732260|Letermovir|letermovir|mesh-list
43892466|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43892467|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892468|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892469|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892470|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
43892471|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892472|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
43892473|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892474|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
43659166|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
43659167|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
43659168|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
43659169|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659170|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659171|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43850802|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850809|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43850810|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
43892475|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892476|NCT04708340|Protective Agents|protective agents|mesh-ancestor
43892477|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892478|NCT04701281|Capecitabine|capecitabine|mesh-list
43892482|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892483|NCT04690231|Etoposide|etoposide|mesh-list
43892484|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
43892485|NCT04690231|Apatinib|apatinib|mesh-list
43892486|NCT04690231|Ifosfamide|ifosfamide|mesh-list
43892487|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
43892488|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892489|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892490|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43892491|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43892492|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892493|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892494|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892495|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43892496|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
43892497|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
43892498|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892499|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850814|NCT05182840|Empagliflozin|empagliflozin|mesh-list
43850815|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43850816|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850817|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43850818|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850819|NCT05153304|Nivolumab|nivolumab|mesh-list
43850820|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43659172|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43659173|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
43659174|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
43659175|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659176|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43659177|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43659178|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43659179|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659181|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43892500|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892501|NCT04651439|Lenograstim|lenograstim|mesh-list
43892502|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43892503|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
43892504|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137258|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137259|NCT00167648|Leuprolide|leuprolide|mesh-list
44137260|NCT00167648|Goserelin|goserelin|mesh-list
44137261|NCT00167648|Estradiol|estradiol|mesh-list
44137262|NCT00167648|Estrogens|estrogens|mesh-ancestor
44137263|NCT00167648|Hormones|hormones|mesh-ancestor
44137264|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137265|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137266|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44137267|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
44137268|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
44137269|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44137270|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137274|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137275|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
44137276|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44137277|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137278|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
44137279|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137280|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44137281|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44137282|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44137283|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44137284|NCT00167687|Prazosin|prazosin|mesh-list
44137285|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137286|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
44137287|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
44137288|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44137289|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137290|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137291|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137292|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137293|NCT00167713|Ibuprofen|ibuprofen|mesh-list
44137294|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44137295|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44137296|NCT00167713|Analgesics|analgesics|mesh-ancestor
44137297|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
44137298|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846660|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43846661|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
43846662|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846663|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846664|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43846665|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44137299|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137300|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137301|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137302|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44137303|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137304|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137305|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
43892505|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
43892512|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892513|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
43892514|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
43892515|NCT04602845|Fentanyl|fentanyl|mesh-list
43892516|NCT04602845|Midazolam|midazolam|mesh-list
43892517|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43892518|NCT04602845|Narcotics|narcotics|mesh-ancestor
43659266|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43659268|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659269|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659270|NCT02940002|Betamethasone|betamethasone|mesh-list
43659271|NCT02940002|Clobetasol|clobetasol|mesh-list
43659272|NCT02940002|Calcipotriene|calcipotriene|mesh-list
43850893|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43850895|NCT04951206|Hormones|hormones|mesh-ancestor
43850896|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43850897|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850898|NCT04933903|Nivolumab|nivolumab|mesh-list
43850899|NCT04933903|Ipilimumab|ipilimumab|mesh-list
43850900|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850901|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850902|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43850903|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659289|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43659290|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659291|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43659292|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850912|NCT04906395|Tamoxifen|tamoxifen|mesh-list
43850913|NCT04906395|Letrozole|letrozole|mesh-list
43850914|NCT04906395|Anastrozole|anastrozole|mesh-list
43850915|NCT04906395|Exemestane|exemestane|mesh-list
43850916|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850920|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850921|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43659312|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43659313|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43659314|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892519|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892520|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892521|NCT04602845|Analgesics|analgesics|mesh-ancestor
43892522|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
43892523|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892524|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43892525|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892526|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
43892527|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
43892528|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892529|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43892530|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43892531|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43892532|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
43659315|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
43892533|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
43892534|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892535|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892536|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892537|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892538|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892539|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892540|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43892541|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892542|NCT04597476|Fucoidan|fucoidan|mesh-list
43892543|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43659316|NCT02939482|Hormones|hormones|mesh-ancestor
43659317|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659318|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659319|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659320|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
43659321|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659322|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659323|NCT02939430|Atropine|atropine|mesh-list
43659324|NCT02939430|Neostigmine|neostigmine|mesh-list
43659325|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43659326|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43659327|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43892544|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892545|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
43892546|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892547|NCT04597320|Fentanyl|fentanyl|mesh-list
43892548|NCT04597320|Midazolam|midazolam|mesh-list
43892549|NCT04597320|Esketamine|esketamine|mesh-list
43775421|NCT02345746|Vitamins|vitamins|mesh-ancestor
44164822|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892552|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892553|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892554|NCT04597320|Analgesics|analgesics|mesh-ancestor
43892555|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
43892556|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892557|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43892558|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892559|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
43892560|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
43892561|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892562|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43892563|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43892564|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43892565|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
43892566|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
43892567|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892568|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892569|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
43892571|NCT04568200|Carboplatin|carboplatin|mesh-list
43892572|NCT04568200|Durvalumab|durvalumab|mesh-list
43892573|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892574|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892575|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892576|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892577|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892578|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892579|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892580|NCT04559529|Levetiracetam|levetiracetam|mesh-list
43892581|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
43892582|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
43892583|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
43892584|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
43892592|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
43892593|NCT04524702|Paclitaxel|paclitaxel|mesh-list
43892594|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43892595|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892596|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892597|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892598|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892599|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892600|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892601|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43892602|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
43892603|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
43892604|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892605|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892606|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892607|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
43659372|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850928|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43850929|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
43850930|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
43850931|NCT04904588|Melphalan|melphalan|mesh-list
43850932|NCT04904588|Busulfan|busulfan|mesh-list
43850944|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43850945|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850946|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43850947|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43850948|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
43850949|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43850950|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850951|NCT04903314|Cenobamate|cenobamate|mesh-list
43892608|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892609|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
43892610|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43892611|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43892612|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892613|NCT04509414|Midazolam|midazolam|mesh-list
43892614|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
43892615|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892616|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892617|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892618|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892619|NCT04509414|Analgesics|analgesics|mesh-ancestor
43892620|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
43892621|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892622|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892623|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892624|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892625|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892630|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43892631|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43892632|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892633|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
43892635|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
43892636|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
43892637|NCT04505059|Anesthetics|anesthetics|mesh-list
43892638|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892639|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892640|NCT04500574|Latanoprost|latanoprost|mesh-list
43892641|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43659468|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43659469|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659470|NCT02938286|Epinephrine|epinephrine|mesh-list
43659471|NCT02938286|Carticaine|carticaine|mesh-list
43659472|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43659473|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43659474|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659475|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659476|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659477|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659478|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43659479|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43659480|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
43659481|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659493|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43659494|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43659495|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43659496|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
43659497|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659498|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892642|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43892643|NCT04493151|Imipenem|imipenem|mesh-list
43892644|NCT04493151|Relebactam|relebactam|mesh-list
43892645|NCT04493151|Cilastatin|cilastatin|mesh-list
43892646|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43892647|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892648|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
43892649|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892650|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892651|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43892652|NCT04485325|Etanercept|etanercept|mesh-list
43892653|NCT04485325|Tofacitinib|tofacitinib|mesh-list
43892654|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43892655|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43892656|NCT04485325|Analgesics|analgesics|mesh-ancestor
43892657|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
43892658|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892659|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892660|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892661|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892662|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892663|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43892664|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
43892665|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892671|NCT04476420|Betamethasone|betamethasone|mesh-list
43892672|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
43892673|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43892674|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
43892675|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43892676|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43892677|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
43892678|NCT04476420|Hormones|hormones|mesh-ancestor
43892679|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892680|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892681|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43892682|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
43892683|NCT04475705|Propofol|propofol|mesh-list
43659499|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659500|NCT02937662|Cytarabine|cytarabine|mesh-list
43659501|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
43892684|NCT04475705|Sevoflurane|sevoflurane|mesh-list
43659502|NCT02937662|Idarubicin|idarubicin|mesh-list
43659503|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659504|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
43851011|NCT04759586|Cortisone|cortisone|mesh-list
43659521|NCT02937857|Expectorants|expectorants|mesh-list
43659522|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
43892685|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892686|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892687|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892688|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892689|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
43892690|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
43892691|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43892692|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43892693|NCT04473508|Ropivacaine|ropivacaine|mesh-list
43892694|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
43892695|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
43892696|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892697|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892698|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
43892700|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
43892718|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892719|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43892720|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43892721|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
43892722|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
43892723|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892724|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43892725|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43892726|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892727|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892728|NCT04429321|Nivolumab|nivolumab|mesh-list
43892729|NCT04429321|Ipilimumab|ipilimumab|mesh-list
43892730|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892731|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892732|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43892733|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892734|NCT04392622|Cisplatin|cisplatin|mesh-list
43659523|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659524|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
43659525|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
43659526|NCT02937844|Fludarabine|fludarabine|mesh-list
43659527|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659528|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
43659529|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659530|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43659531|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43659532|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
43892735|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892736|NCT04390958|Paclitaxel|paclitaxel|mesh-list
43892737|NCT04390958|Cisplatin|cisplatin|mesh-list
43892738|NCT04390958|Capecitabine|capecitabine|mesh-list
43892739|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43892740|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892741|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892742|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892743|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892744|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892764|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892765|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892766|NCT04359147|Urological Agents|urological agents|mesh-ancestor
43892767|NCT04355585|Colchicine|colchicine|mesh-list
43892768|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
43892769|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43892770|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
43892771|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
43892772|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
43892773|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892774|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892775|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
43892776|NCT04345666|Testosterone|testosterone|mesh-list
43892777|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
43892778|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
43892779|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43892780|NCT04345666|Androgens|androgens|mesh-ancestor
43892781|NCT04345666|Hormones|hormones|mesh-ancestor
43892782|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43892783|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892784|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43892785|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892812|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
43892813|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43892814|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43892815|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892816|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892817|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892818|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892819|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892820|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43892821|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
43892822|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43892823|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43892824|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43892825|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
43892826|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892827|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
43892828|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43892829|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43892830|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892832|NCT04289142|Analgesics|analgesics|mesh-ancestor
43892865|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
43892866|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
43892867|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43659533|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851029|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892868|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43892869|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43892870|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
43892871|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43892872|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892873|NCT04252105|Antioxidants|antioxidants|mesh-list
43892874|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892875|NCT04252105|Protective Agents|protective agents|mesh-ancestor
43892876|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892877|NCT04251585|Insulin|insulin|mesh-list
43892878|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43892879|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43892924|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892925|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
43659534|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659535|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43659537|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43659538|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43659539|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43659545|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43659546|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43659547|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659548|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659550|NCT02937896|Coagulants|coagulants|mesh-ancestor
43659551|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43659552|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
43659553|NCT02937792|Bupivacaine|bupivacaine|mesh-list
43659554|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
43659555|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
43659556|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659557|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851031|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43851032|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
43851033|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851034|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851035|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43851036|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851037|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43851038|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43892926|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43892927|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
43892928|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43892929|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43892930|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43892931|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
43892932|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43892933|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
43892934|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43892935|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43892936|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43892937|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43892938|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892939|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43892940|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43892941|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43892942|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43892943|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43892944|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43892945|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43892946|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
43892947|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
43892948|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
43892949|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
43892970|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892971|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43892972|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892973|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892974|NCT04173949|Ramipril|ramipril|mesh-list
43892975|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43892976|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
43892977|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43892978|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892979|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43892980|NCT04170556|Nivolumab|nivolumab|mesh-list
43892981|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43892982|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43892983|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43892984|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43892985|NCT04130659|Omeprazole|omeprazole|mesh-list
43892986|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43892987|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43892988|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43893024|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893025|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
43893026|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43893027|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43893028|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43893029|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
43893030|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893031|NCT04080947|Montelukast|montelukast|mesh-list
43893032|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43893033|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
43893034|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43851104|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
43659645|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43893035|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
43893036|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893037|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893038|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43893039|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43893040|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893041|NCT04064931|Niacin|niacin|mesh-list
43893042|NCT04064931|Vitamins|vitamins|mesh-ancestor
43893043|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
43893044|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893045|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43893046|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
43893047|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893048|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43893049|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
43893050|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
43893051|NCT04056910|Nivolumab|nivolumab|mesh-list
43893052|NCT04056910|Ivosidenib|ivosidenib|mesh-list
43893053|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893054|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893055|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43893065|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
43893066|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893067|NCT03976973|Protective Agents|protective agents|mesh-ancestor
43893068|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893069|NCT03976973|Antidotes|antidotes|mesh-ancestor
44137313|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
44137314|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137315|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137316|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44137317|NCT00167739|Renal Agents|renal agents|mesh-ancestor
44137318|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44137319|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137320|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44137321|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137322|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44137323|NCT00167739|Analgesics|analgesics|mesh-ancestor
44137324|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
44137326|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
44137327|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44137328|NCT00167791|Rituximab|rituximab|mesh-list
44137329|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137330|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137331|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
44137332|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893084|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43893085|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
43893086|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893087|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893088|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893089|NCT03840291|Edoxaban|edoxaban|mesh-list
43893090|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43893091|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
43893092|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43893093|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893094|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893095|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893096|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
43893097|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43893098|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43893099|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
43893100|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
43893101|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43893102|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43893103|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659652|NCT02936492|Clobetasol|clobetasol|mesh-list
43851105|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851106|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893141|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
43893142|NCT03756961|Remifentanil|remifentanil|mesh-list
43893143|NCT03756961|Oxycodone|oxycodone|mesh-list
43893144|NCT03756961|Propofol|propofol|mesh-list
43893145|NCT03756961|Desflurane|desflurane|mesh-list
43893146|NCT03756961|Esketamine|esketamine|mesh-list
43893147|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
43893148|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
43893149|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893150|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893151|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
43893152|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893153|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43893154|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43893155|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43893156|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893203|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893204|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43893205|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893206|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893207|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893208|NCT03642067|Nivolumab|nivolumab|mesh-list
43893209|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893210|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893211|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43893212|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893213|NCT03583307|Sirolimus|sirolimus|mesh-list
43893214|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893215|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893216|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43893217|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893218|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
43893259|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893260|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893262|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893263|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893264|NCT03487666|Capecitabine|capecitabine|mesh-list
43893265|NCT03487666|Nivolumab|nivolumab|mesh-list
43893266|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893267|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
43893268|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893269|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893270|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893271|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43893272|NCT03467867|Rituximab|rituximab|mesh-list
43893273|NCT03467867|Venetoclax|venetoclax|mesh-list
43893274|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893275|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893276|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
43893309|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893310|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43893311|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43893312|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
43893313|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893314|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893315|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43893316|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43893317|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
43893318|NCT03431948|Nivolumab|nivolumab|mesh-list
43893319|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893320|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893321|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43893322|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893323|NCT03427463|Morphine|morphine|mesh-list
43893324|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43893325|NCT03427463|Narcotics|narcotics|mesh-ancestor
43893326|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893327|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893328|NCT03427463|Analgesics|analgesics|mesh-ancestor
43893329|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
43893330|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893331|NCT03417544|Trastuzumab|trastuzumab|mesh-list
43893332|NCT03417544|Pertuzumab|pertuzumab|mesh-list
43893333|NCT03417544|Atezolizumab|atezolizumab|mesh-list
43893334|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893335|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893336|NCT03376672|Dexamethasone|dexamethasone|mesh-list
43893337|NCT03376672|Lenalidomide|lenalidomide|mesh-list
43893338|NCT03376672|Ixazomib|ixazomib|mesh-list
43893339|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893340|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
43893341|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
43893342|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893343|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893350|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
43893351|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43893352|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43893353|NCT03376672|Growth Substances|growth substances|mesh-ancestor
43893354|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
43893355|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893356|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893357|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893359|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43893360|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
43893361|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
43893362|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893363|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893364|NCT03361852|Rituximab|rituximab|mesh-list
43893366|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893367|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893368|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
43893369|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893370|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43893371|NCT03314181|Dexamethasone|dexamethasone|mesh-list
43893372|NCT03314181|Bortezomib|bortezomib|mesh-list
43893373|NCT03314181|Venetoclax|venetoclax|mesh-list
43893374|NCT03314181|Daratumumab|daratumumab|mesh-list
43893375|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893376|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
43893377|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
43893378|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893379|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893380|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893381|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
43893382|NCT03314181|Hormones|hormones|mesh-ancestor
43851112|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851113|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
43851114|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659680|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659682|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43851149|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851157|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893383|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893384|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893389|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43893390|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
43893391|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893392|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893393|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893394|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893395|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
43893396|NCT03266783|Apixaban|apixaban|mesh-list
43893397|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43893398|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
43893399|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43893400|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
43893401|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893402|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893403|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
43893404|NCT03187509|Torsemide|torsemide|mesh-list
43893405|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43893406|NCT03187509|Diuretics|diuretics|mesh-ancestor
43893407|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
43893408|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893409|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43893410|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893411|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893440|NCT02967640|Analgesics|analgesics|mesh-ancestor
43893441|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
43893442|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893443|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893444|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43893445|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43893446|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
43893447|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
43893448|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893449|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43893450|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43893451|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893452|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893453|NCT02897375|Cisplatin|cisplatin|mesh-list
43893454|NCT02897375|Carboplatin|carboplatin|mesh-list
43893455|NCT02897375|Palbociclib|palbociclib|mesh-list
43893456|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893457|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893458|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893459|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893460|NCT02788981|Paclitaxel|paclitaxel|mesh-list
43893461|NCT02788981|Mifepristone|mifepristone|mesh-list
43893462|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43893463|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893464|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893465|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893466|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893467|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893468|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43893469|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
43893470|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43893482|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43893483|NCT02788773|Durvalumab|durvalumab|mesh-list
43893484|NCT02788773|Tremelimumab|tremelimumab|mesh-list
43893485|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893486|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893487|NCT02767557|Gemcitabine|gemcitabine|mesh-list
43893488|NCT02767557|Paclitaxel|paclitaxel|mesh-list
43893489|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43893490|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893491|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893492|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893493|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893494|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659728|NCT02935764|Irinotecan|irinotecan|mesh-list
43659729|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
43659730|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659731|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43659732|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659733|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659734|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
43659735|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851160|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851162|NCT04551196|Ibuprofen|ibuprofen|mesh-list
43851163|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43851164|NCT04551196|Analgesics|analgesics|mesh-ancestor
43851165|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
43851166|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851167|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893495|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893496|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
43893497|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
43893498|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893499|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893500|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893501|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
43893502|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893503|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
43893504|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43893506|NCT02682004|Serotonin|serotonin|mesh-list
43893533|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893535|NCT02542657|Dexamethasone|dexamethasone|mesh-list
43893536|NCT02542657|Pomalidomide|pomalidomide|mesh-list
43893537|NCT02542657|Ixazomib|ixazomib|mesh-list
43893538|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893539|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
43893540|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
43893541|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893542|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893543|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893544|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
43893545|NCT02542657|Hormones|hormones|mesh-ancestor
43893546|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893547|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893548|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851168|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
43851169|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43851170|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43851171|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43659747|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43659748|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
43659749|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659751|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
43893549|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893550|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893551|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893552|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43893553|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893554|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43893555|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43893556|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
43893557|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43893582|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43893583|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43893584|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893585|NCT02384239|Tamoxifen|tamoxifen|mesh-list
43893586|NCT02384239|Fulvestrant|fulvestrant|mesh-list
43893587|NCT02384239|Palbociclib|palbociclib|mesh-list
43893588|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43893589|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
44137351|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43893590|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893591|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893592|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893593|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893594|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43893595|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43893596|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43893597|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43893598|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893599|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893600|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893601|NCT02361801|Dobutamine|dobutamine|mesh-list
43893602|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43893603|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
43893604|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
43893605|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893606|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893607|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43893608|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43893609|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43893610|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137352|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
44137361|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137362|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44137363|NCT00167843|Renal Agents|renal agents|mesh-ancestor
44137364|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43871134|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137365|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
44137367|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137368|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137369|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659811|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43659812|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659813|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659814|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43659815|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
43659816|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
43659817|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
43659818|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659819|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
44137370|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137371|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44137372|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
44137373|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137374|NCT00167882|Mesalamine|mesalamine|mesh-list
44137375|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44137376|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44137377|NCT00167882|Analgesics|analgesics|mesh-ancestor
44137378|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
44137379|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137380|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137381|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137382|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137383|NCT00167908|Amifostine|amifostine|mesh-list
44137385|NCT00167908|Protective Agents|protective agents|mesh-ancestor
43893623|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43893624|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
43893625|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
43893626|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
43893627|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
43893628|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893629|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893630|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
43893631|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
43893632|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893633|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43893634|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43893635|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43893636|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893637|NCT02353247|Norethindrone|norethindrone|mesh-list
43893638|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
43893639|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43893640|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43893641|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43893642|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
43893643|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659820|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43562881|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659830|NCT02935855|Warfarin|warfarin|mesh-list
43659831|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
43659832|NCT02935855|Dabigatran|dabigatran|mesh-list
43659833|NCT02935855|Apixaban|apixaban|mesh-list
43659834|NCT02935855|Edoxaban|edoxaban|mesh-list
43893644|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893645|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43893646|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43893647|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43893648|NCT02254941|Antibodies|antibodies|mesh-list
43893649|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
43893650|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43893651|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
43893652|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893679|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43893680|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893681|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
43893682|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893683|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893684|NCT02098954|Antiviral Agents|antiviral agents|mesh-ancestor
43893685|NCT02098954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893686|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893687|NCT02098954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43893688|NCT02098954|Immunologic Factors|immunologic factors|mesh-ancestor
43893689|NCT02098954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893690|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893691|NCT01837277|Efavirenz|efavirenz|mesh-list
43893692|NCT01837277|Dolutegravir|dolutegravir|mesh-list
43893693|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43893694|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43893695|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893696|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893697|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
43893698|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893699|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43893700|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43893701|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43893702|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43893703|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43893704|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43893705|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43893706|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
44164823|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635708|NCT05192889|Navitoclax|navitoclax|mesh-list
43893708|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43893709|NCT01765218|Topiramate|topiramate|mesh-list
43893710|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
43893711|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43659835|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
43659836|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43659837|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
43659838|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43659839|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
43659840|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659852|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43893712|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893713|NCT01653925|Dutasteride|dutasteride|mesh-list
43893714|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43893715|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43893716|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893717|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893718|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
43893719|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893720|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893721|NCT01525329|Fluorouracil|fluorouracil|mesh-list
43659904|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
43659905|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43659906|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659907|NCT02935075|Tenofovir|tenofovir|mesh-list
43659908|NCT02935075|Lamivudine|lamivudine|mesh-list
43659909|NCT02935075|Efavirenz|efavirenz|mesh-list
43659910|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
43851212|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43851213|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43659911|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43659912|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43659913|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43659914|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659915|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659916|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43659917|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43659918|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43659919|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43659946|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659947|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43659949|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659950|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659951|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43659952|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
43893722|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
43893723|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893724|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893725|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893727|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
43893728|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893729|NCT01482286|Metformin|metformin|mesh-list
43893730|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43893731|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893732|NCT01061840|Molgramostim|molgramostim|mesh-list
43893733|NCT01061840|Modafinil|modafinil|mesh-list
43893734|NCT01061840|Vaccines|vaccines|mesh-list
43893735|NCT01061840|Sargramostim|sargramostim|mesh-list
43893736|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
43893737|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893738|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893739|NCT01061840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43893740|NCT01061840|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43893741|NCT01061840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43893742|NCT01061840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43893744|NCT00107250|Paclitaxel|paclitaxel|mesh-list
43893747|NCT00107250|Cediranib|cediranib|mesh-list
43893748|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43893749|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893750|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893751|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893752|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893753|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893754|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43893755|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
43893756|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893757|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893758|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
43893759|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43893760|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
43893761|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43893762|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893763|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43893764|NCT05285449|Cannabidiol|cannabidiol|mesh-list
43893765|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
43893766|NCT05285397|Liraglutide|liraglutide|mesh-list
43893767|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43659953|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
43659954|NCT02934945|Hormones|hormones|mesh-ancestor
43659955|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43851218|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
43659994|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659995|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43659996|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659997|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43659998|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43659999|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43660000|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43562905|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
43660016|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703238|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
43849646|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893768|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893769|NCT05285397|Incretins|incretins|mesh-ancestor
43893770|NCT05285397|Hormones|hormones|mesh-ancestor
43893771|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893772|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
43893773|NCT05285384|Paraproteins|paraproteins|mesh-list
43893795|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43893796|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43893797|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893798|NCT05284994|Osimertinib|osimertinib|mesh-list
43893799|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893800|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43893801|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893802|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893804|NCT05284942|Prednisone|prednisone|mesh-list
43893805|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893806|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
43893807|NCT05284942|Hormones|hormones|mesh-ancestor
43893808|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893809|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893810|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893811|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893812|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43893813|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43893814|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
43893815|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43893816|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893817|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893818|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893819|NCT05284851|Vaccines|vaccines|mesh-list
43893820|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
43893821|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893822|NCT05284734|Anesthetics|anesthetics|mesh-list
43893823|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893824|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137400|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
43660017|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660018|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660019|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660020|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43660021|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
43825602|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43825603|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825604|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825605|NCT05563012|Capecitabine|capecitabine|mesh-list
43825606|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
43825607|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43825608|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
43825609|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825610|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825611|NCT05562882|Daratumumab|daratumumab|mesh-list
43851223|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137401|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137402|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
44137403|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137410|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
44137412|NCT00167960|beta-Lactams|beta-lactams|mesh-list
44137413|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44137414|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137415|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
44137416|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893825|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
43893826|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43893827|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893828|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893829|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43893830|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43893831|NCT05284448|Protective Agents|protective agents|mesh-ancestor
43893832|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893833|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
43893834|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43893835|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
43893836|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43893837|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893838|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43893839|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893840|NCT05284136|Prednisolone|prednisolone|mesh-list
43893841|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893842|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
43893843|NCT05284136|Hormones|hormones|mesh-ancestor
43893847|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43893868|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893869|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43893870|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
43893871|NCT05283954|Hormones|hormones|mesh-ancestor
43893872|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893873|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43893874|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825631|NCT05560945|Fluorides|fluorides|mesh-list
43825632|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
43825633|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
43825634|NCT05560945|Protective Agents|protective agents|mesh-ancestor
43825635|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825636|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43825637|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825638|NCT05560542|Dexamethasone|dexamethasone|mesh-list
43825639|NCT05560542|Atropine|atropine|mesh-list
43825640|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825641|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
43893875|NCT05283954|Protective Agents|protective agents|mesh-ancestor
43893876|NCT05283954|Antioxidants|antioxidants|mesh-ancestor
43893877|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893878|NCT05283954|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43893879|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43893880|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893881|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893882|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
43893883|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43893884|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
43893885|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43893886|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43893887|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43893888|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893889|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43893890|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893891|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
43893892|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
43893893|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43893894|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43893895|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
43893896|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
43893897|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
43893898|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
43893899|NCT05283850|Calcium|calcium|mesh-list
43893907|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
43893908|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893909|NCT05283551|Famciclovir|famciclovir|mesh-list
43893910|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
43893911|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893912|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43893913|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43893914|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893915|NCT05283421|Estrogens|estrogens|mesh-list
43893916|NCT05283421|Hormones|hormones|mesh-ancestor
43893917|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43893918|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893919|NCT05262205|Anesthetics|anesthetics|mesh-list
43893920|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43893921|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893922|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
43893923|NCT05252884|Calcitriol|calcitriol|mesh-list
43893924|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
43893925|NCT05252884|Calcium|calcium|mesh-list
43893926|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43893927|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893928|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43893929|NCT05252884|Antacids|antacids|mesh-ancestor
43893930|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893931|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43893932|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43893956|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
43893957|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893958|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893959|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893960|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43893961|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43893962|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43893963|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893964|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893965|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893966|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43893967|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43893968|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43893969|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
43893970|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43893971|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
43645287|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
43893972|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893973|NCT05161351|Vitamin D|vitamin d|mesh-list
43893974|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
43893975|NCT05161351|Baclofen|baclofen|mesh-list
43893976|NCT05161351|Vitamins|vitamins|mesh-ancestor
43893977|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
43893978|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43893979|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43893980|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43893981|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43893982|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43893983|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43893984|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43893985|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
43893994|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43893995|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43893996|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43893997|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
43893998|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43893999|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
43894000|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43894001|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43894002|NCT05137496|Prednisolone|prednisolone|mesh-list
43894003|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
43894004|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43894005|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
43894006|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894007|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
43894008|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
43894009|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894010|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894011|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894049|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43894050|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894051|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
43894052|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894053|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
43894054|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894055|NCT04837768|Progesterone|progesterone|mesh-list
43894056|NCT04837768|Progestins|progestins|mesh-ancestor
43894057|NCT04837768|Hormones|hormones|mesh-ancestor
43894058|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894059|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894060|NCT04769388|Carboplatin|carboplatin|mesh-list
43894061|NCT04769388|Pemetrexed|pemetrexed|mesh-list
43894062|NCT04769388|Osimertinib|osimertinib|mesh-list
43894063|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894064|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894065|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894066|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43894067|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43894068|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43894069|NCT04759248|Trastuzumab|trastuzumab|mesh-list
43894070|NCT04759248|Atezolizumab|atezolizumab|mesh-list
43894071|NCT04759248|Vinorelbine|vinorelbine|mesh-list
43894072|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894073|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894074|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43894097|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894098|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894099|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
43894100|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
43894101|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
43894102|NCT04656067|Ethamsylate|ethamsylate|mesh-list
43894103|NCT04656067|Oxytocin|oxytocin|mesh-list
43894104|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
43894105|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43825642|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
43894106|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894107|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43894108|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43894109|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894110|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
43894111|NCT04656067|Coagulants|coagulants|mesh-ancestor
43894112|NCT04531943|Progesterone|progesterone|mesh-list
43894113|NCT04531943|Estrogens|estrogens|mesh-list
43894114|NCT04531943|Progestins|progestins|mesh-ancestor
43894115|NCT04531943|Hormones|hormones|mesh-ancestor
43894116|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894117|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894118|NCT04394117|Losartan|losartan|mesh-list
43894119|NCT04394117|Valsartan|valsartan|mesh-list
43894120|NCT04394117|Telmisartan|telmisartan|mesh-list
43894121|NCT04394117|Candesartan|candesartan|mesh-list
44137429|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
44137430|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44137431|NCT00168012|Antibodies|antibodies|mesh-list
44137432|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
43851228|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
44137433|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851229|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660034|NCT02934464|Protective Agents|protective agents|mesh-ancestor
43660035|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660036|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
43660037|NCT02934464|Vitamins|vitamins|mesh-ancestor
43660038|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
43660039|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
43660040|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43660041|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
43660042|NCT02934321|Erythritol|erythritol|mesh-list
43660090|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660091|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43660092|NCT02934204|Methotrexate|methotrexate|mesh-list
43660093|NCT02934204|Temozolomide|temozolomide|mesh-list
43660094|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43660095|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
43660096|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43660097|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137434|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
44137435|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44137436|NCT00168025|Antibodies|antibodies|mesh-list
44137437|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
44137438|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137439|NCT00168051|Factor VIII|factor viii|mesh-list
44137440|NCT00168051|Coagulants|coagulants|mesh-ancestor
44137441|NCT00168077|Thrombin|thrombin|mesh-list
44137442|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
44137443|NCT00168077|Coagulants|coagulants|mesh-ancestor
44137444|NCT00168090|Factor VIII|factor viii|mesh-list
44137445|NCT00168090|Coagulants|coagulants|mesh-ancestor
44137446|NCT00168168|Lenograstim|lenograstim|mesh-list
44137447|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43894145|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43894146|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43894147|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
43894148|NCT04125550|Propofol|propofol|mesh-list
43894149|NCT04125550|Sevoflurane|sevoflurane|mesh-list
43894150|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43894151|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894152|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894153|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43894154|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
43894155|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
43894156|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43894157|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43894158|NCT04106856|Losartan|losartan|mesh-list
43660098|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43894159|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894160|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43894161|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43894162|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43894204|NCT03825302|Diuretics|diuretics|mesh-ancestor
43894205|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
43894206|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894207|NCT03825302|Miotics|miotics|mesh-ancestor
43894208|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
43894209|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894210|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43894211|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43894212|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
43894213|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43894214|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43894215|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
43894216|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894217|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894218|NCT03537599|Daratumumab|daratumumab|mesh-list
43894219|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894220|NCT03434730|Cyclosporine|cyclosporine|mesh-list
43894221|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
43894222|NCT03434730|Lenograstim|lenograstim|mesh-list
43894223|NCT03434730|Cyclosporins|cyclosporins|mesh-list
43894224|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43660099|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
43894225|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
43660100|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660101|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660102|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
43660103|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894226|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894227|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894228|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894229|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894230|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
43894231|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894232|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894251|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894254|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894255|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43894256|NCT03351348|Bupivacaine|bupivacaine|mesh-list
43894257|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894258|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
43894259|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894260|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894261|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
43894262|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894263|NCT03289039|Fulvestrant|fulvestrant|mesh-list
43894264|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43894265|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894266|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43894267|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43894268|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
43894269|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894270|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894272|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894273|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894274|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43894275|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894276|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894277|NCT03101722|Huperzine A|huperzine a|mesh-list
43894278|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
43894279|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894286|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
43894298|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894299|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894300|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43894301|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894302|NCT03015090|Theophylline|theophylline|mesh-list
43894303|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43660116|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
43660117|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43562906|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851236|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851237|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660130|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660131|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660132|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
43660133|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660134|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
43660135|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894304|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
43894305|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894306|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894307|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43894308|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
43894309|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43894310|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894311|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894312|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
43894313|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43894314|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43894315|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
43894316|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894317|NCT03000374|Leucovorin|leucovorin|mesh-list
43894318|NCT03000374|Fluorouracil|fluorouracil|mesh-list
43894319|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
43894320|NCT03000374|Panitumumab|panitumumab|mesh-list
43894321|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
43871136|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894322|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894323|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43894324|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894325|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894326|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
43894327|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894340|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137469|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
44137470|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137471|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
44137472|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44137473|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44137474|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
44137475|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137476|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137477|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137478|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
43562907|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137479|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44137480|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44137481|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44137482|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137483|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137484|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
44137485|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137486|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137487|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44137488|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137489|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
44137490|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43894341|NCT02800941|Warfarin|warfarin|mesh-list
43894342|NCT02800941|Anticoagulants|anticoagulants|mesh-list
43894343|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
43894344|NCT02800941|Fluindione|fluindione|mesh-list
43894345|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
43894346|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894347|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660168|NCT02933788|Analgesics|analgesics|mesh-ancestor
43660169|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
43660170|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660171|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660172|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660173|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660174|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43660175|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43894348|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43894349|NCT02359097|Hematinics|hematinics|mesh-ancestor
43894350|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43894351|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43894359|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894360|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
43894361|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894362|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894363|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894364|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
43894365|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894366|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894367|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894368|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43894369|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894370|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43894371|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43894372|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
43894373|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894374|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894375|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43894376|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43894378|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894379|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894380|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43894381|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43894382|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43894383|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
43894384|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894406|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894407|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
43894408|NCT00303849|Carboplatin|carboplatin|mesh-list
43660177|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43660178|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43660179|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660180|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
43660181|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43660182|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
43660183|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43660184|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
43894410|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
43894411|NCT00303849|Melphalan|melphalan|mesh-list
43894412|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
43894413|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
43894414|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43894415|NCT00303849|Mannitol|mannitol|mesh-list
43894416|NCT00303849|Antidotes|antidotes|mesh-list
43894417|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137491|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43894418|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43894419|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43894420|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43894421|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894422|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894423|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44137496|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137497|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137498|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44137499|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137500|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
44137501|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44137502|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44137503|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44137504|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137505|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137506|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
44137507|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137508|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137509|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44137510|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137511|NCT00168467|Ramipril|ramipril|mesh-list
44137512|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
44137513|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
44137514|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137515|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137516|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137517|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
44137518|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44137519|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44137520|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44137521|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137522|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894461|NCT03819413|Antibodies|antibodies|mesh-list
43894462|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
43894463|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
43894464|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660185|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
43894465|NCT03819452|Vitamin D|vitamin d|mesh-list
43894466|NCT03819452|Vitamins|vitamins|mesh-ancestor
43851238|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660186|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43660187|NCT02933788|Protective Agents|protective agents|mesh-ancestor
43660188|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43660189|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43660190|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
43660191|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
43660192|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660193|NCT02933658|Amlodipine|amlodipine|mesh-list
43660194|NCT02933658|Telmisartan|telmisartan|mesh-list
43660195|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43894472|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894474|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894475|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
43894476|NCT03811366|Hormones|hormones|mesh-ancestor
43894477|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894478|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894479|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43894480|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894481|NCT03806543|Vancomycin|vancomycin|mesh-list
43894482|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894483|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894484|NCT03804099|Aflibercept|aflibercept|mesh-list
43894485|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43894486|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43894487|NCT03804099|Growth Substances|growth substances|mesh-ancestor
43894488|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894489|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
43894490|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894491|NCT03797547|Aflibercept|aflibercept|mesh-list
43894492|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43894493|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43894495|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894496|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
43894497|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894498|NCT03793400|Bevacizumab|bevacizumab|mesh-list
43894499|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894500|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894501|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43894502|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43894517|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894518|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43894519|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43894520|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43894521|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43894523|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
43894524|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
43894525|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894526|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
43894527|NCT03760562|Hormones|hormones|mesh-ancestor
43894528|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894529|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894548|NCT05142319|Vaccines|vaccines|mesh-list
43894549|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
43894550|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894551|NCT05142085|Mineral Oil|mineral oil|mesh-list
43894552|NCT05142085|Emollients|emollients|mesh-ancestor
43894553|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894554|NCT05141968|Vitamin D|vitamin d|mesh-list
43645808|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
43894530|NCT03751397|Cystatins|cystatins|mesh-list
43894531|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43894532|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
43894533|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660215|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660216|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660217|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660218|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660219|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
43660220|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
43660221|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43660222|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43660223|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43894534|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894535|NCT03744546|Tilavonemab|tilavonemab|mesh-list
43894536|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
43894537|NCT03738683|Tazobactam|tazobactam|mesh-list
43894538|NCT03738683|Piperacillin|piperacillin|mesh-list
43894539|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43894545|NCT03738553|Trastuzumab|trastuzumab|mesh-list
43894563|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894564|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
43894565|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894566|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894567|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43894568|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43894569|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43894570|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894571|NCT05141474|Aldesleukin|aldesleukin|mesh-list
43894572|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
43894623|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43894624|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
43894625|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894626|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894627|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43894628|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43894629|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894630|NCT05064449|Analgesics|analgesics|mesh-ancestor
43894631|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
43894632|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894633|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894634|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894635|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43894636|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43894637|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894638|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894639|NCT05046639|Lidocaine|lidocaine|mesh-list
43894641|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
43894642|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894643|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894644|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
43894645|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894646|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894647|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43894648|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43894649|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43894650|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894651|NCT05033639|Melatonin|melatonin|mesh-list
44137531|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137532|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44137533|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
44137534|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137535|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137536|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660224|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43660225|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
43660226|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43660227|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
43660228|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
43660229|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660240|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
44137537|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44137538|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137539|NCT00168519|Nitroprusside|nitroprusside|mesh-list
44137540|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137541|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
44137542|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
44137543|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137544|NCT00168532|Trimethoprim|trimethoprim|mesh-list
44137545|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
44137546|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
44137547|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43645964|NCT03681639|Cobalt|cobalt|mesh-list
43894657|NCT04870138|Azithromycin|azithromycin|mesh-list
43894658|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
43894659|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
43894660|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43894661|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894662|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43894663|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43894664|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894665|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894666|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894684|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
43894685|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
43894686|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43871137|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43894688|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894689|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
43894690|NCT04649060|Hormones|hormones|mesh-ancestor
43894691|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43894692|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43894693|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894694|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894695|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
43894696|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894697|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894698|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894699|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
43894700|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
43894701|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43894702|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43894703|NCT04558190|Ubiquinone|ubiquinone|mesh-list
43894704|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43894705|NCT04558190|Albuterol|albuterol|mesh-list
43894706|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43894707|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
43894708|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894709|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894710|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43894711|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
43894712|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
43894713|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43894714|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43894715|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43894716|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43894717|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
43894723|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
43894724|NCT04551365|Chitosan|chitosan|mesh-list
43894725|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43894726|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43894727|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
43894728|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894729|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43894730|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
43894731|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
43894732|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
43894733|NCT04551365|Coagulants|coagulants|mesh-ancestor
43894734|NCT04535089|Lidocaine|lidocaine|mesh-list
43894735|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
43660273|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660274|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660275|NCT02933099|Dexamethasone|dexamethasone|mesh-list
43660276|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
43894736|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894737|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
43894738|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894739|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894740|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
43894741|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894742|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894743|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43894744|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43894745|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43894746|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894747|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43894748|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894749|NCT04535089|Analgesics|analgesics|mesh-ancestor
43894771|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
43894772|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
43894773|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
43894774|NCT04109885|Promethazine|promethazine|mesh-list
43894775|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
43894776|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43894777|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43894778|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43894779|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894780|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
43894781|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
43894782|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
43894783|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894784|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
43894785|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
43851242|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660277|NCT02933099|Aprepitant|aprepitant|mesh-list
43660278|NCT02933099|Palonosetron|palonosetron|mesh-list
43660279|NCT02933099|BB 1101|bb 1101|mesh-list
43660280|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43660281|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
43660282|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
43660283|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660284|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825685|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43825686|NCT05436522|Propofol|propofol|mesh-list
43825687|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825688|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825689|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825690|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825691|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
43825692|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
43825693|NCT05366283|Sargramostim|sargramostim|mesh-list
43660370|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
43660371|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660372|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43660373|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660374|NCT02932007|Analgesics|analgesics|mesh-ancestor
43894786|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43894787|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43894788|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
43894789|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
43894790|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894791|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894792|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43894793|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
43894794|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894795|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43894796|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43894797|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43894798|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43894819|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43894820|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43894821|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
43894822|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894823|NCT04058197|Deferoxamine|deferoxamine|mesh-list
43894824|NCT04058197|Siderophores|siderophores|mesh-ancestor
43894825|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43894826|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
43894827|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
43894828|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894829|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43894830|NCT03999411|Nicotine|nicotine|mesh-list
43894831|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
43894832|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894833|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43894834|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
43894835|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894836|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894838|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43894839|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
43894840|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894841|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894873|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43894874|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
43894875|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894876|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894877|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894878|NCT02852057|Timolol|timolol|mesh-list
43894879|NCT02852057|Dorzolamide|dorzolamide|mesh-list
43894880|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43894881|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43894882|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
43894883|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894884|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894885|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894886|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894887|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43894888|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43894889|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43894890|NCT02481245|Bezafibrate|bezafibrate|mesh-list
43894891|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43894892|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
43894893|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894894|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43894895|NCT02477384|Propranolol|propranolol|mesh-list
43894896|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43894897|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43894898|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
43894899|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43894900|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894901|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894902|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894903|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43894912|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
43894913|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894914|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43894915|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43894916|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43894917|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43894918|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894920|NCT02393794|Nivolumab|nivolumab|mesh-list
43894921|NCT02393794|Romidepsin|romidepsin|mesh-list
43894922|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43894923|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894924|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894925|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43894926|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137549|NCT00168532|Renal Agents|renal agents|mesh-ancestor
43894943|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894944|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
43894945|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
43894946|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
43894947|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43894948|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43894949|NCT01976286|Analgesics|analgesics|mesh-ancestor
43894950|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
43894951|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43894952|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894953|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43894954|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625397|NCT03102242|Atezolizumab|atezolizumab|mesh-list
43894955|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43894957|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894958|NCT01775644|Bevacizumab|bevacizumab|mesh-list
43894959|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43894960|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894961|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43894962|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43894963|NCT01775644|Growth Substances|growth substances|mesh-ancestor
43894964|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894965|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
43894967|NCT01131169|Fludarabine|fludarabine|mesh-list
43894968|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
43894969|NCT01131169|Melphalan|melphalan|mesh-list
43894970|NCT01131169|Busulfan|busulfan|mesh-list
43894971|NCT01131169|Lenograstim|lenograstim|mesh-list
43894972|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43894973|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43894974|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
43894975|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43894976|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43894977|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
43894982|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
43849648|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43894983|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43894984|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43894985|NCT00882505|Vitamin D|vitamin d|mesh-list
43894986|NCT00882505|Vitamins|vitamins|mesh-ancestor
43894987|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
43894988|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894989|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43894990|NCT00735657|Iodine|iodine|mesh-list
43894991|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43894992|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43894993|NCT00735657|Trace Elements|trace elements|mesh-ancestor
43894994|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
43894995|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43894996|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
43894997|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
43894998|NCT00258427|Busulfan|busulfan|mesh-list
43894999|NCT00258427|Fludarabine|fludarabine|mesh-list
43895000|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
43895001|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43895002|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895003|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
43895004|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895005|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895006|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895007|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
43895008|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895009|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895030|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43895031|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
43895033|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
43895034|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895035|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
43895036|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
43895037|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43895038|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895039|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895040|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895041|NCT03723538|Analgesics|analgesics|mesh-ancestor
43895042|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
43895043|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895044|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43851282|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851283|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
43851284|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43851285|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851286|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
43851287|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849649|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895045|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43895046|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43895047|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
43895048|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895049|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895050|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
43895051|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43895052|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43895053|NCT00000371|Cycloserine|cycloserine|mesh-list
43895054|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43895055|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895056|NCT00000371|Renal Agents|renal agents|mesh-ancestor
43895057|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43895058|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
43895059|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895060|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
43895076|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
43895077|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44158387|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43646297|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895078|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895079|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
43895080|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895081|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895082|NCT05384821|Irinotecan|irinotecan|mesh-list
43895083|NCT05384821|Etoposide|etoposide|mesh-list
43895084|NCT05384821|Vincristine|vincristine|mesh-list
43895085|NCT05384821|Temozolomide|temozolomide|mesh-list
43895086|NCT05384821|Tretinoin|tretinoin|mesh-list
43895087|NCT05384821|Isotretinoin|isotretinoin|mesh-list
43895088|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43895089|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43895090|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895091|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895092|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895093|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43895094|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43895095|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
43895096|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
43895097|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
43895098|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895099|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
43895100|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
43895118|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895119|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895120|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895121|NCT05384366|Paclitaxel|paclitaxel|mesh-list
43895122|NCT05384366|Carboplatin|carboplatin|mesh-list
43895123|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43895124|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895125|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
43895126|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
43895127|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
43895128|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895129|NCT05384210|Gabapentin|gabapentin|mesh-list
43895130|NCT05384210|Milnacipran|milnacipran|mesh-list
43895131|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
43895132|NCT05384210|Analgesics|analgesics|mesh-ancestor
43895133|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
43895134|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895135|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895136|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
43895137|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43895138|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43895139|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43851288|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43851290|NCT04329494|Protective Agents|protective agents|mesh-ancestor
43895140|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895141|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43895142|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43895143|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895144|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895145|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
43895146|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43895147|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43895148|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895149|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895150|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
43895156|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895157|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895158|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895159|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895160|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43895161|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895162|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895163|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
43895164|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895165|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895166|NCT05383625|Vaccines|vaccines|mesh-list
43895167|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
43895168|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895169|NCT05383534|Propofol|propofol|mesh-list
43895170|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43895171|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895172|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895173|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43895174|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
43895175|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
43895176|NCT05383521|Tinidazole|tinidazole|mesh-list
43895177|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
43895178|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895179|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895184|NCT05383313|Midazolam|midazolam|mesh-list
43895206|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
43895207|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
43895208|NCT05383300|Oxytocin|oxytocin|mesh-list
43895209|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
43895210|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43895211|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895212|NCT05383183|Choline|choline|mesh-list
43895213|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
43895214|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43895215|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
43895216|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895217|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895218|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43895219|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
44137579|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137580|NCT00168649|Vitamin A|vitamin a|mesh-list
44137581|NCT00168649|Vitamins|vitamins|mesh-ancestor
44137582|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
44137583|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137584|NCT00168688|Micronutrients|micronutrients|mesh-list
44137585|NCT00168688|Trace Elements|trace elements|mesh-list
44137586|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137587|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
44137588|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895220|NCT05379803|Aflutinib|aflutinib|mesh-list
43895250|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
43895251|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895252|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895253|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
43895254|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895255|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43895256|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43895257|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43895258|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895259|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895260|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43895261|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43895262|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
43895263|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43895264|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43895265|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43895266|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43895267|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43895268|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
43895269|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895270|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
43895271|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
43895272|NCT05294588|Cefixime|cefixime|mesh-list
43895273|NCT05294588|Vaccines|vaccines|mesh-list
43895274|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
43895275|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895276|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895277|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895278|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43895279|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43895280|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895281|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895282|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895283|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43895284|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43895287|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895288|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895289|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43895290|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43895291|NCT05262244|Growth Substances|growth substances|mesh-ancestor
43895292|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895293|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
43646523|NCT03043014|Misoprostol|misoprostol|mesh-list
43895294|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895295|NCT05231460|Narcotics|narcotics|mesh-list
43895296|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895297|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895298|NCT05231460|Analgesics|analgesics|mesh-ancestor
43660418|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660420|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660421|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660422|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
43660423|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43660424|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660425|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660426|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660427|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
43895299|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
43895300|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895301|NCT05212571|Ketamine|ketamine|mesh-list
43895302|NCT05212571|Esketamine|esketamine|mesh-list
43895303|NCT05212571|Analgesics|analgesics|mesh-ancestor
43895304|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
43895305|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895306|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895307|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43895308|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43895309|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
43895310|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
43895311|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895312|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43895313|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43895314|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895315|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895316|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
43895317|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895328|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43895329|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43895330|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
43895331|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43895333|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
43895334|NCT05096169|Clomiphene|clomiphene|mesh-list
43895335|NCT05096169|Enclomiphene|enclomiphene|mesh-list
43895336|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
43895337|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
43895338|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43895339|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
43895340|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
43895341|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895342|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43895343|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
43895344|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895345|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895346|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43895347|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
43895348|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43895349|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43851311|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
43895350|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43895351|NCT05085054|Osimertinib|osimertinib|mesh-list
43851312|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851313|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851314|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43851315|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851316|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43851317|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43851318|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851319|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43851320|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
43660446|NCT02931877|Sevoflurane|sevoflurane|mesh-list
43895352|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895353|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895354|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895355|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895356|NCT04940338|Dexamethasone|dexamethasone|mesh-list
43895357|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
43895358|NCT04940338|Bromfenac|bromfenac|mesh-list
43895360|NCT04940338|BB 1101|bb 1101|mesh-list
43895371|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895372|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
43895373|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895374|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895375|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43895376|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43895377|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895379|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
43895380|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895381|NCT04918069|Capsaicin|capsaicin|mesh-list
43895382|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
43895383|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895384|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
43895385|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895386|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895387|NCT04588727|Aspirin|aspirin|mesh-list
43895388|NCT04588727|Ticagrelor|ticagrelor|mesh-list
43895389|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43895390|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895391|NCT04588727|Analgesics|analgesics|mesh-ancestor
43895392|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
43895393|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895395|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895396|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895397|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43895398|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43895399|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895400|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43895401|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43895402|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895403|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
43895404|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43895409|NCT04521803|Rifampin|rifampin|mesh-list
43895412|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895413|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895414|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
43895415|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43895416|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895417|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895418|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43895419|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43895420|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43895421|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43895422|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43895423|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43895424|NCT04502706|Rituximab|rituximab|mesh-list
43895425|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895426|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895427|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
43562908|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660542|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43660543|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660544|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43660545|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43849651|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
43849652|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895428|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895429|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895430|NCT04487145|Piperaquine|piperaquine|mesh-list
43895431|NCT04487145|Artenimol|artenimol|mesh-list
43895432|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
43895433|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43895434|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43895435|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895461|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895462|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43895463|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895464|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895465|NCT04264806|Azacitidine|azacitidine|mesh-list
43895466|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43895467|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
43895468|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895469|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895470|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895471|NCT04263831|Aldesleukin|aldesleukin|mesh-list
43895472|NCT04263831|Interleukin-2|interleukin-2|mesh-list
43895473|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895474|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895475|NCT04263831|Analgesics|analgesics|mesh-ancestor
43895476|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
43895477|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895478|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895479|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43895480|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43895481|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
43895482|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895483|NCT04261049|Triamcinolone|triamcinolone|mesh-list
43895484|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43660546|NCT02930954|Growth Substances|growth substances|mesh-ancestor
43660547|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660548|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
43660549|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660550|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
43660551|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660552|NCT02930954|Antiviral Agents|antiviral agents|mesh-ancestor
43660553|NCT02930954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660554|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660562|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660564|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
43660565|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
43660568|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
43895485|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43895486|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43895487|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895488|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
43895489|NCT04261049|Hormones|hormones|mesh-ancestor
43895490|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895491|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895492|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895493|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
44137593|NCT00168714|Interferon-beta|interferon-beta|mesh-list
44137594|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
44137595|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137596|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
44137597|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137598|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
44137599|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137600|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
44137601|NCT00168740|Rituximab|rituximab|mesh-list
44137602|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43660666|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660667|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
43660668|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660669|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660670|NCT02929693|Gefitinib|gefitinib|mesh-list
43660671|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660672|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43660673|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660694|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660695|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43660696|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43660738|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
43660739|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43660740|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43660741|NCT02929134|Doxycycline|doxycycline|mesh-list
43660742|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43660743|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660744|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
43660745|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43660746|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137603|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137604|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
44137605|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137606|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137607|NCT00168753|Alefacept|alefacept|mesh-list
44137608|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
44137609|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
44137610|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137611|NCT00168766|Interferons|interferons|mesh-list
43895499|NCT04192019|Glucagon|glucagon|mesh-list
43895500|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43895501|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895502|NCT04192019|Hormones|hormones|mesh-ancestor
43895503|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895504|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895505|NCT04192019|Incretins|incretins|mesh-ancestor
43895506|NCT04166474|Dolutegravir|dolutegravir|mesh-list
43895507|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43895508|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43895509|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895510|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895511|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43895512|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43895513|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
43895523|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895525|NCT04116541|Trametinib|trametinib|mesh-list
43660772|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43660773|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
43660774|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660775|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660776|NCT02929316|Vedolizumab|vedolizumab|mesh-list
43660777|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660778|NCT02929095|Midazolam|midazolam|mesh-list
43660779|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
43660780|NCT02929095|Remifentanil|remifentanil|mesh-list
43660845|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660846|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660847|NCT02928614|Incretins|incretins|mesh-ancestor
43660848|NCT02928614|Hormones|hormones|mesh-ancestor
43660849|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660850|NCT02928601|Ondansetron|ondansetron|mesh-list
43895526|NCT04116541|Dabrafenib|dabrafenib|mesh-list
43895527|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895528|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895529|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895530|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895531|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
43895532|NCT04059458|Calcium|calcium|mesh-list
43895533|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43895534|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895535|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895536|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
43895537|NCT04059445|Calcium|calcium|mesh-list
43895538|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43895539|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895540|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895541|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
43895542|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43895543|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
43895544|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43895545|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895546|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43895547|NCT03961516|Pancrelipase|pancrelipase|mesh-list
43895548|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895549|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
43895550|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43895551|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43895552|NCT03942887|Prednisolone|prednisolone|mesh-list
43895553|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
43895554|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
43895555|NCT03942887|Rituximab|rituximab|mesh-list
43895556|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43895564|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895565|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895566|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895567|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895568|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895569|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
43895570|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
43895571|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895572|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43895573|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
44137612|NCT00168766|Interferon-beta|interferon-beta|mesh-list
43895575|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895576|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43895577|NCT03942887|Protective Agents|protective agents|mesh-ancestor
43895578|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43895579|NCT03887624|Ethosuximide|ethosuximide|mesh-list
43895580|NCT03887624|Citalopram|citalopram|mesh-list
43660851|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
43660852|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
43660853|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660854|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660855|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43660913|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
43660914|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660915|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660916|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
43660917|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895581|NCT03887624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43895582|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43895583|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895584|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895585|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895586|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
43895587|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895588|NCT03887624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43895589|NCT03887624|Antidepressive Agents|antidepressive agents|mesh-ancestor
43895590|NCT03887624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895591|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
43895592|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43895593|NCT03876119|Plasminogen|plasminogen|mesh-list
43895594|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43895595|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43895602|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895603|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895604|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43895605|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43895606|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
43895607|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895608|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895609|NCT03821545|Lidocaine|lidocaine|mesh-list
43895610|NCT03821545|Ketamine|ketamine|mesh-list
43895611|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
43895612|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
43895613|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895614|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660918|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43660919|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
43660920|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43660921|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660922|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660923|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660924|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
43660925|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43660926|NCT02927951|Pregabalin|pregabalin|mesh-list
43660927|NCT02927951|Analgesics|analgesics|mesh-ancestor
43660928|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
43660929|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660930|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660931|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
43660932|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43660933|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43660934|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660935|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43660936|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43895615|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
43895616|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895617|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43895618|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43895619|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43895620|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895621|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895622|NCT03821545|Analgesics|analgesics|mesh-ancestor
43895623|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43895652|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895653|NCT03632187|Abatacept|abatacept|mesh-list
43895654|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43895655|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895656|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895657|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895658|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
43895659|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895660|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895661|NCT03587142|Buspirone|buspirone|mesh-list
43895662|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43895663|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43895664|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895665|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895666|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43895667|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43895668|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
43895669|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895670|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895671|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
43895672|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43895673|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895674|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895675|NCT03582917|Vitamins|vitamins|mesh-ancestor
43895676|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
43895677|NCT03452930|Benzimidazole|benzimidazole|mesh-list
43895678|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
43895679|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43895680|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895698|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43895699|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43895700|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43895701|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43895702|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43895703|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895704|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
43895705|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43895706|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895707|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43895708|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895709|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
43895710|NCT03233854|Fludarabine|fludarabine|mesh-list
43661031|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661032|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43661033|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43661034|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
43661035|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
43895711|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
43895712|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895713|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
43895714|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895715|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895716|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895717|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
43895718|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895719|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895720|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895721|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43895722|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
43895723|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
43895724|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43895725|NCT03210688|Prednisone|prednisone|mesh-list
43895726|NCT03210688|Prednisolone|prednisolone|mesh-list
43895743|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895744|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895745|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43895746|NCT03174847|Diuretics|diuretics|mesh-ancestor
43895747|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
43895748|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43895749|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43895750|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43895751|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895752|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895753|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
43895754|NCT03174847|Hormones|hormones|mesh-ancestor
43895755|NCT03089983|Isoniazid|isoniazid|mesh-list
43895756|NCT03089983|Rifapentine|rifapentine|mesh-list
43895757|NCT03089983|Buprenorphine|buprenorphine|mesh-list
43895758|NCT03089983|Methadone|methadone|mesh-list
43895759|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43895760|NCT03089983|Naloxone|naloxone|mesh-list
43895761|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43895762|NCT03089983|Narcotics|narcotics|mesh-ancestor
43895763|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43895764|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895765|NCT03089983|Analgesics|analgesics|mesh-ancestor
43895766|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
43895767|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895768|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43895769|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
43895770|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
43895771|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
43895772|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895773|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661036|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
43661037|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43661038|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43661039|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43661074|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661075|NCT02926183|Gemcitabine|gemcitabine|mesh-list
43661076|NCT02926183|Paclitaxel|paclitaxel|mesh-list
43661077|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43661078|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895774|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43895775|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43895776|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
43895778|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43895781|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43895783|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
43895784|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895785|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43895786|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
43895787|NCT02953145|Coagulants|coagulants|mesh-ancestor
44137613|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
44137614|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
44137615|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137616|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
44137617|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137618|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44137619|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
44137620|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
44137621|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137622|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137623|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137624|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
43895788|NCT02925195|Vitamin D|vitamin d|mesh-list
43895789|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
43895790|NCT02925195|Vitamins|vitamins|mesh-ancestor
43895791|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
43895792|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895793|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43895794|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43895795|NCT02916979|Methotrexate|methotrexate|mesh-list
43895796|NCT02916979|Fludarabine|fludarabine|mesh-list
43895797|NCT02916979|Busulfan|busulfan|mesh-list
43895798|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
43895799|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43895800|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
43895801|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43895802|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895803|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43895811|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
43895812|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895813|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43895814|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
43895815|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895816|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895817|NCT02310269|Pasireotide|pasireotide|mesh-list
43895818|NCT02310269|Hormones|hormones|mesh-ancestor
43895819|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43895820|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895821|NCT02261636|Mesalamine|mesalamine|mesh-list
43895822|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661086|NCT02926183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661087|NCT02926183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661088|NCT02926183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43661089|NCT02926183|Immunologic Factors|immunologic factors|mesh-ancestor
43661090|NCT02926183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895823|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895824|NCT02261636|Analgesics|analgesics|mesh-ancestor
43895825|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
43895826|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43895827|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895828|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895829|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895830|NCT02256696|Rifampin|rifampin|mesh-list
43895831|NCT02256696|Rifabutin|rifabutin|mesh-list
43895832|NCT02256696|Isoniazid|isoniazid|mesh-list
43895833|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
43895834|NCT02256696|Ethambutol|ethambutol|mesh-list
43895835|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43895836|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
43895860|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43895861|NCT01918397|Levofloxacin|levofloxacin|mesh-list
43646941|NCT02654119|Antibodies|antibodies|mesh-list
43895862|NCT01918397|Ofloxacin|ofloxacin|mesh-list
44137625|NCT00168766|Hormones|hormones|mesh-ancestor
43895863|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43895864|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895865|NCT01918397|Renal Agents|renal agents|mesh-ancestor
43895866|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43895867|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43895868|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43895869|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895870|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895871|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895872|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43895873|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43895874|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
43895875|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
43895876|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43895877|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43895878|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895879|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895880|NCT01757782|Urological Agents|urological agents|mesh-ancestor
43895881|NCT01612351|Paclitaxel|paclitaxel|mesh-list
43895882|NCT01612351|Cisplatin|cisplatin|mesh-list
43895883|NCT01612351|Carboplatin|carboplatin|mesh-list
43895884|NCT01612351|Lapatinib|lapatinib|mesh-list
43895885|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43895886|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895887|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
43895888|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
43895889|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
43895890|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895891|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43895892|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895898|NCT00003270|Cyclosporine|cyclosporine|mesh-list
43895899|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
43895900|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
43895901|NCT00003270|Busulfan|busulfan|mesh-list
43895902|NCT00003270|Cyclosporins|cyclosporins|mesh-list
43849654|NCT03904498|Tolcapone|tolcapone|mesh-list
43849655|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43895903|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43895904|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43895905|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
43895906|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43895907|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895908|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43895909|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
43895910|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895911|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43895912|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43895913|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43895914|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
43895915|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43895916|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
43895917|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43895918|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895919|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
43895920|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
43895924|NCT00003270|Hormones|hormones|mesh-ancestor
43895951|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43895952|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43895953|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43895954|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43895956|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43895957|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43895958|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43895959|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896015|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43896016|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896017|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43896018|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43896019|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896020|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
43896021|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43896022|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43896023|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43896024|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
43896025|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896026|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43896027|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
43896028|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43896029|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
43896030|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
44137626|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137627|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
44137628|NCT00168766|Protective Agents|protective agents|mesh-ancestor
44137629|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
44137630|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43661121|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661122|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
43661123|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661124|NCT02925975|Carvedilol|carvedilol|mesh-list
43661125|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43661126|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43661152|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43661153|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661156|NCT02925247|Anticoagulants|anticoagulants|mesh-list
44137632|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44137633|NCT00168779|Telmisartan|telmisartan|mesh-list
44137634|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137635|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44137636|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44137637|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137638|NCT00168779|Diuretics|diuretics|mesh-ancestor
44137639|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
44137640|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137641|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44137642|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137650|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44137651|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44137652|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44137653|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137655|NCT00168870|Treosulfan|treosulfan|mesh-list
44137656|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44137657|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
44137658|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137659|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137660|NCT00168870|Antiviral Agents|antiviral agents|mesh-ancestor
44137661|NCT00168870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137662|NCT00168870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137663|NCT00168870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137664|NCT00168870|Immunologic Factors|immunologic factors|mesh-ancestor
44137665|NCT00168870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137666|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44137667|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
44137668|NCT00168883|Paclitaxel|paclitaxel|mesh-list
44137669|NCT00168883|Vinorelbine|vinorelbine|mesh-list
44137670|NCT00168883|Carboplatin|carboplatin|mesh-list
44137671|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44137672|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137673|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137674|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
44137675|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137676|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896046|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43896047|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43896048|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896049|NCT05232123|Cannabidiol|cannabidiol|mesh-list
43896050|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
43896051|NCT05231330|Fluorides|fluorides|mesh-list
43896052|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
43896053|NCT05231330|Protective Agents|protective agents|mesh-ancestor
43896054|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896055|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43896056|NCT05231148|Calcium|calcium|mesh-list
43896057|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43896058|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896059|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896060|NCT05230797|Zinc|zinc|mesh-list
43896061|NCT05230797|Propolis|propolis|mesh-list
43896062|NCT05230797|Eugenol|eugenol|mesh-list
43896063|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
43661206|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
43896064|NCT05230797|Trace Elements|trace elements|mesh-ancestor
43896104|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661207|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661208|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43896106|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43896107|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
43896108|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43896109|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896110|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43896111|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
43896112|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896113|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896114|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896115|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896116|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43896117|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896118|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
43896119|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896120|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43896121|NCT05203276|Endostar protein|endostar protein|mesh-list
43896122|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896123|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896124|NCT05203276|Growth Substances|growth substances|mesh-ancestor
43896125|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896126|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896127|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896128|NCT05184777|Estradiol|estradiol|mesh-list
43896130|NCT05184777|Estrogens|estrogens|mesh-ancestor
43896131|NCT05184777|Hormones|hormones|mesh-ancestor
43896132|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896133|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896134|NCT05184777|Progestins|progestins|mesh-ancestor
44137683|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137684|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137685|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44137686|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44137687|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
43778586|NCT05034809|Melatonin|melatonin|mesh-list
44164824|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137688|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
44137689|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44137690|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137691|NCT00168909|Vitamins|vitamins|mesh-ancestor
44137692|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
44137693|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
44137694|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44137695|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
44137696|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137697|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137698|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
44137699|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
44137706|NCT00169000|Docetaxel|docetaxel|mesh-list
43896155|NCT05045170|Propofol|propofol|mesh-list
43896156|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
43896157|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896158|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896159|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43896160|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43896161|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
43661269|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43896162|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896163|NCT05045170|Analgesics|analgesics|mesh-ancestor
43896164|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
43896165|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896166|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43661270|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661271|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43661289|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851391|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43896167|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43896168|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43896169|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
43896170|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896171|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896172|NCT05042934|Irinotecan|irinotecan|mesh-list
43896173|NCT05042934|Camptothecin|camptothecin|mesh-list
43896174|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43896175|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43896176|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896177|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896178|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896179|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43896180|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
43896181|NCT05014230|Narcotics|narcotics|mesh-ancestor
43896182|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896183|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896197|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
43896198|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896199|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896200|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43896201|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43896202|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43896203|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
43896204|NCT04965220|Trametinib|trametinib|mesh-list
43896205|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896206|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896207|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137732|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43647258|NCT02126917|Ethanol|ethanol|mesh-list
43896208|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896209|NCT04928950|Charcoal|charcoal|mesh-list
43896210|NCT04928950|Antidotes|antidotes|mesh-ancestor
43896211|NCT04928950|Protective Agents|protective agents|mesh-ancestor
43849656|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43896212|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896213|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
43896214|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43896215|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43896216|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43896217|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
43896218|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896219|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896220|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896221|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
43896222|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43896223|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
43896224|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896225|NCT05370729|Expectorants|expectorants|mesh-ancestor
43896226|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
43896227|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43896237|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43896238|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661311|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661312|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661356|NCT02923934|Ipilimumab|ipilimumab|mesh-list
43661357|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43661358|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661359|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43661360|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661361|NCT02924090|Ketamine|ketamine|mesh-list
43661362|NCT02924090|Etomidate|etomidate|mesh-list
43661363|NCT02924090|Analgesics|analgesics|mesh-ancestor
43661364|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
43896239|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896240|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43896241|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896242|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
43896243|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43896244|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43896245|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43896246|NCT05370599|Diuretics|diuretics|mesh-ancestor
43896247|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
43896248|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43896249|NCT05370313|Nicotine|nicotine|mesh-list
43896250|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43896251|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
43896252|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896253|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896254|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43896255|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43896256|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
43896257|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896258|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896259|NCT05369650|Lidocaine|lidocaine|mesh-list
43896260|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896261|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
43896262|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896263|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43647339|NCT02009449|Vitamins|vitamins|mesh-ancestor
43896282|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896283|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
43896284|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896285|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896286|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
43896287|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896288|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43896289|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896290|NCT05369468|Analgesics|analgesics|mesh-ancestor
43896291|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43896292|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
44137755|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
44137756|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
44137757|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137758|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137759|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44137760|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
44137761|NCT00169065|Olanzapine|olanzapine|mesh-list
44137762|NCT00169065|Clozapine|clozapine|mesh-list
43661365|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661366|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661367|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43661368|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43661369|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
43661370|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
43661381|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
43661382|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661383|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661384|NCT02923856|Clarithromycin|clarithromycin|mesh-list
43661385|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661386|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661387|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
44137763|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
44137764|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
44137765|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44137766|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137767|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44137768|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44137769|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43896321|NCT05369091|Simvastatin|simvastatin|mesh-list
43896322|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43896323|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43896324|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
43896325|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896326|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43896327|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43896328|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896364|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896365|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43896366|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43896367|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43896368|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
43896369|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896370|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896406|NCT05269030|Hormones|hormones|mesh-ancestor
43896407|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43896408|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43896409|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896410|NCT05269017|Vitamin D|vitamin d|mesh-list
43896411|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
43896412|NCT05269017|Budesonide|budesonide|mesh-list
43896413|NCT05269017|Vitamins|vitamins|mesh-ancestor
43896414|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
43896472|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896473|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896474|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896475|NCT04429425|Anesthetics|anesthetics|mesh-list
43896476|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896477|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896478|NCT04411550|Pertuzumab|pertuzumab|mesh-list
43896479|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896480|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896481|NCT04347434|Atorvastatin|atorvastatin|mesh-list
43896482|NCT04347434|Ezetimibe|ezetimibe|mesh-list
43896483|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43896484|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43896485|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
43896486|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896487|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43896488|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43896489|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896490|NCT04346914|Carboplatin|carboplatin|mesh-list
43896492|NCT04346914|Antibodies|antibodies|mesh-list
43896529|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896530|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43896531|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43896532|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896533|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896534|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
43896535|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43661388|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896536|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
43661389|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661390|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43661391|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43661451|NCT02922933|Entinostat|entinostat|mesh-list
43896537|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
43896538|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896539|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43896540|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
43896541|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
43896542|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43896543|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43896544|NCT04287790|Naltrexone|naltrexone|mesh-list
43896546|NCT04287790|Acamprosate|acamprosate|mesh-list
43896547|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43896548|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43896586|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43896587|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
43896588|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
43896589|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
43896590|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
43896591|NCT04255927|Triclosan|triclosan|mesh-list
43896592|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43896593|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896594|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43896595|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43896596|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
43896597|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896598|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44137770|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137771|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137772|NCT00169065|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44137773|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44137774|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44137775|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137776|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137777|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
44137778|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137779|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
44137780|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
44137781|NCT00169078|Chloroquine|chloroquine|mesh-list
44137782|NCT00169078|Amebicides|amebicides|mesh-ancestor
44137783|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44137784|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137785|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137786|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
44137787|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137788|NCT00169091|Haloperidol|haloperidol|mesh-list
44137789|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
44137790|NCT00169091|Clozapine|clozapine|mesh-list
44137791|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
43896599|NCT04028245|Spartalizumab|spartalizumab|mesh-list
43896600|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43661457|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661458|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661459|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43661460|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
43661461|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
43661462|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661463|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661464|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661465|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43661466|NCT02922946|Entinostat|entinostat|mesh-list
43661467|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661472|NCT02922803|Vitamin D|vitamin d|mesh-list
43896605|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43896606|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43896607|NCT03976245|Analgesics|analgesics|mesh-ancestor
43896608|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
43896609|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896610|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896611|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43896612|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896613|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43896614|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896615|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
43896616|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896617|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896618|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896620|NCT03974854|Capecitabine|capecitabine|mesh-list
43896621|NCT03974854|Irinotecan|irinotecan|mesh-list
43896622|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43896623|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
43896624|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896625|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896662|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43896663|NCT03775629|Narcotics|narcotics|mesh-ancestor
43896664|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896665|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896666|NCT03775629|Analgesics|analgesics|mesh-ancestor
43896667|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
43896668|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896669|NCT03763305|Fentanyl|fentanyl|mesh-list
43896670|NCT03763305|Remifentanil|remifentanil|mesh-list
43896671|NCT03763305|Propofol|propofol|mesh-list
43896672|NCT03763305|Sevoflurane|sevoflurane|mesh-list
43896673|NCT03763305|Desflurane|desflurane|mesh-list
43896674|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43661541|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661542|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661551|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661552|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43661553|NCT02922426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43661554|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43661555|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661556|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661557|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43661558|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
43661571|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661572|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661573|NCT02922283|Analgesics|analgesics|mesh-ancestor
43661574|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
43661575|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661576|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661577|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
43661578|NCT02922075|Amoxicillin|amoxicillin|mesh-list
43661579|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
43661580|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43896675|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43647697|NCT05620589|Amoxicillin|amoxicillin|mesh-list
43896676|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896677|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896678|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43896679|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
43896680|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
43896681|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43661620|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661621|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661622|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43661623|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43661624|NCT02921984|Cisplatin|cisplatin|mesh-list
43661625|NCT02921984|Docetaxel|docetaxel|mesh-list
43661626|NCT02921984|Pemetrexed|pemetrexed|mesh-list
43661627|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661628|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661629|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661630|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661631|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661632|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661633|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43661634|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43661635|NCT02921659|Niacinamide|niacinamide|mesh-list
43825776|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43825777|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43825778|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825779|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825780|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
43825781|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825782|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43825783|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43825784|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43661646|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43661647|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
43896682|NCT03763305|Narcotics|narcotics|mesh-ancestor
43896683|NCT03763305|Analgesics|analgesics|mesh-ancestor
43896684|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
43896685|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896686|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43896687|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43896688|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43896689|NCT03689699|Nivolumab|nivolumab|mesh-list
43896690|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896691|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896692|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43896693|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896694|NCT03628391|Haloperidol|haloperidol|mesh-list
43896695|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
43896702|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43896703|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896704|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896705|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43896707|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896708|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896709|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43896710|NCT03602261|Calcifediol|calcifediol|mesh-list
43896711|NCT03602261|Vitamins|vitamins|mesh-ancestor
43896712|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
43896713|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896714|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43896715|NCT03571945|Anesthetics|anesthetics|mesh-list
43896716|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896717|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896718|NCT03511963|Bevacizumab|bevacizumab|mesh-list
43896719|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43896720|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896721|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896722|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896723|NCT03511963|Growth Substances|growth substances|mesh-ancestor
43896726|NCT03493152|Everolimus|everolimus|mesh-list
43896753|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896755|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896756|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896757|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
43896758|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896759|NCT03232918|Oxytocin|oxytocin|mesh-list
43896760|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
43896761|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43661648|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661649|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43661650|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43661651|NCT02921269|Growth Substances|growth substances|mesh-ancestor
43661652|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896762|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896763|NCT03096080|XL647|xl647|mesh-list
43896764|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896765|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43896766|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896767|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896768|NCT02926586|Cytarabine|cytarabine|mesh-list
43896769|NCT02926586|Fludarabine|fludarabine|mesh-list
43896770|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896771|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43896772|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
43896773|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896774|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896775|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
43896776|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896777|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
43896778|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43896791|NCT02553642|Nivolumab|nivolumab|mesh-list
44137797|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44137798|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44137799|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44137800|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
44137801|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
44137802|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44137803|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137804|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
44137805|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
44137806|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
44137807|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
44137808|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
44137809|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
44137810|NCT00169130|Doxorubicin|doxorubicin|mesh-list
44137811|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44137812|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
44137813|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137814|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43896831|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
43896832|NCT01744912|Lenalidomide|lenalidomide|mesh-list
43896833|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
43896834|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896835|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43896836|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43896837|NCT01744912|Growth Substances|growth substances|mesh-ancestor
43896838|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
43896839|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43896840|NCT01505465|Melatonin|melatonin|mesh-list
43896841|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
43896843|NCT01505465|Protective Agents|protective agents|mesh-ancestor
43896894|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
43896895|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
43896896|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
43896897|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896898|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896899|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43896900|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
43896901|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43896902|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896903|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43896904|NCT04698434|Esketamine|esketamine|mesh-list
43896905|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
43896906|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43896907|NCT04681430|Gabexate|gabexate|mesh-list
43896908|NCT04681430|Camostat|camostat|mesh-list
43896909|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
43896910|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43896911|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43896912|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43896913|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43896949|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
43896950|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
43896951|NCT04618523|Artesunate|artesunate|mesh-list
43896952|NCT04618523|Lumefantrine|lumefantrine|mesh-list
43896953|NCT04618523|Artemether|artemether|mesh-list
43896954|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43896955|NCT04618523|Amodiaquine|amodiaquine|mesh-list
43896956|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
43896957|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43896958|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44137860|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137861|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
44137862|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137863|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137864|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
43896980|NCT04567407|Ropivacaine|ropivacaine|mesh-list
43896981|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
43896982|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
43896983|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43896984|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896985|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
43896986|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43896987|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43896988|NCT04541290|Tacrolimus|tacrolimus|mesh-list
43896989|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43896990|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
43896991|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43896992|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43896993|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897099|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
43897100|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43897101|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43897102|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897103|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897104|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897105|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
43897106|NCT04331938|Anesthetics|anesthetics|mesh-list
43661723|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661724|NCT02920801|Metformin|metformin|mesh-list
43661725|NCT02920801|Saxagliptin|saxagliptin|mesh-list
43661737|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
43661738|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
43661739|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661740|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851432|NCT04055753|Doxorubicin|doxorubicin|mesh-list
43851433|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43851434|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851435|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43661756|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43661757|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43661758|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897107|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897108|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897109|NCT04326738|Midazolam|midazolam|mesh-list
43661760|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43897110|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43897111|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43897112|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43897113|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897114|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43897115|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43897116|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43897117|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43897118|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
43897119|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
43897120|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
43897121|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
43897122|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897123|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897124|NCT04288427|Finasteride|finasteride|mesh-list
43897125|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43897126|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43897143|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897145|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897146|NCT04171167|Fluticasone|fluticasone|mesh-list
43897147|NCT04171167|Xhance|xhance|mesh-list
43897148|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897149|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43897150|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
43897151|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897152|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897153|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43897154|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897155|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
43897156|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43897157|NCT04134000|Atezolizumab|atezolizumab|mesh-list
43897158|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897159|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
43897160|NCT03952299|Oxybutynin|oxybutynin|mesh-list
43897161|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
43897162|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
43897163|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897164|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897173|NCT03952299|Renal Agents|renal agents|mesh-ancestor
43897197|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897198|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897199|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897200|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897201|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897202|NCT03840200|Rucaparib|rucaparib|mesh-list
43897203|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43897205|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897206|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137866|NCT00169182|Cisplatin|cisplatin|mesh-list
44137867|NCT00169182|Docetaxel|docetaxel|mesh-list
44137868|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137869|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137870|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
44137871|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
44137872|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137873|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
44137874|NCT00169182|Vitamins|vitamins|mesh-ancestor
44137875|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
44137876|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137877|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44137878|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
44137911|NCT00169221|Cisplatin|cisplatin|mesh-list
44137912|NCT00169221|Gefitinib|gefitinib|mesh-list
44137913|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137914|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44137915|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44137916|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137917|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43661824|NCT02919917|Midodrine|midodrine|mesh-list
44137918|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
44137919|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137920|NCT00169247|Cisplatin|cisplatin|mesh-list
44137921|NCT00169247|Cetuximab|cetuximab|mesh-list
44137922|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137923|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137924|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
44137925|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
44137926|NCT00169299|Estrogens|estrogens|mesh-list
44137927|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
44137928|NCT00169299|Hormones|hormones|mesh-ancestor
44137929|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44137930|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137931|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44137932|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44137933|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44137934|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
44137935|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44137936|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43897208|NCT03830918|Atezolizumab|atezolizumab|mesh-list
43897209|NCT03830918|Niraparib|niraparib|mesh-list
43897210|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43897211|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897226|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897227|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43897228|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
43897229|NCT03828292|Hormones|hormones|mesh-ancestor
43897230|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897231|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897232|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897233|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
43897234|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43897235|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43897236|NCT03828292|Growth Substances|growth substances|mesh-ancestor
43897237|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
43897238|NCT03769285|Niacinamide|niacinamide|mesh-list
43897239|NCT03769285|Niacin|niacin|mesh-list
43897240|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
43897241|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
43897242|NCT03769285|Vitamins|vitamins|mesh-ancestor
43897243|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
43897244|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897245|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43897246|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
43897247|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897248|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43897249|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
43897250|NCT03761030|Levodopa|levodopa|mesh-list
43897251|NCT03761030|Carbidopa|carbidopa|mesh-list
43897252|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43897253|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43897254|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43897255|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
43897256|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897257|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897258|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897259|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43661842|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661843|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
43897268|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897269|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43897270|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43897271|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897272|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897273|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43897274|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897275|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897276|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897277|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43897278|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43897279|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43897280|NCT03656081|Amebicides|amebicides|mesh-ancestor
43897281|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43897282|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43897283|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43897284|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897285|NCT03645408|Exenatide|exenatide|mesh-list
43897286|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43897287|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897288|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43897289|NCT03645408|Incretins|incretins|mesh-ancestor
43897290|NCT03645408|Hormones|hormones|mesh-ancestor
43897291|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897292|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
43897293|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43897294|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
43897295|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43897309|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897310|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43897311|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43897312|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
43897314|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
43897315|NCT03476317|Neomycin|neomycin|mesh-list
43897316|NCT03476317|Fluconazole|fluconazole|mesh-list
43897317|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43897318|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43897319|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897320|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897321|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897322|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897323|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897324|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897325|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43661845|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661846|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661847|NCT02920190|Incretins|incretins|mesh-ancestor
43661848|NCT02920190|Hormones|hormones|mesh-ancestor
43661849|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825789|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43825790|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
43825791|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825792|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43825793|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
43825794|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43825795|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43851444|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43851445|NCT04040452|Analgesics|analgesics|mesh-ancestor
43897338|NCT03416153|Paclitaxel|paclitaxel|mesh-list
43897365|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897366|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
43897367|NCT03309150|Paclitaxel|paclitaxel|mesh-list
43897368|NCT03309150|Carboplatin|carboplatin|mesh-list
43897369|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897370|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897371|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897372|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
43897373|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
43897374|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897375|NCT03217201|Methamphetamine|methamphetamine|mesh-list
43897376|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43897377|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897378|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
43897379|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
43897380|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897381|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
43897382|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897383|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897384|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
43897385|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43897386|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43897387|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43897388|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43897389|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
43897413|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897414|NCT03059173|Inositol|inositol|mesh-list
43897415|NCT03059173|Clomiphene|clomiphene|mesh-list
43897416|NCT03059173|Enclomiphene|enclomiphene|mesh-list
43897417|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
43897418|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43897419|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897420|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897421|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897422|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43897423|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
43897424|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43851450|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43661877|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661878|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43661879|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43661880|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43661881|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43661883|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
43661884|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43662015|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662016|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662017|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
43662018|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43662019|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43662020|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43662021|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43662024|NCT02918760|Analgesics|analgesics|mesh-ancestor
43662025|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
43662026|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897425|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43897426|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43897427|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
43897428|NCT03059173|Vitamins|vitamins|mesh-ancestor
43648448|NCT03162731|Nivolumab|nivolumab|mesh-list
43897429|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
43897430|NCT03013491|Ipilimumab|ipilimumab|mesh-list
43897431|NCT03013491|Vemurafenib|vemurafenib|mesh-list
43897432|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897433|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897434|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43897438|NCT02947503|Metformin|metformin|mesh-list
44137942|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
44137943|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44137944|NCT00169468|Rituximab|rituximab|mesh-list
44137945|NCT00169468|Bortezomib|bortezomib|mesh-list
44137946|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137947|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137948|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
44137949|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44137950|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44137951|NCT00169520|Docetaxel|docetaxel|mesh-list
44137952|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137953|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
44137954|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
43662054|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43662055|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662057|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
43662058|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662059|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662092|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662093|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
43662247|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662248|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662249|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43662250|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662251|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
43662252|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43662299|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662300|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43662301|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825835|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
44137955|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
43825836|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
43825837|NCT04934722|Androgens|androgens|mesh-list
43825838|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44137956|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44137957|NCT00169533|Lapatinib|lapatinib|mesh-list
44137958|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44137959|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897478|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897479|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897480|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
43897481|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897482|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43897483|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897484|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897485|NCT02728050|Analgesics|analgesics|mesh-ancestor
43897486|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
43897487|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897488|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897489|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897490|NCT02705963|Trametinib|trametinib|mesh-list
43897491|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43897492|NCT02705963|Norethindrone|norethindrone|mesh-list
43897493|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
43897494|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
43897495|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
43897496|NCT02705963|Estradiol|estradiol|mesh-list
43897497|NCT02705963|Estrogens|estrogens|mesh-ancestor
43897498|NCT02705963|Hormones|hormones|mesh-ancestor
43897499|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897500|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897501|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43897502|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43897503|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43662351|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43897504|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662352|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
43662353|NCT02915289|Povidone|povidone|mesh-list
43662354|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43662355|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662356|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
43662357|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
43662358|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
43662359|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
43662360|NCT02915354|Etanercept|etanercept|mesh-list
43662361|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43662362|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662364|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
43662365|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662366|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662367|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662368|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662369|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662370|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851511|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662405|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662406|NCT02915042|Analgesics|analgesics|mesh-ancestor
43897505|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43897506|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897507|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897508|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43897509|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43897510|NCT02662257|Propofol|propofol|mesh-list
43897511|NCT02662257|Sevoflurane|sevoflurane|mesh-list
43897512|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43897515|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43897517|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
43897518|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43897519|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43897520|NCT02648477|Doxorubicin|doxorubicin|mesh-list
43897521|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43897522|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
43897523|NCT02648477|Letrozole|letrozole|mesh-list
43897524|NCT02648477|Anastrozole|anastrozole|mesh-list
43897525|NCT02648477|Exemestane|exemestane|mesh-list
43897526|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43897527|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897528|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43897529|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43897530|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897531|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897532|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43897533|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43897534|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43897535|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43648562|NCT01326000|Cetuximab|cetuximab|mesh-list
43897536|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897537|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897538|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897539|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897540|NCT02626507|Fulvestrant|fulvestrant|mesh-list
43897541|NCT02626507|Goserelin|goserelin|mesh-list
43897542|NCT02626507|Palbociclib|palbociclib|mesh-list
43662408|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662409|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43662410|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43662411|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43662412|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
43662413|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662414|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662415|NCT02914886|Insulin|insulin|mesh-list
43662416|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43897543|NCT02626507|Gedatolisib|gedatolisib|mesh-list
43897564|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43897565|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43897566|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43897567|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43897568|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897569|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43897570|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43897571|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
43897630|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897631|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
43897632|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897633|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897634|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
43897635|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897636|NCT02386774|Benoxinate|benoxinate|mesh-list
43897697|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897698|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897699|NCT01893320|Decitabine|decitabine|mesh-list
43897700|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897701|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
43897702|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897704|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897705|NCT01854268|Capsaicin|capsaicin|mesh-list
43897706|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
43897707|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
43897708|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
43897709|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43897710|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897758|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43897759|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43897760|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897761|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897762|NCT00780403|Cetirizine|cetirizine|mesh-list
43897763|NCT00780403|Desloratadine|desloratadine|mesh-list
43897764|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43897765|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43897766|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43897767|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
43897768|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
43897769|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662457|NCT02914015|Morphine|morphine|mesh-list
43662458|NCT02914015|Ropivacaine|ropivacaine|mesh-list
43662459|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
43662460|NCT02914015|Anesthetics|anesthetics|mesh-list
43662461|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43662462|NCT02914015|Narcotics|narcotics|mesh-ancestor
43662463|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662464|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662465|NCT02914015|Analgesics|analgesics|mesh-ancestor
43662476|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
43662477|NCT02914054|Hormones|hormones|mesh-ancestor
43662478|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662479|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43662480|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897770|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897771|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897772|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897773|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897774|NCT00779116|Cetirizine|cetirizine|mesh-list
43897775|NCT00779116|Desloratadine|desloratadine|mesh-list
43897776|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43897777|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43897812|NCT00671528|Gentamicins|gentamicins|mesh-list
43897813|NCT00671528|Clotrimazole|clotrimazole|mesh-list
43897814|NCT00671528|Miconazole|miconazole|mesh-list
43897815|NCT00671528|Betamethasone|betamethasone|mesh-list
43897816|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
43897817|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43897818|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
43897819|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43897820|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897821|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
43662481|NCT02914145|Piperaquine|piperaquine|mesh-list
43662482|NCT02914145|Artenimol|artenimol|mesh-list
43662483|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
43662484|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43662485|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43662486|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662487|NCT02913885|Fluorides|fluorides|mesh-list
43662488|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
43662489|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
43662490|NCT02913885|Protective Agents|protective agents|mesh-ancestor
43662491|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662492|NCT02914028|Acetaminophen|acetaminophen|mesh-list
43662493|NCT02914028|Tramadol|tramadol|mesh-list
43662494|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43897822|NCT00671528|Hormones|hormones|mesh-ancestor
43897823|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897824|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897825|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43897826|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
43897827|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43897828|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43897829|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43897830|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897831|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897832|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43897833|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
43897834|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43897835|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43897836|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43897837|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
43897838|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43897839|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43897840|NCT00359138|Cetirizine|cetirizine|mesh-list
43662586|NCT02913690|Vitamins|vitamins|mesh-ancestor
43662587|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
43662588|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662589|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
43662590|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662591|NCT02913690|Protective Agents|protective agents|mesh-ancestor
43662592|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
43662593|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
43662594|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43662614|NCT02913066|Cisplatin|cisplatin|mesh-list
43662615|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662650|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
43662657|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
43662658|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
43662659|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662660|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43662661|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43662662|NCT02912702|Dexamethasone|dexamethasone|mesh-list
43662663|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
43662664|NCT02912702|Doxorubicin|doxorubicin|mesh-list
43662665|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43662666|NCT02912702|Etoposide|etoposide|mesh-list
43662667|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
43662684|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662695|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43849659|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897841|NCT00359138|Loratadine|loratadine|mesh-list
43897842|NCT00359138|Levocetirizine|levocetirizine|mesh-list
43897843|NCT00359138|Desloratadine|desloratadine|mesh-list
43897844|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43897852|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43897853|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
43897854|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
43897855|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
43897856|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
43897858|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
43897859|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
43897860|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43897861|NCT00350701|Androgens|androgens|mesh-ancestor
43897862|NCT00350701|Hormones|hormones|mesh-ancestor
43897863|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897864|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897865|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897866|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897867|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
43897868|NCT00305344|Vaccines|vaccines|mesh-list
43662729|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
43662772|NCT02911961|Acetaminophen|acetaminophen|mesh-list
43662773|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662774|NCT02911961|Analgesics|analgesics|mesh-ancestor
43662775|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
43662776|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662777|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662778|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
43662779|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
43662780|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43662781|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43662782|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662783|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43662784|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662806|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
43662807|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43662808|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43662809|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43662810|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43662811|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662812|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662825|NCT02911350|Hormones|hormones|mesh-list
43662826|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897869|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
43897870|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897871|NCT00003644|Paclitaxel|paclitaxel|mesh-list
43897872|NCT00003644|Carboplatin|carboplatin|mesh-list
43897873|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43897874|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897875|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
43897907|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897908|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897909|NCT00003910|Prednisone|prednisone|mesh-list
43897910|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
43897912|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43897913|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
43662837|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662838|NCT02911272|Oxytocin|oxytocin|mesh-list
43662839|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
43662840|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662841|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662842|NCT02910778|Ticagrelor|ticagrelor|mesh-list
43662843|NCT02910778|Atorvastatin|atorvastatin|mesh-list
43662844|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43662845|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43662846|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
43662847|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662848|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43897914|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43897915|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43897916|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43897917|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
43897918|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43897919|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43897920|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43897921|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43897922|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
43897923|NCT00003910|Hormones|hormones|mesh-ancestor
43897924|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43897925|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43897926|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43897927|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
43897928|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43897929|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43897930|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
43897931|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
43897932|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43897933|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43897934|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43897955|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
44138019|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44138020|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44138021|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138022|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138023|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138024|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44138025|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44138026|NCT00169611|Methylphenidate|methylphenidate|mesh-list
44138027|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44138028|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138029|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44138030|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44138031|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138032|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138033|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
44138034|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138035|NCT00169624|Metformin|metformin|mesh-list
44138036|NCT00169624|Gliclazide|gliclazide|mesh-list
44138037|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43898019|NCT00005803|Cyclosporins|cyclosporins|mesh-list
43898020|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898021|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
43898022|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898023|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898024|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43898025|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
43898026|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898027|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898028|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43898029|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898030|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
43898031|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898032|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43662849|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43662850|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662851|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43662852|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43662901|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
43662902|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43662903|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898033|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898034|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898035|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
43898036|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898037|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
43898038|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
43898039|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43898048|NCT00005901|Pamidronate|pamidronate|mesh-list
43898071|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898072|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
43898073|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898074|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898075|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43898076|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
43898077|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43898078|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43898079|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43898080|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898081|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898082|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898084|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43898085|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
43898086|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43898087|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43898088|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43898089|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43898090|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898091|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
43898092|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898093|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898094|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43898096|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898119|NCT05347381|Dexamethasone|dexamethasone|mesh-list
43898120|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43898121|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
43898122|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
43898123|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898124|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898125|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898126|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
43898127|NCT05347381|Hormones|hormones|mesh-ancestor
43662940|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662941|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43662942|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43662943|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43662945|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43662946|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
43662947|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825932|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43825933|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43825934|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
43825935|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825937|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
43825938|NCT04356950|Coagulants|coagulants|mesh-ancestor
43825939|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
43898128|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898129|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43898130|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898131|NCT05347160|Calcium|calcium|mesh-list
43898132|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898133|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898134|NCT05347134|Gemcitabine|gemcitabine|mesh-list
43898135|NCT05347134|Capecitabine|capecitabine|mesh-list
43898136|NCT05347134|Vinorelbine|vinorelbine|mesh-list
43898137|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898138|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
43898139|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898140|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898141|NCT05347134|Antiviral Agents|antiviral agents|mesh-ancestor
43898142|NCT05347134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898143|NCT05347134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898168|NCT05346419|Vitamin D|vitamin d|mesh-list
43898169|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
43898170|NCT05346419|Vitamins|vitamins|mesh-ancestor
43898171|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
43898172|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898173|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43898174|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43898175|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43898176|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662961|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43662962|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662963|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43662964|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
43662993|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43662994|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43662995|NCT02910245|Analgesics|analgesics|mesh-ancestor
43662996|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
43663009|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
43663010|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663011|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663012|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663013|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
43663014|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663015|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663016|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43663017|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
43663047|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
43663048|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663049|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663050|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43663167|NCT05296213|Fluorides|fluorides|mesh-list
43663168|NCT05296213|Caseins|caseins|mesh-list
43663169|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43663170|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663171|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
43663172|NCT05296213|Protective Agents|protective agents|mesh-ancestor
43663173|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
43663174|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
43663175|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663176|NCT05287568|Venetoclax|venetoclax|mesh-list
43663178|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663179|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
43663185|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663186|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
43663187|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663188|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
43663189|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43898177|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43898178|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43898179|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
43898180|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898181|NCT05346211|Curcumin|curcumin|mesh-list
43898182|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43898183|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898184|NCT05346211|Analgesics|analgesics|mesh-ancestor
43898185|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
43898193|NCT05346159|Androgens|androgens|mesh-list
43898223|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898224|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
43898225|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898226|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43898227|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43898228|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
43898229|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43898230|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43898231|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43898232|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898233|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898234|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
43898235|NCT05345938|Analgesics|analgesics|mesh-ancestor
43898236|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
43898237|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898238|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898239|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898240|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43898241|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898242|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898243|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898244|NCT05345808|Triamcinolone|triamcinolone|mesh-list
43898245|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43898249|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
43898272|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898273|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43898274|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43898275|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43898276|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
43898277|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43898278|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898279|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43898280|NCT05345574|Narcotics|narcotics|mesh-ancestor
43898281|NCT05343117|Palbociclib|palbociclib|mesh-list
43898282|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898283|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43898284|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898285|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898286|NCT05334433|Anesthetics|anesthetics|mesh-list
43898287|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898288|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898289|NCT05315336|Antibodies|antibodies|mesh-list
43898290|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
43898291|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138043|NCT00169819|Abciximab|abciximab|mesh-list
43898292|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
43898293|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898326|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898327|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898328|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898329|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898330|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
43849662|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43898397|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898398|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
43898399|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898400|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898401|NCT04073784|Antiviral Agents|antiviral agents|mesh-ancestor
43898402|NCT04073784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898403|NCT04073784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898404|NCT04073784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898405|NCT04073784|Immunologic Factors|immunologic factors|mesh-ancestor
43898406|NCT04073784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898407|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43898408|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
43898409|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43898410|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898411|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898412|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898413|NCT03933306|Analgesics|analgesics|mesh-ancestor
43898414|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
43898415|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898416|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43898417|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43898450|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898451|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898452|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43898453|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898454|NCT03751124|Norethindrone|norethindrone|mesh-list
43663190|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898455|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
43898456|NCT03751124|Estradiol|estradiol|mesh-list
43898457|NCT03751124|Relugolix|relugolix|mesh-list
43898458|NCT03751124|Estrogens|estrogens|mesh-ancestor
43898459|NCT03751124|Hormones|hormones|mesh-ancestor
43898460|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898461|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898462|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43898463|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
43898464|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43898465|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43898466|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43898467|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43898468|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43898469|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
43898470|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898471|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
43898472|NCT03629483|Ropivacaine|ropivacaine|mesh-list
43898473|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43898498|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898499|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
44138045|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44138047|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663191|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663194|NCT05259631|Sevoflurane|sevoflurane|mesh-list
44138048|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138049|NCT00169845|Tocopherols|tocopherols|mesh-list
43898545|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898546|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898547|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898548|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43898549|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43898550|NCT05586802|Anastrozole|anastrozole|mesh-list
43898551|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43898552|NCT05586802|Testosterone|testosterone|mesh-list
43898553|NCT05586802|Androgens|androgens|mesh-ancestor
43898554|NCT05586802|Hormones|hormones|mesh-ancestor
43898609|NCT05586620|Mitomycin|mitomycin|mesh-list
43898610|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43898611|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898612|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
43898613|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898614|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43898615|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898616|NCT05586568|Itraconazole|itraconazole|mesh-list
43898617|NCT05586568|Rifampin|rifampin|mesh-list
43898618|NCT05586568|Esomeprazole|esomeprazole|mesh-list
43898619|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43898620|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898621|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43898622|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898623|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898624|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
43898625|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898626|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43898627|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43898628|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43898629|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
43898630|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898631|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898632|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43898633|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43898634|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
43898635|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43898636|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
43898653|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43898654|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898655|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898656|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898657|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898658|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898659|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43898660|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
43898667|NCT05586464|Bismuth|bismuth|mesh-list
43663218|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43663219|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43663220|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
43663221|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43663222|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43663223|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43851545|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43825967|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825968|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825969|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
43825970|NCT04151667|Hormones|hormones|mesh-ancestor
43898718|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43898719|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898720|NCT05585905|Nitrous Oxide|nitrous oxide|mesh-list
43898721|NCT05585905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43898722|NCT05585905|Anesthetics, General|anesthetics, general|mesh-ancestor
43825971|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825972|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43898723|NCT05585905|Anesthetics|anesthetics|mesh-ancestor
43898724|NCT05585905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898725|NCT05585905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825973|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825974|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
43825975|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43825976|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43825977|NCT04151667|Growth Substances|growth substances|mesh-ancestor
43825978|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
43663231|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43663232|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663234|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663235|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663236|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
43663237|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663238|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43663239|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
43663240|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663241|NCT05124067|Dexamethasone|dexamethasone|mesh-list
43663242|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
43663243|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
43663244|NCT05124067|Ondansetron|ondansetron|mesh-list
43663245|NCT05124067|BB 1101|bb 1101|mesh-list
43663246|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663247|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
43663248|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
43663249|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663283|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898726|NCT05585905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43898727|NCT05585905|Analgesics|analgesics|mesh-ancestor
43898728|NCT05585905|Sensory System Agents|sensory system agents|mesh-ancestor
43898729|NCT05585905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898730|NCT05585866|Anesthetics|anesthetics|mesh-list
43898731|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898732|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898733|NCT05585814|Bevacizumab|bevacizumab|mesh-list
43898734|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
43898735|NCT05585814|Capecitabine|capecitabine|mesh-list
43898736|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
43898737|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898774|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898775|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43898776|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43898777|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138069|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138070|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138071|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
44138072|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
44138073|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138075|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43898815|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898816|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43898817|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
43898818|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898819|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43898820|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43898821|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898822|NCT05571644|Antidotes|antidotes|mesh-ancestor
43898823|NCT05571644|Protective Agents|protective agents|mesh-ancestor
43898824|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
43898825|NCT05571644|Vitamins|vitamins|mesh-ancestor
43898826|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
43898827|NCT05417113|Bupivacaine|bupivacaine|mesh-list
43898828|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
43898829|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
43898830|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898831|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898832|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
43898833|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898834|NCT05320692|Apatinib|apatinib|mesh-list
43898835|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
43898836|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663284|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663285|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663286|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663287|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
43663288|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
43663289|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663290|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663291|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43663292|NCT05123040|Protective Agents|protective agents|mesh-ancestor
43663293|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
43663294|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43898837|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43898838|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43898839|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898840|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43898841|NCT05320692|Estrogens|estrogens|mesh-ancestor
43898842|NCT05320692|Hormones|hormones|mesh-ancestor
43898844|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898862|NCT05261321|Hormones|hormones|mesh-ancestor
43898863|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43898864|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43898865|NCT05228314|Vaccines|vaccines|mesh-list
43898866|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
43898867|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
43898868|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898869|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43898871|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898872|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898873|NCT05171946|Vaccines|vaccines|mesh-list
43898874|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
43898875|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898876|NCT05137067|Cisplatin|cisplatin|mesh-list
43898877|NCT05137067|Docetaxel|docetaxel|mesh-list
43898878|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
43898879|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
43898880|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
43898881|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
43898882|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898883|NCT05098067|Ondansetron|ondansetron|mesh-list
43898884|NCT05098067|Metoclopramide|metoclopramide|mesh-list
43898885|NCT05098067|Capsaicin|capsaicin|mesh-list
43898886|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
43898887|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
43898888|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898889|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898890|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43898912|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43898913|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43898914|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43898915|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
43898916|NCT05053867|Coagulants|coagulants|mesh-ancestor
43898917|NCT05005260|Bupivacaine|bupivacaine|mesh-list
43898918|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
43898919|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
43898920|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43898921|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898922|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
43898923|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43898924|NCT04991324|Vitamin D|vitamin d|mesh-list
43898925|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
43898926|NCT04991324|Vitamins|vitamins|mesh-ancestor
43898927|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
44138101|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138102|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44138103|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138104|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138105|NCT00170053|Sirolimus|sirolimus|mesh-list
44138106|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663295|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138107|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663296|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663297|NCT05105061|Ketamine|ketamine|mesh-list
43663298|NCT05105061|Analgesics|analgesics|mesh-ancestor
43663299|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
43663300|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663301|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663302|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
44138108|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44138109|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138110|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
44138111|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138112|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
44138113|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138114|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
44138115|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138116|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138117|NCT00170196|Prednisone|prednisone|mesh-list
44138118|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44138119|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
44138120|NCT00170196|Hormones|hormones|mesh-ancestor
44138121|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44138122|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138123|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138124|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138125|NCT00170209|Rifampin|rifampin|mesh-list
43898975|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898976|NCT04634604|Growth Substances|growth substances|mesh-ancestor
43898977|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898978|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898980|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43898981|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43898982|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43898983|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43898984|NCT04634578|Growth Substances|growth substances|mesh-ancestor
43898985|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43898986|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
43898987|NCT04564612|Itraconazole|itraconazole|mesh-list
43663320|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663321|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43898988|NCT04564612|Rabeprazole|rabeprazole|mesh-list
43898989|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
43898990|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43898991|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43899004|NCT04520451|Hormones|hormones|mesh-ancestor
43899032|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43899033|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43899034|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
43899035|NCT04310995|Vitamins|vitamins|mesh-ancestor
43899036|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
43899038|NCT04306900|Paclitaxel|paclitaxel|mesh-list
43899039|NCT04306900|Docetaxel|docetaxel|mesh-list
43899040|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43899041|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
43899042|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899043|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899044|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899045|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899046|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899047|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43630023|NCT03055741|Donepezil|donepezil|mesh-list
43899048|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899049|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
43899050|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
43899051|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899052|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899053|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899054|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
43899055|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899056|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899058|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
43899059|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43899060|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43899061|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43899064|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43899080|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43899081|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899082|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899083|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899084|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43899085|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43899086|NCT04283656|Estrogens|estrogens|mesh-ancestor
43899087|NCT04283656|Hormones|hormones|mesh-ancestor
43899088|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899089|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663322|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43663323|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
43663324|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663325|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663326|NCT05011214|Ketamine|ketamine|mesh-list
43663327|NCT05011214|Sevoflurane|sevoflurane|mesh-list
43663328|NCT05011214|Esketamine|esketamine|mesh-list
43663329|NCT05011214|Analgesics|analgesics|mesh-ancestor
43663337|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663338|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43663339|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43663340|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663341|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899090|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43899091|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
43899092|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43899093|NCT04283656|Diuretics|diuretics|mesh-ancestor
43899094|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
43899095|NCT04211259|Loratadine|loratadine|mesh-list
43899096|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
43899097|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
43899098|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43899099|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43899100|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43899101|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
43899102|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
43899103|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899104|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899105|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899106|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43899126|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899127|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
43899128|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899129|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43899130|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43899132|NCT04192253|Carboplatin|carboplatin|mesh-list
43899133|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899134|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899135|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899136|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899137|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899138|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899139|NCT04161664|Paclitaxel|paclitaxel|mesh-list
43899140|NCT04161664|Carboplatin|carboplatin|mesh-list
43899141|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899142|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899143|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899144|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899145|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899146|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899147|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43899148|NCT04136366|Methotrexate|methotrexate|mesh-list
43663342|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663343|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43663344|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
43663345|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663346|NCT04965155|Dexamethasone|dexamethasone|mesh-list
43663347|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663348|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
43663349|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
43663350|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43851565|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43663361|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
43663362|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663363|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663364|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899149|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43899150|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
43899151|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43899152|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899153|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899154|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
43899155|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899156|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899157|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
43899158|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899165|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
43899166|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899167|NCT03969420|Cytarabine|cytarabine|mesh-list
43899168|NCT03969420|Alvocidib|alvocidib|mesh-list
43899169|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899170|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
43899171|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899233|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43899234|NCT03584516|Protective Agents|protective agents|mesh-ancestor
43899235|NCT03562377|Vaccines|vaccines|mesh-list
43899236|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
43899237|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899238|NCT03523975|Rituximab|rituximab|mesh-list
43899239|NCT03523975|Lenalidomide|lenalidomide|mesh-list
43899240|NCT03523975|Venetoclax|venetoclax|mesh-list
43899241|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899242|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899243|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
43899244|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899245|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899246|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43899247|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43899248|NCT03523975|Growth Substances|growth substances|mesh-ancestor
43899249|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899250|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43899251|NCT03510208|Panitumumab|panitumumab|mesh-list
43899252|NCT03510208|Antibodies|antibodies|mesh-list
43899253|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
43899254|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43899255|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
43899256|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899257|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899258|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
43899259|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43899260|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899261|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
43899262|NCT03395912|Anesthetics|anesthetics|mesh-list
43899263|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
43899264|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138143|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
44138144|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44138145|NCT00170222|Doxycycline|doxycycline|mesh-list
44138146|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44138147|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138148|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
44138149|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
44138150|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
44138151|NCT00170378|Enoxaparin|enoxaparin|mesh-list
43663365|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
43663366|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663367|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663368|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43663369|NCT04932083|Fentanyl|fentanyl|mesh-list
43663370|NCT04932083|Midazolam|midazolam|mesh-list
43663371|NCT04932083|Nalbuphine|nalbuphine|mesh-list
44138152|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
44138153|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43899277|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
43899278|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899279|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899280|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899281|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
43899282|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
43899283|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
43899284|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899286|NCT03300544|Fluorouracil|fluorouracil|mesh-list
43899287|NCT03300544|Capecitabine|capecitabine|mesh-list
43899288|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
43899289|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43899290|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
43899291|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899292|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899293|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899294|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899295|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
43899296|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899297|NCT03300544|Antidotes|antidotes|mesh-ancestor
43899298|NCT03300544|Protective Agents|protective agents|mesh-ancestor
43899299|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
43899300|NCT03300544|Vitamins|vitamins|mesh-ancestor
43899301|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
43899307|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
43899329|NCT03247413|Dexamethasone|dexamethasone|mesh-list
43899330|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899331|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
43899332|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
43899333|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899334|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899335|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43899336|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
43899337|NCT03247413|Hormones|hormones|mesh-ancestor
43899338|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899339|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899340|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899341|NCT03233204|Olaparib|olaparib|mesh-list
43899342|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43899343|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899344|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899346|NCT03218826|Docetaxel|docetaxel|mesh-list
43899388|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663396|NCT04907253|Protective Agents|protective agents|mesh-ancestor
43663397|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663398|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43663399|NCT04890873|Antacids|antacids|mesh-ancestor
43663400|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663401|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663402|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
43663403|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43663404|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43663405|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663406|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
43663407|NCT04863339|Coagulants|coagulants|mesh-ancestor
43663408|NCT04858490|Diazepam|diazepam|mesh-list
43663409|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43663410|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
43899389|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899390|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899391|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
43899392|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899393|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899394|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43899395|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899396|NCT02917993|Osimertinib|osimertinib|mesh-list
43899397|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899398|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899399|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899400|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663429|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663430|NCT04819399|Catumaxomab|catumaxomab|mesh-list
43663431|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663432|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
43663433|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43663434|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
43663435|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825979|NCT04138706|Vancomycin|vancomycin|mesh-list
43663465|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43899401|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43899402|NCT02763137|Carbidopa|carbidopa|mesh-list
43899446|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899447|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
43899448|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899449|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899450|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899451|NCT02432378|Celecoxib|celecoxib|mesh-list
43899452|NCT02432378|Cisplatin|cisplatin|mesh-list
43899453|NCT02432378|Vaccines|vaccines|mesh-list
43899454|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
43899455|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899456|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899457|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43899458|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43899459|NCT02432378|Analgesics|analgesics|mesh-ancestor
43899460|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
43899461|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899462|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43899463|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43899464|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43899465|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43899466|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899467|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899468|NCT02428192|Nivolumab|nivolumab|mesh-list
43899469|NCT02428192|Ipilimumab|ipilimumab|mesh-list
43899470|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899471|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899472|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43899473|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899474|NCT02390284|Timolol|timolol|mesh-list
43899475|NCT02390284|Bimatoprost|bimatoprost|mesh-list
43899476|NCT02390284|Travoprost|travoprost|mesh-list
43899477|NCT02390284|Dorzolamide|dorzolamide|mesh-list
43899478|NCT02390284|Acetazolamide|acetazolamide|mesh-list
43899488|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43899489|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43899490|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43899491|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43899492|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
43899493|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43899494|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899495|NCT02390284|Diuretics|diuretics|mesh-ancestor
43899496|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
43899497|NCT02314169|Nivolumab|nivolumab|mesh-list
43899498|NCT02314169|Ipilimumab|ipilimumab|mesh-list
43899499|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899500|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899501|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43899502|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899504|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
43899505|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
43899506|NCT01682187|Lomustine|lomustine|mesh-list
43899507|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43899508|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
43899509|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899545|NCT00585559|Antidotes|antidotes|mesh-ancestor
43663484|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663485|NCT04630964|Niacin|niacin|mesh-list
43663486|NCT04630964|Psilocybin|psilocybin|mesh-list
43663487|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43663488|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
43663489|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663490|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43663491|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
43663492|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
43663493|NCT04630964|Vitamins|vitamins|mesh-ancestor
43899546|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
43899547|NCT00217737|Leucovorin|leucovorin|mesh-list
43899548|NCT00217737|Folic Acid|folic acid|mesh-list
43899549|NCT00217737|Bevacizumab|bevacizumab|mesh-list
43899550|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43899551|NCT00217737|Fluorouracil|fluorouracil|mesh-list
43899552|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
43899553|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
43899554|NCT00217737|Antibodies|antibodies|mesh-list
43899555|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
43899556|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43899557|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
43899558|NCT00217737|Calcium|calcium|mesh-list
43899559|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
43899560|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899561|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43899562|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43899563|NCT00217737|Growth Substances|growth substances|mesh-ancestor
43899564|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899565|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899566|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
43899567|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43899568|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43899569|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
43899570|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899571|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43899572|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43899573|NCT00217737|Antidotes|antidotes|mesh-ancestor
43899574|NCT00217737|Protective Agents|protective agents|mesh-ancestor
43899575|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
43899576|NCT00217737|Vitamins|vitamins|mesh-ancestor
43899577|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
43899578|NCT00217737|Hematinics|hematinics|mesh-ancestor
43899579|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
43899589|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43899590|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899591|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899592|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899594|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43899595|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43899596|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43899597|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43899598|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
43899599|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899600|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899601|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899603|NCT03012984|Morphine|morphine|mesh-list
43899648|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
43899649|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899650|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43650291|NCT03015727|Cisplatin|cisplatin|mesh-list
43899651|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138203|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
44138204|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138206|NCT00170664|Carboplatin|carboplatin|mesh-list
44138207|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
44138208|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138209|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
44138210|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
44138211|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
44138212|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138213|NCT00170677|Topotecan|topotecan|mesh-list
44138214|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44138215|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44138216|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138217|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138218|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138219|NCT00170690|Treosulfan|treosulfan|mesh-list
44138220|NCT00170690|Busulfan|busulfan|mesh-list
44138251|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138252|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138253|NCT00170755|Darifenacin|darifenacin|mesh-list
44138254|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
44138255|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
44138256|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138257|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138258|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138259|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138260|NCT00170755|Urological Agents|urological agents|mesh-ancestor
44138261|NCT00170768|Oxybutynin|oxybutynin|mesh-list
44138262|NCT00170768|Darifenacin|darifenacin|mesh-list
44138263|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
44138264|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
43849663|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138265|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899685|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43899686|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43899687|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
43899688|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43899689|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899690|NCT02207712|Ranibizumab|ranibizumab|mesh-list
43899691|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43899692|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43899693|NCT02207712|Growth Substances|growth substances|mesh-ancestor
43899694|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899695|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
43899696|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899697|NCT02119468|Dexamethasone|dexamethasone|mesh-list
43899698|NCT02119468|Pomalidomide|pomalidomide|mesh-list
43899699|NCT02119468|Ixazomib|ixazomib|mesh-list
43899747|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
43899749|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43899750|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43899774|NCT00006178|Sirolimus|sirolimus|mesh-list
43899817|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899818|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899819|NCT00010439|Alendronate|alendronate|mesh-list
43663515|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43663516|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663571|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
43663572|NCT04390698|Anesthetics|anesthetics|mesh-list
43663573|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663574|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663575|NCT04390698|Narcotics|narcotics|mesh-ancestor
43663576|NCT04390698|Analgesics|analgesics|mesh-ancestor
43663621|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43663622|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663623|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
43663624|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
43663625|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663626|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899820|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43899821|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899822|NCT00011986|Gemcitabine|gemcitabine|mesh-list
43899823|NCT00011986|Paclitaxel|paclitaxel|mesh-list
43899824|NCT00011986|Carboplatin|carboplatin|mesh-list
43899825|NCT00011986|Doxorubicin|doxorubicin|mesh-list
43899826|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43899827|NCT00011986|Topotecan|topotecan|mesh-list
43899828|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43899829|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899882|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
43899883|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
43899884|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43899885|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
43899886|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899887|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
43899888|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899889|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43899890|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899891|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899892|NCT00016718|Emtricitabine|emtricitabine|mesh-list
43899893|NCT00016718|Efavirenz|efavirenz|mesh-list
43899894|NCT00016718|Didanosine|didanosine|mesh-list
43899895|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
43899896|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899897|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43899898|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43899899|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899900|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899937|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43899938|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43899939|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43899940|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43899941|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43899942|NCT00018031|Ribavirin|ribavirin|mesh-list
43899943|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43899944|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
43899945|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
43899946|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43899947|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
43899948|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43899949|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
43899951|NCT00019682|Aldesleukin|aldesleukin|mesh-list
43899998|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43899999|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900000|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43900001|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43900002|NCT00026221|Growth Substances|growth substances|mesh-ancestor
43900003|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900004|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
43900005|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
43900006|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900007|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
43900008|NCT00028093|Ribavirin|ribavirin|mesh-list
43900009|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43900010|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
43900011|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
43900012|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900013|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
43663627|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663628|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43663629|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43663630|NCT04299880|Growth Substances|growth substances|mesh-ancestor
43663631|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663638|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663639|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
43900014|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900015|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
43900016|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900017|NCT00028262|Cysteamine|cysteamine|mesh-list
43900018|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
43900019|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900020|NCT00029107|Rituximab|rituximab|mesh-list
43900021|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900022|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900023|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
43900024|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900025|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900026|NCT00029536|Progesterone|progesterone|mesh-list
43900027|NCT00029536|Progestins|progestins|mesh-ancestor
43900028|NCT00029536|Hormones|hormones|mesh-ancestor
43650540|NCT03013400|Ebselen|ebselen|mesh-list
43900029|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900031|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43900039|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43900040|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43900041|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43900042|NCT00030264|Methotrexate|methotrexate|mesh-list
43900043|NCT00030264|Vinblastine|vinblastine|mesh-list
43900044|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43900045|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
43900046|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43900047|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900048|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900105|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900106|NCT00036569|Interferons|interferons|mesh-list
43900107|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
43900108|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900109|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
43900110|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900111|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
43900112|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900113|NCT00036738|Cyclosporine|cyclosporine|mesh-list
43900114|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
43900116|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900117|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
43900118|NCT00036738|Dasatinib|dasatinib|mesh-list
43900119|NCT00036738|Cyclosporins|cyclosporins|mesh-list
43900120|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900168|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43900169|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
43900170|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43900171|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900172|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
43900173|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900174|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43900175|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43900176|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
43900177|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900178|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900179|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900180|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900183|NCT00038857|Fludarabine|fludarabine|mesh-list
43900231|NCT00040846|Cyclosporine|cyclosporine|mesh-list
43900232|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
43851578|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851579|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
43663674|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663675|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900233|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43900234|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
43900235|NCT00040846|Fludarabine|fludarabine|mesh-list
43900236|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900237|NCT00040846|Antibodies|antibodies|mesh-list
43900238|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
43900239|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43900299|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900300|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
43900301|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900302|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900303|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900304|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
43900305|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900306|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900307|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900308|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900309|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900310|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
43900311|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43900312|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43900313|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900314|NCT00041938|Aspirin|aspirin|mesh-list
43900315|NCT00041938|Warfarin|warfarin|mesh-list
43900316|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43900317|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43900318|NCT00041938|Analgesics|analgesics|mesh-ancestor
43900319|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
43900320|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900321|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900322|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900323|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900324|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43900325|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43900326|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900327|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43900328|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43900329|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900330|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
43900331|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
43900332|NCT00042224|Clozapine|clozapine|mesh-list
43900333|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900337|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900338|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900339|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900340|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900341|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900342|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
43900343|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
43900344|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43900345|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900346|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900348|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900401|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900402|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
43900403|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
43900404|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
43900405|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900406|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900471|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900472|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900473|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900474|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
43900475|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900476|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900477|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
43900478|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900479|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
43900480|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900481|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43900482|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43900483|NCT00047697|Donepezil|donepezil|mesh-list
43900484|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43900485|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900486|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900487|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
43900492|NCT00048737|Rituximab|rituximab|mesh-list
43900528|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900529|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900530|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826052|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826053|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
43900531|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900532|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900533|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900534|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900535|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900536|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900537|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900538|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
43900539|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900540|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900541|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900542|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900543|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900544|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900545|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
43900546|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43900547|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43900550|NCT00049036|Prednisone|prednisone|mesh-list
43900582|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
43900583|NCT00049504|Fludarabine|fludarabine|mesh-list
43900584|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
43900585|NCT00049504|Tacrolimus|tacrolimus|mesh-list
43900586|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900587|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
43900588|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900589|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43900590|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43900591|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
43900649|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900650|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43900651|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43900652|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
43900653|NCT00052910|Antidotes|antidotes|mesh-ancestor
43900654|NCT00052910|Protective Agents|protective agents|mesh-ancestor
43900655|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
43900656|NCT00052910|Vitamins|vitamins|mesh-ancestor
43900657|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
43900658|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900659|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900661|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849666|NCT03903809|Hematinics|hematinics|mesh-ancestor
43900686|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43900687|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900688|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
43900689|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900691|NCT00053703|Risperidone|risperidone|mesh-list
43900692|NCT00053703|Molindone|molindone|mesh-list
43900693|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43900694|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
43900695|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43900696|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900697|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900698|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43900699|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43900700|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43900701|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900702|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900703|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
43900704|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
43900705|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
43900706|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900707|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900741|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43900742|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
43900743|NCT00053989|Hormones|hormones|mesh-ancestor
43900744|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900745|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43900746|NCT00053989|Protective Agents|protective agents|mesh-ancestor
43900747|NCT00054028|Suramin|suramin|mesh-list
43900748|NCT00054028|Paclitaxel|paclitaxel|mesh-list
43900749|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900750|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900751|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900752|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900753|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900754|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43900756|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
43900801|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43900802|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43900803|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43900804|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43900805|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43900806|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43900807|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
43900808|NCT00054665|Hormones|hormones|mesh-ancestor
43900809|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900866|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43900867|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43900868|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
43900869|NCT00056550|Antithrombins|antithrombins|mesh-list
43900870|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
43900871|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43900872|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
43900937|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43900938|NCT00059228|Estradiol|estradiol|mesh-list
43900939|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43900940|NCT00059228|Estrogens|estrogens|mesh-ancestor
43900941|NCT00059228|Hormones|hormones|mesh-ancestor
43900942|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43900943|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43900944|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43900945|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
43900946|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43900947|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43900948|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
43900949|NCT00059475|Interleukin-2|interleukin-2|mesh-list
43663684|NCT04239053|Bupivacaine|bupivacaine|mesh-list
43663685|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
43663686|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
43663687|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663688|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663689|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
43900950|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43900951|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43900952|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43900953|NCT00059475|Analgesics|analgesics|mesh-ancestor
43900954|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
43900955|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43900993|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43900994|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
43900995|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
43900996|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
43900998|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
43901029|NCT00061373|Aspirin|aspirin|mesh-list
43901065|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901066|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43901067|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43901068|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43901069|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43901070|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901071|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43901072|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901073|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901074|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901075|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43901076|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901077|NCT00061893|Analgesics|analgesics|mesh-ancestor
43901078|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
43901079|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901080|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901081|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43901082|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43901083|NCT00062738|Paroxetine|paroxetine|mesh-list
43663690|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663691|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
43901084|NCT00062738|Nortriptyline|nortriptyline|mesh-list
43901085|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43901086|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901087|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901088|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901089|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901113|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901114|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
43901115|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43901116|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901117|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901118|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
43901119|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43901120|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901121|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43901122|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43663692|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43663693|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
43663694|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663695|NCT04119284|Protective Agents|protective agents|mesh-ancestor
43663696|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663697|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
43901123|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43901124|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
43901125|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901126|NCT00063570|Gemcitabine|gemcitabine|mesh-list
43901127|NCT00063570|Pemetrexed|pemetrexed|mesh-list
43901128|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901129|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
43901130|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901131|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901132|NCT00063570|Antiviral Agents|antiviral agents|mesh-ancestor
43901133|NCT00063570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901134|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901135|NCT00063570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901136|NCT00063570|Immunologic Factors|immunologic factors|mesh-ancestor
43901137|NCT00063570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901138|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43901139|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43901140|NCT00063622|Vitamin E|vitamin e|mesh-list
43901141|NCT00063622|Pioglitazone|pioglitazone|mesh-list
43651447|NCT03007121|Dsuvia|dsuvia|mesh-list
43901142|NCT00063622|Vitamins|vitamins|mesh-ancestor
43901143|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
43901144|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901145|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43901146|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
43901147|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901152|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
43901153|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901154|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43901155|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
43901156|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901157|NCT00063635|Protective Agents|protective agents|mesh-ancestor
43901158|NCT00064038|Dexamethasone|dexamethasone|mesh-list
43901159|NCT00064038|Lenalidomide|lenalidomide|mesh-list
43901160|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43901161|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
43901162|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
43901163|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43901164|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901165|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43901166|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
43901167|NCT00064038|Hormones|hormones|mesh-ancestor
43901169|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43901211|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901212|NCT00066781|Gemcitabine|gemcitabine|mesh-list
43901213|NCT00066781|Irinotecan|irinotecan|mesh-list
43901214|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901215|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
43901216|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901217|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901227|NCT00066937|Nortriptyline|nortriptyline|mesh-list
43901280|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901281|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901282|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901283|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901284|NCT00068575|Interferons|interferons|mesh-list
43901285|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
43901286|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
43901345|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43663723|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
43663724|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663725|NCT03883893|Acetaminophen|acetaminophen|mesh-list
43663726|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901346|NCT00071721|Valproic Acid|valproic acid|mesh-list
43901347|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
43901348|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901349|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901350|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
43901351|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901352|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901353|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
43901354|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43901355|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901356|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43901412|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901413|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
43901414|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901415|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901416|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43901417|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901418|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901419|NCT00072566|Growth Substances|growth substances|mesh-ancestor
43901420|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901421|NCT00073073|Vitamin D|vitamin d|mesh-list
43901422|NCT00073073|Exemestane|exemestane|mesh-list
43901423|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
43901424|NCT00073073|Calcium|calcium|mesh-list
43901425|NCT00073073|Vitamins|vitamins|mesh-ancestor
43901426|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
43901427|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901428|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43901429|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43901430|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901431|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43901432|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43901465|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901466|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
43901467|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901468|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901469|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43901470|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
43901471|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901472|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901473|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43901474|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43901475|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43901476|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43901477|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43901478|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901479|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901480|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
43901481|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
43901482|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901483|NCT00074165|Antidotes|antidotes|mesh-ancestor
43901485|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
43901519|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43901520|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
43901521|NCT00074308|Antibodies|antibodies|mesh-list
43663735|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663736|NCT03782740|Melatonin|melatonin|mesh-list
43663737|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
43663738|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663739|NCT03782740|Protective Agents|protective agents|mesh-ancestor
43663740|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663741|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663742|NCT03778424|Rufinamide|rufinamide|mesh-list
43901522|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
43901523|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43901524|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901525|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901526|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901527|NCT00074308|Growth Substances|growth substances|mesh-ancestor
43901528|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901529|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901530|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
43901531|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43901532|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901533|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901534|NCT00074802|Paroxetine|paroxetine|mesh-list
43901535|NCT00074802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43901575|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43901576|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43901578|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43901579|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43901580|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
43901581|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901646|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
43901648|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901649|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
43901650|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901651|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43901652|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901653|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901654|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43901655|NCT00078559|Analgesics|analgesics|mesh-ancestor
43901656|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
43901711|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43901712|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43901713|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
43901714|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43901715|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901716|NCT00078715|Urological Agents|urological agents|mesh-ancestor
43901717|NCT00078754|Valproic Acid|valproic acid|mesh-list
43901718|NCT00078754|Fluoxetine|fluoxetine|mesh-list
43901719|NCT00078754|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43901720|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43901721|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43901722|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901773|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43663743|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
43663744|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43663745|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43663746|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43663747|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663748|NCT03777904|Iron|iron|mesh-list
43663749|NCT03777904|Trace Elements|trace elements|mesh-ancestor
43901774|NCT00081861|Growth Substances|growth substances|mesh-ancestor
43901775|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901776|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901777|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
43901778|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43901779|NCT00081939|Thalidomide|thalidomide|mesh-list
43901780|NCT00081939|Bortezomib|bortezomib|mesh-list
43901781|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901782|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901783|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
43901784|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901785|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
43901786|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901787|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901814|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901815|NCT00083174|Exemestane|exemestane|mesh-list
43901816|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901817|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43901818|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43901819|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901820|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43901821|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43901822|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
43901823|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43901824|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901825|NCT00083382|Pamidronate|pamidronate|mesh-list
43901826|NCT00083382|Thalidomide|thalidomide|mesh-list
43901827|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43901828|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
43901829|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901873|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43901874|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43901875|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
43663779|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43663781|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663782|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
43663783|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43663784|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663785|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663786|NCT03686150|Vitamin D|vitamin d|mesh-list
43663787|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
43663788|NCT03686150|Vitamins|vitamins|mesh-ancestor
43663789|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
43663790|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663791|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43663792|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43663793|NCT03685253|Niacinamide|niacinamide|mesh-list
43663794|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
43901876|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901877|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43901878|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
43901879|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
43901880|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
43901881|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
43901882|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
44138324|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
43901883|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43901884|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43901885|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43901886|NCT00083551|Growth Substances|growth substances|mesh-ancestor
43901887|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
43901890|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901934|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
43901935|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43901936|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901937|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
43901938|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43901939|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43901940|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43901941|NCT00085839|Paclitaxel|paclitaxel|mesh-list
43901942|NCT00085839|Carboplatin|carboplatin|mesh-list
43901943|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43901944|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43901945|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43901998|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43901999|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902000|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902001|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43902002|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43902003|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43902004|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
43902005|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902006|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902007|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43902008|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43902009|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
43902010|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43902011|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43902012|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
43902013|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43902014|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43902015|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902016|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663805|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663806|NCT03138733|Daptomycin|daptomycin|mesh-list
43663807|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
43663808|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
43663809|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663810|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663811|NCT02834559|Fluorouracil|fluorouracil|mesh-list
43663812|NCT02834559|Heparin|heparin|mesh-list
43663813|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43663814|NCT02834559|Tinzaparin|tinzaparin|mesh-list
43663815|NCT02834559|Dalteparin|dalteparin|mesh-list
43663816|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
43663817|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663818|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902017|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902018|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902019|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43902020|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43902021|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43902022|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43902023|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902024|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902031|NCT00088699|Ketamine|ketamine|mesh-list
43902041|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43902042|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43902043|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902044|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902045|NCT00088985|Trastuzumab|trastuzumab|mesh-list
43902046|NCT00088985|Vinorelbine|vinorelbine|mesh-list
43902047|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902048|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902049|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43902050|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
43902051|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
43902052|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
43902053|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902054|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
43902055|NCT00089011|Fludarabine|fludarabine|mesh-list
43902056|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902057|NCT00089011|Tacrolimus|tacrolimus|mesh-list
43902058|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902059|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902060|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
43902061|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902063|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
43902095|NCT00089102|Irinotecan|irinotecan|mesh-list
43902096|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902097|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
43902098|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902099|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902100|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
43902101|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902102|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902103|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902104|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
43902105|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902106|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43902107|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902108|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
43902109|NCT00090051|Rituximab|rituximab|mesh-list
43652157|NCT03002090|Iron|iron|mesh-list
43902110|NCT00090051|Fludarabine|fludarabine|mesh-list
43902111|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902112|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902113|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
43902114|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902115|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902116|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43902117|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
43902118|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902142|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43902143|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
43902144|NCT00091260|Hormones|hormones|mesh-ancestor
43902145|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902146|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902147|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902148|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
43902149|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902150|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902151|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
43902207|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902208|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902209|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43849671|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849672|NCT03901573|Atezolizumab|atezolizumab|mesh-list
43902210|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
43902211|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43902212|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
43902213|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902214|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902215|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43902216|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
43902217|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
43902218|NCT00094887|Protective Agents|protective agents|mesh-ancestor
43902219|NCT00094900|Rilonacept|rilonacept|mesh-list
43902220|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902221|NCT00095563|Lapatinib|lapatinib|mesh-list
43902222|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902223|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902224|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902225|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902226|NCT00095875|Cisplatin|cisplatin|mesh-list
43902227|NCT00095875|Carboplatin|carboplatin|mesh-list
43902228|NCT00095875|Docetaxel|docetaxel|mesh-list
43902229|NCT00095875|Fluorouracil|fluorouracil|mesh-list
43902230|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902231|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
43902232|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
43902233|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
43902234|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902235|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
43902236|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902237|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902251|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902252|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902253|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43902254|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902256|NCT00096161|Cyclosporine|cyclosporine|mesh-list
43902257|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
43902258|NCT00096161|Vidarabine|vidarabine|mesh-list
43902259|NCT00096161|Pentostatin|pentostatin|mesh-list
43902260|NCT00096161|Cyclosporins|cyclosporins|mesh-list
43902261|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138325|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43902262|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902263|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902264|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
43633390|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
43902265|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902266|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
43902267|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902268|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902269|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902270|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902271|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902272|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902273|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902274|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902275|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902276|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
43902277|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
43902278|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
43902279|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
43902280|NCT00096460|Carmustine|carmustine|mesh-list
43902281|NCT00096460|Rituximab|rituximab|mesh-list
43902282|NCT00096460|Methotrexate|methotrexate|mesh-list
43902283|NCT00096460|Fludarabine|fludarabine|mesh-list
43902284|NCT00096460|Etoposide|etoposide|mesh-list
43663819|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663820|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663842|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663843|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
43663844|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
43663846|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
43902285|NCT00096460|Tacrolimus|tacrolimus|mesh-list
43902291|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
43902292|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902293|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902294|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43902295|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902296|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43902297|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
43902298|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43902299|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902300|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
43902301|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902302|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902303|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43902304|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43902305|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43902306|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43902307|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902308|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902309|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43902310|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902311|NCT00097448|Prednisone|prednisone|mesh-list
43902312|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
43902313|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43902314|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43902315|NCT00097448|Prednisolone|prednisolone|mesh-list
43902316|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
43902317|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43902318|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
43902319|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902320|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
43902321|NCT00097448|Hormones|hormones|mesh-ancestor
43902322|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902323|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902329|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43902330|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43902331|NCT00097448|Protective Agents|protective agents|mesh-ancestor
43902332|NCT00097669|Folic Acid|folic acid|mesh-list
43902333|NCT00097669|Hematinics|hematinics|mesh-ancestor
43902334|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
43902335|NCT00097669|Vitamins|vitamins|mesh-ancestor
43902336|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
43902337|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902338|NCT00097695|Icatibant|icatibant|mesh-list
43902339|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43902341|NCT00097695|Analgesics|analgesics|mesh-ancestor
43902342|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
43902343|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902344|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902345|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902346|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902347|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43902348|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43902349|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902350|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43663849|NCT05467670|Doxorubicin|doxorubicin|mesh-list
43902351|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902383|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43663850|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43663851|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
43663852|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43663853|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663854|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43663855|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902384|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902385|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
43902386|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902387|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902388|NCT00098956|Topotecan|topotecan|mesh-list
43902389|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
43902396|NCT00099021|Pioglitazone|pioglitazone|mesh-list
43902451|NCT00100841|Protective Agents|protective agents|mesh-ancestor
43902452|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
43902453|NCT00100841|Vitamins|vitamins|mesh-ancestor
43902454|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
43902455|NCT00101036|Lapatinib|lapatinib|mesh-list
43902456|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902457|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902458|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902459|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902460|NCT00101361|Oxandrolone|oxandrolone|mesh-list
43902461|NCT00101361|Androgens|androgens|mesh-ancestor
43902462|NCT00101361|Hormones|hormones|mesh-ancestor
43902463|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902464|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902465|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
43902466|NCT00101413|Sorafenib|sorafenib|mesh-list
43902467|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902468|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902469|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902470|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902471|NCT00101647|Dasatinib|dasatinib|mesh-list
43902472|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902473|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902474|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902475|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902476|NCT00101660|Dasatinib|dasatinib|mesh-list
43902477|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902478|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902479|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902481|NCT00101816|Dasatinib|dasatinib|mesh-list
43902495|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902496|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902497|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43902498|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43902499|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
43902500|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43902501|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43902502|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43902503|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43902504|NCT00103116|Vaccines|vaccines|mesh-list
43902505|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
43902506|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902507|NCT00103194|Lapatinib|lapatinib|mesh-list
43902557|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902558|NCT00105001|Tacrolimus|tacrolimus|mesh-list
43902559|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902560|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652481|NCT02995005|Tenofovir|tenofovir|mesh-list
43902561|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
43902562|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902563|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902564|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
43902565|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902566|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902567|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902568|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902569|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902570|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902574|NCT00105027|Triamcinolone|triamcinolone|mesh-list
43902615|NCT00107536|Lapatinib|lapatinib|mesh-list
43902616|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849674|NCT03900624|Dexamethasone|dexamethasone|mesh-list
43902617|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43902618|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902619|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902620|NCT00107744|Caseins|caseins|mesh-list
43902621|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
43902622|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
43902623|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902624|NCT00108524|Orlistat|orlistat|mesh-list
43902625|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902626|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902627|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43902628|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43902629|NCT00108550|Gabapentin|gabapentin|mesh-list
43902630|NCT00108550|Analgesics|analgesics|mesh-ancestor
43902631|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
43902632|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902633|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902634|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
43902635|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43902636|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902637|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902638|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902639|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43902640|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43902641|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902643|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
44138327|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138328|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138329|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44138330|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44138331|NCT00170898|Analgesics|analgesics|mesh-ancestor
44138332|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
44138333|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138334|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138335|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826091|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138336|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138338|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138339|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138340|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138341|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663860|NCT05467436|Anesthetics|anesthetics|mesh-list
43663861|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
43663862|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663863|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663864|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
43663865|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663866|NCT05467384|Amlodipine|amlodipine|mesh-list
43663867|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43663868|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43663877|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43663879|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43663880|NCT05467189|Busulfan|busulfan|mesh-list
43663881|NCT05467189|Lapatinib|lapatinib|mesh-list
43663882|NCT05467189|Afatinib|afatinib|mesh-list
43663883|NCT05467189|Crizotinib|crizotinib|mesh-list
43663884|NCT05467189|Ceritinib|ceritinib|mesh-list
44138342|NCT00170937|Valsartan|valsartan|mesh-list
44138343|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138344|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138345|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138346|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138347|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138348|NCT00170937|Diuretics|diuretics|mesh-ancestor
44138349|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138350|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138352|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138371|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663891|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
44138372|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138373|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138374|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43652622|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43902660|NCT00110461|Aripiprazole|aripiprazole|mesh-list
43902661|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
43902662|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902663|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43902664|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43902665|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43902666|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902667|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
43902668|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
43902669|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902670|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902671|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43902672|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43902673|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
43902674|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43902675|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43902676|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43902677|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43902678|NCT00110513|Antithrombins|antithrombins|mesh-list
43902679|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
43902680|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43902681|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
43902682|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902683|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902684|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
43902685|NCT00111657|Rasburicase|rasburicase|mesh-list
43902686|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
43902687|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902688|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
43633906|NCT05697029|Tetrandrine|tetrandrine|mesh-list
43902695|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902696|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663892|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663893|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
43663894|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663895|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43663896|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43663897|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43663900|NCT05466708|Ketamine|ketamine|mesh-list
43902697|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902698|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902700|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43902701|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43902702|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
43902703|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902704|NCT00112593|Cyclosporine|cyclosporine|mesh-list
43902705|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
43902706|NCT00112593|Fludarabine|fludarabine|mesh-list
43902707|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
43902708|NCT00112593|Cyclosporins|cyclosporins|mesh-list
43902709|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902710|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902711|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
43902712|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902713|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902714|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
43902715|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902716|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902717|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
43902718|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902719|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902720|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902721|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902722|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902723|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902726|NCT00112671|Sorafenib|sorafenib|mesh-list
43902739|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
43902741|NCT00112827|Lenalidomide|lenalidomide|mesh-list
43902742|NCT00112827|Lenograstim|lenograstim|mesh-list
43902743|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902744|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
43902745|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902746|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902747|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43902748|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
43902749|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902750|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902751|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43902752|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43902753|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43902801|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902803|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43902804|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
43902805|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902806|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902807|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902808|NCT00114114|Goserelin|goserelin|mesh-list
43902809|NCT00114114|Testosterone|testosterone|mesh-list
43902810|NCT00114114|Androgens|androgens|mesh-ancestor
43902811|NCT00114114|Hormones|hormones|mesh-ancestor
44138375|NCT00170989|Valsartan|valsartan|mesh-list
43902812|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902813|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902814|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902815|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902816|NCT00114504|Simvastatin|simvastatin|mesh-list
43902817|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43902818|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43902819|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
43902820|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663909|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43663910|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43663911|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43663912|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
43663913|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703312|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43902821|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43902822|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43902823|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902824|NCT00115297|Montelukast|montelukast|mesh-list
43902825|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43902826|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
43902827|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43902834|NCT00116207|Niacinamide|niacinamide|mesh-list
43902846|NCT00116207|Vitamins|vitamins|mesh-ancestor
43902847|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
43902848|NCT00116857|Sertraline|sertraline|mesh-list
43902849|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
43902850|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902851|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43902852|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43902853|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43902854|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902855|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43902856|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
43902857|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902858|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
43902859|NCT00117715|Caffeine|caffeine|mesh-list
43902860|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43902861|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902862|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43902863|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902902|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
43902903|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902904|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902905|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43902906|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43902907|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902908|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43902909|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43902910|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902911|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902912|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
43663914|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663915|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43663916|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663917|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
43663918|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
43663919|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43663920|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43663921|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
43663922|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902914|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43902915|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43902916|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43902917|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
43902918|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
43902919|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
43902920|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
43902921|NCT00118274|Vaccines|vaccines|mesh-list
43902922|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
43902923|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
43902924|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902925|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43902926|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902933|NCT00118352|Cyclosporine|cyclosporine|mesh-list
43902952|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902953|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
43902954|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902955|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43902956|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43902957|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43902958|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
43902959|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43902960|NCT00118365|Eflornithine|eflornithine|mesh-list
43902961|NCT00118365|Sulindac|sulindac|mesh-list
43902962|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43902963|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43902964|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43902965|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43902966|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43902967|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43902968|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902969|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43902970|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43902971|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43902972|NCT00118365|Analgesics|analgesics|mesh-ancestor
43902973|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
43663942|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663943|NCT05466578|Abrocitinib|abrocitinib|mesh-list
43663944|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43663945|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43902974|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43902975|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43902976|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43902977|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43902978|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43902979|NCT00118378|Modafinil|modafinil|mesh-list
43902986|NCT00118404|Fluoxetine|fluoxetine|mesh-list
43902995|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
43902996|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43902997|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43902998|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43902999|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903000|NCT00118742|Cyclosporine|cyclosporine|mesh-list
43903001|NCT00118742|Sirolimus|sirolimus|mesh-list
43903002|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
43903003|NCT00118742|Tacrolimus|tacrolimus|mesh-list
43903004|NCT00118742|Cyclosporins|cyclosporins|mesh-list
43903005|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903006|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
43903007|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903008|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903009|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903010|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903011|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
43903012|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903013|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903014|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903015|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43903016|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903017|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43903018|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
43903019|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903020|NCT00118755|Bevacizumab|bevacizumab|mesh-list
43903021|NCT00118755|Capecitabine|capecitabine|mesh-list
43903022|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
43903023|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903024|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903025|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43903026|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903027|NCT00118755|Growth Substances|growth substances|mesh-ancestor
43903028|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903029|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903031|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
43903035|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
43903036|NCT00119158|Tacrolimus|tacrolimus|mesh-list
43903037|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903038|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43903039|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
43903040|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903041|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903042|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43903043|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
43903044|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903045|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43903046|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43663980|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
43663988|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43663989|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43663990|NCT05465304|Azithromycin|azithromycin|mesh-list
43663991|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43663992|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43663993|NCT05464836|Venetoclax|venetoclax|mesh-list
43663994|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663995|NCT05464654|Estrogens|estrogens|mesh-list
43663997|NCT05464654|Hormones|hormones|mesh-ancestor
43903047|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903048|NCT00119158|Analgesics|analgesics|mesh-ancestor
43903049|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
43903050|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903051|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903052|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
43903053|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903054|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903055|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903056|NCT00119392|Cyclosporine|cyclosporine|mesh-list
43903057|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
43903058|NCT00119392|Rituximab|rituximab|mesh-list
43903059|NCT00119392|Fludarabine|fludarabine|mesh-list
43903060|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
43903062|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43903063|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903064|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903065|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
43903066|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903067|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903080|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903082|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43903083|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903084|NCT00120523|Analgesics|analgesics|mesh-ancestor
43903085|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
43903086|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903087|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903088|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903089|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903090|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903091|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903092|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
43903093|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903094|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903095|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903096|NCT00121186|Methotrexate|methotrexate|mesh-list
43903097|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
43903098|NCT00121186|Fludarabine|fludarabine|mesh-list
43903099|NCT00121186|Melphalan|melphalan|mesh-list
43903100|NCT00121186|Tacrolimus|tacrolimus|mesh-list
43903101|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43903102|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
43903103|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43903104|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903105|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43652969|NCT02987244|Etoposide|etoposide|mesh-list
43851583|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43903128|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903129|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
43903130|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903131|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903132|NCT00121251|Antiviral Agents|antiviral agents|mesh-ancestor
43903133|NCT00121251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43634335|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
43903135|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903136|NCT00121251|Immunologic Factors|immunologic factors|mesh-ancestor
43903137|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903138|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43903139|NCT00121719|Lenvatinib|lenvatinib|mesh-list
43903140|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903141|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43903142|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903143|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903144|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
43903145|NCT00121810|Sirolimus|sirolimus|mesh-list
43903146|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
43903147|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43903148|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903149|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43903150|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
43903151|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903152|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903153|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903154|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903155|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
43903156|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903172|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903173|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903174|NCT00122447|Aspirin|aspirin|mesh-list
43903175|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
43903176|NCT00122447|Olmesartan|olmesartan|mesh-list
43903177|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43903178|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903179|NCT00122447|Analgesics|analgesics|mesh-ancestor
43903180|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
43903181|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903182|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903183|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43903184|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903185|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43903186|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43903187|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903188|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43903189|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43903190|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903191|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
43903192|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43903193|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43903194|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43903195|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
43903224|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43903225|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43903226|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
43903227|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
43903228|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903229|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903230|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43903231|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43826095|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826097|NCT03150173|Buprenorphine|buprenorphine|mesh-list
43826098|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43903232|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43903233|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
43903234|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903235|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903236|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
43903237|NCT00123604|Protective Agents|protective agents|mesh-ancestor
43903238|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43903239|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903240|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43903282|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903283|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903284|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903285|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
43903286|NCT00124579|Hormones|hormones|mesh-ancestor
43903287|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903288|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903289|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903290|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903291|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
43903292|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
43903345|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43903346|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903347|NCT00125931|Pentazocine|pentazocine|mesh-list
43903348|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43903349|NCT00125931|Narcotics|narcotics|mesh-ancestor
43903350|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903351|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903352|NCT00125931|Analgesics|analgesics|mesh-ancestor
43903353|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
43903354|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903355|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43903356|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43903357|NCT00125957|Bupropion|bupropion|mesh-list
43903358|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903359|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903360|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903371|NCT00127218|Niacin|niacin|mesh-list
43903403|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903404|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903405|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
43903407|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903408|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43903409|NCT00128180|Protective Agents|protective agents|mesh-ancestor
43903410|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826108|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826109|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826110|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826111|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826112|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826113|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664028|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664029|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
43664030|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664036|NCT05356104|Exenatide|exenatide|mesh-list
43664052|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43664053|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
43664054|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43664055|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43664056|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43664057|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43664058|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664059|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664061|NCT05341167|Protective Agents|protective agents|mesh-ancestor
43903411|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903412|NCT00130780|Bevacizumab|bevacizumab|mesh-list
44138391|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43634709|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
44138392|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138393|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138394|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138395|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138396|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43664066|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664067|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664068|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
43664069|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43664070|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664071|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664072|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138398|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138399|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138400|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138401|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43903496|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43903497|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43903498|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
43903499|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43903500|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903501|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43903502|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43903503|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
43903504|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903505|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43903506|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
43903507|NCT00134017|Busulfan|busulfan|mesh-list
43903508|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43903509|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
43634786|NCT05519839|Vaccines|vaccines|mesh-list
43903510|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903511|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903512|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43903552|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903553|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903554|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43903555|NCT00137969|Analgesics|analgesics|mesh-ancestor
43903556|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
43903557|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903558|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
43903559|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43903560|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43903561|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903562|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
43903563|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
43903564|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
43903565|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
43903566|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903567|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43664151|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43664152|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664153|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664154|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43664155|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
43664156|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
43664157|NCT05258279|Carboplatin|carboplatin|mesh-list
43664158|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
43664159|NCT05258279|Pemetrexed|pemetrexed|mesh-list
43903568|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
43903569|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
43903570|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903571|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903572|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43903573|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
43903574|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903575|NCT00138125|Trastuzumab|trastuzumab|mesh-list
43903577|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903578|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903579|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43903580|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43903581|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43903582|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
43903583|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903584|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903585|NCT00138203|Vorinostat|vorinostat|mesh-list
43903586|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903592|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43903593|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43903594|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903595|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43903596|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43903598|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903599|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
43903600|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43903606|NCT00141739|Etanercept|etanercept|mesh-list
43903657|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903658|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43903659|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43903660|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43903661|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43903662|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903664|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
43903665|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903666|NCT00144391|Testosterone|testosterone|mesh-list
43903667|NCT00144391|Androgens|androgens|mesh-ancestor
43903668|NCT00144391|Hormones|hormones|mesh-ancestor
43903669|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903670|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903671|NCT00144963|Dexamethasone|dexamethasone|mesh-list
43903672|NCT00144963|Vincristine|vincristine|mesh-list
43903712|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43903713|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43903714|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43903716|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
43903717|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903718|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903719|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903720|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903722|NCT00145587|Antibodies|antibodies|mesh-list
43903777|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903778|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903779|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43903780|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43903781|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903782|NCT00149734|Ondansetron|ondansetron|mesh-list
43903783|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
43903784|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
43903785|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903786|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903787|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43903788|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
43903789|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
43903790|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43903791|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
43903792|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903793|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903794|NCT00149734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43903795|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43903796|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903797|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903798|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43903799|NCT00149799|Citalopram|citalopram|mesh-list
43903800|NCT00149799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43903801|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43903802|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903803|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903804|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903805|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
43903806|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903807|NCT00149799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43903808|NCT00149799|Antidepressive Agents|antidepressive agents|mesh-ancestor
43903818|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43903819|NCT00151814|Olmesartan|olmesartan|mesh-list
43903820|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43903821|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43903822|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43903823|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43664181|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43664182|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
43664183|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43664184|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43664185|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43664186|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43664187|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664188|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664189|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43664190|NCT05231980|Protective Agents|protective agents|mesh-ancestor
43664191|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
43664192|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43664193|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
43664194|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
43664195|NCT05231980|Vitamins|vitamins|mesh-ancestor
43664196|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
43664197|NCT05209035|Trazodone|trazodone|mesh-list
43664205|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903824|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903826|NCT00153166|Atorvastatin|atorvastatin|mesh-list
43903827|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43903828|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43903829|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
43903830|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903831|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43903832|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43903833|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903834|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43903835|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903836|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43903837|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903838|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43903839|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43903840|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903841|NCT00153842|Bexarotene|bexarotene|mesh-list
43903842|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903843|NCT00153985|Fludarabine|fludarabine|mesh-list
43903865|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43903866|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43903867|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43903868|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903869|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903870|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
43903871|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43903872|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43903873|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43903874|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43903875|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903876|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
43903877|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903878|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903879|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43903880|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903881|NCT00156923|Naltrexone|naltrexone|mesh-list
43903882|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43903883|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43903884|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903885|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
43903886|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903888|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43903889|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43903890|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903891|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
43903892|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43903893|NCT00157573|Sargramostim|sargramostim|mesh-list
43903894|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
43903895|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903896|NCT00158223|Pimozide|pimozide|mesh-list
43903897|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43903898|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43903899|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43903900|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903905|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903906|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43903907|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43826129|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826130|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826131|NCT02717507|Carvedilol|carvedilol|mesh-list
43826132|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43826133|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43903908|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
43903909|NCT00158379|Paclitaxel|paclitaxel|mesh-list
43903910|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43903911|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43903912|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
43903913|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
43903914|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
43903915|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903916|NCT00158743|Digoxin|digoxin|mesh-list
43903917|NCT00158743|Antibodies|antibodies|mesh-list
43903918|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
43903919|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
43903920|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903921|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43903922|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43903959|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43903960|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43903961|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43903962|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43903963|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
43903964|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43903965|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43903966|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903967|NCT00163293|Ciclesonide|ciclesonide|mesh-list
43903968|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
43903969|NCT00163293|Hormones|hormones|mesh-ancestor
43903970|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43903971|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43903972|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43903974|NCT00166036|Pravastatin|pravastatin|mesh-list
43903975|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43903976|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43903977|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
43904014|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138407|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43826134|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
43826135|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826136|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826137|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826138|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43826139|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
43826140|NCT02717507|Protective Agents|protective agents|mesh-ancestor
43826141|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138408|NCT00171028|Valsartan|valsartan|mesh-list
44138409|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138410|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43826142|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43826143|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43826144|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138411|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138412|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138413|NCT00171041|Valsartan|valsartan|mesh-list
44138414|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138415|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43904048|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
43904049|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904050|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904051|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904052|NCT00168298|Dexamethasone|dexamethasone|mesh-list
43904053|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
43904055|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43904056|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
43904057|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
43635481|NCT05286814|Leucovorin|leucovorin|mesh-list
43904058|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904059|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904060|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904061|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
43904062|NCT00168298|Hormones|hormones|mesh-ancestor
43904063|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904064|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904107|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904108|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43904109|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904110|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
43904111|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43904112|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43904113|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43904114|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904115|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904116|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904117|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904118|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904119|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43904120|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904121|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
43904122|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43904123|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43904124|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43904125|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904158|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
43904159|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43904160|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
43904161|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904162|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904163|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664277|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904164|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904165|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904166|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904167|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43904168|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
43904169|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904170|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
43904171|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
43904172|NCT00176228|Lamotrigine|lamotrigine|mesh-list
43904173|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
43904174|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43904175|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904176|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904177|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43904178|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904179|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43904180|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904181|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904182|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904183|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43904184|NCT00176306|Levofloxacin|levofloxacin|mesh-list
43904185|NCT00176306|Ofloxacin|ofloxacin|mesh-list
43904186|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43904187|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904188|NCT00176306|Renal Agents|renal agents|mesh-ancestor
43904189|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904190|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904192|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904198|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43904199|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904200|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904201|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
43851585|NCT03526900|Atezolizumab|atezolizumab|mesh-list
43664313|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
43904202|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904203|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904204|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43904205|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
43904206|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904207|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
43904208|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
43904209|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
43904210|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
43904211|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904212|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
43904213|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904214|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904215|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904216|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43904217|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
43904218|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
43904219|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904220|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904221|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43904222|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43904223|NCT00176800|Growth Substances|growth substances|mesh-ancestor
43904224|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904225|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
43904226|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904227|NCT00176826|Busulfan|busulfan|mesh-list
43904236|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
43904243|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904244|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904245|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904246|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
43904247|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904248|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904249|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904250|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904251|NCT00176852|Vidarabine|vidarabine|mesh-list
43904252|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
43904253|NCT00176852|Busulfan|busulfan|mesh-list
43904254|NCT00176852|Fludarabine|fludarabine|mesh-list
43904255|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
43904256|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
43904257|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904258|NCT00176852|Lenograstim|lenograstim|mesh-list
43904259|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904260|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
43904261|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904262|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904263|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904264|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
43904265|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904266|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904295|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43904296|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43904297|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43904298|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
43904299|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904300|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904301|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
43904302|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904303|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904304|NCT00176878|Fludarabine|fludarabine|mesh-list
43904305|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
43904306|NCT00176878|Busulfan|busulfan|mesh-list
43904307|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904308|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904309|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904310|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
43904311|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904312|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904313|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
43904314|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904315|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
43904316|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904317|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904318|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
43904319|NCT00176904|Busulfan|busulfan|mesh-list
43904320|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904321|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904322|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
43904323|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904324|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904325|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904338|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
43904339|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904340|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904341|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904342|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
43904343|NCT00176930|Busulfan|busulfan|mesh-list
43904344|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904345|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
43904346|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904347|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904348|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904349|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
43904350|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904351|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904352|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904353|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
43904354|NCT00177047|Melphalan|melphalan|mesh-list
43904355|NCT00177047|Lenograstim|lenograstim|mesh-list
43904356|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904357|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
43904358|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904359|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904360|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904361|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
43904362|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904363|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904364|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904365|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904366|NCT00177255|Docetaxel|docetaxel|mesh-list
43904367|NCT00177255|Capecitabine|capecitabine|mesh-list
43664459|NCT04865029|Progesterone|progesterone|mesh-list
43664460|NCT04865029|Estrogens|estrogens|mesh-ancestor
43664461|NCT04865029|Hormones|hormones|mesh-ancestor
43664462|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43664463|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664464|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43664465|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
43664466|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904368|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904369|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904370|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904379|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904380|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
43904381|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904382|NCT00178503|Methylphenidate|methylphenidate|mesh-list
43904383|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43904384|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904385|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43904386|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904387|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904388|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904389|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
43904390|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904391|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
43904392|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43904393|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43904394|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43904395|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904396|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904397|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904398|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904399|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904400|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43904401|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904402|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
43904403|NCT00178841|Bexarotene|bexarotene|mesh-list
43904404|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43904406|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904424|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904425|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
43904426|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904427|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
43904428|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904429|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43904430|NCT00180687|Bupivacaine|bupivacaine|mesh-list
43904431|NCT00180687|Coal Tar|coal tar|mesh-list
43904432|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
43904433|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
43904434|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904435|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904436|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
43904437|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904438|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
43904439|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
43904440|NCT00181714|Methylphenidate|methylphenidate|mesh-list
43904441|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43904442|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904443|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43904444|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904445|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904446|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904447|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
43904448|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904449|NCT00182000|Cycloserine|cycloserine|mesh-list
43904450|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43904451|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904452|NCT00182000|Renal Agents|renal agents|mesh-ancestor
43904453|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43904454|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
43904455|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904456|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
43904463|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43904464|NCT00182767|Epothilone B|epothilone b|mesh-list
43904465|NCT00182767|Epothilones|epothilones|mesh-list
43904466|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43904467|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904468|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43664512|NCT04727775|Favipiravir|favipiravir|mesh-list
43664513|NCT04727775|Remdesivir|remdesivir|mesh-list
43664514|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
43664515|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664516|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
43664517|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664518|NCT04696042|Lanreotide|lanreotide|mesh-list
43664649|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43664650|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43664651|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43664652|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43664653|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43664654|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43664655|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664657|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43664658|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43664659|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664660|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664661|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43664662|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664663|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
43904469|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904470|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904471|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904472|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904473|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904474|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904475|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
43904476|NCT00182793|Melphalan|melphalan|mesh-list
43904477|NCT00182793|Thiotepa|thiotepa|mesh-list
43904478|NCT00182793|Carboplatin|carboplatin|mesh-list
43904479|NCT00182793|Trastuzumab|trastuzumab|mesh-list
43904480|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904481|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
43904482|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904483|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904484|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43904485|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
43904486|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904487|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904488|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43904489|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904490|NCT00183092|Quinacrine|quinacrine|mesh-list
43904491|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
43904492|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43904493|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
43904494|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43904495|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904496|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
43904497|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43904498|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
43904499|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904503|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43904504|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904505|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904506|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904507|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904508|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
43904509|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904510|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43904511|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
43904512|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904513|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43904514|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43904515|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904516|NCT00183443|Valproic Acid|valproic acid|mesh-list
43904517|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43904518|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
43904519|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904520|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43904521|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904522|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904523|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904524|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904525|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904526|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
43904527|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
43904528|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
43904529|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664746|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904530|NCT00183469|Lamotrigine|lamotrigine|mesh-list
43826255|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826256|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826257|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826258|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826259|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826260|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826261|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826262|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
43826263|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
43826282|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43826283|NCT05499234|Narcotics|narcotics|mesh-ancestor
43826284|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826285|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43904531|NCT00183469|Valproic Acid|valproic acid|mesh-list
43904532|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
43904542|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43904543|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904544|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
43904545|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904546|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
43904547|NCT00183677|Citalopram|citalopram|mesh-list
43904548|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43904549|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904550|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904551|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904552|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904553|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
43904554|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904555|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43904556|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
43904557|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904558|NCT00183729|Memantine|memantine|mesh-list
43904559|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43904560|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43904561|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
43904562|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904563|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904564|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904565|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43904566|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43904567|NCT00183794|Gemcitabine|gemcitabine|mesh-list
43904590|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
43904591|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43904592|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43904593|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43904594|NCT00185692|Cyclosporins|cyclosporins|mesh-list
43904595|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43904596|NCT00185692|Lenograstim|lenograstim|mesh-list
43904597|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43904598|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
43904599|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904600|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904601|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904602|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
43904603|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904604|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
43904605|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664766|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
43664767|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43664768|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
43664769|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664770|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664771|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43664772|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
43664773|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
43664774|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43664775|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904606|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
43904647|NCT00186017|Olanzapine|olanzapine|mesh-list
43904648|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
43904649|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
43904650|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904651|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904652|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904653|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43904654|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904655|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904656|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904657|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43904658|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43904659|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904660|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904661|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904662|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
43904663|NCT00186056|Mifepristone|mifepristone|mesh-list
43904664|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43904665|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
43904666|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904667|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904668|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43904669|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43904670|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43904671|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
43904672|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43904673|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43904674|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
43904675|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904676|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
43904677|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43904678|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43904679|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
43904685|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904686|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43904688|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43904689|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904690|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904691|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43904692|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
43904693|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904694|NCT00186446|Bupropion|bupropion|mesh-list
43904695|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43904696|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
43904697|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904698|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43904699|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43664833|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
43664834|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
43664847|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
43664849|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43904700|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43904743|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
43904744|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904745|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43904746|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
43904747|NCT00186875|Hormones|hormones|mesh-ancestor
43904748|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43904749|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664908|NCT03646058|Buprenorphine|buprenorphine|mesh-list
43664909|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43664910|NCT03646058|Narcotics|narcotics|mesh-ancestor
43664911|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664912|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664913|NCT03646058|Analgesics|analgesics|mesh-ancestor
43664938|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664939|NCT03522961|Renal Agents|renal agents|mesh-ancestor
43664940|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43664941|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43664942|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851594|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664943|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664944|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43664945|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43664946|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
43664947|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664948|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43664949|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664950|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43904750|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
43904751|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904752|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43904753|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
43904754|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43904755|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904756|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
43904757|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
43904758|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43904759|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
44157271|NCT00233961|Lenograstim|lenograstim|mesh-list
43654204|NCT02977208|Gabapentin|gabapentin|mesh-list
43904760|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43904761|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904762|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904795|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904796|NCT00189137|Gemcitabine|gemcitabine|mesh-list
43904797|NCT00189137|Docetaxel|docetaxel|mesh-list
43904798|NCT00189137|Doxorubicin|doxorubicin|mesh-list
43904799|NCT00189137|Ifosfamide|ifosfamide|mesh-list
43904800|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904801|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
43904802|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904803|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904804|NCT00189137|Antiviral Agents|antiviral agents|mesh-ancestor
43904805|NCT00189137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904806|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904807|NCT00189137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904808|NCT00189137|Immunologic Factors|immunologic factors|mesh-ancestor
43904809|NCT00189137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904810|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904811|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904812|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904818|NCT00189228|Omalizumab|omalizumab|mesh-list
43904851|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904852|NCT00193037|Docetaxel|docetaxel|mesh-list
43904853|NCT00193037|Doxorubicin|doxorubicin|mesh-list
43904854|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43904855|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904856|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904857|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904858|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904859|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904860|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43904861|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904915|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904916|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904917|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904918|NCT00193492|Bevacizumab|bevacizumab|mesh-list
43904919|NCT00193492|Rituximab|rituximab|mesh-list
43904920|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904921|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904922|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43904923|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43904924|NCT00193492|Growth Substances|growth substances|mesh-ancestor
43904925|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904926|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
43904927|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
43904928|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43904929|NCT00193596|Gemcitabine|gemcitabine|mesh-list
43904930|NCT00193596|Paclitaxel|paclitaxel|mesh-list
43904931|NCT00193596|Etoposide|etoposide|mesh-list
43904932|NCT00193596|Carboplatin|carboplatin|mesh-list
43904933|NCT00193596|Irinotecan|irinotecan|mesh-list
43904934|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43904935|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43904936|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
43904937|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
43904938|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
43904939|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904940|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43904941|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
43904942|NCT00193596|Antiviral Agents|antiviral agents|mesh-ancestor
43904943|NCT00193596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904944|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904945|NCT00193596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43904961|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904962|NCT00194129|Valproic Acid|valproic acid|mesh-list
43904963|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
43904964|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
43904965|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43904966|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904967|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904968|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
43904969|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43904970|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826297|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43826298|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43826299|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826301|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826302|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826303|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
43826304|NCT05499026|Cathartics|cathartics|mesh-ancestor
43826305|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826306|NCT05498896|Paclitaxel|paclitaxel|mesh-list
43826307|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
43826308|NCT05498896|Doxorubicin|doxorubicin|mesh-list
43826309|NCT05498896|Atezolizumab|atezolizumab|mesh-list
43826310|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43904971|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904972|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
43904973|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
43904974|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43904975|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
43904976|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
43904977|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
43904978|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43904979|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43904980|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43904981|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43904982|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43904983|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665066|NCT03253289|Meclizine|meclizine|mesh-list
43665067|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
43665068|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
43665069|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665070|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665071|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665072|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43665073|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
43665074|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
43665075|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665076|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665077|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43665078|NCT03250832|Bevacizumab|bevacizumab|mesh-list
43665079|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665080|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665081|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43665082|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43665083|NCT03250832|Growth Substances|growth substances|mesh-ancestor
43665084|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665085|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
43665086|NCT03245021|Rituximab|rituximab|mesh-list
43665087|NCT03245021|Nivolumab|nivolumab|mesh-list
43665088|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43904984|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824969|NCT05506319|Vasopressins|vasopressins|mesh-list
43904985|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43904986|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44138435|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138437|NCT00171093|Simvastatin|simvastatin|mesh-list
44138453|NCT00171119|Valsartan|valsartan|mesh-list
44138454|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138455|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138456|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138457|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138458|NCT00171132|Atenolol|atenolol|mesh-list
44138459|NCT00171132|Valsartan|valsartan|mesh-list
44138460|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138461|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138462|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138463|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138464|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138465|NCT00171132|Diuretics|diuretics|mesh-ancestor
44138466|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138467|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138468|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43904991|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43904992|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
43904993|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665113|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43665115|NCT02690064|Vitamins|vitamins|mesh-list
43904994|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43904995|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43904996|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43904997|NCT00194779|Tamoxifen|tamoxifen|mesh-list
43904998|NCT00194779|Vinorelbine|vinorelbine|mesh-list
43904999|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
43905000|NCT00194779|Doxorubicin|doxorubicin|mesh-list
43905001|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43905002|NCT00194779|Capecitabine|capecitabine|mesh-list
43905003|NCT00194779|Methotrexate|methotrexate|mesh-list
43905004|NCT00194779|Trastuzumab|trastuzumab|mesh-list
43905005|NCT00194779|Letrozole|letrozole|mesh-list
43905007|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905051|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905052|NCT00195403|Analgesics|analgesics|mesh-ancestor
43905053|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
43905054|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905055|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905056|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905057|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905058|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905059|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905060|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
43654440|NCT02975440|Rifampin|rifampin|mesh-list
43905061|NCT00195624|Cyclosporine|cyclosporine|mesh-list
43905062|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
43905063|NCT00195624|Cyclosporins|cyclosporins|mesh-list
43905064|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905065|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905066|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905067|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
43905068|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905069|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
43905070|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905071|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
43905072|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905073|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43905101|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43905102|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905103|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43905104|NCT00200902|Citalopram|citalopram|mesh-list
43905105|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43905106|NCT00200902|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43905107|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905108|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905109|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665249|NCT01803152|Vaccines|vaccines|mesh-list
43905110|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905111|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
43665262|NCT01715974|Molgramostim|molgramostim|mesh-list
43905112|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905113|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43905114|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
43905115|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905116|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905117|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43905118|NCT00200902|Analgesics|analgesics|mesh-ancestor
43905119|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
43905120|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
43905121|NCT00201123|Interferons|interferons|mesh-list
43905126|NCT00201448|Vaccines|vaccines|mesh-list
43905154|NCT00201773|Celecoxib|celecoxib|mesh-list
43905155|NCT00201773|Exemestane|exemestane|mesh-list
43905156|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905157|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905158|NCT00201773|Analgesics|analgesics|mesh-ancestor
43905159|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
43905160|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905161|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905162|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905163|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905164|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43905165|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43905166|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905167|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665292|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43905168|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905169|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43905170|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43905171|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43665293|NCT01462890|Growth Substances|growth substances|mesh-ancestor
43905172|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
43905173|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905174|NCT00201825|Docetaxel|docetaxel|mesh-list
43905175|NCT00201825|Capecitabine|capecitabine|mesh-list
43905176|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905177|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905178|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905179|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905180|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905181|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905182|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
43905183|NCT00201838|Gemcitabine|gemcitabine|mesh-list
43905184|NCT00201838|Etanercept|etanercept|mesh-list
43905186|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
43905196|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905197|NCT00201838|Analgesics|analgesics|mesh-ancestor
43905198|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
43905199|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905200|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905201|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905202|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905203|NCT00201864|Fulvestrant|fulvestrant|mesh-list
43905204|NCT00201864|Exemestane|exemestane|mesh-list
43905205|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905206|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905207|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43905208|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43905209|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
43905210|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905211|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905212|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43905213|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43665360|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43665361|NCT05471063|Amebicides|amebicides|mesh-ancestor
43665362|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43905214|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905215|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905216|NCT00201877|Rituximab|rituximab|mesh-list
43905217|NCT00201877|Bortezomib|bortezomib|mesh-list
43905218|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905219|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905220|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
43905221|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905222|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905223|NCT00202449|Prazosin|prazosin|mesh-list
43905224|NCT00202449|Paroxetine|paroxetine|mesh-list
43905225|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43905230|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
43905238|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43905239|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43905240|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43905241|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43905242|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
43905244|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43905245|NCT00202722|Narcotics|narcotics|mesh-ancestor
43905246|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905247|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905248|NCT00202722|Analgesics|analgesics|mesh-ancestor
43905249|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
43905250|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905251|NCT00202930|Rituximab|rituximab|mesh-list
43905252|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905253|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905254|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
43905255|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905256|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905295|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
43905296|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43905297|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905298|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43905299|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43905300|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43905301|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43905302|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905303|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43905304|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43905305|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905306|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905307|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905309|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
43905310|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43905311|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905352|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43905353|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43905355|NCT00210353|Rituximab|rituximab|mesh-list
43905356|NCT00210353|Chlorambucil|chlorambucil|mesh-list
43654661|NCT02974426|Cisplatin|cisplatin|mesh-list
43905357|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905358|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905359|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
43905360|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905361|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905362|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905363|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
43905364|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905365|NCT00210470|Zinc|zinc|mesh-list
43905366|NCT00210470|Indomethacin|indomethacin|mesh-list
43905367|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
43905368|NCT00210470|Omeprazole|omeprazole|mesh-list
43905369|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905370|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
43905371|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905372|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905373|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43905374|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
43905375|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905376|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905377|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43905378|NCT00210470|Trace Elements|trace elements|mesh-ancestor
43905379|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
43905381|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905382|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43905383|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905384|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905386|NCT00210470|Analgesics|analgesics|mesh-ancestor
43665443|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905393|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43905395|NCT00211692|Ribavirin|ribavirin|mesh-list
43905396|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
43905397|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
43905398|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905399|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
43905400|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905401|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
43905402|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905403|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
43905404|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905405|NCT00213239|Remifentanil|remifentanil|mesh-list
43905406|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43905407|NCT00213239|Narcotics|narcotics|mesh-ancestor
43905408|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905409|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905410|NCT00213239|Analgesics|analgesics|mesh-ancestor
43905411|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
43905412|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905413|NCT00214890|Tenofovir|tenofovir|mesh-list
43905414|NCT00214890|Abacavir|abacavir|mesh-list
43905415|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
43905416|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905417|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43905418|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905419|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905443|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905444|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905445|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905446|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905447|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43905448|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43905449|NCT00216099|Hematinics|hematinics|mesh-ancestor
43905450|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
43905451|NCT00216125|Cisplatin|cisplatin|mesh-list
43905452|NCT00216125|Docetaxel|docetaxel|mesh-list
43905453|NCT00216125|Etoposide|etoposide|mesh-list
43905454|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905455|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905456|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905457|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905458|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905459|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905460|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43905461|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43905462|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905464|NCT00217399|Anastrozole|anastrozole|mesh-list
43905465|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905466|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43905467|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905469|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905493|NCT00218023|Carbidopa|carbidopa|mesh-list
43905494|NCT00218023|Modafinil|modafinil|mesh-list
43905495|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43905496|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43905497|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905498|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
43905499|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905500|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43905501|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43905502|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
43905503|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905504|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905505|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43905506|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905507|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43905508|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43905509|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43905510|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43905511|NCT00218062|Modafinil|modafinil|mesh-list
43905512|NCT00218062|Amphetamine|amphetamine|mesh-list
43905513|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
43905514|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43905515|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905516|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43905517|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43905518|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43905519|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905520|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
43637139|NCT04677543|Azithromycin|azithromycin|mesh-list
43665601|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665602|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43905522|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905523|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
43905524|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905525|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43905526|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43905531|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43905532|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905533|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43905534|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43905535|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43905536|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905537|NCT00218426|Naltrexone|naltrexone|mesh-list
43905538|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43905539|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43905540|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905541|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
43905542|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905543|NCT00218439|Paroxetine|paroxetine|mesh-list
43905544|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43905545|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905546|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905547|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905548|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905549|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
43905550|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905551|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43905552|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
43826386|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826387|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826388|NCT05498233|Pyridoxine|pyridoxine|mesh-list
43826389|NCT05498233|Doxylamine|doxylamine|mesh-list
43826390|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
43826391|NCT05498233|Vitamins|vitamins|mesh-ancestor
43826392|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
43665629|NCT05468047|Ketamine|ketamine|mesh-list
43665630|NCT05468047|Analgesics|analgesics|mesh-ancestor
43665631|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
43665632|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665633|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665634|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43665635|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43665636|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
43665637|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
43665643|NCT05467878|Anesthetics|anesthetics|mesh-list
43665658|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665660|NCT05466305|Trace Elements|trace elements|mesh-ancestor
43665661|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
43665662|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665689|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665711|NCT05527470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665712|NCT05527470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665713|NCT05527470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851610|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
43665714|NCT05527470|Immunologic Factors|immunologic factors|mesh-ancestor
43826422|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826424|NCT05498025|Antidotes|antidotes|mesh-ancestor
43826425|NCT05498025|Protective Agents|protective agents|mesh-ancestor
43826426|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826427|NCT05498012|Cannabidiol|cannabidiol|mesh-list
43826428|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
43826429|NCT05497934|Glycerol|glycerol|mesh-list
43826430|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43826431|NCT05497934|Protective Agents|protective agents|mesh-ancestor
43826432|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826433|NCT05497843|Chiauranib|chiauranib|mesh-list
43826434|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665779|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
43665780|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
43665781|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
43665782|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905553|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905578|NCT00221299|Hormones|hormones|mesh-list
43905579|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
43905580|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905581|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905582|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43905583|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905584|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905585|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43905586|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43905587|NCT00221338|Gabapentin|gabapentin|mesh-list
43905588|NCT00221338|Analgesics|analgesics|mesh-ancestor
43905589|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
43905590|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905591|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905592|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
43905593|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43905594|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43905595|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905596|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905597|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43905598|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43905599|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905600|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905601|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
43905602|NCT00222131|Esomeprazole|esomeprazole|mesh-list
43905603|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43665857|NCT05239182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665858|NCT05239182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665859|NCT05239182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665860|NCT05239182|Immunologic Factors|immunologic factors|mesh-ancestor
43665861|NCT05239182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665862|NCT05226299|Capsaicin|capsaicin|mesh-list
43665863|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
43665864|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
43826482|NCT05497674|Rifampin|rifampin|mesh-list
43905623|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905624|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43905625|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43905626|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905627|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905628|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43905629|NCT00223665|Leuprolide|leuprolide|mesh-list
43905630|NCT00223665|Flutamide|flutamide|mesh-list
43637304|NCT04626518|Lenvatinib|lenvatinib|mesh-list
43905631|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43905632|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
43905633|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43905634|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905635|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43905636|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905637|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
43905638|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
43905639|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43905640|NCT00223678|Sirolimus|sirolimus|mesh-list
43905641|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43905642|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43905643|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43905644|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905645|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
43905646|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905647|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
43905648|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905649|NCT00223704|Icatibant|icatibant|mesh-list
43905650|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
43665904|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665906|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43665907|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43665908|NCT05119257|Antibodies|antibodies|mesh-list
43665909|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43665910|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
43665911|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665912|NCT05112549|Nivolumab|nivolumab|mesh-list
43665913|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905651|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43905652|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43905653|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654886|NCT02973035|Amlodipine|amlodipine|mesh-list
43905654|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
43905655|NCT00223704|Coagulants|coagulants|mesh-ancestor
43905656|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43905657|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43905660|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43905661|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905662|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43905663|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43905664|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
43905665|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
43905666|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43905667|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905668|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
43905670|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
44138504|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138505|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44138506|NCT00171327|Valsartan|valsartan|mesh-list
44138507|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43905725|NCT00225498|Olanzapine|olanzapine|mesh-list
43905726|NCT00225498|Risperidone|risperidone|mesh-list
43905727|NCT00225498|Ziprasidone|ziprasidone|mesh-list
43905728|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43905729|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
43905730|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905731|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905732|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905733|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43905734|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43665941|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665942|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43665943|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
43665953|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665954|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
43665955|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43905735|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905736|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905781|NCT00226577|Pemetrexed|pemetrexed|mesh-list
43905782|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905783|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
43905853|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905854|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43905855|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905856|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
43905858|NCT00227617|Protective Agents|protective agents|mesh-ancestor
43905859|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
43905860|NCT00227617|Vitamins|vitamins|mesh-ancestor
43905861|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
43905862|NCT00227760|Cediranib|cediranib|mesh-list
43851640|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43905863|NCT00227760|Maleic acid|maleic acid|mesh-list
43851641|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851642|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43851643|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851649|NCT03243175|Apixaban|apixaban|mesh-list
43851650|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43905864|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905865|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905866|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905867|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43905868|NCT00227994|Donepezil|donepezil|mesh-list
43905869|NCT00227994|Galantamine|galantamine|mesh-list
43905870|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43905871|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905872|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905873|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
43905874|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905875|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905876|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
43905877|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43905880|NCT00228943|Tryptophan|tryptophan|mesh-list
43905904|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
43905905|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
43905906|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
43905907|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905908|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43905909|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905910|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43905911|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905912|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905913|NCT00230737|Melatonin|melatonin|mesh-list
43905914|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
43905915|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905916|NCT00230737|Protective Agents|protective agents|mesh-ancestor
43905917|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666255|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43666256|NCT04158440|Cisplatin|cisplatin|mesh-list
43666257|NCT04158440|Carboplatin|carboplatin|mesh-list
43666258|NCT04158440|Pemetrexed|pemetrexed|mesh-list
43666259|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666260|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666261|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666262|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666263|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666264|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666265|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666266|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666267|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43666268|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
43826532|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666271|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43666320|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905918|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43905919|NCT00231309|Lenograstim|lenograstim|mesh-list
43905920|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43905921|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
43905922|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905923|NCT00231868|Paclitaxel|paclitaxel|mesh-list
43905924|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43905925|NCT00231868|Carboplatin|carboplatin|mesh-list
43905926|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43905927|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905932|NCT00232479|Carboplatin|carboplatin|mesh-list
43905954|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43905955|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
43905956|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43905957|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
43905958|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905960|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
43905961|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905962|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43905963|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43905964|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43905965|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905966|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43905967|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
43905968|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905969|NCT00234078|Rebamipide|rebamipide|mesh-list
43905970|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43905971|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43905972|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
43905973|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43905974|NCT00234078|Protective Agents|protective agents|mesh-ancestor
43905975|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43905976|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43905977|NCT00234832|Sibutramine|sibutramine|mesh-list
43905978|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
43905979|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43905980|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
43905981|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43905982|NCT00234884|Adalimumab|adalimumab|mesh-list
43906005|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906006|NCT00236977|Hematinics|hematinics|mesh-ancestor
43906007|NCT00237666|Ziprasidone|ziprasidone|mesh-list
43666483|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
43666484|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666486|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
43666487|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43851679|NCT03032328|Vitamin D|vitamin d|mesh-list
43666524|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666525|NCT03757585|Protective Agents|protective agents|mesh-ancestor
43666526|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666527|NCT03757585|Antidotes|antidotes|mesh-ancestor
43666528|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
43666530|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
43666531|NCT03757403|Mebendazole|mebendazole|mesh-list
43666532|NCT03757403|Piperazine|piperazine|mesh-list
43851730|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906008|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43906009|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
43906010|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906011|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906012|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906013|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43906014|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906015|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906068|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43906069|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
43906070|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906071|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906072|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43906073|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
43906074|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43906075|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
43906076|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906077|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906078|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43906079|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
43906080|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
43906081|NCT00240487|Protective Agents|protective agents|mesh-ancestor
43906082|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
43906083|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43906084|NCT00240526|Antibodies|antibodies|mesh-list
43906085|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
43906086|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906087|NCT00240981|Testosterone|testosterone|mesh-list
43906088|NCT00240981|Androgens|androgens|mesh-ancestor
43906089|NCT00240981|Hormones|hormones|mesh-ancestor
43906090|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906092|NCT00241176|Aripiprazole|aripiprazole|mesh-list
43906118|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
43906119|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43851738|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666599|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43666600|NCT03511196|Prednisone|prednisone|mesh-list
43666601|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
43666602|NCT03511196|Androgens|androgens|mesh-list
43666621|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666622|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666623|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
43906120|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906121|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906122|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43906123|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43906124|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
43906125|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
43906126|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
43906127|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906128|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43906129|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
43906130|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906131|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43906132|NCT00241904|Protective Agents|protective agents|mesh-ancestor
43906133|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
43906134|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43851789|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851790|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
43851791|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851792|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851793|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43906135|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906136|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906137|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43906138|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43906139|NCT00242502|Bevacizumab|bevacizumab|mesh-list
43906140|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43906141|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906154|NCT00242632|Memantine|memantine|mesh-list
43906166|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906167|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906168|NCT00243152|Lamotrigine|lamotrigine|mesh-list
43906169|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
43906170|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43906171|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906172|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906173|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43906174|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906175|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43906176|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43906177|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906178|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906179|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43906180|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
43906181|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906182|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43906185|NCT00244985|Rituximab|rituximab|mesh-list
43906219|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43906220|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43906221|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906222|NCT00246441|Paroxetine|paroxetine|mesh-list
43906223|NCT00246441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43906224|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906225|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906226|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906227|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906228|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
43906229|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906230|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43906231|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906232|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906233|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43666982|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43666983|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
43826614|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826616|NCT05496179|Prucalopride|prucalopride|mesh-list
43826617|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
43666997|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
43667028|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667029|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43667030|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
43667031|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
43667032|NCT01628029|Melatonin|melatonin|mesh-list
43906234|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43906235|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906236|NCT00246519|Atenolol|atenolol|mesh-list
43906237|NCT00246519|Metoprolol|metoprolol|mesh-list
43906238|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43906239|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
43906240|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43906241|NCT00246519|Diuretics|diuretics|mesh-ancestor
43906242|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
43906267|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906268|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43906269|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43906270|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906271|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43906272|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43906273|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
43906274|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43667066|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
43667067|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667068|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667069|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667074|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43667075|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43667076|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43667077|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43667078|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667079|NCT01125761|Clemastine|clemastine|mesh-list
43667080|NCT01125761|Dexamethasone|dexamethasone|mesh-list
43851857|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851858|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851859|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43667086|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667087|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667088|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667089|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
43667090|NCT01125761|Hormones|hormones|mesh-ancestor
43667091|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667092|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667093|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667094|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
43667095|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906275|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43906333|NCT00248560|Antiviral Agents|antiviral agents|mesh-ancestor
43906334|NCT00248560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906335|NCT00248560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906336|NCT00248560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906337|NCT00248560|Immunologic Factors|immunologic factors|mesh-ancestor
43906338|NCT00248560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906339|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
43906340|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906341|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906342|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
43906343|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43906344|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43906345|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906346|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906347|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906348|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906349|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43906350|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906351|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43906352|NCT00248807|Enalaprilat|enalaprilat|mesh-list
43906353|NCT00248807|Enalapril|enalapril|mesh-list
43906354|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43906355|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
43906356|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906372|NCT00250926|Rituximab|rituximab|mesh-list
43906382|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
43906383|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906384|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43906385|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
43906386|NCT00250926|Hormones|hormones|mesh-ancestor
43906387|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906388|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906389|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157292|NCT00234026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667130|NCT00871013|Bortezomib|bortezomib|mesh-list
43667131|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43667132|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
43667133|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667134|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43851860|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43667135|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667136|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
43667137|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667138|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667139|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43667140|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667141|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
43667142|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
43667143|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667144|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667145|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
43667146|NCT00871013|Hormones|hormones|mesh-ancestor
44157293|NCT00234091|Ritonavir|ritonavir|mesh-list
44157294|NCT00234091|Lopinavir|lopinavir|mesh-list
44157295|NCT00234091|Nelfinavir|nelfinavir|mesh-list
44157296|NCT00234091|Lamivudine|lamivudine|mesh-list
44157297|NCT00234091|Zidovudine|zidovudine|mesh-list
44157298|NCT00234091|Nevirapine|nevirapine|mesh-list
44157299|NCT00234091|Abacavir|abacavir|mesh-list
44157300|NCT00234091|Efavirenz|efavirenz|mesh-list
44157301|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
44157302|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44157303|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
44157304|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157305|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157306|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44157307|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44157320|NCT00234117|Rabeprazole|rabeprazole|mesh-list
43906447|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43906448|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906449|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43906450|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
43906451|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43906452|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
43906453|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
43906454|NCT00254410|Rituximab|rituximab|mesh-list
43906455|NCT00254410|Fludarabine|fludarabine|mesh-list
43906456|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
43906457|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906458|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
43906459|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851900|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851901|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851902|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43667218|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667219|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43667220|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
43667221|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667222|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
43667223|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
43667224|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
43667586|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43667587|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667588|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
43667589|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43667590|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43667591|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43667592|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
43667593|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667594|NCT04961541|Vaccines|vaccines|mesh-list
43667595|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
43667596|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667597|NCT04910815|Rifaximin|rifaximin|mesh-list
43667598|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667599|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667600|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667601|NCT04902703|Molgramostim|molgramostim|mesh-list
43667602|NCT04902703|Sargramostim|sargramostim|mesh-list
43906460|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906461|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906462|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
43906463|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906464|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906465|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43906466|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906467|NCT00254410|Analgesics|analgesics|mesh-ancestor
43906468|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
43906469|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43906470|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906471|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906472|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906495|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906496|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906497|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906498|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906499|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
43906500|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906501|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906502|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43906503|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
43906559|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43906560|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906561|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906562|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906563|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906627|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43906628|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43906629|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906630|NCT00257894|Baclofen|baclofen|mesh-list
43906637|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
43906697|NCT00258349|Vorinostat|vorinostat|mesh-list
43667687|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667688|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667689|NCT04816877|Analgesics|analgesics|mesh-ancestor
43667715|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826661|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826662|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43826663|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
43826664|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826665|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826666|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846775|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43846776|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
43667716|NCT04766853|Dexamethasone|dexamethasone|mesh-list
43667717|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
43667718|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667719|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
43667720|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
43667721|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667806|NCT04704271|Hormones|hormones|mesh-ancestor
43906698|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43906699|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906700|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43906701|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906702|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906703|NCT00258362|Carboplatin|carboplatin|mesh-list
43906704|NCT00258362|Docetaxel|docetaxel|mesh-list
43906705|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906706|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
43906707|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
43906708|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
43906709|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906710|NCT00258817|Vaccines|vaccines|mesh-list
43906711|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
43638585|NCT04002947|Rituximab|rituximab|mesh-list
43906712|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906713|NCT00258830|Vaccines|vaccines|mesh-list
43906714|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
43906715|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906716|NCT00259090|Fulvestrant|fulvestrant|mesh-list
43906717|NCT00259090|Anastrozole|anastrozole|mesh-list
43906718|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43906719|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906720|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43906721|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43906722|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
43906723|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43906743|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43906744|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
43906745|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906746|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
43906747|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43906748|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
43906749|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43906750|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43906753|NCT00260962|Olanzapine|olanzapine|mesh-list
43906811|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43667807|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667808|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
43906812|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
43906813|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43906816|NCT00264641|Insulin|insulin|mesh-list
43906886|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43906887|NCT00266799|Capecitabine|capecitabine|mesh-list
43906888|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43906889|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43906890|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43906891|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43906892|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43906893|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43906894|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906895|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
43906896|NCT00266851|Azithromycin|azithromycin|mesh-list
43906950|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43906951|NCT00267696|Growth Substances|growth substances|mesh-ancestor
43906952|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43906953|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
43906954|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43906955|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
43906957|NCT00267696|Antiviral Agents|antiviral agents|mesh-ancestor
43907020|NCT00271570|Antibodies|antibodies|mesh-list
43907021|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
43655981|NCT02964949|Edoxaban|edoxaban|mesh-list
43907022|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43907023|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
43907024|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907028|NCT00272311|Aspirin|aspirin|mesh-list
43907089|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43907090|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43907091|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907093|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907094|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
43907095|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656069|NCT02963402|Adalimumab|adalimumab|mesh-list
43907096|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907097|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
43907098|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907099|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138536|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138537|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
44138538|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
44138539|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138540|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
44138541|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
44138542|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44138543|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138544|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138545|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138547|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44138548|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
44138549|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138550|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138551|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138552|NCT00171431|Tegaserod|tegaserod|mesh-list
43907129|NCT00281021|Digoxin|digoxin|mesh-list
43907164|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907165|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
43907166|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907167|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907168|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43907169|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
43907170|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907171|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907172|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43907173|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907174|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43907227|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907228|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907230|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43907231|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43907244|NCT00285467|Vitamin D|vitamin d|mesh-list
43907297|NCT00287222|Growth Substances|growth substances|mesh-ancestor
43907298|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907299|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907300|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907369|NCT00288067|Protective Agents|protective agents|mesh-ancestor
43907370|NCT00288366|Aripiprazole|aripiprazole|mesh-list
43907371|NCT00288366|Ziprasidone|ziprasidone|mesh-list
43907372|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
43907373|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907374|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43907375|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43907376|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43907377|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907378|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
43907379|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
43907380|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907381|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907382|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43907383|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43907384|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
43907427|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907428|NCT00290329|Vaccines|vaccines|mesh-list
43907429|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
43907430|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907431|NCT00290472|Sirolimus|sirolimus|mesh-list
43907432|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43907433|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907434|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43907435|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907436|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
43907437|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43907438|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
43667809|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43667811|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
43667812|NCT04664972|Cisplatin|cisplatin|mesh-list
43667813|NCT04664972|Docetaxel|docetaxel|mesh-list
43907439|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907440|NCT00290537|Paclitaxel|paclitaxel|mesh-list
43907441|NCT00290537|Carboplatin|carboplatin|mesh-list
43907442|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43907443|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907444|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
43907445|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
43907446|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
43907447|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907448|NCT00290615|Bevacizumab|bevacizumab|mesh-list
43907449|NCT00290615|Cetuximab|cetuximab|mesh-list
43907450|NCT00290615|Capecitabine|capecitabine|mesh-list
43907451|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
43907452|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43907453|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907462|NCT00290654|Tamoxifen|tamoxifen|mesh-list
43907474|NCT00290810|Antibodies|antibodies|mesh-list
43907476|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43907477|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907478|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907479|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907480|NCT00290810|Growth Substances|growth substances|mesh-ancestor
43907481|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907482|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
43907483|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
43907484|NCT00291135|Letrozole|letrozole|mesh-list
43907485|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907486|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43907487|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43907537|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907538|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
43907539|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43907540|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43907541|NCT00292162|Diuretics|diuretics|mesh-ancestor
43907542|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
43907543|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
43907544|NCT00292162|Protective Agents|protective agents|mesh-ancestor
43907603|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667814|NCT04664972|Doxorubicin|doxorubicin|mesh-list
43667815|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43667816|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
43667817|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667818|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43907604|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907605|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43907606|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43907607|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
43907608|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907609|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907610|NCT00296192|Rotigotine|rotigotine|mesh-list
43907611|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
43907666|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43907667|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
43907668|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43907669|NCT00298233|Oseltamivir|oseltamivir|mesh-list
43907670|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
43907671|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43907672|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907673|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907674|NCT00298610|Artesunate|artesunate|mesh-list
43907675|NCT00298610|Atovaquone|atovaquone|mesh-list
43907676|NCT00298610|Proguanil|proguanil|mesh-list
43907677|NCT00298610|Quinidine|quinidine|mesh-list
43907706|NCT00299221|Tacrolimus|tacrolimus|mesh-list
43907728|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907729|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907730|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907731|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
43907732|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43907733|NCT00299988|Antibodies|antibodies|mesh-list
43907734|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
43907735|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43667819|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43667820|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
43667821|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667822|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667823|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43667824|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
43667825|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
43667826|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667827|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43667828|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43667829|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43667830|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667832|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43667833|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667834|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907736|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
43907737|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138580|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
44138581|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138582|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
44138583|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138584|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907770|NCT00300456|Simvastatin|simvastatin|mesh-list
43907829|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907830|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43907831|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907832|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907833|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
43907834|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43907835|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907836|NCT00302068|Sertraline|sertraline|mesh-list
43907837|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
43907838|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43907839|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43907840|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907887|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907888|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
43907889|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43907890|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
43907891|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907892|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43907893|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43907894|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43907895|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43907896|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907897|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
43907898|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43907899|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907945|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43907946|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43907947|NCT05267366|Growth Substances|growth substances|mesh-ancestor
43907948|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43907949|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667835|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667836|NCT04638309|Azacitidine|azacitidine|mesh-list
43667837|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43667838|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
43667839|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667840|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667841|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907950|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907952|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43907953|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43907954|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43907955|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43907977|NCT05266794|Selenium|selenium|mesh-list
43908009|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908010|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908011|NCT05266651|Urological Agents|urological agents|mesh-ancestor
43908012|NCT05266560|Propofol|propofol|mesh-list
43908013|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43908014|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43640031|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
43908015|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908076|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43908077|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908078|NCT05265793|Apatinib|apatinib|mesh-list
43908079|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908080|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908081|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908082|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138588|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44138589|NCT00171509|Cyclosporine|cyclosporine|mesh-list
44138590|NCT00171509|Cyclosporins|cyclosporins|mesh-list
44138591|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138642|NCT00171574|Protective Agents|protective agents|mesh-ancestor
43908083|NCT05240781|Sirolimus|sirolimus|mesh-list
43908084|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908085|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908086|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908087|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667843|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
43667844|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43667845|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667846|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667847|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
43667848|NCT04635007|Coagulants|coagulants|mesh-ancestor
43667849|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43667850|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
43667851|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43667852|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667853|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43667854|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667855|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
43667856|NCT04632927|Ustekinumab|ustekinumab|mesh-list
43667857|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
43667858|NCT04592419|Aflibercept|aflibercept|mesh-list
43667859|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43908153|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908154|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43908155|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43908156|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43908157|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908158|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
43908159|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43908160|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43908161|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43908220|NCT04586660|Denosumab|denosumab|mesh-list
43908221|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43908222|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908223|NCT04528212|Glimepiride|glimepiride|mesh-list
43908224|NCT04528212|Curcumin|curcumin|mesh-list
43908225|NCT04528212|Fenofibrate|fenofibrate|mesh-list
43908226|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908227|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43908289|NCT04251351|Acetaminophen|acetaminophen|mesh-list
43908290|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908291|NCT04251351|Analgesics|analgesics|mesh-ancestor
43908292|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
43908293|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908294|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908295|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
43908296|NCT04248569|Nivolumab|nivolumab|mesh-list
43908297|NCT04248569|Ipilimumab|ipilimumab|mesh-list
43908298|NCT04248569|Poly ICLC|poly iclc|mesh-list
43908299|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43908300|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908301|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43908302|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908303|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
43908352|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908353|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
43908354|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43667860|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667861|NCT04592419|Growth Substances|growth substances|mesh-ancestor
43667862|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667863|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667864|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667865|NCT04561739|Aspirin|aspirin|mesh-list
43667866|NCT04561739|Sirolimus|sirolimus|mesh-list
43667867|NCT04561739|Paclitaxel|paclitaxel|mesh-list
43667868|NCT04561739|Clopidogrel|clopidogrel|mesh-list
43667870|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43667871|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667872|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
43667873|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
43667874|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
43908355|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
43908356|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908357|NCT04123873|Acetaminophen|acetaminophen|mesh-list
43908358|NCT04123873|Dexamethasone|dexamethasone|mesh-list
43908359|NCT04123873|Ibuprofen|ibuprofen|mesh-list
43908360|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43908361|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
43908362|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
43908363|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908364|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908365|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43908366|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
43908367|NCT04123873|Hormones|hormones|mesh-ancestor
43908368|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43908369|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43908370|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908371|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43908372|NCT04123873|Analgesics|analgesics|mesh-ancestor
43908373|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
43908374|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
44138647|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138648|NCT00171600|Valsartan|valsartan|mesh-list
44138649|NCT00171600|Lisinopril|lisinopril|mesh-list
44138650|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138651|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
44138652|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138653|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138654|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43908401|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908402|NCT03917966|Docetaxel|docetaxel|mesh-list
43908403|NCT03917966|Apatinib|apatinib|mesh-list
43908404|NCT03917966|Nedaplatin|nedaplatin|mesh-list
43908405|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908406|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
43908407|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
43908408|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
43908409|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908410|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43908467|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908468|NCT03366415|Gemcitabine|gemcitabine|mesh-list
43908469|NCT03366415|Cisplatin|cisplatin|mesh-list
43908470|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908471|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908472|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
43908473|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908474|NCT03366415|Antiviral Agents|antiviral agents|mesh-ancestor
43908534|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908535|NCT03017131|Aldesleukin|aldesleukin|mesh-list
43908536|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
43667875|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908537|NCT03017131|Decitabine|decitabine|mesh-list
43908538|NCT03017131|Interleukin-2|interleukin-2|mesh-list
43667876|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667877|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667878|NCT04561739|Analgesics|analgesics|mesh-ancestor
43667879|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
43667880|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667881|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667882|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43667883|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667889|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
43667890|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43667891|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43667892|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43667893|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
43667894|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667895|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667896|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667897|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43667898|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
43667899|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908539|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908540|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
43908541|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908542|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908543|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908544|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
43908545|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908546|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908547|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908548|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908596|NCT02823002|Lidocaine|lidocaine|mesh-list
43908597|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
43908598|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
43908599|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43908600|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908601|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
43908602|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908666|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43908667|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908668|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
43908669|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908670|NCT01595321|Leucovorin|leucovorin|mesh-list
43908671|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
43908672|NCT01595321|Fluorouracil|fluorouracil|mesh-list
43908673|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
43908674|NCT01595321|Irinotecan|irinotecan|mesh-list
43908675|NCT01595321|Folfirinox|folfirinox|mesh-list
43908676|NCT01595321|Vaccines|vaccines|mesh-list
43908677|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
43908678|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908679|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43908680|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43908681|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43908682|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
43908683|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908684|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908685|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908686|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
43908687|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43908688|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43908689|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43667900|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
43667901|NCT04537598|Morphine|morphine|mesh-list
43667902|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43667903|NCT04537598|Narcotics|narcotics|mesh-ancestor
43667904|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43667905|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667906|NCT04537598|Analgesics|analgesics|mesh-ancestor
43667907|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
43667908|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908690|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908691|NCT01595321|Antidotes|antidotes|mesh-ancestor
43908692|NCT01595321|Protective Agents|protective agents|mesh-ancestor
43908693|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
43908694|NCT01595321|Vitamins|vitamins|mesh-ancestor
43908695|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
43908696|NCT01552590|Tolvaptan|tolvaptan|mesh-list
43908713|NCT01000467|Protective Agents|protective agents|mesh-ancestor
43908714|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908716|NCT00549978|Probucol|probucol|mesh-list
43908717|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908718|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
43908719|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908721|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43908781|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908782|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43908783|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43908784|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43908785|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43908786|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
43908787|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43908788|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43908789|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43908790|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
44138708|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138709|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138715|NCT00171691|Diclofenac|diclofenac|mesh-list
44138758|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
44138759|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
44138760|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667909|NCT04497142|Levetiracetam|levetiracetam|mesh-list
43667911|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
44138761|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667912|NCT04481555|Azithromycin|azithromycin|mesh-list
43667913|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43667914|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667915|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
43667916|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667917|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
43667918|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43667919|NCT04453839|Protective Agents|protective agents|mesh-ancestor
43667920|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667921|NCT04445025|Leuprolide|leuprolide|mesh-list
43667922|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43667923|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
43667924|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43667925|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667927|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667928|NCT04432974|Anesthetics|anesthetics|mesh-list
43667929|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44138762|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
44138763|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
44138764|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
44138765|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
44138766|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138767|NCT00171769|Certoparin|certoparin|mesh-list
44138768|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
44138769|NCT00171782|Valsartan|valsartan|mesh-list
44138770|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
44138771|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
44138772|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43657688|NCT02951637|Carboplatin|carboplatin|mesh-list
43908791|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
43908792|NCT00305760|Cetuximab|cetuximab|mesh-list
43908793|NCT00305760|Vaccines|vaccines|mesh-list
43908794|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
43908804|NCT00305942|Carboplatin|carboplatin|mesh-list
43908831|NCT00306488|Antioxidants|antioxidants|mesh-list
43908832|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43908833|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43908834|NCT00306488|Protective Agents|protective agents|mesh-ancestor
43908835|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908836|NCT00309465|Insulin|insulin|mesh-list
43908837|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43908838|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
43908839|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43908840|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908897|NCT00310791|Estrogens|estrogens|mesh-list
43908898|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
43908899|NCT00310791|Progestins|progestins|mesh-list
43908900|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43908901|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908902|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43908903|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
43908904|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43908905|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43908906|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43908961|NCT00315302|Atropine|atropine|mesh-list
43908962|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43908963|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43908964|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43908965|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
43908966|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43908967|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43908968|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43667938|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667939|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667940|NCT04418557|Antibodies|antibodies|mesh-list
43667941|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
43667942|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667943|NCT04396496|Daratumumab|daratumumab|mesh-list
43667944|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667945|NCT04378933|Methamphetamine|methamphetamine|mesh-list
43667946|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43667947|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667948|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
43667949|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
43667950|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667951|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
43667954|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
43908969|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
43908970|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
43908971|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
43908972|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43908973|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43908974|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
43909024|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909025|NCT00318136|Paclitaxel|paclitaxel|mesh-list
43909026|NCT00318136|Bevacizumab|bevacizumab|mesh-list
43909027|NCT00318136|Carboplatin|carboplatin|mesh-list
43909028|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43909029|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909030|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
43909031|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
43909032|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
43909033|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909034|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909035|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909036|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909037|NCT00318136|Growth Substances|growth substances|mesh-ancestor
43909076|NCT00318708|Xhance|xhance|mesh-list
43909082|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909083|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43909084|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
43909085|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909086|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43909087|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909088|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909089|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43657879|NCT02949843|Nivolumab|nivolumab|mesh-list
43667955|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43667956|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43667957|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667958|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43826667|NCT05495750|Bupivacaine|bupivacaine|mesh-list
43826668|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
43826669|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
43826670|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826671|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826672|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
43909090|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909091|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909144|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43909146|NCT00320749|Capecitabine|capecitabine|mesh-list
43909147|NCT00320749|Docetaxel|docetaxel|mesh-list
43909148|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909149|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
43909150|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909151|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909152|NCT00320749|Antiviral Agents|antiviral agents|mesh-ancestor
43909153|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909154|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909155|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909156|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
43909157|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909158|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
43909159|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
43909160|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43909161|NCT00321594|Belinostat|belinostat|mesh-list
43909204|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
43909205|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
43909206|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909207|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909208|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909209|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43909210|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909211|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909212|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43909213|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43909214|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43909215|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
43909216|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43909217|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909218|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
43909219|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43909220|NCT00322335|PENTA|penta|mesh-list
43909221|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
43909222|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43909223|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43909225|NCT00322439|Etanercept|etanercept|mesh-list
43909257|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909258|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
43909259|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909260|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43826673|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909261|NCT00323739|Bevacizumab|bevacizumab|mesh-list
43826675|NCT05495620|Lenalidomide|lenalidomide|mesh-list
43826676|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909262|NCT00323739|Everolimus|everolimus|mesh-list
43909263|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909264|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909265|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909266|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909267|NCT00323739|Growth Substances|growth substances|mesh-ancestor
43909268|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909269|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909270|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826678|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
43909271|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
43909272|NCT00324259|Estradiol|estradiol|mesh-list
43909273|NCT00324259|Estrogens|estrogens|mesh-ancestor
43909274|NCT00324259|Hormones|hormones|mesh-ancestor
43909275|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909276|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909277|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
43909278|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
43909279|NCT00324272|Coagulants|coagulants|mesh-ancestor
43909310|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909311|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909312|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
43909313|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43909314|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909315|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909316|NCT00324896|Eszopiclone|eszopiclone|mesh-list
43909317|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43909318|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909319|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909321|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
43909322|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909323|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909324|NCT00325403|Treprostinil|treprostinil|mesh-list
43909325|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43909326|NCT00325442|Treprostinil|treprostinil|mesh-list
43909327|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43909328|NCT00325780|Pitavastatin|pitavastatin|mesh-list
43909329|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43909330|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43909331|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43909332|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
43909334|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909363|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909365|NCT00326872|Maleic acid|maleic acid|mesh-list
43909366|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909367|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909368|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909369|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138773|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
44138774|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138775|NCT00171782|Diuretics|diuretics|mesh-ancestor
44138776|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
44138777|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138778|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
44138779|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138780|NCT00171795|Rivastigmine|rivastigmine|mesh-list
44138781|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
44138789|NCT00171808|Letrozole|letrozole|mesh-list
43909400|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
43909401|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909402|NCT00328770|Sirolimus|sirolimus|mesh-list
43909403|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826679|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826680|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826681|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909404|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909405|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909406|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909466|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43909467|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43909468|NCT00330733|Analgesics|analgesics|mesh-ancestor
43909469|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
43909470|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909471|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909472|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909473|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43909474|NCT00330863|Olanzapine|olanzapine|mesh-list
43909475|NCT00330863|Risperidone|risperidone|mesh-list
43909476|NCT00330863|Aripiprazole|aripiprazole|mesh-list
43909477|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43909478|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43909479|NCT00330863|Ziprasidone|ziprasidone|mesh-list
43909480|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909481|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
43909482|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909483|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826682|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
43826683|NCT05495620|Hormones|hormones|mesh-ancestor
43826684|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909484|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909485|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43909486|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43909487|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909488|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43909489|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909490|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
43909491|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
43909515|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909517|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43909518|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
43909519|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43909520|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
43909521|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909522|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909523|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909524|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909525|NCT00332163|Irinotecan|irinotecan|mesh-list
43909526|NCT00332163|Panitumumab|panitumumab|mesh-list
43909527|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43909528|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43909529|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909530|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909572|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
43909573|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43909574|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909575|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43909576|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
43909577|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909578|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909579|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909580|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909581|NCT00333814|Dexamethasone|dexamethasone|mesh-list
43909582|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
43909583|NCT00333814|BB 1101|bb 1101|mesh-list
43909584|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909585|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
43909586|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
43909587|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43909588|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909589|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909590|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
43909591|NCT00333814|Hormones|hormones|mesh-ancestor
43909592|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43909593|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43909594|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909595|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
43909596|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909597|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909599|NCT00334074|Clofarabine|clofarabine|mesh-list
43909600|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909601|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
43909602|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909603|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909604|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
43909605|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909606|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909607|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
43909608|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909610|NCT00334633|Tinidazole|tinidazole|mesh-list
43909611|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909612|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909613|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43909614|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43909615|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
43909616|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909617|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43909618|NCT00335283|Lansoprazole|lansoprazole|mesh-list
43909619|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
43909620|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43826685|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826686|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909621|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43909622|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43909623|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909624|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909625|NCT00335478|Daptomycin|daptomycin|mesh-list
43909626|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43909627|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909628|NCT00335504|Sulindac|sulindac|mesh-list
43909629|NCT00335504|Atorvastatin|atorvastatin|mesh-list
43909630|NCT00335504|Calcium|calcium|mesh-list
43909631|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43909632|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909662|NCT00336232|Coagulants|coagulants|mesh-ancestor
43909663|NCT00336323|Bevacizumab|bevacizumab|mesh-list
43909664|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909665|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909666|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43909667|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43909668|NCT00336323|Growth Substances|growth substances|mesh-ancestor
43909669|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909670|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
43909671|NCT00336700|Gemcitabine|gemcitabine|mesh-list
43909672|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43909673|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909674|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
43909675|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909676|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909722|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43909723|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909724|NCT00338039|Gemcitabine|gemcitabine|mesh-list
43909725|NCT00338039|Capecitabine|capecitabine|mesh-list
43909726|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
43909727|NCT00338039|Cetuximab|cetuximab|mesh-list
43909728|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43909729|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
43909730|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909731|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909732|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
43909786|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43909787|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909789|NCT00342355|Lopinavir|lopinavir|mesh-list
43909790|NCT00342355|Lamivudine|lamivudine|mesh-list
43909791|NCT00342355|Zidovudine|zidovudine|mesh-list
43909792|NCT00342355|Didanosine|didanosine|mesh-list
43909793|NCT00342355|Stavudine|stavudine|mesh-list
43909794|NCT00342355|Efavirenz|efavirenz|mesh-list
43909795|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43909796|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43909797|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
43909798|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43909799|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909800|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43909801|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43909802|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
43909803|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43909804|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43909805|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43909806|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43909807|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43909808|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
43909809|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43909810|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43909837|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909838|NCT00343083|Paclitaxel|paclitaxel|mesh-list
43909839|NCT00343083|Carboplatin|carboplatin|mesh-list
43909840|NCT00343083|Cetuximab|cetuximab|mesh-list
43909841|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43909842|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43909843|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
43909844|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
43909845|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
43909846|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909847|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43909848|NCT00343460|Dexamethasone|dexamethasone|mesh-list
43909849|NCT00343460|Palonosetron|palonosetron|mesh-list
43826687|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
43826688|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43826689|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826690|NCT05495620|Growth Substances|growth substances|mesh-ancestor
43826691|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667959|NCT04351737|Dexamethasone|dexamethasone|mesh-list
43667960|NCT04351737|Prednisolone|prednisolone|mesh-list
43909850|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43909899|NCT00343863|Palonosetron|palonosetron|mesh-list
43909900|NCT00343863|Antiemetics|antiemetics|mesh-list
43909901|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43909902|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
43909903|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909969|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43909970|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43909971|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43909972|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43909973|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
43909974|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43909975|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43909976|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43909977|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43909979|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
43909980|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43909981|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909982|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
43909983|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43909984|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43909985|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43909986|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43909996|NCT00345865|Cytarabine|cytarabine|mesh-list
43910025|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910026|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910027|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
43910028|NCT00349336|Bevacizumab|bevacizumab|mesh-list
43910029|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910030|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910031|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910093|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910094|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910095|NCT00350532|Clonidine|clonidine|mesh-list
43910096|NCT00350532|Analgesics|analgesics|mesh-ancestor
43910097|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
43910098|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910099|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910100|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43910101|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
43910102|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
43910103|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43910104|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43910105|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43910106|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
43910107|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910108|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910109|NCT00351000|Ziprasidone|ziprasidone|mesh-list
43910110|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43910111|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
43910112|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910146|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43910147|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
43910148|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910149|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910150|NCT00351416|Letrozole|letrozole|mesh-list
43910151|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43910152|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
43910153|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910154|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43910156|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667961|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43667962|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
43667963|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43667964|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
43667965|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43667966|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
43667967|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910157|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43910158|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
43910159|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910160|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910161|NCT00351936|Aripiprazole|aripiprazole|mesh-list
43910162|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
43910163|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910164|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43910165|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43849689|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910166|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910199|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910200|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910201|NCT00352781|Nicotine|nicotine|mesh-list
43910202|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43910203|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
43910204|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910205|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910206|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43910207|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43910208|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
43910209|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910210|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910211|NCT00352794|Prednisone|prednisone|mesh-list
43910212|NCT00352794|Lenalidomide|lenalidomide|mesh-list
43910213|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910214|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
43910215|NCT00352794|Hormones|hormones|mesh-ancestor
43910216|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910217|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910218|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43910219|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910220|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
43849690|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849691|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
43849692|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849693|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
43910221|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910222|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910223|NCT00352794|Growth Substances|growth substances|mesh-ancestor
43910225|NCT00352911|Mifepristone|mifepristone|mesh-list
43910226|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43910227|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
43910228|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43910229|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910230|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43910231|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43910232|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43910233|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
43910238|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
43910239|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43910240|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43910241|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
43910242|NCT00352976|Sirolimus|sirolimus|mesh-list
43910243|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
43910244|NCT00352976|Fludarabine|fludarabine|mesh-list
43910245|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910246|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
43910247|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910248|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910249|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910250|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
43910251|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910252|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910253|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910254|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910292|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
43910293|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43910294|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910295|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
43910296|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43910297|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43910298|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
43910299|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910300|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43910301|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
43910302|NCT00353652|Spironolactone|spironolactone|mesh-list
43910303|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43910304|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849694|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43910305|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910306|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910307|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43910350|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
43910351|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43910352|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
43910353|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43910354|NCT00354770|Expectorants|expectorants|mesh-ancestor
43910355|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
43910356|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43910357|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
43910419|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910420|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910421|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910422|NCT00356031|Growth Substances|growth substances|mesh-ancestor
43910423|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910424|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910425|NCT00356993|Nicotine|nicotine|mesh-list
43910426|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43910427|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
43910428|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910429|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910430|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43910431|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43910432|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
43910433|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667968|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
43667969|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
43910434|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910435|NCT00357032|Belinostat|belinostat|mesh-list
43910436|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910440|NCT00357162|Belinostat|belinostat|mesh-list
43910476|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
43910477|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910478|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910479|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43910480|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43910481|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
43910482|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910483|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43910484|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
43910485|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
43910486|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
43910487|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43910488|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
43910489|NCT00358579|Coagulants|coagulants|mesh-ancestor
43910490|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43910491|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
43910492|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
43910493|NCT00358657|Sirolimus|sirolimus|mesh-list
43910494|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
43910495|NCT00358657|Fludarabine|fludarabine|mesh-list
43910496|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
43910497|NCT00358657|Tacrolimus|tacrolimus|mesh-list
43910498|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910499|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
43910500|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910501|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910502|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910503|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
43910504|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910505|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910523|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
43910524|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43910525|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43910526|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910527|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910528|NCT00359736|Urological Agents|urological agents|mesh-ancestor
43910529|NCT00360126|Lamotrigine|lamotrigine|mesh-list
43910530|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
43910531|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43910532|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43910533|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910534|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43910535|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910536|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43910537|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43910538|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910539|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910540|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43910542|NCT00360360|Bevacizumab|bevacizumab|mesh-list
43910543|NCT00360360|Carboplatin|carboplatin|mesh-list
43910544|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43910574|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
43910575|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
43910576|NCT00360672|Lenalidomide|lenalidomide|mesh-list
43910577|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
43910578|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910579|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910580|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910581|NCT00360672|Growth Substances|growth substances|mesh-ancestor
43910582|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910583|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910584|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
43910585|NCT00360685|Methotrexate|methotrexate|mesh-list
43910587|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43910588|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
43910589|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43910590|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910591|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910593|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910594|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910595|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
43910596|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910597|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43910598|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910623|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43910624|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910625|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910626|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910627|NCT00360971|Cisplatin|cisplatin|mesh-list
43910628|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910629|NCT00361140|Fludarabine|fludarabine|mesh-list
43910630|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
43910631|NCT00361140|Busulfan|busulfan|mesh-list
43910632|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910633|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910634|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
43910635|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910637|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
43910638|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910639|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
43910684|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
43910685|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910686|NCT00363077|Vaccines|vaccines|mesh-list
43910687|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
43910688|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910689|NCT00363168|Ranibizumab|ranibizumab|mesh-list
43910690|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910691|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910696|NCT00363779|Cyclosporine|cyclosporine|mesh-list
43910749|NCT00365209|Analgesics|analgesics|mesh-ancestor
43910750|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
43910751|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910752|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910753|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43910754|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910755|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849695|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910756|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910757|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910758|NCT00365261|Eszopiclone|eszopiclone|mesh-list
43910759|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43910760|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910761|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910762|NCT00365274|Prednisone|prednisone|mesh-list
43910763|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
43910764|NCT00365274|Doxorubicin|doxorubicin|mesh-list
43910765|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43910766|NCT00365274|Vincristine|vincristine|mesh-list
43910804|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910805|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910806|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910807|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
43910808|NCT00365417|Bevacizumab|bevacizumab|mesh-list
43910809|NCT00365417|Docetaxel|docetaxel|mesh-list
43910810|NCT00365417|Doxorubicin|doxorubicin|mesh-list
43910811|NCT00365417|Capecitabine|capecitabine|mesh-list
43910812|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43910813|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
43910814|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910815|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43910816|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43910817|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
43910818|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910819|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910820|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43910821|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43910822|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910823|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910824|NCT00365417|Growth Substances|growth substances|mesh-ancestor
43910825|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910826|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
43910827|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
43910828|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
43910829|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43910830|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43910831|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43667970|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43910832|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667971|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667972|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43667973|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
43667974|NCT04351737|Hormones|hormones|mesh-ancestor
43667975|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667976|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667977|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667978|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43667979|NCT04351737|Protective Agents|protective agents|mesh-ancestor
43667980|NCT04347915|Clevudine|clevudine|mesh-list
43667981|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
43910833|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910834|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
43910835|NCT00365599|Tamoxifen|tamoxifen|mesh-list
43910836|NCT00365599|Vorinostat|vorinostat|mesh-list
43910837|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910838|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43910839|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
43910842|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43910843|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910844|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43667982|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667983|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
43667984|NCT04347798|Chloroquine|chloroquine|mesh-list
43667985|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
43667986|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43667987|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43667988|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43667989|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667990|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667991|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667992|NCT04347798|Amebicides|amebicides|mesh-ancestor
43667993|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
43910845|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43910846|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43910847|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43910848|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910849|NCT00365859|Aripiprazole|aripiprazole|mesh-list
43910850|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
43910851|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43910852|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43910853|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43910854|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43910855|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910870|NCT00366106|Bortezomib|bortezomib|mesh-list
43910900|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910901|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910902|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910903|NCT00367601|Growth Substances|growth substances|mesh-ancestor
43910904|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910905|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910906|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910907|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910908|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910909|NCT00368290|Modafinil|modafinil|mesh-list
43910910|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43910911|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910912|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43667996|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
43667997|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43667998|NCT04326673|Androgens|androgens|mesh-ancestor
43667999|NCT04326673|Hormones|hormones|mesh-ancestor
43668000|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43910913|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43910914|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43910916|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
44138808|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
44138809|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
44138810|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138811|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138812|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
44138813|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
44138814|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44138815|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138816|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
43668001|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138817|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138818|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138819|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138820|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138821|NCT00171886|Octreotide|octreotide|mesh-list
44138822|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44138823|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44138824|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138825|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
44138826|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138827|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44138828|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668002|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668003|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668004|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
43668005|NCT04307953|Saracatinib|saracatinib|mesh-list
43668006|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668007|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668008|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138829|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138830|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
44138831|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138855|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43910944|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910945|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43910946|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43910947|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910948|NCT00369590|Aflibercept|aflibercept|mesh-list
43910949|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
43910950|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43910951|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43910952|NCT00369590|Growth Substances|growth substances|mesh-ancestor
43910953|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43910954|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
43910955|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43910956|NCT00369746|Citalopram|citalopram|mesh-list
43910957|NCT00369746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43910958|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43910959|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43910960|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43910961|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43910962|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
43910963|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668009|NCT04297267|Gemcitabine|gemcitabine|mesh-list
43668010|NCT04297267|Cisplatin|cisplatin|mesh-list
43668011|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668012|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43910992|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43910993|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43910994|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43910995|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
43910996|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
43910997|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43910998|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
43910999|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
43911000|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43911001|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43911002|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911003|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911004|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911005|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911007|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
43911008|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911009|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911010|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43911011|NCT05287256|Analgesics|analgesics|mesh-ancestor
43911012|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
43911013|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911014|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43911015|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43911016|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911017|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911018|NCT05287256|Hormones|hormones|mesh-ancestor
43911019|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911020|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
43911021|NCT05287191|Digoxin|digoxin|mesh-list
43911035|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
43911036|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911037|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43911038|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911039|NCT05287191|Protective Agents|protective agents|mesh-ancestor
43911040|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
43911041|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43911042|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43911043|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43911044|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43911045|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43911046|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43911047|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43911049|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
43911050|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
43911051|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911052|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911053|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43911089|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911090|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43911091|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43911092|NCT05286268|Plasminogen|plasminogen|mesh-list
43911093|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43911094|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43911095|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911096|NCT05286008|Dexamethasone|dexamethasone|mesh-list
43911097|NCT05286008|Ropivacaine|ropivacaine|mesh-list
43911098|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911099|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
43911100|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
43911101|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911102|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911103|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911104|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
43911105|NCT05286008|Hormones|hormones|mesh-ancestor
43911106|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911107|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911108|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911109|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
43911110|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
43911111|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911112|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
43911113|NCT05285943|Betamethasone|betamethasone|mesh-list
43911114|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
43911115|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43911116|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
43911117|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43911118|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911119|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
43911120|NCT05285943|Hormones|hormones|mesh-ancestor
43668013|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
43668014|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668015|NCT04297267|Antiviral Agents|antiviral agents|mesh-ancestor
43911121|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911131|NCT05250050|Levofloxacin|levofloxacin|mesh-list
43911132|NCT05250050|Tetracycline|tetracycline|mesh-list
43911133|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
43911134|NCT05250050|Esomeprazole|esomeprazole|mesh-list
43911135|NCT05250050|Bismuth|bismuth|mesh-list
43911136|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911137|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911138|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911139|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43911140|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43911141|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43911142|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911143|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43911144|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911145|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43911146|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43911147|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43911148|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43911149|NCT05250050|Renal Agents|renal agents|mesh-ancestor
43911150|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911151|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911152|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911153|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43911154|NCT05250050|Antacids|antacids|mesh-ancestor
43911155|NCT05250050|Diuretics|diuretics|mesh-ancestor
43911156|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
43911157|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668016|NCT04297267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911158|NCT05250050|Expectorants|expectorants|mesh-ancestor
43668017|NCT04297267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668018|NCT04297267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668019|NCT04297267|Immunologic Factors|immunologic factors|mesh-ancestor
43668020|NCT04297267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668021|NCT04283513|Ribavirin|ribavirin|mesh-list
43668022|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
43668023|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668024|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
43911159|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
43911160|NCT05220462|Midazolam|midazolam|mesh-list
44138858|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138859|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138860|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
44138861|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138862|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138863|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
44138864|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44138865|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138867|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
44138868|NCT00172068|Calcium|calcium|mesh-list
44138869|NCT00172068|Vitamins|vitamins|mesh-ancestor
43659536|NCT02937896|Ketorolac|ketorolac|mesh-list
43911175|NCT05189756|Aprepitant|aprepitant|mesh-list
43911176|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
43911177|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
43911178|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
43911179|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911180|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911181|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911182|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43911183|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911184|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911239|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
43911240|NCT05075330|Narcotics|narcotics|mesh-ancestor
43911241|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911242|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911243|NCT05075330|Analgesics|analgesics|mesh-ancestor
43911244|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
43911245|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911246|NCT05069038|Palbociclib|palbociclib|mesh-list
43911247|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911248|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911249|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911250|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911251|NCT04976283|Pioglitazone|pioglitazone|mesh-list
43911252|NCT04976283|Empagliflozin|empagliflozin|mesh-list
43911253|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43911254|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911255|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43911256|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911258|NCT04971187|Carboplatin|carboplatin|mesh-list
43911259|NCT04971187|Pemetrexed|pemetrexed|mesh-list
43911260|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911261|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911262|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911263|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43911264|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43911265|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
43911266|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
43911267|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911268|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911269|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43911270|NCT04901975|Spironolactone|spironolactone|mesh-list
43911272|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
43911281|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911282|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911283|NCT04899388|Analgesics|analgesics|mesh-ancestor
43911284|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
43911285|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911286|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43911287|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43911288|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
43911289|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
43849696|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43849697|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911291|NCT04892186|Metformin|metformin|mesh-list
43911292|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43911293|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911294|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
43911295|NCT04892186|Vitamins|vitamins|mesh-ancestor
43911296|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
43911297|NCT04884763|Erenumab|erenumab|mesh-list
43911298|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43911299|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911300|NCT04884763|Analgesics|analgesics|mesh-ancestor
43911301|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
43911302|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911303|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911304|NCT04802590|Venetoclax|venetoclax|mesh-list
43911305|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911306|NCT04681443|Phenol|phenol|mesh-list
43911307|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43911308|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911309|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
43911310|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43911311|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43911312|NCT04600141|Heparin|heparin|mesh-list
44164825|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44164826|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
44164827|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
44164828|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44164829|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
44164830|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164831|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164832|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164833|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
44164834|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44164835|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
44164836|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
43911314|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
43911315|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43911316|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43911317|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911318|NCT04517799|Cannabidiol|cannabidiol|mesh-list
43911319|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
43911320|NCT04504318|Enoxaparin|enoxaparin|mesh-list
43911321|NCT04504318|Apixaban|apixaban|mesh-list
43911322|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
43911323|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43911324|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43911325|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911326|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43911327|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
43911328|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43911329|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
43911330|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911331|NCT04417179|Bupivacaine|bupivacaine|mesh-list
43911332|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
43911333|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
43911334|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911335|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911336|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
43911337|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138913|NCT00172809|Interferons|interferons|mesh-list
44138914|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
44138915|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
44138916|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43668025|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164837|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
44164838|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164839|NCT00257972|Aripiprazole|aripiprazole|mesh-list
44164841|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164842|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44164843|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44164844|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44164845|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164846|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
44164847|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
44164848|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44164849|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164850|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
44164851|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
44164852|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
44164853|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
44164870|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
44164871|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138917|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138918|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
44138919|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790627|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44138920|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
44138921|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138923|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44138924|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138925|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138926|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44138927|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138928|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
44138929|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
44138930|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44138931|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
44138932|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
44138933|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
44138934|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
44138935|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44138936|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138937|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
44138938|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44138939|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138940|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43790632|NCT02464878|Etanercept|etanercept|mesh-list
44164872|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164873|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164874|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44164875|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164876|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
44164877|NCT00258063|Norelgestromin|norelgestromin|mesh-list
44164878|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
44164879|NCT00258063|Estradiol|estradiol|mesh-list
44164880|NCT00258063|Estrogens|estrogens|mesh-ancestor
44164881|NCT00258063|Hormones|hormones|mesh-ancestor
44164882|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44164883|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164884|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
44164885|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164886|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
44164887|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
44164888|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
44164889|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
43668026|NCT04249596|Tianeptine|tianeptine|mesh-list
43668027|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43668028|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
43668029|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44164890|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
44164891|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164892|NCT00258089|Levofloxacin|levofloxacin|mesh-list
44138941|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44138942|NCT00173862|Gemcitabine|gemcitabine|mesh-list
44138943|NCT00173862|Ifosfamide|ifosfamide|mesh-list
44138944|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44138945|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
44138946|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44138947|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138948|NCT00173862|Antiviral Agents|antiviral agents|mesh-ancestor
44138949|NCT00173862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44138950|NCT00173862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44138951|NCT00173862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44138952|NCT00173862|Immunologic Factors|immunologic factors|mesh-ancestor
44138953|NCT00173862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44138954|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
44138955|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
44138956|NCT00173875|Gefitinib|gefitinib|mesh-list
44138957|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44138958|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911356|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911358|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
43911359|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43911360|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43911361|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43911362|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43911363|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
43911420|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43911421|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43849699|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43849700|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849701|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
43849702|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849703|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849704|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
43849705|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43911422|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43911423|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911424|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43911425|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
43911426|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
43911427|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
43911428|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
43911429|NCT03983226|Gemcitabine|gemcitabine|mesh-list
43911430|NCT03983226|Cisplatin|cisplatin|mesh-list
43911431|NCT03983226|Carboplatin|carboplatin|mesh-list
43911432|NCT03983226|Doxorubicin|doxorubicin|mesh-list
43911433|NCT03983226|Niraparib|niraparib|mesh-list
43911435|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911436|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911437|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
43911438|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911439|NCT03983226|Antiviral Agents|antiviral agents|mesh-ancestor
43911440|NCT03983226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668030|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
43668031|NCT04227275|Fludarabine|fludarabine|mesh-list
43668032|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43849706|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43911441|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911442|NCT03983226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911443|NCT03983226|Immunologic Factors|immunologic factors|mesh-ancestor
43911444|NCT03983226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911445|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43911446|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911447|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911448|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43911449|NCT03948347|Liraglutide|liraglutide|mesh-list
43911450|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43911451|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911452|NCT03948347|Incretins|incretins|mesh-ancestor
43911453|NCT03948347|Hormones|hormones|mesh-ancestor
43911454|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911455|NCT03924401|Abatacept|abatacept|mesh-list
43911456|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
44164893|NCT00258089|Ofloxacin|ofloxacin|mesh-list
43668033|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668034|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
43668035|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668036|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164894|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43668037|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668038|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
43668039|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668040|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668041|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668042|NCT04224571|Rituximab|rituximab|mesh-list
43668043|NCT04224571|Bortezomib|bortezomib|mesh-list
43668044|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44164895|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164896|NCT00258089|Renal Agents|renal agents|mesh-ancestor
44164897|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164898|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911457|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911458|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911459|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911460|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
43911461|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911462|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911463|NCT03873805|Vidarabine|vidarabine|mesh-list
43911464|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
43911465|NCT03873805|Fludarabine|fludarabine|mesh-list
43911466|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
43911467|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911468|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
43911469|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911470|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911471|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43911472|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
43911473|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911474|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911475|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911476|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911477|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
43911478|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
43911479|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911480|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
43911481|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911482|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911483|NCT03859024|Acetaminophen|acetaminophen|mesh-list
43911484|NCT03859024|Dexamethasone|dexamethasone|mesh-list
43911485|NCT03859024|Ibuprofen|ibuprofen|mesh-list
43911486|NCT03859024|Celecoxib|celecoxib|mesh-list
43911487|NCT03859024|Oxycodone|oxycodone|mesh-list
43911488|NCT03859024|Gabapentin|gabapentin|mesh-list
43911489|NCT03859024|Bupivacaine|bupivacaine|mesh-list
43911490|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911491|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
43911492|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
43911493|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911494|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911496|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
43911497|NCT03859024|Hormones|hormones|mesh-ancestor
43911498|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911499|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911500|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911501|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
43911502|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
43911503|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911504|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
43911505|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43911506|NCT03859024|Analgesics|analgesics|mesh-ancestor
43911507|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
43911508|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43911509|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911510|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43911511|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911512|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790789|NCT05130398|Vaccines|vaccines|mesh-list
44164899|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164900|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164901|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164902|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164903|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
44164904|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44164905|NCT00258102|Levofloxacin|levofloxacin|mesh-list
44164906|NCT00258102|Ofloxacin|ofloxacin|mesh-list
44164907|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
44164908|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164909|NCT00258102|Renal Agents|renal agents|mesh-ancestor
44164910|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164911|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
44164912|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164913|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668045|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668046|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
44164933|NCT00258232|Capecitabine|capecitabine|mesh-list
44164934|NCT00258232|Irinotecan|irinotecan|mesh-list
44164935|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44164936|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
44164937|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164938|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44164939|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
44164940|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
44164941|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44164942|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44164943|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44164944|NCT00258232|Analgesics|analgesics|mesh-ancestor
44164945|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
44164946|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44164947|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164948|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164949|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44164950|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
44164951|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44164952|NCT00258245|Aspirin|aspirin|mesh-list
44164953|NCT00258245|Vitamins|vitamins|mesh-list
44164954|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
44164955|NCT00258245|Thalidomide|thalidomide|mesh-list
44164956|NCT00258245|Dexamethasone|dexamethasone|mesh-list
44164957|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
44173268|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911513|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43911514|NCT03859024|Narcotics|narcotics|mesh-ancestor
43849707|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849708|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
43849709|NCT03897621|Coagulants|coagulants|mesh-ancestor
43849710|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43849711|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43849712|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
43849713|NCT03897309|Vaccines|vaccines|mesh-list
43849714|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
43849715|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849716|NCT03896737|Thalidomide|thalidomide|mesh-list
43849717|NCT03896737|Dexamethasone|dexamethasone|mesh-list
43849718|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
43849719|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
43849720|NCT03896737|Bortezomib|bortezomib|mesh-list
43849721|NCT03896737|Daratumumab|daratumumab|mesh-list
43849722|NCT03896737|BB 1101|bb 1101|mesh-list
43849723|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849724|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
43849725|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849726|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849727|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43849728|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
43911515|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43911516|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
43911517|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43911518|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43911519|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911520|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43911521|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43911522|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911523|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
43911524|NCT03809000|Leuprolide|leuprolide|mesh-list
43911525|NCT03809000|Goserelin|goserelin|mesh-list
43911526|NCT03809000|Bicalutamide|bicalutamide|mesh-list
43911527|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911528|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911529|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43911530|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
43911531|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911532|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911533|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911534|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
43911535|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668047|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668048|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668049|NCT04185051|Aticaprant|aticaprant|mesh-list
43849729|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849730|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849731|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911536|NCT03729869|Progesterone|progesterone|mesh-list
43911537|NCT03729869|Progestins|progestins|mesh-ancestor
43911538|NCT03729869|Hormones|hormones|mesh-ancestor
43911539|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911540|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911541|NCT03675412|Caffeine|caffeine|mesh-list
43911542|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43911543|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911557|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911558|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
43911559|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911560|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43911561|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43911562|NCT03561584|Analgesics|analgesics|mesh-ancestor
43668050|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43668051|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668052|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
43911563|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
44157334|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
43911564|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911565|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911567|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911568|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911569|NCT03554083|Atezolizumab|atezolizumab|mesh-list
43911570|NCT03554083|Vemurafenib|vemurafenib|mesh-list
43911571|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43911572|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911573|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
43911574|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911575|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911576|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911577|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44164958|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
44164959|NCT00258245|Bortezomib|bortezomib|mesh-list
44164960|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
44164961|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
44164962|NCT00258245|BB 1101|bb 1101|mesh-list
44164963|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
44164964|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44164965|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44164966|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
44164984|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44164985|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44164986|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44164988|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
44164989|NCT00258245|Protective Agents|protective agents|mesh-ancestor
44164990|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44164991|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
44164992|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
44164993|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44164994|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44164995|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
44164996|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
44164997|NCT00258245|Growth Substances|growth substances|mesh-ancestor
44164998|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
43668053|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668054|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
44165000|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
44165001|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165002|NCT00258271|Cytarabine|cytarabine|mesh-list
44165003|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
44165004|NCT00258271|Cladribine|cladribine|mesh-list
44165005|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165006|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
44165007|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165008|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165009|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
43636347|NCT04981158|Anesthetics|anesthetics|mesh-list
43911579|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911580|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911584|NCT03284723|Letrozole|letrozole|mesh-list
43911585|NCT03284723|Palbociclib|palbociclib|mesh-list
43911586|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911587|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43911588|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43911589|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911590|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911591|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43911592|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43911593|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911594|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911595|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911596|NCT03130127|Terlipressin|terlipressin|mesh-list
43911597|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43911598|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43911599|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
43911600|NCT03127774|Cisplatin|cisplatin|mesh-list
43911601|NCT03127774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911602|NCT03127774|Antidotes|antidotes|mesh-ancestor
43911603|NCT03127774|Protective Agents|protective agents|mesh-ancestor
43911604|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911605|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
44165010|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165011|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165012|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
44165013|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165014|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165015|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165016|NCT00258284|Docetaxel|docetaxel|mesh-list
44165017|NCT00258284|Capecitabine|capecitabine|mesh-list
44165018|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165019|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165020|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165021|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165022|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165023|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165024|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
44165036|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165037|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
44165038|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165040|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
44165041|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
44165042|NCT00258336|Antibodies|antibodies|mesh-list
44165043|NCT00258336|Sargramostim|sargramostim|mesh-list
43911606|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911607|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
43911608|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911609|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911610|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
43911611|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
43911612|NCT03127267|Riluzole|riluzole|mesh-list
43911613|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
43911614|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43911615|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43911616|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43911617|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911618|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911619|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43911620|NCT03127267|Protective Agents|protective agents|mesh-ancestor
43911621|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43911622|NCT03057795|Nivolumab|nivolumab|mesh-list
43911623|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43911624|NCT03057795|Antibodies|antibodies|mesh-list
43911625|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
43911626|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43911627|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
43911628|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
43911629|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911630|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911631|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43911632|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911633|NCT02947685|Trastuzumab|trastuzumab|mesh-list
43911634|NCT02947685|Pertuzumab|pertuzumab|mesh-list
43911635|NCT02947685|Letrozole|letrozole|mesh-list
43911636|NCT02947685|Fulvestrant|fulvestrant|mesh-list
43911637|NCT02947685|Palbociclib|palbociclib|mesh-list
43911638|NCT02947685|Anastrozole|anastrozole|mesh-list
43911639|NCT02947685|Exemestane|exemestane|mesh-list
43911640|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911647|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
43911648|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911649|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911650|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911651|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43911652|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911653|NCT02845882|Cytarabine|cytarabine|mesh-list
43911654|NCT02845882|Dexamethasone|dexamethasone|mesh-list
43911655|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
43911656|NCT02845882|Prednisone|prednisone|mesh-list
43911657|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
43911658|NCT02845882|Ifosfamide|ifosfamide|mesh-list
43911659|NCT02845882|Doxorubicin|doxorubicin|mesh-list
43911660|NCT02845882|Methotrexate|methotrexate|mesh-list
43911661|NCT02845882|Etoposide|etoposide|mesh-list
43911662|NCT02845882|Vincristine|vincristine|mesh-list
43668055|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43668056|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
43911663|NCT02845882|Daunorubicin|daunorubicin|mesh-list
43911664|NCT02845882|Asparaginase|asparaginase|mesh-list
43911665|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
43911666|NCT02845882|Vindesine|vindesine|mesh-list
43911667|NCT02845882|Pegaspargase|pegaspargase|mesh-list
43911668|NCT02845882|BB 1101|bb 1101|mesh-list
43911669|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165045|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165046|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165047|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
44165048|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165049|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165050|NCT00258375|Docetaxel|docetaxel|mesh-list
44165051|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165052|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165053|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165054|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165055|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165056|NCT00258388|Prednisone|prednisone|mesh-list
44165057|NCT00258388|Docetaxel|docetaxel|mesh-list
44165058|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165059|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165060|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165061|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165062|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165063|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165064|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
44165065|NCT00258388|Hormones|hormones|mesh-ancestor
44165066|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165067|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165068|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165069|NCT00258479|Modafinil|modafinil|mesh-list
44165070|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
44165071|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165072|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
44165073|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
44165074|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
44165075|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165076|NCT00258557|Darunavir|darunavir|mesh-list
44165077|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43911671|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911673|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43911674|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
43911675|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911676|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911677|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911678|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43911679|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
43911680|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
43911681|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911682|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43911683|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
43911684|NCT02845882|Hormones|hormones|mesh-ancestor
43911685|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911686|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43911687|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
43911688|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911689|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43911690|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911691|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911692|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43911693|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
43911694|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43911695|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911696|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
43911697|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
44165078|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
44165079|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
44165080|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165081|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165082|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
44165083|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
44165084|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
44165085|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165086|NCT00258596|Sirolimus|sirolimus|mesh-list
44165087|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
44165088|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165117|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165118|NCT00258739|Gemcitabine|gemcitabine|mesh-list
44165119|NCT00258739|Carboplatin|carboplatin|mesh-list
44165121|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165122|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165123|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
44165124|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165125|NCT00258739|Antiviral Agents|antiviral agents|mesh-ancestor
43911698|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43911699|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43911700|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911701|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
43911702|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911703|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911704|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911705|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911706|NCT02662634|Paclitaxel|paclitaxel|mesh-list
43911707|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43911708|NCT02662634|Cisplatin|cisplatin|mesh-list
43911709|NCT02662634|Carboplatin|carboplatin|mesh-list
43911710|NCT02662634|Pemetrexed|pemetrexed|mesh-list
43911711|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911712|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911713|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911714|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911715|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911716|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911717|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911718|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43911719|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43911720|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
43911721|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911722|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911723|NCT02448420|Trastuzumab|trastuzumab|mesh-list
43911724|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43911725|NCT02448420|Palbociclib|palbociclib|mesh-list
43911726|NCT02448420|Antibodies|antibodies|mesh-list
43911727|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
43911728|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
44157335|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157337|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44157338|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
44157339|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
44157340|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
44157341|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44157342|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157343|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157344|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
44157345|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157346|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44157347|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
44157348|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
44157349|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157350|NCT00234234|Adalimumab|adalimumab|mesh-list
44157351|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157352|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157353|NCT00234299|Aspirin|aspirin|mesh-list
44157354|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
44157355|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
44157356|NCT00234299|Analgesics|analgesics|mesh-ancestor
44157357|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
44165126|NCT00258739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165127|NCT00258739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165128|NCT00258739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165129|NCT00258739|Immunologic Factors|immunologic factors|mesh-ancestor
44165130|NCT00258739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165131|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
44165132|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
44165133|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
44165155|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
44165156|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
44165157|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165159|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
44165160|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165161|NCT00259051|Omeprazole|omeprazole|mesh-list
44165162|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44165163|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165164|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44165165|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165166|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165167|NCT00259064|Gefitinib|gefitinib|mesh-list
44165168|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165169|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
44165170|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43637069|NCT04697628|Topotecan|topotecan|mesh-list
44157360|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44157361|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44157362|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
44157363|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
44157364|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157365|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
44157366|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
44157367|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44157368|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
44157369|NCT00234312|Citalopram|citalopram|mesh-list
44157370|NCT00234312|Sertraline|sertraline|mesh-list
44157371|NCT00234312|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
44157372|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
44157373|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44157374|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44157375|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44157376|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
44157377|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165171|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165172|NCT00259077|Omeprazole|omeprazole|mesh-list
44165173|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
44165174|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165175|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
44165176|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165177|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165178|NCT00259116|Methocarbamol|methocarbamol|mesh-list
44165179|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
44165180|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165181|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
44165182|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165183|NCT00259129|Sorafenib|sorafenib|mesh-list
44165184|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165229|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165230|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165232|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668057|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
44165233|NCT00259376|Dronedarone|dronedarone|mesh-list
44165234|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43668059|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668060|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849732|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165235|NCT00259402|Cisplatin|cisplatin|mesh-list
44165236|NCT00259402|Fluorouracil|fluorouracil|mesh-list
44165237|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
44165238|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165239|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
44165240|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165241|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165242|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165243|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
44165244|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165245|NCT00259428|Dronedarone|dronedarone|mesh-list
44165246|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
44157378|NCT00234312|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
44157379|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
43660061|NCT02934035|Analgesics|analgesics|mesh-ancestor
43911744|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43911745|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43668061|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
43911746|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43911747|NCT02405676|Cytarabine|cytarabine|mesh-list
43911748|NCT02405676|Prednisone|prednisone|mesh-list
43911749|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
43911750|NCT02405676|Ifosfamide|ifosfamide|mesh-list
43911751|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
43911752|NCT02405676|Rituximab|rituximab|mesh-list
43911753|NCT02405676|Methotrexate|methotrexate|mesh-list
43911754|NCT02405676|Etoposide|etoposide|mesh-list
43911755|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
43911756|NCT02405676|Vincristine|vincristine|mesh-list
43911757|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911758|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
43911759|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668062|NCT04176393|Ivosidenib|ivosidenib|mesh-list
43668063|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911760|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43911761|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43911762|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
43911764|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911797|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911798|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911799|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911800|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911801|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
43911802|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
43911803|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911804|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911805|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
43911806|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911807|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43911808|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
43911809|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911810|NCT02337634|Silymarin|silymarin|mesh-list
43911811|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
43911812|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911813|NCT02337634|Protective Agents|protective agents|mesh-ancestor
43911814|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911815|NCT02336087|Metformin|metformin|mesh-list
43911816|NCT02336087|Gemcitabine|gemcitabine|mesh-list
43911817|NCT02336087|Paclitaxel|paclitaxel|mesh-list
43911818|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43911819|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911820|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790997|NCT02207465|Paclitaxel|paclitaxel|mesh-list
44165247|NCT00259441|Simvastatin|simvastatin|mesh-list
44165248|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44165249|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44165250|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
44165251|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165252|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43849733|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
44165253|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
44165254|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165255|NCT00259636|Zonisamide|zonisamide|mesh-list
44165256|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
44165257|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
44165258|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
44165259|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165260|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
44165261|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165262|NCT00259662|Atorvastatin|atorvastatin|mesh-list
44165263|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
44165264|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
44165265|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
44165266|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165267|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
44165268|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43911821|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911822|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911823|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911824|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911825|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911826|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
43911827|NCT02336087|Antiviral Agents|antiviral agents|mesh-ancestor
43911828|NCT02336087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911829|NCT02336087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911830|NCT02336087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911831|NCT02336087|Immunologic Factors|immunologic factors|mesh-ancestor
43911832|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911833|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43911834|NCT02335580|Somatostatin|somatostatin|mesh-list
43911835|NCT02335580|Hormones|hormones|mesh-ancestor
43911836|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668064|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911837|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911838|NCT02277782|Fentanyl|fentanyl|mesh-list
43911839|NCT02277782|Hydromorphone|hydromorphone|mesh-list
43911840|NCT02277782|Bupivacaine|bupivacaine|mesh-list
43911841|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43911842|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
43911843|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43911844|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911845|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
43911846|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911847|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43911848|NCT02277782|Narcotics|narcotics|mesh-ancestor
43911849|NCT02277782|Analgesics|analgesics|mesh-ancestor
43911850|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
44165269|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165270|NCT00259675|Gemcitabine|gemcitabine|mesh-list
44165271|NCT00259675|Carboplatin|carboplatin|mesh-list
44165272|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165273|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
44165274|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
44165275|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165276|NCT00259675|Antiviral Agents|antiviral agents|mesh-ancestor
44165277|NCT00259675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
44165278|NCT00259675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
44165279|NCT00259675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
44165280|NCT00259675|Immunologic Factors|immunologic factors|mesh-ancestor
44165281|NCT00259675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165282|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
44165283|NCT00259701|Acetylcholine|acetylcholine|mesh-list
44165284|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
43911851|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43668065|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911852|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
43911854|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
43849734|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
43911855|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
43911856|NCT02271230|Vitamins|vitamins|mesh-list
43911857|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
43911858|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911859|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43911860|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43911861|NCT02048150|Antibodies|antibodies|mesh-list
43911862|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43911863|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
43911864|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911865|NCT01996449|Amlodipine|amlodipine|mesh-list
43911866|NCT01996449|Eplerenone|eplerenone|mesh-list
43911867|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43911868|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43911869|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43911870|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911871|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43911872|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911873|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
43911874|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
44165285|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
44165286|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
44165287|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165288|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165320|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165321|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165322|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
44165323|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165324|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
44165325|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165326|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44165327|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44165328|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
44165329|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
44165330|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44165331|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44165332|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
44165333|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668066|NCT04171050|Anesthetics|anesthetics|mesh-list
43668067|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
43668068|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165334|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165335|NCT00259792|Budesonide|budesonide|mesh-list
44165336|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
44165337|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
44165338|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
44165339|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
44165340|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43911875|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
43911876|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43911877|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43911878|NCT01996449|Diuretics|diuretics|mesh-ancestor
43911879|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
43911880|NCT01958190|Sirolimus|sirolimus|mesh-list
43911881|NCT01958190|Tacrolimus|tacrolimus|mesh-list
43911882|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911883|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
43911884|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911885|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43911886|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911887|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911888|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43911889|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911893|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
43911936|NCT01494662|Trastuzumab|trastuzumab|mesh-list
43911937|NCT01494662|Maytansine|maytansine|mesh-list
43911938|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43911939|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911940|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
43911941|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911942|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911943|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43911944|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911945|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
43911946|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
43911947|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
43911948|NCT01476839|Cytarabine|cytarabine|mesh-list
43911949|NCT01476839|Etoposide|etoposide|mesh-list
43911950|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
43911951|NCT01476839|Melphalan|melphalan|mesh-list
43911952|NCT01476839|Carmustine|carmustine|mesh-list
43911953|NCT01476839|Basiliximab|basiliximab|mesh-list
43911954|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43911955|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911956|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43911957|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43911958|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840868|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
44165341|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165342|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
44165343|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
44165344|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
44165345|NCT00259792|Hormones|hormones|mesh-ancestor
44165346|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
44165347|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43849735|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165348|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
44165349|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
44165350|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
44165351|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
44165352|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
44165353|NCT00259805|Rituximab|rituximab|mesh-list
44165354|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
44165355|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
44165356|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
44165357|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165358|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
44165359|NCT00259870|Olanzapine|olanzapine|mesh-list
44165360|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
44165361|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
44165362|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
44165363|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
44165364|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
44165365|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
44165366|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
44165367|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
44165368|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43911959|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911960|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43911961|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
43911962|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
43911963|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43911964|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43911965|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
43911966|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911967|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43911968|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
43911969|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43911970|NCT01388920|Tesamorelin|tesamorelin|mesh-list
43911971|NCT01388920|Growth Substances|growth substances|mesh-ancestor
43911972|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911973|NCT01164202|Sunitinib|sunitinib|mesh-list
43911974|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43911975|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43911976|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43911977|NCT01164202|Growth Substances|growth substances|mesh-ancestor
43911978|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43911979|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
43911980|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43911981|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43911982|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43911983|NCT01163357|Sirolimus|sirolimus|mesh-list
43911984|NCT01163357|Fludarabine|fludarabine|mesh-list
43911985|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
43911986|NCT01163357|Bortezomib|bortezomib|mesh-list
43911987|NCT01163357|Melphalan|melphalan|mesh-list
43911988|NCT01163357|Tacrolimus|tacrolimus|mesh-list
43911989|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840891|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
43912002|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912003|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
43912004|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912005|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
43912006|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912007|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
43668069|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668070|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
43668071|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668072|NCT04157153|Sirolimus|sirolimus|mesh-list
43849736|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43912008|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912009|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43912010|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912011|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
43912012|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912013|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912014|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43912015|NCT00638898|Melphalan|melphalan|mesh-list
43912016|NCT00638898|Busulfan|busulfan|mesh-list
43912017|NCT00638898|Topotecan|topotecan|mesh-list
43912018|NCT00638898|Lenograstim|lenograstim|mesh-list
43912019|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43912020|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
43912021|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43912022|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43912023|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
43912024|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43912025|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43912026|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668073|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43912027|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43912028|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43912029|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43912030|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912032|NCT00576979|Etoposide|etoposide|mesh-list
43912046|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43912047|NCT00538031|Celecoxib|celecoxib|mesh-list
43912048|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
43779760|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779762|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
43779763|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779764|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43779765|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43779766|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
43779767|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43779768|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43779802|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779805|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779806|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779807|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43779808|NCT04167033|Hormones|hormones|mesh-list
43779809|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43779810|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779811|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43710350|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710430|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43710431|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710432|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710433|NCT01269424|Temozolomide|temozolomide|mesh-list
43710434|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
43710435|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43710436|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
43710437|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710438|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710439|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710440|NCT00715611|Cisplatin|cisplatin|mesh-list
43710441|NCT00715611|Carboplatin|carboplatin|mesh-list
43710442|NCT00715611|Pemetrexed|pemetrexed|mesh-list
43710443|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710444|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710445|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710446|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43710447|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43710448|NCT00382200|Decitabine|decitabine|mesh-list
43710449|NCT00382200|Tretinoin|tretinoin|mesh-list
43779888|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43779889|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779890|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779891|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779892|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43779893|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
43779894|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779895|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43779898|NCT03317223|Lansoprazole|lansoprazole|mesh-list
43779899|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43779900|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43779901|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43779902|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779903|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653239|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43653241|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
43653242|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779904|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43710451|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
43710452|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710453|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710454|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710455|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
43710456|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
43710457|NCT02696928|Lumefantrine|lumefantrine|mesh-list
43710458|NCT02696928|Primaquine|primaquine|mesh-list
43779905|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43779906|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43779907|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43779908|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43779917|NCT02787590|Simvastatin|simvastatin|mesh-list
43779918|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43779919|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43779920|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
43779921|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779922|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43779923|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43779924|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43779926|NCT02659813|Nickel|nickel|mesh-list
43779927|NCT02659813|Trace Elements|trace elements|mesh-ancestor
43779928|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
43779929|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779930|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
43779931|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43779932|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779933|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779934|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43779935|NCT02566863|Analgesics|analgesics|mesh-ancestor
43779936|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
43779937|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43779938|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43779939|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43779940|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43779941|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
43779942|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43779943|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779944|NCT05084456|Docetaxel|docetaxel|mesh-list
43779945|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779946|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
43779947|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
43779948|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
43779949|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43779950|NCT05084365|Sulforaphane|sulforaphane|mesh-list
43668078|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668079|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
43849737|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
43779951|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43779952|NCT05084365|Protective Agents|protective agents|mesh-ancestor
43779953|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43779954|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779955|NCT05084235|Empagliflozin|empagliflozin|mesh-list
43779956|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43710476|NCT02696694|Progestins|progestins|mesh-ancestor
43839250|NCT04787744|Bicalutamide|bicalutamide|mesh-list
43839251|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43839252|NCT04787744|Flutamide|flutamide|mesh-list
43839253|NCT04787744|Nilutamide|nilutamide|mesh-list
43839254|NCT04787744|Relugolix|relugolix|mesh-list
43839255|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839256|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
43839257|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
43839258|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653246|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
43653247|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653248|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653249|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653250|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653251|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
43644228|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43644229|NCT04692077|Tenofovir|tenofovir|mesh-list
43653253|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43653254|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43653255|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43653256|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
43653257|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43653258|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43653259|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
43653260|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653261|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
43653262|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43653263|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43653264|NCT02985372|Cytarabine|cytarabine|mesh-list
43653265|NCT02985372|Decitabine|decitabine|mesh-list
43653266|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43653267|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
43653268|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653269|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839259|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839260|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839261|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
43839262|NCT04787744|Hormones|hormones|mesh-ancestor
43839263|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839264|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839265|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839266|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
43839267|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
43839268|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839269|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839270|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43839271|NCT04787744|Protective Agents|protective agents|mesh-ancestor
43839272|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43839273|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
43849738|NCT03896737|Hormones|hormones|mesh-ancestor
43839274|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43839275|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
43839276|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
43839277|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
43839278|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43839279|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
43839280|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43839281|NCT04787341|Panitumumab|panitumumab|mesh-list
43839282|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839283|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653270|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
43653271|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653272|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653273|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
43653274|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653275|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653276|NCT02985216|Pregabalin|pregabalin|mesh-list
43653277|NCT02985216|Analgesics|analgesics|mesh-ancestor
43653278|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
43644283|NCT04677114|Narcotics|narcotics|mesh-ancestor
43653279|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653280|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653282|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43653283|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653284|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653285|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43653286|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43653287|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653288|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653289|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43653290|NCT02985333|Dexamethasone|dexamethasone|mesh-list
43839284|NCT04786964|Folic Acid|folic acid|mesh-list
43839285|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
43839286|NCT04786964|Hydroxocobalamin|hydroxocobalamin|mesh-list
43839287|NCT04786964|Dexamethasone|dexamethasone|mesh-list
43839288|NCT04786964|Carboplatin|carboplatin|mesh-list
43839289|NCT04786964|Pemetrexed|pemetrexed|mesh-list
43839290|NCT04786964|Vitamins|vitamins|mesh-ancestor
43839291|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
43839292|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839293|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839294|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
43839295|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
43779991|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43779992|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43779993|NCT05083689|Bevacizumab|bevacizumab|mesh-list
43779994|NCT05083689|Timolol|timolol|mesh-list
43779995|NCT05083689|Dorzolamide|dorzolamide|mesh-list
43779996|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
43779997|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43779998|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43779999|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43780000|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43780001|NCT05083689|Growth Substances|growth substances|mesh-ancestor
43780002|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780003|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
43780004|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43780005|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43780006|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780007|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644302|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43780008|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780009|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43780010|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43780011|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43780012|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43780013|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43653293|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653294|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653295|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653296|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653297|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653298|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653299|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653300|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
43653301|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653302|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653303|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43653304|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
43653305|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43653306|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653307|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
43653308|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
43653309|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653310|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653311|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
43780014|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780015|NCT05083455|Enoxaparin|enoxaparin|mesh-list
43780016|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
43780017|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43780018|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
43780021|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668080|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780022|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780023|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
43780024|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43780025|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780060|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43780061|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780062|NCT05083013|Analgesics|analgesics|mesh-ancestor
43780063|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
43780064|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780065|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780066|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780089|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43780090|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43780091|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780092|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780093|NCT05082441|Bupivacaine|bupivacaine|mesh-list
43780094|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
43780104|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43780105|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43780106|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43780107|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
43780108|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780109|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43780110|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43780111|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780112|NCT05049902|Amoxicillin|amoxicillin|mesh-list
43780113|NCT05049902|Metronidazole|metronidazole|mesh-list
43780114|NCT05049902|Clarithromycin|clarithromycin|mesh-list
43780115|NCT05049902|Tetracycline|tetracycline|mesh-list
43780116|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
43780117|NCT05049902|Bismuth|bismuth|mesh-list
43780118|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780119|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43780149|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43780150|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43780151|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780152|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780153|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780155|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43780156|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
43780157|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780158|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43780159|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43780160|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
43780161|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
43780162|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780163|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780164|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780165|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43780169|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780170|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43780171|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43780172|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43780173|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43780174|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
43780175|NCT04941040|Anesthetics|anesthetics|mesh-list
43780176|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780177|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780178|NCT04941040|Narcotics|narcotics|mesh-ancestor
43780179|NCT04941040|Analgesics|analgesics|mesh-ancestor
43780180|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
43780181|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780182|NCT04934410|Midazolam|midazolam|mesh-list
43780183|NCT04934410|Etomidate|etomidate|mesh-list
43780184|NCT04934410|Sevoflurane|sevoflurane|mesh-list
43780192|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780193|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
43780194|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
43780195|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
43780196|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
43780197|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780198|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780199|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43780200|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43780201|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
43780202|NCT04918927|Favipiravir|favipiravir|mesh-list
43780203|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43780204|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780205|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
43780206|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43780207|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43780208|NCT04873297|Metoclopramide|metoclopramide|mesh-list
43780209|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
43780210|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
43780211|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668082|NCT04082650|Vitamins|vitamins|mesh-ancestor
43668083|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
43668084|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668085|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43780212|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780213|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780214|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43780215|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43780216|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
43780232|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43780233|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780234|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780235|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43780236|NCT04858711|Analgesics|analgesics|mesh-ancestor
43780237|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43780238|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43780239|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43780240|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780253|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
43780254|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839303|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839304|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839305|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43839306|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43839308|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
43839309|NCT04786548|Celecoxib|celecoxib|mesh-list
43839310|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848136|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848137|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
43848138|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848139|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43848140|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43848141|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43848142|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848143|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848145|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848146|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848147|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848148|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848149|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
43848150|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848151|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848152|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
43848153|NCT04046263|Hematinics|hematinics|mesh-ancestor
43848154|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
43848155|NCT04046094|Vitamins|vitamins|mesh-ancestor
43848156|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
43848157|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780281|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780282|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780284|NCT05392673|Bilirubin|bilirubin|mesh-list
43780285|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
43780286|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780287|NCT05392673|Protective Agents|protective agents|mesh-ancestor
43780288|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644604|NCT04542733|Tacrolimus|tacrolimus|mesh-list
43780327|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43780328|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780329|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839329|NCT04785274|Chrysarobin|chrysarobin|mesh-list
43780330|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780331|NCT05391724|Brincidofovir|brincidofovir|mesh-list
43780332|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
43780333|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780334|NCT05391451|Anesthetics|anesthetics|mesh-list
43780335|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780336|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780337|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
43780339|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43780340|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43780341|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780342|NCT05386784|Vitamins|vitamins|mesh-ancestor
43780343|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
43780344|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43780345|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43780346|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
43780364|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780366|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43780367|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43780368|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
43780369|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43780370|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780371|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
43780372|NCT05385562|Hormones|hormones|mesh-ancestor
43780373|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780374|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780375|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780376|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
43780377|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780378|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780379|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43780380|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
43780381|NCT05385562|Protective Agents|protective agents|mesh-ancestor
43780382|NCT05385263|Nivolumab|nivolumab|mesh-list
43780383|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780384|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780385|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43780386|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780387|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
43780388|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780429|NCT05318157|Hormones|hormones|mesh-ancestor
43780430|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780432|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
43780433|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
43780434|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780435|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780436|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43839330|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43839331|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43839332|NCT04785274|Analgesics|analgesics|mesh-ancestor
43839333|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
43839334|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839335|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839336|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839337|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839342|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43839343|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839344|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43839345|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839346|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
43839347|NCT04784247|Lenvatinib|lenvatinib|mesh-list
43839348|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839349|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839350|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43839351|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43703527|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839352|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668086|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
43668087|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43668088|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839353|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
43839354|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
43839355|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839356|NCT04783792|Protective Agents|protective agents|mesh-ancestor
43839357|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839358|NCT04783792|Vitamins|vitamins|mesh-ancestor
43839359|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
43839360|NCT04783675|Rituximab|rituximab|mesh-list
43839361|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839362|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839363|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
43839364|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839365|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839366|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
43839367|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839368|NCT04782804|Capecitabine|capecitabine|mesh-list
43839369|NCT04782804|Antibodies|antibodies|mesh-list
43839370|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
43839371|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839372|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43839373|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
43839374|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839375|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839376|NCT04782778|Bupivacaine|bupivacaine|mesh-list
43587124|NCT03397264|Aflibercept|aflibercept|mesh-list
43780437|NCT05275205|Aflibercept|aflibercept|mesh-list
43780438|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43780439|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43780440|NCT05275205|Growth Substances|growth substances|mesh-ancestor
43780441|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780442|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
43780449|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653312|NCT02985333|Hormones|hormones|mesh-ancestor
43653313|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653314|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43653315|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43653316|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
43653317|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43653318|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43653319|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849739|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653320|NCT02985255|Cisplatin|cisplatin|mesh-list
43653321|NCT02985255|Docetaxel|docetaxel|mesh-list
43653322|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653323|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653324|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653325|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653326|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653327|NCT02985203|Vinorelbine|vinorelbine|mesh-list
43653328|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653329|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780451|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780452|NCT05138575|Empagliflozin|empagliflozin|mesh-list
43780453|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43780454|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780455|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43780456|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780457|NCT05046184|Midazolam|midazolam|mesh-list
43780458|NCT05046184|Ketamine|ketamine|mesh-list
43780459|NCT05046184|Analgesics|analgesics|mesh-ancestor
43780460|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
43780461|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780462|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780463|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43780464|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780490|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780491|NCT05005728|Carboplatin|carboplatin|mesh-list
43780493|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780494|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43780495|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780496|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780497|NCT04983095|Hormones|hormones|mesh-list
43780498|NCT04983095|Androgens|androgens|mesh-list
43653331|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653332|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653333|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653334|NCT02985554|Nivolumab|nivolumab|mesh-list
43780499|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
43780500|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780501|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780502|NCT04762316|Pyridoxal|pyridoxal|mesh-list
43780503|NCT04762316|Pyridoxine|pyridoxine|mesh-list
43780504|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
43780505|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
43780506|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
43780507|NCT04762316|Vitamins|vitamins|mesh-ancestor
43780508|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
43780509|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780510|NCT04753957|Progesterone|progesterone|mesh-list
43780511|NCT04753957|Progestins|progestins|mesh-ancestor
43587194|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
43780512|NCT04753957|Hormones|hormones|mesh-ancestor
43839377|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
43703528|NCT02710409|Vaccines|vaccines|mesh-list
43668089|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
43668090|NCT03994705|Fludarabine|fludarabine|mesh-list
43668091|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849740|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43780513|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780514|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780516|NCT04751994|Cathartics|cathartics|mesh-ancestor
43780517|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780518|NCT04738422|Glycine|glycine|mesh-list
43780519|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
43780520|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839393|NCT04779307|Vedolizumab|vedolizumab|mesh-list
43839394|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839395|NCT04778176|Levodopa|levodopa|mesh-list
43839396|NCT04778176|Carbidopa|carbidopa|mesh-list
43839397|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43839398|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43839399|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
43839400|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839401|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839402|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839403|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43839405|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43839406|NCT04776980|Hematinics|hematinics|mesh-ancestor
43839407|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43839408|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43839409|NCT04776369|Lidocaine|lidocaine|mesh-list
43839410|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
43839411|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
43839412|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
43839413|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839414|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839415|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
43839416|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839417|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43839424|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43839425|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43839426|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
43839427|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43839428|NCT04775381|Vitamin D|vitamin d|mesh-list
43839429|NCT04775381|Vitamins|vitamins|mesh-ancestor
43839430|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
43839431|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839432|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43839433|NCT04774991|Azithromycin|azithromycin|mesh-list
43839434|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653346|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780533|NCT04655586|Anticoagulants|anticoagulants|mesh-list
43780534|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43780535|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780536|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780537|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
43780538|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43780539|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780540|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780541|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
43780542|NCT04651166|Coagulants|coagulants|mesh-ancestor
43780543|NCT04572217|Topiramate|topiramate|mesh-list
43780544|NCT04572217|Phentermine|phentermine|mesh-list
43780545|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
43780546|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43780547|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780548|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43780549|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
43780550|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43780551|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
43780552|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
43780553|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780554|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780555|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780556|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780558|NCT04551261|Tenofovir|tenofovir|mesh-list
43780559|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43780560|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43780561|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780562|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780563|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780564|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43780565|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43780566|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
43780567|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780568|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43780569|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43780570|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43780601|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
43780602|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780603|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780604|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43587344|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
43780605|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
43780606|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
43780607|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780608|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780609|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
43780610|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780612|NCT04278092|Cetuximab|cetuximab|mesh-list
43668092|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
43780613|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849741|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
43780614|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780615|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
43780616|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
43780627|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43780628|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
43780629|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
43780630|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780631|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780634|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
43780636|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
43653347|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
43824802|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43824803|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824804|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
43824805|NCT05507983|Coagulants|coagulants|mesh-ancestor
43824806|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
43824807|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43824808|NCT05507957|Ethanol|ethanol|mesh-list
43824809|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
43824810|NCT05507957|Disinfectants|disinfectants|mesh-list
43824811|NCT05507957|Povidone|povidone|mesh-list
43780637|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780638|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43780639|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43780640|NCT04133311|Latanoprost|latanoprost|mesh-list
43780641|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43780642|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43780643|NCT04065113|Ethanol|ethanol|mesh-list
43780644|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43780645|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780646|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780647|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780648|NCT04052776|Levodopa|levodopa|mesh-list
43780649|NCT04052776|Carbidopa|carbidopa|mesh-list
43780650|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43780651|NCT04052776|Buspirone|buspirone|mesh-list
43780652|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43780653|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43780654|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
43780655|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780656|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780657|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780660|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43780661|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43780662|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780663|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43780664|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43780665|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
43780666|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43780667|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
43780668|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
43780669|NCT04035187|Itraconazole|itraconazole|mesh-list
43780670|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
43780671|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43780672|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
43780673|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780674|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43780675|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43780676|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780677|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780678|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43780679|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
43780680|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43587432|NCT03394989|Xhance|xhance|mesh-list
43780701|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43780702|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780704|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43780705|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780706|NCT03867799|Nivolumab|nivolumab|mesh-list
43849742|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780707|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780708|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780709|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43824812|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43824813|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824814|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
43780710|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839435|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839436|NCT04774107|Ribavirin|ribavirin|mesh-list
43839437|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
43839438|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839439|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
43839440|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839441|NCT04772547|Vigabatrin|vigabatrin|mesh-list
43839442|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
43839443|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839446|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839447|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839448|NCT04771767|Ketamine|ketamine|mesh-list
43839449|NCT04771767|Analgesics|analgesics|mesh-ancestor
43839450|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
43839451|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839452|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839453|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43839454|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43839455|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
43839456|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
43839457|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839458|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43839459|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43848181|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848183|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
43848184|NCT04044001|Ethambutol|ethambutol|mesh-list
43848185|NCT04044001|Dolutegravir|dolutegravir|mesh-list
43848186|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
43848187|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43848188|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848189|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848190|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848191|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43780711|NCT03782818|Olaparib|olaparib|mesh-list
43780712|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43780713|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780714|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780715|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780716|NCT03519906|Metoprolol|metoprolol|mesh-list
43780717|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43780718|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43780719|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
43780720|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
43780721|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780722|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780723|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43780724|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43780725|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43780726|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780727|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780728|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780730|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43780731|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43780732|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43780733|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43668093|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668094|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668095|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668096|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
43668097|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780734|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780735|NCT03476811|Analgesics|analgesics|mesh-list
43780736|NCT03476811|Bupivacaine|bupivacaine|mesh-list
43780737|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
43780738|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
43780739|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824816|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824817|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
43824818|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
43780740|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780741|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
43780742|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780743|NCT03464942|Atezolizumab|atezolizumab|mesh-list
43780744|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780745|NCT03410654|Tacrolimus|tacrolimus|mesh-list
43780746|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780747|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
43780748|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780749|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43780750|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780751|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780752|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
43780781|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
43780782|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780783|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780784|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780785|NCT03137966|Deferoxamine|deferoxamine|mesh-list
43780786|NCT03137966|Siderophores|siderophores|mesh-ancestor
43780787|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43780788|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
43780789|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
43780790|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780791|NCT03114865|Dexamethasone|dexamethasone|mesh-list
43780792|NCT03114865|Blinatumomab|blinatumomab|mesh-list
43780793|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43780794|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780795|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
43780796|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
43780797|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43780798|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780799|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43824829|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
43824830|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824831|NCT05507658|Capecitabine|capecitabine|mesh-list
43824832|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
43824833|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824834|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
43824835|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824836|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824837|NCT05507606|Bevacizumab|bevacizumab|mesh-list
43824838|NCT05507606|Carboplatin|carboplatin|mesh-list
43824839|NCT05507606|Pemetrexed|pemetrexed|mesh-list
43824840|NCT05507606|Osimertinib|osimertinib|mesh-list
43824841|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824842|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824843|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43708230|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
43849746|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43824844|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43824845|NCT05507606|Growth Substances|growth substances|mesh-ancestor
43824846|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824847|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
43824848|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824849|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824850|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43824851|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43824852|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43780815|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43780816|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780817|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
43780818|NCT03025035|Olaparib|olaparib|mesh-list
43780819|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780820|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780821|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43780822|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824853|NCT05507580|Upadacitinib|upadacitinib|mesh-list
43824854|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43824855|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43824856|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780823|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780824|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
43780825|NCT02998567|Guadecitabine|guadecitabine|mesh-list
43780826|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780827|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780828|NCT02985619|Triamcinolone|triamcinolone|mesh-list
43780829|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43668098|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668099|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668100|NCT03991936|Triamcinolone|triamcinolone|mesh-list
43668101|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43668102|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43668103|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43668104|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668105|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
43668106|NCT03991936|Hormones|hormones|mesh-ancestor
43668107|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668108|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668109|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780830|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43780831|NCT02985619|Bevacizumab|bevacizumab|mesh-list
43780832|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43780833|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780834|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780835|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43780836|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43780837|NCT02985619|Growth Substances|growth substances|mesh-ancestor
43780838|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780839|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
43780840|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43780841|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
43780842|NCT02985619|Hormones|hormones|mesh-ancestor
43780843|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780844|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780871|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
43780872|NCT02322099|Vitamin D|vitamin d|mesh-list
43780873|NCT02322099|Tenofovir|tenofovir|mesh-list
43780874|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
43587658|NCT03393780|Hormones|hormones|mesh-ancestor
43780875|NCT02322099|Calcium|calcium|mesh-list
43780876|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43780877|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780878|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
43780879|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43780880|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43780881|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43780882|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43780883|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780884|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43780885|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43780886|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43780887|NCT02322099|Antacids|antacids|mesh-ancestor
43780888|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43780889|NCT02322099|Vitamins|vitamins|mesh-ancestor
43780890|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
43780891|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
43780910|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43780911|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780912|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
43780913|NCT02229968|Coagulants|coagulants|mesh-ancestor
43780915|NCT02037529|Halichondrin B|halichondrin b|mesh-list
43780916|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43780917|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43780918|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780919|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
43780920|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
43780921|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780922|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780923|NCT02003742|Tamsulosin|tamsulosin|mesh-list
43780924|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43780925|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43780926|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43780927|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
43780928|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780929|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780930|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668110|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
43668111|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668112|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668113|NCT03986424|Memantine|memantine|mesh-list
43668114|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43849747|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43849748|NCT03896737|Growth Substances|growth substances|mesh-ancestor
43780931|NCT02003742|Urological Agents|urological agents|mesh-ancestor
43780932|NCT01884259|Cisplatin|cisplatin|mesh-list
43824857|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824858|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43824859|NCT05507554|Analgesics|analgesics|mesh-list
43824860|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43824861|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780933|NCT01884259|Docetaxel|docetaxel|mesh-list
43780934|NCT01884259|Fluorouracil|fluorouracil|mesh-list
43780935|NCT01884259|Cetuximab|cetuximab|mesh-list
43780936|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43780937|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
43780938|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
43780939|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
43780940|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780941|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
43780942|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43780943|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43780944|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
43780945|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780946|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43780947|NCT01828697|Enoxaparin|enoxaparin|mesh-list
43780949|NCT01828697|Tinzaparin|tinzaparin|mesh-list
43780950|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43780952|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
43780953|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
43780982|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780983|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43780984|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
43780985|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780986|NCT00223171|Androgens|androgens|mesh-list
43780987|NCT00223171|Hormones|hormones|mesh-ancestor
43780988|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43780989|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780990|NCT04631393|Alfentanil|alfentanil|mesh-list
43780991|NCT04631393|Propofol|propofol|mesh-list
43780992|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43780993|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43780994|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780995|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43780996|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
43781024|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
43781025|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781026|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781027|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781029|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
43781030|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
43781031|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781032|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781033|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43781034|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43781035|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43781036|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781037|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
43781049|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849749|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
43781050|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781051|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781052|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781053|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781054|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
43781055|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781056|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781057|NCT03955640|Olaparib|olaparib|mesh-list
43781058|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43781059|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781060|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781061|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781062|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
43781063|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43781065|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
43781066|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
43781067|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43781068|NCT03910738|Androgens|androgens|mesh-ancestor
43781069|NCT03910738|Hormones|hormones|mesh-ancestor
43781070|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781071|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781072|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781073|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781074|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
43781075|NCT03890744|Docetaxel|docetaxel|mesh-list
43781076|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781077|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781078|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781079|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781081|NCT03820817|Rifaximin|rifaximin|mesh-list
43781082|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43781083|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781084|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781085|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
43781086|NCT03789097|Poly ICLC|poly iclc|mesh-list
43781087|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781088|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781089|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
43781090|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
43781091|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781123|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668115|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43668116|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
43668117|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668118|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849750|NCT03896230|Ketamine|ketamine|mesh-list
43781124|NCT02914470|Atezolizumab|atezolizumab|mesh-list
43781125|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781126|NCT02484716|Timolol|timolol|mesh-list
43781127|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43781128|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43781129|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781130|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781131|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781132|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781133|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43653348|NCT02985281|Ribavirin|ribavirin|mesh-list
43653349|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
43653350|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
43653351|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653352|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
43653353|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653354|NCT02985125|Everolimus|everolimus|mesh-list
43781143|NCT05088330|Daratumumab|daratumumab|mesh-list
43781144|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781145|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43781146|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781147|NCT05088174|Cyclosporine|cyclosporine|mesh-list
43781148|NCT05088174|Cyclosporins|cyclosporins|mesh-list
43781149|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781150|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781151|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781152|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
43781153|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781154|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
43781155|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781156|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781159|NCT05088083|Paclitaxel|paclitaxel|mesh-list
43781160|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43781161|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781162|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781163|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781164|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781165|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781166|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
43781167|NCT05088057|Docetaxel|docetaxel|mesh-list
43781168|NCT05088057|Doxorubicin|doxorubicin|mesh-list
43781169|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781170|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
43781171|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781172|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781173|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43781175|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781176|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781177|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43781178|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
43781179|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
43781180|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781181|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43781182|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43781183|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781184|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781185|NCT05087797|Nicorandil|nicorandil|mesh-list
43781186|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43781187|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781188|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
43781189|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
43781190|NCT05087797|Vitamins|vitamins|mesh-ancestor
43781191|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
43781192|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653356|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653357|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
43653358|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653359|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43781193|NCT05087706|Bicalutamide|bicalutamide|mesh-list
43781194|NCT05087706|Leuprolide|leuprolide|mesh-list
43781195|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
43781196|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
43781197|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781198|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849751|NCT03896230|Analgesics|analgesics|mesh-ancestor
43781199|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781200|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43781201|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
43839471|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43839472|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43839473|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43839474|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43839475|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43839476|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43839477|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
43839478|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839479|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839482|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839483|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
43839484|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
43839485|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
43839486|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839487|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43839488|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43839489|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839490|NCT04769414|Gemcitabine|gemcitabine|mesh-list
43839491|NCT04769414|Fluorouracil|fluorouracil|mesh-list
43839492|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43839493|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
43839494|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839495|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839496|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
43839497|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781226|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781227|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781228|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43781229|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
43781230|NCT05086848|Leucovorin|leucovorin|mesh-list
43781231|NCT05086848|Fluorouracil|fluorouracil|mesh-list
43781232|NCT05086848|Irinotecan|irinotecan|mesh-list
43781233|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
43781234|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781235|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43781236|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781237|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781238|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
43781239|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781240|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43781241|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781244|NCT05086848|Protective Agents|protective agents|mesh-ancestor
43781245|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
43781246|NCT05086848|Vitamins|vitamins|mesh-ancestor
43781247|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
43781248|NCT05086822|Irinotecan|irinotecan|mesh-list
43781249|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43781250|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781251|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781252|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781253|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781254|NCT05086614|Thymalfasin|thymalfasin|mesh-list
43849752|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
43653360|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43781259|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43781260|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43781261|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43781262|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43781263|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43781264|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
43781265|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781266|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781267|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781270|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781271|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781272|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781273|NCT05085652|Anesthetics|anesthetics|mesh-list
43781274|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781275|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781276|NCT05085587|Fluticasone|fluticasone|mesh-list
43781277|NCT05085587|Xhance|xhance|mesh-list
43781278|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43781279|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43781280|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781313|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43781314|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781315|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781316|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781317|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781318|NCT05084573|Bupivacaine|bupivacaine|mesh-list
43781319|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653369|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653370|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653371|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43668120|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43849753|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849754|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849755|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43653372|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781320|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
43781321|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781342|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781344|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781345|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781346|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43781347|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43781348|NCT05068206|Growth Substances|growth substances|mesh-ancestor
43781349|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781350|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
43781351|NCT05063370|Simendan|simendan|mesh-list
43781352|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43781353|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
43781354|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43781355|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43781356|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781357|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781358|NCT05063370|Protective Agents|protective agents|mesh-ancestor
43781359|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781360|NCT05063006|Methamphetamine|methamphetamine|mesh-list
43781361|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43781362|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781363|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
43781364|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
43781365|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781366|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
43781367|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781368|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781369|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781370|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43781371|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43781372|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781373|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43781374|NCT05028257|Vaccines|vaccines|mesh-list
43781407|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781409|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
43781410|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43781411|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781412|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43839538|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43839539|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653373|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653374|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43653376|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653377|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653378|NCT02985086|Cefoxitin|cefoxitin|mesh-list
43653382|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653383|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653384|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653385|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
43653386|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653387|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653388|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653389|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653390|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
43653391|NCT02984865|Sufentanil|sufentanil|mesh-list
43653392|NCT02984865|Nalbuphine|nalbuphine|mesh-list
43653393|NCT02984865|Dsuvia|dsuvia|mesh-list
43653394|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43653395|NCT02984865|Narcotics|narcotics|mesh-ancestor
43653396|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653397|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653398|NCT02984865|Analgesics|analgesics|mesh-ancestor
43653399|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
43653400|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653401|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43653402|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43653403|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
43653404|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
43653405|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653406|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653407|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653408|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653409|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653410|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653411|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653412|NCT02984852|Tenofovir|tenofovir|mesh-list
43653413|NCT02984852|Emtricitabine|emtricitabine|mesh-list
43653414|NCT02984852|Darunavir|darunavir|mesh-list
43839559|NCT04763577|Kininogens|kininogens|mesh-list
43839560|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839561|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43839562|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
43839563|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839564|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653422|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43653423|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43653424|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43653425|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43781434|NCT04861558|Irinotecan|irinotecan|mesh-list
43781435|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
43781436|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781437|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43781438|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781439|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781440|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
43781441|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781442|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43781443|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781444|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781445|NCT04837235|Hemay005|hemay005|mesh-list
43781446|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781447|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43781448|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43781449|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781450|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849756|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43781452|NCT04771962|Desflurane|desflurane|mesh-list
43781453|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43781468|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
43781469|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
43781470|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781471|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781472|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781473|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
43781474|NCT04726098|Hormones|hormones|mesh-ancestor
43781475|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781476|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781477|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781478|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
43781479|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781480|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781481|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
43781482|NCT04699071|Lenvatinib|lenvatinib|mesh-list
43781483|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781484|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781485|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43781486|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781487|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781488|NCT04648189|Cetuximab|cetuximab|mesh-list
43781489|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781490|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781491|NCT04643249|Repaglinide|repaglinide|mesh-list
43781492|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
43781493|NCT04643249|Midazolam|midazolam|mesh-list
43781495|NCT04643249|Caffeine|caffeine|mesh-list
43781496|NCT04643249|Bupropion|bupropion|mesh-list
43781497|NCT04643249|Omeprazole|omeprazole|mesh-list
43781498|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43781499|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43781500|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781501|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781502|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43781503|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43781504|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43781505|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43781506|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
43781508|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
43781509|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
43781510|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781511|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781512|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43781513|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781514|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43781515|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781516|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43781521|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43781522|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
43781523|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43781524|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43781525|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781527|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43781528|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43781529|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
43781530|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
43781531|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43781532|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43781533|NCT04643249|Analgesics|analgesics|mesh-ancestor
43781540|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43781541|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43781542|NCT04558294|Ketanserin|ketanserin|mesh-list
43781543|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43781544|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
43781545|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781546|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43781547|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43781548|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
43781549|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781550|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781551|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43781552|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781553|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43781554|NCT04537897|Midazolam|midazolam|mesh-list
43781555|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43781556|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43781557|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781558|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668121|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43668122|NCT03978208|Naproxen|naproxen|mesh-list
43781559|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43781560|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43781561|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43781562|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43781563|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
43781564|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
43781565|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
43781566|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
43781567|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43588462|NCT03387787|Insulin|insulin|mesh-list
43781568|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781569|NCT04507581|Anesthetics|anesthetics|mesh-list
43781570|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781571|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781572|NCT04507438|Donepezil|donepezil|mesh-list
43781573|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43781574|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781575|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781576|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
43781577|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781578|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781579|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
43781581|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
43781582|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43781583|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781584|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781598|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43781599|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781600|NCT04362566|Bupivacaine|bupivacaine|mesh-list
43781601|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
43781602|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
43781603|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781604|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781605|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
43653453|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
43781613|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43781614|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
43781615|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43781616|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43781617|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781618|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781619|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781620|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668123|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43781621|NCT04335084|Antioxidants|antioxidants|mesh-ancestor
43668124|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43668125|NCT03978208|Analgesics|analgesics|mesh-ancestor
43781622|NCT04335084|Protective Agents|protective agents|mesh-ancestor
43839575|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839576|NCT04761601|Gemcitabine|gemcitabine|mesh-list
43839577|NCT04761601|Paclitaxel|paclitaxel|mesh-list
43839578|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43839579|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839580|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
43839582|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
43839583|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839584|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43839586|NCT04761601|Antiviral Agents|antiviral agents|mesh-ancestor
43839587|NCT04761601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839588|NCT04761601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839589|NCT04761601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43839590|NCT04761601|Immunologic Factors|immunologic factors|mesh-ancestor
43839592|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
43839593|NCT04761133|Povidone|povidone|mesh-list
43839594|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
43839595|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
43848193|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
43781623|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43781624|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43781625|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781626|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
43781646|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43781647|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43781649|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
43781650|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43781651|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
43781652|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781653|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
43781654|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
43781655|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781656|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781657|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781658|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
43781660|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781661|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781662|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781663|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43781664|NCT03898154|Protective Agents|protective agents|mesh-ancestor
43781665|NCT03845140|Praziquantel|praziquantel|mesh-list
43781666|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
43781667|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43781668|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781669|NCT03827447|Vancomycin|vancomycin|mesh-list
43781670|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43781671|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781672|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
43781673|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43781674|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43781675|NCT03697031|Hormones|hormones|mesh-ancestor
43781676|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653459|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653461|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43653462|NCT02984293|Atorvastatin|atorvastatin|mesh-list
43653463|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43588632|NCT03386630|Dsuvia|dsuvia|mesh-list
43781678|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
43781680|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
43781681|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781682|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781683|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43781685|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781686|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781687|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
43781688|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781689|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781690|NCT03469050|Rifaximin|rifaximin|mesh-list
43781691|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43781692|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781694|NCT03415061|Insulin|insulin|mesh-list
43781695|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43781696|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43781697|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781698|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
43781699|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43781700|NCT03327844|Metronidazole|metronidazole|mesh-list
43781701|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
43781702|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43781703|NCT03327844|Calcium|calcium|mesh-list
43781704|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43781705|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781706|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43781707|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781708|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
43781709|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43781710|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43781711|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43781712|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43781713|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781714|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849759|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43781716|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43781717|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43781718|NCT03158883|Avelumab|avelumab|mesh-list
43781719|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781720|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781756|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839596|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43839597|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839598|NCT04757883|Antibodies|antibodies|mesh-list
43839599|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
43839600|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653464|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43653465|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
43653466|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653467|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43653468|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43653469|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653470|NCT02984176|Simethicone|simethicone|mesh-list
43653471|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
43839601|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
43839613|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
43839615|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43839616|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43839617|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43839618|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839619|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839620|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839622|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
43839623|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839624|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
43839625|NCT04757740|Hormones|hormones|mesh-ancestor
43839626|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839627|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43839628|NCT04757740|Protective Agents|protective agents|mesh-ancestor
43839629|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839630|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839631|NCT04757636|Aflibercept|aflibercept|mesh-list
43839632|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43839633|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43839634|NCT04757636|Growth Substances|growth substances|mesh-ancestor
43839635|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839636|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
43839637|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839638|NCT04757610|Ranibizumab|ranibizumab|mesh-list
43839639|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43839640|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43839641|NCT04757610|Growth Substances|growth substances|mesh-ancestor
43839642|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839643|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
43839644|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839645|NCT04756505|Interleukin-12|interleukin-12|mesh-list
43839646|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
43839647|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43839648|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
43839649|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839650|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43839651|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43839652|NCT04756505|Growth Substances|growth substances|mesh-ancestor
43839653|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
43839654|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668126|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
43839656|NCT04755764|Labetalol|labetalol|mesh-list
43839657|NCT04755764|Nifedipine|nifedipine|mesh-list
43839658|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43839659|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43839660|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839661|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43839662|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839663|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839664|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
43839665|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781769|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
43781770|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653472|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653474|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653475|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
43653476|NCT02984111|Hematinics|hematinics|mesh-ancestor
43653477|NCT02984072|Menthol|menthol|mesh-list
43653478|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
43781771|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781772|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781773|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781774|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43781775|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43781776|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43781777|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43781778|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781779|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
43781780|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781781|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43781782|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781783|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43849760|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43781784|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
43781785|NCT02770040|Infliximab|infliximab|mesh-list
43781786|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
43781787|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781788|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781789|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
43781790|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43781794|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781795|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
43781796|NCT02624765|Digoxin|digoxin|mesh-list
43781797|NCT02624765|Sotalol|sotalol|mesh-list
43781798|NCT02624765|Flecainide|flecainide|mesh-list
43781799|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43781800|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43781801|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781802|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781803|NCT02624765|Protective Agents|protective agents|mesh-ancestor
43781804|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781805|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43781806|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43781807|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781808|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781809|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
43781810|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
43781811|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781812|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43781813|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43781814|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781815|NCT05090449|Losartan|losartan|mesh-list
43781826|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781827|NCT05090176|Povidone|povidone|mesh-list
43781828|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
43781829|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
43781831|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
43781832|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781833|NCT05090124|Adalimumab|adalimumab|mesh-list
43781834|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43781835|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43781836|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
43781837|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43781838|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
43781839|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781840|NCT05089981|Expectorants|expectorants|mesh-ancestor
43781841|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
43781842|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43653479|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653480|NCT02983591|Misoprostol|misoprostol|mesh-list
43653481|NCT02983591|Oxytocin|oxytocin|mesh-list
43653482|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
43653483|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653484|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781843|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
43849761|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43608189|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43608190|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
43608191|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608192|NCT03198013|Prednisolone|prednisolone|mesh-list
43608193|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43608194|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
43608195|NCT03198013|Hormones|hormones|mesh-ancestor
43608196|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608197|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43608198|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608199|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43608200|NCT03197584|Leucovorin|leucovorin|mesh-list
43608201|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
43608228|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
43608229|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608230|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43608231|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43608232|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
43608233|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43608235|NCT03197493|Carbidopa|carbidopa|mesh-list
43608236|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43608237|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43608238|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43781844|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781845|NCT05089981|Protective Agents|protective agents|mesh-ancestor
43781846|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781847|NCT05089981|Antidotes|antidotes|mesh-ancestor
43781848|NCT05089604|Tacrolimus|tacrolimus|mesh-list
43781849|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43781850|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
43781851|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781852|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43781853|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781854|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781855|NCT05089539|Valsartan|valsartan|mesh-list
43781856|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43781857|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781858|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43781859|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43781860|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781861|NCT05089448|Amlodipine|amlodipine|mesh-list
43781862|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43781863|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43781864|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43781865|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781866|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43781867|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781868|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
43781869|NCT05089383|Progesterone|progesterone|mesh-list
43781879|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781880|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43781881|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
43781882|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43781884|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781885|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43781886|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43781887|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
43781888|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
43781889|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781890|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781891|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781892|NCT05088720|Misoprostol|misoprostol|mesh-list
43781893|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43781894|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
43781895|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781896|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781897|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43781898|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781899|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
43781900|NCT05088707|Misoprostol|misoprostol|mesh-list
43781901|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43781902|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
43781903|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781904|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781905|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43781906|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781908|NCT05084118|Landiolol|landiolol|mesh-list
43781909|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43849762|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849763|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781910|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43781911|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
43781912|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43781913|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653485|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653486|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
43653487|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653488|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653489|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43781914|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781915|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43781916|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
43781917|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781918|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
43781919|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781920|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781921|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43781922|NCT05077540|Misoprostol|misoprostol|mesh-list
43781923|NCT05077540|Oxytocin|oxytocin|mesh-list
43781924|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
43781925|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43781926|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781927|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43781928|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
43781929|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43781930|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781931|NCT05057468|Cyclosporine|cyclosporine|mesh-list
43781932|NCT05057468|Rituximab|rituximab|mesh-list
43781933|NCT05057468|Cyclosporins|cyclosporins|mesh-list
43781934|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43781935|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781936|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
43781973|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43781974|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43781975|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43781986|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43781987|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
43781988|NCT04908592|Hormones|hormones|mesh-ancestor
43781989|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43781990|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43781991|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43781992|NCT04850651|Fluconazole|fluconazole|mesh-list
43781993|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
43781994|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43781995|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43781996|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43781997|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43781998|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43781999|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43782000|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668127|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849765|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
43782001|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782002|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782003|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43782004|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43839669|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
43839670|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839671|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43839672|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43839673|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43839674|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
43839675|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43839676|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
43839677|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43839678|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43839679|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
43839680|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43839681|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
43839682|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839683|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
43839684|NCT04755634|Protective Agents|protective agents|mesh-ancestor
43848194|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43653491|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653492|NCT02983773|Dronabinol|dronabinol|mesh-list
43653493|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
43653494|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653495|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43653496|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653497|NCT02983773|Analgesics|analgesics|mesh-ancestor
43653498|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
43653499|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653500|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43653501|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43848195|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43848196|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43848197|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43848198|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43848199|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
43848201|NCT04041973|Artemether|artemether|mesh-list
43848202|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43848203|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
43848204|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43848205|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43848206|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848207|NCT04040621|Ceftazidime|ceftazidime|mesh-list
43848208|NCT04040621|Avibactam|avibactam|mesh-list
43848209|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
43848210|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43848211|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848212|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43848217|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848218|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848219|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848221|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
43848222|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848223|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43782005|NCT04788550|Listerine|listerine|mesh-list
43782006|NCT04788550|Fluorides|fluorides|mesh-list
43782007|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
43782008|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
43782009|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
43782011|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782012|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43782013|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782014|NCT04759768|Naltrexone|naltrexone|mesh-list
43782015|NCT04759768|Nalmefene|nalmefene|mesh-list
43782016|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43782017|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782018|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
43782019|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782020|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43782021|NCT04757493|Prucalopride|prucalopride|mesh-list
43782022|NCT04757493|Laxatives|laxatives|mesh-ancestor
43782024|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43782025|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43849766|NCT03895801|Vilobelimab|vilobelimab|mesh-list
43653508|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653509|NCT02983734|Renal Agents|renal agents|mesh-ancestor
43653510|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43653511|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
43653512|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782035|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782036|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
43782037|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782038|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782039|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43782040|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782041|NCT04565483|Benralizumab|benralizumab|mesh-list
43782042|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43782043|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782044|NCT04536194|Dopamine|dopamine|mesh-list
43782049|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782050|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782051|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782052|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
43782053|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
43782054|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782055|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43782056|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43782057|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
43782058|NCT04536194|Protective Agents|protective agents|mesh-ancestor
43782059|NCT04449042|Anesthetics|anesthetics|mesh-list
43782060|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782061|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782062|NCT04341090|Apatinib|apatinib|mesh-list
43782063|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782064|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43782065|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782066|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782067|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
43782068|NCT04263896|Laxatives|laxatives|mesh-ancestor
43782069|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782070|NCT04254731|Methadone|methadone|mesh-list
43782071|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43782072|NCT04254731|Narcotics|narcotics|mesh-ancestor
43782073|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782074|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782076|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
43782077|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782078|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
43782079|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782080|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
43782081|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782082|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782083|NCT04089150|Leucovorin|leucovorin|mesh-list
43782084|NCT04089150|Gemcitabine|gemcitabine|mesh-list
43782085|NCT04089150|Paclitaxel|paclitaxel|mesh-list
43782108|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
43782109|NCT04089150|Vitamins|vitamins|mesh-ancestor
43782110|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
43782111|NCT04082780|Rifamycins|rifamycins|mesh-list
43782112|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
43782113|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782114|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782115|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782116|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43782117|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43782118|NCT03925350|Niraparib|niraparib|mesh-list
43782119|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43782120|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782121|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782122|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782123|NCT03906526|Nivolumab|nivolumab|mesh-list
43782124|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782125|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782126|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43782127|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782129|NCT03408652|Denosumab|denosumab|mesh-list
43782130|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782131|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782132|NCT03263117|Anesthetics|anesthetics|mesh-list
43782133|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782134|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782135|NCT02969850|Vitamin D|vitamin d|mesh-list
43782136|NCT02969850|Calcium|calcium|mesh-list
43782137|NCT02969850|Vitamins|vitamins|mesh-ancestor
43782138|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
43782139|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782140|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43782151|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782152|NCT02339766|Analgesics|analgesics|mesh-ancestor
43782153|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
43782154|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839685|NCT04755218|Misoprostol|misoprostol|mesh-list
43839686|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43839687|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
43839688|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43839689|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839692|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
43839693|NCT04754399|Cannabidiol|cannabidiol|mesh-list
43839694|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
43839695|NCT04753970|Cilostazol|cilostazol|mesh-list
43839696|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43839697|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
43839698|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839699|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839700|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43839701|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
43839702|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43839703|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839704|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839705|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43653514|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653515|NCT02983630|Penicillins|penicillins|mesh-list
43653516|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43839706|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
43839707|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43839708|NCT04753970|Protective Agents|protective agents|mesh-ancestor
43839709|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43839710|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43839711|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839712|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
43839713|NCT04753372|Aspirin|aspirin|mesh-list
43839714|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
43839715|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43839716|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
43839717|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43839718|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
43839719|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839720|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839721|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
43839722|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43839723|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43839724|NCT04753372|Analgesics|analgesics|mesh-ancestor
43839725|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
43839726|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839727|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839728|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782155|NCT05091775|Mesalamine|mesalamine|mesh-list
43782156|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43782158|NCT05091775|Analgesics|analgesics|mesh-ancestor
43782159|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
43782160|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782161|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782173|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782174|NCT05091177|Acetylcholine|acetylcholine|mesh-list
43782175|NCT05091177|Antibodies|antibodies|mesh-list
43849768|NCT03895801|Hormones|hormones|mesh-ancestor
43782176|NCT05091177|Neostigmine|neostigmine|mesh-list
43782177|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
43782178|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782179|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43782180|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782181|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782182|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
43782183|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782184|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43782185|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
43782186|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782187|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782188|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43782190|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782191|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782192|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782193|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782194|NCT05091151|Analgesics|analgesics|mesh-ancestor
43782195|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
43782196|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782197|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43782198|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782199|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782200|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782201|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782202|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782203|NCT05091138|Buprenorphine|buprenorphine|mesh-list
43782204|NCT05091138|Bupivacaine|bupivacaine|mesh-list
43782205|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782206|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
43782207|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782211|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43653517|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782212|NCT05091138|Narcotics|narcotics|mesh-ancestor
43782213|NCT05091138|Analgesics|analgesics|mesh-ancestor
43668128|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668129|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668130|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782214|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43782215|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
43782216|NCT05091099|Alendronate|alendronate|mesh-list
43782217|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782218|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782219|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
43782220|NCT05091086|Denosumab|denosumab|mesh-list
43782221|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782241|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43782242|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43782245|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43782246|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782247|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43782248|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
43782249|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43782250|NCT05090592|Atropine|atropine|mesh-list
43782251|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43782252|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43782253|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43782254|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
43782255|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782256|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782257|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43782258|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782259|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
43782260|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
43782261|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43782262|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43782263|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
43782264|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782265|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782266|NCT05081336|Ezetimibe|ezetimibe|mesh-list
43782267|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43782268|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782269|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
43782270|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782271|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43782288|NCT05069129|Vaccines|vaccines|mesh-list
43782289|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
43782290|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782291|NCT05067985|Anesthetics|anesthetics|mesh-list
43782292|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782293|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782294|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43782295|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43782296|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782297|NCT04952350|Atorvastatin|atorvastatin|mesh-list
43782298|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43782299|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782301|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782302|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43782303|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43782304|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782305|NCT04866017|Durvalumab|durvalumab|mesh-list
43782306|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782307|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782308|NCT04850144|Bromides|bromides|mesh-list
43782309|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
43782310|NCT04850144|Charcoal|charcoal|mesh-list
43782311|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43782312|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
43782313|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782314|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653520|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43653521|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43653522|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43653523|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43782315|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43782316|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782317|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
43782318|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43782319|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
43782320|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782321|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782322|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
43782323|NCT04850144|Antidotes|antidotes|mesh-ancestor
43782324|NCT04850144|Protective Agents|protective agents|mesh-ancestor
43782325|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
43782326|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43782327|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43782328|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
43782329|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782330|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782331|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43839729|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43839730|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43839731|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43839732|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43839733|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43839734|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
43839746|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839748|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
43839749|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839750|NCT04752059|Trastuzumab|trastuzumab|mesh-list
43589453|NCT03379909|Metformin|metformin|mesh-list
43782341|NCT04590794|Plasminogen|plasminogen|mesh-list
43782342|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43782346|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43782347|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43782348|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782349|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782350|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782351|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782352|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43782353|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
43782354|NCT04543643|Protective Agents|protective agents|mesh-ancestor
43782355|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43782356|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653524|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
43653525|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653526|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653527|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782357|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43782358|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782359|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43782360|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43782361|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
43782362|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782363|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849769|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782369|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43782370|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782373|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782374|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782375|NCT04287660|Clarithromycin|clarithromycin|mesh-list
43782376|NCT04287660|Dexamethasone|dexamethasone|mesh-list
43782377|NCT04287660|Lenalidomide|lenalidomide|mesh-list
43782378|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782379|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
43782380|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
43782381|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782382|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782383|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782384|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
43782385|NCT04287660|Hormones|hormones|mesh-ancestor
43782386|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782387|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43782388|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782389|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
43782390|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43782391|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43782392|NCT04287660|Growth Substances|growth substances|mesh-ancestor
43782393|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
43782394|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782395|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782396|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43782397|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782398|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782399|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43782400|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43782401|NCT04058158|Eculizumab|eculizumab|mesh-list
43782402|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43782403|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782404|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
43782405|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782406|NCT03922620|Bupivacaine|bupivacaine|mesh-list
43782407|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782408|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
43782409|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782410|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782411|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
43782412|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43589513|NCT03378726|Micronutrients|micronutrients|mesh-list
43782414|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
43782415|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43782416|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43782417|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43782418|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782419|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782420|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
43782421|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
43782422|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782423|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782424|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43653528|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43653529|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
43653530|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653531|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653532|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
43653533|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43653534|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43653535|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782425|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43782426|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
43782427|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43782428|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43782429|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43782430|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43782451|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782452|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
43782453|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782454|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43782455|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43782457|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782458|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782459|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782460|NCT05094596|Montelukast|montelukast|mesh-list
43782461|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43782462|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782463|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43782464|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
43782465|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782466|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782467|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43782468|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43782469|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782471|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
43782472|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
43782473|NCT05094492|Protective Agents|protective agents|mesh-ancestor
43668131|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
43849770|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782474|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782475|NCT05094414|Valacyclovir|valacyclovir|mesh-list
43782476|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
43782477|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782478|NCT05094375|Misoprostol|misoprostol|mesh-list
43782479|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43782480|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
43782481|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43782482|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782483|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43782484|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782485|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
43782486|NCT05093907|Capecitabine|capecitabine|mesh-list
43782487|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782495|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782496|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782497|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
43782499|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43782500|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43782501|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43782502|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43782503|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782504|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
43782505|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43782506|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
43782507|NCT05093231|Olaparib|olaparib|mesh-list
43782508|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653537|NCT02983214|Protective Agents|protective agents|mesh-ancestor
43653538|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43653539|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43653540|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653541|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
43653542|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653543|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653544|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653545|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824866|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43824867|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782509|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782510|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43782511|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536571|NCT04717765|Vitamin E|vitamin e|mesh-list
43536572|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
43536573|NCT04717765|Tocopherols|tocopherols|mesh-list
43536574|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
43536581|NCT04704219|Lenvatinib|lenvatinib|mesh-list
43536582|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536583|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536584|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43536585|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536586|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536587|NCT04671355|Fluticasone|fluticasone|mesh-list
43536588|NCT04671355|Xhance|xhance|mesh-list
43536589|NCT04671355|Beclomethasone|beclomethasone|mesh-list
43536590|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
43536591|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
43849771|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43608239|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
43608240|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43608241|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782512|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839751|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839752|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839754|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839755|NCT04751877|Dexamethasone|dexamethasone|mesh-list
43839756|NCT04751877|Lenalidomide|lenalidomide|mesh-list
43839757|NCT04751877|Bortezomib|bortezomib|mesh-list
43839758|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839759|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
43839760|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
43839761|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839762|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839763|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839764|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
43839765|NCT04751877|Hormones|hormones|mesh-ancestor
43839766|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839767|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839768|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839769|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
43839770|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43839771|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43839772|NCT04751877|Growth Substances|growth substances|mesh-ancestor
43839773|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
43839774|NCT04750902|Listerine|listerine|mesh-list
43536592|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43536593|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43839775|NCT04750902|Fluorides|fluorides|mesh-list
43839776|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
43839777|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
43839778|NCT04750902|Protective Agents|protective agents|mesh-ancestor
43839779|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839780|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43839781|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839782|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
43839783|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43839784|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839786|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43839787|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839788|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839789|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839790|NCT04750473|Edetic Acid|edetic acid|mesh-list
43839791|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43839792|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
43536594|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
43536595|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536596|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536597|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43536614|NCT04625088|Atropine|atropine|mesh-list
43839793|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
43839794|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782534|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782535|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43824868|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824869|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43824870|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43824871|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
43824872|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824873|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824874|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43824875|NCT05507229|Vaccines|vaccines|mesh-list
43824876|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
43824877|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824878|NCT05507112|Capecitabine|capecitabine|mesh-list
43824879|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43824880|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824881|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
43782536|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43782537|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43782538|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43782539|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782540|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782541|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782542|NCT05089526|Analgesics|analgesics|mesh-ancestor
43782543|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43782544|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782545|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782546|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782547|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782548|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43782549|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43782550|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
43782551|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43782564|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782566|NCT04993560|Vaccines|vaccines|mesh-list
43782584|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
43536630|NCT04597671|Durvalumab|durvalumab|mesh-list
43782585|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782586|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782587|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782588|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43782589|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
43782590|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43782591|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782592|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782593|NCT04770454|Buspirone|buspirone|mesh-list
43782594|NCT04770454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43782595|NCT04770454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43782596|NCT04770454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782597|NCT04770454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782598|NCT04770454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43782599|NCT04770454|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43782602|NCT04770454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782604|NCT04691128|Propofol|propofol|mesh-list
43782605|NCT04691128|Desflurane|desflurane|mesh-list
43782606|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824882|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824883|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824885|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43824886|NCT05506969|Vaccines|vaccines|mesh-list
43824887|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
43824888|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
43824889|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824890|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43824894|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782607|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782608|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782609|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43782610|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
43782611|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43782612|NCT04682522|Metronidazole|metronidazole|mesh-list
43782613|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782614|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782615|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43782616|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43782617|NCT04657809|Insulin|insulin|mesh-list
43782618|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43782619|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782620|NCT04601584|Antibodies|antibodies|mesh-list
43782621|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
43782622|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
43782623|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782624|NCT04585854|Caffeine|caffeine|mesh-list
43782625|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43782632|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
43782633|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782634|NCT04582981|Raltitrexed|raltitrexed|mesh-list
43782635|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782636|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
43782637|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782639|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43782642|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43782643|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782644|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43782645|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
43782646|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
43782647|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782648|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782649|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782651|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43782652|NCT04492306|Protective Agents|protective agents|mesh-ancestor
43782653|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782654|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43782655|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
43782656|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782657|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
43782658|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43782659|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
43782660|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782661|NCT04429802|Prucalopride|prucalopride|mesh-list
43782662|NCT04429802|Laxatives|laxatives|mesh-ancestor
43824895|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824896|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43824897|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782663|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782664|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
43782665|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43782667|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782668|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782669|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782670|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
43782671|NCT04387760|Favipiravir|favipiravir|mesh-list
43782672|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
43782673|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43782674|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43782675|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536673|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43782676|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782677|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782678|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782679|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
43536674|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43782681|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
43782682|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782683|NCT04331756|Anesthetics|anesthetics|mesh-list
43782684|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536675|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536677|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
43536678|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
43536679|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536680|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
43536681|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43536682|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536683|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536684|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782685|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839803|NCT04749394|Apatinib|apatinib|mesh-list
43839804|NCT04749394|Antibodies|antibodies|mesh-list
43839805|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
43839806|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43839807|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
43839808|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839809|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536689|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43536690|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43839818|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839819|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43839820|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839821|NCT04748042|Prednisone|prednisone|mesh-list
43839822|NCT04748042|Olaparib|olaparib|mesh-list
43839823|NCT04748042|Androgens|androgens|mesh-list
43839824|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839825|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
43839826|NCT04748042|Hormones|hormones|mesh-ancestor
43839827|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839828|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839829|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839830|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839831|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43782686|NCT04085445|Paclitaxel|paclitaxel|mesh-list
43782687|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43782688|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782689|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
43782690|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
43782691|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
43782692|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782693|NCT03710876|Gemcitabine|gemcitabine|mesh-list
43782694|NCT03710876|Celecoxib|celecoxib|mesh-list
43782695|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782696|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
43782697|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782698|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782699|NCT03710876|Antiviral Agents|antiviral agents|mesh-ancestor
43782700|NCT03710876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782701|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782702|NCT03710876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782703|NCT03710876|Immunologic Factors|immunologic factors|mesh-ancestor
43782704|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782705|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43782706|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782707|NCT03710876|Analgesics|analgesics|mesh-ancestor
43782714|NCT03688828|Amoxicillin|amoxicillin|mesh-list
43782715|NCT03688828|Clarithromycin|clarithromycin|mesh-list
43782716|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
43782717|NCT03688828|Esomeprazole|esomeprazole|mesh-list
43782718|NCT03688828|Bismuth|bismuth|mesh-list
43782719|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782720|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43782721|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43782722|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43782723|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782724|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43782725|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782726|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43782727|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43782728|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43782729|NCT03688828|Antacids|antacids|mesh-ancestor
43782730|NCT03688828|Diuretics|diuretics|mesh-ancestor
43782743|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782745|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
43782746|NCT03643822|Hormones|hormones|mesh-ancestor
43782753|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43782754|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782755|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43782756|NCT03643822|Analgesics|analgesics|mesh-ancestor
43782757|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
43782758|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43782759|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43782760|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43782761|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
43782762|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43782763|NCT03634150|Doxorubicin|doxorubicin|mesh-list
43782764|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43782765|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782766|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43782767|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43782768|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782769|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782770|NCT03593759|Prednisone|prednisone|mesh-list
43782771|NCT03593759|Prednisolone|prednisolone|mesh-list
43782772|NCT03593759|Methotrexate|methotrexate|mesh-list
43782773|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43782774|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
43782775|NCT03593759|Hormones|hormones|mesh-ancestor
43782776|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782777|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782778|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43824900|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
43824901|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824902|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536794|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824904|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
43824905|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43536795|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
43824906|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
43824907|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43824908|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43824909|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824910|NCT05506501|Anesthetics|anesthetics|mesh-list
43824911|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824912|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824913|NCT05506488|Dasatinib|dasatinib|mesh-list
43824914|NCT05506488|Quercetin|quercetin|mesh-list
43824915|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824916|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43824917|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782802|NCT03329378|Doxorubicin|doxorubicin|mesh-list
43782803|NCT03329378|Trastuzumab|trastuzumab|mesh-list
43782804|NCT03329378|Pertuzumab|pertuzumab|mesh-list
43782805|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43782806|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782807|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
43782808|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
43782809|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
43782810|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782811|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782812|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
43782813|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782814|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43782815|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43782816|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
43782817|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43782818|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43782819|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43782820|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43782821|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782822|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782823|NCT03268083|Vaccines|vaccines|mesh-list
43782824|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
43782825|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782826|NCT03170817|Regadenoson|regadenoson|mesh-list
43782827|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43782828|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43782830|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
43782850|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782852|NCT02926651|Coagulants|coagulants|mesh-ancestor
43782853|NCT02896335|Palbociclib|palbociclib|mesh-list
43536819|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782854|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782855|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43782856|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782857|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782858|NCT02605148|Vitamin D|vitamin d|mesh-list
43782859|NCT02605148|Vitamins|vitamins|mesh-ancestor
43824918|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824919|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
43782860|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
43782861|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782862|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43782863|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
43782864|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782865|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782866|NCT02395640|Capecitabine|capecitabine|mesh-list
43782867|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
43782868|NCT02395640|Epirubicin|epirubicin|mesh-list
43782869|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43782870|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
43782871|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782872|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782873|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43782874|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43782875|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43782876|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782877|NCT05096715|Bevacizumab|bevacizumab|mesh-list
43782878|NCT05096715|Atezolizumab|atezolizumab|mesh-list
43782879|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43782880|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782881|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43782882|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43782883|NCT05096715|Growth Substances|growth substances|mesh-ancestor
43782884|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782901|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839832|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839833|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839834|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
43839835|NCT04747795|Vitamins|vitamins|mesh-ancestor
43839836|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
43839837|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839838|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
43839839|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839840|NCT04747795|Protective Agents|protective agents|mesh-ancestor
43839841|NCT04747301|Dinoprostone|dinoprostone|mesh-list
43839842|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
43839843|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43839844|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839845|NCT04747145|Temozolomide|temozolomide|mesh-list
43839846|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43839847|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
43839848|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839849|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839850|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
43839851|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43839852|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839853|NCT04746339|Apixaban|apixaban|mesh-list
43839854|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43839855|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
43839856|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43839857|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
43839858|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839859|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839860|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
43536831|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839861|NCT04745949|Prednisone|prednisone|mesh-list
43839862|NCT04745949|Cortisone|cortisone|mesh-list
43839863|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
43839864|NCT04745949|Rituximab|rituximab|mesh-list
43839865|NCT04745949|Doxorubicin|doxorubicin|mesh-list
43839868|NCT04745949|Daunorubicin|daunorubicin|mesh-list
43839869|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43839870|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43839871|NCT04745949|Antibodies|antibodies|mesh-list
43839872|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
43839880|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
43839881|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536844|NCT03740009|Estrogens|estrogens|mesh-list
43839882|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839883|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43824920|NCT05506488|Protective Agents|protective agents|mesh-ancestor
43824921|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824922|NCT05506462|Ketamine|ketamine|mesh-list
43653546|NCT02983344|Fentanyl|fentanyl|mesh-list
43653547|NCT02983344|Ropivacaine|ropivacaine|mesh-list
43653548|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653549|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
43653550|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653551|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653552|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
43839884|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43839885|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43839886|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43839887|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839888|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839889|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
43839891|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839892|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839893|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43839894|NCT04745377|Antibodies|antibodies|mesh-list
43839895|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
43839896|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839897|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43839898|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43782918|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782919|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43782920|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782921|NCT05095480|Red yeast rice|red yeast rice|mesh-list
43782922|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43782923|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43782924|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43782925|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
43782926|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782927|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782928|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43782929|NCT05095467|Paclitaxel|paclitaxel|mesh-list
43782930|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43782931|NCT05095467|Tegafur|tegafur|mesh-list
43782932|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43782934|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
43782935|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
43782936|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
43782937|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782951|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43782952|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43782954|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536845|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43653562|NCT02983084|Trace Elements|trace elements|mesh-ancestor
43653563|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
43653564|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653565|NCT02983422|Aminophylline|aminophylline|mesh-list
43653566|NCT02983422|Furosemide|furosemide|mesh-list
43653567|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43653568|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
43653569|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653570|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653571|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43653572|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
43653573|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43782955|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43782956|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
43782958|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
43782959|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43782960|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43782962|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43782964|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
43782965|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43782966|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43782967|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43782968|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43782969|NCT05095077|Urological Agents|urological agents|mesh-ancestor
43782970|NCT05095025|Bupivacaine|bupivacaine|mesh-list
43782971|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
43782972|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
43782973|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43782974|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782975|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
43782976|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782977|NCT05091619|Vaccines|vaccines|mesh-list
43782978|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
43703531|NCT02710396|Paclitaxel|paclitaxel|mesh-list
43782979|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782980|NCT05084027|Fludarabine|fludarabine|mesh-list
43782981|NCT05084027|Melphalan|melphalan|mesh-list
43782982|NCT05084027|Venetoclax|venetoclax|mesh-list
43782983|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43782984|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43590234|NCT03372850|Esomeprazole|esomeprazole|mesh-list
43782985|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43782986|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
43782987|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782988|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43782989|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
43782990|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43782991|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43782992|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43782993|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43782994|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43782995|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43782996|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43782997|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43703532|NCT02710396|Carboplatin|carboplatin|mesh-list
43783014|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783015|NCT05001360|Nivolumab|nivolumab|mesh-list
43783016|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43783017|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653574|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43653575|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653576|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653577|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43653578|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43783018|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783019|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783020|NCT04901299|Fulvestrant|fulvestrant|mesh-list
43783021|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783022|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783023|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43783024|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43783025|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
43783028|NCT04793100|Aflibercept|aflibercept|mesh-list
43783029|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43783030|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43536934|NCT03476330|Quercetin|quercetin|mesh-list
43536935|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
43783031|NCT04793100|Growth Substances|growth substances|mesh-ancestor
43783032|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783034|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783035|NCT04760028|Anesthetics|anesthetics|mesh-list
43783036|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783037|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783039|NCT04492891|Cyclosporins|cyclosporins|mesh-list
43783040|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783041|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783042|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783043|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
43783044|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783045|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
43783046|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783047|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783048|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783049|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43783050|NCT04430985|Leucovorin|leucovorin|mesh-list
43783051|NCT04430985|Fluorouracil|fluorouracil|mesh-list
43783052|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
43783053|NCT04430985|Nivolumab|nivolumab|mesh-list
43783054|NCT04430985|Ipilimumab|ipilimumab|mesh-list
43783055|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
43783056|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783057|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783058|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783077|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43783078|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783079|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
43783080|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
43783081|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
43783082|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783083|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783084|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43783085|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43783086|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783087|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
43783088|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783089|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
43783090|NCT04064814|Flunarizine|flunarizine|mesh-list
43783091|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
43783092|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783093|NCT04064814|Protective Agents|protective agents|mesh-ancestor
43783094|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783095|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
43783096|NCT04064814|Vitamins|vitamins|mesh-ancestor
43783097|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
43783098|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
43653579|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
43653580|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653581|NCT02983422|Protective Agents|protective agents|mesh-ancestor
43783101|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43783103|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
43783104|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
43783105|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783106|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
43783107|NCT03981952|Vaccines|vaccines|mesh-list
43783108|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
43783109|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783110|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
43783111|NCT03968939|Promethazine|promethazine|mesh-list
43783112|NCT03968939|Melatonin|melatonin|mesh-list
43783113|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
43783114|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783115|NCT03968939|Protective Agents|protective agents|mesh-ancestor
43783116|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783117|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783135|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43783136|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43783137|NCT03856619|Analgesics|analgesics|mesh-ancestor
43783139|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783143|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783144|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
43839903|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43839904|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839905|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
43839906|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43839907|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43839908|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43848224|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43848225|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43848226|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
43848227|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848228|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848229|NCT04039464|Bosentan|bosentan|mesh-list
43848230|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
43848231|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
43848232|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43848233|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43848234|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848235|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848236|NCT04039464|Urological Agents|urological agents|mesh-ancestor
43848243|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848244|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848245|NCT04039087|Urological Agents|urological agents|mesh-ancestor
43653584|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43653585|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43653586|NCT02983097|Cytarabine|cytarabine|mesh-list
43653587|NCT02983097|Dexamethasone|dexamethasone|mesh-list
43653588|NCT02983097|Rituximab|rituximab|mesh-list
43653589|NCT02983097|Cisplatin|cisplatin|mesh-list
43653590|NCT02983097|Carboplatin|carboplatin|mesh-list
43653591|NCT02983097|Lenalidomide|lenalidomide|mesh-list
43653592|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653593|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537009|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43703533|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
43783161|NCT03806309|Vitamins|vitamins|mesh-ancestor
43783162|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
43783163|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
43783164|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43783165|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43783166|NCT03636165|Prednisolone|prednisolone|mesh-list
43783167|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
43783168|NCT03636165|Ropivacaine|ropivacaine|mesh-list
43783169|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43783170|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
43783171|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
43783172|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
43783173|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783174|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783205|NCT03046862|Durvalumab|durvalumab|mesh-list
43783206|NCT03046862|Tremelimumab|tremelimumab|mesh-list
43783207|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783208|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783209|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
43783210|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783211|NCT03046862|Antiviral Agents|antiviral agents|mesh-ancestor
43783212|NCT03046862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783213|NCT03046862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653594|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
43653595|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653596|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653597|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43653598|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
43537010|NCT02980666|Protective Agents|protective agents|mesh-ancestor
43537011|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537012|NCT02962102|Calcitriol|calcitriol|mesh-list
43537013|NCT02962102|Calcifediol|calcifediol|mesh-list
43537014|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43537015|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537016|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43537017|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783214|NCT03046862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783215|NCT03046862|Immunologic Factors|immunologic factors|mesh-ancestor
43783216|NCT03046862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783217|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783218|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43783242|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783243|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43783244|NCT02643056|Panitumumab|panitumumab|mesh-list
43783245|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783246|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783247|NCT02471118|Adalimumab|adalimumab|mesh-list
43783248|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783249|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783250|NCT02398396|Lactitol|lactitol|mesh-list
43783251|NCT02398396|Cathartics|cathartics|mesh-ancestor
43783252|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783253|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43783254|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
43783255|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783256|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43783257|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43783258|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783259|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783260|NCT05098119|Paclitaxel|paclitaxel|mesh-list
43783261|NCT05098119|Carboplatin|carboplatin|mesh-list
43783262|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43783263|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783264|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537018|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783265|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
43783266|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
43783267|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783269|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43783270|NCT05097950|Analgesics|analgesics|mesh-ancestor
43783271|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
43783272|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783299|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
43783300|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783301|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783303|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
43783304|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
43783305|NCT05097365|Vitamins|vitamins|mesh-ancestor
43783306|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
43783307|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783308|NCT05097365|Hematinics|hematinics|mesh-ancestor
43783309|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
43783310|NCT05097248|Doxorubicin|doxorubicin|mesh-list
43783311|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43783312|NCT05097248|Losartan|losartan|mesh-list
43783313|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43783315|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43783316|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43783317|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783318|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537067|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
43783319|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43783320|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43783321|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43783322|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43783334|NCT05097209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783335|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
43783336|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
43783337|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43783338|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43783339|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43653599|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
43653600|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653601|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653602|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
43653603|NCT02983097|Hormones|hormones|mesh-ancestor
43653604|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653605|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783340|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783341|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783342|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
43783343|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783344|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783345|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43783346|NCT05089851|Protective Agents|protective agents|mesh-ancestor
43783347|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783348|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43783349|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783350|NCT05087940|Diuretics|diuretics|mesh-list
43783351|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43783352|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
43783353|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783354|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783355|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783356|NCT05083325|Oseltamivir|oseltamivir|mesh-list
43783357|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
43783358|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783359|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783360|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783361|NCT05060484|Vaccines|vaccines|mesh-list
43783362|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
43783363|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783364|NCT05057572|Carvedilol|carvedilol|mesh-list
43783365|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43537139|NCT02372630|Incretins|incretins|mesh-ancestor
43783366|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43783367|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
43783368|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783369|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783370|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783371|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43783372|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
43783373|NCT05057572|Protective Agents|protective agents|mesh-ancestor
43783374|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43783375|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43783376|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43783377|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
43783378|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43783379|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43783380|NCT05026801|Azithromycin|azithromycin|mesh-list
43783381|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
43703534|NCT02710396|Pemetrexed|pemetrexed|mesh-list
43653608|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653609|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
43653610|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653611|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653612|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43653613|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43653614|NCT02983097|Growth Substances|growth substances|mesh-ancestor
43653615|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
43653616|NCT02983383|Anesthetics|anesthetics|mesh-list
43653617|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653618|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653619|NCT02982798|Metformin|metformin|mesh-list
43839916|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43839918|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43839919|NCT04742036|Paclitaxel|paclitaxel|mesh-list
43839920|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43839954|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
43839955|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
43839956|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839957|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
43839958|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783418|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783420|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
43783421|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
43783422|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
43783423|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43783424|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
43783425|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43783427|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43537167|NCT01774721|Gefitinib|gefitinib|mesh-list
43783428|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43783429|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43783430|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783431|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783432|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43783433|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43783434|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783435|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783436|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783437|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
43783438|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43783439|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783440|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43783441|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783443|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537184|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783444|NCT04613622|Venetoclax|venetoclax|mesh-list
43783445|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783446|NCT04523935|Topiramate|topiramate|mesh-list
43783447|NCT04523935|Lamotrigine|lamotrigine|mesh-list
43783458|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783459|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783460|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43783461|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43783462|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653620|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43653621|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653622|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653623|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43783463|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783464|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43783465|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43783466|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783467|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783468|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
43783484|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43783486|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43783487|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
43783488|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
43783491|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43783493|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
43783494|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
43783495|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43783496|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43783497|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43783498|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43783499|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
43783500|NCT04515186|Miltefosine|miltefosine|mesh-list
43783501|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
43783502|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
43783503|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783504|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783505|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43783506|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43783507|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
43783508|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
43653629|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653630|NCT02982889|Bupivacaine|bupivacaine|mesh-list
43653631|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
43653632|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653633|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
43653634|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653635|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653636|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
43653637|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653638|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43653639|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
43653640|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
43653641|NCT02982889|Protective Agents|protective agents|mesh-ancestor
43653642|NCT02982694|Bevacizumab|bevacizumab|mesh-list
43653643|NCT02982694|Atezolizumab|atezolizumab|mesh-list
43653644|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537314|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
43537315|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537316|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43537317|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43537318|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43537319|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
43537320|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537321|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653645|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653646|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43653647|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43653648|NCT02982694|Growth Substances|growth substances|mesh-ancestor
43653649|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653650|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
43653652|NCT02982850|Warfarin|warfarin|mesh-list
43653653|NCT02982850|Dabigatran|dabigatran|mesh-list
43537364|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537365|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537366|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43537367|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
43537368|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43537369|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43537371|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
43653654|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43653655|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43653656|NCT02982850|Analgesics|analgesics|mesh-ancestor
43653657|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
43653658|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783520|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653659|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653660|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783521|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783523|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43783524|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
43783525|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783526|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783527|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43783529|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
43783530|NCT04305145|Prednisone|prednisone|mesh-list
43783531|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
43783532|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43537429|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43537430|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43783533|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43537431|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537432|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
43537433|NCT05672459|Fludarabine|fludarabine|mesh-list
43537434|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
43783534|NCT04305145|Prednisolone|prednisolone|mesh-list
43783535|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
43783536|NCT04305145|Infliximab|infliximab|mesh-list
43783537|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43783538|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
43783539|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783540|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
43783541|NCT04305145|Hormones|hormones|mesh-ancestor
43783542|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783543|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783544|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783545|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783546|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
43783547|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
43783548|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783549|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783550|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43783551|NCT04305145|Protective Agents|protective agents|mesh-ancestor
43783552|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
43839976|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
43839977|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43839978|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
43839979|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
43839980|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43839981|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43839982|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43839983|NCT04738318|Hormones|hormones|mesh-ancestor
43537494|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43839984|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43839985|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43839986|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43839987|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43839988|NCT04738318|Protective Agents|protective agents|mesh-ancestor
43839989|NCT04738149|Bimatoprost|bimatoprost|mesh-list
43840004|NCT04734405|Fluconazole|fluconazole|mesh-list
43840005|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
43783554|NCT04188145|Bevacizumab|bevacizumab|mesh-list
43783555|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43783556|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783557|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43783558|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43783559|NCT04188145|Growth Substances|growth substances|mesh-ancestor
43783560|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783561|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
43783562|NCT04181606|Esmolol|esmolol|mesh-list
43783564|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43783565|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43783566|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
43783567|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783568|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783569|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783570|NCT04128774|Dexamethasone|dexamethasone|mesh-list
43783571|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
43783572|NCT04128774|BB 1101|bb 1101|mesh-list
43783573|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783574|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
43783575|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
43783576|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653661|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43653662|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43653663|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43653664|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537646|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
43783577|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783578|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783579|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
43783580|NCT04128774|Hormones|hormones|mesh-ancestor
43783581|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783582|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43783583|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783584|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
43783585|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783586|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783587|NCT04088123|Ticagrelor|ticagrelor|mesh-list
43783588|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43783589|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43783590|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43783591|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43783592|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
43783593|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783623|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43783624|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43783625|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783626|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783627|NCT03477851|Tramadol|tramadol|mesh-list
43783628|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43783629|NCT03477851|Narcotics|narcotics|mesh-ancestor
43783630|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783631|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783632|NCT03477851|Analgesics|analgesics|mesh-ancestor
43783633|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
43783634|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783635|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43537712|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537713|NCT05374512|Paclitaxel|paclitaxel|mesh-list
43537714|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43537715|NCT05374512|Carboplatin|carboplatin|mesh-list
43537724|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
43783636|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
43783637|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783638|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
43783639|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783640|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783641|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
43783642|NCT03412188|Hormones|hormones|mesh-ancestor
43783669|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43783670|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783671|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783672|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43783673|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43783674|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43783675|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43783676|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43783677|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43783683|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43783703|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43783704|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783705|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
43783706|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783708|NCT02595060|Sargramostim|sargramostim|mesh-list
43783709|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653665|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43653666|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43653667|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653668|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
43653669|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
43653670|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
43653671|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43840012|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
43840013|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840014|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840015|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43840016|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43840017|NCT04734262|Paclitaxel|paclitaxel|mesh-list
43840018|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43840019|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840020|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840021|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537853|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
43840022|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840023|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
43783743|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
43783744|NCT05100719|Emollients|emollients|mesh-ancestor
43783745|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
43783746|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
43783747|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
43783748|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783749|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783750|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
43783751|NCT05100563|Naltrexone|naltrexone|mesh-list
43783752|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43783753|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43783754|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783755|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
43783756|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537974|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537975|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537976|NCT05160922|Crizotinib|crizotinib|mesh-list
43537977|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537978|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43537979|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783757|NCT05100446|Amoxicillin|amoxicillin|mesh-list
43783758|NCT05100446|Esomeprazole|esomeprazole|mesh-list
43783759|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43783760|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783761|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43783762|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783763|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43783764|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783765|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783766|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
43783767|NCT05100329|Analgesics|analgesics|mesh-ancestor
43783768|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
43783769|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783770|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783771|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783772|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43783773|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43783774|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783775|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783776|NCT05100303|Cytarabine|cytarabine|mesh-list
43783777|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
43783778|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43783779|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
43783780|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783781|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783782|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
43783783|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783784|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43783785|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
43783786|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783787|NCT05100303|Analgesics|analgesics|mesh-ancestor
43783788|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
43653672|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
43653673|NCT02982551|Insulin|insulin|mesh-list
43653674|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653675|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653676|NCT02982486|Nivolumab|nivolumab|mesh-list
43653677|NCT02982486|Ipilimumab|ipilimumab|mesh-list
43653678|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653679|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653680|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43653681|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653682|NCT02982577|Pilocarpine|pilocarpine|mesh-list
43653683|NCT02982577|Miotics|miotics|mesh-ancestor
43653685|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653686|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653688|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43653689|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
43653690|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43734411|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653691|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538121|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43538122|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538123|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43538124|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43538126|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
43538127|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538128|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783818|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783820|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783822|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
43783823|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43783824|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783825|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43783826|NCT05099198|Glimepiride|glimepiride|mesh-list
43783827|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43783828|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783829|NCT05099198|Incretins|incretins|mesh-ancestor
43783830|NCT05099198|Hormones|hormones|mesh-ancestor
43783831|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43783832|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43783833|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
43783834|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43783853|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
43783854|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43783856|NCT05087615|Metoclopramide|metoclopramide|mesh-list
43783857|NCT05087615|Granisetron|granisetron|mesh-list
43783858|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
43783859|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
43783860|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783861|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783862|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43783866|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
43783867|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43783868|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783869|NCT05087615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43783870|NCT05087615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43783871|NCT05087615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653693|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43653694|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43783875|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43783876|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
43783877|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
43783878|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
43783879|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783880|NCT04911660|Empagliflozin|empagliflozin|mesh-list
43783881|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43783882|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43783883|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43538360|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
43783884|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783885|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
43783887|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43783888|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
43783889|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43783890|NCT04825704|Bupivacaine|bupivacaine|mesh-list
43783891|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
43783956|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43783957|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43653697|NCT02982512|Analgesics|analgesics|mesh-ancestor
43653698|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
43783989|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43783990|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43783991|NCT04176718|Dexamethasone|dexamethasone|mesh-list
43783992|NCT04176718|Daratumumab|daratumumab|mesh-list
43783993|NCT04176718|Pomalidomide|pomalidomide|mesh-list
43538409|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43538410|NCT04804553|Analgesics|analgesics|mesh-ancestor
43538411|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
43783994|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43783995|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
43783996|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
43783997|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43783998|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43783999|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849566|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43784013|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
43784014|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784015|NCT03481842|Axitinib|axitinib|mesh-list
43784016|NCT03481842|Afatinib|afatinib|mesh-list
43784017|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784018|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784048|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43784049|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
43538474|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43538475|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
43538476|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
43538479|NCT04751383|Dinutuximab|dinutuximab|mesh-list
43784050|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43784067|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784068|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
43784069|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
43784070|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784071|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784072|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784073|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
43784074|NCT02718833|Hormones|hormones|mesh-ancestor
43784075|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784076|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784102|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
43784103|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784104|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784105|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784106|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784107|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43784108|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43784109|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
43784110|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784111|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43784112|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43784113|NCT05102422|Propofol|propofol|mesh-list
43784120|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
43538544|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43784121|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43784122|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43784123|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
43784124|NCT05102396|Oxybutynin|oxybutynin|mesh-list
43784125|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
43784126|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
43784127|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784128|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784129|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43784130|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43784131|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
43784132|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784133|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784134|NCT05102396|Urological Agents|urological agents|mesh-ancestor
43784135|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43784147|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43784148|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784149|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784150|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784151|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784152|NCT05102045|Memantine|memantine|mesh-list
43784153|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
43784154|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43784155|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43784159|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784160|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43538606|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
43784161|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43784162|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784163|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
43784165|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
43784166|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784168|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
43784169|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
43784170|NCT05101811|Vitamins|vitamins|mesh-list
43784171|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
43784172|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784173|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43784174|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43784175|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43784181|NCT05101785|Carticaine|carticaine|mesh-list
43784182|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
43784183|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
43784184|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
43784185|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784186|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784187|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
43784188|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784189|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43784190|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43538660|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
43784191|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43784192|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784193|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784194|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43784195|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784196|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784197|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784198|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43784215|NCT05101291|Bupivacaine|bupivacaine|mesh-list
43784216|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
43784217|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
43538708|NCT04396821|Paclitaxel|paclitaxel|mesh-list
43538709|NCT04396821|Nivolumab|nivolumab|mesh-list
43538710|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43538711|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538712|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538713|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538714|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538715|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538716|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538717|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538718|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
43538719|NCT04396821|Antiviral Agents|antiviral agents|mesh-ancestor
43538720|NCT04396821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538721|NCT04396821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538722|NCT04396821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538723|NCT04396821|Immunologic Factors|immunologic factors|mesh-ancestor
43538732|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
43538733|NCT04339062|Hormones|hormones|mesh-ancestor
43538735|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538736|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538737|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538738|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538739|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
43538740|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43538746|NCT04332068|Permethrin|permethrin|mesh-list
43784218|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784220|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
43784221|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784223|NCT05092074|Velpatasvir|velpatasvir|mesh-list
43784224|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
43784225|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784226|NCT05083949|Metformin|metformin|mesh-list
43784227|NCT05083949|Empagliflozin|empagliflozin|mesh-list
43784228|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784229|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784230|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43784231|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840064|NCT04730999|Bevacizumab|bevacizumab|mesh-list
43784244|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
43784245|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
43784246|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
43784247|NCT04894864|Anesthetics|anesthetics|mesh-list
43784248|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784249|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784250|NCT04894864|Narcotics|narcotics|mesh-ancestor
43784251|NCT04894864|Analgesics|analgesics|mesh-ancestor
43784252|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
43784253|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784255|NCT04719065|Analgesics|analgesics|mesh-ancestor
43784256|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
43784257|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653729|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653730|NCT02982395|Ethanol|ethanol|mesh-list
43653731|NCT02982395|Docetaxel|docetaxel|mesh-list
43653732|NCT02982395|Mitomycins|mitomycins|mesh-list
43784258|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784270|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784272|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
43784273|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784285|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784286|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784287|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784288|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784289|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784291|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
43784292|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784293|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43784294|NCT04364776|Durvalumab|durvalumab|mesh-list
43784295|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784296|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784297|NCT04351295|Chloroquine|chloroquine|mesh-list
43784298|NCT04351295|Favipiravir|favipiravir|mesh-list
43784299|NCT04351295|Amebicides|amebicides|mesh-ancestor
43784300|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43538873|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784301|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784302|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784304|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784305|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
43784307|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784308|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784309|NCT04271293|Edoxaban|edoxaban|mesh-list
43784310|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43784311|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
43784312|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43784313|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
43784314|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784315|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784316|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
43784317|NCT03838744|Olaparib|olaparib|mesh-list
43784318|NCT03838744|Trabectedin|trabectedin|mesh-list
43784319|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43784320|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784321|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784322|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784323|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784324|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
43784325|NCT03736629|Azithromycin|azithromycin|mesh-list
43784326|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43840104|NCT04730531|Epinephrine|epinephrine|mesh-list
43840105|NCT04730531|Bupivacaine|bupivacaine|mesh-list
43653734|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653735|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653736|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653737|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653738|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653739|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43653740|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
43653741|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43653742|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653743|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43653744|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653745|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539073|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539080|NCT03891953|Spartalizumab|spartalizumab|mesh-list
43653746|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653747|NCT02982005|Brodalumab|brodalumab|mesh-list
43840106|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
43840107|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
43840108|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840109|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840110|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
43840111|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840112|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43840113|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43840114|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784340|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43784341|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784342|NCT03430791|Nivolumab|nivolumab|mesh-list
43784343|NCT03430791|Ipilimumab|ipilimumab|mesh-list
43784344|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784379|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
43784380|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43784381|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
43784382|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
43784383|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
43784394|NCT03023124|Dacarbazine|dacarbazine|mesh-list
43784395|NCT03023124|Trabectedin|trabectedin|mesh-list
43784396|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43784397|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784398|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43653748|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
43653749|NCT02982148|Methylene Blue|methylene blue|mesh-list
43653750|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653751|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653752|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43653755|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653756|NCT02981784|Ponatinib|ponatinib|mesh-list
43653757|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653758|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43653759|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653760|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653761|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
43653762|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653763|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653764|NCT02981719|Gemcitabine|gemcitabine|mesh-list
43653765|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539146|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43653766|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
43653767|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653768|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653769|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
43653770|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653771|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653772|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43653773|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
43653774|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653775|NCT02981615|Levofloxacin|levofloxacin|mesh-list
43653776|NCT02981615|Ofloxacin|ofloxacin|mesh-list
43653777|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43653778|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653779|NCT02981615|Renal Agents|renal agents|mesh-ancestor
43653780|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653781|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43653782|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43653783|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784399|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784400|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784401|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784402|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43784403|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
43784405|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43784406|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784407|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
43784408|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784410|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
43784411|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784412|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43784413|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784414|NCT02683018|Analgesics|analgesics|mesh-ancestor
43784425|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653784|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653785|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653786|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43539183|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
43539190|NCT03614949|Atezolizumab|atezolizumab|mesh-list
43653787|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43824923|NCT05506462|Analgesics|analgesics|mesh-ancestor
43824924|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
43824925|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824926|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824927|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43824928|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43824929|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
43824930|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
43824931|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824932|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43784426|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43784427|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784428|NCT02675842|Analgesics|analgesics|mesh-ancestor
43784429|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
43784430|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784431|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43784432|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43784434|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784436|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784437|NCT02615119|Isoproterenol|isoproterenol|mesh-list
43784438|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43784439|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784440|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784441|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784442|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784452|NCT02598349|Capecitabine|capecitabine|mesh-list
43784453|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43784454|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
43784455|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784456|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784457|NCT02555293|Rifaximin|rifaximin|mesh-list
43784458|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43539376|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
43784459|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784460|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784462|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784463|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784464|NCT05104138|Eplerenone|eplerenone|mesh-list
43784465|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43784466|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
43784467|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784468|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784469|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43784471|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
43784472|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43784473|NCT05103813|Beraprost|beraprost|mesh-list
43784474|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43784475|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
43784476|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
43824933|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43824935|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824937|NCT05506410|Prednisone|prednisone|mesh-list
43824938|NCT05506410|Rituximab|rituximab|mesh-list
43539454|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539457|NCT02967757|Liraglutide|liraglutide|mesh-list
43824939|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43653788|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43784477|NCT05103501|Fluorouracil|fluorouracil|mesh-list
43784478|NCT05103501|Cisplatin|cisplatin|mesh-list
43784479|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43784480|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784481|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784482|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
43539511|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539512|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
43539513|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539514|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
43539515|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539516|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784483|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784484|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43784485|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43784486|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
43784487|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784488|NCT05103397|Prednisolone|prednisolone|mesh-list
43784489|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43784490|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
43784491|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43784492|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
43784493|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43784494|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
43784495|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784496|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
43784497|NCT05103397|Hormones|hormones|mesh-ancestor
43784498|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784499|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784500|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784501|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784502|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
43784503|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
43784504|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784505|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784506|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43784507|NCT05103397|Protective Agents|protective agents|mesh-ancestor
43784541|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784542|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784543|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539583|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784544|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
43539584|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539585|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539586|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539587|NCT02304458|Nivolumab|nivolumab|mesh-list
43539588|NCT02304458|Ipilimumab|ipilimumab|mesh-list
43539589|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539590|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539591|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43539592|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539593|NCT02282059|Sunitinib|sunitinib|mesh-list
43539594|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784545|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43784546|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43784547|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784548|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
43784563|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784565|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43784566|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
43784568|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539622|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43784570|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784571|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
43784572|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43784573|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
43784574|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43784575|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43784576|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784577|NCT04985851|Durvalumab|durvalumab|mesh-list
43653791|NCT02981329|Metformin|metformin|mesh-list
43653792|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653793|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653794|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
43653795|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43653796|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653797|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43653798|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
43784578|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43784579|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43784580|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784581|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
43784582|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784584|NCT04976374|Gabapentin|gabapentin|mesh-list
43840144|NCT04729114|Dexamethasone|dexamethasone|mesh-list
43840145|NCT04729114|Prednisone|prednisone|mesh-list
43840146|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840147|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
43784619|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43539841|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43784620|NCT04794205|Analgesics|analgesics|mesh-ancestor
43784624|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539845|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
43784625|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784627|NCT04725032|Sevoflurane|sevoflurane|mesh-list
43784628|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784629|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784630|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784631|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43784632|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
43784633|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
43784634|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43784635|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43784636|NCT04716114|Cytarabine|cytarabine|mesh-list
43784637|NCT04716114|Fludarabine|fludarabine|mesh-list
43784638|NCT04716114|Azacitidine|azacitidine|mesh-list
43784639|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
43784640|NCT04716114|Aclarubicin|aclarubicin|mesh-list
43784641|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784642|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43784644|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784645|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668249|NCT03736616|Melphalan|melphalan|mesh-list
43784646|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
43784647|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784648|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
43784649|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784650|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784651|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43784652|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43784653|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43784654|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43540018|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
43540020|NCT00724789|Ganirelix|ganirelix|mesh-list
43784655|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43784656|NCT04655222|Interferons|interferons|mesh-list
43784676|NCT04519905|Carboplatin|carboplatin|mesh-list
43784677|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43784678|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784679|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
43784680|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
43784681|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
43784682|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784684|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
43784685|NCT04482686|Vitamins|vitamins|mesh-list
43784688|NCT04482686|Doxycycline|doxycycline|mesh-list
43784689|NCT04482686|Ivermectin|ivermectin|mesh-list
43653799|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43653800|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653801|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653802|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653804|NCT02981212|Prednisolone|prednisolone|mesh-list
43653805|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43653806|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43784690|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
43784691|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
43784692|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784693|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43784694|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43784695|NCT04482686|Trace Elements|trace elements|mesh-ancestor
43784696|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
43784697|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784698|NCT04482686|Protective Agents|protective agents|mesh-ancestor
43784699|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784700|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784701|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
43784702|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43784703|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43784704|NCT04482686|Astringents|astringents|mesh-ancestor
43784705|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784706|NCT04423341|Cannabidiol|cannabidiol|mesh-list
43784707|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
43784708|NCT04323462|Insulin|insulin|mesh-list
43784709|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43784711|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784712|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784713|NCT04318392|Dimercaprol|dimercaprol|mesh-list
43540102|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540103|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540104|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43784714|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
43540105|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43540106|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540109|NCT00519857|Hormones|hormones|mesh-ancestor
43784729|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43784730|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43784731|NCT04125771|Analgesics|analgesics|mesh-ancestor
43784732|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
43784733|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784734|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784735|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784736|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43784737|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43784738|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784739|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784740|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
43784759|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43540190|NCT00395408|Beclomethasone|beclomethasone|mesh-list
43784760|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43784761|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43784762|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784763|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784764|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784765|NCT02850263|Aflibercept|aflibercept|mesh-list
43784766|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43784767|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43784768|NCT02850263|Growth Substances|growth substances|mesh-ancestor
43784769|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784770|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
43784789|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43784790|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43784791|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43784792|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784793|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
43784794|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784795|NCT05106179|Propranolol|propranolol|mesh-list
43784797|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43784798|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43784799|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
43784800|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43784801|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784802|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784803|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43784804|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43784805|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
43784806|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
43784807|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
43784808|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784809|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43840158|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43840159|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840160|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840161|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43840162|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840163|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840164|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
43840165|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
43840166|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840167|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840168|NCT04728971|Caspofungin|caspofungin|mesh-list
43840169|NCT04728971|Micafungin|micafungin|mesh-list
43840170|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
43653815|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
43653817|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653818|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653819|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43653820|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
43653821|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
43653822|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43653823|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653824|NCT02981264|Lidocaine|lidocaine|mesh-list
43653825|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653826|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
43653827|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653828|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840171|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840172|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840173|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840174|NCT04728360|Ustekinumab|ustekinumab|mesh-list
43840175|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
43784829|NCT05105412|Antiviral Agents|antiviral agents|mesh-ancestor
43784830|NCT05105412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43784831|NCT05105412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43784832|NCT05105412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43784833|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
43784834|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831494|NCT05311436|Vitamins|vitamins|mesh-ancestor
43784835|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43784836|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43784850|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43784851|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
43784853|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43784854|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784855|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43784856|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43784857|NCT05105022|Propofol|propofol|mesh-list
43784858|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43784859|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43784895|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43784896|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784897|NCT05104333|Vaccines|vaccines|mesh-list
43784898|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
43784899|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784900|NCT05104281|Osimertinib|osimertinib|mesh-list
43784930|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653829|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
43653830|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653831|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43653832|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43703567|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703568|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
43840193|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840194|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840195|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43840196|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840197|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
43840198|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43840199|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840200|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840201|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840202|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
43840203|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
43848275|NCT04036305|Lidocaine|lidocaine|mesh-list
43848276|NCT04036305|Bupivacaine|bupivacaine|mesh-list
43848277|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
43848278|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
43848279|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848280|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848281|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
43848282|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43784940|NCT04593914|Protective Agents|protective agents|mesh-list
43784941|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784942|NCT04573504|Clindamycin|clindamycin|mesh-list
43784943|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
43784977|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43784979|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43784980|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43784981|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43784982|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43784983|NCT03903692|Laxatives|laxatives|mesh-ancestor
43540344|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43784984|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43784985|NCT03769688|Metronidazole|metronidazole|mesh-list
43785008|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43785009|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653835|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653837|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43653838|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43653839|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43653840|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
43653841|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43653842|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653843|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653844|NCT02981459|Urological Agents|urological agents|mesh-ancestor
43785012|NCT03164564|Cabotegravir|cabotegravir|mesh-list
43785013|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
43785014|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785015|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43785017|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785018|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785019|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43785020|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43785021|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43785022|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43785023|NCT03100045|Artesunate|artesunate|mesh-list
43785024|NCT03100045|Artemisinins|artemisinins|mesh-list
43785025|NCT03100045|Artemisinin|artemisinin|mesh-list
43785026|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
43785063|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
43785064|NCT05108051|Oseltamivir|oseltamivir|mesh-list
43785065|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
43785066|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785067|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785068|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540416|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
43785069|NCT05107921|Bromfenac|bromfenac|mesh-list
43840225|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540417|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540418|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540419|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540420|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540421|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540422|NCT00043108|Paclitaxel|paclitaxel|mesh-list
43540423|NCT00043108|Carboplatin|carboplatin|mesh-list
43840260|NCT04722354|Growth Substances|growth substances|mesh-ancestor
43840261|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840263|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840264|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43840265|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840266|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840268|NCT04720105|Tazarotene|tazarotene|mesh-list
43840269|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840270|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
43840271|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43785108|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
43785109|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540469|NCT05224336|Psilocybin|psilocybin|mesh-list
43785110|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785111|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43785112|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43785113|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785114|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785115|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540617|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785116|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43785117|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43785118|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43785119|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43785120|NCT05106803|Renal Agents|renal agents|mesh-ancestor
43785121|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
43785122|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43785123|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43785124|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43653846|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43653847|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653848|NCT02981095|Bupivacaine|bupivacaine|mesh-list
43653849|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653850|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
43653851|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653852|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653853|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
43734412|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
43653854|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653856|NCT02980991|Pemetrexed|pemetrexed|mesh-list
43653857|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653858|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785126|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43785146|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43785147|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540714|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540715|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
43540716|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
43540717|NCT04479566|Calcium|calcium|mesh-list
43540718|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540719|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540720|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
43540721|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43540722|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540723|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540724|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
43540725|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43540726|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540727|NCT04479566|Antacids|antacids|mesh-ancestor
43540728|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43540729|NCT04356495|Ciclesonide|ciclesonide|mesh-list
43540730|NCT04356495|Interferons|interferons|mesh-list
43540731|NCT04356495|Interferon-beta|interferon-beta|mesh-list
43540732|NCT04356495|Telmisartan|telmisartan|mesh-list
43540733|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
43540734|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540735|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540736|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
43540737|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785148|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43785149|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43785150|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785151|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43785152|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
43785153|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43785154|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43785155|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
43785156|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785157|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43785158|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43785159|NCT05083000|Topotecan|topotecan|mesh-list
43785160|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43785161|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43785162|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785163|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785164|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785166|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
43785167|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785168|NCT04903093|Famotidine|famotidine|mesh-list
43785169|NCT04903093|Abrocitinib|abrocitinib|mesh-list
43785170|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43785178|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785179|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785180|NCT04771689|Buprenorphine|buprenorphine|mesh-list
43653861|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43653863|NCT02981030|Mifepristone|mifepristone|mesh-list
43653864|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43653865|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
43653867|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653868|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43653869|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653870|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
43653874|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43653875|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
43785181|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43785182|NCT04771689|Naloxone|naloxone|mesh-list
43785183|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43785185|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785186|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785187|NCT04771689|Analgesics|analgesics|mesh-ancestor
43785188|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
43785190|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43785192|NCT04695106|Dabigatran|dabigatran|mesh-list
43785193|NCT04695106|Clopidogrel|clopidogrel|mesh-list
43785194|NCT04695106|Ticagrelor|ticagrelor|mesh-list
43785196|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785197|NCT04695106|Analgesics|analgesics|mesh-ancestor
43785198|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
43785199|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785200|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785201|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785202|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785203|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43785204|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43785205|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785206|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43785208|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785209|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
43785210|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43785211|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43785212|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43785213|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
43785214|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785215|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
43785216|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43653876|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43653877|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43653878|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
43653879|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540801|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540802|NCT03843008|Protective Agents|protective agents|mesh-ancestor
43540803|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540804|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653880|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
43653881|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43785217|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
43785218|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
43785242|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785244|NCT04316364|Carboplatin|carboplatin|mesh-list
43785245|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43785246|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785247|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43785248|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
43785249|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
43785250|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785251|NCT04210141|Antivenins|antivenins|mesh-list
43785252|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
43785253|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785254|NCT04018872|Itraconazole|itraconazole|mesh-list
43785256|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540826|NCT03772353|Letrozole|letrozole|mesh-list
43785257|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43785258|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43785259|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785260|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785261|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43785262|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
43785263|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43785264|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785265|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43785267|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43785268|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
43785269|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785270|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785289|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43785290|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785291|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785292|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
43785293|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785295|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43785296|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43785297|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
43785298|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
43785299|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785300|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785301|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43785302|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43785303|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43785304|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
43785305|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785306|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785307|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
43785308|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43785309|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785310|NCT03293017|Diazepam|diazepam|mesh-list
43785311|NCT03293017|Baclofen|baclofen|mesh-list
43785312|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43785313|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785314|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43785315|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43653882|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43540930|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
43653884|NCT02980809|Topotecan|topotecan|mesh-list
43541008|NCT01965132|Etanercept|etanercept|mesh-list
43653885|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653886|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43785316|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43785317|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
43785318|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
43785319|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785320|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785321|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43785322|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
43785323|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
43785324|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
43785325|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785326|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43785327|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541081|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43785341|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43785342|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
43840284|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43840285|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
43840286|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43840288|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840289|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43840290|NCT04717973|Vitamin D|vitamin d|mesh-list
43840291|NCT04717973|Vitamins|vitamins|mesh-list
43840292|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
43840293|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
43840294|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
43840295|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840296|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43840297|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
43840298|NCT04717973|Hematinics|hematinics|mesh-ancestor
43840299|NCT04716933|Cisplatin|cisplatin|mesh-list
43840300|NCT04716933|Carboplatin|carboplatin|mesh-list
43840301|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
43840302|NCT04716933|Pemetrexed|pemetrexed|mesh-list
43840303|NCT04716933|Lenvatinib|lenvatinib|mesh-list
43840306|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840307|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840308|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43840310|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43840311|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
43840312|NCT04714372|Fludarabine|fludarabine|mesh-list
43840313|NCT04714372|Daratumumab|daratumumab|mesh-list
43840314|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43840315|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
43840316|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840317|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840318|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43840319|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
43840320|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840322|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43840323|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43840324|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
43840325|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840326|NCT04712903|Cisplatin|cisplatin|mesh-list
43840327|NCT04712903|Carboplatin|carboplatin|mesh-list
43840328|NCT04712903|Etoposide|etoposide|mesh-list
43840331|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840332|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43840333|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43840334|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785357|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43785359|NCT02982668|Mosapride|mosapride|mesh-list
43653887|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653888|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653889|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43653890|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43653891|NCT02980926|Bupivacaine|bupivacaine|mesh-list
43653892|NCT02980926|Mepivacaine|mepivacaine|mesh-list
43653893|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
43653894|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
43653895|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653896|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653897|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
43653898|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785360|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
43785361|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
43785362|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785363|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785364|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785365|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43785366|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43785367|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
43785368|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785369|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785370|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43785371|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
43785372|NCT02749513|Itraconazole|itraconazole|mesh-list
43785400|NCT05110339|Ropivacaine|ropivacaine|mesh-list
43785401|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43785402|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785403|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785404|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43785405|NCT05110339|Analgesics|analgesics|mesh-ancestor
43785406|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
43785407|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785408|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43785409|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43785410|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43785411|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
43541232|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785412|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785413|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785414|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785415|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
43785416|NCT05110170|Goserelin|goserelin|mesh-list
43785435|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
43785437|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785438|NCT05109390|Cyclosporine|cyclosporine|mesh-list
43785439|NCT05109390|Simethicone|simethicone|mesh-list
43785440|NCT05109390|Omeprazole|omeprazole|mesh-list
43785441|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
43785442|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
43785443|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
43785444|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
43785445|NCT05109390|Antacids|antacids|mesh-list
43785446|NCT05109390|Tacrolimus|tacrolimus|mesh-list
43785447|NCT05109390|Cyclosporins|cyclosporins|mesh-list
43785448|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785449|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785450|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
43785451|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43785452|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785453|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785454|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
43653900|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43785456|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
43785457|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785458|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785459|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43785460|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
43785461|NCT05109390|Emollients|emollients|mesh-ancestor
43785463|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785464|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43785465|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43785466|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785467|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785468|NCT05109377|Urological Agents|urological agents|mesh-ancestor
43541285|NCT00408863|Hormones|hormones|mesh-ancestor
43541286|NCT05581940|Bupivacaine|bupivacaine|mesh-list
43541287|NCT05581940|Anesthetics|anesthetics|mesh-list
43541288|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
43541289|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541314|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541315|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541316|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541317|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
43541319|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541320|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541321|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541322|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
43541323|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43541324|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541325|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43541347|NCT05528848|Fentanyl|fentanyl|mesh-list
43785469|NCT05109312|Acetaminophen|acetaminophen|mesh-list
43785470|NCT05109312|Ibuprofen|ibuprofen|mesh-list
43785471|NCT05109312|Bupivacaine|bupivacaine|mesh-list
43785472|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785474|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785475|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785476|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
43785491|NCT05108714|Lidocaine|lidocaine|mesh-list
43785492|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785493|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
43785494|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541363|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541364|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785497|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785498|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43785499|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43785500|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43785501|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785502|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785503|NCT05108597|Misoprostol|misoprostol|mesh-list
43785504|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43785505|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
43785506|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785507|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785508|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43785509|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785510|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
43785511|NCT05108545|Amphotericin B|amphotericin b|mesh-list
43785512|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43785513|NCT05108545|Amebicides|amebicides|mesh-ancestor
43785514|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43785515|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43785516|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785517|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43785518|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
43785519|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
43785520|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43785521|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43785522|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785523|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
43785524|NCT05102695|Coagulants|coagulants|mesh-ancestor
43785525|NCT05093920|Doxorubicin|doxorubicin|mesh-list
43785526|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43785527|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43785528|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541428|NCT05472792|Exemestane|exemestane|mesh-list
43541430|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43785529|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43785532|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785533|NCT05007769|Atezolizumab|atezolizumab|mesh-list
43785534|NCT05007769|Ramucirumab|ramucirumab|mesh-list
43785535|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785536|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
43653908|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
43785550|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785551|NCT04595864|Antidotes|antidotes|mesh-ancestor
43785552|NCT04595864|Protective Agents|protective agents|mesh-ancestor
43785553|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
43785555|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
43848286|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848287|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848289|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
43848290|NCT04036188|Triamcinolone|triamcinolone|mesh-list
43848291|NCT04036188|Vitamins|vitamins|mesh-ancestor
43848292|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
43848316|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43848317|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43848318|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
43848319|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848320|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848321|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848322|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43848323|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43848324|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
43848325|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848326|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43848327|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
43848328|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
43848329|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
43848330|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43848331|NCT04032067|Finasteride|finasteride|mesh-list
43848332|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43848333|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43848334|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848335|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848337|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848338|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848339|NCT04032067|Urological Agents|urological agents|mesh-ancestor
43849003|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43849004|NCT03974828|Anesthetics|anesthetics|mesh-list
43849005|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849006|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785583|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785584|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785585|NCT04383119|Antiviral Agents|antiviral agents|mesh-ancestor
43785586|NCT04383119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785587|NCT04383119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785588|NCT04383119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785589|NCT04383119|Immunologic Factors|immunologic factors|mesh-ancestor
43541534|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43785590|NCT04383119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653909|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653910|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785591|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43785592|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
43785593|NCT04339218|Carboplatin|carboplatin|mesh-list
43785624|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43785625|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43785626|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43785627|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785628|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43785629|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43593437|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785630|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785631|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43785632|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43785633|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
43785634|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43785652|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43785653|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785655|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
43785656|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541535|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
43785658|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541536|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785659|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785660|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43785661|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43785662|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43785663|NCT04040738|Anesthetics|anesthetics|mesh-list
43785664|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785665|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785666|NCT03943342|Venetoclax|venetoclax|mesh-list
43785667|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43785669|NCT03783351|Ticagrelor|ticagrelor|mesh-list
43785670|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43541553|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785671|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43785672|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43785693|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43785694|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43653912|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
43653913|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653914|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653915|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43653916|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653917|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
43653918|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
43653919|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
43785695|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785697|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
43785698|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785699|NCT03540875|Remifentanil|remifentanil|mesh-list
43785700|NCT03540875|Propofol|propofol|mesh-list
43785701|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
43785702|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785703|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785704|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43785705|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43785706|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
43785707|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43785708|NCT03540875|Narcotics|narcotics|mesh-ancestor
43785709|NCT03540875|Analgesics|analgesics|mesh-ancestor
43785710|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
43785711|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785712|NCT03536507|Acetazolamide|acetazolamide|mesh-list
43785713|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
43785714|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43785715|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785716|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785717|NCT03536507|Diuretics|diuretics|mesh-ancestor
43785718|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
43785719|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785720|NCT03522246|Nivolumab|nivolumab|mesh-list
43785758|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43785759|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
43785760|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43785761|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43785762|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43840347|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43840348|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
43840350|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541693|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541694|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43541695|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541696|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
43541697|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541698|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541699|NCT04812470|Analgesics|analgesics|mesh-ancestor
43541700|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
43840351|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43840352|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43840353|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
43840354|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840355|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840356|NCT04709211|Bupivacaine|bupivacaine|mesh-list
43840357|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
43840358|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
43840359|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840360|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840361|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
43840362|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840363|NCT04708067|Atezolizumab|atezolizumab|mesh-list
43840364|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840365|NCT04706026|Anesthetics|anesthetics|mesh-list
43653922|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43840367|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840368|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
43840369|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785797|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43785798|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
43785799|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
43785800|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
43785801|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43785803|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785804|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43785805|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785806|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43785807|NCT05110482|Oxytocin|oxytocin|mesh-list
43785808|NCT05110482|Carbetocin|carbetocin|mesh-list
43785809|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
43785810|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43785811|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785812|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
43785813|NCT05110469|Meperidine|meperidine|mesh-list
43785814|NCT05110469|Analgesics|analgesics|mesh-ancestor
43785815|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
43785816|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785817|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785818|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
43785819|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785820|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43785821|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
43785857|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43785858|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
43785859|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785860|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
43785861|NCT05099250|Bupivacaine|bupivacaine|mesh-list
43785862|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785864|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785865|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541764|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
43785866|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
43785867|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785868|NCT05099250|Analgesics|analgesics|mesh-ancestor
43785869|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43785870|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
43785871|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43785909|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785910|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43785911|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
43785912|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785913|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43785914|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
43785915|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
43785916|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43785917|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785919|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
43785920|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43785921|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43653924|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43653925|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
43653926|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43653927|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43653928|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43785922|NCT04685772|Prednisolone|prednisolone|mesh-list
43785923|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
43785924|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43785926|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43785927|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
43785964|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
43785965|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
43785978|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43785979|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840386|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840387|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
43840388|NCT04701008|Ketamine|ketamine|mesh-list
43840389|NCT04701008|Analgesics|analgesics|mesh-ancestor
43840390|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
43785981|NCT04335058|Lactoferrin|lactoferrin|mesh-list
43785982|NCT04335058|Trace Elements|trace elements|mesh-ancestor
43785983|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
43785984|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785985|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43785987|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43785988|NCT04285255|Lidocaine|lidocaine|mesh-list
43785989|NCT04285255|Fentanyl|fentanyl|mesh-list
43785990|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
43785991|NCT04285255|Ketamine|ketamine|mesh-list
43785992|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
43785993|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
43785994|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43785995|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43785996|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
43785997|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43785999|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43786000|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43786001|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43786002|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786003|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43786004|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786005|NCT04285255|Analgesics|analgesics|mesh-ancestor
43786006|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43786007|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43786008|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786009|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786010|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786011|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43786012|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43786013|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
43786014|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43786015|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43786016|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43786017|NCT04285255|Narcotics|narcotics|mesh-ancestor
43786018|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43786019|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
43786020|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
43786021|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786022|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786023|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786024|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
43786025|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653929|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43653930|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43653931|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
43653932|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786028|NCT04196075|Andrographolide|andrographolide|mesh-list
43786034|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786035|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786036|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786037|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43786038|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43786039|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786040|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
43786041|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786042|NCT04169828|Leucovorin|leucovorin|mesh-list
43786043|NCT04169828|Folic Acid|folic acid|mesh-list
43786044|NCT04169828|Methotrexate|methotrexate|mesh-list
43786045|NCT04169828|Ondansetron|ondansetron|mesh-list
43786046|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
43786047|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43786048|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
43786049|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786050|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786051|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43786052|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
43786053|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786054|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786056|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541888|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786057|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786058|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786059|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
43786060|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786061|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43786062|NCT04169828|Antidotes|antidotes|mesh-ancestor
43786063|NCT04169828|Protective Agents|protective agents|mesh-ancestor
43786069|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786070|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786071|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
43786072|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43786073|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
43786074|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786076|NCT04169828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43786077|NCT04169828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786078|NCT04169828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786079|NCT04169828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43786080|NCT04169828|Hematinics|hematinics|mesh-ancestor
43786081|NCT04030182|Vitamin D|vitamin d|mesh-list
43786082|NCT04030182|Vitamins|vitamins|mesh-ancestor
43786083|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
43786084|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786085|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43786086|NCT04000555|Vancomycin|vancomycin|mesh-list
43786087|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43786088|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786089|NCT03863483|Docetaxel|docetaxel|mesh-list
43786090|NCT03863483|Pemetrexed|pemetrexed|mesh-list
43541889|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
43541890|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
43541891|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541892|NCT03532139|Enoxaparin|enoxaparin|mesh-list
43541893|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
43541894|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43541895|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43786091|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541896|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43786092|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
43653933|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786094|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
43786095|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786096|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786097|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786098|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43786099|NCT03830411|Docetaxel|docetaxel|mesh-list
43786100|NCT03830411|Pemetrexed|pemetrexed|mesh-list
43786101|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786102|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
43786103|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
43786104|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
43786105|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786106|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786107|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786108|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43786109|NCT03661632|Nivolumab|nivolumab|mesh-list
43786110|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786111|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786112|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43786113|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786117|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786118|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43786119|NCT03456882|RNS60|rns60|mesh-list
43786120|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786121|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786122|NCT03456882|Analgesics|analgesics|mesh-ancestor
43786123|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
43786124|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786125|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786126|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786127|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541903|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43541904|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43541905|NCT03416348|Ethanol|ethanol|mesh-list
43668324|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668325|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668326|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43668327|NCT03642132|Bevacizumab|bevacizumab|mesh-list
43668328|NCT03642132|Avelumab|avelumab|mesh-list
43668329|NCT03642132|Talazoparib|talazoparib|mesh-list
43668330|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541906|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43541907|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541908|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541909|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541910|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
43541911|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786128|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43786129|NCT03300479|Urapidil|urapidil|mesh-list
43786130|NCT03300479|Clevidipine|clevidipine|mesh-list
43786131|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43786132|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43830877|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786133|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786134|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43786135|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786136|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43786162|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
43786163|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786164|NCT05116150|Protective Agents|protective agents|mesh-ancestor
43786165|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786166|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43786167|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
43786168|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786169|NCT05116098|Protective Agents|protective agents|mesh-ancestor
43786170|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786171|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43786172|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43786174|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43786176|NCT05115578|Remifentanil|remifentanil|mesh-list
43786177|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43786178|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43786179|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786180|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786181|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43786182|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43653936|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653938|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
43653939|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43653940|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43786196|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43786197|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
43786198|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786199|NCT05115149|Protective Agents|protective agents|mesh-ancestor
43786200|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541920|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541921|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
43541922|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
43541923|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541924|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541930|NCT03320434|Protective Agents|protective agents|mesh-ancestor
43541931|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541933|NCT03243552|Levodopa|levodopa|mesh-list
43786201|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43786202|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786205|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786206|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786207|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786208|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840400|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840401|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840403|NCT04700839|Canagliflozin|canagliflozin|mesh-list
43840404|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43840405|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43840406|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840407|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840408|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
43840409|NCT04700696|Narcotics|narcotics|mesh-ancestor
43840410|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840411|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840412|NCT04700696|Analgesics|analgesics|mesh-ancestor
43840413|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
43840414|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840415|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43541951|NCT03198351|Teriflunomide|teriflunomide|mesh-list
43840416|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43840417|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840418|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
43840419|NCT04699838|Cisplatin|cisplatin|mesh-list
43840420|NCT04699838|Carboplatin|carboplatin|mesh-list
43840421|NCT04699838|Etoposide|etoposide|mesh-list
43840422|NCT04699838|Durvalumab|durvalumab|mesh-list
43840423|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653941|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43840424|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840425|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43840426|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43703638|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43840428|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840429|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840430|NCT04698850|Ranibizumab|ranibizumab|mesh-list
43840431|NCT04698850|Aflibercept|aflibercept|mesh-list
43542007|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
43542008|NCT02843074|Hormones|hormones|mesh-ancestor
43542009|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542010|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43840432|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840433|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43840434|NCT04698850|Growth Substances|growth substances|mesh-ancestor
43840435|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840436|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840437|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840439|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43840440|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786211|NCT05114239|Timolol|timolol|mesh-list
43786212|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43786213|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43786214|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43786215|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43786216|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786217|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786218|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786219|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786220|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43703779|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43786245|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786247|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43786249|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786250|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43786251|NCT05112692|Progestins|progestins|mesh-ancestor
43786252|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
43786253|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786254|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644744|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
43786256|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
43786257|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
43786259|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786260|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786261|NCT05105919|Analgesics|analgesics|mesh-ancestor
43786262|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
43786263|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786264|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786265|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786266|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786267|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43786268|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43786269|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786270|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786271|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43786297|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786298|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786300|NCT05068336|Sevoflurane|sevoflurane|mesh-list
43786301|NCT05068336|Desflurane|desflurane|mesh-list
43786302|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786303|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786304|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786305|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43786307|NCT05040126|Linezolid|linezolid|mesh-list
43786308|NCT05040126|Bedaquiline|bedaquiline|mesh-list
43786310|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653943|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653944|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653945|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43653946|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43653947|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43653948|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43653949|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
43653950|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43653952|NCT02980562|Cathartics|cathartics|mesh-ancestor
43653953|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653955|NCT02980497|Ethanol|ethanol|mesh-list
43653956|NCT02980497|Listerine|listerine|mesh-list
43653957|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
43653959|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43653960|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653961|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786311|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43786312|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786313|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786315|NCT05015335|Adalimumab|adalimumab|mesh-list
43786316|NCT05015335|Methotrexate|methotrexate|mesh-list
43786317|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43786319|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786320|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786321|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43840448|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840450|NCT04697602|Febuxostat|febuxostat|mesh-list
43840451|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
43840452|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840453|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840454|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840455|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840456|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840457|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840458|NCT04697498|Anesthetics|anesthetics|mesh-list
43840459|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43653965|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43653966|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
43653967|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
43786337|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43786338|NCT04954339|Growth Substances|growth substances|mesh-ancestor
43786339|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786340|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
43786341|NCT04939753|Sevoflurane|sevoflurane|mesh-list
43786342|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786343|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43786344|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
43786345|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
43786346|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786347|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786348|NCT04819568|Terlipressin|terlipressin|mesh-list
43786374|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786375|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786376|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
43786377|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43786378|NCT04748250|Estrogens|estrogens|mesh-ancestor
43786379|NCT04748250|Hormones|hormones|mesh-ancestor
43786380|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786381|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786382|NCT04726878|Acetaminophen|acetaminophen|mesh-list
43786383|NCT04726878|Oxycodone|oxycodone|mesh-list
43786384|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43703953|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
43786385|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786386|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786387|NCT04726878|Analgesics|analgesics|mesh-ancestor
43786388|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
43786389|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786390|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
43786391|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43786392|NCT04726878|Narcotics|narcotics|mesh-ancestor
43786393|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
43786394|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786395|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43786396|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43786397|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
43786398|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
43786409|NCT04557215|Protective Agents|protective agents|mesh-ancestor
43786410|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786412|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43786413|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786414|NCT04526197|Celecoxib|celecoxib|mesh-list
43786415|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43786416|NCT04526197|Choline|choline|mesh-list
43786417|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786418|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786419|NCT04526197|Analgesics|analgesics|mesh-ancestor
43786420|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
43786421|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786422|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786423|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786424|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786425|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43786426|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43786427|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786428|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786429|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
43786430|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43786431|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
43786432|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786433|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43786434|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
43786435|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
43653968|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653970|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
43786436|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
43786437|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43786438|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43786439|NCT04526197|Growth Substances|growth substances|mesh-ancestor
43786440|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
43786441|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786446|NCT04424225|Psilocybin|psilocybin|mesh-list
43786447|NCT04424225|Vitamins|vitamins|mesh-ancestor
43786448|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
43786449|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786450|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
43786451|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43786452|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
43786453|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786454|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43786455|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
43786456|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
43786457|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43786458|NCT04418895|Leucovorin|leucovorin|mesh-list
43786459|NCT04418895|Fluorouracil|fluorouracil|mesh-list
43786460|NCT04418895|Capecitabine|capecitabine|mesh-list
43786461|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
43786462|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
43786463|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786464|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
43786465|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786466|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43786467|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786493|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
43786494|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786495|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
43786496|NCT04332445|Protective Agents|protective agents|mesh-ancestor
43786497|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
43786499|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43786500|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786501|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786502|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786503|NCT04314050|Analgesics|analgesics|mesh-ancestor
43786504|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
43786505|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786508|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786509|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786510|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786511|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786512|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43786513|NCT04314050|Narcotics|narcotics|mesh-ancestor
43786514|NCT04299373|Ethanol|ethanol|mesh-list
43786516|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542138|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786517|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786522|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786523|NCT04198961|Analgesics|analgesics|mesh-ancestor
43786524|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
43786525|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786526|NCT04189510|Pancrelipase|pancrelipase|mesh-list
43786527|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786528|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43786529|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786530|NCT03891849|Octreotide|octreotide|mesh-list
43786531|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786532|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786533|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786534|NCT03890133|Pregabalin|pregabalin|mesh-list
43786535|NCT03890133|Analgesics|analgesics|mesh-ancestor
43786536|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
43786538|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786539|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
43786540|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43786555|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43786556|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43786557|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786558|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786559|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786560|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786561|NCT03727139|Rasagiline|rasagiline|mesh-list
43786562|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43786563|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786564|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786567|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786568|NCT03723772|Insulin|insulin|mesh-list
43542237|NCT03704480|Durvalumab|durvalumab|mesh-list
43786569|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43786570|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43786571|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786575|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786576|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786577|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43653974|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43653975|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43653976|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
43786578|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43786579|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786580|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786581|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786583|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43786584|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786585|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
43786587|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
43786588|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43786589|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644771|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786591|NCT03342417|Ipilimumab|ipilimumab|mesh-list
43594516|NCT03333083|Lamivudine|lamivudine|mesh-list
43786592|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786593|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786595|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786596|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43786597|NCT03234309|Hematinics|hematinics|mesh-ancestor
43786598|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43786627|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
43786628|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786629|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43786630|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786631|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703954|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786632|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786634|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
43786635|NCT02807779|Dexamethasone|dexamethasone|mesh-list
43786636|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786637|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
43786638|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
43786639|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786640|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786641|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786643|NCT02807779|Hormones|hormones|mesh-ancestor
43786644|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786645|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786646|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786647|NCT02680561|Fluticasone|fluticasone|mesh-list
43786657|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786658|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786659|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43786660|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43786661|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43786663|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786664|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786665|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786666|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
43542323|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786668|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786669|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
43786670|NCT02636036|Nivolumab|nivolumab|mesh-list
43786671|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786672|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786673|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43786674|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786675|NCT02592031|Goserelin|goserelin|mesh-list
43786676|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786677|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786678|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
43786679|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43786680|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43653977|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43703955|NCT02707328|Gemcitabine|gemcitabine|mesh-list
43653978|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653979|NCT02980094|Vitamins|vitamins|mesh-list
43653980|NCT02980094|Vitamin E|vitamin e|mesh-list
43653981|NCT02980094|Tocopherols|tocopherols|mesh-list
43653982|NCT02980094|Tocotrienols|tocotrienols|mesh-list
43653984|NCT02980094|Selenium|selenium|mesh-list
43653985|NCT02980094|Antioxidants|antioxidants|mesh-list
43653986|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
43653987|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703957|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43653988|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43653989|NCT02980094|Protective Agents|protective agents|mesh-ancestor
43653990|NCT02980094|Trace Elements|trace elements|mesh-ancestor
43653991|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43653992|NCT02979886|Menotropins|menotropins|mesh-list
43653993|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
43653994|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43653995|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
43653996|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43653997|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43653998|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43653999|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43654000|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654002|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
43654003|NCT02980016|Isoniazid|isoniazid|mesh-list
43654004|NCT02980016|Rifapentine|rifapentine|mesh-list
43654005|NCT02980016|Rifampin|rifampin|mesh-list
43654006|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
43654007|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654010|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43654011|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
43654012|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654013|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43786681|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786682|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
43786683|NCT02568124|Coagulants|coagulants|mesh-ancestor
43786684|NCT02437604|Fluticasone|fluticasone|mesh-list
43786686|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43786687|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43786688|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786689|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43786690|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
43786691|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786692|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786693|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43542468|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43786694|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786695|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786696|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43786697|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43786698|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43786699|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786700|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786701|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786702|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786703|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
43786704|NCT02437604|Hormones|hormones|mesh-ancestor
43786705|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786706|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
43786707|NCT02384577|Budesonide|budesonide|mesh-list
43786708|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
43786709|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786710|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43786711|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
43786712|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786719|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43786720|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43786721|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43786722|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
43786724|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840467|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
43840468|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840469|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840470|NCT04695769|Ribavirin|ribavirin|mesh-list
43840471|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
43840472|NCT04695769|Velpatasvir|velpatasvir|mesh-list
43840473|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43840474|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
43840475|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542505|NCT03702140|Teriparatide|teriparatide|mesh-list
43840476|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
43840477|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840478|NCT04694846|Bupropion|bupropion|mesh-list
43840479|NCT04694846|Nicotine|nicotine|mesh-list
43840480|NCT04694846|Varenicline|varenicline|mesh-list
43840481|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43840482|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
43840484|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840485|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43594684|NCT03332069|Cisplatin|cisplatin|mesh-list
43786725|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
43786726|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43786727|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
43786728|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786729|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786730|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43786731|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786732|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
43786733|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43786734|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
43786735|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786748|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43786749|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786750|NCT01975298|Interferons|interferons|mesh-list
43786751|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
43786752|NCT01975298|Interferon-beta|interferon-beta|mesh-list
43786753|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786754|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
43786755|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786756|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43786757|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
43786758|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786759|NCT01624480|Modafinil|modafinil|mesh-list
43786760|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43786761|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786762|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43786763|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43786764|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43786765|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786766|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
43786767|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786768|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
43786769|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786770|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786771|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43786772|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
43786773|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786774|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786805|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786806|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
43786807|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43786808|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
43786809|NCT05116995|Ticagrelor|ticagrelor|mesh-list
43786810|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786811|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43786812|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43786813|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43786814|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
43786815|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786816|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786817|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43594765|NCT03330990|Midazolam|midazolam|mesh-list
43786820|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43786832|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786833|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
43786834|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
43786835|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
43786836|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542583|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542584|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
43542585|NCT03701672|Analgesics|analgesics|mesh-list
43542586|NCT03701672|Narcotics|narcotics|mesh-ancestor
43542587|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542588|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542589|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
43542590|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542591|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
43542592|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43542593|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542594|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542595|NCT03701529|Anesthetics|anesthetics|mesh-list
43542596|NCT03701529|Propofol|propofol|mesh-list
43542597|NCT03701529|Sevoflurane|sevoflurane|mesh-list
43542598|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542599|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542600|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43542605|NCT03701503|Hormones|hormones|mesh-list
43786837|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43786839|NCT05116462|Antiviral Agents|antiviral agents|mesh-ancestor
43786840|NCT05116462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786841|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786842|NCT05116462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43786843|NCT05116462|Immunologic Factors|immunologic factors|mesh-ancestor
43786844|NCT05116462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786845|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786846|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43786848|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43786849|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
43786850|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
43786851|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43786852|NCT05116371|Estradiol|estradiol|mesh-list
43786853|NCT05116371|Estrogens|estrogens|mesh-ancestor
43786854|NCT05116371|Hormones|hormones|mesh-ancestor
43786855|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786856|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786857|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43786858|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43786859|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43786865|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786866|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
43786867|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
43786868|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542608|NCT03701451|Decitabine|decitabine|mesh-list
43786869|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786870|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786871|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
43786872|NCT05116345|Hormones|hormones|mesh-ancestor
43786873|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43786874|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43786875|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786876|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
43786877|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786878|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786879|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
43786880|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43786881|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
43786882|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786883|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
43786884|NCT05116306|Protective Agents|protective agents|mesh-ancestor
43786885|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
43786886|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
43786887|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
43786888|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786892|NCT05076097|Rituximab|rituximab|mesh-list
43786893|NCT05076097|Lenalidomide|lenalidomide|mesh-list
43786894|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786895|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786896|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
43786897|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786898|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786899|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43786900|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43786901|NCT05076097|Growth Substances|growth substances|mesh-ancestor
43542672|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542682|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43542683|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542684|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43542685|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542686|NCT03700801|Incretins|incretins|mesh-ancestor
43542687|NCT03700801|Hormones|hormones|mesh-ancestor
43542688|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542689|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43542690|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
43542691|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542692|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
43542693|NCT03700788|Calcium|calcium|mesh-list
43542694|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43542695|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542696|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43542699|NCT03700749|Iodine|iodine|mesh-list
43786902|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840486|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43840488|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43840489|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840490|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43840491|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
43840492|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840493|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43598712|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43840494|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43840495|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43840496|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
43840497|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43840498|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43840499|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848340|NCT04030455|Cisplatin|cisplatin|mesh-list
43848341|NCT04030455|Carboplatin|carboplatin|mesh-list
43848342|NCT04030455|Docetaxel|docetaxel|mesh-list
43848343|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
43848344|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848345|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848346|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
43848347|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
43848348|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848349|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848350|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43599314|NCT03291249|Omeprazole|omeprazole|mesh-list
43848354|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
43848355|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848356|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848357|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43599504|NCT03289728|Dobutamine|dobutamine|mesh-list
43848358|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43848359|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848360|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
43848361|NCT04026256|Denosumab|denosumab|mesh-list
43848362|NCT04026256|Teriparatide|teriparatide|mesh-list
43848363|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43848364|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542707|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
43848365|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43848366|NCT04025489|Vitamin D|vitamin d|mesh-list
43848367|NCT04025489|Vitamins|vitamins|mesh-ancestor
43848368|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
43848369|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848372|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43848373|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848374|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848375|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43848376|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848377|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
43786906|NCT05002530|Vitamins|vitamins|mesh-list
43786907|NCT05002530|Tretinoin|tretinoin|mesh-list
43786908|NCT05002530|Isotretinoin|isotretinoin|mesh-list
43786909|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
43786910|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786911|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43786912|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43786913|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786914|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
43786915|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786916|NCT04753437|Amoxicillin|amoxicillin|mesh-list
43786918|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
43786919|NCT04753437|Esomeprazole|esomeprazole|mesh-list
43786920|NCT04753437|Bismuth|bismuth|mesh-list
43786921|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542749|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542750|NCT03700333|Pemetrexed|pemetrexed|mesh-list
43542751|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542752|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542753|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542754|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43786922|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43786923|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43786924|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43786925|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43786926|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43786927|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43600208|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43600209|NCT03280849|Chitosan|chitosan|mesh-list
43600210|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43786928|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43786929|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43786930|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43786931|NCT04753437|Antacids|antacids|mesh-ancestor
43786932|NCT04753437|Diuretics|diuretics|mesh-ancestor
43786933|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
43786934|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786935|NCT04753437|Expectorants|expectorants|mesh-ancestor
43786936|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
43786942|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786944|NCT04675333|Carboplatin|carboplatin|mesh-list
43542793|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43542794|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542795|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43542796|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542797|NCT03699696|Propofol|propofol|mesh-list
43786946|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786947|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786948|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
43786949|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43786950|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43786951|NCT04671953|Metformin|metformin|mesh-list
43786952|NCT04671953|BMS-986165|bms-986165|mesh-list
43786953|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43786954|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786955|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
43786956|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43786957|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43786958|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786966|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43786967|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43786968|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43786969|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43786970|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786971|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43786972|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43786973|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
43600590|NCT04877821|Carboplatin|carboplatin|mesh-list
43786974|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43786975|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786976|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786978|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
43594986|NCT03328975|Hormones|hormones|mesh-ancestor
43786979|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786980|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43600821|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
43786986|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43786987|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43786988|NCT04418479|Analgesics|analgesics|mesh-ancestor
43786989|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
43786990|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542848|NCT03699332|Labetuzumab|labetuzumab|mesh-list
43542849|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542850|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542851|NCT03699293|Aspirin|aspirin|mesh-list
43542852|NCT03699293|Celecoxib|celecoxib|mesh-list
43786991|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43786992|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43786993|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43786994|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43786995|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43786996|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43786997|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43786998|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43786999|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787000|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
43787001|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43787002|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43787003|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43787004|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
43787005|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787006|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43787007|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
43787008|NCT04370379|Aflibercept|aflibercept|mesh-list
43787009|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43787010|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43787011|NCT04370379|Growth Substances|growth substances|mesh-ancestor
43787012|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787013|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
43787014|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787015|NCT04305899|BMS-986165|bms-986165|mesh-list
43787016|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787017|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43787018|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787019|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787020|NCT04153604|Doxycycline|doxycycline|mesh-list
43787021|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43787022|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787023|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
43787024|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43787032|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
43787033|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787034|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787035|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787036|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787037|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43787038|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43601016|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
43787039|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787040|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43787041|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43787042|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787043|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
43787044|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43787045|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43542927|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43542928|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542929|NCT03698734|Analgesics|analgesics|mesh-ancestor
43542930|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
43542931|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542932|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787046|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43787047|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
43787048|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787049|NCT04006119|Cemiplimab|cemiplimab|mesh-list
43787050|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787051|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787052|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
43787053|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
43787054|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787055|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787056|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787057|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43787058|NCT03890887|Itraconazole|itraconazole|mesh-list
43787059|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
43787060|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787061|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43787062|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43787063|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787064|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43601190|NCT03266601|Ribavirin|ribavirin|mesh-list
43787065|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43787066|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
43787067|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787068|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787070|NCT03827213|Bupivacaine|bupivacaine|mesh-list
43787073|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787074|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787075|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
43601640|NCT03262727|BMS-986165|bms-986165|mesh-list
43542988|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43542989|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542990|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542991|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43542992|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
43542993|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
43542994|NCT03698513|Aspirin|aspirin|mesh-list
43542995|NCT03698513|Clopidogrel|clopidogrel|mesh-list
43542996|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43787076|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787077|NCT03797469|Niacinamide|niacinamide|mesh-list
43787079|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
43787080|NCT03797469|Vitamins|vitamins|mesh-ancestor
43787081|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
43787082|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787083|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
43787084|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43787085|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
43787086|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787087|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43787088|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
43840500|NCT04693156|Bupivacaine|bupivacaine|mesh-list
43840501|NCT04693156|Prilocaine|prilocaine|mesh-list
43840502|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
43840503|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
43840504|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840516|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840517|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43602028|NCT03258931|Cytarabine|cytarabine|mesh-list
43840518|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840519|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840520|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
43840521|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43840523|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43840524|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
43840525|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43840526|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
43840527|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840528|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840530|NCT04687761|Cytarabine|cytarabine|mesh-list
43840531|NCT04687761|Azacitidine|azacitidine|mesh-list
43840532|NCT04687761|Venetoclax|venetoclax|mesh-list
43840533|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43840534|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
43840535|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840536|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840537|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
43840538|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849013|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
43654018|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43654019|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43654020|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43654021|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43654022|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43654023|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43824940|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43824941|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824942|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
43824943|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824944|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787108|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43787109|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787110|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
43787111|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787112|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43787113|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787115|NCT03463408|Ipilimumab|ipilimumab|mesh-list
43824948|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43824949|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787122|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43787123|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43604131|NCT03239821|Codeine|codeine|mesh-list
43787124|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
43787125|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787126|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43787127|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43787128|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787141|NCT01909414|Vaccines|vaccines|mesh-list
43787142|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
43787143|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787144|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43787145|NCT01698307|Adalimumab|adalimumab|mesh-list
43787146|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787147|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787148|NCT05118984|Azithromycin|azithromycin|mesh-list
43787149|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43787150|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787151|NCT05118672|Acetaminophen|acetaminophen|mesh-list
43787152|NCT05118672|Fexofenadine|fexofenadine|mesh-list
43787153|NCT05118672|Phenylephrine|phenylephrine|mesh-list
43787154|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
43787155|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787156|NCT05118672|Analgesics|analgesics|mesh-ancestor
43787157|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
43787158|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787159|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787160|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
43787161|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43787162|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
43787163|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
43543043|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
43543044|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543045|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43543046|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543047|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543048|NCT03698383|Trastuzumab|trastuzumab|mesh-list
43543049|NCT03698383|Gedatolisib|gedatolisib|mesh-list
43787165|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43787166|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
43787167|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
43787168|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43787169|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43787170|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43787171|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787172|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787173|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43604602|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787174|NCT05118672|Protective Agents|protective agents|mesh-ancestor
43787175|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43787176|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43787177|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43787178|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
43787179|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
43787180|NCT05118542|Methimazole|methimazole|mesh-list
43787181|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
43787182|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
43787183|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
43703958|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787184|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787185|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43604846|NCT03234660|Analgesics|analgesics|mesh-ancestor
43787187|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787189|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
43787190|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
43787195|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43787196|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43787197|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787198|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787199|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543076|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43543077|NCT03698227|Protective Agents|protective agents|mesh-ancestor
43824950|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43824951|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
43824952|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824953|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
43824954|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43824955|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43824956|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43824957|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
43824958|NCT05506332|Venetoclax|venetoclax|mesh-list
43787201|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
43787202|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787204|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
43787205|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
43787207|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787208|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43787209|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43787210|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43605258|NCT03229668|Pregabalin|pregabalin|mesh-list
43787211|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43787212|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787214|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787215|NCT05018013|Analgesics|analgesics|mesh-ancestor
43787216|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
43787217|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543112|NCT03697746|Ibuprofen|ibuprofen|mesh-list
43543113|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43543114|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543115|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43543116|NCT03697746|Analgesics|analgesics|mesh-ancestor
43543117|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
43543118|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543119|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543120|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543121|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543122|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543123|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543124|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543125|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
43543126|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
43543127|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43543128|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43543129|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543131|NCT03697681|Coagulants|coagulants|mesh-ancestor
43543132|NCT03697668|Piperaquine|piperaquine|mesh-list
43543133|NCT03697668|Artenimol|artenimol|mesh-list
43543134|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
43543137|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787218|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
43787219|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787220|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
43787221|NCT04818372|Dexamethasone|dexamethasone|mesh-list
43787222|NCT04818372|Lenalidomide|lenalidomide|mesh-list
43787223|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787224|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
43787225|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
43787226|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787227|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43605571|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43703959|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
43787228|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787229|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
43787230|NCT04818372|Hormones|hormones|mesh-ancestor
43703960|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
43606043|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
43787231|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787232|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787233|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43606687|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43787234|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
43787235|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43787236|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43787237|NCT04818372|Growth Substances|growth substances|mesh-ancestor
43787238|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
43787239|NCT04784299|Lidocaine|lidocaine|mesh-list
43787240|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787241|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
43787242|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787243|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787244|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
43787245|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787246|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43787247|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43787248|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43787249|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43787250|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787251|NCT04645316|Propofol|propofol|mesh-list
43787252|NCT04645316|Sevoflurane|sevoflurane|mesh-list
43787253|NCT04645316|Desflurane|desflurane|mesh-list
43543140|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43543141|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43543142|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43543143|NCT03697655|Daratumumab|daratumumab|mesh-list
43543144|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543145|NCT03697564|Gemcitabine|gemcitabine|mesh-list
43543146|NCT03697564|Nivolumab|nivolumab|mesh-list
43787254|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43543147|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43543148|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
43543150|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787255|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43824959|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
43824960|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824961|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
43824962|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787256|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787257|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43787258|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
43787259|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
43787264|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787265|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787267|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
43787268|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787269|NCT04530604|Defibrotide|defibrotide|mesh-list
43787270|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43787272|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787273|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43787274|NCT04247750|Sirolimus|sirolimus|mesh-list
43787275|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43787276|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43607297|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
43787277|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43787278|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787279|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
43787280|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787281|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
43787282|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787283|NCT04169698|Denosumab|denosumab|mesh-list
43787284|NCT04169698|Alendronate|alendronate|mesh-list
43787285|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43787286|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787288|NCT03906617|Epinephrine|epinephrine|mesh-list
43787289|NCT03906617|Bupivacaine|bupivacaine|mesh-list
43787290|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787291|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
43787292|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
43787293|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43607752|NCT03200093|Vancomycin|vancomycin|mesh-list
43787294|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787296|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
43787297|NCT03906617|Hormones|hormones|mesh-ancestor
43787298|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787299|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787300|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787301|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787302|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
43787303|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787304|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
43787305|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43787306|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43787307|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787308|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787309|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787310|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43787311|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43787312|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43787313|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
43787314|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
43787315|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
43543166|NCT03697239|Cisplatin|cisplatin|mesh-list
43543167|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43787316|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43840539|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43840540|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
43840541|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840542|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840543|NCT04687514|Dulaglutide|dulaglutide|mesh-list
43840544|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43840545|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840546|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
43703961|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840547|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43840549|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43824963|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43654024|NCT02979665|Ranibizumab|ranibizumab|mesh-list
43654025|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43654026|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43654027|NCT02979665|Growth Substances|growth substances|mesh-ancestor
43654028|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654029|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654032|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43654033|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43840550|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787323|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787324|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787325|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
43787326|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
43787327|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787328|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787329|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43787330|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43787331|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
43787332|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43787333|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43787334|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43787335|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43787336|NCT03862859|Warfarin|warfarin|mesh-list
43787337|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
43787338|NCT03807817|Ethanol|ethanol|mesh-list
43608548|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787339|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43787340|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787341|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787342|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787343|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
43787344|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787345|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787347|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43704022|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
43787348|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787349|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787350|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787351|NCT03677115|Analgesics|analgesics|mesh-ancestor
43787352|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
43787353|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787354|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43787355|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43787356|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43787357|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787358|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43609005|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43609006|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787359|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787360|NCT03673228|Nicotine|nicotine|mesh-list
43787361|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43787362|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
43787363|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787390|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787391|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787392|NCT02184767|Loxapine|loxapine|mesh-list
43787393|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43787394|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654035|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
43654036|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654037|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43787395|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43609360|NCT03189069|Warfarin|warfarin|mesh-list
43787396|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787397|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787398|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43787399|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
43787400|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787401|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787402|NCT02122718|Allopurinol|allopurinol|mesh-list
43787403|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
43787404|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787405|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787406|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
43787407|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787408|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43787409|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
43787410|NCT02122718|Protective Agents|protective agents|mesh-ancestor
43787411|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543214|NCT03696940|Atorvastatin|atorvastatin|mesh-list
43787424|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787426|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43609453|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43609454|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43609455|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43609456|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
43609457|NCT03188198|Hormones|hormones|mesh-ancestor
43609458|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787427|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787429|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43787430|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43787431|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43787432|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
43787433|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787434|NCT01593241|Carboplatin|carboplatin|mesh-list
43787435|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787436|NCT00307242|Adefovir|adefovir|mesh-list
43787437|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
43787438|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
43787439|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787440|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43787441|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43787442|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787443|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787444|NCT05120687|Cyclosporine|cyclosporine|mesh-list
43787445|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
43787446|NCT05120687|Adalimumab|adalimumab|mesh-list
43543240|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787447|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
43787448|NCT05120687|Methotrexate|methotrexate|mesh-list
43787449|NCT05120687|Cyclosporins|cyclosporins|mesh-list
43543241|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543242|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543243|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43543244|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
43543245|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543246|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543247|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43543248|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43787450|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787451|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
43787452|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787453|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787454|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43787455|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
43787456|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787457|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787458|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43787459|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43787460|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
43787461|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43787462|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43787463|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
43787464|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787465|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787466|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43787467|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43787468|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
43787469|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787470|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43787471|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43787472|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43787473|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
43654038|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43654039|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654040|NCT02979548|Ondansetron|ondansetron|mesh-list
43654042|NCT02979548|Metoclopramide|metoclopramide|mesh-list
43654043|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
43654044|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
43654045|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654046|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787482|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
43787483|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787485|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
43787486|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787487|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787488|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787489|NCT05119452|Adalimumab|adalimumab|mesh-list
43787490|NCT05119452|Etanercept|etanercept|mesh-list
43787491|NCT05119452|Golimumab|golimumab|mesh-list
43787492|NCT05119452|Infliximab|infliximab|mesh-list
43787493|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
43787494|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
43787495|NCT05119452|Tofacitinib|tofacitinib|mesh-list
43787496|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787497|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787498|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787499|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43787500|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787501|NCT05119452|Analgesics|analgesics|mesh-ancestor
43787502|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
43787503|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787504|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787505|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787506|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
43787507|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43787508|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787509|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787510|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43787511|NCT05108155|Tacrine|tacrine|mesh-list
43787512|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43787513|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787514|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787515|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
43787516|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787517|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543319|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543320|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
43543321|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
43543322|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543323|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543324|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543325|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
43543326|NCT03695744|Hormones|hormones|mesh-ancestor
43543327|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43543328|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43543329|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543330|NCT03695705|Rifaximin|rifaximin|mesh-list
43543331|NCT03695705|Norfloxacin|norfloxacin|mesh-list
43787518|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43787519|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
43787520|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787521|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
43787522|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
43787523|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43787524|NCT05021861|Estradiol|estradiol|mesh-list
43787525|NCT05021861|Cyproterone|cyproterone|mesh-list
43734415|NCT02540070|Epinephrine|epinephrine|mesh-list
43787526|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
43787527|NCT05021861|Estrogens|estrogens|mesh-ancestor
43787528|NCT05021861|Hormones|hormones|mesh-ancestor
43787529|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787530|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787531|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43787532|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
43787533|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43787536|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43787537|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
43787538|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
43787539|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543343|NCT03695640|Analgesics|analgesics|mesh-ancestor
43543344|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
43543345|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543354|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543356|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43543357|NCT03695107|Nifedipine|nifedipine|mesh-list
43543358|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43668399|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668400|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668401|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
43668402|NCT03413800|Hormones|hormones|mesh-ancestor
43543359|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43543360|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543361|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43543362|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543363|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
43543364|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
43787540|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43787553|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654047|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654048|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
43654049|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787554|NCT04814745|Analgesics|analgesics|mesh-ancestor
43787555|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
43787556|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787557|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787558|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
43840551|NCT04685577|Nefopam|nefopam|mesh-list
43840552|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43840553|NCT04685577|Analgesics|analgesics|mesh-ancestor
43840554|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
43840555|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840556|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840557|NCT04684238|Midazolam|midazolam|mesh-list
43840558|NCT04684238|Isoflurane|isoflurane|mesh-list
43840559|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43840560|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43840561|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840562|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840563|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43840564|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43840565|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43840566|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43840567|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
43840568|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
43609809|NCT03185403|Narcotics|narcotics|mesh-ancestor
43787585|NCT04640571|Cathartics|cathartics|mesh-ancestor
43787586|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787587|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43787588|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
43787589|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43787590|NCT04572100|Paclitaxel|paclitaxel|mesh-list
43787591|NCT04572100|Carboplatin|carboplatin|mesh-list
43787592|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43787593|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787594|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
43787595|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
43787596|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
43787597|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787623|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787624|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787625|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
43787626|NCT04431141|Empagliflozin|empagliflozin|mesh-list
43787627|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43787628|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787629|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43787630|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787631|NCT04412395|Lactoferrin|lactoferrin|mesh-list
43787632|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787633|NCT04310748|Anesthetics|anesthetics|mesh-list
43595707|NCT03323047|Acetaminophen|acetaminophen|mesh-list
43787634|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43840575|NCT04683965|Pemetrexed|pemetrexed|mesh-list
43787635|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787636|NCT04294498|Entecavir|entecavir|mesh-list
43787637|NCT04294498|Durvalumab|durvalumab|mesh-list
43787638|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787639|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787640|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
43787641|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787642|NCT04188418|Fentanyl|fentanyl|mesh-list
43787643|NCT04188418|Morphine|morphine|mesh-list
43787644|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43787645|NCT04188418|Narcotics|narcotics|mesh-ancestor
43787646|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787647|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787648|NCT04188418|Analgesics|analgesics|mesh-ancestor
43787649|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
43787650|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787651|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43787652|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43654054|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43654055|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654056|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654057|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654058|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43654059|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43787653|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
43787654|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
43787655|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43787656|NCT03814317|Treprostinil|treprostinil|mesh-list
43668406|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
43787657|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43787658|NCT03688633|Candesartan|candesartan|mesh-list
43787659|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43787660|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43787661|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43787662|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787663|NCT03441750|Metformin|metformin|mesh-list
43787664|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43787665|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787666|NCT03423264|Gabapentin|gabapentin|mesh-list
43787667|NCT03423264|Analgesics|analgesics|mesh-ancestor
43787668|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
43787669|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787670|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787671|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
43787672|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43787673|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43787674|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787675|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787676|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43787683|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787684|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787685|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43787686|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
43787687|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43787688|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787689|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43787690|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43787691|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43787692|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
43787693|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43787694|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43787695|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
43787696|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787697|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
43787698|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43787699|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43787700|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
43787701|NCT03107182|Promethazine|promethazine|mesh-list
43787702|NCT03107182|Dexamethasone|dexamethasone|mesh-list
43787703|NCT03107182|Paclitaxel|paclitaxel|mesh-list
43787704|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43787705|NCT03107182|Carboplatin|carboplatin|mesh-list
43787706|NCT03107182|Nivolumab|nivolumab|mesh-list
43787707|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
43787708|NCT03107182|Famotidine|famotidine|mesh-list
43787709|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43787710|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787711|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
43787712|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
43787713|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
43787714|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787715|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43610121|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43787716|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
43787717|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
43787718|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787719|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787720|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43787721|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
43654060|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43654061|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43654062|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
43654063|NCT02979561|Warfarin|warfarin|mesh-list
43668422|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43654064|NCT02979561|Dabigatran|dabigatran|mesh-list
43787722|NCT03107182|Hormones|hormones|mesh-ancestor
43787723|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43787724|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787725|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43787726|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43787727|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
43787728|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787729|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43787730|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43787731|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43787732|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787733|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787734|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
43787735|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
43787736|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43787737|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
43787738|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
43787739|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787740|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43787741|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
43787742|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
43787743|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43787744|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43787745|NCT02969837|Dexamethasone|dexamethasone|mesh-list
43787760|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43787761|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43787762|NCT02969837|Growth Substances|growth substances|mesh-ancestor
43787763|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
43787764|NCT02802852|Lenograstim|lenograstim|mesh-list
43787765|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43787766|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
43787767|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787768|NCT02789020|Rasagiline|rasagiline|mesh-list
43787769|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43787770|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787771|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787772|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43787773|NCT02789020|Protective Agents|protective agents|mesh-ancestor
43787791|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
43654067|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43610253|NCT03181685|Hormones|hormones|mesh-ancestor
43787811|NCT05122455|Edoxaban|edoxaban|mesh-list
43787812|NCT05122455|Clopidogrel|clopidogrel|mesh-list
43787813|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43787814|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43543529|NCT03693248|Paclitaxel|paclitaxel|mesh-list
43787815|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43787816|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43787817|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
43787818|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787819|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787820|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787821|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43787822|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
43787823|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43787824|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
43787825|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787826|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
43654068|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
43654069|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43734416|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
43654070|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654071|NCT02979405|Phenylephrine|phenylephrine|mesh-list
43654072|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
43654073|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43654074|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
43654075|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
43787828|NCT05122377|Leuprolide|leuprolide|mesh-list
43787829|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43787830|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787831|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43787832|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
43787833|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43787834|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787835|NCT05122351|Acetaminophen|acetaminophen|mesh-list
43787836|NCT05122351|Bupivacaine|bupivacaine|mesh-list
43787837|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787838|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
43787839|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787840|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787841|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
43787842|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543553|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543554|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543555|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43543556|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43543557|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543558|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543559|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
43543560|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43543561|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43543577|NCT03692754|Calcium|calcium|mesh-list
43787843|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787844|NCT05122351|Analgesics|analgesics|mesh-ancestor
43787845|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
43787846|NCT05122338|Lidocaine|lidocaine|mesh-list
43787847|NCT05122338|Ropivacaine|ropivacaine|mesh-list
43787848|NCT05122338|Esketamine|esketamine|mesh-list
43787849|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
43787850|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
43787851|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43787852|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787853|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
43787854|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787855|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43610396|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
43787856|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43787857|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43787858|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43840580|NCT04683965|Growth Substances|growth substances|mesh-ancestor
43787862|NCT05122117|Methylene Blue|methylene blue|mesh-list
43787863|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787864|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787865|NCT05121883|Edaravone|edaravone|mesh-list
43787866|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43787867|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
43787868|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787869|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43787870|NCT05121883|Protective Agents|protective agents|mesh-ancestor
43787871|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787872|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43787873|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43787874|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787875|NCT05121233|Diclofenac|diclofenac|mesh-list
43787876|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43543582|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543584|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
43787877|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43787878|NCT05121233|Analgesics|analgesics|mesh-ancestor
43787879|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
43787880|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787881|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787882|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43787883|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787884|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43787885|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787886|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787887|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43787888|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
43787889|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
43654076|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654077|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787890|NCT05114720|Docetaxel|docetaxel|mesh-list
43787891|NCT05114720|Doxorubicin|doxorubicin|mesh-list
43787892|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43787893|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43787894|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43787895|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
43787896|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787897|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43787898|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43543597|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543598|NCT03692546|Bupivacaine|bupivacaine|mesh-list
43543599|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
43543600|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
43543601|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43543602|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543603|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
43543604|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543605|NCT03692416|Prednisone|prednisone|mesh-list
43543606|NCT03692416|Ibuprofen|ibuprofen|mesh-list
43543607|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43543608|NCT03692416|Methotrexate|methotrexate|mesh-list
43543609|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43543610|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
43543611|NCT03692416|Hormones|hormones|mesh-ancestor
43543612|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43543613|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543614|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43543615|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43543620|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
43543621|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787899|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
43787900|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787901|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787902|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43787903|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
43787904|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
43787905|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
43787906|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43787907|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43787908|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43787909|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787910|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787911|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43787912|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
43787913|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43787914|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43787915|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43787916|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43787917|NCT05112211|Doxycycline|doxycycline|mesh-list
43787918|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43787931|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787932|NCT05073484|Antibodies|antibodies|mesh-list
43787933|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
43787934|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
43787935|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787936|NCT05229991|Ritonavir|ritonavir|mesh-list
43787937|NCT05229991|Lonafarnib|lonafarnib|mesh-list
43787938|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43787939|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43787940|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
43787941|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787942|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787944|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43668464|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668465|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
43668466|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
43668467|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43787945|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
43787946|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787947|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43787948|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43787949|NCT05229913|Esketamine|esketamine|mesh-list
43787950|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
43787951|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43787952|NCT05229796|Empagliflozin|empagliflozin|mesh-list
43787953|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43787954|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787955|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43787956|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787957|NCT05229627|Methylphenidate|methylphenidate|mesh-list
43787958|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43787959|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43787960|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787961|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43787962|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43787963|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43787964|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787966|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43787967|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43787968|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
43787969|NCT05229536|Vaccines|vaccines|mesh-list
43787970|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
43654078|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
43787971|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787972|NCT05229510|Ribavirin|ribavirin|mesh-list
43787973|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
43787974|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787975|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
43787976|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43787977|NCT05229497|Cisplatin|cisplatin|mesh-list
43787978|NCT05229497|Carboplatin|carboplatin|mesh-list
43787979|NCT05229497|Fluorouracil|fluorouracil|mesh-list
43787980|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787981|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
43787982|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787983|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43787990|NCT05229042|Ricolinostat|ricolinostat|mesh-list
43787992|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43787993|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43787994|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43787995|NCT05228925|Vitamin D|vitamin d|mesh-list
43787996|NCT05228925|Vitamins|vitamins|mesh-ancestor
43787997|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
43787998|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43787999|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43788000|NCT05228743|Paclitaxel|paclitaxel|mesh-list
43788001|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43788002|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788003|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
43788004|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
43788005|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
43788006|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840581|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840582|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840583|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840584|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788007|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
43788008|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43610531|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43788025|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788026|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788027|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788028|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788029|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43788030|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43788031|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
43788032|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788033|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788034|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788035|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
43788036|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
43788037|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43788038|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43788039|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788040|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43788041|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43788042|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788043|NCT05222256|Protective Agents|protective agents|mesh-ancestor
43788044|NCT05188053|Ketorolac|ketorolac|mesh-list
43788045|NCT05188053|Epinephrine|epinephrine|mesh-list
43788046|NCT05188053|Ropivacaine|ropivacaine|mesh-list
43788054|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788055|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788056|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788057|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788058|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43788059|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43654083|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43654084|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788060|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
43788061|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788062|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788064|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
43788065|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43788066|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43788067|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43788068|NCT05188053|Analgesics|analgesics|mesh-ancestor
43788069|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788070|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788071|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43788072|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788073|NCT05183412|Methamphetamine|methamphetamine|mesh-list
43788074|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43788075|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788076|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
43788077|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
43788078|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788079|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
43788080|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788081|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788082|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788083|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43788084|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43788085|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43788086|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43788087|NCT05136326|Capecitabine|capecitabine|mesh-list
43788088|NCT05136326|Temozolomide|temozolomide|mesh-list
43788089|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43788090|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
43788091|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788092|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788093|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43788094|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
43788095|NCT05102149|Vildagliptin|vildagliptin|mesh-list
43788096|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43788097|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788098|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43788099|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
43788100|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788101|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788102|NCT05060991|Antimetabolites|antimetabolites|mesh-list
43788103|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788104|NCT05036421|Empagliflozin|empagliflozin|mesh-list
43788105|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43788106|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788108|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788109|NCT05035186|Amoxicillin|amoxicillin|mesh-list
43788110|NCT05035186|Clarithromycin|clarithromycin|mesh-list
43788111|NCT05035186|Levofloxacin|levofloxacin|mesh-list
43788112|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43788127|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788128|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
43788129|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788130|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788131|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788132|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
43788133|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
43788134|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43788135|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788136|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43788137|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788138|NCT04772209|Heparin|heparin|mesh-list
43788139|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
43788140|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43788141|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43788142|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788143|NCT04620941|Chrysarobin|chrysarobin|mesh-list
43654085|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
43654086|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788144|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43788145|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43788146|NCT04620941|Analgesics|analgesics|mesh-ancestor
43543695|NCT03691896|Vitamins|vitamins|mesh-ancestor
43788147|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
43788148|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788149|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788150|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788151|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788152|NCT04582591|Cannabidiol|cannabidiol|mesh-list
43788153|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
43840585|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43840586|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43840587|NCT04683627|Diclofenac|diclofenac|mesh-list
43734417|NCT02540070|Morphine|morphine|mesh-list
43840588|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43840590|NCT04683627|Analgesics|analgesics|mesh-ancestor
43840591|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
43840592|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840593|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788154|NCT04538534|Nicardipine|nicardipine|mesh-list
43788155|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43788156|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43788157|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43788158|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788159|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43788160|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788161|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788186|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788187|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
43788188|NCT04412694|Hormones|hormones|mesh-ancestor
43788189|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43610975|NCT03175705|Interleukin-2|interleukin-2|mesh-list
43788190|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43788191|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788192|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
43788193|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788194|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788195|NCT04351438|Heparin|heparin|mesh-list
43668502|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668503|NCT03096249|Oxytocin|oxytocin|mesh-list
43668504|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
43668505|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43668506|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788196|NCT04351438|Citric Acid|citric acid|mesh-list
43788197|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
43788198|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
43788199|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43788200|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
43788201|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
43788202|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788203|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43788204|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43788205|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43788206|NCT04278651|Hematinics|hematinics|mesh-ancestor
43788207|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43788208|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43788209|NCT04270643|Vitamin D|vitamin d|mesh-list
43788210|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
43788211|NCT04270643|Vitamins|vitamins|mesh-ancestor
43788212|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
43788213|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788214|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43788224|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788225|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788226|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43788227|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43788228|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788229|NCT04169191|Urological Agents|urological agents|mesh-ancestor
43788230|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43788231|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
43788232|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788233|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788234|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
43788235|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788236|NCT04082728|Dipyrone|dipyrone|mesh-list
43788237|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43788238|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654087|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654088|NCT02979405|Protective Agents|protective agents|mesh-ancestor
43654089|NCT02979392|Paclitaxel|paclitaxel|mesh-list
43654090|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43788239|NCT04082728|Analgesics|analgesics|mesh-ancestor
43788240|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
43788241|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788242|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788243|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788244|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788245|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
43788246|NCT04049786|Metoprolol|metoprolol|mesh-list
43788247|NCT04049786|Carvedilol|carvedilol|mesh-list
43788248|NCT04049786|Midazolam|midazolam|mesh-list
43788249|NCT04049786|Simvastatin|simvastatin|mesh-list
43788250|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43788251|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43788252|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788253|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788254|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43788255|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43788256|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43788257|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43788258|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
43788259|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
43788260|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
43788261|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
43788262|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788263|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43611126|NCT03174080|Fluorides|fluorides|mesh-list
43788264|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43788265|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788266|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
43788267|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788268|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43788269|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788270|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43788271|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43788272|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
43788273|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
43788274|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788275|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43788276|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43788277|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43788278|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788279|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
43788280|NCT04049786|Protective Agents|protective agents|mesh-ancestor
43788281|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43788292|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788293|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788294|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788295|NCT04023253|Urological Agents|urological agents|mesh-ancestor
43788296|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43788297|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43788298|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788299|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788300|NCT03829514|Fenofibrate|fenofibrate|mesh-list
43788301|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788302|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
43788303|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788304|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788305|NCT03801200|Apatinib|apatinib|mesh-list
43543768|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
43543769|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
43543770|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43543771|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43543772|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
43668511|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43668512|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43668513|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43668514|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668515|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668516|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
43668517|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668518|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668519|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43543773|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43543774|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43543775|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
43543776|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
43543777|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543778|NCT03691038|Pregabalin|pregabalin|mesh-list
43543779|NCT03691038|Analgesics|analgesics|mesh-ancestor
43788306|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788307|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788308|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788309|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788310|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
43788311|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43788312|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43788313|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788314|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
43788315|NCT03801122|Coagulants|coagulants|mesh-ancestor
43788316|NCT03788291|Rituximab|rituximab|mesh-list
43654092|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654093|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
43611348|NCT03172741|Hormones|hormones|mesh-ancestor
43654094|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
43654095|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654097|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
43543780|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
43543792|NCT03690778|Metformin|metformin|mesh-list
43788317|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
43788318|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788319|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788323|NCT03713801|Metformin|metformin|mesh-list
43788324|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43788325|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654098|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
43654099|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654100|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
43654101|NCT02979223|Protective Agents|protective agents|mesh-ancestor
43654102|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654103|NCT02979223|Vitamins|vitamins|mesh-ancestor
43788326|NCT03704688|Trametinib|trametinib|mesh-list
43788327|NCT03704688|Ponatinib|ponatinib|mesh-list
43788328|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788329|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788330|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788331|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788332|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
43788333|NCT03684213|Norepinephrine|norepinephrine|mesh-list
43788334|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
43788335|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
43788336|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788337|NCT03684213|Protective Agents|protective agents|mesh-ancestor
43788338|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788339|NCT03684213|Vitamins|vitamins|mesh-ancestor
43788340|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
43788341|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43788342|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788343|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788344|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788345|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
43788346|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
43788347|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788348|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43788349|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788350|NCT03679780|Nitroprusside|nitroprusside|mesh-list
43788351|NCT03679780|BQ 788|bq 788|mesh-list
43668532|NCT03013218|Paclitaxel|paclitaxel|mesh-list
43788352|NCT03679780|Nitroarginine|nitroarginine|mesh-list
43788353|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
43788369|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43788371|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
43788372|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
43788373|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
43788374|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788375|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43788376|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
43788377|NCT03598270|Antiviral Agents|antiviral agents|mesh-ancestor
43788378|NCT03598270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788379|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788380|NCT03598270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788381|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
43788382|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788383|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43788384|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43788385|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43788386|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43788387|NCT03580525|Nicotine|nicotine|mesh-list
43788388|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43788389|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
43788390|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788391|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788392|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43788393|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43788394|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
43788395|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788396|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788397|NCT03560297|Nitrazepam|nitrazepam|mesh-list
43788398|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
43543861|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43543862|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43543863|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43543864|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43543865|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
43543866|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43543867|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43543868|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43543869|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
43543870|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
43543871|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
43543872|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43543873|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43788399|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43788400|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788401|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788402|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43788403|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43788404|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43788405|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
43788406|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
43654104|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
43654105|NCT02979223|Cathartics|cathartics|mesh-ancestor
43654106|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654108|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654109|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
43788407|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788408|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788409|NCT03554707|Bevacizumab|bevacizumab|mesh-list
43788410|NCT03554707|Irinotecan|irinotecan|mesh-list
43788411|NCT03554707|Temozolomide|temozolomide|mesh-list
43788412|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788413|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788414|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43788421|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788422|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788423|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43788424|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
43788425|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
43788426|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43788427|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43788428|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788429|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
43788430|NCT03505723|Coagulants|coagulants|mesh-ancestor
43840594|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840595|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840596|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43840597|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43543902|NCT03689998|Melatonin|melatonin|mesh-list
43840598|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840599|NCT04683315|Gemcitabine|gemcitabine|mesh-list
43840600|NCT04683315|Paclitaxel|paclitaxel|mesh-list
43840601|NCT04683315|Fluorouracil|fluorouracil|mesh-list
43840602|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840603|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840604|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840605|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840606|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840607|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840608|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43840609|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
43840610|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
43840611|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840612|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840613|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43840614|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
43840615|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840616|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
43840617|NCT04682587|Avelumab|avelumab|mesh-list
43840618|NCT04682587|Axitinib|axitinib|mesh-list
43840619|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840620|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840621|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43840622|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840623|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840624|NCT04682158|Paclitaxel|paclitaxel|mesh-list
43840625|NCT04682158|Carboplatin|carboplatin|mesh-list
43840626|NCT04682158|Propranolol|propranolol|mesh-list
43840627|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43840628|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840629|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
43840630|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
43840631|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
43840632|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840633|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43840634|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43840635|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
43840636|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788431|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
43788432|NCT03410875|Vemurafenib|vemurafenib|mesh-list
43788433|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654110|NCT02978976|Hormones|hormones|mesh-ancestor
43654111|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654112|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788434|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788435|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788436|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788437|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788438|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
43788439|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788469|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788470|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43788472|NCT03098836|Prednisone|prednisone|mesh-list
43788473|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
43788474|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788475|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
43788476|NCT03098836|Hormones|hormones|mesh-ancestor
43788477|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788478|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788479|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43788480|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788481|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43788482|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788483|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788491|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788493|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
43788494|NCT03073070|Vitamins|vitamins|mesh-ancestor
43788495|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
43788496|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788497|NCT03060577|Evolocumab|evolocumab|mesh-list
43612381|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788498|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43788499|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788501|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788502|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788503|NCT02939742|Betamethasone|betamethasone|mesh-list
43788504|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788505|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
43788506|NCT02939742|Hormones|hormones|mesh-ancestor
43788507|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788508|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788509|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788510|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788511|NCT02905214|Sirolimus|sirolimus|mesh-list
43788512|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43788513|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788514|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43788515|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788516|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
43788517|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788518|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
43788519|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788520|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
43788521|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
43788522|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43788523|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43788524|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788525|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43612644|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
43788535|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
43788536|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43788537|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
43788538|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788539|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43788540|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43788541|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788542|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788543|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788544|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788545|NCT02673996|Protective Agents|protective agents|mesh-ancestor
43788546|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43788547|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43788548|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788549|NCT01976169|Palbociclib|palbociclib|mesh-list
43788550|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43788551|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788552|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788553|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544007|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
43612799|NCT03163121|Vaccines|vaccines|mesh-list
43612800|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
43788554|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788555|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788557|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
43788558|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
43788559|NCT01631292|Vitamin D|vitamin d|mesh-list
43788560|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
43788561|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
43788562|NCT01631292|Vitamins|vitamins|mesh-list
43788563|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
43788564|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788565|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43612910|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43788566|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43788586|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
43788587|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788588|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43788589|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788590|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788591|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43788592|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654116|NCT02979132|Trace Elements|trace elements|mesh-ancestor
43654117|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
43654118|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654119|NCT02978482|Durvalumab|durvalumab|mesh-list
43654120|NCT02978482|Tremelimumab|tremelimumab|mesh-list
43654121|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43654122|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654123|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654124|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
43613003|NCT03160729|Hormones|hormones|mesh-ancestor
43654125|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654126|NCT02978313|Cetuximab|cetuximab|mesh-list
43654127|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654128|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654129|NCT02978547|Metformin|metformin|mesh-list
43654130|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654131|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654132|NCT02978443|Nivolumab|nivolumab|mesh-list
43788593|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788594|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
43788595|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
43613111|NCT05675800|Psilocybin|psilocybin|mesh-list
43788596|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788597|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
43788598|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
43788599|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788600|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43788601|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
43788602|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
43788603|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43788604|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
43788605|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
43788606|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
43788607|NCT00950846|Busulfan|busulfan|mesh-list
43788608|NCT00950846|Fludarabine|fludarabine|mesh-list
43596731|NCT03315442|Caffeine|caffeine|mesh-list
43788609|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788610|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
43788611|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788612|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788613|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43788614|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
43788615|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788616|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788617|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43788618|NCT00748904|Rifaximin|rifaximin|mesh-list
43788619|NCT00748904|Lactulose|lactulose|mesh-list
43788620|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43788621|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788622|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788632|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788634|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43788635|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
43788636|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43788637|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
43788638|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43788639|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43788640|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43788641|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43788642|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
43788643|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43788644|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43654134|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43654135|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654136|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43544117|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788645|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
43788646|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788647|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
43788648|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43788649|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43788650|NCT00148629|Mebendazole|mebendazole|mesh-list
43788651|NCT00148629|Piperazine|piperazine|mesh-list
43788652|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
43788653|NCT00148629|DMP 777|dmp 777|mesh-list
43788654|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
43788655|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
43788656|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43788657|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788658|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
43788659|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
43788660|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
43788661|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788662|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788663|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788664|NCT05037994|Prednisolone|prednisolone|mesh-list
43788665|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43788666|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
43788667|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43788668|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
43788669|NCT05037994|Gabapentin|gabapentin|mesh-list
43788670|NCT05037994|Bupivacaine|bupivacaine|mesh-list
43788671|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43788672|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
43788673|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788674|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
43788675|NCT05037994|Hormones|hormones|mesh-ancestor
43788676|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43613343|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
43613344|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43613345|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613346|NCT05665699|Allopurinol|allopurinol|mesh-list
43613347|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
43613348|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43613353|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
43613386|NCT05633810|Aspirin|aspirin|mesh-list
43613387|NCT05633810|Colchicine|colchicine|mesh-list
43613388|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43613389|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43613390|NCT05633810|Analgesics|analgesics|mesh-ancestor
43613391|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
43613392|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43613393|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43613394|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43788677|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788678|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43788679|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788680|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
43788681|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
43788682|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544207|NCT03686618|Secretin|secretin|mesh-list
43788683|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43788684|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43596812|NCT03314792|Oxycodone|oxycodone|mesh-list
43788685|NCT05037994|Protective Agents|protective agents|mesh-ancestor
43788686|NCT05037994|Analgesics|analgesics|mesh-ancestor
43788687|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
43788688|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
43788699|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
43788700|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
43788701|NCT05036434|Lenvatinib|lenvatinib|mesh-list
43788702|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788703|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788704|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43544242|NCT03685084|Piperacillin|piperacillin|mesh-list
43544243|NCT03685084|Cefepime|cefepime|mesh-list
43544244|NCT03685084|Lactams|lactams|mesh-list
43544245|NCT03685084|beta-Lactams|beta-lactams|mesh-list
43544246|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
43544247|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43788705|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544248|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544253|NCT03685032|Dexamethasone|dexamethasone|mesh-list
43788706|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788707|NCT04984616|Atorvastatin|atorvastatin|mesh-list
43788708|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43788709|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43788710|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
43788711|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788712|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43788713|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43788714|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788715|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
43788716|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43788717|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
43788718|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788719|NCT04904952|Expectorants|expectorants|mesh-ancestor
43788720|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788721|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43788722|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
43654137|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654138|NCT02977897|Octreotide|octreotide|mesh-list
43654139|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654140|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43654141|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654142|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43654143|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43654144|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
43654145|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43788723|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788724|NCT04904952|Protective Agents|protective agents|mesh-ancestor
43788725|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788726|NCT04904952|Antidotes|antidotes|mesh-ancestor
43788727|NCT04810910|Molgramostim|molgramostim|mesh-list
43788728|NCT04810910|Sargramostim|sargramostim|mesh-list
43788729|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
43788730|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788731|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788732|NCT04746989|Allopurinol|allopurinol|mesh-list
43788733|NCT04746989|Probenecid|probenecid|mesh-list
43613476|NCT05538091|Atezolizumab|atezolizumab|mesh-list
43668556|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
43613477|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43613485|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
43613486|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43613487|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
43788743|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
43788745|NCT04729049|Morphine|morphine|mesh-list
43788746|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43788747|NCT04729049|Narcotics|narcotics|mesh-ancestor
43788748|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788749|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788750|NCT04729049|Analgesics|analgesics|mesh-ancestor
43544328|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
43544329|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43544331|NCT03684330|Vitamin D|vitamin d|mesh-list
43788751|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
43788752|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788753|NCT04663711|Anesthetics|anesthetics|mesh-list
43613562|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43654147|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43654148|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43654149|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43654151|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
43654152|NCT02978040|Cangrelor|cangrelor|mesh-list
43654153|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43613760|NCT05003713|Hormones|hormones|mesh-ancestor
43788763|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43788765|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788766|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788767|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
43788768|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788769|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43788770|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788771|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
43788772|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788773|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43788774|NCT04562558|Antidotes|antidotes|mesh-ancestor
43788775|NCT04562558|Protective Agents|protective agents|mesh-ancestor
43788778|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
43788779|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43788780|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43788781|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43654156|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654157|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43654158|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43654159|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43654160|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
43654161|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654162|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544453|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43544454|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
43544455|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43544463|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544464|NCT03682172|Incretins|incretins|mesh-ancestor
43544465|NCT03681613|Pyrantel|pyrantel|mesh-list
43544466|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
43544467|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
43544468|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
43544469|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43544470|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43544471|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43544472|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43544473|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43544474|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544475|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544476|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
43544477|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
43544478|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654163|NCT02977832|Alfuzosin|alfuzosin|mesh-list
43654164|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43654165|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43654166|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43654167|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788782|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43788783|NCT04529876|Abatacept|abatacept|mesh-list
43788784|NCT04529876|Tofacitinib|tofacitinib|mesh-list
43788785|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43788786|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788787|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788788|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788789|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
43788790|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788791|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788792|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43788793|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788794|NCT04529863|Abatacept|abatacept|mesh-list
43788795|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43668585|NCT02781519|Hormones|hormones|mesh-ancestor
43788806|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788807|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43788808|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43788809|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788811|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788812|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
43788813|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43788814|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43788815|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43788816|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43788817|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788818|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
43788819|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788820|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788822|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788823|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
43544523|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
43544524|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43544525|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43544546|NCT03680638|Protective Agents|protective agents|mesh-ancestor
43544547|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544548|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43668595|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668596|NCT02711969|Apatinib|apatinib|mesh-list
43668597|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668598|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43668599|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668600|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668601|NCT02655562|Montelukast|montelukast|mesh-list
43668602|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43668603|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788824|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43788825|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43788826|NCT04402385|Aspirin|aspirin|mesh-list
43788827|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43788828|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43788829|NCT04402385|Analgesics|analgesics|mesh-ancestor
43788830|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
43788831|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788832|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788834|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43788835|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43788836|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43788837|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788838|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43654168|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654169|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43614371|NCT04057898|Ibudilast|ibudilast|mesh-list
43668610|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654170|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654171|NCT02977832|Urological Agents|urological agents|mesh-ancestor
43824964|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43788839|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43788840|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43788841|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
43788843|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43788844|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43788845|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43788846|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43788847|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
43788848|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788849|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788850|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788851|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
43788852|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
43788853|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
43788854|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43788855|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43788856|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
43788857|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788875|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
43788876|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788877|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
43788878|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788879|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788880|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
43788881|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788882|NCT03874091|Epinephrine|epinephrine|mesh-list
43788883|NCT03874091|Racepinephrine|racepinephrine|mesh-list
43788884|NCT03874091|Morphine|morphine|mesh-list
43544626|NCT03680378|Cefepime|cefepime|mesh-list
43544627|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43788885|NCT03874091|Bupivacaine|bupivacaine|mesh-list
43788886|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
43788887|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
43788888|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
43788889|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788890|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788891|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
43788892|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788893|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43788894|NCT03874091|Narcotics|narcotics|mesh-ancestor
43788895|NCT03874091|Analgesics|analgesics|mesh-ancestor
43614579|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
43788896|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43788897|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43788898|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
43788899|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788900|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788901|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43788902|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43788903|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
43788904|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43788913|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43788914|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544649|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788915|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
43788916|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788939|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788940|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43788941|NCT03612921|Analgesics|analgesics|mesh-ancestor
43788942|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
43824965|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
43824966|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788943|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788945|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
43614818|NCT02881086|Vindesine|vindesine|mesh-list
43788958|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
43788959|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
43788960|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43788961|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43788962|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43788963|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43544689|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43788964|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
43788965|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
43788966|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43788967|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43788968|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
43788969|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43788970|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
43788971|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788972|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
43788973|NCT03200288|Protective Agents|protective agents|mesh-ancestor
43788974|NCT03066739|Remifentanil|remifentanil|mesh-list
43788975|NCT03066739|Naloxone|naloxone|mesh-list
43788976|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43788979|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43788980|NCT03066739|Analgesics|analgesics|mesh-ancestor
43788981|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
43788982|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43788983|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43788984|NCT02929485|Bromocriptine|bromocriptine|mesh-list
43788985|NCT02929485|Tolcapone|tolcapone|mesh-list
43789009|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43789010|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43789011|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789012|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789013|NCT02795351|Urological Agents|urological agents|mesh-ancestor
43789014|NCT02683265|Methylphenidate|methylphenidate|mesh-list
43789015|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43789016|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789017|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43789018|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789021|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
43597143|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
43789022|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789024|NCT02604446|Tapentadol|tapentadol|mesh-list
43789025|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43789026|NCT02604446|Narcotics|narcotics|mesh-ancestor
43789027|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43615553|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43615591|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789028|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43544751|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43544753|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43789029|NCT02604446|Analgesics|analgesics|mesh-ancestor
43789030|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
43789031|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789032|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43789033|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789034|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43615679|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43840656|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43840657|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840658|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840659|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43840660|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848378|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43848380|NCT04023071|Fludarabine|fludarabine|mesh-list
43848381|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
43848382|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848383|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
43848384|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848385|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848386|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848387|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
43848388|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848389|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848390|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43848391|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848392|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
43848393|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
43615825|NCT03146325|Antacids|antacids|mesh-ancestor
43789045|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789046|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789047|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
43789048|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43789050|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789051|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789052|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43789053|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43789054|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43615901|NCT05255575|Ertapenem|ertapenem|mesh-list
43789055|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789057|NCT01710176|Gemcitabine|gemcitabine|mesh-list
43789058|NCT01710176|Docetaxel|docetaxel|mesh-list
43789059|NCT01710176|Etoposide|etoposide|mesh-list
43789060|NCT01710176|Epirubicin|epirubicin|mesh-list
43789061|NCT01710176|Ifosfamide|ifosfamide|mesh-list
43789062|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
43789063|NCT01710176|Dacarbazine|dacarbazine|mesh-list
43789064|NCT01710176|Trabectedin|trabectedin|mesh-list
43616026|NCT05012865|Avelumab|avelumab|mesh-list
43789065|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789066|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
43544843|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43789067|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789068|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789069|NCT01710176|Antiviral Agents|antiviral agents|mesh-ancestor
43789070|NCT01710176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789071|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789072|NCT01710176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789073|NCT01710176|Immunologic Factors|immunologic factors|mesh-ancestor
43789074|NCT01710176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789075|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789076|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
43789077|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
43616120|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
43616262|NCT04509973|Hormones|hormones|mesh-ancestor
43789078|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43789079|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43789080|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43789081|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43789082|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43789083|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
43789084|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43789085|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43789086|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789087|NCT00584246|Pregabalin|pregabalin|mesh-list
43789088|NCT00584246|Analgesics|analgesics|mesh-ancestor
43789089|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
43789090|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789091|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789092|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
43789096|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43789097|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43789098|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43789099|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789100|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43616516|NCT02586831|Analgesics|analgesics|mesh-ancestor
43789102|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
43789103|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
43789104|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
43789129|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43789131|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
43789132|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
43789133|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789134|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789135|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789136|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43789137|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43789138|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789139|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789140|NCT05123976|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43789142|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43734420|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789143|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789144|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789145|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
43789146|NCT05123781|Metformin|metformin|mesh-list
43789147|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789148|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789149|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43789150|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789166|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789168|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
43789169|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43789170|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
43789171|NCT05115773|Anesthetics|anesthetics|mesh-list
43789172|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789173|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789174|NCT05069974|Linezolid|linezolid|mesh-list
43789175|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789176|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789177|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43789178|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789179|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789180|NCT05052099|Bevacizumab|bevacizumab|mesh-list
43789181|NCT05052099|Atezolizumab|atezolizumab|mesh-list
43789182|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789183|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789184|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43789185|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43789186|NCT05052099|Growth Substances|growth substances|mesh-ancestor
43789187|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789188|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
43789189|NCT05041920|Omeprazole|omeprazole|mesh-list
43597370|NCT03309215|Nickel|nickel|mesh-list
43545015|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43616930|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43789194|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789195|NCT05001802|Ropivacaine|ropivacaine|mesh-list
43789196|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
43789197|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
43789198|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789199|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789200|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
43789201|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789202|NCT04975958|Atezolizumab|atezolizumab|mesh-list
43789203|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789204|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43789205|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
43789206|NCT04921189|Thiamine|thiamine|mesh-list
43789207|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
43789208|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
43789218|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43789219|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789220|NCT04875871|Trace Elements|trace elements|mesh-ancestor
43617060|NCT03142516|Leucovorin|leucovorin|mesh-list
43789222|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789224|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
43789225|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
43789226|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789227|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789228|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
43789229|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789230|NCT04781725|Cisplatin|cisplatin|mesh-list
43789231|NCT04781725|Vinblastine|vinblastine|mesh-list
43789232|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789233|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43789234|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789235|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
43789236|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
43789237|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617119|NCT03142542|Udenafil|udenafil|mesh-list
43617312|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43789240|NCT04737603|Naloxone|naloxone|mesh-list
43789241|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43789242|NCT04737603|Narcotics|narcotics|mesh-ancestor
43789243|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545049|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43545050|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43545051|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545052|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545053|NCT03676088|Mitogens|mitogens|mesh-list
43545054|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
43545055|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545060|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
43545061|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43545062|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43545063|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545064|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
43545065|NCT03676023|Coagulants|coagulants|mesh-ancestor
43545066|NCT03675854|Cefazolin|cefazolin|mesh-list
43545067|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789244|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789245|NCT04737603|Analgesics|analgesics|mesh-ancestor
43789246|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
43789247|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789248|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43789249|NCT04637620|Sertraline|sertraline|mesh-list
43789250|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
43789251|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43668697|NCT02178410|Vitamin D|vitamin d|mesh-list
43668722|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
43668723|NCT01808456|Vaccines|vaccines|mesh-list
43789252|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43789253|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789264|NCT04595994|Antiviral Agents|antiviral agents|mesh-ancestor
43789265|NCT04595994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789266|NCT04595994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789267|NCT04595994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43789268|NCT04595994|Immunologic Factors|immunologic factors|mesh-ancestor
43789269|NCT04595994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789270|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
43789271|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789272|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789273|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43789274|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43789275|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789276|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789277|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789280|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
43789281|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43789282|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
43617784|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43617785|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43617786|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43789283|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43789284|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
43789285|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789286|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
43789287|NCT04563559|Hormones|hormones|mesh-ancestor
43789288|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789289|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789290|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43789291|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789292|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
43789293|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
43789294|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789295|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789296|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43789297|NCT04563559|Protective Agents|protective agents|mesh-ancestor
43617863|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
43789298|NCT04359017|Lidocaine|lidocaine|mesh-list
43789299|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
43789300|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
43789301|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789302|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789303|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
43789308|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789309|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789310|NCT04353310|Curcumin|curcumin|mesh-list
43789311|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43597532|NCT03307941|Fluorouracil|fluorouracil|mesh-list
43789312|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43789313|NCT04353310|Analgesics|analgesics|mesh-ancestor
43789314|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
43789339|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
43789340|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789341|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789342|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
43789343|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789344|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789345|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43789346|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43789347|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789348|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789349|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
43789350|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
43789351|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43789352|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43789353|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43789354|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789355|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43789356|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
43789357|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789358|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
43789360|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43789361|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43789362|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789363|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789364|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789377|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
43789378|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43789379|NCT03889795|Metformin|metformin|mesh-list
43789380|NCT03889795|Digoxin|digoxin|mesh-list
43789381|NCT03889795|Simvastatin|simvastatin|mesh-list
43789382|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789383|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789384|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43789385|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43789386|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
43545295|NCT03674008|Propofol|propofol|mesh-list
43789387|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789388|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43789389|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43789390|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789391|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789392|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43789393|NCT03889795|Protective Agents|protective agents|mesh-ancestor
43789395|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43789396|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789397|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789398|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
43789399|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
43789400|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789401|NCT03843151|Itraconazole|itraconazole|mesh-list
43545319|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545320|NCT03673501|Sunitinib|sunitinib|mesh-list
43789402|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
43618198|NCT03132623|Analgesics|analgesics|mesh-ancestor
43789404|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43789405|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43789406|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789407|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789408|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43789409|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
43789410|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789411|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789412|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43789413|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
43618323|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789418|NCT03822793|Coagulants|coagulants|mesh-ancestor
43789419|NCT03663166|Nivolumab|nivolumab|mesh-list
43789420|NCT03663166|Ipilimumab|ipilimumab|mesh-list
43789421|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789422|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789427|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43789428|NCT03306394|Trifluridine|trifluridine|mesh-list
43618409|NCT03131973|Vitamins|vitamins|mesh-ancestor
43789432|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789433|NCT02267343|Nivolumab|nivolumab|mesh-list
43545372|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545373|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789434|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789435|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789436|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43789437|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789438|NCT02261285|Nivolumab|nivolumab|mesh-list
43789439|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789440|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789441|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43618530|NCT03131141|Lefamulin|lefamulin|mesh-list
43618601|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43789456|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789458|NCT02256800|Protective Agents|protective agents|mesh-ancestor
43789459|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
43545428|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545429|NCT03671915|Insulin|insulin|mesh-list
43545430|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789460|NCT02256800|Vitamins|vitamins|mesh-ancestor
43789461|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
43789462|NCT02203682|Doxycycline|doxycycline|mesh-list
43789463|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789464|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789465|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
43789466|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43654172|NCT02978066|Anesthetics|anesthetics|mesh-list
43654173|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654174|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654175|NCT02978001|Glycerol|glycerol|mesh-list
43654176|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43654177|NCT02978001|Protective Agents|protective agents|mesh-ancestor
43654178|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654179|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
43789467|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43789468|NCT01903486|Prednisone|prednisone|mesh-list
43789469|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789470|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
43789471|NCT01903486|Hormones|hormones|mesh-ancestor
43789472|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789473|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789474|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43840720|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
43840721|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840722|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840723|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840725|NCT04675931|Lumefantrine|lumefantrine|mesh-list
43618848|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
43618849|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43618850|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43618851|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43618852|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840726|NCT04675931|Artemether|artemether|mesh-list
43840727|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
43840728|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
43840729|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43840730|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43840731|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43840732|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840733|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
43618902|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43545496|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43545497|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
43545498|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
43545499|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
43545500|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43618903|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43618904|NCT03127189|Rilpivirine|rilpivirine|mesh-list
43618905|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43618907|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840735|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43840736|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
43840737|NCT04675788|Ibutilide|ibutilide|mesh-list
43840738|NCT04675788|Testosterone|testosterone|mesh-list
43840739|NCT04675788|Progesterone|progesterone|mesh-list
43840740|NCT04675788|Androgens|androgens|mesh-ancestor
43840741|NCT04675788|Hormones|hormones|mesh-ancestor
43840742|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840743|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840744|NCT04675788|Progestins|progestins|mesh-ancestor
43840745|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789485|NCT01288625|Amifostine|amifostine|mesh-list
43789486|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43789487|NCT01288625|Protective Agents|protective agents|mesh-ancestor
43789488|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789489|NCT00599170|Rituximab|rituximab|mesh-list
43545501|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43545502|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545504|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43545505|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545506|NCT03671109|Piperaquine|piperaquine|mesh-list
43545507|NCT03671109|Artenimol|artenimol|mesh-list
43545508|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
43545509|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43545510|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43545511|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43545512|NCT03671070|Epinephrine|epinephrine|mesh-list
43545513|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43545514|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43545515|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
43545516|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545517|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545518|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789490|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789491|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545519|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43545520|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43545521|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
43545522|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789492|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
43789493|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789494|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43789495|NCT05128292|Selenium|selenium|mesh-list
43789496|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
43789497|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789506|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43789507|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
43789508|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43618990|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43618991|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
43618992|NCT03126656|Testosterone|testosterone|mesh-list
43618993|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
43618994|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
43618995|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43618996|NCT03126656|Androgens|androgens|mesh-ancestor
43618998|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43619002|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
43789509|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789510|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789511|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43789512|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789513|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43789514|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
43654181|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43654182|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43654183|NCT02977741|Olanzapine|olanzapine|mesh-list
43789515|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
43789517|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
43789518|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789519|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789520|NCT05127980|Antibodies|antibodies|mesh-list
43789521|NCT05127980|Autoantibodies|autoantibodies|mesh-list
43789522|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
43789523|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789524|NCT05127746|Donepezil|donepezil|mesh-list
43789525|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43545543|NCT03671044|Docetaxel|docetaxel|mesh-list
43619813|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789558|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789560|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789561|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789564|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
43789565|NCT05126602|Vitamins|vitamins|mesh-list
43789566|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
43789567|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789568|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43789569|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43789570|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
43789571|NCT05126004|Azacitidine|azacitidine|mesh-list
43789572|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43789573|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43789574|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
43654184|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
43654185|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
43654186|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654187|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789575|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789576|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789577|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789578|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
43789579|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789580|NCT05126004|Expectorants|expectorants|mesh-ancestor
43789581|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
43789582|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43789583|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
43789584|NCT05126004|Protective Agents|protective agents|mesh-ancestor
43789585|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789586|NCT05126004|Antidotes|antidotes|mesh-ancestor
43789587|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
43789588|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43789589|NCT05125640|Progesterone|progesterone|mesh-list
43789590|NCT05125640|Progestins|progestins|mesh-ancestor
43545582|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545583|NCT03670758|Protein S|protein s|mesh-list
43545584|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
43545585|NCT03670706|Analgesics|analgesics|mesh-list
43545586|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
43545587|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545588|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545589|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
43545590|NCT03670212|Yohimbine|yohimbine|mesh-list
43545591|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43545592|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
43545593|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
43545594|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545595|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789613|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789614|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789615|NCT05125549|Clopidogrel|clopidogrel|mesh-list
43789616|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43789617|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43789618|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43789619|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43789620|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
43789621|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789622|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789623|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789624|NCT05125380|Acetic Acid|acetic acid|mesh-list
43789625|NCT05125380|Retinol acetate|retinol acetate|mesh-list
43789626|NCT05125380|Lugol's solution|lugol's solution|mesh-list
43789627|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43789628|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789629|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43789630|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
43789631|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789632|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43789633|NCT05125380|Protective Agents|protective agents|mesh-ancestor
43789634|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789635|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
43789636|NCT05125380|Coagulants|coagulants|mesh-ancestor
43789637|NCT05125328|Remifentanil|remifentanil|mesh-list
43789638|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43789639|NCT05125328|Narcotics|narcotics|mesh-ancestor
43789640|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668764|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789641|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789642|NCT05125328|Analgesics|analgesics|mesh-ancestor
43789643|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
43789677|NCT05124717|Metformin|metformin|mesh-list
43789678|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789679|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840746|NCT04673448|Niraparib|niraparib|mesh-list
43789680|NCT05124431|Everolimus|everolimus|mesh-list
43545661|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43668765|NCT01497392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668766|NCT01497392|Immunologic Factors|immunologic factors|mesh-ancestor
43668767|NCT01497392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668769|NCT01367002|Carboplatin|carboplatin|mesh-list
43789697|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43789698|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789699|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789700|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789701|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789702|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43789703|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
43789704|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43789705|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43789706|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43789707|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789708|NCT05104918|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43789709|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
43789710|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43654188|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654190|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654191|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654192|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654193|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43654194|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43654195|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789712|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43789713|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43789715|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43789716|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43789717|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789718|NCT05087914|Naproxen|naproxen|mesh-list
43789719|NCT05087914|Levodopa|levodopa|mesh-list
43789720|NCT05087914|Carbidopa|carbidopa|mesh-list
43789721|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43789722|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43789723|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43789724|NCT05087914|Analgesics|analgesics|mesh-ancestor
43789725|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
43789726|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789727|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789728|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789729|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43545788|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
43545812|NCT03668418|Taxane|taxane|mesh-list
43789730|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
43789731|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43789732|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789733|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789735|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43789736|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
43789753|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
43789754|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789755|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43789756|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43789757|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43789758|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
43789759|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43620624|NCT03928275|Aldesleukin|aldesleukin|mesh-list
43620625|NCT03928275|Interleukin-2|interleukin-2|mesh-list
43620626|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
43789760|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789761|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
43789762|NCT04933331|Fluorides|fluorides|mesh-list
43789763|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
43789764|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
43789765|NCT04933331|Protective Agents|protective agents|mesh-ancestor
43789766|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789767|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43789768|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789769|NCT04932213|Tropicamide|tropicamide|mesh-list
43789778|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789780|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43789781|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43789782|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
43789783|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789784|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654196|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654197|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654198|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
43654200|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
43654201|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654202|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
43789785|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43789786|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43789787|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
43789788|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789789|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43789790|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43789791|NCT04901988|Nivolumab|nivolumab|mesh-list
43545834|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43545835|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43545836|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43545837|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545842|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545844|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789792|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789793|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789801|NCT04846218|Progestins|progestins|mesh-ancestor
43789802|NCT04846218|Hormones|hormones|mesh-ancestor
43789803|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789804|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789805|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
43789806|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43789807|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
43789808|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43789809|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43789810|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43789811|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789812|NCT04841499|Niacinamide|niacinamide|mesh-list
43789814|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
43789815|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
43789816|NCT04841499|Vitamins|vitamins|mesh-ancestor
43789817|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
43789818|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43621024|NCT03119636|Levodopa|levodopa|mesh-list
43789819|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43789820|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
43789821|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789822|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43545862|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43545863|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43545864|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43545865|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43668784|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43668785|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
43668786|NCT01014546|Vitamins|vitamins|mesh-list
43668787|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
43668788|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
43668789|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
43668790|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668791|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
43668792|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668793|NCT01014546|Protective Agents|protective agents|mesh-ancestor
43668794|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43545866|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43545867|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
43545868|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43545869|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43545870|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43545871|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43545872|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43545874|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43545875|NCT03667352|Fentanyl|fentanyl|mesh-list
43545876|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43789823|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
43789824|NCT04773405|Lidocaine|lidocaine|mesh-list
43789825|NCT04773405|Epinephrine|epinephrine|mesh-list
43789826|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
43789827|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
43789828|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
43789829|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789830|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789831|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
43789832|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789833|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789834|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43789835|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43789836|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789837|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789838|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43789839|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43789840|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
43789841|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789842|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43789843|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43789844|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
43654203|NCT02977611|Hematinics|hematinics|mesh-ancestor
43654205|NCT02977208|Analgesics|analgesics|mesh-ancestor
43654206|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
43654207|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654208|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789845|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43789846|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
43789848|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
43789849|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43789850|NCT04754061|Psilocybin|psilocybin|mesh-list
43789851|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
43789852|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789871|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789872|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43789874|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43789875|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
43789876|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43789877|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789878|NCT04693468|Palbociclib|palbociclib|mesh-list
43789879|NCT04693468|Axitinib|axitinib|mesh-list
43789880|NCT04693468|Crizotinib|crizotinib|mesh-list
43789881|NCT04693468|Talazoparib|talazoparib|mesh-list
43789882|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789883|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43789884|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789885|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789886|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43789887|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43789888|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43789889|NCT04654312|Diuretics|diuretics|mesh-ancestor
43789890|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
43789891|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789892|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43789893|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43789896|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43789897|NCT04635644|Narcotics|narcotics|mesh-ancestor
43789898|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789899|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789900|NCT04635644|Analgesics|analgesics|mesh-ancestor
43789901|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
43789902|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789903|NCT04617067|Gemcitabine|gemcitabine|mesh-list
43789904|NCT04617067|Paclitaxel|paclitaxel|mesh-list
43789905|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43789906|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789907|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
43789908|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
43789936|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43789938|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43789939|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43789940|NCT04572828|Analgesics|analgesics|mesh-ancestor
43789941|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
43789942|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43789943|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789944|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43789945|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43789946|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
43545926|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43789947|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43789948|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789949|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789950|NCT04564625|Vitamin D|vitamin d|mesh-list
43789951|NCT04564625|Vitamins|vitamins|mesh-ancestor
43789952|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
43789960|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789961|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654209|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
43621408|NCT03116516|Amlodipine|amlodipine|mesh-list
43654210|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43654211|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654212|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654213|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654214|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43654215|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43789962|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43789963|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789965|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43789966|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
43789967|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
43789968|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
43789969|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
43789970|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43621485|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43621486|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43621487|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
43621488|NCT03115697|Rifaximin|rifaximin|mesh-list
43621489|NCT03115697|Lactulose|lactulose|mesh-list
43789971|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43789972|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789973|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
43789974|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43789975|NCT04413526|Estrogens|estrogens|mesh-ancestor
43789977|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43789978|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789979|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43789980|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789981|NCT04373733|Favipiravir|favipiravir|mesh-list
43789982|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
43789983|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43789984|NCT04266912|Avelumab|avelumab|mesh-list
43789985|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43789986|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43789987|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43789988|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
43789989|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43789990|NCT04264663|Furazolidone|furazolidone|mesh-list
43790016|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
43790017|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790018|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790019|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790020|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790021|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43621551|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43790022|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790025|NCT04122287|Tinidazole|tinidazole|mesh-list
43790026|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43790027|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43598321|NCT03301025|Pregabalin|pregabalin|mesh-list
43790028|NCT04122287|Renal Agents|renal agents|mesh-ancestor
43790029|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790030|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43790031|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43790032|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790033|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790034|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790035|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43790036|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43790037|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
43790038|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43790039|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43790040|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43790057|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790058|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790059|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43790062|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43790063|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654216|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654217|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654218|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
43654219|NCT02977169|Cisplatin|cisplatin|mesh-list
43621756|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790073|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790075|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
43790076|NCT03568929|Idelalisib|idelalisib|mesh-list
43790077|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790078|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790079|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790080|NCT03510390|Metformin|metformin|mesh-list
43790081|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43790082|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790083|NCT03291990|Temozolomide|temozolomide|mesh-list
43790084|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790085|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
43546018|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43621974|NCT03111511|Drospirenone|drospirenone|mesh-list
43621975|NCT03111511|Midazolam|midazolam|mesh-list
43790086|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790087|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790088|NCT03277924|Cisplatin|cisplatin|mesh-list
43790089|NCT03277924|Doxorubicin|doxorubicin|mesh-list
43790090|NCT03277924|Methotrexate|methotrexate|mesh-list
43790091|NCT03277924|Nivolumab|nivolumab|mesh-list
43790092|NCT03277924|Sunitinib|sunitinib|mesh-list
43790093|NCT03277924|Epirubicin|epirubicin|mesh-list
43790095|NCT03277924|Dacarbazine|dacarbazine|mesh-list
43790096|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790097|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43790098|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43790099|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43790100|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790101|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790102|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43790103|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
43790104|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43546045|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43546046|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546047|NCT03666208|Sirolimus|sirolimus|mesh-list
43546053|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43546054|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
43546055|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546056|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
43546057|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
43790105|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790106|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790107|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
43790108|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
43790109|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43790110|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790111|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
43790112|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790113|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43790114|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790115|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43790116|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43790117|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43790119|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654248|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654249|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
43790120|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43790121|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790122|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
43546096|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
43546097|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43546098|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790123|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
43790124|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
43790143|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
43790144|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
43790145|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790146|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790147|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
43790148|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790149|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43790150|NCT03023462|Narcotics|narcotics|mesh-ancestor
43790151|NCT03023462|Analgesics|analgesics|mesh-ancestor
43790152|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
43790153|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
43790154|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790155|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
43790156|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
43790157|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43790158|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
43790159|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790160|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790161|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43790162|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43790163|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43790164|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43790165|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43790166|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43790167|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43790168|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
43790170|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43790171|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
43790172|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790173|NCT02865928|Bupivacaine|bupivacaine|mesh-list
43790174|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
43790175|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
43790177|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790178|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
43790179|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790181|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546150|NCT03664986|Bupivacaine|bupivacaine|mesh-list
43546151|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
43790182|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43790183|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790189|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790190|NCT02512692|Gemcitabine|gemcitabine|mesh-list
43790191|NCT02512692|Cisplatin|cisplatin|mesh-list
43790207|NCT02214407|Decitabine|decitabine|mesh-list
43790208|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
43790209|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790210|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
43790211|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790212|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790213|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790214|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
43790215|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43790217|NCT01899989|Carboplatin|carboplatin|mesh-list
43790218|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790219|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43790220|NCT01594398|Exemestane|exemestane|mesh-list
43790221|NCT01594398|Entinostat|entinostat|mesh-list
43790222|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790223|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43790224|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790225|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790226|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43790227|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43790228|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43654250|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654251|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
43654252|NCT02977065|Atorvastatin|atorvastatin|mesh-list
43654253|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43654254|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43790229|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
43790230|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790231|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790232|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43790233|NCT01573429|Bisphenol A|bisphenol a|mesh-list
43790234|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43546237|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790235|NCT01573429|Estrogens|estrogens|mesh-ancestor
43790236|NCT01573429|Hormones|hormones|mesh-ancestor
43790237|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790238|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790239|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43790240|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
43790241|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790242|NCT01573429|Protective Agents|protective agents|mesh-ancestor
43790243|NCT00807651|Insulin|insulin|mesh-list
43790244|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43790245|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43622485|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
43790246|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790247|NCT00700791|Vitamins|vitamins|mesh-list
43790248|NCT00700791|Vitamin E|vitamin e|mesh-list
43790249|NCT00700791|Tocopherols|tocopherols|mesh-list
43790250|NCT00700791|Tocotrienols|tocotrienols|mesh-list
43790251|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
43790268|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790269|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790270|NCT05129085|Dexamethasone|dexamethasone|mesh-list
43790271|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790272|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
43790273|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
43790274|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790275|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790276|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790279|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790280|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43790281|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790282|NCT05129033|Omalizumab|omalizumab|mesh-list
43790283|NCT05129033|Itraconazole|itraconazole|mesh-list
43790285|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790286|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
43790288|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790289|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790290|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43790291|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790292|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
43790293|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790294|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43790296|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790297|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790298|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43790299|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
43790300|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43790301|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43546342|NCT03662724|Venetoclax|venetoclax|mesh-list
43790302|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43790303|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
43790304|NCT05128916|Terbinafine|terbinafine|mesh-list
43790305|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
43790306|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790307|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790335|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43654255|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43654256|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
43654257|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654258|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43623062|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790336|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790337|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790338|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790339|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790340|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790341|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790342|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790343|NCT04969731|Gemcitabine|gemcitabine|mesh-list
43790344|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790345|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
43790346|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790347|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790348|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
43790349|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790350|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790351|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790352|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
43790353|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790355|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790356|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790357|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840810|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
43840812|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
43840813|NCT04670666|Metformin|metformin|mesh-list
43840814|NCT04670666|Empagliflozin|empagliflozin|mesh-list
43840815|NCT04670666|Linagliptin|linagliptin|mesh-list
43840816|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43840817|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840818|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43840819|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840820|NCT04670666|Incretins|incretins|mesh-ancestor
43840821|NCT04670666|Hormones|hormones|mesh-ancestor
43546404|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
43546406|NCT03662269|Indomethacin|indomethacin|mesh-list
43840822|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43840823|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43840824|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
43840825|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43840826|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
43840827|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840828|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840829|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43840831|NCT04669171|Lenalidomide|lenalidomide|mesh-list
43840832|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43840833|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840834|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
43790386|NCT04366518|Scopolamine|scopolamine|mesh-list
43790387|NCT04366518|Rivastigmine|rivastigmine|mesh-list
43790388|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43790389|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43790390|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790391|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790392|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
43790393|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790394|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790395|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43790396|NCT04366518|Protective Agents|protective agents|mesh-ancestor
43790397|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43790432|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790433|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790434|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43790435|NCT04113720|Analgesics|analgesics|mesh-ancestor
43790436|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
43790437|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790438|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43790469|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43790470|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43790471|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43790472|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43790473|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790474|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
43790475|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790476|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790477|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43790478|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790479|NCT04047862|Paclitaxel|paclitaxel|mesh-list
43790480|NCT04047862|Etoposide|etoposide|mesh-list
43790481|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43790482|NCT04047862|Cisplatin|cisplatin|mesh-list
43790483|NCT04047862|Carboplatin|carboplatin|mesh-list
43790484|NCT04047862|Fluorouracil|fluorouracil|mesh-list
43790485|NCT04047862|Capecitabine|capecitabine|mesh-list
43654266|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654267|NCT02977000|Propranolol|propranolol|mesh-list
43654268|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43654269|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43790497|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
43790498|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790499|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43546464|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43546467|NCT03661892|Hormones|hormones|mesh-ancestor
43790500|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43790501|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790502|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43790503|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43790504|NCT04038489|Aspirin|aspirin|mesh-list
43790505|NCT04038489|Tamoxifen|tamoxifen|mesh-list
43790506|NCT04038489|Paclitaxel|paclitaxel|mesh-list
43790507|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
43790508|NCT04038489|Doxorubicin|doxorubicin|mesh-list
43790509|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43790510|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790511|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790512|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790513|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790514|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790515|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790516|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
43790517|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790518|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790519|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43623740|NCT03966014|Amoxicillin|amoxicillin|mesh-list
43790520|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
43546537|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546538|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
43790521|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43790522|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43790523|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43790524|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43790525|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790526|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43790527|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43790529|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
43790530|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790531|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790532|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43790533|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43790534|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43790535|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43790536|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
43790537|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43623835|NCT03734744|Vitamin D|vitamin d|mesh-list
43790538|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
43790539|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790540|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43790541|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43790542|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43790543|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43790544|NCT03956368|Atorvastatin|atorvastatin|mesh-list
43623899|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
43790545|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43790546|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43790547|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
43790548|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790560|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43790561|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43790562|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43790563|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
43790564|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
43790565|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
43790566|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
43790567|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790568|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790569|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
43790570|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790571|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790572|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
43546570|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43790573|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
43654270|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
43654271|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43546571|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546572|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546573|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43546574|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
43668886|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654272|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654273|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790574|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790575|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43790576|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43790577|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43790578|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
43790580|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
43790581|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790582|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790583|NCT03665506|Trifluridine|trifluridine|mesh-list
43790584|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
43790585|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624114|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43624115|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43624116|NCT05403749|Growth Substances|growth substances|mesh-ancestor
43624117|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624118|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
43624119|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624121|NCT05403723|Carboplatin|carboplatin|mesh-list
43546598|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43546599|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43546600|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
43546601|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546602|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546603|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43546604|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546605|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43546606|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
43546607|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546608|NCT03660267|Caffeine|caffeine|mesh-list
43546609|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43546610|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43546611|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43546612|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546613|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624122|NCT05403723|Etoposide|etoposide|mesh-list
43624123|NCT05403723|Durvalumab|durvalumab|mesh-list
43624135|NCT05403307|Vaccines|vaccines|mesh-list
43624158|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
43624159|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43624160|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
43790587|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790588|NCT03389022|Ketamine|ketamine|mesh-list
43790589|NCT03389022|Analgesics|analgesics|mesh-ancestor
43790590|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
43790591|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790592|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790599|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43790600|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790601|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790603|NCT03319459|Cetuximab|cetuximab|mesh-list
43790604|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790605|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790606|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
43790607|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43790676|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790678|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840842|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43840843|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546634|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43624438|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43624439|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
43624440|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43624441|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
43624444|NCT04475991|Maraviroc|maraviroc|mesh-list
43840845|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
43840846|NCT04667572|Vitamins|vitamins|mesh-ancestor
43840847|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
43790679|NCT00754949|Azithromycin|azithromycin|mesh-list
43654274|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43654275|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43654276|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
43654277|NCT02976987|Cidofovir|cidofovir|mesh-list
43790680|NCT00754949|Dexamethasone|dexamethasone|mesh-list
43790681|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
43790682|NCT00754949|BB 1101|bb 1101|mesh-list
43790683|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790684|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
43790685|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
43790686|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790687|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790688|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790689|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
43790690|NCT00754949|Hormones|hormones|mesh-ancestor
43790691|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790692|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43790693|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790694|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
43790695|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546675|NCT03659058|Colchicine|colchicine|mesh-list
43790696|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790697|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43790698|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790699|NCT05132023|Metformin|metformin|mesh-list
43790700|NCT05132023|Empagliflozin|empagliflozin|mesh-list
43790710|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
43790711|NCT05131893|Capecitabine|capecitabine|mesh-list
43790712|NCT05131893|Trastuzumab|trastuzumab|mesh-list
43790713|NCT05131893|Letrozole|letrozole|mesh-list
43790714|NCT05131893|Epirubicin|epirubicin|mesh-list
43790715|NCT05131893|Pertuzumab|pertuzumab|mesh-list
43790716|NCT05131893|Goserelin|goserelin|mesh-list
43624493|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
43790717|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790718|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
43790719|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
43790720|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
43790721|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790722|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790723|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
43546726|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43790724|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790725|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790726|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43790727|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
43790728|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43790729|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790731|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790732|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43790733|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43790734|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790817|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790819|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
43790820|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790879|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
43790880|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43790881|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43790882|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790883|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
43790885|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43654278|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
43654279|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654281|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546777|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
43654282|NCT02976805|Bisacodyl|bisacodyl|mesh-list
43654283|NCT02976805|Cathartics|cathartics|mesh-ancestor
43790970|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790971|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43790972|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43790973|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
43790974|NCT03094234|Propranolol|propranolol|mesh-list
43790975|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43790976|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43790977|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
43790978|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790979|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790980|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790981|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43790982|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43790983|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
43624921|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790984|NCT03034564|Droxidopa|droxidopa|mesh-list
43790985|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43790986|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43790987|NCT03034538|Zonisamide|zonisamide|mesh-list
43790988|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
43790989|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43790990|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43790991|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790992|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43790993|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790994|NCT02468180|Polidocanol|polidocanol|mesh-list
43790995|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43790996|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43791084|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
43791085|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43791086|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43791087|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43791088|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43791089|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43791090|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43791091|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43791092|NCT05134298|Meropenem|meropenem|mesh-list
43791093|NCT05134298|Tazobactam|tazobactam|mesh-list
43791094|NCT05134298|Piperacillin|piperacillin|mesh-list
43625031|NCT00790218|Adenosine|adenosine|mesh-list
43791095|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43791096|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791097|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791098|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43791099|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791100|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791101|NCT05134220|Calcium|calcium|mesh-list
43791103|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791104|NCT05134194|Gemcitabine|gemcitabine|mesh-list
43654284|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654285|NCT02976805|Laxatives|laxatives|mesh-ancestor
43654286|NCT02976909|Paclitaxel|paclitaxel|mesh-list
43654287|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43654288|NCT02976909|Cisplatin|cisplatin|mesh-list
43654289|NCT02976909|Fluorouracil|fluorouracil|mesh-list
43654290|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43791105|NCT05134194|Capecitabine|capecitabine|mesh-list
43791106|NCT05134194|Vinorelbine|vinorelbine|mesh-list
43791107|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791108|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
43791109|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791110|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791111|NCT05134194|Antiviral Agents|antiviral agents|mesh-ancestor
43791112|NCT05134194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791113|NCT05134194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791114|NCT05134194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791115|NCT05134194|Immunologic Factors|immunologic factors|mesh-ancestor
43791116|NCT05134194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791117|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43791118|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
43791119|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
43791120|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
43791121|NCT05133791|Annexin A5|annexin a5|mesh-list
43791122|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791123|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43840866|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791202|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
43791203|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791204|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791205|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43791220|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43791221|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43654291|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654292|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654293|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
43625430|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625432|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
43625433|NCT03101579|Hydroxocobalamin|hydroxocobalamin|mesh-list
43625434|NCT03101579|Dexamethasone|dexamethasone|mesh-list
43625435|NCT03101579|Pemetrexed|pemetrexed|mesh-list
43625436|NCT03101579|Vitamins|vitamins|mesh-ancestor
43625437|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
43625438|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625439|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43625440|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
43625441|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
43625442|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625443|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625444|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
43625445|NCT03101579|Hormones|hormones|mesh-ancestor
43625446|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625447|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625448|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625449|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625450|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625451|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43625453|NCT03101579|Hematinics|hematinics|mesh-ancestor
43654294|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
43654295|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654296|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
43654297|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43654298|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43654299|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
43654300|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654302|NCT02976727|Lidocaine|lidocaine|mesh-list
43654303|NCT02976727|Prilocaine|prilocaine|mesh-list
43654304|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43654305|NCT02976727|Calcipotriene|calcipotriene|mesh-list
43654306|NCT02976727|Vitamins|vitamins|mesh-ancestor
43654307|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
43654308|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654309|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654310|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
43654311|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654312|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
43654313|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654314|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43654315|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43654316|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43625462|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
43625463|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625464|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625465|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43625467|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
43625468|NCT03101319|Vitamins|vitamins|mesh-ancestor
43625469|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
43625510|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625511|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625512|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
43625513|NCT03101137|Hormones|hormones|mesh-ancestor
43625514|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625515|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625516|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625517|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
43625518|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
43625519|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625520|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
43625522|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
43654317|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654318|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654319|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43654320|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
43654321|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43654333|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654334|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43625597|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
43625598|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43625599|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625600|NCT03100318|Dotinurad|dotinurad|mesh-list
43625601|NCT03100318|Benzbromarone|benzbromarone|mesh-list
43625602|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
43625603|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
43625604|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43625605|NCT03100318|Renal Agents|renal agents|mesh-ancestor
43625606|NCT03100422|Armin|armin|mesh-list
43625607|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43625608|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625610|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
43654336|NCT02976896|Apatinib|apatinib|mesh-list
43654337|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43546935|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
43546936|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43546937|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43546938|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43546939|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43546940|NCT03657550|Niacin|niacin|mesh-list
43546941|NCT03657550|Amlodipine|amlodipine|mesh-list
43546942|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43546943|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43546944|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43546948|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
43791223|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43791224|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43791225|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791226|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791227|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791228|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43625655|NCT03099616|Propofol|propofol|mesh-list
43625656|NCT03099616|Desflurane|desflurane|mesh-list
43625657|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43625658|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625659|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625660|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43625661|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
43625662|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
43625663|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43625664|NCT03099382|Docetaxel|docetaxel|mesh-list
43625665|NCT03099382|Irinotecan|irinotecan|mesh-list
43625666|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625667|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
43625668|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
43625669|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
43625670|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625671|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43625672|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43625673|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625674|NCT03099278|Ezetimibe|ezetimibe|mesh-list
43625675|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43625676|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43791229|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791230|NCT05121038|Leucovorin|leucovorin|mesh-list
43791231|NCT05121038|Fluorouracil|fluorouracil|mesh-list
43791232|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
43791233|NCT05121038|Irinotecan|irinotecan|mesh-list
43791234|NCT05121038|Panitumumab|panitumumab|mesh-list
43791235|NCT05121038|Folfirinox|folfirinox|mesh-list
43791236|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
43791237|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791238|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791239|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791240|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791241|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
43791242|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791243|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43791244|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43791245|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791246|NCT05121038|Antidotes|antidotes|mesh-ancestor
43546974|NCT03657420|Pomalidomide|pomalidomide|mesh-list
43546975|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43546976|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
43791247|NCT05121038|Protective Agents|protective agents|mesh-ancestor
43791248|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
43546977|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
43625732|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43625733|NCT03098875|Narcotics|narcotics|mesh-ancestor
43625737|NCT03099031|Tinzaparin|tinzaparin|mesh-list
43791249|NCT05121038|Vitamins|vitamins|mesh-ancestor
43791250|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
43791251|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791252|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
43791253|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
43791254|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
43791255|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43791256|NCT05031442|Protective Agents|protective agents|mesh-ancestor
43791257|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791258|NCT05030857|Midazolam|midazolam|mesh-list
43625788|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43625789|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43625790|NCT03098680|Protective Agents|protective agents|mesh-ancestor
43625791|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43625792|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43625793|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43625794|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43625795|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
43625796|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43625797|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43625798|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43625799|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43625800|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43625801|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625802|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625803|NCT03098407|Buprenorphine|buprenorphine|mesh-list
43625804|NCT03098407|Methadone|methadone|mesh-list
43791260|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43791261|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791262|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791263|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43791264|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43791265|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791266|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43791267|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
43791268|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
43654345|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43654346|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625836|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
43625837|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43625838|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625839|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43625840|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
43625841|NCT03098225|Hormones|hormones|mesh-ancestor
43625842|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43625843|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43625844|NCT03098225|Protective Agents|protective agents|mesh-ancestor
43625845|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43625846|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625847|NCT03098160|Ipilimumab|ipilimumab|mesh-list
43547062|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
43547076|NCT03656614|Neostigmine|neostigmine|mesh-list
43625848|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43625849|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625850|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43625851|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625852|NCT03098199|Menotropins|menotropins|mesh-list
43625853|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625854|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43849431|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
43625855|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
43625856|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43625857|NCT03098121|Grazoprevir|grazoprevir|mesh-list
43625858|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
43625859|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43625860|NCT03097848|Sorafenib|sorafenib|mesh-list
43625861|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43625862|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43625863|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625864|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654347|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654349|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43654350|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
43654351|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654352|NCT02976597|Morphine|morphine|mesh-list
43791330|NCT04313608|Antiviral Agents|antiviral agents|mesh-ancestor
43791331|NCT04313608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791332|NCT04313608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791333|NCT04313608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43791334|NCT04313608|Immunologic Factors|immunologic factors|mesh-ancestor
43791335|NCT04313608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791359|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791360|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791361|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43791362|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43791363|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
43625865|NCT03097900|Caffeine|caffeine|mesh-list
43625866|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
43625867|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625868|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43625869|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43625870|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43625871|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625872|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43625873|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43625874|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
43625875|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43625876|NCT03097835|Anesthetics|anesthetics|mesh-list
43625877|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43625878|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791364|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43791365|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
43791366|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43791367|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43791368|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791369|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791370|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43791371|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43791372|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
43791373|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43625907|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43791374|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43791375|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791376|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43791377|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791379|NCT03854578|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43791380|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43791381|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791382|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791383|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791384|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
43791385|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791386|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43625982|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43625983|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43625984|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625985|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
43625986|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
43625987|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43625990|NCT03096704|Vitamin D|vitamin d|mesh-list
43791422|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791424|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654353|NCT02976597|Bupivacaine|bupivacaine|mesh-list
43654354|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654355|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
43626034|NCT03096457|Paromomycin|paromomycin|mesh-list
43626035|NCT03096457|Pentamidine|pentamidine|mesh-list
43791425|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791426|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791465|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43668981|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43791466|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791467|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791468|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791469|NCT00071552|Fluticasone|fluticasone|mesh-list
43791470|NCT00071552|Xhance|xhance|mesh-list
43791471|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791472|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43791473|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
43626122|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43626123|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43626211|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
43626212|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626213|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43626214|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43626215|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43626216|NCT03095001|Growth Substances|growth substances|mesh-ancestor
43626217|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791474|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791475|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791476|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43791477|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791478|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
43791479|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43791480|NCT05136534|Anesthetics|anesthetics|mesh-list
43547138|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43791481|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43791482|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840927|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
43840929|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
43840930|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840931|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
43840932|NCT04664933|Protective Agents|protective agents|mesh-ancestor
43840933|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840934|NCT04663750|Aflibercept|aflibercept|mesh-list
43626271|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626272|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43626273|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43626274|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
43626275|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43626276|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
43626277|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
43626278|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
43626279|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43626280|NCT03094533|Propofol|propofol|mesh-list
43626281|NCT03094533|Sevoflurane|sevoflurane|mesh-list
43626282|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43626283|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43626284|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626285|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43626286|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
43626287|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
43626288|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626289|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43626290|NCT03094403|Azelaic acid|azelaic acid|mesh-list
43626291|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43626292|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840938|NCT04663750|Growth Substances|growth substances|mesh-ancestor
43840939|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840940|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840941|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791507|NCT05135442|Bortezomib|bortezomib|mesh-list
43791508|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791509|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43791510|NCT05135286|Carbachol|carbachol|mesh-list
43791511|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791512|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43791513|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43791514|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43791515|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791516|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791517|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791518|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791519|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43626309|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43626310|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43626311|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
43626312|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43626313|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43791530|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43791531|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43791532|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43791534|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
43791535|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
43791536|NCT05135013|Estradiol|estradiol|mesh-list
43791537|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43791538|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
43791539|NCT05135013|Estrogens|estrogens|mesh-ancestor
43669008|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
43791540|NCT05135013|Hormones|hormones|mesh-ancestor
43791541|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43791542|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626427|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43626428|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626429|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626430|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43547274|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
43626431|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43791543|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43791544|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
43791545|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43791546|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43791590|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791591|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791592|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43547275|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
43547276|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
43669022|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
43669023|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43669024|NCT02908191|Tenofovir|tenofovir|mesh-list
43669025|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43547277|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43547278|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547279|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43547280|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43547281|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43547282|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43547283|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
43547287|NCT03654027|Docetaxel|docetaxel|mesh-list
43791593|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43791594|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791595|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791596|NCT05060523|Tolvaptan|tolvaptan|mesh-list
43791597|NCT05060523|Midodrine|midodrine|mesh-list
43791598|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43791599|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791600|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
43791601|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626478|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43626538|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43626539|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
43626540|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43626541|NCT03091595|Diuretics|diuretics|mesh-ancestor
43626542|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
43626543|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
43626544|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43626545|NCT03091504|Albuterol|albuterol|mesh-list
43791607|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43791609|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791610|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791611|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
43791612|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547313|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43547314|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
43547315|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547316|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43547317|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43547318|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43547319|NCT03653520|Diazepam|diazepam|mesh-list
43791613|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
43791614|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791615|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791616|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43626743|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43626744|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626745|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43626746|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43626747|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
43626748|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626750|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43626751|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
43626752|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626753|NCT03086005|Metformin|metformin|mesh-list
43626754|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626755|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547360|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43547361|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43547362|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547363|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547365|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43547366|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547367|NCT03652896|Liver Extracts|liver extracts|mesh-list
43547368|NCT03652896|Hematinics|hematinics|mesh-ancestor
43547369|NCT03652857|Apatinib|apatinib|mesh-list
43547370|NCT03652857|Vinorelbine|vinorelbine|mesh-list
43626756|NCT03085784|Aflibercept|aflibercept|mesh-list
43791842|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43791843|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43791844|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791845|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791846|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791847|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791848|NCT03976934|Urological Agents|urological agents|mesh-ancestor
43791869|NCT03770546|Betamethasone|betamethasone|mesh-list
43791870|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791871|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
43791872|NCT03770546|Hormones|hormones|mesh-ancestor
43791873|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43626844|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626845|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
43626846|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43626847|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791874|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791875|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43791876|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
43791878|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791879|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791880|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
43791881|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547410|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547411|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547413|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547414|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
43547415|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43547416|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43547417|NCT03652480|Prednisolone|prednisolone|mesh-list
43547418|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
43547419|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43547420|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
43547421|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43547422|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
43547423|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
43547424|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547425|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547426|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43547427|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
43547428|NCT03652480|Hormones|hormones|mesh-ancestor
43547429|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547430|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43547431|NCT03652480|Protective Agents|protective agents|mesh-ancestor
43791882|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791883|NCT03627858|Beclomethasone|beclomethasone|mesh-list
43626912|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791884|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
43791885|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
43791886|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43791887|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
43791888|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840961|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
43791925|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43626984|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43626985|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43626986|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43626987|NCT03078842|Zinc|zinc|mesh-list
43626988|NCT03078842|Trace Elements|trace elements|mesh-ancestor
43626989|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
43626990|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626991|NCT03078725|Metformin|metformin|mesh-list
43626992|NCT03078725|Glyburide|glyburide|mesh-list
43626993|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43626994|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43626995|NCT03078465|Clopidogrel|clopidogrel|mesh-list
43626996|NCT03078465|Ticagrelor|ticagrelor|mesh-list
43626997|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43626998|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43626999|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43792144|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
43792145|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792146|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43792147|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43792148|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
43547439|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43547440|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547441|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43547442|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547443|NCT03652467|Siderophores|siderophores|mesh-ancestor
43547444|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43547445|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
43547446|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
43547447|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547448|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43547450|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792149|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
43792150|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43792151|NCT05137145|Linaclotide|linaclotide|mesh-list
43627037|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43627038|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43627039|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43627040|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627097|NCT03077503|Fentanyl|fentanyl|mesh-list
43627098|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
43627099|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43627100|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627101|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627102|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627103|NCT03077503|Analgesics|analgesics|mesh-ancestor
43627104|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
43627105|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627106|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43627107|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43792153|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
43792154|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792155|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792157|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792158|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792159|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
43792160|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792161|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792162|NCT05136924|Varenicline|varenicline|mesh-list
43792185|NCT05135143|Antioxidants|antioxidants|mesh-list
43792186|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792187|NCT05135143|Protective Agents|protective agents|mesh-ancestor
43792188|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792189|NCT05133453|Pirfenidone|pirfenidone|mesh-list
43792190|NCT05133453|Analgesics|analgesics|mesh-ancestor
43792315|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43792316|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
43547470|NCT03652116|Meperidine|meperidine|mesh-list
43547471|NCT03652116|Bupivacaine|bupivacaine|mesh-list
43547473|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
43627124|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792320|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792321|NCT05303961|Rebamipide|rebamipide|mesh-list
43792322|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43792323|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792324|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
43792325|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792326|NCT05303961|Protective Agents|protective agents|mesh-ancestor
43792327|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792328|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792382|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792384|NCT05303090|Lenvatinib|lenvatinib|mesh-list
43792385|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792386|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43792387|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792388|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792389|NCT05302999|Gabapentin|gabapentin|mesh-list
43627193|NCT03076320|Adapalene|adapalene|mesh-list
43627194|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43627195|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
43849435|NCT03928288|Cabergoline|cabergoline|mesh-list
43627196|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43627197|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627198|NCT03076320|Analgesics|analgesics|mesh-ancestor
43627199|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
43627200|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627201|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627202|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43627203|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43627204|NCT03076281|Metformin|metformin|mesh-list
43627205|NCT03076281|Doxycycline|doxycycline|mesh-list
43669026|NCT02908191|Entecavir|entecavir|mesh-list
43669027|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
43669028|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43669029|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43669031|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43627206|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43627207|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627208|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43627209|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43627210|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
43627211|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43627212|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43627213|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
43627214|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43627215|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43627216|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627217|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43627218|NCT03076099|Analgesics|analgesics|mesh-ancestor
43627219|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
43627220|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43627221|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43627222|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43627223|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43627224|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
43792390|NCT05302999|Analgesics|analgesics|mesh-ancestor
43792391|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
43792392|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792393|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792394|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
43792395|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43792396|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43792397|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792398|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792399|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43792400|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43792401|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792402|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792403|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
43627274|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
43627275|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627277|NCT03074994|Anesthetics|anesthetics|mesh-list
43627313|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43627314|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43627315|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547561|NCT03651531|Metformin|metformin|mesh-list
43547564|NCT03651427|Estradiol|estradiol|mesh-list
43841056|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841057|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841058|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
43841059|NCT04654689|Protective Agents|protective agents|mesh-ancestor
43841060|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43841061|NCT04653831|Pirfenidone|pirfenidone|mesh-list
43841062|NCT04653831|Analgesics|analgesics|mesh-ancestor
43841068|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841069|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841070|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841071|NCT04653246|Dexamethasone|dexamethasone|mesh-list
43841072|NCT04653246|Lenalidomide|lenalidomide|mesh-list
43841073|NCT04653246|Bortezomib|bortezomib|mesh-list
43841074|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841075|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
43841076|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
43841077|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841078|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841079|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43841080|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
43841081|NCT04653246|Hormones|hormones|mesh-ancestor
43760840|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43760841|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43760842|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43760843|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760844|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43760845|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43760846|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43760847|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43760849|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841082|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43841083|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43841084|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841085|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
43841086|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43841087|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43841088|NCT04653246|Growth Substances|growth substances|mesh-ancestor
43841089|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
43841090|NCT04652700|Tenofovir|tenofovir|mesh-list
43841091|NCT04652700|Emtricitabine|emtricitabine|mesh-list
43848456|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43792416|NCT05302726|Estrogens|estrogens|mesh-list
43792417|NCT05302726|Hormones|hormones|mesh-ancestor
43792418|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43760875|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
43760876|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43760877|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43760878|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
43760879|NCT02442752|Lansoprazole|lansoprazole|mesh-list
43760880|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43760881|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43760882|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43760883|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43760884|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43760885|NCT02442362|Paclitaxel|paclitaxel|mesh-list
43760886|NCT02442362|Fluorouracil|fluorouracil|mesh-list
43792419|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792420|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
43792421|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
43792422|NCT05302713|Calcium|calcium|mesh-list
43792423|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43792424|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792425|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43792468|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43792469|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43792470|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792471|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43792472|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
43760985|NCT02441933|Taxane|taxane|mesh-list
43792525|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792526|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43792527|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
43792528|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43792529|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43761037|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43761038|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761039|NCT02441894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43761040|NCT02441894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43761041|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761235|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761236|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761237|NCT02440399|Acetaminophen|acetaminophen|mesh-list
43761316|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792583|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792584|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792585|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
43792586|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
43792587|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43792589|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841100|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43841101|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43841102|NCT04652544|Vitamin D|vitamin d|mesh-list
43841103|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
43841104|NCT04652544|Vitamins|vitamins|mesh-ancestor
43841105|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
43761499|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
43761500|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43837413|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43837414|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837415|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43837416|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
43837417|NCT04910503|Hormones|hormones|mesh-ancestor
43837418|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837419|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43837420|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43837421|NCT04910425|Fluorides|fluorides|mesh-list
43837422|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
43837423|NCT04910425|Protective Agents|protective agents|mesh-ancestor
43837424|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837425|NCT04909515|Isotretinoin|isotretinoin|mesh-list
43837426|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
43837427|NCT04909333|Exenatide|exenatide|mesh-list
43837428|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43837429|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43837430|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43837431|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43837432|NCT04909333|Incretins|incretins|mesh-ancestor
43837433|NCT04909333|Hormones|hormones|mesh-ancestor
43837434|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43837435|NCT04909021|Vaccines|vaccines|mesh-list
43837436|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
43837437|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792685|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792686|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43792728|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43837450|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43792730|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43792731|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43792732|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792733|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792734|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792735|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43792736|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
43792737|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792738|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792739|NCT05097274|Choline|choline|mesh-list
43792854|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43792855|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43761565|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43761566|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43761567|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
43761568|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
43761569|NCT02438072|Analgesics|analgesics|mesh-ancestor
43761570|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
43761571|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761572|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43566121|NCT00838630|Cilostazol|cilostazol|mesh-list
43761573|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761574|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761575|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43761577|NCT02438020|Metformin|metformin|mesh-list
43792866|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43792867|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
43792868|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792869|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43792870|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43792871|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
43792872|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792873|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792874|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43792876|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
43792877|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792878|NCT04881539|Cannabidiol|cannabidiol|mesh-list
43761615|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43761616|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
43547703|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43547705|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43547706|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43547707|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547709|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43547710|NCT03649334|Fentanyl|fentanyl|mesh-list
43547711|NCT03649334|Ketamine|ketamine|mesh-list
43547712|NCT03649334|Analgesics|analgesics|mesh-ancestor
43547713|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
43547714|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43547715|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43547716|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43547717|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43547718|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
43547719|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
43761625|NCT02437045|Meropenem|meropenem|mesh-list
43761626|NCT02437045|Tazobactam|tazobactam|mesh-list
43792879|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
43792880|NCT04880278|Nabilone|nabilone|mesh-list
43792881|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
43792882|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
43792883|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761663|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
43792884|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792885|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792886|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43792887|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43792888|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792889|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43669049|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43669050|NCT02908165|Estrogens|estrogens|mesh-ancestor
43669051|NCT02908165|Hormones|hormones|mesh-ancestor
43669052|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43669053|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43669054|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43547722|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43547723|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547724|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547725|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43547726|NCT03649334|Narcotics|narcotics|mesh-ancestor
43792890|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
43792891|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43792892|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792893|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43792894|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43792895|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
43792896|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792897|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792898|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43792899|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
43792900|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792901|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792902|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43792903|NCT04820686|Tenofovir|tenofovir|mesh-list
43792904|NCT04820686|Entecavir|entecavir|mesh-list
43792909|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841148|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841149|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
43841150|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
43841151|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
43841152|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841154|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43841155|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43841156|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
43547772|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43547773|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
43547774|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43547792|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547793|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547794|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43547795|NCT03648684|Caffeine|caffeine|mesh-list
43547796|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43547797|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710567|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710568|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43710569|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43710570|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710571|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
43710572|NCT02696642|Maytansine|maytansine|mesh-list
43710573|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43710574|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43710575|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
43849949|NCT05702879|Ozanimod|ozanimod|mesh-list
43841157|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841158|NCT04649398|Nimodipine|nimodipine|mesh-list
43841159|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43841160|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43841161|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654356|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761849|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43761850|NCT02435654|Olanzapine|olanzapine|mesh-list
43761851|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
43761852|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
43761853|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761854|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761855|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43761856|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43761857|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43654357|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654359|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654360|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43654361|NCT02976597|Narcotics|narcotics|mesh-ancestor
43654362|NCT02976597|Analgesics|analgesics|mesh-ancestor
43654363|NCT02976194|Ranibizumab|ranibizumab|mesh-list
43654364|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43654365|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43654366|NCT02976194|Growth Substances|growth substances|mesh-ancestor
43654367|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654368|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654369|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654370|NCT02976467|Fulacimstat|fulacimstat|mesh-list
43841162|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710576|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
43710577|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
43710578|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710579|NCT02696460|Lidocaine|lidocaine|mesh-list
43710580|NCT02696460|Prilocaine|prilocaine|mesh-list
43841163|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841164|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841165|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
43841166|NCT04646967|Acetaminophen|acetaminophen|mesh-list
43841167|NCT04646967|Ibuprofen|ibuprofen|mesh-list
43841168|NCT04646967|Ketorolac|ketorolac|mesh-list
43841169|NCT04646967|Bupivacaine|bupivacaine|mesh-list
43841170|NCT04646967|Sevoflurane|sevoflurane|mesh-list
43841171|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841172|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
43841173|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841174|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841175|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
43761890|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
43761891|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43761892|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761893|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
43761894|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43761895|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43841176|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841177|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841178|NCT04646967|Analgesics|analgesics|mesh-ancestor
43841179|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
43841180|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841181|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841182|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841183|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43841184|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841185|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841186|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43841187|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43841188|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
43841189|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
43841190|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43841191|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841192|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43841193|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
43841194|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43792941|NCT04732195|Pilocarpine|pilocarpine|mesh-list
43792942|NCT04732195|Miotics|miotics|mesh-ancestor
43792943|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
43792944|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654371|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654372|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654373|NCT02976441|Temozolomide|temozolomide|mesh-list
43761984|NCT02434653|Chrysarobin|chrysarobin|mesh-list
43761985|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43761986|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43761987|NCT02434653|Analgesics|analgesics|mesh-ancestor
43761990|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43761991|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43761993|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
43793056|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793057|NCT04529278|Liraglutide|liraglutide|mesh-list
43793058|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654374|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43654375|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
43654376|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43547805|NCT03648671|Rasagiline|rasagiline|mesh-list
43654377|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43824967|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43824968|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43824970|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
43824971|NCT05506319|Norepinephrine|norepinephrine|mesh-list
43824972|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43762229|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762230|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43762336|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43762337|NCT02432677|Narcotics|narcotics|mesh-ancestor
43762338|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43762339|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43762340|NCT02432677|Analgesics|analgesics|mesh-ancestor
43762341|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
43762342|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43762343|NCT02432651|Xanthohumol|xanthohumol|mesh-list
43762344|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43762345|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43762346|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43793059|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793060|NCT04529278|Incretins|incretins|mesh-ancestor
43793063|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
43793064|NCT04518410|Gabexate|gabexate|mesh-list
43793065|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
43793066|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43793067|NCT04518410|Antibodies|antibodies|mesh-list
43793068|NCT04518410|Camostat|camostat|mesh-list
43793069|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
43793070|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793071|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
43793072|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793073|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793074|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43793075|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43793076|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
43547847|NCT03648333|Vitamins|vitamins|mesh-ancestor
43793077|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
43793078|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793079|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43793080|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841200|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848477|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
43848479|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848480|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848481|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
43848482|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848483|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43793110|NCT04398914|Paclitaxel|paclitaxel|mesh-list
43793111|NCT04398914|Trastuzumab|trastuzumab|mesh-list
43793112|NCT04398914|Pertuzumab|pertuzumab|mesh-list
43793113|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793114|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793115|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793116|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
43793117|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
43793118|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793119|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43793120|NCT04374578|Dulaglutide|dulaglutide|mesh-list
43793121|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793122|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793123|NCT04348032|Apatinib|apatinib|mesh-list
43762448|NCT02431975|Ritonavir|ritonavir|mesh-list
43793124|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43547874|NCT03648008|Hydromorphone|hydromorphone|mesh-list
43793125|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43793126|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793127|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793128|NCT04301310|Rifampin|rifampin|mesh-list
43793129|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43793130|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
43793131|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43793132|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793133|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
43824975|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824976|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824977|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824978|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
43824979|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
43824980|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43824981|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43824982|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
43824983|NCT05506319|Coagulants|coagulants|mesh-ancestor
43824984|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43824985|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
43824986|NCT05506137|Pilocarpine|pilocarpine|mesh-list
43824987|NCT05506137|Miotics|miotics|mesh-ancestor
43824988|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
43762505|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
43762508|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43824990|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43824991|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43824992|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43824993|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
43824994|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43824995|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846538|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793138|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43793139|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43793140|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43793141|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43793142|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43793144|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43793145|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43847919|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
43847920|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43847921|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43847922|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43847928|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43847929|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
43847930|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
43847931|NCT04069052|Protective Agents|protective agents|mesh-ancestor
43847932|NCT04066764|Nadroparin|nadroparin|mesh-list
43847933|NCT04066764|Warfarin|warfarin|mesh-list
43847934|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
43847935|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
43793146|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846544|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
43846545|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
43547913|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43547914|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43846546|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846547|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846548|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
43846549|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846550|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43846551|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43846552|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43846553|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43793147|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793148|NCT04282629|Milrinone|milrinone|mesh-list
43793149|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43793150|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43793151|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
43793152|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43793153|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43793154|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793155|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793156|NCT04282629|Protective Agents|protective agents|mesh-ancestor
43793157|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793158|NCT04280939|Anesthetics|anesthetics|mesh-list
43793159|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793160|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793221|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43793222|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793223|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43793224|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793225|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793227|NCT04140968|Progestins|progestins|mesh-ancestor
43793263|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43793264|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793266|NCT04089865|Coagulants|coagulants|mesh-ancestor
43793267|NCT04086147|Tenecteplase|tenecteplase|mesh-list
43793268|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43793269|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43793270|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793272|NCT04084860|Analgesics|analgesics|mesh-ancestor
43793273|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
43547936|NCT03647579|Analgesics|analgesics|mesh-ancestor
43793274|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793275|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793284|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846554|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793285|NCT04079738|Ixazomib|ixazomib|mesh-list
43793286|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793287|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
43793288|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793289|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793290|NCT05431764|Gemcitabine|gemcitabine|mesh-list
43793291|NCT05431764|Cisplatin|cisplatin|mesh-list
43793292|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43793293|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793294|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43762844|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43762845|NCT02429219|Ethanol|ethanol|mesh-list
43762850|NCT02429193|Prednisone|prednisone|mesh-list
43793295|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793296|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
43793297|NCT05431764|Antiviral Agents|antiviral agents|mesh-ancestor
43762901|NCT02429232|Pioglitazone|pioglitazone|mesh-list
43793298|NCT05431764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793299|NCT05431764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793300|NCT05431764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793301|NCT05431764|Immunologic Factors|immunologic factors|mesh-ancestor
43793302|NCT05431764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793303|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
43793304|NCT05431413|Fluoxetine|fluoxetine|mesh-list
43793305|NCT05431413|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43841246|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841247|NCT04641338|Dipyrone|dipyrone|mesh-list
43841248|NCT04641338|Codeine|codeine|mesh-list
43710649|NCT02695810|Metformin|metformin|mesh-list
43841249|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43841250|NCT04641338|Narcotics|narcotics|mesh-ancestor
43841251|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841252|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841253|NCT04641338|Analgesics|analgesics|mesh-ancestor
43841254|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
43841255|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841256|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
43841257|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
43841258|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841259|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43841260|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841261|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43841262|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
43841263|NCT04641195|Vitamin D|vitamin d|mesh-list
43841264|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
43841265|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
43841266|NCT04641195|Vitamins|vitamins|mesh-list
43763111|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793367|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43793368|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43793369|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793370|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793371|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43793372|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43793373|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
43763159|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763160|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
43763161|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763164|NCT02428062|Epinephrine|epinephrine|mesh-list
43763165|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
43548004|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43548005|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763166|NCT02428062|Norepinephrine|norepinephrine|mesh-list
43763167|NCT02428062|Ephedrine|ephedrine|mesh-list
43763168|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43548006|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
43763169|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763170|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43763171|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43763172|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
43763173|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763174|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763175|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43763176|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43763177|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
43763178|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763179|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43763180|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
43793374|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793375|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793376|NCT05430087|Vitamin D|vitamin d|mesh-list
43793408|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43793410|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
43793411|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43793412|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43793413|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43793414|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793415|NCT05410847|Paclitaxel|paclitaxel|mesh-list
43793416|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43793418|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
43793450|NCT05342844|Analgesics|analgesics|mesh-ancestor
43793451|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
43793452|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793453|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43793454|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43793455|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43793456|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
43793457|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548029|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
43548038|NCT03646500|Remifentanil|remifentanil|mesh-list
43793458|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763243|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43763252|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43763253|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43763254|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
43763255|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43763256|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43763257|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763258|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
43763317|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43763318|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43763319|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43763320|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
43763321|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
43710691|NCT02695771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43710692|NCT02695771|Immunologic Factors|immunologic factors|mesh-ancestor
43710693|NCT02695771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710694|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43710695|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
43710696|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43710697|NCT02695862|Terlipressin|terlipressin|mesh-list
43710698|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43710699|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43710700|NCT02695758|Bupivacaine|bupivacaine|mesh-list
43710701|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
43710702|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
43710703|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43710704|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710705|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
43831635|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
43831637|NCT05303792|Doxorubicin|doxorubicin|mesh-list
43831638|NCT05303792|Methotrexate|methotrexate|mesh-list
43831639|NCT05303792|Vincristine|vincristine|mesh-list
43831640|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
43831641|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43831642|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43831643|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
43763322|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
43763323|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
43763324|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
43763330|NCT02426723|Dexamethasone|dexamethasone|mesh-list
43763412|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763413|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
43763423|NCT02426177|Labetalol|labetalol|mesh-list
43846571|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43846572|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
43763442|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43763443|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
43763444|NCT02426164|Epinephrine|epinephrine|mesh-list
43763445|NCT02426164|Morphine|morphine|mesh-list
43763446|NCT02426164|Bupivacaine|bupivacaine|mesh-list
43763447|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
43763448|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
43763449|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43763450|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763451|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
43763452|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548065|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43548066|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43548067|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43763453|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43763454|NCT02426164|Narcotics|narcotics|mesh-ancestor
43763455|NCT02426164|Analgesics|analgesics|mesh-ancestor
43548068|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
43548069|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43548070|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548071|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548072|NCT03646292|Pioglitazone|pioglitazone|mesh-list
43548073|NCT03646292|Empagliflozin|empagliflozin|mesh-list
43548074|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43548075|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548076|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43548077|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548078|NCT03646266|Bromides|bromides|mesh-list
43548079|NCT03646266|Rocuronium|rocuronium|mesh-list
43548080|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
43548081|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43763456|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43763457|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
43548089|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548091|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
43763458|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
43763461|NCT02426164|Hormones|hormones|mesh-ancestor
43846573|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846574|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846575|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43793818|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43793819|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793820|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793821|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43793822|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
43793855|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
43793856|NCT03136445|Coagulants|coagulants|mesh-ancestor
43763490|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763491|NCT02426008|Mitogens|mitogens|mesh-list
43763492|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
43763493|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763529|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763530|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
43763531|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43763532|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
43763533|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763534|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43763535|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43763536|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
43763537|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
43763538|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43793858|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793859|NCT03136029|Protective Agents|protective agents|mesh-ancestor
43793860|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793861|NCT02979522|Doxorubicin|doxorubicin|mesh-list
43793862|NCT02979522|Dacarbazine|dacarbazine|mesh-list
43793863|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43793864|NCT02979522|Vinblastine|vinblastine|mesh-list
43793865|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43793866|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793867|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43846577|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
43846578|NCT04191447|Hormones|hormones|mesh-ancestor
43846579|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763575|NCT02425488|Coal Tar|coal tar|mesh-list
43763605|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43763606|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43763607|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
43763608|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763609|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763610|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763611|NCT02425241|Vaccines|vaccines|mesh-list
43763612|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
43763613|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548104|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43548105|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43548106|NCT03645668|Meropenem|meropenem|mesh-list
43548108|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548109|NCT03645642|Midodrine|midodrine|mesh-list
43548110|NCT03645642|Diuretics|diuretics|mesh-list
43548123|NCT03645304|Ropivacaine|ropivacaine|mesh-list
43763614|NCT02425137|Gemcitabine|gemcitabine|mesh-list
43846581|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43654380|NCT02976246|Vitamins|vitamins|mesh-ancestor
43654381|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
43654382|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654383|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43654384|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43704118|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43763668|NCT02424695|Gabapentin|gabapentin|mesh-list
43763669|NCT02424695|Analgesics|analgesics|mesh-ancestor
43763670|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
43763671|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548126|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548127|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548128|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
43548129|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548130|NCT03645200|Apatinib|apatinib|mesh-list
43548131|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43548132|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43548133|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548134|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548135|NCT03645187|Celecoxib|celecoxib|mesh-list
43548136|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43548138|NCT03645187|Analgesics|analgesics|mesh-ancestor
43763672|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43763732|NCT02424435|Hormones|hormones|mesh-ancestor
43763733|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43763734|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43763735|NCT02424435|Protective Agents|protective agents|mesh-ancestor
43763736|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43763737|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763738|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
43763739|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
43763740|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43794089|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43794090|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
43794091|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
43794092|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
43794093|NCT03930680|Razoxane|razoxane|mesh-list
43794094|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794095|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43841376|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
43794096|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43794097|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794098|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794099|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654387|NCT02976246|Coagulants|coagulants|mesh-ancestor
43654388|NCT02976116|Gefitinib|gefitinib|mesh-list
43654389|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654390|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43837666|NCT04898075|Nicotine|nicotine|mesh-list
43837667|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43837668|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
43763861|NCT02423811|Fursultiamin|fursultiamin|mesh-list
43763862|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
43654391|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548181|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43548182|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43548183|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
43548184|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43548185|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548186|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
43548187|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
43548188|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43548189|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548190|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43548191|NCT03644667|Protective Agents|protective agents|mesh-ancestor
43548193|NCT03644641|Desflurane|desflurane|mesh-list
43548194|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43794100|NCT03930680|Protective Agents|protective agents|mesh-ancestor
43794101|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794102|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
43794103|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
43794104|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43794105|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43794106|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794108|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43794109|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43794110|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794111|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794112|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
43794113|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794114|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43794115|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43763921|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763922|NCT02423824|Liraglutide|liraglutide|mesh-list
43763923|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43763936|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
43763937|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43763938|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43763939|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
43763940|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763941|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43763942|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
43763943|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43763944|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43763945|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
43763946|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43763947|NCT02423265|Ranolazine|ranolazine|mesh-list
43763948|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43763954|NCT02423239|HU 211|hu 211|mesh-list
43763974|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43763975|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43763976|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43763977|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43763978|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43763979|NCT02423239|Protective Agents|protective agents|mesh-ancestor
43763980|NCT02422784|Vitamin D|vitamin d|mesh-list
43794116|NCT03864094|Phenylephrine|phenylephrine|mesh-list
43794117|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
43794118|NCT03864094|Norepinephrine|norepinephrine|mesh-list
43794144|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
43794145|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794146|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794147|NCT03864094|Protective Agents|protective agents|mesh-ancestor
43794148|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43794149|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43794150|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43794151|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
43794152|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43794153|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794154|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
43794155|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
43794156|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794162|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43794163|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794164|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
43794171|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794220|NCT03750786|Leucovorin|leucovorin|mesh-list
43794221|NCT03750786|Antidotes|antidotes|mesh-ancestor
43794222|NCT03750786|Protective Agents|protective agents|mesh-ancestor
43794223|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794224|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
43794295|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
43794296|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794297|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794298|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794299|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43764184|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
43764185|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43764186|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43764187|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764188|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43764189|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43764190|NCT02422030|Atorvastatin|atorvastatin|mesh-list
43764191|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
43837711|NCT04892875|Cisplatin|cisplatin|mesh-list
43794300|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43794301|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794302|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654392|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654393|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
43654394|NCT02975921|Povidone|povidone|mesh-list
43654395|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
43654396|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
43654397|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43654398|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548334|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43654399|NCT02975843|Beclomethasone|beclomethasone|mesh-list
43654400|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
43654401|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
43654403|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
43654404|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654405|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764348|NCT02420782|Miotics|miotics|mesh-ancestor
43764418|NCT02420080|Brincidofovir|brincidofovir|mesh-list
43654406|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43654407|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794303|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43794305|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43794306|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43794307|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794308|NCT03581734|Vaccines|vaccines|mesh-list
43794309|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
43794310|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794311|NCT03576989|Mineral Oil|mineral oil|mesh-list
43794312|NCT03576989|Emollients|emollients|mesh-ancestor
43794313|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
43794314|NCT03493646|Azacitidine|azacitidine|mesh-list
43764553|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43764556|NCT02419105|Vitamin D|vitamin d|mesh-list
43794318|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794319|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794320|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794421|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43764846|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43764847|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43764848|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
43764851|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
43794422|NCT03189641|Protective Agents|protective agents|mesh-ancestor
43794423|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43794424|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43794425|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794426|NCT03161223|Azacitidine|azacitidine|mesh-list
43794427|NCT03161223|Durvalumab|durvalumab|mesh-list
43794663|NCT02163356|Ketoconazole|ketoconazole|mesh-list
43794664|NCT02163356|Vincristine|vincristine|mesh-list
43794665|NCT02163356|Fenretinide|fenretinide|mesh-list
43794666|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43794667|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794668|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
43794669|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
43765220|NCT02415062|Donepezil|donepezil|mesh-list
43548388|NCT03642600|Incretins|incretins|mesh-ancestor
43765312|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43794670|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
43794673|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794674|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43654408|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43654409|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43654410|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43794675|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43794676|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794677|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43794678|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
43765380|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794679|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794680|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794681|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43794682|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43794683|NCT02163356|Protective Agents|protective agents|mesh-ancestor
43794684|NCT02102477|Androgens|androgens|mesh-list
43794685|NCT02102477|Hormones|hormones|mesh-ancestor
43794686|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794687|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765561|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794688|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
43794732|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794733|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794734|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
43794735|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794736|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794737|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
43794738|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765793|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43765794|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43548418|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43548419|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
43548421|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43765795|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43765796|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765797|NCT02411344|Pertuzumab|pertuzumab|mesh-list
43765798|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43765863|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43765864|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43765865|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43765866|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43765867|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43765868|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43765869|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
43765870|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43710786|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710787|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
43710788|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43710789|NCT02695212|Apremilast|apremilast|mesh-list
43710790|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43710791|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43710792|NCT02695212|Analgesics|analgesics|mesh-ancestor
43765871|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
43765872|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
43765873|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
43765877|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43765878|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43765879|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43765880|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43765881|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43765882|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
43765883|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
43765884|NCT02410720|Cathartics|cathartics|mesh-ancestor
43837828|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
43765885|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43548512|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
43548513|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43548514|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43548516|NCT03640468|Lidocaine|lidocaine|mesh-list
43548517|NCT03640468|Midazolam|midazolam|mesh-list
43548518|NCT03640468|Ketamine|ketamine|mesh-list
43548519|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
43548520|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
43548521|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43548522|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43548553|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
43548554|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
43548555|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43548556|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
43548557|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
43548558|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
43548563|NCT03640390|Analgesics|analgesics|mesh-ancestor
43794739|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794740|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794741|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43794742|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43841478|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
43794743|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43794744|NCT01850355|Buspirone|buspirone|mesh-list
43794745|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43794746|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43794747|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43837881|NCT04882839|Psilocybin|psilocybin|mesh-list
43794748|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794749|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43794750|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43794751|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
43794752|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43794753|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794755|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43794756|NCT01799629|Protective Agents|protective agents|mesh-ancestor
43794791|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43654412|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654413|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841491|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
43548586|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
43548587|NCT03640351|Protective Agents|protective agents|mesh-ancestor
43548588|NCT03640273|Loratadine|loratadine|mesh-list
43548589|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
43548590|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
43548591|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43548592|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43548593|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43548594|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
43548595|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
43548596|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841492|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43841494|NCT04613830|Bupivacaine|bupivacaine|mesh-list
43841495|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
43794990|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43794991|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43794992|NCT04563338|Growth Substances|growth substances|mesh-ancestor
43794993|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794994|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794996|NCT04498273|Apixaban|apixaban|mesh-list
43794997|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43794998|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794999|NCT04498273|Analgesics|analgesics|mesh-ancestor
43795000|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
43795001|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795002|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795003|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795004|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43795005|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43795006|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43795007|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795008|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43795009|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43795010|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795011|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
43795096|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795097|NCT05243355|Endostatins|endostatins|mesh-list
43795098|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795099|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43795100|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43795101|NCT05243355|Growth Substances|growth substances|mesh-ancestor
43795102|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795103|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
43795106|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
43795107|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
43795108|NCT05243290|Vitamins|vitamins|mesh-ancestor
43795109|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
43795110|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43710803|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43710804|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710805|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43710806|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
43710807|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795111|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795112|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
43795113|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795114|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795115|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
43795116|NCT05239533|Nivolumab|nivolumab|mesh-list
43795117|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43795246|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43795247|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43795248|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795249|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43548768|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43795250|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795252|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
43795253|NCT04509401|Pyridoxal|pyridoxal|mesh-list
43795254|NCT04509401|Pyridoxine|pyridoxine|mesh-list
43795255|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
43795256|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
43795257|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795258|NCT04457596|Trastuzumab|trastuzumab|mesh-list
43795259|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43795260|NCT04457596|Maytansine|maytansine|mesh-list
43795261|NCT04457596|Tucatinib|tucatinib|mesh-list
43841595|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841596|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
43766598|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
43766599|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43766600|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43766629|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43841597|NCT04602754|Empagliflozin|empagliflozin|mesh-list
43841598|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43841599|NCT04602754|Calcium|calcium|mesh-list
43841600|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841601|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841602|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43841604|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43841605|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
43841606|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43766809|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
43841607|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43841608|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43841609|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43710838|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
43841610|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43841611|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43841612|NCT04602494|Varenicline|varenicline|mesh-list
43766843|NCT02404779|Cisatracurium|cisatracurium|mesh-list
43841613|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43841614|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43841615|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841616|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795325|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43795326|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43795327|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795328|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
43766918|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43766919|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43766920|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43766921|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43766922|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43766924|NCT02404142|Atracurium|atracurium|mesh-list
43766980|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43766981|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43766982|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43766983|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43795397|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795398|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
43795399|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795400|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795401|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795402|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795404|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795405|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795406|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
43795407|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795408|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795409|NCT03882892|Ezetimibe|ezetimibe|mesh-list
43795410|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795411|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795412|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
43710854|NCT02694263|Canagliflozin|canagliflozin|mesh-list
43795413|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654414|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43654415|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43654416|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43654417|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
43654418|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654419|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
43654420|NCT02975843|Hormones|hormones|mesh-ancestor
43654421|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43767207|NCT02403037|Emetics|emetics|mesh-list
43654422|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
43654423|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43654424|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795414|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795415|NCT03867318|Atorvastatin|atorvastatin|mesh-list
43795416|NCT03867318|Ezetimibe|ezetimibe|mesh-list
43795417|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795438|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795441|NCT03865082|Ipilimumab|ipilimumab|mesh-list
43795442|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795443|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795444|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43795445|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795446|NCT03713944|Bevacizumab|bevacizumab|mesh-list
43795447|NCT03713944|Carboplatin|carboplatin|mesh-list
43795448|NCT03713944|Pemetrexed|pemetrexed|mesh-list
43795449|NCT03713944|Atezolizumab|atezolizumab|mesh-list
43795450|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795451|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795452|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43795453|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43795454|NCT03713944|Growth Substances|growth substances|mesh-ancestor
43795455|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795456|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
43795457|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795458|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795459|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43795460|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43795461|NCT03681561|Nivolumab|nivolumab|mesh-list
43795466|NCT03639246|Paclitaxel|paclitaxel|mesh-list
43795467|NCT03639246|Doxorubicin|doxorubicin|mesh-list
43795468|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43795469|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43795470|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795539|NCT03363763|Sirolimus|sirolimus|mesh-list
43795588|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43795589|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795591|NCT03138720|Paclitaxel|paclitaxel|mesh-list
43795592|NCT03138720|Cisplatin|cisplatin|mesh-list
43795593|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43767714|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43767715|NCT02400047|Analgesics|analgesics|mesh-ancestor
43767716|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
43767717|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43767718|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43767719|NCT02399800|Triamcinolone|triamcinolone|mesh-list
43767739|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43767741|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795595|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795596|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
43795597|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795598|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
43795599|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654425|NCT02976012|Aflibercept|aflibercept|mesh-list
43767907|NCT02398448|Protective Agents|protective agents|mesh-ancestor
43767908|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43767909|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43841670|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
43841671|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704119|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43768111|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
43841672|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841673|NCT04599140|Nivolumab|nivolumab|mesh-list
43841674|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841675|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841676|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841677|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841678|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
43841679|NCT04597619|Analgesics|analgesics|mesh-ancestor
43841680|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
43768206|NCT02396862|Factor VIII|factor viii|mesh-list
43841681|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841682|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841683|NCT04597190|Norepinephrine|norepinephrine|mesh-list
43841684|NCT04597190|Serotonin|serotonin|mesh-list
43841685|NCT04597190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43841686|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43795681|NCT01554410|Gemcitabine|gemcitabine|mesh-list
43795700|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43795701|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
43795702|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795703|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795705|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795706|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795707|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795708|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795709|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795710|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795711|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795712|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795713|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
43795714|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
43795715|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795716|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795717|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795718|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
43795719|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654428|NCT02976012|Growth Substances|growth substances|mesh-ancestor
43654429|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654430|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654431|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654432|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
43654433|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43654434|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
43654435|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43654436|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
43654437|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654438|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795720|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795721|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795722|NCT00805584|Desloratadine|desloratadine|mesh-list
43795723|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795724|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795725|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795726|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795727|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795728|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43549014|NCT03636932|Antidotes|antidotes|mesh-ancestor
43549015|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43549016|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549018|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43549019|NCT03636685|Carboplatin|carboplatin|mesh-list
43549020|NCT03636685|Pemetrexed|pemetrexed|mesh-list
43549021|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43549022|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549023|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
43549024|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
43549025|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
43549026|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549027|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795729|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795730|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795731|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
43768424|NCT02394496|Fulvestrant|fulvestrant|mesh-list
43795734|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795735|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795736|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795737|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768474|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768475|NCT02394197|Chloroquine|chloroquine|mesh-list
43654442|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43654443|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654444|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549061|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654445|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43768564|NCT02394054|Vasopressins|vasopressins|mesh-list
43768565|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
43768566|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
43768567|NCT02394054|Coagulants|coagulants|mesh-ancestor
43768568|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43795883|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795884|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795886|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795887|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
43549062|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43549063|NCT03636373|Analgesics|analgesics|mesh-ancestor
43549064|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
43549076|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549077|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43549078|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
43549079|NCT03636308|Antiviral Agents|antiviral agents|mesh-ancestor
43549080|NCT03636308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549081|NCT03636308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549082|NCT03636308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549083|NCT03636308|Immunologic Factors|immunologic factors|mesh-ancestor
43549084|NCT03636308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549085|NCT03636178|Daminozide|daminozide|mesh-list
43549086|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
43549087|NCT03636178|Growth Substances|growth substances|mesh-ancestor
43549088|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549089|NCT03636048|Bupivacaine|bupivacaine|mesh-list
43549090|NCT03636048|Anesthetics|anesthetics|mesh-list
43795888|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795889|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795890|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795891|NCT00653835|Simvastatin|simvastatin|mesh-list
43795892|NCT00653835|Ezetimibe|ezetimibe|mesh-list
43795893|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795894|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795895|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
43768629|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
43795896|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795897|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43768738|NCT02392780|Hormones|hormones|mesh-ancestor
43795898|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795899|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795900|NCT00653796|Atorvastatin|atorvastatin|mesh-list
43795901|NCT00653796|Ezetimibe|ezetimibe|mesh-list
43795902|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43710963|NCT02693392|Metformin|metformin|mesh-list
43795903|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795904|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
43795905|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795906|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43795907|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43795908|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796068|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
43796069|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796070|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796071|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
43796072|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796073|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43796074|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43796075|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43796076|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796077|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796078|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43796079|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43796080|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
43796081|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796082|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43796083|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43796084|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
43796085|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43796086|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796087|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
43796088|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
43654457|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
43654458|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654459|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654460|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
43654461|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654462|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549224|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43549225|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
43549226|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43549227|NCT03634735|Thiamine|thiamine|mesh-list
43549228|NCT03634735|Vitamins|vitamins|mesh-ancestor
43549229|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
43549230|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549231|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
43549232|NCT03634605|Tetracycline|tetracycline|mesh-list
43549233|NCT03634605|Lidocaine|lidocaine|mesh-list
43549234|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
43549235|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
43549236|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43549237|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549238|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
43549239|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43549240|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43654463|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43654464|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43654465|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43654476|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654478|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796673|NCT05061732|Amoxicillin|amoxicillin|mesh-list
43796674|NCT05061732|Metronidazole|metronidazole|mesh-list
43796675|NCT05061732|Clarithromycin|clarithromycin|mesh-list
43796676|NCT05061732|Doxycycline|doxycycline|mesh-list
43796686|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43796687|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43654479|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43654480|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43654481|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654482|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654483|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654484|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43654485|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43654486|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43654487|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
43654499|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796914|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43796915|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796916|NCT05054465|Venetoclax|venetoclax|mesh-list
43796917|NCT05054465|Navitoclax|navitoclax|mesh-list
43769684|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
43769685|NCT02385474|Protective Agents|protective agents|mesh-ancestor
43549260|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549261|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43549262|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711011|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43711012|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43711013|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43711014|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711015|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
43711016|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711017|NCT02692248|Gemcitabine|gemcitabine|mesh-list
43711018|NCT02692248|Dexamethasone|dexamethasone|mesh-list
43711019|NCT02692248|Rituximab|rituximab|mesh-list
43711020|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
43549280|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
43769686|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769687|NCT02385461|Heparin|heparin|mesh-list
43769688|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43769689|NCT02385461|Tinzaparin|tinzaparin|mesh-list
43769690|NCT02385461|Dalteparin|dalteparin|mesh-list
43769691|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
43769692|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43769693|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43769694|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43769695|NCT02385448|Dienogest|dienogest|mesh-list
43769696|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43769697|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43769698|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43769699|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
43769700|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43769701|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43769702|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43769703|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43769704|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43769706|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
43796919|NCT05054478|Daratumumab|daratumumab|mesh-list
43796920|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796921|NCT05054426|Methotrexate|methotrexate|mesh-list
43796922|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43796923|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
43796924|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43796925|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43549282|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43549283|NCT03634202|Capecitabine|capecitabine|mesh-list
43549284|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796926|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796927|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
43796928|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796929|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796930|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796931|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796945|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796946|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
43796947|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43796948|NCT05054114|Interferons|interferons|mesh-list
43796950|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796951|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
43796952|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43549326|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43549327|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43796953|NCT05053594|Neostigmine|neostigmine|mesh-list
43796954|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43796955|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43549328|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
43549329|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43549330|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796956|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796957|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
43796958|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43796959|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796960|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43796961|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
43796962|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796963|NCT05053893|Valsartan|valsartan|mesh-list
43796964|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43796965|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43796966|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43796967|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43796968|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796969|NCT05053841|Metformin|metformin|mesh-list
43796970|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43796971|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841820|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
43841821|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841822|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43797082|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797084|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43797085|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43797086|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797087|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797088|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797089|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797090|NCT05050656|Analgesics|analgesics|mesh-ancestor
43797091|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
43797092|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797093|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
43797094|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43797095|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
43797096|NCT05050604|Choline|choline|mesh-list
43797097|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
43797151|NCT05049473|Prednisone|prednisone|mesh-list
43797164|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43797165|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
43797200|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797250|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797251|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797253|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43797254|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797255|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43769909|NCT02384343|Analgesics|analgesics|mesh-ancestor
43797256|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43797258|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654513|NCT02975076|Clopidogrel|clopidogrel|mesh-list
43654514|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654515|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654516|NCT02975076|Analgesics|analgesics|mesh-ancestor
43654517|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
43654518|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770040|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43770043|NCT02383030|Fulvestrant|fulvestrant|mesh-list
43838261|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43838262|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43838264|NCT04857203|Vitamins|vitamins|mesh-ancestor
43838265|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
43838266|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43838267|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43838268|NCT04856761|Capecitabine|capecitabine|mesh-list
43654519|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654520|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654521|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43654522|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43654523|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43654524|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797259|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797354|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797355|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43797356|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797358|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
43549450|NCT03632772|Urological Agents|urological agents|mesh-ancestor
43797359|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43797360|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43797361|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43797362|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
43797363|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43797364|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43797365|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
43797366|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797367|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
43797368|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43797369|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43797370|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
43797371|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43797372|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797374|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43797375|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797376|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43797377|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
43797378|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
43797379|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797380|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797381|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797383|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43770277|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
43654536|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654537|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43607105|NCT03205228|Omeprazole|omeprazole|mesh-list
43797501|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43797502|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797503|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797504|NCT05043896|Urological Agents|urological agents|mesh-ancestor
43797505|NCT05043688|Paclitaxel|paclitaxel|mesh-list
43797506|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43797507|NCT05043688|Carboplatin|carboplatin|mesh-list
43797508|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43770470|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
43770471|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
43770472|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43770475|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43797570|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
43797571|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797572|NCT05042245|Protective Agents|protective agents|mesh-ancestor
43797573|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797574|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
43797575|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43797576|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797578|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43797579|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
43797580|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
43797581|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
43797582|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797583|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797584|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797585|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43770623|NCT02378441|Metformin|metformin|mesh-list
43797586|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797587|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43797589|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43549596|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
43797590|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43797621|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797622|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43654541|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654542|NCT02975323|Carvedilol|carvedilol|mesh-list
43654543|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43654544|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43797623|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
43797624|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
43797625|NCT05041270|Nalbuphine|nalbuphine|mesh-list
43797626|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43797627|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797628|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797629|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797630|NCT05041270|Analgesics|analgesics|mesh-ancestor
43797631|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
43770725|NCT02377401|Zanamivir|zanamivir|mesh-list
43797708|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
43797709|NCT05038072|Hormones|hormones|mesh-ancestor
43797710|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797711|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797712|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797713|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
43797714|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43770810|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43770811|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43770812|NCT02376478|Analgesics|analgesics|mesh-ancestor
43770813|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
43797715|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797716|NCT05038007|Bupivacaine|bupivacaine|mesh-list
43797931|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798018|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798019|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
43654545|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
43654546|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654547|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654548|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654549|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43654550|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
43798020|NCT05032781|Minocycline|minocycline|mesh-list
43798021|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43798022|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798023|NCT05032261|Norepinephrine|norepinephrine|mesh-list
43798024|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43798025|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43798026|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
43798027|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798028|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798029|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798030|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
43798031|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
43798032|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798033|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43798034|NCT05032287|Tamsulosin|tamsulosin|mesh-list
43798035|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43798036|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43798037|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43798038|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
43798039|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798040|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798041|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798042|NCT05032287|Urological Agents|urological agents|mesh-ancestor
43798043|NCT05032248|Tacrolimus|tacrolimus|mesh-list
43798044|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798045|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
43798046|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798047|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43798048|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841971|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43841972|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841973|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841974|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
43798066|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
43654552|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43654553|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654554|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43654555|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
43654556|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43654559|NCT02975141|Paclitaxel|paclitaxel|mesh-list
43798115|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798116|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798117|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43798118|NCT05030545|Diuretics|diuretics|mesh-ancestor
43798119|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
43798120|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43549694|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43798121|NCT05030545|Hormones|hormones|mesh-ancestor
43798122|NCT05030116|Domperidone|domperidone|mesh-list
43798123|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
43798124|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
43798125|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798126|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798128|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43798129|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
43798130|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798131|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798132|NCT05030077|Gemcitabine|gemcitabine|mesh-list
43798133|NCT05030077|Cisplatin|cisplatin|mesh-list
43798134|NCT05030077|Carboplatin|carboplatin|mesh-list
43798135|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798136|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798137|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
43798138|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798139|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
43798140|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798141|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798148|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798149|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798150|NCT05029076|Liraglutide|liraglutide|mesh-list
43798151|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43798152|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798153|NCT05029076|Incretins|incretins|mesh-ancestor
43798202|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43798203|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43798204|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43798205|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
43798206|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
43798207|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43549750|NCT03630029|Hematinics|hematinics|mesh-ancestor
43798208|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798209|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43798210|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798211|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
43798212|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43798213|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798214|NCT05028322|Imiquimod|imiquimod|mesh-list
43798215|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43798216|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
43798217|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798218|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798219|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
43654560|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43654561|NCT02975141|Afatinib|afatinib|mesh-list
43838423|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
43838424|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
43771124|NCT02374567|Diazepam|diazepam|mesh-list
43771125|NCT02374567|Triazolam|triazolam|mesh-list
43771126|NCT02374567|Acamprosate|acamprosate|mesh-list
43771127|NCT02374567|Gabapentin|gabapentin|mesh-list
43798284|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43798285|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798286|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
43798287|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798288|NCT05026229|Cytarabine|cytarabine|mesh-list
43798289|NCT05026229|Prednisone|prednisone|mesh-list
43798290|NCT05026229|Methotrexate|methotrexate|mesh-list
43798291|NCT05026229|Vincristine|vincristine|mesh-list
43798292|NCT05026229|Dasatinib|dasatinib|mesh-list
43798293|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798294|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
43798295|NCT05026229|Hormones|hormones|mesh-ancestor
43798296|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43549821|NCT03629262|Sufentanil|sufentanil|mesh-list
43798297|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771226|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43771236|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
43798302|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43798303|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798305|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798306|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
43798307|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798308|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43798309|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43771302|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771303|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43771304|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43771305|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43771306|NCT02373943|Carotenoids|carotenoids|mesh-list
43771307|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
43771308|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43549833|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43771309|NCT02373943|Protective Agents|protective agents|mesh-ancestor
43771310|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798312|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43798314|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798315|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43798316|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
43798317|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
43798318|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
43549882|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
43798319|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43798320|NCT05025228|Acetaminophen|acetaminophen|mesh-list
43798321|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43798322|NCT05025228|Analgesics|analgesics|mesh-ancestor
43798323|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
43798324|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798325|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798326|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
43798327|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
43798328|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842057|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43842058|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
43711184|NCT02690987|Incretins|incretins|mesh-ancestor
43842059|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842060|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842061|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43842062|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798333|NCT05025098|Azacitidine|azacitidine|mesh-list
43798335|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798336|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
43798337|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798338|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550000|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43798339|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798340|NCT05024799|Fentanyl|fentanyl|mesh-list
43798341|NCT05024799|Butorphanol|butorphanol|mesh-list
43798342|NCT05024799|Propofol|propofol|mesh-list
43798343|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43798344|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798345|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798346|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43798347|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
43798348|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
43798349|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43771362|NCT02373514|Analgesics|analgesics|mesh-ancestor
43771363|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
43771364|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771365|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798351|NCT05024799|Analgesics|analgesics|mesh-ancestor
43798352|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
43798353|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798354|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43798355|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
43798356|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798357|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43798358|NCT05024825|Acetaminophen|acetaminophen|mesh-list
43798359|NCT05024825|Ibuprofen|ibuprofen|mesh-list
43798360|NCT05024825|Gabapentin|gabapentin|mesh-list
43798361|NCT05024825|Hydrocodone|hydrocodone|mesh-list
43798390|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798391|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798398|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43798400|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771483|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43798460|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798461|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43798463|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
43798464|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
43798465|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43798466|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798467|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43798468|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43798469|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43798470|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550130|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
43550131|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43654562|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43654563|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654564|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654565|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
43654566|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
43798471|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798472|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798473|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
43798474|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
43798475|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798476|NCT05023863|Protective Agents|protective agents|mesh-ancestor
43798504|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43798505|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43798506|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43798507|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798508|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43798509|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43798510|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43798511|NCT05023577|Renal Agents|renal agents|mesh-ancestor
43798512|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43798513|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798514|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798515|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43798516|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43798517|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43798518|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43798520|NCT05023577|Diuretics|diuretics|mesh-ancestor
43798521|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
43798522|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798523|NCT05023577|Expectorants|expectorants|mesh-ancestor
43798524|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798526|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
43798527|NCT05023122|Calcium|calcium|mesh-list
43798528|NCT05023122|Vitamins|vitamins|mesh-ancestor
43550170|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43550171|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43550172|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
43550173|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550174|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43550175|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43550176|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550177|NCT03625076|Lidocaine|lidocaine|mesh-list
43550178|NCT03625076|Propofol|propofol|mesh-list
43550179|NCT03625076|Etomidate|etomidate|mesh-list
43550180|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
43798529|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
43798530|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798633|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43798634|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798635|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798636|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43798638|NCT05019690|Apatinib|apatinib|mesh-list
43798640|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43798641|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798642|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
43798643|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
43798644|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
43798645|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798646|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43798647|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798648|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43798649|NCT05019417|Glycerol|glycerol|mesh-list
43798650|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43798651|NCT05019417|Protective Agents|protective agents|mesh-ancestor
43798652|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798653|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798654|NCT05018923|Metronidazole|metronidazole|mesh-list
43798655|NCT05018923|Doxycycline|doxycycline|mesh-list
43798656|NCT05018923|Tetracycline|tetracycline|mesh-list
43771612|NCT02372812|Dexamethasone|dexamethasone|mesh-list
43771613|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771614|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
43771615|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
43711233|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
43711234|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43711235|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
43711236|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711237|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711238|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43711239|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711240|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43550200|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43550201|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550202|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43771616|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771617|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771618|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43771619|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
43771621|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43771622|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43771623|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43771624|NCT02372604|Cetirizine|cetirizine|mesh-list
43771625|NCT02372604|Levocetirizine|levocetirizine|mesh-list
43771626|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43771627|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43771628|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
43771634|NCT02372110|Caffeine|caffeine|mesh-list
43711241|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43711242|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43711243|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43711244|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
43654567|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654568|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43798673|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
43798674|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798675|NCT05018923|Expectorants|expectorants|mesh-ancestor
43798676|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798677|NCT05019326|Andrographolide|andrographolide|mesh-list
43798678|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43798679|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43798680|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43798681|NCT05019326|Analgesics|analgesics|mesh-ancestor
43798682|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
43798683|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798684|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798685|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43798686|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43798687|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43798688|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798689|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
43798690|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43798691|NCT05018988|Vitamin D|vitamin d|mesh-list
43798692|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
43798693|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
43798694|NCT05018988|Vitamins|vitamins|mesh-list
43798695|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
43798696|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798697|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43798698|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43798699|NCT05018962|Paclitaxel|paclitaxel|mesh-list
43798700|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43798701|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798702|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
43711257|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798703|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
43798704|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
43798705|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43771675|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771676|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
43771677|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43771678|NCT02372357|Posaconazole|posaconazole|mesh-list
43771679|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
43771680|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43771681|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43771682|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43771683|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43771684|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43798781|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43608575|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
43798782|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
43798783|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
43798785|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798786|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43771742|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43771743|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43771744|NCT02371590|Lenalidomide|lenalidomide|mesh-list
43771745|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
43771746|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
43838492|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
43798787|NCT05017272|Analgesics|analgesics|mesh-ancestor
43550311|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43798788|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
43798789|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798790|NCT05017116|Entecavir|entecavir|mesh-list
43798791|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
43798792|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798793|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
43798794|NCT05016713|Fluorides|fluorides|mesh-list
43798795|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
43798796|NCT05016713|Protective Agents|protective agents|mesh-ancestor
43798797|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798798|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43798799|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43798800|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
43798801|NCT05016128|Ketamine|ketamine|mesh-list
43798802|NCT05016128|Esketamine|esketamine|mesh-list
43798826|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798827|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43798828|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
43771767|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43771768|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43771821|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43771822|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43771823|NCT02370680|Aspirin|aspirin|mesh-list
43798829|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43798830|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798831|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43798832|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43798833|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43798835|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43798836|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
43798837|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798839|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43798840|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43798841|NCT05016440|Protective Agents|protective agents|mesh-ancestor
43798842|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798843|NCT05016349|Tamoxifen|tamoxifen|mesh-list
43798844|NCT05016349|Tocopherols|tocopherols|mesh-list
43798845|NCT05016349|Tretinoin|tretinoin|mesh-list
43798846|NCT05016349|Alitretinoin|alitretinoin|mesh-list
43798847|NCT05016349|Cannabidiol|cannabidiol|mesh-list
43798848|NCT05016349|Isotretinoin|isotretinoin|mesh-list
43798849|NCT05016349|Mifepristone|mifepristone|mesh-list
43798850|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43798851|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
43654570|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
43654571|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654572|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654573|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43798885|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43798886|NCT05016063|Fludarabine|fludarabine|mesh-list
43798887|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
43798888|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798889|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798914|NCT05015621|Fluorouracil|fluorouracil|mesh-list
43798915|NCT05015621|Irinotecan|irinotecan|mesh-list
43798916|NCT05015621|Calcium|calcium|mesh-list
43711284|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43798917|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
43798918|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43798919|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798920|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
43798927|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43798928|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43798929|NCT05015621|Antidotes|antidotes|mesh-ancestor
43798930|NCT05015621|Protective Agents|protective agents|mesh-ancestor
43798931|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
43798932|NCT05015621|Vitamins|vitamins|mesh-ancestor
43798933|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
43798934|NCT05015829|Dobutamine|dobutamine|mesh-list
43798935|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43798936|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
43799059|NCT05014100|Lenalidomide|lenalidomide|mesh-list
43799060|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
43799061|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799062|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43799063|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43799064|NCT05014100|Growth Substances|growth substances|mesh-ancestor
43799065|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
43799066|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799067|NCT05014048|Vitamin D|vitamin d|mesh-list
43799068|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
43799069|NCT05014048|Vitamins|vitamins|mesh-ancestor
43799070|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
43711304|NCT02690103|Ribavirin|ribavirin|mesh-list
43799104|NCT05013034|Basiliximab|basiliximab|mesh-list
43799105|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799106|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
43772296|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43772297|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
43838539|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799107|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799108|NCT05013151|Castor Oil|castor oil|mesh-list
43799109|NCT05013151|Cathartics|cathartics|mesh-ancestor
43799110|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799111|NCT05013268|Paclitaxel|paclitaxel|mesh-list
43799112|NCT05013268|Docetaxel|docetaxel|mesh-list
43799113|NCT05013268|Cisplatin|cisplatin|mesh-list
43799114|NCT05013268|Carboplatin|carboplatin|mesh-list
43627423|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799202|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799203|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43799204|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799205|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799206|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
43799207|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799208|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43799209|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799210|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799211|NCT05009953|Antidotes|antidotes|mesh-ancestor
43772319|NCT02366884|Clotrimazole|clotrimazole|mesh-list
43799212|NCT05009953|Protective Agents|protective agents|mesh-ancestor
43799213|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
43799215|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
43799216|NCT05009342|Calpastatin|calpastatin|mesh-list
43799217|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43799218|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
43799219|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799220|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799221|NCT05009498|Vitamin D|vitamin d|mesh-list
43799222|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
43799223|NCT05009498|Vitamins|vitamins|mesh-ancestor
43799225|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799226|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43550609|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
43550610|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799227|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43550611|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43550612|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43550613|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43772411|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550614|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43772412|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43772414|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43654576|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654577|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
43654578|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43654579|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
43654580|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654581|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
43654582|NCT02974985|Protective Agents|protective agents|mesh-ancestor
43799229|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799230|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799231|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43772461|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43772462|NCT02365857|Analgesics|analgesics|mesh-ancestor
43772469|NCT02365935|Paclitaxel|paclitaxel|mesh-list
43799275|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799276|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43799277|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
43799278|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799279|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
43550649|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43799280|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43799281|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43799282|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654583|NCT02974920|Aspirin|aspirin|mesh-list
43654584|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
43799285|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799286|NCT05008367|Dexamethasone|dexamethasone|mesh-list
43550652|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550653|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43550654|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
43550657|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43550658|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43550660|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43550661|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43550662|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550663|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43550664|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
43550665|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
43550666|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
43550667|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550668|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711366|NCT02689921|Trastuzumab|trastuzumab|mesh-list
43799287|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799288|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
43799289|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
43799290|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799291|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799292|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799293|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
43799294|NCT05008367|Hormones|hormones|mesh-ancestor
43799295|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799296|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799386|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
43772656|NCT02364765|Narcotics|narcotics|mesh-ancestor
43772671|NCT02364479|Etanercept|etanercept|mesh-list
43799387|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799388|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
43799389|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799390|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711376|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711377|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711378|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43550669|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43550670|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43550671|NCT03620929|Estradiol|estradiol|mesh-list
43550672|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43550673|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
43550674|NCT03620929|Estrogens|estrogens|mesh-ancestor
43550675|NCT03620929|Hormones|hormones|mesh-ancestor
43550682|NCT03620929|Progestins|progestins|mesh-ancestor
43799391|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43799392|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
43799393|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43799395|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43799397|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
43842149|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43799494|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
43799495|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43799496|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
43799497|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799498|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799499|NCT05006001|Colchicine|colchicine|mesh-list
43799500|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
43799501|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799502|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
43773719|NCT02357563|Leuprolide|leuprolide|mesh-list
43799505|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799506|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799507|NCT05006209|Calcium|calcium|mesh-list
43799508|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43799509|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799510|NCT05006235|Epinephrine|epinephrine|mesh-list
43799511|NCT05006235|Albuterol|albuterol|mesh-list
43550713|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43550714|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43550715|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550716|NCT03620760|Aspirin|aspirin|mesh-list
43550717|NCT03620760|Ticagrelor|ticagrelor|mesh-list
43550718|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43550719|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43550720|NCT03620760|Analgesics|analgesics|mesh-ancestor
43550721|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
43799512|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43799513|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799514|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799515|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799516|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654591|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654592|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43654593|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43654594|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43704120|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
43654595|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799517|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799518|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43799519|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43799521|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799530|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
43799555|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43799556|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799557|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799558|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550766|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43550767|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43550768|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43550769|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43550770|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43550771|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43550772|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
43550773|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43550774|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
43550775|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
43799559|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
43799589|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799590|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799591|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799592|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
43799593|NCT05004753|Hormones|hormones|mesh-ancestor
43799594|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799595|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799596|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799597|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
43799598|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43799599|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43799600|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799601|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
43799602|NCT05004519|Remifentanil|remifentanil|mesh-list
43799603|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43799604|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43550819|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550820|NCT03620292|Bevacizumab|bevacizumab|mesh-list
43550821|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43550822|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43550823|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43799605|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799606|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43799607|NCT05004519|Analgesics|analgesics|mesh-ancestor
43799608|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
43799634|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799635|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43799636|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
43799637|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799676|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43799677|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
43799678|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
43799679|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799680|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
43799681|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43799682|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43799684|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
43799685|NCT05003596|Narcotics|narcotics|mesh-list
43799686|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43799687|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
43711427|NCT02689726|Imiquimod|imiquimod|mesh-list
43799688|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654596|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43654597|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654598|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654599|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
43654600|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43654601|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
43799689|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
43799690|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
43799691|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43609506|NCT03187795|Mirabegron|mirabegron|mesh-list
43799834|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
43799835|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799836|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799837|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
43799838|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
43799839|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799840|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
43799841|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799842|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
43799843|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43799895|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799896|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799897|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43799898|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799899|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799901|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43799902|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799903|NCT04999878|Gemcitabine|gemcitabine|mesh-list
43799904|NCT04999878|Dexamethasone|dexamethasone|mesh-list
43799905|NCT04999878|Etoposide|etoposide|mesh-list
43799906|NCT04999878|Cisplatin|cisplatin|mesh-list
43799907|NCT04999878|Pegaspargase|pegaspargase|mesh-list
43799908|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43799909|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
43799923|NCT04999878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43799924|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799925|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43799926|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
43799927|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799928|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43799929|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799931|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43799932|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
43799933|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799934|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654602|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43654603|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
43654604|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
43654605|NCT02974933|Pemetrexed|pemetrexed|mesh-list
43654606|NCT02974933|Apatinib|apatinib|mesh-list
43654607|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799935|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43799936|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
43799937|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
43799938|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43799939|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
43550932|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
43799940|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799941|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799942|NCT04999540|Fulvestrant|fulvestrant|mesh-list
43799943|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799944|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799945|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43799946|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43799947|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
43799948|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799949|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799950|NCT04999293|Clopidogrel|clopidogrel|mesh-list
43799951|NCT04999293|Ticagrelor|ticagrelor|mesh-list
43799952|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43799953|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43799954|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43799955|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43799956|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
43799957|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43799958|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800044|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43800045|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
43800046|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43800047|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43800122|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800124|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800125|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
43800126|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
43800127|NCT04996550|Metoprolol|metoprolol|mesh-list
43800128|NCT04996550|Carvedilol|carvedilol|mesh-list
43800129|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43800130|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43800131|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
43800132|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
43800136|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43800137|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43800147|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43800148|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43800149|NCT04996485|Ustekinumab|ustekinumab|mesh-list
43800150|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
43800151|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
43800152|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800153|NCT04996290|Ropivacaine|ropivacaine|mesh-list
43800154|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
43800155|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
43800156|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800191|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800193|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800194|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800195|NCT04994951|Triamcinolone|triamcinolone|mesh-list
43800196|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43800197|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43800198|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43800199|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800200|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
43800201|NCT04994951|Hormones|hormones|mesh-ancestor
43800202|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800203|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800204|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43800205|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
43800206|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800207|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800208|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
43654610|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43654611|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654612|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43654613|NCT02974712|Fentanyl|fentanyl|mesh-list
43654614|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43654615|NCT02974712|Narcotics|narcotics|mesh-ancestor
43838798|NCT04820673|Sarecycline|sarecycline|mesh-list
43654616|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800291|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43800293|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800294|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800295|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
43800296|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43800298|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
43800299|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800300|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800301|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800302|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
43610176|NCT03182374|Protective Agents|protective agents|mesh-ancestor
43800303|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
43711498|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43711499|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800304|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800305|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
43800306|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43800327|NCT04991584|Esomeprazole|esomeprazole|mesh-list
43800328|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800329|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800330|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43800331|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800332|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43800333|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800334|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800335|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43800336|NCT04991584|Renal Agents|renal agents|mesh-ancestor
43800337|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43800338|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43800339|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800340|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43775196|NCT02347319|Silymarin|silymarin|mesh-list
43800341|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43800342|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43800343|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43800344|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43800345|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43800346|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43800347|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43800349|NCT04991896|Sotalol|sotalol|mesh-list
43800350|NCT04991896|Flecainide|flecainide|mesh-list
43800351|NCT04991896|Bisoprolol|bisoprolol|mesh-list
43800352|NCT04991896|Betaxolol|betaxolol|mesh-list
43800353|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43654617|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654619|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
43800354|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43800355|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
43800356|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
43800357|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800358|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800359|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43800360|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43800361|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43800362|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
43800363|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800364|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848561|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43848562|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848563|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
43848564|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43848565|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848566|NCT04009109|Growth Substances|growth substances|mesh-ancestor
43848567|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
43848568|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
43848569|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551119|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551120|NCT03617055|Cystatins|cystatins|mesh-list
43551121|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43551122|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
43551123|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551124|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551126|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551127|NCT03617016|Domperidone|domperidone|mesh-list
43551128|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
43551129|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
43711531|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
43711550|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43711551|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43711552|NCT02689037|Analgesics|analgesics|mesh-ancestor
43711553|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
43711554|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711555|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711556|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551134|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
43551135|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43551136|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551137|NCT03616808|Hemostatics|hemostatics|mesh-list
43551150|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551151|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
43551153|NCT03616639|Oxycodone|oxycodone|mesh-list
43848570|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848571|NCT04008264|Scopolamine|scopolamine|mesh-list
43848587|NCT04007393|Phentermine|phentermine|mesh-list
43848588|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
43848589|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43848590|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43775375|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
43848591|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43848592|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
43848593|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43848594|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
43848595|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
43848596|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848597|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
43760766|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551154|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43551155|NCT03616639|Narcotics|narcotics|mesh-ancestor
43551156|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551157|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551158|NCT03616639|Analgesics|analgesics|mesh-ancestor
43551159|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
43551160|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551161|NCT03616561|Apremilast|apremilast|mesh-list
43551162|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43551163|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551164|NCT03616561|Analgesics|analgesics|mesh-ancestor
43551165|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
43551166|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551167|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551168|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848598|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848599|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848601|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
43848602|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43848603|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849014|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849015|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43775409|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
43775410|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
43849016|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
43849017|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43849018|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43551199|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43551200|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551212|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43551213|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551214|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
43551215|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551216|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551217|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43551218|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43551219|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43551220|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551222|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43551223|NCT03616236|Naloxone|naloxone|mesh-list
43551224|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43551225|NCT03616236|Narcotics|narcotics|mesh-ancestor
43849019|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849020|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43849021|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43849022|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43849023|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849024|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
43849025|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43849026|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
43849027|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849028|NCT03970954|Interleukin-2|interleukin-2|mesh-list
43849029|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849030|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849031|NCT03970954|Analgesics|analgesics|mesh-ancestor
43849032|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
43849033|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849034|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800372|NCT04991207|Zamicastat|zamicastat|mesh-list
43800373|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43800374|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43800375|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800376|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800377|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
43551259|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43551260|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551261|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551262|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43551263|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551264|NCT03615768|Analgesics|analgesics|mesh-ancestor
43551265|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
43551266|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43551268|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43551269|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551271|NCT03615677|Esomeprazole|esomeprazole|mesh-list
43551272|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43654620|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654621|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43654622|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43654623|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
43654624|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
43800411|NCT04991012|Triamcinolone|triamcinolone|mesh-list
43800412|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43800414|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43800415|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800417|NCT04991012|Hormones|hormones|mesh-ancestor
43800418|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800419|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800420|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43800438|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800439|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
43800440|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800441|NCT04990791|Aspirin|aspirin|mesh-list
43800442|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
43800443|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43800444|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551286|NCT03615313|Antibodies|antibodies|mesh-list
43551287|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
43551288|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551289|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43551290|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43551291|NCT03614832|Clopidogrel|clopidogrel|mesh-list
43800445|NCT04990791|Analgesics|analgesics|mesh-ancestor
43800446|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
43800447|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800448|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800449|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800450|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800451|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43800452|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43800453|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800454|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43800455|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43800456|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800457|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
43800458|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43800459|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
43800460|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43800461|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
43800462|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
43800463|NCT04990752|Urinastatin|urinastatin|mesh-list
43800464|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43800465|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43800466|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
43551322|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43551323|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
43800467|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800468|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800469|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
43800470|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800472|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
43800473|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43800474|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
43800475|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800476|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800478|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800479|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
43800480|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43800489|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43800490|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800491|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43800492|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800493|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
43775640|NCT02344602|Febuxostat|febuxostat|mesh-list
43800495|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
43800496|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43800497|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43800498|NCT04989127|Penicillins|penicillins|mesh-list
43800499|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43800500|NCT04989127|Analgesics|analgesics|mesh-list
43800501|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654626|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
43654627|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43654628|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
43654629|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800502|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
43800503|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
43551423|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43800504|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800505|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800506|NCT04989140|Dexamethasone|dexamethasone|mesh-list
43800507|NCT04989140|Pomalidomide|pomalidomide|mesh-list
43800508|NCT04989140|Ixazomib|ixazomib|mesh-list
43800509|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800510|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
43800511|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
43800512|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800513|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711654|NCT02688361|Antidotes|antidotes|mesh-ancestor
43711655|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
43711656|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43711659|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
43800514|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800515|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
43800517|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800518|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43800519|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800520|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
43800521|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43800522|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43831758|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800523|NCT04989140|Growth Substances|growth substances|mesh-ancestor
43800524|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
43800670|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
43800671|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43800672|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
43800673|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800674|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
43800675|NCT04986644|Protective Agents|protective agents|mesh-ancestor
43551531|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43551532|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43551533|NCT03612739|Azacitidine|azacitidine|mesh-list
43551534|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43551535|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
43551536|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551537|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800677|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43800678|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800679|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43800680|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43610715|NCT03177980|Clonidine|clonidine|mesh-list
43800681|NCT04986371|Niraparib|niraparib|mesh-list
43800682|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43800683|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800684|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800722|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654636|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43654637|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43800724|NCT04985435|Analgesics|analgesics|mesh-ancestor
43800725|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
43800726|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800727|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800728|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800729|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43800730|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
43800731|NCT04985344|Propranolol|propranolol|mesh-list
43800732|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43800733|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43800734|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
43800735|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800736|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800737|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800738|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43800739|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43800759|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800760|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43800762|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
43800763|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43800764|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43800765|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43800766|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43800767|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800768|NCT04985110|Renal Agents|renal agents|mesh-ancestor
43800769|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800770|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
43800771|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43800772|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43800844|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800893|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800920|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
43800921|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800922|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800923|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800924|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
43800925|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842343|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842345|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654638|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43654639|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654640|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43711767|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654641|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654642|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842348|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
43842349|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43842350|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
43842351|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842352|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842353|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842354|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43842355|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842356|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842357|NCT04533880|Calcium|calcium|mesh-list
43842358|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43842359|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801027|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43801028|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43801029|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
43551650|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43551651|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43551652|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43551653|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551654|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43551655|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43801030|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43801031|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43801032|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
43801033|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801034|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801036|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43842375|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842376|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842378|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842379|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842380|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43842381|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43842382|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
43842383|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842384|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
43842385|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
43842386|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
43842387|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842388|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842390|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842391|NCT04531462|Empagliflozin|empagliflozin|mesh-list
43551703|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43551704|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43711790|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711791|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43711792|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43711793|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43711794|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711795|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
43711796|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711797|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
43842392|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43801111|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801112|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801113|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
43801114|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
43801115|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801116|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43801117|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43801118|NCT05549206|Vaccines|vaccines|mesh-list
43801119|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
43801120|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801121|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43801122|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
43801123|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801124|NCT05537883|Bupivacaine|bupivacaine|mesh-list
43801125|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
43801126|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
43654643|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
43654644|NCT02974387|Fluorometholone|fluorometholone|mesh-list
43654645|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43704121|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43801260|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43801262|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43801263|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801264|NCT05379166|Azacitidine|azacitidine|mesh-list
43801265|NCT05379166|Venetoclax|venetoclax|mesh-list
43551731|NCT03610932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551732|NCT03610932|Antioxidants|antioxidants|mesh-ancestor
43551733|NCT03610932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551734|NCT03610932|Protective Agents|protective agents|mesh-ancestor
43801266|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43801320|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43801321|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43801322|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
43801323|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801324|NCT05315713|Atezolizumab|atezolizumab|mesh-list
43801325|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801326|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43801327|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801328|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842407|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43842408|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43842409|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842410|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842411|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43842412|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43842413|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
43842414|NCT04530539|Melatonin|melatonin|mesh-list
43842415|NCT04530539|Vitamins|vitamins|mesh-ancestor
43842416|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
43551750|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43551751|NCT03610893|Analgesics|analgesics|mesh-ancestor
43551752|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
43551753|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43711851|NCT02686905|Vitamin D|vitamin d|mesh-list
43842417|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842418|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
43801431|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654648|NCT02974387|Hormones|hormones|mesh-ancestor
43654649|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43551780|NCT03610282|Propofol|propofol|mesh-list
43654650|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654651|NCT02974504|Linagliptin|linagliptin|mesh-list
43654652|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654653|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654654|NCT02974504|Incretins|incretins|mesh-ancestor
43551781|NCT03610282|Methylphenidate|methylphenidate|mesh-list
43551782|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43711863|NCT02686619|Sirolimus|sirolimus|mesh-list
43801506|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801507|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
43801508|NCT04859764|Betamethasone|betamethasone|mesh-list
43801509|NCT04859764|Bupivacaine|bupivacaine|mesh-list
43801510|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
43801511|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
43801512|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801513|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801514|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
43801515|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801516|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801517|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
43801518|NCT04859764|Hormones|hormones|mesh-ancestor
43801519|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801520|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43801521|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
43801522|NCT04805515|Nicotine|nicotine|mesh-list
43801523|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43801524|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
43801525|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801526|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801527|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43801528|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43777196|NCT02333305|Vitamins|vitamins|mesh-ancestor
43801529|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
43801530|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847453|NCT04105946|Remifentanil|remifentanil|mesh-list
43711938|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
43711939|NCT02686385|Prednisolone|prednisolone|mesh-list
43711940|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43711941|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711942|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
43711944|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43711945|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801531|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801533|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43801534|NCT04794790|Naloxone|naloxone|mesh-list
43801535|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43801536|NCT04794790|Narcotics|narcotics|mesh-ancestor
43801537|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801538|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801539|NCT04794790|Analgesics|analgesics|mesh-ancestor
43824996|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
43824997|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43704122|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
43824998|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43824999|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43825000|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551905|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
43551906|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43551907|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43551908|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
43551909|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43711950|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43711951|NCT02686385|Expectorants|expectorants|mesh-ancestor
43711952|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
43711953|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43711954|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
43711955|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43711956|NCT02686385|Antidotes|antidotes|mesh-ancestor
43711957|NCT02686151|Dexamethasone|dexamethasone|mesh-list
43711958|NCT02686151|Letrozole|letrozole|mesh-list
43711959|NCT02686151|Polygeline|polygeline|mesh-list
43711960|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43711961|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
43711962|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
43711963|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43711964|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43711965|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43711966|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
43551910|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801540|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
43801541|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801542|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43801543|NCT04794699|Gemcitabine|gemcitabine|mesh-list
43801544|NCT04794699|Paclitaxel|paclitaxel|mesh-list
43801545|NCT04794699|Docetaxel|docetaxel|mesh-list
43801546|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43801547|NCT04794699|Pemetrexed|pemetrexed|mesh-list
43801548|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801549|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801550|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
43801551|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
43801748|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801749|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801752|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801753|NCT04225598|Buprenorphine|buprenorphine|mesh-list
43711979|NCT02686242|Anesthetics|anesthetics|mesh-list
43801754|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43825002|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43825003|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43825004|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43825005|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43801814|NCT04166318|Fluorouracil|fluorouracil|mesh-list
43801815|NCT04166318|Capecitabine|capecitabine|mesh-list
43801816|NCT04166318|Mitomycins|mitomycins|mesh-list
43712022|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43801853|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43801882|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801883|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
43801884|NCT04042701|Trastuzumab|trastuzumab|mesh-list
43801885|NCT04042701|Camptothecin|camptothecin|mesh-list
43801886|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
43801887|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801888|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801889|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43801890|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43801891|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43801892|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801893|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801894|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
43801895|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801896|NCT04033237|Nicotine|nicotine|mesh-list
43801897|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43801898|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
43801899|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801906|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
43801907|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43842523|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43612145|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
43801908|NCT03971734|Regadenoson|regadenoson|mesh-list
43801909|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
43801910|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43801911|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
43801912|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
43801913|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801914|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801915|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801917|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43777667|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
43801918|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43801919|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
43801920|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801921|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801922|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801923|NCT03893630|Aspirin|aspirin|mesh-list
43801924|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43801925|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43801926|NCT03893630|Analgesics|analgesics|mesh-ancestor
43801927|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
43801928|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801929|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801930|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801931|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801932|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43801933|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43825006|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
43825007|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825008|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801935|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43801936|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43801937|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801938|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
43801939|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
43801940|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43712228|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
43712229|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712230|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712231|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43712232|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43712233|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43712234|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
43712235|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712236|NCT02685176|Charcoal|charcoal|mesh-list
43712237|NCT02685176|Antidotes|antidotes|mesh-ancestor
43801941|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801942|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43801943|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
43801944|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801945|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
43801946|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801947|NCT03866174|Niacin|niacin|mesh-list
43801948|NCT03866174|Psilocybin|psilocybin|mesh-list
43801949|NCT03866174|Vitamins|vitamins|mesh-ancestor
43801950|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
43801951|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801952|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
43801953|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43801954|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
43801955|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801956|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43801957|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
43801958|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
43801959|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43801960|NCT03853395|Antibodies|antibodies|mesh-list
43712295|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43712296|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43712297|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43712298|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43712299|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43712300|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43712301|NCT02684487|Vitamin D|vitamin d|mesh-list
43712302|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
43712304|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
43712305|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712306|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43712307|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43831814|NCT05294835|Analgesics|analgesics|mesh-ancestor
43831815|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
43831816|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43831817|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43831818|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43831819|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43831820|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
43831821|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
43831822|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712309|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43712310|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43712311|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43712312|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
43801961|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
43801962|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43777821|NCT02329535|Hormones|hormones|mesh-ancestor
43802196|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802198|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43802199|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802201|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
43802203|NCT02633059|Ichthammol|ichthammol|mesh-list
43802204|NCT02633059|BB 1101|bb 1101|mesh-list
43802205|NCT02633059|Glycine|glycine|mesh-list
43802206|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802207|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
43802208|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
43802209|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802210|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802240|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802242|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825010|NCT05505539|Fluorouracil|fluorouracil|mesh-list
43825011|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
43712313|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712314|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712315|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712316|NCT02684669|Naloxone|naloxone|mesh-list
43712347|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43712348|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
43712349|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712350|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43712351|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43825012|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825013|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802243|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43802244|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802245|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43802246|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43802247|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802248|NCT02575794|Analgesics|analgesics|mesh-ancestor
43777903|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
43802249|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
43802250|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802251|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802252|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802253|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
43802254|NCT02394834|Leucovorin|leucovorin|mesh-list
43802255|NCT02394834|Bevacizumab|bevacizumab|mesh-list
43712479|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712480|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712481|NCT02683213|Fluoxetine|fluoxetine|mesh-list
43712482|NCT02683213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43712483|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43712484|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712485|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802256|NCT02394834|Panitumumab|panitumumab|mesh-list
43802257|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
43802258|NCT02394834|Fluorouracil|fluorouracil|mesh-list
43802259|NCT02394834|Calcium|calcium|mesh-list
43802260|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
43802261|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802262|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802263|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43802264|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43802265|NCT02394834|Growth Substances|growth substances|mesh-ancestor
43802266|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802267|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
43802268|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43802269|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43802270|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
43802271|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802272|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802273|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802274|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
43802275|NCT02394834|Antidotes|antidotes|mesh-ancestor
43712648|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43712649|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43712650|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712651|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43712652|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
43712653|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43712654|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43712655|NCT02682459|Lisinopril|lisinopril|mesh-list
43712656|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43712657|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
43712658|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43712659|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43712660|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43712661|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43712662|NCT02682459|Protective Agents|protective agents|mesh-ancestor
43712663|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712664|NCT02682225|Ketamine|ketamine|mesh-list
43712665|NCT02682225|Esketamine|esketamine|mesh-list
43712666|NCT02682225|Analgesics|analgesics|mesh-ancestor
43712667|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
43712686|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43712688|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43712689|NCT02682082|Bupivacaine|bupivacaine|mesh-list
43712690|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
43712691|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
43712692|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43712693|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712694|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
43712695|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712696|NCT02681848|Nicotine|nicotine|mesh-list
43712697|NCT02681848|Varenicline|varenicline|mesh-list
43712698|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43712699|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
43712700|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43712701|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43712702|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43712703|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43712704|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
43712705|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43712707|NCT02681887|Melatonin|melatonin|mesh-list
43802276|NCT02394834|Protective Agents|protective agents|mesh-ancestor
43802407|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
43802408|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802409|NCT00660673|Levodopa|levodopa|mesh-list
43802410|NCT00660673|Carbidopa|carbidopa|mesh-list
43802411|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
43802412|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43802413|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43802414|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
43802415|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802416|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802417|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802418|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43802419|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825014|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825015|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825016|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
43825017|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825019|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
43825020|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802530|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802558|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43802585|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43778383|NCT02326727|Propofol|propofol|mesh-list
43802613|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
43712899|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
43712900|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43712901|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43712904|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
43712995|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43712996|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43712997|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802614|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802615|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802616|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802617|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
43802618|NCT04980105|Hormones|hormones|mesh-ancestor
43802619|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802620|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43802621|NCT04980105|Protective Agents|protective agents|mesh-ancestor
43802622|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802623|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802624|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43802625|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
43802626|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
43802627|NCT04979663|Gemcitabine|gemcitabine|mesh-list
43802628|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
43713103|NCT02678780|Lenvatinib|lenvatinib|mesh-list
43713104|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43713105|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43713106|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831887|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43831888|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831889|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43831890|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43802629|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802630|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
43802631|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802632|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802633|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
43802634|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802635|NCT04979663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802636|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802637|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
43802638|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802639|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
43802640|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43802641|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43802642|NCT04979650|Prednisolone|prednisolone|mesh-list
43802643|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
43802644|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43802645|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
43802646|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802647|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
43802648|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
43802649|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802650|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802651|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802652|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
43802653|NCT04979650|Hormones|hormones|mesh-ancestor
43802654|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802655|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43802656|NCT04979650|Protective Agents|protective agents|mesh-ancestor
43802657|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43802658|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802659|NCT04979585|Paclitaxel|paclitaxel|mesh-list
43802660|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802661|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802662|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802837|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
43839049|NCT04799431|Poly I-C|poly i-c|mesh-list
43802839|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802840|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
43802842|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
43802843|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43802844|NCT04977544|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43802845|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43802846|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802855|NCT04977557|Thiamine|thiamine|mesh-list
43802856|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
43802857|NCT04977557|Vitamins|vitamins|mesh-ancestor
43802858|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
43802859|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802860|NCT04977388|Droxidopa|droxidopa|mesh-list
43802861|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43802862|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43713346|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
43713347|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
43713348|NCT02677376|Protective Agents|protective agents|mesh-ancestor
43713349|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713351|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802863|NCT04976816|Triamcinolone|triamcinolone|mesh-list
43802864|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43802865|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43802866|NCT04976816|Betamethasone|betamethasone|mesh-list
43802867|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
43802868|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43802869|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
43802870|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43802871|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43802872|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802873|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
43802874|NCT04976816|Hormones|hormones|mesh-ancestor
43802875|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802876|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802877|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802878|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
43802879|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802880|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802881|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43802882|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
43802883|NCT04976673|Triamcinolone|triamcinolone|mesh-list
43802884|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43802885|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43831907|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43802886|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43802887|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802888|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
43802889|NCT04976673|Hormones|hormones|mesh-ancestor
43825030|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43825031|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43825032|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825033|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825034|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43802890|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802891|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802892|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802893|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
43802894|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802895|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802896|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43802897|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802976|NCT04974723|Teriparatide|teriparatide|mesh-list
43802977|NCT04974723|Abaloparatide|abaloparatide|mesh-list
43802978|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43613339|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
43831908|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43831909|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
43831910|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43831911|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802997|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43825036|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43825037|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
43825038|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43825039|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43825040|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825041|NCT05505253|Vitamins|vitamins|mesh-ancestor
43803012|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
43803013|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803014|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43803015|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
43803016|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43803017|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
43803018|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43803019|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803020|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43803081|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
43803082|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803083|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803084|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803085|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43831932|NCT05289830|Citalopram|citalopram|mesh-list
43831933|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43831935|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803086|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803087|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803122|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842661|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842662|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43778615|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
43842663|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842664|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43842665|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43842666|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842667|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43842668|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43842669|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842670|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
43842671|NCT04516941|Colchicine|colchicine|mesh-list
43842672|NCT04516941|Edoxaban|edoxaban|mesh-list
43842673|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
43842674|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842675|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
43842676|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
43842677|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
43842678|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842679|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842680|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43842681|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
43842682|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43842683|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
43842684|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842685|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
43842686|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
43842687|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
43842688|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
43842689|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842690|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825043|NCT05505123|Propofol|propofol|mesh-list
43825044|NCT05505123|Sevoflurane|sevoflurane|mesh-list
43825045|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43825046|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825047|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825048|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43825049|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
43825050|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
43842691|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
43842692|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713484|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713485|NCT02675868|Phenylephrine|phenylephrine|mesh-list
43713486|NCT02675868|Vasopressins|vasopressins|mesh-list
43713487|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
43713488|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
43713489|NCT02675868|Norepinephrine|norepinephrine|mesh-list
43713490|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43713491|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
43713492|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
43713493|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43713494|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713495|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
43713496|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43713497|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
43713498|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
43713499|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43713506|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
43713537|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
43713538|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43713539|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
43713540|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713541|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713542|NCT02675647|Heparin|heparin|mesh-list
43713543|NCT02675647|Protamines|protamines|mesh-list
43713555|NCT02675530|Ketamine|ketamine|mesh-list
43842693|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842694|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43842695|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43842696|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842697|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
43778886|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
43842699|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43842700|NCT04516148|Clindamycin|clindamycin|mesh-list
43842701|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
43842702|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
43842703|NCT04516148|Cefazolin|cefazolin|mesh-list
43842704|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43803250|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
43803251|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43842741|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
43842743|NCT04513951|Cetuximab|cetuximab|mesh-list
43842744|NCT04513951|Avelumab|avelumab|mesh-list
43825051|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43842745|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
43803341|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43803344|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43803345|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803346|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803347|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43803349|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
43803350|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43803351|NCT04967950|Methotrexate|methotrexate|mesh-list
43803352|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43803353|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43803354|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
43803355|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43803356|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803357|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43713697|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43831974|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
43831975|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
43831976|NCT05288023|Azithromycin|azithromycin|mesh-list
43713698|NCT02674997|Factor VIII|factor viii|mesh-list
43713699|NCT02674997|Coagulants|coagulants|mesh-ancestor
43713700|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
43713701|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
43713702|NCT02674737|Tramadol|tramadol|mesh-list
43713703|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43713704|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713705|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713706|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43713707|NCT02674737|Analgesics|analgesics|mesh-ancestor
43713708|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
43713711|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43713712|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43713713|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
43713714|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713716|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43803358|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
43803359|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803360|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803361|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
43803362|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803363|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43779060|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803364|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803365|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
43803366|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803367|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803368|NCT04967326|Carbamazepine|carbamazepine|mesh-list
43803369|NCT04967326|Phenytoin|phenytoin|mesh-list
43803370|NCT04967326|Valproic Acid|valproic acid|mesh-list
43803371|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
43713806|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43713807|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43713808|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43713809|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43713810|NCT02673840|Ketotifen|ketotifen|mesh-list
43713811|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
43713812|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
43803372|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803373|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803374|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
43803375|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803376|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803379|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803380|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43839201|NCT04793906|Iron|iron|mesh-list
43803381|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803383|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
43803384|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803385|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43803386|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803387|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43713813|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43713814|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
43713815|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
43713816|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43713817|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43713818|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43713819|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43713820|NCT02673814|Durvalumab|durvalumab|mesh-list
43713826|NCT02673606|Estradiol|estradiol|mesh-list
43803388|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43803389|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43803390|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43803391|NCT04967417|Paclitaxel|paclitaxel|mesh-list
43803392|NCT04967417|Carboplatin|carboplatin|mesh-list
43803393|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
43803394|NCT04967417|Pemetrexed|pemetrexed|mesh-list
43803395|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43803396|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803397|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
43803398|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
43803399|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803400|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832033|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43832034|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
43832035|NCT05284409|Hormones|hormones|mesh-ancestor
43832036|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832037|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832038|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832039|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43832040|NCT05284409|Analgesics|analgesics|mesh-ancestor
43832041|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
43832042|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
43714073|NCT02671175|Artemisinins|artemisinins|mesh-list
43714074|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
43803401|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803402|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803403|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43803404|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803405|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43803406|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
43803407|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
43825052|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43825053|NCT05505006|Folic Acid|folic acid|mesh-list
43825054|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
43825056|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
43825057|NCT05505006|Vitamins|vitamins|mesh-ancestor
43825058|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
43825059|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803408|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
43803409|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803410|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
43714255|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43714256|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
43714257|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803411|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714258|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43714259|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43714260|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714261|NCT02670096|Acetazolamide|acetazolamide|mesh-list
43714262|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
43714263|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43714264|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714265|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714266|NCT02670096|Diuretics|diuretics|mesh-ancestor
43714267|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
43803412|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43780303|NCT05392257|Growth Substances|growth substances|mesh-ancestor
43803467|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43803468|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803469|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803470|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803471|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43803472|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43803473|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43803474|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43849037|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
43803475|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43842784|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842785|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
43842786|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
43842787|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842788|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842789|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43842790|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
43842792|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842793|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43842794|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842795|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
43842796|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842797|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842798|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
43842799|NCT04512365|Dronabinol|dronabinol|mesh-list
43842800|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
43842802|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842811|NCT04512365|Hormones|hormones|mesh-ancestor
43842812|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848611|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848612|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848613|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
43848614|NCT04007029|Fludarabine|fludarabine|mesh-list
43848615|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
43848616|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
43848617|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
43848618|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848619|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
43848620|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848621|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848622|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848623|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
43825060|NCT05504967|Dexamethasone|dexamethasone|mesh-list
43654662|NCT02974426|Carboplatin|carboplatin|mesh-list
43654663|NCT02974426|Pemetrexed|pemetrexed|mesh-list
43654664|NCT02974426|Vinorelbine|vinorelbine|mesh-list
43654665|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654666|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654667|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654668|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43654669|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654670|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43654671|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
43654672|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
43654673|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
43848624|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43780905|NCT02267252|Antibodies|antibodies|mesh-list
43848626|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43848627|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43848628|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
43848629|NCT04006522|Atezolizumab|atezolizumab|mesh-list
43848630|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848631|NCT04005859|Lidocaine|lidocaine|mesh-list
43848632|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714404|NCT02668861|Budesonide|budesonide|mesh-list
43714405|NCT02668861|Vitamins|vitamins|mesh-ancestor
43714406|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
43714407|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848633|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
43848634|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848635|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848636|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
43781140|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43803592|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43803646|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43803647|NCT04962386|Progesterone|progesterone|mesh-list
43803648|NCT04962386|Estrogens|estrogens|mesh-list
43803649|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803650|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803651|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43803652|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
43803653|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43803654|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43803655|NCT04962386|Progestins|progestins|mesh-ancestor
43803656|NCT04962308|Vaccines|vaccines|mesh-list
43803657|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
43803658|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842813|NCT04510922|Droxidopa|droxidopa|mesh-list
43842814|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43842815|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43842816|NCT04510844|Evolocumab|evolocumab|mesh-list
43842817|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43842818|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43842819|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
43842832|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842833|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43842834|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43842835|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842836|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43842837|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43842838|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43842839|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43842840|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842841|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43714409|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842842|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
43842843|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43842844|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
43842845|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43842846|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43842847|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842848|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43842849|NCT04508244|Propranolol|propranolol|mesh-list
43842850|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43842851|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43842852|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
43842853|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842854|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842855|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842856|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43842857|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43842858|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842859|NCT04507919|Dabrafenib|dabrafenib|mesh-list
43842860|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842861|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43842862|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842863|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842864|NCT04507477|Rituximab|rituximab|mesh-list
43842865|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43842866|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654684|NCT02974361|Analgesics|analgesics|mesh-ancestor
43781641|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
43842873|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803700|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803702|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
43803703|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803704|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803705|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
43803706|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43803707|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43714503|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714504|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43714505|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43714506|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43714507|NCT02667730|Acetaminophen|acetaminophen|mesh-list
43714508|NCT02667730|Celecoxib|celecoxib|mesh-list
43714509|NCT02667730|Naproxen|naproxen|mesh-list
43714552|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
43714553|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43714554|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832073|NCT05281471|Carboplatin|carboplatin|mesh-list
43714568|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
43714569|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714570|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
43803708|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43803709|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43803710|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803711|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803712|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43803713|NCT04961268|Narcotics|narcotics|mesh-ancestor
43803714|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803715|NCT04961307|Trastuzumab|trastuzumab|mesh-list
43803739|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43803740|NCT04959721|Bupivacaine|bupivacaine|mesh-list
43803741|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43803742|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803743|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
43781744|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43803744|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803745|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803746|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
43803747|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803748|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43803749|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
43803750|NCT04959721|Hormones|hormones|mesh-ancestor
43803751|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803752|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803753|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
43803754|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803755|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803756|NCT04959786|Ribavirin|ribavirin|mesh-list
43803757|NCT04959786|Ivermectin|ivermectin|mesh-list
43803758|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
43803759|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
43803760|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803761|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
43803762|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803763|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43803764|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
43803765|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
43803766|NCT04959578|Hematinics|hematinics|mesh-ancestor
43803767|NCT04959253|Psilocybin|psilocybin|mesh-list
43803768|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
43803769|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803770|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803771|NCT04959500|Temozolomide|temozolomide|mesh-list
43803772|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43803773|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
43842892|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43714637|NCT02666716|Fluconazole|fluconazole|mesh-list
43714638|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
43842893|NCT04503161|Estrogens|estrogens|mesh-ancestor
43842894|NCT04503161|Hormones|hormones|mesh-ancestor
43842895|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714639|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842896|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842897|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43842898|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
43842899|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43842900|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43842901|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
43803922|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
43803923|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803924|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803928|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43803929|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
43803930|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
43803931|NCT04952207|Grazoprevir|grazoprevir|mesh-list
43803932|NCT04952207|Ledipasvir|ledipasvir|mesh-list
43803933|NCT04952207|Velpatasvir|velpatasvir|mesh-list
43803934|NCT04952207|Asunaprevir|asunaprevir|mesh-list
43803935|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803936|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
43803937|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803960|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
43803961|NCT04952051|Amlodipine|amlodipine|mesh-list
43803962|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43803963|NCT04952051|Enalapril|enalapril|mesh-list
43803964|NCT04952051|Enalaprilat|enalaprilat|mesh-list
43803965|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43803966|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43803967|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714661|NCT02666534|Prilocaine|prilocaine|mesh-list
43803968|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714662|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43714663|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43714664|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
43714665|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714666|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
43714669|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
43714670|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43714671|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43714672|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43714673|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43714674|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43714675|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714676|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43714677|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
43714678|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
43714679|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
43714680|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
43714681|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714682|NCT02666170|Protective Agents|protective agents|mesh-ancestor
43714683|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43714684|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
43803969|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43803970|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803971|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
43803972|NCT04952051|Diuretics|diuretics|mesh-ancestor
43803973|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
43803974|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43803975|NCT04952051|Hematinics|hematinics|mesh-ancestor
43803976|NCT04952051|Vitamins|vitamins|mesh-ancestor
43803977|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
43803978|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43803979|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
43803980|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803981|NCT04951791|SMOFlipid|smoflipid|mesh-list
43803982|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43803983|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43803984|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43803985|NCT04951713|Clarithromycin|clarithromycin|mesh-list
43803986|NCT04951713|Rifampin|rifampin|mesh-list
43803987|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43803988|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803989|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43803990|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803991|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803992|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43803994|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43803995|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
43803996|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
43803997|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43803998|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43803999|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43804000|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43804001|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43804002|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43804003|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43804004|NCT04951752|Ropivacaine|ropivacaine|mesh-list
43804005|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
43804102|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
43804194|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714718|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
43714719|NCT02666443|Hormones|hormones|mesh-ancestor
43714720|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43714721|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43714722|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43714726|NCT02666417|Iron|iron|mesh-list
43714788|NCT02665936|Dexamethasone|dexamethasone|mesh-list
43714803|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714804|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714805|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43714806|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
43714807|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
43714808|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43714809|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
43714810|NCT02665871|Vaccines|vaccines|mesh-list
43832093|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832094|NCT05281471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43832095|NCT05281471|Immunologic Factors|immunologic factors|mesh-ancestor
43804196|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43804197|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43804198|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
43804364|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804365|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
43804366|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804373|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804374|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804375|NCT04946383|Dasatinib|dasatinib|mesh-list
43804376|NCT04946383|Quercetin|quercetin|mesh-list
43804377|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804378|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43804379|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804380|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804381|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
43804382|NCT04946383|Protective Agents|protective agents|mesh-ancestor
43804383|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804384|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
43804385|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804386|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
43804387|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804388|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804389|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43804391|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804392|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832096|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43832102|NCT05280769|Lobeline|lobeline|mesh-list
43804393|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43804394|NCT04946162|Tadalafil|tadalafil|mesh-list
43804395|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804396|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43804397|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43804398|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804399|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804400|NCT04946162|Urological Agents|urological agents|mesh-ancestor
43804401|NCT04946227|Paclitaxel|paclitaxel|mesh-list
43804402|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
43804403|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43804404|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804405|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43783948|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
43804407|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804408|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804409|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804410|NCT04946123|Selenium|selenium|mesh-list
43804411|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
43804412|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804413|NCT04946123|Protective Agents|protective agents|mesh-ancestor
43804414|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804415|NCT04946123|Trace Elements|trace elements|mesh-ancestor
43804416|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
43804417|NCT04945824|Dexamethasone|dexamethasone|mesh-list
43551962|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
43551963|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43551964|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
43551965|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43551966|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43551967|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43551968|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
43551969|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43551970|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43551972|NCT03608514|Terlipressin|terlipressin|mesh-list
43804418|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804419|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
43784349|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43804465|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43804466|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804467|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804486|NCT04945070|Insulin|insulin|mesh-list
43804498|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43804499|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804500|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
43804501|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804502|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804503|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43804504|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
43804505|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804506|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552030|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43552031|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
43552032|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43552033|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43552034|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552035|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552036|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552037|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552038|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
43552049|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552050|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552051|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552052|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43552053|NCT03608007|Ensartinib|ensartinib|mesh-list
43552054|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552055|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43552056|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552057|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552058|NCT03607955|Paclitaxel|paclitaxel|mesh-list
43552059|NCT03607955|Carboplatin|carboplatin|mesh-list
43552060|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43552061|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552062|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
43804507|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43804508|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804509|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
43804510|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
43804511|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804512|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804513|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
43804514|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804515|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43804516|NCT04945096|Expectorants|expectorants|mesh-ancestor
43804587|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
43804588|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
43804589|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
43804590|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804732|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43784971|NCT04230746|Renal Agents|renal agents|mesh-ancestor
43804759|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804761|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804762|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804763|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804764|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
43654692|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654693|NCT02974348|Acetaminophen|acetaminophen|mesh-list
43654694|NCT02974348|Amoxicillin|amoxicillin|mesh-list
43654695|NCT02974348|Artesunate|artesunate|mesh-list
43804765|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804766|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
43804767|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804769|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43804771|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804772|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804773|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43552063|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
43552064|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
43552065|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552066|NCT03607916|Morphine|morphine|mesh-list
43552067|NCT03607916|Prilocaine|prilocaine|mesh-list
43552068|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43552069|NCT03607916|Narcotics|narcotics|mesh-ancestor
43552070|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552071|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552072|NCT03607916|Analgesics|analgesics|mesh-ancestor
43552073|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
43552074|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552075|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
43552076|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
43714944|NCT02665039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43714945|NCT02665039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43714946|NCT02665039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43714947|NCT02665039|Immunologic Factors|immunologic factors|mesh-ancestor
43714948|NCT02665039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804774|NCT04941846|Nimodipine|nimodipine|mesh-list
43804775|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43804776|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43804777|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804778|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804779|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43804780|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804781|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804782|NCT04941625|Cystatins|cystatins|mesh-list
43804783|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
43804784|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
43804785|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804786|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804787|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43804788|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804789|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804790|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
43804791|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43804792|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
43804825|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43804826|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804827|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804828|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43804830|NCT04940845|Denosumab|denosumab|mesh-list
43804831|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43804832|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804833|NCT04940546|Bevacizumab|bevacizumab|mesh-list
43804834|NCT04940546|Capecitabine|capecitabine|mesh-list
43804970|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804971|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
43804972|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804973|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804975|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
43627424|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43805006|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805009|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
43805010|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43805011|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43714956|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43714957|NCT02664649|Apixaban|apixaban|mesh-list
43714959|NCT02664649|Anticoagulants|anticoagulants|mesh-list
43714960|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
43714961|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43714962|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
43714963|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805012|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805013|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805014|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805015|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43654697|NCT02974348|Piperaquine|piperaquine|mesh-list
43654698|NCT02974348|Artenimol|artenimol|mesh-list
43654699|NCT02974348|Mefloquine|mefloquine|mesh-list
43654700|NCT02974348|Quinine|quinine|mesh-list
43654701|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654702|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654703|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805016|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43805017|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
43805018|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43805091|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805092|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43704123|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43805093|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805094|NCT04936282|Tacrolimus|tacrolimus|mesh-list
43805150|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43805151|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43805152|NCT04935515|Anticoagulants|anticoagulants|mesh-list
43805153|NCT04935515|Coagulants|coagulants|mesh-list
43805154|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
43805155|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
43805156|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805157|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
43805158|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
43805159|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43627426|NCT03072992|Paclitaxel|paclitaxel|mesh-list
43843071|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
43843072|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843073|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843074|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43843075|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43805162|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
43805163|NCT04935541|Remifentanil|remifentanil|mesh-list
43805164|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43805165|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805166|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805167|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805234|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805235|NCT04934475|Lenalidomide|lenalidomide|mesh-list
43805236|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
43805237|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805238|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43805239|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43805240|NCT04934475|Growth Substances|growth substances|mesh-ancestor
43805241|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
43805242|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805243|NCT04933630|Norepinephrine|norepinephrine|mesh-list
43805244|NCT04933630|Serotonin|serotonin|mesh-list
43805245|NCT04933630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
43805246|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43805247|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805248|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805344|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805345|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805346|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43714974|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
43714975|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805347|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43805348|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805349|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805350|NCT04931524|Mitogens|mitogens|mesh-list
43805351|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
43805352|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805353|NCT04931355|Cetrorelix|cetrorelix|mesh-list
43840346|NCT04709471|Nicotine|nicotine|mesh-list
43715012|NCT02663960|Citric Acid|citric acid|mesh-list
43715013|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
43715014|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
43715015|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43715016|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
43715017|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
43715018|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805354|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805355|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805356|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43805357|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
43805358|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43805359|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
43805360|NCT04930952|Ethanol|ethanol|mesh-list
43805361|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43805362|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805363|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805364|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805365|NCT04931225|Landiolol|landiolol|mesh-list
43805366|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43805367|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43805368|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805369|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805370|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805371|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805372|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805373|NCT04931108|Atenolol|atenolol|mesh-list
43805374|NCT04931108|Nitrendipine|nitrendipine|mesh-list
43805375|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43552199|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
43552200|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
43552201|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552202|NCT03606928|Antidotes|antidotes|mesh-ancestor
43552206|NCT03606928|Vitamins|vitamins|mesh-ancestor
43805376|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43805377|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
43805378|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
43805379|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805380|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805381|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43805382|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43805383|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43805384|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805385|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805386|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805387|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43805409|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
43805410|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
43805411|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805412|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654707|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654708|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
43805414|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
43805415|NCT04930211|Hormones|hormones|mesh-ancestor
43805416|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805417|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805418|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805419|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805420|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
43805421|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805422|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
43805423|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805424|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43805425|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43805426|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805427|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805428|NCT04930185|Vaccines|vaccines|mesh-list
43805429|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
43805430|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805431|NCT04930133|Afatinib|afatinib|mesh-list
43805432|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805433|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805434|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843157|NCT04484272|Narcotics|narcotics|mesh-ancestor
43843158|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843159|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843160|NCT04484272|Analgesics|analgesics|mesh-ancestor
43843161|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
43843185|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843186|NCT04481451|Ropivacaine|ropivacaine|mesh-list
43843187|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
43843188|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
43843189|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43786188|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
43843190|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843191|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
43843192|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843193|NCT04481113|Niraparib|niraparib|mesh-list
43843194|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43843195|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843196|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843197|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843198|NCT04479306|Osimertinib|osimertinib|mesh-list
43805471|NCT04929522|Anesthetics|anesthetics|mesh-list
43805472|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805473|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805474|NCT04929509|Listerine|listerine|mesh-list
43805475|NCT04929509|Fluorides|fluorides|mesh-list
43805476|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
43805477|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
43805478|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
43805479|NCT04929509|Protective Agents|protective agents|mesh-ancestor
43552322|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
43552323|NCT03605758|Ivermectin|ivermectin|mesh-list
43552324|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43552325|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552326|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
43552327|NCT03605589|Blinatumomab|blinatumomab|mesh-list
43552328|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43552329|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43552330|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
43552331|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43715060|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43715061|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43715062|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
43715063|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715064|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715065|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
43805480|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805481|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43805482|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805483|NCT04928365|Antibodies|antibodies|mesh-list
43805484|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43805485|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
43805486|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715066|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
43715067|NCT02663713|Clopidogrel|clopidogrel|mesh-list
43715069|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43715070|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43805527|NCT04927949|Cangrelor|cangrelor|mesh-list
43715071|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43552351|NCT03605173|Vitamins|vitamins|mesh-list
43805528|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43654709|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
43654710|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43654711|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43654712|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654713|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
43654714|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
43805529|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43805530|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43805531|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43805532|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
43805533|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805534|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805535|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805536|NCT04928586|Pirfenidone|pirfenidone|mesh-list
43805544|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805545|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805546|NCT04928651|Clonidine|clonidine|mesh-list
43805547|NCT04928651|Analgesics|analgesics|mesh-ancestor
43805548|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
43805549|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805550|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805551|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43805552|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
43805553|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
43805554|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43805555|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43805556|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805557|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805558|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805559|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805561|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43805562|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552420|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
43805563|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805564|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805565|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
43805566|NCT04927481|Analgesics|analgesics|mesh-ancestor
43805567|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
43805568|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805569|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805570|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805571|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43805572|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805573|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805574|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805575|NCT04927299|Losartan|losartan|mesh-list
43832117|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
43805576|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43805577|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
43805578|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43805579|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43805580|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43805581|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43654715|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43654717|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43654718|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43654719|NCT02974166|Ibuprofen|ibuprofen|mesh-list
43654720|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43654721|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
43654722|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654723|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848701|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848702|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43848703|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
43848704|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848705|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43848706|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848707|NCT04002011|Warfarin|warfarin|mesh-list
43848708|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
43848709|NCT04002011|Dabigatran|dabigatran|mesh-list
43552505|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
43552506|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43848710|NCT04002011|Apixaban|apixaban|mesh-list
43848711|NCT04002011|Edoxaban|edoxaban|mesh-list
43848712|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
43848713|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43848714|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
43848715|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43848716|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
43848717|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848718|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848719|NCT04001504|Vaccines|vaccines|mesh-list
43654724|NCT02974166|Analgesics|analgesics|mesh-ancestor
43654725|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
43654726|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654727|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654728|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43654729|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43654730|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805688|NCT04922359|Lidocaine|lidocaine|mesh-list
43805689|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805690|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
43805691|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805692|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805693|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
43805694|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805695|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43787370|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
43805696|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43805697|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43805698|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805699|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805700|NCT04922450|Paclitaxel|paclitaxel|mesh-list
43805701|NCT04922450|Cisplatin|cisplatin|mesh-list
43805702|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43805703|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43805704|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43787920|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
43805710|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704124|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43805809|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43805810|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654731|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654732|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43654733|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
43654734|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43654735|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43805891|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
43805892|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805893|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43805894|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43805895|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43805896|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843244|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843245|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843246|NCT04471818|Ketamine|ketamine|mesh-list
43843247|NCT04471818|Analgesics|analgesics|mesh-ancestor
43552656|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552657|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552658|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
43552659|NCT03602508|Mirabegron|mirabegron|mesh-list
43552660|NCT03602508|Fesoterodine|fesoterodine|mesh-list
43552661|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
43552662|NCT03602508|Oxybutynin|oxybutynin|mesh-list
43552663|NCT03602508|Darifenacin|darifenacin|mesh-list
43552664|NCT03602508|Propiverine|propiverine|mesh-list
43552665|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43552680|NCT03602469|Propofol|propofol|mesh-list
43843248|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
43843252|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43843253|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
43843254|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
43843255|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843256|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43843257|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43843258|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843259|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843260|NCT04470973|Amikacin|amikacin|mesh-list
43843261|NCT04470973|Cefuroxime|cefuroxime|mesh-list
43843262|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
43843263|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43843264|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843265|NCT04470843|Acetazolamide|acetazolamide|mesh-list
43843266|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
43843267|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43843268|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848720|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
43805897|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
43788583|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805900|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
43805915|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805916|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805917|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805918|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805919|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43654736|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43654737|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43805920|NCT04919174|Narcotics|narcotics|mesh-ancestor
43805921|NCT04918914|Dapsone|dapsone|mesh-list
43805922|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805923|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
43805924|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43805925|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43805926|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43805927|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805928|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552684|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
43552685|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43552686|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552687|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
43552688|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552697|NCT03602430|Vitamin D|vitamin d|mesh-list
43805929|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
43805930|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805931|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
43805932|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43805933|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43805934|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805936|NCT04918589|Coagulants|coagulants|mesh-ancestor
43805937|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
43805938|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43805939|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43805940|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805941|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
43805942|NCT04918576|Coagulants|coagulants|mesh-ancestor
43805943|NCT04918524|Aspirin|aspirin|mesh-list
43805944|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
43805945|NCT04918524|Prednisone|prednisone|mesh-list
43805946|NCT04918524|Heparin|heparin|mesh-list
43805947|NCT04918524|Enoxaparin|enoxaparin|mesh-list
43805948|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43805949|NCT04918524|Tinzaparin|tinzaparin|mesh-list
43805950|NCT04918524|Dalteparin|dalteparin|mesh-list
43805951|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43805952|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
43805953|NCT04918524|Hormones|hormones|mesh-ancestor
43805954|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805955|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552726|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552727|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552728|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43552729|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43552730|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43552731|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43552732|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43552733|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43552735|NCT03602131|Busulfan|busulfan|mesh-list
43805956|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805957|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805958|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43805959|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43805960|NCT04918524|Analgesics|analgesics|mesh-ancestor
43805961|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
43840677|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805962|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806028|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43806029|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
43806031|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43789322|NCT04234022|Pomalidomide|pomalidomide|mesh-list
43806032|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806034|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806035|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
43806036|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806037|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806038|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
43806039|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806040|NCT04917718|Tacrolimus|tacrolimus|mesh-list
43806041|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806042|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
43806043|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806044|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43806046|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43617182|NCT03141593|Vitamin D|vitamin d|mesh-list
43806048|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43654738|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654739|NCT02974270|Leuprolide|leuprolide|mesh-list
43654740|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43654741|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
43552773|NCT03601975|Cisplatin|cisplatin|mesh-list
43654742|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43806049|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806050|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43806051|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806053|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806054|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806055|NCT04917757|Dexamethasone|dexamethasone|mesh-list
43806056|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806057|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
43806059|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806060|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806062|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
43806063|NCT04917757|Hormones|hormones|mesh-ancestor
43806064|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806065|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806066|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806067|NCT04917497|Simendan|simendan|mesh-list
43806068|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43806069|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
43806070|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43806071|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43806072|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806073|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806074|NCT04917497|Protective Agents|protective agents|mesh-ancestor
43806075|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806076|NCT04917458|Vitamin D|vitamin d|mesh-list
43806077|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
43806078|NCT04917458|Vitamins|vitamins|mesh-ancestor
43806079|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
43806080|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806081|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806082|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43806083|NCT04917484|Octreotide|octreotide|mesh-list
43806084|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43806085|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806086|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806087|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806088|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43715133|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
43806240|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806241|NCT04915807|Paclitaxel|paclitaxel|mesh-list
43806242|NCT04915807|Irinotecan|irinotecan|mesh-list
43806243|NCT04915807|Ramucirumab|ramucirumab|mesh-list
43806244|NCT04915807|Taxane|taxane|mesh-list
43806245|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43806246|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806247|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
43806248|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806249|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806250|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806251|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43806252|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43806253|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806254|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43806255|NCT04915586|Plasminogen|plasminogen|mesh-list
43806256|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43806257|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43654743|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654744|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43654745|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654746|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43654747|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43654748|NCT02973958|Acetaminophen|acetaminophen|mesh-list
43806258|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806259|NCT04915482|Rituximab|rituximab|mesh-list
43806260|NCT04915482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806261|NCT04915482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806262|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
43806263|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806264|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806265|NCT04915456|Prednisolone|prednisolone|mesh-list
43806266|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806267|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
43806268|NCT04915456|Hormones|hormones|mesh-ancestor
43552846|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43552848|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
43552852|NCT03601611|Hormones|hormones|mesh-ancestor
43806269|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806270|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806271|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806272|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806274|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
43806275|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43806276|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806277|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806278|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
43790495|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43790496|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790549|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43790550|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43790551|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790552|NCT03933007|Fexofenadine|fexofenadine|mesh-list
43806283|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43806284|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806286|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
43843277|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790608|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
43790609|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790610|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
43790611|NCT03318874|Protective Agents|protective agents|mesh-ancestor
43790612|NCT03259698|Tenofovir|tenofovir|mesh-list
43790613|NCT03259698|Emtricitabine|emtricitabine|mesh-list
43790614|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43715152|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790615|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
43790616|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790617|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43790618|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43790619|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790620|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790621|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43790622|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43790623|NCT02648581|Ustekinumab|ustekinumab|mesh-list
43790624|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
43790625|NCT02609815|Metformin|metformin|mesh-list
43790626|NCT02609815|Glimepiride|glimepiride|mesh-list
43790628|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790629|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43790631|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
43790633|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
43790634|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43790635|NCT02464878|Basiliximab|basiliximab|mesh-list
43790636|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
43790637|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
43790638|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43790639|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43790640|NCT02464878|Analgesics|analgesics|mesh-ancestor
43790641|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
43790642|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43790643|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43552883|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43552884|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43552885|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43552886|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43552887|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
43552888|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43552889|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552900|NCT03600974|Citalopram|citalopram|mesh-list
43790644|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43790645|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43790646|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790647|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43790648|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
43790649|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43790651|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
43790652|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790653|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790654|NCT02010606|Bevacizumab|bevacizumab|mesh-list
43790655|NCT02010606|Temozolomide|temozolomide|mesh-list
43790666|NCT01794520|Dexamethasone|dexamethasone|mesh-list
43806334|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806335|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43806336|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43552917|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654752|NCT02973958|Sevoflurane|sevoflurane|mesh-list
43654753|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654754|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
43654755|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654756|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654757|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
43654758|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654759|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43654760|NCT02973958|Analgesics|analgesics|mesh-ancestor
43654761|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
43790703|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43790704|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790706|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
43790707|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790708|NCT05131893|Tamoxifen|tamoxifen|mesh-list
43790709|NCT05131893|Docetaxel|docetaxel|mesh-list
43790736|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
43790737|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790738|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43790739|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43790740|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43790741|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806342|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
43806343|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43806344|NCT04913831|Protective Agents|protective agents|mesh-ancestor
43790777|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43790778|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43790779|NCT05130619|Ethanol|ethanol|mesh-list
43790780|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43790781|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790782|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790783|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790790|NCT05130398|Immunologic Factors|immunologic factors|mesh-ancestor
43790791|NCT05130398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790792|NCT05045950|Memantine|memantine|mesh-list
43790793|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43790794|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43790795|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
43790796|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790797|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790798|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790799|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43790800|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43790801|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43790802|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43806354|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806355|NCT04913389|Diuretics|diuretics|mesh-ancestor
43806356|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
43806357|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806358|NCT04913402|Sufentanil|sufentanil|mesh-list
43806359|NCT04913402|Dsuvia|dsuvia|mesh-list
43806360|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43806361|NCT04913402|Narcotics|narcotics|mesh-ancestor
43806362|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806363|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806364|NCT04913402|Analgesics|analgesics|mesh-ancestor
43806365|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
43790839|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715282|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43552956|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43552957|NCT03600857|Misoprostol|misoprostol|mesh-list
43552958|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43790840|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790841|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43790842|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
43790843|NCT04968899|Hormones|hormones|mesh-ancestor
43790844|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43790845|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43790846|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43790847|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
43790848|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43790849|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43790850|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43790851|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43790852|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790853|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43790854|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43790855|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43790856|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
43790857|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790858|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790859|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43790860|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43790861|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
43840848|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840849|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43840850|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
43840851|NCT04667039|Ranibizumab|ranibizumab|mesh-list
43553002|NCT03600623|Fluorouracil|fluorouracil|mesh-list
43553003|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
43553004|NCT03600623|Irinotecan|irinotecan|mesh-list
43553005|NCT03600623|Folfirinox|folfirinox|mesh-list
43553006|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43553007|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553008|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
43553009|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
43553010|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
43553011|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553012|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43553013|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
43553014|NCT03600623|Antiviral Agents|antiviral agents|mesh-ancestor
43553015|NCT03600623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553016|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553017|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43840852|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43840853|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43840854|NCT04667039|Growth Substances|growth substances|mesh-ancestor
43840855|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840856|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
43840857|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840859|NCT04666714|Analgesics|analgesics|mesh-ancestor
43599235|NCT03292575|Anticoagulants|anticoagulants|mesh-list
43806367|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43806368|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43843307|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843308|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843309|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843311|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43790904|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43790905|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43790906|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43790907|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790908|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43790909|NCT04325880|Urological Agents|urological agents|mesh-ancestor
43790910|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43790911|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43790912|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
43790913|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43790914|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43790915|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43790916|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
43790917|NCT04263350|Cobicistat|cobicistat|mesh-list
43790918|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43790919|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43790920|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
43790921|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43790922|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790923|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43790924|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43790925|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
43790926|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43790927|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43790929|NCT04202458|Tenecteplase|tenecteplase|mesh-list
43790930|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43790931|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43832131|NCT05279937|Lidocaine|lidocaine|mesh-list
43790932|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790933|NCT04184453|Deferiprone|deferiprone|mesh-list
43790934|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43790935|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
43790936|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
43790937|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43790938|NCT04101643|Evolocumab|evolocumab|mesh-list
43843312|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
43843313|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843314|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843315|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43843316|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43843317|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
43843318|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843319|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843320|NCT04463680|Rifampin|rifampin|mesh-list
43843321|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43843322|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
43843323|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43843324|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843325|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
43843326|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43843327|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843328|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843329|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43790961|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
43790962|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43790963|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43790964|NCT03171805|Propranolol|propranolol|mesh-list
43790965|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43790998|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43790999|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43791000|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791001|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
43791002|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
43791003|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
43791004|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791005|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
43791006|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
43791007|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
43791008|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791009|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791010|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791011|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43791012|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
43791013|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
43791014|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791016|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
43843330|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43843331|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43806523|NCT04910165|Ropivacaine|ropivacaine|mesh-list
43806524|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
43806525|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
43806526|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806527|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806528|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
43806529|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806530|NCT04909931|Vitamin D|vitamin d|mesh-list
43806632|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806634|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
43806635|NCT04908813|Trastuzumab|trastuzumab|mesh-list
43791021|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43791032|NCT01210768|Epirubicin|epirubicin|mesh-list
43654766|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654767|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654768|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43806638|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806639|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806640|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843345|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
43843346|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843347|NCT04463030|Protective Agents|protective agents|mesh-ancestor
43843348|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
43553113|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43843349|NCT04462406|Nivolumab|nivolumab|mesh-list
43843350|NCT04462406|Ipilimumab|ipilimumab|mesh-list
43843351|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843352|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843353|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43843354|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843355|NCT04462315|Cobalt|cobalt|mesh-list
43843356|NCT04462315|Chromium|chromium|mesh-list
43843357|NCT04462315|Everolimus|everolimus|mesh-list
43843358|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843359|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843360|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
43843361|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843362|NCT04462315|Trace Elements|trace elements|mesh-ancestor
43843363|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
43843364|NCT04461288|Nicotine|nicotine|mesh-list
43843365|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43843366|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
43843367|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843368|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843369|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43843370|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43843371|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
43843372|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843373|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843374|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
43843375|NCT04460872|Testosterone|testosterone|mesh-list
43806646|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806647|NCT04908345|Analgesics|analgesics|mesh-ancestor
43806648|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
43806649|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806650|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43806651|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43806653|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
43806654|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
43806655|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
43806656|NCT04907708|Metformin|metformin|mesh-list
43806657|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43806658|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806659|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
43806660|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43806661|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43806662|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806663|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
43806664|NCT04907812|Coagulants|coagulants|mesh-ancestor
43806665|NCT04907864|Ibuprofen|ibuprofen|mesh-list
43806666|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43806667|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43806668|NCT04907864|Analgesics|analgesics|mesh-ancestor
43840905|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848403|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
43791124|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
43791125|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43791126|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43791127|NCT05133635|Prednisolone|prednisolone|mesh-list
43791128|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
43791129|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43791130|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
43791131|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43791132|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
43791133|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
43791134|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791135|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791136|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43791137|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
43791138|NCT05133635|Hormones|hormones|mesh-ancestor
43715361|NCT02661373|Cobicistat|cobicistat|mesh-list
43654778|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806846|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43806847|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806848|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43806850|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806851|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806853|NCT04906161|Calcium|calcium|mesh-list
43806854|NCT04906161|Vitamins|vitamins|mesh-ancestor
43806855|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
43806856|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806857|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43806858|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806859|NCT04905953|Neostigmine|neostigmine|mesh-list
43806860|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43806861|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791177|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43791178|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43791179|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43791180|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43791294|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
43791295|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791296|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791298|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
43791299|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791300|NCT04656964|Midazolam|midazolam|mesh-list
43791301|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43791302|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654783|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43654784|NCT02973724|Narcotics|narcotics|mesh-ancestor
43654785|NCT02973724|Analgesics|analgesics|mesh-ancestor
43654786|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
43654787|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654788|NCT02973776|Clobetasol|clobetasol|mesh-list
43654789|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43654790|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806901|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806902|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
43806903|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
43806904|NCT04904185|Fludarabine|fludarabine|mesh-list
43806905|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
43806906|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806907|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
43806908|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806909|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43791326|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43791327|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
43791328|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791329|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791336|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791338|NCT04311710|Ipilimumab|ipilimumab|mesh-list
43791343|NCT04244877|Rifaximin|rifaximin|mesh-list
43791438|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791439|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43791440|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
43791441|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791442|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791443|NCT01752049|Timolol|timolol|mesh-list
43791444|NCT01752049|Maleic acid|maleic acid|mesh-list
43791445|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43791446|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43791447|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806943|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43806944|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
43806945|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
43806946|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806947|NCT04903808|Protective Agents|protective agents|mesh-ancestor
43806948|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806949|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43806950|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840923|NCT04665648|Nicorandil|nicorandil|mesh-list
43840924|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43840925|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43840926|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
43840928|NCT04665648|Vitamins|vitamins|mesh-ancestor
43791547|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43791548|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43791549|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43791550|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
43791553|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
43807086|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654791|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
43654792|NCT02973776|Hormones|hormones|mesh-ancestor
43807087|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807088|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
43807089|NCT04902105|Valproic Acid|valproic acid|mesh-list
43807090|NCT04902105|Ecopipam|ecopipam|mesh-list
43807091|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
43807092|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807093|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807094|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
43791602|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
43791603|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
43791604|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807103|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
43807104|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43807105|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807106|NCT04902105|Analgesics|analgesics|mesh-ancestor
43807107|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
43791675|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
43791676|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43791677|NCT04849832|Fesoterodine|fesoterodine|mesh-list
43791678|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43791679|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43791680|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
43791681|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791682|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791686|NCT04717154|Ipilimumab|ipilimumab|mesh-list
43807108|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807109|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807110|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807111|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43843462|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
43843463|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43843464|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843465|NCT04452461|Leucovorin|leucovorin|mesh-list
43807179|NCT04900948|Prednisolone|prednisolone|mesh-list
43807183|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43807184|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
43807185|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807186|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
43807187|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
43807188|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807189|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807190|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807191|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
43807192|NCT04900948|Hormones|hormones|mesh-ancestor
43848428|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848429|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
43848430|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553218|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43553219|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43553220|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43553221|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
43553222|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
43791728|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553226|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
43553227|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43791729|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43791730|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791731|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791732|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43791734|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
43791735|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43791856|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
43791857|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791858|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43791859|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
43791860|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43791861|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43791862|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43791918|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43791919|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43791920|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791921|NCT03126643|Nivolumab|nivolumab|mesh-list
43791922|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43791923|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791924|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43791926|NCT03126617|Elotuzumab|elotuzumab|mesh-list
43807193|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807283|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
43807284|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43807285|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
43807286|NCT04900129|Protective Agents|protective agents|mesh-ancestor
43807287|NCT04900129|Antidotes|antidotes|mesh-ancestor
43807288|NCT04899765|Vaccines|vaccines|mesh-list
43807289|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
43807290|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
43807291|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43791985|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43791986|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43791987|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43791988|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
43791989|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43791991|NCT02582697|Etoposide|etoposide|mesh-list
43791992|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
43791993|NCT02582697|Bleomycin|bleomycin|mesh-list
43791994|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43791995|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43791996|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43791997|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792045|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43792072|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792073|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792074|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792075|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792096|NCT05137522|Hormones|hormones|mesh-ancestor
43807297|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
43807298|NCT04899570|Vindesine|vindesine|mesh-list
43807299|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807300|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
43807301|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807302|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807303|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43807304|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
43807305|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807306|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807307|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43807308|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43807309|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807310|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
43807311|NCT04899570|Hormones|hormones|mesh-ancestor
43807312|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807313|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43792098|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43792102|NCT05137288|Atropine|atropine|mesh-list
43807314|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43807315|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43807316|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43807317|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807318|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43807319|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43807320|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
43807321|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
43807322|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
43807323|NCT04899453|Rituximab|rituximab|mesh-list
43807324|NCT04899453|Methotrexate|methotrexate|mesh-list
43807325|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
43807326|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43807327|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807328|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
43807329|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807330|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43807331|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43807332|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
43792183|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792184|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792191|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
43792192|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43792193|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792194|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43792195|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792196|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807333|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553320|NCT03586934|Celecoxib|celecoxib|mesh-list
43807334|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807335|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
43807336|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654808|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
43654809|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654810|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654812|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43654813|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
43654814|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807337|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807359|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43807360|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807361|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
43807362|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807363|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807364|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43807365|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43807366|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807367|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43840989|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
43840990|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43840991|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43840992|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43840993|NCT04658927|Dexamethasone|dexamethasone|mesh-list
43840994|NCT04658927|Prednisone|prednisone|mesh-list
43840995|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43840996|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
43840997|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
43840998|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43840999|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841000|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807378|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807379|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807380|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
43841017|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841018|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807382|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807383|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807384|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807385|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807386|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
43807387|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807388|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843518|NCT04447352|Fluorouracil|fluorouracil|mesh-list
43843519|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
43843520|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843521|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
43843522|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
43843523|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
43843524|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553329|NCT03586934|Narcotics|narcotics|mesh-ancestor
43843525|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
43843526|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43843527|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43843528|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
43843529|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843530|NCT04447352|Antidotes|antidotes|mesh-ancestor
43843531|NCT04447352|Protective Agents|protective agents|mesh-ancestor
43843532|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
43843533|NCT04447352|Vitamins|vitamins|mesh-ancestor
43843534|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
43843535|NCT04447235|Ivermectin|ivermectin|mesh-list
43843536|NCT04447235|Losartan|losartan|mesh-list
43843537|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43792268|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792269|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792270|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43792271|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792272|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
43792273|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
43792274|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43792275|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792276|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792297|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43792298|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43792299|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43792300|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43792301|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792302|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
43792303|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43792305|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
43792307|NCT05304351|Vaccines|vaccines|mesh-list
43841065|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841066|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841067|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43792426|NCT05302713|Antacids|antacids|mesh-ancestor
43792427|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792428|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43792429|NCT05302531|Amoxicillin|amoxicillin|mesh-list
43792430|NCT05302531|Levofloxacin|levofloxacin|mesh-list
43792431|NCT05302531|Ofloxacin|ofloxacin|mesh-list
43843539|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43843540|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43553351|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
43553352|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553353|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553354|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
43553357|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43843541|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843542|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843543|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843544|NCT04444830|Ketorolac|ketorolac|mesh-list
43843545|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654815|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654816|NCT02973659|Urological Agents|urological agents|mesh-ancestor
43654817|NCT02973620|Simendan|simendan|mesh-list
43654818|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43792550|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43792551|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43792552|NCT05284656|Protective Agents|protective agents|mesh-ancestor
43792553|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
43792554|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43654819|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
43807423|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43807424|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43807425|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43807426|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
43807427|NCT04898699|Tenofovir|tenofovir|mesh-list
43807428|NCT04898699|Emtricitabine|emtricitabine|mesh-list
43807430|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
43807431|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807432|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43792629|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807444|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43807476|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
43807477|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807478|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807479|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
43807480|NCT04898270|Flupenthixol|flupenthixol|mesh-list
43807481|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43807482|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43807483|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807484|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807485|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43807486|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43807487|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
43807488|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807489|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807556|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43843569|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43843570|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43843572|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43704125|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43792687|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43792689|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
43792690|NCT05128617|Epirubicin|epirubicin|mesh-list
43654822|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654823|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654824|NCT02973620|Protective Agents|protective agents|mesh-ancestor
43654825|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654826|NCT02973451|Bupivacaine|bupivacaine|mesh-list
43715436|NCT02660866|Vorapaxar|vorapaxar|mesh-list
43654827|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
43654828|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
43654829|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807629|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807630|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43807631|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43807632|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807634|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
43807635|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807636|NCT04895137|Bevacizumab|bevacizumab|mesh-list
43807637|NCT04895137|Antibodies|antibodies|mesh-list
43807638|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43807639|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43807640|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807641|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43807642|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43807643|NCT04895137|Growth Substances|growth substances|mesh-ancestor
43807644|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807645|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
43807646|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
43807647|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
43807648|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43807649|NCT04894617|Amantadine|amantadine|mesh-list
43807650|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43807651|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43807652|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
43792810|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43792811|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43792812|NCT04965454|Choline|choline|mesh-list
43792813|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
43807653|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807654|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
43807655|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807656|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807657|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807658|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807659|NCT04894617|Analgesics|analgesics|mesh-ancestor
43807660|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
43807661|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807663|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
43807664|NCT04893993|Vitamins|vitamins|mesh-ancestor
43807665|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
43807666|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807667|NCT04893980|Aldesleukin|aldesleukin|mesh-list
43807668|NCT04893980|Interleukin-2|interleukin-2|mesh-list
43654830|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654831|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
43654832|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654833|NCT02973464|Valganciclovir|valganciclovir|mesh-list
43654834|NCT02973464|Ganciclovir|ganciclovir|mesh-list
43654835|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
43654836|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
43807669|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807670|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807671|NCT04893980|Analgesics|analgesics|mesh-ancestor
43807672|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
43553402|NCT03584360|Betamethasone|betamethasone|mesh-list
43553403|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
43553404|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43553405|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
43553406|NCT03584360|Calcipotriene|calcipotriene|mesh-list
43553407|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43553408|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43553409|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
43553410|NCT03584360|Hormones|hormones|mesh-ancestor
43807673|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807674|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807675|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43807676|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43807677|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
43807678|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807679|NCT04893733|Folic Acid|folic acid|mesh-list
43807680|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
43807689|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
43807690|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807691|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43807693|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807694|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43807695|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43807696|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807697|NCT04893629|Protective Agents|protective agents|mesh-ancestor
43807698|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43807699|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
43807700|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43792963|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43792964|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43792965|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43792966|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43792967|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43792968|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43792969|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43792970|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43792971|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43792972|NCT04696757|Capecitabine|capecitabine|mesh-list
43793017|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
43793018|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793019|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43793020|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43793021|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43793022|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
43793023|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43793024|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793025|NCT04636333|Vaccines|vaccines|mesh-list
43793026|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
43553421|NCT03584360|Vitamins|vitamins|mesh-ancestor
43793027|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793028|NCT04623216|Azacitidine|azacitidine|mesh-list
43793030|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
43807701|NCT04893525|Buprenorphine|buprenorphine|mesh-list
43807702|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43807703|NCT04893525|Naloxone|naloxone|mesh-list
43807704|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43807705|NCT04893525|Narcotics|narcotics|mesh-ancestor
43807706|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43807707|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807708|NCT04893525|Analgesics|analgesics|mesh-ancestor
43807709|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
43841209|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841210|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43841211|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43841212|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841213|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
43848457|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848458|NCT04017962|Letermovir|letermovir|mesh-list
43848459|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848460|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848461|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848462|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848463|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
43715447|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
43715448|NCT02660762|Pegaspargase|pegaspargase|mesh-list
43715449|NCT02660762|Thioguanine|thioguanine|mesh-list
43715450|NCT02660762|BB 1101|bb 1101|mesh-list
43715451|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43715453|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715454|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43715455|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43715456|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
43715458|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715461|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
43715462|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
43715463|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715464|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715465|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
43715466|NCT02660762|Hormones|hormones|mesh-ancestor
43832169|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43807710|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807712|NCT04893356|Dacarbazine|dacarbazine|mesh-list
43807713|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43807714|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
43807715|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807716|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807717|NCT04892732|Budesonide|budesonide|mesh-list
43807718|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
43807719|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43793098|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793100|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793101|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807720|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43807721|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
43807722|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807723|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807724|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43807725|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
43807726|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
43807727|NCT04892732|Hormones|hormones|mesh-ancestor
43807728|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43807729|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43807730|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43807731|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43807732|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807733|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807734|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807735|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
43807736|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
43654837|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654838|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43654839|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807737|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43807739|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807740|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807741|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43807742|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
43793355|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
43807743|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43807744|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43807745|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43807746|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807747|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807803|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
43807804|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807805|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
43793425|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
43807806|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807807|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
43807808|NCT04891861|Apixaban|apixaban|mesh-list
43807809|NCT04891861|Edoxaban|edoxaban|mesh-list
43807810|NCT04891861|Dabigatran|dabigatran|mesh-list
43807811|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43807812|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
43807813|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43807814|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
43807815|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807816|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807817|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
43807818|NCT04891744|Thalidomide|thalidomide|mesh-list
43807819|NCT04891744|Dexamethasone|dexamethasone|mesh-list
43807820|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807821|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
43807822|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
43807823|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553555|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715533|NCT02660606|Analgesics|analgesics|mesh-ancestor
43807824|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807825|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807826|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
43807827|NCT04891744|Hormones|hormones|mesh-ancestor
43807891|NCT04891211|Vitamins|vitamins|mesh-ancestor
43807892|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
43807893|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807894|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43807895|NCT04890626|Tenofovir|tenofovir|mesh-list
43807896|NCT04890626|Emtricitabine|emtricitabine|mesh-list
43807897|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43807898|NCT04890626|Dexamethasone|dexamethasone|mesh-list
43807899|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
43807901|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43807902|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
43807903|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
43807904|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807905|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807919|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43807920|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43807921|NCT04890522|Gemcitabine|gemcitabine|mesh-list
43807922|NCT04890522|Cisplatin|cisplatin|mesh-list
43807923|NCT04890522|Fluorouracil|fluorouracil|mesh-list
43807924|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807925|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43807926|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
43807927|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807928|NCT04890522|Antiviral Agents|antiviral agents|mesh-ancestor
43807929|NCT04890522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807930|NCT04890522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43619414|NCT03122665|Nefopam|nefopam|mesh-list
43807931|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807932|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
43807934|NCT04890561|Lemborexant|lemborexant|mesh-list
43807935|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
43793544|NCT05150704|Protective Agents|protective agents|mesh-ancestor
43793545|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43793546|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793547|NCT04954599|Carboplatin|carboplatin|mesh-list
43793548|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
43793549|NCT04954599|Nivolumab|nivolumab|mesh-list
43793550|NCT04954599|Ipilimumab|ipilimumab|mesh-list
43807948|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
43807949|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807950|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
43807951|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807952|NCT04890418|Ketamine|ketamine|mesh-list
43807953|NCT04890418|Analgesics|analgesics|mesh-ancestor
43807954|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
43793590|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793591|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793592|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
43793593|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793594|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43807958|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43807959|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
43807960|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
43793604|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793605|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43793606|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793607|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
43793608|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
43793609|NCT04821869|Albuterol|albuterol|mesh-list
43793610|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43793611|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
43793612|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793613|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793614|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43793615|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
43807964|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715563|NCT02660060|Protective Agents|protective agents|mesh-ancestor
43715564|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715565|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43715566|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43715567|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
43715568|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
43553605|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553606|NCT03579758|Antiviral Agents|antiviral agents|mesh-ancestor
43553607|NCT03579758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553608|NCT03579758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553609|NCT03579758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43553610|NCT03579758|Immunologic Factors|immunologic factors|mesh-ancestor
43553611|NCT03579758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807965|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654845|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654847|NCT02973581|Dipyrone|dipyrone|mesh-list
43654848|NCT02973581|Lidocaine|lidocaine|mesh-list
43654849|NCT02973581|Bupivacaine|bupivacaine|mesh-list
43654850|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
43654851|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
43841287|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
43841288|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841289|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43654852|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
43654853|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43654854|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807966|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
43807967|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43807968|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807969|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807970|NCT04890470|Vasopressins|vasopressins|mesh-list
43807971|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
43807972|NCT04890470|Oxytocin|oxytocin|mesh-list
43807973|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
43807974|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43807975|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807976|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
43807977|NCT04890470|Coagulants|coagulants|mesh-ancestor
43807978|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43807979|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43807980|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
43807995|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43807996|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843623|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843624|NCT04438824|Palbociclib|palbociclib|mesh-list
43843625|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843626|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843627|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843628|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843630|NCT04437888|Analgesics|analgesics|mesh-ancestor
43843631|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
43843632|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843633|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843634|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43843635|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43843636|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
43843637|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
43843638|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843639|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43843640|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43553645|NCT03579082|Decitabine|decitabine|mesh-list
43553646|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43715569|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715570|NCT02660047|Liraglutide|liraglutide|mesh-list
43715571|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43715572|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715573|NCT02660047|Incretins|incretins|mesh-ancestor
43715574|NCT02660047|Hormones|hormones|mesh-ancestor
43715575|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43715576|NCT02659683|Esomeprazole|esomeprazole|mesh-list
43715577|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43715580|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843642|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843643|NCT04437017|Dexamethasone|dexamethasone|mesh-list
43843644|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
43843645|NCT04437017|Olanzapine|olanzapine|mesh-list
43843646|NCT04437017|Serotonin|serotonin|mesh-list
43843647|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843648|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
43843649|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
43843650|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843651|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843652|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843653|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
43843654|NCT04437017|Hormones|hormones|mesh-ancestor
43704126|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43793671|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
43793672|NCT04622917|Hormones|hormones|mesh-ancestor
43793673|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43793674|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43793675|NCT04622917|Protective Agents|protective agents|mesh-ancestor
43793676|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43793677|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43793678|NCT04569994|Insulin|insulin|mesh-list
43793679|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43793680|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793681|NCT04335968|Melatonin|melatonin|mesh-list
43793682|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
43793683|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654856|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654857|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43654858|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43808009|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808010|NCT04888663|Paclitaxel|paclitaxel|mesh-list
43808011|NCT04888663|Trastuzumab|trastuzumab|mesh-list
43808012|NCT04888663|Ramucirumab|ramucirumab|mesh-list
43793732|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43793733|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793734|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43793735|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43793737|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
43808015|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808016|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808017|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808018|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808019|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808021|NCT04888728|Paroxetine|paroxetine|mesh-list
43808022|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43808029|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43808030|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
43808031|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43808032|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43808033|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43808034|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808035|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43808036|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
43715583|NCT02659761|Abacavir|abacavir|mesh-list
43715584|NCT02659761|Dolutegravir|dolutegravir|mesh-list
43715585|NCT02659761|Triumeq|triumeq|mesh-list
43808037|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43808038|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43793751|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
43793752|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
43793753|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43793754|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43793755|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
43793756|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43793770|NCT03915964|Adalimumab|adalimumab|mesh-list
43808050|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808051|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43808052|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
43808053|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808054|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808055|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43808056|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654863|NCT02973581|Analgesics|analgesics|mesh-ancestor
43654864|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
43654865|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43654866|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808059|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
43808060|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43808061|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43808062|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43808063|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
43808064|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808065|NCT04888715|Pirfenidone|pirfenidone|mesh-list
43808066|NCT04888715|Nintedanib|nintedanib|mesh-list
43808067|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808068|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43808069|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808070|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808071|NCT04888715|Analgesics|analgesics|mesh-ancestor
43808091|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
43808092|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808093|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808094|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
43808095|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808096|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43808097|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43808098|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808099|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808100|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808101|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43808102|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43808103|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
43808104|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
43808105|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43808106|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43808107|NCT04887961|Trabectedin|trabectedin|mesh-list
43808108|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43808109|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
43808110|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808111|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808112|NCT04887649|Morphine|morphine|mesh-list
43808113|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43793802|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
43793803|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43793804|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
43793805|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43808124|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808125|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808136|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808137|NCT04887467|Apomorphine|apomorphine|mesh-list
43808138|NCT04887467|Emetics|emetics|mesh-ancestor
43808139|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808140|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
43808141|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808142|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43715652|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
43715671|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715672|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43715673|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43715674|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
43715675|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
43715676|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715677|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43808143|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
43808144|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
43808145|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808146|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841358|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43841359|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
43841360|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841361|NCT04627922|Expectorants|expectorants|mesh-ancestor
43841362|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
43841363|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43841364|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
43841365|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841366|NCT04627922|Protective Agents|protective agents|mesh-ancestor
43841367|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841368|NCT04627922|Antidotes|antidotes|mesh-ancestor
43841369|NCT04627870|Paclitaxel|paclitaxel|mesh-list
43841370|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43841371|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841372|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43841373|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43793902|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793903|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793904|NCT02577120|Decanoic acid|decanoic acid|mesh-list
43793905|NCT02577120|Petrolatum|petrolatum|mesh-list
43793906|NCT02577120|Emollients|emollients|mesh-ancestor
43793907|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
43793909|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43793910|NCT02576717|Ozanimod|ozanimod|mesh-list
43793911|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43793912|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793913|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808157|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
43793976|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43793977|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43793978|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43793979|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43793980|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43793981|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
43793982|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43793983|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43793984|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
43793985|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
43793986|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43793987|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43793988|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
43808158|NCT04887493|Urological Agents|urological agents|mesh-ancestor
43808159|NCT04887311|Tempol|tempol|mesh-list
43715771|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43715772|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
43715773|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43715774|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715776|NCT02658721|Lidocaine|lidocaine|mesh-list
43715777|NCT02658721|Atropine|atropine|mesh-list
43715778|NCT02658721|Ephedrine|ephedrine|mesh-list
43715779|NCT02658721|Fentanyl|fentanyl|mesh-list
43715780|NCT02658721|Midazolam|midazolam|mesh-list
43715781|NCT02658721|Tramadol|tramadol|mesh-list
43715782|NCT02658721|Ondansetron|ondansetron|mesh-list
43715783|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
43715784|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
43715785|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808160|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
43808161|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808162|NCT04887311|Protective Agents|protective agents|mesh-ancestor
43808163|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808164|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43808165|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808166|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43808167|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43808168|NCT04886869|Caffeine|caffeine|mesh-list
43808169|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43794026|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
43808170|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808171|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43808172|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808173|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808174|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43808175|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43808176|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
43808177|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843662|NCT04437017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43843663|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43843664|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43794052|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843695|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43843696|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43841387|NCT04624178|Rucaparib|rucaparib|mesh-list
43841388|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841389|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841390|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841391|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841392|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43841393|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841394|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
43843698|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843699|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843700|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43808179|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
43808180|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
43808181|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
43808182|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808183|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
43808184|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808185|NCT04886752|Protective Agents|protective agents|mesh-ancestor
43841420|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
43841421|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841422|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43841423|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43841424|NCT04621435|Copper|copper|mesh-list
43841425|NCT04621435|Trace Elements|trace elements|mesh-ancestor
43841426|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
43841427|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808196|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808198|NCT04886193|Protective Agents|protective agents|mesh-ancestor
43808199|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808200|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
43808201|NCT04886193|Vitamins|vitamins|mesh-ancestor
43808202|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
43808203|NCT04885764|Vaccines|vaccines|mesh-list
43808226|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808228|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
43808229|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808230|NCT04885751|Rebamipide|rebamipide|mesh-list
43808234|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808236|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808264|NCT04884997|Temozolomide|temozolomide|mesh-list
43715850|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43715851|NCT02658409|Vaccines|vaccines|mesh-list
43715852|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
43715853|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715854|NCT02658188|Gabapentin|gabapentin|mesh-list
43715855|NCT02658188|Analgesics|analgesics|mesh-ancestor
43715856|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
43715857|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715858|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715859|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
43715860|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43715861|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43715862|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43715863|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43832194|NCT05279092|Dexamethasone|dexamethasone|mesh-list
43832195|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
43832196|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43808265|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43808266|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
43808267|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808268|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808270|NCT04884906|Cisplatin|cisplatin|mesh-list
43808271|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808272|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808273|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808274|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
43808275|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808276|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808277|NCT04885075|Midazolam|midazolam|mesh-list
43808278|NCT04885075|Diazepam|diazepam|mesh-list
43808279|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43794228|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
43794229|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43794230|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794231|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43794232|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43794233|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808388|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
43808389|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808391|NCT04882813|Incretins|incretins|mesh-ancestor
43808392|NCT04882813|Hormones|hormones|mesh-ancestor
43808393|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808394|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43808395|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
43808396|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808397|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808398|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43808399|NCT04883125|Pioglitazone|pioglitazone|mesh-list
43808400|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808401|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808413|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43808414|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808415|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43808416|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808417|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808418|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
43808419|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794272|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43794273|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43794274|NCT03643744|Analgesics|analgesics|mesh-ancestor
43794275|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
43794276|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794277|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794278|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794279|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794280|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43794281|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43794282|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794283|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794284|NCT03600090|Paclitaxel|paclitaxel|mesh-list
43794285|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43794286|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794287|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
43794288|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
43794289|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
43794290|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794291|NCT03595150|Diclofenac|diclofenac|mesh-list
43794292|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43841476|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841477|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794321|NCT03457896|Trastuzumab|trastuzumab|mesh-list
43794322|NCT03457896|Cetuximab|cetuximab|mesh-list
43794323|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43794324|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794325|NCT03451370|Bevacizumab|bevacizumab|mesh-list
43794326|NCT03451370|Capecitabine|capecitabine|mesh-list
43794327|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
43808486|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43808487|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808488|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808490|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
43794419|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43843727|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
43843728|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
43843729|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
43843730|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843731|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808505|NCT04881110|Liraglutide|liraglutide|mesh-list
43808506|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43794469|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
43794470|NCT03083067|Budesonide|budesonide|mesh-list
43794471|NCT03083067|Bromides|bromides|mesh-list
43794472|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
43794473|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
43794474|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43794475|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43794476|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
43715921|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
43715922|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43715923|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43850017|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43850023|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43850024|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43850025|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794477|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43794478|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794479|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43794480|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
43794481|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
43794482|NCT03083067|Hormones|hormones|mesh-ancestor
43794483|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43794484|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43808581|NCT04879030|Levofloxacin|levofloxacin|mesh-list
43808583|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
43808584|NCT04879030|Tazobactam|tazobactam|mesh-list
43808585|NCT04879030|Piperacillin|piperacillin|mesh-list
43808586|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
43808587|NCT04879030|Imipenem|imipenem|mesh-list
43808588|NCT04879030|Ceftazidime|ceftazidime|mesh-list
43808589|NCT04879030|Ertapenem|ertapenem|mesh-list
43808590|NCT04879030|Lactams|lactams|mesh-list
43808591|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43808592|NCT04879030|Cefotaxime|cefotaxime|mesh-list
43794529|NCT02838745|Pemetrexed|pemetrexed|mesh-list
43794530|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794531|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43794532|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808623|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808625|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43794569|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794570|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43794571|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43794590|NCT02592707|Dexamethasone|dexamethasone|mesh-list
43843790|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43843791|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843792|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808671|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43808672|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
43808673|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808674|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43808675|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43808676|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
43808677|NCT05257395|Letrozole|letrozole|mesh-list
43808678|NCT05257395|Anastrozole|anastrozole|mesh-list
43808679|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43715949|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715950|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
43715952|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43715953|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
43715954|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43715955|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
43715956|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43715957|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43715959|NCT02657512|Antidotes|antidotes|mesh-ancestor
43715960|NCT02657512|Protective Agents|protective agents|mesh-ancestor
43715961|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43715962|NCT02657486|Infigratinib|infigratinib|mesh-list
43808680|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43808707|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808708|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
43808709|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808710|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808712|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43808713|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808714|NCT05256472|Axitinib|axitinib|mesh-list
43808715|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808716|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794634|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
43794635|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794636|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43794637|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43794638|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43794639|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43794708|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43794709|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43794710|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43794711|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43794712|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43794713|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
43794714|NCT02013336|Irinotecan|irinotecan|mesh-list
43794715|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43794716|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
43794718|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43794799|NCT01347970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43704127|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43704128|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43704138|NCT02706236|Pancrelipase|pancrelipase|mesh-list
43808721|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43808722|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43808723|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808724|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808725|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808726|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808728|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
43808729|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808730|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
43808731|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43808732|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
43808733|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43808734|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808735|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43808736|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808737|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43808738|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43808739|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808740|NCT05256173|Melatonin|melatonin|mesh-list
43808741|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
43808742|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808743|NCT05256173|Protective Agents|protective agents|mesh-ancestor
43794828|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43808814|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
43808815|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43808816|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43843816|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843817|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43843818|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43843819|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
43843820|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43841509|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841510|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43841511|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43841512|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
43841513|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
43841514|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43841515|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43841516|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43841517|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841518|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841521|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43843823|NCT04425070|Gemcitabine|gemcitabine|mesh-list
43843824|NCT04425070|Carboplatin|carboplatin|mesh-list
43843825|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
43843826|NCT04425070|Etoposide|etoposide|mesh-list
43843827|NCT04425070|Ifosfamide|ifosfamide|mesh-list
43843828|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843829|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43794928|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43794929|NCT05001815|Insulin|insulin|mesh-list
43794930|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43794931|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43794932|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43794933|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
43808821|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43808823|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
43808824|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
43716008|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716009|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716010|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43716011|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43716012|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
43808825|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
43808827|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43808828|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43808829|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43808831|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808832|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43808833|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43808834|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43808852|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
43808853|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43808854|NCT05028608|Analgesics|analgesics|mesh-ancestor
43808855|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
43808856|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808857|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43808858|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43795066|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808864|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716085|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43808865|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808866|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43808867|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43808868|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808870|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43808871|NCT04685876|Bupivacaine|bupivacaine|mesh-list
43808872|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
43795129|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808875|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808876|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
43808877|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43808878|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43808879|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43808880|NCT04676399|Diuretics|diuretics|mesh-ancestor
43808881|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
43808882|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808883|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43808884|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43704139|NCT02706236|Pancreatin|pancreatin|mesh-list
43808886|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
43716136|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43808887|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43808888|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808889|NCT04569045|Lidocaine|lidocaine|mesh-list
43808890|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
43808891|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
43808892|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43808923|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43808924|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
43716137|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
43795186|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
43795187|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716138|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
43716139|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43716140|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43716141|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43716142|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
43795188|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795189|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43795190|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43795191|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
43795192|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795193|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43795194|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43795195|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
43795196|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43808925|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43808926|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
43808927|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43808928|NCT04481048|Expectorants|expectorants|mesh-ancestor
43808929|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
43808930|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43808931|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
43808932|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43808933|NCT04481048|Protective Agents|protective agents|mesh-ancestor
43795264|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43795265|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
43795266|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
43795267|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
43795268|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795269|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43795270|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795271|NCT04430426|Glycolic acid|glycolic acid|mesh-list
43808967|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808968|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
43808969|NCT04423055|Etonogestrel|etonogestrel|mesh-list
43808970|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43808971|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795324|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43841555|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
43841556|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43841557|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
43841558|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841559|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841560|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
43841561|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841564|NCT04605393|Dronabinol|dronabinol|mesh-list
43808972|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43808973|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43808974|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
43808975|NCT04389073|Bevacizumab|bevacizumab|mesh-list
43808976|NCT04389073|Cisplatin|cisplatin|mesh-list
43808977|NCT04389073|Capecitabine|capecitabine|mesh-list
43808978|NCT04389073|Vinorelbine|vinorelbine|mesh-list
43808979|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43808980|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
43808981|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43808982|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43808983|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43795432|NCT03867110|Ezetimibe|ezetimibe|mesh-list
43716166|NCT02655614|Midazolam|midazolam|mesh-list
43795433|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43795434|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795562|NCT03308396|Durvalumab|durvalumab|mesh-list
43795563|NCT03308396|Guadecitabine|guadecitabine|mesh-list
43795564|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43795565|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43795566|NCT03251911|Ivacaftor|ivacaftor|mesh-list
43809039|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809040|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
43809041|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
43809042|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809043|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809044|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809045|NCT04112095|Norgestrel|norgestrel|mesh-list
43809046|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43809047|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43795581|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795582|NCT03221400|Antidotes|antidotes|mesh-ancestor
43795583|NCT03221400|Protective Agents|protective agents|mesh-ancestor
43795584|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
43795585|NCT03221400|Vitamins|vitamins|mesh-ancestor
43795586|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
43809055|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43809056|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809057|NCT04050553|Incretins|incretins|mesh-ancestor
43809060|NCT03946891|Furosemide|furosemide|mesh-list
43809061|NCT03946891|Diuretics|diuretics|mesh-ancestor
43809062|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
43809063|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809064|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43809065|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43809066|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809067|NCT03911453|Rucaparib|rucaparib|mesh-list
43809095|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809096|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809098|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809099|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43809100|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43809101|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809102|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43795602|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
43795603|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43795604|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809103|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43809104|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43795655|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43795657|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
43809110|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843831|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843867|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
43843868|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
43843869|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843871|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809118|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43809119|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
43809120|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809121|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809122|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809127|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654870|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654871|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43654872|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654874|NCT02973204|Sorafenib|sorafenib|mesh-list
43809128|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
43809129|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809130|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809131|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43809132|NCT03352934|Avelumab|avelumab|mesh-list
43809133|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43809134|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809135|NCT03300817|Poly ICLC|poly iclc|mesh-list
43809136|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
43809137|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
43809138|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809139|NCT03257033|Gemcitabine|gemcitabine|mesh-list
43809140|NCT03257033|Paclitaxel|paclitaxel|mesh-list
43809141|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43809142|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809143|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
43809144|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
43809145|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
43809146|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809147|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43809148|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
43809149|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
43795825|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795826|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
43795827|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43795828|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
43795829|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43795830|NCT00783133|Fexofenadine|fexofenadine|mesh-list
43795831|NCT00783133|Desloratadine|desloratadine|mesh-list
43795832|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43795833|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
43795834|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795835|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795836|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795837|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43795838|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43795839|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
43795841|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43809150|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809151|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809152|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43809153|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
43553707|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43553708|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43553709|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553710|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
43553711|NCT03578679|Ivermectin|ivermectin|mesh-list
43553712|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43553713|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553714|NCT03578640|Grazoprevir|grazoprevir|mesh-list
43553715|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
43553716|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43553718|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809154|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809155|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
43809156|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43809157|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809158|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
43809222|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43809223|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43795851|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
43795852|NCT00763529|Fluticasone|fluticasone|mesh-list
43795853|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
43795918|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43795919|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
43809244|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809245|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
43654876|NCT02973204|Lanreotide|lanreotide|mesh-list
43654877|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654878|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43654879|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
43849595|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43849596|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
43849597|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849598|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849599|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43849600|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849601|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
43809246|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809264|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809267|NCT04876716|Isavuconazole|isavuconazole|mesh-list
43809268|NCT04876716|Anidulafungin|anidulafungin|mesh-list
43809269|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
43809276|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
43795984|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43795985|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43795986|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
43795987|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43795988|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43795989|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43795990|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
43795991|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
43795992|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43795993|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
43795994|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43795995|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
43796013|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796014|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796015|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43796016|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43796041|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796043|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43796044|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796045|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
43796046|NCT03965741|Apixaban|apixaban|mesh-list
43796047|NCT03965741|Dabigatran|dabigatran|mesh-list
43796048|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43796049|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
43796050|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43809278|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809279|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43809281|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43809282|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43809283|NCT04876638|Minocycline|minocycline|mesh-list
43809284|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43809285|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809322|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809323|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796117|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
43809421|NCT04874675|Diclofenac|diclofenac|mesh-list
43809422|NCT04874675|Codeine|codeine|mesh-list
43809423|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796168|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796170|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43796171|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796172|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796173|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43796174|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43796175|NCT05073640|Protective Agents|protective agents|mesh-ancestor
43796176|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809451|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43809452|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43809453|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
43809454|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809455|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
43809456|NCT04874428|Apixaban|apixaban|mesh-list
43809457|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43796212|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796213|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796214|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
43809492|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43809493|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43809494|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43654883|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654885|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43654887|NCT02973035|Valsartan|valsartan|mesh-list
43654888|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43654889|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43654890|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43809495|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809496|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
43809497|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43809498|NCT04873349|Oleuropein|oleuropein|mesh-list
43809525|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809527|NCT04873011|Quinine|quinine|mesh-list
43809528|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
43796262|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43796263|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809529|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43809530|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43809531|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716175|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43716177|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
43809532|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43809533|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809534|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43809535|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796297|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43796298|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796299|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
43796300|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
43796301|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43796302|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796303|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796304|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
43796305|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43796306|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796307|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796308|NCT05070468|Dexamethasone|dexamethasone|mesh-list
43841718|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848520|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
43848521|NCT04011163|Morphine|morphine|mesh-list
43848522|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43848523|NCT04011163|Narcotics|narcotics|mesh-ancestor
43848524|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43848525|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848526|NCT04011163|Analgesics|analgesics|mesh-ancestor
43848527|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
43796354|NCT05069870|Itraconazole|itraconazole|mesh-list
43796355|NCT05069870|Rifampin|rifampin|mesh-list
43843944|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43843945|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
43796373|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43796374|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43796375|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43796376|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43796377|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43796378|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43796379|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43553731|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553732|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43553733|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43553734|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43553735|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
43553736|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43553737|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553738|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43553739|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43553740|NCT03578263|Oxytocin|oxytocin|mesh-list
43553741|NCT03578263|Carbetocin|carbetocin|mesh-list
43809568|NCT04872881|Propofol|propofol|mesh-list
43809569|NCT04872881|Rocuronium|rocuronium|mesh-list
43809570|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43809571|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43809572|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809573|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43809574|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
43809575|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
43796423|NCT05068960|Bupivacaine|bupivacaine|mesh-list
43796424|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
43796425|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
43796426|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796427|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796428|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
43796429|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796430|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
43796431|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43796432|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796433|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
43796434|NCT05068453|Antibodies|antibodies|mesh-list
43796435|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43796436|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
43796437|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796438|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
43796439|NCT05067699|Calcifediol|calcifediol|mesh-list
43796440|NCT05067699|Vitamins|vitamins|mesh-ancestor
43796441|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
43796442|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796443|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43796444|NCT05067530|Paclitaxel|paclitaxel|mesh-list
43809579|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
43654891|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654892|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43654893|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654894|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
43654895|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43654896|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43654897|NCT02972918|Simendan|simendan|mesh-list
43654898|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43809580|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796464|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
43553759|NCT03578042|Diuretics|diuretics|mesh-ancestor
43796465|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43796466|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43796467|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796468|NCT05067309|Letrozole|letrozole|mesh-list
43796469|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796470|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43796471|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43809617|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
43809618|NCT04872283|Oxycodone|oxycodone|mesh-list
43809619|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43796487|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43796488|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796489|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43796490|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796491|NCT05066516|Incretins|incretins|mesh-ancestor
43796493|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796494|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43796495|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
43796496|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796497|NCT05066633|Metoprolol|metoprolol|mesh-list
43796498|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43796499|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43796500|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
43796501|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
43796502|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796503|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796504|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43796505|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43796506|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43796507|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
43796508|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809661|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809662|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43809663|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43809664|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841740|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841741|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43841742|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43841743|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43841744|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43841745|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841746|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43841747|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
43841749|NCT04594239|Protective Agents|protective agents|mesh-ancestor
43841750|NCT04594018|Minoxidil|minoxidil|mesh-list
43841751|NCT04594018|Finasteride|finasteride|mesh-list
43841752|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43841753|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
43809701|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809703|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
43809704|NCT04871750|Caseins|caseins|mesh-list
43809705|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
43809706|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
43809707|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809708|NCT04871646|Nafamostat|nafamostat|mesh-list
43809709|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809710|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809711|NCT04871646|Analgesics|analgesics|mesh-ancestor
43809712|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
43796638|NCT05062486|Curcumin|curcumin|mesh-list
43796639|NCT05062486|Resveratrol|resveratrol|mesh-list
43796640|NCT05062486|Quercetin|quercetin|mesh-list
43553779|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
43553780|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553781|NCT03577860|Bupivacaine|bupivacaine|mesh-list
43553782|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
43553783|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
43553784|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43553785|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553786|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
43553787|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553788|NCT03577834|Acetic Acid|acetic acid|mesh-list
43553789|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43553790|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796641|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43553791|NCT03577782|Vedolizumab|vedolizumab|mesh-list
43796642|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43796643|NCT05062486|Analgesics|analgesics|mesh-ancestor
43796644|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
43796645|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796646|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796647|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796648|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43796649|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796650|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796709|NCT05061641|Hormones|hormones|mesh-ancestor
43796710|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43796711|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796712|NCT05061147|Azacitidine|azacitidine|mesh-list
43796713|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43796714|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
43796715|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796716|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796717|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841759|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43809718|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
43809719|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809720|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809721|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43809722|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43809749|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809751|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
43809752|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43841769|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
43841770|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43841771|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809756|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809757|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809758|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43809759|NCT04870372|Protective Agents|protective agents|mesh-ancestor
43809760|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809763|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809764|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43809800|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43809802|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43553815|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809803|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43809804|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43809806|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43809807|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43809808|NCT04870190|Osimertinib|osimertinib|mesh-list
43809828|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
43809829|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796798|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43796799|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43796800|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
43796801|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43796802|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43796803|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43796804|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43796805|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43796806|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796807|NCT05058755|Etoposide|etoposide|mesh-list
43796808|NCT05058755|Lenalidomide|lenalidomide|mesh-list
43796809|NCT05058755|Azacitidine|azacitidine|mesh-list
43796810|NCT05058755|Pegaspargase|pegaspargase|mesh-list
43796811|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43796812|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43796813|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43796814|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43796815|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796832|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
43796833|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43796834|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43796835|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43796836|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
43606243|NCT03220867|Risperidone|risperidone|mesh-list
43841780|NCT04592016|Coal Tar|coal tar|mesh-list
43796846|NCT05058105|Meropenem|meropenem|mesh-list
43843989|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848739|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43848740|NCT03998709|Hormones|hormones|mesh-ancestor
43848741|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848742|NCT03997968|Gemcitabine|gemcitabine|mesh-list
43848743|NCT03997968|Rituximab|rituximab|mesh-list
43848744|NCT03997968|Capecitabine|capecitabine|mesh-list
43848745|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43848746|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43796869|NCT05057351|Glycerol|glycerol|mesh-list
43848747|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848748|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
43848749|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848750|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848751|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43848752|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
43716253|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848753|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809855|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
43809856|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43796887|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43796888|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43796889|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43796890|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
43796891|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43796892|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
43809857|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43654902|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654903|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654904|NCT02972918|Protective Agents|protective agents|mesh-ancestor
43809858|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809859|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43809860|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809861|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43809862|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43809863|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
43809864|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841849|NCT04586166|Imidacloprid|imidacloprid|mesh-list
43841850|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
43841851|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43841852|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841853|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841854|NCT04585737|Tenofovir|tenofovir|mesh-list
43841855|NCT04585737|Lamivudine|lamivudine|mesh-list
43841856|NCT04585737|Emtricitabine|emtricitabine|mesh-list
43841857|NCT04585737|Dolutegravir|dolutegravir|mesh-list
43841858|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43841859|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
43841860|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43809867|NCT04869046|Analgesics|analgesics|mesh-list
43809868|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
43809869|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43809870|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
43809871|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43809872|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43809874|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43809904|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
43809915|NCT04868175|Travoprost|travoprost|mesh-list
43809916|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43809917|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43809918|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
43809919|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809920|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809955|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43716265|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
43716266|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43809958|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43809960|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43716267|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43553835|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553836|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43553837|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43809961|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843992|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43843993|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43810004|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810005|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43810006|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810007|NCT04866355|Ibuprofen|ibuprofen|mesh-list
43810036|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810037|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810038|NCT04865705|Paclitaxel|paclitaxel|mesh-list
43810039|NCT04865705|Cisplatin|cisplatin|mesh-list
43810040|NCT04865705|Carboplatin|carboplatin|mesh-list
43810041|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43810042|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797112|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797113|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43797114|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43797115|NCT05050357|Hormones|hormones|mesh-ancestor
43553850|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797116|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797117|NCT05050188|Lansoprazole|lansoprazole|mesh-list
43797118|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
43797119|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43797120|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43797121|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43606611|NCT03209622|Nicotine|nicotine|mesh-list
43797122|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797123|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797124|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
43797125|NCT05050071|Calcium|calcium|mesh-list
43797126|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43797127|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797128|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43797129|NCT05050448|Diclofenac|diclofenac|mesh-list
43797130|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43797142|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43797143|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797144|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
43797145|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797146|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43797147|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43797148|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841864|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810043|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
43810044|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
43810045|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
43716330|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810046|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810047|NCT04865991|Propofol|propofol|mesh-list
43810048|NCT04865991|Sevoflurane|sevoflurane|mesh-list
43810049|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43810050|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810051|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810052|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810053|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
43810054|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
43810055|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43810089|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
43810090|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
43810091|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
43810092|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654905|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654906|NCT02972957|Azithromycin|azithromycin|mesh-list
43654907|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43654908|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43654909|NCT02972983|Daptomycin|daptomycin|mesh-list
43654910|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43810093|NCT04865224|Chrysarobin|chrysarobin|mesh-list
43810094|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43810095|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810096|NCT04865224|Analgesics|analgesics|mesh-ancestor
43810167|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844050|NCT04410991|Teriflunomide|teriflunomide|mesh-list
43844051|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43810196|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43810197|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
43810198|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43810199|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
43810200|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43810201|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
43810202|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810203|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
43810204|NCT04863742|Hormones|hormones|mesh-ancestor
43810205|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810206|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810207|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43810208|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810209|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
43797167|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810211|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43553900|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
43553901|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43553902|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43553903|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43553904|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43553905|NCT03576677|Protective Agents|protective agents|mesh-ancestor
43553906|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43553907|NCT03576651|Bevacizumab|bevacizumab|mesh-list
43832265|NCT05276531|Progesterone|progesterone|mesh-list
43810212|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43810213|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43810214|NCT04863742|Protective Agents|protective agents|mesh-ancestor
43810215|NCT04863807|Anesthetics|anesthetics|mesh-list
43810216|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810217|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810218|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
43810219|NCT04863430|Apatinib|apatinib|mesh-list
43810220|NCT04863430|Tegafur|tegafur|mesh-list
43797219|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810222|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810223|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810224|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810225|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797294|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797296|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43797297|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43797298|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797299|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
43797300|NCT05047133|Coagulants|coagulants|mesh-ancestor
43797301|NCT05047393|Vitamin D|vitamin d|mesh-list
43797302|NCT05047393|Vitamins|vitamins|mesh-ancestor
43797390|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797392|NCT05045248|Apraclonidine|apraclonidine|mesh-list
43716379|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716380|NCT02654171|Ziresovir|ziresovir|mesh-list
43716381|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
43716382|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43716383|NCT02654288|Gemcitabine|gemcitabine|mesh-list
43716384|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716386|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797393|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43797394|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797395|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797396|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797397|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797398|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797399|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797400|NCT05045274|Aspirin|aspirin|mesh-list
43797401|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
43797402|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
43797403|NCT05045274|Giapreza|giapreza|mesh-list
43797404|NCT05045274|Clopidogrel|clopidogrel|mesh-list
43797405|NCT05045274|Ticagrelor|ticagrelor|mesh-list
43797409|NCT05045274|Diuretics|diuretics|mesh-list
43797426|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43797427|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43797428|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
43797429|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43797430|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43797431|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43797432|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
43797433|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797434|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43797435|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43797436|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43797437|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797438|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
43797439|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43716455|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797440|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
43797441|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43797442|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
43810234|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810236|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43810237|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
43810238|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810239|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810240|NCT04863274|Atorvastatin|atorvastatin|mesh-list
43810241|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43810242|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43810243|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
43810244|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810245|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43810246|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43810247|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810248|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43810249|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43810250|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
43810251|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797443|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43797444|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43797445|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
43797446|NCT05045274|Hormones|hormones|mesh-ancestor
43797447|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43797448|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
43797449|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43797450|NCT05045443|Curcumin|curcumin|mesh-list
43797451|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43797452|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43797453|NCT05045443|Analgesics|analgesics|mesh-ancestor
43797454|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
43797455|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797456|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797457|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43797458|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848542|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797459|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797460|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797461|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797462|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43797463|NCT05045053|Lifitegrast|lifitegrast|mesh-list
43797464|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43797465|NCT05044728|Paclitaxel|paclitaxel|mesh-list
43797466|NCT05044728|Carboplatin|carboplatin|mesh-list
43797467|NCT05044728|Antibodies|antibodies|mesh-list
43797468|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43797469|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810252|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810306|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
43810307|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
43810309|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810310|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
43810311|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43810312|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
43810313|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797471|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
43797472|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
43797473|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797474|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
43797475|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797476|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
43797477|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43797478|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
43797479|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797480|NCT05044364|Clevidipine|clevidipine|mesh-list
43797481|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43716535|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797482|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43797483|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797484|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43797485|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797486|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
43797487|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43797488|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43797489|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797490|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797491|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797492|NCT05043740|Evolocumab|evolocumab|mesh-list
43797493|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43797494|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797495|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
43797496|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797497|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43797498|NCT05043896|Tadalafil|tadalafil|mesh-list
43797499|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
43797500|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43810320|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43810321|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844052|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844053|NCT04410991|Analgesics|analgesics|mesh-ancestor
43622282|NCT03109080|Adenosine|adenosine|mesh-list
43844101|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
43844102|NCT04407390|Vitamins|vitamins|mesh-ancestor
43810322|NCT04861142|Denosumab|denosumab|mesh-list
43810323|NCT04861142|Alendronate|alendronate|mesh-list
43810324|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43654919|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
43654920|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43654921|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654922|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43810325|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810326|NCT04861103|Enoxaparin|enoxaparin|mesh-list
43810327|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
43810328|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43810329|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43810330|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810331|NCT04860674|Carboplatin|carboplatin|mesh-list
43810332|NCT04860674|Etoposide|etoposide|mesh-list
43810333|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43716554|NCT02653131|Hormones|hormones|mesh-ancestor
43810334|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810335|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43810336|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43810337|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43810338|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810339|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716583|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43810363|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810364|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810365|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810366|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
43810367|NCT04860531|Hormones|hormones|mesh-ancestor
43810368|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810369|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43810370|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
43810371|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
43810372|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
43810373|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810374|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810375|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810376|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43841931|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716584|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716585|NCT02652884|Betamethasone|betamethasone|mesh-list
43716586|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
43716587|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716588|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
43716589|NCT02652884|Hormones|hormones|mesh-ancestor
43716590|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43716591|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716592|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43716593|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
43716594|NCT02652871|Cytarabine|cytarabine|mesh-list
43716595|NCT02652871|Idarubicin|idarubicin|mesh-list
43716596|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43716597|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
43841932|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43841933|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43841934|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43841935|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841936|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
43841937|NCT04571632|Ipilimumab|ipilimumab|mesh-list
43841938|NCT04571632|Avelumab|avelumab|mesh-list
43841939|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43841940|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43841941|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43841942|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43841943|NCT04571580|Reteplase|reteplase|mesh-list
43841944|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43841945|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43797560|NCT05042336|Lenvatinib|lenvatinib|mesh-list
43810380|NCT04860167|Lidocaine|lidocaine|mesh-list
43810381|NCT04860167|Propofol|propofol|mesh-list
43810382|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43810383|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810384|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810385|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810386|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
43810387|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
43810388|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43810389|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810390|NCT04860167|Analgesics|analgesics|mesh-ancestor
43810391|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
43810417|NCT04860011|Diuretics|diuretics|mesh-ancestor
43810418|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
43810419|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43810420|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810421|NCT04859738|Lidocaine|lidocaine|mesh-list
43810422|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810423|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
43810424|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716650|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
43716651|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716652|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716653|NCT02652741|Enalapril|enalapril|mesh-list
43716654|NCT02652741|Enalaprilat|enalaprilat|mesh-list
43716655|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43716656|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
43716657|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716658|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716661|NCT02652507|Ketamine|ketamine|mesh-list
43716683|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716684|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43716685|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43716686|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
43716687|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716688|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43716689|NCT02652312|Diclofenac|diclofenac|mesh-list
43716690|NCT02652312|Fentanyl|fentanyl|mesh-list
43716691|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
43810425|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810426|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
43810427|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810428|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43810429|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810430|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43810431|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810432|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810433|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
43810434|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810436|NCT04860219|Lactoferrin|lactoferrin|mesh-list
43654923|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
43654924|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
43654926|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810437|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810438|NCT04859621|Vitamin D|vitamin d|mesh-list
43810439|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
43810440|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
43810441|NCT04859621|Vitamins|vitamins|mesh-list
43810442|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43810443|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
43810444|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810445|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43810473|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810475|NCT04859452|Glyburide|glyburide|mesh-list
43810476|NCT04859452|Valsartan|valsartan|mesh-list
43810477|NCT04859452|Simvastatin|simvastatin|mesh-list
43716694|NCT02652312|Desflurane|desflurane|mesh-list
43716695|NCT02652312|Atracurium|atracurium|mesh-list
43716696|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43716697|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716698|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810478|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810479|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810480|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43810481|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43810482|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
43810483|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810484|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43810485|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43810486|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810487|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43810488|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43797610|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797611|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
43797612|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797613|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43797614|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
43797615|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43797616|NCT05041790|Choline|choline|mesh-list
43797617|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
43797618|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43797619|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
43797620|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797632|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716753|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716754|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
43716769|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
43716770|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716771|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43716774|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43716775|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43716776|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43716777|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43716778|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43716779|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716780|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
43716781|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43716782|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43716783|NCT02651792|Meperidine|meperidine|mesh-list
43716784|NCT02651792|Ketamine|ketamine|mesh-list
43716785|NCT02651792|Propofol|propofol|mesh-list
43716786|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43716787|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43716790|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
43716815|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43716816|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43716817|NCT02651610|Paclitaxel|paclitaxel|mesh-list
43797633|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43797634|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797635|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797636|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797637|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797638|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797639|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43797640|NCT05041270|Narcotics|narcotics|mesh-ancestor
43797641|NCT05040906|Rituximab|rituximab|mesh-list
43797642|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797647|NCT05040828|Montelukast|montelukast|mesh-list
43810489|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43810490|NCT04859361|Imiquimod|imiquimod|mesh-list
43810491|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43844107|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844108|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43844109|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
43844127|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844128|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43844129|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844130|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
43844131|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43844132|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
43844133|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844134|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844136|NCT04405596|Expectorants|expectorants|mesh-ancestor
43844137|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
43844138|NCT04405037|Alvimopan|alvimopan|mesh-list
43844139|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844140|NCT04404088|Rituximab|rituximab|mesh-list
43844141|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43844142|NCT04404088|Lenalidomide|lenalidomide|mesh-list
43844143|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
43844144|NCT04404088|Antibodies|antibodies|mesh-list
43844145|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
43844146|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43844147|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
43844148|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844149|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844150|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844151|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43844152|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43844153|NCT04404088|Growth Substances|growth substances|mesh-ancestor
43844154|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
43844155|NCT04402346|Pancrelipase|pancrelipase|mesh-list
43844156|NCT04402346|Pancreatin|pancreatin|mesh-list
43844157|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43844158|NCT04400201|Propofol|propofol|mesh-list
43844159|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43797654|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43716818|NCT02651610|Docetaxel|docetaxel|mesh-list
43797655|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43797656|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797657|NCT05040724|Ivermectin|ivermectin|mesh-list
43797658|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43797659|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797660|NCT05040594|Lidocaine|lidocaine|mesh-list
43797661|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
43797662|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
43797663|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797664|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797665|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
43797666|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43797667|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43797668|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43797669|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43844161|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844162|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43844163|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
43844164|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
43844165|NCT04400175|Silicon|silicon|mesh-list
43844166|NCT04400175|Trace Elements|trace elements|mesh-ancestor
43654927|NCT02972723|Metformin|metformin|mesh-list
43654928|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43654929|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654930|NCT02972762|Propofol|propofol|mesh-list
43654931|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43654932|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43797683|NCT05039580|Hormones|hormones|mesh-ancestor
43654934|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43844167|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
43810526|NCT04858516|Trastuzumab|trastuzumab|mesh-list
43810527|NCT04858516|Palbociclib|palbociclib|mesh-list
43810528|NCT04858516|Exemestane|exemestane|mesh-list
43810529|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810530|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810559|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43810560|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43810561|NCT04857801|Protective Agents|protective agents|mesh-ancestor
43810562|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810563|NCT04857320|Insulin|insulin|mesh-list
43810564|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43810565|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810566|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810567|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43810568|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43797699|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43797700|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43797701|NCT05038657|Atezolizumab|atezolizumab|mesh-list
43797702|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797703|NCT05038072|Triamcinolone|triamcinolone|mesh-list
43810573|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810574|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810575|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43810576|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43810600|NCT04856852|Trace Elements|trace elements|mesh-ancestor
43810601|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
43810602|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810606|NCT04856787|Fluorouracil|fluorouracil|mesh-list
43810607|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
43810608|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810609|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43810610|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810611|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797801|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797802|NCT05036005|Pertuzumab|pertuzumab|mesh-list
43553951|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43797803|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797804|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797805|NCT05035953|Edaravone|edaravone|mesh-list
43797806|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43797807|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
43797808|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797809|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43797810|NCT05035953|Protective Agents|protective agents|mesh-ancestor
43797811|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797812|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
43797813|NCT05036174|Promethazine|promethazine|mesh-list
43797814|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43797815|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43797816|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810612|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
43810613|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810614|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
43810615|NCT04856969|Olmesartan|olmesartan|mesh-list
43810616|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43810617|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810618|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810619|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797848|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797849|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
43797850|NCT05035381|Leucovorin|leucovorin|mesh-list
43797851|NCT05035381|Bevacizumab|bevacizumab|mesh-list
43797852|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
43797853|NCT05035381|Fluorouracil|fluorouracil|mesh-list
43797854|NCT05035381|Irinotecan|irinotecan|mesh-list
43797855|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43797856|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43797857|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43797858|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43797859|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43797860|NCT05035381|Growth Substances|growth substances|mesh-ancestor
43797861|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43797862|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
43797863|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
43797864|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797865|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43797866|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43797867|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
43797868|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43716872|NCT02651636|Hematinics|hematinics|mesh-ancestor
43716873|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
43797869|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43797870|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43797871|NCT05035381|Antidotes|antidotes|mesh-ancestor
43797872|NCT05035381|Protective Agents|protective agents|mesh-ancestor
43797873|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
43797889|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43797890|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43797891|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
43797892|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43797893|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43797894|NCT05035498|Protective Agents|protective agents|mesh-ancestor
43797895|NCT05035485|Phenylephrine|phenylephrine|mesh-list
43797896|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
43797897|NCT05035485|Norepinephrine|norepinephrine|mesh-list
43797898|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43810624|NCT04856644|Rifapentine|rifapentine|mesh-list
43810625|NCT04856644|Rifampin|rifampin|mesh-list
43810657|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810658|NCT04856137|Paclitaxel|paclitaxel|mesh-list
43810659|NCT04856137|Rituximab|rituximab|mesh-list
43810660|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43810661|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810662|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
43810663|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
43654935|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
43654936|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
43654937|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
43654938|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43654939|NCT02972463|Antibodies|antibodies|mesh-list
43654940|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
43654941|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825061|NCT05504967|Ropivacaine|ropivacaine|mesh-list
43825062|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825063|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
43825064|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
43825065|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810664|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
43798004|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
43798005|NCT05033535|Olmesartan|olmesartan|mesh-list
43798006|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
43798007|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43798008|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43798009|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43798154|NCT05029076|Hormones|hormones|mesh-ancestor
43842013|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43842014|NCT04562532|Sirolimus|sirolimus|mesh-list
43842015|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43842016|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842017|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43842018|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842019|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
43848545|NCT04009668|Adalimumab|adalimumab|mesh-list
43810685|NCT04856111|Pirfenidone|pirfenidone|mesh-list
43798243|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43798244|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
43798245|NCT05027581|Protective Agents|protective agents|mesh-ancestor
43798246|NCT05027126|Folic Acid|folic acid|mesh-list
43810688|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810689|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810690|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810691|NCT04856111|Analgesics|analgesics|mesh-ancestor
43810734|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
43810736|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43825066|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825067|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825068|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
43825069|NCT05504967|Hormones|hormones|mesh-ancestor
43654942|NCT02972450|Vedolizumab|vedolizumab|mesh-list
43654943|NCT02972450|Vaccines|vaccines|mesh-list
43654944|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
43654945|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810737|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43810738|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
43810739|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810740|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
43810741|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810742|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810743|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810744|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810745|NCT04854759|Analgesics|analgesics|mesh-ancestor
43716893|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43716894|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43716895|NCT02651350|Prednisolone|prednisolone|mesh-list
43716896|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
43716897|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43716898|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
43716899|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43716900|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
43716901|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
43716902|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43716903|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43716904|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43716905|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
43554018|NCT03576105|Methylene Blue|methylene blue|mesh-list
43554032|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554033|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554034|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
43554035|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554036|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43554037|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810774|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
43810775|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
43810777|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810778|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43810779|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43810780|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810870|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
43810871|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810872|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
43810873|NCT04851548|Protective Agents|protective agents|mesh-ancestor
43810874|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43810875|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43798386|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
43798387|NCT05024604|Progesterone|progesterone|mesh-list
43798388|NCT05024604|Progestins|progestins|mesh-ancestor
43798389|NCT05024604|Hormones|hormones|mesh-ancestor
43798394|NCT05024448|Prednisone|prednisone|mesh-list
43798401|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43798402|NCT05024877|Stanozolol|stanozolol|mesh-list
43798404|NCT05024877|Hormones|hormones|mesh-ancestor
43798407|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
43810876|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810878|NCT04852081|Letrozole|letrozole|mesh-list
43554038|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43554039|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554040|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554041|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43554043|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43810879|NCT04852081|Fulvestrant|fulvestrant|mesh-list
43810880|NCT04852081|Palbociclib|palbociclib|mesh-list
43810881|NCT04852081|Anastrozole|anastrozole|mesh-list
43810882|NCT04852081|Exemestane|exemestane|mesh-list
43810921|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
43810922|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43810923|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810924|NCT04851015|Renal Agents|renal agents|mesh-ancestor
43810925|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
43810926|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43810927|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43810928|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43654946|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43654947|NCT02972476|Fluticasone|fluticasone|mesh-list
43654948|NCT02972476|Xhance|xhance|mesh-list
43654949|NCT02972476|Budesonide|budesonide|mesh-list
43554055|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554056|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554057|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554058|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43654950|NCT02972476|Bromides|bromides|mesh-list
43654951|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
43654952|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43810929|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810930|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810931|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43810932|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43810933|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43810934|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43810935|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43810936|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43810937|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810938|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
43810939|NCT04851002|Mitogens|mitogens|mesh-list
43810940|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
43810941|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810942|NCT04850911|Ketamine|ketamine|mesh-list
43810962|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
43810963|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
43810964|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43810965|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810966|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43810967|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
43842078|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43842079|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842080|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43842081|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43798536|NCT05021887|Fluticasone|fluticasone|mesh-list
43798537|NCT05021887|Xhance|xhance|mesh-list
43798538|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43810968|NCT04850885|Hormones|hormones|mesh-ancestor
43810969|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43810970|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43810971|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810972|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554100|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43810973|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
43810974|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810975|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
43810976|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43810977|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43810978|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43810979|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43810980|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43798576|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43798577|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43798578|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
43810981|NCT04850950|Tenofovir|tenofovir|mesh-list
43810982|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
43810983|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810984|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43810985|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43810986|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810987|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810988|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43810989|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43810990|NCT04850755|Nivolumab|nivolumab|mesh-list
43810991|NCT04850755|Ipilimumab|ipilimumab|mesh-list
43810992|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43810993|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43810995|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810996|NCT04850560|Decitabine|decitabine|mesh-list
43811021|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811022|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811023|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811024|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43811025|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43811026|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554129|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554130|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
43554131|NCT03574857|Metolazone|metolazone|mesh-list
43554132|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
43554133|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43554134|NCT03574857|Diuretics|diuretics|mesh-ancestor
43554135|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
43554136|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554137|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43554138|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554139|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554140|NCT03574701|Vitamin A|vitamin a|mesh-list
43554141|NCT03574701|Vitamins|vitamins|mesh-ancestor
43554142|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
43554148|NCT03574649|Carboplatin|carboplatin|mesh-list
43811027|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43811028|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43811029|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811031|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43811032|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43811033|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43654953|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43654954|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43654955|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43654956|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
43654957|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811034|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
43811035|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811036|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43811037|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
43811038|NCT04850235|Paclitaxel|paclitaxel|mesh-list
43811039|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811040|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811041|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811042|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811043|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811044|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811045|NCT04850261|Nafarelin|nafarelin|mesh-list
43811067|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43811068|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43811069|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811070|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43811071|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43811072|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811093|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
43811094|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811096|NCT04849533|Prednisone|prednisone|mesh-list
43811097|NCT04849533|Everolimus|everolimus|mesh-list
43811098|NCT04849533|Abatacept|abatacept|mesh-list
43811099|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
43811100|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43811101|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811102|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
43811103|NCT04849533|Hormones|hormones|mesh-ancestor
43811104|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811105|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811106|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811107|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811108|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811109|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
43798746|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43798747|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
43811113|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811114|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811115|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811116|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811117|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43811118|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811119|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
43811120|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811121|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811122|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43811123|NCT04849013|Ketanserin|ketanserin|mesh-list
43811124|NCT04849013|Mescaline|mescaline|mesh-list
43811125|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43811126|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43811127|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43811128|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
43798834|NCT05016440|Lisinopril|lisinopril|mesh-list
43811139|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554251|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
43554252|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554253|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554254|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43554255|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
43554256|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43554257|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
43554258|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554259|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43554261|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811140|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811142|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43811143|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43811144|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43811145|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
43811146|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
43811147|NCT04849299|Cyclosporine|cyclosporine|mesh-list
43811148|NCT04849299|Cyclosporins|cyclosporins|mesh-list
43811149|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811150|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811151|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811152|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
43811153|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811154|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
43811155|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811156|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811157|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844267|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
43844268|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
43811173|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811175|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
43811176|NCT04848259|BB 1101|bb 1101|mesh-list
43811177|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811178|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
43811179|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
43811180|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811181|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811182|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811183|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
43811184|NCT04848259|Hormones|hormones|mesh-ancestor
43811185|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811186|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811187|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811188|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
43811208|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43811209|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43654965|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654966|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43654967|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43654968|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43654969|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
43554280|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811210|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811211|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842138|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842139|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842140|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842141|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43842142|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
43842143|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43842144|NCT04550104|Olaparib|olaparib|mesh-list
43842145|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43842146|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842147|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43608958|NCT03193463|Topotecan|topotecan|mesh-list
43799155|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43811214|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811215|NCT04848181|Urological Agents|urological agents|mesh-ancestor
43811216|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
43811217|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811218|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43811219|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
43799191|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43799192|NCT05010434|Growth Substances|growth substances|mesh-ancestor
43799193|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799194|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
43799195|NCT05010356|Insulin|insulin|mesh-list
43799196|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43799197|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799198|NCT05009953|Leucovorin|leucovorin|mesh-list
43799199|NCT05009953|Fluorouracil|fluorouracil|mesh-list
43811220|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43811222|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811224|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811225|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811227|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43811228|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43811229|NCT04847895|Growth Substances|growth substances|mesh-ancestor
43811230|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811231|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
43844284|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43799266|NCT05008666|Azacitidine|azacitidine|mesh-list
43799352|NCT05007587|Antidotes|antidotes|mesh-ancestor
43799353|NCT05007587|Protective Agents|protective agents|mesh-ancestor
43799354|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
43799355|NCT05007587|Vitamins|vitamins|mesh-ancestor
43799356|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
43799357|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43799358|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799359|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43799360|NCT05007860|Vaccines|vaccines|mesh-list
43799361|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
43799362|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799363|NCT05007340|Dimercaprol|dimercaprol|mesh-list
43799364|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
43799365|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
43799367|NCT05006911|Bromfenac|bromfenac|mesh-list
43811239|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
43811267|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811268|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811269|NCT04847024|Analgesics|analgesics|mesh-ancestor
43811270|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
43811271|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811272|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811273|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811274|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811275|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43811276|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43811277|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811278|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811279|NCT04847245|Pregabalin|pregabalin|mesh-list
43799419|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43799420|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
43799421|NCT05006898|Miotics|miotics|mesh-ancestor
43799422|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43799423|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43799424|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
43799425|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
43799426|NCT05006846|Narcotics|narcotics|mesh-ancestor
43717039|NCT02650479|Palonosetron|palonosetron|mesh-list
43717040|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43799427|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799428|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799429|NCT05006846|Analgesics|analgesics|mesh-ancestor
43799430|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
43799431|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811287|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43811288|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811322|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43811323|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811325|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799468|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
43799469|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799470|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43799471|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43799472|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
43799473|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799474|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799475|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43717068|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717069|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799481|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
43811342|NCT04846634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811343|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811344|NCT04846634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811345|NCT04846634|Immunologic Factors|immunologic factors|mesh-ancestor
43811346|NCT04846634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811347|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43811348|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43811349|NCT04846452|Paclitaxel|paclitaxel|mesh-list
43811350|NCT04846452|Cisplatin|cisplatin|mesh-list
43811351|NCT04846452|Carboplatin|carboplatin|mesh-list
43811352|NCT04846452|Pemetrexed|pemetrexed|mesh-list
43811353|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43811354|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811355|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
43811356|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
43811357|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
43811358|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811359|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811360|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43811361|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43717070|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43717071|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717072|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717073|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43717074|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43717075|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43717076|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
43717104|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
43717105|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717106|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717108|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43811362|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43811363|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43811364|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811365|NCT04846335|Doxycycline|doxycycline|mesh-list
43811366|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811369|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43811370|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43844286|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43844287|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43844288|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
43844289|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
43844290|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
43844291|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
43844292|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844293|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844294|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
43844295|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
43844296|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43844297|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43844298|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43844299|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844300|NCT04387942|Aldesleukin|aldesleukin|mesh-list
43844301|NCT04387942|Interleukin-2|interleukin-2|mesh-list
43844302|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811393|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811394|NCT04845646|Itraconazole|itraconazole|mesh-list
43811395|NCT04845646|Phenytoin|phenytoin|mesh-list
43811396|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
43811397|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811398|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43811399|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43654976|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
43654977|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654978|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43654979|NCT02972333|Osimertinib|osimertinib|mesh-list
43811401|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811402|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43811403|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
43811404|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811405|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811406|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43811407|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
43717114|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
43717115|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
43717116|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717117|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811408|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43811409|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43811410|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811411|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43811412|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43811413|NCT04845399|Factor VIII|factor viii|mesh-list
43811414|NCT04845399|Coagulants|coagulants|mesh-ancestor
43811415|NCT04844996|Ezetimibe|ezetimibe|mesh-list
43811416|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43811417|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43811418|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
43799647|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799648|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811419|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811420|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43811421|NCT04845061|Nebivolol|nebivolol|mesh-list
43811422|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43811423|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811424|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43811425|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43811426|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43811427|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
43811428|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811466|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
43811467|NCT04843553|Vitamins|vitamins|mesh-ancestor
43811468|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
43811501|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811502|NCT04843280|Coal Tar|coal tar|mesh-list
43811503|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
43811504|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
43811505|NCT04843098|Paclitaxel|paclitaxel|mesh-list
43811506|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43844348|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
43844349|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844350|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844351|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
43844352|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844353|NCT04385940|Vitamin D|vitamin d|mesh-list
43799649|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
43799650|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43799651|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43799652|NCT05003765|Narcotics|narcotics|mesh-ancestor
43799653|NCT05003765|Analgesics|analgesics|mesh-ancestor
43799654|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43799655|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43799656|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
43799657|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43799658|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43799659|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799660|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43799661|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
43799662|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43799663|NCT05003752|Goserelin|goserelin|mesh-list
43799664|NCT05003752|Androgens|androgens|mesh-list
43799665|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799666|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799667|NCT05003752|Hormones|hormones|mesh-ancestor
43799668|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844354|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
43844355|NCT04385940|Vitamins|vitamins|mesh-ancestor
43844356|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
43844357|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811540|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811541|NCT04842487|Prednisone|prednisone|mesh-list
43811542|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
43811543|NCT04842487|Rituximab|rituximab|mesh-list
43811544|NCT04842487|Vincristine|vincristine|mesh-list
43811545|NCT04842487|Lenalidomide|lenalidomide|mesh-list
43811546|NCT04842487|Doxorubicin|doxorubicin|mesh-list
43799698|NCT05003596|Protective Agents|protective agents|mesh-ancestor
43799699|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43799700|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799701|NCT05003596|Analgesics|analgesics|mesh-ancestor
43799702|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
43799703|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43799704|NCT05003700|Lenvatinib|lenvatinib|mesh-list
43799709|NCT05002725|Lidocaine|lidocaine|mesh-list
43811547|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43811548|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811549|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
43811550|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811551|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811582|NCT04842526|Irinotecan|irinotecan|mesh-list
43811583|NCT04842526|Temozolomide|temozolomide|mesh-list
43811584|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43811585|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799735|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799736|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43799737|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
43799738|NCT05002517|Hormones|hormones|mesh-ancestor
43799739|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43799740|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43811587|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654982|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654983|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654984|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43654985|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43654987|NCT02972346|Hormones|hormones|mesh-ancestor
43654988|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43654989|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43654990|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717163|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43654991|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654992|NCT02972411|Acetazolamide|acetazolamide|mesh-list
43654993|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
43654994|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43811588|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799809|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799810|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43799811|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43799812|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43799813|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799814|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799815|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43799816|NCT05001529|Antibodies|antibodies|mesh-list
43799817|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
43799818|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799819|NCT05001243|Bromfenac|bromfenac|mesh-list
43799820|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43799821|NCT05001243|Phenylephrine|phenylephrine|mesh-list
43799822|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
43799823|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
43799824|NCT05001243|Pilocarpine|pilocarpine|mesh-list
43799825|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43799826|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
43799827|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43799828|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
43799829|NCT05001243|Protective Agents|protective agents|mesh-ancestor
43811589|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43811590|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
43811591|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
43811592|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43811593|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
43811594|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811622|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811623|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
43811624|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43842160|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43799867|NCT05001074|Tacrolimus|tacrolimus|mesh-list
43811625|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
43811626|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811627|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811628|NCT04841018|Dexamethasone|dexamethasone|mesh-list
43811629|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
43811630|NCT04841018|BB 1101|bb 1101|mesh-list
43811631|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811632|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
43811633|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
43811634|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811635|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811636|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43811637|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
43811638|NCT04841018|Hormones|hormones|mesh-ancestor
43811639|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811640|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43811641|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43799992|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43799993|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43799994|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43799995|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43799996|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43799997|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43799998|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
43799999|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717195|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717196|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717197|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43717198|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
43717199|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43717200|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43717201|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43717202|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43717203|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43717204|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
43717205|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811716|NCT04839549|Fluorometholone|fluorometholone|mesh-list
43811717|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811718|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811719|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
43811721|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811722|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43654995|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43654996|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43654997|NCT02972411|Diuretics|diuretics|mesh-ancestor
43654998|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
43654999|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655000|NCT02972268|Tamsulosin|tamsulosin|mesh-list
43811723|NCT04839627|Progesterone|progesterone|mesh-list
43811724|NCT04839627|Progestins|progestins|mesh-ancestor
43811725|NCT04839627|Hormones|hormones|mesh-ancestor
43811726|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43811796|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
43811797|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43811798|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
43811799|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
43811800|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811801|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811802|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
43811803|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43811804|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
43811805|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
43811806|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43811836|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
43811837|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717229|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43717230|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
43717231|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717232|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717234|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43717246|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43717247|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717248|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
43717249|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717250|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717251|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717252|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717257|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43717258|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43717259|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
43717260|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717261|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717262|NCT02648854|Metformin|metformin|mesh-list
43717263|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43717264|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717265|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
43811838|NCT04837664|Nystatin|nystatin|mesh-list
43811839|NCT04837664|Curcumin|curcumin|mesh-list
43811840|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43811841|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43811842|NCT04837664|Analgesics|analgesics|mesh-ancestor
43811843|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
43811844|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43811845|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811846|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811847|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811848|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811849|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43811850|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811851|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43811852|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43811876|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43811878|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811879|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
43844365|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844366|NCT04385277|Vitamin A|vitamin a|mesh-list
43844367|NCT04385277|Irinotecan|irinotecan|mesh-list
43844368|NCT04385277|Temozolomide|temozolomide|mesh-list
43844369|NCT04385277|Tretinoin|tretinoin|mesh-list
43844370|NCT04385277|Dinutuximab|dinutuximab|mesh-list
43844371|NCT04385277|Isotretinoin|isotretinoin|mesh-list
43844372|NCT04385277|Sargramostim|sargramostim|mesh-list
43844373|NCT04385277|Vitamins|vitamins|mesh-ancestor
43844374|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
43844375|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844376|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43800055|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43800056|NCT04997837|Capecitabine|capecitabine|mesh-list
43800057|NCT04997837|Tegafur|tegafur|mesh-list
43800058|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
43800059|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43800060|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43800061|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
43800062|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800063|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717266|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43717267|NCT02649075|Antibodies|antibodies|mesh-list
43800064|NCT04997707|Propofol|propofol|mesh-list
43800065|NCT04997707|Sevoflurane|sevoflurane|mesh-list
43800066|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43800067|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800068|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800069|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43800070|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
43800071|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
43844377|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43844378|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844379|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844380|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655001|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
43655002|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43655003|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43655004|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43655005|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655006|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655007|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842176|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
43842177|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842178|NCT04547842|Dexamethasone|dexamethasone|mesh-list
43842179|NCT04547842|Mirtazapine|mirtazapine|mesh-list
43842180|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43842181|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
43842182|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
43842183|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842184|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844385|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
43844387|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
43844388|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844389|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844390|NCT04383743|Cisplatin|cisplatin|mesh-list
43844391|NCT04383743|Doxorubicin|doxorubicin|mesh-list
43811884|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43811886|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
43811887|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43811889|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811890|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43811891|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43811892|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
43811893|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43811894|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43811895|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43655018|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
43655019|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800218|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43800219|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43800220|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800221|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800222|NCT04994860|Urological Agents|urological agents|mesh-ancestor
43800224|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800225|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800226|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
43800227|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800228|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800229|NCT04994743|Cortisone|cortisone|mesh-list
43800230|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43811959|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43811960|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
43811961|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811962|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43811963|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43811964|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
43842215|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43811965|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811966|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43811967|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43811968|NCT04836078|Chitosan|chitosan|mesh-list
43811969|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43811970|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43811971|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
43811972|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43811973|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43811974|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
43812012|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812031|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812032|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812034|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812036|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
43812037|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812038|NCT04835259|Protective Agents|protective agents|mesh-ancestor
43812039|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812040|NCT04835259|Trace Elements|trace elements|mesh-ancestor
43812041|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
43812042|NCT04835233|Methyldopa|methyldopa|mesh-list
43848586|NCT04007393|Topiramate|topiramate|mesh-list
43812043|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43624338|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812044|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
43812045|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
43812046|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812047|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812048|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43812049|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43800559|NCT04988932|Protective Agents|protective agents|mesh-ancestor
43800561|NCT04989348|Progestins|progestins|mesh-list
43800562|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
43800563|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800564|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800565|NCT04988776|Bupivacaine|bupivacaine|mesh-list
43800566|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
43800567|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
43812050|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43812051|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
43812052|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812053|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812055|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812056|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812057|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812058|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812059|NCT04835064|Gemcitabine|gemcitabine|mesh-list
43812060|NCT04835064|Paclitaxel|paclitaxel|mesh-list
43812061|NCT04835064|Folfirinox|folfirinox|mesh-list
43812062|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43655020|NCT02972255|Meropenem|meropenem|mesh-list
43655021|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43655022|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655023|NCT02971930|Factor VIII|factor viii|mesh-list
43800586|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800588|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43800589|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800590|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800591|NCT04988646|Acyclovir|acyclovir|mesh-list
43800592|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
43800593|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800594|NCT04988191|Bevacizumab|bevacizumab|mesh-list
43800595|NCT04988191|Irinotecan|irinotecan|mesh-list
43800596|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43800597|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800598|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43655024|NCT02971930|Coagulants|coagulants|mesh-ancestor
43655025|NCT02971982|Dexamethasone|dexamethasone|mesh-list
43655026|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
43655027|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
43655029|NCT02971982|Bortezomib|bortezomib|mesh-list
43655030|NCT02971982|BB 1101|bb 1101|mesh-list
43655031|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812063|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812064|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
43812065|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
43812066|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
43812067|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800599|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43800600|NCT04988191|Growth Substances|growth substances|mesh-ancestor
43800601|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800602|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
43800603|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43800604|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43800605|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800606|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842224|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43842225|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842226|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
43842227|NCT04543227|Narcotics|narcotics|mesh-ancestor
43842228|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842229|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842230|NCT04543227|Analgesics|analgesics|mesh-ancestor
43842231|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
43842232|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43842233|NCT04542993|Zinc|zinc|mesh-list
43842234|NCT04542993|Resveratrol|resveratrol|mesh-list
43842235|NCT04542993|Picolinic acid|picolinic acid|mesh-list
43842236|NCT04542993|Trace Elements|trace elements|mesh-ancestor
43842237|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
43842238|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842239|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
43842240|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842241|NCT04542993|Protective Agents|protective agents|mesh-ancestor
43842242|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842243|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43842244|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43842245|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
43842246|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
43842248|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
43842249|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842250|NCT04540861|Siponimod|siponimod|mesh-list
43842251|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43842252|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842253|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842254|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
43554529|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43554530|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
43554531|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842255|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842256|NCT04540744|Tadalafil|tadalafil|mesh-list
43842257|NCT04540744|Macitentan|macitentan|mesh-list
43842258|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842259|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43842260|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43842261|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842262|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842263|NCT04540744|Urological Agents|urological agents|mesh-ancestor
43842264|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43842265|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43842266|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43842267|NCT04540120|Dapansutrile|dapansutrile|mesh-list
43812126|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
43812127|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43800609|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800610|NCT04987632|Letrozole|letrozole|mesh-list
43800611|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800612|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43800613|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43800614|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800615|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800616|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43800617|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
43800618|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800619|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800620|NCT04987450|Prednisone|prednisone|mesh-list
43800621|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
43800622|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43800623|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43554561|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43554562|NCT03571230|Antacids|antacids|mesh-ancestor
43554563|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554564|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43554565|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43554566|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43554567|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
43554568|NCT03571126|Olanzapine|olanzapine|mesh-list
43554569|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
43554570|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
43554571|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554572|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554573|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554574|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43554575|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43554576|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554577|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43554578|NCT03571126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43554579|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43554580|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43554582|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800624|NCT04987450|Prednisolone|prednisolone|mesh-list
43800625|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
43800626|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43800723|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43800740|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
43842321|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43842323|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842324|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
43842325|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43842326|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43842327|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812136|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
43812137|NCT04834752|Famotidine|famotidine|mesh-list
43812138|NCT04834752|Ranitidine|ranitidine|mesh-list
43812139|NCT04834752|Cimetidine|cimetidine|mesh-list
43812140|NCT04834752|Nizatidine|nizatidine|mesh-list
43812141|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43812142|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812143|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43812144|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812145|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842338|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43842339|NCT04539327|Rucaparib|rucaparib|mesh-list
43842340|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43842341|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842342|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800754|NCT04985201|Simvastatin|simvastatin|mesh-list
43800755|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43800756|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43554583|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
43554584|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
43717337|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
43717338|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717339|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717340|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43717341|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
43717343|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
43717344|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43717345|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43717346|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
43717347|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717348|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717349|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43717350|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43717351|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43832301|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832302|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43832303|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43832304|NCT05272969|Vitamin D|vitamin d|mesh-list
43832305|NCT05272969|Calcium|calcium|mesh-list
43800773|NCT04984408|Vaccines|vaccines|mesh-list
43812147|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
43812148|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
43812149|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43812150|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844429|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844430|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844431|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844432|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
43844433|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844434|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
43844435|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844436|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844437|NCT04381143|Aspirin|aspirin|mesh-list
43844438|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844439|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844440|NCT04381143|Analgesics|analgesics|mesh-ancestor
43844441|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
43844442|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844443|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800818|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43800819|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43800820|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43800822|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
43800823|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43800824|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800825|NCT04983160|Allopurinol|allopurinol|mesh-list
43800826|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
43800827|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800828|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800829|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
43800830|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43800831|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43800832|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
43800833|NCT04983160|Protective Agents|protective agents|mesh-ancestor
43800834|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800835|NCT04982861|Cefixime|cefixime|mesh-list
43844444|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844445|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844446|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844447|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43844448|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844449|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844450|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43832310|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43832311|NCT05272605|Vaccines|vaccines|mesh-list
43832312|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
43844451|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655037|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655038|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844452|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
43844453|NCT04380545|Interferons|interferons|mesh-list
43844454|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
43844455|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
43844456|NCT04380545|Fluorouracil|fluorouracil|mesh-list
43800836|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43800837|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43800838|NCT04982874|Furosemide|furosemide|mesh-list
43800839|NCT04982874|Diuretics|diuretics|mesh-ancestor
43800845|NCT04982809|Dexamethasone|dexamethasone|mesh-list
43844459|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844460|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43812190|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43812191|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812192|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
43812193|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812194|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812195|NCT04834115|Ivermectin|ivermectin|mesh-list
43812196|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43812197|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812198|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
43800880|NCT05635929|Betaine|betaine|mesh-list
43812199|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43812200|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812201|NCT04833738|Triamcinolone|triamcinolone|mesh-list
43812202|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43812203|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43812204|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
43812205|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43812206|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812210|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812211|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43812213|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812214|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812215|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43800927|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
43800928|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43800929|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43800930|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43800931|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43800932|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43800933|NCT05635370|Protective Agents|protective agents|mesh-ancestor
43800934|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800935|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
43800936|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43800937|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
43800938|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43800939|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
43800940|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800941|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43800942|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
43800943|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43800944|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43812216|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
43812217|NCT04833738|Protective Agents|protective agents|mesh-ancestor
43812219|NCT04833777|Bupivacaine|bupivacaine|mesh-list
43812220|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
43812221|NCT04833777|Anesthetics|anesthetics|mesh-list
43812222|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812223|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812224|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
43812225|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832331|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
43812226|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43812227|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43812228|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43812229|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43812230|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812231|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
43800969|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43800970|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
43800971|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
43800972|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43800973|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43800974|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43800975|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
43800976|NCT05635227|Hormones|hormones|mesh-ancestor
43800977|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43800978|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43800979|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43800980|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43800981|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43812232|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812233|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812234|NCT04833218|Propranolol|propranolol|mesh-list
43812235|NCT04833218|Clonidine|clonidine|mesh-list
43812236|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43812237|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43812238|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
43812240|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812241|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812242|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43812243|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43812244|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
43812245|NCT04833218|Analgesics|analgesics|mesh-ancestor
43812246|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
43812247|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812248|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
43812249|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
43812250|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43812251|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43801062|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
43801063|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801064|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801065|NCT05629494|Ibuprofen|ibuprofen|mesh-list
43801066|NCT05629494|Naproxen|naproxen|mesh-list
43801067|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43801068|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43801069|NCT05629494|Analgesics|analgesics|mesh-ancestor
43801070|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
43801071|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655039|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43655040|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43655041|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812252|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43812253|NCT04833374|Prednisone|prednisone|mesh-list
43812254|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
43812255|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43812256|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43812257|NCT04833374|Prednisolone|prednisolone|mesh-list
43812258|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
43812259|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43812260|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
43812261|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832342|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43812262|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
43812263|NCT04833374|Hormones|hormones|mesh-ancestor
43812264|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812265|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812266|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43812267|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812268|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
43812269|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
43812270|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812271|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43812272|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43812273|NCT04833374|Protective Agents|protective agents|mesh-ancestor
43812274|NCT04833101|Vaccines|vaccines|mesh-list
43812275|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
43812276|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812277|NCT04833036|Irinotecan|irinotecan|mesh-list
43812278|NCT04833036|Cetuximab|cetuximab|mesh-list
43812310|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43624642|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
43812311|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
43812312|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812313|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
43812314|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812315|NCT04832945|Ivermectin|ivermectin|mesh-list
43812316|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43812317|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801151|NCT05491278|Narcotics|narcotics|mesh-ancestor
43801152|NCT05491278|Analgesics|analgesics|mesh-ancestor
43801153|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
43801154|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801155|NCT05487092|Letrozole|letrozole|mesh-list
43801156|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801157|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43801158|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43801159|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801160|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801161|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43801162|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
43801163|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801164|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801165|NCT05485831|Cannabidiol|cannabidiol|mesh-list
43801166|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
43801167|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
43801168|NCT05478278|Psilocybin|psilocybin|mesh-list
43801169|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43801170|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801171|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43801172|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43801173|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849035|NCT03970720|Metoclopramide|metoclopramide|mesh-list
43801174|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801175|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801176|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844485|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43812338|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812340|NCT04831528|Trastuzumab|trastuzumab|mesh-list
43812342|NCT04831528|Pertuzumab|pertuzumab|mesh-list
43812343|NCT04831528|Lapatinib|lapatinib|mesh-list
43801190|NCT05459402|Methadone|methadone|mesh-list
43801191|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43801192|NCT05459402|Narcotics|narcotics|mesh-ancestor
43801193|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43801194|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801195|NCT05459402|Analgesics|analgesics|mesh-ancestor
43554609|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554610|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554611|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43554612|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
43801196|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
43801197|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801198|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
43801199|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
43801209|NCT05458479|Fluoxetine|fluoxetine|mesh-list
43812415|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
43801240|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801241|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43801242|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801243|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
43801244|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801245|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801246|NCT05438043|Growth Substances|growth substances|mesh-ancestor
43801247|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801249|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43801250|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
43655053|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
43655054|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43812423|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43812424|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43812425|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43812426|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43554618|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554619|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554621|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
43554622|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43832345|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832346|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43832347|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43832348|NCT05271084|Protective Agents|protective agents|mesh-ancestor
43832349|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
43832350|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43832351|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
43847462|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43847463|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43847464|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
43847465|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43847466|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43847467|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43812427|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
43812429|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
43812430|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
43812431|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801318|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43812468|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812469|NCT04829019|Osimertinib|osimertinib|mesh-list
43812470|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812471|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655055|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43655056|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43812472|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812473|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812475|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43812476|NCT04828824|Norgestimate|norgestimate|mesh-list
43554628|NCT03570541|Acetaminophen|acetaminophen|mesh-list
43554629|NCT03570541|Morphine|morphine|mesh-list
43554630|NCT03570541|Ropivacaine|ropivacaine|mesh-list
43554631|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43554632|NCT03570541|Narcotics|narcotics|mesh-ancestor
43554633|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554634|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554636|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
43554637|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554638|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
43554639|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
43554640|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43554641|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
43554642|NCT03570346|Hemay005|hemay005|mesh-list
43554643|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
43554644|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43554645|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43554646|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812477|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
43812478|NCT04828824|Estradiol|estradiol|mesh-list
43812479|NCT04828824|Estrogens|estrogens|mesh-ancestor
43812480|NCT04828824|Hormones|hormones|mesh-ancestor
43812481|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812482|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812483|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43812484|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
43812485|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43812486|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43812487|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43812488|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43842464|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43812489|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43812490|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43812491|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812492|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43812493|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43812494|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812495|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812496|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812497|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43844513|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844514|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844515|NCT04370483|Leflunomide|leflunomide|mesh-list
43844516|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844517|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844518|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844519|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
43844520|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848771|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554688|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554689|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
43554690|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554691|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43554692|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43554694|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43554695|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43554696|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
43554698|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
43848772|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848773|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848774|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848775|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848776|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43848777|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
43848778|NCT03997370|Carboplatin|carboplatin|mesh-list
43848779|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848780|NCT03997266|Gentamicins|gentamicins|mesh-list
43848781|NCT03997266|Ampicillin|ampicillin|mesh-list
43848782|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43848783|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848784|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43848785|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848786|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848787|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
43848788|NCT03993353|Tadalafil|tadalafil|mesh-list
43848789|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812530|NCT04827966|Caseins|caseins|mesh-list
43801344|NCT05284214|Ipilimumab|ipilimumab|mesh-list
43801345|NCT05284214|Sargramostim|sargramostim|mesh-list
43801346|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801348|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43801349|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801350|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
43801351|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801353|NCT05268744|Trace Elements|trace elements|mesh-list
43801354|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801355|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43801359|NCT05253131|Durvalumab|durvalumab|mesh-list
43812531|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43812532|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812533|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43812534|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
43812535|NCT04827966|Protective Agents|protective agents|mesh-ancestor
43812536|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43812537|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554723|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554725|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43554726|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43554727|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
43554728|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43554729|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43554730|NCT03569540|Glyburide|glyburide|mesh-list
43554731|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43554732|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554733|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
43554734|NCT03569046|Bupivacaine|bupivacaine|mesh-list
43554735|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
43554736|NCT03569046|Anesthetics|anesthetics|mesh-list
43554737|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
43554738|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812538|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
43812539|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
43812540|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43624994|NCT00977691|Sirolimus|sirolimus|mesh-list
43812572|NCT04826822|Dexamethasone|dexamethasone|mesh-list
43812573|NCT04826822|Spironolactone|spironolactone|mesh-list
43812574|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43812575|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
43812576|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
43801410|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43801414|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
43655057|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655059|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
43655060|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
43655063|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812577|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812580|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
43812581|NCT04826822|Hormones|hormones|mesh-ancestor
43812582|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812583|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43812584|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812585|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43812621|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43812622|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43812623|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43812679|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
43812680|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812681|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43812682|NCT04824586|Insulin|insulin|mesh-list
43812683|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43812684|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43812717|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812718|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812719|NCT04824352|Apatinib|apatinib|mesh-list
43812720|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812721|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812722|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812723|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812724|NCT04824404|Buprenorphine|buprenorphine|mesh-list
43812742|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43812743|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
43812744|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812745|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812746|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43812747|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43812749|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
43801488|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801489|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
43801490|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
43801491|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43801492|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43801493|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801494|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43801495|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
43717372|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
43717373|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
43717374|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43717375|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
43717376|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717377|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812782|NCT04823260|Vitamins|vitamins|mesh-ancestor
43812783|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
43812784|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812785|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43812786|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
43812787|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812788|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43812789|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
43812790|NCT04822909|Thalidomide|thalidomide|mesh-list
43812791|NCT04822909|Apremilast|apremilast|mesh-list
43812792|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43812793|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43812794|NCT04822909|Analgesics|analgesics|mesh-ancestor
43812795|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
43812809|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43812810|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43812811|NCT04822909|Growth Substances|growth substances|mesh-ancestor
43812812|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801572|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43801573|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
43801574|NCT04782687|Hormones|hormones|mesh-ancestor
43801575|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43801576|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43844573|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844575|NCT04361162|Ipilimumab|ipilimumab|mesh-list
43655064|NCT02971878|Protective Agents|protective agents|mesh-ancestor
43655065|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655066|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
43655068|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
43844576|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844577|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844578|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844579|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844580|NCT04360889|Tocopherols|tocopherols|mesh-list
43844581|NCT04360889|Vitamin E|vitamin e|mesh-list
43844582|NCT04360889|Tocotrienols|tocotrienols|mesh-list
43844583|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
43844584|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
43717385|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
43717386|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
43717391|NCT02648633|Nivolumab|nivolumab|mesh-list
43844597|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
43844598|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43844599|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
43844600|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844601|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844602|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43844603|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
43844604|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43844605|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
43844606|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844607|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43844608|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43844609|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
43844610|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
43844611|NCT04358588|Protective Agents|protective agents|mesh-ancestor
43844612|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
43844613|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43812853|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
43812854|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43812855|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43812856|NCT04822012|Antibodies|antibodies|mesh-list
43812857|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
43812858|NCT04822012|Progesterone|progesterone|mesh-list
43812859|NCT04822012|Estrogens|estrogens|mesh-list
43842490|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43842491|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43812860|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
43812861|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812862|NCT04822012|Progestins|progestins|mesh-ancestor
43812863|NCT04822012|Hormones|hormones|mesh-ancestor
43812864|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43812865|NCT04822038|Vitamin D|vitamin d|mesh-list
43812866|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
43655069|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
43655070|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
43554746|NCT03568968|Vitamins|vitamins|mesh-ancestor
43655071|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655072|NCT02971878|Expectorants|expectorants|mesh-ancestor
43655073|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655074|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43655075|NCT02971878|Antidotes|antidotes|mesh-ancestor
43655076|NCT02971644|Cobalt|cobalt|mesh-list
43655077|NCT02971644|Trace Elements|trace elements|mesh-ancestor
43655078|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
43655079|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655080|NCT02971475|Analgesics|analgesics|mesh-list
43812867|NCT04822038|Vitamins|vitamins|mesh-ancestor
43812868|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
43812869|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812870|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43812871|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43812872|NCT04821947|Bupivacaine|bupivacaine|mesh-list
43812873|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
43812874|NCT04821947|Anesthetics|anesthetics|mesh-list
43812875|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43812912|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43812913|NCT04821323|Diuretics|diuretics|mesh-ancestor
43812914|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
43812915|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812916|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43812917|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43812918|NCT04821323|Analgesics|analgesics|mesh-ancestor
43842521|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43842522|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801612|NCT04680052|Rituximab|rituximab|mesh-list
43801613|NCT04680052|Lenalidomide|lenalidomide|mesh-list
43801614|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801647|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43812919|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
43812920|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43812948|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43812949|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812950|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812951|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812952|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43812953|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
43812954|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43812955|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43812956|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43812957|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43812958|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43801791|NCT04179162|Antiviral Agents|antiviral agents|mesh-ancestor
43801792|NCT04179162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43801793|NCT04179162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43801794|NCT04179162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43801795|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
43801796|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801797|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43801818|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
43801819|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43812959|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43812960|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
43812961|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43812962|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43812963|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813030|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813031|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813032|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813033|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43844642|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43717444|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844643|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
43717451|NCT02647671|Antacids|antacids|mesh-ancestor
43844644|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43844645|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
43844646|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43801880|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801881|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43801900|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801901|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43801902|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43801903|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
43801904|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43801905|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801967|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43801968|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801969|NCT03778957|Bevacizumab|bevacizumab|mesh-list
43801970|NCT03778957|Durvalumab|durvalumab|mesh-list
43801971|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43801972|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43801973|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43801974|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43801975|NCT03778957|Growth Substances|growth substances|mesh-ancestor
43801976|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801977|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
43801978|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43801979|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43801980|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
43801981|NCT03726749|Prednisone|prednisone|mesh-list
43801982|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
43801983|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43801984|NCT03726749|Hormones|hormones|mesh-ancestor
43813107|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43813108|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813109|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813110|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813111|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43813116|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813117|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43813118|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43813119|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43813120|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
43813121|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813122|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43813123|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43813125|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43612301|NCT03166787|Antidotes|antidotes|mesh-ancestor
43801987|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43801988|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813126|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813128|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
43813129|NCT04817982|Lidocaine|lidocaine|mesh-list
43813130|NCT04817982|BB 1101|bb 1101|mesh-list
43813131|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813132|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
43813133|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
43813134|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813135|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813136|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813137|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
43813138|NCT04817982|Hormones|hormones|mesh-ancestor
43813139|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813140|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43813141|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813142|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813143|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813144|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813145|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
43813146|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
43813147|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813148|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
43813149|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43801990|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43801991|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43801992|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801993|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
43801994|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43801995|NCT03647774|Naltrexone|naltrexone|mesh-list
43801996|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43717474|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
43801997|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43801998|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43801999|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
43802000|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802001|NCT03617718|Glycine|glycine|mesh-list
43802002|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
43802003|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802004|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802005|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802006|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43813151|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43813152|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813153|NCT04818099|Vortioxetine|vortioxetine|mesh-list
43813154|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
43813155|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43813156|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43813157|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813158|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813159|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813160|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43813161|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43813162|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43813163|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655083|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655084|NCT02971696|Sorafenib|sorafenib|mesh-list
43655085|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655086|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655087|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655088|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655089|NCT02971423|Imipenem|imipenem|mesh-list
43655090|NCT02971423|Sulbactam|sulbactam|mesh-list
43655091|NCT02971423|Cilastatin|cilastatin|mesh-list
43813164|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813165|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
43813166|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43813167|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43813168|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43813169|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43813170|NCT04818151|Warfarin|warfarin|mesh-list
43813171|NCT04818151|Apixaban|apixaban|mesh-list
43813172|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
43813173|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43813174|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
43813175|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43813176|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813177|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813178|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813179|NCT04817800|Azelastine|azelastine|mesh-list
43813180|NCT04817800|Beclomethasone|beclomethasone|mesh-list
43813181|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844677|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844679|NCT04354428|Protective Agents|protective agents|mesh-ancestor
43844680|NCT04352439|Aspirin|aspirin|mesh-list
43844681|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844682|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813324|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813325|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813326|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43813327|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43813328|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813330|NCT04815200|Nickel|nickel|mesh-list
43813331|NCT04815200|Trace Elements|trace elements|mesh-ancestor
43802069|NCT03337698|Evolocumab|evolocumab|mesh-list
43802070|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802071|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802072|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43802073|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43802074|NCT03337698|Growth Substances|growth substances|mesh-ancestor
43802075|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802076|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
43802077|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802078|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
43802079|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802080|NCT03337698|Antiviral Agents|antiviral agents|mesh-ancestor
43802081|NCT03337698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802082|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802083|NCT03337698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802084|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
43802085|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802086|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802092|NCT03337698|Hormones|hormones|mesh-ancestor
43813387|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43813388|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554837|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
43813389|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813390|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
43813392|NCT04814381|Analgesics|analgesics|mesh-ancestor
43813393|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
43802116|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
43802117|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43802118|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43802119|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43802120|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
43802121|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43802122|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
43802123|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
43802124|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
43802125|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43802126|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
43802127|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43802128|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43802129|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813394|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813395|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717511|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43717512|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
43717513|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43717514|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
43717515|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
43717516|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717517|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717518|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717519|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
43717521|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717522|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43717523|NCT02647255|Protective Agents|protective agents|mesh-ancestor
43717524|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43717525|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717526|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
43717527|NCT02647268|Oxytocin|oxytocin|mesh-list
43717528|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
43717529|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43717571|NCT02646800|Micafungin|micafungin|mesh-list
43813396|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43813421|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813422|NCT04813848|Fluorides|fluorides|mesh-list
43813423|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
43813424|NCT04813848|Protective Agents|protective agents|mesh-ancestor
43813425|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813426|NCT04813523|Cisplatin|cisplatin|mesh-list
43813427|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
43802165|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802166|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43802167|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43802168|NCT03030378|Growth Substances|growth substances|mesh-ancestor
43802169|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
43802170|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43802171|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43813433|NCT04813471|Atorvastatin|atorvastatin|mesh-list
43813434|NCT04813471|Vitamins|vitamins|mesh-ancestor
43813435|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
43813436|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813437|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43813438|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43813439|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
43813440|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655098|NCT02971410|Simvastatin|simvastatin|mesh-list
43655099|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43655100|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43655101|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
43655102|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802291|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
43802292|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802293|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802294|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
43802295|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802296|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802297|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43802298|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
43717574|NCT02646774|Micafungin|micafungin|mesh-list
43717575|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
43717576|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43717577|NCT02647086|Metoprolol|metoprolol|mesh-list
43717578|NCT02647086|Midazolam|midazolam|mesh-list
43717579|NCT02647086|Caffeine|caffeine|mesh-list
43717580|NCT02647086|Omeprazole|omeprazole|mesh-list
43717581|NCT02647086|Warfarin|warfarin|mesh-list
43717582|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43717583|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43717584|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717585|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717586|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43802299|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802300|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802301|NCT02229149|Paclitaxel|paclitaxel|mesh-list
43802302|NCT02229149|Vinorelbine|vinorelbine|mesh-list
43802303|NCT02229149|Docetaxel|docetaxel|mesh-list
43802304|NCT02229149|Capecitabine|capecitabine|mesh-list
43802305|NCT02229149|Trastuzumab|trastuzumab|mesh-list
43802306|NCT02229149|Pertuzumab|pertuzumab|mesh-list
43802307|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43802308|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802309|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
43802310|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
43802311|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
43802312|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802313|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802314|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
43802315|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43802316|NCT02201992|Crizotinib|crizotinib|mesh-list
43813441|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43813442|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43813443|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813444|NCT04813471|Hematinics|hematinics|mesh-ancestor
43813445|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43813446|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43813447|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
43813477|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
43813478|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813479|NCT04812509|Denosumab|denosumab|mesh-list
43717587|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43717588|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43717589|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43717590|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
43717591|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
43554871|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43554872|NCT03567434|Ethanol|ethanol|mesh-list
43554873|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43554874|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554875|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554876|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554878|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
43554879|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43554883|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
43813480|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43813481|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813482|NCT04811573|Thalidomide|thalidomide|mesh-list
43813483|NCT04811573|Apremilast|apremilast|mesh-list
43813484|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813485|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813486|NCT04811573|Analgesics|analgesics|mesh-ancestor
43813487|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
43813488|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813489|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813490|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813491|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813492|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43802317|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802318|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43802319|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802320|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802321|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
43802322|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802323|NCT01995578|Azacitidine|azacitidine|mesh-list
43802324|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802325|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
43802326|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802327|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802328|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554902|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43554903|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43802329|NCT01750073|Paclitaxel|paclitaxel|mesh-list
43802330|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
43802331|NCT01750073|Doxorubicin|doxorubicin|mesh-list
43802332|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43802333|NCT01750073|Trastuzumab|trastuzumab|mesh-list
43802334|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43554904|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
43554905|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554906|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554907|NCT03567343|Melatonin|melatonin|mesh-list
43554908|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
43554909|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554910|NCT03567343|Protective Agents|protective agents|mesh-ancestor
43554911|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43554912|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43554913|NCT03567304|Rilpivirine|rilpivirine|mesh-list
43554914|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43554915|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43554916|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554917|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802335|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43802336|NCT01750073|Antibodies|antibodies|mesh-list
43813527|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43813528|NCT04811274|Dimercaprol|dimercaprol|mesh-list
43813580|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43813582|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813583|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
43813584|NCT04810754|Daratumumab|daratumumab|mesh-list
43813585|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813586|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43813587|NCT04810507|Anagliptin|anagliptin|mesh-list
43813588|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43802349|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43802350|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
43802351|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43554918|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
43717592|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
43717593|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
43717594|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43717595|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717596|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
43717597|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43717598|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43717599|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43717600|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717601|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43717602|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43554919|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554920|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43554921|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43554922|NCT03567135|Temozolomide|temozolomide|mesh-list
43554923|NCT03567135|Apatinib|apatinib|mesh-list
43554924|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43554925|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
43554926|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554927|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43554928|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43554929|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43554930|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
43554931|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802352|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43802353|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43802354|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43802355|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802356|NCT01697527|Aldesleukin|aldesleukin|mesh-list
43802357|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
43802358|NCT01697527|Fludarabine|fludarabine|mesh-list
43802359|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
43802360|NCT01697527|Interleukin-2|interleukin-2|mesh-list
43813589|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813591|NCT04810507|Hormones|hormones|mesh-ancestor
43813592|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813593|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43813594|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813595|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813596|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813597|NCT04810585|Aflibercept|aflibercept|mesh-list
43813598|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43813599|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43813600|NCT04810585|Growth Substances|growth substances|mesh-ancestor
43813601|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813602|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
43813603|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813604|NCT04809818|Aspirin|aspirin|mesh-list
43813605|NCT04809818|Dabigatran|dabigatran|mesh-list
43813606|NCT04809818|Apixaban|apixaban|mesh-list
43813610|NCT04809818|Analgesics|analgesics|mesh-ancestor
43813611|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
43813612|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813613|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802423|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
43802424|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43802425|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43802426|NCT00382070|Letrozole|letrozole|mesh-list
43813621|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655103|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43655104|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43554932|NCT03566914|Tadalafil|tadalafil|mesh-list
43554933|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
43717603|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43717604|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43717605|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
43717606|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43717607|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43717608|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
43717609|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
43717610|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717611|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43717612|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43717613|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43717614|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
43717615|NCT02646904|Beclomethasone|beclomethasone|mesh-list
43554935|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43554937|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554938|NCT03566914|Urological Agents|urological agents|mesh-ancestor
43655105|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655107|NCT02971540|Tramadol|tramadol|mesh-list
43655108|NCT02971540|Bupivacaine|bupivacaine|mesh-list
43655109|NCT02971540|Ropivacaine|ropivacaine|mesh-list
43655110|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
43655111|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
43655112|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655113|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655114|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
43655115|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813622|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
43802482|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43802483|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43802484|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802485|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43802486|NCT04981951|Analgesics|analgesics|mesh-ancestor
43802487|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
43802488|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802489|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43802490|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43802491|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43802492|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
43802493|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802494|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802495|NCT04981886|Bimatoprost|bimatoprost|mesh-list
43813636|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813637|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813638|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
43813639|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813640|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
43655117|NCT02971540|Narcotics|narcotics|mesh-ancestor
43655118|NCT02971540|Analgesics|analgesics|mesh-ancestor
43655119|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43655120|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43655121|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655122|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655123|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
43655124|NCT02971397|Cytarabine|cytarabine|mesh-list
43655125|NCT02971397|Daunorubicin|daunorubicin|mesh-list
43655126|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43802545|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802546|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43802547|NCT04981704|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43802548|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43655128|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655129|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655130|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
43655131|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43554950|NCT03566394|Analgesics|analgesics|mesh-ancestor
43554951|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
43554952|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43554953|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655132|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655133|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
43842557|NCT04522622|Protective Agents|protective agents|mesh-ancestor
43842558|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842559|NCT04522622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43842560|NCT04522622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842563|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
43655135|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43655136|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43655137|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43655138|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655139|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
43655140|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43813641|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
43813642|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
43813643|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
43813644|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813645|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43813646|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
43813647|NCT04809649|Itraconazole|itraconazole|mesh-list
43813648|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
43813649|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813712|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
43813713|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813714|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43813715|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43813716|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813717|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813718|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43813719|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
43813720|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813721|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813722|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43844745|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
43844746|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844747|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43848792|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43848793|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43848795|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848796|NCT03993353|Urological Agents|urological agents|mesh-ancestor
43848797|NCT03993262|Bortezomib|bortezomib|mesh-list
43848798|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848799|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848800|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
43848801|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848802|NCT03992196|Rotigotine|rotigotine|mesh-list
43848803|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
43848804|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
43848805|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848806|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554974|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43717623|NCT02646709|Ketamine|ketamine|mesh-list
43848807|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848808|NCT03992131|Rucaparib|rucaparib|mesh-list
43848809|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43848810|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848811|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802682|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
43802683|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802684|NCT04979923|Lidocaine|lidocaine|mesh-list
43802685|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
43802686|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
43802687|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43802688|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802689|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
43802690|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802691|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43802692|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43802693|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43802694|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43802695|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802696|NCT04979468|Lamivudine|lamivudine|mesh-list
43802697|NCT04979468|Dolutegravir|dolutegravir|mesh-list
43802698|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43802699|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43802700|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802701|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848812|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848813|NCT03989362|Ipilimumab|ipilimumab|mesh-list
43848814|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848815|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848816|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43848817|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848818|NCT03989115|Osimertinib|osimertinib|mesh-list
43848819|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848820|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43848821|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848822|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848823|NCT03987711|Warfarin|warfarin|mesh-list
43848824|NCT03987711|Apixaban|apixaban|mesh-list
43848825|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
43848826|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43848827|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
43848828|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43848829|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
43813735|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813736|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813737|NCT04808895|Analgesics|analgesics|mesh-ancestor
43813738|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
43813739|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802725|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43802726|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
43802727|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
43802728|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
43802729|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802730|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43813740|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813741|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813742|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813743|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43554977|NCT03566329|Analgesics|analgesics|mesh-ancestor
43813744|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43813745|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813857|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43813858|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802770|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
43802771|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
43802772|NCT04977778|Protective Agents|protective agents|mesh-ancestor
43802773|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802774|NCT04977674|Naltrexone|naltrexone|mesh-list
43802775|NCT04977674|Ketamine|ketamine|mesh-list
43802776|NCT04977674|Analgesics|analgesics|mesh-ancestor
43802777|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
43802778|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43802779|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802780|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43802781|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43802782|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
43802783|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
43802784|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43802785|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43802786|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43802787|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43802788|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802789|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43802790|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43813859|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813860|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43813861|NCT04807335|Narcotics|narcotics|mesh-ancestor
43813862|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43813863|NCT04807101|Midazolam|midazolam|mesh-list
43717646|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43813864|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43717647|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
43717648|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43717649|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717650|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43717651|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43717652|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717653|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832353|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43832354|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
43832355|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832356|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43832357|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832358|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
43832359|NCT05268510|Olaparib|olaparib|mesh-list
43554990|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43554991|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43813865|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43813866|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813867|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802801|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
43802802|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802803|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
43802804|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43802805|NCT04977661|Protective Agents|protective agents|mesh-ancestor
43802806|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43802807|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43802808|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43802809|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43802810|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
43802811|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43802812|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43802813|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43802814|NCT04977427|Prednisolone|prednisolone|mesh-list
43802815|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43802816|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
43802817|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43717656|NCT02646397|Fosinopril|fosinopril|mesh-list
43802818|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
43802819|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43802820|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
43802821|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43802822|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
43802823|NCT04977427|Hormones|hormones|mesh-ancestor
43802824|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43802825|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802827|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813868|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43655144|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655145|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43655146|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
43655147|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813869|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813870|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43813871|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43813872|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
43802852|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43802853|NCT04977401|Protective Agents|protective agents|mesh-ancestor
43802854|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43802913|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813908|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
43813909|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
43813910|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43813911|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813912|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43813913|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813914|NCT04806906|Azacitidine|azacitidine|mesh-list
43813915|NCT04806906|Cc-486|cc-486|mesh-list
43813916|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43813917|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
43813918|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813949|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
43813950|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43813951|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43813952|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43813953|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
43813954|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
43655149|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655151|NCT02971254|Sevoflurane|sevoflurane|mesh-list
43655152|NCT02971254|Desflurane|desflurane|mesh-list
43655153|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43813955|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43813956|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43813957|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813958|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43813959|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43813960|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43813961|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813962|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43813963|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43813964|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43813997|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
43813998|NCT04805710|Clopidogrel|clopidogrel|mesh-list
43813999|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814000|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43814001|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43814002|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43814003|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
43814004|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814005|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814006|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814007|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43814008|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
43814009|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43814010|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
43814011|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814012|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
43814013|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
43803047|NCT04973579|Anesthetics|anesthetics|mesh-list
43803048|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814014|NCT04805229|Narcotics|narcotics|mesh-ancestor
43814015|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814016|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814017|NCT04805229|Analgesics|analgesics|mesh-ancestor
43814018|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
43814019|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814020|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
43814021|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
43717711|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814022|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43814023|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814024|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814025|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
43814026|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43814027|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814028|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814029|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
43814030|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814031|NCT04804696|Paclitaxel|paclitaxel|mesh-list
43814032|NCT04804696|Cisplatin|cisplatin|mesh-list
43814033|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43814034|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814035|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
43814098|NCT04803474|Hormones|hormones|mesh-list
43613536|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848610|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803128|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803129|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43803130|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43803131|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803133|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43803134|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
43803135|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803136|NCT04971291|Bupropion|bupropion|mesh-list
43803137|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43803138|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
43803139|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803140|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43814099|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814100|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814101|NCT04803370|Antibodies|antibodies|mesh-list
43814102|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
43814103|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844792|NCT04338659|Antibodies|antibodies|mesh-list
43844793|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43844794|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
43844795|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844796|NCT04338399|Paclitaxel|paclitaxel|mesh-list
43814115|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43814116|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43814117|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43814118|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814119|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814120|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
43814121|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814122|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43814123|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814124|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814125|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43814126|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814127|NCT04802928|Isoniazid|isoniazid|mesh-list
43717751|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
43717752|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717753|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43717754|NCT02646072|Ketorolac|ketorolac|mesh-list
43717755|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43717756|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43717757|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43717758|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814128|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
43814129|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43814132|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43814133|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
43814134|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814135|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43814165|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
43814166|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
43814167|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
43803183|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803184|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803185|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803186|NCT04970576|Warfarin|warfarin|mesh-list
43803187|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
43803188|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
43803189|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43803190|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
43803191|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43803192|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
43803193|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803194|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803195|NCT04970667|Flupenthixol|flupenthixol|mesh-list
43803196|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
43803197|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43803198|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43803199|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803200|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803201|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803202|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43803203|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
43803204|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803205|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803206|NCT04970602|Methylene Blue|methylene blue|mesh-list
43803207|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814177|NCT04802980|Gemcitabine|gemcitabine|mesh-list
43814178|NCT04802980|Paclitaxel|paclitaxel|mesh-list
43814179|NCT04802980|Cisplatin|cisplatin|mesh-list
43717759|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43717760|NCT02646072|Analgesics|analgesics|mesh-ancestor
43717761|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
43717762|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43717769|NCT02645747|Aflibercept|aflibercept|mesh-list
43717774|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
43717775|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717776|NCT02645864|Irinotecan|irinotecan|mesh-list
43717777|NCT02645864|Apatinib|apatinib|mesh-list
43717778|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43717779|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43717780|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43717781|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717782|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43717783|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43717784|NCT02645994|Anesthetics|anesthetics|mesh-list
43717785|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43717786|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43717787|NCT02645734|Bevacizumab|bevacizumab|mesh-list
43717788|NCT02645734|Aflibercept|aflibercept|mesh-list
43814180|NCT04802980|Carboplatin|carboplatin|mesh-list
43814181|NCT04802980|Capecitabine|capecitabine|mesh-list
43814182|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
43814183|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43814184|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814185|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
43814212|NCT04801888|Vaccines|vaccines|mesh-list
43814213|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
43814214|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814215|NCT04801940|Apixaban|apixaban|mesh-list
43814216|NCT04801940|Atorvastatin|atorvastatin|mesh-list
43814217|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43814218|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43803213|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43803214|NCT04970251|Growth Substances|growth substances|mesh-ancestor
43803215|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803216|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
43803217|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803255|NCT04970238|Protective Agents|protective agents|mesh-ancestor
43803256|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803258|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803259|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43803260|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803261|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803262|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43803263|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803264|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43655166|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
43655167|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655168|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43655169|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655170|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43655171|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43655172|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655173|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655174|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
43655175|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43655176|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655177|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
43655178|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43655179|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
43655180|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43655181|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655182|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655183|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655186|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
43655187|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655188|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43655189|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655190|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655191|NCT02970916|Aflibercept|aflibercept|mesh-list
43814219|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
43814220|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803298|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
43803299|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43803300|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803301|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803302|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803303|NCT04968392|Analgesics|analgesics|mesh-ancestor
43803304|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
43803308|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43814234|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814235|NCT04801511|Protective Agents|protective agents|mesh-ancestor
43814240|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555073|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555077|NCT03565354|Hematinics|hematinics|mesh-ancestor
43814241|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814242|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43814244|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
43814245|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43814247|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
43814248|NCT04801485|Vitamins|vitamins|mesh-ancestor
43814249|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
43814250|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814251|NCT04801342|Memantine|memantine|mesh-list
43814252|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43814253|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43814254|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
43814255|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814256|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814257|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842720|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842721|NCT04515329|Cyclosporine|cyclosporine|mesh-list
43842722|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
43842723|NCT04515329|Cyclosporins|cyclosporins|mesh-list
43842724|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43842725|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842726|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43842727|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
43842728|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842729|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
43842730|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43842731|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
43842732|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43842733|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43842734|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43842735|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43842736|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43842737|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43842738|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842739|NCT04513951|Leucovorin|leucovorin|mesh-list
43842740|NCT04513951|Fluorouracil|fluorouracil|mesh-list
43842759|NCT04513951|Vitamins|vitamins|mesh-ancestor
43842764|NCT04513808|Sevoflurane|sevoflurane|mesh-list
43842765|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43842766|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842767|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43842768|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43842769|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
43842770|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43842771|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43814258|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43814259|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43814260|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43814261|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
43814262|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43555106|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43814263|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814264|NCT04800978|Durvalumab|durvalumab|mesh-list
43814265|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814266|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814267|NCT04801017|Artemisinins|artemisinins|mesh-list
43814269|NCT04801017|Trabedersen|trabedersen|mesh-list
43814270|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
43814271|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43814272|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43814273|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814274|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814275|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43814276|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43814277|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814278|NCT04801199|Incretins|incretins|mesh-ancestor
43814279|NCT04801199|Hormones|hormones|mesh-ancestor
43803421|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43803422|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43803423|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43803424|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43803425|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803426|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803427|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43803428|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
43803429|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43803430|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803431|NCT04966429|Maraviroc|maraviroc|mesh-list
43803432|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
43803433|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
43803434|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803435|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43803436|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43803437|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
43803440|NCT04965831|Aflutinib|aflutinib|mesh-list
43844814|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655192|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43655193|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43844815|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844816|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844817|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43844819|NCT04331691|Spironolactone|spironolactone|mesh-list
43844820|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43844821|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
43844822|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43844823|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844824|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43844825|NCT04331691|Diuretics|diuretics|mesh-ancestor
43844826|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
43844827|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
43814318|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43717812|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814320|NCT04799002|Melphalan|melphalan|mesh-list
43814321|NCT04799002|Topotecan|topotecan|mesh-list
43814322|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43814387|NCT04798391|Dexamethasone|dexamethasone|mesh-list
43814388|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814389|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
43814390|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
43814391|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814392|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814393|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814394|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
43814395|NCT04798391|Hormones|hormones|mesh-ancestor
43814396|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814397|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814398|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814399|NCT04797949|Aspirin|aspirin|mesh-list
43814400|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43814401|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43803456|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43803457|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43803458|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
43803459|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803460|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803461|NCT04965662|Tenofovir|tenofovir|mesh-list
43803462|NCT04965662|Emtricitabine|emtricitabine|mesh-list
43849607|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814448|NCT04796857|Lenalidomide|lenalidomide|mesh-list
43814449|NCT04796857|Antibodies|antibodies|mesh-list
43814450|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
43814451|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814452|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43814453|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43814454|NCT04796857|Growth Substances|growth substances|mesh-ancestor
43814455|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
43555146|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814456|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814457|NCT04796623|Fulvestrant|fulvestrant|mesh-list
43814458|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43814459|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814460|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43814461|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43814462|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
43734423|NCT02540070|Analgesics|analgesics|mesh-ancestor
43814463|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814464|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814466|NCT04796688|Fludarabine|fludarabine|mesh-list
43814467|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844841|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43844842|NCT04331132|Tolvaptan|tolvaptan|mesh-list
43844843|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43844844|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844845|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
43814479|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
43814480|NCT04796428|Empagliflozin|empagliflozin|mesh-list
43814481|NCT04796428|Canagliflozin|canagliflozin|mesh-list
43814482|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43655194|NCT02970916|Growth Substances|growth substances|mesh-ancestor
43655195|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655196|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
43849619|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43849620|NCT03907046|Analgesics|analgesics|mesh-ancestor
43849621|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
43849622|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803463|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43803464|NCT04965662|Maraviroc|maraviroc|mesh-list
43803465|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
43803466|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848637|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848638|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43848639|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43848640|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43814483|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814484|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43814485|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814486|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
43814488|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814489|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
43814490|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814491|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814492|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43814493|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
43814494|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814495|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814496|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43814497|NCT04796025|Bevacizumab|bevacizumab|mesh-list
43814523|NCT04794426|Protective Agents|protective agents|mesh-ancestor
43814524|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814525|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
43814526|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43814527|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43814528|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43848641|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848642|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848644|NCT04005170|Cisplatin|cisplatin|mesh-list
43814542|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43814543|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814544|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43814545|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43814546|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814624|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43814625|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43814626|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814627|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655197|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655199|NCT02970630|Tacrolimus|tacrolimus|mesh-list
43655200|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803513|NCT04964180|Indomethacin|indomethacin|mesh-list
43803514|NCT04964180|Lidocaine|lidocaine|mesh-list
43555213|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555214|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43803515|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
43803517|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803518|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803519|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
43814628|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43814629|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
43814710|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43814711|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814712|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
43814713|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814715|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43814716|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43814718|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
43814719|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43814720|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
43814721|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814722|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
43814723|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
43614332|NCT04149145|Niraparib|niraparib|mesh-list
43848654|NCT04004611|Analgesics|analgesics|mesh-ancestor
43803659|NCT04961970|Leucovorin|leucovorin|mesh-list
43803660|NCT04961970|Gemcitabine|gemcitabine|mesh-list
43803661|NCT04961970|Cisplatin|cisplatin|mesh-list
43803662|NCT04961970|Fluorouracil|fluorouracil|mesh-list
43803663|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
43803664|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803665|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43803666|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
43803667|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803668|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
43555252|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43803669|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849623|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803671|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43803672|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
43803673|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803674|NCT04961970|Antidotes|antidotes|mesh-ancestor
43803675|NCT04961970|Protective Agents|protective agents|mesh-ancestor
43803676|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
43803677|NCT04961970|Vitamins|vitamins|mesh-ancestor
43803678|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
43803679|NCT04961684|Amorolfine|amorolfine|mesh-list
43803682|NCT04961918|Durvalumab|durvalumab|mesh-list
43814724|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814725|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814727|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
43814728|NCT04791202|Hormones|hormones|mesh-ancestor
43814729|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43814730|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43803716|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803717|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803718|NCT04961138|Lenvatinib|lenvatinib|mesh-list
43803719|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803720|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803721|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803722|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803723|NCT04960943|Trastuzumab|trastuzumab|mesh-list
43803724|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43803725|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803726|NCT04960657|Glyburide|glyburide|mesh-list
43803727|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
43803728|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43803729|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803730|NCT04960657|Growth Substances|growth substances|mesh-ancestor
43803731|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
43803732|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803733|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803734|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
43803735|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
43803736|NCT04960293|Coagulants|coagulants|mesh-ancestor
43803737|NCT04959721|Triamcinolone|triamcinolone|mesh-list
43803738|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43842912|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43842913|NCT04500860|Urological Agents|urological agents|mesh-ancestor
43842914|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43842915|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43842916|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
43842917|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43842918|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43842919|NCT04500847|Emtricitabine|emtricitabine|mesh-list
43842920|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
43814868|NCT04788654|Celecoxib|celecoxib|mesh-list
43814869|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814870|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
43814907|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814930|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814931|NCT04787289|Bevacizumab|bevacizumab|mesh-list
43814932|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43814933|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814934|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43814935|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43814936|NCT04787289|Growth Substances|growth substances|mesh-ancestor
43814937|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814938|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
43655202|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655203|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43655204|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803779|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43803780|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43803781|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
43803782|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43803783|NCT04958187|Mitogens|mitogens|mesh-list
43803784|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
43803785|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803786|NCT04958473|Axitinib|axitinib|mesh-list
43803787|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43803788|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43803789|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43803790|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803791|NCT04957940|SMOFlipid|smoflipid|mesh-list
43803792|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
43803793|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43803794|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43803810|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43803811|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43803812|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43803813|NCT04957420|Rotigotine|rotigotine|mesh-list
43803814|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
43555327|NCT03563235|Calcitriol|calcitriol|mesh-list
43803815|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
43803816|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43803818|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814941|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43814942|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814943|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814944|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43814945|NCT04786795|Pancreatin|pancreatin|mesh-list
43814946|NCT04786795|Pancrelipase|pancrelipase|mesh-list
43814947|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43814948|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43814949|NCT04786158|Apomorphine|apomorphine|mesh-list
43814951|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804108|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43804109|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43804110|NCT04949932|Turmeric extract|turmeric extract|mesh-list
43804112|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804113|NCT04949932|Protective Agents|protective agents|mesh-ancestor
43804114|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804116|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43804117|NCT04949347|Protective Agents|protective agents|mesh-ancestor
43804118|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804156|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804157|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804158|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43804160|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43804161|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
43804162|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
43804163|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804204|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804205|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
43804206|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804207|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43804208|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43804209|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804210|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804211|NCT04948151|Urological Agents|urological agents|mesh-ancestor
43804213|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
43804214|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
43804215|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804216|NCT04947566|Ibuprofen|ibuprofen|mesh-list
43804217|NCT04947566|Naproxen|naproxen|mesh-list
43804218|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43804219|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804220|NCT04947566|Analgesics|analgesics|mesh-ancestor
43804221|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
43804222|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804228|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804230|NCT04947423|Scopolamine|scopolamine|mesh-list
43844950|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844951|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844952|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
43844953|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844954|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43844955|NCT04319627|Calcium|calcium|mesh-list
43844956|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43844957|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844958|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43844959|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43844960|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
43804264|NCT04947111|Antibodies|antibodies|mesh-list
43804265|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
43804266|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
43804267|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
43804268|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804269|NCT04946929|Heparin|heparin|mesh-list
43804270|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43804271|NCT04946929|Tinzaparin|tinzaparin|mesh-list
43804272|NCT04946929|Dalteparin|dalteparin|mesh-list
43804273|NCT04946929|Ticagrelor|ticagrelor|mesh-list
43804274|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
43804275|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43804276|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43804277|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804278|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43804279|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43804280|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43804281|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43804282|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
43804283|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804284|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804285|NCT04947345|Propofol|propofol|mesh-list
43804286|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43804287|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804288|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804289|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43804290|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
43555395|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555396|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
43555397|NCT03563144|Antiviral Agents|antiviral agents|mesh-ancestor
43555398|NCT03563144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555399|NCT03563144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555400|NCT03563144|Antidotes|antidotes|mesh-ancestor
43555401|NCT03563144|Protective Agents|protective agents|mesh-ancestor
43555402|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
43555403|NCT03563144|Vitamins|vitamins|mesh-ancestor
43804291|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
43804292|NCT04947189|Dexamethasone|dexamethasone|mesh-list
43804293|NCT04947189|Docetaxel|docetaxel|mesh-list
43844961|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844962|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43844963|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43844964|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844965|NCT04319224|Nivolumab|nivolumab|mesh-list
43844966|NCT04319224|Ipilimumab|ipilimumab|mesh-list
43815095|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
43815096|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815097|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43815098|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43815099|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43804294|NCT04947189|Seviteronel|seviteronel|mesh-list
43804295|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804296|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
43804297|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
43804298|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804299|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804300|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804301|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
43804302|NCT04947189|Hormones|hormones|mesh-ancestor
43804303|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804304|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804305|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804306|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
43815129|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43815131|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815132|NCT05471700|Azacitidine|azacitidine|mesh-list
43815133|NCT05471700|Venetoclax|venetoclax|mesh-list
43815134|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815135|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
43815136|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815137|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815138|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815139|NCT05471687|Adenosine|adenosine|mesh-list
43815140|NCT05471687|Analgesics|analgesics|mesh-ancestor
43815141|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
43844999|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845000|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43845001|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
43845002|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43845003|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845004|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845005|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845007|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845008|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845009|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
43845010|NCT04314843|Fludarabine|fludarabine|mesh-list
43845011|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845012|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
43815188|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
43804343|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804344|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804345|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43804346|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43804347|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804348|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43804349|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43804350|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804352|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43804353|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43804354|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43804420|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
43804421|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804422|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804423|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804424|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
43804426|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804427|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804428|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804429|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43804430|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
43655207|NCT02970643|Olanzapine|olanzapine|mesh-list
43655208|NCT02970643|Palonosetron|palonosetron|mesh-list
43815195|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43815197|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
43815198|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
43815199|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815229|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815230|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815231|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
43815232|NCT05269849|Sirolimus|sirolimus|mesh-list
43815233|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43804431|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804433|NCT04945694|Propofol|propofol|mesh-list
43804434|NCT04945694|Sevoflurane|sevoflurane|mesh-list
43804435|NCT04945694|Atracurium|atracurium|mesh-list
43804436|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43804437|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804438|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804439|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43804440|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
43804441|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
43804442|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43615230|NCT03159078|Imipenem|imipenem|mesh-list
43804443|NCT04945694|Narcotics|narcotics|mesh-ancestor
43804444|NCT04945694|Analgesics|analgesics|mesh-ancestor
43804445|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
43804446|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815234|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815235|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43815236|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815237|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
43815238|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815239|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
43815240|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815241|NCT05248620|Amoxicillin|amoxicillin|mesh-list
43815242|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43815243|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815244|NCT05240131|Atezolizumab|atezolizumab|mesh-list
43815245|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815246|NCT05226455|Azacitidine|azacitidine|mesh-list
43815247|NCT05226455|Venetoclax|venetoclax|mesh-list
43815248|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43717885|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
43717886|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43815249|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
43815250|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815251|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815252|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815253|NCT05188339|Heparin|heparin|mesh-list
43815254|NCT05188339|Citric Acid|citric acid|mesh-list
43815255|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
43815256|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
43815257|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43815258|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
43815259|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
43815260|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815261|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43815262|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43815263|NCT05139472|Empagliflozin|empagliflozin|mesh-list
43815264|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43815265|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815266|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43815267|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804459|NCT04945577|Vitamins|vitamins|mesh-ancestor
43804460|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
43804468|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
43804469|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804470|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804471|NCT04945226|Urological Agents|urological agents|mesh-ancestor
43804472|NCT04945434|Methamphetamine|methamphetamine|mesh-list
43804475|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
43815269|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
43815270|NCT05035862|Prednisone|prednisone|mesh-list
43717950|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832364|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815271|NCT05035862|Albuterol|albuterol|mesh-list
43815272|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815273|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
43815274|NCT05035862|Hormones|hormones|mesh-ancestor
43815275|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815276|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815277|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43815278|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815279|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
43815280|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815281|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43815282|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
43815283|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655210|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
43655211|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655212|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655213|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655214|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43655215|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43655216|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655217|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43655218|NCT02970643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43655219|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43655220|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43655221|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655222|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655223|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
43815305|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815306|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
43815307|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815308|NCT04970901|Gemcitabine|gemcitabine|mesh-list
43815309|NCT04970901|Lenalidomide|lenalidomide|mesh-list
43815310|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43815311|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815312|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
43815313|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815314|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815315|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
43815316|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815317|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815318|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43815319|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
43815320|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815321|NCT04970901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43815322|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43717991|NCT02644707|Protective Agents|protective agents|mesh-ancestor
43842985|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43815323|NCT04970901|Growth Substances|growth substances|mesh-ancestor
43815324|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
43815325|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815326|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
43815327|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815328|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815329|NCT04848857|Colchicine|colchicine|mesh-list
43815340|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
43815341|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
43815342|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
43815343|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815344|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815345|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43815346|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43815347|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43815348|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43804536|NCT04944524|Tofacitinib|tofacitinib|mesh-list
43804537|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43804538|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
43815349|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815350|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
43815351|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43815352|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815353|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815354|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43655224|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43655225|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43815355|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804630|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804631|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43804632|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
43804633|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804634|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804636|NCT04943146|Prednisone|prednisone|mesh-list
43804637|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43804638|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
43804639|NCT04943146|Hormones|hormones|mesh-ancestor
43804640|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43804641|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804642|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43804643|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804644|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43804645|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43804646|NCT04943146|Analgesics|analgesics|mesh-ancestor
43804647|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
43804648|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804649|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804650|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43804651|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43555424|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43804652|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804653|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43804654|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43804655|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804656|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
43815356|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815357|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
43815358|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815360|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
43815361|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815362|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815363|NCT04628988|Prednisone|prednisone|mesh-list
43815364|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
43815365|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43815366|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
43815367|NCT04628988|Hormones|hormones|mesh-ancestor
43815368|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43815369|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815370|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43815371|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815372|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815373|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815374|NCT04618016|Vitamins|vitamins|mesh-list
43815375|NCT04618016|Vitamin E|vitamin e|mesh-list
43815376|NCT04618016|Tocopherols|tocopherols|mesh-list
43815377|NCT04618016|Tocotrienols|tocotrienols|mesh-list
43815378|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
43815379|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
43804657|NCT04942860|Methotrexate|methotrexate|mesh-list
43804658|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43804659|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
43804660|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43804661|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804662|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43804663|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
43804664|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804665|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804666|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
43804667|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804668|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43804669|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43804670|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
43804671|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43804672|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43804674|NCT04942834|Sotalol|sotalol|mesh-list
43804675|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43804676|NCT04942834|Dronedarone|dronedarone|mesh-list
43804677|NCT04942834|Propafenone|propafenone|mesh-list
43804678|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804679|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43804680|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43815381|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
43815382|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815383|NCT04618016|Protective Agents|protective agents|mesh-ancestor
43815384|NCT04583969|Remdesivir|remdesivir|mesh-list
43815385|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
43815386|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815387|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
43815388|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815389|NCT04550442|Azacitidine|azacitidine|mesh-list
43815390|NCT04550442|Venetoclax|venetoclax|mesh-list
43815391|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43815392|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
43815393|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815395|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845058|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845059|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845060|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43845061|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43845063|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845064|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845065|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43815504|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815505|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
43815506|NCT03962114|Niacinamide|niacinamide|mesh-list
43815507|NCT03962114|Niacin|niacin|mesh-list
43815508|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
43815509|NCT03962114|Vitamins|vitamins|mesh-ancestor
43815510|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
43815511|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718051|NCT02644499|Prednisolone|prednisolone|mesh-list
43815512|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
43718052|NCT02644499|Methotrexate|methotrexate|mesh-list
43718053|NCT02644499|Leflunomide|leflunomide|mesh-list
43718054|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
43718056|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
43815513|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43815514|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
43815515|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815516|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43815517|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
43815518|NCT03938389|Valsartan|valsartan|mesh-list
43804686|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43804687|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43804688|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43804689|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43804690|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43804691|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
43804692|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804693|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804694|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
43804695|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
43804696|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815519|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43815520|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43815521|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43815522|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43815523|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815525|NCT03901001|Oseltamivir|oseltamivir|mesh-list
43655227|NCT02970539|Ramucirumab|ramucirumab|mesh-list
43655228|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43655229|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655230|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
43804697|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43804698|NCT04942652|Itraconazole|itraconazole|mesh-list
43804699|NCT04942652|Esomeprazole|esomeprazole|mesh-list
43804700|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43718087|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43718088|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
43718089|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
43718092|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
43555482|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43555483|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43555484|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43555485|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555486|NCT03562507|Nivolumab|nivolumab|mesh-list
43555487|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555488|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43555489|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43555490|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43555491|NCT03562468|Niacinamide|niacinamide|mesh-list
43555493|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
43804701|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43804702|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43804703|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804704|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804705|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
43804706|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804707|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43804708|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43815592|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815593|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815595|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43815596|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815597|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43815598|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
43815599|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815600|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43815601|NCT03596918|Vincristine|vincristine|mesh-list
43815603|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43815604|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815605|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
43815606|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
43815679|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43815680|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43815681|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815693|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
43815694|NCT03511118|Coagulants|coagulants|mesh-ancestor
43815695|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43815696|NCT03511118|Narcotics|narcotics|mesh-ancestor
43815697|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43815698|NCT03511118|Analgesics|analgesics|mesh-ancestor
43815699|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
43815700|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815701|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
43815702|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43815703|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43815704|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815705|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43815706|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43815707|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815708|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
43815709|NCT03511118|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43815710|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43815711|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43815712|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
43815713|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43815714|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
43815715|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
43815716|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43815717|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43815718|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
43815719|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
43815720|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815721|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
43815722|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815723|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43555529|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43555530|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
43555531|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
43555532|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43555533|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43555534|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43555535|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43555536|NCT03562169|Growth Substances|growth substances|mesh-ancestor
43815724|NCT03511118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43815725|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43815726|NCT03511118|Diuretics|diuretics|mesh-ancestor
43815727|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
43815728|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43815729|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
43815730|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43815731|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43815732|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43815733|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43815734|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815735|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43655233|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825070|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825071|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43825072|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825073|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
43825074|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
43825075|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825076|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
43815736|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43815737|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43815738|NCT03511118|Renal Agents|renal agents|mesh-ancestor
43815739|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43815740|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43815741|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43815742|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
43815775|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
43804816|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43804817|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43804818|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804819|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804820|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43815782|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43815783|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43815784|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
43815785|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
43815786|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
43815787|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
43815788|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815814|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815816|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
43815817|NCT03016533|Lamivudine|lamivudine|mesh-list
43815818|NCT03016533|Dolutegravir|dolutegravir|mesh-list
43555545|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
43555547|NCT03562130|Teduglutide|teduglutide|mesh-list
43815819|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43815820|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43815821|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43804849|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804850|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804851|NCT04940273|Analgesics|analgesics|mesh-ancestor
43804852|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
43804853|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804854|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
43804855|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43804856|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43804857|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43804858|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804859|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804860|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
43804861|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804862|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804863|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43804864|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804865|NCT04939857|Trimetazidine|trimetazidine|mesh-list
43804866|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
43804867|NCT04939779|Delpazolid|delpazolid|mesh-list
43804868|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
43804869|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43804870|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804871|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43804872|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815824|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43815825|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43815826|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43815827|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43815828|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43815829|NCT02977156|Ipilimumab|ipilimumab|mesh-list
43815830|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43815831|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815832|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43815833|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815834|NCT02885974|Gemcitabine|gemcitabine|mesh-list
43815835|NCT02885974|Celecoxib|celecoxib|mesh-list
43815836|NCT02885974|Cisplatin|cisplatin|mesh-list
43815837|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845093|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43845094|NCT04307511|Analgesics|analgesics|mesh-ancestor
43845095|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
43845096|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845097|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845098|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718144|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
43845099|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845100|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43845101|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43825077|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
43825078|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
43825079|NCT05504863|Hematinics|hematinics|mesh-ancestor
43825080|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
43825081|NCT05504720|Trastuzumab|trastuzumab|mesh-list
43845102|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845135|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845136|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845137|NCT04302181|Ropivacaine|ropivacaine|mesh-list
43845138|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
43845139|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
43804873|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804874|NCT04939675|Lamotrigine|lamotrigine|mesh-list
43804875|NCT04939675|Zonisamide|zonisamide|mesh-list
43804876|NCT04939675|Levetiracetam|levetiracetam|mesh-list
43804877|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
43804878|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
43804879|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43804880|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43804881|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804882|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43804883|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804884|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43804885|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43804886|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804887|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43804888|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43804889|NCT04939766|Insulin|insulin|mesh-list
43849626|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43815857|NCT02866643|Etonogestrel|etonogestrel|mesh-list
43815858|NCT02866643|Desogestrel|desogestrel|mesh-list
43815859|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43815893|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
43555576|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43555577|NCT03561558|Analgesics|analgesics|mesh-ancestor
43815895|NCT02790515|Rituximab|rituximab|mesh-list
43555578|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
43815896|NCT02790515|Fludarabine|fludarabine|mesh-list
43815897|NCT02790515|Blinatumomab|blinatumomab|mesh-list
43815898|NCT02790515|Tacrolimus|tacrolimus|mesh-list
43815899|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
43815931|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43815933|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815934|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43815935|NCT02715609|Trace Elements|trace elements|mesh-ancestor
43815936|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
43815937|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815938|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43815969|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43815970|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804890|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43804891|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804893|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
43804894|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43804895|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43804896|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43804897|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43555591|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43804898|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804899|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43804900|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43804901|NCT04938583|Paclitaxel|paclitaxel|mesh-list
43804902|NCT04938583|Bevacizumab|bevacizumab|mesh-list
43804903|NCT04938583|Carboplatin|carboplatin|mesh-list
43804904|NCT04938583|Oregovomab|oregovomab|mesh-list
43804905|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43804906|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43804907|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
43804908|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
43804910|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804911|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43804912|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43804913|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43804914|NCT04938583|Growth Substances|growth substances|mesh-ancestor
43804915|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804916|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
43804917|NCT04938713|Ketamine|ketamine|mesh-list
43804918|NCT04938713|Esketamine|esketamine|mesh-list
43804919|NCT04938713|Analgesics|analgesics|mesh-ancestor
43804920|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
43804921|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43804922|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43804923|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43804924|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43804925|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
43804926|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
43804927|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804928|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43804929|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43804930|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43804931|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43804932|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
43804933|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43843007|NCT04495088|Vitamins|vitamins|mesh-ancestor
43843008|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
43843009|NCT04495088|Hematinics|hematinics|mesh-ancestor
43843010|NCT04494958|Palbociclib|palbociclib|mesh-list
43843011|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843012|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843013|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843014|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843015|NCT04494503|Rituximab|rituximab|mesh-list
43843016|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843018|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
43848658|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848660|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43848661|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848662|NCT04003948|Ibogaine|ibogaine|mesh-list
43848663|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
43848666|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43555630|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555631|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
43848667|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43555640|NCT03560908|Dasatinib|dasatinib|mesh-list
43848668|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848669|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848670|NCT04003922|Adalimumab|adalimumab|mesh-list
43848671|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848672|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848673|NCT04003246|Durvalumab|durvalumab|mesh-list
43848674|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43848675|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43848676|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848677|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
43804934|NCT04938453|Nintedanib|nintedanib|mesh-list
43816033|NCT02227940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825082|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825083|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825085|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825086|NCT05504642|Nivolumab|nivolumab|mesh-list
43804959|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
43804960|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43804961|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43804962|NCT04938037|Prednisolone|prednisolone|mesh-list
43804963|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
43804964|NCT04938037|Bupivacaine|bupivacaine|mesh-list
43804965|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43804966|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
43804967|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
43804968|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
43804969|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43804974|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
43804992|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43805079|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43805080|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805081|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
43805082|NCT04936971|Everolimus|everolimus|mesh-list
43805083|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816040|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816041|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816078|NCT05475041|Hematinics|hematinics|mesh-ancestor
43816079|NCT05474950|Minocycline|minocycline|mesh-list
43816080|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816081|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816082|NCT05474937|Midazolam|midazolam|mesh-list
43816083|NCT05474937|Ketamine|ketamine|mesh-list
43816084|NCT05474937|Propofol|propofol|mesh-list
43816117|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
43816118|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816119|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43816159|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43816160|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43816162|NCT05474664|Camostat|camostat|mesh-list
43845169|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43805144|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805146|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
43805147|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
43805148|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805149|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43805160|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805161|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816188|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43816189|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43816190|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
43816192|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43816193|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43816194|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816195|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816196|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816197|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816198|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43816199|NCT05473819|Anesthetics|anesthetics|mesh-list
43816200|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816201|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816202|NCT05473806|Pioglitazone|pioglitazone|mesh-list
43816203|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43816204|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816205|NCT05473741|Risperidone|risperidone|mesh-list
43816206|NCT05473741|Aripiprazole|aripiprazole|mesh-list
43816207|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43816208|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
43816209|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43816210|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
43816211|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43555654|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816212|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816213|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816214|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43825088|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
43825089|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843068|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843069|NCT04489589|Midodrine|midodrine|mesh-list
43843070|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
43805168|NCT04935541|Analgesics|analgesics|mesh-ancestor
43805169|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
43805170|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805171|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43805172|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43805173|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805174|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805175|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805176|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805177|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43805178|NCT04935541|Narcotics|narcotics|mesh-ancestor
43805179|NCT04935034|Vitamin D|vitamin d|mesh-list
43805180|NCT04935034|Vitamins|vitamins|mesh-ancestor
43805181|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
43805182|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805183|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43805184|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43805185|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
43825090|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825091|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43825092|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825093|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816215|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816216|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43816217|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43816218|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
43816257|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43816258|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816259|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43816260|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816261|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43816262|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43816263|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43816264|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43555691|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43555692|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
43816265|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805186|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43805187|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
43805188|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805189|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805190|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43805192|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43805193|NCT04935073|Hormones|hormones|mesh-ancestor
43816266|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816267|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816268|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816269|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43816270|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
43816271|NCT05347459|Empagliflozin|empagliflozin|mesh-list
43816272|NCT05347459|Linagliptin|linagliptin|mesh-list
43816273|NCT05347459|Vildagliptin|vildagliptin|mesh-list
43816274|NCT05347459|Canagliflozin|canagliflozin|mesh-list
43816275|NCT05347459|Saxagliptin|saxagliptin|mesh-list
43816276|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43816277|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816278|NCT05347459|Incretins|incretins|mesh-ancestor
43816280|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816281|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43816282|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
43816283|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816284|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816285|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43816286|NCT05346445|Fluoxetine|fluoxetine|mesh-list
43816287|NCT05346445|Citalopram|citalopram|mesh-list
43805194|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805195|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805196|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43718238|NCT02643914|Nicotine|nicotine|mesh-list
43805197|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
43805198|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43805199|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
43805200|NCT04934852|Ephedrine|ephedrine|mesh-list
43805201|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
43805202|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43805203|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805205|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
43805206|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805207|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43805208|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805209|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805210|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805211|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43805212|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43816321|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43816322|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43816323|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
43816324|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43816325|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43816326|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
43816327|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43816328|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43816329|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
43816331|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816332|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
43816333|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816334|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43816335|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43816336|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
43816337|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816338|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816339|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43562869|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43845172|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43845173|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43825095|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
43825096|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825097|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845174|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43845175|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845176|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845177|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
43845178|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845179|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43845180|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43845181|NCT04297254|Lenvatinib|lenvatinib|mesh-list
43555753|NCT03560024|Growth Substances|growth substances|mesh-ancestor
43845182|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845183|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43845184|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845185|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845186|NCT04297176|Vancomycin|vancomycin|mesh-list
43845187|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845188|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845189|NCT04295941|Trazodone|trazodone|mesh-list
43845190|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43845191|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43845192|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845193|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845194|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43805273|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
43816408|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43816409|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816411|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43816483|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816547|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816549|NCT04733963|Capecitabine|capecitabine|mesh-list
43805329|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805330|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805331|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805332|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843076|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43843077|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43843078|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
43843079|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843080|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843082|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
43843083|NCT04488874|Diuretics|diuretics|mesh-ancestor
43843084|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
43843085|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843086|NCT04488315|Dexamethasone|dexamethasone|mesh-list
43843087|NCT04488315|Ropivacaine|ropivacaine|mesh-list
43843088|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843089|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
43843090|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
43843091|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43843092|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843093|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43843094|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
43843095|NCT04488315|Hormones|hormones|mesh-ancestor
43843096|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843097|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843099|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
43816555|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816556|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
43816557|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43555772|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43816558|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
43816559|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816561|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43816562|NCT04716413|Narcotics|narcotics|mesh-ancestor
43816563|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816564|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816565|NCT04716413|Analgesics|analgesics|mesh-ancestor
43816566|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
43816567|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845195|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43845196|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43843109|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43843110|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43843111|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843112|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843113|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43843114|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
43843115|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843116|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843117|NCT04486352|Bevacizumab|bevacizumab|mesh-list
43843118|NCT04486352|Trastuzumab|trastuzumab|mesh-list
43843119|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43843120|NCT04486352|Atezolizumab|atezolizumab|mesh-list
43843121|NCT04486352|Maytansine|maytansine|mesh-list
43843122|NCT04486352|Talazoparib|talazoparib|mesh-list
43843123|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43843124|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43555796|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43843125|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843126|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43843127|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43843128|NCT04486352|Growth Substances|growth substances|mesh-ancestor
43843129|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43616282|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43816571|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
43816572|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816573|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
43816574|NCT04589611|Protective Agents|protective agents|mesh-ancestor
43816575|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43816576|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816577|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
43816614|NCT04428086|Apatinib|apatinib|mesh-list
43816615|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43816637|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43816638|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43816639|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
43816640|NCT04416386|Vitamins|vitamins|mesh-ancestor
43816641|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
43816642|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816644|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816645|NCT04416386|Protective Agents|protective agents|mesh-ancestor
43816646|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
43816647|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43816648|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
43816649|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816650|NCT04374461|Expectorants|expectorants|mesh-ancestor
43816651|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
43816652|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43816653|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
43816654|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816655|NCT04374461|Protective Agents|protective agents|mesh-ancestor
43816656|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816657|NCT04374461|Antidotes|antidotes|mesh-ancestor
43816658|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
43816659|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
43816660|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43816661|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43816662|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816663|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
43816664|NCT04373603|Coagulants|coagulants|mesh-ancestor
43816665|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43816666|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
43816667|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816694|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43843182|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43843183|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43843184|NCT04483739|Growth Substances|growth substances|mesh-ancestor
43805487|NCT04928495|Ascorbic Acid|ascorbic acid|mesh-list
43805488|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
43805489|NCT04928495|Bromhexine|bromhexine|mesh-list
43805490|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43805491|NCT04928495|Vitamins|vitamins|mesh-ancestor
43805492|NCT04928495|Micronutrients|micronutrients|mesh-ancestor
43805493|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805494|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
43805495|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805496|NCT04928495|Protective Agents|protective agents|mesh-ancestor
43805497|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
43805498|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805499|NCT04928495|Expectorants|expectorants|mesh-ancestor
43805500|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
43805501|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43805502|NCT04928495|Antidotes|antidotes|mesh-ancestor
43805503|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
43805504|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
43805505|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43805506|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
43805507|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805508|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43805509|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805510|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
43805511|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43805512|NCT04928066|Prednisone|prednisone|mesh-list
43805513|NCT04928066|Tofacitinib|tofacitinib|mesh-list
43805514|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43805515|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
43805519|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805520|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805521|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805522|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805523|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805525|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
43805526|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805582|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805583|NCT04927299|Diuretics|diuretics|mesh-ancestor
43805584|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
43805585|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805586|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
43805587|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805588|NCT04927000|Tofacitinib|tofacitinib|mesh-list
43805589|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43805590|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805592|NCT04926753|Cisplatin|cisplatin|mesh-list
43816703|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
43816704|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718292|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
43816705|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816707|NCT04313634|Quercetin|quercetin|mesh-list
43816708|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816709|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816710|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816711|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816712|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
43825103|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825105|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
43825106|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43825107|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43825108|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816713|NCT04313634|Protective Agents|protective agents|mesh-ancestor
43816714|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816715|NCT04278755|Drospirenone|drospirenone|mesh-list
43816716|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43816724|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
43805600|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805601|NCT04926480|Anesthetics|anesthetics|mesh-list
43805602|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805603|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43627427|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43805604|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43805605|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805606|NCT04927039|Iloprost|iloprost|mesh-list
43805607|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43805608|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
43805609|NCT04926532|Sorafenib|sorafenib|mesh-list
43805610|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805611|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816725|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43816726|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43816727|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43816728|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43816729|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43816730|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
43816731|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43816732|NCT04278755|Diuretics|diuretics|mesh-ancestor
43816733|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
43816734|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
43816735|NCT04277975|Narcotics|narcotics|mesh-ancestor
43816736|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816737|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816738|NCT04277975|Analgesics|analgesics|mesh-ancestor
43816739|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
43816740|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816741|NCT04231539|Nicotine|nicotine|mesh-list
43816742|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43555832|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43555833|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
43555834|NCT03558919|Mirabegron|mirabegron|mesh-list
43816743|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
43816744|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816745|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816746|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43816747|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43816748|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
43816749|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816750|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816751|NCT04225221|Leuprolide|leuprolide|mesh-list
43816752|NCT04225221|Estradiol|estradiol|mesh-list
43816753|NCT04225221|Progesterone|progesterone|mesh-list
43816754|NCT04225221|Estrogens|estrogens|mesh-ancestor
43816755|NCT04225221|Hormones|hormones|mesh-ancestor
43816756|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816757|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816758|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43816759|NCT04225221|Progestins|progestins|mesh-ancestor
43816760|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43816761|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
43816762|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816763|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816764|NCT04174352|Tamoxifen|tamoxifen|mesh-list
43718342|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
43832452|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
43816765|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43816766|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
43816767|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816768|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816769|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816770|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816771|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43816772|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43816773|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43816774|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
43816775|NCT04134325|Nivolumab|nivolumab|mesh-list
43816776|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816777|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816778|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43816779|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816780|NCT04089072|Phenylephrine|phenylephrine|mesh-list
43816781|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
43825109|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
43825110|NCT05504577|Coagulants|coagulants|mesh-ancestor
43825111|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
43825112|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43825113|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43805632|NCT04924647|Dexamethasone|dexamethasone|mesh-list
43805633|NCT04924647|Lenalidomide|lenalidomide|mesh-list
43805634|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43805635|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
43805636|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
43805637|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805638|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825114|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718454|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43718455|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
43718456|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43718457|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
43718458|NCT02642718|Ketorolac|ketorolac|mesh-list
43718459|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
43718460|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43718461|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43718462|NCT02642718|Analgesics|analgesics|mesh-ancestor
43718463|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
43718464|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718465|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718466|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43718467|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43639131|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
43825115|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43825116|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43825117|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825118|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816806|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
43816807|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
43816808|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816809|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816810|NCT03995628|Dexamethasone|dexamethasone|mesh-list
43816811|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816812|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
43816813|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
43816814|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816815|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816816|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43816817|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
43816819|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816820|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43816821|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825130|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
43825131|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805640|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
43805641|NCT04924647|Hormones|hormones|mesh-ancestor
43805642|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43805643|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43805644|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805645|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
43805646|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43805647|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43805648|NCT04924647|Growth Substances|growth substances|mesh-ancestor
43805649|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
43805650|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
43805651|NCT04924192|Irinotecan|irinotecan|mesh-list
43805660|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
43816839|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43816840|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
43816841|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816842|NCT03908736|Picolinic acid|picolinic acid|mesh-list
43816843|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43816844|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
43816845|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
43805679|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43805680|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805681|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43805682|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805683|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805684|NCT04923113|Antacids|antacids|mesh-ancestor
43718507|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718508|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
43718509|NCT02642484|Antacids|antacids|mesh-ancestor
43718510|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43718511|NCT02642419|Aspirin|aspirin|mesh-list
43616713|NCT03144596|Tamsulosin|tamsulosin|mesh-list
43805685|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43849627|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43849628|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805686|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43805687|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
43843206|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843207|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43843208|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43843209|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843210|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843211|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43843212|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
43843213|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843214|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843215|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43816851|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816853|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
43816854|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43816855|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816856|NCT03810794|Donepezil|donepezil|mesh-list
43816857|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43816858|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43816859|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816860|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
43816861|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843229|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43843230|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843231|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43843232|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
43843233|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
43843234|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43843235|NCT04474353|Temozolomide|temozolomide|mesh-list
43843236|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43843237|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
43843238|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843239|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843240|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
43843241|NCT04474002|Cathartics|cathartics|mesh-ancestor
43843242|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43848682|NCT04002401|Rituximab|rituximab|mesh-list
43848683|NCT04002401|Fludarabine|fludarabine|mesh-list
43816866|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816867|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43816868|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816869|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
43718789|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43718790|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718791|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
43718792|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
43718793|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43718794|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43718795|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43718796|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
43718797|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43718798|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43718799|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43718800|NCT02640846|Protective Agents|protective agents|mesh-ancestor
43718801|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43718802|NCT02640898|Docetaxel|docetaxel|mesh-list
43718803|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816870|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43816871|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816872|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816873|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43816874|NCT03708315|Analgesics|analgesics|mesh-ancestor
43816875|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
43816876|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816877|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43816878|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43816879|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43816880|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
43816881|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43816882|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816883|NCT03660488|Penicillins|penicillins|mesh-list
43816898|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
43816899|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43816900|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655235|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43655236|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43655237|NCT02970604|Analgesics|analgesics|mesh-ancestor
43655238|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
43655239|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655240|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655241|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43816901|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
43816903|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
43816904|NCT03502330|Nivolumab|nivolumab|mesh-list
43816905|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816906|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816907|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43816908|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816909|NCT03464084|Melatonin|melatonin|mesh-list
43816910|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
43816911|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816912|NCT03464084|Protective Agents|protective agents|mesh-ancestor
43816913|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43718837|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43718838|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43718839|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43718840|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
43718841|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43718842|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
43816914|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43816915|NCT03397953|Vinorelbine|vinorelbine|mesh-list
43816916|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816917|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816918|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816919|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
43849629|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43816921|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816922|NCT03334682|Doxycycline|doxycycline|mesh-list
43816923|NCT03334682|Spironolactone|spironolactone|mesh-list
43816924|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816925|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816926|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
43816927|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43816928|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43816929|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43816930|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562870|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43816931|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816932|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816933|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43816934|NCT03334682|Diuretics|diuretics|mesh-ancestor
43816935|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
43805724|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
43805725|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
43805726|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
43805727|NCT04922151|Ranibizumab|ranibizumab|mesh-list
43805728|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43805729|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43805730|NCT04922151|Growth Substances|growth substances|mesh-ancestor
43805731|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805732|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
43805733|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805734|NCT04921930|Artesunate|artesunate|mesh-list
43805735|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
43805736|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43805737|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43805738|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43805739|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805740|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
43805741|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
43805742|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43805743|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
43805744|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
43805745|NCT04921878|Analgesics|analgesics|mesh-ancestor
43805755|NCT04921657|Simvastatin|simvastatin|mesh-list
43816937|NCT03173066|Hematinics|hematinics|mesh-ancestor
43816938|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
43816939|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43816941|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43816942|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43816943|NCT03085680|Analgesics|analgesics|mesh-ancestor
43816944|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
43816945|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43816946|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816959|NCT03032107|Trastuzumab|trastuzumab|mesh-list
43816960|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43816961|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816962|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816963|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816964|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
43805761|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43616862|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43805762|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43805763|NCT04921670|Infliximab|infliximab|mesh-list
43805764|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
43805765|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43805766|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43718988|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43805767|NCT04921904|Ramucirumab|ramucirumab|mesh-list
43805768|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805769|NCT04921566|Torsemide|torsemide|mesh-list
43718989|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805770|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43805771|NCT04921566|Diuretics|diuretics|mesh-ancestor
43805772|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
43805773|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805774|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43805775|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43805776|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43805777|NCT04921306|Clenbuterol|clenbuterol|mesh-list
43805778|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43805779|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43805780|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
43805781|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43805782|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816966|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816967|NCT03029598|Carboplatin|carboplatin|mesh-list
43816968|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
43816969|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816970|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43655242|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655243|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43655244|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43655245|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655246|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43655247|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43655248|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655249|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
43655250|NCT02970682|Tamoxifen|tamoxifen|mesh-list
43655251|NCT02970682|Fulvestrant|fulvestrant|mesh-list
43655252|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43655253|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43655254|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
43816971|NCT02946788|Minocycline|minocycline|mesh-list
43816972|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43816973|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816974|NCT02705859|Trastuzumab|trastuzumab|mesh-list
43816975|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43816976|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816977|NCT02642640|Melatonin|melatonin|mesh-list
43816978|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
43816979|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816980|NCT02642640|Protective Agents|protective agents|mesh-ancestor
43816981|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816982|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43805783|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805784|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43805785|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
43805786|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43805787|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43805795|NCT04921111|Antacids|antacids|mesh-ancestor
43816983|NCT02587247|Antibodies|antibodies|mesh-list
43816984|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
43816985|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816986|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
43816987|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43816988|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
43816989|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43816990|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
43816991|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43832511|NCT05260359|Emollients|emollients|mesh-ancestor
43805825|NCT04920968|Rituximab|rituximab|mesh-list
43805826|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
43805827|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43805828|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805829|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
43805830|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805831|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805832|NCT04920747|Taxane|taxane|mesh-list
43805833|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43805834|NCT04920760|Vitamin A|vitamin a|mesh-list
43805835|NCT04920760|Vitamins|vitamins|mesh-ancestor
43616937|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43805836|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
43843243|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
43805837|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43805838|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
43805839|NCT04920669|Bupivacaine|bupivacaine|mesh-list
43805840|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
43805841|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
43817001|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817002|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43817003|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43806004|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817057|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817058|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
43817059|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817061|NCT02037048|Paclitaxel|paclitaxel|mesh-list
43817062|NCT02037048|Carboplatin|carboplatin|mesh-list
43817063|NCT02037048|Fluorouracil|fluorouracil|mesh-list
43817064|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
43817065|NCT02037048|Calcium|calcium|mesh-list
43817066|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
43817067|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43817068|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817069|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
43817070|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806017|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806018|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806019|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806020|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
43806021|NCT04918953|Hormones|hormones|mesh-ancestor
43847494|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806022|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806023|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43806024|NCT04918953|Protective Agents|protective agents|mesh-ancestor
43806025|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43847496|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43847497|NCT04099888|Gemcitabine|gemcitabine|mesh-list
43719002|NCT02639143|Clopidogrel|clopidogrel|mesh-list
43719003|NCT02639143|Ticagrelor|ticagrelor|mesh-list
43719004|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43719005|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43719006|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43719012|NCT02639234|Nivolumab|nivolumab|mesh-list
43719063|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719064|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719065|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
43806026|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806089|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806091|NCT04917250|Dexamethasone|dexamethasone|mesh-list
43806092|NCT04917250|Etoposide|etoposide|mesh-list
43806093|NCT04917250|Pegaspargase|pegaspargase|mesh-list
43806094|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806095|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
43806096|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
43806097|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806098|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806099|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806100|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
43806101|NCT04917250|Hormones|hormones|mesh-ancestor
43817075|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
43817076|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817077|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817078|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
43817079|NCT02037048|Antidotes|antidotes|mesh-ancestor
43817080|NCT02037048|Protective Agents|protective agents|mesh-ancestor
43817081|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
43817082|NCT02037048|Vitamins|vitamins|mesh-ancestor
43817083|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
43817084|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
43817085|NCT01852890|Gemcitabine|gemcitabine|mesh-list
43817086|NCT01852890|Vitamins|vitamins|mesh-ancestor
43817087|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
43817088|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817089|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817090|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
43817091|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817092|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817093|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
43817094|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817095|NCT01852890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817096|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817097|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
43817098|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
43817099|NCT01852890|Protective Agents|protective agents|mesh-ancestor
43817100|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
43817120|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
43817121|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
43817122|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845219|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817123|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817124|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817125|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
43719212|NCT02638285|Clomiphene|clomiphene|mesh-list
43806102|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806103|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806104|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806105|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43806106|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
43806107|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806108|NCT04917250|Antiviral Agents|antiviral agents|mesh-ancestor
43806109|NCT04917250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817128|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43817129|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817130|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
43817131|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
43817132|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
43817133|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817135|NCT01318317|Rituximab|rituximab|mesh-list
43817136|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43817137|NCT01318317|Antibodies|antibodies|mesh-list
43817138|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
43817139|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43817140|NCT01318317|Lenograstim|lenograstim|mesh-list
43817141|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
43817142|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817143|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817144|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817145|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43817146|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43817147|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43655255|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655256|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655257|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817148|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
43817149|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817150|NCT01121224|Clopidogrel|clopidogrel|mesh-list
43817151|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43817152|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43817154|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43817155|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
43817156|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817157|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817158|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845220|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845221|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
43845222|NCT04295330|Lidocaine|lidocaine|mesh-list
43845223|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
43845224|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
43845225|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806150|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
43719228|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719230|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43806151|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806152|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
43806153|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806154|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806155|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806156|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806157|NCT04916665|Teduglutide|teduglutide|mesh-list
43806158|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806159|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43806160|NCT04916665|Protective Agents|protective agents|mesh-ancestor
43806161|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806162|NCT04916509|Fulvestrant|fulvestrant|mesh-list
43806163|NCT04916509|Palbociclib|palbociclib|mesh-list
43806164|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43806165|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806166|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806167|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43806168|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43806169|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
43806170|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806171|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806172|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43806173|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806174|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806175|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43806176|NCT04916574|Antibodies|antibodies|mesh-list
43806177|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
43806178|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806179|NCT04916418|Ropivacaine|ropivacaine|mesh-list
43845228|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845229|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43719260|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832553|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832555|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
43832556|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832557|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43832558|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
43832559|NCT05257083|Hormones|hormones|mesh-ancestor
43832560|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43832561|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43832562|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832563|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43832564|NCT05257083|Growth Substances|growth substances|mesh-ancestor
43832565|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
43832566|NCT05256823|Celecoxib|celecoxib|mesh-list
43832569|NCT05256823|Analgesics|analgesics|mesh-ancestor
43719306|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43719308|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845230|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43845231|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43845232|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845233|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845234|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43845241|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43845242|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845243|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845244|NCT04294654|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43845245|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43845246|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43806180|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
43806181|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
43806182|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806183|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806184|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
43806185|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806186|NCT04916353|Triamcinolone|triamcinolone|mesh-list
43806187|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43806188|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43806189|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43806190|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806191|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
43806192|NCT04916353|Hormones|hormones|mesh-ancestor
43806193|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806194|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806195|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806196|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
43806197|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806198|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806199|NCT04916093|Metformin|metformin|mesh-list
43806200|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43806201|NCT04916093|Vildagliptin|vildagliptin|mesh-list
43806202|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43806203|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806204|NCT04916093|Incretins|incretins|mesh-ancestor
43806205|NCT04916093|Hormones|hormones|mesh-ancestor
43806207|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43719385|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845248|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845249|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
43845250|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43845251|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43845252|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43845253|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43848834|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
43817159|NCT00664040|Aspirin|aspirin|mesh-list
43806209|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806210|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806212|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43806213|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
43806214|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806215|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806216|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806217|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806218|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43806219|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43806220|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806221|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
43806222|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43817160|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817161|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817162|NCT00664040|Analgesics|analgesics|mesh-ancestor
43817163|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
43817164|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817165|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817166|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806223|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806224|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
43806225|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43806226|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
43806227|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806228|NCT04916080|Expectorants|expectorants|mesh-ancestor
43806229|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
43806230|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43806231|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
43806232|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806233|NCT04916080|Protective Agents|protective agents|mesh-ancestor
43806234|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806235|NCT04916080|Antidotes|antidotes|mesh-ancestor
43806287|NCT04914936|Omeprazole|omeprazole|mesh-list
43806288|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
43806289|NCT04914936|Calcium|calcium|mesh-list
43806290|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43806291|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806292|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43806293|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806294|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43806295|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817167|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817168|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43817169|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43817170|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817171|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43817172|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817173|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817175|NCT00559182|Omeprazole|omeprazole|mesh-list
43817176|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43817177|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817178|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43817179|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849630|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43849631|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806319|NCT04914598|Endostar protein|endostar protein|mesh-list
43806320|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806321|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43806322|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43806323|NCT04914598|Growth Substances|growth substances|mesh-ancestor
43806324|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806325|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843275|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43843276|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43806369|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
43806370|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
43806371|NCT04913103|Rituximab|rituximab|mesh-list
43806372|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43806373|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806374|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806375|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
43806376|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806377|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806378|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43806379|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
43806380|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806381|NCT04912934|Insulin|insulin|mesh-list
43806382|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43817180|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817182|NCT00476190|Dexamethasone|dexamethasone|mesh-list
43655258|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655259|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43655260|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43655261|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43655262|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43655263|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43655264|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655265|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655266|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
43817183|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
43806383|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806384|NCT04912700|Vaccines|vaccines|mesh-list
43806385|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
43806386|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806387|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
43806388|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
43806389|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43806390|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43806391|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806392|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806393|NCT04912726|Urological Agents|urological agents|mesh-ancestor
43806394|NCT04912167|Valsartan|valsartan|mesh-list
43806395|NCT04912167|Enalapril|enalapril|mesh-list
43806396|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43806397|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43555896|NCT03557853|Golimumab|golimumab|mesh-list
43806398|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43806399|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43843279|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43806405|NCT04912271|Aprepitant|aprepitant|mesh-list
43806421|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806422|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806423|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43806453|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43806454|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43806455|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43806456|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
43817185|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43817186|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43817187|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
43817188|NCT00476190|Doxorubicin|doxorubicin|mesh-list
43817189|NCT00476190|Methotrexate|methotrexate|mesh-list
43817191|NCT00476190|Vincristine|vincristine|mesh-list
43817192|NCT00476190|Asparaginase|asparaginase|mesh-list
43817193|NCT00476190|Pegaspargase|pegaspargase|mesh-list
43817194|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817195|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
43817196|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817197|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817198|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43817199|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
43817200|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817201|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817202|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43817203|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817204|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
43817205|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
43817221|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817222|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43817223|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43817224|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43817225|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
43817226|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817227|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
43817228|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
43817229|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
43817230|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43806521|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806522|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806531|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
43806533|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
43806534|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806535|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43806536|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43806537|NCT04909918|Dexamethasone|dexamethasone|mesh-list
43806538|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
43806539|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43806540|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43806541|NCT04909918|Prednisolone|prednisolone|mesh-list
43806542|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
43806543|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43806544|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
43806545|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806547|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
43806548|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806549|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806550|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806551|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
43806552|NCT04909918|Hormones|hormones|mesh-ancestor
43806553|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43806554|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43806555|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806556|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43806557|NCT04909918|Protective Agents|protective agents|mesh-ancestor
43806558|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
43806559|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43806560|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806561|NCT04909619|Anesthetics|anesthetics|mesh-list
43806562|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
43806563|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806565|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
43817231|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43817232|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817233|NCT05558397|Morphine|morphine|mesh-list
43817234|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43817235|NCT05558397|Narcotics|narcotics|mesh-ancestor
43817236|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817237|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817238|NCT05558397|Analgesics|analgesics|mesh-ancestor
43817239|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
43719569|NCT02635282|Ketamine|ketamine|mesh-list
43719570|NCT02635282|Analgesics|analgesics|mesh-ancestor
43719571|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
43719572|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719573|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719574|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43719575|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817240|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817241|NCT05558319|Dexamethasone|dexamethasone|mesh-list
43817242|NCT05558319|Lenalidomide|lenalidomide|mesh-list
43817243|NCT05558319|Bortezomib|bortezomib|mesh-list
43817244|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817245|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
43817246|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
43817247|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806613|NCT04909151|Methamphetamine|methamphetamine|mesh-list
43806614|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43806615|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806616|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
43806617|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
43806618|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806619|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
43806620|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655274|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655275|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655277|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
43655278|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655279|NCT02970175|Terlipressin|terlipressin|mesh-list
43655280|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43655281|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43655282|NCT02970097|Fentanyl|fentanyl|mesh-list
43655283|NCT02970097|Midazolam|midazolam|mesh-list
43655284|NCT02970097|Ropivacaine|ropivacaine|mesh-list
43655285|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43655286|NCT02970097|Narcotics|narcotics|mesh-ancestor
43655287|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655288|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655289|NCT02970097|Analgesics|analgesics|mesh-ancestor
43655290|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
43655291|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817253|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817254|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817255|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
43817256|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43817257|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43817258|NCT05558319|Growth Substances|growth substances|mesh-ancestor
43817259|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
43843379|NCT04460872|Androgens|androgens|mesh-ancestor
43843381|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843382|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843383|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843384|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843385|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
43843386|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
43555950|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
43843387|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
43843388|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843389|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
43843390|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43843391|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
43843392|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843393|NCT04459052|Expectorants|expectorants|mesh-ancestor
43843394|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
43843395|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43843396|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
43843397|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843398|NCT04459052|Protective Agents|protective agents|mesh-ancestor
43843399|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843400|NCT04459052|Antidotes|antidotes|mesh-ancestor
43843401|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
43843402|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843403|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
43843404|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817261|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817262|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
43817263|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817264|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
43817276|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817278|NCT05558124|Cytarabine|cytarabine|mesh-list
43817279|NCT05558124|Daunorubicin|daunorubicin|mesh-list
43817280|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
43817281|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817282|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
43817283|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817284|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817285|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
43817286|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43843405|NCT04457284|Cisplatin|cisplatin|mesh-list
43843406|NCT04457284|Nivolumab|nivolumab|mesh-list
43843407|NCT04457284|Temozolomide|temozolomide|mesh-list
43806642|NCT04908345|Methadone|methadone|mesh-list
43806643|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43555978|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43555979|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
43555980|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43555981|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43555982|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43555983|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43555984|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
43555985|NCT03556839|Paclitaxel|paclitaxel|mesh-list
43719576|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
43719577|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
43719578|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806644|NCT04908345|Narcotics|narcotics|mesh-ancestor
43806645|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806669|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
43806670|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806671|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806672|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43806673|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806674|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43806675|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806676|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806677|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
43806678|NCT04907838|BQ 788|bq 788|mesh-list
43806679|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43806680|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43806681|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806682|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43806683|NCT04907474|Phenylephrine|phenylephrine|mesh-list
43817287|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817288|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
43817289|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817290|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43817291|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43655292|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43655293|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43655294|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
43655296|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43655297|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43806701|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806702|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806703|NCT04907474|Protective Agents|protective agents|mesh-ancestor
43806704|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43806705|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43806706|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
43806709|NCT04907747|Esomeprazole|esomeprazole|mesh-list
43806710|NCT04907747|Bismuth|bismuth|mesh-list
43806711|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43806712|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43806713|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43806714|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43806715|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43806716|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655298|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43817292|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43817293|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817294|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817295|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43817296|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
43817297|NCT05557903|Antibodies|antibodies|mesh-list
43817298|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
43817299|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43817300|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
43817301|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817302|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817303|NCT05557838|Durvalumab|durvalumab|mesh-list
43817304|NCT05557838|Tremelimumab|tremelimumab|mesh-list
43817305|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817306|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43630495|NCT03051711|Pyrazole|pyrazole|mesh-list
43817307|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43817308|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
43817309|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43555998|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43555999|NCT03556839|Growth Substances|growth substances|mesh-ancestor
43817310|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
43817311|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43556000|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817312|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43617983|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43806717|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806718|NCT04907747|Antacids|antacids|mesh-ancestor
43806719|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43806720|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43806721|NCT04907747|Renal Agents|renal agents|mesh-ancestor
43806722|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
43806723|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43806724|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43806725|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
43806726|NCT04907123|Diuretics|diuretics|mesh-list
43806727|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
43806728|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806729|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43806730|NCT04907110|Niacinamide|niacinamide|mesh-list
43806731|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
43806732|NCT04907110|Vitamins|vitamins|mesh-ancestor
43806733|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
43806735|NCT04907344|Paclitaxel|paclitaxel|mesh-list
43817313|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43817314|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817315|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817316|NCT05557591|Cemiplimab|cemiplimab|mesh-list
43817317|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817318|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817319|NCT05557578|Gemcitabine|gemcitabine|mesh-list
43817320|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
43817321|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817322|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
43817323|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817324|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817325|NCT05557578|Antiviral Agents|antiviral agents|mesh-ancestor
43817326|NCT05557578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817327|NCT05557578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817336|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817337|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
43817338|NCT05557149|Cocaine|cocaine|mesh-list
43817339|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817340|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
43817341|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817342|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817343|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
43817344|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817345|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43817346|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43817347|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43817348|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43806752|NCT04906876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556009|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806753|NCT04906876|Immunologic Factors|immunologic factors|mesh-ancestor
43556011|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43806754|NCT04906876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806755|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
43806756|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
43806757|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
43806758|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
43806759|NCT04906772|Ketamine|ketamine|mesh-list
43806760|NCT04906772|Propofol|propofol|mesh-list
43817349|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817350|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
43817351|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817352|NCT05557136|Ether|ether|mesh-list
43817353|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43817354|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
43817355|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
43817356|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817357|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817358|NCT05557110|Blinatumomab|blinatumomab|mesh-list
43817359|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817360|NCT05556889|Iodine|iodine|mesh-list
43817361|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43719593|NCT02635074|Idarubicin|idarubicin|mesh-list
43719594|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43719595|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
43719596|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719598|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
43719599|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719600|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43719601|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
43719602|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719603|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43719604|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556037|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43556038|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43556039|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556040|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
43556041|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43556042|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
43556043|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556045|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
43556046|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43556047|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
43556048|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556049|NCT03556371|Protective Agents|protective agents|mesh-ancestor
43655299|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43806807|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806808|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43806809|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
43806811|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43817362|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817363|NCT05556889|Trace Elements|trace elements|mesh-ancestor
43817364|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
43817365|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817367|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
43817368|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845254|NCT04292756|Triamcinolone|triamcinolone|mesh-list
43845255|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43845256|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43845257|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43845258|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845259|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
43845260|NCT04292756|Hormones|hormones|mesh-ancestor
43845261|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845262|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43806813|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43806814|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43806815|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
43806816|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
43806817|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806818|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806819|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43806820|NCT04906317|Narcotics|narcotics|mesh-ancestor
43806821|NCT04906317|Analgesics|analgesics|mesh-ancestor
43806822|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
43806823|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43806824|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
43806825|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43806826|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43806833|NCT04906304|Everolimus|everolimus|mesh-list
43845263|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845264|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
43845265|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845266|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845267|NCT04292743|Leucovorin|leucovorin|mesh-list
43845268|NCT04292743|Fluorouracil|fluorouracil|mesh-list
43845269|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
43845270|NCT04292743|Irinotecan|irinotecan|mesh-list
43845271|NCT04292743|Folfirinox|folfirinox|mesh-list
43817369|NCT05556473|Tryptophan|tryptophan|mesh-list
43556060|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556061|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43556062|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556063|NCT03555994|Liraglutide|liraglutide|mesh-list
43817370|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43817371|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
43817372|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817373|NCT05556408|Propofol|propofol|mesh-list
43817374|NCT05556408|Succinylcholine|succinylcholine|mesh-list
43817375|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43817376|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817377|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817396|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817397|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
43817398|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817399|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817400|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
43817401|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817402|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817403|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
43817404|NCT05556122|Hormones|hormones|mesh-ancestor
43817405|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817406|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43817407|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
43817408|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
43817409|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
43817410|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43817411|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43817412|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655312|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655313|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
43655314|NCT02970084|Coagulants|coagulants|mesh-ancestor
43655315|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
43655316|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655317|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
43719614|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719615|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43719616|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43719617|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43806882|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43806884|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43806885|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43806886|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43806887|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43806888|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43806889|NCT04905563|Narcotics|narcotics|mesh-ancestor
43817418|NCT05555823|Celecoxib|celecoxib|mesh-list
43817419|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817420|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817421|NCT05555823|Analgesics|analgesics|mesh-ancestor
43817422|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
43817423|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817424|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817425|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817426|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817427|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43817428|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817429|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817430|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817431|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43817432|NCT05555667|Propofol|propofol|mesh-list
43817433|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43817434|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817445|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817446|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817447|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817448|NCT05555641|Analgesics|analgesics|mesh-ancestor
43817449|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
43817450|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817451|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817452|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817453|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817454|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
43817455|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849633|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43655325|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
43655326|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
43817456|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43817457|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43817458|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43817459|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817460|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
43817461|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
43817462|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817463|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
43817464|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
43817465|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817466|NCT05555576|Ascorbic Acid|ascorbic acid|mesh-list
43817468|NCT05555576|Micronutrients|micronutrients|mesh-ancestor
43817469|NCT05555576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817470|NCT05555576|Antioxidants|antioxidants|mesh-ancestor
43817471|NCT05555576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817472|NCT05555576|Protective Agents|protective agents|mesh-ancestor
43817473|NCT05555316|Lenvatinib|lenvatinib|mesh-list
43817474|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817475|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43817476|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817477|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817478|NCT05555303|Amikacin|amikacin|mesh-list
43806890|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43806892|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
43843408|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843409|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843410|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43843411|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719640|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43719641|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43843412|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43843413|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
43843414|NCT04457232|FAPI-46|fapi-46|mesh-list
43843415|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43843416|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843417|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
43843418|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843419|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843420|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43843421|NCT04456699|Leucovorin|leucovorin|mesh-list
43843422|NCT04456699|Bevacizumab|bevacizumab|mesh-list
43843423|NCT04456699|Fluorouracil|fluorouracil|mesh-list
43843424|NCT04456699|Capecitabine|capecitabine|mesh-list
43843425|NCT04456699|Olaparib|olaparib|mesh-list
43817497|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817498|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43817499|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
43817500|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
43817501|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43655327|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43655328|NCT02969720|Protective Agents|protective agents|mesh-ancestor
43655329|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655330|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
43655331|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43655332|NCT02969746|Charcoal|charcoal|mesh-list
43655333|NCT02969746|Antidotes|antidotes|mesh-ancestor
43655334|NCT02969746|Protective Agents|protective agents|mesh-ancestor
43655335|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655336|NCT02969733|Lidocaine|lidocaine|mesh-list
43655337|NCT02969733|Ketamine|ketamine|mesh-list
43655338|NCT02969733|Analgesics|analgesics|mesh-ancestor
43655339|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
43655340|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655341|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843426|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
43843427|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43843428|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843429|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43843430|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43843431|NCT04456699|Growth Substances|growth substances|mesh-ancestor
43843439|NCT04456699|Antidotes|antidotes|mesh-ancestor
43655342|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43655343|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817502|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817503|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817504|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817505|NCT05554848|Analgesics|analgesics|mesh-ancestor
43817506|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
43817507|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817508|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43817509|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43817510|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43817511|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817512|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817521|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43817522|NCT05554822|Aspirin|aspirin|mesh-list
43843444|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43843445|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843446|NCT04455750|Leuprolide|leuprolide|mesh-list
43843447|NCT04455750|Goserelin|goserelin|mesh-list
43843448|NCT04455750|Rucaparib|rucaparib|mesh-list
43843449|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43843450|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
43556104|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43843451|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43843452|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556105|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43556106|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556107|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43556108|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843453|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43843454|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843455|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43843456|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817523|NCT05554822|Clopidogrel|clopidogrel|mesh-list
43817524|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817525|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817526|NCT05554822|Analgesics|analgesics|mesh-ancestor
43817527|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
43817528|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817529|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817530|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817531|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817532|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43817533|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43817534|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817535|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43817536|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817537|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817538|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
43817539|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43817540|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43817541|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43817542|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
43817543|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817544|NCT05554731|Hemostatics|hemostatics|mesh-list
43817545|NCT05554731|Coagulants|coagulants|mesh-ancestor
43817546|NCT05554627|Aripiprazole|aripiprazole|mesh-list
43817547|NCT05554627|Esketamine|esketamine|mesh-list
43817548|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
43817549|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817550|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43817551|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43655344|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
43655345|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
43655346|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655347|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43655348|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43817552|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817553|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43630742|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
43817554|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
43817556|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817557|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556111|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43556112|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43556113|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43556114|NCT03555526|Renal Agents|renal agents|mesh-ancestor
43556115|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43556116|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43556117|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556118|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43556119|NCT03555526|Antacids|antacids|mesh-ancestor
43556120|NCT03555487|Choline|choline|mesh-list
43556121|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
43556122|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43817558|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43817559|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43817560|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
43817561|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43817562|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43817563|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43817564|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43817565|NCT05554276|Antibodies|antibodies|mesh-list
43817566|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
43817567|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817568|NCT05554224|Liver Extracts|liver extracts|mesh-list
43817569|NCT05554224|Hematinics|hematinics|mesh-ancestor
43845273|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845274|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845275|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43806980|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43806981|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43806982|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
43806983|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43806988|NCT04903275|Fluorides|fluorides|mesh-list
43845277|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
43845278|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845279|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43845280|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43845296|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43845297|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
43845298|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845299|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845300|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43845301|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
43845302|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845303|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
43845304|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845306|NCT04292054|Tazobactam|tazobactam|mesh-list
43807024|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
43807025|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807026|NCT04902885|Carboplatin|carboplatin|mesh-list
43807027|NCT04902885|Etoposide|etoposide|mesh-list
43807028|NCT04902885|Topotecan|topotecan|mesh-list
43807029|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807030|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43807031|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43807032|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43807033|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807034|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807035|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43807036|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
43807037|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43807038|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43807039|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807040|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
43807041|NCT04902950|Coagulants|coagulants|mesh-ancestor
43807042|NCT04902638|Dexamethasone|dexamethasone|mesh-list
43807043|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556130|NCT03555188|Ondansetron|ondansetron|mesh-list
43556131|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
43556132|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
43556133|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556134|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556135|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43556136|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
43556137|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
43556138|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43556139|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
43556140|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807044|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
43807045|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
43845307|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845308|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845309|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43845310|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845311|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845312|NCT04291885|Avelumab|avelumab|mesh-list
43845313|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845314|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845315|NCT04291508|Acetaminophen|acetaminophen|mesh-list
43845316|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
43845317|NCT04291508|Vitamins|vitamins|mesh-ancestor
43845318|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
43845319|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845320|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43807046|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43807047|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807048|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807049|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
43807050|NCT04902638|Hormones|hormones|mesh-ancestor
43845327|NCT04291508|Protective Agents|protective agents|mesh-ancestor
43845328|NCT04290624|Listerine|listerine|mesh-list
43845329|NCT04290624|Fluorides|fluorides|mesh-list
43845330|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
43630818|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
43845331|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
43845332|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
43845333|NCT04290624|Protective Agents|protective agents|mesh-ancestor
43845334|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817573|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817576|NCT05554185|Aspirin|aspirin|mesh-list
43817577|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817578|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817589|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43817590|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817591|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
43817592|NCT05554133|Proflavine|proflavine|mesh-list
43817593|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43817594|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817595|NCT05554094|Psilocybin|psilocybin|mesh-list
43817596|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
43817597|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817598|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817599|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43817600|NCT05554055|Dalteparin|dalteparin|mesh-list
43817601|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
43817602|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43817603|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43817604|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817605|NCT05554003|Temozolomide|temozolomide|mesh-list
43556141|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556142|NCT03555188|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43817606|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43817607|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
43817608|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556143|NCT03555188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556144|NCT03555188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556145|NCT03555188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556146|NCT03555188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43556147|NCT03555136|Vortioxetine|vortioxetine|mesh-list
43556148|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
43817609|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817610|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43817611|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817612|NCT05553717|Carvedilol|carvedilol|mesh-list
43817613|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43817614|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43817615|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817616|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807132|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807133|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807134|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43807135|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43807136|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43807137|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807138|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807139|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43807140|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43807141|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43807142|NCT04901117|Amoxicillin|amoxicillin|mesh-list
43807143|NCT04901117|Metronidazole|metronidazole|mesh-list
43807144|NCT04901117|Clarithromycin|clarithromycin|mesh-list
43807145|NCT04901117|Tetracycline|tetracycline|mesh-list
43655355|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43817643|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817644|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43817645|NCT05553665|Narcotics|narcotics|mesh-ancestor
43817646|NCT05553665|Analgesics|analgesics|mesh-ancestor
43817647|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43817648|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817649|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
43817650|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43817651|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43817652|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43817653|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817654|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
43817655|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
43817656|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817657|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
43817658|NCT05553496|Cyclosporine|cyclosporine|mesh-list
43817659|NCT05553496|Dexamethasone|dexamethasone|mesh-list
43817660|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
43817661|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
43817663|NCT05553496|Tacrolimus|tacrolimus|mesh-list
43817664|NCT05553496|Cyclosporins|cyclosporins|mesh-list
43817665|NCT05553496|BB 1101|bb 1101|mesh-list
43817666|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43817667|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
43817668|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817669|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817670|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43817671|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
43817672|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817673|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817674|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43817688|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
43817689|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817690|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
43817691|NCT05553184|Niacin|niacin|mesh-list
43817692|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
43817693|NCT05553184|Niacinamide|niacinamide|mesh-list
43817694|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
43817695|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43817697|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556157|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556158|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556160|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43817698|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817699|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43807204|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43807205|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
43807206|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43807207|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817700|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
43817701|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43817702|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43817703|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43817704|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817705|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817706|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817707|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43817708|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
43817709|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43817710|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
43817711|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
43817712|NCT05553184|Vitamins|vitamins|mesh-ancestor
43817713|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
43817714|NCT05553093|Insulin|insulin|mesh-list
43655357|NCT02969629|Emetics|emetics|mesh-ancestor
43655358|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655359|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
43655360|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655361|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43655362|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
43655363|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
43655364|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817715|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43817716|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
43719650|NCT02634476|Ethanol|ethanol|mesh-list
43817717|NCT05553093|Tirzepatide|tirzepatide|mesh-list
43817718|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43817719|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817720|NCT05553093|Incretins|incretins|mesh-ancestor
43817721|NCT05553093|Hormones|hormones|mesh-ancestor
43817722|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817723|NCT05553067|Antibodies|antibodies|mesh-list
43817724|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
43817725|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817726|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
43817727|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817728|NCT05552937|Lenalidomide|lenalidomide|mesh-list
43807208|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817729|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
43817730|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807209|NCT04901104|Thymalfasin|thymalfasin|mesh-list
43807210|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43807211|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
43807212|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817732|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43817733|NCT05552937|Growth Substances|growth substances|mesh-ancestor
43817734|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
43817735|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817736|NCT05552807|Paclitaxel|paclitaxel|mesh-list
43817737|NCT05552807|Docetaxel|docetaxel|mesh-list
43817738|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43817762|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
43817763|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817764|NCT05552586|Protective Agents|protective agents|mesh-ancestor
43556198|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556199|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
43556201|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
43556202|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43556203|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556204|NCT03554590|Insulin|insulin|mesh-list
43719661|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719662|NCT02634463|Olanzapine|olanzapine|mesh-list
43719663|NCT02634463|Risperidone|risperidone|mesh-list
43719664|NCT02634463|Aripiprazole|aripiprazole|mesh-list
43719665|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43719666|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43719667|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
43719668|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719669|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43719670|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817774|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
43817775|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817776|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43817777|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817779|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43817780|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43817781|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43817782|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817783|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817784|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817785|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43817786|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817787|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
43817788|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43817789|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43817790|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
43817791|NCT05552287|Infliximab|infliximab|mesh-list
43807242|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43807243|NCT04900311|Trastuzumab|trastuzumab|mesh-list
43807244|NCT04900311|Pertuzumab|pertuzumab|mesh-list
43807246|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807339|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43817793|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817794|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43817796|NCT05551910|Propofol|propofol|mesh-list
43817797|NCT05551910|Esketamine|esketamine|mesh-list
43817798|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43817799|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719671|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43719672|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719673|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719674|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817800|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719675|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43719676|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
43719677|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
43719678|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
43719679|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719680|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43719681|NCT02634463|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43556205|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43556206|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556208|NCT03554447|Dexetimide|dexetimide|mesh-list
43556209|NCT03554447|Citalopram|citalopram|mesh-list
43556210|NCT03554447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43556211|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43556212|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556213|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556214|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556215|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
43556216|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817801|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817802|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
43817803|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
43817804|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43817805|NCT05551910|Narcotics|narcotics|mesh-ancestor
43817806|NCT05551910|Analgesics|analgesics|mesh-ancestor
43817807|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
43817808|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655365|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655366|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
43655367|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655368|NCT02969681|Vitamins|vitamins|mesh-ancestor
43655369|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
43655370|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
43655371|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655372|NCT02969681|Protective Agents|protective agents|mesh-ancestor
43655373|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
43655374|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43817809|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
43817810|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845335|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43845336|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845337|NCT04289805|Letrozole|letrozole|mesh-list
43845338|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845339|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43556217|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43556218|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
43556219|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845340|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43845341|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845342|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845343|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43845344|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
43845345|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845346|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845347|NCT04289779|Atezolizumab|atezolizumab|mesh-list
43845348|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845349|NCT04288778|Metformin|metformin|mesh-list
43845350|NCT04288778|Canagliflozin|canagliflozin|mesh-list
43845351|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845352|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845353|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43845354|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817838|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43817839|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
43817840|NCT05551624|Protective Agents|protective agents|mesh-ancestor
43817841|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817842|NCT05551624|Antidotes|antidotes|mesh-ancestor
43817843|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
43817844|NCT05551598|Analgesics|analgesics|mesh-ancestor
43817845|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
43817846|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817847|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817848|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817849|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43817850|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43817851|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817852|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817862|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43817867|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817868|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817869|NCT05551221|Urological Agents|urological agents|mesh-ancestor
43817871|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43817872|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817873|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43817874|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43817875|NCT05551208|Growth Substances|growth substances|mesh-ancestor
43556290|NCT03554109|Antidotes|antidotes|mesh-ancestor
43655375|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655376|NCT02969447|Oxytocin|oxytocin|mesh-list
43655377|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
43655378|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43655379|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655380|NCT02969473|Cisplatin|cisplatin|mesh-list
43655381|NCT02969473|Docetaxel|docetaxel|mesh-list
43655382|NCT02969473|Fluorouracil|fluorouracil|mesh-list
43655383|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655384|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
43655385|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
43655386|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
43655387|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655388|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
43655389|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43817876|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817877|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
43817878|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
43817879|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43817880|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817881|NCT05550597|Fentanyl|fentanyl|mesh-list
43817882|NCT05550597|Bupivacaine|bupivacaine|mesh-list
43817883|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
43817884|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
43817885|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43817886|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817887|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
43817888|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817889|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43817890|NCT05550597|Narcotics|narcotics|mesh-ancestor
43817891|NCT05550597|Analgesics|analgesics|mesh-ancestor
43817892|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43817893|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43817894|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
43817895|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43817896|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43817897|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43817898|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43807515|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
43807516|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807517|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43807518|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43807519|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43807520|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43807521|NCT04897386|Pemetrexed|pemetrexed|mesh-list
43807522|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43807523|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817899|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817901|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817902|NCT05550506|Analgesics|analgesics|mesh-ancestor
43817903|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
43817904|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817905|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
43817906|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43817907|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
43817908|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
43817909|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43817910|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817911|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43817912|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817913|NCT05550415|Simvastatin|simvastatin|mesh-list
43817914|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43817915|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43817916|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
43655390|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655392|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655393|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
43655394|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
43655395|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655396|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
43817917|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817944|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43817945|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43817946|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817947|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
43817948|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43817949|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817950|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
43817951|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
43817952|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817953|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43817954|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43817955|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
43817956|NCT05550246|Urological Agents|urological agents|mesh-ancestor
43817958|NCT05550207|Rizatriptan|rizatriptan|mesh-list
43817959|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43817960|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43817961|NCT05550207|Analgesics|analgesics|mesh-ancestor
43817962|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
43556341|NCT03553433|Analgesics|analgesics|mesh-ancestor
43556342|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
43556343|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556344|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556345|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556346|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556347|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43556348|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43556349|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556350|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556352|NCT03553329|Dabrafenib|dabrafenib|mesh-list
43556353|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556354|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43556355|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43719702|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43817963|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817964|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817965|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817978|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43817979|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43817980|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43817981|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817982|NCT05549973|Dexamethasone|dexamethasone|mesh-list
43817983|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43817984|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
43817985|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
43817986|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43817987|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817988|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817989|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
43817990|NCT05549973|Hormones|hormones|mesh-ancestor
43817991|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817992|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43817993|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845357|NCT04283500|Naloxone|naloxone|mesh-list
43845358|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43845359|NCT04283500|Narcotics|narcotics|mesh-ancestor
43845360|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845361|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845362|NCT04283500|Analgesics|analgesics|mesh-ancestor
43845363|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
43845364|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845365|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43845366|NCT04282187|Azacitidine|azacitidine|mesh-list
43845367|NCT04282187|Decitabine|decitabine|mesh-list
43845368|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43845369|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845370|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
43845371|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845372|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845373|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845374|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43845375|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
43845376|NCT04282174|Melphalan|melphalan|mesh-list
43845377|NCT04282174|Busulfan|busulfan|mesh-list
43719703|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
43719706|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43719707|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43719708|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719709|NCT02634281|Varenicline|varenicline|mesh-list
43719710|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43719711|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43719712|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845378|NCT04282174|Thiotepa|thiotepa|mesh-list
43845379|NCT04282174|Fludarabine|fludarabine|mesh-list
43655397|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655398|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43655399|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43655400|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845380|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845381|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
43807613|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43807614|NCT04895800|Caffeine|caffeine|mesh-list
43807615|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43807616|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807617|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43807618|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43807619|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807620|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43807621|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43807622|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
43807623|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807682|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
43807683|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43807684|NCT04893733|Hematinics|hematinics|mesh-ancestor
43807685|NCT04893629|Digoxin|digoxin|mesh-list
43807686|NCT04893629|Captopril|captopril|mesh-list
43807687|NCT04893629|Furosemide|furosemide|mesh-list
43807688|NCT04893629|Diuretics|diuretics|mesh-ancestor
43807748|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818004|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818005|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43818006|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43818007|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43818008|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818009|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43818010|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43818011|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43818012|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43818013|NCT05549583|Metformin|metformin|mesh-list
43818015|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43818016|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818017|NCT05549583|Incretins|incretins|mesh-ancestor
43818018|NCT05549583|Hormones|hormones|mesh-ancestor
43818019|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818020|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43818021|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
43818022|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818023|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818024|NCT05549570|Metformin|metformin|mesh-list
43818025|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43818026|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43818027|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818028|NCT05549570|Incretins|incretins|mesh-ancestor
43818029|NCT05549570|Hormones|hormones|mesh-ancestor
43818030|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818031|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43818032|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
43818033|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818034|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556384|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
43818035|NCT05549505|Anastrozole|anastrozole|mesh-list
43818036|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43818037|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818045|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818046|NCT05549492|Buprenorphine|buprenorphine|mesh-list
43818047|NCT05549492|Ropivacaine|ropivacaine|mesh-list
43818048|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818049|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
43818050|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818051|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818052|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
43818053|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818054|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43818055|NCT05549492|Narcotics|narcotics|mesh-ancestor
43818056|NCT05549492|Analgesics|analgesics|mesh-ancestor
43818057|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43818058|NCT05549466|Gemcitabine|gemcitabine|mesh-list
43818059|NCT05549466|Capecitabine|capecitabine|mesh-list
43818061|NCT05549466|Apatinib|apatinib|mesh-list
43818062|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818063|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
43818064|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818065|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818066|NCT05549466|Antiviral Agents|antiviral agents|mesh-ancestor
43818067|NCT05549466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655405|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43807767|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43807768|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
43807769|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43807770|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43807771|NCT04892511|Protective Agents|protective agents|mesh-ancestor
43807772|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43655408|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43655409|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655410|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
43818068|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818069|NCT05549466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818070|NCT05549466|Immunologic Factors|immunologic factors|mesh-ancestor
43818071|NCT05549466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631377|NCT03044938|Albuterol|albuterol|mesh-list
43818072|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
43818073|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
43818074|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
43818075|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43818076|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43818077|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818078|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818079|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
43818080|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818081|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818082|NCT05549284|Rituximab|rituximab|mesh-list
43818083|NCT05549284|Methotrexate|methotrexate|mesh-list
43818084|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818085|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818086|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
43818087|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818088|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818089|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43818090|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
43818091|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43818092|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818093|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
43818094|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818095|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818096|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818097|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43818098|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818099|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43818100|NCT05549167|Sirolimus|sirolimus|mesh-list
43818101|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818102|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818103|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43818138|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818139|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843581|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843582|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843583|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43843584|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
43843585|NCT04440371|Hormones|hormones|mesh-ancestor
43843586|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43843587|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43843589|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818141|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
43818142|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719723|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
43719724|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
43719725|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43719726|NCT02634255|Narcotics|narcotics|mesh-ancestor
43719727|NCT02634255|Analgesics|analgesics|mesh-ancestor
43818143|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43818144|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43631451|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
43818162|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43818163|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
43818164|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
43818165|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818166|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818167|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818168|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
43818169|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43818170|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
43818171|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43843599|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43843600|NCT04439318|Protective Agents|protective agents|mesh-ancestor
43843601|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843602|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43843603|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
43843604|NCT04439292|Trametinib|trametinib|mesh-list
43843605|NCT04439292|Dabrafenib|dabrafenib|mesh-list
43843606|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
43843607|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843608|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43843609|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843610|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843611|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43843612|NCT04439292|Protective Agents|protective agents|mesh-ancestor
43843613|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43843614|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43843615|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
43843616|NCT04439227|Adavosertib|adavosertib|mesh-list
43843617|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43843618|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43843619|NCT04439201|Palbociclib|palbociclib|mesh-list
43843620|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43843621|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655411|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43655412|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43655414|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
43655415|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43655416|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655417|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655418|NCT02969239|Phenylephrine|phenylephrine|mesh-list
43655419|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
43655420|NCT02969239|Norepinephrine|norepinephrine|mesh-list
43655421|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
43655422|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43655423|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
43845399|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845400|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845401|NCT04281420|Niacin|niacin|mesh-list
43845402|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43845403|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
43845404|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845405|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43845406|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
43845407|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
43845408|NCT04281420|Vitamins|vitamins|mesh-ancestor
43845409|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
43845410|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845411|NCT04280406|Azithromycin|azithromycin|mesh-list
43845412|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845413|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845414|NCT04280055|Psilocybin|psilocybin|mesh-list
43845415|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
43845416|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845417|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43845418|NCT04279561|Edetic Acid|edetic acid|mesh-list
43556484|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43556485|NCT03552575|Valsartan|valsartan|mesh-list
43556486|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43556487|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43556488|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43556489|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43556490|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556491|NCT03552406|Cetuximab|cetuximab|mesh-list
43556492|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43556493|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556495|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
43556505|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556506|NCT03552211|Biotin|biotin|mesh-list
43556507|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
43556508|NCT03552211|Vitamins|vitamins|mesh-ancestor
43556509|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
43556510|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556511|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
43845419|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43845420|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
43845421|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
43845422|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818201|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818202|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818203|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
43818204|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
43818205|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43818206|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818207|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818208|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43818209|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43818210|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43818245|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818246|NCT05546879|Bevacizumab|bevacizumab|mesh-list
43818247|NCT05546879|Atezolizumab|atezolizumab|mesh-list
43818248|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818249|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818250|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43818264|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
43818265|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43818266|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818267|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818268|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43818269|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43818270|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818271|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818272|NCT05546853|Antidotes|antidotes|mesh-ancestor
43818273|NCT05546853|Protective Agents|protective agents|mesh-ancestor
43818274|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
43818275|NCT05546853|Vitamins|vitamins|mesh-ancestor
43818276|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
43818277|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
43818278|NCT05546762|Povidone|povidone|mesh-list
43818279|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
43818280|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
43818281|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43818282|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818283|NCT05546710|Anesthetics|anesthetics|mesh-list
43818303|NCT05546411|Protective Agents|protective agents|mesh-ancestor
43818304|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
43818305|NCT05546411|Vitamins|vitamins|mesh-ancestor
43818306|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
43818307|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43818308|NCT05546359|Dexamethasone|dexamethasone|mesh-list
43818309|NCT05546359|Ondansetron|ondansetron|mesh-list
43818310|NCT05546359|Amisulpride|amisulpride|mesh-list
43818311|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818312|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
43818313|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
43818314|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818315|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818316|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818317|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
43818318|NCT05546359|Hormones|hormones|mesh-ancestor
43843719|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
43843720|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43848731|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848732|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43848733|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848734|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43848735|NCT03998709|Somatostatin|somatostatin|mesh-list
43808335|NCT04884282|Docetaxel|docetaxel|mesh-list
43556528|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818319|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818320|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43818322|NCT05546359|Antipruritics|antipruritics|mesh-ancestor
43818323|NCT05546359|Dermatologic Agents|dermatologic agents|mesh-ancestor
43655431|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43655432|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43655433|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655434|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655435|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655436|NCT02969239|Protective Agents|protective agents|mesh-ancestor
43818324|NCT05546359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43818325|NCT05546359|Serotonin Agents|serotonin agents|mesh-ancestor
43818326|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818327|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818328|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43818329|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43818330|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818331|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818332|NCT05546359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43818333|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43818335|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43818336|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
43818369|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845457|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845458|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
43845459|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845460|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845461|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
43845462|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43845463|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43845464|NCT04277845|Growth Substances|growth substances|mesh-ancestor
43845465|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
43845466|NCT04277442|Nivolumab|nivolumab|mesh-list
43845467|NCT04277442|Decitabine|decitabine|mesh-list
43845468|NCT04277442|Venetoclax|venetoclax|mesh-list
43845469|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845470|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845471|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845472|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845473|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845474|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
43845475|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845476|NCT04276155|Anticoagulants|anticoagulants|mesh-list
43845477|NCT04275518|Cytarabine|cytarabine|mesh-list
43845478|NCT04275518|Azacitidine|azacitidine|mesh-list
43845479|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845480|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
43845481|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845482|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845483|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
43845484|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845485|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845486|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
43845487|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845488|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845489|NCT04275375|Anesthetics|anesthetics|mesh-list
43845491|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845492|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43845493|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
43655437|NCT02968901|Tadalafil|tadalafil|mesh-list
43655438|NCT02968901|Macitentan|macitentan|mesh-list
43655439|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
43655440|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43655441|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43655442|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556540|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818416|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43818417|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818418|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818419|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43818420|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
43818422|NCT05545384|Rituximab|rituximab|mesh-list
43818423|NCT05545384|Azathioprine|azathioprine|mesh-list
43818424|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818425|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818426|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
43818427|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818428|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818429|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
43818430|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818431|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43818432|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43818433|NCT05545059|Amlodipine|amlodipine|mesh-list
43818434|NCT05545059|Valsartan|valsartan|mesh-list
43818435|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
43818436|NCT05545059|Spironolactone|spironolactone|mesh-list
43818437|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43818438|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43818439|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43818440|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818441|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818442|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43818443|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43631862|NCT03041779|Acetaminophen|acetaminophen|mesh-list
43818444|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
43818473|NCT05544253|Mitomycins|mitomycins|mesh-list
43818474|NCT05544253|Mitomycin|mitomycin|mesh-list
43818475|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43818476|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818477|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
43818478|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818479|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43818482|NCT05544045|Antacids|antacids|mesh-ancestor
43818483|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818484|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43818485|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43818486|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43818487|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818488|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
43818489|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43818496|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818497|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
43818498|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818499|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
43818500|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818501|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818502|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
43818504|NCT05543746|Brexanolone|brexanolone|mesh-list
43818505|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
43818506|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655443|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655444|NCT02968901|Urological Agents|urological agents|mesh-ancestor
43655445|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
43655446|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
43556548|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43556549|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43556550|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43556552|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
43556553|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556554|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655447|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
43655448|NCT02968927|Vitamin D|vitamin d|mesh-list
43845547|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845548|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43845549|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
43845550|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
43845551|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845552|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845553|NCT04268407|Amoxicillin|amoxicillin|mesh-list
43845554|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
43845555|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
43845556|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43845557|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845558|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845559|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43845560|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818511|NCT05543694|Bupivacaine|bupivacaine|mesh-list
43818512|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818513|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
43818514|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818515|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818516|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
43818517|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818518|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
43818519|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43818520|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43818521|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818522|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
43556557|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43818523|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818524|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
43556558|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556559|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556560|NCT03551652|Rocuronium|rocuronium|mesh-list
43556561|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43556562|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43556563|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43556564|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556574|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
43556575|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556577|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
43556578|NCT03551548|Diuretics|diuretics|mesh-ancestor
43719748|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719749|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719750|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719751|NCT02634021|Analgesics|analgesics|mesh-ancestor
43719752|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
43719753|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43719754|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43719755|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43818525|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43818526|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
43818527|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818528|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
43818529|NCT05543434|Protective Agents|protective agents|mesh-ancestor
43818530|NCT05543330|Cisplatin|cisplatin|mesh-list
43818531|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818532|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43818533|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43818534|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818535|NCT05543122|Fluconazole|fluconazole|mesh-list
43818536|NCT05543122|Methotrexate|methotrexate|mesh-list
43818537|NCT05543122|Atenolol|atenolol|mesh-list
43818538|NCT05543122|Lamotrigine|lamotrigine|mesh-list
43818539|NCT05543122|Lacosamide|lacosamide|mesh-list
43818540|NCT05543122|Levetiracetam|levetiracetam|mesh-list
43818541|NCT05543122|Brivaracetam|brivaracetam|mesh-list
43818542|NCT05543122|Citalopram|citalopram|mesh-list
43818543|NCT05543122|Bupropion|bupropion|mesh-list
43818544|NCT05543122|Ezetimibe|ezetimibe|mesh-list
43818545|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43818546|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
43818559|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43818561|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43818562|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818563|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818564|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
43818565|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43818566|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
43818567|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818568|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
43818569|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818570|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43818571|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43818572|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43655449|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
43655450|NCT02968927|Rifabutin|rifabutin|mesh-list
43655451|NCT02968927|Everolimus|everolimus|mesh-list
43818573|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43818574|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
43818575|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43818576|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43818577|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
43818578|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
43818579|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
43818580|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818581|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43818582|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43818583|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
43818584|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43632059|NCT03040128|Minocycline|minocycline|mesh-list
43556579|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
43556580|NCT03551210|Levofloxacin|levofloxacin|mesh-list
43818585|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43848842|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43818586|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43818587|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43818591|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818592|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43818593|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43818594|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43818595|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43818597|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43818598|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43818599|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43818600|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
43818602|NCT05542615|Analgesics|analgesics|mesh-ancestor
43818603|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
43818604|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818649|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43818650|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
43818651|NCT05542095|Simvastatin|simvastatin|mesh-list
43818652|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43818653|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43818654|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
43818655|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818656|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43818657|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43818658|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818659|NCT05541757|Heparin|heparin|mesh-list
43818660|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
43818661|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43818662|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43818663|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845588|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
43845589|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845590|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
43845591|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43845592|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845593|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845594|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43845595|NCT04266145|Analgesics|analgesics|mesh-ancestor
43845596|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
43845597|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845598|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43845599|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43845600|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43845602|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845603|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655452|NCT02968927|Auranofin|auranofin|mesh-list
43655453|NCT02968927|CC-11050|cc-11050|mesh-list
43655454|NCT02968927|Vitamins|vitamins|mesh-ancestor
43655455|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
43655456|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845604|NCT04265534|Folic Acid|folic acid|mesh-list
43845605|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
43845606|NCT04265534|Hydroxocobalamin|hydroxocobalamin|mesh-list
43845607|NCT04265534|Dexamethasone|dexamethasone|mesh-list
43845608|NCT04265534|Carboplatin|carboplatin|mesh-list
43818664|NCT05541640|Lidocaine|lidocaine|mesh-list
43818697|NCT05541185|Lidocaine|lidocaine|mesh-list
43556603|NCT03551197|Hormones|hormones|mesh-ancestor
43818698|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
43818699|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
43818700|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818701|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818702|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
43818703|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818704|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43818722|NCT05541172|Androgens|androgens|mesh-ancestor
43818724|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43818725|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818726|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43818727|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818728|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
43818729|NCT05541107|Amphotericin B|amphotericin b|mesh-list
43818730|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
43818731|NCT05541107|Amebicides|amebicides|mesh-ancestor
43818732|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43818733|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43818734|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43818735|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818736|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
43818737|NCT05540977|Donepezil|donepezil|mesh-list
43818738|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43818739|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818740|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818741|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
43818742|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818743|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818745|NCT05540951|Bevacizumab|bevacizumab|mesh-list
43818746|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818747|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818748|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43818749|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43818750|NCT05540951|Growth Substances|growth substances|mesh-ancestor
43818751|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818752|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
43818753|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43818754|NCT05540834|Plasminogen|plasminogen|mesh-list
43818755|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43818756|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43818757|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818758|NCT05540600|Digoxin|digoxin|mesh-list
43818759|NCT05540600|Bisoprolol|bisoprolol|mesh-list
43818760|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43818761|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43818762|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818801|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818802|NCT05540275|Bevacizumab|bevacizumab|mesh-list
43818816|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
43818817|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818818|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
43818819|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818820|NCT05539989|Vaccines|vaccines|mesh-list
43818821|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
43818822|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
43818823|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818824|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43818826|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43818827|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
43556620|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556621|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556622|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43655457|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43655458|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818828|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
43818829|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43818830|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43818831|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845609|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
43845611|NCT04265534|Vitamins|vitamins|mesh-ancestor
43845613|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845614|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845615|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
43845616|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
43845617|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845618|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43845619|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
43845620|NCT04265534|Hormones|hormones|mesh-ancestor
43845621|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845622|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43845623|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845624|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845625|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845626|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845627|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43845628|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43845629|NCT04265534|Hematinics|hematinics|mesh-ancestor
43719761|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43719762|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43719763|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43719764|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43719765|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
43719767|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
43719768|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
43719769|NCT02633969|Indomethacin|indomethacin|mesh-list
43719770|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43719771|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43719772|NCT02633969|Analgesics|analgesics|mesh-ancestor
43556637|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43556638|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43556639|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43556640|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43556641|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556642|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
43556643|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
43556644|NCT03550859|Telmisartan|telmisartan|mesh-list
43556645|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43556646|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43556648|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
43845630|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
43845631|NCT04262934|Vitamin D|vitamin d|mesh-list
43845632|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
43845633|NCT04262934|Vitamins|vitamins|mesh-ancestor
43845634|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
43845635|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845636|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43845637|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43845638|NCT04262843|Vidarabine|vidarabine|mesh-list
43845639|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
43845640|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
43845641|NCT04262843|Fludarabine|fludarabine|mesh-list
43845642|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
43845643|NCT04262843|Tacrolimus|tacrolimus|mesh-list
43818836|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43818837|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
43818838|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
43818839|NCT05539118|Interferons|interferons|mesh-list
43818840|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818841|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
43818843|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
43556658|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556659|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
43818844|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43818845|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
43818846|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43556660|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556661|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556662|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43556663|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
43556665|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818847|NCT05539053|Expectorants|expectorants|mesh-ancestor
43818848|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
43818851|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818852|NCT05539053|Protective Agents|protective agents|mesh-ancestor
43818885|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818886|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818887|NCT05538026|Analgesics|analgesics|mesh-ancestor
43818888|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
43818889|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818890|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818891|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818892|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818893|NCT05537948|Pitavastatin|pitavastatin|mesh-list
43818894|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43818908|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818909|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818910|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
43818911|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818912|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818913|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43818914|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43818915|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43809593|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43809750|NCT04870372|Selegiline|selegiline|mesh-list
43818917|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
43818918|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
43818919|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556691|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556692|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
43556693|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43556694|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43556695|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43556696|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43556697|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556698|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
43556706|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43556707|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556708|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43556711|NCT03549897|Albuterol|albuterol|mesh-list
43845651|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845652|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845653|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43845654|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845655|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
43845656|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
43845657|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845658|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43845659|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845660|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43845661|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43845662|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
43845663|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43845664|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43845665|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
43845666|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845667|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845668|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
43845669|NCT04262492|Apixaban|apixaban|mesh-list
43845670|NCT04262492|Edoxaban|edoxaban|mesh-list
43845671|NCT04262492|Dabigatran|dabigatran|mesh-list
43845672|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43845673|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
43843968|NCT04415151|Tofacitinib|tofacitinib|mesh-list
43845675|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
43845676|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845677|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845678|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
43845679|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
43845680|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
43845681|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845682|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
43845683|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845684|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845685|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43845686|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
43845699|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845700|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
43845701|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845704|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845705|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
43845706|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845707|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845708|NCT04258111|Antibodies|antibodies|mesh-list
43845709|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
43845710|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
43845711|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845712|NCT04257682|Bupivacaine|bupivacaine|mesh-list
43845713|NCT04257682|Ropivacaine|ropivacaine|mesh-list
43818920|NCT05537402|Bevacizumab|bevacizumab|mesh-list
43818921|NCT05537402|Atezolizumab|atezolizumab|mesh-list
43818922|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43818923|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43818924|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43818925|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43818926|NCT05537402|Growth Substances|growth substances|mesh-ancestor
43818927|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818928|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
43818930|NCT05537272|Tadalafil|tadalafil|mesh-list
43556734|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818931|NCT05537272|Tamsulosin|tamsulosin|mesh-list
43818932|NCT05537272|Vitamins|vitamins|mesh-ancestor
43818933|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
43818934|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818935|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
43818936|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655459|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655460|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
43655461|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43655462|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43818937|NCT05537272|Protective Agents|protective agents|mesh-ancestor
43818938|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
43818939|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43818940|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43818941|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43818942|NCT05537272|Urological Agents|urological agents|mesh-ancestor
43818943|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43818944|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43818945|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43818946|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
43818947|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818948|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
43844001|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
43844002|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43844003|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
43844004|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43844005|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43844006|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
43844007|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
43844008|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
43844009|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43844010|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844011|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844012|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844013|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43844014|NCT04411836|Primaquine|primaquine|mesh-list
43818960|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
43818961|NCT05537194|Calcium|calcium|mesh-list
43818962|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43818963|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818964|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43818965|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43818966|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818967|NCT05537090|Midazolam|midazolam|mesh-list
43818968|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43818969|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43818970|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43818971|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818972|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43818973|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43818974|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43818975|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43818976|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
43818977|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
43818978|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
43818979|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
43818980|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43818981|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43818982|NCT05536882|Adapalene|adapalene|mesh-list
43818983|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43818984|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
43818985|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43818986|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43818987|NCT05536882|Analgesics|analgesics|mesh-ancestor
43818988|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
43818989|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43818990|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818991|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43818992|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43818993|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
43818994|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
43818995|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43818996|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
43818997|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43818998|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
43818999|NCT05536661|Protective Agents|protective agents|mesh-ancestor
43819000|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43655463|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655464|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43655465|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
43655466|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43655467|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43655468|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43655469|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655470|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819001|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43819002|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
43819003|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
43819004|NCT05536596|Melatonin|melatonin|mesh-list
43819005|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
43819029|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
43819030|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819031|NCT05536414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43810123|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43810124|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43810125|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810126|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
43810127|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
43627430|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819032|NCT05536414|Antidepressive Agents|antidepressive agents|mesh-ancestor
43819033|NCT05536414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43819034|NCT05536284|Bisoprolol|bisoprolol|mesh-list
43819035|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43819036|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
43819037|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
43819038|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819039|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819040|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43819041|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43819042|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43819043|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
43819044|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819045|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819046|NCT05536271|Bisoprolol|bisoprolol|mesh-list
43819047|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43819048|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
43819049|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
43819050|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819051|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556749|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43556750|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
43556751|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556752|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556753|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43556754|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
43556755|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43850112|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43819052|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43819080|NCT05536128|Fulvestrant|fulvestrant|mesh-list
43819081|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43819082|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819083|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819084|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819085|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819086|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43819087|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43819088|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
43819089|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819090|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819091|NCT05536102|Doxorubicin|doxorubicin|mesh-list
43819092|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43819093|NCT05536102|Capecitabine|capecitabine|mesh-list
43819111|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43819112|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819113|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
43819114|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819115|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
43844073|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844074|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819116|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43819117|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43819120|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819121|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
43819122|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43819123|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43819124|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43819125|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
43819126|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
43819127|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819128|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
43819129|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43819130|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43819131|NCT05535998|Estrogens|estrogens|mesh-ancestor
43819132|NCT05535998|Hormones|hormones|mesh-ancestor
43819133|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819134|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655476|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43655477|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655478|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655479|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
43655480|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
43655481|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43655482|NCT02968693|Protective Agents|protective agents|mesh-ancestor
43655483|NCT02968719|Donepezil|donepezil|mesh-list
43655484|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43655485|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655486|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655487|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
43819135|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819136|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819137|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819138|NCT05535738|Fluticasone|fluticasone|mesh-list
43819139|NCT05535738|Xhance|xhance|mesh-list
43819140|NCT05535738|Adalimumab|adalimumab|mesh-list
43819141|NCT05535738|Triamcinolone|triamcinolone|mesh-list
43819142|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43810643|NCT04856371|Letrozole|letrozole|mesh-list
43819178|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819179|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556758|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43819180|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819181|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819182|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845716|NCT04257682|Anesthetics|anesthetics|mesh-list
43845717|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845718|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848871|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
43848872|NCT03984097|Hormones|hormones|mesh-ancestor
43848873|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43848874|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43848875|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848876|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
43848877|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43848878|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43848879|NCT03984097|Growth Substances|growth substances|mesh-ancestor
43848880|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
43848881|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
43848882|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43848883|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
43848884|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848885|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43848886|NCT03981796|Paclitaxel|paclitaxel|mesh-list
43848887|NCT03981796|Carboplatin|carboplatin|mesh-list
43848888|NCT03981796|Niraparib|niraparib|mesh-list
43848889|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43655488|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655489|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825136|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43825137|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825138|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825139|NCT05504330|Aspirin|aspirin|mesh-list
43825140|NCT05504330|Clopidogrel|clopidogrel|mesh-list
43825141|NCT05504330|Atorvastatin|atorvastatin|mesh-list
43825142|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848890|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848891|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
43848892|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
43848893|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
43819183|NCT05535517|Emollients|emollients|mesh-list
43819184|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
43819185|NCT05535413|Capecitabine|capecitabine|mesh-list
43556766|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556776|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
43556777|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43719801|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719802|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719805|NCT02633878|Hormones|hormones|mesh-ancestor
43719806|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43719807|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43719808|NCT02633696|Silybin|silybin|mesh-list
43719809|NCT02633696|Silymarin|silymarin|mesh-list
43719810|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
43719816|NCT02633683|Gabapentin|gabapentin|mesh-list
43819186|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819187|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
43819188|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819189|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819190|NCT05535322|Insulin|insulin|mesh-list
43819191|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43819192|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819193|NCT05535309|Sulbactam|sulbactam|mesh-list
43819194|NCT05535309|Cefoperazone|cefoperazone|mesh-list
43819195|NCT05535309|Sulperazone|sulperazone|mesh-list
43819196|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43819197|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819198|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43819199|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819200|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819201|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43819202|NCT05535309|Renal Agents|renal agents|mesh-ancestor
43819203|NCT05592509|Vitamins|vitamins|mesh-list
43810729|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
43819231|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819232|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819233|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
43819234|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43810761|NCT04854460|Ivermectin|ivermectin|mesh-list
43819235|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819246|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819247|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819248|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43819251|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
43819252|NCT05591417|Morphine|morphine|mesh-list
43819253|NCT05591417|BB 1101|bb 1101|mesh-list
43810800|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43810801|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43810802|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43810804|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
43819260|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
43819261|NCT05591417|Hormones|hormones|mesh-ancestor
43819262|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819263|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819264|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819265|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
43819266|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556782|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43556783|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43556784|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43556785|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43556787|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
43556788|NCT03549663|Tacrolimus|tacrolimus|mesh-list
43556789|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556790|NCT03549663|Hormones|hormones|mesh-ancestor
43556791|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43556792|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556793|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43556794|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43556795|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43556796|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
43556797|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43819267|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819268|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43819269|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819270|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43819271|NCT05591417|Analgesics|analgesics|mesh-ancestor
43819272|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
43819273|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43819274|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43819275|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43819276|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
43819277|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819278|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43819279|NCT05591417|Narcotics|narcotics|mesh-ancestor
43819280|NCT05591235|Metformin|metformin|mesh-list
43819281|NCT05591235|Pioglitazone|pioglitazone|mesh-list
43819282|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
43810842|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
43810843|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810844|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810845|NCT04852510|Metformin|metformin|mesh-list
43810846|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43810847|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810848|NCT04852315|Caffeine|caffeine|mesh-list
43810849|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43810850|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43810851|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43810852|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810853|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43810854|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43819284|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819285|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43819286|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819287|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
43819288|NCT05591170|Vitamin D|vitamin d|mesh-list
43819289|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819290|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819291|NCT05591170|Vitamins|vitamins|mesh-ancestor
43819292|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
43819293|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819294|NCT05591118|Anticoagulants|anticoagulants|mesh-list
43819295|NCT05589792|Acetazolamide|acetazolamide|mesh-list
43819296|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
43819297|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43819298|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819310|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43819311|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
43825145|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
43825146|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825147|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825148|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819312|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845736|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43845737|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
43845738|NCT04253457|Hormones|hormones|mesh-ancestor
43810862|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556800|NCT03549611|Acetaminophen|acetaminophen|mesh-list
43556801|NCT03549611|Celecoxib|celecoxib|mesh-list
43556802|NCT03549611|Oxycodone|oxycodone|mesh-list
43556803|NCT03549611|Gabapentin|gabapentin|mesh-list
43556804|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43810863|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43810864|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43844193|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
43844196|NCT04397679|Amebicides|amebicides|mesh-ancestor
43845739|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43845740|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845742|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43845743|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845744|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845745|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845746|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
43845747|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845748|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
43845749|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43845750|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43845752|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43845753|NCT04251910|Analgesics|analgesics|mesh-ancestor
43845754|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
43845755|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845756|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43845757|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43845758|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43845759|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
43845760|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845761|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845762|NCT04251065|Daratumumab|daratumumab|mesh-list
43845763|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845764|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43845765|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
43845766|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43845767|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845768|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845769|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845770|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845771|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845772|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
43845773|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43845774|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43845776|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
43845777|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845778|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845779|NCT04249232|Abaloparatide|abaloparatide|mesh-list
43702914|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43704140|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819352|NCT05517668|Protective Agents|protective agents|mesh-ancestor
43819353|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819354|NCT05517668|Antidotes|antidotes|mesh-ancestor
43819355|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819356|NCT05497778|Gemcitabine|gemcitabine|mesh-list
43819357|NCT05497778|Paclitaxel|paclitaxel|mesh-list
43819358|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43819359|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819360|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819361|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
43819362|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819363|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
43556816|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43556817|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43819364|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819365|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819366|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
43819367|NCT05497778|Antiviral Agents|antiviral agents|mesh-ancestor
43819368|NCT05497778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819369|NCT05497778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819375|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819376|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819378|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
43819379|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819380|NCT05481736|Psilocybin|psilocybin|mesh-list
43819381|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
43819382|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825151|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43825152|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819383|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43819384|NCT05461261|Prednisolone|prednisolone|mesh-list
43819385|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43819386|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
43819387|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43819388|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
43819390|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43819391|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
43819392|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819393|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
43819394|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819395|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
43819396|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43633156|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43819397|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819398|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
43819399|NCT05461261|Hormones|hormones|mesh-ancestor
43819428|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43819429|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43819430|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819431|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819432|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
43819433|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
43819434|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43819435|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819436|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43819437|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43819438|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
43819439|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43819440|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43819488|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
43819489|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43819490|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819491|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43819492|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819493|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43819494|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43819495|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819497|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
43819498|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819499|NCT05078671|Cobicistat|cobicistat|mesh-list
43819500|NCT05078671|Olaparib|olaparib|mesh-list
43819501|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43819502|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819503|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819504|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819505|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43819506|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43556833|NCT03549312|Velpatasvir|velpatasvir|mesh-list
43819507|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
43819508|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819511|NCT05044468|Lidocaine|lidocaine|mesh-list
43819512|NCT05044468|Bupivacaine|bupivacaine|mesh-list
43819513|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
43819514|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
43819515|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819516|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819517|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
43819518|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819519|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43819520|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43819521|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43704141|NCT05265676|Enoxaparin|enoxaparin|mesh-list
43819523|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845860|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43845861|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819533|NCT05007262|Calcium|calcium|mesh-list
43819570|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819571|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819572|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43819573|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819574|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819623|NCT04592952|Calcitonin|calcitonin|mesh-list
43819624|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
43819625|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
43819626|NCT04592952|Erenumab|erenumab|mesh-list
43819627|NCT04592952|Katacalcin|katacalcin|mesh-list
43819628|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
43819629|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819630|NCT04592952|Analgesics|analgesics|mesh-ancestor
43819631|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
43819632|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819633|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819634|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819635|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43819636|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
43819637|NCT04590963|Cetuximab|cetuximab|mesh-list
43819638|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819639|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819640|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43819641|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
43819642|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819644|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43819645|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825162|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43556850|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
43556851|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43825163|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43556852|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43556853|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
43556854|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655491|NCT02968641|Ritonavir|ritonavir|mesh-list
43655492|NCT02968641|Lonafarnib|lonafarnib|mesh-list
43819646|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43819647|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819648|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
43819676|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43819678|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819679|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819680|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
43819681|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819682|NCT04062201|Levofloxacin|levofloxacin|mesh-list
43819683|NCT04062201|Ofloxacin|ofloxacin|mesh-list
43819684|NCT04062201|Isoniazid|isoniazid|mesh-list
43819685|NCT04062201|Linezolid|linezolid|mesh-list
43819686|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
43819687|NCT04062201|Ethambutol|ethambutol|mesh-list
43819688|NCT04062201|Bedaquiline|bedaquiline|mesh-list
43819689|NCT04062201|Clofazimine|clofazimine|mesh-list
43819690|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43819691|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819692|NCT04062201|Renal Agents|renal agents|mesh-ancestor
43819693|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43819694|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43819695|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43819696|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819709|NCT04023669|Gemcitabine|gemcitabine|mesh-list
43819710|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
43811916|NCT04836728|Paclitaxel|paclitaxel|mesh-list
43819711|NCT04023669|Lenograstim|lenograstim|mesh-list
43819712|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819713|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
43819714|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819715|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819716|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43819717|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
43819718|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819719|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43812006|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
43819720|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43819721|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819723|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
43819724|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819725|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819726|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43819727|NCT04015869|Pregnanolone|pregnanolone|mesh-list
43819728|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
43819729|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819730|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819731|NCT03980483|Methotrexate|methotrexate|mesh-list
43819732|NCT03980483|Tofacitinib|tofacitinib|mesh-list
43819733|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43819734|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
43819735|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43819736|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819737|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819738|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
43819739|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819740|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819741|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
43819742|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819743|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43819744|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819745|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
43819746|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819747|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43819748|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43819749|NCT03862157|Azacitidine|azacitidine|mesh-list
43819750|NCT03862157|Venetoclax|venetoclax|mesh-list
43819751|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
43819752|NCT03862157|Pevonedistat|pevonedistat|mesh-list
43719831|NCT02633813|Naftifine|naftifine|mesh-list
43819753|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43819754|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
43655494|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43655495|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
43655496|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655497|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819755|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819756|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845862|NCT04241640|Nefopam|nefopam|mesh-list
43819773|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43819774|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819775|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819777|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819778|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43819779|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
43819780|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43819781|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43819782|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43819783|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43819784|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43819785|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43819786|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
43819787|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
43819788|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
43812180|NCT04834375|BB 1101|bb 1101|mesh-list
43819789|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
43819790|NCT03743402|Narcotics|narcotics|mesh-ancestor
43819791|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819792|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819793|NCT03743402|Analgesics|analgesics|mesh-ancestor
43819794|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
43819795|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819796|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
43819797|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43819798|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819799|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43819800|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819801|NCT03640026|Tacrolimus|tacrolimus|mesh-list
43819802|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819803|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
43819804|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819805|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43819872|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
43819873|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819874|NCT02968810|Simvastatin|simvastatin|mesh-list
43819875|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43819876|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43819877|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
43819878|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819879|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43819880|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43819881|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819882|NCT02967692|Trametinib|trametinib|mesh-list
43819883|NCT02967692|Dabrafenib|dabrafenib|mesh-list
43819884|NCT02967692|Spartalizumab|spartalizumab|mesh-list
43819907|NCT02520154|Carboplatin|carboplatin|mesh-list
43819908|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
43819909|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43819910|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43819911|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43819912|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
43819913|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
43819914|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
43832633|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
43703008|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43819915|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819916|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43819917|NCT02502006|Celecoxib|celecoxib|mesh-list
43819918|NCT02502006|Naproxen|naproxen|mesh-list
43819919|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43655498|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43655499|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43655500|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
43819920|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43819921|NCT02502006|Analgesics|analgesics|mesh-ancestor
43819922|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
43819923|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43819924|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819925|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43819926|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43819927|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43819928|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43819929|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819930|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819931|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
43819932|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
43819933|NCT01905631|Promethazine|promethazine|mesh-list
43819934|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43624909|NCT01295944|Bevacizumab|bevacizumab|mesh-list
43819936|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819999|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820001|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820002|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820003|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820004|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
43820005|NCT05535231|Protective Agents|protective agents|mesh-ancestor
43820006|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
43820007|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820008|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820009|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
43820010|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820011|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
43556867|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43556869|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
43556870|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43556871|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43556872|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43556873|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43556874|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
43556875|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
43556876|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43556877|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43556878|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
43820012|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820013|NCT05679310|Protective Agents|protective agents|mesh-ancestor
43820014|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820015|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43820016|NCT05679258|Daratumumab|daratumumab|mesh-list
43820017|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43820018|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820019|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
43820020|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820021|NCT05679193|Propranolol|propranolol|mesh-list
43820023|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43820024|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820094|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43820095|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820096|NCT05678738|Antioxidants|antioxidants|mesh-list
43820097|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820098|NCT05678738|Protective Agents|protective agents|mesh-ancestor
43820099|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845866|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845875|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43845876|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
43845877|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845878|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845879|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43845880|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
43845881|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43845882|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43812588|NCT04826822|Diuretics|diuretics|mesh-ancestor
43845883|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845884|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
43845885|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43845886|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43845887|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
43845888|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43845889|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
43845890|NCT04240171|Glimepiride|glimepiride|mesh-list
43845891|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43655501|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655502|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43655503|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43655505|NCT02968498|Lactulose|lactulose|mesh-list
43655506|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43845893|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845894|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845895|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43820101|NCT05678647|Trace Elements|trace elements|mesh-ancestor
43820102|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
43820103|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820104|NCT05678621|Amoxicillin|amoxicillin|mesh-list
43820105|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
43820106|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
43556879|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556880|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43556881|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43832640|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43832641|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
43832643|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43832644|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820107|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
43820108|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43820109|NCT05678621|Trimethoprim|trimethoprim|mesh-list
43820110|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
43820111|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
43820112|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43820113|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820114|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
43820115|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820116|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43820117|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820118|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820119|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820120|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820121|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43820122|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43820123|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43820124|NCT05678621|Renal Agents|renal agents|mesh-ancestor
43820125|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
43820126|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43820127|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820128|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43820129|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43820130|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43820131|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43820132|NCT05678413|Paclitaxel|paclitaxel|mesh-list
43820133|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43820134|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820135|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
43820136|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
43820144|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43820145|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820146|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43556887|NCT03549026|Analgesics|analgesics|mesh-ancestor
43556888|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
43556889|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43556890|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
43556891|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43556892|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
43556894|NCT03548948|Trace Elements|trace elements|mesh-ancestor
43556895|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
43556896|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556906|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556907|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
43556908|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43556909|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
43556910|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43556911|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
43556912|NCT03548662|Protective Agents|protective agents|mesh-ancestor
43556913|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
43556914|NCT03548493|Fentanyl|fentanyl|mesh-list
43556915|NCT03548493|Propofol|propofol|mesh-list
43556916|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43556917|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820147|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
43820149|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820150|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
43812712|NCT04824612|Hormones|hormones|mesh-ancestor
43820151|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820152|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43820153|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820154|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820155|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
43820156|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43820157|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820158|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820159|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820160|NCT05678257|Leucovorin|leucovorin|mesh-list
43820161|NCT05678257|Bevacizumab|bevacizumab|mesh-list
43820162|NCT05678257|Fluorouracil|fluorouracil|mesh-list
43820163|NCT05678257|Irinotecan|irinotecan|mesh-list
43820164|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
43820165|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820166|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820167|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43655507|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43655508|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655509|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
43655510|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
43820168|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43820169|NCT05678257|Growth Substances|growth substances|mesh-ancestor
43820170|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820171|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
43820172|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
43820173|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820174|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43820175|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820176|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
43820177|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43820178|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820179|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820180|NCT05678257|Antidotes|antidotes|mesh-ancestor
43820181|NCT05678257|Protective Agents|protective agents|mesh-ancestor
43820182|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
43820183|NCT05678257|Vitamins|vitamins|mesh-ancestor
43820184|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
43820185|NCT05678244|Acetaminophen|acetaminophen|mesh-list
43820186|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820187|NCT05678244|Analgesics|analgesics|mesh-ancestor
43820188|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
43820189|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820190|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820191|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
43820192|NCT05678192|Hormones|hormones|mesh-list
43820193|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820194|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820195|NCT05678114|Inositol|inositol|mesh-list
43820196|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
43820197|NCT05678114|Vitamins|vitamins|mesh-ancestor
43820198|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
43820199|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820200|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
43820201|NCT05678036|Narcotics|narcotics|mesh-ancestor
43820202|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820203|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820204|NCT05678036|Analgesics|analgesics|mesh-ancestor
43820205|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
43820206|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820244|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
43820260|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820261|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820262|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
43820263|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820264|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43820265|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43820266|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820267|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820268|NCT05677490|Antidotes|antidotes|mesh-ancestor
43820269|NCT05677490|Protective Agents|protective agents|mesh-ancestor
43820270|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
43820272|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
43820273|NCT05677373|Trametinib|trametinib|mesh-list
43820274|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820275|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820276|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820277|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820278|NCT05677334|Insulin|insulin|mesh-list
43820279|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43820280|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43820281|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820282|NCT05677282|Azithromycin|azithromycin|mesh-list
43820283|NCT05677282|Rifaximin|rifaximin|mesh-list
43820284|NCT05677282|Loperamide|loperamide|mesh-list
43820285|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
43820286|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43820287|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820288|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820291|NCT05677126|Selenious Acid|selenious acid|mesh-list
43655511|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655512|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
43655513|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655514|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820292|NCT05677126|Micronutrients|micronutrients|mesh-list
43820293|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820294|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43820295|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
43820296|NCT05676112|Pirfenidone|pirfenidone|mesh-list
43820297|NCT05676112|Nintedanib|nintedanib|mesh-list
43820298|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820299|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820300|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820301|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820302|NCT05676112|Analgesics|analgesics|mesh-ancestor
43820303|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
43820304|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820305|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820306|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43820307|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820308|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820309|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43845896|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43820323|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43844631|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43844632|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43557006|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43557007|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844633|NCT04356729|Bevacizumab|bevacizumab|mesh-list
43844634|NCT04356729|Atezolizumab|atezolizumab|mesh-list
43820324|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43820325|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820326|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820327|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820328|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820381|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820382|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43820383|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43820384|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43820385|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820386|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820387|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820388|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43820389|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43820390|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820391|NCT05624281|Nintedanib|nintedanib|mesh-list
43820392|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820393|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43820394|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820395|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820396|NCT05623020|Dexamethasone|dexamethasone|mesh-list
43820397|NCT05623020|Lenalidomide|lenalidomide|mesh-list
43820398|NCT05623020|Daratumumab|daratumumab|mesh-list
43820399|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820400|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
43820401|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
43820402|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820403|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820404|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820405|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
43820406|NCT05623020|Hormones|hormones|mesh-ancestor
43820407|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820408|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43820409|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820410|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
43820411|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43832673|NCT05254925|Emollients|emollients|mesh-ancestor
43832674|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
43820412|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43820413|NCT05623020|Growth Substances|growth substances|mesh-ancestor
43820447|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820449|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43820450|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43820451|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655515|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655516|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43655517|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43655518|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820469|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
43820470|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43820471|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820472|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820473|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820474|NCT05595083|Analgesics|analgesics|mesh-ancestor
43820475|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
43820476|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820477|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43812910|NCT04821323|Mannitol|mannitol|mesh-list
43820478|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43820479|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43820480|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820481|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820482|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820483|NCT05593575|Valsartan|valsartan|mesh-list
43820484|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820485|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43820486|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43557054|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557058|NCT03547024|Midazolam|midazolam|mesh-list
43820487|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820488|NCT05579509|Fentanyl|fentanyl|mesh-list
43820489|NCT05579509|Midazolam|midazolam|mesh-list
43820490|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43820491|NCT05579509|Narcotics|narcotics|mesh-ancestor
43820492|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820493|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820494|NCT05579509|Analgesics|analgesics|mesh-ancestor
43820495|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
43820496|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820497|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43820498|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43820499|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
43820500|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
43820501|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43820502|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43820503|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43820504|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820505|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
43820506|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
43820507|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820508|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820509|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
43820512|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
43820513|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820514|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820515|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43820516|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
43820528|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43820529|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820530|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820531|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820532|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820533|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43820534|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43655519|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43655520|NCT02968394|Omalizumab|omalizumab|mesh-list
43655521|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43655522|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43655523|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655524|NCT02968342|Progesterone|progesterone|mesh-list
43820536|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43820537|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820538|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43820539|NCT05569681|Bemiparin|bemiparin|mesh-list
43820540|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
43820541|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43820542|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43820543|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820544|NCT05564637|Treprostinil|treprostinil|mesh-list
43820545|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820546|NCT05562999|Bromides|bromides|mesh-list
43820547|NCT05562999|Rocuronium|rocuronium|mesh-list
43820548|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
43820549|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43820550|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43820551|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43820552|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820553|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820554|NCT05553938|Empagliflozin|empagliflozin|mesh-list
43820555|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43820556|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820557|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43557087|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43820558|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557088|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820559|NCT05531942|Aspirin|aspirin|mesh-list
43820560|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43820561|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820562|NCT05531942|Analgesics|analgesics|mesh-ancestor
43820563|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
43820565|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820566|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43820567|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43820568|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43820569|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43820570|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820571|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43820572|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43820573|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820574|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
43845904|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43845905|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845906|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43845907|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820583|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820584|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43820585|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820586|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43820587|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43820588|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820589|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43820655|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820657|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43820658|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
43820659|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43820660|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820661|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
43820679|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
43820680|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43820681|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
43655526|NCT02968342|Hormones|hormones|mesh-ancestor
43655527|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655528|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655529|NCT02968303|Vemurafenib|vemurafenib|mesh-list
43655530|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655531|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655532|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655533|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655534|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
43655535|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
43655536|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655537|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655538|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655539|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
43655540|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
43655541|NCT02968160|Telmisartan|telmisartan|mesh-list
43820682|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820683|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820684|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
43820686|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43820687|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
43703009|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
43820688|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820689|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820690|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43820691|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43820692|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
43820693|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820694|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820696|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43820697|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820698|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820699|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43820700|NCT05361837|Analgesics|analgesics|mesh-ancestor
43820701|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
43820702|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820703|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43820704|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43820705|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43820706|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820707|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43719856|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
43703010|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43820708|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820709|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
43820710|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820711|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820712|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43820713|NCT05354453|Protective Agents|protective agents|mesh-ancestor
43820714|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820742|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43820743|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820744|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820745|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655542|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43655543|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43655544|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43820746|NCT05318469|Ivermectin|ivermectin|mesh-list
43813064|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43813065|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43813066|NCT04819828|Analgesics|analgesics|mesh-ancestor
43813067|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
43813068|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813069|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813070|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813071|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813072|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43813073|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813074|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813075|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43813076|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43813077|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43813078|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
43813079|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43813080|NCT04819828|Urological Agents|urological agents|mesh-ancestor
43813081|NCT04818931|Cefazolin|cefazolin|mesh-list
43813082|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43813083|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813084|NCT04819204|Cetrorelix|cetrorelix|mesh-list
43813085|NCT04819204|Testosterone|testosterone|mesh-list
43813086|NCT04819204|Androgens|androgens|mesh-ancestor
43813087|NCT04819204|Hormones|hormones|mesh-ancestor
43813088|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43820747|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43820748|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820749|NCT05299866|Ketamine|ketamine|mesh-list
43820750|NCT05299866|Esketamine|esketamine|mesh-list
43820751|NCT05299866|Analgesics|analgesics|mesh-ancestor
43820752|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
43820753|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820754|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820755|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43820756|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43820757|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
43820759|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43719866|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43719867|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43820760|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43820761|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43820762|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820763|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820776|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43813184|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813185|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813186|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813187|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
43813188|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43813189|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
43813190|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813191|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
43813192|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813193|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813200|NCT04817527|Edaravone|edaravone|mesh-list
43820777|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
43820778|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43820779|NCT05298696|Protective Agents|protective agents|mesh-ancestor
43820780|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43820781|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43820782|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820783|NCT05297864|Niraparib|niraparib|mesh-list
43820784|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43820785|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820786|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820787|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820788|NCT05297032|Quercetin|quercetin|mesh-list
43820789|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
43820790|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820791|NCT05297032|Protective Agents|protective agents|mesh-ancestor
43820792|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820793|NCT05285982|Nintedanib|nintedanib|mesh-list
43820794|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820795|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43634686|NCT05571059|Ifetroban|ifetroban|mesh-list
43820796|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820797|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820798|NCT05267886|Dobutamine|dobutamine|mesh-list
43820799|NCT05267886|Milrinone|milrinone|mesh-list
43820800|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43820801|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
43820802|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
43820803|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813228|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813229|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844653|NCT04354428|Ritonavir|ritonavir|mesh-list
43844654|NCT04354428|Lopinavir|lopinavir|mesh-list
43557180|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844655|NCT04354428|Azithromycin|azithromycin|mesh-list
43844656|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
43844657|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43844658|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43844660|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844661|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844662|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43844663|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43844664|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
43844665|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844666|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43844667|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43844668|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43844669|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
43844670|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43844671|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43844672|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844673|NCT04354428|Hematinics|hematinics|mesh-ancestor
43844674|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
43844675|NCT04354428|Vitamins|vitamins|mesh-ancestor
43820804|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820805|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
43820806|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43820807|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43820808|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820809|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820810|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820811|NCT05267886|Protective Agents|protective agents|mesh-ancestor
43820812|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43820813|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
43820814|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43557205|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
43820815|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43820816|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820818|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43820819|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43820820|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43820821|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820822|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820823|NCT05262764|Empagliflozin|empagliflozin|mesh-list
43845941|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43655545|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
43813262|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43813263|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43813264|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43813266|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
43813267|NCT04816097|Dexamethasone|dexamethasone|mesh-list
43813268|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43813269|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43813270|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
43813271|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
43813272|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813273|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813274|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43813275|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
43813276|NCT04816097|Hormones|hormones|mesh-ancestor
43813277|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43813278|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43813280|NCT04816240|Midodrine|midodrine|mesh-list
43655546|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845942|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845943|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
43845944|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
43845946|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845947|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43845949|NCT04229004|Antiviral Agents|antiviral agents|mesh-ancestor
43845950|NCT04229004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845951|NCT04229004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43845952|NCT04229004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43845953|NCT04229004|Immunologic Factors|immunologic factors|mesh-ancestor
43845954|NCT04229004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845955|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845956|NCT04228289|Oxytocin|oxytocin|mesh-list
43845957|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
43845958|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43845959|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845960|NCT04227678|Heparin|heparin|mesh-list
43845961|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
43845962|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43845963|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43820842|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
43820843|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820844|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
43820845|NCT05189704|Narcotics|narcotics|mesh-ancestor
43820870|NCT05139238|Labetalol|labetalol|mesh-list
43820871|NCT05139238|Nifedipine|nifedipine|mesh-list
43820872|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43734435|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
43820873|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43820874|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820875|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43820876|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820877|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
43820878|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
43820879|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43820880|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43820881|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43820882|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
43820883|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820884|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820885|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
43820886|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
43820887|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844696|NCT04348292|Sirolimus|sirolimus|mesh-list
43844697|NCT04348292|Durvalumab|durvalumab|mesh-list
43844698|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
43844699|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43844700|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
43844701|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43844702|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43844703|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43844704|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844705|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
43844706|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43844707|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
43844708|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820888|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43820889|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43820890|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
43820891|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43820892|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
43820893|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43820894|NCT05123365|Expectorants|expectorants|mesh-ancestor
43820895|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
43820896|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43820906|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820907|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
43820908|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43820915|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43820916|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43820917|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43820918|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557326|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
43820919|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820920|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820921|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
43655547|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43655548|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43655549|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820932|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
43820933|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43820934|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820935|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43820936|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43820937|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
43820938|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
43820939|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43820940|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43820941|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43820942|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43820943|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820944|NCT05048797|Cisplatin|cisplatin|mesh-list
43820945|NCT05048797|Carboplatin|carboplatin|mesh-list
43820947|NCT05048797|Trastuzumab|trastuzumab|mesh-list
43820948|NCT05048797|Pemetrexed|pemetrexed|mesh-list
43820949|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820950|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43820951|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43820952|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820953|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43820954|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43820955|NCT05041907|Ritonavir|ritonavir|mesh-list
43813468|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
43813469|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43813470|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43813471|NCT04812860|Tramadol|tramadol|mesh-list
43813472|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43813473|NCT04812860|Narcotics|narcotics|mesh-ancestor
43813474|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43813475|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813476|NCT04812860|Analgesics|analgesics|mesh-ancestor
43813493|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43813494|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43813495|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813496|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43813497|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
43813498|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
43557357|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557358|NCT03542955|Etoricoxib|etoricoxib|mesh-list
43813499|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43813500|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813501|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43813502|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43813503|NCT04811573|Growth Substances|growth substances|mesh-ancestor
43813504|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
43813505|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844716|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
43844735|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
43844737|NCT04341350|Propofol|propofol|mesh-list
43844738|NCT04341350|Isoflurane|isoflurane|mesh-list
43844739|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43844740|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844741|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844742|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43844743|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
43813506|NCT04811911|Methotrexate|methotrexate|mesh-list
43813507|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43813508|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
43813509|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43813510|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813511|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43813512|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
43813513|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43813514|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820960|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43820961|NCT05041907|Fluoxetine|fluoxetine|mesh-list
43820962|NCT05041907|Antibodies|antibodies|mesh-list
43820963|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
43820964|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43820965|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
43820999|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43557394|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
43557395|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
43821017|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821018|NCT04964947|Tobramycin|tobramycin|mesh-list
43821019|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821020|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821021|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
43821022|NCT04956640|Cetuximab|cetuximab|mesh-list
43821023|NCT04956640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
43821024|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43813556|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
43821028|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821029|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
43821030|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
43821031|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43821032|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821033|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821034|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43821035|NCT04953156|Analgesics|analgesics|mesh-ancestor
43821036|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
43821037|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821038|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43821039|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43821040|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43655550|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43846582|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43821041|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
43821042|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821043|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821044|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
43821045|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
43821046|NCT04938024|Vitamins|vitamins|mesh-ancestor
43821047|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
43821048|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821049|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
43821050|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821051|NCT04938024|Protective Agents|protective agents|mesh-ancestor
43821052|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43821053|NCT04915729|Tenecteplase|tenecteplase|mesh-list
43821054|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43821055|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43821056|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821057|NCT04909801|Adalimumab|adalimumab|mesh-list
43821058|NCT04909801|Methotrexate|methotrexate|mesh-list
43821059|NCT04909801|Abatacept|abatacept|mesh-list
43813677|NCT04809142|Antiviral Agents|antiviral agents|mesh-ancestor
43813678|NCT04809142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43813679|NCT04809142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43557430|NCT03542357|Katacalcin|katacalcin|mesh-list
43813680|NCT04809142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43813681|NCT04809142|Immunologic Factors|immunologic factors|mesh-ancestor
43813682|NCT04809142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813683|NCT04809181|Azacitidine|azacitidine|mesh-list
43813684|NCT04809181|Venetoclax|venetoclax|mesh-list
43813685|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43813686|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
43813687|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821070|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43821071|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821072|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
43821073|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821074|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43821075|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821076|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43845964|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845966|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43845967|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
43845968|NCT04227028|Antibodies|antibodies|mesh-list
43845969|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
43845970|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43845971|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
43845972|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845973|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43845974|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43845975|NCT04227028|Growth Substances|growth substances|mesh-ancestor
43845976|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845977|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
43845978|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
43845979|NCT04226950|Interferons|interferons|mesh-list
43845980|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
43845981|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
43845982|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
43845983|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845984|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
43845985|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845986|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
43845987|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845988|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
43845989|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43845990|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
43845991|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43845992|NCT04226456|Expectorants|expectorants|mesh-ancestor
43845993|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
43845994|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43845995|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
43845996|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845997|NCT04226456|Protective Agents|protective agents|mesh-ancestor
43845998|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845999|NCT04226456|Antidotes|antidotes|mesh-ancestor
43846000|NCT04226365|Nortriptyline|nortriptyline|mesh-list
43846001|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
43846002|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
43813801|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43813802|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43813803|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43813804|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
43813805|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43846006|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846007|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846009|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846010|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846025|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846026|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
43844782|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
43844783|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844784|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844785|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
43846029|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
43846030|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846031|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
43821077|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
43821078|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43821079|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
43821080|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821081|NCT04884035|Prednisone|prednisone|mesh-list
43821082|NCT04884035|Prednisolone|prednisolone|mesh-list
43821083|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
43821084|NCT04884035|Rituximab|rituximab|mesh-list
43821085|NCT04884035|Doxorubicin|doxorubicin|mesh-list
43821086|NCT04884035|Vincristine|vincristine|mesh-list
43821087|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821088|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
43821089|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821090|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821091|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43821092|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
43821093|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821094|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821095|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43821096|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821097|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43821098|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821099|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821100|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821101|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821102|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
43821103|NCT04884035|Hormones|hormones|mesh-ancestor
43821104|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821105|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821106|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821107|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821108|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821109|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821110|NCT04860960|Betadex|betadex|mesh-list
43821111|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
43821112|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814055|NCT04803539|Apatinib|apatinib|mesh-list
43814056|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43814057|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
43814058|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814059|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814060|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43814061|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814062|NCT04803500|Simvastatin|simvastatin|mesh-list
43814063|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43814064|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43814065|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
43814066|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814067|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43814068|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43814069|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814070|NCT04803318|Everolimus|everolimus|mesh-list
43821117|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821134|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43821136|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
43821137|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
43821138|NCT04756557|Protective Agents|protective agents|mesh-ancestor
43821139|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821141|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43821142|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43821143|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43821144|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43821157|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821158|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821159|NCT04620746|Penicillins|penicillins|mesh-list
43821160|NCT04620746|Penicillin G|penicillin g|mesh-list
43814199|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43814200|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814201|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814202|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43814203|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
43814204|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
43814205|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43814206|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43814207|NCT04802083|Eculizumab|eculizumab|mesh-list
43814208|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43814209|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43814210|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
43557490|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
43557492|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43814211|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814237|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43814238|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814239|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43814243|NCT04801303|Vitamins|vitamins|mesh-ancestor
43821172|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821173|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821174|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821208|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
43821209|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821210|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821211|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43821212|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43821213|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43821214|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43821230|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
43821231|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
43821232|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
43821233|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821234|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821235|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821236|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
43821237|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821238|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821239|NCT04532528|Dabigatran|dabigatran|mesh-list
43821240|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
43821241|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43821242|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
43821243|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821244|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821245|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
43821246|NCT04529265|Methylene Blue|methylene blue|mesh-list
43821247|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821248|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821249|NCT04526288|Cytarabine|cytarabine|mesh-list
43821250|NCT04526288|Daunorubicin|daunorubicin|mesh-list
43821251|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821252|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
43821253|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821254|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821255|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
43821256|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821257|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821258|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
43821265|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
43821266|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43821267|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43821268|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821269|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821270|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821271|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43821273|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43821274|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821275|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821276|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43821277|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
43821313|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821367|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
43821368|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43821369|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
43821370|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821371|NCT04381897|Expectorants|expectorants|mesh-ancestor
43557531|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
43821372|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
43821373|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43821374|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
43821375|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821376|NCT04381897|Protective Agents|protective agents|mesh-ancestor
43821377|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821378|NCT04381897|Antidotes|antidotes|mesh-ancestor
43821379|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
43821380|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
43821382|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821384|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43821385|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
43821404|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821405|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821406|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821407|NCT04314895|Paclitaxel|paclitaxel|mesh-list
43821408|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43821409|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821410|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821411|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821412|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821413|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821414|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821419|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
43814332|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814334|NCT04799184|Racepinephrine|racepinephrine|mesh-list
43814335|NCT04799184|Bupivacaine|bupivacaine|mesh-list
43814336|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
43814337|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
43814338|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
43814339|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
43814340|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821421|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821426|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821427|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43821428|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43821429|NCT04298528|Analgesics|analgesics|mesh-ancestor
43821430|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
43821431|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821432|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
43821433|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
43821434|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821435|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821437|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821438|NCT04291079|Antibodies|antibodies|mesh-list
43821439|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
43821440|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821441|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
43821503|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821504|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821505|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43821506|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821507|NCT04154150|Ketamine|ketamine|mesh-list
43821508|NCT04154150|Analgesics|analgesics|mesh-ancestor
43821509|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
43814383|NCT04798443|Protective Agents|protective agents|mesh-ancestor
43814384|NCT04798313|Denosumab|denosumab|mesh-list
43814385|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43814386|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814403|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
43814404|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814405|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814406|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814407|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43814408|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43814409|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43814410|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814413|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821517|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43821518|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43821519|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43821520|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821521|NCT04126031|Ceftazidime|ceftazidime|mesh-list
43821522|NCT04126031|Avibactam|avibactam|mesh-list
43821523|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
43821524|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821539|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821540|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821541|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821542|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821543|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821544|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821545|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
43821546|NCT04097730|Vitamins|vitamins|mesh-ancestor
43821547|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
43821548|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43821549|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821550|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
43821551|NCT04097730|Hormones|hormones|mesh-ancestor
43821552|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821554|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821555|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821556|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821557|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821558|NCT04076059|Androgens|androgens|mesh-list
43821559|NCT04076059|Hormones|hormones|mesh-ancestor
43821560|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821565|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821566|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821567|NCT04067648|Analgesics|analgesics|mesh-ancestor
43821568|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
43821569|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821570|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43821571|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43821572|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
43821573|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
43821574|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43821575|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
43821576|NCT04016389|Paclitaxel|paclitaxel|mesh-list
43821577|NCT04016389|Cisplatin|cisplatin|mesh-list
43821578|NCT04016389|Carboplatin|carboplatin|mesh-list
43821579|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821580|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821581|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821582|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821583|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821584|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635605|NCT05249426|Cetuximab|cetuximab|mesh-list
43846053|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
43846054|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
43846055|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846056|NCT04218968|Carvedilol|carvedilol|mesh-list
43846057|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43846058|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43846059|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846060|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846061|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846062|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846063|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43846064|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
43846065|NCT04218968|Protective Agents|protective agents|mesh-ancestor
43844846|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844847|NCT04330729|Aspirin|aspirin|mesh-list
43844848|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844849|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844850|NCT04330729|Analgesics|analgesics|mesh-ancestor
43844851|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
43844852|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844853|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844854|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844855|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844856|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43844857|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43844858|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844859|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43844860|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43844861|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844862|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
43844863|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
43844864|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43846066|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43846067|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846068|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43846069|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
43846070|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43846071|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43846072|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
43846073|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
43846074|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846075|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43846076|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846078|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
43846079|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846080|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43846081|NCT04216797|Diazepam|diazepam|mesh-list
43846082|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43846083|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
43821625|NCT03724084|Cytarabine|cytarabine|mesh-list
43821626|NCT03724084|Daunorubicin|daunorubicin|mesh-list
43821649|NCT03660059|Peficitinib|peficitinib|mesh-list
43821650|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821651|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821652|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821653|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
43821654|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821656|NCT03597347|Sargramostim|sargramostim|mesh-list
43821657|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821658|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
43821659|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821661|NCT03595124|Axitinib|axitinib|mesh-list
43821662|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821663|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821664|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43821665|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821666|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43821667|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821668|NCT03594110|Empagliflozin|empagliflozin|mesh-list
43821669|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43821670|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821671|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43821672|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821673|NCT03582618|Sorafenib|sorafenib|mesh-list
43821674|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844886|NCT04329065|Paclitaxel|paclitaxel|mesh-list
43821690|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43821691|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
43557637|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
43557638|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557639|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43557641|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557642|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
43557643|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43557644|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43557645|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43557647|NCT03540368|Coagulants|coagulants|mesh-ancestor
43557651|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43557652|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43557654|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
43557655|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43557656|NCT03540199|Antibodies|antibodies|mesh-list
43557657|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43821693|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821694|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821695|NCT03554044|Tamoxifen|tamoxifen|mesh-list
43821696|NCT03554044|Gemcitabine|gemcitabine|mesh-list
43821697|NCT03554044|Paclitaxel|paclitaxel|mesh-list
43821698|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43821699|NCT03554044|Carboplatin|carboplatin|mesh-list
43821700|NCT03554044|Letrozole|letrozole|mesh-list
43821701|NCT03554044|Fulvestrant|fulvestrant|mesh-list
43821702|NCT03554044|Anastrozole|anastrozole|mesh-list
43821703|NCT03554044|Exemestane|exemestane|mesh-list
43821704|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
43821705|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821706|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821707|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821708|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821709|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821710|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814577|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43814578|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43814579|NCT04793243|Vitamin D|vitamin d|mesh-list
43814580|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
43814581|NCT04793243|Vitamins|vitamins|mesh-ancestor
43814582|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
43814583|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814584|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43821711|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821712|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
43821713|NCT03554044|Antiviral Agents|antiviral agents|mesh-ancestor
43821714|NCT03554044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821715|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821716|NCT03554044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821717|NCT03554044|Immunologic Factors|immunologic factors|mesh-ancestor
43821718|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821719|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43821720|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43557669|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
43821721|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43821722|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
43821723|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821724|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821725|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43821726|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43821727|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43821728|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43821729|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821730|NCT03547973|Gemcitabine|gemcitabine|mesh-list
43821731|NCT03547973|Cisplatin|cisplatin|mesh-list
43821733|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
43821734|NCT03547973|Avelumab|avelumab|mesh-list
43821735|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821736|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43821737|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
43821738|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821739|NCT03547973|Antiviral Agents|antiviral agents|mesh-ancestor
43821740|NCT03547973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821741|NCT03547973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821768|NCT03478878|Vitamin A|vitamin a|mesh-list
43821769|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
43821770|NCT03478878|Vitamins|vitamins|mesh-ancestor
43814682|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
43814683|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43814684|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43814685|NCT04791345|Prednisolone|prednisolone|mesh-list
43814686|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
43814687|NCT04791345|Deflazacort|deflazacort|mesh-list
43814688|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43814689|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
43814690|NCT04791345|BB 1101|bb 1101|mesh-list
43814691|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43814692|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
43814693|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
43814694|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814695|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814735|NCT04790838|Xhance|xhance|mesh-list
43814756|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
43814757|NCT04791020|Lidocaine|lidocaine|mesh-list
43814758|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
43814759|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
43814760|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43814761|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814762|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
43814763|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43814764|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43814765|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43814766|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43814767|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814768|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844911|NCT04326283|Riluzole|riluzole|mesh-list
43844912|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43844913|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43844914|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43844915|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844916|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
43844917|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43821774|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821775|NCT03478878|Protective Agents|protective agents|mesh-ancestor
43846084|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
43821776|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43557701|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
43821777|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821778|NCT03467958|Ozanimod|ozanimod|mesh-list
43821779|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43821780|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821781|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821782|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
43821783|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821784|NCT03464045|Empagliflozin|empagliflozin|mesh-list
43821785|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43821786|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
43821787|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821805|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821806|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43821807|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
43821809|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821810|NCT03440112|Clarithromycin|clarithromycin|mesh-list
43821811|NCT03440112|Flumazenil|flumazenil|mesh-list
43821812|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821813|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821814|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43821815|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821816|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821817|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43821818|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43814775|NCT04790708|Octreotide|octreotide|mesh-list
43821831|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821832|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821834|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821835|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821836|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43821837|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43821838|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821839|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43821840|NCT03365882|Trastuzumab|trastuzumab|mesh-list
43821841|NCT03365882|Cetuximab|cetuximab|mesh-list
43821842|NCT03365882|Pertuzumab|pertuzumab|mesh-list
43821843|NCT03365882|Irinotecan|irinotecan|mesh-list
43821844|NCT03365882|Camptothecin|camptothecin|mesh-list
43821845|NCT03365882|Antibodies|antibodies|mesh-list
43821846|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
43821847|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43821906|NCT03151811|Dexamethasone|dexamethasone|mesh-list
43821907|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
43821909|NCT03151811|Pomalidomide|pomalidomide|mesh-list
43821910|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43821911|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
43557712|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
43821912|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
43557713|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
43557714|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
43821913|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821914|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821915|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43821916|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
43821917|NCT03151811|Hormones|hormones|mesh-ancestor
43821918|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43821919|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43821920|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821921|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43821922|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
43821923|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43635981|NCT05103358|Sirolimus|sirolimus|mesh-list
43821924|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43821925|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821926|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
43821927|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43821928|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43821929|NCT03151811|Growth Substances|growth substances|mesh-ancestor
43821930|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
43821932|NCT03099174|Fulvestrant|fulvestrant|mesh-list
43821933|NCT03099174|Anastrozole|anastrozole|mesh-list
43821934|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821983|NCT03025880|Antiviral Agents|antiviral agents|mesh-ancestor
43821984|NCT03025880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821985|NCT03025880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821986|NCT03025880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43821987|NCT03025880|Immunologic Factors|immunologic factors|mesh-ancestor
43821988|NCT03025880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821989|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821990|NCT03009201|Doxorubicin|doxorubicin|mesh-list
43821991|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43821992|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43821993|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821994|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43821995|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43821996|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43821997|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821998|NCT03009019|Celecoxib|celecoxib|mesh-list
43821999|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43822000|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822001|NCT03009019|Analgesics|analgesics|mesh-ancestor
43822002|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
43822003|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822004|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822005|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822006|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43557742|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43557743|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822007|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43822008|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43822009|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822010|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822012|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43822013|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822014|NCT03006276|Analgesics|analgesics|mesh-ancestor
43822015|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
43822016|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822017|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822018|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822019|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822020|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43822021|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43822042|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43822043|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822044|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822045|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43822046|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43822047|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822048|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43822049|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
43822050|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
43822051|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
43822052|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822053|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
43822054|NCT02889523|Hormones|hormones|mesh-ancestor
43822055|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822056|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822061|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822063|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822064|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
43822065|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822066|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822067|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43846085|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
43846086|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846087|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846088|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846089|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43846090|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43822069|NCT02813785|Atezolizumab|atezolizumab|mesh-list
43822070|NCT02813785|Antibodies|antibodies|mesh-list
43822071|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
43822072|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822073|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822074|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
43822075|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
43822076|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
43822077|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822078|NCT02812524|Ipilimumab|ipilimumab|mesh-list
43822079|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822080|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822081|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43822082|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822083|NCT02733042|Rituximab|rituximab|mesh-list
43822084|NCT02733042|Durvalumab|durvalumab|mesh-list
43822085|NCT02733042|Lenalidomide|lenalidomide|mesh-list
43822086|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43822087|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822088|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822089|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
43822090|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822091|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822127|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822128|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
43822129|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
43822157|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822158|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43822159|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43822160|NCT02332577|Amoxicillin|amoxicillin|mesh-list
43822161|NCT02332577|Pristinamycin|pristinamycin|mesh-list
43822162|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822163|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822164|NCT02326805|Metronidazole|metronidazole|mesh-list
43822165|NCT02326805|Vaccines|vaccines|mesh-list
43822166|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
43822167|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822172|NCT02311920|Nivolumab|nivolumab|mesh-list
43822173|NCT02311920|Ipilimumab|ipilimumab|mesh-list
43822174|NCT02311920|Temozolomide|temozolomide|mesh-list
43822175|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822176|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822192|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822194|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43822195|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822196|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43822197|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43822198|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43822199|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43822200|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43822201|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43822202|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822203|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822204|NCT02204085|Decitabine|decitabine|mesh-list
43822205|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822206|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
43822207|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822208|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822209|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822210|NCT02141542|Tremelimumab|tremelimumab|mesh-list
43822211|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822215|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43822216|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43822217|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822218|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
43822219|NCT01990352|Doxorubicin|doxorubicin|mesh-list
43822220|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43822221|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822222|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822223|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43822224|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43822225|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822226|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822227|NCT01954979|Abatacept|abatacept|mesh-list
43814981|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43814982|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43814983|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43814984|NCT04785755|Etilefrine|etilefrine|mesh-list
43814985|NCT04785755|Furosemide|furosemide|mesh-list
43814986|NCT04785755|Spironolactone|spironolactone|mesh-list
43814987|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43814988|NCT04785755|Diuretics|diuretics|mesh-list
43814989|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
43814990|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43814991|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43814992|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43814993|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822228|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43720018|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822229|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822230|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822231|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822232|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
43822233|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822302|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822303|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822304|NCT01604265|Nabiximols|nabiximols|mesh-list
43822305|NCT01604265|Analgesics|analgesics|mesh-ancestor
43822306|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
43822307|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822308|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822309|NCT01553214|Dexamethasone|dexamethasone|mesh-list
43822310|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822351|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822352|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822353|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822354|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
43822355|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822356|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
43655551|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43655552|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43655553|NCT02968082|Scopolamine|scopolamine|mesh-list
43655554|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43655555|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43655556|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
43814994|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43720034|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822358|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822360|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822361|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822362|NCT00551460|Methotrexate|methotrexate|mesh-list
43822363|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
43822364|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
43822365|NCT00551460|Tretinoin|tretinoin|mesh-list
43822366|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
43822367|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43822369|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43822370|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822371|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822372|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
43822373|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822374|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822375|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
43822376|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822377|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43822378|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822379|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
43822380|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822381|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43822382|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
43822383|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822384|NCT00521846|Cimetidine|cimetidine|mesh-list
43822385|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43822386|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822387|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43822388|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
43822389|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
43822390|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822391|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822392|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822393|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43822394|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43822395|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822396|NCT00492856|Methotrexate|methotrexate|mesh-list
43822397|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
43822398|NCT00492856|Tretinoin|tretinoin|mesh-list
43822399|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43822400|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
43822401|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43822402|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822403|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822404|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
43846102|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846104|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43846142|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846143|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846144|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43846145|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846146|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
43846147|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
43846148|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655558|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655559|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822467|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43822468|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
43822494|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43822495|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822496|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
43815045|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43844941|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43844942|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43844943|NCT04320914|Analgesics|analgesics|mesh-ancestor
43844944|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
43844945|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43844946|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43844947|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43844948|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43844967|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43844969|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43844970|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43844971|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
43822497|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822498|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
43822499|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822502|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822503|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822504|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822505|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
43822506|NCT05534529|Rezafungin|rezafungin|mesh-list
43822507|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
43822508|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822509|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
43822510|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
43822511|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
43822512|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43822513|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822514|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
43822515|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43822516|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822517|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822552|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
43822553|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43822554|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43822575|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846165|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43846166|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43846167|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
43815046|NCT04785118|Scopolamine|scopolamine|mesh-list
43815047|NCT04785118|Ondansetron|ondansetron|mesh-list
43815048|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
43815049|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
43815050|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
43815051|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815052|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815053|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815054|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
43815055|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
43815056|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43815057|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
43815058|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815059|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846168|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846169|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43846170|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
43846171|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846172|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846173|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43846174|NCT04216524|Protective Agents|protective agents|mesh-ancestor
43846175|NCT04215848|Budesonide|budesonide|mesh-list
43846176|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
43846177|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43846178|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43846179|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
43846180|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846181|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846182|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43822656|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43822657|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
43822658|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703011|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43822659|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43822660|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
43822661|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43822662|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43822663|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43822664|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822665|NCT05532306|Ribavirin|ribavirin|mesh-list
43822666|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
43822667|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822668|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
43822669|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822670|NCT05532280|Etoricoxib|etoricoxib|mesh-list
43822671|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43822672|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43822673|NCT05532280|Analgesics|analgesics|mesh-ancestor
43822674|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
43822675|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822676|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822677|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822678|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822679|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43822680|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43822681|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815401|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815402|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
43815403|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43815404|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815405|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43815406|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822682|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822683|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
43822684|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43822685|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822686|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43822687|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43822688|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822689|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822690|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822691|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43822710|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43822711|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
43822712|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43822713|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43822714|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
43822715|NCT05532215|Misoprostol|misoprostol|mesh-list
43822717|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
43822718|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43655566|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43655567|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
43822719|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815473|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
43815474|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43815475|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43815476|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43815477|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
43822720|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43822722|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43822723|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822724|NCT05532163|Natalizumab|natalizumab|mesh-list
43822725|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
43822726|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822727|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
43822728|NCT05532111|Rituximab|rituximab|mesh-list
43822729|NCT05532111|Tacrolimus|tacrolimus|mesh-list
43822730|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
43815558|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43815559|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43815560|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43815561|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43815562|NCT03819517|Resveratrol|resveratrol|mesh-list
43815627|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822731|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43822732|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
43822733|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822734|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822735|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822736|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
43703012|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822737|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822738|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822739|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43822740|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822741|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43822742|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822744|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822745|NCT05532085|Analgesics|analgesics|mesh-list
43822746|NCT05532085|Anesthetics|anesthetics|mesh-list
43822809|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822810|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43822811|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43845143|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43845144|NCT04300790|Metformin|metformin|mesh-list
43845145|NCT04300790|Letrozole|letrozole|mesh-list
43845146|NCT04300790|Fulvestrant|fulvestrant|mesh-list
43845147|NCT04300790|Exemestane|exemestane|mesh-list
43822819|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43822820|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
43822821|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822822|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822823|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43822824|NCT05531591|Aripiprazole|aripiprazole|mesh-list
43822825|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
43822826|NCT05531591|Bupropion|bupropion|mesh-list
43822827|NCT05531591|Nortriptyline|nortriptyline|mesh-list
43822828|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43822829|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
43822830|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43822879|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822880|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822881|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43822882|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43822884|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43822916|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822917|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
43822918|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
43822919|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822920|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655569|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
43655570|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655571|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43655572|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43655573|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43822921|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43822922|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
43822923|NCT05530811|Hormones|hormones|mesh-ancestor
43822924|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43822926|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822927|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
43822962|NCT05530122|Ustekinumab|ustekinumab|mesh-list
43822963|NCT05530122|Vedolizumab|vedolizumab|mesh-list
43822964|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43822965|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822966|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823058|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
43823059|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
43823060|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43823061|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43823062|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
43823063|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823064|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823065|NCT05528913|Benralizumab|benralizumab|mesh-list
43823066|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43823067|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
43823068|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
43816236|NCT05458726|Osimertinib|osimertinib|mesh-list
43816237|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43816238|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43816239|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
43816240|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
43823072|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823073|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823074|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43823075|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
43823076|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823094|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823096|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823097|NCT05528718|Analgesics|analgesics|mesh-ancestor
43823098|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
43823099|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823100|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
43823101|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
43823102|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823103|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43823104|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823105|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823106|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823107|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43816308|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43816309|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43816310|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
43816311|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43816312|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816313|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43816314|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
43816315|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823111|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
43823112|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823113|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43823114|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43823115|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823116|NCT05528458|Osimertinib|osimertinib|mesh-list
43823117|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823118|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43655574|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655575|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43655576|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43655577|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
43823119|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823120|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823121|NCT05528419|Valsartan|valsartan|mesh-list
43823122|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43823123|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43823124|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43823125|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43720115|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
43823126|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823127|NCT05528198|Montelukast|montelukast|mesh-list
43823128|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43823129|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
43823130|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43823131|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
43823165|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
43823166|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823167|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
43823168|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43823169|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
43846225|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43846226|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846227|NCT04212416|Leflunomide|leflunomide|mesh-list
43846228|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846229|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846231|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
43846232|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846233|NCT04212039|Bupivacaine|bupivacaine|mesh-list
43846234|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
43846235|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
43846236|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43846237|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846238|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
43846239|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848908|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43848909|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43848913|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43848914|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43848915|NCT03980509|Analgesics|analgesics|mesh-ancestor
43848916|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
43848917|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43848918|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43848919|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43848920|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823173|NCT05527444|Thalidomide|thalidomide|mesh-list
43823174|NCT05527444|Adalimumab|adalimumab|mesh-list
43823175|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43558090|NCT03535870|Xhance|xhance|mesh-list
43558091|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43823176|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823177|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823178|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823179|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
43823180|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823181|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
43823182|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823183|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823184|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43823185|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43823186|NCT05527444|Growth Substances|growth substances|mesh-ancestor
43823187|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
43823188|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823189|NCT05527418|Dasatinib|dasatinib|mesh-list
43823190|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823191|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823192|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823193|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655578|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43655579|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
43655580|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655581|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
43823194|NCT05527340|Dexamethasone|dexamethasone|mesh-list
43823195|NCT05527340|Daratumumab|daratumumab|mesh-list
43823196|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823197|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
43823198|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
43823199|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823200|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823201|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823202|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
43823203|NCT05527340|Hormones|hormones|mesh-ancestor
43823204|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823205|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43823206|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823207|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
43823208|NCT05527275|Analgesics|analgesics|mesh-ancestor
43823209|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
43823210|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720124|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720125|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
43720126|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
43720127|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
43734436|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43720128|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558125|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43558126|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
43823211|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823212|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823213|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43823214|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43823215|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823216|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823217|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
43816470|NCT04870359|Hormones|hormones|mesh-ancestor
43823218|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
43823219|NCT05527106|Vitamins|vitamins|mesh-ancestor
43823220|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
43823221|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823222|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
43823223|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823224|NCT05527106|Protective Agents|protective agents|mesh-ancestor
43823225|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
43823226|NCT05527054|Diuretics|diuretics|mesh-list
43823246|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43823247|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823248|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823249|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823251|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43823252|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43823253|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823254|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
43823255|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
43823256|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
43823257|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
43823258|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823259|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823261|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823262|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43823263|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823264|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823265|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43823266|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43823267|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43823268|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43823269|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43823270|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43823271|NCT05526911|Protective Agents|protective agents|mesh-ancestor
43823272|NCT05526898|Triamcinolone|triamcinolone|mesh-list
43823273|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823274|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
43823275|NCT05526898|Hormones|hormones|mesh-ancestor
43558159|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43558160|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43558161|NCT03535558|Renal Agents|renal agents|mesh-ancestor
43558162|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
43558163|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43558164|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43558165|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43823276|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823277|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823278|NCT05526820|Vaccines|vaccines|mesh-list
43823279|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
43655582|NCT02967874|Protective Agents|protective agents|mesh-ancestor
43655583|NCT02967887|Cisplatin|cisplatin|mesh-list
43655584|NCT02967887|Fluorouracil|fluorouracil|mesh-list
43655585|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655586|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
43823280|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43816889|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43816890|NCT03544606|Pyridoxine|pyridoxine|mesh-list
43816891|NCT03544606|Isosorbide|isosorbide|mesh-list
43823281|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
43823282|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
43823283|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823284|NCT05526794|Analgesics|analgesics|mesh-list
43823285|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
43846240|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
43846241|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
43846242|NCT04209218|Dexamethasone|dexamethasone|mesh-list
43846243|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
43846244|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43558183|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43558184|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43558185|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
43558186|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43558188|NCT03535480|Lenograstim|lenograstim|mesh-list
43846245|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
43823345|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43817036|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43817037|NCT02367105|Testosterone|testosterone|mesh-list
43817038|NCT02367105|Androgens|androgens|mesh-ancestor
43817039|NCT02367105|Hormones|hormones|mesh-ancestor
43817040|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43817041|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43817042|NCT02197039|Esomeprazole|esomeprazole|mesh-list
43558236|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
43817043|NCT02197039|Pantoprazole|pantoprazole|mesh-list
43817044|NCT02197039|Hemostatics|hemostatics|mesh-list
43817045|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43817046|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43817047|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43817048|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558237|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
43558238|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
43558239|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
43558240|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558241|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558242|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43558243|NCT03535103|Hormones|hormones|mesh-ancestor
43558244|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43558245|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558246|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
43817060|NCT02037048|Leucovorin|leucovorin|mesh-list
43817101|NCT01757418|Antibodies|antibodies|mesh-list
43817102|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
43823346|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
43823347|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823348|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823349|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43823354|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823355|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823356|NCT05525247|Antiviral Agents|antiviral agents|mesh-ancestor
43823357|NCT05525247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823358|NCT05525247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823359|NCT05525247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823360|NCT05525247|Immunologic Factors|immunologic factors|mesh-ancestor
43823361|NCT05525247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823362|NCT05525234|Thalidomide|thalidomide|mesh-list
43823363|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823364|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
43823365|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823366|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
43823419|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823420|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
43823422|NCT05523986|Vitamins|vitamins|mesh-ancestor
43823423|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
43823424|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823425|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43823426|NCT05523934|Capsaicin|capsaicin|mesh-list
43823427|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
43823428|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823429|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
43823430|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823431|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823432|NCT05523869|Topotecan|topotecan|mesh-list
43558289|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43558290|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43558291|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43558292|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43558293|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
43558294|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
43558295|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
43558296|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43558297|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558298|NCT03534869|Analgesics|analgesics|mesh-list
43558299|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
43558300|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43558301|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558302|NCT03534713|Paclitaxel|paclitaxel|mesh-list
43558303|NCT03534713|Cisplatin|cisplatin|mesh-list
43558304|NCT03534713|Carboplatin|carboplatin|mesh-list
43558305|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823433|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43823434|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43823435|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823436|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823437|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823438|NCT05523661|Dasatinib|dasatinib|mesh-list
43823439|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823440|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823441|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823442|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846246|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
43846247|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846248|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846249|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43846250|NCT04209218|Hormones|hormones|mesh-ancestor
43846251|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43846252|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43846253|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846254|NCT04209075|Metformin|metformin|mesh-list
43655587|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846255|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43823453|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43823454|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43823455|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
43823456|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43823457|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43823458|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43823459|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
43823460|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43823461|NCT05523102|Acetaminophen|acetaminophen|mesh-list
43823462|NCT05523102|Ketorolac|ketorolac|mesh-list
43823463|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43823464|NCT05523102|Analgesics|analgesics|mesh-ancestor
43818112|NCT05548998|Anesthetics|anesthetics|mesh-list
43823465|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
43823466|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823467|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823468|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
43720129|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43720130|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720131|NCT02631928|Insulin|insulin|mesh-list
43720132|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43720133|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
43720134|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43558311|NCT03534674|Vitamin D|vitamin d|mesh-list
43823469|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43823470|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823524|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823526|NCT05522231|Axitinib|axitinib|mesh-list
43846296|NCT04205968|Fluorouracil|fluorouracil|mesh-list
43846297|NCT04205968|Irinotecan|irinotecan|mesh-list
43846298|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43846299|NCT04205968|Ramucirumab|ramucirumab|mesh-list
43641577|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641578|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
43641580|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43641581|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43641582|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43641583|NCT05607316|Metformin|metformin|mesh-list
43641584|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43641585|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641586|NCT05603702|Lacosamide|lacosamide|mesh-list
43641587|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
43641588|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43641589|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43641590|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43641591|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641593|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
43641594|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641595|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641596|NCT05599516|Vaccines|vaccines|mesh-list
43641597|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
43641598|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641599|NCT05597098|Cantharidin|cantharidin|mesh-list
43641600|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641601|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641602|NCT05594823|Furosemide|furosemide|mesh-list
43641603|NCT05594823|Diuretics|diuretics|mesh-list
43641604|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
43558330|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641605|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641606|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43845546|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43641607|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43641608|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641609|NCT05591755|Ketotifen|ketotifen|mesh-list
43641610|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43641611|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43641612|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43641613|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43641614|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43641615|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43655588|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43655589|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655590|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
43655591|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641616|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43641617|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
43641618|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641619|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641620|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641621|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
43641622|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
43641623|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43641624|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
43641693|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
43641695|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641696|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43641697|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43641698|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641699|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
43641700|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641702|NCT05575999|Ketamine|ketamine|mesh-list
43641703|NCT05575999|Bupivacaine|bupivacaine|mesh-list
43641720|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641721|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641722|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43641723|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641724|NCT05574387|Metformin|metformin|mesh-list
43641725|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43641726|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641727|NCT05573607|Chromium|chromium|mesh-list
43641728|NCT05573607|Trace Elements|trace elements|mesh-ancestor
43641729|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
43641730|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641731|NCT05567835|Leucovorin|leucovorin|mesh-list
43641732|NCT05567835|Docetaxel|docetaxel|mesh-list
43641733|NCT05567835|Fluorouracil|fluorouracil|mesh-list
43641734|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
43641735|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641736|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
43641738|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
43641739|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641740|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
43641741|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641742|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641743|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
43641744|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641745|NCT05567835|Antidotes|antidotes|mesh-ancestor
43641746|NCT05567835|Protective Agents|protective agents|mesh-ancestor
43641747|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
43641748|NCT05567835|Vitamins|vitamins|mesh-ancestor
43641749|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
43641750|NCT05565352|Ketamine|ketamine|mesh-list
43641751|NCT05565352|Analgesics|analgesics|mesh-ancestor
43641752|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
43641753|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641754|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641755|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43641756|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43641757|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
43641758|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
43641759|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641760|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43641761|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43641762|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43641763|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823562|NCT05521633|Metformin|metformin|mesh-list
43823563|NCT05521633|Pioglitazone|pioglitazone|mesh-list
43823564|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655592|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
43655593|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655594|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823565|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823566|NCT05521386|Caffeine|caffeine|mesh-list
43641839|NCT05556746|Rifampin|rifampin|mesh-list
43641840|NCT05556746|Clofazimine|clofazimine|mesh-list
43641841|NCT05556746|Isoniazid|isoniazid|mesh-list
43641842|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
43641843|NCT05556746|Ethambutol|ethambutol|mesh-list
43641844|NCT05556746|Bedaquiline|bedaquiline|mesh-list
43641845|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43641846|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
43641847|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641848|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641849|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
43641850|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43641851|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641868|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641869|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
43641870|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641871|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
43641872|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641873|NCT05554965|Propofol|propofol|mesh-list
43641874|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43641875|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641876|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641877|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43641878|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
43641879|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
43641880|NCT05554419|Cytarabine|cytarabine|mesh-list
43641881|NCT05554419|Azacitidine|azacitidine|mesh-list
43641882|NCT05554419|Daunorubicin|daunorubicin|mesh-list
43641883|NCT05554419|Venetoclax|venetoclax|mesh-list
43641884|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641885|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
43641886|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558409|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558410|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641887|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641888|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
43641889|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641890|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641891|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
43818696|NCT05541185|Naproxen|naproxen|mesh-list
43641898|NCT05554406|Azacitidine|azacitidine|mesh-list
43641899|NCT05554406|Daunorubicin|daunorubicin|mesh-list
43641900|NCT05554406|Venetoclax|venetoclax|mesh-list
43641901|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641902|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
43641903|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641904|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641905|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
43641906|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641907|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641908|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
43641957|NCT05538819|Glimepiride|glimepiride|mesh-list
43641958|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43641959|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43641960|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641961|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641962|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
43641963|NCT05536856|Fluorouracil|fluorouracil|mesh-list
43641964|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
43655595|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43655596|NCT02967302|Triamcinolone|triamcinolone|mesh-list
43655597|NCT02967302|Morphine|morphine|mesh-list
43655598|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43655599|NCT02967302|Narcotics|narcotics|mesh-ancestor
43641965|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641966|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641967|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720279|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43720280|NCT02631031|Valsartan|valsartan|mesh-list
43720281|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43720282|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43720283|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43641968|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43641969|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
43641970|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641971|NCT05531955|Pirfenidone|pirfenidone|mesh-list
43641972|NCT05531955|Analgesics|analgesics|mesh-ancestor
43641973|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
43641974|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641975|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641976|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43641977|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43641978|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641979|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641980|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641981|NCT05530421|Dexamethasone|dexamethasone|mesh-list
43641982|NCT05530421|Venetoclax|venetoclax|mesh-list
43641983|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641984|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
43641985|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
43641986|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641987|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641988|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43641989|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
43641990|NCT05530421|Hormones|hormones|mesh-ancestor
43642021|NCT05523440|Niraparib|niraparib|mesh-list
43642022|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642023|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642024|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43642025|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43642026|NCT05523440|Growth Substances|growth substances|mesh-ancestor
43558466|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642027|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642028|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
43642029|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43642030|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642031|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642032|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
43642033|NCT05523323|Lenvatinib|lenvatinib|mesh-list
43642034|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642035|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642036|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823629|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
43823630|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823631|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823632|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823633|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823634|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
43823635|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823636|NCT05520658|Diuretics|diuretics|mesh-ancestor
43823637|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
43846304|NCT04205968|Lexatumumab|lexatumumab|mesh-list
43642039|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
43642040|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
43642041|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642042|NCT05516953|Baclofen|baclofen|mesh-list
43642043|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43642044|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642045|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43642046|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642047|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
43642048|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
43642049|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
43642050|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642051|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642052|NCT05514990|Dexamethasone|dexamethasone|mesh-list
43642053|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
43655600|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43655601|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655602|NCT02967302|Analgesics|analgesics|mesh-ancestor
43655603|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
43655604|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655605|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655606|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
43642054|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
43642055|NCT05514990|Bortezomib|bortezomib|mesh-list
43642056|NCT05514990|Ichthammol|ichthammol|mesh-list
43642057|NCT05514990|BB 1101|bb 1101|mesh-list
43642058|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642059|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
43642089|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642090|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642091|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642092|NCT05511415|Analgesics|analgesics|mesh-ancestor
43642093|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
43642094|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642095|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43642096|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43642097|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720383|NCT02630420|Cetuximab|cetuximab|mesh-list
43642098|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558524|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642099|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642100|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642102|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43642127|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642128|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43642129|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43642130|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
43642131|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642132|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43642133|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
43642134|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
43642135|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
43642136|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43642137|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
43642138|NCT05507476|Coagulants|coagulants|mesh-ancestor
43642139|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43642140|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
43642141|NCT05505825|Chiauranib|chiauranib|mesh-list
43642142|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642143|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43642144|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642145|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642146|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
43642147|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642148|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642149|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642150|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642151|NCT05500703|Analgesics|analgesics|mesh-ancestor
43642152|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
43642153|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642169|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642170|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642171|NCT05493475|Analgesics|analgesics|mesh-ancestor
43642172|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
43642173|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642174|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43642175|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642176|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
43642177|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
43642178|NCT05486416|Propofol|propofol|mesh-list
43642179|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642180|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642181|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642182|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642183|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
43655607|NCT02967302|Hormones|hormones|mesh-ancestor
43655608|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655609|NCT02967653|Atorvastatin|atorvastatin|mesh-list
43655610|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43642184|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
43642185|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
43642186|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
43642187|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43558601|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43558602|NCT05263505|Methotrexate|methotrexate|mesh-list
43558603|NCT05263505|Azathioprine|azathioprine|mesh-list
43720429|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
43832760|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43720430|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720431|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43720432|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43720433|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846305|NCT04205968|Calcium|calcium|mesh-list
43638642|NCT03983850|Sirolimus|sirolimus|mesh-list
43642188|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43642189|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43642190|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642191|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642192|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642193|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642194|NCT05486026|Analgesics|analgesics|mesh-ancestor
43642195|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
43642196|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642197|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
43642198|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642200|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642201|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43642202|NCT05484492|Calcium|calcium|mesh-list
43642203|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43642204|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642205|NCT05482334|Molgramostim|molgramostim|mesh-list
43642207|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
43642208|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43845687|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43845688|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43845691|NCT04261855|Avelumab|avelumab|mesh-list
43642209|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642211|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43642246|NCT05476770|Hormones|hormones|mesh-ancestor
43642247|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642248|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43642249|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642250|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43642251|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
43642252|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43642277|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
43642279|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642280|NCT05473910|Protective Agents|protective agents|mesh-ancestor
43642281|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642282|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43642283|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823638|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
43823639|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43823641|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43823642|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823643|NCT05520658|Protective Agents|protective agents|mesh-ancestor
43823644|NCT05520645|Propofol|propofol|mesh-list
43823645|NCT05520645|Etomidate|etomidate|mesh-list
43823646|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823647|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823648|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823649|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823650|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
43823651|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
43823652|NCT05520073|Ascorbic Acid|ascorbic acid|mesh-list
43823653|NCT05520073|Vitamins|vitamins|mesh-ancestor
43823654|NCT05520073|Micronutrients|micronutrients|mesh-ancestor
43823673|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
43823674|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823675|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
43823676|NCT05519813|Metformin|metformin|mesh-list
43823677|NCT05519813|Pioglitazone|pioglitazone|mesh-list
43823678|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655612|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
43823679|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846307|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43846308|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846309|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
43846310|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
43846311|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
43846312|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846313|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
43846314|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846315|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43846316|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43846317|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
43642284|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43642285|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43642286|NCT05473273|Estradiol|estradiol|mesh-list
43642287|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43642288|NCT05473273|Progesterone|progesterone|mesh-list
43642289|NCT05473273|Estrogens|estrogens|mesh-ancestor
43642290|NCT05473273|Hormones|hormones|mesh-ancestor
43642291|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642292|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642293|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43642295|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43642296|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43642297|NCT05473273|Progestins|progestins|mesh-ancestor
43642298|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
43642299|NCT05466799|Irinotecan|irinotecan|mesh-list
43642300|NCT05466799|Folfirinox|folfirinox|mesh-list
43642301|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642302|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43642303|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43642324|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43642325|NCT05462730|Prednisolone|prednisolone|mesh-list
43819225|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
43642326|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
43642327|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43642328|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
43642329|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43642330|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
43642331|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
43558669|NCT05261997|Pancreatin|pancreatin|mesh-list
43642332|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642333|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642334|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43642335|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
43642336|NCT05462730|Hormones|hormones|mesh-ancestor
43642337|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642338|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43642339|NCT05462730|Protective Agents|protective agents|mesh-ancestor
43642340|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43642341|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642342|NCT05458401|Trastuzumab|trastuzumab|mesh-list
43642343|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642344|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642345|NCT05456685|Carboplatin|carboplatin|mesh-list
43642346|NCT05456685|Maytansine|maytansine|mesh-list
43642347|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642348|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43642349|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
43642350|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
43642351|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
43642352|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642353|NCT05440968|Chrysarobin|chrysarobin|mesh-list
43642354|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43642355|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642390|NCT05438277|Triamcinolone|triamcinolone|mesh-list
43642391|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43642392|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43642425|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43642426|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
43642427|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655613|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655614|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43655615|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43655616|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655617|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
43655618|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642428|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43642430|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43642431|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43642432|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
43642434|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43720528|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642467|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
43642468|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43642469|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43642470|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642471|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642472|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642473|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43642474|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642499|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43642500|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43642501|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
43642502|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43642503|NCT05422365|Antibodies|antibodies|mesh-list
43642504|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
43642505|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43642507|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642508|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43642509|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43642510|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642511|NCT05417165|Vaccines|vaccines|mesh-list
43642512|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43642513|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
43642514|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642515|NCT05411575|Plerixafor|plerixafor|mesh-list
43642516|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43823681|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43823682|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823710|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43823711|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43823712|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
43823713|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823714|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823715|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43823716|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
43823717|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
43823718|NCT05519514|Hormones|hormones|mesh-ancestor
43823719|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823720|NCT05519410|Lenvatinib|lenvatinib|mesh-list
43823721|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823722|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43823723|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823724|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823725|NCT05519371|Propofol|propofol|mesh-list
43823726|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823727|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642543|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43642544|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642545|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642546|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43642547|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43642548|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
43655619|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655620|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43655621|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43655622|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655623|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655624|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655625|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43655626|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43655627|NCT02967614|Timolol|timolol|mesh-list
43655628|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
43655629|NCT02967614|Dorzolamide|dorzolamide|mesh-list
43642585|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
43642617|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43642618|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
43642619|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
43642620|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642621|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642622|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642623|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43642658|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642659|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642660|NCT05357846|Paclitaxel|paclitaxel|mesh-list
43642661|NCT05357846|Cisplatin|cisplatin|mesh-list
43642662|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43642675|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43642676|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43642677|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642678|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
43819425|NCT05361993|Aripiprazole|aripiprazole|mesh-list
43642682|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642683|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642684|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
43642685|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642686|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43642687|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43642688|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43642689|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43642690|NCT05344625|Ketamine|ketamine|mesh-list
43642691|NCT05344625|Analgesics|analgesics|mesh-ancestor
43642692|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
43642693|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642694|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642695|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43642696|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43720611|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
43558764|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
43642697|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
43642698|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
43642699|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43819474|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
43633235|NCT05611463|Cisplatin|cisplatin|mesh-list
43819475|NCT05156268|Olaparib|olaparib|mesh-list
43819480|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819482|NCT05134441|Calcium|calcium|mesh-list
43819483|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43642700|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43642701|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43642702|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642703|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642704|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
43642705|NCT05341154|Ketamine|ketamine|mesh-list
43642706|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642707|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642708|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642709|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642711|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
43642712|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655630|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43655631|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43655632|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655633|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655634|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642713|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43642714|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43642715|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43642716|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642717|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642718|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642719|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43642720|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642721|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
43642722|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
43642740|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43642741|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
43642742|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642745|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
43642746|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642747|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642748|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
43642749|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642750|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642751|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
43642752|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
43642753|NCT05327231|Docetaxel|docetaxel|mesh-list
43642754|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642755|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
43642756|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
43642757|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
43642758|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642759|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
43642760|NCT05325281|Gemcitabine|gemcitabine|mesh-list
43819576|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43819577|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
43819578|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
43819579|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
43819580|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720639|NCT02628587|Clopidogrel|clopidogrel|mesh-list
43720640|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720652|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
43819581|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43819582|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43819583|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43819584|NCT04809051|Metronidazole|metronidazole|mesh-list
43819585|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43819586|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642761|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43642762|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
43642763|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642764|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642765|NCT05325281|Antiviral Agents|antiviral agents|mesh-ancestor
43642766|NCT05325281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642767|NCT05325281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642768|NCT05325281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43819599|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43819600|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43819601|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819602|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
43819603|NCT04676555|Ofatumumab|ofatumumab|mesh-list
43819604|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
43819605|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642769|NCT05325281|Immunologic Factors|immunologic factors|mesh-ancestor
43642770|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642771|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
43642772|NCT05325281|Protective Agents|protective agents|mesh-ancestor
43642773|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
43642774|NCT05325281|Vitamins|vitamins|mesh-ancestor
43642775|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
43642776|NCT05324462|Xultophy|xultophy|mesh-list
43642777|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43642778|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642779|NCT05324462|Incretins|incretins|mesh-ancestor
43642780|NCT05324462|Hormones|hormones|mesh-ancestor
43642781|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642782|NCT05323955|Trastuzumab|trastuzumab|mesh-list
43642783|NCT05323955|Pertuzumab|pertuzumab|mesh-list
43642784|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43642785|NCT05323955|Maytansine|maytansine|mesh-list
43642786|NCT05323955|Tucatinib|tucatinib|mesh-list
43642787|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43642788|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642789|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43642790|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
43642791|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
43642792|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
43642793|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642794|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43642795|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642797|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43655635|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655636|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43655637|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43655638|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43642798|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43642799|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43823757|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
43639395|NCT03313180|Nintedanib|nintedanib|mesh-list
43642800|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642801|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43558789|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
43558791|NCT05057130|Cisplatin|cisplatin|mesh-list
43642802|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43642803|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43642804|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
43642805|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642806|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642807|NCT05323019|Ketamine|ketamine|mesh-list
43642808|NCT05323019|Esketamine|esketamine|mesh-list
43642809|NCT05323019|Analgesics|analgesics|mesh-ancestor
43642810|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
43642811|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642812|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642813|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43642814|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642815|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
43642816|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
43642825|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642826|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642827|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43642828|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43642829|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642830|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642831|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642832|NCT05309629|Carboplatin|carboplatin|mesh-list
43642833|NCT05309629|Etoposide|etoposide|mesh-list
43642834|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642835|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43642836|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43642837|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43642838|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43642839|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642840|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
43642841|NCT05306873|Cyclosporine|cyclosporine|mesh-list
43642842|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43642843|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642844|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43642845|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
43642846|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43642847|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43642848|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720654|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43720655|NCT02628574|Antiviral Agents|antiviral agents|mesh-ancestor
43720656|NCT02628574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43720657|NCT02628574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720658|NCT02628574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43720659|NCT02628574|Immunologic Factors|immunologic factors|mesh-ancestor
43720660|NCT02628574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720661|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43720662|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43720663|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43720664|NCT02628392|Firuglipel|firuglipel|mesh-list
43720665|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43720666|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720667|NCT02628392|Incretins|incretins|mesh-ancestor
43720668|NCT02628392|Hormones|hormones|mesh-ancestor
43720669|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43642849|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642850|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
43642851|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
43819825|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
43819826|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43819827|NCT03341962|Calcium|calcium|mesh-list
43819828|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43819831|NCT03340506|Dabrafenib|dabrafenib|mesh-list
43642853|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
43642854|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642855|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43642856|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43642857|NCT05302804|Menthol|menthol|mesh-list
43642858|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
43642859|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642860|NCT05298202|Capsaicin|capsaicin|mesh-list
43642861|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
43642862|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642863|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
43642864|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642865|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642866|NCT05289804|Lidocaine|lidocaine|mesh-list
43642867|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
43642868|NCT05289804|Prilocaine|prilocaine|mesh-list
43642869|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43655639|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43655640|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43655641|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43655642|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43655643|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
43655644|NCT02967380|Antidotes|antidotes|mesh-ancestor
43655645|NCT02967380|Protective Agents|protective agents|mesh-ancestor
43655646|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655647|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
43642870|NCT05289804|Anesthetics|anesthetics|mesh-list
43642871|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642872|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642873|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
43642874|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642875|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642876|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43642877|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43642878|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642879|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43819950|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43819951|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
43819952|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
43642881|NCT05289440|Esketamine|esketamine|mesh-list
43642896|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
43642897|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642899|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43642900|NCT05283304|Narcotics|narcotics|mesh-ancestor
43642901|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642902|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642903|NCT05283304|Analgesics|analgesics|mesh-ancestor
43642904|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
43642905|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642906|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43642907|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
43820029|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43820030|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
43642908|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43558816|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
43558817|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642909|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642910|NCT05277922|Nitroprusside|nitroprusside|mesh-list
43642911|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43642912|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
43642913|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43642914|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642915|NCT05263986|Adagrasib|adagrasib|mesh-list
43642916|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43642917|NCT05262270|Naltrexone|naltrexone|mesh-list
43642918|NCT05262270|Buprenorphine|buprenorphine|mesh-list
43642919|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43642920|NCT05262270|Narcotics|narcotics|mesh-ancestor
43642921|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642922|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642923|NCT05262270|Analgesics|analgesics|mesh-ancestor
43642924|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
43642925|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642926|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43642927|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43642928|NCT05259787|Propofol|propofol|mesh-list
43642929|NCT05259787|Etomidate|etomidate|mesh-list
43642930|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642931|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642932|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642933|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43642934|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
43642935|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
43642936|NCT05256069|Propranolol|propranolol|mesh-list
43642937|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43642938|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43642939|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642940|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642941|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642969|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655648|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
43655649|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820362|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43820363|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43820364|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43820365|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
43820366|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43820367|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43720670|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43820368|NCT05644665|Ozanimod|ozanimod|mesh-list
43720671|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
43720672|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720673|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43558827|NCT05041062|Nivolumab|nivolumab|mesh-list
43558828|NCT05041062|Ipilimumab|ipilimumab|mesh-list
43820371|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43655653|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43655654|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
43655655|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
43642971|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43642972|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642973|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642974|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43642975|NCT05226325|Analgesics|analgesics|mesh-ancestor
43642976|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
43642977|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642978|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43642979|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43642980|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43642981|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
43642982|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43642983|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642984|NCT05221190|Lidocaine|lidocaine|mesh-list
43642985|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
43642986|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
43642987|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43642988|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43642989|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
43642990|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43642991|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43642992|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43642993|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43642994|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43642995|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43642996|NCT05221021|Mirabegron|mirabegron|mesh-list
43642997|NCT05221021|Estradiol|estradiol|mesh-list
43642998|NCT05221021|Estrogens|estrogens|mesh-list
43642999|NCT05221021|Hormones|hormones|mesh-ancestor
43643064|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643065|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643067|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
43643092|NCT05195918|Nintedanib|nintedanib|mesh-list
43643093|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
43643094|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643095|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643096|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643097|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643099|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
43643100|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643101|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643102|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43643103|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643104|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643105|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643106|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
43643107|NCT05195918|Protective Agents|protective agents|mesh-ancestor
43643108|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
43558840|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643109|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43643110|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43643111|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
43643112|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43643113|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643114|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655656|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655657|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655658|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643123|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643124|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643126|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
43643127|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
43643128|NCT05190705|BB 1101|bb 1101|mesh-list
43643129|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643130|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
43643131|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
43643132|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643133|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643134|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643135|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
43643136|NCT05190705|Hormones|hormones|mesh-ancestor
43643137|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643138|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643139|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643140|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
43643141|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643142|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643143|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643144|NCT05180942|Atorvastatin|atorvastatin|mesh-list
43643145|NCT05180942|Calcium|calcium|mesh-list
43643146|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43643147|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643148|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43643149|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43643150|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
43643151|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643152|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43643153|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43643154|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643155|NCT05180357|Benralizumab|benralizumab|mesh-list
43643156|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43643157|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
43643158|NCT05180097|Gemcitabine|gemcitabine|mesh-list
43832813|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
43643159|NCT05180097|Dexamethasone|dexamethasone|mesh-list
43643160|NCT05180097|Cisplatin|cisplatin|mesh-list
43832814|NCT05249972|Calcipotriene|calcipotriene|mesh-list
43643161|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
43643162|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43643163|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643164|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
43643165|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
43643166|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643167|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643168|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643169|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
43643170|NCT05180097|Hormones|hormones|mesh-ancestor
43643171|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643172|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643173|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643174|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643175|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
43643176|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643177|NCT05180097|Antiviral Agents|antiviral agents|mesh-ancestor
43643178|NCT05180097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643179|NCT05180097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643214|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
43643215|NCT05168930|Venetoclax|venetoclax|mesh-list
43643216|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
43643217|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643218|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43643219|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643220|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643242|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43643243|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
43643244|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43655659|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
43655660|NCT02967276|Hormones|hormones|mesh-ancestor
43643245|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
43643246|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43643247|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643248|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43643283|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43643284|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43643285|NCT05126966|Growth Substances|growth substances|mesh-ancestor
43643286|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643320|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43643321|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643322|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643323|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
43643324|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
43643325|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643326|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643327|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
43643328|NCT05099471|Hormones|hormones|mesh-ancestor
43643329|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643330|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43558912|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43643331|NCT05098847|Lenvatinib|lenvatinib|mesh-list
43643332|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643361|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
43643362|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43643363|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
43643364|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43643365|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823774|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
43823775|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43823776|NCT05519059|Paclitaxel|paclitaxel|mesh-list
43823777|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823778|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43820899|NCT05123365|Protective Agents|protective agents|mesh-ancestor
43823779|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
43823780|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
43823781|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823782|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823783|NCT05518994|Bevacizumab|bevacizumab|mesh-list
43823784|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43823785|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643394|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643395|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
43643396|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643397|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643399|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43643400|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
43643401|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643402|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643403|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43643404|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43643405|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
43643406|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643407|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643408|NCT05060003|Atezolizumab|atezolizumab|mesh-list
43643409|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643414|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643415|NCT05055726|Benzydamine|benzydamine|mesh-list
43643416|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643417|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
43643418|NCT05054348|Cemiplimab|cemiplimab|mesh-list
43643419|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643420|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643421|NCT05047601|Ritonavir|ritonavir|mesh-list
43643422|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43643423|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43643424|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
43643425|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643426|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643427|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43655661|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43655662|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43655663|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655664|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655666|NCT02967432|Petrolatum|petrolatum|mesh-list
43655667|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43821013|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
43643428|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43643429|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
43643430|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643431|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43643432|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43643433|NCT05042466|Psilocybin|psilocybin|mesh-list
43643434|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
43643435|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643436|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43643437|NCT05035277|Aspirin|aspirin|mesh-list
43643438|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
43643439|NCT05035277|Apixaban|apixaban|mesh-list
43643440|NCT05035277|Edoxaban|edoxaban|mesh-list
43643441|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43643442|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
43643443|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43643444|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
43643445|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643446|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643447|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
43643448|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43643449|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43643450|NCT05035277|Analgesics|analgesics|mesh-ancestor
43643451|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
43643452|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643453|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643454|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643455|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643456|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43643457|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43643458|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43643459|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43643460|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
43643461|NCT05020600|Pregabalin|pregabalin|mesh-list
43643462|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
43643463|NCT05020600|Amitriptyline|amitriptyline|mesh-list
43643464|NCT05020600|Analgesics|analgesics|mesh-ancestor
43643465|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
43643466|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846023|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
43643468|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
43643469|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43643470|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43643471|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643472|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43643473|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43643474|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43643475|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643476|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43643477|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43643478|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43643479|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643480|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
43643481|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
43643514|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643515|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643516|NCT05018221|Cathartics|cathartics|mesh-ancestor
43643517|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643518|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
43643519|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643521|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643522|NCT05011487|Cisplatin|cisplatin|mesh-list
43655668|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43655669|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43655670|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43720900|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655671|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643524|NCT05011487|Osimertinib|osimertinib|mesh-list
43643525|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643526|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643527|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643528|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43643559|NCT04981509|Growth Substances|growth substances|mesh-ancestor
43643560|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643561|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
43643562|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
43643563|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
43643564|NCT04981509|Protective Agents|protective agents|mesh-ancestor
43643565|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43643566|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643568|NCT04974398|Cisplatin|cisplatin|mesh-list
43643569|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643570|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643571|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
43643572|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643573|NCT04974398|Antiviral Agents|antiviral agents|mesh-ancestor
43643574|NCT04974398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643594|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43643620|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643622|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643623|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643624|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43643625|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643626|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
43643627|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43643628|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
43643629|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643630|NCT04944836|Clomiphene|clomiphene|mesh-list
43643631|NCT04944836|Enclomiphene|enclomiphene|mesh-list
43643632|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
43643633|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43643634|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
43832846|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
43832847|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832848|NCT05248945|Carbamazepine|carbamazepine|mesh-list
43694094|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43643635|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643636|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643637|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43643638|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
43643639|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43643640|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43643641|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43643643|NCT04943848|Vaccines|vaccines|mesh-list
43643644|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
43643645|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643682|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
43643683|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643684|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643685|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43643686|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43643699|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
43643700|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
43643701|NCT04937166|Azacitidine|azacitidine|mesh-list
43643702|NCT04937166|Venetoclax|venetoclax|mesh-list
43643703|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43643704|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
43643705|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643706|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643707|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643708|NCT04934020|Metronidazole|metronidazole|mesh-list
43643709|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643710|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43643711|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43643712|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43655672|NCT02967432|Emollients|emollients|mesh-ancestor
43655673|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
43655674|NCT02967172|Epinephrine|epinephrine|mesh-list
43655675|NCT02967172|Morphine|morphine|mesh-list
43655676|NCT02967172|Ropivacaine|ropivacaine|mesh-list
43655677|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43655678|NCT02967172|Narcotics|narcotics|mesh-ancestor
43655679|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643713|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
43821346|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43643714|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643715|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643716|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43643717|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
43643718|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643719|NCT04925167|Heparin|heparin|mesh-list
43643721|NCT04925167|Argatroban|argatroban|mesh-list
43643722|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
43643723|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43643724|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43720932|NCT02626169|Clopidogrel|clopidogrel|mesh-list
43720933|NCT02626169|Ticagrelor|ticagrelor|mesh-list
43720934|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43720935|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43720936|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43720937|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43720938|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
43720939|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43720940|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43720941|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43720942|NCT02626208|ST 1435|st 1435|mesh-list
43720943|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
43720944|NCT02626208|Estradiol|estradiol|mesh-list
43643725|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643726|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
43643727|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43643728|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
43643729|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643730|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43643731|NCT04921358|Docetaxel|docetaxel|mesh-list
43643732|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643733|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
43643734|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
43643735|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
43643736|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643737|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
43643738|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821392|NCT04341571|Metformin|metformin|mesh-list
43643739|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643741|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643742|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643743|NCT04915287|Maleic acid|maleic acid|mesh-list
43643744|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643745|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643746|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
43643747|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643748|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43643749|NCT04913311|Dimercaprol|dimercaprol|mesh-list
43643764|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643765|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43643766|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
43643767|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
43643768|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43643769|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43643770|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43643771|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43643772|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643773|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643774|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643775|NCT04912596|Miotics|miotics|mesh-ancestor
43643776|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
43643777|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
43643778|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
43643779|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43643780|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
43643781|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
43643787|NCT04911127|Cannabidiol|cannabidiol|mesh-list
43655680|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655682|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
43655683|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655684|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
43643788|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
43643789|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43643790|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43643791|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43643792|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43643793|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643794|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
43643795|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643796|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643797|NCT04904614|Letermovir|letermovir|mesh-list
43643798|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43643799|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643800|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643802|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
43643803|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643804|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43643805|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43643819|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
43643820|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
43643821|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643822|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823826|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823827|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43823828|NCT05518578|Protective Agents|protective agents|mesh-ancestor
43823829|NCT05518526|Annamycin|annamycin|mesh-list
43821538|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43821587|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
43821588|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43821589|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821590|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
43821591|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
43821592|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
43821593|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43821594|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821595|NCT03908437|Buprenorphine|buprenorphine|mesh-list
43821596|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43821598|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43821599|NCT03908437|Narcotics|narcotics|mesh-ancestor
43821600|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43821601|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43821602|NCT03908437|Analgesics|analgesics|mesh-ancestor
43821603|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
43821604|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43821605|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43821606|NCT03851614|Durvalumab|durvalumab|mesh-list
43821607|NCT03851614|Olaparib|olaparib|mesh-list
43821608|NCT03851614|Cediranib|cediranib|mesh-list
43821609|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43821610|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43821612|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823830|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43720965|NCT02626481|Dexamethasone|dexamethasone|mesh-list
43823831|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823832|NCT05518513|Bupivacaine|bupivacaine|mesh-list
43823833|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
43823834|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
43823835|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823836|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823837|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
43643853|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
43643854|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643855|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
43643856|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
43643857|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
43643858|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643869|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
43643871|NCT04880577|Rituximab|rituximab|mesh-list
43643872|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
43643873|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43643874|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643875|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
43643876|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643877|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43643878|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
43643879|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643880|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43643881|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43643882|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643883|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643884|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43643885|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43643886|NCT04879992|Amoxicillin|amoxicillin|mesh-list
43643887|NCT04879992|Metronidazole|metronidazole|mesh-list
43643888|NCT04879992|Tetracycline|tetracycline|mesh-list
43643889|NCT04879992|Rifabutin|rifabutin|mesh-list
43643890|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
43643891|NCT04879992|Esomeprazole|esomeprazole|mesh-list
43643892|NCT04879992|Bismuth|bismuth|mesh-list
43643893|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643894|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43655685|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
43655686|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43655687|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43655688|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655689|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643895|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643896|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43643897|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43643898|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43643899|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643900|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43643901|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643903|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43643904|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43643905|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
43643906|NCT04879992|Diuretics|diuretics|mesh-ancestor
43643907|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
43643908|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643909|NCT04879992|Expectorants|expectorants|mesh-ancestor
43643910|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
43643911|NCT04874935|Lansoprazole|lansoprazole|mesh-list
43643912|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
43643913|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43643914|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643915|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43643916|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43643917|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643918|NCT04854837|Remdesivir|remdesivir|mesh-list
43643919|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
43643920|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643921|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
43643922|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43643923|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
43643924|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
43643925|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643926|NCT04841668|Metformin|metformin|mesh-list
43643949|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
43643950|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643951|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
43643952|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
43643953|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643954|NCT04817189|Dexamethasone|dexamethasone|mesh-list
43643955|NCT04817189|Ondansetron|ondansetron|mesh-list
43643956|NCT04817189|Palonosetron|palonosetron|mesh-list
43643957|NCT04817189|Granisetron|granisetron|mesh-list
43643958|NCT04817189|Tropisetron|tropisetron|mesh-list
43643959|NCT04817189|Dolasetron|dolasetron|mesh-list
43643960|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43643961|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
43643962|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
43643963|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43643964|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43643965|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43643966|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
43643967|NCT04817189|Hormones|hormones|mesh-ancestor
43643968|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43643969|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43643970|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43643971|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
43821895|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822098|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643972|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
43643973|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43643974|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
43643975|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43643976|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43643977|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43643978|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43643979|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43643980|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43643981|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43643982|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43823858|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43822237|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43822238|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
43822239|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43822240|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822241|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43822242|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
43822243|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822244|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822245|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823859|NCT05518383|Methotrexate|methotrexate|mesh-list
43655690|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655691|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43655692|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43823861|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
43823862|NCT05518383|Vincristine|vincristine|mesh-list
43823863|NCT05518383|Idarubicin|idarubicin|mesh-list
43823864|NCT05518383|Carboplatin|carboplatin|mesh-list
43823865|NCT05518383|BB 1101|bb 1101|mesh-list
43823866|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43823867|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
43823868|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823888|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43823889|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43823890|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
43822291|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
43822292|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43822293|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43822411|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
43822412|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43822413|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43822414|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
43822415|NCT00352027|Prednisone|prednisone|mesh-list
43822416|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
43822417|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
43822418|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
43822419|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
43822420|NCT00352027|Doxorubicin|doxorubicin|mesh-list
43823891|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43823892|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43823894|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823895|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43823896|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43823897|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823898|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
43721049|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
43823899|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721051|NCT02625506|Narcotics|narcotics|mesh-ancestor
43823900|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
43823901|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
43823902|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
43823903|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
43823904|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43823905|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43823906|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823908|NCT05518279|Coagulants|coagulants|mesh-ancestor
43640777|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
43644012|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
43644013|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43644014|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
43644015|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43644016|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644017|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644018|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43644019|NCT04785287|Nivolumab|nivolumab|mesh-list
43644021|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
43644022|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644023|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
43644024|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644055|NCT04770272|Epirubicin|epirubicin|mesh-list
43644056|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644057|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644058|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644059|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644060|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644061|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644062|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644063|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644064|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
43644065|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644066|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43703111|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644084|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
43644085|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43644086|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644087|NCT04756765|Talazoparib|talazoparib|mesh-list
43644088|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43644089|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644090|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644091|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644092|NCT04750460|Teriparatide|teriparatide|mesh-list
43644093|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43644094|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655693|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
43655694|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43655695|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655696|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
43655697|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
43644095|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43644096|NCT04745988|Leucovorin|leucovorin|mesh-list
43644097|NCT04745988|Docetaxel|docetaxel|mesh-list
43644098|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
43558982|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
43644099|NCT04745988|Fluorouracil|fluorouracil|mesh-list
43644100|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
43644102|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
43644103|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644104|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644105|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644106|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644107|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644108|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43822957|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43822958|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43822959|NCT05530122|Adalimumab|adalimumab|mesh-list
43822960|NCT05530122|Golimumab|golimumab|mesh-list
43644115|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644117|NCT04745988|Protective Agents|protective agents|mesh-ancestor
43644118|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
43644119|NCT04745988|Vitamins|vitamins|mesh-ancestor
43644120|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
43644121|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43644122|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
43823030|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823031|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823032|NCT05529095|Apomorphine|apomorphine|mesh-list
43823033|NCT05529095|Emetics|emetics|mesh-ancestor
43823034|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823035|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
43823036|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43823037|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43823038|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
43823039|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
43823040|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823042|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
43644123|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644124|NCT04744649|Fluorouracil|fluorouracil|mesh-list
43644148|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644149|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43644150|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
43644151|NCT04734210|Betamethasone|betamethasone|mesh-list
43644152|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
43644153|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43644154|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
43644155|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43644156|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644157|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
43721125|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644158|NCT04734210|Hormones|hormones|mesh-ancestor
43644159|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43644160|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644161|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644162|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644164|NCT04728230|Etoposide|etoposide|mesh-list
43644165|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
43644166|NCT04728230|Durvalumab|durvalumab|mesh-list
43644167|NCT04728230|Olaparib|olaparib|mesh-list
43644168|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
43644169|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
43644170|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43644171|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
43644172|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644173|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43644174|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43644175|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43644176|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644202|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43644203|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
43644204|NCT04712942|Azacitidine|azacitidine|mesh-list
43644205|NCT04712942|Pevonedistat|pevonedistat|mesh-list
43644206|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644207|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
43848910|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
43848911|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43848912|NCT03980509|Curcumin|curcumin|mesh-list
43823227|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
43823229|NCT05526924|Fluorouracil|fluorouracil|mesh-list
43644208|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644209|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43644210|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43644211|NCT04708613|Corticosterone|corticosterone|mesh-list
43655698|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43655699|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
43655700|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43655701|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655702|NCT02967211|Insulin|insulin|mesh-list
43655703|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43655704|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
43655705|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
43655706|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
43721168|NCT02624817|Glyburide|glyburide|mesh-list
43655707|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
43655708|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
43655709|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43823317|NCT05525546|Vaccines|vaccines|mesh-list
43655710|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655711|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
43655712|NCT02966912|Antacids|antacids|mesh-ancestor
43655713|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644212|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43644213|NCT04700527|Butyric Acid|butyric acid|mesh-list
43644214|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
43644215|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
43655716|NCT02967029|Esmolol|esmolol|mesh-list
43655717|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43655718|NCT02967029|Narcotics|narcotics|mesh-ancestor
43655719|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823390|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
43823391|NCT05525065|Hormones|hormones|mesh-ancestor
43823392|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43823393|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823394|NCT05524974|Paclitaxel|paclitaxel|mesh-list
43823395|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
43823396|NCT05524974|Apatinib|apatinib|mesh-list
43823397|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43849638|NCT03905798|Lorazepam|lorazepam|mesh-list
43823398|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823399|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
43823400|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
43655723|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43655724|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43721204|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43655725|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43655726|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43655727|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
43655728|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43655729|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43655730|NCT02967094|Expectorants|expectorants|mesh-list
43655731|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
43655740|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655742|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825172|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825173|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825174|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43825175|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43825176|NCT05504278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43825189|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846583|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
43846584|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43846585|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846586|NCT04191434|Budesonide|budesonide|mesh-list
43823449|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
43823450|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43823451|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823452|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43823471|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43823472|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43823473|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43823474|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43823475|NCT05523037|Sevoflurane|sevoflurane|mesh-list
43823476|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43823477|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43823478|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
43823479|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
43823480|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823481|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823482|NCT05522998|Propofol|propofol|mesh-list
43823483|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43823484|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43823485|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43823486|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43823487|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
43823488|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
43655768|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43655769|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43655771|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
43655772|NCT02966587|Durvalumab|durvalumab|mesh-list
43655773|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
43655774|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43655775|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
43655776|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43655777|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43655778|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
43655779|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43655780|NCT02966457|Colistin|colistin|mesh-list
43655781|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823489|NCT05522894|Paclitaxel|paclitaxel|mesh-list
43823490|NCT05522894|Cisplatin|cisplatin|mesh-list
43823491|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43823492|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823493|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
43823494|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
43823497|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
43703112|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
43703113|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43703114|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43703115|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43703116|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43703117|NCT02712775|Minocycline|minocycline|mesh-list
43703118|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43703119|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823547|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
43823548|NCT05521997|Cisplatin|cisplatin|mesh-list
43823549|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43823550|NCT05521880|Oritavancin|oritavancin|mesh-list
43823551|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43823552|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43823553|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43823554|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
43823555|NCT05521828|Hormones|hormones|mesh-ancestor
43823556|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43641536|NCT05610527|Etonogestrel|etonogestrel|mesh-list
43641537|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43641538|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
43641539|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43641540|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641541|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43641542|NCT05610384|Ibuprofen|ibuprofen|mesh-list
43641543|NCT05610384|Ketorolac|ketorolac|mesh-list
43641544|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43641545|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43641546|NCT05610384|Analgesics|analgesics|mesh-ancestor
43641547|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
43641548|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641549|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641550|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641551|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43641552|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43641553|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641554|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641555|NCT05610371|Lidocaine|lidocaine|mesh-list
43559047|NCT04424641|Antibodies|antibodies|mesh-list
43641556|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
43641557|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
43641558|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43641559|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641560|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
43641561|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43641562|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43641563|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43641564|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43641680|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
43641681|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641682|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43849639|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
43641779|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
43641780|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43641781|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641782|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43641783|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
43641784|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43641785|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43641786|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43641856|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43641857|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43641858|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43641859|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43641860|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43641861|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
43641862|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43641863|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43641864|NCT05556681|Sirolimus|sirolimus|mesh-list
43641865|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43641866|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43641867|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43641909|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43641910|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43641914|NCT05554380|Paclitaxel|paclitaxel|mesh-list
43656123|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
43656134|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
43850279|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43823765|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43823766|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43823767|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43823768|NCT05519072|Renal Agents|renal agents|mesh-ancestor
43823769|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
43656255|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
43656257|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43656258|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656259|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43703121|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43656362|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656364|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43656365|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
43656366|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656367|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43656368|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43656369|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43656370|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656371|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
43656373|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
43656374|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656375|NCT02961842|Ephedrine|ephedrine|mesh-list
43656376|NCT02961842|Fentanyl|fentanyl|mesh-list
43656396|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656399|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
43721327|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721328|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
43721329|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721330|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721331|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
43721332|NCT02624141|Hematinics|hematinics|mesh-ancestor
43721333|NCT02623881|Progesterone|progesterone|mesh-list
43559076|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43656400|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
43656401|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656402|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656403|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
43823881|NCT05518383|Hormones|hormones|mesh-ancestor
43656404|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656406|NCT02962024|Narcotics|narcotics|mesh-ancestor
43656407|NCT02962024|Analgesics|analgesics|mesh-ancestor
43656408|NCT02962037|Melatonin|melatonin|mesh-list
43656409|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
43656410|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656411|NCT02962037|Protective Agents|protective agents|mesh-ancestor
43656414|NCT02961816|Pyridoxine|pyridoxine|mesh-list
43656420|NCT02961816|Panobinostat|panobinostat|mesh-list
43656421|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644139|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43644140|NCT04739670|Growth Substances|growth substances|mesh-ancestor
43644141|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644142|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
43644143|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43644144|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
43644145|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644146|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
43644147|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644177|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644178|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43644179|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
43644180|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43644181|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43644182|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
43644183|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
43644184|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
43644185|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
43644186|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
43644187|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43644188|NCT04723472|Cefuroxime|cefuroxime|mesh-list
43644189|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
43644190|NCT04723472|Bismuth|bismuth|mesh-list
43721421|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
43644191|NCT04723472|Antacids|antacids|mesh-ancestor
43644192|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43644193|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43644194|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43644195|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43644196|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
43721442|NCT02623127|Sunitinib|sunitinib|mesh-list
43644197|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
43656437|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656439|NCT02961816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656440|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656441|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43656442|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43656443|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
43656444|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43656445|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43656446|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
43656448|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
43656449|NCT02961803|Biotin|biotin|mesh-list
43656450|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
43656451|NCT02961803|Vitamins|vitamins|mesh-ancestor
43656452|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
43656454|NCT02961660|Odalasvir|odalasvir|mesh-list
43656461|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43656462|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656463|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656465|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
43656466|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656467|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
43656468|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656469|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656470|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656471|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43656473|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43656474|NCT02961166|Antibodies|antibodies|mesh-list
43656475|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
43656476|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656477|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
43559147|NCT04163185|Meloxicam|meloxicam|mesh-list
43656478|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
43656479|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656480|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
43656481|NCT02961361|Ropivacaine|ropivacaine|mesh-list
43656482|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43656483|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656484|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656485|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656486|NCT02961361|Analgesics|analgesics|mesh-ancestor
43656487|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
43850137|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850138|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43850139|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
43850140|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43850141|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
43850151|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
43850152|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656591|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656592|NCT02960035|Etanercept|etanercept|mesh-list
43656593|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656594|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656595|NCT02960035|Analgesics|analgesics|mesh-ancestor
43656596|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
43656597|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656598|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656599|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656600|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43656601|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656602|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43656603|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
43656604|NCT02959879|Folfirinox|folfirinox|mesh-list
43656605|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656606|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
43721507|NCT02622906|Pasireotide|pasireotide|mesh-list
43656607|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
43656608|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43656612|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
43656613|NCT02959762|Vitamin MK 7|vitamin mk 7|mesh-list
43656614|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
43656615|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656616|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43656633|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
43656635|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43656636|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656638|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
43656639|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43656640|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
43656641|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656692|NCT02959411|Diuretics|diuretics|mesh-list
43656693|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
43656694|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656695|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
43656696|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656697|NCT02959125|Micronutrients|micronutrients|mesh-list
43656698|NCT02959125|Trace Elements|trace elements|mesh-list
43656699|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656700|NCT02959112|Indomethacin|indomethacin|mesh-list
43656701|NCT02959112|Epinephrine|epinephrine|mesh-list
43656702|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43656703|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43656704|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
43656705|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656706|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656707|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656708|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43656717|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43656718|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656719|NCT02959112|Analgesics|analgesics|mesh-ancestor
43656727|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656728|NCT02959060|Rifampin|rifampin|mesh-list
43656729|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43656730|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
43656731|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43656732|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656733|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
43656734|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43656735|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656736|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656737|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43656738|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43825273|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825274|NCT05503667|Bevacizumab|bevacizumab|mesh-list
43656772|NCT02958800|Risperidone|risperidone|mesh-list
43656773|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43656774|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
43656775|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43656776|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
43656777|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656778|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656779|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656780|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43656781|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656782|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43656783|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43656784|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
43656785|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
43656786|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
43656787|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656788|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721533|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
43721534|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721536|NCT02622802|Acetaminophen|acetaminophen|mesh-list
43721537|NCT02622802|Azithromycin|azithromycin|mesh-list
43721538|NCT02622802|Erythromycin|erythromycin|mesh-list
43721539|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
43721540|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
43721541|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
43721542|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43721543|NCT02622802|Analgesics|analgesics|mesh-ancestor
43721544|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
43721545|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721546|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721547|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
43656789|NCT02958800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43656822|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43656823|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656825|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43656826|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43656827|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
43656828|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43656829|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43656830|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43656831|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43656832|NCT02958566|Narcotics|narcotics|mesh-ancestor
43656833|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43656834|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43656835|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
43656836|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
43656837|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43656838|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43656878|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43656880|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43656881|NCT02958046|Domperidone|domperidone|mesh-list
43656882|NCT02958046|Lansoprazole|lansoprazole|mesh-list
43656883|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
43656884|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43656885|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43656886|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43656887|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656888|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656889|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
43656890|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
43656891|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656892|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656893|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43721548|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43721549|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43721550|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43721551|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43721552|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43721553|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43656894|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
43656899|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43656900|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43656901|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43656902|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850261|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43850262|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43850263|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43850264|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43850273|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
43656911|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43656912|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43656913|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43656914|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43656915|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43827087|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43656935|NCT02957903|Ropivacaine|ropivacaine|mesh-list
43656936|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
43656937|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
43656938|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43656939|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43656940|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
43656941|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43656942|NCT02957864|Tenofovir|tenofovir|mesh-list
43657004|NCT02957448|Rifampin|rifampin|mesh-list
43657005|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43657006|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
43657007|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43657008|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657009|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
43657010|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43657011|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657012|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657013|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43657014|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43657015|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
43657016|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43657017|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43657018|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43657048|NCT02957266|Cisplatin|cisplatin|mesh-list
43657049|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657050|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657051|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
43721590|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43657052|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657053|NCT02957266|Antiviral Agents|antiviral agents|mesh-ancestor
43657054|NCT02957266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657055|NCT02957266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657056|NCT02957266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657057|NCT02957266|Immunologic Factors|immunologic factors|mesh-ancestor
43657058|NCT02957266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657063|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657065|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43657066|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657067|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43657068|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825276|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850289|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657073|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657074|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657075|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657077|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43657078|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657086|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657087|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43657088|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43657090|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
43657091|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657093|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43657094|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43657095|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43657096|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43657097|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657098|NCT02956252|Anesthetics|anesthetics|mesh-list
43657099|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657100|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657101|NCT02956408|Vitamin D|vitamin d|mesh-list
43657102|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
43657103|NCT02956408|Vitamins|vitamins|mesh-ancestor
43657104|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
43657105|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657106|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43657111|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
43657112|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
43657113|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657114|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43657115|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
43657116|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657118|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
43657119|NCT02955810|Bortezomib|bortezomib|mesh-list
43657120|NCT02955810|Daratumumab|daratumumab|mesh-list
43657121|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850299|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657125|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43657136|NCT02955810|Hormones|hormones|mesh-ancestor
43657137|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657138|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657139|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43657140|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43657141|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
43850302|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43850303|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
43850304|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43850305|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43850306|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43850307|NCT05696626|Fulvestrant|fulvestrant|mesh-list
43850308|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850309|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43721681|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
43657143|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657144|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850290|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657145|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657166|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
43657195|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657196|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
43657197|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
43657198|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657199|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657200|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43657201|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
43657202|NCT02955641|Hormones|hormones|mesh-ancestor
43657203|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43657204|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657205|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657206|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43657207|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43657208|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657209|NCT02955641|Analgesics|analgesics|mesh-ancestor
43850489|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43850514|NCT05409066|Rituximab|rituximab|mesh-list
43721727|NCT02621320|Vitamin D|vitamin d|mesh-list
43721728|NCT02621320|Vitamins|vitamins|mesh-ancestor
43721729|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
43721730|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43721731|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43832928|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43832929|NCT05246046|Bromides|bromides|mesh-list
43832930|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
43832931|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43832932|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
43832933|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43832934|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43832935|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43832936|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850515|NCT05409066|Lenalidomide|lenalidomide|mesh-list
43850516|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850519|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850520|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43850521|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43657239|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657240|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43657241|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850586|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43850587|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43850589|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850590|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43850591|NCT05372991|Atropine|atropine|mesh-list
43850592|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43850593|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43850594|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43850595|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
43850596|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850648|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43850649|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
43850650|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43850651|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43850652|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
43850653|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
43850654|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
43850657|NCT05352282|Fentanyl|fentanyl|mesh-list
43850658|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43850659|NCT05352282|Narcotics|narcotics|mesh-ancestor
43850660|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850661|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850662|NCT05352282|Analgesics|analgesics|mesh-ancestor
43850663|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
43850664|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657367|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657369|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
43657370|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657371|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657372|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43657373|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
43657374|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657375|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
43657376|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43657377|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
43657378|NCT02953275|Vedolizumab|vedolizumab|mesh-list
43721733|NCT02621255|Anesthetics|anesthetics|mesh-list
43657379|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43657380|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846606|NCT04191096|Androgens|androgens|mesh-list
43721734|NCT02621255|Sevoflurane|sevoflurane|mesh-list
43721743|NCT02621112|Imiquimod|imiquimod|mesh-list
43827090|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43657381|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657382|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43657383|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43850689|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43850690|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850691|NCT05350202|Empagliflozin|empagliflozin|mesh-list
43850692|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43850693|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850694|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43850695|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850696|NCT05339087|Riociguat|riociguat|mesh-list
43850697|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
43850698|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850699|NCT05312645|Diclofenac|diclofenac|mesh-list
43850700|NCT05312645|Petrolatum|petrolatum|mesh-list
43850701|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43850702|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657400|NCT02953210|Isoflurane|isoflurane|mesh-list
43657401|NCT02953210|Ranitidine|ranitidine|mesh-list
43657402|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43657403|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43657404|NCT02953210|Rocuronium|rocuronium|mesh-list
43657405|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657406|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
43657407|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
43657408|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657409|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657423|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43657425|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43657426|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43657427|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
43657428|NCT02953210|Analgesics|analgesics|mesh-ancestor
43657429|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43657430|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43850784|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850785|NCT05212246|Imiquimod|imiquimod|mesh-list
43850786|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43850787|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
43850788|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850791|NCT05189457|Docetaxel|docetaxel|mesh-list
43850793|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43850794|NCT05189457|Hormones|hormones|mesh-list
43850795|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
43850796|NCT05189457|Relugolix|relugolix|mesh-list
43850797|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850798|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
43850803|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850804|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43850805|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
43850806|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43850807|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43850808|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
43657431|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43657432|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657433|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43657434|NCT02953210|Narcotics|narcotics|mesh-ancestor
43657435|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43657436|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43657437|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43657438|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43657439|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
43657440|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
43657441|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
43657445|NCT02953210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43657446|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43657447|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43657448|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43848923|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43848925|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43851080|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851124|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43851125|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43851126|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43851127|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851128|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851243|NCT04393298|Antidotes|antidotes|mesh-ancestor
43657674|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
43657675|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43657676|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43657677|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43559295|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657678|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43657679|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43657680|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
43657681|NCT02951897|Cisplatin|cisplatin|mesh-list
43657682|NCT02951897|Pemetrexed|pemetrexed|mesh-list
43657683|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657684|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657685|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657686|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43657687|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43657689|NCT02951637|Pemetrexed|pemetrexed|mesh-list
43657690|NCT02951637|Gefitinib|gefitinib|mesh-list
43657691|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657692|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657693|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657694|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43657695|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43657696|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43825395|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825396|NCT05501483|Pioglitazone|pioglitazone|mesh-list
43825397|NCT05501483|Empagliflozin|empagliflozin|mesh-list
43825398|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43825399|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825400|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43825401|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825402|NCT05501340|Molgramostim|molgramostim|mesh-list
43825403|NCT05501340|Sargramostim|sargramostim|mesh-list
43825404|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825405|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
43825406|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825407|NCT05501288|Pholcodine|pholcodine|mesh-list
43825408|NCT05501288|Analgesics|analgesics|mesh-ancestor
43825409|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
43825410|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721836|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825411|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825412|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
43825413|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
43825414|NCT05501158|Tamoxifen|tamoxifen|mesh-list
43825415|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43825416|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
43657703|NCT02951234|Analgesics|analgesics|mesh-ancestor
43657704|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
43657705|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657706|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657707|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43657708|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43657709|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43657710|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43657711|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657712|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43657713|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43657714|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657715|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
43657716|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
43657717|NCT02951260|Metformin|metformin|mesh-list
43657718|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43657719|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657720|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
43657721|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43850471|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43850472|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43850473|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850474|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
43850475|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
43657735|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657737|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43657738|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
43657739|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43657740|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
43657741|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657822|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657823|NCT02950155|Rituximab|rituximab|mesh-list
43657829|NCT02950038|Nivolumab|nivolumab|mesh-list
43657830|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43657831|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657832|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43657833|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657834|NCT02949752|Aripiprazole|aripiprazole|mesh-list
43657835|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
43657836|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43657837|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43657838|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43657839|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43657840|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657841|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
43657842|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
43721874|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43657843|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657844|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657845|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43657846|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43657847|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
43657848|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43657849|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43657850|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43657851|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43657852|NCT02949895|Cisplatin|cisplatin|mesh-list
43657853|NCT02949895|Etoposide|etoposide|mesh-list
43657856|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43657857|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43657858|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43657859|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657860|NCT02949648|Nicotine|nicotine|mesh-list
43657861|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43657862|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
43657863|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43657864|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43657865|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43657866|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43657867|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
43657868|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43657869|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657870|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
43657871|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43657872|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43657873|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
43657874|NCT02949765|Iron|iron|mesh-list
43657875|NCT02949765|Trace Elements|trace elements|mesh-ancestor
43657876|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
43657877|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825421|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43850481|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
43850482|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
43850483|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
43825423|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43825424|NCT05501080|Spironolactone|spironolactone|mesh-list
43825425|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43825426|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825427|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43721909|NCT02619994|Ofloxacin|ofloxacin|mesh-list
43825428|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825448|NCT05500690|Folic Acid|folic acid|mesh-list
43825450|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
43825451|NCT05500690|Vitamins|vitamins|mesh-ancestor
43825452|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
43825453|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825454|NCT05500677|Lidocaine|lidocaine|mesh-list
43825455|NCT05500677|Fentanyl|fentanyl|mesh-list
43825456|NCT05500677|Tramadol|tramadol|mesh-list
43825457|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
43825458|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
43825459|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825460|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825462|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825463|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43825464|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43825465|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43825466|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43825467|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825468|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43825469|NCT05500677|Narcotics|narcotics|mesh-ancestor
43825470|NCT05500677|Analgesics|analgesics|mesh-ancestor
43825471|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43825472|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43657972|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
43657993|NCT02948348|Nivolumab|nivolumab|mesh-list
43657994|NCT02948348|Ipilimumab|ipilimumab|mesh-list
43657995|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43657996|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
43657997|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43657998|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43657999|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43658000|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43658001|NCT02948283|Metformin|metformin|mesh-list
43658002|NCT02948283|Ritonavir|ritonavir|mesh-list
43658003|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43658004|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658036|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
43658037|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
43658038|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658039|NCT02947932|Indomethacin|indomethacin|mesh-list
43658040|NCT02947932|Resveratrol|resveratrol|mesh-list
43658041|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
43658042|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658043|NCT02947932|Protective Agents|protective agents|mesh-ancestor
43658044|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658045|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658046|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658083|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658084|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
43658085|NCT02947854|Poly ICLC|poly iclc|mesh-list
43658086|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
43658087|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
43658088|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
43658089|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658090|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43658091|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
43658092|NCT02947763|Metronidazole|metronidazole|mesh-list
43658093|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
43658094|NCT02947763|Minocycline|minocycline|mesh-list
43658095|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658096|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658097|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43658098|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43658099|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43658100|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43658101|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658102|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658103|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658104|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43658105|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43658106|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
43658107|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43658108|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43658109|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43658110|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43658111|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658112|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
43658113|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43658114|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658115|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43658116|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43658117|NCT02947737|Gentamicins|gentamicins|mesh-list
43658118|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658119|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658120|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43658121|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658122|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825475|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43825487|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825489|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43658123|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
43658189|NCT02946944|Urological Agents|urological agents|mesh-ancestor
43851773|NCT02379416|Paclitaxel|paclitaxel|mesh-list
43851802|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851872|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
43851873|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658292|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43721956|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
43721958|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43658347|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43658348|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43658349|NCT02945956|Entecavir|entecavir|mesh-list
43658350|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
43658351|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43658352|NCT02945696|Ropivacaine|ropivacaine|mesh-list
43658363|NCT02945644|Trazodone|trazodone|mesh-list
43658364|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43658365|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43658366|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43658367|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43658368|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43658369|NCT02945644|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43658673|NCT02943798|Paclitaxel|paclitaxel|mesh-list
43658674|NCT02943798|Etoposide|etoposide|mesh-list
43658675|NCT02943798|Carboplatin|carboplatin|mesh-list
43658676|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43658677|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658678|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
43658679|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
43658680|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
43658681|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658682|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43658683|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43658684|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658699|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43658700|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43658701|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
43658702|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43658703|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658704|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43849641|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
43850714|NCT05289063|Atorvastatin|atorvastatin|mesh-list
43850715|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43850716|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43850717|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
43850718|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850719|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43850720|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43850721|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658736|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658737|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658739|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
43658740|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43658741|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43658793|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43658794|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43658795|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43658796|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43658797|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43658798|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
43850763|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
43658951|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43658952|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43658953|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43721993|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
43721994|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43721995|NCT02619578|Narcotics|narcotics|mesh-ancestor
43721996|NCT02619578|Analgesics|analgesics|mesh-ancestor
43721997|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
43721998|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43721999|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43722000|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43559333|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
43658954|NCT02941822|Ambroxol|ambroxol|mesh-list
43658955|NCT02941822|Expectorants|expectorants|mesh-ancestor
43851993|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43659105|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659106|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43659107|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43659108|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
43659109|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659110|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
43659111|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
43659112|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43659113|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659114|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659115|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
43659116|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43659117|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43850811|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43850812|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
43850813|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
43659180|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43659182|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43659183|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43659184|NCT02940535|Menotropins|menotropins|mesh-list
43659185|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
43659186|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43659187|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
43850822|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43659208|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
43659209|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722006|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722008|NCT02619526|Nebivolol|nebivolol|mesh-list
43722009|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43722010|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43722011|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659210|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43659211|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
43659212|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43659213|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43659214|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
43659215|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850852|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43846658|NCT04184869|Belinostat|belinostat|mesh-list
43846659|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43852003|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659328|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
43659329|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659330|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659331|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43659332|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
43659333|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
43659347|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43659348|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659349|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
43659350|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659351|NCT02939417|Protective Agents|protective agents|mesh-ancestor
43659352|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659353|NCT02939274|Verteporfin|verteporfin|mesh-list
43659354|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43659355|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
43659357|NCT02939248|Naloxone|naloxone|mesh-list
43659358|NCT02939248|Ticagrelor|ticagrelor|mesh-list
43659359|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43659360|NCT02939248|Narcotics|narcotics|mesh-ancestor
43659367|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43559352|NCT03840837|Rivastigmine|rivastigmine|mesh-list
43659368|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43659369|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43659370|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
43659371|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43850933|NCT04904588|Fludarabine|fludarabine|mesh-list
43850934|NCT04904588|Tacrolimus|tacrolimus|mesh-list
43850935|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43850936|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
43850937|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43850938|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43850939|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43850940|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
43850941|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850943|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43850952|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
43659382|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43659383|NCT02939235|Narcotics|narcotics|mesh-ancestor
43659384|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659385|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659410|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659411|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659412|NCT02938975|Protective Agents|protective agents|mesh-ancestor
43659413|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722043|NCT02619201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43559382|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
43850977|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43850978|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43850979|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
43850980|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43850981|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43850982|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
43850983|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
43850984|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43659443|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43850991|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
43562880|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
43659451|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43659453|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
43659454|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659455|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659456|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43659457|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43659458|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43659459|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
43659460|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659461|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659462|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43659463|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659464|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43659465|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
43659466|NCT02938273|Cetuximab|cetuximab|mesh-list
43659467|NCT02938273|Avelumab|avelumab|mesh-list
43659570|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659571|NCT02937402|Dimercaprol|dimercaprol|mesh-list
43659572|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
43659573|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
43659574|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659575|NCT02937415|Antioxidants|antioxidants|mesh-list
43851102|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
43851103|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43659646|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
43722092|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43722093|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43722094|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722095|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722096|NCT02619019|Narcotics|narcotics|mesh-ancestor
43722097|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43722098|NCT02619019|Analgesics|analgesics|mesh-ancestor
43722110|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43722111|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43722112|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
43722113|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
43722114|NCT02618876|Nalbuphine|nalbuphine|mesh-list
43722115|NCT02618876|Bupivacaine|bupivacaine|mesh-list
43659647|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
43659648|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43659649|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722164|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43659650|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
43659651|NCT02936661|Coagulants|coagulants|mesh-ancestor
43825593|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43825594|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43825595|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825596|NCT05563220|Everolimus|everolimus|mesh-list
43825597|NCT05563220|Palbociclib|palbociclib|mesh-list
43825598|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825599|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43825600|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
43825601|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849644|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43851107|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
43851108|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851109|NCT04628767|Antiviral Agents|antiviral agents|mesh-ancestor
43851110|NCT04628767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43851111|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43659653|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659654|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
43659655|NCT02936492|Hormones|hormones|mesh-ancestor
43659656|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659657|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722165|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43722166|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43659658|NCT02936427|Dexamethasone|dexamethasone|mesh-list
43659659|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
43659660|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
43659661|NCT02936427|BB 1101|bb 1101|mesh-list
43659662|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659663|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
43659664|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
43659665|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43659666|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659667|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659668|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
43659669|NCT02936427|Hormones|hormones|mesh-ancestor
43659670|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659671|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43659672|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43659750|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43659752|NCT02935998|Ziprasidone|ziprasidone|mesh-list
43659753|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43659754|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
43659755|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43659756|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851190|NCT04434092|Eculizumab|eculizumab|mesh-list
43851191|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43851192|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851193|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
43851194|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851195|NCT04432584|Eculizumab|eculizumab|mesh-list
43851196|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43851197|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43851198|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
43851199|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43851200|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
43851201|NCT04422431|Choline|choline|mesh-list
43851202|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
43851203|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43851204|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
43851205|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851206|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43659794|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43659795|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43659796|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43659797|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43659798|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43659799|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
43659800|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
43659802|NCT02935972|Diazepam|diazepam|mesh-list
43659803|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
43659804|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
43659805|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43659806|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659853|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
43659854|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
43659855|NCT02935582|Betamethasone|betamethasone|mesh-list
43659856|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
43659857|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
43659858|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
43659859|NCT02935582|Calcipotriene|calcipotriene|mesh-list
43659860|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43659861|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43659862|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
43659863|NCT02935582|Hormones|hormones|mesh-ancestor
43659864|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43659865|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43659866|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43659867|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
43659868|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
43659869|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43659870|NCT02935530|Tinzaparin|tinzaparin|mesh-list
43825627|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825628|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
43825629|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43825630|NCT05560945|Listerine|listerine|mesh-list
43660104|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43660105|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660106|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
43660107|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43660108|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43660109|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43660110|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
43660111|NCT02934061|Tizanidine|tizanidine|mesh-list
43660112|NCT02934061|Analgesics|analgesics|mesh-ancestor
43660113|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
43660114|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660115|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660176|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833028|NCT05238948|Midazolam|midazolam|mesh-list
43660196|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43660197|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43660198|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849647|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43660241|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43660242|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660243|NCT02933684|Cycloserine|cycloserine|mesh-list
43660244|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43660245|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660246|NCT02933684|Renal Agents|renal agents|mesh-ancestor
43660271|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660272|NCT02932826|Insulin|insulin|mesh-list
43660409|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43660410|NCT02932137|Analgesics|analgesics|mesh-ancestor
43660411|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
43660412|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660413|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660414|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
43660415|NCT02932254|Analgesics|analgesics|mesh-ancestor
43660416|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
43660417|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660439|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43660440|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43660441|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43660442|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43660443|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833035|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833038|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
43851310|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43851322|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43660444|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660447|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43660448|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660449|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660450|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43660451|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
43660452|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
43660453|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43849650|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
43660566|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43660567|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660616|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660642|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43660643|NCT02929797|Antiviral Agents|antiviral agents|mesh-ancestor
43660644|NCT02929797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43660645|NCT02929797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43660646|NCT02929797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43660647|NCT02929797|Immunologic Factors|immunologic factors|mesh-ancestor
43660648|NCT02929797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43660649|NCT02929901|Caffeine|caffeine|mesh-list
43660660|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43660661|NCT02929706|Azathioprine|azathioprine|mesh-list
43660662|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
43660663|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43660664|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43660665|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43661079|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
43661080|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
43661081|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
43661082|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661083|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43661084|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
43661085|NCT02926183|Antiviral Agents|antiviral agents|mesh-ancestor
43849653|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661154|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43661155|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43661157|NCT02925416|Oritavancin|oritavancin|mesh-list
43661158|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43661159|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661160|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
43661161|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43661203|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
43661204|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43661205|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722312|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722313|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43703239|NCT02711982|Hormones|hormones|mesh-ancestor
43661209|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43661210|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43661211|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661212|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661214|NCT02924974|Narcotics|narcotics|mesh-ancestor
43661215|NCT02924974|Analgesics|analgesics|mesh-ancestor
43661264|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43661265|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43661266|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661267|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43661268|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43661449|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43661452|NCT02922933|Omeprazole|omeprazole|mesh-list
43661453|NCT02922933|Famotidine|famotidine|mesh-list
43661454|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43661455|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43661456|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43661468|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43661469|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661470|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661471|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
43661473|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
43849658|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661653|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
43661664|NCT02921282|Protective Agents|protective agents|mesh-ancestor
43661696|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43661697|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43661698|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
43661706|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43661707|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43661708|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661709|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
43661711|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
43661712|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43661713|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43661714|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43661715|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43661716|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661717|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43661718|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43661719|NCT02920827|Dapivirine|dapivirine|mesh-list
43661720|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43661721|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43661722|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
43661761|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
43661762|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43562912|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
43661818|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
43661819|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
43661820|NCT02920372|Hematinics|hematinics|mesh-ancestor
43661821|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43661822|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43661823|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43661825|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
43661826|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
43661827|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43661829|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43661831|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43661832|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43851449|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43825839|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43825840|NCT04934722|Hormones|hormones|mesh-ancestor
43825841|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43825842|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825843|NCT04916613|Androgens|androgens|mesh-list
43662315|NCT02916147|Propofol|propofol|mesh-list
43662316|NCT02916147|Sevoflurane|sevoflurane|mesh-list
43662317|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43662318|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662319|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662320|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43662321|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
43662407|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
43825857|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825858|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
43825859|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43825861|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
43825862|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43825863|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43825864|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
43825865|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43825866|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43825867|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
43825868|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43825869|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
43825871|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
43825872|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43825873|NCT04551352|Adalimumab|adalimumab|mesh-list
43662512|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43662513|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
43662514|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
43662515|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43662557|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662558|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662576|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43662577|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662578|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
43662579|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43662580|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43662581|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43662582|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43662583|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43662584|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722349|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
43722350|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
43662827|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662828|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
43662829|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
43662830|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
43662831|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43662832|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43662833|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43662835|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
43662836|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43662904|NCT02910570|Liraglutide|liraglutide|mesh-list
43662954|NCT02910050|Letrozole|letrozole|mesh-list
43662955|NCT02910050|Anastrozole|anastrozole|mesh-list
43662956|NCT02910050|Exemestane|exemestane|mesh-list
43662957|NCT02910050|Bicalutamide|bicalutamide|mesh-list
43662958|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
43662959|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43662960|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43663051|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663052|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
43663053|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
43663054|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43849661|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
43663192|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663195|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663196|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663197|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663198|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663199|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
43663200|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
43663201|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43663202|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43663204|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
43663205|NCT05247268|Megestrol|megestrol|mesh-list
43663212|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663213|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43663214|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
43825940|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
43663215|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663216|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663217|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43663372|NCT04932083|Bupivacaine|bupivacaine|mesh-list
43722380|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663391|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663392|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663393|NCT04907253|Quercetin|quercetin|mesh-list
43663394|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
43663395|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663494|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
43663640|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43663641|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43849664|NCT03904329|Anticoagulants|anticoagulants|mesh-list
43663676|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43663677|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
43663678|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43663679|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43663680|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43663681|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43663682|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663683|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849665|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
43663698|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663699|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663714|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43663716|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663717|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663718|NCT03888079|Anesthetics|anesthetics|mesh-list
43663719|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
43663720|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
43663721|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663722|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663727|NCT03883893|Analgesics|analgesics|mesh-ancestor
43663728|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
43663729|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663730|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663731|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
43663732|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
43663733|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43663734|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43849668|NCT03903185|Ledipasvir|ledipasvir|mesh-list
43849669|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43663750|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
43663761|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663762|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43663765|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
43663766|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
43663767|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663768|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
43663769|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663770|NCT03719092|Protective Agents|protective agents|mesh-ancestor
43663771|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43663772|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663773|NCT03694262|Bevacizumab|bevacizumab|mesh-list
43663774|NCT03694262|Atezolizumab|atezolizumab|mesh-list
43663775|NCT03694262|Rucaparib|rucaparib|mesh-list
43663776|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663777|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663778|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43663795|NCT03685253|Vitamins|vitamins|mesh-ancestor
43663796|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
43663797|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663798|NCT03669367|Abatacept|abatacept|mesh-list
43663799|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43663800|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663801|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663802|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43663803|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
43663804|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849670|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
43663845|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
43663847|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663848|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849673|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663856|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663857|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663858|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43663898|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663899|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
43663901|NCT05466708|Esketamine|esketamine|mesh-list
43663902|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663903|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663904|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663905|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43663906|NCT05466708|Analgesics|analgesics|mesh-ancestor
43663907|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
43663908|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849675|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663923|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
43663924|NCT05466695|Tadalafil|tadalafil|mesh-list
43663925|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
43663926|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43663927|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43663928|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663929|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663930|NCT05466695|Urological Agents|urological agents|mesh-ancestor
43663931|NCT05466604|Dexamethasone|dexamethasone|mesh-list
43663932|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43663933|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
43663934|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
43663935|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43663936|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663937|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43663938|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
43663940|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43663941|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43663946|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663947|NCT05466279|Midazolam|midazolam|mesh-list
43663948|NCT05466279|Propofol|propofol|mesh-list
43663949|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43663950|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43663951|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663952|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43663953|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
43663954|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
43663955|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43663956|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43663957|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43663958|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43663959|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
43663960|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
43663961|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43663962|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663963|NCT05466149|Aflutinib|aflutinib|mesh-list
43663964|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43663965|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43663966|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663968|NCT05466019|Docetaxel|docetaxel|mesh-list
43663969|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
43663970|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43663971|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
43663972|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
43663973|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
43663974|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43663975|NCT05466019|Antidotes|antidotes|mesh-ancestor
43663976|NCT05466019|Protective Agents|protective agents|mesh-ancestor
43663977|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43663978|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
43663979|NCT05466019|Vitamins|vitamins|mesh-ancestor
43663996|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
43663998|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849676|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
43826099|NCT03150173|Narcotics|narcotics|mesh-ancestor
43826100|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826101|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826102|NCT03150173|Analgesics|analgesics|mesh-ancestor
43826103|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
43826104|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722547|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43722548|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43722549|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826105|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43826106|NCT03056001|Doxorubicin|doxorubicin|mesh-list
43826107|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
43826114|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826115|NCT03015740|Nivolumab|nivolumab|mesh-list
43826116|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826117|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826118|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43826119|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826120|NCT02994576|Atezolizumab|atezolizumab|mesh-list
43664018|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
43664019|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
43664020|NCT05399173|Coagulants|coagulants|mesh-ancestor
43664021|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
43664022|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
43664023|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664024|NCT05386030|Lidocaine|lidocaine|mesh-list
43664025|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664026|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
43664027|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664060|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664062|NCT05324761|Pregabalin|pregabalin|mesh-list
43664063|NCT05324761|Gabapentin|gabapentin|mesh-list
43664064|NCT05324761|Analgesics|analgesics|mesh-ancestor
43664065|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
43664073|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43664074|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664075|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664076|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664087|NCT05308030|Aspirin|aspirin|mesh-list
43664099|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722566|NCT02615873|Levodopa|levodopa|mesh-list
43664100|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664101|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43664102|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664103|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
43664104|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43664105|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
43664106|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43664107|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664108|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
43664109|NCT05293600|Acetazolamide|acetazolamide|mesh-list
43664110|NCT05293600|Eszopiclone|eszopiclone|mesh-list
43664111|NCT05293600|Trazodone|trazodone|mesh-list
43664112|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43664113|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43664114|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43664115|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664116|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664117|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664118|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664119|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664120|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
43664121|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
43664122|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664123|NCT05293600|Diuretics|diuretics|mesh-ancestor
43664124|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
43664125|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43664126|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664127|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43664128|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664129|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664130|NCT05293600|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664132|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43664133|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
43664134|NCT05281185|Factor VIII|factor viii|mesh-list
43664135|NCT05281185|Coagulants|coagulants|mesh-ancestor
43664136|NCT05280106|Citric Acid|citric acid|mesh-list
43664137|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
43664138|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
43664139|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
43664140|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43664141|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
43664142|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
43664143|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664144|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43664160|NCT05258279|Lenvatinib|lenvatinib|mesh-list
43664161|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664162|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664163|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664164|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664165|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43664166|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43664167|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43664168|NCT05238207|Psyllium|psyllium|mesh-list
43664169|NCT05238207|Cathartics|cathartics|mesh-ancestor
43664170|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664171|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
43664172|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
43664173|NCT05231980|Clomiphene|clomiphene|mesh-list
43664174|NCT05231980|Enclomiphene|enclomiphene|mesh-list
43664175|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
43664176|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664177|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43664178|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
43664180|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849677|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
43664206|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664208|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
43664209|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43664210|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
43826121|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826122|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
43826123|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
43826124|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43826125|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826126|NCT02721459|Vemurafenib|vemurafenib|mesh-list
43826127|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826145|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43826146|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43826147|NCT02709512|Cisplatin|cisplatin|mesh-list
43826148|NCT02709512|Pemetrexed|pemetrexed|mesh-list
43664235|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664236|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43664237|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43664238|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664239|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722639|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
43722640|NCT02615561|Vitamins|vitamins|mesh-ancestor
43722641|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
43833046|NCT05237947|Vaccines|vaccines|mesh-list
43722642|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722643|NCT02615574|Interferons|interferons|mesh-list
43722644|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43722645|NCT02615574|Celecoxib|celecoxib|mesh-list
43722646|NCT02615574|Vaccines|vaccines|mesh-list
43722647|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
43664241|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43664242|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664243|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664276|NCT05132153|Protective Agents|protective agents|mesh-ancestor
43664314|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826160|NCT02489903|Irinotecan|irinotecan|mesh-list
43826161|NCT02489903|Pemetrexed|pemetrexed|mesh-list
43826163|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826164|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826165|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
43826166|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
43826191|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
43826192|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826193|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826194|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826195|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826196|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826197|NCT01918527|Capecitabine|capecitabine|mesh-list
43826198|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
43826199|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826200|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
43826202|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826205|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826206|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
43826207|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826208|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43846744|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43846745|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43846746|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43846747|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43846748|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43846749|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43846750|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43664403|NCT04910100|Nebivolol|nebivolol|mesh-list
43664404|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43664405|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43664406|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43664407|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43664408|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664409|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664410|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664411|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664412|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664413|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43664414|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
43664442|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
43664443|NCT04883632|Lidocaine|lidocaine|mesh-list
43664444|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664445|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
43664446|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664447|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664448|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
43664449|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664450|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664451|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43664452|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43664453|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43664454|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664455|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43664456|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43664457|NCT04865029|Estradiol|estradiol|mesh-list
43664458|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43664467|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43664468|NCT04865029|Progestins|progestins|mesh-ancestor
43664481|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43664482|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664484|NCT04752033|Hydromorphone|hydromorphone|mesh-list
43664485|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43664486|NCT04752033|Narcotics|narcotics|mesh-ancestor
43664487|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664488|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722648|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664489|NCT04752033|Analgesics|analgesics|mesh-ancestor
43664490|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
43664491|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664492|NCT04749641|Vaccines|vaccines|mesh-list
43664493|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
43664494|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664495|NCT04736901|Enoxaparin|enoxaparin|mesh-list
43664496|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
43664497|NCT04736901|Apixaban|apixaban|mesh-list
43664498|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
43664499|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43664500|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
43664501|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43664502|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664503|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664504|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664505|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
43664506|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43664507|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43664508|NCT04734678|Infliximab|infliximab|mesh-list
43664509|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
43664510|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43664511|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664519|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664520|NCT04693169|Choline|choline|mesh-list
43664521|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
43664522|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43664533|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43851590|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664576|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722712|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722713|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
43722714|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722715|NCT02615262|Dexamethasone|dexamethasone|mesh-list
43722716|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43722717|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
43722718|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
43722719|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43722720|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722721|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43722722|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
43722723|NCT02615262|Hormones|hormones|mesh-ancestor
43833047|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
43664577|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
43664578|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43664579|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664580|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
43664581|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664582|NCT04546230|Anesthetics|anesthetics|mesh-list
43664583|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664584|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826209|NCT01174199|Sirolimus|sirolimus|mesh-list
43826210|NCT01174199|Vorinostat|vorinostat|mesh-list
43826211|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826212|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43664606|NCT04449198|Protective Agents|protective agents|mesh-ancestor
43664607|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664608|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664609|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664610|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
43664611|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664612|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43664613|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664614|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664615|NCT04322565|Colchicine|colchicine|mesh-list
43664616|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
43664617|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43664618|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
43664619|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
43664620|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
43664621|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664622|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664623|NCT04312503|Olanzapine|olanzapine|mesh-list
43664624|NCT04312503|Risperidone|risperidone|mesh-list
43664625|NCT04312503|Aripiprazole|aripiprazole|mesh-list
43664626|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43664627|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43664628|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43664648|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43664665|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43664666|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664667|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
43664668|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
43664669|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
43664745|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
43664747|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664748|NCT04090879|Nicotine|nicotine|mesh-list
43664749|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43664750|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
43722767|NCT02614612|Protective Agents|protective agents|mesh-ancestor
43722769|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43722770|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722771|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
43722772|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
43722773|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
43722774|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722775|NCT02614482|Fesoterodine|fesoterodine|mesh-list
43722776|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43722777|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43722778|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
43722779|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722780|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664751|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664752|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664753|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43664754|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43562915|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826250|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43826251|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
43826252|NCT00054158|Hormones|hormones|mesh-ancestor
43826253|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826254|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43826287|NCT05499117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43664776|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664777|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664778|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
43664779|NCT03994874|Furosemide|furosemide|mesh-list
43664780|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
43664781|NCT03994874|Diuretics|diuretics|mesh-list
43664782|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
43664783|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
43664784|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664785|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43846752|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
43664786|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664787|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43664788|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
43664789|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43664790|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664791|NCT03933215|Cladribine|cladribine|mesh-list
43664792|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664793|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664794|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
43664795|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664796|NCT03878589|Oxytocin|oxytocin|mesh-list
43664797|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
43664806|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664807|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664809|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
43664810|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
43664811|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43664812|NCT03813875|Narcotics|narcotics|mesh-ancestor
43664813|NCT03813875|Analgesics|analgesics|mesh-ancestor
43664814|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
43664815|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43664816|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43664817|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43664818|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664819|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664820|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
43664821|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
43664822|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43722784|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
43664823|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664824|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43664825|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43664826|NCT03809442|Dexamethasone|dexamethasone|mesh-list
43664827|NCT03809442|Midazolam|midazolam|mesh-list
43664828|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
43664829|NCT03809442|Ketamine|ketamine|mesh-list
43664830|NCT03809442|Tramadol|tramadol|mesh-list
43664831|NCT03809442|Ropivacaine|ropivacaine|mesh-list
43664832|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43849678|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849679|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849680|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849681|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
43849682|NCT03900624|Hormones|hormones|mesh-ancestor
43849683|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849684|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849685|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849686|NCT03899467|Androgens|androgens|mesh-list
43664848|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43664850|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43664851|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664852|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43664853|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664854|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43664855|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43664856|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
43664857|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
43664858|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43664859|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43664860|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
43664861|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43664862|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43664863|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43664864|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43664865|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
43664867|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43722810|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664869|NCT03781362|Capecitabine|capecitabine|mesh-list
43664870|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43664871|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
43562916|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43664882|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664883|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43664884|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43664885|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
43664886|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664887|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664889|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
43664890|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664891|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664892|NCT03678506|Apixaban|apixaban|mesh-list
43664893|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43664894|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
43664895|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43664896|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
43664897|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43664898|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664899|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
43664900|NCT03669523|Denosumab|denosumab|mesh-list
43664901|NCT03669523|Nivolumab|nivolumab|mesh-list
43664902|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43664903|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43664904|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43664905|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43664906|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43664907|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664951|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722852|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
43722854|NCT02613676|Protective Agents|protective agents|mesh-ancestor
43664952|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43664953|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43664954|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43664955|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
43664979|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
43664980|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
43664981|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664982|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
43664983|NCT03382938|Ropivacaine|ropivacaine|mesh-list
43664984|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43664985|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43664986|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43664987|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43664988|NCT03382938|Analgesics|analgesics|mesh-ancestor
43665002|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43665003|NCT03377543|Analgesics|analgesics|mesh-ancestor
43665004|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
43665005|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665006|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665007|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665008|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43665009|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43665010|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665011|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43665012|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43665013|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665014|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
43665015|NCT03374956|Liraglutide|liraglutide|mesh-list
43722910|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665016|NCT03374956|Topiramate|topiramate|mesh-list
43665017|NCT03374956|Phentermine|phentermine|mesh-list
43665018|NCT03374956|Naltrexone|naltrexone|mesh-list
43665019|NCT03374956|Bupropion|bupropion|mesh-list
43665020|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43665021|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43665022|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665023|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
43665029|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43665030|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
43665031|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43665032|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43665033|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43665034|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665035|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665036|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
43665037|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665038|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43665039|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43665040|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43722960|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43722961|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43722962|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43722963|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
43722964|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43722965|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43722966|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43722967|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
43722968|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
43722969|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
43665041|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
43665042|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43665043|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
43665044|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43665059|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
43665060|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665061|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665062|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43826291|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826292|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
43826293|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826294|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43826295|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
43826296|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43851595|NCT03463525|Osimertinib|osimertinib|mesh-list
43851596|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851597|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43846753|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
43665089|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665090|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
43665091|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665092|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665093|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665094|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665095|NCT03244176|Avelumab|avelumab|mesh-list
43665104|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
43665105|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665106|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43665107|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43665108|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665109|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
43665110|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665111|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43723018|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43665112|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43665114|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43665155|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665157|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43665158|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665159|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43665160|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665161|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665162|NCT02226276|Copper|copper|mesh-list
43665163|NCT02226276|Trastuzumab|trastuzumab|mesh-list
43665164|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
43665165|NCT02226276|Maytansine|maytansine|mesh-list
43665166|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43665167|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
43665168|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665169|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665170|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665171|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43665215|NCT02071862|Docetaxel|docetaxel|mesh-list
43665216|NCT02071862|Everolimus|everolimus|mesh-list
43665217|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43665218|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665219|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
43665220|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
43665221|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
43665222|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665223|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665224|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
43665225|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665227|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43665228|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665229|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
43665230|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
43665231|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43723093|NCT02612181|Analgesics|analgesics|mesh-ancestor
43665232|NCT01933815|Bevacizumab|bevacizumab|mesh-list
43665233|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665234|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665235|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43665236|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43665237|NCT01933815|Growth Substances|growth substances|mesh-ancestor
43665238|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665239|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
43665240|NCT01808820|Imiquimod|imiquimod|mesh-list
43665246|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
43665247|NCT01803152|Gemcitabine|gemcitabine|mesh-list
43665248|NCT01803152|Imiquimod|imiquimod|mesh-list
43665250|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
43665251|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665252|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43665253|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
43665254|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665255|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665256|NCT01803152|Antiviral Agents|antiviral agents|mesh-ancestor
43665257|NCT01803152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665258|NCT01803152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665259|NCT01803152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665260|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665261|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
43665263|NCT01715974|Sargramostim|sargramostim|mesh-list
43665264|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
43665265|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665266|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665267|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43665268|NCT01468896|Cetuximab|cetuximab|mesh-list
43665269|NCT01468896|Interleukin-12|interleukin-12|mesh-list
43665270|NCT01468896|Antibodies|antibodies|mesh-list
43665271|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
43665272|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43665273|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
43665274|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665275|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665290|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665291|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43665294|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665295|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
43665296|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
43665297|NCT01413100|Plerixafor|plerixafor|mesh-list
43665298|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
43665299|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
43665300|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
43665301|NCT01413100|Lenograstim|lenograstim|mesh-list
43665302|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665303|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
43665304|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665305|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665306|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43665307|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
43851598|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665308|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665309|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665310|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43665311|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43665312|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43665313|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43665314|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
43665315|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665316|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665317|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665318|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43665319|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43665320|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
43665321|NCT05471479|Charcoal|charcoal|mesh-list
43665322|NCT05471479|Antidotes|antidotes|mesh-ancestor
43665323|NCT05471479|Protective Agents|protective agents|mesh-ancestor
43665324|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665350|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665351|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43665352|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43665354|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665355|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43665356|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665357|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665358|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665359|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43665363|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43665364|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665365|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
43665366|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43665367|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
43665368|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43665369|NCT05471063|Protective Agents|protective agents|mesh-ancestor
43665370|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665371|NCT05471050|Danazol|danazol|mesh-list
43665372|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43665373|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665374|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665375|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665376|NCT05470972|Ethanol|ethanol|mesh-list
43559511|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
43665377|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43559512|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
43665378|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665379|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665380|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665381|NCT05470764|Amlodipine|amlodipine|mesh-list
43665382|NCT05470764|Perindopril|perindopril|mesh-list
43665383|NCT05470764|Indapamide|indapamide|mesh-list
43665384|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43665385|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43665386|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43665387|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665388|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43665389|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665390|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
43665391|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
43665392|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
43665393|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665394|NCT05470764|Diuretics|diuretics|mesh-ancestor
43826314|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
43826315|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826316|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43826317|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
43826318|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826319|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826320|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43826321|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
43826322|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43826323|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43826324|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43826325|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43826326|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826327|NCT05498857|Ephedrine|ephedrine|mesh-list
43826328|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43826329|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826330|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
43665417|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665418|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43665419|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665420|NCT05470166|Lidocaine|lidocaine|mesh-list
43665421|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
43665422|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
43723173|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
43665423|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665424|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665425|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
43665426|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665427|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43665439|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
43665440|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
43665441|NCT05469750|Capecitabine|capecitabine|mesh-list
43665442|NCT05469750|Letrozole|letrozole|mesh-list
43665444|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
43665445|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665446|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665447|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43665448|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43665449|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665450|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43665451|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665452|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665453|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665471|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
43665472|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665473|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665474|NCT05469412|Midazolam|midazolam|mesh-list
43665475|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43665476|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43665477|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665478|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665479|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43665480|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43665481|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43665482|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43665483|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
43665484|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
43665485|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
43665486|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
43665487|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665488|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665489|NCT05469386|Methylphenidate|methylphenidate|mesh-list
43665490|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43665491|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665492|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43665540|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665541|NCT05469061|Cisplatin|cisplatin|mesh-list
43665542|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665543|NCT05469035|Heparin|heparin|mesh-list
43665544|NCT05469035|Calcium heparin|calcium heparin|mesh-list
43665545|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
43665546|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43665547|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43665548|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665551|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665552|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723213|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665554|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43723215|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665555|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43665556|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665557|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665558|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
43665559|NCT05468840|Ketamine|ketamine|mesh-list
43665560|NCT05468840|Analgesics|analgesics|mesh-ancestor
43665561|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
43665562|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665563|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665564|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43665565|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43665566|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
43665567|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
43665568|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43665569|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43665570|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43665571|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665572|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665573|NCT05468645|Hemay005|hemay005|mesh-list
43665574|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
43665575|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43665576|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43665597|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43665598|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43665599|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43665600|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849687|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
43723234|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43723235|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43723236|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849688|NCT03899467|Hormones|hormones|mesh-ancestor
43665603|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
43665604|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665605|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665607|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43665608|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665609|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665610|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665611|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43826362|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43826363|NCT05498636|Growth Substances|growth substances|mesh-ancestor
43826364|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
43826365|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43826366|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826367|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43826368|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
43826369|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43826370|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43826371|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43826372|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826373|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826374|NCT05498389|Osimertinib|osimertinib|mesh-list
43826375|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826376|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43826377|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826378|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826380|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43826381|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826382|NCT05498259|Rituximab|rituximab|mesh-list
43826383|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43826384|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826385|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
43665715|NCT05527470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665717|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43665718|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
43665719|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665720|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665721|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43665722|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43665723|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
43665724|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665725|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665726|NCT05507892|Canagliflozin|canagliflozin|mesh-list
43665727|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43665728|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665729|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43826399|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
43826400|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
43826401|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43826402|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43826403|NCT05498116|Montelukast|montelukast|mesh-list
43826404|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43826405|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
43826406|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43826407|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
43826408|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43826409|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826410|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43826420|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43826421|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665783|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665784|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
43665802|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665803|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665804|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665805|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
43665806|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
43665807|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43665808|NCT05275738|Niacinamide|niacinamide|mesh-list
43665809|NCT05275738|Niacin|niacin|mesh-list
43665810|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
43723291|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
43665811|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
43665812|NCT05275738|Vitamins|vitamins|mesh-ancestor
43723295|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43665813|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
43665814|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665815|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43665816|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
43851611|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
43851612|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
43665853|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
43665854|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665855|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665856|NCT05239182|Antiviral Agents|antiviral agents|mesh-ancestor
43665865|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
43665866|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665884|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43665885|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665886|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826462|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
43826463|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
43826465|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43826466|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826467|NCT05497765|Protective Agents|protective agents|mesh-ancestor
43826468|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826476|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43826477|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
43826478|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
43826479|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43826480|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43826481|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43826483|NCT05497674|Probenecid|probenecid|mesh-list
43826484|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43826485|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
43826486|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43826487|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43826488|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
43826489|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43826490|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43826491|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43846764|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43846765|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43846766|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43665914|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665915|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43665916|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665917|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43723319|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
43665918|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43665919|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665920|NCT05100472|Androgens|androgens|mesh-list
43665921|NCT05100472|Hormones|hormones|mesh-ancestor
43665922|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43665923|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665924|NCT05086692|Interleukin-2|interleukin-2|mesh-list
43665925|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43665926|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43665927|NCT05086692|Analgesics|analgesics|mesh-ancestor
43665928|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
43665929|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43665930|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665931|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
43665932|NCT05077254|Vaccines|vaccines|mesh-list
43665933|NCT05077254|Tacrolimus|tacrolimus|mesh-list
43665934|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
43665935|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43665936|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43665937|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43665938|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43665939|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43665940|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43665956|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43665967|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43665968|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43666020|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43666021|NCT04898231|Prednisolone|prednisolone|mesh-list
43666022|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
43666023|NCT04898231|Infliximab|infliximab|mesh-list
43559549|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43666024|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43666025|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43666026|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
43666027|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43666028|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
43666029|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
43666030|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43666031|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666032|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666033|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
43666034|NCT04898231|Hormones|hormones|mesh-ancestor
43666035|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43666060|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43666071|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666072|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43666073|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43666074|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666075|NCT04662944|Ranibizumab|ranibizumab|mesh-list
43666076|NCT04662944|Aflibercept|aflibercept|mesh-list
43666077|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43666078|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43666079|NCT04662944|Growth Substances|growth substances|mesh-ancestor
43851639|NCT03355976|Ipilimumab|ipilimumab|mesh-list
43851651|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
43851652|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43666150|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43666151|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666152|NCT04382326|Vaccines|vaccines|mesh-list
43666153|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43666154|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
43666155|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666156|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
43666157|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43666158|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
43666159|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666160|NCT04362527|Milrinone|milrinone|mesh-list
43666161|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43666162|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43666163|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43666164|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
43666165|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
43666166|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43666179|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
43666180|NCT04291001|Etonogestrel|etonogestrel|mesh-list
43666181|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43666182|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
43666183|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666184|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666185|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43666186|NCT04288089|Palbociclib|palbociclib|mesh-list
43666187|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666188|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43666189|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666200|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666201|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43666202|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666203|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
43666204|NCT04202809|Durvalumab|durvalumab|mesh-list
43666205|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43723388|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43723389|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666206|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666207|NCT04188405|Decitabine|decitabine|mesh-list
43666208|NCT04188405|Venetoclax|venetoclax|mesh-list
43666209|NCT04188405|Ponatinib|ponatinib|mesh-list
43666210|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666211|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
43666212|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666213|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666214|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666215|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43666216|NCT04187053|Methylene Blue|methylene blue|mesh-list
43666217|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666272|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43666273|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43666274|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666293|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43666319|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43666321|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
43666322|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
43666323|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
43666324|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851656|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
43851731|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
43851732|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851733|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851734|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851735|NCT02738866|Fulvestrant|fulvestrant|mesh-list
43851736|NCT02738866|Palbociclib|palbociclib|mesh-list
43851737|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43666624|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666625|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666626|NCT03421353|Gemcitabine|gemcitabine|mesh-list
43666627|NCT03421353|Paclitaxel|paclitaxel|mesh-list
43666628|NCT03421353|Cisplatin|cisplatin|mesh-list
43666629|NCT03421353|Carboplatin|carboplatin|mesh-list
43851764|NCT02395666|Eflornithine|eflornithine|mesh-list
43851765|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851766|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
43851772|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851774|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43851775|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43851777|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851778|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
43851788|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666763|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43666765|NCT03147612|Antibodies|antibodies|mesh-list
43666766|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
43666767|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43666768|NCT03147612|Lenograstim|lenograstim|mesh-list
43666769|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
43666770|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666771|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
43666772|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666773|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43666774|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666775|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
43851794|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
43851795|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43666796|NCT03075423|Nivolumab|nivolumab|mesh-list
43666797|NCT03075423|Ipilimumab|ipilimumab|mesh-list
43666798|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43666799|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666800|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43666801|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666802|NCT03016819|Dacarbazine|dacarbazine|mesh-list
43666803|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43666804|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
43666805|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666806|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666808|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43666809|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666810|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666811|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666812|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666813|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43666814|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43851797|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
43666838|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43666839|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
43851800|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43851801|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43666852|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43723500|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
43666853|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666854|NCT02722616|Pancrelipase|pancrelipase|mesh-list
43666855|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43666856|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
43666858|NCT02605421|Thiotepa|thiotepa|mesh-list
43666859|NCT02605421|Carboplatin|carboplatin|mesh-list
43666860|NCT02605421|Etoposide|etoposide|mesh-list
43666861|NCT02605421|Lenograstim|lenograstim|mesh-list
43666911|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43666912|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43666913|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43666914|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43666938|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43666940|NCT02465268|Sargramostim|sargramostim|mesh-list
43666941|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
43666942|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666943|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43666944|NCT02203643|Dexamethasone|dexamethasone|mesh-list
43666945|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
43666946|NCT02203643|Lenalidomide|lenalidomide|mesh-list
43666947|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43666948|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
43666949|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43666950|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667096|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667097|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
43667098|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
43667099|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43667100|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
43667128|NCT00871013|Etoposide|etoposide|mesh-list
43667129|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43667147|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43667148|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43667225|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43667226|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43667227|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43667228|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43667229|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667242|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667243|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43667244|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667245|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43667246|NCT05353140|Aspirin|aspirin|mesh-list
43667247|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
43667248|NCT05353140|Clopidogrel|clopidogrel|mesh-list
43667249|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43667250|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43667251|NCT05353140|Analgesics|analgesics|mesh-ancestor
43667252|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
43667253|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43667254|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667255|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43723578|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43723579|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43723580|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43723581|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
43723582|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723583|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723584|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723585|NCT02608918|BMS-955176|bms-955176|mesh-list
43723586|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43723587|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43723588|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
43723597|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
43723598|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
43723599|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43723600|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723601|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723602|NCT02608931|Dronabinol|dronabinol|mesh-list
43723603|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
43723604|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723605|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43723606|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43723607|NCT02608931|Analgesics|analgesics|mesh-ancestor
43667256|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43667536|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
43667537|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826638|NCT05495958|Vitamins|vitamins|mesh-ancestor
43826639|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
43851951|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
43851952|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
43851953|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667585|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43667603|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
43667604|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667605|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667606|NCT04899778|Iron|iron|mesh-list
43667607|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43667682|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43667683|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
43667684|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667686|NCT04816877|Narcotics|narcotics|mesh-ancestor
43833136|NCT05236036|Temozolomide|temozolomide|mesh-list
43667884|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43723824|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43723917|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43723918|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
43723919|NCT02607332|Paclitaxel|paclitaxel|mesh-list
43723920|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43723921|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43723922|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
43723923|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
43723924|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
43667885|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43667886|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43667887|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43724122|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43724123|NCT02606084|Esketamine|esketamine|mesh-list
43724127|NCT02605915|Carboplatin|carboplatin|mesh-list
43667888|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43667930|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43667931|NCT04426825|Bevacizumab|bevacizumab|mesh-list
43667932|NCT04426825|Atezolizumab|atezolizumab|mesh-list
43667933|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43667934|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43667935|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43667936|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43667937|NCT04426825|Growth Substances|growth substances|mesh-ancestor
43667952|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43667953|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849743|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
43724199|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724200|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43849744|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43849745|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536598|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
43536599|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
43536600|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43536601|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43536602|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43536603|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43536604|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
43536605|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43536606|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536607|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43536608|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43536609|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43536610|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
43536611|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
43536613|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668132|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43668133|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536615|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43536616|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43536617|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43536618|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
43536619|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536620|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43724609|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
43724610|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724611|NCT02603315|Growth Substances|growth substances|mesh-ancestor
43724612|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559555|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
43559556|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43559557|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
43559558|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43559559|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559560|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
43559561|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43559562|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43724614|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43536621|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43536622|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
43724627|NCT02603081|Ebselen|ebselen|mesh-list
43536624|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
43536625|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43536626|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43536627|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
43536628|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43536629|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536631|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536632|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536633|NCT04564898|Trifluridine|trifluridine|mesh-list
43536634|NCT04564898|Bevacizumab|bevacizumab|mesh-list
43536635|NCT04564898|Capecitabine|capecitabine|mesh-list
43847514|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536636|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536637|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536638|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43536639|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43536640|NCT04564898|Growth Substances|growth substances|mesh-ancestor
43536641|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536642|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
43536643|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43536644|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
43536647|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536648|NCT04562779|Naltrexone|naltrexone|mesh-list
43536649|NCT04562779|Ketamine|ketamine|mesh-list
43536650|NCT04562779|Analgesics|analgesics|mesh-ancestor
43724743|NCT02602509|Rifampin|rifampin|mesh-list
43536651|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
43536652|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43724811|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
43536653|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536654|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43536655|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43536656|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
43536657|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
43849772|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536658|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536659|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43536660|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43536661|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43724935|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43724936|NCT02601365|Molgramostim|molgramostim|mesh-list
43724937|NCT02601365|Sargramostim|sargramostim|mesh-list
43724938|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
43724941|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
43536662|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536663|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
43536664|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43536665|NCT04547790|Psyllium|psyllium|mesh-list
43536666|NCT04547790|Cathartics|cathartics|mesh-ancestor
43536667|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43536668|NCT04523363|Metformin|metformin|mesh-list
43536669|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43536670|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536672|NCT04509050|Elexacaftor|elexacaftor|mesh-list
43536686|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
43536687|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536688|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43668134|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668135|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
43668136|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668137|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
43668138|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725109|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725110|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725111|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
43668139|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668140|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668141|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
43668142|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668143|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536691|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
43536692|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833307|NCT05218603|Bortezomib|bortezomib|mesh-list
43725183|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43725184|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725185|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725186|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
43725188|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
43725189|NCT02599675|Vitamins|vitamins|mesh-ancestor
43725190|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
43725191|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725192|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43725193|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725194|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
43725195|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536693|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536694|NCT04446390|Listerine|listerine|mesh-list
43536695|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
43536696|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
43536697|NCT04446390|Protective Agents|protective agents|mesh-ancestor
43536698|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536699|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43536700|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536701|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
43536702|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43536703|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43536704|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
43536705|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536706|NCT04390945|Capecitabine|capecitabine|mesh-list
43536707|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43725257|NCT02599480|Mirabegron|mirabegron|mesh-list
43536708|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
43536709|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536710|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536711|NCT04381364|Ciclesonide|ciclesonide|mesh-list
43536712|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
43536713|NCT04381364|Hormones|hormones|mesh-ancestor
43536714|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536715|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536716|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43725346|NCT02598791|Glucagon|glucagon|mesh-list
43725347|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
43725348|NCT02598791|Incretins|incretins|mesh-ancestor
43725349|NCT02598791|Hormones|hormones|mesh-ancestor
43725350|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43725351|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725352|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43725353|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
43725354|NCT02598635|Vitamin D|vitamin d|mesh-list
43725355|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43725356|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536717|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
43536718|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536730|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43536731|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
43536732|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
43536733|NCT04291521|Analgesics|analgesics|mesh-ancestor
43725454|NCT02597699|Sufentanil|sufentanil|mesh-list
43536734|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
43536735|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536736|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43536737|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43536738|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43536739|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43536740|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536741|NCT04204941|Doxorubicin|doxorubicin|mesh-list
43536742|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43536743|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43536744|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536745|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43536746|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43536747|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725550|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43725551|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725552|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725553|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43725554|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43725555|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
43725556|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
43725557|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
43725558|NCT02597166|Ledipasvir|ledipasvir|mesh-list
43725559|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
43725561|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
43725571|NCT02596984|Caspofungin|caspofungin|mesh-list
43725572|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
43725573|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725574|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725575|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725610|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43725611|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43725612|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
43725613|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725614|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
43725615|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725616|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43725617|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
43725619|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43725620|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43725621|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
43536748|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668144|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668145|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
43668146|NCT03935893|Fludarabine|fludarabine|mesh-list
43668147|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668148|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
43668149|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668150|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668151|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43536749|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
43536750|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
43536751|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43536752|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
43536753|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536754|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725697|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536755|NCT04183452|Progestins|progestins|mesh-ancestor
43536756|NCT04183452|Hormones|hormones|mesh-ancestor
43536757|NCT04155710|Interleukin-2|interleukin-2|mesh-list
43536758|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536759|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43536760|NCT04155710|Analgesics|analgesics|mesh-ancestor
43536761|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
43536762|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536763|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43725758|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43725759|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43725760|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725761|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725806|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43725807|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43725808|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43725809|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43725810|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43725811|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725812|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
43725813|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43725814|NCT02595190|Narcotics|narcotics|mesh-ancestor
43725819|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
43725820|NCT02595242|Vincristine|vincristine|mesh-list
43725821|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43725822|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
43536764|NCT04095208|Nivolumab|nivolumab|mesh-list
43536765|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536766|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536767|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43536768|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536769|NCT04067609|Dexamethasone|dexamethasone|mesh-list
43536770|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43536771|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
43536772|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
43536773|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536774|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536775|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43536776|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
43536778|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536779|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43536780|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536781|NCT04042077|Vancomycin|vancomycin|mesh-list
43536782|NCT04042077|Tazobactam|tazobactam|mesh-list
43536785|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
43536787|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43536788|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536789|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43536790|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536791|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536792|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43536793|NCT04008238|Trabectedin|trabectedin|mesh-list
43536796|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536797|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536798|NCT03995017|Nivolumab|nivolumab|mesh-list
43536799|NCT03995017|Ramucirumab|ramucirumab|mesh-list
43536800|NCT03995017|Rucaparib|rucaparib|mesh-list
43536801|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536802|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536803|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43536804|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536805|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43536806|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536807|NCT03980314|Nivolumab|nivolumab|mesh-list
43668152|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
43536808|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536809|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536810|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43725979|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43725980|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43725981|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
43725982|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43725983|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43725984|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43725985|NCT02593708|Paclitaxel|paclitaxel|mesh-list
43725986|NCT02593708|Trastuzumab|trastuzumab|mesh-list
43725987|NCT02593708|Pertuzumab|pertuzumab|mesh-list
43725989|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43725990|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
43725991|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
43725992|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
43725993|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43725994|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43725995|NCT02593695|Fluoxetine|fluoxetine|mesh-list
43726020|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726021|NCT02593526|Bumetanide|bumetanide|mesh-list
43536811|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536812|NCT03926299|Clobetasol|clobetasol|mesh-list
43536813|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43536814|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
43536815|NCT03926299|Hormones|hormones|mesh-ancestor
43536816|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536817|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536818|NCT03841097|Tacrolimus|tacrolimus|mesh-list
43726068|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726073|NCT02593500|Hormones|hormones|mesh-ancestor
43849773|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43536820|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
43536821|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536822|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43536823|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536824|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536825|NCT03814356|Methylphenidate|methylphenidate|mesh-list
43536826|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43536827|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536828|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43726139|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726141|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43726142|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
43726143|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726144|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43726145|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726146|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
43726147|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43726148|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
43726149|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
43726150|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
43726151|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43726201|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726202|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536829|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43536830|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43639124|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849774|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43536832|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
43536833|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43536834|NCT03811847|Methylphenidate|methylphenidate|mesh-list
43536835|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43536836|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536837|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43536838|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43536839|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43536840|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536841|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
43726341|NCT02591914|Growth Substances|growth substances|mesh-ancestor
43726342|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726343|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
43536842|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43849775|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
43536846|NCT03740009|Hormones|hormones|mesh-ancestor
43536847|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536848|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536849|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43536850|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43536851|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
43536861|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43536862|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43726443|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536863|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536864|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43536865|NCT03705845|Tocotrienols|tocotrienols|mesh-list
43536867|NCT03705845|Tocopherols|tocopherols|mesh-list
43536868|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
43536869|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536870|NCT03705845|Protective Agents|protective agents|mesh-ancestor
43536871|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536873|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
43536874|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
43536875|NCT03674320|Testosterone|testosterone|mesh-list
43833483|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833484|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833485|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
43833486|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43833487|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43833488|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833489|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43833490|NCT05206435|Nicotine|nicotine|mesh-list
43833491|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43833492|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
43833493|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833494|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833500|NCT05205811|Zonisamide|zonisamide|mesh-list
43833501|NCT05205811|Bupropion|bupropion|mesh-list
43833502|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43833503|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
43833504|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43833505|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43833506|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43833507|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833508|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43833509|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
43726731|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43726732|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43726733|NCT02588417|Dexamethasone|dexamethasone|mesh-list
43536876|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
43536877|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
43536878|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43536879|NCT03674320|Androgens|androgens|mesh-ancestor
43536880|NCT03674320|Hormones|hormones|mesh-ancestor
43639125|NCT03570619|Nivolumab|nivolumab|mesh-list
43536881|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536882|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536883|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43536884|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536885|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
43668153|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668154|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668155|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668157|NCT03918252|Ipilimumab|ipilimumab|mesh-list
43668158|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668159|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536886|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
43536887|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43726734|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
43726735|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726736|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
43726737|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
43726738|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726739|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43726740|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43726741|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
43726742|NCT02588417|Hormones|hormones|mesh-ancestor
43726743|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43726754|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43726755|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
43726756|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43536888|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536889|NCT03639610|Dexamethasone|dexamethasone|mesh-list
43536890|NCT03639610|Melphalan|melphalan|mesh-list
43536891|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43536892|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
43536893|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
43536894|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536895|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536896|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43536897|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
43536898|NCT03639610|Hormones|hormones|mesh-ancestor
43536899|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43536900|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43536901|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43726812|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536902|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43536903|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
43536904|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536905|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43536906|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43536907|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
43536908|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
43536909|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43536910|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536911|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536912|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43536914|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43536915|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43536916|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536917|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536925|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536926|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726936|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
43726937|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
43726938|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43726939|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
43726948|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43726949|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43726950|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43726951|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43726952|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
43726953|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43726954|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
43726955|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
43726956|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43726957|NCT02586753|Paclitaxel|paclitaxel|mesh-list
43726959|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43536927|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43536929|NCT03520491|Ipilimumab|ipilimumab|mesh-list
43536930|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43536931|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536932|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43536933|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43849776|NCT03895502|Edoxaban|edoxaban|mesh-list
43536936|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536937|NCT03476330|Protective Agents|protective agents|mesh-ancestor
43536938|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536939|NCT03473977|Benralizumab|benralizumab|mesh-list
43536940|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43536941|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
43536942|NCT03437421|Vitamin D|vitamin d|mesh-list
43833528|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43833546|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43833547|NCT05204667|Analgesics|analgesics|mesh-ancestor
43833548|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
43833549|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43833550|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833551|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
43833552|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43833553|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43833554|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43833555|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43833556|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43833558|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43536943|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
43536945|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
43536946|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536947|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43536948|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43536949|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43536950|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43536951|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536952|NCT03396211|Nivolumab|nivolumab|mesh-list
43536953|NCT03396211|Apatinib|apatinib|mesh-list
43536954|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668160|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43668161|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668162|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
43536955|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536956|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43536957|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727018|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
43559629|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43536958|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43536959|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536960|NCT03392441|Insulin|insulin|mesh-list
43536961|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43536962|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536963|NCT03389243|Acetaminophen|acetaminophen|mesh-list
43536964|NCT03389243|Dipyrone|dipyrone|mesh-list
43536965|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43536966|NCT03389243|Analgesics|analgesics|mesh-ancestor
43536967|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
43849777|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43849778|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
43536968|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536969|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43536970|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
43536971|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43536972|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43536973|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43536974|NCT03243838|Apatinib|apatinib|mesh-list
43536975|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43536976|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43727174|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
43536977|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43536978|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536979|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
43536980|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
43536981|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43536982|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43536983|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43536984|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
43536985|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43536986|NCT03051282|Enalapril|enalapril|mesh-list
43536996|NCT03039673|Analgesics|analgesics|mesh-ancestor
43536997|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
43833567|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
43833568|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
43727279|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727280|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
43727281|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
43727282|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
43727283|NCT02584751|Protective Agents|protective agents|mesh-ancestor
43727284|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
43727285|NCT02584738|Prednisolone|prednisolone|mesh-list
43727286|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
43727287|NCT02584738|Bromides|bromides|mesh-list
43727288|NCT02584738|Albuterol|albuterol|mesh-list
43727289|NCT02584738|Ipratropium|ipratropium|mesh-list
43727290|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43727291|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
43727292|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
43727293|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727294|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727295|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727296|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
43727297|NCT02584738|Hormones|hormones|mesh-ancestor
43727299|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43536998|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43536999|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537000|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
43537001|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43537002|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43537003|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537004|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537005|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43727334|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
43559743|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43559744|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43559745|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43559746|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
43559747|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
43559748|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
43559749|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43559750|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43559751|NCT03345082|Ranibizumab|ranibizumab|mesh-list
43559754|NCT03345082|Growth Substances|growth substances|mesh-ancestor
43537006|NCT03039673|Protective Agents|protective agents|mesh-ancestor
43537007|NCT02980666|Teduglutide|teduglutide|mesh-list
43537008|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43849779|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43537019|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43537020|NCT02962102|Vitamins|vitamins|mesh-ancestor
43537021|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
43537022|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43537023|NCT02950259|Indomethacin|indomethacin|mesh-list
43537025|NCT02950259|Omeprazole|omeprazole|mesh-list
43537026|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537027|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
43537028|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537029|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537030|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537031|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
43668163|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43668164|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43668165|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43537032|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537033|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537034|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43537035|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43537036|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727491|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537037|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43537038|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537039|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43537040|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43537041|NCT02950259|Analgesics|analgesics|mesh-ancestor
43537042|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
43537043|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537044|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537045|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
43537046|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
43727531|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43727532|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43727533|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43727534|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
43727535|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727536|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
43727537|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
43727538|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43727539|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43727541|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
43727542|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43727543|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
43727545|NCT02583217|Remifentanil|remifentanil|mesh-list
43727546|NCT02583217|Propofol|propofol|mesh-list
43727547|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43727548|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43727549|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43727550|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43727551|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
43727552|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
43559818|NCT03191864|Xhance|xhance|mesh-list
43537047|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43537048|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43537049|NCT02947750|Folic Acid|folic acid|mesh-list
43537050|NCT02947750|Hematinics|hematinics|mesh-ancestor
43537051|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
43537052|NCT02947750|Vitamins|vitamins|mesh-ancestor
43537056|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
43537057|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43727569|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
43537058|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
43537059|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43727570|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43727571|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43727572|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
43727573|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43727574|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
43727575|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43727576|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
43727577|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43727578|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43559830|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
43559831|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43559832|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43559833|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
43559834|NCT03187834|Renal Agents|renal agents|mesh-ancestor
43559835|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
43559836|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43537060|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537061|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537062|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
43537063|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537064|NCT02777424|Thrombin|thrombin|mesh-list
43537065|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
43537066|NCT02777424|Coagulants|coagulants|mesh-ancestor
43537068|NCT02630368|Avelumab|avelumab|mesh-list
43727594|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
43727595|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43537069|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537070|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
43537071|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537073|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537074|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
43537075|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537076|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537077|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43537078|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537079|NCT02613416|Denosumab|denosumab|mesh-list
43537080|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43537081|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537082|NCT02601014|Nivolumab|nivolumab|mesh-list
43537083|NCT02601014|Ipilimumab|ipilimumab|mesh-list
43537084|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537085|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537086|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43537087|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537088|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43537089|NCT02581787|Antibodies|antibodies|mesh-list
43537090|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
43537091|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43537092|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
43559867|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537093|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
43537094|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537095|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537096|NCT02581085|Tocotrienols|tocotrienols|mesh-list
43537097|NCT02581085|Vitamin E|vitamin e|mesh-list
43537098|NCT02581085|Tocopherols|tocopherols|mesh-list
43537099|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
43537100|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537101|NCT02581085|Protective Agents|protective agents|mesh-ancestor
43537102|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537103|NCT02581085|Vitamins|vitamins|mesh-ancestor
43537104|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
43537105|NCT02516696|Clarithromycin|clarithromycin|mesh-list
43537106|NCT02516696|Dexamethasone|dexamethasone|mesh-list
43537107|NCT02516696|Lenalidomide|lenalidomide|mesh-list
43537108|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537109|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
43537110|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
43537111|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537112|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537113|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537114|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
43537115|NCT02516696|Hormones|hormones|mesh-ancestor
43849780|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
43849781|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43849782|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43734427|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43537116|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537117|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537118|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537119|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
43537120|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537121|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537122|NCT02516696|Growth Substances|growth substances|mesh-ancestor
43537123|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537124|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43537125|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537138|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537140|NCT02372630|Hormones|hormones|mesh-ancestor
43727845|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43727846|NCT02581566|Analgesics|analgesics|mesh-ancestor
43727849|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43537141|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537142|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
43537143|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
43537144|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537145|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537146|NCT02224573|Cannabidiol|cannabidiol|mesh-list
43537147|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
43537148|NCT02164643|Flutemetamol|flutemetamol|mesh-list
43537149|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43537150|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537151|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43537152|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43537153|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537154|NCT02123823|Everolimus|everolimus|mesh-list
43537155|NCT02123823|Exemestane|exemestane|mesh-list
43537156|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537157|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537158|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
43537159|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537160|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43537161|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43537162|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537163|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537164|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43537165|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
43537166|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537168|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537169|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43537170|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537171|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537172|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
43537173|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43537174|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43537175|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43537176|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
43560021|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43560022|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43562919|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
43560039|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
43560040|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560041|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560042|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43560043|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43560044|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43560045|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
43560046|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560047|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560048|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43560049|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
43560050|NCT05309928|Amoxicillin|amoxicillin|mesh-list
43560052|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43560053|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560054|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
43560055|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
43560056|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562920|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
43537177|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537178|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537179|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537180|NCT05693090|Osimertinib|osimertinib|mesh-list
43537181|NCT05693090|Tipifarnib|tipifarnib|mesh-list
43537182|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537183|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43849783|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
43537185|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537198|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560072|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560073|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43560074|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43560076|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
43560077|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560078|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560079|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43560081|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
43560082|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
43560083|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560084|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560085|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
43560086|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560088|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
43560089|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
43560090|NCT05259527|Vitamins|vitamins|mesh-list
43560091|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
43728072|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668166|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668167|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
43668168|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668169|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537199|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43537200|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537201|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537202|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
43537203|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
43537204|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537226|NCT05692856|Clenbuterol|clenbuterol|mesh-list
43537227|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43537228|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43537229|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
43537230|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43833670|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
43537231|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537232|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537233|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43537234|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
43537235|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537236|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43537237|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
43537238|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
43537239|NCT05692843|Cyclosporine|cyclosporine|mesh-list
43537240|NCT05692843|Cyclosporins|cyclosporins|mesh-list
43537241|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537242|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537243|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537244|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
43537245|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537246|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
43537247|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537248|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537249|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537253|NCT05692739|Cyclosporine|cyclosporine|mesh-list
43537254|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
43537255|NCT05692739|Cyclosporins|cyclosporins|mesh-list
43537256|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537257|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537258|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537259|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537260|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
43537261|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
43537262|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537263|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537264|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537265|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43537266|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
43537269|NCT05692570|Cobicistat|cobicistat|mesh-list
43668170|NCT03851588|Dolutegravir|dolutegravir|mesh-list
43668171|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43668172|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43668173|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537270|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
43560113|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537271|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
43537272|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
43537273|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537274|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537275|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43537276|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43537277|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
43537278|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537279|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43537280|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43537281|NCT05692245|Dexamethasone|dexamethasone|mesh-list
43537282|NCT05692245|Ondansetron|ondansetron|mesh-list
43537283|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537284|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
43537285|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
43537286|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537287|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537288|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537289|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
43537290|NCT05692245|Hormones|hormones|mesh-ancestor
43537291|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537292|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537293|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537294|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
43537295|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537296|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43537297|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
43537298|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537299|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537300|NCT05692245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43537301|NCT05692245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43537302|NCT05692245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537303|NCT05692245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43537304|NCT05692245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43537305|NCT05692180|Benralizumab|benralizumab|mesh-list
43537306|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43537307|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
43537308|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
43537309|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43537310|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43734428|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43537311|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537312|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43537313|NCT05692167|Analgesics|analgesics|mesh-ancestor
43537331|NCT05691959|Calcium|calcium|mesh-list
43537332|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43537333|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537334|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
43728200|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728201|NCT02578472|Zolpidem|zolpidem|mesh-list
43728202|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43728203|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43728204|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43560126|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43668174|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537335|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537336|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537337|NCT05691764|Cyclosporine|cyclosporine|mesh-list
43537338|NCT05691764|Cyclosporins|cyclosporins|mesh-list
43537339|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537340|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537341|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537342|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
43537343|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537344|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
43537345|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537346|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537347|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537348|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43537349|NCT05691712|Tirzepatide|tirzepatide|mesh-list
43537350|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43537351|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537352|NCT05691712|Incretins|incretins|mesh-ancestor
43537353|NCT05691712|Hormones|hormones|mesh-ancestor
43537354|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537355|NCT05691699|Itraconazole|itraconazole|mesh-list
43537356|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
43537357|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537358|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43537359|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43537360|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537361|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537362|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43537363|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
43639126|NCT03570619|Ipilimumab|ipilimumab|mesh-list
43537370|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537372|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537373|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537374|NCT05691517|Exatecan|exatecan|mesh-list
43537376|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43537377|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43537378|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537379|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537380|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537381|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537382|NCT05691491|Temozolomide|temozolomide|mesh-list
43537383|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537384|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
43537385|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537386|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537387|NCT05691478|Cisplatin|cisplatin|mesh-list
43537388|NCT05691478|Doxorubicin|doxorubicin|mesh-list
43537389|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43537390|NCT05691478|Methotrexate|methotrexate|mesh-list
43537391|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537392|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43537393|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43537394|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43537396|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537397|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43728205|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560159|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560160|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
43537398|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
43537399|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43537400|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537401|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43537402|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
43537403|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537404|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43537405|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668175|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43668176|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43537406|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
43537407|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537412|NCT05691400|Palbociclib|palbociclib|mesh-list
43537413|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537414|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43537415|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537416|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537417|NCT05689710|Inositol|inositol|mesh-list
43537418|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
43537419|NCT05689710|Vitamins|vitamins|mesh-ancestor
43537420|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
43537421|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537422|NCT05689450|Amikacin|amikacin|mesh-list
43537423|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43537424|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537428|NCT05684172|Tenecteplase|tenecteplase|mesh-list
43537435|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537436|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
43537437|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537438|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537439|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537440|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
43537441|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537442|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560172|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43560173|NCT05139017|Gemcitabine|gemcitabine|mesh-list
43560175|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
43560176|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43537443|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43728216|NCT02578043|Clindamycin|clindamycin|mesh-list
43728217|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
43537444|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43537445|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
43537446|NCT05669625|Vaccines|vaccines|mesh-list
43537447|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
43537448|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537456|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537457|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537458|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537459|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43537460|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43537461|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43537462|NCT05650164|Avelumab|avelumab|mesh-list
43537463|NCT05650164|Axitinib|axitinib|mesh-list
43537464|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537465|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537466|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43537467|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537468|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537469|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
43537470|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537471|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43537472|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537473|NCT05628363|Androgens|androgens|mesh-list
43537474|NCT05628363|Hormones|hormones|mesh-ancestor
43537480|NCT05626257|Omalizumab|omalizumab|mesh-list
43537481|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43537482|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43537483|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
43728239|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728240|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537484|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
43537485|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537491|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537492|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
43849784|NCT03891901|Isoniazid|isoniazid|mesh-list
43537493|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537495|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43537496|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43537497|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43537498|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537500|NCT05603832|Bupivacaine|bupivacaine|mesh-list
43537501|NCT05603832|Methocarbamol|methocarbamol|mesh-list
43537502|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
43537503|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
43537504|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537505|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537506|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
43537507|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537508|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43537509|NCT05603832|Analgesics|analgesics|mesh-ancestor
43537510|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
43537511|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
43537512|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43537513|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
43537514|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537515|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537519|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
43537520|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43537521|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537529|NCT05549726|Cabotegravir|cabotegravir|mesh-list
43537530|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43537531|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43537532|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537533|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537534|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43537535|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43537536|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
43537537|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537538|NCT05544136|Carboplatin|carboplatin|mesh-list
43537539|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537540|NCT05530707|Niacinamide|niacinamide|mesh-list
43537541|NCT05530707|Niacin|niacin|mesh-list
43537542|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
43537543|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
43537544|NCT05530707|Vitamins|vitamins|mesh-ancestor
43537545|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
43537546|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728276|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
43728277|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728278|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728279|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
43728280|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43728281|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43728282|NCT02577809|Narcotics|narcotics|mesh-ancestor
43728283|NCT02577809|Analgesics|analgesics|mesh-ancestor
43537547|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43537553|NCT05515627|Atezolizumab|atezolizumab|mesh-list
43537554|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537555|NCT05515575|Niraparib|niraparib|mesh-list
43537556|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43537557|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831445|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
43537558|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537559|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537560|NCT05514054|Tamoxifen|tamoxifen|mesh-list
43537561|NCT05514054|Letrozole|letrozole|mesh-list
43537562|NCT05514054|Anastrozole|anastrozole|mesh-list
43537563|NCT05514054|Exemestane|exemestane|mesh-list
43537564|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537565|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43537566|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43537567|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537568|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668180|NCT03818685|Nivolumab|nivolumab|mesh-list
43668181|NCT03818685|Ipilimumab|ipilimumab|mesh-list
43537569|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43537570|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
43537571|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537572|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537573|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537574|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43537575|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43537576|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43537599|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
43537601|NCT05501548|Vitamins|vitamins|mesh-ancestor
43537602|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
43537603|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537604|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
43537605|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537606|NCT05501548|Protective Agents|protective agents|mesh-ancestor
43537607|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43537608|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537609|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537610|NCT05483491|Aldesleukin|aldesleukin|mesh-list
43537611|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537612|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43537613|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43537614|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
43537615|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537616|NCT05467176|Relugolix|relugolix|mesh-list
43537617|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
43537618|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
43537629|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43537630|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43537631|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537632|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537633|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537634|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537635|NCT05446870|Growth Substances|growth substances|mesh-ancestor
43537636|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537637|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537638|NCT05434689|Dexamethasone|dexamethasone|mesh-list
43537639|NCT05434689|Daratumumab|daratumumab|mesh-list
43537640|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537641|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
43537642|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
43537643|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537644|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537645|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537647|NCT05434689|Hormones|hormones|mesh-ancestor
43833703|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43833704|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43833705|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43833706|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
43833707|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
43833708|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43833709|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43833710|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43833717|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43833724|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43833725|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43728431|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43728432|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728433|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728434|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
43728435|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43728436|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43728437|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
43728438|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
43728439|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43728440|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
43728442|NCT02577094|Busulfan|busulfan|mesh-list
43537648|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537649|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668182|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43668183|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
43537650|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537652|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
43537653|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
43537654|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537655|NCT05418582|Carbamazepine|carbamazepine|mesh-list
43728516|NCT02576600|Analgesics|analgesics|mesh-ancestor
43537656|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
43537657|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
43537658|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43537659|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537660|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537661|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43537662|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43537663|NCT05418582|Analgesics|analgesics|mesh-ancestor
43537664|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
43537665|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537666|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43537667|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43537668|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537669|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43537670|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43537671|NCT05408910|Rifaximin|rifaximin|mesh-list
43537672|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43537673|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537674|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537675|NCT05406401|Prednisone|prednisone|mesh-list
43537676|NCT05406401|Prednisolone|prednisolone|mesh-list
43537677|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
43537678|NCT05406401|Rituximab|rituximab|mesh-list
43537679|NCT05406401|Doxorubicin|doxorubicin|mesh-list
43537680|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537681|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
43728673|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43537682|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43728674|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43728675|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
43728676|NCT02575924|Imidacloprid|imidacloprid|mesh-list
43728677|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
43728678|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43728679|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537683|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43537684|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537692|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43537693|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537694|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537695|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
43537697|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537698|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537699|NCT05389462|Gemcitabine|gemcitabine|mesh-list
43537700|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43537701|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
43537702|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537703|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43728730|NCT02575729|Hormones|hormones|mesh-ancestor
43537704|NCT05389462|Antiviral Agents|antiviral agents|mesh-ancestor
43537705|NCT05389462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537706|NCT05389462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537707|NCT05389462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537708|NCT05389462|Immunologic Factors|immunologic factors|mesh-ancestor
43728770|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43537709|NCT05389462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537710|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
43537711|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537725|NCT05370235|Afamelanotide|afamelanotide|mesh-list
43537726|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537727|NCT05361395|Carboplatin|carboplatin|mesh-list
43537728|NCT05361395|Etoposide|etoposide|mesh-list
43537729|NCT05361395|Atezolizumab|atezolizumab|mesh-list
43537730|NCT05361395|Durvalumab|durvalumab|mesh-list
43668184|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668185|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668186|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537731|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537732|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537733|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43537734|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43537735|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537736|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537737|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537738|NCT05355701|Cetuximab|cetuximab|mesh-list
43537739|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537740|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537750|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43537751|NCT05351229|Narcotics|narcotics|mesh-ancestor
43537763|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537765|NCT05319587|Cytarabine|cytarabine|mesh-list
43537766|NCT05319587|Annamycin|annamycin|mesh-list
43537767|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43537768|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
43537769|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537770|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537771|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
43537772|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537773|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537774|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
43537775|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537776|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43537777|NCT05317416|Lenalidomide|lenalidomide|mesh-list
43537778|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
43537779|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537780|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537781|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537782|NCT05317416|Growth Substances|growth substances|mesh-ancestor
43537783|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537784|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537785|NCT05315648|Anesthetics|anesthetics|mesh-list
43537786|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537787|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537788|NCT05309694|Copper|copper|mesh-list
43537789|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
43537790|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43537791|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537792|NCT05309694|Trace Elements|trace elements|mesh-ancestor
43537793|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
43537794|NCT05304468|Cisplatin|cisplatin|mesh-list
43537795|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537804|NCT05288166|Prednisone|prednisone|mesh-list
43537805|NCT05288166|Prednisolone|prednisolone|mesh-list
43537806|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537807|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
43537808|NCT05288166|Hormones|hormones|mesh-ancestor
43537809|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537810|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537811|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43728862|NCT02575092|Enalaprilat|enalaprilat|mesh-list
43537812|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537813|NCT05288062|Dexamethasone|dexamethasone|mesh-list
43537814|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
43537815|NCT05288062|Lenalidomide|lenalidomide|mesh-list
43537816|NCT05288062|Pomalidomide|pomalidomide|mesh-list
43537817|NCT05288062|Ichthammol|ichthammol|mesh-list
43537818|NCT05288062|BB 1101|bb 1101|mesh-list
43537819|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537820|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
43537821|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
43537822|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537823|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537824|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537825|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
43537826|NCT05288062|Hormones|hormones|mesh-ancestor
43537827|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537828|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537829|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537830|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
43537831|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537832|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537833|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
43537834|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537835|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537836|NCT05288062|Growth Substances|growth substances|mesh-ancestor
43537837|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537838|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537839|NCT05283109|Vaccines|vaccines|mesh-list
43537840|NCT05283109|Poly ICLC|poly iclc|mesh-list
43537841|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
43537850|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
43537851|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
43537852|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537854|NCT05244460|Promethazine|promethazine|mesh-list
43560433|NCT04596657|Vitamins|vitamins|mesh-ancestor
43560434|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
43560435|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560436|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43729022|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
43729023|NCT02574221|Protective Agents|protective agents|mesh-ancestor
43729024|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537856|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
43537857|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43537858|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43537859|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537860|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
43537861|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
43537862|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
43729061|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43537863|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537864|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
43537865|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
43537866|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537867|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43537868|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
43537869|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
43537870|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537871|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537872|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43537873|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
43537874|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
43537875|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43537876|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43537877|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43537878|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43537879|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43537880|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43537881|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
43537882|NCT05239741|Leucovorin|leucovorin|mesh-list
43537883|NCT05239741|Bevacizumab|bevacizumab|mesh-list
43537884|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
43537885|NCT05239741|Cetuximab|cetuximab|mesh-list
43537886|NCT05239741|Fluorouracil|fluorouracil|mesh-list
43537887|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
43537888|NCT05239741|Irinotecan|irinotecan|mesh-list
43537889|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537890|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537891|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537892|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43537893|NCT05239741|Growth Substances|growth substances|mesh-ancestor
43537894|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729137|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729138|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729139|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
43729140|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729141|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729142|NCT02573597|Narcotics|narcotics|mesh-ancestor
43729143|NCT02573597|Analgesics|analgesics|mesh-ancestor
43729144|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43729145|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43729146|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
43729147|NCT02573519|Acetylcholine|acetylcholine|mesh-list
43729148|NCT02573519|Donepezil|donepezil|mesh-list
43729149|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
43729150|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43729151|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729153|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
43537895|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
43537896|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
43537897|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537898|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43537899|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537900|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
43537901|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43537902|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43537903|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537904|NCT05239741|Antidotes|antidotes|mesh-ancestor
43537905|NCT05239741|Protective Agents|protective agents|mesh-ancestor
43537906|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
43537907|NCT05239741|Vitamins|vitamins|mesh-ancestor
43537908|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
43537915|NCT05200286|Olorofim|olorofim|mesh-list
43537916|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
43537917|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537918|NCT05199818|Palonosetron|palonosetron|mesh-list
43537919|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
43537920|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
43537921|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43537922|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537923|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43537924|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
43537925|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43537926|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
43537927|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43537928|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537929|NCT05198934|Trifluridine|trifluridine|mesh-list
43537930|NCT05198934|Panitumumab|panitumumab|mesh-list
43537931|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537932|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537933|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
43537934|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537935|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
43537936|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43537937|NCT05190770|Triamcinolone|triamcinolone|mesh-list
43537938|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
43537939|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
43537940|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
43537941|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43537942|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
43537944|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43537945|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43537946|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537947|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
43537948|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43537949|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537950|NCT05176483|Nivolumab|nivolumab|mesh-list
43729176|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
43537951|NCT05176483|Ipilimumab|ipilimumab|mesh-list
43537952|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537953|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537954|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43537955|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537956|NCT05173987|Paclitaxel|paclitaxel|mesh-list
43537957|NCT05173987|Docetaxel|docetaxel|mesh-list
43537958|NCT05173987|Cisplatin|cisplatin|mesh-list
43537959|NCT05173987|Carboplatin|carboplatin|mesh-list
43537960|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
43537961|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43537962|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537963|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
43537964|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
43537965|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
43537966|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537967|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43537968|NCT05169567|Fulvestrant|fulvestrant|mesh-list
43537969|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43537970|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43537971|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43537972|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43537973|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
43849785|NCT03891901|Rifabutin|rifabutin|mesh-list
43849786|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
43537980|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43537981|NCT05152628|Tacrolimus|tacrolimus|mesh-list
43537982|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43537996|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43537997|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43729353|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729354|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43537998|NCT05151731|Growth Substances|growth substances|mesh-ancestor
43729355|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
43729356|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43729357|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43729358|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
43729359|NCT02572336|Plasminogen|plasminogen|mesh-list
43729360|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43729361|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43729362|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43729363|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729364|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
43729365|NCT02572375|Codeine|codeine|mesh-list
43729366|NCT02572375|Guaifenesin|guaifenesin|mesh-list
43729367|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
43729368|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43729369|NCT02572375|Narcotics|narcotics|mesh-ancestor
43729370|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43729371|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729372|NCT02572375|Analgesics|analgesics|mesh-ancestor
43537999|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538000|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
43538001|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538008|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
43538009|NCT05108935|Buprenorphine|buprenorphine|mesh-list
43538010|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
43538011|NCT05108935|Naloxone|naloxone|mesh-list
43538012|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43538013|NCT05108935|Narcotics|narcotics|mesh-ancestor
43538014|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538015|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43729394|NCT02571842|Prednisolone|prednisolone|mesh-list
43833827|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43833828|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
43833830|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538016|NCT05108935|Analgesics|analgesics|mesh-ancestor
43538017|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
43538018|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538019|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43538020|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43538021|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43538022|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538023|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538024|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
43538025|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538026|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43538027|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43538028|NCT05104723|Tofacitinib|tofacitinib|mesh-list
43538029|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538030|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538031|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538032|NCT05091567|Carboplatin|carboplatin|mesh-list
43538033|NCT05091567|Etoposide|etoposide|mesh-list
43538034|NCT05091567|Atezolizumab|atezolizumab|mesh-list
43538035|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43729464|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
43729465|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43729466|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43729467|NCT02571517|Prednisolone|prednisolone|mesh-list
43729468|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
43729469|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43538036|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538037|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538038|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538039|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538040|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538041|NCT05077904|Alprazolam|alprazolam|mesh-list
43538042|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43538052|NCT05076617|Alprazolam|alprazolam|mesh-list
43538053|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43729515|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538054|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538055|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538056|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43538057|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43538058|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43538059|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
43538060|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
43538061|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538062|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538063|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
43729593|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
43729595|NCT02570971|Mannitol|mannitol|mesh-list
43538064|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538065|NCT05065411|Everolimus|everolimus|mesh-list
43538066|NCT05065411|Fulvestrant|fulvestrant|mesh-list
43538067|NCT05065411|Exemestane|exemestane|mesh-list
43538068|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538069|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538070|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
43538071|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538072|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538073|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43538074|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43538075|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
43538076|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538077|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43538078|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43538079|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538080|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538081|NCT05058924|Aspirin|aspirin|mesh-list
43538082|NCT05058924|Heparin|heparin|mesh-list
43538083|NCT05058924|Calcium heparin|calcium heparin|mesh-list
43538084|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43538085|NCT05058924|Tinzaparin|tinzaparin|mesh-list
43538086|NCT05058924|Dalteparin|dalteparin|mesh-list
43538087|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43538088|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43538089|NCT05058924|Analgesics|analgesics|mesh-ancestor
43538090|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
43538091|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538092|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538093|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538094|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43560501|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43560502|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
43560503|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
43560504|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43560505|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560506|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43560507|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
43560508|NCT04484623|Hormones|hormones|mesh-ancestor
43560509|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43833883|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
43833884|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
43729695|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43729696|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729697|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729698|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43729699|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43729700|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43729701|NCT02569866|Cephalexin|cephalexin|mesh-list
43729702|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43729703|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43729704|NCT02570035|Mirabegron|mirabegron|mesh-list
43729705|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
43729707|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43538095|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43538096|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43538097|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538098|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43538099|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43538100|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538101|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
43538102|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
43538104|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538105|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538106|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538107|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538120|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43538129|NCT05024773|Paclitaxel|paclitaxel|mesh-list
43538130|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
43538131|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538132|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538133|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538134|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538135|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538136|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538137|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43538138|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
43538139|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538140|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
43538141|NCT05024773|Protective Agents|protective agents|mesh-ancestor
43538142|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
43729785|NCT02569346|Lamivudine|lamivudine|mesh-list
43729786|NCT02569346|Abacavir|abacavir|mesh-list
43668187|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43668188|NCT03798405|Analgesics|analgesics|mesh-list
43538143|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
43538144|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43538145|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538146|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
43538147|NCT05020860|Paclitaxel|paclitaxel|mesh-list
43538148|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
43538149|NCT05020860|Carboplatin|carboplatin|mesh-list
43538150|NCT05020860|Doxorubicin|doxorubicin|mesh-list
43538151|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
43538152|NCT05020860|Trastuzumab|trastuzumab|mesh-list
43538153|NCT05020860|Pertuzumab|pertuzumab|mesh-list
43538154|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538155|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538156|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538157|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538158|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538159|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538160|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538161|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
43538162|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538163|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538164|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43538165|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
43538166|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43538167|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538168|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538169|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538185|NCT04995029|Analgesics|analgesics|mesh-ancestor
43538186|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
43729843|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538187|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43729846|NCT02568995|Ketorolac|ketorolac|mesh-list
43538188|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
43538189|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
43538190|NCT04977791|Antibodies|antibodies|mesh-list
43538191|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43538192|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
43538193|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538194|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538195|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538196|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
43538197|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43560653|NCT03859687|Vitamins|vitamins|mesh-list
43560654|NCT03859687|Vitamin A|vitamin a|mesh-list
43729988|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43538198|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538199|NCT04953962|Cisplatin|cisplatin|mesh-list
43538200|NCT04953962|Nivolumab|nivolumab|mesh-list
43538201|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538202|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538203|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538204|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538211|NCT04948814|Vancomycin|vancomycin|mesh-list
43538212|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43538213|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538214|NCT04933617|Prednisone|prednisone|mesh-list
43538215|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
43538216|NCT04933617|Rituximab|rituximab|mesh-list
43538217|NCT04933617|Doxorubicin|doxorubicin|mesh-list
43538218|NCT04933617|Etoposide|etoposide|mesh-list
43538219|NCT04933617|Vincristine|vincristine|mesh-list
43538220|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538221|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
43668189|NCT03798405|Narcotics|narcotics|mesh-list
43668190|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
43668191|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668192|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560778|NCT03321513|Bevacizumab|bevacizumab|mesh-list
43538222|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538223|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538224|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43538225|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
43538226|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538227|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538228|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43538229|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538230|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538239|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538240|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538241|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538242|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538244|NCT04924101|Carboplatin|carboplatin|mesh-list
43538245|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
43538246|NCT04924101|Etoposide|etoposide|mesh-list
43538247|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
43538251|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538252|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538253|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538254|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538255|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730073|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43730074|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
43538256|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538259|NCT04895358|Paclitaxel|paclitaxel|mesh-list
43538260|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43538261|NCT04895358|Doxorubicin|doxorubicin|mesh-list
43538262|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43538263|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
43538264|NCT04895358|Capecitabine|capecitabine|mesh-list
43538265|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538266|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538267|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538268|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538269|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560828|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43560829|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43560830|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
43560831|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
43560832|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
43560833|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43560834|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43560835|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
43560836|NCT03184870|Antiviral Agents|antiviral agents|mesh-ancestor
43560837|NCT03184870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538270|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538271|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538272|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538273|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538274|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43831446|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
43849787|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538275|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43730165|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730166|NCT02567175|Domperidone|domperidone|mesh-list
43730167|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
43730168|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
43730169|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43730170|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730171|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730172|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43730173|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
43730174|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43560860|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43560862|NCT03117751|Dexamethasone|dexamethasone|mesh-list
43560863|NCT03117751|Prednisone|prednisone|mesh-list
43560864|NCT03117751|Prednisolone|prednisolone|mesh-list
43560865|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
43560878|NCT03117751|Clofarabine|clofarabine|mesh-list
43560879|NCT03117751|Pegaspargase|pegaspargase|mesh-list
43560880|NCT03117751|Thioguanine|thioguanine|mesh-list
43538276|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538277|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
43538278|NCT04887298|Annamycin|annamycin|mesh-list
43538279|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538280|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538281|NCT04883346|Liraglutide|liraglutide|mesh-list
43538282|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43538283|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538284|NCT04883346|Incretins|incretins|mesh-ancestor
43560881|NCT03117751|Blinatumomab|blinatumomab|mesh-list
43560882|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
43560884|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
43538285|NCT04883346|Hormones|hormones|mesh-ancestor
43538286|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668193|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43826693|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43826694|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43826695|NCT05495100|Azacitidine|azacitidine|mesh-list
43826696|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
43538301|NCT04862975|Dolutegravir|dolutegravir|mesh-list
43538302|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
43538303|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538304|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43538305|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43538306|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538307|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538308|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43730209|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43730210|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730211|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
43730212|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730213|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
43730214|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
43730215|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538309|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43538310|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43538311|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43538312|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43538313|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43538314|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43538315|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43538316|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43538317|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43538318|NCT04847453|Dexamethasone|dexamethasone|mesh-list
43538319|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
43538320|NCT04847453|Venetoclax|venetoclax|mesh-list
43538328|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538329|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538330|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43538332|NCT04847453|Hormones|hormones|mesh-ancestor
43538333|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538334|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538335|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538336|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
43538337|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538338|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538339|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
43538340|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
43538342|NCT04829383|Bevacizumab|bevacizumab|mesh-list
43538343|NCT04829383|Atezolizumab|atezolizumab|mesh-list
43538344|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538345|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538346|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43538347|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43538348|NCT04829383|Growth Substances|growth substances|mesh-ancestor
43730443|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730444|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43730445|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43730446|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730447|NCT02565303|Ropivacaine|ropivacaine|mesh-list
43730448|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
43730449|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
43730450|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538349|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538350|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
43538351|NCT04827147|Methamphetamine|methamphetamine|mesh-list
43538352|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43538353|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538354|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
43538355|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
43538356|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538357|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
43538358|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538359|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730488|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
43730489|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730490|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730502|NCT02564237|Vaccines|vaccines|mesh-list
43730523|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43730524|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43730525|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
43730526|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43730527|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730528|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
43730530|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43730531|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
43730532|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730533|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43730534|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43730535|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730536|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43730537|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730538|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43730539|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
43730540|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43538361|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43538362|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43538363|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43538364|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43826697|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43826699|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538365|NCT04826237|Dexamethasone|dexamethasone|mesh-list
43538366|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
43538367|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43730541|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730542|NCT02563795|Fentanyl|fentanyl|mesh-list
43730543|NCT02563795|Bupivacaine|bupivacaine|mesh-list
43730609|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538368|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43538369|NCT04826237|Prednisolone|prednisolone|mesh-list
43538370|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
43538371|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
43538372|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43538373|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
43538374|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538375|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
43538376|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
43730649|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730650|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43730651|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
43730652|NCT02563288|Esmolol|esmolol|mesh-list
43730653|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
43561049|NCT02358031|Carboplatin|carboplatin|mesh-list
43561050|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
43561051|NCT02358031|Cetuximab|cetuximab|mesh-list
43561052|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561053|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561054|NCT02250664|Nicotine|nicotine|mesh-list
43561055|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
43561056|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
43561057|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561059|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
43538377|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538378|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538379|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43538380|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
43538382|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538383|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538384|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538385|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43538386|NCT04826237|Protective Agents|protective agents|mesh-ancestor
43538387|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43538392|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43538393|NCT04812548|Azacitidine|azacitidine|mesh-list
43538395|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538396|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
43538397|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538398|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730695|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
43730696|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
43730697|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43730698|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43730699|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43730700|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
43730701|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43730702|NCT02563054|Cisplatin|cisplatin|mesh-list
43730703|NCT02563054|Fluorouracil|fluorouracil|mesh-list
43730704|NCT02563054|Capecitabine|capecitabine|mesh-list
43730705|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43730706|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
43730707|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730708|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43730709|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43730710|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
43730711|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43730712|NCT02563041|Heparin|heparin|mesh-list
43730713|NCT02563041|Calcium heparin|calcium heparin|mesh-list
43730714|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
43730715|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43730716|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43730717|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43730718|NCT02562950|Midazolam|midazolam|mesh-list
43730719|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43730720|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43730721|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43730722|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538399|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538400|NCT04808245|Atezolizumab|atezolizumab|mesh-list
43538401|NCT04808245|Imiquimod|imiquimod|mesh-list
43538402|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538403|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43538404|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
43538405|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538406|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
43538407|NCT04804553|Apremilast|apremilast|mesh-list
43538408|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43538412|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538413|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538414|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538415|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538416|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
43538417|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43538418|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538419|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538422|NCT04803877|Nivolumab|nivolumab|mesh-list
43538423|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538424|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538425|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538426|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538427|NCT04802161|Cytarabine|cytarabine|mesh-list
43538428|NCT04802161|Daunorubicin|daunorubicin|mesh-list
43538429|NCT04802161|Pomalidomide|pomalidomide|mesh-list
43538430|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538431|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
43538432|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538433|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538434|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
43538435|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43730724|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43730725|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43730726|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43538436|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538437|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
43826700|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826701|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538438|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538439|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538440|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538441|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538442|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538443|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43538444|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43538445|NCT04802161|Growth Substances|growth substances|mesh-ancestor
43538446|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
43538448|NCT04786873|Analgesics|analgesics|mesh-ancestor
43538449|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
43538450|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538451|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538452|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43538453|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
43561147|NCT01165645|Lopinavir|lopinavir|mesh-list
43561153|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43538454|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
43538455|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43538456|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43538457|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43538458|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
43538459|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538468|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538469|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538470|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43538471|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538472|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538473|NCT04761393|Xenon|xenon|mesh-list
43538477|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538478|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538480|NCT04751383|Magrolimab|magrolimab|mesh-list
43538481|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538482|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538483|NCT04738097|Clopidogrel|clopidogrel|mesh-list
43538484|NCT04738097|Ticagrelor|ticagrelor|mesh-list
43538485|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43730856|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538486|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43538487|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43730857|NCT02561936|Rilpivirine|rilpivirine|mesh-list
43730858|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43730859|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43538488|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43538489|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
43538490|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538491|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538492|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538493|NCT04737109|Androgens|androgens|mesh-list
43538494|NCT04737109|Hormones|hormones|mesh-ancestor
43538495|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538496|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538504|NCT04731480|Propofol|propofol|mesh-list
43538505|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43730941|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
43730942|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43538506|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538507|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538509|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
43538510|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
43538511|NCT04722523|Cisplatin|cisplatin|mesh-list
43538512|NCT04722523|Carboplatin|carboplatin|mesh-list
43538513|NCT04722523|Docetaxel|docetaxel|mesh-list
43538514|NCT04722523|Cetuximab|cetuximab|mesh-list
43538515|NCT04722523|Cemiplimab|cemiplimab|mesh-list
43538516|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43826702|NCT05495100|Analgesics|analgesics|mesh-ancestor
43826703|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
43668195|NCT03789916|Ticagrelor|ticagrelor|mesh-list
43538517|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538518|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538519|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538520|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538521|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538522|NCT04718389|Benralizumab|benralizumab|mesh-list
43538523|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43538524|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
43538532|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538533|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538534|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538535|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538536|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538537|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538538|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538539|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43538540|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43538541|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43731011|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43731012|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43731013|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731014|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731015|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43731016|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43731017|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
43731018|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731019|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
43731020|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43731021|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731022|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43731023|NCT02560376|Exenatide|exenatide|mesh-list
43731031|NCT02560220|Mitomycin|mitomycin|mesh-list
43538542|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
43538543|NCT04710134|Reslizumab|reslizumab|mesh-list
43538545|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
43538546|NCT04704154|Nivolumab|nivolumab|mesh-list
43538547|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538548|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538549|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538550|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538551|NCT04700124|Gemcitabine|gemcitabine|mesh-list
43538552|NCT04700124|Cisplatin|cisplatin|mesh-list
43538553|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
43538554|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538555|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538556|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
43538557|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538558|NCT04700124|Antiviral Agents|antiviral agents|mesh-ancestor
43538559|NCT04700124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538560|NCT04700124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538561|NCT04700124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538562|NCT04700124|Immunologic Factors|immunologic factors|mesh-ancestor
43538563|NCT04700124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538564|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538565|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43538566|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43538567|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43538568|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538569|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43538570|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538571|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
43538572|NCT04678401|Thiotepa|thiotepa|mesh-list
43538573|NCT04678401|Fludarabine|fludarabine|mesh-list
43538574|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538575|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
43538576|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538577|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538578|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43538579|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
43538580|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538581|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538582|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43538583|NCT04633239|Olaparib|olaparib|mesh-list
43538584|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
43538586|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538587|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538588|NCT04626596|Etonogestrel|etonogestrel|mesh-list
43538589|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43668196|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43538590|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
43538605|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43849788|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538608|NCT04584112|Doxorubicin|doxorubicin|mesh-list
43538609|NCT04584112|Atezolizumab|atezolizumab|mesh-list
43538610|NCT04584112|Molgramostim|molgramostim|mesh-list
43538611|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43833978|NCT05171335|Lenvatinib|lenvatinib|mesh-list
43561360|NCT02811939|Dronabinol|dronabinol|mesh-list
43538612|NCT04584112|Lenograstim|lenograstim|mesh-list
43538613|NCT04584112|Sargramostim|sargramostim|mesh-list
43538614|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538615|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538616|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538617|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538618|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538619|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538620|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538621|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
43538622|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538623|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43538624|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43538625|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
43538626|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43538627|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538628|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43538629|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43538630|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538631|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43538632|NCT04564755|Abrocitinib|abrocitinib|mesh-list
43538633|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538634|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561437|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43561438|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43561439|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43561440|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561441|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
43538635|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538636|NCT04544111|Trametinib|trametinib|mesh-list
43538637|NCT04544111|Dabrafenib|dabrafenib|mesh-list
43538638|NCT04544111|Spartalizumab|spartalizumab|mesh-list
43538639|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538640|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43538641|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538642|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538643|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538644|NCT04542135|Sulindac|sulindac|mesh-list
43538645|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43538646|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43538647|NCT04542135|Analgesics|analgesics|mesh-ancestor
43538648|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
43538649|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538650|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538655|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538656|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538657|NCT04531059|Metronidazole|metronidazole|mesh-list
43538658|NCT04531059|Minocycline|minocycline|mesh-list
43538659|NCT04531059|Tetracycline|tetracycline|mesh-list
43538662|NCT04531059|Bismuth|bismuth|mesh-list
43538663|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538664|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538665|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43538666|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43538667|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43538668|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43538669|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43538670|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
43538671|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561461|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43561462|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43538672|NCT04531059|Antacids|antacids|mesh-ancestor
43561463|NCT02689258|Bupivacaine|bupivacaine|mesh-list
43561464|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
43561465|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
43561466|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561467|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561468|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
43561469|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561470|NCT02683239|Fasinumab|fasinumab|mesh-list
43561471|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43561472|NCT02683239|Analgesics|analgesics|mesh-ancestor
43561473|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
43561474|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561475|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561476|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
43561477|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43561478|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43538673|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43538674|NCT04531059|Diuretics|diuretics|mesh-ancestor
43538675|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
43538676|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538677|NCT04531059|Expectorants|expectorants|mesh-ancestor
43538678|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
43538679|NCT04530981|Repaglinide|repaglinide|mesh-list
43538680|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43668197|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43731270|NCT02558517|Hormones|hormones|mesh-ancestor
43668198|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43668199|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43668200|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
43538681|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538682|NCT04514497|Irinotecan|irinotecan|mesh-list
43538683|NCT04514497|Topotecan|topotecan|mesh-list
43538684|NCT04514497|Camptothecin|camptothecin|mesh-list
43538685|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43538686|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43834031|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731272|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538687|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538688|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538689|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538690|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538691|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
43538692|NCT04475939|Niraparib|niraparib|mesh-list
43538693|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538694|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538695|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43538696|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538697|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538698|NCT04449549|Paclitaxel|paclitaxel|mesh-list
43538699|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538700|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538701|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538702|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538703|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538704|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538705|NCT04429334|Nangibotide|nangibotide|mesh-list
43538706|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538707|NCT04396821|Gemcitabine|gemcitabine|mesh-list
43849789|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538741|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538742|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43538743|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
43538744|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538747|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43731348|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538748|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538749|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538750|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538751|NCT04323436|Spartalizumab|spartalizumab|mesh-list
43538752|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538753|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538754|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538755|NCT04313244|Vaccines|vaccines|mesh-list
43538756|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
43538757|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538785|NCT04303169|Tretinoin|tretinoin|mesh-list
43538786|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538787|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538788|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
43538789|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
43538808|NCT04266301|Azacitidine|azacitidine|mesh-list
43538809|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538810|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
43538811|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538812|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538813|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538814|NCT04261439|Spartalizumab|spartalizumab|mesh-list
43538815|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538816|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538817|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538818|NCT04241185|Gemcitabine|gemcitabine|mesh-list
43538820|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
43538821|NCT04241185|Fluorouracil|fluorouracil|mesh-list
43538822|NCT04241185|Mitomycins|mitomycins|mesh-list
43538823|NCT04241185|Mitomycin|mitomycin|mesh-list
43731421|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43731422|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43731423|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43731424|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731425|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
43538824|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538825|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538826|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
43538827|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538828|NCT04241185|Antiviral Agents|antiviral agents|mesh-ancestor
43538829|NCT04241185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43538830|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538831|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538832|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
43538833|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538834|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538835|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43668202|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561692|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668203|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538837|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43538838|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
43538839|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538840|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43538841|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
43538842|NCT04210115|Leucovorin|leucovorin|mesh-list
43538843|NCT04210115|Cisplatin|cisplatin|mesh-list
43538844|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
43538845|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
43538846|NCT04210115|Calcium|calcium|mesh-list
43538847|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
43538848|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538849|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43538850|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538851|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43538852|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538853|NCT04210115|Antidotes|antidotes|mesh-ancestor
43538854|NCT04210115|Protective Agents|protective agents|mesh-ancestor
43538855|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
43538856|NCT04210115|Vitamins|vitamins|mesh-ancestor
43538857|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
43538858|NCT04196257|Paclitaxel|paclitaxel|mesh-list
43538859|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538860|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538861|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538862|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538869|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
43538870|NCT04195256|Ketamine|ketamine|mesh-list
43538871|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43538872|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43538874|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43538875|NCT04195256|Analgesics|analgesics|mesh-ancestor
43538876|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
43538877|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43538878|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43538879|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43538880|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43538881|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
43538882|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538883|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538884|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43538885|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43538886|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
43538888|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43538889|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43538890|NCT04176016|Edetic Acid|edetic acid|mesh-list
43538891|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
43538892|NCT04176016|Antidotes|antidotes|mesh-ancestor
43538893|NCT04176016|Protective Agents|protective agents|mesh-ancestor
43538894|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538895|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
43538896|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
43538897|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538898|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
43538899|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
43538900|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
43538901|NCT04158258|Bevacizumab|bevacizumab|mesh-list
43538902|NCT04158258|Trastuzumab|trastuzumab|mesh-list
43538903|NCT04158258|Pertuzumab|pertuzumab|mesh-list
43538904|NCT04158258|Capecitabine|capecitabine|mesh-list
43538905|NCT04158258|Atezolizumab|atezolizumab|mesh-list
43538906|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538907|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538908|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43538909|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43538910|NCT04158258|Growth Substances|growth substances|mesh-ancestor
43538911|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538912|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
43538913|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43538914|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
43538915|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538916|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
43538917|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538918|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538919|NCT04125836|Octreotide|octreotide|mesh-list
43538920|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43538921|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43734429|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
43538922|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538924|NCT04108104|Prazosin|prazosin|mesh-list
43538925|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43538926|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43538927|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43538928|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43538929|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
43538930|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43538931|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538932|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538933|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
43538938|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
43538939|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43538940|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
43538941|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43538942|NCT04091750|Nivolumab|nivolumab|mesh-list
43538943|NCT04091750|Ipilimumab|ipilimumab|mesh-list
43538944|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538945|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538946|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43538947|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538948|NCT04090398|Paclitaxel|paclitaxel|mesh-list
43538949|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43538950|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
43538951|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43538952|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538953|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538954|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538955|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538956|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538957|NCT04045028|Rituximab|rituximab|mesh-list
43538958|NCT04045028|Atezolizumab|atezolizumab|mesh-list
43538959|NCT04045028|Daratumumab|daratumumab|mesh-list
43538960|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43538961|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538962|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
43538963|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538964|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43731499|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
43731500|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731501|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538965|NCT04034095|Prednisolone|prednisolone|mesh-list
43538966|NCT04034095|Docetaxel|docetaxel|mesh-list
43538967|NCT04034095|Bicalutamide|bicalutamide|mesh-list
43538968|NCT04034095|Androgens|androgens|mesh-list
43538969|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538970|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
43538971|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
43538972|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
43538973|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538974|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43538975|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
43538976|NCT04034095|Hormones|hormones|mesh-ancestor
43538977|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43538978|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538979|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43538980|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
43538981|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
43538983|NCT04019327|Talazoparib|talazoparib|mesh-list
43538984|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43538985|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
43538986|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538987|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668204|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43668205|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43668207|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
43668208|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668209|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43668210|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668211|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43668212|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43668213|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43668214|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668215|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
43668216|NCT03782103|Ethanol|ethanol|mesh-list
43538988|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43538989|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538990|NCT03986034|Venetoclax|venetoclax|mesh-list
43538991|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43538992|NCT03971253|Peficitinib|peficitinib|mesh-list
43538993|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43538994|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43538995|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43538996|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
43538997|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43538998|NCT03952637|Sirolimus|sirolimus|mesh-list
43538999|NCT03952637|Prednisone|prednisone|mesh-list
43539000|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
43539001|NCT03952637|Rituximab|rituximab|mesh-list
43539002|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539003|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539004|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
43539005|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539006|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539008|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
43539009|NCT03952637|Hormones|hormones|mesh-ancestor
43539010|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539026|NCT03944772|Pemetrexed|pemetrexed|mesh-list
43539027|NCT03944772|Durvalumab|durvalumab|mesh-list
43539028|NCT03944772|Gefitinib|gefitinib|mesh-list
43539029|NCT03944772|Osimertinib|osimertinib|mesh-list
43539030|NCT03944772|Necitumumab|necitumumab|mesh-list
43539031|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731518|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539032|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539033|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539034|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43539035|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539036|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539037|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43539038|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43539039|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539040|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539056|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
43539057|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539058|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539060|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539061|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539062|NCT03904199|Insulin|insulin|mesh-list
43539063|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43539064|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43539065|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539066|NCT03902951|Leuprolide|leuprolide|mesh-list
43539067|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
43539068|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43539069|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
43539070|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43668217|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
43668218|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43539071|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539072|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43708720|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539074|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43539075|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539076|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539077|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539078|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539079|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43539081|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43539082|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539083|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539099|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539100|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539101|NCT03845517|PF-06700841|pf-06700841|mesh-list
43539102|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539103|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539104|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539105|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
43539106|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539107|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539108|NCT03831932|Osimertinib|osimertinib|mesh-list
43539109|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539110|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539111|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539112|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539115|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539116|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539117|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
43539118|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539119|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539120|NCT03767933|Acetaminophen|acetaminophen|mesh-list
43539121|NCT03767933|Ibuprofen|ibuprofen|mesh-list
43539122|NCT03767933|Hydromorphone|hydromorphone|mesh-list
43539123|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43539132|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43731538|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
43539133|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539134|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539135|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43539136|NCT03767933|Narcotics|narcotics|mesh-ancestor
43539137|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539138|NCT03765918|Cisplatin|cisplatin|mesh-list
43539139|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
43539140|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539141|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539142|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
43539143|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539144|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539145|NCT03687957|Temozolomide|temozolomide|mesh-list
43539147|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
43539148|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539149|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539150|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
43539151|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539152|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539153|NCT03659539|Propofol|propofol|mesh-list
43539154|NCT03659539|Desflurane|desflurane|mesh-list
43539155|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43539156|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539157|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539158|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43539159|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
43539160|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
43539161|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43668219|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43668220|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668221|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539162|NCT03653832|Clonidine|clonidine|mesh-list
43539168|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43539169|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
43539170|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
43539171|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43539172|NCT03653832|Analgesics|analgesics|mesh-ancestor
43539175|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43539176|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43539178|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
43539179|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539180|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539181|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43539182|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
43539191|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539192|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
43539193|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43539195|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43539196|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731546|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539197|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
43539198|NCT03604315|Protective Agents|protective agents|mesh-ancestor
43539199|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539200|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
43539201|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
43539202|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539203|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
43539204|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43539211|NCT03565991|Talazoparib|talazoparib|mesh-list
43539212|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539213|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539214|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43539215|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539216|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539220|NCT03501368|Trametinib|trametinib|mesh-list
43539221|NCT03501368|Ceritinib|ceritinib|mesh-list
43539222|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539223|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539224|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539225|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539226|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
43539227|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539228|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539229|NCT03470311|Benralizumab|benralizumab|mesh-list
43539230|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539231|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539232|NCT03442088|Apremilast|apremilast|mesh-list
43539233|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43539234|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43539235|NCT03442088|Analgesics|analgesics|mesh-ancestor
43539236|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
43539237|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539238|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539239|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539240|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539242|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43539243|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539244|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668222|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668223|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
43539246|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539247|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539248|NCT03408340|Fentanyl|fentanyl|mesh-list
43731586|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731587|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
43731588|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43731589|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43731590|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43539249|NCT03408340|Ketamine|ketamine|mesh-list
43539250|NCT03408340|Propofol|propofol|mesh-list
43539251|NCT03408340|Sevoflurane|sevoflurane|mesh-list
43539252|NCT03408340|Rocuronium|rocuronium|mesh-list
43539253|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
43539254|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539255|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539256|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
43539257|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539258|NCT03408340|Analgesics|analgesics|mesh-ancestor
43539259|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43539260|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43539261|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
43539262|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43539263|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43539264|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539265|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539266|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43539267|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43539268|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43539269|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43539270|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43539272|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43539273|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43539274|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43539275|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
43539280|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539281|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539282|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539283|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43539284|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43539285|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539286|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539287|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539288|NCT03388749|Annamycin|annamycin|mesh-list
43539289|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43539290|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539291|NCT03377699|Insulin|insulin|mesh-list
43539292|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43539293|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
43539294|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
43539295|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43539296|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539297|NCT03358030|Riboflavin|riboflavin|mesh-list
43539298|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
43561709|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
43561710|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561711|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561712|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43561713|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561714|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539299|NCT03358030|Vitamins|vitamins|mesh-ancestor
43539300|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
43539301|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539302|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43539303|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
43539304|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
43539305|NCT03342937|Capecitabine|capecitabine|mesh-list
43539306|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
43539307|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539308|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539309|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539311|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539312|NCT03330405|Avelumab|avelumab|mesh-list
43539313|NCT03330405|Talazoparib|talazoparib|mesh-list
43539314|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43539315|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539316|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539317|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
43539318|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539319|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43668224|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
43668225|NCT03778931|Fulvestrant|fulvestrant|mesh-list
43668226|NCT03778931|Anastrozole|anastrozole|mesh-list
43539320|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539321|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539323|NCT03283761|Paclitaxel|paclitaxel|mesh-list
43539324|NCT03283761|Fluorouracil|fluorouracil|mesh-list
43539325|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
43539326|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539327|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539328|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
43539329|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539330|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
43539331|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539332|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
43539333|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539334|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43539335|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
43539336|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539337|NCT03283761|Antidotes|antidotes|mesh-ancestor
43539338|NCT03283761|Protective Agents|protective agents|mesh-ancestor
43539339|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
43539340|NCT03283761|Vitamins|vitamins|mesh-ancestor
43539341|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
43539342|NCT03281369|Leucovorin|leucovorin|mesh-list
43539343|NCT03281369|Linagliptin|linagliptin|mesh-list
43539344|NCT03281369|Fluorouracil|fluorouracil|mesh-list
43539345|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
43539346|NCT03281369|Atezolizumab|atezolizumab|mesh-list
43539347|NCT03281369|Ramucirumab|ramucirumab|mesh-list
43539348|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43539349|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539350|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539367|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539368|NCT03237780|Atezolizumab|atezolizumab|mesh-list
43539369|NCT03237780|Halichondrin B|halichondrin b|mesh-list
43539370|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43539371|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539372|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
43539373|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539374|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
43539375|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539377|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539378|NCT03223610|Prednisone|prednisone|mesh-list
43539379|NCT03223610|Lenalidomide|lenalidomide|mesh-list
43539380|NCT03223610|Venetoclax|venetoclax|mesh-list
43539381|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
43539382|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539383|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
43539384|NCT03223610|Hormones|hormones|mesh-ancestor
43539385|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539386|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539387|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539388|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539389|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
43539390|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43539391|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43539392|NCT03223610|Growth Substances|growth substances|mesh-ancestor
43539393|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
43539394|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539395|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
43539396|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539397|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539398|NCT03209401|Carboplatin|carboplatin|mesh-list
43539399|NCT03209401|Niraparib|niraparib|mesh-list
43539400|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539401|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43539402|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539403|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539404|NCT03207867|Spartalizumab|spartalizumab|mesh-list
43539405|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43539406|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539407|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539408|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43668227|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43668228|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668229|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43539409|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43539410|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539420|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43539421|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
43539422|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539423|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539424|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539425|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43539426|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539427|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
43539428|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539429|NCT03182244|Analgesics|analgesics|mesh-ancestor
43539430|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
43539431|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539432|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43539433|NCT03066648|Azacitidine|azacitidine|mesh-list
43539434|NCT03066648|Decitabine|decitabine|mesh-list
43539435|NCT03066648|Spartalizumab|spartalizumab|mesh-list
43539436|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43539437|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
43539438|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539439|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539440|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539441|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43539442|NCT02975934|Docetaxel|docetaxel|mesh-list
43539443|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
43539444|NCT02975934|Rucaparib|rucaparib|mesh-list
43539445|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539446|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
43539447|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539448|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
43539449|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539450|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43539451|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539452|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539453|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43561724|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43561725|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561727|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43561728|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43831491|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
43539455|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43539456|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43539458|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43539459|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539460|NCT02967757|Incretins|incretins|mesh-ancestor
43539461|NCT02967757|Hormones|hormones|mesh-ancestor
43539462|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539463|NCT02962050|Capsaicin|capsaicin|mesh-list
43539464|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
43539466|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
43539467|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539468|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539469|NCT02960659|Metformin|metformin|mesh-list
43539470|NCT02960659|Liraglutide|liraglutide|mesh-list
43539471|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43539472|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539473|NCT02960659|Incretins|incretins|mesh-ancestor
43539474|NCT02960659|Hormones|hormones|mesh-ancestor
43539475|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539477|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539478|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539481|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
43539482|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43539483|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539484|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43539485|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43539486|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668230|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43731592|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731593|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731594|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
43731596|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43731597|NCT02556879|Liver Extracts|liver extracts|mesh-list
43731598|NCT02556879|Antibodies|antibodies|mesh-list
43731614|NCT02556723|Aflibercept|aflibercept|mesh-list
43731615|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43731616|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43731617|NCT02556723|Growth Substances|growth substances|mesh-ancestor
43731618|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731619|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731620|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43731621|NCT02556658|Anesthetics|anesthetics|mesh-list
43731622|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43561729|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
43561730|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561731|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43561732|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
43561733|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43539487|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539488|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
43539489|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539490|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43539491|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
43539492|NCT02861573|Dexamethasone|dexamethasone|mesh-list
43539493|NCT02861573|Prednisone|prednisone|mesh-list
43539494|NCT02861573|Carboplatin|carboplatin|mesh-list
43539495|NCT02861573|Docetaxel|docetaxel|mesh-list
43539496|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
43539497|NCT02861573|Etoposide|etoposide|mesh-list
43539498|NCT02861573|Olaparib|olaparib|mesh-list
43539499|NCT02861573|Lenvatinib|lenvatinib|mesh-list
43539500|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
43539501|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539502|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
43539503|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
43539504|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539505|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539506|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43539507|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
43539508|NCT02861573|Hormones|hormones|mesh-ancestor
43539509|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539510|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539517|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539518|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539519|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43539520|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539521|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43539522|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539523|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43539524|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539525|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43539526|NCT02807883|Blinatumomab|blinatumomab|mesh-list
43539527|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539528|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
43539529|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
43539530|NCT02759380|Estrogens|estrogens|mesh-ancestor
43539531|NCT02759380|Hormones|hormones|mesh-ancestor
43539532|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539533|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539534|NCT02743494|Nivolumab|nivolumab|mesh-list
43539535|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539536|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539537|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43731623|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731624|NCT02556814|Dexamethasone|dexamethasone|mesh-list
43539538|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539539|NCT02707042|Amoxicillin|amoxicillin|mesh-list
43539540|NCT02707042|Azithromycin|azithromycin|mesh-list
43539541|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43539542|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539543|NCT02609828|Tanezumab|tanezumab|mesh-list
43539544|NCT02609828|Analgesics|analgesics|mesh-ancestor
43539545|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
43539546|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43539547|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539548|NCT02599714|Fulvestrant|fulvestrant|mesh-list
43539549|NCT02599714|Palbociclib|palbociclib|mesh-list
43539550|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539551|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539564|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
43539565|NCT02584478|Topotecan|topotecan|mesh-list
43539566|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539567|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539568|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
43539569|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539570|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
43539571|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668231|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539572|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43539573|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539574|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43539575|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539576|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43539577|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
43539578|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539579|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539580|NCT02319837|Leuprolide|leuprolide|mesh-list
43539581|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43539582|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
43539595|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43539596|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43539597|NCT02282059|Growth Substances|growth substances|mesh-ancestor
43539598|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539599|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
43539600|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539601|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539602|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539603|NCT02185560|Sorafenib|sorafenib|mesh-list
43539604|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539605|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539606|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539607|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539608|NCT02169310|Raclopride|raclopride|mesh-list
43539609|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43539610|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43539611|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43539612|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539620|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539621|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539623|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539624|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43539625|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539626|NCT01995513|Prednisone|prednisone|mesh-list
43539627|NCT01995513|Prednisolone|prednisolone|mesh-list
43539628|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
43539629|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539630|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
43539631|NCT01995513|Hormones|hormones|mesh-ancestor
43539632|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539633|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539634|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539635|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539636|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43539637|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539638|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539639|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539640|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43539641|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
43539642|NCT01896999|Nivolumab|nivolumab|mesh-list
43539643|NCT01896999|Ipilimumab|ipilimumab|mesh-list
43539644|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43539645|NCT01896999|Antibodies|antibodies|mesh-list
43539646|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
43539647|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43539648|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
43539649|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
43668232|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668233|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539650|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539651|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539652|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43539653|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539654|NCT01445509|Bevacizumab|bevacizumab|mesh-list
43539656|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539657|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539658|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43539659|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43539660|NCT01445509|Growth Substances|growth substances|mesh-ancestor
43539661|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539662|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
43731648|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
43539663|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539664|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539665|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539666|NCT01436968|Valacyclovir|valacyclovir|mesh-list
43539667|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
43539668|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539669|NCT01294020|Tacrolimus|tacrolimus|mesh-list
43539670|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43539671|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
43539672|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539673|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43539674|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539675|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539676|NCT00092222|Interferons|interferons|mesh-list
43539677|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
43539679|NCT00092222|Valganciclovir|valganciclovir|mesh-list
43539680|NCT00092222|Sirolimus|sirolimus|mesh-list
43539681|NCT00092222|Prednisone|prednisone|mesh-list
43539682|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
43539695|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539696|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539697|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43539698|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539699|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43539700|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43539701|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43539702|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539703|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539704|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
43539706|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539707|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539708|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43539709|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
43539710|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539711|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
43731659|NCT02556411|Hormones|hormones|mesh-ancestor
43539712|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
43539713|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
43539714|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43539715|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
43539716|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
43539717|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43539718|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43539719|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43539720|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43539721|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
43539722|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43539723|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43539724|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43539725|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43539726|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
43539727|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43539728|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539729|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43539730|NCT01656434|Estrogens|estrogens|mesh-ancestor
43539731|NCT01656434|Hormones|hormones|mesh-ancestor
43668234|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43668235|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43539732|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539733|NCT01656434|Trace Elements|trace elements|mesh-ancestor
43539734|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
43539735|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43539736|NCT01599494|Progesterone|progesterone|mesh-list
43539737|NCT01599494|Ganirelix|ganirelix|mesh-list
43539738|NCT01599494|Progestins|progestins|mesh-ancestor
43539739|NCT01599494|Hormones|hormones|mesh-ancestor
43539740|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539741|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539742|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43539743|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539744|NCT01518517|Asparaginase|asparaginase|mesh-list
43539745|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539746|NCT01496118|Panobinostat|panobinostat|mesh-list
43539747|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539749|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539750|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539752|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539753|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43539754|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539755|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539756|NCT01350934|Vitamin D|vitamin d|mesh-list
43539757|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
43539758|NCT01350934|Alendronate|alendronate|mesh-list
43539759|NCT01350934|Calcitriol|calcitriol|mesh-list
43539760|NCT01350934|Calcium|calcium|mesh-list
43539761|NCT01350934|Vitamins|vitamins|mesh-ancestor
43539762|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
43539763|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539764|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43539765|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43539766|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
43539767|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43539768|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539769|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43539770|NCT01304511|Ganirelix|ganirelix|mesh-list
43539771|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
43731677|NCT02556268|Triumeq|triumeq|mesh-list
43539772|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539773|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539774|NCT01286207|Rizatriptan|rizatriptan|mesh-list
43539775|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43539776|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
43539777|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539778|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539779|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539780|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
43539782|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43539783|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
43539784|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43539785|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43539786|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539787|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43539788|NCT01146418|Hormones|hormones|mesh-ancestor
43539789|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539790|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539791|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43539792|NCT01144416|Hormones|hormones|mesh-ancestor
43539793|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539794|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539795|NCT01077817|Alendronate|alendronate|mesh-list
43539796|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
43539797|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
43539798|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43539799|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
43539800|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43539801|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539802|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43539803|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43668236|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668237|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668238|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
43668239|NCT03776136|Lenvatinib|lenvatinib|mesh-list
43668240|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43539804|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539805|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43539806|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43539807|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539808|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539809|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43731691|NCT02556229|Aflibercept|aflibercept|mesh-list
43539810|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43539811|NCT00974571|Cetirizine|cetirizine|mesh-list
43539812|NCT00974571|Montelukast|montelukast|mesh-list
43539813|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539814|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539815|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539816|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539817|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539818|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539830|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539831|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539832|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539833|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539834|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539835|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539836|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539837|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539838|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539839|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
43539840|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
43539842|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43539843|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43539844|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
43539846|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539847|NCT00968201|Montelukast|montelukast|mesh-list
43539848|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539849|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539850|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539851|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539852|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539853|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539854|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539855|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539856|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539857|NCT00968149|Montelukast|montelukast|mesh-list
43539858|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539859|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539860|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539861|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539862|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539863|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539864|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539865|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539866|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539867|NCT00963469|Loratadine|loratadine|mesh-list
43539868|NCT00963469|Montelukast|montelukast|mesh-list
43539869|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539870|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539871|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43731746|NCT02555813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731747|NCT02555813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731748|NCT02555813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43731749|NCT02555813|Immunologic Factors|immunologic factors|mesh-ancestor
43731750|NCT02555813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731751|NCT02555800|Cidofovir|cidofovir|mesh-list
43731752|NCT02555800|Bevacizumab|bevacizumab|mesh-list
43539872|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539873|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43668241|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668242|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43668243|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668244|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668246|NCT03736616|Rituximab|rituximab|mesh-list
43668247|NCT03736616|Carboplatin|carboplatin|mesh-list
43668248|NCT03736616|Etoposide|etoposide|mesh-list
43539874|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539875|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539881|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43539882|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43539883|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
43539885|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539886|NCT00960141|Loratadine|loratadine|mesh-list
43539887|NCT00960141|Montelukast|montelukast|mesh-list
43539888|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539889|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539890|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539891|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539892|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43831492|NCT05311436|Hematinics|hematinics|mesh-ancestor
43539893|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539894|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539895|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539896|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539897|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
43539898|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
43539899|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43539900|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
43539901|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43539902|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
43539903|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
43539904|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539905|NCT00943683|Montelukast|montelukast|mesh-list
43539906|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539907|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539908|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539909|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539910|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539911|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539912|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539913|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539914|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539915|NCT00943397|Montelukast|montelukast|mesh-list
43539916|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539917|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539918|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43539919|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539920|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539921|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539922|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539923|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43539924|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539925|NCT00911547|Beclomethasone|beclomethasone|mesh-list
43539926|NCT00911547|Montelukast|montelukast|mesh-list
43539927|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43539928|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
43539929|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43561868|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43561869|NCT01625234|Ensartinib|ensartinib|mesh-list
43561870|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539930|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539931|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539932|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539933|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43539934|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43668250|NCT03736616|Ifosfamide|ifosfamide|mesh-list
43668251|NCT03736616|Carmustine|carmustine|mesh-list
43668252|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
43539935|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539936|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539937|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
43539938|NCT00911547|Hormones|hormones|mesh-ancestor
43539939|NCT00899379|Rizatriptan|rizatriptan|mesh-list
43539940|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43539947|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43831493|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
43539948|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43539949|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43539950|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
43539951|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539952|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539953|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539954|NCT00897949|Rizatriptan|rizatriptan|mesh-list
43539955|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43539956|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
43539957|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539958|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539959|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539960|NCT00897104|Sumatriptan|sumatriptan|mesh-list
43539961|NCT00897104|Rizatriptan|rizatriptan|mesh-list
43561877|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43561878|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43561879|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
43561880|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
43561888|NCT01621243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43561889|NCT01621243|Immunologic Factors|immunologic factors|mesh-ancestor
43561890|NCT01621243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561891|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
43561892|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43561893|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539962|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43539963|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43539964|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43539965|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
43539966|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43539967|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539968|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539969|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
43539970|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43539971|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
43539972|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43539973|NCT00803790|Vitamin D|vitamin d|mesh-list
43539974|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
43539975|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
43539976|NCT00803790|Alendronate|alendronate|mesh-list
43539977|NCT00803790|Vitamins|vitamins|mesh-list
43539978|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
43539979|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539980|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43539981|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43539982|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
43539983|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
43539984|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43539985|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43539986|NCT00745108|Tibolone|tibolone|mesh-list
43539987|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43539988|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43539989|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43539990|NCT00745108|Hormones|hormones|mesh-ancestor
43539991|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43539992|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
43539993|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
43539994|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43539995|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43539996|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
43539997|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
43539998|NCT00725491|Ganirelix|ganirelix|mesh-list
43539999|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
43540000|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43540001|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
43540002|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540003|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561930|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
43561931|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561932|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43561933|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43561934|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43561935|NCT01594983|Fenofibrate|fenofibrate|mesh-list
43561936|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43561937|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
43561938|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540004|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43540005|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43540006|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540007|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
43668253|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668254|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540015|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43540016|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540017|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43540021|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540022|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540023|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540024|NCT00711607|Estradiol|estradiol|mesh-list
43540025|NCT00711607|Estrogens|estrogens|mesh-ancestor
43540026|NCT00711607|Hormones|hormones|mesh-ancestor
43540027|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540028|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540029|NCT00702845|Hormones|hormones|mesh-list
43540030|NCT00702845|Progesterone|progesterone|mesh-list
43540031|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43540032|NCT00702845|Ganirelix|ganirelix|mesh-list
43540033|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540034|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540035|NCT00702845|Progestins|progestins|mesh-ancestor
43540036|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540037|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43540038|NCT00702806|Ganirelix|ganirelix|mesh-list
43540039|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540040|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540041|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540042|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540043|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
43540044|NCT00697255|Hormones|hormones|mesh-list
43540045|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43540046|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540047|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540048|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540049|NCT00696878|Progesterone|progesterone|mesh-list
43540050|NCT00696878|Progestins|progestins|mesh-ancestor
43540051|NCT00696878|Hormones|hormones|mesh-ancestor
43540052|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540053|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540054|NCT00696800|Progesterone|progesterone|mesh-list
43540055|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43540056|NCT00696800|Ganirelix|ganirelix|mesh-list
43540057|NCT00696800|Progestins|progestins|mesh-ancestor
43540058|NCT00696800|Hormones|hormones|mesh-ancestor
43540059|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540060|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540061|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540062|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43540063|NCT00647933|Lynestrenol|lynestrenol|mesh-list
43540064|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43540065|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43540066|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43540067|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
43540068|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540069|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540070|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43540071|NCT00647933|Estrogens|estrogens|mesh-ancestor
43540072|NCT00647933|Hormones|hormones|mesh-ancestor
43540084|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43540086|NCT00616967|Vorinostat|vorinostat|mesh-list
43540087|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43540088|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540089|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
43540090|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
43540091|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
43540092|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540093|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
43540094|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668255|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
43668256|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668257|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540095|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43540097|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540098|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540099|NCT00519857|Tibolone|tibolone|mesh-list
43540100|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
43540101|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540107|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43540108|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
43540110|NCT00480662|Alendronate|alendronate|mesh-list
43540111|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540112|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540113|NCT00461032|Montelukast|montelukast|mesh-list
43540114|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540115|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540116|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540117|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540118|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540119|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540120|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540121|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540122|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540123|NCT00446056|Ketotifen|ketotifen|mesh-list
43540124|NCT00446056|Montelukast|montelukast|mesh-list
43540125|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540126|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540127|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540128|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540129|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540130|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540131|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540132|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540139|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
43540140|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43540141|NCT00442338|Aminophylline|aminophylline|mesh-list
43540142|NCT00442338|Theophylline|theophylline|mesh-list
43540143|NCT00442338|Montelukast|montelukast|mesh-list
43540144|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540145|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540146|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540147|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540148|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540149|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540150|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540151|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540152|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540153|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43540154|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
43540155|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540156|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43540157|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43540158|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540159|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43540160|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43540161|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
43540162|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540163|NCT00442338|Protective Agents|protective agents|mesh-ancestor
43540164|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
43668259|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43668260|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43668261|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540165|NCT00431093|Tibolone|tibolone|mesh-list
43540166|NCT00431093|Estradiol|estradiol|mesh-list
43540167|NCT00431093|Estrogens|estrogens|mesh-ancestor
43540168|NCT00431093|Hormones|hormones|mesh-ancestor
43540169|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540170|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540171|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
43540172|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540173|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43540174|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43540175|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540176|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43540177|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
43540178|NCT00398931|Alendronate|alendronate|mesh-list
43540179|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540180|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540181|NCT00398606|Alendronate|alendronate|mesh-list
43540182|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
43540183|NCT00398606|Calcium|calcium|mesh-list
43540184|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540185|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540186|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540187|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540188|NCT00398606|Antacids|antacids|mesh-ancestor
43540189|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43540191|NCT00395408|Montelukast|montelukast|mesh-list
43540192|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540193|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540194|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540195|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540196|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540197|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540198|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540199|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540200|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540209|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540210|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540211|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43561974|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43561975|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43561976|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43561977|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
43561978|NCT01591473|Poly I-C|poly i-c|mesh-list
43561979|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
43561980|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561981|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
43561982|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
43561983|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43561984|NCT01591447|Solithromycin|solithromycin|mesh-list
43561985|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43561986|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43561987|NCT01590719|Leucovorin|leucovorin|mesh-list
43561988|NCT01590719|Folic Acid|folic acid|mesh-list
43540212|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540213|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540214|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
43540215|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540216|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43540217|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540218|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540219|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43540220|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43540222|NCT00289874|Montelukast|montelukast|mesh-list
43540223|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540224|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540225|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540226|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540227|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540228|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540229|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540230|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540231|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540232|NCT00250458|Rizatriptan|rizatriptan|mesh-list
43540233|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43540234|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
43668262|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668263|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43540235|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540236|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540237|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540238|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43540239|NCT00245570|Montelukast|montelukast|mesh-list
43540240|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43540241|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
43540242|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540243|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540244|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540245|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540246|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43540247|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43540248|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43540249|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
43540250|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540251|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731758|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731760|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
43731761|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43731762|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731763|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731764|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
43731765|NCT02555852|Esomeprazole|esomeprazole|mesh-list
43731766|NCT02555852|Omeprazole|omeprazole|mesh-list
43731767|NCT02555852|Rabeprazole|rabeprazole|mesh-list
43731768|NCT02555852|Pantoprazole|pantoprazole|mesh-list
43731769|NCT02555852|Lansoprazole|lansoprazole|mesh-list
43731770|NCT02555852|Famotidine|famotidine|mesh-list
43731771|NCT02555852|Ranitidine|ranitidine|mesh-list
43731772|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
43731773|NCT02555852|Cimetidine|cimetidine|mesh-list
43731774|NCT02555852|Nizatidine|nizatidine|mesh-list
43540252|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540253|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540254|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540255|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540256|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540257|NCT00229970|Montelukast|montelukast|mesh-list
43540258|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540259|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540260|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540261|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540262|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540264|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540265|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540266|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540268|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540269|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540270|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540271|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540272|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540273|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540274|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540275|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540276|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540277|NCT00140881|Montelukast|montelukast|mesh-list
43731777|NCT02555852|Bismuth|bismuth|mesh-list
43731778|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
43731779|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
43731780|NCT02555852|Histamine|histamine|mesh-list
43731781|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
43731782|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731783|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
43731784|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43540278|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540279|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540280|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540281|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540282|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540283|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540284|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540285|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540286|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540287|NCT00111722|Rizatriptan|rizatriptan|mesh-list
43540289|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540290|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540291|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43540292|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
43540293|NCT00111709|Rizatriptan|rizatriptan|mesh-list
43540294|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540295|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540296|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540297|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43540298|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
43540299|NCT00095004|Rizatriptan|rizatriptan|mesh-list
43668264|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
43668265|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
43540300|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540301|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540302|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540303|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43540304|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
43540305|NCT00092963|Rizatriptan|rizatriptan|mesh-list
43540306|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540307|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540308|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540309|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43540310|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
43540311|NCT00092885|Montelukast|montelukast|mesh-list
43540312|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540313|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540314|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540315|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540316|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540317|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540318|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540319|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540320|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540321|NCT00092131|Montelukast|montelukast|mesh-list
43540322|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540323|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540324|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540325|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540326|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540327|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540328|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43731817|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43731818|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43540335|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540336|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540337|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540338|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540339|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540340|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540342|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540343|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540345|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540346|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540347|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540348|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540349|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540350|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540351|NCT00092092|Budesonide|budesonide|mesh-list
43540352|NCT00092092|Montelukast|montelukast|mesh-list
43540353|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43540354|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43540355|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
43540356|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540357|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540358|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540359|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540360|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
43540361|NCT00092092|Hormones|hormones|mesh-ancestor
43831508|NCT05307926|Lenvatinib|lenvatinib|mesh-list
43849790|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540362|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540363|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540364|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540365|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540366|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540367|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540368|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
43540369|NCT00092066|Vitamin D|vitamin d|mesh-list
43540370|NCT00092066|Alendronate|alendronate|mesh-list
43668266|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668267|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43668268|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43668269|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
43540371|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540372|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540373|NCT00092066|Vitamins|vitamins|mesh-ancestor
43540374|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
43540375|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540376|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
43540377|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540378|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540379|NCT00092040|Alendronate|alendronate|mesh-list
43834086|NCT05166343|Epinephrine|epinephrine|mesh-list
43540380|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
43540381|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540382|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540383|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540384|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43540385|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540386|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540388|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540389|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540390|NCT00092014|Vitamin D|vitamin d|mesh-list
43540391|NCT00092014|Alendronate|alendronate|mesh-list
43540392|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
43540393|NCT00092014|Calcium|calcium|mesh-list
43540394|NCT00092014|Vitamins|vitamins|mesh-ancestor
43540399|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43540400|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540401|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540402|NCT00090142|Montelukast|montelukast|mesh-list
43540403|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540404|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540405|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540407|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540408|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540409|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
43540410|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43540411|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540412|NCT00076973|Montelukast|montelukast|mesh-list
43540413|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540414|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540415|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
43540424|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43540425|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540426|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
43540427|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
43540428|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
43540429|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540430|NCT05225597|Carbachol|carbachol|mesh-list
43540431|NCT05225597|Epinephrine|epinephrine|mesh-list
43540432|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43540433|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43540435|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540436|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540437|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540438|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43540439|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43540440|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
43834101|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43834102|NCT05165966|Vaccines|vaccines|mesh-list
43834103|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
43834104|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668270|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43668271|NCT03718403|Theophylline|theophylline|mesh-list
43668272|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43668273|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
43540441|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540442|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540443|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540444|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
43540445|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
43540446|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43540447|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43540448|NCT05225597|Miotics|miotics|mesh-ancestor
43540449|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43540450|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
43540451|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43540452|NCT05225597|Analgesics|analgesics|mesh-ancestor
43540453|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
43540454|NCT05225597|Protective Agents|protective agents|mesh-ancestor
43540455|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
43540456|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43540457|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540458|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43540459|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540461|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540462|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540463|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43540470|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43540471|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
43540472|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540473|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43540474|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
43540475|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
43540476|NCT05224336|Vitamins|vitamins|mesh-ancestor
43540477|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
43540478|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540479|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
43540481|NCT05224167|Melatonin|melatonin|mesh-list
43540482|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
43540483|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
43540484|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540485|NCT05224167|Protective Agents|protective agents|mesh-ancestor
43540486|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540487|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540488|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
43540489|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
43540490|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
43540491|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
43540492|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
43540493|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540494|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
43540495|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540496|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43540497|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540498|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540500|NCT05223907|Etomidate|etomidate|mesh-list
43540501|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43540502|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540503|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540504|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43540505|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
43540506|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
43540507|NCT05223647|Carboplatin|carboplatin|mesh-list
43540508|NCT05223647|Etoposide|etoposide|mesh-list
43540509|NCT05223647|Durvalumab|durvalumab|mesh-list
43540510|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540511|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43540512|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43540513|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43540514|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540515|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668274|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668275|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668276|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43668277|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540516|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540517|NCT05223400|Clindamycin|clindamycin|mesh-list
43540518|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
43540519|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
43540520|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540521|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540522|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43540523|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540524|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540525|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
43540526|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
43540527|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
43540528|NCT05202002|Hormones|hormones|mesh-ancestor
43849791|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
43849792|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43834149|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731842|NCT02555358|Docetaxel|docetaxel|mesh-list
43540529|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540530|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540531|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540532|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540533|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
43540534|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43540535|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540536|NCT05169866|Amiodarone|amiodarone|mesh-list
43540545|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43540546|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540547|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43540548|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
43540549|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43540550|NCT05153395|Insulin|insulin|mesh-list
43540551|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
43540552|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43540553|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540555|NCT05137600|Midazolam|midazolam|mesh-list
43540556|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43540557|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43540558|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540559|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540560|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43540561|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43540562|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43540563|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43540564|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
43540565|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
43540566|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
43540567|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
43540568|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540569|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540570|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540571|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540572|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
43540573|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540574|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43540575|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43540576|NCT05137548|Tenofovir|tenofovir|mesh-list
43540577|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
43540578|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540579|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43540580|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43540581|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540582|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540583|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43540584|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43540585|NCT05091294|Anesthetics|anesthetics|mesh-list
43540586|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
43540587|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43668278|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43668279|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540588|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540589|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
43540590|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540591|NCT05072704|Sufentanil|sufentanil|mesh-list
43540592|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
43540593|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43540594|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540595|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540596|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43540597|NCT05072704|Analgesics|analgesics|mesh-ancestor
43540598|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
43540599|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540600|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43540601|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43540602|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43731902|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
43540611|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
43540612|NCT05041426|Valganciclovir|valganciclovir|mesh-list
43540613|NCT05041426|Letermovir|letermovir|mesh-list
43540614|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
43540615|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540616|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43540618|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540619|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540620|NCT04987372|Lidocaine|lidocaine|mesh-list
43540621|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
43540622|NCT04987372|Pregabalin|pregabalin|mesh-list
43540623|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
43540624|NCT04987372|Ketamine|ketamine|mesh-list
43540625|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
43540626|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
43540627|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540628|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540640|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43540641|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43540642|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
43540643|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540644|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43540645|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43540646|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
43540647|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43540648|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43540649|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
43540650|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43540651|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43540652|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43540653|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43540654|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43540655|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
43540656|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540668|NCT04905862|Antipyretics|antipyretics|mesh-list
43540669|NCT04905862|Analgesics|analgesics|mesh-list
43540670|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
43540671|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540672|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540673|NCT04898309|Complement C1s|complement c1s|mesh-list
43540674|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
43540675|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
43540676|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
43540677|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540678|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43540679|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43540682|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43540683|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43540684|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540685|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540686|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
43540687|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540688|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43540689|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43540690|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43540691|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43540696|NCT04787692|Analgesics|analgesics|mesh-ancestor
43540697|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
43540698|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540699|NCT04741945|Metformin|metformin|mesh-list
43731965|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
43731966|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
43731967|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43731968|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43731969|NCT02554045|Urological Agents|urological agents|mesh-ancestor
43731970|NCT02553824|Topiramate|topiramate|mesh-list
43731971|NCT02553824|Phentermine|phentermine|mesh-list
43731972|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
43731973|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43731974|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43731975|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43731976|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
43731977|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
43731978|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
43731979|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
43731980|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43731981|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
43731982|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540700|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43540701|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540702|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
43540703|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
43540704|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43540705|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540706|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540707|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43540708|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540709|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540710|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
43540711|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540712|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
43540713|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
43540738|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43540739|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43540740|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43540741|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540742|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
43540743|NCT04356495|Hormones|hormones|mesh-ancestor
43540744|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540745|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43540746|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
43540747|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43540748|NCT04200963|Nivolumab|nivolumab|mesh-list
43540749|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540750|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540751|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43540752|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540753|NCT04200911|Sirolimus|sirolimus|mesh-list
43540754|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43540755|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540756|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43540757|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540759|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43540760|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
43731999|NCT02553603|Growth Substances|growth substances|mesh-ancestor
43834153|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834154|NCT05159830|Cannabidiol|cannabidiol|mesh-list
43834155|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
43834156|NCT05159752|Afamelanotide|afamelanotide|mesh-list
43834157|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
43834158|NCT05159245|Trastuzumab|trastuzumab|mesh-list
43834159|NCT05159245|Pertuzumab|pertuzumab|mesh-list
43834160|NCT05159245|Atezolizumab|atezolizumab|mesh-list
43834161|NCT05159245|Trametinib|trametinib|mesh-list
43834162|NCT05159245|Vemurafenib|vemurafenib|mesh-list
43834163|NCT05159245|Dabrafenib|dabrafenib|mesh-list
43834164|NCT05159245|Pralsetinib|pralsetinib|mesh-list
43834165|NCT05159245|Entrectinib|entrectinib|mesh-list
43834166|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43834167|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43834168|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43834169|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562009|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43847610|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43668280|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668281|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
43668282|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43668283|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43540761|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540769|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540771|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43540772|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43540773|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43540774|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
43540775|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540776|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540777|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43540778|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
43540779|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
43540780|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
43540781|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43540782|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43540783|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
43540784|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540785|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540787|NCT03882918|Analgesics|analgesics|mesh-ancestor
43540788|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
43540789|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540790|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540791|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
43540792|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
43540793|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
43540794|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540795|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540796|NCT03878459|Pioglitazone|pioglitazone|mesh-list
43540797|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43540798|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540799|NCT03843008|Melatonin|melatonin|mesh-list
43540800|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
43540805|NCT03840616|Fluconazole|fluconazole|mesh-list
43540806|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
43540807|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540808|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43540809|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43540810|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540811|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540812|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43540813|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
43540814|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540815|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540816|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
43540817|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
43540818|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
43540819|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43540820|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43540821|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
43540822|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540823|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540824|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540825|NCT03787654|Urological Agents|urological agents|mesh-ancestor
43540835|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540836|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540837|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43540838|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43540839|NCT03649633|Vitamins|vitamins|mesh-list
43668284|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
43668285|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540840|NCT03649633|Ascorbic Acid|ascorbic acid|mesh-list
43540841|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
43540842|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
43540843|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540844|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43540845|NCT03649633|Antioxidants|antioxidants|mesh-ancestor
43540846|NCT03649633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540847|NCT03649633|Protective Agents|protective agents|mesh-ancestor
43540849|NCT03623373|Rituximab|rituximab|mesh-list
43540850|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
43540851|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
43540852|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540853|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540854|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
43540855|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540856|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540857|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43540858|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
43540859|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540860|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
43540861|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540862|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43540863|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43540864|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
43540865|NCT03603964|Guadecitabine|guadecitabine|mesh-list
43540866|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540867|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
43540868|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
43540869|NCT03512210|Velpatasvir|velpatasvir|mesh-list
43540870|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
43540871|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43540872|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
43540873|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
43540874|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540875|NCT03383770|Anesthetics|anesthetics|mesh-list
43540876|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43540877|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540878|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43540879|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540880|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540881|NCT02668822|Ibuprofen|ibuprofen|mesh-list
43540882|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43540883|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43540884|NCT02668822|Analgesics|analgesics|mesh-ancestor
43540885|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
43540886|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540887|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540888|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43540889|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540890|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43540891|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540892|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540899|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43540900|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43540901|NCT02668783|Analgesics|analgesics|mesh-ancestor
43540902|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
43540903|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43540904|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540905|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43540906|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540907|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43540908|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540909|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540910|NCT02668783|Estrogens|estrogens|mesh-ancestor
43540911|NCT02668783|Hormones|hormones|mesh-ancestor
43540912|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540913|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43540914|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
43847611|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43847612|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
43847613|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732004|NCT02553083|Amoxicillin|amoxicillin|mesh-list
43732005|NCT02553083|Doxycycline|doxycycline|mesh-list
43732006|NCT02553083|Esomeprazole|esomeprazole|mesh-list
43540915|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43668286|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
43668287|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
43668288|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540916|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43540917|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
43540918|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
43540919|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
43540920|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43540921|NCT02616146|Etonogestrel|etonogestrel|mesh-list
43540922|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43540924|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
43540925|NCT02616146|Estrogens|estrogens|mesh-ancestor
43540926|NCT02616146|Hormones|hormones|mesh-ancestor
43540927|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43540928|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540929|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43540931|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540932|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43540933|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43540934|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43540935|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43540936|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43540937|NCT02316834|Talazoparib|talazoparib|mesh-list
43540938|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43540939|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43540940|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540941|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540942|NCT02293655|Methylphenidate|methylphenidate|mesh-list
43540943|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43540944|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540945|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
43540946|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43540947|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43540948|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540949|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
43540950|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43540952|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43540953|NCT02275546|Desogestrel|desogestrel|mesh-list
43540954|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43540955|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
43540956|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43540957|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540958|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43540959|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43540960|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43540961|NCT02275546|Estrogens|estrogens|mesh-ancestor
43540962|NCT02275546|Hormones|hormones|mesh-ancestor
43540976|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540977|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
43540978|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540979|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540980|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43540981|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43540982|NCT02077166|Growth Substances|growth substances|mesh-ancestor
43540983|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
43540984|NCT02027935|Aldesleukin|aldesleukin|mesh-list
43540985|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
43540987|NCT02027935|Interleukin-2|interleukin-2|mesh-list
43540988|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43540989|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
43540990|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43540991|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43540992|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43540993|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
43540994|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732077|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
43540995|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43540996|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43540997|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43540998|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43668289|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43540999|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541001|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
43541002|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541003|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43541004|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43541005|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
43541006|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541009|NCT01965132|Golimumab|golimumab|mesh-list
43541010|NCT01965132|Abatacept|abatacept|mesh-list
43541011|NCT01965132|Infliximab|infliximab|mesh-list
43541012|NCT01965132|Upadacitinib|upadacitinib|mesh-list
43541013|NCT01965132|Ustekinumab|ustekinumab|mesh-list
43541014|NCT01965132|Ixekizumab|ixekizumab|mesh-list
43541015|NCT01965132|Tofacitinib|tofacitinib|mesh-list
43541016|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541017|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
43541018|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541019|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541020|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541021|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541022|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541023|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541024|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541025|NCT01965132|Analgesics|analgesics|mesh-ancestor
43541026|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
43541029|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43541030|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541031|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43541032|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541033|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
43541034|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
43541035|NCT01891344|Rucaparib|rucaparib|mesh-list
43541036|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43541037|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541038|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541039|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541040|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43541041|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43541042|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541043|NCT01670656|Ibuprofen|ibuprofen|mesh-list
43541044|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
43541045|NCT01670656|Etonogestrel|etonogestrel|mesh-list
43732085|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
43732128|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732129|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43732130|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732132|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
43732133|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732134|NCT02551523|Dolutegravir|dolutegravir|mesh-list
43732135|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
43732136|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
43732137|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
43732138|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541046|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541047|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541048|NCT01670656|Analgesics|analgesics|mesh-ancestor
43541049|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
43541050|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541051|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541052|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541053|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541054|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43541055|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541056|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541057|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541058|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541059|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541061|NCT01498770|Risperidone|risperidone|mesh-list
43541062|NCT01498770|Aripiprazole|aripiprazole|mesh-list
43541063|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43541064|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
43541065|NCT01498770|Ziprasidone|ziprasidone|mesh-list
43541066|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43541067|NCT01498770|Clozapine|clozapine|mesh-list
43541068|NCT01498770|Asenapine|asenapine|mesh-list
43541069|NCT01498770|Amisulpride|amisulpride|mesh-list
43541070|NCT01498770|Iloperidone|iloperidone|mesh-list
43541071|NCT01498770|Sertindole|sertindole|mesh-list
43541072|NCT01498770|Zotepine|zotepine|mesh-list
43541073|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43541074|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
43541075|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43668290|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668291|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
43668292|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
43668293|NCT03689946|Listerine|listerine|mesh-list
43541076|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541077|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541078|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43541079|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43562013|NCT01577654|Folic Acid|folic acid|mesh-list
43541080|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541082|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43541083|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
43541084|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
43541085|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
43541086|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541087|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541088|NCT01498770|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43541089|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43541090|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43541091|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
43541092|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
43541093|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
43541094|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
43541095|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43541096|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43541106|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541107|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541108|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
43541109|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541110|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541111|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
43541113|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43541114|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
43541115|NCT01044056|NuvaRing|nuvaring|mesh-list
43541116|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
43541117|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541118|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541119|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541120|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541121|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541122|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541123|NCT01044056|Estrogens|estrogens|mesh-ancestor
43541124|NCT01044056|Hormones|hormones|mesh-ancestor
43541125|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541126|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
43541127|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
43541128|NCT01005056|Desogestrel|desogestrel|mesh-list
43541129|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541130|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43541131|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541132|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541133|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541134|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43834176|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
43834177|NCT05157971|Methotrexate|methotrexate|mesh-list
43834180|NCT05157971|Venetoclax|venetoclax|mesh-list
43541135|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541136|NCT01005056|Estrogens|estrogens|mesh-ancestor
43541137|NCT01005056|Hormones|hormones|mesh-ancestor
43734430|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541138|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541139|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541140|NCT01005056|Progestins|progestins|mesh-ancestor
43541141|NCT00967746|Etonogestrel|etonogestrel|mesh-list
43541142|NCT00967746|Desogestrel|desogestrel|mesh-list
43541143|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541144|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541145|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541146|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541147|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541148|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541149|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43541150|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541151|NCT00967746|Progestins|progestins|mesh-ancestor
43668295|NCT03689946|Fluorides|fluorides|mesh-list
43668296|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
43668297|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
43541152|NCT00967746|Hormones|hormones|mesh-ancestor
43541153|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541154|NCT00944216|Emollients|emollients|mesh-list
43541155|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541156|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
43541157|NCT00920634|Hormones|hormones|mesh-ancestor
43541158|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541159|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541167|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
43541168|NCT00886691|Antibodies|antibodies|mesh-list
43541169|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
43541170|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43541171|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
43541172|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541173|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43541174|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43541175|NCT00886691|Growth Substances|growth substances|mesh-ancestor
43541176|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541177|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
43541178|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
43541179|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541180|NCT00878462|Asenapine|asenapine|mesh-list
43541181|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43541182|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43541183|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541184|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541185|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43541186|NCT00778999|Desogestrel|desogestrel|mesh-list
43541187|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541188|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43541189|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541190|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541191|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541192|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541193|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541194|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541195|NCT00778999|Progestins|progestins|mesh-ancestor
43541196|NCT00778999|Hormones|hormones|mesh-ancestor
43541197|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541198|NCT00725413|Etonogestrel|etonogestrel|mesh-list
43541199|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541200|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541201|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541202|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541203|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43732179|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541204|NCT00651807|Etonogestrel|etonogestrel|mesh-list
43541205|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541206|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541207|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541208|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541209|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541210|NCT00620464|Etonogestrel|etonogestrel|mesh-list
43541211|NCT00620464|Desogestrel|desogestrel|mesh-list
43541212|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541213|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541214|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541215|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541216|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541217|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541218|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43541219|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541221|NCT00620464|Hormones|hormones|mesh-ancestor
43541222|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541223|NCT00620035|Etonogestrel|etonogestrel|mesh-list
43541224|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541225|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541226|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541227|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668298|NCT03689946|Protective Agents|protective agents|mesh-ancestor
43668299|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541233|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541234|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
43541235|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541236|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43541237|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541238|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
43541239|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43541240|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
43541241|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
43541242|NCT00431431|Tibolone|tibolone|mesh-list
43541243|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
43541244|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541245|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541246|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541247|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541248|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541249|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541250|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43541251|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
43541252|NCT00431431|Hormones|hormones|mesh-ancestor
43541253|NCT00413764|Tibolone|tibolone|mesh-list
43541254|NCT00413764|Norethindrone|norethindrone|mesh-list
43541255|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
43541256|NCT00413764|Estradiol|estradiol|mesh-list
43541257|NCT00413764|Estrogens|estrogens|mesh-ancestor
43541258|NCT00413764|Hormones|hormones|mesh-ancestor
43541259|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541260|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541261|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
43541262|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
43541263|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43541264|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43541265|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541266|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
43732187|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43732188|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43732189|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732190|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43732191|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43732192|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
43732193|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
43541267|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
43541268|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
43541269|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541270|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541271|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541272|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541273|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43541274|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
43541275|NCT00408863|Tibolone|tibolone|mesh-list
43541276|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
43541277|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541278|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541279|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541280|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43541281|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541282|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541283|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43541284|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
43541326|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541348|NCT05528848|Carfentanil|carfentanil|mesh-list
43541349|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43541350|NCT05528848|Narcotics|narcotics|mesh-ancestor
43541351|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541352|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541353|NCT05528848|Analgesics|analgesics|mesh-ancestor
43541354|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
43541355|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541356|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43541358|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
43541359|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
43541360|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
43541361|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541362|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43541366|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541367|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541368|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43541369|NCT05506930|Morphine|morphine|mesh-list
43541370|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43541371|NCT05506930|Narcotics|narcotics|mesh-ancestor
43541372|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541373|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541374|NCT05506930|Analgesics|analgesics|mesh-ancestor
43541375|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
43668305|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541376|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541377|NCT05500170|Niacinamide|niacinamide|mesh-list
43541379|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
43541380|NCT05500170|Vitamins|vitamins|mesh-ancestor
43541381|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
43541382|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541383|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
43541384|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43541385|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
43541386|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541387|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43541388|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
43541389|NCT05480150|Dexetimide|dexetimide|mesh-list
43732194|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
43541390|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
43541391|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
43541392|NCT05480150|Citalopram|citalopram|mesh-list
43541393|NCT05480150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43541394|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43541395|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43541396|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541397|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541398|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
43541399|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541400|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43541401|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
43541402|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43541403|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43541405|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
43541406|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
43541407|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541408|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43541409|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43541410|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
43541411|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43541412|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43541413|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541414|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
43541415|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43541417|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
43541418|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
43541419|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43541420|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
43541421|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
43541422|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
43541424|NCT05472792|Toremifene|toremifene|mesh-list
43541425|NCT05472792|Letrozole|letrozole|mesh-list
43541426|NCT05472792|Fulvestrant|fulvestrant|mesh-list
43541427|NCT05472792|Anastrozole|anastrozole|mesh-list
43541429|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541431|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43541432|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541433|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541434|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
43541435|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541436|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541437|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541438|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541439|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43541440|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43541448|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43541449|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43732222|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732223|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732224|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732225|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
43732226|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43732227|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732229|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
43732230|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
43732231|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
43732232|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43732233|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
43541451|NCT05464264|Ketamine|ketamine|mesh-list
43541452|NCT05464264|Analgesics|analgesics|mesh-ancestor
43541453|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
43541454|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541455|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541456|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43541457|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43668306|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43668307|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
43668308|NCT03684590|Narcotics|narcotics|mesh-ancestor
43668309|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541458|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
43541459|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
43541460|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541461|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43541462|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43541463|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541464|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541465|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
43541466|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43541467|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541468|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43541469|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541470|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43541471|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541472|NCT05458375|Estradiol|estradiol|mesh-list
43541473|NCT05458375|Estrogens|estrogens|mesh-ancestor
43541474|NCT05458375|Hormones|hormones|mesh-ancestor
43541475|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541476|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541477|NCT05457959|Poly I-C|poly i-c|mesh-list
43541478|NCT05457959|Nivolumab|nivolumab|mesh-list
43541479|NCT05457959|Ipilimumab|ipilimumab|mesh-list
43541480|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
43541481|NCT05457959|Vaccines|vaccines|mesh-list
43541482|NCT05457959|Poly ICLC|poly iclc|mesh-list
43541483|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
43541484|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541485|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541486|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541487|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43541488|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541489|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
43541490|NCT05457959|Laxatives|laxatives|mesh-ancestor
43541491|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541492|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
43541493|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541494|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
43541495|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
43541496|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
43541497|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541498|NCT05423249|Protective Agents|protective agents|mesh-ancestor
43541499|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541500|NCT05423249|Vitamins|vitamins|mesh-ancestor
43541501|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
43541502|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
43541503|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541504|NCT05422794|Paclitaxel|paclitaxel|mesh-list
43541505|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
43541506|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
43541513|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541514|NCT05391126|Irinotecan|irinotecan|mesh-list
43541515|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
43732234|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
43732235|NCT02551042|Factor VIII|factor viii|mesh-list
43732236|NCT02551042|Coagulants|coagulants|mesh-ancestor
43732237|NCT02551029|Capsaicin|capsaicin|mesh-list
43732238|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
43541516|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43732239|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541517|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541518|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541520|NCT05358548|Paclitaxel|paclitaxel|mesh-list
43541521|NCT05358548|Carboplatin|carboplatin|mesh-list
43541522|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
43541523|NCT05358548|Fluorouracil|fluorouracil|mesh-list
43541524|NCT05358548|Pemetrexed|pemetrexed|mesh-list
43541525|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43541526|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541527|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
43541528|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
43541529|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
43541530|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668310|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541531|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541532|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
43541533|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43541537|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541538|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43541539|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43541540|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
43541541|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541542|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541543|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
43541544|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
43541545|NCT05320926|Aspirin|aspirin|mesh-list
43541546|NCT05320926|Clopidogrel|clopidogrel|mesh-list
43541547|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541548|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541549|NCT05320926|Analgesics|analgesics|mesh-ancestor
43541550|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
43541551|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541552|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541554|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541555|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43541556|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43541557|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541558|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43732242|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732243|NCT02550977|Gestodene|gestodene|mesh-list
43732244|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
43541559|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43541560|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541561|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
43541562|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
43541563|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
43541564|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43541565|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
43541566|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541567|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
43541568|NCT05296512|Lenvatinib|lenvatinib|mesh-list
43541569|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541570|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541571|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43541572|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541573|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541574|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
43541578|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43541579|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541582|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43541583|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541584|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541585|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43541586|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
43541587|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
43541588|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43541589|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43541590|NCT05239910|Tenalisib|tenalisib|mesh-list
43541591|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
43541592|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541593|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541595|NCT05234307|Adenosine|adenosine|mesh-list
43541596|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
43541597|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541598|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541599|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43541600|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541601|NCT05234307|Analgesics|analgesics|mesh-ancestor
43541602|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
43541603|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541604|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541605|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43668312|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
43668313|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541606|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
43541607|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
43541608|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
43541609|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
43541610|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541611|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
43541612|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
43541613|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
43541614|NCT05231590|Paraproteins|paraproteins|mesh-list
43541615|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
43541616|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541617|NCT05188677|Vaccines|vaccines|mesh-list
43541618|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
43541619|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541621|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
43541622|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541623|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541624|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541625|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43541626|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43541627|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43541628|NCT05115838|Islatravir|islatravir|mesh-list
43541629|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
43541630|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541631|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541632|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541633|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43732324|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43732325|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
43732326|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732327|NCT02550483|Protective Agents|protective agents|mesh-ancestor
43732328|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732329|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43732330|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
43732331|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732332|NCT02550483|Provitamins|provitamins|mesh-ancestor
43732333|NCT02550483|Vitamins|vitamins|mesh-ancestor
43732334|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
43732335|NCT02550717|Aspirin|aspirin|mesh-list
43732336|NCT02550717|Anticoagulants|anticoagulants|mesh-list
43732337|NCT02550717|Clopidogrel|clopidogrel|mesh-list
43732338|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43732339|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732340|NCT02550717|Analgesics|analgesics|mesh-ancestor
43732341|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
43732342|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732343|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732344|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541634|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43541635|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
43541636|NCT05097599|Trastuzumab|trastuzumab|mesh-list
43541637|NCT05097599|Talazoparib|talazoparib|mesh-list
43541638|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541639|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541640|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43541641|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541642|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541643|NCT05093608|Bevacizumab|bevacizumab|mesh-list
43541644|NCT05093608|Atezolizumab|atezolizumab|mesh-list
43541645|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541646|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541647|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43541656|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
43541658|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541659|NCT04907227|Dexamethasone|dexamethasone|mesh-list
43541660|NCT04907227|Prednisone|prednisone|mesh-list
43541661|NCT04907227|Docetaxel|docetaxel|mesh-list
43541662|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
43541663|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541664|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
43541665|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
43541666|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541667|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541668|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541669|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
43541671|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541672|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43541673|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541674|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
43541675|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
43541676|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
43541677|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541678|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541679|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
43541680|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
43541681|NCT04891172|Antibodies|antibodies|mesh-list
43732345|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541682|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
43668315|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
43668316|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
43668317|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668318|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
43668319|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43541683|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
43541684|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
43541685|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541686|NCT04856904|Trifarotene|trifarotene|mesh-list
43541687|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541688|NCT04812470|Melphalan|melphalan|mesh-list
43541689|NCT04812470|Interleukin-2|interleukin-2|mesh-list
43541690|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43541691|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
43541692|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541701|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541703|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541704|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541705|NCT04796714|Analgesics|analgesics|mesh-ancestor
43541706|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
43541707|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541708|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541709|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541710|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541711|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43541712|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43541713|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541721|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43541722|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732389|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732390|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43732391|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732392|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
43732393|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732394|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732395|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
43732396|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43732397|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732398|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43732399|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
43732400|NCT02550067|Copper|copper|mesh-list
43541723|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43541724|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
43541725|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541726|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541727|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541728|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
43541730|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
43541731|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541732|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
43541733|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
43541735|NCT04774237|Analgesics|analgesics|mesh-ancestor
43541736|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
43541737|NCT04774237|Protective Agents|protective agents|mesh-ancestor
43541738|NCT04713631|Artesunate|artesunate|mesh-list
43541739|NCT04713631|Curcumin|curcumin|mesh-list
43541740|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541741|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541742|NCT04713631|Analgesics|analgesics|mesh-ancestor
43541743|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
43541744|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541745|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541746|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541747|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541748|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541749|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541750|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541751|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
43562058|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
43562059|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
43562060|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43562061|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43562062|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43562063|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
43562064|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43562065|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43562066|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
43562067|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43562068|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
43562069|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43562070|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
43562071|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43562072|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43562073|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43732468|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
43732470|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
43732471|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
43732472|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
43541752|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43541753|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43668320|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43668321|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541754|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541756|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
43541757|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43541758|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
43541759|NCT04660240|Sirolimus|sirolimus|mesh-list
43541760|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43541761|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541762|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43541763|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541765|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541766|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
43541767|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541768|NCT04575688|Bupivacaine|bupivacaine|mesh-list
43541769|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
43541770|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
43541771|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541772|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541773|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
43541774|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541775|NCT04561648|Heparin|heparin|mesh-list
43541776|NCT04561648|Calcium heparin|calcium heparin|mesh-list
43541777|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
43541778|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43541779|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43541780|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541781|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43541788|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
43541789|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541790|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541791|NCT04535271|Antiviral Agents|antiviral agents|mesh-ancestor
43541792|NCT04535271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541793|NCT04535271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541794|NCT04535271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541795|NCT04535271|Immunologic Factors|immunologic factors|mesh-ancestor
43541796|NCT04535271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541797|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43541798|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
43541799|NCT04520178|Carbidopa|carbidopa|mesh-list
43541800|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
43541801|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43541802|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43541803|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
43541804|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541805|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541806|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541807|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
43541808|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541809|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
43541810|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
43541811|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43541812|NCT04247165|Gemcitabine|gemcitabine|mesh-list
43541813|NCT04247165|Paclitaxel|paclitaxel|mesh-list
43541815|NCT04247165|Ipilimumab|ipilimumab|mesh-list
43541816|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43541817|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541818|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
43541819|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
43732479|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
43732480|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
43732481|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
43541820|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732483|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43541821|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541822|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43541823|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
43541824|NCT04247165|Antiviral Agents|antiviral agents|mesh-ancestor
43541825|NCT04247165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541826|NCT04247165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541827|NCT04247165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541828|NCT04247165|Immunologic Factors|immunologic factors|mesh-ancestor
43541829|NCT04247165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668322|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43668323|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
43541830|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43541831|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43541833|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43541834|NCT04238780|Narcotics|narcotics|mesh-ancestor
43541835|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541836|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541837|NCT04238780|Analgesics|analgesics|mesh-ancestor
43541838|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
43541839|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541840|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43541841|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43541842|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
43541843|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
43541844|NCT04200313|Pancrelipase|pancrelipase|mesh-list
43541845|NCT04200313|Pancreatin|pancreatin|mesh-list
43541846|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541847|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
43541848|NCT04187105|Fludarabine|fludarabine|mesh-list
43541849|NCT04187105|Tacrolimus|tacrolimus|mesh-list
43541850|NCT04187105|Complement Factor H|complement factor h|mesh-list
43541851|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541852|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
43541853|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541857|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541859|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43541860|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43541861|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541862|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
43541863|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
43541864|NCT03943147|BMS-986165|bms-986165|mesh-list
43732489|NCT02550327|Immunologic Factors|immunologic factors|mesh-ancestor
43732490|NCT02550327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732491|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43732492|NCT02549846|Atorvastatin|atorvastatin|mesh-list
43732493|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43732494|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43732495|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43732496|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
43732497|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732498|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43732499|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43732500|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541865|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43541866|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541867|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43541868|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
43541869|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43541870|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541871|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541872|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541873|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541874|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43541875|NCT03856788|Bupivacaine|bupivacaine|mesh-list
43541876|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
43541877|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
43541878|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541879|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541880|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
43541881|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541882|NCT03722576|Calcium|calcium|mesh-list
43541883|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43541884|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541885|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
43541886|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
43541887|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
43639127|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43849793|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43541897|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
43541898|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541899|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43541900|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
43541901|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541902|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
43541912|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541913|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
43541914|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43732501|NCT02549924|Resveratrol|resveratrol|mesh-list
43732502|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
43732503|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732504|NCT02549924|Protective Agents|protective agents|mesh-ancestor
43541915|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
43541916|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43541917|NCT03320434|Prednisolone|prednisolone|mesh-list
43541918|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43541919|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
43541932|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541934|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
43541935|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
43541936|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
43541937|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541938|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541939|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541940|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
43541941|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43541942|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43541943|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43541944|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43541945|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541946|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
43541947|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541948|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541949|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43541950|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43849794|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
43541952|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541953|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541954|NCT03198351|Analgesics|analgesics|mesh-ancestor
43541955|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
43541956|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541957|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541958|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43562081|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43541959|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541960|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43541961|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
43541962|NCT03182179|Ondansetron|ondansetron|mesh-list
43541963|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
43541964|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
43541965|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541966|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541967|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43541968|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
43541969|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
43541970|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
43668331|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668332|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43668333|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43541971|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
43541972|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43541973|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541974|NCT03182179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43541975|NCT03182179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43541976|NCT03182179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43541977|NCT03182179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43541978|NCT03182179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43541980|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43541981|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43541982|NCT03122613|Analgesics|analgesics|mesh-ancestor
43541983|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
43541984|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43541985|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43541986|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43541987|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43541988|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43541989|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43541990|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43541991|NCT03034096|Propofol|propofol|mesh-list
43541992|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43541993|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542000|NCT02843074|Elotuzumab|elotuzumab|mesh-list
43542001|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542002|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
43542003|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
43542004|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542005|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542006|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542011|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542012|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
43542013|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
43542014|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
43542015|NCT02843074|Growth Substances|growth substances|mesh-ancestor
43562097|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43562098|NCT01527916|Donepezil|donepezil|mesh-list
43562099|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
43562101|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732523|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732524|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
43732525|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43732526|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732527|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542016|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
43542021|NCT02727998|Midazolam|midazolam|mesh-list
43542022|NCT02727998|Ketamine|ketamine|mesh-list
43542023|NCT02727998|Analgesics|analgesics|mesh-ancestor
43542024|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
43542025|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542026|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542027|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
43542028|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43542029|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
43542030|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
43542031|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542032|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
43542033|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
43542034|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542035|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542036|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43542037|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43542038|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43542039|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43542040|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43542041|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
43542042|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
43542043|NCT02636270|Mecasermin|mecasermin|mesh-list
43542045|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542046|NCT02499120|Cetuximab|cetuximab|mesh-list
43542047|NCT02499120|Palbociclib|palbociclib|mesh-list
43542048|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542049|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542050|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43542051|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542052|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542053|NCT02415036|Melphalan|melphalan|mesh-list
43542054|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43542055|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
43542056|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542057|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542058|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43542059|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542060|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
43542061|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542062|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
43542063|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43542064|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
43542068|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43542069|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
43542070|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542071|NCT02117700|Protective Agents|protective agents|mesh-ancestor
43542072|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542073|NCT02117700|Antidotes|antidotes|mesh-ancestor
43542074|NCT02108990|Acetaminophen|acetaminophen|mesh-list
43542075|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542076|NCT02108990|Analgesics|analgesics|mesh-ancestor
43542077|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
43732568|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
43542078|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542079|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542080|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
43542081|NCT00976131|Ubiquinone|ubiquinone|mesh-list
43542082|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
43542083|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
43542084|NCT00976131|Doxorubicin|doxorubicin|mesh-list
43542085|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542086|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
43542087|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542088|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542089|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43732590|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43732591|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43849795|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43849796|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
43542090|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
43542091|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542092|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542093|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43542094|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
43542095|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43542096|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
43542097|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542098|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
43542099|NCT00976131|Vitamins|vitamins|mesh-ancestor
43542100|NCT00521222|Fluticasone|fluticasone|mesh-list
43542101|NCT00521222|Xhance|xhance|mesh-list
43542102|NCT00521222|Albuterol|albuterol|mesh-list
43732592|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43732593|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
43732594|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43732595|NCT02549105|Lidocaine|lidocaine|mesh-list
43732596|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
43732597|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
43732599|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732600|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732601|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
43732602|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732603|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43542103|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
43542104|NCT00521222|Ipratropium|ipratropium|mesh-list
43542105|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
43732604|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43732605|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43732606|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732607|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542106|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542107|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43542108|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
43542109|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542110|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542111|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43542112|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542113|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
43542114|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
43542115|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
43542116|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43542117|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43542118|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542119|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542120|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542122|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43542123|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43542124|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
43542125|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
43668335|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43668336|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
43668337|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43542126|NCT00521222|Hormones|hormones|mesh-ancestor
43542127|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542128|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
43542129|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
43542130|NCT00403793|Etonogestrel|etonogestrel|mesh-list
43542131|NCT00403793|Testosterone|testosterone|mesh-list
43542132|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
43542133|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
43542134|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
43542135|NCT00403793|Androgens|androgens|mesh-ancestor
43542136|NCT00403793|Hormones|hormones|mesh-ancestor
43542137|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849797|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43542139|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43542144|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43542145|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
43542147|NCT00143182|Asenapine|asenapine|mesh-list
43542148|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
43542149|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
43542150|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542151|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542152|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542153|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
43542154|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43542155|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542156|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43542157|NCT00143182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
43542158|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43542159|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542160|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542161|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542162|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
43542163|NCT03705442|Loperamide|loperamide|mesh-list
43542164|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
43542165|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542166|NCT03705351|Temozolomide|temozolomide|mesh-list
43542167|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43542168|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
43542169|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542170|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542171|NCT03705195|Gliclazide|gliclazide|mesh-list
43542172|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
43542173|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542174|NCT03705065|Bupivacaine|bupivacaine|mesh-list
43542175|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542176|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
43542177|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542178|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542179|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
43542180|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542181|NCT03704909|Epinephrine|epinephrine|mesh-list
43542184|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
43542185|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43542186|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43542187|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542188|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542189|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542190|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542191|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
43542192|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43542193|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
43542194|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542195|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43542196|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
43732609|NCT02549001|Amorolfine|amorolfine|mesh-list
43732610|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
43732611|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732612|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
43732613|NCT02548923|Propofol|propofol|mesh-list
43732614|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43732615|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43732616|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732617|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43542197|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
43542198|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
43542199|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43668338|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542200|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
43542201|NCT03704831|Anesthetics|anesthetics|mesh-list
43542202|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
43542203|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542204|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542205|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
43542206|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542207|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
43732618|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
43732619|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
43732620|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43732621|NCT02548923|Analgesics|analgesics|mesh-ancestor
43732622|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
43732623|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732624|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
43732625|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732626|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732627|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542208|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
43542211|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542213|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542214|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
43542215|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542216|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542217|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
43542218|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542219|NCT03704623|Acetaminophen|acetaminophen|mesh-list
43542220|NCT03704623|Parecoxib|parecoxib|mesh-list
43542221|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542222|NCT03704623|Analgesics|analgesics|mesh-ancestor
43542223|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
43542224|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542225|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542226|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
43542227|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
43542228|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
43542229|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542230|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542231|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43542232|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542233|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542234|NCT03704506|Amoxicillin|amoxicillin|mesh-list
43709236|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
43542235|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43542236|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542238|NCT03704480|Tremelimumab|tremelimumab|mesh-list
43542239|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542240|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542241|NCT03704246|Antibodies|antibodies|mesh-list
43542242|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43542243|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
43542244|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542245|NCT03704220|Warfarin|warfarin|mesh-list
43542246|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
43542247|NCT03704181|Colchicine|colchicine|mesh-list
43542248|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
43542249|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542250|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542251|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542252|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732725|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542253|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542254|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542255|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
43542256|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43542257|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
43542258|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43542259|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542260|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542261|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
43542262|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542263|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542264|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43542265|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542266|NCT03704077|Paclitaxel|paclitaxel|mesh-list
43542267|NCT03704077|Nivolumab|nivolumab|mesh-list
43542268|NCT03704077|Ramucirumab|ramucirumab|mesh-list
43542269|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542270|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732726|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43732727|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
43732728|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732729|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43732730|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
43732731|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43732732|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
43732733|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43732734|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43542271|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542272|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542273|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542274|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668339|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668340|NCT03615326|Cisplatin|cisplatin|mesh-list
43542275|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542276|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43542277|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
43542278|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542279|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542281|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542285|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542286|NCT03703427|Capecitabine|capecitabine|mesh-list
43542287|NCT03703427|Vinorelbine|vinorelbine|mesh-list
43542288|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542289|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
43542290|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542291|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542292|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542293|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542294|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542295|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542296|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
43542297|NCT03703349|Analgesics|analgesics|mesh-ancestor
43542298|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
43542299|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542300|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542301|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
43542302|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542303|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43542304|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
43542305|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
43542306|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542307|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542308|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43542309|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
43542310|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43542311|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
43542312|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
43542313|NCT03703154|Tacrolimus|tacrolimus|mesh-list
43542314|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542315|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
43542316|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542317|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
43542318|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542319|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542320|NCT03703089|Gemcitabine|gemcitabine|mesh-list
43542321|NCT03703089|Paclitaxel|paclitaxel|mesh-list
43542322|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542324|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542325|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542326|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
43732762|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43732763|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43732764|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43732765|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732766|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43732767|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43732768|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
43732769|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542327|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542328|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542329|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
43542330|NCT03703089|Antiviral Agents|antiviral agents|mesh-ancestor
43542331|NCT03703089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542332|NCT03703089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542333|NCT03703089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542334|NCT03703089|Immunologic Factors|immunologic factors|mesh-ancestor
43542335|NCT03703089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542336|NCT03703063|Leucovorin|leucovorin|mesh-list
43542337|NCT03703063|Gemcitabine|gemcitabine|mesh-list
43542338|NCT03703063|Paclitaxel|paclitaxel|mesh-list
43542339|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542340|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542341|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542342|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542343|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542344|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542345|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542346|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
43542347|NCT03703063|Antiviral Agents|antiviral agents|mesh-ancestor
43542348|NCT03703063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43668341|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
43668342|NCT03615326|Capecitabine|capecitabine|mesh-list
43668344|NCT03615326|Trastuzumab|trastuzumab|mesh-list
43542349|NCT03703063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542350|NCT03703063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542351|NCT03703063|Immunologic Factors|immunologic factors|mesh-ancestor
43542352|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542353|NCT03703063|Antidotes|antidotes|mesh-ancestor
43542354|NCT03703063|Protective Agents|protective agents|mesh-ancestor
43542370|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542371|NCT03702959|Betamethasone|betamethasone|mesh-list
43542372|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542373|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
43542374|NCT03702959|Hormones|hormones|mesh-ancestor
43542375|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542376|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542377|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43542378|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542379|NCT03702946|Oxytocin|oxytocin|mesh-list
43542380|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
43542381|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
43542382|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542383|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43542384|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43542385|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542386|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
43542387|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542388|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542389|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
43542390|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
43542391|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
43542392|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542393|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542394|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542395|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542396|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542397|NCT03702803|Alprazolam|alprazolam|mesh-list
43562118|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
43562119|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
43562120|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43562121|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542398|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43542399|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542400|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542401|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
43542402|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
43542403|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
43542404|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
43542405|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
43542406|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542407|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542408|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
43542409|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
43542410|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
43542411|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542412|NCT03702738|Expectorants|expectorants|mesh-ancestor
43542413|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542414|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43542431|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542432|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
43542433|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542435|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
43542436|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
43542437|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
43542438|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
43542439|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
43542440|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
43542441|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542442|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542443|NCT03702530|Albendazole|albendazole|mesh-list
43542444|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
43542445|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
43542446|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542447|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
43542448|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
43668345|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43668346|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43668347|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542449|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
43542450|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542451|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
43542452|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
43542453|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542454|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542456|NCT03702491|Apatinib|apatinib|mesh-list
43542457|NCT03702491|Tegafur|tegafur|mesh-list
43542458|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542459|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43542460|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542461|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542462|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542463|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
43732785|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732786|NCT02548403|Emollients|emollients|mesh-ancestor
43732787|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
43732788|NCT02548117|Finasteride|finasteride|mesh-list
43732789|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
43732790|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
43732791|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732793|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
43542464|NCT03702426|Norfloxacin|norfloxacin|mesh-list
43542465|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43542466|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542467|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
43542469|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542470|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542471|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542472|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
43542473|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
43542474|NCT03702400|Phenylephrine|phenylephrine|mesh-list
43542475|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
43542483|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
43542484|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
43542485|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542486|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
43542487|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
43542488|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
43542489|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542490|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542491|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542492|NCT03702400|Protective Agents|protective agents|mesh-ancestor
43542494|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542495|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542496|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
43542497|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542498|NCT03702205|Betaine|betaine|mesh-list
43542499|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542500|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
43542501|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43542502|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
43542503|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542504|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43542506|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
43542507|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542508|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43542509|NCT03702023|Acetaminophen|acetaminophen|mesh-list
43542510|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542511|NCT03702023|Analgesics|analgesics|mesh-ancestor
43542512|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
43542513|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542514|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542515|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
43542516|NCT03701984|Lidocaine|lidocaine|mesh-list
43542517|NCT03701984|Tramadol|tramadol|mesh-list
43542518|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542519|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
43542520|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542521|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542522|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
43542523|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43668348|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
43668349|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668350|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
43732802|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668351|NCT03610412|Antacids|antacids|mesh-ancestor
43668352|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43668353|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43668354|NCT03579966|Amifampridine|amifampridine|mesh-list
43542524|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43542525|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
43542526|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
43542527|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542528|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542529|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
43542530|NCT03701984|Narcotics|narcotics|mesh-ancestor
43542531|NCT03701984|Analgesics|analgesics|mesh-ancestor
43542532|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
43542533|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
43542534|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
43542535|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
43542536|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542537|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
43542538|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542539|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542540|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43542541|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542542|NCT03701880|Bisoprolol|bisoprolol|mesh-list
43542551|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
43542552|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542553|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542554|NCT03701750|Heparin|heparin|mesh-list
43542555|NCT03701750|Enoxaparin|enoxaparin|mesh-list
43542556|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
43542557|NCT03701750|Tinzaparin|tinzaparin|mesh-list
43542558|NCT03701750|Dalteparin|dalteparin|mesh-list
43542559|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
43542560|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
43542561|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
43542562|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
43542563|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542564|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
43542565|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
43542566|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
43542567|NCT03701698|Prednisolone|prednisolone|mesh-list
43542568|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
43542569|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
43542570|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
43542571|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542573|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
43542574|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542575|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542576|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542577|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
43542579|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542580|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
43542581|NCT03701698|Protective Agents|protective agents|mesh-ancestor
43542582|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43849798|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
43849799|NCT03891706|Interleukin-2|interleukin-2|mesh-list
43732848|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
43732849|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
43732850|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43732851|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
43732852|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
43732853|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43732854|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
43732855|NCT02547792|Vaccines|vaccines|mesh-list
43542601|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43542602|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
43542603|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
43542604|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
43542606|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43849807|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43849808|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542607|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542609|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542610|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
43542626|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542627|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
43542628|NCT03701321|Hormones|hormones|mesh-ancestor
43542629|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542630|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43542631|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542632|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
43542633|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542634|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542635|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
43542637|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
43542638|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
43542639|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
43542640|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542641|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542642|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
43542643|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43732856|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
43732857|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43732859|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
43732860|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43732861|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43732862|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732863|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
43732865|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
43542644|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
43542645|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542646|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542648|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542649|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
43542650|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542651|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542652|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
43542653|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542654|NCT03701087|Vitamin D|vitamin d|mesh-list
43542655|NCT03701087|Vitamins|vitamins|mesh-ancestor
43542656|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
43542657|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542658|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
43542659|NCT03701022|Apatinib|apatinib|mesh-list
43542660|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542661|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43542662|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542663|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542664|NCT03700905|Nivolumab|nivolumab|mesh-list
43542665|NCT03700905|Ipilimumab|ipilimumab|mesh-list
43542666|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542667|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542668|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
43542669|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542670|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
43542671|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
43542697|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542698|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
43542700|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
43542701|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
43542702|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
43542703|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
43542704|NCT03700749|Povidone|povidone|mesh-list
43542705|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
43542706|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43849809|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542708|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
43542709|NCT03700749|Trace Elements|trace elements|mesh-ancestor
43542710|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
43542711|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542712|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
43542713|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
43542714|NCT03700645|Allopurinol|allopurinol|mesh-list
43542715|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
43542716|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542717|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542718|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
43542719|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542720|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
43542721|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
43542722|NCT03700645|Protective Agents|protective agents|mesh-ancestor
43542723|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542724|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
43542725|NCT03700515|Hematinics|hematinics|mesh-ancestor
43542726|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
43542727|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
43542728|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
43732946|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43732947|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
43542729|NCT03700489|Protective Agents|protective agents|mesh-ancestor
43542730|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542731|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
43542732|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
43542733|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
43542734|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
43542735|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
43542736|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542737|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542738|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
43542739|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
43542740|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542741|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542748|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542755|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
43542756|NCT03700229|Rituximab|rituximab|mesh-list
43542757|NCT03700229|Bortezomib|bortezomib|mesh-list
43542758|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542759|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542760|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
43542761|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542762|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
43542763|NCT03700177|Dexamethasone|dexamethasone|mesh-list
43542764|NCT03700177|Ropivacaine|ropivacaine|mesh-list
43542765|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
43542766|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
43542767|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
43542768|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542769|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542770|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
43542771|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
43542772|NCT03700177|Hormones|hormones|mesh-ancestor
43542773|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
43542774|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
43542775|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542776|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
43542777|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
43542778|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542779|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
43542780|NCT03699904|Valacyclovir|valacyclovir|mesh-list
43542781|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
43542782|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
43542783|NCT03699839|Vaccines|vaccines|mesh-list
43542784|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
43542785|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542786|NCT03699774|Firuglipel|firuglipel|mesh-list
43542787|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
43542788|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
43542789|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
43542790|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
43542791|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542792|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
43542798|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
43542799|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
43542800|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542801|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
43732961|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542802|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
43542803|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
43542804|NCT03699449|Paclitaxel|paclitaxel|mesh-list
43542805|NCT03699449|Durvalumab|durvalumab|mesh-list
43542806|NCT03699449|Olaparib|olaparib|mesh-list
43542807|NCT03699449|Tremelimumab|tremelimumab|mesh-list
43542808|NCT03699449|Cediranib|cediranib|mesh-list
43542809|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
43542810|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
43542811|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542812|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
43542816|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542817|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
43542818|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542819|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
43542820|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542821|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
43542822|NCT03699423|Atropine|atropine|mesh-list
43542823|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
43542824|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
43542825|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
43542826|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
43542827|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
43542828|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
43542829|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542830|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542831|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
43542832|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
43542833|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
43542834|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
43542835|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
43542836|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
43542838|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
43542839|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542840|NCT03699384|Azacitidine|azacitidine|mesh-list
43542841|NCT03699384|Avelumab|avelumab|mesh-list
43542842|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
43542843|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
43542844|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
43542845|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
43542846|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
43542847|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
43542853|NCT03699293|Naproxen|naproxen|mesh-list
43542854|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
43542855|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
43542856|NCT03699293|Analgesics|analgesics|mesh-ancestor
43542857|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
43542858|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
43542859|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
43542860|NCT03699293|Anti-Infl